id|nct_id|mesh_term|downcase_mesh_term|mesh_type
83549597|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
83550267|NCT04341727|Azithromycin|azithromycin|mesh-list
83550593|NCT02976896|Apatinib|apatinib|mesh-list
83550648|NCT02240628|Lidocaine|lidocaine|mesh-list
83550799|NCT02597101|Metformin|metformin|mesh-list
83551828|NCT05441761|Hormones|hormones|mesh-ancestor
83552378|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552603|NCT00369811|Fentanyl|fentanyl|mesh-list
83552830|NCT00059930|Vitamins|vitamins|mesh-ancestor
83552977|NCT05438810|Goserelin|goserelin|mesh-list
83553122|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
83553201|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553350|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553719|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
83553796|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
83554392|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83554916|NCT02783443|Anesthetics|anesthetics|mesh-list
83554994|NCT02785159|Tazarotene|tazarotene|mesh-list
83555839|NCT05748587|Iron|iron|mesh-list
83556129|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556506|NCT04414761|Cetrorelix|cetrorelix|mesh-list
83556659|NCT03901001|Sirolimus|sirolimus|mesh-list
83556825|NCT03456076|Pemetrexed|pemetrexed|mesh-list
83557037|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83557115|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
83557186|NCT03053401|Anesthetics|anesthetics|mesh-list
83557332|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
83557636|NCT03123848|Darunavir|darunavir|mesh-list
83557708|NCT03088345|Vasopressins|vasopressins|mesh-list
83557863|NCT03093272|Prednisone|prednisone|mesh-list
83558093|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
83558231|NCT05324384|Sirolimus|sirolimus|mesh-list
83558607|NCT05406674|Cisplatin|cisplatin|mesh-list
83558748|NCT02076217|Copper|copper|mesh-list
83558911|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
83559014|NCT03424681|Modafinil|modafinil|mesh-list
83559102|NCT04332536|Codeine|codeine|mesh-list
83559133|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83559294|NCT03355820|Antibodies|antibodies|mesh-list
83559586|NCT03525548|Elexacaftor|elexacaftor|mesh-list
83559676|NCT04501640|Mirabegron|mirabegron|mesh-list
83559815|NCT04352660|Mitomycins|mitomycins|mesh-list
83560127|NCT00422864|Leucovorin|leucovorin|mesh-list
83560277|NCT03831854|Lamotrigine|lamotrigine|mesh-list
83560407|NCT03799484|Petrolatum|petrolatum|mesh-list
83560484|NCT03771560|Leucovorin|leucovorin|mesh-list
83560559|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
83560758|NCT03723980|Propolis|propolis|mesh-list
83561217|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
83561291|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
83561516|NCT00634322|Antidotes|antidotes|mesh-ancestor
83561899|NCT00521924|Amebicides|amebicides|mesh-ancestor
83562123|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562271|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
83562411|NCT00000896|Indinavir|indinavir|mesh-list
83562492|NCT00000914|Ritonavir|ritonavir|mesh-list
83562715|NCT00000254|Isoflurane|isoflurane|mesh-list
83562791|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
83563087|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563689|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563838|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564060|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83564661|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
83564741|NCT00002498|Analgesics|analgesics|mesh-ancestor
83565145|NCT00002618|Cobalt|cobalt|mesh-list
83565192|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
83565491|NCT00002738|Leucovorin|leucovorin|mesh-list
83565952|NCT01583647|Vitamins|vitamins|mesh-ancestor
83566030|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
83566204|NCT05387941|Hormones|hormones|mesh-ancestor
83566745|NCT04330664|Adagrasib|adagrasib|mesh-list
83566784|NCT00000277|Mazindol|mazindol|mesh-list
83567085|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567536|NCT00000991|Pentamidine|pentamidine|mesh-list
83567926|NCT00002347|Zidovudine|zidovudine|mesh-list
83568675|NCT00003068|Thiotepa|thiotepa|mesh-list
83568897|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568971|NCT00002239|Ritonavir|ritonavir|mesh-list
83569203|NCT00002551|Leucovorin|leucovorin|mesh-list
83027762|NCT04899193|Hormones|hormones|mesh-ancestor
83569873|NCT00003446|Antidotes|antidotes|mesh-ancestor
83569947|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570025|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028427|NCT03902509|Analgesics|analgesics|mesh-ancestor
83570331|NCT00003554|Prednisone|prednisone|mesh-list
83570406|NCT00003572|Tacrolimus|tacrolimus|mesh-list
83570557|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83571040|NCT00004160|Paclitaxel|paclitaxel|mesh-list
83571171|NCT00002785|Vitamins|vitamins|mesh-ancestor
83571244|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571310|NCT00004862|Cytarabine|cytarabine|mesh-list
83571765|NCT00384878|Leucovorin|leucovorin|mesh-list
83571847|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83572683|NCT04456699|Leucovorin|leucovorin|mesh-list
83572825|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
83573956|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
83574265|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
83574496|NCT00003127|Paclitaxel|paclitaxel|mesh-list
83575110|NCT00003223|Retinamide|retinamide|mesh-list
83575255|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575937|NCT00004489|Alendronate|alendronate|mesh-list
83576021|NCT00005113|Sirolimus|sirolimus|mesh-list
83576166|NCT00004699|Mitogens|mitogens|mesh-list
83576317|NCT00005797|Busulfan|busulfan|mesh-list
83576688|NCT02138916|Benralizumab|benralizumab|mesh-list
83576764|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
83577082|NCT02044302|Morphine|morphine|mesh-list
83577367|NCT02036502|Hormones|hormones|mesh-ancestor
83577583|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83577817|NCT01945242|Alogliptin|alogliptin|mesh-list
83577982|NCT01939002|Naproxen|naproxen|mesh-list
83578252|NCT01929876|Itraconazole|itraconazole|mesh-list
83578848|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
83578922|NCT01978535|Trace Elements|trace elements|mesh-ancestor
83579070|NCT00673595|Varenicline|varenicline|mesh-list
83579146|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
83579302|NCT00000737|Hormones|hormones|mesh-ancestor
83579374|NCT00428207|Insulin|insulin|mesh-list
83579453|NCT00281879|Cytarabine|cytarabine|mesh-list
83579528|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
83579757|NCT00000215|Pergolide|pergolide|mesh-list
83579982|NCT00001067|Stavudine|stavudine|mesh-list
83580068|NCT00000311|Methadone|methadone|mesh-list
83580912|NCT00002141|Abacavir|abacavir|mesh-list
83581346|NCT00002183|Lamivudine|lamivudine|mesh-list
83581571|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
83582177|NCT05522465|Dexamethasone|dexamethasone|mesh-list
83582555|NCT00002921|Suramin|suramin|mesh-list
83582652|NCT03058289|Ipilimumab|ipilimumab|mesh-list
83582778|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
83583235|NCT00002831|Methotrexate|methotrexate|mesh-list
83583996|NCT00003287|Calcium|calcium|mesh-list
83584149|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584388|NCT00004913|Vitamins|vitamins|mesh-ancestor
83584527|NCT00005039|Vaccines|vaccines|mesh-list
83584891|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
83585188|NCT05892913|Adrenergic Agents|adrenergic agents|mesh-ancestor
83585274|NCT05829655|Suvorexant|suvorexant|mesh-list
83586087|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586173|NCT04519151|Lenvatinib|lenvatinib|mesh-list
83586237|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
83586321|NCT04241185|Gemcitabine|gemcitabine|mesh-list
83586795|NCT02246920|Xhance|xhance|mesh-list
83586839|NCT01473628|Rituximab|rituximab|mesh-list
83587434|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83587706|NCT04414800|Fentanyl|fentanyl|mesh-list
83587801|NCT01856790|Hormones|hormones|mesh-ancestor
83588000|NCT01832766|Dronabinol|dronabinol|mesh-list
83588188|NCT01826370|Incretins|incretins|mesh-ancestor
83588261|NCT01797432|Hormones|hormones|mesh-ancestor
83588389|NCT01817790|Xhance|xhance|mesh-list
83588645|NCT01769508|Lapatinib|lapatinib|mesh-list
83588795|NCT01766310|Folic Acid|folic acid|mesh-list
83589443|NCT01721070|Dsuvia|dsuvia|mesh-list
83589822|NCT01686828|Letrozole|letrozole|mesh-list
83590168|NCT01582152|Bevacizumab|bevacizumab|mesh-list
83590246|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
83590332|NCT01529346|Ibuprofen|ibuprofen|mesh-list
83590433|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
83590651|NCT01519674|Hormones|hormones|mesh-ancestor
83590801|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
83590876|NCT01459614|Gemcitabine|gemcitabine|mesh-list
83590956|NCT01500720|Topotecan|topotecan|mesh-list
83591327|NCT01470612|Tofacitinib|tofacitinib|mesh-list
83591481|NCT03026478|Clobetasol|clobetasol|mesh-list
83591556|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
83591711|NCT04044222|Etoposide|etoposide|mesh-list
83591930|NCT01422876|Incretins|incretins|mesh-ancestor
83592078|NCT01383486|Analgesics|analgesics|mesh-ancestor
83592393|NCT04009668|Adalimumab|adalimumab|mesh-list
83592688|NCT03591900|Insulin|insulin|mesh-list
83592762|NCT04196400|Betamethasone|betamethasone|mesh-list
83593285|NCT05583474|Carteolol|carteolol|mesh-list
83593359|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83593512|NCT03941496|Azacitidine|azacitidine|mesh-list
83594256|NCT03865992|Curcumin|curcumin|mesh-list
83594331|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
83594658|NCT03817320|Vitamins|vitamins|mesh-ancestor
83594797|NCT03522168|Risperidone|risperidone|mesh-list
83595015|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595163|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
83595541|NCT03083184|Ethanol|ethanol|mesh-list
83595688|NCT03292926|Dexamethasone|dexamethasone|mesh-list
83596229|NCT04276428|Insulin|insulin|mesh-list
83596905|NCT01926288|Entecavir|entecavir|mesh-list
83597736|NCT01454622|Metformin|metformin|mesh-list
83598025|NCT02859402|Fludarabine|fludarabine|mesh-list
83598246|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83598397|NCT04390854|Clotrimazole|clotrimazole|mesh-list
83598646|NCT05585580|Paclitaxel|paclitaxel|mesh-list
83598708|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
83599126|NCT01851642|Albuterol|albuterol|mesh-list
83599158|NCT01212822|Leucovorin|leucovorin|mesh-list
83599307|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599609|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
83058294|NCT03690583|Zinc|zinc|mesh-list
83600660|NCT00118404|Fluoxetine|fluoxetine|mesh-list
83601187|NCT00338598|Glycine|glycine|mesh-list
83601505|NCT03983226|Taxane|taxane|mesh-list
83601570|NCT00305760|Cetuximab|cetuximab|mesh-list
83602237|NCT00413166|Idarubicin|idarubicin|mesh-list
83602312|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603290|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
83603444|NCT04388124|Bosentan|bosentan|mesh-list
83603676|NCT02783430|Ketamine|ketamine|mesh-list
83604042|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
83604128|NCT01115803|Everolimus|everolimus|mesh-list
83604502|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83604574|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
83604650|NCT05091346|Lenvatinib|lenvatinib|mesh-list
83604803|NCT04821856|Cannabidiol|cannabidiol|mesh-list
83605028|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
83605703|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606158|NCT04354662|Vitamins|vitamins|mesh-ancestor
83606615|NCT04330872|Aspirin|aspirin|mesh-list
83606924|NCT03016806|Mesna|mesna|mesh-list
83607365|NCT02975076|Aspirin|aspirin|mesh-list
83607512|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
83608712|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83608861|NCT00759642|Lapatinib|lapatinib|mesh-list
83608937|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83609254|NCT00803010|Sirolimus|sirolimus|mesh-list
83609389|NCT00820872|Carboplatin|carboplatin|mesh-list
83609461|NCT02682888|Oxytocin|oxytocin|mesh-list
83609534|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83609683|NCT00845130|Vitamins|vitamins|mesh-list
83610063|NCT00911586|Testosterone|testosterone|mesh-list
83610664|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
83610889|NCT02406222|Hormones|hormones|mesh-ancestor
83611323|NCT05820685|Hormones|hormones|mesh-ancestor
83611765|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83611842|NCT04704141|Hormones|hormones|mesh-list
83611987|NCT04249037|Emtricitabine|emtricitabine|mesh-list
83612438|NCT01084278|Colchicine|colchicine|mesh-list
83612736|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83612897|NCT01135368|Lansoprazole|lansoprazole|mesh-list
83613025|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
83613247|NCT01206660|Desoximetasone|desoximetasone|mesh-list
83613324|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
83613398|NCT01225068|Analgesics|analgesics|mesh-ancestor
83613474|NCT01238640|Nicotine|nicotine|mesh-list
83613616|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
83614067|NCT01331694|Hormones|hormones|mesh-ancestor
83614215|NCT01363050|Ketorolac|ketorolac|mesh-list
83614674|NCT01468584|Ribavirin|ribavirin|mesh-list
83614737|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83614822|NCT01513122|Ritonavir|ritonavir|mesh-list
83615286|NCT05672394|Lidocaine|lidocaine|mesh-list
83615444|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
83615974|NCT01707420|Gabapentin|gabapentin|mesh-list
83616191|NCT01722318|Plecanatide|plecanatide|mesh-list
83616493|NCT01753362|Liraglutide|liraglutide|mesh-list
83617095|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
83617396|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617472|NCT01881828|Metformin|metformin|mesh-list
83617767|NCT01958112|Trametinib|trametinib|mesh-list
83617987|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
83618586|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619109|NCT02244918|Nicotine|nicotine|mesh-list
83620007|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
83620601|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620756|NCT02420652|Aspirin|aspirin|mesh-list
83620822|NCT02025036|Capecitabine|capecitabine|mesh-list
83620974|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621051|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621206|NCT02508636|Leuprolide|leuprolide|mesh-list
83621876|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
83622038|NCT05510856|Lacosamide|lacosamide|mesh-list
83622100|NCT04511052|Carotenoids|carotenoids|mesh-list
83622400|NCT02704104|Hemostatics|hemostatics|mesh-list
83361874|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
83622552|NCT05439564|Narcotics|narcotics|mesh-ancestor
83622914|NCT04104438|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83622995|NCT05444478|Lenvatinib|lenvatinib|mesh-list
83623741|NCT02933034|Manganese|manganese|mesh-list
83624038|NCT03070470|Dofetilide|dofetilide|mesh-list
83625091|NCT02974686|Everolimus|everolimus|mesh-list
83625764|NCT04043520|Estradiol|estradiol|mesh-list
83626290|NCT00000510|Aspirin|aspirin|mesh-list
83626365|NCT00000702|Zidovudine|zidovudine|mesh-list
83626513|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83626595|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
83626668|NCT00000996|Doxorubicin|doxorubicin|mesh-list
83627266|NCT00002214|Capravirine|capravirine|mesh-list
83627646|NCT00002448|Efavirenz|efavirenz|mesh-list
83627798|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
83627959|NCT00002598|Cytarabine|cytarabine|mesh-list
83628031|NCT00002616|Thiotepa|thiotepa|mesh-list
83628834|NCT03459222|Nivolumab|nivolumab|mesh-list
83629139|NCT00002970|Cytarabine|cytarabine|mesh-list
83629291|NCT00003072|Paclitaxel|paclitaxel|mesh-list
83629443|NCT00003018|Leucovorin|leucovorin|mesh-list
83629681|NCT00003402|Dexamethasone|dexamethasone|mesh-list
83629752|NCT00003462|Busulfan|busulfan|mesh-list
83629907|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
83630353|NCT00004032|Interferons|interferons|mesh-list
83630753|NCT00004344|Leuprolide|leuprolide|mesh-list
83630884|NCT00004482|Protective Agents|protective agents|mesh-ancestor
83631498|NCT00355524|Ritonavir|ritonavir|mesh-list
83631648|NCT00357318|Bevacizumab|bevacizumab|mesh-list
83632029|NCT00366834|Casopitant|casopitant|mesh-list
83632328|NCT00373464|Etoricoxib|etoricoxib|mesh-list
83632761|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
83632835|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
83632924|NCT02998242|Apatinib|apatinib|mesh-list
83633135|NCT01270932|BB 1101|bb 1101|mesh-list
83634409|NCT01726530|Fentanyl|fentanyl|mesh-list
83634489|NCT01729806|Rituximab|rituximab|mesh-list
83634560|NCT01048788|Tolvaptan|tolvaptan|mesh-list
83634628|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
83634940|NCT02244294|Tamsulosin|tamsulosin|mesh-list
83635307|NCT00556920|Carvedilol|carvedilol|mesh-list
83635444|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
83635898|NCT05419427|Denosumab|denosumab|mesh-list
82790449|NCT03453840|Lumefantrine|lumefantrine|mesh-list
83636578|NCT03769181|Cemiplimab|cemiplimab|mesh-list
83636655|NCT03426904|Antidotes|antidotes|mesh-ancestor
83637548|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83637602|NCT01387399|Cisplatin|cisplatin|mesh-list
83637959|NCT01389544|Narcotics|narcotics|mesh-ancestor
83638319|NCT01391715|Rabeprazole|rabeprazole|mesh-list
83638979|NCT01395420|Ceftazidime|ceftazidime|mesh-list
83639107|NCT01395875|Xhance|xhance|mesh-list
83639126|NCT01395927|Canagliflozin|canagliflozin|mesh-list
83639265|NCT01397019|Leucovorin|leucovorin|mesh-list
83639415|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83639553|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640011|NCT05064137|Listerine|listerine|mesh-list
83640235|NCT04399746|Vitamins|vitamins|mesh-ancestor
83640390|NCT03858621|Analgesics|analgesics|mesh-ancestor
83640765|NCT02889900|Olaparib|olaparib|mesh-list
83640847|NCT02711826|Analgesics|analgesics|mesh-ancestor
83641226|NCT01334606|Insulin|insulin|mesh-list
83641305|NCT00447122|Gemcitabine|gemcitabine|mesh-list
83641740|NCT01400568|Xhance|xhance|mesh-list
83641899|NCT01401387|Pancreatin|pancreatin|mesh-list
83641974|NCT01402089|Sunitinib|sunitinib|mesh-list
83642434|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
83642578|NCT01405079|Gefitinib|gefitinib|mesh-list
83642793|NCT01406080|Adapalene|adapalene|mesh-list
83642871|NCT01406327|Ambrisentan|ambrisentan|mesh-list
83643025|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
83643179|NCT01408836|Hormones|hormones|mesh-ancestor
83643254|NCT01409148|Antibodies|antibodies|mesh-list
83643324|NCT01409408|Amlodipine|amlodipine|mesh-list
83643518|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
83643691|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83643770|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83643917|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
83643983|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83644177|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83644242|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83644454|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644848|NCT01420406|Vitamin A|vitamin a|mesh-list
83645037|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83645113|NCT01422096|Leuprolide|leuprolide|mesh-list
83645538|NCT01424332|Aspirin|aspirin|mesh-list
83645895|NCT05386186|Hormones|hormones|mesh-ancestor
83645968|NCT05385094|Cystatins|cystatins|mesh-list
83646050|NCT04850378|Dalteparin|dalteparin|mesh-list
83646232|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83646294|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
83646343|NCT02547662|Ixazomib|ixazomib|mesh-list
83646556|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
83646631|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
83646703|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646781|NCT01427985|Atropine|atropine|mesh-list
83647018|NCT01429415|Analgesics|analgesics|mesh-ancestor
83647172|NCT01430065|Tacrolimus|tacrolimus|mesh-list
83647618|NCT01432470|Oxytocin|oxytocin|mesh-list
83648213|NCT01436422|Vaccines|vaccines|mesh-list
83648358|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83648960|NCT03671746|Ketorolac|ketorolac|mesh-list
83649496|NCT01440361|Belimumab|belimumab|mesh-list
83649933|NCT01442818|Hydromorphone|hydromorphone|mesh-list
83650057|NCT01443195|Iron|iron|mesh-list
83650620|NCT01446497|Timolol|timolol|mesh-list
83650843|NCT01448239|Antimetabolites|antimetabolites|mesh-ancestor
83650992|NCT01448772|Hormones|hormones|mesh-ancestor
83651371|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
83651674|NCT01462669|Ezogabine|ezogabine|mesh-list
83651761|NCT01463592|Iodine|iodine|mesh-list
83651905|NCT01464476|Azimilide|azimilide|mesh-list
83652126|NCT01467648|Doripenem|doripenem|mesh-list
83652347|NCT01469169|Iloprost|iloprost|mesh-list
83653101|NCT01474265|Varenicline|varenicline|mesh-list
83653551|NCT01477294|Caffeine|caffeine|mesh-list
83654074|NCT01480336|Amiodarone|amiodarone|mesh-list
83654372|NCT01482052|Vaccines|vaccines|mesh-list
83654446|NCT01482416|Estrogens|estrogens|mesh-list
83654593|NCT01484015|Cefepime|cefepime|mesh-list
83655199|NCT01487421|Insulin|insulin|mesh-list
83655649|NCT01489943|Midazolam|midazolam|mesh-list
83656252|NCT01493570|BI 409306|bi 409306|mesh-list
83656625|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
83656701|NCT01496105|Lidocaine|lidocaine|mesh-list
83656922|NCT01497470|Paclitaxel|paclitaxel|mesh-list
83656999|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657145|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83657296|NCT01499771|Atorvastatin|atorvastatin|mesh-list
83657384|NCT01500473|Hormones|hormones|mesh-ancestor
83657465|NCT01500850|Insulin|insulin|mesh-list
83657603|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
82812751|NCT00286234|Niacin|niacin|mesh-list
83658122|NCT01503450|Olanzapine|olanzapine|mesh-list
83658205|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
83658440|NCT01504776|Bortezomib|bortezomib|mesh-list
83658647|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83658872|NCT01506752|Donepezil|donepezil|mesh-list
83659098|NCT01507597|Glucagon|glucagon|mesh-list
83659171|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
83659398|NCT01509001|Metformin|metformin|mesh-list
83659472|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83659634|NCT01510613|Hormones|hormones|mesh-ancestor
83659775|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83659996|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83660097|NCT01512537|Vitamin D|vitamin d|mesh-list
83660143|NCT01512953|Lansoprazole|lansoprazole|mesh-list
82815253|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83660594|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660665|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83660740|NCT01514903|Urological Agents|urological agents|mesh-ancestor
83660835|NCT01516710|Liver Extracts|liver extracts|mesh-list
83661567|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
83661864|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
83662017|NCT01523314|Hormones|hormones|mesh-ancestor
83662107|NCT01523639|Metformin|metformin|mesh-list
83662172|NCT01524094|Leucovorin|leucovorin|mesh-list
83662502|NCT01526161|Xhance|xhance|mesh-list
83663066|NCT01528865|Tenofovir|tenofovir|mesh-list
83663145|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
83663438|NCT01530503|Mitomycin|mitomycin|mesh-list
83663896|NCT01533272|Maraviroc|maraviroc|mesh-list
83664125|NCT01534585|Paclitaxel|paclitaxel|mesh-list
83664884|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664972|NCT01539174|Hormones|hormones|mesh-ancestor
83665550|NCT01542424|Insulin|insulin|mesh-list
83665921|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665995|NCT01544972|Acetaminophen|acetaminophen|mesh-list
83666075|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
83666295|NCT01547416|Fentanyl|fentanyl|mesh-list
83666675|NCT01549743|Celecoxib|celecoxib|mesh-list
83666817|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
83667037|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
83667192|NCT01553721|Udenafil|udenafil|mesh-list
83667517|NCT01556191|Gefitinib|gefitinib|mesh-list
83667642|NCT05847049|Nepafenac|nepafenac|mesh-list
83667728|NCT05840536|Furosemide|furosemide|mesh-list
83668241|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83668465|NCT04895592|Ichthammol|ichthammol|mesh-list
83668989|NCT04014075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669216|NCT03625986|Nicotine|nicotine|mesh-list
83669755|NCT02360280|Midazolam|midazolam|mesh-list
83670121|NCT01557270|Analgesics|analgesics|mesh-ancestor
83670487|NCT01559727|Hormones|hormones|mesh-ancestor
83670635|NCT05491304|Etoposide|etoposide|mesh-list
83671230|NCT01566890|Regadenoson|regadenoson|mesh-list
83671370|NCT01570582|Gemcitabine|gemcitabine|mesh-list
83671537|NCT01571570|Simeprevir|simeprevir|mesh-list
83671593|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
83671745|NCT01572350|Bevacizumab|bevacizumab|mesh-list
83671895|NCT01573286|Glucagon|glucagon|mesh-list
83672115|NCT01575418|Protective Agents|protective agents|mesh-ancestor
83672190|NCT01576029|Docetaxel|docetaxel|mesh-list
83672267|NCT01576692|Aldesleukin|aldesleukin|mesh-list
83672629|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672704|NCT01579019|Ritonavir|ritonavir|mesh-list
83672777|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673454|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
83673830|NCT01594229|Rituximab|rituximab|mesh-list
83674279|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83674817|NCT01598948|Mipomersen|mipomersen|mesh-list
83674888|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83675204|NCT05106192|Bexarotene|bexarotene|mesh-list
83675338|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
83675851|NCT05274243|Phenol|phenol|mesh-list
83676102|NCT03736863|Apatinib|apatinib|mesh-list
83676147|NCT03499899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676604|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
83676815|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
83677191|NCT01611909|Terpin|terpin|mesh-list
83677360|NCT01612975|Naproxen|naproxen|mesh-list
83677789|NCT01615081|Insulin|insulin|mesh-list
83678095|NCT01617135|Levodopa|levodopa|mesh-list
83678375|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
83678896|NCT01621386|Hormones|hormones|mesh-ancestor
83678967|NCT01621750|Clopidogrel|clopidogrel|mesh-list
83679189|NCT01623375|Insulin|insulin|mesh-list
83679411|NCT01624766|Denosumab|denosumab|mesh-list
83679487|NCT01625520|Hormones|hormones|mesh-ancestor
83679633|NCT01627041|Cytarabine|cytarabine|mesh-list
83679855|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
83680005|NCT01629212|Tiropramide|tiropramide|mesh-list
83680157|NCT01630083|Capecitabine|capecitabine|mesh-list
83680384|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
83680455|NCT01631838|Vitamin E|vitamin e|mesh-list
83680681|NCT01633970|Vitamins|vitamins|mesh-ancestor
83681214|NCT01636700|Tramadol|tramadol|mesh-list
83681505|NCT01637818|Acetaminophen|acetaminophen|mesh-list
83682271|NCT01650870|Lactulose|lactulose|mesh-list
83682632|NCT01652547|Pasireotide|pasireotide|mesh-list
83682948|NCT01654497|HU 211|hu 211|mesh-list
83683006|NCT01654809|Vaccines|vaccines|mesh-list
83683080|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
83683521|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83683595|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
83683667|NCT01657851|Urological Agents|urological agents|mesh-ancestor
83683891|NCT01659086|Vaccines|vaccines|mesh-list
83684100|NCT01659944|Metoprolol|metoprolol|mesh-list
83684252|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684400|NCT01661751|Vaccines|vaccines|mesh-list
83684705|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83684931|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
83685081|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83685389|NCT01669044|Propofol|propofol|mesh-list
83685457|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
83685605|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83685908|NCT05596214|Curcumin|curcumin|mesh-list
83686057|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83686134|NCT04925960|Epalrestat|epalrestat|mesh-list
83686809|NCT05837091|Anesthetics|anesthetics|mesh-ancestor
83686958|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
83687115|NCT05233566|Ketamine|ketamine|mesh-list
83687287|NCT04335058|Iron|iron|mesh-list
83687353|NCT04075136|Hormones|hormones|mesh-ancestor
83687565|NCT02667418|Vancomycin|vancomycin|mesh-list
83687901|NCT01690338|Bromides|bromides|mesh-list
83688144|NCT01691495|PENTA|penta|mesh-list
83688169|NCT01691677|Beclomethasone|beclomethasone|mesh-list
82843328|NCT03864016|Dsuvia|dsuvia|mesh-list
83688473|NCT05288725|Hormones|hormones|mesh-ancestor
83689048|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
83689498|NCT04659382|Bevacizumab|bevacizumab|mesh-list
83689794|NCT04157881|Dabigatran|dabigatran|mesh-list
83689944|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
83690166|NCT05800847|Anticonvulsants|anticonvulsants|mesh-ancestor
83690239|NCT05797597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690384|NCT05566665|Meropenem|meropenem|mesh-list
83691316|NCT03785106|Vitamins|vitamins|mesh-list
83691344|NCT03782142|Tenofovir|tenofovir|mesh-list
83691495|NCT03651102|Growth Substances|growth substances|mesh-ancestor
83691565|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
83691712|NCT05438108|Growth Substances|growth substances|mesh-ancestor
83691786|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83692625|NCT01997463|Albuterol|albuterol|mesh-list
83692923|NCT00880893|Vaccines|vaccines|mesh-list
83693526|NCT01697826|Miconazole|miconazole|mesh-list
83693815|NCT01699919|Lidocaine|lidocaine|mesh-list
83694263|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
83694345|NCT01703234|Ramipril|ramipril|mesh-list
83695035|NCT01707537|Vaccines|vaccines|mesh-list
83695300|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
83695822|NCT01711970|Paclitaxel|paclitaxel|mesh-list
83695898|NCT01712464|Oxytocin|oxytocin|mesh-list
83695994|NCT01712893|Goserelin|goserelin|mesh-list
83696182|NCT01714037|Docetaxel|docetaxel|mesh-list
83696325|NCT01714427|Hormones|hormones|mesh-ancestor
83697067|NCT01718912|Nystatin|nystatin|mesh-list
83698051|NCT01734044|Hormones|hormones|mesh-ancestor
83698348|NCT01736150|Sevelamer|sevelamer|mesh-list
83698486|NCT01737177|Lenalidomide|lenalidomide|mesh-list
83698710|NCT01738724|Hormones|hormones|mesh-ancestor
83698781|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
83698865|NCT01739673|Riboflavin|riboflavin|mesh-list
83699158|NCT01742247|Palmidrol|palmidrol|mesh-list
83699383|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83699453|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
83699515|NCT01743690|Ionophores|ionophores|mesh-ancestor
83699662|NCT01744366|Goserelin|goserelin|mesh-list
83699734|NCT01744626|Rituximab|rituximab|mesh-list
83699805|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83700105|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
83701069|NCT01753375|Vitamin D|vitamin d|mesh-list
83701176|NCT01754701|Iron|iron|mesh-list
83701296|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
83701885|NCT01758185|Vaccines|vaccines|mesh-list
83701951|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702103|NCT01759706|Hormones|hormones|mesh-ancestor
83702180|NCT01759940|Ropivacaine|ropivacaine|mesh-list
83702331|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83702405|NCT01760694|Antidotes|antidotes|mesh-ancestor
83702478|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
83702554|NCT01761513|Esomeprazole|esomeprazole|mesh-list
83702791|NCT01762670|Metronidazole|metronidazole|mesh-list
83702871|NCT01762995|Calcium|calcium|mesh-list
83702930|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
83703074|NCT01763424|Calcitriol|calcitriol|mesh-list
83703150|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83703452|NCT01766414|Complement C1s|complement c1s|mesh-list
83703520|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83703593|NCT01767532|Cephalexin|cephalexin|mesh-list
83703823|NCT01768507|Resveratrol|resveratrol|mesh-list
83703957|NCT01769183|Squalamine|squalamine|mesh-list
83704025|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83704190|NCT01770210|Atorvastatin|atorvastatin|mesh-list
83704252|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83704391|NCT01771822|Ibuprofen|ibuprofen|mesh-list
83704826|NCT01775397|Vancomycin|vancomycin|mesh-list
83705102|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83705180|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
83705557|NCT01781052|Iloprost|iloprost|mesh-list
83705786|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
83706232|NCT01785979|Hormones|hormones|mesh-ancestor
83706390|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
83706606|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83706738|NCT01789437|Hormones|hormones|mesh-ancestor
83706965|NCT01796132|Analgesics|analgesics|mesh-ancestor
83707110|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
83707182|NCT01800487|Protective Agents|protective agents|mesh-ancestor
83707328|NCT01801774|Hormones|hormones|mesh-ancestor
83707615|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
83707697|NCT01804712|Rituximab|rituximab|mesh-list
83707843|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
83708066|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708441|NCT01812928|Analgesics|analgesics|mesh-ancestor
83708950|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
83709174|NCT01817257|Enoxaparin|enoxaparin|mesh-list
83709249|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709323|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
83709405|NCT01818908|Hormones|hormones|mesh-ancestor
83709465|NCT01819285|Hormones|hormones|mesh-ancestor
83709601|NCT01820312|Paclitaxel|paclitaxel|mesh-list
83709673|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
83710618|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
83710682|NCT01827878|Lisinopril|lisinopril|mesh-list
83710758|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
83711114|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83711887|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
83711963|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83712095|NCT01845701|Artemether|artemether|mesh-list
83712916|NCT01851941|Leucovorin|leucovorin|mesh-list
83713001|NCT01852461|Beractant|beractant|mesh-list
83713361|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713445|NCT01855581|Ketamine|ketamine|mesh-list
83713608|NCT01856517|Clonidine|clonidine|mesh-list
83713664|NCT01856959|Analgesics|analgesics|mesh-ancestor
83714055|NCT01858311|Vitamin E|vitamin e|mesh-list
83714111|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83714188|NCT01858909|Melatonin|melatonin|mesh-list
83714409|NCT01860625|Donepezil|donepezil|mesh-list
83714708|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
83715069|NCT01865175|Iron|iron|mesh-list
83715120|NCT01865331|Insulin|insulin|mesh-list
83715202|NCT01866241|Misoprostol|misoprostol|mesh-list
83715341|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
83715495|NCT01868581|Insulin|insulin|mesh-list
83715681|NCT01870011|Propofol|propofol|mesh-list
83715791|NCT01870284|Adalimumab|adalimumab|mesh-list
83716158|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83717501|NCT04062656|Docetaxel|docetaxel|mesh-list
83717786|NCT03317158|Docetaxel|docetaxel|mesh-list
83718096|NCT01873157|Bortezomib|bortezomib|mesh-list
83718311|NCT01874639|Coagulants|coagulants|mesh-ancestor
83718387|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718679|NCT01877746|Prednisone|prednisone|mesh-list
83718981|NCT01880125|Narcotics|narcotics|mesh-ancestor
83719057|NCT01880463|Vitamin D|vitamin d|mesh-list
83719287|NCT01883167|Febuxostat|febuxostat|mesh-list
83720174|NCT01888354|Hormones|hormones|mesh-ancestor
83720245|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83721281|NCT01903070|Linagliptin|linagliptin|mesh-list
83721417|NCT01904162|Finafloxacin|finafloxacin|mesh-list
83721641|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721954|NCT01907776|Arbekacin|arbekacin|mesh-list
83722342|NCT01910415|Ivacaftor|ivacaftor|mesh-list
83722468|NCT01911195|Isoflurane|isoflurane|mesh-list
83722629|NCT01911975|Lacosamide|lacosamide|mesh-list
83722695|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
83723288|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83723507|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83723632|NCT01918150|Cobalt|cobalt|mesh-list
83723959|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
83724261|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83724412|NCT01931683|Remifentanil|remifentanil|mesh-list
83724485|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725006|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725080|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83725161|NCT01936090|Bortezomib|bortezomib|mesh-list
83725228|NCT01936350|Urological Agents|urological agents|mesh-ancestor
83725304|NCT01937104|Analgesics|analgesics|mesh-ancestor
83725902|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726267|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
83726349|NCT01943136|Mupirocin|mupirocin|mesh-list
83726485|NCT01944085|Vitamins|vitamins|mesh-ancestor
83726699|NCT01945801|Diuretics|diuretics|mesh-ancestor
83727135|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
83727359|NCT04609098|Piperaquine|piperaquine|mesh-list
83727877|NCT05005455|Bevacizumab|bevacizumab|mesh-list
83728021|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
83728166|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
83728340|NCT01946607|Citalopram|citalopram|mesh-list
83728594|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83728820|NCT01949818|Prednisone|prednisone|mesh-list
83729610|NCT05864144|Cemiplimab|cemiplimab|mesh-list
83730169|NCT04663347|Hormones|hormones|mesh-ancestor
83730309|NCT04201964|Tenecteplase|tenecteplase|mesh-list
83731073|NCT01953172|Vitamins|vitamins|mesh-ancestor
83731216|NCT01953848|Tamsulosin|tamsulosin|mesh-list
83731312|NCT01954186|Oxytocin|oxytocin|mesh-list
83731513|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83731595|NCT01955824|Lidocaine|lidocaine|mesh-list
83731910|NCT01958684|Copper|copper|mesh-list
83732028|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732325|NCT01961752|Hormones|hormones|mesh-ancestor
83732550|NCT01963832|Fluoxetine|fluoxetine|mesh-list
83732695|NCT01964391|Docetaxel|docetaxel|mesh-list
83732770|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
83732918|NCT01965626|Oseltamivir|oseltamivir|mesh-list
83733283|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
83734085|NCT01973751|Budesonide|budesonide|mesh-list
83734305|NCT01975259|Glucagon|glucagon|mesh-list
83735134|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
83735204|NCT01982799|Analgesics|analgesics|mesh-ancestor
83735356|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
83735664|NCT01985789|Promethazine|promethazine|mesh-list
83735808|NCT01986465|Prednisolone|prednisolone|mesh-list
83736109|NCT01989000|Imidazole|imidazole|mesh-list
83736258|NCT01990079|Bupropion|bupropion|mesh-list
83736331|NCT01990755|Olanzapine|olanzapine|mesh-list
83736481|NCT01991327|Clomiphene|clomiphene|mesh-list
83736711|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
83736932|NCT01995019|Protective Agents|protective agents|mesh-ancestor
83737079|NCT01996150|Eusol|eusol|mesh-list
83737227|NCT01996735|Ticagrelor|ticagrelor|mesh-list
83737307|NCT01997294|Atorvastatin|atorvastatin|mesh-list
83737451|NCT01998295|Lumefantrine|lumefantrine|mesh-list
83737683|NCT02000193|Fulvestrant|fulvestrant|mesh-list
83737841|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
83737995|NCT02001948|Morphine|morphine|mesh-list
83738062|NCT02002195|Antidotes|antidotes|mesh-ancestor
83738880|NCT02008123|Primidone|primidone|mesh-list
83739025|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
83739391|NCT04975334|Hormones|hormones|mesh-ancestor
83739545|NCT04112641|Niacinamide|niacinamide|mesh-list
83739617|NCT03994731|Analgesics|analgesics|mesh-ancestor
83739849|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
83740069|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83740819|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83741044|NCT02015728|Etoposide|etoposide|mesh-list
83741871|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
83741940|NCT02021851|Dexamethasone|dexamethasone|mesh-list
83742088|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
83742305|NCT02023892|Atorvastatin|atorvastatin|mesh-list
83742522|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742814|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83742944|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
83743092|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
83743241|NCT02029534|Atorvastatin|atorvastatin|mesh-list
83743313|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83743692|NCT02040883|Aripiprazole|aripiprazole|mesh-list
83743944|NCT02043054|Hormones|hormones|mesh-ancestor
83744725|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
83744913|NCT00005940|Iodine|iodine|mesh-list
83745093|NCT00005979|Antidotes|antidotes|mesh-ancestor
83745548|NCT04803084|TEMPO|tempo|mesh-list
83745746|NCT02936505|Tacrolimus|tacrolimus|mesh-list
83745898|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
83746129|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
83746570|NCT00005863|Daunorubicin|daunorubicin|mesh-list
83746722|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
83747099|NCT00006022|Aldesleukin|aldesleukin|mesh-list
83747181|NCT00006040|Etoposide|etoposide|mesh-list
83747386|NCT05660200|Iron|iron|mesh-list
83747476|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83748129|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
83748272|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
83748572|NCT00006292|Infliximab|infliximab|mesh-list
83748707|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
83749078|NCT00008268|Melphalan|melphalan|mesh-list
83749744|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83749906|NCT00388882|Bromides|bromides|mesh-list
83749974|NCT00000514|Atenolol|atenolol|mesh-list
83750045|NCT00000553|Niacin|niacin|mesh-list
83750123|NCT00000568|Ipratropium|ipratropium|mesh-list
83750197|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
83750415|NCT00000793|Mexiletine|mexiletine|mesh-list
83751103|NCT00001333|Topotecan|topotecan|mesh-list
83751305|NCT00001741|Losartan|losartan|mesh-list
83751674|NCT03164980|Trabectedin|trabectedin|mesh-list
83751765|NCT00423475|Goserelin|goserelin|mesh-list
83751895|NCT04888858|Bupivacaine|bupivacaine|mesh-list
83751974|NCT00000588|Pyridoxal|pyridoxal|mesh-list
83752043|NCT04544683|BB 1101|bb 1101|mesh-list
83752192|NCT00000678|Zidovudine|zidovudine|mesh-list
83752271|NCT00000690|Dextrans|dextrans|mesh-list
82907950|NCT03941925|Levan|levan|mesh-list
83752946|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753172|NCT00005834|Thalidomide|thalidomide|mesh-list
83753324|NCT00005858|Immunotoxins|immunotoxins|mesh-list
83753403|NCT00001113|Zidovudine|zidovudine|mesh-list
83753622|NCT00009802|Paclitaxel|paclitaxel|mesh-list
82909128|NCT03925155|Iodine|iodine|mesh-list
83753919|NCT00011635|Silymarin|silymarin|mesh-list
83754670|NCT00016198|Leucovorin|leucovorin|mesh-list
83754817|NCT00016900|Paclitaxel|paclitaxel|mesh-list
83754890|NCT00006029|Gemcitabine|gemcitabine|mesh-list
83755199|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83755786|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756159|NCT03912818|Carboplatin|carboplatin|mesh-list
83756835|NCT04078568|Aspirin|aspirin|mesh-list
83757072|NCT03772964|Metformin|metformin|mesh-list
83757277|NCT00276718|Carboplatin|carboplatin|mesh-list
83757641|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
83757705|NCT02966665|Vitamins|vitamins|mesh-list
83757996|NCT00084604|Bevacizumab|bevacizumab|mesh-list
83758153|NCT00085345|Vitamins|vitamins|mesh-ancestor
83758234|NCT00006089|Antibodies|antibodies|mesh-list
83758298|NCT00086359|Ritonavir|ritonavir|mesh-list
83758834|NCT00423865|Everolimus|everolimus|mesh-list
83760530|NCT00400855|Xhance|xhance|mesh-list
83760877|NCT00103753|Deferiprone|deferiprone|mesh-list
83760956|NCT00388076|Paclitaxel|paclitaxel|mesh-list
83761769|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
83762069|NCT00007358|Dexamethasone|dexamethasone|mesh-list
83762239|NCT00112879|Mitogens|mitogens|mesh-list
83762293|NCT00007787|Cyclosporins|cyclosporins|mesh-list
83762443|NCT00113971|Epratuzumab|epratuzumab|mesh-list
83762521|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
83762675|NCT00115375|Clopidogrel|clopidogrel|mesh-list
83763200|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
83763585|NCT00121459|Psyllium|psyllium|mesh-list
83763648|NCT00121888|Paroxetine|paroxetine|mesh-list
83764247|NCT00019786|Melphalan|melphalan|mesh-list
83764399|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
83764628|NCT00021463|Lamivudine|lamivudine|mesh-list
83765289|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
83765517|NCT00024544|Antibodies|antibodies|mesh-list
83765814|NCT00025636|Methotrexate|methotrexate|mesh-list
83765992|NCT00026962|Estradiol|estradiol|mesh-list
83766272|NCT00011973|Fenretinide|fenretinide|mesh-list
83766352|NCT00027976|Celecoxib|celecoxib|mesh-list
83766597|NCT00028717|Prednisone|prednisone|mesh-list
83766939|NCT00000503|Streptokinase|streptokinase|mesh-list
83767237|NCT00031564|Aldesleukin|aldesleukin|mesh-list
83767386|NCT00032149|Etoposide|etoposide|mesh-list
83767463|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83767909|NCT00013962|Vitamin D|vitamin d|mesh-list
83768291|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768590|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768665|NCT00036166|Micafungin|micafungin|mesh-list
83768858|NCT00037063|Vitamin E|vitamin e|mesh-list
83768883|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
83769031|NCT00037882|Interferons|interferons|mesh-list
83769182|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769254|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769704|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
83769929|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770155|NCT00039208|Irinotecan|irinotecan|mesh-list
83770754|NCT00042718|Amoxicillin|amoxicillin|mesh-list
83770824|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770900|NCT02970604|Aspirin|aspirin|mesh-list
83770979|NCT00043771|Tolvaptan|tolvaptan|mesh-list
83771410|NCT00001688|Stavudine|stavudine|mesh-list
83771485|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
83771788|NCT00047281|Thalidomide|thalidomide|mesh-list
83772830|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772914|NCT00055042|Vitamin E|vitamin e|mesh-list
83773281|NCT02969746|Charcoal|charcoal|mesh-list
83773425|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
83773648|NCT00060385|Hormones|hormones|mesh-ancestor
83773868|NCT00398554|Doxorubicin|doxorubicin|mesh-list
83773943|NCT00062062|Paclitaxel|paclitaxel|mesh-list
83774239|NCT00065143|Clofarabine|clofarabine|mesh-list
83774696|NCT00399061|Cyclosporine|cyclosporine|mesh-list
83774989|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
83775135|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775214|NCT00072553|Antidotes|antidotes|mesh-ancestor
83775505|NCT04730245|Rifaximin|rifaximin|mesh-list
83775580|NCT00075205|Hormones|hormones|mesh-ancestor
83776688|NCT00083083|Paclitaxel|paclitaxel|mesh-list
83776826|NCT05568082|Itraconazole|itraconazole|mesh-list
83777117|NCT00137020|Ziprasidone|ziprasidone|mesh-list
83777563|NCT00139750|Varenicline|varenicline|mesh-list
83777939|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83778158|NCT00143689|Ritonavir|ritonavir|mesh-list
83778822|NCT00393471|Etanercept|etanercept|mesh-list
83778897|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779048|NCT01903421|Analgesics|analgesics|mesh-ancestor
83779274|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
83779654|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
83780028|NCT00846144|Copper|copper|mesh-list
83780328|NCT00276276|Topotecan|topotecan|mesh-list
83781275|NCT00128739|Budesonide|budesonide|mesh-list
83781642|NCT00019422|Carboplatin|carboplatin|mesh-list
83782096|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
83782170|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
83782323|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
83782867|NCT00025467|Thalidomide|thalidomide|mesh-list
83782935|NCT00025740|Clonazepam|clonazepam|mesh-list
83783151|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83783251|NCT00027924|Busulfan|busulfan|mesh-list
83783980|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83784336|NCT00032799|Natalizumab|natalizumab|mesh-list
83785145|NCT00036387|Infliximab|infliximab|mesh-list
83785653|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
83785803|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
83785953|NCT00276029|Analgesics|analgesics|mesh-ancestor
83786114|NCT00275093|Sirolimus|sirolimus|mesh-list
83786250|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
83786473|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786628|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
83786943|NCT05215730|Copper|copper|mesh-list
83787146|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
83787221|NCT04654689|Curcumin|curcumin|mesh-list
83787677|NCT03596164|Teduglutide|teduglutide|mesh-list
83787823|NCT03098225|Prednisolone|prednisolone|mesh-list
83787900|NCT02855944|Cisplatin|cisplatin|mesh-list
83788127|NCT00644189|Clofarabine|clofarabine|mesh-list
83788204|NCT05772832|Narcotics|narcotics|mesh-ancestor
83788431|NCT05650736|Abrocitinib|abrocitinib|mesh-list
83788586|NCT04892511|Labetalol|labetalol|mesh-list
83788730|NCT04702256|Prednisolone|prednisolone|mesh-list
83788953|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83789026|NCT04124991|Durvalumab|durvalumab|mesh-list
83789408|NCT02225600|Oxytocin|oxytocin|mesh-list
83789634|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
83790085|NCT00040209|Emetics|emetics|mesh-ancestor
83790236|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
83790469|NCT00021827|Hormones|hormones|mesh-list
83790771|NCT00023153|Adefovir|adefovir|mesh-list
83790844|NCT00023348|Isoniazid|isoniazid|mesh-list
83791063|NCT00023933|Antibodies|antibodies|mesh-list
83791367|NCT00052689|Gemcitabine|gemcitabine|mesh-list
83791440|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791619|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
83791825|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791901|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792428|NCT00028613|Antibodies|antibodies|mesh-list
83792519|NCT00028925|Topotecan|topotecan|mesh-list
83792732|NCT00057447|Interferons|interferons|mesh-list
83793028|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83793481|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
83793931|NCT00034541|Paclitaxel|paclitaxel|mesh-list
83794222|NCT00035321|Olanzapine|olanzapine|mesh-list
83794443|NCT00063687|Oxypurinol|oxypurinol|mesh-list
83794964|NCT00070122|Antidotes|antidotes|mesh-ancestor
83795042|NCT00066378|Gefitinib|gefitinib|mesh-list
83795115|NCT00070434|Vitamins|vitamins|mesh-ancestor
83795418|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
83795643|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
83795928|NCT00204061|Amisulpride|amisulpride|mesh-list
83795984|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
83796060|NCT00072267|Topotecan|topotecan|mesh-list
83796265|NCT00072618|Analgesics|analgesics|mesh-ancestor
83796492|NCT00207532|Folic Acid|folic acid|mesh-list
83796580|NCT00040508|Sirolimus|sirolimus|mesh-list
83796940|NCT00209521|Fospropofol|fospropofol|mesh-list
83797461|NCT00411736|Azithromycin|azithromycin|mesh-list
83798204|NCT00218569|Naltrexone|naltrexone|mesh-list
83798354|NCT00219973|Bemiparin|bemiparin|mesh-list
83798716|NCT00043004|Leucovorin|leucovorin|mesh-list
83799018|NCT00124930|Olanzapine|olanzapine|mesh-list
83799907|NCT00078975|Gemcitabine|gemcitabine|mesh-list
83800036|NCT00044993|Docetaxel|docetaxel|mesh-list
83800197|NCT00075231|Ritonavir|ritonavir|mesh-list
83800354|NCT00045773|Sertraline|sertraline|mesh-list
83800666|NCT00397592|Hormones|hormones|mesh-list
83800948|NCT00133237|Sirolimus|sirolimus|mesh-list
83801706|NCT00146146|Androgens|androgens|mesh-ancestor
83801784|NCT00146614|Sirolimus|sirolimus|mesh-list
83802292|NCT00148837|Interferons|interferons|mesh-list
83802370|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
83802451|NCT00049088|Docetaxel|docetaxel|mesh-list
83802520|NCT00150046|Everolimus|everolimus|mesh-list
83802590|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803089|NCT00152308|Sirolimus|sirolimus|mesh-list
83803684|NCT00154687|Paclitaxel|paclitaxel|mesh-list
83803899|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
83803966|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
83804349|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83804429|NCT00160030|Cisplatin|cisplatin|mesh-list
83804496|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83804861|NCT00162604|Cefuroxime|cefuroxime|mesh-list
83804932|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
83805306|NCT00053807|Interferons|interferons|mesh-list
83805682|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
83805833|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83805913|NCT00168883|Paclitaxel|paclitaxel|mesh-list
83805988|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
83806136|NCT00170209|Rifampin|rifampin|mesh-list
83806280|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806433|NCT00055679|Fluorouracil|fluorouracil|mesh-list
83807381|NCT00408382|Atorvastatin|atorvastatin|mesh-list
83807454|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
83807532|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
83807602|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
83807979|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
83808131|NCT00185302|Entinostat|entinostat|mesh-list
83808276|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
83808424|NCT00187330|Antidotes|antidotes|mesh-ancestor
83808502|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83808805|NCT00189748|Tacrolimus|tacrolimus|mesh-list
83809083|NCT02922894|Trazodone|trazodone|mesh-list
83809222|NCT00059813|Interferons|interferons|mesh-list
83809523|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83809671|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809909|NCT00196690|Donepezil|donepezil|mesh-list
83810415|NCT00199576|Hormones|hormones|mesh-ancestor
83810501|NCT00200434|Nebivolol|nebivolol|mesh-list
83810567|NCT00061256|Antacids|antacids|mesh-ancestor
83810789|NCT00085761|Capsaicin|capsaicin|mesh-list
83811234|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811459|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83811918|NCT00096291|Paclitaxel|paclitaxel|mesh-list
83811992|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
83812064|NCT00228358|Analgesics|analgesics|mesh-ancestor
83812505|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
83813185|NCT00234949|Cephalexin|cephalexin|mesh-list
83813410|NCT00236587|Risperidone|risperidone|mesh-list
83813561|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
83813643|NCT04709770|Simethicone|simethicone|mesh-list
83813710|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83813873|NCT00098358|Zileuton|zileuton|mesh-list
83814604|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
83814683|NCT00244075|Hormones|hormones|mesh-list
83814828|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
83814900|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83815279|NCT00099684|Ezetimibe|ezetimibe|mesh-list
83815797|NCT00251485|Cetuximab|cetuximab|mesh-list
83815949|NCT00104013|Xaliproden|xaliproden|mesh-list
83816099|NCT00253396|Heparin|heparin|mesh-list
83816235|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
83816393|NCT00070148|Megestrol|megestrol|mesh-list
83816462|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972102|NCT02507284|SRX246|srx246|mesh-list
83817065|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
83817293|NCT00261820|Sirolimus|sirolimus|mesh-list
83817737|NCT00265408|Aspirin|aspirin|mesh-list
83817806|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
83818029|NCT00073580|Hirudins|hirudins|mesh-list
83818107|NCT00268372|Docetaxel|docetaxel|mesh-list
83818628|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83818706|NCT00271804|Bortezomib|bortezomib|mesh-list
83818854|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
83819485|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83819853|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83820297|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
83820376|NCT00285766|Selegiline|selegiline|mesh-list
83820742|NCT00287560|Propofol|propofol|mesh-list
83820821|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
83820896|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
83820963|NCT00289861|Risperidone|risperidone|mesh-list
83821063|NCT00290680|Celecoxib|celecoxib|mesh-list
83821184|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
83821262|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821337|NCT00275041|Irinotecan|irinotecan|mesh-list
83821425|NCT00119301|Antidotes|antidotes|mesh-ancestor
83821784|NCT00079586|Bivalirudin|bivalirudin|mesh-list
83822009|NCT00300352|Vitamins|vitamins|mesh-ancestor
83822611|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822705|NCT00081302|Paclitaxel|paclitaxel|mesh-list
83822769|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
83823418|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83823493|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823645|NCT00083408|Pamidronate|pamidronate|mesh-list
83823944|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
83824240|NCT00089115|Antibodies|antibodies|mesh-list
83824383|NCT00293371|Hormones|hormones|mesh-ancestor
83824454|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
83824864|NCT00296530|Xhance|xhance|mesh-list
83825048|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825340|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
83825937|NCT00315016|Fosinopril|fosinopril|mesh-list
83826301|NCT00092313|Acetaminophen|acetaminophen|mesh-list
83827348|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827425|NCT00085163|Antidotes|antidotes|mesh-ancestor
83827503|NCT00326131|Taxane|taxane|mesh-list
83827568|NCT00093678|Analgesics|analgesics|mesh-ancestor
83828047|NCT00086528|XL647|xl647|mesh-list
83828094|NCT00124566|Analgesics|analgesics|mesh-ancestor
83828612|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
83828682|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828975|NCT05820997|Ropivacaine|ropivacaine|mesh-list
83829340|NCT05145309|Cathartics|cathartics|mesh-ancestor
83829418|NCT04981509|Listerine|listerine|mesh-list
83829495|NCT04857931|Colchicine|colchicine|mesh-list
83829729|NCT04302870|Analgesics|analgesics|mesh-ancestor
83829964|NCT03803787|Budesonide|budesonide|mesh-list
83830180|NCT03191864|Xhance|xhance|mesh-list
83830546|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
83830692|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
83830844|NCT00332995|Dapivirine|dapivirine|mesh-list
83830903|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830985|NCT00421018|Montelukast|montelukast|mesh-list
83831051|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
83831960|NCT00346567|Zidovudine|zidovudine|mesh-list
83832109|NCT00347113|Praziquantel|praziquantel|mesh-list
83832337|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
83832406|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83832557|NCT04704622|Midazolam|midazolam|mesh-list
83832642|NCT00092300|Valdecoxib|valdecoxib|mesh-list
83832984|NCT00094289|Disulfiram|disulfiram|mesh-list
83833267|NCT00095927|Paclitaxel|paclitaxel|mesh-list
83833313|NCT00429871|Docetaxel|docetaxel|mesh-list
83833518|NCT00430924|Eplerenone|eplerenone|mesh-list
83834152|NCT01050790|Lenalidomide|lenalidomide|mesh-list
83834607|NCT04244058|Amantadine|amantadine|mesh-list
83834660|NCT04728659|Ganirelix|ganirelix|mesh-list
83834797|NCT00400790|Desflurane|desflurane|mesh-list
83835490|NCT04729088|Isosorbide|isosorbide|mesh-list
83835578|NCT00137007|Ampicillin|ampicillin|mesh-list
83835712|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
83835786|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83835962|NCT00434824|Hormones|hormones|mesh-ancestor
83836232|NCT00436423|Gemcitabine|gemcitabine|mesh-list
83836602|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
83836677|NCT00107471|Topotecan|topotecan|mesh-list
83836750|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
83836825|NCT00441415|Adapalene|adapalene|mesh-list
83837032|NCT00404586|Xhance|xhance|mesh-list
83837194|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
83837351|NCT00451594|Hormones|hormones|mesh-ancestor
83837568|NCT00109187|Omalizumab|omalizumab|mesh-list
83837642|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
83837941|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83838088|NCT00454558|Riociguat|riociguat|mesh-list
83838233|NCT00457717|Atropine|atropine|mesh-list
83838453|NCT00144417|Rifampin|rifampin|mesh-list
83838697|NCT00349492|Cisplatin|cisplatin|mesh-list
83839123|NCT00352144|Eszopiclone|eszopiclone|mesh-list
83839201|NCT00352378|Docetaxel|docetaxel|mesh-list
83839568|NCT00444379|Efavirenz|efavirenz|mesh-list
83839720|NCT00114023|Imiquimod|imiquimod|mesh-list
83839939|NCT00447031|Hormones|hormones|mesh-ancestor
83840244|NCT00115154|Imiquimod|imiquimod|mesh-list
83840319|NCT00450736|Celecoxib|celecoxib|mesh-list
83840704|NCT03273556|Lidocaine|lidocaine|mesh-list
83840846|NCT00462553|Gemcitabine|gemcitabine|mesh-list
83840919|NCT00463021|Vitamins|vitamins|mesh-ancestor
83841006|NCT00463957|Tadalafil|tadalafil|mesh-list
83841378|NCT00474838|Metformin|metformin|mesh-list
83841541|NCT00476164|Rituximab|rituximab|mesh-list
83842506|NCT00120380|Iloprost|iloprost|mesh-list
83842797|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
83842870|NCT02274181|Enclomiphene|enclomiphene|mesh-list
83843022|NCT00486421|Prednisone|prednisone|mesh-list
83843161|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
83843231|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83843456|NCT00490204|Cetirizine|cetirizine|mesh-list
83843614|NCT00122603|Saquinavir|saquinavir|mesh-list
83844053|NCT01244698|Clindamycin|clindamycin|mesh-list
83844579|NCT00499018|Hormones|hormones|mesh-ancestor
83844650|NCT01245361|Infliximab|infliximab|mesh-list
83542530|NCT03596723|Hormones|hormones|mesh-ancestor
83542605|NCT04734665|Niraparib|niraparib|mesh-list
83543040|NCT04329494|Leucovorin|leucovorin|mesh-list
83543272|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543494|NCT00361868|Metformin|metformin|mesh-list
83543570|NCT00361166|Pimavanserin|pimavanserin|mesh-list
83543863|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
83544389|NCT05717335|Thrombin|thrombin|mesh-list
83545513|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
83545817|NCT00002835|Carmustine|carmustine|mesh-list
83545976|NCT00002865|Antidotes|antidotes|mesh-ancestor
83546192|NCT00002889|Leuprolide|leuprolide|mesh-list
83546803|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83546953|NCT00004197|Vaccines|vaccines|mesh-list
83547032|NCT00004221|Paclitaxel|paclitaxel|mesh-list
83547705|NCT00003891|Lurtotecan|lurtotecan|mesh-list
83548022|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
83548163|NCT04829799|Ketorolac|ketorolac|mesh-list
83548236|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548387|NCT00363259|Ribavirin|ribavirin|mesh-list
83548540|NCT02533466|Listerine|listerine|mesh-list
83549074|NCT02516150|Hormones|hormones|mesh-ancestor
83845557|NCT03868722|Venetoclax|venetoclax|mesh-list
83845718|NCT00402974|Vitamin K|vitamin k|mesh-list
83846533|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
83846690|NCT00141570|Estrogens|estrogens|mesh-list
83846839|NCT00142038|Docetaxel|docetaxel|mesh-list
83847510|NCT00137657|Trimethoprim|trimethoprim|mesh-list
83847656|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
83847822|NCT00154401|Hormones|hormones|mesh-ancestor
83847953|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
83848408|NCT00141011|Ancrod|ancrod|mesh-list
83848691|NCT00505336|Eplerenone|eplerenone|mesh-list
83848834|NCT00162591|Remifentanil|remifentanil|mesh-list
83849566|NCT05147194|Trimetazidine|trimetazidine|mesh-list
83849691|NCT05148910|Copper|copper|mesh-list
83850094|NCT00508690|Kanamycin|kanamycin|mesh-list
83850245|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
83850779|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
83851310|NCT00158574|Dapsone|dapsone|mesh-list
83851530|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
83851674|NCT00511849|Paclitaxel|paclitaxel|mesh-list
83851750|NCT00511225|Vitamin D|vitamin d|mesh-list
83851826|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852050|NCT00514618|Misoprostol|misoprostol|mesh-list
83852129|NCT00151203|Hormones|hormones|mesh-ancestor
83852593|NCT05822765|Mydriatics|mydriatics|mesh-ancestor
83852886|NCT05226598|Pemetrexed|pemetrexed|mesh-list
83853037|NCT04892017|Trametinib|trametinib|mesh-list
83854094|NCT00517621|Paclitaxel|paclitaxel|mesh-list
83854527|NCT00521170|Levocetirizine|levocetirizine|mesh-list
83854748|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854979|NCT00512824|Calcium|calcium|mesh-list
83855276|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
83855573|NCT02448095|Ponatinib|ponatinib|mesh-list
83855646|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83855798|NCT00407862|Losartan|losartan|mesh-list
83855963|NCT00528658|Ibuprofen|ibuprofen|mesh-list
83856320|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
83856397|NCT00169221|Gefitinib|gefitinib|mesh-list
83857138|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
83857290|NCT00148382|Cetilistat|cetilistat|mesh-list
83857593|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83857958|NCT05785026|Menthol|menthol|mesh-list
83858109|NCT05724316|Vitamins|vitamins|mesh-ancestor
83858410|NCT04777422|Defibrotide|defibrotide|mesh-list
83858857|NCT03283150|Propofol|propofol|mesh-list
83858938|NCT03056040|Eculizumab|eculizumab|mesh-list
83859006|NCT02296125|Osimertinib|osimertinib|mesh-list
83859157|NCT00326456|Paclitaxel|paclitaxel|mesh-list
83859322|NCT00150215|Olanzapine|olanzapine|mesh-list
83859460|NCT02912182|Prednisolone|prednisolone|mesh-list
83859534|NCT00171327|Valsartan|valsartan|mesh-list
83859599|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83859751|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
83859897|NCT00151346|Narcotics|narcotics|mesh-ancestor
83860045|NCT05308030|Aspirin|aspirin|mesh-list
83860259|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
83860713|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83861910|NCT00181935|Olanzapine|olanzapine|mesh-list
83862054|NCT05470972|Ethanol|ethanol|mesh-list
83862207|NCT00156650|Testosterone|testosterone|mesh-list
83862362|NCT00536770|Vitamins|vitamins|mesh-ancestor
83862520|NCT00534391|Polymyxins|polymyxins|mesh-list
83862739|NCT04686643|Diuretics|diuretics|mesh-ancestor
83862963|NCT00158483|Acyclovir|acyclovir|mesh-list
83863196|NCT00158990|Sertraline|sertraline|mesh-list
83863418|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
83863566|NCT00159536|Metformin|metformin|mesh-list
83863716|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
83863945|NCT00543829|Tamoxifen|tamoxifen|mesh-list
83864836|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
83864980|NCT00551239|Pixantrone|pixantrone|mesh-list
83865784|NCT05807932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83866535|NCT03396445|Pemetrexed|pemetrexed|mesh-list
83866613|NCT03311555|Docetaxel|docetaxel|mesh-list
83866764|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866919|NCT01196936|Tamoxifen|tamoxifen|mesh-list
83867269|NCT00193674|Hormones|hormones|mesh-ancestor
83867344|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83867567|NCT03978208|Naproxen|naproxen|mesh-list
83868240|NCT00167648|Leuprolide|leuprolide|mesh-list
83868312|NCT02906059|Irinotecan|irinotecan|mesh-list
83868523|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868749|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868824|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
83869280|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
83869430|NCT03097939|Nivolumab|nivolumab|mesh-list
83869564|NCT02492776|Omeprazole|omeprazole|mesh-list
83869783|NCT00171665|Analgesics|analgesics|mesh-ancestor
83869932|NCT02240407|Analgesics|analgesics|mesh-ancestor
83870535|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870760|NCT01768975|Dapansutrile|dapansutrile|mesh-list
83870988|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871214|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871375|NCT04424602|Dimethoate|dimethoate|mesh-list
83871513|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871675|NCT03252808|Paclitaxel|paclitaxel|mesh-list
83872190|NCT00200226|Misoprostol|misoprostol|mesh-list
83872357|NCT03454789|Lidocaine|lidocaine|mesh-list
83872933|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
83873022|NCT04630522|Vitamin D|vitamin d|mesh-list
83873385|NCT00187005|Idarubicin|idarubicin|mesh-list
83873460|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
83873555|NCT00180635|Pimagedine|pimagedine|mesh-list
83873991|NCT00411372|Fluticasone|fluticasone|mesh-list
83874215|NCT00209625|Leucovorin|leucovorin|mesh-list
83874354|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83874708|NCT00590629|Niacin|niacin|mesh-list
83874748|NCT00477295|Zonisamide|zonisamide|mesh-list
83874799|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
83874871|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83875250|NCT00210912|Topiramate|topiramate|mesh-list
83876302|NCT00220350|Leuprolide|leuprolide|mesh-list
83876372|NCT00220506|Modafinil|modafinil|mesh-list
83876658|NCT00221286|Tenofovir|tenofovir|mesh-list
83876805|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877172|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
83877246|NCT00192725|Tryptophan|tryptophan|mesh-list
83877321|NCT00411996|Ritonavir|ritonavir|mesh-list
83878071|NCT00194480|Interferons|interferons|mesh-list
83878222|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
83878367|NCT00413127|Lidocaine|lidocaine|mesh-list
83878823|NCT00202787|Vitamins|vitamins|mesh-ancestor
83880163|NCT00410852|Insulin|insulin|mesh-list
83880455|NCT00411125|Calcitonin|calcitonin|mesh-list
83880823|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83880969|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
83881045|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881865|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
83882113|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
83882279|NCT04680091|Efavirenz|efavirenz|mesh-list
83882320|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
83882411|NCT04669366|Sunitinib|sunitinib|mesh-list
83882472|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
83882547|NCT00212069|Carboplatin|carboplatin|mesh-list
83883139|NCT00215228|Escitalopram|escitalopram|mesh-list
83883220|NCT04668352|Dactolisib|dactolisib|mesh-list
83883364|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
83883525|NCT00216164|Rituximab|rituximab|mesh-list
83883664|NCT00216554|Risperidone|risperidone|mesh-list
83884343|NCT00246168|Narcotics|narcotics|mesh-ancestor
83884416|NCT04628884|Heparin|heparin|mesh-list
83884492|NCT00246402|Acipimox|acipimox|mesh-list
83884863|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83885086|NCT00243204|Docetaxel|docetaxel|mesh-list
83885234|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83885623|NCT00248157|Octreotide|octreotide|mesh-list
83885694|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
83885983|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
83886497|NCT00565708|Aspirin|aspirin|mesh-list
83886941|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887317|NCT04587115|Risperidone|risperidone|mesh-list
83887705|NCT04582786|Morphine|morphine|mesh-list
83887773|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
83887849|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83888222|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888443|NCT00254865|Hormones|hormones|mesh-ancestor
83888592|NCT00574756|Ranolazine|ranolazine|mesh-list
83888816|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888966|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
83889568|NCT01059188|Docetaxel|docetaxel|mesh-list
83889713|NCT00199316|Narcotics|narcotics|mesh-ancestor
83889864|NCT00236769|Norelgestromin|norelgestromin|mesh-list
83890384|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890841|NCT04560751|Lenvatinib|lenvatinib|mesh-list
83891289|NCT00267306|Visilizumab|visilizumab|mesh-list
83891966|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
83892031|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
83892558|NCT02213653|Trace Elements|trace elements|mesh-ancestor
83892857|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
83893304|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893760|NCT00263094|Rofecoxib|rofecoxib|mesh-list
83893844|NCT04532671|Ether|ether|mesh-list
83894586|NCT05074810|Sotorasib|sotorasib|mesh-list
83894742|NCT04886531|Letrozole|letrozole|mesh-list
83894880|NCT04452877|Trametinib|trametinib|mesh-list
83895033|NCT04023331|Copper|copper|mesh-list
83895184|NCT03521037|Rucaparib|rucaparib|mesh-list
83895257|NCT03424005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83895558|NCT01081951|Olaparib|olaparib|mesh-list
83896016|NCT01644994|Cisplatin|cisplatin|mesh-list
83896309|NCT02279563|Xhance|xhance|mesh-list
83896611|NCT00241007|Valsartan|valsartan|mesh-list
83896673|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
83896747|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
83896821|NCT02219737|Carboplatin|carboplatin|mesh-list
83897127|NCT00273390|Infliximab|infliximab|mesh-list
83897497|NCT00244907|Protective Agents|protective agents|mesh-ancestor
83897564|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897790|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898461|NCT00279084|Analgesics|analgesics|mesh-ancestor
83898995|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
83899490|NCT00252863|Xhance|xhance|mesh-list
83899531|NCT01681537|Cytarabine|cytarabine|mesh-list
83899596|NCT00281307|Vitamins|vitamins|mesh-ancestor
83899785|NCT00253175|Topiramate|topiramate|mesh-list
83899822|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
83899898|NCT00281502|Rifaximin|rifaximin|mesh-list
83900047|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
83900804|NCT00270543|Vitamins|vitamins|mesh-ancestor
83900878|NCT02488408|Cytarabine|cytarabine|mesh-list
83900965|NCT01609816|Dasatinib|dasatinib|mesh-list
83901176|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
83901251|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
83901329|NCT01601938|Selenium|selenium|mesh-list
83901408|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
83901700|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
83902079|NCT00291720|Spironolactone|spironolactone|mesh-list
83902149|NCT00272064|Insulin|insulin|mesh-list
83902299|NCT00260039|Vaccines|vaccines|mesh-list
83902986|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83903426|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903732|NCT00266591|Topiramate|topiramate|mesh-list
83903882|NCT00267332|Modafinil|modafinil|mesh-list
83904247|NCT00269126|Hormones|hormones|mesh-ancestor
83904701|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
83904771|NCT00272207|Nabilone|nabilone|mesh-list
83905066|NCT00418704|Docetaxel|docetaxel|mesh-list
83905139|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83905214|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905367|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83905668|NCT00278252|Etoposide|etoposide|mesh-list
83906420|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906495|NCT00317733|Ketoprofen|ketoprofen|mesh-list
83906575|NCT00317928|Metformin|metformin|mesh-list
83906732|NCT00311961|Hormones|hormones|mesh-ancestor
83906879|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
83907872|NCT01059825|Metformin|metformin|mesh-list
83907933|NCT00323505|Interferons|interferons|mesh-list
83908160|NCT00324129|Mocetinostat|mocetinostat|mesh-list
83908391|NCT00291980|Vaccines|vaccines|mesh-list
83908756|NCT00293969|Analgesics|analgesics|mesh-ancestor
83909210|NCT00296465|Clomiphene|clomiphene|mesh-list
83909351|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
83909572|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83909719|NCT00300560|Colistin|colistin|mesh-list
83909794|NCT00301223|Pregabalin|pregabalin|mesh-list
83909950|NCT05238831|Immunotoxins|immunotoxins|mesh-ancestor
83910319|NCT00304226|Amlodipine|amlodipine|mesh-list
83910391|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
83910465|NCT00332553|Estradiol|estradiol|mesh-list
83910680|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
83910916|NCT00330252|Rituximab|rituximab|mesh-list
83911065|NCT00451880|Famotidine|famotidine|mesh-list
83911654|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
83912259|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83912559|NCT00312260|Gabapentin|gabapentin|mesh-list
83912711|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
83912929|NCT00314171|Brinzolamide|brinzolamide|mesh-list
83913010|NCT00314561|Pioglitazone|pioglitazone|mesh-list
83913079|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
83913230|NCT00315926|Melatonin|melatonin|mesh-list
83913608|NCT00345306|Hormones|hormones|mesh-ancestor
83913986|NCT00319709|Amibegron|amibegron|mesh-list
83914074|NCT00351507|Vildagliptin|vildagliptin|mesh-list
83914435|NCT00331500|Analgesics|analgesics|mesh-ancestor
83914507|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915182|NCT00426933|Vancomycin|vancomycin|mesh-list
83915845|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915991|NCT00328718|Xhance|xhance|mesh-list
83916167|NCT00329381|Omalizumab|omalizumab|mesh-list
83916212|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
83916291|NCT00430170|Caffeine|caffeine|mesh-list
83916518|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
83916890|NCT00333164|Cilostazol|cilostazol|mesh-list
83917110|NCT00334256|Tenofovir|tenofovir|mesh-list
83917178|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
83918011|NCT00339014|Zonisamide|zonisamide|mesh-list
83918141|NCT00452244|Gefitinib|gefitinib|mesh-list
83918746|NCT00454545|Atorvastatin|atorvastatin|mesh-list
83918920|NCT00455091|Lamivudine|lamivudine|mesh-list
83918973|NCT02273817|Hormones|hormones|mesh-ancestor
83919042|NCT00455286|Methotrexate|methotrexate|mesh-list
83919189|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83919413|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
83919561|NCT00350051|Prednisone|prednisone|mesh-list
83919708|NCT00351143|Xhance|xhance|mesh-list
83919862|NCT00465621|Latanoprost|latanoprost|mesh-list
83920086|NCT00466869|Betahistine|betahistine|mesh-list
83920237|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83920612|NCT00460083|Analgesics|analgesics|mesh-ancestor
83921279|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
83921357|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83921430|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921725|NCT00472134|Bupivacaine|bupivacaine|mesh-list
83922169|NCT00435305|Tazobactam|tazobactam|mesh-list
83922333|NCT00436787|PENTA|penta|mesh-list
83922692|NCT00475137|Lamotrigine|lamotrigine|mesh-list
83922770|NCT00439049|Naltrexone|naltrexone|mesh-list
83922920|NCT00476268|Beclomethasone|beclomethasone|mesh-list
83923137|NCT00440687|Fluticasone|fluticasone|mesh-list
83923212|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83923287|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83923586|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
83923809|NCT00441597|Atorvastatin|atorvastatin|mesh-list
83923961|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
83924637|NCT00458315|Growth Substances|growth substances|mesh-ancestor
83924709|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83924863|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83924939|NCT00495729|Simvastatin|simvastatin|mesh-list
83925118|NCT00496392|Fentanyl|fentanyl|mesh-list
83925389|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
83925469|NCT00497601|Amphotericin B|amphotericin b|mesh-list
83925538|NCT00464165|Hormones|hormones|mesh-ancestor
83925623|NCT01327612|Antidotes|antidotes|mesh-ancestor
83925687|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83925762|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
83926135|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83926317|NCT01371877|Vitamin D|vitamin d|mesh-list
83926478|NCT00473915|Xhance|xhance|mesh-list
83926659|NCT00500253|Protective Agents|protective agents|mesh-ancestor
83926736|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
83926819|NCT01606345|Valrubicin|valrubicin|mesh-list
83927425|NCT00601588|Sertraline|sertraline|mesh-list
83927550|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
83927776|NCT04325698|Bevacizumab|bevacizumab|mesh-list
83927928|NCT00494715|Valsartan|valsartan|mesh-list
83928075|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
83928301|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
83928379|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
83928527|NCT00479609|Hormones|hormones|mesh-ancestor
83928675|NCT00481364|Atorvastatin|atorvastatin|mesh-list
83928900|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929050|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
83929132|NCT00482573|Epinephrine|epinephrine|mesh-list
83929199|NCT01309204|Brinzolamide|brinzolamide|mesh-list
83929270|NCT00483054|Efavirenz|efavirenz|mesh-list
83929347|NCT01241019|Topiramate|topiramate|mesh-list
83930164|NCT00489593|Fluoxetine|fluoxetine|mesh-list
83930451|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930528|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
83930599|NCT00490997|Ketamine|ketamine|mesh-list
83930745|NCT01242098|Fluticasone|fluticasone|mesh-list
83930825|NCT00487032|Fluticasone|fluticasone|mesh-list
83930910|NCT00487136|Warfarin|warfarin|mesh-list
83930967|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931052|NCT00487448|Cytarabine|cytarabine|mesh-list
83931197|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
83931265|NCT00487799|Ularitide|ularitide|mesh-list
83931868|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931949|NCT05148546|Nivolumab|nivolumab|mesh-list
83932241|NCT05145270|Sulforaphane|sulforaphane|mesh-list
83932470|NCT00499850|Leucovorin|leucovorin|mesh-list
83932543|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83933066|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83933296|NCT01249430|Analgesics|analgesics|mesh-ancestor
83933781|NCT01244984|Xhance|xhance|mesh-list
83933829|NCT02955641|Dexamethasone|dexamethasone|mesh-list
83933905|NCT01241240|Timolol|timolol|mesh-list
83934057|NCT04519463|Lidocaine|lidocaine|mesh-list
83934128|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
83934500|NCT00517257|Atorvastatin|atorvastatin|mesh-list
83934601|NCT04516304|Equol|equol|mesh-list
83935318|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83935399|NCT00523692|Analgesics|analgesics|mesh-ancestor
83935471|NCT00523926|Bedaquiline|bedaquiline|mesh-list
83936148|NCT00508859|Sertraline|sertraline|mesh-list
83936230|NCT04692285|Zolpidem|zolpidem|mesh-list
83937274|NCT00516152|Busulfan|busulfan|mesh-list
83937658|NCT02939547|Betadex|betadex|mesh-list
83937809|NCT00519116|Sirolimus|sirolimus|mesh-list
83938031|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938109|NCT00523133|Naltrexone|naltrexone|mesh-list
83938330|NCT00523289|Bupivacaine|bupivacaine|mesh-list
83938408|NCT00523757|Spironolactone|spironolactone|mesh-list
83938858|NCT02929095|Remifentanil|remifentanil|mesh-list
83939084|NCT00526877|Risperidone|risperidone|mesh-list
83939384|NCT02926053|Analgesics|analgesics|mesh-ancestor
83939760|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939839|NCT00531791|Prednisone|prednisone|mesh-list
83940066|NCT02916381|Anesthetics|anesthetics|mesh-list
83940139|NCT03160638|Azithromycin|azithromycin|mesh-list
83941504|NCT00532272|Letrozole|letrozole|mesh-list
83941584|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
83941656|NCT02921360|Analgesics|analgesics|mesh-ancestor
83941733|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83941804|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83941956|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942256|NCT00532623|Gemcitabine|gemcitabine|mesh-list
83942555|NCT05209035|Trazodone|trazodone|mesh-list
83943161|NCT05469347|Alirocumab|alirocumab|mesh-list
83943232|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83943476|NCT00597064|Prednisone|prednisone|mesh-list
83943694|NCT04685642|Aspirin|aspirin|mesh-list
83943979|NCT00552149|Cetuximab|cetuximab|mesh-list
83944270|NCT04207021|Curcumin|curcumin|mesh-list
83944492|NCT02605421|Lenograstim|lenograstim|mesh-list
83944652|NCT04283513|Ribavirin|ribavirin|mesh-list
83944876|NCT01244620|Tadalafil|tadalafil|mesh-list
83944944|NCT03736616|Cytarabine|cytarabine|mesh-list
83945544|NCT01263496|Alogliptin|alogliptin|mesh-list
83946074|NCT00548964|Ketamine|ketamine|mesh-list
83946145|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83946514|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
83946663|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
83946815|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
83947097|NCT05255367|Phenol|phenol|mesh-list
83947111|NCT03639389|Morphine|morphine|mesh-list
83947336|NCT02389985|Paclitaxel|paclitaxel|mesh-list
83947637|NCT01962636|Cyclosporine|cyclosporine|mesh-list
83947712|NCT01209832|Midazolam|midazolam|mesh-list
83947859|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948020|NCT04663763|Antibodies|antibodies|mesh-list
83948385|NCT04658732|Analgesics|analgesics|mesh-ancestor
83948461|NCT00541086|Tamoxifen|tamoxifen|mesh-list
83948620|NCT04655807|Adalimumab|adalimumab|mesh-list
83948690|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
83949061|NCT00543504|Bevacizumab|bevacizumab|mesh-list
83949658|NCT02906163|Gefitinib|gefitinib|mesh-list
83949894|NCT04640324|Vitamin D|vitamin d|mesh-list
83950033|NCT00559676|Leucovorin|leucovorin|mesh-list
83950111|NCT04680819|Propolis|propolis|mesh-list
83950185|NCT00553722|Diuretics|diuretics|mesh-ancestor
83950264|NCT01227967|Analgesics|analgesics|mesh-ancestor
83950482|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
83950559|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83950727|NCT05657704|Tramadol|tramadol|mesh-list
83950790|NCT01221727|Denosumab|denosumab|mesh-list
83950938|NCT00447863|Estradiol|estradiol|mesh-list
83951012|NCT01220128|Epirubicin|epirubicin|mesh-list
83951086|NCT05424393|Analgesics|analgesics|mesh-ancestor
83951160|NCT05468359|Growth Substances|growth substances|mesh-ancestor
83951536|NCT01217944|Ranibizumab|ranibizumab|mesh-list
83951773|NCT02928575|Sunitinib|sunitinib|mesh-list
83951833|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
83951911|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
83951983|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952288|NCT02915042|Analgesics|analgesics|mesh-ancestor
83952883|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83953108|NCT01871415|Metformin|metformin|mesh-list
83953272|NCT01818921|CKD732|ckd732|mesh-list
83953491|NCT01712451|Xhance|xhance|mesh-list
83953561|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
83953644|NCT00533585|Paclitaxel|paclitaxel|mesh-list
83953711|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83953794|NCT00556608|Hylan|hylan|mesh-list
83954312|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
83954401|NCT02466867|Naftifine|naftifine|mesh-list
83954542|NCT00538811|Amantadine|amantadine|mesh-list
83954698|NCT00540137|Ritonavir|ritonavir|mesh-list
83955369|NCT05823883|Metformin|metformin|mesh-list
83955507|NCT05751629|Niraparib|niraparib|mesh-list
83955858|NCT04778410|Cc-486|cc-486|mesh-list
83956042|NCT04397003|Durvalumab|durvalumab|mesh-list
83956170|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
83956325|NCT03043872|Carboplatin|carboplatin|mesh-list
83956403|NCT02293954|Antibodies|antibodies|mesh-list
83957655|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
83957878|NCT04626063|Acetaminophen|acetaminophen|mesh-list
83959228|NCT00563589|Methotrexate|methotrexate|mesh-list
83959605|NCT01165138|Xhance|xhance|mesh-list
83960054|NCT04608981|Diclofenac|diclofenac|mesh-list
83960356|NCT00564603|Hormones|hormones|mesh-ancestor
83960574|NCT04674956|Paclitaxel|paclitaxel|mesh-list
83960631|NCT01159912|Xhance|xhance|mesh-list
83960726|NCT04314193|Hormones|hormones|mesh-ancestor
83960952|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
83961837|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
83961924|NCT04618952|Calcium|calcium|mesh-list
83961994|NCT00569712|Budesonide|budesonide|mesh-list
83962289|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962386|NCT00563615|Tegaserod|tegaserod|mesh-list
83963185|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83963487|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
83963716|NCT04584710|Dactolisib|dactolisib|mesh-list
83963865|NCT01145482|Insulin|insulin|mesh-list
83963936|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
83964080|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83964170|NCT00584532|Genistein|genistein|mesh-list
83964231|NCT00571298|Amifostine|amifostine|mesh-list
83964377|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
83964451|NCT00585741|Alovudine|alovudine|mesh-list
83964524|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
83965584|NCT00476151|Ketamine|ketamine|mesh-list
83965898|NCT00583271|Ethanol|ethanol|mesh-list
83205424|NCT04920747|Taxane|taxane|mesh-list
83966251|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
83966544|NCT00588926|Remifentanil|remifentanil|mesh-list
83967221|NCT00194012|Aripiprazole|aripiprazole|mesh-list
83967669|NCT00477971|Hormones|hormones|mesh-ancestor
83967742|NCT00475670|Trastuzumab|trastuzumab|mesh-list
83967967|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968349|NCT04551768|Ribavirin|ribavirin|mesh-list
83968411|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
83968712|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83969093|NCT00575978|Hydralazine|hydralazine|mesh-list
83969164|NCT00576173|Analgesics|analgesics|mesh-ancestor
83969616|NCT00577694|Immunotoxins|immunotoxins|mesh-ancestor
83969996|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
83970065|NCT04531371|Analgesics|analgesics|mesh-ancestor
83970140|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
83970657|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83971036|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971187|NCT04547426|Nicotine|nicotine|mesh-list
83971560|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
83971709|NCT02215460|Azithromycin|azithromycin|mesh-list
83972076|NCT01178671|Sertraline|sertraline|mesh-list
83973065|NCT01177540|Decitabine|decitabine|mesh-list
83973133|NCT01640639|Thalidomide|thalidomide|mesh-list
83973285|NCT02755844|Metformin|metformin|mesh-list
83973358|NCT01641341|Pancreatin|pancreatin|mesh-list
83973430|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
83973655|NCT01646567|Hormones|hormones|mesh-ancestor
83973730|NCT01604382|Narcotics|narcotics|mesh-ancestor
83973809|NCT01604928|Mirabegron|mirabegron|mesh-list
83973878|NCT01605357|Mannitol|mannitol|mesh-list
83973956|NCT01648556|Prednisone|prednisone|mesh-list
83974036|NCT01684085|Lorazepam|lorazepam|mesh-list
83974118|NCT01689129|Insulin|insulin|mesh-list
83974180|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
83974866|NCT01685255|Tamoxifen|tamoxifen|mesh-list
83975001|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
83975754|NCT02485418|Propofol|propofol|mesh-list
83975898|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
83976277|NCT00593580|Vitamin D|vitamin d|mesh-list
83976428|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
83976579|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83976657|NCT02271464|Growth Substances|growth substances|mesh-ancestor
83976729|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83977027|NCT01335464|Nintedanib|nintedanib|mesh-list
83977321|NCT01348763|Maraviroc|maraviroc|mesh-list
83977985|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
83978211|NCT04908865|Belimumab|belimumab|mesh-list
83978285|NCT00598533|Sirolimus|sirolimus|mesh-list
83978507|NCT01323582|Azithromycin|azithromycin|mesh-list
83978736|NCT01313858|Golimumab|golimumab|mesh-list
83979195|NCT02875873|Methamphetamine|methamphetamine|mesh-list
83979862|NCT01048099|Pertuzumab|pertuzumab|mesh-list
83979926|NCT01045447|Insulin|insulin|mesh-list
83980069|NCT00626977|Analgesics|analgesics|mesh-ancestor
83980443|NCT01093222|Sorafenib|sorafenib|mesh-list
83980592|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83980808|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
83980885|NCT01293123|Tenofovir|tenofovir|mesh-list
83981190|NCT01281969|Antibodies|antibodies|mesh-list
83981497|NCT00627991|Valsartan|valsartan|mesh-list
83981571|NCT01012219|Vitamins|vitamins|mesh-ancestor
83981710|NCT04295551|Ritonavir|ritonavir|mesh-list
83982317|NCT01298778|Morphine|morphine|mesh-list
83982540|NCT04305964|Silicon|silicon|mesh-list
83982686|NCT01283334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83982835|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
83982907|NCT02889432|Protective Agents|protective agents|mesh-ancestor
83982984|NCT01029652|Triamcinolone|triamcinolone|mesh-list
83983504|NCT01056718|Nebivolol|nebivolol|mesh-list
83984098|NCT01007149|Omalizumab|omalizumab|mesh-list
83984174|NCT01294592|Urological Agents|urological agents|mesh-ancestor
83984398|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
83984627|NCT00985621|Tanezumab|tanezumab|mesh-list
83984711|NCT00982657|Sunitinib|sunitinib|mesh-list
83984925|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
83985230|NCT04294966|Dronabinol|dronabinol|mesh-list
83985294|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
83985591|NCT01307267|Rituximab|rituximab|mesh-list
83985671|NCT01305941|Trastuzumab|trastuzumab|mesh-list
83985812|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83985887|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
83986269|NCT00998296|Nintedanib|nintedanib|mesh-list
83986760|NCT01170039|Lubiprostone|lubiprostone|mesh-list
83986842|NCT01254630|Vaccines|vaccines|mesh-list
83986909|NCT01290887|Reslizumab|reslizumab|mesh-list
83986980|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83987273|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987347|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987422|NCT00955357|Lacosamide|lacosamide|mesh-list
83987571|NCT01239342|Everolimus|everolimus|mesh-list
83987643|NCT01162239|Varenicline|varenicline|mesh-list
83988101|NCT04268563|Metformin|metformin|mesh-list
83988155|NCT00943735|Urological Agents|urological agents|mesh-ancestor
83988238|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
83988302|NCT00602407|Cilostazol|cilostazol|mesh-list
83988376|NCT01142193|Topiramate|topiramate|mesh-list
83988595|NCT02691156|Bilirubin|bilirubin|mesh-list
83988820|NCT01266590|Digoxin|digoxin|mesh-list
83989405|NCT05331469|Insulin|insulin|mesh-list
83990376|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
83990453|NCT00623987|Warfarin|warfarin|mesh-list
83990523|NCT02029001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83990743|NCT00996580|Estradiol|estradiol|mesh-list
83991258|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
83991506|NCT02867020|Prednisone|prednisone|mesh-list
83991937|NCT00625911|Ketamine|ketamine|mesh-list
83992026|NCT01109979|Estradiol|estradiol|mesh-list
83992155|NCT01101321|Oxycodone|oxycodone|mesh-list
83992289|NCT01251146|Atenolol|atenolol|mesh-list
83992357|NCT02878161|Methotrexate|methotrexate|mesh-list
83992453|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
83992589|NCT01251653|Gemcitabine|gemcitabine|mesh-list
83992647|NCT02877537|Albuterol|albuterol|mesh-list
83992787|NCT01080807|Modafinil|modafinil|mesh-list
83992858|NCT02864758|Vitamin K|vitamin k|mesh-list
83993208|NCT04319549|Eusol|eusol|mesh-list
83993296|NCT01868269|Hormones|hormones|mesh-ancestor
83994090|NCT02845999|Cetuximab|cetuximab|mesh-list
83994177|NCT00968968|Trastuzumab|trastuzumab|mesh-list
83994232|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
83994393|NCT01229267|Vaccines|vaccines|mesh-list
83994923|NCT00629824|Ribavirin|ribavirin|mesh-list
83995860|NCT01061151|Ritonavir|ritonavir|mesh-list
83996089|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996363|NCT04192903|Cisplatin|cisplatin|mesh-list
83996572|NCT02809105|Linaclotide|linaclotide|mesh-list
83996871|NCT04301895|Analgesics|analgesics|mesh-ancestor
83997398|NCT01196052|Maytansine|maytansine|mesh-list
83997688|NCT02781493|Prucalopride|prucalopride|mesh-list
83997838|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
83998212|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
83998300|NCT02771743|Analgesics|analgesics|mesh-ancestor
83998595|NCT02767999|Fluoxetine|fluoxetine|mesh-list
83998662|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
83998816|NCT05357040|Analgesics|analgesics|mesh-ancestor
83999719|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999877|NCT02753647|Prednisone|prednisone|mesh-list
84000020|NCT02750293|Vitamin D|vitamin d|mesh-list
84000240|NCT02695381|Lidocaine|lidocaine|mesh-list
84000696|NCT02730949|Inositol|inositol|mesh-list
84000921|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
84001530|NCT00940342|Rituximab|rituximab|mesh-list
84001606|NCT00605098|Ritonavir|ritonavir|mesh-list
84001829|NCT01010217|Tacrolimus|tacrolimus|mesh-list
84001985|NCT00933244|Vitamin D|vitamin d|mesh-list
84002205|NCT04527757|Anesthetics|anesthetics|mesh-list
84002283|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
84002394|NCT00613717|Iron|iron|mesh-list
84002554|NCT02118727|Memantine|memantine|mesh-list
84002881|NCT01012713|Vitamins|vitamins|mesh-ancestor
84002964|NCT02701933|Ketamine|ketamine|mesh-list
84004218|NCT02689141|Ofatumumab|ofatumumab|mesh-list
84004293|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
84004443|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
84004819|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005500|NCT01147848|Fluticasone|fluticasone|mesh-list
84005585|NCT00610246|Sorafenib|sorafenib|mesh-list
84006091|NCT02678767|Hematinics|hematinics|mesh-ancestor
84006243|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
84006317|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84006852|NCT05892510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84007550|NCT05095116|Xhance|xhance|mesh-list
84007772|NCT04802161|Cytarabine|cytarabine|mesh-list
84007913|NCT04410653|Afatinib|afatinib|mesh-list
84008136|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008445|NCT02960022|Prednisone|prednisone|mesh-list
84008659|NCT02396043|Asparaginase|asparaginase|mesh-list
84008809|NCT00544830|Bicalutamide|bicalutamide|mesh-list
84008969|NCT00002514|Vitamins|vitamins|mesh-ancestor
84009189|NCT04287387|Pioglitazone|pioglitazone|mesh-list
84009259|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
84009488|NCT02668159|Vitamin D|vitamin d|mesh-list
84009781|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
84009857|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
84009932|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010079|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
84010158|NCT01167192|Carboplatin|carboplatin|mesh-list
84010678|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
84010768|NCT00648817|Tenofovir|tenofovir|mesh-list
84010821|NCT05438498|Antiviral Agents|antiviral agents|mesh-ancestor
84010894|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011120|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
84011416|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
84011489|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84011567|NCT02650609|Prednisolone|prednisolone|mesh-list
84012093|NCT00632086|Aspirin|aspirin|mesh-list
84012394|NCT00910975|Interferons|interferons|mesh-list
84012543|NCT00654121|Insulin|insulin|mesh-list
84012844|NCT02638831|Ketorolac|ketorolac|mesh-list
84012914|NCT02645461|Protective Agents|protective agents|mesh-ancestor
84013064|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
84013216|NCT02858505|Iron|iron|mesh-list
84013365|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013796|NCT02850250|Cefuroxime|cefuroxime|mesh-list
84014249|NCT04481308|Narcotics|narcotics|mesh-ancestor
84014402|NCT03524326|Lenvatinib|lenvatinib|mesh-list
84014479|NCT00794794|Cetirizine|cetirizine|mesh-list
84014775|NCT00657397|Narcotics|narcotics|mesh-ancestor
84015071|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015152|NCT02630485|Vitamins|vitamins|mesh-ancestor
84015747|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
84015914|NCT01157117|Omalizumab|omalizumab|mesh-list
84016121|NCT00889252|Ketotifen|ketotifen|mesh-list
84016418|NCT04157491|Antibodies|antibodies|mesh-list
84016562|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
84017014|NCT00677755|Misoprostol|misoprostol|mesh-list
84017161|NCT02823106|Verapamil|verapamil|mesh-list
84017529|NCT02818270|Albuterol|albuterol|mesh-list
84017750|NCT05658874|Gabapentin|gabapentin|mesh-list
84018490|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84018563|NCT00684229|Anesthetics|anesthetics|mesh-list
84019236|NCT01149473|Diuretics|diuretics|mesh-ancestor
84019991|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
84020153|NCT02785978|Levodopa|levodopa|mesh-list
84020215|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
84020292|NCT04230460|Ethanol|ethanol|mesh-list
84020363|NCT00864097|Analgesics|analgesics|mesh-ancestor
84020441|NCT02615041|Meropenem|meropenem|mesh-list
84020529|NCT04132063|Levetiracetam|levetiracetam|mesh-list
84020658|NCT02781064|Atorvastatin|atorvastatin|mesh-list
84020814|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
84021335|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
84021408|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84021514|NCT02771704|Iodine|iodine|mesh-list
84021559|NCT02770378|Temozolomide|temozolomide|mesh-list
84021633|NCT00943917|Exenatide|exenatide|mesh-list
84021716|NCT02851095|Metformin|metformin|mesh-list
84021860|NCT02696512|Vitamins|vitamins|mesh-ancestor
84021940|NCT02767024|Nitroprusside|nitroprusside|mesh-list
84022093|NCT02762812|Infliximab|infliximab|mesh-list
84022310|NCT05383131|Nintedanib|nintedanib|mesh-list
84022680|NCT02757196|Rituximab|rituximab|mesh-list
84022758|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
84022911|NCT04220632|Hormones|hormones|mesh-ancestor
84022983|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
84023282|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
84023431|NCT04745910|Uric Acid|uric acid|mesh-list
84023665|NCT01071798|Rituximab|rituximab|mesh-list
84023975|NCT03633058|Ketamine|ketamine|mesh-list
84024706|NCT02882477|Deferiprone|deferiprone|mesh-list
84025003|NCT02710552|Indapamide|indapamide|mesh-list
84025312|NCT04231318|Triamcinolone|triamcinolone|mesh-list
84025819|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
84025965|NCT00609375|Cefepime|cefepime|mesh-list
84026112|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
84026337|NCT00608595|Analgesics|analgesics|mesh-ancestor
84026415|NCT00609531|Citalopram|citalopram|mesh-list
84026493|NCT00927069|Adalimumab|adalimumab|mesh-list
84026779|NCT01030536|Immunoconjugates|immunoconjugates|mesh-ancestor
84027082|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
84027158|NCT02705638|Rituximab|rituximab|mesh-list
84027243|NCT02699710|Vitamins|vitamins|mesh-ancestor
84027529|NCT04300686|Antibodies|antibodies|mesh-list
84027904|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027980|NCT00832819|Paclitaxel|paclitaxel|mesh-list
84028277|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
84028350|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84028431|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84028516|NCT01091519|Fesoterodine|fesoterodine|mesh-list
84028649|NCT00631527|Sunitinib|sunitinib|mesh-list
84028802|NCT04648540|Narcotics|narcotics|mesh-ancestor
84028953|NCT00621556|Secretin|secretin|mesh-list
84029328|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84029708|NCT03844750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030316|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
84030613|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84030692|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
84031007|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
84031101|NCT02870634|Copper|copper|mesh-list
84031146|NCT00998946|Vitamins|vitamins|mesh-list
84031302|NCT04292886|Tamoxifen|tamoxifen|mesh-list
84031435|NCT02665624|Sennosides|sennosides|mesh-list
84031513|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
84031590|NCT02663440|Temozolomide|temozolomide|mesh-list
84031882|NCT02658838|Heparin|heparin|mesh-list
84032032|NCT01170962|Ribavirin|ribavirin|mesh-list
84032108|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032330|NCT00600886|Octreotide|octreotide|mesh-list
84032634|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
84033160|NCT00817531|Dasatinib|dasatinib|mesh-list
84033381|NCT00816595|Bevacizumab|bevacizumab|mesh-list
84034132|NCT00655330|Valsartan|valsartan|mesh-list
84034281|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84034581|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
84034808|NCT00657202|Ranibizumab|ranibizumab|mesh-list
84034887|NCT01077713|Bevacizumab|bevacizumab|mesh-list
84035029|NCT02865642|Serotonin|serotonin|mesh-list
84035178|NCT00975000|Cinacalcet|cinacalcet|mesh-list
84035325|NCT05780073|Dasatinib|dasatinib|mesh-list
84035400|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
84035559|NCT05444946|Itraconazole|itraconazole|mesh-list
84035698|NCT04907370|Antibodies|antibodies|mesh-list
84035998|NCT03871621|Metformin|metformin|mesh-list
84036146|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
84036294|NCT02582008|Bupropion|bupropion|mesh-list
84036602|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
84036742|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
84036822|NCT04646187|Adalimumab|adalimumab|mesh-list
84036963|NCT00662896|Analgesics|analgesics|mesh-ancestor
84037186|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
84037265|NCT03773445|Golimumab|golimumab|mesh-list
84037483|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
84037570|NCT02191566|Tegafur|tegafur|mesh-list
84037639|NCT00668356|Didanosine|didanosine|mesh-list
84037708|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037876|NCT00809341|Hormones|hormones|mesh-ancestor
84037934|NCT00808639|Vinblastine|vinblastine|mesh-list
84038159|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
84038380|NCT00807937|Lorazepam|lorazepam|mesh-list
84038676|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84038749|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
84039052|NCT00952068|Tramadol|tramadol|mesh-list
84039138|NCT00946998|Sertraline|sertraline|mesh-list
84039344|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84039648|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
84040118|NCT02848209|Phenol|phenol|mesh-list
84040320|NCT00157911|Simvastatin|simvastatin|mesh-list
84040640|NCT04268394|Analgesics|analgesics|mesh-ancestor
84040773|NCT00686140|Celecoxib|celecoxib|mesh-list
84040834|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
84041080|NCT04138888|Olmesartan|olmesartan|mesh-list
84041513|NCT02624440|Clarithromycin|clarithromycin|mesh-list
84041595|NCT00674596|Ramipril|ramipril|mesh-list
84041961|NCT00871000|Antidotes|antidotes|mesh-ancestor
84042039|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84042111|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042328|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
84042400|NCT00868192|Bevacizumab|bevacizumab|mesh-list
84043221|NCT00796549|Afatinib|afatinib|mesh-list
84043595|NCT02617654|Liraglutide|liraglutide|mesh-list
84043674|NCT00899847|Acetaminophen|acetaminophen|mesh-list
84043749|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
84044051|NCT01074008|Ritonavir|ritonavir|mesh-list
84044127|NCT01067144|Gabapentin|gabapentin|mesh-list
84044284|NCT05304663|Lomustine|lomustine|mesh-list
84044343|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
84044566|NCT04254744|Sevoflurane|sevoflurane|mesh-list
84044939|NCT00914940|Fludarabine|fludarabine|mesh-list
84045088|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
84045165|NCT00626600|Analgesics|analgesics|mesh-ancestor
84045539|NCT00632268|Leucovorin|leucovorin|mesh-list
84045612|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045914|NCT02612272|Hormones|hormones|mesh-ancestor
84045997|NCT02825121|Iodine|iodine|mesh-list
84046201|NCT00766675|Analgesics|analgesics|mesh-ancestor
84046447|NCT02817477|Ketamine|ketamine|mesh-list
84046719|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
84047240|NCT00907374|Benazepril|benazepril|mesh-list
84047313|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
84047689|NCT05761444|Atorvastatin|atorvastatin|mesh-list
84048069|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
84048218|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
84048298|NCT04408625|Sirolimus|sirolimus|mesh-list
84048371|NCT04114136|Metformin|metformin|mesh-list
84048667|NCT02845596|Fludarabine|fludarabine|mesh-list
84048743|NCT02256865|Testosterone|testosterone|mesh-list
84048904|NCT02796183|Bevacizumab|bevacizumab|mesh-list
84049035|NCT02793843|Dexamethasone|dexamethasone|mesh-list
84049266|NCT00816166|Aspirin|aspirin|mesh-list
84050391|NCT05241912|Dobutamine|dobutamine|mesh-list
84050681|NCT04095013|Analgesics|analgesics|mesh-ancestor
84050758|NCT02599675|Vitamin D|vitamin d|mesh-list
84051583|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
84051638|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84051791|NCT02764281|Dexamethasone|dexamethasone|mesh-list
84051990|NCT02695797|Hormones|hormones|mesh-ancestor
84052142|NCT02753205|Analgesics|analgesics|mesh-ancestor
84052662|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
84053029|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84053481|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
84053771|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
84054000|NCT00914056|Lactulose|lactulose|mesh-list
84054148|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
84054305|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
84055049|NCT03484923|Spartalizumab|spartalizumab|mesh-list
84055123|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
84055273|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
84055444|NCT03414723|Ramipril|ramipril|mesh-list
84055487|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
84055567|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
84055642|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84055722|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
84055868|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84056388|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056610|NCT02706015|Dipyrone|dipyrone|mesh-list
84057356|NCT02698995|Narcotics|narcotics|mesh-ancestor
84057507|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84057691|NCT00920725|Insulin|insulin|mesh-list
84057735|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
84057808|NCT04116073|Antibodies|antibodies|mesh-list
84058055|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
84058728|NCT00780910|Ribavirin|ribavirin|mesh-list
84059167|NCT02871518|Cisplatin|cisplatin|mesh-list
84059318|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84059471|NCT04188171|Polidocanol|polidocanol|mesh-list
84059544|NCT00621387|Ofloxacin|ofloxacin|mesh-list
84060217|NCT00769132|Vitamins|vitamins|mesh-ancestor
84060388|NCT04073173|Analgesics|analgesics|mesh-list
84060703|NCT00715273|Niacin|niacin|mesh-list
84060828|NCT00603447|Hormones|hormones|mesh-ancestor
84061194|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
84061719|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061795|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061870|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84062180|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
84062318|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062563|NCT00730093|Vitamins|vitamins|mesh-ancestor
84062913|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
84062998|NCT00642135|Phenylephrine|phenylephrine|mesh-list
84063160|NCT02674737|Tramadol|tramadol|mesh-list
84063515|NCT00738985|Simvastatin|simvastatin|mesh-list
84064263|NCT00741325|Lenograstim|lenograstim|mesh-list
84064409|NCT04578613|Rituximab|rituximab|mesh-list
84064556|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
84065069|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
84065211|NCT00961298|Analgesics|analgesics|mesh-ancestor
84065836|NCT01012037|Hormones|hormones|mesh-ancestor
84066110|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066184|NCT00628667|Esomeprazole|esomeprazole|mesh-list
84066410|NCT01005251|Lesogaberan|lesogaberan|mesh-list
84066562|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
84066801|NCT00694369|Ibuprofen|ibuprofen|mesh-list
84067690|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84067841|NCT00572455|Latanoprost|latanoprost|mesh-list
84067917|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
84068522|NCT00754429|Losartan|losartan|mesh-list
84069007|NCT05170009|Baloxavir|baloxavir|mesh-list
84069304|NCT04767061|Bisoprolol|bisoprolol|mesh-list
84069461|NCT04115956|Hormones|hormones|mesh-ancestor
84069607|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
84069907|NCT05857267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84070885|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
84070959|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
84071556|NCT04416568|Nivolumab|nivolumab|mesh-list
84071705|NCT00775177|Doxycycline|doxycycline|mesh-list
84071861|NCT00668863|Vitamins|vitamins|mesh-ancestor
84072079|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
84072303|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84072381|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
84072532|NCT00769405|Antidotes|antidotes|mesh-ancestor
84072770|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
84072832|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84072905|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
84072982|NCT00665431|Analgesics|analgesics|mesh-ancestor
84073127|NCT02631603|Hormones|hormones|mesh-ancestor
84073203|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84075144|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
84075222|NCT00924950|Vitamins|vitamins|mesh-ancestor
84075293|NCT00797485|Leucovorin|leucovorin|mesh-list
84075515|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84075743|NCT05832619|Serotonin Agents|serotonin agents|mesh-ancestor
84075816|NCT05830539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076191|NCT05295784|Caffeine|caffeine|mesh-list
84076340|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
84076881|NCT02473497|Crizotinib|crizotinib|mesh-list
84077168|NCT04291313|Vitamin D|vitamin d|mesh-list
84077239|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077383|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
84077532|NCT03853187|Durvalumab|durvalumab|mesh-list
84077680|NCT04133571|Lidocaine|lidocaine|mesh-list
84078814|NCT00810667|Serotonin Agents|serotonin agents|mesh-ancestor
84078960|NCT04045093|Warfarin|warfarin|mesh-list
84079110|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
84079329|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
84080153|NCT00568399|Antidotes|antidotes|mesh-ancestor
84080310|NCT02862509|Budesonide|budesonide|mesh-list
84080388|NCT04283435|Estradiol|estradiol|mesh-list
84080528|NCT00626275|Naproxen|naproxen|mesh-list
84080830|NCT02845778|Melatonin|melatonin|mesh-list
84080901|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080984|NCT00896454|Denosumab|denosumab|mesh-list
84081428|NCT05878574|Heparin|heparin|mesh-list
84081876|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84082248|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
84082403|NCT04005716|Tislelizumab|tislelizumab|mesh-list
84082478|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
84082567|NCT03467373|Hormones|hormones|mesh-ancestor
84082776|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082927|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323518|NCT01969721|Xhance|xhance|mesh-list
84083692|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
84084584|NCT02611635|Warfarin|warfarin|mesh-list
84084659|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84084808|NCT00829179|Omalizumab|omalizumab|mesh-list
84084957|NCT02820948|Tocotrienols|tocotrienols|mesh-list
84085112|NCT02818140|Ropivacaine|ropivacaine|mesh-list
84085180|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
84085478|NCT00837187|Analgesics|analgesics|mesh-ancestor
84086005|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84086237|NCT02803788|Ramosetron|ramosetron|mesh-list
84086461|NCT00855361|Rabeprazole|rabeprazole|mesh-list
84087047|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84087507|NCT00876889|Riluzole|riluzole|mesh-list
84087953|NCT00874861|Poly ICLC|poly iclc|mesh-list
84088100|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088477|NCT00634686|Calcium|calcium|mesh-list
84089147|NCT04204928|Pralsetinib|pralsetinib|mesh-list
84089526|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
84089750|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
84089831|NCT02770950|Indomethacin|indomethacin|mesh-list
84090199|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84090271|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84090346|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84090496|NCT02696460|Prilocaine|prilocaine|mesh-list
84090571|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84090944|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
84091021|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
84091169|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
84091324|NCT00631085|Tocopherols|tocopherols|mesh-list
84092514|NCT00005112|Hormones|hormones|mesh-list
84092795|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
84092947|NCT05378867|Bevacizumab|bevacizumab|mesh-list
84093174|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093326|NCT00931645|Hormones|hormones|mesh-ancestor
84093481|NCT05379647|Rituximab|rituximab|mesh-list
84093792|NCT02747316|Iron|iron|mesh-list
84093853|NCT02741232|Lidocaine|lidocaine|mesh-list
84094227|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84094303|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
84094467|NCT05786885|Vitamins|vitamins|mesh-list
84094599|NCT05685628|Charcoal|charcoal|mesh-list
84094676|NCT05567731|Hormones|hormones|mesh-list
84094897|NCT05211804|Growth Substances|growth substances|mesh-ancestor
84095114|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
84095191|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84095264|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
84095336|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095637|NCT02617589|Nivolumab|nivolumab|mesh-list
84095786|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095937|NCT05590598|Azelastine|azelastine|mesh-list
84096090|NCT02729766|Empagliflozin|empagliflozin|mesh-list
84096318|NCT02738814|Propofol|propofol|mesh-list
84096379|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
84096451|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
84096543|NCT02738346|Etoposide|etoposide|mesh-list
84096606|NCT05906199|Aspirin|aspirin|mesh-list
84096846|NCT05843565|Cobalt|cobalt|mesh-list
84097352|NCT05311176|Paclitaxel|paclitaxel|mesh-list
84098185|NCT03816345|Nivolumab|nivolumab|mesh-list
84098410|NCT03317457|Doxorubicin|doxorubicin|mesh-list
84098484|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84098641|NCT02119468|Ixazomib|ixazomib|mesh-list
84098709|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098792|NCT01164228|Sunitinib|sunitinib|mesh-list
84099011|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
84099164|NCT00003010|Marimastat|marimastat|mesh-list
84099385|NCT00929669|Pasireotide|pasireotide|mesh-list
84100207|NCT02793986|Analgesics|analgesics|mesh-ancestor
84100884|NCT02796794|Genistein|genistein|mesh-list
84100962|NCT04096599|Fluorides|fluorides|mesh-list
84101476|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84101703|NCT02721888|Liraglutide|liraglutide|mesh-list
84101854|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
84102073|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102244|NCT02711202|Sirolimus|sirolimus|mesh-list
84102309|NCT04942886|Entecavir|entecavir|mesh-list
84102379|NCT00562627|Narcotics|narcotics|mesh-ancestor
84102454|NCT02710656|Paclitaxel|paclitaxel|mesh-list
84102599|NCT00921557|Vitamin D|vitamin d|mesh-list
84102758|NCT04821284|Antidotes|antidotes|mesh-ancestor
84102828|NCT00611910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102981|NCT02774096|Xenon|xenon|mesh-list
84103426|NCT00910221|Atorvastatin|atorvastatin|mesh-list
84103503|NCT02766140|Docetaxel|docetaxel|mesh-list
84104024|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84104169|NCT00949663|Hormones|hormones|mesh-ancestor
84104316|NCT02659761|Abacavir|abacavir|mesh-list
84104328|NCT05343546|Copper|copper|mesh-list
84104400|NCT00954811|Hormones|hormones|mesh-ancestor
84104537|NCT00649311|Diuretics|diuretics|mesh-ancestor
84104614|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
84105056|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
84105129|NCT04219046|Naloxegol|naloxegol|mesh-list
84105203|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84105581|NCT00616746|Ethanol|ethanol|mesh-list
84105725|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
84106178|NCT02731430|Analgesics|analgesics|mesh-ancestor
84106931|NCT00782288|Digitoxin|digitoxin|mesh-list
84107501|NCT04164615|Capecitabine|capecitabine|mesh-list
84107731|NCT02707250|Meperidine|meperidine|mesh-list
84107877|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
84107951|NCT04470674|Carboplatin|carboplatin|mesh-list
84108317|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
84108826|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84109433|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84109737|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
84109887|NCT00903617|Niacin|niacin|mesh-list
84110100|NCT00621036|Thiotepa|thiotepa|mesh-list
84110176|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84110476|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110556|NCT00380627|Etoricoxib|etoricoxib|mesh-list
84110619|NCT03711318|Naloxone|naloxone|mesh-list
84110693|NCT02686710|Propofol|propofol|mesh-list
84110843|NCT00619034|Analgesics|analgesics|mesh-ancestor
84110916|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
84110990|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
84111226|NCT00619424|Pemetrexed|pemetrexed|mesh-list
84111295|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
84111514|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111589|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
84111667|NCT02673606|Estradiol|estradiol|mesh-list
84112111|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
84112181|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84112334|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
84112409|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84112573|NCT04170270|Omeprazole|omeprazole|mesh-list
84112855|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113005|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
84113233|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113758|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
84113906|NCT00650910|Lapatinib|lapatinib|mesh-list
84114058|NCT00887549|Pemetrexed|pemetrexed|mesh-list
84114278|NCT00652860|Ifosfamide|ifosfamide|mesh-list
84114492|NCT00603512|Tofacitinib|tofacitinib|mesh-list
84114577|NCT04165512|Triamcinolone|triamcinolone|mesh-list
84114720|NCT02642484|Antacids|antacids|mesh-ancestor
84114793|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115093|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
84116207|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
84116359|NCT03549715|Durvalumab|durvalumab|mesh-list
84116433|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
84116509|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
84116590|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
84117184|NCT02816567|Narcotics|narcotics|mesh-ancestor
84117262|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118082|NCT00644774|Azithromycin|azithromycin|mesh-list
84118772|NCT04156464|Lorazepam|lorazepam|mesh-list
84118834|NCT00974155|Dexetimide|dexetimide|mesh-list
84118984|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119134|NCT02664116|Ketorolac|ketorolac|mesh-list
84119216|NCT05342597|Edaravone|edaravone|mesh-list
84119360|NCT00693381|Prednisone|prednisone|mesh-list
84119600|NCT02781467|Fludarabine|fludarabine|mesh-list
84119665|NCT02784743|Ivermectin|ivermectin|mesh-list
84119738|NCT05340803|Analgesics|analgesics|mesh-ancestor
84120482|NCT02656082|Etanercept|etanercept|mesh-list
84120783|NCT00983047|Docetaxel|docetaxel|mesh-list
84121015|NCT00600938|Deferasirox|deferasirox|mesh-list
84121089|NCT02775539|Mirabegron|mirabegron|mesh-list
84121173|NCT00988897|Vitamins|vitamins|mesh-ancestor
84121386|NCT04006483|Fluorides|fluorides|mesh-list
84122360|NCT02579356|Telmisartan|telmisartan|mesh-list
84122509|NCT02763059|Hormones|hormones|mesh-ancestor
84123032|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
84123191|NCT02575222|Nivolumab|nivolumab|mesh-list
84123257|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123411|NCT00681174|Acetaminophen|acetaminophen|mesh-list
84123792|NCT02750969|Lidocaine|lidocaine|mesh-list
84123911|NCT04069858|Entecavir|entecavir|mesh-list
84124009|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
84124160|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
84124465|NCT00990535|Octreotide|octreotide|mesh-list
84124758|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
84124848|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
84125074|NCT02742233|Saxagliptin|saxagliptin|mesh-list
84125229|NCT02741219|Dsuvia|dsuvia|mesh-list
84125443|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
84125749|NCT00721240|Montelukast|montelukast|mesh-list
84125904|NCT00536731|Hormones|hormones|mesh-ancestor
84126494|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126942|NCT00993109|Valsartan|valsartan|mesh-list
84128460|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
84128685|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84128761|NCT02715479|Dolutegravir|dolutegravir|mesh-list
84128908|NCT02714699|Bromides|bromides|mesh-list
84129058|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
84129444|NCT02615574|Celecoxib|celecoxib|mesh-list
84129961|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84130186|NCT00733720|Analgesics|analgesics|mesh-ancestor
84130263|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
84130408|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130563|NCT04246541|Ketorolac|ketorolac|mesh-list
84130863|NCT00851799|Ritonavir|ritonavir|mesh-list
84131236|NCT00736294|Ramipril|ramipril|mesh-list
84131464|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
84131608|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131682|NCT03632213|Losartan|losartan|mesh-list
84131904|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
84131977|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
84132057|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
84132129|NCT04491643|Megestrol|megestrol|mesh-list
84132347|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132502|NCT00613769|Cefuroxime|cefuroxime|mesh-list
84132571|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
84132786|NCT02702843|Xenon|xenon|mesh-list
84132868|NCT00856986|Metformin|metformin|mesh-list
84133320|NCT02701127|Niacin|niacin|mesh-list
84133407|NCT00669656|Hormones|hormones|mesh-ancestor
84133470|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
84133786|NCT01009801|Everolimus|everolimus|mesh-list
84133912|NCT01015417|Amoxicillin|amoxicillin|mesh-list
84133989|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
84134214|NCT04154852|Folic Acid|folic acid|mesh-list
84134441|NCT00678626|Docetaxel|docetaxel|mesh-list
84134667|NCT00854724|Puerarin|puerarin|mesh-list
84134818|NCT00822237|Vaccines|vaccines|mesh-list
84135119|NCT00742846|Lidocaine|lidocaine|mesh-list
84135268|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
84135428|NCT00686192|Calcium|calcium|mesh-list
84135505|NCT00621101|Sirolimus|sirolimus|mesh-list
84135656|NCT00622115|Enoxaparin|enoxaparin|mesh-list
84135953|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
84136026|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
84136244|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
84136556|NCT01014559|Oxycodone|oxycodone|mesh-list
84136846|NCT00499369|Leucovorin|leucovorin|mesh-list
84137073|NCT00498433|Amlodipine|amlodipine|mesh-list
84137221|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
84137600|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
84137903|NCT04119752|Curcumin|curcumin|mesh-list
84138202|NCT02684123|Apremilast|apremilast|mesh-list
84138274|NCT02683733|Curcumin|curcumin|mesh-list
84138574|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138883|NCT02678975|Copper|copper|mesh-list
84138952|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
84139358|NCT00644891|Cefdinir|cefdinir|mesh-list
84139491|NCT02668679|Hormones|hormones|mesh-list
84139560|NCT02667197|Narcotics|narcotics|mesh-ancestor
84139627|NCT02666417|Iron|iron|mesh-list
84139922|NCT00648791|Finasteride|finasteride|mesh-list
84140067|NCT00648869|Metformin|metformin|mesh-list
84140441|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84140746|NCT02644499|Folic Acid|folic acid|mesh-list
84140817|NCT00651599|Estradiol|estradiol|mesh-list
84141037|NCT02641457|Aflibercept|aflibercept|mesh-list
84141112|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141346|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
84141571|NCT00703638|Pemetrexed|pemetrexed|mesh-list
84141643|NCT02118467|Synephrine|synephrine|mesh-list
84142089|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
84142187|NCT04158713|Artenimol|artenimol|mesh-list
84142697|NCT05357768|Formaldehyde|formaldehyde|mesh-list
84143228|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
84143532|NCT03115567|Hormones|hormones|mesh-ancestor
84143598|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
84143675|NCT00858273|Insulin|insulin|mesh-list
84143976|NCT00666887|Minocycline|minocycline|mesh-list
84144273|NCT00708240|Escitalopram|escitalopram|mesh-list
84144341|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144500|NCT00911651|Bromides|bromides|mesh-list
84144867|NCT00674687|Gabapentin|gabapentin|mesh-list
84144937|NCT00674999|Bacitracin|bacitracin|mesh-list
84145021|NCT00675545|Carboplatin|carboplatin|mesh-list
84145772|NCT00822120|Hormones|hormones|mesh-ancestor
84145917|NCT02559388|Montelukast|montelukast|mesh-list
84145987|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
84146212|NCT00770302|Hormones|hormones|mesh-ancestor
84146281|NCT00820950|Hormones|hormones|mesh-ancestor
84146575|NCT00775840|Candesartan|candesartan|mesh-list
84146878|NCT04150757|Ketamine|ketamine|mesh-list
84146954|NCT00820170|Paclitaxel|paclitaxel|mesh-list
84147251|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
84147554|NCT00683735|Hormones|hormones|mesh-ancestor
84148067|NCT02555800|Bevacizumab|bevacizumab|mesh-list
84148384|NCT00873119|Paclitaxel|paclitaxel|mesh-list
84148988|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
83684373|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84149355|NCT04030988|Dexamethasone|dexamethasone|mesh-list
84149579|NCT00659230|Dopamine|dopamine|mesh-list
84149727|NCT04031027|Apremilast|apremilast|mesh-list
84149809|NCT02608710|Verinurad|verinurad|mesh-list
84149951|NCT04961190|Paroxetine|paroxetine|mesh-list
84150245|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
84151606|NCT03746275|Aspirin|aspirin|mesh-list
84151748|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84151824|NCT01026961|Acetaminophen|acetaminophen|mesh-list
84151899|NCT00830804|Ritonavir|ritonavir|mesh-list
84151974|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84152508|NCT00811096|Tinidazole|tinidazole|mesh-list
84152656|NCT00811408|Cidofovir|cidofovir|mesh-list
84153771|NCT00640510|Olanzapine|olanzapine|mesh-list
84153914|NCT00794040|Citalopram|citalopram|mesh-list
84154073|NCT00633880|Droxidopa|droxidopa|mesh-list
84154328|NCT00626392|Niacin|niacin|mesh-list
84154373|NCT00624052|Amlodipine|amlodipine|mesh-list
84155112|NCT04101474|Ketamine|ketamine|mesh-list
84155257|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84155706|NCT00842153|Clobetasol|clobetasol|mesh-list
84155784|NCT00703469|Nivolumab|nivolumab|mesh-list
84156227|NCT00834899|Eptifibatide|eptifibatide|mesh-list
84156301|NCT03908060|Morphine|morphine|mesh-list
84156370|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
84156593|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
84156849|NCT02610881|Iron|iron|mesh-list
84156896|NCT00708773|Irinotecan|irinotecan|mesh-list
84157191|NCT03977142|Chrysarobin|chrysarobin|mesh-list
84157634|NCT00819767|Valsartan|valsartan|mesh-list
84158015|NCT00914576|Vitamins|vitamins|mesh-list
84158542|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
84158611|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
84158688|NCT00724815|Sumatriptan|sumatriptan|mesh-list
84158766|NCT00734994|Mitomycins|mitomycins|mesh-list
84159443|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
84159511|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
84159582|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
84159659|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
84159883|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
84160105|NCT00774800|Insulin|insulin|mesh-list
84160258|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84160412|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84160487|NCT00765674|Amlodipine|amlodipine|mesh-list
83684374|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84160806|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
84161021|NCT05674695|Omalizumab|omalizumab|mesh-list
84161088|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
84161310|NCT00759356|Morphine|morphine|mesh-list
84161684|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
84162287|NCT04108013|Carboplatin|carboplatin|mesh-list
84162514|NCT02600780|Allopurinol|allopurinol|mesh-list
84162588|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
84163039|NCT00720096|Topotecan|topotecan|mesh-list
84163416|NCT02596334|Abacavir|abacavir|mesh-list
84163724|NCT00441337|Nivolumab|nivolumab|mesh-list
84163799|NCT03949153|Nivolumab|nivolumab|mesh-list
84163941|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
84164023|NCT00715689|Hormones|hormones|mesh-list
84164246|NCT00720135|Antibodies|antibodies|mesh-list
84164625|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
84164933|NCT02586636|Metformin|metformin|mesh-list
84165079|NCT00724035|Narcotics|narcotics|mesh-ancestor
84165537|NCT00730197|Albuterol|albuterol|mesh-list
84166209|NCT00921063|Alprazolam|alprazolam|mesh-list
83684375|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684376|NCT01661530|Vitamin E|vitamin e|mesh-list
83684377|NCT01661530|Vitamins|vitamins|mesh-ancestor
83684378|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
83684379|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684380|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
83684381|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684382|NCT01661530|Protective Agents|protective agents|mesh-ancestor
83684383|NCT01661556|Miconazole|miconazole|mesh-list
83684384|NCT01661556|Hydroquinone|hydroquinone|mesh-list
83684385|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
83684386|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684387|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83684388|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83684389|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684390|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684391|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83684392|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684393|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684394|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684395|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83684396|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83684397|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
82839206|NCT03920878|Growth Substances|growth substances|mesh-ancestor
83684398|NCT01661556|Protective Agents|protective agents|mesh-ancestor
83684399|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83684401|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
83684402|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684403|NCT01661777|Diuretics|diuretics|mesh-list
83684404|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
83684405|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83684406|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
83684407|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684408|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
83684409|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684410|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684411|NCT01661855|Riluzole|riluzole|mesh-list
83549517|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83549518|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
83549519|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83549520|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83549521|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83549522|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83549523|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549524|NCT05731778|Listerine|listerine|mesh-list
83549525|NCT05731778|Fluorides|fluorides|mesh-list
83549526|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
83549527|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
83549528|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
83549529|NCT05731778|Protective Agents|protective agents|mesh-ancestor
83549530|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549531|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83549532|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549533|NCT05477264|Tislelizumab|tislelizumab|mesh-list
83549534|NCT05477264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549535|NCT05477264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549536|NCT00422318|Benzbromarone|benzbromarone|mesh-list
83549537|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
83549538|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
83549539|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549540|NCT00364754|Tesmilifene|tesmilifene|mesh-list
83549541|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
83549542|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
83549543|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549544|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549545|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549546|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83549547|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
83549548|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83549549|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549550|NCT04741880|Lidocaine|lidocaine|mesh-list
83549551|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
83549552|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
83549553|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549554|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549555|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
83549556|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549557|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83549558|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83549559|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83549560|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83549561|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549562|NCT04742504|Benralizumab|benralizumab|mesh-list
83549563|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83549564|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83549565|NCT00365924|Teriparatide|teriparatide|mesh-list
83549566|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83549567|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549568|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83549569|NCT05360030|Ketamine|ketamine|mesh-list
83549570|NCT05360030|Naloxone|naloxone|mesh-list
83549571|NCT05360030|Analgesics|analgesics|mesh-ancestor
83549572|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
83549573|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549574|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549575|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83549576|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83549577|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
83549578|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
83549579|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549580|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83549581|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83549582|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549583|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549584|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83549585|NCT04158362|Paclitaxel|paclitaxel|mesh-list
83549586|NCT04158362|Capecitabine|capecitabine|mesh-list
83549587|NCT04158362|Letrozole|letrozole|mesh-list
83549588|NCT04158362|Fulvestrant|fulvestrant|mesh-list
83549589|NCT04158362|Anastrozole|anastrozole|mesh-list
83549590|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83549591|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549592|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549593|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549594|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549595|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549596|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83549598|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83549599|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83549600|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549601|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83549602|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
83549603|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549604|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549605|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549606|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83549607|NCT05272202|Propofol|propofol|mesh-list
83549608|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83549609|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549610|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549611|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83549612|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
83549613|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
83549614|NCT01575834|Denosumab|denosumab|mesh-list
83549615|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83549616|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549617|NCT04718792|Psilocybin|psilocybin|mesh-list
83549618|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
83549619|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549620|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83549621|NCT05707442|Acetazolamide|acetazolamide|mesh-list
83549622|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
83549623|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83549624|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549625|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549626|NCT05707442|Diuretics|diuretics|mesh-ancestor
83549627|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
83549628|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549629|NCT04604132|Paclitaxel|paclitaxel|mesh-list
83549630|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83549631|NCT04604132|Atezolizumab|atezolizumab|mesh-list
83549632|NCT04604132|Ramucirumab|ramucirumab|mesh-list
83549633|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83549634|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83549635|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549636|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549637|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549638|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549639|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549640|NCT04604132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83549641|NCT04604132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549642|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
83549643|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549644|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83549645|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549646|NCT05193188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549647|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549648|NCT04799262|Prednisone|prednisone|mesh-list
83549649|NCT04799262|Tofacitinib|tofacitinib|mesh-list
83549650|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549651|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
83549652|NCT04799262|Hormones|hormones|mesh-ancestor
83549653|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549654|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549655|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549656|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549657|NCT04799262|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83549658|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83549659|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549660|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549661|NCT00851136|Bevacizumab|bevacizumab|mesh-list
83549662|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549663|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549664|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83549665|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83549666|NCT00851136|Growth Substances|growth substances|mesh-ancestor
83549667|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549668|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
83549669|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
83549670|NCT00366470|Vitamin D|vitamin d|mesh-list
83549671|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83549672|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549673|NCT00366470|Vitamins|vitamins|mesh-ancestor
83549674|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
83549675|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83549676|NCT04537286|Paclitaxel|paclitaxel|mesh-list
83549677|NCT04537286|Cisplatin|cisplatin|mesh-list
83549678|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83549679|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549680|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549681|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549682|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549683|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549684|NCT02620904|Mifepristone|mifepristone|mesh-list
83549685|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83549686|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
83549687|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83549688|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549689|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83549690|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83549691|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83549692|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
83549693|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83549694|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83549695|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
83549696|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549697|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
83549698|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83549699|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83549700|NCT00300768|Ivermectin|ivermectin|mesh-list
83549701|NCT00300768|Moxidectin|moxidectin|mesh-list
83549702|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83549703|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549704|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
83549705|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
83549706|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
83549707|NCT02621060|Antacids|antacids|mesh-ancestor
83549708|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549709|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83549710|NCT04740554|Prednisone|prednisone|mesh-list
83549711|NCT04740554|Deflazacort|deflazacort|mesh-list
83549712|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549713|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
83549714|NCT04740554|Hormones|hormones|mesh-ancestor
83549715|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549716|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549717|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549718|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549719|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83549720|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
83549721|NCT04506086|Blinatumomab|blinatumomab|mesh-list
83549722|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549723|NCT02624180|Colchicine|colchicine|mesh-list
83549724|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
83549725|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549726|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549727|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549728|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549729|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549730|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549731|NCT05068232|Carboplatin|carboplatin|mesh-list
83549732|NCT05068232|Etoposide|etoposide|mesh-list
83549733|NCT05068232|Durvalumab|durvalumab|mesh-list
83549734|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549735|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83549736|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83549737|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83549738|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549739|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549740|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549741|NCT04326764|Panobinostat|panobinostat|mesh-list
83549742|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549743|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83549744|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549745|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549746|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83549747|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83549748|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
83549749|NCT02629094|Eplerenone|eplerenone|mesh-list
83549750|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83549751|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
83549752|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549753|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549754|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83549755|NCT02629094|Diuretics|diuretics|mesh-ancestor
83549756|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
83549757|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83549758|NCT02630030|Ixazomib|ixazomib|mesh-list
83549759|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549760|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
83549761|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549762|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549763|NCT04289792|Paclitaxel|paclitaxel|mesh-list
83549764|NCT04289792|Gemcitabine|gemcitabine|mesh-list
83549765|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83549766|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549767|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549768|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549769|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549770|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549771|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83549772|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
83549773|NCT02631590|Gemcitabine|gemcitabine|mesh-list
83549774|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549775|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83549776|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
83549777|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549778|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
83549779|NCT02253654|Hematinics|hematinics|mesh-ancestor
83549780|NCT02252406|Ranolazine|ranolazine|mesh-list
83549781|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83549782|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83549783|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549784|NCT02252016|Grazoprevir|grazoprevir|mesh-list
83549785|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
83549786|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549787|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83549788|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83549789|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
83549790|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549791|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83549792|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549793|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83549794|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549795|NCT02706847|Upadacitinib|upadacitinib|mesh-list
83549796|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83549797|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83549798|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549799|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549800|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549801|NCT02470741|Letrozole|letrozole|mesh-list
83549802|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549803|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83549804|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83549805|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549806|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549807|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83549808|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
83549809|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549810|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549811|NCT02544607|Ketamine|ketamine|mesh-list
83549812|NCT02544607|Analgesics|analgesics|mesh-ancestor
83549813|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
83549814|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834807|NCT00135408|Budesonide|budesonide|mesh-list
83549815|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549816|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83549817|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83549818|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
83549819|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
83549820|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549821|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83549822|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83549823|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549824|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549825|NCT00363571|Acetazolamide|acetazolamide|mesh-list
83549826|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
83549827|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83549828|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549829|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549830|NCT00363571|Diuretics|diuretics|mesh-ancestor
83549831|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
83549832|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549833|NCT04744675|Triamcinolone|triamcinolone|mesh-list
83549834|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83549835|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83549836|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83549837|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549838|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
83549839|NCT04744675|Hormones|hormones|mesh-ancestor
83549840|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549841|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549842|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83549843|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
83549844|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549845|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549846|NCT02471521|Rocuronium|rocuronium|mesh-list
83549847|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83549848|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83549849|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83549850|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549851|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549852|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
83549853|NCT02624479|Antidotes|antidotes|mesh-ancestor
83549854|NCT02624479|Protective Agents|protective agents|mesh-ancestor
83549855|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549856|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
83549857|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549858|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
83549859|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83549860|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549861|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
83549862|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
83549863|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
83549864|NCT02472223|Povidone|povidone|mesh-list
83549865|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
83549866|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
83549867|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
83549868|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83549869|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549870|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83549871|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83549872|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
83549873|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83549874|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549875|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83549876|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83549877|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549878|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549879|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549880|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83549881|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83549882|NCT02473783|Sertraline|sertraline|mesh-list
83549883|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
83549884|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83549885|NCT02473783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83549886|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83549887|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83834808|NCT00135408|Ipilimumab|ipilimumab|mesh-list
83549888|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549889|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549890|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
83549891|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549892|NCT02247804|Timolol|timolol|mesh-list
83549893|NCT02247804|Bimatoprost|bimatoprost|mesh-list
83549894|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83549895|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83549896|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
83549897|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549898|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549899|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549900|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83549901|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83549902|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
83549903|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83549904|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83549905|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549906|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549907|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83549908|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83549909|NCT00366938|Analgesics|analgesics|mesh-ancestor
83549910|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
83549911|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549912|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549913|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549914|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549915|NCT05026320|Diclofenac|diclofenac|mesh-list
83549916|NCT05026320|Naproxen|naproxen|mesh-list
83549917|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83549918|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83549919|NCT05026320|Analgesics|analgesics|mesh-ancestor
83549920|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
83549921|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549922|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549923|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549924|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549925|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83549926|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549927|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549928|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
83549929|NCT04068272|Bosentan|bosentan|mesh-list
83549930|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83549931|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83549932|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549933|NCT04058756|Spartalizumab|spartalizumab|mesh-list
83549934|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83549935|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549936|NCT04058756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549937|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549938|NCT02243202|Canagliflozin|canagliflozin|mesh-list
83549939|NCT02243202|Phentermine|phentermine|mesh-list
83549940|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83549941|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549942|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83549943|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549944|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83549945|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
83549946|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83549947|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
83549948|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
83549949|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549950|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
83549951|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549952|NCT04050410|Moxonidine|moxonidine|mesh-list
83549953|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83549954|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
83549955|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83549956|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83549957|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83549958|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83549959|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83549960|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549961|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
83549962|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549963|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549964|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83549965|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549966|NCT04235036|Rituximab|rituximab|mesh-list
83549967|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549968|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549969|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
83549970|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549971|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549972|NCT02560051|Ketoconazole|ketoconazole|mesh-list
83549973|NCT02560051|Docetaxel|docetaxel|mesh-list
83549974|NCT02560051|Doxorubicin|doxorubicin|mesh-list
83549975|NCT02560051|Estramustine|estramustine|mesh-list
83549976|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549977|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549978|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549979|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549980|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549981|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83549982|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83549983|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83549984|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549985|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
83549986|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549987|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83549988|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83549989|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83549990|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
83549991|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549992|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549993|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83549994|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83549995|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
83549996|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549997|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83549998|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83549999|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83550000|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550001|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550002|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83550003|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550004|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550005|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
83550006|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550007|NCT00367718|Bortezomib|bortezomib|mesh-list
83550008|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550009|NCT02474407|Diazepam|diazepam|mesh-list
83550010|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83550011|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
83550012|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
83550013|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
83550014|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550015|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550016|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83550017|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83550018|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550019|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83550020|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83550021|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83550022|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83550023|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83550024|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83550025|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
83550026|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
83550027|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
83550028|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
83550029|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550030|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550031|NCT05588492|Rifamycins|rifamycins|mesh-list
83550032|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
83550033|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550034|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550035|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550036|NCT03777956|Lacosamide|lacosamide|mesh-list
83550037|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
83550038|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83550039|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83550040|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550041|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550042|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
83550043|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
83550044|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
83550045|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550046|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550047|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
83550048|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550049|NCT02563093|Vaccines|vaccines|mesh-list
83550050|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
83550051|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550052|NCT02564029|Lorazepam|lorazepam|mesh-list
83550053|NCT02564029|PF-06372865|pf-06372865|mesh-list
83550054|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
83550055|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
83550056|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
83550057|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550058|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550059|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83550060|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83550061|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550062|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83550063|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83550064|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83550065|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
83550066|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
83550067|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550068|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550069|NCT05588336|Morphine|morphine|mesh-list
83550070|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83550071|NCT05588336|Narcotics|narcotics|mesh-ancestor
83550072|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550073|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550074|NCT05588336|Analgesics|analgesics|mesh-ancestor
83550075|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
83550076|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550077|NCT02564497|Abatacept|abatacept|mesh-list
83550078|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83550079|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550080|NCT02564497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83550081|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550082|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550083|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
83550084|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550085|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550086|NCT02565901|Sirolimus|sirolimus|mesh-list
83550087|NCT02565901|Carboplatin|carboplatin|mesh-list
83550088|NCT02565901|Docetaxel|docetaxel|mesh-list
83550089|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550090|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
83550091|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83550092|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83550093|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550094|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550095|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550096|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83550097|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
83550098|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550099|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
83550100|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550101|NCT03926624|Cytarabine|cytarabine|mesh-list
83550102|NCT03926624|Fludarabine|fludarabine|mesh-list
83550103|NCT03926624|Etoposide|etoposide|mesh-list
83550104|NCT03926624|Azacitidine|azacitidine|mesh-list
83550105|NCT03926624|Decitabine|decitabine|mesh-list
83550106|NCT03926624|Venetoclax|venetoclax|mesh-list
83550107|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
83550108|NCT03926624|Idarubicin|idarubicin|mesh-list
83550109|NCT03926624|Cladribine|cladribine|mesh-list
83550110|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550111|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83550112|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
83684412|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
83550113|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550114|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550115|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
83550116|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550117|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83550118|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83550119|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83550120|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550121|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
83550122|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550123|NCT03926624|Analgesics|analgesics|mesh-ancestor
83550124|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
83550125|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550126|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83550127|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
83550128|NCT05588102|Citalopram|citalopram|mesh-list
83550129|NCT05588102|Fluoxetine|fluoxetine|mesh-list
83550130|NCT05588102|Paroxetine|paroxetine|mesh-list
83550131|NCT05588102|Sertraline|sertraline|mesh-list
83550132|NCT05588102|Escitalopram|escitalopram|mesh-list
83550133|NCT05588102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83550134|NCT05588102|Serotonin|serotonin|mesh-list
83550135|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83550136|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550137|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550138|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550139|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
83550140|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550141|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83550142|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
83550143|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83550144|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83550145|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83550146|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550147|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83550148|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83550149|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550150|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83550151|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83550152|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83550153|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83550154|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550155|NCT03551210|Levofloxacin|levofloxacin|mesh-list
83550156|NCT03551210|Ofloxacin|ofloxacin|mesh-list
83550157|NCT03551210|Nemonoxacin|nemonoxacin|mesh-list
83550158|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83550159|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550160|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550161|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83550162|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83550163|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550164|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550165|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550166|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83550167|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83550168|NCT02482675|Caseins|caseins|mesh-list
83550169|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
83550170|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
83550171|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550172|NCT00364195|Tesmilifene|tesmilifene|mesh-list
83550173|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
83550174|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
83550175|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550176|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550177|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550178|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83550179|NCT02566369|Trifarotene|trifarotene|mesh-list
83550180|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
83550181|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
83550182|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550183|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83550184|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83550185|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
83550186|NCT02571439|Ropivacaine|ropivacaine|mesh-list
83550187|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
83550188|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
83550189|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550190|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550191|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
83550192|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550193|NCT02573857|Artefenomel|artefenomel|mesh-list
83550194|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
83550195|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83550196|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83550197|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550198|NCT03678428|Leucovorin|leucovorin|mesh-list
83550199|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
83550200|NCT03678428|Irinotecan|irinotecan|mesh-list
83550201|NCT03678428|Floxuridine|floxuridine|mesh-list
83550202|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550203|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83550204|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83550205|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550206|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550207|NCT03678428|Antidotes|antidotes|mesh-ancestor
83550208|NCT03678428|Protective Agents|protective agents|mesh-ancestor
83550209|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550210|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
83550211|NCT03678428|Vitamins|vitamins|mesh-ancestor
83550212|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
83550213|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83550214|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
83550215|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
83550216|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83550217|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
83550218|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
83550219|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83550220|NCT02577601|Estradiol|estradiol|mesh-list
83550221|NCT02577601|Estrogens|estrogens|mesh-ancestor
83550222|NCT02577601|Hormones|hormones|mesh-ancestor
83550223|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83550224|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550225|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83550226|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
83550227|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83550228|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83550229|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83550230|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83550231|NCT02577991|Triamcinolone|triamcinolone|mesh-list
83550232|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83550233|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550234|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
83550235|NCT02577991|Hormones|hormones|mesh-ancestor
83550236|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83550237|NCT02207634|Evolocumab|evolocumab|mesh-list
83550238|NCT02207634|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83550239|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83550240|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83550241|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
83550242|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550243|NCT02207634|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83550244|NCT02207634|Protease Inhibitors|protease inhibitors|mesh-ancestor
83550245|NCT02207634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550246|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83550247|NCT02484859|Metoprolol|metoprolol|mesh-list
83550248|NCT02484859|Remifentanil|remifentanil|mesh-list
83550249|NCT02484859|Tramadol|tramadol|mesh-list
83550250|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83550251|NCT02484859|Narcotics|narcotics|mesh-ancestor
83550252|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550253|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550254|NCT02484859|Analgesics|analgesics|mesh-ancestor
83550255|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
83550256|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550257|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83550258|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550259|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
83550260|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
83550261|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83008407|NCT01333267|Hormones|hormones|mesh-list
83550262|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83550263|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83550264|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550265|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550266|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550268|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
83550269|NCT04341727|Chloroquine|chloroquine|mesh-list
83550270|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83550271|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550272|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550273|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
83550274|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83550275|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83550276|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550277|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550278|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550279|NCT04341727|Amebicides|amebicides|mesh-ancestor
83550280|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83550281|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83550282|NCT04341727|Analgesics|analgesics|mesh-ancestor
83550283|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
83550284|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550285|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550286|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83550287|NCT04341727|Filaricides|filaricides|mesh-ancestor
83550288|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
83550289|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
83550290|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83550291|NCT00367094|Benazepril|benazepril|mesh-list
83550292|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550293|NCT00367094|Diuretics|diuretics|mesh-ancestor
83550294|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
83550295|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550296|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83550297|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550298|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550299|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83550300|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83550301|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550302|NCT02581111|Naloxone|naloxone|mesh-list
83550303|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83550304|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550305|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
83550306|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550307|NCT05587400|Dobutamine|dobutamine|mesh-list
83550308|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
83550309|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83550310|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
83550311|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550312|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550313|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83550314|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
83550315|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83550316|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
83550317|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550318|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550319|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83550320|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
83550321|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
83550322|NCT05587400|Protective Agents|protective agents|mesh-ancestor
83550323|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83550324|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
83550325|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83550326|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83550327|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83550328|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550329|NCT04339868|Terlipressin|terlipressin|mesh-list
83550330|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550331|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83550332|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83550333|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
83550334|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550335|NCT00367250|Trastuzumab|trastuzumab|mesh-list
83550336|NCT00367250|Cetuximab|cetuximab|mesh-list
83550337|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83550338|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550339|NCT02489227|Adalimumab|adalimumab|mesh-list
83550340|NCT02489227|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83550341|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83550342|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550343|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
83550344|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83550345|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83550346|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550347|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
83550348|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83550349|NCT02207556|Doxycycline|doxycycline|mesh-list
83550350|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550351|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550352|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
83550353|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83550354|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83550355|NCT02572609|Ambroxol|ambroxol|mesh-list
83550356|NCT02572609|Expectorants|expectorants|mesh-ancestor
83550357|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
83550358|NCT02587117|Prednisolone|prednisolone|mesh-list
83550359|NCT02587117|Lycopene|lycopene|mesh-list
83550360|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83550361|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
83550362|NCT02587117|Hormones|hormones|mesh-ancestor
83550363|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83550364|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550365|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83550366|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550367|NCT02587117|Protective Agents|protective agents|mesh-ancestor
83550368|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
83550369|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550370|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83550371|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83550372|NCT02587351|Metoprolol|metoprolol|mesh-list
83550373|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83550374|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550375|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
83550376|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
83550377|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550378|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550379|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83550380|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83550381|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83550382|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550383|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550384|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550385|NCT05553314|Carvedilol|carvedilol|mesh-list
83550386|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83550387|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83550388|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550389|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550390|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550391|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550392|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550393|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
83550394|NCT05553314|Protective Agents|protective agents|mesh-ancestor
83550395|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83550396|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550397|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83550398|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
83550399|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83550400|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83550401|NCT03260504|Aldesleukin|aldesleukin|mesh-list
83550402|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
83550403|NCT03260504|Interleukin-2|interleukin-2|mesh-list
83550404|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
83550405|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
83550406|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83550407|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550408|NCT03260504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83550409|NCT03260504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550410|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
83550411|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550412|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83550413|NCT03260504|Analgesics|analgesics|mesh-ancestor
83550414|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
83550415|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550416|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83008548|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
83550417|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83550418|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
83550419|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550420|NCT00422396|Fenofibrate|fenofibrate|mesh-list
83550421|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83550422|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
83550423|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550424|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83550425|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83550426|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83550427|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
83550428|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550429|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550430|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83550431|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83550432|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83550433|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83550434|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83550435|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550436|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550437|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550438|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
83550439|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
83550440|NCT05249023|Butyric Acid|butyric acid|mesh-list
83550441|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
83550442|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
83550443|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550444|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550445|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550446|NCT02495779|Tenofovir|tenofovir|mesh-list
83550447|NCT02495779|Emtricitabine|emtricitabine|mesh-list
83550448|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
83550449|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550450|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83550451|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83550452|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550453|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550454|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83550455|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83550456|NCT03241771|Naloxone|naloxone|mesh-list
83550457|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83550458|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550459|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
83550460|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550461|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
83550462|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
83550463|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550464|NCT02502487|Ropivacaine|ropivacaine|mesh-list
83550465|NCT02502487|Tetracaine|tetracaine|mesh-list
83550466|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
83550467|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
83550468|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550469|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550470|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
83550471|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550472|NCT03238196|Fulvestrant|fulvestrant|mesh-list
83550473|NCT03238196|Palbociclib|palbociclib|mesh-list
83550474|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83550475|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550476|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83550477|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83550478|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
83550479|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83550480|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550481|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83550482|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550483|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550484|NCT02632045|Fulvestrant|fulvestrant|mesh-list
83550485|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83550486|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550487|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83550488|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83550489|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
83550490|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83550491|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550492|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
83550493|NCT02503735|Ledipasvir|ledipasvir|mesh-list
83550494|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
83550495|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550496|NCT04001881|Anesthetics|anesthetics|mesh-list
83550497|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550498|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550499|NCT03019640|Cytarabine|cytarabine|mesh-list
83550500|NCT03019640|Rituximab|rituximab|mesh-list
83550501|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83550502|NCT03019640|Etoposide|etoposide|mesh-list
83550503|NCT03019640|Lenalidomide|lenalidomide|mesh-list
83550504|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
83550505|NCT03019640|Melphalan|melphalan|mesh-list
83550506|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
83550507|NCT03019640|Carmustine|carmustine|mesh-list
83550508|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
83550509|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83550510|NCT03019640|Antibodies|antibodies|mesh-list
83550511|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
83550512|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83550513|NCT03019640|Lenograstim|lenograstim|mesh-list
83550514|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
83550515|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550516|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550517|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550518|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83550519|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83550520|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83550521|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550522|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550523|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83550524|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
83550525|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
83550526|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550527|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550528|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83550529|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83550530|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83550531|NCT03019640|Growth Substances|growth substances|mesh-ancestor
83550532|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
83550533|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83550534|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
83550535|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83550536|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
83550537|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
83550538|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
83550539|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
83550540|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
83550541|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
83550542|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83550543|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
83550544|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550545|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
83550546|NCT02136901|Protective Agents|protective agents|mesh-ancestor
83550547|NCT02507011|Carvedilol|carvedilol|mesh-list
83550548|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83550549|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83550550|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550551|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550552|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550553|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550554|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550555|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
83550556|NCT02507011|Protective Agents|protective agents|mesh-ancestor
83550557|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83550558|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550559|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83550560|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
83550561|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83550562|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83550563|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
83550564|NCT02977286|Naloxegol|naloxegol|mesh-list
83550565|NCT02977286|Bisacodyl|bisacodyl|mesh-list
83008691|NCT01377051|Maleic acid|maleic acid|mesh-list
83550566|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
83550567|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83550568|NCT02977286|Cathartics|cathartics|mesh-ancestor
83550569|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83550570|NCT02977286|Laxatives|laxatives|mesh-ancestor
83550571|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83550572|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550573|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
83550574|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550575|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
83550576|NCT05345210|Amoxicillin|amoxicillin|mesh-list
83550577|NCT05345210|Clarithromycin|clarithromycin|mesh-list
83550578|NCT05345210|Tetracycline|tetracycline|mesh-list
83550579|NCT05345210|Furazolidone|furazolidone|mesh-list
83550580|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550581|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550582|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83550583|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550584|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550585|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83550586|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83550587|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83550588|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83550589|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83550590|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83550591|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83550592|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83550594|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550595|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83550596|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550597|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550598|NCT01810705|Asparaginase|asparaginase|mesh-list
83550599|NCT01810705|Eryaspase|eryaspase|mesh-list
83550600|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550601|NCT02508103|Oxytocin|oxytocin|mesh-list
83550602|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
83550603|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83550604|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550605|NCT02508259|Suramin|suramin|mesh-list
83550606|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
83550607|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
83550608|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83550609|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550610|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550611|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83550612|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83550613|NCT02848820|Amoxicillin|amoxicillin|mesh-list
83550614|NCT02848820|Gentamicins|gentamicins|mesh-list
83550615|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83550616|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
83550617|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
83550618|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550619|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550620|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83550621|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550622|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550623|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83550624|NCT00534469|Cytarabine|cytarabine|mesh-list
83550625|NCT00534469|Aldesleukin|aldesleukin|mesh-list
83550626|NCT00534469|Etoposide|etoposide|mesh-list
83550627|NCT00534469|Idarubicin|idarubicin|mesh-list
83550628|NCT00534469|Busulfan|busulfan|mesh-list
83550629|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83550630|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550631|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83550632|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83550633|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550634|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550635|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83550636|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
83550637|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
83550638|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550639|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550640|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
83550641|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550642|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
83550643|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83550644|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83550645|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83550646|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83550647|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83550649|NCT02240628|Tetracaine|tetracaine|mesh-list
83550650|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
83550651|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
83550652|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550653|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550654|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
83550655|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550656|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83550657|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83550658|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83550659|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550660|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550661|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
83550662|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83550663|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83550664|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550665|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
83550666|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83550667|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83550668|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83550669|NCT02207400|Listerine|listerine|mesh-list
83550670|NCT02207400|Fluorides|fluorides|mesh-list
83550671|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
83550672|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
83550673|NCT02207400|Protective Agents|protective agents|mesh-ancestor
83550674|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550675|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83550676|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550677|NCT02511535|Vaccines|vaccines|mesh-list
83550678|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
83550679|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550680|NCT03545035|Rituximab|rituximab|mesh-list
83550681|NCT03545035|Idelalisib|idelalisib|mesh-list
83550682|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83550683|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550684|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
83550685|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550686|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550687|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550688|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550689|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83550690|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83550691|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550692|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
83550693|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
83550694|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83550695|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550696|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83550697|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550698|NCT02512783|Lidocaine|lidocaine|mesh-list
83550699|NCT02512783|Propofol|propofol|mesh-list
83550700|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
83550701|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
83550702|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550703|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550704|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
83550705|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550706|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83550707|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83550708|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83550709|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550710|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550711|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83550712|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83550713|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
83550714|NCT02513095|Dantrolene|dantrolene|mesh-list
83550715|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83550716|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550717|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83550718|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550719|NCT02513719|Everolimus|everolimus|mesh-list
83550720|NCT02513719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83550721|NCT02513719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83550722|NCT02513719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550723|NCT02513719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550724|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550725|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
83550726|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550727|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550728|NCT00363727|Ropinirole|ropinirole|mesh-list
83550729|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83550730|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83550731|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
83550732|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
83550733|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550734|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550735|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550736|NCT04340869|Theobromine|theobromine|mesh-list
83550737|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83550738|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
83550739|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550740|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550741|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83550742|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
83550743|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
83550744|NCT00366067|Phenytoin|phenytoin|mesh-list
83550745|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
83550746|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83550747|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83550748|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550749|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550750|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83550751|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83550752|NCT00364429|Lorazepam|lorazepam|mesh-list
83550753|NCT00364429|Risperidone|risperidone|mesh-list
83550754|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83550755|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
83550756|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550757|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550758|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550759|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83550760|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83550761|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550762|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83550763|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83550764|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
83550765|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
83550766|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
83550767|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
83550768|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550769|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83550770|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83550771|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83550772|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
83550773|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
83550774|NCT02593903|Trimethoprim|trimethoprim|mesh-list
83550775|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83550776|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
83550777|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83550778|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550779|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
83550780|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83550781|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83550782|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83550783|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550784|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550785|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83550786|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83550787|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83550788|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550789|NCT02596867|Propranolol|propranolol|mesh-list
83550790|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83550791|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83550792|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550793|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124597|NCT04374773|Dronabinol|dronabinol|mesh-list
83008936|NCT03604016|Tenofovir|tenofovir|mesh-list
83550794|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550795|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550796|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83550797|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550798|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
83550800|NCT02597101|Saxagliptin|saxagliptin|mesh-list
83550801|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83550802|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550803|NCT02597101|Incretins|incretins|mesh-ancestor
83550804|NCT02597101|Hormones|hormones|mesh-ancestor
83550805|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83550806|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83550807|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
83550808|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550809|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550810|NCT02600611|Vancomycin|vancomycin|mesh-list
83550811|NCT02600611|Iclaprim|iclaprim|mesh-list
83550812|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550813|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550814|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83550815|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550816|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550817|NCT02600767|Lumefantrine|lumefantrine|mesh-list
83550818|NCT02600767|Artemether|artemether|mesh-list
83550819|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83550820|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
83550821|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83550822|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83550823|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550824|NCT00365287|Cyclosporine|cyclosporine|mesh-list
83550825|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
83550826|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
83550827|NCT00365287|Fludarabine|fludarabine|mesh-list
83550828|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
83550829|NCT00365287|Cyclosporins|cyclosporins|mesh-list
83550830|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83550831|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550832|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
83550833|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550834|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550835|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83550836|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
83550837|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550838|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550839|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83550840|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83550841|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
83550842|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550843|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
83550844|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550845|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
83550846|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83550847|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83550848|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83550849|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
83550850|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550851|NCT04743193|Sevoflurane|sevoflurane|mesh-list
83550852|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
83550853|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550854|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550855|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83550856|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83550857|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
83550858|NCT05572645|Trastuzumab|trastuzumab|mesh-list
83550859|NCT05572645|Pertuzumab|pertuzumab|mesh-list
83550860|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83550861|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550862|NCT02608177|Linagliptin|linagliptin|mesh-list
83550863|NCT02608177|Glipizide|glipizide|mesh-list
83550864|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83550865|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550866|NCT02608177|Incretins|incretins|mesh-ancestor
83550867|NCT02608177|Hormones|hormones|mesh-ancestor
83439768|NCT04399226|Ketamine|ketamine|mesh-list
83550868|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83550869|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83550870|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
83550871|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550872|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550873|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
83550874|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83550875|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
83550876|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550877|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
83550878|NCT02608489|Protective Agents|protective agents|mesh-ancestor
83550879|NCT02611765|Penicillins|penicillins|mesh-list
83550880|NCT02611765|Penicillin G|penicillin g|mesh-list
83550881|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83550882|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
83550883|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83550884|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83550885|NCT05552287|Infliximab|infliximab|mesh-list
83550886|NCT05552287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83550887|NCT05552287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83550888|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
83550889|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83550890|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550891|NCT02616523|Lidocaine|lidocaine|mesh-list
83550892|NCT02616523|Fentanyl|fentanyl|mesh-list
83550893|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
83550894|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
83550895|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
83550896|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83550897|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550898|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
83550899|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83550900|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83550901|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83550902|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83550903|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550904|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550905|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83550906|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83550907|NCT02616523|Analgesics|analgesics|mesh-ancestor
83550908|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83550909|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83550910|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83550911|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550912|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550913|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83550914|NCT02616523|Narcotics|narcotics|mesh-ancestor
83550915|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83550916|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83550917|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
83550918|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83550919|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
83550920|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550921|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83550922|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
83550923|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550924|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550925|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83550926|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83550927|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83550928|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
83550929|NCT05528419|Valsartan|valsartan|mesh-list
83550930|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83550931|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83550932|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83550933|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83550934|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550935|NCT05485831|Cannabidiol|cannabidiol|mesh-list
83550936|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
83550937|NCT05480293|Ranibizumab|ranibizumab|mesh-list
83550938|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83550939|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83550940|NCT05480293|Growth Substances|growth substances|mesh-ancestor
83550941|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550942|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
83550943|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550944|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
83550945|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83550946|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
83550947|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83550948|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
83550949|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550950|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550951|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
83550952|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
83550953|NCT00365755|Melphalan|melphalan|mesh-list
83550954|NCT00365755|Carboplatin|carboplatin|mesh-list
83550955|NCT00365755|Etoposide|etoposide|mesh-list
83550956|NCT00365755|Vincristine|vincristine|mesh-list
83550957|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83550958|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
83550959|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550960|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83550961|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83550962|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
83550963|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550964|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550965|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83550966|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83550967|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83550968|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83550969|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550970|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
83550971|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
83550972|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
83550973|NCT05730907|Simendan|simendan|mesh-list
83550974|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83550975|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
83550976|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83550977|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83550978|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83550979|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550980|NCT05730907|Protective Agents|protective agents|mesh-ancestor
83550981|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550982|NCT05355337|Pramipexole|pramipexole|mesh-list
83550983|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
83550984|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550985|NCT05355337|Protective Agents|protective agents|mesh-ancestor
83550986|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83550987|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83550988|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83550989|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
83550990|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
83550991|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83550992|NCT04340401|Capecitabine|capecitabine|mesh-list
83550993|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
83550994|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83550995|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
83550996|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83550997|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83550998|NCT04143607|Gefitinib|gefitinib|mesh-list
83550999|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551000|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83551001|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551002|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551003|NCT04802863|Imipenem|imipenem|mesh-list
83551004|NCT04802863|Cilastatin|cilastatin|mesh-list
83551005|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83551006|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551007|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
83551008|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551009|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551010|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
83551011|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551012|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551013|NCT04682431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83551014|NCT04682431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551015|NCT04622839|Acetaminophen|acetaminophen|mesh-list
83551016|NCT04622839|Ibuprofen|ibuprofen|mesh-list
83551017|NCT04622839|Diclofenac|diclofenac|mesh-list
83551018|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83551019|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83009155|NCT02232087|Hormones|hormones|mesh-ancestor
83551020|NCT04622839|Analgesics|analgesics|mesh-ancestor
83551021|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
83551022|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551023|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551024|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551025|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551026|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83551027|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551028|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551029|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
83551030|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
83551031|NCT02619799|Midazolam|midazolam|mesh-list
83551032|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83551033|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83551034|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551035|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551036|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83551037|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83551038|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83551039|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83551040|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
83551041|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
83551042|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
83551043|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
83551044|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551045|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551046|NCT02619799|Analgesics|analgesics|mesh-ancestor
83551047|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
83551048|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551049|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83551050|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
83551051|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83551052|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83551053|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83551054|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
83551055|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83551056|NCT04592809|Midazolam|midazolam|mesh-list
83551057|NCT04592809|Ketamine|ketamine|mesh-list
83551058|NCT04592809|Analgesics|analgesics|mesh-ancestor
83551059|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
83551060|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551061|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551062|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83551063|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83551064|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
83551065|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
83551066|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551067|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83551068|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83551069|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551070|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551071|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83551072|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83551073|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83551074|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83551075|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83551076|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
83551077|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
83551078|NCT04741165|Bevacizumab|bevacizumab|mesh-list
83551079|NCT04741165|Lenvatinib|lenvatinib|mesh-list
83551080|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551081|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551082|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83551083|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83551084|NCT04741165|Growth Substances|growth substances|mesh-ancestor
83551085|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551086|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
83551087|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83551088|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551089|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551090|NCT02625181|Promethazine|promethazine|mesh-list
83551091|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
83551092|NCT02625181|Meclizine|meclizine|mesh-list
83551093|NCT02625181|Dexamethasone|dexamethasone|mesh-list
83551094|NCT02625181|Fentanyl|fentanyl|mesh-list
83009223|NCT03606590|Sorafenib|sorafenib|mesh-list
83551095|NCT02625181|Sufentanil|sufentanil|mesh-list
83551096|NCT02625181|Scopolamine|scopolamine|mesh-list
83551097|NCT02625181|Oxymorphone|oxymorphone|mesh-list
83551098|NCT02625181|Meperidine|meperidine|mesh-list
83551099|NCT02625181|Droperidol|droperidol|mesh-list
83551100|NCT02625181|Ketamine|ketamine|mesh-list
83551101|NCT02625181|Morphine|morphine|mesh-list
83551102|NCT02625181|Remifentanil|remifentanil|mesh-list
83551103|NCT02625181|Oxycodone|oxycodone|mesh-list
83551104|NCT02625181|Methadone|methadone|mesh-list
83551105|NCT02625181|Hydromorphone|hydromorphone|mesh-list
83551106|NCT02625181|Hydrocodone|hydrocodone|mesh-list
83551107|NCT02625181|Alfentanil|alfentanil|mesh-list
83551108|NCT02625181|Haloperidol|haloperidol|mesh-list
83551109|NCT02625181|Ondansetron|ondansetron|mesh-list
83551110|NCT02625181|Aprepitant|aprepitant|mesh-list
83551111|NCT02625181|Palonosetron|palonosetron|mesh-list
83551112|NCT02625181|Metoclopramide|metoclopramide|mesh-list
83551113|NCT02625181|Granisetron|granisetron|mesh-list
83551114|NCT02625181|Ramosetron|ramosetron|mesh-list
83551115|NCT02625181|Tropisetron|tropisetron|mesh-list
83551116|NCT02625181|Dolasetron|dolasetron|mesh-list
83551117|NCT02625181|Anesthetics|anesthetics|mesh-list
83551118|NCT02625181|Propofol|propofol|mesh-list
83551119|NCT02625181|Sevoflurane|sevoflurane|mesh-list
83551120|NCT02625181|Desflurane|desflurane|mesh-list
83551121|NCT02625181|Isoflurane|isoflurane|mesh-list
83551122|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83551123|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551124|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
83551125|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
83551126|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551127|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551128|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83551129|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
83551130|NCT02625181|Hormones|hormones|mesh-ancestor
83551131|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551132|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83551133|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551134|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551135|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83551136|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83551137|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
83551138|NCT02625181|Analgesics|analgesics|mesh-ancestor
83551139|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
83551140|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83551141|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83551142|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83551143|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551144|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551145|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83551146|NCT02625181|Narcotics|narcotics|mesh-ancestor
83551147|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83551148|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83551149|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83551150|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
83551151|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
83551152|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83551153|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83551154|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
83551155|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
83551156|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
83551157|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83551158|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83551159|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83551160|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83551161|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83551162|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
83551163|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83551164|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83551165|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
83551166|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83551167|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
83551168|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83551169|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
83551170|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83551171|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
83551172|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
83551173|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83551174|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83551175|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
83551176|NCT02630017|Methylphenidate|methylphenidate|mesh-list
83551177|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83551178|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551179|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83551180|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83551181|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83551182|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551183|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
83551184|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551185|NCT02630719|Timolol|timolol|mesh-list
83551186|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83551187|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
83551188|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83551189|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83551190|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83551191|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
83551192|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551193|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551194|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551195|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83551196|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83551197|NCT04979377|Insulin|insulin|mesh-list
83551198|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83551199|NCT04979377|Hormones|hormones|mesh-list
83551200|NCT04979377|Testosterone|testosterone|mesh-list
83551201|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83551202|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83551203|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551204|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551205|NCT04979377|Androgens|androgens|mesh-ancestor
83551206|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83551207|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
83551208|NCT02633371|Oxybutynin|oxybutynin|mesh-list
83551209|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
83551210|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
83551211|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551212|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551213|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83551214|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83551215|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
83551216|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551217|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551218|NCT02633371|Urological Agents|urological agents|mesh-ancestor
83551219|NCT04159519|Budesonide|budesonide|mesh-list
83551220|NCT04159519|Albuterol|albuterol|mesh-list
83551221|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
83551222|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83551223|NCT04159519|Benralizumab|benralizumab|mesh-list
83551224|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551225|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83551226|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
83551227|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551228|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551229|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83551230|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
83551231|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
83551232|NCT04159519|Hormones|hormones|mesh-ancestor
83551233|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551234|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83551235|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83551236|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83551237|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
83551238|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551239|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551240|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
83551241|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83551242|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83551243|NCT04913311|Dimercaprol|dimercaprol|mesh-list
83551244|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
83551245|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
83551246|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551247|NCT04913311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551248|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551249|NCT04054375|Prednisone|prednisone|mesh-list
83551250|NCT04054375|Prednisolone|prednisolone|mesh-list
83551251|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551252|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
83551253|NCT04054375|Hormones|hormones|mesh-ancestor
83551254|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551255|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551256|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83551257|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551258|NCT02634073|Lamivudine|lamivudine|mesh-list
83551259|NCT02634073|Sorbitol|sorbitol|mesh-list
83551260|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83551261|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83551262|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551263|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551264|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
83551265|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551266|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83551267|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83551268|NCT02634073|Cathartics|cathartics|mesh-ancestor
83551269|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83551270|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83551271|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83551272|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
83551273|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83551274|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551275|NCT00367393|Analgesics|analgesics|mesh-ancestor
83551276|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
83551277|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551278|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551279|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551280|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551281|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83551282|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83551283|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
83551284|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83551285|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551286|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551287|NCT00367471|Paclitaxel|paclitaxel|mesh-list
83551288|NCT00367471|Carboplatin|carboplatin|mesh-list
83551289|NCT00367471|Trastuzumab|trastuzumab|mesh-list
83551290|NCT00367471|Lapatinib|lapatinib|mesh-list
83551291|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83551292|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551293|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
83551294|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
83551295|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
83551296|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551297|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551298|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83551299|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551300|NCT02207244|Adalimumab|adalimumab|mesh-list
83551301|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83551302|NCT02207244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83551303|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551304|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551305|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
83551306|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551307|NCT02207088|Ritonavir|ritonavir|mesh-list
83551308|NCT02207088|Ribavirin|ribavirin|mesh-list
83551309|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83551310|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83551311|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
83551312|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551313|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551314|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83551315|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83551316|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
83551317|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551318|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83551319|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83551320|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
83551321|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
83551322|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83551323|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
83551324|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551325|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83551326|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83551327|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83551328|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551329|NCT02206620|Donepezil|donepezil|mesh-list
83551330|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83551331|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551332|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551333|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
83551334|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551335|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551336|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
83551337|NCT02239926|Ranolazine|ranolazine|mesh-list
83551338|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83551339|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83551340|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551341|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
83551342|NCT02239692|Cathartics|cathartics|mesh-ancestor
83551343|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83551344|NCT02641561|Indomethacin|indomethacin|mesh-list
83551345|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83551346|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551347|NCT02641561|Analgesics|analgesics|mesh-ancestor
83551348|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
83551349|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551350|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551351|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551352|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551353|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
83551354|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
83551355|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83551356|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83551357|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551358|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551359|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
83551360|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83551361|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
83551362|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551363|NCT02206152|Expectorants|expectorants|mesh-ancestor
83551364|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
83551365|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83551366|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
83551367|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551368|NCT02206152|Protective Agents|protective agents|mesh-ancestor
83551369|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551370|NCT02206152|Antidotes|antidotes|mesh-ancestor
83551371|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
83551372|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83551373|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
83551374|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
83551375|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83551376|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83551377|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551378|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83551379|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551380|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551381|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83551382|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83551383|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
83551384|NCT04146571|Ensartinib|ensartinib|mesh-list
83551385|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551386|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83551387|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551388|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551389|NCT02204982|Rituximab|rituximab|mesh-list
83551390|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551391|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551392|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
83551393|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551394|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551395|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
83551396|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83551397|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551398|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551399|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551400|NCT05342376|Analgesics|analgesics|mesh-ancestor
83551401|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
83551402|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551403|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83551404|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83551405|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83551406|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83551407|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551408|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551409|NCT02237196|Immunomodulating Agents|immunomodulating agents|mesh-list
83551410|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
83551411|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551412|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83551413|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
83551414|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83551415|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551416|NCT04776096|Analgesics|analgesics|mesh-ancestor
83551417|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
83551418|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551419|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551420|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551421|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551422|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83551423|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83551424|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83551425|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
83551426|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
83551427|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551428|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551429|NCT04684212|Warfarin|warfarin|mesh-list
83551430|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
83551431|NCT04684212|Dabigatran|dabigatran|mesh-list
83551432|NCT04684212|Edoxaban|edoxaban|mesh-list
83551433|NCT04684212|Apixaban|apixaban|mesh-list
83551434|NCT04684212|Betrixaban|betrixaban|mesh-list
83551435|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
83551436|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83551437|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
83551438|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83551439|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
83551440|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551441|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551442|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
83551443|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551444|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551445|NCT03250273|Nivolumab|nivolumab|mesh-list
83551446|NCT03250273|Entinostat|entinostat|mesh-list
83551447|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551448|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551449|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83551450|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551451|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83551452|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551453|NCT02203032|Ustekinumab|ustekinumab|mesh-list
83551454|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83551455|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
83551456|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
83551457|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551458|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83551459|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551460|NCT02169414|Levodopa|levodopa|mesh-list
83551461|NCT02169414|Carbidopa|carbidopa|mesh-list
83551462|NCT02169414|Opicapone|opicapone|mesh-list
83551463|NCT02169414|Benserazide|benserazide|mesh-list
83551464|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83551465|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83551466|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
83551467|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551468|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551469|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551470|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83551471|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551472|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83551473|NCT03213457|Norethindrone|norethindrone|mesh-list
83551474|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
83551475|NCT03213457|Estradiol|estradiol|mesh-list
83551476|NCT03213457|Estrogens|estrogens|mesh-ancestor
83551477|NCT03213457|Hormones|hormones|mesh-ancestor
83551478|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551479|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551480|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83551481|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
83551482|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83551483|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83551484|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83551485|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83551486|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83551487|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
83551488|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83551489|NCT02201940|Velpatasvir|velpatasvir|mesh-list
83551490|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
83551491|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551492|NCT05588869|Cyclosporine|cyclosporine|mesh-list
83551493|NCT05588869|Cyclosporins|cyclosporins|mesh-list
83551494|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551495|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551496|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83551497|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
83551498|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551499|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
83551500|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551501|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
83551502|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551503|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83551504|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
83551505|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83551506|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551507|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551508|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551509|NCT02169336|Analgesics|analgesics|mesh-ancestor
83551510|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
83551511|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551512|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83551513|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83551514|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83551515|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
83551516|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551517|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551518|NCT03043807|Docetaxel|docetaxel|mesh-list
83551519|NCT03043807|Leuprolide|leuprolide|mesh-list
83551520|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
83551521|NCT03043807|Bicalutamide|bicalutamide|mesh-list
83551522|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551523|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83551524|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83551525|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83551526|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551527|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83551528|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
83551529|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83551530|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551531|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83551532|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83551533|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551534|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
83551535|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551536|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83551537|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
83551538|NCT02609828|Tanezumab|tanezumab|mesh-list
83551539|NCT02609828|Analgesics|analgesics|mesh-ancestor
83551540|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
83551541|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551542|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551543|NCT05588557|Bupivacaine|bupivacaine|mesh-list
83551544|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
83551545|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
83551546|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440438|NCT00602771|Etoposide|etoposide|mesh-list
83551547|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551548|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
83551549|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551550|NCT01632306|Leucovorin|leucovorin|mesh-list
83551551|NCT01632306|Paclitaxel|paclitaxel|mesh-list
83551552|NCT01632306|Gemcitabine|gemcitabine|mesh-list
83551553|NCT01632306|Fluorouracil|fluorouracil|mesh-list
83009688|NCT03579836|Gemcitabine|gemcitabine|mesh-list
83551554|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
83551555|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83551556|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551557|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
83551558|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
83551559|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
83551560|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551561|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83551562|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
83551563|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83551564|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
83551565|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551566|NCT01632306|Antidotes|antidotes|mesh-ancestor
83551567|NCT01632306|Protective Agents|protective agents|mesh-ancestor
83551568|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
83551569|NCT01632306|Vitamins|vitamins|mesh-ancestor
83551570|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
83551571|NCT02201784|Ropivacaine|ropivacaine|mesh-list
83551572|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
83551573|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
83551574|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
83551575|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551576|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551577|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
83551578|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551579|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
83551580|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
83551581|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551582|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551583|NCT02018263|Cocaine|cocaine|mesh-list
83551584|NCT02018263|Nicotine|nicotine|mesh-list
83551585|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83551586|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
83551587|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551588|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551589|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83551590|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83551591|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
83551592|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551593|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551594|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
83551595|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
83551596|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551597|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
83551598|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83551599|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83551600|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83551601|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83551602|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
83551603|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83551604|NCT02168946|Meropenem|meropenem|mesh-list
83551605|NCT02168946|Vaborbactam|vaborbactam|mesh-list
83551606|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83551607|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83551608|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551609|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
83551610|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551611|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551612|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
83551613|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83551614|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83551615|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551616|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
83551617|NCT02650856|Coagulants|coagulants|mesh-ancestor
83551618|NCT02168478|Neomycin|neomycin|mesh-list
83551619|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83551620|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551621|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83551622|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551623|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551624|NCT00367874|Buprenorphine|buprenorphine|mesh-list
83551625|NCT00367874|Valproic Acid|valproic acid|mesh-list
83551626|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83551627|NCT00367874|Narcotics|narcotics|mesh-ancestor
83551628|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551629|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551630|NCT00367874|Analgesics|analgesics|mesh-ancestor
83551631|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
83551632|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551633|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83551634|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
83551635|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551636|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551637|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
83551638|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551639|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
83551640|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83551641|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83551642|NCT00367562|Valsartan|valsartan|mesh-list
83551643|NCT00367562|Enalapril|enalapril|mesh-list
83551644|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83551645|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83551646|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83551647|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551648|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83551649|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
83551650|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551651|NCT02302976|Exenatide|exenatide|mesh-list
83551652|NCT02302976|Cocaine|cocaine|mesh-list
83551653|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83551654|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551655|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83551656|NCT02302976|Incretins|incretins|mesh-ancestor
83551657|NCT02302976|Hormones|hormones|mesh-ancestor
83551658|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551659|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
83551660|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
83551661|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551662|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
83551663|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551664|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83551665|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83551666|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83551667|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83551668|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551669|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
83551670|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551671|NCT05073692|Liraglutide|liraglutide|mesh-list
83551672|NCT05073692|Empagliflozin|empagliflozin|mesh-list
83551673|NCT05073692|Exenatide|exenatide|mesh-list
83551674|NCT05073692|Glimepiride|glimepiride|mesh-list
83551675|NCT05073692|Linagliptin|linagliptin|mesh-list
83551676|NCT05073692|Saxagliptin|saxagliptin|mesh-list
83551677|NCT05073692|Alogliptin|alogliptin|mesh-list
83551678|NCT05073692|Glipizide|glipizide|mesh-list
83551679|NCT05073692|Glucagon|glucagon|mesh-list
83551680|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83551681|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83551682|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551683|NCT05073692|Incretins|incretins|mesh-ancestor
83551684|NCT05073692|Hormones|hormones|mesh-ancestor
83551685|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551686|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83551687|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551688|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83551689|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83551690|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83551691|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
83551692|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83551693|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
83551694|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551695|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83551696|NCT02244164|Liraglutide|liraglutide|mesh-list
83551697|NCT02244164|Exenatide|exenatide|mesh-list
83551698|NCT02244164|Lixisenatide|lixisenatide|mesh-list
83551699|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83551700|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83551701|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551702|NCT02244164|Incretins|incretins|mesh-ancestor
83551703|NCT02244164|Hormones|hormones|mesh-ancestor
83551704|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551705|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83551706|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
83009832|NCT02428647|Zinc|zinc|mesh-list
83551707|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551708|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551709|NCT02152670|Raclopride|raclopride|mesh-list
83551710|NCT02152670|Methylphenidate|methylphenidate|mesh-list
83551711|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
83551712|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83551713|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551714|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83551715|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83551716|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83551717|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551718|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
83551719|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551720|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83551721|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83551722|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551723|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83551724|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83551725|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551726|NCT02028806|Leucovorin|leucovorin|mesh-list
83551727|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
83551728|NCT02028806|Irinotecan|irinotecan|mesh-list
83551729|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551730|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83551731|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83551732|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551733|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551734|NCT02028806|Antidotes|antidotes|mesh-ancestor
83551735|NCT02028806|Protective Agents|protective agents|mesh-ancestor
83551736|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551737|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
83551738|NCT02028806|Vitamins|vitamins|mesh-ancestor
83551739|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
83551740|NCT01756118|Dactolisib|dactolisib|mesh-list
83551741|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551742|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83551743|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551744|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
83551745|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83551746|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83551747|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551748|NCT02657252|Polidocanol|polidocanol|mesh-list
83551749|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83551750|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83551751|NCT04740086|Calcium|calcium|mesh-list
83551752|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83551753|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551754|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
83551755|NCT04739618|Ipilimumab|ipilimumab|mesh-list
83551756|NCT04739618|Sargramostim|sargramostim|mesh-list
83551757|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551758|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551759|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83551760|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551761|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
83551762|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551763|NCT02684942|Fentanyl|fentanyl|mesh-list
83551764|NCT02684942|Meperidine|meperidine|mesh-list
83551765|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83551766|NCT02684942|Narcotics|narcotics|mesh-ancestor
83551767|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551768|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551769|NCT02684942|Analgesics|analgesics|mesh-ancestor
83551770|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
83551771|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551772|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83551773|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83551774|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
83551775|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
83551776|NCT04739774|Itraconazole|itraconazole|mesh-list
83551777|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
83551778|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551779|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83551780|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83551781|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834809|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551782|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551783|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83551784|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
83551785|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551786|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551787|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83551788|NCT02660918|Bupivacaine|bupivacaine|mesh-list
83551789|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
83551790|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
83551791|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551792|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551793|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
83551794|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551795|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
83551796|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83551797|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83551798|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551799|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551800|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83551801|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551802|NCT00367315|Analgesics|analgesics|mesh-ancestor
83551803|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
83551804|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551805|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551806|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551807|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551808|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
83551809|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83551810|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
83551811|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551812|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551813|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83551814|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
83551815|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551816|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551817|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83551818|NCT05441761|Dexamethasone|dexamethasone|mesh-list
83551819|NCT05441761|Gemcitabine|gemcitabine|mesh-list
83551820|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
83551821|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551822|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
83551823|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
83551824|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551825|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551826|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83551827|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
83551829|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551830|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83551831|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551832|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83551833|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
83551834|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551835|NCT05441761|Analgesics|analgesics|mesh-ancestor
83551836|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
83551837|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83551838|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83551839|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551840|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83551841|NCT05587621|Ezetimibe|ezetimibe|mesh-list
83551842|NCT05587621|Evolocumab|evolocumab|mesh-list
83551843|NCT05587621|Alirocumab|alirocumab|mesh-list
83551844|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83551845|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83551846|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
83551847|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551848|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83551849|NCT05587621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83551850|NCT05587621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83551851|NCT05587621|Protease Inhibitors|protease inhibitors|mesh-ancestor
83551852|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551853|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83551854|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551855|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
83551856|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83551857|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551858|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83551859|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551860|NCT02688829|Sirolimus|sirolimus|mesh-list
83551861|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83551862|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551863|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83551864|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551865|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
83551866|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83551867|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
83551868|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551869|NCT02688842|Sirolimus|sirolimus|mesh-list
83551870|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83551871|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551872|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83551873|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551874|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
83551875|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83551876|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
83551877|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551878|NCT02689063|Acetaminophen|acetaminophen|mesh-list
83551879|NCT02689063|Ibuprofen|ibuprofen|mesh-list
83551880|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551881|NCT02689063|Analgesics|analgesics|mesh-ancestor
83551882|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
83551883|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551884|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551885|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
83551886|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83551887|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551888|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551889|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83551890|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551891|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551892|NCT02690935|Immunomodulating Agents|immunomodulating agents|mesh-list
83551893|NCT02690935|Immunologic Factors|immunologic factors|mesh-ancestor
83551894|NCT02690935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551895|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
83551896|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551897|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83551898|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551899|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551900|NCT02666846|Ibuprofen|ibuprofen|mesh-list
83551901|NCT02666846|Diclofenac|diclofenac|mesh-list
83551902|NCT02666846|Salicylates|salicylates|mesh-list
83551903|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
83551904|NCT02666846|Menthol|menthol|mesh-list
83551905|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83551906|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83551907|NCT02666846|Analgesics|analgesics|mesh-ancestor
83551908|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
83551909|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551910|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551911|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551912|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83551913|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83551914|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551915|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551916|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
83551917|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
83551918|NCT02643979|Ketamine|ketamine|mesh-list
83551919|NCT02643979|Propofol|propofol|mesh-list
83551920|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83551921|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551922|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551923|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83551924|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
83551925|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
83551926|NCT02643979|Analgesics|analgesics|mesh-ancestor
83010054|NCT02904096|Lidocaine|lidocaine|mesh-list
83551927|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
83551928|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551929|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83551930|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83551931|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83551932|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551933|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551934|NCT05587231|Fluorometholone|fluorometholone|mesh-list
83551935|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83551936|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551937|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
83551938|NCT05587231|Hormones|hormones|mesh-ancestor
83551939|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83551940|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83551941|NCT02667704|Nintedanib|nintedanib|mesh-list
83551942|NCT02667704|Bosentan|bosentan|mesh-list
83551943|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551944|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83551945|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551946|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551947|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83551948|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83551949|NCT02645617|Imidacloprid|imidacloprid|mesh-list
83551950|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
83551951|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551952|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551953|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551954|NCT02694601|Caffeine|caffeine|mesh-list
83551955|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83551956|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551957|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83551958|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551959|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551960|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83551961|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83551962|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
83551963|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83551964|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
83551965|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551966|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551967|NCT02690948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83551968|NCT02690948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551969|NCT02698735|Gentamicins|gentamicins|mesh-list
83551970|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83551971|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83551972|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83551973|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83551974|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551975|NCT02691416|Propofol|propofol|mesh-list
83551976|NCT02691416|Sevoflurane|sevoflurane|mesh-list
83551977|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83551978|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551979|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551980|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83551981|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
83551982|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
83551983|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83551984|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83551985|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
83551986|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83551987|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83551988|NCT02650999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83551989|NCT02650999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83551990|NCT05502211|Lidocaine|lidocaine|mesh-list
83551991|NCT05502211|Fentanyl|fentanyl|mesh-list
83551992|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
83551993|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
83551994|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83551995|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83551996|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
83551997|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83551998|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83551999|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83552000|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84124598|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
83010153|NCT03647670|Midazolam|midazolam|mesh-list
83552001|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552002|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552003|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83552004|NCT05502211|Narcotics|narcotics|mesh-ancestor
83552005|NCT05502211|Analgesics|analgesics|mesh-ancestor
83552006|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83552007|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83552008|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
83552009|NCT02674412|Buspirone|buspirone|mesh-list
83552010|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83552011|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83552012|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552013|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552014|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552015|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83552016|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
83552017|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552018|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552019|NCT04708106|Menthol|menthol|mesh-list
83552020|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
83552021|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83552022|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
83552023|NCT02697188|Testosterone|testosterone|mesh-list
83552024|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
83552025|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
83552026|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83552027|NCT02697188|Androgens|androgens|mesh-ancestor
83552028|NCT02697188|Hormones|hormones|mesh-ancestor
83552029|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552030|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552031|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552032|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552033|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
83552034|NCT04707560|Heparin|heparin|mesh-list
83552035|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
83552036|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83552037|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83552038|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552039|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83552040|NCT02653183|Laxatives|laxatives|mesh-ancestor
83552041|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552042|NCT02701400|Durvalumab|durvalumab|mesh-list
83552043|NCT02701400|Ipilimumab|ipilimumab|mesh-list
83552044|NCT02701400|Tremelimumab|tremelimumab|mesh-list
83552045|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552046|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552047|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83552048|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552049|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
83552050|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83552051|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552052|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552053|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
83552054|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552055|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552056|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
83552057|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83552058|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552059|NCT05470465|Oxycodone|oxycodone|mesh-list
83552060|NCT05470465|Paroxetine|paroxetine|mesh-list
83552061|NCT05470465|Escitalopram|escitalopram|mesh-list
83552062|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83552063|NCT05470465|Narcotics|narcotics|mesh-ancestor
83552064|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552065|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552066|NCT05470465|Analgesics|analgesics|mesh-ancestor
83552067|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
83552068|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552069|NCT05470465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83552070|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83552071|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552072|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552073|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552074|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
83552075|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83552076|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
83552077|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552078|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83552079|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83552080|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552081|NCT00368030|Eszopiclone|eszopiclone|mesh-list
83552082|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83552083|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552084|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552085|NCT02656069|Glucagon|glucagon|mesh-list
83552086|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83552087|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552088|NCT02656069|Hormones|hormones|mesh-ancestor
83552089|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552090|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552091|NCT02656069|Incretins|incretins|mesh-ancestor
83552092|NCT05351762|Paclitaxel|paclitaxel|mesh-list
83552093|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
83552094|NCT05351762|Nedaplatin|nedaplatin|mesh-list
83552095|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83552096|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552097|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83552098|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83552099|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83552100|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552101|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552102|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
83552103|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552104|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552105|NCT02708641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83552106|NCT02708641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552107|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
83552108|NCT02710981|Clomiphene|clomiphene|mesh-list
83552109|NCT02710981|Enclomiphene|enclomiphene|mesh-list
83552110|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
83552111|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552112|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552113|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83552114|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83552115|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552116|NCT02710981|Urological Agents|urological agents|mesh-ancestor
83552117|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83552118|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
83552119|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552120|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552121|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83552122|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
83552123|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83552124|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83552125|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83552126|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
83552127|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83552128|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552129|NCT04738838|Oxytocin|oxytocin|mesh-list
83552130|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
83552131|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83552132|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552133|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83552134|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83552135|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
83552136|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552137|NCT02659501|Acetaminophen|acetaminophen|mesh-list
83552138|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83552139|NCT02659501|Epinephrine|epinephrine|mesh-list
83552140|NCT02659501|Diazepam|diazepam|mesh-list
83552141|NCT02659501|Morphine|morphine|mesh-list
83552142|NCT02659501|Hydrocodone|hydrocodone|mesh-list
83552143|NCT02659501|Bupivacaine|bupivacaine|mesh-list
83552144|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
83552145|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
83552146|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552147|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552148|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
83552149|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552150|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83552151|NCT02659501|Narcotics|narcotics|mesh-ancestor
83552152|NCT02659501|Analgesics|analgesics|mesh-ancestor
83552153|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83552154|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
83552155|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83552156|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83552157|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
83552158|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552159|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552160|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83552161|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83552162|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
83552163|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83552164|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
83552165|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
83552166|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
83552167|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83552168|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
83552169|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83552170|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
83552171|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
83552172|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552173|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83552174|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83552175|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83552176|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83552177|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83552178|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552179|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83552180|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
83552181|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
83552182|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
83552183|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83552184|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552185|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83552186|NCT00367939|Amlodipine|amlodipine|mesh-list
83552187|NCT00367939|Valsartan|valsartan|mesh-list
83552188|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83552189|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83552190|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552191|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552192|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83552193|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552194|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552195|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83552196|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83552197|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83552198|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83552199|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552200|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83552201|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
83552202|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552203|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
83552204|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83552205|NCT02722837|Velpatasvir|velpatasvir|mesh-list
83552206|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
83552207|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552208|NCT02710526|Buprenorphine|buprenorphine|mesh-list
83552209|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83552210|NCT02710526|Narcotics|narcotics|mesh-ancestor
83552211|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552212|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552213|NCT02710526|Analgesics|analgesics|mesh-ancestor
83552214|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
83552215|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552216|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83552217|NCT02664961|Bevacizumab|bevacizumab|mesh-list
83552218|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552219|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552220|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83552221|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83552222|NCT02664961|Growth Substances|growth substances|mesh-ancestor
83552223|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552224|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
83552225|NCT02665273|Bupivacaine|bupivacaine|mesh-list
83552226|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
83552227|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
83552228|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552229|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552230|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
83552231|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552232|NCT02713178|Bupivacaine|bupivacaine|mesh-list
83552233|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
83552234|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
83552235|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552236|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552237|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
83552238|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552239|NCT04130438|Nebivolol|nebivolol|mesh-list
83552240|NCT04130438|Diltiazem|diltiazem|mesh-list
83552241|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83552242|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552243|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83552244|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83552245|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83552246|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
83552247|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552248|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552249|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552250|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83552251|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552252|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83552253|NCT04048850|Grazoprevir|grazoprevir|mesh-list
83552254|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83552255|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
83552256|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552257|NCT05261672|Midazolam|midazolam|mesh-list
83552258|NCT05261672|Bupivacaine|bupivacaine|mesh-list
83552259|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
83552260|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
83552261|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552262|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552263|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
83552264|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552265|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83552266|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83552267|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83552268|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83552269|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552270|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83552271|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
83552272|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
83552273|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
83552274|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552275|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552276|NCT02714504|Voriconazole|voriconazole|mesh-list
83552277|NCT02714504|Posaconazole|posaconazole|mesh-list
83552278|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
83552279|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552280|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83552281|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83552282|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552283|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552284|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83552285|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
83552286|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552287|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552288|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83552289|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83552290|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83552291|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83552292|NCT05221502|Bedaquiline|bedaquiline|mesh-list
83552293|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
83552294|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
83552295|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83552296|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552297|NCT00368576|Darapladib|darapladib|mesh-list
83552298|NCT00368576|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83552299|NCT00368576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552300|NCT00368576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552301|NCT02730247|Paclitaxel|paclitaxel|mesh-list
83010434|NCT03574064|Glucagon|glucagon|mesh-list
83552302|NCT02730247|Ramucirumab|ramucirumab|mesh-list
83552303|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83552304|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552305|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
83552306|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
83552307|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
83552308|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552309|NCT03889106|Ribavirin|ribavirin|mesh-list
83552310|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
83552311|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552312|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
83552313|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552314|NCT00368329|Carboplatin|carboplatin|mesh-list
83552315|NCT00368329|Fluorouracil|fluorouracil|mesh-list
83552316|NCT00368329|Capecitabine|capecitabine|mesh-list
83552317|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83552318|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552319|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
83552320|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552321|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83552322|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83552323|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
83552324|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552325|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83552326|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
83552327|NCT02670343|Testosterone|testosterone|mesh-list
83552328|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
83552329|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
83552330|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83552331|NCT02670343|Androgens|androgens|mesh-ancestor
83552332|NCT02670343|Hormones|hormones|mesh-ancestor
83552333|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552334|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552335|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552336|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552337|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
83552338|NCT03697850|Atezolizumab|atezolizumab|mesh-list
83552339|NCT03697850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83552340|NCT03697850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552341|NCT03697850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552342|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552343|NCT02730884|ON 01910|on 01910|mesh-list
83552344|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552345|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83552346|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552347|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552348|NCT02732587|Saracatinib|saracatinib|mesh-list
83552349|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552350|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552351|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552352|NCT02731820|Vitamin D|vitamin d|mesh-list
83552353|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
83552354|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
83552355|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
83552356|NCT02731820|Calcium|calcium|mesh-list
83552357|NCT02731820|Vitamins|vitamins|mesh-ancestor
83552358|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
83552359|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552360|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83552361|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83552362|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552363|NCT02731820|Antacids|antacids|mesh-ancestor
83552364|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552365|NCT02731820|Diuretics|diuretics|mesh-ancestor
83552366|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
83552367|NCT02731820|Expectorants|expectorants|mesh-ancestor
83552368|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
83552369|NCT02732899|Sirolimus|sirolimus|mesh-list
83552370|NCT02732899|Aflibercept|aflibercept|mesh-list
83552371|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83552372|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552373|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83552374|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552375|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
83552376|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83552377|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
83010511|NCT02899728|Cisplatin|cisplatin|mesh-list
83552379|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83552380|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83552381|NCT02732899|Growth Substances|growth substances|mesh-ancestor
83552382|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
83552383|NCT02733757|Clonidine|clonidine|mesh-list
83552384|NCT02733757|Analgesics|analgesics|mesh-ancestor
83552385|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
83552386|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552387|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552388|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83552389|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
83552390|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
83552391|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83552392|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83552393|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83552394|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
83552395|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552396|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552397|NCT00368264|Infliximab|infliximab|mesh-list
83552398|NCT00368264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83552399|NCT00368264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552400|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
83552401|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552402|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83552403|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
83552404|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
83552405|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552406|NCT02734147|Protective Agents|protective agents|mesh-ancestor
83552407|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552408|NCT02734147|Vitamins|vitamins|mesh-ancestor
83552409|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
83552410|NCT00368342|Azithromycin|azithromycin|mesh-list
83552411|NCT00368342|Clarithromycin|clarithromycin|mesh-list
83552412|NCT00368342|Erythromycin|erythromycin|mesh-list
83552413|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
83552414|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83552415|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
83552416|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83552417|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552418|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83552419|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552420|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552421|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83552422|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83552423|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552424|NCT03609008|Cromakalim|cromakalim|mesh-list
83552425|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83552426|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83552427|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
83552428|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552429|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552430|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83552431|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
83552432|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
83552433|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552434|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
83552435|NCT02734238|Testosterone|testosterone|mesh-list
83552436|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
83552437|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
83552438|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83552439|NCT02734238|Androgens|androgens|mesh-ancestor
83552440|NCT02734238|Hormones|hormones|mesh-ancestor
83552441|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552442|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552443|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552444|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552445|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
83552446|NCT04707547|Nivolumab|nivolumab|mesh-list
83552447|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552448|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552449|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83552450|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552451|NCT03535376|Valsartan|valsartan|mesh-list
83552452|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83552453|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83552454|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83552455|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552456|NCT02736175|Dexamethasone|dexamethasone|mesh-list
83552457|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552458|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
83552459|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
83552460|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552461|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552462|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552463|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
83552464|NCT02736175|Hormones|hormones|mesh-ancestor
83552465|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552466|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552467|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552468|NCT00369356|Prednisone|prednisone|mesh-list
83552469|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552470|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
83552471|NCT00369356|Hormones|hormones|mesh-ancestor
83552472|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552473|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552474|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552475|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552476|NCT04947085|Ketamine|ketamine|mesh-list
83552477|NCT04947085|Analgesics|analgesics|mesh-ancestor
83552478|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
83552479|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552480|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552481|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83552482|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83552483|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
83552484|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
83552485|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552486|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83552487|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83552488|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552489|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552490|NCT03357224|Atezolizumab|atezolizumab|mesh-list
83552491|NCT03357224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83552492|NCT03357224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552493|NCT03357224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552494|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552495|NCT04947020|Metformin|metformin|mesh-list
83552496|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83552497|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552498|NCT02679469|Nalmefene|nalmefene|mesh-list
83552499|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83552500|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552501|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
83552502|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552503|NCT04915508|Hormones|hormones|mesh-list
83552504|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552505|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552506|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
83552507|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83552508|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83552509|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552510|NCT05445661|Mannitol|mannitol|mesh-list
83552511|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83552512|NCT05445661|Diuretics|diuretics|mesh-ancestor
83552513|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
83552514|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552515|NCT04805125|Vaccines|vaccines|mesh-list
83552516|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
83552517|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552518|NCT00368017|Pioglitazone|pioglitazone|mesh-list
83552519|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83552520|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552521|NCT00367627|Albendazole|albendazole|mesh-list
83552522|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
83552523|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83552524|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552525|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
83552526|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83552527|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83552528|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
83552529|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
83552530|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
83552531|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552532|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552533|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83552534|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552535|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552536|NCT05424523|Omalizumab|omalizumab|mesh-list
83552537|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83552538|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83552539|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
83552540|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
83552541|NCT05442931|Pregabalin|pregabalin|mesh-list
83552542|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
83552543|NCT05442931|Analgesics|analgesics|mesh-ancestor
83552544|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
83552545|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552546|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552547|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
83552548|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83552549|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552550|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552551|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83552552|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83552553|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83552554|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552555|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552556|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
83552557|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83552558|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
83552559|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83552560|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552561|NCT05439499|Letrozole|letrozole|mesh-list
83552562|NCT05439499|Anastrozole|anastrozole|mesh-list
83552563|NCT05439499|Goserelin|goserelin|mesh-list
83552564|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552565|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83552566|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83552567|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552568|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552569|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83552570|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83552571|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552572|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552573|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552574|NCT04003987|Bupivacaine|bupivacaine|mesh-list
83552575|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
83552576|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
83552577|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552578|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552579|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
83552580|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552581|NCT05448001|Lansoprazole|lansoprazole|mesh-list
83552582|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
83552583|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83552584|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552585|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83552586|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552587|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552588|NCT05447455|Anesthetics|anesthetics|mesh-list
83552589|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
83552590|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552591|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552592|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
83552593|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552594|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
83552595|NCT00369733|Hematinics|hematinics|mesh-ancestor
83552596|NCT00368719|Tacrolimus|tacrolimus|mesh-list
83552597|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83552598|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
83552599|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552600|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83552601|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010730|NCT01339819|Dabigatran|dabigatran|mesh-list
83552602|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552604|NCT00369811|Oxycodone|oxycodone|mesh-list
83552605|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83552606|NCT00369811|Narcotics|narcotics|mesh-ancestor
83552607|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552608|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552609|NCT00369811|Analgesics|analgesics|mesh-ancestor
83552610|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
83552611|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552612|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83552613|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83552614|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
83552615|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
83552616|NCT03615547|Clomiphene|clomiphene|mesh-list
83552617|NCT03615547|Enclomiphene|enclomiphene|mesh-list
83552618|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
83552619|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83552620|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
83552621|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552622|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552623|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83552624|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
83552625|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83552626|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83552627|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83552628|NCT05023993|Niacinamide|niacinamide|mesh-list
83552629|NCT05023993|Niacin|niacin|mesh-list
83552630|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
83552631|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
83552632|NCT05023993|Vitamins|vitamins|mesh-ancestor
83552633|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
83552634|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552635|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83552636|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
83552637|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552638|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83552639|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552640|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83552641|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
83552642|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552643|NCT03122509|Durvalumab|durvalumab|mesh-list
83552644|NCT03122509|Tremelimumab|tremelimumab|mesh-list
83552645|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552646|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552647|NCT03113695|Lenalidomide|lenalidomide|mesh-list
83552648|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
83552649|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
83552650|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552651|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83552652|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83552653|NCT03113695|Growth Substances|growth substances|mesh-ancestor
83552654|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
83552655|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552656|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552657|NCT05315947|Brivaracetam|brivaracetam|mesh-list
83552658|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
83552659|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83552660|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83552661|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83552662|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552663|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552664|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552665|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552666|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
83552667|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552668|NCT05444738|Oxytocin|oxytocin|mesh-list
83552669|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
83552670|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83552671|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552672|NCT05243953|Cromakalim|cromakalim|mesh-list
83552673|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83552674|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83552675|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
83552676|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552677|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552678|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83552679|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
83552680|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
83552681|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552682|NCT02757313|Dronabinol|dronabinol|mesh-list
83552683|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
83552684|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552685|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552686|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83552687|NCT02757313|Analgesics|analgesics|mesh-ancestor
83552688|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
83552689|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552690|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83552691|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83552692|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552693|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552694|NCT02757313|Hormones|hormones|mesh-ancestor
83552695|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552696|NCT02514278|Capecitabine|capecitabine|mesh-list
83552697|NCT02514278|Folfirinox|folfirinox|mesh-list
83552698|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83552699|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
83552700|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552701|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552702|NCT02379806|Enoxaparin|enoxaparin|mesh-list
83552703|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
83552704|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83552705|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83552706|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552707|NCT02358356|Capecitabine|capecitabine|mesh-list
83552708|NCT02358356|Temozolomide|temozolomide|mesh-list
83552709|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83552710|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
83552711|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552712|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552713|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83552714|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
83552715|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
83552716|NCT04700761|Anesthetics|anesthetics|mesh-list
83552717|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552718|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552719|NCT04700761|Narcotics|narcotics|mesh-ancestor
83552720|NCT04700761|Analgesics|analgesics|mesh-ancestor
83552721|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
83552722|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552723|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
83552724|NCT04651088|Diuretics|diuretics|mesh-ancestor
83552725|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
83552726|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552727|NCT04651088|Expectorants|expectorants|mesh-ancestor
83552728|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
83552729|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
83552730|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552731|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552732|NCT04595617|Antibodies|antibodies|mesh-list
83552733|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
83552734|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552735|NCT02162810|Prednisolone|prednisolone|mesh-list
83552736|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552737|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
83552738|NCT02162810|Hormones|hormones|mesh-ancestor
83552739|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552740|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552741|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552742|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552743|NCT00368498|Teicoplanin|teicoplanin|mesh-list
83552744|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83552745|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552746|NCT05172817|Adalimumab|adalimumab|mesh-list
83552747|NCT05172817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83552748|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552749|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83552750|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
83552751|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552752|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010897|NCT01334333|Tacrolimus|tacrolimus|mesh-list
83552753|NCT05145907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83552754|NCT05145907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552755|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
83552756|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83552757|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
83552758|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83552759|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552760|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83552761|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552762|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552763|NCT04545151|Verapamil|verapamil|mesh-list
83552764|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83552765|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83552766|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552767|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552768|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83552769|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552770|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
83552771|NCT00961142|Fludarabine|fludarabine|mesh-list
83552772|NCT00961142|Melphalan|melphalan|mesh-list
83552773|NCT00961142|Thiotepa|thiotepa|mesh-list
83552774|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
83552775|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552776|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552777|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83552778|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
83552779|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552780|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83552781|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
83552782|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83552783|NCT04523701|SMOFlipid|smoflipid|mesh-list
83552784|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83552785|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83552786|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83552787|NCT04338373|Atropine|atropine|mesh-list
83552788|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83552789|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83552790|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83552791|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
83552792|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552793|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552794|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83552795|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
83552796|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
83552797|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
83552798|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83552799|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83552800|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
83552801|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552802|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552803|NCT00059930|Leucovorin|leucovorin|mesh-list
83552804|NCT00059930|Dexamethasone|dexamethasone|mesh-list
83552805|NCT00059930|Fluorouracil|fluorouracil|mesh-list
83552806|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
83552807|NCT00059930|Floxuridine|floxuridine|mesh-list
83552808|NCT00059930|Calcium|calcium|mesh-list
83552809|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
83552810|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552811|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
83552812|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
83552813|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552814|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552815|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83552816|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
83552817|NCT00059930|Hormones|hormones|mesh-ancestor
83552818|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552819|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552820|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552821|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83552822|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
83552823|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552824|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83552825|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83552826|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
83552827|NCT00059930|Antidotes|antidotes|mesh-ancestor
83011027|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
83552828|NCT00059930|Protective Agents|protective agents|mesh-ancestor
83552829|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
83552831|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
83552832|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
83552833|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83552834|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
83552835|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552836|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83552837|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552838|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
83552839|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552840|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
83552841|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83552842|NCT00369031|Protective Agents|protective agents|mesh-ancestor
83552843|NCT05443178|Isoniazid|isoniazid|mesh-list
83552844|NCT05443178|Ethambutol|ethambutol|mesh-list
83552845|NCT05443178|Chloroquine|chloroquine|mesh-list
83552846|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
83552847|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83552848|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83552849|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552850|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83552851|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83552852|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
83552853|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83552854|NCT05443178|Amebicides|amebicides|mesh-ancestor
83552855|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83552856|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83552857|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
83552858|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83552859|NCT05064319|Gabapentin|gabapentin|mesh-list
83552860|NCT05064319|Analgesics|analgesics|mesh-ancestor
83552861|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
83552862|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552863|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552864|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
83552865|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83552866|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83552867|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552868|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83552869|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83552870|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83552871|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552872|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552873|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
83552874|NCT05061901|Lisinopril|lisinopril|mesh-list
83552875|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83552876|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
83552877|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552878|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552879|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83552880|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83552881|NCT05061901|Protective Agents|protective agents|mesh-ancestor
83552882|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552883|NCT04338919|Aspirin|aspirin|mesh-list
83552884|NCT04338919|Ticagrelor|ticagrelor|mesh-list
83552885|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83552886|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83552887|NCT04338919|Analgesics|analgesics|mesh-ancestor
83552888|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
83552889|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552890|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552891|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552892|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83552893|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83552894|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83552895|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552896|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83552897|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83552898|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552899|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
83552900|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83552901|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83552902|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83552903|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
83552904|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552905|NCT05451290|Gemcitabine|gemcitabine|mesh-list
83552906|NCT05451290|Tegafur|tegafur|mesh-list
83552907|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
83552908|NCT05451290|Apatinib|apatinib|mesh-list
83552909|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83552910|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
83552911|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552912|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552913|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83552914|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552915|NCT00369889|Bevacizumab|bevacizumab|mesh-list
83552916|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83552917|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552918|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552919|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83552920|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83552921|NCT00369889|Growth Substances|growth substances|mesh-ancestor
83552922|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552923|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
83552924|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83552925|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552926|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552927|NCT00369044|Prednisone|prednisone|mesh-list
83552928|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83552929|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
83552930|NCT00369044|Hormones|hormones|mesh-ancestor
83552931|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552932|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552933|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552934|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552935|NCT00370045|Bivalirudin|bivalirudin|mesh-list
83552936|NCT00370045|Eptifibatide|eptifibatide|mesh-list
83552937|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
83552938|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83552939|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
83552940|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552941|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552942|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
83552943|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83552944|NCT05451056|Sotorasib|sotorasib|mesh-list
83552945|NCT05451056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83552946|NCT05451056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552947|NCT05451056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83552948|NCT05451056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552949|NCT05441150|Ketamine|ketamine|mesh-list
83552950|NCT05441150|Analgesics|analgesics|mesh-ancestor
83552951|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
83552952|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83552953|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552954|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83552955|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83552956|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
83552957|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
83552958|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552959|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83552960|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83552961|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552962|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552963|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83552964|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83552965|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83552966|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552967|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
83552968|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83552969|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552970|NCT04238624|Trametinib|trametinib|mesh-list
83552971|NCT04238624|Dabrafenib|dabrafenib|mesh-list
83552972|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552973|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83552974|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552975|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552976|NCT05438810|Fulvestrant|fulvestrant|mesh-list
83552978|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83552979|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83552980|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83552981|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83552982|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
83552983|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83552984|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552985|NCT04747496|Edoxaban|edoxaban|mesh-list
83552986|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83552987|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
83552988|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83552989|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
83552990|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83552991|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83552992|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
83552993|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
83552994|NCT05451121|Propofol|propofol|mesh-list
83552995|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83552996|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83552997|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83552998|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83552999|NCT05451121|Analgesics|analgesics|mesh-ancestor
83553000|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
83553001|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553002|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83553003|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83553004|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83553005|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83553006|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553007|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553008|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83553009|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
83553010|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
83553011|NCT04967443|Prazosin|prazosin|mesh-list
83553012|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83553013|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83553014|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83553015|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83553016|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
83553017|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553018|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553019|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553020|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
83553021|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553022|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
83553023|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
83553024|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553025|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
83553026|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83553027|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83553028|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83553029|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83553030|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553031|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
83553032|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553033|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553034|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83553035|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553036|NCT05450042|Paclitaxel|paclitaxel|mesh-list
83553037|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83553038|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553039|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553040|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553041|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553042|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553043|NCT05447936|Vitamin D|vitamin d|mesh-list
83553044|NCT05447936|Vitamins|vitamins|mesh-ancestor
83553045|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
83553046|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553047|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83553048|NCT04739384|Ticagrelor|ticagrelor|mesh-list
83553049|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83011180|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
83553050|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83553051|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83553052|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83553053|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
83553054|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553055|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553056|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553057|NCT04704596|Anesthetics|anesthetics|mesh-list
83553058|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553059|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553060|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
83553061|NCT05450497|Propofol|propofol|mesh-list
83553062|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83553063|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553064|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553065|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83553066|NCT05450497|Analgesics|analgesics|mesh-ancestor
83553067|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
83553068|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553069|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83553070|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83553071|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83553072|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
83553073|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553074|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553075|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83553076|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
83553077|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
83553078|NCT02230332|Alendronate|alendronate|mesh-list
83553079|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83553080|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553081|NCT05449028|Bismuth|bismuth|mesh-list
83553082|NCT05449028|Antacids|antacids|mesh-ancestor
83553083|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553084|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553085|NCT04845139|Nivolumab|nivolumab|mesh-list
83553086|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553087|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553088|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553089|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553090|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
83553091|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
83553092|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83553093|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553094|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553095|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
83553096|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83553097|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553098|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553099|NCT05449483|Paclitaxel|paclitaxel|mesh-list
83553100|NCT05449483|Tislelizumab|tislelizumab|mesh-list
83553101|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83553102|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553103|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553104|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553105|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553106|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553107|NCT05449483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553108|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83553109|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83553110|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553111|NCT04793659|Fasudil|fasudil|mesh-list
83553112|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
83553113|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83553114|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83684413|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83553115|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553116|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83553117|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553118|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
83553119|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83553120|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553121|NCT05448937|Eugenol|eugenol|mesh-list
83553123|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553124|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
83553125|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83553126|NCT05448937|Protective Agents|protective agents|mesh-ancestor
83553127|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553128|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553129|NCT00370201|Colchicine|colchicine|mesh-list
83553130|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
83553131|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553132|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553133|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553134|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553135|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553136|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553137|NCT05448781|Paclitaxel|paclitaxel|mesh-list
83553138|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83553139|NCT05448781|Carboplatin|carboplatin|mesh-list
83553140|NCT05448781|Pemetrexed|pemetrexed|mesh-list
83553141|NCT05448781|Endostatins|endostatins|mesh-list
83553142|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83553143|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553144|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553145|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553146|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553147|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553148|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553149|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83553150|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83553151|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83553152|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83553153|NCT05448781|Growth Substances|growth substances|mesh-ancestor
83553154|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553155|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
83553156|NCT03182426|Liraglutide|liraglutide|mesh-list
83553157|NCT03182426|Plerixafor|plerixafor|mesh-list
83553158|NCT03182426|Etanercept|etanercept|mesh-list
83553159|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
83553160|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83553161|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83553162|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553163|NCT03182426|Incretins|incretins|mesh-ancestor
83553164|NCT03182426|Hormones|hormones|mesh-ancestor
83553165|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553166|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83553167|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83553168|NCT03182426|Analgesics|analgesics|mesh-ancestor
83553169|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
83553170|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553171|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553172|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553173|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553174|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83553175|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
83553176|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553177|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553178|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83553179|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83553180|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
83553181|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553182|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83553183|NCT03233347|Nivolumab|nivolumab|mesh-list
83553184|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83553185|NCT03233347|Doxorubicin|doxorubicin|mesh-list
83553186|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83553187|NCT03233347|Daunorubicin|daunorubicin|mesh-list
83553188|NCT03233347|Dacarbazine|dacarbazine|mesh-list
83553189|NCT03233347|Vinblastine|vinblastine|mesh-list
83553190|NCT03233347|Antibodies|antibodies|mesh-list
83553191|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
83553192|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83553193|NCT03233347|Imidazole|imidazole|mesh-list
83553194|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
83553195|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
83553196|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553197|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553198|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83553199|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83553200|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83553202|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553203|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553204|NCT03233347|Immunotoxins|immunotoxins|mesh-ancestor
83553205|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83553206|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
83553207|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83553208|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553209|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553210|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553211|NCT04502966|Immunomodulating Agents|immunomodulating agents|mesh-list
83553212|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
83553213|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83553214|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553215|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
83553216|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553217|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553218|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83553219|NCT03036488|Paclitaxel|paclitaxel|mesh-list
83553220|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
83553221|NCT03036488|Carboplatin|carboplatin|mesh-list
83553222|NCT03036488|Doxorubicin|doxorubicin|mesh-list
83553223|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
83553224|NCT03036488|Epirubicin|epirubicin|mesh-list
83553225|NCT03036488|Lenograstim|lenograstim|mesh-list
83553226|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83553227|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553228|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553229|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553230|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553231|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553232|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83553233|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
83553234|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553235|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553236|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83553237|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
83553238|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83553239|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83553240|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83553241|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83553242|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553243|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553244|NCT03036488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553245|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83553246|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83553247|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83553248|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83553249|NCT00370825|Miltefosine|miltefosine|mesh-list
83553250|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
83553251|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553252|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83553253|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83553254|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553255|NCT04450316|Naltrexone|naltrexone|mesh-list
83553256|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83553257|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83553258|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553259|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
83553260|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553261|NCT05398094|Sotorasib|sotorasib|mesh-list
83553262|NCT05398094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553263|NCT05398094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553264|NCT05398094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553265|NCT05398094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553266|NCT05377424|Istradefylline|istradefylline|mesh-list
83553267|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83553268|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83553269|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83553270|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
83553271|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553272|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553273|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553274|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
83553275|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553276|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553277|NCT02535247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553278|NCT02535247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553279|NCT04417920|Mitomycins|mitomycins|mesh-list
83553280|NCT04417920|Mitomycin|mitomycin|mesh-list
83553281|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83553282|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553283|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
83553284|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553285|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83553286|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553287|NCT02626130|Tremelimumab|tremelimumab|mesh-list
83553288|NCT02626130|Ipilimumab|ipilimumab|mesh-list
83553289|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553290|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553291|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553292|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553293|NCT02618720|Ornidazole|ornidazole|mesh-list
83553294|NCT02618720|Amebicides|amebicides|mesh-ancestor
83553295|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83553296|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83553297|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553298|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83553299|NCT03758989|Prednisone|prednisone|mesh-list
83553300|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
83553301|NCT03758989|Rituximab|rituximab|mesh-list
83553302|NCT03758989|Doxorubicin|doxorubicin|mesh-list
83553303|NCT03758989|Vincristine|vincristine|mesh-list
83553304|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83553305|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
83553306|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553307|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553308|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83553309|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
83553310|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553311|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553312|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83553313|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553314|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83553315|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83553316|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83553317|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553318|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553319|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
83553320|NCT03758989|Hormones|hormones|mesh-ancestor
83553321|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553322|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83553323|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83553324|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553325|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553326|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553327|NCT02042989|Vorinostat|vorinostat|mesh-list
83553328|NCT02042989|Ixazomib|ixazomib|mesh-list
83553329|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553330|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83553331|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553332|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553333|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
83553334|NCT04093531|Ustekinumab|ustekinumab|mesh-list
83553335|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553336|NCT04065841|Licogliflozin|licogliflozin|mesh-list
83553337|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83553338|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553339|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83553340|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553341|NCT05208944|Cemiplimab|cemiplimab|mesh-list
83553342|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553343|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553344|NCT01809379|Cisplatin|cisplatin|mesh-list
83553345|NCT01809379|Doxorubicin|doxorubicin|mesh-list
83553346|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553347|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83553348|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83553349|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83553351|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553352|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
83553353|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83553354|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553355|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83553356|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553357|NCT05202158|Gentamicins|gentamicins|mesh-list
83553358|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83553359|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553360|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83553361|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553362|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553363|NCT00370370|Triamcinolone|triamcinolone|mesh-list
83553364|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83553365|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83553366|NCT00370370|Bevacizumab|bevacizumab|mesh-list
83553367|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83553368|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553369|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553370|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83553371|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83553372|NCT00370370|Growth Substances|growth substances|mesh-ancestor
83553373|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553374|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83553375|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553376|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
83553377|NCT00370370|Hormones|hormones|mesh-ancestor
83553378|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553379|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83553380|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
83553381|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553382|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553383|NCT02197416|Dabigatran|dabigatran|mesh-list
83553384|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
83553385|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83553386|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
83553387|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553388|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553389|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
83553390|NCT00370591|Fluticasone|fluticasone|mesh-list
83553391|NCT00370591|Xhance|xhance|mesh-list
83553392|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83553393|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553394|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83553395|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
83553396|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553397|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553398|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83553399|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
83553400|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553401|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83553402|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83553403|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83553404|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83553405|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
83553406|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553407|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553408|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83553409|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553410|NCT00371527|Ipratropium|ipratropium|mesh-list
83553411|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83553412|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
83553413|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553414|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553415|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83553416|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
83553417|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83553418|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
83553419|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553420|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553421|NCT00392756|Hormones|hormones|mesh-list
83011549|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553422|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553423|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553424|NCT03908593|Pantoprazole|pantoprazole|mesh-list
83553425|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83553426|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553427|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83553428|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553429|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553430|NCT04027322|Dexamethasone|dexamethasone|mesh-list
83553431|NCT04027322|Budesonide|budesonide|mesh-list
83553432|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553433|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
83553434|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
83553435|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553436|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553437|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553438|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
83553439|NCT04027322|Hormones|hormones|mesh-ancestor
83553440|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553441|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83553442|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553443|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83553444|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83553445|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
83553446|NCT03845257|Dimercaprol|dimercaprol|mesh-list
83553447|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
83553448|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
83553449|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553450|NCT00371072|Mitomycins|mitomycins|mesh-list
83553451|NCT00371072|Mitomycin|mitomycin|mesh-list
83553452|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83553453|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553454|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
83553455|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553456|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83553457|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553458|NCT05454332|Caffeine|caffeine|mesh-list
83553459|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83553460|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553461|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83553462|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553463|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553464|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83553465|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83553466|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
83553467|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553468|NCT03924518|Granisetron|granisetron|mesh-list
83553469|NCT03924518|Serotonin|serotonin|mesh-list
83553470|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
83553471|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
83553472|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553473|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553474|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553475|NCT03924518|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83553476|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83553477|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
83553478|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553479|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553480|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83553481|NCT05454085|Bisphenol A|bisphenol a|mesh-list
83553482|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83553483|NCT05454085|Estrogens|estrogens|mesh-ancestor
83553484|NCT05454085|Hormones|hormones|mesh-ancestor
83553485|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553486|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553487|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83553488|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
83553489|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553490|NCT05454085|Protective Agents|protective agents|mesh-ancestor
83553491|NCT03886922|Cromakalim|cromakalim|mesh-list
83553492|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83553493|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83553494|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
83553495|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553496|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553497|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83553498|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
83553499|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
83553500|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
83553501|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
83553502|NCT05453552|Busulfan|busulfan|mesh-list
83553503|NCT05453552|Fludarabine|fludarabine|mesh-list
83553504|NCT05453552|Decitabine|decitabine|mesh-list
83553505|NCT05453552|Lenograstim|lenograstim|mesh-list
83553506|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83553507|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
83553508|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553509|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553510|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83553511|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
83553512|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553513|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553514|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83553515|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83553516|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
83553517|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553518|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83553519|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
83553520|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83553521|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83553522|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553523|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
83553524|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553525|NCT02165202|Rilpivirine|rilpivirine|mesh-list
83553526|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83553527|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83553528|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553529|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553530|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
83553531|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553532|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83553533|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83553534|NCT01628874|Lidocaine|lidocaine|mesh-list
83553535|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83553536|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
83553537|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
83553538|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553539|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553540|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
83553541|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553542|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83553543|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83553544|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83553545|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83553546|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553547|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83553548|NCT04891718|Nivolumab|nivolumab|mesh-list
83553549|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553550|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553551|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83553552|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553553|NCT03770689|Capecitabine|capecitabine|mesh-list
83553554|NCT03770689|Peposertib|peposertib|mesh-list
83553555|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83553556|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
83553557|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553558|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553559|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83553560|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553561|NCT00371306|Metformin|metformin|mesh-list
83553562|NCT00371306|Glyburide|glyburide|mesh-list
83553563|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83553564|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553565|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
83553566|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
83553567|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83553568|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
83553569|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553570|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553571|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83553572|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
83553573|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83553574|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83553575|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83553576|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
83553577|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553578|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553579|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83553580|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83553581|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83553582|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
83553583|NCT05453929|Rocuronium|rocuronium|mesh-list
83553584|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83553585|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83553586|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83553587|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553588|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553589|NCT00370760|Dexamethasone|dexamethasone|mesh-list
83553590|NCT00370760|Colchicine|colchicine|mesh-list
83553591|NCT00370760|Heparin|heparin|mesh-list
83553592|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83553593|NCT00370760|Tinzaparin|tinzaparin|mesh-list
83553594|NCT00370760|Dalteparin|dalteparin|mesh-list
83553595|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553596|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
83553597|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
83553598|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553599|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553600|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553601|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
83553602|NCT00370760|Hormones|hormones|mesh-ancestor
83553603|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553604|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83553605|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553606|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
83553607|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83553608|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83553609|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553610|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
83553611|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553612|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553613|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553614|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553615|NCT03737461|Lidocaine|lidocaine|mesh-list
83553616|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
83553617|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
83553618|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553619|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553620|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
83553621|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553622|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83553623|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83553624|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83553625|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83553626|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553627|NCT05203562|Letrozole|letrozole|mesh-list
83553628|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553629|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83553630|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83553631|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553632|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553633|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83553634|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
83553635|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553636|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553637|NCT04766762|Flunarizine|flunarizine|mesh-list
83553638|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
83553639|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83442551|NCT00775411|Hormones|hormones|mesh-ancestor
83553640|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83553641|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553642|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83553643|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011777|NCT03145207|Lidocaine|lidocaine|mesh-list
83553644|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83553645|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
83553646|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
83553647|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553648|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
83553649|NCT04330040|Olaparib|olaparib|mesh-list
83553650|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83553651|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553652|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553653|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553654|NCT02737891|Metoprolol|metoprolol|mesh-list
83553655|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83553656|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83553657|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
83553658|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
83553659|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553660|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553661|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83553662|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83553663|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83553664|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83553665|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553666|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553667|NCT05055050|Imiquimod|imiquimod|mesh-list
83553668|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83553669|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
83553670|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553671|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553672|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
83553673|NCT02196558|Quetmolimab|quetmolimab|mesh-list
83553674|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553675|NCT04809662|Imiquimod|imiquimod|mesh-list
83553676|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83553677|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
83553678|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553679|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553680|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
83553681|NCT02196324|Serlopitant|serlopitant|mesh-list
83553682|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83553683|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553684|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553685|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553686|NCT05450419|Vitamin D|vitamin d|mesh-list
83553687|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
83553688|NCT05450419|Vitamins|vitamins|mesh-ancestor
83553689|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
83553690|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553691|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83553692|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83553693|NCT05443009|Lidocaine|lidocaine|mesh-list
83553694|NCT05443009|Carticaine|carticaine|mesh-list
83553695|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
83553696|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
83553697|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553698|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553699|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
83553700|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553701|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83553702|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83553703|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83553704|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83553705|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553706|NCT00370669|Triamcinolone|triamcinolone|mesh-list
83553707|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83553708|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83553709|NCT00370669|Bevacizumab|bevacizumab|mesh-list
83553710|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83553711|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83553712|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553713|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83553714|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83553715|NCT00370669|Growth Substances|growth substances|mesh-ancestor
83553716|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553717|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83553718|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553720|NCT00370669|Hormones|hormones|mesh-ancestor
83553721|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553722|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83553723|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
83553724|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553725|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553726|NCT05378971|Pomalidomide|pomalidomide|mesh-list
83553727|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
83553728|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553729|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83553730|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83553731|NCT05378971|Growth Substances|growth substances|mesh-ancestor
83553732|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
83553733|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553734|NCT04337450|Lamivudine|lamivudine|mesh-list
83553735|NCT04337450|Dolutegravir|dolutegravir|mesh-list
83553736|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83553737|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83553738|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553739|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553740|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
83553741|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553742|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83553743|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83553744|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83553745|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83553746|NCT02740543|Fluticasone|fluticasone|mesh-list
83553747|NCT02740543|Xhance|xhance|mesh-list
83553748|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553749|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83553750|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
83553751|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553752|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553753|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83553754|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
83553755|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553756|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83553757|NCT00370747|Ecabet|ecabet|mesh-list
83553758|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553759|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83553760|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553761|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
83553762|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553763|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553764|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83553765|NCT00370747|Protective Agents|protective agents|mesh-ancestor
83553766|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553767|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553768|NCT02752256|Plasminogen|plasminogen|mesh-list
83553769|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83553770|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83553771|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83553772|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553773|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83553774|NCT02227446|Vancomycin|vancomycin|mesh-list
83553775|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553776|NCT04738058|Lactoferrin|lactoferrin|mesh-list
83553777|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553778|NCT02227368|Ticagrelor|ticagrelor|mesh-list
83553779|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553780|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553781|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83553782|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83553783|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83553784|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83553785|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
83553786|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553787|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83553788|NCT02162862|Bupropion|bupropion|mesh-list
83553789|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83553790|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
83553791|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83553792|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83011926|NCT01345981|Lidocaine|lidocaine|mesh-list
83553793|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83553794|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83553795|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553797|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553798|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553799|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83553800|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83553801|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553802|NCT05277727|Fucoidan|fucoidan|mesh-list
83553803|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83553804|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553805|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
83553806|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553807|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83553808|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83553809|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83553810|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
83553811|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553812|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83553813|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83553814|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553815|NCT02754518|Valsartan|valsartan|mesh-list
83553816|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83553817|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83553818|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83553819|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83553820|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553821|NCT02751385|Nintedanib|nintedanib|mesh-list
83553822|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83553823|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83553824|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553825|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83553826|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553827|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553828|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83553829|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
83553830|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83553831|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553832|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83553833|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83553834|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83553835|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83553836|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83553837|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83553838|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83553839|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83553840|NCT05349032|Curcumin|curcumin|mesh-list
83553841|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83553842|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83553843|NCT05349032|Analgesics|analgesics|mesh-ancestor
83553844|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
83553845|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553846|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553847|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553848|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553849|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553850|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553851|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553852|NCT05057689|Fentanyl|fentanyl|mesh-list
83553853|NCT05057689|Midazolam|midazolam|mesh-list
83553854|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
83553855|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83553856|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553857|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553858|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83553859|NCT05057689|Analgesics|analgesics|mesh-ancestor
83553860|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
83553861|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553862|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83553863|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83553864|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83553865|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83553866|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553867|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553868|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83553869|NCT05057689|Narcotics|narcotics|mesh-ancestor
83553870|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83553871|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83553872|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
83553873|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
83553874|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83553875|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83553876|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83553877|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
83553878|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
83553879|NCT05032183|Leucovorin|leucovorin|mesh-list
83553880|NCT05032183|Cytarabine|cytarabine|mesh-list
83553881|NCT05032183|Dexamethasone|dexamethasone|mesh-list
83553882|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
83553883|NCT05032183|Prednisone|prednisone|mesh-list
83553884|NCT05032183|Cortisone|cortisone|mesh-list
83553885|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
83553886|NCT05032183|Rituximab|rituximab|mesh-list
83553887|NCT05032183|Methotrexate|methotrexate|mesh-list
83553888|NCT05032183|Vincristine|vincristine|mesh-list
83553889|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
83553890|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83553891|NCT05032183|Antibodies|antibodies|mesh-list
83553892|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
83553893|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83553894|NCT05032183|Lenograstim|lenograstim|mesh-list
83553895|NCT05032183|BB 1101|bb 1101|mesh-list
83553896|NCT05032183|Mesna|mesna|mesh-list
83553897|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83553898|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
83553899|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553900|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553901|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83553902|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
83553903|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553904|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553905|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83553906|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553907|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
83553908|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
83553909|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553910|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553911|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
83553912|NCT05032183|Hormones|hormones|mesh-ancestor
83553913|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553914|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83553915|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
83553916|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553917|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83553918|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
83553919|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83553920|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83553921|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
83553922|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
83553923|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83553924|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83553925|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
83553926|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83553927|NCT05032183|Antidotes|antidotes|mesh-ancestor
83553928|NCT05032183|Protective Agents|protective agents|mesh-ancestor
83553929|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
83553930|NCT05032183|Vitamins|vitamins|mesh-ancestor
83553931|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
83553932|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83553933|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83553934|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83553935|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83553936|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83553937|NCT04737980|Dexamethasone|dexamethasone|mesh-list
83553938|NCT04737980|Bupivacaine|bupivacaine|mesh-list
83553939|NCT04737980|Ropivacaine|ropivacaine|mesh-list
83553940|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553941|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
83553942|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
83553943|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553944|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553945|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553946|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
83553947|NCT04737980|Hormones|hormones|mesh-ancestor
83553948|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83553949|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83553950|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83553951|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
83553952|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
83553953|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553954|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
83553955|NCT00371696|Acetaminophen|acetaminophen|mesh-list
83553956|NCT00371696|Diclofenac|diclofenac|mesh-list
83553957|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83553958|NCT00371696|Analgesics|analgesics|mesh-ancestor
83553959|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
83553960|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553961|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553962|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
83553963|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83553964|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83553965|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83553966|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83553967|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83553968|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553969|NCT02756624|Cetirizine|cetirizine|mesh-list
83553970|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83553971|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83553972|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83553973|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
83553974|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
83553975|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553976|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553977|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553978|NCT02958800|Olanzapine|olanzapine|mesh-list
83553979|NCT02958800|Risperidone|risperidone|mesh-list
83553980|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83553981|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
83553982|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83553983|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
83553984|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83553985|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83553986|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83553987|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83553988|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83553989|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83553990|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83553991|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
83553992|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
83553993|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
83553994|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83553995|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83553996|NCT02958800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83553997|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83553998|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83553999|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
83554000|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
83554001|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83554002|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554003|NCT04738045|Ritonavir|ritonavir|mesh-list
83554004|NCT04738045|Lopinavir|lopinavir|mesh-list
83554005|NCT04738045|Remdesivir|remdesivir|mesh-list
83554006|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83554007|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83554008|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
83554009|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554010|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554011|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83554012|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83554013|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
83554014|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554015|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83554016|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83554017|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
83834810|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554018|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83554019|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83554020|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554021|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
83554022|NCT04587973|Ropivacaine|ropivacaine|mesh-list
83554023|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83554024|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554025|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554026|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83554027|NCT04587973|Analgesics|analgesics|mesh-ancestor
83554028|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
83554029|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554030|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83554031|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83554032|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83554033|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
83554034|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554035|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554036|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
83554037|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
83554038|NCT04516915|Oseltamivir|oseltamivir|mesh-list
83554039|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
83554040|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554041|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554042|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554043|NCT02753881|Doxorubicin|doxorubicin|mesh-list
83554044|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83554045|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83554046|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554047|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83554048|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83554049|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554050|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554051|NCT00425360|Gemcitabine|gemcitabine|mesh-list
83554052|NCT00425360|Capecitabine|capecitabine|mesh-list
83554053|NCT00425360|Sargramostim|sargramostim|mesh-list
83554054|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83554055|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
83554056|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554057|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554058|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
83554059|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554060|NCT04337606|Decitabine|decitabine|mesh-list
83554061|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83554062|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
83554063|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554064|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554065|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554066|NCT01190306|Riboflavin|riboflavin|mesh-list
83554067|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
83554068|NCT01190306|Vitamins|vitamins|mesh-ancestor
83554069|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
83554070|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554071|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83554072|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
83554073|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
83554074|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554075|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554076|NCT02759575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554077|NCT02759575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554078|NCT05320718|Ropivacaine|ropivacaine|mesh-list
83554079|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
83554080|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
83554081|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554082|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554083|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
83554084|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554085|NCT02739698|Paclitaxel|paclitaxel|mesh-list
83554086|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83554087|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554088|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
83554089|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
83554090|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
83554091|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554092|NCT04336904|Favipiravir|favipiravir|mesh-list
83554093|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
83554094|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554095|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
83554096|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554097|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554098|NCT02767934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554099|NCT02767934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554100|NCT02194998|Ritonavir|ritonavir|mesh-list
83554101|NCT02194998|Ribavirin|ribavirin|mesh-list
83554102|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83554103|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83554104|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83554105|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554106|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554107|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83554108|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83554109|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
83554110|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554111|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83554112|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83554113|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
83554114|NCT02194062|Fluticasone|fluticasone|mesh-list
83554115|NCT02194062|Xhance|xhance|mesh-list
83554116|NCT02194062|Budesonide|budesonide|mesh-list
83554117|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554118|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83554119|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
83554120|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554121|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554122|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83554123|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554124|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83554125|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83554126|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
83554127|NCT02194062|Hormones|hormones|mesh-ancestor
83554128|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554129|NCT02768558|Nivolumab|nivolumab|mesh-list
83554130|NCT02768558|Etoposide|etoposide|mesh-list
83554131|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554132|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554133|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554134|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554135|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83554136|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83554137|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83554138|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554139|NCT02192970|Bevacizumab|bevacizumab|mesh-list
83554140|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554141|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554142|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83554143|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83554144|NCT02192970|Growth Substances|growth substances|mesh-ancestor
83554145|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554146|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
83554147|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
83554148|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554149|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
83554150|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83554151|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554152|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83554153|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554154|NCT02762071|Bupivacaine|bupivacaine|mesh-list
83554155|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
83554156|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
83554157|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554158|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554159|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
83554160|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554161|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
83554162|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83554163|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83554164|NCT04336891|Estradiol|estradiol|mesh-list
83554165|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83554166|NCT04336891|Testosterone|testosterone|mesh-list
83554167|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
83554168|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
83554169|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83554170|NCT04336891|Estrogens|estrogens|mesh-ancestor
83554171|NCT04336891|Hormones|hormones|mesh-ancestor
83554172|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554173|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554174|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83554175|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
83554176|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83554177|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83554178|NCT04336891|Androgens|androgens|mesh-ancestor
83554179|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83554180|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554181|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
83554182|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
83554183|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83554184|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83554185|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
83554186|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554187|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554188|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83554189|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554190|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83554191|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
83554192|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554193|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554194|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83554195|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
83554196|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
83554197|NCT04337918|Protective Agents|protective agents|mesh-ancestor
83554198|NCT02747186|Lidocaine|lidocaine|mesh-list
83554199|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
83554200|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
83554201|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554202|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554203|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
83554204|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554205|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83554206|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83554207|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83554208|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83554209|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554210|NCT02766517|Capsaicin|capsaicin|mesh-list
83554211|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
83554212|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
83554213|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
83554214|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554215|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554216|NCT04336046|Bupivacaine|bupivacaine|mesh-list
83554217|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
83554218|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
83554219|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554220|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554221|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
83554222|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554223|NCT05348239|Copper|copper|mesh-list
83554224|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
83554225|NCT05348239|Trace Elements|trace elements|mesh-ancestor
83554226|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
83554227|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554228|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83554229|NCT05348239|Protective Agents|protective agents|mesh-ancestor
83554230|NCT02766673|Albuterol|albuterol|mesh-list
83554231|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83554232|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
83554233|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554234|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554235|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83554236|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554237|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
83554238|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83554239|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83554240|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83554241|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83554242|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
83554243|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554244|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554245|NCT00372008|Testosterone|testosterone|mesh-list
83554246|NCT00372008|Androgens|androgens|mesh-ancestor
83554247|NCT00372008|Hormones|hormones|mesh-ancestor
83554248|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554249|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554250|NCT02973763|Aflutinib|aflutinib|mesh-list
83554251|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83554252|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554253|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554254|NCT04337593|Pegaspargase|pegaspargase|mesh-list
83554255|NCT04337593|Basiliximab|basiliximab|mesh-list
83554256|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554257|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83554258|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
83554259|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554260|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
83554261|NCT05339581|Tislelizumab|tislelizumab|mesh-list
83554262|NCT05339581|Lenvatinib|lenvatinib|mesh-list
83554263|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554264|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554265|NCT05339581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554266|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554267|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83554268|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554269|NCT04064684|Budesonide|budesonide|mesh-list
83554270|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554271|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83554272|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
83554273|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554274|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554275|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83554276|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554277|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
83554278|NCT04064684|Hormones|hormones|mesh-ancestor
83554279|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554280|NCT02192190|Celecoxib|celecoxib|mesh-list
83554281|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83554282|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83554283|NCT02192190|Analgesics|analgesics|mesh-ancestor
83554284|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
83554285|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554286|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554287|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554288|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554289|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83554290|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83554291|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554292|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554293|NCT02748889|Carboplatin|carboplatin|mesh-list
83554294|NCT02748889|Etoposide|etoposide|mesh-list
83554295|NCT02748889|Atezolizumab|atezolizumab|mesh-list
83554296|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554297|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83554298|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83554299|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83554300|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554301|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554302|NCT02748889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554303|NCT02748889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554304|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83554305|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
83554306|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554307|NCT04654988|Prednisone|prednisone|mesh-list
83554308|NCT04654988|Azathioprine|azathioprine|mesh-list
83554309|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554310|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
83554311|NCT04654988|Hormones|hormones|mesh-ancestor
83554312|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554313|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554314|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83554315|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554316|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
83554317|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554318|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83554319|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83554320|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
83554321|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554322|NCT02224560|Cannabidiol|cannabidiol|mesh-list
83554323|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
83554324|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
83554325|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83554326|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554327|NCT02973776|Clobetasol|clobetasol|mesh-list
83554328|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83554329|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554330|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
83554331|NCT02973776|Hormones|hormones|mesh-ancestor
83554332|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554333|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554334|NCT02161458|Dexetimide|dexetimide|mesh-list
83554335|NCT02161458|Citalopram|citalopram|mesh-list
83554336|NCT02161458|Escitalopram|escitalopram|mesh-list
83554337|NCT02161458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83554338|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83554339|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83554340|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554341|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554342|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
83554343|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554344|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83554345|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83554346|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
83554347|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
83554348|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554349|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83554350|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83554351|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
83554352|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83554353|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
83554354|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83554355|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83554356|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83554357|NCT04507022|Estradiol|estradiol|mesh-list
83554358|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83554359|NCT04507022|Progesterone|progesterone|mesh-list
83554360|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83554361|NCT04507022|Estrogens|estrogens|mesh-ancestor
83554362|NCT04507022|Hormones|hormones|mesh-ancestor
83554363|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554364|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554365|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83554366|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
83554367|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83554368|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83554369|NCT04507022|Progestins|progestins|mesh-ancestor
83554370|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83554371|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554372|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554373|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83554374|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
83554375|NCT00372788|Pemetrexed|pemetrexed|mesh-list
83554376|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554377|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554378|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554379|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83554380|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83554381|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
83554382|NCT00372476|Vinorelbine|vinorelbine|mesh-list
83554383|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554384|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83554385|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554386|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554387|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83554388|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
83554389|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
83554390|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
83012524|NCT03046927|Vitamin D|vitamin d|mesh-list
83554391|NCT04737967|Memantine|memantine|mesh-list
83554393|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83554394|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83554395|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
83554396|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554397|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554398|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554399|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83554400|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83554401|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83554402|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83554403|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83554404|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83554405|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
83554406|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83554407|NCT04334629|Ibuprofen|ibuprofen|mesh-list
83554408|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83554409|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83554410|NCT04334629|Analgesics|analgesics|mesh-ancestor
83554411|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
83554412|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554413|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554414|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554415|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554416|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83554417|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554418|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554419|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
83554420|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83554421|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
83554422|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554423|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
83554424|NCT04766918|Protective Agents|protective agents|mesh-ancestor
83554425|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83554426|NCT04367090|Docetaxel|docetaxel|mesh-list
83554427|NCT04367090|Trastuzumab|trastuzumab|mesh-list
83554428|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554429|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
83554430|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
83554431|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
83554432|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554433|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554434|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
83554435|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554436|NCT00371995|Amphotericin B|amphotericin b|mesh-list
83554437|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83554438|NCT00371995|Miltefosine|miltefosine|mesh-list
83554439|NCT00371995|Amebicides|amebicides|mesh-ancestor
83554440|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83554441|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83554442|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554443|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83554444|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
83554445|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554446|NCT04193306|Alirocumab|alirocumab|mesh-list
83554447|NCT04193306|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83554448|NCT04193306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83554449|NCT04193306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83554450|NCT04193306|Antimetabolites|antimetabolites|mesh-ancestor
83554451|NCT04193306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554452|NCT04193306|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83554453|NCT04193306|Protease Inhibitors|protease inhibitors|mesh-ancestor
83554454|NCT04193306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554455|NCT04193306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83554456|NCT02303678|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
83554457|NCT02303678|Immunoconjugates|immunoconjugates|mesh-ancestor
83554458|NCT02303678|Immunologic Factors|immunologic factors|mesh-ancestor
83554459|NCT02303678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554460|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
83443368|NCT02008617|Bupivacaine|bupivacaine|mesh-list
83554461|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83554462|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83554463|NCT00372307|Analgesics|analgesics|mesh-ancestor
83554464|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
83554465|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554466|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554467|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554468|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554469|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
83554470|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83554471|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
83554472|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83554473|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554474|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554475|NCT04647110|Crizotinib|crizotinib|mesh-list
83554476|NCT04647110|Ceritinib|ceritinib|mesh-list
83554477|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554478|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83554479|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554480|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554481|NCT04061330|Ketamine|ketamine|mesh-list
83554482|NCT04061330|Morphine|morphine|mesh-list
83554483|NCT04061330|Analgesics|analgesics|mesh-ancestor
83554484|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
83554485|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554486|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554487|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83554488|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83554489|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
83554490|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
83554491|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554492|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83554493|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83554494|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554495|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554496|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83554497|NCT04061330|Narcotics|narcotics|mesh-ancestor
83554498|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
83554499|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
83554500|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83554501|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
83554502|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83554503|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83554504|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554505|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83554506|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554507|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554508|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83554509|NCT05125237|Amiloride|amiloride|mesh-list
83554510|NCT05125237|Triamterene|triamterene|mesh-list
83554511|NCT05125237|Diuretics|diuretics|mesh-ancestor
83554512|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
83554513|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554514|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83554515|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83554516|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83554517|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554518|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83554519|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83554520|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
83554521|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83554522|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
83554523|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554524|NCT04792021|Expectorants|expectorants|mesh-ancestor
83554525|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554526|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83554527|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
83554528|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554529|NCT04792021|Protective Agents|protective agents|mesh-ancestor
83554530|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554531|NCT04792021|Antidotes|antidotes|mesh-ancestor
83554532|NCT03713437|Insulin|insulin|mesh-list
83554533|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83554534|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554535|NCT04333927|Immunomodulating Agents|immunomodulating agents|mesh-list
83554536|NCT04333927|Immunologic Factors|immunologic factors|mesh-ancestor
83554537|NCT04333927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554538|NCT04334005|Vitamin D|vitamin d|mesh-list
83554539|NCT04334005|Vitamins|vitamins|mesh-ancestor
83554540|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
83554541|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554542|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83554543|NCT00966914|Paclitaxel|paclitaxel|mesh-list
83554544|NCT00966914|Docetaxel|docetaxel|mesh-list
83554545|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83554546|NCT00966914|Cisplatin|cisplatin|mesh-list
83554547|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
83554548|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83554549|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554550|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
83554551|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
83554552|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
83554553|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554554|NCT00966914|Protective Agents|protective agents|mesh-ancestor
83554555|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554556|NCT03229057|Metformin|metformin|mesh-list
83554557|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83554558|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554559|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
83554560|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83554561|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83554562|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554563|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
83554564|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554565|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554566|NCT04430959|Candesartan|candesartan|mesh-list
83554567|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83554568|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83554569|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83554570|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554571|NCT04737655|Beclomethasone|beclomethasone|mesh-list
83554572|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
83554573|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
83554574|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83554575|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
83554576|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554577|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554578|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83554579|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554580|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83554581|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83554582|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83554583|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83554584|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554585|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554586|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83554587|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83554588|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83554589|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
83554590|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554591|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
83554592|NCT04737655|Hormones|hormones|mesh-ancestor
83554593|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554594|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
83554595|NCT05063396|Anesthetics|anesthetics|mesh-list
83554596|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554597|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554598|NCT05063396|Narcotics|narcotics|mesh-ancestor
83554599|NCT05063396|Analgesics|analgesics|mesh-ancestor
83554600|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
83554601|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554602|NCT05055752|Aspirin|aspirin|mesh-list
83554603|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83554604|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83554605|NCT05055752|Analgesics|analgesics|mesh-ancestor
83554606|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
83554607|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554608|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554609|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554610|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554611|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83554612|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83554613|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554614|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83012753|NCT01349647|Vaccines|vaccines|mesh-list
83554615|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83554616|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554617|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
83554618|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
83554619|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
83554620|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83554621|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554622|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554623|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
83554624|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83554625|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554626|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554627|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
83554628|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83554629|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554630|NCT04762381|Dexamethasone|dexamethasone|mesh-list
83554631|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
83554632|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83554633|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554634|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
83554635|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
83554636|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554637|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554638|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83554639|NCT04762381|Hormones|hormones|mesh-ancestor
83554640|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554641|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83554642|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554643|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
83554644|NCT01547468|Narcotics|narcotics|mesh-ancestor
83554645|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554646|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554647|NCT01547468|Analgesics|analgesics|mesh-ancestor
83554648|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
83554649|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554650|NCT04333628|Chloroquine|chloroquine|mesh-list
83554651|NCT04333628|Amebicides|amebicides|mesh-ancestor
83554652|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83554653|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83554654|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554655|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
83554656|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554657|NCT00373412|Vaccines|vaccines|mesh-list
83554658|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
83554659|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554660|NCT00373178|Metformin|metformin|mesh-list
83554661|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
83554662|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83554663|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554664|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
83554665|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554666|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554667|NCT03254732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554668|NCT03254732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554669|NCT01163383|Iodine|iodine|mesh-list
83554670|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
83554671|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83554672|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83554673|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554674|NCT01163383|Trace Elements|trace elements|mesh-ancestor
83554675|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
83554676|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554677|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554678|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554679|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554680|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83554681|NCT02923466|Interferon-beta|interferon-beta|mesh-list
83554682|NCT02923466|Avelumab|avelumab|mesh-list
83554683|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554684|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554685|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
83554686|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554687|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
83554688|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554689|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
83554690|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
83554691|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012901|NCT05654090|Sulbactam|sulbactam|mesh-list
83554692|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
83554693|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554694|NCT02885012|Ambrisentan|ambrisentan|mesh-list
83554695|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83554696|NCT00372853|Tremelimumab|tremelimumab|mesh-list
83554697|NCT00372853|Ipilimumab|ipilimumab|mesh-list
83554698|NCT00372853|Sunitinib|sunitinib|mesh-list
83554699|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554700|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554701|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554702|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554703|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83554704|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83554705|NCT00372853|Growth Substances|growth substances|mesh-ancestor
83554706|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554707|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
83554708|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83554709|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554710|NCT02885636|Albuterol|albuterol|mesh-list
83554711|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83554712|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
83554713|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554714|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554715|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83554716|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554717|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
83554718|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83554719|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83554720|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83554721|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83554722|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
83554723|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554724|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554725|NCT00373087|Entacapone|entacapone|mesh-list
83554726|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83554727|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83554728|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554729|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83554730|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554731|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
83554732|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83554733|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554734|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83554735|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554736|NCT02892110|Varenicline|varenicline|mesh-list
83554737|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83554738|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83554739|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
83554740|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554741|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554742|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554743|NCT02779166|Celecoxib|celecoxib|mesh-list
83554744|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83554745|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83554746|NCT02779166|Analgesics|analgesics|mesh-ancestor
83554747|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
83554748|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554749|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554750|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554751|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554752|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83554753|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83554754|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554755|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554756|NCT00373165|Ganciclovir|ganciclovir|mesh-list
83554757|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83554758|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
83554759|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554760|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83554761|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554762|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554763|NCT04333550|Deferoxamine|deferoxamine|mesh-list
83554764|NCT04333550|Siderophores|siderophores|mesh-ancestor
83554765|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83554766|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
83554767|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
83554768|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554769|NCT02827838|Durvalumab|durvalumab|mesh-list
83554770|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
83554771|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83554772|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
83554773|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554774|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554775|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
83554776|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554777|NCT02902172|Acetaminophen|acetaminophen|mesh-list
83554778|NCT02902172|Ibuprofen|ibuprofen|mesh-list
83554779|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83554780|NCT02902172|Analgesics|analgesics|mesh-ancestor
83554781|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
83554782|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554783|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554784|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
83554785|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83554786|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554787|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83554788|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83554789|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554790|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554791|NCT04233229|Insulin|insulin|mesh-list
83554792|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83554793|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554794|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
83554795|NCT04208347|Apatinib|apatinib|mesh-list
83554796|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554797|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83554798|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554799|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554800|NCT02777749|Bupivacaine|bupivacaine|mesh-list
83554801|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
83554802|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
83554803|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554804|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554805|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
83554806|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554807|NCT02785172|Clobetasol|clobetasol|mesh-list
83554808|NCT02785172|Halobetasol|halobetasol|mesh-list
83554809|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83554810|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554811|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
83554812|NCT02785172|Hormones|hormones|mesh-ancestor
83554813|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554814|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554815|NCT02582125|Nivolumab|nivolumab|mesh-list
83554816|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554817|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554818|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554819|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554820|NCT02785406|Suvorexant|suvorexant|mesh-list
83554821|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83554822|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83554823|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554824|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554825|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83554826|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554827|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554828|NCT02062489|Tamoxifen|tamoxifen|mesh-list
83554829|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83554830|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
83554831|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554832|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554833|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83554834|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554835|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83554836|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83554837|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83554838|NCT02780869|Thrombin|thrombin|mesh-list
83554839|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83554840|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
83554841|NCT02780869|Coagulants|coagulants|mesh-ancestor
83554842|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
83554843|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
83554844|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83554845|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83554846|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554847|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554848|NCT02908490|Urological Agents|urological agents|mesh-ancestor
83554849|NCT02911844|Fulvestrant|fulvestrant|mesh-list
83554850|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83554851|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554852|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83554853|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83554854|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
83554855|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554856|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554857|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
83554858|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83554859|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83554860|NCT02790788|Prednisolone|prednisolone|mesh-list
83554861|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
83554862|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
83554863|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83554864|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83554865|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
83554866|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83554867|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
83554868|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
83554869|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554870|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554871|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83554872|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
83554873|NCT02790788|Hormones|hormones|mesh-ancestor
83554874|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554875|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83554876|NCT02790788|Protective Agents|protective agents|mesh-ancestor
83554877|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83554878|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554879|NCT02888665|Doxorubicin|doxorubicin|mesh-list
83554880|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83554881|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
83554882|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83554883|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554884|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83554885|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83554886|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554887|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554888|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83554889|NCT02888665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83554890|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
83554891|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83554892|NCT02781571|Velpatasvir|velpatasvir|mesh-list
83554893|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
83554894|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554895|NCT02918630|Nicotine|nicotine|mesh-list
83554896|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83554897|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
83554898|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554899|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554900|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83554901|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83554902|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
83554903|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554904|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554905|NCT02781649|Ribavirin|ribavirin|mesh-list
83554906|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
83554907|NCT02781649|Grazoprevir|grazoprevir|mesh-list
83554908|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83554909|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
83554910|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554911|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
83554912|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554913|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83554914|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554915|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554917|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554918|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554919|NCT00373568|Miltefosine|miltefosine|mesh-list
83554920|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
83554921|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554922|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554923|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83554924|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83554925|NCT03002012|Fluconazole|fluconazole|mesh-list
83554926|NCT03002012|Sertraline|sertraline|mesh-list
83554927|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
83554928|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83554929|NCT03002012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83554930|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83554931|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83554932|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554933|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554934|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
83554935|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554936|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
83554937|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554938|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83554939|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83554940|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83554941|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83554942|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
83554943|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83554944|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83554945|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83554946|NCT00373646|Thalidomide|thalidomide|mesh-list
83554947|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83554948|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
83554949|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554950|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
83554951|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83554952|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83554953|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83554954|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83554955|NCT00373646|Growth Substances|growth substances|mesh-ancestor
83554956|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
83554957|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83554958|NCT03001453|Epinephrine|epinephrine|mesh-list
83554959|NCT03001453|Bupivacaine|bupivacaine|mesh-list
83554960|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
83554961|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
83554962|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554963|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554964|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
83554965|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554966|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83554967|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83554968|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
83554969|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554970|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554971|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83554972|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83554973|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
83554974|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83554975|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
83554976|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
83554977|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
83554978|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83554979|NCT03001843|Ketamine|ketamine|mesh-list
83554980|NCT03001843|Narcotics|narcotics|mesh-list
83554981|NCT03001843|Analgesics|analgesics|mesh-ancestor
83554982|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
83554983|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83554984|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83554985|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83554986|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83554987|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
83554988|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
83554989|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83554990|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83554991|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83554992|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83554993|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83554995|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83554996|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
83554997|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
83554998|NCT02786719|Doxorubicin|doxorubicin|mesh-list
83554999|NCT02786719|Etoposide|etoposide|mesh-list
83555000|NCT02786719|Vincristine|vincristine|mesh-list
83555001|NCT02786719|Topotecan|topotecan|mesh-list
83555002|NCT02786719|Sargramostim|sargramostim|mesh-list
83555003|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83555004|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
83555005|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555006|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555007|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83555008|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
83555009|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555010|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555011|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83555012|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83555013|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83555014|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83555015|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555016|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83555017|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
83555018|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
83555019|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
83555020|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83555021|NCT03003949|Estradiol|estradiol|mesh-list
83555022|NCT03003949|Progesterone|progesterone|mesh-list
83555023|NCT03003949|Estrogens|estrogens|mesh-ancestor
83555024|NCT03003949|Hormones|hormones|mesh-ancestor
83555025|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555026|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555027|NCT03003949|Progestins|progestins|mesh-ancestor
83555028|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
83555029|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83555030|NCT03007225|Estrogens|estrogens|mesh-ancestor
83555031|NCT03007225|Hormones|hormones|mesh-ancestor
83555032|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555033|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555034|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555035|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555036|NCT02800148|Azelaic acid|azelaic acid|mesh-list
83555037|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555038|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
83555039|NCT02902081|Cannabidiol|cannabidiol|mesh-list
83555040|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
83555041|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
83555042|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83555043|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
83555044|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555045|NCT02791945|Expectorants|expectorants|mesh-ancestor
83555046|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
83555047|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83555048|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
83555049|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555050|NCT02791945|Protective Agents|protective agents|mesh-ancestor
83555051|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555052|NCT02791945|Antidotes|antidotes|mesh-ancestor
83555053|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83555054|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83555055|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
83555056|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83555057|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
83555058|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555059|NCT02804594|Expectorants|expectorants|mesh-ancestor
83555060|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
83555061|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83555062|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
83555063|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555064|NCT02804594|Protective Agents|protective agents|mesh-ancestor
83555065|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555066|NCT02804594|Antidotes|antidotes|mesh-ancestor
83555067|NCT00374192|Eszopiclone|eszopiclone|mesh-list
83555068|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83555069|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555070|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555071|NCT02806544|Tamoxifen|tamoxifen|mesh-list
83555072|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83555073|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
83555074|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555075|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555076|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555077|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555078|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83555079|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83555080|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83555081|NCT00374348|Aripiprazole|aripiprazole|mesh-list
83555082|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
83555083|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83555084|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83555085|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83555086|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555087|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555088|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
83555089|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
83555090|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555091|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555092|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83555093|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83555094|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
83555095|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83555096|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83555097|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83555098|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83555099|NCT02933372|Varenicline|varenicline|mesh-list
83555100|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83555101|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83555102|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
83555103|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555104|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555105|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555106|NCT02902237|Thromboplastin|thromboplastin|mesh-list
83555107|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
83555108|NCT02902237|Coagulants|coagulants|mesh-ancestor
83555109|NCT02903407|Midazolam|midazolam|mesh-list
83555110|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
83555111|NCT02903407|Propofol|propofol|mesh-list
83555112|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83555113|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555114|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555115|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555116|NCT02903407|Analgesics|analgesics|mesh-ancestor
83555117|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
83555118|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555119|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83555120|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83555121|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83555122|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83555123|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555124|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555125|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83555126|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
83555127|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
83555128|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83555129|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83555130|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83555131|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83555132|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
83555133|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
83555134|NCT02905981|Citric Acid|citric acid|mesh-list
83555135|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
83555136|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
83555137|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83555138|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
83555139|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
83555140|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555141|NCT00374023|Vitamin A|vitamin a|mesh-list
83555142|NCT00374023|Vitamins|vitamins|mesh-ancestor
83555143|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
83555144|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555145|NCT02812238|Niacinamide|niacinamide|mesh-list
83555146|NCT02812238|Niacin|niacin|mesh-list
83555147|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
83555148|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
83555149|NCT02812238|Vitamins|vitamins|mesh-ancestor
83555150|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
83555151|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555152|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83555153|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
83555154|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555155|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83555156|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
83555157|NCT03015961|Bupivacaine|bupivacaine|mesh-list
83555158|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
83555159|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
83555160|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555161|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555162|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
83555163|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555164|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
83555165|NCT03018223|Sirolimus|sirolimus|mesh-list
83555166|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
83555167|NCT03018223|Busulfan|busulfan|mesh-list
83555168|NCT03018223|Fludarabine|fludarabine|mesh-list
83555169|NCT03018223|Lenograstim|lenograstim|mesh-list
83555170|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83555171|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
83555172|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555173|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555174|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83555175|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
83555176|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555177|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555178|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83555179|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83555180|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83555181|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
83555182|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83555183|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555184|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555185|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
83555186|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83555187|NCT03018925|Golimumab|golimumab|mesh-list
83555188|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83555189|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555190|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83555191|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
83555192|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555193|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83555194|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83555195|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83555196|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
83555197|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555198|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555199|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83555200|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83555201|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
83555202|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555203|NCT03019939|Isavuconazole|isavuconazole|mesh-list
83555204|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
83555205|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555206|NCT03020095|Ritonavir|ritonavir|mesh-list
83555207|NCT03020095|Ribavirin|ribavirin|mesh-list
83555208|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83555209|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83555210|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
83555211|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555212|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555213|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83555214|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83555215|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
83555216|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555217|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83555218|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83555219|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
83555220|NCT02934698|Ivacaftor|ivacaftor|mesh-list
83555221|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83555222|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83555223|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555224|NCT03021343|Colchicine|colchicine|mesh-list
83555225|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
83555226|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555227|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
83555228|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
83555229|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
83555230|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555231|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555232|NCT03025945|Nepafenac|nepafenac|mesh-list
83555233|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83555234|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555235|NCT03025945|Analgesics|analgesics|mesh-ancestor
83555236|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
83555237|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555238|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555239|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555240|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555241|NCT02937506|Fentanyl|fentanyl|mesh-list
83555242|NCT02937506|Midazolam|midazolam|mesh-list
83555243|NCT02937506|Propofol|propofol|mesh-list
83555244|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83555245|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555246|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555247|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83555248|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
83555249|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
83555250|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83555251|NCT02937506|Narcotics|narcotics|mesh-ancestor
83555252|NCT02937506|Analgesics|analgesics|mesh-ancestor
83555253|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
83555254|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555255|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83555256|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83555257|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83555258|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83555259|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
83555260|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
83555261|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555262|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555263|NCT03026803|Capecitabine|capecitabine|mesh-list
83555264|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
83555265|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83555266|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
83555267|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555268|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555269|NCT03027661|Bupivacaine|bupivacaine|mesh-list
83555270|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
83555271|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
83555272|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555273|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555274|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
83555275|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555276|NCT03022526|Fentanyl|fentanyl|mesh-list
83555277|NCT03022526|Bupivacaine|bupivacaine|mesh-list
83555278|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
83555279|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
83555280|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555281|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555282|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
83555283|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555284|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83555285|NCT03022526|Narcotics|narcotics|mesh-ancestor
83555286|NCT03022526|Analgesics|analgesics|mesh-ancestor
83555287|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83555288|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83555289|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
83555290|NCT02794441|Dexamethasone|dexamethasone|mesh-list
83555291|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555292|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
83555293|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
83555294|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555295|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555296|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555297|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
83555298|NCT02794441|Hormones|hormones|mesh-ancestor
83555299|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555300|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555301|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555302|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83555303|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83555304|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
83555305|NCT02941640|Hormones|hormones|mesh-ancestor
83555306|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555307|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555308|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555309|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555310|NCT02823080|Cetrorelix|cetrorelix|mesh-list
83555311|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83555312|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
83555313|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555314|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555315|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83555316|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555317|NCT03022916|Efinaconazole|efinaconazole|mesh-list
83555318|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83555319|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
83555320|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555321|NCT03031795|Ketorolac|ketorolac|mesh-list
83555322|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83555323|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555324|NCT03031795|Analgesics|analgesics|mesh-ancestor
83555325|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
83555326|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555327|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555328|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555329|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555330|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83555331|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555332|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555333|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
83555334|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83555335|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555336|NCT02909959|Sulforaphane|sulforaphane|mesh-list
83555337|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83555338|NCT02909959|Protective Agents|protective agents|mesh-ancestor
83555339|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555340|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555341|NCT00373802|Phenylephrine|phenylephrine|mesh-list
83555342|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
83555343|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83555344|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
83555345|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
83555346|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555347|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555348|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
83555349|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83555350|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
83555351|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
83555352|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83555353|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83555354|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83555355|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
83555356|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555357|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555358|NCT00373802|Protective Agents|protective agents|mesh-ancestor
83555359|NCT02945150|Grazoprevir|grazoprevir|mesh-list
83555360|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
83555361|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555362|NCT03032965|Adenosine|adenosine|mesh-list
83555363|NCT03032965|Isoproterenol|isoproterenol|mesh-list
83555364|NCT03032965|Analgesics|analgesics|mesh-ancestor
83444272|NCT00354627|Etravirine|etravirine|mesh-list
83555365|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
83555366|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555367|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555368|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83555369|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
83555370|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83555371|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
83555372|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
83555373|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555374|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555375|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83555376|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83555377|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
83555378|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83555379|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
83555380|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83555381|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
83555382|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83555383|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
83555384|NCT03032965|Protective Agents|protective agents|mesh-ancestor
83555385|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
83555386|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
83555387|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555388|NCT03030638|Olodaterol|olodaterol|mesh-list
83555389|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83555390|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
83555391|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555392|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555393|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83555394|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
83555395|NCT02949674|Bupivacaine|bupivacaine|mesh-list
83555396|NCT02949674|Ropivacaine|ropivacaine|mesh-list
83555397|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
83555398|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
83555399|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555400|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555401|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
83555402|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555403|NCT03033511|Dexamethasone|dexamethasone|mesh-list
83555404|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
83555405|NCT03033511|BB 1101|bb 1101|mesh-list
83555406|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83555407|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
83555408|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555409|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
83555410|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
83555411|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555412|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555413|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555414|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
83555415|NCT03033511|Hormones|hormones|mesh-ancestor
83555416|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555417|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555418|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555419|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
83555420|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555421|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555422|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
83555423|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
83555424|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83555425|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83555426|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83555427|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83555428|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
83555429|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555430|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555431|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555432|NCT03035929|Dexamethasone|dexamethasone|mesh-list
83555433|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
83555434|NCT03035929|BB 1101|bb 1101|mesh-list
83555435|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555436|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
83555437|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
83555438|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555439|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444353|NCT02379195|Analgesics|analgesics|mesh-ancestor
83555440|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555441|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
83555442|NCT03035929|Hormones|hormones|mesh-ancestor
83555443|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555444|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555445|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555446|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
83555447|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555448|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555449|NCT02951702|Vancomycin|vancomycin|mesh-list
83555450|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83555451|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555452|NCT02831816|Ethanol|ethanol|mesh-list
83555453|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
83555454|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83555455|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83555456|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555457|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555458|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555459|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
83555460|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
83555461|NCT03036163|Macozinone|macozinone|mesh-list
83555462|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
83555463|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83555464|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555465|NCT02953886|Fluorides|fluorides|mesh-list
83555466|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
83555467|NCT02953886|Protective Agents|protective agents|mesh-ancestor
83555468|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555469|NCT02802241|Peppermint oil|peppermint oil|mesh-list
83555470|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
83555471|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
83555472|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555473|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555474|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555475|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
83555476|NCT03035708|Varenicline|varenicline|mesh-list
83555477|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83555478|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83555479|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
83555480|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555481|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555482|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555483|NCT00374426|Sertraline|sertraline|mesh-list
83555484|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
83555485|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83555486|NCT00374426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83555487|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83555488|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83555489|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555490|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555491|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
83555492|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555493|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83555494|NCT02916745|Trioxsalen|trioxsalen|mesh-list
83555495|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555496|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
83555497|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83555498|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
83555499|NCT02954198|Prednisone|prednisone|mesh-list
83555500|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
83555501|NCT02954198|Everolimus|everolimus|mesh-list
83555502|NCT02954198|Tacrolimus|tacrolimus|mesh-list
83555503|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555504|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
83555505|NCT02954198|Hormones|hormones|mesh-ancestor
83555506|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555507|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555508|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555509|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555510|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83555511|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
83555512|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83555513|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555514|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555515|NCT02954198|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83555516|NCT02954198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83555517|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83555518|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83555519|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
83555520|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83555521|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555522|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
83555523|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
83555524|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555525|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555526|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83555527|NCT02954198|Protective Agents|protective agents|mesh-ancestor
83555528|NCT02956070|Dexamethasone|dexamethasone|mesh-list
83555529|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
83555530|NCT02956070|BB 1101|bb 1101|mesh-list
83555531|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555532|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
83555533|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
83555534|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555535|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555536|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555537|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
83555538|NCT02956070|Hormones|hormones|mesh-ancestor
83555539|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555540|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555541|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555542|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83555543|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555544|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555545|NCT02956616|Ketorolac|ketorolac|mesh-list
83555546|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83555547|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555548|NCT02956616|Analgesics|analgesics|mesh-ancestor
83555549|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
83555550|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555551|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555552|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555553|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555554|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83555555|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555556|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555557|NCT02958956|Pioglitazone|pioglitazone|mesh-list
83555558|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83555559|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555560|NCT05829603|Harmine|harmine|mesh-list
83555561|NCT05829603|Hallucinogens|hallucinogens|mesh-ancestor
83555562|NCT05829603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555563|NCT05829603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83555564|NCT05829603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83555565|NCT05829603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555566|NCT05829603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555567|NCT05829551|Ritonavir|ritonavir|mesh-list
83555568|NCT05829551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83555569|NCT05829551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83555570|NCT05829551|Protease Inhibitors|protease inhibitors|mesh-ancestor
83555571|NCT05829551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555572|NCT05829551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555573|NCT05829551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83555574|NCT05829551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83555575|NCT05829551|Antiviral Agents|antiviral agents|mesh-ancestor
83555576|NCT05829551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555577|NCT05829551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83555578|NCT05829551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83555579|NCT05829460|Progestins|progestins|mesh-list
83555580|NCT05829460|Hormones|hormones|mesh-ancestor
83555581|NCT05829460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555582|NCT05829460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555583|NCT05829434|Cytarabine|cytarabine|mesh-list
83555584|NCT05829434|Magrolimab|magrolimab|mesh-list
83555585|NCT05829434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83555586|NCT05829434|Antimetabolites|antimetabolites|mesh-ancestor
83555587|NCT05829434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555588|NCT05829434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555589|NCT05829434|Antiviral Agents|antiviral agents|mesh-ancestor
83555590|NCT05829434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555591|NCT05829434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83555592|NCT05829434|Immunologic Factors|immunologic factors|mesh-ancestor
83555593|NCT05829434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555594|NCT05829434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83555595|NCT05829317|Magnesium Sulfate|magnesium sulfate|mesh-list
83555596|NCT05829317|Analgesics|analgesics|mesh-ancestor
83555597|NCT05829317|Sensory System Agents|sensory system agents|mesh-ancestor
83555598|NCT05829317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555599|NCT05829317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555600|NCT05829317|Anesthetics|anesthetics|mesh-ancestor
83555601|NCT05829317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555602|NCT05829317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83555603|NCT05829317|Anticonvulsants|anticonvulsants|mesh-ancestor
83555604|NCT05829317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83555605|NCT05829317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83555606|NCT05829317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555607|NCT05829317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83555608|NCT05829317|Tocolytic Agents|tocolytic agents|mesh-ancestor
83555609|NCT05829317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555610|NCT05829148|Pregabalin|pregabalin|mesh-list
83555611|NCT05829148|Dexmedetomidine|dexmedetomidine|mesh-list
83555612|NCT05829148|Melatonin|melatonin|mesh-list
83555613|NCT05829148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83555614|NCT05829148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555615|NCT05829148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555616|NCT05829148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555617|NCT05829148|Analgesics|analgesics|mesh-ancestor
83555618|NCT05829148|Sensory System Agents|sensory system agents|mesh-ancestor
83555619|NCT05829148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555620|NCT05829148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83555621|NCT05829148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83555622|NCT05829148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83555623|NCT05829148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83555624|NCT05829148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555625|NCT05829148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555626|NCT05829148|Anticonvulsants|anticonvulsants|mesh-ancestor
83555627|NCT05829148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83555628|NCT05829148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83555629|NCT05829148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83555630|NCT05829148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83555631|NCT05829148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83555632|NCT05829148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83555633|NCT05829148|Antioxidants|antioxidants|mesh-ancestor
83555634|NCT05829148|Protective Agents|protective agents|mesh-ancestor
83555635|NCT05829057|Interleukin-2|interleukin-2|mesh-list
83555636|NCT05829057|Antibodies|antibodies|mesh-list
83555637|NCT05829057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83555638|NCT05829057|Immunologic Factors|immunologic factors|mesh-ancestor
83555639|NCT05829057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555640|NCT05829057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555641|NCT05829057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555642|NCT05829057|Analgesics|analgesics|mesh-ancestor
83555643|NCT05829057|Sensory System Agents|sensory system agents|mesh-ancestor
83555644|NCT05829057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555645|NCT05829044|Melatonin|melatonin|mesh-list
83555646|NCT05829044|Antioxidants|antioxidants|mesh-ancestor
83555647|NCT05829044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555648|NCT05829044|Protective Agents|protective agents|mesh-ancestor
83555649|NCT05829044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555650|NCT05829044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555651|NCT05828966|Magnesium Sulfate|magnesium sulfate|mesh-list
83555652|NCT05828966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83555653|NCT05828966|Analgesics|analgesics|mesh-ancestor
83555654|NCT05828966|Sensory System Agents|sensory system agents|mesh-ancestor
83555655|NCT05828966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555656|NCT05828966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555657|NCT05828966|Anesthetics|anesthetics|mesh-ancestor
83555658|NCT05828966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555659|NCT05828966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83555660|NCT05828966|Anticonvulsants|anticonvulsants|mesh-ancestor
83555661|NCT05828966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83555662|NCT05828966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83555663|NCT05828966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83444570|NCT02394951|Pregabalin|pregabalin|mesh-list
83555664|NCT05828966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83555665|NCT05828966|Tocolytic Agents|tocolytic agents|mesh-ancestor
83555666|NCT05828966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555667|NCT05828836|Allopurinol|allopurinol|mesh-list
83555668|NCT05828836|Antimetabolites|antimetabolites|mesh-ancestor
83555669|NCT05828836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555670|NCT05828836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555671|NCT05828836|Gout Suppressants|gout suppressants|mesh-ancestor
83555672|NCT05828836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555673|NCT05828836|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83013804|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555674|NCT05828836|Antioxidants|antioxidants|mesh-ancestor
83555675|NCT05828836|Protective Agents|protective agents|mesh-ancestor
83555676|NCT05828836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555677|NCT05828810|Chlorhexidine|chlorhexidine|mesh-list
83555678|NCT05828810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83555679|NCT05828810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555680|NCT05828810|Disinfectants|disinfectants|mesh-ancestor
83555681|NCT05828550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83555682|NCT05828550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555683|NCT05828381|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83555684|NCT05828381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555685|NCT05828199|Dexmedetomidine|dexmedetomidine|mesh-list
83555686|NCT05828199|Ketamine|ketamine|mesh-list
83555687|NCT05828199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83555688|NCT05828199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555689|NCT05828199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555690|NCT05828199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555691|NCT05828199|Analgesics|analgesics|mesh-ancestor
83555692|NCT05828199|Sensory System Agents|sensory system agents|mesh-ancestor
83555693|NCT05828199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555694|NCT05828199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83555695|NCT05828199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83555696|NCT05828199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83555697|NCT05828199|Adrenergic Agents|adrenergic agents|mesh-ancestor
83555698|NCT05828199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555699|NCT05828199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555700|NCT05828199|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83555701|NCT05828199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83555702|NCT05828199|Anesthetics, General|anesthetics, general|mesh-ancestor
83555703|NCT05828199|Anesthetics|anesthetics|mesh-ancestor
83555704|NCT05828199|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83555705|NCT05828199|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83555706|NCT05827991|Minoxidil|minoxidil|mesh-list
83555707|NCT05827991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83555708|NCT05827991|Vasodilator Agents|vasodilator agents|mesh-ancestor
83555709|NCT05827796|Paclitaxel|paclitaxel|mesh-list
83555710|NCT05827796|Gemcitabine|gemcitabine|mesh-list
83555711|NCT05827796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83555712|NCT05827796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83555713|NCT05827796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555714|NCT05827796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83555715|NCT05827796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83555716|NCT05827796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83555717|NCT05827796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555718|NCT05827796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83555719|NCT05827796|Antimetabolites|antimetabolites|mesh-ancestor
83555720|NCT05827770|Temozolomide|temozolomide|mesh-list
83555721|NCT05827770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83555722|NCT05827770|Alkylating Agents|alkylating agents|mesh-ancestor
83555723|NCT05827770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555724|NCT05827770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555725|NCT05827549|Blinatumomab|blinatumomab|mesh-list
83555726|NCT05827549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555727|NCT05827497|Methotrexate|methotrexate|mesh-list
83555728|NCT05827497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83555729|NCT05827497|Abortifacient Agents|abortifacient agents|mesh-ancestor
83555730|NCT05827497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555731|NCT05827497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555732|NCT05827497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83555733|NCT05827497|Antimetabolites|antimetabolites|mesh-ancestor
83555734|NCT05827497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555735|NCT05827497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555736|NCT05827497|Dermatologic Agents|dermatologic agents|mesh-ancestor
83555737|NCT05827497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555738|NCT05827497|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83555739|NCT05827497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83555740|NCT05827497|Immunologic Factors|immunologic factors|mesh-ancestor
83555741|NCT05827497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83555742|NCT05827497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83555743|NCT05827484|Losartan|losartan|mesh-list
83555744|NCT05827484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83555745|NCT05827484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83555746|NCT05827484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83555747|NCT05827484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83555748|NCT05827484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555749|NCT05827263|Salicylic Acid|salicylic acid|mesh-list
83555750|NCT05827263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555751|NCT05827263|Antifungal Agents|antifungal agents|mesh-ancestor
83555752|NCT05827263|Keratolytic Agents|keratolytic agents|mesh-ancestor
83555753|NCT05827263|Dermatologic Agents|dermatologic agents|mesh-ancestor
83555754|NCT05826119|Magnesium Sulfate|magnesium sulfate|mesh-list
83555755|NCT05826119|Analgesics|analgesics|mesh-ancestor
83555756|NCT05826119|Sensory System Agents|sensory system agents|mesh-ancestor
83555757|NCT05826119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555758|NCT05826119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555759|NCT05826119|Anesthetics|anesthetics|mesh-ancestor
83555760|NCT05826119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555761|NCT05826119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83555762|NCT05826119|Anticonvulsants|anticonvulsants|mesh-ancestor
83555763|NCT05826119|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83555764|NCT05826119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83555765|NCT05826119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555766|NCT05826119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83555767|NCT05826119|Tocolytic Agents|tocolytic agents|mesh-ancestor
83555768|NCT05826119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555769|NCT05825443|Paclitaxel|paclitaxel|mesh-list
83555770|NCT05825443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83555771|NCT05825443|Cisplatin|cisplatin|mesh-list
83555772|NCT05825443|Carboplatin|carboplatin|mesh-list
83555773|NCT05825443|Pemetrexed|pemetrexed|mesh-list
83555774|NCT05825443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83555775|NCT05825443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555776|NCT05825443|Tubulin Modulators|tubulin modulators|mesh-ancestor
83555777|NCT05825443|Antimitotic Agents|antimitotic agents|mesh-ancestor
83555778|NCT05825443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83555779|NCT05825443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555780|NCT05825443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555781|NCT05825443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83555782|NCT05825443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83555783|NCT05824299|Anesthetics|anesthetics|mesh-list
83555784|NCT05824299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555785|NCT05824299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555786|NCT05822934|Carboplatin|carboplatin|mesh-list
83555787|NCT05822934|Gemcitabine|gemcitabine|mesh-list
83555788|NCT05822934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555789|NCT05822934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83555790|NCT05822934|Antimetabolites|antimetabolites|mesh-ancestor
83555791|NCT05822934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555792|NCT05821972|Dexmedetomidine|dexmedetomidine|mesh-list
83555793|NCT05821972|Ketamine|ketamine|mesh-list
83555794|NCT05821972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83555795|NCT05821972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555796|NCT05821972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555797|NCT05821972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555798|NCT05821972|Analgesics|analgesics|mesh-ancestor
83555799|NCT05821972|Sensory System Agents|sensory system agents|mesh-ancestor
83555800|NCT05821972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555801|NCT05821972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83555802|NCT05821972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83555803|NCT05821972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83555804|NCT05821972|Adrenergic Agents|adrenergic agents|mesh-ancestor
83555805|NCT05821972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555806|NCT05821972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555807|NCT05821972|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83555808|NCT05821972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83555809|NCT05821972|Anesthetics, General|anesthetics, general|mesh-ancestor
83555810|NCT05821972|Anesthetics|anesthetics|mesh-ancestor
83555811|NCT05821972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83555812|NCT05821972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83555813|NCT05790213|Androgens|androgens|mesh-list
83555814|NCT05790213|Hormones|hormones|mesh-ancestor
83555815|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555816|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555817|NCT05786066|Ketamine|ketamine|mesh-list
83555818|NCT05786066|Analgesics|analgesics|mesh-ancestor
83555819|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
83555820|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555821|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555822|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83555823|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83555824|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
83555825|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
83555826|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555827|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83555828|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83555829|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555830|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555831|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
83555832|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555833|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
83555834|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555835|NCT05774236|Dinoprostone|dinoprostone|mesh-list
83555836|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
83555837|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555838|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555840|NCT05748587|Deferoxamine|deferoxamine|mesh-list
83555841|NCT05748587|Trace Elements|trace elements|mesh-ancestor
83555842|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
83555843|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555844|NCT05748587|Siderophores|siderophores|mesh-ancestor
83555845|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83555846|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
83555847|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
83555848|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555849|NCT05728814|Dostarlimab|dostarlimab|mesh-list
83555850|NCT05728814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555851|NCT05707468|Hormones|hormones|mesh-list
83555852|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555853|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555854|NCT05700903|Leuprolide|leuprolide|mesh-list
83555855|NCT05700903|Goserelin|goserelin|mesh-list
83555856|NCT05700903|Flutamide|flutamide|mesh-list
83555857|NCT05700903|Bicalutamide|bicalutamide|mesh-list
83555858|NCT05700903|Hormones|hormones|mesh-list
83555859|NCT05700903|Androgens|androgens|mesh-list
83555860|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
83555861|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555862|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555863|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83555864|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
83555865|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555866|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555867|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555868|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
83555869|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
83555870|NCT05698381|Acetic Acid|acetic acid|mesh-list
83555871|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83555872|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83555873|NCT05683535|Atropine|atropine|mesh-list
83555874|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83555875|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83555876|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83555877|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
83555878|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555879|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555880|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83555881|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
83555882|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
83555883|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
83555884|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83555885|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83555886|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
83555887|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555888|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555889|NCT05678244|Acetaminophen|acetaminophen|mesh-list
83555890|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555891|NCT05678244|Analgesics|analgesics|mesh-ancestor
83555892|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
83555893|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555894|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555895|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
83555896|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83555897|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555898|NCT05675800|Psilocybin|psilocybin|mesh-list
83014030|NCT04739865|Psilocybin|psilocybin|mesh-list
83555899|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
83555900|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555901|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83555902|NCT05675319|Dexamethasone|dexamethasone|mesh-list
83555903|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
83555904|NCT05675319|Lenalidomide|lenalidomide|mesh-list
83555905|NCT05675319|Bortezomib|bortezomib|mesh-list
83555906|NCT05675319|Daratumumab|daratumumab|mesh-list
83555907|NCT05675319|Pomalidomide|pomalidomide|mesh-list
83555908|NCT05675319|Ixazomib|ixazomib|mesh-list
83555909|NCT05675319|Elotuzumab|elotuzumab|mesh-list
83555910|NCT05675319|BB 1101|bb 1101|mesh-list
83555911|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83555912|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83555913|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
83555914|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
83555915|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555916|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555917|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555918|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
83555919|NCT05675319|Hormones|hormones|mesh-ancestor
83555920|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83555921|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83555922|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555923|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
83555924|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83555925|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555926|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
83555927|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83555928|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83555929|NCT05675319|Growth Substances|growth substances|mesh-ancestor
83555930|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
83555931|NCT05674487|Misoprostol|misoprostol|mesh-list
83555932|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83555933|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
83555934|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555935|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555936|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83555937|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83555938|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
83555939|NCT05661955|Tislelizumab|tislelizumab|mesh-list
83555940|NCT05661955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83555941|NCT05661955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83555942|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
83555943|NCT05644873|Analgesics|analgesics|mesh-ancestor
83555944|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
83555945|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555946|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555947|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
83555948|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555949|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83555950|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
83555951|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83555952|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83555953|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555954|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83555955|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
83555956|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83555957|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
83555958|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83555959|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83555960|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555961|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83555962|NCT05641376|Analgesics|analgesics|mesh-ancestor
83555963|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
83555964|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555965|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83555966|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83555967|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83555968|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83555969|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83555970|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555971|NCT05615311|Vitamin D|vitamin d|mesh-list
83555972|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
83555973|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
83555974|NCT05615311|Vitamins|vitamins|mesh-list
83555975|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
83555976|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555977|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83555978|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83555979|NCT05607615|Betadex|betadex|mesh-list
83555980|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
83555981|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555982|NCT05593939|Niacinamide|niacinamide|mesh-list
83555983|NCT05593939|Niacin|niacin|mesh-list
83555984|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
83555985|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
83555986|NCT05593939|Vitamins|vitamins|mesh-ancestor
83555987|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
83555988|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555989|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83555990|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
83555991|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83555992|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83555993|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
83555994|NCT05577845|Ramosetron|ramosetron|mesh-list
83555995|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
83555996|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
83555997|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83555998|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83555999|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556000|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83556001|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
83556002|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556003|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556004|NCT05527912|Rituximab|rituximab|mesh-list
83556005|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
83556006|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556007|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556008|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
83556009|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556010|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83556011|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556012|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556013|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556014|NCT05504083|Benzbromarone|benzbromarone|mesh-list
83556015|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
83556016|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
83556017|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83556018|NCT05491187|Fentanyl|fentanyl|mesh-list
83556019|NCT05491187|Bupivacaine|bupivacaine|mesh-list
83556020|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
83556021|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
83556022|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556023|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556024|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
83556025|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556026|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83556027|NCT05491187|Narcotics|narcotics|mesh-ancestor
83556028|NCT05491187|Analgesics|analgesics|mesh-ancestor
83556029|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83556030|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83556031|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
83556032|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
83556033|NCT05480878|Escitalopram|escitalopram|mesh-list
83556034|NCT05480878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83556035|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83556036|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83556037|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556038|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556039|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
83556040|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556041|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83556042|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556043|NCT05464680|Dimercaprol|dimercaprol|mesh-list
83556044|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
83556045|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
83556046|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556047|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
83556048|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83556049|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83556050|NCT05462730|Prednisolone|prednisolone|mesh-list
83556051|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
83556052|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83556053|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
83556054|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83556055|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
83556056|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
83556057|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556058|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556059|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556060|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
83556061|NCT05462730|Hormones|hormones|mesh-ancestor
83556062|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556063|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83556064|NCT05462730|Protective Agents|protective agents|mesh-ancestor
83556065|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83556066|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556067|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
83556068|NCT05462236|Irinotecan|irinotecan|mesh-list
83556069|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556070|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556071|NCT05462236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556072|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556073|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83556074|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83556075|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556076|NCT05417594|Temozolomide|temozolomide|mesh-list
83556077|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83556078|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
83556079|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556080|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556081|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83556082|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83556083|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
83556084|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556085|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556086|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556087|NCT05398367|Galactogogues|galactogogues|mesh-list
83556088|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556089|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
83556090|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556091|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556092|NCT05383716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556093|NCT05383716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556094|NCT05378945|Varenicline|varenicline|mesh-list
83556095|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83556096|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83556097|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
83556098|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556099|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556100|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556101|NCT05376319|Rituximab|rituximab|mesh-list
83556102|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
83556103|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556104|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556105|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
83556106|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556107|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83556108|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
83556109|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556110|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
83556111|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
83556112|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
83556113|NCT05358587|Anesthetics|anesthetics|mesh-list
83556114|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
83556115|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83556116|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556117|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556118|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
83556119|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556120|NCT05330377|Cytarabine|cytarabine|mesh-list
83556121|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
83556122|NCT05330377|Cladribine|cladribine|mesh-list
83556123|NCT05330377|Lenograstim|lenograstim|mesh-list
83556124|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83556125|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
83556126|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556127|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556128|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
83556130|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83556131|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
83556132|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556133|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83556134|NCT05330377|Analgesics|analgesics|mesh-ancestor
83556135|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
83556136|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556137|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83556138|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83556139|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556140|NCT05326087|Cetrorelix|cetrorelix|mesh-list
83556141|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83556142|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
83556143|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556144|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556145|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
83556146|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556147|NCT05323435|Vaccines|vaccines|mesh-list
83556148|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
83556149|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556150|NCT05322252|Misoprostol|misoprostol|mesh-list
83556151|NCT05322252|Mifepristone|mifepristone|mesh-list
83556152|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83556153|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
83556154|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556155|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556156|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83556157|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556158|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
83556159|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83556160|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83556161|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83556162|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83556163|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
83556164|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83556165|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83556166|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83556167|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556168|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
83556169|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83556170|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83556171|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83556172|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
83556173|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556174|NCT05288062|Dexamethasone|dexamethasone|mesh-list
83556175|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
83556176|NCT05288062|Lenalidomide|lenalidomide|mesh-list
83556177|NCT05288062|Pomalidomide|pomalidomide|mesh-list
83556178|NCT05288062|Ichthammol|ichthammol|mesh-list
83556179|NCT05288062|BB 1101|bb 1101|mesh-list
83556180|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83556181|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
83556182|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
83556183|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556184|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556185|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556186|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
83556187|NCT05288062|Hormones|hormones|mesh-ancestor
83556188|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556189|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83556190|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556191|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
83556192|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556193|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556194|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
83556195|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83556196|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83556197|NCT05288062|Growth Substances|growth substances|mesh-ancestor
83556198|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
83556199|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83556200|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
83556201|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83556202|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83014330|NCT02793128|Mitomycins|mitomycins|mesh-list
83556203|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556204|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
83556205|NCT05246943|Coagulants|coagulants|mesh-ancestor
83556206|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83556207|NCT05239468|Bezafibrate|bezafibrate|mesh-list
83556208|NCT05239468|Cathartics|cathartics|mesh-ancestor
83556209|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556210|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83556211|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
83556212|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556213|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83556214|NCT05212454|Capecitabine|capecitabine|mesh-list
83556215|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83556216|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
83556217|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556218|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556219|NCT05157581|Methoxsalen|methoxsalen|mesh-list
83556220|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83556221|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
83556222|NCT05096845|Vaccines|vaccines|mesh-list
83556223|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
83556224|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556225|NCT05091866|Progesterone|progesterone|mesh-list
83556226|NCT05091866|Progestins|progestins|mesh-list
83556227|NCT05091866|Hormones|hormones|mesh-ancestor
83556228|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556229|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556230|NCT05084989|Vaccines|vaccines|mesh-list
83556231|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
83556232|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556233|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83556234|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83556235|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556236|NCT05042700|Melatonin|melatonin|mesh-list
83556237|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
83556238|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556239|NCT05042700|Protective Agents|protective agents|mesh-ancestor
83556240|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556241|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556242|NCT05010954|Lansoprazole|lansoprazole|mesh-list
83556243|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
83556244|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83556245|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556246|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83556247|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556248|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556249|NCT05001724|Docetaxel|docetaxel|mesh-list
83556250|NCT05001724|Lenvatinib|lenvatinib|mesh-list
83556251|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556252|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556253|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556254|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556255|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556256|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556257|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556258|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
83556259|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83556260|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83556261|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556262|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
83556263|NCT04996368|Coagulants|coagulants|mesh-ancestor
83556264|NCT04994444|Nicotine|nicotine|mesh-list
83556265|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83556266|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
83556267|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556268|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556269|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83556270|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83556271|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
83556272|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556273|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556274|NCT04987892|Tamsulosin|tamsulosin|mesh-list
83556275|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83556276|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83556277|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83556278|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
83556279|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556280|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556281|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556282|NCT04987892|Urological Agents|urological agents|mesh-ancestor
83556283|NCT05019222|Anesthetics|anesthetics|mesh-list
83556284|NCT05019222|Sevoflurane|sevoflurane|mesh-list
83556285|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556286|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556287|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83556288|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83556289|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
83556290|NCT04966702|Ivermectin|ivermectin|mesh-list
83556291|NCT04966702|Albendazole|albendazole|mesh-list
83556292|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83556293|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556294|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
83556295|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
83556296|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83556297|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83556298|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556299|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556300|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556301|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556302|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556303|NCT04966663|Carboplatin|carboplatin|mesh-list
83556304|NCT04966663|Gemcitabine|gemcitabine|mesh-list
83556305|NCT04966663|Nivolumab|nivolumab|mesh-list
83556306|NCT04966663|Pemetrexed|pemetrexed|mesh-list
83556307|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556308|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83556309|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
83556310|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556311|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556312|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556313|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556314|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83556315|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83556316|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83556317|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83556318|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83556319|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556320|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556321|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83556322|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83556323|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83556324|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
83556325|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556326|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556327|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83556328|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83556329|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
83556330|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
83556331|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83556332|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83556333|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556334|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
83556335|NCT04902950|Coagulants|coagulants|mesh-ancestor
83556336|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
83556337|NCT04889118|Lenvatinib|lenvatinib|mesh-list
83556338|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556339|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556340|NCT04889118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556341|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556342|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556343|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556344|NCT04838301|Pregnanolone|pregnanolone|mesh-list
83556345|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
83556346|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556347|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556348|NCT04819971|Docetaxel|docetaxel|mesh-list
83556349|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
83556350|NCT04819971|Trastuzumab|trastuzumab|mesh-list
83556351|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556352|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556353|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556354|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556355|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556356|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556357|NCT04724148|Fentanyl|fentanyl|mesh-list
83556358|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83556359|NCT04724148|Narcotics|narcotics|mesh-ancestor
83556360|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556361|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556362|NCT04724148|Analgesics|analgesics|mesh-ancestor
83556363|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
83556364|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556365|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83556366|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83556367|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
83556368|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
83556369|NCT04703803|Lidocaine|lidocaine|mesh-list
83556370|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
83556371|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
83556372|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556373|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556374|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
83556375|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556376|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83556377|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83556378|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83556379|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83556380|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556381|NCT04695080|Cladribine|cladribine|mesh-list
83556382|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556383|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83556384|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
83556385|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556386|NCT04681417|Carboplatin|carboplatin|mesh-list
83556387|NCT04681417|Etoposide|etoposide|mesh-list
83556388|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
83556389|NCT04681417|Vincristine|vincristine|mesh-list
83556390|NCT04681417|Melphalan|melphalan|mesh-list
83556391|NCT04681417|Topotecan|topotecan|mesh-list
83556392|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556393|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83556394|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83556395|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83556396|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556397|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556398|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556399|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556400|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556401|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83556402|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
83556403|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83556404|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83556405|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
83556406|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556407|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83556408|NCT04670978|Bevacizumab|bevacizumab|mesh-list
83556409|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556410|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556411|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83556412|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83556413|NCT04670978|Growth Substances|growth substances|mesh-ancestor
83556414|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556415|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83556416|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
83556417|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556418|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556419|NCT04639180|Apatinib|apatinib|mesh-list
83556420|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556421|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556422|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556423|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556424|NCT04594694|Bezafibrate|bezafibrate|mesh-list
83556425|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83556426|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
83556427|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014553|NCT01356043|Vitamins|vitamins|mesh-ancestor
83556428|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83556429|NCT04531943|Progesterone|progesterone|mesh-list
83556430|NCT04531943|Estrogens|estrogens|mesh-list
83556431|NCT04531943|Progestins|progestins|mesh-ancestor
83556432|NCT04531943|Hormones|hormones|mesh-ancestor
83556433|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556434|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556435|NCT04522973|Ethanol|ethanol|mesh-list
83556436|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83556437|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556438|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556439|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556440|NCT04520048|Acetylcholine|acetylcholine|mesh-list
83556441|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
83556442|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83556443|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
83556444|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556445|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556446|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556447|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
83556448|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556449|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556450|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
83556451|NCT04505774|Empagliflozin|empagliflozin|mesh-list
83556452|NCT04505774|Canagliflozin|canagliflozin|mesh-list
83556453|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
83556454|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83556455|NCT04505774|Heparin|heparin|mesh-list
83556456|NCT04505774|Calcium heparin|calcium heparin|mesh-list
83556457|NCT04505774|Enoxaparin|enoxaparin|mesh-list
83556458|NCT04505774|Dalteparin|dalteparin|mesh-list
83556459|NCT04505774|Tinzaparin|tinzaparin|mesh-list
83556460|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83556461|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
83556462|NCT04505774|Clopidogrel|clopidogrel|mesh-list
83556463|NCT04505774|Ticagrelor|ticagrelor|mesh-list
83556464|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83556465|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83556466|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83556467|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83556468|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
83556469|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556470|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556471|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556472|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
83556473|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83556474|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83556475|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83556476|NCT04503460|Fluticasone|fluticasone|mesh-list
83556477|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83556478|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83556479|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83556480|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83556481|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
83556482|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556483|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556484|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83556485|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
83556486|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83556487|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83556488|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83556489|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83556490|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83445392|NCT00848783|Floxuridine|floxuridine|mesh-list
83556491|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
83556492|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556493|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556494|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
83556495|NCT04503460|Hormones|hormones|mesh-ancestor
83556496|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556497|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
83556498|NCT04460326|Insulin|insulin|mesh-list
83556499|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83556500|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
83556501|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
83556502|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83556503|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556504|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83556505|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
83556507|NCT04414761|Progesterone|progesterone|mesh-list
83556508|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
83556509|NCT04414761|Ganirelix|ganirelix|mesh-list
83556510|NCT04414761|Progestins|progestins|mesh-ancestor
83556511|NCT04414761|Hormones|hormones|mesh-ancestor
83556512|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556513|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556514|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83556515|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83556516|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83556517|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
83556518|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556519|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83556520|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83556521|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83556522|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83556523|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556524|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
83556525|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83556526|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
83556527|NCT04414748|Cetrorelix|cetrorelix|mesh-list
83556528|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
83556529|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83556530|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
83556531|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556532|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556533|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
83556534|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556535|NCT04414748|Progestins|progestins|mesh-ancestor
83556536|NCT04414748|Hormones|hormones|mesh-ancestor
83556537|NCT04395196|Choline|choline|mesh-list
83556538|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
83556539|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83556540|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
83556541|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556542|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556543|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83556544|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
83556545|NCT04300647|Atezolizumab|atezolizumab|mesh-list
83556546|NCT04300647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556547|NCT04300647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556548|NCT04300647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556549|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556550|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
83556551|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556552|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556553|NCT04234113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556554|NCT04234113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556555|NCT04233515|Anticoagulants|anticoagulants|mesh-list
83556556|NCT04169373|Upadacitinib|upadacitinib|mesh-list
83556557|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83556558|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556559|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556560|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556561|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83556562|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
83556563|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83556564|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
83556565|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556566|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556567|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83556568|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83556569|NCT04150042|Vitamins|vitamins|mesh-list
83556570|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
83556571|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
83556572|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
83556573|NCT04150042|Ethanol|ethanol|mesh-list
83556574|NCT04150042|Melphalan|melphalan|mesh-list
83556575|NCT04150042|Carmustine|carmustine|mesh-list
83556576|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
83556577|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556578|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83556579|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
83556580|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556581|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556582|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83556583|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83556584|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
83556585|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
83556586|NCT04150042|Protective Agents|protective agents|mesh-ancestor
83556587|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
83556588|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83556589|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556590|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556591|NCT04150042|Hematinics|hematinics|mesh-ancestor
83556592|NCT04141644|Ipilimumab|ipilimumab|mesh-list
83556593|NCT04141644|Osimertinib|osimertinib|mesh-list
83556594|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556595|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556596|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556597|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556598|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556599|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556600|NCT04125927|Cysteamine|cysteamine|mesh-list
83556601|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83556602|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556603|NCT04109729|Nivolumab|nivolumab|mesh-list
83556604|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556605|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556606|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556607|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556608|NCT04093024|Nintedanib|nintedanib|mesh-list
83556609|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556610|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556611|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556612|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556613|NCT04091503|Temozolomide|temozolomide|mesh-list
83556614|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83556615|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
83556616|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556617|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556618|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
83556619|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83556620|NCT04044534|Insulin|insulin|mesh-list
83556621|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83556622|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556623|NCT04020913|Hormones|hormones|mesh-list
83556624|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556625|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556626|NCT04014790|KRN 7000|krn 7000|mesh-list
83556627|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83556628|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
83556629|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556630|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556631|NCT03971474|Gemcitabine|gemcitabine|mesh-list
83556632|NCT03971474|Docetaxel|docetaxel|mesh-list
83556633|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
83556634|NCT03971474|Pemetrexed|pemetrexed|mesh-list
83556635|NCT03971474|Ramucirumab|ramucirumab|mesh-list
83556636|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83556637|NCT03971474|Antibodies|antibodies|mesh-list
83556638|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
83556639|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83556640|NCT03971474|Lexatumumab|lexatumumab|mesh-list
83556641|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
83556642|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83445545|NCT00855413|Ritonavir|ritonavir|mesh-list
83556643|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83556644|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
83556645|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556646|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556647|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556648|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556649|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556650|NCT03971474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556651|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556652|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83556653|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83556654|NCT03965234|Cisplatin|cisplatin|mesh-list
83556655|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556656|NCT03921060|Denosumab|denosumab|mesh-list
83556657|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83556658|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556660|NCT03901001|Oseltamivir|oseltamivir|mesh-list
83556661|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83556662|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556663|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83556664|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556665|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
83556666|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83556667|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
83556668|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556669|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556670|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556671|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
83556672|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
83556673|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83556674|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
83556675|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556676|NCT03900988|Expectorants|expectorants|mesh-ancestor
83556677|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
83556678|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83556679|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
83556680|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556681|NCT03900988|Protective Agents|protective agents|mesh-ancestor
83556682|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556683|NCT03900988|Antidotes|antidotes|mesh-ancestor
83556684|NCT03866239|Atezolizumab|atezolizumab|mesh-list
83556685|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
83556686|NCT03866239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556687|NCT03866239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556688|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556689|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556690|NCT03859973|BI 425809|bi 425809|mesh-list
83556691|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
83556692|NCT03827070|Afatinib|afatinib|mesh-list
83556693|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556694|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556695|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556696|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556697|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
83556698|NCT03820986|Lenvatinib|lenvatinib|mesh-list
83556699|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556700|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556701|NCT03820986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556702|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556703|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556704|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556705|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
83556706|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83556707|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
83556708|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556709|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556710|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83556711|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83556712|NCT03748303|Pregnanolone|pregnanolone|mesh-list
83556713|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
83556714|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556715|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556716|NCT03680053|Cetrorelix|cetrorelix|mesh-list
83556717|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
83556718|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83556719|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
83556720|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556721|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556722|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83556723|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556724|NCT03680053|Progestins|progestins|mesh-ancestor
83556725|NCT03680053|Hormones|hormones|mesh-ancestor
83556726|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
83556727|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556728|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556729|NCT03672630|Azithromycin|azithromycin|mesh-list
83556730|NCT03672630|Rifampin|rifampin|mesh-list
83556731|NCT03672630|Ethambutol|ethambutol|mesh-list
83556732|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83556733|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556734|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83556735|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
83556736|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
83556737|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83556738|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556739|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556740|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83556741|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83556742|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83556743|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83556744|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83556745|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83556746|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
83556747|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83556748|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
83556749|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556750|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556751|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83556752|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83556753|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83556754|NCT03656718|Nivolumab|nivolumab|mesh-list
83556755|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556756|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556757|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556758|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556759|NCT03646175|Choline|choline|mesh-list
83556760|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
83556761|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83556762|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
83556763|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556764|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83556765|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83556766|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
83556767|NCT03632369|Xenon|xenon|mesh-list
83556768|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83556769|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
83556770|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
83556771|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556772|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556773|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
83556774|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83556775|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556776|NCT03605342|Buprenorphine|buprenorphine|mesh-list
83556777|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83556778|NCT03605342|Narcotics|narcotics|mesh-ancestor
83556779|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556780|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556781|NCT03605342|Analgesics|analgesics|mesh-ancestor
83556782|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
83556783|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556784|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83556785|NCT03598842|Metronidazole|metronidazole|mesh-list
83556786|NCT03598842|Ivermectin|ivermectin|mesh-list
83556787|NCT03598842|Albendazole|albendazole|mesh-list
83556788|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
83556789|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556790|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83556791|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83556792|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
83556793|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
83556794|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83556795|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556796|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556797|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556798|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556799|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556800|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83556801|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83556802|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556803|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556804|NCT03587844|Immunotoxins|immunotoxins|mesh-ancestor
83556805|NCT03587844|Immunoconjugates|immunoconjugates|mesh-ancestor
83556806|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
83556807|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556808|NCT03471364|Ketoconazole|ketoconazole|mesh-list
83556809|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
83556810|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556811|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83556812|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83556813|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556814|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556815|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83556816|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83556817|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556818|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556819|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83556820|NCT03469284|Methylene Blue|methylene blue|mesh-list
83556821|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556822|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556823|NCT03456076|Carboplatin|carboplatin|mesh-list
83556824|NCT03456076|Gemcitabine|gemcitabine|mesh-list
83556826|NCT03456076|Vinorelbine|vinorelbine|mesh-list
83556827|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556828|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83556829|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
83556830|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556831|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556832|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83556833|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83556834|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83556835|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556836|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556837|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556838|NCT03425331|Nivolumab|nivolumab|mesh-list
83556839|NCT03425331|Ipilimumab|ipilimumab|mesh-list
83556840|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556841|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556842|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556843|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556844|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
83556845|NCT03366155|Irinotecan|irinotecan|mesh-list
83556846|NCT03366155|Cetuximab|cetuximab|mesh-list
83556847|NCT03366155|Panitumumab|panitumumab|mesh-list
83556848|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556849|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83556850|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83556851|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556852|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556853|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556854|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
83556855|NCT03276832|Imiquimod|imiquimod|mesh-list
83556856|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556857|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556858|NCT03276832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556859|NCT03276832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556860|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83556861|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
83556862|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556863|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
83556864|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
83556865|NCT03211416|Sorafenib|sorafenib|mesh-list
83556866|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556867|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556868|NCT03211416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83684414|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83556869|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556870|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556871|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556872|NCT03149211|UB-421|ub-421|mesh-list
83556873|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83556874|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
83556875|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556876|NCT03141671|Prednisone|prednisone|mesh-list
83556877|NCT03141671|Bicalutamide|bicalutamide|mesh-list
83556878|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83556879|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
83556880|NCT03141671|Hormones|hormones|mesh-ancestor
83556881|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83556882|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556883|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83556884|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556885|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
83556886|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
83556887|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
83556888|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556889|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556890|NCT03062358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556891|NCT03062358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556892|NCT03049462|Mirabegron|mirabegron|mesh-list
83556893|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556894|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556895|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83556896|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83556897|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83556898|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
83556899|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556900|NCT03049462|Urological Agents|urological agents|mesh-ancestor
83556901|NCT03043430|Midazolam|midazolam|mesh-list
83556902|NCT03043430|Ketamine|ketamine|mesh-list
83556903|NCT03043430|Analgesics|analgesics|mesh-ancestor
83556904|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
83556905|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556906|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556907|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83556908|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83556909|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
83556910|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
83556911|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83556912|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83556913|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83556914|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556915|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556916|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83556917|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83556918|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83556919|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83556920|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83556921|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
83556922|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
83556923|NCT03035890|Immunomodulating Agents|immunomodulating agents|mesh-list
83556924|NCT03035890|Immunologic Factors|immunologic factors|mesh-ancestor
83556925|NCT03035890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556926|NCT03004261|Ganciclovir|ganciclovir|mesh-list
83556927|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83556928|NCT03004261|Foscarnet|foscarnet|mesh-list
83556929|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
83556930|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83556931|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83556932|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556933|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556934|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83556935|NCT02913482|Risdiplam|risdiplam|mesh-list
83556936|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83556937|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83556938|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556939|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
83556940|NCT02856425|Nintedanib|nintedanib|mesh-list
83556941|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556942|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556943|NCT02856425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556944|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556945|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83556946|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556947|NCT02839642|Rivastigmine|rivastigmine|mesh-list
83556948|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83556949|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556950|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556951|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
83556952|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83556953|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556954|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83556955|NCT02839642|Protective Agents|protective agents|mesh-ancestor
83556956|NCT02785952|Nivolumab|nivolumab|mesh-list
83556957|NCT02785952|Ipilimumab|ipilimumab|mesh-list
83556958|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83556959|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556960|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83556961|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556962|NCT02652195|Oxytocin|oxytocin|mesh-list
83556963|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
83556964|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556965|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556966|NCT02567409|Cisplatin|cisplatin|mesh-list
83556967|NCT02567409|Gemcitabine|gemcitabine|mesh-list
83556968|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556969|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83556970|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
83556971|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556972|NCT02443727|Oxytocin|oxytocin|mesh-list
83556973|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
83556974|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83556975|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83556976|NCT02429700|Paclitaxel|paclitaxel|mesh-list
83556977|NCT02429700|Etoposide|etoposide|mesh-list
83556978|NCT02429700|Carboplatin|carboplatin|mesh-list
83556979|NCT02429700|Bleomycin|bleomycin|mesh-list
83556980|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83556981|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556982|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556983|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556984|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556985|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83556986|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83556987|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83556988|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83556989|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83556990|NCT02429687|Paclitaxel|paclitaxel|mesh-list
83556991|NCT02429687|Etoposide|etoposide|mesh-list
83556992|NCT02429687|Carboplatin|carboplatin|mesh-list
83556993|NCT02429687|Bleomycin|bleomycin|mesh-list
83556994|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83556995|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83556996|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
83556997|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
83556998|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
83556999|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557000|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83557001|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83557002|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557003|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83557004|NCT02194829|Paclitaxel|paclitaxel|mesh-list
83557005|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83557006|NCT02194829|Gemcitabine|gemcitabine|mesh-list
83557007|NCT02194829|Adavosertib|adavosertib|mesh-list
83557008|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83557009|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557010|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83557011|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83557012|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83557013|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557014|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83557015|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
83557016|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557017|NCT01740557|Aldesleukin|aldesleukin|mesh-list
83557018|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
83557019|NCT01740557|Fludarabine|fludarabine|mesh-list
83557020|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
83557021|NCT01740557|Interleukin-2|interleukin-2|mesh-list
83557022|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83557023|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
83557024|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557025|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83557026|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83557027|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
83557028|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557029|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557030|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83557031|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83557032|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
83557033|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83557034|NCT01740557|Analgesics|analgesics|mesh-ancestor
83557035|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
83557036|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557038|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83557039|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
83557040|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557041|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
83557042|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83557043|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83557044|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557045|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
83557046|NCT01370460|Coagulants|coagulants|mesh-ancestor
83557047|NCT01203020|Fludarabine|fludarabine|mesh-list
83557048|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
83557049|NCT01203020|Busulfan|busulfan|mesh-list
83557050|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557051|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83557052|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
83557053|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557054|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83557055|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
83557056|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557057|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
83557058|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83557059|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83557060|NCT00621192|Meropenem|meropenem|mesh-list
83557061|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83557062|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557063|NCT00364286|Dasatinib|dasatinib|mesh-list
83557064|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557065|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83557066|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557067|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557068|NCT00255346|Dasatinib|dasatinib|mesh-list
83557069|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557070|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83557071|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557072|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557073|NCT02834624|Poractant alfa|poractant alfa|mesh-list
83557074|NCT02834624|Calfactant|calfactant|mesh-list
83557075|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83557076|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
83557077|NCT02837744|Hemostatics|hemostatics|mesh-list
83557078|NCT02837744|Coagulants|coagulants|mesh-ancestor
83557079|NCT02918617|Fluorides|fluorides|mesh-list
83557080|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
83557081|NCT02918617|Protective Agents|protective agents|mesh-ancestor
83557082|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557083|NCT02839772|Glycerol|glycerol|mesh-list
83557084|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83557085|NCT02839772|Protective Agents|protective agents|mesh-ancestor
83557086|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557087|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83557088|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83557089|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557090|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557091|NCT03043105|Thalidomide|thalidomide|mesh-list
83557092|NCT03043105|Prednisone|prednisone|mesh-list
83557093|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
83557094|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83557095|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
83557096|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557097|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83557098|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83557099|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
83557100|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557101|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557102|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83557103|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557104|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
83557105|NCT03043105|Hormones|hormones|mesh-ancestor
83557106|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557107|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557108|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
83557109|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83015230|NCT02071316|Esomeprazole|esomeprazole|mesh-list
83557110|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557111|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83557112|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83557113|NCT03043105|Growth Substances|growth substances|mesh-ancestor
83557114|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
83557116|NCT00374647|Sirolimus|sirolimus|mesh-list
83557117|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83557118|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557119|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83557120|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
83557121|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83557122|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557123|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557124|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557125|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
83557126|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83557127|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
83557128|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557129|NCT02964416|Tramadol|tramadol|mesh-list
83557130|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557131|NCT02964416|Narcotics|narcotics|mesh-ancestor
83557132|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557133|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557134|NCT02964416|Analgesics|analgesics|mesh-ancestor
83557135|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
83557136|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557137|NCT02812771|Efinaconazole|efinaconazole|mesh-list
83557138|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
83557139|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557140|NCT02969876|Vortioxetine|vortioxetine|mesh-list
83557141|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
83557142|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83557143|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83557144|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83557145|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557146|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557147|NCT02969876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83557148|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83557149|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557150|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557151|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557152|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
83557153|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83557154|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83557155|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83557156|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83557157|NCT02970032|Heparin|heparin|mesh-list
83557158|NCT02970032|Calcium heparin|calcium heparin|mesh-list
83557159|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
83557160|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83557161|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83557162|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557163|NCT02813551|Torsemide|torsemide|mesh-list
83557164|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83557165|NCT02813551|Diuretics|diuretics|mesh-ancestor
83557166|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
83557167|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557168|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83557169|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557170|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557171|NCT02817763|Dipyrone|dipyrone|mesh-list
83557172|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83557173|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83557174|NCT02817763|Analgesics|analgesics|mesh-ancestor
83557175|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
83557176|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557177|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557178|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557179|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83557180|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
83557181|NCT02846792|Nivolumab|nivolumab|mesh-list
83557182|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015333|NCT03353675|Nivolumab|nivolumab|mesh-list
83557183|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557184|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83557185|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557187|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
83557188|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557189|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557190|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
83557191|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557192|NCT03054103|Midazolam|midazolam|mesh-list
83557193|NCT03054103|Ketamine|ketamine|mesh-list
83557194|NCT03054103|Analgesics|analgesics|mesh-ancestor
83557195|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
83557196|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557197|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557198|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83557199|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83557200|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
83557201|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
83557202|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557203|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83557204|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83557205|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557206|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557207|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83557208|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83557209|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83557210|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83557211|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83557212|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
83557213|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
83557214|NCT03043274|Cangrelor|cangrelor|mesh-list
83557215|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83557216|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83557217|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83557218|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83557219|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
83557220|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557221|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557222|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557223|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
83557224|NCT03054805|Antacids|antacids|mesh-ancestor
83557225|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557226|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557227|NCT00374101|Omeprazole|omeprazole|mesh-list
83557228|NCT00374101|Pantoprazole|pantoprazole|mesh-list
83557229|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83557230|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557231|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83557232|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557233|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557234|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
83557235|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83557236|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83557237|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83557238|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557239|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557240|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
83557241|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557242|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557243|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83557244|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557245|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
83557246|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83557247|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557248|NCT03050294|Desoximetasone|desoximetasone|mesh-list
83557249|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557250|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
83557251|NCT03050294|Hormones|hormones|mesh-ancestor
83557252|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557253|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557254|NCT02831569|Loxoprofen|loxoprofen|mesh-list
83557255|NCT02831569|Methocarbamol|methocarbamol|mesh-list
83015391|NCT01358045|Calcitriol|calcitriol|mesh-list
83557256|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83557257|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83557258|NCT02831569|Analgesics|analgesics|mesh-ancestor
83557259|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
83557260|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557261|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557262|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557263|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83557264|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83557265|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83557266|NCT03065179|Nivolumab|nivolumab|mesh-list
83557267|NCT03065179|Ipilimumab|ipilimumab|mesh-list
83557268|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83557269|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557270|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83557271|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557272|NCT02988050|Lidocaine|lidocaine|mesh-list
83557273|NCT02988050|Epinephrine|epinephrine|mesh-list
83557274|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
83557275|NCT02988050|Remifentanil|remifentanil|mesh-list
83557276|NCT02988050|Bupivacaine|bupivacaine|mesh-list
83557277|NCT02988050|Propofol|propofol|mesh-list
83557278|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
83557279|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
83557280|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557281|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557282|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
83557283|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557284|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83557285|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83557286|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83557287|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557288|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557289|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83557290|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83557291|NCT02988050|Analgesics|analgesics|mesh-ancestor
83557292|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83557293|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83557294|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83557295|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
83557296|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557297|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83557298|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
83557299|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557300|NCT02988050|Narcotics|narcotics|mesh-ancestor
83557301|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83557302|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83557303|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
83557304|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83557305|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
83557306|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
83557307|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
83557308|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83557309|NCT02988986|Tamoxifen|tamoxifen|mesh-list
83557310|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83557311|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
83557312|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557313|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557314|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557315|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557316|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83557317|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83557318|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83557319|NCT02832115|Lidocaine|lidocaine|mesh-list
83557320|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
83557321|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
83557322|NCT02832115|Anesthetics|anesthetics|mesh-list
83557323|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557324|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557325|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
83557326|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557327|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83557328|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83557329|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83557330|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557331|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557333|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83557334|NCT03054506|Laxatives|laxatives|mesh-ancestor
83557335|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557336|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
83557337|NCT02935699|Promethazine|promethazine|mesh-list
83557338|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83557339|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83557340|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557341|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557342|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
83557343|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
83557344|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
83557345|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557346|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
83557347|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
83557348|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557349|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83557350|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
83557351|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
83557352|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557353|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557354|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83557355|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
83557356|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
83557357|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83557358|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83557359|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83557360|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83557361|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
83557362|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557363|NCT02841241|Esmolol|esmolol|mesh-list
83557364|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83557365|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83557366|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83557367|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83557368|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557369|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557370|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557371|NCT00374881|Phenylephrine|phenylephrine|mesh-list
83557372|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
83557373|NCT00374881|Morphine|morphine|mesh-list
83557374|NCT00374881|Sorbitol|sorbitol|mesh-list
83557375|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557376|NCT00374881|Narcotics|narcotics|mesh-ancestor
83557377|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557378|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557379|NCT00374881|Analgesics|analgesics|mesh-ancestor
83557380|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
83557381|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557382|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83557383|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
83557384|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
83557385|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
83557386|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83557387|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
83557388|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
83557389|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83557390|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83557391|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83557392|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
83557393|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557394|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557395|NCT00374881|Protective Agents|protective agents|mesh-ancestor
83557396|NCT00374881|Cathartics|cathartics|mesh-ancestor
83557397|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557398|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
83557399|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83557400|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557401|NCT02846233|Metformin|metformin|mesh-list
83557402|NCT02846233|Empagliflozin|empagliflozin|mesh-list
83557403|NCT02846233|Dulaglutide|dulaglutide|mesh-list
83557404|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83557405|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
83557406|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83557407|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557408|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557409|NCT02846233|Incretins|incretins|mesh-ancestor
83557410|NCT02846233|Hormones|hormones|mesh-ancestor
83557411|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557412|NCT02865590|Cimetidine|cimetidine|mesh-list
83557413|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83557414|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557415|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83557416|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
83557417|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
83557418|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557419|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557420|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557421|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83557422|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83557423|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557424|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
83557425|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83557426|NCT02868242|Ledipasvir|ledipasvir|mesh-list
83557427|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
83557428|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557429|NCT03075553|Nivolumab|nivolumab|mesh-list
83557430|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83557431|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557432|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83557433|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557434|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
83557435|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
83557436|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
83557437|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557438|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557439|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
83557440|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557441|NCT02997722|Ketamine|ketamine|mesh-list
83557442|NCT02997722|Analgesics|analgesics|mesh-ancestor
83557443|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
83557444|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557445|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557446|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83557447|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83557448|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
83557449|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
83557450|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557451|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83557452|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83557453|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557454|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557455|NCT03108482|Celecoxib|celecoxib|mesh-list
83557456|NCT03108482|Tramadol|tramadol|mesh-list
83557457|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83557458|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83557459|NCT03108482|Analgesics|analgesics|mesh-ancestor
83557460|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
83557461|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557462|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557463|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557464|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83557465|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83557466|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83557467|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557468|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557469|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557470|NCT03108482|Narcotics|narcotics|mesh-ancestor
83557471|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557472|NCT02850601|Dexamethasone|dexamethasone|mesh-list
83557473|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557474|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
83557475|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
83557476|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557477|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557478|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557479|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
83557480|NCT02850601|Hormones|hormones|mesh-ancestor
83557481|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557482|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557483|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557484|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
83557485|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83557486|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557487|NCT03057704|Lidocaine|lidocaine|mesh-list
83557488|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
83557489|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
83557490|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557491|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557492|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
83557493|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557494|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83557495|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83557496|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83557497|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557498|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557499|NCT02874092|Ticagrelor|ticagrelor|mesh-list
83557500|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83557501|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83557502|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83557503|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83557504|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
83557505|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557506|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557507|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557508|NCT02876900|Asenapine|asenapine|mesh-list
83557509|NCT02876900|Maleic acid|maleic acid|mesh-list
83557510|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557511|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557512|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83557513|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83557514|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557515|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557516|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83557517|NCT02878382|Calcipotriene|calcipotriene|mesh-list
83557518|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
83557519|NCT03117140|Dexamethasone|dexamethasone|mesh-list
83557520|NCT03117140|Clonidine|clonidine|mesh-list
83557521|NCT03117140|Buprenorphine|buprenorphine|mesh-list
83557522|NCT03117140|Ropivacaine|ropivacaine|mesh-list
83557523|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557524|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
83557525|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
83557526|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557527|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557528|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557529|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
83557530|NCT03117140|Hormones|hormones|mesh-ancestor
83557531|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557532|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557533|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557534|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
83557535|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
83557536|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557537|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
83557538|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557539|NCT03117140|Narcotics|narcotics|mesh-ancestor
83557540|NCT03117140|Analgesics|analgesics|mesh-ancestor
83557541|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83557542|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83557543|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
83557544|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83557545|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83557546|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83557547|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
83557548|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557549|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557550|NCT03118466|Cytarabine|cytarabine|mesh-list
83557551|NCT03118466|Etoposide|etoposide|mesh-list
83557552|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
83557553|NCT03118466|Lenalidomide|lenalidomide|mesh-list
83557554|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83557555|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557556|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83557557|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83557558|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557559|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557560|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83557561|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
83557562|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
83557563|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557564|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83557565|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
83557566|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557567|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83557568|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83557569|NCT03118466|Growth Substances|growth substances|mesh-ancestor
83557570|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
83557571|NCT03118466|Analgesics|analgesics|mesh-ancestor
83557572|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
83557573|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557574|NCT03068312|Ivacaftor|ivacaftor|mesh-list
83557575|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83557576|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557577|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557578|NCT03119168|Simethicone|simethicone|mesh-list
83557579|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
83557580|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557581|NCT03119168|Emollients|emollients|mesh-ancestor
83557582|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
83557583|NCT03070730|Atenolol|atenolol|mesh-list
83557584|NCT03070730|Droxidopa|droxidopa|mesh-list
83557585|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83557586|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83557587|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
83557588|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
83557589|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557590|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557591|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83557592|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83557593|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83557594|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
83557595|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557596|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557597|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83557598|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83557599|NCT05405270|Imiquimod|imiquimod|mesh-list
83557600|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83557601|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
83557602|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557603|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557604|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
83557605|NCT03121820|Memantine|memantine|mesh-list
83557606|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83557607|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83557608|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
83557609|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557610|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557611|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557612|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83557613|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83557614|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83557615|NCT03123614|Prednisolone|prednisolone|mesh-list
83557616|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83557617|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
83557618|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83557619|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
83557620|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83557621|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
83557622|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557623|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
83557624|NCT03123614|Hormones|hormones|mesh-ancestor
83557625|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557626|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557627|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557628|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557629|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
83015757|NCT05188859|Pemetrexed|pemetrexed|mesh-list
83557630|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
83557631|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557632|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557633|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83557634|NCT03123614|Protective Agents|protective agents|mesh-ancestor
83557635|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83557637|NCT03123848|Cobicistat|cobicistat|mesh-list
83557638|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83557639|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83557640|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83557641|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
83557642|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557643|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557644|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83557645|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83557646|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
83557647|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557648|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83557649|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83557650|NCT02946073|Buprenorphine|buprenorphine|mesh-list
83557651|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557652|NCT02946073|Narcotics|narcotics|mesh-ancestor
83557653|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557654|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557655|NCT02946073|Analgesics|analgesics|mesh-ancestor
83557656|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
83557657|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557658|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83557659|NCT03071744|Fentanyl|fentanyl|mesh-list
83557660|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557661|NCT03071744|Narcotics|narcotics|mesh-ancestor
83557662|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557663|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557664|NCT03071744|Analgesics|analgesics|mesh-ancestor
83557665|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
83557666|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557667|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83557668|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83557669|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
83557670|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
83557671|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
83557672|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83557673|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83557674|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83557675|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
83557676|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557677|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83557678|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83557679|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557680|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83557681|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83557682|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557683|NCT05404334|Androgens|androgens|mesh-list
83557684|NCT05404334|Hormones|hormones|mesh-ancestor
83557685|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557686|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557687|NCT00374894|Succimer|succimer|mesh-list
83557688|NCT00374894|Antidotes|antidotes|mesh-ancestor
83557689|NCT00374894|Protective Agents|protective agents|mesh-ancestor
83557690|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557691|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
83557692|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
83557693|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557694|NCT03088267|Amphetamine|amphetamine|mesh-list
83557695|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83557696|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557697|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
83557698|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
83557699|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557700|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
83557701|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557702|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557703|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
83557704|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83557705|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83557706|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83557707|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83557709|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
83557710|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
83557711|NCT03088345|Coagulants|coagulants|mesh-ancestor
83557712|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83557713|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83557714|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
83557715|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557716|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83557717|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557718|NCT02858713|Betamethasone|betamethasone|mesh-list
83557719|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
83557720|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83557721|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
83557722|NCT02858713|Calcipotriene|calcipotriene|mesh-list
83557723|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83557724|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557725|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
83557726|NCT02858713|Hormones|hormones|mesh-ancestor
83557727|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557728|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557729|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83557730|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
83557731|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
83557732|NCT00375050|Riluzole|riluzole|mesh-list
83557733|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
83557734|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83557735|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83557736|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557737|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557738|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557739|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83557740|NCT00375050|Protective Agents|protective agents|mesh-ancestor
83557741|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
83557742|NCT02860507|Neostigmine|neostigmine|mesh-list
83557743|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83557744|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557745|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557746|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
83557747|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557748|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557749|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83557750|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
83557751|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557752|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83557753|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83557754|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83557755|NCT03082196|Fluorides|fluorides|mesh-list
83557756|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
83557757|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
83557758|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
83557759|NCT03082196|Protective Agents|protective agents|mesh-ancestor
83557760|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557761|NCT02861131|Neostigmine|neostigmine|mesh-list
83557762|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83557763|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557764|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557765|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
83557766|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557767|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557768|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83557769|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
83557770|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557771|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83557772|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83557773|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83557774|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557775|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557776|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
83557777|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015903|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83557778|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83557779|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83557780|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83557781|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557782|NCT02953561|Azacitidine|azacitidine|mesh-list
83557783|NCT02953561|Avelumab|avelumab|mesh-list
83557784|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83557785|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83557786|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
83557787|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557788|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557789|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557790|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83557791|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
83557792|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557793|NCT03090620|Lorazepam|lorazepam|mesh-list
83557794|NCT03090620|Physostigmine|physostigmine|mesh-list
83557795|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
83557796|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
83557797|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
83557798|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557799|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557800|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557801|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83557802|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557803|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83557804|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83557805|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83557806|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
83557807|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
83557808|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557809|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557810|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83557811|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557812|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
83557813|NCT03090620|Miotics|miotics|mesh-ancestor
83557814|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
83557815|NCT02953873|Prednisone|prednisone|mesh-list
83557816|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
83557817|NCT02953873|Tacrolimus|tacrolimus|mesh-list
83557818|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557819|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
83557820|NCT02953873|Hormones|hormones|mesh-ancestor
83557821|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557822|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557823|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557824|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557825|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83557826|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
83557827|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83557828|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557829|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557830|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83557831|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83557832|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
83557833|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83557834|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557835|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
83557836|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
83557837|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557838|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557839|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83557840|NCT02953873|Protective Agents|protective agents|mesh-ancestor
83557841|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
83557842|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83557843|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557844|NCT03091478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83557845|NCT03091478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557846|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
83557847|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83557848|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
83557849|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557850|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
83557851|NCT02867605|Protective Agents|protective agents|mesh-ancestor
83557852|NCT00375596|Ketotifen|ketotifen|mesh-list
83557853|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83557854|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
83557855|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
83557856|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83557857|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
83557858|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
83557859|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557860|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557861|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557862|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83557864|NCT03093272|Docetaxel|docetaxel|mesh-list
83557865|NCT03093272|Leuprolide|leuprolide|mesh-list
83557866|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557867|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
83557868|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
83557869|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
83557870|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557871|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557872|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
83557873|NCT03093272|Hormones|hormones|mesh-ancestor
83557874|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557875|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557876|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557877|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83557878|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
83557879|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83557880|NCT03100123|Aspirin|aspirin|mesh-list
83557881|NCT03100123|Heparin|heparin|mesh-list
83557882|NCT03100123|Enoxaparin|enoxaparin|mesh-list
83557883|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83557884|NCT03100123|Tinzaparin|tinzaparin|mesh-list
83557885|NCT03100123|Dalteparin|dalteparin|mesh-list
83557886|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83557887|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83557888|NCT03100123|Analgesics|analgesics|mesh-ancestor
83557889|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
83557890|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557891|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557892|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557893|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83557894|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83557895|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83557896|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557897|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83557898|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83557899|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557900|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
83557901|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
83557902|NCT02957305|Misoprostol|misoprostol|mesh-list
83557903|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83557904|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
83557905|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83557906|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557907|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83557908|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557909|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
83557910|NCT04611152|Aflibercept|aflibercept|mesh-list
83557911|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83557912|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83557913|NCT04611152|Growth Substances|growth substances|mesh-ancestor
83557914|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557915|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83557916|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557917|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
83557918|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83557919|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
83557920|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83557921|NCT03104725|Expectorants|expectorants|mesh-ancestor
83557922|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
83557923|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83557924|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
83557925|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557926|NCT03104725|Protective Agents|protective agents|mesh-ancestor
83557927|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557928|NCT03104725|Antidotes|antidotes|mesh-ancestor
83557929|NCT03154658|Ropivacaine|ropivacaine|mesh-list
83557930|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016052|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
83016128|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557931|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
83557932|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557933|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557934|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
83557935|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557936|NCT03098420|Dexamethasone|dexamethasone|mesh-list
83557937|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
83557938|NCT03098420|Morphine|morphine|mesh-list
83557939|NCT03098420|Bupivacaine|bupivacaine|mesh-list
83557940|NCT03098420|Ropivacaine|ropivacaine|mesh-list
83557941|NCT03098420|BB 1101|bb 1101|mesh-list
83557942|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83557943|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
83557944|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
83557945|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557946|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557947|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83557948|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
83557949|NCT03098420|Hormones|hormones|mesh-ancestor
83557950|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83557951|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83557952|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557953|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
83557954|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557955|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557956|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
83557957|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
83557958|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557959|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
83557960|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83557961|NCT03098420|Narcotics|narcotics|mesh-ancestor
83557962|NCT03098420|Analgesics|analgesics|mesh-ancestor
83557963|NCT02878057|Apatinib|apatinib|mesh-list
83557964|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83557965|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83557966|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83557967|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557968|NCT00422617|Alefacept|alefacept|mesh-list
83557969|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
83557970|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
83557971|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557972|NCT03104738|Insulin|insulin|mesh-list
83557973|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83557974|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557975|NCT03163472|Anesthetics|anesthetics|mesh-list
83557976|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
83557977|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83557978|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557979|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
83557980|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557981|NCT04468568|Terbutaline|terbutaline|mesh-list
83557982|NCT04468568|Atosiban|atosiban|mesh-list
83557983|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83557984|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
83557985|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83557986|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83557987|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83557988|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
83557989|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
83557990|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
83557991|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83557992|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83557993|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83557994|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83557995|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
83557996|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83557997|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83557998|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
83557999|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558000|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
83558001|NCT03168308|Neostigmine|neostigmine|mesh-list
83558002|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83558003|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558004|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558005|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558006|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558007|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558008|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83558009|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
83558010|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558011|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83558012|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83558013|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83558014|NCT03109015|Sunitinib|sunitinib|mesh-list
83558015|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558016|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83558017|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83558018|NCT03109015|Growth Substances|growth substances|mesh-ancestor
83558019|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558020|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
83558021|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83558022|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558023|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558024|NCT03115177|Doxycycline|doxycycline|mesh-list
83558025|NCT03115177|Cefazolin|cefazolin|mesh-list
83558026|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83558027|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558028|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
83558029|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83558030|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83558031|NCT03174158|Nicotine|nicotine|mesh-list
83558032|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83558033|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
83558034|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558035|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558036|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83558037|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83558038|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558039|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558040|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558041|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
83558042|NCT03115801|Nivolumab|nivolumab|mesh-list
83558043|NCT03115801|Atezolizumab|atezolizumab|mesh-list
83558044|NCT03115801|Immunomodulating Agents|immunomodulating agents|mesh-list
83558045|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
83558046|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558047|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558048|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558049|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558050|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558051|NCT00422708|Anesthetics|anesthetics|mesh-list
83558052|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558053|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558054|NCT03117517|Metformin|metformin|mesh-list
83558055|NCT03117517|Pioglitazone|pioglitazone|mesh-list
83558056|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83558057|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558058|NCT00375284|Pramipexole|pramipexole|mesh-list
83558059|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
83558060|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558061|NCT00375284|Protective Agents|protective agents|mesh-ancestor
83558062|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558063|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83558064|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83558065|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
83558066|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
83558067|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558068|NCT02966275|Glucagon|glucagon|mesh-list
83558069|NCT02966275|Pancrelipase|pancrelipase|mesh-list
83558070|NCT02966275|Pancreatin|pancreatin|mesh-list
83558071|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83558072|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558073|NCT02966275|Hormones|hormones|mesh-ancestor
83558074|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558075|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558076|NCT02966275|Incretins|incretins|mesh-ancestor
83558077|NCT04122170|Aspirin|aspirin|mesh-list
83558078|NCT04122170|Ticagrelor|ticagrelor|mesh-list
83558079|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83558080|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83558081|NCT04122170|Analgesics|analgesics|mesh-ancestor
83558082|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
83558083|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558084|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558085|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558086|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558087|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83558088|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83558089|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558090|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83558091|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83558092|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558094|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83558095|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83558096|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83558097|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
83558098|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558099|NCT03795350|Beclomethasone|beclomethasone|mesh-list
83558100|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
83558101|NCT03795350|Bromides|bromides|mesh-list
83558102|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
83558103|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83558104|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
83558105|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558106|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558107|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83558108|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
83558109|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83558110|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83558111|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83558112|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
83558113|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558114|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558115|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
83558116|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83558117|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83558118|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83558119|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558120|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558121|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
83558122|NCT03795350|Hormones|hormones|mesh-ancestor
83558123|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558124|NCT03118843|Velpatasvir|velpatasvir|mesh-list
83558125|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
83558126|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558127|NCT02222922|Fluconazole|fluconazole|mesh-list
83558128|NCT02222922|Avelumab|avelumab|mesh-list
83558129|NCT02222922|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
83558130|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558131|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558132|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
83558133|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558134|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83558135|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83558136|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558137|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558138|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83558139|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
83558140|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558141|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558142|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83558143|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83558144|NCT02222922|Immunoconjugates|immunoconjugates|mesh-ancestor
83558145|NCT02222922|Immunologic Factors|immunologic factors|mesh-ancestor
83558146|NCT03503942|Metformin|metformin|mesh-list
83558147|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83558148|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558149|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
83558150|NCT03122587|Vitamins|vitamins|mesh-ancestor
83558151|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
83558152|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558153|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83558154|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83558155|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
83016280|NCT02087462|Diclofenac|diclofenac|mesh-list
83558156|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558157|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83558158|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83558159|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83558160|NCT02161146|Analgesics|analgesics|mesh-ancestor
83558161|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
83558162|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558163|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558164|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558165|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558166|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83558167|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83558168|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83558169|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
83558170|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
83558171|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558172|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558173|NCT03447782|Naltrexone|naltrexone|mesh-list
83558174|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83558175|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83558176|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558177|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
83558178|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558179|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
83558180|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558181|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558182|NCT03123055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558183|NCT03123055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558184|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
83558185|NCT02969317|Olodaterol|olodaterol|mesh-list
83558186|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83558187|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
83558188|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558189|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558190|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83558191|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
83558192|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
83558193|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83558194|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558195|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558196|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558197|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
83558198|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
83558199|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
83558200|NCT05347082|Vitamin D|vitamin d|mesh-list
83558201|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83558202|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558203|NCT05347082|Vitamins|vitamins|mesh-ancestor
83558204|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
83558205|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83558206|NCT04736420|Warfarin|warfarin|mesh-list
83558207|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
83558208|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
83558209|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83558210|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
83558211|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83558212|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
83558213|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558214|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558215|NCT03087578|Mirabegron|mirabegron|mesh-list
83558216|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83558217|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83558218|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83558219|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
83558220|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558221|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558222|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558223|NCT03087578|Urological Agents|urological agents|mesh-ancestor
83558224|NCT02807558|Azacitidine|azacitidine|mesh-list
83558225|NCT02807558|Daratumumab|daratumumab|mesh-list
83558226|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83558227|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
83558228|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558229|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558230|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558232|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83558233|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558234|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83558235|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558236|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
83558237|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83558238|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
83558239|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558240|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83558241|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
83558242|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83558243|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83558244|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83558245|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83558246|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
83558247|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558248|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558249|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558250|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83558251|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83558252|NCT04736810|Gemcitabine|gemcitabine|mesh-list
83558253|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558254|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83558255|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
83558256|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558257|NCT03132571|Naltrexone|naltrexone|mesh-list
83558258|NCT03132571|Bupropion|bupropion|mesh-list
83558259|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83558260|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83558261|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558262|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
83558263|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558264|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83558265|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83558266|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83558267|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83558268|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83558269|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83558270|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558271|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
83558272|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558273|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83558274|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83558275|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558276|NCT05267054|Rituximab|rituximab|mesh-list
83558277|NCT05267054|Tislelizumab|tislelizumab|mesh-list
83558278|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558279|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558280|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
83558281|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558282|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558283|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
83558284|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558285|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558286|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
83558287|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
83558288|NCT02002130|Butyric Acid|butyric acid|mesh-list
83558289|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83558290|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
83558291|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558292|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
83558293|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558294|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558295|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
83558296|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
83558297|NCT01306994|Adenosine|adenosine|mesh-list
83558298|NCT01306994|Analgesics|analgesics|mesh-ancestor
83558299|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
83558300|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558301|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558302|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83558303|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
83558304|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83558305|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
83558306|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
83558307|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558308|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558309|NCT02979301|Tamoxifen|tamoxifen|mesh-list
83558310|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83558311|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
83558312|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558313|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558314|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83558315|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558316|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83558317|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83558318|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83558319|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
83558320|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83558321|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83558322|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558323|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
83558324|NCT00375440|Coagulants|coagulants|mesh-ancestor
83558325|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
83558326|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
83558327|NCT05113004|Leflunomide|leflunomide|mesh-list
83558328|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83558329|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558330|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83558331|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
83558332|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83558333|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558334|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558335|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558336|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
83558337|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83558338|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83558339|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558340|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83558341|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
83558342|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558343|NCT02983981|Desoximetasone|desoximetasone|mesh-list
83558344|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558345|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
83558346|NCT02983981|Hormones|hormones|mesh-ancestor
83558347|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558348|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558349|NCT00375583|Albendazole|albendazole|mesh-list
83558350|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
83558351|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83558352|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558353|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
83558354|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83558355|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83558356|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83558357|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83558358|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83558359|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558360|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558361|NCT03143569|Heparin|heparin|mesh-list
83558362|NCT03143569|Calcium heparin|calcium heparin|mesh-list
83558363|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
83558364|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83558365|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83558366|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558367|NCT03149887|Bupivacaine|bupivacaine|mesh-list
83558368|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
83558369|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
83558370|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558371|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558372|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
83558373|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558374|NCT02988349|Listerine|listerine|mesh-list
83558375|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
83558376|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
83558377|NCT02988349|Protective Agents|protective agents|mesh-ancestor
83558378|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016509|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83558379|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83558380|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558381|NCT02159352|Ritonavir|ritonavir|mesh-list
83558382|NCT02159352|Lopinavir|lopinavir|mesh-list
83558383|NCT02159352|Darunavir|darunavir|mesh-list
83558384|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83558385|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83558386|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
83558387|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558388|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558389|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83558390|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83558391|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
83558392|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558393|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83558394|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83558395|NCT02187744|Carboplatin|carboplatin|mesh-list
83558396|NCT02187744|Docetaxel|docetaxel|mesh-list
83558397|NCT02187744|Trastuzumab|trastuzumab|mesh-list
83558398|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558399|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
83558400|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
83558401|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83558402|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558403|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558404|NCT03154333|Diacerein|diacerein|mesh-list
83558405|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558406|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
83558407|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83558408|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83558409|NCT02995915|Bupropion|bupropion|mesh-list
83558410|NCT02995915|Nicotine|nicotine|mesh-list
83558411|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83558412|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
83558413|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558414|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558415|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83558416|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83558417|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558418|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558419|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558420|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83558421|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
83558422|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83558423|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83558424|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83558425|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83558426|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
83558427|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83558428|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83558429|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558430|NCT03163303|Nicotine|nicotine|mesh-list
83558431|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83558432|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
83558433|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558434|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558435|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83558436|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83558437|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558438|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558439|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558440|NCT03000283|Conivaptan|conivaptan|mesh-list
83558441|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83558442|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558443|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
83558444|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558445|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
83558446|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83558447|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558448|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83558449|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558450|NCT03168841|Efinaconazole|efinaconazole|mesh-list
83558451|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
83558452|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558453|NCT03865615|Oxytocin|oxytocin|mesh-list
83558454|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
83558455|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83558456|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558457|NCT03185546|Nicotine|nicotine|mesh-list
83558458|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83558459|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
83558460|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558461|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558462|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83558463|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83558464|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558465|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558466|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558467|NCT02186652|Pantoprazole|pantoprazole|mesh-list
83558468|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83558469|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558470|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83558471|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558472|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558473|NCT03606889|Bupivacaine|bupivacaine|mesh-list
83558474|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
83558475|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
83558476|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558477|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558478|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
83558479|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558480|NCT05363917|Folic Acid|folic acid|mesh-list
83558481|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
83558482|NCT05363917|Hematinics|hematinics|mesh-ancestor
83558483|NCT05363917|Vitamins|vitamins|mesh-ancestor
83558484|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
83558485|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558486|NCT03187730|Nicotine|nicotine|mesh-list
83558487|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83558488|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
83558489|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558490|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558491|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83558492|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83558493|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558494|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558495|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558496|NCT03261193|Bupivacaine|bupivacaine|mesh-list
83558497|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
83558498|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
83558499|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558500|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558501|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
83558502|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558503|NCT00375661|Interferons|interferons|mesh-list
83558504|NCT00375661|Ribavirin|ribavirin|mesh-list
83558505|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
83558506|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
83558507|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558508|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
83558509|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558510|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
83558511|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558512|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
83558513|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558514|NCT04736186|Loperamide|loperamide|mesh-list
83558515|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
83558516|NCT04736186|Bentonite|bentonite|mesh-list
83558517|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558518|NCT04736186|Antidotes|antidotes|mesh-ancestor
83558519|NCT04736186|Protective Agents|protective agents|mesh-ancestor
83558520|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558521|NCT04941170|Bupivacaine|bupivacaine|mesh-list
83558522|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
83558523|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
83558524|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558525|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558526|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
83361587|NCT01581281|Topiramate|topiramate|mesh-list
83558527|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558528|NCT05357911|Digoxin|digoxin|mesh-list
83558529|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83558530|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83558531|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558532|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558533|NCT05357911|Protective Agents|protective agents|mesh-ancestor
83558534|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558535|NCT03374839|Nivolumab|nivolumab|mesh-list
83558536|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558537|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558538|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558539|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558540|NCT03347929|Naproxen|naproxen|mesh-list
83558541|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83558542|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83558543|NCT03347929|Analgesics|analgesics|mesh-ancestor
83558544|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
83558545|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558546|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558547|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558548|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558549|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
83558550|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83558551|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558552|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558553|NCT02221674|Tapentadol|tapentadol|mesh-list
83558554|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83558555|NCT02221674|Narcotics|narcotics|mesh-ancestor
83558556|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558557|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558558|NCT02221674|Analgesics|analgesics|mesh-ancestor
83558559|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
83558560|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558561|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83558562|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83558563|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83558564|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558565|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
83558566|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558567|NCT04736719|Warfarin|warfarin|mesh-list
83558568|NCT04736719|Apixaban|apixaban|mesh-list
83558569|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
83558570|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83558571|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
83558572|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83558573|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
83558574|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558575|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558576|NCT02221284|Alogliptin|alogliptin|mesh-list
83558577|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83558578|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558579|NCT02221284|Incretins|incretins|mesh-ancestor
83558580|NCT02221284|Hormones|hormones|mesh-ancestor
83558581|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558582|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83558583|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
83558584|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558585|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558586|NCT04736108|Prednisolone|prednisolone|mesh-list
83558587|NCT04736108|Goserelin|goserelin|mesh-list
83558588|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
83558589|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558590|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
83558591|NCT04736108|Hormones|hormones|mesh-ancestor
83558592|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558593|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558594|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83558595|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558596|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83558597|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558598|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558599|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
83558600|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83558601|NCT02971033|Ezetimibe|ezetimibe|mesh-list
83558602|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83558603|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83558604|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
83558605|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558606|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83558608|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558609|NCT05341375|Anesthetics|anesthetics|mesh-list
83558610|NCT05341375|Esketamine|esketamine|mesh-list
83558611|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558612|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558613|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
83558614|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83558615|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
83558616|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558617|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558618|NCT03196232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558619|NCT03196232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558620|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
83558621|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
83558622|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83558623|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83558624|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558625|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558626|NCT04356716|Urological Agents|urological agents|mesh-ancestor
83558627|NCT03200587|Avelumab|avelumab|mesh-list
83558628|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558629|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558630|NCT03198884|Dolutegravir|dolutegravir|mesh-list
83558631|NCT03198884|Darunavir|darunavir|mesh-list
83558632|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83558633|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83558634|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558635|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558636|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83558637|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83558638|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
83558639|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558640|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83558641|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83558642|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
83558643|NCT01801189|Pregabalin|pregabalin|mesh-list
83558644|NCT01801189|Analgesics|analgesics|mesh-ancestor
83558645|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
83558646|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558647|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558648|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
83558649|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83558650|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83558651|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558652|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83558653|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83558654|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83558655|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558656|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83558657|NCT04275362|Cimetidine|cimetidine|mesh-list
83558658|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83558659|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558660|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83558661|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
83558662|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
83558663|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558664|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558665|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558666|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83558667|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83558668|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558669|NCT05178043|Nivolumab|nivolumab|mesh-list
83558670|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558671|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558672|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558673|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558674|NCT00716755|Olanzapine|olanzapine|mesh-list
83558675|NCT00716755|Risperidone|risperidone|mesh-list
83558676|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83558677|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
83558678|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558679|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558680|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558681|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83558682|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83558683|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558684|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83558685|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83558686|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
83558687|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
83558688|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
83558689|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558690|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558691|NCT00716755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83558692|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83558693|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83558694|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
83558695|NCT05406050|Vitamin D|vitamin d|mesh-list
83558696|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83558697|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558698|NCT05406050|Vitamins|vitamins|mesh-ancestor
83558699|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
83558700|NCT03202550|Oxycodone|oxycodone|mesh-list
83558701|NCT03202550|Lorazepam|lorazepam|mesh-list
83558702|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83558703|NCT03202550|Narcotics|narcotics|mesh-ancestor
83558704|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558705|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558706|NCT03202550|Analgesics|analgesics|mesh-ancestor
83558707|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
83558708|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558709|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
83558710|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
83558711|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
83558712|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558713|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83558714|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83558715|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83558716|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83558717|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
83558718|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
83558719|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558720|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558721|NCT04088786|Irinotecan|irinotecan|mesh-list
83558722|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83558723|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83558724|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558725|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558726|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558727|NCT00392821|Everolimus|everolimus|mesh-list
83558728|NCT00392821|Sorafenib|sorafenib|mesh-list
83558729|NCT00392821|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83558730|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83558731|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558732|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558733|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83558734|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
83558735|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558736|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558737|NCT04708171|Anesthetics|anesthetics|mesh-list
83558738|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558739|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558740|NCT03290378|Tramadol|tramadol|mesh-list
83558741|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83558742|NCT03290378|Narcotics|narcotics|mesh-ancestor
83558743|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558744|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558745|NCT03290378|Analgesics|analgesics|mesh-ancestor
83558746|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
83558747|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558749|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83558750|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
83558751|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
83558752|NCT02076217|Etonogestrel|etonogestrel|mesh-list
83558753|NCT02076217|Desogestrel|desogestrel|mesh-list
83558754|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83558755|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558756|NCT02076217|Trace Elements|trace elements|mesh-ancestor
83558757|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
83558758|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83558759|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83558760|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83558761|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83558762|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83558763|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83558764|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83558765|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558766|NCT02076217|Progestins|progestins|mesh-ancestor
83558767|NCT02076217|Hormones|hormones|mesh-ancestor
83558768|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558769|NCT03291080|Tretinoin|tretinoin|mesh-list
83558770|NCT03291080|Isotretinoin|isotretinoin|mesh-list
83558771|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558772|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
83558773|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
83558774|NCT04874545|Propofol|propofol|mesh-list
83558775|NCT04874545|Sevoflurane|sevoflurane|mesh-list
83558776|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83558777|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558778|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558779|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83558780|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
83558781|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
83558782|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83558783|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83558784|NCT03181009|Omalizumab|omalizumab|mesh-list
83558785|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83558786|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83558787|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
83558788|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83558789|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83558790|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83558791|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558792|NCT03296072|Listerine|listerine|mesh-list
83558793|NCT03296072|Fluorides|fluorides|mesh-list
83558794|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
83558795|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
83558796|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
83558797|NCT03296072|Protective Agents|protective agents|mesh-ancestor
83558798|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558799|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83558800|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558801|NCT03185065|Amantadine|amantadine|mesh-list
83558802|NCT03185065|Methylphenidate|methylphenidate|mesh-list
83558803|NCT03185065|Modafinil|modafinil|mesh-list
83558804|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83558805|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558806|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83558807|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83558808|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83558809|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558810|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
83558811|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558812|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83558813|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83558814|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83558815|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83558816|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83558817|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
83558818|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558819|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83558820|NCT03185065|Analgesics|analgesics|mesh-ancestor
83558821|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
83558822|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558823|NCT02220894|Paclitaxel|paclitaxel|mesh-list
83558824|NCT02220894|Carboplatin|carboplatin|mesh-list
83558825|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
83558826|NCT02220894|Pemetrexed|pemetrexed|mesh-list
83558827|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83558828|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558829|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
83558830|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
83558831|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
83558832|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558833|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558834|NCT02220894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558835|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558836|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83558837|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83558838|NCT02159040|Azacitidine|azacitidine|mesh-list
83558839|NCT02159040|Deferasirox|deferasirox|mesh-list
83558840|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83558841|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
83558842|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558843|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558844|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558845|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83558846|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
83558847|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
83558848|NCT03189589|Nemiralisib|nemiralisib|mesh-list
83558849|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83558850|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558851|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558852|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83558853|NCT03216902|Latanoprost|latanoprost|mesh-list
83558854|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83558855|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
83558856|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558857|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558858|NCT03190213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558859|NCT03190213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558860|NCT01632150|Thalidomide|thalidomide|mesh-list
83558861|NCT01632150|Dexamethasone|dexamethasone|mesh-list
83558862|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
83558863|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
83558864|NCT01632150|Elotuzumab|elotuzumab|mesh-list
83558865|NCT01632150|BB 1101|bb 1101|mesh-list
83558866|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83558867|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
83558868|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558869|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558870|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83558871|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
83558872|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558873|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558874|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83558875|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558876|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
83558877|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
83558878|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558879|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558880|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
83558881|NCT01632150|Hormones|hormones|mesh-ancestor
83558882|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558883|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83558884|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
83558885|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558886|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
83558887|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83558888|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83558889|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83558890|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83558891|NCT01632150|Growth Substances|growth substances|mesh-ancestor
83558892|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
83558893|NCT02185014|Adalimumab|adalimumab|mesh-list
83558894|NCT02185014|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83558895|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558896|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558897|NCT03297944|Zolpidem|zolpidem|mesh-list
83558898|NCT03297944|Alprazolam|alprazolam|mesh-list
83558899|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83558900|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83558901|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558902|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558903|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83558904|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
83558905|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
83558906|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558907|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558908|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83558909|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83558910|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83558912|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
83558913|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558914|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558915|NCT04333004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558916|NCT04333004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558917|NCT03219866|Budesonide|budesonide|mesh-list
83558918|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
83558919|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83558920|NCT03219866|Ipratropium|ipratropium|mesh-list
83558921|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558922|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83558923|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
83558924|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558925|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558926|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83558927|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
83558928|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
83558929|NCT03219866|Hormones|hormones|mesh-ancestor
83558930|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83558931|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
83558932|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83558933|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
83558934|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83558935|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558936|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
83558937|NCT03300674|Lidocaine|lidocaine|mesh-list
83558938|NCT03300674|Hydromorphone|hydromorphone|mesh-list
83558939|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
83558940|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
83558941|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558942|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558943|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
83558944|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558945|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83558946|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83558947|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83558948|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83558949|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558950|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83558951|NCT03300674|Narcotics|narcotics|mesh-ancestor
83558952|NCT03300674|Analgesics|analgesics|mesh-ancestor
83558953|NCT02158806|Aspirin|aspirin|mesh-list
83558954|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83558955|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83558956|NCT02158806|Analgesics|analgesics|mesh-ancestor
83558957|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
83558958|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558959|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558960|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83558961|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83558962|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83558963|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83558964|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558965|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83558966|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83558967|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83558968|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
83558969|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
83558970|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83558971|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83558972|NCT03197389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83558973|NCT03197389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83558974|NCT03198871|Acetaminophen|acetaminophen|mesh-list
83558975|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83558976|NCT03198871|Analgesics|analgesics|mesh-ancestor
83558977|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
83558978|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558979|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558980|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
83558981|NCT02157948|Denosumab|denosumab|mesh-list
83558982|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83558983|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558984|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
83558985|NCT03220958|Promethazine|promethazine|mesh-list
83558986|NCT03220958|Metoclopramide|metoclopramide|mesh-list
83558987|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83558988|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83558989|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83558990|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83558991|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
83558992|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
83558993|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
83558994|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83558995|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
83558996|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
83558997|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83558998|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83558999|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
83559000|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
83559001|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559002|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559003|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83559004|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
83559005|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
83559006|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83559007|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83559008|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
83559009|NCT02182830|Empagliflozin|empagliflozin|mesh-list
83559010|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83559011|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559012|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83559013|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559015|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83559016|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559017|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83559018|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83559019|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83559020|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559021|NCT03303794|Bupivacaine|bupivacaine|mesh-list
83559022|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559023|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
83559024|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559025|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559026|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
83559027|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559028|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
83559029|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83559030|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559031|NCT03435614|Analgesics|analgesics|mesh-list
83559032|NCT03435614|Narcotics|narcotics|mesh-list
83559033|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559034|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559035|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
83559036|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559037|NCT03437564|Vortioxetine|vortioxetine|mesh-list
83559038|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
83559039|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83559040|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83559041|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83559042|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559043|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559044|NCT03437564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83559045|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83559046|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83559047|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559048|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559049|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
83559050|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83559051|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83559052|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83559053|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83559054|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
83559055|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83559056|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
83559057|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559058|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
83559059|NCT03438266|Protective Agents|protective agents|mesh-ancestor
83559060|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
83559061|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83559062|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
83559063|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83559064|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
83559065|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559066|NCT03228914|Phenylephrine|phenylephrine|mesh-list
83559067|NCT03228914|Epinephrine|epinephrine|mesh-list
83559068|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
83559069|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83559070|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83559071|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
83559072|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559073|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559074|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559075|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83559076|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83559077|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
83559078|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559079|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83559080|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559081|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
83559082|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
83559083|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83559084|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
83559085|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83559086|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83559087|NCT03228914|Protective Agents|protective agents|mesh-ancestor
83559088|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
83559089|NCT03316976|Lansoprazole|lansoprazole|mesh-list
83559090|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83559091|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83559092|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83559093|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559094|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559095|NCT03234374|Bupivacaine|bupivacaine|mesh-list
83559096|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559097|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
83559098|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559099|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559100|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
83559101|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559103|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83559104|NCT04332536|Narcotics|narcotics|mesh-ancestor
83559105|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559106|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559107|NCT04332536|Analgesics|analgesics|mesh-ancestor
83559108|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
83559109|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559110|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
83559111|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559112|NCT03236168|Ivermectin|ivermectin|mesh-list
83559113|NCT03236168|Permethrin|permethrin|mesh-list
83559114|NCT03236168|Malathion|malathion|mesh-list
83559115|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83559116|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559117|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559118|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559119|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83559120|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
83559121|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559122|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559123|NCT03306589|Molgramostim|molgramostim|mesh-list
83559124|NCT03306589|Sargramostim|sargramostim|mesh-list
83559125|NCT03306589|Cantharidin|cantharidin|mesh-list
83559126|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
83559127|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559128|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559129|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559130|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559131|NCT03312517|Suvorexant|suvorexant|mesh-list
83559132|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83559134|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559135|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559136|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83559137|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559138|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559139|NCT03315559|Nemiralisib|nemiralisib|mesh-list
83559140|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83559141|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559142|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559143|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83559144|NCT03239522|Glycine|glycine|mesh-list
83559145|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
83559146|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559147|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559148|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559149|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83559150|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
83559151|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83559152|NCT03242408|Testosterone|testosterone|mesh-list
83559153|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
83559154|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
83559155|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83559156|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559157|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
83559158|NCT03242408|Hormones|hormones|mesh-ancestor
83559159|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83559160|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559161|NCT03242408|Androgens|androgens|mesh-ancestor
83559162|NCT03459794|Ivermectin|ivermectin|mesh-list
83559163|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83559164|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559165|NCT03211117|Docetaxel|docetaxel|mesh-list
83559166|NCT03211117|Doxorubicin|doxorubicin|mesh-list
83559167|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83559168|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
83559169|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559170|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
83559171|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
83559172|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
83559173|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559174|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83559175|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83559176|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83559177|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559178|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83559179|NCT03211117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83559180|NCT00376285|Fenofibrate|fenofibrate|mesh-list
83559181|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83559182|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
83559183|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559184|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83559185|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
83559186|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83559187|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559188|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
83559189|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83559190|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83559191|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559192|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
83559193|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559194|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559195|NCT03245762|Oxytocin|oxytocin|mesh-list
83559196|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
83559197|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83559198|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559199|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
83559200|NCT03322657|Neostigmine|neostigmine|mesh-list
83559201|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83559202|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559203|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559204|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
83559205|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559206|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559207|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83559208|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
83559209|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559210|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83559211|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83559212|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83559213|NCT03324451|Insulin|insulin|mesh-list
83559214|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83559215|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559216|NCT03247790|Lasmiditan|lasmiditan|mesh-list
83559217|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83559218|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
83559219|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559220|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559221|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559222|NCT03249272|Adenosine|adenosine|mesh-list
83559223|NCT03249272|Regadenoson|regadenoson|mesh-list
83559224|NCT03249272|Analgesics|analgesics|mesh-ancestor
83559225|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
83559226|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559227|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559228|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83559229|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
83559230|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83559231|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
83559232|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
83559233|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559234|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559235|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83559236|NCT03468920|Acetaminophen|acetaminophen|mesh-list
83559237|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83559238|NCT03468920|Analgesics|analgesics|mesh-ancestor
83559239|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
83559240|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559241|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559242|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
83559243|NCT02181816|Amlodipine|amlodipine|mesh-list
83559244|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83559245|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83559246|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83559247|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83559248|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559249|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83559250|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559251|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
83559252|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83559253|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83559254|NCT03256136|Carboplatin|carboplatin|mesh-list
83559255|NCT03256136|Nivolumab|nivolumab|mesh-list
83559256|NCT03256136|Pemetrexed|pemetrexed|mesh-list
83559257|NCT03256136|Ipilimumab|ipilimumab|mesh-list
83559258|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559259|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83559260|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83559261|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559262|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559263|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83559264|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83559265|NCT03344510|Anesthetics|anesthetics|mesh-list
83559266|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559267|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559268|NCT03478982|Alprazolam|alprazolam|mesh-list
83559269|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83559270|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559271|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559272|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83559273|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83559274|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83559275|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
83559276|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
83559277|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559278|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559279|NCT03270332|Albuterol|albuterol|mesh-list
83559280|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83559281|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
83559282|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559283|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559284|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83559285|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559286|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
83559287|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83559288|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83559289|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83559290|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83559291|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
83559292|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559293|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559295|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
83559296|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559297|NCT03357614|Amoxicillin|amoxicillin|mesh-list
83559298|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
83559299|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
83559300|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
83559301|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83559302|NCT03357614|Ertapenem|ertapenem|mesh-list
83559303|NCT03357614|Lactams|lactams|mesh-list
83559304|NCT03357614|Probenecid|probenecid|mesh-list
83559305|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83559306|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559307|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83559308|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83559309|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559310|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559311|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559312|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83559313|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83559314|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83559315|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
83559316|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
83559317|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559318|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
83559319|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
83559320|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83559321|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83559322|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559323|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559324|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559325|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559326|NCT02216214|Mirabegron|mirabegron|mesh-list
83559327|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83559328|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83559329|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83559330|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
83559331|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559332|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559333|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559334|NCT02216214|Urological Agents|urological agents|mesh-ancestor
83559335|NCT00376376|Levofloxacin|levofloxacin|mesh-list
83559336|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83559337|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559338|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83559339|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83559340|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83559341|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559342|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559343|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559344|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83559345|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83559346|NCT02181504|Ranibizumab|ranibizumab|mesh-list
83559347|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83559348|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83559349|NCT02181504|Growth Substances|growth substances|mesh-ancestor
83559350|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559351|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
83559352|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559353|NCT02213094|Vitamins|vitamins|mesh-list
83559354|NCT02213094|Niacinamide|niacinamide|mesh-list
83559355|NCT02213094|Niacin|niacin|mesh-list
83559356|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
83559357|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
83559358|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
83559359|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559360|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83559361|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
83559362|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559363|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83559364|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
83559365|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83559366|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
83559367|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83559368|NCT01629966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83559369|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83559370|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83559371|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559372|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559373|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
83559374|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559375|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83559376|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83559377|NCT02177838|Cetuximab|cetuximab|mesh-list
83559378|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83559379|NCT02177838|Antibodies|antibodies|mesh-list
83559380|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
83559381|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83559382|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
83559383|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559384|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559385|NCT03283436|Bupivacaine|bupivacaine|mesh-list
83559386|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559387|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
83559388|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559389|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559390|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
83559391|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559392|NCT00376064|Octreotide|octreotide|mesh-list
83559393|NCT00376064|Cabergoline|cabergoline|mesh-list
83559394|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83559395|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83559396|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559397|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83559398|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83559399|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
83559400|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
83559401|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559402|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559403|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559404|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
83559405|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83559406|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
83559407|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559408|NCT03581084|Expectorants|expectorants|mesh-ancestor
83559409|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559410|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83559411|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
83559412|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559413|NCT03581084|Protective Agents|protective agents|mesh-ancestor
83559414|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559415|NCT03581084|Antidotes|antidotes|mesh-ancestor
83559416|NCT03383588|Epinephrine|epinephrine|mesh-list
83559417|NCT03383588|Fentanyl|fentanyl|mesh-list
83559418|NCT03383588|Morphine|morphine|mesh-list
83559419|NCT03383588|Bupivacaine|bupivacaine|mesh-list
83559420|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559421|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
83559422|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559423|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559424|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
83559425|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559426|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83559427|NCT03383588|Narcotics|narcotics|mesh-ancestor
83559428|NCT03383588|Analgesics|analgesics|mesh-ancestor
83361606|NCT01580969|Bevacizumab|bevacizumab|mesh-list
83559429|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83559430|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83559431|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
83559432|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83559433|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83559434|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
83559435|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83448348|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
83559436|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559437|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83559438|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83559439|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
83559440|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83559441|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559442|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
83559443|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
83559444|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83559445|NCT03388268|Vancomycin|vancomycin|mesh-list
83559446|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83559447|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559448|NCT03393494|Adapalene|adapalene|mesh-list
83559449|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83559450|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
83559451|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83559452|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83559453|NCT03393494|Analgesics|analgesics|mesh-ancestor
83559454|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
83559455|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559456|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559457|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83559458|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559459|NCT03588806|Oxycodone|oxycodone|mesh-list
83559460|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83559461|NCT03588806|Narcotics|narcotics|mesh-ancestor
83559462|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559463|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559464|NCT03588806|Analgesics|analgesics|mesh-ancestor
83559465|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
83559466|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559467|NCT02176356|Bimatoprost|bimatoprost|mesh-list
83559468|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83559469|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
83559470|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83559471|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83559472|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
83559473|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83559474|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83559475|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83559476|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559477|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
83559478|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559479|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559480|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83559481|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559482|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83559483|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83559484|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
83559485|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
83559486|NCT02176356|Protective Agents|protective agents|mesh-ancestor
83559487|NCT03591068|Fluticasone|fluticasone|mesh-list
83559488|NCT03591068|Xhance|xhance|mesh-list
83559489|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83559490|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83559491|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
83559492|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559493|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559494|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83559495|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559496|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
83559497|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83559498|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
83559499|NCT03395990|Procaine|procaine|mesh-list
83559500|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559501|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
83559502|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559503|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559504|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
83559505|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559506|NCT02175966|Ribavirin|ribavirin|mesh-list
83559507|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
83559508|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
83834811|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83559509|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559510|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
83559511|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559512|NCT02136576|Listerine|listerine|mesh-list
83559513|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
83559514|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
83559515|NCT02136576|Protective Agents|protective agents|mesh-ancestor
83559516|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559517|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83559518|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559519|NCT03398330|Oxycodone|oxycodone|mesh-list
83559520|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83559521|NCT03398330|Narcotics|narcotics|mesh-ancestor
83559522|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559523|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559524|NCT03398330|Analgesics|analgesics|mesh-ancestor
83559525|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
83559526|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559527|NCT00376766|Levetiracetam|levetiracetam|mesh-list
83559528|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
83559529|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
83559530|NCT03403712|Dexamethasone|dexamethasone|mesh-list
83559531|NCT03403712|Palonosetron|palonosetron|mesh-list
83559532|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83559533|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
83559534|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
83559535|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559536|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559537|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83559538|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
83559539|NCT03403712|Hormones|hormones|mesh-ancestor
83559540|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83559541|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83559542|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559543|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83559544|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83559545|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
83559546|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559547|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559548|NCT03404648|Choline|choline|mesh-list
83559549|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
83559550|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83559551|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
83559552|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559553|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83559554|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83559555|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
83559556|NCT03383198|Bupivacaine|bupivacaine|mesh-list
83559557|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559558|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
83559559|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559560|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559561|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
83559562|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559563|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
83559564|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83559565|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
83559566|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83559567|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
83559568|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559569|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559570|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
83559571|NCT03523988|Acetaminophen|acetaminophen|mesh-list
83559572|NCT03523988|Ibuprofen|ibuprofen|mesh-list
83559573|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83559574|NCT03523988|Analgesics|analgesics|mesh-ancestor
83559575|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
83559576|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559577|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559578|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
83559579|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83559580|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83559581|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559582|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83559583|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559584|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559585|NCT03525548|Ivacaftor|ivacaftor|mesh-list
83559587|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83559588|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83559589|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559590|NCT03528512|Fentanyl|fentanyl|mesh-list
83559591|NCT03528512|Midazolam|midazolam|mesh-list
83559592|NCT03528512|Ketamine|ketamine|mesh-list
83559593|NCT03528512|Analgesics|analgesics|mesh-ancestor
83559594|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
83559595|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559596|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559597|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83559598|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83559599|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
83559600|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
83559601|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559602|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83559603|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83559604|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559605|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559606|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83559607|NCT03528512|Narcotics|narcotics|mesh-ancestor
83559608|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83559609|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83559610|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83559611|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83559612|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83559613|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
83559614|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
83559615|NCT02133924|Prednisone|prednisone|mesh-list
83559616|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
83559617|NCT02133924|Natalizumab|natalizumab|mesh-list
83559618|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83559619|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
83559620|NCT02133924|Hormones|hormones|mesh-ancestor
83559621|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83559622|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559623|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83559624|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559625|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
83559626|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
83559627|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559628|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83559629|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83559630|NCT02133924|Protective Agents|protective agents|mesh-ancestor
83559631|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
83559632|NCT03537404|Ritonavir|ritonavir|mesh-list
83559633|NCT03537404|Tenofovir|tenofovir|mesh-list
83559634|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
83559635|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83559636|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83559637|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
83559638|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559639|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559640|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83559641|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83559642|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
83559643|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559644|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83559645|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83559646|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83559647|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83559648|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83559649|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83559650|NCT03626714|Tacrolimus|tacrolimus|mesh-list
83559651|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83559652|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
83559653|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559654|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83559655|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559656|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559657|NCT03538808|Varenicline|varenicline|mesh-list
83559658|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83017799|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83559659|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83559660|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
83559661|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559662|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559663|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559664|NCT00377000|Clindamycin|clindamycin|mesh-list
83559665|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
83559666|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
83559667|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83559668|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83559669|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559670|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83559671|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559672|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559673|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
83559674|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83559675|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559677|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83559678|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83559679|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83559680|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
83559681|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559682|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559683|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559684|NCT04501640|Urological Agents|urological agents|mesh-ancestor
83559685|NCT04757610|Ranibizumab|ranibizumab|mesh-list
83559686|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83559687|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83559688|NCT04757610|Growth Substances|growth substances|mesh-ancestor
83559689|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559690|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83559691|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559692|NCT03633344|Silicon|silicon|mesh-list
83559693|NCT03633344|Trace Elements|trace elements|mesh-ancestor
83559694|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
83559695|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559696|NCT02171130|Glucagon|glucagon|mesh-list
83559697|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83559698|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83559699|NCT02171130|Hormones|hormones|mesh-ancestor
83559700|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83559701|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559702|NCT02171130|Incretins|incretins|mesh-ancestor
83559703|NCT04749810|Eculizumab|eculizumab|mesh-list
83559704|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83559705|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83559706|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
83559707|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559708|NCT00377078|Lactoferrin|lactoferrin|mesh-list
83559709|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559710|NCT04495712|Spironolactone|spironolactone|mesh-list
83559711|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83559712|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
83559713|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83559714|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559715|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83559716|NCT04495712|Diuretics|diuretics|mesh-ancestor
83559717|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
83559718|NCT03553940|Vaccines|vaccines|mesh-list
83559719|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
83559720|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559721|NCT04456634|Lumefantrine|lumefantrine|mesh-list
83559722|NCT04456634|Artemether|artemether|mesh-list
83559723|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83559724|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
83559725|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83559726|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83559727|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559728|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
83559729|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83559730|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
83559731|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559732|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
83559733|NCT00377624|Protective Agents|protective agents|mesh-ancestor
83559734|NCT03562988|Vitamins|vitamins|mesh-list
83559735|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
83559736|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
83559737|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559738|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
83559739|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559740|NCT03562988|Protective Agents|protective agents|mesh-ancestor
83559741|NCT03644108|Guaifenesin|guaifenesin|mesh-list
83559742|NCT03644108|Expectorants|expectorants|mesh-ancestor
83559743|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559744|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
83559745|NCT04713956|Busulfan|busulfan|mesh-list
83559746|NCT04713956|Fludarabine|fludarabine|mesh-list
83559747|NCT04713956|Decitabine|decitabine|mesh-list
83559748|NCT04713956|Lenograstim|lenograstim|mesh-list
83559749|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83559750|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
83559751|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559752|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559753|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83559754|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
83559755|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559756|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559757|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83559758|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83559759|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
83559760|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559761|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83559762|NCT04425746|Afamelanotide|afamelanotide|mesh-list
83559763|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
83559764|NCT04392362|Adenosine|adenosine|mesh-list
83559765|NCT04392362|Analgesics|analgesics|mesh-ancestor
83559766|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
83559767|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559768|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559769|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83559770|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
83559771|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83559772|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
83559773|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
83559774|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559775|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559776|NCT04734782|Antibodies|antibodies|mesh-list
83559777|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
83559778|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559779|NCT04390022|Ivermectin|ivermectin|mesh-list
83559780|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83559781|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559782|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
83559783|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
83559784|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
83559785|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559786|NCT03570476|Olaparib|olaparib|mesh-list
83559787|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83559788|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559789|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559790|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559791|NCT03571724|Menthol|menthol|mesh-list
83559792|NCT03571724|Nicotine|nicotine|mesh-list
83559793|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83559794|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
83559795|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559796|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559797|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83559798|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83559799|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
83559800|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559801|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559802|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
83559803|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
83559804|NCT03572972|Warfarin|warfarin|mesh-list
83559805|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
83559806|NCT03572972|Dabigatran|dabigatran|mesh-list
83559807|NCT03572972|Apixaban|apixaban|mesh-list
83559808|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
83559809|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83559810|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
83559811|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83559812|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
83559813|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559814|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559816|NCT04352660|Mitomycin|mitomycin|mesh-list
83559817|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83559818|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559819|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
83559820|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559821|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83559822|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559823|NCT04342130|Morphine|morphine|mesh-list
83559824|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83559825|NCT04342130|Narcotics|narcotics|mesh-ancestor
83559826|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559827|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559828|NCT04342130|Analgesics|analgesics|mesh-ancestor
83559829|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
83559830|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559831|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
83559832|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83559833|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83559834|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559835|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
83559836|NCT04338074|Coagulants|coagulants|mesh-ancestor
83559837|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
83559838|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83559839|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
83559840|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559841|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559842|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83559843|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
83559844|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
83559845|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83559846|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
83559847|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559848|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559849|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
83559850|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83559851|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559852|NCT04337138|Immunotoxins|immunotoxins|mesh-ancestor
83559853|NCT04337138|Immunoconjugates|immunoconjugates|mesh-ancestor
83559854|NCT04337138|Immunologic Factors|immunologic factors|mesh-ancestor
83559855|NCT04337138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559856|NCT00422773|Cetuximab|cetuximab|mesh-list
83559857|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83559858|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559859|NCT03329209|Vedolizumab|vedolizumab|mesh-list
83559860|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83559861|NCT03661346|Labetalol|labetalol|mesh-list
83559862|NCT03661346|Esmolol|esmolol|mesh-list
83559863|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83559864|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83559865|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83559866|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
83559867|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559868|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559869|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559870|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83559871|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
83559872|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
83559873|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559874|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83559875|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83559876|NCT03329911|Paclitaxel|paclitaxel|mesh-list
83559877|NCT03329911|Carboplatin|carboplatin|mesh-list
83559878|NCT03329911|Bevacizumab|bevacizumab|mesh-list
83559879|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83559880|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83559881|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
83559882|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
83559883|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
83559884|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559885|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83559886|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83559887|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83559888|NCT03329911|Growth Substances|growth substances|mesh-ancestor
83559889|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559890|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
83559891|NCT04322396|Azithromycin|azithromycin|mesh-list
83559892|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
83559893|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83559894|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559895|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
83559896|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83448797|NCT00883103|Lidocaine|lidocaine|mesh-list
83559897|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83559898|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559899|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559900|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559901|NCT03330457|Betrixaban|betrixaban|mesh-list
83559902|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83559903|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
83559904|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83559905|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
83559906|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559907|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559908|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
83559909|NCT03961100|Entrectinib|entrectinib|mesh-list
83559910|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83559911|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559912|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559913|NCT03336853|Hybenx|hybenx|mesh-list
83559914|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
83559915|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
83559916|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559917|NCT03225313|Bupivacaine|bupivacaine|mesh-list
83559918|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83559919|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559920|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
83559921|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559922|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559923|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
83559924|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559925|NCT03949244|Latanoprost|latanoprost|mesh-list
83559926|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83559927|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83559928|NCT03948386|Bupivacaine|bupivacaine|mesh-list
83559929|NCT03948386|Mepivacaine|mepivacaine|mesh-list
83559930|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
83559931|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
83559932|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83559933|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559934|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
83559935|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559936|NCT03445195|Imipenem|imipenem|mesh-list
83559937|NCT03445195|Sulbactam|sulbactam|mesh-list
83559938|NCT03445195|Durlobactam|durlobactam|mesh-list
83559939|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83559940|NCT03445195|Cilastatin|cilastatin|mesh-list
83559941|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83559942|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559943|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
83559944|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559945|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559946|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83559947|NCT04277936|Levetiracetam|levetiracetam|mesh-list
83559948|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
83559949|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
83559950|NCT03670160|Clonidine|clonidine|mesh-list
83559951|NCT03670160|Phenobarbital|phenobarbital|mesh-list
83559952|NCT03670160|Analgesics|analgesics|mesh-ancestor
83559953|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
83559954|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83559955|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559956|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83559957|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
83559958|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
83559959|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83559960|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83559961|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83559962|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
83559963|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83559964|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559965|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
83559966|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83559967|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018173|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559968|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83559969|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83559970|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
83559971|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
82858581|NCT05841420|Paclitaxel|paclitaxel|mesh-list
83559972|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83559973|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83559974|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83559975|NCT00375895|Cyclosporine|cyclosporine|mesh-list
83559976|NCT00375895|Cyclosporins|cyclosporins|mesh-list
83559977|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559978|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559979|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83559980|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
83559981|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559982|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
83559983|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83559984|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
83559985|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83559986|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83559987|NCT03338803|Linagliptin|linagliptin|mesh-list
83559988|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83559989|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83559990|NCT03338803|Incretins|incretins|mesh-ancestor
83559991|NCT03338803|Hormones|hormones|mesh-ancestor
83559992|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83559993|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83559994|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
83559995|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83559996|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83559997|NCT00377936|Gemcitabine|gemcitabine|mesh-list
83559998|NCT00377936|Paclitaxel|paclitaxel|mesh-list
83559999|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83560000|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
83560001|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560002|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560003|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83560004|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
83560005|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
83560006|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
83560007|NCT03696758|Metoprolol|metoprolol|mesh-list
83560008|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
83560009|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
83560010|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83560011|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83560012|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560013|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560014|NCT03696758|Urological Agents|urological agents|mesh-ancestor
83560015|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83560016|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83560017|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
83560018|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
83560019|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560020|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560021|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83560022|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83560023|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83560024|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560025|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560026|NCT03233737|Anesthetics|anesthetics|mesh-list
83560027|NCT03233737|Tetracaine|tetracaine|mesh-list
83560028|NCT03233737|Benzocaine|benzocaine|mesh-list
83560029|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560030|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560031|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560032|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
83560033|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560034|NCT03711578|Tenalisib|tenalisib|mesh-list
83560035|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83560036|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560037|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560038|NCT03463915|Triamcinolone|triamcinolone|mesh-list
83560039|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83560040|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83560041|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83560042|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83560043|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
83560044|NCT03463915|Hormones|hormones|mesh-ancestor
83560045|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83560046|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560047|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83560048|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
83560049|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560050|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560051|NCT03473665|Celecoxib|celecoxib|mesh-list
83560052|NCT03473665|Diclofenac|diclofenac|mesh-list
83560053|NCT03473665|Indomethacin|indomethacin|mesh-list
83560054|NCT03473665|Meloxicam|meloxicam|mesh-list
83560055|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83560056|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560057|NCT03473665|Analgesics|analgesics|mesh-ancestor
83560058|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
83560059|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560060|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560061|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83560062|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83560063|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83560064|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83560065|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560066|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560067|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
83560068|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
83560069|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83560070|NCT03717506|Clindamycin|clindamycin|mesh-list
83560071|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
83560072|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
83560073|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83560074|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560075|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83560076|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560077|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560078|NCT03861338|Buprenorphine|buprenorphine|mesh-list
83560079|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83560080|NCT03861338|Narcotics|narcotics|mesh-ancestor
83560081|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560082|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560083|NCT03861338|Analgesics|analgesics|mesh-ancestor
83560084|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
83560085|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560086|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83560087|NCT00377780|Docetaxel|docetaxel|mesh-list
83560088|NCT00377780|Doxorubicin|doxorubicin|mesh-list
83560089|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83560090|NCT00377780|Trastuzumab|trastuzumab|mesh-list
83560091|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560092|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
83560093|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
83560094|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
83560095|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560096|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83560097|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83560098|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83560099|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560100|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83560101|NCT00376519|Cyclosporine|cyclosporine|mesh-list
83560102|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
83560103|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
83560104|NCT00376519|Fludarabine|fludarabine|mesh-list
83560105|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
83560106|NCT00376519|Cyclosporins|cyclosporins|mesh-list
83560107|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83560108|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
83560109|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560110|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83560111|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83560112|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
83560113|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560114|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560115|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83560116|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83560117|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
83560118|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560119|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
83560120|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560121|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83560122|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83560123|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83560124|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83560125|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
83560126|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83560128|NCT00422864|Fluorouracil|fluorouracil|mesh-list
83560129|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
83560130|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
83560131|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560132|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83560133|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560134|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83560135|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
83560136|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560137|NCT00422864|Antidotes|antidotes|mesh-ancestor
83560138|NCT00422864|Protective Agents|protective agents|mesh-ancestor
83560139|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
83560140|NCT00422864|Vitamins|vitamins|mesh-ancestor
83560141|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
83560142|NCT03373591|Bupivacaine|bupivacaine|mesh-list
83560143|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560144|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
83560145|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560146|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560147|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
83560148|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560149|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
83560150|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560151|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560152|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560153|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560154|NCT03378973|Analgesics|analgesics|mesh-ancestor
83560155|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
83560156|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560157|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83560158|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83560159|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83560160|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560161|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560162|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560163|NCT04121078|Rifampin|rifampin|mesh-list
83560164|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83560165|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
83560166|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83560167|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560168|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
83560169|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83560170|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560171|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560172|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83560173|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83560174|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83560175|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83560176|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83560177|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83560178|NCT03248947|Buprenorphine|buprenorphine|mesh-list
83560179|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83560180|NCT03248947|Naloxone|naloxone|mesh-list
83560181|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83560182|NCT03248947|Narcotics|narcotics|mesh-ancestor
83560183|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560184|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560185|NCT03248947|Analgesics|analgesics|mesh-ancestor
83560186|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
83560187|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560188|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83560189|NCT04114058|Bupivacaine|bupivacaine|mesh-list
83018328|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
83560190|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560191|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
83560192|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560193|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560194|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
83560195|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560196|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83560197|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560198|NCT00376831|Fentanyl|fentanyl|mesh-list
83560199|NCT00376831|Midazolam|midazolam|mesh-list
83560200|NCT00376831|Ketamine|ketamine|mesh-list
83560201|NCT00376831|Analgesics|analgesics|mesh-ancestor
83560202|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
83560203|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560204|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560205|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83560206|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560207|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
83560208|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
83560209|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560210|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83560211|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83560212|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560213|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560214|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83560215|NCT00376831|Narcotics|narcotics|mesh-ancestor
83560216|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83560217|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560218|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83560219|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560220|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560221|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
83560222|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
83560223|NCT03857750|Rocuronium|rocuronium|mesh-list
83560224|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83560225|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83560226|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83560227|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560228|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560229|NCT03828422|Calcium|calcium|mesh-list
83560230|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83560231|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560232|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
83560233|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83560234|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560235|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
83560236|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560237|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
83560238|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83560239|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
83560240|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560241|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
83560242|NCT04081610|Protective Agents|protective agents|mesh-ancestor
83560243|NCT03840278|Pancrelipase|pancrelipase|mesh-list
83560244|NCT03840278|Pancreatin|pancreatin|mesh-list
83560245|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83560246|NCT03838874|Bupivacaine|bupivacaine|mesh-list
83560247|NCT03838874|Mepivacaine|mepivacaine|mesh-list
83560248|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560249|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
83560250|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560251|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560252|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
83560253|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560254|NCT04045964|Nicotine|nicotine|mesh-list
83560255|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83560256|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
83560257|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560258|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560259|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83560260|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83560261|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
83560262|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560263|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560264|NCT05314400|Liver Extracts|liver extracts|mesh-list
83361609|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83560265|NCT05314400|Hematinics|hematinics|mesh-ancestor
83560266|NCT04039412|Levofloxacin|levofloxacin|mesh-list
83560267|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83560268|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560269|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83560270|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83560271|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83560272|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560273|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560274|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560275|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83560276|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83560278|NCT03831854|Ketamine|ketamine|mesh-list
83560279|NCT03831854|Analgesics|analgesics|mesh-ancestor
83560280|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
83560281|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560282|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560283|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83560284|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560285|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
83560286|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
83560287|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560288|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83560289|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83560290|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560291|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560292|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
83560293|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83560294|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560295|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83560296|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83560297|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560298|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560299|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83560300|NCT03806270|Midazolam|midazolam|mesh-list
83560301|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
83560302|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83560303|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560304|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560305|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560306|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83560307|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560308|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560309|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560310|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
83560311|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
83560312|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
83560313|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
83560314|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560315|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560316|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
83560317|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
83560318|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83560319|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
83560320|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
83560321|NCT03497845|Vaccines|vaccines|mesh-list
83560322|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
83560323|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560324|NCT04036292|Varenicline|varenicline|mesh-list
83560325|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83560326|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83560327|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
83560328|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560329|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560330|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560331|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83018469|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018470|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018471|NCT01374763|Analgesics|analgesics|mesh-ancestor
83018472|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
83018473|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018474|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83018475|NCT02747004|Tamoxifen|tamoxifen|mesh-list
83018476|NCT02747004|Loperamide|loperamide|mesh-list
83018477|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
83018478|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83018479|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83560332|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83560333|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560334|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560335|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
83560336|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560337|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560338|NCT00377390|Omalizumab|omalizumab|mesh-list
83560339|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83560340|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83560341|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
83560342|NCT03820388|Propofol|propofol|mesh-list
83560343|NCT03820388|Etomidate|etomidate|mesh-list
83560344|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560345|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560346|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560347|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560348|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
83560349|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
83560350|NCT03264157|Vaccines|vaccines|mesh-list
83560351|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
83560352|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560353|NCT04029584|Rifampin|rifampin|mesh-list
83560354|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83560355|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
83560356|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83560357|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560358|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
83560359|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83560360|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560361|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560362|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83560363|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83560364|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83560365|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83560366|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83560367|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83560368|NCT04028960|Insulin|insulin|mesh-list
83560369|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83560370|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83560371|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560372|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
83560373|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83560374|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
83560375|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
83560376|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560377|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560378|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560379|NCT03502915|Analgesics|analgesics|mesh-ancestor
83560380|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
83560381|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560382|NCT03506347|Vancomycin|vancomycin|mesh-list
83560383|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83560384|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560385|NCT03266419|Rocuronium|rocuronium|mesh-list
83560386|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83560387|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83560388|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83560389|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560390|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560391|NCT00377468|Dronabinol|dronabinol|mesh-list
83560392|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
83560393|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560394|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560395|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560396|NCT00377468|Analgesics|analgesics|mesh-ancestor
83560397|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
83560398|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560399|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83560400|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83560401|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560402|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560403|NCT00377468|Hormones|hormones|mesh-ancestor
83560404|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83560405|NCT03799484|Lidocaine|lidocaine|mesh-list
83560406|NCT03799484|Prilocaine|prilocaine|mesh-list
83560408|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
83560409|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83560410|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83560411|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560412|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
83560413|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560414|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560415|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
83560416|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560417|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83560418|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83560419|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83560420|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560421|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560422|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83560423|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
83560424|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560425|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83560426|NCT03799484|Emollients|emollients|mesh-ancestor
83560427|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83560428|NCT00377546|Ketorolac|ketorolac|mesh-list
83560429|NCT00377546|Nepafenac|nepafenac|mesh-list
83560430|NCT00377546|Bromfenac|bromfenac|mesh-list
83560431|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83560432|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560433|NCT00377546|Analgesics|analgesics|mesh-ancestor
83560434|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
83560435|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560436|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560437|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83560438|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83560439|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83560440|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560441|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560442|NCT04290494|Plasminogen|plasminogen|mesh-list
83560443|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83560444|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83560445|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560446|NCT04005404|Ropivacaine|ropivacaine|mesh-list
83560447|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560448|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
83560449|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560450|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560451|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
83560452|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560453|NCT03232892|Trametinib|trametinib|mesh-list
83560454|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560455|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83560456|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560457|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560458|NCT03510481|Lumefantrine|lumefantrine|mesh-list
83560459|NCT03510481|Artemether|artemether|mesh-list
83560460|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
83560461|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83560462|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83560463|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560464|NCT03109418|Ketamine|ketamine|mesh-list
83560465|NCT03109418|Analgesics|analgesics|mesh-ancestor
83560466|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
83560467|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560468|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560469|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83560470|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560471|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
83560472|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
83560473|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560474|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83560475|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83560476|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560477|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560478|NCT03404167|Zoliflodacin|zoliflodacin|mesh-list
83560479|NCT03404167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83560480|NCT03404167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83560481|NCT03404167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560482|NCT03404167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560483|NCT03404167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560485|NCT03771560|Folic Acid|folic acid|mesh-list
83560486|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
83560487|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560488|NCT03771560|Antidotes|antidotes|mesh-ancestor
83560489|NCT03771560|Protective Agents|protective agents|mesh-ancestor
83560490|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
83560491|NCT03771560|Vitamins|vitamins|mesh-ancestor
83560492|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
83560493|NCT03771560|Hematinics|hematinics|mesh-ancestor
83560494|NCT03767738|Aflibercept|aflibercept|mesh-list
83560495|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83560496|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83560497|NCT03767738|Growth Substances|growth substances|mesh-ancestor
83560498|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560499|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
83560500|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560501|NCT02973620|Simendan|simendan|mesh-list
83560502|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83560503|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
83560504|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83560505|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83560506|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560507|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560508|NCT02973620|Protective Agents|protective agents|mesh-ancestor
83560509|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560510|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
83560511|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560512|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560513|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560514|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560515|NCT05313386|Analgesics|analgesics|mesh-ancestor
83560516|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
83560517|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560518|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83560519|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83560520|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83560521|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560522|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560523|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560524|NCT04018664|Nalbuphine|nalbuphine|mesh-list
83560525|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83560526|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83560527|NCT04018664|Narcotics|narcotics|mesh-ancestor
83560528|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560529|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560530|NCT04018664|Analgesics|analgesics|mesh-ancestor
83560531|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
83560532|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560533|NCT03031340|Pregabalin|pregabalin|mesh-list
83560534|NCT03031340|Analgesics|analgesics|mesh-ancestor
83560535|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
83560536|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560537|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560538|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
83560539|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83560540|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560541|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560542|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83560543|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83560544|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560545|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560546|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560547|NCT03405259|Fluorides|fluorides|mesh-list
83560548|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
83560549|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
83560550|NCT03405259|Protective Agents|protective agents|mesh-ancestor
83560551|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560552|NCT03513757|Lidocaine|lidocaine|mesh-list
83560553|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
83560554|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
83560555|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
83560556|NCT03513757|Propofol|propofol|mesh-list
83560557|NCT03513757|Sevoflurane|sevoflurane|mesh-list
83560558|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560560|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560561|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560562|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
83560563|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560564|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83560565|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83560566|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83560567|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560568|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560569|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560570|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560571|NCT03513757|Analgesics|analgesics|mesh-ancestor
83560572|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83560573|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83560574|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83560575|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560576|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560577|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560578|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
83560579|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83560580|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83560581|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83560582|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83560583|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83560584|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
83560585|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
83560586|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83560587|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560588|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83560589|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560590|NCT03756038|Lorazepam|lorazepam|mesh-list
83560591|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
83560592|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
83560593|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
83560594|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560595|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560596|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83560597|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560598|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560599|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83560600|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560601|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560602|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
83560603|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
83560604|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560605|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560606|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
83560607|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83560608|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
83560609|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83560610|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560611|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83560612|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83560613|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83560614|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
83560615|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83560616|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
83560617|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560618|NCT01495988|Bevacizumab|bevacizumab|mesh-list
83560619|NCT01495988|Vemurafenib|vemurafenib|mesh-list
83560620|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83560621|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560622|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83560623|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83560624|NCT01495988|Growth Substances|growth substances|mesh-ancestor
83560625|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560626|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
83560627|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83560628|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560629|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560630|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
83560631|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
83560632|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560633|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560634|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560635|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
83560636|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
83560637|NCT03415243|Acetaminophen|acetaminophen|mesh-list
83560638|NCT03415243|Phenylephrine|phenylephrine|mesh-list
83560639|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
83560640|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
83560641|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560642|NCT03415243|Analgesics|analgesics|mesh-ancestor
83560643|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
83560644|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560645|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560646|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
83560647|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83560648|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
83560649|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
83560650|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
83560651|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83560652|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
83560653|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
83560654|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83560655|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83560656|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83560657|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560658|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560659|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560660|NCT03415243|Protective Agents|protective agents|mesh-ancestor
83560661|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
83560662|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83560663|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83560664|NCT02892500|Betamethasone|betamethasone|mesh-list
83560665|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
83560666|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83560667|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
83560668|NCT02892500|Bupivacaine|bupivacaine|mesh-list
83560669|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83560670|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560671|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
83560672|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560673|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560674|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
83560675|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560676|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83560677|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
83560678|NCT02892500|Hormones|hormones|mesh-ancestor
83560679|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83560680|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83560681|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
83560682|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
83560683|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83560684|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83560685|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560686|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
83560687|NCT00378872|Coagulants|coagulants|mesh-ancestor
83560688|NCT00378404|Docetaxel|docetaxel|mesh-list
83560689|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560690|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
83560691|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
83560692|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
83560693|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560694|NCT03742154|Varenicline|varenicline|mesh-list
83560695|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83560696|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83560697|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
83560698|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560699|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560700|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560701|NCT02734940|Lidocaine|lidocaine|mesh-list
83560702|NCT02734940|Fentanyl|fentanyl|mesh-list
83560703|NCT02734940|Ketamine|ketamine|mesh-list
83560704|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
83560705|NCT02734940|Morphine|morphine|mesh-list
83560706|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560707|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
83560708|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560709|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560710|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
83560711|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560712|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83560713|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83560714|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83560715|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83684415|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560716|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560717|NCT02734940|Analgesics|analgesics|mesh-ancestor
83560718|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83560719|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560720|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
83560721|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83560722|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83560723|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560724|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83560725|NCT02734940|Narcotics|narcotics|mesh-ancestor
83560726|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83560727|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560728|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560729|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83560730|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83560731|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83560732|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560733|NCT00378092|Risperidone|risperidone|mesh-list
83560734|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83560735|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
83560736|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560737|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560738|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560739|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83560740|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560741|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560742|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560743|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83560744|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
83560745|NCT01347632|Metronidazole|metronidazole|mesh-list
83560746|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560747|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83560748|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83560749|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83560750|NCT02679560|Bupivacaine|bupivacaine|mesh-list
83560751|NCT02679560|Ropivacaine|ropivacaine|mesh-list
83560752|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
83560753|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
83560754|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560755|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560756|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
83560757|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560759|NCT03723980|Calcium|calcium|mesh-list
83560760|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83560761|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560762|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560763|NCT01240304|Gemcitabine|gemcitabine|mesh-list
83560764|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83560765|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
83560766|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560767|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560768|NCT02614586|Ondansetron|ondansetron|mesh-list
83560769|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
83560770|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
83560771|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560772|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560773|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83560774|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
83560775|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
83560776|NCT02614586|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83560777|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83560778|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
83560779|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560780|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560781|NCT01211756|Oxytocin|oxytocin|mesh-list
83560782|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
83560783|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83018915|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
83560784|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560785|NCT03591458|Amitriptyline|amitriptyline|mesh-list
83560786|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83560787|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
83560788|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560789|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560790|NCT03591458|Analgesics|analgesics|mesh-ancestor
83560791|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
83560792|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560793|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560794|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83560795|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83560796|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560797|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560798|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560799|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560800|NCT03565328|Niacinamide|niacinamide|mesh-list
83560801|NCT03565328|Niacin|niacin|mesh-list
83560802|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
83560803|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
83560804|NCT03565328|Vitamins|vitamins|mesh-ancestor
83560805|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
83560806|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560807|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83560808|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
83560809|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560810|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83560811|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
83560812|NCT01206296|Gemcitabine|gemcitabine|mesh-list
83560813|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83560814|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
83560815|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560816|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560817|NCT02593682|Suvorexant|suvorexant|mesh-list
83560818|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83560819|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560820|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560821|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560822|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83560823|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560824|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560825|NCT01200602|Megestrol|megestrol|mesh-list
83560826|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
83560827|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83560828|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83560829|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83560830|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
83560831|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83560832|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560833|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83560834|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83560835|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83560836|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560837|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
83560838|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83560839|NCT01194908|Tamoxifen|tamoxifen|mesh-list
83560840|NCT01194908|Decitabine|decitabine|mesh-list
83560841|NCT01194908|Panobinostat|panobinostat|mesh-list
83560842|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83560843|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
83560844|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560845|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560846|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560847|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83560848|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
83560849|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83560850|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560851|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83560852|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83560853|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83560854|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83560855|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83560856|NCT01163084|Leuprolide|leuprolide|mesh-list
83560857|NCT01163084|Goserelin|goserelin|mesh-list
83560858|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83560859|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
83560860|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83560861|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560862|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83560863|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560864|NCT01155518|Clomiphene|clomiphene|mesh-list
83560865|NCT01155518|Testosterone|testosterone|mesh-list
83560866|NCT01155518|Androgens|androgens|mesh-ancestor
83560867|NCT01155518|Hormones|hormones|mesh-ancestor
83560868|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83560869|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560870|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83560871|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
83560872|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83560873|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
83560874|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83560875|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83560876|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83560877|NCT03490916|Acetazolamide|acetazolamide|mesh-list
83560878|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
83560879|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83560880|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560881|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560882|NCT03490916|Diuretics|diuretics|mesh-ancestor
83560883|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
83560884|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560885|NCT03333746|Nivolumab|nivolumab|mesh-list
83560886|NCT03333746|Lenalidomide|lenalidomide|mesh-list
83560887|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83560888|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560889|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83560890|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560891|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
83560892|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560893|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83560894|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83560895|NCT03333746|Growth Substances|growth substances|mesh-ancestor
83560896|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
83560897|NCT01139996|Clonidine|clonidine|mesh-list
83560898|NCT01139996|Analgesics|analgesics|mesh-ancestor
83560899|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
83560900|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560901|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560902|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83560903|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
83560904|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
83560905|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83560906|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83560907|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83560908|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560909|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560910|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560911|NCT02417870|Aldesleukin|aldesleukin|mesh-list
83560912|NCT02417870|Interleukin-2|interleukin-2|mesh-list
83560913|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83560914|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83560915|NCT02417870|Analgesics|analgesics|mesh-ancestor
83560916|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
83560917|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83560918|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560919|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83560920|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83560921|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
83560922|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560923|NCT01131884|Alendronate|alendronate|mesh-list
83560924|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83560925|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560926|NCT02389712|Lamotrigine|lamotrigine|mesh-list
83560927|NCT02389712|Fluoxetine|fluoxetine|mesh-list
83560928|NCT02389712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83560929|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83560930|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560931|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560932|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019142|NCT05812430|Cisplatin|cisplatin|mesh-list
83560933|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
83560934|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560935|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83560936|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
83560937|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83449851|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
83560938|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83560939|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83560940|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83560941|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
83560942|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83560943|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83560944|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83560945|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560946|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560947|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83560948|NCT02369744|Tamsulosin|tamsulosin|mesh-list
83560949|NCT02369744|Silodosin|silodosin|mesh-list
83560950|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83560951|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83560952|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83560953|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
83560954|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560955|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560956|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560957|NCT02369744|Urological Agents|urological agents|mesh-ancestor
83560958|NCT03577171|Entecavir|entecavir|mesh-list
83560959|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
83560960|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83560961|NCT02367170|Midazolam|midazolam|mesh-list
83560962|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83560963|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83560964|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83560965|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560966|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83560967|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83560968|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560969|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83560970|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
83560971|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
83560972|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
83560973|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
83560974|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560975|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560976|NCT01078844|Memantine|memantine|mesh-list
83560977|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83560978|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83560979|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
83560980|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560981|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560982|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560983|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83560984|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83560985|NCT00376051|Citalopram|citalopram|mesh-list
83560986|NCT00376051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83560987|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83560988|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83560989|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83560990|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83560991|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
83560992|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83560993|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83560994|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
83560995|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83560996|NCT01072526|Cyclosporine|cyclosporine|mesh-list
83560997|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
83560998|NCT01072526|Cyclosporins|cyclosporins|mesh-list
83560999|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561000|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561001|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561002|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
83561003|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561004|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
83561005|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561006|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561007|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561008|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83561009|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83561010|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83561011|NCT05312840|Carboplatin|carboplatin|mesh-list
83561012|NCT05312840|Gemcitabine|gemcitabine|mesh-list
83561013|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561014|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83561015|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
83561016|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561017|NCT00376129|Alefacept|alefacept|mesh-list
83561018|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561019|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
83561020|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561021|NCT01035944|Chitosan|chitosan|mesh-list
83561022|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83561023|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83561024|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
83561025|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561026|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83561027|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
83561028|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
83561029|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
83561030|NCT01035944|Coagulants|coagulants|mesh-ancestor
83561031|NCT00378638|Bevacizumab|bevacizumab|mesh-list
83561032|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83561033|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561034|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83561035|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83561036|NCT00378638|Growth Substances|growth substances|mesh-ancestor
83561037|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561038|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
83561039|NCT03582553|Naringenin|naringenin|mesh-list
83561040|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83561041|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561042|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83561043|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
83561044|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561045|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561046|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
83561047|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83561048|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83561049|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
83561050|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561051|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83561052|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
83561053|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
83561054|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83561055|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83561056|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561057|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561058|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561059|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561060|NCT01023620|Pioglitazone|pioglitazone|mesh-list
83561061|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83561062|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561063|NCT03595579|Bupropion|bupropion|mesh-list
83561064|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83561065|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
83561066|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83561067|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83561068|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83561069|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561070|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561071|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
83561072|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561073|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561074|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83561075|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83561076|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561077|NCT02200328|Metronidazole|metronidazole|mesh-list
83561078|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561079|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83561080|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83019219|NCT05810350|Pemetrexed|pemetrexed|mesh-list
83561081|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83561082|NCT04327843|Haloperidol|haloperidol|mesh-list
83561083|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
83561084|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
83561085|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
83561086|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561087|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561088|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561089|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83561090|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83561091|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561092|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83561093|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83561094|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
83561095|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561096|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561097|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83561098|NCT02147834|Ranolazine|ranolazine|mesh-list
83561099|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83561100|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561101|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561102|NCT00979550|Imiquimod|imiquimod|mesh-list
83561103|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83561104|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
83561105|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561106|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561107|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
83561108|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
83561109|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83561110|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561111|NCT00379730|Prednisolone|prednisolone|mesh-list
83561112|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561113|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
83561114|NCT00379730|Hormones|hormones|mesh-ancestor
83561115|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561116|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561117|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83561118|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561119|NCT02074904|Topiramate|topiramate|mesh-list
83561120|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
83561121|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83561122|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561123|NCT02043860|Melphalan|melphalan|mesh-list
83561124|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
83561125|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561126|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83561127|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
83561128|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561129|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561130|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83561131|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561132|NCT01974284|Ethanol|ethanol|mesh-list
83561133|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83561134|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561135|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561136|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561137|NCT00869414|Insulin|insulin|mesh-list
83561138|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83561139|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
83561140|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83561141|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561142|NCT00843986|Conivaptan|conivaptan|mesh-list
83019293|NCT05801224|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019294|NCT05801224|Gasotransmitters|gasotransmitters|mesh-ancestor
83019295|NCT05801224|Protective Agents|protective agents|mesh-ancestor
83019296|NCT05793489|Silybin|silybin|mesh-list
83019297|NCT05793489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83019298|NCT05793489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019299|NCT05793489|Protective Agents|protective agents|mesh-ancestor
83019300|NCT05793489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019301|NCT05754853|Paclitaxel|paclitaxel|mesh-list
83019302|NCT05754853|Docetaxel|docetaxel|mesh-list
83019303|NCT05754853|Gemcitabine|gemcitabine|mesh-list
83019304|NCT05754853|Pemetrexed|pemetrexed|mesh-list
83019305|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83561143|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83561144|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561145|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
83561146|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561147|NCT03608839|Dexamethasone|dexamethasone|mesh-list
83561148|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
83561149|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83561150|NCT03608839|BB 1101|bb 1101|mesh-list
83561151|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561152|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
83561153|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
83561154|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561155|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561156|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561157|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
83561158|NCT03608839|Hormones|hormones|mesh-ancestor
83561159|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561160|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83561161|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561162|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83561163|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561164|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561165|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83561166|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
83561167|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
83561168|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561169|NCT03610399|Primaquine|primaquine|mesh-list
83561170|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
83561171|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83561172|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83561173|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561174|NCT03610633|Oxytocin|oxytocin|mesh-list
83561175|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
83561176|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83561177|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561178|NCT00832520|Mirtazapine|mirtazapine|mesh-list
83561179|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
83561180|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83561181|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83561182|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
83561183|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
83561184|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561185|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561186|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561187|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83561188|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83561189|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561190|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83561191|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83561192|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83561193|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
83561194|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83561195|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83561196|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
83561197|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83561198|NCT03545893|Ibuprofen|ibuprofen|mesh-list
83561199|NCT03545893|Oxycodone|oxycodone|mesh-list
83561200|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83561201|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83561202|NCT03545893|Analgesics|analgesics|mesh-ancestor
83561203|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
83561204|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561205|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561206|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561207|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561208|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83561209|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561210|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561211|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83561212|NCT03545893|Narcotics|narcotics|mesh-ancestor
83561213|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561214|NCT01877564|Metformin|metformin|mesh-list
83561215|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83561216|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019368|NCT05692869|Propranolol|propranolol|mesh-list
83561218|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561219|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
83561220|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83561221|NCT00376987|Protective Agents|protective agents|mesh-ancestor
83450155|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
83561222|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561223|NCT01889420|Everolimus|everolimus|mesh-list
83561224|NCT01889420|Pomalidomide|pomalidomide|mesh-list
83561225|NCT01889420|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83561226|NCT01889420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83561227|NCT01889420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561228|NCT01889420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561229|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561230|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
83561231|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561232|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561233|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83561234|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83561235|NCT01889420|Growth Substances|growth substances|mesh-ancestor
83561236|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
83561237|NCT00379028|Fluticasone|fluticasone|mesh-list
83561238|NCT00379028|Budesonide|budesonide|mesh-list
83561239|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
83561240|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83561241|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561242|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83561243|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
83561244|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561245|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561246|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83561247|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
83561248|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561249|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83561250|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
83561251|NCT00379028|Hormones|hormones|mesh-ancestor
83561252|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561253|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83561254|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83561255|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83561256|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
83561257|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561258|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561259|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83561260|NCT05286554|Hormones|hormones|mesh-list
83561261|NCT05286554|Progesterone|progesterone|mesh-list
83561262|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561263|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561264|NCT05286554|Progestins|progestins|mesh-ancestor
83561265|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
83561266|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83561267|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
83561268|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83561269|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83561270|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83561271|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561272|NCT00379262|Fluorouracil|fluorouracil|mesh-list
83561273|NCT00379262|Capecitabine|capecitabine|mesh-list
83561274|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
83561275|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561276|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83561277|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561278|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561279|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
83561280|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561281|NCT00793520|Milnacipran|milnacipran|mesh-list
83561282|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
83561283|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83561284|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83561285|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561286|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561287|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561288|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561289|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83561290|NCT00793520|Analgesics|analgesics|mesh-ancestor
83561292|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561293|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
83561294|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83561295|NCT03621085|Ketamine|ketamine|mesh-list
83561296|NCT03621085|Analgesics|analgesics|mesh-ancestor
83561297|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
83561298|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561299|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561300|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83561301|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83561302|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
83561303|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
83561304|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561305|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83561306|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83561307|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561308|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561309|NCT00795236|Melatonin|melatonin|mesh-list
83561310|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
83561311|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561312|NCT00795236|Protective Agents|protective agents|mesh-ancestor
83561313|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561314|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561315|NCT00790478|Melatonin|melatonin|mesh-list
83561316|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
83561317|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561318|NCT00790478|Protective Agents|protective agents|mesh-ancestor
83561319|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561320|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561321|NCT04490239|Heparin|heparin|mesh-list
83561322|NCT04490239|Calcium heparin|calcium heparin|mesh-list
83561323|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
83561324|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83561325|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83561326|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561327|NCT00791336|Nelfinavir|nelfinavir|mesh-list
83561328|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83561329|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83561330|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
83561331|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561332|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561333|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83561334|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83561335|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
83561336|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561337|NCT00771602|Rituximab|rituximab|mesh-list
83561338|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
83561339|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83561340|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561341|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
83561342|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561343|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561344|NCT01804166|Infliximab|infliximab|mesh-list
83561345|NCT01804166|Golimumab|golimumab|mesh-list
83561346|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83561347|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561348|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561349|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561350|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561351|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561352|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
83561353|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561354|NCT04459585|Dabigatran|dabigatran|mesh-list
83561355|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
83561356|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83561357|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
83561358|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561359|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561360|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
83561361|NCT05080556|Carboplatin|carboplatin|mesh-list
83561362|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561363|NCT01797380|Escitalopram|escitalopram|mesh-list
83561364|NCT01797380|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83561365|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83561366|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561367|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561368|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561369|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
83561370|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561371|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
83561372|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83561373|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83561374|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83561375|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561376|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561377|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
83561378|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561379|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561380|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83561381|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561382|NCT00726830|Morphine|morphine|mesh-list
83561383|NCT00726830|Oxycodone|oxycodone|mesh-list
83561384|NCT00726830|Methadone|methadone|mesh-list
83561385|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83561386|NCT00726830|Narcotics|narcotics|mesh-ancestor
83561387|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561388|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561389|NCT00726830|Analgesics|analgesics|mesh-ancestor
83561390|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
83561391|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561392|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
83561393|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
83561394|NCT00691652|Rituximab|rituximab|mesh-list
83561395|NCT00691652|Clofarabine|clofarabine|mesh-list
83561396|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83561397|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561398|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
83561399|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561400|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561401|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83561402|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
83561403|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561404|NCT00691574|Melatonin|melatonin|mesh-list
83561405|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
83561406|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561407|NCT00691574|Protective Agents|protective agents|mesh-ancestor
83561408|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561409|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561410|NCT00685880|Betamethasone|betamethasone|mesh-list
83561411|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
83561412|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561413|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
83561414|NCT00685880|Hormones|hormones|mesh-ancestor
83561415|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561416|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561417|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83561418|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
83561419|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83561420|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
83561421|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561422|NCT00681044|Melphalan|melphalan|mesh-list
83561423|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
83561424|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561425|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83561426|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
83561427|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561428|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561429|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83561430|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561431|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
83561432|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83561433|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
83561434|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561435|NCT03633487|Guaifenesin|guaifenesin|mesh-list
83561436|NCT03633487|Expectorants|expectorants|mesh-ancestor
83561437|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83561438|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
83561439|NCT00423020|Hematinics|hematinics|mesh-ancestor
83561440|NCT01756586|Dexamethasone|dexamethasone|mesh-list
83561441|NCT01756586|Bupivacaine|bupivacaine|mesh-list
83561442|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561443|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
83561444|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
83561445|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561446|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561447|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561448|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
83561449|NCT01756586|Hormones|hormones|mesh-ancestor
83561450|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561451|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83561452|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561453|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
83561454|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
83561455|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561456|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
83561457|NCT03636061|Varenicline|varenicline|mesh-list
83561458|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83561459|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83561460|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
83561461|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561462|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561463|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561464|NCT00661466|Bupivacaine|bupivacaine|mesh-list
83561465|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
83561466|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
83561467|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561468|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561469|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
83561470|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561471|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
83561472|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83561473|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561474|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83561475|NCT01718444|Clomiphene|clomiphene|mesh-list
83561476|NCT01718444|Enclomiphene|enclomiphene|mesh-list
83561477|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
83561478|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
83561479|NCT01718444|Progestins|progestins|mesh-list
83561480|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83561481|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
83561482|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561483|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561484|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83561485|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
83561486|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83561487|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83561488|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83561489|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83561490|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83561491|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83561492|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
83561493|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83561494|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83561495|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83561496|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83561497|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561498|NCT01718444|Hormones|hormones|mesh-ancestor
83561499|NCT00638222|Carvedilol|carvedilol|mesh-list
83561500|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83561501|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83561502|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83561503|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561504|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561505|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561506|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83561507|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
83561508|NCT00638222|Protective Agents|protective agents|mesh-ancestor
83561509|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83561510|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561511|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83561512|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
83561513|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83561514|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83561515|NCT00634322|Leucovorin|leucovorin|mesh-list
83561517|NCT00634322|Protective Agents|protective agents|mesh-ancestor
83561518|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561519|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
83561520|NCT00634322|Vitamins|vitamins|mesh-ancestor
83561521|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
83561522|NCT00379886|Thiopental|thiopental|mesh-list
83561523|NCT00379886|Propofol|propofol|mesh-list
83561524|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83561525|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561526|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561527|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83561528|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
83561529|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
83561530|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
83561531|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
83561532|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
83561533|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561534|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561535|NCT01705106|Celecoxib|celecoxib|mesh-list
83561536|NCT01705106|Capecitabine|capecitabine|mesh-list
83561537|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83561538|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
83561539|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561540|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561541|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83561542|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83561543|NCT01705106|Analgesics|analgesics|mesh-ancestor
83561544|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
83561545|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561546|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561547|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561548|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561549|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83561550|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83561551|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561552|NCT00624650|Phenylephrine|phenylephrine|mesh-list
83561553|NCT00624650|Dobutamine|dobutamine|mesh-list
83561554|NCT00624650|Furosemide|furosemide|mesh-list
83561555|NCT00624650|Vasopressins|vasopressins|mesh-list
83561556|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
83561557|NCT00624650|Epinephrine|epinephrine|mesh-list
83561558|NCT00624650|Racepinephrine|racepinephrine|mesh-list
83561559|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
83561560|NCT00624650|Norepinephrine|norepinephrine|mesh-list
83561561|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83561562|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
83561563|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83561564|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83561565|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
83561566|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561567|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561568|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561569|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83561570|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83561571|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
83561572|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561573|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83561574|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
83561575|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
83561576|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
83561577|NCT00624650|Diuretics|diuretics|mesh-ancestor
83561578|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
83561579|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83561580|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561581|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83561582|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
83561583|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83561584|NCT00624650|Protective Agents|protective agents|mesh-ancestor
83561585|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
83561586|NCT00624650|Coagulants|coagulants|mesh-ancestor
83561587|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83561588|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83561589|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
83561590|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83561591|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83561592|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
83561593|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561594|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83561595|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83561596|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561597|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561598|NCT00377143|Warfarin|warfarin|mesh-list
83561599|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
83561600|NCT00610532|Probenecid|probenecid|mesh-list
83561601|NCT00610532|Phenytoin|phenytoin|mesh-list
83561602|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
83561603|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83561604|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83561605|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561606|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561607|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83561608|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83561609|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
83561610|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
83561611|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561612|NCT03642457|Bupivacaine|bupivacaine|mesh-list
83561613|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
83561614|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
83561615|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561616|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561617|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
83561618|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561619|NCT00379418|Abciximab|abciximab|mesh-list
83561620|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
83561621|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83561622|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
83561623|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83561624|NCT00378716|Leucovorin|leucovorin|mesh-list
83561625|NCT00378716|Fluorouracil|fluorouracil|mesh-list
83561626|NCT00378716|Tegafur|tegafur|mesh-list
83561627|NCT00378716|Calcium|calcium|mesh-list
83561628|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
83561629|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83561630|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561631|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
83561632|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561633|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83561634|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561635|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561636|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
83561637|NCT00378716|Antidotes|antidotes|mesh-ancestor
83561638|NCT00378716|Protective Agents|protective agents|mesh-ancestor
83561639|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
83561640|NCT00378716|Vitamins|vitamins|mesh-ancestor
83561641|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
83561642|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
83561643|NCT03644095|Guaifenesin|guaifenesin|mesh-list
83561644|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83561645|NCT03644095|Expectorants|expectorants|mesh-ancestor
83561646|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
83561647|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83561648|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83561649|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
83561650|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561651|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561652|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561653|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
83561654|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83561655|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
83561656|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
83561657|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561658|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
83561659|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83561660|NCT01633814|Estradiol|estradiol|mesh-list
83561661|NCT01633814|Estrogens|estrogens|mesh-ancestor
83561662|NCT01633814|Hormones|hormones|mesh-ancestor
83561663|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561664|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561665|NCT04585490|Paclitaxel|paclitaxel|mesh-list
83561666|NCT04585490|Cisplatin|cisplatin|mesh-list
83561667|NCT04585490|Carboplatin|carboplatin|mesh-list
83561668|NCT04585490|Pemetrexed|pemetrexed|mesh-list
83561669|NCT04585490|Durvalumab|durvalumab|mesh-list
83561670|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83561671|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83561672|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561673|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
83561674|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
83561675|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
83561676|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561677|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561678|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83561679|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83561680|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83561681|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
83561682|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561683|NCT04714099|Cyclosporine|cyclosporine|mesh-list
83561684|NCT04714099|Cyclosporins|cyclosporins|mesh-list
83561685|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561686|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561687|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561688|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
83561689|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561690|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
83561691|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561692|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561693|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561694|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83561695|NCT04566770|Vaccines|vaccines|mesh-list
83561696|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
83561697|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561698|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
83561699|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83561700|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83561701|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561702|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561703|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83561704|NCT04342663|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83561705|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83561706|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561707|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561708|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561709|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
83561710|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83561711|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
83561712|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83561713|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83561714|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561715|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83561716|NCT00589550|Interferons|interferons|mesh-list
83561717|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
83561718|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
83561719|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83561720|NCT00589550|Sorafenib|sorafenib|mesh-list
83561721|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561722|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
83561723|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561724|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83561725|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561726|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561727|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
83561728|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561729|NCT01636466|Everolimus|everolimus|mesh-list
83561730|NCT01636466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83561731|NCT01636466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83561732|NCT01636466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561733|NCT01636466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561734|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561735|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
83561736|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561737|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561738|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
83561739|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561740|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
83561741|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561742|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561743|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83561744|NCT04499924|Paclitaxel|paclitaxel|mesh-list
83561745|NCT04499924|Trastuzumab|trastuzumab|mesh-list
83561746|NCT04499924|Ramucirumab|ramucirumab|mesh-list
83561747|NCT04499924|Tucatinib|tucatinib|mesh-list
83561748|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83561749|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561750|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
83561751|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
83561752|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
83561753|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561754|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83561755|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83561756|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561757|NCT03949621|Vedolizumab|vedolizumab|mesh-list
83561758|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561759|NCT04429880|Oxytocin|oxytocin|mesh-list
83561760|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
83561761|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83561762|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561763|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
83561764|NCT04311632|Tacrolimus|tacrolimus|mesh-list
83561765|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561766|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
83561767|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561768|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83561769|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561770|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561771|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83561772|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561773|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83561774|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
83561775|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83561776|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561777|NCT01692158|Heparin|heparin|mesh-list
83561778|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83561779|NCT01692158|Tinzaparin|tinzaparin|mesh-list
83561780|NCT01692158|Dalteparin|dalteparin|mesh-list
83561781|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
83561782|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83561783|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83561784|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561785|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
83561786|NCT01570634|Loperamide|loperamide|mesh-list
83561787|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
83561788|NCT01570634|Calcium|calcium|mesh-list
83561789|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83561790|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561791|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561792|NCT03928327|Itraconazole|itraconazole|mesh-list
83561793|NCT03928327|Rifampin|rifampin|mesh-list
83561794|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
83561795|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561796|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83561797|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83561798|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561799|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561800|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83561801|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
83561802|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561803|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561804|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83561805|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83561806|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
83561807|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83561808|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
83561809|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83561810|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83561811|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83561812|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83561813|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83561814|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83561815|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83561816|NCT01055756|Loratadine|loratadine|mesh-list
83561817|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
83561818|NCT01055756|Ephedrine|ephedrine|mesh-list
83019958|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83561819|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
83561820|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561821|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83561822|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83561823|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83561824|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
83561825|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
83561826|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83561827|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561828|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561829|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83561830|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
83561831|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561832|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83561833|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
83561834|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
83561835|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83561836|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83561837|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
83561838|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
83561839|NCT00652574|Dasatinib|dasatinib|mesh-list
83561840|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561841|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83561842|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561843|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561844|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
83561845|NCT01550510|Irinotecan|irinotecan|mesh-list
83561846|NCT01550510|Camptothecin|camptothecin|mesh-list
83561847|NCT01550510|Vitamins|vitamins|mesh-ancestor
83561848|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
83561849|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561850|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83561851|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83561852|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561853|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561854|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561855|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
83561856|NCT01550510|Protective Agents|protective agents|mesh-ancestor
83561857|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83561858|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
83561859|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
83561860|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83561861|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83561862|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561863|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561864|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561865|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83561866|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
83561867|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
83561868|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83561869|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83561870|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561871|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83561872|NCT00521924|Cyclosporine|cyclosporine|mesh-list
83561873|NCT00521924|Chloroquine|chloroquine|mesh-list
83561874|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
83561875|NCT00521924|Infliximab|infliximab|mesh-list
83561876|NCT00521924|Methotrexate|methotrexate|mesh-list
83561877|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
83561878|NCT00521924|Cyclosporins|cyclosporins|mesh-list
83561879|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83561880|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
83561881|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83561882|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561883|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83561884|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
83561885|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561886|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561887|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561888|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561889|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83561890|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83561891|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
83561892|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83561893|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
83561894|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561895|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83561896|NCT00521924|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83561897|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561898|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83561900|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83561901|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83561902|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
83561903|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83561904|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83561905|NCT00521924|Analgesics|analgesics|mesh-ancestor
83561906|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
83561907|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561908|NCT03927781|Pregabalin|pregabalin|mesh-list
83561909|NCT03927781|Analgesics|analgesics|mesh-ancestor
83561910|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
83561911|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561912|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561913|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
83561914|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83561915|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83561916|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561917|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83561918|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83561919|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83561920|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561921|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83561922|NCT00379964|Caspofungin|caspofungin|mesh-list
83561923|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
83561924|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561925|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561926|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561927|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83561928|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
83561929|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561930|NCT01526408|Famciclovir|famciclovir|mesh-list
83561931|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
83561932|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561933|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83561934|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561935|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561936|NCT04713644|Propofol|propofol|mesh-list
83561937|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83561938|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561939|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561940|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83561941|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
83561942|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
83561943|NCT00000734|Zidovudine|zidovudine|mesh-list
83561944|NCT00000734|Trimethoprim|trimethoprim|mesh-list
83561945|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
83561946|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83561947|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
83561948|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83561949|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83561950|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83561951|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83561952|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
83561953|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561954|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83561955|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83561956|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83561957|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
83561958|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83561959|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83561960|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83561961|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83561962|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83561963|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83561964|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83561965|NCT03663283|Bupivacaine|bupivacaine|mesh-list
83561966|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
83561967|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
83561968|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561969|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561970|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
83561971|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561972|NCT00000764|Interferons|interferons|mesh-list
83561973|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
83561974|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
83561975|NCT00000764|Isotretinoin|isotretinoin|mesh-list
83561976|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83561977|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
83561978|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83561979|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
83561980|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561981|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
83561982|NCT03909763|Danazol|danazol|mesh-list
83561983|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83561984|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
83561985|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83561986|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561987|NCT00484718|Celecoxib|celecoxib|mesh-list
83561988|NCT00484718|Oxycodone|oxycodone|mesh-list
83561989|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83561990|NCT00484718|Narcotics|narcotics|mesh-ancestor
83561991|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83561992|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83561993|NCT00484718|Analgesics|analgesics|mesh-ancestor
83561994|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
83561995|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83561996|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83561997|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83561998|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83561999|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562000|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83562001|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83562002|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562003|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562004|NCT03665155|Daratumumab|daratumumab|mesh-list
83562005|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562006|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83562007|NCT00448682|Leucovorin|leucovorin|mesh-list
83562008|NCT00448682|Docetaxel|docetaxel|mesh-list
83562009|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
83562010|NCT00448682|Floxuridine|floxuridine|mesh-list
83562011|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
83562012|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562013|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
83562014|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
83562015|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
83562016|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562017|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562018|NCT00448682|Antidotes|antidotes|mesh-ancestor
83562019|NCT00448682|Protective Agents|protective agents|mesh-ancestor
83562020|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
83562021|NCT00448682|Vitamins|vitamins|mesh-ancestor
83562022|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
83562023|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83562024|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
83562025|NCT04713488|Vaccines|vaccines|mesh-list
83562026|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
83562027|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562028|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83562029|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83562030|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562031|NCT00380120|Warfarin|warfarin|mesh-list
83562032|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
83562033|NCT00000770|Zidovudine|zidovudine|mesh-list
83562034|NCT00000770|Nevirapine|nevirapine|mesh-list
83562035|NCT00000770|Didanosine|didanosine|mesh-list
83562036|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
83562037|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562038|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562039|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562040|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562041|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
83562042|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020187|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
83562043|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562044|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562045|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562046|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562047|NCT00368654|Methotrexate|methotrexate|mesh-list
83562048|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83562049|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
83562050|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83562051|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562052|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83562053|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
83562054|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562055|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562056|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
83562057|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562058|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83562059|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83562060|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
83562061|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562062|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562063|NCT00000776|Fluconazole|fluconazole|mesh-list
83562064|NCT00000776|Amphotericin B|amphotericin b|mesh-list
83562065|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83562066|NCT00000776|Flucytosine|flucytosine|mesh-list
83562067|NCT00000776|Dexamethasone|dexamethasone|mesh-list
83562068|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83562069|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
83562070|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
83562071|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562072|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562073|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83562074|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
83562075|NCT00000776|Hormones|hormones|mesh-ancestor
83562076|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83562077|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83562078|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562079|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
83562080|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562081|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83562082|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562083|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562084|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562085|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83562086|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
83562087|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83562088|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83562089|NCT00000776|Amebicides|amebicides|mesh-ancestor
83562090|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562091|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562092|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562093|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
83562094|NCT04283773|Antibodies|antibodies|mesh-list
83562095|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
83562096|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83562097|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
83562098|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562099|NCT00329732|Lidocaine|lidocaine|mesh-list
83562100|NCT00329732|Bupivacaine|bupivacaine|mesh-list
83562101|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
83562102|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
83562103|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562104|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562105|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
83562106|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562107|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83562108|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83562109|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83562110|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83562111|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562112|NCT00000782|Vaccines|vaccines|mesh-list
83562113|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
83562114|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562115|NCT00000800|Zidovudine|zidovudine|mesh-list
83562116|NCT00000800|Methadone|methadone|mesh-list
83562117|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
83562118|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562119|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562120|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562121|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562122|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
83562124|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562125|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562126|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562127|NCT00000800|Narcotics|narcotics|mesh-ancestor
83562128|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562129|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562130|NCT00000800|Analgesics|analgesics|mesh-ancestor
83562131|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
83562132|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562133|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
83562134|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
83562135|NCT03679975|Riluzole|riluzole|mesh-list
83562136|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
83562137|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83562138|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83562139|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562140|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562141|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562142|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83562143|NCT03679975|Protective Agents|protective agents|mesh-ancestor
83562144|NCT03887299|Disinfectants|disinfectants|mesh-list
83562145|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562146|NCT03684265|Meloxicam|meloxicam|mesh-list
83562147|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83562148|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562149|NCT03684265|Analgesics|analgesics|mesh-ancestor
83562150|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
83562151|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562152|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562153|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83562154|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562155|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83562156|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83562157|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562158|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562159|NCT00218036|Dexetimide|dexetimide|mesh-list
83562160|NCT00218036|Modafinil|modafinil|mesh-list
83562161|NCT00218036|Citalopram|citalopram|mesh-list
83562162|NCT00218036|Escitalopram|escitalopram|mesh-list
83562163|NCT00218036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83562164|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83562165|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83562166|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562167|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562168|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
83562169|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562170|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83562171|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
83562172|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83562173|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83562174|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83562175|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
83562176|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
83562177|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562178|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83562179|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83562180|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
83562181|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83562182|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83562183|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562184|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562185|NCT00233090|Modafinil|modafinil|mesh-list
83562186|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83562187|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562188|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83562189|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562190|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562191|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562192|NCT02921906|Acetaminophen|acetaminophen|mesh-list
83562193|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562194|NCT02921906|Analgesics|analgesics|mesh-ancestor
83562195|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
83562196|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562197|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562198|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
83562199|NCT00000812|Thalidomide|thalidomide|mesh-list
83562200|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83562201|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
83562202|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562203|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
83562204|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562205|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562206|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83562207|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83562208|NCT00000812|Growth Substances|growth substances|mesh-ancestor
83562209|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
83562210|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562211|NCT00000818|Zidovudine|zidovudine|mesh-list
83562212|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
83562213|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562214|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562215|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562216|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562217|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
83562218|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562219|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562220|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562221|NCT00177866|Celecoxib|celecoxib|mesh-list
83562222|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83562223|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562224|NCT00177866|Analgesics|analgesics|mesh-ancestor
83562225|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
83562226|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562227|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562228|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83562229|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562230|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83562231|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83562232|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562233|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562234|NCT00089414|Drospirenone|drospirenone|mesh-list
83562235|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83562236|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83562237|NCT00089414|Estradiol|estradiol|mesh-list
83562238|NCT00089414|Progesterone|progesterone|mesh-list
83562239|NCT00089414|Estrogens|estrogens|mesh-ancestor
83562240|NCT00089414|Hormones|hormones|mesh-ancestor
83562241|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83562242|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562243|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83562244|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
83562245|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83562246|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83562247|NCT00089414|Progestins|progestins|mesh-ancestor
83562248|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83562249|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83562250|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83562251|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
83562252|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83562253|NCT00089414|Diuretics|diuretics|mesh-ancestor
83562254|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
83562255|NCT00075608|Melphalan|melphalan|mesh-list
83562256|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
83562257|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562258|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83562259|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
83562260|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562261|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562262|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83562263|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83562264|NCT03704467|Carboplatin|carboplatin|mesh-list
83562265|NCT03704467|Avelumab|avelumab|mesh-list
83562266|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562267|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83562268|NCT00000842|Mitogens|mitogens|mesh-list
83562269|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
83562270|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562272|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83562273|NCT00000848|Indinavir|indinavir|mesh-list
83562274|NCT00000848|Saquinavir|saquinavir|mesh-list
83562275|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562276|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562277|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562278|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451196|NCT03834233|Nivolumab|nivolumab|mesh-list
83562279|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562280|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562281|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562282|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
83562283|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562284|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83562285|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562286|NCT01795586|Carboplatin|carboplatin|mesh-list
83562287|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562288|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
83562289|NCT02212574|Lomustine|lomustine|mesh-list
83562290|NCT02212574|Vincristine|vincristine|mesh-list
83562291|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83562292|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
83562293|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562294|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562295|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83562296|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
83562297|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562298|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562299|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83562300|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83562301|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
83562302|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
83562303|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
83562304|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83562305|NCT00000854|Nandrolone|nandrolone|mesh-list
83562306|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83562307|NCT00000854|Androgens|androgens|mesh-ancestor
83562308|NCT00000854|Hormones|hormones|mesh-ancestor
83562309|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83562310|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562311|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
83562312|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83562313|NCT04298918|Trastuzumab|trastuzumab|mesh-list
83562314|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83562315|NCT04298918|Venetoclax|venetoclax|mesh-list
83562316|NCT04298918|Maytansine|maytansine|mesh-list
83562317|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83562318|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562319|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83562320|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83562321|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83562322|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83562323|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562324|NCT04298918|Immunotoxins|immunotoxins|mesh-ancestor
83562325|NCT04298918|Immunoconjugates|immunoconjugates|mesh-ancestor
83562326|NCT04298918|Immunologic Factors|immunologic factors|mesh-ancestor
83562327|NCT04298918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562328|NCT00001676|Fludarabine|fludarabine|mesh-list
83562329|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562330|NCT03714919|Acetaminophen|acetaminophen|mesh-list
83562331|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
83562332|NCT03714919|Ketamine|ketamine|mesh-list
83562333|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
83562334|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83562335|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562336|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562337|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562338|NCT03714919|Analgesics|analgesics|mesh-ancestor
83562339|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
83562340|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562341|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83562342|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83562343|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83562344|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83562345|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562346|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361619|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83562347|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83562348|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83562349|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
83562350|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
83562351|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83451276|NCT01721915|Vitamin D|vitamin d|mesh-list
83562352|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83562353|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
83562354|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
83562355|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
83562356|NCT00000872|Lamivudine|lamivudine|mesh-list
83562357|NCT00000872|Zidovudine|zidovudine|mesh-list
83562358|NCT00000872|Nevirapine|nevirapine|mesh-list
83562359|NCT00000872|Abacavir|abacavir|mesh-list
83562360|NCT00000872|Stavudine|stavudine|mesh-list
83562361|NCT00000872|Nelfinavir|nelfinavir|mesh-list
83562362|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562363|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562364|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562365|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562366|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
83562367|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562368|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562369|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562370|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
83562371|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562372|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562373|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562374|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562375|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562376|NCT00000878|Lamivudine|lamivudine|mesh-list
83562377|NCT00000878|Zidovudine|zidovudine|mesh-list
83562378|NCT00000878|Stavudine|stavudine|mesh-list
83562379|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562380|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562381|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562382|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562383|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
83562384|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562385|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562386|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562387|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
83562388|NCT04204057|Tenalisib|tenalisib|mesh-list
83562389|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83562390|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562391|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562392|NCT00001736|Cysteamine|cysteamine|mesh-list
83562393|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83562394|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562395|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
83562396|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83562397|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
83562398|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562399|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83562400|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562401|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
83562402|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562403|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
83562404|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83562405|NCT00000884|Protective Agents|protective agents|mesh-ancestor
83562406|NCT00000896|Lamivudine|lamivudine|mesh-list
83562407|NCT00000896|Zidovudine|zidovudine|mesh-list
83562408|NCT00000896|Nevirapine|nevirapine|mesh-list
83562409|NCT00000896|Stavudine|stavudine|mesh-list
83020560|NCT03436433|Levetiracetam|levetiracetam|mesh-list
83020561|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
83020562|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
83020563|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83020564|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83020565|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83020566|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020567|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
83020568|NCT04227275|Fludarabine|fludarabine|mesh-list
83020569|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83020570|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020571|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
83562410|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83562412|NCT00000896|Interleukin-12|interleukin-12|mesh-list
83562413|NCT00000896|Sargramostim|sargramostim|mesh-list
83562414|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562415|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562416|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83451347|NCT04357093|Listerine|listerine|mesh-list
83562417|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562418|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
83562419|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562420|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562421|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562422|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
83562423|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
83562424|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562425|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562426|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562427|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562428|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562429|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562430|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562431|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83562432|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83562433|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83562434|NCT00000896|Growth Substances|growth substances|mesh-ancestor
83562435|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
83562436|NCT00001790|Micafungin|micafungin|mesh-list
83562437|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
83562438|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562439|NCT00000902|Ritonavir|ritonavir|mesh-list
83562440|NCT00000902|Nelfinavir|nelfinavir|mesh-list
83562441|NCT00000902|Lamivudine|lamivudine|mesh-list
83562442|NCT00000902|Zidovudine|zidovudine|mesh-list
83562443|NCT00000902|Nevirapine|nevirapine|mesh-list
83562444|NCT00000902|Stavudine|stavudine|mesh-list
83562445|NCT00000902|Didanosine|didanosine|mesh-list
83562446|NCT00000902|Zalcitabine|zalcitabine|mesh-list
83562447|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562448|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562449|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562450|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562451|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562452|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562453|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562454|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
83562455|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562456|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83562457|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562458|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562459|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562460|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
83562461|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562462|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562463|NCT04331600|Chloroquine|chloroquine|mesh-list
83562464|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83562465|NCT04331600|Amebicides|amebicides|mesh-ancestor
83562466|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562467|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562468|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562469|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
83562470|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562471|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83562472|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562473|NCT04331600|Analgesics|analgesics|mesh-ancestor
83562474|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
83562475|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562476|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562477|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83562478|NCT04331600|Filaricides|filaricides|mesh-ancestor
83562479|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
83562480|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
83562481|NCT00000188|Selegiline|selegiline|mesh-list
83562482|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
83562483|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83562484|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83562485|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83562486|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83020650|NCT03279289|Leucovorin|leucovorin|mesh-list
83562487|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562488|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562489|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83562490|NCT00000188|Protective Agents|protective agents|mesh-ancestor
83562491|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562493|NCT00000914|Nelfinavir|nelfinavir|mesh-list
83562494|NCT00000914|Indinavir|indinavir|mesh-list
83562495|NCT00000914|Efavirenz|efavirenz|mesh-list
83562496|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562497|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562498|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562499|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562500|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562501|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562502|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562503|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
83562504|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562505|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83562506|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562507|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562508|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562509|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83562510|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83562511|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83562512|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562513|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562514|NCT00000920|Ritonavir|ritonavir|mesh-list
83562515|NCT00000920|Saquinavir|saquinavir|mesh-list
83562516|NCT00000920|Lamivudine|lamivudine|mesh-list
83562517|NCT00000920|Zidovudine|zidovudine|mesh-list
83562518|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562519|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562520|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562521|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562522|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562523|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562524|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562525|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
83562526|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562527|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83562528|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562529|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562530|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562531|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
83562532|NCT00000938|Doxycycline|doxycycline|mesh-list
83562533|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
83562534|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562535|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562536|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
83562537|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562538|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562539|NCT00001862|Etanercept|etanercept|mesh-list
83562540|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83562541|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562542|NCT00001862|Analgesics|analgesics|mesh-ancestor
83562543|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
83562544|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562545|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562546|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83562547|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562548|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83562549|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83562550|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
83562551|NCT00000194|Cycloserine|cycloserine|mesh-list
83562552|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83562553|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562554|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83562555|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
83562556|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562557|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
83562558|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562559|NCT00000200|Methadone|methadone|mesh-list
83562560|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562561|NCT00000200|Narcotics|narcotics|mesh-ancestor
83562562|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562563|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562564|NCT00000200|Analgesics|analgesics|mesh-ancestor
83562565|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
83562566|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562567|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
83562568|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
83562569|NCT00000206|Buprenorphine|buprenorphine|mesh-list
83562570|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562571|NCT00000206|Narcotics|narcotics|mesh-ancestor
83562572|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562573|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562574|NCT00000206|Analgesics|analgesics|mesh-ancestor
83562575|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
83562576|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562577|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83562578|NCT00000944|Lamivudine|lamivudine|mesh-list
83562579|NCT00000944|Zidovudine|zidovudine|mesh-list
83562580|NCT00000944|Indinavir|indinavir|mesh-list
83562581|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562582|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562583|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562584|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562585|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
83562586|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562587|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562588|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562589|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
83562590|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562591|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562592|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562593|NCT00000950|Pyridoxine|pyridoxine|mesh-list
83562594|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
83562595|NCT00000950|Rifampin|rifampin|mesh-list
83562596|NCT00000950|Isoniazid|isoniazid|mesh-list
83562597|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
83562598|NCT00000950|Ethambutol|ethambutol|mesh-list
83562599|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83562600|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
83562601|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562602|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562603|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
83562604|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562605|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562606|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562607|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83562608|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562609|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83562610|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83562611|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83562612|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562613|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83562614|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83562615|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
83562616|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83562617|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
83562618|NCT00000950|Vitamins|vitamins|mesh-ancestor
83562619|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
83562620|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562621|NCT00000218|Carbamazepine|carbamazepine|mesh-list
83562622|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
83562623|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
83562624|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83562625|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562626|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562627|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83562628|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562629|NCT00000218|Analgesics|analgesics|mesh-ancestor
83562630|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
83562631|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562632|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83562633|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83562634|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562635|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562636|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83020785|NCT02949284|Prednisone|prednisone|mesh-list
83562637|NCT00000224|Buprenorphine|buprenorphine|mesh-list
83562638|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562639|NCT00000224|Narcotics|narcotics|mesh-ancestor
83562640|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562641|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562642|NCT00000224|Analgesics|analgesics|mesh-ancestor
83562643|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
83562644|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562645|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83562646|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
83562647|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
83562648|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562649|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562650|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562651|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562652|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562653|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83562654|NCT00000230|Buprenorphine|buprenorphine|mesh-list
83562655|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562656|NCT00000230|Narcotics|narcotics|mesh-ancestor
83562657|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562658|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562659|NCT00000230|Analgesics|analgesics|mesh-ancestor
83562660|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
83562661|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562662|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83562663|NCT00000236|Buprenorphine|buprenorphine|mesh-list
83562664|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83562665|NCT00000236|Naloxone|naloxone|mesh-list
83562666|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562667|NCT00000236|Narcotics|narcotics|mesh-ancestor
83562668|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562669|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562670|NCT00000236|Analgesics|analgesics|mesh-ancestor
83562671|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
83562672|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562673|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83562674|NCT00000974|Pentamidine|pentamidine|mesh-list
83562675|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
83562676|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562677|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562678|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562679|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83562680|NCT00000242|Carbamazepine|carbamazepine|mesh-list
83562681|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
83562682|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
83562683|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83562684|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562685|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562686|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83562687|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562688|NCT00000242|Analgesics|analgesics|mesh-ancestor
83562689|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
83562690|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562691|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83562692|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83562693|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562694|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83562695|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83562696|NCT00000980|Spiramycin|spiramycin|mesh-list
83562697|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562698|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562699|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
83562700|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562701|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562702|NCT00000992|Itraconazole|itraconazole|mesh-list
83562703|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
83562704|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562705|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83562706|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562707|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562708|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562709|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83562710|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
83562711|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83562712|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562713|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83562714|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
83562716|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83562717|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
83562718|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
83562719|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562720|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562721|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562722|NCT00000254|Analgesics|analgesics|mesh-ancestor
83562723|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
83562724|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562725|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
83562726|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83562727|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
83562728|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
83562729|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562730|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562731|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83562732|NCT00000260|Analgesics|analgesics|mesh-ancestor
83562733|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
83562734|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562735|NCT00000266|Flupenthixol|flupenthixol|mesh-list
83562736|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83562737|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83562738|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83562739|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562740|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562741|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83562742|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83562743|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
83562744|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562745|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562746|NCT00001016|Leucovorin|leucovorin|mesh-list
83562747|NCT00001016|Trimetrexate|trimetrexate|mesh-list
83562748|NCT00001016|Calcium|calcium|mesh-list
83562749|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
83562750|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83562751|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562752|NCT00001016|Antidotes|antidotes|mesh-ancestor
83562753|NCT00001016|Protective Agents|protective agents|mesh-ancestor
83562754|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
83562755|NCT00001016|Vitamins|vitamins|mesh-ancestor
83562756|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
83562757|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
83562758|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562759|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83562760|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
83562761|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562762|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562763|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83562764|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562765|NCT03811951|Insulin|insulin|mesh-list
83562766|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83562767|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562768|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
83562769|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562770|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83562771|NCT04332289|Protective Agents|protective agents|mesh-ancestor
83562772|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562773|NCT00001022|Zidovudine|zidovudine|mesh-list
83562774|NCT00001022|Didanosine|didanosine|mesh-list
83562775|NCT00001022|Zalcitabine|zalcitabine|mesh-list
83562776|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
83562777|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562778|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83562779|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562780|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562781|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
83562782|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562783|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562784|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562785|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
83562786|NCT05218148|Trastuzumab|trastuzumab|mesh-list
83562787|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562788|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020933|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
83562789|NCT00001934|Daclizumab|daclizumab|mesh-list
83562790|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83562792|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562793|NCT00000278|Disulfiram|disulfiram|mesh-list
83562794|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83562795|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83562796|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562797|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562798|NCT00001028|Dapsone|dapsone|mesh-list
83562799|NCT00001028|Pentamidine|pentamidine|mesh-list
83562800|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562801|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
83562802|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562803|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562804|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83562805|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562806|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562807|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
83562808|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562809|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
83562810|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83562811|NCT00001940|Voriconazole|voriconazole|mesh-list
83562812|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
83562813|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562814|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83562815|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562816|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562817|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562818|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83562819|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
83562820|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83562821|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562822|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83562823|NCT03907033|Bupivacaine|bupivacaine|mesh-list
83562824|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
83562825|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
83562826|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562827|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562828|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
83562829|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562830|NCT00001034|Ganciclovir|ganciclovir|mesh-list
83562831|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83562832|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
83562833|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562834|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562835|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562836|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562837|NCT03818815|Amoxicillin|amoxicillin|mesh-list
83562838|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
83562839|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
83562840|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83562841|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562842|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562843|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83562844|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562845|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562846|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
83562847|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83562848|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
83562849|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562850|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562851|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83562852|NCT00001964|Cyclosporine|cyclosporine|mesh-list
83562853|NCT00001964|Cyclosporins|cyclosporins|mesh-list
83562854|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562855|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562856|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83562857|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
83562858|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562859|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
83562860|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562861|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
83562862|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021011|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
83562863|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83562864|NCT03801265|Ropivacaine|ropivacaine|mesh-list
83562865|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
83562866|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
83562867|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562868|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562869|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
83562870|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562871|NCT00000290|Cocaine|cocaine|mesh-list
83562872|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83562873|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
83562874|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562875|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562876|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
83562877|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562878|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83562879|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83562880|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83562881|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83562882|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562883|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
83562884|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562885|NCT00000212|Desipramine|desipramine|mesh-list
83562886|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83562887|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
83562888|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83562889|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562890|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562891|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83562892|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83562893|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83562894|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
83562895|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562896|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562897|NCT00000302|Buprenorphine|buprenorphine|mesh-list
83562898|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562899|NCT00000302|Narcotics|narcotics|mesh-ancestor
83562900|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562901|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562902|NCT00000302|Analgesics|analgesics|mesh-ancestor
83562903|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
83562904|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562905|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83562906|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83562907|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83562908|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
83562909|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562910|NCT00001052|Antacids|antacids|mesh-ancestor
83562911|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562912|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83562913|NCT00001058|Ritonavir|ritonavir|mesh-list
83562914|NCT00001058|Indinavir|indinavir|mesh-list
83562915|NCT00001058|Clarithromycin|clarithromycin|mesh-list
83562916|NCT00001058|Ethambutol|ethambutol|mesh-list
83562917|NCT00001058|Rifabutin|rifabutin|mesh-list
83562918|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83562919|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83562920|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
83562921|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562922|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562923|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83562924|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83562925|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
83562926|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562927|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83562928|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83562929|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83562930|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83562931|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
83562932|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83562933|NCT00000308|Amphetamine|amphetamine|mesh-list
83562934|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
83562935|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83562936|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562937|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
83562938|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
83562939|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562940|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
83562941|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562942|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562943|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
83562944|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83562945|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83562946|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83562947|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83562948|NCT00001994|Atovaquone|atovaquone|mesh-list
83562949|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562950|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
83562951|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83562952|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83562953|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83562954|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562955|NCT00000320|Buprenorphine|buprenorphine|mesh-list
83562956|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562957|NCT00000320|Narcotics|narcotics|mesh-ancestor
83562958|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562959|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562960|NCT00000320|Analgesics|analgesics|mesh-ancestor
83562961|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
83562962|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562963|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83562964|NCT00000326|Heroin|heroin|mesh-list
83562965|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83562966|NCT00000326|Narcotics|narcotics|mesh-ancestor
83562967|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83562968|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562969|NCT00000326|Analgesics|analgesics|mesh-ancestor
83562970|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
83562971|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562972|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
83562973|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83562974|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83562975|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
83562976|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562977|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562978|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562979|NCT00002000|Valacyclovir|valacyclovir|mesh-list
83562980|NCT00002000|Acyclovir|acyclovir|mesh-list
83562981|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
83562982|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83562983|NCT03979807|Bromides|bromides|mesh-list
83562984|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
83562985|NCT03979807|Olodaterol|olodaterol|mesh-list
83562986|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83562987|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
83562988|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83562989|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83562990|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83562991|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
83562992|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
83562993|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83562994|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
83562995|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83562996|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83562997|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
83562998|NCT00001082|Adefovir|adefovir|mesh-list
83562999|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83563000|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
83563001|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563002|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563003|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563004|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563005|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563006|NCT00002006|Zidovudine|zidovudine|mesh-list
83563007|NCT00002006|Sargramostim|sargramostim|mesh-list
83563008|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
83563009|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563010|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563011|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563012|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563013|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
83563014|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563015|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563016|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563017|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
83563018|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563019|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
83563020|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83563021|NCT04169113|Narcotics|narcotics|mesh-ancestor
83563022|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83563023|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563024|NCT04169113|Analgesics|analgesics|mesh-ancestor
83563025|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
83563026|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563027|NCT00002012|Interferons|interferons|mesh-list
83563028|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
83563029|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563030|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
83563031|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563032|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
83563033|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563034|NCT00380276|Tarenflurbil|tarenflurbil|mesh-list
83563035|NCT00380276|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83563036|NCT00380276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563037|NCT00380276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563038|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
83563039|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83563040|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83563041|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563042|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563043|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
83563044|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83563045|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83563046|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563047|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83563048|NCT03799783|Analgesics|analgesics|mesh-ancestor
83563049|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
83563050|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563051|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83563052|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83563053|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83563054|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
83563055|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563056|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563057|NCT00001088|Bupivacaine|bupivacaine|mesh-list
83563058|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
83563059|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
83563060|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83563061|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563062|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
83563063|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563064|NCT00001094|Lamivudine|lamivudine|mesh-list
83563065|NCT00001094|Zidovudine|zidovudine|mesh-list
83563066|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83563067|NCT00001094|Delavirdine|delavirdine|mesh-list
83563068|NCT00001094|Nelfinavir|nelfinavir|mesh-list
83563069|NCT00001094|Saquinavir|saquinavir|mesh-list
83563070|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563071|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563072|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563073|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563074|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
83563075|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563076|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563077|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563078|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
83563079|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83563080|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83563081|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83563082|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83563083|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563084|NCT00001100|Ganciclovir|ganciclovir|mesh-list
83563085|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83563086|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
83563088|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563089|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563090|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563091|NCT00000332|Nimodipine|nimodipine|mesh-list
83563092|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83563093|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83563094|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83563095|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563096|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83563097|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563098|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
83563099|NCT00000338|Lisuride|lisuride|mesh-list
83563100|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83563101|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83563102|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83563103|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
83563104|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563105|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563106|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563107|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
83563108|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
83563109|NCT04085341|Sunitinib|sunitinib|mesh-list
83563110|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563111|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83563112|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83563113|NCT04085341|Growth Substances|growth substances|mesh-ancestor
83563114|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563115|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
83563116|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83563117|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563118|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563119|NCT00002018|Interferons|interferons|mesh-list
83563120|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
83563121|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563122|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
83563123|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563124|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
83563125|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563126|NCT00002024|Ganciclovir|ganciclovir|mesh-list
83563127|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83563128|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
83563129|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563130|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563131|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563132|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563133|NCT00001106|Zidovudine|zidovudine|mesh-list
83563134|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
83563135|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563136|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563137|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563138|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563139|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
83563140|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563141|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563142|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563143|NCT00000344|Buprenorphine|buprenorphine|mesh-list
83563144|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83563145|NCT00000344|Naloxone|naloxone|mesh-list
83563146|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83563147|NCT00000344|Narcotics|narcotics|mesh-ancestor
83563148|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83563149|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563150|NCT00000344|Analgesics|analgesics|mesh-ancestor
83563151|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
83563152|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563153|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83563154|NCT04103515|Cimetidine|cimetidine|mesh-list
83563155|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83563156|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83563157|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83563158|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
83563159|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
83563160|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563161|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563162|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563163|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83563164|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563165|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563166|NCT00002030|Pentamidine|pentamidine|mesh-list
83563167|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
83563168|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563169|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83452104|NCT03490825|Melatonin|melatonin|mesh-list
83563170|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83563171|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83563172|NCT00001112|Interferons|interferons|mesh-list
83563173|NCT00001112|Zidovudine|zidovudine|mesh-list
83563174|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
83563175|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563176|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
83563177|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563178|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
83563179|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563180|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563181|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563182|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563183|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563184|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563185|NCT00002036|Immune Sera|immune sera|mesh-list
83563186|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
83563187|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563188|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83563189|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83563190|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83563191|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83563192|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83563193|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83563194|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83563195|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
83563196|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563197|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563198|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563199|NCT00000374|Olanzapine|olanzapine|mesh-list
83563200|NCT00000374|Risperidone|risperidone|mesh-list
83563201|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83563202|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
83563203|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563204|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563205|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563206|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83563207|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83563208|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83563209|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83563210|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83563211|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
83563212|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
83563213|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
83563214|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563215|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83563216|NCT00000374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83563217|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83563218|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83563219|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
83563220|NCT00002042|Hematinics|hematinics|mesh-ancestor
83563221|NCT03789175|Niacinamide|niacinamide|mesh-list
83563222|NCT03789175|Niacin|niacin|mesh-list
83563223|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
83563224|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
83563225|NCT03789175|Vitamins|vitamins|mesh-ancestor
83563226|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
83563227|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563228|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83563229|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
83563230|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563231|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83563232|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
83563233|NCT00002048|Zidovudine|zidovudine|mesh-list
83563234|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
83563235|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563236|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563237|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563238|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563239|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
83563240|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563241|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563242|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563243|NCT00002054|Pentamidine|pentamidine|mesh-list
83563244|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
83563245|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563246|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83563247|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83563248|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83563249|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
83563250|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83563251|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
83563252|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563253|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
83563254|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563255|NCT00002066|Thymopentin|thymopentin|mesh-list
83563256|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83563257|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
83563258|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563259|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
83563260|NCT00002072|Hematinics|hematinics|mesh-ancestor
83563261|NCT00002078|Interferons|interferons|mesh-list
83563262|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
83563263|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563264|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
83563265|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563266|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
83563267|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563268|NCT00000440|Naltrexone|naltrexone|mesh-list
83563269|NCT00000440|Sertraline|sertraline|mesh-list
83563270|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83563271|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83563272|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563273|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
83563274|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563275|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
83563276|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83563277|NCT00000440|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83563278|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83563279|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83563280|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563281|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563282|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
83563283|NCT00002084|Valacyclovir|valacyclovir|mesh-list
83563284|NCT00002084|Acyclovir|acyclovir|mesh-list
83563285|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
83563286|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563287|NCT00000446|Sertraline|sertraline|mesh-list
83563288|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
83563289|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83563290|NCT00000446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83563291|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83563292|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83563293|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563294|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563295|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
83563296|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563297|NCT04131517|Padsevonil|padsevonil|mesh-list
83563298|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83563299|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83563300|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83563301|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
83563302|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83563303|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563304|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83563305|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83563306|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83563307|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83563308|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83563309|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83563310|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83563311|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83563312|NCT04131517|Anticonvulsants|anticonvulsants|mesh-ancestor
83563313|NCT00001256|Prednisone|prednisone|mesh-list
83563314|NCT00001256|Methotrexate|methotrexate|mesh-list
83563315|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83563316|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
83563317|NCT00001256|Hormones|hormones|mesh-ancestor
83563318|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563319|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563320|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83563321|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563322|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83563323|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
83563324|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83563325|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83563326|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
83563327|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563328|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
83563329|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563330|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83563331|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83563332|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
83563333|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83563334|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563335|NCT00000452|Naltrexone|naltrexone|mesh-list
83563336|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83563337|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83563338|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563339|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
83563340|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563341|NCT00000458|Sertraline|sertraline|mesh-list
83563342|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
83563343|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83563344|NCT00000458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83563345|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83563346|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83563347|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563348|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563349|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
83563350|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563351|NCT03782233|Bromides|bromides|mesh-list
83563352|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83563353|NCT03782233|Rocuronium|rocuronium|mesh-list
83563354|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
83563355|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83563356|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83563357|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83563358|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563359|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563360|NCT00002090|Azithromycin|azithromycin|mesh-list
83563361|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83563362|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563363|NCT00002096|Zidovudine|zidovudine|mesh-list
83563364|NCT00002096|Didanosine|didanosine|mesh-list
83563365|NCT00002096|Ganciclovir|ganciclovir|mesh-list
83563366|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83563367|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
83563368|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563369|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563370|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563371|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563372|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
83563373|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563374|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563375|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563376|NCT00002102|Leucovorin|leucovorin|mesh-list
83563377|NCT00002102|Trimetrexate|trimetrexate|mesh-list
83563378|NCT00002102|Calcium|calcium|mesh-list
83563379|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
83563380|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83563381|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563382|NCT00002102|Antidotes|antidotes|mesh-ancestor
83563383|NCT00002102|Protective Agents|protective agents|mesh-ancestor
83563384|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
83563385|NCT00002102|Vitamins|vitamins|mesh-ancestor
83563386|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
83563387|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
83563388|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563389|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83563390|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
83563391|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563392|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563393|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83563394|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563395|NCT00002108|Lamivudine|lamivudine|mesh-list
83563396|NCT00002108|Zidovudine|zidovudine|mesh-list
83563397|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563398|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563399|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563400|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563401|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
83563402|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563403|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563404|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563405|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
83563406|NCT00381134|Losartan|losartan|mesh-list
83563407|NCT00381134|Spironolactone|spironolactone|mesh-list
83563408|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83563409|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83563410|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83563411|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83563412|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563413|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83563414|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
83563415|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563416|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563417|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83563418|NCT00381134|Diuretics|diuretics|mesh-ancestor
83563419|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
83563420|NCT00000506|Phentermine|phentermine|mesh-list
83563421|NCT00000506|Fenfluramine|fenfluramine|mesh-list
83563422|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83563423|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563424|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
83563425|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83563426|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
83563427|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
83563428|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563429|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
83563430|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563431|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563432|NCT00000506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83563433|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83563434|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83563435|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
83563436|NCT00000512|Niacin|niacin|mesh-list
83563437|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
83563438|NCT00000512|Lovastatin|lovastatin|mesh-list
83563439|NCT00000512|L 647318|l 647318|mesh-list
83563440|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
83563441|NCT00000512|Colestipol|colestipol|mesh-list
83563442|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83563443|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
83563444|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563445|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83563446|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
83563447|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
83563448|NCT00000512|Vitamins|vitamins|mesh-ancestor
83563449|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
83563450|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563451|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83563452|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83563453|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563454|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
83563455|NCT00380822|Miglitol|miglitol|mesh-list
83563456|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563457|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563458|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83563459|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563460|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83563461|NCT00000542|Amlodipine|amlodipine|mesh-list
83563462|NCT00000542|Lisinopril|lisinopril|mesh-list
83563463|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
83563464|NCT00000542|Doxazosin|doxazosin|mesh-list
83563465|NCT00000542|Pravastatin|pravastatin|mesh-list
83563466|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83563467|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83563468|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83563469|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83452406|NCT03002974|Hormones|hormones|mesh-ancestor
83563470|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563471|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83563472|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563473|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
83563474|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83563475|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83563476|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
83563477|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83563478|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83563479|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563480|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
83563481|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83563482|NCT00000542|Protective Agents|protective agents|mesh-ancestor
83563483|NCT00000542|Diuretics|diuretics|mesh-ancestor
83563484|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
83563485|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83563486|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83563487|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83563488|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83563489|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83563490|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563491|NCT00002120|Leucovorin|leucovorin|mesh-list
83563492|NCT00002120|Trimethoprim|trimethoprim|mesh-list
83563493|NCT00002120|Dapsone|dapsone|mesh-list
83563494|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
83563495|NCT00002120|Trimetrexate|trimetrexate|mesh-list
83563496|NCT00002120|Calcium|calcium|mesh-list
83563497|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
83563498|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83563499|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563500|NCT00002120|Antidotes|antidotes|mesh-ancestor
83563501|NCT00002120|Protective Agents|protective agents|mesh-ancestor
83563502|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
83563503|NCT00002120|Vitamins|vitamins|mesh-ancestor
83563504|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
83563505|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83563506|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563507|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
83563508|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83563509|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83563510|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83563511|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563512|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563513|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83563514|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83563515|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563516|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
83563517|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83563518|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
83563519|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83563520|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
83563521|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563522|NCT00002126|Lenograstim|lenograstim|mesh-list
83563523|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83563524|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
83563525|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563526|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83563527|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83563528|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563529|NCT03189433|Dantrolene|dantrolene|mesh-list
83563530|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83563531|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563532|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83563533|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563534|NCT00002132|Itraconazole|itraconazole|mesh-list
83563535|NCT00002132|Fluconazole|fluconazole|mesh-list
83563536|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
83021695|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
83563537|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563538|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83563539|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563540|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563541|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563542|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83563543|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
83563544|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563545|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563546|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83563547|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83563548|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83563549|NCT00002144|Foscarnet|foscarnet|mesh-list
83563550|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83563551|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
83563552|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563553|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563554|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563555|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563556|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563557|NCT00000578|Beclomethasone|beclomethasone|mesh-list
83563558|NCT00000578|Theophylline|theophylline|mesh-list
83563559|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83563560|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
83563561|NCT00000578|Hormones|hormones|mesh-ancestor
83563562|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563563|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563564|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83563565|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
83563566|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83563567|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
83563568|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563569|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83563570|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563571|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563572|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
83563573|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83563574|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83563575|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
83563576|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563577|NCT03774745|Mifepristone|mifepristone|mesh-list
83563578|NCT03774745|Progesterone|progesterone|mesh-list
83563579|NCT03774745|Progestins|progestins|mesh-ancestor
83563580|NCT03774745|Hormones|hormones|mesh-ancestor
83563581|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563582|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563583|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83563584|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
83563585|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83563586|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83563587|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83563588|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83563589|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
83563590|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83563591|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83563592|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
83563593|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
83563594|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83563595|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83563596|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
83563597|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83563598|NCT00000584|Antibodies|antibodies|mesh-list
83563599|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
83563600|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563601|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
83563602|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83563603|NCT00000590|Antibodies|antibodies|mesh-list
83563604|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
83563605|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563606|NCT00000614|Warfarin|warfarin|mesh-list
83563607|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
83563608|NCT02973464|Valganciclovir|valganciclovir|mesh-list
83563609|NCT02973464|Ganciclovir|ganciclovir|mesh-list
83563610|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83563611|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
83563612|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021782|NCT02130830|Lidocaine|lidocaine|mesh-list
83563613|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563614|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563615|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563616|NCT00000626|Doxorubicin|doxorubicin|mesh-list
83563617|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83563618|NCT00000626|Bleomycin|bleomycin|mesh-list
83563619|NCT00000626|Dacarbazine|dacarbazine|mesh-list
83563620|NCT00000626|Vinblastine|vinblastine|mesh-list
83563621|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83563622|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563623|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83563624|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83563625|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563626|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563627|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83563628|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
83563629|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83563630|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
83563631|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
83563632|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
83563633|NCT03109873|Metformin|metformin|mesh-list
83563634|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83563635|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563636|NCT04713254|Metoprolol|metoprolol|mesh-list
83563637|NCT04713254|Midazolam|midazolam|mesh-list
83563638|NCT04713254|Bupropion|bupropion|mesh-list
83563639|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83563640|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83563641|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83563642|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563643|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83563644|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83563645|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83563646|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83563647|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
83563648|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
83563649|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
83563650|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
83563651|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563652|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563653|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83563654|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
83563655|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83563656|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83563657|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83563658|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
83563659|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83563660|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563661|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563662|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83563663|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83563664|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
83563665|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
83563666|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563667|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83563668|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83563669|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83563670|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
83563671|NCT00002156|Ganciclovir|ganciclovir|mesh-list
83563672|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83563673|NCT00002156|Fomivirsen|fomivirsen|mesh-list
83563674|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
83563675|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563676|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563677|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563678|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563679|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83563680|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83563681|NCT00002162|Lamivudine|lamivudine|mesh-list
83563682|NCT00002162|Zidovudine|zidovudine|mesh-list
83563683|NCT00002162|Stavudine|stavudine|mesh-list
83563684|NCT00002162|Didanosine|didanosine|mesh-list
83563685|NCT00002162|Zalcitabine|zalcitabine|mesh-list
83563686|NCT00002162|Saquinavir|saquinavir|mesh-list
83563687|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563688|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83021846|NCT01319279|Hydrocodone|hydrocodone|mesh-list
83563690|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563691|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
83563692|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563693|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563694|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563695|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
83563696|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83563697|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83563698|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
83563699|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83563700|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563701|NCT00000638|Pyridoxine|pyridoxine|mesh-list
83563702|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
83563703|NCT00000638|Rifampin|rifampin|mesh-list
83563704|NCT00000638|Isoniazid|isoniazid|mesh-list
83563705|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
83563706|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83563707|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
83563708|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83563709|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563710|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
83563711|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563712|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563713|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563714|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83563715|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83563716|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83563717|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83563718|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83563719|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83563720|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83563721|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83563722|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
83563723|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83563724|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
83563725|NCT00000638|Vitamins|vitamins|mesh-ancestor
83563726|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
83563727|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563728|NCT00000650|Ditiocarb|ditiocarb|mesh-list
83563729|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83563730|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
83563731|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563732|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
83563733|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563734|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
83563735|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
83563736|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563737|NCT00000656|Zidovudine|zidovudine|mesh-list
83563738|NCT00000656|Didanosine|didanosine|mesh-list
83563739|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
83563740|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563741|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563742|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563743|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563744|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
83563745|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563746|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563747|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563748|NCT00000662|Zidovudine|zidovudine|mesh-list
83563749|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
83563750|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563751|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563752|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563753|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563754|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
83563755|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563756|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563757|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563758|NCT00002168|Lamivudine|lamivudine|mesh-list
83563759|NCT00002168|Zidovudine|zidovudine|mesh-list
83563760|NCT00002168|Stavudine|stavudine|mesh-list
83563761|NCT00002168|Didanosine|didanosine|mesh-list
83563762|NCT00002168|Indinavir|indinavir|mesh-list
83563763|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83021920|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83022007|NCT03548714|Ethanol|ethanol|mesh-list
83563764|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563765|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563766|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563767|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
83563768|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563769|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563770|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563771|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
83563772|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83563773|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83563774|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
83563775|NCT00001442|Paclitaxel|paclitaxel|mesh-list
83563776|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83563777|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563778|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83563779|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83563780|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83563781|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563782|NCT00002174|Thalidomide|thalidomide|mesh-list
83563783|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83563784|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
83563785|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563786|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
83563787|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83563788|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563789|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83563790|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83563791|NCT00002174|Growth Substances|growth substances|mesh-ancestor
83563792|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
83563793|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563794|NCT00000668|Ganciclovir|ganciclovir|mesh-list
83563795|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83563796|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
83563797|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563798|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563799|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563800|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563801|NCT00000680|Zidovudine|zidovudine|mesh-list
83563802|NCT00000680|Aldesleukin|aldesleukin|mesh-list
83563803|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
83563804|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563805|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563806|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563807|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563808|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
83563809|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563810|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563811|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563812|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563813|NCT00000692|Miglustat|miglustat|mesh-list
83563814|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563815|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563816|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563817|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563818|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
83563819|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563820|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83563821|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83563822|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563823|NCT00000698|Ganciclovir|ganciclovir|mesh-list
83563824|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83563825|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
83563826|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563827|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563828|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563829|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563830|NCT03764449|Balovaptan|balovaptan|mesh-list
83563831|NCT03764449|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83563832|NCT03764449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563833|NCT03764449|Natriuretic Agents|natriuretic agents|mesh-ancestor
83563834|NCT03764449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563835|NCT00002180|Tenofovir|tenofovir|mesh-list
83563836|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
83563837|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563839|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563840|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563841|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563842|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563843|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563844|NCT00002186|Acyclovir|acyclovir|mesh-list
83563845|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
83563846|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563847|NCT00001502|Carboplatin|carboplatin|mesh-list
83563848|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563849|NCT00002192|Azithromycin|azithromycin|mesh-list
83563850|NCT00002192|Clarithromycin|clarithromycin|mesh-list
83563851|NCT00002192|Ethambutol|ethambutol|mesh-list
83563852|NCT00002192|Rifapentine|rifapentine|mesh-list
83563853|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83563854|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563855|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83563856|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563857|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563858|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83563859|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563860|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
83563861|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83563862|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
83563863|NCT00002198|Abacavir|abacavir|mesh-list
83563864|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563865|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563866|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563867|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563868|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
83563869|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563870|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563871|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563872|NCT00000704|Zalcitabine|zalcitabine|mesh-list
83563873|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
83563874|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563875|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563876|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563877|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563878|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
83563879|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563880|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563881|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563882|NCT00000728|Zidovudine|zidovudine|mesh-list
83563883|NCT00000728|Aldesleukin|aldesleukin|mesh-list
83563884|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
83563885|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563886|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563887|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563888|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563889|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
83563890|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563891|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563892|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563893|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563894|NCT00001520|Neostigmine|neostigmine|mesh-list
83563895|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83563896|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563897|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563898|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
83563899|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83563900|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563901|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83563902|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
83563903|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83563904|NCT00001526|Daclizumab|daclizumab|mesh-list
83563905|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83563906|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
83563907|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563908|NCT00002294|Fluconazole|fluconazole|mesh-list
83563909|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
83563910|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563911|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83022082|NCT01356797|Fentanyl|fentanyl|mesh-list
83022145|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
83563912|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563913|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563914|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563915|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83563916|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
83563917|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563918|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563919|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83563920|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83563921|NCT03758365|Triamcinolone|triamcinolone|mesh-list
83563922|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83563923|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83563924|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
83563925|NCT03758365|Betamethasone|betamethasone|mesh-list
83563926|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
83563927|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83563928|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
83563929|NCT03758365|Clobetasol|clobetasol|mesh-list
83563930|NCT03758365|Desonide|desonide|mesh-list
83563931|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
83563932|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83563933|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83563934|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83563935|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
83563936|NCT03758365|Hormones|hormones|mesh-ancestor
83563937|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563938|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563939|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83563940|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
83563941|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563942|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563943|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83563944|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
83563945|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
83563946|NCT00002300|Megestrol|megestrol|mesh-list
83563947|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
83563948|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83563949|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83563950|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83563951|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
83563952|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83563953|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563954|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83563955|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83563956|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83563957|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83563958|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
83563959|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83563960|NCT00002306|Fluconazole|fluconazole|mesh-list
83563961|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
83563962|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563963|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83563964|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83563965|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563966|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563967|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83563968|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
83563969|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83563970|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83563971|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83563972|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83563973|NCT00002210|Delavirdine|delavirdine|mesh-list
83563974|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563975|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563976|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563977|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563978|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
83563979|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563980|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563981|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563982|NCT00002216|Lamivudine|lamivudine|mesh-list
83563983|NCT00002216|Zidovudine|zidovudine|mesh-list
83563984|NCT00002216|Abacavir|abacavir|mesh-list
83563985|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83563986|NCT00002216|Nelfinavir|nelfinavir|mesh-list
83563987|NCT00002216|Amprenavir|amprenavir|mesh-list
83563988|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83563989|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83563990|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83563991|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83563992|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
83563993|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83563994|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83563995|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83563996|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
83563997|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83563998|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83563999|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564000|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83564001|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
83564002|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564003|NCT00002222|Valganciclovir|valganciclovir|mesh-list
83564004|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
83564005|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564006|NCT00002312|Zidovudine|zidovudine|mesh-list
83564007|NCT00002312|Delavirdine|delavirdine|mesh-list
83564008|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
83564009|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564010|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564011|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564012|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564013|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
83564014|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564015|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564016|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564017|NCT00002318|Doxorubicin|doxorubicin|mesh-list
83564018|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83564019|NCT00002318|Bleomycin|bleomycin|mesh-list
83564020|NCT00002318|Vincristine|vincristine|mesh-list
83564021|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83564022|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564023|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564024|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564025|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564026|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564027|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564028|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83564029|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83564030|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83564031|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
83564032|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83564033|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83564034|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564035|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564036|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564037|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
83564038|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564039|NCT04714177|Edaravone|edaravone|mesh-list
83564040|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83564041|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
83564042|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564043|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83564044|NCT04714177|Protective Agents|protective agents|mesh-ancestor
83564045|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564046|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
83564047|NCT00001628|Giapreza|giapreza|mesh-list
83564048|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
83564049|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
83564050|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83564051|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83564052|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564053|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564054|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564055|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83564056|NCT00002234|Lamivudine|lamivudine|mesh-list
83564057|NCT00002234|Efavirenz|efavirenz|mesh-list
83564058|NCT00002234|Didanosine|didanosine|mesh-list
83022224|NCT03862170|Cefazolin|cefazolin|mesh-list
83564059|NCT00002234|Adefovir|adefovir|mesh-list
83564061|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564062|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564063|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564064|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564065|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
83564066|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564067|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564068|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564069|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83564070|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564071|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83564072|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83564073|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83564074|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83564075|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
83564076|NCT04070287|Antibodies|antibodies|mesh-list
83564077|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
83564078|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
83564079|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564080|NCT00002324|Zidovudine|zidovudine|mesh-list
83564081|NCT00002324|Nevirapine|nevirapine|mesh-list
83564082|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
83564083|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564084|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564085|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564086|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564087|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
83564088|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564089|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564090|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564091|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83564092|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83564093|NCT00002330|Ganciclovir|ganciclovir|mesh-list
83564094|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83564095|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
83564096|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564097|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564098|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564099|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564100|NCT03740659|Levofloxacin|levofloxacin|mesh-list
83564101|NCT03740659|Ofloxacin|ofloxacin|mesh-list
83564102|NCT03740659|Dexamethasone|dexamethasone|mesh-list
83564103|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
83564104|NCT03740659|BB 1101|bb 1101|mesh-list
83564105|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564106|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
83564107|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
83564108|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564109|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564110|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564111|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
83564112|NCT03740659|Hormones|hormones|mesh-ancestor
83564113|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564114|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83564115|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564116|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564117|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564118|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564119|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83564120|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564121|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564122|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564123|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564124|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83564125|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564126|NCT00002336|Clarithromycin|clarithromycin|mesh-list
83564127|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564128|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564129|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83564130|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564131|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564132|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83564133|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564134|NCT00001646|Voriconazole|voriconazole|mesh-list
83564135|NCT00001646|Amphotericin B|amphotericin b|mesh-list
83564136|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83564137|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
83564138|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564139|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83564140|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564141|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564142|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564143|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83564144|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83564145|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564146|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564147|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83564148|NCT00001646|Amebicides|amebicides|mesh-ancestor
83564149|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83564150|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83564151|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564152|NCT00001658|Amoxicillin|amoxicillin|mesh-list
83564153|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564154|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564155|NCT00002252|Octreotide|octreotide|mesh-list
83564156|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564157|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83564158|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564159|NCT00002348|Mitoguazone|mitoguazone|mesh-list
83564160|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564161|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564162|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564163|NCT02721277|SMOFlipid|smoflipid|mesh-list
83564164|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83564165|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83564166|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83564167|NCT05752526|Diclofenac|diclofenac|mesh-list
83564168|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83564169|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83564170|NCT05752526|Analgesics|analgesics|mesh-ancestor
83564171|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
83564172|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564173|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564174|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564175|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564176|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83564177|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564178|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564179|NCT00378235|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83564180|NCT00378235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564181|NCT00002270|Interferons|interferons|mesh-list
83564182|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
83564183|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
83564184|NCT00002270|Zidovudine|zidovudine|mesh-list
83564185|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564186|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
83564187|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564188|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
83564189|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564190|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
83564191|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564192|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564193|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564194|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564195|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564196|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564197|NCT00002354|Stavudine|stavudine|mesh-list
83564198|NCT00002354|Indinavir|indinavir|mesh-list
83564199|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
83564200|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564201|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564202|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564203|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564204|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
83022373|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
83564205|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564206|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564207|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564208|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83564209|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83564210|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564211|NCT00002360|Didanosine|didanosine|mesh-list
83564212|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
83564213|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564214|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564215|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564216|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564217|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
83564218|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564219|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564220|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564221|NCT00002276|Zidovudine|zidovudine|mesh-list
83564222|NCT00002276|Ibuprofen|ibuprofen|mesh-list
83564223|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83564224|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83564225|NCT00002276|Analgesics|analgesics|mesh-ancestor
83564226|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
83564227|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564228|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564229|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564230|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564231|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83564232|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564233|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564234|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
83564235|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564236|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564237|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
83564238|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564239|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564240|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564241|NCT00378547|Acetaminophen|acetaminophen|mesh-list
83564242|NCT00378547|Dexamethasone|dexamethasone|mesh-list
83564243|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
83564244|NCT00378547|Pregabalin|pregabalin|mesh-list
83564245|NCT00378547|BB 1101|bb 1101|mesh-list
83564246|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564247|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
83564248|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
83564249|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564250|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564251|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564252|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
83564253|NCT00378547|Hormones|hormones|mesh-ancestor
83564254|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564255|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83564256|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564257|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564258|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564259|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564260|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83564261|NCT00378547|Analgesics|analgesics|mesh-ancestor
83564262|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
83564263|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
83564264|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
83564265|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83564266|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83564267|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83564268|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83564269|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83564270|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83564271|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83564272|NCT00002282|Fluconazole|fluconazole|mesh-list
83564273|NCT00002282|Clotrimazole|clotrimazole|mesh-list
83564274|NCT00002282|Miconazole|miconazole|mesh-list
83564275|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
83564276|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564277|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83564278|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83022450|NCT05417893|Sirolimus|sirolimus|mesh-list
83564279|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564280|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564281|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83564282|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
83564283|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564284|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564285|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83564286|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83564287|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83564288|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83564289|NCT02658877|Omalizumab|omalizumab|mesh-list
83564290|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83564291|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83564292|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
83564293|NCT00002288|Zidovudine|zidovudine|mesh-list
83564294|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
83564295|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564296|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564297|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564298|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564299|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
83564300|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564301|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564302|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564303|NCT00002366|Ritonavir|ritonavir|mesh-list
83564304|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83564305|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83564306|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564307|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564308|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564309|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564310|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564311|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
83564312|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564313|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83564314|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564315|NCT00378313|Paclitaxel|paclitaxel|mesh-list
83564316|NCT00378313|Gemcitabine|gemcitabine|mesh-list
83564317|NCT00378313|Epirubicin|epirubicin|mesh-list
83564318|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564319|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564320|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
83564321|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
83564322|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
83564323|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564324|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564325|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
83564326|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83564327|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564328|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564329|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564330|NCT00002372|Nelfinavir|nelfinavir|mesh-list
83564331|NCT00002372|Indinavir|indinavir|mesh-list
83564332|NCT00002372|Saquinavir|saquinavir|mesh-list
83564333|NCT00002372|Amprenavir|amprenavir|mesh-list
83564334|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83564335|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83564336|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564337|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564338|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564339|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564340|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564341|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
83564342|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564343|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83564344|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564345|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83564346|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
83564347|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564348|NCT00002378|Ritonavir|ritonavir|mesh-list
83564349|NCT00002378|Nelfinavir|nelfinavir|mesh-list
83564350|NCT00002378|Saquinavir|saquinavir|mesh-list
83564351|NCT00002378|Lamivudine|lamivudine|mesh-list
83564352|NCT00002378|Zidovudine|zidovudine|mesh-list
83564353|NCT00002378|Stavudine|stavudine|mesh-list
83564354|NCT00002378|Delavirdine|delavirdine|mesh-list
83564355|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83022518|NCT03412799|Paclitaxel|paclitaxel|mesh-list
83564356|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83564357|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564358|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564359|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564360|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564361|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564362|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
83564363|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564364|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83564365|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564366|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564367|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564368|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
83564369|NCT02589145|Pyridoxine|pyridoxine|mesh-list
83564370|NCT02589145|Dexamethasone|dexamethasone|mesh-list
83564371|NCT02589145|Rituximab|rituximab|mesh-list
83564372|NCT02589145|Gemcitabine|gemcitabine|mesh-list
83564373|NCT02589145|Lenalidomide|lenalidomide|mesh-list
83564374|NCT02589145|Melphalan|melphalan|mesh-list
83564375|NCT02589145|Busulfan|busulfan|mesh-list
83564376|NCT02589145|Vorinostat|vorinostat|mesh-list
83564377|NCT02589145|Enoxaparin|enoxaparin|mesh-list
83564378|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83564379|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564380|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
83564381|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564382|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564383|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564384|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
83564385|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
83564386|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564387|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564388|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
83564389|NCT02589145|Hormones|hormones|mesh-ancestor
83564390|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564391|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83564392|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564393|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
83564394|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564395|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83564396|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83564397|NCT02589145|Growth Substances|growth substances|mesh-ancestor
83564398|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
83564399|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564400|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
83564401|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564402|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564403|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
83564404|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83564405|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83564406|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83564407|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564408|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
83564409|NCT02589145|Vitamins|vitamins|mesh-ancestor
83564410|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
83564411|NCT00002384|Cidofovir|cidofovir|mesh-list
83564412|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
83564413|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564414|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564415|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564416|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
83564417|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
83564418|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83564419|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564420|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83564421|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
83564422|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
83564423|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83564424|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564425|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564426|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83564427|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
83564428|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83564429|NCT00002390|Abacavir|abacavir|mesh-list
83564430|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564431|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564432|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022591|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
83564433|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564434|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
83564435|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564436|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564437|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564438|NCT00002396|Tenofovir|tenofovir|mesh-list
83564439|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
83564440|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564441|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564442|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564443|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564444|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564445|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564446|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564447|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83564448|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83564449|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
83564450|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564451|NCT00002402|Antacids|antacids|mesh-ancestor
83564452|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564453|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564454|NCT00002420|Stavudine|stavudine|mesh-list
83564455|NCT00002420|Didanosine|didanosine|mesh-list
83564456|NCT00002420|Delavirdine|delavirdine|mesh-list
83564457|NCT00002420|Emivirine|emivirine|mesh-list
83564458|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
83564459|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564460|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
83564461|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564462|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564463|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564464|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
83564465|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564466|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
83564467|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564468|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564469|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564470|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
83564471|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83564472|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564473|NCT04024501|Verinurad|verinurad|mesh-list
83564474|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
83564475|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564476|NCT05709626|Aspirin|aspirin|mesh-list
83564477|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83564478|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83564479|NCT05709626|Analgesics|analgesics|mesh-ancestor
83564480|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
83564481|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564482|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564483|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564484|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564485|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83564486|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83564487|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564488|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83564489|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83564490|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564491|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
83564492|NCT03538015|Carvedilol|carvedilol|mesh-list
83564493|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83564494|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83564495|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
83564496|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83564497|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564498|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564499|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83564500|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
83564501|NCT03538015|Protective Agents|protective agents|mesh-ancestor
83564502|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83564503|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83564504|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83564505|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
83564506|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83564507|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83564508|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83564509|NCT03342157|Sennosides|sennosides|mesh-list
83564510|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
83564511|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564512|NCT03342157|Laxatives|laxatives|mesh-ancestor
83564513|NCT04331210|Diclofenac|diclofenac|mesh-list
83564514|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83564515|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83564516|NCT04331210|Analgesics|analgesics|mesh-ancestor
83564517|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
83564518|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564519|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564520|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564521|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564522|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83564523|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564524|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564525|NCT00002426|Adefovir|adefovir|mesh-list
83564526|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83564527|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
83564528|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564529|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564530|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564531|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564532|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564533|NCT00002432|Foscarnet|foscarnet|mesh-list
83564534|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83564535|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
83564536|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564537|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564538|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564539|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564540|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564541|NCT05701436|Leucovorin|leucovorin|mesh-list
83564542|NCT05701436|Doxorubicin|doxorubicin|mesh-list
83564543|NCT05701436|Fluorouracil|fluorouracil|mesh-list
83564544|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
83564545|NCT05701436|Raltitrexed|raltitrexed|mesh-list
83564546|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564547|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83564548|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564549|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564550|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564551|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564552|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
83564553|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564554|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564555|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
83564556|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564557|NCT05701436|Antidotes|antidotes|mesh-ancestor
83564558|NCT05701436|Protective Agents|protective agents|mesh-ancestor
83564559|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
83564560|NCT05701436|Vitamins|vitamins|mesh-ancestor
83564561|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
83564562|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83564563|NCT02487277|Paclitaxel|paclitaxel|mesh-list
83564564|NCT02487277|Gemcitabine|gemcitabine|mesh-list
83564565|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564566|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564567|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
83564568|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
83564569|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
83564570|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564571|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564572|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
83564573|NCT00002438|Itraconazole|itraconazole|mesh-list
83564574|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
83564575|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564576|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83564577|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564578|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564579|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564580|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83564581|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
83564582|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564583|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564584|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83564585|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
83564586|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83564587|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564588|NCT02436265|Dexamethasone|dexamethasone|mesh-list
83564589|NCT02436265|Ropivacaine|ropivacaine|mesh-list
83564590|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564591|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
83564592|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
83564593|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564594|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564595|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564596|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
83564597|NCT02436265|Hormones|hormones|mesh-ancestor
83564598|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564599|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83564600|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564601|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
83564602|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
83564603|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83564604|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
83564605|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
83564606|NCT05751746|Analgesics|analgesics|mesh-ancestor
83564607|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
83564608|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564609|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564610|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
83564611|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83564612|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83564613|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
83564614|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83564615|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83564616|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564617|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83564618|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
83564619|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83564620|NCT00002450|Tenofovir|tenofovir|mesh-list
83564621|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
83564622|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564623|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83564624|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564625|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564626|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564627|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564628|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564629|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
83564630|NCT03277183|Hematinics|hematinics|mesh-ancestor
83564631|NCT00002456|Cyclosporine|cyclosporine|mesh-list
83564632|NCT00002456|Methotrexate|methotrexate|mesh-list
83564633|NCT00002456|Cyclosporins|cyclosporins|mesh-list
83564634|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83564635|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
83564636|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83564637|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564638|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564639|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
83564640|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564641|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564642|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
83564643|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564644|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83564645|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564646|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
83564647|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564648|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564649|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
83564650|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564651|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83564652|NCT01525927|Cisplatin|cisplatin|mesh-list
83564653|NCT01525927|Carboplatin|carboplatin|mesh-list
83564654|NCT01525927|Etoposide|etoposide|mesh-list
83564655|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564656|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564657|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564658|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564659|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564660|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564662|NCT00002474|Carboplatin|carboplatin|mesh-list
83564663|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
83564664|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564665|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
83564666|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564667|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564668|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564669|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
83564670|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564671|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564672|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564673|NCT00002474|Analgesics|analgesics|mesh-ancestor
83564674|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
83564675|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564676|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564677|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564678|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564679|NCT00002492|Doxorubicin|doxorubicin|mesh-list
83564680|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83564681|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564682|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83564683|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564684|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564685|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564686|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564687|NCT05751512|Methotrexate|methotrexate|mesh-list
83564688|NCT05751512|Cetuximab|cetuximab|mesh-list
83564689|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83564690|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
83564691|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83564692|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564693|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564694|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
83564695|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564696|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564697|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
83564698|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564699|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83564700|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564701|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
83564702|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564703|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564704|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83564705|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83564706|NCT02373865|Glimepiride|glimepiride|mesh-list
83564707|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83564708|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564709|NCT02373865|Incretins|incretins|mesh-ancestor
83564710|NCT02373865|Hormones|hormones|mesh-ancestor
83564711|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564712|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83564713|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
83564714|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564715|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564716|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83564717|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564718|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
83564719|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
83564720|NCT00002498|Fluorouracil|fluorouracil|mesh-list
83564721|NCT00002498|Methotrexate|methotrexate|mesh-list
83564722|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
83564723|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564724|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
83564725|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564726|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564727|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564728|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
83564729|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564730|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564731|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564732|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
83564733|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83022889|NCT03576378|Analgesics|analgesics|mesh-ancestor
83564734|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83564735|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
83564736|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83564737|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
83564738|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564739|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83564740|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564742|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
83564743|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564744|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564745|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564746|NCT00002504|Interferons|interferons|mesh-list
83564747|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
83564748|NCT00002504|Aldesleukin|aldesleukin|mesh-list
83564749|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564750|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
83564751|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564752|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
83564753|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564754|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83564755|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83564756|NCT02360059|Metformin|metformin|mesh-list
83564757|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83564758|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564759|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
83564760|NCT00002510|Etoposide|etoposide|mesh-list
83564761|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564762|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
83564763|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564764|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564765|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564766|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
83564767|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564768|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564769|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564770|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564771|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564772|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564773|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564774|NCT01500109|Acetaminophen|acetaminophen|mesh-list
83564775|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83564776|NCT01500109|Analgesics|analgesics|mesh-ancestor
83564777|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
83564778|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564779|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564780|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
83564781|NCT00002516|Cobalt|cobalt|mesh-list
83564782|NCT00002516|Dactinomycin|dactinomycin|mesh-list
83564783|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
83564784|NCT00002516|Ifosfamide|ifosfamide|mesh-list
83564785|NCT00002516|Doxorubicin|doxorubicin|mesh-list
83564786|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83564787|NCT00002516|Etoposide|etoposide|mesh-list
83564788|NCT00002516|Vincristine|vincristine|mesh-list
83564789|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564790|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
83564791|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564792|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564793|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564794|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
83564795|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564796|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564797|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564798|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83564799|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564800|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564801|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564802|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564803|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
83564804|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
83564805|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
83564806|NCT00002516|Trace Elements|trace elements|mesh-ancestor
83564807|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
83564808|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564809|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564810|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83564811|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564812|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
83564813|NCT00002522|Etoposide|etoposide|mesh-list
83564814|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564815|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
83564816|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564817|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564818|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564819|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
83564820|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564821|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564822|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564823|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564824|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564825|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564826|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564827|NCT00002528|Tamoxifen|tamoxifen|mesh-list
83564828|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83564829|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
83564830|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564831|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564832|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83564833|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564834|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83564835|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83564836|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83564837|NCT02341495|Vitamin D|vitamin d|mesh-list
83564838|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
83564839|NCT02341495|Azacitidine|azacitidine|mesh-list
83564840|NCT02341495|Deferasirox|deferasirox|mesh-list
83564841|NCT02341495|Vitamins|vitamins|mesh-ancestor
83564842|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
83564843|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564844|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83564845|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564846|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
83564847|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564848|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564849|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564850|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83564851|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83564852|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
83564853|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
83564854|NCT00002534|Cytarabine|cytarabine|mesh-list
83564855|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
83564856|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
83564857|NCT00002534|Thiotepa|thiotepa|mesh-list
83564858|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83564859|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564860|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
83564861|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564862|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564863|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564864|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
83564865|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564866|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564867|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564868|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564869|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
83564870|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
83564871|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564872|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564873|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
83564874|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
83564875|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83564876|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83564877|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
83564878|NCT00002534|Hormones|hormones|mesh-ancestor
83564879|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564880|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83564881|NCT00002534|Protective Agents|protective agents|mesh-ancestor
83564882|NCT00002546|Ifosfamide|ifosfamide|mesh-list
83564883|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564884|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564885|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
83023117|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
83564886|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564887|NCT00378625|Artesunate|artesunate|mesh-list
83564888|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
83564889|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83564890|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83564891|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564892|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564893|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
83564894|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
83564895|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83564896|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
83564897|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83564898|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
83564899|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
83564900|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
83564901|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83564902|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564903|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83564904|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83564905|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83564906|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83564907|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83564908|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83564909|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83564910|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564911|NCT00002552|Leucovorin|leucovorin|mesh-list
83564912|NCT00002552|Cytarabine|cytarabine|mesh-list
83564913|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
83564914|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83564915|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83564916|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83564917|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
83564918|NCT00002552|Carmustine|carmustine|mesh-list
83564919|NCT00002552|Methotrexate|methotrexate|mesh-list
83564920|NCT00002552|Etoposide|etoposide|mesh-list
83564921|NCT00002552|Sargramostim|sargramostim|mesh-list
83564922|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
83564923|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564924|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
83564925|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564926|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83564927|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83564928|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
83564929|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564930|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564931|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83564932|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83564933|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
83564934|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83564935|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564936|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
83564937|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
83564938|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564939|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83564940|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83564941|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83564942|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564943|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564944|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
83564945|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564946|NCT00002552|Antidotes|antidotes|mesh-ancestor
83564947|NCT00002552|Protective Agents|protective agents|mesh-ancestor
83564948|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
83564949|NCT00002552|Vitamins|vitamins|mesh-ancestor
83564950|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
83564951|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83564952|NCT00378781|Minocycline|minocycline|mesh-list
83564953|NCT00378781|Heparin|heparin|mesh-list
83564954|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
83564955|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83564956|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83564957|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564958|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83564959|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564960|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83564961|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
83564962|NCT05750966|Gentamicins|gentamicins|mesh-list
83564963|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
83564964|NCT05750966|Cefuroxime|cefuroxime|mesh-list
83564965|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
83564966|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83564967|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83564968|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
83453900|NCT00975637|Brodalumab|brodalumab|mesh-list
83564969|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83564970|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83564971|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83564972|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564973|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564974|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83564975|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83564976|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83564977|NCT00377923|Progesterone|progesterone|mesh-list
83564978|NCT00377923|Progestins|progestins|mesh-ancestor
83564979|NCT00377923|Hormones|hormones|mesh-ancestor
83564980|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83564981|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564982|NCT00002570|Leucovorin|leucovorin|mesh-list
83564983|NCT00002570|Fluorouracil|fluorouracil|mesh-list
83564984|NCT00002570|Calcium|calcium|mesh-list
83564985|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
83564986|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83564987|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83564988|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
83564989|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83564990|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83564991|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83564992|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83564993|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
83564994|NCT00002570|Antidotes|antidotes|mesh-ancestor
83564995|NCT00002570|Protective Agents|protective agents|mesh-ancestor
83564996|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
83564997|NCT00002570|Vitamins|vitamins|mesh-ancestor
83564998|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
83564999|NCT00002576|Prednisolone|prednisolone|mesh-list
83565000|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
83565001|NCT00002576|Doxorubicin|doxorubicin|mesh-list
83565002|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83565003|NCT00002576|Vincristine|vincristine|mesh-list
83565004|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
83565005|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565006|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
83565007|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565008|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565009|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565010|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
83565011|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565012|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565013|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565014|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565015|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565016|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565017|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565018|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565019|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565020|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565021|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565022|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565023|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
83565024|NCT00002576|Hormones|hormones|mesh-ancestor
83565025|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565026|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565027|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565028|NCT00002576|Analgesics|analgesics|mesh-ancestor
83565029|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
83565030|NCT00002582|Tamoxifen|tamoxifen|mesh-list
83565031|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
83565032|NCT00002582|Doxorubicin|doxorubicin|mesh-list
83565033|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83565034|NCT00002582|Fluorouracil|fluorouracil|mesh-list
83565035|NCT00002582|Methotrexate|methotrexate|mesh-list
83565036|NCT00002582|Leuprolide|leuprolide|mesh-list
83565037|NCT00002582|Goserelin|goserelin|mesh-list
83565038|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565039|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
83565040|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023268|NCT01366547|Abacavir|abacavir|mesh-list
83565041|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565042|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565043|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
83565044|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565045|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565046|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565047|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565048|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565049|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565050|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565051|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
83565052|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565053|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83565054|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
83565055|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565056|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565057|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565058|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83565059|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83565060|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
83565061|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565062|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565063|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83565064|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83565065|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83565066|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83565067|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
83565068|NCT00002588|Etoposide|etoposide|mesh-list
83565069|NCT00002588|Topotecan|topotecan|mesh-list
83565070|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565071|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565072|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565073|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565074|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565075|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565076|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83565077|NCT02239627|Clonidine|clonidine|mesh-list
83565078|NCT02239627|Analgesics|analgesics|mesh-ancestor
83565079|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
83565080|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565081|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565082|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83565083|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
83565084|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
83565085|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83565086|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83565087|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83565088|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83565089|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83565090|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565091|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
83565092|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83565093|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565094|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
83565095|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
83565096|NCT00002594|Melphalan|melphalan|mesh-list
83565097|NCT00002594|Molgramostim|molgramostim|mesh-list
83565098|NCT00002594|Sargramostim|sargramostim|mesh-list
83565099|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565100|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
83565101|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565102|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565103|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565104|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
83565105|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565106|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565107|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565108|NCT02234011|Ketamine|ketamine|mesh-list
83565109|NCT02234011|Analgesics|analgesics|mesh-ancestor
83565110|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
83565111|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565112|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565113|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83565114|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83565115|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
83565116|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
83565117|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83565118|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83565119|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83565120|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83565121|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565122|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
83565123|NCT00002600|Carboplatin|carboplatin|mesh-list
83565124|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565125|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
83565126|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565127|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565128|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565129|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
83565130|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565131|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565132|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565133|NCT02177773|Octreotide|octreotide|mesh-list
83565134|NCT02177773|Edotreotide|edotreotide|mesh-list
83565135|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83565136|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565137|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565138|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83565139|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565140|NCT02144155|Oxytocin|oxytocin|mesh-list
83565141|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
83565142|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565143|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565144|NCT00002618|Leucovorin|leucovorin|mesh-list
83565146|NCT00002618|Cytarabine|cytarabine|mesh-list
83565147|NCT00002618|Prednisone|prednisone|mesh-list
83565148|NCT00002618|Doxorubicin|doxorubicin|mesh-list
83565149|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83565150|NCT00002618|Methotrexate|methotrexate|mesh-list
83565151|NCT00002618|Vincristine|vincristine|mesh-list
83565152|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
83565153|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
83565154|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565155|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565156|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565157|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565158|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565159|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565160|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565161|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565162|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
83565163|NCT00002618|Hormones|hormones|mesh-ancestor
83565164|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565165|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565166|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83565167|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
83565168|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565169|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565170|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
83565171|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565172|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565173|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565174|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
83565175|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565176|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83565177|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
83565178|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565179|NCT00002618|Antidotes|antidotes|mesh-ancestor
83565180|NCT00002618|Protective Agents|protective agents|mesh-ancestor
83565181|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
83565182|NCT00002618|Vitamins|vitamins|mesh-ancestor
83565183|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
83565184|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565185|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565186|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565187|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565188|NCT00002618|Trace Elements|trace elements|mesh-ancestor
83565189|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
83565190|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83565191|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
83565193|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83565194|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565195|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83565196|NCT02145169|Analgesics|analgesics|mesh-ancestor
83565197|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
83565198|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565199|NCT02110069|Sirolimus|sirolimus|mesh-list
83565200|NCT02110069|Vincristine|vincristine|mesh-list
83565201|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565202|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565203|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565204|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565205|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565206|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565207|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83565208|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565209|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565210|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
83565211|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565212|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
83565213|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565214|NCT00002630|Cobalt|cobalt|mesh-list
83565215|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
83565216|NCT00002630|Melphalan|melphalan|mesh-list
83565217|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565218|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
83565219|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565220|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565221|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565222|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
83565223|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565224|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565225|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565226|NCT00002630|Trace Elements|trace elements|mesh-ancestor
83565227|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
83565228|NCT00002642|Cobalt|cobalt|mesh-list
83565229|NCT00002642|Etoposide|etoposide|mesh-list
83565230|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565231|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565232|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565233|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565234|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565235|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565236|NCT00002642|Trace Elements|trace elements|mesh-ancestor
83565237|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
83565238|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565239|NCT03983941|Ropivacaine|ropivacaine|mesh-list
83565240|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
83565241|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
83565242|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83565243|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565244|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
83565245|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565246|NCT05750030|Bevacizumab|bevacizumab|mesh-list
83565247|NCT05750030|Atezolizumab|atezolizumab|mesh-list
83565248|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83565249|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565250|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83565251|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83565252|NCT05750030|Growth Substances|growth substances|mesh-ancestor
83565253|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565254|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
83565255|NCT05750030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83565256|NCT05750030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565257|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83565258|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83565259|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
83565260|NCT00002654|Cobalt|cobalt|mesh-list
83565261|NCT00002654|Trace Elements|trace elements|mesh-ancestor
83565262|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
83565263|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565264|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
83565265|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83565266|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565267|NCT01434745|Simvastatin|simvastatin|mesh-list
83565268|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83565269|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83565270|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
83565271|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565272|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83565273|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83565274|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565275|NCT01401049|Lidocaine|lidocaine|mesh-list
83565276|NCT01401049|Propofol|propofol|mesh-list
83565277|NCT01401049|Fospropofol|fospropofol|mesh-list
83565278|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
83565279|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
83565280|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83565281|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565282|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
83565283|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565284|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83565285|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83565286|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83565287|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83565288|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565289|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83565290|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83565291|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
83565292|NCT00381758|Methylphenidate|methylphenidate|mesh-list
83565293|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83565294|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565295|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83565296|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83565297|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83565298|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565299|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
83565300|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83565301|NCT01402531|Bevacizumab|bevacizumab|mesh-list
83565302|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83565303|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565304|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83565305|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83565306|NCT01402531|Growth Substances|growth substances|mesh-ancestor
83565307|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565308|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
83565309|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
83565310|NCT00381836|Hematinics|hematinics|mesh-ancestor
83565311|NCT01971853|Analgesics|analgesics|mesh-list
83565312|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
83565313|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565314|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565315|NCT00002678|Dexamethasone|dexamethasone|mesh-list
83565316|NCT00002678|Prednisone|prednisone|mesh-list
83565317|NCT00002678|Melphalan|melphalan|mesh-list
83565318|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565319|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
83565320|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
83565321|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565322|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565323|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83565324|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
83565325|NCT00002678|Hormones|hormones|mesh-ancestor
83565326|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565327|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565328|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565329|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565330|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
83565331|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565332|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565333|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565334|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
83565335|NCT01397695|Bevacizumab|bevacizumab|mesh-list
83565336|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83565337|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565338|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83565339|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83565340|NCT01397695|Growth Substances|growth substances|mesh-ancestor
83565341|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565342|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
83565343|NCT00002684|Paclitaxel|paclitaxel|mesh-list
83565344|NCT00002684|Ifosfamide|ifosfamide|mesh-list
83565345|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565346|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565347|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565348|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565349|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565350|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565351|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565352|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
83565353|NCT02972918|Simendan|simendan|mesh-list
83565354|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83565355|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
83565356|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83565357|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83565358|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565359|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565360|NCT02972918|Protective Agents|protective agents|mesh-ancestor
83565361|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565362|NCT05600491|Temozolomide|temozolomide|mesh-list
83565363|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565364|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
83565365|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565366|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565367|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
83565368|NCT00002696|Doxorubicin|doxorubicin|mesh-list
83565369|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83565370|NCT00002696|Fluorouracil|fluorouracil|mesh-list
83565371|NCT00002696|Methotrexate|methotrexate|mesh-list
83565372|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565373|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
83565374|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565375|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565376|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565377|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
83565378|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565379|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565380|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565381|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565382|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565383|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565384|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565385|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
83565386|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565387|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83565388|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
83565389|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565390|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565391|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565392|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83565393|NCT00002702|Aldesleukin|aldesleukin|mesh-list
83565394|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565395|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83565396|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83565397|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
83565398|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565399|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
83565400|NCT01890577|Hematinics|hematinics|mesh-ancestor
83565401|NCT01315873|Bortezomib|bortezomib|mesh-list
83565402|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83565403|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565404|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565405|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
83565406|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565407|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
83565408|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83565409|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
83565410|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565411|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
83565412|NCT01895959|Protective Agents|protective agents|mesh-ancestor
83565413|NCT01303003|Dexamethasone|dexamethasone|mesh-list
83565414|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565415|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
83565416|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
83565417|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565418|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565419|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83565420|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
83565421|NCT01303003|Hormones|hormones|mesh-ancestor
83565422|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565423|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565424|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565425|NCT00002714|Prednisone|prednisone|mesh-list
83565426|NCT00002714|Doxorubicin|doxorubicin|mesh-list
83565427|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83565428|NCT00002714|Bleomycin|bleomycin|mesh-list
83565429|NCT00002714|Etoposide|etoposide|mesh-list
83565430|NCT00002714|Vincristine|vincristine|mesh-list
83565431|NCT00002714|Vinblastine|vinblastine|mesh-list
83565432|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
83565433|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565434|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565435|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565436|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565437|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565438|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565439|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565440|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
83565441|NCT00002714|Hormones|hormones|mesh-ancestor
83565442|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565443|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565444|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565445|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565446|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565447|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565448|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565449|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
83565450|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565451|NCT00002720|Tamoxifen|tamoxifen|mesh-list
83565452|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83565453|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
83565454|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565455|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565456|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565457|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565458|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83565459|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83565460|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83565461|NCT01821859|Bevacizumab|bevacizumab|mesh-list
83565462|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83565463|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83565464|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565465|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83565466|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83565467|NCT01821859|Growth Substances|growth substances|mesh-ancestor
83565468|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565469|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
83565470|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83565471|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
83565472|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565473|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83565474|NCT01194427|Tamoxifen|tamoxifen|mesh-list
83565475|NCT01194427|Vorinostat|vorinostat|mesh-list
83565476|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83565477|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
83565478|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565479|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565480|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565481|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565482|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83565483|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83565484|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83565485|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83565486|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565487|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565488|NCT05599555|Vaccines|vaccines|mesh-list
83565489|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
83565490|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565492|NCT00002738|Trimetrexate|trimetrexate|mesh-list
83565493|NCT00002738|Calcium|calcium|mesh-list
83565494|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
83565495|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83565496|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565497|NCT00002738|Antidotes|antidotes|mesh-ancestor
83565498|NCT00002738|Protective Agents|protective agents|mesh-ancestor
83565499|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
83565500|NCT00002738|Vitamins|vitamins|mesh-ancestor
83565501|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
83565502|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
83565503|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565504|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565505|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
83565506|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565507|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565508|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565509|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565510|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
83565511|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83565512|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
83565513|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565514|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
83565515|NCT04706455|Protective Agents|protective agents|mesh-ancestor
83565516|NCT00002744|Cobalt|cobalt|mesh-list
83565517|NCT00002744|Cytarabine|cytarabine|mesh-list
83565518|NCT00002744|Dexamethasone|dexamethasone|mesh-list
83565519|NCT00002744|Prednisone|prednisone|mesh-list
83565520|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
83565521|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83565522|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83565523|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83565524|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
83565525|NCT00002744|Doxorubicin|doxorubicin|mesh-list
83565526|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83565527|NCT00002744|Methotrexate|methotrexate|mesh-list
83565528|NCT00002744|Vincristine|vincristine|mesh-list
83565529|NCT00002744|Daunorubicin|daunorubicin|mesh-list
83565530|NCT00002744|Asparaginase|asparaginase|mesh-list
83565531|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
83565532|NCT00002744|Pegaspargase|pegaspargase|mesh-list
83565533|NCT00002744|Thioguanine|thioguanine|mesh-list
83565534|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565535|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
83565536|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565537|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565538|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565539|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
83565540|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565541|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565542|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565543|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565544|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
83565545|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
83565546|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565547|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83565548|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
83565549|NCT00002744|Hormones|hormones|mesh-ancestor
83565550|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565551|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565552|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565553|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565554|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565555|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565556|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83565557|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
83565558|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565559|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565560|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
83565561|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565562|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565563|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83565564|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
83565565|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565566|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565567|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565568|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565569|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565570|NCT00002744|Trace Elements|trace elements|mesh-ancestor
83565571|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
83565572|NCT01788475|Dexamethasone|dexamethasone|mesh-list
83565573|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
83565574|NCT01788475|BB 1101|bb 1101|mesh-list
83565575|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565576|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
83565577|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
83565578|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565579|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565580|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83565581|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
83565582|NCT01788475|Hormones|hormones|mesh-ancestor
83565583|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565584|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565585|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565586|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
83565587|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565588|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565589|NCT01183897|Immunomodulating Agents|immunomodulating agents|mesh-list
83565590|NCT01183897|Immunologic Factors|immunologic factors|mesh-ancestor
83565591|NCT01183897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565592|NCT00381914|Vitamin D|vitamin d|mesh-list
83565593|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
83565594|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
83565595|NCT00381914|Vitamins|vitamins|mesh-list
83565596|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
83565597|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565598|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83565599|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83565600|NCT00423007|Bromfenac|bromfenac|mesh-list
83565601|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83565602|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83565603|NCT00423007|Analgesics|analgesics|mesh-ancestor
83565604|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
83565605|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565606|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565607|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565608|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565609|NCT04713787|Albendazole|albendazole|mesh-list
83565610|NCT04713787|Oxfendazole|oxfendazole|mesh-list
83565611|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
83565612|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83565613|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565614|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
83565615|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83565616|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83565617|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565618|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565619|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565620|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565621|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565622|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
83565623|NCT00002750|Melphalan|melphalan|mesh-list
83565624|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565625|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
83565626|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565627|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565628|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565629|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565630|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
83565631|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565632|NCT00002756|Leucovorin|leucovorin|mesh-list
83565633|NCT00002756|Cytarabine|cytarabine|mesh-list
83565634|NCT00002756|Prednisone|prednisone|mesh-list
83565635|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
83565636|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83565637|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83565638|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83565639|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
83565640|NCT00002756|Methotrexate|methotrexate|mesh-list
83565641|NCT00002756|Etoposide|etoposide|mesh-list
83565642|NCT00002756|Vincristine|vincristine|mesh-list
83565643|NCT00002756|Daunorubicin|daunorubicin|mesh-list
83565644|NCT00002756|Asparaginase|asparaginase|mesh-list
83565645|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
83565646|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
83565647|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565648|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
83565649|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565650|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565651|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565652|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
83565653|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565654|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565655|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565656|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565657|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
83565658|NCT00002756|Hormones|hormones|mesh-ancestor
83565659|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565660|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565661|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83565662|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
83565663|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565664|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565665|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
83565666|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565667|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565668|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565669|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83565670|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565671|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565672|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565673|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
83565674|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565675|NCT00002756|Antidotes|antidotes|mesh-ancestor
83565676|NCT00002756|Protective Agents|protective agents|mesh-ancestor
83565677|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
83565678|NCT00002756|Vitamins|vitamins|mesh-ancestor
83565679|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
83565680|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565681|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565682|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565683|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83565684|NCT01183429|Tretinoin|tretinoin|mesh-list
83565685|NCT01183429|Isotretinoin|isotretinoin|mesh-list
83565686|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565687|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
83565688|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565689|NCT01157533|Vancomycin|vancomycin|mesh-list
83565690|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83565691|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565692|NCT05749016|Paclitaxel|paclitaxel|mesh-list
83565693|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83565694|NCT05749016|Carboplatin|carboplatin|mesh-list
83565695|NCT05749016|Pertuzumab|pertuzumab|mesh-list
83565696|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565697|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565698|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565699|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565700|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565701|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565702|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83565703|NCT01756573|Bupivacaine|bupivacaine|mesh-list
83565704|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
83565705|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
83565706|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83565707|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565708|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
83565709|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565710|NCT01126801|Estradiol|estradiol|mesh-list
83565711|NCT01126801|Estrogens|estrogens|mesh-ancestor
83565712|NCT01126801|Hormones|hormones|mesh-ancestor
83565713|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565714|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565715|NCT01702909|Interleukin-2|interleukin-2|mesh-list
83565716|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565717|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83565718|NCT01702909|Analgesics|analgesics|mesh-ancestor
83023879|NCT02144792|Verapamil|verapamil|mesh-list
83565719|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
83565720|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565721|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565722|NCT00002768|Cytarabine|cytarabine|mesh-list
83565723|NCT00002768|Methotrexate|methotrexate|mesh-list
83565724|NCT00002768|Etoposide|etoposide|mesh-list
83565725|NCT00002768|Busulfan|busulfan|mesh-list
83565726|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83565727|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
83565728|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565729|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565730|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565731|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
83565732|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565733|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565734|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565735|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565736|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565737|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565738|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
83565739|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565740|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83565741|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83565742|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83565743|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83565744|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
83565745|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565746|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
83565747|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565748|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565749|NCT00002774|Cisplatin|cisplatin|mesh-list
83565750|NCT00002774|Fluorouracil|fluorouracil|mesh-list
83565751|NCT00002774|Tirapazamine|tirapazamine|mesh-list
83565752|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565753|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
83565754|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565755|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565756|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565757|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
83565758|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565759|NCT00002780|Aldesleukin|aldesleukin|mesh-list
83565760|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
83565761|NCT00002780|Thiotepa|thiotepa|mesh-list
83565762|NCT00002780|Carboplatin|carboplatin|mesh-list
83565763|NCT00002780|Sargramostim|sargramostim|mesh-list
83565764|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565765|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
83565766|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565767|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565768|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565769|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
83565770|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565771|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565772|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565773|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83565774|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83565775|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
83565776|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565777|NCT01692691|Dacarbazine|dacarbazine|mesh-list
83565778|NCT01692691|Carmustine|carmustine|mesh-list
83565779|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565780|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
83565781|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565782|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565783|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
83565784|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565785|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565786|NCT01122511|Dexamethasone|dexamethasone|mesh-list
83565787|NCT01122511|Ranibizumab|ranibizumab|mesh-list
83565788|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565789|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
83565790|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
83565791|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565792|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565793|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83565794|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
83565795|NCT01122511|Hormones|hormones|mesh-ancestor
83023956|NCT02145338|Cephalexin|cephalexin|mesh-list
83565796|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565797|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565798|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565799|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83565800|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83565801|NCT01122511|Growth Substances|growth substances|mesh-ancestor
83565802|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
83565803|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
83565804|NCT05535218|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83565805|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83565806|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565807|NCT05535218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83565808|NCT05535218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565809|NCT05535218|Immunoconjugates|immunoconjugates|mesh-ancestor
83565810|NCT05535218|Immunologic Factors|immunologic factors|mesh-ancestor
83565811|NCT05535218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565812|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
83565813|NCT05531708|Fludarabine|fludarabine|mesh-list
83565814|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565815|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
83565816|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565817|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565818|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565819|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
83565820|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565821|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565822|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565823|NCT01663285|Gemcitabine|gemcitabine|mesh-list
83565824|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565825|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565826|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
83565827|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565828|NCT00002786|Aldesleukin|aldesleukin|mesh-list
83565829|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565830|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83565831|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83565832|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
83565833|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565834|NCT00378937|Acetaminophen|acetaminophen|mesh-list
83565835|NCT00378937|Morphine|morphine|mesh-list
83565836|NCT00378937|Oxycodone|oxycodone|mesh-list
83565837|NCT00378937|Codeine|codeine|mesh-list
83565838|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
83565839|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
83565840|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83565841|NCT00378937|Narcotics|narcotics|mesh-ancestor
83565842|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83565843|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565844|NCT00378937|Analgesics|analgesics|mesh-ancestor
83565845|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
83565846|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565847|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83565848|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
83565849|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
83565850|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83565851|NCT00002792|Cyclosporine|cyclosporine|mesh-list
83565852|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
83565853|NCT00002792|Busulfan|busulfan|mesh-list
83565854|NCT00002792|Methotrexate|methotrexate|mesh-list
83565855|NCT00002792|Tacrolimus|tacrolimus|mesh-list
83565856|NCT00002792|Cyclosporins|cyclosporins|mesh-list
83565857|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565858|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
83565859|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565860|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565861|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565862|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
83565863|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565864|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565865|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565866|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83565867|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
83565868|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83565869|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83565870|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
83565871|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83565872|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565873|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83565874|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83565875|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83565876|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
83565877|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565878|NCT01090141|Micafungin|micafungin|mesh-list
83024105|NCT04544267|Vaccines|vaccines|mesh-list
83565879|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
83565880|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83565881|NCT01048723|Everolimus|everolimus|mesh-list
83565882|NCT01048723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83565883|NCT01048723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83565884|NCT01048723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83565885|NCT01048723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565886|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565887|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
83565888|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565889|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565890|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
83565891|NCT05513612|Fludarabine|fludarabine|mesh-list
83565892|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83565893|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
83565894|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565895|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83565896|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83565897|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
83565898|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565899|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565900|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83565901|NCT05594407|Lidocaine|lidocaine|mesh-list
83565902|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
83565903|NCT05594407|Ketamine|ketamine|mesh-list
83565904|NCT05594407|Remifentanil|remifentanil|mesh-list
83565905|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
83565906|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
83565907|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83565908|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565909|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
83565910|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565911|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83565912|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83565913|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83565914|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83565915|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565916|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83565917|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83565918|NCT05594407|Analgesics|analgesics|mesh-ancestor
83565919|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83565920|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83565921|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83565922|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83565923|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83565924|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83565925|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83565926|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
83565927|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83565928|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83565929|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83565930|NCT05594407|Narcotics|narcotics|mesh-ancestor
83565931|NCT00379717|Docetaxel|docetaxel|mesh-list
83565932|NCT00379717|Cisplatin|cisplatin|mesh-list
83565933|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565934|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83565935|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83565936|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83565937|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565938|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
83565939|NCT04706377|Vitamins|vitamins|mesh-ancestor
83565940|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
83565941|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565942|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
83565943|NCT01583647|Niacin|niacin|mesh-list
83565944|NCT01583647|Niacinamide|niacinamide|mesh-list
83565945|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
83565946|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83565947|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
83565948|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565949|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83565950|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
83565951|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
83565953|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
83565954|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565955|NCT04403516|Dexamethasone|dexamethasone|mesh-list
83565956|NCT04403516|Prednisolone|prednisolone|mesh-list
83565957|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83565958|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
83565959|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83565960|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
83565961|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83565962|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
83565963|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83565964|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
83565965|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
83565966|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565967|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565968|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83565969|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
83565970|NCT04403516|Hormones|hormones|mesh-ancestor
83565971|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83565972|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83565973|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83565974|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83565975|NCT04403516|Protective Agents|protective agents|mesh-ancestor
83565976|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
83565977|NCT01555489|Vitamins|vitamins|mesh-ancestor
83565978|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
83565979|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565980|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
83565981|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565982|NCT01555489|Protective Agents|protective agents|mesh-ancestor
83565983|NCT05243654|Metformin|metformin|mesh-list
83565984|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83565985|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565986|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83565987|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83565988|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83565989|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83565990|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83565991|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83565992|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83565993|NCT01035073|Analgesics|analgesics|mesh-ancestor
83565994|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
83565995|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83565996|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
83565997|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83565998|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
83565999|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
83566000|NCT04331743|Analgesics|analgesics|mesh-ancestor
83566001|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
83566002|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566003|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566004|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566005|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83566006|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83566007|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566008|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566009|NCT05296759|Gabapentin|gabapentin|mesh-list
83566010|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83566011|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
83566012|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83566013|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83566014|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83566015|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566016|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566017|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
83566018|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566019|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566020|NCT05296759|Analgesics|analgesics|mesh-ancestor
83566021|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
83566022|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566023|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
83566024|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83566025|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83566026|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566027|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566028|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83566029|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83566031|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83454944|NCT00991081|Bupropion|bupropion|mesh-list
83566032|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83566033|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
83566034|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
83566035|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83566036|NCT05546047|Tacrolimus|tacrolimus|mesh-list
83566037|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566038|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
83566039|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566040|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83566041|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566042|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566043|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
83566044|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
83566045|NCT01532635|Tacrolimus|tacrolimus|mesh-list
83566046|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566047|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
83566048|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566049|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566050|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83566051|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
83566052|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566053|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566054|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83566055|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83566056|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566057|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83566058|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83566059|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
83566060|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83566061|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566062|NCT00986947|Rituximab|rituximab|mesh-list
83566063|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566064|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566065|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
83566066|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566067|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566068|NCT00539617|Leucovorin|leucovorin|mesh-list
83566069|NCT00539617|Fluorouracil|fluorouracil|mesh-list
83566070|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
83566071|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83566072|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
83566073|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566074|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83566075|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566076|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566077|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
83566078|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566079|NCT00539617|Antidotes|antidotes|mesh-ancestor
83566080|NCT00539617|Protective Agents|protective agents|mesh-ancestor
83566081|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
83566082|NCT00539617|Vitamins|vitamins|mesh-ancestor
83566083|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
83566084|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83566085|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566086|NCT05467514|Liraglutide|liraglutide|mesh-list
83566087|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83566088|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566089|NCT05467514|Incretins|incretins|mesh-ancestor
83566090|NCT05467514|Hormones|hormones|mesh-ancestor
83566091|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566092|NCT00976339|Vitamin D|vitamin d|mesh-list
83566093|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
83566094|NCT00976339|Vitamins|vitamins|mesh-ancestor
83566095|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
83566096|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566097|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83566098|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83566099|NCT04579640|Vitamin D|vitamin d|mesh-list
83566100|NCT04579640|Vitamins|vitamins|mesh-ancestor
83566101|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
83566102|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566103|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83566104|NCT00523939|Cytarabine|cytarabine|mesh-list
83566105|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83566106|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
83566107|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566108|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566109|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
83566110|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566111|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566112|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
83566113|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566114|NCT00382538|Mifepristone|mifepristone|mesh-list
83566115|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83566116|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
83566117|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83566118|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566119|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83566120|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83566121|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83566122|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
83566123|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83566124|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83566125|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
83566126|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566127|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
83566128|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83566129|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83566130|NCT00954187|Pregabalin|pregabalin|mesh-list
83566131|NCT00954187|Gabapentin|gabapentin|mesh-list
83566132|NCT00954187|Analgesics|analgesics|mesh-ancestor
83566133|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
83566134|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566135|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566136|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
83566137|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83566138|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566139|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566140|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83566141|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83566142|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83566143|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566144|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566145|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83566146|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83566147|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566148|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
83566149|NCT04796012|Irinotecan|irinotecan|mesh-list
83566150|NCT04796012|Vincristine|vincristine|mesh-list
83566151|NCT04796012|Temozolomide|temozolomide|mesh-list
83566152|NCT04796012|Atezolizumab|atezolizumab|mesh-list
83566153|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83566154|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83566155|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566156|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566157|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566158|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83566159|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
83566160|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83566161|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83566162|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83566163|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
83566164|NCT04796012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83566165|NCT04796012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566166|NCT00947791|Midazolam|midazolam|mesh-list
83566167|NCT00947791|Ketamine|ketamine|mesh-list
83566168|NCT00947791|Analgesics|analgesics|mesh-ancestor
83566169|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
83566170|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566171|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566172|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83566173|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83566174|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
83566175|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
83566176|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566177|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83566178|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83566179|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566180|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566181|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83566182|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83566183|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83566184|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83566185|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566186|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
83566187|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
83566188|NCT05136326|Capecitabine|capecitabine|mesh-list
83566189|NCT05136326|Temozolomide|temozolomide|mesh-list
83566190|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83566191|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
83566192|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566193|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566194|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83566195|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
83566196|NCT05387941|Dexamethasone|dexamethasone|mesh-list
83566197|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83566198|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
83566199|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
83566200|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566201|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566202|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83566203|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
83566205|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566206|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83566207|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566208|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
83566209|NCT00379015|Docetaxel|docetaxel|mesh-list
83566210|NCT00379015|Trastuzumab|trastuzumab|mesh-list
83566211|NCT00379015|Epirubicin|epirubicin|mesh-list
83566212|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566213|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
83566214|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566215|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566216|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83566217|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
83566218|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566219|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566220|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83566221|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83566222|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83566223|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83566224|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566225|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83566226|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83566227|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83566228|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566229|NCT00911053|Melatonin|melatonin|mesh-list
83566230|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
83566231|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566232|NCT00911053|Protective Agents|protective agents|mesh-ancestor
83566233|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566234|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566235|NCT04713176|Remdesivir|remdesivir|mesh-list
83566236|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
83566237|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566238|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
83566239|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566240|NCT04713410|Prednisolone|prednisolone|mesh-list
83566241|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83566242|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
83566243|NCT04713410|Hormones|hormones|mesh-ancestor
83566244|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566245|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566246|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83566247|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566248|NCT04713332|Vitamin E|vitamin e|mesh-list
83361639|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
83566249|NCT04713332|Tocopherols|tocopherols|mesh-list
83566250|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
83566251|NCT04713332|Vitamins|vitamins|mesh-ancestor
83566252|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
83566253|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566254|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
83566255|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566256|NCT04713332|Protective Agents|protective agents|mesh-ancestor
83566257|NCT00476827|Paclitaxel|paclitaxel|mesh-list
83566258|NCT00476827|Vinorelbine|vinorelbine|mesh-list
83566259|NCT00476827|Docetaxel|docetaxel|mesh-list
83566260|NCT00476827|Bevacizumab|bevacizumab|mesh-list
83566261|NCT00476827|Gemcitabine|gemcitabine|mesh-list
83566262|NCT00476827|Irinotecan|irinotecan|mesh-list
83566263|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83566264|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566265|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83566266|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83566267|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83566268|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566269|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566270|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566271|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566272|NCT00476827|Growth Substances|growth substances|mesh-ancestor
83566273|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566274|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566275|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83566276|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
83566277|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83566278|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83566279|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566280|NCT00459121|Paclitaxel|paclitaxel|mesh-list
83566281|NCT00459121|Carboplatin|carboplatin|mesh-list
83566282|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83566283|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566284|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
83566285|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
83566286|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
83566287|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566288|NCT00904423|Vitamin D|vitamin d|mesh-list
83566289|NCT00904423|Vitamins|vitamins|mesh-ancestor
83566290|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
83566291|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566292|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83566293|NCT05328895|Betahistine|betahistine|mesh-list
83566294|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
83566295|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
83566296|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
83566297|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566298|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566299|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566300|NCT00879619|Prednisone|prednisone|mesh-list
83566301|NCT00879619|Cortisone|cortisone|mesh-list
83566302|NCT00879619|Docetaxel|docetaxel|mesh-list
83566303|NCT00879619|Sunitinib|sunitinib|mesh-list
83566304|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566305|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
83566306|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
83566307|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
83566308|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566309|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83566310|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
83566311|NCT00879619|Hormones|hormones|mesh-ancestor
83566312|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566313|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566314|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83566315|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566316|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566317|NCT00879619|Growth Substances|growth substances|mesh-ancestor
83566318|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566319|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83566320|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566321|NCT00822679|Eszopiclone|eszopiclone|mesh-list
83566322|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83566323|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566324|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566325|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83566326|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83566327|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83566328|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
83566329|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566330|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566331|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566332|NCT00323635|Urological Agents|urological agents|mesh-ancestor
83566333|NCT00314353|Bevacizumab|bevacizumab|mesh-list
83566334|NCT00314353|Capecitabine|capecitabine|mesh-list
83566335|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
83566336|NCT00314353|Irinotecan|irinotecan|mesh-list
83566337|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566338|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566339|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566340|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566341|NCT00314353|Growth Substances|growth substances|mesh-ancestor
83566342|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566343|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566344|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83566345|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
83566346|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566347|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83566348|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83566349|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566350|NCT00279409|Aripiprazole|aripiprazole|mesh-list
83566351|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
83566352|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566353|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83566354|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83566355|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566356|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566357|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
83566358|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
83566359|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566360|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566361|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83566362|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83566363|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
83566364|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83566365|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83566366|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83566367|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83566368|NCT05007392|Febuxostat|febuxostat|mesh-list
83566369|NCT05007392|Dotinurad|dotinurad|mesh-list
83566370|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
83566371|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566372|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
83566373|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83566374|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83566375|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83566376|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
83566377|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566378|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83566379|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83566380|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566381|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
83566382|NCT00801931|Melphalan|melphalan|mesh-list
83566383|NCT00801931|Busulfan|busulfan|mesh-list
83566384|NCT00801931|Thiotepa|thiotepa|mesh-list
83566385|NCT00801931|Fludarabine|fludarabine|mesh-list
83566386|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
83566387|NCT00801931|Phenytoin|phenytoin|mesh-list
83566388|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
83566389|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
83566390|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83566391|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566392|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
83566393|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566394|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566395|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83566396|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
83566397|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566398|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566399|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83566400|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566401|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
83566402|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83566403|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83566404|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566405|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83566406|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83566407|NCT00780481|Bradykinin|bradykinin|mesh-list
83566408|NCT00780481|Kininogens|kininogens|mesh-list
83566409|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
83566410|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83566411|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
83566412|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566413|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566414|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
83566415|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83566416|NCT05345990|Antibodies|antibodies|mesh-list
83566417|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
83566418|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566419|NCT00019747|Thalidomide|thalidomide|mesh-list
83566420|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566421|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
83566422|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566423|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
83566424|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83566425|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566426|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566427|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566428|NCT00019747|Growth Substances|growth substances|mesh-ancestor
83566429|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566430|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566431|NCT05048719|Dulaglutide|dulaglutide|mesh-list
83566432|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83566433|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566434|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
83566435|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83566436|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83566437|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
83566438|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566439|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566440|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566441|NCT00759577|Urological Agents|urological agents|mesh-ancestor
83566442|NCT00746239|Dexetimide|dexetimide|mesh-list
83566443|NCT00746239|Citalopram|citalopram|mesh-list
83566444|NCT00746239|Escitalopram|escitalopram|mesh-list
83566445|NCT00746239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83566446|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83566447|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566448|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566449|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566450|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
83566451|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566452|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83566453|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83566454|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
83566455|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
83566456|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566457|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83566458|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83566459|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
83566460|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83566461|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
83566462|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566463|NCT04977674|Naltrexone|naltrexone|mesh-list
83566464|NCT04977674|Ketamine|ketamine|mesh-list
83566465|NCT04977674|Analgesics|analgesics|mesh-ancestor
83566466|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
83566467|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566468|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566469|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83566470|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83566471|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
83566472|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
83566473|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566474|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83566475|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83566476|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566477|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566478|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83566479|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83566480|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83566481|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83566482|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83566483|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566484|NCT00402883|Folic Acid|folic acid|mesh-list
83566485|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
83566486|NCT00402883|Hydroxocobalamin|hydroxocobalamin|mesh-list
83566487|NCT00402883|Bevacizumab|bevacizumab|mesh-list
83566488|NCT00402883|Carboplatin|carboplatin|mesh-list
83566489|NCT00402883|Pemetrexed|pemetrexed|mesh-list
83566490|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566491|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566492|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566493|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566494|NCT00402883|Growth Substances|growth substances|mesh-ancestor
83566495|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566496|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566497|NCT00402883|Vitamins|vitamins|mesh-ancestor
83566498|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
83566499|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566500|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566501|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83566502|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83566503|NCT00402883|Hematinics|hematinics|mesh-ancestor
83566504|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
83566505|NCT04939844|Lenalidomide|lenalidomide|mesh-list
83566506|NCT04939844|Bortezomib|bortezomib|mesh-list
83566507|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
83566508|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566509|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566510|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566511|NCT04939844|Growth Substances|growth substances|mesh-ancestor
83566512|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566513|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566514|NCT05295212|Atezolizumab|atezolizumab|mesh-list
83566515|NCT05295212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83566516|NCT05295212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566517|NCT05295212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566518|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566519|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
83566520|NCT05286320|Lenvatinib|lenvatinib|mesh-list
83566521|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566522|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566523|NCT05286320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83566524|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566525|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83566526|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566527|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
83566528|NCT00728845|Paclitaxel|paclitaxel|mesh-list
83566529|NCT00728845|Bevacizumab|bevacizumab|mesh-list
83566530|NCT00728845|Carboplatin|carboplatin|mesh-list
83566531|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83566532|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566533|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83566534|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83566535|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83566536|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566537|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566538|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566539|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566540|NCT00728845|Growth Substances|growth substances|mesh-ancestor
83566541|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566542|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566543|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
83566544|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83566545|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83566546|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566547|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566548|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566549|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
83566550|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566551|NCT05278676|Dotinurad|dotinurad|mesh-list
83566552|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
83566553|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
83566554|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566555|NCT00703885|Alprazolam|alprazolam|mesh-list
83566556|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83566557|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566558|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566559|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83566560|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83566561|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566562|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
83566563|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
83566564|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566565|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566566|NCT00703339|Treprostinil|treprostinil|mesh-list
83566567|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83566568|NCT04330586|Ciclesonide|ciclesonide|mesh-list
83566569|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
83566570|NCT04330586|Hormones|hormones|mesh-ancestor
83566571|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566572|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566573|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83566574|NCT00382694|Fludarabine|fludarabine|mesh-list
83566575|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566576|NCT00673309|Insulin|insulin|mesh-list
83566577|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83566578|NCT00673309|Itraconazole|itraconazole|mesh-list
83566579|NCT00673309|Propranolol|propranolol|mesh-list
83566580|NCT00673309|Hormones|hormones|mesh-list
83566581|NCT00673309|Oxandrolone|oxandrolone|mesh-list
83566582|NCT00673309|Nandrolone|nandrolone|mesh-list
83566583|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83566584|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566585|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566586|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566587|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
83566588|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566589|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83566590|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83566591|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566592|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83566593|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
83566594|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83566595|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83566596|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83566597|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
83566598|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566599|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83566600|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83566601|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
83566602|NCT00673309|Androgens|androgens|mesh-ancestor
83566603|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
83566604|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
83566605|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83566606|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83566607|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566608|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
83566609|NCT04508036|Coagulants|coagulants|mesh-ancestor
83566610|NCT04828057|Timolol|timolol|mesh-list
83566611|NCT04828057|Bimatoprost|bimatoprost|mesh-list
83566612|NCT04828057|Travoprost|travoprost|mesh-list
83566613|NCT04828057|Latanoprost|latanoprost|mesh-list
83566614|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566615|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83566616|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83566617|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83566618|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566619|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566620|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83566621|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83566622|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83566623|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83566624|NCT02973451|Bupivacaine|bupivacaine|mesh-list
83566625|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
83566626|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
83566627|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566628|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566629|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
83566630|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566631|NCT00000199|Piracetam|piracetam|mesh-list
83566632|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83566633|NCT00000199|Protective Agents|protective agents|mesh-ancestor
83566634|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566635|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
83566636|NCT00668785|Ranibizumab|ranibizumab|mesh-list
83566637|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566638|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566639|NCT00668785|Growth Substances|growth substances|mesh-ancestor
83566640|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566641|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566642|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566643|NCT00655057|Citalopram|citalopram|mesh-list
83566644|NCT00655057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83566645|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83566646|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566647|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566648|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566649|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
83566650|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566651|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83566652|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
83566653|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566654|NCT00000211|Buprenorphine|buprenorphine|mesh-list
83566655|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83566656|NCT00000211|Narcotics|narcotics|mesh-ancestor
83566657|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566658|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566659|NCT00000211|Analgesics|analgesics|mesh-ancestor
83566660|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
83566661|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566662|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83566663|NCT04358432|Ezetimibe|ezetimibe|mesh-list
83566664|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83566665|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83566666|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
83566667|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566668|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83566669|NCT00000217|Carbamazepine|carbamazepine|mesh-list
83566670|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
83566671|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
83566672|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83566673|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566674|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566675|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566676|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83566677|NCT00000217|Analgesics|analgesics|mesh-ancestor
83566678|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
83566679|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566680|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83566681|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566682|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566683|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83566684|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83566685|NCT00000223|Buprenorphine|buprenorphine|mesh-list
83566686|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83566687|NCT00000223|Narcotics|narcotics|mesh-ancestor
83566688|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566689|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566690|NCT00000223|Analgesics|analgesics|mesh-ancestor
83566691|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
83566692|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566693|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83566694|NCT00000229|Buprenorphine|buprenorphine|mesh-list
83566695|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83566696|NCT00000229|Narcotics|narcotics|mesh-ancestor
83566697|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566698|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566699|NCT00000229|Analgesics|analgesics|mesh-ancestor
83566700|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
83566701|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566702|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83566703|NCT00000235|Buprenorphine|buprenorphine|mesh-list
83566704|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83566705|NCT00000235|Narcotics|narcotics|mesh-ancestor
83566706|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566707|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566708|NCT00000235|Analgesics|analgesics|mesh-ancestor
83566709|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
83566710|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566711|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83566712|NCT00000241|Flupenthixol|flupenthixol|mesh-list
83566713|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83566714|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83566715|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83566716|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566717|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566718|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566719|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83566720|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
83566721|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566722|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566723|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
83566724|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83566725|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
83566726|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
83566727|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566728|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566729|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83566730|NCT00000253|Analgesics|analgesics|mesh-ancestor
83566731|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
83566732|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566733|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
83566734|NCT00000259|Sevoflurane|sevoflurane|mesh-list
83566735|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83566736|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83566737|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
83566738|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
83566739|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566740|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566741|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83566742|NCT00000259|Analgesics|analgesics|mesh-ancestor
83566743|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
83566744|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566746|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566747|NCT00379405|Ritonavir|ritonavir|mesh-list
83566748|NCT00379405|Saquinavir|saquinavir|mesh-list
83566749|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83566750|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83566751|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
83566752|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566753|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566754|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83566755|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83566756|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
83566757|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566758|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83566759|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83566760|NCT00379483|Deferasirox|deferasirox|mesh-list
83566761|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83566762|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
83566763|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
83566764|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566765|NCT00607477|Minoxidil|minoxidil|mesh-list
83566766|NCT00607477|Hydralazine|hydralazine|mesh-list
83566767|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83566768|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
83566769|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
83566770|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83566771|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566772|NCT00000271|Desipramine|desipramine|mesh-list
83566773|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83566774|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
83566775|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566776|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566777|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566778|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83566779|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83566780|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566781|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
83566782|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566783|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566785|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83566786|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566787|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83566788|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83566789|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566790|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566791|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
83566792|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566793|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83566794|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
83566795|NCT00599131|Docetaxel|docetaxel|mesh-list
83566796|NCT00599131|Fluorouracil|fluorouracil|mesh-list
83566797|NCT00599131|Cetuximab|cetuximab|mesh-list
83566798|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566799|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
83566800|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
83566801|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
83566802|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566803|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
83566804|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83566805|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83566806|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
83566807|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566808|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566809|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
83566810|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83566811|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
83566812|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
83566813|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566814|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566815|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83566816|NCT04302350|Analgesics|analgesics|mesh-ancestor
83566817|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
83566818|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566819|NCT00584935|Rituximab|rituximab|mesh-list
83566820|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83566821|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566822|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
83566823|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566824|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566825|NCT04295486|Aspirin|aspirin|mesh-list
83566826|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83566827|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83566828|NCT04295486|Analgesics|analgesics|mesh-ancestor
83566829|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
83566830|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566831|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566832|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83566833|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566834|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83566835|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83566836|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566837|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83566838|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83566839|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566840|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
83566841|NCT00000289|Ondansetron|ondansetron|mesh-list
83566842|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
83566843|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
83566844|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566845|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566846|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83566847|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
83566848|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
83566849|NCT00000289|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83566850|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83566851|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
83566852|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566853|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566854|NCT00000295|Progesterone|progesterone|mesh-list
83566855|NCT00000295|Progestins|progestins|mesh-ancestor
83566856|NCT00000295|Hormones|hormones|mesh-ancestor
83024987|NCT05008510|Camptothecin|camptothecin|mesh-list
83566857|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566858|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566859|NCT00000733|Ribavirin|ribavirin|mesh-list
83566860|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
83566861|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566862|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
83566863|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566864|NCT04246723|Ritonavir|ritonavir|mesh-list
83566865|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
83566866|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83566867|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83566868|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
83566869|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566870|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566871|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83566872|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83566873|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
83566874|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566875|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83566876|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83566877|NCT00000301|Amantadine|amantadine|mesh-list
83566878|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83566879|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83566880|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
83566881|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566882|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
83566883|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566884|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566885|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566886|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83566887|NCT00000301|Analgesics|analgesics|mesh-ancestor
83566888|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
83566889|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566890|NCT00000307|Naltrexone|naltrexone|mesh-list
83566891|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83566892|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83566893|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566894|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
83566895|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566896|NCT00000313|Fenfluramine|fenfluramine|mesh-list
83566897|NCT00000313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83566898|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83566899|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83566900|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566901|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566902|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
83566903|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566904|NCT00000319|Buprenorphine|buprenorphine|mesh-list
83566905|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83566906|NCT00000319|Narcotics|narcotics|mesh-ancestor
83566907|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566908|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566909|NCT00000319|Analgesics|analgesics|mesh-ancestor
83566910|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
83566911|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566912|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83566913|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83566914|NCT00000325|Hormones|hormones|mesh-ancestor
83566915|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566916|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566917|NCT04181203|Leuprolide|leuprolide|mesh-list
83566918|NCT04181203|Goserelin|goserelin|mesh-list
83566919|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83566920|NCT04181203|Hormones|hormones|mesh-list
83566921|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83566922|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566923|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83566924|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
83566925|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83566926|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83566927|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566928|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
83566929|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83566930|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
83566931|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83566932|NCT03521102|Acetaminophen|acetaminophen|mesh-list
83566933|NCT03521102|Hydromorphone|hydromorphone|mesh-list
83566934|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83566935|NCT03521102|Analgesics|analgesics|mesh-ancestor
83566936|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
83566937|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83566938|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566939|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
83566940|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83566941|NCT03521102|Narcotics|narcotics|mesh-ancestor
83566942|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83566943|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
83566944|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83566945|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566946|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83566947|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83566948|NCT00000763|Growth Substances|growth substances|mesh-ancestor
83566949|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566950|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
83566951|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83566952|NCT00380263|Growth Substances|growth substances|mesh-ancestor
83566953|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566954|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
83566955|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83566956|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566957|NCT00000769|Interleukin-4|interleukin-4|mesh-list
83566958|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83566959|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
83566960|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566961|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83566962|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83566963|NCT05440591|Metformin|metformin|mesh-list
83566964|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
83566965|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83566966|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566967|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83566968|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566969|NCT04099303|Vaccines|vaccines|mesh-list
83566970|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
83566971|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566972|NCT00379951|Ertapenem|ertapenem|mesh-list
83566973|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83566974|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566975|NCT00000337|Selegiline|selegiline|mesh-list
83566976|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
83566977|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83566978|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83566979|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83566980|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83566981|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566982|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566983|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83566984|NCT00000337|Protective Agents|protective agents|mesh-ancestor
83566985|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83566986|NCT00000781|Zidovudine|zidovudine|mesh-list
83566987|NCT00000781|Nevirapine|nevirapine|mesh-list
83566988|NCT00000781|Didanosine|didanosine|mesh-list
83566989|NCT00000781|Zalcitabine|zalcitabine|mesh-list
83566990|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
83566991|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83566992|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83566993|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83566994|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83566995|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
83566996|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83566997|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83566998|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83566999|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83567000|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83567001|NCT00000349|Flupenthixol|flupenthixol|mesh-list
83567002|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83567003|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83567004|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83567005|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025140|NCT02470585|Paclitaxel|paclitaxel|mesh-list
83567006|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567007|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567008|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83567009|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
83567010|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567011|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567012|NCT00000805|Ganciclovir|ganciclovir|mesh-list
83567013|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83567014|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
83567015|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567016|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567017|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567018|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567019|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83567020|NCT04270682|Cathartics|cathartics|mesh-ancestor
83567021|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83567022|NCT00000355|Buprenorphine|buprenorphine|mesh-list
83567023|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83567024|NCT00000355|Narcotics|narcotics|mesh-ancestor
83567025|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83567026|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567027|NCT00000355|Analgesics|analgesics|mesh-ancestor
83567028|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
83567029|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567030|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83567031|NCT04022785|Azacitidine|azacitidine|mesh-list
83567032|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83567033|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
83567034|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567035|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567036|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567037|NCT00000361|Methotrexate|methotrexate|mesh-list
83567038|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83567039|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
83567040|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83567041|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567042|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83567043|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
83567044|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567045|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567046|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83567047|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567048|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83567049|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83567050|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
83567051|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83567052|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567053|NCT00000811|Azithromycin|azithromycin|mesh-list
83567054|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83567055|NCT00000811|Trimethoprim|trimethoprim|mesh-list
83567056|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
83567057|NCT00000811|Atovaquone|atovaquone|mesh-list
83567058|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567059|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567060|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83567061|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
83567062|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83567063|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567064|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83567065|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567066|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567067|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83567068|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83567069|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567070|NCT00000373|Olanzapine|olanzapine|mesh-list
83567071|NCT00000373|Fluoxetine|fluoxetine|mesh-list
83567072|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
83567073|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
83567074|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567075|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567076|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83567077|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83567078|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83567079|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83567080|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567081|NCT00000373|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83567082|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83567083|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83567084|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567086|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
83567087|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83567088|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
83567089|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83567090|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567091|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567092|NCT00000823|Zidovudine|zidovudine|mesh-list
83567093|NCT00000823|Didanosine|didanosine|mesh-list
83567094|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
83567095|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567096|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567097|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567098|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567099|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
83567100|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567101|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567102|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567103|NCT00000379|Fluoxetine|fluoxetine|mesh-list
83567104|NCT00000379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83567105|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83567106|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83567107|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567108|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567109|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
83567110|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567111|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83567112|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
83567113|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567114|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83567115|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567116|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567117|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
83567118|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
83567119|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567120|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567121|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567122|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
83567123|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83567124|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83567125|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567126|NCT00002894|Paclitaxel|paclitaxel|mesh-list
83567127|NCT00002894|Carboplatin|carboplatin|mesh-list
83567128|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83567129|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567130|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
83567131|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
83567132|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
83567133|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567134|NCT00000829|Vaccines|vaccines|mesh-list
83567135|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83567136|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
83567137|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567138|NCT03282344|Nivolumab|nivolumab|mesh-list
83567139|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83567140|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567141|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83567142|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567143|NCT00000403|Doxycycline|doxycycline|mesh-list
83567144|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567145|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567146|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
83567147|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83567148|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567149|NCT00000841|Lamivudine|lamivudine|mesh-list
83567150|NCT00000841|Zidovudine|zidovudine|mesh-list
83567151|NCT00000841|Stavudine|stavudine|mesh-list
83567152|NCT00000841|Indinavir|indinavir|mesh-list
83025294|NCT05351229|Morphine|morphine|mesh-list
83567153|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567154|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567155|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567156|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567157|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
83567158|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567159|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567160|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567161|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
83567162|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83567163|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83567164|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
83567165|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
83567166|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83567167|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
83567168|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567169|NCT04226456|Expectorants|expectorants|mesh-ancestor
83567170|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
83567171|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83567172|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
83567173|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567174|NCT04226456|Protective Agents|protective agents|mesh-ancestor
83567175|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567176|NCT04226456|Antidotes|antidotes|mesh-ancestor
83567177|NCT00000415|Calcium|calcium|mesh-list
83567178|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83567179|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567180|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
83567181|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83567182|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
83567183|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567184|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83567185|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567186|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
83567187|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567188|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
83567189|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83567190|NCT00000847|Protective Agents|protective agents|mesh-ancestor
83567191|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
83567192|NCT04195568|Antacids|antacids|mesh-ancestor
83567193|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567194|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83567195|NCT00000439|Valproic Acid|valproic acid|mesh-list
83567196|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
83567197|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567198|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567199|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
83567200|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567201|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567202|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
83567203|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83567204|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83567205|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567206|NCT00002912|Etoposide|etoposide|mesh-list
83567207|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
83567208|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83567209|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567210|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83567211|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83567212|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567213|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567214|NCT00002912|Analgesics|analgesics|mesh-ancestor
83567215|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
83567216|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567217|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567218|NCT04183790|Ivacaftor|ivacaftor|mesh-list
83567219|NCT04183790|Elexacaftor|elexacaftor|mesh-list
83567220|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83567221|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83567222|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567223|NCT00000445|Naltrexone|naltrexone|mesh-list
83567224|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83567225|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83025364|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
83567226|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567227|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
83567228|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567229|NCT00000451|Naltrexone|naltrexone|mesh-list
83567230|NCT00000451|Sertraline|sertraline|mesh-list
83567231|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83567232|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83567233|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567234|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
83567235|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567236|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
83567237|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567238|NCT00000451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83567239|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83567240|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83567241|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567242|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567243|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
83567244|NCT00000865|Lamivudine|lamivudine|mesh-list
83567245|NCT00000865|Zidovudine|zidovudine|mesh-list
83567246|NCT00000865|Abacavir|abacavir|mesh-list
83567247|NCT00000865|Stavudine|stavudine|mesh-list
83567248|NCT00000865|Didanosine|didanosine|mesh-list
83567249|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567250|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567251|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567252|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567253|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
83567254|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567255|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567256|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567257|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
83567258|NCT00000469|Aspirin|aspirin|mesh-list
83567259|NCT00000469|Lovastatin|lovastatin|mesh-list
83567260|NCT00000469|L 647318|l 647318|mesh-list
83567261|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
83567262|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83567263|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83567264|NCT00000469|Analgesics|analgesics|mesh-ancestor
83567265|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
83567266|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567267|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567268|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83567269|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83567270|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83567271|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83567272|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567273|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83567274|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83567275|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567276|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
83567277|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83567278|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83567279|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
83567280|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83567281|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83567282|NCT00000889|Aldesleukin|aldesleukin|mesh-list
83567283|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567284|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567285|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567286|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
83567287|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567288|NCT00000505|Plasminogen|plasminogen|mesh-list
83567289|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83567290|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83567291|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83567292|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567293|NCT00000901|Lamivudine|lamivudine|mesh-list
83567294|NCT00000901|Stavudine|stavudine|mesh-list
83567295|NCT00000901|Indinavir|indinavir|mesh-list
83567296|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567297|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567298|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567299|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567300|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
83567301|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567302|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567303|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567304|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
83567305|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83567306|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83567307|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
83567308|NCT00000541|Vitamins|vitamins|mesh-list
83567309|NCT00000541|Folic Acid|folic acid|mesh-list
83567310|NCT00000541|Vitamin E|vitamin e|mesh-list
83567311|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
83567312|NCT00000541|Hydroxocobalamin|hydroxocobalamin|mesh-list
83567313|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
83567314|NCT00000541|Pyridoxal|pyridoxal|mesh-list
83567315|NCT00000541|Pyridoxine|pyridoxine|mesh-list
83567316|NCT00000541|Beta Carotene|beta carotene|mesh-list
83567317|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
83567318|NCT00000541|Carotenoids|carotenoids|mesh-list
83567319|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
83567320|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567321|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
83567322|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567323|NCT00000541|Protective Agents|protective agents|mesh-ancestor
83567324|NCT00000541|Hematinics|hematinics|mesh-ancestor
83567325|NCT00000541|Provitamins|provitamins|mesh-ancestor
83567326|NCT00000913|Ritonavir|ritonavir|mesh-list
83567327|NCT00000913|Nelfinavir|nelfinavir|mesh-list
83567328|NCT00000913|Saquinavir|saquinavir|mesh-list
83567329|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83567330|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83567331|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
83567332|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567333|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567334|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567335|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567336|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
83567337|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567338|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83567339|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567340|NCT00000547|Enalapril|enalapril|mesh-list
83567341|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83567342|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
83567343|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567344|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567345|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83567346|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83567347|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83567348|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567349|NCT00000577|Colchicine|colchicine|mesh-list
83567350|NCT00000577|Albuterol|albuterol|mesh-list
83567351|NCT00000577|Hormones|hormones|mesh-list
83567352|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
83567353|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
83567354|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83567355|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567356|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83567357|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
83567358|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567359|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83567360|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
83567361|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
83567362|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83567363|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83567364|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83567365|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567366|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567367|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
83567368|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83567369|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83567370|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83567371|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83567372|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567373|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
83567374|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83567375|NCT03015896|Nivolumab|nivolumab|mesh-list
83567376|NCT03015896|Lenalidomide|lenalidomide|mesh-list
83567377|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83567378|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567379|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83567380|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567381|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
83567382|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567383|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83567384|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83567385|NCT03015896|Growth Substances|growth substances|mesh-ancestor
83567386|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
83567387|NCT02994836|Adalimumab|adalimumab|mesh-list
83567388|NCT02994836|Infliximab|infliximab|mesh-list
83567389|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83567390|NCT02994836|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83567391|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83567392|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83567393|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
83567394|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83567395|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83567396|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567397|NCT00000613|Genistein|genistein|mesh-list
83567398|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83567399|NCT00000613|Protective Agents|protective agents|mesh-ancestor
83567400|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567401|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567402|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83567403|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567404|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567405|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
83567406|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83567407|NCT00000613|Estrogens|estrogens|mesh-ancestor
83567408|NCT00000613|Hormones|hormones|mesh-ancestor
83567409|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83567410|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
83567411|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83567412|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567413|NCT02909348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83567414|NCT02909348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567415|NCT00000949|Aldesleukin|aldesleukin|mesh-list
83567416|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567417|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567418|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567419|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
83567420|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567421|NCT00002936|Etoposide|etoposide|mesh-list
83567422|NCT00002936|Altretamine|altretamine|mesh-list
83567423|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83567424|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567425|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83567426|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83567427|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567428|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567429|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83567430|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
83567431|NCT00000649|Zidovudine|zidovudine|mesh-list
83567432|NCT00000649|Nevirapine|nevirapine|mesh-list
83567433|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
83567434|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567435|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567436|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567437|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567438|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
83567439|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567440|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567441|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567442|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83567443|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83567444|NCT00000961|Zidovudine|zidovudine|mesh-list
83567445|NCT00000961|Immune Sera|immune sera|mesh-list
83567446|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
83567447|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567448|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567449|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567450|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567451|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
83567452|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567453|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567454|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567455|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
83567456|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567457|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83567458|NCT04048304|Vancomycin|vancomycin|mesh-list
83567459|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567460|NCT00000655|Trimethoprim|trimethoprim|mesh-list
83567461|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83567462|NCT00000655|Atovaquone|atovaquone|mesh-list
83567463|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
83567464|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83567465|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567466|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
83567467|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83567468|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567469|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83567470|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567471|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567472|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83567473|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83567474|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567475|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567476|NCT00002948|Topotecan|topotecan|mesh-list
83567477|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83567478|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83567479|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567480|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567481|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567482|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83567483|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
83567484|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567485|NCT00000967|Interferons|interferons|mesh-list
83567486|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
83567487|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
83567488|NCT00000967|Zidovudine|zidovudine|mesh-list
83567489|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567490|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
83567491|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567492|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
83567493|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567494|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
83567495|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567496|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567497|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567498|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567499|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567500|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567501|NCT00000661|Zidovudine|zidovudine|mesh-list
83567502|NCT00000661|Oxazepam|oxazepam|mesh-list
83567503|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
83567504|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567505|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567506|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567507|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567508|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
83567509|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567510|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567511|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567512|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83567513|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83567514|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567515|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83567516|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83567517|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567518|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
83567519|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
83567520|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567521|NCT00000979|Zidovudine|zidovudine|mesh-list
83567522|NCT00000979|Didanosine|didanosine|mesh-list
83567523|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
83567524|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567525|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567526|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567527|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567528|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
83567529|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567530|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567531|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567532|NCT00000991|Zidovudine|zidovudine|mesh-list
83567533|NCT00000991|Trimethoprim|trimethoprim|mesh-list
83567534|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
83567535|NCT00000991|Dapsone|dapsone|mesh-list
83567537|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83567538|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
83567539|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567540|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567541|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567542|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567543|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
83567544|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567545|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567546|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567547|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83567548|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
83567549|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83567550|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567551|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83567552|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83567553|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83567554|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567555|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
83567556|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567557|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
83567558|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83567559|NCT00000673|Ganciclovir|ganciclovir|mesh-list
83567560|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83567561|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
83567562|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567563|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567564|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567565|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567566|NCT00000685|Zidovudine|zidovudine|mesh-list
83567567|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
83567568|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567569|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567570|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567571|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567572|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
83567573|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567574|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567575|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567576|NCT00002972|Paclitaxel|paclitaxel|mesh-list
83567577|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83567578|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567579|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
83567580|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
83567581|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
83567582|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567583|NCT00000691|Foscarnet|foscarnet|mesh-list
83567584|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83567585|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
83567586|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567587|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567588|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567589|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567590|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567591|NCT00002984|Paclitaxel|paclitaxel|mesh-list
83567592|NCT00002984|Fluorouracil|fluorouracil|mesh-list
83567593|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83567594|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567595|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
83567596|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
83567597|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
83567598|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567599|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
83567600|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83567601|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83567602|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
83567603|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567604|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
83567605|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83567606|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
83567607|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567608|NCT00000997|Zalcitabine|zalcitabine|mesh-list
83567609|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
83567610|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567611|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567612|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567613|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567614|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
83567615|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567616|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567617|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567618|NCT00000697|Foscarnet|foscarnet|mesh-list
83567619|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83567620|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
83567621|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567622|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567623|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567624|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567625|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567626|NCT00001009|Dextrans|dextrans|mesh-list
83567627|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
83567628|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
83567629|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
83567630|NCT00000703|Leucovorin|leucovorin|mesh-list
83567631|NCT00000703|Cytarabine|cytarabine|mesh-list
83567632|NCT00000703|Zidovudine|zidovudine|mesh-list
83567633|NCT00000703|Dexamethasone|dexamethasone|mesh-list
83567634|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
83567635|NCT00000703|Doxorubicin|doxorubicin|mesh-list
83567636|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83567637|NCT00000703|Methotrexate|methotrexate|mesh-list
83567638|NCT00000703|Vincristine|vincristine|mesh-list
83567639|NCT00000703|Bleomycin|bleomycin|mesh-list
83567640|NCT00000703|Allopurinol|allopurinol|mesh-list
83567641|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
83567642|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83567643|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
83567644|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567645|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83567646|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83567647|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
83567648|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567649|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567650|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83567651|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83567652|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
83567653|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
83567654|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567655|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83567656|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
83567657|NCT00000703|Hormones|hormones|mesh-ancestor
83567658|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83567659|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83567660|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83567661|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83567662|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83567663|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567664|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83567665|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
83567666|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83567667|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83567668|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
83567669|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
83567670|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83567671|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567672|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
83567673|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567674|NCT00000703|Antidotes|antidotes|mesh-ancestor
83567675|NCT00000703|Protective Agents|protective agents|mesh-ancestor
83567676|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
83567677|NCT00000703|Vitamins|vitamins|mesh-ancestor
83567678|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
83567679|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83567680|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
83567681|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
83567682|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
83567683|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567684|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567685|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567686|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
83567687|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83567688|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
83567689|NCT00001015|Ribavirin|ribavirin|mesh-list
83567690|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
83567691|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567692|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
83567693|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567694|NCT00000709|Zidovudine|zidovudine|mesh-list
83567695|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
83567696|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567697|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567698|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567699|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567700|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
83567701|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567702|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567703|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567704|NCT00001027|Pentamidine|pentamidine|mesh-list
83567705|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
83567706|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567707|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83567708|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567709|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83567710|NCT00000727|Zidovudine|zidovudine|mesh-list
83567711|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
83567712|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
83567713|NCT00000727|Trimethoprim|trimethoprim|mesh-list
83567714|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
83567715|NCT00000727|Pentamidine|pentamidine|mesh-list
83567716|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83567717|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
83567718|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567719|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567720|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567721|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567722|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
83567723|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567724|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567725|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567726|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
83567727|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83567728|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567729|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83567730|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83567731|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83567732|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83567733|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567734|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
83567735|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83567736|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567737|NCT00001039|Clarithromycin|clarithromycin|mesh-list
83567738|NCT00001039|Ethambutol|ethambutol|mesh-list
83567739|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567740|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567741|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83567742|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567743|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567744|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83567745|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567746|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
83567747|NCT00001057|Zidovudine|zidovudine|mesh-list
83567748|NCT00001057|Didanosine|didanosine|mesh-list
83567749|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
83567750|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567751|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567752|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567753|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567754|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
83567755|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567756|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567757|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567758|NCT00002293|Nystatin|nystatin|mesh-list
83567759|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567760|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567761|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
83567762|NCT00002293|Ionophores|ionophores|mesh-ancestor
83567763|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83845092|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83567764|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567765|NCT00002299|Interferons|interferons|mesh-list
83567766|NCT00002299|Interferon-beta|interferon-beta|mesh-list
83567767|NCT00002299|Ganciclovir|ganciclovir|mesh-list
83567768|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83567769|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
83567770|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567771|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
83567772|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567773|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
83567774|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567775|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567776|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567777|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567778|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83567779|NCT00001063|Zidovudine|zidovudine|mesh-list
83567780|NCT00001063|Stavudine|stavudine|mesh-list
83567781|NCT00001063|Didanosine|didanosine|mesh-list
83567782|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
83567783|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567784|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567785|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567786|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567787|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
83567788|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567789|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567790|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567791|NCT00002305|Fluconazole|fluconazole|mesh-list
83567792|NCT00002305|Amphotericin B|amphotericin b|mesh-list
83567793|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83567794|NCT00002305|Flucytosine|flucytosine|mesh-list
83567795|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
83567796|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567797|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83567798|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567799|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567800|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567801|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83567802|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
83567803|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83567804|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567805|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83567806|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83567807|NCT00002305|Amebicides|amebicides|mesh-ancestor
83567808|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83567809|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567810|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83567811|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
83567812|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
83567813|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83567814|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567815|NCT00002311|Wobenzym|wobenzym|mesh-list
83567816|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83567817|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
83567818|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567819|NCT00002317|Leucovorin|leucovorin|mesh-list
83567820|NCT00002317|Trimetrexate|trimetrexate|mesh-list
83567821|NCT00002317|Calcium|calcium|mesh-list
83567822|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
83567823|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83567824|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567825|NCT00002317|Antidotes|antidotes|mesh-ancestor
83567826|NCT00002317|Protective Agents|protective agents|mesh-ancestor
83567827|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
83567828|NCT00002317|Vitamins|vitamins|mesh-ancestor
83567829|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
83567830|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
83567831|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567832|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83567833|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
83567834|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567835|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567836|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83567837|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567838|NCT00001123|Ribavirin|ribavirin|mesh-list
83567839|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
83845093|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567840|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567841|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
83567842|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567843|NCT00002323|Zidovudine|zidovudine|mesh-list
83567844|NCT00002323|Nevirapine|nevirapine|mesh-list
83567845|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
83567846|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567847|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567848|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567849|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567850|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
83567851|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567852|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567853|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567854|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83567855|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83567856|NCT00380965|Nabilone|nabilone|mesh-list
83567857|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
83567858|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
83567859|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567860|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567861|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83567862|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83567863|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83567864|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83567865|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567866|NCT00001135|Nevirapine|nevirapine|mesh-list
83567867|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567868|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567869|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567870|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567871|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
83567872|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567873|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567874|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567875|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83567876|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83567877|NCT00003002|Sargramostim|sargramostim|mesh-list
83567878|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
83567879|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567880|NCT00001891|Dobutamine|dobutamine|mesh-list
83567881|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83567882|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
83567883|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
83567884|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567885|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567886|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83567887|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83567888|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83567889|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83567890|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567891|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567892|NCT00001891|Protective Agents|protective agents|mesh-ancestor
83567893|NCT00383864|Interferons|interferons|mesh-list
83567894|NCT00383864|Ribavirin|ribavirin|mesh-list
83567895|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567896|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
83567897|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567898|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
83567899|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567900|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
83567901|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83567902|NCT00001903|Antibodies|antibodies|mesh-list
83567903|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
83567904|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567905|NCT00002335|Emtricitabine|emtricitabine|mesh-list
83567906|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
83567907|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567908|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567909|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567910|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567911|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567912|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567913|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567914|NCT00002341|Itraconazole|itraconazole|mesh-list
83567915|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
83567916|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567917|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83567918|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567919|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567920|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567921|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83567922|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
83567923|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83567924|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567925|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83567927|NCT00002347|Nevirapine|nevirapine|mesh-list
83567928|NCT00002347|Zalcitabine|zalcitabine|mesh-list
83567929|NCT00002347|Saquinavir|saquinavir|mesh-list
83567930|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
83567931|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567932|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83567933|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567934|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567935|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
83567936|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567937|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83567938|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83567939|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83567940|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83567941|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83567942|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83567943|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
83567944|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83567945|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83567946|NCT00001237|Molgramostim|molgramostim|mesh-list
83567947|NCT00001237|Sargramostim|sargramostim|mesh-list
83567948|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
83567949|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567950|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83567951|NCT00001933|Nefiracetam|nefiracetam|mesh-list
83567952|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83567953|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83567954|NCT00001933|Protective Agents|protective agents|mesh-ancestor
83567955|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567956|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
83567957|NCT00001249|Antibodies|antibodies|mesh-list
83567958|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
83567959|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567960|NCT00380575|Conivaptan|conivaptan|mesh-list
83567961|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83567962|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567963|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
83567964|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567965|NCT00001963|Chrysarobin|chrysarobin|mesh-list
83567966|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
83567967|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83567968|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
83567969|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83567970|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83567971|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83567972|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
83567973|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83567974|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
83567975|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567976|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83567977|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83567978|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
83567979|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
83567980|NCT00001963|Protective Agents|protective agents|mesh-ancestor
83567981|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83567982|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83567983|NCT00001963|Analgesics|analgesics|mesh-ancestor
83567984|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
83567985|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83567986|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83567987|NCT00002377|Valganciclovir|valganciclovir|mesh-list
83567988|NCT00002377|Ganciclovir|ganciclovir|mesh-list
83567989|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83567990|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
83567991|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83567992|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83567993|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83567994|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83567995|NCT00001339|Doxorubicin|doxorubicin|mesh-list
83567996|NCT00001339|Etoposide|etoposide|mesh-list
83567997|NCT00001339|Vincristine|vincristine|mesh-list
83567998|NCT00001339|Mitotane|mitotane|mesh-list
83567999|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568000|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568001|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568002|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568003|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568004|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568005|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83568006|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
83568007|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
83568008|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
83568009|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83568010|NCT00001993|Miglustat|miglustat|mesh-list
83568011|NCT00001993|Zidovudine|zidovudine|mesh-list
83568012|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
83568013|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568014|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568015|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568016|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568017|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
83568018|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568019|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568020|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568021|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83568022|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83568023|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568024|NCT00001999|Ganciclovir|ganciclovir|mesh-list
83568025|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83568026|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
83568027|NCT00001999|Antibodies|antibodies|mesh-list
83568028|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
83568029|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568030|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568031|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568032|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568033|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
83568034|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568035|NCT00002383|Saquinavir|saquinavir|mesh-list
83568036|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568037|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568038|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568039|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568040|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568041|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568042|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568043|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
83568044|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568045|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83568046|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568047|NCT00002389|Lamivudine|lamivudine|mesh-list
83568048|NCT00002389|Zidovudine|zidovudine|mesh-list
83568049|NCT00002389|Abacavir|abacavir|mesh-list
83568050|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568051|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568052|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568053|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568054|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
83568055|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568056|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568057|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568058|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
83568059|NCT00001357|Interleukin-2|interleukin-2|mesh-list
83568060|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568061|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83568062|NCT00001357|Analgesics|analgesics|mesh-ancestor
83568063|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
83568064|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568065|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568066|NCT00001381|Suramin|suramin|mesh-list
83568067|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
83568068|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
83568069|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83568070|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568071|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568072|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83456963|NCT03503578|Sevoflurane|sevoflurane|mesh-list
83568073|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83568074|NCT00002011|Methoxsalen|methoxsalen|mesh-list
83568075|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83568076|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
83568077|NCT00002017|Interleukin-2|interleukin-2|mesh-list
83568078|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568079|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83568080|NCT00002017|Analgesics|analgesics|mesh-ancestor
83568081|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
83568082|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568083|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568084|NCT00002023|Zidovudine|zidovudine|mesh-list
83568085|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
83568086|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568087|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568088|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568089|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568090|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
83568091|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568092|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568093|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568094|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83568095|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83568096|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83568097|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83568098|NCT00002035|Zidovudine|zidovudine|mesh-list
83568099|NCT00002035|Didanosine|didanosine|mesh-list
83568100|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
83568101|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568102|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568103|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568104|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568105|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
83568106|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568107|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568108|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568109|NCT00002041|Amphotericin B|amphotericin b|mesh-list
83568110|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83568111|NCT00002041|Amebicides|amebicides|mesh-ancestor
83568112|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83568113|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83568114|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568115|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83568116|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
83568117|NCT00002047|Zidovudine|zidovudine|mesh-list
83568118|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
83568119|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568120|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568121|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568122|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568123|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
83568124|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568125|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568126|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568127|NCT00002053|Pentamidine|pentamidine|mesh-list
83568128|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
83568129|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568130|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83568131|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83568132|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83568133|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
83568134|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83568135|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
83568136|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568137|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
83568138|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568139|NCT00002065|Disulfiram|disulfiram|mesh-list
83568140|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83568141|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83568142|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845094|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568143|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568144|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
83568145|NCT00002071|Hematinics|hematinics|mesh-ancestor
83568146|NCT00002395|Topotecan|topotecan|mesh-list
83568147|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83568148|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568149|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568150|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568151|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568152|NCT00002401|Lamivudine|lamivudine|mesh-list
83568153|NCT00002401|Zidovudine|zidovudine|mesh-list
83568154|NCT00002401|Delavirdine|delavirdine|mesh-list
83568155|NCT00002401|Indinavir|indinavir|mesh-list
83568156|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568157|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568158|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568159|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568160|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
83568161|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568162|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568163|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568164|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
83568165|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568166|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568167|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568168|NCT00002407|Lamivudine|lamivudine|mesh-list
83568169|NCT00002407|Nevirapine|nevirapine|mesh-list
83568170|NCT00002407|Stavudine|stavudine|mesh-list
83568171|NCT00002407|Didanosine|didanosine|mesh-list
83568172|NCT00002407|Indinavir|indinavir|mesh-list
83568173|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568174|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568175|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568176|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568177|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
83568178|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568179|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568180|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568181|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83568182|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83568183|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
83568184|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568185|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568186|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568187|NCT00002413|Emivirine|emivirine|mesh-list
83568188|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568189|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568190|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568191|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568192|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
83568193|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568194|NCT00002419|Efavirenz|efavirenz|mesh-list
83568195|NCT00002419|Abacavir|abacavir|mesh-list
83568196|NCT00002419|Adefovir|adefovir|mesh-list
83568197|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83568198|NCT00002419|Amprenavir|amprenavir|mesh-list
83568199|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568200|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568201|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568202|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568203|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
83568204|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568205|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83568206|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568207|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83568208|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83568209|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83568210|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83568211|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568212|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568213|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83568214|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
83568215|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83568216|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568217|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568218|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568219|NCT00381511|Heparin|heparin|mesh-list
83568220|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83568221|NCT00381511|Tinzaparin|tinzaparin|mesh-list
83568222|NCT00381511|Dalteparin|dalteparin|mesh-list
83568223|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
83568224|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83568225|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83568226|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568227|NCT00002425|Saquinavir|saquinavir|mesh-list
83568228|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568229|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568230|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568231|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568232|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568233|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568234|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568235|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
83568236|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568237|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83568238|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568239|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
83568240|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83568241|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83568242|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568243|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
83568244|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
83568245|NCT00002077|Fluconazole|fluconazole|mesh-list
83568246|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
83568247|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568248|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83568249|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568250|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568251|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568252|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83568253|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
83568254|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568255|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568256|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83568257|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83568258|NCT00002089|Azithromycin|azithromycin|mesh-list
83568259|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83568260|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568261|NCT00002095|Ganciclovir|ganciclovir|mesh-list
83568262|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83568263|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
83568264|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568265|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568266|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568267|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568268|NCT00002101|Clarithromycin|clarithromycin|mesh-list
83568269|NCT00002101|Ethambutol|ethambutol|mesh-list
83568270|NCT00002101|Rifabutin|rifabutin|mesh-list
83568271|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83568272|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568273|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83568274|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568275|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568276|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83568277|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568278|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
83568279|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83568280|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
83568281|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83568282|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568283|NCT02335424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83568284|NCT02335424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568285|NCT00002107|Aldesleukin|aldesleukin|mesh-list
83568286|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568287|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568288|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568289|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
83568290|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568291|NCT00002113|Fluconazole|fluconazole|mesh-list
83568292|NCT00002113|Flucytosine|flucytosine|mesh-list
83568293|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
83568294|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568295|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83568296|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568297|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568298|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568299|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83568300|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
83568301|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568302|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568303|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83568304|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83568305|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
83568306|NCT00002437|Cidofovir|cidofovir|mesh-list
83568307|NCT00002437|Probenecid|probenecid|mesh-list
83568308|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
83568309|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
83568310|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568311|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
83568312|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568313|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568314|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568315|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
83568316|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83568317|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83568318|NCT04329650|Prednisolone|prednisolone|mesh-list
83568319|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
83568320|NCT04329650|Siltuximab|siltuximab|mesh-list
83568321|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83568322|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
83568323|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83568324|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
83568325|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
83568326|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568327|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568328|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83568329|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
83568330|NCT04329650|Hormones|hormones|mesh-ancestor
83568331|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568332|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83568333|NCT04329650|Protective Agents|protective agents|mesh-ancestor
83568334|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83568335|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568336|NCT00002443|Zidovudine|zidovudine|mesh-list
83568337|NCT00002443|Indinavir|indinavir|mesh-list
83568338|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
83568339|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568340|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568341|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568342|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568343|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
83568344|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568345|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568346|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568347|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568348|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568349|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568350|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
83568351|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83568352|NCT00001561|Antibodies|antibodies|mesh-list
83568353|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83568354|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
83568355|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568356|NCT00002449|Aldesleukin|aldesleukin|mesh-list
83568357|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568358|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568359|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568360|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
83568361|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568362|NCT00003014|Carboplatin|carboplatin|mesh-list
83568363|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568364|NCT00002125|Foscarnet|foscarnet|mesh-list
83568365|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83568366|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
83568367|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568368|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568369|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568370|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568371|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568372|NCT00001579|Leucovorin|leucovorin|mesh-list
83568373|NCT00001579|Fluorouracil|fluorouracil|mesh-list
83568374|NCT00001579|Eniluracil|eniluracil|mesh-list
83568375|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
83568376|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568377|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83568378|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568379|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568380|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
83568381|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568382|NCT00001579|Antidotes|antidotes|mesh-ancestor
83568383|NCT00001579|Protective Agents|protective agents|mesh-ancestor
83568384|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
83568385|NCT00001579|Vitamins|vitamins|mesh-ancestor
83568386|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
83568387|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568388|NCT00003020|Immunotoxins|immunotoxins|mesh-list
83568389|NCT00003020|Immunoconjugates|immunoconjugates|mesh-ancestor
83568390|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
83568391|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568392|NCT00002131|Vesnarinone|vesnarinone|mesh-list
83568393|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83568394|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
83568395|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568396|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568397|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
83568398|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568399|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83568400|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83568401|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568402|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568403|NCT00002131|Protective Agents|protective agents|mesh-ancestor
83568404|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83568405|NCT00380887|Estrogens|estrogens|mesh-ancestor
83568406|NCT00380887|Hormones|hormones|mesh-ancestor
83568407|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568408|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568409|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
83568410|NCT00002461|Carmustine|carmustine|mesh-list
83568411|NCT00002461|Etoposide|etoposide|mesh-list
83568412|NCT00002461|Sargramostim|sargramostim|mesh-list
83568413|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568414|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
83568415|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568416|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568417|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568418|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
83568419|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568420|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568421|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568422|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83568423|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568424|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568425|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568426|NCT00003026|Bicalutamide|bicalutamide|mesh-list
83568427|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83568428|NCT00003026|Flutamide|flutamide|mesh-list
83568429|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
83568430|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
83568431|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568432|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568433|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568434|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
83568435|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83568436|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
83568437|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83568438|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83568439|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83568440|NCT00002143|Acitretin|acitretin|mesh-list
83568441|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
83568442|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83568443|NCT00002149|Amoxicillin|amoxicillin|mesh-list
83568444|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
83568445|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
83568446|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
83568447|NCT00002149|Ephedrine|ephedrine|mesh-list
83568448|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83568449|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568450|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83568451|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568452|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568453|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83568454|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
83568455|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568456|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568457|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83568458|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83568459|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
83568460|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83568461|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83568462|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
83568463|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83568464|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83568465|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83568466|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568467|NCT03868046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83568468|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568469|NCT02973295|Silymarin|silymarin|mesh-list
83568470|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
83568471|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568472|NCT02973295|Protective Agents|protective agents|mesh-ancestor
83568473|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568474|NCT00003032|Tamoxifen|tamoxifen|mesh-list
83568475|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
83568476|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
83568477|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568478|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
83568479|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568480|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568481|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568482|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
83568483|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568484|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568485|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568486|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83568487|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
83568488|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568489|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83568490|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83568491|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83568492|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83568493|NCT00003032|Analgesics|analgesics|mesh-ancestor
83568494|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
83568495|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568496|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568497|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568498|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568499|NCT00002155|Lamivudine|lamivudine|mesh-list
83568500|NCT00002155|Zidovudine|zidovudine|mesh-list
83568501|NCT00002155|Indinavir|indinavir|mesh-list
83568502|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568503|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568504|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568505|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568506|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
83568507|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568508|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568509|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568510|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
83568511|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568512|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568513|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568514|NCT00003038|Suramin|suramin|mesh-list
83568515|NCT00003038|Doxorubicin|doxorubicin|mesh-list
83568516|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83568517|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568518|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568519|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568520|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568521|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568522|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568523|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
83568524|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
83568525|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83568526|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568527|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83568528|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83568529|NCT00003044|Cisplatin|cisplatin|mesh-list
83568530|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568531|NCT00002161|Adefovir|adefovir|mesh-list
83568532|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83568533|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
83568534|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568535|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568536|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568537|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568538|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568539|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
83568540|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83568541|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
83568542|NCT03805022|Doxorubicin|doxorubicin|mesh-list
83568543|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83568544|NCT03805022|Ifosfamide|ifosfamide|mesh-list
83568545|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
83568546|NCT03805022|Dacarbazine|dacarbazine|mesh-list
83568547|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568548|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568549|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568550|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568551|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568552|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568553|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568554|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
83568555|NCT05752435|Bleomycin|bleomycin|mesh-list
83568556|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568557|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568558|NCT00003050|Tamoxifen|tamoxifen|mesh-list
83568559|NCT00003050|Paclitaxel|paclitaxel|mesh-list
83568560|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
83568561|NCT00003050|Doxorubicin|doxorubicin|mesh-list
83568562|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83568563|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83568564|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568565|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
83568566|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
83568567|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
83568568|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568569|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568570|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
83568571|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568572|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568573|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568574|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
83568575|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568576|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568577|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568578|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568579|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568580|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83568581|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83568582|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568583|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83568584|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83568585|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83568586|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83568587|NCT00002179|Lamivudine|lamivudine|mesh-list
83568588|NCT00002179|Zidovudine|zidovudine|mesh-list
83568589|NCT00002179|Indinavir|indinavir|mesh-list
83568590|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568591|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568592|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568593|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568594|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
83568595|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568596|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568597|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568598|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
83568599|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568600|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568601|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568602|NCT00003056|Cyclosporine|cyclosporine|mesh-list
83568603|NCT00003056|Methotrexate|methotrexate|mesh-list
83568604|NCT00003056|Cyclosporins|cyclosporins|mesh-list
83568605|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83568606|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
83568607|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83568608|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568609|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83568610|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
83568611|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568612|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568613|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83568614|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568615|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83568616|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568617|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
83568618|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568619|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568620|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
83568621|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568622|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83568623|NCT00002185|Nelfinavir|nelfinavir|mesh-list
83568624|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568625|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568626|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568627|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568628|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568629|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568630|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568631|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
83568632|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568633|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
83568634|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83568635|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83568636|NCT00003062|Temozolomide|temozolomide|mesh-list
83568637|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568638|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
83568639|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568640|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568641|NCT00002191|Albendazole|albendazole|mesh-list
83568642|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
83568643|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83568644|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568645|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
83568646|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83568647|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83568648|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
83568649|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
83568650|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
83568651|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568652|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568653|NCT00383396|Cyclosporine|cyclosporine|mesh-list
83568654|NCT00383396|Cyclosporins|cyclosporins|mesh-list
83568655|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568656|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568657|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568658|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
83568659|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568660|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
83568661|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568662|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
83568663|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568664|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83568665|NCT00002197|Abacavir|abacavir|mesh-list
83568666|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568667|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568668|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568669|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568670|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
83568671|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568672|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568673|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568674|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
83568676|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
83568677|NCT00003068|Amifostine|amifostine|mesh-list
83568678|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568679|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
83568680|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568681|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568682|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568683|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
83568684|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568685|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568686|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568687|NCT00003068|Analgesics|analgesics|mesh-ancestor
83568688|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
83568689|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568690|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568691|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568692|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568693|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83568694|NCT00003068|Protective Agents|protective agents|mesh-ancestor
83568695|NCT00003080|Tamoxifen|tamoxifen|mesh-list
83568696|NCT00003080|Melphalan|melphalan|mesh-list
83568697|NCT00003080|Thiotepa|thiotepa|mesh-list
83568698|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
83568699|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568700|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568701|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
83568702|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568703|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568704|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568705|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
83568706|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568707|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83568708|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83568709|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568710|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83568711|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83568712|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83568713|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83568714|NCT00003080|Analgesics|analgesics|mesh-ancestor
83568715|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
83568716|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568717|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568718|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568719|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568720|NCT00002203|Lamivudine|lamivudine|mesh-list
83568721|NCT00002203|Zidovudine|zidovudine|mesh-list
83568722|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83568723|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568724|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568725|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568726|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568727|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
83568728|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568729|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568730|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568731|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
83568732|NCT01568918|Tamsulosin|tamsulosin|mesh-list
83568733|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83568734|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83568735|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83568736|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83568737|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83568738|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568739|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568740|NCT01568918|Urological Agents|urological agents|mesh-ancestor
83568741|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
83568742|NCT00003086|Carboplatin|carboplatin|mesh-list
83568743|NCT00003086|Doxorubicin|doxorubicin|mesh-list
83568744|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83568745|NCT00003086|Fluorouracil|fluorouracil|mesh-list
83568746|NCT00003086|Melphalan|melphalan|mesh-list
83568747|NCT00003086|Ifosfamide|ifosfamide|mesh-list
83568748|NCT00003086|Thiotepa|thiotepa|mesh-list
83568749|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83568750|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568751|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568752|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568753|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
83568754|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568755|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568756|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568757|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
83568758|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568759|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568760|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568761|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568762|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568763|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
83568764|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83568765|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83568766|NCT00003086|Analgesics|analgesics|mesh-ancestor
83568767|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
83568768|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568769|NCT00003092|Paclitaxel|paclitaxel|mesh-list
83568770|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83568771|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568772|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
83568773|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
83568774|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
83568775|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568776|NCT00381199|Amitriptyline|amitriptyline|mesh-list
83568777|NCT00381199|Nabilone|nabilone|mesh-list
83568778|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83568779|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
83568780|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83568781|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83568782|NCT00381199|Analgesics|analgesics|mesh-ancestor
83568783|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
83568784|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568785|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568786|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83568787|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83568788|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83568789|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568790|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
83568791|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83568792|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
83568793|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
83568794|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83568795|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83568796|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83568797|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83568798|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
83568799|NCT00002509|Carboplatin|carboplatin|mesh-list
83568800|NCT00002509|Etoposide|etoposide|mesh-list
83568801|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568802|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
83568803|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568804|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568805|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568806|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
83568807|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568808|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568809|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568810|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83568811|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568812|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568813|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568814|NCT00002515|Carboplatin|carboplatin|mesh-list
83568815|NCT00002515|Topotecan|topotecan|mesh-list
83568816|NCT00002515|Thiotepa|thiotepa|mesh-list
83568817|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568818|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
83568819|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568820|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83568821|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568822|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026935|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
83027012|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83568823|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568824|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568825|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
83568826|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568827|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568828|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
83568829|NCT00002521|Etoposide|etoposide|mesh-list
83568830|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568831|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
83568832|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568833|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568834|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568835|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
83568836|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568837|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568838|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568839|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83568840|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568841|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568842|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568843|NCT00003110|Bleomycin|bleomycin|mesh-list
83568844|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568845|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568846|NCT00002215|Nelfinavir|nelfinavir|mesh-list
83568847|NCT00002215|Emivirine|emivirine|mesh-list
83568848|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568849|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568850|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568851|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568852|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568853|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568854|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568855|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
83568856|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568857|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568858|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568859|NCT00003116|Cyclosporine|cyclosporine|mesh-list
83568860|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
83568861|NCT00003116|Busulfan|busulfan|mesh-list
83568862|NCT00003116|Cyclosporins|cyclosporins|mesh-list
83568863|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83568864|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
83568865|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568866|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568867|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568868|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
83568869|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568870|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568871|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83568872|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568873|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
83568874|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568875|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
83568876|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83568877|NCT00002227|Lamivudine|lamivudine|mesh-list
83568878|NCT00002227|Efavirenz|efavirenz|mesh-list
83568879|NCT00002227|Stavudine|stavudine|mesh-list
83568880|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568881|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568882|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568883|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568884|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
83568885|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568886|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568887|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568888|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83568889|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568890|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83568891|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83568892|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83568893|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83568894|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
83568895|NCT03689972|Natalizumab|natalizumab|mesh-list
83568896|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
83568898|NCT00002233|Lamivudine|lamivudine|mesh-list
83568899|NCT00002233|Abacavir|abacavir|mesh-list
83568900|NCT00002233|Indinavir|indinavir|mesh-list
83568901|NCT00002233|Amprenavir|amprenavir|mesh-list
83568902|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568903|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568904|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568905|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568906|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
83568907|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568908|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568909|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568910|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568911|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568912|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568913|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83568914|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
83568915|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83568916|NCT00002527|Aspirin|aspirin|mesh-list
83568917|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83568918|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83568919|NCT00002527|Analgesics|analgesics|mesh-ancestor
83568920|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
83568921|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568922|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568923|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83568924|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83568925|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83568926|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83568927|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568928|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83568929|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83568930|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568931|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
83568932|NCT03688178|Temozolomide|temozolomide|mesh-list
83568933|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83568934|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
83568935|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568936|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568937|NCT00002533|Fluconazole|fluconazole|mesh-list
83568938|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
83568939|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568940|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83568941|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568942|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568943|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568944|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83568945|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
83568946|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83568947|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568948|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83568949|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83568950|NCT00002539|Doxorubicin|doxorubicin|mesh-list
83568951|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83568952|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83568953|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83568954|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83568955|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83568956|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568957|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568958|NCT00381589|Bromides|bromides|mesh-list
83568959|NCT00381589|Ipratropium|ipratropium|mesh-list
83568960|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
83568961|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83568962|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
83568963|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83568964|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83568965|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83568966|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
83568967|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83568968|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
83568969|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83568970|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568972|NCT00002239|Amprenavir|amprenavir|mesh-list
83568973|NCT00002239|Abacavir|abacavir|mesh-list
83568974|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
83568975|NCT00002239|Efavirenz|efavirenz|mesh-list
83568976|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83568977|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83568978|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
83568979|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83568980|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83568981|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83568982|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83568983|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
83568984|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83568985|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83568986|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83568987|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83568988|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83568989|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83568990|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83568991|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83568992|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83568993|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83568994|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83568995|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
83568996|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83568997|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83568998|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83568999|NCT00383474|Bortezomib|bortezomib|mesh-list
83569000|NCT00383474|Tipifarnib|tipifarnib|mesh-list
83569001|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569002|NCT00002245|Lamivudine|lamivudine|mesh-list
83569003|NCT00002245|Abacavir|abacavir|mesh-list
83569004|NCT00002245|Amprenavir|amprenavir|mesh-list
83569005|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83569006|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569007|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569008|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569009|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
83569010|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569011|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569012|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83569013|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83569014|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
83569015|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83569016|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83569017|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83569018|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
83569019|NCT00003128|Paclitaxel|paclitaxel|mesh-list
83569020|NCT00003128|Ifosfamide|ifosfamide|mesh-list
83569021|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569022|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569023|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569024|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569025|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569026|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569027|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569028|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
83569029|NCT04331197|Letrozole|letrozole|mesh-list
83569030|NCT04331197|Clomiphene|clomiphene|mesh-list
83569031|NCT04331197|Enclomiphene|enclomiphene|mesh-list
83569032|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
83569033|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569034|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569035|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83569036|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83569037|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569038|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83569039|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
83569040|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569041|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569042|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83569043|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
83569044|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83569045|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83569046|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83569047|NCT05751733|Sunitinib|sunitinib|mesh-list
83569048|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
83569049|NCT05751733|Apatinib|apatinib|mesh-list
83569050|NCT05751733|Dasatinib|dasatinib|mesh-list
83569051|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569052|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83569053|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83569054|NCT05751733|Growth Substances|growth substances|mesh-ancestor
83569055|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569056|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
83569057|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83569058|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569059|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569060|NCT00002798|Cytarabine|cytarabine|mesh-list
83569061|NCT00002798|Aldesleukin|aldesleukin|mesh-list
83569062|NCT00002798|Dexamethasone|dexamethasone|mesh-list
83569063|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
83569064|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83569065|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83569066|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83569067|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
83569068|NCT00002798|Busulfan|busulfan|mesh-list
83569069|NCT00002798|Methotrexate|methotrexate|mesh-list
83569070|NCT00002798|Fludarabine|fludarabine|mesh-list
83569071|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
83569072|NCT00002798|Etoposide|etoposide|mesh-list
83569073|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
83569074|NCT00002798|Daunorubicin|daunorubicin|mesh-list
83569075|NCT00002798|Interleukin-2|interleukin-2|mesh-list
83569076|NCT00002798|Asparaginase|asparaginase|mesh-list
83569077|NCT00002798|Idarubicin|idarubicin|mesh-list
83569078|NCT00002798|Thioguanine|thioguanine|mesh-list
83569079|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569080|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
83569081|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569082|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569083|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569084|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
83569085|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569086|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569087|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569088|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83569089|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
83569090|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
83569091|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83569092|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83569093|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
83569094|NCT00002798|Hormones|hormones|mesh-ancestor
83569095|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569096|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83569097|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83569098|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
83569099|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83569100|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569101|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
83569102|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83569103|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569104|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83569105|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569106|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569107|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569108|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569109|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
83569110|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569111|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569112|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83569113|NCT00002798|Analgesics|analgesics|mesh-ancestor
83569114|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
83569115|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569116|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83027239|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569117|NCT00002251|Ganciclovir|ganciclovir|mesh-list
83569118|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83569119|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
83569120|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569121|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569122|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569123|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569124|NCT00002257|Ganciclovir|ganciclovir|mesh-list
83569125|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83569126|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
83569127|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569128|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569129|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569130|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569131|NCT00003134|Irinotecan|irinotecan|mesh-list
83569132|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83569133|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569134|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569135|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569136|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569137|NCT00002545|Carmustine|carmustine|mesh-list
83569138|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569139|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
83569140|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569141|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569142|NCT00002804|Cobalt|cobalt|mesh-list
83569143|NCT00002804|Doxorubicin|doxorubicin|mesh-list
83569144|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83569145|NCT00002804|Vincristine|vincristine|mesh-list
83569146|NCT00002804|Ifosfamide|ifosfamide|mesh-list
83569147|NCT00002804|Lenograstim|lenograstim|mesh-list
83569148|NCT00002804|Mesna|mesna|mesh-list
83569149|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569150|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569151|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569152|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569153|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569154|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569155|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83569156|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
83569157|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569158|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569159|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569160|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569161|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569162|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569163|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
83569164|NCT00002804|Protective Agents|protective agents|mesh-ancestor
83569165|NCT00002804|Trace Elements|trace elements|mesh-ancestor
83569166|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
83569167|NCT00002810|Melphalan|melphalan|mesh-list
83569168|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
83569169|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569170|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569171|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
83569172|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569173|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569174|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569175|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569176|NCT00003140|Letrozole|letrozole|mesh-list
83569177|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569178|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83569179|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83569180|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569181|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569182|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83569183|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
83569184|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569185|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569186|NCT00003392|Paclitaxel|paclitaxel|mesh-list
83569187|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
83569188|NCT00003392|Carboplatin|carboplatin|mesh-list
83569189|NCT00003392|Melphalan|melphalan|mesh-list
83569190|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569191|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569192|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569193|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569194|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569195|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569196|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569197|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
83569198|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569199|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569200|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569201|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
83569202|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569204|NCT00002551|Levamisole|levamisole|mesh-list
83569205|NCT00002551|Fluorouracil|fluorouracil|mesh-list
83569206|NCT00002551|Calcium|calcium|mesh-list
83569207|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
83569208|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83569209|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569210|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
83569211|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569212|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569213|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569214|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569215|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
83569216|NCT00002551|Antidotes|antidotes|mesh-ancestor
83569217|NCT00002551|Protective Agents|protective agents|mesh-ancestor
83569218|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
83569219|NCT00002551|Vitamins|vitamins|mesh-ancestor
83569220|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
83569221|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83569222|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
83569223|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
83569224|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83569225|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569226|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569227|NCT00003146|Melphalan|melphalan|mesh-list
83569228|NCT00003146|Busulfan|busulfan|mesh-list
83569229|NCT00003146|Thiotepa|thiotepa|mesh-list
83569230|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569231|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
83569232|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569233|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569234|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569235|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569236|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
83569237|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569238|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
83569239|NCT00003398|Thiotepa|thiotepa|mesh-list
83569240|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83569241|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569242|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
83569243|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569244|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569245|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569246|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
83569247|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569248|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569249|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569250|NCT00002263|Zidovudine|zidovudine|mesh-list
83569251|NCT00002263|Sargramostim|sargramostim|mesh-list
83569252|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
83569253|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569254|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83569255|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569256|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569257|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
83569258|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569259|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569260|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83027386|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027387|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027388|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83027389|NCT02153450|Metformin|metformin|mesh-list
83027390|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83027391|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027392|NCT05598281|Sotorasib|sotorasib|mesh-list
83027393|NCT05598281|Digoxin|digoxin|mesh-list
83027394|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83027395|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83027396|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027398|NCT05598281|Protective Agents|protective agents|mesh-ancestor
83569261|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
83569262|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569263|NCT00002816|Leucovorin|leucovorin|mesh-list
83569264|NCT00002816|Cobalt|cobalt|mesh-list
83569265|NCT00002816|Cytarabine|cytarabine|mesh-list
83569266|NCT00002816|Dexamethasone|dexamethasone|mesh-list
83569267|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
83569268|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83569269|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83569270|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83569271|NCT00002816|Methotrexate|methotrexate|mesh-list
83569272|NCT00002816|Etoposide|etoposide|mesh-list
83569273|NCT00002816|Vincristine|vincristine|mesh-list
83569274|NCT00002816|Asparaginase|asparaginase|mesh-list
83569275|NCT00002816|Ifosfamide|ifosfamide|mesh-list
83569276|NCT00002816|Idarubicin|idarubicin|mesh-list
83569277|NCT00002816|Pegaspargase|pegaspargase|mesh-list
83569278|NCT00002816|Thioguanine|thioguanine|mesh-list
83569279|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
83569280|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83569281|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
83569282|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
83569283|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83569284|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569285|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83569286|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
83569287|NCT00002816|Hormones|hormones|mesh-ancestor
83569288|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569289|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83569290|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569291|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83569292|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
83569293|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83569294|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569295|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
83569296|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569297|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
83569298|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569299|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83569300|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569301|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
83569302|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569303|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569304|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569305|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569306|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569307|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
83569308|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569309|NCT00002816|Antidotes|antidotes|mesh-ancestor
83569310|NCT00002816|Protective Agents|protective agents|mesh-ancestor
83569311|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
83569312|NCT00002816|Vitamins|vitamins|mesh-ancestor
83569313|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
83569314|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569315|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569316|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569317|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569318|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
83569319|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569320|NCT00002816|Trace Elements|trace elements|mesh-ancestor
83569321|NCT00002269|Zidovudine|zidovudine|mesh-list
83569322|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83569323|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
83569324|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569325|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83569326|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569327|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569328|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
83569329|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569330|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569331|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83569332|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83569333|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83569334|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83569335|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83569336|NCT00003152|Interferons|interferons|mesh-list
83569337|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
83569338|NCT00003152|Prednisone|prednisone|mesh-list
83569339|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
83569340|NCT00003152|Vincristine|vincristine|mesh-list
83569341|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569342|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
83569343|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569344|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569345|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569346|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
83569347|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569348|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569349|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569350|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83569351|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
83569352|NCT00003152|Hormones|hormones|mesh-ancestor
83569353|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569354|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83569355|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
83569356|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569357|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569358|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569359|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569360|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569361|NCT05751421|Meloxicam|meloxicam|mesh-list
83569362|NCT05751421|Bupivacaine|bupivacaine|mesh-list
83569363|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83569364|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
83569365|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
83569366|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83569367|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569368|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
83569369|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83569370|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83569371|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83569372|NCT05751421|Analgesics|analgesics|mesh-ancestor
83569373|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83569374|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569375|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83569376|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83569377|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569378|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569379|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
83569380|NCT00002822|Ifosfamide|ifosfamide|mesh-list
83569381|NCT00002822|Carboplatin|carboplatin|mesh-list
83569382|NCT00002822|Doxorubicin|doxorubicin|mesh-list
83569383|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83569384|NCT00002822|Etoposide|etoposide|mesh-list
83569385|NCT00002822|Vincristine|vincristine|mesh-list
83569386|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569387|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
83569388|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569389|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569390|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569391|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
83569392|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569393|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569394|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569395|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569396|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569397|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569398|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569399|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569400|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569401|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569402|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569403|NCT00002281|Zidovudine|zidovudine|mesh-list
83569404|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
83569405|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
83569406|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569407|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83569408|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569409|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569410|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
83569411|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569412|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569413|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83569414|NCT00002281|Hematinics|hematinics|mesh-ancestor
83569415|NCT00002287|Zidovudine|zidovudine|mesh-list
83569416|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
83569417|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569418|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83569419|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569420|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569421|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
83569422|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569423|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569424|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83569425|NCT00002828|Fluorouracil|fluorouracil|mesh-list
83569426|NCT00002828|Raltitrexed|raltitrexed|mesh-list
83569427|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
83569428|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569429|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569430|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569431|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569432|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
83569433|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569434|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83569435|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569436|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
83569437|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569438|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83569439|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
83569440|NCT00384020|Paroxetine|paroxetine|mesh-list
83569441|NCT00384020|Escitalopram|escitalopram|mesh-list
83569442|NCT00384020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83569443|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83569444|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83569445|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569446|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83569447|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
83569448|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569449|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83569450|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
83569451|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83569452|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83569453|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83569454|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569455|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83569456|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83569457|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83569458|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
83569459|NCT00002557|Leucovorin|leucovorin|mesh-list
83569460|NCT00002557|Doxorubicin|doxorubicin|mesh-list
83569461|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83569462|NCT00002557|Etoposide|etoposide|mesh-list
83569463|NCT00002557|Methotrexate|methotrexate|mesh-list
83569464|NCT00002557|Calcium|calcium|mesh-list
83569465|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
83569466|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569467|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569468|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569469|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569470|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569471|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569472|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83569473|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569474|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83569475|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
83569476|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83569477|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569478|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
83569479|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
83569480|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83569481|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569482|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
83569483|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569484|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569485|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569486|NCT00002557|Antidotes|antidotes|mesh-ancestor
83569487|NCT00002557|Protective Agents|protective agents|mesh-ancestor
83569488|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
83569489|NCT00002557|Vitamins|vitamins|mesh-ancestor
83569490|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
83027610|NCT01381601|Sunitinib|sunitinib|mesh-list
83569491|NCT00003158|Paclitaxel|paclitaxel|mesh-list
83569492|NCT00003158|Etoposide|etoposide|mesh-list
83569493|NCT00003158|Carboplatin|carboplatin|mesh-list
83569494|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569495|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569496|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569497|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569498|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569499|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569500|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569501|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569502|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569503|NCT00003416|Interferons|interferons|mesh-list
83569504|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
83569505|NCT00003416|Dexamethasone|dexamethasone|mesh-list
83569506|NCT00003416|Melphalan|melphalan|mesh-list
83569507|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83569508|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
83569509|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
83569510|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83569511|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569512|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83569513|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
83569514|NCT00003416|Hormones|hormones|mesh-ancestor
83569515|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569516|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83569517|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569518|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
83569519|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569520|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
83569521|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569522|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
83569523|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569524|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569525|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569526|NCT00002569|Vincristine|vincristine|mesh-list
83569527|NCT00002569|Lomustine|lomustine|mesh-list
83569528|NCT00002569|Procarbazine|procarbazine|mesh-list
83569529|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569530|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569531|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569532|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569533|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569534|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569535|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569536|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
83569537|NCT00002840|Vincristine|vincristine|mesh-list
83569538|NCT00002840|Lomustine|lomustine|mesh-list
83569539|NCT00002840|Procarbazine|procarbazine|mesh-list
83569540|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569541|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569542|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569543|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569544|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569545|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569546|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569547|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
83569548|NCT00002846|Aldesleukin|aldesleukin|mesh-list
83569549|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569550|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569551|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83569552|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
83569553|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569554|NCT05720767|Itraconazole|itraconazole|mesh-list
83569555|NCT05720767|Rifampin|rifampin|mesh-list
83569556|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
83569557|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569558|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83569559|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83569560|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569561|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569562|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83569563|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
83569564|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569565|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569566|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83569567|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83569568|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
83569569|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83569570|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
83569571|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569572|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83569573|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83569574|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83569575|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83569576|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83569577|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83569578|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
83569579|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569580|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83569581|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
83569582|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569583|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83569584|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83569585|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569586|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569587|NCT00002852|Paclitaxel|paclitaxel|mesh-list
83569588|NCT00002852|Carboplatin|carboplatin|mesh-list
83569589|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569590|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569591|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569592|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569593|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569594|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569595|NCT00003422|Leucovorin|leucovorin|mesh-list
83569596|NCT00003422|Fluorouracil|fluorouracil|mesh-list
83569597|NCT00003422|Calcium|calcium|mesh-list
83569598|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
83569599|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83569600|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569601|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
83569602|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569603|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569604|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569605|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569606|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
83569607|NCT00003422|Antidotes|antidotes|mesh-ancestor
83569608|NCT00003422|Protective Agents|protective agents|mesh-ancestor
83569609|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
83569610|NCT00003422|Vitamins|vitamins|mesh-ancestor
83569611|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
83569612|NCT00003176|Temozolomide|temozolomide|mesh-list
83569613|NCT00003176|Carmustine|carmustine|mesh-list
83569614|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569615|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
83569616|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569617|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569618|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
83569619|NCT00002858|Doxorubicin|doxorubicin|mesh-list
83569620|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83569621|NCT00002858|Etoposide|etoposide|mesh-list
83569622|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569623|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
83569624|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569625|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569626|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569627|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
83569628|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569629|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569630|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569631|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569632|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569633|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569634|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569635|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569636|NCT00002864|Tamoxifen|tamoxifen|mesh-list
83569637|NCT00002864|Octreotide|octreotide|mesh-list
83569638|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83569639|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
83569640|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569641|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569642|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83569643|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569644|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83569645|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83569646|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83569647|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83569648|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
83569649|NCT00002870|Thiotepa|thiotepa|mesh-list
83569650|NCT00002870|Fluorouracil|fluorouracil|mesh-list
83569651|NCT00002870|Epirubicin|epirubicin|mesh-list
83569652|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569653|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
83569654|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569655|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569656|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569657|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
83569658|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569659|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569660|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569661|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
83569662|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569663|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569664|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569665|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569666|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569667|NCT00002581|Tamoxifen|tamoxifen|mesh-list
83569668|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
83569669|NCT00002581|Fluorouracil|fluorouracil|mesh-list
83569670|NCT00002581|Methotrexate|methotrexate|mesh-list
83569671|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569672|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
83569673|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569674|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569675|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569676|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
83569677|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569678|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569679|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569680|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
83569681|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569682|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83569683|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
83569684|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83569685|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
83569686|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569687|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83569688|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569689|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83569690|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
83569691|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569692|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83569693|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83569694|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83569695|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83569696|NCT00003182|Gemcitabine|gemcitabine|mesh-list
83569697|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569698|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569699|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
83569700|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569701|NCT00002587|Paclitaxel|paclitaxel|mesh-list
83569702|NCT00002587|Topotecan|topotecan|mesh-list
83569703|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569704|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569705|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569706|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569707|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569708|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569709|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83569710|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569711|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569712|NCT00002876|Etoposide|etoposide|mesh-list
83569713|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569714|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569715|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569716|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569717|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569718|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569719|NCT00002593|Leucovorin|leucovorin|mesh-list
83569720|NCT00002593|Levamisole|levamisole|mesh-list
83569721|NCT00002593|Fluorouracil|fluorouracil|mesh-list
83569722|NCT00002593|Calcium|calcium|mesh-list
83569723|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
83569724|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83569725|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569726|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
83569727|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569728|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569729|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569730|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569731|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
83569732|NCT00002593|Antidotes|antidotes|mesh-ancestor
83569733|NCT00002593|Protective Agents|protective agents|mesh-ancestor
83569734|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
83569735|NCT00002593|Vitamins|vitamins|mesh-ancestor
83569736|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
83569737|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83569738|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
83569739|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
83569740|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83569741|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569742|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569743|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
83569744|NCT00003194|Thiotepa|thiotepa|mesh-list
83569745|NCT00003194|Carboplatin|carboplatin|mesh-list
83569746|NCT00003194|Etoposide|etoposide|mesh-list
83569747|NCT00003194|Topotecan|topotecan|mesh-list
83569748|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569749|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
83569750|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569751|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569752|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569753|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
83569754|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569755|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569756|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569757|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569758|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569759|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569760|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569761|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83569762|NCT00002882|Interferons|interferons|mesh-list
83569763|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
83569764|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
83569765|NCT00002882|Aldesleukin|aldesleukin|mesh-list
83569766|NCT00002882|Cisplatin|cisplatin|mesh-list
83569767|NCT00002882|Interleukin-2|interleukin-2|mesh-list
83569768|NCT00002882|Dacarbazine|dacarbazine|mesh-list
83569769|NCT00002882|Vinblastine|vinblastine|mesh-list
83569770|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569771|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
83569772|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569773|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
83569774|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569775|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83569776|NCT00002882|Analgesics|analgesics|mesh-ancestor
83569777|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
83569778|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83569779|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83569780|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83569781|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569782|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
83569783|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569784|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569785|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569786|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569787|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
83027905|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
83569788|NCT00002888|Paclitaxel|paclitaxel|mesh-list
83569789|NCT00002888|Fluorouracil|fluorouracil|mesh-list
83569790|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569791|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569792|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569793|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569794|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569795|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569796|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
83569797|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569798|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569799|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
83569800|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569801|NCT00002599|Cobalt|cobalt|mesh-list
83569802|NCT00002599|Interferons|interferons|mesh-list
83569803|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
83569804|NCT00002599|Prednisone|prednisone|mesh-list
83569805|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
83569806|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
83569807|NCT00002599|Melphalan|melphalan|mesh-list
83569808|NCT00002599|Carmustine|carmustine|mesh-list
83569809|NCT00002599|Doxorubicin|doxorubicin|mesh-list
83569810|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83569811|NCT00002599|Vincristine|vincristine|mesh-list
83569812|NCT00002599|Sargramostim|sargramostim|mesh-list
83569813|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569814|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
83569815|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569816|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569817|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569818|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
83569819|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569820|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569821|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569822|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569823|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569824|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569825|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569826|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83569827|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
83569828|NCT00002599|Hormones|hormones|mesh-ancestor
83569829|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83569830|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83569831|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
83569832|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569833|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569834|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569835|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569836|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569837|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
83569838|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
83569839|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83569840|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83569841|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83569842|NCT00002599|Protective Agents|protective agents|mesh-ancestor
83569843|NCT00002599|Trace Elements|trace elements|mesh-ancestor
83569844|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
83569845|NCT00003440|Paclitaxel|paclitaxel|mesh-list
83569846|NCT00003440|Trastuzumab|trastuzumab|mesh-list
83569847|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569848|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569849|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569850|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569851|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569852|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569853|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83569854|NCT00003200|Docetaxel|docetaxel|mesh-list
83569855|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569856|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569857|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569858|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569859|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569860|NCT00003446|Leucovorin|leucovorin|mesh-list
83569861|NCT00003446|Trimetrexate|trimetrexate|mesh-list
83569862|NCT00003446|Fluorouracil|fluorouracil|mesh-list
83569863|NCT00003446|Calcium|calcium|mesh-list
83569864|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
83569865|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83569866|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569867|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
83027988|NCT00911547|Hormones|hormones|mesh-ancestor
83569868|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569869|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569870|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569871|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83458772|NCT00957593|Oxytocin|oxytocin|mesh-list
83569872|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
83569874|NCT00003446|Protective Agents|protective agents|mesh-ancestor
83569875|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
83569876|NCT00003446|Vitamins|vitamins|mesh-ancestor
83569877|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
83569878|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
83569879|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569880|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83569881|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569882|NCT00003938|Amphotericin B|amphotericin b|mesh-list
83569883|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83569884|NCT00003938|Amebicides|amebicides|mesh-ancestor
83569885|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83569886|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83569887|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569888|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83569889|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
83569890|NCT00003212|Doxorubicin|doxorubicin|mesh-list
83569891|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83569892|NCT00003212|Ifosfamide|ifosfamide|mesh-list
83569893|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569894|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569895|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569896|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569897|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569898|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569899|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569900|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
83569901|NCT00002611|Dactinomycin|dactinomycin|mesh-list
83569902|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
83569903|NCT00002611|Doxorubicin|doxorubicin|mesh-list
83569904|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83569905|NCT00002611|Etoposide|etoposide|mesh-list
83569906|NCT00002611|Vincristine|vincristine|mesh-list
83569907|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569908|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
83569909|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569910|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569911|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569912|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
83569913|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569914|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569915|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569916|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83569917|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83569918|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569919|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569920|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569921|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569922|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569923|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569924|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83569925|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569926|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83569927|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83569928|NCT00003944|Paclitaxel|paclitaxel|mesh-list
83569929|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
83569930|NCT00003944|Carboplatin|carboplatin|mesh-list
83569931|NCT00003944|Topotecan|topotecan|mesh-list
83569932|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569933|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569934|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569935|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569936|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569937|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569938|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569939|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
83569940|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569941|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569942|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569943|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
83569944|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83569945|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83569946|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569948|NCT00003950|Cyclosporine|cyclosporine|mesh-list
83569949|NCT00003950|Irinotecan|irinotecan|mesh-list
83569950|NCT00003950|Cyclosporins|cyclosporins|mesh-list
83569951|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83569952|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83569953|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569954|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569955|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569956|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569957|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
83569958|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569959|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
83569960|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83569961|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83569962|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83569963|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83569964|NCT00003464|Temozolomide|temozolomide|mesh-list
83569965|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83569966|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
83569967|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569968|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569969|NCT00003230|Paclitaxel|paclitaxel|mesh-list
83569970|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83569971|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569972|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83569973|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83569974|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83569975|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569976|NCT00003956|Leucovorin|leucovorin|mesh-list
83569977|NCT00003956|Fluorouracil|fluorouracil|mesh-list
83569978|NCT00003956|Calcium|calcium|mesh-list
83569979|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
83569980|NCT00003956|Lonafarnib|lonafarnib|mesh-list
83569981|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83569982|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83569983|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
83569984|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83569985|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83569986|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569987|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83569988|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
83569989|NCT00003956|Antidotes|antidotes|mesh-ancestor
83569990|NCT00003956|Protective Agents|protective agents|mesh-ancestor
83569991|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
83569992|NCT00003956|Vitamins|vitamins|mesh-ancestor
83569993|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
83569994|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83569995|NCT00002623|Carboplatin|carboplatin|mesh-list
83569996|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569997|NCT00003962|Aldesleukin|aldesleukin|mesh-list
83569998|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83569999|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83570000|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83570001|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
83570002|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570003|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
83570004|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83570005|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
83570006|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570007|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570008|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
83570009|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570010|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
83570011|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570012|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570013|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570014|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
83570015|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570016|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570017|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570018|NCT00002635|Lenograstim|lenograstim|mesh-list
83570019|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83570020|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
83570021|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570022|NCT00003242|Paclitaxel|paclitaxel|mesh-list
83570023|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
83570024|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570026|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570027|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570028|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570029|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570030|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83570031|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
83570032|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570033|NCT05664061|Fluticasone|fluticasone|mesh-list
83570034|NCT05664061|Xhance|xhance|mesh-list
83570035|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83570036|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83570037|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570038|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83570039|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
83570040|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570041|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570042|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83570043|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
83570044|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570045|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83570046|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83570047|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83570048|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83570049|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83570050|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83570051|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570052|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
83570053|NCT05664061|Hormones|hormones|mesh-ancestor
83570054|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570055|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
83570056|NCT00003248|Rituximab|rituximab|mesh-list
83570057|NCT00003248|Fludarabine|fludarabine|mesh-list
83570058|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
83570059|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570060|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570061|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
83570062|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570063|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570064|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570065|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
83570066|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570067|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570068|NCT05663905|Ambroxol|ambroxol|mesh-list
83570069|NCT05663905|Expectorants|expectorants|mesh-ancestor
83570070|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
83570071|NCT00002641|Doxorubicin|doxorubicin|mesh-list
83570072|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570073|NCT00002641|Ifosfamide|ifosfamide|mesh-list
83570074|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570075|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570076|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570077|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570078|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570079|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570080|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570081|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
83570082|NCT00003992|Tamoxifen|tamoxifen|mesh-list
83570083|NCT00003992|Paclitaxel|paclitaxel|mesh-list
83570084|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
83570085|NCT00003992|Doxorubicin|doxorubicin|mesh-list
83570086|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570087|NCT00003992|Trastuzumab|trastuzumab|mesh-list
83570088|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570089|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570090|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570091|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570092|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570093|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570094|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570095|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
83570096|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028204|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
83570097|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570098|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570099|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
83570100|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570101|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570102|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570103|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570104|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570105|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570106|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83570107|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
83570108|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570109|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570110|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83570111|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83570112|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83570113|NCT00002647|Verteporfin|verteporfin|mesh-list
83570114|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83570115|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570116|NCT00002653|Prednisone|prednisone|mesh-list
83570117|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
83570118|NCT00002653|Melphalan|melphalan|mesh-list
83570119|NCT00002653|Carmustine|carmustine|mesh-list
83570120|NCT00002653|Doxorubicin|doxorubicin|mesh-list
83570121|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570122|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570123|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
83570124|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570125|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570126|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570127|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
83570128|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570129|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570130|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570131|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570132|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570133|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570134|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570135|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570136|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
83570137|NCT00002653|Hormones|hormones|mesh-ancestor
83570138|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570139|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570140|NCT00003254|Fluorouracil|fluorouracil|mesh-list
83570141|NCT00003254|Eniluracil|eniluracil|mesh-list
83570142|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
83570143|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570144|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570145|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570146|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570147|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
83570148|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570149|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570150|NCT00002659|Cisplatin|cisplatin|mesh-list
83570151|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570152|NCT00003998|Paclitaxel|paclitaxel|mesh-list
83570153|NCT00003998|Docetaxel|docetaxel|mesh-list
83570154|NCT00003998|Carboplatin|carboplatin|mesh-list
83570155|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570156|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570157|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570158|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570159|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570160|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570161|NCT00004004|Procarbazine|procarbazine|mesh-list
83570162|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570163|NCT00003260|Leucovorin|leucovorin|mesh-list
83570164|NCT00003260|Fluorouracil|fluorouracil|mesh-list
83570165|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
83570166|NCT00003260|Irinotecan|irinotecan|mesh-list
83570167|NCT00003260|Calcium|calcium|mesh-list
83570168|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
83570169|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83570170|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028280|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
83570171|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
83570172|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570173|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570174|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570175|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570176|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
83570177|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83570178|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570179|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570180|NCT00003260|Antidotes|antidotes|mesh-ancestor
83570181|NCT00003260|Protective Agents|protective agents|mesh-ancestor
83570182|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
83570183|NCT00003260|Vitamins|vitamins|mesh-ancestor
83570184|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
83570185|NCT00002665|Leucovorin|leucovorin|mesh-list
83570186|NCT00002665|Cytarabine|cytarabine|mesh-list
83570187|NCT00002665|Dexamethasone|dexamethasone|mesh-list
83570188|NCT00002665|Prednisone|prednisone|mesh-list
83570189|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
83570190|NCT00002665|Doxorubicin|doxorubicin|mesh-list
83570191|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570192|NCT00002665|Methotrexate|methotrexate|mesh-list
83570193|NCT00002665|Etoposide|etoposide|mesh-list
83570194|NCT00002665|Vincristine|vincristine|mesh-list
83570195|NCT00002665|Daunorubicin|daunorubicin|mesh-list
83570196|NCT00002665|Asparaginase|asparaginase|mesh-list
83570197|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
83570198|NCT00002665|Thioguanine|thioguanine|mesh-list
83570199|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
83570200|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570201|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
83570202|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570203|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570204|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570205|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
83570206|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570207|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570208|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570209|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570210|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
83570211|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
83570212|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570213|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83570214|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
83570215|NCT00002665|Hormones|hormones|mesh-ancestor
83570216|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570217|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570218|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570219|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570220|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570221|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570222|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83570223|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
83570224|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83570225|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570226|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
83570227|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570228|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83570229|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570230|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570231|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
83570232|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570233|NCT00002665|Antidotes|antidotes|mesh-ancestor
83570234|NCT00002665|Protective Agents|protective agents|mesh-ancestor
83570235|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
83570236|NCT00002665|Vitamins|vitamins|mesh-ancestor
83570237|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
83570238|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570239|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570240|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570241|NCT00003536|Methotrexate|methotrexate|mesh-list
83570242|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83570243|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
83570244|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83570245|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570246|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570247|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
83570248|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570249|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570250|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570251|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570252|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83570253|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570254|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
83570255|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570256|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570257|NCT00003542|Interferons|interferons|mesh-list
83570258|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
83570259|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570260|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
83570261|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570262|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
83570263|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570264|NCT00004010|Prednisone|prednisone|mesh-list
83570265|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
83570266|NCT00004010|Dacarbazine|dacarbazine|mesh-list
83570267|NCT00004010|Doxorubicin|doxorubicin|mesh-list
83570268|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570269|NCT00004010|Etoposide|etoposide|mesh-list
83570270|NCT00004010|Vincristine|vincristine|mesh-list
83570271|NCT00004010|Bleomycin|bleomycin|mesh-list
83570272|NCT00004010|Vinblastine|vinblastine|mesh-list
83570273|NCT00004010|Procarbazine|procarbazine|mesh-list
83570274|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570275|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
83570276|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570277|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570278|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570279|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
83570280|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570281|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570282|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570283|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570284|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570285|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570286|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570287|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570288|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
83570289|NCT00004010|Hormones|hormones|mesh-ancestor
83570290|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570291|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570292|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570293|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570294|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570295|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570296|NCT00004016|Interferons|interferons|mesh-list
83570297|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
83570298|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570299|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
83570300|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570301|NCT00004022|Aldesleukin|aldesleukin|mesh-list
83570302|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
83570303|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570304|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83570305|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83570306|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
83570307|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570308|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
83570309|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570310|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570311|NCT00381901|Trastuzumab|trastuzumab|mesh-list
83570312|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570313|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570314|NCT00003278|Dexamethasone|dexamethasone|mesh-list
83570315|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570316|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
83570317|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
83570318|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570319|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570320|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83570321|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
83570322|NCT00003278|Hormones|hormones|mesh-ancestor
83570323|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570324|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570325|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570326|NCT00004028|Carmustine|carmustine|mesh-list
83570327|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570328|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
83570329|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570330|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570332|NCT00003554|Rituximab|rituximab|mesh-list
83570333|NCT00003554|Melphalan|melphalan|mesh-list
83570334|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570335|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570336|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
83570337|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570338|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570339|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570340|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
83570341|NCT00003554|Hormones|hormones|mesh-ancestor
83570342|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570343|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570344|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570345|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
83570346|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570347|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570348|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570349|NCT00003284|Paclitaxel|paclitaxel|mesh-list
83570350|NCT00003284|Etoposide|etoposide|mesh-list
83570351|NCT00003284|Carboplatin|carboplatin|mesh-list
83570352|NCT00003284|Ifosfamide|ifosfamide|mesh-list
83570353|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570354|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570355|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570356|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570357|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570358|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570359|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570360|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570361|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570362|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570363|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
83570364|NCT00384410|Nabilone|nabilone|mesh-list
83570365|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
83570366|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
83570367|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570368|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570369|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83570370|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83570371|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83570372|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83570373|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83570374|NCT00004040|Interferons|interferons|mesh-list
83570375|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
83570376|NCT00004040|Rituximab|rituximab|mesh-list
83570377|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570378|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570379|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
83570380|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570381|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570382|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
83570383|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570384|NCT00004046|Exatecan|exatecan|mesh-list
83570385|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83570386|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570387|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570388|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570389|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570390|NCT00003560|Carboplatin|carboplatin|mesh-list
83570391|NCT00003560|Docetaxel|docetaxel|mesh-list
83570392|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570393|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570394|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570395|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570396|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570397|NCT00003290|Hormones|hormones|mesh-list
83570398|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570399|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570400|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
83570401|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83570402|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570403|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83570404|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570405|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
83570407|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570408|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
83570409|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570410|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83570411|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570412|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570413|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570414|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570415|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83570416|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
83570417|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83570418|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570419|NCT00002689|Dexamethasone|dexamethasone|mesh-list
83570420|NCT00002689|Fluorouracil|fluorouracil|mesh-list
83570421|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570422|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
83570423|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
83570424|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570425|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570426|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83570427|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
83570428|NCT00002689|Hormones|hormones|mesh-ancestor
83570429|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570430|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570431|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570432|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
83570433|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570434|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570435|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570436|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
83570437|NCT00003296|Doxorubicin|doxorubicin|mesh-list
83570438|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570439|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570440|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570441|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570442|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570443|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570444|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570445|NCT00004064|Oregovomab|oregovomab|mesh-list
83570446|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570447|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570448|NCT00382057|Anastrozole|anastrozole|mesh-list
83570449|NCT00382057|Goserelin|goserelin|mesh-list
83570450|NCT00382057|Testosterone|testosterone|mesh-list
83570451|NCT00382057|Androgens|androgens|mesh-ancestor
83570452|NCT00382057|Hormones|hormones|mesh-ancestor
83570453|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570454|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570455|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570456|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570457|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83570458|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83570459|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570460|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570461|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83570462|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
83570463|NCT00003578|Cytarabine|cytarabine|mesh-list
83570464|NCT00003578|Prednisone|prednisone|mesh-list
83570465|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
83570466|NCT00003578|Melphalan|melphalan|mesh-list
83570467|NCT00003578|Carmustine|carmustine|mesh-list
83570468|NCT00003578|Doxorubicin|doxorubicin|mesh-list
83570469|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570470|NCT00003578|Etoposide|etoposide|mesh-list
83570471|NCT00003578|Vincristine|vincristine|mesh-list
83570472|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570473|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
83570474|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570475|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570476|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570477|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
83570478|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570479|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570480|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570481|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570482|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570483|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570484|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570485|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570486|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
83570487|NCT00003578|Hormones|hormones|mesh-ancestor
83570488|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570489|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570490|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570491|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570492|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
83570493|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
83570494|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570495|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570496|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570497|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570498|NCT00003584|Prednisone|prednisone|mesh-list
83570499|NCT00003584|Estramustine|estramustine|mesh-list
83570500|NCT00003584|Vinorelbine|vinorelbine|mesh-list
83570501|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570502|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
83570503|NCT00003584|Hormones|hormones|mesh-ancestor
83570504|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570505|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570506|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570507|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570508|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570509|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570510|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570511|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570512|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570513|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570514|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
83570515|NCT00002701|Cytarabine|cytarabine|mesh-list
83570516|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
83570517|NCT00002701|Busulfan|busulfan|mesh-list
83570518|NCT00002701|Methotrexate|methotrexate|mesh-list
83570519|NCT00002701|Etoposide|etoposide|mesh-list
83570520|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
83570521|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
83570522|NCT00002701|Idarubicin|idarubicin|mesh-list
83570523|NCT00002701|Tretinoin|tretinoin|mesh-list
83570524|NCT00002701|Thioguanine|thioguanine|mesh-list
83570525|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570526|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
83570527|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570528|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570529|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570530|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
83570531|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570532|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570533|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570534|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83570535|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
83570536|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83570537|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570538|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
83570539|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570540|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570541|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83570542|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570543|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570544|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570545|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570546|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
83570547|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570548|NCT00002701|Analgesics|analgesics|mesh-ancestor
83570549|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
83570550|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570551|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83028650|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
83570552|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
83570553|NCT00004070|Interleukin-12|interleukin-12|mesh-list
83570554|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83570555|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
83570556|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570558|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83570559|NCT00004070|Growth Substances|growth substances|mesh-ancestor
83570560|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
83570561|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570562|NCT00004082|Carboplatin|carboplatin|mesh-list
83570563|NCT00004082|Gemcitabine|gemcitabine|mesh-list
83570564|NCT00004082|Docetaxel|docetaxel|mesh-list
83570565|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570566|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570567|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
83570568|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570569|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570570|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570571|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570572|NCT00002707|Tamoxifen|tamoxifen|mesh-list
83570573|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
83570574|NCT00002707|Docetaxel|docetaxel|mesh-list
83570575|NCT00002707|Doxorubicin|doxorubicin|mesh-list
83570576|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570577|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
83570578|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570579|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570580|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570581|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
83570582|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570583|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570584|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570585|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570586|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570587|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570588|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570589|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570590|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570591|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570592|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83570593|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
83570594|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570595|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570596|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83570597|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83570598|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83570599|NCT00003596|Fluorouracil|fluorouracil|mesh-list
83570600|NCT00003596|Mitomycins|mitomycins|mesh-list
83570601|NCT00003596|Mitomycin|mitomycin|mesh-list
83570602|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570603|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
83570604|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570605|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570606|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570607|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
83570608|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570609|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570610|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
83570611|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570612|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570613|NCT00002719|Cytarabine|cytarabine|mesh-list
83570614|NCT00002719|Etoposide|etoposide|mesh-list
83570615|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
83570616|NCT00002719|Idarubicin|idarubicin|mesh-list
83570617|NCT00002719|Carmustine|carmustine|mesh-list
83570618|NCT00002719|Amsacrine|amsacrine|mesh-list
83570619|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570620|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570621|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570622|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570623|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570624|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570625|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570626|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
83570627|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
83570628|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570629|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570630|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
83028734|NCT03540836|Cortisone|cortisone|mesh-list
83570631|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570632|NCT00002719|Analgesics|analgesics|mesh-ancestor
83570633|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
83570634|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570635|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570636|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570637|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
83570638|NCT00003326|Paclitaxel|paclitaxel|mesh-list
83570639|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570640|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570641|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570642|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570643|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570644|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570645|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
83570646|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83570647|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
83570648|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570649|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570650|NCT00003602|Cytarabine|cytarabine|mesh-list
83570651|NCT00003602|Etoposide|etoposide|mesh-list
83570652|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
83570653|NCT00003602|Idarubicin|idarubicin|mesh-list
83570654|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570655|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570656|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570657|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570658|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570659|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570660|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570661|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
83570662|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
83570663|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570664|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570665|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
83570666|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570667|NCT00003602|Analgesics|analgesics|mesh-ancestor
83570668|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
83570669|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570670|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570671|NCT04609423|Vitamin D|vitamin d|mesh-list
83570672|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
83570673|NCT04609423|Vitamins|vitamins|mesh-ancestor
83570674|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
83570675|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570676|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83570677|NCT00003332|Gemcitabine|gemcitabine|mesh-list
83570678|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570679|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570680|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
83570681|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570682|NCT00004094|Paclitaxel|paclitaxel|mesh-list
83570683|NCT00004094|Carboplatin|carboplatin|mesh-list
83570684|NCT00004094|Fluorouracil|fluorouracil|mesh-list
83570685|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
83570686|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570687|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570688|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570689|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570690|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570691|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570692|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
83570693|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570694|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570695|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
83570696|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570697|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
83570698|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570699|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570700|NCT00004100|Gemcitabine|gemcitabine|mesh-list
83570701|NCT00004100|Vinorelbine|vinorelbine|mesh-list
83570702|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570703|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570704|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
83570705|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570706|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570707|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570708|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570709|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570710|NCT00002737|Interferons|interferons|mesh-list
83570711|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
83570712|NCT00002737|Isotretinoin|isotretinoin|mesh-list
83570713|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570714|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
83570715|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570716|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
83570717|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570718|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570719|NCT00003338|Epratuzumab|epratuzumab|mesh-list
83570720|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570721|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570722|NCT00003620|Alvocidib|alvocidib|mesh-list
83570723|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570724|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
83570725|NCT00003620|Growth Substances|growth substances|mesh-ancestor
83570726|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570727|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83570728|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570729|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570730|NCT00003344|Irinotecan|irinotecan|mesh-list
83570731|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83570732|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570733|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570734|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570735|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570736|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
83570737|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570738|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570739|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570740|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570741|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570742|NCT00003632|Cytarabine|cytarabine|mesh-list
83570743|NCT00003632|Methotrexate|methotrexate|mesh-list
83570744|NCT00003632|Etoposide|etoposide|mesh-list
83570745|NCT00003632|Melphalan|melphalan|mesh-list
83570746|NCT00003632|Carmustine|carmustine|mesh-list
83570747|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83570748|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
83570749|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83570750|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570751|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570752|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
83570753|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570754|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570755|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570756|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570757|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83570758|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570759|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
83570760|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570761|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570762|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570763|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570764|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570765|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
83570766|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570767|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570768|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
83570769|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570770|NCT00004112|Prednisone|prednisone|mesh-list
83570771|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
83570772|NCT00004112|Rituximab|rituximab|mesh-list
83570773|NCT00004112|Doxorubicin|doxorubicin|mesh-list
83570774|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570775|NCT00004112|Vincristine|vincristine|mesh-list
83570776|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570777|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
83570778|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570779|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570780|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570781|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
83570782|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570783|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570784|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570785|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570786|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570787|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570788|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570789|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570790|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570791|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
83570792|NCT00004112|Hormones|hormones|mesh-ancestor
83570793|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570794|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570795|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570796|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570797|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570798|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570799|NCT00003350|Paclitaxel|paclitaxel|mesh-list
83570800|NCT00003350|Doxorubicin|doxorubicin|mesh-list
83570801|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570802|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570803|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570804|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570805|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570806|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570807|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570808|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570809|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570810|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570811|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570812|NCT05584267|Immunomodulating Agents|immunomodulating agents|mesh-list
83570813|NCT05584267|Immunologic Factors|immunologic factors|mesh-ancestor
83570814|NCT05584267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570815|NCT00003356|Aldesleukin|aldesleukin|mesh-list
83570816|NCT00003356|Rituximab|rituximab|mesh-list
83570817|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83570818|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570819|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
83570820|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570821|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570822|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83570823|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83570824|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
83570825|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570826|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
83570827|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83570828|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
83570829|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570830|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
83570831|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570832|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570833|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570834|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
83570835|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570836|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570837|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570838|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83570839|NCT00004142|Fluorouracil|fluorouracil|mesh-list
83570840|NCT00004142|Floxuridine|floxuridine|mesh-list
83570841|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
83570842|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570843|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570844|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570845|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570846|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
83570847|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570848|NCT00002749|Carboplatin|carboplatin|mesh-list
83570849|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570850|NCT00003362|Sargramostim|sargramostim|mesh-list
83570851|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
83570852|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
83570853|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570854|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83570855|NCT00003650|Cytarabine|cytarabine|mesh-list
83570856|NCT00003650|Dexamethasone|dexamethasone|mesh-list
83570857|NCT00003650|Prednisone|prednisone|mesh-list
83570858|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
83570859|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
83570860|NCT00003650|Methotrexate|methotrexate|mesh-list
83570861|NCT00003650|Etoposide|etoposide|mesh-list
83570862|NCT00003650|Vincristine|vincristine|mesh-list
83570863|NCT00003650|Daunorubicin|daunorubicin|mesh-list
83570864|NCT00003650|Asparaginase|asparaginase|mesh-list
83570865|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
83570866|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
83570867|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570868|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
83570869|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570870|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570871|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570872|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
83570873|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570874|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570875|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570876|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83570877|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
83570878|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
83570879|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83570880|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83570881|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
83570882|NCT00003650|Hormones|hormones|mesh-ancestor
83570883|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570884|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570885|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83570886|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
83570887|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83570888|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570889|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
83570890|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570891|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570892|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83570893|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570894|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83570895|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570896|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570897|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
83570898|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570899|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
83570900|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
83570901|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
83570902|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83570903|NCT00003650|Protective Agents|protective agents|mesh-ancestor
83570904|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570905|NCT00003650|Analgesics|analgesics|mesh-ancestor
83570906|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
83570907|NCT00002755|Tamoxifen|tamoxifen|mesh-list
83570908|NCT00002755|Cobalt|cobalt|mesh-list
83570909|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
83570910|NCT00002755|Thiotepa|thiotepa|mesh-list
83570911|NCT00002755|Doxorubicin|doxorubicin|mesh-list
83570912|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83570913|NCT00002755|Fluorouracil|fluorouracil|mesh-list
83570914|NCT00002755|Methotrexate|methotrexate|mesh-list
83570915|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570916|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
83570917|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570918|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570919|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570920|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
83570921|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570922|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570923|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570924|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570925|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570926|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570927|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570928|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
83570929|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570930|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83570931|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
83570932|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83570933|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570934|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83570935|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83570936|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83570937|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83570938|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83570939|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83570940|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83570941|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83570942|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83570943|NCT00002755|Trace Elements|trace elements|mesh-ancestor
83570944|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
83570945|NCT00002761|Interferons|interferons|mesh-list
83570946|NCT00002761|Cytarabine|cytarabine|mesh-list
83570947|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
83570948|NCT00002761|Cyclosporine|cyclosporine|mesh-list
83570949|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
83570950|NCT00002761|Busulfan|busulfan|mesh-list
83570951|NCT00002761|Idarubicin|idarubicin|mesh-list
83570952|NCT00002761|Cyclosporins|cyclosporins|mesh-list
83570953|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570954|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
83570955|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570956|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570957|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570958|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
83570959|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570960|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570961|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570962|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
83570963|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570964|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83570965|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
83570966|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570967|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
83570968|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83570969|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83570970|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83570971|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83570972|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83570973|NCT00382135|Tadalafil|tadalafil|mesh-list
83570974|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
83570975|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83570976|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83570977|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570978|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570979|NCT00382135|Urological Agents|urological agents|mesh-ancestor
83570980|NCT00003662|Cyclosporine|cyclosporine|mesh-list
83570981|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
83570982|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
83570983|NCT00003662|Melphalan|melphalan|mesh-list
83570984|NCT00003662|Busulfan|busulfan|mesh-list
83570985|NCT00003662|Cyclosporins|cyclosporins|mesh-list
83570986|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83570987|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83570988|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
83570989|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83570990|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83570991|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83570992|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
83570993|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83570994|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83570995|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83570996|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83570997|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
83570998|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83570999|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571000|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83571001|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571002|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
83571003|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
83571004|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571005|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571006|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
83571007|NCT00003662|Hormones|hormones|mesh-ancestor
83571008|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571009|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83571010|NCT00003662|Protective Agents|protective agents|mesh-ancestor
83571011|NCT00004154|Fenretinide|fenretinide|mesh-list
83571012|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571013|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83571014|NCT00004154|Protective Agents|protective agents|mesh-ancestor
83571015|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571016|NCT00002767|Interferons|interferons|mesh-list
83571017|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
83571018|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
83571019|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571020|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
83571021|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571022|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
83571023|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571024|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83571025|NCT00002773|Interferons|interferons|mesh-list
83571026|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
83571027|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
83571028|NCT00002773|Sargramostim|sargramostim|mesh-list
83571029|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571030|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
83571031|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571032|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571033|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571034|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
83571035|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571036|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571037|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571038|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
83571039|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571041|NCT00004160|Gemcitabine|gemcitabine|mesh-list
83571042|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571043|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571044|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571045|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571046|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571047|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571048|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571049|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
83571050|NCT00003368|Irinotecan|irinotecan|mesh-list
83571051|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83571052|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571053|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571054|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571055|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571056|NCT00003674|Dalteparin|dalteparin|mesh-list
83571057|NCT00003674|Tinzaparin|tinzaparin|mesh-list
83571058|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83571059|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
83571060|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83571061|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83571062|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571063|NCT00003380|Doxorubicin|doxorubicin|mesh-list
83571064|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83571065|NCT00003380|Etoposide|etoposide|mesh-list
83571066|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571067|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571068|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571069|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571070|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571071|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571072|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571073|NCT00002779|Fludarabine|fludarabine|mesh-list
83571074|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
83571075|NCT00002779|Octreotide|octreotide|mesh-list
83571076|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571077|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571078|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
83571079|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571080|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571081|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
83571082|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571083|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571084|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571085|NCT00003680|Tamoxifen|tamoxifen|mesh-list
83571086|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
83571087|NCT00003680|Thiotepa|thiotepa|mesh-list
83571088|NCT00003680|Fluorouracil|fluorouracil|mesh-list
83571089|NCT00003680|Methotrexate|methotrexate|mesh-list
83571090|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571091|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
83571092|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571093|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571094|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571095|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
83571096|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571097|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571098|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571099|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
83571100|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571101|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83571102|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
83571103|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83571104|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571105|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571106|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83571107|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571108|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83571109|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
83571110|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571111|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571112|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83571113|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83571114|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83571115|NCT00002785|Leucovorin|leucovorin|mesh-list
83571116|NCT00002785|Cobalt|cobalt|mesh-list
83571117|NCT00002785|Cytarabine|cytarabine|mesh-list
83571118|NCT00002785|Cyclosporine|cyclosporine|mesh-list
83571119|NCT00002785|Dexamethasone|dexamethasone|mesh-list
83571120|NCT00002785|Prednisone|prednisone|mesh-list
83571121|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
83571122|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
83571123|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83571124|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83571125|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83571126|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
83571127|NCT00002785|Methotrexate|methotrexate|mesh-list
83571128|NCT00002785|Etoposide|etoposide|mesh-list
83571129|NCT00002785|Vincristine|vincristine|mesh-list
83571130|NCT00002785|Daunorubicin|daunorubicin|mesh-list
83571131|NCT00002785|Asparaginase|asparaginase|mesh-list
83571132|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
83571133|NCT00002785|Pegaspargase|pegaspargase|mesh-list
83571134|NCT00002785|Cyclosporins|cyclosporins|mesh-list
83571135|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
83571136|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571137|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
83571138|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571139|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571140|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571141|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
83571142|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571143|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571144|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571145|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571146|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
83571147|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
83571148|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571149|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571150|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
83571151|NCT00002785|Hormones|hormones|mesh-ancestor
83571152|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571153|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571154|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83571155|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
83571156|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83571157|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571158|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
83571159|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571160|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571161|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83571162|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571163|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571164|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571165|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571166|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
83571167|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029333|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
83571168|NCT00002785|Antidotes|antidotes|mesh-ancestor
83571169|NCT00002785|Protective Agents|protective agents|mesh-ancestor
83571170|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
83571172|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
83571173|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571174|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571175|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571176|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
83571177|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83571178|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83571179|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571180|NCT00002785|Trace Elements|trace elements|mesh-ancestor
83571181|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83571182|NCT00004184|Antibodies|antibodies|mesh-list
83571183|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83571184|NCT00004184|Sargramostim|sargramostim|mesh-list
83571185|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
83571186|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
83571187|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571188|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83571189|NCT00004184|Antacids|antacids|mesh-ancestor
83571190|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571191|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571192|NCT00003386|Paclitaxel|paclitaxel|mesh-list
83571193|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
83571194|NCT00003386|Carboplatin|carboplatin|mesh-list
83571195|NCT00003386|Vaccines|vaccines|mesh-list
83571196|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
83571197|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
83571198|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571199|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571200|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571201|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571202|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571203|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571204|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571205|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571206|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571207|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571208|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
83571209|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571210|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83571211|NCT00384566|Metoprolol|metoprolol|mesh-list
83571212|NCT00384566|Carvedilol|carvedilol|mesh-list
83571213|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83571214|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83571215|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
83571216|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
83571217|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571218|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571219|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83571220|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83571221|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83571222|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
83571223|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571224|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571225|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
83571226|NCT00384566|Protective Agents|protective agents|mesh-ancestor
83571227|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83571228|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83571229|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571230|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
83571231|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83571232|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83571233|NCT00004832|Amifampridine|amifampridine|mesh-list
83571234|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83571235|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571236|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571237|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83571238|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83571239|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571240|NCT00002791|Doxorubicin|doxorubicin|mesh-list
83571241|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83571242|NCT00002791|Ifosfamide|ifosfamide|mesh-list
83571243|NCT00002791|Dacarbazine|dacarbazine|mesh-list
83571245|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571246|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571247|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571248|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571249|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571250|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571251|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
83571252|NCT00004190|Gemcitabine|gemcitabine|mesh-list
83571253|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
83571254|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571255|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
83571256|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571257|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571258|NCT00004196|Interferons|interferons|mesh-list
83571259|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
83571260|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571261|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
83571262|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571263|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
83571264|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571265|NCT00004838|Succimer|succimer|mesh-list
83571266|NCT00004838|Antidotes|antidotes|mesh-ancestor
83571267|NCT00004838|Protective Agents|protective agents|mesh-ancestor
83571268|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571269|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
83571270|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
83571271|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571272|NCT00004202|Paclitaxel|paclitaxel|mesh-list
83571273|NCT00004202|Carboplatin|carboplatin|mesh-list
83571274|NCT00004202|Efaproxiral|efaproxiral|mesh-list
83571275|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571276|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571277|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571278|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571279|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571280|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571281|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
83571282|NCT00003686|Pilocarpine|pilocarpine|mesh-list
83571283|NCT00003686|Miotics|miotics|mesh-ancestor
83571284|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
83571285|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571286|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571287|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83571288|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83571289|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
83571290|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571291|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571292|NCT05495035|Dexamethasone|dexamethasone|mesh-list
83571293|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571294|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
83571295|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
83571296|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571297|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571298|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571299|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
83571300|NCT05495035|Hormones|hormones|mesh-ancestor
83571301|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571302|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571303|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571304|NCT00004856|Trastuzumab|trastuzumab|mesh-list
83571305|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83571306|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571307|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
83029406|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
83029407|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83029408|NCT02172014|Narcotics|narcotics|mesh-ancestor
83029409|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029410|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029411|NCT02172014|Analgesics|analgesics|mesh-ancestor
83029412|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
83029413|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029414|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83029415|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83029416|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
83571308|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571309|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571311|NCT00004862|Fludarabine|fludarabine|mesh-list
83571312|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
83571313|NCT00004862|Oblimersen|oblimersen|mesh-list
83571314|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571315|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571316|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
83571317|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571318|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571319|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
83571320|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571321|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
83571322|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571323|NCT00004220|Gemcitabine|gemcitabine|mesh-list
83571324|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
83571325|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571326|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
83571327|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571328|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571329|NCT00003704|Capecitabine|capecitabine|mesh-list
83571330|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571331|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
83571332|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571333|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571334|NCT00004868|Semaxinib|semaxinib|mesh-list
83571335|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83571336|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83571337|NCT00004868|Growth Substances|growth substances|mesh-ancestor
83571338|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571339|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
83571340|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571341|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83571342|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571343|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571344|NCT00003710|Irinotecan|irinotecan|mesh-list
83571345|NCT00003710|Mitomycins|mitomycins|mesh-list
83571346|NCT00003710|Mitomycin|mitomycin|mesh-list
83571347|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83571348|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571349|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571350|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571351|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571352|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571353|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
83571354|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571355|NCT00004232|Cyclosporine|cyclosporine|mesh-list
83571356|NCT00004232|Prednisone|prednisone|mesh-list
83571357|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
83571358|NCT00004232|Cyclosporins|cyclosporins|mesh-list
83571359|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571360|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
83571361|NCT00004232|Hormones|hormones|mesh-ancestor
83571362|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571363|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571364|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571365|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571366|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
83571367|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571368|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571369|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571370|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
83571371|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571372|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571373|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571374|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83571375|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
83571376|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
83571377|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571378|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571379|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83571380|NCT00004232|Protective Agents|protective agents|mesh-ancestor
83571381|NCT00004874|Iodine|iodine|mesh-list
83571382|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
83571383|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83571384|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571385|NCT00004874|Trace Elements|trace elements|mesh-ancestor
83571386|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
83571387|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571388|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571389|NCT00004244|Interferons|interferons|mesh-list
83571390|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
83571391|NCT00004244|Interleukin-12|interleukin-12|mesh-list
83571392|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571393|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
83571394|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571395|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
83571396|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571397|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83571398|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83571399|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83571400|NCT00004244|Growth Substances|growth substances|mesh-ancestor
83571401|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
83571402|NCT00004880|Vaccines|vaccines|mesh-list
83571403|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
83571404|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571405|NCT00004250|Dactinomycin|dactinomycin|mesh-list
83571406|NCT00004250|Melphalan|melphalan|mesh-list
83571407|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571408|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
83571409|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571410|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571411|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571412|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571413|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
83571414|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571415|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83571416|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571417|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571418|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83571419|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571420|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571421|NCT00003728|Leucovorin|leucovorin|mesh-list
83571422|NCT00003728|Cytarabine|cytarabine|mesh-list
83571423|NCT00003728|Dexamethasone|dexamethasone|mesh-list
83571424|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
83571425|NCT00003728|Prednisolone|prednisolone|mesh-list
83571426|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
83571427|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83571428|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83571429|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83571430|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
83571431|NCT00003728|Doxorubicin|doxorubicin|mesh-list
83571432|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83571433|NCT00003728|Methotrexate|methotrexate|mesh-list
83571434|NCT00003728|Etoposide|etoposide|mesh-list
83571435|NCT00003728|Vincristine|vincristine|mesh-list
83571436|NCT00003728|Daunorubicin|daunorubicin|mesh-list
83571437|NCT00003728|Asparaginase|asparaginase|mesh-list
83571438|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
83571439|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
83571440|NCT00003728|Thioguanine|thioguanine|mesh-list
83571441|NCT00003728|Vindesine|vindesine|mesh-list
83571442|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
83571443|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571444|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
83571445|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571446|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571447|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571448|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
83571449|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571450|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571451|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571452|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571453|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
83571454|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
83571455|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571456|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571457|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
83571458|NCT00003728|Hormones|hormones|mesh-ancestor
83571459|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571460|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571461|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571462|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571463|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571464|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571465|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83571466|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
83571467|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83571468|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571469|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
83571470|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571471|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83571472|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571473|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571474|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
83571475|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571476|NCT00003728|Antidotes|antidotes|mesh-ancestor
83571477|NCT00003728|Protective Agents|protective agents|mesh-ancestor
83571478|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
83571479|NCT00003728|Vitamins|vitamins|mesh-ancestor
83571480|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
83571481|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571482|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571483|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571484|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83571485|NCT00003728|Analgesics|analgesics|mesh-ancestor
83571486|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
83571487|NCT00004886|Docetaxel|docetaxel|mesh-list
83571488|NCT00004886|Dofequidar|dofequidar|mesh-list
83571489|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571490|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571491|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571492|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571493|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571494|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83571495|NCT00003734|Flutamide|flutamide|mesh-list
83571496|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
83571497|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83571498|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
83571499|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83571500|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571501|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83571502|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571503|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571504|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
83571505|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
83571506|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571507|NCT00003740|Trastuzumab|trastuzumab|mesh-list
83571508|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83571509|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571510|NCT05477875|Acetaminophen|acetaminophen|mesh-list
83571511|NCT05477875|Dronabinol|dronabinol|mesh-list
83571512|NCT05477875|Codeine|codeine|mesh-list
83571513|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83571514|NCT05477875|Analgesics|analgesics|mesh-ancestor
83571515|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
83571516|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571517|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571518|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
83571519|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
83571520|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83571521|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83571522|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83571523|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571524|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571525|NCT05477875|Hormones|hormones|mesh-ancestor
83571526|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571527|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83571528|NCT05477875|Narcotics|narcotics|mesh-ancestor
83571529|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83571530|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
83571531|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
83571532|NCT00004256|Sargramostim|sargramostim|mesh-list
83571533|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
83571534|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571535|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
83571536|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571537|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83571538|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
83029634|NCT02174666|Estrogens|estrogens|mesh-ancestor
83571539|NCT00004892|Carmustine|carmustine|mesh-list
83571540|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83571541|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571542|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
83571543|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571544|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571545|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571546|NCT00004268|Midodrine|midodrine|mesh-list
83571547|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
83571548|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
83571549|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571550|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571551|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83571552|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83571553|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83571554|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83571555|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
83571556|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571557|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571558|NCT00004274|Estrogens|estrogens|mesh-list
83571559|NCT00004274|Hormones|hormones|mesh-ancestor
83571560|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571561|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571562|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
83571563|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
83571564|NCT00004904|Etoposide|etoposide|mesh-list
83571565|NCT00004904|Cladribine|cladribine|mesh-list
83571566|NCT00004904|Tacrolimus|tacrolimus|mesh-list
83571567|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83571568|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571569|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
83571570|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571571|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571572|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571573|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
83571574|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571575|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571576|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571577|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571578|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571579|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571580|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571581|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83571582|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571583|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
83571584|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
83571585|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571586|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571587|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
83571588|NCT00004904|Hormones|hormones|mesh-ancestor
83571589|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571590|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83571591|NCT00004904|Protective Agents|protective agents|mesh-ancestor
83571592|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
83571593|NCT00004286|Antibodies|antibodies|mesh-list
83571594|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
83571595|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83571596|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83571597|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
83571598|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571599|NCT00003746|Cladribine|cladribine|mesh-list
83571600|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571601|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571602|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
83571603|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571604|NCT00003752|Bexarotene|bexarotene|mesh-list
83571605|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571606|NCT00003758|Cytarabine|cytarabine|mesh-list
83571607|NCT00003758|Idarubicin|idarubicin|mesh-list
83571608|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571609|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
83571610|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571611|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571612|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
83571613|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029728|NCT03694587|Ibuprofen|ibuprofen|mesh-list
83571614|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571615|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
83571616|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571617|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571618|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571619|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571620|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571621|NCT00004310|Clomipramine|clomipramine|mesh-list
83571622|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83571623|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
83571624|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83571625|NCT00004310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83571626|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83571627|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83571628|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571629|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571630|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
83571631|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571632|NCT00004922|Irinotecan|irinotecan|mesh-list
83571633|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83571634|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571635|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571636|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571637|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571638|NCT00004316|Capsaicin|capsaicin|mesh-list
83571639|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
83571640|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571641|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
83571642|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571643|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571644|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
83571645|NCT00004928|Calcitriol|calcitriol|mesh-list
83571646|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83571647|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571648|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571649|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83571650|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83571651|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571652|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83571653|NCT00004928|Vitamins|vitamins|mesh-ancestor
83571654|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
83571655|NCT00004328|Enalapril|enalapril|mesh-list
83571656|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
83571657|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83571658|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
83571659|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571660|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571661|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83571662|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
83571663|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
83571664|NCT00004934|Paclitaxel|paclitaxel|mesh-list
83571665|NCT00004934|Carboplatin|carboplatin|mesh-list
83571666|NCT00004934|Epirubicin|epirubicin|mesh-list
83571667|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571668|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571669|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571670|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571671|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571672|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571673|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571674|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571675|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571676|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571677|NCT00003776|Leucovorin|leucovorin|mesh-list
83571678|NCT00003776|Trimetrexate|trimetrexate|mesh-list
83571679|NCT00003776|Doxorubicin|doxorubicin|mesh-list
83571680|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83571681|NCT00003776|Methotrexate|methotrexate|mesh-list
83571682|NCT00003776|Ifosfamide|ifosfamide|mesh-list
83571683|NCT00003776|Calcium|calcium|mesh-list
83571684|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
83571685|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571686|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571687|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571688|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571689|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845095|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571690|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571691|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571692|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571693|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83571694|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
83571695|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83571696|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571697|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
83571698|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571699|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83571700|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571701|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
83571702|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571703|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571704|NCT00003776|Antidotes|antidotes|mesh-ancestor
83571705|NCT00003776|Protective Agents|protective agents|mesh-ancestor
83571706|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
83571707|NCT00003776|Vitamins|vitamins|mesh-ancestor
83571708|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
83571709|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571710|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
83571711|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
83571712|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571713|NCT00003788|Carmustine|carmustine|mesh-list
83571714|NCT00003788|Lomustine|lomustine|mesh-list
83571715|NCT00003788|Procarbazine|procarbazine|mesh-list
83571716|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83571717|NCT00003788|Trioxsalen|trioxsalen|mesh-list
83571718|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571719|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
83571720|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571721|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571722|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
83571723|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83571724|NCT00004340|Calcitriol|calcitriol|mesh-list
83571725|NCT00004340|Hormones|hormones|mesh-list
83571726|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571727|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571728|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571729|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83571730|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83571731|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571732|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83571733|NCT00004340|Vitamins|vitamins|mesh-ancestor
83571734|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
83571735|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83571736|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83571737|NCT00004346|Lovastatin|lovastatin|mesh-list
83571738|NCT00004346|L 647318|l 647318|mesh-list
83571739|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
83571740|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83571741|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83571742|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
83571743|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571744|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83571745|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83571746|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571747|NCT00004346|Cathartics|cathartics|mesh-ancestor
83571748|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571749|NCT00384800|Thalidomide|thalidomide|mesh-list
83571750|NCT00384800|Tegafur|tegafur|mesh-list
83571751|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571752|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
83571753|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571754|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
83571755|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83571756|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571757|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83571758|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83571759|NCT00384800|Growth Substances|growth substances|mesh-ancestor
83571760|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83571761|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571762|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571763|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
83571764|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571766|NCT00384878|Fluorouracil|fluorouracil|mesh-list
83571767|NCT00384878|Cetuximab|cetuximab|mesh-list
83571768|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571769|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
83571770|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571771|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571772|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571773|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
83571774|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571775|NCT00384878|Antidotes|antidotes|mesh-ancestor
83571776|NCT00384878|Protective Agents|protective agents|mesh-ancestor
83571777|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
83571778|NCT00384878|Vitamins|vitamins|mesh-ancestor
83571779|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
83571780|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83571781|NCT02972762|Propofol|propofol|mesh-list
83571782|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83571783|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83571784|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571785|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83571786|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
83571787|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
83571788|NCT00004358|Calcitonin|calcitonin|mesh-list
83571789|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
83571790|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83571791|NCT00004358|Katacalcin|katacalcin|mesh-list
83571792|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571793|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571794|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83571795|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
83571796|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83571797|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
83571798|NCT00004364|Coagulants|coagulants|mesh-ancestor
83571799|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83571800|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
83571801|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571802|NCT00005000|Lamivudine|lamivudine|mesh-list
83571803|NCT00005000|Zidovudine|zidovudine|mesh-list
83571804|NCT00005000|Efavirenz|efavirenz|mesh-list
83571805|NCT00005000|Stavudine|stavudine|mesh-list
83571806|NCT00005000|Didanosine|didanosine|mesh-list
83571807|NCT00005000|Nelfinavir|nelfinavir|mesh-list
83571808|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83571809|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83571810|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571811|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571812|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571813|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
83571814|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571815|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83571816|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83571817|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
83571818|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83571819|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83571820|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83571821|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83571822|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83571823|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83571824|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83571825|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83571826|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
83571827|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83571828|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
83571829|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571830|NCT00004376|Guanfacine|guanfacine|mesh-list
83571831|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83571832|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83571833|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83571834|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83571835|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83571836|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571837|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571838|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571839|NCT00005006|Alendronate|alendronate|mesh-list
83571840|NCT00005006|Teriparatide|teriparatide|mesh-list
83571841|NCT00005006|Hormones|hormones|mesh-list
83571842|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
83571843|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571844|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571845|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83571846|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571848|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571849|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571850|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83571851|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
83571852|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571853|NCT00004400|Testosterone|testosterone|mesh-list
83571854|NCT00004400|Androgens|androgens|mesh-ancestor
83571855|NCT00004400|Hormones|hormones|mesh-ancestor
83571856|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571857|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571858|NCT00003812|Paclitaxel|paclitaxel|mesh-list
83571859|NCT00003812|Etoposide|etoposide|mesh-list
83571860|NCT00003812|Carboplatin|carboplatin|mesh-list
83571861|NCT00003812|Topotecan|topotecan|mesh-list
83571862|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83571863|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571864|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83571865|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83571866|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83571867|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571868|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571869|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571870|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571871|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83571872|NCT00005018|Efavirenz|efavirenz|mesh-list
83571873|NCT00005018|Abacavir|abacavir|mesh-list
83571874|NCT00005018|Didanosine|didanosine|mesh-list
83571875|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
83571876|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83571877|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83571878|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571879|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571880|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
83571881|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571882|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83571883|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83571884|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83571885|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83571886|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83571887|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83571888|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571889|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
83571890|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83571891|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83571892|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
83571893|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83571894|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
83571895|NCT00003824|Cephalexin|cephalexin|mesh-list
83571896|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83571897|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571898|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571899|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571900|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571901|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571902|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83571903|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83571904|NCT00004406|Hormones|hormones|mesh-list
83571905|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
83571906|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571907|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571908|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571909|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
83571910|NCT00005024|Carboplatin|carboplatin|mesh-list
83571911|NCT00005024|Doxorubicin|doxorubicin|mesh-list
83571912|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83571913|NCT00005024|Granisetron|granisetron|mesh-list
83571914|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571915|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
83571916|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571917|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571918|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83571919|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
83571920|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571921|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571922|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83571923|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83571924|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83571925|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571926|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571927|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
83571928|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
83571929|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571930|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83571931|NCT00005024|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83571932|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83571933|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
83571934|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571935|NCT00005030|Lonafarnib|lonafarnib|mesh-list
83571936|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571937|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571938|NCT00004424|Fentanyl|fentanyl|mesh-list
83571939|NCT00004424|Midazolam|midazolam|mesh-list
83571940|NCT00004424|Propofol|propofol|mesh-list
83571941|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83571942|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83571943|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571944|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83571945|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
83571946|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
83571947|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83571948|NCT00004424|Narcotics|narcotics|mesh-ancestor
83571949|NCT00004424|Analgesics|analgesics|mesh-ancestor
83571950|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
83571951|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83571952|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83571953|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83571954|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83571955|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83571956|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
83571957|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
83571958|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83571959|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571960|NCT00004430|Prednisolone|prednisolone|mesh-list
83571961|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571962|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
83571963|NCT00004430|Hormones|hormones|mesh-ancestor
83571964|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83571965|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571966|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83571967|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571968|NCT00003842|Interleukin-4|interleukin-4|mesh-list
83571969|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83571970|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
83571971|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571972|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571973|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83571974|NCT00005036|Leucovorin|leucovorin|mesh-list
83571975|NCT00005036|Fluorouracil|fluorouracil|mesh-list
83571976|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
83571977|NCT00005036|Irinotecan|irinotecan|mesh-list
83571978|NCT00005036|Calcium|calcium|mesh-list
83571979|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
83571980|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83571981|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83571982|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
83571983|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83571984|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83571985|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83571986|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83571987|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
83571988|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83571989|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83571990|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83571991|NCT00005036|Antidotes|antidotes|mesh-ancestor
83571992|NCT00005036|Protective Agents|protective agents|mesh-ancestor
83571993|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
83571994|NCT00005036|Vitamins|vitamins|mesh-ancestor
83571995|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
83571996|NCT00004436|Prednisone|prednisone|mesh-list
83571997|NCT00004436|Leuprolide|leuprolide|mesh-list
83571998|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83571999|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
83572000|NCT00004436|Hormones|hormones|mesh-ancestor
83684416|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572001|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572002|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572003|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572004|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572005|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83572006|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
83572007|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572008|NCT00005042|Semaxinib|semaxinib|mesh-list
83572009|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83572010|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83572011|NCT00005042|Growth Substances|growth substances|mesh-ancestor
83572012|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572013|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
83572014|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572015|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83572016|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572017|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572018|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83572019|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83572020|NCT00004442|Cholic Acids|cholic acids|mesh-list
83572021|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83572022|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83572023|NCT00004442|Cathartics|cathartics|mesh-ancestor
83572024|NCT05444569|Liraglutide|liraglutide|mesh-list
83572025|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83572026|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572027|NCT05444569|Incretins|incretins|mesh-ancestor
83572028|NCT05444569|Hormones|hormones|mesh-ancestor
83572029|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572030|NCT00004448|Prednisone|prednisone|mesh-list
83572031|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572032|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
83572033|NCT00004448|Hormones|hormones|mesh-ancestor
83572034|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572035|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572036|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572037|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572038|NCT00003860|Carboplatin|carboplatin|mesh-list
83572039|NCT00003860|Etoposide|etoposide|mesh-list
83572040|NCT00003860|Ifosfamide|ifosfamide|mesh-list
83572041|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572042|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572043|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83572044|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83572045|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572046|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572047|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572048|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
83572049|NCT00005048|Paclitaxel|paclitaxel|mesh-list
83572050|NCT00005048|Estramustine|estramustine|mesh-list
83572051|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572052|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572053|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572054|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572055|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572056|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572057|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572058|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
83572059|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572060|NCT04756765|Talazoparib|talazoparib|mesh-list
83572061|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83572062|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572063|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572064|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572065|NCT00004466|Atorvastatin|atorvastatin|mesh-list
83572066|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83572067|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83572068|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
83572069|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572070|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83572071|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83572072|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572073|NCT00005054|Temozolomide|temozolomide|mesh-list
83572074|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572075|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
83572076|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572077|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572078|NCT00004478|Droxidopa|droxidopa|mesh-list
83572079|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83572080|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83572081|NCT00003878|Carmustine|carmustine|mesh-list
83572082|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572083|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
83572084|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572085|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572086|NCT00005060|Docetaxel|docetaxel|mesh-list
83572087|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572088|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572089|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572090|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572091|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572092|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
83572093|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83572094|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572095|NCT00005066|Carmustine|carmustine|mesh-list
83572096|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83572097|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572098|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
83572099|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572100|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572101|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572102|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83572103|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
83572104|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572105|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83572106|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83572107|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
83572108|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572109|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572110|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83572111|NCT00005072|Interleukin-2|interleukin-2|mesh-list
83572112|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572113|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83572114|NCT00005072|Analgesics|analgesics|mesh-ancestor
83572115|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
83572116|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572117|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572118|NCT00004496|Hormones|hormones|mesh-list
83572119|NCT00004496|alpha-MSH|alpha-msh|mesh-list
83572120|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83572121|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83572122|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
83572123|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572124|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572125|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572126|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572127|NCT00003902|Capecitabine|capecitabine|mesh-list
83572128|NCT00003902|Vinorelbine|vinorelbine|mesh-list
83572129|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83572130|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
83572131|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572132|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572133|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572134|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572135|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572136|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572137|NCT00003908|Carboplatin|carboplatin|mesh-list
83572138|NCT00003908|Docetaxel|docetaxel|mesh-list
83572139|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572140|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572141|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572142|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572143|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572144|NCT00382837|Epratuzumab|epratuzumab|mesh-list
83572145|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83572146|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572147|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
83572148|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572149|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572150|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572151|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572152|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572153|NCT00005078|Paclitaxel|paclitaxel|mesh-list
83572154|NCT00005078|Carboplatin|carboplatin|mesh-list
83572155|NCT00005078|Tirapazamine|tirapazamine|mesh-list
83572156|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572157|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572158|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572159|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572160|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572161|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572162|NCT04698031|Aspirin|aspirin|mesh-list
83572163|NCT04698031|Clopidogrel|clopidogrel|mesh-list
83572164|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83572165|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83572166|NCT04698031|Analgesics|analgesics|mesh-ancestor
83572167|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
83572168|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572169|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572170|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572171|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572172|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83572173|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83572174|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572175|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83572176|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83572177|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572178|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
83572179|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83572180|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83572181|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83572182|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
83572183|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572184|NCT00003920|Cyclosporine|cyclosporine|mesh-list
83572185|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83572186|NCT00003920|Antibodies|antibodies|mesh-list
83572187|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
83572188|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83572189|NCT00003920|Cyclosporins|cyclosporins|mesh-list
83572190|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
83572191|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572192|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572193|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572194|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572195|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572196|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
83572197|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572198|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
83572199|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572200|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83572201|NCT00003926|Melphalan|melphalan|mesh-list
83572202|NCT00003926|Busulfan|busulfan|mesh-list
83572203|NCT00003926|Thiotepa|thiotepa|mesh-list
83572204|NCT00003926|Lenograstim|lenograstim|mesh-list
83572205|NCT00003926|Amifostine|amifostine|mesh-list
83572206|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83572207|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
83572208|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572209|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572210|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
83572211|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572212|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572213|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83572214|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572215|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83572216|NCT00003926|Protective Agents|protective agents|mesh-ancestor
83572217|NCT05122819|Anesthetics|anesthetics|mesh-list
83572218|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83572219|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572220|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
83572221|NCT00005090|Dacarbazine|dacarbazine|mesh-list
83572222|NCT00005090|Carmustine|carmustine|mesh-list
83572223|NCT00005090|Doxorubicin|doxorubicin|mesh-list
83572224|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83572225|NCT00005090|Etoposide|etoposide|mesh-list
83572226|NCT00005090|Bleomycin|bleomycin|mesh-list
83572227|NCT00005090|Vinblastine|vinblastine|mesh-list
83572228|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572229|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
83572230|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572231|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572232|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572233|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
83572234|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572235|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572236|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83572237|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83572238|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83572239|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83572240|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572241|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572242|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572243|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572244|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572245|NCT00004580|Ritonavir|ritonavir|mesh-list
83572246|NCT00004580|Lopinavir|lopinavir|mesh-list
83572247|NCT00004580|Nevirapine|nevirapine|mesh-list
83572248|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83572249|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83572250|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
83572251|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572252|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572253|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83572254|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83572255|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
83572256|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572257|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83572258|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83572259|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83572260|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572261|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83572262|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83572263|NCT00005096|Docetaxel|docetaxel|mesh-list
83572264|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572265|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572266|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572267|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572268|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572269|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
83572270|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83572271|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572272|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
83572273|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83572274|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83572275|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
83572276|NCT00004646|Prednisone|prednisone|mesh-list
83572277|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572278|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
83572279|NCT00004646|Hormones|hormones|mesh-ancestor
83572280|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572281|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572282|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572283|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572284|NCT00005108|Estradiol|estradiol|mesh-list
83572285|NCT00005108|Progesterone|progesterone|mesh-list
83572286|NCT00005108|Estrogens|estrogens|mesh-ancestor
83572287|NCT00005108|Hormones|hormones|mesh-ancestor
83572288|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572289|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572290|NCT00005108|Progestins|progestins|mesh-ancestor
83572291|NCT00004652|Pimozide|pimozide|mesh-list
83572292|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83572293|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83572294|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83572295|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572296|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83572297|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83572298|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
83572299|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572300|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572301|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83572302|NCT00005120|Calanolide A|calanolide a|mesh-list
83572303|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83572304|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83572305|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
83572306|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572307|NCT00004664|Megestrol|megestrol|mesh-list
83572308|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83572309|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83572310|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83572311|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
83572312|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572313|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572314|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83572315|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83572316|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572317|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572318|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
83572319|NCT00004682|Antibodies|antibodies|mesh-list
83572320|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
83572321|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83572322|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83572323|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
83572324|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572325|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
83572326|NCT00004688|Carmustine|carmustine|mesh-list
83572327|NCT00004688|Streptozocin|streptozocin|mesh-list
83572328|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
83572329|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572330|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83572331|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572332|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572333|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
83572334|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572335|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572336|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572337|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572338|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
83572339|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83572340|NCT00004694|Heparin|heparin|mesh-list
83572341|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
83572342|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83572343|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83572344|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572345|NCT04608409|Paclitaxel|paclitaxel|mesh-list
83572346|NCT04608409|Lapatinib|lapatinib|mesh-list
83572347|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572348|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572349|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572350|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572351|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572352|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572353|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83572354|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572355|NCT00004700|Mitogens|mitogens|mesh-list
83572356|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572357|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572358|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
83572359|NCT00004730|Analgesics|analgesics|mesh-ancestor
83572360|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
83572361|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572362|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572363|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
83572364|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83572365|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83572366|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
83572367|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83572368|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83572369|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572370|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83572371|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
83572372|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572373|NCT00004736|Lamivudine|lamivudine|mesh-list
83572374|NCT00004736|Zidovudine|zidovudine|mesh-list
83572375|NCT00004736|Stavudine|stavudine|mesh-list
83572376|NCT00004736|Nelfinavir|nelfinavir|mesh-list
83572377|NCT00004736|Isoniazid|isoniazid|mesh-list
83572378|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
83572379|NCT00004736|Ethambutol|ethambutol|mesh-list
83572380|NCT00004736|Rifabutin|rifabutin|mesh-list
83572381|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83572382|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572383|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572384|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572385|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
83572386|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572387|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83572388|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83572389|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
83572390|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
83572391|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83572392|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83572393|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83572394|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83572395|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83572396|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83572397|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
83572398|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83572399|NCT00004748|Methotrexate|methotrexate|mesh-list
83572400|NCT00004748|Colchicine|colchicine|mesh-list
83572401|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83572402|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83572403|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
83572404|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572405|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572406|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83572407|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
83572408|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572409|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572410|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
83572411|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572412|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83572413|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572414|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
83572415|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572416|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572417|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
83572418|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572419|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572420|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572421|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83572422|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83572423|NCT04585477|Durvalumab|durvalumab|mesh-list
83572424|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83572425|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572426|NCT00004754|Epoprostenol|epoprostenol|mesh-list
83572427|NCT00004754|Tezosentan|tezosentan|mesh-list
83572428|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83572429|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83572430|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
83572431|NCT00005576|Aldesleukin|aldesleukin|mesh-list
83572432|NCT00005576|Interleukin-2|interleukin-2|mesh-list
83572433|NCT00005576|Dinutuximab|dinutuximab|mesh-list
83572434|NCT00005576|Isotretinoin|isotretinoin|mesh-list
83572435|NCT00005576|Antibodies|antibodies|mesh-list
83572436|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83572437|NCT00005576|Sargramostim|sargramostim|mesh-list
83572438|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
83572439|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572440|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572441|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83572442|NCT00005576|Analgesics|analgesics|mesh-ancestor
83572443|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
83572444|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572445|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83572446|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83572447|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
83572448|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572449|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
83572450|NCT04713163|Vaccines|vaccines|mesh-list
83572451|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
83572452|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572453|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
83572454|NCT00004772|Antibodies|antibodies|mesh-list
83572455|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
83572456|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83572457|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83572458|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
83572459|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572460|NCT04712929|Fluconazole|fluconazole|mesh-list
83572461|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
83572462|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572463|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83572464|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83572465|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572466|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572467|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83572468|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
83572469|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572470|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572471|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83572472|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83572473|NCT00004784|Methotrexate|methotrexate|mesh-list
83572474|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83572475|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83572476|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
83572477|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572478|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572479|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83572480|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
83572481|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572482|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572483|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83572484|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572485|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83572486|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572487|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
83572488|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572489|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572490|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83572491|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83572492|NCT00004796|Lactulose|lactulose|mesh-list
83572493|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83572494|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
83572495|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83572496|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572497|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572498|NCT00004808|Fluconazole|fluconazole|mesh-list
83572499|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
83572500|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572501|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83572502|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83572503|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572504|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572505|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83572506|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
83572507|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572508|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572509|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83572510|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83572511|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
83572512|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
83572513|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83572514|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
83572515|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572516|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572517|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572518|NCT00004826|Clozapine|clozapine|mesh-list
83572519|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83572520|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
83572521|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572522|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572523|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572524|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83572525|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83572526|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83572527|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83572528|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
83572529|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
83572530|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
83572531|NCT04555603|Avelumab|avelumab|mesh-list
83572532|NCT04555603|Axitinib|axitinib|mesh-list
83572533|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83572534|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572535|NCT04555603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83572536|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572537|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83572538|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572539|NCT04552327|Diclofenac|diclofenac|mesh-list
83572540|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83572541|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83572542|NCT04552327|Analgesics|analgesics|mesh-ancestor
83572543|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
83572544|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572545|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572546|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572547|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572548|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83572549|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572550|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572551|NCT00004778|Dexamethasone|dexamethasone|mesh-list
83572552|NCT00004778|Betamethasone|betamethasone|mesh-list
83572553|NCT00004778|Hormones|hormones|mesh-list
83572554|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
83572555|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572556|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
83572557|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
83572558|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572559|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572560|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83572561|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
83572562|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572563|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572564|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572565|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83572566|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
83572567|NCT00005612|Paclitaxel|paclitaxel|mesh-list
83572568|NCT00005612|Etoposide|etoposide|mesh-list
83572569|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
83572570|NCT00005612|Carboplatin|carboplatin|mesh-list
83572571|NCT00005612|Topotecan|topotecan|mesh-list
83572572|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572573|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572574|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572575|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572576|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572577|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572578|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572579|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
83572580|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572581|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572582|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572583|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
83572584|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83572585|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83572586|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83572587|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572588|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83572589|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
83572590|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572591|NCT04534153|Fexofenadine|fexofenadine|mesh-list
83572592|NCT04534153|Terfenadine|terfenadine|mesh-list
83572593|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83572594|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83572595|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83030682|NCT02186990|Propofol|propofol|mesh-list
83572596|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
83572597|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
83845096|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572598|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572599|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572600|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572601|NCT00005624|Tacedinaline|tacedinaline|mesh-list
83572602|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83572603|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572604|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572605|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572606|NCT00385502|Econazole|econazole|mesh-list
83572607|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
83572608|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572609|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83572610|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83572611|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572612|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572613|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83572614|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
83572615|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572616|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572617|NCT00005630|Sargramostim|sargramostim|mesh-list
83572618|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
83572619|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572620|NCT00005636|Pemetrexed|pemetrexed|mesh-list
83572621|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572622|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572623|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572624|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83572625|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572626|NCT00005642|Semaxinib|semaxinib|mesh-list
83572627|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83572628|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83572629|NCT00005642|Growth Substances|growth substances|mesh-ancestor
83572630|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572631|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
83572632|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572633|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83572634|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572635|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572636|NCT00005648|Gemcitabine|gemcitabine|mesh-list
83572637|NCT00005648|Tipifarnib|tipifarnib|mesh-list
83572638|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83572639|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
83572640|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572641|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572642|NCT00005654|Metformin|metformin|mesh-list
83572643|NCT00005654|Clomiphene|clomiphene|mesh-list
83572644|NCT00005654|Enclomiphene|enclomiphene|mesh-list
83572645|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
83572646|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83572647|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572648|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83572649|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
83572650|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572651|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83572652|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
83572653|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572654|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83572655|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83572656|NCT00005684|Heparin|heparin|mesh-list
83572657|NCT00005684|Warfarin|warfarin|mesh-list
83572658|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
83572659|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83572660|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83572661|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572662|NCT00386282|Misoprostol|misoprostol|mesh-list
83572663|NCT00386282|Mifepristone|mifepristone|mesh-list
83572664|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83572665|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
83572666|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572667|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572668|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83572669|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83572670|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
83572671|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83572672|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83572673|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83572674|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83572675|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
83572676|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83572677|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83572678|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
83572679|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572680|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
83572681|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83572682|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83572684|NCT04456699|Bevacizumab|bevacizumab|mesh-list
83572685|NCT04456699|Fluorouracil|fluorouracil|mesh-list
83572686|NCT04456699|Capecitabine|capecitabine|mesh-list
83572687|NCT04456699|Olaparib|olaparib|mesh-list
83572688|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
83572689|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83572690|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572691|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83572692|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83572693|NCT04456699|Growth Substances|growth substances|mesh-ancestor
83572694|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572695|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
83572696|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
83572697|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572698|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83572699|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572700|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
83572701|NCT04456699|Antidotes|antidotes|mesh-ancestor
83572702|NCT04456699|Protective Agents|protective agents|mesh-ancestor
83572703|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
83572704|NCT04456699|Vitamins|vitamins|mesh-ancestor
83572705|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
83572706|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83572707|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572708|NCT00385658|Simvastatin|simvastatin|mesh-list
83572709|NCT00385658|Ezetimibe|ezetimibe|mesh-list
83572710|NCT00385658|Fenofibrate|fenofibrate|mesh-list
83572711|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83572712|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83572713|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
83572714|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572715|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83572716|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83572717|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572718|NCT00005762|Ritonavir|ritonavir|mesh-list
83572719|NCT00005762|Nelfinavir|nelfinavir|mesh-list
83572720|NCT00005762|Indinavir|indinavir|mesh-list
83572721|NCT00005762|Saquinavir|saquinavir|mesh-list
83572722|NCT00005762|Amprenavir|amprenavir|mesh-list
83572723|NCT00005762|Efavirenz|efavirenz|mesh-list
83572724|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83572725|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83572726|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
83572727|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572728|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572729|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83572730|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83572731|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
83572732|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572733|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83572734|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83572735|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83572736|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572737|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83572738|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83572739|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83572740|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83572741|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83572742|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83030828|NCT02187614|Analgesics|analgesics|mesh-ancestor
83572743|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
83572744|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83572745|NCT00005768|Estrogens|estrogens|mesh-list
83572746|NCT00005768|Hormones|hormones|mesh-ancestor
83572747|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572748|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572749|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83572750|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
83572751|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
83572752|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572753|NCT00005792|Etoposide|etoposide|mesh-list
83572754|NCT00005792|Melphalan|melphalan|mesh-list
83572755|NCT00005792|Topotecan|topotecan|mesh-list
83572756|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
83572757|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572758|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572759|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83572760|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83572761|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572762|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572763|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572764|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
83572765|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83572766|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572767|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
83572768|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572769|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83572770|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
83572771|NCT00005798|Thiotepa|thiotepa|mesh-list
83572772|NCT00005798|Carboplatin|carboplatin|mesh-list
83572773|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572774|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
83572775|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572776|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572777|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572778|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
83572779|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572780|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572781|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83572782|NCT00005810|Carboplatin|carboplatin|mesh-list
83572783|NCT00005810|Docetaxel|docetaxel|mesh-list
83572784|NCT00005810|Estramustine|estramustine|mesh-list
83572785|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572786|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572787|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572788|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572789|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572790|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572791|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
83572792|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572793|NCT00385970|Leucovorin|leucovorin|mesh-list
83572794|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
83572795|NCT00385970|Tegafur|tegafur|mesh-list
83572796|NCT00385970|Calcium|calcium|mesh-list
83572797|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
83572798|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83572799|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572800|NCT00385970|Antidotes|antidotes|mesh-ancestor
83572801|NCT00385970|Protective Agents|protective agents|mesh-ancestor
83572802|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
83572803|NCT00385970|Vitamins|vitamins|mesh-ancestor
83572804|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
83572805|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83572806|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
83572807|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572808|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572809|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83572810|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
83572811|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83572812|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
83572813|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572814|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
83572815|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83572816|NCT05006677|Vitamin K|vitamin k|mesh-list
83572817|NCT05006677|Anticoagulants|anticoagulants|mesh-list
83572818|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83572819|NCT05006677|Vitamins|vitamins|mesh-ancestor
83572820|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
83572821|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572822|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83572823|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83572824|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572826|NCT05006677|Coagulants|coagulants|mesh-ancestor
83572827|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83572828|NCT00386126|Hematinics|hematinics|mesh-ancestor
83572829|NCT05296603|Lenvatinib|lenvatinib|mesh-list
83572830|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572831|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83572832|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572833|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572834|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
83572835|NCT04569890|Prednisone|prednisone|mesh-list
83572836|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
83572837|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572838|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
83572839|NCT04569890|Hormones|hormones|mesh-ancestor
83572840|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572841|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572842|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572843|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572844|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
83572845|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83572846|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83572847|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572848|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572849|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572850|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572851|NCT04569890|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83572852|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572853|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
83572854|NCT00423163|Voriconazole|voriconazole|mesh-list
83572855|NCT00423163|Micafungin|micafungin|mesh-list
83572856|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
83572857|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572858|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83572859|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83572860|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572861|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572862|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83572863|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
83572864|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572865|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572866|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83572867|NCT04379635|Paclitaxel|paclitaxel|mesh-list
83572868|NCT04379635|Carboplatin|carboplatin|mesh-list
83572869|NCT04379635|Pemetrexed|pemetrexed|mesh-list
83572870|NCT04379635|Tislelizumab|tislelizumab|mesh-list
83572871|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83572872|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572873|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83572874|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83572875|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83572876|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572877|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83572878|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83572879|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83572880|NCT04379635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83572881|NCT04568876|Palmidrol|palmidrol|mesh-list
83572882|NCT04568876|Analgesics|analgesics|mesh-ancestor
83572883|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
83572884|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572885|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572886|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83572887|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83572888|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572889|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572890|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
83572891|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83572892|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83572893|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83572894|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572895|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572896|NCT04568876|Hormones|hormones|mesh-ancestor
83030975|NCT03755973|Hormones|hormones|mesh-ancestor
83572897|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572898|NCT04338061|Teriflunomide|teriflunomide|mesh-list
83572899|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83572900|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83572901|NCT04338061|Analgesics|analgesics|mesh-ancestor
83572902|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
83572903|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572904|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572905|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83572906|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572907|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572908|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
83572909|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83572910|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83572911|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83572912|NCT02210702|Norethindrone|norethindrone|mesh-list
83572913|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
83572914|NCT02210702|Estradiol|estradiol|mesh-list
83572915|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83572916|NCT02210702|Estrogens|estrogens|mesh-ancestor
83572917|NCT02210702|Hormones|hormones|mesh-ancestor
83572918|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572919|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572920|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83572921|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
83572922|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83572923|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83572924|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83572925|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83572926|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83572927|NCT04568096|Tamoxifen|tamoxifen|mesh-list
83572928|NCT04568096|Tretinoin|tretinoin|mesh-list
83572929|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83572930|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
83572931|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83572932|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572933|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83572934|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572935|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83572936|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83572937|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83572938|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
83572939|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
83572940|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83572941|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
83572942|NCT02278172|Vitamin D|vitamin d|mesh-list
83572943|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
83572944|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
83572945|NCT02278172|Vitamins|vitamins|mesh-list
83572946|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
83572947|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572948|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83572949|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83572950|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83572951|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83572952|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
83572953|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
83572954|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
83572955|NCT02210858|Tipifarnib|tipifarnib|mesh-list
83572956|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572957|NCT04565678|Mitapivat|mitapivat|mesh-list
83572958|NCT04565678|Enzyme Activators|enzyme activators|mesh-ancestor
83572959|NCT04565678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572960|NCT04564430|Clonidine|clonidine|mesh-list
83572961|NCT04564430|Analgesics|analgesics|mesh-ancestor
83572962|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
83572963|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572964|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572965|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83572966|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
83572967|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
83572968|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83572969|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83572970|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83031048|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
83572971|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
83572972|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572973|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572974|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
83572975|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572976|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
83572977|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83572978|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
83572979|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572980|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83572981|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83572982|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
83572983|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572984|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83572985|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83572986|NCT04563962|Methamphetamine|methamphetamine|mesh-list
83572987|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83572988|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83572989|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
83572990|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
83572991|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83572992|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
83572993|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83572994|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83572995|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
83572996|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83572997|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83572998|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83572999|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83573000|NCT02211482|Lamivudine|lamivudine|mesh-list
83573001|NCT02211482|Dolutegravir|dolutegravir|mesh-list
83573002|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83573003|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573004|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573005|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573006|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
83573007|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573008|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83573009|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83573010|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83573011|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83573012|NCT04929847|Emollients|emollients|mesh-list
83573013|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573014|NCT04561934|Fluorides|fluorides|mesh-list
83573015|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
83573016|NCT04561934|Protective Agents|protective agents|mesh-ancestor
83573017|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573018|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
83573019|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
83573020|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83573021|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83573022|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573023|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573024|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573025|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573026|NCT04563260|Palonosetron|palonosetron|mesh-list
83573027|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
83573028|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
83573029|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573030|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573031|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573032|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83573033|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83573034|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
83573035|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83573036|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573037|NCT04173793|Ezetimibe|ezetimibe|mesh-list
83573038|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83573039|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83573040|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
83573041|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573042|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83573043|NCT04561466|Bezafibrate|bezafibrate|mesh-list
83573044|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83573045|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
84124599|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573046|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573047|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83573048|NCT04561856|Dexamethasone|dexamethasone|mesh-list
83573049|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
83573050|NCT04561856|BB 1101|bb 1101|mesh-list
83573051|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573052|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
83573053|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
83573054|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573055|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573056|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573057|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
83573058|NCT04561856|Hormones|hormones|mesh-ancestor
83573059|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573060|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573061|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573062|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
83573063|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573064|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573065|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83573066|NCT04173403|Ezetimibe|ezetimibe|mesh-list
83573067|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83573068|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83573069|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
83573070|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573071|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83573072|NCT03539887|Ketamine|ketamine|mesh-list
83573073|NCT03539887|Analgesics|analgesics|mesh-ancestor
83573074|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
83573075|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573076|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573077|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83573078|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83573079|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
83573080|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
83573081|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83573082|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83573083|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83573084|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83573085|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573086|NCT04123717|Acetaminophen|acetaminophen|mesh-list
83573087|NCT04123717|Ibuprofen|ibuprofen|mesh-list
83573088|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83573089|NCT04123717|Analgesics|analgesics|mesh-ancestor
83573090|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
83573091|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573092|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573093|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
83573094|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83573095|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573096|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573097|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83573098|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573099|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573100|NCT03472495|Diltiazem|diltiazem|mesh-list
83573101|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83573102|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83573103|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83573104|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573105|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83573106|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573107|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
83573108|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
83573109|NCT04094701|Narcotics|narcotics|mesh-ancestor
83573110|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83573111|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573112|NCT04094701|Analgesics|analgesics|mesh-ancestor
83573113|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
83573114|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573115|NCT03351361|Nivolumab|nivolumab|mesh-list
83573116|NCT03351361|Ipilimumab|ipilimumab|mesh-list
83573117|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83573118|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573119|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83573120|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573121|NCT03234907|Vedolizumab|vedolizumab|mesh-list
83573122|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573123|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
83573124|NCT03228667|Nivolumab|nivolumab|mesh-list
83573125|NCT03228667|Atezolizumab|atezolizumab|mesh-list
83573126|NCT03228667|Durvalumab|durvalumab|mesh-list
83573127|NCT03228667|Avelumab|avelumab|mesh-list
83573128|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83573129|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83573130|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573131|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83573132|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573133|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
83573134|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573135|NCT04330027|Mitogens|mitogens|mesh-list
83573136|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573137|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573138|NCT00002893|Leucovorin|leucovorin|mesh-list
83573139|NCT00002893|Fluorouracil|fluorouracil|mesh-list
83573140|NCT00002893|Raltitrexed|raltitrexed|mesh-list
83573141|NCT00002893|Calcium|calcium|mesh-list
83573142|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
83573143|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83573144|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573145|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
83573146|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573147|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573148|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573149|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573150|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
83573151|NCT00002893|Antidotes|antidotes|mesh-ancestor
83573152|NCT00002893|Protective Agents|protective agents|mesh-ancestor
83573153|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
83573154|NCT00002893|Vitamins|vitamins|mesh-ancestor
83573155|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
83573156|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83573157|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573158|NCT03905941|Metformin|metformin|mesh-list
83573159|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
83573160|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83573161|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573162|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83573163|NCT03818581|Suvorexant|suvorexant|mesh-list
83573164|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83573165|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83573166|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83573167|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573168|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83573169|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83573170|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573171|NCT00002905|Zidovudine|zidovudine|mesh-list
83573172|NCT00002905|Didanosine|didanosine|mesh-list
83573173|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
83573174|NCT00002905|Prednimustine|prednimustine|mesh-list
83573175|NCT00002905|Doxorubicin|doxorubicin|mesh-list
83573176|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83573177|NCT00002905|Etoposide|etoposide|mesh-list
83573178|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
83573179|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573180|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
83573181|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573182|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573183|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573184|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
83573185|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573186|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573187|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573188|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573189|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573190|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573191|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573192|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573193|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
83573194|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83573195|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573196|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
83573197|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573198|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83573199|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83573200|NCT00002905|Analgesics|analgesics|mesh-ancestor
83573201|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
83573202|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573203|NCT00002911|Marimastat|marimastat|mesh-list
83573204|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573205|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573206|NCT00002917|Paclitaxel|paclitaxel|mesh-list
83573207|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573208|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573209|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573210|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573211|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573212|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573213|NCT00383695|Capecitabine|capecitabine|mesh-list
83573214|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
83573215|NCT00383695|Cetuximab|cetuximab|mesh-list
83573216|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573217|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
83573218|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573219|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573220|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83573221|NCT00383851|Temozolomide|temozolomide|mesh-list
83573222|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83573223|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573224|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
83573225|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573226|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573227|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
83573228|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
83573229|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573230|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83573231|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83573232|NCT00383851|Growth Substances|growth substances|mesh-ancestor
83573233|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573234|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
83573235|NCT00002923|KRN 5500|krn 5500|mesh-list
83573236|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573237|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83573238|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573239|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573240|NCT02636569|Diclofenac|diclofenac|mesh-list
83573241|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83573242|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83573243|NCT02636569|Analgesics|analgesics|mesh-ancestor
83573244|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
83573245|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573246|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573247|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573248|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573249|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83573250|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573251|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573252|NCT02461927|Midazolam|midazolam|mesh-list
83573253|NCT02461927|Naltrexone|naltrexone|mesh-list
83573254|NCT02461927|Ketamine|ketamine|mesh-list
83573255|NCT02461927|Analgesics|analgesics|mesh-ancestor
83573256|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
83573257|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573258|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573259|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83573260|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83573261|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
83573262|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
83573263|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83573264|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83573265|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83573266|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83573267|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573268|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83573269|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83573270|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83573271|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83573272|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83573273|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
83573274|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
83573275|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83573276|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83573277|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83573278|NCT00002935|Trioxsalen|trioxsalen|mesh-list
83573279|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573280|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573281|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83573282|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
83573283|NCT00002941|Carmustine|carmustine|mesh-list
83573284|NCT00002941|Etoposide|etoposide|mesh-list
83573285|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573286|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
83573287|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573288|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573289|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573290|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
83573291|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573292|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573293|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573294|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573295|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573296|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573297|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573298|NCT00002953|Paclitaxel|paclitaxel|mesh-list
83573299|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
83573300|NCT00002953|Epirubicin|epirubicin|mesh-list
83573301|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573302|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573303|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573304|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573305|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573306|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573307|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573308|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
83573309|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573310|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573311|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573312|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
83573313|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573314|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573315|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573316|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573317|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573318|NCT03693781|Colchicine|colchicine|mesh-list
83573319|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
83573320|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573321|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573322|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573323|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573324|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573325|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573326|NCT02283853|Interferons|interferons|mesh-list
83573327|NCT02283853|Interferon-beta|interferon-beta|mesh-list
83573328|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
83573329|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83573330|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573331|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
83573332|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573333|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573334|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573335|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
83573336|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573337|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83573338|NCT03668041|Gabapentin|gabapentin|mesh-list
83573339|NCT03668041|Trazodone|trazodone|mesh-list
83573340|NCT03668041|Eszopiclone|eszopiclone|mesh-list
83573341|NCT03668041|Analgesics|analgesics|mesh-ancestor
83573342|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
83573343|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573344|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573345|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
83573346|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83573347|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83573348|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83573349|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83573350|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83573351|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83573352|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83573353|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573354|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
83573355|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83573356|NCT03668041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83573357|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83573358|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83573359|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
83573360|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83573361|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
83573362|NCT00002965|Interferons|interferons|mesh-list
83573363|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
83573364|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
83573365|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83573366|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573367|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
83573368|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573369|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
83573370|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573371|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83573372|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573373|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573374|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573375|NCT00002977|Melphalan|melphalan|mesh-list
83573376|NCT00002977|Thiotepa|thiotepa|mesh-list
83573377|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
83573378|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573379|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573380|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
83573381|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573382|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573383|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573384|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573385|NCT00003391|Antibodies|antibodies|mesh-list
83573386|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83573387|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
83573388|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573389|NCT00003397|Dexamethasone|dexamethasone|mesh-list
83573390|NCT00003397|Paclitaxel|paclitaxel|mesh-list
83573391|NCT00003397|Etoposide|etoposide|mesh-list
83573392|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
83573393|NCT00003397|Rituximab|rituximab|mesh-list
83573394|NCT00003397|Gemcitabine|gemcitabine|mesh-list
83573395|NCT00003397|Melphalan|melphalan|mesh-list
83573396|NCT00003397|Carmustine|carmustine|mesh-list
83573397|NCT00003397|Sargramostim|sargramostim|mesh-list
83573398|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573399|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573400|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573401|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573402|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573403|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573404|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573405|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
83573406|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573407|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573408|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573409|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
83573410|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573411|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83573412|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573413|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
83573414|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
83573415|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573416|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573417|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
83573418|NCT00003397|Hormones|hormones|mesh-ancestor
83573419|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573420|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573421|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573422|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
83573423|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573424|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573425|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573426|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
83573427|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573428|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83573429|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573430|NCT00003415|Topotecan|topotecan|mesh-list
83573431|NCT00003415|Amifostine|amifostine|mesh-list
83573432|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83573433|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573434|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573435|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573436|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573437|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83573438|NCT00003415|Protective Agents|protective agents|mesh-ancestor
83573439|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573440|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
83573441|NCT00002989|Melphalan|melphalan|mesh-list
83573442|NCT00002989|Busulfan|busulfan|mesh-list
83573443|NCT00002989|Idarubicin|idarubicin|mesh-list
83573444|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573445|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
83573446|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573447|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573448|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573449|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
83573450|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573451|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573452|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573453|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573454|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573455|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573456|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573457|NCT00002995|Dactinomycin|dactinomycin|mesh-list
83573458|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
83573459|NCT00002995|Vincristine|vincristine|mesh-list
83573460|NCT00002995|Sargramostim|sargramostim|mesh-list
83573461|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573462|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
83573463|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573464|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573465|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573466|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
83573467|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573468|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573469|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573470|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573471|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573472|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573473|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573474|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83573475|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573476|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573477|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83573478|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573479|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573480|NCT00003001|Leucovorin|leucovorin|mesh-list
83573481|NCT00003001|Gemcitabine|gemcitabine|mesh-list
83573482|NCT00003001|Fluorouracil|fluorouracil|mesh-list
83573483|NCT00003001|Calcium|calcium|mesh-list
83573484|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
83573485|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573486|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
83573487|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573488|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573489|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83573490|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573491|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573492|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
83573493|NCT00003001|Antidotes|antidotes|mesh-ancestor
83573494|NCT00003001|Protective Agents|protective agents|mesh-ancestor
83573495|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
83573496|NCT00003001|Vitamins|vitamins|mesh-ancestor
83573497|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
83573498|NCT00003421|Prednisolone|prednisolone|mesh-list
83573499|NCT00003421|Doxorubicin|doxorubicin|mesh-list
83573500|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83573501|NCT00003421|Bleomycin|bleomycin|mesh-list
83573502|NCT00003421|Etoposide|etoposide|mesh-list
83573503|NCT00003421|Vincristine|vincristine|mesh-list
83573504|NCT00003421|Dacarbazine|dacarbazine|mesh-list
83573505|NCT00003421|Vinblastine|vinblastine|mesh-list
83573506|NCT00003421|Procarbazine|procarbazine|mesh-list
83573507|NCT00003421|Chlorambucil|chlorambucil|mesh-list
83573508|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573509|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573510|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573511|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573512|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573513|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573514|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573515|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573516|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573517|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573518|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573519|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
83573520|NCT00003421|Hormones|hormones|mesh-ancestor
83573521|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573522|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573523|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573524|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573525|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
83573526|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
83573527|NCT00003427|Irinotecan|irinotecan|mesh-list
83573528|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573529|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83573530|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573531|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573532|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573533|NCT00003439|Interleukin-12|interleukin-12|mesh-list
83573534|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83573535|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
83573536|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573537|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83573538|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83573539|NCT00003439|Growth Substances|growth substances|mesh-ancestor
83573540|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
83573541|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573542|NCT00003007|Interferons|interferons|mesh-list
83573543|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
83573544|NCT00003007|Dexamethasone|dexamethasone|mesh-list
83573545|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
83573546|NCT00003007|Melphalan|melphalan|mesh-list
83573547|NCT00003007|Sargramostim|sargramostim|mesh-list
83573548|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573549|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
83573550|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573551|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573552|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573553|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
83573554|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573555|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573556|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573557|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573558|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
83573559|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
83573560|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573561|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573562|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
83573563|NCT00003007|Hormones|hormones|mesh-ancestor
83573564|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573565|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573566|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
83573567|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573568|NCT01478035|Phenytoin|phenytoin|mesh-list
83573569|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
83573570|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83573571|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83573572|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83573573|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573574|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83573575|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83573576|NCT00003013|Tamoxifen|tamoxifen|mesh-list
83573577|NCT00003013|Paclitaxel|paclitaxel|mesh-list
83573578|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
83031637|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
83573579|NCT00003013|Doxorubicin|doxorubicin|mesh-list
83573580|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83573581|NCT00003013|Fluorouracil|fluorouracil|mesh-list
83573582|NCT00003013|Methotrexate|methotrexate|mesh-list
83573583|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573584|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573585|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573586|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573587|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573588|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573589|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573590|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
83573591|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573592|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573593|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573594|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
83573595|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573596|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573597|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573598|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573599|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573600|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
83573601|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573602|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83573603|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
83573604|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83573605|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573606|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83573607|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573608|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83573609|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
83573610|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573611|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573612|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83573613|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83573614|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83573615|NCT00003445|Docetaxel|docetaxel|mesh-list
83573616|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573617|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573618|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573619|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573620|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573621|NCT00003451|Interferons|interferons|mesh-list
83573622|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
83573623|NCT00003451|Interleukin-12|interleukin-12|mesh-list
83573624|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573625|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
83573626|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573627|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
83573628|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573629|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83573630|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83573631|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83573632|NCT00003451|Growth Substances|growth substances|mesh-ancestor
83573633|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
83573634|NCT00003463|Irinotecan|irinotecan|mesh-list
83573635|NCT00003463|Carmustine|carmustine|mesh-list
83573636|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83573637|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573638|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573639|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573640|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573641|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573642|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
83573643|NCT00003019|Methotrexate|methotrexate|mesh-list
83573644|NCT00003019|Vinblastine|vinblastine|mesh-list
83573645|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83573646|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
83573647|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83573648|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573649|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573650|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
83573651|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031716|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
83573652|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573653|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573654|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573655|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83573656|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573657|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
83573658|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573659|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573660|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573661|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573662|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573663|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573664|NCT01120249|Everolimus|everolimus|mesh-list
83573665|NCT01120249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83573666|NCT01120249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83573667|NCT01120249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573668|NCT01120249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573669|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573670|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
83573671|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573672|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573673|NCT00003493|Dexamethasone|dexamethasone|mesh-list
83573674|NCT00003493|Doxorubicin|doxorubicin|mesh-list
83573675|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83573676|NCT00003493|Vincristine|vincristine|mesh-list
83573677|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573678|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
83573679|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
83573680|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573681|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573682|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573683|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
83573684|NCT00003493|Hormones|hormones|mesh-ancestor
83573685|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573686|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573687|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573688|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573689|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573690|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573691|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573692|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573693|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573694|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573695|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573696|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573697|NCT00788125|Carboplatin|carboplatin|mesh-list
83573698|NCT00788125|Etoposide|etoposide|mesh-list
83573699|NCT00788125|Dasatinib|dasatinib|mesh-list
83573700|NCT00788125|Ifosfamide|ifosfamide|mesh-list
83573701|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
83573702|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573703|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573704|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573705|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573706|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573707|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573708|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83573709|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573710|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
83573711|NCT00003031|Voriconazole|voriconazole|mesh-list
83573712|NCT00003031|Amphotericin B|amphotericin b|mesh-list
83573713|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83573714|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
83573715|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
83573716|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
83573717|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573718|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83573719|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83573720|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573721|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573722|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83573723|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
83573724|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124600|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83031792|NCT02201576|Bortezomib|bortezomib|mesh-list
83573725|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573726|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83573727|NCT00003031|Amebicides|amebicides|mesh-ancestor
83573728|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83573729|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83573730|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83573731|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83573732|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573733|NCT00003517|Leuprolide|leuprolide|mesh-list
83573734|NCT00003517|Flutamide|flutamide|mesh-list
83573735|NCT00003517|Bicalutamide|bicalutamide|mesh-list
83573736|NCT00003517|Hormones|hormones|mesh-list
83573737|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
83573738|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573739|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573740|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83573741|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
83573742|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83573743|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573744|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573745|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
83573746|NCT00003037|Gemcitabine|gemcitabine|mesh-list
83573747|NCT00003037|Docetaxel|docetaxel|mesh-list
83573748|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573749|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573750|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
83573751|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573752|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573753|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573754|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573755|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
83573756|NCT00002803|Doxorubicin|doxorubicin|mesh-list
83573757|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83573758|NCT00002803|Vincristine|vincristine|mesh-list
83573759|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573760|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
83573761|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573762|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573763|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573764|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
83573765|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573766|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573767|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573768|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573769|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573770|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573771|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573772|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573773|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573774|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573775|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573776|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83573777|NCT00383929|Candesartan|candesartan|mesh-list
83573778|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
83573779|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83573780|NCT00383929|Diuretics|diuretics|mesh-ancestor
83573781|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
83573782|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573783|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83573784|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83573785|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573786|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83573787|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83573788|NCT00003541|Prednisone|prednisone|mesh-list
83573789|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
83573790|NCT00003541|Ifosfamide|ifosfamide|mesh-list
83573791|NCT00003541|Carboplatin|carboplatin|mesh-list
83573792|NCT00003541|Doxorubicin|doxorubicin|mesh-list
83573793|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83573794|NCT00003541|Etoposide|etoposide|mesh-list
83573795|NCT00003541|Vincristine|vincristine|mesh-list
83573796|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573797|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
83573798|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573799|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031871|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
83573800|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573801|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
83573802|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573803|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573804|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573805|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573806|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573807|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573808|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573809|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573810|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
83573811|NCT00003541|Hormones|hormones|mesh-ancestor
83573812|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573813|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573814|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573815|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573816|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573817|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573818|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
83573819|NCT00002809|Methotrexate|methotrexate|mesh-list
83573820|NCT00002809|Tacrolimus|tacrolimus|mesh-list
83573821|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83573822|NCT00002809|Sargramostim|sargramostim|mesh-list
83573823|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
83573824|NCT00002809|Antibodies|antibodies|mesh-list
83573825|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
83573826|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83573827|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83573828|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573829|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
83573830|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573831|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573832|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573833|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
83573834|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573835|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573836|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573837|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83573838|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
83573839|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83573840|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573841|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
83573842|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573843|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573844|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83573845|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573846|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83573847|NCT00383539|Vaccines|vaccines|mesh-list
83573848|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
83573849|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573850|NCT00002827|Cobalt|cobalt|mesh-list
83573851|NCT00002827|Doxorubicin|doxorubicin|mesh-list
83573852|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83573853|NCT00002827|Bleomycin|bleomycin|mesh-list
83573854|NCT00002827|Etoposide|etoposide|mesh-list
83573855|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
83573856|NCT00002827|Vincristine|vincristine|mesh-list
83573857|NCT00002827|Razoxane|razoxane|mesh-list
83573858|NCT00002827|Lenograstim|lenograstim|mesh-list
83573859|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573860|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573861|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573862|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573863|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573864|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573865|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83573866|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83573867|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
83573868|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573869|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573870|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573871|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573872|NCT00002827|Trace Elements|trace elements|mesh-ancestor
83573873|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
83573874|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83573875|NCT00002827|Protective Agents|protective agents|mesh-ancestor
83573876|NCT00384475|Ciclesonide|ciclesonide|mesh-list
83573877|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
83573878|NCT00384475|Hormones|hormones|mesh-ancestor
83462762|NCT05484648|Hormones|hormones|mesh-ancestor
83573879|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573880|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573881|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83573882|NCT00003565|Docetaxel|docetaxel|mesh-list
83573883|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573884|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
83573885|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
83573886|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
83573887|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573888|NCT00003049|Leucovorin|leucovorin|mesh-list
83573889|NCT00003049|Fluorouracil|fluorouracil|mesh-list
83573890|NCT00003049|Calcium|calcium|mesh-list
83573891|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
83573892|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83573893|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573894|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
83573895|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573896|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573897|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573898|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573899|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
83573900|NCT00003049|Antidotes|antidotes|mesh-ancestor
83573901|NCT00003049|Protective Agents|protective agents|mesh-ancestor
83573902|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
83573903|NCT00003049|Vitamins|vitamins|mesh-ancestor
83573904|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
83573905|NCT00003055|Irinotecan|irinotecan|mesh-list
83573906|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573907|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83573908|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573909|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573910|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573911|NCT00002833|Cytarabine|cytarabine|mesh-list
83573912|NCT00002833|Cyclosporine|cyclosporine|mesh-list
83573913|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
83573914|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83573915|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83573916|NCT00002833|Prednisolone|prednisolone|mesh-list
83573917|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
83573918|NCT00002833|Fludarabine|fludarabine|mesh-list
83573919|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
83573920|NCT00002833|Idarubicin|idarubicin|mesh-list
83573921|NCT00002833|Cladribine|cladribine|mesh-list
83573922|NCT00002833|Cyclosporins|cyclosporins|mesh-list
83573923|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83573924|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
83573925|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573926|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573927|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
83573928|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573929|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573930|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
83573931|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573932|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
83573933|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573934|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573935|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
83573936|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573937|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573938|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83573939|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83573940|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
83573941|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
83573942|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83573943|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83573944|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
83573945|NCT00002833|Hormones|hormones|mesh-ancestor
83573946|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83573947|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83573948|NCT00002833|Protective Agents|protective agents|mesh-ancestor
83573949|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83573950|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573951|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573952|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83032019|NCT02419417|Nivolumab|nivolumab|mesh-list
83573953|NCT00003061|Cytarabine|cytarabine|mesh-list
83573954|NCT00003061|Methotrexate|methotrexate|mesh-list
83462848|NCT01188421|Clonidine|clonidine|mesh-list
83573955|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83573957|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83573958|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573959|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573960|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
83573961|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573962|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573963|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573964|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573965|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83573966|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573967|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
83573968|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573969|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573970|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
83573971|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83573972|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
83573973|NCT00003577|Fluorouracil|fluorouracil|mesh-list
83573974|NCT00003577|Methotrexate|methotrexate|mesh-list
83573975|NCT00003577|Epirubicin|epirubicin|mesh-list
83573976|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83573977|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
83573978|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83573979|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83573980|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83573981|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
83573982|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83573983|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573984|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83573985|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
83573986|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83573987|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83573988|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
83573989|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83573990|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
83573991|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83573992|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83573993|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83573994|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83573995|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83573996|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83573997|NCT00002839|Fluorouracil|fluorouracil|mesh-list
83573998|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83573999|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
83574000|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574001|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574002|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574003|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
83574004|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574005|NCT00003583|Etoposide|etoposide|mesh-list
83574006|NCT00003583|Amifostine|amifostine|mesh-list
83574007|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574008|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574009|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574010|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574011|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574012|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574013|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83574014|NCT00003583|Protective Agents|protective agents|mesh-ancestor
83574015|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574016|NCT00002845|Aldesleukin|aldesleukin|mesh-list
83574017|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574018|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83574019|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83574020|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
83574021|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574022|NCT00003067|Aldesleukin|aldesleukin|mesh-list
83574023|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574024|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83574025|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83574026|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
83574027|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574028|NCT00003589|Paclitaxel|paclitaxel|mesh-list
83574029|NCT00003589|Gemcitabine|gemcitabine|mesh-list
83574030|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574031|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574032|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574033|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574034|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574035|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574036|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574037|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
83574038|NCT00003595|Prednisone|prednisone|mesh-list
83574039|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
83574040|NCT00003595|Rituximab|rituximab|mesh-list
83574041|NCT00003595|Doxorubicin|doxorubicin|mesh-list
83574042|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574043|NCT00003595|Vincristine|vincristine|mesh-list
83574044|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574045|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
83574046|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574047|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574048|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574049|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
83574050|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574051|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574052|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574053|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83574054|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574055|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574056|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574057|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574058|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83574059|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
83574060|NCT00003595|Hormones|hormones|mesh-ancestor
83574061|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83574062|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83574063|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574064|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574065|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574066|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574067|NCT00003073|Cytarabine|cytarabine|mesh-list
83574068|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574069|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
83574070|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574071|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574072|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
83574073|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574074|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574075|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
83574076|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574077|NCT00003079|Cytarabine|cytarabine|mesh-list
83574078|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
83574079|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574080|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
83574081|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574082|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574083|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
83574084|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574085|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574086|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
83574087|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574088|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83574089|NCT00002869|Interferons|interferons|mesh-list
83574090|NCT00002869|Cytarabine|cytarabine|mesh-list
83574091|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
83574092|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
83574093|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574094|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
83574095|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574096|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574097|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
83574098|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574099|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574100|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
83574101|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574102|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
83574103|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574104|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83574105|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
83574106|NCT00002875|Lomustine|lomustine|mesh-list
83574107|NCT00002875|Cisplatin|cisplatin|mesh-list
83574108|NCT00002875|Vincristine|vincristine|mesh-list
83574109|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574110|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
83574111|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574112|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574113|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574114|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
83574115|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574116|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574117|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574118|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574119|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574120|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574121|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574122|NCT00003613|Carmustine|carmustine|mesh-list
83574123|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83574124|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574125|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
83574126|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574127|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574128|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574129|NCT00002881|Suramin|suramin|mesh-list
83574130|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
83574131|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83574132|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83574133|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83574134|NCT00002881|Leuprolide|leuprolide|mesh-list
83574135|NCT00002881|Goserelin|goserelin|mesh-list
83574136|NCT00002881|Flutamide|flutamide|mesh-list
83574137|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83574138|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83574139|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
83574140|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83574141|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574142|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83574143|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574144|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
83574145|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
83574146|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83574147|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
83574148|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
83574149|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83574150|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574151|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83574152|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83574153|NCT00003091|Interferons|interferons|mesh-list
83574154|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
83574155|NCT00003091|Aldesleukin|aldesleukin|mesh-list
83574156|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574157|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
83574158|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574159|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
83574160|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574161|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83574162|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83574163|NCT00003619|Vitamin E|vitamin e|mesh-list
83574164|NCT00003619|Cytarabine|cytarabine|mesh-list
83574165|NCT00003619|Fludarabine|fludarabine|mesh-list
83574166|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
83574167|NCT00003619|Etoposide|etoposide|mesh-list
83574168|NCT00003619|Busulfan|busulfan|mesh-list
83574169|NCT00003619|Topotecan|topotecan|mesh-list
83574170|NCT00003619|Isotretinoin|isotretinoin|mesh-list
83574171|NCT00003619|Vitamins|vitamins|mesh-ancestor
83574172|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
83574173|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574174|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574175|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574176|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
83574177|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574178|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574179|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
83574180|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574181|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574182|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574183|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574184|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
83574185|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574186|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
83574187|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574188|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574189|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574190|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
83574191|NCT00003619|Protective Agents|protective agents|mesh-ancestor
83574192|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
83574193|NCT00002887|Etoposide|etoposide|mesh-list
83574194|NCT00002887|Vinorelbine|vinorelbine|mesh-list
83574195|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
83574196|NCT00002887|Vinblastine|vinblastine|mesh-list
83574197|NCT00002887|Vindesine|vindesine|mesh-list
83574198|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574199|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574200|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574201|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574202|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574203|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574204|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574205|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574206|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574207|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
83574208|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83574209|NCT00003937|Cisplatin|cisplatin|mesh-list
83574210|NCT00003937|Doxorubicin|doxorubicin|mesh-list
83574211|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574212|NCT00003937|Methotrexate|methotrexate|mesh-list
83574213|NCT00003937|Etoposide|etoposide|mesh-list
83574214|NCT00003937|Ifosfamide|ifosfamide|mesh-list
83574215|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
83574216|NCT00003937|Razoxane|razoxane|mesh-list
83574217|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574218|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574219|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574220|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574221|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574222|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574223|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83574224|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
83574225|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83574226|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574227|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574228|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
83574229|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
83574230|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83574231|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574232|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
83574233|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574234|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83574235|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574236|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574237|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
83574238|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83574239|NCT00003937|Protective Agents|protective agents|mesh-ancestor
83574240|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574241|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574242|NCT00003625|Cyclosporine|cyclosporine|mesh-list
83574243|NCT00003625|Etoposide|etoposide|mesh-list
83574244|NCT00003625|Vincristine|vincristine|mesh-list
83574245|NCT00003625|Cyclosporins|cyclosporins|mesh-list
83574246|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574247|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574248|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574249|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574250|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574251|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574252|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574253|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574254|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574255|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574256|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
83574257|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574258|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
83574259|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574260|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
83574261|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574262|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83574263|NCT00003637|Fluorouracil|fluorouracil|mesh-list
83574264|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574266|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574267|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574268|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574269|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
83574270|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574271|NCT00003943|Paclitaxel|paclitaxel|mesh-list
83574272|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
83574273|NCT00003943|Carboplatin|carboplatin|mesh-list
83574274|NCT00003943|Topotecan|topotecan|mesh-list
83574275|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574276|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574277|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574278|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574279|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574280|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574281|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574282|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
83574283|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574284|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574285|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574286|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
83574287|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574288|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574289|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574290|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574291|NCT00003955|Dactinomycin|dactinomycin|mesh-list
83574292|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
83574293|NCT00003955|Irinotecan|irinotecan|mesh-list
83574294|NCT00003955|Vincristine|vincristine|mesh-list
83574295|NCT00003955|Sargramostim|sargramostim|mesh-list
83574296|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574297|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
83574298|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574299|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574300|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574301|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
83574302|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574303|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574304|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574305|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574306|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574307|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574308|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574309|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574310|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574311|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574312|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83574313|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574314|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574315|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83574316|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83574317|NCT00003103|Docetaxel|docetaxel|mesh-list
83574318|NCT00003103|Oblimersen|oblimersen|mesh-list
83574319|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574320|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574321|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574322|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574323|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574324|NCT00003109|Irinotecan|irinotecan|mesh-list
83574325|NCT00003109|Raltitrexed|raltitrexed|mesh-list
83574326|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574327|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574328|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574329|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574330|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574331|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574332|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
83574333|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83574334|NCT00003643|Paclitaxel|paclitaxel|mesh-list
83574335|NCT00003643|Etoposide|etoposide|mesh-list
83574336|NCT00003643|Bleomycin|bleomycin|mesh-list
83574337|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574338|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032392|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
83574339|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574340|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574341|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574342|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574343|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574344|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574345|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574346|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574347|NCT00003961|Sargramostim|sargramostim|mesh-list
83574348|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
83574349|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574350|NCT00003661|Cyclosporine|cyclosporine|mesh-list
83574351|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
83574352|NCT00003661|Melphalan|melphalan|mesh-list
83574353|NCT00003661|Busulfan|busulfan|mesh-list
83574354|NCT00003661|Cyclosporins|cyclosporins|mesh-list
83574355|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83574356|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574357|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574358|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574359|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
83574360|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574361|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
83574362|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574363|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
83574364|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574365|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83574366|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83574367|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
83574368|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
83574369|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83574370|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83574371|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
83574372|NCT00003661|Hormones|hormones|mesh-ancestor
83574373|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83574374|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83574375|NCT00003661|Protective Agents|protective agents|mesh-ancestor
83574376|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574377|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574378|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
83574379|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574380|NCT00003967|Etoposide|etoposide|mesh-list
83574381|NCT00003967|Topotecan|topotecan|mesh-list
83574382|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574383|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574384|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574385|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574386|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574387|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574388|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574389|NCT00003115|Hydromorphone|hydromorphone|mesh-list
83574390|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83574391|NCT00003115|Narcotics|narcotics|mesh-ancestor
83574392|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83574393|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574394|NCT00003115|Analgesics|analgesics|mesh-ancestor
83574395|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
83574396|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83574397|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
83574398|NCT00003667|Doxorubicin|doxorubicin|mesh-list
83574399|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574400|NCT00003667|Vincristine|vincristine|mesh-list
83574401|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
83574402|NCT00003667|Razoxane|razoxane|mesh-list
83574403|NCT00003667|Glycerol|glycerol|mesh-list
83574404|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574405|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
83574406|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574407|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574408|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574409|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
83574410|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574411|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574412|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574413|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574414|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574415|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574416|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574417|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574418|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574419|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574420|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574421|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83574422|NCT00003667|Protective Agents|protective agents|mesh-ancestor
83574423|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83574424|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
83574425|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83574426|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574427|NCT00003673|Immunotoxins|immunotoxins|mesh-ancestor
83574428|NCT00003673|Immunoconjugates|immunoconjugates|mesh-ancestor
83574429|NCT00003673|Immunologic Factors|immunologic factors|mesh-ancestor
83574430|NCT00003673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574431|NCT00003679|Tamoxifen|tamoxifen|mesh-list
83574432|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
83574433|NCT00003679|Docetaxel|docetaxel|mesh-list
83574434|NCT00003679|Doxorubicin|doxorubicin|mesh-list
83574435|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574436|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574437|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
83574438|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574439|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574440|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574441|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
83574442|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574443|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574444|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574445|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574446|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574447|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574448|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574449|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574450|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574451|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574452|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83574453|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
83574454|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83574455|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83574456|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83574457|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83574458|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83574459|NCT00003985|KRN 7000|krn 7000|mesh-list
83574460|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83574461|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
83574462|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574463|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574464|NCT00384553|Rituximab|rituximab|mesh-list
83574465|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83574466|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574467|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
83574468|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574469|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574470|NCT00003991|Aldesleukin|aldesleukin|mesh-list
83574471|NCT00003991|Histamine|histamine|mesh-list
83574472|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
83574473|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574474|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83574475|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83574476|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
83574477|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574478|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
83574479|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
83574480|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83574481|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574482|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574483|NCT00003997|Irofulven|irofulven|mesh-list
83574484|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574485|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
83574486|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574487|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574488|NCT00384631|Bevacizumab|bevacizumab|mesh-list
83032544|NCT02067078|Hormones|hormones|mesh-ancestor
83574489|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83574490|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574491|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83574492|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83574493|NCT00384631|Growth Substances|growth substances|mesh-ancestor
83574494|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574495|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
83574497|NCT00003127|Carboplatin|carboplatin|mesh-list
83574498|NCT00003127|Amifostine|amifostine|mesh-list
83574499|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574500|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574501|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574502|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574503|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574504|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574505|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83574506|NCT00003127|Protective Agents|protective agents|mesh-ancestor
83574507|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574508|NCT00004003|Gemcitabine|gemcitabine|mesh-list
83574509|NCT00004003|Fluorouracil|fluorouracil|mesh-list
83574510|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574511|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574512|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
83574513|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574514|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574515|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
83574516|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574517|NCT00004009|Tipifarnib|tipifarnib|mesh-list
83574518|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574519|NCT00003133|Paclitaxel|paclitaxel|mesh-list
83574520|NCT00003133|Gemcitabine|gemcitabine|mesh-list
83574521|NCT00003133|Doxorubicin|doxorubicin|mesh-list
83574522|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574523|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574524|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574525|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574526|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574527|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574528|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574529|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574530|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
83574531|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574532|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574533|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574534|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574535|NCT00003691|Paclitaxel|paclitaxel|mesh-list
83574536|NCT00003691|Doxorubicin|doxorubicin|mesh-list
83574537|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574538|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574539|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574540|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574541|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574542|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574543|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574544|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574545|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574546|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574547|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574548|NCT00003139|Pilocarpine|pilocarpine|mesh-list
83574549|NCT00003139|Miotics|miotics|mesh-ancestor
83574550|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
83574551|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83574552|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574553|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83574554|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83574555|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
83574556|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83574557|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574558|NCT00003697|Vadimezan|vadimezan|mesh-list
83574559|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574560|NCT02972983|Daptomycin|daptomycin|mesh-list
83574561|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83574562|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574563|NCT00003709|Carbendazim|carbendazim|mesh-list
83032612|NCT02070510|Lisinopril|lisinopril|mesh-list
83574564|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
83574565|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
83574566|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83574567|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574568|NCT00003145|Cyclosporine|cyclosporine|mesh-list
83574569|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
83574570|NCT00003145|Fludarabine|fludarabine|mesh-list
83574571|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
83574572|NCT00003145|Cyclosporins|cyclosporins|mesh-list
83574573|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574574|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574575|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
83574576|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574577|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574578|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
83574579|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574580|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574581|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
83574582|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574583|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83574584|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574585|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83574586|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574587|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83574588|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
83574589|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83574590|NCT00004039|Interferons|interferons|mesh-list
83574591|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
83574592|NCT00004039|Prednisone|prednisone|mesh-list
83574593|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
83574594|NCT00004039|Rituximab|rituximab|mesh-list
83574595|NCT00004039|Doxorubicin|doxorubicin|mesh-list
83574596|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574597|NCT00004039|Vincristine|vincristine|mesh-list
83574598|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574599|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
83574600|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574601|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574602|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574603|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
83574604|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574605|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574606|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574607|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83574608|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574609|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574610|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574611|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574612|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83574613|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
83574614|NCT00004039|Hormones|hormones|mesh-ancestor
83574615|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83574616|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83574617|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
83574618|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574619|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574620|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574621|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574622|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574623|NCT00003151|Amoxicillin|amoxicillin|mesh-list
83574624|NCT00003151|Metronidazole|metronidazole|mesh-list
83574625|NCT00003151|Clarithromycin|clarithromycin|mesh-list
83574626|NCT00003151|Tetracycline|tetracycline|mesh-list
83574627|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83574628|NCT00003151|Omeprazole|omeprazole|mesh-list
83574629|NCT00003151|Bismuth|bismuth|mesh-list
83574630|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83574631|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574632|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83574633|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83574634|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83574635|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83574636|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83574637|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574638|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574639|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83574640|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83574641|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83574642|NCT00003151|Antacids|antacids|mesh-ancestor
83574643|NCT00004045|Exatecan|exatecan|mesh-list
83574644|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574645|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574646|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574647|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574648|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574649|NCT00003715|Interferons|interferons|mesh-list
83574650|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
83574651|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
83574652|NCT00003715|Vaccines|vaccines|mesh-list
83574653|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
83574654|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
83574655|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574656|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574657|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574658|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574659|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
83574660|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574661|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574662|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574663|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
83574664|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574665|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83574666|NCT00004051|Irinotecan|irinotecan|mesh-list
83574667|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574668|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574669|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574670|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574671|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574672|NCT00003727|Interferons|interferons|mesh-list
83574673|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
83574674|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
83574675|NCT00003727|Melphalan|melphalan|mesh-list
83574676|NCT00003727|Carmustine|carmustine|mesh-list
83574677|NCT00003727|Gemcitabine|gemcitabine|mesh-list
83574678|NCT00003727|Etoposide|etoposide|mesh-list
83574679|NCT00003727|Sargramostim|sargramostim|mesh-list
83574680|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574681|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
83574682|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574683|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574684|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574685|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
83574686|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574687|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574688|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574689|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574690|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
83574691|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574692|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574693|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574694|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574695|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
83574696|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574697|NCT00003157|Gemcitabine|gemcitabine|mesh-list
83574698|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574699|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574700|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
83574701|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574702|NCT00004057|Paclitaxel|paclitaxel|mesh-list
83574703|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574704|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574705|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574706|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574707|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574708|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574709|NCT00004063|Interferons|interferons|mesh-list
83574710|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
83574711|NCT00004063|Gemcitabine|gemcitabine|mesh-list
83574712|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574713|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574714|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
83574715|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574716|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
83574717|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574718|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
83574719|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574720|NCT00003733|Paclitaxel|paclitaxel|mesh-list
83574721|NCT00003733|Carboplatin|carboplatin|mesh-list
83574722|NCT00003733|Topotecan|topotecan|mesh-list
83574723|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574724|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574725|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574726|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574727|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574728|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574729|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574730|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574731|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574732|NCT00003739|Lenograstim|lenograstim|mesh-list
83574733|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83574734|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
83574735|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574736|NCT00003745|Topotecan|topotecan|mesh-list
83574737|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83574738|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574739|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574740|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574741|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574742|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
83574743|NCT00003163|Melphalan|melphalan|mesh-list
83574744|NCT00003163|Sargramostim|sargramostim|mesh-list
83574745|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574746|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
83574747|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574748|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574749|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574750|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
83574751|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574752|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574753|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574754|NCT00004081|Docetaxel|docetaxel|mesh-list
83574755|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574756|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574757|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574758|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574759|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574760|NCT00003751|Penicillamine|penicillamine|mesh-list
83574761|NCT00003751|Antidotes|antidotes|mesh-ancestor
83574762|NCT00003751|Protective Agents|protective agents|mesh-ancestor
83574763|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574764|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
83574765|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
83574766|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574767|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574768|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83574769|NCT00004087|Antibodies|antibodies|mesh-list
83574770|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
83574771|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83574772|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
83574773|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574774|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574775|NCT00003757|Rituximab|rituximab|mesh-list
83574776|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83574777|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574778|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
83574779|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574780|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574781|NCT00003175|Fluorouracil|fluorouracil|mesh-list
83574782|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
83574783|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574784|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574785|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574786|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574787|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
83574788|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574789|NCT00004099|Leucovorin|leucovorin|mesh-list
83574790|NCT00004099|Fluorouracil|fluorouracil|mesh-list
83574791|NCT00004099|Calcium|calcium|mesh-list
83574792|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
83574793|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574794|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83574795|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574796|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
83574797|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574798|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574799|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574800|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
83574801|NCT00004099|Antidotes|antidotes|mesh-ancestor
83574802|NCT00004099|Protective Agents|protective agents|mesh-ancestor
83574803|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
83574804|NCT00004099|Vitamins|vitamins|mesh-ancestor
83574805|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
83574806|NCT00003763|Folic Acid|folic acid|mesh-list
83574807|NCT00003763|Hematinics|hematinics|mesh-ancestor
83574808|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
83574809|NCT00003763|Vitamins|vitamins|mesh-ancestor
83574810|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
83574811|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574812|NCT00003181|Aldesleukin|aldesleukin|mesh-list
83574813|NCT00003181|Vinblastine|vinblastine|mesh-list
83574814|NCT00003181|Sargramostim|sargramostim|mesh-list
83574815|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
83574816|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574817|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574818|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83574819|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83574820|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
83574821|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574822|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574823|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574824|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574825|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574826|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574827|NCT00004105|Paclitaxel|paclitaxel|mesh-list
83574828|NCT00004105|Vinorelbine|vinorelbine|mesh-list
83574829|NCT00004105|Estramustine|estramustine|mesh-list
83574830|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574831|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574832|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574833|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574834|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574835|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574836|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574837|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
83574838|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83574839|NCT00003187|Cytarabine|cytarabine|mesh-list
83574840|NCT00003187|Cyclosporine|cyclosporine|mesh-list
83574841|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
83574842|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
83574843|NCT00003187|Methotrexate|methotrexate|mesh-list
83574844|NCT00003187|Cyclosporins|cyclosporins|mesh-list
83574845|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574846|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
83574847|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574848|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574849|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574850|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
83574851|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574852|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574853|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574854|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83574855|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
83574856|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83574857|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574858|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
83574859|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
83574860|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574861|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83574862|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83574863|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
83574864|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574865|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
83574866|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83574867|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83574868|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
83574869|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
83574870|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83574871|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83574872|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
83574873|NCT00003187|Hormones|hormones|mesh-ancestor
83574874|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83574875|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83574876|NCT00003187|Protective Agents|protective agents|mesh-ancestor
83574877|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
83574878|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574879|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574880|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574881|NCT00003775|Leflunomide|leflunomide|mesh-list
83574882|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574883|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574884|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574885|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
83574886|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574887|NCT00004123|Doxorubicin|doxorubicin|mesh-list
83574888|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83574889|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83574890|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574891|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83574892|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83574893|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574894|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574895|NCT00003781|Docetaxel|docetaxel|mesh-list
83574896|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574897|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574898|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574899|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574900|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574901|NCT00003193|Paclitaxel|paclitaxel|mesh-list
83574902|NCT00003193|Amifostine|amifostine|mesh-list
83574903|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574904|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574905|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574906|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574907|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574908|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574909|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83574910|NCT00003193|Protective Agents|protective agents|mesh-ancestor
83574911|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574912|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
83574913|NCT00004135|Fludarabine|fludarabine|mesh-list
83574914|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
83574915|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574916|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
83574917|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574918|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574919|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574920|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
83574921|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574922|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574923|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574924|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574925|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
83574926|NCT00004141|Dacarbazine|dacarbazine|mesh-list
83574927|NCT00004141|Molgramostim|molgramostim|mesh-list
83574928|NCT00004141|Sargramostim|sargramostim|mesh-list
83574929|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574930|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574931|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
83574932|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574933|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
83574934|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574935|NCT02972905|Nemiralisib|nemiralisib|mesh-list
83574936|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83574937|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574938|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574939|NCT00003799|Leucovorin|leucovorin|mesh-list
83574940|NCT00003799|Fluorouracil|fluorouracil|mesh-list
83574941|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
83574942|NCT00003799|Calcium|calcium|mesh-list
83574943|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
83574944|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83574945|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574946|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
83574947|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574948|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574949|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574950|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574951|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
83574952|NCT00003799|Antidotes|antidotes|mesh-ancestor
83574953|NCT00003799|Protective Agents|protective agents|mesh-ancestor
83574954|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
83574955|NCT00003799|Vitamins|vitamins|mesh-ancestor
83574956|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
83574957|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
83574958|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83574959|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
83574960|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574961|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574962|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
83574963|NCT00003211|Vincristine|vincristine|mesh-list
83574964|NCT00003211|Amifostine|amifostine|mesh-list
83574965|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83574966|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
83574967|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83574968|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83574969|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83574970|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
83574971|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574972|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574973|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83574974|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574975|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574976|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574977|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574978|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83574979|NCT00003211|Protective Agents|protective agents|mesh-ancestor
83574980|NCT00003805|Vancomycin|vancomycin|mesh-list
83574981|NCT00003805|Tazobactam|tazobactam|mesh-list
83574982|NCT00003805|Piperacillin|piperacillin|mesh-list
83574983|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83574984|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83574985|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83574986|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83574987|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83574988|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574989|NCT00004159|Paclitaxel|paclitaxel|mesh-list
83574990|NCT00004159|Gemcitabine|gemcitabine|mesh-list
83574991|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83574992|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83574993|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83574994|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83574995|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83574996|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83574997|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83574998|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
83574999|NCT00003811|Etoposide|etoposide|mesh-list
83575000|NCT00003811|Bleomycin|bleomycin|mesh-list
83575001|NCT00003811|Amifostine|amifostine|mesh-list
83575002|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575003|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575004|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575005|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575006|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575007|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575008|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575009|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83575010|NCT00003811|Protective Agents|protective agents|mesh-ancestor
83575011|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575012|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83575013|NCT00004177|Antibodies|antibodies|mesh-list
83575014|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
83575015|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83575016|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
83575017|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575018|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575019|NCT00003817|Ondansetron|ondansetron|mesh-list
83575020|NCT00003817|Granisetron|granisetron|mesh-list
83575021|NCT00003817|Tropisetron|tropisetron|mesh-list
83575022|NCT00003817|Dolasetron|dolasetron|mesh-list
83575023|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
83575024|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
83575025|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575026|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033072|NCT02225210|Narcotics|narcotics|mesh-ancestor
83575027|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575028|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
83575029|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
83575030|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83575031|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83575032|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
83575033|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83575034|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575035|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
83575036|NCT00003829|Fludarabine|fludarabine|mesh-list
83575037|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
83575038|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575039|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
83575040|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575041|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575042|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575043|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
83575044|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575045|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575046|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575047|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575048|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
83575049|NCT04329403|Adapalene|adapalene|mesh-list
83575050|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83575051|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83575052|NCT04329403|Analgesics|analgesics|mesh-ancestor
83575053|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
83575054|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575055|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575056|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83575057|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575058|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83575059|NCT00003217|Cytarabine|cytarabine|mesh-list
83575060|NCT00003217|Dexamethasone|dexamethasone|mesh-list
83575061|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
83575062|NCT00003217|Doxorubicin|doxorubicin|mesh-list
83575063|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83575064|NCT00003217|Methotrexate|methotrexate|mesh-list
83575065|NCT00003217|Vincristine|vincristine|mesh-list
83575066|NCT00003217|Lenograstim|lenograstim|mesh-list
83575067|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575068|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
83575069|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575070|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575071|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575072|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
83575073|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575074|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575075|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575076|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83575077|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
83575078|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
83575079|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575080|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575081|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
83575082|NCT00003217|Hormones|hormones|mesh-ancestor
83575083|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575084|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83575085|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575086|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575087|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575088|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575089|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83575090|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
83575091|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83575092|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575093|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
83575094|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
83575095|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83575096|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83575097|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
83575098|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575099|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83575100|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575101|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83033143|NCT04504045|Metformin|metformin|mesh-list
83575102|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575103|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575104|NCT00004183|Capecitabine|capecitabine|mesh-list
83575105|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575106|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
83575107|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575108|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575109|NCT00003223|Fenretinide|fenretinide|mesh-list
83575111|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575112|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83575113|NCT00003223|Protective Agents|protective agents|mesh-ancestor
83575114|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575115|NCT00004189|Cisplatin|cisplatin|mesh-list
83575116|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575117|NCT00003229|Aldesleukin|aldesleukin|mesh-list
83575118|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575119|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83575120|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83575121|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
83575122|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575123|NCT00003835|Leucovorin|leucovorin|mesh-list
83575124|NCT00003835|Fluorouracil|fluorouracil|mesh-list
83575125|NCT00003835|Irinotecan|irinotecan|mesh-list
83575126|NCT00003835|Calcium|calcium|mesh-list
83575127|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
83575128|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575129|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575130|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
83575131|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575132|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575133|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575134|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575135|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
83575136|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83575137|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575138|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575139|NCT00003835|Antidotes|antidotes|mesh-ancestor
83575140|NCT00003835|Protective Agents|protective agents|mesh-ancestor
83575141|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
83575142|NCT00003835|Vitamins|vitamins|mesh-ancestor
83575143|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
83575144|NCT00003847|Doxorubicin|doxorubicin|mesh-list
83575145|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83575146|NCT00003847|Vincristine|vincristine|mesh-list
83575147|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575148|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575149|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575150|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575151|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575152|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575153|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575154|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575155|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575156|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575157|NCT00004195|Eniluracil|eniluracil|mesh-list
83575158|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575159|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575160|NCT00003853|Esorubicin|esorubicin|mesh-list
83575161|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575162|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575163|NCT00385021|Leucovorin|leucovorin|mesh-list
83575164|NCT00385021|Fluorouracil|fluorouracil|mesh-list
83575165|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
83575166|NCT00385021|Bevacizumab|bevacizumab|mesh-list
83575167|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
83575168|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575169|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575170|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575171|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575172|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
83575173|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575174|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83575175|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83033216|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
83575176|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83575177|NCT00385021|Growth Substances|growth substances|mesh-ancestor
83575178|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
83575179|NCT00385021|Antidotes|antidotes|mesh-ancestor
83575180|NCT00385021|Protective Agents|protective agents|mesh-ancestor
83575181|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
83575182|NCT00385021|Vitamins|vitamins|mesh-ancestor
83575183|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
83575184|NCT00004201|Carboplatin|carboplatin|mesh-list
83575185|NCT00004201|Gemcitabine|gemcitabine|mesh-list
83575186|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575187|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575188|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
83575189|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575190|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
83575191|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575192|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
83575193|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575194|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575195|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
83575196|NCT00003859|Carboplatin|carboplatin|mesh-list
83575197|NCT00003859|Etoposide|etoposide|mesh-list
83575198|NCT00003859|Vincristine|vincristine|mesh-list
83575199|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575200|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
83575201|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575202|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575203|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575204|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
83575205|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575206|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575207|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575208|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575209|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575210|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575211|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575212|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575213|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575214|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575215|NCT00003865|Toremifene|toremifene|mesh-list
83575216|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83575217|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575218|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83575219|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83575220|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
83575221|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575222|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575223|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83575224|NCT00004207|Daunorubicin|daunorubicin|mesh-list
83575225|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575226|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575227|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575228|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575229|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575230|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575231|NCT00004219|Granisetron|granisetron|mesh-list
83575232|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
83575233|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
83575234|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575235|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575236|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575237|NCT00004219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83575238|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83575239|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
83575240|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83575241|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575242|NCT00003877|Paclitaxel|paclitaxel|mesh-list
83575243|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
83575244|NCT00003877|Carboplatin|carboplatin|mesh-list
83575245|NCT00003877|Thiotepa|thiotepa|mesh-list
83575246|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575247|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575248|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575249|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575250|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575251|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575252|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575253|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
83575254|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575256|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575257|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
83575258|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575259|NCT00003883|Itraconazole|itraconazole|mesh-list
83575260|NCT00003883|Fluconazole|fluconazole|mesh-list
83575261|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
83575262|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575263|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83575264|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83575265|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575266|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575267|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83575268|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
83575269|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575270|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575271|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83575272|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83575273|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83575274|NCT04225819|Vitamin D|vitamin d|mesh-list
83575275|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
83575276|NCT04225819|Vitamins|vitamins|mesh-ancestor
83575277|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
83575278|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575279|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83575280|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575281|NCT00003253|Paclitaxel|paclitaxel|mesh-list
83575282|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
83575283|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575284|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575285|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575286|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575287|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575288|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
83575289|NCT00004237|Doxorubicin|doxorubicin|mesh-list
83575290|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83575291|NCT00004237|Vinorelbine|vinorelbine|mesh-list
83575292|NCT00004237|Epirubicin|epirubicin|mesh-list
83575293|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
83575294|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575295|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
83575296|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575297|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575298|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575299|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
83575300|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575301|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575302|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575303|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575304|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575305|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575306|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575307|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575308|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575309|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575310|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575311|NCT00004237|Analgesics|analgesics|mesh-ancestor
83575312|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
83575313|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575314|NCT00003259|Vinorelbine|vinorelbine|mesh-list
83575315|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575316|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575317|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575318|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575319|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575320|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575321|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
83575322|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
83575323|NCT00003913|Busulfan|busulfan|mesh-list
83575324|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83575325|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575326|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
83575327|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575328|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575329|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575330|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
83575331|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575332|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575333|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575334|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83575335|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
83575336|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
83575337|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575338|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575339|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
83575340|NCT00003913|Hormones|hormones|mesh-ancestor
83575341|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575342|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83575343|NCT00003913|Protective Agents|protective agents|mesh-ancestor
83575344|NCT00004243|Docetaxel|docetaxel|mesh-list
83575345|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
83575346|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575347|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575348|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575349|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575350|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575351|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83575352|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83575353|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
83575354|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575355|NCT00003925|Leucovorin|leucovorin|mesh-list
83575356|NCT00003925|Gemcitabine|gemcitabine|mesh-list
83575357|NCT00003925|Tegafur|tegafur|mesh-list
83575358|NCT00003925|Calcium|calcium|mesh-list
83575359|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
83575360|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575361|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
83575362|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575363|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575364|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575365|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575366|NCT00003925|Antidotes|antidotes|mesh-ancestor
83575367|NCT00003925|Protective Agents|protective agents|mesh-ancestor
83575368|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
83575369|NCT00003925|Vitamins|vitamins|mesh-ancestor
83575370|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
83575371|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
83575372|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
83575373|NCT00004255|Fludarabine|fludarabine|mesh-list
83575374|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
83575375|NCT00004255|Tacrolimus|tacrolimus|mesh-list
83575376|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83575377|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575378|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
83575379|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575380|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575381|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575382|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
83575383|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575384|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575385|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575386|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575387|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
83575388|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83575389|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575390|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83575391|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
83575392|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
83575393|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575394|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575395|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
83575396|NCT00004255|Hormones|hormones|mesh-ancestor
83575397|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575398|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83575399|NCT00004255|Protective Agents|protective agents|mesh-ancestor
83575400|NCT00004261|Antibodies|antibodies|mesh-list
83575401|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
83575402|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575403|NCT00004297|Diazepam|diazepam|mesh-list
83575404|NCT00004297|Lorazepam|lorazepam|mesh-list
83575405|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
83575406|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
83033521|NCT02226926|Aspirin|aspirin|mesh-list
83575407|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
83575408|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575409|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575410|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575411|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83575412|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83575413|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83575414|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83575415|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83575416|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
83575417|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
83575418|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83575419|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575420|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83575421|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83575422|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83575423|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83575424|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
83575425|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
83575426|NCT00004855|Ritonavir|ritonavir|mesh-list
83575427|NCT00004855|Lopinavir|lopinavir|mesh-list
83575428|NCT00004855|Lamivudine|lamivudine|mesh-list
83575429|NCT00004855|Nevirapine|nevirapine|mesh-list
83575430|NCT00004855|Abacavir|abacavir|mesh-list
83575431|NCT00004855|Stavudine|stavudine|mesh-list
83575432|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83575433|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83575434|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83575435|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575436|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575437|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83575438|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83575439|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
83575440|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575441|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83575442|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83575443|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83575444|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83575445|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83575446|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83575447|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
83575448|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83575449|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575450|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83575451|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575452|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575453|NCT00004861|Gemcitabine|gemcitabine|mesh-list
83575454|NCT00004861|Tacedinaline|tacedinaline|mesh-list
83575455|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575456|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
83575457|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575458|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575459|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83575460|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575461|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83575462|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83575463|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575464|NCT04074343|Irinotecan|irinotecan|mesh-list
83575465|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83575466|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575467|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575468|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575469|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575470|NCT00003301|Irinotecan|irinotecan|mesh-list
83575471|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83575472|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575473|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575474|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575475|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575476|NCT00003307|Amifostine|amifostine|mesh-list
83575477|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83575478|NCT00003307|Protective Agents|protective agents|mesh-ancestor
83575479|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575480|NCT00004327|Octreotide|octreotide|mesh-list
83575481|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575482|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83575483|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575484|NCT00003313|Paclitaxel|paclitaxel|mesh-list
83575485|NCT00003313|Carboplatin|carboplatin|mesh-list
83575486|NCT00003313|Amifostine|amifostine|mesh-list
83575487|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575488|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575489|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575490|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575491|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575492|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575493|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575494|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83575495|NCT00003313|Protective Agents|protective agents|mesh-ancestor
83575496|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83575497|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83575498|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575499|NCT00004873|Docetaxel|docetaxel|mesh-list
83575500|NCT00004873|Fluorouracil|fluorouracil|mesh-list
83575501|NCT00004873|Epirubicin|epirubicin|mesh-list
83575502|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575503|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575504|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575505|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575506|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575507|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
83575508|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575509|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575510|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
83575511|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575512|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575513|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575514|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575515|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575516|NCT00004879|Panitumumab|panitumumab|mesh-list
83575517|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83575518|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575519|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83575520|NCT00004339|Trientine|trientine|mesh-list
83575521|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
83575522|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
83575523|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575524|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575525|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83575526|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83575527|NCT00004339|Growth Substances|growth substances|mesh-ancestor
83575528|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575529|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83575530|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575531|NCT00003331|Leucovorin|leucovorin|mesh-list
83575532|NCT00003331|Fluorouracil|fluorouracil|mesh-list
83575533|NCT00003331|Topotecan|topotecan|mesh-list
83575534|NCT00003331|Calcium|calcium|mesh-list
83575535|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
83575536|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575537|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575538|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
83575539|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575540|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575541|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575542|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575543|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
83575544|NCT00003331|Antidotes|antidotes|mesh-ancestor
83575545|NCT00003331|Protective Agents|protective agents|mesh-ancestor
83575546|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
83575547|NCT00003331|Vitamins|vitamins|mesh-ancestor
83575548|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
83575549|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83575550|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575551|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575552|NCT00004885|Leucovorin|leucovorin|mesh-list
83575553|NCT00004885|Fluorouracil|fluorouracil|mesh-list
83575554|NCT00004885|Irinotecan|irinotecan|mesh-list
83575555|NCT00004885|Calcium|calcium|mesh-list
83575556|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
83575557|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575558|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575559|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
83575560|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575561|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575562|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575563|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575564|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
83575565|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83575566|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575567|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575568|NCT00004885|Antidotes|antidotes|mesh-ancestor
83575569|NCT00004885|Protective Agents|protective agents|mesh-ancestor
83575570|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
83575571|NCT00004885|Vitamins|vitamins|mesh-ancestor
83575572|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
83575573|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83575574|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83575575|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575576|NCT00003337|Epratuzumab|epratuzumab|mesh-list
83575577|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83575578|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575579|NCT00003343|Prednisone|prednisone|mesh-list
83575580|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
83575581|NCT00003343|Prinomastat|prinomastat|mesh-list
83575582|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83575583|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
83575584|NCT00003343|Hormones|hormones|mesh-ancestor
83575585|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575586|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575587|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83575588|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575589|NCT00003343|Analgesics|analgesics|mesh-ancestor
83575590|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
83575591|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575592|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575593|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575594|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575595|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575596|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
83575597|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
83575598|NCT00004903|Interferons|interferons|mesh-list
83575599|NCT00004903|Cytarabine|cytarabine|mesh-list
83575600|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
83575601|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
83575602|NCT00004903|Melphalan|melphalan|mesh-list
83575603|NCT00004903|Etoposide|etoposide|mesh-list
83575604|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575605|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
83575606|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575607|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575608|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575609|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
83575610|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575611|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575612|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575613|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575614|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575615|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575616|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575617|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
83575618|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575619|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575620|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
83575621|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
83575622|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83575623|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83575624|NCT00004357|Prednisolone|prednisolone|mesh-list
83575625|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
83575626|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83575627|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
83575628|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83575629|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
83575630|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
83575631|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575632|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033678|NCT02083692|Metformin|metformin|mesh-list
83575633|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575634|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
83575635|NCT00004357|Hormones|hormones|mesh-ancestor
83575636|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575637|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83575638|NCT00004357|Protective Agents|protective agents|mesh-ancestor
83575639|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83575640|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575641|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
83575642|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83575643|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
83575644|NCT00004363|Coagulants|coagulants|mesh-ancestor
83575645|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83575646|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
83575647|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575648|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83575649|NCT04069117|Letrozole|letrozole|mesh-list
83575650|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575651|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83575652|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83575653|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575654|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575655|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83575656|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
83575657|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575658|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575659|NCT00004921|Paclitaxel|paclitaxel|mesh-list
83575660|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
83575661|NCT00004921|Carboplatin|carboplatin|mesh-list
83575662|NCT00004921|Melphalan|melphalan|mesh-list
83575663|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575664|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575665|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575666|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575667|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575668|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575669|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575670|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
83575671|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575672|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575673|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575674|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
83575675|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575676|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
83575677|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
83575678|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575679|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
83575680|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575681|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575682|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83575683|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575684|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83575685|NCT00004981|Lamivudine|lamivudine|mesh-list
83575686|NCT00004981|Zidovudine|zidovudine|mesh-list
83575687|NCT00004981|Abacavir|abacavir|mesh-list
83575688|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
83575689|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83575690|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83575691|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83575692|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575693|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575694|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
83575695|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575696|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83575697|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83575698|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
83575699|NCT00004993|Hormones|hormones|mesh-list
83575700|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
83575701|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575702|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575703|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575704|NCT00004999|Lamivudine|lamivudine|mesh-list
83575705|NCT00004999|Zidovudine|zidovudine|mesh-list
83575706|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83575707|NCT00004999|Capravirine|capravirine|mesh-list
83575708|NCT00004999|Nelfinavir|nelfinavir|mesh-list
83575709|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83575710|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83575711|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575712|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575713|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
83575714|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575715|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83575716|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83575717|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
83575718|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83575719|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83575720|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
83575721|NCT00003361|Decitabine|decitabine|mesh-list
83575722|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575723|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
83575724|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575725|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575726|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575727|NCT00003367|Vitamin E|vitamin e|mesh-list
83575728|NCT00003367|Vitamins|vitamins|mesh-ancestor
83575729|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
83575730|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575731|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
83575732|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575733|NCT00003367|Protective Agents|protective agents|mesh-ancestor
83575734|NCT00003379|Paclitaxel|paclitaxel|mesh-list
83575735|NCT00003379|Cisplatin|cisplatin|mesh-list
83575736|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575737|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575738|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575739|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575740|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575741|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575742|NCT00003385|Paclitaxel|paclitaxel|mesh-list
83575743|NCT00003385|Carboplatin|carboplatin|mesh-list
83575744|NCT00003385|Doxorubicin|doxorubicin|mesh-list
83575745|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83575746|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575747|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575748|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575749|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575750|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575751|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575752|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575753|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575754|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575755|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575756|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83575757|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575758|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575759|NCT00005005|Alendronate|alendronate|mesh-list
83575760|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83575761|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575762|NCT00004393|Risperidone|risperidone|mesh-list
83575763|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83575764|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
83575765|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83575766|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575767|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575768|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83575769|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83575770|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83575771|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83575772|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83575773|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
83575774|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
83575775|NCT00004399|Nimodipine|nimodipine|mesh-list
83575776|NCT00004399|Analgesics|analgesics|mesh-ancestor
83575777|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
83575778|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575779|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575780|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
83575781|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83575782|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83575783|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
83575784|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83575785|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83575786|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575787|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575788|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
83575789|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83575790|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83575791|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
83575792|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83575793|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
83575794|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83575795|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575796|NCT00005017|Ritonavir|ritonavir|mesh-list
83575797|NCT00005017|Amprenavir|amprenavir|mesh-list
83575798|NCT00005017|Lamivudine|lamivudine|mesh-list
83575799|NCT00005017|Abacavir|abacavir|mesh-list
83575800|NCT00005017|Stavudine|stavudine|mesh-list
83575801|NCT00005017|Efavirenz|efavirenz|mesh-list
83575802|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83575803|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83575804|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
83575805|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575806|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575807|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83575808|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83575809|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
83575810|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575811|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83575812|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83575813|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83575814|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83575815|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83575816|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83575817|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83575818|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83575819|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83575820|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
83575821|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83575822|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
83575823|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83575824|NCT00005023|Sargramostim|sargramostim|mesh-list
83575825|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
83575826|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575827|NCT00005029|Topotecan|topotecan|mesh-list
83575828|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83575829|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575830|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575831|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575832|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575833|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
83575834|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575835|NCT00004429|Hormones|hormones|mesh-list
83575836|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575837|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575838|NCT00005041|Tipifarnib|tipifarnib|mesh-list
83575839|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575840|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83575841|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83575842|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83575843|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575844|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
83575845|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575846|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
83575847|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83575848|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575849|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575850|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83575851|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
83575852|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
83575853|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575854|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575855|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83575856|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83575857|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83575858|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
83575859|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83575860|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83575861|NCT00005575|Imipramine|imipramine|mesh-list
83575862|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83575863|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
83575864|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83575865|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83575866|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83575867|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83575868|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575869|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
83575870|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83575871|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575872|NCT00005059|Paclitaxel|paclitaxel|mesh-list
83575873|NCT00005059|Carboplatin|carboplatin|mesh-list
83575874|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575875|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575876|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575877|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575878|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575879|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575880|NCT00005065|Paclitaxel|paclitaxel|mesh-list
83575881|NCT00005065|Carboplatin|carboplatin|mesh-list
83575882|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
83575883|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575884|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575885|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575886|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575887|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575888|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575889|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83575890|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
83575891|NCT00386191|Clopidogrel|clopidogrel|mesh-list
83575892|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83575893|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83575894|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83575895|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83575896|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
83575897|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83575898|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575899|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575900|NCT00386269|Codeine|codeine|mesh-list
83575901|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83575902|NCT00386269|Narcotics|narcotics|mesh-ancestor
83575903|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83575904|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575905|NCT00386269|Analgesics|analgesics|mesh-ancestor
83575906|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
83575907|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83575908|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
83575909|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
83575910|NCT00005581|Paclitaxel|paclitaxel|mesh-list
83575911|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
83575912|NCT00005581|Fluorouracil|fluorouracil|mesh-list
83575913|NCT00005581|Epirubicin|epirubicin|mesh-list
83575914|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575915|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575916|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575917|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575918|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
83575919|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575920|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575921|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
83575922|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575923|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575924|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575925|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
83575926|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575927|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
83575928|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575929|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575930|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575931|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575932|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575933|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
83575934|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575935|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
83575936|NCT00004489|Vitamin D|vitamin d|mesh-list
83575938|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
83575939|NCT00004489|Calcium|calcium|mesh-list
83575940|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83575941|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575942|NCT00004489|Vitamins|vitamins|mesh-ancestor
83575943|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
83575944|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83575945|NCT00004489|Antacids|antacids|mesh-ancestor
83575946|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575947|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83575948|NCT00005593|Carboplatin|carboplatin|mesh-list
83575949|NCT00005593|Fludarabine|fludarabine|mesh-list
83575950|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
83575951|NCT00005593|Topotecan|topotecan|mesh-list
83575952|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575953|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83575954|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
83575955|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575956|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575957|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
83575958|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575959|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83575960|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575961|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575962|NCT00004495|Folic Acid|folic acid|mesh-list
83575963|NCT00004495|Pyridoxine|pyridoxine|mesh-list
83575964|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
83575965|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
83575966|NCT00004495|Hematinics|hematinics|mesh-ancestor
83575967|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
83575968|NCT00004495|Vitamins|vitamins|mesh-ancestor
83575969|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
83575970|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575971|NCT00005089|Prednisone|prednisone|mesh-list
83575972|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
83575973|NCT00005089|Rituximab|rituximab|mesh-list
83575974|NCT00005089|Doxorubicin|doxorubicin|mesh-list
83575975|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83575976|NCT00005089|Vincristine|vincristine|mesh-list
83575977|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83575978|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
83575979|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83575980|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83575981|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83575982|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
83575983|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83575984|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83575985|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83575986|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83575987|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83575988|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83575989|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83575990|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83575991|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83575992|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
83575993|NCT00005089|Hormones|hormones|mesh-ancestor
83575994|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83575995|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83575996|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83575997|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83575998|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83575999|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576000|NCT00005599|Paclitaxel|paclitaxel|mesh-list
83576001|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
83576002|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83576003|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576004|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83576005|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83576006|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576007|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576008|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83576009|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
83576010|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576011|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
83576012|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83576013|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576014|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83576015|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
83576016|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576017|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576018|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576019|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576020|NCT00005113|Cyclosporine|cyclosporine|mesh-list
83576022|NCT00005113|Tacrolimus|tacrolimus|mesh-list
83576023|NCT00005113|Cyclosporins|cyclosporins|mesh-list
83576024|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576025|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
83576026|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576027|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83576028|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576029|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576030|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
83576031|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576032|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576033|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576034|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576035|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83576036|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576037|NCT00004573|Ganciclovir|ganciclovir|mesh-list
83576038|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83576039|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
83576040|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576041|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83576042|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576043|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576044|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
83576045|NCT00005623|Cyproterone|cyproterone|mesh-list
83576046|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
83576047|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
83576048|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576049|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576050|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576051|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83576052|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
83576053|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83576054|NCT00005119|Calcium|calcium|mesh-list
83576055|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83576056|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576057|NCT00004585|Lamivudine|lamivudine|mesh-list
83576058|NCT00004585|Zidovudine|zidovudine|mesh-list
83576059|NCT00004585|Efavirenz|efavirenz|mesh-list
83576060|NCT00004585|Abacavir|abacavir|mesh-list
83576061|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
83576062|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83576063|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83576064|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83576065|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576066|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576067|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
83576068|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576069|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83576070|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83576071|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
83576072|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83576073|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83576074|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83576075|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83576076|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83576077|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83576078|NCT00005635|Paclitaxel|paclitaxel|mesh-list
83034108|NCT02232932|Hematinics|hematinics|mesh-ancestor
83034109|NCT02230358|Anesthetics|anesthetics|mesh-list
83034110|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034111|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034120|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83034121|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83034122|NCT04049864|Lenalidomide|lenalidomide|mesh-list
83034123|NCT04049864|Vaccines|vaccines|mesh-list
83034124|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
83576079|NCT00005635|Trastuzumab|trastuzumab|mesh-list
83576080|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83576081|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576082|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83576083|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83576084|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576085|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576086|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83576087|NCT00005641|Leucovorin|leucovorin|mesh-list
83576088|NCT00005641|Cyclosporine|cyclosporine|mesh-list
83576089|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
83576090|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
83576091|NCT00005641|Busulfan|busulfan|mesh-list
83576092|NCT00005641|Methotrexate|methotrexate|mesh-list
83576093|NCT00005641|Cyclosporins|cyclosporins|mesh-list
83576094|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83576095|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
83576096|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576097|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
83576098|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576099|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576100|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83576101|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
83576102|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576103|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576104|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83576105|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83576106|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
83576107|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83576108|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83576109|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
83576110|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576111|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576112|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83576113|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83576114|NCT00005641|Antidotes|antidotes|mesh-ancestor
83576115|NCT00005641|Protective Agents|protective agents|mesh-ancestor
83576116|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
83576117|NCT00005641|Vitamins|vitamins|mesh-ancestor
83576118|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
83576119|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
83576120|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576121|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83576122|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576123|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
83576124|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
83576125|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576126|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83576127|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
83576128|NCT00005641|Hormones|hormones|mesh-ancestor
83576129|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576130|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83576131|NCT00005647|Paclitaxel|paclitaxel|mesh-list
83576132|NCT00005647|Semaxinib|semaxinib|mesh-list
83576133|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83576134|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576135|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
83576136|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
83576137|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576138|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576139|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83576140|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83576141|NCT00005647|Growth Substances|growth substances|mesh-ancestor
83576142|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576143|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
83576144|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83576145|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576146|NCT00005665|Interferons|interferons|mesh-list
83576147|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
83576148|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576149|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
83576150|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576151|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
83576152|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576153|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
83576154|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576155|NCT00385411|Valproic Acid|valproic acid|mesh-list
83576156|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
83576157|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576158|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576159|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
83576160|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576161|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576162|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
83576163|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83576164|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83576165|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83576167|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576168|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576169|NCT00004705|Amiloride|amiloride|mesh-list
83576170|NCT00004705|Diuretics|diuretics|mesh-ancestor
83576171|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
83576172|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576173|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83576174|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83576175|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83576176|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576177|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83576178|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83576179|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
83576180|NCT00004747|Antibodies|antibodies|mesh-list
83576181|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
83576182|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83576183|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83576184|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
83576185|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576186|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
83576187|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83576188|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83576189|NCT00004759|Prednisolone|prednisolone|mesh-list
83576190|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
83576191|NCT00004759|Tirilazad|tirilazad|mesh-list
83576192|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83576193|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
83576194|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576195|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
83576196|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
83576197|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576198|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576199|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83576200|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
83576201|NCT00004759|Hormones|hormones|mesh-ancestor
83576202|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576203|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83576204|NCT00004759|Protective Agents|protective agents|mesh-ancestor
83576205|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83576206|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576207|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
83576208|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576209|NCT00004771|Leuprolide|leuprolide|mesh-list
83576210|NCT00004771|Testosterone|testosterone|mesh-list
83576211|NCT00004771|Androgens|androgens|mesh-ancestor
83576212|NCT00004771|Hormones|hormones|mesh-ancestor
83576213|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576214|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576215|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83576216|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576217|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83576218|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
83576219|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83576220|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83576221|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576222|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576223|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83576224|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83576225|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
83576226|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576227|NCT00004807|Topiramate|topiramate|mesh-list
83576228|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
83576229|NCT00004807|Donepezil|donepezil|mesh-list
83576230|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83576231|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576232|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576233|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
83576234|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576235|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576236|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
83576237|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
83576238|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576239|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
83576240|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576241|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83576242|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83576243|NCT00004825|Insulin|insulin|mesh-list
83576244|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83576245|NCT00004825|Mitogens|mitogens|mesh-list
83576246|NCT00004825|Mecasermin|mecasermin|mesh-list
83576247|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576248|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576249|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576250|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576251|NCT00004825|Growth Substances|growth substances|mesh-ancestor
83576252|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83576253|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83576254|NCT00385645|Zidovudine|zidovudine|mesh-list
83576255|NCT00385645|Lamivudine|lamivudine|mesh-list
83576256|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83576257|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83576258|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
83576259|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576260|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576261|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83576262|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83576263|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
83576264|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576265|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83576266|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83576267|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
83576268|NCT00385957|Lamivudine|lamivudine|mesh-list
83576269|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83576270|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83576271|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576272|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576273|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
83576274|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576275|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83576276|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83576277|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83576278|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576279|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576280|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
83576281|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83576282|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
83576283|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576284|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576285|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83576286|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576287|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83576288|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
83576289|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576290|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576291|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83576292|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
83576293|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
83576294|NCT00005773|Protective Agents|protective agents|mesh-ancestor
83576295|NCT00005779|Interleukin-12|interleukin-12|mesh-list
83576296|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83576297|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
83576298|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576299|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83576300|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83576301|NCT00005779|Growth Substances|growth substances|mesh-ancestor
83576302|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
83576303|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576304|NCT00005791|Fluorouracil|fluorouracil|mesh-list
83576305|NCT00005791|Irinotecan|irinotecan|mesh-list
83576306|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576307|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
83576308|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576309|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83576310|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576311|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
83576312|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576313|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83576314|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83576315|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576316|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
83576318|NCT00005797|Etoposide|etoposide|mesh-list
83576319|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576320|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
83576321|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576322|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576323|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83576324|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
83576325|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576326|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576327|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83576328|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83576329|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83576330|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83576331|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576332|NCT00005815|Thalidomide|thalidomide|mesh-list
83576333|NCT00005815|Temozolomide|temozolomide|mesh-list
83576334|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83576335|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
83576336|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576337|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576338|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576339|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
83576340|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576341|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
83576342|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576343|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576344|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83576345|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83576346|NCT00005815|Growth Substances|growth substances|mesh-ancestor
83576347|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83576348|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
83576349|NCT02132754|MK-4166|mk-4166|mesh-list
83576350|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83576351|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576352|NCT02132754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83576353|NCT02132754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576354|NCT02151786|Lansoprazole|lansoprazole|mesh-list
83576355|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
83576356|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83576357|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83576358|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83576359|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576360|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576361|NCT02106156|Interferons|interferons|mesh-list
83576362|NCT02106156|Ribavirin|ribavirin|mesh-list
83576363|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
83576364|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
83576365|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83576366|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576367|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
83576368|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576369|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
83576370|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576371|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
83576372|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576373|NCT02131272|Insulin|insulin|mesh-list
83576374|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83576375|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
83576376|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
83576377|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
83576378|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
83576379|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576380|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576381|NCT02130882|Benralizumab|benralizumab|mesh-list
83576382|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83576383|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576384|NCT02149836|Ezogabine|ezogabine|mesh-list
83576385|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
83576386|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83576387|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576388|NCT02130024|Ranibizumab|ranibizumab|mesh-list
83576389|NCT02130024|Aflibercept|aflibercept|mesh-list
83576390|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83576391|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83576392|NCT02130024|Growth Substances|growth substances|mesh-ancestor
83576393|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576394|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
83576395|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576396|NCT02105688|Grazoprevir|grazoprevir|mesh-list
83576397|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
83576398|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576399|NCT02105454|Ribavirin|ribavirin|mesh-list
83576400|NCT02105454|Grazoprevir|grazoprevir|mesh-list
83576401|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
83576402|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576403|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
83576404|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576405|NCT02104752|Curcumin|curcumin|mesh-list
83576406|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83576407|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83576408|NCT02104752|Analgesics|analgesics|mesh-ancestor
83576409|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
83576410|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576411|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576412|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576413|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576414|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576415|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576416|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576417|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
83576418|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576419|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576420|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
83576421|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
83576422|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576423|NCT02127372|Cisplatin|cisplatin|mesh-list
83576424|NCT02127372|Docetaxel|docetaxel|mesh-list
83576425|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
83576426|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576427|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83576428|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83576429|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576430|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576431|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83576432|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576433|NCT02125734|Bromides|bromides|mesh-list
83576434|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
83576435|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83576436|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
83576437|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576438|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576439|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83576440|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576441|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
83576442|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83576443|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
83576444|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576445|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576446|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
83576447|NCT02124798|Belimumab|belimumab|mesh-list
83576448|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576449|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
83576450|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576451|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
83576452|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
83576453|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83576454|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576455|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
83576456|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
83576457|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576458|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83034502|NCT01084252|BB 1101|bb 1101|mesh-list
83576459|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
83576460|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
83576461|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
83576462|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83576463|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83576464|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576465|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83576466|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83576467|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83576468|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83576469|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83576470|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83576471|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576472|NCT02124564|Lacosamide|lacosamide|mesh-list
83576473|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
83576474|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83576475|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83576476|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83576477|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576478|NCT02100696|Etrolizumab|etrolizumab|mesh-list
83576479|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83576480|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
83576481|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576482|NCT02123472|Cephalexin|cephalexin|mesh-list
83576483|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576484|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576485|NCT02145078|Gemcitabine|gemcitabine|mesh-list
83576486|NCT02145078|Docetaxel|docetaxel|mesh-list
83576487|NCT02145078|Pemetrexed|pemetrexed|mesh-list
83576488|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83576489|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
83576490|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576491|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576492|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
83576493|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
83576494|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576495|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576496|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83576497|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83576498|NCT02100228|Vitamin K|vitamin k|mesh-list
83576499|NCT02100228|Heparin|heparin|mesh-list
83576500|NCT02100228|Apixaban|apixaban|mesh-list
83576501|NCT02100228|Vitamins|vitamins|mesh-ancestor
83576502|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
83576503|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576504|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
83576505|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83576506|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83576507|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576508|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83576509|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
83576510|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83576511|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83576512|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576513|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83576514|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
83576515|NCT02100228|Coagulants|coagulants|mesh-ancestor
83576516|NCT02099838|Metformin|metformin|mesh-list
83576517|NCT02099838|Pioglitazone|pioglitazone|mesh-list
83576518|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576519|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576520|NCT02099682|Lansoprazole|lansoprazole|mesh-list
83576521|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
83576522|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83576523|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83576524|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83576525|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576526|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576527|NCT02098746|Pioglitazone|pioglitazone|mesh-list
83576528|NCT02098746|Glimepiride|glimepiride|mesh-list
83576529|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576530|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576531|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83576532|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576533|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
83576534|NCT02122770|Itraconazole|itraconazole|mesh-list
83576535|NCT02122770|Fluconazole|fluconazole|mesh-list
83576536|NCT02122770|Paclitaxel|paclitaxel|mesh-list
83576537|NCT02122770|Docetaxel|docetaxel|mesh-list
83576538|NCT02122770|Carboplatin|carboplatin|mesh-list
83576539|NCT02122770|Pevonedistat|pevonedistat|mesh-list
83576540|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83576541|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576542|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
83576543|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
83576544|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
83576545|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576546|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
83576547|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576548|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83576549|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83576550|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576551|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83576552|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
83576553|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576554|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576555|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83576556|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83576557|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83576558|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83576559|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576560|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576561|NCT02122380|Incretins|incretins|mesh-ancestor
83576562|NCT02122380|Hormones|hormones|mesh-ancestor
83576563|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576564|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83576565|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
83576566|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576567|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576568|NCT02121756|Dipyridamole|dipyridamole|mesh-list
83576569|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83576570|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576571|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576572|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83576573|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
83576574|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83576575|NCT02141490|Hematinics|hematinics|mesh-ancestor
83576576|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83576577|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83576578|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
83576579|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83576580|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83576581|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
83576582|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576583|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83576584|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83576585|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576586|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576587|NCT02096952|Methylphenidate|methylphenidate|mesh-list
83576588|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83576589|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576590|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83576591|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83576592|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83576593|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576594|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
83576595|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576596|NCT02120898|Imiquimod|imiquimod|mesh-list
83576597|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83576598|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
83576599|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576600|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576601|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
83576602|NCT02120664|Corticosterone|corticosterone|mesh-list
83576603|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576604|NCT01627860|Topiramate|topiramate|mesh-list
83576605|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
83576606|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576607|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576608|NCT04732494|Tislelizumab|tislelizumab|mesh-list
83576609|NCT04732494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83576610|NCT04732494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576611|NCT01627782|Ketamine|ketamine|mesh-list
83034632|NCT04788550|Listerine|listerine|mesh-list
83576612|NCT01627782|Analgesics|analgesics|mesh-ancestor
83576613|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
83576614|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576615|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576616|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83576617|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83576618|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
83576619|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
83576620|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83576621|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83576622|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83576623|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576624|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576625|NCT02119650|Pemetrexed|pemetrexed|mesh-list
83576626|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576627|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576628|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576629|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83576630|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83576631|NCT02119416|Caffeine|caffeine|mesh-list
83576632|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83576633|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576634|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83576635|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576636|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576637|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83576638|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83576639|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
83576640|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576641|NCT02140164|Minocycline|minocycline|mesh-list
83576642|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576643|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576644|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83576645|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83576646|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
83576647|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576648|NCT02119026|Bevacizumab|bevacizumab|mesh-list
83576649|NCT02119026|Capecitabine|capecitabine|mesh-list
83576650|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
83576651|NCT02119026|Irinotecan|irinotecan|mesh-list
83576652|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83576653|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576654|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83576655|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83576656|NCT02119026|Growth Substances|growth substances|mesh-ancestor
83576657|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576658|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
83576659|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83576660|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
83576661|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576662|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83576663|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83576664|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576665|NCT02095158|Phenylephrine|phenylephrine|mesh-list
83576666|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
83576667|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83576668|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83576669|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83576670|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576671|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576672|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576673|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
83576674|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
83576675|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576676|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
83576677|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83576678|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576679|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83576680|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
83576681|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83576682|NCT02095158|Protective Agents|protective agents|mesh-ancestor
83576683|NCT02118714|Atrasentan|atrasentan|mesh-list
83576684|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576685|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83576686|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83576687|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576689|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83576690|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576691|NCT02118012|Ribavirin|ribavirin|mesh-list
83576692|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
83576693|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576694|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
83576695|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576696|NCT02138838|Cinacalcet|cinacalcet|mesh-list
83576697|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83576698|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576699|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83576700|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
83576701|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576702|NCT02092350|Grazoprevir|grazoprevir|mesh-list
83576703|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
83576704|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576705|NCT02138136|Lubiprostone|lubiprostone|mesh-list
83576706|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83576707|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83576708|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576709|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
83576710|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
83576711|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
83576712|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
83576713|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576714|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83576715|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576716|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576717|NCT02092116|Romidepsin|romidepsin|mesh-list
83576718|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83576719|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576720|NCT02092116|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83576721|NCT02092116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576722|NCT02092116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576723|NCT02091414|Cyclosporine|cyclosporine|mesh-list
83576724|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
83576725|NCT02091414|Cyclosporins|cyclosporins|mesh-list
83576726|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576727|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576728|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576729|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
83576730|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576731|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
83576732|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576733|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576734|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576735|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83576736|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83576737|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576738|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83576739|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
83576740|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576741|NCT04731558|Enoxaparin|enoxaparin|mesh-list
83576742|NCT04731558|Dalteparin|dalteparin|mesh-list
83576743|NCT04731558|Tinzaparin|tinzaparin|mesh-list
83576744|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83576745|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
83576746|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83576747|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83576748|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576749|NCT02116530|Dexamethasone|dexamethasone|mesh-list
83576750|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
83576751|NCT02116530|Doxorubicin|doxorubicin|mesh-list
83576752|NCT02116530|Ondansetron|ondansetron|mesh-list
83576753|NCT02116530|Olanzapine|olanzapine|mesh-list
83576754|NCT02116530|Aprepitant|aprepitant|mesh-list
83576755|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
83576756|NCT02116530|Palonosetron|palonosetron|mesh-list
83576757|NCT02116530|Granisetron|granisetron|mesh-list
83576758|NCT02116530|Antiemetics|antiemetics|mesh-list
83576759|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576760|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
83576761|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576762|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576763|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83576765|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576766|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576767|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83576768|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576769|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
83576770|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576771|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83576772|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
83576773|NCT02116530|Hormones|hormones|mesh-ancestor
83576774|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576775|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83576776|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83576777|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83576778|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83576779|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576780|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
83576781|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576782|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83576783|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83576784|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
83576785|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576786|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83576787|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83576788|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83576789|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83576790|NCT02116530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83576791|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83576792|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83576793|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83576794|NCT02072226|Aspirin|aspirin|mesh-list
83576795|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83576796|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83576797|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83576798|NCT02072226|Analgesics|analgesics|mesh-ancestor
83576799|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
83576800|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576801|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576802|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576803|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576804|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83576805|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83576806|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576807|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83576808|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83576809|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576810|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
83576811|NCT04730856|Tinzaparin|tinzaparin|mesh-list
83576812|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83576813|NCT04730856|Dalteparin|dalteparin|mesh-list
83576814|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
83576815|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83576816|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83576817|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576818|NCT02114892|Resveratrol|resveratrol|mesh-list
83576819|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
83576820|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576821|NCT02114892|Protective Agents|protective agents|mesh-ancestor
83576822|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576823|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576824|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83576825|NCT02070744|Ivacaftor|ivacaftor|mesh-list
83576826|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83576827|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83576828|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576829|NCT04741698|Propranolol|propranolol|mesh-list
83576830|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83576831|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83576832|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
83576833|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576834|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034930|NCT01418222|Leucovorin|leucovorin|mesh-list
83576835|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576836|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83576837|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83576838|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
83576839|NCT02111850|Aldesleukin|aldesleukin|mesh-list
83576840|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
83576841|NCT02111850|Fludarabine|fludarabine|mesh-list
83576842|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83576843|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
83576844|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576845|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83576846|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83576847|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
83576848|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576849|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576850|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83576851|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83576852|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83576853|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
83576854|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576855|NCT02085252|Bicalutamide|bicalutamide|mesh-list
83576856|NCT02085252|Leuprolide|leuprolide|mesh-list
83576857|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
83576858|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83576859|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576860|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576861|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576862|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83576863|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
83576864|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83576865|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83576866|NCT02084238|Interleukin-2|interleukin-2|mesh-list
83576867|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576868|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83576869|NCT02084238|Analgesics|analgesics|mesh-ancestor
83576870|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
83576871|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576872|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576873|NCT02084082|Metformin|metformin|mesh-list
83576874|NCT02084082|Linagliptin|linagliptin|mesh-list
83576875|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83576876|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576877|NCT02084082|Incretins|incretins|mesh-ancestor
83576878|NCT02084082|Hormones|hormones|mesh-ancestor
83576879|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576880|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83576881|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
83576882|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576883|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576884|NCT02083926|Ketamine|ketamine|mesh-list
83576885|NCT02083926|Analgesics|analgesics|mesh-ancestor
83576886|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
83576887|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576888|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576889|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83576890|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83576891|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
83576892|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
83576893|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83576894|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83576895|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83576896|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576897|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576898|NCT02083380|Piperaquine|piperaquine|mesh-list
83576899|NCT02083380|Artefenomel|artefenomel|mesh-list
83576900|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
83576901|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83576902|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83576903|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576904|NCT02109744|Decitabine|decitabine|mesh-list
83576905|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83576906|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
83576907|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576908|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576909|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83576910|NCT04185402|Azithromycin|azithromycin|mesh-list
83576911|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576912|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576913|NCT04728360|Ustekinumab|ustekinumab|mesh-list
83576914|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576915|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
83576916|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
83576917|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83576918|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
83576919|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576920|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576921|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83576922|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576923|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
83576924|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83576925|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
83576926|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83576927|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576928|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576929|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576930|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83576931|NCT02082912|Cycloserine|cycloserine|mesh-list
83576932|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83576933|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576934|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83576935|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
83576936|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83576937|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
83576938|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576939|NCT02082522|Cisplatin|cisplatin|mesh-list
83576940|NCT02082522|Gemcitabine|gemcitabine|mesh-list
83576941|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83576942|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
83576943|NCT02082522|Trioxsalen|trioxsalen|mesh-list
83576944|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576945|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83576946|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
83576947|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576948|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576949|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83576950|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
83576951|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83576952|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83576953|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
83576954|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83576955|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83576956|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
83576957|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576958|NCT02082210|Ramucirumab|ramucirumab|mesh-list
83576959|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83576960|NCT02107014|Naltrexone|naltrexone|mesh-list
83576961|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83576962|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83576963|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576964|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
83576965|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576966|NCT01624974|Montelukast|montelukast|mesh-list
83576967|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83576968|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576969|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83576970|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
83576971|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83576972|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576973|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83576974|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83576975|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83576976|NCT01624662|Fluticasone|fluticasone|mesh-list
83576977|NCT01624662|Xhance|xhance|mesh-list
83576978|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83576979|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83576980|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
83576981|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576982|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576983|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83576984|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
83576985|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83576986|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83576987|NCT02106390|Vaccines|vaccines|mesh-list
83576988|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
83576989|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576990|NCT02064894|Ibuprofen|ibuprofen|mesh-list
83576991|NCT02064894|Morphine|morphine|mesh-list
83576992|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83576993|NCT02064894|Narcotics|narcotics|mesh-ancestor
83576994|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83576995|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83576996|NCT02064894|Analgesics|analgesics|mesh-ancestor
83576997|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
83576998|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83576999|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83577000|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577001|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577002|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577003|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83577004|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577005|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577006|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
83577007|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83577008|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
83577009|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577010|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577011|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
83577012|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577013|NCT01624194|Oxytocin|oxytocin|mesh-list
83577014|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
83577015|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83577016|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577017|NCT02079636|Gemcitabine|gemcitabine|mesh-list
83577018|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
83577019|NCT02079636|Pemetrexed|pemetrexed|mesh-list
83577020|NCT02079636|Ramucirumab|ramucirumab|mesh-list
83577021|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83577022|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
83577023|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577024|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577025|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577026|NCT02079636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83577027|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577028|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83577029|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83577030|NCT02079246|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83577031|NCT02079246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83577032|NCT02079246|Serotonin Agents|serotonin agents|mesh-ancestor
83577033|NCT02079246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577034|NCT02079246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577035|NCT02079246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577036|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83577037|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
83577038|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577039|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
83577040|NCT02045862|Mirabegron|mirabegron|mesh-list
83577041|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83577042|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83577043|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577044|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577045|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577046|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577047|NCT02045862|Urological Agents|urological agents|mesh-ancestor
83577048|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83577049|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83577050|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83577051|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
83577052|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
83577053|NCT04182984|Prednisone|prednisone|mesh-list
83577054|NCT04182984|Azathioprine|azathioprine|mesh-list
83577055|NCT04182984|Bromides|bromides|mesh-list
83577056|NCT04182984|Tacrolimus|tacrolimus|mesh-list
83577057|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83577058|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83577059|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577060|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
83577061|NCT04182984|Hormones|hormones|mesh-ancestor
83577062|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577063|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577064|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83577065|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577066|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
83577067|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83577068|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577069|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577070|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83577071|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83577072|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
83577073|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83577074|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577075|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
83577076|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
83577077|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83577078|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577079|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83577080|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577081|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577083|NCT02044302|Narcotics|narcotics|mesh-list
83577084|NCT02044302|Analgesics|analgesics|mesh-list
83577085|NCT02044302|Bupivacaine|bupivacaine|mesh-list
83577086|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
83577087|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
83577088|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
83577089|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577090|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577091|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
83577092|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577093|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83577094|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83577095|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83577096|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577097|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577098|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577099|NCT02062944|Sirolimus|sirolimus|mesh-list
83577100|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83577101|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83577102|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577103|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83577104|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577105|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
83577106|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
83577107|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577108|NCT02062632|Doxepin|doxepin|mesh-list
83577109|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83577110|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83577111|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577112|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577113|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83577114|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
83577115|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83577116|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
83577117|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
83577118|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577119|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577120|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
83577121|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83577122|NCT02043366|Sufentanil|sufentanil|mesh-list
83577123|NCT02043366|Remifentanil|remifentanil|mesh-list
83577124|NCT02043366|Butorphanol|butorphanol|mesh-list
83577125|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83577126|NCT02043366|Narcotics|narcotics|mesh-ancestor
83577127|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577128|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577129|NCT02043366|Analgesics|analgesics|mesh-ancestor
83577130|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
83577131|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577132|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83577133|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83577134|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
83577135|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
83577136|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83577137|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577138|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577139|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577140|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83577141|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577142|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577143|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
83577144|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
83577145|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83577146|NCT02060370|Sunitinib|sunitinib|mesh-list
83577147|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577148|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83577149|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83577150|NCT02060370|Growth Substances|growth substances|mesh-ancestor
83577151|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577152|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83577153|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577154|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577155|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577156|NCT01622088|Pramipexole|pramipexole|mesh-list
83577157|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
83577158|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577159|NCT01622088|Protective Agents|protective agents|mesh-ancestor
83577160|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577161|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83577162|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83577163|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
83577164|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
83577165|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577166|NCT02021292|Macitentan|macitentan|mesh-list
83577167|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83577168|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83577169|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577170|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83577171|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
83577172|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
83577173|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83577174|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577175|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
83577176|NCT02043132|Coagulants|coagulants|mesh-ancestor
83577177|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
83577178|NCT02059434|LAS190792|las190792|mesh-list
83577179|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83577180|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
83577181|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577182|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577183|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83577184|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83577185|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
83577186|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83577187|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577188|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577189|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577190|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83577191|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83577192|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83577193|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83577194|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83577195|NCT02059278|Latanoprost|latanoprost|mesh-list
83577196|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83577197|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83577198|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
83577199|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83577200|NCT04722354|Growth Substances|growth substances|mesh-ancestor
83577201|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577202|NCT02020512|Bimatoprost|bimatoprost|mesh-list
83577203|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83577204|NCT02019420|Linezolid|linezolid|mesh-list
83577205|NCT02019420|Tedizolid|tedizolid|mesh-list
83577206|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
83577207|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83577208|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466064|NCT00000664|Zidovudine|zidovudine|mesh-list
83577209|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83577210|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577211|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577212|NCT02058966|Entacapone|entacapone|mesh-list
83577213|NCT02058966|Methamphetamine|methamphetamine|mesh-list
83577214|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83577215|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83577216|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83577217|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577218|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577219|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83577220|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577221|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
83577222|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
83577223|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577224|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
83577225|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577226|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
83577227|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83577228|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83577229|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83577230|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83577231|NCT02017860|Everolimus|everolimus|mesh-list
83577232|NCT02017860|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83577233|NCT02017860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577234|NCT02017860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577235|NCT02017860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577236|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577237|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
83577238|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577239|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577240|NCT02040870|Ceritinib|ceritinib|mesh-list
83577241|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577242|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577243|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577244|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577245|NCT04720716|Sorafenib|sorafenib|mesh-list
83577246|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577247|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577248|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577249|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577250|NCT02039778|Temozolomide|temozolomide|mesh-list
83577251|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83577252|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
83577253|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577254|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577255|NCT02015676|Paclitaxel|paclitaxel|mesh-list
83577256|NCT02015676|Trastuzumab|trastuzumab|mesh-list
83577257|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83577258|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577259|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83577260|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83577261|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83577262|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577263|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577264|NCT02058108|Telbivudine|telbivudine|mesh-list
83577265|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
83577266|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577267|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83577268|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577269|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577270|NCT04678362|Avelumab|avelumab|mesh-list
83577271|NCT04678362|Talazoparib|talazoparib|mesh-list
83577272|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577273|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577274|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83577275|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577276|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577277|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
83577278|NCT04678050|Ketamine|ketamine|mesh-list
83577279|NCT04678050|Propofol|propofol|mesh-list
83577280|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83577281|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577282|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577283|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577284|NCT04678050|Analgesics|analgesics|mesh-ancestor
83035304|NCT01489046|Tenofovir|tenofovir|mesh-list
83577285|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
83577286|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577287|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83577288|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83577289|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83577290|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
83577291|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577292|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577293|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83577294|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
83577295|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
83577296|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83577297|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83577298|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83577299|NCT02038920|Vedolizumab|vedolizumab|mesh-list
83577300|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83577301|NCT01622868|Lapatinib|lapatinib|mesh-list
83577302|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577303|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577304|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577305|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577306|NCT02014740|Metformin|metformin|mesh-list
83577307|NCT02014740|Liraglutide|liraglutide|mesh-list
83577308|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83577309|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577310|NCT02014740|Incretins|incretins|mesh-ancestor
83577311|NCT02014740|Hormones|hormones|mesh-ancestor
83577312|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577313|NCT02014584|Dutasteride|dutasteride|mesh-list
83577314|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83577315|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83577316|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577317|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577318|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
83577319|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577320|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577321|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83577322|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
83577323|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577324|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83577325|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
83577326|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577327|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
83577328|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
83577329|NCT02057250|Methotrexate|methotrexate|mesh-list
83577330|NCT02057250|Leflunomide|leflunomide|mesh-list
83577331|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83577332|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
83577333|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83577334|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577335|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83577336|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
83577337|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577338|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577339|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
83577340|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577341|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83577342|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577343|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
83577344|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577345|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83577346|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
83577347|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83577348|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83577349|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577350|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83577351|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577352|NCT02057250|Analgesics|analgesics|mesh-ancestor
83577353|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
83577354|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577355|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577356|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83577357|NCT02036502|Dexamethasone|dexamethasone|mesh-list
83577358|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
83035448|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
83577359|NCT02036502|Lenalidomide|lenalidomide|mesh-list
83577360|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577361|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
83577362|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
83577363|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577364|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577365|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83577366|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
83577368|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577369|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83577370|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577371|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577372|NCT02036502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83577373|NCT02036502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577374|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
83577375|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83577376|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83577377|NCT02036502|Growth Substances|growth substances|mesh-ancestor
83577378|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
83577379|NCT02056626|Carvedilol|carvedilol|mesh-list
83577380|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83577381|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83577382|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
83577383|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577384|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577385|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577386|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83577387|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
83577388|NCT02056626|Protective Agents|protective agents|mesh-ancestor
83577389|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83577390|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83577391|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83577392|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
83577393|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83577394|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83577395|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
83577396|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83577397|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577398|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83577399|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83577400|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577401|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577402|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577403|NCT02034552|Prednisone|prednisone|mesh-list
83577404|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
83577405|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83577406|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577407|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
83577408|NCT02034552|Hormones|hormones|mesh-ancestor
83577409|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577410|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577411|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83577412|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577413|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83577414|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577415|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577416|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
83577417|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83577418|NCT02011386|Golimumab|golimumab|mesh-list
83577419|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83577420|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577421|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577422|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
83577423|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577424|NCT02034162|Mebendazole|mebendazole|mesh-list
83577425|NCT02034162|Piperazine|piperazine|mesh-list
83577426|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
83577427|NCT02034162|DMP 777|dmp 777|mesh-list
83577428|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
83577429|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
83577430|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83577431|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577432|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
83577433|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
83577434|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
83577435|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577436|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577437|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577438|NCT02034006|Ranibizumab|ranibizumab|mesh-list
83577439|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83577440|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83577441|NCT02034006|Growth Substances|growth substances|mesh-ancestor
83577442|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577443|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
83577444|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577445|NCT04675788|Ibutilide|ibutilide|mesh-list
83577446|NCT04675788|Testosterone|testosterone|mesh-list
83577447|NCT04675788|Progesterone|progesterone|mesh-list
83577448|NCT04675788|Androgens|androgens|mesh-ancestor
83577449|NCT04675788|Hormones|hormones|mesh-ancestor
83577450|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577451|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577452|NCT04675788|Progestins|progestins|mesh-ancestor
83577453|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83577454|NCT02052960|Cisplatin|cisplatin|mesh-list
83577455|NCT02052960|Fluorouracil|fluorouracil|mesh-list
83577456|NCT02052960|Cetuximab|cetuximab|mesh-list
83577457|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577458|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
83577459|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577460|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83577461|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577462|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
83577463|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577464|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577465|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83577466|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
83577467|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577468|NCT02052414|Gabapentin|gabapentin|mesh-list
83577469|NCT02052414|Analgesics|analgesics|mesh-ancestor
83577470|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
83577471|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577472|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577473|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
83577474|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83577475|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83577476|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577477|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83577478|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83577479|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83577480|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577481|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577482|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
83577483|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83577484|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
83577485|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577486|NCT01363440|Aflibercept|aflibercept|mesh-list
83577487|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83577488|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83577489|NCT01363440|Growth Substances|growth substances|mesh-ancestor
83577490|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577491|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
83577492|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577493|NCT02007096|Bupivacaine|bupivacaine|mesh-list
83577494|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
83577495|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
83577496|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577497|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577498|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
83577499|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577500|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
83577501|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83577502|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83577503|NCT02006706|Prednisolone|prednisolone|mesh-list
83577504|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
83577505|NCT02006706|Rituximab|rituximab|mesh-list
83577506|NCT02006706|Methotrexate|methotrexate|mesh-list
83577507|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83577508|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
83577509|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577510|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577511|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
83577512|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577513|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577514|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83577515|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
83577516|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83577517|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83577518|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
83577519|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577520|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83577521|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577522|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83577523|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577524|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83577525|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577526|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
83577527|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
83577528|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577529|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83577530|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
83577531|NCT02006706|Hormones|hormones|mesh-ancestor
83577532|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577533|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83577534|NCT02006706|Protective Agents|protective agents|mesh-ancestor
83577535|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83577536|NCT02049138|Upadacitinib|upadacitinib|mesh-list
83577537|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83577538|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577539|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577540|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577541|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577542|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83577543|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83577544|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577545|NCT02048904|Incretins|incretins|mesh-ancestor
83577546|NCT02048904|Hormones|hormones|mesh-ancestor
83577547|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577548|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83577549|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
83577550|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577551|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577552|NCT02006628|Cannabidiol|cannabidiol|mesh-list
83577553|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
83577554|NCT02029638|Acetaminophen|acetaminophen|mesh-list
83577555|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
83577556|NCT02029638|Promethazine|promethazine|mesh-list
83577557|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
83577558|NCT02029638|Prednisone|prednisone|mesh-list
83577559|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
83577560|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
83577561|NCT02029638|Fludarabine|fludarabine|mesh-list
83577562|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
83577563|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83577564|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577565|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
83577566|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577567|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577568|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83577569|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
83577570|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577571|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577572|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83577573|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577574|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
83577575|NCT02029638|Hormones|hormones|mesh-ancestor
83577576|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577577|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83577578|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577579|NCT02029638|Analgesics|analgesics|mesh-ancestor
83577580|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
83577581|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035598|NCT02084472|Protective Agents|protective agents|mesh-ancestor
83577582|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
83577584|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83577585|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
83577586|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83577587|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577588|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577589|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
83577590|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
83577591|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83577592|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83577593|NCT02029638|Protective Agents|protective agents|mesh-ancestor
83577594|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83577595|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83577596|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577597|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
83577598|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
83577599|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83577600|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
83577601|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
83577602|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577603|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83577604|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
83577605|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
83577606|NCT02047734|Interferons|interferons|mesh-list
83577607|NCT02047734|Interferon-beta|interferon-beta|mesh-list
83577608|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
83577609|NCT02047734|Ozanimod|ozanimod|mesh-list
83577610|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577611|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
83577612|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577613|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
83577614|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577615|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83577616|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83577617|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577618|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577619|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83577620|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577621|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577622|NCT01994850|Immunotoxins|immunotoxins|mesh-ancestor
83577623|NCT01994850|Immunoconjugates|immunoconjugates|mesh-ancestor
83577624|NCT01994850|Immunologic Factors|immunologic factors|mesh-ancestor
83577625|NCT01994850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577626|NCT01994382|Rituximab|rituximab|mesh-list
83577627|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577628|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577629|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
83577630|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577631|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577632|NCT02003898|Insulin|insulin|mesh-list
83577633|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83577634|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577635|NCT01994226|Naproxen|naproxen|mesh-list
83577636|NCT01994226|Colchicine|colchicine|mesh-list
83577637|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83577638|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577639|NCT01994226|Analgesics|analgesics|mesh-ancestor
83577640|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
83577641|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577642|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577643|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577644|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577645|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
83577646|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83577647|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577648|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577649|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
83577650|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
83577651|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
83577652|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577653|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
83577654|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83577655|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83577656|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83577657|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83577658|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83577659|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577660|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577661|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577662|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577663|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83577664|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577665|NCT02023866|Cysteamine|cysteamine|mesh-list
83577666|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83577667|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577668|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83577669|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83577670|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83577671|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83577672|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
83577673|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577674|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577675|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83577676|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83577677|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
83577678|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577679|NCT01990560|Mifepristone|mifepristone|mesh-list
83577680|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83577681|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
83577682|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83577683|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577684|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83577685|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83577686|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83577687|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
83577688|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83577689|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83577690|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
83577691|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577692|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
83577693|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83577694|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83577695|NCT01967628|Vitamin D|vitamin d|mesh-list
83577696|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
83577697|NCT01967628|Vitamins|vitamins|mesh-ancestor
83577698|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
83577699|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577700|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83577701|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83577702|NCT01998906|Paclitaxel|paclitaxel|mesh-list
83577703|NCT01998906|Doxorubicin|doxorubicin|mesh-list
83577704|NCT01998906|Trastuzumab|trastuzumab|mesh-list
83577705|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83577706|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577707|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
83577708|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
83577709|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
83577710|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577711|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83577712|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83577713|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83577714|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577715|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577716|NCT01967550|Diclofenac|diclofenac|mesh-list
83577717|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83577718|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577719|NCT01967550|Analgesics|analgesics|mesh-ancestor
83577720|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
83577721|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577722|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577723|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577724|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577725|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83577726|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577727|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577728|NCT01989546|Talazoparib|talazoparib|mesh-list
83577729|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83577730|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577731|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577732|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577733|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83577734|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
83577735|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577736|NCT01989156|Menthol|menthol|mesh-list
83577737|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
83577738|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
83577739|NCT01965834|Fenofibrate|fenofibrate|mesh-list
83577740|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
83577741|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83577742|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
83577743|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577744|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83577745|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83577746|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83577747|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577748|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577749|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577750|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577751|NCT01987596|Lenograstim|lenograstim|mesh-list
83577752|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83577753|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
83577754|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577755|NCT01964898|Nicotine|nicotine|mesh-list
83577756|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83577757|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
83577758|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577759|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577760|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83577761|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83577762|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577763|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577764|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577765|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
83577766|NCT01964352|Olodaterol|olodaterol|mesh-list
83577767|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83577768|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
83577769|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577770|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577771|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83577772|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
83577773|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
83577774|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83577775|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577776|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577777|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577778|NCT01946412|Ivacaftor|ivacaftor|mesh-list
83577779|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83577780|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83577781|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577782|NCT01945866|Dexamethasone|dexamethasone|mesh-list
83577783|NCT01945866|Ranibizumab|ranibizumab|mesh-list
83577784|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83577785|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
83577786|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
83577787|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577788|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577789|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83577790|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
83577791|NCT01945866|Hormones|hormones|mesh-ancestor
83577792|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577793|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83577794|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577795|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83577796|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83577797|NCT01945866|Growth Substances|growth substances|mesh-ancestor
83577798|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
83577799|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83577800|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83577801|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83577802|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577803|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577804|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83035832|NCT01133990|Vitamins|vitamins|mesh-ancestor
83577805|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83577806|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83577807|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83577808|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
83577809|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577810|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577811|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83577812|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83577813|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
83577814|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83577815|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83577816|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
83577818|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83577819|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577820|NCT01945242|Incretins|incretins|mesh-ancestor
83577821|NCT01945242|Hormones|hormones|mesh-ancestor
83577822|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83577823|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83577824|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
83577825|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577826|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577827|NCT01945086|Ustekinumab|ustekinumab|mesh-list
83577828|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
83577829|NCT04658160|Imidacloprid|imidacloprid|mesh-list
83577830|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577831|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577832|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577833|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577834|NCT01963728|Insulin|insulin|mesh-list
83577835|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83577836|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
83577837|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
83577838|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
83577839|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
83577840|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83577841|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577842|NCT01962948|Paclitaxel|paclitaxel|mesh-list
83577843|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83577844|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577845|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
83577846|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
83577847|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
83577848|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577849|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
83577850|NCT01985334|Bromides|bromides|mesh-list
83577851|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
83577852|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577853|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83577854|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83577855|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83577856|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
83577857|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577858|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577859|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
83577860|NCT01944774|Nemonoxacin|nemonoxacin|mesh-list
83577861|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83577862|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577863|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83577864|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83577865|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577866|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577867|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577868|NCT04665648|Nicorandil|nicorandil|mesh-list
83577869|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83577870|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83577871|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
83577872|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
83577873|NCT04665648|Vitamins|vitamins|mesh-ancestor
83577874|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
83577875|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577876|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83577877|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
83577878|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577879|NCT01942590|Clenbuterol|clenbuterol|mesh-list
83577880|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83577881|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83577882|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
83577883|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577884|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577885|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577886|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83577887|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
83577888|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577889|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83577890|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
83577891|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
83577892|NCT01984242|Bevacizumab|bevacizumab|mesh-list
83577893|NCT01984242|Atezolizumab|atezolizumab|mesh-list
83577894|NCT01984242|Sunitinib|sunitinib|mesh-list
83577895|NCT01984242|Antibodies|antibodies|mesh-list
83577896|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83577897|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83577898|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577899|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83577900|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83577901|NCT01984242|Growth Substances|growth substances|mesh-ancestor
83577902|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577903|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83577904|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
83577905|NCT01984242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83577906|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577907|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83577908|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577909|NCT01960842|Levodopa|levodopa|mesh-list
83577910|NCT01960842|Carbidopa|carbidopa|mesh-list
83577911|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83577912|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83577913|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83577914|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
83577915|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577916|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577917|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577918|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83577919|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577920|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83577921|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
83577922|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
83577923|NCT01984164|Candesartan|candesartan|mesh-list
83577924|NCT01984164|Lisinopril|lisinopril|mesh-list
83577925|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83577926|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83577927|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83577928|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577929|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83577930|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
83577931|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577932|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83577933|NCT01984164|Protective Agents|protective agents|mesh-ancestor
83577934|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577935|NCT01983774|Esomeprazole|esomeprazole|mesh-list
83577936|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83577937|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83577938|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83577939|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577940|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577941|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
83577942|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
83577943|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83577944|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
83577945|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577946|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577947|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83577948|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
83577949|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577950|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577951|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83577952|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83035981|NCT02089308|Nicotine|nicotine|mesh-list
83577953|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83577954|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
83577955|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83577956|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577957|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577958|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
83577959|NCT01940484|Hematinics|hematinics|mesh-ancestor
83577960|NCT01960296|Clopidogrel|clopidogrel|mesh-list
83577961|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83577962|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83577963|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83577964|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83577965|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
83577966|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83577967|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577968|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577969|NCT01939314|Bupivacaine|bupivacaine|mesh-list
83577970|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
83577971|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
83577972|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83577973|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577974|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
83577975|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577976|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83577977|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
83577978|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577979|NCT01939002|Interferons|interferons|mesh-list
83577980|NCT01939002|Interferon-beta|interferon-beta|mesh-list
83577981|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
83577983|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83577984|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83577985|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83577986|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
83577987|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83577988|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83577989|NCT01939002|Analgesics|analgesics|mesh-ancestor
83577990|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
83577991|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83577992|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83577993|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83577994|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
83577995|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83577996|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83577997|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83577998|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
83577999|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83578000|NCT01938846|Paclitaxel|paclitaxel|mesh-list
83578001|NCT01938846|Exemestane|exemestane|mesh-list
83578002|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83578003|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578004|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83578005|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83578006|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83578007|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578008|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83578009|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83578010|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578011|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83578012|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
83578013|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578014|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578015|NCT01960140|Simvastatin|simvastatin|mesh-list
83578016|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83578017|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83578018|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
83578019|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578020|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83578021|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83578022|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578023|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
83578024|NCT01959672|Leucovorin|leucovorin|mesh-list
83578025|NCT01959672|Folic Acid|folic acid|mesh-list
83578026|NCT01959672|Nelfinavir|nelfinavir|mesh-list
83578027|NCT01959672|Gemcitabine|gemcitabine|mesh-list
83578028|NCT01959672|Fluorouracil|fluorouracil|mesh-list
83578029|NCT01959672|Oregovomab|oregovomab|mesh-list
83578030|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83578031|NCT01959672|Antibodies|antibodies|mesh-list
83578032|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
83578033|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83578034|NCT01959672|Calcium|calcium|mesh-list
83578035|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
83578036|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
83578037|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578038|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83578039|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
83578040|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578041|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578042|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83578043|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83578044|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83578045|NCT01959672|Antidotes|antidotes|mesh-ancestor
83578046|NCT01959672|Protective Agents|protective agents|mesh-ancestor
83578047|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
83578048|NCT01959672|Vitamins|vitamins|mesh-ancestor
83578049|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
83578050|NCT01959672|Hematinics|hematinics|mesh-ancestor
83578051|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83578052|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83578053|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578054|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578055|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83578056|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83578057|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
83578058|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578059|NCT01980888|Rituximab|rituximab|mesh-list
83578060|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83578061|NCT01980888|Idelalisib|idelalisib|mesh-list
83578062|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83578063|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578064|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
83578065|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578066|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578067|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83578068|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
83578069|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578070|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578071|NCT04650282|Lidocaine|lidocaine|mesh-list
83578072|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
83578073|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
83578074|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578075|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578076|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
83578077|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578078|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83578079|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83578080|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83578081|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578082|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578083|NCT01937364|Baclofen|baclofen|mesh-list
83578084|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83578085|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578086|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83578087|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578088|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83578089|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
83578090|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
83578091|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578092|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578093|NCT01979952|Nintedanib|nintedanib|mesh-list
83578094|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578095|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578096|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578097|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578098|NCT01999218|Metformin|metformin|mesh-list
83578099|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83578100|NCT01999218|Glimepiride|glimepiride|mesh-list
83578101|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
83578102|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83578103|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578104|NCT01999218|Incretins|incretins|mesh-ancestor
83578105|NCT01999218|Hormones|hormones|mesh-ancestor
83578106|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578107|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83578108|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578109|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578110|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578111|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83578112|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83578113|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
83578114|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83578115|NCT01936974|Bevacizumab|bevacizumab|mesh-list
83578116|NCT01936974|Carboplatin|carboplatin|mesh-list
83578117|NCT01936974|Gemcitabine|gemcitabine|mesh-list
83578118|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
83578119|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83578120|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578121|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83578122|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83578123|NCT01936974|Growth Substances|growth substances|mesh-ancestor
83578124|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578125|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
83578126|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83578127|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
83578128|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578129|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
83578130|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
83578131|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83578132|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
83578133|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578134|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578135|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83578136|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
83578137|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
83578138|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83578139|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83578140|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578141|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578142|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83578143|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83578144|NCT01979016|Emollients|emollients|mesh-list
83578145|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
83578146|NCT01935336|Ponatinib|ponatinib|mesh-list
83578147|NCT01935336|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83578148|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578149|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578150|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578151|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578152|NCT01978236|Trametinib|trametinib|mesh-list
83578153|NCT01978236|Dabrafenib|dabrafenib|mesh-list
83578154|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578155|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578156|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578157|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578158|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83578159|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578160|NCT01934556|Ranibizumab|ranibizumab|mesh-list
83578161|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83578162|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83578163|NCT01934556|Growth Substances|growth substances|mesh-ancestor
83578164|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578165|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
83578166|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578167|NCT04411212|Lenograstim|lenograstim|mesh-list
83578168|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83578169|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
83578170|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578171|NCT01620138|Cabergoline|cabergoline|mesh-list
83578172|NCT01620138|Pasireotide|pasireotide|mesh-list
83578173|NCT01620138|Hormones|hormones|mesh-ancestor
83578174|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578175|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578176|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83578177|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83578178|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
83578179|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
83578180|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578181|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578182|NCT01932996|Nicotine|nicotine|mesh-list
83578183|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83578184|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
83578185|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578186|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578187|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83578188|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83578189|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
83578190|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578191|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578192|NCT01932762|Ribavirin|ribavirin|mesh-list
83578193|NCT01932762|Grazoprevir|grazoprevir|mesh-list
83578194|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
83578195|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578196|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
83578197|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578198|NCT01977456|Eptifibatide|eptifibatide|mesh-list
83578199|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83578200|NCT01957644|Azacitidine|azacitidine|mesh-list
83578201|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83578202|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
83578203|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578204|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578205|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578206|NCT01931202|Escitalopram|escitalopram|mesh-list
83578207|NCT01931202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83578208|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83578209|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578210|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578211|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578212|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
83578213|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578214|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
83578215|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83578216|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578217|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83578218|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
83578219|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83578220|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578221|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578222|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578223|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83578224|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83578225|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578226|NCT01930188|Incretins|incretins|mesh-ancestor
83578227|NCT01930188|Hormones|hormones|mesh-ancestor
83578228|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578229|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83578230|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578231|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578232|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578233|NCT01976364|Methotrexate|methotrexate|mesh-list
83578234|NCT01976364|Tofacitinib|tofacitinib|mesh-list
83578235|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83578236|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
83578237|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83578238|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578239|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83578240|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
83578241|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578242|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578243|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
83578244|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578245|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83578246|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83578247|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
83578248|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578249|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83578250|NCT01976364|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83578251|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83036270|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83578253|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
83578254|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578255|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83578256|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83578257|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578258|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578259|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83578260|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
83578261|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578262|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578263|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83578264|NCT01928940|Trametinib|trametinib|mesh-list
83578265|NCT01928940|Dabrafenib|dabrafenib|mesh-list
83578266|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578267|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578268|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578269|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578270|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
83578271|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578272|NCT01975272|Iron|iron|mesh-list
83578273|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
83578274|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
83578275|NCT01975272|Trace Elements|trace elements|mesh-ancestor
83578276|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
83578277|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578278|NCT01975272|Hematinics|hematinics|mesh-ancestor
83578279|NCT03965039|Fluorides|fluorides|mesh-list
83578280|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
83578281|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
83578282|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
83578283|NCT03965039|Protective Agents|protective agents|mesh-ancestor
83578284|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578285|NCT03961295|Vedolizumab|vedolizumab|mesh-list
83578286|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578287|NCT03935399|Oxytocin|oxytocin|mesh-list
83578288|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
83578289|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83578290|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578291|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83578292|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
83578293|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578294|NCT03993119|Anticoagulants|anticoagulants|mesh-list
83578295|NCT03910439|Avelumab|avelumab|mesh-list
83578296|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83578297|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578298|NCT03895307|Anesthetics|anesthetics|mesh-list
83578299|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
83578300|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578301|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578302|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
83578303|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578304|NCT03888755|Icatibant|icatibant|mesh-list
83578305|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83578306|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83578307|NCT03888755|Analgesics|analgesics|mesh-ancestor
83578308|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
83578309|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578310|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578311|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578312|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578313|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83578314|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83578315|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578316|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83578317|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83578318|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
83578319|NCT00378755|Bortezomib|bortezomib|mesh-list
83578320|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578321|NCT00378833|Niacin|niacin|mesh-list
83578322|NCT00378833|Niacinamide|niacinamide|mesh-list
83578323|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
83578324|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83467280|NCT00002476|Cobalt|cobalt|mesh-list
83578325|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
83578326|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036390|NCT05617508|Niacin|niacin|mesh-list
83578327|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83578328|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
83578329|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
83578330|NCT00378833|Vitamins|vitamins|mesh-ancestor
83578331|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
83578332|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578333|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
83578334|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83578335|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83578336|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83578337|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578338|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578339|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
83578340|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578341|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578342|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83578343|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578344|NCT03888365|Treprostinil|treprostinil|mesh-list
83578345|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83578346|NCT00377975|Pioglitazone|pioglitazone|mesh-list
83578347|NCT00377975|Ephedrine|ephedrine|mesh-list
83578348|NCT00377975|Caffeine|caffeine|mesh-list
83578349|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83578350|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578351|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83578352|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83578353|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578354|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578355|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83578356|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83578357|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
83578358|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578359|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
83578360|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
83578361|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578362|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83578363|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83578364|NCT02994251|Gemcitabine|gemcitabine|mesh-list
83578365|NCT02994251|Doxorubicin|doxorubicin|mesh-list
83578366|NCT02994251|Mitomycins|mitomycins|mesh-list
83578367|NCT02994251|Mitomycin|mitomycin|mesh-list
83578368|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578369|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83578370|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
83578371|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578372|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83578373|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83578374|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83578375|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578376|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
83578377|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83578378|NCT02936999|Vitamin D|vitamin d|mesh-list
83578379|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
83578380|NCT02936999|Vitamins|vitamins|mesh-ancestor
83578381|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
83578382|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578383|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83578384|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83578385|NCT02826551|Bupivacaine|bupivacaine|mesh-list
83578386|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
83578387|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
83578388|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578389|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578390|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
83578391|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578392|NCT00378443|Prednisone|prednisone|mesh-list
83578393|NCT00378443|Losartan|losartan|mesh-list
83578394|NCT00378443|Cilazapril|cilazapril|mesh-list
83578395|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578396|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
83578397|NCT00378443|Hormones|hormones|mesh-ancestor
83578398|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578399|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578400|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83578401|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036433|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83578402|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83036499|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
83578403|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83578404|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83578405|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83578406|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578407|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83578408|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578409|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578410|NCT01340573|Interferons|interferons|mesh-list
83578411|NCT01340573|Ribavirin|ribavirin|mesh-list
83578412|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83578413|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578414|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
83578415|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578416|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
83578417|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578418|NCT01340885|Rivastigmine|rivastigmine|mesh-list
83578419|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83578420|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83578421|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83578422|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578423|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578424|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
83578425|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578426|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578427|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83578428|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578429|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
83578430|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83578431|NCT01340885|Protective Agents|protective agents|mesh-ancestor
83578432|NCT01326923|Cetuximab|cetuximab|mesh-list
83578433|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83578434|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578435|NCT03855059|Dexamethasone|dexamethasone|mesh-list
83578436|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
83578437|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83578438|NCT03855059|BB 1101|bb 1101|mesh-list
83578439|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578440|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
83578441|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
83578442|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578443|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578444|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578445|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
83578446|NCT03855059|Hormones|hormones|mesh-ancestor
83578447|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578448|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83578449|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578450|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578451|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578452|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578453|NCT01301963|Plerixafor|plerixafor|mesh-list
83578454|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83578455|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83578456|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
83578457|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578458|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
83578459|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83578460|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83578461|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578462|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578463|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
83578464|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578465|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578466|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83578467|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578468|NCT02708849|Lamotrigine|lamotrigine|mesh-list
83578469|NCT02708849|Ketamine|ketamine|mesh-list
83578470|NCT02708849|Analgesics|analgesics|mesh-ancestor
83578471|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
83578472|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578473|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578474|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83578475|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83578476|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
83578477|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
83578478|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578479|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83578480|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83578481|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578482|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578483|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
83578484|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83578485|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578486|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83578487|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83578488|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83578489|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83578490|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83578491|NCT01222871|Triamcinolone|triamcinolone|mesh-list
83578492|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578493|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
83578494|NCT01222871|Hormones|hormones|mesh-ancestor
83578495|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578496|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578497|NCT01219673|Minocycline|minocycline|mesh-list
83578498|NCT01219673|Modafinil|modafinil|mesh-list
83578499|NCT01219673|Bupropion|bupropion|mesh-list
83578500|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83578501|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
83578502|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83578503|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83578504|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83578505|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578506|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578507|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
83578508|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578509|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578510|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83578511|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83578512|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578513|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83578514|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578515|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83578516|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83578517|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83578518|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83578519|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
83578520|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83578521|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83578522|NCT01216631|Prednisolone|prednisolone|mesh-list
83578523|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
83578524|NCT01216631|Infliximab|infliximab|mesh-list
83578525|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83578526|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
83578527|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578528|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
83578529|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
83578530|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578531|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578532|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578533|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
83578534|NCT01216631|Hormones|hormones|mesh-ancestor
83578535|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578536|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83578537|NCT01216631|Protective Agents|protective agents|mesh-ancestor
83578538|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83578539|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578540|NCT01216631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83578541|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83578542|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578543|NCT02693717|Pemetrexed|pemetrexed|mesh-list
83578544|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578545|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578546|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578547|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83578548|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83578549|NCT03860753|Pioglitazone|pioglitazone|mesh-list
83578550|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83578551|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578552|NCT02687165|Cycloserine|cycloserine|mesh-list
83578553|NCT02687165|Milnacipran|milnacipran|mesh-list
83578554|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
83578555|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83578556|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578557|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83578558|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
83578559|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83578560|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
83578561|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578562|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83578563|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83578564|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578565|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578566|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578567|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83578568|NCT02687165|Analgesics|analgesics|mesh-ancestor
83578569|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
83578570|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578571|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
83578572|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83578573|NCT01169753|Modafinil|modafinil|mesh-list
83578574|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83578575|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578576|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83578577|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83578578|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83578579|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578580|NCT02654639|Bevacizumab|bevacizumab|mesh-list
83578581|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83578582|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578583|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83578584|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83578585|NCT02654639|Growth Substances|growth substances|mesh-ancestor
83578586|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578587|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
83578588|NCT02634827|Decitabine|decitabine|mesh-list
83578589|NCT02634827|Midostaurin|midostaurin|mesh-list
83578590|NCT02634827|Staurosporine|staurosporine|mesh-list
83578591|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83578592|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
83578593|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578594|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578595|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578596|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578597|NCT02506985|Warfarin|warfarin|mesh-list
83578598|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
83578599|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
83578600|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83578601|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
83578602|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83578603|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578604|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578605|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578606|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
83578607|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578608|NCT01133639|Ketorolac|ketorolac|mesh-list
83578609|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83578610|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83578611|NCT01133639|Analgesics|analgesics|mesh-ancestor
83578612|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
83578613|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578614|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578615|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578616|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578617|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83578618|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578619|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578620|NCT00378911|Sunitinib|sunitinib|mesh-list
83578621|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578622|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83578623|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83578624|NCT00378911|Growth Substances|growth substances|mesh-ancestor
83578625|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578626|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
83578627|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578628|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578629|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578630|NCT03822377|Ticagrelor|ticagrelor|mesh-list
83578631|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83578632|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83578633|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83578634|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83578635|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
83578636|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578637|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578638|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578639|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
83578640|NCT02501759|Antidotes|antidotes|mesh-ancestor
83578641|NCT02501759|Protective Agents|protective agents|mesh-ancestor
83578642|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578643|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
83578644|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
83578645|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578646|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83578647|NCT02499887|Prednisone|prednisone|mesh-list
83578648|NCT02499887|Albuterol|albuterol|mesh-list
83578649|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578650|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
83578651|NCT02499887|Hormones|hormones|mesh-ancestor
83578652|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578653|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578654|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83578655|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578656|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83578657|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
83578658|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578659|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83578660|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
83578661|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
83578662|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83578663|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83578664|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83578665|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83578666|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
83578667|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578668|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578669|NCT02504099|Ritonavir|ritonavir|mesh-list
83578670|NCT02504099|Ribavirin|ribavirin|mesh-list
83578671|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83578672|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83578673|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578674|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578675|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578676|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83578677|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83578678|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
83578679|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578680|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83578681|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83578682|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
83578683|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83578684|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578685|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578686|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578687|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578688|NCT01094561|Secretin|secretin|mesh-list
83578689|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578690|NCT01094561|Hormones|hormones|mesh-ancestor
83578691|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578692|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578693|NCT01074437|Prednisolone|prednisolone|mesh-list
83578694|NCT01074437|Propranolol|propranolol|mesh-list
83578695|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578696|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
83578697|NCT01074437|Hormones|hormones|mesh-ancestor
83578698|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578699|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578700|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83578701|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578702|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83578703|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83578704|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83578705|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578706|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578707|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83578708|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83578709|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
83578710|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83578711|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83578712|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
83578713|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578714|NCT03807245|Antacids|antacids|mesh-ancestor
83578715|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578716|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578717|NCT03796013|Entrectinib|entrectinib|mesh-list
83578718|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83578719|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578720|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578721|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
83578722|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83578723|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578724|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578725|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83578726|NCT03793751|Analgesics|analgesics|mesh-ancestor
83578727|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
83578728|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578729|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83578730|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83578731|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83578732|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
83578733|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578734|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578735|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
83578736|NCT02351063|Diuretics|diuretics|mesh-list
83578737|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83578738|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83578739|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83578740|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
83578741|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578742|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578743|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578744|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578745|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83578746|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
83578747|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578748|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83578749|NCT01016561|Cisplatin|cisplatin|mesh-list
83578750|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578751|NCT01009931|Dexamethasone|dexamethasone|mesh-list
83578752|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
83578753|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
83578754|NCT01009931|Choline|choline|mesh-list
83578755|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83578756|NCT01009931|BB 1101|bb 1101|mesh-list
83578757|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83578758|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
83578759|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
83578760|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578761|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578762|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578763|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
83578764|NCT01009931|Hormones|hormones|mesh-ancestor
83578765|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578766|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83578767|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578768|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
83578769|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578770|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578771|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
83578772|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83578773|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
83578774|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83578775|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
83578776|NCT01009931|Analgesics|analgesics|mesh-ancestor
83578777|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
83578778|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83578779|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83578780|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578781|NCT03792191|Fentanyl|fentanyl|mesh-list
83578782|NCT03792191|Bupivacaine|bupivacaine|mesh-list
83578783|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
83578784|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
83578785|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578786|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578787|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
83578788|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578789|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83578790|NCT03792191|Narcotics|narcotics|mesh-ancestor
83578791|NCT03792191|Analgesics|analgesics|mesh-ancestor
83578792|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83578793|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83578794|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
83578795|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83578796|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83578797|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83578798|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
83578799|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578800|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83578801|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83578802|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578803|NCT00983645|Cyclosporine|cyclosporine|mesh-list
83578804|NCT00983645|Tacrolimus|tacrolimus|mesh-list
83578805|NCT00983645|Cyclosporins|cyclosporins|mesh-list
83578806|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83578807|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
83578808|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578809|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83578810|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578811|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578812|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
83578813|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578814|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83578815|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578816|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83578817|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83578818|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83578819|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
83578820|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578821|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83578822|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83578823|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578824|NCT00957827|Cephalexin|cephalexin|mesh-list
83578825|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83578826|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578827|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
83578828|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
83578829|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578830|NCT00962429|Protective Agents|protective agents|mesh-ancestor
83578831|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578832|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
83578833|NCT00962429|Vitamins|vitamins|mesh-ancestor
83578834|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
83578835|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83578836|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578837|NCT00920309|Sirolimus|sirolimus|mesh-list
83578838|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83578839|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578840|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83578841|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578842|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
83578843|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83578844|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
83578845|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578846|NCT02075411|Bupivacaine|bupivacaine|mesh-list
83036896|NCT04549467|Tenofovir|tenofovir|mesh-list
83578847|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
83578849|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578850|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578851|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
83578852|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578853|NCT03753113|Minoxidil|minoxidil|mesh-list
83578854|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83578855|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
83578856|NCT02075021|Paclitaxel|paclitaxel|mesh-list
83578857|NCT02075021|Lenalidomide|lenalidomide|mesh-list
83578858|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83578859|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578860|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83578861|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83578862|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83578863|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578864|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
83578865|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578866|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83578867|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83578868|NCT02075021|Growth Substances|growth substances|mesh-ancestor
83578869|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
83578870|NCT02057237|Mitotane|mitotane|mesh-list
83578871|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83578872|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578873|NCT00378677|Cyclosporine|cyclosporine|mesh-list
83578874|NCT00378677|Cyclosporins|cyclosporins|mesh-list
83578875|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578876|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578877|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83578878|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
83578879|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578880|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
83578881|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578882|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
83578883|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83578884|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83578885|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
83578886|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83578887|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83578888|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83578889|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83578890|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578891|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
83578892|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578893|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578894|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83578895|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578896|NCT02017379|Erythromycin|erythromycin|mesh-list
83578897|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
83578898|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83578899|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
83578900|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83578901|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578902|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578903|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83578904|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578905|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578906|NCT01997567|Ropivacaine|ropivacaine|mesh-list
83578907|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
83578908|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
83578909|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83578910|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578911|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
83578912|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83578913|NCT00825227|Modafinil|modafinil|mesh-list
83578914|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83578915|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578916|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83578917|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83578918|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83578919|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578920|NCT01978535|Iron|iron|mesh-list
83578921|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83578923|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
83578924|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578925|NCT01978535|Hematinics|hematinics|mesh-ancestor
83578926|NCT00808769|Omeprazole|omeprazole|mesh-list
83578927|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83578928|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83578929|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578930|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83578931|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578932|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578933|NCT00379067|Tamsulosin|tamsulosin|mesh-list
83578934|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83578935|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83578936|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83578937|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
83578938|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83578939|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578940|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578941|NCT00379067|Urological Agents|urological agents|mesh-ancestor
83578942|NCT00378287|Rabeprazole|rabeprazole|mesh-list
83578943|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83578944|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83578945|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83578946|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578947|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578948|NCT01938833|Paclitaxel|paclitaxel|mesh-list
83578949|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83578950|NCT01938833|Romidepsin|romidepsin|mesh-list
83578951|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83578952|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578953|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
83578954|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83578955|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83578956|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578957|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83578958|NCT01938833|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83578959|NCT01938833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83578960|NCT01893359|Riboflavin|riboflavin|mesh-list
83578961|NCT01893359|Dextrans|dextrans|mesh-list
83578962|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83578963|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83578964|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
83578965|NCT01893359|Vitamins|vitamins|mesh-ancestor
83578966|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
83578967|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578968|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83578969|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83578970|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
83578971|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
83578972|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
83578973|NCT00795665|Bevacizumab|bevacizumab|mesh-list
83578974|NCT00795665|Carmustine|carmustine|mesh-list
83578975|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83578976|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578977|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83578978|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83578979|NCT00795665|Growth Substances|growth substances|mesh-ancestor
83578980|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578981|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
83578982|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83578983|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
83578984|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83578985|NCT00791843|Hormones|hormones|mesh-list
83578986|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
83578987|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83578988|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578989|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83578990|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
83578991|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83578992|NCT00780455|Interferons|interferons|mesh-list
83578993|NCT00780455|Interferon-beta|interferon-beta|mesh-list
83578994|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
83578995|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83578996|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
83578997|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83578998|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
83578999|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579000|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83579001|NCT00755261|Bevacizumab|bevacizumab|mesh-list
83579002|NCT00755261|Doxorubicin|doxorubicin|mesh-list
83579003|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83579004|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579005|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83579006|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83579007|NCT00755261|Growth Substances|growth substances|mesh-ancestor
83579008|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579009|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
83579010|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83579011|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83579012|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83579013|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579014|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579015|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
83579016|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83579017|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579018|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579019|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579020|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83579021|NCT00746603|Simvastatin|simvastatin|mesh-list
83579022|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83579023|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83579024|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
83579025|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579026|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83579027|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83579028|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579029|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83579030|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579031|NCT00716807|Nalbuphine|nalbuphine|mesh-list
83579032|NCT00716807|Naloxone|naloxone|mesh-list
83579033|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83579034|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579035|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
83579036|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579037|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83579038|NCT00716807|Narcotics|narcotics|mesh-ancestor
83579039|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579040|NCT00716807|Analgesics|analgesics|mesh-ancestor
83579041|NCT03426137|Ketorolac|ketorolac|mesh-list
83579042|NCT03426137|Oxycodone|oxycodone|mesh-list
83579043|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83579044|NCT03426137|Narcotics|narcotics|mesh-ancestor
83579045|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579046|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579047|NCT03426137|Analgesics|analgesics|mesh-ancestor
83579048|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
83579049|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579050|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83579051|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579052|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83579053|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579054|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83579055|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579056|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579057|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83579058|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83579059|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579060|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83579061|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83579062|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83579063|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579064|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
83579065|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579066|NCT00669461|Lubiprostone|lubiprostone|mesh-list
83579067|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83579068|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83579069|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579071|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83579072|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83579073|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
83579074|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579075|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579076|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579077|NCT03248141|Factor VIII|factor viii|mesh-list
83579078|NCT03248141|Coagulants|coagulants|mesh-ancestor
83579079|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
83579080|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579081|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83579082|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83579083|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
83579084|NCT01754987|Sorafenib|sorafenib|mesh-list
83579085|NCT01754987|Vitamins|vitamins|mesh-ancestor
83579086|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
83579087|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579088|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579089|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83579090|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579091|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579092|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
83579093|NCT01754987|Protective Agents|protective agents|mesh-ancestor
83579094|NCT00652457|Memantine|memantine|mesh-list
83579095|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83579096|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83579097|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
83579098|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579099|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579100|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579101|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83579102|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83579103|NCT00625703|Linezolid|linezolid|mesh-list
83579104|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83579105|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579106|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83579107|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579108|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579109|NCT00616577|Ropivacaine|ropivacaine|mesh-list
83579110|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
83579111|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
83579112|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579113|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579114|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
83579115|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579116|NCT00616343|Zonisamide|zonisamide|mesh-list
83579117|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
83579118|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83579119|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83579120|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579121|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83579122|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579123|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
83579124|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83579125|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
83579126|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579127|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579128|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83579129|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
83579130|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83579131|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
83579132|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579133|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579134|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83579135|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
83579136|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
83579137|NCT05599919|Protective Agents|protective agents|mesh-ancestor
83579138|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83579139|NCT01645709|Verapamil|verapamil|mesh-list
83579140|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83579141|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83579142|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83579143|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579144|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83579145|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579147|NCT00608465|Ramipril|ramipril|mesh-list
83579148|NCT00608465|Eplerenone|eplerenone|mesh-list
83579149|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83579150|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
83579151|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579152|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579153|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83579154|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83579155|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
83579156|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83579157|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579158|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83579159|NCT00608465|Diuretics|diuretics|mesh-ancestor
83579160|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
83579161|NCT00608777|Betamethasone|betamethasone|mesh-list
83579162|NCT00608777|Calcipotriene|calcipotriene|mesh-list
83579163|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83579164|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
83579165|NCT00608777|Hormones|hormones|mesh-ancestor
83579166|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83579167|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579168|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83579169|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
83579170|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
83579171|NCT00379457|Dactinomycin|dactinomycin|mesh-list
83579172|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
83579173|NCT00379457|Ifosfamide|ifosfamide|mesh-list
83579174|NCT00379457|Carboplatin|carboplatin|mesh-list
83579175|NCT00379457|Doxorubicin|doxorubicin|mesh-list
83579176|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83579177|NCT00379457|Etoposide|etoposide|mesh-list
83579178|NCT00379457|Vincristine|vincristine|mesh-list
83579179|NCT00379457|Topotecan|topotecan|mesh-list
83579180|NCT00379457|Vinorelbine|vinorelbine|mesh-list
83579181|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83579182|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
83579183|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579184|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579185|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83579186|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
83579187|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579188|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579189|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83579190|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83579191|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83579192|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83579193|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579194|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83579195|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83579196|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83579197|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83579198|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83579199|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83579200|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579201|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83579202|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579203|NCT01629329|Aspirin|aspirin|mesh-list
83579204|NCT01629329|Acetaminophen|acetaminophen|mesh-list
83579205|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
83579206|NCT01629329|Caffeine|caffeine|mesh-list
83579207|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83579208|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579209|NCT01629329|Analgesics|analgesics|mesh-ancestor
83579210|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
83579211|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579212|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579213|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83579214|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579215|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83579216|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83579217|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579218|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83579219|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83579220|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579221|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
83579222|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83579223|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83579224|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83579225|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83579226|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
83579227|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579228|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
83579229|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
83579230|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83579231|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83579232|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83579233|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579234|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83579235|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83579236|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
83579237|NCT01606709|Leuprolide|leuprolide|mesh-list
83579238|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83579239|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
83579240|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83579241|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579242|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83579243|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579244|NCT00423059|Bevacizumab|bevacizumab|mesh-list
83579245|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83579246|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579247|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83579248|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83579249|NCT00423059|Growth Substances|growth substances|mesh-ancestor
83579250|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579251|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
83579252|NCT00585611|Atorvastatin|atorvastatin|mesh-list
83579253|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83579254|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83579255|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
83579256|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579257|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83579258|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83579259|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579260|NCT00379691|Phenylephrine|phenylephrine|mesh-list
83579261|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
83579262|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83579263|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
83579264|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
83579265|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579266|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579267|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
83579268|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83579269|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
83579270|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
83579271|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83579272|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83579273|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83579274|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
83579275|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579276|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579277|NCT00379691|Protective Agents|protective agents|mesh-ancestor
83579278|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
83579279|NCT01685333|Hematinics|hematinics|mesh-ancestor
83579280|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83579281|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83579282|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83579283|NCT00546455|Fenretinide|fenretinide|mesh-list
83579284|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579285|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83579286|NCT00546455|Protective Agents|protective agents|mesh-ancestor
83579287|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579288|NCT00000737|Megestrol|megestrol|mesh-list
83579289|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
83579290|NCT00000737|Dronabinol|dronabinol|mesh-list
83579291|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
83579292|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579293|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83579294|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579295|NCT00000737|Analgesics|analgesics|mesh-ancestor
83579296|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
83579297|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579298|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83579299|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83579300|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579301|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579303|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83579304|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83579305|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83579306|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83579307|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
83579308|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83579309|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83579310|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83579311|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83579312|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579313|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
83579314|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83579315|NCT00528437|Carboplatin|carboplatin|mesh-list
83579316|NCT00528437|Temozolomide|temozolomide|mesh-list
83579317|NCT00528437|Thiotepa|thiotepa|mesh-list
83579318|NCT00528437|Tretinoin|tretinoin|mesh-list
83579319|NCT00528437|Isotretinoin|isotretinoin|mesh-list
83579320|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579321|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83579322|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
83579323|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579324|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83579325|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83579326|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
83579327|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579328|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
83579329|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83579330|NCT00000743|Zidovudine|zidovudine|mesh-list
83579331|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
83579332|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579333|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579334|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579335|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579336|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
83579337|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579338|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579339|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579340|NCT00506909|Oxytocin|oxytocin|mesh-list
83579341|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
83579342|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83579343|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579344|NCT00500045|Niacin|niacin|mesh-list
83579345|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
83579346|NCT00500045|Niacinamide|niacinamide|mesh-list
83579347|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83579348|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
83579349|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579350|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83579351|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
83579352|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
83579353|NCT00500045|Vitamins|vitamins|mesh-ancestor
83579354|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
83579355|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579356|NCT00000767|Vaccines|vaccines|mesh-list
83579357|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
83579358|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579359|NCT05383547|Bortezomib|bortezomib|mesh-list
83579360|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579361|NCT00456989|Docetaxel|docetaxel|mesh-list
83579362|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579363|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
83579364|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
83579365|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
83579366|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579367|NCT00000773|Atovaquone|atovaquone|mesh-list
83579368|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579369|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
83579370|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83579371|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83579372|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579373|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579375|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83579376|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
83579377|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
83579378|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83579379|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
83579380|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83579381|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579382|NCT00000791|Zidovudine|zidovudine|mesh-list
83579383|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
83579384|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579385|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579386|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579387|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579388|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
83579389|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579390|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579391|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579392|NCT00379847|Conivaptan|conivaptan|mesh-list
83579393|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83579394|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579395|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
83579396|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579397|NCT00374543|Ziprasidone|ziprasidone|mesh-list
83579398|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83579399|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
83579400|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579401|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579402|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579403|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83579404|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83579405|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579406|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83579407|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83579408|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
83579409|NCT00000803|Zidovudine|zidovudine|mesh-list
83579410|NCT00000803|Didanosine|didanosine|mesh-list
83579411|NCT00000803|Delavirdine|delavirdine|mesh-list
83579412|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
83579413|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579414|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579415|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579416|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579417|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
83579418|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579419|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579420|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579421|NCT00299195|Sulindac|sulindac|mesh-list
83579422|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83579423|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579424|NCT00299195|Analgesics|analgesics|mesh-ancestor
83579425|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
83579426|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579427|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579428|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83579429|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579430|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579431|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83579432|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579433|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579434|NCT01351415|Bevacizumab|bevacizumab|mesh-list
83579435|NCT01351415|Docetaxel|docetaxel|mesh-list
83579436|NCT01351415|Pemetrexed|pemetrexed|mesh-list
83579437|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83579438|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83579439|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579440|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83579441|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83579442|NCT01351415|Growth Substances|growth substances|mesh-ancestor
83579443|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579444|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
83579445|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
83579446|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
83579447|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
83579448|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579449|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579450|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83579451|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579452|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83579454|NCT00281879|Cyclosporine|cyclosporine|mesh-list
83579455|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
83579456|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
83579457|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
83579458|NCT00281879|Melphalan|melphalan|mesh-list
83579459|NCT00281879|Busulfan|busulfan|mesh-list
83579460|NCT00281879|Carmustine|carmustine|mesh-list
83579461|NCT00281879|Methotrexate|methotrexate|mesh-list
83579462|NCT00281879|Fludarabine|fludarabine|mesh-list
83579463|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
83579464|NCT00281879|Etoposide|etoposide|mesh-list
83579465|NCT00281879|Tacrolimus|tacrolimus|mesh-list
83579466|NCT00281879|Cyclosporins|cyclosporins|mesh-list
83579467|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83579468|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83579469|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
83579470|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579471|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579472|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83579473|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
83579474|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579475|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579476|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83579477|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83579478|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
83579479|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83579480|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83579481|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
83579482|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
83579483|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579484|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83579485|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579486|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83579487|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83579488|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83579489|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
83579490|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579491|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83579492|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
83579493|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83579494|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83579495|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
83579496|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83579497|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83579498|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
83579499|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
83579500|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579501|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83579502|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
83579503|NCT00281879|Hormones|hormones|mesh-ancestor
83579504|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83579505|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83579506|NCT00281879|Protective Agents|protective agents|mesh-ancestor
83579507|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83579508|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83579509|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
83579510|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579511|NCT00000809|Antacids|antacids|mesh-ancestor
83579512|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579513|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83579514|NCT05091203|Vitamin D|vitamin d|mesh-list
83579515|NCT05091203|Vitamins|vitamins|mesh-ancestor
83579516|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
83579517|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579518|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83579519|NCT00240227|Prazosin|prazosin|mesh-list
83037538|NCT00835484|Cefdinir|cefdinir|mesh-list
83579520|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83579521|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83579522|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83579523|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83579524|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
83579525|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579526|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579527|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579529|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83579530|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579531|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579532|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83579533|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83579534|NCT00205049|Protective Agents|protective agents|mesh-ancestor
83579535|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579536|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
83579537|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83579538|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
83579539|NCT00000833|Ribavirin|ribavirin|mesh-list
83579540|NCT00000833|Didanosine|didanosine|mesh-list
83579541|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
83579542|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579543|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
83579544|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579545|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579546|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579547|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579548|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579549|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579550|NCT00000839|Didanosine|didanosine|mesh-list
83579551|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
83579552|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579553|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579554|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579555|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579556|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
83579557|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579558|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579559|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579560|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
83579561|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
83579562|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83579563|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83579564|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579565|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579566|NCT00133679|Urological Agents|urological agents|mesh-ancestor
83579567|NCT00000875|Acetaminophen|acetaminophen|mesh-list
83579568|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
83579569|NCT00000875|Promethazine|promethazine|mesh-list
83579570|NCT00000875|Lamivudine|lamivudine|mesh-list
83579571|NCT00000875|Zidovudine|zidovudine|mesh-list
83579572|NCT00000875|Aldesleukin|aldesleukin|mesh-list
83579573|NCT00000875|Indinavir|indinavir|mesh-list
83579574|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579575|NCT00000875|Analgesics|analgesics|mesh-ancestor
83579576|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
83579577|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579578|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579579|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
83579580|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579581|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579582|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579583|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579584|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
83579585|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579586|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579587|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579588|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
83579589|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579590|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83579591|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83579592|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579593|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
83579594|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
83579595|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
83579596|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
83579597|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83579598|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83579599|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
83579600|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
83579601|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579602|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83579603|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
83579604|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83579605|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83579606|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83579607|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
83579608|NCT04941833|Desogestrel|desogestrel|mesh-list
83579609|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83579610|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83579611|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83579612|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
83579613|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83579614|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579615|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83579616|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83579617|NCT04941833|Progestins|progestins|mesh-ancestor
83579618|NCT04941833|Hormones|hormones|mesh-ancestor
83579619|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83579620|NCT04841369|Vaccines|vaccines|mesh-list
83579621|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
83579622|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579623|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83579624|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83579625|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
83579626|NCT00521885|Enoxaparin|enoxaparin|mesh-list
83579627|NCT00521885|Fondaparinux|fondaparinux|mesh-list
83579628|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
83579629|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83579630|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83579631|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579632|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83579633|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
83579634|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83579635|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
83579636|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579637|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
83579638|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
83579639|NCT00000881|Cidofovir|cidofovir|mesh-list
83579640|NCT00000881|Probenecid|probenecid|mesh-list
83579641|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
83579642|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
83579643|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579644|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
83579645|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579646|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579647|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579648|NCT00000887|Lamivudine|lamivudine|mesh-list
83579649|NCT00000887|Zidovudine|zidovudine|mesh-list
83579650|NCT00000887|Nelfinavir|nelfinavir|mesh-list
83579651|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579652|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579653|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579654|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579655|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
83579656|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579657|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579658|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579659|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
83579660|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83579661|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83579662|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
83579663|NCT00000119|Heparin|heparin|mesh-list
83579664|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
83579665|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83579666|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83579667|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579668|NCT00000923|Lamivudine|lamivudine|mesh-list
83579669|NCT00000923|Zidovudine|zidovudine|mesh-list
83579670|NCT00000923|Stavudine|stavudine|mesh-list
83037688|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
83579671|NCT00000923|Didanosine|didanosine|mesh-list
83579672|NCT00000923|Aldesleukin|aldesleukin|mesh-list
83579673|NCT00000923|Indinavir|indinavir|mesh-list
83579674|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579675|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579676|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579677|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579678|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
83579679|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579680|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579681|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579682|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
83579683|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579684|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83579685|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83579686|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
83579687|NCT00000161|Aspirin|aspirin|mesh-list
83579688|NCT00000161|Vitamins|vitamins|mesh-list
83579689|NCT00000161|Vitamin E|vitamin e|mesh-list
83579690|NCT00000161|Beta Carotene|beta carotene|mesh-list
83579691|NCT00000161|Carotenoids|carotenoids|mesh-list
83579692|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
83579693|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579694|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83579695|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579696|NCT00000161|Analgesics|analgesics|mesh-ancestor
83579697|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
83579698|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579699|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83579700|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579701|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83579702|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83579703|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579704|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83579705|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83579706|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579707|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
83579708|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
83579709|NCT00000161|Protective Agents|protective agents|mesh-ancestor
83579710|NCT00000161|Provitamins|provitamins|mesh-ancestor
83579711|NCT00000929|Nonoxynol|nonoxynol|mesh-list
83579712|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83579713|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83579714|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579715|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83579716|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
83579717|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83579718|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83579719|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
83579720|NCT00000935|Antibodies|antibodies|mesh-list
83579721|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
83579722|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83579723|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83579724|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
83579725|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579726|NCT00000197|Propranolol|propranolol|mesh-list
83579727|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83579728|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83579729|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
83579730|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579731|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579732|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579733|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83579734|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83579735|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
83579736|NCT00000947|Azithromycin|azithromycin|mesh-list
83579737|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83579738|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579739|NCT00000203|Buprenorphine|buprenorphine|mesh-list
83579740|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83579741|NCT00000203|Narcotics|narcotics|mesh-ancestor
83579742|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579743|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579744|NCT00000203|Analgesics|analgesics|mesh-ancestor
83579745|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
83579746|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579747|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83579748|NCT00000209|Buprenorphine|buprenorphine|mesh-list
83579749|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83579750|NCT00000209|Narcotics|narcotics|mesh-ancestor
83579751|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579752|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579753|NCT00000209|Analgesics|analgesics|mesh-ancestor
83579754|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
83579755|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579756|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83579758|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
83579759|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
83579760|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579761|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579762|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579763|NCT00000953|Acyclovir|acyclovir|mesh-list
83579764|NCT00000953|Sorivudine|sorivudine|mesh-list
83579765|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
83579766|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579767|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579768|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579769|NCT00000983|Zidovudine|zidovudine|mesh-list
83579770|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
83579771|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579772|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579773|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579774|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579775|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
83579776|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579777|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579778|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579779|NCT00000227|Buprenorphine|buprenorphine|mesh-list
83579780|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83579781|NCT00000227|Narcotics|narcotics|mesh-ancestor
83579782|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579783|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579784|NCT00000227|Analgesics|analgesics|mesh-ancestor
83579785|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
83579786|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579787|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83579788|NCT00000233|Buprenorphine|buprenorphine|mesh-list
83579789|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83579790|NCT00000233|Narcotics|narcotics|mesh-ancestor
83579791|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579792|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579793|NCT00000233|Analgesics|analgesics|mesh-ancestor
83579794|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
83579795|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579796|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83579797|NCT00000239|Buprenorphine|buprenorphine|mesh-list
83579798|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83579799|NCT00000239|Narcotics|narcotics|mesh-ancestor
83579800|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579801|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579802|NCT00000239|Analgesics|analgesics|mesh-ancestor
83579803|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
83579804|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579805|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83579806|NCT00000245|Desipramine|desipramine|mesh-list
83579807|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83579808|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
83579809|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83579810|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579811|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579812|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83579813|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83579814|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83579815|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
83579816|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579817|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579818|NCT00000263|Ethanol|ethanol|mesh-list
83579819|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
83579820|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83579821|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579822|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579823|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579824|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83579825|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
83579826|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
83579827|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579828|NCT00000263|Analgesics|analgesics|mesh-ancestor
83579829|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
83037844|NCT04178993|Analgesics|analgesics|mesh-ancestor
83579830|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579831|NCT00000269|Pergolide|pergolide|mesh-list
83579832|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
83579833|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
83579834|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579835|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579836|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579837|NCT04030559|Niraparib|niraparib|mesh-list
83579838|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83579839|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579840|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579841|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579842|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
83579843|NCT03967223|Fludarabine|fludarabine|mesh-list
83579844|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83579845|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
83579846|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579847|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579848|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83579849|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
83579850|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579851|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579852|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83579853|NCT00000989|Zidovudine|zidovudine|mesh-list
83579854|NCT00000989|Ganciclovir|ganciclovir|mesh-list
83579855|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83579856|NCT00000989|Sargramostim|sargramostim|mesh-list
83579857|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
83579858|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579859|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579860|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579861|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579862|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
83579863|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579864|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579865|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579866|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
83579867|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579868|NCT00000995|Zidovudine|zidovudine|mesh-list
83579869|NCT00000995|Ganciclovir|ganciclovir|mesh-list
83579870|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83579871|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
83579872|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579873|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579874|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579875|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579876|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
83579877|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579878|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579879|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579880|NCT00001025|Zidovudine|zidovudine|mesh-list
83579881|NCT00001025|Didanosine|didanosine|mesh-list
83579882|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
83579883|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579884|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579885|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579886|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579887|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
83579888|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579889|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579890|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579891|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
83579892|NCT03121001|Sirolimus|sirolimus|mesh-list
83579893|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
83579894|NCT03121001|Fludarabine|fludarabine|mesh-list
83579895|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
83579896|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83579897|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
83579898|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579899|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579900|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83579901|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
83579902|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579903|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579904|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83579905|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83579906|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83579907|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
83579908|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83579909|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579910|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579911|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
83579912|NCT03055247|Ibuprofen|ibuprofen|mesh-list
83579913|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83579914|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579915|NCT03055247|Analgesics|analgesics|mesh-ancestor
83579916|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
83579917|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579918|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579919|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83579920|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83579921|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83579922|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579923|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579924|NCT00001049|Zidovudine|zidovudine|mesh-list
83579925|NCT00001049|Didanosine|didanosine|mesh-list
83579926|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
83579927|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579928|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579929|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579930|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579931|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
83579932|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579933|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579934|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579935|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
83579936|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83579937|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
83579938|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579939|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83579940|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83579941|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
83579942|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579943|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
83579944|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83579945|NCT00001055|Protective Agents|protective agents|mesh-ancestor
83579946|NCT00000275|Flupenthixol|flupenthixol|mesh-list
83579947|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83579948|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83579949|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83579950|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83579951|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579952|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83579953|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83579954|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
83579955|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579956|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579957|NCT00001061|Ganciclovir|ganciclovir|mesh-list
83579958|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83579959|NCT00001061|Foscarnet|foscarnet|mesh-list
83579960|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83579961|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
83579962|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579963|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579964|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579965|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579966|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579967|NCT00000281|Amantadine|amantadine|mesh-list
83579968|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83579969|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83579970|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
83579971|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579972|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
83579973|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83579974|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579975|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83579976|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83579977|NCT00000281|Analgesics|analgesics|mesh-ancestor
83579978|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
83579979|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83579980|NCT00001067|Lamivudine|lamivudine|mesh-list
83579981|NCT00001067|Zidovudine|zidovudine|mesh-list
83579983|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83579984|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83579985|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83579986|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83579987|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
83579988|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83579989|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83579990|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83579991|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
83579992|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
83579993|NCT00001079|Megestrol|megestrol|mesh-list
83579994|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
83579995|NCT00001079|Testosterone|testosterone|mesh-list
83579996|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
83579997|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
83579998|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83579999|NCT00001079|Androgens|androgens|mesh-ancestor
83580000|NCT00001079|Hormones|hormones|mesh-ancestor
83580001|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83580002|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580003|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83580004|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580005|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
83580006|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83580007|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83580008|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83580009|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
83580010|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83580011|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83580012|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83580013|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
83580014|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83580015|NCT00000293|Nefazodone|nefazodone|mesh-list
83580016|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83580017|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83580018|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83580019|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580020|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580021|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580022|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83580023|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
83580024|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83580025|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83580026|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83580027|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
83580028|NCT00001091|Ritonavir|ritonavir|mesh-list
83580029|NCT00001091|Nelfinavir|nelfinavir|mesh-list
83580030|NCT00001091|Lamivudine|lamivudine|mesh-list
83580031|NCT00001091|Nevirapine|nevirapine|mesh-list
83580032|NCT00001091|Stavudine|stavudine|mesh-list
83580033|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580034|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580035|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580036|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580037|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580038|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580039|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580040|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
83580041|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580042|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83580043|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580044|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580045|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580046|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83580047|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83580048|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
83580049|NCT00000299|Buprenorphine|buprenorphine|mesh-list
83580050|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83580051|NCT00000299|Narcotics|narcotics|mesh-ancestor
83580052|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580053|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580054|NCT00000299|Analgesics|analgesics|mesh-ancestor
83580055|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
83580056|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580057|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83580058|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
83580059|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83580060|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580061|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83580062|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83580063|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83580064|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580065|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
83580066|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580067|NCT00000311|Buprenorphine|buprenorphine|mesh-list
83580069|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83580070|NCT00000311|Narcotics|narcotics|mesh-ancestor
83580071|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580072|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580073|NCT00000311|Analgesics|analgesics|mesh-ancestor
83580074|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
83580075|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580076|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83580077|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
83580078|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83580079|NCT00000317|Risperidone|risperidone|mesh-list
83580080|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83580081|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
83580082|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580083|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580084|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580085|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83580086|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83580087|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580088|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83580089|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83580090|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
83580091|NCT00001115|Acyclovir|acyclovir|mesh-list
83580092|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
83580093|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580094|NCT00001757|Voriconazole|voriconazole|mesh-list
83580095|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
83580096|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580097|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83580098|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580099|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580100|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580101|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83580102|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
83580103|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83580104|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580105|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83580106|NCT00001133|Ritonavir|ritonavir|mesh-list
83580107|NCT00001133|Indinavir|indinavir|mesh-list
83580108|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580109|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580110|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580111|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580112|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580113|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580114|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580115|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
83580116|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580117|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83580118|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580119|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
83580120|NCT00000329|Narcotics|narcotics|mesh-ancestor
83580121|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580122|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580123|NCT00000329|Analgesics|analgesics|mesh-ancestor
83580124|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
83580125|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580126|NCT00000335|Morphine|morphine|mesh-list
83580127|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83580128|NCT00000335|Narcotics|narcotics|mesh-ancestor
83580129|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580130|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580131|NCT00000335|Analgesics|analgesics|mesh-ancestor
83580132|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
83580133|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580134|NCT00000341|Buprenorphine|buprenorphine|mesh-list
83580135|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83580136|NCT00000341|Narcotics|narcotics|mesh-ancestor
83580137|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580138|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580139|NCT00000341|Analgesics|analgesics|mesh-ancestor
83580140|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
83580141|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580142|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83580143|NCT00000347|Risperidone|risperidone|mesh-list
83580144|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83580145|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
83580146|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580147|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580148|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580149|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83580150|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83580151|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580152|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83580153|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83580154|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
83580155|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
83580156|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580157|NCT00001193|Melphalan|melphalan|mesh-list
83580158|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83580159|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
83580160|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580161|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580162|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83580163|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83580164|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
83580165|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580166|NCT00000353|Buprenorphine|buprenorphine|mesh-list
83580167|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83580168|NCT00000353|Naloxone|naloxone|mesh-list
83580169|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83580170|NCT00000353|Narcotics|narcotics|mesh-ancestor
83580171|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580172|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580173|NCT00000353|Analgesics|analgesics|mesh-ancestor
83580174|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
83580175|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580176|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83580177|NCT00000377|Nortriptyline|nortriptyline|mesh-list
83580178|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83580179|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
83580180|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83580181|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83580182|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83580183|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83580184|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580185|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
83580186|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580187|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580188|NCT00001865|Daclizumab|daclizumab|mesh-list
83580189|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83580190|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
83580191|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580192|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
83580193|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83580194|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83580195|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580196|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580197|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83580198|NCT00000389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83580199|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83580200|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83580201|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580202|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580203|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
83580204|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83580205|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
83580206|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83580207|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580208|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580209|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83580210|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
83580211|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83580212|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580213|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580214|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83580215|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83580216|NCT00001877|Protective Agents|protective agents|mesh-ancestor
83580217|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580218|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
83580219|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83580220|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
83580221|NCT00380939|Atorvastatin|atorvastatin|mesh-list
83580222|NCT00380939|Pravastatin|pravastatin|mesh-list
83580223|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83580224|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83580225|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
83580226|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580227|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83580228|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83580229|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580230|NCT00001889|Dobutamine|dobutamine|mesh-list
83580231|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83580232|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
83580233|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
83580234|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580235|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580236|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83580237|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83580238|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83580239|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
83580240|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580241|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580242|NCT00001889|Protective Agents|protective agents|mesh-ancestor
83580243|NCT00001901|Etanercept|etanercept|mesh-list
83580244|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83580245|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83580246|NCT00001901|Analgesics|analgesics|mesh-ancestor
83580247|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
83580248|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580249|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580250|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83580251|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83580252|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83580253|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83580254|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
83580255|NCT00000437|Naltrexone|naltrexone|mesh-list
83580256|NCT00000437|Nicotine|nicotine|mesh-list
83580257|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83580258|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
83580259|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580260|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580261|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83580262|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83580263|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
83580264|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580265|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580266|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83580267|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83580268|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
83580269|NCT00000443|Ondansetron|ondansetron|mesh-list
83580270|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
83580271|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
83580272|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580273|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580274|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83580275|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
83580276|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
83580277|NCT00000443|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83580278|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83580279|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
83580280|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83469186|NCT04199572|Diclofenac|diclofenac|mesh-list
83580281|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580282|NCT00000449|Naltrexone|naltrexone|mesh-list
83580283|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83580284|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83580285|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580286|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
83580287|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580288|NCT00000455|Naltrexone|naltrexone|mesh-list
83580289|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83580290|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83580291|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580292|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
83580293|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580294|NCT00001307|Capsaicin|capsaicin|mesh-list
83580295|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
83580296|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
83580297|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
83580298|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580299|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580300|NCT04713761|Carboplatin|carboplatin|mesh-list
83580301|NCT04713761|Pemetrexed|pemetrexed|mesh-list
83580302|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580303|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580304|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580305|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83580306|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580307|NCT00001937|Fluconazole|fluconazole|mesh-list
83580308|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
83580309|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580310|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83580311|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580312|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580313|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580314|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83580315|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
83580316|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83580317|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580318|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83580319|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83580320|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83580321|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83580322|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580323|NCT04331327|Mitogens|mitogens|mesh-list
83580324|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
83580325|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580326|NCT00001955|Celecoxib|celecoxib|mesh-list
83580327|NCT00001955|Etanercept|etanercept|mesh-list
83580328|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83580329|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83580330|NCT00001955|Analgesics|analgesics|mesh-ancestor
83580331|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
83580332|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580333|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580334|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83580335|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83580336|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83580337|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83580338|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580339|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580340|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83580341|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83580342|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
83580343|NCT04943783|Atorvastatin|atorvastatin|mesh-list
83580344|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83580345|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83580346|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
83580347|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580348|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83580349|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83580350|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580351|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83580352|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
83580353|NCT00000605|Hormones|hormones|mesh-list
83580354|NCT00000605|Estrogens|estrogens|mesh-list
83580355|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83580356|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580357|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83580358|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83580359|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83580360|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
83580361|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83580362|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83580363|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83580364|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83580365|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83580366|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580367|NCT00000617|Azithromycin|azithromycin|mesh-list
83580368|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83580369|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580370|NCT00000623|Decitabine|decitabine|mesh-list
83580371|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
83580372|NCT00000623|Deferiprone|deferiprone|mesh-list
83580373|NCT00000623|Deferoxamine|deferoxamine|mesh-list
83580374|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83580375|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
83580376|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580377|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580378|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580379|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
83580380|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83580381|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83580382|NCT00000623|Urological Agents|urological agents|mesh-ancestor
83580383|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83580384|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
83580385|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
83580386|NCT00000623|Siderophores|siderophores|mesh-ancestor
83580387|NCT00001991|Atovaquone|atovaquone|mesh-list
83580388|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580389|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
83580390|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83580391|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83580392|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580393|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580394|NCT00001997|Zidovudine|zidovudine|mesh-list
83580395|NCT00001997|Didanosine|didanosine|mesh-list
83580396|NCT00001997|Interleukin-2|interleukin-2|mesh-list
83580397|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580398|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83580399|NCT00001997|Analgesics|analgesics|mesh-ancestor
83580400|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
83580401|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580402|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580403|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
83580404|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580405|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580406|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580407|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580408|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
83580409|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580410|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580411|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580412|NCT00002003|Etoposide|etoposide|mesh-list
83580413|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
83580414|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83580415|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580416|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83580417|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83580418|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580419|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580420|NCT00002003|Analgesics|analgesics|mesh-ancestor
83580421|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
83580422|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580423|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580424|NCT00002009|Sargramostim|sargramostim|mesh-list
83580425|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
83580426|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580427|NCT00000629|Zidovudine|zidovudine|mesh-list
83580428|NCT00000629|Valproic Acid|valproic acid|mesh-list
83580429|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
83580430|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580431|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580432|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580433|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580434|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
83580435|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580436|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580437|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580438|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
83580439|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
83580440|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580441|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580442|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
83580443|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83580444|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580445|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83580446|NCT00000647|Interferons|interferons|mesh-list
83580447|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
83580448|NCT00000647|Zidovudine|zidovudine|mesh-list
83580449|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83580450|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580451|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
83580452|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580453|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
83580454|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580455|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
83580456|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580457|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580458|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580459|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580460|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580461|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580462|NCT00000653|Zalcitabine|zalcitabine|mesh-list
83580463|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
83580464|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580465|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580466|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580467|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580468|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
83580469|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580470|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580471|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580472|NCT00001409|Interleukin-2|interleukin-2|mesh-list
83580473|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580474|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83580475|NCT00001409|Analgesics|analgesics|mesh-ancestor
83580476|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
83580477|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580478|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580479|NCT00000659|Zidovudine|zidovudine|mesh-list
83580480|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
83580481|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580482|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580483|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580484|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580485|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
83580486|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580487|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580488|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580489|NCT00381017|Interferons|interferons|mesh-list
83580490|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
83580491|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
83580492|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83580493|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580494|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
83580495|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580496|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
83580497|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580498|NCT00002015|Ganciclovir|ganciclovir|mesh-list
83580499|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83580500|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
83580501|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580502|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580503|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580504|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580505|NCT00002021|Foscarnet|foscarnet|mesh-list
83580506|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83580507|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
83580508|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580509|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580510|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580511|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580512|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580513|NCT00002027|Diclazuril|diclazuril|mesh-list
83580514|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
83580515|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83580516|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83580517|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580518|NCT00000695|Interferons|interferons|mesh-list
83580519|NCT00000695|Zidovudine|zidovudine|mesh-list
83580520|NCT00000695|Interferon-beta|interferon-beta|mesh-list
83580521|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
83580522|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580523|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
83580524|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580525|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
83580526|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580527|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580528|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580529|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580530|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580531|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580532|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
83580533|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580534|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83580535|NCT00000701|Zidovudine|zidovudine|mesh-list
83580536|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
83580537|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580538|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580539|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580540|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580541|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
83580542|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580543|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580544|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580545|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83580546|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
83580547|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580548|NCT00000725|Interferons|interferons|mesh-list
83580549|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
83580550|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
83580551|NCT00000725|Zidovudine|zidovudine|mesh-list
83580552|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580553|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
83580554|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580555|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
83580556|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580557|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
83580558|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580559|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580560|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580561|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580562|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580563|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580564|NCT00002033|Zidovudine|zidovudine|mesh-list
83580565|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
83580566|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580567|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580568|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580569|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580570|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
83580571|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580572|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580573|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580574|NCT00002039|Foscarnet|foscarnet|mesh-list
83580575|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83580576|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
83580577|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580578|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580579|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580580|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124601|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83580581|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580582|NCT00000731|Acetaminophen|acetaminophen|mesh-list
83580583|NCT00000731|Zidovudine|zidovudine|mesh-list
83580584|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83580585|NCT00000731|Analgesics|analgesics|mesh-ancestor
83580586|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
83580587|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580588|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580589|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
83580590|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
83580591|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580592|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580593|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580594|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580595|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
83580596|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580597|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580598|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580599|NCT00002045|Zidovudine|zidovudine|mesh-list
83580600|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
83580601|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580602|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580603|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580604|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580605|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
83580606|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580607|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580608|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580609|NCT00002051|Thymopentin|thymopentin|mesh-list
83580610|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83580611|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
83580612|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580613|NCT00001499|Paclitaxel|paclitaxel|mesh-list
83580614|NCT00001499|Cisplatin|cisplatin|mesh-list
83580615|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83580616|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580617|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83580618|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83580619|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83580620|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580621|NCT00002057|Nystatin|nystatin|mesh-list
83580622|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83580623|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580624|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
83580625|NCT00002057|Ionophores|ionophores|mesh-ancestor
83580626|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83580627|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580628|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
83580629|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83580630|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
83580631|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580632|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
83580633|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580634|NCT00001535|Interleukin-2|interleukin-2|mesh-list
83580635|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580636|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83580637|NCT00001535|Analgesics|analgesics|mesh-ancestor
83580638|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
83580639|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580640|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580641|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
83580642|NCT00002303|Hematinics|hematinics|mesh-ancestor
83580643|NCT00002063|Zidovudine|zidovudine|mesh-list
83580644|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
83580645|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580646|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580647|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580648|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580649|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
83580650|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580651|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580652|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580653|NCT00002069|Ditiocarb|ditiocarb|mesh-list
83580654|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83580655|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
83469561|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
83580656|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580657|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
83580658|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580659|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
83580660|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
83580661|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580662|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83580663|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580664|NCT00002309|Azithromycin|azithromycin|mesh-list
83580665|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83580666|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580667|NCT00002315|Acyclovir|acyclovir|mesh-list
83580668|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
83580669|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
83580670|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580671|NCT00002075|Fluconazole|fluconazole|mesh-list
83580672|NCT00002075|Amphotericin B|amphotericin b|mesh-list
83580673|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83580674|NCT00002075|Flucytosine|flucytosine|mesh-list
83580675|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
83580676|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580677|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83580678|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580679|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580680|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580681|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83580682|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
83580683|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83580684|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580685|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83580686|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83580687|NCT00002075|Amebicides|amebicides|mesh-ancestor
83580688|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83580689|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83580690|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83580691|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
83580692|NCT00001577|Melphalan|melphalan|mesh-list
83580693|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83580694|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
83580695|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580696|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580697|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83580698|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83580699|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
83580700|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580701|NCT00002081|Zidovudine|zidovudine|mesh-list
83580702|NCT00002081|Zalcitabine|zalcitabine|mesh-list
83580703|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
83580704|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580705|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580706|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580707|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580708|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
83580709|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580710|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580711|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580712|NCT00002093|Doxorubicin|doxorubicin|mesh-list
83580713|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83580714|NCT00002093|Daunorubicin|daunorubicin|mesh-list
83580715|NCT00002093|Bleomycin|bleomycin|mesh-list
83580716|NCT00002093|Vincristine|vincristine|mesh-list
83580717|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83580718|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580719|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83580720|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83580721|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580722|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580723|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83580724|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
83580725|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
83580726|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
83580727|NCT00002099|Didanosine|didanosine|mesh-list
83580728|NCT00002099|Lentinan|lentinan|mesh-list
83580729|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
83580730|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580731|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580732|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580733|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580734|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
83580735|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580736|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580737|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580738|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83580739|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
83580740|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580741|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580742|NCT00002321|Aldesleukin|aldesleukin|mesh-list
83580743|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580744|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580745|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580746|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
83580747|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580748|NCT00002327|Cidofovir|cidofovir|mesh-list
83580749|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
83580750|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580751|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580752|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580753|NCT00002333|Saquinavir|saquinavir|mesh-list
83580754|NCT00002333|Zalcitabine|zalcitabine|mesh-list
83580755|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580756|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580757|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580758|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580759|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580760|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580761|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580762|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
83580763|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580764|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83580765|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580766|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
83580767|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580768|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580769|NCT00002339|Fluconazole|fluconazole|mesh-list
83580770|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
83580771|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580772|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83580773|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580774|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580775|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580776|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83580777|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
83580778|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83580779|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580780|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83580781|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83580782|NCT00002105|Doxorubicin|doxorubicin|mesh-list
83580783|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83580784|NCT00002105|Bleomycin|bleomycin|mesh-list
83580785|NCT00002105|Vincristine|vincristine|mesh-list
83580786|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83580787|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580788|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83580789|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83580790|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580791|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580792|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83580793|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
83580794|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
83580795|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
83580796|NCT00002345|Megestrol|megestrol|mesh-list
83580797|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
83580798|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83580799|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83580800|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83580801|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
83580802|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83580803|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580804|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83580805|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83580806|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83580807|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580808|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
83580809|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83580810|NCT00002111|Saquinavir|saquinavir|mesh-list
83580811|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580812|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580813|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580814|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580815|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580816|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580817|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580818|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
83580819|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580820|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83580821|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580822|NCT00002351|Indinavir|indinavir|mesh-list
83580823|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580824|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580825|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580826|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580827|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580828|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580829|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580830|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
83580831|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580832|NCT00002357|Zidovudine|zidovudine|mesh-list
83580833|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
83580834|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580835|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580836|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580837|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580838|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
83580839|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580840|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580841|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580842|NCT00002117|Zidovudine|zidovudine|mesh-list
83580843|NCT00002117|Zalcitabine|zalcitabine|mesh-list
83580844|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
83580845|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580846|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580847|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580848|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580849|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
83580850|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580851|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580852|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580853|NCT00002123|Didanosine|didanosine|mesh-list
83580854|NCT00002123|Delavirdine|delavirdine|mesh-list
83580855|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
83580856|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580857|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580858|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580859|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580860|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
83580861|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580862|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580863|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580864|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
83580865|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83580866|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
83580867|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580868|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83580869|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83580870|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
83580871|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580872|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580873|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83580874|NCT05752409|Ketamine|ketamine|mesh-list
83580875|NCT05752409|Propofol|propofol|mesh-list
83580876|NCT05752409|Esketamine|esketamine|mesh-list
83580877|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83580878|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83580879|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580880|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83580881|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
83580882|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
83580883|NCT05752409|Analgesics|analgesics|mesh-ancestor
83580884|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
83580885|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83580886|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83580887|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83580888|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83580889|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83580890|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580891|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
83580892|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83580893|NCT00002129|Vesnarinone|vesnarinone|mesh-list
83580894|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83580895|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
83580896|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83580897|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83580898|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
83580899|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580900|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83580901|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83580902|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580903|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580904|NCT00002129|Protective Agents|protective agents|mesh-ancestor
83580905|NCT00002135|Ganciclovir|ganciclovir|mesh-list
83580906|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83580907|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
83580908|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580909|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580910|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580911|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580913|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580914|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580915|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580916|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580917|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
83580918|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580919|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580920|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580921|NCT00002369|Lamivudine|lamivudine|mesh-list
83580922|NCT00002369|Zidovudine|zidovudine|mesh-list
83580923|NCT00002369|Stavudine|stavudine|mesh-list
83580924|NCT00002369|Indinavir|indinavir|mesh-list
83580925|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580926|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580927|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580928|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580929|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
83580930|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580931|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580932|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580933|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
83580934|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580935|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580936|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580937|NCT00002375|Nelfinavir|nelfinavir|mesh-list
83580938|NCT00002375|Indinavir|indinavir|mesh-list
83580939|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580940|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580941|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580942|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580943|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580944|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580945|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580946|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
83580947|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580948|NCT00002381|Nevirapine|nevirapine|mesh-list
83580949|NCT00002381|Stavudine|stavudine|mesh-list
83580950|NCT00002381|Nelfinavir|nelfinavir|mesh-list
83580951|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580952|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580953|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580954|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580955|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
83580956|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038975|NCT05073172|Petrolatum|petrolatum|mesh-list
83580957|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580958|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580959|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83580960|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83580961|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580962|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580963|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580964|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
83580965|NCT00002387|Efavirenz|efavirenz|mesh-list
83580966|NCT00002387|Indinavir|indinavir|mesh-list
83580967|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580968|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580969|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580970|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580971|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
83580972|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580973|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83580974|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580975|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83580976|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83580977|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83580978|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83580979|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580980|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83580981|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
83580982|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83580983|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83580984|NCT00002393|Efavirenz|efavirenz|mesh-list
83580985|NCT00002393|Indinavir|indinavir|mesh-list
83580986|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83580987|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83580988|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83580989|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83580990|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
83580991|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83580992|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83580993|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83580994|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83580995|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83580996|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83580997|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83580998|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83580999|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581000|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581001|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581002|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581003|NCT00002399|Fluconazole|fluconazole|mesh-list
83581004|NCT00002399|Posaconazole|posaconazole|mesh-list
83581005|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
83581006|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581007|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83581008|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83581009|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581010|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581011|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83581012|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
83581013|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581014|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581015|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83581016|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83581017|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83581018|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83581019|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83581020|NCT00002405|Amprenavir|amprenavir|mesh-list
83581021|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83581022|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
83581023|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581024|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581025|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581026|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581027|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581028|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581029|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581030|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581031|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581032|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
83581033|NCT00002417|Amprenavir|amprenavir|mesh-list
83581034|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83581035|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
83581036|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581037|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581038|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581039|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581040|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581041|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581042|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581043|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581044|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581045|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
83581046|NCT00002423|Lamivudine|lamivudine|mesh-list
83581047|NCT00002423|Abacavir|abacavir|mesh-list
83581048|NCT00002423|Nelfinavir|nelfinavir|mesh-list
83581049|NCT00002423|Indinavir|indinavir|mesh-list
83581050|NCT00002423|Amprenavir|amprenavir|mesh-list
83581051|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581052|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581053|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581054|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581055|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
83581056|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581057|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581058|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581059|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581060|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581061|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581062|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83581063|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
83581064|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581065|NCT02973581|Acetaminophen|acetaminophen|mesh-list
83581066|NCT02973581|Dipyrone|dipyrone|mesh-list
83581067|NCT02973581|Lidocaine|lidocaine|mesh-list
83581068|NCT02973581|Bupivacaine|bupivacaine|mesh-list
83581069|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
83581070|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
83581071|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
83581072|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83581073|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581074|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
83581075|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83581076|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83581077|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83581078|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83581079|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83581080|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581081|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83581082|NCT02973581|Analgesics|analgesics|mesh-ancestor
83581083|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
83581084|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83581085|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83581086|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581087|NCT00002435|Zidovudine|zidovudine|mesh-list
83581088|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
83581089|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581090|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581091|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581092|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581093|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
83581094|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581095|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581096|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581097|NCT00002447|Ritonavir|ritonavir|mesh-list
83581098|NCT00002447|Saquinavir|saquinavir|mesh-list
83581099|NCT00002447|Efavirenz|efavirenz|mesh-list
83581100|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581101|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83039108|NCT05116462|Pemetrexed|pemetrexed|mesh-list
83581102|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581103|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581104|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581105|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581106|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581107|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
83581108|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581109|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83581110|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83581111|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581112|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581113|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83581114|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83581115|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83581116|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83581117|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83581118|NCT00002453|Tenofovir|tenofovir|mesh-list
83581119|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
83581120|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581121|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581122|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581123|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581124|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581125|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581126|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581127|NCT00002465|Megestrol|megestrol|mesh-list
83581128|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
83581129|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83581130|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83581131|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83581132|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
83581133|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83581134|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581135|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83581136|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83581137|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83581138|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581139|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
83581140|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83581141|NCT00002471|Leucovorin|leucovorin|mesh-list
83581142|NCT00002471|Cytarabine|cytarabine|mesh-list
83581143|NCT00002471|Dexamethasone|dexamethasone|mesh-list
83581144|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
83581145|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
83581146|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83581147|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83581148|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83581149|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
83581150|NCT00002471|Thiotepa|thiotepa|mesh-list
83581151|NCT00002471|Methotrexate|methotrexate|mesh-list
83581152|NCT00002471|Etoposide|etoposide|mesh-list
83581153|NCT00002471|Vincristine|vincristine|mesh-list
83581154|NCT00002471|Daunorubicin|daunorubicin|mesh-list
83581155|NCT00002471|Asparaginase|asparaginase|mesh-list
83581156|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
83581157|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581158|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
83581159|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581160|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581161|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581162|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
83581163|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581164|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581165|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581166|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83581167|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
83581168|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
83581169|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83581170|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83581171|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
83581172|NCT00002471|Hormones|hormones|mesh-ancestor
83581173|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581174|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83581175|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83581176|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
83581177|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83581178|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581179|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
83581180|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
83581181|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581182|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83581183|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581184|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581185|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581186|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581187|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
83581188|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581189|NCT00002471|Antidotes|antidotes|mesh-ancestor
83581190|NCT00002471|Protective Agents|protective agents|mesh-ancestor
83581191|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
83581192|NCT00002471|Vitamins|vitamins|mesh-ancestor
83581193|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
83581194|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581195|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581196|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581197|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83581198|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581199|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
83581200|NCT00002477|Carboplatin|carboplatin|mesh-list
83581201|NCT00002477|Doxorubicin|doxorubicin|mesh-list
83581202|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83581203|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581204|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
83581205|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581206|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581207|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581208|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
83581209|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581210|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581211|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581212|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581213|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581214|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581215|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581216|NCT00002489|Leucovorin|leucovorin|mesh-list
83581217|NCT00002489|Dactinomycin|dactinomycin|mesh-list
83581218|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
83581219|NCT00002489|Carboplatin|carboplatin|mesh-list
83581220|NCT00002489|Doxorubicin|doxorubicin|mesh-list
83581221|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83581222|NCT00002489|Methotrexate|methotrexate|mesh-list
83581223|NCT00002489|Etoposide|etoposide|mesh-list
83581224|NCT00002489|Vincristine|vincristine|mesh-list
83581225|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
83581226|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581227|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
83581228|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581229|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581230|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581231|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
83581232|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581233|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581234|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581235|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581236|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581237|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581238|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581239|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83581240|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
83581241|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83581242|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581243|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
83581244|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
83581245|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83581246|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581247|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581248|NCT00002489|Antidotes|antidotes|mesh-ancestor
83581249|NCT00002489|Protective Agents|protective agents|mesh-ancestor
83581250|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
83581251|NCT00002489|Vitamins|vitamins|mesh-ancestor
83581252|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
83581253|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581254|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581255|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581256|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581257|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581258|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83581259|NCT00002495|Doxorubicin|doxorubicin|mesh-list
83581260|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83581261|NCT00002495|Vinblastine|vinblastine|mesh-list
83581262|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581263|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581264|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581265|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581266|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581267|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581268|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581269|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581270|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581271|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581272|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
83581273|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581274|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
83581275|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581276|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581277|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581278|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
83581279|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581280|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581281|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581282|NCT00002147|Doxorubicin|doxorubicin|mesh-list
83581283|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83581284|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581285|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581286|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581287|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581288|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581289|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581290|NCT00002159|Itraconazole|itraconazole|mesh-list
83581291|NCT00002159|Amphotericin B|amphotericin b|mesh-list
83581292|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83581293|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
83581294|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581295|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83581296|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83581297|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581298|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581299|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83581300|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
83581301|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581302|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581303|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83581304|NCT00002159|Amebicides|amebicides|mesh-ancestor
83581305|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83581306|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83581307|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581308|NCT00002165|Nelfinavir|nelfinavir|mesh-list
83581309|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581310|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581311|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581312|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581313|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581314|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581315|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581316|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
83581317|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581318|NCT00002171|Nelfinavir|nelfinavir|mesh-list
83581319|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581320|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581321|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581322|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581323|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581324|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581325|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581326|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
83581327|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581328|NCT00002177|Nelfinavir|nelfinavir|mesh-list
83581329|NCT00002177|Stavudine|stavudine|mesh-list
83581330|NCT00002177|Didanosine|didanosine|mesh-list
83581331|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
83581332|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581333|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
83039334|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581334|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581335|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581336|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581337|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581338|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581339|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581340|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581341|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581342|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
83581343|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581344|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
83581345|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581347|NCT00002183|Zidovudine|zidovudine|mesh-list
83581348|NCT00002183|Abacavir|abacavir|mesh-list
83581349|NCT00002183|Amprenavir|amprenavir|mesh-list
83581350|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581351|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581352|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581353|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581354|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
83581355|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581356|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581357|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581358|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
83581359|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83581360|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
83581361|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581362|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581363|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581364|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581365|NCT00002189|Paclitaxel|paclitaxel|mesh-list
83581366|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581367|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581368|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581369|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581370|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581371|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581372|NCT00002195|Lamivudine|lamivudine|mesh-list
83581373|NCT00002195|Zidovudine|zidovudine|mesh-list
83581374|NCT00002195|Amprenavir|amprenavir|mesh-list
83581375|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581376|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581377|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581378|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581379|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
83581380|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581381|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581382|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581383|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
83581384|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83581385|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
83581386|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581387|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581388|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581389|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581390|NCT00002201|Ritonavir|ritonavir|mesh-list
83581391|NCT00002201|Nelfinavir|nelfinavir|mesh-list
83581392|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581393|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581394|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581395|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581396|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581397|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581398|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581399|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
83581400|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581401|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83581402|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83581403|NCT00002213|Efavirenz|efavirenz|mesh-list
83581404|NCT00002213|Abacavir|abacavir|mesh-list
83581405|NCT00002213|Amprenavir|amprenavir|mesh-list
83581406|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83470314|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581407|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581408|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581409|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581410|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
83581411|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581412|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83581413|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83581414|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83581415|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83581416|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83581417|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83581418|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581419|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581420|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83581421|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
83581422|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581423|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581424|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581425|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581426|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83581427|NCT00381251|Estrogens|estrogens|mesh-ancestor
83581428|NCT00381251|Hormones|hormones|mesh-ancestor
83581429|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581430|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581431|NCT00002219|Nelfinavir|nelfinavir|mesh-list
83581432|NCT00002219|Adefovir|adefovir|mesh-list
83581433|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83581434|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83581435|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83581436|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
83581437|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581438|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581439|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581440|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581441|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
83581442|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581443|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581444|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581445|NCT00002225|Efavirenz|efavirenz|mesh-list
83581446|NCT00002225|Stavudine|stavudine|mesh-list
83581447|NCT00002225|Didanosine|didanosine|mesh-list
83581448|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581449|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581450|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581451|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581452|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
83581453|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581454|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83581455|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83581456|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83581457|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83581458|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83581459|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83581460|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
83581461|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581462|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581463|NCT00002243|Calanolide A|calanolide a|mesh-list
83581464|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581465|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581466|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
83581467|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581468|NCT00002249|Levofloxacin|levofloxacin|mesh-list
83581469|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83581470|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581471|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581472|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581473|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581474|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581475|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581476|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581477|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83581478|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83581479|NCT00002255|Zidovudine|zidovudine|mesh-list
83581480|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
83581481|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
83581482|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581483|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581484|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581485|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581486|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
83581487|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581488|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581489|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581490|NCT00002255|Hematinics|hematinics|mesh-ancestor
83581491|NCT00002261|Vaccines|vaccines|mesh-list
83581492|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
83581493|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581494|NCT00002507|Mitomycins|mitomycins|mesh-list
83581495|NCT00002507|Mitomycin|mitomycin|mesh-list
83581496|NCT00002507|Porfiromycin|porfiromycin|mesh-list
83581497|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581498|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581499|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
83581500|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581501|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581502|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581503|NCT00002519|Paclitaxel|paclitaxel|mesh-list
83581504|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581505|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581506|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581507|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581508|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581509|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581510|NCT00002267|Rifabutin|rifabutin|mesh-list
83581511|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83581512|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581513|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83581514|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
83581515|NCT00002273|Ganciclovir|ganciclovir|mesh-list
83581516|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83581517|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
83581518|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581519|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581520|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581521|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581522|NCT00002279|Zalcitabine|zalcitabine|mesh-list
83581523|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
83581524|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581525|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581526|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581527|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581528|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
83581529|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581530|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581531|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581532|NCT00002285|Zidovudine|zidovudine|mesh-list
83581533|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
83581534|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581535|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83581536|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581537|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581538|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
83581539|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581540|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581541|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581542|NCT00002531|Leucovorin|leucovorin|mesh-list
83581543|NCT00002531|Cytarabine|cytarabine|mesh-list
83581544|NCT00002531|Dexamethasone|dexamethasone|mesh-list
83581545|NCT00002531|Prednisolone|prednisolone|mesh-list
83581546|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
83581547|NCT00002531|Ifosfamide|ifosfamide|mesh-list
83581548|NCT00002531|Doxorubicin|doxorubicin|mesh-list
83581549|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83581550|NCT00002531|Methotrexate|methotrexate|mesh-list
83581551|NCT00002531|Etoposide|etoposide|mesh-list
83581552|NCT00002531|Vincristine|vincristine|mesh-list
83581553|NCT00002531|Daunorubicin|daunorubicin|mesh-list
83581554|NCT00002531|Asparaginase|asparaginase|mesh-list
83581555|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
83581556|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
83581557|NCT00002531|Thioguanine|thioguanine|mesh-list
83581558|NCT00002531|Vindesine|vindesine|mesh-list
83581559|NCT00002531|Teniposide|teniposide|mesh-list
83581560|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
83581561|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581562|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
83581563|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581564|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581565|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581566|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
83581567|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581568|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581569|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581570|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83581572|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
83581573|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83581574|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83581575|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
83581576|NCT00002531|Hormones|hormones|mesh-ancestor
83581577|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581578|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83581579|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581580|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581581|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581582|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581583|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83581584|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
83581585|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83581586|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581587|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
83581588|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
83581589|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83581590|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581591|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581592|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
83581593|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581594|NCT00002531|Antidotes|antidotes|mesh-ancestor
83581595|NCT00002531|Protective Agents|protective agents|mesh-ancestor
83581596|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
83581597|NCT00002531|Vitamins|vitamins|mesh-ancestor
83581598|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
83581599|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581600|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581601|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581602|NCT00002531|Analgesics|analgesics|mesh-ancestor
83581603|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
83581604|NCT00002537|Topotecan|topotecan|mesh-list
83581605|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83581606|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581607|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581608|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581609|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581610|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
83581611|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83581612|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581613|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581614|NCT00002291|Pentamidine|pentamidine|mesh-list
83581615|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
83581616|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581617|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83581618|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83581619|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83581620|NCT00002549|Cytarabine|cytarabine|mesh-list
83581621|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
83581622|NCT00002549|Busulfan|busulfan|mesh-list
83581623|NCT00002549|Etoposide|etoposide|mesh-list
83581624|NCT00002549|Daunorubicin|daunorubicin|mesh-list
83581625|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
83581626|NCT00002549|Idarubicin|idarubicin|mesh-list
83581627|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581628|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
83581629|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581630|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581631|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581632|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
83581633|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581634|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581635|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581636|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581637|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581638|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581639|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581640|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581641|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
83581642|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
83581643|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581644|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581645|NCT00002549|Analgesics|analgesics|mesh-ancestor
83581646|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
83581647|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83581648|NCT00002555|Cobalt|cobalt|mesh-list
83581649|NCT00002555|Trace Elements|trace elements|mesh-ancestor
83581650|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
83581651|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581652|NCT00002561|Doxorubicin|doxorubicin|mesh-list
83581653|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83581654|NCT00002561|Bleomycin|bleomycin|mesh-list
83581655|NCT00002561|Dacarbazine|dacarbazine|mesh-list
83581656|NCT00002561|Vinblastine|vinblastine|mesh-list
83581657|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581658|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581659|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581660|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581661|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581662|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581663|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581664|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
83581665|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581666|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581667|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581668|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581669|NCT00002567|Etoposide|etoposide|mesh-list
83581670|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581671|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581672|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581673|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581674|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581675|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581676|NCT00002579|Tamoxifen|tamoxifen|mesh-list
83581677|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
83581678|NCT00002579|Fluorouracil|fluorouracil|mesh-list
83581679|NCT00002579|Methotrexate|methotrexate|mesh-list
83581680|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581681|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
83581682|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581683|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581684|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581685|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
83581686|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581687|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581688|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581689|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
83581690|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581691|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83581692|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
83581693|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83581694|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
83581695|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581696|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83581697|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581698|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83581699|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
83581700|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581701|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83581702|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83581703|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83581704|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83581705|NCT00002585|NSC 366140|nsc 366140|mesh-list
83581706|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581707|NCT00002609|Cytarabine|cytarabine|mesh-list
83581708|NCT00002609|Idarubicin|idarubicin|mesh-list
83581709|NCT00002609|Lintuzumab|lintuzumab|mesh-list
83581710|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581711|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
83684417|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581712|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581713|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581714|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
83039725|NCT02285972|Tenoxicam|tenoxicam|mesh-list
83581715|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581716|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581717|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
83581718|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581719|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581720|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581721|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581722|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581723|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83581724|NCT00002615|Fluorouracil|fluorouracil|mesh-list
83581725|NCT00002615|Epirubicin|epirubicin|mesh-list
83581726|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581727|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
83581728|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581729|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581730|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581731|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
83581732|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581733|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581734|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581735|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581736|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581737|NCT00002621|Interferons|interferons|mesh-list
83581738|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
83581739|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
83581740|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581741|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
83581742|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581743|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
83581744|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581745|NCT00002627|Paclitaxel|paclitaxel|mesh-list
83581746|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
83581747|NCT00002627|Carboplatin|carboplatin|mesh-list
83581748|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581749|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581750|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581751|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581752|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581753|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581754|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581755|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
83581756|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581757|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581758|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581759|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
83581760|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581761|NCT00002633|Leuprolide|leuprolide|mesh-list
83581762|NCT00002633|Goserelin|goserelin|mesh-list
83581763|NCT00002633|Flutamide|flutamide|mesh-list
83581764|NCT00002633|Bicalutamide|bicalutamide|mesh-list
83581765|NCT00002633|Nilutamide|nilutamide|mesh-list
83581766|NCT00002633|Buserelin|buserelin|mesh-list
83581767|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83581768|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
83581769|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83581770|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581771|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83581772|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581773|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
83581774|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
83581775|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581776|NCT00002639|Suramin|suramin|mesh-list
83581777|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
83581778|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
83581779|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83581780|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581781|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581782|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83581783|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83581784|NCT00002657|Interferons|interferons|mesh-list
83581785|NCT00002657|Cytarabine|cytarabine|mesh-list
83581786|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
83581787|NCT00002657|Prednisone|prednisone|mesh-list
83581788|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
83581789|NCT00002657|Doxorubicin|doxorubicin|mesh-list
83581790|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83581791|NCT00002657|Methotrexate|methotrexate|mesh-list
83581792|NCT00002657|Etoposide|etoposide|mesh-list
83581793|NCT00002657|Vincristine|vincristine|mesh-list
83581794|NCT00002657|Bleomycin|bleomycin|mesh-list
83581795|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581796|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
83581797|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581798|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581799|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581800|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
83581801|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581802|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581803|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581804|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581805|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581806|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581807|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581808|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83581809|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
83581810|NCT00002657|Hormones|hormones|mesh-ancestor
83581811|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581812|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83581813|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83581814|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
83581815|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83581816|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581817|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
83581818|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
83581819|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83581820|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83581821|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581822|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
83581823|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581824|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581825|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581826|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581827|NCT05673785|Prednisone|prednisone|mesh-list
83581828|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
83581829|NCT05673785|Doxorubicin|doxorubicin|mesh-list
83581830|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83581831|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581832|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
83581833|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581834|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581835|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581836|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
83581837|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581838|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581839|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581840|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83581841|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581842|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581843|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581844|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83581845|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
83581846|NCT05673785|Hormones|hormones|mesh-ancestor
83581847|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83581848|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83581849|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83581850|NCT05673785|Immunotoxins|immunotoxins|mesh-ancestor
83581851|NCT05673785|Immunoconjugates|immunoconjugates|mesh-ancestor
83581852|NCT00381875|Sargramostim|sargramostim|mesh-list
83581853|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
83581854|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
83581855|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581856|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83581857|NCT00002669|Interferons|interferons|mesh-list
83581858|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
83581859|NCT00002669|Aldesleukin|aldesleukin|mesh-list
83581860|NCT00002669|Dacarbazine|dacarbazine|mesh-list
83581861|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581862|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
83581863|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581864|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
83581865|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581866|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581867|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83039856|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83581868|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581869|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
83581870|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581871|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
83581872|NCT00002675|Carboplatin|carboplatin|mesh-list
83581873|NCT00002675|Etoposide|etoposide|mesh-list
83581874|NCT00002675|Vincristine|vincristine|mesh-list
83581875|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581876|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
83581877|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581878|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83581879|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83581880|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
83581881|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581882|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581883|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83581884|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581885|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83581886|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581887|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581888|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581889|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581890|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581891|NCT00002681|Aldesleukin|aldesleukin|mesh-list
83581892|NCT00002681|Daclizumab|daclizumab|mesh-list
83581893|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581894|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581895|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581896|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
83581897|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581898|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581899|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
83581900|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581901|NCT02973113|Nivolumab|nivolumab|mesh-list
83581902|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83581903|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581904|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83581905|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581906|NCT00002687|Aldesleukin|aldesleukin|mesh-list
83581907|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581908|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83581909|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83581910|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
83581911|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581912|NCT00002693|Carboplatin|carboplatin|mesh-list
83581913|NCT00002693|Topotecan|topotecan|mesh-list
83581914|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581915|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83581916|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581917|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581918|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581919|NCT00002705|Topotecan|topotecan|mesh-list
83581920|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83581921|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581922|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581923|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581924|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581925|NCT00002711|Paclitaxel|paclitaxel|mesh-list
83581926|NCT00002711|Cisplatin|cisplatin|mesh-list
83581927|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581928|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581929|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581930|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581931|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581932|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581933|NCT00002717|Paclitaxel|paclitaxel|mesh-list
83581934|NCT00002717|Cisplatin|cisplatin|mesh-list
83581935|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83581936|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581937|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83581938|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83581939|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83581940|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581941|NCT00002723|Suramin|suramin|mesh-list
83581942|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
83581943|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
83581944|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83581945|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83581946|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581947|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83581948|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83581949|NCT00002735|Cobalt|cobalt|mesh-list
83581950|NCT00002735|Cisplatin|cisplatin|mesh-list
83581951|NCT00002735|Fluorouracil|fluorouracil|mesh-list
83581952|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581953|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
83581954|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581955|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581956|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581957|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
83581958|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581959|NCT00002735|Trace Elements|trace elements|mesh-ancestor
83581960|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
83581961|NCT00002747|Cobalt|cobalt|mesh-list
83581962|NCT00002747|Fluorouracil|fluorouracil|mesh-list
83581963|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581964|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
83581965|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581966|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83581967|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581968|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
83581969|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581970|NCT00002747|Trace Elements|trace elements|mesh-ancestor
83581971|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
83581972|NCT02973035|Amlodipine|amlodipine|mesh-list
83581973|NCT02973035|Valsartan|valsartan|mesh-list
83581974|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83581975|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83581976|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83581977|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581978|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83581979|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581980|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
83581981|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83581982|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83581983|NCT00002753|Antibodies|antibodies|mesh-list
83581984|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83581985|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
83581986|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581987|NCT00002759|Cyclosporine|cyclosporine|mesh-list
83581988|NCT00002759|Irinotecan|irinotecan|mesh-list
83581989|NCT00002759|Phenobarbital|phenobarbital|mesh-list
83581990|NCT00002759|Cyclosporins|cyclosporins|mesh-list
83581991|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83581992|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83581993|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83581994|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83581995|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83581996|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83581997|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
83581998|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83581999|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
83582000|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582001|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
83582002|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582003|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83582004|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
83582005|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83582006|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582007|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83582008|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83582009|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582010|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
83582011|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
83582012|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83582013|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83582014|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83582015|NCT00002765|Immunotoxins|immunotoxins|mesh-list
83582016|NCT00002765|Immunoconjugates|immunoconjugates|mesh-ancestor
83582017|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
83040009|NCT02099916|Menotropins|menotropins|mesh-list
83582018|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582019|NCT00002771|Interferons|interferons|mesh-list
83582020|NCT00002771|Cytarabine|cytarabine|mesh-list
83582021|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
83582022|NCT00002771|Busulfan|busulfan|mesh-list
83582023|NCT00002771|Idarubicin|idarubicin|mesh-list
83582024|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
83582025|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582026|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
83582027|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582028|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582029|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
83582030|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582031|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582032|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
83582033|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582034|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
83582035|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582036|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582037|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582038|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582039|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582040|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582041|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
83582042|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83582043|NCT00002777|Tamoxifen|tamoxifen|mesh-list
83582044|NCT00002777|Exemestane|exemestane|mesh-list
83582045|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582046|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83582047|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
83582048|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582049|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582050|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83582051|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582052|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83582053|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83582054|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83582055|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83582056|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83582057|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582058|NCT00002783|Leucovorin|leucovorin|mesh-list
83582059|NCT00002783|Fluorouracil|fluorouracil|mesh-list
83582060|NCT00002783|Floxuridine|floxuridine|mesh-list
83582061|NCT00002783|Calcium|calcium|mesh-list
83582062|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
83582063|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582064|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83582065|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582066|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
83582067|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582068|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582069|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582070|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
83582071|NCT00002783|Antidotes|antidotes|mesh-ancestor
83582072|NCT00002783|Protective Agents|protective agents|mesh-ancestor
83582073|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
83582074|NCT00002783|Vitamins|vitamins|mesh-ancestor
83582075|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
83582076|NCT00002789|Cyclosporine|cyclosporine|mesh-list
83582077|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
83582078|NCT00002789|Busulfan|busulfan|mesh-list
83582079|NCT00002789|Methotrexate|methotrexate|mesh-list
83582080|NCT00002789|Cyclosporins|cyclosporins|mesh-list
83582081|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582082|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
83582083|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582084|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582085|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582086|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
83582087|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582088|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582089|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582090|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83582091|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
83582092|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83582093|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582094|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
83582095|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
83582096|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582097|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84124602|NCT04374773|Analgesics|analgesics|mesh-ancestor
83582098|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83582099|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
83582100|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582101|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83582102|NCT00381953|Interferons|interferons|mesh-list
83582103|NCT00381953|Ribavirin|ribavirin|mesh-list
83582104|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
83582105|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
83582106|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83582107|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582108|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
83582109|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582110|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
83582111|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582112|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
83582113|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582114|NCT00382343|Trimethoprim|trimethoprim|mesh-list
83582115|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83582116|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
83582117|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83582118|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582119|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
83582120|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83582121|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83582122|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83582123|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582124|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582125|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83582126|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83582127|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83582128|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83582129|NCT05749445|Ritonavir|ritonavir|mesh-list
83582130|NCT05749445|Nirmatrelvir|nirmatrelvir|mesh-list
83582131|NCT05749445|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83582132|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83582133|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83582134|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
83582135|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582136|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582137|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83582138|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83582139|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
83582140|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582141|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83582142|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83582143|NCT05749367|Ropivacaine|ropivacaine|mesh-list
83582144|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83582145|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
83582146|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
83582147|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582148|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582149|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
83582150|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582151|NCT05749289|Octreotide|octreotide|mesh-list
83582152|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83582153|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83582154|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582155|NCT02972957|Azithromycin|azithromycin|mesh-list
83582156|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83582157|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582158|NCT05545319|Ritonavir|ritonavir|mesh-list
83582159|NCT05545319|Nirmatrelvir|nirmatrelvir|mesh-list
83582160|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83582161|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83582162|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
83582163|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582164|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582165|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83582166|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83582167|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
83582168|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582169|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83582170|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83582171|NCT05523869|Topotecan|topotecan|mesh-list
83582172|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83582173|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582174|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582175|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582176|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582178|NCT05522465|Prednisone|prednisone|mesh-list
83582179|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83582180|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
83582181|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
83582182|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582183|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582184|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83582185|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
83582186|NCT05522465|Hormones|hormones|mesh-ancestor
83582187|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582188|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83582189|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582190|NCT05215691|Morphine|morphine|mesh-list
83582191|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83582192|NCT05215691|Narcotics|narcotics|mesh-ancestor
83582193|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582194|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582195|NCT05215691|Analgesics|analgesics|mesh-ancestor
83582196|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
83582197|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582198|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83582199|NCT05204147|Antibodies|antibodies|mesh-list
83582200|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
83582201|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83582202|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83582203|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
83582204|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582205|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582206|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
83582207|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
83582208|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582209|NCT04824053|Selenium|selenium|mesh-list
83582210|NCT04824053|Caseins|caseins|mesh-list
83582211|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
83582212|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582213|NCT04824053|Protective Agents|protective agents|mesh-ancestor
83582214|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582215|NCT04824053|Trace Elements|trace elements|mesh-ancestor
83582216|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
83582217|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
83582218|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
83582219|NCT04811339|Bismuth|bismuth|mesh-list
83582220|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83582221|NCT04811339|Antacids|antacids|mesh-ancestor
83582222|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582223|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83582224|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
83582225|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
83582226|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582227|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582228|NCT05406713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83582229|NCT05406713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582230|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
83582231|NCT04783415|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83582232|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582233|NCT04783415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83582234|NCT04783415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582235|NCT04783415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582236|NCT04331093|Apatinib|apatinib|mesh-list
83582237|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582238|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83582239|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582240|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582241|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
83582242|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83582243|NCT00382421|Aspirin|aspirin|mesh-list
83582244|NCT00382421|Amlodipine|amlodipine|mesh-list
83582245|NCT00382421|Bisoprolol|bisoprolol|mesh-list
83582246|NCT00382421|Molsidomine|molsidomine|mesh-list
83582247|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83040234|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
83582248|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83582249|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83582250|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582251|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83582252|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582253|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
83582254|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83582255|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83582256|NCT00382421|Analgesics|analgesics|mesh-ancestor
83582257|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
83582258|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582259|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83582260|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582261|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83582262|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83582263|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83582264|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83582265|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582266|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
83582267|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
83582268|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
83582269|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83582270|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83582271|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83582272|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
83582273|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582274|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83582275|NCT05343455|Doxycycline|doxycycline|mesh-list
83582276|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83582277|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582278|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
83582279|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83582280|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83582281|NCT05069831|Abrocitinib|abrocitinib|mesh-list
83582282|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83582283|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582284|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582285|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
83582286|NCT05049863|Irinotecan|irinotecan|mesh-list
83582287|NCT05049863|Allopurinol|allopurinol|mesh-list
83582288|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83582289|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582290|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582291|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582292|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582293|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582294|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83582295|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
83582296|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83582297|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582298|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
83582299|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
83582300|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582301|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83582302|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
83582303|NCT05049863|Protective Agents|protective agents|mesh-ancestor
83582304|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582305|NCT05312255|Propranolol|propranolol|mesh-list
83582306|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83582307|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
83582308|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
83582309|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582310|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582311|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582312|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83582313|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83582314|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
83582315|NCT05015621|Leucovorin|leucovorin|mesh-list
83582316|NCT05015621|Fluorouracil|fluorouracil|mesh-list
83582317|NCT05015621|Irinotecan|irinotecan|mesh-list
83582318|NCT05015621|Calcium|calcium|mesh-list
83582319|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
83582320|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83582321|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582322|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
83582323|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582324|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582325|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582326|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582327|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
83582328|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83582329|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582330|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582331|NCT05015621|Antidotes|antidotes|mesh-ancestor
83582332|NCT05015621|Protective Agents|protective agents|mesh-ancestor
83582333|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
83582334|NCT05015621|Vitamins|vitamins|mesh-ancestor
83582335|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
83582336|NCT05007509|Vaccines|vaccines|mesh-list
83582337|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
83582338|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582339|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
83582340|NCT05289167|Bortezomib|bortezomib|mesh-list
83582341|NCT05289167|Abatacept|abatacept|mesh-list
83582342|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582343|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
83582344|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582345|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582346|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582347|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
83582348|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582349|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582350|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582351|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83582352|NCT05289167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582353|NCT00382499|Lidocaine|lidocaine|mesh-list
83582354|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
83582355|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
83582356|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582357|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582358|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
83582359|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582360|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83582361|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83582362|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83582363|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83582364|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582365|NCT04330547|Analgesics|analgesics|mesh-list
83582366|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
83582367|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582368|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582369|NCT00382889|Beclomethasone|beclomethasone|mesh-list
83582370|NCT00382889|Albuterol|albuterol|mesh-list
83582371|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83582372|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
83582373|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582374|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582375|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83582376|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
83582377|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
83582378|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83582379|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83582380|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83582381|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83582382|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
83582383|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582384|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582385|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83582386|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
83582387|NCT00382889|Hormones|hormones|mesh-ancestor
83582388|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582389|NCT04977167|Antibodies|antibodies|mesh-list
83582390|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
83582391|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582392|NCT04482959|Carbetocin|carbetocin|mesh-list
83582393|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
83582394|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83582395|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582396|NCT04581395|Rocuronium|rocuronium|mesh-list
83582397|NCT04581395|Succinylcholine|succinylcholine|mesh-list
83582398|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83040382|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
83582399|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83582400|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83582401|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582402|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582403|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83582404|NCT04571879|Lidocaine|lidocaine|mesh-list
83582405|NCT04571879|Midazolam|midazolam|mesh-list
83582406|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
83582407|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
83582408|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582409|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582410|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
83582411|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582412|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83582413|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83582414|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83582415|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83582416|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582417|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83582418|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83582419|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83582420|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83582421|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83582422|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83582423|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
83582424|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
83582425|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
83582426|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582427|NCT04563533|Vaccines|vaccines|mesh-list
83582428|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
83582429|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582430|NCT05251259|Montelukast|montelukast|mesh-list
83582431|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83582432|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
83582433|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83582434|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
83582435|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582436|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582437|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83582438|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83582439|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582440|NCT04332107|Azithromycin|azithromycin|mesh-list
83582441|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83582442|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582443|NCT04329065|Paclitaxel|paclitaxel|mesh-list
83582444|NCT04329065|Trastuzumab|trastuzumab|mesh-list
83582445|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83582446|NCT04329065|Pertuzumab|pertuzumab|mesh-list
83582447|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83582448|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83582449|NCT04329065|Vaccines|vaccines|mesh-list
83582450|NCT04329065|Antibodies|antibodies|mesh-list
83582451|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
83582452|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83582453|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
83582454|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
83582455|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582456|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582457|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582458|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582459|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582460|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582461|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582462|NCT04328285|Ritonavir|ritonavir|mesh-list
83582463|NCT04328285|Lopinavir|lopinavir|mesh-list
83582464|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
83582465|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83582466|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83582467|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
83582468|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582469|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582470|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83582471|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83582472|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
83582473|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040465|NCT02656797|Amphotericin B|amphotericin b|mesh-list
83582474|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83582475|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83582476|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
83582477|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83582478|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83582479|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582480|NCT04928261|Trastuzumab|trastuzumab|mesh-list
83582481|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582482|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582483|NCT04920539|Dronabinol|dronabinol|mesh-list
83582484|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
83582485|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582486|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83582487|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83582488|NCT04920539|Analgesics|analgesics|mesh-ancestor
83582489|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
83582490|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582491|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83582492|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83582493|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582494|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582495|NCT04920539|Hormones|hormones|mesh-ancestor
83582496|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582497|NCT04882241|Leucovorin|leucovorin|mesh-list
83582498|NCT04882241|Docetaxel|docetaxel|mesh-list
83582499|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
83582500|NCT04882241|Fluorouracil|fluorouracil|mesh-list
83582501|NCT04882241|Capecitabine|capecitabine|mesh-list
83582502|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
83582503|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582504|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582505|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582506|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582507|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582508|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582509|NCT04882241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83582510|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
83582511|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582512|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582513|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
83582514|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582515|NCT04882241|Antidotes|antidotes|mesh-ancestor
83582516|NCT04882241|Protective Agents|protective agents|mesh-ancestor
83582517|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
83582518|NCT04882241|Vitamins|vitamins|mesh-ancestor
83582519|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
83582520|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83582521|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
83582522|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582523|NCT03575195|Rifaximin|rifaximin|mesh-list
83582524|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83582525|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582526|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83582527|NCT00002897|Fluorouracil|fluorouracil|mesh-list
83582528|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582529|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
83582530|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582531|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582532|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582533|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
83582534|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582535|NCT00002903|Docetaxel|docetaxel|mesh-list
83582536|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582537|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582538|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582539|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582540|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582541|NCT03375203|Zolpidem|zolpidem|mesh-list
83582542|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83582543|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83582544|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582545|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582546|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83582547|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
83582548|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
83040533|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
83582549|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582550|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582551|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83582552|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582553|NCT00002915|Penclomedine|penclomedine|mesh-list
83582554|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582556|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
83582557|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83582558|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83582559|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83582560|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83582561|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
83582562|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
83582563|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83582564|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582565|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582566|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83582567|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83582568|NCT00383045|Naltrexone|naltrexone|mesh-list
83582569|NCT00383045|Buprenorphine|buprenorphine|mesh-list
83582570|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83582571|NCT00383045|Narcotics|narcotics|mesh-ancestor
83582572|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582573|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582574|NCT00383045|Analgesics|analgesics|mesh-ancestor
83582575|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
83582576|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582577|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83582578|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83582579|NCT00383591|Vaccines|vaccines|mesh-list
83582580|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
83582581|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582582|NCT00002933|Irinotecan|irinotecan|mesh-list
83582583|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83582584|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582585|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582586|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582587|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582588|NCT00002939|Paclitaxel|paclitaxel|mesh-list
83582589|NCT00002939|Irinotecan|irinotecan|mesh-list
83582590|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582591|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582592|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582593|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582594|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582595|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582596|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83582597|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582598|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582599|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
83582600|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582601|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582602|NCT04009967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83582603|NCT04009967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582604|NCT03085823|Sirolimus|sirolimus|mesh-list
83582605|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83582606|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582607|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582608|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582609|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
83582610|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582611|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
83582612|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582613|NCT00002945|Cytarabine|cytarabine|mesh-list
83582614|NCT00002945|Aldesleukin|aldesleukin|mesh-list
83582615|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
83582616|NCT00002945|Melphalan|melphalan|mesh-list
83582617|NCT00002945|Etoposide|etoposide|mesh-list
83582618|NCT00002945|Idarubicin|idarubicin|mesh-list
83582619|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582620|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
83582621|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582622|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582623|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582624|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
83582625|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582626|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582627|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582628|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582629|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582630|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582631|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582632|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582633|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
83582634|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
83582635|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582636|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83582637|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83582638|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582639|NCT00002951|Fluorouracil|fluorouracil|mesh-list
83582640|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
83582641|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
83582642|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582643|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582644|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582645|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582646|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
83582647|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582648|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
83582649|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582650|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83582651|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
83582653|NCT03058289|Antibodies|antibodies|mesh-list
83582654|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
83582655|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
83582656|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582657|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582658|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582659|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83582660|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582661|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83582662|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83582663|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
83582664|NCT00002969|Paclitaxel|paclitaxel|mesh-list
83582665|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582666|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582667|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582668|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582669|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582670|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582671|NCT00002987|Prednisolone|prednisolone|mesh-list
83582672|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
83582673|NCT00002987|Doxorubicin|doxorubicin|mesh-list
83582674|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83582675|NCT00002987|Etoposide|etoposide|mesh-list
83582676|NCT00002987|Vincristine|vincristine|mesh-list
83582677|NCT00002987|Bleomycin|bleomycin|mesh-list
83582678|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582679|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
83582680|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582681|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582682|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582683|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
83582684|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582685|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582686|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582687|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582688|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582689|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582690|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582691|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582692|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582693|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582694|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582695|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83582696|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
83582697|NCT00002987|Hormones|hormones|mesh-ancestor
83582698|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582699|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83582700|NCT02919683|Nivolumab|nivolumab|mesh-list
83582701|NCT02919683|Ipilimumab|ipilimumab|mesh-list
83582702|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582703|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582704|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83582705|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582706|NCT03933293|Ezetimibe|ezetimibe|mesh-list
83582707|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83582708|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83582709|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
83582710|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582711|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83582712|NCT00002993|Doxorubicin|doxorubicin|mesh-list
83582713|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83582714|NCT00002993|Mitomycins|mitomycins|mesh-list
83582715|NCT00002993|Mitomycin|mitomycin|mesh-list
83582716|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582717|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582718|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582719|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582720|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582721|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582722|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
83582723|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83582724|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83582725|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83582726|NCT01928082|Estradiol|estradiol|mesh-list
83582727|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83582728|NCT01928082|Estrogens|estrogens|mesh-ancestor
83582729|NCT01928082|Hormones|hormones|mesh-ancestor
83582730|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582731|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582732|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83582733|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
83582734|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83582735|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83582736|NCT00002999|Fluorouracil|fluorouracil|mesh-list
83582737|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582738|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
83582739|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582740|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582741|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582742|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
83582743|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582744|NCT00003005|Cordycepin|cordycepin|mesh-list
83582745|NCT00003005|Pentostatin|pentostatin|mesh-list
83582746|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582747|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83582748|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582749|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582750|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
83582751|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582752|NCT03905603|Cosyntropin|cosyntropin|mesh-list
83582753|NCT03905603|Hormones|hormones|mesh-ancestor
83582754|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582755|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582756|NCT00003011|Marimastat|marimastat|mesh-list
83582757|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582758|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582759|NCT00003017|Interleukin-12|interleukin-12|mesh-list
83582760|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83582761|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
83582762|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582763|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83582764|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83582765|NCT00003017|Growth Substances|growth substances|mesh-ancestor
83582766|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
83582767|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582768|NCT00003023|Vaccines|vaccines|mesh-list
83582769|NCT00003023|Antibodies|antibodies|mesh-list
83582770|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83582771|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
83582772|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
83582773|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582774|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83582775|NCT03850067|Carboplatin|carboplatin|mesh-list
83582776|NCT03850067|Nivolumab|nivolumab|mesh-list
83582777|NCT03850067|Etoposide|etoposide|mesh-list
83582779|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582780|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582781|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83582782|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582783|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582784|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582785|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582786|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582787|NCT00003029|Fluorouracil|fluorouracil|mesh-list
83582788|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582789|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
83582790|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582791|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582792|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582793|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
83582794|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582795|NCT00003035|Tamoxifen|tamoxifen|mesh-list
83582796|NCT00003035|Paclitaxel|paclitaxel|mesh-list
83582797|NCT00003035|Doxorubicin|doxorubicin|mesh-list
83582798|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83582799|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582800|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582801|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582802|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582803|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582804|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582805|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582806|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582807|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582808|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582809|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582810|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83582811|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
83582812|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582813|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83582814|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83582815|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83582816|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83582817|NCT00003041|NSC 366140|nsc 366140|mesh-list
83582818|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582819|NCT00003053|Etoposide|etoposide|mesh-list
83582820|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582821|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582822|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582823|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582824|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582825|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582826|NCT00003065|Paclitaxel|paclitaxel|mesh-list
83582827|NCT00003065|Topotecan|topotecan|mesh-list
83582828|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582829|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582830|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582831|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582832|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582833|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582834|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83582835|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582836|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582837|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
83582838|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
83582839|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83582840|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83582841|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582842|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582843|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582844|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582845|NCT00383357|Zolpidem|zolpidem|mesh-list
83582846|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83582847|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83582848|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582849|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040852|NCT03656679|Iodine|iodine|mesh-list
83582850|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83582851|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
83582852|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
83582853|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83582854|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582855|NCT00003089|Paclitaxel|paclitaxel|mesh-list
83582856|NCT00003089|Carboplatin|carboplatin|mesh-list
83582857|NCT00003089|Amifostine|amifostine|mesh-list
83582858|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582859|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582860|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582861|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582862|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582863|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582864|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83582865|NCT00003089|Protective Agents|protective agents|mesh-ancestor
83582866|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582867|NCT03713801|Metformin|metformin|mesh-list
83582868|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83582869|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582870|NCT00003101|Vincristine|vincristine|mesh-list
83582871|NCT00003101|Busulfan|busulfan|mesh-list
83582872|NCT00003101|Thiotepa|thiotepa|mesh-list
83582873|NCT00003101|Lomustine|lomustine|mesh-list
83582874|NCT00003101|Procarbazine|procarbazine|mesh-list
83582875|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
83582876|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582877|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582878|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582879|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582880|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582881|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582882|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582883|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
83582884|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582885|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582886|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582887|NCT03690869|Cemiplimab|cemiplimab|mesh-list
83582888|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83582889|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582890|NCT00003107|Interleukin-12|interleukin-12|mesh-list
83582891|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83582892|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
83582893|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582894|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83582895|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83582896|NCT00003107|Growth Substances|growth substances|mesh-ancestor
83582897|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
83582898|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582899|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
83582900|NCT00003113|Lomustine|lomustine|mesh-list
83582901|NCT00003113|Etoposide|etoposide|mesh-list
83582902|NCT00003113|Procarbazine|procarbazine|mesh-list
83582903|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582904|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
83582905|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582906|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582907|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582908|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
83582909|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582910|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582911|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582912|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582913|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582914|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582915|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582916|NCT01545557|Lidocaine|lidocaine|mesh-list
83582917|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
83582918|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
83582919|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
83582920|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83582921|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582922|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
83040923|NCT02105610|Desflurane|desflurane|mesh-list
83582923|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582924|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83582925|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83582926|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83582927|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83582928|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582929|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83582930|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
83582931|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
83582932|NCT01545557|Protective Agents|protective agents|mesh-ancestor
83582933|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
83582934|NCT00003119|Carboplatin|carboplatin|mesh-list
83582935|NCT00003119|Doxorubicin|doxorubicin|mesh-list
83582936|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83582937|NCT00003119|Etoposide|etoposide|mesh-list
83582938|NCT00003119|Sargramostim|sargramostim|mesh-list
83582939|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582940|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
83582941|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582942|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582943|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582944|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
83582945|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582946|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582947|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582948|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83582949|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582950|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582951|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582952|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582953|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
83582954|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582955|NCT00003401|Dexamethasone|dexamethasone|mesh-list
83582956|NCT00003401|Paclitaxel|paclitaxel|mesh-list
83582957|NCT00003401|Etoposide|etoposide|mesh-list
83582958|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
83582959|NCT00003401|Gemcitabine|gemcitabine|mesh-list
83582960|NCT00003401|Melphalan|melphalan|mesh-list
83582961|NCT00003401|Carmustine|carmustine|mesh-list
83582962|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83582963|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582964|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
83582965|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
83582966|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
83582967|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83582968|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83582969|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
83582970|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582971|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83582972|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83582973|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
83582974|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83582975|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83582976|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
83582977|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
83582978|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83582979|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83582980|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
83582981|NCT00003401|Hormones|hormones|mesh-ancestor
83582982|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83582983|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83582984|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83582985|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
83582986|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83582987|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83582988|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83582989|NCT00003125|Aldesleukin|aldesleukin|mesh-list
83582990|NCT00003125|Vaccines|vaccines|mesh-list
83582991|NCT00003125|Sargramostim|sargramostim|mesh-list
83582992|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
83582993|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83582994|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83582995|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83582996|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83582997|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
83582998|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83582999|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
83583000|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83583001|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583002|NCT00003131|Immunotoxins|immunotoxins|mesh-ancestor
83583003|NCT00003131|Immunoconjugates|immunoconjugates|mesh-ancestor
83583004|NCT00003131|Immunologic Factors|immunologic factors|mesh-ancestor
83583005|NCT00003131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583006|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
83583007|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83583008|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83583009|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83583010|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83583011|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583012|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
83583013|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83583014|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583015|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83583016|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83583017|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
83583018|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83583019|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583020|NCT00003413|Paclitaxel|paclitaxel|mesh-list
83583021|NCT00003413|Melphalan|melphalan|mesh-list
83583022|NCT00003413|Carmustine|carmustine|mesh-list
83583023|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583024|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583025|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583026|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583027|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583028|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583029|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
83583030|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583031|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583032|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
83583033|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583034|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583035|NCT00003137|Irinotecan|irinotecan|mesh-list
83583036|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83583037|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583038|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583039|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583040|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583041|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
83583042|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583043|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
83583044|NCT00003425|Melphalan|melphalan|mesh-list
83583045|NCT00003425|Amifostine|amifostine|mesh-list
83583046|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583047|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
83583048|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583049|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583050|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583051|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
83583052|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583053|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583054|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583055|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83583056|NCT00003425|Protective Agents|protective agents|mesh-ancestor
83583057|NCT00330551|Risperidone|risperidone|mesh-list
83583058|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83583059|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
83583060|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83583061|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583062|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583063|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83583064|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83583065|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83583066|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83583067|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83583068|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
83583069|NCT00001259|Leuprolide|leuprolide|mesh-list
83583070|NCT00001259|Estradiol|estradiol|mesh-list
83583071|NCT00001259|Progesterone|progesterone|mesh-list
83583072|NCT00001259|Estrogens|estrogens|mesh-ancestor
83583073|NCT00001259|Hormones|hormones|mesh-ancestor
83583074|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583075|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583076|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583077|NCT00001259|Progestins|progestins|mesh-ancestor
83583078|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83583079|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
83583080|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583081|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583082|NCT00003143|Amifostine|amifostine|mesh-list
83583083|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83583084|NCT00003143|Protective Agents|protective agents|mesh-ancestor
83583085|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583086|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
83583087|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83583088|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
83583089|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583090|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83583091|NCT00003431|Protective Agents|protective agents|mesh-ancestor
83583092|NCT00003149|Interleukin-12|interleukin-12|mesh-list
83583093|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83583094|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
83583095|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583096|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83583097|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83583098|NCT00003149|Growth Substances|growth substances|mesh-ancestor
83583099|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
83583100|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583101|NCT00003437|Cytarabine|cytarabine|mesh-list
83583102|NCT00003437|Dexamethasone|dexamethasone|mesh-list
83583103|NCT00003437|Prednisolone|prednisolone|mesh-list
83583104|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
83583105|NCT00003437|Doxorubicin|doxorubicin|mesh-list
83583106|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83583107|NCT00003437|Methotrexate|methotrexate|mesh-list
83583108|NCT00003437|Vincristine|vincristine|mesh-list
83583109|NCT00003437|Daunorubicin|daunorubicin|mesh-list
83583110|NCT00003437|Asparaginase|asparaginase|mesh-list
83583111|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
83583112|NCT00003437|Pegaspargase|pegaspargase|mesh-list
83583113|NCT00003437|Thioguanine|thioguanine|mesh-list
83583114|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583115|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
83583116|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583117|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583118|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583119|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
83583120|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583121|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583122|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583123|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583124|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
83583125|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
83583126|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83583127|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83583128|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
83583129|NCT00003437|Hormones|hormones|mesh-ancestor
83583130|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583131|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583132|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583133|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583134|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583135|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583136|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83583137|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
83583138|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583139|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583140|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
83583141|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583142|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83583143|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83583144|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
83583145|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583146|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583147|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583148|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583149|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583150|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
83583151|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83583152|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
83583153|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583154|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583155|NCT00003449|Dexamethasone|dexamethasone|mesh-list
83583156|NCT00003449|Paclitaxel|paclitaxel|mesh-list
83583157|NCT00003449|Gemcitabine|gemcitabine|mesh-list
83583158|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583159|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583160|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583161|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583162|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583163|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583164|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583165|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
83583166|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
83583167|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83583168|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583169|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83583170|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
83583171|NCT00003449|Hormones|hormones|mesh-ancestor
83583172|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583173|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583174|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583175|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
83583176|NCT00002801|Leucovorin|leucovorin|mesh-list
83583177|NCT00002801|Tegafur|tegafur|mesh-list
83583178|NCT00002801|Calcium|calcium|mesh-list
83583179|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
83583180|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83583181|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583182|NCT00002801|Antidotes|antidotes|mesh-ancestor
83583183|NCT00002801|Protective Agents|protective agents|mesh-ancestor
83583184|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
83583185|NCT00002801|Vitamins|vitamins|mesh-ancestor
83583186|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
83583187|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583188|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
83583189|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583190|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583191|NCT00002813|Vinorelbine|vinorelbine|mesh-list
83583192|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583193|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583194|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583195|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583196|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583197|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583198|NCT00002819|Paclitaxel|paclitaxel|mesh-list
83583199|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
83583200|NCT00002819|Carboplatin|carboplatin|mesh-list
83583201|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
83583202|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583203|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583204|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583205|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583206|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583207|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583208|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583209|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
83583210|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583211|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583212|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583213|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
83583214|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583215|NCT00002819|Analgesics|analgesics|mesh-ancestor
83583216|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
83583217|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83583218|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583219|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583220|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583221|NCT00002825|Docetaxel|docetaxel|mesh-list
83583222|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583223|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583224|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583225|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583226|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583227|NCT00002831|Cyclosporine|cyclosporine|mesh-list
83583228|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
83583229|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83583230|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83583231|NCT00002831|Prednisolone|prednisolone|mesh-list
83583232|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
83583233|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
83583234|NCT00002831|Busulfan|busulfan|mesh-list
83583236|NCT00002831|Decitabine|decitabine|mesh-list
83583237|NCT00002831|Tacrolimus|tacrolimus|mesh-list
83583238|NCT00002831|Cyclosporins|cyclosporins|mesh-list
83583239|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83583240|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
83583241|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583242|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
83583243|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583244|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583245|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583246|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
83583247|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583248|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583249|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583250|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83583251|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
83583252|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583253|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583254|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
83583255|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583256|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583257|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83583258|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83583259|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83583260|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
83583261|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583262|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583263|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
83583264|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
83583265|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83583266|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83583267|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
83583268|NCT00002831|Hormones|hormones|mesh-ancestor
83583269|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583270|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83583271|NCT00002831|Protective Agents|protective agents|mesh-ancestor
83583272|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583273|NCT00002837|Paclitaxel|paclitaxel|mesh-list
83583274|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
83583275|NCT00002837|Doxorubicin|doxorubicin|mesh-list
83583276|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83583277|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583278|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583279|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583280|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583281|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583282|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583283|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583284|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
83583285|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583286|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583287|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583288|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
83583289|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583290|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583291|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583292|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583293|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583294|NCT00003461|Antibodies|antibodies|mesh-list
83583295|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83583296|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
83583297|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583298|NCT00003467|Carmustine|carmustine|mesh-list
83583299|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583300|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
83583301|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583302|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583303|NCT00002849|Interferons|interferons|mesh-list
83583304|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
83583305|NCT00002849|Dexamethasone|dexamethasone|mesh-list
83583306|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583307|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
83583308|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
83583309|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041279|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83583310|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583311|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83583312|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
83583313|NCT00002849|Hormones|hormones|mesh-ancestor
83583314|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583315|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583316|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583317|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
83583318|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583319|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
83583320|NCT00002855|Ketoconazole|ketoconazole|mesh-list
83583321|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
83583322|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83583323|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83583324|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83583325|NCT00002855|Doxorubicin|doxorubicin|mesh-list
83583326|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83583327|NCT00002855|Bicalutamide|bicalutamide|mesh-list
83583328|NCT00002855|Vinblastine|vinblastine|mesh-list
83583329|NCT00002855|Flutamide|flutamide|mesh-list
83583330|NCT00002855|Estramustine|estramustine|mesh-list
83583331|NCT00002855|Nilutamide|nilutamide|mesh-list
83583332|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583333|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583334|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583335|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583336|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583337|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583338|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583339|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
83583340|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583341|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83583342|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83583343|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83583344|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
83583345|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583346|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583347|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83583348|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
83583349|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583350|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583351|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583352|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583353|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583354|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583355|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
83583356|NCT00003173|Thiotepa|thiotepa|mesh-list
83583357|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
83583358|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583359|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583360|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
83583361|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583362|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583363|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583364|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583365|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83583366|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
83583367|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83583368|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83583369|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83583370|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
83583371|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583372|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583373|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83583374|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83583375|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83583376|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583377|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583378|NCT00002879|Cladribine|cladribine|mesh-list
83583379|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583380|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583381|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
83583382|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583383|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
83583384|NCT00003185|Sargramostim|sargramostim|mesh-list
83583385|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583386|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
83583387|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583388|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583389|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583390|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
83583391|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583392|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583393|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583394|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
83583395|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583396|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583397|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583398|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583399|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583400|NCT00003935|Etoposide|etoposide|mesh-list
83583401|NCT00003935|Vincristine|vincristine|mesh-list
83583402|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583403|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583404|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583405|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583406|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583407|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583408|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583409|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583410|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583411|NCT00003191|Fenretinide|fenretinide|mesh-list
83583412|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583413|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83583414|NCT00003191|Protective Agents|protective agents|mesh-ancestor
83583415|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583416|NCT00003941|Etoposide|etoposide|mesh-list
83583417|NCT00003941|Ifosfamide|ifosfamide|mesh-list
83583418|NCT00003941|Bleomycin|bleomycin|mesh-list
83583419|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583420|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583421|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583422|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583423|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583424|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583425|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583426|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
83583427|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583428|NCT00384527|Vancomycin|vancomycin|mesh-list
83583429|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
83583430|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83583431|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583432|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83583433|NCT00003569|Paclitaxel|paclitaxel|mesh-list
83583434|NCT00003569|Cisplatin|cisplatin|mesh-list
83583435|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583436|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583437|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583438|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583439|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583440|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583441|NCT00003953|Tamoxifen|tamoxifen|mesh-list
83583442|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
83583443|NCT00003953|Docetaxel|docetaxel|mesh-list
83583444|NCT00003953|Doxorubicin|doxorubicin|mesh-list
83583445|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83583446|NCT00003953|Fluorouracil|fluorouracil|mesh-list
83583447|NCT00003953|Methotrexate|methotrexate|mesh-list
83583448|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583449|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
83583450|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583451|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583452|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583453|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
83583454|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583455|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583456|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583457|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583458|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041440|NCT04221555|Docetaxel|docetaxel|mesh-list
83583459|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583460|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583461|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583462|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583463|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583464|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
83583465|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583466|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83583467|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
83583468|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583469|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583470|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83583471|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83583472|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83583473|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
83583474|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583475|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583476|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83583477|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83583478|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83583479|NCT00003959|Sargramostim|sargramostim|mesh-list
83583480|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
83583481|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583482|NCT02972723|Metformin|metformin|mesh-list
83583483|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83583484|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583485|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
83583486|NCT00003203|Cisplatin|cisplatin|mesh-list
83583487|NCT00003203|Carboplatin|carboplatin|mesh-list
83583488|NCT00003203|Vincristine|vincristine|mesh-list
83583489|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583490|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
83583491|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583492|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583493|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583494|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
83583495|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583496|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583497|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583498|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583499|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583500|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583501|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583502|NCT00003575|Etoposide|etoposide|mesh-list
83583503|NCT00003575|Ifosfamide|ifosfamide|mesh-list
83583504|NCT00003575|Interleukin-12|interleukin-12|mesh-list
83583505|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583506|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583507|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583508|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583509|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583510|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583511|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83583512|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
83583513|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583514|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583515|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
83583516|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83583517|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83583518|NCT00003575|Growth Substances|growth substances|mesh-ancestor
83583519|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
83583520|NCT00003539|Paclitaxel|paclitaxel|mesh-list
83583521|NCT00003539|Trastuzumab|trastuzumab|mesh-list
83583522|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583523|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583524|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583525|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583526|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
83684418|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83583527|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583528|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83583529|NCT00003209|Fluorouracil|fluorouracil|mesh-list
83583530|NCT00003209|Methotrexate|methotrexate|mesh-list
83583531|NCT00003209|Ifosfamide|ifosfamide|mesh-list
83583532|NCT00003209|Mitomycins|mitomycins|mesh-list
83583533|NCT00003209|Mitomycin|mitomycin|mesh-list
83583534|NCT00003209|Bleomycin|bleomycin|mesh-list
83583535|NCT00003209|Vinblastine|vinblastine|mesh-list
83583536|NCT00003209|Vindesine|vindesine|mesh-list
83583537|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583538|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
83583539|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583540|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583541|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583542|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
83583543|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583544|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83583545|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
83583546|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583547|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583548|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583549|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83583550|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583551|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83583552|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583553|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
83583554|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583555|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583556|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583557|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583558|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583559|NCT00003587|Paclitaxel|paclitaxel|mesh-list
83583560|NCT00003587|Vinorelbine|vinorelbine|mesh-list
83583561|NCT00003587|Docetaxel|docetaxel|mesh-list
83583562|NCT00003587|Carboplatin|carboplatin|mesh-list
83583563|NCT00003587|Gemcitabine|gemcitabine|mesh-list
83583564|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583565|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583566|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583567|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583568|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583569|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583570|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583571|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
83583572|NCT00003215|Leucovorin|leucovorin|mesh-list
83583573|NCT00003215|Cytarabine|cytarabine|mesh-list
83583574|NCT00003215|Prednisone|prednisone|mesh-list
83583575|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
83583576|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
83583577|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83583578|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83583579|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83583580|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
83583581|NCT00003215|Melphalan|melphalan|mesh-list
83583582|NCT00003215|Doxorubicin|doxorubicin|mesh-list
83583583|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83583584|NCT00003215|Methotrexate|methotrexate|mesh-list
83583585|NCT00003215|Etoposide|etoposide|mesh-list
83583586|NCT00003215|Vincristine|vincristine|mesh-list
83583587|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
83583588|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
83583589|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583590|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
83583591|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583592|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583593|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583594|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
83583595|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583596|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583597|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583598|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583599|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583600|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583601|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583602|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583603|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
83583604|NCT00003215|Hormones|hormones|mesh-ancestor
83583605|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583606|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583607|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83583608|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
83583609|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583610|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583611|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
83041579|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583612|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583613|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83583614|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83583615|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583616|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
83583617|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583618|NCT00003215|Antidotes|antidotes|mesh-ancestor
83583619|NCT00003215|Protective Agents|protective agents|mesh-ancestor
83583620|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
83583621|NCT00003215|Vitamins|vitamins|mesh-ancestor
83583622|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
83583623|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583624|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583625|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583626|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
83583627|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
83583628|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83583629|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83583630|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83583631|NCT00003215|Analgesics|analgesics|mesh-ancestor
83583632|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
83583633|NCT00003995|Trastuzumab|trastuzumab|mesh-list
83583634|NCT00003995|Irinotecan|irinotecan|mesh-list
83583635|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83583636|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583637|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83583638|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583639|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583640|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583641|NCT00003593|Cytarabine|cytarabine|mesh-list
83583642|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
83583643|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83583644|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83583645|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83583646|NCT00003593|Methotrexate|methotrexate|mesh-list
83583647|NCT00003593|Thioguanine|thioguanine|mesh-list
83583648|NCT00003593|Daunorubicin|daunorubicin|mesh-list
83583649|NCT00003593|Asparaginase|asparaginase|mesh-list
83583650|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83583651|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
83583652|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83583653|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583654|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583655|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
83583656|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583657|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583658|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583659|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583660|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83583661|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583662|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
83583663|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583664|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83583665|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
83583666|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583667|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583668|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583669|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583670|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583671|NCT00003599|Vitamin E|vitamin e|mesh-list
83583672|NCT00003599|Tocopherols|tocopherols|mesh-list
83583673|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
83583674|NCT00003599|Isotretinoin|isotretinoin|mesh-list
83583675|NCT00003599|Vitamins|vitamins|mesh-ancestor
83583676|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
83583677|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583678|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
83583679|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583680|NCT00003599|Protective Agents|protective agents|mesh-ancestor
83583681|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583682|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
83583683|NCT00003605|Rituximab|rituximab|mesh-list
83583684|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583685|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
83041656|NCT02116842|Narcotics|narcotics|mesh-ancestor
83583686|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583687|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583688|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583689|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
83583690|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583691|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583692|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583693|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83583694|NCT00003611|Acitretin|acitretin|mesh-list
83583695|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
83583696|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83583697|NCT00003617|Clarithromycin|clarithromycin|mesh-list
83583698|NCT00003617|Tinidazole|tinidazole|mesh-list
83583699|NCT00003617|Chlorambucil|chlorambucil|mesh-list
83583700|NCT00003617|Omeprazole|omeprazole|mesh-list
83583701|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83583702|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83583703|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83583704|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583705|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583706|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83583707|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583708|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83583709|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83583710|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83583711|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583712|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
83583713|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583714|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83583715|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83583716|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83583717|NCT00004001|Prednisone|prednisone|mesh-list
83583718|NCT00004001|Docetaxel|docetaxel|mesh-list
83583719|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
83583720|NCT00004001|Estramustine|estramustine|mesh-list
83583721|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583722|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583723|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583724|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583725|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583726|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83583727|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
83583728|NCT00004001|Hormones|hormones|mesh-ancestor
83583729|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83583730|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583731|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83583732|NCT00004001|Analgesics|analgesics|mesh-ancestor
83583733|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
83583734|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83583735|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583736|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583737|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583738|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583739|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
83583740|NCT00004013|Paclitaxel|paclitaxel|mesh-list
83583741|NCT00004013|Trastuzumab|trastuzumab|mesh-list
83583742|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583743|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583744|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583745|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583746|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583747|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583748|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83583749|NCT00004025|Aldesleukin|aldesleukin|mesh-list
83583750|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583751|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83583752|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83583753|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
83583754|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583755|NCT00004037|Docetaxel|docetaxel|mesh-list
83583756|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583757|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583758|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583759|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583760|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583761|NCT00004043|Calcitriol|calcitriol|mesh-list
83583762|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83041735|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83583763|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583764|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83583765|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83583766|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583767|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83583768|NCT00004043|Vitamins|vitamins|mesh-ancestor
83583769|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
83583770|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83583771|NCT00004055|Paclitaxel|paclitaxel|mesh-list
83583772|NCT00004055|Topotecan|topotecan|mesh-list
83583773|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583774|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583775|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583776|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583777|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583778|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583779|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83583780|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583781|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583782|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
83583783|NCT00004061|Ifosfamide|ifosfamide|mesh-list
83583784|NCT00004061|Etoposide|etoposide|mesh-list
83583785|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583786|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
83583787|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583788|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583789|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583790|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
83583791|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583792|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583793|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583794|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583795|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583796|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583797|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583798|NCT00004067|Paclitaxel|paclitaxel|mesh-list
83583799|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
83583800|NCT00004067|Doxorubicin|doxorubicin|mesh-list
83583801|NCT00004067|Trastuzumab|trastuzumab|mesh-list
83583802|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83583803|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583804|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583805|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583806|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583807|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583808|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583809|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583810|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
83583811|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583812|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583813|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583814|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
83583815|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583816|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583817|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583818|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583819|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583820|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83583821|NCT00004073|Suramin|suramin|mesh-list
83583822|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
83583823|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
83583824|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83583825|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583826|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583827|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83583828|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83583829|NCT00004085|Antibodies|antibodies|mesh-list
83583830|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83583831|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
83583832|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583833|NCT00004091|Antibodies|antibodies|mesh-list
83583834|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
83041808|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
83583835|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583836|NCT00004097|Paclitaxel|paclitaxel|mesh-list
83583837|NCT00004097|Gemcitabine|gemcitabine|mesh-list
83583838|NCT00004097|Fluorouracil|fluorouracil|mesh-list
83583839|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583840|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583841|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583842|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583843|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583844|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583845|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583846|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
83583847|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583848|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
83583849|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583850|NCT00004103|Irinotecan|irinotecan|mesh-list
83583851|NCT00004103|Floxuridine|floxuridine|mesh-list
83583852|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583853|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83583854|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583855|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583856|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583857|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583858|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
83583859|NCT00004109|Doxorubicin|doxorubicin|mesh-list
83583860|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83583861|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83583862|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583863|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583864|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583865|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583866|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583867|NCT00003239|Interferons|interferons|mesh-list
83583868|NCT00003239|Cytarabine|cytarabine|mesh-list
83583869|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
83583870|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
83583871|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
83583872|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583873|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
83583874|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583875|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583876|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
83583877|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583878|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583879|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
83583880|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583881|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583882|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83583883|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583884|NCT00004115|Antibodies|antibodies|mesh-list
83583885|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83583886|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
83583887|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583888|NCT00003245|Irinotecan|irinotecan|mesh-list
83583889|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83583890|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583891|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583892|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583893|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583894|NCT00004127|Leucovorin|leucovorin|mesh-list
83583895|NCT00004127|Fluorouracil|fluorouracil|mesh-list
83583896|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
83583897|NCT00004127|Calcium|calcium|mesh-list
83583898|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
83583899|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83583900|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583901|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
83583902|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583903|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583904|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583905|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583906|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
83583907|NCT00004127|Antidotes|antidotes|mesh-ancestor
83583908|NCT00004127|Protective Agents|protective agents|mesh-ancestor
83583909|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
83583910|NCT00004127|Vitamins|vitamins|mesh-ancestor
83583911|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
83583912|NCT00003251|Paclitaxel|paclitaxel|mesh-list
83583913|NCT00003251|Amifostine|amifostine|mesh-list
83583914|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583915|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583916|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583917|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583918|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583919|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583920|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83583921|NCT00003251|Protective Agents|protective agents|mesh-ancestor
83583922|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583923|NCT00004139|Gemcitabine|gemcitabine|mesh-list
83583924|NCT00004139|Docetaxel|docetaxel|mesh-list
83583925|NCT00004139|Irinotecan|irinotecan|mesh-list
83583926|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583927|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
83583928|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583929|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583930|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583931|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583932|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583933|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83583934|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583935|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583936|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
83583937|NCT00004145|Fludarabine|fludarabine|mesh-list
83583938|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
83583939|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83583940|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583941|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
83583942|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583943|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583944|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583945|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
83583946|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583947|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583948|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583949|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83583950|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
83583951|NCT00003263|Interferons|interferons|mesh-list
83583952|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
83583953|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583954|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
83583955|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83583956|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
83583957|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583958|NCT00004157|Oprelvekin|oprelvekin|mesh-list
83583959|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583960|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
83583961|NCT00003269|Etoposide|etoposide|mesh-list
83583962|NCT00003269|Sargramostim|sargramostim|mesh-list
83583963|NCT00003269|Amifostine|amifostine|mesh-list
83583964|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83583965|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
83583966|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83583967|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83583968|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83583969|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
83583970|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583971|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583972|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83583973|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583974|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83583975|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583976|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583977|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83583978|NCT00003269|Protective Agents|protective agents|mesh-ancestor
83583979|NCT00004163|Trastuzumab|trastuzumab|mesh-list
83583980|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83583981|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583982|NCT00003281|Paclitaxel|paclitaxel|mesh-list
83583983|NCT00003281|Topotecan|topotecan|mesh-list
83583984|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83583985|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83583986|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83583987|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83583988|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83583989|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83583990|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83583991|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83583992|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83583993|NCT00003287|Leucovorin|leucovorin|mesh-list
83583994|NCT00003287|Fluorouracil|fluorouracil|mesh-list
83583995|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
83583997|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
83583998|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83583999|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584000|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
83584001|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584002|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584003|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584004|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584005|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
83584006|NCT00003287|Antidotes|antidotes|mesh-ancestor
83584007|NCT00003287|Protective Agents|protective agents|mesh-ancestor
83584008|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
83584009|NCT00003287|Vitamins|vitamins|mesh-ancestor
83584010|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
83584011|NCT00004187|Capecitabine|capecitabine|mesh-list
83584012|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
83584013|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584014|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
83584015|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584016|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584017|NCT00384137|Tacrolimus|tacrolimus|mesh-list
83584018|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584019|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
83584020|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584021|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83584022|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584023|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584024|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
83584025|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83584026|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584027|NCT00003293|Procarbazine|procarbazine|mesh-list
83584028|NCT00003293|Leflunomide|leflunomide|mesh-list
83584029|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584030|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584031|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584032|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
83584033|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584034|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584035|NCT00004199|Gemcitabine|gemcitabine|mesh-list
83584036|NCT00004199|Prinomastat|prinomastat|mesh-list
83584037|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584038|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584039|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
83584040|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584041|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
83584042|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
83584043|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584044|NCT00003299|Paclitaxel|paclitaxel|mesh-list
83584045|NCT00003299|Etoposide|etoposide|mesh-list
83584046|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584047|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584048|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584049|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584050|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584051|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584052|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83584053|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584054|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584055|NCT00004205|Tamoxifen|tamoxifen|mesh-list
83584056|NCT00004205|Letrozole|letrozole|mesh-list
83584057|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584058|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584059|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83584060|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83584061|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584062|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83584063|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
83584064|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584065|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584066|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584067|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83584068|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83584069|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83584070|NCT00003305|Leucovorin|leucovorin|mesh-list
83584071|NCT00003305|Calcium|calcium|mesh-list
83584072|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
83584073|NCT00003305|Aminopterin|aminopterin|mesh-list
83584074|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83584075|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584076|NCT00003305|Antidotes|antidotes|mesh-ancestor
83584077|NCT00003305|Protective Agents|protective agents|mesh-ancestor
83584078|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
83584079|NCT00003305|Vitamins|vitamins|mesh-ancestor
83584080|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
83584081|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83584082|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584083|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584084|NCT00003311|Cytarabine|cytarabine|mesh-list
83584085|NCT00003311|Dexamethasone|dexamethasone|mesh-list
83584086|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
83584087|NCT00003311|Doxorubicin|doxorubicin|mesh-list
83584088|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83584089|NCT00003311|Methotrexate|methotrexate|mesh-list
83584090|NCT00003311|Vincristine|vincristine|mesh-list
83584091|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584092|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
83584093|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584094|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584095|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584096|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
83584097|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584098|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584099|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83584100|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584101|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
83584102|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
83584103|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584104|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584105|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
83584106|NCT00003311|Hormones|hormones|mesh-ancestor
83584107|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584108|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584109|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83584110|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83584111|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584112|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584113|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83584114|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
83584115|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83584116|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584117|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
83584118|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83584119|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83584120|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584121|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
83584122|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584123|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584124|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584125|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584126|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584127|NCT00003317|Paclitaxel|paclitaxel|mesh-list
83584128|NCT00003317|Carboplatin|carboplatin|mesh-list
83584129|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584130|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584131|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584132|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584133|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584134|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584135|NCT00004217|Cytarabine|cytarabine|mesh-list
83584136|NCT00004217|Daunorubicin|daunorubicin|mesh-list
83584137|NCT00004217|Sargramostim|sargramostim|mesh-list
83584138|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584139|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
83584140|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584141|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584142|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
83584143|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584144|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584145|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
83584146|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584147|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83584148|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83584150|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584151|NCT00003323|Flutamide|flutamide|mesh-list
83584152|NCT00003323|Finasteride|finasteride|mesh-list
83584153|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83584154|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83584155|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584156|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584157|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
83584158|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584159|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584160|NCT00003323|Urological Agents|urological agents|mesh-ancestor
83584161|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
83584162|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584163|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584164|NCT00004229|Endostatins|endostatins|mesh-list
83584165|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584166|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83584167|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83584168|NCT00004229|Growth Substances|growth substances|mesh-ancestor
83584169|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584170|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
83584171|NCT00004235|Docetaxel|docetaxel|mesh-list
83584172|NCT00004235|Irinotecan|irinotecan|mesh-list
83584173|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584174|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584175|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584176|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584177|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584178|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83584179|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584180|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584181|NCT00003335|Cyclosporine|cyclosporine|mesh-list
83584182|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
83584183|NCT00003335|Melphalan|melphalan|mesh-list
83584184|NCT00003335|Busulfan|busulfan|mesh-list
83584185|NCT00003335|Cyclosporins|cyclosporins|mesh-list
83584186|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83584187|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584188|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584189|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584190|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
83584191|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584192|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
83584193|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584194|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
83584195|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584196|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83584197|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584198|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
83584199|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
83584200|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584201|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584202|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
83584203|NCT00003335|Hormones|hormones|mesh-ancestor
83584204|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584205|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83584206|NCT00003335|Protective Agents|protective agents|mesh-ancestor
83584207|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584208|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584209|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
83584210|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83584211|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
83584212|NCT00003341|Hematinics|hematinics|mesh-ancestor
83584213|NCT00004253|Paclitaxel|paclitaxel|mesh-list
83584214|NCT00004253|Carboplatin|carboplatin|mesh-list
83584215|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584216|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584217|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584218|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584219|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584220|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584221|NCT00004265|Paclitaxel|paclitaxel|mesh-list
83584222|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584223|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584224|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584225|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584226|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584227|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584228|NCT00003365|Curcumin|curcumin|mesh-list
83584229|NCT00003365|Sulindac|sulindac|mesh-list
83584230|NCT00003365|Quercetin|quercetin|mesh-list
83584231|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83584232|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83584233|NCT00003365|Analgesics|analgesics|mesh-ancestor
83584234|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
83584235|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584236|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584237|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584238|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584239|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584240|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584241|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584242|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
83584243|NCT00003365|Protective Agents|protective agents|mesh-ancestor
83584244|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83584245|NCT00004829|Tobramycin|tobramycin|mesh-list
83584246|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83584247|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584248|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83584249|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83584250|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
83584251|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584252|NCT00004853|Lenograstim|lenograstim|mesh-list
83584253|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83584254|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
83584255|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584256|NCT00004865|Paclitaxel|paclitaxel|mesh-list
83584257|NCT00004865|Fluorouracil|fluorouracil|mesh-list
83584258|NCT00004865|Cetuximab|cetuximab|mesh-list
83584259|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584260|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584261|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584262|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584263|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584264|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584265|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
83584266|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584267|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584268|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
83584269|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584270|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83584271|NCT00004361|Citric Acid|citric acid|mesh-list
83584272|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
83584273|NCT00004361|Calcium|calcium|mesh-list
83584274|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83584275|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584276|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
83584277|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83584278|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
83584279|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
83584280|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584281|NCT00004373|Alprazolam|alprazolam|mesh-list
83584282|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83584283|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83584284|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584285|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83584286|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83584287|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83584288|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
83584289|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
83584290|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584291|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584292|NCT00004871|Azacitidine|azacitidine|mesh-list
83584293|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83584294|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83042258|NCT04469114|Tofacitinib|tofacitinib|mesh-list
83584295|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
83584296|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584297|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584298|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584299|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83584300|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584301|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584302|NCT00004883|Trastuzumab|trastuzumab|mesh-list
83584303|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83584304|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584305|NCT00004403|Albendazole|albendazole|mesh-list
83584306|NCT00004403|Dexamethasone|dexamethasone|mesh-list
83584307|NCT00004403|Phenytoin|phenytoin|mesh-list
83584308|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584309|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
83584310|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
83584311|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584312|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584313|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584314|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
83584315|NCT00004403|Hormones|hormones|mesh-ancestor
83584316|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584317|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584318|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584319|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
83584320|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83584321|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584322|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
83584323|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83584324|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83584325|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584326|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584327|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584328|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584329|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
83584330|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83584331|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83584332|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83584333|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83584334|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83584335|NCT00004889|Rituximab|rituximab|mesh-list
83584336|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83584337|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584338|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
83584339|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584340|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584341|NCT00385307|Amibegron|amibegron|mesh-list
83584342|NCT00385307|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83584343|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83584344|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83584345|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
83584346|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584347|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584348|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584349|NCT00385307|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83584350|NCT00004901|Fluorouracil|fluorouracil|mesh-list
83584351|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
83584352|NCT00004901|Eniluracil|eniluracil|mesh-list
83584353|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
83584354|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584355|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584356|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584357|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584358|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
83584359|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584360|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
83584361|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584362|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584363|NCT00004433|Pergolide|pergolide|mesh-list
83584364|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
83584365|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
83584366|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584367|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584368|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584369|NCT00004913|Leucovorin|leucovorin|mesh-list
83584370|NCT00004913|Docetaxel|docetaxel|mesh-list
83584371|NCT00004913|Fluorouracil|fluorouracil|mesh-list
83584372|NCT00004913|Calcium|calcium|mesh-list
83584373|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
83584374|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584375|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584376|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584377|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584378|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584379|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83584380|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584381|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
83584382|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584383|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584384|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
83584385|NCT00004913|Antidotes|antidotes|mesh-ancestor
83584386|NCT00004913|Protective Agents|protective agents|mesh-ancestor
83584387|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
83584389|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
83584390|NCT00004919|Irinotecan|irinotecan|mesh-list
83584391|NCT00004919|Amifostine|amifostine|mesh-list
83584392|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584393|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83584394|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584395|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584396|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584397|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83584398|NCT00004919|Protective Agents|protective agents|mesh-ancestor
83584399|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584400|NCT00004925|Doxorubicin|doxorubicin|mesh-list
83584401|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83584402|NCT00004925|Trastuzumab|trastuzumab|mesh-list
83584403|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83584404|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584405|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83584406|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584407|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584408|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584409|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83584410|NCT00004931|Leucovorin|leucovorin|mesh-list
83584411|NCT00004931|Fluorouracil|fluorouracil|mesh-list
83584412|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
83584413|NCT00004931|Calcium|calcium|mesh-list
83584414|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
83584415|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83584416|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584417|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
83584418|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584419|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584420|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584421|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584422|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
83584423|NCT00004931|Antidotes|antidotes|mesh-ancestor
83584424|NCT00004931|Protective Agents|protective agents|mesh-ancestor
83584425|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
83584426|NCT00004931|Vitamins|vitamins|mesh-ancestor
83584427|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
83584428|NCT00004979|Paclitaxel|paclitaxel|mesh-list
83584429|NCT00004979|Topotecan|topotecan|mesh-list
83584430|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584431|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584432|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584433|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584434|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584435|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584436|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83584437|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584438|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584439|NCT00004985|Nelfinavir|nelfinavir|mesh-list
83584440|NCT00004985|Capravirine|capravirine|mesh-list
83584441|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83584442|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83584443|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
83584444|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584445|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584446|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83584447|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83584448|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
83584449|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584450|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83584451|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584452|NCT00004997|Leucovorin|leucovorin|mesh-list
83584453|NCT00004997|Antidotes|antidotes|mesh-ancestor
83584454|NCT00004997|Protective Agents|protective agents|mesh-ancestor
83584455|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584456|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
83584457|NCT00004997|Vitamins|vitamins|mesh-ancestor
83584458|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
83584459|NCT00005009|Vaccines|vaccines|mesh-list
83584460|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
83584461|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584462|NCT00004583|Ritonavir|ritonavir|mesh-list
83584463|NCT00004583|Lopinavir|lopinavir|mesh-list
83584464|NCT00004583|Nelfinavir|nelfinavir|mesh-list
83584465|NCT00004583|Lamivudine|lamivudine|mesh-list
83584466|NCT00004583|Stavudine|stavudine|mesh-list
83584467|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83584468|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83584469|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83584470|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584471|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584472|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83584473|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83584474|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
83584475|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584476|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83584477|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83584478|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83584479|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584480|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
83584481|NCT00005015|Fluoxetine|fluoxetine|mesh-list
83584482|NCT00005015|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83584483|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83584484|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83584485|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584486|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584487|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
83584488|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584489|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83584490|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
83584491|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83584492|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83584493|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83584494|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584495|NCT00004637|Vitamin E|vitamin e|mesh-list
83584496|NCT00004637|Vitamins|vitamins|mesh-ancestor
83584497|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
83584498|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584499|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
83584500|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584501|NCT00004637|Protective Agents|protective agents|mesh-ancestor
83584502|NCT00005021|Paclitaxel|paclitaxel|mesh-list
83584503|NCT00005021|Carboplatin|carboplatin|mesh-list
83584504|NCT00005021|Topotecan|topotecan|mesh-list
83584505|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584506|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584507|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584508|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584509|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584510|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584511|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83584512|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584513|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584514|NCT00004643|Cytarabine|cytarabine|mesh-list
83584515|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584516|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
83584517|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584518|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584519|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
83584520|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584521|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584522|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
83584523|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584524|NCT00005033|Trastuzumab|trastuzumab|mesh-list
83584525|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83584526|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584528|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
83584529|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584530|NCT00004685|Albuterol|albuterol|mesh-list
83584531|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83584532|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
83584533|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584534|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584535|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83584536|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
83584537|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
83584538|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83584539|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83584540|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83584541|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83584542|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
83584543|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584544|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584545|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83584546|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584547|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83584548|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83584549|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584550|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83584551|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584552|NCT00005051|Paclitaxel|paclitaxel|mesh-list
83584553|NCT00005051|Carboplatin|carboplatin|mesh-list
83584554|NCT00005051|Topotecan|topotecan|mesh-list
83584555|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584556|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584557|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584558|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584559|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584560|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584561|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83584562|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584563|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584564|NCT00004697|Choline|choline|mesh-list
83584565|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
83584566|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83584567|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
83584568|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584569|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584570|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83584571|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
83584572|NCT00004727|Aspirin|aspirin|mesh-list
83584573|NCT00004727|Ticlopidine|ticlopidine|mesh-list
83584574|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83584575|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83584576|NCT00004727|Analgesics|analgesics|mesh-ancestor
83584577|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
83584578|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584579|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584580|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584581|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584582|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83584583|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83584584|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584585|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83584586|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83584587|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584588|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
83584589|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83584590|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83584591|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83584592|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
83584593|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584594|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83584595|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83584596|NCT00004733|Levodopa|levodopa|mesh-list
83584597|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83584598|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83584599|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
83584600|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584601|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584602|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584603|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83584604|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
83584605|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584606|NCT00005057|Ganciclovir|ganciclovir|mesh-list
83584607|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83584608|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
83584609|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584610|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584611|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584612|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584613|NCT00004757|Acyclovir|acyclovir|mesh-list
83584614|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
83584615|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584616|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
83584617|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584618|NCT00004763|Leuprolide|leuprolide|mesh-list
83584619|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83584620|NCT00004763|Norethindrone|norethindrone|mesh-list
83584621|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
83584622|NCT00004763|Norinyl|norinyl|mesh-list
83584623|NCT00004763|Estradiol|estradiol|mesh-list
83584624|NCT00004763|Estrogens|estrogens|mesh-ancestor
83584625|NCT00004763|Hormones|hormones|mesh-ancestor
83584626|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584627|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584628|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83584629|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
83584630|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83584631|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83584632|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83584633|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
83584634|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584635|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584636|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83584637|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83584638|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83584639|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83584640|NCT00004787|Lenograstim|lenograstim|mesh-list
83584641|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83584642|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
83584643|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584644|NCT00005081|Carmustine|carmustine|mesh-list
83584645|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83584646|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584647|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
83584648|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584649|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584650|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584651|NCT00005087|Paclitaxel|paclitaxel|mesh-list
83584652|NCT00005087|Cisplatin|cisplatin|mesh-list
83584653|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584654|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584655|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584656|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584657|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584658|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584659|NCT00004799|Vaccines|vaccines|mesh-list
83584660|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
83584661|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584662|NCT00005093|Gemcitabine|gemcitabine|mesh-list
83584663|NCT00005093|Tacedinaline|tacedinaline|mesh-list
83584664|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584665|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
83584666|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584667|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684419|NCT01661855|Protective Agents|protective agents|mesh-ancestor
83042629|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042630|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83042631|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
83042632|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042635|NCT02122692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83584668|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83584669|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584670|NCT00004811|Itraconazole|itraconazole|mesh-list
83584671|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
83584672|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584673|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83584674|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83584675|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584676|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584677|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83584678|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
83584679|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584680|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584681|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83584682|NCT00004817|Phenytoin|phenytoin|mesh-list
83584683|NCT00004817|Valproic Acid|valproic acid|mesh-list
83584684|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
83584685|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584686|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584687|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
83584688|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584689|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584690|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
83584691|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83584692|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83584693|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83584694|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83584695|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83584696|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83584697|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83584698|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83584699|NCT00005117|Pravastatin|pravastatin|mesh-list
83584700|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83584701|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83584702|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
83584703|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584704|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83584705|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83584706|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584707|NCT00385385|KRM 1648|krm 1648|mesh-list
83584708|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83584709|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
83584710|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83584711|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584712|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
83584713|NCT00385463|Montelukast|montelukast|mesh-list
83584714|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83584715|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83584716|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83584717|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83584718|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
83584719|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584720|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584721|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83584722|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83584723|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584724|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83584725|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
83584726|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584727|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
83584728|NCT00385463|Hormones|hormones|mesh-ancestor
83584729|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
83584730|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
83584731|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83584732|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
83684420|NCT01661868|Olaparib|olaparib|mesh-list
83584733|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584734|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
83584735|NCT00423371|Protective Agents|protective agents|mesh-ancestor
83584736|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
83584737|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584738|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584739|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584740|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584741|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584742|NCT00005585|Leucovorin|leucovorin|mesh-list
83584743|NCT00005585|Cytarabine|cytarabine|mesh-list
83584744|NCT00005585|Dexamethasone|dexamethasone|mesh-list
83584745|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
83584746|NCT00005585|Methotrexate|methotrexate|mesh-list
83584747|NCT00005585|Vincristine|vincristine|mesh-list
83584748|NCT00005585|Daunorubicin|daunorubicin|mesh-list
83584749|NCT00005585|Asparaginase|asparaginase|mesh-list
83584750|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
83584751|NCT00005585|Pegaspargase|pegaspargase|mesh-list
83584752|NCT00005585|Thioguanine|thioguanine|mesh-list
83584753|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
83584754|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584755|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
83584756|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584757|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584758|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584759|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
83584760|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584761|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584762|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83584763|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584764|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
83584765|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
83584766|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584767|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584768|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
83584769|NCT00005585|Hormones|hormones|mesh-ancestor
83584770|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584771|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584772|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83584773|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
83584774|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83584775|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584776|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
83584777|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83584778|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584779|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83584780|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584781|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
83584782|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584783|NCT00005585|Antidotes|antidotes|mesh-ancestor
83584784|NCT00005585|Protective Agents|protective agents|mesh-ancestor
83584785|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
83584786|NCT00005585|Vitamins|vitamins|mesh-ancestor
83584787|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
83584788|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584789|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584790|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584791|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584792|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83584793|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83584794|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584795|NCT00005591|Gemcitabine|gemcitabine|mesh-list
83584796|NCT00005591|Cetuximab|cetuximab|mesh-list
83584797|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584798|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
83584799|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584800|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584801|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83584802|NCT01926444|Trimebutine|trimebutine|mesh-list
83584803|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584804|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
83584805|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
83584806|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584807|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584808|NCT00005597|Temozolomide|temozolomide|mesh-list
83584809|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584810|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
83584811|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042778|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042779|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83042780|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042781|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042782|NCT01674010|Inositol|inositol|mesh-list
83042783|NCT01674010|Lamotrigine|lamotrigine|mesh-list
83042784|NCT01674010|Valproic Acid|valproic acid|mesh-list
83584812|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584813|NCT04172844|Azacitidine|azacitidine|mesh-list
83584814|NCT04172844|Venetoclax|venetoclax|mesh-list
83584815|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83584816|NCT04172844|Pevonedistat|pevonedistat|mesh-list
83584817|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584818|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
83584819|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584820|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584821|NCT00005603|Cytarabine|cytarabine|mesh-list
83584822|NCT00005603|Dexamethasone|dexamethasone|mesh-list
83584823|NCT00005603|Prednisone|prednisone|mesh-list
83584824|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
83584825|NCT00005603|Doxorubicin|doxorubicin|mesh-list
83584826|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83584827|NCT00005603|Methotrexate|methotrexate|mesh-list
83584828|NCT00005603|Vincristine|vincristine|mesh-list
83584829|NCT00005603|Daunorubicin|daunorubicin|mesh-list
83584830|NCT00005603|Asparaginase|asparaginase|mesh-list
83584831|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
83584832|NCT00005603|Thioguanine|thioguanine|mesh-list
83584833|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83584834|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
83584835|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584836|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584837|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584838|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
83584839|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584840|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584841|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83584842|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584843|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
83584844|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
83584845|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584846|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584847|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
83584848|NCT00005603|Hormones|hormones|mesh-ancestor
83584849|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584850|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584851|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83584852|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83584853|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83584854|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584855|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83584856|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
83584857|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83584858|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584859|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
83584860|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83584861|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83584862|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584863|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
83584864|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584865|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83584866|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584867|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584868|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584869|NCT00005609|Rituximab|rituximab|mesh-list
83584870|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83584871|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584872|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
83584873|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584874|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83584875|NCT00005615|Interferons|interferons|mesh-list
83584876|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
83584877|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584878|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
83584879|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584880|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
83584881|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584882|NCT00005627|Carboplatin|carboplatin|mesh-list
83584883|NCT00005627|Docetaxel|docetaxel|mesh-list
83584884|NCT00005627|Estramustine|estramustine|mesh-list
83584885|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584886|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584887|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584888|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584889|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584890|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584892|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584893|NCT00005639|Azacitidine|azacitidine|mesh-list
83584894|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83584895|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83584896|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
83584897|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584898|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584899|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584900|NCT00005663|Valacyclovir|valacyclovir|mesh-list
83584901|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
83584902|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584903|NCT00385853|Temozolomide|temozolomide|mesh-list
83584904|NCT00385853|Vatalanib|vatalanib|mesh-list
83584905|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584906|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
83584907|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584908|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584909|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83584910|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584911|NCT00005765|Nicotine|nicotine|mesh-list
83584912|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83584913|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
83584914|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584915|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584916|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83584917|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83584918|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
83584919|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584920|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584921|NCT00005777|Dexamethasone|dexamethasone|mesh-list
83584922|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584923|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
83584924|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
83584925|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584926|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584927|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83584928|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
83584929|NCT00005777|Hormones|hormones|mesh-ancestor
83584930|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83584931|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83584932|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584933|NCT00385931|Valsartan|valsartan|mesh-list
83584934|NCT00385931|Simvastatin|simvastatin|mesh-list
83584935|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83584936|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83584937|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
83584938|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584939|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83584940|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83584941|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584942|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83584943|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83584944|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83584945|NCT00386399|Mitomycins|mitomycins|mesh-list
83584946|NCT00386399|Mitomycin|mitomycin|mesh-list
83584947|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83584948|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584949|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
83584950|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584951|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83584952|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83584953|NCT00005807|Epothilones|epothilones|mesh-list
83584954|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83584955|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83584956|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83584957|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584958|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584959|NCT00005813|Antibodies|antibodies|mesh-list
83584960|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83584961|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
83584962|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584963|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
83584964|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83584965|NCT00003647|Dacarbazine|dacarbazine|mesh-list
83584966|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83584967|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
83584968|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584969|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584970|NCT05895526|Fluorides|fluorides|mesh-list
83584971|NCT05895526|Fluorides, Topical|fluorides, topical|mesh-list
83584972|NCT05895526|Cariostatic Agents|cariostatic agents|mesh-ancestor
83584973|NCT05895526|Protective Agents|protective agents|mesh-ancestor
83584974|NCT05895526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584975|NCT05895513|Pimavanserin|pimavanserin|mesh-list
83584976|NCT05895513|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83584977|NCT05895513|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83584978|NCT05895513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83584979|NCT05895513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83584980|NCT05895513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83584981|NCT05895513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584982|NCT05895513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83584983|NCT05895513|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83584984|NCT05895513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83584985|NCT05895513|Serotonin Agents|serotonin agents|mesh-ancestor
83584986|NCT05895513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83584987|NCT05895513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83584988|NCT05895448|Sofosbuvir|sofosbuvir|mesh-list
83584989|NCT05895448|Velpatasvir|velpatasvir|mesh-list
83584990|NCT05895448|Antiviral Agents|antiviral agents|mesh-ancestor
83584991|NCT05895448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83584992|NCT05895370|Interleukin-2|interleukin-2|mesh-list
83584993|NCT05895370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83584994|NCT05895370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83584995|NCT05895370|Analgesics|analgesics|mesh-ancestor
83584996|NCT05895370|Sensory System Agents|sensory system agents|mesh-ancestor
83584997|NCT05895370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83584998|NCT05895370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83584999|NCT05895305|Paclitaxel|paclitaxel|mesh-list
83585000|NCT05895305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585001|NCT05895305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585002|NCT05895305|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585003|NCT05895305|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585004|NCT05895305|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585005|NCT05895305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585006|NCT05895240|Urinastatin|urinastatin|mesh-list
83585007|NCT05895240|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83585008|NCT05895240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83585009|NCT05895240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83585010|NCT05895240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585011|NCT05895240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585012|NCT05895201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83585013|NCT05895201|Cyclophosphamide|cyclophosphamide|mesh-list
83585014|NCT05895201|Bortezomib|bortezomib|mesh-list
83585015|NCT05895201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83585016|NCT05895201|Immunologic Factors|immunologic factors|mesh-ancestor
83585017|NCT05895201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585018|NCT05895201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585019|NCT05895201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83585020|NCT05895201|Alkylating Agents|alkylating agents|mesh-ancestor
83585021|NCT05895201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585022|NCT05895201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585023|NCT05895201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83585024|NCT05895201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83585025|NCT05895201|Incretins|incretins|mesh-ancestor
83585026|NCT05895201|Hormones|hormones|mesh-ancestor
83585027|NCT05895201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585028|NCT05895201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83585029|NCT05895201|Protease Inhibitors|protease inhibitors|mesh-ancestor
83585030|NCT05895201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585031|NCT05895136|Enoxaparin|enoxaparin|mesh-list
83585032|NCT05895136|Anticoagulants|anticoagulants|mesh-ancestor
83585033|NCT05895136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83585034|NCT05895136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83585035|NCT05895136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585036|NCT05895123|Atorvastatin|atorvastatin|mesh-list
83585037|NCT05895123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83585038|NCT05895123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83585039|NCT05895123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83043010|NCT05252754|Analgesics|analgesics|mesh-ancestor
83585040|NCT05895123|Antimetabolites|antimetabolites|mesh-ancestor
83585041|NCT05895123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585042|NCT05895123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83585043|NCT05895123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83585044|NCT05895123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585045|NCT05894954|Hormones|hormones|mesh-list
83585046|NCT05894954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585047|NCT05894954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585048|NCT05894928|Cholestyramine Resin|cholestyramine resin|mesh-list
83585049|NCT05894928|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83585050|NCT05894928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83585051|NCT05894928|Antimetabolites|antimetabolites|mesh-ancestor
83585052|NCT05894928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585053|NCT05894928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83585054|NCT05894889|Paclitaxel|paclitaxel|mesh-list
83585055|NCT05894889|Carboplatin|carboplatin|mesh-list
83585056|NCT05894889|Pembrolizumab|pembrolizumab|mesh-list
83585057|NCT05894889|Pemetrexed|pemetrexed|mesh-list
83585058|NCT05894889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585059|NCT05894889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585060|NCT05894889|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585061|NCT05894889|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585062|NCT05894889|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585063|NCT05894889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585064|NCT05894889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585065|NCT05894889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585066|NCT05894889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585067|NCT05894889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83585068|NCT05894889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585069|NCT05894824|Ramucirumab|ramucirumab|mesh-list
83585070|NCT05894824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585071|NCT05894577|Montelukast|montelukast|mesh-list
83585072|NCT05894577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83585073|NCT05894577|Respiratory System Agents|respiratory system agents|mesh-ancestor
83585074|NCT05894577|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83585075|NCT05894577|Hormone Antagonists|hormone antagonists|mesh-ancestor
83585076|NCT05894577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585077|NCT05894577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585078|NCT05894577|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83585079|NCT05894577|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83585080|NCT05894577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585081|NCT05894564|Fluvoxamine|fluvoxamine|mesh-list
83585082|NCT05894564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585083|NCT05894564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585084|NCT05894564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83585085|NCT05894564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83585086|NCT05894564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585087|NCT05894564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585088|NCT05894564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83585089|NCT05894564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83585090|NCT05894564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83585091|NCT05894564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83585092|NCT05894564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585093|NCT05894564|Serotonin Agents|serotonin agents|mesh-ancestor
83585094|NCT05894564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83585095|NCT05894564|Antidepressive Agents|antidepressive agents|mesh-ancestor
83585096|NCT05894564|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83585097|NCT05894564|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83585098|NCT05894564|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83585099|NCT05894538|Ivermectin|ivermectin|mesh-list
83585100|NCT05894538|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83585101|NCT05894538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585102|NCT05894486|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83585103|NCT05894486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83585104|NCT05894486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585105|NCT05894447|Pembrolizumab|pembrolizumab|mesh-list
83585106|NCT05894447|Obinutuzumab|obinutuzumab|mesh-list
83585107|NCT05894447|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
83585108|NCT05894447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585109|NCT05894447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585110|NCT05894447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585111|NCT05894447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585112|NCT05894447|Immunoconjugates|immunoconjugates|mesh-ancestor
83585113|NCT05894447|Immunologic Factors|immunologic factors|mesh-ancestor
83585114|NCT05894447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585115|NCT05894200|Fluorides|fluorides|mesh-list
83585116|NCT05894200|Cariostatic Agents|cariostatic agents|mesh-ancestor
83585117|NCT05894200|Protective Agents|protective agents|mesh-ancestor
83585118|NCT05894200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585119|NCT05894057|Midazolam|midazolam|mesh-list
83585120|NCT05894057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83585121|NCT05894057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83585122|NCT05894057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585123|NCT05894057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585124|NCT05894057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83585125|NCT05894057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83585126|NCT05894057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83585127|NCT05894057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83585128|NCT05894057|Anesthetics, General|anesthetics, general|mesh-ancestor
83585129|NCT05894057|Anesthetics|anesthetics|mesh-ancestor
83585130|NCT05894057|GABA Modulators|gaba modulators|mesh-ancestor
83585131|NCT05894057|GABA Agents|gaba agents|mesh-ancestor
83585132|NCT05894057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585133|NCT05894057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585134|NCT05894018|Fluzoparib|fluzoparib|mesh-list
83585135|NCT05894018|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83585136|NCT05894018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585137|NCT05894018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585138|NCT05894018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585139|NCT05893888|Cisplatin|cisplatin|mesh-list
83585140|NCT05893888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585141|NCT05893862|Moxifloxacin|moxifloxacin|mesh-list
83585142|NCT05893862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83585143|NCT05893862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585144|NCT05893862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83585145|NCT05893862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83585146|NCT05893862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585147|NCT05893862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585148|NCT05893862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585149|NCT05893810|Mupirocin|mupirocin|mesh-list
83585150|NCT05893810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83585151|NCT05893810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585152|NCT05893810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83585153|NCT05893810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585154|NCT05893810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585155|NCT05893654|Melphalan|melphalan|mesh-list
83585156|NCT05893654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83585157|NCT05893654|Alkylating Agents|alkylating agents|mesh-ancestor
83585158|NCT05893654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585159|NCT05893654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585160|NCT05893654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83585161|NCT05893654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83585162|NCT05893654|Immunologic Factors|immunologic factors|mesh-ancestor
83585163|NCT05893654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585164|NCT05893511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83585165|NCT05893511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585166|NCT05893472|Venetoclax|venetoclax|mesh-list
83585167|NCT05893472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585168|NCT05892913|Atropine|atropine|mesh-list
83585169|NCT05892913|Ephedrine|ephedrine|mesh-list
83585170|NCT05892913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83585171|NCT05892913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83585172|NCT05892913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83585173|NCT05892913|Autonomic Agents|autonomic agents|mesh-ancestor
83585174|NCT05892913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585175|NCT05892913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585176|NCT05892913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83585177|NCT05892913|Respiratory System Agents|respiratory system agents|mesh-ancestor
83585178|NCT05892913|Mydriatics|mydriatics|mesh-ancestor
83585179|NCT05892913|Parasympatholytics|parasympatholytics|mesh-ancestor
83585180|NCT05892913|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83585181|NCT05892913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83585182|NCT05892913|Cholinergic Agents|cholinergic agents|mesh-ancestor
83585183|NCT05892913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585184|NCT05892913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585185|NCT05892913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83585186|NCT05892913|Sympathomimetics|sympathomimetics|mesh-ancestor
83585187|NCT05892913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83585189|NCT05890352|Lenalidomide|lenalidomide|mesh-list
83585190|NCT05890352|Zanubrutinib|zanubrutinib|mesh-list
83585191|NCT05890352|Immunoglobulins|immunoglobulins|mesh-list
83585192|NCT05890352|Immunologic Factors|immunologic factors|mesh-ancestor
83585193|NCT05890352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585194|NCT05890352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83585195|NCT05890352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83585196|NCT05890352|Growth Substances|growth substances|mesh-ancestor
83585197|NCT05890352|Growth Inhibitors|growth inhibitors|mesh-ancestor
83585198|NCT05890352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585199|NCT05890352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585200|NCT05890352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585201|NCT05890352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585202|NCT05889741|Ropivacaine|ropivacaine|mesh-list
83585203|NCT05889741|Anesthetics, Local|anesthetics, local|mesh-ancestor
83585204|NCT05889741|Anesthetics|anesthetics|mesh-ancestor
83585205|NCT05889741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585206|NCT05889741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585207|NCT05889741|Sensory System Agents|sensory system agents|mesh-ancestor
83585208|NCT05889741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585209|NCT05887830|Nivolumab|nivolumab|mesh-list
83585210|NCT05887830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585211|NCT05887830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585212|NCT05887830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585213|NCT05887830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585214|NCT05885230|Lidocaine|lidocaine|mesh-list
83585215|NCT05885230|Bupivacaine|bupivacaine|mesh-list
83585216|NCT05885230|Anesthetics, Local|anesthetics, local|mesh-ancestor
83585217|NCT05885230|Anesthetics|anesthetics|mesh-ancestor
83585218|NCT05885230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585219|NCT05885230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585220|NCT05885230|Sensory System Agents|sensory system agents|mesh-ancestor
83585221|NCT05885230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585222|NCT05885230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83585223|NCT05885230|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83585224|NCT05885230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83585225|NCT05885230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83585226|NCT05885230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585227|NCT05877027|Diclofenac|diclofenac|mesh-list
83585228|NCT05877027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83585229|NCT05877027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83585230|NCT05877027|Analgesics|analgesics|mesh-ancestor
83585231|NCT05877027|Sensory System Agents|sensory system agents|mesh-ancestor
83585232|NCT05877027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585233|NCT05877027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585234|NCT05877027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83585235|NCT05877027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585236|NCT05877027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83585237|NCT05877027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585238|NCT05877027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585239|NCT05867121|Paclitaxel|paclitaxel|mesh-list
83585240|NCT05867121|Gemcitabine|gemcitabine|mesh-list
83585241|NCT05867121|Capecitabine|capecitabine|mesh-list
83585242|NCT05867121|Oxaliplatin|oxaliplatin|mesh-list
83585243|NCT05867121|Nivolumab|nivolumab|mesh-list
83585244|NCT05867121|Atezolizumab|atezolizumab|mesh-list
83585245|NCT05867121|Tegafur|tegafur|mesh-list
83585246|NCT05867121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585247|NCT05867121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585248|NCT05867121|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585249|NCT05867121|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585250|NCT05867121|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585251|NCT05867121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585252|NCT05867121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83585253|NCT05867121|Antimetabolites|antimetabolites|mesh-ancestor
83585254|NCT05867121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585255|NCT05867121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585256|NCT05861258|Minocycline|minocycline|mesh-list
83585257|NCT05861258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83585258|NCT05861258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585259|NCT05840211|Paclitaxel|paclitaxel|mesh-list
83585260|NCT05840211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83585261|NCT05840211|Capecitabine|capecitabine|mesh-list
83585262|NCT05840211|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83585263|NCT05840211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585264|NCT05840211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585265|NCT05840211|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585266|NCT05840211|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585267|NCT05840211|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585268|NCT05840211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585269|NCT05840211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83585270|NCT05840211|Antimetabolites|antimetabolites|mesh-ancestor
83585271|NCT05840211|Immunoconjugates|immunoconjugates|mesh-ancestor
83585272|NCT05840211|Immunologic Factors|immunologic factors|mesh-ancestor
83585273|NCT05840211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585275|NCT05829655|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83585276|NCT05829655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83585277|NCT05829655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585278|NCT05829655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585279|NCT05829655|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83585280|NCT05829655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585281|NCT05829655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585282|NCT05810480|Immunoglobulins|immunoglobulins|mesh-list
83585283|NCT05810480|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83585284|NCT05810480|Antibodies|antibodies|mesh-list
83585285|NCT05810480|Immunoglobulin G|immunoglobulin g|mesh-list
83585286|NCT05810480|Autoantibodies|autoantibodies|mesh-list
83585287|NCT05810480|Immunologic Factors|immunologic factors|mesh-ancestor
83585288|NCT05810480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585289|NCT05807204|Acetylcysteine|acetylcysteine|mesh-list
83585290|NCT05807204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83585291|NCT05807204|Antiviral Agents|antiviral agents|mesh-ancestor
83585292|NCT05807204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585293|NCT05807204|Expectorants|expectorants|mesh-ancestor
83585294|NCT05807204|Respiratory System Agents|respiratory system agents|mesh-ancestor
83585295|NCT05807204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83585296|NCT05807204|Antioxidants|antioxidants|mesh-ancestor
83585297|NCT05807204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585298|NCT05807204|Protective Agents|protective agents|mesh-ancestor
83585299|NCT05807204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585300|NCT05807204|Antidotes|antidotes|mesh-ancestor
83585301|NCT05784571|Insulin|insulin|mesh-list
83585302|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83585303|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585304|NCT05779943|Furosemide|furosemide|mesh-list
83585305|NCT05779943|Fluorides|fluorides|mesh-list
83585306|NCT05779943|Diuretics|diuretics|mesh-ancestor
83585307|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
83585308|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585309|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83585310|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83585311|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585312|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
83585313|NCT05779943|Protective Agents|protective agents|mesh-ancestor
83585314|NCT05779007|Pirfenidone|pirfenidone|mesh-list
83585315|NCT05779007|Nintedanib|nintedanib|mesh-list
83585316|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585317|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585318|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585319|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585320|NCT05779007|Analgesics|analgesics|mesh-ancestor
83585321|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
83585322|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585323|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585324|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83585325|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83585326|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83585327|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585328|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
83585329|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
83585330|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585331|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585332|NCT05775471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585333|NCT05775471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585334|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
83585335|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585336|NCT05767047|Apremilast|apremilast|mesh-list
83043302|NCT02129322|Sorafenib|sorafenib|mesh-list
83585337|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83585338|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83585339|NCT05767047|Analgesics|analgesics|mesh-ancestor
83585340|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
83585341|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585342|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585343|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83585344|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585345|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83585346|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83585347|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585348|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585349|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
83585350|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
83585351|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585352|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585353|NCT05756569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585354|NCT05756569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585355|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
83585356|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585357|NCT05727098|Ketamine|ketamine|mesh-list
83585358|NCT05727098|Bupivacaine|bupivacaine|mesh-list
83585359|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
83585360|NCT05727098|Anesthetics|anesthetics|mesh-list
83585361|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585362|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585363|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
83585364|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585365|NCT05727098|Analgesics|analgesics|mesh-ancestor
83585366|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83585367|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83585368|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
83585369|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83585370|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83585371|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585372|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585373|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
83585374|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83585375|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585376|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585377|NCT05691699|Itraconazole|itraconazole|mesh-list
83585378|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
83585379|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585380|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83585381|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83585382|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585383|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585384|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83585385|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
83585386|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585387|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585388|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83585389|NCT05687058|Empagliflozin|empagliflozin|mesh-list
83585390|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83585391|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585392|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83585393|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585394|NCT05681884|Faricimab|faricimab|mesh-list
83585395|NCT05681884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83585396|NCT05681884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83585397|NCT05681884|Growth Substances|growth substances|mesh-ancestor
83585398|NCT05681884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585399|NCT05681884|Growth Inhibitors|growth inhibitors|mesh-ancestor
83585400|NCT05681884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585401|NCT05677451|Remibrutinib|remibrutinib|mesh-list
83585402|NCT05677451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585403|NCT05677451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585404|NCT05677451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585405|NCT05664737|Luspatercept|luspatercept|mesh-list
83585406|NCT05664737|Hematinics|hematinics|mesh-ancestor
83585407|NCT05656352|Chrysarobin|chrysarobin|mesh-list
83585408|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83585409|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83585410|NCT05656352|Analgesics|analgesics|mesh-ancestor
83585411|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
83585412|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585413|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585414|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83585415|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585416|NCT05645718|Cytarabine|cytarabine|mesh-list
83585417|NCT05645718|Dexamethasone|dexamethasone|mesh-list
83585418|NCT05645718|Prednisone|prednisone|mesh-list
83585419|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
83585420|NCT05645718|Rituximab|rituximab|mesh-list
83585421|NCT05645718|Methotrexate|methotrexate|mesh-list
83585422|NCT05645718|Vincristine|vincristine|mesh-list
83585423|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
83585424|NCT05645718|Blinatumomab|blinatumomab|mesh-list
83585425|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83585426|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83585427|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
83585428|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585429|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585430|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83585431|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
83585432|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585433|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585434|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83585435|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585436|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83585437|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
83585438|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
83585439|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585440|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83585441|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
83585442|NCT05645718|Hormones|hormones|mesh-ancestor
83585443|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585444|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83585445|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83585446|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
83585447|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83585448|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83585449|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
83585450|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
83585451|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585452|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83585453|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585454|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
83585455|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585456|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585457|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585458|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585459|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585460|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83585461|NCT05645718|Immunotoxins|immunotoxins|mesh-ancestor
83585462|NCT05645718|Immunoconjugates|immunoconjugates|mesh-ancestor
83585463|NCT05641142|Anticoagulants|anticoagulants|mesh-list
83585464|NCT05638620|Bupivacaine|bupivacaine|mesh-list
83585465|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
83585466|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
83585467|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585468|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585469|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
83585470|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585471|NCT05635110|Rifampin|rifampin|mesh-list
83585472|NCT05635110|Omeprazole|omeprazole|mesh-list
83585473|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83585474|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83585475|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83585476|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585477|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585478|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83585479|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
83585480|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83585481|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585482|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
83585483|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585484|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83585485|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83585486|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83585487|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83585488|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83585489|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83585490|NCT05632809|Durvalumab|durvalumab|mesh-list
83585491|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585492|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585493|NCT05631093|Islatravir|islatravir|mesh-list
83585494|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
83585495|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585496|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585497|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585498|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83585499|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585500|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83585501|NCT05610527|Etonogestrel|etonogestrel|mesh-list
83585502|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83585503|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
83585504|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83585505|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585506|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83585507|NCT05608369|Vorinostat|vorinostat|mesh-list
83585508|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585509|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83585510|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585511|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585512|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
83585513|NCT05608291|Cemiplimab|cemiplimab|mesh-list
83585514|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585515|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585516|NCT05608291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585517|NCT05608291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585518|NCT05590468|Niacinamide|niacinamide|mesh-list
83585519|NCT05590468|Niacin|niacin|mesh-list
83585520|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
83585521|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
83585522|NCT05590468|Vitamins|vitamins|mesh-ancestor
83585523|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
83585524|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585525|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83585526|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
83585527|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585528|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83585529|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
83585530|NCT05565560|Apremilast|apremilast|mesh-list
83585531|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83585532|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83585533|NCT05565560|Analgesics|analgesics|mesh-ancestor
83585534|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
83585535|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585536|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585537|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83585538|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585539|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83585540|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83585541|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585542|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585543|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
83585544|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83585545|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
83585546|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585547|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585548|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83585549|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
83585550|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83585551|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
83585552|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585553|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585554|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83585555|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
83585556|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
83585557|NCT05564546|Protective Agents|protective agents|mesh-ancestor
83585558|NCT05555615|Pimavanserin|pimavanserin|mesh-list
83585559|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83585560|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83585561|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83585562|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83585563|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585564|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585565|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83585566|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83585567|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83585568|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
83585569|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585570|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585571|NCT05553366|Acetaminophen|acetaminophen|mesh-list
83585572|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83585573|NCT05553366|Analgesics|analgesics|mesh-ancestor
83585574|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
83585575|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585576|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585577|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
83585578|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
83585579|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585580|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
83585581|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585582|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585583|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585584|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83585585|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
83585586|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585587|NCT05541341|Tisagenlecleucel|tisagenlecleucel|mesh-list
83585588|NCT05541341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585589|NCT05541341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585590|NCT05527808|Carboplatin|carboplatin|mesh-list
83585591|NCT05527808|Pemetrexed|pemetrexed|mesh-list
83585592|NCT05527808|Tislelizumab|tislelizumab|mesh-list
83585593|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585594|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585595|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585596|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83585597|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585598|NCT05527808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585599|NCT05523895|Pimavanserin|pimavanserin|mesh-list
83585600|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83585601|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83585602|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83585603|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83585604|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83585605|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585606|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83585607|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83585608|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83585609|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
83585610|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585611|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585612|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83585613|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83585614|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585615|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585616|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83585617|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83585618|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585619|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
83585620|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585621|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83585622|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83585623|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83585624|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83585625|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83585626|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83585627|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585628|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585629|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585630|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
83585631|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83585632|NCT05426031|Protamines|protamines|mesh-list
83585633|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
83585634|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585635|NCT05426031|Coagulants|coagulants|mesh-ancestor
83585636|NCT05423106|Tenofovir|tenofovir|mesh-list
83585637|NCT05423106|Entecavir|entecavir|mesh-list
83585638|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
83585639|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585640|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83585641|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585642|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585643|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585644|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83585645|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83585646|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
83585647|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83585648|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
83585649|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83585650|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
83585651|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585652|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585653|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
83585654|NCT05371964|Imetelstat|imetelstat|mesh-list
83585655|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
83585656|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585657|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585658|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585659|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83585660|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83585661|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
83585662|NCT05342636|Paclitaxel|paclitaxel|mesh-list
83585663|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
83585664|NCT05342636|Irinotecan|irinotecan|mesh-list
83585665|NCT05342636|Lenvatinib|lenvatinib|mesh-list
83585666|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
83585667|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585668|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585669|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585670|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585671|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585672|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585673|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585674|NCT05342636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585675|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83585676|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83585677|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585678|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
83585679|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585680|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585681|NCT05319873|Carboplatin|carboplatin|mesh-list
83585682|NCT05319873|Docetaxel|docetaxel|mesh-list
83585683|NCT05319873|Trastuzumab|trastuzumab|mesh-list
83585684|NCT05319873|Fulvestrant|fulvestrant|mesh-list
83585685|NCT05319873|Pertuzumab|pertuzumab|mesh-list
83585686|NCT05319873|Tucatinib|tucatinib|mesh-list
83585687|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83585688|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83585689|NCT05319873|Antibodies|antibodies|mesh-list
83585690|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
83585691|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83585692|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
83585693|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585694|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585695|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585696|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585697|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585698|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585699|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83585700|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83585701|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83585702|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
83585703|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585704|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585705|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585706|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83585707|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585708|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585709|NCT05254002|Empagliflozin|empagliflozin|mesh-list
83585710|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83585711|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585712|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83585713|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585714|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
83585715|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585716|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
83585717|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585718|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585719|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83585720|NCT05239741|Leucovorin|leucovorin|mesh-list
83585721|NCT05239741|Bevacizumab|bevacizumab|mesh-list
83585722|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
83585723|NCT05239741|Cetuximab|cetuximab|mesh-list
83585724|NCT05239741|Fluorouracil|fluorouracil|mesh-list
83585725|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
83585726|NCT05239741|Irinotecan|irinotecan|mesh-list
83585727|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585728|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585729|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83585730|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83585731|NCT05239741|Growth Substances|growth substances|mesh-ancestor
83585732|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585733|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
83585734|NCT05239741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585735|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585736|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
83585737|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83585738|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83585739|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
83585740|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83585741|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83585742|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585743|NCT05239741|Antidotes|antidotes|mesh-ancestor
83585744|NCT05239741|Protective Agents|protective agents|mesh-ancestor
83585745|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
83585746|NCT05239741|Vitamins|vitamins|mesh-ancestor
83585747|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
83585748|NCT05211895|Durvalumab|durvalumab|mesh-list
83585749|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585750|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585751|NCT05206266|Turmeric extract|turmeric extract|mesh-list
83585752|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
83585753|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585754|NCT05206266|Protective Agents|protective agents|mesh-ancestor
83585755|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585756|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83585757|NCT05188326|Azacitidine|azacitidine|mesh-list
83585758|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83585759|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
83585760|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585761|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585762|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585763|NCT05186974|Carboplatin|carboplatin|mesh-list
83585764|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
83585765|NCT05186974|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83585766|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585767|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585768|NCT05186974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83585769|NCT05186974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585770|NCT05186974|Immunoconjugates|immunoconjugates|mesh-ancestor
83585771|NCT05186974|Immunologic Factors|immunologic factors|mesh-ancestor
83585772|NCT05186974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585773|NCT05180942|Atorvastatin|atorvastatin|mesh-list
83585774|NCT05180942|Calcium|calcium|mesh-list
83585775|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83585776|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585777|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83585778|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83585779|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
83585780|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585781|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83585782|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83585783|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585784|NCT05171075|Dalteparin|dalteparin|mesh-list
83585785|NCT05171075|Tinzaparin|tinzaparin|mesh-list
83585786|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83585787|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
83585788|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83585789|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83585790|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585791|NCT05171049|Apixaban|apixaban|mesh-list
83585792|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83585793|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
83585794|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83585795|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83585796|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585797|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585798|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
83585799|NCT05164653|Valsartan|valsartan|mesh-list
83585800|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
83585801|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83585802|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83585803|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83585804|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83585805|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83585806|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585807|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83585808|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
83585809|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585810|NCT05160896|Bevacizumab|bevacizumab|mesh-list
83585811|NCT05160896|Cetuximab|cetuximab|mesh-list
83585812|NCT05160896|Irinotecan|irinotecan|mesh-list
83585813|NCT05160896|Raltitrexed|raltitrexed|mesh-list
83585814|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585815|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585816|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83585817|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83585818|NCT05160896|Growth Substances|growth substances|mesh-ancestor
83585819|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585820|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
83585821|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83585822|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83585823|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585824|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585825|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83585826|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
83585827|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83585828|NCT05148962|Vaccines|vaccines|mesh-list
83585829|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
83585830|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585831|NCT05137054|Lenalidomide|lenalidomide|mesh-list
83585832|NCT05137054|Pomalidomide|pomalidomide|mesh-list
83585833|NCT05137054|Bortezomib|bortezomib|mesh-list
83585834|NCT05137054|Daratumumab|daratumumab|mesh-list
83585835|NCT05137054|Cemiplimab|cemiplimab|mesh-list
83585836|NCT05137054|Nirogacestat|nirogacestat|mesh-list
83585837|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
83585838|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585839|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83585840|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83585841|NCT05137054|Growth Substances|growth substances|mesh-ancestor
83585842|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
83585843|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585844|NCT05137054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585845|NCT05137054|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83585846|NCT05137054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585847|NCT05137054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585848|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
83585849|NCT05129670|Antacids|antacids|mesh-ancestor
83585850|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585851|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83585852|NCT05128617|Paclitaxel|paclitaxel|mesh-list
83585853|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
83585854|NCT05128617|Epirubicin|epirubicin|mesh-list
83585855|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585856|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585857|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585858|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585859|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585860|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585861|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83585862|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
83585863|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585864|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585865|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83585866|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
83585867|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83585868|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83585869|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83585870|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83585871|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585872|NCT05107375|Vaccines|vaccines|mesh-list
83585873|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
83585874|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585875|NCT05094128|Upadacitinib|upadacitinib|mesh-list
83585876|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83585877|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585878|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585879|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585880|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585881|NCT05090033|Ofatumumab|ofatumumab|mesh-list
83585882|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585883|NCT05065957|Capecitabine|capecitabine|mesh-list
83585884|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83585885|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
83585886|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585887|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585888|NCT05043090|Durvalumab|durvalumab|mesh-list
83585889|NCT05043090|Sunitinib|sunitinib|mesh-list
83585890|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585891|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585892|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83585893|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83585894|NCT05043090|Growth Substances|growth substances|mesh-ancestor
83585895|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585896|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
83585897|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585898|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585899|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585900|NCT05036278|Factor VIII|factor viii|mesh-list
83585901|NCT05036278|Coagulants|coagulants|mesh-ancestor
83585902|NCT05031520|Metoprolol|metoprolol|mesh-list
83585903|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
83585904|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83585905|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83585906|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
83585907|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
83585908|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83585909|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585910|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83585911|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83585912|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83585913|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
83585914|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83585915|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585916|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
83585917|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
83585918|NCT05018585|Vitamin D|vitamin d|mesh-list
83585919|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83585920|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83585921|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
83585922|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585923|NCT05018585|Antacids|antacids|mesh-ancestor
83585924|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585925|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83585926|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83585927|NCT05018585|Vitamins|vitamins|mesh-ancestor
83585928|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
83585929|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83585930|NCT04989829|Omeprazole|omeprazole|mesh-list
83585931|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83585932|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83585933|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83585934|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585935|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585936|NCT04988035|Remdesivir|remdesivir|mesh-list
83585937|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
83585938|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585939|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
83585940|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83585941|NCT04939792|Vitamin D|vitamin d|mesh-list
83585942|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
83585943|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
83585944|NCT04939792|Vitamins|vitamins|mesh-list
83585945|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
83585946|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585947|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83585948|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83585949|NCT04921358|Docetaxel|docetaxel|mesh-list
83585950|NCT04921358|Tislelizumab|tislelizumab|mesh-list
83585951|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585952|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585953|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585954|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585955|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585956|NCT04921358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83585957|NCT04850495|Prednisone|prednisone|mesh-list
83585958|NCT04850495|Cortisone|cortisone|mesh-list
83585959|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
83585960|NCT04850495|Rituximab|rituximab|mesh-list
83585961|NCT04850495|Doxorubicin|doxorubicin|mesh-list
83585962|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83585963|NCT04850495|Vincristine|vincristine|mesh-list
83585964|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
83585965|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83585966|NCT04850495|Antibodies|antibodies|mesh-list
83585967|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
83585968|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83585969|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83585970|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
83585971|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585972|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83585973|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83585974|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
83585975|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83585976|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83585977|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83585978|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83585979|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83585980|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83585981|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83585982|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83585983|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
83585984|NCT04850495|Hormones|hormones|mesh-ancestor
83585985|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585986|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83585987|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83585988|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
83585989|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
83585990|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
83585991|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83585992|NCT04847557|Tirzepatide|tirzepatide|mesh-list
83585993|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83585994|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83585995|NCT04847557|Incretins|incretins|mesh-ancestor
83585996|NCT04847557|Hormones|hormones|mesh-ancestor
83585997|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83585998|NCT04804735|Anesthetics|anesthetics|mesh-list
83585999|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83586000|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586001|NCT04804553|Apremilast|apremilast|mesh-list
83586002|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83586003|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83586004|NCT04804553|Analgesics|analgesics|mesh-ancestor
83586005|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
83586006|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586007|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586008|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83586009|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043974|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83586010|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83586011|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83586012|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586013|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586014|NCT04763135|Mirtazapine|mirtazapine|mesh-list
83586015|NCT04763135|Escitalopram|escitalopram|mesh-list
83586016|NCT04763135|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83586017|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83586018|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83586019|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586020|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83586021|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
83586022|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586023|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
83586024|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83586025|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83586026|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
83586027|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
83586028|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83586029|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83586030|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83586031|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83586032|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83586033|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83586034|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
83586035|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83586036|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83586037|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83586038|NCT04762979|Fulvestrant|fulvestrant|mesh-list
83586039|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83586040|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83586041|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586042|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83586043|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83586044|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
83586045|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586046|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586047|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83586048|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586049|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586050|NCT04762069|Lomustine|lomustine|mesh-list
83586051|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586052|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
83586053|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586054|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586055|NCT04723134|Leucovorin|leucovorin|mesh-list
83586056|NCT04723134|Folic Acid|folic acid|mesh-list
83586057|NCT04723134|Calcium|calcium|mesh-list
83586058|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
83586059|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83586060|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586061|NCT04723134|Antidotes|antidotes|mesh-ancestor
83586062|NCT04723134|Protective Agents|protective agents|mesh-ancestor
83586063|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
83586064|NCT04723134|Vitamins|vitamins|mesh-ancestor
83586065|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
83586066|NCT04723134|Hematinics|hematinics|mesh-ancestor
83586067|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83586068|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83586069|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586070|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
83586071|NCT04700072|Lenvatinib|lenvatinib|mesh-list
83586072|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586073|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586074|NCT04700072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586075|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586076|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586077|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586078|NCT04676334|Rucaparib|rucaparib|mesh-list
83586079|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83586080|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586081|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586082|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586083|NCT04666272|Trametinib|trametinib|mesh-list
83586084|NCT04666272|Dabrafenib|dabrafenib|mesh-list
83586085|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586086|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586088|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586089|NCT04649060|Dexamethasone|dexamethasone|mesh-list
83586090|NCT04649060|Melphalan|melphalan|mesh-list
83586091|NCT04649060|Daratumumab|daratumumab|mesh-list
83586092|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83586093|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
83586094|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
83586095|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586096|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586097|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83586098|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
83586099|NCT04649060|Hormones|hormones|mesh-ancestor
83586100|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586101|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83586102|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586103|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586104|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
83586105|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586106|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83586107|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586108|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
83586109|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
83586110|NCT04608487|Fludarabine|fludarabine|mesh-list
83586111|NCT04608487|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83586112|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586113|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
83586114|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586115|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586116|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586117|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
83586118|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586119|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586120|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83586121|NCT04608487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586122|NCT04602767|Phenylephrine|phenylephrine|mesh-list
83586123|NCT04602767|Vasopressins|vasopressins|mesh-list
83586124|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
83586125|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
83586126|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83586127|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
83586128|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
83586129|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586130|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586131|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
83586132|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83586133|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
83586134|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
83586135|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83586136|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83586137|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83586138|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
83586139|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83586140|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586141|NCT04602767|Protective Agents|protective agents|mesh-ancestor
83586142|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
83586143|NCT04602767|Coagulants|coagulants|mesh-ancestor
83586144|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83586145|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
83586146|NCT04586231|Lenvatinib|lenvatinib|mesh-list
83586147|NCT04586231|Belzutifan|belzutifan|mesh-list
83586148|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586149|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586150|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586151|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586152|NCT04581447|Metformin|metformin|mesh-list
83586153|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83586154|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586155|NCT04524689|Carboplatin|carboplatin|mesh-list
83586156|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
83586157|NCT04524689|Pemetrexed|pemetrexed|mesh-list
83586158|NCT04524689|Maytansine|maytansine|mesh-list
83586159|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586160|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586161|NCT04524689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586162|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586163|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586164|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83586165|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83586166|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83586167|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586168|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586169|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586170|NCT04520685|Cannabidiol|cannabidiol|mesh-list
83586171|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
83586172|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
83586174|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586175|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586176|NCT04519151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586177|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586178|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586179|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586180|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83586181|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83586182|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83586183|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586184|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
83586185|NCT04497012|Iron|iron|mesh-list
83586186|NCT04497012|Trace Elements|trace elements|mesh-ancestor
83586187|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
83586188|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586189|NCT04484259|Aspirin|aspirin|mesh-list
83586190|NCT04484259|Clopidogrel|clopidogrel|mesh-list
83586191|NCT04484259|Ticagrelor|ticagrelor|mesh-list
83586192|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83586193|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83586194|NCT04484259|Analgesics|analgesics|mesh-ancestor
83586195|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
83586196|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586197|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586198|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83586199|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586200|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83586201|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83586202|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586203|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83586204|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83586205|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586206|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
83586207|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83586208|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83586209|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83586210|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
83586211|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83586212|NCT04463693|Etonogestrel|etonogestrel|mesh-list
83586213|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83586214|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
83586215|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83586216|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586217|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83586218|NCT04417621|Trametinib|trametinib|mesh-list
83586219|NCT04417621|Naporafenib|naporafenib|mesh-list
83586220|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586221|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586222|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586223|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586224|NCT04392011|Midazolam|midazolam|mesh-list
83586225|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
83586226|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83586227|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83586228|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83586229|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586230|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83586231|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83586232|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83586233|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83586234|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
83586235|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
83586236|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
83586238|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83586239|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586240|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
83586241|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
83586242|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83586243|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83586244|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
83586245|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
83586246|NCT04370301|Melphalan|melphalan|mesh-list
83586247|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
83586248|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83586249|NCT04370301|Fludarabine|fludarabine|mesh-list
83586250|NCT04370301|Tacrolimus|tacrolimus|mesh-list
83586251|NCT04370301|Lenograstim|lenograstim|mesh-list
83586252|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83586253|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586254|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
83586255|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586256|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586257|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586258|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
83586259|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586260|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586261|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83586262|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83586263|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586264|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83586265|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83586266|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
83586267|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83586268|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83586269|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83586270|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586271|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
83586272|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586273|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586274|NCT04348916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586275|NCT04348916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586276|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
83586277|NCT04305041|Lenvatinib|lenvatinib|mesh-list
83586278|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586279|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586280|NCT04305041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586281|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586282|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586283|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586284|NCT04299113|Vinorelbine|vinorelbine|mesh-list
83586285|NCT04299113|Mocetinostat|mocetinostat|mesh-list
83586286|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83586287|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586288|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586289|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586290|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586291|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586292|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83586293|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586294|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
83586295|NCT04291001|Etonogestrel|etonogestrel|mesh-list
83586296|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83586297|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
83586298|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83586299|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586300|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83586301|NCT04285580|Bimatoprost|bimatoprost|mesh-list
83586302|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83586303|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
83586304|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83586305|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83586306|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586307|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
83586308|NCT04272606|Coagulants|coagulants|mesh-ancestor
83586309|NCT04245371|Lidocaine|lidocaine|mesh-list
83586310|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
83586311|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
83586312|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83586313|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586314|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
83586315|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586316|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83586317|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83586318|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83586319|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83586320|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586322|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
83586323|NCT04241185|Fluorouracil|fluorouracil|mesh-list
83586324|NCT04241185|Mitomycins|mitomycins|mesh-list
83586325|NCT04241185|Mitomycin|mitomycin|mesh-list
83586326|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586327|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586328|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
83586329|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586330|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586331|NCT04241185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586332|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586333|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
83586334|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586335|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83586336|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
83586337|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83586338|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586339|NCT04231539|Nicotine|nicotine|mesh-list
83586340|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83586341|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
83586342|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586343|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586344|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83586345|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83586346|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
83586347|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83586348|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586349|NCT04200313|Pancrelipase|pancrelipase|mesh-list
83586350|NCT04200313|Pancreatin|pancreatin|mesh-list
83586351|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83586352|NCT04200248|Aflibercept|aflibercept|mesh-list
83586353|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83586354|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83586355|NCT04200248|Growth Substances|growth substances|mesh-ancestor
83586356|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586357|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
83586358|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586359|NCT04137887|Vaccines|vaccines|mesh-list
83586360|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
83586361|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586362|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83586363|NCT04113382|Laxatives|laxatives|mesh-ancestor
83586364|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83586365|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
83586366|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586367|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586368|NCT04095273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586369|NCT04095273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586370|NCT03992131|Rucaparib|rucaparib|mesh-list
83586371|NCT03992131|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83586372|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83586373|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586374|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586375|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586376|NCT03992131|Immunoconjugates|immunoconjugates|mesh-ancestor
83586377|NCT03992131|Immunologic Factors|immunologic factors|mesh-ancestor
83586378|NCT03992131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586379|NCT03954366|Rucaparib|rucaparib|mesh-list
83586380|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83586381|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
83586382|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
83586383|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83586384|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83586385|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
83044391|NCT04671355|Xhance|xhance|mesh-list
83586386|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586387|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83586388|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83586389|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586390|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83586391|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586392|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83586393|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83586394|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586395|NCT03940703|Osimertinib|osimertinib|mesh-list
83586396|NCT03940703|Tepotinib|tepotinib|mesh-list
83586397|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586398|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586399|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586400|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586401|NCT03923270|Durvalumab|durvalumab|mesh-list
83586402|NCT03923270|Olaparib|olaparib|mesh-list
83586403|NCT03923270|Tremelimumab|tremelimumab|mesh-list
83586404|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83586405|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586406|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586407|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83586408|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586409|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586410|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
83586411|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586412|NCT03912220|Niacinamide|niacinamide|mesh-list
83586413|NCT03912220|Niacin|niacin|mesh-list
83586414|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
83586415|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
83586416|NCT03912220|Vitamins|vitamins|mesh-ancestor
83586417|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
83586418|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586419|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83586420|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
83586421|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586422|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83586423|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
83586424|NCT03889912|Cemiplimab|cemiplimab|mesh-list
83586425|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586426|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586427|NCT03872791|Paclitaxel|paclitaxel|mesh-list
83586428|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83586429|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586430|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586431|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586432|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586433|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586434|NCT03864042|Losartan|losartan|mesh-list
83586435|NCT03864042|Midazolam|midazolam|mesh-list
83586436|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
83586437|NCT03864042|Caffeine|caffeine|mesh-list
83586438|NCT03864042|Modafinil|modafinil|mesh-list
83586439|NCT03864042|Bupropion|bupropion|mesh-list
83586440|NCT03864042|Omeprazole|omeprazole|mesh-list
83586441|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83586442|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83586443|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83586444|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83586445|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586446|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83586447|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83586448|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83586449|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83586450|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
83586451|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
83586452|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
83586453|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
83586454|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475362|NCT00117962|Pemetrexed|pemetrexed|mesh-list
83586455|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586456|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83586457|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83586458|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
83586459|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83586460|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83586461|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586462|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83586463|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83586464|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83586465|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83586466|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83586467|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83586468|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83586469|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83586470|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
83586471|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83586472|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83586473|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83586474|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83586475|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
83586476|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83586477|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83586478|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83586479|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
83586480|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83586481|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83586482|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83586483|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83586484|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83586485|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
83586486|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
83586487|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83586488|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83586489|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83586490|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
83586491|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586492|NCT03737604|Bupivacaine|bupivacaine|mesh-list
83586493|NCT03737604|Ropivacaine|ropivacaine|mesh-list
83586494|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
83586495|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
83586496|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83586497|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586498|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
83586499|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586500|NCT03726879|Paclitaxel|paclitaxel|mesh-list
83586501|NCT03726879|Maytansine|maytansine|mesh-list
83586502|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83586503|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
83586504|NCT03726879|Doxorubicin|doxorubicin|mesh-list
83586505|NCT03726879|Trastuzumab|trastuzumab|mesh-list
83586506|NCT03726879|Atezolizumab|atezolizumab|mesh-list
83586507|NCT03726879|Pertuzumab|pertuzumab|mesh-list
83586508|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83586509|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586510|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586511|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586512|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586513|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586514|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586515|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
83586516|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586517|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586518|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586519|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
83586520|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83586521|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83586522|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83586523|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83586524|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586525|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586526|NCT03726879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586527|NCT03726879|Immunotoxins|immunotoxins|mesh-ancestor
83586528|NCT03726879|Immunoconjugates|immunoconjugates|mesh-ancestor
83586529|NCT03695380|Atezolizumab|atezolizumab|mesh-list
83586530|NCT03695380|Niraparib|niraparib|mesh-list
83586531|NCT03695380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586532|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586533|NCT03695380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586534|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586535|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83586536|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586537|NCT03682068|Carboplatin|carboplatin|mesh-list
83586538|NCT03682068|Gemcitabine|gemcitabine|mesh-list
83586539|NCT03682068|Durvalumab|durvalumab|mesh-list
83586540|NCT03682068|Tremelimumab|tremelimumab|mesh-list
83586541|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586542|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586543|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
83586544|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586545|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586546|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
83586547|NCT03676504|Fludarabine|fludarabine|mesh-list
83586548|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586549|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
83586550|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586551|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586552|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586553|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
83586554|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586555|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586556|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83586557|NCT03637764|Atezolizumab|atezolizumab|mesh-list
83586558|NCT03637764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586559|NCT03637764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586560|NCT03637764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586561|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586562|NCT03600155|Nivolumab|nivolumab|mesh-list
83586563|NCT03600155|Ipilimumab|ipilimumab|mesh-list
83586564|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586565|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586566|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586567|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586568|NCT03597594|Fludarabine|fludarabine|mesh-list
83586569|NCT03597594|Busulfan|busulfan|mesh-list
83586570|NCT03597594|Thiotepa|thiotepa|mesh-list
83586571|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
83586572|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83586573|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586574|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586575|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586576|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
83586577|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586578|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
83586579|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586580|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83586581|NCT03563690|Celecoxib|celecoxib|mesh-list
83586582|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83586583|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83586584|NCT03563690|Analgesics|analgesics|mesh-ancestor
83586585|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
83586586|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586587|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586588|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83586589|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586590|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83586591|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83586592|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586593|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586594|NCT03557008|Metronidazole|metronidazole|mesh-list
83586595|NCT03557008|Vancomycin|vancomycin|mesh-list
83586596|NCT03557008|Neomycin|neomycin|mesh-list
83586597|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83586598|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83586599|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83586600|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83586601|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83586602|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586603|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586604|NCT03509012|Paclitaxel|paclitaxel|mesh-list
83586605|NCT03509012|Etoposide|etoposide|mesh-list
83586606|NCT03509012|Cisplatin|cisplatin|mesh-list
83586607|NCT03509012|Carboplatin|carboplatin|mesh-list
83586608|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
83586609|NCT03509012|Pemetrexed|pemetrexed|mesh-list
83586610|NCT03509012|Durvalumab|durvalumab|mesh-list
83586611|NCT03509012|Tremelimumab|tremelimumab|mesh-list
83586612|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83586613|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586614|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586615|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586616|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586617|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586618|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83586619|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83586620|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586621|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83586622|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83586623|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586624|NCT03404193|Decitabine|decitabine|mesh-list
83586625|NCT03404193|Venetoclax|venetoclax|mesh-list
83586626|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586627|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
83586628|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586629|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586630|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586631|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
83586632|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586633|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586634|NCT03395847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586635|NCT03395847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586636|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
83586637|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83586638|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586639|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586640|NCT03347617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586641|NCT03347617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586642|NCT03347617|Hematinics|hematinics|mesh-ancestor
83586643|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83586644|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83586645|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
83586646|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586647|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
83586648|NCT03310957|SGN-LIV1A|sgn-liv1a|mesh-list
83586649|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586650|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586651|NCT03310957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586652|NCT03310957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586653|NCT03310957|Immunoconjugates|immunoconjugates|mesh-ancestor
83586654|NCT03310957|Immunologic Factors|immunologic factors|mesh-ancestor
83586655|NCT03310957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586656|NCT03281369|Leucovorin|leucovorin|mesh-list
83586657|NCT03281369|Linagliptin|linagliptin|mesh-list
83586658|NCT03281369|Paclitaxel|paclitaxel|mesh-list
83586659|NCT03281369|Fluorouracil|fluorouracil|mesh-list
83586660|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
83586661|NCT03281369|Atezolizumab|atezolizumab|mesh-list
83586662|NCT03281369|Ramucirumab|ramucirumab|mesh-list
83586663|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83586664|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83586665|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586666|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586667|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586668|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586669|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586670|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
83586671|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586672|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586673|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
83586674|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586675|NCT03281369|Antidotes|antidotes|mesh-ancestor
83586676|NCT03281369|Protective Agents|protective agents|mesh-ancestor
83586677|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
83586678|NCT03281369|Vitamins|vitamins|mesh-ancestor
83586679|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
83586680|NCT03281369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586681|NCT03281369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586682|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83586683|NCT03281369|Incretins|incretins|mesh-ancestor
83586684|NCT03281369|Hormones|hormones|mesh-ancestor
83586685|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586686|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83586687|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
83586688|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586689|NCT03258593|Durvalumab|durvalumab|mesh-list
83586690|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586691|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586692|NCT03178149|Tacrolimus|tacrolimus|mesh-list
83586693|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586694|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
83586695|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586696|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83586697|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586698|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586699|NCT03136029|Antioxidants|antioxidants|mesh-list
83586700|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586701|NCT03136029|Protective Agents|protective agents|mesh-ancestor
83586702|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586703|NCT03040999|Cisplatin|cisplatin|mesh-list
83586704|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
83586705|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586706|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586707|NCT03040999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586708|NCT03040999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586709|NCT02990338|Dexamethasone|dexamethasone|mesh-list
83586710|NCT02990338|Pomalidomide|pomalidomide|mesh-list
83586711|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83586712|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
83586713|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
83586714|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586715|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586716|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83586717|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
83586718|NCT02990338|Hormones|hormones|mesh-ancestor
83586719|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586720|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83586721|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586722|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
83586723|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83586724|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83586725|NCT02990338|Growth Substances|growth substances|mesh-ancestor
83586726|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
83586727|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
83586728|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586729|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586730|NCT02971956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586731|NCT02971956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586732|NCT02861300|Capecitabine|capecitabine|mesh-list
83586733|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586734|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
83586735|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586736|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586737|NCT02787369|Idelalisib|idelalisib|mesh-list
83586738|NCT02787369|Ricolinostat|ricolinostat|mesh-list
83586739|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586740|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586741|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586742|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83586743|NCT02576509|Nivolumab|nivolumab|mesh-list
83586744|NCT02576509|Sorafenib|sorafenib|mesh-list
83586745|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586746|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586747|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83586748|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586749|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586750|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586751|NCT02366728|Temozolomide|temozolomide|mesh-list
83586752|NCT02366728|Basiliximab|basiliximab|mesh-list
83586753|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
83586754|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586755|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586756|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
83586757|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586758|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586759|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586760|NCT02333370|Tamoxifen|tamoxifen|mesh-list
83586761|NCT02333370|Letrozole|letrozole|mesh-list
83586762|NCT02333370|Fulvestrant|fulvestrant|mesh-list
83586763|NCT02333370|Goserelin|goserelin|mesh-list
83586764|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586765|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83586766|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83586767|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586768|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586769|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83586770|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
83586771|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586772|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586773|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83586774|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83586775|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83586776|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83586777|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83586778|NCT02303444|Sorafenib|sorafenib|mesh-list
83586779|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586780|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83586781|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586782|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586783|NCT02264678|Carboplatin|carboplatin|mesh-list
83586784|NCT02264678|Durvalumab|durvalumab|mesh-list
83586785|NCT02264678|Olaparib|olaparib|mesh-list
83586786|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83586787|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586788|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586789|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
83586790|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586791|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83586792|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586793|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586794|NCT02246920|Fluticasone|fluticasone|mesh-list
83586796|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83586797|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83586798|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
83586799|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586800|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586801|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83586802|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
83586803|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
83586804|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83586805|NCT01972919|Gemcitabine|gemcitabine|mesh-list
83586806|NCT01972919|Capecitabine|capecitabine|mesh-list
83586807|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586808|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
83586809|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586810|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586811|NCT01832402|Fentanyl|fentanyl|mesh-list
83586812|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83586813|NCT01832402|Narcotics|narcotics|mesh-ancestor
83586814|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83586815|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586816|NCT01832402|Analgesics|analgesics|mesh-ancestor
83586817|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
83586818|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586819|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83586820|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83586821|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
83586822|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
83586823|NCT01661881|Cytarabine|cytarabine|mesh-list
83586824|NCT01661881|Rituximab|rituximab|mesh-list
83586825|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83586826|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83586827|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586828|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
83586829|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586830|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586831|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586832|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
83586833|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586834|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
83586835|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83586836|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586837|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586838|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
83586840|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83586841|NCT01473628|Antibodies|antibodies|mesh-list
83586842|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
83586843|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83586844|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
83586845|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586846|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586847|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586848|NCT01210625|Psyllium|psyllium|mesh-list
83586849|NCT01210625|Cathartics|cathartics|mesh-ancestor
83586850|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83586851|NCT01009190|Carboplatin|carboplatin|mesh-list
83586852|NCT01009190|Rucaparib|rucaparib|mesh-list
83586853|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586854|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83586855|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586856|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586857|NCT00321555|Immunotoxins|immunotoxins|mesh-list
83586858|NCT00321555|Immunoconjugates|immunoconjugates|mesh-ancestor
83586859|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
83586860|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586861|NCT00003653|Leuprolide|leuprolide|mesh-list
83586862|NCT00003653|Goserelin|goserelin|mesh-list
83586863|NCT00003653|Flutamide|flutamide|mesh-list
83586864|NCT00003653|Bicalutamide|bicalutamide|mesh-list
83586865|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
83586866|NCT00003653|Nilutamide|nilutamide|mesh-list
83586867|NCT00003653|Buserelin|buserelin|mesh-list
83586868|NCT00003653|Cyproterone|cyproterone|mesh-list
83586869|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83586870|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
83586871|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83586872|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586873|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83586874|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586875|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
83586876|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
83586877|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586878|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83586879|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
83586880|NCT00003671|Leucovorin|leucovorin|mesh-list
83586881|NCT00003671|Cytarabine|cytarabine|mesh-list
83586882|NCT00003671|Dexamethasone|dexamethasone|mesh-list
83586883|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
83586884|NCT00003671|Methotrexate|methotrexate|mesh-list
83586885|NCT00003671|Vincristine|vincristine|mesh-list
83586886|NCT00003671|Daunorubicin|daunorubicin|mesh-list
83586887|NCT00003671|Asparaginase|asparaginase|mesh-list
83586888|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
83586889|NCT00003671|Thioguanine|thioguanine|mesh-list
83586890|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
83586891|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83586892|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
83586893|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586894|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83586895|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586896|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
83586897|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586898|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586899|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83586900|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83586901|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
83586902|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
83586903|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83586904|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83586905|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
83586906|NCT00003671|Hormones|hormones|mesh-ancestor
83586907|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586908|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83586909|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83586910|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
83586911|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83586912|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586913|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
83586914|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83586915|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586916|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83586917|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83586918|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
83586919|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83586920|NCT00003671|Antidotes|antidotes|mesh-ancestor
83586921|NCT00003671|Protective Agents|protective agents|mesh-ancestor
83586922|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
83586923|NCT00003671|Vitamins|vitamins|mesh-ancestor
83586924|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
83586925|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83586926|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586927|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586928|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586929|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83586930|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83586931|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83586932|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
83586933|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586934|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
83586935|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
83586936|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
83586937|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586938|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83586939|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83586940|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83586941|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83586942|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586943|NCT00384605|Hormones|hormones|mesh-ancestor
83586944|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586945|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586946|NCT00003683|Doxorubicin|doxorubicin|mesh-list
83586947|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83586948|NCT00003683|Ifosfamide|ifosfamide|mesh-list
83586949|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83586950|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586951|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83586952|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83586953|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586954|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586955|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586956|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
83586957|NCT00003707|Gemcitabine|gemcitabine|mesh-list
83586958|NCT00003707|Tipifarnib|tipifarnib|mesh-list
83586959|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83586960|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
83586961|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586962|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586963|NCT00003719|Irinotecan|irinotecan|mesh-list
83586964|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83586965|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83586966|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586967|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586968|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586969|NCT00003725|Valrubicin|valrubicin|mesh-list
83586970|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586971|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83586972|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83586973|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586974|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586975|NCT00003731|Temozolomide|temozolomide|mesh-list
83586976|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83586977|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
83586978|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586979|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586980|NCT00003743|Aldesleukin|aldesleukin|mesh-list
83586981|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83586982|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83586983|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83586984|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
83586985|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83586986|NCT00384917|Ketoconazole|ketoconazole|mesh-list
83586987|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
83586988|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83586989|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83586990|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83586991|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83586992|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83586993|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83586994|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
83586995|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83586996|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83586997|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83586998|NCT05444153|Empagliflozin|empagliflozin|mesh-list
83586999|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83587000|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587001|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83587002|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587003|NCT00003797|Gemcitabine|gemcitabine|mesh-list
83587004|NCT00003797|Trastuzumab|trastuzumab|mesh-list
83587005|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587006|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
83587007|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587008|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587009|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83587010|NCT00003803|Gemcitabine|gemcitabine|mesh-list
83587011|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587012|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587013|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
83587014|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587015|NCT00003815|Cytarabine|cytarabine|mesh-list
83587016|NCT00003815|Prednisolone|prednisolone|mesh-list
83587017|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
83587018|NCT00003815|Melphalan|melphalan|mesh-list
83587019|NCT00003815|Carmustine|carmustine|mesh-list
83587020|NCT00003815|Doxorubicin|doxorubicin|mesh-list
83587021|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83587022|NCT00003815|Etoposide|etoposide|mesh-list
83587023|NCT00003815|Vincristine|vincristine|mesh-list
83587024|NCT00003815|Bleomycin|bleomycin|mesh-list
83587025|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83587026|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
83587027|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587028|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83587029|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83587030|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
83587031|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587032|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587033|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83587034|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83587035|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83587036|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83587037|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587038|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83587039|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587040|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
83587041|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
83587042|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587043|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
83587044|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
83587045|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
83587046|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587047|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
83587048|NCT00003815|Hormones|hormones|mesh-ancestor
83587049|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587050|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83587051|NCT00003821|Aminopterin|aminopterin|mesh-list
83587052|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83587053|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587054|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587055|NCT00003827|Cytarabine|cytarabine|mesh-list
83587056|NCT00003827|Topotecan|topotecan|mesh-list
83587057|NCT00003827|Amifostine|amifostine|mesh-list
83587058|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587059|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
83587060|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587061|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587062|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
83587063|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587064|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83587065|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
83587066|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587067|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83587068|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83587069|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587070|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83587071|NCT00003827|Protective Agents|protective agents|mesh-ancestor
83587072|NCT00003851|Gemcitabine|gemcitabine|mesh-list
83587073|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587074|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
83587075|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587076|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587077|NCT00003881|Paclitaxel|paclitaxel|mesh-list
83587078|NCT00003881|Carboplatin|carboplatin|mesh-list
83587079|NCT00003881|Trastuzumab|trastuzumab|mesh-list
83587080|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83587081|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587082|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83587083|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83587084|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83587085|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587086|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83587087|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
83587088|NCT00003893|Doxorubicin|doxorubicin|mesh-list
83587089|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83587090|NCT00003893|Fluorouracil|fluorouracil|mesh-list
83587091|NCT00003893|Methotrexate|methotrexate|mesh-list
83587092|NCT00003893|Epirubicin|epirubicin|mesh-list
83587093|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
83587094|NCT00003893|Mitomycins|mitomycins|mesh-list
83587095|NCT00003893|Mitomycin|mitomycin|mesh-list
83587096|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83587097|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
83587098|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587099|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83587100|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83587101|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
83587102|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587103|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587104|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83587105|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83587106|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83587107|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83587108|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587109|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
83587110|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587111|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83587112|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
83587113|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83587114|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
83587115|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83587116|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83587117|NCT00003893|Analgesics|analgesics|mesh-ancestor
83587118|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
83587119|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587120|NCT00003899|Paclitaxel|paclitaxel|mesh-list
83587121|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
83587122|NCT00003899|Melphalan|melphalan|mesh-list
83587123|NCT00003899|Thiotepa|thiotepa|mesh-list
83587124|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83587125|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587126|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
83587127|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
83587128|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
83587129|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587130|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83587131|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
83587132|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587133|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83587134|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83587135|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
83587136|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83587137|NCT00003917|Topotecan|topotecan|mesh-list
83587138|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83587139|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83587140|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587141|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587142|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587143|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83587144|NCT00003923|Trioxsalen|trioxsalen|mesh-list
83587145|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587146|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
83587147|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83587148|NCT00003929|Lomustine|lomustine|mesh-list
83587149|NCT00003929|Procarbazine|procarbazine|mesh-list
83587150|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83587151|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
83587152|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587153|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587154|NCT02210663|Veliparib|veliparib|mesh-list
83587155|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83587156|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587157|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587158|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587159|NCT04568837|Dexamethasone|dexamethasone|mesh-list
83587160|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
83587161|NCT04568837|Prednisone|prednisone|mesh-list
83587162|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83587163|NCT04568837|BB 1101|bb 1101|mesh-list
83587164|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587165|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
83587166|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
83587167|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587168|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587169|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587170|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
83587171|NCT04568837|Hormones|hormones|mesh-ancestor
83587172|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587173|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83587174|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587175|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
83587176|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587177|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587178|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
83587179|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83587180|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
83587181|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83587182|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
83587183|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587184|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587185|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
83587186|NCT04564469|Furosemide|furosemide|mesh-list
83587187|NCT04564469|Diuretics|diuretics|mesh-ancestor
83587188|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
83587189|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587190|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83587191|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83587192|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587193|NCT04564001|Infliximab|infliximab|mesh-list
83587194|NCT04564001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83587195|NCT04564001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587196|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
83587197|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587198|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83587199|NCT04568603|Islatravir|islatravir|mesh-list
83587200|NCT04568603|Methadone|methadone|mesh-list
83587201|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83587202|NCT04568603|Narcotics|narcotics|mesh-ancestor
83587203|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587204|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587205|NCT04568603|Analgesics|analgesics|mesh-ancestor
83587206|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
83587207|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587208|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
83587209|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
83587210|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
83587211|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587212|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587213|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587214|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83587215|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83587216|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83587217|NCT04563299|Prednisolone|prednisolone|mesh-list
83587218|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83587219|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
83587220|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83587221|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
83587222|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83587223|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
83587224|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587225|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
83587226|NCT04563299|Hormones|hormones|mesh-ancestor
83587227|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587228|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587229|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83587230|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587231|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
83587232|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
83587233|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587234|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587235|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83587236|NCT04563299|Protective Agents|protective agents|mesh-ancestor
83587237|NCT04561817|Paclitaxel|paclitaxel|mesh-list
83587238|NCT04561817|Ipatasertib|ipatasertib|mesh-list
83587239|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83587240|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587241|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
83587242|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
83587243|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
83587244|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587245|NCT04561817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83587246|NCT04561817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587247|NCT02211833|Pemetrexed|pemetrexed|mesh-list
83587248|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587249|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587250|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587251|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83587252|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83587253|NCT02211443|Antibodies|antibodies|mesh-list
83587254|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83587255|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
83587256|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587257|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
83587258|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83587259|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
83587260|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587261|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
83587262|NCT02211521|Protective Agents|protective agents|mesh-ancestor
83587263|NCT01597908|Trametinib|trametinib|mesh-list
83587264|NCT01597908|Vemurafenib|vemurafenib|mesh-list
83587265|NCT01597908|Dabrafenib|dabrafenib|mesh-list
83587266|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587267|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83587268|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587269|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587270|NCT01948908|Midazolam|midazolam|mesh-list
83587271|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83587272|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83587273|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587274|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587275|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83587276|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83587277|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83587278|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83587279|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
83587280|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
83587281|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
83587282|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
83587283|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587284|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587285|NCT01925274|Irinotecan|irinotecan|mesh-list
83587286|NCT01925274|Cetuximab|cetuximab|mesh-list
83587287|NCT01925274|Gedatolisib|gedatolisib|mesh-list
83587288|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83587289|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83587290|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587291|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587292|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587293|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045235|NCT05830799|Nintedanib|nintedanib|mesh-list
83587294|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83587295|NCT01948830|Ranibizumab|ranibizumab|mesh-list
83587296|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83587297|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83587298|NCT01948830|Growth Substances|growth substances|mesh-ancestor
83587299|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587300|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
83587301|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587302|NCT01972464|Progesterone|progesterone|mesh-list
83587303|NCT01972464|Progestins|progestins|mesh-ancestor
83587304|NCT01972464|Hormones|hormones|mesh-ancestor
83587305|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587306|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587307|NCT01924182|Morphine|morphine|mesh-list
83587308|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83587309|NCT01924182|Narcotics|narcotics|mesh-ancestor
83587310|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587311|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587312|NCT01924182|Analgesics|analgesics|mesh-ancestor
83587313|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
83587314|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587315|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
83587316|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
83587317|NCT01946880|Chloroquine|chloroquine|mesh-list
83587318|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83587319|NCT01946880|Prednisone|prednisone|mesh-list
83587320|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587321|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
83587322|NCT01946880|Hormones|hormones|mesh-ancestor
83587323|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587324|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587325|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83587326|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587327|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83587328|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83587329|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
83587330|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83587331|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587332|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587333|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587334|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
83587335|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83587336|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83587337|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83587338|NCT01946880|Amebicides|amebicides|mesh-ancestor
83587339|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83587340|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83587341|NCT01946880|Analgesics|analgesics|mesh-ancestor
83587342|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
83587343|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587344|NCT01946880|Filaricides|filaricides|mesh-ancestor
83587345|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
83587346|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
83587347|NCT01972152|Glucagon|glucagon|mesh-list
83587348|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587349|NCT01972152|Hormones|hormones|mesh-ancestor
83587350|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587351|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587352|NCT01972074|Memantine|memantine|mesh-list
83587353|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83587354|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83587355|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
83587356|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587357|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587358|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587359|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83587360|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83587361|NCT01618266|Dexamethasone|dexamethasone|mesh-list
83587362|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587363|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
83587364|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
83587365|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587366|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587367|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045310|NCT05731843|Ruzasvir|ruzasvir|mesh-list
83587368|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
83587369|NCT01618266|Hormones|hormones|mesh-ancestor
83587370|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587371|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83587372|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587373|NCT01918332|Valsartan|valsartan|mesh-list
83587374|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83587375|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83587376|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83587377|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
83587378|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587379|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83587380|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83587381|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587382|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83587383|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83587384|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83587385|NCT01922934|Topiramate|topiramate|mesh-list
83587386|NCT01922934|Phentermine|phentermine|mesh-list
83587387|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
83587388|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83587389|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587390|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83587391|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
83587392|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83587393|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
83587394|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
83587395|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587396|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587397|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587398|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587399|NCT01921140|Olaparib|olaparib|mesh-list
83587400|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83587401|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587402|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587403|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587404|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
83587405|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83587406|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83587407|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83587408|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83587409|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587410|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
83587411|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587412|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587413|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83587414|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587415|NCT01916226|Cetirizine|cetirizine|mesh-list
83587416|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83587417|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83587418|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83587419|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
83587420|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
83587421|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587422|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587423|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587424|NCT01915914|Fluticasone|fluticasone|mesh-list
83587425|NCT01915914|Xhance|xhance|mesh-list
83587426|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587427|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83587428|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
83587429|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587430|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587431|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83587432|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
83587433|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
83045382|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83045383|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83045384|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
83045385|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045386|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045387|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83045388|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83045389|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
83045390|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
83587435|NCT01968954|Bococizumab|bococizumab|mesh-list
83587436|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83587437|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83587438|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
83587439|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587440|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83587441|NCT01919190|Bupivacaine|bupivacaine|mesh-list
83587442|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
83587443|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
83587444|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587445|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587446|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
83587447|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587448|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83587449|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83587450|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83587451|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587452|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587453|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83587454|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83587455|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83587456|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83587457|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587458|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587459|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587460|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83587461|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83587462|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
83587463|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83587464|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83587465|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
83587466|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83587467|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83587468|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83587469|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83587470|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587471|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587472|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587473|NCT01914666|Analgesics|analgesics|mesh-ancestor
83587474|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
83587475|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587476|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
83587477|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83587478|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
83587479|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
83587480|NCT01913340|Hematinics|hematinics|mesh-ancestor
83587481|NCT01912872|Omalizumab|omalizumab|mesh-list
83587482|NCT01912872|Budesonide|budesonide|mesh-list
83587483|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
83587484|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587485|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83587486|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
83587487|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587488|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587489|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83587490|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
83587491|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
83587492|NCT01912872|Hormones|hormones|mesh-ancestor
83587493|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587494|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83587495|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83587496|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83587497|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587498|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362139|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83045456|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045457|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83045458|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045459|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
83045460|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045461|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
83045462|NCT05571514|Calcium|calcium|mesh-list
83587499|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587500|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83587501|NCT01911780|Amlodipine|amlodipine|mesh-list
83587502|NCT01911780|Telmisartan|telmisartan|mesh-list
83587503|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83587504|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83587505|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83587506|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83587507|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587508|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83587509|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587510|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
83587511|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83587512|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83587513|NCT01911780|Diuretics|diuretics|mesh-ancestor
83587514|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
83587515|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83587516|NCT01911546|Everolimus|everolimus|mesh-list
83587517|NCT01911546|Tacrolimus|tacrolimus|mesh-list
83587518|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83587519|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
83587520|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587521|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83587522|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587523|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587524|NCT01911546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83587525|NCT01911546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83587526|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587527|NCT01908816|Ranibizumab|ranibizumab|mesh-list
83587528|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83587529|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83587530|NCT01908816|Growth Substances|growth substances|mesh-ancestor
83587531|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587532|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
83587533|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587534|NCT01908582|Rifampin|rifampin|mesh-list
83587535|NCT01908582|Evacetrapib|evacetrapib|mesh-list
83587536|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83587537|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
83587538|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83587539|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587540|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
83587541|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83587542|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587543|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587544|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83587545|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83587546|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83587547|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83587548|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83587549|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83587550|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83587551|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83587552|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
83587553|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83587554|NCT01907100|Cisplatin|cisplatin|mesh-list
83587555|NCT01907100|Pemetrexed|pemetrexed|mesh-list
83587556|NCT01907100|Nintedanib|nintedanib|mesh-list
83587557|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587558|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587559|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587560|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83587561|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83587562|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83587563|NCT01889862|Dextrans|dextrans|mesh-list
83587564|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
83587565|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
83587566|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
83045534|NCT05361395|Carboplatin|carboplatin|mesh-list
83045535|NCT05361395|Etoposide|etoposide|mesh-list
83045536|NCT05361395|Atezolizumab|atezolizumab|mesh-list
83045537|NCT05361395|Durvalumab|durvalumab|mesh-list
83045538|NCT05361395|AMG 757|amg 757|mesh-list
83045539|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045547|NCT05351541|Zolpidem|zolpidem|mesh-list
83587567|NCT01887288|Capecitabine|capecitabine|mesh-list
83587568|NCT01887288|Digoxin|digoxin|mesh-list
83587569|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587570|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
83587571|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587572|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587573|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83587574|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83587575|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587576|NCT01887288|Protective Agents|protective agents|mesh-ancestor
83587577|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587578|NCT03405714|Brivaracetam|brivaracetam|mesh-list
83587579|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
83587580|NCT01885182|Oxycodone|oxycodone|mesh-list
83587581|NCT01885182|Naloxone|naloxone|mesh-list
83587582|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83587583|NCT01885182|Narcotics|narcotics|mesh-ancestor
83587584|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587585|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587586|NCT01885182|Analgesics|analgesics|mesh-ancestor
83587587|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
83587588|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587589|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83587590|NCT01885104|Bisacodyl|bisacodyl|mesh-list
83587591|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83587592|NCT01885104|Laxatives|laxatives|mesh-list
83587593|NCT01885104|Cathartics|cathartics|mesh-ancestor
83587594|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587595|NCT01906008|Minocycline|minocycline|mesh-list
83587596|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83587597|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587598|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
83587599|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83587600|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587601|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587602|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83587603|NCT01904760|Analgesics|analgesics|mesh-ancestor
83587604|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
83587605|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587606|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83587607|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83587608|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83587609|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587610|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587611|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587612|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83587613|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83587614|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587615|NCT01881126|Timolol|timolol|mesh-list
83587616|NCT01881126|Bimatoprost|bimatoprost|mesh-list
83587617|NCT01881126|Travoprost|travoprost|mesh-list
83587618|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587619|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83587620|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83587621|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587622|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587623|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587624|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83587625|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83587626|NCT01880736|Insulin|insulin|mesh-list
83587627|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83587628|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
83587629|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83587630|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587631|NCT01880424|Linaclotide|linaclotide|mesh-list
83587632|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83587633|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
84124603|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
83045604|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045605|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83045606|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83045607|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045608|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
83045609|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045610|NCT05298085|Oxytocin|oxytocin|mesh-list
83045611|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
83045612|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83045614|NCT05291598|Ketorolac|ketorolac|mesh-list
83587634|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587635|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587636|NCT01862874|Vaccines|vaccines|mesh-list
83587637|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
83587638|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587639|NCT01903434|Evacetrapib|evacetrapib|mesh-list
83587640|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83587641|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83587642|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
83587643|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587644|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83587645|NCT01903356|Linagliptin|linagliptin|mesh-list
83587646|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83587647|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587648|NCT01903356|Incretins|incretins|mesh-ancestor
83587649|NCT01903356|Hormones|hormones|mesh-ancestor
83587650|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587651|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83587652|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
83587653|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587654|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587655|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
83587656|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
83587657|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587658|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587659|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587660|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
83587661|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
83587662|NCT01902966|Propranolol|propranolol|mesh-list
83587663|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83587664|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83587665|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587666|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587667|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587668|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587669|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83587670|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83587671|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
83587672|NCT01862328|Paclitaxel|paclitaxel|mesh-list
83587673|NCT01862328|Docetaxel|docetaxel|mesh-list
83587674|NCT01862328|Carboplatin|carboplatin|mesh-list
83587675|NCT01862328|Gemcitabine|gemcitabine|mesh-list
83587676|NCT01862328|Pevonedistat|pevonedistat|mesh-list
83587677|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83587678|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587679|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
83587680|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
83587681|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
83587682|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587683|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587684|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
83587685|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587686|NCT01862250|Clonidine|clonidine|mesh-list
83587687|NCT01862250|Analgesics|analgesics|mesh-ancestor
83587688|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
83587689|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587690|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587691|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83587692|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
83587693|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
83587694|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83587695|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83587696|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83587697|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587698|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587699|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587700|NCT01876446|Irinotecan|irinotecan|mesh-list
83587701|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83045680|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045681|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
83045682|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045683|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045684|NCT05180097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045685|NCT05180097|Immunotoxins|immunotoxins|mesh-ancestor
83045688|NCT05171166|Leucovorin|leucovorin|mesh-list
83587702|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83587703|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587704|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587705|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587707|NCT04414800|Ketamine|ketamine|mesh-list
83587708|NCT04414800|Analgesics|analgesics|mesh-ancestor
83587709|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
83587710|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587711|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587712|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83587713|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83587714|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
83587715|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
83587716|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587717|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83587718|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83587719|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587720|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587721|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83587722|NCT04414800|Narcotics|narcotics|mesh-ancestor
83587723|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83587724|NCT01898442|Ticagrelor|ticagrelor|mesh-list
83587725|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83587726|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83587727|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83587728|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83587729|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
83587730|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587731|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587732|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587733|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
83587734|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83587735|NCT01898130|Bevacizumab|bevacizumab|mesh-list
83587736|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83587737|NCT01898130|Antibodies|antibodies|mesh-list
83587738|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
83587739|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83587740|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587741|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83587742|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83587743|NCT01898130|Growth Substances|growth substances|mesh-ancestor
83587744|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587745|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
83587746|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
83587747|NCT01876368|Olmesartan|olmesartan|mesh-list
83587748|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83587749|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83587750|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83587751|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83587752|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83587753|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587754|NCT01873950|Quinidine|quinidine|mesh-list
83587755|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
83587756|NCT01873950|Verapamil|verapamil|mesh-list
83587757|NCT01873950|Dofetilide|dofetilide|mesh-list
83587758|NCT01873950|Ranolazine|ranolazine|mesh-list
83587759|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83587760|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83587761|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83587762|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587763|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83587764|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587765|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
83587766|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83587767|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83587768|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83587769|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
83587770|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587771|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
83587772|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83587773|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83587774|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83045762|NCT05065866|Azacitidine|azacitidine|mesh-list
83587775|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587776|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83587777|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83587778|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
83587779|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83587780|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83587781|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83587782|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83587783|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83587784|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83587785|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83587786|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
83587787|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83587788|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587789|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83587790|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83587791|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83587792|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83587793|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83587794|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83587795|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83587796|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83587797|NCT01856790|Liraglutide|liraglutide|mesh-list
83587798|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83587799|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587800|NCT01856790|Incretins|incretins|mesh-ancestor
83587802|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587803|NCT01856322|Sulindac|sulindac|mesh-list
83587804|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83587805|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83587806|NCT01856322|Analgesics|analgesics|mesh-ancestor
83587807|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
83587808|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587809|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587810|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587811|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83587812|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587813|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83587814|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587815|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587816|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83587817|NCT01871532|Hormones|hormones|mesh-ancestor
83587818|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587819|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587820|NCT01855074|Risperidone|risperidone|mesh-list
83587821|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83587822|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
83587823|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587824|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587825|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587826|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83587827|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83587828|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587829|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83587830|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83587831|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
83587832|NCT01895322|Tolvaptan|tolvaptan|mesh-list
83587833|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83587834|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587835|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
83587836|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587837|NCT01894776|Maraviroc|maraviroc|mesh-list
83587838|NCT01894776|Rifabutin|rifabutin|mesh-list
83587839|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83587840|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83587841|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587842|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83587843|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83587844|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
83587845|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587846|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83587847|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83587848|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83587849|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
83587850|NCT01854918|Evolocumab|evolocumab|mesh-list
83587851|NCT01854918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83587852|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83587853|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83587854|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
83587855|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587856|NCT01854918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83587857|NCT01854918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83587858|NCT01854918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587859|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83587860|NCT01894152|Everolimus|everolimus|mesh-list
83587861|NCT01894152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83587862|NCT01894152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83587863|NCT01894152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587864|NCT01894152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587865|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83587866|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
83587867|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587868|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587869|NCT01854528|Interferons|interferons|mesh-list
83587870|NCT01854528|Ribavirin|ribavirin|mesh-list
83587871|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587872|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
83587873|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587874|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
83587875|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587876|NCT01853982|Tazobactam|tazobactam|mesh-list
83587877|NCT01853982|Piperacillin|piperacillin|mesh-list
83587878|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83587879|NCT01853982|Ceftolozane|ceftolozane|mesh-list
83587880|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83587881|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83587882|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587883|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83587884|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587885|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587886|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83587887|NCT01853280|Methylphenidate|methylphenidate|mesh-list
83587888|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83587889|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587890|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83587891|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83587892|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83587893|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587894|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
83587895|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83587896|NCT01891890|Lamotrigine|lamotrigine|mesh-list
83587897|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
83587898|NCT01891890|Levetiracetam|levetiracetam|mesh-list
83587899|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
83587900|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
83587901|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83587902|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83587903|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587904|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83587905|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587906|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83587907|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83587908|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587909|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83587910|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83587911|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83587912|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83587913|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83587914|NCT01852812|Montelukast|montelukast|mesh-list
83587915|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83587916|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
83045908|NCT04685616|Dacarbazine|dacarbazine|mesh-list
83045909|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83045910|NCT04685616|Vinblastine|vinblastine|mesh-list
83587917|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83587918|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
83587919|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587920|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587921|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83587922|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83587923|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587924|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
83587925|NCT01869192|Docetaxel|docetaxel|mesh-list
83587926|NCT01869192|Capecitabine|capecitabine|mesh-list
83587927|NCT01869192|Epirubicin|epirubicin|mesh-list
83587928|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83587929|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
83587930|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587931|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83587932|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83587933|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
83587934|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587935|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587936|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83587937|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
83587938|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
83587939|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
83587940|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83587941|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
83587942|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83587943|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83587944|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83587945|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587946|NCT01851720|Fentanyl|fentanyl|mesh-list
83587947|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83587948|NCT01851720|Narcotics|narcotics|mesh-ancestor
83587949|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83587950|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587951|NCT01851720|Analgesics|analgesics|mesh-ancestor
83587952|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
83587953|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587954|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83587955|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83587956|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
83587957|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
83587958|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
83587959|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83587960|NCT01851330|Ledipasvir|ledipasvir|mesh-list
83587961|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
83587962|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83587963|NCT01868022|Paclitaxel|paclitaxel|mesh-list
83587964|NCT01868022|Docetaxel|docetaxel|mesh-list
83587965|NCT01868022|Carboplatin|carboplatin|mesh-list
83587966|NCT01868022|Pemetrexed|pemetrexed|mesh-list
83587967|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83587968|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587969|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83587970|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83587971|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83587972|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587973|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587974|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83587975|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83587976|NCT01850004|Dasatinib|dasatinib|mesh-list
83587977|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587978|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83587979|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587980|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587981|NCT01867710|Dexamethasone|dexamethasone|mesh-list
83587982|NCT01867710|Prednisone|prednisone|mesh-list
83587983|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
83587984|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83587985|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
83587986|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
83587987|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83587988|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83587989|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83587990|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
83587991|NCT01867710|Hormones|hormones|mesh-ancestor
83587992|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83587993|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83587994|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83587995|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83587996|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83587997|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83587998|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
83587999|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83588001|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
83588002|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588003|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83588004|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83588005|NCT01832766|Analgesics|analgesics|mesh-ancestor
83588006|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
83588007|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588008|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83588009|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83588010|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588011|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588012|NCT01832766|Hormones|hormones|mesh-ancestor
83588013|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588014|NCT01832532|Liraglutide|liraglutide|mesh-list
83588015|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588016|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588017|NCT01832532|Incretins|incretins|mesh-ancestor
83588018|NCT01832532|Hormones|hormones|mesh-ancestor
83588019|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588020|NCT04414956|Vitamin K|vitamin k|mesh-list
83588021|NCT04414956|Agglutinins|agglutinins|mesh-list
83588022|NCT04414956|Vitamins|vitamins|mesh-ancestor
83588023|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
83588024|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588025|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83588026|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83588027|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588028|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
83588029|NCT04414956|Coagulants|coagulants|mesh-ancestor
83588030|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
83588031|NCT01848990|Insulin|insulin|mesh-list
83588032|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83588033|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
83588034|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
83588035|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
83588036|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588037|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588038|NCT01867086|Carboplatin|carboplatin|mesh-list
83588039|NCT01867086|Vaccines|vaccines|mesh-list
83588040|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
83588041|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588042|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588043|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
83588044|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588045|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588046|NCT01848834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83588047|NCT01848834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588048|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83588049|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
83588050|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588051|NCT01848210|Troxerutin|troxerutin|mesh-list
83588052|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
83046059|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046060|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
83046061|NCT04060030|Leucovorin|leucovorin|mesh-list
83046062|NCT04060030|Calcium|calcium|mesh-list
83046063|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
83046064|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83046065|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046066|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83046067|NCT04060030|Antidotes|antidotes|mesh-ancestor
83477014|NCT01108445|Everolimus|everolimus|mesh-list
83046068|NCT04060030|Protective Agents|protective agents|mesh-ancestor
83046069|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
83046070|NCT04060030|Vitamins|vitamins|mesh-ancestor
83046071|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
83046072|NCT04008797|Lenvatinib|lenvatinib|mesh-list
83046073|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046074|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83588053|NCT01830816|Ixazomib|ixazomib|mesh-list
83588054|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588055|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
83588056|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588057|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588058|NCT01846416|Atezolizumab|atezolizumab|mesh-list
83588059|NCT01846416|Antibodies|antibodies|mesh-list
83588060|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
83588061|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588062|NCT01846416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83588063|NCT01846416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588064|NCT01846416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588065|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588066|NCT04589754|Ifosfamide|ifosfamide|mesh-list
83588067|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588068|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588069|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83588070|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
83588071|NCT01846104|Vaccines|vaccines|mesh-list
83588072|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
83588073|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588074|NCT01803282|Leucovorin|leucovorin|mesh-list
83588075|NCT01803282|Paclitaxel|paclitaxel|mesh-list
83588076|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83588077|NCT01803282|Bevacizumab|bevacizumab|mesh-list
83588078|NCT01803282|Carboplatin|carboplatin|mesh-list
83588079|NCT01803282|Gemcitabine|gemcitabine|mesh-list
83588080|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
83588081|NCT01803282|Irinotecan|irinotecan|mesh-list
83588082|NCT01803282|Pemetrexed|pemetrexed|mesh-list
83588083|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83588084|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588085|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
83588086|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
83588087|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
83588088|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588089|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588090|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83588091|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83588092|NCT01803282|Growth Substances|growth substances|mesh-ancestor
83588093|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588094|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
83588095|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588096|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
83588097|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83588098|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83588099|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588100|NCT01803282|Antidotes|antidotes|mesh-ancestor
83588101|NCT01803282|Protective Agents|protective agents|mesh-ancestor
83588102|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
83588103|NCT01803282|Vitamins|vitamins|mesh-ancestor
83588104|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
83588105|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83588106|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83588107|NCT01844778|Tobramycin|tobramycin|mesh-list
83588108|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83046135|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
83046136|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83046137|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046138|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046139|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046140|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83046141|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83046142|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046143|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046144|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83046145|NCT03677596|Immunotoxins|immunotoxins|mesh-ancestor
83046146|NCT03677596|Immunoconjugates|immunoconjugates|mesh-ancestor
83046147|NCT03677596|Immunologic Factors|immunologic factors|mesh-ancestor
83477081|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
83046148|NCT03677596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046154|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
83046155|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046156|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046157|NCT03637803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046158|NCT03637803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588109|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588110|NCT01802580|Fluocinonide|fluocinonide|mesh-list
83588111|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588112|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
83588113|NCT01802580|Hormones|hormones|mesh-ancestor
83588114|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588115|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588116|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83588117|NCT01611090|Rituximab|rituximab|mesh-list
83588118|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83588119|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588120|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588121|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
83588122|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588123|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588124|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83588125|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
83588126|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588127|NCT01844700|Risperidone|risperidone|mesh-list
83588128|NCT01844700|Aripiprazole|aripiprazole|mesh-list
83588129|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83588130|NCT01844700|Ziprasidone|ziprasidone|mesh-list
83588131|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83588132|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
83588133|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588134|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588135|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588136|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83588137|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83588138|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83588139|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83588140|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83588141|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
83588142|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
83588143|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
83588144|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83588145|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83588146|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83588147|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83588148|NCT01827384|Carboplatin|carboplatin|mesh-list
83588149|NCT01827384|Everolimus|everolimus|mesh-list
83588150|NCT01827384|Temozolomide|temozolomide|mesh-list
83588151|NCT01827384|Trametinib|trametinib|mesh-list
83588152|NCT01827384|Veliparib|veliparib|mesh-list
83588153|NCT01827384|Adavosertib|adavosertib|mesh-list
83588154|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588155|NCT01827384|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83588156|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83588157|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588158|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588159|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588160|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
83588161|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588162|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83588163|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
83588164|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83588165|NCT01844076|Quinacrine|quinacrine|mesh-list
83588166|NCT01844076|Capecitabine|capecitabine|mesh-list
83588167|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588168|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
83588169|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588170|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588171|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
83588172|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83588173|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
83588174|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83588175|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588176|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
83588177|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83588178|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
83588179|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588180|NCT01826448|Vemurafenib|vemurafenib|mesh-list
83588181|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588182|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83588183|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588184|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588185|NCT01826370|Linagliptin|linagliptin|mesh-list
83588186|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588187|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588189|NCT01826370|Hormones|hormones|mesh-ancestor
83588190|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588191|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83588192|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
83588193|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588194|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588195|NCT01799226|Triclosan|triclosan|mesh-list
83588196|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83588197|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588198|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83588199|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83588200|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
83588201|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588202|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83588203|NCT01798992|Metoprolol|metoprolol|mesh-list
83588204|NCT01798992|Carvedilol|carvedilol|mesh-list
83588205|NCT01798992|Doxazosin|doxazosin|mesh-list
83588206|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83588207|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83588208|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
83588209|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
83588210|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588211|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588212|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83588213|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83588214|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83588215|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
83588216|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588217|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588218|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
83588219|NCT01798992|Protective Agents|protective agents|mesh-ancestor
83588220|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83588221|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588222|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83588223|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
83588224|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83588225|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83588226|NCT01798056|Vaccines|vaccines|mesh-list
83588227|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
83588228|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588229|NCT01824342|Denosumab|denosumab|mesh-list
83588230|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83588231|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588232|NCT01823328|Ketamine|ketamine|mesh-list
83588233|NCT01823328|Etomidate|etomidate|mesh-list
83588234|NCT01823328|Analgesics|analgesics|mesh-ancestor
83588235|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
83588236|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588237|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588238|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83588239|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83588240|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
83588241|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
83588242|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83588243|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83588244|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83588245|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588246|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588247|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83588248|NCT01840410|Ranibizumab|ranibizumab|mesh-list
83588249|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83588250|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83588251|NCT01840410|Growth Substances|growth substances|mesh-ancestor
83588252|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588253|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
83588254|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588255|NCT01797432|Triamcinolone|triamcinolone|mesh-list
83588256|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83588257|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83588258|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83588259|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588260|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
83588262|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588263|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588264|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588265|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
83588266|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588267|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588268|NCT01797120|Everolimus|everolimus|mesh-list
83588269|NCT01797120|MTOR Inhibitors|mtor inhibitors|mesh-list
83588270|NCT01797120|Fulvestrant|fulvestrant|mesh-list
83588271|NCT01797120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83588272|NCT01797120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588273|NCT01797120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588274|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588275|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
83588276|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588277|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588278|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83588279|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83588280|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83588281|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
83588282|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588283|NCT01796964|Aflibercept|aflibercept|mesh-list
83588284|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83588285|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83588286|NCT01796964|Growth Substances|growth substances|mesh-ancestor
83588287|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588288|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
83588289|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588290|NCT01794780|Fluticasone|fluticasone|mesh-list
83588291|NCT01794780|Budesonide|budesonide|mesh-list
83588292|NCT01794780|Theophylline|theophylline|mesh-list
83588293|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
83588294|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
83588295|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83588296|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588297|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83588298|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
83588299|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588300|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588301|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83588302|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
83588303|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
83588304|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83588305|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
83588306|NCT01794780|Hormones|hormones|mesh-ancestor
83588307|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588308|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83588309|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83588310|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83588311|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
83588312|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588313|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588314|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
83588315|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83588316|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
83588317|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83588318|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588319|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
83588320|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83588321|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83588322|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
83588323|NCT01838616|Oxycodone|oxycodone|mesh-list
83588324|NCT01838616|Tapentadol|tapentadol|mesh-list
83588325|NCT01838616|Naloxone|naloxone|mesh-list
83588326|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83588327|NCT01838616|Narcotics|narcotics|mesh-ancestor
83588328|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83588329|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588330|NCT01838616|Analgesics|analgesics|mesh-ancestor
83588331|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
83588332|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588333|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83588334|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83588335|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83588336|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588337|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588338|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
83588339|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588340|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83588341|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83588342|NCT01609218|Charcoal|charcoal|mesh-list
83588343|NCT01609218|Antidotes|antidotes|mesh-ancestor
83588344|NCT01609218|Protective Agents|protective agents|mesh-ancestor
83588345|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588346|NCT04580472|Clindamycin|clindamycin|mesh-list
83588347|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
83588348|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
83588349|NCT04580472|Cephalexin|cephalexin|mesh-list
83588350|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83588351|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588352|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83588353|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588354|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588355|NCT01611558|Ipilimumab|ipilimumab|mesh-list
83588356|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588357|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588358|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83588359|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588360|NCT01818726|Deferasirox|deferasirox|mesh-list
83588361|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83588362|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
83588363|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
83588364|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588365|NCT01818336|Amoxicillin|amoxicillin|mesh-list
83588366|NCT01818336|Penicillins|penicillins|mesh-list
83588367|NCT01818336|Penicillin G|penicillin g|mesh-list
83588368|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83588369|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588370|NCT01818258|Ritonavir|ritonavir|mesh-list
83588371|NCT01818258|Lopinavir|lopinavir|mesh-list
83588372|NCT01818258|Lamivudine|lamivudine|mesh-list
83588373|NCT01818258|Zidovudine|zidovudine|mesh-list
83588374|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83588375|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83588376|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
83588377|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588378|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588379|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83588380|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83588381|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
83588382|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588383|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83588384|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83588385|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83588386|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83588387|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
83588388|NCT01817790|Fluticasone|fluticasone|mesh-list
83588390|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588391|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83588392|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
83588393|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588394|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588395|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83588396|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
83588397|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
83588398|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83588399|NCT01793688|Ampicillin|ampicillin|mesh-list
83588400|NCT01793688|Sulbactam|sulbactam|mesh-list
83588401|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83588402|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588403|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83588404|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588405|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588406|NCT01792830|Metformin|metformin|mesh-list
83588407|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
83588408|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588409|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588410|NCT01792518|Linagliptin|linagliptin|mesh-list
83046443|NCT01969578|Paclitaxel|paclitaxel|mesh-list
83588411|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588412|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588413|NCT01792518|Incretins|incretins|mesh-ancestor
83588414|NCT01792518|Hormones|hormones|mesh-ancestor
83588415|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588416|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83588417|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
83588418|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588419|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588420|NCT01792284|Insulin|insulin|mesh-list
83588421|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83588422|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
83588423|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588424|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588425|NCT04414566|Cisplatin|cisplatin|mesh-list
83588426|NCT04414566|Gemcitabine|gemcitabine|mesh-list
83588427|NCT04414566|Docetaxel|docetaxel|mesh-list
83588428|NCT04414566|Fluorouracil|fluorouracil|mesh-list
83588429|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588430|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588431|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
83588432|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588433|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
83588434|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
83588435|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
83588436|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588437|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
83588438|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588439|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
83588440|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588441|NCT04592016|Diclofenac|diclofenac|mesh-list
83588442|NCT04592016|Coal Tar|coal tar|mesh-list
83588443|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83588444|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83588445|NCT04592016|Analgesics|analgesics|mesh-ancestor
83588446|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
83588447|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588448|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588449|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588450|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588451|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83588452|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588453|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588454|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
83588455|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
83588456|NCT01837680|Insulin|insulin|mesh-list
83588457|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83588458|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588459|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588460|NCT01836276|Varenicline|varenicline|mesh-list
83588461|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83588462|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83588463|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
83588464|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588465|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588466|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588467|NCT01790568|Methotrexate|methotrexate|mesh-list
83588468|NCT01790568|Vorinostat|vorinostat|mesh-list
83588469|NCT01790568|Tacrolimus|tacrolimus|mesh-list
83588470|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83588471|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
83588472|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83588473|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588474|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588475|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
83588476|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588477|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588478|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
83588479|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588480|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83588481|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588482|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
83588483|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588484|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83588485|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83588486|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83588487|NCT01836198|Clarithromycin|clarithromycin|mesh-list
83588488|NCT01836198|Ketoconazole|ketoconazole|mesh-list
83588489|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
83588490|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83588491|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588492|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83588493|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588494|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588495|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83588496|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83588497|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
83588498|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83588499|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83588500|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
83588501|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588502|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588503|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83588504|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
83588505|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83588506|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83588507|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83588508|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83588509|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588510|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83588511|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83588512|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588513|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588514|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
83588515|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588516|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
83588517|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588518|NCT01789320|Triamcinolone|triamcinolone|mesh-list
83588519|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83588520|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83588521|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83588522|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588523|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
83588524|NCT01789320|Hormones|hormones|mesh-ancestor
83588525|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588526|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588527|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588528|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
83588529|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588530|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588531|NCT01788228|Vaccines|vaccines|mesh-list
83588532|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
83588533|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588534|NCT01607346|Ezogabine|ezogabine|mesh-list
83588535|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
83588536|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588537|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588538|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83588539|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83588540|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588541|NCT01606800|Ribavirin|ribavirin|mesh-list
83588542|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
83588543|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83588544|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
83588545|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588546|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
83588547|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588548|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588549|NCT01814748|Metformin|metformin|mesh-list
83588550|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588551|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588552|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
83588553|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83588554|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83588555|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83588556|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588557|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588558|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
83588559|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588560|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588561|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83588562|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588563|NCT01814046|Aldesleukin|aldesleukin|mesh-list
83588564|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
83588565|NCT01814046|Fludarabine|fludarabine|mesh-list
83588566|NCT01814046|Interleukin-2|interleukin-2|mesh-list
83588567|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588568|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
83588569|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588570|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588571|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83588572|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
83588573|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588574|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588575|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83588576|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83588577|NCT01814046|Analgesics|analgesics|mesh-ancestor
83588578|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
83588579|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588580|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83588581|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83588582|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
83588583|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588584|NCT01813890|Tapentadol|tapentadol|mesh-list
83588585|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83588586|NCT01813890|Narcotics|narcotics|mesh-ancestor
83588587|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83588588|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588589|NCT01813890|Analgesics|analgesics|mesh-ancestor
83588590|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
83588591|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588592|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83588593|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83588594|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588595|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588596|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
83588597|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588598|NCT01813422|Evolocumab|evolocumab|mesh-list
83588599|NCT01813422|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83588600|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83588601|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83588602|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
83588603|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588604|NCT01813422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83588605|NCT01813422|Protease Inhibitors|protease inhibitors|mesh-ancestor
83588606|NCT01813422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588607|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83588608|NCT01786668|Tofacitinib|tofacitinib|mesh-list
83588609|NCT01786668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83588610|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83588611|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588612|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588613|NCT04414254|Cefprozil|cefprozil|mesh-list
83588614|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83588615|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588616|NCT01770912|Triamcinolone|triamcinolone|mesh-list
83588617|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83588618|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83588619|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83588620|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588621|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
83588622|NCT01770912|Hormones|hormones|mesh-ancestor
83588623|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588624|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588625|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588626|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
83588627|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588628|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588629|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
83588630|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83588631|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588632|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588633|NCT01811238|Oxycodone|oxycodone|mesh-list
83588634|NCT01811238|Naloxone|naloxone|mesh-list
83588635|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83588636|NCT01811238|Narcotics|narcotics|mesh-ancestor
83588637|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83588638|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588639|NCT01811238|Analgesics|analgesics|mesh-ancestor
83588640|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
83588641|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588642|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83588643|NCT01769508|Fluorouracil|fluorouracil|mesh-list
83588644|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
83588646|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
83588647|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588648|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588649|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588650|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588651|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
83588652|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588653|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83588654|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588655|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83588656|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
83588657|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
83588658|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83588659|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83588660|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83588661|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83588662|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588663|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
83588664|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588665|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588666|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
83588667|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
83588668|NCT01810302|Nicardipine|nicardipine|mesh-list
83588669|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83588670|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83588671|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588672|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588673|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83588674|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588675|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
83588676|NCT01783938|Nivolumab|nivolumab|mesh-list
83588677|NCT01783938|Ipilimumab|ipilimumab|mesh-list
83588678|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588679|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588680|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83588681|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588682|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
83588683|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
83588684|NCT01768572|Methotrexate|methotrexate|mesh-list
83588685|NCT01768572|Leflunomide|leflunomide|mesh-list
83588686|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83588687|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
83588688|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83588689|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588690|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588691|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
83588692|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588693|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588694|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83588695|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588696|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83588697|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588698|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
83588699|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588700|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83588701|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
83588702|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83588703|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83588704|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588705|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83588706|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83588707|NCT01768572|Analgesics|analgesics|mesh-ancestor
83588708|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
83046733|NCT05430802|Pemetrexed|pemetrexed|mesh-list
83588709|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588710|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588711|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83588712|NCT01783548|Beclomethasone|beclomethasone|mesh-list
83588713|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588714|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
83588715|NCT01783548|Hormones|hormones|mesh-ancestor
83588716|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588717|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588718|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83588719|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
83588720|NCT01809210|Carboplatin|carboplatin|mesh-list
83588721|NCT01809210|Gemcitabine|gemcitabine|mesh-list
83588722|NCT01809210|Pemetrexed|pemetrexed|mesh-list
83588723|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588724|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588725|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
83588726|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588727|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588728|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83588729|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83588730|NCT01809132|Zinc|zinc|mesh-list
83588731|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
83588732|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83588733|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83588734|NCT01809132|Prednisolone|prednisolone|mesh-list
83588735|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
83588736|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83588737|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
83588738|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
83588739|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83588740|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
83588741|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588742|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
83588743|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
83588744|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588745|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588746|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83588747|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
83588748|NCT01809132|Hormones|hormones|mesh-ancestor
83588749|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588750|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83588751|NCT01809132|Protective Agents|protective agents|mesh-ancestor
83588752|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83588753|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588754|NCT01809132|Trace Elements|trace elements|mesh-ancestor
83588755|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
83588756|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588757|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83588758|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588759|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588760|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83588761|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83588762|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
83588763|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83588764|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
83588765|NCT01809132|Astringents|astringents|mesh-ancestor
83588766|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
83588767|NCT01766778|Metformin|metformin|mesh-list
83588768|NCT01766778|Vildagliptin|vildagliptin|mesh-list
83588769|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588770|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588771|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83588772|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
83588773|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588774|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588775|NCT01808196|Losartan|losartan|mesh-list
83588776|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
83588777|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83588778|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83588779|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83588780|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83588781|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588782|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83588783|NCT01808118|Adalimumab|adalimumab|mesh-list
83588784|NCT01808118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83588785|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588786|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588787|NCT01782690|Gemcitabine|gemcitabine|mesh-list
83588788|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83588789|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588790|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
83588791|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588792|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588793|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83588794|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588796|NCT01766310|Hematinics|hematinics|mesh-ancestor
83588797|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
83588798|NCT01766310|Vitamins|vitamins|mesh-ancestor
83588799|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
83588800|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588801|NCT01782222|Rotigotine|rotigotine|mesh-list
83588802|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
83588803|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
83588804|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588805|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588806|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588807|NCT01807182|Aldesleukin|aldesleukin|mesh-list
83588808|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
83588809|NCT01807182|Fludarabine|fludarabine|mesh-list
83588810|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
83588811|NCT01807182|Interleukin-2|interleukin-2|mesh-list
83588812|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588813|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
83588814|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588815|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588816|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83588817|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
83588818|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588819|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588820|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83588821|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588822|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
83588823|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83588824|NCT01807182|Analgesics|analgesics|mesh-ancestor
83588825|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
83588826|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588827|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83588828|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83588829|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
83588830|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588831|NCT01765764|Bimatoprost|bimatoprost|mesh-list
83588832|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83588833|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83588834|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
83588835|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
83588836|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588837|NCT01780974|Protective Agents|protective agents|mesh-ancestor
83588838|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588839|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
83588840|NCT01780974|Vitamins|vitamins|mesh-ancestor
83588841|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
83588842|NCT01780662|Gemcitabine|gemcitabine|mesh-list
83588843|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83588844|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83588845|NCT01780662|Antibodies|antibodies|mesh-list
83588846|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
83588847|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83588848|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
83588849|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
83588850|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588851|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83588852|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
83588853|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588854|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588855|NCT01780662|Immunotoxins|immunotoxins|mesh-ancestor
83046873|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83046874|NCT03519542|Growth Substances|growth substances|mesh-ancestor
83046875|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588856|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83588857|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83588858|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83588859|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
83588860|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588861|NCT01762800|Fluticasone|fluticasone|mesh-list
83588862|NCT01762800|Xhance|xhance|mesh-list
83588863|NCT01762800|Bromides|bromides|mesh-list
83588864|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
83588865|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83588866|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83588867|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588868|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83588869|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
83588870|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588871|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588872|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83588873|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
83588874|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
83588875|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83588876|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
83588877|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83588878|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
83588879|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588880|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588881|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83588882|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83588883|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83588884|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
83588885|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
83588886|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
83588887|NCT01762800|Hormones|hormones|mesh-ancestor
83588888|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588889|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
83588890|NCT04562532|Sirolimus|sirolimus|mesh-list
83588891|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83588892|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83588893|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83588894|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588895|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
83588896|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588897|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
83588898|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588899|NCT01778010|Cocaine|cocaine|mesh-list
83588900|NCT01778010|Modafinil|modafinil|mesh-list
83588901|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83588902|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588903|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83588904|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83588905|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83588906|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588907|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
83588908|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
83588909|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83588910|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
83588911|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588912|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83588913|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83588914|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83588915|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588916|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
83588917|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588918|NCT01777854|Omeprazole|omeprazole|mesh-list
83588919|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83588920|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83588921|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83588922|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588923|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588924|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
83588925|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83588926|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83588927|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83588928|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83588929|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588930|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
83588931|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83588932|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588933|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83588934|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83588935|NCT01777542|Insulin|insulin|mesh-list
83588936|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83588937|NCT01777542|Mitogens|mitogens|mesh-list
83588938|NCT01777542|Mecasermin|mecasermin|mesh-list
83588939|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83588940|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588941|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83588942|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588943|NCT01777542|Growth Substances|growth substances|mesh-ancestor
83588944|NCT01777152|Prednisone|prednisone|mesh-list
83588945|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
83588946|NCT01777152|Doxorubicin|doxorubicin|mesh-list
83588947|NCT01777152|Vincristine|vincristine|mesh-list
83588948|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83588949|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83588950|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
83588951|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588952|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588953|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83588954|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
83588955|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588956|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588957|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83588958|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83588959|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83588960|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83588961|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588962|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83588963|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
83588964|NCT01777152|Hormones|hormones|mesh-ancestor
83588965|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83588966|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83588967|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83588968|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
83588969|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
83588970|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
83588971|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588972|NCT01777152|Immunotoxins|immunotoxins|mesh-ancestor
83588973|NCT01777152|Immunoconjugates|immunoconjugates|mesh-ancestor
83588974|NCT01775124|Ranibizumab|ranibizumab|mesh-list
83588975|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83588976|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83588977|NCT01775124|Growth Substances|growth substances|mesh-ancestor
83588978|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588979|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
83588980|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588981|NCT01733316|Cysteamine|cysteamine|mesh-list
83588982|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83588983|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588984|NCT01732926|Rituximab|rituximab|mesh-list
83588985|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83588986|NCT01732926|Idelalisib|idelalisib|mesh-list
83588987|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83588988|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83588989|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
83588990|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83588991|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83588992|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83588993|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
83588994|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83588995|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83588996|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
83588997|NCT01732770|Denosumab|denosumab|mesh-list
83588998|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83588999|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589000|NCT01774968|Insulin|insulin|mesh-list
83589001|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83589002|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589003|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
83589004|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589005|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589006|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83589007|NCT01755702|Acetaminophen|acetaminophen|mesh-list
83589008|NCT01755702|Ibuprofen|ibuprofen|mesh-list
83589009|NCT01755702|Caffeine|caffeine|mesh-list
83589010|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83589011|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589012|NCT01755702|Analgesics|analgesics|mesh-ancestor
83589013|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
83589014|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589015|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589016|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589017|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589018|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83589019|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589020|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589021|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
83589022|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83589023|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83589024|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83589025|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83589026|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
83589027|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589028|NCT01732458|Ondansetron|ondansetron|mesh-list
83589029|NCT01732458|Aprepitant|aprepitant|mesh-list
83589030|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
83589031|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
83589032|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
83589033|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589034|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589035|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83589036|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
83589037|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589038|NCT01732458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83589039|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83589040|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
83589041|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589042|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589043|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83589044|NCT01708902|Metformin|metformin|mesh-list
83589045|NCT01708902|Linagliptin|linagliptin|mesh-list
83589046|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83589047|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589048|NCT01708902|Incretins|incretins|mesh-ancestor
83589049|NCT01708902|Hormones|hormones|mesh-ancestor
83589050|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589051|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83589052|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
83589053|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589054|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589055|NCT01755546|Buprenorphine|buprenorphine|mesh-list
83589056|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83589057|NCT01755546|Narcotics|narcotics|mesh-ancestor
83589058|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589059|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589060|NCT01755546|Analgesics|analgesics|mesh-ancestor
83589061|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
83589062|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589063|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83589064|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
83589065|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83589066|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589067|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589068|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589069|NCT04413864|Analgesics|analgesics|mesh-ancestor
83589070|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
83589071|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589072|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83589073|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83589074|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83589075|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
83478052|NCT01481545|Vitamins|vitamins|mesh-ancestor
83589076|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589077|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589078|NCT01755234|Propofol|propofol|mesh-list
83589079|NCT01755234|Sevoflurane|sevoflurane|mesh-list
83589080|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83589081|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589082|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589083|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83589084|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
83589085|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
83589086|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83589087|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83589088|NCT01730586|Paclitaxel|paclitaxel|mesh-list
83589089|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83589090|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83589091|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589092|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
83589093|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
83589094|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
83589095|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589096|NCT01755156|Metformin|metformin|mesh-list
83589097|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
83589098|NCT01755156|Glimepiride|glimepiride|mesh-list
83589099|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83589100|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589101|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83589102|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589103|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
83589104|NCT01754376|Aldesleukin|aldesleukin|mesh-list
83589105|NCT01754376|Interleukin-2|interleukin-2|mesh-list
83589106|NCT01754376|Vemurafenib|vemurafenib|mesh-list
83589107|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589108|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589109|NCT01754376|Analgesics|analgesics|mesh-ancestor
83589110|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
83589111|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589112|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589113|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83589114|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83589115|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
83589116|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589117|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83589118|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589119|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589120|NCT01605396|Exemestane|exemestane|mesh-list
83589121|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589122|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83589123|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83589124|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589125|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589126|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83589127|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
83589128|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589129|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589130|NCT01730118|Mitogens|mitogens|mesh-list
83589131|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83589132|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589133|NCT01730040|Atorvastatin|atorvastatin|mesh-list
83589134|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83589135|NCT01730040|Ezetimibe|ezetimibe|mesh-list
83589136|NCT01730040|Alirocumab|alirocumab|mesh-list
83589137|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83589138|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83589139|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
83589140|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589141|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83589142|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83589143|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589144|NCT01730040|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83589145|NCT01730040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83589146|NCT01730040|Protease Inhibitors|protease inhibitors|mesh-ancestor
83589147|NCT01706328|Fluticasone|fluticasone|mesh-list
83589148|NCT01706328|Xhance|xhance|mesh-list
83589149|NCT01706328|Albuterol|albuterol|mesh-list
83589150|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83589151|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589152|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83589153|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
83589154|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589155|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589156|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83047173|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83047174|NCT03748966|Calcitriol|calcitriol|mesh-list
83047175|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83589157|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
83589158|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589159|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83589160|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83589161|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83589162|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83589163|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
83589164|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589165|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589166|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
83589167|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83589168|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
83589169|NCT01706250|Salicylates|salicylates|mesh-list
83589170|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589171|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
83589172|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
83589173|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589174|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83589175|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589176|NCT01706250|Analgesics|analgesics|mesh-ancestor
83589177|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
83589178|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589179|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589180|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589181|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589182|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83589183|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589184|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589185|NCT01729728|Tapentadol|tapentadol|mesh-list
83589186|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83589187|NCT01729728|Narcotics|narcotics|mesh-ancestor
83589188|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589189|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589190|NCT01729728|Analgesics|analgesics|mesh-ancestor
83589191|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
83589192|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589193|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83589194|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83589195|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83589196|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589197|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
83589198|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589199|NCT01728324|Ribavirin|ribavirin|mesh-list
83589200|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
83589201|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589202|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
83589203|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589204|NCT01728246|Acetaminophen|acetaminophen|mesh-list
83589205|NCT01728246|Tramadol|tramadol|mesh-list
83589206|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589207|NCT01728246|Analgesics|analgesics|mesh-ancestor
83589208|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
83589209|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589210|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589211|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
83589212|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83589213|NCT01728246|Narcotics|narcotics|mesh-ancestor
83589214|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589215|NCT04414020|Progesterone|progesterone|mesh-list
83589216|NCT04414020|Progestins|progestins|mesh-ancestor
83589217|NCT04414020|Hormones|hormones|mesh-ancestor
83589218|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589219|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589220|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83589221|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83478195|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
83589222|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589223|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589224|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
83589225|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589226|NCT01751802|Ecopipam|ecopipam|mesh-list
83589227|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83589228|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83589229|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589230|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589231|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83047257|NCT05891119|Vitamin K|vitamin k|mesh-list
83589232|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83589233|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
83589234|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589235|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589236|NCT01703286|Glimepiride|glimepiride|mesh-list
83589237|NCT01703286|Linagliptin|linagliptin|mesh-list
83589238|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83589239|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83589240|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589241|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589242|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
83589243|NCT01703286|Incretins|incretins|mesh-ancestor
83589244|NCT01703286|Hormones|hormones|mesh-ancestor
83589245|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589246|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83589247|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
83589248|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589249|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589250|NCT01727700|Aripiprazole|aripiprazole|mesh-list
83589251|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
83589252|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83589253|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83589254|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83589255|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589256|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589257|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
83589258|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
83589259|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589260|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589261|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83589262|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83589263|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
83589264|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83589265|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83589266|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83589267|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83589268|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83589269|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
83589270|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83589271|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83589272|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83589273|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589274|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589275|NCT01725126|Metformin|metformin|mesh-list
83589276|NCT01725126|Liraglutide|liraglutide|mesh-list
83589277|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83589278|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589279|NCT01725126|Incretins|incretins|mesh-ancestor
83589280|NCT01725126|Hormones|hormones|mesh-ancestor
83589281|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589282|NCT01751724|Caffeine|caffeine|mesh-list
83589283|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
83589284|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589285|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83589286|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589287|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83589288|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589289|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83589290|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83589291|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
83589292|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589293|NCT01751646|Vitamin D|vitamin d|mesh-list
83589294|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
83589295|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
83589296|NCT01751646|Vitamins|vitamins|mesh-list
83589297|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
83589298|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589299|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83589300|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83589301|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
83589302|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83589303|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83589304|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
83589305|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589306|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83589307|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83589308|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589309|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589310|NCT01751178|Ethanol|ethanol|mesh-list
83589311|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
83589312|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83589313|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83589314|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589315|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589316|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589317|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
83589318|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589319|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83589320|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83589321|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83589322|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589323|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589324|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83589325|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83589326|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83589327|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
83589328|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589329|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589330|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83589331|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83589332|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
83589333|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
83589334|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
83589335|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589336|NCT01722162|Bevacizumab|bevacizumab|mesh-list
83589337|NCT01722162|Capecitabine|capecitabine|mesh-list
83589338|NCT01722162|Levocetirizine|levocetirizine|mesh-list
83589339|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589340|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589341|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83589342|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83589343|NCT01722162|Growth Substances|growth substances|mesh-ancestor
83589344|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589345|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
83589346|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83589347|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
83589348|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589349|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83589350|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83589351|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
83589352|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
83589353|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589354|NCT01721772|Nivolumab|nivolumab|mesh-list
83589355|NCT01721772|Dacarbazine|dacarbazine|mesh-list
83589356|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589357|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589358|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83589359|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589360|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83589361|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
83589362|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83589363|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
83589364|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589365|NCT01701258|Amisulpride|amisulpride|mesh-list
83589366|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83589367|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83589368|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589369|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589370|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83589371|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83589372|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
83589373|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589374|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589375|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83589376|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
83589377|NCT01700946|Cytarabine|cytarabine|mesh-list
83589378|NCT01700946|Aldesleukin|aldesleukin|mesh-list
83589379|NCT01700946|Dexamethasone|dexamethasone|mesh-list
83589380|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
83589381|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83589382|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83589383|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83589384|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
83589385|NCT01700946|Rituximab|rituximab|mesh-list
83589386|NCT01700946|Methotrexate|methotrexate|mesh-list
83589387|NCT01700946|Etoposide|etoposide|mesh-list
83589388|NCT01700946|Vincristine|vincristine|mesh-list
83589389|NCT01700946|Interleukin-2|interleukin-2|mesh-list
83589390|NCT01700946|Asparaginase|asparaginase|mesh-list
83589391|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
83589392|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
83589393|NCT01700946|Clofarabine|clofarabine|mesh-list
83589394|NCT01700946|Vinblastine|vinblastine|mesh-list
83589395|NCT01700946|Pegaspargase|pegaspargase|mesh-list
83589396|NCT01700946|Teniposide|teniposide|mesh-list
83589397|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589398|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
83589399|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589400|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589401|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83589402|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
83589403|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589404|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589405|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83589406|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589407|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589408|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
83589409|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
83589410|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589411|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83589412|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
83589413|NCT01700946|Hormones|hormones|mesh-ancestor
83589414|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589415|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83589416|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83589417|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
83589418|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83589419|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83589420|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
83589421|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589422|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589423|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83589424|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83589425|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83589426|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83589427|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83589428|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
83589429|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589430|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
83589431|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
83589432|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
83589433|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589434|NCT01700946|Analgesics|analgesics|mesh-ancestor
83589435|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
83589436|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83589437|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83589438|NCT01748994|Pioglitazone|pioglitazone|mesh-list
83589439|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83589440|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589441|NCT01721070|Ketoconazole|ketoconazole|mesh-list
83589442|NCT01721070|Sufentanil|sufentanil|mesh-list
83589444|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83589445|NCT01721070|Narcotics|narcotics|mesh-ancestor
83589446|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478423|NCT00349778|Melphalan|melphalan|mesh-list
83589447|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589448|NCT01721070|Analgesics|analgesics|mesh-ancestor
83589449|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
83589450|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589451|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83589452|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83589453|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
83589454|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
83589455|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
83589456|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589457|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83589458|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83589459|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589460|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589461|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83589462|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
83589463|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589464|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83589465|NCT01748292|Ranibizumab|ranibizumab|mesh-list
83589466|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83589467|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83589468|NCT01748292|Growth Substances|growth substances|mesh-ancestor
83589469|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589470|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
83589471|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589472|NCT01720602|Letrozole|letrozole|mesh-list
83589473|NCT01720602|Anastrozole|anastrozole|mesh-list
83589474|NCT01720602|Vorinostat|vorinostat|mesh-list
83589475|NCT01720602|Exemestane|exemestane|mesh-list
83589476|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83589477|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589478|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83589479|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83589480|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589481|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589482|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83589483|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
83589484|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589485|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589486|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83589487|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83589488|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83589489|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
83589490|NCT01746732|Evacetrapib|evacetrapib|mesh-list
83589491|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83589492|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83589493|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83589494|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
83589495|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589496|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83589497|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83589498|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589499|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83589500|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83589501|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589502|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589503|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83589504|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
83589505|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83589506|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589507|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83589508|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83589509|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83589510|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
83589511|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
83589512|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83589513|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83589514|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589515|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589516|NCT01720524|Urological Agents|urological agents|mesh-ancestor
83589517|NCT01717638|Vaccines|vaccines|mesh-list
83589518|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
83478504|NCT00306488|Antioxidants|antioxidants|mesh-list
83589519|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589520|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
83589521|NCT01745094|Mirabegron|mirabegron|mesh-list
83589522|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83589523|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83589524|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
83589525|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589526|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589527|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589528|NCT01745094|Urological Agents|urological agents|mesh-ancestor
83589529|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83589530|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83589531|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83589532|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83589533|NCT01717326|Ribavirin|ribavirin|mesh-list
83589534|NCT01717326|Grazoprevir|grazoprevir|mesh-list
83589535|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
83589536|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589537|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
83589538|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589539|NCT01744782|Cysteamine|cysteamine|mesh-list
83589540|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83589541|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589542|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
83589543|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
83589544|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589545|NCT01742286|Ceritinib|ceritinib|mesh-list
83589546|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589547|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83589548|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589549|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589550|NCT01716234|Posaconazole|posaconazole|mesh-list
83589551|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
83589552|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589553|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83589554|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83589555|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83589556|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83589557|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83589558|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589559|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589560|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83589561|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
83589562|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589563|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589564|NCT01716156|Ribavirin|ribavirin|mesh-list
83589565|NCT01716156|Grazoprevir|grazoprevir|mesh-list
83589566|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
83589567|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589568|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
83589569|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589570|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
83589571|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83589572|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
83589573|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589574|NCT01739790|Expectorants|expectorants|mesh-ancestor
83589575|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
83589576|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83589577|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
83589578|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589579|NCT01739790|Protective Agents|protective agents|mesh-ancestor
83589580|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589581|NCT01739790|Antidotes|antidotes|mesh-ancestor
83589582|NCT01696032|Paclitaxel|paclitaxel|mesh-list
83589583|NCT01696032|Carboplatin|carboplatin|mesh-list
83589584|NCT01696032|Gemcitabine|gemcitabine|mesh-list
83589585|NCT01696032|Doxorubicin|doxorubicin|mesh-list
83589586|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83589587|NCT01696032|Topotecan|topotecan|mesh-list
83589588|NCT01696032|Guadecitabine|guadecitabine|mesh-list
83589589|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83589590|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589591|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
83589592|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
83589593|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
83589594|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589595|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83589596|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
83589597|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83589598|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83589599|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83589600|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589601|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83589602|NCT01695954|Ritonavir|ritonavir|mesh-list
83589603|NCT01695954|Darunavir|darunavir|mesh-list
83589604|NCT01695954|Efavirenz|efavirenz|mesh-list
83589605|NCT01695954|Pitavastatin|pitavastatin|mesh-list
83589606|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83589607|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83589608|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
83047626|NCT05760378|Carboplatin|carboplatin|mesh-list
83589609|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589610|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589611|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83589612|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83589613|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
83589614|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589615|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83589616|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83589617|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83589618|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83589619|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83589620|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83589621|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83589622|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83589623|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83589624|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83589625|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83589626|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83589627|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
83589628|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83589629|NCT01694706|Omeprazole|omeprazole|mesh-list
83589630|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83589631|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83589632|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83589633|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589634|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589635|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
83589636|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83589637|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83589638|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83589639|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
83589640|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589641|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589642|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589643|NCT01739400|Macitentan|macitentan|mesh-list
83589644|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83589645|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83589646|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589647|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83589648|NCT01712178|Adalimumab|adalimumab|mesh-list
83589649|NCT01712178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83589650|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589651|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589652|NCT01693068|Dacarbazine|dacarbazine|mesh-list
83589653|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83589654|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
83589655|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589656|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589657|NCT01691898|Rituximab|rituximab|mesh-list
83589658|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
83589659|NCT01691898|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83589660|NCT01691898|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
83589661|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589662|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589663|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
83589664|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589665|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589666|NCT01691898|Immunoconjugates|immunoconjugates|mesh-ancestor
83589667|NCT01737840|Pantoprazole|pantoprazole|mesh-list
83589668|NCT01737840|Ranitidine|ranitidine|mesh-list
83047703|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047704|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
83047705|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83047706|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83047707|NCT05663957|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83047708|NCT05663957|Antiviral Agents|antiviral agents|mesh-ancestor
83047709|NCT05663957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047710|NCT05660967|Lenalidomide|lenalidomide|mesh-list
83047711|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
83047712|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047713|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83047714|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83047715|NCT05660967|Growth Substances|growth substances|mesh-ancestor
83589669|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83589670|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83589671|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83589672|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83589673|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589674|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589675|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83589676|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
83589677|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
83589678|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589679|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589680|NCT01711866|Rotigotine|rotigotine|mesh-list
83589681|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
83589682|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
83589683|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589684|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589685|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589686|NCT01691508|Prednisone|prednisone|mesh-list
83589687|NCT01691508|Prednisolone|prednisolone|mesh-list
83589688|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589689|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
83589690|NCT01691508|Hormones|hormones|mesh-ancestor
83589691|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589692|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589693|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83589694|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589695|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83589696|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
83589697|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83589698|NCT01709838|Deferasirox|deferasirox|mesh-list
83589699|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83589700|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
83589701|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
83589702|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589703|NCT01688466|Pomalidomide|pomalidomide|mesh-list
83589704|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
83589705|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589706|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83589707|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83589708|NCT01688466|Growth Substances|growth substances|mesh-ancestor
83589709|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
83589710|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589711|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
83589712|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83589713|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83589714|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83589715|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83589716|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589717|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
83589718|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589719|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589720|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83589721|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589722|NCT01681992|Vaccines|vaccines|mesh-list
83589723|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
83589724|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589725|NCT01687998|Evacetrapib|evacetrapib|mesh-list
83589726|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83589727|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83589728|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
83589729|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589730|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83589731|NCT01681212|Ipilimumab|ipilimumab|mesh-list
83589732|NCT01681212|Dacarbazine|dacarbazine|mesh-list
83589733|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589734|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589735|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83589736|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589737|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83589738|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
83589739|NCT01687296|Fluticasone|fluticasone|mesh-list
83589740|NCT01687296|Xhance|xhance|mesh-list
83589741|NCT01687296|Prednisone|prednisone|mesh-list
83589742|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83589743|NCT01687296|Albuterol|albuterol|mesh-list
83589744|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589745|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
83589746|NCT01687296|Hormones|hormones|mesh-ancestor
83589747|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589748|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589749|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83589750|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589751|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83589752|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
83589753|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589754|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83589755|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
83589756|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589757|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83589758|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
83589759|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83589760|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83589761|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83589762|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83589763|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
83589764|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589765|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589766|NCT01568892|Dolutegravir|dolutegravir|mesh-list
83589767|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83589768|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83589769|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589770|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589771|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83589772|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83589773|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
83589774|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589775|NCT01568112|Aspirin|aspirin|mesh-list
83589776|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83589777|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83589778|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589779|NCT01568112|Analgesics|analgesics|mesh-ancestor
83589780|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
83589781|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589782|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589783|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589784|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589785|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83589786|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83589787|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589788|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83589789|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83589790|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589791|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
83589792|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589793|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589794|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
83589795|NCT01568034|Levodopa|levodopa|mesh-list
83589796|NCT01568034|Carbidopa|carbidopa|mesh-list
83589797|NCT01568034|Opicapone|opicapone|mesh-list
83589798|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83589799|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83589800|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
83589801|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589802|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589803|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589804|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83589805|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589806|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83589807|NCT01687218|Tenofovir|tenofovir|mesh-list
83589808|NCT01687218|Emtricitabine|emtricitabine|mesh-list
83589809|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83589810|NCT01687218|Glycerol|glycerol|mesh-list
83589811|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
83589812|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047853|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047854|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047855|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83047856|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
83047857|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83047863|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
83047931|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
83589813|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83589814|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83589815|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589816|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589817|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83589818|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83589819|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83589820|NCT01687218|Protective Agents|protective agents|mesh-ancestor
83589821|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589823|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
83589824|NCT01686828|Acyline|acyline|mesh-list
83589825|NCT01686828|Testosterone|testosterone|mesh-list
83589826|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
83589827|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
83589828|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83589829|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589830|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83589831|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83589832|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589833|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589834|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83589835|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
83589836|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589837|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589838|NCT01686828|Androgens|androgens|mesh-ancestor
83589839|NCT01686828|Hormones|hormones|mesh-ancestor
83589840|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83589841|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
83589842|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
83589843|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83589844|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83589845|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83589846|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83589847|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589848|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
83589849|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589850|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589851|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83589852|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589853|NCT01684878|Paclitaxel|paclitaxel|mesh-list
83589854|NCT01684878|Gemcitabine|gemcitabine|mesh-list
83589855|NCT01684878|Topotecan|topotecan|mesh-list
83589856|NCT01684878|Pertuzumab|pertuzumab|mesh-list
83589857|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83589858|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589859|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
83589860|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
83589861|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
83589862|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589863|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83589864|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
83589865|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83589866|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83589867|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589868|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589869|NCT01684722|Vitamin D|vitamin d|mesh-list
83589870|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
83589871|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
83589872|NCT01684722|Vitamins|vitamins|mesh-list
83589873|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
83589874|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589875|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83589876|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83589877|NCT01592292|Adalimumab|adalimumab|mesh-list
83589878|NCT01592292|Infliximab|infliximab|mesh-list
83589879|NCT01592292|Etanercept|etanercept|mesh-list
83589880|NCT01592292|Rituximab|rituximab|mesh-list
83589881|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589882|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589883|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
83589884|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589885|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589886|NCT01592292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83589887|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83589888|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
83589889|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83589890|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83589891|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83589892|NCT01592292|Analgesics|analgesics|mesh-ancestor
83589893|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
83589894|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589895|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589896|NCT01565850|Darunavir|darunavir|mesh-list
83589897|NCT01565850|Cobicistat|cobicistat|mesh-list
83589898|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589899|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589900|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
83589901|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589902|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83589903|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83589904|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83589905|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83589906|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83589907|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83589908|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83589909|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
83589910|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83589911|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83589912|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83589913|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83589914|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589915|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589916|NCT01565694|Urological Agents|urological agents|mesh-ancestor
83589917|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
83589918|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589919|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
83589920|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589921|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589922|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83589923|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
83589924|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589925|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589926|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83589927|NCT01565148|Ranibizumab|ranibizumab|mesh-list
83589928|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83589929|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83589930|NCT01565148|Growth Substances|growth substances|mesh-ancestor
83589931|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589932|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
83589933|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589934|NCT04410354|Remdesivir|remdesivir|mesh-list
83589935|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
83589936|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589937|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
83589938|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589939|NCT01564758|Linezolid|linezolid|mesh-list
83589940|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83589941|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589942|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83589943|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589944|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589945|NCT01589094|Gemcitabine|gemcitabine|mesh-list
83589946|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589947|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83589948|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
83589949|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589950|NCT01563354|Everolimus|everolimus|mesh-list
83589951|NCT01563354|Pasireotide|pasireotide|mesh-list
83589952|NCT01563354|Somatostatin|somatostatin|mesh-list
83589953|NCT01563354|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83589954|NCT01563354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83589955|NCT01563354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83589956|NCT01563354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589957|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589958|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
83589959|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589960|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589961|NCT01563354|Hormones|hormones|mesh-ancestor
84124604|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589962|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83589963|NCT03027960|Empagliflozin|empagliflozin|mesh-list
83589964|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83589965|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589966|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83589967|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589968|NCT01539642|Sufentanil|sufentanil|mesh-list
83589969|NCT01539642|Dsuvia|dsuvia|mesh-list
83589970|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83589971|NCT01539642|Narcotics|narcotics|mesh-ancestor
83589972|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83589973|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589974|NCT01539642|Analgesics|analgesics|mesh-ancestor
83589975|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
83589976|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83589977|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83589978|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83589979|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
83589980|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
83589981|NCT01538472|Cytarabine|cytarabine|mesh-list
83589982|NCT01538472|Rituximab|rituximab|mesh-list
83589983|NCT01538472|Melphalan|melphalan|mesh-list
83589984|NCT01538472|Carmustine|carmustine|mesh-list
83589985|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83589986|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83589987|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83589988|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
83589989|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83589990|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83589991|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83589992|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
83589993|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83589994|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
83589995|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83589996|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83589997|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83589998|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
83589999|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83590000|NCT01562028|Bevacizumab|bevacizumab|mesh-list
83590001|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83590002|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83590003|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590004|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83590005|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83590006|NCT01562028|Growth Substances|growth substances|mesh-ancestor
83590007|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590008|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83590009|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83590010|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590011|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590012|NCT04767828|Capecitabine|capecitabine|mesh-list
83590013|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83590014|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
83590015|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590016|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590017|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
83590018|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590019|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048080|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048081|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83048082|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
83048083|NCT04900792|Temozolomide|temozolomide|mesh-list
83048084|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83048085|NCT04900792|Vitamins|vitamins|mesh-ancestor
83048086|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
83048087|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048088|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048089|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
83048090|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048091|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048092|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
83048093|NCT04900792|Protective Agents|protective agents|mesh-ancestor
83048094|NCT04900792|Hematinics|hematinics|mesh-ancestor
83048096|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83590020|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83590021|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83590022|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83590023|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590024|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590025|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590026|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590027|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
83590028|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83590029|NCT01585428|Aldesleukin|aldesleukin|mesh-list
83590030|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
83590031|NCT01585428|Fludarabine|fludarabine|mesh-list
83590032|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590033|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
83590034|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590035|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590036|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83590037|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
83590038|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590039|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590040|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83590041|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83590042|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83590043|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
83590044|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590045|NCT01585272|Rivastigmine|rivastigmine|mesh-list
83590046|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83590047|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590048|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590049|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
83590050|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590051|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590052|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83590053|NCT01585272|Protective Agents|protective agents|mesh-ancestor
83590054|NCT01585194|Nivolumab|nivolumab|mesh-list
83590055|NCT01585194|Ipilimumab|ipilimumab|mesh-list
83590056|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83590057|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590058|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83590059|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590060|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83590061|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83590062|NCT01585038|Efavirenz|efavirenz|mesh-list
83590063|NCT01585038|Rilpivirine|rilpivirine|mesh-list
83590064|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83590065|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83590066|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590067|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590068|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
83590069|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590070|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83590071|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83590072|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83590073|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83590074|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83590075|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83590076|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83590077|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83590078|NCT01559844|Ribavirin|ribavirin|mesh-list
83590079|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
83590080|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
83590081|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590082|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
83590083|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590084|NCT01584648|Trametinib|trametinib|mesh-list
83590085|NCT01584648|Dabrafenib|dabrafenib|mesh-list
83590086|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590087|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83590088|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590089|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590090|NCT01559454|Buprenorphine|buprenorphine|mesh-list
83590091|NCT01559454|Methadone|methadone|mesh-list
83590092|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83590093|NCT01559454|Naloxone|naloxone|mesh-list
83590094|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83590095|NCT01559454|Narcotics|narcotics|mesh-ancestor
83590096|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590097|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590098|NCT01559454|Analgesics|analgesics|mesh-ancestor
83590099|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
83590100|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590101|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83590102|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
83590103|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590104|NCT01583166|Epinephrine|epinephrine|mesh-list
83590105|NCT01583166|Bupivacaine|bupivacaine|mesh-list
83590106|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
83590107|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
83590108|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590109|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590110|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
83590111|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590112|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83590113|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83590114|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590115|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590116|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590117|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83590118|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83590119|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
83590120|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83590121|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590122|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
83590123|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
83590124|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83590125|NCT01582854|Actovegin|actovegin|mesh-list
83590126|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83590127|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590128|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83590129|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83590130|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
83590131|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590132|NCT01582854|Protective Agents|protective agents|mesh-ancestor
83590133|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83590134|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83590135|NCT01582308|Vildagliptin|vildagliptin|mesh-list
83590136|NCT01582308|Saxagliptin|saxagliptin|mesh-list
83590137|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590138|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590139|NCT01582308|Incretins|incretins|mesh-ancestor
83590140|NCT01582308|Hormones|hormones|mesh-ancestor
83590141|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590142|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83590143|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
83590144|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590145|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590146|NCT01558674|Torsemide|torsemide|mesh-list
83590147|NCT01558674|Furosemide|furosemide|mesh-list
83590148|NCT01558674|Diuretics|diuretics|mesh-ancestor
83590149|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
83590150|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590151|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83590152|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590153|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590154|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83590155|NCT01535040|Memantine|memantine|mesh-list
83590156|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83590157|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83590158|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
83590159|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590160|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590161|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590162|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83590163|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83590164|NCT01534962|Ranolazine|ranolazine|mesh-list
83590165|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83590166|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590167|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590169|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83590170|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590171|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83590172|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83590173|NCT01582152|Growth Substances|growth substances|mesh-ancestor
83590174|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590175|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83590176|NCT01557504|Metformin|metformin|mesh-list
83590177|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83590178|NCT01557504|Hormones|hormones|mesh-list
83590179|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590180|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590181|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590182|NCT01557504|Incretins|incretins|mesh-ancestor
83590183|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83590184|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
83590185|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590186|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590187|NCT01580670|Infliximab|infliximab|mesh-list
83590188|NCT01580670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83590189|NCT01580670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590190|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
83590191|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83590192|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590193|NCT01534260|Bortezomib|bortezomib|mesh-list
83590194|NCT01534260|Sorafenib|sorafenib|mesh-list
83590195|NCT01534260|Vorinostat|vorinostat|mesh-list
83590196|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590197|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83590198|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590199|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590200|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83590201|NCT01534182|Interferons|interferons|mesh-list
83590202|NCT01534182|Interferon-beta|interferon-beta|mesh-list
83590203|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
83590204|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83590205|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
83590206|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590207|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
83590208|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590209|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
83590210|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590211|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83590212|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590213|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590214|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83590215|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590216|NCT01579812|Metformin|metformin|mesh-list
83590217|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590218|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590219|NCT01579578|Paclitaxel|paclitaxel|mesh-list
83590220|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83590221|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590222|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83590223|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83590224|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83590225|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590226|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83590227|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83590228|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83590229|NCT01578486|Analgesics|analgesics|mesh-ancestor
83590230|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
83590231|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590232|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590233|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590234|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590235|NCT01555164|Metformin|metformin|mesh-list
83590236|NCT01555164|Ranolazine|ranolazine|mesh-list
83590237|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590238|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590239|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83590240|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590241|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590242|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
83590243|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83590244|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
83590245|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590247|NCT03028428|Protective Agents|protective agents|mesh-ancestor
83590248|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83590249|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83590250|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590251|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590252|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
83590253|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590254|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83590255|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83590256|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83590257|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590258|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590259|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83590260|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83590261|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83590262|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
83590263|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590264|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590265|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83590266|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83590267|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
83590268|NCT01554618|Exenatide|exenatide|mesh-list
83590269|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590270|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590271|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83590272|NCT01554618|Incretins|incretins|mesh-ancestor
83590273|NCT01554618|Hormones|hormones|mesh-ancestor
83590274|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590275|NCT01531998|Dexamethasone|dexamethasone|mesh-list
83590276|NCT01531998|Lenalidomide|lenalidomide|mesh-list
83590277|NCT01531998|Bortezomib|bortezomib|mesh-list
83590278|NCT01531998|Siltuximab|siltuximab|mesh-list
83590279|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590280|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
83590281|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
83590282|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590283|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590284|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83590285|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
83590286|NCT01531998|Hormones|hormones|mesh-ancestor
83590287|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590288|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83590289|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590290|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
83590291|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83590292|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83590293|NCT01531998|Growth Substances|growth substances|mesh-ancestor
83590294|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
83590295|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
83590296|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
83590297|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83590298|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590299|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590300|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
83590301|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83590302|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590303|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590304|NCT01553136|Varenicline|varenicline|mesh-list
83590305|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83590306|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83590307|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
83590308|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590309|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590310|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590311|NCT01552902|Methylphenidate|methylphenidate|mesh-list
83590312|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83590313|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83590314|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048380|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
83048381|NCT04430738|Vitamins|vitamins|mesh-ancestor
83590315|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83590316|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83590317|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590318|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590319|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
83590320|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590321|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
83590322|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83590323|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83590324|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83590325|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590326|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590327|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
83590328|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590329|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590330|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83590331|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590333|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83590334|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83590335|NCT01529346|Analgesics|analgesics|mesh-ancestor
83590336|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
83590337|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590338|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590339|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590340|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590341|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83590342|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590343|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590344|NCT01529268|Cysteamine|cysteamine|mesh-list
83590345|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83590346|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590347|NCT01529112|Lenvatinib|lenvatinib|mesh-list
83590348|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590349|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83590350|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590351|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590352|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
83048493|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
83048494|NCT04218799|Mupirocin|mupirocin|mesh-list
83048495|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83048496|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048497|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
83048498|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83048499|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83048500|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048501|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048502|NCT04195555|Ivosidenib|ivosidenib|mesh-list
83048503|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048504|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048505|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048506|NCT04189445|Futibatinib|futibatinib|mesh-list
83048507|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048508|NCT04179032|Belimumab|belimumab|mesh-list
83048509|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048510|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
83048511|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048512|NCT04170153|Niraparib|niraparib|mesh-list
83048513|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83048514|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479401|NCT05659056|Paclitaxel|paclitaxel|mesh-list
83048515|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048516|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048517|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83048518|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
83048519|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048520|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83048521|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83048522|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048523|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048524|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83048525|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83590353|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83590354|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83590355|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83590356|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590357|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590358|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
83590359|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590360|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590361|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83590362|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590363|NCT01528254|Metformin|metformin|mesh-list
83590364|NCT01528254|Vildagliptin|vildagliptin|mesh-list
83590365|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590366|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590367|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83590368|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
83590369|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590370|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590371|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83590372|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
83590373|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
83590374|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83590375|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83590376|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83590377|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590378|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590379|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590380|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590381|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
83590382|NCT01525602|Paclitaxel|paclitaxel|mesh-list
83590383|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83590384|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590385|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
83590386|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
83590387|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
83590388|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590389|NCT01549002|Fentanyl|fentanyl|mesh-list
83590390|NCT01549002|Morphine|morphine|mesh-list
83590391|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83590392|NCT01549002|Narcotics|narcotics|mesh-ancestor
83590393|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590394|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590395|NCT01549002|Analgesics|analgesics|mesh-ancestor
83590396|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
83590397|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590398|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83590399|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83590400|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
83590401|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
83590402|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83590403|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
83590404|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590405|NCT01572792|Bromides|bromides|mesh-list
83590406|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
83590407|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83590408|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
83590409|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590410|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590411|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83590412|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590413|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83590414|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83590415|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83590416|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590417|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590418|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590419|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
83590420|NCT01547598|Timolol|timolol|mesh-list
83590421|NCT01547598|Bimatoprost|bimatoprost|mesh-list
83590422|NCT01547598|Travoprost|travoprost|mesh-list
83590423|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83590424|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83590425|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83590426|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83590427|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590428|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590429|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590430|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590431|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83590432|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83590434|NCT01547286|Miotics|miotics|mesh-ancestor
83590435|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
83590436|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590437|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590438|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83590439|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83590440|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590441|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83590442|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83590443|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
83590444|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590445|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590446|NCT01524978|Cetuximab|cetuximab|mesh-list
83590447|NCT01524978|Vemurafenib|vemurafenib|mesh-list
83590448|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83590449|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590450|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83590451|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590452|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590453|NCT01524198|Budesonide|budesonide|mesh-list
83590454|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590455|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83590456|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
83590457|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590458|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590459|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83590460|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590461|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
83590462|NCT01524198|Hormones|hormones|mesh-ancestor
83590463|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590464|NCT01523886|Rocuronium|rocuronium|mesh-list
83590465|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83590466|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83590467|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83590468|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590469|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590470|NCT01546038|Cytarabine|cytarabine|mesh-list
83590471|NCT01546038|Decitabine|decitabine|mesh-list
83590472|NCT01546038|Daunorubicin|daunorubicin|mesh-list
83590473|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83590474|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
83590475|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590476|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590477|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
83590478|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590479|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590480|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
83590481|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590482|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83590483|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83590484|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83590485|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590486|NCT01571232|Dexamethasone|dexamethasone|mesh-list
83590487|NCT01571232|Bevacizumab|bevacizumab|mesh-list
83590488|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83590489|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590490|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83590491|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83590492|NCT01571232|Growth Substances|growth substances|mesh-ancestor
83590493|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590494|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
83590495|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590496|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
83590497|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
83590498|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590499|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83590500|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
83590501|NCT01571232|Hormones|hormones|mesh-ancestor
83590502|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590503|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83590504|NCT01522950|Atenolol|atenolol|mesh-list
83590505|NCT01522950|Nebivolol|nebivolol|mesh-list
83590506|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83590507|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83590508|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
83590509|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
83590510|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590511|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590512|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83590513|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83590514|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83590515|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590516|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590517|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590518|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
83590519|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83590520|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83590521|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83590522|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83590523|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83590524|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83590525|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590526|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590527|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590528|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590529|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590530|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
83590531|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590532|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83590533|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590534|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590535|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
83590536|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590537|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590538|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83590539|NCT01518192|Doxycycline|doxycycline|mesh-list
83590540|NCT01518192|Cefuroxime|cefuroxime|mesh-list
83590541|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
83590542|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83590543|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590544|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
83590545|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83590546|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83590547|NCT01517802|Prednisone|prednisone|mesh-list
83590548|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
83590549|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590550|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
83590551|NCT01517802|Hormones|hormones|mesh-ancestor
83590552|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590553|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590554|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83590555|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590556|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83590557|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590558|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590559|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
83590560|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83590561|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
83590562|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83590563|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
83590564|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590565|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590566|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83590567|NCT04714710|Diuretics|diuretics|mesh-ancestor
83590568|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
83590569|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83590570|NCT01520922|Ofatumumab|ofatumumab|mesh-list
83590571|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83590572|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
83590573|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590574|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590575|NCT01517412|Metformin|metformin|mesh-list
83590576|NCT01517412|Lixisenatide|lixisenatide|mesh-list
83590577|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590578|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590579|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83590580|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
83590581|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83590582|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83590583|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
83590584|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590585|NCT01516008|Tapentadol|tapentadol|mesh-list
83590586|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83590587|NCT01516008|Narcotics|narcotics|mesh-ancestor
83590588|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590589|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590590|NCT01516008|Analgesics|analgesics|mesh-ancestor
83590591|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
83590592|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590593|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83590594|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83590595|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590596|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590597|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590598|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590599|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
83590600|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
83590601|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83590602|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
83590603|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590604|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590605|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590606|NCT01489020|Immunomodulating Agents|immunomodulating agents|mesh-list
83590607|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
83590608|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590609|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83590610|NCT01514448|Everolimus|everolimus|mesh-list
83590611|NCT01514448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83590612|NCT01514448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83590613|NCT01514448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590614|NCT01514448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590615|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590616|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
83590617|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590618|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590619|NCT01514370|Interferons|interferons|mesh-list
83590620|NCT01514370|Interferon-beta|interferon-beta|mesh-list
83590621|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
83590622|NCT01514370|Curcumin|curcumin|mesh-list
83590623|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590624|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
83590625|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590626|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83590627|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83590628|NCT01514370|Analgesics|analgesics|mesh-ancestor
83590629|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
83590630|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590631|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590632|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590633|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590634|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590635|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590636|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
83590637|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83590638|NCT01519674|Insulin|insulin|mesh-list
83590639|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83590640|NCT01519674|Metformin|metformin|mesh-list
83590641|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
83590642|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
83590643|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83590644|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83590645|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
83590646|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83590647|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
83590648|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590649|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590650|NCT01519674|Incretins|incretins|mesh-ancestor
83590652|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590653|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83590654|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
83590655|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590656|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590657|NCT01519518|Heparin|heparin|mesh-list
83590658|NCT01519518|Calcium heparin|calcium heparin|mesh-list
83590659|NCT01519518|Bivalirudin|bivalirudin|mesh-list
83590660|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
83590661|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83590662|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83590663|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590664|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
83590665|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83590666|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
83590667|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590668|NCT01518972|Prazosin|prazosin|mesh-list
83590669|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83590670|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83590671|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83590672|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83590673|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590674|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590675|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590676|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590677|NCT01513590|Insulin|insulin|mesh-list
83590678|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
83590679|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590680|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590681|NCT04672512|Prednisone|prednisone|mesh-list
83590682|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590683|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
83590684|NCT04672512|Hormones|hormones|mesh-ancestor
83590685|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590686|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590687|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83590688|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590689|NCT01512108|Liraglutide|liraglutide|mesh-list
83590690|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83590691|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590692|NCT01512108|Incretins|incretins|mesh-ancestor
83590693|NCT01512108|Hormones|hormones|mesh-ancestor
83590694|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590695|NCT01486758|Azithromycin|azithromycin|mesh-list
83590696|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83590697|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590698|NCT01463982|Capecitabine|capecitabine|mesh-list
83590699|NCT01463982|Irinotecan|irinotecan|mesh-list
83590700|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83590701|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
83590702|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590703|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590704|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83590705|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83590706|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590707|NCT01510158|Allopurinol|allopurinol|mesh-list
83590708|NCT01510158|Lesinurad|lesinurad|mesh-list
83590709|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
83590710|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590711|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590712|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
83590713|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590714|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83590715|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
83590716|NCT01510158|Protective Agents|protective agents|mesh-ancestor
83590717|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590718|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
83590719|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83590720|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83590721|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83590722|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590723|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590724|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
83048844|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
83590725|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590726|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590727|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83590728|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590729|NCT01484496|Belimumab|belimumab|mesh-list
83590730|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590731|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
83590732|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590733|NCT01509846|Vaccines|vaccines|mesh-list
83590734|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
83590735|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590736|NCT01462344|Fluticasone|fluticasone|mesh-list
83590737|NCT01462344|Xhance|xhance|mesh-list
83590738|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83590739|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83590740|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
83590741|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590742|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590743|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83590744|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590745|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
83590746|NCT01462344|Hormones|hormones|mesh-ancestor
83590747|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590748|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
83590749|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590750|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
83590751|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83590752|NCT01462266|Metformin|metformin|mesh-list
83590753|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
83590754|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83590755|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590756|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590757|NCT01462266|Incretins|incretins|mesh-ancestor
83590758|NCT01462266|Hormones|hormones|mesh-ancestor
83590759|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83590760|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83590761|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
83590762|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590763|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590764|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
83590765|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
83590766|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83590767|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
83590768|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590769|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590770|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83590771|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590772|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83590773|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83590774|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83590775|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
83590776|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590777|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590778|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83590779|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83590780|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83590781|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
83590782|NCT01508676|Diclofenac|diclofenac|mesh-list
83590783|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83590784|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83590785|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83590786|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83590787|NCT01508676|Analgesics|analgesics|mesh-ancestor
83590788|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
83590789|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590790|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590791|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590792|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83590793|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590794|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590795|NCT02985372|Cytarabine|cytarabine|mesh-list
83590796|NCT02985372|Decitabine|decitabine|mesh-list
83590797|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83590798|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
83590799|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590800|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590802|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590803|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590804|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
83590805|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590806|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590807|NCT02985216|Pregabalin|pregabalin|mesh-list
83590808|NCT02985216|Analgesics|analgesics|mesh-ancestor
83590809|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
83590810|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590811|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590812|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
83590813|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83590814|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590815|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590816|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83590817|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83590818|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83590819|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83590820|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83590821|NCT01461096|Vaccines|vaccines|mesh-list
83590822|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
83590823|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590824|NCT01480674|Trastuzumab|trastuzumab|mesh-list
83590825|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83590826|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590827|NCT01506882|Levetiracetam|levetiracetam|mesh-list
83590828|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
83590829|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
83590830|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
83590831|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83590832|NCT01506726|Salicylates|salicylates|mesh-list
83590833|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83590834|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83590835|NCT01506726|Analgesics|analgesics|mesh-ancestor
83590836|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
83590837|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83590838|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590839|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83590840|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590841|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83590842|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590843|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590844|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590845|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
83590846|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
83590847|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
83590848|NCT01505868|Carboplatin|carboplatin|mesh-list
83590849|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590850|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
83590851|NCT01505634|Imipenem|imipenem|mesh-list
83590852|NCT01505634|Relebactam|relebactam|mesh-list
83590853|NCT01505634|Cilastatin|cilastatin|mesh-list
83590854|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83590855|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590856|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83590857|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83590858|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590859|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590860|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590861|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83590862|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83590863|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
83479922|NCT04756050|Prilocaine|prilocaine|mesh-list
83590864|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83590865|NCT01460628|Modafinil|modafinil|mesh-list
83590866|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83590867|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590868|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83590869|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83590870|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83590871|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590872|NCT01480596|Belimumab|belimumab|mesh-list
83590873|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590874|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
83590875|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590877|NCT01459614|Docetaxel|docetaxel|mesh-list
83590878|NCT01459614|Capecitabine|capecitabine|mesh-list
83590879|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590880|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83590881|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
83590882|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590883|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
83590884|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
83590885|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
83590886|NCT01458522|Lacosamide|lacosamide|mesh-list
83590887|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
83590888|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
83590889|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83590890|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83590891|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83590892|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590893|NCT03026946|Cyclosporine|cyclosporine|mesh-list
83590894|NCT03026946|Alitretinoin|alitretinoin|mesh-list
83590895|NCT03026946|Cyclosporins|cyclosporins|mesh-list
83590896|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590897|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590898|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83590899|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
83590900|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590901|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
83590902|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590903|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83590904|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83590905|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83590906|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590907|NCT01458366|Carboplatin|carboplatin|mesh-list
83590908|NCT01458366|Etoposide|etoposide|mesh-list
83590909|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
83590910|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83590911|NCT01458366|Ofatumumab|ofatumumab|mesh-list
83590912|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590913|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83590914|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83590915|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83590916|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590917|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590918|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83590919|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
83590920|NCT01458210|Dulaglutide|dulaglutide|mesh-list
83590921|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
83590922|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83590923|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83590924|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590925|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83590926|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590927|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83590928|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83590929|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590930|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590931|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590932|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83590933|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
83590934|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83590935|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83590936|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83590937|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83590938|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
83590939|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590940|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83590941|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83590942|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590943|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590944|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
83590945|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83590946|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
83590947|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590948|NCT01501110|Expectorants|expectorants|mesh-ancestor
83590949|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83590950|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83590951|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
83590952|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590953|NCT01501110|Protective Agents|protective agents|mesh-ancestor
83590954|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590955|NCT01501110|Antidotes|antidotes|mesh-ancestor
83590957|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83590958|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83590959|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590960|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590961|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590962|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83590963|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83590964|NCT01455012|Rotigotine|rotigotine|mesh-list
83590965|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
83590966|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
83590967|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83590968|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590969|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83590970|NCT01454778|Paclitaxel|paclitaxel|mesh-list
83590971|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83590972|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83590973|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
83590974|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83590975|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83590976|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590977|NCT01454076|Clarithromycin|clarithromycin|mesh-list
83590978|NCT01454076|Rifampin|rifampin|mesh-list
83590979|NCT01454076|Ketoconazole|ketoconazole|mesh-list
83590980|NCT01454076|Ixazomib|ixazomib|mesh-list
83590981|NCT01454076|Glycine|glycine|mesh-list
83590982|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83590983|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83590984|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83590985|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83590986|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83590987|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83590988|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83590989|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83590990|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
83590991|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
83590992|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83590993|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83590994|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83590995|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83590996|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83590997|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83590998|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83590999|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
83591000|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83591001|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83591002|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
83591003|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591004|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591005|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591006|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591007|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
83591008|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591009|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83591010|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
83591011|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591012|NCT01453374|Naltrexone|naltrexone|mesh-list
83591013|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83591014|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83591015|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591016|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
83591017|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591018|NCT01453140|Sirolimus|sirolimus|mesh-list
83591019|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
83591020|NCT01453140|Temsirolimus|temsirolimus|mesh-list
83591021|NCT01453140|Interleukin-2|interleukin-2|mesh-list
83591022|NCT01453140|Azacitidine|azacitidine|mesh-list
83591023|NCT01453140|MTOR Inhibitors|mtor inhibitors|mesh-list
83591024|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83591025|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
83591026|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591027|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591028|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83591029|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
83591030|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591031|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591032|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83591033|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83591034|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591035|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83591036|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
83591037|NCT01453140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591038|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591039|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83591040|NCT01453140|Analgesics|analgesics|mesh-ancestor
83591041|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
83591042|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591043|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83591044|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
83591045|NCT01499940|Vitamin D|vitamin d|mesh-list
83591046|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
83591047|NCT01499940|Vitamins|vitamins|mesh-ancestor
83591048|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
83591049|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591050|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83591051|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83591052|NCT01499160|Everolimus|everolimus|mesh-list
83591053|NCT01499160|Letrozole|letrozole|mesh-list
83591054|NCT01499160|Lapatinib|lapatinib|mesh-list
83591055|NCT01499160|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83591056|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591057|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591058|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591059|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83591060|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
83591061|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591062|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591063|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83591064|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83591065|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83591066|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
83591067|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591068|NCT01498068|Interferons|interferons|mesh-list
83591069|NCT01498068|Ribavirin|ribavirin|mesh-list
83591070|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
83591071|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
83591072|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83591073|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591074|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
83591075|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591076|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
83591077|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591078|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
83591079|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591080|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
83591081|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
83591082|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591083|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
83591084|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83591085|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83591086|NCT01496976|Prednisolone|prednisolone|mesh-list
83591087|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
83591088|NCT01496976|Lenalidomide|lenalidomide|mesh-list
83591089|NCT01496976|Ofatumumab|ofatumumab|mesh-list
83480140|NCT04553692|Docetaxel|docetaxel|mesh-list
83591090|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83591091|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
83591092|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
83591093|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591094|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83591095|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83591096|NCT01496976|Growth Substances|growth substances|mesh-ancestor
83591097|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
83591098|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591099|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591100|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
83591101|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
83591102|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591103|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83591104|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
83591105|NCT01496976|Hormones|hormones|mesh-ancestor
83591106|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591107|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83591108|NCT01496976|Protective Agents|protective agents|mesh-ancestor
83591109|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83591110|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83591111|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
83591112|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591113|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83591114|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83591115|NCT01451814|Nicotine|nicotine|mesh-list
83591116|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83591117|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
83591118|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591119|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591120|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83591121|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83591122|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
83591123|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591124|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591125|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83591126|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83591127|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83591128|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591129|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83591130|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
83591131|NCT04408326|Giapreza|giapreza|mesh-list
83591132|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
83591133|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591134|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83591135|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83591136|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591137|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591138|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591139|NCT01474746|Sertraline|sertraline|mesh-list
83591140|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
83591141|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83591142|NCT01474746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83591143|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83591144|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83591145|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591146|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591147|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
83591148|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591149|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
83591150|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83591151|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591152|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83591153|NCT01474512|Ixekizumab|ixekizumab|mesh-list
83591154|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
83591155|NCT02985606|Caffeine|caffeine|mesh-list
83591156|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83591157|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591158|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83591159|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591160|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591161|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83591162|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83591163|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
83591164|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591165|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
83591166|NCT01473732|Everolimus|everolimus|mesh-list
83591167|NCT01473732|Tacrolimus|tacrolimus|mesh-list
83591168|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83591169|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
83591170|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591171|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83591172|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591173|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591174|NCT01473732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83591175|NCT01473732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591176|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591177|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83591178|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83591179|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
83591180|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83591181|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591182|NCT01450098|Evacetrapib|evacetrapib|mesh-list
83591183|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
83591184|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83591185|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83591186|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
83591187|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591188|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83591189|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
83591190|NCT01450098|Protective Agents|protective agents|mesh-ancestor
83591191|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591192|NCT01449630|Celecoxib|celecoxib|mesh-list
83591193|NCT01449630|LY3031207|ly3031207|mesh-list
83591194|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83591195|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83591196|NCT01449630|Analgesics|analgesics|mesh-ancestor
83591197|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
83591198|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591199|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591200|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591201|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591202|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83591203|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83591204|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591205|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591206|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
83591207|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
83591208|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591209|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
83591210|NCT01473420|Hematinics|hematinics|mesh-ancestor
83591211|NCT04674774|Lansoprazole|lansoprazole|mesh-list
83591212|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
83591213|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83591214|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83591215|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83591216|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591217|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591218|NCT01492686|Edaravone|edaravone|mesh-list
83591219|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83591220|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
83591221|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591222|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83591223|NCT01492686|Protective Agents|protective agents|mesh-ancestor
83591224|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591225|NCT01449006|Maraviroc|maraviroc|mesh-list
83591226|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83591227|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83591228|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591229|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83591230|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83591231|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
83591232|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591233|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83591234|NCT01491672|Everolimus|everolimus|mesh-list
83591235|NCT01491672|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83591236|NCT01491672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591237|NCT01491672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591238|NCT01491672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591239|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83591240|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
83591241|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591242|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591243|NCT01447446|Ribavirin|ribavirin|mesh-list
83591244|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
83591245|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
83591246|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83591247|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83591248|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83049366|NCT05213650|Methamphetamine|methamphetamine|mesh-list
83591249|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
83591250|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591251|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
83591252|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591253|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
83591254|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591255|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591256|NCT01471782|Blinatumomab|blinatumomab|mesh-list
83591257|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591258|NCT01490580|Atropine|atropine|mesh-list
83591259|NCT01490580|Sufentanil|sufentanil|mesh-list
83591260|NCT01490580|Propofol|propofol|mesh-list
83591261|NCT01490580|Atracurium|atracurium|mesh-list
83591262|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83591263|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83591264|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591265|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83591266|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
83591267|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
83591268|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83591269|NCT01490580|Narcotics|narcotics|mesh-ancestor
83591270|NCT01490580|Analgesics|analgesics|mesh-ancestor
83591271|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
83591272|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591273|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83591274|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83591275|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83591276|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
83591277|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83591278|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
83591279|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
83591280|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
83591281|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83591282|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83591283|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
83591284|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591285|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591286|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83591287|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83591288|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83591289|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83591290|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83591291|NCT01490190|Etonogestrel|etonogestrel|mesh-list
83591292|NCT01490190|NuvaRing|nuvaring|mesh-list
83591293|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83591294|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83591295|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83591296|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
83591297|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83591298|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591299|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83591300|NCT01490190|Estrogens|estrogens|mesh-ancestor
83591301|NCT01490190|Hormones|hormones|mesh-ancestor
83591302|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591303|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
83591304|NCT01446042|Testosterone|testosterone|mesh-list
83591305|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
83591306|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
83591307|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83591308|NCT01446042|Androgens|androgens|mesh-ancestor
83591309|NCT01446042|Hormones|hormones|mesh-ancestor
83591310|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591311|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83480374|NCT04191499|Inavolisib|inavolisib|mesh-list
83591312|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83591313|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591314|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
83591315|NCT01445886|Calcitriol|calcitriol|mesh-list
83591316|NCT01445886|Calcipotriene|calcipotriene|mesh-list
83591317|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
83591318|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83591319|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591320|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83591321|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83591322|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591323|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83591324|NCT01445886|Vitamins|vitamins|mesh-ancestor
83591325|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
83591326|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83591328|NCT01470612|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83591329|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591330|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591331|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591332|NCT04073316|Warfarin|warfarin|mesh-list
83591333|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
83591334|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
83591335|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83591336|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
83591337|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83591338|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591339|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591340|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591341|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
83591342|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83591343|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
83591344|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
83591345|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83591346|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591347|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83591348|NCT04089852|Analgesics|analgesics|mesh-ancestor
83591349|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
83591350|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591351|NCT03026244|Vitamin D|vitamin d|mesh-list
83591352|NCT03026244|Caseins|caseins|mesh-list
83591353|NCT03026244|Vitamins|vitamins|mesh-ancestor
83591354|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
83591355|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591356|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83591357|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
83591358|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
83591359|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591360|NCT01470144|Epoprostenol|epoprostenol|mesh-list
83591361|NCT01470144|Tezosentan|tezosentan|mesh-list
83591362|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83591363|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83591364|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
83591365|NCT01443858|Meclizine|meclizine|mesh-list
83591366|NCT01443858|Nicotine|nicotine|mesh-list
83591367|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83591368|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
83591369|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591370|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591371|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83591372|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83591373|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
83591374|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591375|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591376|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
83591377|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83591378|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83591379|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
83591380|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
83591381|NCT01443858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83591382|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83591383|NCT01443078|Carboplatin|carboplatin|mesh-list
83591384|NCT01443078|Gemcitabine|gemcitabine|mesh-list
83591385|NCT01443078|Docetaxel|docetaxel|mesh-list
83591386|NCT01443078|Pemetrexed|pemetrexed|mesh-list
83591387|NCT01443078|Vinorelbine|vinorelbine|mesh-list
83591388|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591389|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83591390|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
83591391|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591392|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
83591393|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
83591394|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
83591395|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591396|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83591397|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83591398|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83591399|NCT01439880|Evolocumab|evolocumab|mesh-list
83591400|NCT01439880|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83591401|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83591402|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83591403|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
83591404|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591405|NCT01439880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83591406|NCT01439880|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591407|NCT01439880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591408|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83591409|NCT01469364|Aztreonam|aztreonam|mesh-list
83591410|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83591411|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591412|NCT01439568|Carboplatin|carboplatin|mesh-list
83591413|NCT01439568|Etoposide|etoposide|mesh-list
83591414|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591415|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83591416|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83591417|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83591418|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591419|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591420|NCT01469052|Axitinib|axitinib|mesh-list
83591421|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591422|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591423|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591424|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591425|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
83591426|NCT01468818|Fludarabine|fludarabine|mesh-list
83591427|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83591428|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
83591429|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591430|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591431|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83591432|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
83591433|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591434|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591435|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83591436|NCT01442376|Ondansetron|ondansetron|mesh-list
83591437|NCT01442376|Palonosetron|palonosetron|mesh-list
83591438|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
83591439|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
83591440|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591441|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591442|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83591443|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
83591444|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
83591445|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83591446|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83591447|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
83591448|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591449|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591450|NCT01442064|Ranibizumab|ranibizumab|mesh-list
83591451|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83591452|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83591453|NCT01442064|Growth Substances|growth substances|mesh-ancestor
83591454|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591455|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
83591456|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591457|NCT01441596|Vinorelbine|vinorelbine|mesh-list
83591458|NCT01441596|Afatinib|afatinib|mesh-list
83591459|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83591460|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591461|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
83591462|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
83591463|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83591464|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591465|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591466|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591467|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83591468|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83591469|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83591470|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83591471|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591472|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591473|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591474|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83591475|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
83591476|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83591477|NCT03026478|Betamethasone|betamethasone|mesh-list
83591478|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
83591479|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83591480|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
83591482|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83591483|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591484|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
83591485|NCT03026478|Hormones|hormones|mesh-ancestor
83591486|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591487|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591488|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83591489|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
83591490|NCT04066764|Nadroparin|nadroparin|mesh-list
83591491|NCT04066764|Warfarin|warfarin|mesh-list
83591492|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
83591493|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
83591494|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83591495|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
83591496|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83591497|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591498|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591499|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591500|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83591501|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83591502|NCT01437540|Bromides|bromides|mesh-list
83591503|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
83591504|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83591505|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
83591506|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591507|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591508|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83591509|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
83591510|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83591511|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83591512|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83591513|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
83591514|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591515|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591516|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
83591517|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
83591518|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591519|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
83591520|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
83591521|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
83591522|NCT01467492|Interferons|interferons|mesh-list
83591523|NCT01467492|Ribavirin|ribavirin|mesh-list
83591524|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
83591525|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
83591526|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83591527|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591528|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
83591529|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591530|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
83591531|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591532|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
83591533|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591534|NCT01466790|Ribavirin|ribavirin|mesh-list
83591535|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
83591536|NCT01466790|Simeprevir|simeprevir|mesh-list
83591537|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
83591538|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591539|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
83591540|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591541|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591542|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591543|NCT01418352|Aripiprazole|aripiprazole|mesh-list
83591544|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
83591545|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83591546|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83591547|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83591548|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83591549|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591550|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
83591551|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
83591552|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591553|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591554|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83591555|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83591557|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83591558|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83591559|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83591560|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83591561|NCT01436370|Vaccines|vaccines|mesh-list
83591562|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
83591563|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591564|NCT01465464|Orantinib|orantinib|mesh-list
83591565|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591566|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591567|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591568|NCT01465386|Bortezomib|bortezomib|mesh-list
83591569|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591570|NCT04082364|Trastuzumab|trastuzumab|mesh-list
83591571|NCT04082364|Margetuximab|margetuximab|mesh-list
83591572|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83591573|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591574|NCT01465230|Lenalidomide|lenalidomide|mesh-list
83591575|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
83591576|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591577|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83591578|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83591579|NCT01465230|Growth Substances|growth substances|mesh-ancestor
83591580|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
83591581|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591582|NCT03820830|Palbociclib|palbociclib|mesh-list
83591583|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591584|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591585|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591586|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591587|NCT01435122|Axitinib|axitinib|mesh-list
83591588|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591589|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591590|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591591|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591592|NCT01393626|Tofacitinib|tofacitinib|mesh-list
83591593|NCT01393626|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83591594|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591595|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591596|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591597|NCT01393158|Apremilast|apremilast|mesh-list
83591598|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83591599|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83591600|NCT01393158|Analgesics|analgesics|mesh-ancestor
83591601|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
83591602|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591603|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591604|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591605|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591606|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83591607|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83591608|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591609|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591610|NCT01413360|Vitamins|vitamins|mesh-list
83591611|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
83591612|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
83591613|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591614|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
83591615|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591616|NCT01413360|Protective Agents|protective agents|mesh-ancestor
83591617|NCT03815448|Methotrexate|methotrexate|mesh-list
83591618|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83591619|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
83591620|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83591621|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591622|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83591623|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
83591624|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591625|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591626|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83591627|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591628|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83591629|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83591630|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
83591631|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591632|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83591633|NCT01392378|Acetaminophen|acetaminophen|mesh-list
83591634|NCT01392378|Ibuprofen|ibuprofen|mesh-list
83591635|NCT01392378|Vaccines|vaccines|mesh-list
83591636|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83591637|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
83591638|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591639|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83591640|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83591641|NCT01392378|Analgesics|analgesics|mesh-ancestor
83591642|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
83591643|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591644|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591645|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591646|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83591647|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591648|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591649|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
83591650|NCT01412424|Octreotide|octreotide|mesh-list
83591651|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83591652|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83591653|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591654|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83591655|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
83591656|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591657|NCT01432938|Dulaglutide|dulaglutide|mesh-list
83591658|NCT01432938|Warfarin|warfarin|mesh-list
83591659|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
83591660|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83591661|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591662|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83591663|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83591664|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591665|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591666|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83591667|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83591668|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591669|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
83591670|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591671|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83591672|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591673|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591674|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591675|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83591676|NCT01391130|Sunitinib|sunitinib|mesh-list
83591677|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591678|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83591679|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83591680|NCT01391130|Growth Substances|growth substances|mesh-ancestor
83591681|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591682|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
83591683|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83591684|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591685|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591686|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
83591687|NCT04046094|Vitamins|vitamins|mesh-ancestor
83591688|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
83591689|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591690|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
83480746|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
83591691|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591692|NCT04046094|Protective Agents|protective agents|mesh-ancestor
83591693|NCT01410240|Hemostatics|hemostatics|mesh-list
83591694|NCT01410240|Coagulants|coagulants|mesh-ancestor
83591695|NCT01408914|Rifampin|rifampin|mesh-list
83591696|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83591697|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
83591698|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83591699|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591700|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
83591701|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83591702|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591703|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591704|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83591705|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83591706|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83591707|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83591708|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83591709|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83591710|NCT04044222|Carboplatin|carboplatin|mesh-list
83591712|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
83591713|NCT04044222|Ifosfamide|ifosfamide|mesh-list
83591714|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
83591715|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591716|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83591717|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83591718|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83591719|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591720|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591721|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83591722|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
83591723|NCT01390428|Grazoprevir|grazoprevir|mesh-list
83591724|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
83591725|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591726|NCT01429584|Bupivacaine|bupivacaine|mesh-list
83591727|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
83591728|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
83591729|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83591730|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591731|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
83591732|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591733|NCT01405950|Clonidine|clonidine|mesh-list
83591734|NCT01405950|Tizanidine|tizanidine|mesh-list
83591735|NCT01405950|Analgesics|analgesics|mesh-ancestor
83591736|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
83591737|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591738|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591739|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
83591740|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83591741|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83591742|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
83591743|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
83591744|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83591745|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83591746|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83591747|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
83591748|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591749|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591750|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83591751|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
83591752|NCT01405560|Ribavirin|ribavirin|mesh-list
83591753|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
83591754|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591755|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
83591756|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591757|NCT01428882|Midazolam|midazolam|mesh-list
83591758|NCT01428882|Propofol|propofol|mesh-list
83591759|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83591760|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83591761|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591762|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83591763|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
83591764|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
83591765|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83591766|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83591767|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83591768|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83591769|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
83591770|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
83591771|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591772|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591773|NCT01428258|Coal Tar|coal tar|mesh-list
83591774|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
83591775|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
83591776|NCT01442688|Amoxicillin|amoxicillin|mesh-list
83591777|NCT01442688|Mesalamine|mesalamine|mesh-list
83591778|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83591779|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049915|NCT03636256|Docetaxel|docetaxel|mesh-list
83591780|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83591781|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83591782|NCT01442688|Analgesics|analgesics|mesh-ancestor
83591783|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
83591784|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591785|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591786|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591787|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591788|NCT03814200|Rifampin|rifampin|mesh-list
83591789|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83591790|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
83591791|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83591792|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591793|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
83591794|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83591795|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591796|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591797|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83591798|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83591799|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83591800|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83591801|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83591802|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83591803|NCT01426854|Nepafenac|nepafenac|mesh-list
83591804|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83591805|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83591806|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83591807|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83591808|NCT01426854|Analgesics|analgesics|mesh-ancestor
83591809|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
83591810|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591811|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591812|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591813|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83591814|NCT04051320|Leuprolide|leuprolide|mesh-list
83591815|NCT04051320|Estradiol|estradiol|mesh-list
83591816|NCT04051320|Progesterone|progesterone|mesh-list
83591817|NCT04051320|Estrogens|estrogens|mesh-ancestor
83591818|NCT04051320|Hormones|hormones|mesh-ancestor
83591819|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591820|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591821|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83591822|NCT04051320|Progestins|progestins|mesh-ancestor
83591823|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83591824|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
83591825|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83591826|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591827|NCT01403610|Bevacizumab|bevacizumab|mesh-list
83591828|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
83591829|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83591830|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591831|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83591832|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83591833|NCT01403610|Growth Substances|growth substances|mesh-ancestor
83591834|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591835|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83591836|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83591837|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
83591838|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591839|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83591840|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
83591841|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591842|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83591843|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83591844|NCT01389102|Estradiol|estradiol|mesh-list
83591845|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83591846|NCT01389102|Estrogens|estrogens|mesh-ancestor
83591847|NCT01389102|Hormones|hormones|mesh-ancestor
83591848|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591849|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591850|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83591851|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
83591852|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83049982|NCT04474600|Propofol|propofol|mesh-list
83591853|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83591854|NCT01402284|Dexamethasone|dexamethasone|mesh-list
83591855|NCT01402284|Lenalidomide|lenalidomide|mesh-list
83591856|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591857|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
83591858|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
83591859|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591860|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591861|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83591862|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
83591863|NCT01402284|Hormones|hormones|mesh-ancestor
83591864|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591865|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83591866|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591867|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
83591868|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83591869|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83591870|NCT01402284|Growth Substances|growth substances|mesh-ancestor
83591871|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
83591872|NCT01388790|Cetuximab|cetuximab|mesh-list
83591873|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591874|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83591875|NCT01388478|Pramipexole|pramipexole|mesh-list
83591876|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
83591877|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591878|NCT01388478|Protective Agents|protective agents|mesh-ancestor
83591879|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591880|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83591881|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83591882|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
83591883|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
83591884|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591885|NCT01423812|Ritonavir|ritonavir|mesh-list
83591886|NCT01423812|Darunavir|darunavir|mesh-list
83591887|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83591888|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83591889|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591890|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591891|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591892|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83591893|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83591894|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
83591895|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591896|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83591897|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83591898|NCT01400958|Modafinil|modafinil|mesh-list
83591899|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83591900|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591901|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83591902|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83591903|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83591904|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591905|NCT01400412|Ritonavir|ritonavir|mesh-list
83591906|NCT01400412|Darunavir|darunavir|mesh-list
83591907|NCT01400412|Tenofovir|tenofovir|mesh-list
83591908|NCT01400412|Emtricitabine|emtricitabine|mesh-list
83591909|NCT01400412|Maraviroc|maraviroc|mesh-list
83591910|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83591911|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83591912|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591913|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591914|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591915|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83591916|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83591917|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
83591918|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83591919|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83591920|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83591921|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83591922|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83591923|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83591924|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83591925|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83591926|NCT01422876|Linagliptin|linagliptin|mesh-list
83050052|NCT03132194|Dapsone|dapsone|mesh-list
83591927|NCT01422876|Empagliflozin|empagliflozin|mesh-list
83591928|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83591929|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591931|NCT01422876|Hormones|hormones|mesh-ancestor
83591932|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591933|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83591934|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
83591935|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591936|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591937|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83591938|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83591939|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
83591940|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83591941|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83591942|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83591943|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591944|NCT01387932|Doxorubicin|doxorubicin|mesh-list
83591945|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
83591946|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83591947|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83591948|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83591949|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83591950|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83591951|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591952|NCT04413786|Oxytocin|oxytocin|mesh-list
83591953|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
83591954|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83591955|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591956|NCT01422408|Fluocinonide|fluocinonide|mesh-list
83591957|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83591958|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
83591959|NCT01422408|Hormones|hormones|mesh-ancestor
83591960|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591961|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591962|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83591963|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83591964|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83591965|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83591966|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83591967|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591968|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83591969|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83591970|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83591971|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
83591972|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591973|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591974|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83591975|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83591976|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
83591977|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
83591978|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83591979|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83591980|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83591981|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83591982|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83591983|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83591984|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83591985|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83591986|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83591987|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83591988|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
83591989|NCT01386606|Enclomiphene|enclomiphene|mesh-list
83591990|NCT01386606|Clomiphene|clomiphene|mesh-list
83591991|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
83591992|NCT01386606|Testosterone|testosterone|mesh-list
83591993|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
83591994|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
83591995|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83591996|NCT01386606|Androgens|androgens|mesh-ancestor
83591997|NCT01386606|Hormones|hormones|mesh-ancestor
83591998|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83591999|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592000|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83592001|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592002|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
83592003|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83592004|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
83592005|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83592006|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
83592007|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83592008|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83592009|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83592010|NCT01385748|Clonidine|clonidine|mesh-list
83592011|NCT01385748|Analgesics|analgesics|mesh-ancestor
83592012|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
83592013|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592014|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592015|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83592016|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
83592017|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
83592018|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83592019|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83592020|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83592021|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
83592022|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592023|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592024|NCT01397448|Rabeprazole|rabeprazole|mesh-list
83592025|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83592026|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592027|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83592028|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592029|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592030|NCT01384734|Ritonavir|ritonavir|mesh-list
83592031|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83592032|NCT01384734|Tenofovir|tenofovir|mesh-list
83592033|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
83592034|NCT01384734|Fostemsavir|fostemsavir|mesh-list
83592035|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83592036|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83592037|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
83592038|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592039|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592040|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83592041|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83592042|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
83592043|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592044|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83592045|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83592046|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83592047|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83592048|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83592049|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83592050|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83592051|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83592052|NCT01396512|Vaccines|vaccines|mesh-list
83592053|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
83592054|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592055|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83592056|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
83592057|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592058|NCT01383954|Diclofenac|diclofenac|mesh-list
83592059|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83592060|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592061|NCT01383954|Analgesics|analgesics|mesh-ancestor
83592062|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
83592063|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592064|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592065|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592066|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592067|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83592068|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592069|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592070|NCT05365464|Progesterone|progesterone|mesh-list
83592071|NCT05365464|Progestins|progestins|mesh-ancestor
83592072|NCT05365464|Hormones|hormones|mesh-ancestor
83592073|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592074|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592075|NCT01383486|Naproxen|naproxen|mesh-list
83592076|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83592077|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592079|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
83592080|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592081|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592082|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592083|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592084|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
83592085|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83592086|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592087|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592088|NCT04766736|Antibodies|antibodies|mesh-list
83592089|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
83592090|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592091|NCT01396278|Fluticasone|fluticasone|mesh-list
83592092|NCT01396278|Xhance|xhance|mesh-list
83592093|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592094|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83592095|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
83592096|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592097|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592098|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83592099|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83592100|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83592101|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83592102|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
83592103|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
83592104|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
83592105|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592106|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592107|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
83592108|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592109|NCT01383096|Artefenomel|artefenomel|mesh-list
83592110|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83592111|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
83592112|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83592113|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83592114|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592115|NCT01382940|Acetaminophen|acetaminophen|mesh-list
83592116|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
83592117|NCT01382940|Rituximab|rituximab|mesh-list
83592118|NCT01382940|Methotrexate|methotrexate|mesh-list
83592119|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
83592120|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83592121|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592122|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592123|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
83592124|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592125|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592126|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83592127|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
83592128|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83592129|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83592130|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
83592131|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592132|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
83592133|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592134|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83592135|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592136|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83592137|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592138|NCT01382940|Analgesics|analgesics|mesh-ancestor
83592139|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
83592140|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592141|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
83592142|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592143|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
83592144|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
83592145|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592146|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
83592147|NCT01382940|Hormones|hormones|mesh-ancestor
83592148|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592149|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83592150|NCT01382940|Protective Agents|protective agents|mesh-ancestor
83592151|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
83592152|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592153|NCT01381926|Exenatide|exenatide|mesh-list
83592154|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83592155|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592156|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83592157|NCT01381926|Incretins|incretins|mesh-ancestor
83592158|NCT01381926|Hormones|hormones|mesh-ancestor
83592159|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592160|NCT01395888|Fluticasone|fluticasone|mesh-list
83592161|NCT01395888|Xhance|xhance|mesh-list
83592162|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
83592163|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592164|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83592165|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
83592166|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592167|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592168|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83592169|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
83592170|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
83592171|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83592172|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
83592173|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83592174|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
83592175|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592176|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592177|NCT01381692|Sirolimus|sirolimus|mesh-list
83592178|NCT01381692|Dexamethasone|dexamethasone|mesh-list
83592179|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
83592180|NCT01381692|Rituximab|rituximab|mesh-list
83592181|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83592182|NCT01381692|Bortezomib|bortezomib|mesh-list
83592183|NCT01381692|Temsirolimus|temsirolimus|mesh-list
83592184|NCT01381692|MTOR Inhibitors|mtor inhibitors|mesh-list
83592185|NCT01381692|Antibodies|antibodies|mesh-list
83592186|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
83592187|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83592188|NCT01381692|BB 1101|bb 1101|mesh-list
83592189|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
83592190|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592191|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592192|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592193|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592194|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
83592195|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
83592196|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592197|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592198|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
83592199|NCT01381692|Hormones|hormones|mesh-ancestor
83592200|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592201|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83592202|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
83592203|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592204|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592205|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83592206|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592207|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83592208|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
83592209|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592210|NCT01381692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83592211|NCT01395030|Choline|choline|mesh-list
83592212|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
83592213|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83592214|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
83592215|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592216|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83481266|NCT05610384|Analgesics|analgesics|mesh-ancestor
83592217|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83592218|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
83592219|NCT01394952|Dulaglutide|dulaglutide|mesh-list
83592220|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83592221|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592222|NCT01394718|Acetaminophen|acetaminophen|mesh-list
83592223|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592224|NCT01394718|Analgesics|analgesics|mesh-ancestor
83592225|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
83592226|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592227|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592228|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
83592229|NCT01394250|Lidocaine|lidocaine|mesh-list
83592230|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
83592231|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
83592232|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592233|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592234|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
83592235|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592236|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83592237|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83592238|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83592239|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83592240|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592241|NCT01380990|Busulfan|busulfan|mesh-list
83592242|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
83592243|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592244|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592245|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
83592246|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592247|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83592248|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592249|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83592250|NCT05361330|Fluoxetine|fluoxetine|mesh-list
83592251|NCT05361330|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83592252|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83592253|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83592254|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592255|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592256|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
83592257|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592258|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83592259|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
83592260|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83592261|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83592262|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83592263|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592264|NCT00214968|Modafinil|modafinil|mesh-list
83592265|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83592266|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592267|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83592268|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83592269|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83592270|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592271|NCT03592212|Albuterol|albuterol|mesh-list
83592272|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83592273|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
83592274|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592275|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592276|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83592277|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
83592278|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
83592279|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83592280|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83592281|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83592282|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83592283|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
83592284|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592285|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592286|NCT03024450|Trastuzumab|trastuzumab|mesh-list
83592287|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592288|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592289|NCT03997968|Rituximab|rituximab|mesh-list
83592290|NCT03997968|Gemcitabine|gemcitabine|mesh-list
83592291|NCT03997968|Capecitabine|capecitabine|mesh-list
83592292|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83592293|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592294|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592295|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
83592296|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592297|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592298|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83592299|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
83592300|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592301|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83592302|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
83592303|NCT04263090|Nivolumab|nivolumab|mesh-list
83592304|NCT04263090|ON 01910|on 01910|mesh-list
83592305|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592306|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592307|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83592308|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592309|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83592310|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592311|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
83592312|NCT03596424|Ketamine|ketamine|mesh-list
83592313|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83592314|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592315|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592316|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592317|NCT03596424|Analgesics|analgesics|mesh-ancestor
83592318|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
83592319|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592320|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83592321|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83592322|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83592323|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
83592324|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592325|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592326|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83592327|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83592328|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
83592329|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
83592330|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83592331|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83592332|NCT03997266|Gentamicins|gentamicins|mesh-list
83592333|NCT03997266|Ampicillin|ampicillin|mesh-list
83592334|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83592335|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592336|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83592337|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592338|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592339|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
83592340|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83592341|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592342|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83592343|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83592344|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592345|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592346|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592347|NCT05632692|Menthol|menthol|mesh-list
83592348|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
83592349|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
83592350|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
83592351|NCT03594162|Fludarabine|fludarabine|mesh-list
83592352|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592353|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
83592354|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592355|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592356|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83592357|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
83592358|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592359|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592360|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83592361|NCT04407312|Aspirin|aspirin|mesh-list
83592362|NCT04407312|Cilostazol|cilostazol|mesh-list
83592363|NCT04407312|Clopidogrel|clopidogrel|mesh-list
83592364|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83592365|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592366|NCT04407312|Analgesics|analgesics|mesh-ancestor
83592367|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
83592368|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592369|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592370|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592371|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592372|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83592373|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83592374|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592375|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83592376|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83592377|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592378|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
83592379|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83592380|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83592381|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83592382|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
83592383|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592384|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83592385|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
83592386|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83592387|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83592388|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
83592389|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83592390|NCT04407312|Protective Agents|protective agents|mesh-ancestor
83592391|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83592392|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83592394|NCT04009668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83592395|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592396|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592397|NCT04326738|Midazolam|midazolam|mesh-list
83592398|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83592399|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83592400|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592401|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592402|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83592403|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83592404|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83592405|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83592406|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
83592407|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
83592408|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
83592409|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
83592410|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592411|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592412|NCT04347486|Atropine|atropine|mesh-list
83592413|NCT04347486|Neostigmine|neostigmine|mesh-list
83592414|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83592415|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83592416|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83592417|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
83592418|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592419|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592420|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83592421|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
83592422|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
83592423|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
83592424|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83592425|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83592426|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
83592427|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592428|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592429|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83592430|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592431|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83592432|NCT04407234|Acetaminophen|acetaminophen|mesh-list
83592433|NCT04407234|Tirzepatide|tirzepatide|mesh-list
83592434|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592435|NCT04407234|Analgesics|analgesics|mesh-ancestor
83592436|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
83592437|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592438|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592439|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
83592440|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83592441|NCT04407234|Incretins|incretins|mesh-ancestor
83592442|NCT04407234|Hormones|hormones|mesh-ancestor
83592443|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592444|NCT05632224|Aprepitant|aprepitant|mesh-list
83592445|NCT05632224|Granisetron|granisetron|mesh-list
83592446|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
83592447|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
83592448|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592449|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050537|NCT03500120|Captopril|captopril|mesh-list
83592450|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592451|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83592452|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592453|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592454|NCT05632224|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83592455|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83592456|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
83592457|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
83592458|NCT05631912|Fludarabine|fludarabine|mesh-list
83592459|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
83592460|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592461|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
83592462|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592463|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592464|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83592465|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
83592466|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592467|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592468|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83592469|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83592470|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
83592471|NCT03024840|Propofol|propofol|mesh-list
83592472|NCT03024840|Sevoflurane|sevoflurane|mesh-list
83592473|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83592474|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592475|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592476|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83592477|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
83592478|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
83592479|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83592480|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83592481|NCT05631678|Itraconazole|itraconazole|mesh-list
83592482|NCT05631678|Rifampin|rifampin|mesh-list
83592483|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
83592484|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592485|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83592486|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83592487|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592488|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592489|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83592490|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
83592491|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592492|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592493|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83592494|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83592495|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
83592496|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83592497|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
83592498|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83592499|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83592500|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83592501|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83592502|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83592503|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83592504|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83592505|NCT03599778|Apatinib|apatinib|mesh-list
83592506|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592507|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83592508|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592509|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592510|NCT04008264|Scopolamine|scopolamine|mesh-list
83592511|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83592512|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83592513|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
83592514|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
83592515|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592516|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592517|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592518|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
83592519|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83592520|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
83592521|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592522|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592523|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83592524|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
83592525|NCT03595254|Nicotine|nicotine|mesh-list
83592526|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83592527|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
83592528|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592529|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592530|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83592531|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83592532|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
83592533|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592534|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592535|NCT03599466|Lisinopril|lisinopril|mesh-list
83592536|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83592537|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
83592538|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592539|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592540|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83592541|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83592542|NCT03599466|Protective Agents|protective agents|mesh-ancestor
83592543|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592544|NCT03986970|Tenofovir|tenofovir|mesh-list
83592545|NCT03986970|Emtricitabine|emtricitabine|mesh-list
83592546|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
83592547|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592548|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83592549|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83592550|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592551|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592552|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83592553|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83592554|NCT03594396|Durvalumab|durvalumab|mesh-list
83592555|NCT03594396|Olaparib|olaparib|mesh-list
83592556|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592557|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592558|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83592559|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592560|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592561|NCT03594240|Folic Acid|folic acid|mesh-list
83592562|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
83592563|NCT03594240|Vitamins|vitamins|mesh-ancestor
83592564|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
83592565|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592566|NCT03594240|Hematinics|hematinics|mesh-ancestor
83592567|NCT03976362|Paclitaxel|paclitaxel|mesh-list
83592568|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83592569|NCT03976362|Carboplatin|carboplatin|mesh-list
83592570|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
83592571|NCT03976362|Olaparib|olaparib|mesh-list
83592572|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83592573|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592574|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83592575|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83592576|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83592577|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592578|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592579|NCT03976362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83592580|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83592581|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592582|NCT03598374|Folic Acid|folic acid|mesh-list
83592583|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
83592584|NCT03598374|Inositol|inositol|mesh-list
83592585|NCT03598374|Hematinics|hematinics|mesh-ancestor
83592586|NCT03598374|Vitamins|vitamins|mesh-ancestor
83592587|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
83592588|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592589|NCT04407078|Neostigmine|neostigmine|mesh-list
83592590|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83592591|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592592|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592593|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
83592594|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592595|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592596|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83592597|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
83592598|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592599|NCT00217620|Sorafenib|sorafenib|mesh-list
83592600|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592601|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83592602|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592603|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592604|NCT00217464|Fulvestrant|fulvestrant|mesh-list
83592605|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83592606|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592607|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83592608|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83592609|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
83592610|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592611|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592612|NCT03597282|Nivolumab|nivolumab|mesh-list
83592613|NCT03597282|Ipilimumab|ipilimumab|mesh-list
83592614|NCT03597282|Poly ICLC|poly iclc|mesh-list
83592615|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592616|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592617|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83592618|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592619|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
83592620|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
83592621|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592622|NCT03593304|Vitamins|vitamins|mesh-list
83592623|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
83592624|NCT03593304|Pyridoxine|pyridoxine|mesh-list
83592625|NCT03593304|Pyridoxal|pyridoxal|mesh-list
83592626|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
83592627|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
83592628|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
83592629|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592630|NCT00211536|Insulin|insulin|mesh-list
83592631|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83592632|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83592633|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592634|NCT03596970|Everolimus|everolimus|mesh-list
83592635|NCT03596970|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83592636|NCT03596970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83592637|NCT03596970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592638|NCT03596970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592639|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592640|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
83592641|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592642|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592643|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
83592644|NCT03596892|Busulfan|busulfan|mesh-list
83592645|NCT03596892|Decitabine|decitabine|mesh-list
83592646|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592647|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
83592648|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592649|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592650|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83592651|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
83592652|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592653|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592654|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83592655|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83592656|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
83592657|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592658|NCT03592836|Furosemide|furosemide|mesh-list
83592659|NCT03592836|Diuretics|diuretics|mesh-list
83592660|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83592661|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
83592662|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592663|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83592664|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592665|NCT03596502|Warfarin|warfarin|mesh-list
83592666|NCT03596502|Anticoagulants|anticoagulants|mesh-list
83592667|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
83592668|NCT04197570|Analgesics|analgesics|mesh-list
83592669|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83592670|NCT04197570|Anesthetics|anesthetics|mesh-list
83592671|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592672|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592673|NCT04197570|Narcotics|narcotics|mesh-ancestor
83592674|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
83592675|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592676|NCT04197882|Molgramostim|molgramostim|mesh-list
83592677|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592678|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83592679|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83592680|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
83592681|NCT03024216|Atezolizumab|atezolizumab|mesh-list
83592682|NCT03024216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83592683|NCT03024216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592684|NCT03024216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592685|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592686|NCT03981744|Ustekinumab|ustekinumab|mesh-list
83592687|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83592689|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83592690|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592691|NCT03591744|Dexamethasone|dexamethasone|mesh-list
83592692|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
83592693|NCT03591744|Doxorubicin|doxorubicin|mesh-list
83592694|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83592695|NCT03591744|Lenalidomide|lenalidomide|mesh-list
83592696|NCT03591744|Bortezomib|bortezomib|mesh-list
83592697|NCT03591744|Daratumumab|daratumumab|mesh-list
83592698|NCT03591744|Ichthammol|ichthammol|mesh-list
83592699|NCT03591744|BB 1101|bb 1101|mesh-list
83592700|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592701|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
83592702|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
83592703|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592704|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592705|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592706|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
83592707|NCT03591744|Hormones|hormones|mesh-ancestor
83592708|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592709|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83592710|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592711|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83592712|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83592713|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83592714|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592715|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592716|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
83592717|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83592718|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83592719|NCT03591744|Growth Substances|growth substances|mesh-ancestor
83592720|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
83592721|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
83592722|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83592723|NCT04196946|Fentanyl|fentanyl|mesh-list
83592724|NCT04196946|Alfentanil|alfentanil|mesh-list
83592725|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83592726|NCT04196946|Narcotics|narcotics|mesh-ancestor
83592727|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592728|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592729|NCT04196946|Analgesics|analgesics|mesh-ancestor
83592730|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
83592731|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592732|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83592733|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83592734|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
83592735|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
83592736|NCT03023904|Nivolumab|nivolumab|mesh-list
83592737|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592738|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592739|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83592740|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592741|NCT04196010|Cytarabine|cytarabine|mesh-list
83592742|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83592743|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
83592744|NCT04196010|Cladribine|cladribine|mesh-list
83592745|NCT04196010|Lenograstim|lenograstim|mesh-list
83592746|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83592747|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
83592748|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592749|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592750|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
83592751|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592752|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592753|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
83592754|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050841|NCT01366638|Ribavirin|ribavirin|mesh-list
83592755|NCT04196010|Analgesics|analgesics|mesh-ancestor
83592756|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
83592757|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592758|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83592759|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83592760|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592761|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83592763|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592764|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
83592765|NCT04196400|Hormones|hormones|mesh-ancestor
83592766|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592767|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592768|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83592769|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
83592770|NCT03742986|Paclitaxel|paclitaxel|mesh-list
83592771|NCT03742986|Docetaxel|docetaxel|mesh-list
83592772|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83592773|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
83592774|NCT03742986|Doxorubicin|doxorubicin|mesh-list
83592775|NCT03742986|Nivolumab|nivolumab|mesh-list
83592776|NCT03742986|Trastuzumab|trastuzumab|mesh-list
83592777|NCT03742986|Pertuzumab|pertuzumab|mesh-list
83592778|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83592779|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592780|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
83592781|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
83592782|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
83592783|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592784|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592785|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
83592786|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592787|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592788|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83592789|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
83592790|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83592791|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83592792|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83592793|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83592794|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592795|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83592796|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83592797|NCT03023436|Fluorouracil|fluorouracil|mesh-list
83592798|NCT03023436|Capecitabine|capecitabine|mesh-list
83592799|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592800|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
83592801|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592802|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83592803|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592804|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
83592805|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592806|NCT04195074|Tenofovir|tenofovir|mesh-list
83592807|NCT04195074|Entecavir|entecavir|mesh-list
83592808|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
83592809|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592810|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83592811|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83592812|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592813|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592814|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83592815|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83592816|NCT03590262|Metformin|metformin|mesh-list
83592817|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83592818|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592819|NCT04029636|Xenon|xenon|mesh-list
83592820|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83592821|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
83592822|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
83592823|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592824|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592825|NCT04194684|Paclitaxel|paclitaxel|mesh-list
83592826|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83592827|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592828|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
83592829|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
83592830|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
83592831|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592832|NCT04194294|Lidocaine|lidocaine|mesh-list
83592833|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
83592834|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
83592835|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83592836|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592837|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
83592838|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592839|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83592840|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83592841|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83592842|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83592843|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592844|NCT04029090|Edaravone|edaravone|mesh-list
83592845|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83592846|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
83592847|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592848|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83592849|NCT04029090|Protective Agents|protective agents|mesh-ancestor
83592850|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592851|NCT04194216|Clindamycin|clindamycin|mesh-list
83592852|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
83592853|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
83592854|NCT04194216|Cephalexin|cephalexin|mesh-list
83592855|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83592856|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592857|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83592858|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592859|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592860|NCT04193982|Vitamin E|vitamin e|mesh-list
83592861|NCT04193982|Vitamins|vitamins|mesh-ancestor
83592862|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
83592863|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592864|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
83592865|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592866|NCT04193982|Protective Agents|protective agents|mesh-ancestor
83592867|NCT04028778|Gefitinib|gefitinib|mesh-list
83592868|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592869|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83592870|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592871|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592872|NCT04028856|Interferons|interferons|mesh-list
83592873|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592874|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
83592875|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592876|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83592877|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83592878|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83592879|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83592880|NCT04193592|Pirfenidone|pirfenidone|mesh-list
83592881|NCT04193592|Analgesics|analgesics|mesh-ancestor
83592882|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
83592883|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592884|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592885|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83592886|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83592887|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592888|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592889|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592890|NCT03933384|Tenofovir|tenofovir|mesh-list
83592891|NCT03933384|Entecavir|entecavir|mesh-list
83592892|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
83592893|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592894|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83481938|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
83592895|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83592896|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592897|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592898|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83592899|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83592900|NCT04028466|Omeprazole|omeprazole|mesh-list
83592901|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83592902|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592903|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83592904|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592905|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592906|NCT04027764|Paclitaxel|paclitaxel|mesh-list
83592907|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83592908|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592909|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
83592910|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
83592911|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
83592912|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592913|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
83592914|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83592915|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592916|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83592917|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592918|NCT03023358|Prednisone|prednisone|mesh-list
83592919|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
83592920|NCT03023358|Doxorubicin|doxorubicin|mesh-list
83592921|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83592922|NCT03023358|Vincristine|vincristine|mesh-list
83592923|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83592924|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
83592925|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592926|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83592927|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83592928|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
83592929|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592930|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592931|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83592932|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83592933|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83592934|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83592935|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592936|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592937|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
83592938|NCT03023358|Hormones|hormones|mesh-ancestor
83592939|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592940|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83592941|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83592942|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83592943|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83592944|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83592945|NCT04192812|Leuprolide|leuprolide|mesh-list
83592946|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83592947|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
83592948|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83592949|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592950|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83592951|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592952|NCT04407000|Favipiravir|favipiravir|mesh-list
83592953|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
83592954|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83592955|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
83592956|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83592957|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83592958|NCT04192656|Prednisolone|prednisolone|mesh-list
83592959|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
83592960|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83592961|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
83592962|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83592963|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
83592964|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
83592965|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592966|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592967|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83592968|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
83592969|NCT04192656|Hormones|hormones|mesh-ancestor
83592970|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83592971|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83592972|NCT04192656|Protective Agents|protective agents|mesh-ancestor
83592973|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83592974|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83592975|NCT04191954|Fasudil|fasudil|mesh-list
83592976|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83592977|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
83592978|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83592979|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83592980|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83592981|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051059|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
83592982|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83592983|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592984|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
83592985|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83592986|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83592987|NCT04192032|Nicotine|nicotine|mesh-list
83592988|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83592989|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
83592990|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83592991|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83592992|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83592993|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83592994|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
83592995|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83592996|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83592997|NCT03023982|Morphine|morphine|mesh-list
83592998|NCT03023982|Bupivacaine|bupivacaine|mesh-list
83592999|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
83593000|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
83593001|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593002|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593003|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
83593004|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593005|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83593006|NCT03023982|Narcotics|narcotics|mesh-ancestor
83593007|NCT03023982|Analgesics|analgesics|mesh-ancestor
83593008|NCT04192110|Diuretics|diuretics|mesh-list
83593009|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
83593010|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593011|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
83593012|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83593013|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83593014|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593015|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
83593016|NCT04025736|Coagulants|coagulants|mesh-ancestor
83593017|NCT04190160|Xultophy|xultophy|mesh-list
83593018|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83593019|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593020|NCT04190160|Incretins|incretins|mesh-ancestor
83593021|NCT04190160|Hormones|hormones|mesh-ancestor
83593022|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593023|NCT04190004|Vasopressins|vasopressins|mesh-list
83593024|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
83593025|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
83593026|NCT04190004|Coagulants|coagulants|mesh-ancestor
83593027|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83593028|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83593029|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
83593030|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593031|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
83593032|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83593033|NCT03949764|Velpatasvir|velpatasvir|mesh-list
83593034|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
83593035|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593036|NCT04406376|Prednisone|prednisone|mesh-list
83593037|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593038|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
83593039|NCT04406376|Hormones|hormones|mesh-ancestor
83593040|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593041|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593042|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83593043|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593044|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
83593045|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593046|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593047|NCT04024800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83593048|NCT04024800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593049|NCT04198662|Epinephrine|epinephrine|mesh-list
83593050|NCT04198662|Ropivacaine|ropivacaine|mesh-list
83593051|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
83593052|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
83593053|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593054|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593055|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
83593056|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593057|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83593058|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83593059|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83593060|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593061|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593062|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83593063|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83593064|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
83593065|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83593066|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
83593067|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
83593068|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
83593069|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83593070|NCT04406610|Immunomodulating Agents|immunomodulating agents|mesh-list
83593071|NCT04406610|Immunologic Factors|immunologic factors|mesh-ancestor
83593072|NCT04406610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593073|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
83593074|NCT04023630|Clopidogrel|clopidogrel|mesh-list
83593075|NCT04023630|Ticagrelor|ticagrelor|mesh-list
83593076|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83593077|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83593078|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83593079|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83593080|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
83593081|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593082|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593083|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593084|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83593085|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
83593086|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83593087|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
83593088|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593089|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
83593090|NCT04199754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83593091|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
83593092|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593093|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593094|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83593095|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83593096|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593097|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593098|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593099|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83593100|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83593101|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
83593102|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83593103|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593104|NCT04020666|Kallikreins|kallikreins|mesh-list
83593105|NCT04020666|Coagulants|coagulants|mesh-ancestor
83593106|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83593107|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
83593108|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83593109|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593110|NCT03929640|Acetaminophen|acetaminophen|mesh-list
83593111|NCT03929640|Ibuprofen|ibuprofen|mesh-list
83593112|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593113|NCT03929640|Analgesics|analgesics|mesh-ancestor
83593114|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
83593115|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593116|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593117|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
83593118|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83593119|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593120|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593121|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83593122|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593123|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593124|NCT04021992|Rituximab|rituximab|mesh-list
83593125|NCT04021992|Gemcitabine|gemcitabine|mesh-list
83593126|NCT04021992|Doxorubicin|doxorubicin|mesh-list
83593127|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83593128|NCT04021992|Vinorelbine|vinorelbine|mesh-list
83593129|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593130|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593131|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
83593132|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593133|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83051213|NCT03491072|Narcotics|narcotics|mesh-ancestor
83593134|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593135|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
83593136|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593137|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83593138|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83593139|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83593140|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593141|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83593142|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83593143|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83593144|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83593145|NCT03926130|Mirikizumab|mirikizumab|mesh-list
83593146|NCT03926130|Ustekinumab|ustekinumab|mesh-list
83593147|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
83593148|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83593149|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593150|NCT03926130|Analgesics|analgesics|mesh-ancestor
83593151|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
83593152|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593153|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593154|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593155|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593156|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83593157|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83593158|NCT04020588|Minocycline|minocycline|mesh-list
83593159|NCT04020588|Celecoxib|celecoxib|mesh-list
83593160|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83593161|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593162|NCT04020588|Analgesics|analgesics|mesh-ancestor
83593163|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
83593164|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593165|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593166|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593167|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593168|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83593169|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83593170|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593171|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593172|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593173|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593174|NCT04145856|Simethicone|simethicone|mesh-list
83593175|NCT04145856|Alverine|alverine|mesh-list
83593176|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
83593177|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593178|NCT04145856|Emollients|emollients|mesh-ancestor
83593179|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
83593180|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
83593181|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
83593182|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593183|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593184|NCT04140786|Gentamicins|gentamicins|mesh-list
83593185|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593186|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593187|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83593188|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593189|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593190|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83593191|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83593192|NCT04022226|Ketamine|ketamine|mesh-list
83593193|NCT04022226|Methohexital|methohexital|mesh-list
83593194|NCT04022226|Analgesics|analgesics|mesh-ancestor
83593195|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
83593196|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593197|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593198|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83593199|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83593200|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
83593201|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
83593202|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593203|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83593204|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83593205|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593206|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593207|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
83593208|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83593209|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
83593210|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
83593211|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593212|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593213|NCT04025658|Oxytocin|oxytocin|mesh-list
83593214|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
83593215|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83593216|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593217|NCT05586438|Colistin|colistin|mesh-list
83593218|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593219|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593220|NCT04145232|Nivolumab|nivolumab|mesh-list
83593221|NCT04145232|Ipilimumab|ipilimumab|mesh-list
83593222|NCT04145232|Atezolizumab|atezolizumab|mesh-list
83593223|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593224|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593225|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83593226|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593227|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
83593228|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83593229|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83593230|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
83593231|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593232|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593233|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593234|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
83593235|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
83593236|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593237|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
83593238|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83593239|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
83593240|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83593241|NCT04026282|Hormones|hormones|mesh-ancestor
83593242|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593243|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593244|NCT04144218|Lacosamide|lacosamide|mesh-list
83593245|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
83593246|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83593247|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83593248|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83593249|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593250|NCT05580822|Tenecteplase|tenecteplase|mesh-list
83593251|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83593252|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83593253|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593254|NCT05580354|Tislelizumab|tislelizumab|mesh-list
83593255|NCT05580354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593256|NCT05580354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593257|NCT04143906|Carboplatin|carboplatin|mesh-list
83593258|NCT04143906|Gemcitabine|gemcitabine|mesh-list
83593259|NCT04143906|Vinorelbine|vinorelbine|mesh-list
83593260|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593261|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593262|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
83593263|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593264|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83593265|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
83593266|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
83593267|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
83593268|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
83593269|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83593270|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
83593271|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593272|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
83593273|NCT02708706|Protective Agents|protective agents|mesh-ancestor
83593274|NCT05587608|Anesthetics|anesthetics|mesh-list
83593275|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593276|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593277|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
83593278|NCT02703714|Sargramostim|sargramostim|mesh-list
83593279|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593280|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593281|NCT02703714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83593282|NCT02703714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051375|NCT03488810|Hormones|hormones|mesh-list
83051438|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593283|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
83593284|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593286|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83593287|NCT05583474|Latanoprost|latanoprost|mesh-list
83593288|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83593289|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83593290|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83593291|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
83593292|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593293|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593294|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593295|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83593296|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83593297|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
83593298|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
83593299|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593300|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
83593301|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83593302|NCT03904446|Methylergonovine|methylergonovine|mesh-list
83593303|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
83593304|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83593305|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593306|NCT03916068|Vitamin E|vitamin e|mesh-list
83593307|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
83593308|NCT03916068|Vitamins|vitamins|mesh-ancestor
83593309|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
83593310|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593311|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
83593312|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593313|NCT03916068|Protective Agents|protective agents|mesh-ancestor
83593314|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83593315|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593316|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83593317|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83593318|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
83593319|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83593320|NCT04143282|Metformin|metformin|mesh-list
83593321|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83593322|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593323|NCT04149678|Cyclosporine|cyclosporine|mesh-list
83593324|NCT04149678|Cyclosporins|cyclosporins|mesh-list
83593325|NCT04149678|Ozanimod|ozanimod|mesh-list
83593326|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593327|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593328|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83593329|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
83593330|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593331|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
83593332|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593333|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
83593334|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593335|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83593336|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83593337|NCT05581992|Sotorasib|sotorasib|mesh-list
83593338|NCT05581992|Omeprazole|omeprazole|mesh-list
83593339|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83593340|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83593341|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83593342|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593343|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593344|NCT05581992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83593345|NCT05581992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593346|NCT05581992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593347|NCT03020940|Cefuroxime|cefuroxime|mesh-list
83593348|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
83593349|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593350|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593351|NCT03645408|Exenatide|exenatide|mesh-list
83593352|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83593353|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593354|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83593355|NCT03645408|Incretins|incretins|mesh-ancestor
83593356|NCT03645408|Hormones|hormones|mesh-ancestor
83593357|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593358|NCT04141410|Simendan|simendan|mesh-list
83593360|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
83593361|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83593362|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83593363|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593364|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593365|NCT04141410|Protective Agents|protective agents|mesh-ancestor
83593366|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593367|NCT05586204|Vaccines|vaccines|mesh-list
83593368|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
83593369|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593370|NCT04149444|Trifluridine|trifluridine|mesh-list
83593371|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
83593372|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593373|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
83593374|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593375|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
83593376|NCT03020706|Analgesics|analgesics|mesh-ancestor
83593377|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
83593378|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593379|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593380|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
83593381|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593382|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83593383|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
83593384|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83593385|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83593386|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593387|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83593388|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
83593389|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83593390|NCT03900624|Dexamethasone|dexamethasone|mesh-list
83593391|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593392|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
83593393|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
83593394|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593395|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593396|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83593397|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
83593398|NCT03900624|Hormones|hormones|mesh-ancestor
83593399|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593400|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83593401|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593402|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
83593403|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83593404|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
83593405|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593406|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593407|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83593408|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
83593409|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83593410|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
83593411|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593412|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593413|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83593414|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
83593415|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
83593416|NCT04149132|Protective Agents|protective agents|mesh-ancestor
83593417|NCT03908892|Tetracycline|tetracycline|mesh-list
83593418|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593419|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593420|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83593421|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593422|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593423|NCT04140318|Paclitaxel|paclitaxel|mesh-list
83593424|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83593425|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593426|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83593427|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83593428|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83593429|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051511|NCT00363038|Petrolatum|petrolatum|mesh-list
83593430|NCT03021330|Cytarabine|cytarabine|mesh-list
83593431|NCT03021330|Daunorubicin|daunorubicin|mesh-list
83593432|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593433|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
83593434|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593435|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593436|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
83593437|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593438|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83593439|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
83593440|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593441|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83593442|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83593443|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83593444|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593445|NCT04140006|Alendronate|alendronate|mesh-list
83593446|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83593447|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593448|NCT04146324|Nivolumab|nivolumab|mesh-list
83593449|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593450|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593451|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83593452|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593453|NCT03588936|Nivolumab|nivolumab|mesh-list
83593454|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593455|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593456|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83593457|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593458|NCT03022500|Durvalumab|durvalumab|mesh-list
83593459|NCT03022500|Tremelimumab|tremelimumab|mesh-list
83593460|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593461|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593462|NCT04148898|Bevacizumab|bevacizumab|mesh-list
83593463|NCT04148898|Osimertinib|osimertinib|mesh-list
83593464|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83593465|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593466|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83593467|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83593468|NCT04148898|Growth Substances|growth substances|mesh-ancestor
83593469|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593470|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
83593471|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83593472|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593473|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593474|NCT04148820|Aspirin|aspirin|mesh-list
83593475|NCT04148820|Perindopril|perindopril|mesh-list
83593476|NCT04148820|Atorvastatin|atorvastatin|mesh-list
83593477|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83593478|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593479|NCT04148820|Analgesics|analgesics|mesh-ancestor
83593480|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
83593481|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593482|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593483|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593484|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593485|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83593486|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83593487|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593488|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83593489|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83593490|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593491|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
83593492|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83593493|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83593494|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
83593495|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83593496|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83593497|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83593498|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
83593499|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83593500|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83593501|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83593502|NCT03941730|Estradiol|estradiol|mesh-list
83593503|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83593504|NCT03941730|Estrogens|estrogens|mesh-ancestor
83593505|NCT03941730|Hormones|hormones|mesh-ancestor
83593506|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593507|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593508|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83593509|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
83593510|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83593511|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83593513|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593514|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
83593515|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593516|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593517|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593518|NCT03580980|Acetaminophen|acetaminophen|mesh-list
83593519|NCT03580980|Ketamine|ketamine|mesh-list
83593520|NCT03580980|Morphine|morphine|mesh-list
83593521|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
83593522|NCT03580980|Analgesics|analgesics|mesh-ancestor
83593523|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
83593524|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593525|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593526|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83593527|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83593528|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
83593529|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
83593530|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593531|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83593532|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83593533|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593534|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593535|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83593536|NCT03580980|Narcotics|narcotics|mesh-ancestor
83593537|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593538|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
83593539|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
83593540|NCT03587220|Lidocaine|lidocaine|mesh-list
83593541|NCT03587220|Capsaicin|capsaicin|mesh-list
83593542|NCT03587220|Histamine|histamine|mesh-list
83593543|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
83593544|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
83593545|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593546|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593547|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
83593548|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593549|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83593550|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83593551|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83593552|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83593553|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593554|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
83593555|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
83593556|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
83593557|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
83593558|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593559|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83593560|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83593561|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
83593562|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83593563|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
83593564|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593565|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593566|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83593567|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
83593568|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
83593569|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83593570|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
83593571|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593572|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593573|NCT03580590|Diltiazem|diltiazem|mesh-list
83593574|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
83593575|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83593576|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83593577|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593578|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
83593579|NCT03580590|Coagulants|coagulants|mesh-ancestor
83051659|NCT00103662|Plerixafor|plerixafor|mesh-list
83593580|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83593581|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83593582|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83593583|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83593584|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593585|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
83593586|NCT03891576|Niraparib|niraparib|mesh-list
83593587|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83593588|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593589|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593590|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593591|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83593592|NCT03586674|Fenofibrate|fenofibrate|mesh-list
83593593|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83593594|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
83593595|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593596|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83593597|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83593598|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83593599|NCT03346668|Gabapentin|gabapentin|mesh-list
83593600|NCT03346668|Analgesics|analgesics|mesh-ancestor
83593601|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
83593602|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593603|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593604|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
83593605|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83593606|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83593607|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593608|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83593609|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83593610|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83593611|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593612|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593613|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
83593614|NCT03585738|Folic Acid|folic acid|mesh-list
83593615|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
83593616|NCT03585738|Inositol|inositol|mesh-list
83593617|NCT03585738|Hematinics|hematinics|mesh-ancestor
83593618|NCT03585738|Vitamins|vitamins|mesh-ancestor
83593619|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
83593620|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593621|NCT03583164|Olorofim|olorofim|mesh-list
83593622|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
83593623|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593624|NCT03589326|Cytarabine|cytarabine|mesh-list
83593625|NCT03589326|Dexamethasone|dexamethasone|mesh-list
83593626|NCT03589326|Prednisone|prednisone|mesh-list
83593627|NCT03589326|Methotrexate|methotrexate|mesh-list
83593628|NCT03589326|Vincristine|vincristine|mesh-list
83593629|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
83593630|NCT03589326|Ponatinib|ponatinib|mesh-list
83593631|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593632|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
83593633|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
83593634|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593635|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593636|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83593637|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
83593638|NCT03589326|Hormones|hormones|mesh-ancestor
83593639|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593640|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83593641|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593642|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83593643|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
83482688|NCT00475904|Analgesics|analgesics|mesh-ancestor
83593644|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83593645|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593646|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
83593647|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593648|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83593649|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593650|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83593651|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83593652|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
83593653|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593654|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83051736|NCT03097900|Caffeine|caffeine|mesh-list
83593655|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
83593656|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593657|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83593658|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83593659|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83593660|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83593661|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83593662|NCT05701956|Tenecteplase|tenecteplase|mesh-list
83593663|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83593664|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83593665|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593666|NCT03156036|Capecitabine|capecitabine|mesh-list
83593667|NCT03156036|Temozolomide|temozolomide|mesh-list
83593668|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593669|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
83593670|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593671|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593672|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83593673|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
83593674|NCT03583866|Candesartan|candesartan|mesh-list
83593675|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83593676|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83593677|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83593678|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593679|NCT03585426|Vancomycin|vancomycin|mesh-list
83593680|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593681|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593682|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83593683|NCT03585036|Tramadol|tramadol|mesh-list
83593684|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83593685|NCT03585036|Narcotics|narcotics|mesh-ancestor
83593686|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593687|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593688|NCT03585036|Analgesics|analgesics|mesh-ancestor
83593689|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
83593690|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593691|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83593692|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593693|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593694|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593695|NCT03155568|Bupivacaine|bupivacaine|mesh-list
83593696|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
83593697|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
83593698|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593699|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593700|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
83593701|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593702|NCT03159702|Fludarabine|fludarabine|mesh-list
83593703|NCT03159702|Melphalan|melphalan|mesh-list
83593704|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593705|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593706|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83593707|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
83593708|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593709|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83593710|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
83593711|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83593712|NCT03155646|Clonidine|clonidine|mesh-list
83593713|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
83593714|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
83593715|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83593716|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593717|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593718|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593719|NCT03155646|Analgesics|analgesics|mesh-ancestor
83593720|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
83593721|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593722|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83593723|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83593724|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83593725|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
83593726|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593727|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593728|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83593729|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
83593730|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
83593731|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
83593732|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
83593733|NCT03584178|Budesonide|budesonide|mesh-list
83593734|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593735|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83593736|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
83593737|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593738|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593739|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83593740|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
83593741|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
83593742|NCT03584178|Hormones|hormones|mesh-ancestor
83593743|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593744|NCT04405206|Capecitabine|capecitabine|mesh-list
83593745|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
83593746|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593747|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
83593748|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593749|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593750|NCT03101046|Docetaxel|docetaxel|mesh-list
83593751|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593752|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
83593753|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
83593754|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
83593755|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593756|NCT03159936|Tofacitinib|tofacitinib|mesh-list
83593757|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593758|NCT03159936|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83593759|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83593760|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593761|NCT03156816|Colchicine|colchicine|mesh-list
83593762|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
83593763|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593764|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
83593765|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
83593766|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
83593767|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593768|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593769|NCT03583476|Amoxicillin|amoxicillin|mesh-list
83593770|NCT03583476|Metronidazole|metronidazole|mesh-list
83593771|NCT03583476|Clarithromycin|clarithromycin|mesh-list
83593772|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83593773|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593774|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593775|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83593776|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83593777|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83593778|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593779|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593780|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83593781|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83593782|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83593783|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83593784|NCT03583242|Growth Substances|growth substances|mesh-ancestor
83593785|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593786|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83593787|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593788|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
83593789|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593790|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593791|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
83593792|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593793|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
83593794|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593795|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593796|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
83593797|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83593798|NCT03582306|Protective Agents|protective agents|mesh-ancestor
83593799|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593800|NCT03159234|Epinephrine|epinephrine|mesh-list
83593801|NCT03159234|Racepinephrine|racepinephrine|mesh-list
83593802|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
83593803|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83593804|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83593805|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
83593806|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593807|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593808|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593809|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83593810|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83593811|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
83593812|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593813|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83593814|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
83593815|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
83593816|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
83593817|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83593818|NCT05701332|Gemcitabine|gemcitabine|mesh-list
83593819|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
83593820|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83593821|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
83593822|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593823|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593824|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83593825|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
83593826|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593827|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
83593828|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83593829|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593830|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
83593831|NCT05703048|Esmolol|esmolol|mesh-list
83593832|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83593833|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593834|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593835|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593836|NCT05703048|Analgesics|analgesics|mesh-ancestor
83593837|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
83593838|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593839|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83593840|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83593841|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83593842|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83593843|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593844|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593845|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83593846|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83593847|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83593848|NCT03158142|Atropine|atropine|mesh-list
83593849|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83593850|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83593851|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83593852|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
83593853|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593854|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593855|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83593856|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
83593857|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
83593858|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
83593859|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83593860|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83593861|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
83593862|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593863|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593864|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
83593865|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83593866|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593867|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83593868|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83593869|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
83593870|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593871|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
83593872|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83593873|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
83593874|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83593875|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593876|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83593877|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83593878|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83051983|NCT02032797|Hormones|hormones|mesh-ancestor
83593879|NCT01671384|Valproic Acid|valproic acid|mesh-list
83593880|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
83593881|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593882|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593883|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
83593884|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593885|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593886|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
83593887|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83593888|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593889|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83593890|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
83593891|NCT01671774|Interleukin-2|interleukin-2|mesh-list
83593892|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593893|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83593894|NCT01671774|Analgesics|analgesics|mesh-ancestor
83593895|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
83593896|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593897|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593898|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83593899|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
83593900|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83593901|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83593902|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83593903|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
83593904|NCT01672086|Antacids|antacids|mesh-ancestor
83593905|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593906|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83593907|NCT05547750|Vitamin K|vitamin k|mesh-list
83593908|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
83593909|NCT05547750|Vitamins|vitamins|mesh-ancestor
83593910|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
83593911|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593912|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83593913|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83593914|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593915|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
83593916|NCT05547750|Coagulants|coagulants|mesh-ancestor
83593917|NCT04296006|Amphetamine|amphetamine|mesh-list
83593918|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
83593919|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83593920|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593921|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
83593922|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
83593923|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83593924|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
83593925|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593926|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593927|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
83593928|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83593929|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83593930|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83593931|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83593932|NCT01672476|Valsartan|valsartan|mesh-list
83593933|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83593934|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83593935|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83593936|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593937|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83593938|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
83593939|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83593940|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83593941|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83593942|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83593943|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593944|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
83593945|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593946|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593947|NCT05033808|Epirubicin|epirubicin|mesh-list
83593948|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83593949|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593950|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83593951|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83593952|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593953|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593954|NCT04026984|Rifamycins|rifamycins|mesh-list
83593955|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
83593956|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83593957|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83593958|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83593959|NCT04903314|Cenobamate|cenobamate|mesh-list
83593960|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
83593961|NCT03153072|Amiodarone|amiodarone|mesh-list
83593962|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83593963|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
83593964|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83593965|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83593966|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593967|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83593968|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83593969|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83593970|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593971|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83593972|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83593973|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83593974|NCT01673724|Pramipexole|pramipexole|mesh-list
83593975|NCT01673724|Bromocriptine|bromocriptine|mesh-list
83593976|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
83593977|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593978|NCT01673724|Protective Agents|protective agents|mesh-ancestor
83593979|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593980|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83593981|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83593982|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
83593983|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
83593984|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83593985|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
83593986|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593987|NCT04765098|Tamoxifen|tamoxifen|mesh-list
83593988|NCT04765098|Etoposide|etoposide|mesh-list
83593989|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83593990|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83593991|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83593992|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83593993|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83593994|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83593995|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83593996|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
83593997|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83593998|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83593999|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83594000|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83594001|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83594002|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83594003|NCT01674036|Venglustat|venglustat|mesh-list
83594004|NCT01674036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594005|NCT01674036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594006|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
83594007|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
83594008|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594009|NCT03032328|Vitamin D|vitamin d|mesh-list
83594010|NCT03032328|Vitamins|vitamins|mesh-ancestor
83594011|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
83594012|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594013|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83594014|NCT04747392|Teriparatide|teriparatide|mesh-list
83594015|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83594016|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594017|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83594018|NCT01674192|Prucalopride|prucalopride|mesh-list
83594019|NCT01674192|Laxatives|laxatives|mesh-ancestor
83594020|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594021|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83594022|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83594023|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
83594024|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594025|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594026|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594027|NCT01674270|Bicalutamide|bicalutamide|mesh-list
83594028|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
83594029|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
83594030|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594031|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594032|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594033|NCT01674504|Montelukast|montelukast|mesh-list
83594034|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83594035|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83594036|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83594037|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
83594038|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594039|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594040|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83594041|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83594042|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594043|NCT05353062|Epinephrine|epinephrine|mesh-list
83594044|NCT05353062|Hemostatics|hemostatics|mesh-list
83594045|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83594046|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83594047|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83594048|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594049|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594050|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594051|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83594052|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83594053|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
83594054|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594055|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83594056|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
83594057|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
83594058|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
83594059|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83594060|NCT05353062|Coagulants|coagulants|mesh-ancestor
83594061|NCT03152370|Leucovorin|leucovorin|mesh-list
83594062|NCT03152370|Folic Acid|folic acid|mesh-list
83594063|NCT03152370|Capecitabine|capecitabine|mesh-list
83594064|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
83594065|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
83594066|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594067|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
83594068|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594069|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594070|NCT03152370|Antidotes|antidotes|mesh-ancestor
83594071|NCT03152370|Protective Agents|protective agents|mesh-ancestor
83594072|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594073|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
83594074|NCT03152370|Vitamins|vitamins|mesh-ancestor
83594075|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
83594076|NCT03152370|Hematinics|hematinics|mesh-ancestor
83594077|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
83594078|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83594079|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83594080|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594081|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
83594082|NCT02187120|Coagulants|coagulants|mesh-ancestor
83594083|NCT01674738|Bevacizumab|bevacizumab|mesh-list
83594084|NCT01674738|Pemetrexed|pemetrexed|mesh-list
83594085|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594086|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594087|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83594088|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83594089|NCT01674738|Growth Substances|growth substances|mesh-ancestor
83594090|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594091|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
83594092|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594093|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594094|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83594095|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83594096|NCT01675206|Vitamin K|vitamin k|mesh-list
83594097|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
83594098|NCT01675206|Vitamins|vitamins|mesh-ancestor
83594099|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
83594100|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594101|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83594102|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83594103|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594104|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
83594105|NCT01675206|Coagulants|coagulants|mesh-ancestor
83594106|NCT03150576|Paclitaxel|paclitaxel|mesh-list
83594107|NCT03150576|Carboplatin|carboplatin|mesh-list
83594108|NCT03150576|Olaparib|olaparib|mesh-list
83594109|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594110|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594111|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594112|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594113|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594114|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594115|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83594116|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594117|NCT01059786|Rituximab|rituximab|mesh-list
83594118|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83594119|NCT01059786|Pentostatin|pentostatin|mesh-list
83594120|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594121|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594122|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
83594123|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594124|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594125|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83594126|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
83594127|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594128|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83594129|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594130|NCT04747080|Dexamethasone|dexamethasone|mesh-list
83594131|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
83594132|NCT04747080|BB 1101|bb 1101|mesh-list
83594133|NCT04747080|Tacrolimus|tacrolimus|mesh-list
83594134|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83594135|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
83594136|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
83594137|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594138|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594139|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594140|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
83594141|NCT04747080|Hormones|hormones|mesh-ancestor
83594142|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594143|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83594144|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594145|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
83594146|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594147|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594148|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594149|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
83594150|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83594151|NCT01675362|Selenium|selenium|mesh-list
83594152|NCT01675362|Losartan|losartan|mesh-list
83594153|NCT01675362|Verapamil|verapamil|mesh-list
83594154|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
83594155|NCT01675362|Calcium|calcium|mesh-list
83594156|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83594157|NCT01675362|Antioxidants|antioxidants|mesh-list
83594158|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83594159|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594160|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83594161|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83594162|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83594163|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594164|NCT01675362|Protective Agents|protective agents|mesh-ancestor
83594165|NCT01675362|Trace Elements|trace elements|mesh-ancestor
83594166|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
83594167|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83594168|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
83594169|NCT01675518|ASP7991|asp7991|mesh-list
83594170|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83594171|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
83594172|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594173|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594174|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
83594175|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
83594176|NCT01675986|Pregabalin|pregabalin|mesh-list
83052265|NCT03610893|Analgesics|analgesics|mesh-ancestor
83594177|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
83594178|NCT01675986|Analgesics|analgesics|mesh-ancestor
83594179|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
83594180|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594181|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594182|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
83594183|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83594184|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83594185|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594186|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83594187|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83594188|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83594189|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594190|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83594191|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
83594192|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
83594193|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83594194|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
83594195|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
83594196|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594197|NCT03875664|Bupivacaine|bupivacaine|mesh-list
83594198|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
83594199|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
83594200|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594201|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594202|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
83594203|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594204|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
83594205|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
83594206|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83594207|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83594208|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594209|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594210|NCT01670136|Urological Agents|urological agents|mesh-ancestor
83594211|NCT03873480|Epinephrine|epinephrine|mesh-list
83594212|NCT03873480|Bupivacaine|bupivacaine|mesh-list
83594213|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83594214|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83594215|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
83594216|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594217|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594218|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594219|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83594220|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83594221|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
83594222|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594223|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83594224|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
83594225|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
83594226|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
83594227|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83594228|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
83594229|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
83594230|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594231|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
83594232|NCT04764084|Niraparib|niraparib|mesh-list
83594233|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83594234|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594235|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594236|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594237|NCT03866772|Misoprostol|misoprostol|mesh-list
83594238|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83594239|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
83594240|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83594241|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594242|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83594243|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594244|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
83594245|NCT03866538|Budesonide|budesonide|mesh-list
83594246|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83594247|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83594248|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
83594249|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594250|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594251|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83594252|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
83594253|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
83594254|NCT03866538|Hormones|hormones|mesh-ancestor
83594255|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594257|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83594258|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83594259|NCT03865992|Analgesics|analgesics|mesh-ancestor
83594260|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
83594261|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594262|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594263|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83594264|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594265|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594266|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594267|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594268|NCT03865212|Interferons|interferons|mesh-list
83594269|NCT03865212|Interferon-beta|interferon-beta|mesh-list
83594270|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594271|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
83594272|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594273|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
83594274|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594275|NCT01677390|Everolimus|everolimus|mesh-list
83594276|NCT01677390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83594277|NCT01677390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83594278|NCT01677390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594279|NCT01677390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594280|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594281|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
83594282|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594283|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594284|NCT03749070|Silymarin|silymarin|mesh-list
83594285|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
83594286|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594287|NCT03749070|Protective Agents|protective agents|mesh-ancestor
83594288|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594289|NCT03748134|Paclitaxel|paclitaxel|mesh-list
83594290|NCT03748134|Fluorouracil|fluorouracil|mesh-list
83594291|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594292|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594293|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594294|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594295|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594296|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594297|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
83594298|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594299|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594300|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
83594301|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594302|NCT01345656|Spironolactone|spironolactone|mesh-list
83594303|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83594304|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
83594305|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594306|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594307|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83594308|NCT01345656|Diuretics|diuretics|mesh-ancestor
83594309|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
83594310|NCT03747120|Paclitaxel|paclitaxel|mesh-list
83594311|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
83594312|NCT03747120|Trastuzumab|trastuzumab|mesh-list
83594313|NCT03747120|Pertuzumab|pertuzumab|mesh-list
83594314|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594315|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594316|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594317|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594318|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594319|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594320|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594321|NCT03747120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83594322|NCT04763616|Cemiplimab|cemiplimab|mesh-list
83594323|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594324|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594325|NCT03652974|Valproic Acid|valproic acid|mesh-list
83594326|NCT03652974|Clozapine|clozapine|mesh-list
83594327|NCT03652974|Amisulpride|amisulpride|mesh-list
83594328|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
83594329|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594330|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594332|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594333|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594334|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
83594335|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83594336|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594337|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83594338|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83594339|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
83594340|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83594341|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
83594342|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83594343|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
83594344|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83594345|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
83594346|NCT03649152|Propagermanium|propagermanium|mesh-list
83594347|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594348|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
83594349|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
83594350|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594351|NCT03646188|Doxorubicin|doxorubicin|mesh-list
83594352|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83594353|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594354|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594355|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594356|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594357|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594358|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594359|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
83594360|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83594361|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
83594362|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83594363|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594364|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83594365|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83594366|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83594367|NCT02082678|Ondansetron|ondansetron|mesh-list
83594368|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
83594369|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
83594370|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594371|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594372|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594373|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
83594374|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
83594375|NCT02082678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83594376|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83594377|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
83594378|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594379|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594380|NCT03843294|Nivolumab|nivolumab|mesh-list
83594381|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594382|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594383|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83594384|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594385|NCT03834948|Paclitaxel|paclitaxel|mesh-list
83594386|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
83594387|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594388|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594389|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594390|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594391|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594392|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594393|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594394|NCT03834948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83594395|NCT01677468|Doxorubicin|doxorubicin|mesh-list
83594396|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83594397|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83594398|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594399|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594400|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594401|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594402|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052488|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
83594403|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594404|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
83594405|NCT01677468|Coagulants|coagulants|mesh-ancestor
83594406|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
83594407|NCT00003816|Melphalan|melphalan|mesh-list
83594408|NCT00003816|Busulfan|busulfan|mesh-list
83594409|NCT00003816|Thiotepa|thiotepa|mesh-list
83594410|NCT00003816|Carboplatin|carboplatin|mesh-list
83594411|NCT00003816|Fludarabine|fludarabine|mesh-list
83594412|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
83594413|NCT00003816|Etoposide|etoposide|mesh-list
83594414|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83594415|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594416|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
83594417|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594418|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594419|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83594420|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
83594421|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594422|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594423|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83594424|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594425|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
83594426|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594427|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594428|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594429|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594430|NCT03618654|Metformin|metformin|mesh-list
83594431|NCT03618654|Durvalumab|durvalumab|mesh-list
83594432|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
83594433|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83594434|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
83594435|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83594436|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594437|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594438|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594439|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
83594440|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
83594441|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
83594442|NCT03712878|Tacrolimus|tacrolimus|mesh-list
83594443|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594444|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
83594445|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594446|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594447|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83594448|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
83594449|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594450|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594451|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83594452|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83594453|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594454|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594455|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83594456|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
83594457|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83594458|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594459|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
83594460|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83594461|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594462|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594463|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594464|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594465|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594466|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594467|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83594468|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83594469|NCT03611556|Leucovorin|leucovorin|mesh-list
83594470|NCT03611556|Paclitaxel|paclitaxel|mesh-list
83594471|NCT03611556|Gemcitabine|gemcitabine|mesh-list
83594472|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
83594473|NCT03611556|Fluorouracil|fluorouracil|mesh-list
83594474|NCT03611556|Durvalumab|durvalumab|mesh-list
83594475|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
83594476|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594477|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594478|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594479|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594480|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594481|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594482|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594483|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
83594484|NCT03611556|Antidotes|antidotes|mesh-ancestor
83594485|NCT03611556|Protective Agents|protective agents|mesh-ancestor
83594486|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594487|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
83594488|NCT03611556|Vitamins|vitamins|mesh-ancestor
83594489|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
83594490|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594491|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
83594492|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594493|NCT03609060|Dexamethasone|dexamethasone|mesh-list
83594494|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83594495|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
83594496|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
83594497|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594498|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594499|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594500|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
83594501|NCT03609060|Hormones|hormones|mesh-ancestor
83594502|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594503|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83594504|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594505|NCT04762992|Enoxaparin|enoxaparin|mesh-list
83594506|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
83594507|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83594508|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83594509|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594510|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
83594511|NCT03704766|Defensins|defensins|mesh-list
83594512|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594513|NCT03826992|Cytarabine|cytarabine|mesh-list
83594514|NCT03826992|Daunorubicin|daunorubicin|mesh-list
83594515|NCT03826992|Venetoclax|venetoclax|mesh-list
83594516|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594517|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
83594518|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594519|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594520|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
83594521|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594522|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594523|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
83594524|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594525|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594526|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594527|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594528|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594529|NCT00004092|Paclitaxel|paclitaxel|mesh-list
83594530|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
83594531|NCT00004092|Carboplatin|carboplatin|mesh-list
83594532|NCT00004092|Doxorubicin|doxorubicin|mesh-list
83594533|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83594534|NCT00004092|Thiotepa|thiotepa|mesh-list
83594535|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594536|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594537|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594538|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594539|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594540|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594541|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594542|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
83594543|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594544|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594545|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83594546|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
83594547|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83594548|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594549|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594550|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594551|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594552|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83594553|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594554|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83594555|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83594556|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594557|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83594558|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594559|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83594560|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
83594561|NCT03825198|Dexamethasone|dexamethasone|mesh-list
83594562|NCT03825198|Ketorolac|ketorolac|mesh-list
83594563|NCT03825198|Sufentanil|sufentanil|mesh-list
83594564|NCT03825198|Morphine|morphine|mesh-list
83594565|NCT03825198|Bromides|bromides|mesh-list
83594566|NCT03825198|Propofol|propofol|mesh-list
83594567|NCT03825198|Sevoflurane|sevoflurane|mesh-list
83594568|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
83594569|NCT03825198|Rocuronium|rocuronium|mesh-list
83594570|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83594571|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
83594572|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
83594573|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594574|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594575|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594576|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
83594577|NCT03825198|Hormones|hormones|mesh-ancestor
83594578|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594579|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83594580|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594581|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83594582|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594583|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83594584|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
83594585|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
83594586|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83594587|NCT03825198|Narcotics|narcotics|mesh-ancestor
83594588|NCT03825198|Analgesics|analgesics|mesh-ancestor
83594589|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
83594590|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83594591|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83594592|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83594593|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83594594|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594595|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83594596|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594597|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594598|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
83594599|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83594600|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83594601|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83594602|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83594603|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
83594604|NCT03824106|Vitamin D|vitamin d|mesh-list
83594605|NCT03824106|Vitamins|vitamins|mesh-ancestor
83594606|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
83594607|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594608|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83594609|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
83594610|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
83594611|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594612|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594613|NCT03598998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83594614|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594615|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83594616|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594617|NCT03817320|Leucovorin|leucovorin|mesh-list
83594618|NCT03817320|Cytarabine|cytarabine|mesh-list
83594619|NCT03817320|Dexamethasone|dexamethasone|mesh-list
83594620|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
83594621|NCT03817320|Doxorubicin|doxorubicin|mesh-list
83594622|NCT03817320|Methotrexate|methotrexate|mesh-list
83594623|NCT03817320|Vincristine|vincristine|mesh-list
83594624|NCT03817320|Asparaginase|asparaginase|mesh-list
83594625|NCT03817320|Ixazomib|ixazomib|mesh-list
83594626|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83594627|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
83594628|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
83594629|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594630|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594631|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594632|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
83594633|NCT03817320|Hormones|hormones|mesh-ancestor
83594634|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594635|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83594636|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594637|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594638|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594639|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594640|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594641|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594642|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83594643|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
83594644|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83594645|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594646|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
83594647|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
83594648|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83594649|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594650|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
83594651|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594652|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83594653|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
83594654|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594655|NCT03817320|Antidotes|antidotes|mesh-ancestor
83594656|NCT03817320|Protective Agents|protective agents|mesh-ancestor
83594657|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
83594659|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
83594660|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594661|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594662|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594663|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594664|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
83594665|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83594666|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
83594667|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594668|NCT03583086|Nivolumab|nivolumab|mesh-list
83594669|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594670|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594671|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83594672|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594673|NCT03580824|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
83594674|NCT03580824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83594675|NCT03580824|Immunologic Factors|immunologic factors|mesh-ancestor
83594676|NCT03580824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594677|NCT03580356|Omalizumab|omalizumab|mesh-list
83594678|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83594679|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83594680|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
83594681|NCT03575052|Pimavanserin|pimavanserin|mesh-list
83594682|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83594683|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83594684|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83594685|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83594686|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594687|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594688|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83594689|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83594690|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83594691|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
83594692|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594693|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594694|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
83594695|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
83594696|NCT01677546|Insulin|insulin|mesh-list
83594697|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83594698|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83594699|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594700|NCT04403724|Fentanyl|fentanyl|mesh-list
83594701|NCT04403724|Morphine|morphine|mesh-list
83594702|NCT04403724|Bupivacaine|bupivacaine|mesh-list
83594703|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
83594704|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
83594705|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594706|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594707|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
83594708|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594709|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83594710|NCT04403724|Narcotics|narcotics|mesh-ancestor
83594711|NCT04403724|Analgesics|analgesics|mesh-ancestor
83594712|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83594713|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83594714|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
83594715|NCT03567876|Venetoclax|venetoclax|mesh-list
83594716|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594717|NCT04403568|Ursolic acid|ursolic acid|mesh-list
83594718|NCT04403568|Curcumin|curcumin|mesh-list
83594719|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83594720|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83594721|NCT04403568|Analgesics|analgesics|mesh-ancestor
83594722|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
83594723|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594724|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594725|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83594726|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594727|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594728|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594729|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594730|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594731|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594732|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83594733|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
83594734|NCT03564756|Vitamins|vitamins|mesh-ancestor
83594735|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
83594736|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594737|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
83594738|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594739|NCT03564756|Protective Agents|protective agents|mesh-ancestor
83594740|NCT03462966|Rifaximin|rifaximin|mesh-list
83594741|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83594742|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594743|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594744|NCT03531762|Tepotinib|tepotinib|mesh-list
83594745|NCT03531762|Omeprazole|omeprazole|mesh-list
83594746|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83594747|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594748|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83594749|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594750|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594751|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594752|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
83594753|NCT03458598|Narcotics|narcotics|mesh-ancestor
83594754|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594755|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594756|NCT03458598|Analgesics|analgesics|mesh-ancestor
83594757|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
83594758|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594759|NCT03791736|Octreotide|octreotide|mesh-list
83594760|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83594761|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83594762|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594763|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
83594764|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83594765|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83594766|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
83594767|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594768|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83594769|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83594770|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594771|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594772|NCT03524898|Paclitaxel|paclitaxel|mesh-list
83594773|NCT03524898|Gemcitabine|gemcitabine|mesh-list
83594774|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594775|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594776|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594777|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594778|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594779|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594780|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594781|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
83594782|NCT03524820|Cetuximab|cetuximab|mesh-list
83594783|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594784|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594785|NCT03524508|Fluorouracil|fluorouracil|mesh-list
83594786|NCT03524508|Irinotecan|irinotecan|mesh-list
83594787|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
83594788|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594789|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594790|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594791|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594792|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
83594793|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594794|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83594795|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594796|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594798|NCT03522168|Aripiprazole|aripiprazole|mesh-list
83594799|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83594800|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
83594801|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594802|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594803|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594804|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83594805|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83594806|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83594807|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83594808|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83594809|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
83594810|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
83594811|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
83594812|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83594813|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83594814|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83594815|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83594816|NCT03457818|Denosumab|denosumab|mesh-list
83594817|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83594818|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594819|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83594820|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
83594821|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
83594822|NCT01676844|Protective Agents|protective agents|mesh-ancestor
83594823|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594824|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
83594825|NCT04403334|Levofloxacin|levofloxacin|mesh-list
83594826|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83594827|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594828|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594829|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594830|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594831|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594832|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594833|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83594834|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83594835|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83594836|NCT03779646|Bisoprolol|bisoprolol|mesh-list
83594837|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83594838|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
83594839|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
83594840|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594841|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594842|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83594843|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83594844|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83594845|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
83594846|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83594847|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594848|NCT03774732|Paclitaxel|paclitaxel|mesh-list
83594849|NCT03774732|Cisplatin|cisplatin|mesh-list
83594850|NCT03774732|Carboplatin|carboplatin|mesh-list
83594851|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
83594852|NCT03774732|Pemetrexed|pemetrexed|mesh-list
83594853|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594854|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594855|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594856|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594857|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594858|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594859|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83594860|NCT03774732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83594861|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052943|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
83594862|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83594863|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83594864|NCT05347134|Gemcitabine|gemcitabine|mesh-list
83594865|NCT05347134|Capecitabine|capecitabine|mesh-list
83594866|NCT05347134|Vinorelbine|vinorelbine|mesh-list
83594867|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83594868|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
83594869|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594870|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594871|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83594872|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
83594873|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
83594874|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594875|NCT00089778|Aldesleukin|aldesleukin|mesh-list
83594876|NCT00089778|Interleukin-2|interleukin-2|mesh-list
83594877|NCT00089778|Mitogens|mitogens|mesh-list
83594878|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594879|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83594880|NCT00089778|Analgesics|analgesics|mesh-ancestor
83594881|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
83594882|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594883|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594884|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83594885|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594886|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83594887|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83594888|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
83594889|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594890|NCT00089544|Thalidomide|thalidomide|mesh-list
83594891|NCT00089544|Doxorubicin|doxorubicin|mesh-list
83594892|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83594893|NCT00089544|Ifosfamide|ifosfamide|mesh-list
83594894|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
83594895|NCT00089544|Dacarbazine|dacarbazine|mesh-list
83594896|NCT00089544|Imidazole|imidazole|mesh-list
83594897|NCT00089544|Lenograstim|lenograstim|mesh-list
83594898|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594899|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594900|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83594901|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594902|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594903|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594904|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83594905|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
83594906|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594907|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83594908|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
83594909|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594910|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
83594911|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83594912|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594913|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83594914|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83594915|NCT00089544|Growth Substances|growth substances|mesh-ancestor
83594916|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
83594917|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83594918|NCT00089076|Ipilimumab|ipilimumab|mesh-list
83594919|NCT00089076|Antibodies|antibodies|mesh-list
83594920|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
83594921|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83594922|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
83594923|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594924|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594925|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83594926|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594927|NCT03773562|Erenumab|erenumab|mesh-list
83594928|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83594929|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594930|NCT03773562|Analgesics|analgesics|mesh-ancestor
83594931|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
83594932|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83594933|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594934|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83594935|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83594936|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594937|NCT00087594|Ribavirin|ribavirin|mesh-list
83594938|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83594939|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
83594940|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594941|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
83594942|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594943|NCT03770286|Fluorides|fluorides|mesh-list
83594944|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
83594945|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
83594946|NCT03770286|Protective Agents|protective agents|mesh-ancestor
83594947|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594948|NCT00087516|Metformin|metformin|mesh-list
83594949|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83594950|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83594951|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594952|NCT00087516|Incretins|incretins|mesh-ancestor
83594953|NCT00087516|Hormones|hormones|mesh-ancestor
83594954|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83594955|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83594956|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
83594957|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594958|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594959|NCT03768960|Daratumumab|daratumumab|mesh-list
83594960|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594961|NCT00087126|Topotecan|topotecan|mesh-list
83594962|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83594963|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83594964|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594965|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594966|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594967|NCT00086346|Cyclosporine|cyclosporine|mesh-list
83594968|NCT00086346|Sirolimus|sirolimus|mesh-list
83594969|NCT00086346|Tacrolimus|tacrolimus|mesh-list
83594970|NCT00086346|Cyclosporins|cyclosporins|mesh-list
83594971|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594972|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
83594973|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594974|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83594975|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594976|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594977|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
83594978|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83594979|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
83594980|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83594981|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83594982|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83594983|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594984|NCT00085566|Everolimus|everolimus|mesh-list
83594985|NCT00085566|Gefitinib|gefitinib|mesh-list
83594986|NCT00085566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83594987|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83594988|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83594989|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83594990|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83594991|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
83594992|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83594993|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83594994|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
83594995|NCT00085098|Cisplatin|cisplatin|mesh-list
83594996|NCT00085098|Carboplatin|carboplatin|mesh-list
83594997|NCT00085098|Etoposide|etoposide|mesh-list
83594998|NCT00085098|Lenograstim|lenograstim|mesh-list
83594999|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83595000|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
83595001|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595002|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595003|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83595004|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
83595005|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595006|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595007|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83595008|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83595009|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83595010|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83595011|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595012|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83595013|NCT00084864|Calcitriol|calcitriol|mesh-list
83595014|NCT00084864|Dexamethasone|dexamethasone|mesh-list
83595016|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
83595017|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
83595018|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595019|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595020|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83595021|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
83595022|NCT00084864|Hormones|hormones|mesh-ancestor
83595023|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595024|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83595025|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595026|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83595027|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83595028|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595029|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595030|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83595031|NCT00084864|Vitamins|vitamins|mesh-ancestor
83595032|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
83595033|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83595034|NCT01677702|Lactoferrin|lactoferrin|mesh-list
83595035|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595036|NCT01473108|Eplerenone|eplerenone|mesh-list
83595037|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83595038|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
83595039|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595040|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595041|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83595042|NCT01473108|Diuretics|diuretics|mesh-ancestor
83595043|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
83595044|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83595045|NCT00084318|Docetaxel|docetaxel|mesh-list
83595046|NCT00084318|Cetuximab|cetuximab|mesh-list
83595047|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595048|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83595049|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83595050|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83595051|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595052|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595053|NCT00083616|Panitumumab|panitumumab|mesh-list
83595054|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595055|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595056|NCT00083226|Doxorubicin|doxorubicin|mesh-list
83595057|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83595058|NCT00083226|Bortezomib|bortezomib|mesh-list
83595059|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83595060|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595061|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83595062|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83595063|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595064|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595065|NCT00082758|Interleukin-2|interleukin-2|mesh-list
83595066|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
83595067|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595068|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83595069|NCT00082758|Analgesics|analgesics|mesh-ancestor
83595070|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
83595071|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595072|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595073|NCT03438318|Atezolizumab|atezolizumab|mesh-list
83595074|NCT03438318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595075|NCT03438318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595076|NCT03438318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595077|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595078|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
83595079|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83595080|NCT03087942|Growth Substances|growth substances|mesh-ancestor
83595081|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595082|NCT01678092|Omalizumab|omalizumab|mesh-list
83595083|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83595084|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83595085|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
83595086|NCT04402320|Midazolam|midazolam|mesh-list
83595087|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83595088|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83595089|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595090|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595091|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83595092|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83595093|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83595094|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83595095|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
83595096|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
83595097|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
83595098|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
83595099|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595100|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595101|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
83595102|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595103|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595104|NCT03436056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595105|NCT03436056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595106|NCT03088176|Trametinib|trametinib|mesh-list
83595107|NCT03088176|Dabrafenib|dabrafenib|mesh-list
83595108|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83595109|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595110|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595111|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595112|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595113|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595114|NCT01678404|Rituximab|rituximab|mesh-list
83595115|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595116|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595117|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
83595118|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595119|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595120|NCT03087864|Paclitaxel|paclitaxel|mesh-list
83595121|NCT03087864|Carboplatin|carboplatin|mesh-list
83595122|NCT03087864|Atezolizumab|atezolizumab|mesh-list
83595123|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83595124|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595125|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
83595126|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
83595127|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
83595128|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595129|NCT03087864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595130|NCT03087864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595131|NCT01678716|Micronutrients|micronutrients|mesh-list
83595132|NCT01678716|Trace Elements|trace elements|mesh-list
83595133|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595134|NCT00081510|Anastrozole|anastrozole|mesh-list
83595135|NCT00081510|Lonafarnib|lonafarnib|mesh-list
83595136|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83595137|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595138|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83595139|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83595140|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595141|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595142|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83595143|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
83595144|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595145|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595146|NCT00088452|Lamotrigine|lamotrigine|mesh-list
83595147|NCT00088452|Valproic Acid|valproic acid|mesh-list
83595148|NCT00088452|Ethosuximide|ethosuximide|mesh-list
83595149|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
83595150|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83595151|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595152|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595153|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83595154|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595155|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83595156|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83595157|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595158|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83595159|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83595160|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595161|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
83595162|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053234|NCT03605589|Blinatumomab|blinatumomab|mesh-list
83595164|NCT01679106|Fentanyl|fentanyl|mesh-list
83595165|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83595166|NCT01679106|Narcotics|narcotics|mesh-ancestor
83595167|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595168|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595169|NCT01679106|Analgesics|analgesics|mesh-ancestor
83595170|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
83595171|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595172|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83595173|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83595174|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
83595175|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
83595176|NCT04403100|Ritonavir|ritonavir|mesh-list
83595177|NCT04403100|Lopinavir|lopinavir|mesh-list
83595178|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
83595179|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83595180|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83595181|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
83595182|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595183|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595184|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83595185|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83595186|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
83595187|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595188|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83595189|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83595190|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
83595191|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83595192|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83595193|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595194|NCT03086538|Pemetrexed|pemetrexed|mesh-list
83595195|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83595196|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595197|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595198|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595199|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83595200|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83595201|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595202|NCT03473730|Daratumumab|daratumumab|mesh-list
83595203|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595204|NCT03081858|Paclitaxel|paclitaxel|mesh-list
83595205|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83595206|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595207|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
83595208|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
83595209|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
83595210|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595211|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
83595212|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595213|NCT01679574|Metformin|metformin|mesh-list
83595214|NCT01679574|Letrozole|letrozole|mesh-list
83595215|NCT01679574|Clomiphene|clomiphene|mesh-list
83595216|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83595217|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595218|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595219|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83595220|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83595221|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595222|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595223|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83595224|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
83595225|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595226|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83595227|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
83595228|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83595229|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83595230|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83595231|NCT01679652|Nebivolol|nebivolol|mesh-list
83595232|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83595233|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
83595234|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83595235|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83595236|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83595237|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
83595238|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595239|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595240|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595241|NCT04761744|Nivolumab|nivolumab|mesh-list
83595242|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595243|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595244|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595245|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595246|NCT03089658|Avelumab|avelumab|mesh-list
83595247|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595248|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595249|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
83595250|NCT03417492|Citric Acid|citric acid|mesh-list
83595251|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
83595252|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
83595253|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83595254|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
83595255|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
83595256|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595257|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
83595258|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83595259|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83595260|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595261|NCT03417492|Urological Agents|urological agents|mesh-ancestor
83595262|NCT03395184|PF-06700841|pf-06700841|mesh-list
83595263|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595264|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595265|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595266|NCT03080766|Decitabine|decitabine|mesh-list
83595267|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83595268|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
83595269|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595270|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595271|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595272|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
83595273|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83595274|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595275|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
83595276|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83595277|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595278|NCT03088254|Amlodipine|amlodipine|mesh-list
83595279|NCT03088254|Telmisartan|telmisartan|mesh-list
83595280|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83595281|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83595282|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83595283|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595284|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595285|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83595286|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595287|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
83595288|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83595289|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83595290|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
83595291|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83595292|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83595293|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595294|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83595295|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83595296|NCT05685342|Acetaminophen|acetaminophen|mesh-list
83595297|NCT05685342|Ibuprofen|ibuprofen|mesh-list
83595298|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83595299|NCT05685342|Analgesics|analgesics|mesh-ancestor
83595300|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
83595301|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595302|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595303|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
83595304|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83595305|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595306|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595307|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83595308|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595309|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595310|NCT05684718|Itraconazole|itraconazole|mesh-list
83595311|NCT05684718|Rifabutin|rifabutin|mesh-list
83053396|NCT03074578|Hormones|hormones|mesh-ancestor
83595312|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
83595313|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595314|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83595315|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83595316|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595317|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595318|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83595319|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
83595320|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595321|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595322|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83595323|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83595324|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83595325|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
83595326|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
83595327|NCT05684484|Salicylates|salicylates|mesh-list
83595328|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595329|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
83595330|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
83595331|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83595332|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83595333|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83595334|NCT05684484|Analgesics|analgesics|mesh-ancestor
83595335|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
83595336|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595337|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595338|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595339|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595340|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83595341|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595342|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595343|NCT03086382|Lacosamide|lacosamide|mesh-list
83595344|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
83595345|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83595346|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83595347|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595348|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595349|NCT03086226|Itraconazole|itraconazole|mesh-list
83595350|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
83595351|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595352|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83595353|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83595354|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595355|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595356|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83595357|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
83595358|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595359|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595360|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83595361|NCT03085992|Bevacizumab|bevacizumab|mesh-list
83595362|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595363|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595364|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83595365|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83595366|NCT03085992|Growth Substances|growth substances|mesh-ancestor
83595367|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595368|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
83595369|NCT03086070|Omeprazole|omeprazole|mesh-list
83595370|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83595371|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83595372|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83595373|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595374|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595375|NCT05688306|Oprelvekin|oprelvekin|mesh-list
83595376|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595377|NCT03086148|Ketamine|ketamine|mesh-list
83595378|NCT03086148|Analgesics|analgesics|mesh-ancestor
83595379|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
83595380|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595381|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595382|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83595383|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83595384|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
83595385|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
83595386|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595387|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83595388|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83595389|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595390|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595391|NCT03359538|Sirolimus|sirolimus|mesh-list
83595392|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83595393|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595394|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83595395|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595396|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
83595397|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83595398|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
83595399|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595400|NCT05345808|Triamcinolone|triamcinolone|mesh-list
83595401|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83595402|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83595403|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83595404|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595405|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
83595406|NCT05345808|Hormones|hormones|mesh-ancestor
83595407|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595408|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595409|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83595410|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
83595411|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595412|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595413|NCT02336958|Ropivacaine|ropivacaine|mesh-list
83595414|NCT02336958|Prilocaine|prilocaine|mesh-list
83595415|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
83595416|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
83595417|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595418|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595419|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
83595420|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595421|NCT03085368|Trastuzumab|trastuzumab|mesh-list
83595422|NCT03085368|Lapatinib|lapatinib|mesh-list
83595423|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595424|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595425|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595426|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595427|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595428|NCT05638932|Tofacitinib|tofacitinib|mesh-list
83595429|NCT05638932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83595430|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595431|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595432|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595433|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83595434|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83595435|NCT05687760|Calcium|calcium|mesh-list
83595436|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83595437|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595438|NCT03084978|Anesthetics|anesthetics|mesh-list
83595439|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595440|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595441|NCT03084588|Methadone|methadone|mesh-list
83595442|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83595443|NCT03084588|Narcotics|narcotics|mesh-ancestor
83595444|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595445|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595446|NCT03084588|Analgesics|analgesics|mesh-ancestor
83595447|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
83595448|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595449|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
83595450|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
83595451|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
83595452|NCT05345574|Remifentanil|remifentanil|mesh-list
83595453|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83595454|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595455|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595456|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83595457|NCT05345574|Analgesics|analgesics|mesh-ancestor
83595458|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
83595459|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595460|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83595461|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83595462|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83595463|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
83595464|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595465|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595466|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83595467|NCT05345574|Narcotics|narcotics|mesh-ancestor
83595468|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
83595469|NCT05598606|Denosumab|denosumab|mesh-list
83595470|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83595471|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595472|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
83595473|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595474|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595475|NCT03347292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595476|NCT03347292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595477|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
83595478|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83595479|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83595480|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595481|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
83595482|NCT04400916|Coagulants|coagulants|mesh-ancestor
83595483|NCT05582538|Paclitaxel|paclitaxel|mesh-list
83595484|NCT05582538|Durvalumab|durvalumab|mesh-list
83595485|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83595486|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595487|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
83595488|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
83595489|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
83595490|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595491|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595492|NCT03406650|Durvalumab|durvalumab|mesh-list
83595493|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595494|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595495|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
83595496|NCT05571072|Narcotics|narcotics|mesh-ancestor
83595497|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595498|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595499|NCT05571072|Analgesics|analgesics|mesh-ancestor
83595500|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
83595501|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595502|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
83595503|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
83595504|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83595505|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595506|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83595507|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83595508|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595509|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595510|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595511|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
83595512|NCT04279938|Rituximab|rituximab|mesh-list
83595513|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
83595514|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595515|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595516|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
83595517|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595518|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595519|NCT04279938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595520|NCT04279938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595521|NCT05686434|Osimertinib|osimertinib|mesh-list
83595522|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595523|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595524|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595525|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595526|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
83595527|NCT05686356|Bedaquiline|bedaquiline|mesh-list
83595528|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83595529|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
83595530|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595531|NCT05686356|Expectorants|expectorants|mesh-ancestor
83595532|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
83595533|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83595534|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
83595535|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595536|NCT05686356|Protective Agents|protective agents|mesh-ancestor
83595537|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595538|NCT05686356|Antidotes|antidotes|mesh-ancestor
83595539|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
83595540|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83595542|NCT03083184|Enoxaparin|enoxaparin|mesh-list
83595543|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
83595544|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83595545|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83595546|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595547|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83595548|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595549|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595550|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595551|NCT03338244|Azithromycin|azithromycin|mesh-list
83595552|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83595553|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595554|NCT05512962|Triamcinolone|triamcinolone|mesh-list
83595555|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83595556|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83595557|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83595558|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595559|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
83595560|NCT05512962|Hormones|hormones|mesh-ancestor
83595561|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595562|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595563|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83595564|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
83595565|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595566|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595567|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
83595568|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83595569|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83595570|NCT03082092|Prednisolone|prednisolone|mesh-list
83595571|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
83595572|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83595573|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
83595574|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595575|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
83595576|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
83595577|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595578|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595579|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83595580|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
83595581|NCT03082092|Hormones|hormones|mesh-ancestor
83595582|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595583|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83595584|NCT03082092|Protective Agents|protective agents|mesh-ancestor
83595585|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83595586|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595587|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
83595588|NCT04401852|Analgesics|analgesics|mesh-ancestor
83595589|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
83595590|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595591|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595592|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
83595593|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595594|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83595595|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
83595596|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83595597|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595598|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595599|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83595600|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
83595601|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83595602|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
83595603|NCT03328104|Etoposide|etoposide|mesh-list
83595604|NCT03328104|Everolimus|everolimus|mesh-list
83595605|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83595606|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
83595607|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595608|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595609|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83595610|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
83595611|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595612|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595613|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83595614|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83595615|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83595616|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83595617|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595618|NCT03328104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83595619|NCT03328104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595620|NCT03399318|Acetaminophen|acetaminophen|mesh-list
83595621|NCT03399318|Ibuprofen|ibuprofen|mesh-list
83595622|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83595623|NCT03399318|Analgesics|analgesics|mesh-ancestor
83595624|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
83595625|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595626|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595627|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
83595628|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83595629|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595630|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595631|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83595632|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595633|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595634|NCT03082482|Nicotine|nicotine|mesh-list
83595635|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83595636|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
83595637|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595638|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595639|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83595640|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83595641|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
83595642|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595643|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595644|NCT03308916|Liver Extracts|liver extracts|mesh-list
83595645|NCT03308916|Hematinics|hematinics|mesh-ancestor
83595646|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
83595647|NCT03081702|Itraconazole|itraconazole|mesh-list
83595648|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
83595649|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83595650|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83595651|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595652|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595653|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595654|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595655|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
83595656|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83595657|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83595658|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83595659|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
83595660|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595661|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595662|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83595663|NCT04399434|Insulin|insulin|mesh-list
83595664|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83595665|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595666|NCT04760574|Testosterone|testosterone|mesh-list
83595667|NCT04760574|Androgens|androgens|mesh-ancestor
83595668|NCT04760574|Hormones|hormones|mesh-ancestor
83595669|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595670|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595671|NCT03237390|Gemcitabine|gemcitabine|mesh-list
83595672|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83595673|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
83595674|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595675|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595676|NCT03302910|Torsemide|torsemide|mesh-list
83595677|NCT03302910|Furosemide|furosemide|mesh-list
83595678|NCT03302910|Bumetanide|bumetanide|mesh-list
83595679|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
83595680|NCT03302910|Diuretics|diuretics|mesh-list
83595681|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83595682|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
83595683|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595684|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595685|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595686|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
83595687|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83595689|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
83595690|NCT03292926|Bupivacaine|bupivacaine|mesh-list
83595691|NCT03292926|BB 1101|bb 1101|mesh-list
83595692|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595693|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
83595694|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
83595695|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595696|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595697|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83595698|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
83595699|NCT03292926|Hormones|hormones|mesh-ancestor
83595700|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595701|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83595702|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595703|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
83595704|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595705|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595706|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
83595707|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
83595708|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595709|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
83595710|NCT04400136|Lansoprazole|lansoprazole|mesh-list
83595711|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
83595712|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83595713|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83595714|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83595715|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595716|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595717|NCT04962126|Atezolizumab|atezolizumab|mesh-list
83595718|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
83595719|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83595720|NCT04962126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595721|NCT04962126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595722|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595723|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595724|NCT05338086|Vitamin D|vitamin d|mesh-list
83595725|NCT05338086|Denosumab|denosumab|mesh-list
83595726|NCT05338086|Calcium|calcium|mesh-list
83595727|NCT05338086|Vitamins|vitamins|mesh-ancestor
83595728|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
83595729|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595730|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83595731|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83595732|NCT04857840|Firibastat|firibastat|mesh-list
83595733|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83595734|NCT04582968|Capecitabine|capecitabine|mesh-list
83595735|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83595736|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
83595737|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595738|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595739|NCT03261570|Digoxin|digoxin|mesh-list
83595740|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83595741|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83595742|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83595743|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595744|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595745|NCT03261570|Protective Agents|protective agents|mesh-ancestor
83595746|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595747|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83595748|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
83595749|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595750|NCT03227562|Risperidone|risperidone|mesh-list
83595751|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83595752|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
83595753|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595754|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595755|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595756|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83595757|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83595758|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595759|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83595760|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83595761|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
83595762|NCT04278378|Folic Acid|folic acid|mesh-list
83595763|NCT04278378|Riboflavin|riboflavin|mesh-list
83595764|NCT04278378|Hematinics|hematinics|mesh-ancestor
83595765|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
83595766|NCT04278378|Vitamins|vitamins|mesh-ancestor
83595767|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
83595768|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595769|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83595770|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
83595771|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
83595772|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83595773|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83595774|NCT04551144|Estradiol|estradiol|mesh-list
83595775|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83595776|NCT04551144|Testosterone|testosterone|mesh-list
83595777|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
83595778|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
83595779|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83595780|NCT04551144|Estrogens|estrogens|mesh-ancestor
83595781|NCT04551144|Hormones|hormones|mesh-ancestor
83595782|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595783|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595784|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83595785|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
83595786|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83595787|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83595788|NCT04551144|Androgens|androgens|mesh-ancestor
83595789|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83595790|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595791|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
83595792|NCT04785924|Imipenem|imipenem|mesh-list
83595793|NCT04785924|Relebactam|relebactam|mesh-list
83595794|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83595795|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595796|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83595797|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595798|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595799|NCT04451772|Upadacitinib|upadacitinib|mesh-list
83595800|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83595801|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83595802|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595803|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595804|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595805|NCT03831984|Bromfenac|bromfenac|mesh-list
83595806|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
83595807|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83595808|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
83595809|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595810|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
83595811|NCT03831984|Protective Agents|protective agents|mesh-ancestor
83595812|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83595813|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83595814|NCT03831984|Analgesics|analgesics|mesh-ancestor
83595815|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
83595816|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595817|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595818|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83595819|NCT02084706|Triamcinolone|triamcinolone|mesh-list
83595820|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83595821|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83595822|NCT02084706|Lidocaine|lidocaine|mesh-list
83595823|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83595824|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
83595825|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
83595826|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595827|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595828|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
83595829|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595830|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83595831|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83595832|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83595833|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595834|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595835|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83595836|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
83595837|NCT02084706|Hormones|hormones|mesh-ancestor
83595838|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83595839|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83595840|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
83595841|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595842|NCT04704024|Tenofovir|tenofovir|mesh-list
83595843|NCT04704024|Lamivudine|lamivudine|mesh-list
83595844|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
83595845|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595846|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83595847|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83595848|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595849|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595850|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83595851|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83595852|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
83595853|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83595854|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595855|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595856|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83595857|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83595858|NCT04433988|Protective Agents|protective agents|mesh-ancestor
83595859|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595860|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
83595861|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83595862|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
83595863|NCT04685538|Tetracaine|tetracaine|mesh-list
83595864|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
83595865|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
83595866|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
83595867|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595868|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595869|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
83595870|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595871|NCT05121246|Palivizumab|palivizumab|mesh-list
83595872|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
83595873|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595874|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
83595875|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595876|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
83595877|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83595878|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83595879|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595880|NCT04344678|Urological Agents|urological agents|mesh-ancestor
83595881|NCT03249558|Morphine|morphine|mesh-list
83595882|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83595883|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83595884|NCT03249558|Narcotics|narcotics|mesh-ancestor
83595885|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595886|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595887|NCT03249558|Analgesics|analgesics|mesh-ancestor
83595888|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
83595889|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595890|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83595891|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83595892|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595893|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595894|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595895|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
83595896|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83595897|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
83595898|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
83595899|NCT03220776|Gabapentin|gabapentin|mesh-list
83595900|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83595901|NCT03220776|Analgesics|analgesics|mesh-ancestor
83595902|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
83595903|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595904|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595905|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
83595906|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83595907|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83595908|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595909|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83595910|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83595911|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83595912|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83595913|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595914|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
83595915|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
83595916|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83595917|NCT03220776|Expectorants|expectorants|mesh-ancestor
83595918|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
83595919|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83595920|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
83595921|NCT03220776|Protective Agents|protective agents|mesh-ancestor
83595922|NCT03220776|Antidotes|antidotes|mesh-ancestor
83595923|NCT03246828|Gliclazide|gliclazide|mesh-list
83595924|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83595925|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595926|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
83595927|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
83595928|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595929|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
83595930|NCT03918798|Procaine|procaine|mesh-list
83595931|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83595932|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
83595933|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
83595934|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595935|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595936|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
83595937|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595938|NCT03204786|Vasopressins|vasopressins|mesh-list
83595939|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
83595940|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
83595941|NCT03204786|Coagulants|coagulants|mesh-ancestor
83595942|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83595943|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83595944|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
83595945|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595946|NCT03204396|Dulaglutide|dulaglutide|mesh-list
83595947|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83595948|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595949|NCT02008656|Leucovorin|leucovorin|mesh-list
83595950|NCT02008656|Fluorouracil|fluorouracil|mesh-list
83595951|NCT02008656|Capecitabine|capecitabine|mesh-list
83595952|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
83595953|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
83595954|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595955|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83595956|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595957|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83595958|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
83595959|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595960|NCT02008656|Antidotes|antidotes|mesh-ancestor
83595961|NCT02008656|Protective Agents|protective agents|mesh-ancestor
83595962|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
83595963|NCT02008656|Vitamins|vitamins|mesh-ancestor
83595964|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
83595965|NCT04300140|Nivolumab|nivolumab|mesh-list
83595966|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83595967|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595968|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83595969|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595970|NCT03174132|Lidocaine|lidocaine|mesh-list
83595971|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
83595972|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
83595973|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
83595974|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83595975|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595976|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
83595977|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83595978|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83595979|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83595980|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83595981|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83595982|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595983|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83595984|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
83595985|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
83595986|NCT03174132|Protective Agents|protective agents|mesh-ancestor
83595987|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
83595988|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83595989|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83595990|NCT01812252|Azacitidine|azacitidine|mesh-list
83595991|NCT01812252|Decitabine|decitabine|mesh-list
83595992|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83595993|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
83595994|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83595995|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83595996|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83595997|NCT04217694|Memantine|memantine|mesh-list
83595998|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83595999|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83596000|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
83596001|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596002|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596003|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596004|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83596005|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83596006|NCT03818802|Niacinamide|niacinamide|mesh-list
83596007|NCT03818802|Niacin|niacin|mesh-list
83596008|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
83596009|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
83596010|NCT03818802|Vitamins|vitamins|mesh-ancestor
83596011|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
83596012|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596013|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83596014|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
83596015|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596016|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83596017|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
83596018|NCT04398108|Margetuximab|margetuximab|mesh-list
83596019|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596020|NCT01625286|Paclitaxel|paclitaxel|mesh-list
83596021|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83596022|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83596023|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596024|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
83596025|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
83596026|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
83596027|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596028|NCT01583322|Nintedanib|nintedanib|mesh-list
83596029|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596030|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83596031|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596032|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596033|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
83596034|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596035|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596036|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83596037|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83596038|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596039|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596040|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596041|NCT05158062|Paclitaxel|paclitaxel|mesh-list
83596042|NCT05158062|Docetaxel|docetaxel|mesh-list
83596043|NCT05158062|Bevacizumab|bevacizumab|mesh-list
83596044|NCT05158062|Carboplatin|carboplatin|mesh-list
83596045|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
83596046|NCT05158062|Olaparib|olaparib|mesh-list
83596047|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83596048|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596049|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83596050|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83596051|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83596052|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596053|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596054|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83596055|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83596056|NCT05158062|Growth Substances|growth substances|mesh-ancestor
83596057|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596058|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
83596059|NCT05158062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83596060|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83596061|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596062|NCT01176474|Nivolumab|nivolumab|mesh-list
83596063|NCT01176474|Ipilimumab|ipilimumab|mesh-list
83596064|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83054132|NCT04994236|Vitamins|vitamins|mesh-ancestor
83596065|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
83596066|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596067|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596068|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596069|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83596070|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596071|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83596072|NCT01076868|Primaquine|primaquine|mesh-list
83596073|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
83596074|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83596075|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83596076|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596077|NCT03193866|Interferons|interferons|mesh-list
83596078|NCT03193866|Interferon-beta|interferon-beta|mesh-list
83596079|NCT03193866|Rituximab|rituximab|mesh-list
83596080|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
83596081|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
83596082|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83596083|NCT03193866|Natalizumab|natalizumab|mesh-list
83596084|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83596085|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
83596086|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596087|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596088|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
83596089|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596090|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596091|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
83596092|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596093|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83596094|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596095|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83596096|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
83596097|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83596098|NCT04195776|Tenofovir|tenofovir|mesh-list
83596099|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
83596100|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596101|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83596102|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83596103|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596104|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596105|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83596106|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83596107|NCT03708588|Ticagrelor|ticagrelor|mesh-list
83596108|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83596109|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83596110|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83596111|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83596112|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
83596113|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596114|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596115|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596116|NCT04130802|Dexamethasone|dexamethasone|mesh-list
83596117|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596118|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
83596119|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
83596120|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596121|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596122|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596123|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
83596124|NCT04130802|Hormones|hormones|mesh-ancestor
83596125|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596126|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596127|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596128|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
83596129|NCT03087162|Lansoprazole|lansoprazole|mesh-list
83596130|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83596131|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596132|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83596133|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596134|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596135|NCT03165942|Ethanol|ethanol|mesh-list
83596136|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83596137|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596138|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054204|NCT03136263|Oxytocin|oxytocin|mesh-list
83596139|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596140|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
83596141|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596142|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596143|NCT03163992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83596144|NCT03163992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596145|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
83596146|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
83596147|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83596148|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83596149|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596150|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596151|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596152|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596153|NCT03162432|Vitamin D|vitamin d|mesh-list
83596154|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
83596155|NCT03162432|Vitamins|vitamins|mesh-ancestor
83596156|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
83596157|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596158|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83596159|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83596160|NCT03392376|Haloperidol|haloperidol|mesh-list
83596161|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
83596162|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
83596163|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
83596164|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596165|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596166|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596167|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83596168|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83596169|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596170|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83596171|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83596172|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
83596173|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596174|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596175|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83596176|NCT05243628|Insulin|insulin|mesh-list
83596177|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83596178|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83596179|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596180|NCT05249478|Fentanyl|fentanyl|mesh-list
83596181|NCT05249478|Bupivacaine|bupivacaine|mesh-list
83596182|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
83596183|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
83596184|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596185|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596186|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
83596187|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596188|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83596189|NCT05249478|Narcotics|narcotics|mesh-ancestor
83596190|NCT05249478|Analgesics|analgesics|mesh-ancestor
83596191|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83596192|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83596193|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
83596194|NCT05244252|Bupivacaine|bupivacaine|mesh-list
83596195|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
83596196|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
83596197|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596198|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596199|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
83596200|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596201|NCT03286842|Olaparib|olaparib|mesh-list
83596202|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83596203|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596204|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596205|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596206|NCT05240274|Metformin|metformin|mesh-list
83596207|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83596208|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596209|NCT05244018|Vitamin D|vitamin d|mesh-list
83596210|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
83596211|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
83596212|NCT05244018|Vitamins|vitamins|mesh-list
83596213|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
83596214|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596215|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83596216|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83596217|NCT02398500|Ranibizumab|ranibizumab|mesh-list
83596218|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83596219|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83596220|NCT02398500|Growth Substances|growth substances|mesh-ancestor
83596221|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596222|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
83596223|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596224|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
83596225|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
83596226|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596227|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
83596228|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596230|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83596231|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596232|NCT05248932|Norepinephrine|norepinephrine|mesh-list
83596233|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83596234|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83596235|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
83596236|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596237|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596238|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596239|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
83596240|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
83596241|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596242|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83596243|NCT02392026|Metronidazole|metronidazole|mesh-list
83596244|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596245|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596246|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83596247|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83596248|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83596249|NCT02395614|Gentamicins|gentamicins|mesh-list
83596250|NCT02395614|Cefazolin|cefazolin|mesh-list
83596251|NCT02395614|Bacitracin|bacitracin|mesh-list
83596252|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
83596253|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596254|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83596255|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
83596256|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83596257|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596258|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596259|NCT04396938|Lamotrigine|lamotrigine|mesh-list
83596260|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
83596261|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83596262|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83596263|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596264|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83596265|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596266|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83596267|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83596268|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596269|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83596270|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83596271|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83596272|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
83596273|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596274|NCT02914158|Tamoxifen|tamoxifen|mesh-list
83596275|NCT02914158|Leuprolide|leuprolide|mesh-list
83596276|NCT02914158|Goserelin|goserelin|mesh-list
83596277|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83596278|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83596279|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
83596280|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596281|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596282|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596283|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596284|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83596285|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83596286|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83596287|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83596288|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
83596289|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83596290|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83596291|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596292|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596293|NCT03136146|Dexamethasone|dexamethasone|mesh-list
83596294|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
83596295|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
83596296|NCT03136146|Rituximab|rituximab|mesh-list
83596297|NCT03136146|Etoposide|etoposide|mesh-list
83596298|NCT03136146|Vincristine|vincristine|mesh-list
83596299|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
83596300|NCT03136146|Bortezomib|bortezomib|mesh-list
83596301|NCT03136146|Clofarabine|clofarabine|mesh-list
83596302|NCT03136146|Ofatumumab|ofatumumab|mesh-list
83596303|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
83596304|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83596305|NCT03136146|Antibodies|antibodies|mesh-list
83596306|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
83596307|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83596308|NCT03136146|Lenograstim|lenograstim|mesh-list
83596309|NCT03136146|BB 1101|bb 1101|mesh-list
83596310|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83596311|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
83596312|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596313|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596314|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83596315|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
83596316|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596317|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596318|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83596319|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596320|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
83596321|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
83596322|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596323|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596324|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
83596325|NCT03136146|Hormones|hormones|mesh-ancestor
83596326|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596327|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596328|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
83596329|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596330|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83596331|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83596332|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83596333|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83596334|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83596335|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83596336|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83596337|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83596338|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
83596339|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
83596340|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
83596341|NCT05241132|Paclitaxel|paclitaxel|mesh-list
83596342|NCT05241132|Cisplatin|cisplatin|mesh-list
83596343|NCT05241132|Tislelizumab|tislelizumab|mesh-list
83596344|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83596345|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596346|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
83596347|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
83596348|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
83596349|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596350|NCT05241132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596351|NCT05241054|Acetaminophen|acetaminophen|mesh-list
83596352|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
83596353|NCT05241054|Fentanyl|fentanyl|mesh-list
83596354|NCT05241054|Bupivacaine|bupivacaine|mesh-list
83596355|NCT05241054|Propofol|propofol|mesh-list
83596356|NCT05241054|Sevoflurane|sevoflurane|mesh-list
83596357|NCT05241054|Atracurium|atracurium|mesh-list
83596358|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
83596359|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
83596360|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596361|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596362|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
83596363|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596364|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83596365|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83596366|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
83596367|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83596368|NCT05241054|Narcotics|narcotics|mesh-ancestor
83596369|NCT05241054|Analgesics|analgesics|mesh-ancestor
83596370|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83596371|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83596372|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
83596373|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83596374|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83596375|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
83596376|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83596377|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83596378|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83596379|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83596380|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83596381|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
83596382|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596383|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596384|NCT00638508|Ketorolac|ketorolac|mesh-list
83596385|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83596386|NCT00638508|Ropivacaine|ropivacaine|mesh-list
83596387|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
83596388|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
83596389|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596390|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596391|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
83596392|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596393|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83596394|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83596395|NCT00638508|Analgesics|analgesics|mesh-ancestor
83596396|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596397|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596398|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83596399|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596400|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596401|NCT00637806|Megestrol|megestrol|mesh-list
83596402|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
83596403|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83596404|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83596405|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83596406|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
83596407|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83596408|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596409|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83596410|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83596411|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596412|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596413|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
83596414|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83596415|NCT00637728|Megestrol|megestrol|mesh-list
83596416|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
83596417|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83596418|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83596419|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83596420|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
83596421|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83596422|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596423|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83596424|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83596425|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596426|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596427|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
83596428|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83596429|NCT01922466|Loxoprofen|loxoprofen|mesh-list
83596430|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83596431|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83596432|NCT01922466|Analgesics|analgesics|mesh-ancestor
83596433|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
83596434|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596435|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596436|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596437|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596438|NCT00637572|Megestrol|megestrol|mesh-list
83596439|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
83596440|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83596441|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83596442|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83596443|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
83596444|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83596445|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596446|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83596447|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83596448|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596449|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596450|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
83596451|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83596452|NCT00637416|Lansoprazole|lansoprazole|mesh-list
83596453|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
83596454|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83596455|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596456|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83596457|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596458|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596459|NCT00636792|Rituximab|rituximab|mesh-list
83596460|NCT00636792|Bortezomib|bortezomib|mesh-list
83596461|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83596462|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596463|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596464|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
83596465|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596466|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596467|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83596468|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
83596469|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596470|NCT03153462|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83596471|NCT03153462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596472|NCT03153462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596473|NCT00636636|Gabapentin|gabapentin|mesh-list
83596474|NCT00636636|Analgesics|analgesics|mesh-ancestor
83596475|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
83596476|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596477|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596478|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
83596479|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83596480|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83596481|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596482|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83596483|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83596484|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83596485|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596486|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596487|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
83596488|NCT05244954|Chloroquine|chloroquine|mesh-list
83596489|NCT05244954|Piperaquine|piperaquine|mesh-list
83596490|NCT05244954|Artenimol|artenimol|mesh-list
83596491|NCT05244954|Amebicides|amebicides|mesh-ancestor
83596492|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83596493|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83596494|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596495|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
83596496|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596497|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
83596498|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
83596499|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83596500|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596501|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596502|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83596503|NCT01929252|Analgesics|analgesics|mesh-ancestor
83596504|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
83596505|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596506|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83596507|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83596508|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83596509|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
83596510|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596511|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596512|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
83596513|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
83596514|NCT04275960|Selitrectinib|selitrectinib|mesh-list
83596515|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596516|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596517|NCT00634920|Cyclosporine|cyclosporine|mesh-list
83596518|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
83596519|NCT00634920|Prednisolone|prednisolone|mesh-list
83596520|NCT00634920|Everolimus|everolimus|mesh-list
83596521|NCT00634920|Cyclosporins|cyclosporins|mesh-list
83596522|NCT00634920|Basiliximab|basiliximab|mesh-list
83596523|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596524|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596525|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83596526|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
83596527|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596528|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
83596529|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596530|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
83596531|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596532|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83596533|NCT00634920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83596534|NCT00634920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83596535|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596536|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83596537|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83596538|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
83596539|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596540|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596541|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
83596542|NCT00634920|Hormones|hormones|mesh-ancestor
83596543|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596544|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596545|NCT01923012|Vitamin K|vitamin k|mesh-list
83596546|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
83596547|NCT01923012|Vitamins|vitamins|mesh-ancestor
83596548|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
83596549|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596550|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83596551|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83596552|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596553|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
83596554|NCT01923012|Coagulants|coagulants|mesh-ancestor
83596555|NCT01923090|Finasteride|finasteride|mesh-list
83596556|NCT01923090|Dutasteride|dutasteride|mesh-list
83596557|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83596558|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83596559|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596560|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596561|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
83596562|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596563|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596564|NCT01923090|Urological Agents|urological agents|mesh-ancestor
83596565|NCT01929330|Dutasteride|dutasteride|mesh-list
83596566|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83596567|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83596568|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596569|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596570|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
83596571|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596572|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596573|NCT00634842|Insulin|insulin|mesh-list
83596574|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83596575|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
83596576|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83596577|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596578|NCT04396548|Midodrine|midodrine|mesh-list
83596579|NCT04396548|Anesthetics|anesthetics|mesh-list
83596580|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596581|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596582|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
83596583|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
83596584|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596585|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83596586|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83596587|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83596588|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83596589|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
83596590|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596591|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596592|NCT01929798|Pancrelipase|pancrelipase|mesh-list
83596593|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596594|NCT00633984|Cycloserine|cycloserine|mesh-list
83596595|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83596596|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596597|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83596598|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
83596599|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596600|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
83596601|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596602|NCT04395612|Niraparib|niraparib|mesh-list
83596603|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83596604|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596605|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596606|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596607|NCT01923558|Donepezil|donepezil|mesh-list
83596608|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83596609|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596610|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596611|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
83596612|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596613|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596614|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
83596615|NCT01921218|Cyclosporine|cyclosporine|mesh-list
83596616|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
83596617|NCT01921218|Prednisone|prednisone|mesh-list
83596618|NCT01921218|Abatacept|abatacept|mesh-list
83596619|NCT01921218|Tacrolimus|tacrolimus|mesh-list
83596620|NCT01921218|Cyclosporins|cyclosporins|mesh-list
83596621|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83596622|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596623|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
83596624|NCT01921218|Hormones|hormones|mesh-ancestor
83596625|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596626|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596627|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83596628|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596629|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83596630|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
83596631|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596632|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596633|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
83596634|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596635|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
83596636|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596637|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83596638|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83596639|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
83596640|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596641|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83596642|NCT01921218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596643|NCT03129828|Bortezomib|bortezomib|mesh-list
83596644|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596645|NCT01922076|Adavosertib|adavosertib|mesh-list
83596646|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596647|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596648|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83596649|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596650|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83596651|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596652|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596653|NCT00633360|Drospirenone|drospirenone|mesh-list
83596654|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83596655|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83596656|NCT00633360|Estradiol|estradiol|mesh-list
83596657|NCT00633360|Estrogens|estrogens|mesh-ancestor
83596658|NCT00633360|Hormones|hormones|mesh-ancestor
83596659|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596660|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596661|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83596662|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
83596663|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83596664|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83596665|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83596666|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83596667|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83596668|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
83596669|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83596670|NCT00633360|Diuretics|diuretics|mesh-ancestor
83596671|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
83596672|NCT00988260|Ganirelix|ganirelix|mesh-list
83596673|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
83596674|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596675|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596676|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83596677|NCT00633126|Cephalosporins|cephalosporins|mesh-list
83596678|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596679|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596680|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
83596681|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596682|NCT01923870|Enclomiphene|enclomiphene|mesh-list
83596683|NCT01923870|Clomiphene|clomiphene|mesh-list
83596684|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
83596685|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83596686|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
83596687|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596688|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596689|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83596690|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
83596691|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83596692|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83596693|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83596694|NCT00632736|Ropinirole|ropinirole|mesh-list
83596695|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83596696|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83596697|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
83596698|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
83596699|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596700|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596701|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596702|NCT01923948|Pregabalin|pregabalin|mesh-list
83596703|NCT01923948|Analgesics|analgesics|mesh-ancestor
83596704|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
83596705|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596706|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596707|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
83596708|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83596709|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83596710|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596711|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83596712|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83596713|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83596714|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596715|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83596716|NCT00989196|Factor VIII|factor viii|mesh-list
83596717|NCT00989196|Coagulants|coagulants|mesh-ancestor
83596718|NCT00631488|Metformin|metformin|mesh-list
83596719|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83596720|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83596721|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596722|NCT00631488|Incretins|incretins|mesh-ancestor
83596723|NCT00631488|Hormones|hormones|mesh-ancestor
83596724|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596725|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83596726|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
83596727|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596728|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596729|NCT01924104|Aspirin|aspirin|mesh-list
83596730|NCT01924104|Heparin|heparin|mesh-list
83596731|NCT01924104|Calcium heparin|calcium heparin|mesh-list
83596732|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83596733|NCT01924104|Tinzaparin|tinzaparin|mesh-list
83596734|NCT01924104|Dalteparin|dalteparin|mesh-list
83596735|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83596736|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83596737|NCT01924104|Analgesics|analgesics|mesh-ancestor
83596738|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
83596739|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596740|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596741|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596742|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596743|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83596744|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83596745|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596746|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83596747|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83596748|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596749|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
83596750|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
83596751|NCT00987402|Ethanol|ethanol|mesh-list
83596752|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83596753|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596754|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596755|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596756|NCT00630786|Panitumumab|panitumumab|mesh-list
83596757|NCT00630786|Conatumumab|conatumumab|mesh-list
83596758|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596759|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596760|NCT00630396|Minocycline|minocycline|mesh-list
83596761|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596762|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596763|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
83596764|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83596765|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83596766|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596767|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
83596768|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
83596769|NCT00630552|Conatumumab|conatumumab|mesh-list
83596770|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596771|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596772|NCT01925352|Mitogens|mitogens|mesh-list
83596773|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83596774|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596775|NCT03095352|Carboplatin|carboplatin|mesh-list
83596776|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
83596777|NCT03095352|Trastuzumab|trastuzumab|mesh-list
83596778|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596779|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596780|NCT03095352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83596781|NCT03095352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596782|NCT03092856|Axitinib|axitinib|mesh-list
83596783|NCT03092856|Antibodies|antibodies|mesh-list
83596784|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
83596785|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596786|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596787|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83596788|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596789|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596790|NCT01920204|Midostaurin|midostaurin|mesh-list
83596791|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596792|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83596793|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596794|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596795|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
83596796|NCT04275258|Narcotics|narcotics|mesh-ancestor
83596797|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596798|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596799|NCT04275258|Analgesics|analgesics|mesh-ancestor
83596800|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
83596801|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596802|NCT03474744|Rituximab|rituximab|mesh-list
83596803|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596804|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596805|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
83596806|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596807|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596808|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83596809|NCT01925820|Entecavir|entecavir|mesh-list
83596810|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
83596811|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596812|NCT01925898|Midazolam|midazolam|mesh-list
83596813|NCT01925898|Ketamine|ketamine|mesh-list
83596814|NCT01925898|Analgesics|analgesics|mesh-ancestor
83596815|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
83596816|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596817|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596818|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83596819|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83596820|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
83596821|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
83596822|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596823|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83596824|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83596825|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596826|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596827|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83596828|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83596829|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83596830|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83596831|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83596832|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
83596833|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
83596834|NCT00983580|Aspirin|aspirin|mesh-list
83596835|NCT00983580|Eflornithine|eflornithine|mesh-list
83596836|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83596837|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83596838|NCT00983580|Analgesics|analgesics|mesh-ancestor
83596839|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
83596840|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596841|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596842|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83596843|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596844|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83596845|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83596846|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596847|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83596848|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83596849|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596850|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
83596851|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596852|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83596853|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83596854|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83596855|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596856|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83596857|NCT00982878|Maraviroc|maraviroc|mesh-list
83596858|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83596859|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83596860|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596861|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83596862|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83596863|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
83596864|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596865|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83596866|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
83596867|NCT00982488|Dasatinib|dasatinib|mesh-list
83596868|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596869|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83596870|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596871|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596872|NCT00982020|Olanzapine|olanzapine|mesh-list
83596873|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
83596874|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
83596875|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83596876|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596877|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596878|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83596879|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83596880|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83596881|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83596882|NCT00982020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83596883|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83596884|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83596885|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596886|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596887|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
83596888|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
83596889|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
83596890|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596891|NCT01926132|Protective Agents|protective agents|mesh-ancestor
83596892|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596893|NCT01926132|Vitamins|vitamins|mesh-ancestor
83596894|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
83596895|NCT01926210|Letrozole|letrozole|mesh-list
83596896|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054951|NCT03539172|Apatinib|apatinib|mesh-list
83596897|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83596898|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83596899|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596900|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596901|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83596902|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
83596903|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83596904|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596906|NCT01926288|Maleic acid|maleic acid|mesh-list
83596907|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596908|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596909|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
83596910|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596911|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
83596912|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83596913|NCT03118674|Ledipasvir|ledipasvir|mesh-list
83596914|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
83596915|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596916|NCT00981084|Modafinil|modafinil|mesh-list
83596917|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83596918|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596919|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83596920|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83596921|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83596922|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596923|NCT00980148|Azithromycin|azithromycin|mesh-list
83596924|NCT00980148|Doxycycline|doxycycline|mesh-list
83596925|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596926|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596927|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
83596928|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83596929|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83596930|NCT03064854|Paclitaxel|paclitaxel|mesh-list
83596931|NCT03064854|Carboplatin|carboplatin|mesh-list
83596932|NCT03064854|Gemcitabine|gemcitabine|mesh-list
83596933|NCT03064854|Pemetrexed|pemetrexed|mesh-list
83596934|NCT03064854|Spartalizumab|spartalizumab|mesh-list
83596935|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83596936|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596937|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
83596938|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
83596939|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
83596940|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596941|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83596942|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
83596943|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596944|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83596945|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83596946|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83596947|NCT03064854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596948|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
83596949|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83596950|NCT00983814|Carbidopa|carbidopa|mesh-list
83596951|NCT00983814|Droxidopa|droxidopa|mesh-list
83596952|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83596953|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83596954|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
83596955|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83596956|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596957|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596958|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83596959|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596960|NCT01921920|Omeprazole|omeprazole|mesh-list
83596961|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83596962|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83596963|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83596964|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596965|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596966|NCT04275414|Bevacizumab|bevacizumab|mesh-list
83596967|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83596968|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83596969|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83596970|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83596971|NCT04275414|Growth Substances|growth substances|mesh-ancestor
83596972|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596973|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
83596974|NCT04395768|Vitamin D|vitamin d|mesh-list
83596975|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
83596976|NCT04395768|Vitamins|vitamins|mesh-list
83596977|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
83596978|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
83596979|NCT04395768|Hydroxocobalamin|hydroxocobalamin|mesh-list
83596980|NCT04395768|Azithromycin|azithromycin|mesh-list
83596981|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
83596982|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
83596983|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83596984|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83596985|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83596986|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83596987|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83596988|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83596989|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
83596990|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83596991|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83596992|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83596993|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83596994|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
83596995|NCT04395768|Protective Agents|protective agents|mesh-ancestor
83596996|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
83596997|NCT04395768|Hematinics|hematinics|mesh-ancestor
83596998|NCT01927224|Nifurtimox|nifurtimox|mesh-list
83596999|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83597000|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83597001|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83597002|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597003|NCT01922154|Ranibizumab|ranibizumab|mesh-list
83597004|NCT01922154|Mitomycin|mitomycin|mesh-list
83597005|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83597006|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83597007|NCT01922154|Growth Substances|growth substances|mesh-ancestor
83597008|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597009|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
83597010|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597011|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
83597012|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597013|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83597014|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83597015|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597016|NCT03059940|Nicotine|nicotine|mesh-list
83597017|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
83597018|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83597019|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
83597020|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597021|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597022|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83597023|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83597024|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
83597025|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597026|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597027|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
83597028|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
83597029|NCT03423342|Niacinamide|niacinamide|mesh-list
83597030|NCT03423342|Niacin|niacin|mesh-list
83597031|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
83597032|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
83597033|NCT03423342|Vitamins|vitamins|mesh-ancestor
83597034|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
83597035|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597036|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83597037|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
83597038|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597039|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83597040|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
83361744|NCT03166800|Ubiquinone|ubiquinone|mesh-list
83597041|NCT01928160|Carboplatin|carboplatin|mesh-list
83597042|NCT01928160|Pemetrexed|pemetrexed|mesh-list
83597043|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83597044|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597045|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597046|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597047|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83597048|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83597049|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83597050|NCT01928316|Mizolastine|mizolastine|mesh-list
83597051|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83597052|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83597053|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
83597054|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
83597055|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597056|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597057|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597058|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
83597059|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83597060|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
83597061|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597062|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597063|NCT04559646|Hemostatics|hemostatics|mesh-list
83597064|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83597065|NCT04559646|Coagulants|coagulants|mesh-ancestor
83597066|NCT04550520|Glucagon|glucagon|mesh-list
83597067|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597068|NCT04550520|Hormones|hormones|mesh-ancestor
83597069|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597070|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597071|NCT01928628|Valsartan|valsartan|mesh-list
83597072|NCT01928628|Lercanidipine|lercanidipine|mesh-list
83597073|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83597074|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83597075|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83597076|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597077|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83597078|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83597079|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83597080|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597081|NCT01929096|Edaravone|edaravone|mesh-list
83597082|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83597083|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
83597084|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597085|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83597086|NCT01929096|Protective Agents|protective agents|mesh-ancestor
83597087|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597088|NCT03059004|TEMPO|tempo|mesh-list
83597089|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
83597090|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597091|NCT03059004|Protective Agents|protective agents|mesh-ancestor
83597092|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597093|NCT04554888|Doxepin|doxepin|mesh-list
83597094|NCT04554888|Histamine|histamine|mesh-list
83597095|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
83597096|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
83597097|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597098|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597099|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597100|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83597101|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83597102|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597103|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83597104|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
83597105|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83597106|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
83597107|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
83597108|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83597109|NCT05601960|Protective Agents|protective agents|mesh-ancestor
83597110|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597111|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
83597112|NCT05605002|Serotonin|serotonin|mesh-list
83597113|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83597114|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
83597115|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597116|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597117|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597118|NCT03238248|Azacitidine|azacitidine|mesh-list
83597119|NCT03238248|Pevonedistat|pevonedistat|mesh-list
83597120|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597121|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
83055175|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
83597122|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597123|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597124|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597125|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
83597126|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83597127|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597128|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
83597129|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597130|NCT04124016|Protective Agents|protective agents|mesh-ancestor
83597131|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597132|NCT04124094|Fluticasone|fluticasone|mesh-list
83597133|NCT04124094|Xhance|xhance|mesh-list
83597134|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83597135|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83597136|NCT04124094|Charcoal|charcoal|mesh-list
83597137|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597138|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83597139|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
83597140|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597141|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597142|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83597143|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
83597144|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
83597145|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83597146|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83597147|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83597148|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83597149|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83597150|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597151|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597152|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
83597153|NCT04124094|Hormones|hormones|mesh-ancestor
83597154|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597155|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
83597156|NCT04124094|Antidotes|antidotes|mesh-ancestor
83597157|NCT04124094|Protective Agents|protective agents|mesh-ancestor
83597158|NCT03033576|Nivolumab|nivolumab|mesh-list
83597159|NCT03033576|Ipilimumab|ipilimumab|mesh-list
83597160|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597161|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597162|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83597163|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597164|NCT04275024|Calcipotriene|calcipotriene|mesh-list
83597165|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
83597166|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
83597167|NCT04123392|Busulfan|busulfan|mesh-list
83597168|NCT04123392|Decitabine|decitabine|mesh-list
83597169|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83597170|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
83597171|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597172|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597173|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83597174|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
83597175|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597176|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597177|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83597178|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597179|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
83597180|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597181|NCT04760262|Remifentanil|remifentanil|mesh-list
83597182|NCT04760262|Propofol|propofol|mesh-list
83597183|NCT04760262|Sevoflurane|sevoflurane|mesh-list
83597184|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83597185|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597186|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597187|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83597188|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
83597189|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
83597190|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83597191|NCT04760262|Narcotics|narcotics|mesh-ancestor
83597192|NCT04760262|Analgesics|analgesics|mesh-ancestor
83597193|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
83597194|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597195|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83597196|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83597197|NCT03047928|Nivolumab|nivolumab|mesh-list
83597198|NCT03047928|Vaccines|vaccines|mesh-list
83597199|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
83597200|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597201|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597202|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597203|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83597204|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597205|NCT05607810|Aflibercept|aflibercept|mesh-list
83597206|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83597207|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83597208|NCT05607810|Growth Substances|growth substances|mesh-ancestor
83597209|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597210|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
83597211|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597212|NCT04126278|Dexamethasone|dexamethasone|mesh-list
83597213|NCT04126278|Cortisone|cortisone|mesh-list
83597214|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597215|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
83597216|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
83597217|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597218|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597219|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597220|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
83597221|NCT04126278|Hormones|hormones|mesh-ancestor
83597222|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597223|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83597224|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597225|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83597226|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597227|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
83597228|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
83597229|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597230|NCT04121910|Itraconazole|itraconazole|mesh-list
83597231|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
83597232|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597233|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83597234|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83597235|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597236|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597237|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83597238|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
83597239|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597240|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597241|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83597242|NCT04129788|Bisacodyl|bisacodyl|mesh-list
83597243|NCT04129788|Cathartics|cathartics|mesh-ancestor
83597244|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597245|NCT04129788|Laxatives|laxatives|mesh-ancestor
83597246|NCT03831126|Betamethasone|betamethasone|mesh-list
83597247|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
83597248|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83597249|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
83597250|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83597251|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
83597252|NCT03831126|Hormones|hormones|mesh-ancestor
83597253|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597254|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597255|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597256|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83597257|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
83597258|NCT04073784|Gemcitabine|gemcitabine|mesh-list
83597259|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597260|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
83597261|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597262|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597263|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83597264|NCT05606796|Latanoprost|latanoprost|mesh-list
83597265|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83597266|NCT04129710|Rituximab|rituximab|mesh-list
83597267|NCT04129710|Methotrexate|methotrexate|mesh-list
83597268|NCT04129710|Etoposide|etoposide|mesh-list
83597269|NCT04129710|Lenalidomide|lenalidomide|mesh-list
83597270|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597271|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597272|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
83597273|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597274|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597275|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83597276|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
83597277|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83597278|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597279|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
83597280|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597281|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
83597282|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597283|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83597284|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83597285|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83597286|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83597287|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83597288|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83597289|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83597290|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83597291|NCT04129710|Growth Substances|growth substances|mesh-ancestor
83597292|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
83597293|NCT03200808|Methylene Blue|methylene blue|mesh-list
83597294|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597295|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597296|NCT04129008|Aspirin|aspirin|mesh-list
83597297|NCT04129008|Indobufen|indobufen|mesh-list
83597298|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83597299|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83597300|NCT04129008|Analgesics|analgesics|mesh-ancestor
83597301|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
83597302|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597303|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597304|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597305|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597306|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83597307|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83597308|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597309|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83597310|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83597311|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597312|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
83597313|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
83597314|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597315|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
83597316|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597317|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597318|NCT04120350|Rituximab|rituximab|mesh-list
83597319|NCT04120350|Methotrexate|methotrexate|mesh-list
83597320|NCT04120350|Lenalidomide|lenalidomide|mesh-list
83597321|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597322|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597323|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
83597324|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597325|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597326|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83597327|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
83597328|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83597329|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597330|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
83597331|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597332|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
83597333|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597334|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83597335|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83597336|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83597337|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83597338|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83597339|NCT04120350|Growth Substances|growth substances|mesh-ancestor
83597340|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
83597341|NCT04394598|Capecitabine|capecitabine|mesh-list
83597342|NCT04394598|Irinotecan|irinotecan|mesh-list
83597343|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597344|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
83597345|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597346|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055405|NCT00431431|Hormones|hormones|mesh-ancestor
83597347|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83597348|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83597349|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597350|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83597351|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597352|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83597353|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
83597354|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597355|NCT05602428|Anesthetics|anesthetics|mesh-list
83597356|NCT05602428|Esketamine|esketamine|mesh-list
83597357|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597358|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597359|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
83597360|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83597361|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83597362|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
83597363|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597364|NCT04127058|Iloperidone|iloperidone|mesh-list
83597365|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83597366|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83597367|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597368|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597369|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83597370|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
83597371|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
83597372|NCT03012360|Linezolid|linezolid|mesh-list
83597373|NCT03012360|Imipenem|imipenem|mesh-list
83597374|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83597375|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597376|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83597377|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83597378|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597379|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597380|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597381|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83597382|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83597383|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83597384|NCT04120974|Insulin|insulin|mesh-list
83597385|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83597386|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597387|NCT04126668|Vorolanib|vorolanib|mesh-list
83597388|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83597389|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597390|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597391|NCT04758936|Clonidine|clonidine|mesh-list
83597392|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
83597393|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83597394|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597395|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597396|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83597397|NCT04758936|Analgesics|analgesics|mesh-ancestor
83597398|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
83597399|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597400|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83597401|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83597402|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83597403|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
83597404|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597405|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597406|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83597407|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
83597408|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
83597409|NCT04126044|Bevacizumab|bevacizumab|mesh-list
83597410|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597411|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597412|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83597413|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83597414|NCT04126044|Growth Substances|growth substances|mesh-ancestor
83597415|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597416|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
83597417|NCT04758858|Glucagon|glucagon|mesh-list
83597418|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597419|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597420|NCT04758858|Hormones|hormones|mesh-ancestor
83597421|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597422|NCT04125888|Immunomodulating Agents|immunomodulating agents|mesh-list
83597423|NCT04125888|Immunologic Factors|immunologic factors|mesh-ancestor
83597424|NCT04125888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597425|NCT02975310|Anesthetics|anesthetics|mesh-list
83597426|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597427|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597428|NCT04394208|Silymarin|silymarin|mesh-list
83597429|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
83597430|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597431|NCT04394208|Protective Agents|protective agents|mesh-ancestor
83597432|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597433|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
83597434|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83597435|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83597436|NCT03829566|Prednisolone|prednisolone|mesh-list
83597437|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
83597438|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
83597439|NCT03829566|Rituximab|rituximab|mesh-list
83597440|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
83597441|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83597442|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83597443|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
83597444|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83597445|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
83597446|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597447|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597448|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83597449|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
83597450|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597451|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597452|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83597453|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597454|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597455|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
83597456|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
83597457|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597458|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597459|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
83597460|NCT03829566|Hormones|hormones|mesh-ancestor
83597461|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597462|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83597463|NCT03829566|Protective Agents|protective agents|mesh-ancestor
83597464|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83597465|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
83597466|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83597467|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597468|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597469|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83597470|NCT03933306|Analgesics|analgesics|mesh-ancestor
83597471|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
83597472|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597473|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83597474|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83597475|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83597476|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83597477|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597478|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597479|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
83597480|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
83597481|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83597482|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83597483|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597484|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597485|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597486|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597487|NCT02972424|Teriparatide|teriparatide|mesh-list
83597488|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83597489|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597490|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83597491|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
83597492|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597493|NCT04393584|Leucovorin|leucovorin|mesh-list
83597494|NCT04393584|Docetaxel|docetaxel|mesh-list
83597495|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
83597496|NCT04393584|Irinotecan|irinotecan|mesh-list
83597497|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597498|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
83597499|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
83597500|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
83597501|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597502|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83597503|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83597504|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597505|NCT04393584|Antidotes|antidotes|mesh-ancestor
83597506|NCT04393584|Protective Agents|protective agents|mesh-ancestor
83597507|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597508|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
83597509|NCT04393584|Vitamins|vitamins|mesh-ancestor
83597510|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
83597511|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
83597512|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83597513|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
83597514|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597515|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597516|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83597517|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
83597518|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597519|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597520|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83597521|NCT03828474|Acetazolamide|acetazolamide|mesh-list
83597522|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
83597523|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83597524|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597525|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597526|NCT03828474|Diuretics|diuretics|mesh-ancestor
83597527|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
83597528|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597529|NCT03043950|Panitumumab|panitumumab|mesh-list
83597530|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597531|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597532|NCT03828084|Decitabine|decitabine|mesh-list
83597533|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
83597534|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597535|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
83597536|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597537|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597538|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597539|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83597540|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
83597541|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597542|NCT02959164|Gemcitabine|gemcitabine|mesh-list
83597543|NCT02959164|Decitabine|decitabine|mesh-list
83597544|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597545|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
83597546|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597547|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597548|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597549|NCT02983734|Cycloserine|cycloserine|mesh-list
83597550|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83597551|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597552|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83597553|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
83597554|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83597555|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
83486587|NCT00645710|Antibodies|antibodies|mesh-list
83597556|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597557|NCT03821454|Capecitabine|capecitabine|mesh-list
83597558|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597559|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
83597560|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597561|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597562|NCT03820518|Calcitriol|calcitriol|mesh-list
83597563|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83597564|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597565|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83597566|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83597567|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597568|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83597569|NCT03820518|Vitamins|vitamins|mesh-ancestor
83597570|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
83597571|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83597572|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
83597573|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83597574|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83597575|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597576|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
83597577|NCT03820206|Coagulants|coagulants|mesh-ancestor
83597578|NCT02955654|Aripiprazole|aripiprazole|mesh-list
83597579|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
83597580|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83597581|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83597582|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83597583|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597584|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597585|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
83597586|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
83597587|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597588|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597589|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83597590|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83597591|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
83597592|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83597593|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83597594|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83597595|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83597596|NCT04392648|Dexamethasone|dexamethasone|mesh-list
83597597|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
83597598|NCT04392648|Bortezomib|bortezomib|mesh-list
83597599|NCT04392648|Pomalidomide|pomalidomide|mesh-list
83597600|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83597601|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
83597602|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597603|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597604|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83597605|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
83597606|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597607|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597608|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83597609|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597610|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
83597611|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
83597612|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597613|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597614|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
83597615|NCT04392648|Hormones|hormones|mesh-ancestor
83597616|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597617|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83597618|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83597619|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83597620|NCT04392648|Growth Substances|growth substances|mesh-ancestor
83597621|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
83597622|NCT03826602|Metformin|metformin|mesh-list
83597623|NCT03826602|Tucatinib|tucatinib|mesh-list
83597624|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83597625|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597626|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597627|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83597628|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597629|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597630|NCT01453920|Ranibizumab|ranibizumab|mesh-list
83597631|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83597632|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83597633|NCT01453920|Growth Substances|growth substances|mesh-ancestor
83597634|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597635|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
83597636|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597637|NCT03820908|Bisantrene|bisantrene|mesh-list
83597638|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83597639|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597640|NCT02953548|Cannabidiol|cannabidiol|mesh-list
83597641|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
83597642|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
83597643|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83597644|NCT03112044|Velpatasvir|velpatasvir|mesh-list
83597645|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
83055699|NCT02755818|Heparin|heparin|mesh-list
83597646|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597647|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
83597648|NCT02952222|Propofol|propofol|mesh-list
83597649|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83597650|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597651|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597652|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83597653|NCT02952222|Analgesics|analgesics|mesh-ancestor
83597654|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
83597655|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597656|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83597657|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83597658|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83597659|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83597660|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597661|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597662|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83597663|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
83597664|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
83597665|NCT03826368|Cannabidiol|cannabidiol|mesh-list
83597666|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
83597667|NCT04391478|Milrinone|milrinone|mesh-list
83597668|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
83597669|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
83597670|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83597671|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83597672|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597673|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597674|NCT04391478|Urological Agents|urological agents|mesh-ancestor
83597675|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83597676|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83597677|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83597678|NCT04391478|Protective Agents|protective agents|mesh-ancestor
83597679|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597680|NCT03828006|Red yeast rice|red yeast rice|mesh-list
83597681|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83597682|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83597683|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83597684|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
83597685|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597686|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597687|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83597688|NCT01454154|Glyburide|glyburide|mesh-list
83597689|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83597690|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597691|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
83597692|NCT04391868|Citric Acid|citric acid|mesh-list
83597693|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
83597694|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
83597695|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83597696|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
83597697|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
83597698|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597699|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
83597700|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83597701|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83597702|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597703|NCT04391868|Urological Agents|urological agents|mesh-ancestor
83597704|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
83597705|NCT03829332|Lenvatinib|lenvatinib|mesh-list
83597706|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597707|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597708|NCT03829332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83597709|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597710|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83597711|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597712|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
83597713|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83597714|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597715|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597716|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83597717|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83597718|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
83597719|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83597720|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83597721|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83597722|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055771|NCT02174094|Clobazam|clobazam|mesh-list
83597723|NCT01450176|Analgesics|analgesics|mesh-ancestor
83597724|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
83597725|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597726|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597727|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597728|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597729|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83597730|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83597731|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83597732|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
83597733|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
83597734|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597735|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597737|NCT01454622|Canagliflozin|canagliflozin|mesh-list
83597738|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83597739|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597740|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83597741|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597742|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
83597743|NCT01450410|Niacin|niacin|mesh-list
83597744|NCT01450410|Niacinamide|niacinamide|mesh-list
83597745|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
83597746|NCT01450410|Vitamins|vitamins|mesh-ancestor
83597747|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
83597748|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597749|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83597750|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
83597751|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597752|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83597753|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
83597754|NCT01450566|Lidocaine|lidocaine|mesh-list
83597755|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
83597756|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
83597757|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597758|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597759|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
83597760|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597761|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83597762|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83597763|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83597764|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83597765|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597766|NCT02947386|Nivolumab|nivolumab|mesh-list
83597767|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
83597768|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597769|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597770|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83597771|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597772|NCT03043014|Misoprostol|misoprostol|mesh-list
83597773|NCT03043014|Mifepristone|mifepristone|mesh-list
83597774|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83597775|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
83597776|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83597777|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597778|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83597779|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597780|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
83597781|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83597782|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83597783|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83597784|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83597785|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
83597786|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83597787|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83597788|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
83597789|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597790|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
83597791|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83597792|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83597793|NCT02983344|Fentanyl|fentanyl|mesh-list
83597794|NCT02983344|Ropivacaine|ropivacaine|mesh-list
83597795|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
83055846|NCT02174328|Aspirin|aspirin|mesh-list
83597796|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
83597797|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597798|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597799|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
83597800|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597801|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83597802|NCT02983344|Narcotics|narcotics|mesh-ancestor
83597803|NCT02983344|Analgesics|analgesics|mesh-ancestor
83597804|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83597805|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83597806|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
83597807|NCT03824340|Doxycycline|doxycycline|mesh-list
83597808|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83597809|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597810|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
83597811|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83597812|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83597813|NCT01455246|Meropenem|meropenem|mesh-list
83597814|NCT01455246|Daptomycin|daptomycin|mesh-list
83597815|NCT01455246|Ceftazidime|ceftazidime|mesh-list
83597816|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83597817|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597818|NCT02934282|HBOC 201|hboc 201|mesh-list
83597819|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
83597820|NCT03823950|Lenograstim|lenograstim|mesh-list
83597821|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83597822|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
83597823|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597824|NCT01451268|Panobinostat|panobinostat|mesh-list
83597825|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597826|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83597827|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597828|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597829|NCT03823638|Mannitol|mannitol|mesh-list
83597830|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83597831|NCT03823638|Diuretics|diuretics|mesh-ancestor
83597832|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
83597833|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597834|NCT02884908|Pregabalin|pregabalin|mesh-list
83597835|NCT02884908|Analgesics|analgesics|mesh-ancestor
83597836|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
83597837|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597838|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597839|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
83597840|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83597841|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83597842|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597843|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83597844|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83597845|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83597846|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597847|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83597848|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83597849|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83597850|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597851|NCT01451658|Propranolol|propranolol|mesh-list
83597852|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83597853|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83597854|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
83597855|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597856|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597857|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597858|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83597859|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83597860|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
83597861|NCT02861898|Cetuximab|cetuximab|mesh-list
83597862|NCT02861898|Mannitol|mannitol|mesh-list
83597863|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83597864|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597865|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83597866|NCT02861898|Diuretics|diuretics|mesh-ancestor
83597867|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
83597868|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597869|NCT02851056|Lenograstim|lenograstim|mesh-list
83597870|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83597871|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
83597872|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597873|NCT02935374|Amoxicillin|amoxicillin|mesh-list
83597874|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
83597875|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
83597876|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83597877|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597878|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83597879|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597880|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597881|NCT01452750|Lansoprazole|lansoprazole|mesh-list
83597882|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
83597883|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83597884|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597885|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83597886|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597887|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597888|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
83597889|NCT01452828|Tedizolid|tedizolid|mesh-list
83597890|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
83597891|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83597892|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83597893|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83597894|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597895|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597896|NCT01452906|Omeprazole|omeprazole|mesh-list
83597897|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83597898|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597899|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83597900|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597901|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597902|NCT02781090|Nicotine|nicotine|mesh-list
83597903|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83597904|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
83597905|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597906|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597907|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83597908|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83597909|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
83597910|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597911|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597912|NCT03823248|Folic Acid|folic acid|mesh-list
83597913|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
83597914|NCT03823248|Hematinics|hematinics|mesh-ancestor
83597915|NCT03823248|Vitamins|vitamins|mesh-ancestor
83597916|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
83597917|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597918|NCT03822936|Fluorouracil|fluorouracil|mesh-list
83597919|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
83597920|NCT03822936|Irinotecan|irinotecan|mesh-list
83597921|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
83597922|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597923|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83597924|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83597925|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83597926|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
83597927|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597928|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83597929|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83597930|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597931|NCT03822546|Nicotine|nicotine|mesh-list
83597932|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83597933|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
83597934|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597935|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597936|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83597937|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83597938|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
83597939|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597940|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597941|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
83597942|NCT01453686|Clobetasol|clobetasol|mesh-list
83597943|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597944|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
83597945|NCT01453686|Hormones|hormones|mesh-ancestor
83597946|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597947|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597948|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83597949|NCT01455870|Exenatide|exenatide|mesh-list
83597950|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83597951|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597952|NCT01455870|Incretins|incretins|mesh-ancestor
83597953|NCT01455870|Hormones|hormones|mesh-ancestor
83597954|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83597955|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83597956|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
83597957|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597958|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597959|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83597960|NCT01456260|Lansoprazole|lansoprazole|mesh-list
83597961|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
83597962|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83597963|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83597964|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83597965|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597966|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597967|NCT01890408|Ropivacaine|ropivacaine|mesh-list
83597968|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
83597969|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
83597970|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597971|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597972|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
83597973|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597974|NCT04849650|Amisulpride|amisulpride|mesh-list
83597975|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83597976|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83597977|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83597978|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597979|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83597980|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83597981|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
83597982|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83597983|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597984|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83597985|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
83597986|NCT04272372|Ketoprofen|ketoprofen|mesh-list
83597987|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83597988|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83597989|NCT04272372|Analgesics|analgesics|mesh-ancestor
83597990|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
83597991|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83597992|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83597993|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83597994|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83597995|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83597996|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83597997|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83597998|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
83597999|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83598000|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
83598001|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598002|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598003|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83598004|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
83487041|NCT00664430|Calcitriol|calcitriol|mesh-list
83598005|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83598006|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
83598007|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598008|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598009|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83598010|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
83598011|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
83598012|NCT01891500|Protective Agents|protective agents|mesh-ancestor
83598013|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
83598014|NCT02439450|Nivolumab|nivolumab|mesh-list
83598015|NCT02439450|Pemetrexed|pemetrexed|mesh-list
83598016|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83598017|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598018|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83598019|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598020|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598021|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83598022|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83598023|NCT02862132|Vedolizumab|vedolizumab|mesh-list
83598024|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83598026|NCT02859402|Busulfan|busulfan|mesh-list
83598027|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598028|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598029|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598030|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
83598031|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598032|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
83598033|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83598034|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83598035|NCT04844268|Vaccines|vaccines|mesh-list
83598036|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
83598037|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598038|NCT04842552|Hydralazine|hydralazine|mesh-list
83598039|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83598040|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
83598041|NCT02535312|Cisplatin|cisplatin|mesh-list
83598042|NCT02535312|Pemetrexed|pemetrexed|mesh-list
83598043|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598044|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598045|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598046|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83598047|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83598048|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
83598049|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83598050|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
83598051|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
83598052|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598053|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598054|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83598055|NCT01891812|Analgesics|analgesics|mesh-ancestor
83598056|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
83598057|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598058|NCT04390464|Ravulizumab|ravulizumab|mesh-list
83598059|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83598060|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598061|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
83598062|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598063|NCT01892748|Vitamin D|vitamin d|mesh-list
83598064|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
83598065|NCT01892748|Vitamins|vitamins|mesh-ancestor
83598066|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
83598067|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598068|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83598069|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83598070|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
83598071|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83598072|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
83598073|NCT01893060|Povidone|povidone|mesh-list
83598074|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83598075|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598076|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
83598077|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
83598078|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
83598079|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
83598080|NCT02344290|Pitavastatin|pitavastatin|mesh-list
83598081|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83598082|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83598083|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83598084|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
83598085|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598086|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598087|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83598088|NCT02848560|Xenon|xenon|mesh-list
83598089|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83598090|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
83598091|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
83598092|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598093|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598094|NCT01457820|Allopurinol|allopurinol|mesh-list
83598095|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
83598096|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598097|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598098|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
83598099|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598100|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83598101|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
83598102|NCT01457820|Protective Agents|protective agents|mesh-ancestor
83598103|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598104|NCT05020782|Belimumab|belimumab|mesh-list
83598105|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598106|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
83598107|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598108|NCT01893294|Gemcitabine|gemcitabine|mesh-list
83598109|NCT01893294|Fluorouracil|fluorouracil|mesh-list
83598110|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598111|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
83598112|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598113|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598114|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598115|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
83598116|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598117|NCT01458054|Ritonavir|ritonavir|mesh-list
83598118|NCT01458054|Omeprazole|omeprazole|mesh-list
83598119|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83598120|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83598121|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
83598122|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598123|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598124|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83598125|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83598126|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
83598127|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598128|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83598129|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83598130|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83598131|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83598132|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83598133|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
83598134|NCT01893450|Bromocriptine|bromocriptine|mesh-list
83598135|NCT01893450|Methimazole|methimazole|mesh-list
83598136|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83598137|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598138|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598139|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83598140|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83598141|NCT01893450|Protective Agents|protective agents|mesh-ancestor
83598142|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598143|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
83598144|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83598145|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
83598146|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83598147|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83598148|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598149|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598150|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
83598151|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
83598152|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598153|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
83598154|NCT05027100|Irinotecan|irinotecan|mesh-list
83598155|NCT05027100|Tislelizumab|tislelizumab|mesh-list
83598156|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83598157|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83598158|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598159|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598160|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598161|NCT05027100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83598162|NCT01458600|Diclofenac|diclofenac|mesh-list
83598163|NCT01458600|Propranolol|propranolol|mesh-list
83598164|NCT01458600|Metoprolol|metoprolol|mesh-list
83598165|NCT01458600|Methimazole|methimazole|mesh-list
83598166|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83598167|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83598168|NCT01458600|Analgesics|analgesics|mesh-ancestor
83598169|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
83598170|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598171|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598172|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83598173|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598174|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83598175|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598176|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598177|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83598178|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83598179|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
83598180|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598181|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83598182|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83598183|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
83598184|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
83598185|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
83598186|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83598187|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
83598188|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598189|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598190|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
83598191|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
83598192|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83598193|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83598194|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598195|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598196|NCT02832570|Urological Agents|urological agents|mesh-ancestor
83598197|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
83598198|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
83598199|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83598200|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
83598201|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598202|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
83598203|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598204|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598205|NCT01459146|Lumefantrine|lumefantrine|mesh-list
83598206|NCT01459146|Artemether|artemether|mesh-list
83598207|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83598208|NCT01459146|Albendazole|albendazole|mesh-list
83598209|NCT01459146|Praziquantel|praziquantel|mesh-list
83598210|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
83598211|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83598212|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83598213|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598214|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
83598215|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
83598216|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83598217|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598218|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598219|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598220|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598221|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598222|NCT05026398|Fenfluramine|fenfluramine|mesh-list
83598223|NCT05026398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83598224|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83598225|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83598226|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598227|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598228|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
83598229|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598230|NCT05586750|Atorvastatin|atorvastatin|mesh-list
83598231|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83487256|NCT01294163|Propofol|propofol|mesh-list
83598232|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83598233|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
83598234|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598235|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83598236|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83598237|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598238|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83598239|NCT02720094|Cabotegravir|cabotegravir|mesh-list
83598240|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83598241|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83598242|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598243|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598244|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
83598245|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361750|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
83361751|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361752|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361753|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361754|NCT03166254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83598247|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83598248|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83598249|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83598250|NCT02716974|Docetaxel|docetaxel|mesh-list
83598251|NCT02716974|Leuprolide|leuprolide|mesh-list
83598252|NCT02716974|Bicalutamide|bicalutamide|mesh-list
83598253|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598254|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598255|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598256|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598257|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598258|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83598259|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
83598260|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83598261|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598262|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83598263|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
83598264|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598265|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598266|NCT01459380|Bevacizumab|bevacizumab|mesh-list
83598267|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83598268|NCT01459380|Carboplatin|carboplatin|mesh-list
83598269|NCT01459380|Doxorubicin|doxorubicin|mesh-list
83598270|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83598271|NCT01459380|Veliparib|veliparib|mesh-list
83598272|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
83598273|NCT01459380|Antibodies|antibodies|mesh-list
83598274|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
83598275|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83598276|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
83598277|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598278|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83598279|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83598280|NCT01459380|Growth Substances|growth substances|mesh-ancestor
83598281|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598282|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
83598283|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
83598284|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83598285|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83598286|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83598287|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598288|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598289|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83598290|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83598291|NCT04346004|Hematinics|hematinics|mesh-ancestor
83598292|NCT02680314|Methotrexate|methotrexate|mesh-list
83598293|NCT02680314|Misoprostol|misoprostol|mesh-list
83598294|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83598295|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
83598296|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83598297|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598298|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598299|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
83598300|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598301|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598302|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
83598303|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598304|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83598305|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598306|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
83598307|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598308|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83598309|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83598310|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83598311|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
83598312|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83598313|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
83598314|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598315|NCT02706678|Tacrolimus|tacrolimus|mesh-list
83598316|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598317|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
83598318|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598319|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83056369|NCT03062800|Pemetrexed|pemetrexed|mesh-list
83598320|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598321|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598322|NCT02705196|Paclitaxel|paclitaxel|mesh-list
83598323|NCT02705196|Gemcitabine|gemcitabine|mesh-list
83598324|NCT02705196|Atezolizumab|atezolizumab|mesh-list
83598325|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598326|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598327|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598328|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598329|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598330|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598331|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598332|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
83598333|NCT02705196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83598334|NCT02705196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83598335|NCT02703948|Lidocaine|lidocaine|mesh-list
83598336|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
83598337|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
83598338|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598339|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598340|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
83598341|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598342|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83598343|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83598344|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83598345|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83598346|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598347|NCT02677038|Olaparib|olaparib|mesh-list
83598348|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83598349|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598350|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598351|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598352|NCT02666742|Aspirin|aspirin|mesh-list
83598353|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
83598354|NCT02666742|Edoxaban|edoxaban|mesh-list
83598355|NCT02666742|Dabigatran|dabigatran|mesh-list
83598356|NCT02666742|Anticoagulants|anticoagulants|mesh-list
83598357|NCT02666742|Coagulants|coagulants|mesh-list
83598358|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83598359|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83598360|NCT02666742|Analgesics|analgesics|mesh-ancestor
83598361|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
83598362|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598363|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598364|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83598365|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598366|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83598367|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83598368|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598369|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83598370|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83598371|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598372|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
83598373|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83598374|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
83598375|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83598376|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
83598377|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
83598378|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83598379|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83598380|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598381|NCT02684292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83598382|NCT02684292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598383|NCT02684292|Immunotoxins|immunotoxins|mesh-ancestor
83598384|NCT02684292|Immunoconjugates|immunoconjugates|mesh-ancestor
83598385|NCT02684292|Immunologic Factors|immunologic factors|mesh-ancestor
83598386|NCT02684292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598387|NCT05586516|Paclitaxel|paclitaxel|mesh-list
83598388|NCT05586516|Gemcitabine|gemcitabine|mesh-list
83598389|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598390|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598391|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598392|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598393|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598394|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598395|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598396|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
83598398|NCT04390854|Miconazole|miconazole|mesh-list
83598399|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83598400|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598401|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
83598402|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83598403|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83598404|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598405|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598406|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83598407|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598408|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598409|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598410|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83598411|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83598412|NCT02465736|Cisplatin|cisplatin|mesh-list
83598413|NCT02465736|Docetaxel|docetaxel|mesh-list
83598414|NCT02465736|Vinorelbine|vinorelbine|mesh-list
83598415|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598416|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598417|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598418|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598419|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598420|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598421|NCT02630316|Treprostinil|treprostinil|mesh-list
83598422|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83598423|NCT02359968|Paclitaxel|paclitaxel|mesh-list
83598424|NCT02359968|Fluorouracil|fluorouracil|mesh-list
83598425|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
83598426|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598427|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598428|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598429|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598430|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598431|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598432|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
83598433|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598434|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598435|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
83598436|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598437|NCT04757376|Denosumab|denosumab|mesh-list
83598438|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83598439|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598440|NCT02624544|Desonide|desonide|mesh-list
83598441|NCT02624544|Esomeprazole|esomeprazole|mesh-list
83598442|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83598443|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83598444|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83598445|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598446|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598447|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83598448|NCT02603328|Atorvastatin|atorvastatin|mesh-list
83598449|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83598450|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83598451|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
83598452|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598453|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83598454|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83598455|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598456|NCT02323698|Caffeine|caffeine|mesh-list
83598457|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83598458|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598459|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83598460|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598461|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598462|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83598463|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83598464|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
83598465|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598466|NCT01451736|Risperidone|risperidone|mesh-list
83598467|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83598468|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83598469|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
83598470|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598471|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598472|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598473|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83598474|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83598475|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598476|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83598477|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83598478|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
83598479|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83598480|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83598481|NCT02589600|Vitamin D|vitamin d|mesh-list
83598482|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
83598483|NCT02589600|Calcium|calcium|mesh-list
83598484|NCT02589600|Vitamins|vitamins|mesh-ancestor
83598485|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
83598486|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598487|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83598488|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83598489|NCT04758000|Metformin|metformin|mesh-list
83598490|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83598491|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598492|NCT01450956|Sevoflurane|sevoflurane|mesh-list
83598493|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83598494|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83598495|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
83598496|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
83598497|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598498|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598499|NCT02300922|Antibodies|antibodies|mesh-list
83598500|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
83598501|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598502|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
83598503|NCT01453530|Neostigmine|neostigmine|mesh-list
83598504|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83598505|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598506|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598507|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
83598508|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598509|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598510|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83598511|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
83598512|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598513|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83598514|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83598515|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83598516|NCT02983422|Aminophylline|aminophylline|mesh-list
83598517|NCT02983422|Furosemide|furosemide|mesh-list
83598518|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83598519|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
83598520|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598521|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598522|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83598523|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
83598524|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83598525|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83598526|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598527|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598528|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83598529|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83598530|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
83598531|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598532|NCT02983422|Protective Agents|protective agents|mesh-ancestor
83598533|NCT02983422|Diuretics|diuretics|mesh-ancestor
83598534|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
83598535|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83598536|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83598537|NCT05585814|Bevacizumab|bevacizumab|mesh-list
83598538|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
83598539|NCT05585814|Capecitabine|capecitabine|mesh-list
83598540|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
83598541|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83598542|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598543|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83598544|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83598545|NCT05585814|Growth Substances|growth substances|mesh-ancestor
83598546|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598547|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
83598548|NCT05585814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83598549|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598550|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598551|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
83598552|NCT02013648|Cytarabine|cytarabine|mesh-list
83598553|NCT02013648|Daunorubicin|daunorubicin|mesh-list
83598554|NCT02013648|Dasatinib|dasatinib|mesh-list
83598555|NCT02013648|Idarubicin|idarubicin|mesh-list
83598556|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598557|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
83598558|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598559|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598560|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
83598561|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598562|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598563|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
83598564|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598565|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83598566|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83598567|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83598568|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598569|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83598570|NCT05585736|Mydriatics|mydriatics|mesh-list
83598571|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
83598572|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598573|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598574|NCT01989780|Paclitaxel|paclitaxel|mesh-list
83598575|NCT01989780|Bevacizumab|bevacizumab|mesh-list
83598576|NCT01989780|Letrozole|letrozole|mesh-list
83598577|NCT01989780|Fulvestrant|fulvestrant|mesh-list
83598578|NCT01989780|Anastrozole|anastrozole|mesh-list
83598579|NCT01989780|Exemestane|exemestane|mesh-list
83598580|NCT01989780|Goserelin|goserelin|mesh-list
83598581|NCT01989780|Leuprolide|leuprolide|mesh-list
83598582|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598583|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598584|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598585|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598586|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598587|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598588|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83598589|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83598590|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83598591|NCT01989780|Growth Substances|growth substances|mesh-ancestor
83598592|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598593|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
83598594|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83598595|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83598596|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598597|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83598598|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598599|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598600|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83598601|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83598602|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83598603|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
83598604|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83598605|NCT02270814|Paclitaxel|paclitaxel|mesh-list
83598606|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83598607|NCT02270814|Cisplatin|cisplatin|mesh-list
83598608|NCT02270814|Carboplatin|carboplatin|mesh-list
83598609|NCT02270814|Cetuximab|cetuximab|mesh-list
83598610|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598611|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598612|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598613|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598614|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598615|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598616|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83598617|NCT02549898|Cilostazol|cilostazol|mesh-list
83598618|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83598619|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83598620|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
83598621|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598622|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598623|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83598624|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83598625|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83598626|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83598627|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598628|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83598629|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
83598630|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83598631|NCT02549898|Protective Agents|protective agents|mesh-ancestor
83598632|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83598633|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83598634|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598635|NCT02549898|Hematinics|hematinics|mesh-ancestor
83598636|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83598637|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83598638|NCT02538198|Lenalidomide|lenalidomide|mesh-list
83598639|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
83598640|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598641|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83598642|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83598643|NCT02538198|Growth Substances|growth substances|mesh-ancestor
83598644|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
83598645|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598647|NCT05585580|Lenvatinib|lenvatinib|mesh-list
83598648|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598649|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598650|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598651|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598652|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598653|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598654|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83598655|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598656|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
83598657|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83598658|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83598659|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598660|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
83598661|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83598662|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
83598663|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83598664|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83598665|NCT02283996|Prednisolone|prednisolone|mesh-list
83598666|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
83598667|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83598668|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
83598669|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83598670|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
83598671|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
83598672|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598673|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598674|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83598675|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
83598676|NCT02283996|Hormones|hormones|mesh-ancestor
83598677|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598678|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83598679|NCT02283996|Protective Agents|protective agents|mesh-ancestor
83598680|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83598681|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598682|NCT02369484|Afatinib|afatinib|mesh-list
83598683|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598684|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83598685|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598686|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598687|NCT04390152|Ritonavir|ritonavir|mesh-list
83598688|NCT04390152|Lopinavir|lopinavir|mesh-list
83598689|NCT04390152|Azithromycin|azithromycin|mesh-list
83598690|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
83598691|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83598692|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83598693|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
83598694|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598695|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598696|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83598697|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83598698|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
83598699|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598700|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83598701|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83598702|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83598703|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
83598704|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83598705|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83598706|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598707|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83598709|NCT02227992|Coagulants|coagulants|mesh-ancestor
83598710|NCT02496780|Insulin|insulin|mesh-list
83598711|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83598712|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
83598713|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
83598714|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83598715|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598716|NCT01953588|Fulvestrant|fulvestrant|mesh-list
83598717|NCT01953588|Anastrozole|anastrozole|mesh-list
83598718|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83598719|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598720|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83598721|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83598722|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598723|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598724|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598725|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83598726|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83598727|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598728|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598729|NCT01953510|Vaccines|vaccines|mesh-list
83598730|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83598731|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
83598732|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598733|NCT01943994|Psilocybin|psilocybin|mesh-list
83598734|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83598735|NCT01943994|Nicotine|nicotine|mesh-list
83598736|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83598737|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
83598738|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598739|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598740|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83598741|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83598742|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
83598743|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598744|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598745|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
83598746|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83598747|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83598748|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
83598749|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83598750|NCT02456532|Zolpidem|zolpidem|mesh-list
83598751|NCT02456532|Eszopiclone|eszopiclone|mesh-list
83598752|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83598753|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83598754|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598755|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598756|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83598757|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
83598758|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
83598759|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598760|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598761|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
83598762|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83598763|NCT02153580|Fludarabine|fludarabine|mesh-list
83598764|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
83598765|NCT02153580|Etoposide|etoposide|mesh-list
83598766|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
83598767|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
83598768|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598769|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
83598770|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598771|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598772|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83598773|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
83598774|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598775|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598776|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83598777|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598778|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
83598779|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598780|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83598781|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83598782|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598783|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
83598784|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
83598785|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598786|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598787|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598788|NCT05578950|Itraconazole|itraconazole|mesh-list
83598789|NCT05578950|Terbinafine|terbinafine|mesh-list
83598790|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
83598791|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598792|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83598793|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83598794|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598795|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598796|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83598797|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598798|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598799|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598800|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83598801|NCT05586126|Sevoflurane|sevoflurane|mesh-list
83598802|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83598803|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83598804|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
83598805|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
83598806|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598807|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598808|NCT01893996|Adalimumab|adalimumab|mesh-list
83598809|NCT01893996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83598810|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83598811|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598812|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
83598813|NCT02442180|Prednisolone|prednisolone|mesh-list
83598814|NCT02442180|Lenograstim|lenograstim|mesh-list
83598815|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83598816|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
83598817|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598818|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83598819|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
83598820|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
83598821|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598822|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83598823|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
83598824|NCT02442180|Hormones|hormones|mesh-ancestor
83598825|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598826|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83598827|NCT02442180|Protective Agents|protective agents|mesh-ancestor
83598828|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83598829|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598830|NCT01924260|Gemcitabine|gemcitabine|mesh-list
83598831|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83598832|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
83598833|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598834|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598835|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
83598836|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83598837|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
83598838|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598839|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
83598840|NCT02432742|Protective Agents|protective agents|mesh-ancestor
83598841|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
83598842|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83598843|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83598844|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598845|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
83598846|NCT02086500|Coagulants|coagulants|mesh-ancestor
83598847|NCT02104986|Cisplatin|cisplatin|mesh-list
83598848|NCT02104986|Ifosfamide|ifosfamide|mesh-list
83598849|NCT02104986|Bleomycin|bleomycin|mesh-list
83598850|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598851|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83598852|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
83598853|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598854|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83598855|NCT02425566|Trimethaphan|trimethaphan|mesh-list
83598856|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
83598857|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
83598858|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
83598859|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83598860|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83598861|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83598862|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
83598863|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598864|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598865|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83598866|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83598867|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
83598868|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598869|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598870|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
83598871|NCT04757532|Anastrozole|anastrozole|mesh-list
83598872|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
83598873|NCT04757532|Bupropion|bupropion|mesh-list
83598874|NCT04757532|Testosterone|testosterone|mesh-list
83598875|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
83598876|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
83598877|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83598878|NCT04757532|Danazol|danazol|mesh-list
83598879|NCT04757532|Androgens|androgens|mesh-ancestor
83598880|NCT04757532|Hormones|hormones|mesh-ancestor
83598881|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598882|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598883|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83598884|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598885|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
83598886|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83598887|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
83598888|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83598889|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83598890|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83598891|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83598892|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598893|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
83598894|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598895|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83598896|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83598897|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598898|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83598899|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83598900|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83598901|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598902|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83598903|NCT04757532|Diuretics|diuretics|mesh-ancestor
83598904|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
83598905|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83598906|NCT02069730|Androgens|androgens|mesh-list
83598907|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
83598908|NCT02069730|Hormones|hormones|mesh-ancestor
83598909|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598910|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598911|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
83598912|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83598913|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598914|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
83598915|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598916|NCT02068092|Protective Agents|protective agents|mesh-ancestor
83598917|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598918|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83598919|NCT02063022|Dactinomycin|dactinomycin|mesh-list
83598920|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
83598921|NCT02063022|Melphalan|melphalan|mesh-list
83598922|NCT02063022|Busulfan|busulfan|mesh-list
83598923|NCT02063022|Ifosfamide|ifosfamide|mesh-list
83598924|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
83598925|NCT02063022|Doxorubicin|doxorubicin|mesh-list
83056963|NCT03567369|Hormones|hormones|mesh-ancestor
83598926|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83598927|NCT02063022|Etoposide|etoposide|mesh-list
83598928|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
83598929|NCT02063022|Vincristine|vincristine|mesh-list
83598930|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83598931|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
83598932|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598933|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598934|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83598935|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
83598936|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598937|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83598938|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83598939|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83598940|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83598941|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83598942|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83598943|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83598944|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83598945|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83598946|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83598947|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83598948|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83598949|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83598950|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83598951|NCT01895010|Tropisetron|tropisetron|mesh-list
83598952|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
83598953|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
83598954|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598955|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598956|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83598957|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83598958|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83598959|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
83598960|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598961|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598962|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83598963|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83598964|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
83598965|NCT02030028|Hormones|hormones|mesh-ancestor
83598966|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83598967|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598968|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598969|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598970|NCT01896336|Zolpidem|zolpidem|mesh-list
83598971|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83598972|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83598973|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83598974|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598975|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83598976|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
83598977|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
83598978|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598979|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598980|NCT00575718|Nicotine|nicotine|mesh-list
83598981|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83598982|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
83598983|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598984|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598985|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83598986|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83598987|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
83598988|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83598989|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83598990|NCT02087748|Diclofenac|diclofenac|mesh-list
83598991|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83598992|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83598993|NCT02087748|Analgesics|analgesics|mesh-ancestor
83598994|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
83598995|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83598996|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83598997|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057039|NCT04432714|Hormones|hormones|mesh-ancestor
83598998|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83598999|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83599000|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599001|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599002|NCT01490502|Vitamin D|vitamin d|mesh-list
83599003|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
83599004|NCT01490502|Vitamins|vitamins|mesh-ancestor
83599005|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
83599006|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599007|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83599008|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83599009|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
83599010|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83599011|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
83599012|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599013|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
83599014|NCT01428024|Protective Agents|protective agents|mesh-ancestor
83599015|NCT01419834|Antibodies|antibodies|mesh-list
83599016|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83599017|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
83599018|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599019|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
83599020|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83599021|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
83599022|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599023|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
83599024|NCT01412190|Protective Agents|protective agents|mesh-ancestor
83599025|NCT01331148|Vitamin D|vitamin d|mesh-list
83599026|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
83599027|NCT01331148|Vitamins|vitamins|mesh-ancestor
83599028|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
83599029|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599030|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83599031|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83599032|NCT00273624|Olanzapine|olanzapine|mesh-list
83599033|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
83599034|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
83599035|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599036|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599037|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599038|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83599039|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83599040|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599041|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599042|NCT00273624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83599043|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83599044|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83599045|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599046|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599047|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
83599048|NCT00262470|Indomethacin|indomethacin|mesh-list
83599049|NCT00262470|Octreotide|octreotide|mesh-list
83599050|NCT00262470|Propranolol|propranolol|mesh-list
83599051|NCT00262470|Clonidine|clonidine|mesh-list
83599052|NCT00262470|Mecamylamine|mecamylamine|mesh-list
83599053|NCT00262470|Acetazolamide|acetazolamide|mesh-list
83599054|NCT00262470|Isosorbide|isosorbide|mesh-list
83599055|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83599056|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83599057|NCT00262470|Midodrine|midodrine|mesh-list
83599058|NCT00262470|Memantine|memantine|mesh-list
83599059|NCT00262470|Entacapone|entacapone|mesh-list
83599060|NCT00262470|Melatonin|melatonin|mesh-list
83599061|NCT00262470|Modafinil|modafinil|mesh-list
83599062|NCT00262470|Sertraline|sertraline|mesh-list
83599063|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83599064|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
83599065|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599066|NCT00262470|Protective Agents|protective agents|mesh-ancestor
83599067|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599068|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599069|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83599070|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83599071|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
83599072|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599073|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83599074|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83599075|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
83599076|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
83599077|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599078|NCT00262470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83599079|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83599080|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83599081|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
83599082|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83599083|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83599084|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
83599085|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83599086|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83599087|NCT00262470|Analgesics|analgesics|mesh-ancestor
83599088|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
83599089|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599090|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
83599091|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
83599092|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83599093|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83599094|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83599095|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599096|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599097|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599098|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83599099|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83599100|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83599101|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83599102|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83599103|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83599104|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83599105|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599106|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599107|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
83599108|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
83599109|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83599110|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83599111|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599112|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
83599113|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83599114|NCT00262470|Diuretics|diuretics|mesh-ancestor
83599115|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
83599116|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
83599117|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83599118|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83599119|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83599120|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83599121|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83599122|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83599123|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83599124|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83599125|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
83599127|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83599128|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
83599129|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599130|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599131|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83599132|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
83599133|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
83599134|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83599135|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83599136|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83599137|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83599138|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83599139|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599140|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599141|NCT01253070|Cytarabine|cytarabine|mesh-list
83599142|NCT01253070|Sorafenib|sorafenib|mesh-list
83599143|NCT01253070|Daunorubicin|daunorubicin|mesh-list
83599144|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599145|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
83599146|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599147|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599148|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
83599149|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599150|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599151|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
83599152|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599153|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599154|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599155|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83599156|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83599157|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83599159|NCT01212822|Bevacizumab|bevacizumab|mesh-list
83599160|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83599161|NCT01212822|Fluorouracil|fluorouracil|mesh-list
83599162|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
83599163|NCT01212822|Antibodies|antibodies|mesh-list
83599164|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
83599165|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83599166|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
83599167|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599168|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599169|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599170|NCT01212822|Growth Substances|growth substances|mesh-ancestor
83599171|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599172|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599173|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
83599174|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
83599175|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599176|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599177|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599178|NCT01212822|Antidotes|antidotes|mesh-ancestor
83599179|NCT01212822|Protective Agents|protective agents|mesh-ancestor
83599180|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
83599181|NCT01212822|Vitamins|vitamins|mesh-ancestor
83599182|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
83599183|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
83599184|NCT00163566|Androgens|androgens|mesh-ancestor
83599185|NCT00163566|Hormones|hormones|mesh-ancestor
83599186|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599187|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599188|NCT04705662|Lactulose|lactulose|mesh-list
83599189|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599190|NCT04782960|Bupivacaine|bupivacaine|mesh-list
83599191|NCT04782960|Anesthetics|anesthetics|mesh-list
83599192|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
83599193|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599194|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599195|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
83599196|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599197|NCT04634604|Bevacizumab|bevacizumab|mesh-list
83599198|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83599199|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599200|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599201|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599202|NCT04634604|Growth Substances|growth substances|mesh-ancestor
83599203|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599204|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599205|NCT01026012|Regadenoson|regadenoson|mesh-list
83599206|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83599207|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83599208|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
83599209|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
83599210|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599211|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599212|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599213|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
83599214|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83599215|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
83599216|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599217|NCT02088216|Expectorants|expectorants|mesh-ancestor
83599218|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
83599219|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83599220|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
83599221|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599222|NCT02088216|Protective Agents|protective agents|mesh-ancestor
83599223|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599224|NCT02088216|Antidotes|antidotes|mesh-ancestor
83599225|NCT01014936|Tepotinib|tepotinib|mesh-list
83599226|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599227|NCT01896180|Latanoprost|latanoprost|mesh-list
83599228|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83599229|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83599230|NCT00981162|Everolimus|everolimus|mesh-list
83599231|NCT00981162|Sorafenib|sorafenib|mesh-list
83599232|NCT00981162|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83599233|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599234|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599235|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599236|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599237|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
83599238|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599239|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599240|NCT00877500|Epothilones|epothilones|mesh-list
83599241|NCT00877500|Epothilone B|epothilone b|mesh-list
83599242|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
83599243|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
83599244|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
83599245|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599246|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599247|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
83599248|NCT00875004|Hematinics|hematinics|mesh-ancestor
83599249|NCT00869232|Thalidomide|thalidomide|mesh-list
83599250|NCT00869232|Dexamethasone|dexamethasone|mesh-list
83599251|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
83599252|NCT00869232|Melphalan|melphalan|mesh-list
83599253|NCT00869232|Doxorubicin|doxorubicin|mesh-list
83599254|NCT00869232|Etoposide|etoposide|mesh-list
83599255|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83599256|NCT00869232|Bortezomib|bortezomib|mesh-list
83599257|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599258|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
83599259|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599260|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599261|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83599262|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
83599263|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599264|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599265|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83599266|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599267|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
83599268|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
83599269|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599270|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599271|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
83599272|NCT00869232|Hormones|hormones|mesh-ancestor
83599273|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599274|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599275|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83599276|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83599277|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83599278|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599279|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83599280|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
83599281|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83599282|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599283|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599284|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599285|NCT00869232|Growth Substances|growth substances|mesh-ancestor
83599286|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599287|NCT05320692|Apatinib|apatinib|mesh-list
83599288|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
83599289|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599290|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599291|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599292|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599293|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83599294|NCT05320692|Estrogens|estrogens|mesh-ancestor
83599295|NCT05320692|Hormones|hormones|mesh-ancestor
83599296|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599297|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599298|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599299|NCT01763580|Prednisolone|prednisolone|mesh-list
83599300|NCT01763580|Tacrolimus|tacrolimus|mesh-list
83599301|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599302|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
83599303|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599304|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83599305|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599306|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599308|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
83599309|NCT01763580|Hormones|hormones|mesh-ancestor
83599310|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599311|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599312|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599313|NCT03969420|Cytarabine|cytarabine|mesh-list
83599314|NCT03969420|Alvocidib|alvocidib|mesh-list
83599315|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599316|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
83599317|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599318|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599319|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
83599320|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599321|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599322|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
83599323|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599324|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599325|NCT03969420|Growth Substances|growth substances|mesh-ancestor
83599326|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599327|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599328|NCT01740492|Ketamine|ketamine|mesh-list
83599329|NCT01740492|Analgesics|analgesics|mesh-ancestor
83599330|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
83599331|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599332|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599333|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83599334|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83599335|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
83599336|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
83599337|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599338|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83599339|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83599340|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599341|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599342|NCT04780854|Metformin|metformin|mesh-list
83599343|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83599344|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599345|NCT04780152|Fluoxetine|fluoxetine|mesh-list
83599346|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
83599347|NCT04780152|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83599348|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83599349|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83599350|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599351|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599352|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
83599353|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599354|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83599355|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599356|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83599357|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83599358|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599359|NCT00644280|Ranibizumab|ranibizumab|mesh-list
83599360|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599361|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599362|NCT00644280|Growth Substances|growth substances|mesh-ancestor
83599363|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599364|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599365|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599366|NCT04779762|Ustekinumab|ustekinumab|mesh-list
83599367|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
83599368|NCT04777968|Fluorides|fluorides|mesh-list
83599369|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
83599370|NCT04777968|Protective Agents|protective agents|mesh-ancestor
83599371|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599372|NCT01722708|Metronidazole|metronidazole|mesh-list
83599373|NCT01722708|Clindamycin|clindamycin|mesh-list
83599374|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
83599375|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
83599376|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599377|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83599378|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83599379|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83599380|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83599381|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599382|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599383|NCT01711632|Vemurafenib|vemurafenib|mesh-list
83599384|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599385|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599386|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599387|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599388|NCT04756206|Dutasteride|dutasteride|mesh-list
83599389|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83599390|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83599391|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599392|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599393|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
83599394|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599395|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599396|NCT04779060|Dexamethasone|dexamethasone|mesh-list
83599397|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599398|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
83599399|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
83599400|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599401|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599402|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599403|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
83599404|NCT04779060|Hormones|hormones|mesh-ancestor
83599405|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599406|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599407|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599408|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
83599409|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
83599410|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83599411|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83599412|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599413|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83599414|NCT04777110|Esketamine|esketamine|mesh-list
83599415|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
83599416|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599417|NCT01895400|Cilostazol|cilostazol|mesh-list
83599418|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83599419|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
83599420|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599421|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599422|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83599423|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
83599424|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83599425|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83599426|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599427|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83599428|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
83599429|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83599430|NCT01895400|Protective Agents|protective agents|mesh-ancestor
83599431|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83599432|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83599433|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599434|NCT05171946|Vaccines|vaccines|mesh-list
83599435|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
83599436|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599437|NCT05605314|Cyclosporine|cyclosporine|mesh-list
83599438|NCT05605314|Cyclosporins|cyclosporins|mesh-list
83599439|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599440|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599441|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599442|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
83599443|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599444|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
83599445|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599446|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
83599447|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599448|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83599449|NCT05605158|Pioglitazone|pioglitazone|mesh-list
83599450|NCT05605158|Empagliflozin|empagliflozin|mesh-list
83599451|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83599452|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599453|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83599454|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599455|NCT04775238|Copper|copper|mesh-list
83599456|NCT04775238|Trace Elements|trace elements|mesh-ancestor
83599457|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
83599458|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599459|NCT05580042|Tofacitinib|tofacitinib|mesh-list
83599460|NCT05580042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83599461|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599462|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599463|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599464|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
83599465|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
83599466|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599467|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
83599468|NCT03012984|Morphine|morphine|mesh-list
83599469|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83599470|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599471|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599472|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83599473|NCT03012984|Analgesics|analgesics|mesh-ancestor
83599474|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
83599475|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599476|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83599477|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83599478|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83599479|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
83599480|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599481|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599482|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83599483|NCT03012984|Narcotics|narcotics|mesh-ancestor
83599484|NCT02744430|Mirabegron|mirabegron|mesh-list
83599485|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83599486|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83599487|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83599488|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
83599489|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599490|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599491|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599492|NCT02744430|Urological Agents|urological agents|mesh-ancestor
83599493|NCT00054756|Hormones|hormones|mesh-list
83599494|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
83599495|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599496|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599497|NCT01896960|Fentanyl|fentanyl|mesh-list
83599498|NCT01896960|Bupivacaine|bupivacaine|mesh-list
83599499|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
83599500|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
83599501|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599502|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599503|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
83599504|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599505|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83599506|NCT01896960|Narcotics|narcotics|mesh-ancestor
83599507|NCT01896960|Analgesics|analgesics|mesh-ancestor
83599508|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83599509|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83599510|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
83599511|NCT00055692|Bevacizumab|bevacizumab|mesh-list
83599512|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83599513|NCT00055692|Antibodies|antibodies|mesh-list
83599514|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
83599515|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83599516|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599517|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599518|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599519|NCT00055692|Growth Substances|growth substances|mesh-ancestor
83599520|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599521|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599522|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
83599523|NCT04772352|Febuxostat|febuxostat|mesh-list
83599524|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
83599525|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599526|NCT00056472|Olanzapine|olanzapine|mesh-list
83599527|NCT00056472|Sertraline|sertraline|mesh-list
83599528|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
83599529|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
83599530|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599531|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599532|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599533|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83599534|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83599535|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599536|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599537|NCT00056472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83599538|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83599539|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83599540|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599541|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599542|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
83599543|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
83599544|NCT00056550|Antithrombins|antithrombins|mesh-list
83599545|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
83599546|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83599547|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
83599548|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599549|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599550|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
83599551|NCT04771884|Vancomycin|vancomycin|mesh-list
83599552|NCT04771884|Meropenem|meropenem|mesh-list
83599553|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
83599554|NCT04771884|Linezolid|linezolid|mesh-list
83599555|NCT04771884|Ceftazidime|ceftazidime|mesh-list
83599556|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
83599557|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83599558|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599559|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83599560|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599561|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599562|NCT02538744|Doxazosin|doxazosin|mesh-list
83599563|NCT02538744|Cocaine|cocaine|mesh-list
83599564|NCT02538744|Modafinil|modafinil|mesh-list
83599565|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83599566|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599567|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83599568|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83599569|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83599570|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599571|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
83599572|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
83599573|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599574|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
83599575|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599576|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83599577|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83599578|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83599579|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83599580|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
83599581|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599582|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83599583|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83599584|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83599585|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83599586|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
83599587|NCT00060528|Metronidazole|metronidazole|mesh-list
83599588|NCT00060528|Molgramostim|molgramostim|mesh-list
83599589|NCT00060528|Sargramostim|sargramostim|mesh-list
83599590|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
83599591|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599592|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599593|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599594|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83599595|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83599596|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83599597|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
83599598|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83599599|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83599600|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599601|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
83599602|NCT04696224|Coagulants|coagulants|mesh-ancestor
83599603|NCT04753008|Dopamine|dopamine|mesh-list
83599604|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83599605|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
83599606|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
83599607|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599608|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599610|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599611|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599612|NCT04753008|Protective Agents|protective agents|mesh-ancestor
83599613|NCT04771026|Dexamethasone|dexamethasone|mesh-list
83599614|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599615|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
83599616|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
83599617|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599618|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599619|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599620|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
83599621|NCT04771026|Hormones|hormones|mesh-ancestor
83599622|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599623|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599624|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599625|NCT00063570|Gemcitabine|gemcitabine|mesh-list
83599626|NCT00063570|Pemetrexed|pemetrexed|mesh-list
83599627|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599628|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
83599629|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599630|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599631|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599632|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83599633|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83599634|NCT01897038|Sorafenib|sorafenib|mesh-list
83599635|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599636|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599637|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599638|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599639|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
83599640|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83599641|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83599642|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599643|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
83599644|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83599645|NCT00064038|Dexamethasone|dexamethasone|mesh-list
83599646|NCT00064038|Lenalidomide|lenalidomide|mesh-list
83599647|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599648|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
83599649|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
83599650|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599651|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599652|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599653|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
83599654|NCT00064038|Hormones|hormones|mesh-ancestor
83599655|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599656|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599657|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599658|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
83599659|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599660|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599661|NCT00064038|Growth Substances|growth substances|mesh-ancestor
83599662|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599663|NCT01960530|Dexamethasone|dexamethasone|mesh-list
83599664|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
83599665|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83599666|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83599667|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83599668|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599669|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
83599670|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
83599671|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599672|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599673|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599674|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
83599675|NCT01960530|Hormones|hormones|mesh-ancestor
83599676|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599677|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599678|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599679|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
83599680|NCT01897428|Salicylates|salicylates|mesh-list
83599681|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83599682|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83599683|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83599684|NCT01897428|Analgesics|analgesics|mesh-ancestor
83599685|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
83599686|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599687|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599688|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599689|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599690|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83599691|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599692|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599693|NCT00024102|Doxorubicin|doxorubicin|mesh-list
83599694|NCT00024102|Capecitabine|capecitabine|mesh-list
83599695|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83599696|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599697|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83599698|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83599699|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599700|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599701|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599702|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
83599703|NCT00074802|Paroxetine|paroxetine|mesh-list
83599704|NCT00074802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83599705|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83599706|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83599707|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599708|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599709|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
83599710|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599711|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83599712|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
83599713|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599714|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83599715|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83599716|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599717|NCT02505750|Capecitabine|capecitabine|mesh-list
83599718|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599719|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
83599720|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599721|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599722|NCT00030264|Methotrexate|methotrexate|mesh-list
83599723|NCT00030264|Vinblastine|vinblastine|mesh-list
83599724|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83599725|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
83599726|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83599727|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599728|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599729|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
83599730|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599731|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599732|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
83599733|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599734|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83599735|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599736|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
83599737|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599738|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83599739|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83599740|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
83599741|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
83599742|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
83599743|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
83599744|NCT01897116|Vemurafenib|vemurafenib|mesh-list
83599745|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
83599746|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83599747|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83599748|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599749|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599750|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599751|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599752|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599753|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599754|NCT00036738|Cyclosporine|cyclosporine|mesh-list
83599755|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
83599756|NCT00036738|Fludarabine|fludarabine|mesh-list
83599757|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
83599758|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
83599759|NCT00036738|Dasatinib|dasatinib|mesh-list
83599760|NCT00036738|Cyclosporins|cyclosporins|mesh-list
83599761|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599762|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599763|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
83599764|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599765|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599766|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
83599767|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599768|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599769|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
83599770|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599771|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
83599772|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599773|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83599774|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83599775|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83599776|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
83599777|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83599778|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599779|NCT00038610|Cytarabine|cytarabine|mesh-list
83599780|NCT00038610|Dexamethasone|dexamethasone|mesh-list
83599781|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
83599782|NCT00038610|Doxorubicin|doxorubicin|mesh-list
83599783|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83599784|NCT00038610|Methotrexate|methotrexate|mesh-list
83599785|NCT00038610|Vincristine|vincristine|mesh-list
83599786|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
83599787|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599788|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
83599789|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599790|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599791|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83599792|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
83599793|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599794|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599795|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83599796|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599797|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
83599798|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
83599799|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599800|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599801|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
83599802|NCT00038610|Hormones|hormones|mesh-ancestor
83599803|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599804|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599805|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83599806|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83599807|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83599808|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599809|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83599810|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
83599811|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83599812|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83599813|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
83599814|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83599815|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83599816|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83599817|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
83599818|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599819|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83599820|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83599821|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83599822|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83599823|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83599824|NCT00156936|Naltrexone|naltrexone|mesh-list
83057851|NCT02197650|Asparaginase|asparaginase|mesh-list
83599825|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83599826|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83599827|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599828|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
83599829|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599830|NCT00046566|Caseins|caseins|mesh-list
83599831|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
83599832|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
83599833|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599834|NCT00079326|Trastuzumab|trastuzumab|mesh-list
83599835|NCT00079326|Epothilone B|epothilone b|mesh-list
83599836|NCT00079326|Epothilones|epothilones|mesh-list
83599837|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83599838|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599839|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83599840|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83599841|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83599842|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599843|NCT02187354|Blinatumomab|blinatumomab|mesh-list
83599844|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599845|NCT01898052|Anesthetics|anesthetics|mesh-list
83599846|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
83599847|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599848|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599849|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
83599850|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
83599851|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599852|NCT00051168|Travoprost|travoprost|mesh-list
83599853|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83599854|NCT00083382|Pamidronate|pamidronate|mesh-list
83599855|NCT00083382|Thalidomide|thalidomide|mesh-list
83599856|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599857|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
83599858|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599859|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
83599860|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83599861|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599862|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599863|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599864|NCT00083382|Growth Substances|growth substances|mesh-ancestor
83599865|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599866|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599867|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83599868|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
83599869|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599870|NCT00167934|Valproic Acid|valproic acid|mesh-list
83599871|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
83599872|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599873|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599874|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
83599875|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599876|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599877|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
83599878|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83599879|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599880|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599881|NCT00168324|Dexamethasone|dexamethasone|mesh-list
83599882|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
83599883|NCT00168324|BB 1101|bb 1101|mesh-list
83599884|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599885|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
83599886|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
83599887|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599888|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599889|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83599890|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
83599891|NCT00168324|Hormones|hormones|mesh-ancestor
83599892|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83599893|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83599894|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599895|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
83599896|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599897|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599898|NCT02091882|Aripiprazole|aripiprazole|mesh-list
83599899|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
83599900|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599901|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83599902|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83599903|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599904|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599905|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
83599906|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
83599907|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599908|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599909|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83599910|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83599911|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
83599912|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83599913|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83599914|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83599915|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83599916|NCT00085254|Temozolomide|temozolomide|mesh-list
83599917|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83599918|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
83599919|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599920|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599921|NCT00253890|Trazodone|trazodone|mesh-list
83599922|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83599923|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83599924|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83599925|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599926|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83599927|NCT00253890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83599928|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83599929|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83599930|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599931|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83599932|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
83599933|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83599934|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
83599935|NCT00254592|Paclitaxel|paclitaxel|mesh-list
83599936|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83599937|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
83599938|NCT00254592|Bevacizumab|bevacizumab|mesh-list
83599939|NCT00254592|Carboplatin|carboplatin|mesh-list
83599940|NCT00254592|Doxorubicin|doxorubicin|mesh-list
83599941|NCT00254592|Trastuzumab|trastuzumab|mesh-list
83599942|NCT00254592|Sargramostim|sargramostim|mesh-list
83599943|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83599944|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599945|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
83599946|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
83599947|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
83599948|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599949|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599950|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
83599951|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599952|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599953|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83599954|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
83599955|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83599956|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83599957|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83599958|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83599959|NCT00254592|Growth Substances|growth substances|mesh-ancestor
83599960|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
83599961|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83599962|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83599963|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83599964|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599965|NCT00255684|Cyclosporine|cyclosporine|mesh-list
83599966|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
83599967|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
83599968|NCT00255684|Fludarabine|fludarabine|mesh-list
83599969|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
83599970|NCT00255684|Cyclosporins|cyclosporins|mesh-list
83599971|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83599972|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
83599973|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599974|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83599975|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83599976|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
83599977|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83599978|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83599979|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83599980|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83057999|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
83599981|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
83599982|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83599983|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
83599984|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83599985|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
83599986|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83599987|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83599988|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83599989|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
83599990|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83599991|NCT00256776|Thalidomide|thalidomide|mesh-list
83599992|NCT00256776|Dexamethasone|dexamethasone|mesh-list
83599993|NCT00256776|Bortezomib|bortezomib|mesh-list
83599994|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83599995|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
83599996|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
83599997|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83599998|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83599999|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600000|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
83600001|NCT00256776|Hormones|hormones|mesh-ancestor
83600002|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600003|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600004|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600005|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600006|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
83600007|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
83600008|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83600009|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600010|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600011|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600012|NCT00256776|Growth Substances|growth substances|mesh-ancestor
83600013|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600014|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
83600015|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600016|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
83600017|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600018|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600019|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83600020|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
83600021|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600022|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600023|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83600024|NCT00176202|Valproic Acid|valproic acid|mesh-list
83600025|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
83600026|NCT00176202|Risperidone|risperidone|mesh-list
83600027|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
83600028|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83600029|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
83600030|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600031|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600032|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600033|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83600034|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600035|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600036|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83600037|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
83600038|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600039|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
83600040|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
83600041|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
83600042|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
83600043|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
83600044|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83600045|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
83600046|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600047|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600048|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600049|NCT00176826|Busulfan|busulfan|mesh-list
83600050|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
83600051|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600052|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600053|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
83600054|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058079|NCT02206308|Antibodies|antibodies|mesh-list
83600055|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83600056|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600057|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83600058|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
83600059|NCT00176904|Busulfan|busulfan|mesh-list
83600060|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83600061|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600062|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
83600063|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600064|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600065|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83600066|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
83600067|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600068|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600069|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83600070|NCT00179478|Interferons|interferons|mesh-list
83600071|NCT00179478|Interferon-beta|interferon-beta|mesh-list
83600072|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
83600073|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600074|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
83600075|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600076|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
83600077|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600078|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83600079|NCT00182754|Octreotide|octreotide|mesh-list
83600080|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600081|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600082|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600083|NCT00085410|Bortezomib|bortezomib|mesh-list
83600084|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600085|NCT00186498|Memantine|memantine|mesh-list
83600086|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83600087|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83600088|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
83600089|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600090|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600091|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600092|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83600093|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83600094|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
83600095|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83600096|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600097|NCT00087672|Lenalidomide|lenalidomide|mesh-list
83600098|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
83600099|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600100|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600101|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600102|NCT00087672|Growth Substances|growth substances|mesh-ancestor
83600103|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600104|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600105|NCT00088218|Cytarabine|cytarabine|mesh-list
83600106|NCT00088218|Clofarabine|clofarabine|mesh-list
83600107|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600108|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
83600109|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600110|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600111|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
83600112|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600113|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600114|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
83600115|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600116|NCT00189228|Omalizumab|omalizumab|mesh-list
83600117|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83600118|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83600119|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
83600120|NCT00091260|Dexamethasone|dexamethasone|mesh-list
83600121|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
83600122|NCT00091260|Lenalidomide|lenalidomide|mesh-list
83600123|NCT00091260|BB 1101|bb 1101|mesh-list
83600124|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600125|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
83600126|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
83600127|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600128|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600129|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058141|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
83600130|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
83600131|NCT00091260|Hormones|hormones|mesh-ancestor
83600132|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600133|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600134|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600135|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
83600136|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600137|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600138|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
83600139|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600140|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600141|NCT00091260|Growth Substances|growth substances|mesh-ancestor
83600142|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600143|NCT00193128|Docetaxel|docetaxel|mesh-list
83600144|NCT00193128|Capecitabine|capecitabine|mesh-list
83600145|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
83600146|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600147|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
83600148|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
83600149|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
83600150|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600151|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600152|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
83600153|NCT00193596|Paclitaxel|paclitaxel|mesh-list
83600154|NCT00193596|Etoposide|etoposide|mesh-list
83600155|NCT00193596|Carboplatin|carboplatin|mesh-list
83600156|NCT00193596|Gemcitabine|gemcitabine|mesh-list
83600157|NCT00193596|Irinotecan|irinotecan|mesh-list
83600158|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83600159|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600160|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
83600161|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
83600162|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83600163|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600164|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600165|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
83600166|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83600167|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83600168|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600169|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83600170|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
83600171|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
83600172|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
83600173|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83600174|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600175|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83600176|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83600177|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600178|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600179|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600180|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83600181|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83600182|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
83600183|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83600184|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83600185|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83600186|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600187|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
83600188|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600189|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600190|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83600191|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600192|NCT00093756|Paclitaxel|paclitaxel|mesh-list
83600193|NCT00093756|Carboplatin|carboplatin|mesh-list
83600194|NCT00093756|Bortezomib|bortezomib|mesh-list
83600195|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83600196|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600197|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
83600198|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
83600199|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
83600200|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600201|NCT04118556|Sirolimus|sirolimus|mesh-list
83600202|NCT04118556|Infliximab|infliximab|mesh-list
83600203|NCT04118556|Etanercept|etanercept|mesh-list
83600204|NCT04118556|Everolimus|everolimus|mesh-list
83600205|NCT04118556|Vedolizumab|vedolizumab|mesh-list
83600206|NCT04118556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83600207|NCT04118556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600208|NCT04118556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124605|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83600209|NCT04118556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600210|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600211|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
83600212|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600213|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600214|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83600215|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600216|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83600217|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
83600218|NCT04118556|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83600219|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600220|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
83600221|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600222|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600223|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83600224|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83600225|NCT04118556|Analgesics|analgesics|mesh-ancestor
83600226|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
83600227|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600228|NCT00267696|Bevacizumab|bevacizumab|mesh-list
83600229|NCT00267696|Carboplatin|carboplatin|mesh-list
83600230|NCT00267696|Gemcitabine|gemcitabine|mesh-list
83600231|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600232|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600233|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600234|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600235|NCT00267696|Growth Substances|growth substances|mesh-ancestor
83600236|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600237|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600238|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600239|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
83600240|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600241|NCT00195624|Cyclosporine|cyclosporine|mesh-list
83600242|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
83600243|NCT00195624|Cyclosporins|cyclosporins|mesh-list
83600244|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600245|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600246|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600247|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
83600248|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600249|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
83600250|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600251|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
83600252|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600253|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83600254|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600255|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600256|NCT00195702|Adalimumab|adalimumab|mesh-list
83600257|NCT00195702|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83600258|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600259|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600260|NCT00197184|Vaccines|vaccines|mesh-list
83600261|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
83600262|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600263|NCT00098670|Rituximab|rituximab|mesh-list
83600264|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83600265|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
83600266|NCT00098670|Fludarabine|fludarabine|mesh-list
83600267|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
83600268|NCT00098670|Antibodies|antibodies|mesh-list
83600269|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
83600270|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83600271|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
83600272|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600273|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600274|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600275|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600276|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
83600277|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600278|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600279|NCT00201864|Fulvestrant|fulvestrant|mesh-list
83600280|NCT00201864|Exemestane|exemestane|mesh-list
83600281|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600282|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600283|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83058365|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83600284|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83600285|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
83600286|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600287|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600288|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83600289|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83600290|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600291|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600292|NCT00202722|Remifentanil|remifentanil|mesh-list
83600293|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83600294|NCT00202722|Narcotics|narcotics|mesh-ancestor
83600295|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600296|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600297|NCT00202722|Analgesics|analgesics|mesh-ancestor
83600298|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
83600299|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600300|NCT00100698|Hormones|hormones|mesh-list
83600301|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600302|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600303|NCT00103116|Vaccines|vaccines|mesh-list
83600304|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
83600305|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600306|NCT00205374|Cidofovir|cidofovir|mesh-list
83600307|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
83600308|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600309|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600310|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600311|NCT00103194|Lapatinib|lapatinib|mesh-list
83600312|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600313|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600314|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600315|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600316|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
83600317|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83600318|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83600319|NCT00208026|Analgesics|analgesics|mesh-ancestor
83600320|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
83600321|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600322|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600323|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600324|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600325|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83600326|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600327|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
83600328|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83600329|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600330|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600331|NCT00106392|Tacrolimus|tacrolimus|mesh-list
83600332|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600333|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
83600334|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600335|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83600336|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600337|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600338|NCT00211692|Interferons|interferons|mesh-list
83600339|NCT00211692|Ribavirin|ribavirin|mesh-list
83600340|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
83600341|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
83600342|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600343|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
83600344|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600345|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
83600346|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600347|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
83600348|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600349|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83600350|NCT01899690|Clindamycin|clindamycin|mesh-list
83600351|NCT01899690|Cephalexin|cephalexin|mesh-list
83600352|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600353|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83600354|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600355|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600356|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83600357|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83600358|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83600359|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
83600360|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600361|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600362|NCT01899846|Progestins|progestins|mesh-ancestor
83600363|NCT01899846|Hormones|hormones|mesh-ancestor
83600364|NCT00214890|Tenofovir|tenofovir|mesh-list
83600365|NCT00214890|Abacavir|abacavir|mesh-list
83600366|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
83600367|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600368|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83600369|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83600370|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600371|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600372|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83600373|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83600374|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
83600375|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83600376|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83600377|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600378|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83600379|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600380|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83600381|NCT00282282|Sirolimus|sirolimus|mesh-list
83600382|NCT00282282|Fludarabine|fludarabine|mesh-list
83600383|NCT00282282|Busulfan|busulfan|mesh-list
83600384|NCT00282282|Tacrolimus|tacrolimus|mesh-list
83600385|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600386|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600387|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600388|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
83600389|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600390|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83600391|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600392|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83600393|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600394|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83600395|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
83600396|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
83600397|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83600398|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83600399|NCT00282828|Clonazepam|clonazepam|mesh-list
83600400|NCT00282828|Sertraline|sertraline|mesh-list
83600401|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83600402|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
83600403|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600404|NCT00282828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83600405|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83600406|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83600407|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600408|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600409|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
83600410|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600411|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83600412|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83600413|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
83600414|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
83600415|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
83600416|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83600417|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83600418|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
83600419|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600420|NCT00223236|Choline|choline|mesh-list
83600421|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83600422|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
83600423|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83600424|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
83600425|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600426|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600427|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83600428|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
83600429|NCT00223704|Icatibant|icatibant|mesh-list
83600430|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
83600431|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83600432|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83600433|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600434|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
83600435|NCT00223704|Coagulants|coagulants|mesh-ancestor
83600436|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83600437|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83600438|NCT00223704|Analgesics|analgesics|mesh-ancestor
83600439|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
83600440|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600441|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600442|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600443|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600444|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83600445|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83600446|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83600447|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600448|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
83600449|NCT00224952|Carbamazepine|carbamazepine|mesh-list
83600450|NCT00224952|Valproic Acid|valproic acid|mesh-list
83600451|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
83600452|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600453|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600454|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
83600455|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600456|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600457|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
83600458|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83600459|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600460|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600461|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83600462|NCT00224952|Analgesics|analgesics|mesh-ancestor
83600463|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
83600464|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600465|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83600466|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83600467|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83600468|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83600469|NCT00225420|Docetaxel|docetaxel|mesh-list
83600470|NCT00225420|Leuprolide|leuprolide|mesh-list
83600471|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600472|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83600473|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83600474|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83600475|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600476|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83600477|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
83600478|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83600479|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600480|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600481|NCT00225498|Olanzapine|olanzapine|mesh-list
83600482|NCT00225498|Risperidone|risperidone|mesh-list
83600483|NCT00225498|Ziprasidone|ziprasidone|mesh-list
83600484|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83600485|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
83600486|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600487|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600488|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600489|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83600490|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83600491|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600492|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600493|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83600494|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
83600495|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
83600496|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
83600497|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600498|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600499|NCT00225498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83600500|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83600501|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83600502|NCT00225732|Ibuprofen|ibuprofen|mesh-list
83600503|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83600504|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83600505|NCT00225732|Analgesics|analgesics|mesh-ancestor
83600506|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
83600507|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600508|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600509|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600510|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600511|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83600512|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600513|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600514|NCT02096718|Afatinib|afatinib|mesh-list
83600515|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600516|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600517|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600518|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600519|NCT02097732|Ipilimumab|ipilimumab|mesh-list
83600520|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600521|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600522|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83600523|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600524|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
83600525|NCT00286182|Hematinics|hematinics|mesh-ancestor
83600526|NCT00226590|Paclitaxel|paclitaxel|mesh-list
83600527|NCT00226590|Carboplatin|carboplatin|mesh-list
83600528|NCT00226590|Gemcitabine|gemcitabine|mesh-list
83600529|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83600530|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600531|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
83600532|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
83600533|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
83600534|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600535|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600536|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
83600537|NCT00114114|Goserelin|goserelin|mesh-list
83600538|NCT00114114|Testosterone|testosterone|mesh-list
83600539|NCT00114114|Androgens|androgens|mesh-ancestor
83600540|NCT00114114|Hormones|hormones|mesh-ancestor
83600541|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600542|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600543|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600544|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600545|NCT00227760|Cediranib|cediranib|mesh-list
83600546|NCT00227760|Maleic acid|maleic acid|mesh-list
83600547|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600548|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600549|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600550|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600551|NCT00227994|Donepezil|donepezil|mesh-list
83600552|NCT00227994|Galantamine|galantamine|mesh-list
83600553|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83600554|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600555|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600556|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
83600557|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600558|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600559|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
83600560|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83600561|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
83600562|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600563|NCT00114504|Simvastatin|simvastatin|mesh-list
83600564|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83600565|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83600566|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
83600567|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600568|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83600569|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83600570|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600571|NCT01898676|Valproic Acid|valproic acid|mesh-list
83600572|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
83600573|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600574|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600575|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
83600576|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600577|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600578|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
83600579|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83600580|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600581|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600582|NCT00288366|Aripiprazole|aripiprazole|mesh-list
83600583|NCT00288366|Ziprasidone|ziprasidone|mesh-list
83600584|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
83600585|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600586|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83600587|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83600588|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600589|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600590|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
83600591|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
83600592|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600593|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600594|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83600595|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83600596|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
83600597|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83600598|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83600599|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83600600|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83600601|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83600602|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
83600603|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83600604|NCT00288600|Antibodies|antibodies|mesh-list
83600605|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
83600606|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83600607|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
83600608|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600609|NCT00290472|Sirolimus|sirolimus|mesh-list
83600610|NCT00290472|Temsirolimus|temsirolimus|mesh-list
83600611|NCT00290472|MTOR Inhibitors|mtor inhibitors|mesh-list
83600612|NCT00290472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600613|NCT00290472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600614|NCT00290472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600615|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600616|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
83600617|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600618|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600619|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83600620|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600621|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83600622|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
83600623|NCT04752852|Dexamethasone|dexamethasone|mesh-list
83600624|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600625|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
83600626|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
83600627|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600628|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600629|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600630|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
83600631|NCT04752852|Hormones|hormones|mesh-ancestor
83600632|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600633|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600634|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600635|NCT01899144|Albuterol|albuterol|mesh-list
83600636|NCT01899144|Procaterol|procaterol|mesh-list
83600637|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83600638|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
83600639|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600640|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600641|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83600642|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83600643|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
83600644|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83600645|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83600646|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83600647|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83600648|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
83600649|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600650|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600651|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
83600652|NCT00234078|Rebamipide|rebamipide|mesh-list
83600653|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83600654|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600655|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
83600656|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600657|NCT00234078|Protective Agents|protective agents|mesh-ancestor
83600658|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600659|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600661|NCT00118404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83600662|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83600663|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83600664|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600665|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600666|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
83600667|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600668|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83600669|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
83600670|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600671|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83600672|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83600673|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600674|NCT00121836|Bevacizumab|bevacizumab|mesh-list
83600675|NCT00121836|Capecitabine|capecitabine|mesh-list
83600676|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600677|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600678|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600679|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600680|NCT00121836|Growth Substances|growth substances|mesh-ancestor
83600681|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600682|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600683|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600684|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
83600685|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600686|NCT00237666|Ziprasidone|ziprasidone|mesh-list
83600687|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83600688|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
83600689|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600690|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600691|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600692|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83600693|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83600694|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600695|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600696|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83600697|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
83600698|NCT00296322|Mitomycins|mitomycins|mesh-list
83600699|NCT00296322|Mitomycin|mitomycin|mesh-list
83600700|NCT00296322|Doxifluridine|doxifluridine|mesh-list
83600701|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600702|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83600703|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
83600704|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600705|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83600706|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600707|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600708|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
83600709|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600710|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
83600711|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600712|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
83600713|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83600714|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
83600715|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600716|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
83600717|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83600718|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83600719|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600720|NCT00123162|Urological Agents|urological agents|mesh-ancestor
83600721|NCT00123630|Omalizumab|omalizumab|mesh-list
83600722|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83600723|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83600724|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
83600725|NCT00124176|Albuterol|albuterol|mesh-list
83600726|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83600727|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
83600728|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600729|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058746|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058828|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600730|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83600731|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83600732|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
83600733|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83600734|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83600735|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83600736|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83600737|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83600738|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600739|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600740|NCT00240162|Vatalanib|vatalanib|mesh-list
83600741|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600742|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600743|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600744|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
83600745|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83600746|NCT00299988|Antibodies|antibodies|mesh-list
83600747|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
83600748|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83600749|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
83600750|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600751|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
83600752|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
83600753|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
83600754|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83600755|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83600756|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600757|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600758|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600759|NCT00300456|Simvastatin|simvastatin|mesh-list
83600760|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83600761|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83600762|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
83600763|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600764|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83600765|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83600766|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600767|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
83600768|NCT00125034|Cetuximab|cetuximab|mesh-list
83600769|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600770|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600771|NCT02100930|Molgramostim|molgramostim|mesh-list
83600772|NCT02100930|Isotretinoin|isotretinoin|mesh-list
83600773|NCT02100930|Antibodies|antibodies|mesh-list
83600774|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83600775|NCT02100930|Sargramostim|sargramostim|mesh-list
83600776|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
83600777|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600778|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
83600779|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600780|NCT02101008|Disulfiram|disulfiram|mesh-list
83600781|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83600782|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83600783|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600784|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600785|NCT00241176|Aripiprazole|aripiprazole|mesh-list
83600786|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
83600787|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83600788|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83600789|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83600790|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83600791|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600792|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
83600793|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
83600794|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600795|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600796|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83600797|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83600798|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
83600799|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83600800|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83600801|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83600802|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83600803|NCT02102100|Menthol|menthol|mesh-list
83600804|NCT02102100|Nicotine|nicotine|mesh-list
83600805|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83600806|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
83600807|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600808|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600809|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83600810|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83600811|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
83600812|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83600813|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600814|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
83600815|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
83600816|NCT02094534|Insulin|insulin|mesh-list
83600817|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83600818|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600819|NCT00242502|Bevacizumab|bevacizumab|mesh-list
83600820|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83600821|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600822|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600823|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600824|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600825|NCT00242502|Growth Substances|growth substances|mesh-ancestor
83600826|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600827|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600828|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600829|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600830|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600831|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
83600832|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83600833|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600834|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
83600835|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600836|NCT04389060|Protective Agents|protective agents|mesh-ancestor
83600837|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600838|NCT01899066|Carboplatin|carboplatin|mesh-list
83600839|NCT01899066|Etoposide|etoposide|mesh-list
83600840|NCT01899066|Vincristine|vincristine|mesh-list
83600841|NCT01899066|Ranibizumab|ranibizumab|mesh-list
83600842|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600843|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83600844|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83600845|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83600846|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600847|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600848|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83600849|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
83600850|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83600851|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600852|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600853|NCT01899066|Growth Substances|growth substances|mesh-ancestor
83600854|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600855|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600856|NCT00127218|Niacin|niacin|mesh-list
83600857|NCT00127218|Atorvastatin|atorvastatin|mesh-list
83600858|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83600859|NCT00127218|Simvastatin|simvastatin|mesh-list
83600860|NCT00127218|Pravastatin|pravastatin|mesh-list
83600861|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83600862|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83600863|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
83600864|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600865|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83600866|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83600867|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600868|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83600869|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
83600870|NCT00127218|Vitamins|vitamins|mesh-ancestor
83600871|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
83600872|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600873|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
83600874|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83600875|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83600876|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600877|NCT00250926|Dexamethasone|dexamethasone|mesh-list
83600878|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
83600879|NCT00250926|Rituximab|rituximab|mesh-list
83600880|NCT00250926|Bortezomib|bortezomib|mesh-list
83600881|NCT00250926|BB 1101|bb 1101|mesh-list
83600882|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600883|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600884|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
83600885|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600886|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600887|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600888|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
83600889|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
83600890|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600891|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600892|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
83600893|NCT00250926|Hormones|hormones|mesh-ancestor
83600894|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600895|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600896|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
83600897|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600898|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600899|NCT00303966|Sorafenib|sorafenib|mesh-list
83600900|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600901|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600902|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600903|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600904|NCT00304746|Testosterone|testosterone|mesh-list
83600905|NCT00304746|Androgens|androgens|mesh-ancestor
83600906|NCT00304746|Hormones|hormones|mesh-ancestor
83600907|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600908|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600909|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
83600910|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
83600911|NCT00134004|Fludarabine|fludarabine|mesh-list
83600912|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
83600913|NCT00134004|Tacrolimus|tacrolimus|mesh-list
83600914|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600915|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
83600916|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600917|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600918|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83600919|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
83600920|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600921|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600922|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83600923|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600924|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
83600925|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83600926|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600927|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83600928|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83600929|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
83600930|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83600931|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600932|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83600933|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
83600934|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600935|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
83600936|NCT02103114|Antithrombins|antithrombins|mesh-list
83600937|NCT02103114|Thrombin|thrombin|mesh-list
83600938|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
83600939|NCT02103114|Coagulants|coagulants|mesh-ancestor
83600940|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83600941|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
83600942|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600943|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600944|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
83600945|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
83600946|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83600947|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83600948|NCT01790022|Prednisolone|prednisolone|mesh-list
83600949|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
83600950|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83600951|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
83600952|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83600953|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
83600954|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
83600955|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83600956|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600957|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83600958|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
83600959|NCT01790022|Hormones|hormones|mesh-ancestor
83600960|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83600961|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83600962|NCT01790022|Protective Agents|protective agents|mesh-ancestor
83600963|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83600964|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600965|NCT00140556|Bevacizumab|bevacizumab|mesh-list
83600966|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83600967|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600968|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600969|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600970|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600971|NCT00140556|Growth Substances|growth substances|mesh-ancestor
83600972|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600973|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600974|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83600975|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83600976|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600977|NCT00142116|Thalidomide|thalidomide|mesh-list
83600978|NCT00142116|Rituximab|rituximab|mesh-list
83600979|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83600980|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600981|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
83600982|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83600983|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83600984|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83600985|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
83600986|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83600987|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83600988|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83600989|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83600990|NCT00142116|Growth Substances|growth substances|mesh-ancestor
83600991|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
83600992|NCT05201430|Capecitabine|capecitabine|mesh-list
83600993|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
83600994|NCT05201430|Irinotecan|irinotecan|mesh-list
83600995|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83600996|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
83600997|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83600998|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83600999|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83601000|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601001|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601002|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
83601003|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601004|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
83601005|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83601006|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83601007|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601008|NCT00142506|Urological Agents|urological agents|mesh-ancestor
83601009|NCT05266794|Selenium|selenium|mesh-list
83601010|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
83601011|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
83601012|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601013|NCT05266794|Protective Agents|protective agents|mesh-ancestor
83601014|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601015|NCT05266794|Trace Elements|trace elements|mesh-ancestor
83601016|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
83601017|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
83601018|NCT05266794|Vitamins|vitamins|mesh-ancestor
83601019|NCT00142818|Naltrexone|naltrexone|mesh-list
83601020|NCT00142818|Modafinil|modafinil|mesh-list
83601021|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83601022|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83601023|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601024|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
83601025|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601026|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83601027|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83601028|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83601029|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83601030|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601031|NCT05266716|Methamphetamine|methamphetamine|mesh-list
83601032|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83601033|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601034|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
83601035|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
83601036|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601037|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
83601038|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601039|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601040|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
83601041|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83601042|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83601043|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83601044|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83601045|NCT05266560|Propofol|propofol|mesh-list
83601046|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83601047|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601048|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601049|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83601050|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
83601051|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
83601052|NCT00147966|Rituximab|rituximab|mesh-list
83601053|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601054|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601055|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
83601056|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601057|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601058|NCT04528212|Glimepiride|glimepiride|mesh-list
83601059|NCT04528212|Curcumin|curcumin|mesh-list
83601060|NCT04528212|Fenofibrate|fenofibrate|mesh-list
83601061|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83601062|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83601063|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601064|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601065|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
83601066|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83601067|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83601068|NCT04528212|Analgesics|analgesics|mesh-ancestor
83601069|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
83601070|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601071|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83601072|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601073|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601074|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601075|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601076|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83601077|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
83601078|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601079|NCT00148668|Carboplatin|carboplatin|mesh-list
83601080|NCT00148668|Docetaxel|docetaxel|mesh-list
83601081|NCT00148668|Trastuzumab|trastuzumab|mesh-list
83601082|NCT00148668|Vinorelbine|vinorelbine|mesh-list
83601083|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601084|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83601085|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83601086|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83601087|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601088|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601089|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83601090|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
83601091|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601092|NCT00324870|Bevacizumab|bevacizumab|mesh-list
83601093|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83601094|NCT00324870|Vorinostat|vorinostat|mesh-list
83601095|NCT00324870|Antibodies|antibodies|mesh-list
83601096|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
83601097|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83601098|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601099|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601100|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601101|NCT00324870|Growth Substances|growth substances|mesh-ancestor
83601102|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601103|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601104|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
83601105|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83601106|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601107|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601108|NCT00151320|Rituximab|rituximab|mesh-list
83601109|NCT00151320|Bortezomib|bortezomib|mesh-list
83601110|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601111|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601112|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
83601113|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601114|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601115|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
83601116|NCT00328614|Goserelin|goserelin|mesh-list
83601117|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
83601118|NCT00328614|Bicalutamide|bicalutamide|mesh-list
83601119|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83601120|NCT00328614|Androgens|androgens|mesh-list
83601121|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83601122|NCT00328614|Ethylene|ethylene|mesh-list
83601123|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83601124|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601125|NCT00328614|Hormones|hormones|mesh-ancestor
83601126|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83601127|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601128|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
83601129|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601130|NCT00328614|Protective Agents|protective agents|mesh-ancestor
83601131|NCT00328614|Vitamins|vitamins|mesh-ancestor
83601132|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
83601133|NCT00328614|Estrogens|estrogens|mesh-ancestor
83601134|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
83601135|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
83601136|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
83601137|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83601138|NCT00328614|Growth Substances|growth substances|mesh-ancestor
83601139|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83601140|NCT00328614|Analgesics|analgesics|mesh-ancestor
83601141|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
83601142|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601143|NCT00328770|Sirolimus|sirolimus|mesh-list
83601144|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83601145|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601146|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83601147|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601148|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
83601149|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601150|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
83601151|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601152|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83601153|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83601154|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601155|NCT00330876|Pitavastatin|pitavastatin|mesh-list
83601156|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83601157|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83601158|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83601159|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
83601160|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601161|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601162|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601163|NCT00334074|Cytarabine|cytarabine|mesh-list
83601164|NCT00334074|Clofarabine|clofarabine|mesh-list
83601165|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83601166|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
83601167|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601168|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601169|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
83601170|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601171|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601172|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
83601173|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601174|NCT00335478|Daptomycin|daptomycin|mesh-list
83601175|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83601176|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601177|NCT04345926|Propofol|propofol|mesh-list
83601178|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83601179|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601180|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601181|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83601182|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
83601183|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
83059194|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
83601184|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
83601185|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83601186|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601188|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
83601189|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601190|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601191|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601192|NCT00338988|Capecitabine|capecitabine|mesh-list
83601193|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
83601194|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83601195|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
83601196|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601197|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601198|NCT00343044|Bevacizumab|bevacizumab|mesh-list
83601199|NCT00343044|Topotecan|topotecan|mesh-list
83601200|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601201|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601202|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601203|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601204|NCT00343044|Growth Substances|growth substances|mesh-ancestor
83601205|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601206|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601207|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83601208|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601209|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601210|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601211|NCT00344370|Atorvastatin|atorvastatin|mesh-list
83601212|NCT00344370|Pitavastatin|pitavastatin|mesh-list
83601213|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83601214|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83601215|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
83601216|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601217|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601218|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83601219|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601220|NCT00344682|Memantine|memantine|mesh-list
83601221|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83601222|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83601223|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
83601224|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601225|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601226|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601227|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83601228|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83601229|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
83601230|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83601231|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601232|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601233|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83601234|NCT00345384|Analgesics|analgesics|mesh-ancestor
83601235|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
83601236|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601237|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83601238|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83601239|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83601240|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
83601241|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601242|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601243|NCT01791114|Propranolol|propranolol|mesh-list
83601244|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83601245|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83601246|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
83601247|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601248|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601249|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601250|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83601251|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83601252|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
83601253|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83601254|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83601255|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601256|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601257|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
83601258|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601259|NCT00350142|Gemcitabine|gemcitabine|mesh-list
83601260|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83601261|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
83601262|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601263|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601264|NCT00350532|Clonidine|clonidine|mesh-list
83601265|NCT00350532|Analgesics|analgesics|mesh-ancestor
83601266|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
83601267|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601268|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601269|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83601270|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
83601271|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
83601272|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83601273|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83601274|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83601275|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
83601276|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601277|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601278|NCT00351000|Ziprasidone|ziprasidone|mesh-list
83601279|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83601280|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
83601281|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601282|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601283|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601284|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83601285|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601286|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601287|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601288|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83601289|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
83601290|NCT00351936|Aripiprazole|aripiprazole|mesh-list
83601291|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
83601292|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601293|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83601294|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601295|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601296|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601297|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
83601298|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
83601299|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601300|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601301|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83601302|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83601303|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
83601304|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83601305|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83601306|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83601307|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83601308|NCT00352794|Prednisone|prednisone|mesh-list
83601309|NCT00352794|Lenalidomide|lenalidomide|mesh-list
83601310|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83601311|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
83601312|NCT00352794|Hormones|hormones|mesh-ancestor
83601313|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83601314|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601315|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83601316|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601317|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
83601318|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601319|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601320|NCT00352794|Growth Substances|growth substances|mesh-ancestor
83601321|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601322|NCT00353418|Ribavirin|ribavirin|mesh-list
83601323|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83601324|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
83601325|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601326|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
83601327|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601328|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
83601329|NCT00353652|Spironolactone|spironolactone|mesh-list
83601330|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83601331|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
83601332|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83601333|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601334|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83601335|NCT00353652|Diuretics|diuretics|mesh-ancestor
83601336|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
83601337|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83601338|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83601339|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83601340|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601341|NCT02982798|Metformin|metformin|mesh-list
83601342|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83601343|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83601344|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601345|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83601346|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83601347|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
83601348|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601349|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601350|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83601351|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601352|NCT03709914|Fosfomycin|fosfomycin|mesh-list
83601353|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83601354|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601355|NCT01794078|Ambrisentan|ambrisentan|mesh-list
83601356|NCT01794078|Aminophylline|aminophylline|mesh-list
83601357|NCT01794078|Theophylline|theophylline|mesh-list
83601358|NCT01794078|Ethylene|ethylene|mesh-list
83601359|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83601360|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
83601361|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601362|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601363|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83601364|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
83601365|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83601366|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601367|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601368|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
83601369|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83601370|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83601371|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
83601372|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601373|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83601374|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83601375|NCT01794078|Protective Agents|protective agents|mesh-ancestor
83601376|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83601377|NCT01794078|Growth Substances|growth substances|mesh-ancestor
83601378|NCT00354978|Leucovorin|leucovorin|mesh-list
83601379|NCT00354978|Bevacizumab|bevacizumab|mesh-list
83601380|NCT00354978|Fluorouracil|fluorouracil|mesh-list
83601381|NCT00354978|Irinotecan|irinotecan|mesh-list
83601382|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601383|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601384|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601385|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601386|NCT00354978|Growth Substances|growth substances|mesh-ancestor
83601387|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601388|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601389|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
83601390|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601391|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83601392|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601393|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
83601394|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83601395|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601396|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601397|NCT00354978|Antidotes|antidotes|mesh-ancestor
83601398|NCT00354978|Protective Agents|protective agents|mesh-ancestor
83601399|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
83601400|NCT00354978|Vitamins|vitamins|mesh-ancestor
83601401|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
83601402|NCT00357162|Belinostat|belinostat|mesh-list
83601403|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601404|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83601405|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601406|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601407|NCT03549000|Spartalizumab|spartalizumab|mesh-list
83601408|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83601409|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601410|NCT03549000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601411|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601412|NCT03984240|Midazolam|midazolam|mesh-list
83601413|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
83601414|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83601415|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601416|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601417|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83601418|NCT03984240|Analgesics|analgesics|mesh-ancestor
83601419|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
83601420|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601421|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83601422|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83601423|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83601424|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83601425|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601426|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601427|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83601428|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83601429|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601430|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601431|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83601432|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
83601433|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
83601434|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
83601435|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
83601436|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
83601437|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
83601438|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83601439|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83601440|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601441|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601442|NCT00359736|Urological Agents|urological agents|mesh-ancestor
83601443|NCT00360126|Lamotrigine|lamotrigine|mesh-list
83601444|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
83601445|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83601446|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83601447|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601448|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83601449|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601450|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83601451|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601452|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601453|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601454|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83601455|NCT00360360|Paclitaxel|paclitaxel|mesh-list
83601456|NCT00360360|Bevacizumab|bevacizumab|mesh-list
83601457|NCT00360360|Carboplatin|carboplatin|mesh-list
83601458|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83601459|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83601460|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601461|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
83601462|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
83601463|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
83601464|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601465|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601466|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601467|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601468|NCT00360360|Growth Substances|growth substances|mesh-ancestor
83601469|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601470|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601471|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83601472|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601473|NCT01552590|Tolvaptan|tolvaptan|mesh-list
83601474|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83601475|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601476|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
83601477|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601478|NCT00549978|Cilostazol|cilostazol|mesh-list
83601479|NCT00549978|Probucol|probucol|mesh-list
83601480|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83601481|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
83601482|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601483|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601484|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83601485|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
83601486|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83601487|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83601488|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601489|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83601490|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
83601491|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83601492|NCT00549978|Protective Agents|protective agents|mesh-ancestor
83601493|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83601494|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83601495|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601496|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83601497|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83601498|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
83601499|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601500|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
83601501|NCT03983226|Carboplatin|carboplatin|mesh-list
83601502|NCT03983226|Gemcitabine|gemcitabine|mesh-list
83601503|NCT03983226|Doxorubicin|doxorubicin|mesh-list
83601504|NCT03983226|Niraparib|niraparib|mesh-list
83601506|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601507|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83601508|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
83601509|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601510|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83601511|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83601512|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601513|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601514|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83601515|NCT00360672|Lenalidomide|lenalidomide|mesh-list
83601516|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
83601517|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601518|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601519|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601520|NCT00360672|Growth Substances|growth substances|mesh-ancestor
83601521|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601522|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601523|NCT00360828|Irinotecan|irinotecan|mesh-list
83601524|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83601525|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601526|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601527|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601528|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601529|NCT00361140|Fludarabine|fludarabine|mesh-list
83601530|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
83601531|NCT00361140|Busulfan|busulfan|mesh-list
83601532|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601533|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83601534|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
83601535|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601536|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601537|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
83601538|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601539|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
83601540|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83601541|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83601542|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
83601543|NCT00362466|Dasatinib|dasatinib|mesh-list
83601544|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601545|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83601546|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601547|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601548|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
83601549|NCT00305682|Sirolimus|sirolimus|mesh-list
83601550|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
83601551|NCT00305682|Fludarabine|fludarabine|mesh-list
83601552|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83601553|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601554|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
83601555|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601556|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601557|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83601558|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
83601559|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601560|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601561|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83601562|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83601563|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83601564|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
83601565|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83601566|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601567|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601568|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
83601569|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
83601571|NCT00305760|Vaccines|vaccines|mesh-list
83601572|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
83601573|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601574|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601575|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601576|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83601577|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
83601578|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601579|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601580|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83601581|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601582|NCT00309738|Simvastatin|simvastatin|mesh-list
83601583|NCT00309738|Pitavastatin|pitavastatin|mesh-list
83601584|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83601585|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83601586|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
83601587|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601588|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601589|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83601590|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601591|NCT00310050|Pemetrexed|pemetrexed|mesh-list
83601592|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601593|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601594|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601595|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83601596|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83601597|NCT00363168|Ranibizumab|ranibizumab|mesh-list
83601598|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601599|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601600|NCT00363168|Growth Substances|growth substances|mesh-ancestor
83601601|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601602|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601603|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601604|NCT00365274|Prednisone|prednisone|mesh-list
83601605|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
83601606|NCT00365274|Doxorubicin|doxorubicin|mesh-list
83601607|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83601608|NCT00365274|Vincristine|vincristine|mesh-list
83601609|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83601610|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601611|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
83601612|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601613|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601614|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83601615|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
83601616|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601617|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601618|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83601619|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83601620|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83601621|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601622|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601623|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83601624|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
83601625|NCT00365274|Hormones|hormones|mesh-ancestor
83601626|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83601627|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83601628|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83601629|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
83059649|NCT03486236|Ivacaftor|ivacaftor|mesh-list
83601630|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
83601631|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
83601632|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601633|NCT00365274|Immunotoxins|immunotoxins|mesh-ancestor
83601634|NCT00365274|Immunoconjugates|immunoconjugates|mesh-ancestor
83601635|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
83601636|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83601637|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83601638|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83601639|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83601640|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601641|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
83601642|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601643|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601644|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83601645|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601646|NCT02104830|Lenograstim|lenograstim|mesh-list
83601647|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83601648|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
83601649|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601650|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83601651|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601652|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83601653|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601654|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601655|NCT00314106|Aldesleukin|aldesleukin|mesh-list
83601656|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
83601657|NCT00314106|Fludarabine|fludarabine|mesh-list
83601658|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601659|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
83601660|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601661|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601662|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83601663|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
83601664|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601665|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601666|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83601667|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83601668|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83601669|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
83601670|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601671|NCT00316524|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83601672|NCT00316524|Antiviral Agents|antiviral agents|mesh-ancestor
83601673|NCT00316524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601674|NCT00318708|Fluticasone|fluticasone|mesh-list
83601675|NCT00318708|Xhance|xhance|mesh-list
83601676|NCT00318708|Clarithromycin|clarithromycin|mesh-list
83601677|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83601678|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83601679|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
83601680|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601681|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601682|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83601683|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
83601684|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
83601685|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83601686|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83601687|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601688|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83601689|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601690|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601691|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83601692|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83601693|NCT00319644|Dimercaprol|dimercaprol|mesh-list
83601694|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
83601695|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
83601696|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601697|NCT02448420|Trastuzumab|trastuzumab|mesh-list
83601698|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83601699|NCT02448420|Palbociclib|palbociclib|mesh-list
83601700|NCT02448420|Antibodies|antibodies|mesh-list
83601701|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
83601702|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
83601703|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059723|NCT04933864|Methylene Blue|methylene blue|mesh-list
83601704|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601705|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601706|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83601707|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601708|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601709|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83601710|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83601711|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83601712|NCT02448420|Immunotoxins|immunotoxins|mesh-ancestor
83601713|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83601714|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83601715|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83601716|NCT02405676|Cytarabine|cytarabine|mesh-list
83601717|NCT02405676|Prednisone|prednisone|mesh-list
83601718|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
83601719|NCT02405676|Ifosfamide|ifosfamide|mesh-list
83601720|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
83601721|NCT02405676|Rituximab|rituximab|mesh-list
83601722|NCT02405676|Methotrexate|methotrexate|mesh-list
83601723|NCT02405676|Etoposide|etoposide|mesh-list
83601724|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
83601725|NCT02405676|Vincristine|vincristine|mesh-list
83601726|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601727|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
83601728|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601729|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601730|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83601731|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
83601732|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601733|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601734|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83601735|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601736|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83601737|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
83601738|NCT02405676|Hormones|hormones|mesh-ancestor
83601739|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83601740|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83601741|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83601742|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
83601743|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83601744|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83601745|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
83601746|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
83601747|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601748|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83601749|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83601750|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83601751|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83601752|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601753|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
83601754|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601755|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83601756|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83601757|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83601758|NCT00321594|Belinostat|belinostat|mesh-list
83601759|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601760|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83601761|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601762|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601763|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
83601764|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83601765|NCT04751136|Protective Agents|protective agents|mesh-ancestor
83601766|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601767|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
83601768|NCT00390234|Aflibercept|aflibercept|mesh-list
83601769|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
83601770|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601771|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601772|NCT00390234|Growth Substances|growth substances|mesh-ancestor
83601773|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601774|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601775|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601776|NCT00391716|Gabapentin|gabapentin|mesh-list
83601777|NCT00391716|Analgesics|analgesics|mesh-ancestor
83601778|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
83601779|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601780|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601781|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
83601782|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83601783|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601784|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601785|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601786|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83601787|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83601788|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601789|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601790|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
83601791|NCT00392496|Sunitinib|sunitinib|mesh-list
83601792|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601793|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83601794|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83601795|NCT00392496|Growth Substances|growth substances|mesh-ancestor
83601796|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601797|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
83601798|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83601799|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601800|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601801|NCT01958190|Sirolimus|sirolimus|mesh-list
83601802|NCT01958190|Tacrolimus|tacrolimus|mesh-list
83601803|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601804|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
83601805|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601806|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83601807|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601808|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601809|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83601810|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601811|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83601812|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601813|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
83601814|NCT00638898|Melphalan|melphalan|mesh-list
83601815|NCT00638898|Busulfan|busulfan|mesh-list
83601816|NCT00638898|Topotecan|topotecan|mesh-list
83601817|NCT00638898|Lenograstim|lenograstim|mesh-list
83601818|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83601819|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
83601820|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601821|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83601822|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
83601823|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601824|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601825|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83601826|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601827|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83601828|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83601829|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601830|NCT00393978|Topiramate|topiramate|mesh-list
83601831|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83601832|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
83601833|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601834|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83601835|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601836|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601837|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601838|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
83601839|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83601840|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
83601841|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83601842|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601843|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601844|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83601845|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83601846|NCT00397020|Valproic Acid|valproic acid|mesh-list
83601847|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83601848|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
83601849|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601850|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83601851|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601852|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601853|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059876|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83601854|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
83601855|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601856|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601857|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
83601858|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601859|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
83601860|NCT00397878|Saracatinib|saracatinib|mesh-list
83601861|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601862|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601863|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601864|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
83601865|NCT00400686|Hematinics|hematinics|mesh-ancestor
83601866|NCT05220462|Midazolam|midazolam|mesh-list
83601867|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83601868|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83601869|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601870|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601871|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83601872|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601873|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601874|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83601875|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
83601876|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
83601877|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
83601878|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
83601879|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601880|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601881|NCT00373386|Hormones|hormones|mesh-list
83601882|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83601883|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601884|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
83601885|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83601886|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
83601887|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83601888|NCT00374088|Expectorants|expectorants|mesh-ancestor
83601889|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
83601890|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83601891|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
83601892|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601893|NCT00374088|Protective Agents|protective agents|mesh-ancestor
83601894|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601895|NCT00374088|Antidotes|antidotes|mesh-ancestor
83601896|NCT00374244|Pimozide|pimozide|mesh-list
83601897|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83601898|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83601899|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601900|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601901|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83601902|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83601903|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
83601904|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601905|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601906|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83601907|NCT00377832|Acetaminophen|acetaminophen|mesh-list
83601908|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83601909|NCT00377832|Analgesics|analgesics|mesh-ancestor
83601910|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
83601911|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601912|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601913|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
83601914|NCT00401778|Everolimus|everolimus|mesh-list
83601915|NCT00401778|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83601916|NCT00401778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83601917|NCT00401778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601918|NCT00401778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601919|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83601920|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
83601921|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601922|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601923|NCT00402714|Pentostatin|pentostatin|mesh-list
83601924|NCT00402714|Methoxsalen|methoxsalen|mesh-list
83601925|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601926|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83601927|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601928|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601929|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83601930|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
83601931|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
83601932|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83601933|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83601934|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83601935|NCT00405288|Pramoxine|pramoxine|mesh-list
83601936|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83601937|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
83601938|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
83601939|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601940|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601941|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
83601942|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601943|NCT00381810|Acetaminophen|acetaminophen|mesh-list
83601944|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
83601945|NCT00381810|Promethazine|promethazine|mesh-list
83601946|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
83601947|NCT00381810|Rituximab|rituximab|mesh-list
83601948|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83601949|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601950|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
83601951|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601952|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83601953|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83601954|NCT00381810|Analgesics|analgesics|mesh-ancestor
83601955|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
83601956|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83601957|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
83601958|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83601959|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
83601960|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
83601961|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83601962|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
83601963|NCT00381810|Hormones|hormones|mesh-ancestor
83601964|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83601965|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83601966|NCT00381810|Protective Agents|protective agents|mesh-ancestor
83601967|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83601968|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83601969|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83601970|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
83601971|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
83601972|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83601973|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
83601974|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
83601975|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83601976|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601977|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83601978|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
83601979|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83601980|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83601981|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601982|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83601983|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83601984|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83601985|NCT00459732|Zinc|zinc|mesh-list
83601986|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
83601987|NCT00459732|Trace Elements|trace elements|mesh-ancestor
83601988|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
83601989|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83601990|NCT00459732|Astringents|astringents|mesh-ancestor
83601991|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
83601992|NCT00459810|Paclitaxel|paclitaxel|mesh-list
83601993|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83601994|NCT00459810|Estradiol|estradiol|mesh-list
83601995|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83601996|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83601997|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83601998|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83601999|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602000|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602001|NCT00459810|Estrogens|estrogens|mesh-ancestor
83602002|NCT00459810|Hormones|hormones|mesh-ancestor
83602003|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602004|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602005|NCT00405522|Remifentanil|remifentanil|mesh-list
83602006|NCT00405522|Propofol|propofol|mesh-list
83602007|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83602008|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83602009|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602010|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83602011|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
83602012|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
83602013|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83602014|NCT00405522|Narcotics|narcotics|mesh-ancestor
83602015|NCT00405522|Analgesics|analgesics|mesh-ancestor
83602016|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
83602017|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602018|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
83602019|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83602020|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83602021|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83602022|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83602023|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602024|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
83602025|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602026|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602027|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83602028|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602029|NCT00382590|Cytarabine|cytarabine|mesh-list
83602030|NCT00382590|Azacitidine|azacitidine|mesh-list
83602031|NCT00382590|Valproic Acid|valproic acid|mesh-list
83602032|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602033|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
83602034|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602035|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602036|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
83602037|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602038|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602039|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
83602040|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602041|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602042|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
83602043|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
83602044|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602045|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
83602046|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83602047|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83602048|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83602049|NCT00382824|Ubiquinone|ubiquinone|mesh-list
83602050|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
83602051|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
83602052|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602053|NCT00382824|Vitamins|vitamins|mesh-ancestor
83602054|NCT00462072|Infliximab|infliximab|mesh-list
83602055|NCT00462072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83602056|NCT00462072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602057|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602058|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602059|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602060|NCT00462228|Memantine|memantine|mesh-list
83602061|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83602062|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83602063|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
83602064|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602065|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602066|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602067|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83602068|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83602069|NCT00408564|Gemcitabine|gemcitabine|mesh-list
83602070|NCT00408564|Capecitabine|capecitabine|mesh-list
83602071|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
83602072|NCT00408564|Cetuximab|cetuximab|mesh-list
83602073|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602074|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
83602075|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602076|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602077|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602078|NCT00383448|Cyclosporine|cyclosporine|mesh-list
83602079|NCT00383448|Melphalan|melphalan|mesh-list
83602080|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
83602081|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
83602082|NCT00383448|Clofarabine|clofarabine|mesh-list
83602083|NCT00383448|Cyclosporins|cyclosporins|mesh-list
83602084|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602085|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602086|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602087|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
83602088|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602089|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
83602090|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602091|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602092|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602093|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83602094|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602095|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
83602096|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602097|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602098|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602099|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
83602100|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602101|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602102|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
83602103|NCT00384774|Lasmiditan|lasmiditan|mesh-list
83602104|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83602105|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
83602106|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602107|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602108|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602109|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83602110|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602111|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83602112|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602113|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602114|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
83602115|NCT00464646|Bevacizumab|bevacizumab|mesh-list
83602116|NCT00464646|Docetaxel|docetaxel|mesh-list
83602117|NCT00464646|Trastuzumab|trastuzumab|mesh-list
83602118|NCT00464646|Epirubicin|epirubicin|mesh-list
83602119|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602120|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
83602121|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602122|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602123|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602124|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
83602125|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602126|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602127|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602128|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602129|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602130|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602131|NCT00464646|Growth Substances|growth substances|mesh-ancestor
83602132|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602133|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602134|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602135|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602136|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602137|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602138|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602139|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602140|NCT00385008|Naproxen|naproxen|mesh-list
83602141|NCT00385008|Sumatriptan|sumatriptan|mesh-list
83602142|NCT00385008|Eletriptan|eletriptan|mesh-list
83602143|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83602144|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83602145|NCT00385008|Analgesics|analgesics|mesh-ancestor
83602146|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
83602147|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602148|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602149|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602150|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602151|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
83602152|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83602153|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602154|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602155|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83602156|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83602157|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83602158|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
83060183|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
83602159|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602160|NCT00410904|Pemetrexed|pemetrexed|mesh-list
83602161|NCT00410904|Cediranib|cediranib|mesh-list
83602162|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602163|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602164|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602165|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83602166|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602167|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83602168|NCT00385788|Gemcitabine|gemcitabine|mesh-list
83602169|NCT00385788|Methotrexate|methotrexate|mesh-list
83602170|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
83602171|NCT00385788|Fludarabine|fludarabine|mesh-list
83602172|NCT00385788|Melphalan|melphalan|mesh-list
83602173|NCT00385788|Tacrolimus|tacrolimus|mesh-list
83602174|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
83602175|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83602176|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602177|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
83602178|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602179|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602180|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83602181|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
83602182|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83602183|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602184|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602185|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602186|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83602187|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602188|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
83602189|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602190|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602191|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83602192|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602193|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
83602194|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602195|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
83602196|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83602197|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
83602198|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83602199|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602200|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83602201|NCT00412074|Vitamin D|vitamin d|mesh-list
83602202|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
83602203|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
83602204|NCT00412074|Vitamins|vitamins|mesh-list
83602205|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
83602206|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602207|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83602208|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83602209|NCT00412464|PENTA|penta|mesh-list
83602210|NCT00412464|Fondaparinux|fondaparinux|mesh-list
83602211|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83602212|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
83602213|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83602214|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
83602215|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602216|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602217|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
83602218|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83602219|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83602220|NCT00466752|Sorafenib|sorafenib|mesh-list
83602221|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602222|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83602223|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602224|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602225|NCT02115750|Etanercept|etanercept|mesh-list
83602226|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83602227|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83602228|NCT02115750|Analgesics|analgesics|mesh-ancestor
83602229|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
83602230|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602231|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602232|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602233|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602234|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602235|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060260|NCT04014387|Zolpidem|zolpidem|mesh-list
83602236|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
83602238|NCT00413166|Tretinoin|tretinoin|mesh-list
83602239|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
83602240|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
83602241|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602242|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602243|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602244|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602245|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602246|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602247|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
83602248|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602249|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602250|NCT00413166|Immunotoxins|immunotoxins|mesh-ancestor
83602251|NCT00413166|Immunoconjugates|immunoconjugates|mesh-ancestor
83602252|NCT00413166|Immunologic Factors|immunologic factors|mesh-ancestor
83602253|NCT00413166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602254|NCT00413400|Etanercept|etanercept|mesh-list
83602255|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83602256|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83602257|NCT00413400|Analgesics|analgesics|mesh-ancestor
83602258|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
83602259|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602260|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602261|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602262|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602263|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602264|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602265|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
83602266|NCT00413478|Azacitidine|azacitidine|mesh-list
83602267|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602268|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
83602269|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602270|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602271|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602272|NCT00413634|Anagrelide|anagrelide|mesh-list
83602273|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83602274|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83602275|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602276|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83602277|NCT00387036|Fluticasone|fluticasone|mesh-list
83602278|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602279|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83602280|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
83602281|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602282|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602283|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83602284|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
83602285|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602286|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83602287|NCT04388904|Tenofovir|tenofovir|mesh-list
83602288|NCT04388904|Emtricitabine|emtricitabine|mesh-list
83602289|NCT04388904|Darunavir|darunavir|mesh-list
83602290|NCT04388904|Cobicistat|cobicistat|mesh-list
83602291|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83602292|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83602293|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
83602294|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602295|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83602296|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602297|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602298|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602299|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83602300|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83602301|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83602302|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83602303|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
83602304|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83602305|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83602306|NCT00387660|Carboplatin|carboplatin|mesh-list
83602307|NCT00387660|Irinotecan|irinotecan|mesh-list
83602308|NCT00387660|Camptothecin|camptothecin|mesh-list
83602309|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602310|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83602311|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602313|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602314|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83602315|NCT00472056|Cytarabine|cytarabine|mesh-list
83602316|NCT00472056|Rituximab|rituximab|mesh-list
83602317|NCT00472056|Etoposide|etoposide|mesh-list
83602318|NCT00472056|Melphalan|melphalan|mesh-list
83602319|NCT00472056|Carmustine|carmustine|mesh-list
83602320|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602321|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602322|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
83602323|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602324|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602325|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83602326|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602327|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602328|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602329|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602330|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602331|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
83602332|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
83602333|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602334|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602335|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602336|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
83602337|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602338|NCT00415506|Rituximab|rituximab|mesh-list
83602339|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602340|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602341|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
83602342|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602343|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602344|NCT03531918|Cytarabine|cytarabine|mesh-list
83602345|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83602346|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
83602347|NCT03531918|Cladribine|cladribine|mesh-list
83602348|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
83602349|NCT03531918|Calicheamicins|calicheamicins|mesh-list
83602350|NCT03531918|Lenograstim|lenograstim|mesh-list
83602351|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602352|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
83602353|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602354|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602355|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
83602356|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602357|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602358|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
83602359|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602360|NCT03531918|Analgesics|analgesics|mesh-ancestor
83602361|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
83602362|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602363|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602364|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602365|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602366|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83602367|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602368|NCT03531918|Immunotoxins|immunotoxins|mesh-ancestor
83602369|NCT03531918|Immunoconjugates|immunoconjugates|mesh-ancestor
83602370|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602371|NCT00389532|Vaccines|vaccines|mesh-list
83602372|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
83602373|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602374|NCT03520686|Paclitaxel|paclitaxel|mesh-list
83602375|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83602376|NCT03520686|Cisplatin|cisplatin|mesh-list
83602377|NCT03520686|Carboplatin|carboplatin|mesh-list
83602378|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
83602379|NCT03520686|Pemetrexed|pemetrexed|mesh-list
83602380|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83602381|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602382|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602383|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602384|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602385|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602386|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602387|NCT03520686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83602388|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602389|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83602390|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602391|NCT01957956|Temozolomide|temozolomide|mesh-list
83602392|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602393|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
83602394|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602395|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602396|NCT00475878|Escitalopram|escitalopram|mesh-list
83602397|NCT00475878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83602398|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83602399|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83602400|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602401|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602402|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
83602403|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602404|NCT01795170|Pyridoxine|pyridoxine|mesh-list
83602405|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
83602406|NCT01795170|Vitamins|vitamins|mesh-ancestor
83602407|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
83602408|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602409|NCT00477204|Simvastatin|simvastatin|mesh-list
83602410|NCT00477204|Ezetimibe|ezetimibe|mesh-list
83602411|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83602412|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83602413|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83602414|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
83602415|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602416|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83602417|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83602418|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602419|NCT00528450|Idarubicin|idarubicin|mesh-list
83602420|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
83602421|NCT00528450|Tretinoin|tretinoin|mesh-list
83602422|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602423|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602424|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602425|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602426|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602427|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602428|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
83602429|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602430|NCT00478218|Dexamethasone|dexamethasone|mesh-list
83602431|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
83602432|NCT00478218|Lenalidomide|lenalidomide|mesh-list
83602433|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602434|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
83602435|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602436|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602437|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602438|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
83602439|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602440|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602441|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602442|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602443|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
83602444|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
83602445|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602446|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602447|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
83602448|NCT00478218|Hormones|hormones|mesh-ancestor
83602449|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602450|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83602451|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602452|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602453|NCT00478218|Growth Substances|growth substances|mesh-ancestor
83602454|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602455|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
83602456|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83602457|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83602458|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83602459|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83602460|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060482|NCT04979884|Cyclosporine|cyclosporine|mesh-list
83060483|NCT04979884|Interleukin-2|interleukin-2|mesh-list
83602461|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
83602462|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602463|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602464|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83602465|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602466|NCT04270656|Insulin|insulin|mesh-list
83602467|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83602468|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602469|NCT00424554|Temozolomide|temozolomide|mesh-list
83602470|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602471|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
83602472|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602473|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602474|NCT00425802|Cyclosporine|cyclosporine|mesh-list
83602475|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
83602476|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
83602477|NCT00425802|Rituximab|rituximab|mesh-list
83602478|NCT00425802|Fludarabine|fludarabine|mesh-list
83602479|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
83602480|NCT00425802|Cyclosporins|cyclosporins|mesh-list
83602481|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83602482|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602483|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
83602484|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602485|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602486|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602487|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
83602488|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602489|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602490|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602491|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602492|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602493|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
83602494|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602495|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
83602496|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602497|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602498|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83602499|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602500|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83602501|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
83602502|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83602503|NCT00530634|Gemcitabine|gemcitabine|mesh-list
83602504|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602505|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602506|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
83602507|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602508|NCT00531882|Pioglitazone|pioglitazone|mesh-list
83602509|NCT00531882|Ibuprofen|ibuprofen|mesh-list
83602510|NCT00531882|Simvastatin|simvastatin|mesh-list
83602511|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83602512|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83602513|NCT00531882|Analgesics|analgesics|mesh-ancestor
83602514|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
83602515|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602516|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602517|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602518|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602519|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83602520|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602521|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602522|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83602523|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83602524|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
83602525|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83602526|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83060564|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
83060565|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83060566|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83060567|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060568|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
83060569|NCT04918576|Coagulants|coagulants|mesh-ancestor
83060570|NCT03472508|Folic Acid|folic acid|mesh-list
83060571|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
83060572|NCT03472508|Enalapril|enalapril|mesh-list
83602527|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83602528|NCT00428298|Valacyclovir|valacyclovir|mesh-list
83602529|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
83602530|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602531|NCT00486018|Ranibizumab|ranibizumab|mesh-list
83602532|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602533|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602534|NCT00486018|Growth Substances|growth substances|mesh-ancestor
83602535|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602536|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602537|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602538|NCT00486642|Bicalutamide|bicalutamide|mesh-list
83602539|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
83602540|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
83602541|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602542|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602543|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602544|NCT00428922|Bevacizumab|bevacizumab|mesh-list
83602545|NCT00428922|Trastuzumab|trastuzumab|mesh-list
83602546|NCT00428922|Docetaxel|docetaxel|mesh-list
83602547|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602548|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602549|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602550|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602551|NCT00428922|Growth Substances|growth substances|mesh-ancestor
83602552|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602553|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602554|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602555|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602556|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602557|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602558|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
83602559|NCT00533442|Sirolimus|sirolimus|mesh-list
83602560|NCT00533442|Tacrolimus|tacrolimus|mesh-list
83602561|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602562|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
83602563|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602564|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83602565|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602566|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602567|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602568|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602569|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83602570|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
83602571|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83602572|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602573|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
83602574|NCT00533910|Rifaximin|rifaximin|mesh-list
83602575|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83602576|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602577|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602578|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
83602579|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
83602580|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83602581|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83602582|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602583|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602584|NCT01954524|Urological Agents|urological agents|mesh-ancestor
83602585|NCT00535002|Yohimbine|yohimbine|mesh-list
83602586|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
83602587|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
83602588|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602589|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602590|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83602591|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83602592|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83602593|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
83602594|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602595|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602596|NCT00535002|Urological Agents|urological agents|mesh-ancestor
83602597|NCT02117934|Vaccines|vaccines|mesh-list
83602598|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
83602599|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602600|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
83602601|NCT00429702|Promethazine|promethazine|mesh-list
83602602|NCT00429702|Dexamethasone|dexamethasone|mesh-list
83602603|NCT00429702|Lorazepam|lorazepam|mesh-list
83602604|NCT00429702|Ondansetron|ondansetron|mesh-list
83602605|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602606|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
83602607|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
83602608|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602609|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602610|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602611|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
83602612|NCT00429702|Hormones|hormones|mesh-ancestor
83602613|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602614|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83602615|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602616|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602617|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
83602618|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602619|NCT00429702|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83602620|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83602621|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
83602622|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602623|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83602624|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83602625|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83602626|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
83602627|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
83602628|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
83602629|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83602630|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
83602631|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
83602632|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83602633|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
83602634|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83602635|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83602636|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83602637|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
83602638|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
83602639|NCT00535392|Levetiracetam|levetiracetam|mesh-list
83602640|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
83602641|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
83602642|NCT00535782|Methotrexate|methotrexate|mesh-list
83602643|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83602644|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
83602645|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83602646|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602647|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602648|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
83602649|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602650|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602651|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602652|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602653|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83602654|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602655|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
83602656|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602657|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602658|NCT00431184|Pentazocine|pentazocine|mesh-list
83602659|NCT00431184|Lorazepam|lorazepam|mesh-list
83602660|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
83602661|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
83602662|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
83602663|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602664|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602665|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602666|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83602667|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83602668|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83602669|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83602670|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83602671|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
83602672|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
83602673|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602674|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602675|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83602676|NCT00431184|Narcotics|narcotics|mesh-ancestor
83602677|NCT00431184|Analgesics|analgesics|mesh-ancestor
83602678|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
83602679|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83602680|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83602681|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
83060781|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
83602682|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83602683|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83602684|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83602685|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83602686|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602687|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
83602688|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602689|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602690|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83602691|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602692|NCT01795794|Omeprazole|omeprazole|mesh-list
83602693|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83602694|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602695|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83602696|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602697|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602698|NCT01796028|Metformin|metformin|mesh-list
83602699|NCT01796028|Docetaxel|docetaxel|mesh-list
83602700|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83602701|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602702|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602703|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602704|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602705|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602706|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602707|NCT00491244|Interferons|interferons|mesh-list
83602708|NCT00491244|Ribavirin|ribavirin|mesh-list
83602709|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
83602710|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
83602711|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83602712|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602713|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
83602714|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602715|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
83602716|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602717|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
83602718|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602719|NCT00492336|Rasagiline|rasagiline|mesh-list
83602720|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83602721|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602722|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602723|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83602724|NCT00492336|Protective Agents|protective agents|mesh-ancestor
83602725|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602726|NCT00538434|Reslizumab|reslizumab|mesh-list
83602727|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83602728|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83602729|NCT00538824|Thalidomide|thalidomide|mesh-list
83602730|NCT00538824|Dexamethasone|dexamethasone|mesh-list
83602731|NCT00538824|Lenalidomide|lenalidomide|mesh-list
83602732|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602733|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
83602734|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
83602735|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602736|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602737|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602738|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
83602739|NCT00538824|Hormones|hormones|mesh-ancestor
83602740|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602741|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83602742|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602743|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
83602744|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602745|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602746|NCT00538824|Growth Substances|growth substances|mesh-ancestor
83602747|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602748|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602749|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
83602750|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83602751|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602752|NCT00539526|Bimatoprost|bimatoprost|mesh-list
83602753|NCT00539526|Travoprost|travoprost|mesh-list
83602754|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83602755|NCT00539526|Latanoprost|latanoprost|mesh-list
83602756|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83602757|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83602758|NCT01796106|Fluorides|fluorides|mesh-list
83602759|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
83602760|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
83602761|NCT01796106|Protective Agents|protective agents|mesh-ancestor
83602762|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602763|NCT00541242|Bimatoprost|bimatoprost|mesh-list
83602764|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83602765|NCT00541242|Latanoprost|latanoprost|mesh-list
83602766|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83602767|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83602768|NCT00438204|Bevacizumab|bevacizumab|mesh-list
83602769|NCT00438204|Gemcitabine|gemcitabine|mesh-list
83602770|NCT00438204|Pemetrexed|pemetrexed|mesh-list
83602771|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602772|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602773|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602774|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602775|NCT00438204|Growth Substances|growth substances|mesh-ancestor
83602776|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602777|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602778|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602779|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
83602780|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602781|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602782|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83602783|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602784|NCT00439296|Cytarabine|cytarabine|mesh-list
83602785|NCT00439296|Dexamethasone|dexamethasone|mesh-list
83602786|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
83602787|NCT00439296|Doxorubicin|doxorubicin|mesh-list
83602788|NCT00439296|Methotrexate|methotrexate|mesh-list
83602789|NCT00439296|Asparaginase|asparaginase|mesh-list
83602790|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
83602791|NCT00439296|Thioguanine|thioguanine|mesh-list
83602792|NCT00439296|Pegaspargase|pegaspargase|mesh-list
83602793|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602794|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
83602795|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602796|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602797|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602798|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
83602799|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602800|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602801|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602802|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602803|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
83602804|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
83602805|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602806|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83602807|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
83602808|NCT00439296|Hormones|hormones|mesh-ancestor
83602809|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602810|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83602811|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602812|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602813|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602814|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602815|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83602816|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
83602817|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83602818|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602819|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
83602820|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602821|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83602822|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83602823|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
83602824|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602825|NCT03117660|Vitamin A|vitamin a|mesh-list
83602826|NCT03117660|Vitamins|vitamins|mesh-ancestor
83602827|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
83602828|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602829|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83602830|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83602831|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83602832|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
83602833|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602834|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602835|NCT00439374|Progestins|progestins|mesh-ancestor
83602836|NCT00439374|Hormones|hormones|mesh-ancestor
83602837|NCT00439608|Paclitaxel|paclitaxel|mesh-list
83602838|NCT00439608|Carboplatin|carboplatin|mesh-list
83602839|NCT00439608|Cetuximab|cetuximab|mesh-list
83602840|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83602841|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602842|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602843|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602844|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602845|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602846|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602847|NCT04750122|Carboplatin|carboplatin|mesh-list
83602848|NCT04750122|Docetaxel|docetaxel|mesh-list
83602849|NCT04750122|Trastuzumab|trastuzumab|mesh-list
83602850|NCT04750122|Pertuzumab|pertuzumab|mesh-list
83602851|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602852|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602853|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602854|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602855|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602856|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602857|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83602858|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83602859|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83602860|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83602861|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602862|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602863|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602864|NCT00443352|Analgesics|analgesics|mesh-ancestor
83602865|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
83602866|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602867|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
83602868|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83602869|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
83602870|NCT00445302|Plerixafor|plerixafor|mesh-list
83602871|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83602872|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83602873|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
83602874|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83602875|NCT00504504|Rituximab|rituximab|mesh-list
83602876|NCT00504504|Doxorubicin|doxorubicin|mesh-list
83602877|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83602878|NCT00504504|Dacarbazine|dacarbazine|mesh-list
83602879|NCT00504504|Bleomycin|bleomycin|mesh-list
83602880|NCT00504504|Vinblastine|vinblastine|mesh-list
83602881|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602882|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602883|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
83602884|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602885|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602886|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602887|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602888|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602889|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602890|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602891|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602892|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
83602893|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83602894|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602895|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602896|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602897|NCT00504660|Celecoxib|celecoxib|mesh-list
83602898|NCT00504660|Capecitabine|capecitabine|mesh-list
83602899|NCT00504660|Thioguanine|thioguanine|mesh-list
83602900|NCT00504660|Temozolomide|temozolomide|mesh-list
83602901|NCT00504660|Lomustine|lomustine|mesh-list
83602902|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602903|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
83602904|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602905|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602906|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602907|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
83602908|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83602909|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83602910|NCT00504660|Analgesics|analgesics|mesh-ancestor
83602911|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
83602912|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602913|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602914|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602915|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602916|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83602917|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83602918|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602919|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
83602920|NCT00544908|Dasatinib|dasatinib|mesh-list
83602921|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602922|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83602923|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602924|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602925|NCT00447330|Bevacizumab|bevacizumab|mesh-list
83602926|NCT00447330|Capecitabine|capecitabine|mesh-list
83602927|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
83602928|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602929|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602930|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602931|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602932|NCT00447330|Growth Substances|growth substances|mesh-ancestor
83602933|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602934|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602935|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83602936|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
83602937|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602938|NCT02115048|Letrozole|letrozole|mesh-list
83602939|NCT02115048|Afatinib|afatinib|mesh-list
83602940|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602941|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83602942|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83602943|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602944|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602945|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83602946|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
83602947|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83602948|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602949|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83602950|NCT00546156|Paclitaxel|paclitaxel|mesh-list
83602951|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
83602952|NCT00546156|Bevacizumab|bevacizumab|mesh-list
83602953|NCT00546156|Doxorubicin|doxorubicin|mesh-list
83602954|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83602955|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83602956|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
83602957|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
83602958|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
83602959|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602960|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83602961|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
83602962|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602963|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83602964|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83602965|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
83602966|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83602967|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83602968|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83602969|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83602970|NCT00546156|Growth Substances|growth substances|mesh-ancestor
83602971|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
83602972|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83602973|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83602974|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83602975|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602976|NCT00449046|Fluticasone|fluticasone|mesh-list
83602977|NCT00449046|Xhance|xhance|mesh-list
83602978|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83602979|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83602980|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83602981|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
83602982|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83602983|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83602984|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83602985|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
83602986|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
83602987|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83602988|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83602989|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83602990|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83602991|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
83602992|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83602993|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602994|NCT00449748|Everolimus|everolimus|mesh-list
83602995|NCT00449748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83602996|NCT00449748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83602997|NCT00449748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83602998|NCT00449748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83602999|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603000|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
83603001|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603002|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603003|NCT00509496|Aldesleukin|aldesleukin|mesh-list
83603004|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
83603005|NCT00509496|Fludarabine|fludarabine|mesh-list
83603006|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
83603007|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603008|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
83603009|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603010|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603011|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83603012|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
83603013|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603014|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603015|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83603016|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603017|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
83603018|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83603019|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83603020|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
83603021|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603022|NCT00548418|Bevacizumab|bevacizumab|mesh-list
83603023|NCT00548418|Topotecan|topotecan|mesh-list
83603024|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603025|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603026|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83603027|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83603028|NCT00548418|Growth Substances|growth substances|mesh-ancestor
83603029|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603030|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
83603031|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83603032|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83603033|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603034|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603035|NCT00511992|Paclitaxel|paclitaxel|mesh-list
83603036|NCT00511992|Bevacizumab|bevacizumab|mesh-list
83603037|NCT00511992|Cisplatin|cisplatin|mesh-list
83603038|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83603039|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603040|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603041|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603042|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603043|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603044|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603045|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83603046|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83603047|NCT00511992|Growth Substances|growth substances|mesh-ancestor
83603048|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603049|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
83603050|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
83603051|NCT00451698|Hematinics|hematinics|mesh-ancestor
83603052|NCT00549042|Hydromorphone|hydromorphone|mesh-list
83603053|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83603054|NCT00549042|Narcotics|narcotics|mesh-ancestor
83603055|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603056|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603057|NCT00549042|Analgesics|analgesics|mesh-ancestor
83603058|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
83603059|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061078|NCT03054610|Hormones|hormones|mesh-ancestor
83603060|NCT00452868|Donepezil|donepezil|mesh-list
83603061|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83603062|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603063|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603064|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
83603065|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603066|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603067|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
83603068|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83603069|NCT00453336|Trioxsalen|trioxsalen|mesh-list
83603070|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603071|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603072|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83603073|NCT00549822|Letrozole|letrozole|mesh-list
83603074|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603075|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83603076|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83603077|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603078|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603079|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83603080|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
83603081|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83603082|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603083|NCT00550290|Cefazolin|cefazolin|mesh-list
83603084|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83603085|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603086|NCT01797198|Repaglinide|repaglinide|mesh-list
83603087|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
83603088|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83603089|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603090|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83603091|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
83603092|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603093|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83603094|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83603095|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83603096|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603097|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
83603098|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83603099|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
83603100|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603101|NCT00552786|Expectorants|expectorants|mesh-ancestor
83603102|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
83603103|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83603104|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
83603105|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603106|NCT00552786|Protective Agents|protective agents|mesh-ancestor
83603107|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603108|NCT00552786|Antidotes|antidotes|mesh-ancestor
83603109|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
83603110|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603111|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603112|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83603113|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83603114|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603115|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603116|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
83603117|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603118|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603119|NCT00553098|Cyclosporine|cyclosporine|mesh-list
83603120|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
83603121|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83603122|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
83603123|NCT00553098|Fludarabine|fludarabine|mesh-list
83603124|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
83603125|NCT00553098|Antibodies|antibodies|mesh-list
83603126|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
83603127|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83603128|NCT00553098|Cyclosporins|cyclosporins|mesh-list
83603129|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
83603130|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603131|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603132|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603133|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
83603134|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603135|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603136|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061149|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603137|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
83603138|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603139|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603140|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603141|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83603142|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83603143|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83603144|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
83603145|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83603146|NCT00553410|Letrozole|letrozole|mesh-list
83603147|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603148|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83603149|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83603150|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603151|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603152|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83603153|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
83603154|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83603155|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603156|NCT00554970|Budesonide|budesonide|mesh-list
83603157|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83603158|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83603159|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
83603160|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603161|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603162|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83603163|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83603164|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
83603165|NCT00554970|Hormones|hormones|mesh-ancestor
83603166|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83603167|NCT00524472|Insulin|insulin|mesh-list
83603168|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83603169|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83603170|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603171|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
83603172|NCT00555048|Busulfan|busulfan|mesh-list
83603173|NCT00555048|Methotrexate|methotrexate|mesh-list
83603174|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
83603175|NCT00555048|Tacrolimus|tacrolimus|mesh-list
83603176|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603177|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
83603178|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603179|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603180|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83603181|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
83603182|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603183|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603184|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83603185|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83603186|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
83603187|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83603188|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603189|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
83603190|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603191|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603192|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83603193|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83603194|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83603195|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603196|NCT00525798|Calcitonin|calcitonin|mesh-list
83603197|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
83603198|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83603199|NCT00525798|Katacalcin|katacalcin|mesh-list
83603200|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83603201|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603202|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83603203|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
83603204|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
83603205|NCT00525876|Rituximab|rituximab|mesh-list
83603206|NCT00525876|Fludarabine|fludarabine|mesh-list
83603207|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
83603208|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
83603209|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603210|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
83603211|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061229|NCT01510184|Rituximab|rituximab|mesh-list
83603212|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603213|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83603214|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
83603215|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603216|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603217|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83603218|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603219|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603220|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
83603221|NCT00555750|Eszopiclone|eszopiclone|mesh-list
83603222|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83603223|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603224|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603225|NCT00556140|Aripiprazole|aripiprazole|mesh-list
83603226|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
83603227|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603228|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83603229|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83603230|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603231|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603232|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
83603233|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
83603234|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603235|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603236|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83603237|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83603238|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
83603239|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83603240|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83603241|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83603242|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83603243|NCT00527124|Prednisone|prednisone|mesh-list
83603244|NCT00527124|Docetaxel|docetaxel|mesh-list
83603245|NCT00527124|Cediranib|cediranib|mesh-list
83603246|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603247|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603248|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603249|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603250|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603251|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83603252|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
83603253|NCT00527124|Hormones|hormones|mesh-ancestor
83603254|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83603255|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603256|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83603257|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603258|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83603259|NCT00527592|Travoprost|travoprost|mesh-list
83603260|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83603261|NCT00527592|Latanoprost|latanoprost|mesh-list
83603262|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83603263|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83603264|NCT00556452|Busulfan|busulfan|mesh-list
83603265|NCT00556452|Clofarabine|clofarabine|mesh-list
83603266|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
83603267|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603268|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603269|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
83603270|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603271|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83603272|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603273|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83603274|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603275|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
83603276|NCT03158376|Gabapentin|gabapentin|mesh-list
83603277|NCT03158376|Analgesics|analgesics|mesh-ancestor
83603278|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
83603279|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603280|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603281|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
83603282|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83603283|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83061299|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
83603284|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603285|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603286|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83603287|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83603288|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603289|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603291|NCT01797900|Paclitaxel|paclitaxel|mesh-list
83603292|NCT01797900|Cisplatin|cisplatin|mesh-list
83603293|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83603294|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603295|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603296|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603297|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603298|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603299|NCT03572790|Prucalopride|prucalopride|mesh-list
83603300|NCT03572790|Laxatives|laxatives|mesh-ancestor
83603301|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603302|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83603303|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83603304|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
83603305|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603306|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603307|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603308|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
83603309|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603310|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603311|NCT03428802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83603312|NCT03428802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603313|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83603314|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603315|NCT02319486|Carboplatin|carboplatin|mesh-list
83603316|NCT02319486|Etoposide|etoposide|mesh-list
83603317|NCT02319486|Vincristine|vincristine|mesh-list
83603318|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603319|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83603320|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83603321|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83603322|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603323|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603324|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603325|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603326|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603327|NCT03117972|Leucovorin|leucovorin|mesh-list
83603328|NCT03117972|Bevacizumab|bevacizumab|mesh-list
83603329|NCT03117972|Fluorouracil|fluorouracil|mesh-list
83603330|NCT03117972|Capecitabine|capecitabine|mesh-list
83603331|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
83603332|NCT03117972|Irinotecan|irinotecan|mesh-list
83603333|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
83603334|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603335|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603336|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83603337|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83603338|NCT03117972|Growth Substances|growth substances|mesh-ancestor
83603339|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603340|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
83603341|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
83603342|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603343|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603344|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603345|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
83603346|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83603347|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83603348|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603349|NCT03117972|Antidotes|antidotes|mesh-ancestor
83603350|NCT03117972|Protective Agents|protective agents|mesh-ancestor
83603351|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
83603352|NCT03117972|Vitamins|vitamins|mesh-ancestor
83603353|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
83603354|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83603355|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
83603356|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603357|NCT00558012|Vitamin D|vitamin d|mesh-list
83603358|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
83061383|NCT03052348|Ether|ether|mesh-list
83603359|NCT00558012|Calcium|calcium|mesh-list
83603360|NCT00558012|Vitamins|vitamins|mesh-ancestor
83603361|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
83603362|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603363|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83603364|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83603365|NCT00561834|Ranibizumab|ranibizumab|mesh-list
83603366|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83603367|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83603368|NCT00561834|Growth Substances|growth substances|mesh-ancestor
83603369|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603370|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
83603371|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603372|NCT04388202|Sertraline|sertraline|mesh-list
83603373|NCT04388202|Escitalopram|escitalopram|mesh-list
83603374|NCT04388202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83603375|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83603376|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603377|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603378|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603379|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
83603380|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603381|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
83603382|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603383|NCT02128230|Thalidomide|thalidomide|mesh-list
83603384|NCT02128230|Dexamethasone|dexamethasone|mesh-list
83603385|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
83603386|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
83603387|NCT02128230|Melphalan|melphalan|mesh-list
83603388|NCT02128230|Cisplatin|cisplatin|mesh-list
83603389|NCT02128230|Doxorubicin|doxorubicin|mesh-list
83603390|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83603391|NCT02128230|Etoposide|etoposide|mesh-list
83603392|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
83603393|NCT02128230|Lenalidomide|lenalidomide|mesh-list
83603394|NCT02128230|Lenograstim|lenograstim|mesh-list
83603395|NCT02128230|BB 1101|bb 1101|mesh-list
83603396|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603397|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
83603398|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603399|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603400|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83603401|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
83603402|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603403|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603404|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83603405|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83603406|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
83603407|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
83603408|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603409|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603410|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
83603411|NCT02128230|Hormones|hormones|mesh-ancestor
83603412|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83603413|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83603414|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
83603415|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603416|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83603417|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83603418|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83603419|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83603420|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83603421|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83603422|NCT02128230|Growth Substances|growth substances|mesh-ancestor
83603423|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
83603424|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
83603425|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83603426|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603427|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83603428|NCT03416244|Nivolumab|nivolumab|mesh-list
83603429|NCT03416244|Ipilimumab|ipilimumab|mesh-list
83603430|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603431|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603432|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83603433|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603434|NCT05560620|Caffeine|caffeine|mesh-list
83603435|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83603436|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603437|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83603438|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603439|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603440|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83603441|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83603442|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
83603443|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603445|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83603446|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83603447|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603448|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
83603449|NCT03172416|Nivolumab|nivolumab|mesh-list
83603450|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603451|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603452|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83603453|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603454|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
83603455|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83603456|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
83603457|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603458|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
83603459|NCT05559996|Protective Agents|protective agents|mesh-ancestor
83603460|NCT02812212|Diuretics|diuretics|mesh-list
83603461|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
83603462|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603463|NCT05559450|Blinatumomab|blinatumomab|mesh-list
83603464|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603465|NCT00564954|Methylphenidate|methylphenidate|mesh-list
83603466|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83603467|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83603468|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603469|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83603470|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83603471|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603472|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603473|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
83603474|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603475|NCT00565266|Beclomethasone|beclomethasone|mesh-list
83603476|NCT00565266|Bromides|bromides|mesh-list
83603477|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
83603478|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83603479|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83603480|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
83603481|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603482|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603483|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83603484|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
83603485|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
83603486|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83603487|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
83603488|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603489|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603490|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83603491|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83603492|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83603493|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
83603494|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
83603495|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83603496|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
83603497|NCT00565266|Hormones|hormones|mesh-ancestor
83603498|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83603499|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83603500|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
83603501|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83603502|NCT01797978|Methylene Blue|methylene blue|mesh-list
83603503|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603504|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603505|NCT05363202|Fluticasone|fluticasone|mesh-list
83603506|NCT05363202|Xhance|xhance|mesh-list
83603507|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83603508|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83603509|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
83603510|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603511|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603512|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83603513|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
83603514|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603515|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83603516|NCT05461092|Morphine|morphine|mesh-list
83603517|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
83603518|NCT05461092|Bupivacaine|bupivacaine|mesh-list
83603519|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
83603520|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
83603521|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603522|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603523|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
83603524|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603525|NCT05461092|Narcotics|narcotics|mesh-ancestor
83603526|NCT05461092|Analgesics|analgesics|mesh-ancestor
83603527|NCT02129478|Olanzapine|olanzapine|mesh-list
83603528|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
83603529|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
83603530|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603531|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603532|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603533|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83603534|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83603535|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603536|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603537|NCT02129478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83603538|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83603539|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603540|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603541|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603542|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
83603543|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
83603544|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603545|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603546|NCT02129556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83603547|NCT02129556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603548|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
83603549|NCT05362500|Glycolic acid|glycolic acid|mesh-list
83603550|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
83603551|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83603552|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83603553|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603554|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
83603555|NCT05362500|Coagulants|coagulants|mesh-ancestor
83603556|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
83603557|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603558|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83603559|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603560|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83603561|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83603562|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603563|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603564|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
83603565|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603566|NCT05161806|Aflibercept|aflibercept|mesh-list
83603567|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83603568|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83603569|NCT05161806|Growth Substances|growth substances|mesh-ancestor
83603570|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603571|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
83603572|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603573|NCT05362188|Niacinamide|niacinamide|mesh-list
83603574|NCT05362188|Niacin|niacin|mesh-list
83603575|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
83603576|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
83603577|NCT05362188|Vitamins|vitamins|mesh-ancestor
83603578|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
83603579|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603580|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83603581|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
83603582|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603583|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83603584|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
83603585|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
83603586|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603587|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603588|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
83603589|NCT05353374|Petrolatum|petrolatum|mesh-list
83603590|NCT05353374|Emollients|emollients|mesh-ancestor
83603591|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603592|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83603593|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603594|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83603595|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603596|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603597|NCT05214222|Paclitaxel|paclitaxel|mesh-list
83603598|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83603599|NCT05214222|Cisplatin|cisplatin|mesh-list
83603600|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83603601|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603602|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603603|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603604|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603605|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603606|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
83603607|NCT05198232|TEMPO|tempo|mesh-list
83603608|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
83603609|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603610|NCT05198232|Protective Agents|protective agents|mesh-ancestor
83603611|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603612|NCT05198232|Antacids|antacids|mesh-ancestor
83603613|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603614|NCT04747236|Gemcitabine|gemcitabine|mesh-list
83603615|NCT04747236|Azacitidine|azacitidine|mesh-list
83603616|NCT04747236|Romidepsin|romidepsin|mesh-list
83603617|NCT04747236|Belinostat|belinostat|mesh-list
83603618|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603619|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
83603620|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603621|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603622|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603623|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83603624|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83603625|NCT01797666|Pioglitazone|pioglitazone|mesh-list
83603626|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83603627|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603628|NCT05017194|Emodepside|emodepside|mesh-list
83603629|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83603630|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603631|NCT04501380|Rifamycins|rifamycins|mesh-list
83603632|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
83603633|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83603634|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603635|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603636|NCT04465734|Sorafenib|sorafenib|mesh-list
83603637|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603638|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83603639|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603640|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603641|NCT03856632|Liraglutide|liraglutide|mesh-list
83603642|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83603643|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83603644|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603645|NCT03856632|Incretins|incretins|mesh-ancestor
83603646|NCT03856632|Hormones|hormones|mesh-ancestor
83603647|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83603648|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
83603649|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
83603650|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603651|NCT04286178|Vitamins|vitamins|mesh-ancestor
83603652|NCT04655976|Docetaxel|docetaxel|mesh-list
83603653|NCT04655976|Dostarlimab|dostarlimab|mesh-list
83603654|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603655|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603656|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603657|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603658|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603659|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83603660|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
83603661|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603662|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603663|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83061671|NCT03106688|Carfentanil|carfentanil|mesh-list
83603664|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
83603665|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603666|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603667|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83603668|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83603669|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83603670|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83603671|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
83603672|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603673|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83603674|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83603675|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603677|NCT02783430|Milnacipran|milnacipran|mesh-list
83603678|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
83603679|NCT02783430|Analgesics|analgesics|mesh-ancestor
83603680|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
83603681|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603682|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603683|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83603684|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83603685|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
83603686|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
83603687|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603688|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83603689|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83603690|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603691|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603692|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83603693|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83603694|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603695|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83603696|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
83603697|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603698|NCT03642366|Tadalafil|tadalafil|mesh-list
83603699|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
83603700|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83603701|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83603702|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603703|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603704|NCT03642366|Urological Agents|urological agents|mesh-ancestor
83603705|NCT00604968|Doxorubicin|doxorubicin|mesh-list
83603706|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83603707|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83603708|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603709|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83603710|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83603711|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603712|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603713|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83603714|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83603715|NCT00605202|Diuretics|diuretics|mesh-ancestor
83603716|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
83603717|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603718|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83603719|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603720|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603721|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83603722|NCT03548454|Desipramine|desipramine|mesh-list
83603723|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83603724|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83603725|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603726|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603727|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603728|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603729|NCT03548454|Analgesics|analgesics|mesh-ancestor
83603730|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
83603731|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603732|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
83603733|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603734|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
83603735|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83603736|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061820|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
83603737|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83603738|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83603739|NCT00605904|Acamprosate|acamprosate|mesh-list
83603740|NCT00605904|Yohimbine|yohimbine|mesh-list
83603741|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83603742|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
83603743|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
83603744|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603745|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603746|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83603747|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83603748|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83603749|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83603750|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603751|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603752|NCT00605904|Urological Agents|urological agents|mesh-ancestor
83603753|NCT01798914|Insulin|insulin|mesh-list
83603754|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83603755|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603756|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
83603757|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83603758|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83603759|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83603760|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603761|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603762|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
83603763|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603764|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603765|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83603766|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603767|NCT05175768|Niacinamide|niacinamide|mesh-list
83603768|NCT05175768|Niacin|niacin|mesh-list
83603769|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
83603770|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
83603771|NCT05175768|Vitamins|vitamins|mesh-ancestor
83603772|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
83603773|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603774|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83603775|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
83603776|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603777|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83603778|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
83603779|NCT05097846|Amoxicillin|amoxicillin|mesh-list
83603780|NCT05097846|Doxycycline|doxycycline|mesh-list
83603781|NCT05097846|Furazolidone|furazolidone|mesh-list
83603782|NCT05097846|Esomeprazole|esomeprazole|mesh-list
83603783|NCT05097846|Bismuth|bismuth|mesh-list
83603784|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83603785|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603786|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83603787|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603788|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83603789|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603790|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603791|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
83603792|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83603793|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83603794|NCT05097846|Antacids|antacids|mesh-ancestor
83603795|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83603796|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83603797|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83603798|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83603799|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
83603800|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603801|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603802|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603803|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
83603804|NCT02897700|Doxorubicin|doxorubicin|mesh-list
83603805|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83603806|NCT02897700|Fluorouracil|fluorouracil|mesh-list
83603807|NCT02897700|Methotrexate|methotrexate|mesh-list
83603808|NCT02897700|Epirubicin|epirubicin|mesh-list
83603809|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603810|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
83603811|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603812|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603813|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83603814|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
83603815|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603816|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603817|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83603818|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83603819|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83603820|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83603821|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603822|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
83603823|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603824|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83603825|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
83603826|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83603827|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603828|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83603829|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83603830|NCT02889666|Cisplatin|cisplatin|mesh-list
83603831|NCT02889666|Carboplatin|carboplatin|mesh-list
83603832|NCT02889666|Gemcitabine|gemcitabine|mesh-list
83603833|NCT02889666|Docetaxel|docetaxel|mesh-list
83603834|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
83603835|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603836|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603837|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
83603838|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603839|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603840|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603841|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603842|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83603843|NCT00609804|Sorafenib|sorafenib|mesh-list
83603844|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603845|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83603846|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603847|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603848|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
83603849|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
83603850|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
83603851|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603852|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603853|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603854|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83603855|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83603856|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603857|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603858|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83603859|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
83603860|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603861|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603862|NCT02446236|Rituximab|rituximab|mesh-list
83603863|NCT02446236|Lenalidomide|lenalidomide|mesh-list
83603864|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603865|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603866|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
83603867|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603868|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603869|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83603870|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83603871|NCT02446236|Growth Substances|growth substances|mesh-ancestor
83603872|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
83603873|NCT00610740|Gemcitabine|gemcitabine|mesh-list
83603874|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603875|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
83603876|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603877|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603878|NCT00611442|Lubiprostone|lubiprostone|mesh-list
83603879|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83603880|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83603881|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603882|NCT02136420|Promethazine|promethazine|mesh-list
83603883|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
83603884|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
83603885|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
83603886|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83603887|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
83603888|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
83603889|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603890|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603891|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603892|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83603893|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83603894|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83603895|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603896|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
83603897|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
83603898|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
83603899|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603900|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
83603901|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
83603902|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603903|NCT02136498|Varenicline|varenicline|mesh-list
83603904|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83603905|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83603906|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
83603907|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603908|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603909|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603910|NCT00612222|Aldesleukin|aldesleukin|mesh-list
83603911|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
83603912|NCT00612222|Fludarabine|fludarabine|mesh-list
83603913|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
83603914|NCT00612222|Interleukin-2|interleukin-2|mesh-list
83603915|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83603916|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
83603917|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603918|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603919|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83603920|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
83603921|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603922|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603923|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83603924|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603925|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
83603926|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83603927|NCT00612222|Analgesics|analgesics|mesh-ancestor
83603928|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
83603929|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603930|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83603931|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83603932|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
83603933|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83603934|NCT01711242|Capecitabine|capecitabine|mesh-list
83603935|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
83603936|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83603937|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
83603938|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603939|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603940|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83603941|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
83603942|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83603943|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83603944|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
83603945|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603946|NCT04405908|Antacids|antacids|mesh-ancestor
83603947|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603948|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83603949|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83603950|NCT04304274|Morphine|morphine|mesh-list
83603951|NCT04304274|Ropivacaine|ropivacaine|mesh-list
83603952|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83603953|NCT04304274|Narcotics|narcotics|mesh-ancestor
83603954|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603955|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603956|NCT04304274|Analgesics|analgesics|mesh-ancestor
83603957|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
83603958|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603959|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
83603960|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
83603961|NCT02132832|Buspirone|buspirone|mesh-list
83603962|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83061976|NCT02037399|Dexamethasone|dexamethasone|mesh-list
83603963|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83603964|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83603965|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603966|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83603967|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83603968|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
83603969|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83603970|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603971|NCT00614406|Celecoxib|celecoxib|mesh-list
83603972|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83603973|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83603974|NCT00614406|Analgesics|analgesics|mesh-ancestor
83603975|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
83603976|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83603977|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83603978|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83603979|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83603980|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83603981|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83603982|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83603983|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603984|NCT00614484|Paclitaxel|paclitaxel|mesh-list
83603985|NCT00614484|Carboplatin|carboplatin|mesh-list
83603986|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83603987|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603988|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
83603989|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
83603990|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
83603991|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83603992|NCT04159974|Durvalumab|durvalumab|mesh-list
83603993|NCT04159974|Tremelimumab|tremelimumab|mesh-list
83603994|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83603995|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83603996|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
83603997|NCT04142502|Propofol|propofol|mesh-list
83603998|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83603999|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604000|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604001|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83604002|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
83604003|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
83604004|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83604005|NCT04142502|Analgesics|analgesics|mesh-ancestor
83604006|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
83604007|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604008|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83604009|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83604010|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83604011|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
83604012|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604013|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604014|NCT00569010|Cytarabine|cytarabine|mesh-list
83604015|NCT00569010|Azacitidine|azacitidine|mesh-list
83604016|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604017|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
83604018|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604019|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604020|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
83604021|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604022|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604023|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
83604024|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604025|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604026|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
83604027|NCT00616122|Methotrexate|methotrexate|mesh-list
83604028|NCT00616122|Sunitinib|sunitinib|mesh-list
83604029|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604030|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
83604031|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604032|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604033|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83604034|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
83604035|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604036|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604037|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83604038|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83604039|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
83604040|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83604041|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604043|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604044|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604045|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83604046|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83604047|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83604048|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83604049|NCT00616122|Growth Substances|growth substances|mesh-ancestor
83604050|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
83604051|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83604052|NCT00617058|Metformin|metformin|mesh-list
83604053|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83604054|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604055|NCT00618540|Fludarabine|fludarabine|mesh-list
83604056|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
83604057|NCT00618540|Melphalan|melphalan|mesh-list
83604058|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
83604059|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604060|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604061|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
83604062|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604063|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604064|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
83604065|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604066|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83604067|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
83604068|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83604069|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604070|NCT00570960|Dextrans|dextrans|mesh-list
83604071|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
83604072|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
83604073|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
83604074|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83604075|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
83604076|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83604077|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
83604078|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604079|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604080|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83604081|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
83604082|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83604083|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83604084|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83604085|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
83604086|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604087|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604088|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83604089|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83604090|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604091|NCT00574236|Doxorubicin|doxorubicin|mesh-list
83604092|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83604093|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604094|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83604095|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604096|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604097|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604098|NCT00574548|Vaccines|vaccines|mesh-list
83604099|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83604100|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
83604101|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604102|NCT01168219|Methotrexate|methotrexate|mesh-list
83604103|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
83604104|NCT01168219|Azacitidine|azacitidine|mesh-list
83604105|NCT01168219|Fludarabine|fludarabine|mesh-list
83604106|NCT01168219|Busulfan|busulfan|mesh-list
83604107|NCT01168219|Tacrolimus|tacrolimus|mesh-list
83604108|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83604109|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83604110|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
83604111|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83604112|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604113|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604114|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
83604115|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604116|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604117|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604118|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604119|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83604120|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604121|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
83604122|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604123|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83604124|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83604125|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
83604126|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83604127|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83604129|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83604130|NCT01115803|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83604131|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83604132|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604133|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604134|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604135|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
83604136|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604137|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604138|NCT01115569|Hydrocodone|hydrocodone|mesh-list
83604139|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83604140|NCT01115569|Narcotics|narcotics|mesh-ancestor
83604141|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604142|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604143|NCT01115569|Analgesics|analgesics|mesh-ancestor
83604144|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
83604145|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604146|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
83604147|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
83604148|NCT01107886|Saxagliptin|saxagliptin|mesh-list
83604149|NCT01107886|Incretins|incretins|mesh-ancestor
83604150|NCT01107886|Hormones|hormones|mesh-ancestor
83604151|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604152|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604153|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83604154|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
83604155|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604156|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604157|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83604158|NCT01107457|Ixekizumab|ixekizumab|mesh-list
83604159|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604160|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
83604161|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83604162|NCT05767008|Protective Agents|protective agents|mesh-ancestor
83604163|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604164|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604165|NCT05766631|Methadone|methadone|mesh-list
83604166|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83604167|NCT05766631|Narcotics|narcotics|mesh-ancestor
83604168|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604169|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604170|NCT05766631|Analgesics|analgesics|mesh-ancestor
83604171|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
83604172|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604173|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
83604174|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
83604175|NCT05766605|Leucovorin|leucovorin|mesh-list
83604176|NCT05766605|Doxorubicin|doxorubicin|mesh-list
83604177|NCT05766605|Fluorouracil|fluorouracil|mesh-list
83604178|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
83604179|NCT05766605|Raltitrexed|raltitrexed|mesh-list
83604180|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604181|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83604182|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83604183|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604184|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604185|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604186|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
83604187|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604188|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604189|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
83604190|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604191|NCT05766605|Antidotes|antidotes|mesh-ancestor
83604192|NCT05766605|Protective Agents|protective agents|mesh-ancestor
83604193|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
83604194|NCT05766605|Vitamins|vitamins|mesh-ancestor
83604195|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
83604196|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83604197|NCT05766514|Cytarabine|cytarabine|mesh-list
83604198|NCT05766514|Decitabine|decitabine|mesh-list
83604199|NCT05766514|Venetoclax|venetoclax|mesh-list
83604200|NCT05766514|Cladribine|cladribine|mesh-list
83604201|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604202|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
83604203|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604204|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604205|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
83604206|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604207|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604208|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
83604209|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604210|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604211|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
83604212|NCT05766436|Melatonin|melatonin|mesh-list
83604213|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83604214|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604215|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604216|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83604217|NCT05766436|Analgesics|analgesics|mesh-ancestor
83604218|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
83604219|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604220|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83604221|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83604222|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83604223|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83604224|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604225|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604226|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
83604227|NCT05766436|Protective Agents|protective agents|mesh-ancestor
83604228|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
83604229|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83604230|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
83604231|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
83604232|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604233|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604234|NCT05766384|Xenon|xenon|mesh-list
83604235|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83604236|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
83604237|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
83604238|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604239|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604240|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
83604241|NCT05766267|Rifampin|rifampin|mesh-list
83604242|NCT05766267|Isoniazid|isoniazid|mesh-list
83604243|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
83604244|NCT05766267|Ethambutol|ethambutol|mesh-list
83604245|NCT05766267|Rifabutin|rifabutin|mesh-list
83604246|NCT05766267|Bedaquiline|bedaquiline|mesh-list
83604247|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83604248|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604249|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83604250|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604251|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604252|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604253|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604254|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83604255|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
83604256|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
83604257|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83604258|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83604259|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83604260|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83604261|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83604262|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83604263|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83604264|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83604265|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83604266|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
83604267|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83604268|NCT05766176|Antibodies|antibodies|mesh-list
83604269|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
83604270|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
83604271|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604272|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83604273|NCT05766124|Plasminogen|plasminogen|mesh-list
83604274|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83604275|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83604276|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604277|NCT05766085|Dexamethasone|dexamethasone|mesh-list
83604278|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604279|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
83604280|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
83604281|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604282|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604283|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604284|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
83604285|NCT05766085|Hormones|hormones|mesh-ancestor
83604286|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604287|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604288|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604289|NCT05765825|Carboplatin|carboplatin|mesh-list
83604290|NCT05765825|Etoposide|etoposide|mesh-list
83604291|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604292|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83604293|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83604294|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604295|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604296|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604297|NCT05765747|Celecoxib|celecoxib|mesh-list
83604298|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83604299|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83604300|NCT05765747|Analgesics|analgesics|mesh-ancestor
83604301|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
83604302|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604303|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604304|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604305|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604306|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83604307|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83604308|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604309|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604310|NCT05765617|Calcitriol|calcitriol|mesh-list
83604311|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83604312|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604313|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83604314|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83604315|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604316|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83604317|NCT05765617|Vitamins|vitamins|mesh-ancestor
83604318|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
83604319|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83604320|NCT05765578|Vaccines|vaccines|mesh-list
83604321|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
83604322|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604323|NCT05765500|Leuprolide|leuprolide|mesh-list
83604324|NCT05765500|Relugolix|relugolix|mesh-list
83604325|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83604326|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
83604327|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83604328|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604329|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604330|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604331|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
83604332|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
83604333|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604334|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
83604335|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83604336|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83604337|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83604338|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604339|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604340|NCT05765487|Urological Agents|urological agents|mesh-ancestor
83604341|NCT05765357|Trastuzumab|trastuzumab|mesh-list
83604342|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604343|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604344|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
83604345|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83604346|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
83604347|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604348|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
83604349|NCT05765240|Protective Agents|protective agents|mesh-ancestor
83604350|NCT05765110|Dopamine|dopamine|mesh-list
83604351|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
83604352|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83604353|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
83604354|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
83604355|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604356|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604357|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
83604358|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604359|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604360|NCT05765110|Protective Agents|protective agents|mesh-ancestor
83604361|NCT05765097|Pancrelipase|pancrelipase|mesh-list
83604362|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604363|NCT05764811|Canagliflozin|canagliflozin|mesh-list
83604364|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83604365|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604366|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83604367|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604368|NCT05764798|Zolpidem|zolpidem|mesh-list
83604369|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83604370|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83604371|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604372|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604373|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83604374|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
83604375|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
83604376|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604377|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604378|NCT05764746|Artesunate|artesunate|mesh-list
83604379|NCT05764746|Lumefantrine|lumefantrine|mesh-list
83604380|NCT05764746|Artemether|artemether|mesh-list
83604381|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83604382|NCT05764746|Amodiaquine|amodiaquine|mesh-list
83604383|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
83604384|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83604385|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83604386|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604387|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604388|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
83604389|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
83604390|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83604391|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
83604392|NCT05764707|Acetaminophen|acetaminophen|mesh-list
83604393|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83604394|NCT05764707|Analgesics|analgesics|mesh-ancestor
83604395|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
83604396|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604397|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604398|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
83604399|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
83604400|NCT05763602|Povidone|povidone|mesh-list
83604401|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
83604402|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
83604403|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83604404|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604405|NCT05757622|Remifentanil|remifentanil|mesh-list
83604406|NCT05757622|Propofol|propofol|mesh-list
83604407|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83604408|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604409|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604410|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83604411|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
83604412|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
83604413|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83604414|NCT05757622|Narcotics|narcotics|mesh-ancestor
83604415|NCT05757622|Analgesics|analgesics|mesh-ancestor
83604416|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
83604417|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604418|NCT05746819|Antipyretics|antipyretics|mesh-list
83604419|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604420|NCT05746650|Hormones|hormones|mesh-list
83604421|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604422|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604423|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
83604424|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
83604425|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604426|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604427|NCT05731726|Celecoxib|celecoxib|mesh-list
83604428|NCT05731726|Capecitabine|capecitabine|mesh-list
83604429|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
83604430|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604431|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
83604432|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604433|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604434|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83604435|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83604436|NCT05731726|Analgesics|analgesics|mesh-ancestor
83604437|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
83604438|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604439|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604440|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604441|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604442|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83604443|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83604444|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604445|NCT05715931|Leucovorin|leucovorin|mesh-list
83604446|NCT05715931|Docetaxel|docetaxel|mesh-list
83604447|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
83604448|NCT05715931|Trastuzumab|trastuzumab|mesh-list
83604449|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604450|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
83604451|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
83604452|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83604453|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604454|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604455|NCT05715931|Antidotes|antidotes|mesh-ancestor
83604456|NCT05715931|Protective Agents|protective agents|mesh-ancestor
83604457|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604458|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
83604459|NCT05715931|Vitamins|vitamins|mesh-ancestor
83604460|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
83604461|NCT05714384|Calcium|calcium|mesh-list
83604462|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83604463|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604464|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
83604465|NCT05714007|Hematinics|hematinics|mesh-ancestor
83604466|NCT05708183|Micronutrients|micronutrients|mesh-list
83604467|NCT05708183|Trace Elements|trace elements|mesh-list
83604468|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604469|NCT05594823|Furosemide|furosemide|mesh-list
83604470|NCT05594823|Diuretics|diuretics|mesh-list
83604471|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
83604472|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604473|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83604474|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83604475|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604476|NCT05581797|Psilocybin|psilocybin|mesh-list
83604477|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
83604478|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604479|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83604480|NCT05581030|Rituximab|rituximab|mesh-list
83604481|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604482|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604483|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
83604484|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604485|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604486|NCT05510544|Plerixafor|plerixafor|mesh-list
83604487|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83604488|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83604489|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
83604490|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604491|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83604492|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604493|NCT05509699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604494|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604495|NCT05441215|Ritonavir|ritonavir|mesh-list
83604496|NCT05441215|Nirmatrelvir|nirmatrelvir|mesh-list
83604497|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83604498|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83604499|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
83604500|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604501|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604503|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83604504|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
83604505|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604506|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83604507|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83604508|NCT05431777|Avelumab|avelumab|mesh-list
83604509|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604510|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604511|NCT05327647|Bicalutamide|bicalutamide|mesh-list
83604512|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
83604513|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
83604514|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
83604515|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604516|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604517|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604518|NCT05320380|Cytarabine|cytarabine|mesh-list
83604519|NCT05320380|Prednisolone|prednisolone|mesh-list
83604520|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83604521|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
83604522|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83604523|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
83604524|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
83604525|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83604526|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83604527|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83604528|NCT05320380|Cortisone|cortisone|mesh-list
83604529|NCT05320380|Methotrexate|methotrexate|mesh-list
83604530|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
83604531|NCT05320380|Fludarabine|fludarabine|mesh-list
83604532|NCT05320380|Daunorubicin|daunorubicin|mesh-list
83604533|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83604534|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
83604535|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83604536|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
83604537|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83604538|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604539|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604540|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
83604541|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604542|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604543|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604544|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604545|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83604546|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604547|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
83604548|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604549|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83604550|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
83604551|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604552|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604553|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
83604554|NCT05320380|Hormones|hormones|mesh-ancestor
83604555|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604556|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604557|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
83604558|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
83604559|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604560|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604561|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83604562|NCT05320380|Protective Agents|protective agents|mesh-ancestor
83604563|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83604564|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83604565|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604566|NCT05303532|Durvalumab|durvalumab|mesh-list
83604567|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604568|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604569|NCT05263908|Ritonavir|ritonavir|mesh-list
83604570|NCT05263908|Nirmatrelvir|nirmatrelvir|mesh-list
83604571|NCT05263908|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83604572|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83604573|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83604575|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604576|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604577|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83604578|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83604579|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
83604580|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604581|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83604582|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83604583|NCT05259527|Vitamin D|vitamin d|mesh-list
83604584|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
83604585|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
83604586|NCT05259527|Vitamins|vitamins|mesh-list
83604587|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
83604588|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604589|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83604590|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83604591|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
83604592|NCT05256641|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83604593|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604594|NCT05256641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83604595|NCT05256641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604596|NCT05256641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604597|NCT05187377|Hormones|hormones|mesh-list
83604598|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604599|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604600|NCT05177588|Metformin|metformin|mesh-list
83604601|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83604602|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604603|NCT05171660|Bevacizumab|bevacizumab|mesh-list
83604604|NCT05171660|Capecitabine|capecitabine|mesh-list
83604605|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
83604606|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604607|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604608|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83604609|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83604610|NCT05171660|Growth Substances|growth substances|mesh-ancestor
83604611|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604612|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
83604613|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604614|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
83604615|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604616|NCT05153239|Irinotecan|irinotecan|mesh-list
83604617|NCT05153239|Topotecan|topotecan|mesh-list
83604618|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83604619|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604620|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604621|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604622|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604623|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
83604624|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83604625|NCT05140941|Velpatasvir|velpatasvir|mesh-list
83604626|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
83604627|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604628|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
83604629|NCT05133258|Dexamethasone|dexamethasone|mesh-list
83604630|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604631|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
83604632|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
83604633|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604634|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604635|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604636|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
83604637|NCT05133258|Hormones|hormones|mesh-ancestor
83604638|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604639|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604640|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604641|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83604642|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604643|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83604644|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604645|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604646|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604647|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83604648|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83604649|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
83604651|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604652|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604653|NCT05091346|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83604654|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604655|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83604656|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604657|NCT05059873|Prednisone|prednisone|mesh-list
83604658|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604659|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
83604660|NCT05059873|Hormones|hormones|mesh-ancestor
83604661|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604662|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604663|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604664|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604665|NCT05055024|Mazindol|mazindol|mesh-list
83604666|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83604667|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604668|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83604669|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83604670|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83604671|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604672|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
83604673|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604674|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83604675|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
83604676|NCT05053971|Entinostat|entinostat|mesh-list
83604677|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83604678|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604679|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604680|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604681|NCT05047978|Caseins|caseins|mesh-list
83604682|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
83604683|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
83604684|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604685|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
83604686|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604687|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604688|NCT05037552|Hemostatics|hemostatics|mesh-list
83604689|NCT05037552|Coagulants|coagulants|mesh-ancestor
83604690|NCT05028634|Vaccines|vaccines|mesh-list
83604691|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83604692|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
83604693|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604694|NCT05028075|Cobalt|cobalt|mesh-list
83604695|NCT05028075|Trace Elements|trace elements|mesh-ancestor
83604696|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
83604697|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604698|NCT05012631|Losartan|losartan|mesh-list
83604699|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83604700|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83604701|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83604702|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83604703|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604704|NCT04989218|Cisplatin|cisplatin|mesh-list
83604705|NCT04989218|Gemcitabine|gemcitabine|mesh-list
83604706|NCT04989218|Durvalumab|durvalumab|mesh-list
83604707|NCT04989218|Tremelimumab|tremelimumab|mesh-list
83604708|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604709|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604710|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
83604711|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604712|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604713|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83604714|NCT04964544|Calcium|calcium|mesh-list
83604715|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83604716|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604717|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83604718|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83604719|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
83604720|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062732|NCT04867252|Inositol|inositol|mesh-list
83604721|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83604722|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83604723|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604724|NCT04954196|Amlodipine|amlodipine|mesh-list
83604725|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83604726|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83604727|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83604728|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604729|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83604730|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604731|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
83604732|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83604733|NCT04944290|Brinzolamide|brinzolamide|mesh-list
83604734|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83604735|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83604736|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83604737|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83604738|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
83604739|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604740|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604741|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604742|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83604743|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604744|NCT04937166|Azacitidine|azacitidine|mesh-list
83604745|NCT04937166|Venetoclax|venetoclax|mesh-list
83604746|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604747|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
83604748|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604749|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604750|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604751|NCT04931017|Metformin|metformin|mesh-list
83604752|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83604753|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604754|NCT04920032|Irinotecan|irinotecan|mesh-list
83604755|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83604756|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604757|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604758|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604759|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604760|NCT04908176|Midazolam|midazolam|mesh-list
83604761|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83604762|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83604763|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604764|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604765|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83604766|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83604767|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83604768|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83604769|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
83604770|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
83604771|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
83604772|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
83604773|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604774|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604775|NCT04893109|Paclitaxel|paclitaxel|mesh-list
83604776|NCT04893109|Maytansine|maytansine|mesh-list
83604777|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83604778|NCT04893109|Trastuzumab|trastuzumab|mesh-list
83604779|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83604780|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604781|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
83604782|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
83604783|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
83604784|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604785|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604786|NCT04893109|Immunotoxins|immunotoxins|mesh-ancestor
83604787|NCT04893109|Immunoconjugates|immunoconjugates|mesh-ancestor
83604788|NCT04893109|Immunologic Factors|immunologic factors|mesh-ancestor
83604789|NCT04893109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604790|NCT04882540|Brivaracetam|brivaracetam|mesh-list
83604791|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
83604792|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
83604793|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83604794|NCT04859829|Antibodies|antibodies|mesh-list
83604795|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
83604796|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83604797|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
83604798|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604799|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83604800|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83604801|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604802|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
83604804|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
83604805|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83604806|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
83604807|NCT04788043|Magrolimab|magrolimab|mesh-list
83604808|NCT04788043|Antibodies|antibodies|mesh-list
83604809|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
83604810|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83604811|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
83604812|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604813|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604814|NCT04788043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83604815|NCT04788043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604816|NCT04778267|Dexamethasone|dexamethasone|mesh-list
83604817|NCT04778267|Bupivacaine|bupivacaine|mesh-list
83604818|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83604819|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604820|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
83604821|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
83604822|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604823|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604824|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604825|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
83604826|NCT04778267|Hormones|hormones|mesh-ancestor
83604827|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604828|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604829|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604830|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
83604831|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
83604832|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604833|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
83604834|NCT04761627|Ustekinumab|ustekinumab|mesh-list
83604835|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604836|NCT04760691|Tenofovir|tenofovir|mesh-list
83604837|NCT04760691|Emtricitabine|emtricitabine|mesh-list
83604838|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83604839|NCT04760691|Leuprolide|leuprolide|mesh-list
83604840|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83604841|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83604842|NCT04760691|Estradiol|estradiol|mesh-list
83604843|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83604844|NCT04760691|Estrogens|estrogens|mesh-list
83604845|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
83604846|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604847|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83604848|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83604849|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604850|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604851|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83604852|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83604853|NCT04760691|Hormones|hormones|mesh-ancestor
83604854|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604855|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604856|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83604857|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
83604858|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83604859|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83604860|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83604861|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
83604862|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604863|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604864|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
83604865|NCT04735471|Fludarabine|fludarabine|mesh-list
83604866|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604867|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
83604868|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604869|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604870|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83604871|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
83062887|NCT03738618|Hormones|hormones|mesh-ancestor
83604872|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604873|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604874|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83604875|NCT04718181|Omeprazole|omeprazole|mesh-list
83604876|NCT04718181|Risdiplam|risdiplam|mesh-list
83604877|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83604878|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604879|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83604880|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604881|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604882|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83604883|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604884|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604885|NCT04713735|Lactoferrin|lactoferrin|mesh-list
83604886|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604887|NCT04682366|Tamsulosin|tamsulosin|mesh-list
83604888|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83604889|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83604890|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83604891|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
83604892|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83604893|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604894|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604895|NCT04682366|Urological Agents|urological agents|mesh-ancestor
83604896|NCT04656301|Psilocybin|psilocybin|mesh-list
83604897|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
83604898|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604899|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83604900|NCT04573504|Clindamycin|clindamycin|mesh-list
83604901|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
83604902|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
83604903|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83604904|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83604905|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83604906|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83604907|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604908|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604909|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83604910|NCT04560972|Carboplatin|carboplatin|mesh-list
83604911|NCT04560972|Etoposide|etoposide|mesh-list
83604912|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
83604913|NCT04560972|Atezolizumab|atezolizumab|mesh-list
83604914|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
83604915|NCT04560972|LB100|lb100|mesh-list
83604916|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83604917|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604918|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83604919|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83604920|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83604921|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604922|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604923|NCT04560972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83604924|NCT04560972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83604925|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
83604926|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604927|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
83604928|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604929|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
83604930|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
83604931|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
83604932|NCT04521335|Copper|copper|mesh-list
83604933|NCT04521335|Disulfiram|disulfiram|mesh-list
83604934|NCT04521335|Trace Elements|trace elements|mesh-ancestor
83604935|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
83604936|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604937|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83604938|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83604939|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604940|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604941|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
83604942|NCT04515615|Tegafur|tegafur|mesh-list
83604943|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604944|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604945|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
83604946|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604947|NCT04505410|Infliximab|infliximab|mesh-list
83604948|NCT04505410|Ustekinumab|ustekinumab|mesh-list
83604949|NCT04505410|Tofacitinib|tofacitinib|mesh-list
83604950|NCT04505410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83604951|NCT04505410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604952|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604953|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604954|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604955|NCT04505410|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83604956|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83604957|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604958|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604959|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
83604960|NCT04477304|Narcotics|narcotics|mesh-ancestor
83604961|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83604962|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604963|NCT04477304|Analgesics|analgesics|mesh-ancestor
83604964|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
83604965|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604966|NCT04329325|Dexamethasone|dexamethasone|mesh-list
83604967|NCT04329325|Methotrexate|methotrexate|mesh-list
83604968|NCT04329325|Dasatinib|dasatinib|mesh-list
83604969|NCT04329325|Blinatumomab|blinatumomab|mesh-list
83604970|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83604971|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
83604972|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
83604973|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83604974|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83604975|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83604976|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
83604977|NCT04329325|Hormones|hormones|mesh-ancestor
83604978|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83604979|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83604980|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83604981|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83604982|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
83604983|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83604984|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83604985|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
83604986|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83604987|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
83604988|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83604989|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83604990|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83604991|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
83604992|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83604993|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83604994|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83604995|NCT04280692|Lumefantrine|lumefantrine|mesh-list
83604996|NCT04280692|Artemether|artemether|mesh-list
83604997|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
83604998|NCT04280692|Piperaquine|piperaquine|mesh-list
83604999|NCT04280692|Primaquine|primaquine|mesh-list
83605000|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
83605001|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83605002|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83605003|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
83605004|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605005|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605006|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605007|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83605008|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605009|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605010|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83605011|NCT04247126|Paclitaxel|paclitaxel|mesh-list
83605012|NCT04247126|Gemcitabine|gemcitabine|mesh-list
83605013|NCT04247126|Fulvestrant|fulvestrant|mesh-list
83605014|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605015|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605016|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605017|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605018|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605019|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605020|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605021|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
83605022|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83605023|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83605024|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83605025|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
83605026|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605027|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605029|NCT04198766|Antibodies|antibodies|mesh-list
83605030|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
83605031|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605032|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605033|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605034|NCT04198766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605035|NCT04198766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605036|NCT04191889|Apatinib|apatinib|mesh-list
83605037|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605038|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83605039|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605040|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605041|NCT04181996|Colchicine|colchicine|mesh-list
83605042|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
83605043|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605044|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605045|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605046|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605047|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605048|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605049|NCT04179162|Gemcitabine|gemcitabine|mesh-list
83605050|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
83605051|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605052|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
83605053|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605054|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605055|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83605056|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
83605057|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605058|NCT04163432|Carboplatin|carboplatin|mesh-list
83605059|NCT04163432|Pemetrexed|pemetrexed|mesh-list
83605060|NCT04163432|Durvalumab|durvalumab|mesh-list
83605061|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605062|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605063|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605064|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83605065|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83605066|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605067|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
83605068|NCT04151706|Busulfan|busulfan|mesh-list
83605069|NCT04151706|Thiotepa|thiotepa|mesh-list
83605070|NCT04151706|Fludarabine|fludarabine|mesh-list
83605071|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605072|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
83605073|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605074|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605075|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83605076|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
83605077|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605078|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605079|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83605080|NCT04151667|Dexamethasone|dexamethasone|mesh-list
83605081|NCT04151667|Lenalidomide|lenalidomide|mesh-list
83605082|NCT04151667|Bortezomib|bortezomib|mesh-list
83605083|NCT04151667|Daratumumab|daratumumab|mesh-list
83605084|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605085|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
83605086|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
83605087|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605088|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605089|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83605090|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
83605091|NCT04151667|Hormones|hormones|mesh-ancestor
83605092|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605093|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83605094|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605095|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
83605096|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83605097|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83605098|NCT04151667|Growth Substances|growth substances|mesh-ancestor
83605099|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
83605100|NCT04119453|Apatinib|apatinib|mesh-list
83605101|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605102|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83605103|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605104|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605105|NCT04099251|Nivolumab|nivolumab|mesh-list
83605106|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605107|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605108|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605109|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605110|NCT04083235|Leucovorin|leucovorin|mesh-list
83605111|NCT04083235|Paclitaxel|paclitaxel|mesh-list
83605112|NCT04083235|Gemcitabine|gemcitabine|mesh-list
83605113|NCT04083235|Fluorouracil|fluorouracil|mesh-list
83605114|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
83605115|NCT04083235|Irinotecan|irinotecan|mesh-list
83605116|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605117|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605118|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605119|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605120|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605121|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605122|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605123|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
83605124|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605125|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
83605126|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605127|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83605128|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83605129|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605130|NCT04083235|Antidotes|antidotes|mesh-ancestor
83605131|NCT04083235|Protective Agents|protective agents|mesh-ancestor
83605132|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
83605133|NCT04083235|Vitamins|vitamins|mesh-ancestor
83605134|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
83605135|NCT04068610|Leucovorin|leucovorin|mesh-list
83605136|NCT04068610|Durvalumab|durvalumab|mesh-list
83605137|NCT04068610|Fluorouracil|fluorouracil|mesh-list
83605138|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
83605139|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605140|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605141|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605142|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
83605143|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605144|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605145|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605146|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
83605147|NCT04068610|Antidotes|antidotes|mesh-ancestor
83605148|NCT04068610|Protective Agents|protective agents|mesh-ancestor
83605149|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
83605150|NCT04068610|Vitamins|vitamins|mesh-ancestor
83605151|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
83605152|NCT04006119|Cemiplimab|cemiplimab|mesh-list
83605153|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605154|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605155|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
83605156|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83605157|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605158|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83605159|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605160|NCT04002180|Vedolizumab|vedolizumab|mesh-list
83605161|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83605162|NCT04002011|Warfarin|warfarin|mesh-list
83605163|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
83605164|NCT04002011|Dabigatran|dabigatran|mesh-list
83605165|NCT04002011|Apixaban|apixaban|mesh-list
83605166|NCT04002011|Edoxaban|edoxaban|mesh-list
83605167|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
83605168|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83605169|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
83605170|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83605171|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605172|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605173|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605174|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83605175|NCT03903692|Laxatives|laxatives|mesh-ancestor
83605176|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83605177|NCT03884998|Nivolumab|nivolumab|mesh-list
83605178|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605179|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605180|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605181|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605182|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
83605183|NCT03831711|Bombesin|bombesin|mesh-list
83605184|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605185|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83605186|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605187|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83605188|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
83605189|NCT03809624|Antibodies|antibodies|mesh-list
83605190|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
83605191|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605192|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605193|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605194|NCT03809624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605195|NCT03809624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605196|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
83605197|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605198|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
83605199|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605200|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605201|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83605202|NCT03783026|Apremilast|apremilast|mesh-list
83605203|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83605204|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83605205|NCT03783026|Analgesics|analgesics|mesh-ancestor
83605206|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
83605207|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605208|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605209|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605210|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605211|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83605212|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83605213|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605214|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605215|NCT03775460|Prednisolone|prednisolone|mesh-list
83605216|NCT03775460|Methotrexate|methotrexate|mesh-list
83605217|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83605218|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
83605219|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83605220|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605221|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605222|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
83605223|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605224|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605225|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83605226|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605227|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83605228|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605229|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
83605230|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605231|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83605232|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605233|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
83605234|NCT03775460|Hormones|hormones|mesh-ancestor
83605235|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605236|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83605237|NCT03617679|Rucaparib|rucaparib|mesh-list
83605238|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83605239|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605240|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605241|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605242|NCT03591731|Nivolumab|nivolumab|mesh-list
83605243|NCT03591731|Ipilimumab|ipilimumab|mesh-list
83605244|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605245|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605246|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605247|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605248|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83605249|NCT03538691|Dexetimide|dexetimide|mesh-list
83605250|NCT03538691|Citalopram|citalopram|mesh-list
83605251|NCT03538691|Fluoxetine|fluoxetine|mesh-list
83605252|NCT03538691|Paroxetine|paroxetine|mesh-list
83605253|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83605254|NCT03538691|Sertraline|sertraline|mesh-list
83605255|NCT03538691|Escitalopram|escitalopram|mesh-list
83605256|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
83605257|NCT03538691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83605258|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83605259|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83605260|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605261|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83605262|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
83605263|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605264|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83605265|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83605266|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
83605267|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
83605268|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605269|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83605270|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83605271|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
83605272|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83605273|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
83605274|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83605275|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83605276|NCT03538691|Analgesics|analgesics|mesh-ancestor
83605277|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
83605278|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
83605279|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83605280|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83605281|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605282|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
83605283|NCT03489018|Vaccines|vaccines|mesh-list
83605284|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83605285|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
83605286|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605287|NCT03469960|Nivolumab|nivolumab|mesh-list
83605288|NCT03469960|Ipilimumab|ipilimumab|mesh-list
83605289|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605290|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605291|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605292|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605293|NCT03439033|Edetic Acid|edetic acid|mesh-list
83605294|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
83605295|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
83605296|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
83605297|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605298|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
83605299|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83605300|NCT03330886|Atezolizumab|atezolizumab|mesh-list
83605301|NCT03330886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605302|NCT03330886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605303|NCT03330886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605304|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605305|NCT03282799|Etonogestrel|etonogestrel|mesh-list
83605306|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83605307|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
83605308|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83605309|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605310|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83605311|NCT03125928|Paclitaxel|paclitaxel|mesh-list
83605312|NCT03125928|Trastuzumab|trastuzumab|mesh-list
83605313|NCT03125928|Atezolizumab|atezolizumab|mesh-list
83605314|NCT03125928|Pertuzumab|pertuzumab|mesh-list
83605315|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605316|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605317|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605318|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605319|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605320|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605321|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605322|NCT03125928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83063338|NCT03041506|Lidocaine|lidocaine|mesh-list
83605323|NCT03085056|Paclitaxel|paclitaxel|mesh-list
83605324|NCT03085056|Trametinib|trametinib|mesh-list
83605325|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605326|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605327|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605328|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605329|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605330|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605331|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83605332|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605333|NCT03006705|Capecitabine|capecitabine|mesh-list
83605334|NCT03006705|Tegafur|tegafur|mesh-list
83605335|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
83605336|NCT03006705|Nivolumab|nivolumab|mesh-list
83605337|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605338|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
83605339|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605340|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605341|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605342|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605343|NCT02987543|Olaparib|olaparib|mesh-list
83605344|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
83605345|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83605346|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605347|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605348|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605349|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83605350|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
83605351|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605352|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605353|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83605354|NCT02983045|Paclitaxel|paclitaxel|mesh-list
83605355|NCT02983045|Cisplatin|cisplatin|mesh-list
83605356|NCT02983045|Carboplatin|carboplatin|mesh-list
83605357|NCT02983045|Nivolumab|nivolumab|mesh-list
83605358|NCT02983045|Pemetrexed|pemetrexed|mesh-list
83605359|NCT02983045|Ipilimumab|ipilimumab|mesh-list
83605360|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605361|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605362|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605363|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605364|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605365|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605366|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605367|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605368|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605369|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83605370|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83605371|NCT02894398|Letrozole|letrozole|mesh-list
83605372|NCT02894398|Fulvestrant|fulvestrant|mesh-list
83605373|NCT02894398|Palbociclib|palbociclib|mesh-list
83605374|NCT02894398|Anastrozole|anastrozole|mesh-list
83605375|NCT02894398|Exemestane|exemestane|mesh-list
83605376|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605377|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83605378|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83605379|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605380|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605381|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83605382|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
83605383|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605384|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605385|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83605386|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83605387|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83605388|NCT02678052|Vedolizumab|vedolizumab|mesh-list
83605389|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83605390|NCT02576717|Ozanimod|ozanimod|mesh-list
83605391|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83605392|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605393|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605394|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
83605395|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605396|NCT02564263|Paclitaxel|paclitaxel|mesh-list
83605397|NCT02564263|Docetaxel|docetaxel|mesh-list
83605398|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
83605399|NCT02564263|Irinotecan|irinotecan|mesh-list
83605400|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605401|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605402|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605403|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605404|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605405|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605406|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605407|NCT02564263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605408|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83605409|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83605410|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605411|NCT02540018|Paclitaxel|paclitaxel|mesh-list
83605412|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605413|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605414|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605415|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605416|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605417|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605418|NCT02423265|Ranolazine|ranolazine|mesh-list
83605419|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83605420|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83605421|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605422|NCT02368886|Clobetasol|clobetasol|mesh-list
83605423|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605424|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
83605425|NCT02368886|Hormones|hormones|mesh-ancestor
83605426|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605427|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605428|NCT02301286|Aspirin|aspirin|mesh-list
83605429|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83605430|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83605431|NCT02301286|Analgesics|analgesics|mesh-ancestor
83605432|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
83605433|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605434|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605435|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605436|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605437|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83605438|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83605439|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605440|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83605441|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83605442|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605443|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
83605444|NCT02126969|Carboplatin|carboplatin|mesh-list
83605445|NCT02126969|Docetaxel|docetaxel|mesh-list
83605446|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605447|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605448|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605449|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605450|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605451|NCT02099188|Leucovorin|leucovorin|mesh-list
83605452|NCT02099188|Docetaxel|docetaxel|mesh-list
83605453|NCT02099188|Doxorubicin|doxorubicin|mesh-list
83605454|NCT02099188|Fluorouracil|fluorouracil|mesh-list
83605455|NCT02099188|Etoposide|etoposide|mesh-list
83605456|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83605457|NCT02099188|Ifosfamide|ifosfamide|mesh-list
83605458|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605459|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605460|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605461|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605462|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605463|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83605464|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83605465|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83605466|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605467|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
83605468|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605469|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605470|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
83605471|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605472|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605473|NCT02099188|Antidotes|antidotes|mesh-ancestor
83063481|NCT02259738|Kallikreins|kallikreins|mesh-list
83605474|NCT02099188|Protective Agents|protective agents|mesh-ancestor
83605475|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
83605476|NCT02099188|Vitamins|vitamins|mesh-ancestor
83605477|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
83605478|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83605479|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
83605480|NCT02099175|Leucovorin|leucovorin|mesh-list
83605481|NCT02099175|Docetaxel|docetaxel|mesh-list
83605482|NCT02099175|Doxorubicin|doxorubicin|mesh-list
83605483|NCT02099175|Fluorouracil|fluorouracil|mesh-list
83605484|NCT02099175|Etoposide|etoposide|mesh-list
83605485|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83605486|NCT02099175|Ifosfamide|ifosfamide|mesh-list
83605487|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605488|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605489|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605490|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605491|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605492|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83605493|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83605494|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83605495|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605496|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
83605497|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605498|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605499|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
83605500|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605501|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605502|NCT02099175|Antidotes|antidotes|mesh-ancestor
83605503|NCT02099175|Protective Agents|protective agents|mesh-ancestor
83605504|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
83605505|NCT02099175|Vitamins|vitamins|mesh-ancestor
83605506|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
83605507|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83605508|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
83605509|NCT01946074|Paclitaxel|paclitaxel|mesh-list
83605510|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605511|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605512|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605513|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605514|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605515|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605516|NCT01715285|Prednisone|prednisone|mesh-list
83605517|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
83605518|NCT01715285|Androgens|androgens|mesh-list
83605519|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605520|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
83605521|NCT01715285|Hormones|hormones|mesh-ancestor
83605522|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605523|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605524|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83605525|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605526|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83605527|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605528|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605529|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
83605530|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83605531|NCT01705184|Bevacizumab|bevacizumab|mesh-list
83605532|NCT01705184|Pemetrexed|pemetrexed|mesh-list
83605533|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605534|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605535|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83605536|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83605537|NCT01705184|Growth Substances|growth substances|mesh-ancestor
83605538|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605539|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
83605540|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605541|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605542|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83605543|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83605544|NCT01285817|Celecoxib|celecoxib|mesh-list
83605545|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
83605546|NCT01285817|Methotrexate|methotrexate|mesh-list
83605547|NCT01285817|Vinblastine|vinblastine|mesh-list
83605548|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605549|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
83063552|NCT04853758|Valsartan|valsartan|mesh-list
83605550|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605551|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605552|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83605553|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
83605554|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605555|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605556|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83605557|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83605558|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
83605559|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83605560|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605561|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
83605562|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
83605563|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605564|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83605565|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83605566|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83605567|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83605568|NCT01285817|Analgesics|analgesics|mesh-ancestor
83605569|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
83605570|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605571|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605572|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83605573|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83605574|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605575|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605576|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605577|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605578|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83605579|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83605580|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605581|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605582|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
83605583|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605584|NCT01250496|Aminophylline|aminophylline|mesh-list
83605585|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83605586|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
83605587|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605588|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605589|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83605590|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
83605591|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83605592|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83605593|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605594|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605595|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83605596|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83605597|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
83605598|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83605599|NCT01250496|Protective Agents|protective agents|mesh-ancestor
83605600|NCT01105975|Atorvastatin|atorvastatin|mesh-list
83605601|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83605602|NCT01105975|Simvastatin|simvastatin|mesh-list
83605603|NCT01105975|Evacetrapib|evacetrapib|mesh-list
83605604|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83605605|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83605606|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
83605607|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605608|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83605609|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83605610|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605611|NCT00651456|Bevacizumab|bevacizumab|mesh-list
83605612|NCT00651456|Cisplatin|cisplatin|mesh-list
83605613|NCT00651456|Pemetrexed|pemetrexed|mesh-list
83605614|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605615|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605616|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83605617|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83605618|NCT00651456|Growth Substances|growth substances|mesh-ancestor
83605619|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605620|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
83605621|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605622|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605623|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83605624|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83605625|NCT00280202|Dimercaprol|dimercaprol|mesh-list
83605626|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
83605627|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
83605628|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605629|NCT00079417|Iodine|iodine|mesh-list
83605630|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
83605631|NCT00079417|Carboplatin|carboplatin|mesh-list
83605632|NCT00079417|Vincristine|vincristine|mesh-list
83605633|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605634|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605635|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605636|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605637|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605638|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605639|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83605640|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605641|NCT00079417|Trace Elements|trace elements|mesh-ancestor
83605642|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
83605643|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605644|NCT04387500|Axitinib|axitinib|mesh-list
83605645|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605646|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83605647|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605648|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605649|NCT04386876|Ritonavir|ritonavir|mesh-list
83605650|NCT04386876|Lopinavir|lopinavir|mesh-list
83605651|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83605652|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83605653|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605654|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605655|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605656|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83605657|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83605658|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
83605659|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605660|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83605661|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83605662|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
83605663|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83605664|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83605665|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605666|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
83605667|NCT04386642|Coagulants|coagulants|mesh-ancestor
83605668|NCT04385550|Paclitaxel|paclitaxel|mesh-list
83605669|NCT04385550|Docetaxel|docetaxel|mesh-list
83605670|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605671|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605672|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605673|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605674|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
83494668|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
83605675|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605676|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
83605677|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
83605678|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605679|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605680|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605681|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605682|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605683|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605684|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
83605685|NCT04384458|Ivermectin|ivermectin|mesh-list
83605686|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
83605687|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605688|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605689|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605690|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605691|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605692|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605693|NCT04383990|Insulin|insulin|mesh-list
83605694|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83605695|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605696|NCT04381884|Ivermectin|ivermectin|mesh-list
83605697|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605698|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605699|NCT04381962|Azithromycin|azithromycin|mesh-list
83605700|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83605701|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605702|NCT04381104|Acetaminophen|acetaminophen|mesh-list
83605704|NCT04381104|Analgesics|analgesics|mesh-ancestor
83605705|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
83605706|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605707|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605708|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
83605709|NCT04380402|Atorvastatin|atorvastatin|mesh-list
83605710|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83605711|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83605712|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
83605713|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605714|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83605715|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83605716|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605717|NCT04380012|Trastuzumab|trastuzumab|mesh-list
83605718|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605719|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605720|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
83605721|NCT04379310|Calcium|calcium|mesh-list
83605722|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83605723|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83605724|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605725|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605726|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605727|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605728|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83605729|NCT04378608|Ribavirin|ribavirin|mesh-list
83605730|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
83605731|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605732|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
83605733|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605734|NCT04376970|Fluorometholone|fluorometholone|mesh-list
83605735|NCT04376970|Cyclosporine|cyclosporine|mesh-list
83605736|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83605737|NCT04376970|Cyclosporins|cyclosporins|mesh-list
83605738|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605739|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605740|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605741|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
83605742|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605743|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
83605744|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605745|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
83605746|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605747|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83605748|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83605749|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605750|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
83605751|NCT04376970|Hormones|hormones|mesh-ancestor
83605752|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605753|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83605754|NCT04377048|Gemcitabine|gemcitabine|mesh-list
83605755|NCT04377048|Tegafur|tegafur|mesh-list
83605756|NCT04377048|Nivolumab|nivolumab|mesh-list
83605757|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605758|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
83605759|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605760|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605761|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605762|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605763|NCT04376814|Ritonavir|ritonavir|mesh-list
83605764|NCT04376814|Lopinavir|lopinavir|mesh-list
83605765|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
83605766|NCT04376814|Favipiravir|favipiravir|mesh-list
83605767|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83605768|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83605769|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605770|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605771|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605772|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83605773|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83605774|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
83605775|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063778|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
83605776|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83605777|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83605778|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
83605779|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605780|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605781|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605782|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
83605783|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
83605784|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605785|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605786|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605787|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605788|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605789|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605790|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
83605791|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83605792|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83605793|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605794|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83605795|NCT04374318|Analgesics|analgesics|mesh-ancestor
83605796|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
83605797|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83605798|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83605799|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83605800|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83605801|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
83605802|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83605803|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605804|NCT04374552|Azithromycin|azithromycin|mesh-list
83605805|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
83605806|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83605807|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605808|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
83605809|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605810|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605811|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605812|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605813|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605814|NCT04374006|Propolis|propolis|mesh-list
83605815|NCT04374006|Dienogest|dienogest|mesh-list
83605816|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605817|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83605818|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
83605819|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83605820|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605821|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83605822|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83605823|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83605824|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83605825|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
83605826|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605827|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83605828|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605829|NCT04372836|Vasopressins|vasopressins|mesh-list
83605830|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
83605831|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
83605832|NCT04372836|Coagulants|coagulants|mesh-ancestor
83605833|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83605834|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83605835|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
83605836|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605837|NCT04371978|Linagliptin|linagliptin|mesh-list
83605838|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83605839|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605840|NCT04371978|Incretins|incretins|mesh-ancestor
83605841|NCT04371978|Hormones|hormones|mesh-ancestor
83605842|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605843|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83605844|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605845|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605846|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605847|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
83605848|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
83605849|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83605850|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
83605851|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605852|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605853|NCT04370262|Famotidine|famotidine|mesh-list
83605854|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83605855|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83605856|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83605857|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
83605858|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
83605859|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83605860|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605861|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605862|NCT04368546|Sunitinib|sunitinib|mesh-list
83605863|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605864|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83605865|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83605866|NCT04368546|Growth Substances|growth substances|mesh-ancestor
83605867|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605868|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
83605869|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83605870|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605871|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605872|NCT04366596|Paclitaxel|paclitaxel|mesh-list
83605873|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83605874|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605875|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
83605876|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
83605877|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83605878|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605879|NCT04366128|Immunomodulating Agents|immunomodulating agents|mesh-list
83605880|NCT04366128|Immunologic Factors|immunologic factors|mesh-ancestor
83605881|NCT04366128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605882|NCT04366050|Ramipril|ramipril|mesh-list
83605883|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83605884|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605885|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605886|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605887|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83605888|NCT04365582|Ritonavir|ritonavir|mesh-list
83605889|NCT04365582|Lopinavir|lopinavir|mesh-list
83605890|NCT04365582|Azithromycin|azithromycin|mesh-list
83605891|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
83605892|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83605893|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83605894|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605895|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605896|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605897|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83605898|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83605899|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
83605900|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605901|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83605902|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83605903|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83605904|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
83605905|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605906|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605907|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605908|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
83605909|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83605910|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
83605911|NCT04365270|Chitosan|chitosan|mesh-list
83605912|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83605913|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605914|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
83605915|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
83605916|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83605917|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83605918|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
83605919|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605920|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83605921|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
83605922|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
83605923|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
83605924|NCT04365270|Coagulants|coagulants|mesh-ancestor
83605925|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
83605926|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83063927|NCT04822012|Progestins|progestins|mesh-ancestor
83605927|NCT04365270|Protective Agents|protective agents|mesh-ancestor
83605928|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605929|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83605930|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
83605931|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
83605932|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83605933|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605934|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83605935|NCT04365036|Gemcitabine|gemcitabine|mesh-list
83605936|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
83605937|NCT04365036|Pegaspargase|pegaspargase|mesh-list
83605938|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83605939|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
83605940|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605941|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605942|NCT04364022|Ritonavir|ritonavir|mesh-list
83605943|NCT04364022|Lopinavir|lopinavir|mesh-list
83605944|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83605945|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83605946|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
83605947|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605948|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605949|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83605950|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83605951|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
83605952|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605953|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83605954|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83605955|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
83605956|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
83605957|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83605958|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83605959|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83605960|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605961|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605962|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83605963|NCT04362384|Vitamin E|vitamin e|mesh-list
83605964|NCT04362384|Prednisolone|prednisolone|mesh-list
83605965|NCT04362384|Vitamins|vitamins|mesh-ancestor
83605966|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
83605967|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605968|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83605969|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
83605970|NCT04362384|Hormones|hormones|mesh-ancestor
83605971|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83605972|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83605973|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605974|NCT04362384|Protective Agents|protective agents|mesh-ancestor
83605975|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
83605976|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605977|NCT04361214|Leflunomide|leflunomide|mesh-list
83605978|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605979|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605980|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83605981|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
83605982|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605983|NCT04361370|Bevacizumab|bevacizumab|mesh-list
83605984|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
83605985|NCT04361370|Olaparib|olaparib|mesh-list
83605986|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605987|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83605988|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83605989|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83605990|NCT04361370|Growth Substances|growth substances|mesh-ancestor
83605991|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83605992|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83605993|NCT04361370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83605994|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83605995|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83605996|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83605997|NCT04361058|Nivolumab|nivolumab|mesh-list
83605998|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83605999|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606000|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83606001|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606002|NCT04359966|Amoxicillin|amoxicillin|mesh-list
83606003|NCT04359966|Metronidazole|metronidazole|mesh-list
83606004|NCT04359966|Clarithromycin|clarithromycin|mesh-list
83606005|NCT04359966|Levofloxacin|levofloxacin|mesh-list
83606006|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83606007|NCT04359966|Esomeprazole|esomeprazole|mesh-list
83606008|NCT04359966|Bismuth|bismuth|mesh-list
83606009|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83606010|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606011|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606012|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606013|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83606014|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606015|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83606016|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606017|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606018|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83606019|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83606020|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83606021|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83606022|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83606023|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83606024|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606025|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83606026|NCT04359966|Antacids|antacids|mesh-ancestor
83606027|NCT04360122|Levamisole|levamisole|mesh-list
83606028|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
83606029|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83606030|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
83606031|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606032|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
83606033|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
83606034|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606035|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606036|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606037|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
83606038|NCT04360356|Ivermectin|ivermectin|mesh-list
83606039|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
83606040|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606041|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606042|NCT04359576|Hemostatics|hemostatics|mesh-list
83606043|NCT04359576|Coagulants|coagulants|mesh-ancestor
83606044|NCT04358796|Perflubron|perflubron|mesh-list
83606045|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83606046|NCT04358718|Anesthetics|anesthetics|mesh-list
83606047|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606048|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606049|NCT04358562|Gefitinib|gefitinib|mesh-list
83606050|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606051|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83606052|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606053|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606054|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83606055|NCT04358016|Terlipressin|terlipressin|mesh-list
83606056|NCT04358016|Somatostatin|somatostatin|mesh-list
83606057|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83606058|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83606059|NCT04358016|Hormones|hormones|mesh-ancestor
83606060|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606061|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606062|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83606063|NCT04357392|Prednisone|prednisone|mesh-list
83606064|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606065|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606066|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
83606067|NCT04357392|Hormones|hormones|mesh-ancestor
83606068|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606069|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83606070|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606071|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
83606072|NCT04357002|Dinoprostone|dinoprostone|mesh-list
83606073|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83606074|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83606075|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606076|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
83606077|NCT04357002|Coagulants|coagulants|mesh-ancestor
83606078|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
83606079|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83606080|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606081|NCT04356222|Methotrexate|methotrexate|mesh-list
83606082|NCT04356222|Durvalumab|durvalumab|mesh-list
83606083|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83606084|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
83606085|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83606086|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606087|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83606088|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
83606089|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606090|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606091|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83606092|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606093|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83606094|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83606095|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
83606096|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606097|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83606098|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83606099|NCT04356144|Thrombin|thrombin|mesh-list
83606100|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
83606101|NCT04356144|Coagulants|coagulants|mesh-ancestor
83606102|NCT04355598|Lidocaine|lidocaine|mesh-list
83606103|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
83606104|NCT04355598|Prilocaine|prilocaine|mesh-list
83606105|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83606106|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
83606107|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
83606108|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606109|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606110|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
83606111|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606112|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83606113|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83606114|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83606115|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83606116|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606117|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
83606118|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83606119|NCT04355520|Fulvestrant|fulvestrant|mesh-list
83606120|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83606121|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606122|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83606123|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83606124|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
83606125|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606126|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606127|NCT04355052|Azithromycin|azithromycin|mesh-list
83606128|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606129|NCT04355052|Camostat|camostat|mesh-list
83606130|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83606131|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606132|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
83606133|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606134|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606135|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606136|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606137|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606138|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606139|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83606140|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83606141|NCT04354662|Leucovorin|leucovorin|mesh-list
83606142|NCT04354662|Docetaxel|docetaxel|mesh-list
83606143|NCT04354662|Fluorouracil|fluorouracil|mesh-list
83606144|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
83606145|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606146|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
83606147|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
83606148|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
83606149|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606150|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
83606151|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83606152|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83606153|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
83606154|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606155|NCT04354662|Antidotes|antidotes|mesh-ancestor
83606156|NCT04354662|Protective Agents|protective agents|mesh-ancestor
83606157|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
83606159|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
83606160|NCT04354350|Telmisartan|telmisartan|mesh-list
83606161|NCT04354350|Ramipril|ramipril|mesh-list
83606162|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83606163|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83606164|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83606165|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606166|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83606167|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606168|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606169|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606170|NCT04353336|Chloroquine|chloroquine|mesh-list
83606171|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83606172|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
83606173|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606174|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606175|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606176|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606177|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606178|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606179|NCT04353336|Amebicides|amebicides|mesh-ancestor
83606180|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606181|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606182|NCT04353336|Analgesics|analgesics|mesh-ancestor
83606183|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
83606184|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606185|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606186|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606187|NCT04353336|Filaricides|filaricides|mesh-ancestor
83606188|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
83606189|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
83606190|NCT04353180|Tretinoin|tretinoin|mesh-list
83606191|NCT04353180|Isotretinoin|isotretinoin|mesh-list
83606192|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606193|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
83606194|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
83606195|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606196|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
83606197|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606198|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606199|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606200|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606201|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606202|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606203|NCT04352400|Nafamostat|nafamostat|mesh-list
83606204|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606205|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606206|NCT04352400|Analgesics|analgesics|mesh-ancestor
83606207|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
83606208|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606209|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606210|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606211|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606212|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
83606213|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606214|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606215|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606216|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83606217|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83606218|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83606219|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83606220|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
83606221|NCT04351308|Apatinib|apatinib|mesh-list
83606222|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606223|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83606224|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606225|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606226|NCT04351152|Lenzilumab|lenzilumab|mesh-list
83606227|NCT04351152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606228|NCT04350528|Pentobarbital|pentobarbital|mesh-list
83606229|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
83606230|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
83606231|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
83606232|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606233|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606234|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606235|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83606236|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83606237|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606238|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83606239|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83606240|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
83606241|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606242|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606243|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83606244|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83606245|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
83606246|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
83606247|NCT04350684|Interferons|interferons|mesh-list
83606248|NCT04350684|Ritonavir|ritonavir|mesh-list
83606249|NCT04350684|Lopinavir|lopinavir|mesh-list
83606250|NCT04350684|Interferon-beta|interferon-beta|mesh-list
83606251|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
83606252|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606253|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606254|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
83606255|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606256|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83606257|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83606258|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606259|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606260|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606261|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83606262|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83606263|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83606264|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83606265|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
83606266|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606267|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606268|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606269|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
83606270|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606271|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83606272|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606273|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
83606274|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606275|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606276|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606277|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606278|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606279|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606280|NCT04349592|Azithromycin|azithromycin|mesh-list
83606281|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606282|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83606283|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606284|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
83606285|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606286|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606287|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606288|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606289|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606290|NCT04347252|Glucagon|glucagon|mesh-list
83606291|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606292|NCT04347252|Hormones|hormones|mesh-ancestor
83606293|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606294|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606295|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
83606296|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
83606297|NCT04346862|Vitamins|vitamins|mesh-ancestor
83606298|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
83606299|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606300|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
83606301|NCT04345848|Heparin|heparin|mesh-list
83606302|NCT04345848|Enoxaparin|enoxaparin|mesh-list
83606303|NCT04345848|Calcium heparin|calcium heparin|mesh-list
83606304|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
83606305|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83606306|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83606307|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606308|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606309|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
83606310|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606311|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606312|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606313|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606314|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606315|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606316|NCT04345458|Etanercept|etanercept|mesh-list
83606317|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606318|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606319|NCT04345458|Analgesics|analgesics|mesh-ancestor
83606320|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
83606321|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606322|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606323|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606324|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606325|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606326|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83606327|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
83606328|NCT04344756|Heparin|heparin|mesh-list
83606329|NCT04344756|Calcium heparin|calcium heparin|mesh-list
83606330|NCT04344756|Tinzaparin|tinzaparin|mesh-list
83606331|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83606332|NCT04344756|Dalteparin|dalteparin|mesh-list
83606333|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
83606334|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83606335|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83606336|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606337|NCT04344288|Prednisone|prednisone|mesh-list
83606338|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606339|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
83606340|NCT04344288|Hormones|hormones|mesh-ancestor
83606341|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606342|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606343|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83606344|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606345|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
83606346|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
83606347|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
83606348|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606349|NCT04342728|Vitamins|vitamins|mesh-list
83606350|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
83606351|NCT04342728|Zinc|zinc|mesh-list
83606352|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
83606353|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606354|NCT04342728|Trace Elements|trace elements|mesh-ancestor
83606355|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
83606356|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606357|NCT04342728|Protective Agents|protective agents|mesh-ancestor
83606358|NCT04342650|Chloroquine|chloroquine|mesh-list
83606359|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83606360|NCT04342650|Amebicides|amebicides|mesh-ancestor
83606361|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606362|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606363|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606364|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
83606365|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606366|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606367|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606368|NCT04342650|Analgesics|analgesics|mesh-ancestor
83606369|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
83606370|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606371|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606372|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606373|NCT04342650|Filaricides|filaricides|mesh-ancestor
83606374|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
83606375|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
83606376|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
83606377|NCT04341402|Clotrimazole|clotrimazole|mesh-list
83606378|NCT04341402|Miconazole|miconazole|mesh-list
83606379|NCT04341402|Diclofenac|diclofenac|mesh-list
83606380|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606381|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606382|NCT04341402|Analgesics|analgesics|mesh-ancestor
83606383|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
83606384|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064389|NCT02607930|Lamivudine|lamivudine|mesh-list
83606385|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606386|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606387|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606388|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83606389|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606390|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606391|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606392|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83606393|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83606394|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83606395|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83606396|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
83606397|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606398|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83606399|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83606400|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606401|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
83606402|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606403|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606404|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606405|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606406|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606407|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606408|NCT04340778|Lidocaine|lidocaine|mesh-list
83606409|NCT04340778|Prilocaine|prilocaine|mesh-list
83606410|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83606411|NCT04340778|Dinoprostone|dinoprostone|mesh-list
83606412|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
83606413|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
83606414|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606415|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606416|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
83606417|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606418|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83606419|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83606420|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83606421|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83606422|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606423|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
83606424|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83606425|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83606426|NCT04340388|Tenofovir|tenofovir|mesh-list
83606427|NCT04340388|Lamivudine|lamivudine|mesh-list
83606428|NCT04340388|Zidovudine|zidovudine|mesh-list
83606429|NCT04340388|Dolutegravir|dolutegravir|mesh-list
83606430|NCT04340388|Darunavir|darunavir|mesh-list
83606431|NCT04340388|Abacavir|abacavir|mesh-list
83606432|NCT04340388|Cobicistat|cobicistat|mesh-list
83606433|NCT04340388|Rilpivirine|rilpivirine|mesh-list
83606434|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83606435|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
83606436|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606437|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83606438|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83606439|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606440|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606441|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83606442|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
83606443|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83606444|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83606445|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83606446|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83606447|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606448|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83606449|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83606450|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606451|NCT04338906|Camostat|camostat|mesh-list
83606452|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
83606453|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606454|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606455|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606456|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606457|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606458|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606459|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606460|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83606461|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83606462|NCT04338438|Apatinib|apatinib|mesh-list
83606463|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064454|NCT01235754|Testosterone|testosterone|mesh-list
83064532|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
83606464|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83606465|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606466|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606467|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
83606468|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83606469|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83606470|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606471|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
83606472|NCT04338126|Coagulants|coagulants|mesh-ancestor
83606473|NCT04337658|Capecitabine|capecitabine|mesh-list
83606474|NCT04337658|Trastuzumab|trastuzumab|mesh-list
83606475|NCT04337658|Fulvestrant|fulvestrant|mesh-list
83606476|NCT04337658|Pertuzumab|pertuzumab|mesh-list
83606477|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83606478|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
83606479|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606480|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606481|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83606482|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83606483|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83606484|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83606485|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
83606486|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606487|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606488|NCT04337268|Glucagon|glucagon|mesh-list
83606489|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83606490|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606491|NCT04337268|Hormones|hormones|mesh-ancestor
83606492|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606493|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606494|NCT04337268|Incretins|incretins|mesh-ancestor
83606495|NCT04336566|Melatonin|melatonin|mesh-list
83606496|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
83606497|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606498|NCT04336566|Protective Agents|protective agents|mesh-ancestor
83606499|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606500|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606501|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83606502|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
83606503|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606504|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
83606505|NCT04336488|Hormones|hormones|mesh-ancestor
83606506|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606507|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606508|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83606509|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
83606510|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606511|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606512|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606513|NCT04335786|Valsartan|valsartan|mesh-list
83606514|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83606515|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83606516|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83606517|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606518|NCT04334928|Tenofovir|tenofovir|mesh-list
83606519|NCT04334928|Emtricitabine|emtricitabine|mesh-list
83606520|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83606521|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606522|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
83606523|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606524|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83606525|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83606526|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606527|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606528|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83606529|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83606530|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
83606531|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606532|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606533|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606534|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83606535|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606536|NCT04334382|Azithromycin|azithromycin|mesh-list
83606537|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606538|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83606539|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606540|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
83606541|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606542|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606543|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606544|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606545|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606546|NCT04333992|Remifentanil|remifentanil|mesh-list
83606547|NCT04333992|Propofol|propofol|mesh-list
83606548|NCT04333992|Sevoflurane|sevoflurane|mesh-list
83606549|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83606550|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606551|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606552|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83606553|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
83606554|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
83606555|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83606556|NCT04333992|Narcotics|narcotics|mesh-ancestor
83606557|NCT04333992|Analgesics|analgesics|mesh-ancestor
83606558|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
83606559|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606560|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83606561|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83606562|NCT04332978|Fluticasone|fluticasone|mesh-list
83606563|NCT04332978|Xhance|xhance|mesh-list
83606564|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606565|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83606566|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
83606567|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606568|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606569|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83606570|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
83606571|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
83606572|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83606573|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83606574|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83606575|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
83606576|NCT04332276|Dopamine|dopamine|mesh-list
83606577|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83606578|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
83606579|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
83606580|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606581|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606582|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
83606583|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606584|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606585|NCT04332276|Protective Agents|protective agents|mesh-ancestor
83606586|NCT04332042|Tofacitinib|tofacitinib|mesh-list
83606587|NCT04332042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83606588|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83606589|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606590|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606591|NCT04341870|Azithromycin|azithromycin|mesh-list
83606592|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606593|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83606594|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606595|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
83606596|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606597|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606598|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606599|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606600|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606601|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
83606602|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83606603|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606604|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606605|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606606|NCT04331418|Analgesics|analgesics|mesh-ancestor
83606607|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
83606608|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606609|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83606610|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83606611|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83606612|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
83606613|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606614|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606616|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606617|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606618|NCT04330872|Analgesics|analgesics|mesh-ancestor
83606619|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
83606620|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606621|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606622|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606623|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606624|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83606625|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83606626|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606627|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83606628|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83606629|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606630|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
83606631|NCT04330326|Sorbitol|sorbitol|mesh-list
83606632|NCT04330326|Cathartics|cathartics|mesh-ancestor
83606633|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606634|NCT04329858|Methamphetamine|methamphetamine|mesh-list
83606635|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83606636|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606637|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
83606638|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
83606639|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606640|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
83606641|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606642|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606643|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
83606644|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83606645|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83606646|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83606647|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83606648|NCT00704106|Entecavir|entecavir|mesh-list
83606649|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
83606650|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606651|NCT05614752|Fexuprazan|fexuprazan|mesh-list
83606652|NCT05614752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606653|NCT05508594|Sufentanil|sufentanil|mesh-list
83606654|NCT05508594|Ketamine|ketamine|mesh-list
83606655|NCT05508594|Analgesics|analgesics|mesh-ancestor
83606656|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
83606657|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606658|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606659|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83606660|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83606661|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
83606662|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
83606663|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606664|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83606665|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83606666|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606667|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606668|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83606669|NCT05508594|Narcotics|narcotics|mesh-ancestor
83606670|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83606671|NCT05417100|Methadone|methadone|mesh-list
83606672|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83606673|NCT05417100|Narcotics|narcotics|mesh-ancestor
83606674|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606675|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606676|NCT05417100|Analgesics|analgesics|mesh-ancestor
83606677|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
83606678|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606679|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
83606680|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
83606681|NCT05278884|Anesthetics|anesthetics|mesh-list
83606682|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606683|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606684|NCT05136690|Nicotine|nicotine|mesh-list
83606685|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83606686|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
83606687|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606688|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606689|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83606690|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83606691|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
83606692|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606693|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606694|NCT05035680|Vaccines|vaccines|mesh-list
83606695|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
83606696|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606697|NCT04831320|Paclitaxel|paclitaxel|mesh-list
83606698|NCT04831320|Nivolumab|nivolumab|mesh-list
83606699|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83606700|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606701|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83606702|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83606703|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83606704|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606705|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83606706|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83606707|NCT03874884|Olaparib|olaparib|mesh-list
83606708|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83606709|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606710|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606711|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606712|NCT03063450|Nivolumab|nivolumab|mesh-list
83606713|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83606714|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606715|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83606716|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606717|NCT02748018|Insulin|insulin|mesh-list
83606718|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83606719|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606720|NCT01326000|Cetuximab|cetuximab|mesh-list
83606721|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83606722|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606723|NCT03035214|Dexamethasone|dexamethasone|mesh-list
83606724|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
83606725|NCT03035214|BB 1101|bb 1101|mesh-list
83606726|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606727|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
83606728|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
83606729|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606730|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606731|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606732|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
83606733|NCT03035214|Hormones|hormones|mesh-ancestor
83606734|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606735|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83606736|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606737|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
83606738|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606739|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606740|NCT03035058|Vedolizumab|vedolizumab|mesh-list
83606741|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606742|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
83606743|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83606744|NCT03033654|Protective Agents|protective agents|mesh-ancestor
83606745|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606746|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
83606747|NCT03033732|Buprenorphine|buprenorphine|mesh-list
83606748|NCT03033732|Methadone|methadone|mesh-list
83606749|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83606750|NCT03033732|Naloxone|naloxone|mesh-list
83606751|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83606752|NCT03033732|Narcotics|narcotics|mesh-ancestor
83606753|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606754|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606755|NCT03033732|Analgesics|analgesics|mesh-ancestor
83606756|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
83606757|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606758|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83606759|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
83064756|NCT03465410|Tacrolimus|tacrolimus|mesh-list
83606760|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
83606761|NCT03033264|Dinoprostone|dinoprostone|mesh-list
83606762|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
83606763|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83606764|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606765|NCT03033342|Omeprazole|omeprazole|mesh-list
83606766|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83606767|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606768|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83606769|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606770|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606771|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83606772|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83606773|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83606774|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606775|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606776|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
83606777|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606778|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83606779|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83606780|NCT03030690|Methamphetamine|methamphetamine|mesh-list
83606781|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83606782|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606783|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
83606784|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
83606785|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606786|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
83606787|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606788|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606789|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
83606790|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83606791|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83606792|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83606793|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83606794|NCT03030300|Metformin|metformin|mesh-list
83606795|NCT03030300|Pioglitazone|pioglitazone|mesh-list
83606796|NCT03030300|Insulin|insulin|mesh-list
83606797|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83606798|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606799|NCT03029442|Denosumab|denosumab|mesh-list
83606800|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83606801|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606802|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
83606803|NCT03023514|Progesterone|progesterone|mesh-list
83606804|NCT03023514|Progestins|progestins|mesh-ancestor
83606805|NCT03023514|Hormones|hormones|mesh-ancestor
83606806|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606807|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606808|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
83606809|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606810|NCT03023514|Protective Agents|protective agents|mesh-ancestor
83606811|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
83606812|NCT03023514|Vitamins|vitamins|mesh-ancestor
83606813|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
83606814|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
83606815|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
83606816|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83606817|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83606818|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606819|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606820|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606821|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606822|NCT03019848|Curcumin|curcumin|mesh-list
83606823|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606824|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606825|NCT03019848|Analgesics|analgesics|mesh-ancestor
83606826|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
83606827|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606828|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606829|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606830|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606831|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606832|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606833|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606834|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
83606835|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606836|NCT03019536|Flutemetamol|flutemetamol|mesh-list
83606837|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83606838|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606839|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83606840|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83606841|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606842|NCT03018990|Ethanol|ethanol|mesh-list
83606843|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83606844|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606845|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606846|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606847|NCT03018756|Fentanyl|fentanyl|mesh-list
83606848|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83606849|NCT03018756|Narcotics|narcotics|mesh-ancestor
83606850|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606851|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606852|NCT03018756|Analgesics|analgesics|mesh-ancestor
83606853|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
83606854|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606855|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83606856|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83606857|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
83606858|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
83606859|NCT03018444|Atorvastatin|atorvastatin|mesh-list
83606860|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83606861|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83606862|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
83606863|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606864|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83606865|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83606866|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606867|NCT03017430|Ketorolac|ketorolac|mesh-list
83606868|NCT03017430|Phenazepam|phenazepam|mesh-list
83606869|NCT03017430|Clonidine|clonidine|mesh-list
83606870|NCT03017430|Pregabalin|pregabalin|mesh-list
83606871|NCT03017430|Metoclopramide|metoclopramide|mesh-list
83606872|NCT03017430|Loperamide|loperamide|mesh-list
83606873|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
83606874|NCT03017430|Analgesics|analgesics|mesh-ancestor
83606875|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
83606876|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606877|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606878|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
83606879|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83606880|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83606881|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606882|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83606883|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83606884|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83606885|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606886|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83606887|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606888|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606889|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606890|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606891|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83606892|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606893|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83606894|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
83606895|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
83606896|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83606897|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83606898|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83606899|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
83606900|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83606901|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
83606902|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606903|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83606904|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83606905|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
83606906|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83606907|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
83606908|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83606909|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
83606910|NCT03017352|Exenatide|exenatide|mesh-list
83606911|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83606912|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606913|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83606914|NCT03017352|Incretins|incretins|mesh-ancestor
83606915|NCT03017352|Hormones|hormones|mesh-ancestor
83606916|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83606917|NCT03016884|Vaccines|vaccines|mesh-list
83606918|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
83606919|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606920|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
83606921|NCT03016806|Melphalan|melphalan|mesh-list
83606922|NCT03016806|Busulfan|busulfan|mesh-list
83606923|NCT03016806|Fludarabine|fludarabine|mesh-list
83606925|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83606926|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
83606927|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606928|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606929|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83606930|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
83606931|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606932|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606933|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83606934|NCT03016806|Protective Agents|protective agents|mesh-ancestor
83606935|NCT03016650|Acetaminophen|acetaminophen|mesh-list
83606936|NCT03016650|Ibuprofen|ibuprofen|mesh-list
83606937|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606938|NCT03016650|Analgesics|analgesics|mesh-ancestor
83606939|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
83606940|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606941|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606942|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
83606943|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606944|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606945|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606946|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83606947|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83606948|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606949|NCT03016260|Adalimumab|adalimumab|mesh-list
83606950|NCT03016260|Infliximab|infliximab|mesh-list
83606951|NCT03016260|Golimumab|golimumab|mesh-list
83606952|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
83606953|NCT03016260|Etanercept|etanercept|mesh-list
83606954|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83606955|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83606956|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83606957|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
83606958|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83606959|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83606960|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83606961|NCT03016260|Analgesics|analgesics|mesh-ancestor
83606962|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
83606963|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606964|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606965|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83606966|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
83606967|NCT03015246|Morphine|morphine|mesh-list
83606968|NCT03015246|Buprenorphine|buprenorphine|mesh-list
83606969|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83606970|NCT03015246|Naloxone|naloxone|mesh-list
83606971|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83606972|NCT03015246|Narcotics|narcotics|mesh-ancestor
83606973|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606974|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83606975|NCT03015246|Analgesics|analgesics|mesh-ancestor
83606976|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
83606977|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83606978|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83606979|NCT03015168|Capecitabine|capecitabine|mesh-list
83606980|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83606981|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
83606982|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83606983|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606984|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
83606985|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83606986|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
83606987|NCT03014778|Povidone|povidone|mesh-list
83606988|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83606989|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83606990|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
83606991|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
83606992|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
83606993|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
83606994|NCT03014076|Trastuzumab|trastuzumab|mesh-list
83606995|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83606996|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83606997|NCT03013140|Anesthetics|anesthetics|mesh-list
83606998|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83606999|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607000|NCT03011970|Oxytocin|oxytocin|mesh-list
83607001|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
83607002|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83607003|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607004|NCT03010098|Remifentanil|remifentanil|mesh-list
83607005|NCT03010098|Propofol|propofol|mesh-list
83607006|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83607007|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607008|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607009|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83607010|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
83607011|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
83607012|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83607013|NCT03010098|Narcotics|narcotics|mesh-ancestor
83607014|NCT03010098|Analgesics|analgesics|mesh-ancestor
83607015|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
83607016|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607017|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83607018|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83607019|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83607020|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83607021|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
83607022|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607023|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83607024|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83607025|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607026|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83607027|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
83607028|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
83607029|NCT03009006|Calcium|calcium|mesh-list
83607030|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83607031|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607032|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83607033|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83607034|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607035|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
83607036|NCT03008148|Temozolomide|temozolomide|mesh-list
83607037|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83607038|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
83607039|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607040|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607041|NCT03007992|Vinorelbine|vinorelbine|mesh-list
83607042|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83607043|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607044|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83607045|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83607046|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83607047|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607048|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
83607049|NCT03007446|Apatinib|apatinib|mesh-list
83607050|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607051|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607052|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607053|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607054|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
83607055|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83607056|NCT03007524|Calcium|calcium|mesh-list
83607057|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83607058|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607059|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83607060|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83607061|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83607062|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
83607063|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607064|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83607065|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83607066|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065081|NCT04750616|Niacin|niacin|mesh-list
83607067|NCT03006042|Bupivacaine|bupivacaine|mesh-list
83607068|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
83607069|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
83607070|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607071|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607072|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
83607073|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607074|NCT03005496|Vitamin D|vitamin d|mesh-list
83607075|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
83607076|NCT03005496|Beta Carotene|beta carotene|mesh-list
83607077|NCT03005496|Zinc|zinc|mesh-list
83607078|NCT03005496|Dexamethasone|dexamethasone|mesh-list
83607079|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
83607080|NCT03005496|Nifedipine|nifedipine|mesh-list
83607081|NCT03005496|BB 1101|bb 1101|mesh-list
83607082|NCT03005496|Carotenoids|carotenoids|mesh-list
83607083|NCT03005496|Picolinic acid|picolinic acid|mesh-list
83607084|NCT03005496|Vitamins|vitamins|mesh-ancestor
83607085|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
83607086|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607087|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607088|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
83607089|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
83607090|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607091|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83607092|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
83607093|NCT03005496|Hormones|hormones|mesh-ancestor
83607094|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607095|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83607096|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607097|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
83607098|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607099|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607100|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83607101|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83607102|NCT03005496|Trace Elements|trace elements|mesh-ancestor
83607103|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83607104|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83607105|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
83607106|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
83607107|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83607108|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
83607109|NCT03005496|Protective Agents|protective agents|mesh-ancestor
83607110|NCT03005496|Provitamins|provitamins|mesh-ancestor
83607111|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83607112|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
83607113|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
83607114|NCT03005808|Ropivacaine|ropivacaine|mesh-list
83607115|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
83607116|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
83607117|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607118|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607119|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
83607120|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607121|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
83607122|NCT03005340|Vitamin D|vitamin d|mesh-list
83607123|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
83607124|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83607125|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607126|NCT03005340|Vitamins|vitamins|mesh-ancestor
83607127|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
83607128|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83607129|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83607130|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83607131|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
83065129|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065130|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
83065131|NCT03460808|Atorvastatin|atorvastatin|mesh-list
83065132|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83065133|NCT03460808|Danazol|danazol|mesh-list
83065134|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83065135|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83065136|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
83065141|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
83607132|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607133|NCT03005184|Icatibant|icatibant|mesh-list
83607134|NCT03005184|Valsartan|valsartan|mesh-list
83607135|NCT03005184|Enalapril|enalapril|mesh-list
84124606|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83607136|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83607137|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83607138|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83607139|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83607140|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607141|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83607142|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
83607143|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607144|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607145|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607146|NCT03005184|Analgesics|analgesics|mesh-ancestor
83607147|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
83607148|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607149|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607150|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607151|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607152|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83607153|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83607154|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83607155|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83607156|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
83607157|NCT03004014|Propofol|propofol|mesh-list
83607158|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83607159|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607160|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607161|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83607162|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
83607163|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
83607164|NCT03002844|Carboplatin|carboplatin|mesh-list
83607165|NCT03002844|Gemcitabine|gemcitabine|mesh-list
83607166|NCT03002844|Pemetrexed|pemetrexed|mesh-list
83607167|NCT03002844|Gefitinib|gefitinib|mesh-list
83607168|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607169|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83607170|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
83607171|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607172|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607173|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83607174|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83607175|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607176|NCT03002376|Cemiplimab|cemiplimab|mesh-list
83607177|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607178|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607179|NCT03002064|Docetaxel|docetaxel|mesh-list
83607180|NCT03002064|Fluorouracil|fluorouracil|mesh-list
83607181|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607182|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
83607183|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
83607184|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
83607185|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607186|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
83607187|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83607188|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83607189|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
83607190|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607191|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83607192|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
83607193|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607194|NCT03000660|Dexamethasone|dexamethasone|mesh-list
83607195|NCT03000660|Venetoclax|venetoclax|mesh-list
83607196|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607197|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
83607198|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
83607199|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607200|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607201|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83607202|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
83607203|NCT03000660|Hormones|hormones|mesh-ancestor
83607204|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607205|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83607206|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607207|NCT03000036|Doxorubicin|doxorubicin|mesh-list
83607208|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83607209|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83607210|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607211|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83607212|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83607213|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607214|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607215|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
83607216|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
83607217|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
83607218|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83607219|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83607220|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
83607221|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607222|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83607223|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83607224|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607225|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607226|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
83607227|NCT02989272|Analgesics|analgesics|mesh-ancestor
83607228|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
83607229|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607230|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607231|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
83607232|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607233|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83607234|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
83607235|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83607236|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83607237|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607238|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83607239|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
83607240|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83607241|NCT02989038|Nicotine|nicotine|mesh-list
83607242|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83607243|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
83607244|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607245|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607246|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83607247|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83607248|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
83607249|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607250|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607251|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83607252|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83607253|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83607254|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83607255|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607256|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607257|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607258|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
83607259|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83607260|NCT02987556|Insulin|insulin|mesh-list
83607261|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83607262|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607263|NCT02987400|Venetoclax|venetoclax|mesh-list
83607264|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
83607265|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607266|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607267|NCT02987244|Prednisone|prednisone|mesh-list
83607268|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
83607269|NCT02987244|Etoposide|etoposide|mesh-list
83607270|NCT02987244|Epirubicin|epirubicin|mesh-list
83607271|NCT02987244|Vindesine|vindesine|mesh-list
83607272|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83607273|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
83607274|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607275|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607276|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83607277|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
83607278|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607279|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607280|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83607281|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607282|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
83065274|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
83607283|NCT02987244|Hormones|hormones|mesh-ancestor
83607284|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607285|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83607286|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83607287|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83607288|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83607289|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607290|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83607291|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
83607292|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
83607293|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
83607294|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
83607295|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607296|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607297|NCT02987166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83607298|NCT02987166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607299|NCT02982486|Nivolumab|nivolumab|mesh-list
83607300|NCT02982486|Ipilimumab|ipilimumab|mesh-list
83607301|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607302|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607303|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83607304|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607305|NCT02981784|Ponatinib|ponatinib|mesh-list
83607306|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607307|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607308|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607309|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607310|NCT02980926|Bupivacaine|bupivacaine|mesh-list
83607311|NCT02980926|Mepivacaine|mepivacaine|mesh-list
83607312|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
83607313|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
83607314|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607315|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607316|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
83607317|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607318|NCT02980458|Deferiprone|deferiprone|mesh-list
83607319|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83607320|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
83607321|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
83607322|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607323|NCT02978976|Betamethasone|betamethasone|mesh-list
83607324|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607325|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
83607326|NCT02978976|Hormones|hormones|mesh-ancestor
83607327|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607328|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607329|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83607330|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
83607331|NCT02979132|Iron|iron|mesh-list
83607332|NCT02979132|Trace Elements|trace elements|mesh-ancestor
83607333|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
83607334|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607335|NCT02978040|Tirofiban|tirofiban|mesh-list
83607336|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83607337|NCT02978040|Cangrelor|cangrelor|mesh-list
83607338|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83607339|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83607340|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83607341|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607342|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83607343|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83607344|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83607345|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
83607346|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607347|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607348|NCT02976246|Vitamin K|vitamin k|mesh-list
83607349|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
83607350|NCT02976246|Vitamins|vitamins|mesh-ancestor
83607351|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
83607352|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607353|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83607354|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83607355|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607356|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
83607357|NCT02976246|Coagulants|coagulants|mesh-ancestor
83607358|NCT02976012|Aflibercept|aflibercept|mesh-list
83607359|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83607360|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83607361|NCT02976012|Growth Substances|growth substances|mesh-ancestor
83607362|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607363|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
83607364|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607366|NCT02975076|Clopidogrel|clopidogrel|mesh-list
83607367|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607368|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607369|NCT02975076|Analgesics|analgesics|mesh-ancestor
83607370|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
83607371|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607372|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607373|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607374|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607375|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83607376|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83607377|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607378|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83607379|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83607380|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607381|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
83607382|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83607383|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83607384|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83607385|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
83607386|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607387|NCT02974920|Aspirin|aspirin|mesh-list
83607388|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
83607389|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607390|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607391|NCT02974920|Analgesics|analgesics|mesh-ancestor
83607392|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
83607393|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607394|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607395|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607396|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607397|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83607398|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83607399|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607400|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83607401|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83607402|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607403|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
83607404|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83607405|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
83607406|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83607407|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
83607408|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
83607409|NCT02973204|Everolimus|everolimus|mesh-list
83607410|NCT02973204|Sorafenib|sorafenib|mesh-list
83607411|NCT02973204|Octreotide|octreotide|mesh-list
83607412|NCT02973204|Lanreotide|lanreotide|mesh-list
83607413|NCT02973204|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83607414|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607415|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607416|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607417|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83607418|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
83607419|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607420|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607421|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83607422|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83607423|NCT02959476|Ropivacaine|ropivacaine|mesh-list
83607424|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
83607425|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
83607426|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607427|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607428|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
83607429|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607430|NCT02958852|Letrozole|letrozole|mesh-list
83607431|NCT02958852|Fulvestrant|fulvestrant|mesh-list
83607432|NCT02958852|Atorvastatin|atorvastatin|mesh-list
83607433|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83607434|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83607435|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
83607436|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607437|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83607438|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83607439|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607440|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607441|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83607442|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83607443|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83607444|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
83607445|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607446|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607447|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83607448|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83607449|NCT02641782|Aldesleukin|aldesleukin|mesh-list
83607450|NCT02641782|Interleukin-2|interleukin-2|mesh-list
83607451|NCT02641782|Tretinoin|tretinoin|mesh-list
83607452|NCT02641782|Dinutuximab|dinutuximab|mesh-list
83607453|NCT02641782|Isotretinoin|isotretinoin|mesh-list
83607454|NCT02641782|Antibodies|antibodies|mesh-list
83607455|NCT02641782|Sargramostim|sargramostim|mesh-list
83607456|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
83607457|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607458|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607459|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607460|NCT02641782|Analgesics|analgesics|mesh-ancestor
83607461|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
83607462|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607463|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
83607464|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83607465|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83607466|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83607467|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
83607468|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607469|NCT02641314|Celecoxib|celecoxib|mesh-list
83607470|NCT02641314|Propranolol|propranolol|mesh-list
83607471|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607472|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607473|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607474|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607475|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607476|NCT02641314|Analgesics|analgesics|mesh-ancestor
83607477|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
83607478|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607479|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607480|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83607481|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83607482|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607483|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83607484|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83607485|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
83607486|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607487|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83607488|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83607489|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
83607490|NCT04769778|Valsartan|valsartan|mesh-list
83607491|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83607492|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83607493|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83607494|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607495|NCT04769076|Paclitaxel|paclitaxel|mesh-list
83607496|NCT04769076|Cisplatin|cisplatin|mesh-list
83607497|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83607498|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83607499|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607500|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
83607501|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
83607502|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
83607503|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607504|NCT04769076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607505|NCT04768764|Bupivacaine|bupivacaine|mesh-list
83607506|NCT04768764|Anesthetics|anesthetics|mesh-list
83607507|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
83607508|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607509|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607510|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
83607511|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607513|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83607514|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607515|NCT04748562|Progesterone|progesterone|mesh-list
83607516|NCT04748562|Progestins|progestins|mesh-ancestor
83607517|NCT04748562|Hormones|hormones|mesh-ancestor
83607518|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607519|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607520|NCT04745286|Ketamine|ketamine|mesh-list
83607521|NCT04745286|Esketamine|esketamine|mesh-list
83607522|NCT04745286|Analgesics|analgesics|mesh-ancestor
83607523|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
83607524|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607525|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607526|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83607527|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83607528|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
83607529|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
83607530|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607531|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83607532|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83607533|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607534|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607535|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
83607536|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83607537|NCT04745442|Antithrombins|antithrombins|mesh-list
83607538|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
83607539|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83607540|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
83607541|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607542|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607543|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
83607544|NCT04743180|Paclitaxel|paclitaxel|mesh-list
83607545|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83607546|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607547|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
83607548|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
83607549|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
83607550|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607551|NCT04740840|Amlodipine|amlodipine|mesh-list
83607552|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83607553|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83607554|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83607555|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607556|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83607557|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607558|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
83607559|NCT04739826|Flumatinib|flumatinib|mesh-list
83607560|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607561|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607562|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607563|NCT04739202|Bevacizumab|bevacizumab|mesh-list
83607564|NCT04739202|Atezolizumab|atezolizumab|mesh-list
83607565|NCT04739202|Ipatasertib|ipatasertib|mesh-list
83607566|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83607567|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607568|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607569|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83607570|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83607571|NCT04739202|Growth Substances|growth substances|mesh-ancestor
83607572|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607573|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
83607574|NCT04739202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83607575|NCT04739202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607576|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
83607577|NCT04739202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607578|NCT04739202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607579|NCT04738188|Epirubicin|epirubicin|mesh-list
83607580|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83607581|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607582|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83607583|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83607584|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607585|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607586|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83607587|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83607588|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83607589|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
83607590|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607591|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83607592|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83607593|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607594|NCT05314140|Calcium|calcium|mesh-list
83607595|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83607596|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607597|NCT05313906|Cisplatin|cisplatin|mesh-list
83607598|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607599|NCT05313828|Fluorometholone|fluorometholone|mesh-list
83607600|NCT05313828|Tobramycin|tobramycin|mesh-list
83607601|NCT05313828|Acyclovir|acyclovir|mesh-list
83607602|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
83607603|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83607604|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607605|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83607606|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
83607607|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607608|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
83607609|NCT05313828|Protective Agents|protective agents|mesh-ancestor
83607610|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
83607611|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607612|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
83607613|NCT05313828|Hormones|hormones|mesh-ancestor
83607614|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607615|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83607616|NCT05313750|Levofloxacin|levofloxacin|mesh-list
83607617|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
83607618|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
83607619|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83607620|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83607621|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83607622|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83607623|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607624|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607625|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607626|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83607627|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83607628|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
83607629|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83607630|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
83607631|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83607632|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
83607633|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607634|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607635|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
83607636|NCT05139966|Fluorides|fluorides|mesh-list
83607637|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
83607638|NCT05139966|Protective Agents|protective agents|mesh-ancestor
83607639|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607640|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83607641|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83607642|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607643|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
83607644|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83607645|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83607646|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83607647|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83607648|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607649|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
83607650|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607651|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607652|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83607653|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607654|NCT00577590|Metformin|metformin|mesh-list
83607655|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
83607656|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83607657|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607658|NCT00578214|Midazolam|midazolam|mesh-list
83607659|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
83607660|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607661|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607662|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83607663|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83607664|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83607665|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83607666|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83607667|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83607668|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
83607669|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
83607670|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
83607671|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607672|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607673|NCT00580398|Varenicline|varenicline|mesh-list
83607674|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83607675|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83607676|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
83607677|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607678|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607679|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607680|NCT00582660|Celecoxib|celecoxib|mesh-list
83607681|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607682|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607683|NCT00582660|Analgesics|analgesics|mesh-ancestor
83607684|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
83607685|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607686|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607687|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607688|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607689|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83607690|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83607691|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607692|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607693|NCT00582894|Fludarabine|fludarabine|mesh-list
83607694|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
83607695|NCT00582894|Busulfan|busulfan|mesh-list
83607696|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607697|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607698|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83607699|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
83607700|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607701|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607702|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
83607703|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83607704|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83607705|NCT00585780|Prazosin|prazosin|mesh-list
83607706|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83607707|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83607708|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83607709|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83607710|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
83607711|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607712|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607713|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607714|NCT00586482|Nicotine|nicotine|mesh-list
83607715|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83607716|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
83607717|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607718|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607719|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83607720|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83607721|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
83607722|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607723|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607724|NCT03708354|Tocotrienols|tocotrienols|mesh-list
83607725|NCT03708354|Vitamin E|vitamin e|mesh-list
83607726|NCT03708354|Tocopherols|tocopherols|mesh-list
83607727|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
83607728|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607729|NCT03708354|Protective Agents|protective agents|mesh-ancestor
83607730|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607731|NCT03708354|Vitamins|vitamins|mesh-ancestor
83607732|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
83607733|NCT03297684|Aflibercept|aflibercept|mesh-list
83607734|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83607735|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83607736|NCT03297684|Growth Substances|growth substances|mesh-ancestor
83607737|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607738|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83607739|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607740|NCT03262662|Varenicline|varenicline|mesh-list
83607741|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83607742|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83607743|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
83607744|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607745|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607746|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607747|NCT01740648|Fluorouracil|fluorouracil|mesh-list
83607748|NCT01740648|Trametinib|trametinib|mesh-list
83607749|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
83607750|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607751|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83607752|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607753|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83607754|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
83607755|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607756|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607757|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607758|NCT01685424|Etoricoxib|etoricoxib|mesh-list
83607759|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607760|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607761|NCT01685424|Analgesics|analgesics|mesh-ancestor
83607762|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
83607763|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607764|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607765|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607766|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607767|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83607768|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83607769|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607770|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607771|NCT01327638|Etoricoxib|etoricoxib|mesh-list
83607772|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83607773|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607774|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607775|NCT01327638|Analgesics|analgesics|mesh-ancestor
83607776|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
83607777|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607778|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607779|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607780|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607781|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83607782|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607783|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607784|NCT00393354|Etoricoxib|etoricoxib|mesh-list
83607785|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607786|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607787|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607788|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83607789|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83607790|NCT00393354|Analgesics|analgesics|mesh-ancestor
83607791|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
83607792|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83607793|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83607794|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83607795|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83607796|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607797|NCT00166530|Atorvastatin|atorvastatin|mesh-list
83607798|NCT00166530|Simvastatin|simvastatin|mesh-list
83607799|NCT00166530|Ezetimibe|ezetimibe|mesh-list
83607800|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83607801|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83607802|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
83607803|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607804|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83607805|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83607806|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607807|NCT00588900|Irinotecan|irinotecan|mesh-list
83607808|NCT00588900|Cediranib|cediranib|mesh-list
83607809|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83607810|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83607811|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607812|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607813|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607814|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83607815|NCT00589056|Nelfinavir|nelfinavir|mesh-list
83607816|NCT00589056|Etoposide|etoposide|mesh-list
83607817|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607818|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83607819|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83607820|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83607821|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607822|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607823|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83607824|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83607825|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
83607826|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83607827|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83607828|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
83607829|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607830|NCT00590226|Insulin|insulin|mesh-list
83607831|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83607832|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
83607833|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
83607834|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
83607835|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
83607836|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83607837|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607838|NCT00590460|Fludarabine|fludarabine|mesh-list
83607839|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
83607840|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607841|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607842|NCT00590772|Montelukast|montelukast|mesh-list
83607843|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83607844|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
83607845|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83607846|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83607847|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607848|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607849|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83607850|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83607851|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607852|NCT00592176|Bevacizumab|bevacizumab|mesh-list
83607853|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607854|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607855|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83607856|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83607857|NCT00592176|Growth Substances|growth substances|mesh-ancestor
83607858|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607859|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
83607860|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
83607861|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
83607862|NCT00592488|Vitamins|vitamins|mesh-ancestor
83607863|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
83607864|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607865|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
83607866|NCT00595530|Ketamine|ketamine|mesh-list
83607867|NCT00595530|Analgesics|analgesics|mesh-ancestor
83607868|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
83607869|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607870|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607871|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83607872|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83607873|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
83607874|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
83607875|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607876|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83607877|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83607878|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607879|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607880|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
83607881|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
83065862|NCT04037072|Mitomycins|mitomycins|mesh-list
83607882|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065936|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83607883|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607884|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607885|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
83607886|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83607887|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607888|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607889|NCT00597402|Bevacizumab|bevacizumab|mesh-list
83607890|NCT00597402|Irinotecan|irinotecan|mesh-list
83607891|NCT00597402|Temozolomide|temozolomide|mesh-list
83607892|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607893|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607894|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83607895|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83607896|NCT00597402|Growth Substances|growth substances|mesh-ancestor
83607897|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607898|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
83607899|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83607900|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83607901|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607902|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607903|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83607904|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
83607905|NCT00598806|Apaziquone|apaziquone|mesh-list
83607906|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607907|NCT00601926|Bevacizumab|bevacizumab|mesh-list
83607908|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83607909|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607910|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83607911|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83607912|NCT00601926|Growth Substances|growth substances|mesh-ancestor
83607913|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607914|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
83607915|NCT00603018|Fluoxetine|fluoxetine|mesh-list
83607916|NCT00603018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83607917|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83607918|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83607919|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607920|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607921|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
83607922|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607923|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83607924|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
83607925|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83607926|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83607927|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83607928|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607929|NCT00603408|Cisplatin|cisplatin|mesh-list
83607930|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83607931|NCT00603720|Phenylephrine|phenylephrine|mesh-list
83607932|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
83607933|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
83607934|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83607935|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
83607936|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
83607937|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607938|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607939|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
83607940|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83607941|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
83607942|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
83607943|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83607944|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83607945|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83607946|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
83607947|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607948|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607949|NCT00603720|Protective Agents|protective agents|mesh-ancestor
83607950|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607951|NCT00625404|Tenofovir|tenofovir|mesh-list
83607952|NCT00625404|Emtricitabine|emtricitabine|mesh-list
83607953|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83607954|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
83607955|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83607956|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83607957|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83607958|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607959|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607960|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83607961|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83607962|NCT00626340|Fluoxetine|fluoxetine|mesh-list
83607963|NCT00626340|Estrogens|estrogens|mesh-list
83607964|NCT00626340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83607965|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83607966|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83607967|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83607968|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83607969|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
83607970|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607971|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83607972|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
83607973|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83607974|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83607975|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83607976|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83607977|NCT00626340|Hormones|hormones|mesh-ancestor
83607978|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83607979|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
83607980|NCT00626574|Hematinics|hematinics|mesh-ancestor
83607981|NCT00626886|Bupivacaine|bupivacaine|mesh-list
83607982|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
83607983|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
83607984|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83607985|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83607986|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
83607987|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83607988|NCT00628134|Calfactant|calfactant|mesh-list
83607989|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83607990|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
83607991|NCT00632814|Factor VIII|factor viii|mesh-list
83607992|NCT00632814|Coagulants|coagulants|mesh-ancestor
83607993|NCT00632970|Ritonavir|ritonavir|mesh-list
83607994|NCT00632970|Lopinavir|lopinavir|mesh-list
83607995|NCT00632970|Tenofovir|tenofovir|mesh-list
83607996|NCT00632970|Emtricitabine|emtricitabine|mesh-list
83607997|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
83607998|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83607999|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83608000|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83608001|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
83608002|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608003|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608004|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83608005|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83608006|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
83608007|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608008|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83608009|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83608010|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83608011|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83608012|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83608013|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83608014|NCT00635232|Irbesartan|irbesartan|mesh-list
83608015|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83608016|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83608017|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83608018|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608019|NCT00637494|Mifepristone|mifepristone|mesh-list
83608020|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83608021|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
83608022|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83608023|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608024|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83608025|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83608026|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83608027|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
83608028|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83608029|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83608030|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
83608031|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608032|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
83608033|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83608034|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83608035|NCT00638820|Busulfan|busulfan|mesh-list
83608036|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
83608037|NCT00638820|Clofarabine|clofarabine|mesh-list
83608038|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
83608039|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608040|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608041|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
83608042|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608043|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83608044|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608045|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83608046|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608047|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83608048|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
83608049|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
83608050|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
83608051|NCT00641862|Vitamins|vitamins|mesh-ancestor
83608052|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
83608053|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608054|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
83608055|NCT00641862|Hematinics|hematinics|mesh-ancestor
83608056|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
83608057|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83608058|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
83608059|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608060|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608061|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83608062|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
83608063|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83608064|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83608065|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83608066|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
83608067|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608068|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608069|NCT00644592|Fenofibrate|fenofibrate|mesh-list
83608070|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83608071|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
83608072|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608073|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83608074|NCT00645450|Propranolol|propranolol|mesh-list
83608075|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83608076|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83608077|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
83608078|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608079|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608080|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608081|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83608082|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83608083|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
83608084|NCT00647400|Adalimumab|adalimumab|mesh-list
83608085|NCT00647400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83608086|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608087|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608088|NCT00648648|Carboplatin|carboplatin|mesh-list
83608089|NCT00648648|Gemcitabine|gemcitabine|mesh-list
83608090|NCT00648648|Adavosertib|adavosertib|mesh-list
83608091|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608092|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83608093|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
83608094|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608095|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608096|NCT00652314|Thrombin|thrombin|mesh-list
83608097|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
83608098|NCT00652314|Coagulants|coagulants|mesh-ancestor
83608099|NCT00654030|Vaccines|vaccines|mesh-list
83608100|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
83066087|NCT04425018|Trastuzumab|trastuzumab|mesh-list
83608101|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608102|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
83608103|NCT00656448|Hematinics|hematinics|mesh-ancestor
83608104|NCT00660504|Etoposide|etoposide|mesh-list
83608105|NCT00660504|Amrubicin|amrubicin|mesh-list
83608106|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608107|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83608108|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83608109|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83608110|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608111|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608112|NCT00661674|Palonosetron|palonosetron|mesh-list
83608113|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
83608114|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
83608115|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
83608116|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608117|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608118|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608119|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83608120|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83608121|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
83608122|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608123|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608124|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
83608125|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608126|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83608127|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
83608128|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
83608129|NCT00662298|Prednisolone|prednisolone|mesh-list
83608130|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608131|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
83608132|NCT00662298|Hormones|hormones|mesh-ancestor
83608133|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608134|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608135|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83608136|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608137|NCT00666666|Acetic Acid|acetic acid|mesh-list
83608138|NCT00666666|Bicalutamide|bicalutamide|mesh-list
83608139|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
83608140|NCT00666666|Gossypol|gossypol|mesh-list
83608141|NCT00666666|Hormones|hormones|mesh-list
83608142|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608143|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608144|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
83608145|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
83608146|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608147|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83608148|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608149|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83608150|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83608151|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
83608152|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83608153|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83608154|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83608155|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83608156|NCT00666978|Bupropion|bupropion|mesh-list
83608157|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83608158|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
83608159|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83608160|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83608161|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83608162|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608163|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608164|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
83608165|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608166|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608167|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83608168|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83608169|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608170|NCT00670956|Betamethasone|betamethasone|mesh-list
83608171|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608172|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
83608173|NCT00670956|Hormones|hormones|mesh-ancestor
83608174|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608175|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608176|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83608177|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
83608178|NCT00671502|Carisoprodol|carisoprodol|mesh-list
83608179|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83608180|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608181|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83608182|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608183|NCT00671970|Bevacizumab|bevacizumab|mesh-list
83608184|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83608185|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608186|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608187|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83608188|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83608189|NCT00671970|Growth Substances|growth substances|mesh-ancestor
83608190|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608191|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
83608192|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608193|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608194|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608195|NCT00672204|Sirolimus|sirolimus|mesh-list
83608196|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
83608197|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83608198|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83608199|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608200|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83608201|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608202|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
83608203|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608204|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
83608205|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608206|NCT00672438|Alfentanil|alfentanil|mesh-list
83608207|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83608208|NCT00672438|Narcotics|narcotics|mesh-ancestor
83608209|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608210|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608211|NCT00672438|Analgesics|analgesics|mesh-ancestor
83608212|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
83608213|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608214|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83608215|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
83608216|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
83608217|NCT00672594|Sunitinib|sunitinib|mesh-list
83608218|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608219|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83608220|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83608221|NCT00672594|Growth Substances|growth substances|mesh-ancestor
83608222|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608223|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
83608224|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608225|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608226|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608227|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83608228|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
83608229|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83608230|NCT00675792|Bromides|bromides|mesh-list
83608231|NCT00675792|Rocuronium|rocuronium|mesh-list
83608232|NCT00675792|Neostigmine|neostigmine|mesh-list
83608233|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
83608234|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83608235|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83608236|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83608237|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608238|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608239|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83608240|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608241|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608242|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
83608243|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608244|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83608245|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
83608246|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
83608247|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608248|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
83608249|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608250|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608251|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83608252|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
83608253|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608254|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608255|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83608256|NCT00678834|Tocopherols|tocopherols|mesh-list
83608257|NCT00678834|Vitamin E|vitamin e|mesh-list
83608258|NCT00678834|Tocotrienols|tocotrienols|mesh-list
83608259|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
83608260|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
83608261|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608262|NCT00678834|Protective Agents|protective agents|mesh-ancestor
83608263|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608264|NCT00678834|Vitamins|vitamins|mesh-ancestor
83608265|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
83608266|NCT00679380|Budesonide|budesonide|mesh-list
83608267|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608268|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83608269|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
83608270|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608271|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608272|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83608273|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
83608274|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
83608275|NCT00679380|Hormones|hormones|mesh-ancestor
83608276|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608277|NCT00680706|Thiamine|thiamine|mesh-list
83608278|NCT00680706|Vitamins|vitamins|mesh-ancestor
83608279|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
83608280|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608281|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
83608282|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
83608283|NCT00682734|Promethazine|promethazine|mesh-list
83608284|NCT00682734|Metoclopramide|metoclopramide|mesh-list
83608285|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83608286|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83608287|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608288|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608289|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
83608290|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
83608291|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
83608292|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608293|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
83608294|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
83608295|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608296|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83608297|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
83608298|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
83608299|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608300|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608301|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83608302|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
83608303|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608304|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83608305|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83608306|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
83608307|NCT00683046|Fludarabine|fludarabine|mesh-list
83608308|NCT00683046|Melphalan|melphalan|mesh-list
83608309|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
83608310|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608311|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608312|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608313|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
83608314|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608315|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83608316|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
83608317|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83608318|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608319|NCT00687102|Tamoxifen|tamoxifen|mesh-list
83608320|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83608321|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83608322|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
83608323|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608324|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608325|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83608326|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608327|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83608328|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83608329|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83608330|NCT00690924|Calcitriol|calcitriol|mesh-list
83608331|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83608332|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608333|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83608334|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608335|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608336|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83608337|NCT00690924|Vitamins|vitamins|mesh-ancestor
83608338|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
83608339|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83608340|NCT00691002|Calcitriol|calcitriol|mesh-list
83608341|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
83608342|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83608343|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83608344|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83608345|NCT00691002|Calcipotriene|calcipotriene|mesh-list
83608346|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608347|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608348|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83608349|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608350|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83608351|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608352|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608353|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83608354|NCT00691002|Vitamins|vitamins|mesh-ancestor
83608355|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
83608356|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83608357|NCT00695292|Carboplatin|carboplatin|mesh-list
83608358|NCT00695292|Irinotecan|irinotecan|mesh-list
83608359|NCT00695292|Sunitinib|sunitinib|mesh-list
83608360|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608361|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83608362|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83608363|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608364|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608365|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83608366|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83608367|NCT00695292|Growth Substances|growth substances|mesh-ancestor
83608368|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608369|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
83608370|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608371|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
83608372|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83608373|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83608374|NCT00700440|Cetuximab|cetuximab|mesh-list
83608375|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608376|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608377|NCT00701376|Liver Extracts|liver extracts|mesh-list
83608378|NCT00701376|Hematinics|hematinics|mesh-ancestor
83608379|NCT00702780|Escitalopram|escitalopram|mesh-list
83608380|NCT00702780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83608381|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83608382|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608383|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608384|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608385|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
83608386|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608387|NCT00704028|Dextrans|dextrans|mesh-list
83608388|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
83608389|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
83608390|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
83608391|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
83608392|NCT00704028|Hematinics|hematinics|mesh-ancestor
83608393|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
83608394|NCT00704262|Calcipotriene|calcipotriene|mesh-list
83608395|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608396|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608397|NCT00706446|Fluticasone|fluticasone|mesh-list
83608398|NCT00706446|Xhance|xhance|mesh-list
83608399|NCT00706446|Budesonide|budesonide|mesh-list
83608400|NCT00706446|Bromides|bromides|mesh-list
83608401|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
83608402|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
83608403|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83608404|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608405|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83608406|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
83608407|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608408|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608409|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83608410|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
83608411|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608412|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83608413|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
83608414|NCT00706446|Hormones|hormones|mesh-ancestor
83608415|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608416|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83608417|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83608418|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83608419|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
83608420|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608421|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608422|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
83608423|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83608424|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
83608425|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
83608426|NCT00706836|Pregabalin|pregabalin|mesh-list
83608427|NCT00706836|Analgesics|analgesics|mesh-ancestor
83608428|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
83608429|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608430|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608431|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
83608432|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83608433|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608434|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608435|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83608436|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83608437|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83608438|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608439|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83608440|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83608441|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83608442|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608443|NCT00711828|Dexamethasone|dexamethasone|mesh-list
83608444|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
83608445|NCT00711828|Rituximab|rituximab|mesh-list
83608446|NCT00711828|Bortezomib|bortezomib|mesh-list
83608447|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608448|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
83608449|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608450|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608451|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83608452|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
83608453|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608454|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608455|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83608456|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608457|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608458|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
83608459|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
83608460|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608461|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608462|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
83608463|NCT00711828|Hormones|hormones|mesh-ancestor
83608464|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608465|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83608466|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83608467|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
83608468|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608469|NCT00715884|Sirolimus|sirolimus|mesh-list
83608470|NCT00715884|Temsirolimus|temsirolimus|mesh-list
83608471|NCT00715884|MTOR Inhibitors|mtor inhibitors|mesh-list
83608472|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83608473|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608474|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83608475|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608476|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
83608477|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608478|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
83608479|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608480|NCT00715884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608481|NCT00715884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608482|NCT00715884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608483|NCT00716586|Dorzolamide|dorzolamide|mesh-list
83608484|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83608485|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83608486|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608487|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608488|NCT00716742|Bimatoprost|bimatoprost|mesh-list
83608489|NCT00716742|Travoprost|travoprost|mesh-list
83608490|NCT00716742|Latanoprost|latanoprost|mesh-list
83608491|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83608492|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83608493|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83608494|NCT00716820|Sunitinib|sunitinib|mesh-list
83608495|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608496|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83608497|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83608498|NCT00716820|Growth Substances|growth substances|mesh-ancestor
83608499|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608500|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83608501|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608502|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608503|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608504|NCT00717054|Scopolamine|scopolamine|mesh-list
83608505|NCT00717054|Aprepitant|aprepitant|mesh-list
83608506|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83608507|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
83608508|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
83608509|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608510|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608511|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608512|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83608513|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608514|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608515|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83608516|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
83608517|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83608518|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
83608519|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83608520|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
83608521|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
83608522|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83608523|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608524|NCT00719160|Esomeprazole|esomeprazole|mesh-list
83608525|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83608526|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608527|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83608528|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608529|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608530|NCT00720330|Lidocaine|lidocaine|mesh-list
83608531|NCT00720330|Ketamine|ketamine|mesh-list
83608532|NCT00720330|Ropivacaine|ropivacaine|mesh-list
83608533|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
83608534|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
83608535|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608536|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608537|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
83608538|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608539|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83608540|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83608541|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83608542|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608543|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608544|NCT00720330|Analgesics|analgesics|mesh-ancestor
83608545|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83608546|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83608547|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
83608548|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83608549|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83608550|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608551|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83608552|NCT00721188|Hematinics|hematinics|mesh-ancestor
83608553|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
83608554|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83608555|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83608556|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608557|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
83608558|NCT00722436|Coagulants|coagulants|mesh-ancestor
83608559|NCT00724464|Interferons|interferons|mesh-list
83608560|NCT00724464|Ribavirin|ribavirin|mesh-list
83608561|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
83608562|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
83608563|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83608564|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608565|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
83608566|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608567|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
83608568|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608569|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
83608570|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608571|NCT00726414|Quinine|quinine|mesh-list
83608572|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
83608573|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83608574|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83608575|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608576|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83608577|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608578|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83608579|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608580|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83608581|NCT00726414|Analgesics|analgesics|mesh-ancestor
83608582|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
83608583|NCT00727740|Indomethacin|indomethacin|mesh-list
83608584|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83608585|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83608586|NCT00727740|Analgesics|analgesics|mesh-ancestor
83608587|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
83608588|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608589|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608590|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608591|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608592|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
83608593|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
83608594|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83608595|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83608596|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608597|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608598|NCT00728910|Niacin|niacin|mesh-list
83608599|NCT00728910|Atorvastatin|atorvastatin|mesh-list
83608600|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83608601|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83608602|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
83608603|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608604|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83608605|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83608606|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608607|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
83608608|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
83608609|NCT00728910|Vitamins|vitamins|mesh-ancestor
83608610|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
83608611|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608612|NCT00729846|Bevacizumab|bevacizumab|mesh-list
83608613|NCT00729846|Verteporfin|verteporfin|mesh-list
83608614|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608615|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608616|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83608617|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83608618|NCT00729846|Growth Substances|growth substances|mesh-ancestor
83608619|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608620|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
83608621|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83608622|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608623|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
83608624|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83608625|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83608626|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
83608627|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608628|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83608629|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83608630|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608631|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608632|NCT00731874|Tacrolimus|tacrolimus|mesh-list
83608633|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608634|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
83608635|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608636|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83608637|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608638|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608639|NCT00732654|Immunomodulating Agents|immunomodulating agents|mesh-list
83608640|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
83608641|NCT00732654|Caseins|caseins|mesh-list
83608642|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608643|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
83608644|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
83608645|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608646|NCT00733278|Copper|copper|mesh-list
83608647|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
83608648|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83608649|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608650|NCT00733278|Trace Elements|trace elements|mesh-ancestor
83608651|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
83608652|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83608653|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83608654|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608655|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83608656|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83608657|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608658|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608659|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
83608660|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608661|NCT00735306|Bevacizumab|bevacizumab|mesh-list
83608662|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83608663|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608664|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608665|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83608666|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83608667|NCT00735306|Growth Substances|growth substances|mesh-ancestor
83608668|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608669|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
83608670|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608671|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608672|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608673|NCT00735462|Imiquimod|imiquimod|mesh-list
83608674|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83608675|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
83608676|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608677|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608678|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
83608679|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83608680|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
83608681|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
83608682|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608683|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608684|NCT00736632|Vitamin D|vitamin d|mesh-list
83608685|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
83608686|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
83608687|NCT00736632|Vitamins|vitamins|mesh-list
83608688|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
83608689|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608690|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83608691|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83608692|NCT00737178|Copper|copper|mesh-list
83608693|NCT00737178|Trace Elements|trace elements|mesh-ancestor
83608694|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
83608695|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608696|NCT00741156|Enalaprilat|enalaprilat|mesh-list
83608697|NCT00741156|Enalapril|enalapril|mesh-list
83608698|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83608699|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
83608700|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608701|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608702|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83608703|NCT00741468|Tolbutamide|tolbutamide|mesh-list
83608704|NCT00741468|Midazolam|midazolam|mesh-list
83608705|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
83608706|NCT00741468|Caffeine|caffeine|mesh-list
83608707|NCT00741468|Omeprazole|omeprazole|mesh-list
83608708|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83608709|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83608710|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608711|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608713|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83608714|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83608715|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83608716|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
83608717|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
83608718|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
83608719|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
83608720|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608721|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608722|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83608723|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83608724|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608725|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83608726|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83608727|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
83608728|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83608729|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608730|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83608731|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
83608732|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
83608733|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83608734|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83608735|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83608736|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83608737|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83608738|NCT00741858|Estradiol|estradiol|mesh-list
83608739|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83608740|NCT00741858|Estrogens|estrogens|mesh-ancestor
83608741|NCT00741858|Hormones|hormones|mesh-ancestor
83608742|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83608743|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608744|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83608745|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
83608746|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83608747|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83608748|NCT00742872|Mosapride|mosapride|mesh-list
83608749|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608750|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608751|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83608752|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
83608753|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608754|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608755|NCT00743574|Vitamin D|vitamin d|mesh-list
83608756|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
83608757|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
83608758|NCT00743574|Vitamins|vitamins|mesh-list
83608759|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83608760|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
83608761|NCT00743574|Calcium|calcium|mesh-list
83608762|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
83608763|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608764|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83608765|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83608766|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83608767|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83608768|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83608769|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
83608770|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83608771|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83608772|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83608773|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83608774|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83608775|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608776|NCT00743730|Morphine|morphine|mesh-list
83608777|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83608778|NCT00743730|Narcotics|narcotics|mesh-ancestor
83608779|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608780|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608781|NCT00743730|Analgesics|analgesics|mesh-ancestor
83608782|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
83608783|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608784|NCT00745290|Bupivacaine|bupivacaine|mesh-list
83608785|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83608786|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
83608787|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608788|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608789|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
83608790|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608791|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
83608792|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83608793|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83608794|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
83608795|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608796|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83608797|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83608798|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608799|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608800|NCT00753636|Isradipine|isradipine|mesh-list
83608801|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83608802|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83608803|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608804|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608805|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83608806|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608807|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
83608808|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83608809|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608810|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608811|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608812|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608813|NCT00755040|Cyclosporine|cyclosporine|mesh-list
83608814|NCT00755040|Cyclosporins|cyclosporins|mesh-list
83608815|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608816|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608817|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608818|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
83608819|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608820|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
83608821|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608822|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
83608823|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608824|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83608825|NCT00755274|Vaccines|vaccines|mesh-list
83608826|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
83608827|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608828|NCT00756600|Anesthetics|anesthetics|mesh-list
83608829|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608830|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608831|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83608832|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
83608833|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83608834|NCT00758784|Bromfenac|bromfenac|mesh-list
83608835|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83608836|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83608837|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83608838|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83608839|NCT00758784|Analgesics|analgesics|mesh-ancestor
83608840|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
83608841|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608842|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608843|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608844|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608845|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
83608846|NCT00759330|Analgesics|analgesics|mesh-ancestor
83608847|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
83608848|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608849|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608850|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83608851|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83608852|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83608853|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608854|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83608855|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608856|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608857|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83608858|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83608859|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83066842|NCT01359592|Hormones|hormones|mesh-ancestor
83608860|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608862|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608863|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83608864|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608865|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608866|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
83608867|NCT00759798|Rituximab|rituximab|mesh-list
83608868|NCT00759798|Fludarabine|fludarabine|mesh-list
83608869|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83608870|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
83608871|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608872|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83608873|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83608874|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
83608875|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608876|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608877|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83608878|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608879|NCT00760578|Pioglitazone|pioglitazone|mesh-list
83608880|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83608881|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608882|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83608883|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
83608884|NCT00761202|Glycerol|glycerol|mesh-list
83608885|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83608886|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
83608887|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608888|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
83608889|NCT00761202|Protective Agents|protective agents|mesh-ancestor
83608890|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83608891|NCT00761202|Laxatives|laxatives|mesh-ancestor
83608892|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83608893|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
83608894|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83608895|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83608896|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83608897|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608898|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608899|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
83608900|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608901|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608902|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83608903|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608904|NCT00762450|Triclosan|triclosan|mesh-list
83608905|NCT00762450|Fluorides|fluorides|mesh-list
83608906|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
83608907|NCT00762450|Protective Agents|protective agents|mesh-ancestor
83608908|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608909|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83608910|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608911|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83608912|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83608913|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
83608914|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608915|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83608916|NCT00762528|Triclosan|triclosan|mesh-list
83608917|NCT00762528|Fluorides|fluorides|mesh-list
83608918|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
83608919|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
83608920|NCT00762528|Protective Agents|protective agents|mesh-ancestor
83608921|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608922|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83608923|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608924|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83608925|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83608926|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
83608927|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608928|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83608929|NCT00765648|Labetalol|labetalol|mesh-list
83608930|NCT00765648|Nicardipine|nicardipine|mesh-list
83608931|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83608932|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83608933|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
83608934|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608935|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608936|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608938|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
83608939|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
83608940|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608941|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83608942|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83608943|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83608944|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608945|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83608946|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
83608947|NCT00766116|Azacitidine|azacitidine|mesh-list
83608948|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
83608949|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83608950|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
83608951|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608952|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608953|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608954|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83608955|NCT00766116|Immunotoxins|immunotoxins|mesh-ancestor
83608956|NCT00766116|Immunoconjugates|immunoconjugates|mesh-ancestor
83608957|NCT00766116|Immunologic Factors|immunologic factors|mesh-ancestor
83608958|NCT00766116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608959|NCT00767364|Vaccines|vaccines|mesh-list
83608960|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
83608961|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608962|NCT00769314|Acyclovir|acyclovir|mesh-list
83608963|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
83608964|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608965|NCT00769392|Lidocaine|lidocaine|mesh-list
83608966|NCT00769392|Tetracaine|tetracaine|mesh-list
83608967|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
83608968|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83608969|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
83608970|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83608971|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608972|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
83608973|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608974|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83608975|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83608976|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83608977|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83608978|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608979|NCT00770874|Cisplatin|cisplatin|mesh-list
83608980|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83608981|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
83608982|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83608983|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83608984|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
83608985|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83608986|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83608987|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83608988|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83608989|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83608990|NCT00775944|Nicotine|nicotine|mesh-list
83608991|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83608992|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
83608993|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83608994|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83608995|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83608996|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83608997|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83608998|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83608999|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609000|NCT00780234|Pioglitazone|pioglitazone|mesh-list
83609001|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83609002|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609003|NCT00784524|Aldesleukin|aldesleukin|mesh-list
83609004|NCT00784524|Interleukin-2|interleukin-2|mesh-list
83609005|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609006|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83609007|NCT00784524|Analgesics|analgesics|mesh-ancestor
83609008|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
83609009|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609010|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609011|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83609012|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83609013|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
83609014|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609015|NCT00785772|Gabapentin|gabapentin|mesh-list
83609016|NCT00785772|Analgesics|analgesics|mesh-ancestor
83609017|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
83609018|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609019|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609020|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
83609021|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83609022|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83609023|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609024|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83609025|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83609026|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83609027|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609028|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609029|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
83609030|NCT00787332|Desirudin|desirudin|mesh-list
83609031|NCT00787332|Argatroban|argatroban|mesh-list
83609032|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
83609033|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83609034|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
83609035|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609036|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609037|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
83609038|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83609039|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83609040|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83609041|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
83609042|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83609043|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83609044|NCT00787722|Prednisolone|prednisolone|mesh-list
83609045|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
83609046|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
83609047|NCT00787722|Rituximab|rituximab|mesh-list
83609048|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
83609049|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83609050|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83609051|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
83609052|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609053|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
83609054|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609055|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83609056|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83609057|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
83609058|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609059|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609060|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83609061|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609062|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83609063|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
83609064|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
83609065|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609066|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83609067|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
83609068|NCT00787722|Hormones|hormones|mesh-ancestor
83609069|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609070|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83609071|NCT00787722|Protective Agents|protective agents|mesh-ancestor
83609072|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83609073|NCT00788892|Cytarabine|cytarabine|mesh-list
83609074|NCT00788892|Daunorubicin|daunorubicin|mesh-list
83609075|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83609076|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
83609077|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609078|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609079|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
83609080|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609081|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83067056|NCT02070159|Clopidogrel|clopidogrel|mesh-list
83609082|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
83609083|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609084|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83067133|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
83609085|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83609086|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83609087|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609088|NCT00789672|Levodopa|levodopa|mesh-list
83609089|NCT00789672|Carbidopa|carbidopa|mesh-list
83609090|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83609091|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83609092|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
83609093|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609094|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609095|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609096|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83609097|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609098|NCT00789750|Pioglitazone|pioglitazone|mesh-list
83609099|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83609100|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83609101|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609102|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83609103|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83609104|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
83609105|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609106|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83609107|NCT00790062|Oxytocin|oxytocin|mesh-list
83609108|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
83609109|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83609110|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609111|NCT00793572|Cyclosporine|cyclosporine|mesh-list
83609112|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
83609113|NCT00793572|Fludarabine|fludarabine|mesh-list
83609114|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
83609115|NCT00793572|Bortezomib|bortezomib|mesh-list
83609116|NCT00793572|Melphalan|melphalan|mesh-list
83609117|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
83609118|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83609119|NCT00793572|Cyclosporins|cyclosporins|mesh-list
83609120|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609121|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83609122|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
83609123|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609124|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609125|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
83609126|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609127|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609128|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
83609129|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609130|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609131|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83609132|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83609133|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83609134|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83609135|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
83609136|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609137|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83609138|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
83609139|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83609140|NCT00793650|Bortezomib|bortezomib|mesh-list
83609141|NCT00793650|Melphalan|melphalan|mesh-list
83609142|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609143|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83609144|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
83609145|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609146|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83609147|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609148|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
83609149|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609150|NCT00795210|Hormones|hormones|mesh-list
83609151|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
83609152|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609153|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609154|NCT00795288|Simvastatin|simvastatin|mesh-list
83609155|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83609156|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83609157|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
83609158|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609159|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83609160|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83609161|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609162|NCT00795366|Vasopressins|vasopressins|mesh-list
83609163|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
83609164|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
83609165|NCT00795366|Coagulants|coagulants|mesh-ancestor
83609166|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83609167|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83609168|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
83609169|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609170|NCT00796302|Risperidone|risperidone|mesh-list
83609171|NCT00796302|Methylphenidate|methylphenidate|mesh-list
83609172|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83609173|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
83609174|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609175|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609176|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609177|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83609178|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83609179|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609180|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83609181|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83609182|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
83609183|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83609184|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83609185|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83609186|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83609187|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83609188|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83609189|NCT00798018|Lidocaine|lidocaine|mesh-list
83609190|NCT00798018|Tetracaine|tetracaine|mesh-list
83609191|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
83609192|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
83609193|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609194|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609195|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
83609196|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609197|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83609198|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83609199|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83609200|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83609201|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609202|NCT00798720|Bortezomib|bortezomib|mesh-list
83609203|NCT00798720|Vorinostat|vorinostat|mesh-list
83609204|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609205|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83609206|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609207|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609208|NCT00799578|Cysteamine|cysteamine|mesh-list
83609209|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83609210|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609211|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83609212|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83609213|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609214|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609215|NCT00801138|Dexamethasone|dexamethasone|mesh-list
83609216|NCT00801138|Bupivacaine|bupivacaine|mesh-list
83609217|NCT00801138|Ropivacaine|ropivacaine|mesh-list
83609218|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83609219|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
83609220|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
83609221|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609222|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609223|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83609224|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
83609225|NCT00801138|Hormones|hormones|mesh-ancestor
83609226|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609227|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83609228|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609229|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
83609230|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
83609231|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609232|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
83609233|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83609234|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
83067281|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609235|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83609236|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
83609237|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609238|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609239|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83609240|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
83609241|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83609242|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83609243|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83609244|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
83609245|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609246|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609247|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
83609248|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83609249|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
83609250|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83609251|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83609252|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83609253|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609255|NCT00803010|Methotrexate|methotrexate|mesh-list
83609256|NCT00803010|Tacrolimus|tacrolimus|mesh-list
83609257|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83609258|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
83609259|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83609260|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609261|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83609262|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
83609263|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609264|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609265|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609266|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609267|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83609268|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609269|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
83609270|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83609271|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83609272|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83609273|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609274|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609275|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83609276|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
83609277|NCT00803400|Alprazolam|alprazolam|mesh-list
83609278|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83609279|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609280|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609281|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83609282|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83609283|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83609284|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
83609285|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
83609286|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609287|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609288|NCT00804648|Timolol|timolol|mesh-list
83609289|NCT00804648|Maleic acid|maleic acid|mesh-list
83609290|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609291|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609292|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83609293|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83609294|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
83609295|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609296|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609297|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83609298|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83609299|NCT00806598|Cyclosporine|cyclosporine|mesh-list
83609300|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
83609301|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83609302|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83609303|NCT00806598|Prednisolone|prednisolone|mesh-list
83609304|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
83609305|NCT00806598|Cyclosporins|cyclosporins|mesh-list
83609306|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
83609307|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83609308|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83609309|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
83609310|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609311|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609312|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609313|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
83609314|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609315|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
83609316|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609317|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609318|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83609319|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83609320|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83609321|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
83609322|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
83609323|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609324|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83609325|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
83609326|NCT00806598|Hormones|hormones|mesh-ancestor
83609327|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609328|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83609329|NCT00806598|Protective Agents|protective agents|mesh-ancestor
83609330|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83609331|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609332|NCT00807768|Paclitaxel|paclitaxel|mesh-list
83609333|NCT00807768|Carboplatin|carboplatin|mesh-list
83609334|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83609335|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83609336|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609337|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
83609338|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
83609339|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
83609340|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609341|NCT00808470|Beta Carotene|beta carotene|mesh-list
83609342|NCT00808470|Carotenoids|carotenoids|mesh-list
83609343|NCT00808470|Vitamins|vitamins|mesh-ancestor
83609344|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
83609345|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609346|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
83609347|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609348|NCT00808470|Protective Agents|protective agents|mesh-ancestor
83609349|NCT00808470|Provitamins|provitamins|mesh-ancestor
83609350|NCT00810576|Bortezomib|bortezomib|mesh-list
83609351|NCT00810576|Vorinostat|vorinostat|mesh-list
83609352|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609353|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83609354|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609355|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609356|NCT00811434|Lactulose|lactulose|mesh-list
83609357|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83609358|NCT00812604|Analgesics|analgesics|mesh-list
83609359|NCT00812604|Petrolatum|petrolatum|mesh-list
83609360|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
83609361|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609362|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609363|NCT00812604|Emollients|emollients|mesh-ancestor
83609364|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609365|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
83609366|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83609367|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83609368|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83609369|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83609370|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609371|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
83609372|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609373|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609374|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83609375|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609376|NCT00814788|Everolimus|everolimus|mesh-list
83609377|NCT00814788|Bicalutamide|bicalutamide|mesh-list
83609378|NCT00814788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83609379|NCT00814788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83609380|NCT00814788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067356|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
83609381|NCT00814788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609382|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609383|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
83609384|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609385|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609386|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
83609387|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609388|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609390|NCT00820872|Docetaxel|docetaxel|mesh-list
83609391|NCT00820872|Trastuzumab|trastuzumab|mesh-list
83609392|NCT00820872|Lapatinib|lapatinib|mesh-list
83609393|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609394|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
83609395|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
83609396|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
83609397|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609398|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609399|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83609400|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609401|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
83609402|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83609403|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83609404|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
83609405|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609406|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609407|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609408|NCT00821184|Urological Agents|urological agents|mesh-ancestor
83609409|NCT05236842|Sulthiame|sulthiame|mesh-list
83609410|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
83609411|NCT05206812|Durvalumab|durvalumab|mesh-list
83609412|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609413|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609414|NCT05131152|Cyclosporine|cyclosporine|mesh-list
83609415|NCT05131152|Cyclosporins|cyclosporins|mesh-list
83609416|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609417|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609418|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609419|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
83609420|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609421|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
83609422|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609423|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609424|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83609425|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83609426|NCT04900116|Bupivacaine|bupivacaine|mesh-list
83609427|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
83609428|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
83609429|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609430|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609431|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
83609432|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609433|NCT04694976|Vitamin D|vitamin d|mesh-list
83609434|NCT04694976|Vitamins|vitamins|mesh-ancestor
83609435|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
83609436|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609437|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83609438|NCT04603248|Nivolumab|nivolumab|mesh-list
83609439|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609440|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609441|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83609442|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609443|NCT03936270|Letrozole|letrozole|mesh-list
83609444|NCT03936270|Palbociclib|palbociclib|mesh-list
83609445|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609446|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83609447|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83609448|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609449|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609450|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83609451|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609452|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609453|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609454|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83609455|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
83067429|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83609456|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609457|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
83609458|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609459|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609460|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83609462|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
83609463|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83609464|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609465|NCT02641236|Vancomycin|vancomycin|mesh-list
83609466|NCT02641236|Polymyxins|polymyxins|mesh-list
83609467|NCT02641236|Polymyxin B|polymyxin b|mesh-list
83609468|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609469|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609470|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
83609471|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609472|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609473|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83609474|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83609475|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609476|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609477|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609478|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83609479|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83609480|NCT00821886|Carboplatin|carboplatin|mesh-list
83609481|NCT00821886|Trastuzumab|trastuzumab|mesh-list
83609482|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609483|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609484|NCT00821964|Paclitaxel|paclitaxel|mesh-list
83609485|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83609486|NCT00821964|Imiquimod|imiquimod|mesh-list
83609487|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83609488|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609489|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
83609490|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
83609491|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
83609492|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609493|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83609494|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
83609495|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609496|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
83609497|NCT00822354|Tadalafil|tadalafil|mesh-list
83609498|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
83609499|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83609500|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83609501|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609502|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609503|NCT00822354|Urological Agents|urological agents|mesh-ancestor
83609504|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
83609505|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
83609506|NCT00824070|Besifloxacin|besifloxacin|mesh-list
83609507|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83609508|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609509|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609510|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83609511|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83609512|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609513|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609514|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609515|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83609516|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
83609517|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83609518|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609519|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83609520|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83609521|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83609522|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83609523|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83609524|NCT00824460|Iron|iron|mesh-list
83609525|NCT00824460|Sevelamer|sevelamer|mesh-list
83609526|NCT00824460|Trace Elements|trace elements|mesh-ancestor
83609527|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
83609528|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609529|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
83609530|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
83609531|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609532|NCT00824538|Sunitinib|sunitinib|mesh-list
83609533|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609535|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83609536|NCT00824538|Growth Substances|growth substances|mesh-ancestor
83609537|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609538|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
83609539|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83609540|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609541|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609542|NCT00825786|Ropivacaine|ropivacaine|mesh-list
83609543|NCT00825786|Mepivacaine|mepivacaine|mesh-list
83609544|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
83609545|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
83609546|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609547|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609548|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
83609549|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609550|NCT00826800|Bevacizumab|bevacizumab|mesh-list
83609551|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609552|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609553|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83609554|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83609555|NCT00826800|Growth Substances|growth substances|mesh-ancestor
83609556|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609557|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83609558|NCT00830076|Metformin|metformin|mesh-list
83609559|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83609560|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83609561|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609562|NCT00830076|Incretins|incretins|mesh-ancestor
83609563|NCT00830076|Hormones|hormones|mesh-ancestor
83609564|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609565|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83609566|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83609567|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609568|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609569|NCT00830388|Ketoconazole|ketoconazole|mesh-list
83609570|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
83609571|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609572|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83609573|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83609574|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609575|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609576|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83609577|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609578|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609579|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609580|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83609581|NCT00831480|Everolimus|everolimus|mesh-list
83609582|NCT00831480|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83609583|NCT00831480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83609584|NCT00831480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609585|NCT00831480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609586|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609587|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
83609588|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609589|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609590|NCT00832338|Dexamethasone|dexamethasone|mesh-list
83609591|NCT00832338|Docetaxel|docetaxel|mesh-list
83609592|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
83609593|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83609594|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
83609595|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
83609596|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609597|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609598|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83609599|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
83609600|NCT00832338|Hormones|hormones|mesh-ancestor
83609601|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609602|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83609603|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609604|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
83609605|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
83609606|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
83609607|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609608|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609609|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
83609610|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83609611|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83609612|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
83609613|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83609614|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
83609615|NCT00834210|Dapsone|dapsone|mesh-list
83609616|NCT00834210|Tazarotene|tazarotene|mesh-list
83609617|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609618|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
83609619|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83609620|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83609621|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83609622|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609623|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609624|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
83609625|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609626|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609627|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
83609628|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
83609629|NCT00834210|Vitamins|vitamins|mesh-ancestor
83609630|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
83609631|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609632|NCT00834288|Tramadol|tramadol|mesh-list
83609633|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83609634|NCT00834288|Narcotics|narcotics|mesh-ancestor
83609635|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609636|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609637|NCT00834288|Analgesics|analgesics|mesh-ancestor
83609638|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
83609639|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609640|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83609641|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83609642|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609643|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83609644|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609645|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609646|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83609647|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
83609648|NCT00835224|Midodrine|midodrine|mesh-list
83609649|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
83609650|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
83609651|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609652|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609653|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83609654|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83609655|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83609656|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83609657|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
83609658|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609659|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609660|NCT00835926|Vaccines|vaccines|mesh-list
83609661|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
83609662|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609663|NCT00837252|Finasteride|finasteride|mesh-list
83609664|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83609665|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83609666|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609667|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609668|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609669|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609670|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609671|NCT00837252|Urological Agents|urological agents|mesh-ancestor
83609672|NCT00839982|Cytarabine|cytarabine|mesh-list
83609673|NCT00839982|Clofarabine|clofarabine|mesh-list
83609674|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83609675|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
83609676|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609677|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609678|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
83609679|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609680|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609681|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
83609682|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609684|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
83609685|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
83609686|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609687|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
83609688|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609689|NCT00845130|Protective Agents|protective agents|mesh-ancestor
83609690|NCT00848016|Acetic Acid|acetic acid|mesh-list
83609691|NCT00848016|Retinol acetate|retinol acetate|mesh-list
83609692|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
83609693|NCT00848016|Gossypol|gossypol|mesh-list
83609694|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609695|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609696|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83609697|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
83609698|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609699|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83609700|NCT00848016|Protective Agents|protective agents|mesh-ancestor
83609701|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609702|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83609703|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
83609704|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83609705|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83609706|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83609707|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83609708|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83609709|NCT00849810|Metoprolol|metoprolol|mesh-list
83609710|NCT00849810|Nebivolol|nebivolol|mesh-list
83609711|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83609712|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83609713|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
83609714|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
83609715|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609716|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609717|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83609718|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83609719|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83609720|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
83609721|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609722|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609723|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
83609724|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83609725|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83609726|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83609727|NCT00856050|Letrozole|letrozole|mesh-list
83609728|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609729|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83609730|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83609731|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609732|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609733|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83609734|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609735|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609736|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609737|NCT00858468|Vaccines|vaccines|mesh-list
83609738|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
83609739|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609740|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83609741|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83609742|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83609743|NCT00866034|Cetrorelix|cetrorelix|mesh-list
83609744|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83609745|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
83609746|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83609747|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609748|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609749|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609750|NCT00868140|Pioglitazone|pioglitazone|mesh-list
83609751|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83609752|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609753|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83609754|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
83609755|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83609756|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83609757|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83609758|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609759|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609760|NCT00868452|Valproic Acid|valproic acid|mesh-list
83609761|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
83609762|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83609763|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
83609764|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83609765|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609766|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609767|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
83609768|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83609769|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609770|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609771|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
83609772|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
83609773|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609774|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83609775|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83609776|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83609777|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83609778|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
83609779|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83609780|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83609781|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
83609782|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83609783|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83609784|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
83609785|NCT00869622|Vitamin D|vitamin d|mesh-list
83609786|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
83609787|NCT00869622|Calcium|calcium|mesh-list
83609788|NCT00869622|Vitamins|vitamins|mesh-ancestor
83609789|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
83609790|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609791|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83609792|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83609793|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83609794|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83609795|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609796|NCT00871260|Regadenoson|regadenoson|mesh-list
83609797|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83609798|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83609799|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
83609800|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
83609801|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609802|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609803|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609804|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83609805|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609806|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609807|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609808|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83609809|NCT00875550|Fentanyl|fentanyl|mesh-list
83609810|NCT00875550|Midazolam|midazolam|mesh-list
83609811|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
83609812|NCT00875550|Morphine|morphine|mesh-list
83609813|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83609814|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609815|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609816|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83609817|NCT00875550|Analgesics|analgesics|mesh-ancestor
83609818|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
83609819|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609820|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83609821|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83609822|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83609823|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
83609824|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609825|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609826|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83609827|NCT00875550|Narcotics|narcotics|mesh-ancestor
83609828|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83609829|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83609830|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
83609831|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
83609832|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83609833|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83609834|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83609835|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
83609836|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
83609837|NCT00878436|Bicalutamide|bicalutamide|mesh-list
83609838|NCT00878436|Panobinostat|panobinostat|mesh-list
83609839|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
83609840|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609841|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609842|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609843|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609844|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83609845|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609846|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609847|NCT00878826|Enoxaparin|enoxaparin|mesh-list
83609848|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
83609849|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83609850|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83609851|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609852|NCT00879060|Spironolactone|spironolactone|mesh-list
83609853|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83609854|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
83609855|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609856|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609857|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83609858|NCT00879060|Diuretics|diuretics|mesh-ancestor
83609859|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
83609860|NCT00882102|Decitabine|decitabine|mesh-list
83609861|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
83609862|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83609863|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
83609864|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609865|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609866|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609867|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609868|NCT00882102|Immunotoxins|immunotoxins|mesh-ancestor
83609869|NCT00882102|Immunoconjugates|immunoconjugates|mesh-ancestor
83609870|NCT00882102|Immunologic Factors|immunologic factors|mesh-ancestor
83609871|NCT00882102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609872|NCT00884052|Levetiracetam|levetiracetam|mesh-list
83609873|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
83609874|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
83609875|NCT00886236|Gabapentin|gabapentin|mesh-list
83609876|NCT00886236|Analgesics|analgesics|mesh-ancestor
83609877|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
83609878|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609879|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609880|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
83609881|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83609882|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83609883|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609884|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83609885|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83609886|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83609887|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609888|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609889|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
83609890|NCT00886626|Exenatide|exenatide|mesh-list
83609891|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83609892|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609893|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83609894|NCT00886626|Incretins|incretins|mesh-ancestor
83609895|NCT00886626|Hormones|hormones|mesh-ancestor
83609896|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83609897|NCT00887562|Ubiquinone|ubiquinone|mesh-list
83609898|NCT00887562|Idebenone|idebenone|mesh-list
83609899|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
83609900|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609901|NCT00887562|Protective Agents|protective agents|mesh-ancestor
83609902|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609903|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
83609904|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
83609905|NCT00887640|Promethazine|promethazine|mesh-list
83609906|NCT00887640|Sirolimus|sirolimus|mesh-list
83609907|NCT00887640|Temsirolimus|temsirolimus|mesh-list
83609908|NCT00887640|MTOR Inhibitors|mtor inhibitors|mesh-list
83609909|NCT00887640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83609910|NCT00887640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609911|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609912|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83609913|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
83609914|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609915|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609916|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83609917|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83609918|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83609919|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
83609920|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83609921|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83609922|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609923|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
83609924|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
83609925|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
83609926|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609927|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
83609928|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
83609929|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83609930|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83609931|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
83609932|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
83609933|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609934|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83609935|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
83609936|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
83609937|NCT00889200|Eszopiclone|eszopiclone|mesh-list
83609938|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83609939|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83609940|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609941|NCT00892710|Bevacizumab|bevacizumab|mesh-list
83609942|NCT00892710|Carboplatin|carboplatin|mesh-list
83609943|NCT00892710|Pemetrexed|pemetrexed|mesh-list
83609944|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609945|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609946|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83609947|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83609948|NCT00892710|Growth Substances|growth substances|mesh-ancestor
83609949|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609950|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
83609951|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83609952|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609953|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83609954|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83609955|NCT00894504|Carboplatin|carboplatin|mesh-list
83609956|NCT00894504|Gemcitabine|gemcitabine|mesh-list
83609957|NCT00894504|Panitumumab|panitumumab|mesh-list
83609958|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609959|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83609960|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
83609961|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609962|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83609963|NCT00895752|Riluzole|riluzole|mesh-list
83609964|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
83609965|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83609966|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83609967|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609968|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609969|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609970|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83609971|NCT00895752|Protective Agents|protective agents|mesh-ancestor
83609972|NCT00896064|Vaccines|vaccines|mesh-list
83609973|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83609974|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
83609975|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609976|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83609977|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
83609978|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83609979|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83609980|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83609981|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609982|NCT00899574|Imiquimod|imiquimod|mesh-list
83609983|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83609984|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
83609985|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609986|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83609987|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
83609988|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
83609989|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83609990|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83609991|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83609992|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83609993|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83609994|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
83609995|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83609996|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83609997|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83609998|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83609999|NCT00902226|Escitalopram|escitalopram|mesh-list
83610000|NCT00902226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83610001|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83610002|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610003|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610004|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610005|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
83610006|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610007|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
83610008|NCT00903162|Letrozole|letrozole|mesh-list
83610009|NCT00903162|Leuprolide|leuprolide|mesh-list
83610010|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610011|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83610012|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83610013|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610014|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610015|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83610016|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
83610017|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610018|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610019|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83610020|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83610021|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
83610022|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83610023|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83610024|NCT00904488|Metolazone|metolazone|mesh-list
83610025|NCT00904488|Furosemide|furosemide|mesh-list
83610026|NCT00904488|Diuretics|diuretics|mesh-ancestor
83610027|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
83610028|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610029|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83610030|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610031|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610032|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83610033|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83610034|NCT00905580|Pregabalin|pregabalin|mesh-list
83610035|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610036|NCT00905580|Analgesics|analgesics|mesh-ancestor
83610037|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
83610038|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610039|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
83610040|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83610041|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610042|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610043|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83610044|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83610045|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83610046|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610047|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83610048|NCT00908466|Sirolimus|sirolimus|mesh-list
83610049|NCT00908466|Temsirolimus|temsirolimus|mesh-list
83610050|NCT00908466|MTOR Inhibitors|mtor inhibitors|mesh-list
83610051|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83610052|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610053|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83610054|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610055|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
83610056|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610057|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
83610058|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610059|NCT00908466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83610060|NCT00908466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610061|NCT00908466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610062|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
83610064|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
83610065|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
83610066|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83610067|NCT00911586|Androgens|androgens|mesh-ancestor
83610068|NCT00911586|Hormones|hormones|mesh-ancestor
83610069|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610070|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610071|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83610072|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610073|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
83610074|NCT00911742|Tramadol|tramadol|mesh-list
83610075|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83610076|NCT00911742|Narcotics|narcotics|mesh-ancestor
83610077|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610078|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610079|NCT00911742|Analgesics|analgesics|mesh-ancestor
83610080|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
83610081|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610082|NCT00912990|Cisatracurium|cisatracurium|mesh-list
83610083|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83610084|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83610085|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610086|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610087|NCT00913068|Lidocaine|lidocaine|mesh-list
83610088|NCT00913068|Ropivacaine|ropivacaine|mesh-list
83610089|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
83610090|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
83610091|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610092|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610093|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
83610094|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610095|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83610096|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83610097|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83610098|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482033|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83610099|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610100|NCT00916032|Factor VIII|factor viii|mesh-list
83610101|NCT00916032|Coagulants|coagulants|mesh-ancestor
83610102|NCT00922194|Metformin|metformin|mesh-list
83610103|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83610104|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610105|NCT00923910|Acetaminophen|acetaminophen|mesh-list
83610106|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
83610107|NCT00923910|Promethazine|promethazine|mesh-list
83610108|NCT00923910|Interleukin-4|interleukin-4|mesh-list
83610109|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83610110|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83610111|NCT00923910|Analgesics|analgesics|mesh-ancestor
83610112|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
83610113|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610114|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610115|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
83610116|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83610117|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83610118|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610119|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
83610120|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
83610121|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
83610122|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
83610123|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610124|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83610125|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
83610126|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
83610127|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610128|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610129|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83610130|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
83610131|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610132|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83610133|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
83610134|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610135|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610136|NCT00924066|Epothilones|epothilones|mesh-list
83610137|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83610138|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
83610139|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83610140|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610141|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610142|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
83610143|NCT00924612|Testosterone|testosterone|mesh-list
83610144|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
83610145|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
83610146|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83610147|NCT00924612|Androgens|androgens|mesh-ancestor
83610148|NCT00924612|Hormones|hormones|mesh-ancestor
83610149|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610150|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610151|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83610152|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610153|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
83610154|NCT00925782|Melphalan|melphalan|mesh-list
83610155|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610156|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
83610157|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610158|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610159|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83610160|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610161|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
83610162|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610163|NCT00925938|Misoprostol|misoprostol|mesh-list
83610164|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83610165|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
83610166|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83610167|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610168|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83610169|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610170|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
83610171|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83610172|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83610173|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610174|NCT00927888|Bupivacaine|bupivacaine|mesh-list
83610175|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
83610176|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
83610177|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610178|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610179|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
83610180|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610181|NCT00928200|Cytarabine|cytarabine|mesh-list
83610182|NCT00928200|Dexamethasone|dexamethasone|mesh-list
83610183|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
83610184|NCT00928200|Doxorubicin|doxorubicin|mesh-list
83610185|NCT00928200|Methotrexate|methotrexate|mesh-list
83610186|NCT00928200|Vincristine|vincristine|mesh-list
83610187|NCT00928200|Asparaginase|asparaginase|mesh-list
83610188|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
83610189|NCT00928200|Razoxane|razoxane|mesh-list
83610190|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83610191|NCT00928200|BB 1101|bb 1101|mesh-list
83610192|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610193|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
83610194|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
83610195|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610196|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610197|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610198|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
83610199|NCT00928200|Hormones|hormones|mesh-ancestor
83610200|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610201|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83610202|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610203|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
83610204|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610205|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610206|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83610207|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83610208|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83610209|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83610210|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
83610211|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83610212|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83610213|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
83610214|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610215|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83610216|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610217|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
83610218|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610219|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83610220|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
83610221|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610222|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83610223|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83610224|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83610225|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83610226|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83610227|NCT00928200|Protective Agents|protective agents|mesh-ancestor
83610228|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
83610229|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83610230|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83610231|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
83610232|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
83610233|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610234|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610235|NCT00931242|Thalidomide|thalidomide|mesh-list
83610236|NCT00931242|Apremilast|apremilast|mesh-list
83610237|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83610238|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83610239|NCT00931242|Analgesics|analgesics|mesh-ancestor
83610240|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
83610241|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610242|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610243|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610244|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610245|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83610246|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83610247|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610248|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610249|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610250|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
83610251|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
83610252|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83610253|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610254|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83610255|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83610256|NCT00931242|Growth Substances|growth substances|mesh-ancestor
83610257|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83610258|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610259|NCT00932022|Trospium chloride|trospium chloride|mesh-list
83610260|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
83610261|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
83610262|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610263|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610264|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83610265|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83610266|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
83610267|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610268|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610269|NCT00932022|Urological Agents|urological agents|mesh-ancestor
83610270|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83610271|NCT00939120|Dutasteride|dutasteride|mesh-list
83610272|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83610273|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83610274|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610275|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610276|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
83610277|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610278|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610279|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83610280|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83610281|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
83610282|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610283|NCT00939120|Urological Agents|urological agents|mesh-ancestor
83610284|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
83610285|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83610286|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610287|NCT00943098|Diclofenac|diclofenac|mesh-list
83610288|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83610289|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83610290|NCT00943098|Analgesics|analgesics|mesh-ancestor
83610291|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
83610292|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610293|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610294|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610295|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610296|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83610297|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610298|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610299|NCT00943800|Vidarabine|vidarabine|mesh-list
83610300|NCT00943800|Fludarabine|fludarabine|mesh-list
83610301|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
83610302|NCT00943800|Melphalan|melphalan|mesh-list
83610303|NCT00943800|Busulfan|busulfan|mesh-list
83610304|NCT00943800|Thiotepa|thiotepa|mesh-list
83610305|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83610306|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
83610307|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610308|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83610309|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
83610310|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610311|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610312|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
83610313|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610314|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
83610315|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610316|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610317|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
83610318|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83610319|NCT00943878|Vaccines|vaccines|mesh-list
83610320|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
83610321|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610322|NCT00945282|Ritonavir|ritonavir|mesh-list
83610323|NCT00945282|Lopinavir|lopinavir|mesh-list
83610324|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83610325|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83610326|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
83610327|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610328|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610329|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83610330|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83610331|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
83610332|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610333|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83610334|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83610335|NCT00945750|Famotidine|famotidine|mesh-list
83610336|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83610337|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610338|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83610339|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
83610340|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
83610341|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610342|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610343|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610344|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
83610345|NCT00948090|Busulfan|busulfan|mesh-list
83610346|NCT00948090|Etoposide|etoposide|mesh-list
83610347|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610348|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
83610349|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610350|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610351|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610352|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
83610353|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610354|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610355|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83610356|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83610357|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83068321|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
83610358|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83610359|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610360|NCT00950352|Choline|choline|mesh-list
83610361|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83610362|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
83610363|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83610364|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
83610365|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610366|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610367|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83610368|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
83610369|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83610370|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83610371|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83610372|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610373|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610374|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
83610375|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610376|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610377|NCT00955266|Calcium|calcium|mesh-list
83610378|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83610379|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610380|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83610381|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
83610382|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83610383|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83610384|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610385|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610386|NCT00961662|Tagatose|tagatose|mesh-list
83610387|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83610388|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
83610389|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
83610390|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610391|NCT00964548|Dantrolene|dantrolene|mesh-list
83610392|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83610393|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610394|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83610395|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610396|NCT00905268|Idebenone|idebenone|mesh-list
83610397|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
83610398|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610399|NCT00905268|Protective Agents|protective agents|mesh-ancestor
83610400|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610401|NCT00967044|Everolimus|everolimus|mesh-list
83610402|NCT00967044|Panobinostat|panobinostat|mesh-list
83610403|NCT00967044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83610404|NCT00967044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83610405|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610406|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610407|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610408|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
83610409|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610410|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610411|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83610412|NCT00973752|Cytarabine|cytarabine|mesh-list
83610413|NCT00973752|Prednisone|prednisone|mesh-list
83610414|NCT00973752|Doxorubicin|doxorubicin|mesh-list
83610415|NCT00973752|Methotrexate|methotrexate|mesh-list
83610416|NCT00973752|Vincristine|vincristine|mesh-list
83610417|NCT00973752|Asparaginase|asparaginase|mesh-list
83610418|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
83610419|NCT00973752|Clofarabine|clofarabine|mesh-list
83610420|NCT00973752|Pegaspargase|pegaspargase|mesh-list
83610421|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83610422|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610423|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83610424|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83610425|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610426|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610427|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610428|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
83610429|NCT00973752|Hormones|hormones|mesh-ancestor
83610430|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610431|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610432|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83610433|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83610434|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
83610435|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83610436|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83610437|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
83610438|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610439|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83610440|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610441|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
83610442|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610443|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83610444|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
83610445|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610446|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83610447|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
83610448|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
83610449|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
83610450|NCT00974142|Cyclosporine|cyclosporine|mesh-list
83610451|NCT00974142|Cyclosporins|cyclosporins|mesh-list
83610452|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610453|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610454|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610455|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
83610456|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610457|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
83610458|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610459|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610460|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610461|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83610462|NCT00974376|Gabapentin|gabapentin|mesh-list
83610463|NCT00974376|Analgesics|analgesics|mesh-ancestor
83610464|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
83610465|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610466|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610467|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
83610468|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83610469|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83610470|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610471|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83610472|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83610473|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83610474|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610475|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610476|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
83610477|NCT00976248|Everolimus|everolimus|mesh-list
83610478|NCT00976248|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83610479|NCT00976248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83610480|NCT00976248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610481|NCT00976248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610482|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610483|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
83610484|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610485|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610486|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
83610487|NCT00976404|Maraviroc|maraviroc|mesh-list
83610488|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83610489|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83610490|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
83610491|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610492|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83610493|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83610494|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610495|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610496|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83610497|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83610498|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83610499|NCT00983346|Bortezomib|bortezomib|mesh-list
83610500|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610501|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
83610502|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83610503|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610504|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83610505|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610506|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610507|NCT00987480|Cyclosporine|cyclosporine|mesh-list
83610508|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
83610509|NCT00987480|Busulfan|busulfan|mesh-list
83610510|NCT00987480|Fludarabine|fludarabine|mesh-list
83610511|NCT00987480|Cyclosporins|cyclosporins|mesh-list
83610512|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610513|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
83610514|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610515|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610516|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610517|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
83610518|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610519|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610520|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83610521|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610522|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
83610523|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610524|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610525|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83610526|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83610527|NCT00987558|Simvastatin|simvastatin|mesh-list
83610528|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83610529|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83610530|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
83610531|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610532|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83610533|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83610534|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610535|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
83610536|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83610537|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83610538|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610539|NCT00987948|Maraviroc|maraviroc|mesh-list
83610540|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83610541|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83610542|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610543|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83610544|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83610545|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
83610546|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610547|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83610548|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83610549|NCT00989586|Veltuzumab|veltuzumab|mesh-list
83610550|NCT00989586|Antibodies|antibodies|mesh-list
83610551|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
83610552|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83610553|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
83610554|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610555|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610556|NCT00990288|Thrombin|thrombin|mesh-list
83610557|NCT00990288|Hemostatics|hemostatics|mesh-list
83610558|NCT00990288|Coagulants|coagulants|mesh-ancestor
83610559|NCT00991458|Cyclosporine|cyclosporine|mesh-list
83610560|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83610561|NCT00991458|Cyclosporins|cyclosporins|mesh-list
83610562|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610563|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610564|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610565|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
83610566|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610567|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
83610568|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610569|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610570|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610571|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83610572|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83610573|NCT00993798|Bupivacaine|bupivacaine|mesh-list
83610574|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
83610575|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
83610576|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610577|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610578|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
83610579|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610580|NCT00997620|Fluticasone|fluticasone|mesh-list
83610581|NCT00997620|Xhance|xhance|mesh-list
83610582|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610583|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83610584|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
83610585|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610586|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610587|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83610588|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
83610589|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610590|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83610591|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
83610592|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
83610593|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83610594|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610595|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83610596|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83610597|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83610598|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83610599|NCT00998010|Temozolomide|temozolomide|mesh-list
83610600|NCT00998010|Bortezomib|bortezomib|mesh-list
83610601|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610602|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
83610603|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610604|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610605|NCT00999102|Metoprolol|metoprolol|mesh-list
83610606|NCT00999102|Nebivolol|nebivolol|mesh-list
83610607|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83610608|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83610609|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
83610610|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
83610611|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610612|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610613|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83610614|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83610615|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83610616|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
83610617|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610618|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610619|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
83610620|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83610621|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83610622|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83610623|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
83610624|NCT01000818|Omeprazole|omeprazole|mesh-list
83610625|NCT01000818|Famotidine|famotidine|mesh-list
83610626|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83610627|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610628|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83610629|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610630|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610631|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83610632|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83610633|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
83610634|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610635|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83610636|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83610637|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83610638|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
83610639|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
83610640|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610641|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610642|NCT01001052|Colchicine|colchicine|mesh-list
83610643|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
83610644|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610645|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
83610646|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
83610647|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
83610648|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610649|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610650|NCT01001442|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
83610651|NCT01001442|Immunoconjugates|immunoconjugates|mesh-ancestor
83610652|NCT01001442|Immunologic Factors|immunologic factors|mesh-ancestor
83610653|NCT01001442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610654|NCT01003080|Hemostatics|hemostatics|mesh-list
83610655|NCT01003080|Coagulants|coagulants|mesh-ancestor
83610656|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83610657|NCT01003938|Topotecan|topotecan|mesh-list
83610658|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610659|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83610660|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610661|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610662|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83610663|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83610665|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83610666|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83610667|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610668|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
83610669|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
83610670|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610671|NCT01005576|Fludarabine|fludarabine|mesh-list
83610672|NCT01005576|Melphalan|melphalan|mesh-list
83610673|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
83610674|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610675|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610676|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610677|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
83610678|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610679|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610680|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
83610681|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83610682|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83610683|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
83610684|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83610685|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
83610686|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610687|NCT01005810|Expectorants|expectorants|mesh-ancestor
83610688|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
83610689|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83610690|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
83610691|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610692|NCT01005810|Protective Agents|protective agents|mesh-ancestor
83610693|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610694|NCT01005810|Antidotes|antidotes|mesh-ancestor
83610695|NCT01005888|Complement C1s|complement c1s|mesh-list
83610696|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83610697|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83610698|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
83610699|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610700|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83610701|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610702|NCT01007994|Propranolol|propranolol|mesh-list
83610703|NCT01007994|Enalapril|enalapril|mesh-list
83610704|NCT01007994|Isradipine|isradipine|mesh-list
83610705|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83610706|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83610707|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
83610708|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610709|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610710|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610711|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83610712|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83610713|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
83610714|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83610715|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
83610716|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610717|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83610718|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610719|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83610720|NCT01008462|Cytarabine|cytarabine|mesh-list
83610721|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
83610722|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
83610723|NCT01008462|Melphalan|melphalan|mesh-list
83610724|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
83610725|NCT01008462|Carmustine|carmustine|mesh-list
83610726|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83610727|NCT01008462|Fludarabine|fludarabine|mesh-list
83610728|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
83610729|NCT01008462|Etoposide|etoposide|mesh-list
83610730|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
83610731|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
83610732|NCT01008462|Tacrolimus|tacrolimus|mesh-list
83610733|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610734|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
83610735|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610736|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610737|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610738|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
83610739|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610740|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610741|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83610742|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83610743|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
83610744|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83610745|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83610746|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83610747|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610748|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
83610749|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83610750|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83610751|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83610752|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83610753|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
83610754|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83610755|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
83610756|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
83610757|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83610758|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83610759|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83610760|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83610761|NCT01010568|Ofatumumab|ofatumumab|mesh-list
83610762|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83610763|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610764|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
83610765|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610766|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610767|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
83610768|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610769|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83610770|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
83610771|NCT01011816|Coagulants|coagulants|mesh-ancestor
83610772|NCT01011894|Lenalidomide|lenalidomide|mesh-list
83610773|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
83610774|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610775|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83610776|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83610777|NCT01011894|Growth Substances|growth substances|mesh-ancestor
83610778|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
83610779|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610780|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83610781|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
83610782|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
83610783|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610784|NCT01015170|Bupropion|bupropion|mesh-list
83610785|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83610786|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
83610787|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83610788|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83610789|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83610790|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610791|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610792|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
83610793|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610794|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610795|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83610796|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83610797|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610798|NCT01017042|Colchicine|colchicine|mesh-list
83610799|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
83610800|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610801|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83610802|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83610803|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83610804|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610805|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610806|NCT01018056|Riluzole|riluzole|mesh-list
83610807|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
83610808|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83610809|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83610810|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610811|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610812|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610813|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83610814|NCT01018056|Protective Agents|protective agents|mesh-ancestor
83610815|NCT01018134|Desoximetasone|desoximetasone|mesh-list
83610816|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610817|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
83610818|NCT01018134|Hormones|hormones|mesh-ancestor
83610819|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610820|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610821|NCT01020006|Gemcitabine|gemcitabine|mesh-list
83610822|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83610823|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
83610824|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610825|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610826|NCT05395962|Carboplatin|carboplatin|mesh-list
83610827|NCT05395962|Bleomycin|bleomycin|mesh-list
83610828|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610829|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83610830|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
83610831|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610832|NCT05017584|Bupivacaine|bupivacaine|mesh-list
83610833|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
83610834|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
83610835|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610836|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610837|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
83610838|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610839|NCT04999332|Leucovorin|leucovorin|mesh-list
83610840|NCT04999332|Docetaxel|docetaxel|mesh-list
83610841|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
83610842|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
83610843|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610844|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
83610845|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
83610846|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
83610847|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610848|NCT04999332|Antidotes|antidotes|mesh-ancestor
83610849|NCT04999332|Protective Agents|protective agents|mesh-ancestor
83610850|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610851|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
83610852|NCT04999332|Vitamins|vitamins|mesh-ancestor
83610853|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
83610854|NCT04147416|Propofol|propofol|mesh-list
83610855|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83610856|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610857|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610858|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83610859|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
83610860|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
83610861|NCT04098432|Nivolumab|nivolumab|mesh-list
83610862|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83610863|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610864|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83610865|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610866|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
83610867|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610868|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83610869|NCT02662062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83610870|NCT02662062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610871|NCT02406222|Dexamethasone|dexamethasone|mesh-list
83610872|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
83610873|NCT02406222|Pomalidomide|pomalidomide|mesh-list
83610874|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83610875|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
83610876|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610877|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610878|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83610879|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
83610880|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610881|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610882|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83610883|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610884|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
83610885|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
83610886|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610887|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610888|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
83610890|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610891|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83610892|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83610893|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83610894|NCT02406222|Growth Substances|growth substances|mesh-ancestor
83610895|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
83610896|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
83610897|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83610898|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610899|NCT01022190|Etoricoxib|etoricoxib|mesh-list
83610900|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83610901|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83610902|NCT01022190|Analgesics|analgesics|mesh-ancestor
83610903|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
83610904|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610905|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610906|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610907|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83610908|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83610909|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83610910|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610911|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610912|NCT01024686|Vaccines|vaccines|mesh-list
83610913|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
83610914|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610915|NCT01027806|Montelukast|montelukast|mesh-list
83610916|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83610917|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
83610918|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83610919|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
83610920|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610921|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610922|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83610923|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83610924|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610925|NCT01029054|Dexamethasone|dexamethasone|mesh-list
83610926|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
83610927|NCT01029054|Lenalidomide|lenalidomide|mesh-list
83610928|NCT01029054|BB 1101|bb 1101|mesh-list
83610929|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83610930|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
83610931|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
83610932|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83610933|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610934|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83610935|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
83610936|NCT01029054|Hormones|hormones|mesh-ancestor
83610937|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83610938|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83610939|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610940|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
83610941|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610942|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610943|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
83610944|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83610945|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83610946|NCT01029054|Growth Substances|growth substances|mesh-ancestor
83610947|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
83610948|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
83610949|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83610950|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83610951|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610952|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
83610953|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610954|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610955|NCT05592678|Donepezil|donepezil|mesh-list
83610956|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83610957|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610958|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610959|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
83610960|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83610961|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610962|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
83610963|NCT05402826|Vitamin E|vitamin e|mesh-list
83610964|NCT05402826|Vitamins|vitamins|mesh-ancestor
83610965|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
83610966|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610967|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
83610968|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610969|NCT05402826|Protective Agents|protective agents|mesh-ancestor
83610970|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
83610971|NCT05385042|Hydroxocobalamin|hydroxocobalamin|mesh-list
83610972|NCT05385042|Thiamine|thiamine|mesh-list
83610973|NCT05385042|Vitamins|vitamins|mesh-ancestor
83610974|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
83610975|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610976|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
83610977|NCT05385042|Hematinics|hematinics|mesh-ancestor
83610978|NCT05306028|Metformin|metformin|mesh-list
83610979|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83610980|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610981|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
83610982|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83610983|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610984|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83610985|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610986|NCT04780932|Macitentan|macitentan|mesh-list
83610987|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83610988|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83610989|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83610990|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83610991|NCT04316910|Anesthetics|anesthetics|mesh-list
83610992|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
83610993|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83610994|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83610995|NCT04308330|Vorinostat|vorinostat|mesh-list
83610996|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83610997|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83610998|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83610999|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611000|NCT03680508|Dostarlimab|dostarlimab|mesh-list
83611001|NCT03680508|Antibodies|antibodies|mesh-list
83611002|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
83611003|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
83611004|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611005|NCT03680508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611006|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
83611007|NCT01842672|Clofarabine|clofarabine|mesh-list
83611008|NCT01842672|Analgesics|analgesics|mesh-ancestor
83611009|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
83611010|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611011|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611012|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611013|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83611014|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83611015|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611016|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611017|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611018|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
83611019|NCT01034592|Lenalidomide|lenalidomide|mesh-list
83611020|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
83611021|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611022|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83611023|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83611024|NCT01034592|Growth Substances|growth substances|mesh-ancestor
83611025|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
83611026|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611027|NCT01037790|Palbociclib|palbociclib|mesh-list
83611028|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611029|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83611030|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611031|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611032|NCT01043094|Pitavastatin|pitavastatin|mesh-list
83611033|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83611034|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83069003|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
83611035|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83069076|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83611036|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
83611037|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611038|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611039|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83611040|NCT01043640|Cyclosporine|cyclosporine|mesh-list
83611041|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
83611042|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
83611043|NCT01043640|Busulfan|busulfan|mesh-list
83611044|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
83611045|NCT01043640|Cyclosporins|cyclosporins|mesh-list
83611046|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83611047|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
83611048|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611049|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611050|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83611051|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
83611052|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611053|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611054|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83611055|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611056|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
83611057|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611058|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
83611059|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83611060|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83611061|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83611062|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
83611063|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83611064|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611065|NCT01044264|Clindamycin|clindamycin|mesh-list
83611066|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
83611067|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
83611068|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83611069|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83611070|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611071|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83611072|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611073|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611074|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
83611075|NCT01044966|Temozolomide|temozolomide|mesh-list
83611076|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83611077|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
83611078|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611079|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611080|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
83611081|NCT01045122|Propofol|propofol|mesh-list
83611082|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83611083|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611084|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611085|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611086|NCT01045122|Analgesics|analgesics|mesh-ancestor
83611087|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
83611088|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611089|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83069077|NCT02521298|Protective Agents|protective agents|mesh-ancestor
83611090|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83611091|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83069078|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83069079|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069080|NCT00389870|Cyclosporine|cyclosporine|mesh-list
83069081|NCT00389870|Irinotecan|irinotecan|mesh-list
83069082|NCT00389870|Panitumumab|panitumumab|mesh-list
83069083|NCT00389870|Cyclosporins|cyclosporins|mesh-list
83069084|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83069085|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83069086|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069087|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069088|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069089|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069090|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
83069091|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069092|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
83069093|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611092|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
83611093|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611094|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611095|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83611096|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
83611097|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
83611098|NCT01050582|Risperidone|risperidone|mesh-list
83611099|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
83611100|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83611101|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
83611102|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611103|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611104|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611105|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83611106|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611107|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83611108|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83611109|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
83611110|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83611111|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83611112|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83611113|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83611114|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83611115|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83611116|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611117|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83611118|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83611119|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83611120|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611121|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
83611122|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611123|NCT01051596|Temozolomide|temozolomide|mesh-list
83611124|NCT01051596|Veliparib|veliparib|mesh-list
83611125|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83611126|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
83611127|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611128|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611129|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83611130|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611131|NCT01053000|Tazarotene|tazarotene|mesh-list
83611132|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
83611133|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
83611134|NCT05822453|Gemcitabine|gemcitabine|mesh-list
83611135|NCT05822453|Tislelizumab|tislelizumab|mesh-list
83611136|NCT05822453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611137|NCT05822453|Antimetabolites|antimetabolites|mesh-ancestor
83611138|NCT05822453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611139|NCT05822453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611140|NCT05822453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611141|NCT01028820|Aripiprazole|aripiprazole|mesh-list
83611142|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
83611143|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83611144|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83611145|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83611146|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611147|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611148|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
83611149|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
83611150|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611151|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611152|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83611153|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83611154|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
83611155|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83611156|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83611157|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83611158|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83611159|NCT05822362|Cannabidiol|cannabidiol|mesh-list
83611160|NCT05822362|Anticonvulsants|anticonvulsants|mesh-ancestor
83611161|NCT05822323|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83611162|NCT05822323|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83611163|NCT05822323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83611164|NCT05822323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611165|NCT05822323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611166|NCT05822323|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83611167|NCT05822323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83611168|NCT05822323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611169|NCT05822323|Cholinergic Agents|cholinergic agents|mesh-ancestor
83611170|NCT05822323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611171|NCT05821933|Aflutinib|aflutinib|mesh-list
83611172|NCT05821933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83611173|NCT05821933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611174|NCT05821933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611175|NCT05821751|Pembrolizumab|pembrolizumab|mesh-list
83611176|NCT05821751|Nivolumab|nivolumab|mesh-list
83611177|NCT05821751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611178|NCT05821751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611179|NCT05821751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611180|NCT05821751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611181|NCT05821712|Listerine|listerine|mesh-list
83611182|NCT05821712|Fluorides|fluorides|mesh-list
83611183|NCT05821712|Sodium Fluoride|sodium fluoride|mesh-list
83611184|NCT05821712|Cariostatic Agents|cariostatic agents|mesh-ancestor
83611185|NCT05821712|Protective Agents|protective agents|mesh-ancestor
83611186|NCT05821712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611187|NCT05821712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83611188|NCT05821712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611189|NCT05821686|Aldesleukin|aldesleukin|mesh-list
83611190|NCT05821686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611191|NCT05821686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83611192|NCT05821686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83611193|NCT05821686|Antiviral Agents|antiviral agents|mesh-ancestor
83611194|NCT05821686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611195|NCT05821517|Methoxyflurane|methoxyflurane|mesh-list
83611196|NCT05821517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83611197|NCT05821517|Anesthetics, General|anesthetics, general|mesh-ancestor
83611198|NCT05821517|Anesthetics|anesthetics|mesh-ancestor
83611199|NCT05821517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611200|NCT05821517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611201|NCT05821478|Metronidazole|metronidazole|mesh-list
83611202|NCT05821478|Rifampin|rifampin|mesh-list
83611203|NCT05821478|Ceftriaxone|ceftriaxone|mesh-list
83611204|NCT05821478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611205|NCT05821478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83611206|NCT05821478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83611207|NCT05821478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83611208|NCT05821478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83611209|NCT05821478|Antitubercular Agents|antitubercular agents|mesh-ancestor
83611210|NCT05821478|Leprostatic Agents|leprostatic agents|mesh-ancestor
83611211|NCT05821478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83611212|NCT05821478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611213|NCT05821478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611214|NCT05821478|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83611215|NCT05821478|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83611216|NCT05821478|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83611217|NCT05821478|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83611218|NCT05821478|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83611219|NCT05821478|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83611220|NCT05821452|Paclitaxel|paclitaxel|mesh-list
83611221|NCT05821452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83611222|NCT05821452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83611223|NCT05821452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611224|NCT05821452|Tubulin Modulators|tubulin modulators|mesh-ancestor
83611225|NCT05821452|Antimitotic Agents|antimitotic agents|mesh-ancestor
83611226|NCT05821452|Mitosis Modulators|mitosis modulators|mesh-ancestor
83611227|NCT05821452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611228|NCT05821374|Deucravacitinib|deucravacitinib|mesh-list
83611229|NCT05821374|Dermatologic Agents|dermatologic agents|mesh-ancestor
83611230|NCT05821374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83611231|NCT05821374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611232|NCT05821374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611233|NCT05821361|Bevacizumab|bevacizumab|mesh-list
83611234|NCT05821361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611235|NCT05821361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611236|NCT05821361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83611237|NCT05821361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83611238|NCT05821361|Growth Substances|growth substances|mesh-ancestor
83611239|NCT05821361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611240|NCT05821361|Growth Inhibitors|growth inhibitors|mesh-ancestor
83611241|NCT05821192|Dexamethasone|dexamethasone|mesh-list
83611242|NCT05821192|Rituximab|rituximab|mesh-list
83611243|NCT05821192|Gemcitabine|gemcitabine|mesh-list
83611244|NCT05821192|Antibodies|antibodies|mesh-list
83611245|NCT05821192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83611246|NCT05821192|Immunologic Factors|immunologic factors|mesh-ancestor
83611247|NCT05821192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611248|NCT05821192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611249|NCT05821192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611250|NCT05821192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611251|NCT05821192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611252|NCT05821192|Antiemetics|antiemetics|mesh-ancestor
83611253|NCT05821192|Autonomic Agents|autonomic agents|mesh-ancestor
83611254|NCT05821192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611255|NCT05821192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83611256|NCT05821192|Glucocorticoids|glucocorticoids|mesh-ancestor
83611257|NCT05821192|Hormones|hormones|mesh-ancestor
83611258|NCT05821192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611259|NCT05821192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83611260|NCT05821192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611261|NCT05821192|Antimetabolites|antimetabolites|mesh-ancestor
83611262|NCT05821192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611263|NCT05821153|Aldesleukin|aldesleukin|mesh-list
83611264|NCT05821153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611265|NCT05821153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83611266|NCT05821153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83611267|NCT05821153|Antiviral Agents|antiviral agents|mesh-ancestor
83611268|NCT05821153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611269|NCT05821062|Aspirin|aspirin|mesh-list
83611270|NCT05821062|Clopidogrel|clopidogrel|mesh-list
83611271|NCT05821062|Ticagrelor|ticagrelor|mesh-list
83611272|NCT05821062|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83611273|NCT05821062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83611274|NCT05821062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611275|NCT05821062|Analgesics|analgesics|mesh-ancestor
83611276|NCT05821062|Sensory System Agents|sensory system agents|mesh-ancestor
83611277|NCT05821062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611278|NCT05821062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611279|NCT05821062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611280|NCT05821062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611281|NCT05821062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83611282|NCT05821062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83611283|NCT05821062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611284|NCT05821062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83611285|NCT05821062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83611286|NCT05821062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611287|NCT05821062|Antipyretics|antipyretics|mesh-ancestor
83611288|NCT05821062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83611289|NCT05821062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83611290|NCT05821062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83611291|NCT05821062|Purinergic Agents|purinergic agents|mesh-ancestor
83611292|NCT05821062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611293|NCT05820763|Dexamethasone|dexamethasone|mesh-list
83611294|NCT05820763|Lenalidomide|lenalidomide|mesh-list
83611295|NCT05820763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611296|NCT05820763|Antiemetics|antiemetics|mesh-ancestor
83611297|NCT05820763|Autonomic Agents|autonomic agents|mesh-ancestor
83611298|NCT05820763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611299|NCT05820763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611300|NCT05820763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83611301|NCT05820763|Glucocorticoids|glucocorticoids|mesh-ancestor
83611302|NCT05820763|Hormones|hormones|mesh-ancestor
83611303|NCT05820763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611304|NCT05820763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83611305|NCT05820763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611306|NCT05820763|Immunologic Factors|immunologic factors|mesh-ancestor
83611307|NCT05820763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83611308|NCT05820763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83611309|NCT05820763|Growth Substances|growth substances|mesh-ancestor
83611310|NCT05820763|Growth Inhibitors|growth inhibitors|mesh-ancestor
83611311|NCT05820685|Dronabinol|dronabinol|mesh-list
83611312|NCT05820685|Hallucinogens|hallucinogens|mesh-ancestor
83611313|NCT05820685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611314|NCT05820685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83611315|NCT05820685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611316|NCT05820685|Analgesics|analgesics|mesh-ancestor
83611317|NCT05820685|Sensory System Agents|sensory system agents|mesh-ancestor
83611318|NCT05820685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611319|NCT05820685|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83611320|NCT05820685|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83611321|NCT05820685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611322|NCT05820685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611324|NCT05820685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611325|NCT05818553|Pramoxine|pramoxine|mesh-list
83611326|NCT05818553|Anesthetics, Local|anesthetics, local|mesh-ancestor
83611327|NCT05818553|Anesthetics|anesthetics|mesh-ancestor
83611328|NCT05818553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611329|NCT05818553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611330|NCT05818553|Sensory System Agents|sensory system agents|mesh-ancestor
83611331|NCT05818553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611332|NCT05817162|Ropivacaine|ropivacaine|mesh-list
83611333|NCT05817162|Anesthetics, Local|anesthetics, local|mesh-ancestor
83611334|NCT05817162|Anesthetics|anesthetics|mesh-ancestor
83611335|NCT05817162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611336|NCT05817162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611337|NCT05817162|Sensory System Agents|sensory system agents|mesh-ancestor
83611338|NCT05817162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611339|NCT05809180|Rituximab|rituximab|mesh-list
83611340|NCT05809180|Pomalidomide|pomalidomide|mesh-list
83611341|NCT05809180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611342|NCT05809180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611343|NCT05809180|Immunologic Factors|immunologic factors|mesh-ancestor
83611344|NCT05809180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611345|NCT05809180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611346|NCT05809180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83611347|NCT05809180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83611348|NCT05809180|Growth Substances|growth substances|mesh-ancestor
83611349|NCT05809180|Growth Inhibitors|growth inhibitors|mesh-ancestor
83611350|NCT05802238|Tranexamic Acid|tranexamic acid|mesh-list
83611351|NCT05802238|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83611352|NCT05802238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83611353|NCT05802238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611354|NCT05802238|Hemostatics|hemostatics|mesh-ancestor
83611355|NCT05802238|Coagulants|coagulants|mesh-ancestor
83611356|NCT05796570|Decitabine|decitabine|mesh-list
83611357|NCT05796570|Lenograstim|lenograstim|mesh-list
83611358|NCT05796570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83611359|NCT05796570|Immunologic Factors|immunologic factors|mesh-ancestor
83611360|NCT05796570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611361|NCT05796570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611362|NCT05796570|Antimetabolites|antimetabolites|mesh-ancestor
83611363|NCT05796570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611364|NCT05796570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611365|NCT05796570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611366|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83611367|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
83611368|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611369|NCT05738057|Cisplatin|cisplatin|mesh-list
83611370|NCT05738057|Gemcitabine|gemcitabine|mesh-list
83611371|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611372|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611373|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
83611374|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611375|NCT05723055|Nivolumab|nivolumab|mesh-list
83611376|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611377|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611378|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611379|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611380|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
83611381|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83611382|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611383|NCT05689151|Abrocitinib|abrocitinib|mesh-list
83611384|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83611385|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611386|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611387|NCT05668286|Triamcinolone|triamcinolone|mesh-list
83611388|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83611389|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83611390|NCT05668286|Prilocaine|prilocaine|mesh-list
83611391|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83611392|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611393|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
83611394|NCT05668286|Hormones|hormones|mesh-ancestor
83611395|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611396|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611397|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83611398|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
83611399|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611400|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611401|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
83611402|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
83611403|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611404|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
83611405|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611406|NCT05665465|Nicotine|nicotine|mesh-list
83611407|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83611408|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
83611409|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611410|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611411|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83611412|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83611413|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
83611414|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611415|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611416|NCT05664958|Bupivacaine|bupivacaine|mesh-list
83611417|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
83611418|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
83611419|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611420|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611421|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
83611422|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611423|NCT05581823|Carbamazepine|carbamazepine|mesh-list
83611424|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
83611425|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
83611426|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83611427|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611428|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611429|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83611430|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611431|NCT05581823|Analgesics|analgesics|mesh-ancestor
83611432|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
83611433|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611434|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83611435|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83611436|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611437|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83611438|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83611439|NCT05549180|Emtricitabine|emtricitabine|mesh-list
83611440|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
83611441|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611442|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83611443|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83611444|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611445|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611446|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83611447|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83611448|NCT05513001|Remibrutinib|remibrutinib|mesh-list
83611449|NCT05513001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83611450|NCT05513001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611451|NCT05513001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611452|NCT05500599|Fentanyl|fentanyl|mesh-list
83611453|NCT05500599|Midazolam|midazolam|mesh-list
83611454|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83611455|NCT05500599|Narcotics|narcotics|mesh-ancestor
83611456|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611457|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611458|NCT05500599|Analgesics|analgesics|mesh-ancestor
83611459|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
83611460|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611461|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83611462|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83611463|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
83069450|NCT05816694|Epirubicin|epirubicin|mesh-list
83611464|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
83611465|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83611466|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83611467|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83611468|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83611469|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
83611470|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
83611471|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611472|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611473|NCT05498116|Montelukast|montelukast|mesh-list
83611474|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83611475|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
83611476|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83611477|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
83611478|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611479|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611480|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83611481|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83611482|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611483|NCT05480865|Sotorasib|sotorasib|mesh-list
83611484|NCT05480865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611485|NCT05480865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611486|NCT05480865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611487|NCT05480865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611488|NCT05471076|Complement C4b|complement c4b|mesh-list
83611489|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
83611490|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611491|NCT05469178|Carboplatin|carboplatin|mesh-list
83611492|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
83611493|NCT05469178|Pemetrexed|pemetrexed|mesh-list
83611494|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611495|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611496|NCT05469178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611497|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611498|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611499|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83611500|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83611501|NCT05450484|Durvalumab|durvalumab|mesh-list
83611502|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611503|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611504|NCT05402293|Lidocaine|lidocaine|mesh-list
83611505|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
83611506|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
83611507|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611508|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611509|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
83611510|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611511|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83611512|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83611513|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83611514|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83611515|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611516|NCT05398484|Niacin|niacin|mesh-list
83611517|NCT05398484|Psilocybin|psilocybin|mesh-list
83611518|NCT05398484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83611519|NCT05398484|Antimetabolites|antimetabolites|mesh-ancestor
83611520|NCT05398484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611521|NCT05398484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83611522|NCT05398484|Vasodilator Agents|vasodilator agents|mesh-ancestor
83611523|NCT05398484|Vitamin B Complex|vitamin b complex|mesh-ancestor
83611524|NCT05398484|Vitamins|vitamins|mesh-ancestor
83611525|NCT05398484|Micronutrients|micronutrients|mesh-ancestor
83611526|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611527|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
83611528|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83611529|NCT05388058|Cannabidiol|cannabidiol|mesh-list
83611530|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
83611531|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
83611532|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83611533|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
83611534|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611535|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611536|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83611537|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
83611538|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83611539|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
83611540|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611541|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611542|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83611543|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
83611544|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
83611545|NCT05351502|Protective Agents|protective agents|mesh-ancestor
83611546|NCT05327296|Propofol|propofol|mesh-list
83611547|NCT05327296|Isoflurane|isoflurane|mesh-list
83611548|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83611549|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611550|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611551|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83611552|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
83611553|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
83611554|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83611555|NCT05317000|Nivolumab|nivolumab|mesh-list
83611556|NCT05317000|Azacitidine|azacitidine|mesh-list
83611557|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611558|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611559|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611560|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611561|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611562|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
83611563|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611564|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83611565|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
83611566|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83611567|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83611568|NCT05292755|Laxatives|laxatives|mesh-ancestor
83611569|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83611570|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83611571|NCT05283395|Latanoprost|latanoprost|mesh-list
83611572|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83611573|NCT05275205|Aflibercept|aflibercept|mesh-list
83611574|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83611575|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83611576|NCT05275205|Growth Substances|growth substances|mesh-ancestor
83611577|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611578|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
83611579|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611580|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83611581|NCT05270863|Carbachol|carbachol|mesh-list
83611582|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83611583|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83611584|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83611585|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83611586|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83611587|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611588|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611589|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611590|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83611591|NCT05270863|Miotics|miotics|mesh-ancestor
83611592|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
83611593|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611594|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83611595|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
83611596|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611597|NCT05270863|Analgesics|analgesics|mesh-ancestor
83611598|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
83611599|NCT05270863|Protective Agents|protective agents|mesh-ancestor
83611600|NCT05237141|Etonogestrel|etonogestrel|mesh-list
83611601|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83611602|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
83611603|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83611604|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611605|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83611606|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
83611607|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611608|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611609|NCT05232409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611610|NCT05232409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611611|NCT05137262|Cisplatin|cisplatin|mesh-list
83611612|NCT05137262|Doxorubicin|doxorubicin|mesh-list
83611613|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83611614|NCT05137262|Methotrexate|methotrexate|mesh-list
83611615|NCT05137262|Durvalumab|durvalumab|mesh-list
83611616|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
83611617|NCT05137262|Vinblastine|vinblastine|mesh-list
83611618|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611619|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83611620|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83611621|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83611622|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611623|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611624|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83611625|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
83611626|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83611627|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611628|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611629|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
83611630|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
83611631|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83611632|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83611633|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
83611634|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611635|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83611636|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611637|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83611638|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
83611639|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611640|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83611641|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83611642|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
83611643|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
83611644|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
83611645|NCT05124691|Ivermectin|ivermectin|mesh-list
83611646|NCT05124691|Albendazole|albendazole|mesh-list
83611647|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83611648|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611649|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
83611650|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
83611651|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83611652|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83611653|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
83611654|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
83611655|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
83611656|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611657|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611658|NCT05124080|Deucravacitinib|deucravacitinib|mesh-list
83611659|NCT05124080|Dermatologic Agents|dermatologic agents|mesh-ancestor
83611660|NCT05124080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83611661|NCT05124080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611662|NCT05124080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611663|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
83611664|NCT05114837|Fludarabine|fludarabine|mesh-list
83611665|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83611666|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
83611667|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611668|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611669|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83611670|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
83611671|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611672|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611673|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83611674|NCT05014087|Digoxin|digoxin|mesh-list
83611675|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83611676|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83611677|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611678|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611679|NCT05014087|Protective Agents|protective agents|mesh-ancestor
83611680|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611681|NCT04955678|Sorbitol|sorbitol|mesh-list
83611682|NCT04955678|Calcium|calcium|mesh-list
83611683|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83611684|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611685|NCT04955678|Cathartics|cathartics|mesh-ancestor
83611686|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83611687|NCT05175547|Clevidipine|clevidipine|mesh-list
83611688|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83611689|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83611690|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611691|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83611692|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611693|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
83611694|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611695|NCT04908371|Lidocaine|lidocaine|mesh-list
83611696|NCT04908371|Epinephrine|epinephrine|mesh-list
83611697|NCT04908371|Racepinephrine|racepinephrine|mesh-list
83611698|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
83611699|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
83611700|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
83611701|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
83611702|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611703|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611704|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
83611705|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611706|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83611707|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83611708|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83611709|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83611710|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611711|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83611712|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83611713|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83611714|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611715|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83611716|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83611717|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
83611718|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83611719|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
83611720|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
83611721|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
83611722|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83611723|NCT04870645|Chelating Agents|chelating agents|mesh-list
83611724|NCT04870645|Sequestering Agents|sequestering agents|mesh-ancestor
83611725|NCT04870645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611726|NCT04838379|Dexamethasone|dexamethasone|mesh-list
83611727|NCT04838379|Dexmedetomidine|dexmedetomidine|mesh-list
83611728|NCT04838379|Bupivacaine|bupivacaine|mesh-list
83611729|NCT04838379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611730|NCT04838379|Antiemetics|antiemetics|mesh-ancestor
83611731|NCT04838379|Autonomic Agents|autonomic agents|mesh-ancestor
83611732|NCT04838379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611733|NCT04838379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611734|NCT04838379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83611735|NCT04838379|Glucocorticoids|glucocorticoids|mesh-ancestor
83611736|NCT04838379|Hormones|hormones|mesh-ancestor
83611737|NCT04838379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611738|NCT04838379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83611739|NCT04838379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611740|NCT04838379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611741|NCT04838379|Anesthetics, Local|anesthetics, local|mesh-ancestor
83611742|NCT04838379|Anesthetics|anesthetics|mesh-ancestor
83611743|NCT04838379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611744|NCT04838379|Sensory System Agents|sensory system agents|mesh-ancestor
83611745|NCT04838379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83611746|NCT04838379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611747|NCT04838379|Analgesics|analgesics|mesh-ancestor
83611748|NCT04838379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83611749|NCT04838379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83611750|NCT04838379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83611751|NCT04838379|Adrenergic Agents|adrenergic agents|mesh-ancestor
83611752|NCT04838379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611753|NCT04830878|Methotrexate|methotrexate|mesh-list
83611754|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83611755|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
83611756|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83611757|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611758|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83611759|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
83611760|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611761|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611762|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
83611763|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611764|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83069756|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
83611766|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
83611767|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611768|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83611769|NCT04812366|Prednisone|prednisone|mesh-list
83611770|NCT04812366|Docetaxel|docetaxel|mesh-list
83611771|NCT04812366|Atezolizumab|atezolizumab|mesh-list
83611772|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
83611773|NCT04812366|Niraparib|niraparib|mesh-list
83611774|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611775|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
83611776|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
83611777|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
83611778|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611779|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611780|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
83611781|NCT04812366|Hormones|hormones|mesh-ancestor
83611782|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611783|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611784|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83611785|NCT04812366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611786|NCT04812366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611787|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83611788|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611789|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
83611790|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83611791|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83611792|NCT04800107|Curcumin|curcumin|mesh-list
83611793|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83611794|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611795|NCT04800107|Analgesics|analgesics|mesh-ancestor
83611796|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
83611797|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611798|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611799|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83611800|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83611801|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611802|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611803|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611804|NCT04786574|Tolvaptan|tolvaptan|mesh-list
83611805|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83611806|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611807|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
83611808|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611809|NCT04783857|Progesterone|progesterone|mesh-list
83611810|NCT04783857|Progestins|progestins|mesh-ancestor
83611811|NCT04783857|Hormones|hormones|mesh-ancestor
83611812|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611813|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611814|NCT04761159|Ketamine|ketamine|mesh-list
83611815|NCT04761159|Analgesics|analgesics|mesh-ancestor
83611816|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
83611817|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611818|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611819|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83611820|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83611821|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
83611822|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
83611823|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611824|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83611825|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83611826|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611827|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611828|NCT04716296|Ketamine|ketamine|mesh-list
83611829|NCT04716296|Analgesics|analgesics|mesh-ancestor
83611830|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
83611831|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611832|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611833|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83611834|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83611835|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
83611836|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
83611837|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611838|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83611839|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83611840|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611841|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611843|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83611844|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611845|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
83611846|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83611847|NCT04682041|Antibodies|antibodies|mesh-list
83611848|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
83611849|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611850|NCT04675931|Artesunate|artesunate|mesh-list
83611851|NCT04675931|Lumefantrine|lumefantrine|mesh-list
83611852|NCT04675931|Artemether|artemether|mesh-list
83611853|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83611854|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
83611855|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83611856|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83611857|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611858|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611859|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
83611860|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
83611861|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83611862|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
83611863|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83611864|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
83611865|NCT04669678|Etonogestrel|etonogestrel|mesh-list
83611866|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83611867|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83611868|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83611869|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
83611870|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83611871|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611872|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83611873|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83611874|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83611875|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83611876|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611877|NCT04652661|Midazolam|midazolam|mesh-list
83611878|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
83611879|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83611880|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611881|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611882|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83611883|NCT04652661|Analgesics|analgesics|mesh-ancestor
83611884|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
83611885|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611886|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83611887|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83611888|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83611889|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
83611890|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611891|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611892|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83611893|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83611894|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83611895|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83611896|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83611897|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
83611898|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
83611899|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
83611900|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
83611901|NCT04623931|Temozolomide|temozolomide|mesh-list
83611902|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83611903|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
83611904|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611905|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611906|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83611907|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83611908|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
83611909|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
83611910|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611911|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611912|NCT04590781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611913|NCT04590781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611914|NCT04573751|Verapamil|verapamil|mesh-list
83611915|NCT04573751|Epinephrine|epinephrine|mesh-list
83611916|NCT04573751|Racepinephrine|racepinephrine|mesh-list
83611917|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
83611918|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83611919|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83611920|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
83611921|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83611922|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611923|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611924|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83611925|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83611926|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
83611927|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611928|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83611929|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
83611930|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
83611931|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
83611932|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83611933|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83611934|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83611935|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83611936|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83611937|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
83611938|NCT04522622|Teriparatide|teriparatide|mesh-list
83611939|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83611940|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611941|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83611942|NCT04483102|Liver Extracts|liver extracts|mesh-list
83611943|NCT04483102|Hematinics|hematinics|mesh-ancestor
83611944|NCT04474483|Melatonin|melatonin|mesh-list
83611945|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
83611946|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611947|NCT04474483|Protective Agents|protective agents|mesh-ancestor
83611948|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611949|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611950|NCT04432207|Atezolizumab|atezolizumab|mesh-list
83611951|NCT04432207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83611952|NCT04432207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611953|NCT04432207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83611954|NCT04432207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83611955|NCT04425447|Anesthetics|anesthetics|mesh-list
83611956|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611957|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611958|NCT04373707|Enoxaparin|enoxaparin|mesh-list
83611959|NCT04373707|Dalteparin|dalteparin|mesh-list
83611960|NCT04373707|Tinzaparin|tinzaparin|mesh-list
83611961|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83611962|NCT04373707|Nadroparin|nadroparin|mesh-list
83611963|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
83611964|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
83611965|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83611966|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83611967|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611968|NCT04345718|Buprenorphine|buprenorphine|mesh-list
83611969|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
83611970|NCT04345718|Narcotics|narcotics|mesh-ancestor
83611971|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83611972|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83611973|NCT04345718|Analgesics|analgesics|mesh-ancestor
83611974|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
83611975|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83611976|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83611977|NCT04332068|Ivermectin|ivermectin|mesh-list
83611978|NCT04332068|Permethrin|permethrin|mesh-list
83611979|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83611980|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611981|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611982|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611983|NCT04298541|Edotreotide|edotreotide|mesh-list
83611984|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83611985|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611986|NCT04249037|Tenofovir|tenofovir|mesh-list
83070004|NCT05033080|Ivacaftor|ivacaftor|mesh-list
83611988|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83611989|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83611990|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
83611991|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83611992|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83611993|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83611994|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83611995|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83611996|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83611997|NCT04190550|Cytarabine|cytarabine|mesh-list
83611998|NCT04190550|Idarubicin|idarubicin|mesh-list
83611999|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83612000|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
83612001|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612002|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612003|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
83612004|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612005|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612006|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
83612007|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612008|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83612009|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83612010|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83612011|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612012|NCT04158739|Cytarabine|cytarabine|mesh-list
83612013|NCT04158739|Antibodies|antibodies|mesh-list
83612014|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
83612015|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83612016|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
83612017|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612018|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83612019|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
83612020|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612021|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612022|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
83612023|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612024|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612025|NCT04148105|Cilostazol|cilostazol|mesh-list
83612026|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83612027|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
83612028|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501029|NCT01227434|Palbociclib|palbociclib|mesh-list
83612029|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612030|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83612031|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
83612032|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83612033|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83612034|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612035|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83612036|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
83612037|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83612038|NCT04148105|Protective Agents|protective agents|mesh-ancestor
83612039|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83612040|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83612041|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612042|NCT04067518|Pegaspargase|pegaspargase|mesh-list
83612043|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612044|NCT04033419|Memantine|memantine|mesh-list
83612045|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83612046|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83612047|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
83612048|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612049|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612050|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612051|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83612052|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83612053|NCT04014283|Selenium|selenium|mesh-list
83612054|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
83612055|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612056|NCT04014283|Protective Agents|protective agents|mesh-ancestor
83612057|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612058|NCT04014283|Trace Elements|trace elements|mesh-ancestor
83612059|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
83612060|NCT04013542|Nivolumab|nivolumab|mesh-list
83612061|NCT04013542|Ipilimumab|ipilimumab|mesh-list
83070131|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612062|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612063|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612064|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83612065|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612066|NCT04009681|Antibodies|antibodies|mesh-list
83612067|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
83612068|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612069|NCT04000529|Spartalizumab|spartalizumab|mesh-list
83612070|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83612071|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612072|NCT04000529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612073|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612074|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
83612075|NCT04257578|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83612076|NCT04257578|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83612077|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612078|NCT04257578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83612079|NCT04257578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612080|NCT04257578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612081|NCT04257578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612082|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
83612083|NCT03970746|Pemetrexed|pemetrexed|mesh-list
83612084|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612085|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612086|NCT03970746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83612087|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612088|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612089|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83612090|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83612091|NCT03912233|Ivacaftor|ivacaftor|mesh-list
83612092|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83612093|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612094|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612095|NCT03842865|Immunomodulating Agents|immunomodulating agents|mesh-list
83612096|NCT03842865|Immunologic Factors|immunologic factors|mesh-ancestor
83612097|NCT03842865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612098|NCT03834519|Prednisone|prednisone|mesh-list
83612099|NCT03834519|Prednisolone|prednisolone|mesh-list
83612100|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
83612101|NCT03834519|Olaparib|olaparib|mesh-list
83612102|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
83612103|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612104|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612105|NCT03834519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83612106|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612107|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612108|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
83612109|NCT03834519|Hormones|hormones|mesh-ancestor
83612110|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612111|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612112|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83612113|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83612114|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612115|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83612116|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
83612117|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83612118|NCT03810105|Durvalumab|durvalumab|mesh-list
83612119|NCT03810105|Olaparib|olaparib|mesh-list
83612120|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612121|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612122|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83612123|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612124|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612125|NCT03781817|Ketamine|ketamine|mesh-list
83612126|NCT03781817|Analgesics|analgesics|mesh-ancestor
83612127|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
83612128|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612129|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612130|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83612131|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83612132|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
83612133|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
83612134|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612135|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83612136|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83612137|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612138|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612139|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
83612140|NCT03732352|Osimertinib|osimertinib|mesh-list
83612141|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83612142|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83612143|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612144|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612145|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83612146|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612147|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
83612148|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
83612149|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612150|NCT03706690|Durvalumab|durvalumab|mesh-list
83612151|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612152|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612153|NCT03636451|Lidocaine|lidocaine|mesh-list
83612154|NCT03636451|Vasopressins|vasopressins|mesh-list
83612155|NCT03636451|Arginine Vasopressin|arginine vasopressin|mesh-list
83612156|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
83612157|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
83612158|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612159|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612160|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
83612161|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612162|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83612163|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83612164|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83612165|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612166|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612167|NCT03636451|Hemostatics|hemostatics|mesh-ancestor
83612168|NCT03636451|Coagulants|coagulants|mesh-ancestor
83612169|NCT03636451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83612170|NCT03636451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83612171|NCT03636451|Natriuretic Agents|natriuretic agents|mesh-ancestor
83612172|NCT03576989|Mineral Oil|mineral oil|mesh-list
83612173|NCT03576989|Emollients|emollients|mesh-ancestor
83612174|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83612175|NCT03539952|Penicillamine|penicillamine|mesh-list
83612176|NCT03539952|Trientine|trientine|mesh-list
83612177|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
83612178|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
83612179|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612180|NCT03539952|Antidotes|antidotes|mesh-ancestor
83612181|NCT03539952|Protective Agents|protective agents|mesh-ancestor
83612182|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612183|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612184|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
83612185|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
83612186|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612187|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612188|NCT03504163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83612189|NCT03504163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612190|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83612191|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
83612192|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612193|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
83612194|NCT03454035|Palbociclib|palbociclib|mesh-list
83612195|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612196|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83612197|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612198|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612199|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
83612200|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612201|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612202|NCT03295227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83612203|NCT03295227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612204|NCT03278691|Ketorolac|ketorolac|mesh-list
83612205|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83612206|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612207|NCT03278691|Analgesics|analgesics|mesh-ancestor
83612208|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
83612209|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612210|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612211|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612212|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612213|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83612214|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612215|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612216|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
83612217|NCT03105336|Fludarabine|fludarabine|mesh-list
83612218|NCT03105336|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83612219|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612220|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
83612221|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612222|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612223|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83612224|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
83612225|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612226|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612227|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83612228|NCT03105336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612229|NCT03093909|Gemcitabine|gemcitabine|mesh-list
83612230|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83612231|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
83612232|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612233|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612234|NCT03070223|Pitavastatin|pitavastatin|mesh-list
83612235|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83612236|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83612237|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83612238|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
83612239|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612240|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612241|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83612242|NCT02621489|Metformin|metformin|mesh-list
83612243|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
83612244|NCT02621489|Exenatide|exenatide|mesh-list
83612245|NCT02621489|Biguanides|biguanides|mesh-list
83612246|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83612247|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612248|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83612249|NCT02621489|Incretins|incretins|mesh-ancestor
83612250|NCT02621489|Hormones|hormones|mesh-ancestor
83612251|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612252|NCT02596880|Ribavirin|ribavirin|mesh-list
83612253|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
83612254|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
83612255|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612256|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
83612257|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612258|NCT02527434|Durvalumab|durvalumab|mesh-list
83612259|NCT02527434|Tremelimumab|tremelimumab|mesh-list
83612260|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83612261|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612262|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612263|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
83612264|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612265|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83612266|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83612267|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83612268|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83612269|NCT02474368|Cisplatin|cisplatin|mesh-list
83612270|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612271|NCT02320435|Trastuzumab|trastuzumab|mesh-list
83612272|NCT02320435|Pertuzumab|pertuzumab|mesh-list
83612273|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612274|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612275|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
83612276|NCT01995344|Fludarabine|fludarabine|mesh-list
83612277|NCT01995344|Interleukin-2|interleukin-2|mesh-list
83612278|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612279|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
83612280|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612281|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612282|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83612283|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
83612284|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612285|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612286|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83612287|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612288|NCT01995344|Analgesics|analgesics|mesh-ancestor
83612289|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
83612290|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612291|NCT01845688|Losartan|losartan|mesh-list
83612292|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83612293|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83612294|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83612295|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83612296|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612297|NCT01591291|Ondansetron|ondansetron|mesh-list
83612298|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
83612299|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
83612300|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612301|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612302|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612303|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
83612304|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
83612305|NCT01591291|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83612306|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83612307|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
83612308|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612309|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612310|NCT01154920|Paclitaxel|paclitaxel|mesh-list
83612311|NCT01154920|Docetaxel|docetaxel|mesh-list
83612312|NCT01154920|Cisplatin|cisplatin|mesh-list
83612313|NCT01154920|Carboplatin|carboplatin|mesh-list
83612314|NCT01154920|Fluorouracil|fluorouracil|mesh-list
83612315|NCT01154920|Cetuximab|cetuximab|mesh-list
83612316|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83612317|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612318|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
83612319|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
83612320|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
83612321|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612322|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
83612323|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83612324|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612325|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
83612326|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612327|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612328|NCT01093300|Paclitaxel|paclitaxel|mesh-list
83612329|NCT01093300|Everolimus|everolimus|mesh-list
83612330|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83612331|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612332|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
83612333|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
83612334|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
83612335|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612336|NCT01093300|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83612337|NCT01093300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83612338|NCT01093300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612339|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612340|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
83612341|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612342|NCT01053078|Naltrexone|naltrexone|mesh-list
83612343|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83612344|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83612345|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612346|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
83612347|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612348|NCT01053156|Minocycline|minocycline|mesh-list
83612349|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83612350|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612351|NCT01053312|Flutemetamol|flutemetamol|mesh-list
83612352|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83612353|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612354|NCT01054404|Furosemide|furosemide|mesh-list
83612355|NCT01054404|Diuretics|diuretics|mesh-ancestor
83612356|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
83612357|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070355|NCT04402385|Aspirin|aspirin|mesh-list
83612358|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83612359|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612360|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612361|NCT01055184|Vaccines|vaccines|mesh-list
83612362|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
83612363|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612364|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
83612365|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
83612366|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83612367|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83612368|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612369|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612370|NCT01060020|Urological Agents|urological agents|mesh-ancestor
83612371|NCT01060098|Adalimumab|adalimumab|mesh-list
83612372|NCT01060098|Etanercept|etanercept|mesh-list
83612373|NCT01060098|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83612374|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612375|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612376|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83612377|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612378|NCT01060098|Analgesics|analgesics|mesh-ancestor
83612379|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
83612380|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612381|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612382|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612383|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612384|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
83612385|NCT01061034|Aspirin|aspirin|mesh-list
83612386|NCT01061034|Omeprazole|omeprazole|mesh-list
83612387|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83612388|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612389|NCT01061034|Analgesics|analgesics|mesh-ancestor
83612390|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
83612391|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612392|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612393|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612394|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612395|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83612396|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83612397|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612398|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83612399|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83612400|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612401|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
83612402|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83612403|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612404|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83612405|NCT01065558|Ecopipam|ecopipam|mesh-list
83612406|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83612407|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83612408|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612409|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612410|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83612411|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83612412|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
83612413|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612414|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612415|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
83612416|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83612417|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
83612418|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612419|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
83612420|NCT01066026|Protective Agents|protective agents|mesh-ancestor
83612421|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
83612422|NCT01072188|Calcium|calcium|mesh-list
83612423|NCT01072188|Fluorides|fluorides|mesh-list
83612424|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83612425|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612426|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
83612427|NCT01072188|Protective Agents|protective agents|mesh-ancestor
83612428|NCT01072188|Antacids|antacids|mesh-ancestor
83612429|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612430|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612431|NCT01083732|Dabigatran|dabigatran|mesh-list
83612432|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
83612433|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83070429|NCT04253561|Trastuzumab|trastuzumab|mesh-list
83612434|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
83612435|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612436|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612437|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
83612439|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
83612440|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612441|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83612442|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83612443|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83612444|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612445|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612446|NCT01085760|Metronidazole|metronidazole|mesh-list
83612447|NCT01085760|Vancomycin|vancomycin|mesh-list
83612448|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612449|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83612450|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83612451|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83612452|NCT01090752|Metformin|metformin|mesh-list
83612453|NCT01090752|Pioglitazone|pioglitazone|mesh-list
83612454|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83612455|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612456|NCT01093794|Metformin|metformin|mesh-list
83612457|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83612458|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83612459|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612460|NCT01093794|Incretins|incretins|mesh-ancestor
83612461|NCT01093794|Hormones|hormones|mesh-ancestor
83612462|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612463|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83612464|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
83612465|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612466|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612467|NCT01094106|Ropivacaine|ropivacaine|mesh-list
83612468|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
83612469|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
83612470|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612471|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612472|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
83612473|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612474|NCT01094574|Propranolol|propranolol|mesh-list
83612475|NCT01094574|Alfentanil|alfentanil|mesh-list
83612476|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83612477|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83612478|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
83612479|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612480|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612481|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612482|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83612483|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83612484|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
83612485|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83612486|NCT01094574|Narcotics|narcotics|mesh-ancestor
83612487|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612488|NCT01094574|Analgesics|analgesics|mesh-ancestor
83612489|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
83612490|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612491|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83612492|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
83612493|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
83612494|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83612495|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83612496|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612497|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
83612498|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612499|NCT01096290|Lubiprostone|lubiprostone|mesh-list
83612500|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83612501|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612502|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612503|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83612504|NCT01096680|Modafinil|modafinil|mesh-list
83612505|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83612506|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612507|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83612508|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83612509|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612510|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612511|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
83612512|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612513|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83612514|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83612515|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83612516|NCT01096992|Rituximab|rituximab|mesh-list
83612517|NCT01096992|Fludarabine|fludarabine|mesh-list
83612518|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
83612519|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83612520|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612521|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612522|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
83612523|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612524|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612525|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83612526|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
83612527|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612528|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612529|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83612530|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
83612531|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83612532|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83612533|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612534|NCT01097460|Trastuzumab|trastuzumab|mesh-list
83612535|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612536|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612537|NCT01098318|Sertraline|sertraline|mesh-list
83612538|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
83612539|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83612540|NCT01098318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83612541|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83612542|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612543|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612544|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612545|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
83612546|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612547|NCT01100112|Budesonide|budesonide|mesh-list
83612548|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612549|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83612550|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
83612551|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612552|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612553|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83612554|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
83612555|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
83612556|NCT01100112|Hormones|hormones|mesh-ancestor
83612557|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612558|NCT01100268|Methylphenidate|methylphenidate|mesh-list
83612559|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83612560|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612561|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83612562|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83612563|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612564|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612565|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
83612566|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612567|NCT01101750|Vaccines|vaccines|mesh-list
83612568|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
83612569|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612570|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
83612571|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
83612572|NCT01102218|Hematinics|hematinics|mesh-ancestor
83612573|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83612574|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612575|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612576|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83612577|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83612578|NCT01102218|Protective Agents|protective agents|mesh-ancestor
83612579|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612580|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83070601|NCT03800134|Paclitaxel|paclitaxel|mesh-list
83612581|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83612582|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
83612583|NCT01103934|Vitamin D|vitamin d|mesh-list
83612584|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
83612585|NCT01103934|Fluticasone|fluticasone|mesh-list
83612586|NCT01103934|Xhance|xhance|mesh-list
83612587|NCT01103934|Vitamins|vitamins|mesh-ancestor
83612588|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
83612589|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612590|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83612591|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612592|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83612593|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
83612594|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612595|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83612596|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
83612597|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
83612598|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83612599|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83612600|NCT01105650|Cyclosporine|cyclosporine|mesh-list
83612601|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
83612602|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83612603|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83612604|NCT01105650|Prednisolone|prednisolone|mesh-list
83612605|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
83612606|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
83612607|NCT01105650|Fludarabine|fludarabine|mesh-list
83612608|NCT01105650|Interleukin-2|interleukin-2|mesh-list
83612609|NCT01105650|Cyclosporins|cyclosporins|mesh-list
83612610|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83612611|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
83612612|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612613|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
83612614|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612615|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612616|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83612617|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
83612618|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612619|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612620|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83612621|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612622|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
83612623|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612624|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
83612625|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83612626|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612627|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
83612628|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
83612629|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612630|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612631|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
83612632|NCT01105650|Hormones|hormones|mesh-ancestor
83612633|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612634|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83612635|NCT01105650|Protective Agents|protective agents|mesh-ancestor
83612636|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83612637|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612638|NCT01105650|Analgesics|analgesics|mesh-ancestor
83612639|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
83612640|NCT01110876|Temozolomide|temozolomide|mesh-list
83612641|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83612642|NCT01110876|Vorinostat|vorinostat|mesh-list
83612643|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83612644|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
83612645|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612646|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612647|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83612648|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612649|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83612650|NCT01112358|Cetrorelix|cetrorelix|mesh-list
83612651|NCT01112358|Progesterone|progesterone|mesh-list
83612652|NCT01112358|Progestins|progestins|mesh-ancestor
83612653|NCT01112358|Hormones|hormones|mesh-ancestor
83612654|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612655|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612656|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83612657|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
83612658|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83612659|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
83612660|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83612661|NCT01112670|Atorvastatin|atorvastatin|mesh-list
83612662|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83612663|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83612664|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
83612665|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612666|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83612667|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83612668|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612669|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83612670|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612671|NCT01112670|Incretins|incretins|mesh-ancestor
83612672|NCT01112670|Hormones|hormones|mesh-ancestor
83612673|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612674|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83612675|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
83612676|NCT01115556|Ranibizumab|ranibizumab|mesh-list
83612677|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83612678|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83612679|NCT01115556|Growth Substances|growth substances|mesh-ancestor
83612680|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612681|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
83612682|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612683|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83612684|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
83612685|NCT01119222|Promethazine|promethazine|mesh-list
83612686|NCT01119222|Morphine|morphine|mesh-list
83612687|NCT01119222|Gabapentin|gabapentin|mesh-list
83612688|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83612689|NCT01119222|Narcotics|narcotics|mesh-ancestor
83612690|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612691|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612692|NCT01119222|Analgesics|analgesics|mesh-ancestor
83612693|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
83612694|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612695|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
83612696|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83612697|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83612698|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83612699|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83612700|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83612701|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612702|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612703|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
83612704|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83612705|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83612706|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
83612707|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
83612708|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
83612709|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
83612710|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612711|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83612712|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
83612713|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
83612714|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83612715|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
83612716|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83612717|NCT01120236|Leuprolide|leuprolide|mesh-list
83612718|NCT01120236|Goserelin|goserelin|mesh-list
83612719|NCT01120236|Bicalutamide|bicalutamide|mesh-list
83612720|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83612721|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83612722|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
83612723|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83612724|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612725|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83612726|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612727|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
83612728|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
83612729|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612730|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
83612731|NCT01120704|Nicotine|nicotine|mesh-list
83612732|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83612733|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
83612734|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612735|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612737|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83612738|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
83612739|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612740|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612741|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83612742|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
83612743|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83612744|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83612745|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
83612746|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612747|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83612748|NCT05307042|Vasopressins|vasopressins|mesh-list
83612749|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
83612750|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83612751|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
83612752|NCT05307042|Coagulants|coagulants|mesh-ancestor
83612753|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83612754|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83612755|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
83612756|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612757|NCT04974138|Folic Acid|folic acid|mesh-list
83612758|NCT04974138|Amlodipine|amlodipine|mesh-list
83612759|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83612760|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83612761|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612762|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612763|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83612764|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612765|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
83612766|NCT04974138|Hematinics|hematinics|mesh-ancestor
83612767|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
83612768|NCT04974138|Vitamins|vitamins|mesh-ancestor
83612769|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
83612770|NCT04973982|Tacrolimus|tacrolimus|mesh-list
83612771|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612772|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
83612773|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612774|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83612775|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612776|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612777|NCT04187352|Cisplatin|cisplatin|mesh-list
83612778|NCT04187352|Fluorouracil|fluorouracil|mesh-list
83612779|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612780|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
83612781|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612782|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83612783|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612784|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
83612785|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612786|NCT04142892|Onapristone|onapristone|mesh-list
83612787|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612788|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83612789|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
83612790|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83612791|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612792|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
83612793|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612794|NCT03697356|Dexamethasone|dexamethasone|mesh-list
83612795|NCT03697356|Rituximab|rituximab|mesh-list
83612796|NCT03697356|Lenalidomide|lenalidomide|mesh-list
83612797|NCT03697356|Bortezomib|bortezomib|mesh-list
83612798|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612799|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612800|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
83612801|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612802|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612803|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612804|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
83612805|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
83612806|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612807|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612808|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
83612809|NCT03697356|Hormones|hormones|mesh-ancestor
83612810|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070789|NCT03383692|Ritonavir|ritonavir|mesh-list
83612811|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83612812|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83612813|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83612814|NCT03697356|Growth Substances|growth substances|mesh-ancestor
83612815|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
83612816|NCT03616782|Ixazomib|ixazomib|mesh-list
83612817|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612818|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
83612819|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612820|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612821|NCT02410512|Atezolizumab|atezolizumab|mesh-list
83612822|NCT02410512|Antibodies|antibodies|mesh-list
83612823|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
83612824|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83612825|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
83612826|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612827|NCT02410512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83612828|NCT02410512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612829|NCT02410512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83612830|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612831|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83612832|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83612833|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83612834|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612835|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612836|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
83612837|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612838|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612839|NCT01128192|Pasireotide|pasireotide|mesh-list
83612840|NCT01128192|Hormones|hormones|mesh-ancestor
83612841|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612842|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612843|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
83612844|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83612845|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612846|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612847|NCT01128972|Listerine|listerine|mesh-list
83612848|NCT01128972|Fluorides|fluorides|mesh-list
83612849|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
83612850|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
83612851|NCT01128972|Protective Agents|protective agents|mesh-ancestor
83612852|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612853|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83612854|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612855|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
83612856|NCT01129206|Docetaxel|docetaxel|mesh-list
83612857|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83612858|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612859|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83612860|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83612861|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83612862|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612863|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83612864|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
83612865|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
83612866|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612867|NCT01129440|Fluorides|fluorides|mesh-list
83612868|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
83612869|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
83612870|NCT01129440|Protective Agents|protective agents|mesh-ancestor
83612871|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612872|NCT01130844|Mesalamine|mesalamine|mesh-list
83612873|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83612874|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612875|NCT01130844|Analgesics|analgesics|mesh-ancestor
83612876|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
83612877|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612878|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612879|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83612880|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612881|NCT01134198|Mifepristone|mifepristone|mesh-list
83612882|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83361816|NCT02653144|Hormones|hormones|mesh-ancestor
83612883|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
83612884|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83612885|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612886|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83612887|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83612888|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83612889|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
83612890|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83612891|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83612892|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
83612893|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612894|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
83612895|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83612896|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83612898|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
83612899|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83612900|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83612901|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83612902|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612903|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612904|NCT01136226|Leuprolide|leuprolide|mesh-list
83612905|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83612906|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
83612907|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83612908|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612909|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83612910|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612911|NCT01137396|Modafinil|modafinil|mesh-list
83612912|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83612913|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612914|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83612915|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83612916|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83612917|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612918|NCT01139190|Naproxen|naproxen|mesh-list
83612919|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83612920|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83612921|NCT01139190|Analgesics|analgesics|mesh-ancestor
83612922|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
83612923|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83612924|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612925|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501935|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
83612926|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612927|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
83612928|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83612929|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612930|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612931|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
83612932|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612933|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83612934|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612935|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612936|NCT01142310|Lamotrigine|lamotrigine|mesh-list
83612937|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
83612938|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83612939|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83612940|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612941|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83612942|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612943|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83612944|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83612945|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83612946|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83612947|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83612948|NCT01144338|Exenatide|exenatide|mesh-list
83612949|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83612950|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612951|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83612952|NCT01144338|Incretins|incretins|mesh-ancestor
83612953|NCT01144338|Hormones|hormones|mesh-ancestor
83612954|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83612955|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83612956|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
83612957|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83612958|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83612959|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83612960|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83612961|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
83612962|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83612963|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612964|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612965|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83612966|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83612967|NCT01146600|Clarithromycin|clarithromycin|mesh-list
83612968|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83612969|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612970|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83612971|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83612972|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612973|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83612974|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83612975|NCT01146834|Plerixafor|plerixafor|mesh-list
83612976|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
83612977|NCT01146834|Bortezomib|bortezomib|mesh-list
83612978|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612979|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
83612980|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612981|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83612982|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83612983|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
83612984|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83612985|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83612986|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83612987|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83612988|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83612989|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
83612990|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83612991|NCT01147302|Complement C1s|complement c1s|mesh-list
83612992|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83612993|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83612994|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
83612995|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83612996|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83612997|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83612998|NCT01149876|Tretinoin|tretinoin|mesh-list
83612999|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613000|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
83613001|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613002|NCT01150500|Sirolimus|sirolimus|mesh-list
83613003|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83613004|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613005|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83613006|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613007|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
83613008|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613009|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
83613010|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613011|NCT01151046|Exemestane|exemestane|mesh-list
83613012|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613013|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83613014|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83613015|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613016|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613017|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83613018|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
83613019|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613020|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613021|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
83613022|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83361833|NCT00118365|Sulindac|sulindac|mesh-list
83070990|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070991|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
83070992|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
83070993|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070994|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070995|NCT02882282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070997|NCT02872467|Oxytocin|oxytocin|mesh-list
83613023|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
83613024|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613026|NCT01151436|Protective Agents|protective agents|mesh-ancestor
83613027|NCT01153620|Polihexanide|polihexanide|mesh-list
83613028|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
83613029|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613030|NCT01163214|Ropivacaine|ropivacaine|mesh-list
83613031|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
83613032|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
83613033|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613034|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613035|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
83613036|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613037|NCT01163604|Argatroban|argatroban|mesh-list
83613038|NCT01163604|Clopidogrel|clopidogrel|mesh-list
83613039|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613040|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613041|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83613042|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613043|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83613044|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83613045|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83613046|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
83613047|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613048|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
83613049|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83613050|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
83613051|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
83613052|NCT01168674|Ziprasidone|ziprasidone|mesh-list
83613053|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83613054|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
83613055|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613056|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613057|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613058|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83613059|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83613060|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613061|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83613062|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83613063|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
83613064|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
83613065|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
83613066|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83613067|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83613068|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613069|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613070|NCT01168908|Urological Agents|urological agents|mesh-ancestor
83613071|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83613072|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83613073|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
83613074|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83613075|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83613076|NCT01170390|Estradiol|estradiol|mesh-list
83613077|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83613078|NCT01170390|Estrogens|estrogens|mesh-ancestor
83613079|NCT01170390|Hormones|hormones|mesh-ancestor
83613080|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613081|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613082|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83613083|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
83613084|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83613085|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83613086|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83613087|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83613088|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83613089|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83613090|NCT01134510|Complement C1s|complement c1s|mesh-list
83613091|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83613092|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83613093|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
83613094|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613095|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83613096|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613097|NCT01171794|Ibuprofen|ibuprofen|mesh-list
83613098|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83613099|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83613100|NCT01171794|Analgesics|analgesics|mesh-ancestor
83613101|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
83613102|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613103|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613104|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613105|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613106|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83613107|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613108|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613109|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
83613110|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
83613111|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83613112|NCT01172418|Daclizumab|daclizumab|mesh-list
83613113|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
83613114|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613115|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613116|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83613117|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613118|NCT01175148|Atorvastatin|atorvastatin|mesh-list
83613119|NCT01175148|Calcium|calcium|mesh-list
83613120|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83613121|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613122|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83613123|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83613124|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
83613125|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613126|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83613127|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83613128|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613129|NCT01177098|Timolol|timolol|mesh-list
83613130|NCT01177098|Bimatoprost|bimatoprost|mesh-list
83613131|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83613132|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83613133|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83613134|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83613135|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83613136|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613137|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613138|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613139|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83613140|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83613141|NCT01177956|Fluorouracil|fluorouracil|mesh-list
83613142|NCT01177956|Cetuximab|cetuximab|mesh-list
83613143|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613144|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
83613145|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613146|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83613147|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613148|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
83613149|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613150|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83613151|NCT01183650|Tadalafil|tadalafil|mesh-list
83613152|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
83613153|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83613154|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83613155|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613156|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613157|NCT01183650|Urological Agents|urological agents|mesh-ancestor
83613158|NCT01184898|Cytarabine|cytarabine|mesh-list
83613159|NCT01184898|Sirolimus|sirolimus|mesh-list
83613160|NCT01184898|Etoposide|etoposide|mesh-list
83613161|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
83613162|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
83613163|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83613164|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613165|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83613166|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83613167|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613168|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613169|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83613170|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
83613171|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
83613172|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613173|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613174|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
83613175|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613176|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83613177|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83613178|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
83613179|NCT01184898|Analgesics|analgesics|mesh-ancestor
83613180|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
83613181|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613182|NCT01188876|Folic Acid|folic acid|mesh-list
83613183|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
83613184|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
83613185|NCT01188876|Carboplatin|carboplatin|mesh-list
83613186|NCT01188876|Vitamins|vitamins|mesh-ancestor
83613187|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
83613188|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613189|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613190|NCT01188876|Hematinics|hematinics|mesh-ancestor
83613191|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
83613192|NCT01193868|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83613193|NCT01193868|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83613194|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613195|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613196|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
83613197|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83613198|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613199|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613200|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83613201|NCT01195116|Analgesics|analgesics|mesh-ancestor
83613202|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
83613203|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613204|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83613205|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83613206|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83613207|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
83613208|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613209|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613210|NCT01197612|Budesonide|budesonide|mesh-list
83613211|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613212|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83613213|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
83613214|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613215|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613216|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83613217|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
83613218|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
83613219|NCT01197612|Hormones|hormones|mesh-ancestor
83613220|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613221|NCT01198158|Bevacizumab|bevacizumab|mesh-list
83613222|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83613223|NCT01198158|Everolimus|everolimus|mesh-list
83613224|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
83613225|NCT01198158|Antibodies|antibodies|mesh-list
83613226|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
83613227|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83613228|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
83613229|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613230|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83613231|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83613232|NCT01198158|Growth Substances|growth substances|mesh-ancestor
83613233|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613234|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
83613235|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
83613236|NCT01198158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83613237|NCT01198158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83613238|NCT01198158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613239|NCT01198158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613240|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613241|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
83613242|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83613243|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613244|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
83613245|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83613246|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613248|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613249|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
83613250|NCT01206660|Hormones|hormones|mesh-ancestor
83613251|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613252|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613253|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83613254|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
83613255|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83613256|NCT01207908|Mecasermin|mecasermin|mesh-list
83613257|NCT01207908|Growth Substances|growth substances|mesh-ancestor
83613258|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613259|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
83613260|NCT01208922|Rifamycins|rifamycins|mesh-list
83613261|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
83613262|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83613263|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613264|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83613265|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83613266|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613267|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613268|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613269|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83613270|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83613271|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613272|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
83613273|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613274|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613275|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83613276|NCT01210560|Tolvaptan|tolvaptan|mesh-list
83613277|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83613278|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613279|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
83613280|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613281|NCT01211730|Insulin|insulin|mesh-list
83613282|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83613283|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83613284|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613285|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83613286|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83613287|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83613288|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
83613289|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613290|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613291|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83613292|NCT01215318|Silicon|silicon|mesh-list
83613293|NCT01215318|Trace Elements|trace elements|mesh-ancestor
83613294|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
83613295|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613296|NCT01215786|Timolol|timolol|mesh-list
83613297|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83613298|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83613299|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83613300|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83613301|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
83613302|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613303|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613304|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613305|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83613306|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83613307|NCT01216410|Phenylephrine|phenylephrine|mesh-list
83613308|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
83613309|NCT01216410|Ondansetron|ondansetron|mesh-list
83613310|NCT01216410|Metoclopramide|metoclopramide|mesh-list
83613311|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
83613312|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
83613313|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613314|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613315|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83613316|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
83613317|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613318|NCT01216410|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83613319|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83613320|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
83071295|NCT00000524|Cyclosporine|cyclosporine|mesh-list
83613321|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613322|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613323|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83613325|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
83613326|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83613327|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
83613328|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
83613329|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83613330|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83613331|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83613332|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
83613333|NCT01216410|Protective Agents|protective agents|mesh-ancestor
83613334|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83613335|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83613336|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
83613337|NCT01218048|Carboplatin|carboplatin|mesh-list
83613338|NCT01218048|Cetuximab|cetuximab|mesh-list
83613339|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613340|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83613341|NCT01218984|Naltrexone|naltrexone|mesh-list
83613342|NCT01218984|Hydromorphone|hydromorphone|mesh-list
83613343|NCT01218984|Naloxone|naloxone|mesh-list
83613344|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83613345|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83613346|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613347|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
83613348|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613349|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83613350|NCT01218984|Narcotics|narcotics|mesh-ancestor
83613351|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613352|NCT01218984|Analgesics|analgesics|mesh-ancestor
83613353|NCT01222260|Dexamethasone|dexamethasone|mesh-list
83613354|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83613355|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613356|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
83613357|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
83613358|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613359|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613360|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83613361|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
83613362|NCT01222260|Hormones|hormones|mesh-ancestor
83613363|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613364|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83613365|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613366|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83613367|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
83613368|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613369|NCT01222572|Etoposide|etoposide|mesh-list
83613370|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613371|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83613372|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83613373|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83613374|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613375|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613376|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83613377|NCT01222884|Hematinics|hematinics|mesh-ancestor
83613378|NCT01223352|Bosentan|bosentan|mesh-list
83613379|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83613380|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83613381|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613382|NCT01224210|Ambrisentan|ambrisentan|mesh-list
83613383|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83613384|NCT01224678|Vitamin D|vitamin d|mesh-list
83613385|NCT01224678|Vitamins|vitamins|mesh-ancestor
83613386|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
83613387|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613388|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83613389|NCT01225068|Milnacipran|milnacipran|mesh-list
83613390|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
83613391|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83613392|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83613393|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613394|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613395|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071368|NCT00304070|Cisplatin|cisplatin|mesh-list
83613396|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613397|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83613399|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
83613400|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613401|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
83613402|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83613403|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
83613404|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83613405|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83613406|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83613407|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613408|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613409|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
83613410|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613411|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613412|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83613413|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613414|NCT01231230|Fluticasone|fluticasone|mesh-list
83613415|NCT01231230|Xhance|xhance|mesh-list
83613416|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83613417|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83613418|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613419|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83613420|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
83613421|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613422|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613423|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83613424|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
83613425|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613426|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83613427|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83613428|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83613429|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83613430|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
83613431|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613432|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613433|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
83613434|NCT01231230|Hormones|hormones|mesh-ancestor
83613435|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613436|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
83613437|NCT01232946|Insulin|insulin|mesh-list
83613438|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83613439|NCT01232946|Liraglutide|liraglutide|mesh-list
83613440|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
83613441|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83613442|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613443|NCT01232946|Incretins|incretins|mesh-ancestor
83613444|NCT01232946|Hormones|hormones|mesh-ancestor
83613445|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613446|NCT01235910|Cyclosporine|cyclosporine|mesh-list
83613447|NCT01235910|Cyclosporins|cyclosporins|mesh-list
83613448|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613449|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613450|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613451|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
83613452|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613453|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
83613454|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613455|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613456|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613457|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83613458|NCT01236378|Sirolimus|sirolimus|mesh-list
83613459|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83613460|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613461|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83613462|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613463|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
83613464|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613465|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
83613466|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613467|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
83613468|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
83613469|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
83613470|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83613471|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613472|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83613473|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83613475|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83613476|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
83613477|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613478|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613479|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83613480|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83613481|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
83613482|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613483|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613484|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83613485|NCT01247220|Ranibizumab|ranibizumab|mesh-list
83613486|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83613487|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83613488|NCT01247220|Growth Substances|growth substances|mesh-ancestor
83613489|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613490|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
83613491|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613492|NCT01249872|Morphine|morphine|mesh-list
83613493|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
83613494|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83613495|NCT01249872|Narcotics|narcotics|mesh-ancestor
83613496|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613497|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613498|NCT01249872|Analgesics|analgesics|mesh-ancestor
83613499|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
83613500|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613501|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
83613502|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
83613503|NCT01250184|Lidocaine|lidocaine|mesh-list
83613504|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
83613505|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
83613506|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613507|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613508|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
83613509|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613510|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83613511|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83613512|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83613513|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613514|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613515|NCT01250730|Crizotinib|crizotinib|mesh-list
83613516|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613517|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83613518|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613519|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613520|NCT01251978|Ranibizumab|ranibizumab|mesh-list
83613521|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83613522|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83613523|NCT01251978|Growth Substances|growth substances|mesh-ancestor
83613524|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613525|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83613526|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613527|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
83613528|NCT01253460|Rituximab|rituximab|mesh-list
83613529|NCT01253460|Sapacitabine|sapacitabine|mesh-list
83613530|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613531|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
83613532|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613533|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613534|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83613535|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
83613536|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613537|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613538|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83613539|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83613540|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
83613541|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
83361834|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613542|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83071521|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83613543|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83613544|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613545|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613546|NCT01254396|Urological Agents|urological agents|mesh-ancestor
83613547|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83613548|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
83613549|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
83613550|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613551|NCT01244724|Escitalopram|escitalopram|mesh-list
83613552|NCT01244724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83613553|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83613554|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613555|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613556|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613557|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
83613558|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613559|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
83613560|NCT01258374|Darunavir|darunavir|mesh-list
83613561|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83613562|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83613563|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
83613564|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613565|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83613566|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83613567|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613568|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613569|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83613570|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83613571|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
83613572|NCT01262118|Tofacitinib|tofacitinib|mesh-list
83613573|NCT01262118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83613574|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83613575|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613576|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613577|NCT01263132|Thiamine|thiamine|mesh-list
83613578|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
83613579|NCT01263132|Gabapentin|gabapentin|mesh-list
83613580|NCT01263132|Analgesics|analgesics|mesh-ancestor
83613581|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
83613582|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613583|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613584|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
83613585|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83613586|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83613587|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613588|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83613589|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83613590|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83613591|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613592|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613593|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
83613594|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
83613595|NCT01263132|Vitamins|vitamins|mesh-ancestor
83613596|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
83613597|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83613598|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
83613599|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83613600|NCT01270542|Bevacizumab|bevacizumab|mesh-list
83613601|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83613602|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613603|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83613604|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83613605|NCT01270542|Growth Substances|growth substances|mesh-ancestor
83613606|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613607|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
83613608|NCT01271244|Escitalopram|escitalopram|mesh-list
83613609|NCT01271244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83613610|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83613611|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613612|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613613|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613614|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
83613615|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613617|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83613618|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
83613619|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83613620|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613621|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83613622|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83613623|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83613624|NCT01275300|Aspirin|aspirin|mesh-list
83613625|NCT01275300|Niacin|niacin|mesh-list
83613626|NCT01275300|Niacinamide|niacinamide|mesh-list
83613627|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
83613628|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83613629|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83613630|NCT01275300|Analgesics|analgesics|mesh-ancestor
83613631|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
83613632|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613633|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613634|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613635|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613636|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83613637|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83613638|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613639|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83613640|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83613641|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613642|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
83613643|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83613644|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
83613645|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83613646|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
83613647|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
83613648|NCT01275300|Vitamins|vitamins|mesh-ancestor
83613649|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
83613650|NCT01276314|Prednisolone|prednisolone|mesh-list
83613651|NCT01276314|Etanercept|etanercept|mesh-list
83613652|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613653|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
83613654|NCT01276314|Hormones|hormones|mesh-ancestor
83613655|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613656|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613657|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83613658|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613659|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613660|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83613661|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83613662|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83613663|NCT01276314|Analgesics|analgesics|mesh-ancestor
83613664|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
83613665|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613666|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613667|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
83613668|NCT01280058|Paclitaxel|paclitaxel|mesh-list
83613669|NCT01280058|Carboplatin|carboplatin|mesh-list
83613670|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83613671|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83613672|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613673|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
83613674|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
83613675|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
83613676|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613677|NCT01280604|Fenofibrate|fenofibrate|mesh-list
83613678|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83613679|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
83613680|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613681|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83613682|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83613683|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83613684|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83613685|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613686|NCT01285050|Tenofovir|tenofovir|mesh-list
83613687|NCT01285050|Emtricitabine|emtricitabine|mesh-list
83613688|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
83613689|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83613690|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
83613691|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613692|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83613693|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83613694|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613695|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613696|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83613697|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83613698|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83613699|NCT01286454|Fesoterodine|fesoterodine|mesh-list
83613700|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83613701|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83613702|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
83613703|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613704|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613705|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613706|NCT01286454|Urological Agents|urological agents|mesh-ancestor
83613707|NCT01287078|Cyclosporine|cyclosporine|mesh-list
83613708|NCT01287078|Cyclosporins|cyclosporins|mesh-list
83613709|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613710|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613711|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613712|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
83613713|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613714|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
83613715|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613716|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613717|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613718|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83613719|NCT01291056|Clomiphene|clomiphene|mesh-list
83613720|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83613721|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
83613722|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613723|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613724|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83613725|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
83613726|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83613727|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83613728|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83613729|NCT01292304|Tolvaptan|tolvaptan|mesh-list
83613730|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83613731|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613732|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
83613733|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613734|NCT01293396|Insulin|insulin|mesh-list
83613735|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83613736|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
83613737|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
83613738|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83613739|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83613740|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83613741|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613742|NCT01294098|Bupivacaine|bupivacaine|mesh-list
83613743|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
83613744|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
83613745|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613746|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613747|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
83613748|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613749|NCT01295112|Dexamethasone|dexamethasone|mesh-list
83613750|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
83613751|NCT01295112|Bevacizumab|bevacizumab|mesh-list
83613752|NCT01295112|BB 1101|bb 1101|mesh-list
83613753|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83613754|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613755|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83613756|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83613757|NCT01295112|Growth Substances|growth substances|mesh-ancestor
83613758|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613759|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
83613760|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613761|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
83613762|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
83613763|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613764|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83071743|NCT03548428|Atezolizumab|atezolizumab|mesh-list
83613765|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
83613766|NCT01295112|Hormones|hormones|mesh-ancestor
83613767|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613768|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83613769|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
83613770|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613771|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613772|NCT01301742|Empagliflozin|empagliflozin|mesh-list
83613773|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
83613774|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83613775|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613776|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83613777|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613778|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83613779|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
83613780|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83613781|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83613782|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83613783|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613784|NCT01304082|Lidocaine|lidocaine|mesh-list
83613785|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
83613786|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
83613787|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613788|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613789|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
83613790|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613791|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83613792|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83613793|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83613794|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613795|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613796|NCT01304238|PENTA|penta|mesh-list
83613797|NCT01304238|Lepirudin|lepirudin|mesh-list
83613798|NCT01304238|Danaparoid|danaparoid|mesh-list
83613799|NCT01304238|Fondaparinux|fondaparinux|mesh-list
83613800|NCT01304238|Argatroban|argatroban|mesh-list
83613801|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83613802|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
83613803|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83613804|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
83613805|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613806|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613807|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
83613808|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83613809|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83613810|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83613811|NCT01305252|Treprostinil|treprostinil|mesh-list
83613812|NCT01305252|Tadalafil|tadalafil|mesh-list
83613813|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
83613814|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83613815|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83613816|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613817|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613818|NCT01305252|Urological Agents|urological agents|mesh-ancestor
83613819|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83613820|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
83613821|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83613822|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83613823|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83613824|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613825|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613826|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
83613827|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613828|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613829|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83613830|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613831|NCT01308294|Vaccines|vaccines|mesh-list
83613832|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83613833|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
83613834|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613835|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83613836|NCT01308840|Gemcitabine|gemcitabine|mesh-list
83613837|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
83613838|NCT01308840|Panitumumab|panitumumab|mesh-list
83613839|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83613840|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
83613841|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613842|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613843|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83613844|NCT01311102|Lidocaine|lidocaine|mesh-list
83613845|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
83613846|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
83613847|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613848|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613849|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
83613850|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613851|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83613852|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83613853|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83613854|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83613855|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613856|NCT01312038|Simethicone|simethicone|mesh-list
83613857|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
83613858|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613859|NCT01312038|Emollients|emollients|mesh-ancestor
83613860|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613861|NCT01312272|Oxytocin|oxytocin|mesh-list
83613862|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
83613863|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83613864|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613865|NCT01312818|Dexamethasone|dexamethasone|mesh-list
83613866|NCT01312818|Methotrexate|methotrexate|mesh-list
83613867|NCT01312818|Bortezomib|bortezomib|mesh-list
83613868|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
83613869|NCT01312818|Vorinostat|vorinostat|mesh-list
83613870|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613871|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
83613872|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
83613873|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613874|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613875|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83613876|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
83613877|NCT01312818|Hormones|hormones|mesh-ancestor
83613878|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613879|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83613880|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83613881|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83613882|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
83613883|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83613884|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83613885|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
83613886|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613887|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613888|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613889|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83613890|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83613891|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
83613892|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613893|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83613894|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83613895|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83613896|NCT01313520|Infliximab|infliximab|mesh-list
83613897|NCT01313520|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83613898|NCT01313520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613899|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
83613900|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83613901|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83613902|NCT01315002|Nicotine|nicotine|mesh-list
83613903|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83613904|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
83613905|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613906|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613907|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83613908|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83613909|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
83613910|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613911|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613912|NCT01315158|Fentanyl|fentanyl|mesh-list
83613913|NCT01315158|Midazolam|midazolam|mesh-list
83071892|NCT04447274|Apatinib|apatinib|mesh-list
83613914|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
83613915|NCT01315158|Propofol|propofol|mesh-list
83613916|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83613917|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83613918|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613919|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83613920|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
83613921|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
83613922|NCT01315158|Narcotics|narcotics|mesh-ancestor
83613923|NCT01315158|Analgesics|analgesics|mesh-ancestor
83613924|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
83613925|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613926|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83613927|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83613928|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83613929|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83613930|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
83613931|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
83613932|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613933|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613934|NCT01318278|Dopamine|dopamine|mesh-list
83613935|NCT01318278|Vasopressins|vasopressins|mesh-list
83613936|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
83613937|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613938|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
83613939|NCT01318278|Coagulants|coagulants|mesh-ancestor
83613940|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83613941|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83613942|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
83613943|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83613944|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
83613945|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
83613946|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83613947|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
83613948|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83613949|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613950|NCT01318278|Protective Agents|protective agents|mesh-ancestor
83613951|NCT01318356|Doxycycline|doxycycline|mesh-list
83613952|NCT01318356|Tetracycline|tetracycline|mesh-list
83613953|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83613954|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83613955|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
83613956|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83613957|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83613958|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83613959|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83613960|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613961|NCT01324128|Iron|iron|mesh-list
83613962|NCT01324128|Sevelamer|sevelamer|mesh-list
83613963|NCT01324128|Trace Elements|trace elements|mesh-ancestor
83613964|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
83613965|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613966|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
83613967|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
83613968|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613969|NCT01328184|Empagliflozin|empagliflozin|mesh-list
83613970|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
83613971|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83613972|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83613973|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83613974|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83613975|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
83613976|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83613977|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83613978|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83613979|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83613980|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83613981|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83613982|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83613983|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83613984|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83613985|NCT01328184|Estrogens|estrogens|mesh-ancestor
83613986|NCT01328184|Hormones|hormones|mesh-ancestor
83613987|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83613988|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83613989|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83613990|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83613991|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83613992|NCT01328964|Fluticasone|fluticasone|mesh-list
83613993|NCT01328964|Xhance|xhance|mesh-list
83613994|NCT01328964|Budesonide|budesonide|mesh-list
83613995|NCT01328964|Montelukast|montelukast|mesh-list
83613996|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83613997|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83613998|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
83613999|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614000|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614001|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83614002|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614003|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614004|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83614005|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
83614006|NCT01328964|Hormones|hormones|mesh-ancestor
83614007|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614008|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83614009|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
83614010|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83614011|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83614012|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614013|NCT01330134|Lidocaine|lidocaine|mesh-list
83614014|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
83614015|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
83614016|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614017|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614018|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
83614019|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614020|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83614021|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83614022|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83614023|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614024|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614025|NCT01330290|Rotigotine|rotigotine|mesh-list
83614026|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
83614027|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
83614028|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614029|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614030|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614031|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83614032|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
83614033|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83614034|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83614035|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83614036|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614037|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614038|NCT01331694|Fluticasone|fluticasone|mesh-list
83614039|NCT01331694|Bromides|bromides|mesh-list
83614040|NCT01331694|Albuterol|albuterol|mesh-list
83614041|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
83614042|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83614043|NCT01331694|Ipratropium|ipratropium|mesh-list
83614044|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83614045|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614046|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83614047|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
83614048|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614049|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614050|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83614051|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614052|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614053|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83614054|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
83614055|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83614056|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83614057|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614058|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614059|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83614060|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83614061|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83614062|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
83614063|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
83614064|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
83614065|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83072108|NCT03127124|Antidotes|antidotes|mesh-ancestor
83614066|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
83614068|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614069|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
83614070|NCT01333098|Mifepristone|mifepristone|mesh-list
83614071|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83614072|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
83614073|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83614074|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614075|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83614076|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83614077|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83614078|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
83614079|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83614080|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83614081|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
83614082|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614083|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
83614084|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83614085|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83614086|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
83614087|NCT01333488|Analgesics|analgesics|mesh-ancestor
83614088|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
83614089|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614090|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614091|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
83614092|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614093|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83614094|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
83614095|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83614096|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614097|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614098|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83614099|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
83614100|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83614101|NCT01335204|Bavituximab|bavituximab|mesh-list
83614102|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83614103|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614104|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83614105|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
83614106|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83614107|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614108|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83614109|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
83614110|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614111|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614112|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614113|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614114|NCT01337700|Milnacipran|milnacipran|mesh-list
83614115|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
83614116|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83614117|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83614118|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614119|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614120|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614121|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614122|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614123|NCT01337700|Analgesics|analgesics|mesh-ancestor
83614124|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
83614125|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614126|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
83614127|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83614128|NCT01339260|Dexamethasone|dexamethasone|mesh-list
83614129|NCT01339260|Palonosetron|palonosetron|mesh-list
83614130|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614131|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
83614132|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
83614133|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614134|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614135|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83614136|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
83614137|NCT01339260|Hormones|hormones|mesh-ancestor
83614138|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614139|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83614140|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614141|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83614142|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83614143|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
83614144|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614145|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614146|NCT01340586|Apixaban|apixaban|mesh-list
83614147|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83614148|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
83614149|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83614150|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
83614151|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614152|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614153|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
83614154|NCT01342770|Pioglitazone|pioglitazone|mesh-list
83614155|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83614156|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614157|NCT01343004|Teriparatide|teriparatide|mesh-list
83614158|NCT01343004|Abaloparatide|abaloparatide|mesh-list
83614159|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83614160|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614161|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83614162|NCT01347060|Fluticasone|fluticasone|mesh-list
83614163|NCT01347060|Xhance|xhance|mesh-list
83614164|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83614165|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614166|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83614167|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
83614168|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614169|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614170|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83614171|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614172|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614173|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83614174|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83614175|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83614176|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83614177|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
83614178|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614179|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614180|NCT01351740|Ritonavir|ritonavir|mesh-list
83614181|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83614182|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83614183|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83614184|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
83614185|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614186|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614187|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83614188|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83614189|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
83614190|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614191|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83614192|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83614193|NCT01353144|Aspirin|aspirin|mesh-list
83614194|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83614195|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614196|NCT01353144|Analgesics|analgesics|mesh-ancestor
83614197|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
83614198|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614199|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614200|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614201|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614202|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83614203|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83614204|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614205|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83614206|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83614207|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614208|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
83614209|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
83614210|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83614211|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83614212|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614213|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
83614214|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614216|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83614217|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83614218|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614219|NCT01363050|Analgesics|analgesics|mesh-ancestor
83614220|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
83614221|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614222|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614223|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614224|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614225|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83614226|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614227|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614228|NCT01363128|Cytarabine|cytarabine|mesh-list
83614229|NCT01363128|Dexamethasone|dexamethasone|mesh-list
83614230|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
83614231|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
83614232|NCT01363128|Doxorubicin|doxorubicin|mesh-list
83614233|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83614234|NCT01363128|Methotrexate|methotrexate|mesh-list
83614235|NCT01363128|Vincristine|vincristine|mesh-list
83614236|NCT01363128|Ofatumumab|ofatumumab|mesh-list
83614237|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83614238|NCT01363128|BB 1101|bb 1101|mesh-list
83614239|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83614240|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
83614241|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614242|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614243|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83614244|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
83614245|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614246|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614247|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83614248|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614249|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
83614250|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
83614251|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614252|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83614253|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
83614254|NCT01363128|Hormones|hormones|mesh-ancestor
83614255|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614256|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83614257|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83614258|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83614259|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83614260|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614261|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83614262|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
83614263|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83614264|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83614265|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
83614266|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614267|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83614268|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83614269|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
83614270|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614271|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83614272|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
83614273|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
83614274|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
83614275|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
83614276|NCT01365624|Ketorolac|ketorolac|mesh-list
83614277|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83614278|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83614279|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614280|NCT01365624|Analgesics|analgesics|mesh-ancestor
83614281|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
83614282|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072259|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614283|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614284|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614285|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614286|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83614287|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614288|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614289|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
83614290|NCT01371786|Ciclesonide|ciclesonide|mesh-list
83614291|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614292|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614293|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83614294|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
83614295|NCT01371786|Hormones|hormones|mesh-ancestor
83614296|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614297|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614298|NCT01377636|Isoproterenol|isoproterenol|mesh-list
83614299|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83614300|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83614301|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
83614302|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614303|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614304|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614305|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83614306|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
83614307|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614308|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83614309|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614310|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83614311|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
83614312|NCT01377636|Protective Agents|protective agents|mesh-ancestor
83614313|NCT01378416|Decitabine|decitabine|mesh-list
83614314|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83614315|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
83614316|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614317|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614318|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614319|NCT01379664|Sevoflurane|sevoflurane|mesh-list
83614320|NCT01379664|Isoflurane|isoflurane|mesh-list
83614321|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83614322|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83614323|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
83614324|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
83614325|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614326|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614327|NCT01380366|Hormones|hormones|mesh-list
83614328|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614329|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614330|NCT01387464|Bromfenac|bromfenac|mesh-list
83614331|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83614332|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614333|NCT01387464|Analgesics|analgesics|mesh-ancestor
83614334|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
83614335|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614336|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614337|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614338|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614339|NCT01388946|Ropivacaine|ropivacaine|mesh-list
83614340|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
83614341|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
83614342|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614343|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614344|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
83614345|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614346|NCT01390818|Niacinamide|niacinamide|mesh-list
83614347|NCT01390818|Sirolimus|sirolimus|mesh-list
83614348|NCT01390818|MTOR Inhibitors|mtor inhibitors|mesh-list
83614349|NCT01390818|Temsirolimus|temsirolimus|mesh-list
83614350|NCT01390818|Elafin|elafin|mesh-list
83614351|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
83614352|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614353|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614354|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
83614355|NCT01390818|Vitamins|vitamins|mesh-ancestor
83614356|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
83614357|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614358|NCT01390818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83614359|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83614360|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
83072331|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83614361|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614362|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614363|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614364|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83614365|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
83614366|NCT01391286|Bimatoprost|bimatoprost|mesh-list
83614367|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83614368|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83614369|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83614370|NCT01393392|Methadone|methadone|mesh-list
83614371|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83614372|NCT01393392|Narcotics|narcotics|mesh-ancestor
83614373|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614374|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614375|NCT01393392|Analgesics|analgesics|mesh-ancestor
83614376|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
83614377|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614378|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
83614379|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614380|NCT01393704|Vasopressins|vasopressins|mesh-list
83614381|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
83614382|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
83614383|NCT01393704|Coagulants|coagulants|mesh-ancestor
83614384|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83614385|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83614386|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
83614387|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614388|NCT01399008|Colchicine|colchicine|mesh-list
83614389|NCT01399008|Allopurinol|allopurinol|mesh-list
83614390|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
83614391|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614392|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
83614393|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
83614394|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
83614395|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614396|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614397|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
83614398|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614399|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83614400|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
83614401|NCT01399008|Protective Agents|protective agents|mesh-ancestor
83614402|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614403|NCT01399866|Cycloserine|cycloserine|mesh-list
83614404|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83614405|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614406|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83614407|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
83614408|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614409|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
83614410|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614411|NCT01402050|Dinoprostone|dinoprostone|mesh-list
83614412|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
83614413|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83614414|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614415|NCT01403376|Interferons|interferons|mesh-list
83614416|NCT01403376|Interferon-beta|interferon-beta|mesh-list
83614417|NCT01403376|Teriflunomide|teriflunomide|mesh-list
83614418|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
83614419|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614420|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
83614421|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614422|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83614423|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614424|NCT01403376|Analgesics|analgesics|mesh-ancestor
83614425|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
83614426|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614427|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614428|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614429|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614430|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83614431|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
83614432|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83614433|NCT01404936|Interferons|interferons|mesh-list
83614434|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
83614435|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
83614436|NCT01404936|Doxorubicin|doxorubicin|mesh-list
83614437|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83614438|NCT01404936|Bleomycin|bleomycin|mesh-list
83614439|NCT01404936|Dacarbazine|dacarbazine|mesh-list
83072409|NCT02102295|Vitamins|vitamins|mesh-ancestor
83614440|NCT01404936|Vinblastine|vinblastine|mesh-list
83614441|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83614442|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614443|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83614444|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83614445|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614446|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614447|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
83614448|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614449|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
83614450|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614451|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83614452|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
83614453|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83614454|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
83614455|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
83614456|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
83614457|NCT01410084|Vitamin D|vitamin d|mesh-list
83614458|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
83614459|NCT01410084|Vitamins|vitamins|mesh-list
83614460|NCT01410084|Vitamin E|vitamin e|mesh-list
83614461|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
83614462|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614463|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83614464|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83614465|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
83614466|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614467|NCT01410084|Protective Agents|protective agents|mesh-ancestor
83614468|NCT01413516|Varenicline|varenicline|mesh-list
83614469|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83614470|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83614471|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83614472|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614473|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614474|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614475|NCT01413750|Paclitaxel|paclitaxel|mesh-list
83614476|NCT01413750|Carboplatin|carboplatin|mesh-list
83614477|NCT01413750|Vorinostat|vorinostat|mesh-list
83614478|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83614479|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614480|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83614481|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83614482|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83614483|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614484|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83614485|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614486|NCT01417026|Oxytocin|oxytocin|mesh-list
83614487|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
83614488|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83614489|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614490|NCT01420146|Trastuzumab|trastuzumab|mesh-list
83614491|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83614492|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614493|NCT01421472|Paclitaxel|paclitaxel|mesh-list
83614494|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83614495|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614496|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83614497|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83614498|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83614499|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614500|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83614501|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83614502|NCT01428336|Cosyntropin|cosyntropin|mesh-list
83614503|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
83614504|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614505|NCT01428336|Hormones|hormones|mesh-ancestor
83614506|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614507|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614508|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614509|NCT01429272|Aspirin|aspirin|mesh-list
83614510|NCT01429272|Minocycline|minocycline|mesh-list
83614511|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83614512|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614513|NCT01429272|Analgesics|analgesics|mesh-ancestor
83614514|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
83614515|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614516|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614517|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614518|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614519|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83614520|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83614521|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614522|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83614523|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83614524|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614525|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
83614526|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614527|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614528|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83614529|NCT01429350|Plasminogen|plasminogen|mesh-list
83614530|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83614531|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83614532|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614533|NCT01432236|Pregabalin|pregabalin|mesh-list
83614534|NCT01432236|Analgesics|analgesics|mesh-ancestor
83614535|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
83614536|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614537|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614538|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
83614539|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83614540|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614541|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614542|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83614543|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83614544|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83614545|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614546|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83614547|NCT01434186|Metformin|metformin|mesh-list
83614548|NCT01434186|Saxagliptin|saxagliptin|mesh-list
83614549|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83614550|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614551|NCT01434186|Incretins|incretins|mesh-ancestor
83614552|NCT01434186|Hormones|hormones|mesh-ancestor
83614553|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614554|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83614555|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
83614556|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614557|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614558|NCT01434342|Nicotine|nicotine|mesh-list
83614559|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83614560|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
83614561|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614562|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614563|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83614564|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83614565|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
83614566|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614567|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614568|NCT01435824|Amoxicillin|amoxicillin|mesh-list
83614569|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614570|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614571|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
83614572|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83614573|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
83614574|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83614575|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
83614576|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614577|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614578|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
83614579|NCT01438710|Tacrolimus|tacrolimus|mesh-list
83614580|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83614581|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
83614582|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614583|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83614584|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614585|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614586|NCT01443546|Leuprolide|leuprolide|mesh-list
83614587|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83614588|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
83614589|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83072562|NCT03554109|Fluorouracil|fluorouracil|mesh-list
83614590|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614591|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83614592|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614593|NCT01444716|Ofatumumab|ofatumumab|mesh-list
83614594|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83614595|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614596|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
83614597|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614598|NCT01445028|Isotretinoin|isotretinoin|mesh-list
83614599|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614600|NCT01452126|Ropivacaine|ropivacaine|mesh-list
83614601|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
83614602|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
83614603|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614604|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614605|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
83614606|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614607|NCT01457430|Icatibant|icatibant|mesh-list
83614608|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83614609|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83614610|NCT01457430|Analgesics|analgesics|mesh-ancestor
83614611|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
83614612|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614613|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614614|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614615|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614616|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83614617|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83614618|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614619|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83614620|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83614621|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
83614622|NCT01458990|Omeprazole|omeprazole|mesh-list
83614623|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83614624|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83614625|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83614626|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614627|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614628|NCT01460940|Lenalidomide|lenalidomide|mesh-list
83614629|NCT01460940|Panobinostat|panobinostat|mesh-list
83614630|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83614631|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
83614632|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614633|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83503654|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
83614634|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83614635|NCT01460940|Growth Substances|growth substances|mesh-ancestor
83614636|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
83614637|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614638|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614639|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614640|NCT01462812|Sumatriptan|sumatriptan|mesh-list
83614641|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83614642|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83614643|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83614644|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
83614645|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614646|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614647|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614648|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83614649|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
83614650|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83614651|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83614652|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83614653|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
83614654|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83614655|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614656|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83614657|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83614658|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83614659|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83614660|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614661|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83072638|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614662|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
83614663|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83614664|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
83614665|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83614666|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614667|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83614668|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83614669|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614670|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
83614671|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83614672|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614673|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614675|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83614676|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
83614677|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614678|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
83614679|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614680|NCT01472874|Trientine|trientine|mesh-list
83614681|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
83614682|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
83614683|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614684|NCT01474122|Macitentan|macitentan|mesh-list
83614685|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83614686|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83614687|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614688|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83614689|NCT01474200|Furosemide|furosemide|mesh-list
83614690|NCT01474200|Diuretics|diuretics|mesh-list
83614691|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83614692|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
83614693|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614694|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614695|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614696|NCT01474590|Doxycycline|doxycycline|mesh-list
83614697|NCT01474590|Isotretinoin|isotretinoin|mesh-list
83614698|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614699|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614700|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
83614701|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83614702|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83614703|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614704|NCT01477320|Pantoprazole|pantoprazole|mesh-list
83614705|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83614706|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83614707|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83614708|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614709|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614710|NCT01478256|Erythromycin|erythromycin|mesh-list
83614711|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
83614712|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83614713|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
83614714|NCT01478256|Besifloxacin|besifloxacin|mesh-list
83614715|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614716|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614717|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83614718|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83614719|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614720|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614721|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83614722|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83614723|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614724|NCT01479270|Epinephrine|epinephrine|mesh-list
83614725|NCT01479270|Ropivacaine|ropivacaine|mesh-list
83614726|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
83614727|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
83614728|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614729|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614730|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
83614731|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614732|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83614733|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83614734|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
83614735|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614736|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614738|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83614739|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
83614740|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83614741|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614742|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
83614743|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
83614744|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83614745|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
83614746|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
83614747|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614748|NCT01483560|Metformin|metformin|mesh-list
83614749|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83614750|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614751|NCT01484340|Nicotine|nicotine|mesh-list
83614752|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83614753|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
83614754|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614755|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614756|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83614757|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83614758|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
83614759|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614760|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614761|NCT01485588|hI-con1|hi-con1|mesh-list
83614762|NCT01485588|Immunoconjugates|immunoconjugates|mesh-ancestor
83614763|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
83614764|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614765|NCT01488318|Cetuximab|cetuximab|mesh-list
83614766|NCT01488318|Dasatinib|dasatinib|mesh-list
83614767|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83614768|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614769|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83614770|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614771|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614772|NCT01495572|Aldesleukin|aldesleukin|mesh-list
83614773|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
83614774|NCT01495572|Fludarabine|fludarabine|mesh-list
83614775|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83614776|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
83614777|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614778|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83614779|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83614780|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
83614781|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614782|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614783|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83614784|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83614785|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83614786|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
83614787|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614788|NCT01504854|Resveratrol|resveratrol|mesh-list
83614789|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
83614790|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614791|NCT01504854|Protective Agents|protective agents|mesh-ancestor
83614792|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614793|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614794|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83614795|NCT01508832|Lidocaine|lidocaine|mesh-list
83614796|NCT01508832|Bupivacaine|bupivacaine|mesh-list
83614797|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
83614798|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
83614799|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614800|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614801|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
83614802|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614803|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83614804|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83614805|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83614806|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614807|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614808|NCT01511640|Pregabalin|pregabalin|mesh-list
83614809|NCT01511640|Analgesics|analgesics|mesh-ancestor
83614810|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
83614811|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614812|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614813|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
83614814|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83614815|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614816|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614817|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83614818|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83614819|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83614820|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614821|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83614823|NCT01513122|Lopinavir|lopinavir|mesh-list
83614824|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
83614825|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83614826|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83614827|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
83614828|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614829|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614830|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83614831|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83614832|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
83614833|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614834|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83614835|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83614836|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83614837|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83614838|NCT01513902|Tofacitinib|tofacitinib|mesh-list
83614839|NCT01513902|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83614840|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83614841|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614842|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614843|NCT01515540|Lidocaine|lidocaine|mesh-list
83614844|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
83614845|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
83614846|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614847|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614848|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
83614849|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614850|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83614851|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83614852|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83614853|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614854|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614855|NCT01519284|Levodopa|levodopa|mesh-list
83614856|NCT01519284|Carbidopa|carbidopa|mesh-list
83614857|NCT01519284|Opicapone|opicapone|mesh-list
83614858|NCT01519284|Entacapone|entacapone|mesh-list
83614859|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83614860|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83614861|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
83614862|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614863|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614864|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614865|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83614866|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614867|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83614868|NCT01520454|Heparin|heparin|mesh-list
83614869|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83614870|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
83614871|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83614872|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83614873|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614874|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83614875|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83614876|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83614877|NCT01520688|Fluticasone|fluticasone|mesh-list
83614878|NCT01520688|Xhance|xhance|mesh-list
83614879|NCT01520688|Budesonide|budesonide|mesh-list
83614880|NCT01520688|Beclomethasone|beclomethasone|mesh-list
83614881|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83614882|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83614883|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
83614884|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614885|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614886|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83614887|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614888|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
83614889|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83614890|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
83614891|NCT01520688|Hormones|hormones|mesh-ancestor
83614892|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614893|NCT01521546|Eplerenone|eplerenone|mesh-list
83614894|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83614895|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
83614896|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83614897|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614898|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83614899|NCT01521546|Diuretics|diuretics|mesh-ancestor
83614900|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
83614901|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83614902|NCT01523496|Vitamin D|vitamin d|mesh-list
83614903|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
83614904|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
83614905|NCT01523496|Calcifediol|calcifediol|mesh-list
83614906|NCT01523496|Vitamins|vitamins|mesh-list
83614907|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
83614908|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614909|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83614910|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83614911|NCT01526538|Cycloserine|cycloserine|mesh-list
83614912|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83614913|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614914|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83614915|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
83614916|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83614917|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
83614918|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834812|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834813|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834814|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83834815|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
83834816|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834817|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834818|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83834819|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
83834820|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
83834821|NCT00135408|Hormones|hormones|mesh-ancestor
83834822|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834823|NCT00101231|Alvocidib|alvocidib|mesh-list
83834824|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834825|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
83834826|NCT00101231|Growth Substances|growth substances|mesh-ancestor
83834827|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834828|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834829|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834830|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834831|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
83834832|NCT00101270|Irinotecan|irinotecan|mesh-list
83834833|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834834|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83834835|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834836|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834837|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834838|NCT00101309|Aldesleukin|aldesleukin|mesh-list
83834839|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834840|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83834841|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83834842|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
83834843|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834844|NCT00101348|Bevacizumab|bevacizumab|mesh-list
83834845|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83834846|NCT00101348|Cetuximab|cetuximab|mesh-list
83834847|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83834848|NCT00101348|Antibodies|antibodies|mesh-list
83834849|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
83834850|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83834851|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072934|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614919|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
83614920|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83614921|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
83614922|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614923|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614924|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83614925|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614926|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83614927|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
83614928|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614929|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614930|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83614931|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
83614932|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
83614933|NCT01529502|Protective Agents|protective agents|mesh-ancestor
83614934|NCT01532700|Ofatumumab|ofatumumab|mesh-list
83614935|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614936|NCT01533948|Axitinib|axitinib|mesh-list
83614937|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83614938|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83614939|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614940|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614941|NCT01534416|Bupivacaine|bupivacaine|mesh-list
83614942|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
83614943|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
83614944|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614945|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614946|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
83614947|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614948|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
83614949|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83614950|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83614951|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614952|NCT01535976|Ketamine|ketamine|mesh-list
83614953|NCT01535976|Analgesics|analgesics|mesh-ancestor
83614954|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
83614955|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83614956|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614957|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83614958|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83614959|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
83614960|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
83614961|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83614962|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83614963|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83614964|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83614965|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614966|NCT01536366|Repaglinide|repaglinide|mesh-list
83614967|NCT01536366|Opicapone|opicapone|mesh-list
83614968|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83614969|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614970|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83614971|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83614972|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614973|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83614974|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83614975|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
83614976|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83614977|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
83614978|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614979|NCT01537926|Expectorants|expectorants|mesh-ancestor
83614980|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
83614981|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83614982|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
83614983|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83614984|NCT01537926|Protective Agents|protective agents|mesh-ancestor
83614985|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614986|NCT01537926|Antidotes|antidotes|mesh-ancestor
83614987|NCT01538862|Lenograstim|lenograstim|mesh-list
83614988|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83614989|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
83614990|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614991|NCT01541358|Listerine|listerine|mesh-list
83614992|NCT01541358|Fluorides|fluorides|mesh-list
83073009|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83614993|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
83614994|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
83614995|NCT01541358|Protective Agents|protective agents|mesh-ancestor
83614996|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83614997|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83614998|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83614999|NCT01542372|Prazosin|prazosin|mesh-list
83615000|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83615001|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83615002|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83615003|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83615004|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615005|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615006|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615007|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615008|NCT01542684|Azacitidine|azacitidine|mesh-list
83615009|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83615010|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
83615011|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615012|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615013|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615014|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
83615015|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
83615016|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615017|NCT01543074|Protective Agents|protective agents|mesh-ancestor
83615018|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615019|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83615020|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615021|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83615022|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615023|NCT01545336|Anastrozole|anastrozole|mesh-list
83615024|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83615025|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615026|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83615027|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83615028|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615029|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615030|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83615031|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
83615032|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615033|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615034|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
83615035|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83615036|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
83615037|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615038|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615039|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
83615040|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83615041|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
83615042|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615043|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615044|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83615045|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
83615046|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83615047|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83615048|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83615049|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615050|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615051|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615052|NCT01553058|Adalimumab|adalimumab|mesh-list
83615053|NCT01553058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83615054|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615055|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83615056|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83615057|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
83615058|NCT01556724|Ropivacaine|ropivacaine|mesh-list
83615059|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615060|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
83615061|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615062|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615063|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
83615064|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073084|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
83615065|NCT01558128|Amiodarone|amiodarone|mesh-list
83615066|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83615067|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
83615068|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83615069|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615070|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615071|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83615072|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83615073|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83615074|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615075|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83615076|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83615077|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83615078|NCT01559064|Lidocaine|lidocaine|mesh-list
83615079|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
83615080|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615081|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
83615082|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615083|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615084|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
83615085|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615086|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83615087|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83615088|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83615089|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615090|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615091|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83615092|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
83615093|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
83615094|NCT01559064|Protective Agents|protective agents|mesh-ancestor
83615095|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83615096|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
83615097|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83615098|NCT01559922|Protective Agents|protective agents|mesh-ancestor
83615099|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615100|NCT01560624|Treprostinil|treprostinil|mesh-list
83615101|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83615102|NCT01562886|Rilpivirine|rilpivirine|mesh-list
83615103|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83615104|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83615105|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615106|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615107|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
83615108|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615109|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83615110|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83615111|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83615112|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615113|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615114|NCT01564914|Bevacizumab|bevacizumab|mesh-list
83615115|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83615116|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615117|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83615118|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83615119|NCT01564914|Growth Substances|growth substances|mesh-ancestor
83615120|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615121|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
83615122|NCT01565538|Pemetrexed|pemetrexed|mesh-list
83615123|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83615124|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615125|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615126|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615127|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83615128|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83615129|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83615130|NCT01565616|Fludarabine|fludarabine|mesh-list
83615131|NCT01565616|Busulfan|busulfan|mesh-list
83615132|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
83615133|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83615134|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615135|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615136|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83615137|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
83615138|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615139|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
83615140|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83615141|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83615142|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83615143|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83615144|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83615145|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615146|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615147|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615148|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83615149|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83615150|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83615151|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615152|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615153|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615154|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83615155|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83615156|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
83615157|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83615158|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83615159|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
83615160|NCT01569126|Fluoxetine|fluoxetine|mesh-list
83615161|NCT01569126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83615162|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83615163|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615164|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615165|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615166|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
83615167|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615168|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83615169|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
83615170|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615171|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83615172|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83615173|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615174|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83615175|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83615176|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615177|NCT01577706|Alprazolam|alprazolam|mesh-list
83615178|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
83615179|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83615180|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615181|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615182|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83615183|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83615184|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615185|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
83615186|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
83615187|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615188|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615189|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83615190|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83615191|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83615192|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615193|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
83615194|NCT01580592|Omalizumab|omalizumab|mesh-list
83615195|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83615196|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83615197|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83615198|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
83615199|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
83615200|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615201|NCT01588158|Acetaminophen|acetaminophen|mesh-list
83615202|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83615203|NCT01588158|Hydrocodone|hydrocodone|mesh-list
83615204|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83615205|NCT01588158|Analgesics|analgesics|mesh-ancestor
83615206|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
83615207|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615208|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615209|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
83615210|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83615211|NCT01588158|Narcotics|narcotics|mesh-ancestor
83615212|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615213|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
83615214|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
83615215|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83615216|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615217|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83615218|NCT01588470|Pioglitazone|pioglitazone|mesh-list
83615219|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83615220|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615221|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
83615222|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83615223|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83615224|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83615225|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615226|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615227|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
83615228|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615229|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615230|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83615231|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615232|NCT05565924|Biguanides|biguanides|mesh-list
83615233|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83615234|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615235|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83615236|NCT05564832|Pilocarpine|pilocarpine|mesh-list
83615237|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83615238|NCT05564832|Miotics|miotics|mesh-ancestor
83615239|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
83615240|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615241|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615242|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83615243|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83615244|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
83615245|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615246|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615247|NCT05564442|Benzocaine|benzocaine|mesh-list
83615248|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615249|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
83615250|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615251|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615252|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
83615253|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615254|NCT05493540|Ibuprofen|ibuprofen|mesh-list
83615255|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83615256|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83615257|NCT05493540|Analgesics|analgesics|mesh-ancestor
83615258|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
83615259|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615260|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615261|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615262|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83615263|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83615264|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615265|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615266|NCT05672784|Acetaminophen|acetaminophen|mesh-list
83615267|NCT05672784|Meloxicam|meloxicam|mesh-list
83615268|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83615269|NCT05672784|Analgesics|analgesics|mesh-ancestor
83615270|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
83615271|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615272|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615273|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
83615274|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83615275|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615276|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83615277|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83615278|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83615279|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615280|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615281|NCT05672472|Sivelestat|sivelestat|mesh-list
83615282|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83615283|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
83615284|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615285|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615287|NCT05672394|Epinephrine|epinephrine|mesh-list
83615288|NCT05672394|Bupivacaine|bupivacaine|mesh-list
83615289|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615290|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
83615291|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615292|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615293|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
83615294|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615295|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83615296|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83615297|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83615298|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615299|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615300|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83615301|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83615302|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615303|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615304|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83615305|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83615306|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
83615307|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83615308|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
83615309|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
83615310|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
83615311|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83615312|NCT05607342|SR 142801|sr 142801|mesh-list
83615313|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83615314|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83615315|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615316|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615317|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615318|NCT05326464|Tofacitinib|tofacitinib|mesh-list
83615319|NCT05326464|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83615320|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83615321|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615322|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615323|NCT04887792|Acetazolamide|acetazolamide|mesh-list
83615324|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
83615325|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83615326|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615327|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615328|NCT04887792|Diuretics|diuretics|mesh-ancestor
83615329|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
83615330|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615331|NCT04518228|Ritonavir|ritonavir|mesh-list
83615332|NCT04518228|Lopinavir|lopinavir|mesh-list
83615333|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83615334|NCT04518228|Darunavir|darunavir|mesh-list
83615335|NCT04518228|Tenofovir|tenofovir|mesh-list
83615336|NCT04518228|Dolutegravir|dolutegravir|mesh-list
83615337|NCT04518228|Cobicistat|cobicistat|mesh-list
83615338|NCT04518228|Cabotegravir|cabotegravir|mesh-list
83615339|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83615340|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83615341|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83615342|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615343|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615344|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83615345|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83615346|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
83615347|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615348|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83615349|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83615350|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83615351|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83615352|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83615353|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83615354|NCT03729258|Amantadine|amantadine|mesh-list
83615355|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83615356|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83615357|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
83615358|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615359|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
83615360|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615361|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615362|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615363|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83615364|NCT03729258|Analgesics|analgesics|mesh-ancestor
83615365|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
83615366|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615367|NCT03355170|Domperidone|domperidone|mesh-list
83615368|NCT03355170|Lansoprazole|lansoprazole|mesh-list
83615369|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
83615370|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83615371|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83615372|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83615373|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615374|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615375|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
83615376|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
83615377|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615378|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615379|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83615380|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
83615381|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615382|NCT03009240|Decitabine|decitabine|mesh-list
83615383|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83615384|NCT03009240|Pevonedistat|pevonedistat|mesh-list
83615385|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83615386|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
83615387|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615388|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615389|NCT02760498|Cemiplimab|cemiplimab|mesh-list
83615390|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83615391|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615392|NCT02538666|Nivolumab|nivolumab|mesh-list
83615393|NCT02538666|Ipilimumab|ipilimumab|mesh-list
83615394|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83615395|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615396|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83615397|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615398|NCT02407236|Ustekinumab|ustekinumab|mesh-list
83615399|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
83615400|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
83615401|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83615402|NCT05120076|Dexamethasone|dexamethasone|mesh-list
83615403|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
83615404|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615405|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
83615406|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
83615407|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615408|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615409|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83615410|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
83615411|NCT05120076|Hormones|hormones|mesh-ancestor
83615412|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615413|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83615414|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615415|NCT05094804|Docetaxel|docetaxel|mesh-list
83615416|NCT05094804|Cemiplimab|cemiplimab|mesh-list
83615417|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615418|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83615419|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83615420|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83615421|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615422|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83615423|NCT04873596|Midazolam|midazolam|mesh-list
83615424|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
83615425|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83615426|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615427|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615428|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83615429|NCT04873596|Analgesics|analgesics|mesh-ancestor
83615430|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
83615431|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615432|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83615433|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83615434|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83073461|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83615435|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615436|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615437|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615438|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83615439|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83615440|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83615441|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615442|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83615443|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
83615445|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
83615446|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
83615447|NCT04868760|Ipilimumab|ipilimumab|mesh-list
83615448|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83615449|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615450|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83615451|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615452|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
83615453|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
83615454|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83615455|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615456|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615457|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83615458|NCT04508166|Analgesics|analgesics|mesh-ancestor
83615459|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
83615460|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615461|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83615462|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83615463|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83615464|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615465|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615466|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615467|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83615468|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83615469|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
83615470|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
83615471|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
83615472|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83615473|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615474|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83615475|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83615476|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615477|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615478|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615479|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83615480|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83615481|NCT04175964|Metformin|metformin|mesh-list
83615482|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83615483|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615484|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
83615485|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
83615486|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
83615487|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615488|NCT03624270|Protective Agents|protective agents|mesh-ancestor
83615489|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615490|NCT03624270|Vitamins|vitamins|mesh-ancestor
83615491|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
83615492|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615493|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83615494|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83615495|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615496|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615497|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615498|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615499|NCT03455088|Fluoxetine|fluoxetine|mesh-list
83615500|NCT03455088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83615501|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83615502|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615503|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615504|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615505|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
83615506|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615507|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83615508|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
83615509|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615510|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83615511|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83615512|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615513|NCT03355560|Nivolumab|nivolumab|mesh-list
83615514|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83615515|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615516|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83615517|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615518|NCT01600170|Atorvastatin|atorvastatin|mesh-list
83615519|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83615520|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83615521|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
83615522|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615523|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83615524|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83615525|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615526|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
83615527|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83615528|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615529|NCT01605942|Dexamethasone|dexamethasone|mesh-list
83615530|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615531|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
83615532|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
83615533|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615534|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615535|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83615536|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
83615537|NCT01605942|Hormones|hormones|mesh-ancestor
83615538|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615539|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83615540|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615541|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
83615542|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83615543|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83615544|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83615545|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615546|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615547|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
83615548|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615549|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615550|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83615551|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615552|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83615553|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83615554|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615555|NCT01610154|Incretins|incretins|mesh-ancestor
83615556|NCT01610154|Hormones|hormones|mesh-ancestor
83615557|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615558|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83615559|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
83615560|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615561|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615562|NCT01611948|Aprepitant|aprepitant|mesh-list
83615563|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
83615564|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
83615565|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615566|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615567|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83615568|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83615569|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615570|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615571|NCT01612884|Clopidogrel|clopidogrel|mesh-list
83615572|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83615573|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83615574|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83615575|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83615576|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83615577|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
83615578|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615579|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615580|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615581|NCT01614210|Tamoxifen|tamoxifen|mesh-list
83615582|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83615583|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
83615584|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615585|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615586|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83615587|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615588|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83615589|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83615590|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83615591|NCT01616082|Phentermine|phentermine|mesh-list
83615592|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83615593|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615594|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
83615595|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83615596|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
83615597|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
83615598|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615599|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615600|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615601|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615602|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
83615603|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615604|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
83615605|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83615606|NCT01619982|Vancomycin|vancomycin|mesh-list
83615607|NCT01619982|Cefazolin|cefazolin|mesh-list
83615608|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83615609|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615610|NCT01620216|Sorafenib|sorafenib|mesh-list
83615611|NCT01620216|Sunitinib|sunitinib|mesh-list
83615612|NCT01620216|Dasatinib|dasatinib|mesh-list
83615613|NCT01620216|Ponatinib|ponatinib|mesh-list
83615614|NCT01620216|Idelalisib|idelalisib|mesh-list
83615615|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
83615616|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83615617|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83615618|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615619|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615620|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83615621|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83615622|NCT01620216|Growth Substances|growth substances|mesh-ancestor
83615623|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615624|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
83615625|NCT01621230|Fentanyl|fentanyl|mesh-list
83615626|NCT01621230|Bupivacaine|bupivacaine|mesh-list
83615627|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615628|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
83615629|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615630|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615631|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
83615632|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615633|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83615634|NCT01621230|Narcotics|narcotics|mesh-ancestor
83615635|NCT01621230|Analgesics|analgesics|mesh-ancestor
83615636|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83615637|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83615638|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
83615639|NCT01621776|Insulin|insulin|mesh-list
83615640|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83615641|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
83615642|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
83615643|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
83615644|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83615645|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615646|NCT01631682|Propranolol|propranolol|mesh-list
83615647|NCT01631682|Oxytocin|oxytocin|mesh-list
83615648|NCT01631682|Mifepristone|mifepristone|mesh-list
83615649|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
83615650|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83615651|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615652|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83615653|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83615654|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615655|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615656|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615657|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83615658|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83615659|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
83615660|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83615661|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
83615662|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83615663|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83615664|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83615665|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
83615666|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83615667|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83615668|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
83615669|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615670|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
83615671|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83615672|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83615673|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
83615674|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83615675|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83615676|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83615677|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615678|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615679|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
83615680|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615681|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615682|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83615683|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615684|NCT01636206|Lifitegrast|lifitegrast|mesh-list
83615685|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83615686|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83615687|NCT01639872|Risperidone|risperidone|mesh-list
83615688|NCT01639872|Clozapine|clozapine|mesh-list
83615689|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83615690|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
83615691|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615692|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615693|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615694|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83615695|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83615696|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615697|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615698|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83615699|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
83615700|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
83615701|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
83615702|NCT01640340|Dexamethasone|dexamethasone|mesh-list
83615703|NCT01640340|Ondansetron|ondansetron|mesh-list
83615704|NCT01640340|Aprepitant|aprepitant|mesh-list
83615705|NCT01640340|Palonosetron|palonosetron|mesh-list
83615706|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615707|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
83615708|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
83615709|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615710|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615711|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83615712|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
83615713|NCT01640340|Hormones|hormones|mesh-ancestor
83615714|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615715|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83615716|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615717|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
83615718|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
83615719|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83615720|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83615721|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
83615722|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615723|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615724|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83615725|NCT01641120|Interferons|interferons|mesh-list
83615726|NCT01641120|Interferon-beta|interferon-beta|mesh-list
83615727|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
83615728|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615729|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
83615730|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615731|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
83615732|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073762|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615733|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83615734|NCT01643382|Insulin|insulin|mesh-list
83615735|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83615736|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83615737|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615738|NCT01643616|Midazolam|midazolam|mesh-list
83615739|NCT01643616|Ropivacaine|ropivacaine|mesh-list
83615740|NCT01643616|Prilocaine|prilocaine|mesh-list
83615741|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615742|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
83615743|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615744|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615745|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
83615746|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615747|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83615748|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83615749|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83615750|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83615751|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615752|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83615753|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
83615754|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
83615755|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
83615756|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615757|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615758|NCT01644396|Adalimumab|adalimumab|mesh-list
83615759|NCT01644396|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83615760|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615761|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83615762|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
83615763|NCT01645098|Ketamine|ketamine|mesh-list
83615764|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83615765|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615766|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615767|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83615768|NCT01645098|Analgesics|analgesics|mesh-ancestor
83615769|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
83615770|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615771|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83615772|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83615773|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83615774|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615775|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615776|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615777|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83615778|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83615779|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
83615780|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
83615781|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83615782|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83615783|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
83615784|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
83615785|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83615786|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83615787|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615788|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
83615789|NCT01651806|Coagulants|coagulants|mesh-ancestor
83615790|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
83615791|NCT01652040|Testosterone|testosterone|mesh-list
83615792|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
83615793|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
83615794|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83615795|NCT01652040|Androgens|androgens|mesh-ancestor
83615796|NCT01652040|Hormones|hormones|mesh-ancestor
83615797|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615798|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615799|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83615800|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615801|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
83615802|NCT01652976|Leucovorin|leucovorin|mesh-list
83615803|NCT01652976|Fluorouracil|fluorouracil|mesh-list
83615804|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
83615805|NCT01652976|Dasatinib|dasatinib|mesh-list
83615806|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
83615807|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615808|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83615809|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615810|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83615811|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
83615812|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615813|NCT01652976|Antidotes|antidotes|mesh-ancestor
83615814|NCT01652976|Protective Agents|protective agents|mesh-ancestor
83615815|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
83615816|NCT01652976|Vitamins|vitamins|mesh-ancestor
83615817|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
83615818|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83615819|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615820|NCT01656252|Cytarabine|cytarabine|mesh-list
83615821|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83615822|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
83615823|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615824|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615825|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
83615826|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615827|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83615828|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
83615829|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615830|NCT01661088|Folfirinox|folfirinox|mesh-list
83615831|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615832|NCT01661946|Bevacizumab|bevacizumab|mesh-list
83615833|NCT01661946|Ranibizumab|ranibizumab|mesh-list
83615834|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83615835|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615836|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83615837|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83615838|NCT01661946|Growth Substances|growth substances|mesh-ancestor
83615839|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615840|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
83615841|NCT01663272|Gemcitabine|gemcitabine|mesh-list
83615842|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83615843|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
83615844|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615845|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615846|NCT01667796|Vitamin D|vitamin d|mesh-list
83615847|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
83615848|NCT01667796|Vitamins|vitamins|mesh-ancestor
83615849|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
83615850|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615851|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83615852|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83615853|NCT01668030|Bacitracin|bacitracin|mesh-list
83615854|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83615855|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83615856|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83615857|NCT01669434|Ramipril|ramipril|mesh-list
83615858|NCT01669434|Enalapril|enalapril|mesh-list
83615859|NCT01669434|Enalaprilat|enalaprilat|mesh-list
83615860|NCT01669434|Lisinopril|lisinopril|mesh-list
83615861|NCT01669434|Perindopril|perindopril|mesh-list
83615862|NCT01669434|Benazepril|benazepril|mesh-list
83615863|NCT01669434|Captopril|captopril|mesh-list
83615864|NCT01669434|Quinapril|quinapril|mesh-list
83615865|NCT01669434|Trandolapril|trandolapril|mesh-list
83615866|NCT01669434|Fosinopril|fosinopril|mesh-list
83615867|NCT01669434|Moexipril|moexipril|mesh-list
83615868|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83615869|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
83615870|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615871|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615872|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83615873|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83615874|NCT01669434|Protective Agents|protective agents|mesh-ancestor
83615875|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615876|NCT01678794|Candesartan|candesartan|mesh-list
83615877|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83615878|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83615879|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83615880|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615881|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83615882|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
83615883|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615884|NCT01680900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83615885|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83615886|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83073918|NCT00229008|Linezolid|linezolid|mesh-list
83615887|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615888|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615889|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
83615890|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615891|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83615892|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83615893|NCT01682538|Nitisinone|nitisinone|mesh-list
83615894|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615895|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615896|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83615897|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
83615898|NCT01684020|Coagulants|coagulants|mesh-ancestor
83615899|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
83615900|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83615901|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
83615902|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615903|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615904|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83615905|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83615906|NCT01689324|Vaccines|vaccines|mesh-list
83615907|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
83615908|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615909|NCT01692756|Triamcinolone|triamcinolone|mesh-list
83615910|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83615911|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83615912|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83615913|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83615914|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83615915|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
83615916|NCT01692756|Hormones|hormones|mesh-ancestor
83615917|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83615918|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615919|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83615920|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
83615921|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83615922|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615923|NCT01695330|Bortezomib|bortezomib|mesh-list
83615924|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83615925|NCT01701102|Fentanyl|fentanyl|mesh-list
83615926|NCT01701102|Mepivacaine|mepivacaine|mesh-list
83615927|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83615928|NCT01701102|Narcotics|narcotics|mesh-ancestor
83615929|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615930|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615931|NCT01701102|Analgesics|analgesics|mesh-ancestor
83615932|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
83615933|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615934|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83615935|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83615936|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
83615937|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
83615938|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615939|NCT01701414|Bupivacaine|bupivacaine|mesh-list
83615940|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615941|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
83615942|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615943|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615944|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
83615945|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615946|NCT01706952|Epinephrine|epinephrine|mesh-list
83615947|NCT01706952|Racepinephrine|racepinephrine|mesh-list
83615948|NCT01706952|Cocaine|cocaine|mesh-list
83615949|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83615950|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
83615951|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83615952|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83615953|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
83615954|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615955|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615956|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615957|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83615958|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83615959|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
83615960|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615961|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83615962|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
83615963|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
83615964|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
83615965|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83615966|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
83615967|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
83615968|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615969|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
83615970|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83615971|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83615972|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83615973|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
83615975|NCT01707420|Analgesics|analgesics|mesh-ancestor
83615976|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
83615977|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615978|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615979|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
83615980|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83615981|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83615982|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615983|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83615984|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83615985|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83615986|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83615987|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83615988|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
83615989|NCT01708122|Fentanyl|fentanyl|mesh-list
83615990|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83615991|NCT01708122|Narcotics|narcotics|mesh-ancestor
83615992|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83615993|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83615994|NCT01708122|Analgesics|analgesics|mesh-ancestor
83615995|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
83615996|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83615997|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83615998|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83615999|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
83616000|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
83616001|NCT01708278|Folic Acid|folic acid|mesh-list
83616002|NCT01708278|Quercetin|quercetin|mesh-list
83616003|NCT01708278|Hematinics|hematinics|mesh-ancestor
83616004|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
83616005|NCT01708278|Vitamins|vitamins|mesh-ancestor
83616006|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
83616007|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616008|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
83616009|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616010|NCT01708278|Protective Agents|protective agents|mesh-ancestor
83616011|NCT01708590|Brodalumab|brodalumab|mesh-list
83616012|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83616013|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
83616014|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
83616015|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616016|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
83616017|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83616018|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83616019|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616020|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
83616021|NCT05710146|Coagulants|coagulants|mesh-ancestor
83616022|NCT05683548|Interferons|interferons|mesh-list
83616023|NCT05683548|Tenofovir|tenofovir|mesh-list
83616024|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
83616025|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
83616026|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83616027|NCT05683548|REP 2139|rep 2139|mesh-list
83616028|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616029|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
83616030|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616031|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83616032|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83616033|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616034|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074063|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
83616035|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83616036|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83616037|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
83616038|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616039|NCT05661942|Calcium|calcium|mesh-list
83616040|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83616041|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616042|NCT05636436|Vaccines|vaccines|mesh-list
83616043|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
83616044|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616045|NCT05463354|Vaccines|vaccines|mesh-list
83616046|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
83616047|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616048|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
83616049|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83616050|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
83616051|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616052|NCT05340504|Expectorants|expectorants|mesh-ancestor
83616053|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83616054|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83616055|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
83616056|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616057|NCT05340504|Protective Agents|protective agents|mesh-ancestor
83616058|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616059|NCT05340504|Antidotes|antidotes|mesh-ancestor
83616060|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83616061|NCT05330130|Hormones|hormones|mesh-ancestor
83616062|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616063|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616064|NCT05293548|Vaccines|vaccines|mesh-list
83616065|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
83616066|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616067|NCT05157360|Vitamins|vitamins|mesh-list
83616068|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
83616069|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
83616070|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616071|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616072|NCT05136066|Peppermint oil|peppermint oil|mesh-list
83616073|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
83616074|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
83616075|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616076|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616077|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616078|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
83616079|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
83616080|NCT04676802|Narcotics|narcotics|mesh-ancestor
83616081|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616082|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616083|NCT04676802|Analgesics|analgesics|mesh-ancestor
83616084|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
83616085|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616086|NCT04278768|Azacitidine|azacitidine|mesh-list
83616087|NCT04278768|Venetoclax|venetoclax|mesh-list
83616088|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83616089|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
83616090|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616091|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616092|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616093|NCT04068948|Midazolam|midazolam|mesh-list
83616094|NCT04068948|Meperidine|meperidine|mesh-list
83616095|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
83616096|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83616097|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83616098|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616099|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616100|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83616101|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83616102|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83616103|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83616104|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
83616105|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
83616106|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
83616107|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
83616108|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616109|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616110|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83616111|NCT04068948|Narcotics|narcotics|mesh-ancestor
83616112|NCT04068948|Analgesics|analgesics|mesh-ancestor
83074140|NCT04264806|Azacitidine|azacitidine|mesh-list
83616113|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
83616114|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616115|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
83616116|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
83616117|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83616118|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
83616119|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
83616120|NCT03768570|Durvalumab|durvalumab|mesh-list
83616121|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83616122|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616123|NCT03517722|Ustekinumab|ustekinumab|mesh-list
83616124|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
83616125|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83616126|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83616127|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616128|NCT01309074|Pregabalin|pregabalin|mesh-list
83616129|NCT01309074|Sertraline|sertraline|mesh-list
83616130|NCT01309074|Analgesics|analgesics|mesh-ancestor
83616131|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
83616132|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616133|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616134|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
83616135|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83616136|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83616137|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616138|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83616139|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83616140|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83616141|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616142|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83616143|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
83616144|NCT01309074|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83616145|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83616146|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616147|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
83616148|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
83616149|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
83616150|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616151|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616152|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616153|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
83616154|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
83616155|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
83616156|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616157|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616158|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83616159|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83616160|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83616161|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
83616162|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616163|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83616164|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83616165|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616166|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
83616167|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
83616168|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
83616169|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
83616170|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83616171|NCT01721226|Narcotics|narcotics|mesh-ancestor
83616172|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616173|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616174|NCT01721226|Analgesics|analgesics|mesh-ancestor
83616175|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
83616176|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616177|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
83616178|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83616179|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616180|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616181|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83616182|NCT01721460|Analgesics|analgesics|mesh-ancestor
83616183|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
83616184|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616185|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83616186|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83616187|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83616188|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616189|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616190|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616192|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83616193|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
83616194|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616195|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616196|NCT01723722|Methadone|methadone|mesh-list
83616197|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83616198|NCT01723722|Narcotics|narcotics|mesh-ancestor
83616199|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616200|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616201|NCT01723722|Analgesics|analgesics|mesh-ancestor
83616202|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
83616203|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616204|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
83616205|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
83616206|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
83616207|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83616208|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83616209|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616210|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
83616211|NCT01728636|Coagulants|coagulants|mesh-ancestor
83616212|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
83616213|NCT01729338|Lenalidomide|lenalidomide|mesh-list
83616214|NCT01729338|Bortezomib|bortezomib|mesh-list
83616215|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83616216|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
83616217|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616218|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83616219|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83616220|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
83616221|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616222|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616223|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83616224|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83616225|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83616226|NCT01729338|Growth Substances|growth substances|mesh-ancestor
83616227|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
83616228|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
83616229|NCT01729494|Prednisone|prednisone|mesh-list
83616230|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
83616231|NCT01729494|Abatacept|abatacept|mesh-list
83616232|NCT01729494|Tacrolimus|tacrolimus|mesh-list
83616233|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
83616234|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83616235|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616236|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
83616237|NCT01729494|Hormones|hormones|mesh-ancestor
83616238|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616239|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616240|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83616241|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616242|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83616243|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
83616244|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83616245|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616246|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616247|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83616248|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83616249|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
83616250|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83616251|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616252|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83616253|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83616254|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83616255|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
83616256|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616257|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
83616258|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83616259|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616260|NCT05316246|Tislelizumab|tislelizumab|mesh-list
83616261|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83616262|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83616263|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616264|NCT05316246|Immunotoxins|immunotoxins|mesh-ancestor
83616265|NCT05316246|Immunoconjugates|immunoconjugates|mesh-ancestor
83616266|NCT05316246|Immunologic Factors|immunologic factors|mesh-ancestor
83616267|NCT05316246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616268|NCT05316168|Dexamethasone|dexamethasone|mesh-list
83616269|NCT05316168|Bupivacaine|bupivacaine|mesh-list
83616270|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616271|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
83616272|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
83616273|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616274|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616275|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616276|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
83616277|NCT05316168|Hormones|hormones|mesh-ancestor
83616278|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616279|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83616280|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616281|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
83616282|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
83616283|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616284|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
83616285|NCT05315388|Vitamins|vitamins|mesh-list
83616286|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
83616287|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616288|NCT04894188|Goserelin|goserelin|mesh-list
83616289|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83616290|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616291|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
83616292|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83616293|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83616294|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616295|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
83616296|NCT04724772|Coagulants|coagulants|mesh-ancestor
83616297|NCT04196868|Metformin|metformin|mesh-list
83616298|NCT04196868|Methotrexate|methotrexate|mesh-list
83616299|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616300|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616301|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83616302|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
83616303|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83616304|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83616305|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
83616306|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616307|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616308|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83616309|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616310|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83616311|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83616312|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
83616313|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83616314|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83616315|NCT04007874|Vitamin E|vitamin e|mesh-list
83616316|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
83616317|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83616318|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83616319|NCT04007874|Vitamins|vitamins|mesh-ancestor
83616320|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
83616321|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616322|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
83616323|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616324|NCT04007874|Protective Agents|protective agents|mesh-ancestor
83616325|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83616326|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
83616327|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83616328|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83616329|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83616330|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83616331|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83616332|NCT04007874|Estrogens|estrogens|mesh-ancestor
83616333|NCT04007874|Hormones|hormones|mesh-ancestor
83616334|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616335|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83616336|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
83616337|NCT03878472|Apatinib|apatinib|mesh-list
83616338|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616339|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83616340|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616341|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616342|NCT03162510|Paclitaxel|paclitaxel|mesh-list
83616343|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83616344|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
83616345|NCT03162510|Tegafur|tegafur|mesh-list
83616346|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83616347|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616348|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
83616349|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
83616350|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
83616351|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616352|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83616353|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
83616354|NCT02996760|Mitogens|mitogens|mesh-list
83616355|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
83616356|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616357|NCT02987946|Nadroparin|nadroparin|mesh-list
83616358|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
83616359|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83616360|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83616361|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616362|NCT02394132|Imiquimod|imiquimod|mesh-list
83616363|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83616364|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
83616365|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616366|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616367|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
83616368|NCT00700596|Salvinorin A|salvinorin a|mesh-list
83616369|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
83616370|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616371|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83616372|NCT01733472|Remifentanil|remifentanil|mesh-list
83616373|NCT01733472|Propofol|propofol|mesh-list
83616374|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83616375|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616376|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616377|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83616378|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
83616379|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
83616380|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83616381|NCT01733472|Narcotics|narcotics|mesh-ancestor
83616382|NCT01733472|Analgesics|analgesics|mesh-ancestor
83616383|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
83616384|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616385|NCT01736358|Ketorolac|ketorolac|mesh-list
83616386|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83616387|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83616388|NCT01736358|Analgesics|analgesics|mesh-ancestor
83616389|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
83616390|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616391|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616392|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616393|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83616394|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83616395|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616396|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616397|NCT01740258|Bevacizumab|bevacizumab|mesh-list
83616398|NCT01740258|Temozolomide|temozolomide|mesh-list
83616399|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83616400|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616401|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83616402|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83616403|NCT01740258|Growth Substances|growth substances|mesh-ancestor
83616404|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616405|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
83616406|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83616407|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
83616408|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616409|NCT01740414|Ibudilast|ibudilast|mesh-list
83616410|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83616411|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
83616412|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616413|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616414|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83616415|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
83616416|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83616417|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834852|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83616418|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616419|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83616420|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
83616421|NCT01740726|Fluoxetine|fluoxetine|mesh-list
83616422|NCT01740726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83616423|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83616424|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83616425|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616426|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616427|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
83616428|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616429|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83616430|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
83616431|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83616432|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83616433|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83616434|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616435|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83616436|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83616437|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616438|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616439|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616440|NCT01744704|Mitogens|mitogens|mesh-list
83616441|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83616442|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616443|NCT01746264|Vitamin D|vitamin d|mesh-list
83616444|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
83616445|NCT01746264|Vitamins|vitamins|mesh-ancestor
83616446|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
83616447|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616448|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83616449|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83616450|NCT01746420|Becaplermin|becaplermin|mesh-list
83616451|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
83616452|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83616453|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83616454|NCT01746420|Growth Substances|growth substances|mesh-ancestor
83616455|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616456|NCT01749930|Timolol|timolol|mesh-list
83616457|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83616458|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83616459|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616460|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616461|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616462|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616463|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83616464|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83616465|NCT01750086|Denosumab|denosumab|mesh-list
83616466|NCT01750086|Alendronate|alendronate|mesh-list
83616467|NCT01750086|Teriparatide|teriparatide|mesh-list
83616468|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83616469|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616470|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83616471|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
83616472|NCT01750398|Leuprolide|leuprolide|mesh-list
83616473|NCT01750398|Goserelin|goserelin|mesh-list
83616474|NCT01750398|Testosterone|testosterone|mesh-list
83616475|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
83616476|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
83616477|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83616478|NCT01750398|Androgens|androgens|mesh-ancestor
83616479|NCT01750398|Hormones|hormones|mesh-ancestor
83616480|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616481|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616482|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83616483|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616484|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
83616485|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83616486|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
83616487|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83616488|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
83616489|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616490|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83616491|NCT01752426|Protective Agents|protective agents|mesh-ancestor
83616492|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616494|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616495|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616496|NCT01753362|Incretins|incretins|mesh-ancestor
83616497|NCT01753362|Hormones|hormones|mesh-ancestor
83616498|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616499|NCT01758432|Apixaban|apixaban|mesh-list
83616500|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83616501|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
83616502|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83616503|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
83616504|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616505|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616506|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
83616507|NCT01758588|Interferons|interferons|mesh-list
83616508|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
83616509|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83616510|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616511|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
83616512|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616513|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
83616514|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616515|NCT01759602|Complement C1s|complement c1s|mesh-list
83616516|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83616517|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83616518|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
83616519|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616520|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83616521|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83616522|NCT01760304|Budesonide|budesonide|mesh-list
83616523|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
83616524|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616525|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83616526|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
83616527|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616528|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616529|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83616530|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83616531|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
83616532|NCT01760304|Hormones|hormones|mesh-ancestor
83616533|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616534|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83616535|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83616536|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83616537|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616538|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616539|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616540|NCT01763346|Metformin|metformin|mesh-list
83616541|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616542|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616543|NCT01766076|Atorvastatin|atorvastatin|mesh-list
83616544|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83616545|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83616546|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
83616547|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616548|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83616549|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83616550|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616551|NCT01766466|Ticagrelor|ticagrelor|mesh-list
83616552|NCT01766466|Cangrelor|cangrelor|mesh-list
83616553|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83616554|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83616555|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83616556|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83616557|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
83616558|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616559|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616560|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616561|NCT01767792|Bevacizumab|bevacizumab|mesh-list
83616562|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
83616563|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83616564|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616565|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83616566|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83616567|NCT01767792|Growth Substances|growth substances|mesh-ancestor
83616568|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616569|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
83616570|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
83616571|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616572|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
83616573|NCT01769586|Promethazine|promethazine|mesh-list
83616574|NCT01769586|Midazolam|midazolam|mesh-list
83616575|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83616576|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83616577|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616578|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616579|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83616580|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83616581|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83616582|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83616583|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
83616584|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
83616585|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
83616586|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
83616587|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616588|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616589|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83616590|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
83616591|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
83616592|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616593|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
83616594|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
83616595|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616596|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83616597|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
83616598|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
83616599|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83616600|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
83616601|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
83616602|NCT01773954|Aflibercept|aflibercept|mesh-list
83616603|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83616604|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83616605|NCT01773954|Growth Substances|growth substances|mesh-ancestor
83616606|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616607|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
83616608|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616609|NCT01778634|Azithromycin|azithromycin|mesh-list
83616610|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83616611|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616612|NCT01783236|Acetaminophen|acetaminophen|mesh-list
83616613|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83616614|NCT01783236|Analgesics|analgesics|mesh-ancestor
83616615|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
83616616|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616617|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616618|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
83616619|NCT01783470|Mirabegron|mirabegron|mesh-list
83616620|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
83616621|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
83616622|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83616623|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83616624|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616625|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616626|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616627|NCT01783470|Urological Agents|urological agents|mesh-ancestor
83616628|NCT01783860|Azithromycin|azithromycin|mesh-list
83616629|NCT01783860|Doxycycline|doxycycline|mesh-list
83616630|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83616631|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616632|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
83616633|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83616634|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83616635|NCT01785186|Pyridoxine|pyridoxine|mesh-list
83074663|NCT05543122|Fluconazole|fluconazole|mesh-list
83616636|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
83616637|NCT01785186|Rifampin|rifampin|mesh-list
83616638|NCT01785186|Isoniazid|isoniazid|mesh-list
83616639|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
83616640|NCT01785186|Ethambutol|ethambutol|mesh-list
83616641|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83616642|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616643|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83616644|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83616645|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616646|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616647|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616648|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616649|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83616650|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
83616651|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
83616652|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83616653|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83616654|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83616655|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83616656|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83616657|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83616658|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83616659|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83616660|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83616661|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
83616662|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83616663|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
83616664|NCT01785186|Vitamins|vitamins|mesh-ancestor
83616665|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
83616666|NCT01785810|Maraviroc|maraviroc|mesh-list
83616667|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83616668|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83616669|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616670|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83616671|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83616672|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
83616673|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616674|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83616675|NCT01786902|Hormones|hormones|mesh-list
83616676|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616677|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616678|NCT01787916|Liraglutide|liraglutide|mesh-list
83616679|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616680|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616681|NCT01787916|Incretins|incretins|mesh-ancestor
83616682|NCT01787916|Hormones|hormones|mesh-ancestor
83616683|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616684|NCT01790490|Ketamine|ketamine|mesh-list
83616685|NCT01790490|Lorazepam|lorazepam|mesh-list
83616686|NCT01790490|Analgesics|analgesics|mesh-ancestor
83505778|NCT04635189|Hormones|hormones|mesh-ancestor
83616687|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
83616688|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616689|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616690|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83616691|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83616692|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
83616693|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
83616694|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616695|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83616696|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83616697|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616698|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616699|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
83616700|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
83616701|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
83616702|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616703|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83616704|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83616705|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83616706|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83616707|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
83616708|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
83616709|NCT01791972|Albuterol|albuterol|mesh-list
83616710|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83616711|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
83616712|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616713|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616714|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83616715|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
83616716|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
83616717|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83616718|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83616719|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83616720|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83616721|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616722|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616723|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616724|NCT01794702|Cytarabine|cytarabine|mesh-list
83616725|NCT01794702|Decitabine|decitabine|mesh-list
83616726|NCT01794702|Clofarabine|clofarabine|mesh-list
83616727|NCT01794702|Idarubicin|idarubicin|mesh-list
83616728|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83616729|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
83616730|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616731|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616732|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
83616733|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616734|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83616735|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
83616736|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616737|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616738|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83616739|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83616740|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83616741|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
83616742|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616743|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83616744|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616745|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616746|NCT01797822|Dexamethasone|dexamethasone|mesh-list
83616747|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
83616748|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616749|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
83616750|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
83616751|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616752|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616753|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616754|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
83616755|NCT01797822|Hormones|hormones|mesh-ancestor
83616756|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616757|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83616758|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616759|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83616760|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83616761|NCT01809054|Aspirin|aspirin|mesh-list
83616762|NCT01809054|Fondaparinux|fondaparinux|mesh-list
83616763|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83616764|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83616765|NCT01809054|Analgesics|analgesics|mesh-ancestor
83616766|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
83616767|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616768|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616769|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616770|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83616771|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83616772|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83616773|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616774|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83616775|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83616776|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616777|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
83616778|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83616779|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
83616780|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83616781|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
83616782|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
83616783|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
83616784|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83616785|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
83616786|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616787|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616788|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83616789|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
83616790|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
83616791|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83616792|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
83616793|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616794|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616795|NCT01811940|Topiramate|topiramate|mesh-list
83616796|NCT01811940|Adderall|adderall|mesh-list
83616797|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
83616798|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616799|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616800|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83616801|NCT01813734|Ponatinib|ponatinib|mesh-list
83616802|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616803|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83616804|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616805|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616806|NCT01818414|Vitamins|vitamins|mesh-list
83616807|NCT01818414|Folic Acid|folic acid|mesh-list
83616808|NCT01818414|Misoprostol|misoprostol|mesh-list
83616809|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
83616810|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616811|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83616812|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
83616813|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83616814|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83616815|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616816|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
83616817|NCT01818414|Hematinics|hematinics|mesh-ancestor
83616818|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
83616819|NCT01820754|Paclitaxel|paclitaxel|mesh-list
83616820|NCT01820754|Carboplatin|carboplatin|mesh-list
83616821|NCT01820754|Ipilimumab|ipilimumab|mesh-list
83616822|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83616823|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616824|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
83616825|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
83616826|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
83616827|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616828|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83616829|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83616830|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83616831|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83616832|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83616833|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616834|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616835|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83616836|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83616837|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83616838|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83616839|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616840|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616841|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616842|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83616843|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83616844|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
83616845|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83616846|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83616847|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
83616848|NCT01822548|Metformin|metformin|mesh-list
83616849|NCT01822548|Vildagliptin|vildagliptin|mesh-list
83616850|NCT01822548|Glyburide|glyburide|mesh-list
83616851|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616852|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616853|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83616854|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
83616855|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616856|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616857|NCT01825122|Nadolol|nadolol|mesh-list
83616858|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83616859|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83616860|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616861|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616862|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616863|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616864|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83616865|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83616866|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
83616867|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
83616868|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616869|NCT01825512|Deferasirox|deferasirox|mesh-list
83616870|NCT01825512|Deferiprone|deferiprone|mesh-list
83616871|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83616872|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
83616873|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
83616874|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616875|NCT01827462|Vaccines|vaccines|mesh-list
83616876|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
83616877|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616878|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
83616879|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616880|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83616881|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616882|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616883|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
83616884|NCT01828476|Navitoclax|navitoclax|mesh-list
83616885|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
83616886|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83616887|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83616888|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616889|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616890|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616891|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83616892|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616893|NCT01828554|Capecitabine|capecitabine|mesh-list
83616894|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83616895|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
83616896|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616897|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616898|NCT01833546|Gemcitabine|gemcitabine|mesh-list
83616899|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83616900|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
83616901|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616902|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616903|NCT01834404|Topiramate|topiramate|mesh-list
83616904|NCT01834404|Phentermine|phentermine|mesh-list
83616905|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
83616906|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83616907|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616908|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83616909|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
83616910|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83616911|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
83616912|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
83616913|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616914|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616915|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616916|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616917|NCT01835262|Ketamine|ketamine|mesh-list
83616918|NCT01835262|Morphine|morphine|mesh-list
83616919|NCT01835262|Analgesics|analgesics|mesh-ancestor
83616920|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
83616921|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83616922|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616923|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83616924|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83616925|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
83616926|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
83616927|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83616928|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83616929|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83616930|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616931|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616932|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83616933|NCT01835262|Narcotics|narcotics|mesh-ancestor
83616934|NCT01835496|Deferiprone|deferiprone|mesh-list
83616935|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83616936|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
83616937|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
83616938|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616939|NCT01842594|Sirolimus|sirolimus|mesh-list
83616940|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
83616941|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83616942|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616943|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83616944|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616945|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
83616946|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83616947|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
83616948|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616949|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616950|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616951|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
83616952|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83616953|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83616954|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83616955|NCT01843920|Trimethoprim|trimethoprim|mesh-list
83616956|NCT01843920|Polymyxins|polymyxins|mesh-list
83616957|NCT01843920|Polymyxin B|polymyxin b|mesh-list
83616958|NCT01843920|Prednisolone|prednisolone|mesh-list
83616959|NCT01843920|Timolol|timolol|mesh-list
83616960|NCT01843920|Dorzolamide|dorzolamide|mesh-list
83616961|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83616962|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
83616963|NCT01843920|Hormones|hormones|mesh-ancestor
83616964|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83616965|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83616966|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83616967|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83616968|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83616969|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83616970|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
83616971|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83616972|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616973|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83616974|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83616975|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83616976|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83616977|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
83616978|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83616979|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83616980|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83616981|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616982|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83616983|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83616984|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83616985|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83616986|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83616987|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83616988|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83616989|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83616990|NCT01844388|Laxatives|laxatives|mesh-ancestor
83616991|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83616992|NCT01845636|Atropine|atropine|mesh-list
83616993|NCT01845636|Donepezil|donepezil|mesh-list
83616994|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83616995|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83616996|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83616997|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83616998|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83616999|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
83617000|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617001|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617002|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
83617003|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83617004|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83617005|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83617006|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
83617007|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617008|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83617009|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
83617010|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
83617011|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
83617012|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83617013|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83617014|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
83617015|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617016|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83617017|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617018|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617019|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
83617020|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617021|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617022|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83617023|NCT01846728|Estrogens|estrogens|mesh-list
83617024|NCT01846728|Hormones|hormones|mesh-ancestor
83617025|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617026|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617027|NCT01848054|Buprenorphine|buprenorphine|mesh-list
83617028|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83617029|NCT01848054|Naloxone|naloxone|mesh-list
83617030|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83617031|NCT01848054|Narcotics|narcotics|mesh-ancestor
83617032|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617033|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617034|NCT01848054|Analgesics|analgesics|mesh-ancestor
83617035|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
83617036|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617037|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83617038|NCT01849068|Ezetimibe|ezetimibe|mesh-list
83617039|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83617040|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83617041|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
83617042|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617043|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83617044|NCT01849692|Ranibizumab|ranibizumab|mesh-list
83617045|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83617046|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83617047|NCT01849692|Growth Substances|growth substances|mesh-ancestor
83617048|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617049|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
83617050|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617051|NCT01849770|Mexiletine|mexiletine|mesh-list
83617052|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83617053|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83617054|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83617055|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617056|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617057|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
83617058|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83617059|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83617060|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617061|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
83617062|NCT01850394|Coagulants|coagulants|mesh-ancestor
83617063|NCT01852344|Methylphenidate|methylphenidate|mesh-list
83617064|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83617065|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617066|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83617067|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83617068|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617069|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617070|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
83617071|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617072|NCT01856712|Naltrexone|naltrexone|mesh-list
83617073|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83617074|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83617075|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617076|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
83617077|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617078|NCT01858428|Paclitaxel|paclitaxel|mesh-list
83617079|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83617080|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617081|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83617082|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83617083|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83617084|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617085|NCT01861002|Cytarabine|cytarabine|mesh-list
83617086|NCT01861002|Methotrexate|methotrexate|mesh-list
83617087|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
83617088|NCT01861002|Azacitidine|azacitidine|mesh-list
83617089|NCT01861002|Fludarabine|fludarabine|mesh-list
83617090|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83617091|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
83617092|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83617093|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617094|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617096|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617097|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617098|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
83617099|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617100|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83617101|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83617102|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
83617103|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617104|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83617105|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
83617106|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617107|NCT01870596|Cytarabine|cytarabine|mesh-list
83617108|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617109|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
83617110|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617111|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617112|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
83617113|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617114|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83617115|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
83617116|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617117|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83617118|NCT01875510|SMOFlipid|smoflipid|mesh-list
83617119|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83617120|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83617121|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83617122|NCT01876212|Dasatinib|dasatinib|mesh-list
83617123|NCT01876212|Vaccines|vaccines|mesh-list
83617124|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
83617125|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617126|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617127|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83617128|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617129|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617130|NCT01876992|Metformin|metformin|mesh-list
83617131|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83617132|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617133|NCT01877538|Donepezil|donepezil|mesh-list
83617134|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83617135|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617136|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617137|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
83617138|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617139|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617140|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
83617141|NCT01878006|Morphine|morphine|mesh-list
83617142|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83617143|NCT01878006|Narcotics|narcotics|mesh-ancestor
83617144|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617145|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617146|NCT01878006|Analgesics|analgesics|mesh-ancestor
83617147|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
83617148|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617149|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83617150|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
83617151|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83617152|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83617153|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617154|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617155|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
83617156|NCT05327088|Nalbuphine|nalbuphine|mesh-list
83617157|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83617158|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617159|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617160|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83617161|NCT05327088|Analgesics|analgesics|mesh-ancestor
83617162|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
83617163|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617164|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83617165|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83617166|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83617167|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617168|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617169|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617170|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83617171|NCT05327088|Narcotics|narcotics|mesh-ancestor
83617172|NCT05290194|Capecitabine|capecitabine|mesh-list
83617173|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83617174|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617175|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
83617176|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617177|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617178|NCT05290194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617179|NCT05228574|Amiloride|amiloride|mesh-list
83617180|NCT05228574|Diuretics|diuretics|mesh-ancestor
83617181|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
83617182|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617183|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83617184|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83617185|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617186|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617187|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83617188|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83617189|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83617190|NCT04774068|Romidepsin|romidepsin|mesh-list
83617191|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617192|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83617193|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617194|NCT04774068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83617195|NCT04774068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617196|NCT04774068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617197|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83617198|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
83617199|NCT04103034|Coagulants|coagulants|mesh-ancestor
83617200|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83617201|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
83617202|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617203|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
83617204|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
83617205|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617206|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
83617207|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617208|NCT01643460|Ethanol|ethanol|mesh-list
83617209|NCT01643460|Paclitaxel|paclitaxel|mesh-list
83617210|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83617211|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83617212|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617213|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
83617214|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
83617215|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83617216|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617217|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83617218|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617219|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617220|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617221|NCT00954876|Capecitabine|capecitabine|mesh-list
83617222|NCT00954876|Cetuximab|cetuximab|mesh-list
83617223|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617224|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
83617225|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617226|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617227|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617228|NCT05748366|Analgesics|analgesics|mesh-list
83617229|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
83617230|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617231|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617232|NCT05746728|Tislelizumab|tislelizumab|mesh-list
83617233|NCT05746728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617234|NCT05746728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617235|NCT05714670|Curcumin|curcumin|mesh-list
83617236|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83617237|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83617238|NCT05714670|Analgesics|analgesics|mesh-ancestor
83617239|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
83617240|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617241|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617242|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83617243|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617244|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617245|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617246|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617247|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83617248|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
83617249|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
83617250|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
83617251|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83617252|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617253|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83617254|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617255|NCT05505630|Midazolam|midazolam|mesh-list
83617256|NCT05505630|Ketamine|ketamine|mesh-list
83617257|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
83617258|NCT05505630|Anesthetics|anesthetics|mesh-list
83617259|NCT05505630|Analgesics|analgesics|mesh-ancestor
83617260|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
83617261|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617262|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617263|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83617264|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
83617265|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617266|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83617267|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83617268|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617269|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617270|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83617271|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83617272|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83617273|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83617274|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83617275|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
83617276|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
83617277|NCT05472948|Capecitabine|capecitabine|mesh-list
83617278|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617279|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
83617280|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617281|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617282|NCT05215470|Nivolumab|nivolumab|mesh-list
83617283|NCT05215470|Ipilimumab|ipilimumab|mesh-list
83617284|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617285|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617286|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83617287|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617288|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83617289|NCT05206500|Amoxicillin|amoxicillin|mesh-list
83617290|NCT05206500|Metronidazole|metronidazole|mesh-list
83617291|NCT05206500|Clindamycin|clindamycin|mesh-list
83617292|NCT05206500|Linezolid|linezolid|mesh-list
83617293|NCT05206500|Tetracycline|tetracycline|mesh-list
83617294|NCT05206500|Penicillins|penicillins|mesh-list
83617295|NCT05206500|Ampicillin|ampicillin|mesh-list
83617296|NCT05206500|Fosfomycin|fosfomycin|mesh-list
83617297|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
83617298|NCT05206500|Cephalosporins|cephalosporins|mesh-list
83617299|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
83617300|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617301|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83617302|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83617303|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83617304|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617305|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617306|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83617307|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83617308|NCT05163522|Midazolam|midazolam|mesh-list
83617309|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83617310|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83617311|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617312|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617313|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83617314|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83617315|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83617316|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83617317|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
83617318|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
83617319|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
83617320|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
83617321|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617322|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617323|NCT05151588|Docetaxel|docetaxel|mesh-list
83617324|NCT05151588|Fluorouracil|fluorouracil|mesh-list
83617325|NCT05151588|Cisplatin|cisplatin|mesh-list
83617326|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617327|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
83617328|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
83617329|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
83617330|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617331|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
83617332|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617333|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83617334|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
83617335|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617336|NCT04929834|Emollients|emollients|mesh-list
83617337|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83617338|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83617339|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83617340|NCT04470804|Cyclosporine|cyclosporine|mesh-list
83617341|NCT04470804|Sirolimus|sirolimus|mesh-list
83617342|NCT04470804|Temsirolimus|temsirolimus|mesh-list
83617343|NCT04470804|MTOR Inhibitors|mtor inhibitors|mesh-list
83617344|NCT04470804|Cyclosporins|cyclosporins|mesh-list
83617345|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617346|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617347|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83617348|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
83617349|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617350|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
83617351|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617352|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
83617353|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617354|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83617355|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83617356|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83617357|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617358|NCT04470804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83617359|NCT04418466|Risperidone|risperidone|mesh-list
83617360|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83617361|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
83617362|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617363|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617364|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617365|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83617366|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83617367|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617368|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83617369|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83617370|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
83617371|NCT04360044|Dronabinol|dronabinol|mesh-list
83617372|NCT04360044|Cannabidiol|cannabidiol|mesh-list
83617373|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
83617374|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
83617375|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617376|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83617377|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83617378|NCT04360044|Analgesics|analgesics|mesh-ancestor
83617379|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
83617380|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617381|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83617382|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83617383|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617384|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617385|NCT04360044|Hormones|hormones|mesh-ancestor
83617386|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617387|NCT04337814|Ibuprofen|ibuprofen|mesh-list
83617388|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83617389|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83617390|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83617391|NCT04337814|Analgesics|analgesics|mesh-ancestor
83617392|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
83617393|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617394|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617395|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83617397|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83617398|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617399|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617400|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
83617401|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
83617402|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617403|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83617404|NCT04336332|Azithromycin|azithromycin|mesh-list
83617405|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
83617406|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83617407|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617408|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
83617409|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83617410|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83617411|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617412|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617413|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617414|NCT04230408|Paclitaxel|paclitaxel|mesh-list
83617415|NCT04230408|Carboplatin|carboplatin|mesh-list
83617416|NCT04230408|Durvalumab|durvalumab|mesh-list
83617417|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83617418|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617419|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
83617420|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
83617421|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
83617422|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617423|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617424|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
83617425|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617426|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83617427|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617428|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617429|NCT03064542|Carbimazole|carbimazole|mesh-list
83617430|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
83617431|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
83617432|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617433|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617434|NCT02718066|Nivolumab|nivolumab|mesh-list
83617435|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617436|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617437|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83617438|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617439|NCT02004522|Ofatumumab|ofatumumab|mesh-list
83617440|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617441|NCT02000622|Olaparib|olaparib|mesh-list
83617442|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83617443|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617444|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617445|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617446|NCT01472562|Rituximab|rituximab|mesh-list
83617447|NCT01472562|Lenalidomide|lenalidomide|mesh-list
83617448|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617449|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617450|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
83617451|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617452|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617453|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83617454|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83617455|NCT01472562|Growth Substances|growth substances|mesh-ancestor
83617456|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
83617457|NCT01430442|Sumatriptan|sumatriptan|mesh-list
83617458|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83617459|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83617460|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83617461|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
83617462|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617463|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617464|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617465|NCT01420926|Bortezomib|bortezomib|mesh-list
83617466|NCT01420926|Decitabine|decitabine|mesh-list
83617467|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617468|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617469|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
83075559|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83617470|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617471|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617473|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83617474|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617475|NCT01887132|Donepezil|donepezil|mesh-list
83617476|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83617477|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617478|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617479|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
83617480|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617481|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617482|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
83617483|NCT01887990|Ketamine|ketamine|mesh-list
83617484|NCT01887990|Analgesics|analgesics|mesh-ancestor
83617485|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
83617486|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617487|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617488|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83617489|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83617490|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
83617491|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
83617492|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617493|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83617494|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83617495|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617496|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617497|NCT01890642|Lidocaine|lidocaine|mesh-list
83617498|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
83617499|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
83617500|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617501|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617502|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
83617503|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617504|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83617505|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83617506|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83617507|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617508|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617509|NCT01891968|Bortezomib|bortezomib|mesh-list
83617510|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617511|NCT01901250|Fluorides|fluorides|mesh-list
83617512|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
83617513|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
83617514|NCT01901250|Protective Agents|protective agents|mesh-ancestor
83617515|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617516|NCT01904526|Guanfacine|guanfacine|mesh-list
83617517|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83617518|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83617519|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83617520|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83617521|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617522|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617523|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617524|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617525|NCT01906866|Melatonin|melatonin|mesh-list
83617526|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
83617527|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617528|NCT01906866|Protective Agents|protective agents|mesh-ancestor
83617529|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617530|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617531|NCT01907334|Fluticasone|fluticasone|mesh-list
83617532|NCT01907334|Xhance|xhance|mesh-list
83617533|NCT01907334|Albuterol|albuterol|mesh-list
83617534|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83617535|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83617536|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
83617537|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83617538|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83617539|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
83617540|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617541|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617542|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83617543|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
83617544|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
83617545|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83617546|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83617547|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83617548|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83617549|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617550|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617551|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617552|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
83617553|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83617554|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
83617555|NCT01907334|Hormones|hormones|mesh-ancestor
83617556|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617557|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
83617558|NCT01907334|Miotics|miotics|mesh-ancestor
83617559|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83617560|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83617561|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83617562|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83617563|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
83617564|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
83617565|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
83617566|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
83617567|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617568|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617569|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
83617570|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617571|NCT01908972|Prednisolone|prednisolone|mesh-list
83617572|NCT01908972|Propranolol|propranolol|mesh-list
83617573|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83617574|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
83617575|NCT01908972|Hormones|hormones|mesh-ancestor
83617576|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617577|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617578|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83617579|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617580|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83617581|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83617582|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617583|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617584|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617585|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83617586|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83617587|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
83617588|NCT01910064|Adapalene|adapalene|mesh-list
83617589|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83617590|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
83617591|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83617592|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83617593|NCT01910064|Analgesics|analgesics|mesh-ancestor
83617594|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
83617595|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617596|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617597|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83617598|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617599|NCT01912716|Indomethacin|indomethacin|mesh-list
83617600|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83617601|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83617602|NCT01912716|Analgesics|analgesics|mesh-ancestor
83617603|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
83617604|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617605|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617606|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83617607|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617608|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
83617609|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
83617610|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83617611|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83617612|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617613|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617614|NCT01920282|Nebivolol|nebivolol|mesh-list
83617615|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83617616|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
83617617|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83617618|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83617619|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83617620|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617621|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617622|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617623|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617624|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
83617625|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83617626|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
83617627|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83617628|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83617629|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617630|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83617631|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617632|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83617633|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617634|NCT01929642|Sirolimus|sirolimus|mesh-list
83617635|NCT01929642|Everolimus|everolimus|mesh-list
83617636|NCT01929642|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83617637|NCT01929642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83617638|NCT01929642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617639|NCT01929642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617640|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83617641|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
83617642|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617643|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617644|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83617645|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617646|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83617647|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
83617648|NCT01932060|Oxytocin|oxytocin|mesh-list
83617649|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
83617650|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83617651|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617652|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
83617653|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83617654|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
83617655|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617656|NCT01933464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83617657|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83617658|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83617659|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
83617660|NCT01933776|Vaccines|vaccines|mesh-list
83617661|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
83617662|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617663|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83617664|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
83617665|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83617666|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83617667|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
83617668|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617669|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617670|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83617671|NCT01937598|Liraglutide|liraglutide|mesh-list
83617672|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83617673|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617674|NCT01937598|Incretins|incretins|mesh-ancestor
83617675|NCT01937598|Hormones|hormones|mesh-ancestor
83617676|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617677|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83617678|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
83617679|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617680|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617681|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83617682|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83617683|NCT01942668|Estradiol|estradiol|mesh-list
83617684|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83617685|NCT01942668|Progesterone|progesterone|mesh-list
83617686|NCT01942668|Estrogens|estrogens|mesh-ancestor
83617687|NCT01942668|Hormones|hormones|mesh-ancestor
83617688|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617689|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617690|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83617691|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
83617692|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83617693|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83617694|NCT01942668|Progestins|progestins|mesh-ancestor
83617695|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
83617696|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
83617697|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83617698|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83617699|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617700|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617701|NCT01948518|Urological Agents|urological agents|mesh-ancestor
83617702|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
83617703|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83617704|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617705|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83617706|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617707|NCT01949844|Regadenoson|regadenoson|mesh-list
83617708|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83617709|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83617710|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
83617711|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
83617712|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617713|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617714|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617715|NCT01951950|Nicardipine|nicardipine|mesh-list
83617716|NCT01951950|Esmolol|esmolol|mesh-list
83617717|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83617718|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83617719|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83617720|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617721|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617722|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617723|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617724|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83617725|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83617726|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617727|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83617728|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
83617729|NCT01953432|Doxazosin|doxazosin|mesh-list
83617730|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83617731|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83617732|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83617733|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83617734|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617735|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617736|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617737|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617738|NCT01955382|Artesunate|artesunate|mesh-list
83617739|NCT01955382|Amodiaquine|amodiaquine|mesh-list
83617740|NCT01955382|Charcoal|charcoal|mesh-list
83617741|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
83617742|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83617743|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83617744|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617745|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617746|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
83617747|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
83617748|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83617749|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
83617750|NCT01955382|Antidotes|antidotes|mesh-ancestor
83617751|NCT01955382|Protective Agents|protective agents|mesh-ancestor
83617752|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617753|NCT01957410|Ketamine|ketamine|mesh-list
83617754|NCT01957410|Analgesics|analgesics|mesh-ancestor
83617755|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
83617756|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617757|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617758|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83617759|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83617760|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
83617761|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
83617762|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617763|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83617764|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83617765|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617766|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617768|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617769|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83617770|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617771|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617772|NCT05740098|Nicotine|nicotine|mesh-list
83617773|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83617774|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
83617775|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617776|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617777|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83617778|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83617779|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
83617780|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617781|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617782|NCT05739786|Vitamin D|vitamin d|mesh-list
83617783|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
83617784|NCT05739786|Vitamins|vitamins|mesh-ancestor
83617785|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
83617786|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617787|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83617788|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83617789|NCT05739630|Cytarabine|cytarabine|mesh-list
83617790|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
83617791|NCT05739630|Busulfan|busulfan|mesh-list
83617792|NCT05739630|Fludarabine|fludarabine|mesh-list
83617793|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
83617794|NCT05739630|Tacrolimus|tacrolimus|mesh-list
83617795|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83617796|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
83617797|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617798|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617799|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83617800|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
83617801|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617802|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617803|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83617804|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617805|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
83617806|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
83617807|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617808|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83617809|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617810|NCT05739630|Analgesics|analgesics|mesh-ancestor
83617811|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
83617812|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617813|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83617814|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83617815|NCT05739474|Vaccines|vaccines|mesh-list
83617816|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
83617817|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617818|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
83617819|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617820|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617821|NCT05739006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83617822|NCT05739006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617823|NCT05738616|Lenvatinib|lenvatinib|mesh-list
83617824|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617825|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83617826|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617827|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617828|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83617829|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83617830|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617831|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
83617832|NCT05738382|Cetrorelix|cetrorelix|mesh-list
83361848|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075856|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
83075857|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075858|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075859|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075860|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075861|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
83075862|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83075863|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617833|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83617834|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
83617835|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83617836|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617837|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
83617838|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617839|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
83617840|NCT05737680|Colchicine|colchicine|mesh-list
83617841|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
83617842|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83617843|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83617844|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617845|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617846|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617847|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617848|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
83617849|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
83617850|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
83617851|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
83617852|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617853|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83617854|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617855|NCT05735028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617856|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617857|NCT05725200|Gemcitabine|gemcitabine|mesh-list
83617858|NCT05725200|Methotrexate|methotrexate|mesh-list
83617859|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
83617860|NCT05725200|Trastuzumab|trastuzumab|mesh-list
83617861|NCT05725200|Cetuximab|cetuximab|mesh-list
83617862|NCT05725200|Everolimus|everolimus|mesh-list
83617863|NCT05725200|Venetoclax|venetoclax|mesh-list
83617864|NCT05725200|Dasatinib|dasatinib|mesh-list
83617865|NCT05725200|Palbociclib|palbociclib|mesh-list
83617866|NCT05725200|Crizotinib|crizotinib|mesh-list
83617867|NCT05725200|Panobinostat|panobinostat|mesh-list
83617868|NCT05725200|Talazoparib|talazoparib|mesh-list
83617869|NCT05725200|Idelalisib|idelalisib|mesh-list
83617870|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83617871|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
83617872|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617873|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83617874|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83617875|NCT05725200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83617876|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83617877|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
83617878|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83617879|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506970|NCT02368314|Enoxaparin|enoxaparin|mesh-list
83617880|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
83617881|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617882|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83617883|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83617884|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
83617885|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83617886|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83617887|NCT05725200|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83617888|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83617889|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83617890|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83617891|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
83617892|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83617893|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
83617894|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617895|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617896|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83617897|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83617898|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83617899|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
83617900|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617901|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617902|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83617903|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
83617904|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
83617905|NCT05721144|Protective Agents|protective agents|mesh-ancestor
83617906|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83617907|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83617908|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617909|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83617910|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83617911|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617912|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617913|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
83617914|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617915|NCT05650008|Anesthetics|anesthetics|mesh-list
83617916|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617917|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617918|NCT05574894|Hormones|hormones|mesh-list
83617919|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83617920|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617921|NCT05567952|Ritonavir|ritonavir|mesh-list
83617922|NCT05567952|Nirmatrelvir|nirmatrelvir|mesh-list
83617923|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83617924|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83617925|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
83617926|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83617927|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617928|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83617929|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83617930|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
83617931|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83617932|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83617933|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83617934|NCT05530278|Midazolam|midazolam|mesh-list
83617935|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83617936|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83617937|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617938|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617939|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83617940|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83617941|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83617942|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83617943|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
83617944|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
83617945|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
83617946|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
83617947|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617948|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617949|NCT05459298|Vitamin D|vitamin d|mesh-list
83617950|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
83617951|NCT05459298|Vitamins|vitamins|mesh-ancestor
83617952|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
83617953|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617954|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83617955|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83617956|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
83617957|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83617958|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
83617959|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617960|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
83617961|NCT05436288|Protective Agents|protective agents|mesh-ancestor
83617962|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
83617963|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83617964|NCT05245734|Antibodies|antibodies|mesh-list
83617965|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
83617966|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83617967|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
83617968|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617969|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
83617970|NCT05242692|Ketamine|ketamine|mesh-list
83617971|NCT05242692|Esketamine|esketamine|mesh-list
83617972|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83617973|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83617974|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617975|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83617976|NCT05242692|Analgesics|analgesics|mesh-ancestor
83617977|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
83617978|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83617979|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83617980|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83617981|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83076020|NCT02144415|Amphetamine|amphetamine|mesh-list
83617982|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
83617983|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83617984|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617985|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83617986|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83617988|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
83617989|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83617990|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83617991|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
83617992|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83617993|NCT05087940|Diuretics|diuretics|mesh-list
83617994|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83617995|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
83617996|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83617997|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83617998|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83617999|NCT04964934|Letrozole|letrozole|mesh-list
83618000|NCT04964934|Palbociclib|palbociclib|mesh-list
83618001|NCT04964934|Anastrozole|anastrozole|mesh-list
83618002|NCT04964934|Hormones|hormones|mesh-list
83618003|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83618004|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618005|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618006|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618007|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83618008|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83618009|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618010|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618011|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83618012|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
83618013|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83618014|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618015|NCT04922658|Vinorelbine|vinorelbine|mesh-list
83618016|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83618017|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618018|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
83618019|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
83618020|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
83618021|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618022|NCT04883346|Liraglutide|liraglutide|mesh-list
83618023|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83618024|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618025|NCT04883346|Incretins|incretins|mesh-ancestor
83618026|NCT04883346|Hormones|hormones|mesh-ancestor
83618027|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618028|NCT04438902|Osimertinib|osimertinib|mesh-list
83618029|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618030|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83618031|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618032|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618033|NCT04346394|Yohimbine|yohimbine|mesh-list
83618034|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
83618035|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
83618036|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618037|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618038|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83618039|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83618040|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83618041|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618042|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618043|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618044|NCT04346394|Urological Agents|urological agents|mesh-ancestor
83618045|NCT04329390|Anticoagulants|anticoagulants|mesh-list
83618046|NCT04177602|Trifluridine|trifluridine|mesh-list
83618047|NCT04177602|Capecitabine|capecitabine|mesh-list
83618048|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83618049|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
83618050|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618051|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618052|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
83618053|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618054|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
83618055|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83618056|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83618057|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618058|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
83618059|NCT03868956|Coagulants|coagulants|mesh-ancestor
83618060|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
83618061|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83618062|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618063|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83618064|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618065|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618066|NCT03616236|Buprenorphine|buprenorphine|mesh-list
83618067|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83618068|NCT03616236|Naloxone|naloxone|mesh-list
83618069|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83618070|NCT03616236|Narcotics|narcotics|mesh-ancestor
83618071|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618072|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618073|NCT03616236|Analgesics|analgesics|mesh-ancestor
83618074|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
83618075|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618076|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83618077|NCT03551730|Enoxaparin|enoxaparin|mesh-list
83618078|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
83618079|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
83618080|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83618081|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83618082|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618083|NCT03462342|Olaparib|olaparib|mesh-list
83618084|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83618085|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618086|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618087|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618088|NCT03366480|Paclitaxel|paclitaxel|mesh-list
83618089|NCT03366480|Carboplatin|carboplatin|mesh-list
83618090|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83618091|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618092|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
83618093|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
83618094|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
83618095|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618096|NCT03024996|Atezolizumab|atezolizumab|mesh-list
83618097|NCT03024996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83618098|NCT03024996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618099|NCT03024996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83507208|NCT02802111|Albuterol|albuterol|mesh-list
83618100|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618101|NCT02867124|Naltrexone|naltrexone|mesh-list
83618102|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83618103|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83618104|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618105|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
83618106|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618107|NCT02723994|Leucovorin|leucovorin|mesh-list
83618108|NCT02723994|Cytarabine|cytarabine|mesh-list
83618109|NCT02723994|Dexamethasone|dexamethasone|mesh-list
83618110|NCT02723994|Prednisone|prednisone|mesh-list
83618111|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
83618112|NCT02723994|Doxorubicin|doxorubicin|mesh-list
83618113|NCT02723994|Methotrexate|methotrexate|mesh-list
83618114|NCT02723994|Vincristine|vincristine|mesh-list
83618115|NCT02723994|Asparaginase|asparaginase|mesh-list
83618116|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
83618117|NCT02723994|Pegaspargase|pegaspargase|mesh-list
83618118|NCT02723994|Thioguanine|thioguanine|mesh-list
83618119|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
83618120|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83618121|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
83618122|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618123|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618124|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83618125|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
83618126|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618127|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618128|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83618129|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618130|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
83618131|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
83618132|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618133|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618134|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
83618135|NCT02723994|Hormones|hormones|mesh-ancestor
83618136|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618137|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618138|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83618139|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83618140|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83618141|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618142|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83618143|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
83618144|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83618145|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83618146|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
83618147|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618148|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83618149|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83618150|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
83618151|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618152|NCT02723994|Antidotes|antidotes|mesh-ancestor
83618153|NCT02723994|Protective Agents|protective agents|mesh-ancestor
83618154|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
83618155|NCT02723994|Vitamins|vitamins|mesh-ancestor
83618156|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
83618157|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83618158|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
83618159|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
83618160|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
83618161|NCT02534376|Simvastatin|simvastatin|mesh-list
83618162|NCT02534376|Ezetimibe|ezetimibe|mesh-list
83618163|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83618164|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83618165|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
83618166|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618167|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83618168|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83618169|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618170|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
83618171|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83618172|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83618173|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83618174|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618175|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618176|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
83618177|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618178|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618179|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83618180|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618181|NCT02065596|Fludarabine|fludarabine|mesh-list
83618182|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
83618183|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618184|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83618185|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
83618186|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618187|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83618188|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
83618189|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618190|NCT02058420|Tocotrienols|tocotrienols|mesh-list
83618191|NCT02058420|Vitamin E|vitamin e|mesh-list
83618192|NCT02058420|Tocopherols|tocopherols|mesh-list
83618193|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
83618194|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618195|NCT02058420|Protective Agents|protective agents|mesh-ancestor
83618196|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618197|NCT02058420|Vitamins|vitamins|mesh-ancestor
83618198|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
83618199|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
83618200|NCT01976286|Salicylates|salicylates|mesh-list
83618201|NCT01976286|Glycolic acid|glycolic acid|mesh-list
83618202|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618203|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
83618204|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
83618205|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618206|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83618207|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618208|NCT01976286|Analgesics|analgesics|mesh-ancestor
83618209|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
83618210|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618211|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618212|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618213|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618214|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83618215|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618216|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618217|NCT01858740|Methotrexate|methotrexate|mesh-list
83618218|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
83618219|NCT01858740|Fludarabine|fludarabine|mesh-list
83618220|NCT01858740|Thiotepa|thiotepa|mesh-list
83618221|NCT01858740|Tacrolimus|tacrolimus|mesh-list
83618222|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83618223|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
83618224|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83618225|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618226|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83618227|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
83618228|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618229|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618230|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618231|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618232|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83618233|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83618234|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
83618235|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618236|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83618237|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83618238|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83618239|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
83618240|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83618241|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
83618242|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83618243|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83618244|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83618245|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618246|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618247|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
83618248|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618249|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618250|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83618251|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618252|NCT01239030|Methylphenidate|methylphenidate|mesh-list
83618253|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83618254|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618255|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83618256|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83618257|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618258|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618259|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
83618260|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618261|NCT01086540|Acetaminophen|acetaminophen|mesh-list
83618262|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
83618263|NCT01086540|Promethazine|promethazine|mesh-list
83618264|NCT01086540|Prednisone|prednisone|mesh-list
83618265|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
83618266|NCT01086540|Rituximab|rituximab|mesh-list
83618267|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83618268|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618269|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
83618270|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618271|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618272|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618273|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
83618274|NCT01086540|Hormones|hormones|mesh-ancestor
83618275|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618276|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618277|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618278|NCT01086540|Analgesics|analgesics|mesh-ancestor
83618279|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
83618280|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618281|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
83618282|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
83618283|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
83618284|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618285|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83618286|NCT01086540|Protective Agents|protective agents|mesh-ancestor
83618287|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83618288|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83618289|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618290|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618291|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
83618292|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83618293|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
83618294|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
83618295|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618296|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618297|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83618298|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
83618299|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618300|NCT01962870|Vasopressins|vasopressins|mesh-list
83618301|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
83618302|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
83618303|NCT01962870|Coagulants|coagulants|mesh-ancestor
83618304|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83618305|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83618306|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
83618307|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618308|NCT01965366|Dexamethasone|dexamethasone|mesh-list
83618309|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618310|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
83618311|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
83618312|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618313|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618314|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618315|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
83618316|NCT01965366|Hormones|hormones|mesh-ancestor
83618317|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618318|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618319|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618320|NCT01965756|Metformin|metformin|mesh-list
83618321|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83618322|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618323|NCT01967862|Listerine|listerine|mesh-list
83618324|NCT01967862|Fluorides|fluorides|mesh-list
83618325|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
83618326|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
83618327|NCT01967862|Protective Agents|protective agents|mesh-ancestor
83618328|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618329|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83618330|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618331|NCT01976988|Heparin|heparin|mesh-list
83618332|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
83618333|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83618334|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83618335|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618336|NCT01980654|Rituximab|rituximab|mesh-list
83618337|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83618338|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618339|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
83618340|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618341|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618342|NCT01984398|Citric Acid|citric acid|mesh-list
83618343|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
83618344|NCT01984398|Enclomiphene|enclomiphene|mesh-list
83618345|NCT01984398|Clomiphene|clomiphene|mesh-list
83618346|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
83618347|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
83618348|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83618349|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
83618350|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
83618351|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618352|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83618353|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
83618354|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618355|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618356|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83618357|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
83618358|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83618359|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83076376|NCT02290470|Hormones|hormones|mesh-ancestor
83618360|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83618361|NCT01987752|Timolol|timolol|mesh-list
83618362|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83618363|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83618364|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
83618365|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83618366|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618367|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83618368|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83618369|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618370|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618371|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618372|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83618373|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83618374|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83618375|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83618376|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83618377|NCT01988922|Ketamine|ketamine|mesh-list
83618378|NCT01988922|Analgesics|analgesics|mesh-ancestor
83618379|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
83618380|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618381|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618382|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83618383|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83618384|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
83618385|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
83618386|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618387|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83618388|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83618389|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618390|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618391|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
83618392|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83618393|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83618394|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618395|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618396|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618397|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618398|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
83618399|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
83618400|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618401|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
83618402|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83618403|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
83618404|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
83618405|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83618406|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83618407|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618408|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
83618409|NCT01998438|Coagulants|coagulants|mesh-ancestor
83618410|NCT01999530|Prazosin|prazosin|mesh-list
83618411|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83618412|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83618413|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83618414|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83618415|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618416|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618417|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618418|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618419|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83618420|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
83618421|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83618422|NCT01999920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83618423|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83618424|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618425|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618426|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618427|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
83618428|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618429|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83618430|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83618431|NCT02002650|Indomethacin|indomethacin|mesh-list
83618432|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83618433|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618434|NCT02002650|Analgesics|analgesics|mesh-ancestor
83618435|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
83618436|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618437|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618438|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618439|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618440|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
83618441|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
83618442|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83618443|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83618444|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618445|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618446|NCT02004132|Testosterone|testosterone|mesh-list
83618447|NCT02004132|Androgens|androgens|mesh-ancestor
83618448|NCT02004132|Hormones|hormones|mesh-ancestor
83618449|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618450|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618451|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
83618452|NCT02004366|Linagliptin|linagliptin|mesh-list
83618453|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83618454|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618455|NCT02004366|Incretins|incretins|mesh-ancestor
83618456|NCT02004366|Hormones|hormones|mesh-ancestor
83618457|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618458|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83618459|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
83618460|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618461|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618462|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
83618463|NCT02004990|Povidone|povidone|mesh-list
83618464|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
83618465|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
83618466|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83618467|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618468|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
83618469|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83618470|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618471|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618472|NCT02011464|Bupivacaine|bupivacaine|mesh-list
83618473|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618474|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
83618475|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618476|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618477|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
83618478|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618479|NCT02020278|Tolvaptan|tolvaptan|mesh-list
83618480|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83618481|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618482|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
83618483|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618484|NCT02024646|Brodalumab|brodalumab|mesh-list
83618485|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83618486|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618487|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
83618488|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618489|NCT02024724|Dexamethasone|dexamethasone|mesh-list
83618490|NCT02024724|Triamcinolone|triamcinolone|mesh-list
83618491|NCT02024724|Bupivacaine|bupivacaine|mesh-list
83618492|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618493|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
83618494|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
83618495|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618496|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618497|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618498|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
83618499|NCT02024724|Hormones|hormones|mesh-ancestor
83618500|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618501|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618502|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618503|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618504|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
83618505|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618506|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
83618507|NCT02025426|Phenylephrine|phenylephrine|mesh-list
83618508|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
83618509|NCT02025426|Ephedrine|ephedrine|mesh-list
83076531|NCT03387098|Vitamins|vitamins|mesh-ancestor
83618510|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83618511|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
83618512|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
83618513|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618514|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618515|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
83618516|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83618517|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
83618518|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
83618519|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83618520|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83618521|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83618522|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618523|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618524|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618525|NCT02025426|Protective Agents|protective agents|mesh-ancestor
83618526|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83618527|NCT02028780|Dabigatran|dabigatran|mesh-list
83618528|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
83618529|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83618530|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
83618531|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618532|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618533|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
83618534|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
83618535|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83618536|NCT02029872|Mupirocin|mupirocin|mesh-list
83618537|NCT02029872|Calcium|calcium|mesh-list
83618538|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83618539|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618540|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83618541|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618542|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
83618543|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618544|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83618545|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83618546|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618547|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618548|NCT02030574|Gemcitabine|gemcitabine|mesh-list
83618549|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618550|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83618551|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
83618552|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618553|NCT02032212|Nicotine|nicotine|mesh-list
83618554|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83618555|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
83618556|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618557|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618558|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83618559|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83618560|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
83618561|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618562|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618563|NCT02032758|Propranolol|propranolol|mesh-list
83618564|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83618565|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83618566|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618567|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618568|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618569|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618570|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83618571|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83618572|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
83618573|NCT02036424|Dexamethasone|dexamethasone|mesh-list
83618574|NCT02036424|Bevacizumab|bevacizumab|mesh-list
83618575|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83618576|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618577|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83618578|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83618579|NCT02036424|Growth Substances|growth substances|mesh-ancestor
83618580|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618581|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
83618582|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618583|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
83618584|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
83618585|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618587|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
83618588|NCT02036424|Hormones|hormones|mesh-ancestor
83618589|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618590|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618591|NCT02044380|Afatinib|afatinib|mesh-list
83618592|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618593|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83618594|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618595|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618596|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
83618597|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83618598|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83618599|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
83618600|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618601|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618602|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618603|NCT02047032|Urological Agents|urological agents|mesh-ancestor
83618604|NCT02047500|Paclitaxel|paclitaxel|mesh-list
83618605|NCT02047500|Gemcitabine|gemcitabine|mesh-list
83618606|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83618607|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618608|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
83618609|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
83618610|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
83618611|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618612|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83618613|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
83618614|NCT02054754|HU 211|hu 211|mesh-list
83618615|NCT02054754|Dronabinol|dronabinol|mesh-list
83618616|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83618617|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
83618618|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
83618619|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618620|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618621|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618622|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83618623|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83618624|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618625|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618626|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83618627|NCT02054754|Protective Agents|protective agents|mesh-ancestor
83618628|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
83618629|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83618630|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618631|NCT02054754|Analgesics|analgesics|mesh-ancestor
83618632|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
83618633|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83618634|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83618635|NCT02054754|Hormones|hormones|mesh-ancestor
83618636|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618637|NCT02057640|Dexamethasone|dexamethasone|mesh-list
83618638|NCT02057640|Ixazomib|ixazomib|mesh-list
83618639|NCT02057640|Panobinostat|panobinostat|mesh-list
83618640|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618641|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
83618642|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
83618643|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618644|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618645|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618646|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
83618647|NCT02057640|Hormones|hormones|mesh-ancestor
83618648|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618649|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618650|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618651|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
83618652|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618653|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618654|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83618655|NCT02059902|Lidocaine|lidocaine|mesh-list
83618656|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618657|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
83618658|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618659|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618660|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
83618661|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618662|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83618663|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83618664|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83618665|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618666|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618667|NCT02061384|Calcitriol|calcitriol|mesh-list
83618668|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83618669|NCT02061384|Tretinoin|tretinoin|mesh-list
83618670|NCT02061384|Isotretinoin|isotretinoin|mesh-list
83618671|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618672|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
83618673|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618674|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83618675|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618676|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83618677|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618678|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618679|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83618680|NCT02061384|Vitamins|vitamins|mesh-ancestor
83618681|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
83618682|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83618683|NCT02061774|Acetaminophen|acetaminophen|mesh-list
83618684|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618685|NCT02061774|Analgesics|analgesics|mesh-ancestor
83618686|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
83618687|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618688|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618689|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
83618690|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
83618691|NCT02062710|Promethazine|promethazine|mesh-list
83618692|NCT02062710|Phenylephrine|phenylephrine|mesh-list
83618693|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
83618694|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
83618695|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83618696|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
83618697|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
83618698|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618699|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618700|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
83618701|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83618702|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
83618703|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
83618704|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83618705|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83618706|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83618707|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618708|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618709|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618710|NCT02062710|Protective Agents|protective agents|mesh-ancestor
83618711|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83618712|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83618713|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618714|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618715|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
83618716|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
83618717|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
83618718|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618719|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83618720|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
83618721|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
83618722|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83618723|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
83618724|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618725|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
83618726|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83618727|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83618728|NCT02064582|Leuprolide|leuprolide|mesh-list
83618729|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83618730|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
83618731|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83618732|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618733|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618734|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618735|NCT02069184|Acetaminophen|acetaminophen|mesh-list
83618736|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618737|NCT02069184|Analgesics|analgesics|mesh-ancestor
83618738|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
83618739|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618740|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618741|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
83618742|NCT02134314|Complement C1s|complement c1s|mesh-list
83618743|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83618744|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83618745|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
83618746|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618747|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83618748|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83618749|NCT02135016|Lidocaine|lidocaine|mesh-list
83618750|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618751|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
83618752|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618753|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618754|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
83618755|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618756|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83618757|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83618758|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83618759|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618760|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618761|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
83618762|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83618763|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83618764|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618765|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618766|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618767|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618768|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
83618769|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
83618770|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618771|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
83618772|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83618773|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
83618774|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
83618775|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83618776|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
83618777|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
83618778|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618779|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618780|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618781|NCT02139540|Analgesics|analgesics|mesh-ancestor
83618782|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
83618783|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618784|NCT02148588|Lidocaine|lidocaine|mesh-list
83618785|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618786|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
83618787|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618788|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618789|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
83618790|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618791|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83618792|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83618793|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83618794|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618795|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618796|NCT02149524|Trastuzumab|trastuzumab|mesh-list
83618797|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83618798|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618799|NCT02154048|Dexamethasone|dexamethasone|mesh-list
83618800|NCT02154048|Ropivacaine|ropivacaine|mesh-list
83618801|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618802|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
83618803|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
83076829|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83076830|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83076831|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076832|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076833|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618804|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618805|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618806|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618807|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
83618808|NCT02154048|Hormones|hormones|mesh-ancestor
83618809|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618810|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83618811|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618812|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618813|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
83618814|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618815|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
83618816|NCT02156154|Acetaminophen|acetaminophen|mesh-list
83618817|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618818|NCT02156154|Analgesics|analgesics|mesh-ancestor
83618819|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
83618820|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618821|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618822|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
83618823|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
83618824|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83618825|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618826|NCT02159976|Amoxicillin|amoxicillin|mesh-list
83618827|NCT02159976|Metronidazole|metronidazole|mesh-list
83618828|NCT02159976|Clarithromycin|clarithromycin|mesh-list
83618829|NCT02159976|Tetracycline|tetracycline|mesh-list
83618830|NCT02159976|Pantoprazole|pantoprazole|mesh-list
83618831|NCT02159976|Bismuth|bismuth|mesh-list
83618832|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83618833|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618834|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83618835|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83618836|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83618837|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618838|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618839|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83618840|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83618841|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83618842|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83618843|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83618844|NCT02159976|Antacids|antacids|mesh-ancestor
83618845|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
83618846|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83618847|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83618848|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83618849|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618850|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618851|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
83618852|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618853|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618854|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83618855|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618856|NCT02160990|Exenatide|exenatide|mesh-list
83618857|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83618858|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618859|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83618860|NCT02160990|Incretins|incretins|mesh-ancestor
83618861|NCT02160990|Hormones|hormones|mesh-ancestor
83618862|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618863|NCT02164422|Guanfacine|guanfacine|mesh-list
83618864|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83618865|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83618866|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83618867|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83618868|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
83618869|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618870|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618871|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618872|NCT02170662|Bimatoprost|bimatoprost|mesh-list
83618873|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83618874|NCT02173392|Brodalumab|brodalumab|mesh-list
83618875|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
83618876|NCT02178540|Tobramycin|tobramycin|mesh-list
83618877|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83618878|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618879|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
83618880|NCT02178696|Citalopram|citalopram|mesh-list
83618881|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83618882|NCT02178696|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83618883|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83618884|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618885|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618886|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618887|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
83618888|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618889|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83618890|NCT02179788|Metformin|metformin|mesh-list
83618891|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83618892|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618893|NCT02180100|Fluconazole|fluconazole|mesh-list
83618894|NCT02180100|Terconazole|terconazole|mesh-list
83618895|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
83618896|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83618897|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83618898|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83618899|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618900|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618901|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83618902|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
83618903|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83618904|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618905|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83618906|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83618907|NCT02181426|Ketorolac|ketorolac|mesh-list
83618908|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83618909|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618910|NCT02181426|Analgesics|analgesics|mesh-ancestor
83618911|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
83618912|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618913|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618914|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618915|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618916|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83618917|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618918|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618919|NCT02192814|Lacosamide|lacosamide|mesh-list
83618920|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
83618921|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83618922|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83618923|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618924|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618925|NCT02195232|Quercetin|quercetin|mesh-list
83618926|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
83618927|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618928|NCT02195232|Protective Agents|protective agents|mesh-ancestor
83618929|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618930|NCT02196168|Cisplatin|cisplatin|mesh-list
83618931|NCT02196168|Adavosertib|adavosertib|mesh-list
83618932|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618933|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618934|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618935|NCT02201394|Aspirin|aspirin|mesh-list
83618936|NCT02201394|Ticagrelor|ticagrelor|mesh-list
83618937|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83618938|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83618939|NCT02201394|Analgesics|analgesics|mesh-ancestor
83618940|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
83618941|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618942|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618943|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83618944|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83618945|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83618946|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83618947|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618948|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83618949|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83618950|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618951|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
83618952|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83618953|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83618954|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83618955|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
83618956|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618957|NCT02203578|Romidepsin|romidepsin|mesh-list
83618958|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83618959|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83618960|NCT02203578|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83618961|NCT02203578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83618962|NCT02203578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618963|NCT02206776|Midazolam|midazolam|mesh-list
83618964|NCT02206776|Ketamine|ketamine|mesh-list
83618965|NCT02206776|Analgesics|analgesics|mesh-ancestor
83618966|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
83618967|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618968|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618969|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83618970|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83618971|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
83618972|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
83618973|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618974|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83618975|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83618976|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83618977|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618978|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83618979|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83618980|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83618981|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83618982|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83618983|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
83618984|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
83618985|NCT02209272|Lidocaine|lidocaine|mesh-list
83618986|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
83618987|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
83618988|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
83618989|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83618990|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83618991|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
83618992|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83618993|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83618994|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83618995|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83618996|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83618997|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83618998|NCT02214420|Ribavirin|ribavirin|mesh-list
83618999|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
83619000|NCT02214420|Simeprevir|simeprevir|mesh-list
83619001|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
83619002|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619003|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
83619004|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619005|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
83619006|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619007|NCT02215200|Lenograstim|lenograstim|mesh-list
83619008|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
83619009|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83619010|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83619011|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
83619012|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619013|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619014|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
83619015|NCT02218320|Dolutegravir|dolutegravir|mesh-list
83619016|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83619017|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83619018|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
83619019|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619020|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83619021|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83619022|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077055|NCT03385538|Clopidogrel|clopidogrel|mesh-list
83619023|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619024|NCT02222610|Ranibizumab|ranibizumab|mesh-list
83619025|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83619026|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83619027|NCT02222610|Growth Substances|growth substances|mesh-ancestor
83619028|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619029|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83619030|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619031|NCT02223702|Amoxicillin|amoxicillin|mesh-list
83619032|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
83619033|NCT02223702|Metronidazole|metronidazole|mesh-list
83619034|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83619035|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619036|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83619037|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83619038|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619039|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619040|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619041|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83619042|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83619043|NCT02225106|Methylphenidate|methylphenidate|mesh-list
83619044|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83619045|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619046|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83619047|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83619048|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619049|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619050|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
83619051|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619052|NCT02233296|Lasmiditan|lasmiditan|mesh-list
83619053|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83619054|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
83619055|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619056|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619057|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619058|NCT02233998|Listerine|listerine|mesh-list
83619059|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
83619060|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83619061|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619062|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
83619063|NCT02233998|Protective Agents|protective agents|mesh-ancestor
83619064|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619065|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
83619066|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
83619067|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619068|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
83619069|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619070|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619071|NCT02239380|Lorazepam|lorazepam|mesh-list
83619072|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
83619073|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
83619074|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
83619075|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619076|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619077|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619078|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83619079|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619080|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83619081|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83619082|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83619083|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
83619084|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
83619085|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619086|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619087|NCT02239770|Nicotine|nicotine|mesh-list
83619088|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83619089|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
83619090|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619091|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619092|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83619093|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83619094|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
83619095|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619096|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619097|NCT02241486|Fentanyl|fentanyl|mesh-list
83619098|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83619099|NCT02241486|Narcotics|narcotics|mesh-ancestor
83619100|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619101|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619102|NCT02241486|Analgesics|analgesics|mesh-ancestor
83619103|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
83619104|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619105|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83619106|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83619107|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
83619108|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
83619110|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83619111|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
83619112|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619113|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619114|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83619115|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83619116|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
83619117|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619118|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619119|NCT02250612|Timolol|timolol|mesh-list
83619120|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619121|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83619122|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83619123|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
83619124|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619125|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619126|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83619127|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83619128|NCT02251236|Tenofovir|tenofovir|mesh-list
83619129|NCT02251236|Emtricitabine|emtricitabine|mesh-list
83619130|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83619131|NCT02251236|Cobicistat|cobicistat|mesh-list
83619132|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83619133|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83619134|NCT02251236|Elvitegravir|elvitegravir|mesh-list
83619135|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
83619136|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619137|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83619138|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83619139|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619140|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619141|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83619142|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83619143|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83619144|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83619145|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83619146|NCT02251938|Sirolimus|sirolimus|mesh-list
83619147|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83619148|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619149|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83619150|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619151|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
83619152|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619153|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
83619154|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619155|NCT02258412|Ethanol|ethanol|mesh-list
83619156|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83619157|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
83619158|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619159|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619160|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619161|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
83619162|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
83619163|NCT02260440|Azacitidine|azacitidine|mesh-list
83619164|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83619165|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619166|NCT02260440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83619167|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619168|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83619169|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
83619170|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619171|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
83619172|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83619173|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619174|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619175|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619176|NCT02267538|Analgesics|analgesics|mesh-ancestor
83619177|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
83619178|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619179|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83619180|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83619181|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83619182|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
83619183|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619184|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619185|NCT02267772|Acetaminophen|acetaminophen|mesh-list
83619186|NCT02267772|Morphine|morphine|mesh-list
83619187|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83619188|NCT02267772|Narcotics|narcotics|mesh-ancestor
83619189|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619190|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619191|NCT02267772|Analgesics|analgesics|mesh-ancestor
83619192|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
83619193|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619194|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619195|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
83619196|NCT02271906|Afatinib|afatinib|mesh-list
83619197|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619198|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83619199|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619200|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619201|NCT02274870|Bupivacaine|bupivacaine|mesh-list
83619202|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
83619203|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
83619204|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619205|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619206|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
83619207|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619208|NCT02276274|Alogliptin|alogliptin|mesh-list
83619209|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83619210|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619211|NCT02276274|Incretins|incretins|mesh-ancestor
83619212|NCT02276274|Hormones|hormones|mesh-ancestor
83619213|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619214|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83619215|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
83619216|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619217|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619218|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83619219|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
83619220|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83619221|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83619222|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619223|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619224|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
83619225|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83619226|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
83619227|NCT02282514|Rituximab|rituximab|mesh-list
83619228|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
83619229|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619230|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
83619231|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619232|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619233|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83619234|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
83619235|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619236|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619237|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83619238|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83619239|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619240|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
83619241|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
83619242|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619243|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619244|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
83619245|NCT02282514|Hormones|hormones|mesh-ancestor
83619246|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619247|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83619248|NCT02282514|Protective Agents|protective agents|mesh-ancestor
83619249|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83619250|NCT02282904|Sirolimus|sirolimus|mesh-list
83619251|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
83619252|NCT02282904|Busulfan|busulfan|mesh-list
83619253|NCT02282904|Fludarabine|fludarabine|mesh-list
83619254|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619255|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
83619256|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619257|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619258|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83619259|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
83619260|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619261|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619262|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83619263|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83619264|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619265|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83619266|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
83619267|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83619268|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
83619269|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83619270|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83619271|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619272|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619273|NCT02284386|Bupivacaine|bupivacaine|mesh-list
83619274|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
83619275|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
83619276|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619277|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619278|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
83619279|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619280|NCT02284464|Prednisone|prednisone|mesh-list
83619281|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619282|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
83619283|NCT02284464|Hormones|hormones|mesh-ancestor
83619284|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619285|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619286|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83619287|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619288|NCT02284854|Carbamazepine|carbamazepine|mesh-list
83619289|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83619290|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
83619291|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
83619292|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83619293|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619294|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619295|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83619296|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619297|NCT02284854|Analgesics|analgesics|mesh-ancestor
83619298|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
83619299|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619300|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83619301|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619302|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619303|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83619304|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83619305|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83619306|NCT02285634|Lidocaine|lidocaine|mesh-list
83619307|NCT02285634|Phenylephrine|phenylephrine|mesh-list
83619308|NCT02285634|Epinephrine|epinephrine|mesh-list
83619309|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
83619310|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
83619311|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
83619312|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619313|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619314|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
83619315|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619316|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83619317|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83619318|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83619319|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619320|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619321|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83077359|NCT04651348|Antibodies|antibodies|mesh-list
83619322|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83619323|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83619324|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619325|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83619326|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83619327|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
83619328|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83619329|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
83619330|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
83619331|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
83619332|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83619333|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83619334|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
83619335|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83619336|NCT02285634|Protective Agents|protective agents|mesh-ancestor
83619337|NCT02287350|Diclofenac|diclofenac|mesh-list
83619338|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83619339|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619340|NCT02287350|Analgesics|analgesics|mesh-ancestor
83619341|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
83619342|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619343|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619344|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619345|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619346|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83619347|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619348|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619349|NCT02288364|Lidocaine|lidocaine|mesh-list
83619350|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
83619351|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
83619352|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619353|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619354|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
83619355|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619356|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83619357|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83619358|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83619359|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619360|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619361|NCT02289222|Dexamethasone|dexamethasone|mesh-list
83619362|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
83619363|NCT02289222|Pomalidomide|pomalidomide|mesh-list
83619364|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619365|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
83619366|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
83619367|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619368|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619369|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619370|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
83619371|NCT02289222|Hormones|hormones|mesh-ancestor
83619372|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619373|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83619374|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619375|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83619376|NCT02289222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83619377|NCT02289222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619378|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
83619379|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83619380|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83619381|NCT02289222|Growth Substances|growth substances|mesh-ancestor
83619382|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
83619383|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
83619384|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83619385|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
83619386|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619387|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619388|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83619389|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
83619390|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83619391|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83619392|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83619393|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
83619394|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077430|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619395|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619396|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
83619397|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
83619398|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619399|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83619400|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619401|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83619402|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83619403|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83619404|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619405|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619406|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83619407|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619408|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619409|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
83619410|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619411|NCT02299050|Bromocriptine|bromocriptine|mesh-list
83619412|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83619413|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83619414|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83619415|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619416|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619417|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
83619418|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
83619419|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619420|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619421|NCT02302092|Cefepime|cefepime|mesh-list
83619422|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83619423|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619424|NCT02303184|Aflibercept|aflibercept|mesh-list
83619425|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83619426|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83619427|NCT02303184|Growth Substances|growth substances|mesh-ancestor
83619428|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619429|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
83619430|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619431|NCT02304432|Cycloserine|cycloserine|mesh-list
83619432|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83619433|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619434|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83619435|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
83619436|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83619437|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
83619438|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619439|NCT02307318|Hemostatics|hemostatics|mesh-list
83619440|NCT02307318|Coagulants|coagulants|mesh-ancestor
83619441|NCT02312622|Irinotecan|irinotecan|mesh-list
83619442|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
83619443|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83619444|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83619445|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619446|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619447|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619448|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83619449|NCT02314104|Ropivacaine|ropivacaine|mesh-list
83619450|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
83619451|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
83619452|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619453|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619454|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
83619455|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619456|NCT02321748|Montelukast|montelukast|mesh-list
83619457|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83619458|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
83619459|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83619460|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
83619461|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619462|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619463|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83619464|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83619465|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077504|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619466|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83619467|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83619468|NCT02330094|Gabapentin|gabapentin|mesh-list
83619469|NCT02330094|Analgesics|analgesics|mesh-ancestor
83619470|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
83619471|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619472|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619473|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
83619474|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83619475|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83619476|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619477|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83619478|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83619479|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83619480|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619481|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619482|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
83619483|NCT02330172|Neostigmine|neostigmine|mesh-list
83619484|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83619485|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619486|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619487|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
83619488|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619489|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619490|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83619491|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
83619492|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619493|NCT02331108|Propofol|propofol|mesh-list
83619494|NCT02331108|Anesthetics|anesthetics|mesh-list
83619495|NCT02331108|Sevoflurane|sevoflurane|mesh-list
83619496|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83619497|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619498|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619499|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83619500|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
83619501|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83619502|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83619503|NCT02332902|Everolimus|everolimus|mesh-list
83619504|NCT02332902|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83619505|NCT02332902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83619506|NCT02332902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619507|NCT02332902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619508|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619509|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
83619510|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619511|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619512|NCT02340156|Temozolomide|temozolomide|mesh-list
83619513|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83619514|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
83619515|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619516|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619517|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
83619518|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
83619519|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83619520|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83619521|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83619522|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619523|NCT02351700|Ibuprofen|ibuprofen|mesh-list
83619524|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83619525|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619526|NCT02351700|Analgesics|analgesics|mesh-ancestor
83619527|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
83619528|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619529|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619530|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619531|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619532|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83619533|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619534|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619535|NCT02353806|Amlodipine|amlodipine|mesh-list
83619536|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83619537|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83619538|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077579|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83619539|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619540|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83619541|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619542|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
83619543|NCT02354352|Eplerenone|eplerenone|mesh-list
83619544|NCT02354352|Spironolactone|spironolactone|mesh-list
83619545|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83619546|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
83619547|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619548|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619549|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83619550|NCT02354352|Diuretics|diuretics|mesh-ancestor
83619551|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
83619552|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83619553|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
83619554|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619555|NCT02357706|Acetaminophen|acetaminophen|mesh-list
83619556|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619557|NCT02357706|Analgesics|analgesics|mesh-ancestor
83619558|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
83619559|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619560|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619561|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
83619562|NCT02359110|Gabapentin|gabapentin|mesh-list
83619563|NCT02359110|Analgesics|analgesics|mesh-ancestor
83619564|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
83619565|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619566|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619567|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
83619568|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83619569|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83619570|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619571|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83619572|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83619573|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83619574|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619575|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619576|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
83619577|NCT02360124|Fluorides|fluorides|mesh-list
83619578|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
83619579|NCT02360124|Protective Agents|protective agents|mesh-ancestor
83619580|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619581|NCT02369172|Bupropion|bupropion|mesh-list
83619582|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83619583|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
83619584|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83619585|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83619586|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83619587|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83619588|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619589|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
83619590|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619591|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619592|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83619593|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83619594|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619595|NCT02374164|Febuxostat|febuxostat|mesh-list
83619596|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
83619597|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619598|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
83619599|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83619600|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83619601|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619602|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
83619603|NCT02374398|Coagulants|coagulants|mesh-ancestor
83619604|NCT02377752|Doxorubicin|doxorubicin|mesh-list
83619605|NCT02377752|Olaratumab|olaratumab|mesh-list
83619606|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83619607|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619608|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83619609|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83619610|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619611|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619612|NCT02379858|Alvimopan|alvimopan|mesh-list
83077667|NCT03377348|Hormones|hormones|mesh-ancestor
83619613|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619614|NCT02384070|Aspirin|aspirin|mesh-list
83619615|NCT02384070|Bivalirudin|bivalirudin|mesh-list
83619616|NCT02384070|Clopidogrel|clopidogrel|mesh-list
83619617|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83619618|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619619|NCT02384070|Analgesics|analgesics|mesh-ancestor
83619620|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
83619621|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619622|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619623|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619624|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619625|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83619626|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83619627|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619628|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83619629|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83619630|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619631|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
83619632|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83619633|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83619634|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83619635|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
83619636|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619637|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
83619638|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83619639|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83619640|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
83619641|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83619642|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83619643|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83619644|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83619645|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83619646|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83619647|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619648|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619649|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619650|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
83619651|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
83619652|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
83619653|NCT02391714|Povidone|povidone|mesh-list
83619654|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83508757|NCT02994602|Hormones|hormones|mesh-ancestor
83619655|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619656|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
83619657|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
83619658|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
83619659|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83619660|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
83619661|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
83619662|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619663|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619664|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619665|NCT02391714|Analgesics|analgesics|mesh-ancestor
83619666|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
83619667|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619668|NCT02395692|Temozolomide|temozolomide|mesh-list
83619669|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83619670|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
83619671|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619672|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619673|NCT02397954|Ranibizumab|ranibizumab|mesh-list
83619674|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83619675|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83619676|NCT02397954|Growth Substances|growth substances|mesh-ancestor
83619677|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619678|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
83619679|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619680|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83619681|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83619682|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83619683|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619684|NCT02401542|Docetaxel|docetaxel|mesh-list
83619685|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619686|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83619687|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83619688|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83619689|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619690|NCT02411916|Misoprostol|misoprostol|mesh-list
83619691|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83619692|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
83619693|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83619694|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619695|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83619696|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619697|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
83619698|NCT02413320|Paclitaxel|paclitaxel|mesh-list
83619699|NCT02413320|Docetaxel|docetaxel|mesh-list
83619700|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
83619701|NCT02413320|Carboplatin|carboplatin|mesh-list
83619702|NCT02413320|Doxorubicin|doxorubicin|mesh-list
83619703|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83619704|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619705|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83619706|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83619707|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83619708|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619709|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619710|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
83619711|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619712|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619713|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83619714|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
83619715|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83619716|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83619717|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83619718|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83619719|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619720|NCT05718882|Lenvatinib|lenvatinib|mesh-list
83619721|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619722|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83619723|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619724|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619725|NCT05718492|Leucovorin|leucovorin|mesh-list
83619726|NCT05718492|Fluorouracil|fluorouracil|mesh-list
83619727|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
83619728|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
83508833|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83619729|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619730|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83619731|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619732|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619733|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
83619734|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619735|NCT05718492|Antidotes|antidotes|mesh-ancestor
83619736|NCT05718492|Protective Agents|protective agents|mesh-ancestor
83619737|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
83619738|NCT05718492|Vitamins|vitamins|mesh-ancestor
83619739|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
83619740|NCT05718258|Venglustat|venglustat|mesh-list
83619741|NCT05718258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619742|NCT05718258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619743|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
83619744|NCT05718024|Remifentanil|remifentanil|mesh-list
83619745|NCT05718024|Propofol|propofol|mesh-list
83619746|NCT05718024|Esketamine|esketamine|mesh-list
83619747|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83619748|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619749|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619750|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83619751|NCT05718024|Analgesics|analgesics|mesh-ancestor
83619752|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
83619753|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619754|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83619755|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83619756|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83619757|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
83619758|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619759|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619760|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83619761|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
83619762|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
83619763|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83619764|NCT05718024|Narcotics|narcotics|mesh-ancestor
83619765|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
83619766|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83619767|NCT05717790|Gemcitabine|gemcitabine|mesh-list
83619768|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
83619769|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619770|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83619771|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
83619772|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619773|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83619774|NCT05679258|Daratumumab|daratumumab|mesh-list
83619775|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83619776|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619777|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
83619778|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619779|NCT05602272|Anesthetics|anesthetics|mesh-list
83619780|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619781|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619782|NCT05589792|Acetazolamide|acetazolamide|mesh-list
83619783|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
83619784|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83619785|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83619786|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619787|NCT05589792|Diuretics|diuretics|mesh-ancestor
83619788|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
83619789|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619790|NCT05543694|Bupivacaine|bupivacaine|mesh-list
83619791|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
83619792|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
83619793|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619794|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619795|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
83619796|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619797|NCT05495568|Adalimumab|adalimumab|mesh-list
83619798|NCT05495568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83619799|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619800|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619801|NCT05358834|Melatonin|melatonin|mesh-list
83619802|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
83619803|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619804|NCT05358834|Protective Agents|protective agents|mesh-ancestor
83619805|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619806|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619807|NCT05317806|Metformin|metformin|mesh-list
83619808|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83619809|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619810|NCT05273346|Analgesics|analgesics|mesh-list
83619811|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
83619812|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619813|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619814|NCT05105256|Prednisolone|prednisolone|mesh-list
83619815|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619816|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
83619817|NCT05105256|Hormones|hormones|mesh-ancestor
83619818|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619819|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619820|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83619821|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619822|NCT04967196|Nivolumab|nivolumab|mesh-list
83619823|NCT04967196|Ipilimumab|ipilimumab|mesh-list
83619824|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83619825|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619826|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83619827|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619828|NCT04916886|Vaccines|vaccines|mesh-list
83619829|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
83619830|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619831|NCT04907682|Ribavirin|ribavirin|mesh-list
83619832|NCT04907682|Favipiravir|favipiravir|mesh-list
83619833|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
83619834|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619835|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
83619836|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619837|NCT04840992|Vaccines|vaccines|mesh-list
83619838|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
83619839|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619840|NCT04793022|Anesthetics|anesthetics|mesh-list
83619841|NCT04793022|Propofol|propofol|mesh-list
83619842|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619843|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619844|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83619845|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83619846|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
83619847|NCT04776018|Daratumumab|daratumumab|mesh-list
83619848|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619849|NCT04750902|Listerine|listerine|mesh-list
83619850|NCT04750902|Fluorides|fluorides|mesh-list
83619851|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
83619852|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
83619853|NCT04750902|Protective Agents|protective agents|mesh-ancestor
83619854|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619855|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83619856|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619857|NCT04621500|Vitamin D|vitamin d|mesh-list
83619858|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
83619859|NCT04621500|Vitamins|vitamins|mesh-ancestor
83619860|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
83619861|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619862|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83619863|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83619864|NCT04567524|Risperidone|risperidone|mesh-list
83619865|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83619866|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
83619867|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619868|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619869|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619870|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83619871|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83619872|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619873|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83619874|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83619875|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
83619876|NCT04547790|Psyllium|psyllium|mesh-list
83619877|NCT04547790|Cathartics|cathartics|mesh-ancestor
83619878|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619879|NCT04481412|Cetirizine|cetirizine|mesh-list
83619880|NCT04481412|Ethanol|ethanol|mesh-list
83619881|NCT04481412|Minoxidil|minoxidil|mesh-list
83619882|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83619883|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619884|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619885|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619886|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83619887|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83619888|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83619889|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
83619890|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
83619891|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619892|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619893|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83619894|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
83619895|NCT04317300|Varenicline|varenicline|mesh-list
83619896|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83619897|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83619898|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
83619899|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83619900|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619901|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619902|NCT04143204|Insulin|insulin|mesh-list
83619903|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83619904|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619905|NCT04031508|SMOFlipid|smoflipid|mesh-list
83619906|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83619907|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83619908|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83619909|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
83619910|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83619911|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
83619912|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83619913|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
83619914|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619915|NCT03252522|Micronutrients|micronutrients|mesh-list
83619916|NCT03252522|Trace Elements|trace elements|mesh-list
83619917|NCT03252522|Antioxidants|antioxidants|mesh-list
83619918|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619919|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619920|NCT03252522|Protective Agents|protective agents|mesh-ancestor
83619921|NCT03191370|Anesthetics|anesthetics|mesh-list
83619922|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
83078050|NCT02293668|Letrozole|letrozole|mesh-list
83619923|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83619924|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619925|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
83619926|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619927|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
83619928|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83619929|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619930|NCT03179436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83619931|NCT03179436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619932|NCT03149874|Vaccines|vaccines|mesh-list
83619933|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
83619934|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619935|NCT02834052|Poly I-C|poly i-c|mesh-list
83619936|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
83619937|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83619938|NCT02834052|Poly ICLC|poly iclc|mesh-list
83619939|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83619940|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619941|NCT02834052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83619942|NCT02834052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619943|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
83619944|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
83619945|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619946|NCT02834052|Laxatives|laxatives|mesh-ancestor
83619947|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619948|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
83619949|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83619950|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
83619951|NCT02828358|Leucovorin|leucovorin|mesh-list
83619952|NCT02828358|Folic Acid|folic acid|mesh-list
83619953|NCT02828358|Cytarabine|cytarabine|mesh-list
83619954|NCT02828358|Dexamethasone|dexamethasone|mesh-list
83619955|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
83619956|NCT02828358|Prednisolone|prednisolone|mesh-list
83619957|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83619958|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
83619959|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83619960|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
83619961|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
83619962|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83619963|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83619964|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83619965|NCT02828358|Cortisone|cortisone|mesh-list
83619966|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
83619967|NCT02828358|Methotrexate|methotrexate|mesh-list
83619968|NCT02828358|Vincristine|vincristine|mesh-list
83619969|NCT02828358|Azacitidine|azacitidine|mesh-list
83619970|NCT02828358|Daunorubicin|daunorubicin|mesh-list
83619971|NCT02828358|Asparaginase|asparaginase|mesh-list
83619972|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
83619973|NCT02828358|Pegaspargase|pegaspargase|mesh-list
83619974|NCT02828358|Thioguanine|thioguanine|mesh-list
83619975|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83619976|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
83619977|NCT02828358|BB 1101|bb 1101|mesh-list
83619978|NCT02828358|Calcium|calcium|mesh-list
83619979|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
83619980|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
83619981|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83619982|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
83619983|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83619984|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83619985|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83619986|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
83619987|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83619988|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83619989|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83619990|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83619991|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
83619992|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
83619993|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83619994|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83619995|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
83619996|NCT02828358|Hormones|hormones|mesh-ancestor
83834853|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83619997|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83619998|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83619999|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
83620000|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620001|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83620002|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83620003|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83620004|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
83620005|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83620006|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620008|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620009|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83620010|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83620011|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
83620012|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620013|NCT02828358|Antidotes|antidotes|mesh-ancestor
83620014|NCT02828358|Protective Agents|protective agents|mesh-ancestor
83620015|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
83620016|NCT02828358|Vitamins|vitamins|mesh-ancestor
83620017|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
83620018|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620019|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620020|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620021|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620022|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83620023|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83620024|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83620025|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83620026|NCT02828358|Hematinics|hematinics|mesh-ancestor
83620027|NCT02756364|Fulvestrant|fulvestrant|mesh-list
83620028|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83620029|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620030|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83620031|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83620032|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83620033|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83620034|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620035|NCT02519322|Nivolumab|nivolumab|mesh-list
83620036|NCT02519322|Ipilimumab|ipilimumab|mesh-list
83620037|NCT02519322|Relatlimab|relatlimab|mesh-list
83620038|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
83620039|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
83620040|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620041|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620042|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620043|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620044|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
83620045|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620046|NCT02460042|Paclitaxel|paclitaxel|mesh-list
83620047|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620048|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620049|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620050|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620051|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620052|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620053|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
83620054|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
83620055|NCT02272842|Vitamins|vitamins|mesh-ancestor
83620056|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
83620057|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620058|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
83620059|NCT02272842|Hematinics|hematinics|mesh-ancestor
83620060|NCT05722548|Indomethacin|indomethacin|mesh-list
83620061|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83620062|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620063|NCT05722548|Analgesics|analgesics|mesh-ancestor
83620064|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
83620065|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620066|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620067|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83620068|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620069|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
83620070|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
83620071|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83620072|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83620073|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620074|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620075|NCT05722002|Acetaminophen|acetaminophen|mesh-list
83620076|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620077|NCT05722002|Analgesics|analgesics|mesh-ancestor
83620078|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
83620079|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620080|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620081|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
83620082|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83620083|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
83620084|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620085|NCT05721300|Interferons|interferons|mesh-list
83620086|NCT05721300|Tenofovir|tenofovir|mesh-list
83620087|NCT05721300|Entecavir|entecavir|mesh-list
83620088|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620089|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
83620090|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620091|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83620092|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83620093|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620094|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620095|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83620096|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83620097|NCT05720442|Mosapride|mosapride|mesh-list
83620098|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620099|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83620100|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83620101|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
83620102|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620103|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620104|NCT05719818|Diphosphonates|diphosphonates|mesh-list
83620105|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83620106|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620107|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
83620108|NCT05719506|Ketamine|ketamine|mesh-list
83620109|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83620110|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620111|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620112|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620113|NCT05719506|Analgesics|analgesics|mesh-ancestor
83620114|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
83620115|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620116|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83620117|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83620118|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83620119|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
83620120|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620121|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620122|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83620123|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83620124|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
83620125|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
83620126|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83620127|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83620128|NCT05717166|Hormones|hormones|mesh-list
83620129|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83620130|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620131|NCT05716932|Ranibizumab|ranibizumab|mesh-list
83620132|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83620133|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83620134|NCT05716932|Growth Substances|growth substances|mesh-ancestor
83620135|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620136|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
83620137|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620138|NCT05715840|Paclitaxel|paclitaxel|mesh-list
83620139|NCT05715840|Bevacizumab|bevacizumab|mesh-list
83620140|NCT05715840|Carboplatin|carboplatin|mesh-list
83620141|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620142|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620143|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620144|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
83078174|NCT02303106|Lamotrigine|lamotrigine|mesh-list
83620145|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620146|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620147|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620148|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83620149|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83620150|NCT05715840|Growth Substances|growth substances|mesh-ancestor
83620151|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620152|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
83620153|NCT05713734|Thrombin|thrombin|mesh-list
83620154|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
83620155|NCT05713734|Coagulants|coagulants|mesh-ancestor
83620156|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
83620157|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83620158|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620159|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620160|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620161|NCT05698758|Analgesics|analgesics|mesh-ancestor
83620162|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
83620163|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620164|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83620165|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83620166|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83620167|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83620168|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620169|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620170|NCT05683392|Insulin|insulin|mesh-list
83620171|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83620172|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620173|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
83620174|NCT05665062|Fludarabine|fludarabine|mesh-list
83620175|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620176|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
83620177|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620178|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620179|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83620180|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
83620181|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620182|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620183|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83620184|NCT05557812|Eugenol|eugenol|mesh-list
83620185|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
83620186|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
83620187|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620188|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
83620189|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83620190|NCT05557812|Protective Agents|protective agents|mesh-ancestor
83620191|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620192|NCT05557812|Hematinics|hematinics|mesh-ancestor
83620193|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620194|NCT05549466|Gemcitabine|gemcitabine|mesh-list
83620195|NCT05549466|Capecitabine|capecitabine|mesh-list
83620196|NCT05549466|Docetaxel|docetaxel|mesh-list
83620197|NCT05549466|Apatinib|apatinib|mesh-list
83620198|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620199|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
83620200|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620201|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620202|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620203|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620204|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620205|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83620206|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620207|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
83620208|NCT05436678|Celecoxib|celecoxib|mesh-list
83620209|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83620210|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620211|NCT05436678|Analgesics|analgesics|mesh-ancestor
83620212|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
83620213|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620214|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620215|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83620216|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620217|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83620218|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83620219|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620220|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620221|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83620222|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620223|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83620224|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83620225|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620226|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83620227|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83620228|NCT05425056|Sirolimus|sirolimus|mesh-list
83620229|NCT05425056|Temsirolimus|temsirolimus|mesh-list
83620230|NCT05425056|MTOR Inhibitors|mtor inhibitors|mesh-list
83620231|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83620232|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620233|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83620234|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620235|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
83620236|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620237|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
83620238|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620239|NCT05425056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83620240|NCT05425056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620241|NCT05425056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620242|NCT05352282|Fentanyl|fentanyl|mesh-list
83620243|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83620244|NCT05352282|Narcotics|narcotics|mesh-ancestor
83620245|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620246|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620247|NCT05352282|Analgesics|analgesics|mesh-ancestor
83620248|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
83620249|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620250|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83620251|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83620252|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
83620253|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
83620254|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
83620255|NCT05322330|Fludarabine|fludarabine|mesh-list
83620256|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620257|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
83620258|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620259|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620260|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83620261|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
83620262|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620263|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620264|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83620265|NCT05312892|Amlodipine|amlodipine|mesh-list
83620266|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
83620267|NCT05312892|Moxonidine|moxonidine|mesh-list
83620268|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83620269|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83620270|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620271|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83620272|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620273|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
83620274|NCT05309616|Ixekizumab|ixekizumab|mesh-list
83620275|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620276|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
83620277|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
83620278|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
83620279|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83620280|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83620281|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620282|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620283|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620284|NCT05251038|Leucovorin|leucovorin|mesh-list
83620285|NCT05251038|Paclitaxel|paclitaxel|mesh-list
83620286|NCT05251038|Gemcitabine|gemcitabine|mesh-list
83620287|NCT05251038|Fluorouracil|fluorouracil|mesh-list
83620288|NCT05251038|Irinotecan|irinotecan|mesh-list
83620289|NCT05251038|Sotorasib|sotorasib|mesh-list
83620290|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620291|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620292|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620293|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620294|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620295|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620296|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620297|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
83620298|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620299|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
83620300|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620301|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83620302|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83620303|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620304|NCT05251038|Antidotes|antidotes|mesh-ancestor
83620305|NCT05251038|Protective Agents|protective agents|mesh-ancestor
83620306|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
83620307|NCT05251038|Vitamins|vitamins|mesh-ancestor
83620308|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
83620309|NCT05251038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620310|NCT05251038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620311|NCT05217498|Istradefylline|istradefylline|mesh-list
83620312|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83620313|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83620314|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83620315|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
83620316|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620317|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620318|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620319|NCT05091372|Lenalidomide|lenalidomide|mesh-list
83620320|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
83620321|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620322|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83620323|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83620324|NCT05091372|Growth Substances|growth substances|mesh-ancestor
83620325|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
83620326|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620327|NCT05027646|Granisetron|granisetron|mesh-list
83620328|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
83620329|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
83620330|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620331|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620332|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83620333|NCT05027646|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83620334|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83620335|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
83620336|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620337|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620338|NCT04988646|Acyclovir|acyclovir|mesh-list
83620339|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
83620340|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620341|NCT04972110|Olaparib|olaparib|mesh-list
83620342|NCT04972110|Niraparib|niraparib|mesh-list
83620343|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83620344|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620345|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620346|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620347|NCT04926948|Immunomodulating Agents|immunomodulating agents|mesh-list
83620348|NCT04926948|Immunologic Factors|immunologic factors|mesh-ancestor
83620349|NCT04926948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620350|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83620351|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83620352|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620353|NCT04924062|Cisplatin|cisplatin|mesh-list
83620354|NCT04924062|Gemcitabine|gemcitabine|mesh-list
83620355|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
83620356|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620357|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620358|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
83620359|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620360|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620361|NCT04924062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620362|NCT04876638|Minocycline|minocycline|mesh-list
83620363|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83620364|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620365|NCT04754334|Insulin|insulin|mesh-list
83620366|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83620367|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620368|NCT04748796|Landiolol|landiolol|mesh-list
83620369|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83620370|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83620371|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
83620372|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620373|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620374|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620375|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83620376|NCT04625946|Metformin|metformin|mesh-list
83620377|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83620378|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620379|NCT04599816|Simendan|simendan|mesh-list
83620380|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83620381|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
83620382|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83620383|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83620384|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620385|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620386|NCT04599816|Protective Agents|protective agents|mesh-ancestor
83620387|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620388|NCT04546230|Anesthetics|anesthetics|mesh-list
83620389|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620390|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620391|NCT04534218|Aspirin|aspirin|mesh-list
83620392|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
83620393|NCT04534218|Capecitabine|capecitabine|mesh-list
83620394|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620395|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
83620396|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620397|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620398|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83620399|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
83620400|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620401|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620402|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83620403|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620404|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
83620405|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83620406|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620407|NCT04534218|Analgesics|analgesics|mesh-ancestor
83620408|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
83620409|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620410|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83620411|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83620412|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83620413|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83620414|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83620415|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620416|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
83620417|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83620418|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620419|NCT04509414|Midazolam|midazolam|mesh-list
83620420|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
83620421|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83620422|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620423|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620424|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620425|NCT04509414|Analgesics|analgesics|mesh-ancestor
83620426|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
83620427|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620428|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83620429|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83620430|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83620431|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
83620432|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620433|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620434|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83620435|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83620436|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83620437|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83620438|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83620439|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
83620440|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
83620441|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
83620442|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
83620443|NCT04480554|Naltrexone|naltrexone|mesh-list
83620444|NCT04480554|Buprenorphine|buprenorphine|mesh-list
83620445|NCT04480554|Methadone|methadone|mesh-list
83620446|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83620447|NCT04480554|Naloxone|naloxone|mesh-list
83078477|NCT04523792|Buprenorphine|buprenorphine|mesh-list
83620448|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83620449|NCT04480554|Narcotics|narcotics|mesh-ancestor
83620450|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620451|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620452|NCT04480554|Analgesics|analgesics|mesh-ancestor
83620453|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
83620454|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620455|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83620456|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83620457|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
83620458|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
83620459|NCT04320342|Beclomethasone|beclomethasone|mesh-list
83620460|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
83620461|NCT04320342|Bromides|bromides|mesh-list
83620462|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
83620463|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83620464|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
83620465|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620466|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620467|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83620468|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
83620469|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83620470|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83620471|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83620472|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
83620473|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620474|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620475|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
83620476|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83620477|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
83620478|NCT04320342|Hormones|hormones|mesh-ancestor
83620479|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83620480|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83620481|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83620482|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83620483|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
83620484|NCT04307550|Ethanol|ethanol|mesh-list
83620485|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83620486|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620487|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620488|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620489|NCT04164732|Valsartan|valsartan|mesh-list
83620490|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83620491|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83620492|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83620493|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83620494|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620495|NCT04134000|Atezolizumab|atezolizumab|mesh-list
83620496|NCT04134000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620497|NCT04134000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620498|NCT04134000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620499|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620500|NCT04095858|Methotrexate|methotrexate|mesh-list
83620501|NCT04095858|Tacrolimus|tacrolimus|mesh-list
83620502|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83620503|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
83620504|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83620505|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620506|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620507|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
83620508|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620509|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620510|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620511|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620512|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83620513|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620514|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
83620515|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620516|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83620517|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83620518|NCT03937986|Cocaine|cocaine|mesh-list
83620519|NCT03937986|Suvorexant|suvorexant|mesh-list
83620520|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
83620521|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
83620522|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620523|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078619|NCT02304198|Udenafil|udenafil|mesh-list
83620524|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
83620525|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620526|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83620527|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83620528|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83620529|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83620530|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620531|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
83620532|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620533|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83620534|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83620535|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83620536|NCT03873402|Nivolumab|nivolumab|mesh-list
83620537|NCT03873402|Ipilimumab|ipilimumab|mesh-list
83620538|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620539|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620540|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620541|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620542|NCT03813030|Lidocaine|lidocaine|mesh-list
83620543|NCT03813030|Prilocaine|prilocaine|mesh-list
83620544|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
83620545|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
83620546|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620547|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620548|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
83620549|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620550|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83620551|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83620552|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83620553|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83620554|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620555|NCT03778944|Dopamine|dopamine|mesh-list
83620556|NCT03778944|Mannitol|mannitol|mesh-list
83620557|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83620558|NCT03778944|Diuretics|diuretics|mesh-ancestor
83620559|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
83620560|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620561|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83620562|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
83620563|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
83620564|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620565|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
83620566|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620567|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620568|NCT03778944|Protective Agents|protective agents|mesh-ancestor
83620569|NCT03653052|Durvalumab|durvalumab|mesh-list
83620570|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620571|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620572|NCT03640728|Tenofovir|tenofovir|mesh-list
83620573|NCT03640728|Entecavir|entecavir|mesh-list
83620574|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
83620575|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620576|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83620577|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83620578|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620579|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620580|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83620581|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83620582|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
83620583|NCT03606174|Nivolumab|nivolumab|mesh-list
83620584|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620585|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620586|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620587|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620588|NCT03535272|Bismuth|bismuth|mesh-list
83620589|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83620590|NCT03535272|Antacids|antacids|mesh-ancestor
83620591|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620592|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83620593|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
83620594|NCT03529110|Trastuzumab|trastuzumab|mesh-list
83620595|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83620596|NCT03529110|Maytansine|maytansine|mesh-list
83620597|NCT03529110|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83834854|NCT00101348|Growth Substances|growth substances|mesh-ancestor
83620598|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620599|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620600|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620602|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620603|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620604|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620605|NCT03529110|Immunotoxins|immunotoxins|mesh-ancestor
83620606|NCT03529110|Immunoconjugates|immunoconjugates|mesh-ancestor
83620607|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
83620608|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620609|NCT03502746|Nivolumab|nivolumab|mesh-list
83620610|NCT03502746|Ramucirumab|ramucirumab|mesh-list
83620611|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620612|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620613|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620614|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620615|NCT03436368|Anesthetics|anesthetics|mesh-list
83620616|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620617|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620618|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83620619|NCT03393780|Hormones|hormones|mesh-ancestor
83620620|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83620621|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620622|NCT03367572|Dexamethasone|dexamethasone|mesh-list
83620623|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
83620624|NCT03367572|Olanzapine|olanzapine|mesh-list
83620625|NCT03367572|Palonosetron|palonosetron|mesh-list
83620626|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
83620627|NCT03367572|Ichthammol|ichthammol|mesh-list
83620628|NCT03367572|BB 1101|bb 1101|mesh-list
83620629|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83620630|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
83620631|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
83620632|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620633|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620634|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83620635|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
83620636|NCT03367572|Hormones|hormones|mesh-ancestor
83620637|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83620638|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83620639|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620640|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83620641|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83620642|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620643|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83620644|NCT03367572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83620645|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83620646|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83620647|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620648|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620649|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
83620650|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
83620651|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620652|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83620653|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83620654|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620655|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83620656|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
83620657|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
83620658|NCT03321630|Lenvatinib|lenvatinib|mesh-list
83620659|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620660|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620661|NCT03321630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620662|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620663|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83620664|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620665|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83620666|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620667|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620668|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83620669|NCT03249870|Immunotoxins|immunotoxins|mesh-ancestor
83620670|NCT03249870|Immunoconjugates|immunoconjugates|mesh-ancestor
83620671|NCT03249870|Immunologic Factors|immunologic factors|mesh-ancestor
83620672|NCT03249870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620673|NCT03212742|Temozolomide|temozolomide|mesh-list
83620674|NCT03212742|Olaparib|olaparib|mesh-list
83620675|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83620676|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
83620677|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620678|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620679|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83620680|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620681|NCT03202758|Durvalumab|durvalumab|mesh-list
83620682|NCT03202758|Tremelimumab|tremelimumab|mesh-list
83620683|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620684|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620685|NCT03122262|Tenofovir|tenofovir|mesh-list
83620686|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83620687|NCT03122262|Dolutegravir|dolutegravir|mesh-list
83620688|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83620689|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
83620690|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620691|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83620692|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83620693|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620694|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620695|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83620696|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83620697|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83620698|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83620699|NCT03051282|Enalapril|enalapril|mesh-list
83620700|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83620701|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
83620702|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620703|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620704|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83620705|NCT03042546|Calcium|calcium|mesh-list
83509820|NCT04350281|Interferons|interferons|mesh-list
83620706|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83620707|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620708|NCT02748564|Aldesleukin|aldesleukin|mesh-list
83620709|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
83620710|NCT02748564|Interleukin-2|interleukin-2|mesh-list
83620711|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620712|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620713|NCT02748564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620714|NCT02748564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620715|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620716|NCT02748564|Analgesics|analgesics|mesh-ancestor
83620717|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
83620718|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620719|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620720|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83620721|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83620722|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
83620723|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620724|NCT02734602|Ketamine|ketamine|mesh-list
83620725|NCT02734602|Analgesics|analgesics|mesh-ancestor
83620726|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
83620727|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620728|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620729|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83620730|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83620731|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
83620732|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
83620733|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620734|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83620735|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83620736|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620737|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620738|NCT02663622|Methotrexate|methotrexate|mesh-list
83620739|NCT02663622|Tacrolimus|tacrolimus|mesh-list
83620740|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83620741|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
83620742|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83620743|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620744|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620745|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
83620746|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620747|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620748|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620749|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620750|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83620751|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620752|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
83620753|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620754|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83620755|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83620757|NCT02420652|Metformin|metformin|mesh-list
83620758|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83620759|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620760|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83620761|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83620762|NCT02420652|Analgesics|analgesics|mesh-ancestor
83620763|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
83620764|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620765|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83620766|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620767|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83620768|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83620769|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620770|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83620771|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83620772|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620773|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
83620774|NCT02257242|Rituximab|rituximab|mesh-list
83620775|NCT02257242|Vincristine|vincristine|mesh-list
83620776|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83620777|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620778|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620779|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
83509891|NCT01637090|Everolimus|everolimus|mesh-list
83620780|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620781|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620782|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620783|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620784|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620785|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620786|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620787|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83620788|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
83620789|NCT02037048|Leucovorin|leucovorin|mesh-list
83620790|NCT02037048|Paclitaxel|paclitaxel|mesh-list
83620791|NCT02037048|Carboplatin|carboplatin|mesh-list
83620792|NCT02037048|Fluorouracil|fluorouracil|mesh-list
83620793|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
83620794|NCT02037048|Calcium|calcium|mesh-list
83620795|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
83620796|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620797|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620798|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620799|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620800|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620801|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620802|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83620803|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620804|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
83620805|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620806|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620807|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
83620808|NCT02037048|Antidotes|antidotes|mesh-ancestor
83620809|NCT02037048|Protective Agents|protective agents|mesh-ancestor
83620810|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
83620811|NCT02037048|Vitamins|vitamins|mesh-ancestor
83620812|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
83620813|NCT02034630|Busulfan|busulfan|mesh-list
83620814|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
83620815|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620816|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620817|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
83620818|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078843|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
83620819|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83620820|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620821|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83620823|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
83620824|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620825|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
83620826|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620827|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620828|NCT01768338|Ofatumumab|ofatumumab|mesh-list
83620829|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620830|NCT01659606|Cyclosporine|cyclosporine|mesh-list
83620831|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
83620832|NCT01659606|Fludarabine|fludarabine|mesh-list
83620833|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
83620834|NCT01659606|Tacrolimus|tacrolimus|mesh-list
83620835|NCT01659606|Cyclosporins|cyclosporins|mesh-list
83620836|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620837|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620838|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620839|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
83620840|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620841|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83620842|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620843|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
83620844|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620845|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620846|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620847|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83620848|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83620849|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
83620850|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83620851|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620852|NCT00819546|Everolimus|everolimus|mesh-list
83620853|NCT00819546|Midostaurin|midostaurin|mesh-list
83620854|NCT00819546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83620855|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83620856|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620857|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620858|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620859|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
83620860|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620861|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620862|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83620863|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
83620864|NCT00596154|Busulfan|busulfan|mesh-list
83620865|NCT00596154|Thiotepa|thiotepa|mesh-list
83620866|NCT00596154|Rituximab|rituximab|mesh-list
83620867|NCT00596154|Methotrexate|methotrexate|mesh-list
83620868|NCT00596154|Vincristine|vincristine|mesh-list
83620869|NCT00596154|Procarbazine|procarbazine|mesh-list
83620870|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83620871|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
83620872|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620873|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83620874|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83620875|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
83620876|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620877|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620878|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83620879|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620880|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83620881|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
83620882|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83620883|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83620884|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
83620885|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
83620886|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620887|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83620888|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83620889|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620890|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620891|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620892|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620893|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620894|NCT00281658|Paclitaxel|paclitaxel|mesh-list
83620895|NCT00281658|Lapatinib|lapatinib|mesh-list
83620896|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83620897|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620898|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
83620899|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
83620900|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
83620901|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620902|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83620903|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620904|NCT02417844|Tamsulosin|tamsulosin|mesh-list
83620905|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83620906|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83620907|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83620908|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
83620909|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620910|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620911|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620912|NCT02417844|Urological Agents|urological agents|mesh-ancestor
83620913|NCT02418312|Famotidine|famotidine|mesh-list
83620914|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
83620915|NCT02418312|Histamine|histamine|mesh-list
83620916|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83620917|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83620918|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
83620919|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
83620920|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620921|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620922|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620923|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
83620924|NCT02421354|Nivolumab|nivolumab|mesh-list
83620925|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83620926|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83620927|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83620928|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620929|NCT02422290|Ketamine|ketamine|mesh-list
83620930|NCT02422290|Analgesics|analgesics|mesh-ancestor
83510046|NCT01706588|Diclofenac|diclofenac|mesh-list
83620931|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
83620932|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620933|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620934|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83620935|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83620936|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
83620937|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
83620938|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620939|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83620940|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83620941|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83620942|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620943|NCT02430090|Fentanyl|fentanyl|mesh-list
83620944|NCT02430090|Sufentanil|sufentanil|mesh-list
83620945|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
83620946|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83620947|NCT02430090|Narcotics|narcotics|mesh-ancestor
83620948|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83620949|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620950|NCT02430090|Analgesics|analgesics|mesh-ancestor
83620951|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
83620952|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620953|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83620954|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83620955|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
83620956|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
83620957|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
83620958|NCT02431572|Immunomodulating Agents|immunomodulating agents|mesh-list
83620959|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
83620960|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620961|NCT02431650|Primaquine|primaquine|mesh-list
83620962|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
83620963|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83620964|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83620965|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620966|NCT02437344|Naltrexone|naltrexone|mesh-list
83620967|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83620968|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83620969|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620970|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
83620971|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83620972|NCT02440308|Bombesin|bombesin|mesh-list
83620973|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620975|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83620976|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
83620977|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83620978|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83620979|NCT02448654|Tolcapone|tolcapone|mesh-list
83620980|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83620981|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83620982|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83620983|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83620984|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620985|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83620986|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83620987|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83620988|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83620989|NCT02452866|Secnidazole|secnidazole|mesh-list
83620990|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83620991|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83620992|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83620993|NCT02462148|Dexamethasone|dexamethasone|mesh-list
83620994|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
83620995|NCT02462148|Epinephrine|epinephrine|mesh-list
83620996|NCT02462148|Bupivacaine|bupivacaine|mesh-list
83620997|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83620998|NCT02462148|BB 1101|bb 1101|mesh-list
83620999|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621000|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
83621001|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
83621002|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621003|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621004|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621005|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
83621006|NCT02462148|Hormones|hormones|mesh-ancestor
83621007|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621008|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621009|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621010|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
83621011|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621012|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621013|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621014|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
83621015|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621016|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
83621017|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83621018|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83621019|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83621020|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621021|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83621022|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83621023|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83621024|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
83621025|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
83621026|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
83621027|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83621028|NCT02462382|Ropivacaine|ropivacaine|mesh-list
83621029|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621030|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
83621031|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621032|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621033|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
83621034|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621035|NCT02464176|Dexamethasone|dexamethasone|mesh-list
83621036|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
83621037|NCT02464176|Epinephrine|epinephrine|mesh-list
83621038|NCT02464176|Bupivacaine|bupivacaine|mesh-list
83621039|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83621040|NCT02464176|BB 1101|bb 1101|mesh-list
83621041|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621042|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
83621043|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
83621044|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621045|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621046|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621047|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
83621048|NCT02464176|Hormones|hormones|mesh-ancestor
83621049|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621050|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621052|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
83621053|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621054|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621055|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621056|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
83621057|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621058|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
83621059|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83621060|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83621061|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83621062|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621063|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83621064|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83621065|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83621066|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83621067|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
83621068|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
83621069|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83621070|NCT02468700|Dexamethasone|dexamethasone|mesh-list
83621071|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621072|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
83621073|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
83621074|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621075|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621076|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621077|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
83621078|NCT02468700|Hormones|hormones|mesh-ancestor
83621079|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621080|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621081|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621082|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
83621083|NCT02472522|Ropivacaine|ropivacaine|mesh-list
83621084|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
83621085|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83621086|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621087|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621088|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83621089|NCT02472522|Analgesics|analgesics|mesh-ancestor
83621090|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
83621091|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621092|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83621093|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83621094|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
83621095|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621096|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621097|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621098|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
83621099|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83621100|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
83621101|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621102|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
83621103|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
83621104|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621105|NCT02484222|Fentanyl|fentanyl|mesh-list
83621106|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83621107|NCT02484222|Narcotics|narcotics|mesh-ancestor
83621108|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621109|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621110|NCT02484222|Analgesics|analgesics|mesh-ancestor
83621111|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
83621112|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621113|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83621114|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83621115|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
83621116|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
83621117|NCT02486016|Fentanyl|fentanyl|mesh-list
83621118|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83621119|NCT02486016|Narcotics|narcotics|mesh-ancestor
83621120|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079151|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
83621121|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621122|NCT02486016|Analgesics|analgesics|mesh-ancestor
83621123|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
83621124|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621125|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83621126|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83621127|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
83621128|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
83621129|NCT02486328|Midazolam|midazolam|mesh-list
83621130|NCT02486328|Meperidine|meperidine|mesh-list
83621131|NCT02486328|Remifentanil|remifentanil|mesh-list
83621132|NCT02486328|Propofol|propofol|mesh-list
83621133|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83621134|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621135|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621136|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83621137|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
83621138|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
83621139|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83621140|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83621141|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83621142|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83621143|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
83621144|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
83621145|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621146|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621147|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83621148|NCT02486328|Narcotics|narcotics|mesh-ancestor
83621149|NCT02486328|Analgesics|analgesics|mesh-ancestor
83621150|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
83621151|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621152|NCT02491788|Suvorexant|suvorexant|mesh-list
83621153|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83621154|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83621155|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621156|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621157|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83621158|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621159|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621160|NCT02491944|Osimertinib|osimertinib|mesh-list
83621161|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621162|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83621163|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621164|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621165|NCT02492802|Posaconazole|posaconazole|mesh-list
83621166|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
83621167|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621168|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83621169|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83621170|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83621171|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83621172|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83621173|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621174|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621175|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83621176|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
83621177|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621178|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621179|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
83621180|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83621181|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621182|NCT02500602|Doxazosin|doxazosin|mesh-list
83621183|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83621184|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83621185|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83621186|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83621187|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
83621188|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621189|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621190|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621191|NCT02500836|Cocaine|cocaine|mesh-list
83621192|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83621193|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621194|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
83621195|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621196|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621197|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
83621198|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621199|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83621200|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83621201|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83621202|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83621203|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621204|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
83621205|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621207|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83621208|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
83621209|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83621210|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621211|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621212|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621213|NCT02513940|Ibutilide|ibutilide|mesh-list
83621214|NCT02513940|Testosterone|testosterone|mesh-list
83621215|NCT02513940|Progesterone|progesterone|mesh-list
83621216|NCT02513940|Androgens|androgens|mesh-ancestor
83621217|NCT02513940|Hormones|hormones|mesh-ancestor
83621218|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621219|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621220|NCT02513940|Progestins|progestins|mesh-ancestor
83621221|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83621222|NCT02515890|Midazolam|midazolam|mesh-list
83621223|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
83621224|NCT02515890|Ketamine|ketamine|mesh-list
83621225|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83621226|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621227|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621228|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83621229|NCT02515890|Analgesics|analgesics|mesh-ancestor
83621230|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
83621231|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621232|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83621233|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83621234|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83621235|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
83621236|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621237|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621238|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83621239|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83621240|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
83621241|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
83621242|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83621243|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83621244|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83621245|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83621246|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83621247|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83621248|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
83621249|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
83621250|NCT02517996|Lidocaine|lidocaine|mesh-list
83621251|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621252|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
83621253|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621254|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621255|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
83621256|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621257|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83621258|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83621259|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83621260|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83621261|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621262|NCT02525718|Dexamethasone|dexamethasone|mesh-list
83621263|NCT02525718|Epinephrine|epinephrine|mesh-list
83621264|NCT02525718|Bupivacaine|bupivacaine|mesh-list
83621265|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621266|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
83621267|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
83621268|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621269|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621270|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83079356|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
83621271|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
83621272|NCT02525718|Hormones|hormones|mesh-ancestor
83621273|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621274|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621275|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621276|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621277|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
83621278|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621279|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
83621280|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83621281|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83621282|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
83621283|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621284|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621285|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83621286|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83621287|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83621288|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
83621289|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
83621290|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
83621291|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83621292|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
83621293|NCT02527512|Povidone|povidone|mesh-list
83621294|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
83621295|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
83621296|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83621297|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621298|NCT02529072|Nivolumab|nivolumab|mesh-list
83621299|NCT02529072|Vaccines|vaccines|mesh-list
83621300|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
83621301|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621302|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83621303|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621304|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83621305|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621306|NCT02530476|Sorafenib|sorafenib|mesh-list
83621307|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621308|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83621309|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621310|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621311|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
83621312|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83621313|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83621314|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621315|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
83621316|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
83621317|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83621318|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83621319|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621320|NCT02536248|Incretins|incretins|mesh-ancestor
83621321|NCT02536248|Hormones|hormones|mesh-ancestor
83621322|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621323|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83621324|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
83621325|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621326|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621327|NCT02538042|Nicotine|nicotine|mesh-list
83621328|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83621329|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
83621330|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621331|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621332|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83621333|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83621334|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
83621335|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621336|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621337|NCT02538354|Riboflavin|riboflavin|mesh-list
83621338|NCT02538354|Vitamins|vitamins|mesh-ancestor
83621339|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
83621340|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621341|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
83621342|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83621343|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
83621344|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
83621345|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83621346|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83621347|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621348|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
83621349|NCT02540226|Coagulants|coagulants|mesh-ancestor
83621350|NCT02541864|Amoxicillin|amoxicillin|mesh-list
83621351|NCT02541864|Metronidazole|metronidazole|mesh-list
83621352|NCT02541864|Clarithromycin|clarithromycin|mesh-list
83621353|NCT02541864|Tetracycline|tetracycline|mesh-list
83621354|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83621355|NCT02541864|Pantoprazole|pantoprazole|mesh-list
83621356|NCT02541864|Bismuth|bismuth|mesh-list
83621357|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83621358|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621359|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83621360|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83621361|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83621362|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621363|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621364|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83621365|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83621366|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83621367|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621368|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83621369|NCT02541864|Antacids|antacids|mesh-ancestor
83621370|NCT02542410|Cabergoline|cabergoline|mesh-list
83621371|NCT02542410|Norethindrone|norethindrone|mesh-list
83621372|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
83621373|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83621374|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83621375|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83621376|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
83621377|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83621378|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621379|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83621380|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83621381|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83621382|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83621383|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
83621384|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
83621385|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621386|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621387|NCT02544984|Azithromycin|azithromycin|mesh-list
83621388|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83621389|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621390|NCT02547012|Amoxicillin|amoxicillin|mesh-list
83621391|NCT02547012|Levofloxacin|levofloxacin|mesh-list
83621392|NCT02547012|Ofloxacin|ofloxacin|mesh-list
83621393|NCT02547012|Tetracycline|tetracycline|mesh-list
83621394|NCT02547012|Esomeprazole|esomeprazole|mesh-list
83621395|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83621396|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621397|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83621398|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621399|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83621400|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621401|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621402|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83621403|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83621404|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83621405|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621406|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83621407|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83621408|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83621409|NCT02548728|Oxytocin|oxytocin|mesh-list
83621410|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
83621411|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83621412|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621413|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
83621414|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83621415|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83621416|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83621417|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
83621418|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621419|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621420|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621421|NCT02560038|Paclitaxel|paclitaxel|mesh-list
83621422|NCT02560038|Gemcitabine|gemcitabine|mesh-list
83621423|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83621424|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621425|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83621426|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83621427|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83621428|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621429|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83621430|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
83621431|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83621432|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83621433|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
83621434|NCT02561130|Metformin|metformin|mesh-list
83621435|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
83621436|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
83621437|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83621438|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621439|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83621440|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621441|NCT02562066|Amifampridine|amifampridine|mesh-list
83621442|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83621443|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621444|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621445|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83621446|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83621447|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621448|NCT02562924|Prednisone|prednisone|mesh-list
83621449|NCT02562924|Budesonide|budesonide|mesh-list
83621450|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621451|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
83621452|NCT02562924|Hormones|hormones|mesh-ancestor
83621453|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621454|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621455|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621456|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621457|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83621458|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
83621459|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621460|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83621461|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
83621462|NCT02563860|Lovastatin|lovastatin|mesh-list
83621463|NCT02563860|L 647318|l 647318|mesh-list
83621464|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
83621465|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83621466|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83621467|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
83621468|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621469|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83621470|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83621471|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621472|NCT02568852|Anesthetics|anesthetics|mesh-list
83621473|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621474|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621475|NCT02570022|Bupivacaine|bupivacaine|mesh-list
83621476|NCT02570022|Ropivacaine|ropivacaine|mesh-list
83621477|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621478|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
83621479|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621480|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621481|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
83621482|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621483|NCT02572752|Nintedanib|nintedanib|mesh-list
83621484|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621485|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83621486|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621487|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621488|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
83621489|NCT02577042|Atorvastatin|atorvastatin|mesh-list
83621490|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83621491|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83621492|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
83621493|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621494|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83621495|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83621496|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621497|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83621498|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83621499|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
83621500|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621501|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83621502|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83621503|NCT02582970|Bevacizumab|bevacizumab|mesh-list
83621504|NCT02582970|Fluorouracil|fluorouracil|mesh-list
83621505|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
83621506|NCT02582970|Irinotecan|irinotecan|mesh-list
83621507|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83621508|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621509|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83621510|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83621511|NCT02582970|Growth Substances|growth substances|mesh-ancestor
83621512|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621513|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
83621514|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
83621515|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621516|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83621517|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83621518|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
83621519|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83621520|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83621521|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621522|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
83621523|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
83621524|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621525|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
83621526|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83621527|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83621528|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83621529|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83621530|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621531|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
83621532|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621533|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621534|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83621535|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621536|NCT05249556|Ganaxolone|ganaxolone|mesh-list
83621537|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
83621538|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621539|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621540|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621541|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
83621542|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
83621543|NCT05248152|Acetaminophen|acetaminophen|mesh-list
83621544|NCT05248152|Ibuprofen|ibuprofen|mesh-list
83621545|NCT05248152|Pregabalin|pregabalin|mesh-list
83621546|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83621547|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83621548|NCT05248152|Analgesics|analgesics|mesh-ancestor
83621549|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
83621550|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621551|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621552|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621553|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83621554|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83621555|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621556|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621557|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
83621558|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83621559|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83621560|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83621561|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83621562|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83621563|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621564|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83621565|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
83621566|NCT05247684|Paclitaxel|paclitaxel|mesh-list
83621567|NCT05247684|Carboplatin|carboplatin|mesh-list
83621568|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83621569|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621570|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
83621571|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
83621572|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
83621573|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621574|NCT05184348|Acitretin|acitretin|mesh-list
83621575|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
83621576|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
83621577|NCT05132166|Sirolimus|sirolimus|mesh-list
83621578|NCT05132166|Everolimus|everolimus|mesh-list
83621579|NCT05132166|MTOR Inhibitors|mtor inhibitors|mesh-list
83621580|NCT05132166|Temsirolimus|temsirolimus|mesh-list
83621581|NCT05132166|Vedolizumab|vedolizumab|mesh-list
83621582|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83621583|NCT05132166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83621584|NCT05132166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621585|NCT05132166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621586|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83621587|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
83621588|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621589|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621590|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83621591|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621592|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83621593|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
83621594|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621595|NCT04808466|Paclitaxel|paclitaxel|mesh-list
83621596|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83621597|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621598|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
83621599|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
83621600|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
83621601|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621602|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83621603|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83621604|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
83621605|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621606|NCT03907176|Acetaminophen|acetaminophen|mesh-list
83621607|NCT03907176|Ibuprofen|ibuprofen|mesh-list
83621608|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83621609|NCT03907176|Analgesics|analgesics|mesh-ancestor
83621610|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
83621611|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621612|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621613|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
83621614|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83621615|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621616|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83621617|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83621618|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621619|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621620|NCT03675672|Misoprostol|misoprostol|mesh-list
83621621|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83621622|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
83621623|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83621624|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621625|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83621626|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621627|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
83621628|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
83621629|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83621630|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
83621631|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621632|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
83621633|NCT02108496|Protective Agents|protective agents|mesh-ancestor
83621634|NCT02056236|Midazolam|midazolam|mesh-list
83621635|NCT02056236|Levetiracetam|levetiracetam|mesh-list
83621636|NCT02056236|Valproic Acid|valproic acid|mesh-list
83621637|NCT02056236|Lorazepam|lorazepam|mesh-list
83621638|NCT02056236|Thiopental|thiopental|mesh-list
83621639|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
83621640|NCT02056236|Propofol|propofol|mesh-list
83621641|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83621642|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621643|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621644|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83621645|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
83621646|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
83621647|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83621648|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83621649|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83621650|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83621651|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
83621652|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
83621653|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621654|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621655|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
83621656|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621657|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
83621658|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
83621659|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
83621660|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621661|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621662|NCT01962246|Capecitabine|capecitabine|mesh-list
83621663|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
83621664|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83621665|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
83621666|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621667|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621668|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83621669|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
83621670|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621671|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83621672|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
83621673|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621674|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
83621675|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83621676|NCT04945122|Atorvastatin|atorvastatin|mesh-list
83621677|NCT04945122|Pitavastatin|pitavastatin|mesh-list
83621678|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83621679|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83621680|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
83621681|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621682|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83621683|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83621684|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621685|NCT04227366|Methotrexate|methotrexate|mesh-list
83621686|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83621687|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
83621688|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83621689|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621690|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83621691|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
83621692|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621693|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621694|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
83621695|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621696|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83621697|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83621698|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
83621699|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83621700|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83621701|NCT03560466|Prednisone|prednisone|mesh-list
83621702|NCT03560466|Prednisolone|prednisolone|mesh-list
83621703|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621704|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
83621705|NCT03560466|Hormones|hormones|mesh-ancestor
83621706|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621707|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621708|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621709|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621710|NCT03376698|Colchicine|colchicine|mesh-list
83621711|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
83621712|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83621713|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
83621714|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
83621715|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
83621716|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621717|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621718|NCT03295734|Losartan|losartan|mesh-list
83621719|NCT03295734|Perindopril|perindopril|mesh-list
83621720|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83621721|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83621722|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83621723|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83079734|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83621724|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621725|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83621726|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
83621727|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621728|NCT02595684|Tadalafil|tadalafil|mesh-list
83621729|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
83621730|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83621731|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83621732|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621733|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621734|NCT02595684|Urological Agents|urological agents|mesh-ancestor
83621735|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
83621736|NCT02604810|Antibodies|antibodies|mesh-list
83621737|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
83621738|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83621739|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83621740|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
83621741|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
83621742|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621743|NCT02607618|Vancomycin|vancomycin|mesh-list
83621744|NCT02607618|Iclaprim|iclaprim|mesh-list
83621745|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83621746|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621747|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83621748|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621749|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621750|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
83621751|NCT05732064|Esketamine|esketamine|mesh-list
83621752|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83621753|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621754|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621755|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83621756|NCT05732064|Analgesics|analgesics|mesh-ancestor
83621757|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
83621758|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621759|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83621760|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83621761|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83621762|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
83621763|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621764|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621765|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
83621766|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83621767|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83621768|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
83621769|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621770|NCT05731518|Irinotecan|irinotecan|mesh-list
83621771|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83621772|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83621773|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621774|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621775|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621776|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
83621777|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83621778|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83621779|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621780|NCT05730660|Quercetin|quercetin|mesh-list
83621781|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
83621782|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621783|NCT05730660|Protective Agents|protective agents|mesh-ancestor
83621784|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621785|NCT05697276|Lidocaine|lidocaine|mesh-list
83621786|NCT05697276|Bupivacaine|bupivacaine|mesh-list
83621787|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
83621788|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
83621789|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621790|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621791|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
83621792|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621793|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83621794|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83621795|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83621796|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83621797|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621798|NCT05419674|Amoxicillin|amoxicillin|mesh-list
83621799|NCT05419674|Clarithromycin|clarithromycin|mesh-list
83621800|NCT05419674|Rabeprazole|rabeprazole|mesh-list
83621801|NCT05419674|Bismuth|bismuth|mesh-list
83621802|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83621803|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621804|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83621805|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621806|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621807|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83621808|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83621809|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83621810|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621811|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83621812|NCT05419674|Antacids|antacids|mesh-ancestor
83621813|NCT05386524|Bevacizumab|bevacizumab|mesh-list
83621814|NCT05386524|Doxorubicin|doxorubicin|mesh-list
83621815|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83621816|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83621817|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621818|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83621819|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83621820|NCT05386524|Growth Substances|growth substances|mesh-ancestor
83621821|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621822|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
83621823|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83621824|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83621825|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83621826|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621827|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621828|NCT04965714|Nivolumab|nivolumab|mesh-list
83621829|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83621830|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621831|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83621832|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621833|NCT04787562|Imipenem|imipenem|mesh-list
83621834|NCT04787562|Cilastatin|cilastatin|mesh-list
83621835|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83621836|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621837|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
83621838|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621839|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621840|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
83621841|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
83621842|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621843|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
83621844|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
83621845|NCT04355130|Vitamins|vitamins|mesh-ancestor
83621846|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
83621847|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621848|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
83621849|NCT04355130|Hematinics|hematinics|mesh-ancestor
83621850|NCT04266912|Avelumab|avelumab|mesh-list
83621851|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83621852|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83621853|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621854|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
83621855|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621856|NCT04107168|Bevacizumab|bevacizumab|mesh-list
83621857|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
83621858|NCT04107168|Nivolumab|nivolumab|mesh-list
83621859|NCT04107168|Ipilimumab|ipilimumab|mesh-list
83621860|NCT04107168|Atezolizumab|atezolizumab|mesh-list
83621861|NCT04107168|Durvalumab|durvalumab|mesh-list
83621862|NCT04107168|Tremelimumab|tremelimumab|mesh-list
83621863|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83621864|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621865|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83621866|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83621867|NCT04107168|Growth Substances|growth substances|mesh-ancestor
83621868|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621869|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
83621870|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83621871|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079885|NCT05515822|Analgesics|analgesics|mesh-ancestor
83621872|NCT03958344|Prednisolone|prednisolone|mesh-list
83621873|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83621874|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
83621875|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83621877|NCT03958344|Triamcinolone|triamcinolone|mesh-list
83621878|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83621879|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
83621880|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621881|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
83621882|NCT03958344|Hormones|hormones|mesh-ancestor
83621883|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621884|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621885|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621886|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621887|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
83621888|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
83621889|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83621890|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621891|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83621892|NCT03958344|Protective Agents|protective agents|mesh-ancestor
83621893|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
83621894|NCT02960646|Melphalan|melphalan|mesh-list
83621895|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
83621896|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83621897|NCT02960646|Rituximab|rituximab|mesh-list
83621898|NCT02960646|Fludarabine|fludarabine|mesh-list
83621899|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
83621900|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83621901|NCT02960646|Tacrolimus|tacrolimus|mesh-list
83621902|NCT02960646|Antibodies|antibodies|mesh-list
83621903|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
83621904|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83621905|NCT02960646|Lenograstim|lenograstim|mesh-list
83621906|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83621907|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
83621908|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621909|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83621910|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83621911|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
83621912|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621913|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621914|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83621915|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83621916|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
83621917|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83621918|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83621919|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621920|NCT02517684|Prednisolone|prednisolone|mesh-list
83621921|NCT02517684|Infliximab|infliximab|mesh-list
83621922|NCT02517684|Azathioprine|azathioprine|mesh-list
83621923|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83621924|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
83621925|NCT02517684|Hormones|hormones|mesh-ancestor
83621926|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621927|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621928|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83621929|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621930|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621931|NCT02517684|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83621932|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
83621933|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83621934|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
83621935|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621936|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83621937|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83621938|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
83621939|NCT01448616|Tenofovir|tenofovir|mesh-list
83621940|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
83621941|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621942|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83621943|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83621944|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621945|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621946|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83621947|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83621948|NCT00074412|Nevirapine|nevirapine|mesh-list
83621949|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83621950|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83621951|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621952|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621953|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
83621954|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621955|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83621956|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83621957|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83621958|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83621959|NCT02618772|Midazolam|midazolam|mesh-list
83621960|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83621961|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83621962|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83621963|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621964|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83621965|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83621966|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83621967|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83621968|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
83621969|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
83621970|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
83621971|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
83621972|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83621973|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621974|NCT02620878|Pancrelipase|pancrelipase|mesh-list
83621975|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83621976|NCT02624700|Pemetrexed|pemetrexed|mesh-list
83621977|NCT02624700|Sorafenib|sorafenib|mesh-list
83621978|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83621979|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621980|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621981|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83621982|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83621983|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83621984|NCT02631954|Voriconazole|voriconazole|mesh-list
83621985|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
83621986|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83621987|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83621988|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83621989|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83621990|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83621991|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83621992|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
83621993|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83621994|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83621995|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83621996|NCT02632812|Naproxen|naproxen|mesh-list
83621997|NCT02632812|Rebamipide|rebamipide|mesh-list
83621998|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83621999|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83622000|NCT02632812|Analgesics|analgesics|mesh-ancestor
83622001|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
83622002|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622003|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622004|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83622005|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83622006|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
83622007|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83622008|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622009|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622010|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83622011|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83622012|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
83622013|NCT02632812|Protective Agents|protective agents|mesh-ancestor
83622014|NCT02634684|Amphetamine|amphetamine|mesh-list
83622015|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
83622016|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83622017|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622018|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
83622019|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
83622020|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622021|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
83622022|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622023|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622024|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622025|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83622026|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83622027|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622028|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83622029|NCT02635542|Cisatracurium|cisatracurium|mesh-list
83622030|NCT02635542|Succinylcholine|succinylcholine|mesh-list
83622031|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83622032|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83622033|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622034|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622035|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83622036|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
83622037|NCT05585658|Hematinics|hematinics|mesh-ancestor
83622039|NCT05510856|Gabapentin|gabapentin|mesh-list
83622040|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83622041|NCT05510856|Analgesics|analgesics|mesh-ancestor
83622042|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
83622043|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622044|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622045|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
83622046|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83622047|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83622048|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622049|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622050|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83622051|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83622052|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622053|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622054|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
83622055|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83622056|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83511154|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
83622057|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622058|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
83622059|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
83622060|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83622061|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83622062|NCT05281770|Erenumab|erenumab|mesh-list
83622063|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83622064|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622065|NCT05281770|Analgesics|analgesics|mesh-ancestor
83622066|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
83622067|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622068|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622069|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
83622070|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83622071|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622072|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622073|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83622074|NCT05225610|Analgesics|analgesics|mesh-ancestor
83622075|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
83622076|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622077|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83622078|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83622079|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83622080|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622081|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622082|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622083|NCT05150652|Tamoxifen|tamoxifen|mesh-list
83622084|NCT05150652|Letrozole|letrozole|mesh-list
83622085|NCT05150652|Anastrozole|anastrozole|mesh-list
83622086|NCT05150652|Exemestane|exemestane|mesh-list
83622087|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622088|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83622089|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83622090|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622091|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622092|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83622093|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
83622094|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622095|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622096|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83622097|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83622098|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83622099|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83622101|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
83622102|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622103|NCT04511052|Protective Agents|protective agents|mesh-ancestor
83622104|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622105|NCT03693846|Nivolumab|nivolumab|mesh-list
83622106|NCT03693846|Ipilimumab|ipilimumab|mesh-list
83622107|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622108|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622109|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83622110|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622111|NCT03529890|Nivolumab|nivolumab|mesh-list
83622112|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622113|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622114|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83622115|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622116|NCT03471624|Tenofovir|tenofovir|mesh-list
83622117|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
83622118|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622119|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83622120|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83622121|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622122|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622123|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83622124|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83622125|NCT03441048|Cytarabine|cytarabine|mesh-list
83622126|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
83622127|NCT03441048|Cladribine|cladribine|mesh-list
83622128|NCT03441048|Lintuzumab|lintuzumab|mesh-list
83622129|NCT03441048|Lenograstim|lenograstim|mesh-list
83622130|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83622131|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
83622132|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622133|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622134|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
83622135|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622136|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83622137|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
83622138|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622139|NCT03441048|Analgesics|analgesics|mesh-ancestor
83622140|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
83622141|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622142|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83622143|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83622144|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622145|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622146|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83622147|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
83622148|NCT02828592|Fludarabine|fludarabine|mesh-list
83622149|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
83622150|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83622151|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
83622152|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622153|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83622154|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83622155|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
83622156|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622157|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622158|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83622159|NCT02369406|Lamivudine|lamivudine|mesh-list
83622160|NCT02369406|Zidovudine|zidovudine|mesh-list
83622161|NCT02369406|Nevirapine|nevirapine|mesh-list
83622162|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83622163|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83622164|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622165|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622166|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
83622167|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622168|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83622169|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83622170|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
83622171|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83080184|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
83622172|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83622173|NCT02649192|Vitamin D|vitamin d|mesh-list
83622174|NCT02649192|Vitamin A|vitamin a|mesh-list
83622175|NCT02649192|Vitamins|vitamins|mesh-ancestor
83622176|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
83622177|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622178|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83622179|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
83622180|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83622181|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83622182|NCT02652390|Prednisolone|prednisolone|mesh-list
83622183|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
83622184|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83622185|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
83622186|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83622187|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
83622188|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
83622189|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622190|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622191|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83622192|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
83622193|NCT02652390|Hormones|hormones|mesh-ancestor
83622194|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622195|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83622196|NCT02652390|Protective Agents|protective agents|mesh-ancestor
83622197|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83622198|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622199|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
83622200|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
83622201|NCT02653560|Citric Acid|citric acid|mesh-list
83622202|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
83622203|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
83622204|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83622205|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
83622206|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
83622207|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622208|NCT02653560|Diuretics|diuretics|mesh-ancestor
83622209|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
83622210|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622211|NCT02653560|Expectorants|expectorants|mesh-ancestor
83622212|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
83622213|NCT02653560|Cathartics|cathartics|mesh-ancestor
83622214|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83622215|NCT02653872|Itraconazole|itraconazole|mesh-list
83622216|NCT02653872|Verapamil|verapamil|mesh-list
83622217|NCT02653872|Diltiazem|diltiazem|mesh-list
83622218|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
83622219|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622220|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83622221|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83622222|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622223|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622224|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83622225|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
83622226|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622227|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622228|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83622229|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83622230|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83622231|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622232|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83622233|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
83622234|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83622235|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
83622236|NCT02655354|Promethazine|promethazine|mesh-list
83622237|NCT02655354|Prazosin|prazosin|mesh-list
83622238|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83622239|NCT02655354|Mirtazapine|mirtazapine|mesh-list
83622240|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
83622241|NCT02655354|Trazodone|trazodone|mesh-list
83622242|NCT02655354|Sertraline|sertraline|mesh-list
83622243|NCT02655354|Fluoxetine|fluoxetine|mesh-list
83622244|NCT02655354|Paroxetine|paroxetine|mesh-list
83622245|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83622246|NCT02655354|Citalopram|citalopram|mesh-list
83622247|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83622248|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83622249|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622250|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622251|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622252|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622253|NCT02655354|Analgesics|analgesics|mesh-ancestor
83622254|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
83622255|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622256|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
83622257|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622258|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
83622259|NCT02655354|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83622260|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
83622261|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83622262|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83622263|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83622264|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622265|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
83622266|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83622267|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83622268|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622269|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
83622270|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
83622271|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
83622272|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83622273|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83622274|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
83622275|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
83622276|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83622277|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
83622278|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
83622279|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83622280|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83622281|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83622282|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83622283|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83622284|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622285|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83622286|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83622287|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83622288|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83622289|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83622290|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83622291|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83622292|NCT02657928|Letrozole|letrozole|mesh-list
83622293|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622294|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83622295|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83622296|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622297|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622298|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83622299|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
83622300|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622301|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622302|NCT02658240|Epinephrine|epinephrine|mesh-list
83622303|NCT02658240|Ropivacaine|ropivacaine|mesh-list
83622304|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
83622305|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
83622306|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622307|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622308|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
83622309|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622310|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83622311|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83622312|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622313|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622314|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622315|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83622316|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83622317|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
83622318|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83622319|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
83622320|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
83622321|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
83622322|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83622323|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
83622324|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
83622325|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622326|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
83622327|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622328|NCT02665260|Cantharidin|cantharidin|mesh-list
83622329|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622330|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622331|NCT02665728|Laxatives|laxatives|mesh-list
83622332|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83622333|NCT02666352|Ruzasvir|ruzasvir|mesh-list
83622334|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
83622335|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
83622336|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622337|NCT02673138|Canagliflozin|canagliflozin|mesh-list
83622338|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83622339|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622340|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83622341|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622342|NCT02673372|Ketamine|ketamine|mesh-list
83622343|NCT02673372|Morphine|morphine|mesh-list
83622344|NCT02673372|Analgesics|analgesics|mesh-ancestor
83622345|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
83622346|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622347|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622348|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83622349|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83622350|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
83622351|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
83622352|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622353|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83622354|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83622355|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622356|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622357|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83622358|NCT02673372|Narcotics|narcotics|mesh-ancestor
83622359|NCT02682498|Bupivacaine|bupivacaine|mesh-list
83622360|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
83622361|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
83622362|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622363|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622364|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
83622365|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622366|NCT02684136|Suvorexant|suvorexant|mesh-list
83622367|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83622368|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83622369|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622370|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622371|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83622372|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622373|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622374|NCT02695290|Afatinib|afatinib|mesh-list
83622375|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622376|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83622377|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622378|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622379|NCT02695446|Minocycline|minocycline|mesh-list
83622380|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83622381|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622382|NCT02698566|Ranibizumab|ranibizumab|mesh-list
83622383|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83622384|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83622385|NCT02698566|Growth Substances|growth substances|mesh-ancestor
83622386|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622387|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
83622388|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622389|NCT02701062|Warfarin|warfarin|mesh-list
83622390|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
83622391|NCT02701062|Dabigatran|dabigatran|mesh-list
83622392|NCT02701062|Apixaban|apixaban|mesh-list
83622393|NCT02701062|Anticoagulants|anticoagulants|mesh-list
83622394|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83622395|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
83622396|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83622397|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
83622398|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622399|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622401|NCT02704104|Coagulants|coagulants|mesh-ancestor
83622402|NCT02705352|Fluorouracil|fluorouracil|mesh-list
83622403|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
83622404|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622405|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83622406|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622407|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83622408|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
83622409|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622410|NCT02708238|Simethicone|simethicone|mesh-list
83622411|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
83622412|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622413|NCT02708238|Emollients|emollients|mesh-ancestor
83622414|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
83622415|NCT02709018|Losartan|losartan|mesh-list
83622416|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83622417|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83622418|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83622419|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83622420|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622421|NCT02713230|Bupivacaine|bupivacaine|mesh-list
83622422|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
83622423|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
83622424|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622425|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622426|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
83622427|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622428|NCT02713698|Propofol|propofol|mesh-list
83622429|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83622430|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622431|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622432|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83622433|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
83622434|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
83622435|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83622436|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83622437|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83622438|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622439|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622440|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622441|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622442|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83622443|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
83622444|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622445|NCT02716818|Dexamethasone|dexamethasone|mesh-list
83622446|NCT02716818|Prednisone|prednisone|mesh-list
83622447|NCT02716818|Prednisolone|prednisolone|mesh-list
83622448|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
83622449|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83622450|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83622451|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83622452|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
83622453|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83622454|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
83622455|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
83622456|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622457|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622458|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83622459|NCT02716818|Hormones|hormones|mesh-ancestor
83622460|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622461|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83622462|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622463|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
83622464|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83622465|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622466|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83622467|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83622468|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622469|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622470|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622471|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83080488|NCT04500704|Pemetrexed|pemetrexed|mesh-list
83622472|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83622473|NCT02726178|Ibuprofen|ibuprofen|mesh-list
83622474|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83622475|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83622476|NCT02726178|Analgesics|analgesics|mesh-ancestor
83622477|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
83622478|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622479|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622480|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83622481|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83622482|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83622483|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622484|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622485|NCT02733588|Glucagon|glucagon|mesh-list
83622486|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83622487|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83622488|NCT02733588|Hormones|hormones|mesh-ancestor
83622489|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622490|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622491|NCT02733588|Incretins|incretins|mesh-ancestor
83622492|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
83622493|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622494|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83622495|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622496|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622497|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
83622498|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622499|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622500|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83511603|NCT01688336|Leucovorin|leucovorin|mesh-list
83622501|NCT05444088|Bevacizumab|bevacizumab|mesh-list
83622502|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622503|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622504|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83622505|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83622506|NCT05444088|Growth Substances|growth substances|mesh-ancestor
83622507|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622508|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
83622509|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
83622510|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83622511|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83622512|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622513|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83622514|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622515|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83622516|NCT05443932|Diuretics|diuretics|mesh-ancestor
83622517|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
83622518|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83622519|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622520|NCT05443308|Acetazolamide|acetazolamide|mesh-list
83622521|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
83622522|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83622523|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622524|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622525|NCT05443308|Diuretics|diuretics|mesh-ancestor
83622526|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
83622527|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622528|NCT05442996|Antibodies|antibodies|mesh-list
83622529|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
83622530|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83622531|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
83622532|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622533|NCT05441046|Tislelizumab|tislelizumab|mesh-list
83622534|NCT05441046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622535|NCT05441046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622536|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
83622537|NCT05439564|Morphine|morphine|mesh-list
83622538|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83622539|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622540|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622541|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83622542|NCT05439564|Analgesics|analgesics|mesh-ancestor
83622543|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
83622544|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622545|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83622546|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83622547|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83622548|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622549|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622550|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622551|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83622553|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83622554|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622555|NCT05340270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622556|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622557|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83622558|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
83622559|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83622560|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622561|NCT05266404|Incretins|incretins|mesh-ancestor
83622562|NCT05266404|Hormones|hormones|mesh-ancestor
83622563|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622564|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83622565|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
83622566|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622567|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622568|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83622569|NCT05122494|Capecitabine|capecitabine|mesh-list
83622570|NCT05122494|Lapatinib|lapatinib|mesh-list
83622571|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83622572|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
83622573|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622574|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622575|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83622576|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622577|NCT05063604|Citalopram|citalopram|mesh-list
83622578|NCT05063604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83622579|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83622580|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622581|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622582|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622583|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
83622584|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622585|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83622586|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
83622587|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622588|NCT04978428|Cannabidiol|cannabidiol|mesh-list
83622589|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
83622590|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
83622591|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83622592|NCT04780464|Prednisone|prednisone|mesh-list
83622593|NCT04780464|Prednisolone|prednisolone|mesh-list
83622594|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
83622595|NCT04780464|Doxorubicin|doxorubicin|mesh-list
83622596|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83622597|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83622598|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
83622599|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622600|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83622601|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83622602|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
83622603|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622604|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622605|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83622606|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83622607|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83622608|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83622609|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622610|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83622611|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
83622612|NCT04780464|Hormones|hormones|mesh-ancestor
83622613|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622614|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83080642|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
83622615|NCT04495608|Fluconazole|fluconazole|mesh-list
83622616|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
83622617|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622618|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83622619|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83622620|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622621|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622622|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83622623|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
83622624|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622625|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622626|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83622627|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83622628|NCT04238754|Cannabidiol|cannabidiol|mesh-list
83622629|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83622630|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
83622631|NCT04017468|Vancomycin|vancomycin|mesh-list
83622632|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83622633|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622634|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
83622635|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83622636|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622637|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622638|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83622639|NCT03770130|Analgesics|analgesics|mesh-ancestor
83622640|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
83622641|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622642|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83622643|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83622644|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83622645|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622646|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622647|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622648|NCT03586284|Valganciclovir|valganciclovir|mesh-list
83622649|NCT03586284|Ganciclovir|ganciclovir|mesh-list
83622650|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83622651|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
83622652|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622653|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83622654|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622655|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622656|NCT03567642|Etoposide|etoposide|mesh-list
83622657|NCT03567642|Osimertinib|osimertinib|mesh-list
83622658|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83622659|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622660|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83622661|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83622662|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622663|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622664|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83622665|NCT03190668|Cefazolin|cefazolin|mesh-list
83622666|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
83622667|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83622668|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622669|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83622670|NCT01871766|Dactinomycin|dactinomycin|mesh-list
83622671|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
83622672|NCT01871766|Ifosfamide|ifosfamide|mesh-list
83622673|NCT01871766|Bevacizumab|bevacizumab|mesh-list
83622674|NCT01871766|Doxorubicin|doxorubicin|mesh-list
83622675|NCT01871766|Irinotecan|irinotecan|mesh-list
83622676|NCT01871766|Etoposide|etoposide|mesh-list
83622677|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
83622678|NCT01871766|Vincristine|vincristine|mesh-list
83622679|NCT01871766|Sorafenib|sorafenib|mesh-list
83622680|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
83622681|NCT01871766|Razoxane|razoxane|mesh-list
83622682|NCT01871766|Mitogens|mitogens|mesh-list
83622683|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83622684|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
83622685|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622686|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83622687|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83622688|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
83622689|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622690|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622691|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83622692|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622693|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83622694|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83622695|NCT01871766|Growth Substances|growth substances|mesh-ancestor
83622696|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
83622697|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83622698|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83622699|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83622700|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622701|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83622702|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83622703|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
83622704|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
83622705|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
83622706|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83622707|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83622708|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622709|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83622710|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83622711|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83622712|NCT01871766|Protective Agents|protective agents|mesh-ancestor
83622713|NCT05452434|Mirabegron|mirabegron|mesh-list
83622714|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83622715|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83622716|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83622717|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622718|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622719|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622720|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622721|NCT05452434|Urological Agents|urological agents|mesh-ancestor
83622722|NCT05450328|Epoprostenol|epoprostenol|mesh-list
83622723|NCT05450328|Milrinone|milrinone|mesh-list
83622724|NCT05450328|Tezosentan|tezosentan|mesh-list
83622725|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83622726|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83622727|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
83622728|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83622729|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83622730|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622731|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622732|NCT05450328|Protective Agents|protective agents|mesh-ancestor
83622733|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622734|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83622735|NCT05448924|Hormones|hormones|mesh-list
83622736|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622737|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622738|NCT05447364|Pregabalin|pregabalin|mesh-list
83622739|NCT05447364|Analgesics|analgesics|mesh-ancestor
83622740|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
83622741|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622742|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622743|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
83622744|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83622745|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622746|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622747|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83622748|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83622749|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83622750|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622751|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622752|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
83622753|NCT05430750|Sevoflurane|sevoflurane|mesh-list
83622754|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83622755|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83622756|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
83622757|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
83622758|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622759|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622760|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83622761|NCT05430750|Analgesics|analgesics|mesh-ancestor
83622762|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
83622763|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622764|NCT05418036|Sotalol|sotalol|mesh-list
83622765|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83622766|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83622767|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
83622768|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622769|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622770|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622771|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83622772|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
83622773|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
83622774|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622775|NCT05274048|Trastuzumab|trastuzumab|mesh-list
83622776|NCT05274048|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83622777|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622778|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622779|NCT05274048|Immunoconjugates|immunoconjugates|mesh-ancestor
83622780|NCT05274048|Immunologic Factors|immunologic factors|mesh-ancestor
83622781|NCT05274048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622782|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83622783|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83622784|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83622785|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622786|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622787|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622788|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622789|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83622790|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
83622791|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622792|NCT04964466|Becaplermin|becaplermin|mesh-list
83622793|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
83622794|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83622795|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83622796|NCT04964466|Growth Substances|growth substances|mesh-ancestor
83622797|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622798|NCT04727424|Budesonide|budesonide|mesh-list
83622799|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
83622800|NCT04727424|Fluoxetine|fluoxetine|mesh-list
83622801|NCT04727424|Maleic acid|maleic acid|mesh-list
83622802|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83622803|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83622804|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
83622805|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622806|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622807|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83622808|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
83622809|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
83622810|NCT04727424|Hormones|hormones|mesh-ancestor
83622811|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622812|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622813|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622814|NCT04727424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83622815|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83622816|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83622817|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622818|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
83622819|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83622820|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
83622821|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622822|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83622823|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83622824|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83622825|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83622826|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622827|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83622828|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83622829|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83622830|NCT04522206|Oxycodone|oxycodone|mesh-list
83622831|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83622832|NCT04522206|Narcotics|narcotics|mesh-ancestor
83622833|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622834|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622835|NCT04522206|Analgesics|analgesics|mesh-ancestor
83622836|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
83622837|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622838|NCT04519944|Edoxaban|edoxaban|mesh-list
83080942|NCT02504138|Desflurane|desflurane|mesh-list
83622839|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83622840|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
83622841|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83622842|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
83622843|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622844|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622845|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
83622846|NCT04505592|Tenecteplase|tenecteplase|mesh-list
83622847|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83622848|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83622849|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622850|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
83622851|NCT04415892|Capsaicin|capsaicin|mesh-list
83622852|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
83622853|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
83622854|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
83622855|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622856|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622857|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83622858|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622859|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83622860|NCT04415892|Protective Agents|protective agents|mesh-ancestor
83622861|NCT04176354|Letrozole|letrozole|mesh-list
83622862|NCT04176354|Palbociclib|palbociclib|mesh-list
83622863|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83622864|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622865|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83622866|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622867|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622868|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83622869|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684421|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83622870|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83622871|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622872|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83622873|NCT04173780|Atropine|atropine|mesh-list
83622874|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83622875|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83622876|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83622877|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
83622878|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622879|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622880|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83622881|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
83622882|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
83622883|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
83622884|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83622885|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83622886|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
83622887|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622888|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622889|NCT04129554|Tenofovir|tenofovir|mesh-list
83622890|NCT04129554|Entecavir|entecavir|mesh-list
83622891|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
83622892|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
83622893|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622894|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83622895|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83622896|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622897|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622898|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83622899|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83622900|NCT04128540|Fentanyl|fentanyl|mesh-list
83622901|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83622902|NCT04128540|Narcotics|narcotics|mesh-ancestor
83622903|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622904|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622905|NCT04128540|Analgesics|analgesics|mesh-ancestor
83622906|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
83622907|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622908|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83080965|NCT02503826|Dsuvia|dsuvia|mesh-list
83622909|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83622910|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
83622911|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
83622912|NCT04104438|Everolimus|everolimus|mesh-list
83622913|NCT04104438|Basiliximab|basiliximab|mesh-list
83622915|NCT04104438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83622916|NCT04104438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622917|NCT04104438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622918|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83622919|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
83622920|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622921|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622922|NCT03703206|Anesthetics|anesthetics|mesh-list
83622923|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
83622924|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622925|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622926|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
83622927|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83622928|NCT03689244|Selexipag|selexipag|mesh-list
83622929|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83622930|NCT03443856|Nivolumab|nivolumab|mesh-list
83622931|NCT03443856|Ipilimumab|ipilimumab|mesh-list
83622932|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622933|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622934|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83622935|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622936|NCT03260712|Gemcitabine|gemcitabine|mesh-list
83622937|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
83622938|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622939|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83622940|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
83622941|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622942|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83622943|NCT03260712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83622944|NCT03086616|Irinotecan|irinotecan|mesh-list
83622945|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83622946|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83622947|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622948|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622949|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622950|NCT02952924|Midazolam|midazolam|mesh-list
83622951|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83622952|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83622953|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83622954|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622955|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83622956|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83622957|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83622958|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83622959|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
83622960|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
83622961|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
83622962|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
83622963|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83622964|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622965|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
83622966|NCT02905578|Paclitaxel|paclitaxel|mesh-list
83622967|NCT02905578|Gemcitabine|gemcitabine|mesh-list
83622968|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83622969|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622970|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83622971|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83622972|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83622973|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622974|NCT02905578|Vitamins|vitamins|mesh-ancestor
83622975|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
83622976|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83622977|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83622978|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
83622979|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
83622980|NCT02905578|Protective Agents|protective agents|mesh-ancestor
83622981|NCT00677586|Liver Extracts|liver extracts|mesh-list
83622982|NCT00677586|Hematinics|hematinics|mesh-ancestor
83622983|NCT05453448|Tenofovir|tenofovir|mesh-list
83622984|NCT05453448|Entecavir|entecavir|mesh-list
83622985|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
83622986|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83622987|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83622988|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83622989|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622990|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83622991|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83622992|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83622993|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
83622994|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83622996|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83622997|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83622998|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83622999|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623000|NCT05354466|Neostigmine|neostigmine|mesh-list
83623001|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83623002|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623003|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623004|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
83623005|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623006|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623007|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83623008|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
83623009|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623010|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
83623011|NCT04095624|Narcotics|narcotics|mesh-ancestor
83623012|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623013|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623014|NCT04095624|Analgesics|analgesics|mesh-ancestor
83623015|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
83623016|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623017|NCT03745716|Azacitidine|azacitidine|mesh-list
83623018|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83623019|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
83623020|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623021|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623022|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623023|NCT03341676|Dexamethasone|dexamethasone|mesh-list
83623024|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623025|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
83623026|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
83623027|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623028|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623029|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623030|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
83623031|NCT03341676|Hormones|hormones|mesh-ancestor
83623032|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623033|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83623034|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623035|NCT03121716|Gemcitabine|gemcitabine|mesh-list
83623036|NCT03121716|Cisplatin|cisplatin|mesh-list
83623037|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83623038|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
83623039|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623040|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623041|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
83623042|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
83623043|NCT02714634|Methotrexate|methotrexate|mesh-list
83623044|NCT02714634|Leflunomide|leflunomide|mesh-list
83623045|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83623046|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
83623047|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83623048|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623049|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83623050|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
83623051|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623052|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623053|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623054|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623055|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83623056|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83623057|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
83623058|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83623059|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83623060|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
83623061|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83623062|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83623063|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081094|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
83623064|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83623065|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83623066|NCT02714634|Analgesics|analgesics|mesh-ancestor
83623067|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
83623068|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623069|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623070|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623071|NCT02708394|Olanzapine|olanzapine|mesh-list
83623072|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
83623073|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
83623074|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623075|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623076|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623077|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83623078|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83623079|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623080|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83623081|NCT02708394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83623082|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83623083|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623084|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623085|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623086|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
83623087|NCT00553800|Bevacizumab|bevacizumab|mesh-list
83623088|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83623089|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623090|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623091|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83623092|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83623093|NCT00553800|Growth Substances|growth substances|mesh-ancestor
83623094|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623095|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83623096|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83623097|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623098|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623099|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
83623100|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623101|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623102|NCT02740920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83623103|NCT02740920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623104|NCT02747628|Melatonin|melatonin|mesh-list
83623105|NCT02747628|Nicotine|nicotine|mesh-list
83623106|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83623107|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
83623108|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623109|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623110|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83623111|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83623112|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
83623113|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623114|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623115|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
83623116|NCT02747628|Protective Agents|protective agents|mesh-ancestor
83623117|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623118|NCT02754570|Pilocarpine|pilocarpine|mesh-list
83623119|NCT02754570|Miotics|miotics|mesh-ancestor
83623120|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
83623121|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623122|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623123|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83623124|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83623125|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
83623126|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623127|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623128|NCT02765256|Promethazine|promethazine|mesh-list
83623129|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
83623130|NCT02765256|Vancomycin|vancomycin|mesh-list
83623131|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
83623132|NCT02765256|Neomycin|neomycin|mesh-list
83623133|NCT02765256|Fluconazole|fluconazole|mesh-list
83623134|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83623135|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83623136|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623137|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83623138|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83623139|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623140|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623141|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623142|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83623143|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83623144|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
83623145|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83623146|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83623147|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
83623148|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623149|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623150|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83623151|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83623152|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
83623153|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623154|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83623155|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
83623156|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
83623157|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623158|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83623159|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83623160|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83623161|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623162|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
83623163|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
83623164|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
83623165|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623166|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
83623167|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
83623168|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623169|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83623170|NCT02765256|Laxatives|laxatives|mesh-ancestor
83623171|NCT02767128|Citric Acid|citric acid|mesh-list
83623172|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
83623173|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
83623174|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83623175|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
83623176|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
83623177|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623178|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83623179|NCT02769702|Hormones|hormones|mesh-ancestor
83623180|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623181|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623182|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83623183|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623184|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83623185|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623186|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623187|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
83623188|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
83623189|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623190|NCT02773758|Fluorides|fluorides|mesh-list
83623191|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
83623192|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
83623193|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
83623194|NCT02773758|Protective Agents|protective agents|mesh-ancestor
83623195|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623196|NCT02774226|Vitamins|vitamins|mesh-list
83623197|NCT02774226|Vitamin E|vitamin e|mesh-list
83623198|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
83623199|NCT02774226|Antioxidants|antioxidants|mesh-list
83623200|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
83623201|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623202|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623203|NCT02774226|Protective Agents|protective agents|mesh-ancestor
83623204|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
83623205|NCT02775240|Maribavir|maribavir|mesh-list
83623206|NCT02775240|Digoxin|digoxin|mesh-list
83623207|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
83623208|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83623209|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83623210|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623211|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623212|NCT02775240|Protective Agents|protective agents|mesh-ancestor
83623213|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623214|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
83623215|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
83623216|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83623217|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83623218|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623219|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
83623220|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623221|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
83623222|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623223|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
83623224|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83623225|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83623226|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83623227|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623228|NCT05349396|Eszopiclone|eszopiclone|mesh-list
83623229|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83623230|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623231|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623232|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
83623233|NCT05348148|Cetirizine|cetirizine|mesh-list
83623234|NCT05348148|Phenylephrine|phenylephrine|mesh-list
83623235|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
83623236|NCT05348148|Levocetirizine|levocetirizine|mesh-list
83623237|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623238|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623239|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83623240|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83623241|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83623242|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
83623243|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
83623244|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623245|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623246|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623247|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83623248|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83623249|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83623250|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
83623251|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
83623252|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623253|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
83623254|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83623255|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
83623256|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83623257|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
83623258|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83623259|NCT05348148|Protective Agents|protective agents|mesh-ancestor
83623260|NCT05257590|Nivolumab|nivolumab|mesh-list
83623261|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623262|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623263|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83623264|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623265|NCT05456022|Doxorubicin|doxorubicin|mesh-list
83623266|NCT05456022|Quercetin|quercetin|mesh-list
83623267|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83623268|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623269|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83623270|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83623271|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623272|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623273|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
83623274|NCT05456022|Protective Agents|protective agents|mesh-ancestor
83623275|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623276|NCT05453916|Rifaximin|rifaximin|mesh-list
83623277|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
83623278|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83623279|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623280|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623281|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83623282|NCT05273814|Bevacizumab|bevacizumab|mesh-list
83623283|NCT05273814|Tislelizumab|tislelizumab|mesh-list
83623284|NCT05273814|Pemetrexed|pemetrexed|mesh-list
83623285|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83623286|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623287|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623288|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83623289|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83623290|NCT05273814|Growth Substances|growth substances|mesh-ancestor
83623291|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623292|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
83623293|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623294|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623295|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83623296|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83623297|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
83623298|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83623299|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623300|NCT04784208|Hormones|hormones|mesh-list
83623301|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623302|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623303|NCT04024878|Nivolumab|nivolumab|mesh-list
83623304|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623305|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623306|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83623307|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623308|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
83623309|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83623310|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83623311|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83623312|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623313|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623314|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
83623315|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623316|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623317|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83623318|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623319|NCT02529930|Vaccines|vaccines|mesh-list
83623320|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
83623321|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623322|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
83623323|NCT00039780|Protective Agents|protective agents|mesh-ancestor
83623324|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623325|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
83623326|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83623327|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
83623328|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623329|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623330|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83623331|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
83623332|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83623333|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
83623334|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623335|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623336|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83623337|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
83623338|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
83623339|NCT05101746|Protective Agents|protective agents|mesh-ancestor
83623340|NCT04763226|Furosemide|furosemide|mesh-list
83623341|NCT04763226|Diuretics|diuretics|mesh-ancestor
83623342|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
83623343|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623344|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83623345|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623346|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623347|NCT04549428|Atezolizumab|atezolizumab|mesh-list
83623348|NCT04549428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83623349|NCT04549428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623350|NCT04549428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623351|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623352|NCT04340856|Bisacodyl|bisacodyl|mesh-list
83623353|NCT04340856|Laxatives|laxatives|mesh-list
83623354|NCT04340856|Cathartics|cathartics|mesh-ancestor
83623355|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623356|NCT04040790|Phenylephrine|phenylephrine|mesh-list
83623357|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
83623358|NCT04040790|Tropicamide|tropicamide|mesh-list
83623359|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83623360|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
83623361|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
83623362|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623363|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081400|NCT02500940|Vitamins|vitamins|mesh-ancestor
83623364|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
83623365|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83623366|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
83623367|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
83623368|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83623369|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83623370|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83623371|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
83623372|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623373|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623374|NCT04040790|Protective Agents|protective agents|mesh-ancestor
83623375|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83623376|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83623377|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
83623378|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83623379|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83623380|NCT03556800|Estradiol|estradiol|mesh-list
83623381|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83623382|NCT03556800|Estrogens|estrogens|mesh-ancestor
83623383|NCT03556800|Hormones|hormones|mesh-ancestor
83623384|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623385|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623386|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83623387|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
83623388|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83623389|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83623390|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
83623391|NCT04741620|Capsaicin|capsaicin|mesh-list
83623392|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
83623393|NCT04741620|Citric Acid|citric acid|mesh-list
83623394|NCT04741620|Piperine|piperine|mesh-list
83623395|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
83623396|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623397|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
83623398|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623399|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623400|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
83623401|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83623402|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
83623403|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
83623404|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623405|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83623406|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623407|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83623408|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623409|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83623410|NCT04741620|Protective Agents|protective agents|mesh-ancestor
83623411|NCT01785420|Trastuzumab|trastuzumab|mesh-list
83623412|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623413|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623414|NCT00800514|Amantadine|amantadine|mesh-list
83623415|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83623416|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83623417|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
83623418|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623419|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
83623420|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623421|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623422|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623423|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83623424|NCT00800514|Analgesics|analgesics|mesh-ancestor
83623425|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
83623426|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623427|NCT02780622|Oseltamivir|oseltamivir|mesh-list
83623428|NCT02780622|Warfarin|warfarin|mesh-list
83623429|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
83623430|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
83623431|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623432|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623433|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623434|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
83623435|NCT02791308|Tacrolimus|tacrolimus|mesh-list
83623436|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081467|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
83623437|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83623438|NCT02791308|Analgesics|analgesics|mesh-ancestor
83623439|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
83623440|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623441|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623442|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623443|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83623444|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623445|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83623446|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
83623447|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83623448|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623449|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623450|NCT02796144|Metformin|metformin|mesh-list
83623451|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83623452|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623453|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
83623454|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83623455|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623456|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83623457|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83623458|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623459|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623460|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623461|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83623462|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83623463|NCT02813070|Flutemetamol|flutemetamol|mesh-list
83623464|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83623465|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623466|NCT02815644|Empagliflozin|empagliflozin|mesh-list
83623467|NCT02815644|Linagliptin|linagliptin|mesh-list
83623468|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83623469|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623470|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83623471|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623472|NCT02815644|Incretins|incretins|mesh-ancestor
83623473|NCT02815644|Hormones|hormones|mesh-ancestor
83623474|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623475|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83623476|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
83623477|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623478|NCT02820324|Morphine|morphine|mesh-list
83623479|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83623480|NCT02820324|Narcotics|narcotics|mesh-ancestor
83623481|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623482|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623483|NCT02820324|Analgesics|analgesics|mesh-ancestor
83623484|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
83623485|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623486|NCT02821338|Lamotrigine|lamotrigine|mesh-list
83623487|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
83623488|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83623489|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623490|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623491|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83623492|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623493|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83623494|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83623495|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623496|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83623497|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83623498|NCT02835846|Estrogens|estrogens|mesh-list
83623499|NCT02835846|Hormones|hormones|mesh-ancestor
83623500|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623501|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623502|NCT02844582|Prednisone|prednisone|mesh-list
83623503|NCT02844582|Cortisone|cortisone|mesh-list
83623504|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623505|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
83623506|NCT02844582|Hormones|hormones|mesh-ancestor
83623507|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623508|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623509|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83623510|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623511|NCT02845752|Bromides|bromides|mesh-list
83081540|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623512|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
83623513|NCT02845752|Olodaterol|olodaterol|mesh-list
83623514|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83623515|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
83623516|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623517|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623518|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83623519|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
83623520|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
83623521|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83623522|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
83623523|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623524|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623525|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
83623526|NCT02849184|Suvorexant|suvorexant|mesh-list
83623527|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83623528|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83623529|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623530|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623531|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83623532|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623533|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623534|NCT02862912|Fentanyl|fentanyl|mesh-list
83623535|NCT02862912|Bupivacaine|bupivacaine|mesh-list
83623536|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
83623537|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
83623538|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
83623539|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623540|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623541|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
83623542|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623543|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83623544|NCT02862912|Narcotics|narcotics|mesh-ancestor
83623545|NCT02862912|Analgesics|analgesics|mesh-ancestor
83623546|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83623547|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83623548|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
83623549|NCT02864706|Cyclosporine|cyclosporine|mesh-list
83623550|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
83623551|NCT02864706|Everolimus|everolimus|mesh-list
83623552|NCT02864706|Cyclosporins|cyclosporins|mesh-list
83623553|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623554|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623555|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83623556|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
83623557|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623558|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
83623559|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623560|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623561|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83623562|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83623563|NCT02864706|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83623564|NCT02864706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83623565|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623566|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83623567|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83623568|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
83623569|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83623570|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83623571|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83623572|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83623573|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
83623574|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623575|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
83623576|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83623577|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623578|NCT02873286|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83623579|NCT02873286|Antiviral Agents|antiviral agents|mesh-ancestor
83623580|NCT02873286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623581|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83623582|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83623583|NCT02880228|Dexamethasone|dexamethasone|mesh-list
83623584|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
83623585|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
83623586|NCT02880228|Lenalidomide|lenalidomide|mesh-list
83081613|NCT00707174|Imiquimod|imiquimod|mesh-list
83623587|NCT02880228|Ichthammol|ichthammol|mesh-list
83623588|NCT02880228|BB 1101|bb 1101|mesh-list
83623589|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623590|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
83623591|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
83623592|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623593|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623594|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623595|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
83623596|NCT02880228|Hormones|hormones|mesh-ancestor
83623597|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623598|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83623599|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623600|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623601|NCT02880228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83623602|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623603|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
83623604|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83623605|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83623606|NCT02880228|Growth Substances|growth substances|mesh-ancestor
83623607|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
83623608|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83623609|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623610|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623611|NCT02880852|Belimumab|belimumab|mesh-list
83623612|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83623613|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
83623614|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623615|NCT02887404|Analgesics|analgesics|mesh-list
83623616|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
83623617|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623618|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623619|NCT02889510|Liraglutide|liraglutide|mesh-list
83623620|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83623621|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623622|NCT02889510|Incretins|incretins|mesh-ancestor
83623623|NCT02889510|Hormones|hormones|mesh-ancestor
83623624|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623625|NCT02902770|Ketorolac|ketorolac|mesh-list
83623626|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83623627|NCT02902770|Lidocaine|lidocaine|mesh-list
83623628|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
83623629|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
83623630|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623631|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623632|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
83623633|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623634|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83623635|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83623636|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83623637|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623638|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623639|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83623640|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83623641|NCT02902770|Analgesics|analgesics|mesh-ancestor
83623642|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623643|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83623644|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83623645|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623646|NCT02907918|Trastuzumab|trastuzumab|mesh-list
83623647|NCT02907918|Letrozole|letrozole|mesh-list
83623648|NCT02907918|Palbociclib|palbociclib|mesh-list
83623649|NCT02907918|Goserelin|goserelin|mesh-list
83623650|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623651|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623652|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83623653|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83623654|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623655|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623656|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83623657|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
83623658|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623659|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081690|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83623660|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83623661|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83623662|NCT02908620|Anesthetics|anesthetics|mesh-list
83623663|NCT02908620|Tetracaine|tetracaine|mesh-list
83623664|NCT02908620|Benzocaine|benzocaine|mesh-list
83623665|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623666|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623667|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
83623668|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
83623669|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623670|NCT02911818|Liraglutide|liraglutide|mesh-list
83623671|NCT02911818|Phentermine|phentermine|mesh-list
83623672|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83623673|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623674|NCT02911818|Incretins|incretins|mesh-ancestor
83623675|NCT02911818|Hormones|hormones|mesh-ancestor
83623676|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623677|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83623678|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
83623679|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83623680|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
83623681|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
83623682|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623683|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
83623684|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623685|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623686|NCT02912364|Carbamazepine|carbamazepine|mesh-list
83623687|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83623688|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
83623689|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
83623690|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83623691|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623692|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623693|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83623694|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83623695|NCT02912364|Analgesics|analgesics|mesh-ancestor
83623696|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
83623697|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623698|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83623699|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623700|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623701|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83623702|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83623703|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83623704|NCT02913924|Clonazepam|clonazepam|mesh-list
83623705|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
83623706|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
83623707|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
83623708|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623709|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623710|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623711|NCT02917122|Sertraline|sertraline|mesh-list
83623712|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
83623713|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83623714|NCT02917122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83623715|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83623716|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623717|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623718|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623719|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
83623720|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623721|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
83623722|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83623723|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83623724|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623725|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
83623726|NCT02922582|Coagulants|coagulants|mesh-ancestor
83623727|NCT02925858|Ketamine|ketamine|mesh-list
83623728|NCT02925858|Analgesics|analgesics|mesh-ancestor
83623729|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
83623730|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623731|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623732|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83623733|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83623734|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
83623735|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
83623736|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623737|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83623738|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83623739|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623740|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623742|NCT02933034|Trace Elements|trace elements|mesh-ancestor
83623743|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
83623744|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623745|NCT02937168|Reslizumab|reslizumab|mesh-list
83623746|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83623747|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83623748|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623749|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83623750|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
83623751|NCT02937558|Glucagon|glucagon|mesh-list
83623752|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83623753|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623754|NCT02937558|Hormones|hormones|mesh-ancestor
83623755|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623756|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623757|NCT02937558|Incretins|incretins|mesh-ancestor
83623758|NCT02938494|Tazarotene|tazarotene|mesh-list
83623759|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
83623760|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
83623761|NCT02941692|Oxytocin|oxytocin|mesh-list
83623762|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
83623763|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83623764|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623765|NCT02953860|Fulvestrant|fulvestrant|mesh-list
83623766|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83623767|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623768|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83623769|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83623770|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
83623771|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623772|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623773|NCT02956044|Metformin|metformin|mesh-list
83623774|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83623775|NCT02956044|Glimepiride|glimepiride|mesh-list
83623776|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
83623777|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83623778|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623779|NCT02956044|Incretins|incretins|mesh-ancestor
83623780|NCT02956044|Hormones|hormones|mesh-ancestor
83623781|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623782|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83623783|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
83623784|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623785|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623786|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83623787|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83623788|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
83623789|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
83623790|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83623791|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83623792|NCT02956122|Prednisolone|prednisolone|mesh-list
83623793|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
83623794|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83623795|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
83623796|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
83623797|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83623798|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623799|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
83623800|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
83623801|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623802|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623803|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623804|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
83623805|NCT02956122|Hormones|hormones|mesh-ancestor
83623806|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623807|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83623808|NCT02956122|Protective Agents|protective agents|mesh-ancestor
83623809|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83623810|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623811|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623812|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623813|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83623814|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83623815|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
83623816|NCT02956746|Antibodies|antibodies|mesh-list
83623817|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
83623818|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83623819|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83623820|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
83623821|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623822|NCT02967354|Tryptophan|tryptophan|mesh-list
83623823|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83623824|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83623825|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
83623826|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83623827|NCT02968134|Posaconazole|posaconazole|mesh-list
83623828|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
83623829|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623830|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83623831|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83623832|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83623833|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83623834|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83623835|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623836|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623837|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83623838|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
83623839|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623840|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623841|NCT02968368|Ferric maltol|ferric maltol|mesh-list
83623842|NCT02968368|Hematinics|hematinics|mesh-ancestor
83623843|NCT02968914|Benralizumab|benralizumab|mesh-list
83623844|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83623845|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
83623846|NCT02970162|Amifampridine|amifampridine|mesh-list
83623847|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83623848|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623849|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623850|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83623851|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83623852|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623853|NCT02970552|Progesterone|progesterone|mesh-list
83623854|NCT02970552|Progestins|progestins|mesh-ancestor
83623855|NCT02970552|Hormones|hormones|mesh-ancestor
83623856|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623857|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623858|NCT02978508|Permethrin|permethrin|mesh-list
83623859|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623860|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623861|NCT02881008|Entecavir|entecavir|mesh-list
83623862|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
83623863|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623864|NCT02988882|Dexamethasone|dexamethasone|mesh-list
83623865|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623866|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
83623867|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
83623868|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623869|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623870|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83623871|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
83623872|NCT02988882|Hormones|hormones|mesh-ancestor
83623873|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83623874|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83623875|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623876|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
83623877|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83623878|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83623879|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623880|NCT03009162|Lasmiditan|lasmiditan|mesh-list
83623881|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83623882|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
83623883|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623884|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623885|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623886|NCT03009396|Clarithromycin|clarithromycin|mesh-list
83623887|NCT03009396|Rifabutin|rifabutin|mesh-list
83623888|NCT03009396|Clofazimine|clofazimine|mesh-list
83623889|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83623890|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623891|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83623892|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623893|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623894|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83623895|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83623896|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83623897|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
83623898|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83623899|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
83623900|NCT03012594|Lanreotide|lanreotide|mesh-list
83623901|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623902|NCT03017508|Riluzole|riluzole|mesh-list
83623903|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
83623904|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83623905|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83623906|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623907|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623908|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623909|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83623910|NCT03017508|Protective Agents|protective agents|mesh-ancestor
83623911|NCT03020004|Ritonavir|ritonavir|mesh-list
83623912|NCT03020004|Ribavirin|ribavirin|mesh-list
83623913|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83623914|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83623915|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83623916|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
83623917|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623918|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623919|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83623920|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83623921|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
83623922|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623923|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83623924|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83623925|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
83623926|NCT03020082|Ritonavir|ritonavir|mesh-list
83623927|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83623928|NCT03020082|Ribavirin|ribavirin|mesh-list
83623929|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83623930|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83623931|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
83623932|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623933|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623934|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83623935|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83623936|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
83623937|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623938|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83623939|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83623940|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
83623941|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
83623942|NCT03026556|Apixaban|apixaban|mesh-list
83623943|NCT03026556|Dabigatran|dabigatran|mesh-list
83623944|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83623945|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
83623946|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83623947|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
83623948|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83623949|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623950|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
83623951|NCT03035760|Oxfendazole|oxfendazole|mesh-list
83623952|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
83623953|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83623954|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83623955|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
83623956|NCT03036384|Sufentanil|sufentanil|mesh-list
83623957|NCT03036384|Morphine|morphine|mesh-list
83623958|NCT03036384|Prilocaine|prilocaine|mesh-list
83623959|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83623960|NCT03036384|Narcotics|narcotics|mesh-ancestor
83623961|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623962|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623963|NCT03036384|Analgesics|analgesics|mesh-ancestor
83623964|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
83623965|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83623966|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83623967|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83623968|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
83623969|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
83623970|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
83623971|NCT03040362|Lasmiditan|lasmiditan|mesh-list
83623972|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83623973|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
83623974|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83623975|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623976|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623977|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83623978|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
83623979|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
83623980|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623981|NCT03044418|Propofol|propofol|mesh-list
83623982|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
83623983|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83623984|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623985|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83623986|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83623987|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
83623988|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83623989|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
83623990|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
83623991|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623992|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
83623993|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83623994|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83623995|NCT03051672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83623996|NCT03051672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83623997|NCT03057132|Protective Agents|protective agents|mesh-list
83623998|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83623999|NCT03057366|Paclitaxel|paclitaxel|mesh-list
83624000|NCT03057366|Docetaxel|docetaxel|mesh-list
83624001|NCT03057366|Carboplatin|carboplatin|mesh-list
83624002|NCT03057366|Pevonedistat|pevonedistat|mesh-list
83624003|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83624004|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624005|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
83624006|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
83624007|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
83624008|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624009|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624010|NCT03060486|Hybenx|hybenx|mesh-list
83624011|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
83624012|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
83624013|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624014|NCT03061812|Dexamethasone|dexamethasone|mesh-list
83624015|NCT03061812|Topotecan|topotecan|mesh-list
83624016|NCT03061812|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83624017|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624018|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
83624019|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
83624020|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624021|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624022|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624023|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
83624024|NCT03061812|Hormones|hormones|mesh-ancestor
83624025|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83624026|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83624027|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624028|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83624029|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83624030|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624031|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624032|NCT03061812|Immunoconjugates|immunoconjugates|mesh-ancestor
83624033|NCT03061812|Immunologic Factors|immunologic factors|mesh-ancestor
83624034|NCT03070470|Ritonavir|ritonavir|mesh-list
83624035|NCT03070470|Lopinavir|lopinavir|mesh-list
83624036|NCT03070470|Chloroquine|chloroquine|mesh-list
83624037|NCT03070470|Verapamil|verapamil|mesh-list
83082074|NCT02492360|Cisplatin|cisplatin|mesh-list
83624039|NCT03070470|Diltiazem|diltiazem|mesh-list
83624040|NCT03070470|Ranolazine|ranolazine|mesh-list
83624041|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83624042|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83624043|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
83624044|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624045|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624046|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83624047|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83624048|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
83624049|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624050|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83624051|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83624052|NCT03070470|Amebicides|amebicides|mesh-ancestor
83624053|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83624054|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83624055|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
83624056|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624057|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624058|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83624059|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83624060|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624061|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83624062|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
83624063|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83624064|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83624065|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83624066|NCT03070548|Talazoparib|talazoparib|mesh-list
83624067|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83624068|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624069|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624070|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624071|NCT03080142|Bupivacaine|bupivacaine|mesh-list
83624072|NCT03080142|Ropivacaine|ropivacaine|mesh-list
83624073|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624074|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
83624075|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624076|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624077|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
83624078|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624079|NCT03088800|Ibuprofen|ibuprofen|mesh-list
83624080|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83624081|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624082|NCT03088800|Analgesics|analgesics|mesh-ancestor
83624083|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
83624084|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624085|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624086|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624087|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624088|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83624089|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624090|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624091|NCT03096444|Lidocaine|lidocaine|mesh-list
83624092|NCT03096444|Ketamine|ketamine|mesh-list
83624093|NCT03096444|Amitriptyline|amitriptyline|mesh-list
83624094|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624095|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
83624096|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624097|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624098|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
83624099|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624100|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83624101|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83624102|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83624103|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624104|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624105|NCT03096444|Analgesics|analgesics|mesh-ancestor
83624106|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83624107|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83624108|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
83624109|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83624110|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83624111|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624112|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83624113|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
83624114|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83624115|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624116|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83624117|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83624118|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624119|NCT03107754|Lidocaine|lidocaine|mesh-list
83624120|NCT03107754|Anesthetics|anesthetics|mesh-list
83624121|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624122|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624123|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624124|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
83624125|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624126|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83624127|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83624128|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83624129|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624130|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624131|NCT03124758|Chrysarobin|chrysarobin|mesh-list
83624132|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83624133|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624134|NCT03124758|Analgesics|analgesics|mesh-ancestor
83624135|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
83624136|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624137|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624138|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624139|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624140|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
83624141|NCT03148236|Vitamins|vitamins|mesh-ancestor
83624142|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
83624143|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624144|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
83624145|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624146|NCT03148236|Protective Agents|protective agents|mesh-ancestor
83624147|NCT03174366|Denosumab|denosumab|mesh-list
83624148|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83624149|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624150|NCT03177798|Icatibant|icatibant|mesh-list
83624151|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83624152|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624153|NCT03177798|Analgesics|analgesics|mesh-ancestor
83624154|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
83624155|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624156|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624157|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624158|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624159|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83624160|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83624161|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624162|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83624163|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83624164|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
83624165|NCT05093790|Aspirin|aspirin|mesh-list
83624166|NCT05093790|Ticagrelor|ticagrelor|mesh-list
83624167|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83624168|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624169|NCT05093790|Analgesics|analgesics|mesh-ancestor
83624170|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
83624171|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624172|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624173|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624174|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624175|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83624176|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83624177|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624178|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83624179|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83624180|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624181|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
83624182|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83624183|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83624184|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83624185|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
83624186|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624187|NCT04933344|Daptomycin|daptomycin|mesh-list
83624188|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624189|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624190|NCT05406180|Vaccines|vaccines|mesh-list
83624191|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
83624192|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624193|NCT05405478|Omalizumab|omalizumab|mesh-list
83624194|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83624195|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83624196|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
83624197|NCT05262738|Misoprostol|misoprostol|mesh-list
83624198|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83624199|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
83624200|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624201|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624202|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83624203|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624204|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
83624205|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83624206|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624207|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83624208|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
83624209|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624210|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
83624211|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83624212|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624213|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624214|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83624215|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83624216|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
83624217|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83624218|NCT03872700|Fentanyl|fentanyl|mesh-list
83624219|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83624220|NCT03872700|Narcotics|narcotics|mesh-ancestor
83624221|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624222|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624223|NCT03872700|Analgesics|analgesics|mesh-ancestor
83624224|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
83624225|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624226|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83624227|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83624228|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
83624229|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
83624230|NCT03137160|Ixekizumab|ixekizumab|mesh-list
83624231|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624232|NCT02856126|Sorafenib|sorafenib|mesh-list
83624233|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624234|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83624235|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624236|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624237|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
83624238|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83624239|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83624240|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83624241|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624242|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624243|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
83624244|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624245|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624246|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83624247|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624248|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
83624249|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83624250|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624251|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83624252|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
83624253|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624254|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624255|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624256|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624257|NCT04426500|Bupivacaine|bupivacaine|mesh-list
83624258|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624259|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
83624260|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624261|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624262|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
83624263|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624264|NCT04131192|Gemcitabine|gemcitabine|mesh-list
83624265|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83624266|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
83624267|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624268|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624269|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
83624270|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624271|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624272|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
83624273|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
83624274|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83624275|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
83624276|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624277|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
83624278|NCT03883074|Protective Agents|protective agents|mesh-ancestor
83624279|NCT03883074|Antacids|antacids|mesh-ancestor
83624280|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624281|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624282|NCT03670836|Misoprostol|misoprostol|mesh-list
83624283|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83624284|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
83624285|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624286|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624287|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83624288|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624289|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
83624290|NCT03607656|Docetaxel|docetaxel|mesh-list
83624291|NCT03607656|Capecitabine|capecitabine|mesh-list
83624292|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
83624293|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624294|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
83624295|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
83624296|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
83624297|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624298|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83624299|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
83624300|NCT03409614|Cemiplimab|cemiplimab|mesh-list
83624301|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83624302|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624303|NCT02651844|Mifepristone|mifepristone|mesh-list
83624304|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83624305|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
83624306|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624307|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624308|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83624309|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83624310|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83624311|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
83624312|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83624313|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83624314|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
83624315|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83624316|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
83624317|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83624318|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83624319|NCT01463670|Lenalidomide|lenalidomide|mesh-list
83624320|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
83624321|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624322|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83624323|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83624324|NCT01463670|Growth Substances|growth substances|mesh-ancestor
83624325|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
83624326|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624327|NCT00151398|Donepezil|donepezil|mesh-list
83624328|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83624329|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624330|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624331|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
83624332|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624333|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624334|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
83624335|NCT03181308|Nivolumab|nivolumab|mesh-list
83624336|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83624337|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624338|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83624339|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624340|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
83624341|NCT03202134|Anesthetics|anesthetics|mesh-list
83624342|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624343|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624344|NCT03202134|Narcotics|narcotics|mesh-ancestor
83624345|NCT03202134|Analgesics|analgesics|mesh-ancestor
83624346|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
83624347|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624348|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83624349|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
83624350|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83624351|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83624352|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83624353|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624354|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624355|NCT03218592|Tenofovir|tenofovir|mesh-list
83624356|NCT03218592|Emtricitabine|emtricitabine|mesh-list
83624357|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83624358|NCT03218592|Dolutegravir|dolutegravir|mesh-list
83624359|NCT03218592|Maraviroc|maraviroc|mesh-list
83624360|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
83624361|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624362|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83624363|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83624364|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624365|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624366|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83624367|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83624368|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83624369|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83624370|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83624371|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83624372|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83624373|NCT03219294|Bromides|bromides|mesh-list
83624374|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
83624375|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
83624376|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83624377|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83624378|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83624379|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624380|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624381|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83624382|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83624383|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
83624384|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624385|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624386|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
83624387|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83624388|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624389|NCT03223272|Reserpine|reserpine|mesh-list
83624390|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83624391|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83624392|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83624393|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624394|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624395|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83624396|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83624397|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83624398|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624399|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624400|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624401|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624402|NCT03239106|Apremilast|apremilast|mesh-list
83624403|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83624404|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624405|NCT03239106|Analgesics|analgesics|mesh-ancestor
83624406|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
83624407|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624408|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624409|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082437|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83624410|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624411|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83624412|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83624413|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624414|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624415|NCT03257202|Clindamycin|clindamycin|mesh-list
83624416|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
83624417|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
83624418|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83624419|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624420|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624421|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83624422|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624423|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624424|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624425|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83624426|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
83624427|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624428|NCT03278886|Naltrexone|naltrexone|mesh-list
83624429|NCT03278886|Nalmefene|nalmefene|mesh-list
83624430|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83624431|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83624432|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624433|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
83624434|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624435|NCT03285984|Listerine|listerine|mesh-list
83624436|NCT03285984|Fluorides|fluorides|mesh-list
83624437|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
83624438|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
83624439|NCT03285984|Protective Agents|protective agents|mesh-ancestor
83624440|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624441|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83624442|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624443|NCT03287310|Albuterol|albuterol|mesh-list
83624444|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83624445|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
83624446|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624447|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624448|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83624449|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
83624450|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
83624451|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624452|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83624453|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83624454|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83624455|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624456|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624457|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624458|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83624459|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83624460|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83624461|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624462|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624463|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83624464|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624465|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624466|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
83624467|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624468|NCT03315780|Dulaglutide|dulaglutide|mesh-list
83624469|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83624470|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624471|NCT03334734|Isoniazid|isoniazid|mesh-list
83624472|NCT03334734|Macozinone|macozinone|mesh-list
83624473|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
83624474|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624475|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624476|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83624477|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83624478|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
83624479|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624480|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83624481|NCT03336450|Midazolam|midazolam|mesh-list
83624482|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83624483|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83624484|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624485|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624486|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83624487|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83624488|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83624489|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83624490|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
83624491|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
83624492|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
83624493|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
83624494|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624495|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624496|NCT03340350|Minocycline|minocycline|mesh-list
83624497|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624498|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624499|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
83624500|NCT03341910|Tazarotene|tazarotene|mesh-list
83624501|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624502|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
83624503|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
83624504|NCT03341910|Vitamins|vitamins|mesh-ancestor
83624505|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
83624506|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624507|NCT03343080|Lidocaine|lidocaine|mesh-list
83624508|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624509|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
83624510|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624511|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624512|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
83624513|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624514|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83624515|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83624516|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83624517|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624518|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624519|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
83624520|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83624521|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
83624522|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
83624523|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624524|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624525|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624526|NCT03375294|Analgesics|analgesics|mesh-ancestor
83624527|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
83624528|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624529|NCT03395808|Tramadol|tramadol|mesh-list
83624530|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83624531|NCT03395808|Narcotics|narcotics|mesh-ancestor
83624532|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624533|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624534|NCT03395808|Analgesics|analgesics|mesh-ancestor
83624535|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
83624536|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624537|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
83624538|NCT03395886|Remifentanil|remifentanil|mesh-list
83624539|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83624540|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624541|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624542|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624543|NCT03395886|Analgesics|analgesics|mesh-ancestor
83624544|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
83624545|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624546|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83624547|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83624548|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83624549|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624550|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624551|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624552|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83624553|NCT03395886|Narcotics|narcotics|mesh-ancestor
83624554|NCT03426228|Progesterone|progesterone|mesh-list
83624555|NCT03426228|Estrogens|estrogens|mesh-list
83624556|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624557|NCT03426228|Hormones|hormones|mesh-ancestor
83624558|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83624559|NCT03426228|Progestins|progestins|mesh-ancestor
83624560|NCT03430050|Progesterone|progesterone|mesh-list
83624561|NCT03430050|Progestins|progestins|mesh-ancestor
83624562|NCT03430050|Hormones|hormones|mesh-ancestor
83624563|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83624564|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624565|NCT03440424|Lemborexant|lemborexant|mesh-list
83624566|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83624567|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624568|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624569|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83624570|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83624571|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624572|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624573|NCT03448068|Ketamine|ketamine|mesh-list
83624574|NCT03448068|Analgesics|analgesics|mesh-ancestor
83624575|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
83624576|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624577|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624578|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83624579|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83624580|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
83624581|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
83624582|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624583|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83624584|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83624585|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624586|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624587|NCT03453060|Thrombin|thrombin|mesh-list
83624588|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
83624589|NCT03453060|Coagulants|coagulants|mesh-ancestor
83624590|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
83624591|NCT03459612|Promethazine|promethazine|mesh-list
83624592|NCT03459612|Lasmiditan|lasmiditan|mesh-list
83624593|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83624594|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83624595|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624596|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624597|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624598|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
83624599|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
83624600|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624601|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
83624602|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
83624603|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624604|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83624605|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
83624606|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
83624607|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624608|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624609|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83624610|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
83624611|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624612|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83624613|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
83624614|NCT03463512|Racecadotril|racecadotril|mesh-list
83624615|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
83624616|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624617|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
83624618|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624619|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624620|NCT03473184|Diacerein|diacerein|mesh-list
83624621|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624622|NCT03485976|Ixekizumab|ixekizumab|mesh-list
83624623|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624624|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83624625|NCT03496974|Antibodies|antibodies|mesh-list
83624626|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
83624627|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83624628|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
83624629|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624630|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624631|NCT03503292|Ondansetron|ondansetron|mesh-list
83624632|NCT03503292|Granisetron|granisetron|mesh-list
83624633|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
83624634|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
83624635|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624636|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624637|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624638|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
83624639|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624640|NCT03503292|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83624641|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83624642|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
83624643|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624644|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624645|NCT03506724|Labetalol|labetalol|mesh-list
83624646|NCT03506724|Nifedipine|nifedipine|mesh-list
83624647|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83624648|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624649|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624650|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83624651|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624652|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
83624653|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
83624654|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624655|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83624656|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83624657|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624658|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624659|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83624660|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
83624661|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
83624662|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624663|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83624664|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83624665|NCT03509766|Histamine|histamine|mesh-list
83624666|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
83624667|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
83624668|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624669|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624670|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624671|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
83624672|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83624673|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624674|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
83624675|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624676|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
83624677|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
83624678|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
83624679|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624680|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83624681|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83624682|NCT03541356|Carbidopa|carbidopa|mesh-list
83624683|NCT03541356|Levodopa|levodopa|mesh-list
83624684|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83624685|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83624686|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83624687|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
83624688|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624689|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624690|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624691|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83624692|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624693|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
83624694|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83624695|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624696|NCT03572478|Nivolumab|nivolumab|mesh-list
83624697|NCT03572478|Rucaparib|rucaparib|mesh-list
83624698|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83624699|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624700|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83624701|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624702|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83624703|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624704|NCT03574818|Gemcitabine|gemcitabine|mesh-list
83624705|NCT03574818|Necitumumab|necitumumab|mesh-list
83624706|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624707|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83624708|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
83624709|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624710|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83624711|NCT03593538|Metformin|metformin|mesh-list
83624712|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83624713|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624714|NCT03610464|Amphetamine|amphetamine|mesh-list
83624715|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83624716|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624717|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
83624718|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
83624719|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624720|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
83624721|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624722|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624723|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624724|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83624725|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83624726|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624727|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83624728|NCT03615534|Niacin|niacin|mesh-list
83624729|NCT03615534|Fenofibrate|fenofibrate|mesh-list
83624730|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83624731|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
83624732|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624733|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83624734|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
83624735|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
83624736|NCT03615534|Vitamins|vitamins|mesh-ancestor
83624737|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
83624738|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624739|NCT03630198|Lidocaine|lidocaine|mesh-list
83624740|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624741|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
83624742|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624743|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624744|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
83624745|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624746|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83624747|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83624748|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83624749|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83624750|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624751|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83624752|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83624753|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624754|NCT03655080|Paclitaxel|paclitaxel|mesh-list
83624755|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83624756|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83624757|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624758|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83624759|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83624760|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83624761|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624762|NCT03674970|Nicotine|nicotine|mesh-list
83624763|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83624764|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
83624765|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624766|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624767|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83624768|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83624769|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
83624770|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624771|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624772|NCT03704376|Clonidine|clonidine|mesh-list
83624773|NCT03704376|Ropivacaine|ropivacaine|mesh-list
83624774|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624775|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
83624776|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624777|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624778|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
83624779|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624780|NCT03704376|Analgesics|analgesics|mesh-ancestor
83624781|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83624782|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
83624783|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
83624784|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83624785|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83624786|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83624787|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624788|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624789|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624790|NCT03716076|Carbetocin|carbetocin|mesh-list
83624791|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
83624792|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624793|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624794|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
83624795|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
83624796|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624797|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
83624798|NCT03889158|Vaccines|vaccines|mesh-list
83624799|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
83624800|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624801|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
83624802|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624803|NCT03889158|Protective Agents|protective agents|mesh-ancestor
83624804|NCT03889158|Vitamins|vitamins|mesh-ancestor
83624805|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
83624806|NCT04138758|Bromides|bromides|mesh-list
83624807|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
83624808|NCT04138758|Olodaterol|olodaterol|mesh-list
83624809|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83624810|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
83624811|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624812|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624813|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83624814|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
83624815|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
83624816|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83624817|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
83624818|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624819|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624820|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
83624821|NCT04323852|Vitamin D|vitamin d|mesh-list
83624822|NCT04323852|Vitamins|vitamins|mesh-ancestor
83624823|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
83624824|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624825|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83624826|NCT04420572|Betamethasone|betamethasone|mesh-list
83624827|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624828|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
83624829|NCT04420572|Hormones|hormones|mesh-ancestor
83624830|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83624831|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624832|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83624833|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
83624834|NCT03541980|Acetaminophen|acetaminophen|mesh-list
83624835|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624836|NCT03541980|Analgesics|analgesics|mesh-ancestor
83624837|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
83624838|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624839|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624840|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
83624841|NCT04511520|Trimetazidine|trimetazidine|mesh-list
83624842|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
83624843|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
83624844|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624845|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
83624846|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624847|NCT04335552|Azithromycin|azithromycin|mesh-list
83624848|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
83624849|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624850|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624851|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
83624852|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83624853|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83624854|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624855|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624856|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624857|NCT04284930|Bupivacaine|bupivacaine|mesh-list
83624858|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624859|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
83624860|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624861|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624862|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
83624863|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624864|NCT04267770|Insulin|insulin|mesh-list
83624865|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83624866|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83082966|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624867|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624868|NCT04204200|Vitamins|vitamins|mesh-list
83624869|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
83624870|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
83624871|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624872|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
83624873|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624874|NCT04204200|Protective Agents|protective agents|mesh-ancestor
83624875|NCT04179474|Erenumab|erenumab|mesh-list
83624876|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83624877|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624878|NCT04179474|Analgesics|analgesics|mesh-ancestor
83624879|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
83624880|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624881|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624882|NCT04150224|Macozinone|macozinone|mesh-list
83624883|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
83624884|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83624885|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624886|NCT04112160|Ketorolac|ketorolac|mesh-list
83624887|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83624888|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83624889|NCT04112160|Analgesics|analgesics|mesh-ancestor
83624890|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
83624891|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624892|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624893|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83624894|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624895|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83624896|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624897|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624898|NCT04102956|Kallikreins|kallikreins|mesh-list
83624899|NCT04102956|Coagulants|coagulants|mesh-ancestor
83624900|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83624901|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
83624902|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624903|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624904|NCT04053270|Afamelanotide|afamelanotide|mesh-list
83624905|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624906|NCT03976752|Tenofovir|tenofovir|mesh-list
83624907|NCT03976752|Emtricitabine|emtricitabine|mesh-list
83624908|NCT03976752|Cobicistat|cobicistat|mesh-list
83624909|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83624910|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83624911|NCT03976752|Elvitegravir|elvitegravir|mesh-list
83624912|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
83624913|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83624914|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83624915|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83624916|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624917|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624918|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83624919|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83624920|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83624921|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83624922|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83624923|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
83624924|NCT03962634|Tetracaine|tetracaine|mesh-list
83624925|NCT03962634|Carticaine|carticaine|mesh-list
83624926|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
83624927|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
83624928|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83624929|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624930|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
83624931|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83624932|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83624933|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83624934|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83624935|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83624936|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624937|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
83624938|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
83624939|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
83624940|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83624941|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
83624942|NCT03933774|Tretinoin|tretinoin|mesh-list
83624943|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624944|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
83624945|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
83624946|NCT03933618|Anastrozole|anastrozole|mesh-list
83624947|NCT03933618|Clomiphene|clomiphene|mesh-list
83624948|NCT03933618|Enclomiphene|enclomiphene|mesh-list
83624949|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
83624950|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624951|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83624952|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624953|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83624954|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83624955|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624956|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83624957|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
83624958|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83624959|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624960|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83624961|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
83624962|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83624963|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83624964|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83624965|NCT03930264|Azathioprine|azathioprine|mesh-list
83624966|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
83624967|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624968|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83624969|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83624970|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83624971|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
83624972|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624973|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83624974|NCT03861000|BPN14770|bpn14770|mesh-list
83624975|NCT03861000|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83624976|NCT03861000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83624977|NCT03861000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624978|NCT03861000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624979|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83624980|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83624981|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
83624982|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83624983|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83624984|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624985|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
83624986|NCT03856164|Coagulants|coagulants|mesh-ancestor
83624987|NCT03849690|Esomeprazole|esomeprazole|mesh-list
83624988|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83624989|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83624990|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83624991|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83624992|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83624993|NCT03822078|Denosumab|denosumab|mesh-list
83624994|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83624995|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83624996|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
83624997|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83624998|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83624999|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625000|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
83625001|NCT03806556|Coagulants|coagulants|mesh-ancestor
83625002|NCT03812328|Enoxaparin|enoxaparin|mesh-list
83625003|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
83625004|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83625005|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83625006|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625007|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
83625008|NCT03805386|Narcotics|narcotics|mesh-ancestor
83625009|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625010|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625011|NCT03805386|Analgesics|analgesics|mesh-ancestor
83625012|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
83625013|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625014|NCT03796260|Entrectinib|entrectinib|mesh-list
83625015|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625016|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625017|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625018|NCT03796182|Metformin|metformin|mesh-list
83625019|NCT03796182|Abrocitinib|abrocitinib|mesh-list
83625020|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83625021|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625022|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625023|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625024|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625025|NCT03730116|Bisoprolol|bisoprolol|mesh-list
83625026|NCT03730116|Perindopril|perindopril|mesh-list
83625027|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83625028|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
83625029|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
83625030|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625031|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625032|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83625033|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83625034|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83625035|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625036|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625037|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625038|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83625039|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
83625040|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625041|NCT03370536|Ibutilide|ibutilide|mesh-list
83625042|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83625043|NCT03161964|Propranolol|propranolol|mesh-list
83625044|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83625045|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83625046|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625047|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625048|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625049|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625050|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83625051|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83625052|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
83625053|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
83625054|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83625055|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83625056|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83625057|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625058|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625059|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
83625060|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625061|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625062|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83625063|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625064|NCT03042780|Folfirinox|folfirinox|mesh-list
83625065|NCT03042780|Lenograstim|lenograstim|mesh-list
83625066|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83625067|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
83625068|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625069|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625070|NCT02985840|Dexamethasone|dexamethasone|mesh-list
83625071|NCT02985840|Ondansetron|ondansetron|mesh-list
83625072|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83625073|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
83625074|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
83625075|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625076|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625077|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83625078|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
83625079|NCT02985840|Hormones|hormones|mesh-ancestor
83625080|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625081|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83625082|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625083|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
83625084|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
83625085|NCT02985840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83625086|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83625087|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
83625088|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625089|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625090|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
83625092|NCT02974686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83625093|NCT02974686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625094|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625095|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625096|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625097|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
83625098|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625099|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625100|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83625101|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83625102|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
83625103|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83625104|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625105|NCT02966184|Albuterol|albuterol|mesh-list
83625106|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83625107|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
83625108|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625109|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625110|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83625111|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625112|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
83625113|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83625114|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83625115|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83625116|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83625117|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625118|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625119|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625120|NCT02774148|Acetaminophen|acetaminophen|mesh-list
83625121|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83625122|NCT02774148|Analgesics|analgesics|mesh-ancestor
83625123|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
83625124|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625125|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625126|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
83625127|NCT02744352|Ropivacaine|ropivacaine|mesh-list
83625128|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
83625129|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
83625130|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625131|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625132|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
83625133|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625134|NCT02587650|Ceritinib|ceritinib|mesh-list
83625135|NCT02587650|Entrectinib|entrectinib|mesh-list
83625136|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625137|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625138|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625139|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625140|NCT02514252|Fentanyl|fentanyl|mesh-list
83625141|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83625142|NCT02514252|Narcotics|narcotics|mesh-ancestor
83625143|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625144|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625145|NCT02514252|Analgesics|analgesics|mesh-ancestor
83625146|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
83625147|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625148|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83625149|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83625150|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
83625151|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
83625152|NCT02434146|Phenylephrine|phenylephrine|mesh-list
83625153|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
83625154|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83625155|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
83625156|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
83625157|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625158|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625159|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
83625160|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83625161|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
83625162|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625163|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83083191|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
83625164|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83625165|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83625166|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625167|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625168|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625169|NCT02434146|Protective Agents|protective agents|mesh-ancestor
83625170|NCT02382588|Ganciclovir|ganciclovir|mesh-list
83625171|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
83625172|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625173|NCT02345460|Leucovorin|leucovorin|mesh-list
83625174|NCT02345460|Fluorouracil|fluorouracil|mesh-list
83625175|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
83625176|NCT02345460|Irinotecan|irinotecan|mesh-list
83625177|NCT02345460|Calcium|calcium|mesh-list
83625178|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
83625179|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83625180|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625181|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
83625182|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625183|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83625184|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625185|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625186|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
83625187|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83625188|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83625189|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625190|NCT02345460|Antidotes|antidotes|mesh-ancestor
83625191|NCT02345460|Protective Agents|protective agents|mesh-ancestor
83625192|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
83625193|NCT02345460|Vitamins|vitamins|mesh-ancestor
83625194|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
83625195|NCT02345772|Docetaxel|docetaxel|mesh-list
83625196|NCT02345772|Trastuzumab|trastuzumab|mesh-list
83625197|NCT02345772|Fulvestrant|fulvestrant|mesh-list
83625198|NCT02345772|Pertuzumab|pertuzumab|mesh-list
83625199|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625200|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83625201|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83625202|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83625203|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625204|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83625205|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83625206|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83625207|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83625208|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83625209|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625210|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625211|NCT02280252|Paclitaxel|paclitaxel|mesh-list
83625212|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83625213|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625214|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
83625215|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
83625216|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
83625217|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625218|NCT02140788|Metformin|metformin|mesh-list
83625219|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83625220|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625221|NCT02133534|Atorvastatin|atorvastatin|mesh-list
83625222|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83625223|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83625224|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
83625225|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625226|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83625227|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83625228|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625229|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83625230|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83625231|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625232|NCT02015910|Incretins|incretins|mesh-ancestor
83625233|NCT02015910|Hormones|hormones|mesh-ancestor
83625234|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625235|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83625236|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
83625237|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625238|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625239|NCT01980342|Efavirenz|efavirenz|mesh-list
83625240|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83625241|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83625242|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625243|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625244|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
83625245|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625246|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83625247|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83625248|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83625249|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83625250|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83625251|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83625252|NCT01881984|Glycerol|glycerol|mesh-list
83625253|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83625254|NCT01881984|Protective Agents|protective agents|mesh-ancestor
83625255|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625256|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
83625257|NCT01878786|Everolimus|everolimus|mesh-list
83625258|NCT01878786|Tacrolimus|tacrolimus|mesh-list
83625259|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625260|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
83625261|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625262|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83625263|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625264|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625265|NCT01878786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83625266|NCT01878786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83514364|NCT00558896|Hormones|hormones|mesh-ancestor
83625267|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625268|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83625269|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83625270|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
83625271|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83625272|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625273|NCT01851174|Paclitaxel|paclitaxel|mesh-list
83625274|NCT01851174|Gemcitabine|gemcitabine|mesh-list
83625275|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83625276|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625277|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
83625278|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
83625279|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
83625280|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625281|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83625282|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
83625283|NCT01846182|Pregabalin|pregabalin|mesh-list
83625284|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83625285|NCT01846182|Analgesics|analgesics|mesh-ancestor
83625286|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
83625287|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625288|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625289|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
83625290|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83625291|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625292|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625293|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83625294|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83625295|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83625296|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625297|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83625298|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83625299|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83625300|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625301|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
83625302|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
83625303|NCT01800162|Methotrexate|methotrexate|mesh-list
83625304|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83625305|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
83625306|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83625307|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625308|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83625309|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
83625310|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625311|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625312|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
83625313|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625314|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83625315|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625316|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
83625317|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83625318|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83625319|NCT01756560|Bupivacaine|bupivacaine|mesh-list
83625320|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
83625321|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
83625322|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625323|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625324|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
83625325|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625326|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83625327|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83625328|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625329|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83625330|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83625331|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625332|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625333|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
83625334|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625335|NCT01717482|Metformin|metformin|mesh-list
83625336|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83625337|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625338|NCT01702896|Interleukin-2|interleukin-2|mesh-list
83625339|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625340|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83625341|NCT01702896|Analgesics|analgesics|mesh-ancestor
83625342|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
83625343|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625344|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625345|NCT01683864|Cisplatin|cisplatin|mesh-list
83625346|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625347|NCT01608906|Heparin|heparin|mesh-list
83625348|NCT01608906|Calcium heparin|calcium heparin|mesh-list
83625349|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
83625350|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83625351|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83625352|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625353|NCT01602198|Rivastigmine|rivastigmine|mesh-list
83625354|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83625355|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625356|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625357|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
83625358|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625359|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625360|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83625361|NCT01602198|Protective Agents|protective agents|mesh-ancestor
83625362|NCT01545648|Denosumab|denosumab|mesh-list
83625363|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83625364|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625365|NCT01527942|Acetaminophen|acetaminophen|mesh-list
83625366|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83625367|NCT01527942|Analgesics|analgesics|mesh-ancestor
83625368|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
83625369|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625370|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625371|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
83625372|NCT01507584|Bimatoprost|bimatoprost|mesh-list
83625373|NCT01507584|Brinzolamide|brinzolamide|mesh-list
83625374|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83625375|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83625376|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625377|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625378|NCT01483872|Tigecycline|tigecycline|mesh-list
83625379|NCT01483872|Heparin|heparin|mesh-list
83625380|NCT01483872|Calcium heparin|calcium heparin|mesh-list
83625381|NCT01483872|Anticoagulants|anticoagulants|mesh-list
83625382|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625383|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83625384|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83625385|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83625386|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625387|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83625388|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083414|NCT02488694|Pemetrexed|pemetrexed|mesh-list
83625389|NCT01385280|Exemestane|exemestane|mesh-list
83625390|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83625391|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83625392|NCT01385280|Estradiol|estradiol|mesh-list
83625393|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83625394|NCT01385280|Estrogens|estrogens|mesh-ancestor
83625395|NCT01385280|Hormones|hormones|mesh-ancestor
83625396|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625397|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625398|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83625399|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
83625400|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83625401|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83625402|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625403|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83625404|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83625405|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625406|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625407|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83625408|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
83625409|NCT01350258|Fludarabine|fludarabine|mesh-list
83625410|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
83625411|NCT01350258|Melphalan|melphalan|mesh-list
83625412|NCT01350258|Thiotepa|thiotepa|mesh-list
83625413|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625414|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83625415|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
83625416|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625417|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625418|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
83625419|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625420|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83625421|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
83625422|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83625423|NCT01302444|Tadalafil|tadalafil|mesh-list
83625424|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
83625425|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83625426|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83625427|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625428|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625429|NCT01302444|Urological Agents|urological agents|mesh-ancestor
83625430|NCT01292070|Histamine|histamine|mesh-list
83625431|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
83625432|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
83625433|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625434|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625435|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625436|NCT01284504|Celecoxib|celecoxib|mesh-list
83625437|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83625438|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83625439|NCT01284504|Analgesics|analgesics|mesh-ancestor
83625440|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
83625441|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625442|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625443|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83625444|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83625445|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83625446|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83625447|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625448|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625449|NCT01183416|Tretinoin|tretinoin|mesh-list
83625450|NCT01183416|Isotretinoin|isotretinoin|mesh-list
83625451|NCT01183416|Antibodies|antibodies|mesh-list
83625452|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83625453|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
83625454|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625455|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625456|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
83625457|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
83625458|NCT01169610|Varenicline|varenicline|mesh-list
83625459|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83625460|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83625461|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
83625462|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083522|NCT02189343|BB 1101|bb 1101|mesh-list
83625463|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625464|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625465|NCT01166724|Sirolimus|sirolimus|mesh-list
83625466|NCT01166724|Tacrolimus|tacrolimus|mesh-list
83625467|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625468|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
83625469|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625470|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83625471|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625472|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625473|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83625474|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625475|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83625476|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625477|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
83625478|NCT01151904|Timolol|timolol|mesh-list
83625479|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83625480|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83625481|NCT01151904|Latanoprost|latanoprost|mesh-list
83625482|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83625483|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83625484|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83625485|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625486|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625487|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625488|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625489|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83625490|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83625491|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83625492|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83625493|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83625494|NCT01115244|Dapsone|dapsone|mesh-list
83625495|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625496|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
83625497|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83625498|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83625499|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83625500|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625501|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625502|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
83625503|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83625504|NCT01031550|Propofol|propofol|mesh-list
83625505|NCT01031550|Isoflurane|isoflurane|mesh-list
83625506|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83625507|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625508|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625509|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83625510|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
83625511|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
83625512|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83625513|NCT00986310|Fluoxetine|fluoxetine|mesh-list
83625514|NCT00986310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83625515|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83625516|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625517|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625518|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625519|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
83625520|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625521|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83625522|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
83625523|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83625524|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83625525|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83625526|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625527|NCT00907218|Varenicline|varenicline|mesh-list
83625528|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83625529|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83625530|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
83625531|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625532|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625533|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625534|NCT00903396|Palonosetron|palonosetron|mesh-list
83625535|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
83625536|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
83625537|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625538|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625539|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83625540|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83625541|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83625542|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
83625543|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625544|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625545|NCT00875394|Metformin|metformin|mesh-list
83625546|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83625547|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83625548|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625549|NCT00875394|Incretins|incretins|mesh-ancestor
83625550|NCT00875394|Hormones|hormones|mesh-ancestor
83625551|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625552|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83625553|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
83625554|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625555|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625556|NCT00832572|Ranolazine|ranolazine|mesh-list
83625557|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83625558|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625559|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625560|NCT00811590|Everolimus|everolimus|mesh-list
83625561|NCT00811590|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83625562|NCT00811590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625563|NCT00811590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625564|NCT00811590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625565|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625566|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
83625567|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625568|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625569|NCT00749658|Bupropion|bupropion|mesh-list
83625570|NCT00749658|Varenicline|varenicline|mesh-list
83625571|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83625572|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
83625573|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83625574|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83625575|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83625576|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625577|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625578|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
83625579|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625580|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625581|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83625582|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83625583|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625584|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83625585|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83625586|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
83625587|NCT00738972|Valsartan|valsartan|mesh-list
83625588|NCT00738972|Simvastatin|simvastatin|mesh-list
83625589|NCT00738972|Ezetimibe|ezetimibe|mesh-list
83625590|NCT00738972|Pravastatin|pravastatin|mesh-list
83625591|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83625592|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83625593|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
83625594|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625595|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83625596|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83625597|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625598|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83625599|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83625600|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83625601|NCT00726180|Trastuzumab|trastuzumab|mesh-list
83625602|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83625603|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625604|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
83625605|NCT00704496|Ephedrine|ephedrine|mesh-list
83625606|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83625607|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
83625608|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625609|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625610|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83625611|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625612|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
83625613|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83625614|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83625615|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
83625616|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625617|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625618|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625619|NCT00692094|Melatonin|melatonin|mesh-list
83625620|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
83625621|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625622|NCT00692094|Protective Agents|protective agents|mesh-ancestor
83625623|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625624|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625625|NCT00676026|Zolpidem|zolpidem|mesh-list
83625626|NCT00676026|Fluoxetine|fluoxetine|mesh-list
83625627|NCT00676026|Progesterone|progesterone|mesh-list
83625628|NCT00676026|Progestins|progestins|mesh-ancestor
83625629|NCT00676026|Hormones|hormones|mesh-ancestor
83625630|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625631|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625632|NCT00676026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83625633|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83625634|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625635|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625636|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625637|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
83625638|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83625639|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
83625640|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83625641|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83625642|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83625643|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625644|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83625645|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83625646|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625647|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83625648|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
83625649|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
83625650|NCT00656916|Fluticasone|fluticasone|mesh-list
83625651|NCT00656916|Xhance|xhance|mesh-list
83625652|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83625653|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83625654|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
83625655|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625656|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625657|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83625658|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625659|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
83625660|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83625661|NCT00619242|Sorafenib|sorafenib|mesh-list
83625662|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625663|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625664|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625665|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625666|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83625667|NCT00601848|Trioxsalen|trioxsalen|mesh-list
83625668|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625669|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
83625670|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83625671|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
83625672|NCT00586716|Antibodies|antibodies|mesh-list
83625673|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
83625674|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83625675|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83625676|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
83625677|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625678|NCT00571194|Pravastatin|pravastatin|mesh-list
83625679|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83625680|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83625681|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
83625682|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625683|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83625684|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83625685|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625686|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83625687|NCT00570258|Fulvestrant|fulvestrant|mesh-list
83083798|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
83625688|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625689|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625690|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625691|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625692|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83625693|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83625694|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83625695|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
83625696|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625697|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625698|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
83625699|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625700|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
83625701|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625702|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625703|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83625704|NCT00577356|Docetaxel|docetaxel|mesh-list
83625705|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625706|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83625707|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83625708|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83684422|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625709|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625710|NCT00569868|Bortezomib|bortezomib|mesh-list
83625711|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625712|NCT05599230|Ivacaftor|ivacaftor|mesh-list
83625713|NCT05599230|Elexacaftor|elexacaftor|mesh-list
83625714|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83625715|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625716|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625717|NCT05403762|Protective Agents|protective agents|mesh-list
83625718|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625719|NCT05164614|Teriparatide|teriparatide|mesh-list
83625720|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83625721|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625722|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83625723|NCT05001048|Phenylephrine|phenylephrine|mesh-list
83625724|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
83625725|NCT05001048|Synephrine|synephrine|mesh-list
83625726|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83625727|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
83625728|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
83625729|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625730|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625731|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
83625732|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83625733|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
83625734|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625735|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83625736|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83625737|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83625738|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625739|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625740|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625741|NCT05001048|Protective Agents|protective agents|mesh-ancestor
83625742|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83625743|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
83625744|NCT04954638|Eusol|eusol|mesh-list
83625745|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
83625746|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625747|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
83625748|NCT04810572|Silymarin|silymarin|mesh-list
83625749|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
83625750|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625751|NCT04810572|Protective Agents|protective agents|mesh-ancestor
83625752|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625753|NCT04575090|Simvastatin|simvastatin|mesh-list
83625754|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83625755|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83625756|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
83625757|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625758|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83625759|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83625760|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625761|NCT04100772|Vaccines|vaccines|mesh-list
83625762|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
83625763|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625765|NCT04043520|Estrogens|estrogens|mesh-list
83625766|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83625767|NCT04043520|Hormones|hormones|mesh-ancestor
83625768|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625769|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625770|NCT03582930|Calfactant|calfactant|mesh-list
83625771|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83625772|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625773|NCT03472872|Acetaminophen|acetaminophen|mesh-list
83625774|NCT03472872|Ketorolac|ketorolac|mesh-list
83625775|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83625776|NCT03472872|Analgesics|analgesics|mesh-ancestor
83625777|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
83625778|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625779|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625780|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
83625781|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83625782|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83625783|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83625784|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83625785|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625786|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625787|NCT03301038|Rifampin|rifampin|mesh-list
83625788|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83625789|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
83625790|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83625791|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625792|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
83625793|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83625794|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625795|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625796|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83625797|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83625798|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83625799|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83625800|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83625801|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83625802|NCT02411526|Risperidone|risperidone|mesh-list
83625803|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83625804|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
83625805|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625806|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625807|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625808|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83625809|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83625810|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625811|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83625812|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83625813|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
83625814|NCT00564876|Dasatinib|dasatinib|mesh-list
83625815|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625816|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625817|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625818|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625819|NCT00558870|Morphine|morphine|mesh-list
83625820|NCT00558870|Methadone|methadone|mesh-list
83625821|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83625822|NCT00558870|Narcotics|narcotics|mesh-ancestor
83625823|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625824|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625825|NCT00558870|Analgesics|analgesics|mesh-ancestor
83625826|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
83625827|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625828|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
83625829|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625830|NCT00548886|Epinephrine|epinephrine|mesh-list
83625831|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83625832|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83625833|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625834|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625835|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625836|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625837|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83625838|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83625839|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
83625840|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625841|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83625842|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
83625843|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
83625844|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
83625845|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83625846|NCT00538980|Dasatinib|dasatinib|mesh-list
83625847|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625848|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625849|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625850|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625851|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
83625852|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625853|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83625854|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625855|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625856|NCT00506064|Melatonin|melatonin|mesh-list
83625857|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
83625858|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625859|NCT00506064|Protective Agents|protective agents|mesh-ancestor
83625860|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625861|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83625862|NCT00503880|Cytarabine|cytarabine|mesh-list
83625863|NCT00503880|Clofarabine|clofarabine|mesh-list
83625864|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83625865|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
83625866|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625867|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625868|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
83625869|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625870|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625871|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
83625872|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625873|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
83625874|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625875|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83625876|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83625877|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
83625878|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625879|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83625880|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625881|NCT00145704|Vitamin D|vitamin d|mesh-list
83625882|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
83625883|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
83625884|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
83625885|NCT00145704|Diphosphonates|diphosphonates|mesh-list
83625886|NCT00145704|Vitamins|vitamins|mesh-list
83625887|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
83625888|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625889|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83625890|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83625891|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83625892|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83625893|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625894|NCT00108342|Nicotine|nicotine|mesh-list
83625895|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83625896|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
83625897|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625898|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625899|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83625900|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83625901|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
83625902|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625903|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625904|NCT00090870|Interferons|interferons|mesh-list
83625905|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
83625906|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
83625907|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83625908|NCT00090870|Thalidomide|thalidomide|mesh-list
83625909|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780186|NCT00098839|Antidotes|antidotes|mesh-ancestor
83625910|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
83625911|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83625912|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
83625913|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625914|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83625915|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
83625916|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83625917|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83625918|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83625919|NCT00090870|Growth Substances|growth substances|mesh-ancestor
83625920|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
83625921|NCT00074724|Dobutamine|dobutamine|mesh-list
83625922|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83625923|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
83625924|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
83625925|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625926|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625927|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83625928|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83625929|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83625930|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625931|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625932|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625933|NCT00074724|Protective Agents|protective agents|mesh-ancestor
83625934|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
83625935|NCT00058188|Vitamin D|vitamin d|mesh-list
83625936|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
83625937|NCT00058188|Calcium|calcium|mesh-list
83625938|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83625939|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625940|NCT00058188|Vitamins|vitamins|mesh-ancestor
83625941|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
83625942|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83625943|NCT00003726|Lepirudin|lepirudin|mesh-list
83625944|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
83625945|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83625946|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
83625947|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625948|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625949|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
83625950|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83625951|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83625952|NCT02595996|Propranolol|propranolol|mesh-list
83625953|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83625954|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83625955|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625956|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625957|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625958|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625959|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83625960|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83625961|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
83625962|NCT04422210|Carboplatin|carboplatin|mesh-list
83625963|NCT04422210|Etoposide|etoposide|mesh-list
83625964|NCT04422210|Atezolizumab|atezolizumab|mesh-list
83625965|NCT04422210|Venetoclax|venetoclax|mesh-list
83625966|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83625967|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83625968|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83625969|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83625970|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83625971|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625972|NCT04422210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83625973|NCT04422210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83625974|NCT00000132|Betaxolol|betaxolol|mesh-list
83625975|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83625976|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
83625977|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
83625978|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83625979|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625980|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83625981|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83625982|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83625983|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
83625984|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83625985|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83625986|NCT00000138|Acyclovir|acyclovir|mesh-list
83625987|NCT00000138|Prednisolone|prednisolone|mesh-list
83625988|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83625989|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
83625990|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83625991|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
83625992|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83625993|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
83625994|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83625995|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
83625996|NCT00000138|Hormones|hormones|mesh-ancestor
83625997|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83625998|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83625999|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83626000|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626001|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
83626002|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
83626003|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626004|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83626005|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83626006|NCT00000138|Protective Agents|protective agents|mesh-ancestor
83626007|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
83626008|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626009|NCT00000174|Rivastigmine|rivastigmine|mesh-list
83626010|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83626011|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626012|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626013|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
83626014|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626015|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626016|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83626017|NCT00000174|Protective Agents|protective agents|mesh-ancestor
83626018|NCT00000192|Lamotrigine|lamotrigine|mesh-list
83626019|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
83626020|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83626021|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626022|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626023|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83626024|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626025|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83626026|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83626027|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626028|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83626029|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83626030|NCT00000198|Piracetam|piracetam|mesh-list
83626031|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83626032|NCT00000198|Protective Agents|protective agents|mesh-ancestor
83626033|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626034|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
83626035|NCT00000204|Buprenorphine|buprenorphine|mesh-list
83626036|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83626037|NCT00000204|Narcotics|narcotics|mesh-ancestor
83626038|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626039|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626040|NCT00000204|Analgesics|analgesics|mesh-ancestor
83626041|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
83626042|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626043|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626044|NCT00000210|Buprenorphine|buprenorphine|mesh-list
83626045|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83626046|NCT00000210|Narcotics|narcotics|mesh-ancestor
83626047|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626048|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626049|NCT00000210|Analgesics|analgesics|mesh-ancestor
83626050|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
83626051|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626052|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626053|NCT00000222|Buprenorphine|buprenorphine|mesh-list
83626054|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83626055|NCT00000222|Narcotics|narcotics|mesh-ancestor
83626056|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626057|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626058|NCT00000222|Analgesics|analgesics|mesh-ancestor
83626059|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
83626060|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626061|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626062|NCT00000228|Buprenorphine|buprenorphine|mesh-list
83626063|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83626064|NCT00000228|Narcotics|narcotics|mesh-ancestor
83626065|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626066|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626067|NCT00000228|Analgesics|analgesics|mesh-ancestor
83626068|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
83626069|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626070|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626071|NCT00000234|Buprenorphine|buprenorphine|mesh-list
83626072|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83626073|NCT00000234|Narcotics|narcotics|mesh-ancestor
83626074|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626075|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626076|NCT00000234|Analgesics|analgesics|mesh-ancestor
83626077|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
83626078|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626079|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626080|NCT00000240|Buprenorphine|buprenorphine|mesh-list
83626081|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83626082|NCT00000240|Narcotics|narcotics|mesh-ancestor
83626083|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626084|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626085|NCT00000240|Analgesics|analgesics|mesh-ancestor
83626086|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
83626087|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626088|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626089|NCT00000246|Flumazenil|flumazenil|mesh-list
83626090|NCT00000246|Antidotes|antidotes|mesh-ancestor
83626091|NCT00000246|Protective Agents|protective agents|mesh-ancestor
83626092|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626093|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
83626094|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
83626095|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626096|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626097|NCT00000264|Ethanol|ethanol|mesh-list
83626098|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
83626099|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83626100|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626101|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626102|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626103|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83626104|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
83626105|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
83626106|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83626107|NCT00000264|Analgesics|analgesics|mesh-ancestor
83626108|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
83626109|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626110|NCT00000270|Cocaine|cocaine|mesh-list
83626111|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
83626112|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
83626113|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626114|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626115|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
83626116|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626117|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83626118|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83626119|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83626120|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626121|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626122|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
83626123|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626124|NCT00000276|Bupropion|bupropion|mesh-list
83626125|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83626126|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
83626127|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83626128|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83626129|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83626130|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626131|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626132|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
83626133|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626134|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626135|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83626136|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626137|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626138|NCT00000282|Pemoline|pemoline|mesh-list
83626139|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83626140|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626141|NCT00000294|Carvedilol|carvedilol|mesh-list
83626142|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83626143|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83626144|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
83626145|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626146|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626147|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626148|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83626149|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
83626150|NCT00000294|Protective Agents|protective agents|mesh-ancestor
83626151|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83626152|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626153|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83626154|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
83626155|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83626156|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83626157|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
83626158|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83626159|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626160|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83626161|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83626162|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626163|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626164|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
83626165|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626166|NCT00000318|Buprenorphine|buprenorphine|mesh-list
83626167|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83626168|NCT00000318|Narcotics|narcotics|mesh-ancestor
83626169|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626170|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626171|NCT00000318|Analgesics|analgesics|mesh-ancestor
83626172|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
83626173|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626174|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626175|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
83626176|NCT00000330|Narcotics|narcotics|mesh-ancestor
83626177|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626178|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626179|NCT00000330|Analgesics|analgesics|mesh-ancestor
83626180|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
83626181|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626182|NCT00000336|Selegiline|selegiline|mesh-list
83626183|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
83626184|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83626185|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83626186|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83626187|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83626188|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626189|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626190|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83626191|NCT00000336|Protective Agents|protective agents|mesh-ancestor
83626192|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626193|NCT00000342|Risperidone|risperidone|mesh-list
83626194|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83626195|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
83626196|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626197|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626198|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626199|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83626200|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83626201|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626202|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83626203|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83626204|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
83626205|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
83626206|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
83626207|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
83626208|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626209|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626210|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626211|NCT00000354|Lofexidine|lofexidine|mesh-list
83626212|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83626213|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626214|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626215|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
83626216|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626217|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83626218|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83626219|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83626220|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
83626221|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626222|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626223|NCT00000372|Cycloserine|cycloserine|mesh-list
83626224|NCT00000372|Clozapine|clozapine|mesh-list
83626225|NCT00000372|Glycine|glycine|mesh-list
83626226|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83626227|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626228|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83626229|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
83626230|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626231|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
83626232|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626233|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83626234|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
83626235|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626236|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626237|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83626238|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83626239|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83626240|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83626241|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
83626242|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
83626243|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
83626244|NCT00000384|Sertraline|sertraline|mesh-list
83626245|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
83626246|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83626247|NCT00000384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83626248|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83626249|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626250|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626251|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626252|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
83626253|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626254|NCT00000390|Imipramine|imipramine|mesh-list
83626255|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83626256|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
83626257|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83626258|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83626259|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83626260|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626261|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626262|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
83626263|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626264|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626265|NCT00000402|Calcium|calcium|mesh-list
83626266|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83626267|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626268|NCT00000438|Naltrexone|naltrexone|mesh-list
83626269|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83626270|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626271|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626272|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
83626273|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626274|NCT00000444|Nicotine|nicotine|mesh-list
83626275|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83626276|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
83626277|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626278|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626279|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83626280|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83626281|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
83626282|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626283|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626284|NCT00000450|Naltrexone|naltrexone|mesh-list
83626285|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83626286|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83626287|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626288|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
83626289|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626291|NCT00000510|Dipyridamole|dipyridamole|mesh-list
83626292|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83626293|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83626294|NCT00000510|Analgesics|analgesics|mesh-ancestor
83626295|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
83626296|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626297|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626298|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83626299|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83626300|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83626301|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83626302|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626303|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83626304|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83626305|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626306|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
83626307|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83626308|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
83626309|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83626310|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
83626311|NCT00000600|Vitamins|vitamins|mesh-list
83626312|NCT00000600|Vitamin E|vitamin e|mesh-list
83626313|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
83626314|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626315|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
83626316|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626317|NCT00000600|Protective Agents|protective agents|mesh-ancestor
83626318|NCT00000636|Pyridoxine|pyridoxine|mesh-list
83626319|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
83626320|NCT00000636|Rifampin|rifampin|mesh-list
83626321|NCT00000636|Isoniazid|isoniazid|mesh-list
83626322|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
83626323|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83626324|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
83626325|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626326|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626327|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
83626328|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626329|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626330|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626331|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83626332|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83626333|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83626334|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83626335|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83626336|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83626337|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83626338|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83626339|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
83626340|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83626341|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
83626342|NCT00000636|Vitamins|vitamins|mesh-ancestor
83626343|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
83626344|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626345|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
83626346|NCT00000648|Penicillins|penicillins|mesh-list
83626347|NCT00000648|Penicillin G|penicillin g|mesh-list
83626348|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83626349|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
83626350|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626351|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626352|NCT00000654|Fialuridine|fialuridine|mesh-list
83626353|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
83626354|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626355|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626356|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626357|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626358|NCT00000660|Etoposide|etoposide|mesh-list
83626359|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82780628|NCT00752063|Capecitabine|capecitabine|mesh-list
83626360|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626361|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83626362|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83626363|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626364|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626366|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
83626367|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626368|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626369|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626370|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626371|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
83626372|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626373|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626374|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626375|NCT00000714|Leucovorin|leucovorin|mesh-list
83626376|NCT00000714|Trimetrexate|trimetrexate|mesh-list
83626377|NCT00000714|Calcium|calcium|mesh-list
83626378|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
83626379|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83626380|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626381|NCT00000714|Antidotes|antidotes|mesh-ancestor
83626382|NCT00000714|Protective Agents|protective agents|mesh-ancestor
83626383|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
83626384|NCT00000714|Vitamins|vitamins|mesh-ancestor
83626385|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
83626386|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
83626387|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626388|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83626389|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
83626390|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626391|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626392|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83626393|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626394|NCT00000732|Zidovudine|zidovudine|mesh-list
83626395|NCT00000732|Trimethoprim|trimethoprim|mesh-list
83626396|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
83626397|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83626398|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
83626399|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626400|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626401|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626402|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626403|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
83626404|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626405|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626406|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626407|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83626408|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
83626409|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83626410|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83626411|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83626412|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83626413|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83626414|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626415|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626416|NCT00000738|Zidovudine|zidovudine|mesh-list
83626417|NCT00000738|Nimodipine|nimodipine|mesh-list
83626418|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
83626419|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626420|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626421|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626422|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626423|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
83626424|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626425|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626426|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626427|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83626428|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83626429|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626430|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83626431|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626432|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
83626433|NCT00000750|Zidovudine|zidovudine|mesh-list
83626434|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
83626435|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626436|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626437|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626438|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626439|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
83626440|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626441|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626442|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626443|NCT00000804|Indinavir|indinavir|mesh-list
83626444|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83626445|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83626446|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
83626447|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626448|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626449|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626450|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626451|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
83626452|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626453|NCT00000810|Zidovudine|zidovudine|mesh-list
83626454|NCT00000810|Didanosine|didanosine|mesh-list
83626455|NCT00000810|Delavirdine|delavirdine|mesh-list
83626456|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
83626457|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626458|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626459|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626460|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626461|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
83626462|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626463|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626464|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626465|NCT00000834|Lamivudine|lamivudine|mesh-list
83626466|NCT00000834|Zidovudine|zidovudine|mesh-list
83626467|NCT00000834|Methotrexate|methotrexate|mesh-list
83626468|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83626469|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
83626470|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83626471|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626472|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83626473|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
83626474|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626475|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626476|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83626477|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626478|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83626479|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83626480|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
83626481|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83626482|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626483|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626484|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
83626485|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626486|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626487|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626488|NCT00000864|Zidovudine|zidovudine|mesh-list
83626489|NCT00000864|Abacavir|abacavir|mesh-list
83626490|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
83626491|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626492|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626493|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626494|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626495|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
83626496|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626497|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626498|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626499|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83626500|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
83626501|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626502|NCT00000894|Ganciclovir|ganciclovir|mesh-list
83626503|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83626504|NCT00000894|Cidofovir|cidofovir|mesh-list
83626505|NCT00000894|Probenecid|probenecid|mesh-list
83626506|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
83626507|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626508|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626509|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626510|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626511|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
83626512|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
83626514|NCT00000912|Efavirenz|efavirenz|mesh-list
83626515|NCT00000912|Abacavir|abacavir|mesh-list
83626516|NCT00000912|Adefovir|adefovir|mesh-list
83626517|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83626518|NCT00000912|Nelfinavir|nelfinavir|mesh-list
83626519|NCT00000912|Indinavir|indinavir|mesh-list
83626520|NCT00000912|Saquinavir|saquinavir|mesh-list
83626521|NCT00000912|Amprenavir|amprenavir|mesh-list
83626522|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626523|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626524|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626525|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626526|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
83626527|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626528|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83626529|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626530|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83626531|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83626532|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83626533|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83626534|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626535|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626536|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83626537|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83626538|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
83626539|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83626540|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83626541|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
83626542|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626543|NCT00000918|Ritonavir|ritonavir|mesh-list
83626544|NCT00000918|Indinavir|indinavir|mesh-list
83626545|NCT00000918|Saquinavir|saquinavir|mesh-list
83626546|NCT00000918|Amprenavir|amprenavir|mesh-list
83626547|NCT00000918|Lamivudine|lamivudine|mesh-list
83626548|NCT00000918|Zidovudine|zidovudine|mesh-list
83626549|NCT00000918|Stavudine|stavudine|mesh-list
83626550|NCT00000918|Didanosine|didanosine|mesh-list
83626551|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83626552|NCT00000918|Efavirenz|efavirenz|mesh-list
83626553|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83626554|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83626555|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83626556|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626557|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626558|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626559|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626560|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
83626561|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626562|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83626563|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626564|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626565|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626566|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
83626567|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83626568|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83626569|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83626570|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83626571|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83626572|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83626573|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
83626574|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626575|NCT00000924|Ritonavir|ritonavir|mesh-list
83626576|NCT00000924|Nelfinavir|nelfinavir|mesh-list
83626577|NCT00000924|Nevirapine|nevirapine|mesh-list
83626578|NCT00000924|Stavudine|stavudine|mesh-list
83626579|NCT00000924|Didanosine|didanosine|mesh-list
83626580|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83626581|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83626582|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
83626583|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626584|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626585|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626586|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626587|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
83626588|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626589|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83626590|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626591|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626592|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626593|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83626594|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83626596|NCT00000936|Cyclosporine|cyclosporine|mesh-list
83626597|NCT00000936|Cyclosporins|cyclosporins|mesh-list
83626598|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626599|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626600|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83626601|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
83626602|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626603|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
83626604|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626605|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
83626606|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83626607|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83626608|NCT00000942|Nevirapine|nevirapine|mesh-list
83626609|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626610|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626611|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626612|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626613|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
83626614|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626615|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626616|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626617|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83626618|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83626619|NCT00000948|Aldesleukin|aldesleukin|mesh-list
83626620|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626621|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626622|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626623|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
83626624|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626625|NCT00000954|Didanosine|didanosine|mesh-list
83626626|NCT00000954|Zalcitabine|zalcitabine|mesh-list
83626627|NCT00000954|Doxorubicin|doxorubicin|mesh-list
83626628|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83626629|NCT00000954|Bleomycin|bleomycin|mesh-list
83626630|NCT00000954|Vincristine|vincristine|mesh-list
83626631|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83626632|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626633|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83626634|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83626635|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626636|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626637|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83626638|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
83626639|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
83626640|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
83626641|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
83626642|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626643|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626644|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
83626645|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626646|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626647|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626648|NCT00000960|Zidovudine|zidovudine|mesh-list
83626649|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
83626650|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626651|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626652|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626653|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626654|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
83626655|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626656|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626657|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626658|NCT00000990|Zidovudine|zidovudine|mesh-list
83626659|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
83626660|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626661|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626662|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626663|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626664|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
83626665|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626666|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626667|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626669|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83626670|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83626671|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626672|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83626673|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83626674|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626675|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626676|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83626677|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83626678|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
83626679|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626680|NCT00001044|Antacids|antacids|mesh-ancestor
83626681|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626682|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83626683|NCT00001062|Ganciclovir|ganciclovir|mesh-list
83626684|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83626685|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
83626686|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626687|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626688|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626689|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626690|NCT00001068|Lamivudine|lamivudine|mesh-list
83626691|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626692|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626693|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626694|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626695|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
83626696|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626697|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626698|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626699|NCT00001080|Lamivudine|lamivudine|mesh-list
83626700|NCT00001080|Vaccines|vaccines|mesh-list
83626701|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83626702|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
83626703|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626704|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626705|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626706|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626707|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626708|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
83626709|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626710|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626711|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626712|NCT00001104|Zidovudine|zidovudine|mesh-list
83626713|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
83626714|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626715|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626716|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626717|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626718|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
83626719|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626720|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626721|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626722|NCT00001110|Dimercaprol|dimercaprol|mesh-list
83626723|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
83626724|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
83626725|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626726|NCT00001122|Efavirenz|efavirenz|mesh-list
83626727|NCT00001122|Stavudine|stavudine|mesh-list
83626728|NCT00001122|Didanosine|didanosine|mesh-list
83626729|NCT00001122|Nelfinavir|nelfinavir|mesh-list
83626730|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626731|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626732|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626733|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626734|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
83626735|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626736|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83626737|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626738|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83626739|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83626740|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83626741|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83626742|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83626743|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83626744|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
83626745|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626746|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626747|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
83626748|NCT00001128|Azithromycin|azithromycin|mesh-list
83626749|NCT00001128|Paromomycin|paromomycin|mesh-list
83626750|NCT00001128|Interleukin-12|interleukin-12|mesh-list
83626751|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626752|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626753|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83626754|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
83626755|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626756|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83626757|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83626758|NCT00001128|Growth Substances|growth substances|mesh-ancestor
83626759|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
83626760|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626761|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83626762|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83626763|NCT00001296|Interferons|interferons|mesh-list
83626764|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
83626765|NCT00001296|Melphalan|melphalan|mesh-list
83626766|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626767|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
83626768|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626769|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83626770|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
83626771|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626772|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83626773|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83626774|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
83626775|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626776|NCT00001422|Fludarabine|fludarabine|mesh-list
83626777|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626778|NCT00001428|Fluorouracil|fluorouracil|mesh-list
83626779|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
83626780|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626781|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83626782|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626783|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83626784|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
83626785|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626786|NCT00001440|Interleukin-2|interleukin-2|mesh-list
83626787|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626788|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83626789|NCT00001440|Analgesics|analgesics|mesh-ancestor
83626790|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
83626791|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626792|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626793|NCT00001446|Thalidomide|thalidomide|mesh-list
83626794|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83626795|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
83626796|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626797|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
83626798|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626799|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626800|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83626801|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83626802|NCT00001446|Growth Substances|growth substances|mesh-ancestor
83626803|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
83626804|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626805|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
83626806|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83626807|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
83626808|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626809|NCT00001626|Cyclosporine|cyclosporine|mesh-list
83626810|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
83626811|NCT00001626|Cyclosporins|cyclosporins|mesh-list
83626812|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83626813|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83626814|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
83626815|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626816|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83626817|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83626818|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
83626819|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626820|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626821|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83626822|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626823|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
83626824|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626825|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
83626826|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83626827|NCT00001680|Thalidomide|thalidomide|mesh-list
83626828|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83626829|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
83626830|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626831|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
83626832|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626833|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626834|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83626835|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83626836|NCT00001680|Growth Substances|growth substances|mesh-ancestor
83626837|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
83626838|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626839|NCT00001698|Ketorolac|ketorolac|mesh-list
83626840|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83626841|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83626842|NCT00001698|Analgesics|analgesics|mesh-ancestor
83626843|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
83626844|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626845|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626846|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83626847|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83626848|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83626849|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626850|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626851|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
83626852|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
83626853|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83626854|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
83626855|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626856|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626857|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83626858|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
83626859|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83626860|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
83626861|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626862|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83626863|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83626864|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
83626865|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
83626866|NCT00001716|Protective Agents|protective agents|mesh-ancestor
83626867|NCT00001812|Nystatin|nystatin|mesh-list
83626868|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626869|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626870|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
83626871|NCT00001812|Ionophores|ionophores|mesh-ancestor
83626872|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626873|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626874|NCT00001842|Dexamethasone|dexamethasone|mesh-list
83626875|NCT00001842|Lenograstim|lenograstim|mesh-list
83626876|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83626877|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
83626878|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
83626879|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83626880|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626881|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83626882|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
83626883|NCT00001842|Hormones|hormones|mesh-ancestor
83626884|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83626885|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83626886|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626887|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83626888|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
83626889|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83626890|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83626891|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
83626892|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83626893|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626894|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83626895|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83626896|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83626897|NCT00001854|Ribavirin|ribavirin|mesh-list
83626898|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
83626899|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626900|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
83626901|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626902|NCT00001860|Octreotide|octreotide|mesh-list
83626903|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83626904|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83626905|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626906|NCT00001890|Estrogens|estrogens|mesh-list
83626907|NCT00001890|Hormones|hormones|mesh-ancestor
83626908|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83626909|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626910|NCT00001944|Vinorelbine|vinorelbine|mesh-list
83626911|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83626912|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83626913|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
83626914|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
83626915|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
83626916|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626917|NCT00001968|Ritonavir|ritonavir|mesh-list
83626918|NCT00001968|Amprenavir|amprenavir|mesh-list
83626919|NCT00001968|Lamivudine|lamivudine|mesh-list
83626920|NCT00001968|Abacavir|abacavir|mesh-list
83626921|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83626922|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83626923|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
83626924|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626925|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626926|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626927|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626928|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
83626929|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626930|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83626931|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626932|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626933|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626934|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83626935|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
83626936|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626937|NCT00001998|Nystatin|nystatin|mesh-list
83626938|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83626939|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626940|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
83626941|NCT00001998|Ionophores|ionophores|mesh-ancestor
83626942|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83626943|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626944|NCT00002010|Fluconazole|fluconazole|mesh-list
83626945|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
83626946|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626947|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83626948|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626949|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626950|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626951|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83626952|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
83626953|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83626954|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626955|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83626956|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83626957|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
83626958|NCT00002022|Hematinics|hematinics|mesh-ancestor
83626959|NCT00002028|Didanosine|didanosine|mesh-list
83626960|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
83626961|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626962|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626963|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626964|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626965|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
83626966|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626967|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626968|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626969|NCT00002034|Zidovudine|zidovudine|mesh-list
83626970|NCT00002034|Ganciclovir|ganciclovir|mesh-list
83626971|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83626972|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
83626973|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626974|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626975|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626976|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626977|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
83626978|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626979|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83626980|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83626981|NCT00002040|Fluconazole|fluconazole|mesh-list
83626982|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
83626983|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83626984|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83626985|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83626986|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83626987|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626988|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83626989|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
83626990|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83626991|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83626992|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83626993|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83626994|NCT00002046|Zidovudine|zidovudine|mesh-list
83626995|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
83626996|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83626997|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83626998|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83626999|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627000|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
83627001|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627002|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627003|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627004|NCT00002052|Amoxicillin|amoxicillin|mesh-list
83627005|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
83627006|NCT00002052|Ampicillin|ampicillin|mesh-list
83627007|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627008|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627009|NCT00002058|Clofazimine|clofazimine|mesh-list
83627010|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83627011|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
83627012|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627013|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627014|NCT00002064|Clindamycin|clindamycin|mesh-list
83627015|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
83627016|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
83627017|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
83627018|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627019|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627020|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83627021|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627022|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627023|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
83627024|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83627025|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83627026|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83627027|NCT00002070|Ganciclovir|ganciclovir|mesh-list
83627028|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83627029|NCT00002070|Sargramostim|sargramostim|mesh-list
83627030|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
83627031|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627032|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
83627033|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627034|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627035|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627036|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627037|NCT00002076|Fluconazole|fluconazole|mesh-list
83627038|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
83627039|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627040|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83627041|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627042|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627043|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627044|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83627045|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
83627046|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627047|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627048|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83627049|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83627050|NCT00002082|Azithromycin|azithromycin|mesh-list
83627051|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627052|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627053|NCT00002094|Atevirdine|atevirdine|mesh-list
83627054|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627055|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627056|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627057|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627058|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
83627059|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627060|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
83627061|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
83627062|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83627063|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83627064|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627065|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
83627066|NCT00002106|Ranitidine|ranitidine|mesh-list
83627067|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83627068|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83627069|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83627070|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83627071|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
83627072|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
83627073|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83627074|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627075|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627076|NCT00002112|Fluconazole|fluconazole|mesh-list
83627077|NCT00002112|Nystatin|nystatin|mesh-list
83627078|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
83627079|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627080|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83627081|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627082|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627083|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627084|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83627085|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
83627086|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627087|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627088|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83627089|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83627090|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627091|NCT00002112|Ionophores|ionophores|mesh-ancestor
83627092|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83627093|NCT00002118|Zalcitabine|zalcitabine|mesh-list
83627094|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
83627095|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627096|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627097|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627098|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627099|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
83627100|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627101|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627102|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627103|NCT00002124|Lamivudine|lamivudine|mesh-list
83627104|NCT00002124|Zidovudine|zidovudine|mesh-list
83627105|NCT00002124|Delavirdine|delavirdine|mesh-list
83627106|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627107|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627108|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627109|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627110|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
83627111|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781376|NCT01082029|Lansoprazole|lansoprazole|mesh-list
83627112|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627113|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627114|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
83627115|NCT00002130|Vesnarinone|vesnarinone|mesh-list
83627116|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83627117|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
83627118|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627119|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627120|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
83627121|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627122|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83627123|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83627124|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627125|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627126|NCT00002130|Protective Agents|protective agents|mesh-ancestor
83627127|NCT00002142|Cidofovir|cidofovir|mesh-list
83627128|NCT00002142|Probenecid|probenecid|mesh-list
83627129|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
83627130|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
83627131|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627132|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
83627133|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627134|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627135|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627136|NCT00002148|OPC 14117|opc 14117|mesh-list
83627137|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83627138|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
83627139|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627140|NCT00002148|Protective Agents|protective agents|mesh-ancestor
83627141|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627142|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
83627143|NCT00002154|Selegiline|selegiline|mesh-list
83627144|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
83627145|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83627146|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83627147|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83627148|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83627149|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627150|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627151|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83627152|NCT00002154|Protective Agents|protective agents|mesh-ancestor
83627153|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627154|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
83627155|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
83627156|NCT00002154|Vitamins|vitamins|mesh-ancestor
83627157|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
83627158|NCT00002160|Ziconotide|ziconotide|mesh-list
83627159|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83627160|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83627161|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627162|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83627163|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627164|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83627165|NCT00002160|Protective Agents|protective agents|mesh-ancestor
83627166|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83627167|NCT00002160|Analgesics|analgesics|mesh-ancestor
83627168|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
83627169|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83627170|NCT00002166|Nevirapine|nevirapine|mesh-list
83627171|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627172|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627173|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627174|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627175|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
83627176|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627177|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627178|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627179|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83627180|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83627181|NCT00002178|Ritonavir|ritonavir|mesh-list
83627182|NCT00002178|Nelfinavir|nelfinavir|mesh-list
83627183|NCT00002178|Saquinavir|saquinavir|mesh-list
83627184|NCT00002178|Delavirdine|delavirdine|mesh-list
83627185|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627186|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627187|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627188|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627189|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627190|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627191|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627192|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
83627193|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627194|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627195|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627196|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627197|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627198|NCT00002184|Lamivudine|lamivudine|mesh-list
83627199|NCT00002184|Zidovudine|zidovudine|mesh-list
83627200|NCT00002184|Stavudine|stavudine|mesh-list
83627201|NCT00002184|Adefovir|adefovir|mesh-list
83627202|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83627203|NCT00002184|Nelfinavir|nelfinavir|mesh-list
83627204|NCT00002184|Saquinavir|saquinavir|mesh-list
83627205|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627206|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627207|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627208|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627209|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
83627210|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627211|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627212|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627213|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
83627214|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627215|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627216|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627217|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627218|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627219|NCT00002190|Lamivudine|lamivudine|mesh-list
83627220|NCT00002190|Zidovudine|zidovudine|mesh-list
83627221|NCT00002190|Saquinavir|saquinavir|mesh-list
83627222|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627223|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627224|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627225|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627226|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
83627227|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627228|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627229|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627230|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
83627231|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627232|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627233|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627234|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627235|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627236|NCT00002202|Indinavir|indinavir|mesh-list
83627237|NCT00002202|Amprenavir|amprenavir|mesh-list
83627238|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627239|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627240|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627241|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627242|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627243|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627244|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627245|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
83627246|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627247|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83627248|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
83627249|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627250|NCT00002208|Lamivudine|lamivudine|mesh-list
83627251|NCT00002208|Zidovudine|zidovudine|mesh-list
83627252|NCT00002208|Stavudine|stavudine|mesh-list
83627253|NCT00002208|Indinavir|indinavir|mesh-list
83627254|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627255|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627256|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627257|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627258|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
83627259|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627260|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627261|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627262|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
83627263|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627264|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627265|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627267|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627268|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627269|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627270|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627271|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
83627272|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627273|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627274|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627275|NCT00002220|Efavirenz|efavirenz|mesh-list
83627276|NCT00002220|Adefovir|adefovir|mesh-list
83627277|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83627278|NCT00002220|Indinavir|indinavir|mesh-list
83627279|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627280|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627281|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627282|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627283|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
83627284|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627285|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83627286|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627287|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83627288|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83627289|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83627290|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83627291|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627292|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627293|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627294|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627295|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627296|NCT00002226|Semaxinib|semaxinib|mesh-list
83627297|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83627298|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83627299|NCT00002226|Growth Substances|growth substances|mesh-ancestor
83627300|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627301|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
83627302|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627303|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83627304|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627305|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627306|NCT00002238|Interferons|interferons|mesh-list
83627307|NCT00002238|Zidovudine|zidovudine|mesh-list
83627308|NCT00002238|Interferon-beta|interferon-beta|mesh-list
83627309|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
83627310|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627311|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
83627312|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627313|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
83627314|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627315|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627316|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627317|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627318|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627319|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627320|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
83627321|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627322|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83627323|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83627324|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
83627325|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627326|NCT00002256|Zalcitabine|zalcitabine|mesh-list
83627327|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
83627328|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627329|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627330|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627331|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627332|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
83627333|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627334|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627335|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627336|NCT00002274|Didanosine|didanosine|mesh-list
83627337|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
83627338|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627339|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627340|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627341|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627342|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
83627343|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627344|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627345|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627346|NCT00002280|Didanosine|didanosine|mesh-list
83627347|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
83627348|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627349|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627350|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627351|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627352|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
83627353|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627354|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627355|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627356|NCT00002286|Zidovudine|zidovudine|mesh-list
83627357|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
83627358|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627359|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627360|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627361|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627362|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
83627363|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627364|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627365|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627366|NCT00002292|Pentamidine|pentamidine|mesh-list
83627367|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
83627368|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627369|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83627370|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83627371|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83627372|NCT00002298|Ribavirin|ribavirin|mesh-list
83627373|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
83627374|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627375|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
83627376|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627377|NCT00002304|Fluconazole|fluconazole|mesh-list
83627378|NCT00002304|Ketoconazole|ketoconazole|mesh-list
83627379|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
83627380|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627381|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83627382|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627383|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627384|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627385|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83627386|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
83627387|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627388|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627389|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83627390|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83627391|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627392|NCT00002316|Amphotericin B|amphotericin b|mesh-list
83627393|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83627394|NCT00002316|Amebicides|amebicides|mesh-ancestor
83627395|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83627396|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83627397|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627398|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627399|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
83627400|NCT00002322|Zidovudine|zidovudine|mesh-list
83627401|NCT00002322|Atevirdine|atevirdine|mesh-list
83627402|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
83627403|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627404|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627405|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627406|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627407|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
83627408|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627409|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627410|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627411|NCT00002328|Azithromycin|azithromycin|mesh-list
83627412|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83627413|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627414|NCT00002334|Zidovudine|zidovudine|mesh-list
83627415|NCT00002334|Zalcitabine|zalcitabine|mesh-list
83627416|NCT00002334|Saquinavir|saquinavir|mesh-list
83627417|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
83627418|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627419|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627420|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627421|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627422|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
83627423|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627424|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627425|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627426|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627427|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627428|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627429|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627430|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627431|NCT00002340|Atovaquone|atovaquone|mesh-list
83627432|NCT00002340|Pentamidine|pentamidine|mesh-list
83627433|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627434|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
83627435|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83627436|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83627437|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627438|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627439|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
83627440|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83627441|NCT00002346|Adefovir|adefovir|mesh-list
83627442|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83627443|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
83627444|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627445|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627446|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627447|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627448|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627449|NCT00002352|Lobucavir|lobucavir|mesh-list
83627450|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627451|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627452|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627453|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627454|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
83627455|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627456|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627457|NCT00002358|Sorivudine|sorivudine|mesh-list
83627458|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
83627459|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627460|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627461|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627462|NCT00002364|Abacavir|abacavir|mesh-list
83627463|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627464|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627465|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627466|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627467|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
83627468|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627469|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627470|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627471|NCT00002370|Itraconazole|itraconazole|mesh-list
83627472|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
83627473|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627474|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83627475|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627476|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627477|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627478|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83627479|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
83627480|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627481|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627482|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627483|NCT00002376|Lamivudine|lamivudine|mesh-list
83627484|NCT00002376|Zidovudine|zidovudine|mesh-list
83627485|NCT00002376|Stavudine|stavudine|mesh-list
83627486|NCT00002376|Didanosine|didanosine|mesh-list
83627487|NCT00002376|Indinavir|indinavir|mesh-list
83627488|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627489|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82781745|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
83627490|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627491|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627492|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
83627493|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627494|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627495|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627496|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
83627497|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627498|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627499|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627500|NCT00002382|Saquinavir|saquinavir|mesh-list
83627501|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627502|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627503|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627504|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627505|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627506|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627507|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627508|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
83627509|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627510|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627511|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627512|NCT00002388|Abacavir|abacavir|mesh-list
83627513|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627514|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627515|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627516|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627517|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
83627518|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627519|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627520|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627521|NCT00002394|Terbinafine|terbinafine|mesh-list
83627522|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
83627523|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627524|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627525|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627526|NCT00002400|Lamivudine|lamivudine|mesh-list
83627527|NCT00002400|Zidovudine|zidovudine|mesh-list
83627528|NCT00002400|Delavirdine|delavirdine|mesh-list
83627529|NCT00002400|Indinavir|indinavir|mesh-list
83627530|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627531|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627532|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627533|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627534|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
83627535|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627536|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627537|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627538|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
83627539|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627540|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627541|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627542|NCT00002406|Indinavir|indinavir|mesh-list
83627543|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627544|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627545|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627546|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627547|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627548|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627549|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627550|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
83627551|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627552|NCT00002412|Stavudine|stavudine|mesh-list
83627553|NCT00002412|Didanosine|didanosine|mesh-list
83627554|NCT00002412|Emivirine|emivirine|mesh-list
83627555|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
83627556|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627557|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
83627558|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627559|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627560|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627561|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
83627562|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627563|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
83627564|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627565|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82781824|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
83627566|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627567|NCT00002418|Nevirapine|nevirapine|mesh-list
83627568|NCT00002418|Stavudine|stavudine|mesh-list
83627569|NCT00002418|Didanosine|didanosine|mesh-list
83627570|NCT00002418|Emivirine|emivirine|mesh-list
83627571|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
83627572|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627573|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627574|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627575|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627576|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
83627577|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627578|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627579|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627580|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83627581|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83627582|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627583|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
83627584|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
83627585|NCT00002424|Lamivudine|lamivudine|mesh-list
83627586|NCT00002424|Stavudine|stavudine|mesh-list
83627587|NCT00002424|Indinavir|indinavir|mesh-list
83627588|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627589|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627590|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627591|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627592|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
83627593|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627594|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627595|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627596|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
83627597|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627598|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627599|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627600|NCT00002430|Lamivudine|lamivudine|mesh-list
83627601|NCT00002430|Stavudine|stavudine|mesh-list
83627602|NCT00002430|Nelfinavir|nelfinavir|mesh-list
83627603|NCT00002430|Indinavir|indinavir|mesh-list
83627604|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627605|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627606|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627607|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627608|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
83627609|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627610|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627611|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627612|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627613|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627614|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627615|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
83627616|NCT00002436|Lamivudine|lamivudine|mesh-list
83627617|NCT00002436|Zidovudine|zidovudine|mesh-list
83627618|NCT00002436|Zalcitabine|zalcitabine|mesh-list
83627619|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627620|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627621|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627622|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627623|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
83627624|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627625|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627626|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627627|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
83627628|NCT00002442|Lamivudine|lamivudine|mesh-list
83627629|NCT00002442|Stavudine|stavudine|mesh-list
83627630|NCT00002442|Nelfinavir|nelfinavir|mesh-list
83627631|NCT00002442|Indinavir|indinavir|mesh-list
83627632|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627633|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627634|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627635|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627636|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
83627637|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627638|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627639|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627640|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627641|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627642|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627643|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
83627644|NCT00002448|Ritonavir|ritonavir|mesh-list
83627645|NCT00002448|Saquinavir|saquinavir|mesh-list
83627647|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83627648|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83627649|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
83627650|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627651|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627652|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83627653|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83627654|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
83627655|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627656|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83627657|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83627658|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83627659|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627660|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83627661|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83627662|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83627663|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83627664|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83627665|NCT00002460|Tamoxifen|tamoxifen|mesh-list
83627666|NCT00002460|Goserelin|goserelin|mesh-list
83627667|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83627668|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
83627669|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627670|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627671|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83627672|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627673|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83627674|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83627675|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83627676|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
83627677|NCT00002466|Ifosfamide|ifosfamide|mesh-list
83627678|NCT00002466|Doxorubicin|doxorubicin|mesh-list
83627679|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83627680|NCT00002466|Etoposide|etoposide|mesh-list
83627681|NCT00002466|Vincristine|vincristine|mesh-list
83627682|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627683|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
83627684|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627685|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627686|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627687|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
83627688|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627689|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627690|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83627691|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83627692|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627693|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627694|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627695|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627696|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
83627697|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
83627698|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
83627699|NCT00002472|Etoposide|etoposide|mesh-list
83627700|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627701|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627702|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627703|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627704|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627705|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627706|NCT00002478|Etoposide|etoposide|mesh-list
83627707|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627708|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627709|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627710|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627711|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627712|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627713|NCT00002490|Mitomycins|mitomycins|mesh-list
83627714|NCT00002490|Mitomycin|mitomycin|mesh-list
83627715|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
83627716|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83627717|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627718|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
83627719|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627720|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627721|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627722|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83627723|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
83627724|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627725|NCT00002496|Cobalt|cobalt|mesh-list
83627726|NCT00002496|Fluorouracil|fluorouracil|mesh-list
83627727|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627728|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
83627729|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627730|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83627731|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627732|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
83627733|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627734|NCT00002496|Trace Elements|trace elements|mesh-ancestor
83627735|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
83627736|NCT00002502|Cytarabine|cytarabine|mesh-list
83627737|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
83627738|NCT00002502|Busulfan|busulfan|mesh-list
83627739|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627740|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
83627741|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627742|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627743|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627744|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
83627745|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627746|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627747|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83627748|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83627749|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
83627750|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
83627751|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627752|NCT00002508|Carboplatin|carboplatin|mesh-list
83627753|NCT00002508|Etoposide|etoposide|mesh-list
83627754|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627755|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627756|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627757|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627758|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627759|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627760|NCT00002526|Doxorubicin|doxorubicin|mesh-list
83627761|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83627762|NCT00002526|Ifosfamide|ifosfamide|mesh-list
83627763|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83627764|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627765|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627766|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627767|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627768|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627769|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627770|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
83627771|NCT00002532|Leucovorin|leucovorin|mesh-list
83627772|NCT00002532|Cytarabine|cytarabine|mesh-list
83627773|NCT00002532|Dexamethasone|dexamethasone|mesh-list
83627774|NCT00002532|Prednisolone|prednisolone|mesh-list
83627775|NCT00002532|Methotrexate|methotrexate|mesh-list
83627776|NCT00002532|Etoposide|etoposide|mesh-list
83627777|NCT00002532|Daunorubicin|daunorubicin|mesh-list
83627778|NCT00002532|Asparaginase|asparaginase|mesh-list
83627779|NCT00002532|Ifosfamide|ifosfamide|mesh-list
83627780|NCT00002532|Idarubicin|idarubicin|mesh-list
83627781|NCT00002532|Vindesine|vindesine|mesh-list
83627782|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
83627783|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83627784|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
83627785|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
83627786|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83627787|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627788|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83627789|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
83627790|NCT00002532|Hormones|hormones|mesh-ancestor
83627791|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627792|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83627793|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627794|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83627795|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
83627796|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83627797|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83627799|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627800|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
83627801|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627802|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83627803|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627804|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
83627805|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627806|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627807|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627808|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627809|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627810|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
83627811|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627812|NCT00002532|Antidotes|antidotes|mesh-ancestor
83627813|NCT00002532|Protective Agents|protective agents|mesh-ancestor
83627814|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
83627815|NCT00002532|Vitamins|vitamins|mesh-ancestor
83627816|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
83627817|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83627818|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627819|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
83627820|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
83627821|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
83627822|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
83627823|NCT00002544|Docetaxel|docetaxel|mesh-list
83627824|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
83627825|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627826|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
83627827|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
83627828|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
83627829|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627830|NCT00002544|Analgesics|analgesics|mesh-ancestor
83627831|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
83627832|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83627833|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627834|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627835|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627836|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627837|NCT00002550|Etoposide|etoposide|mesh-list
83627838|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627839|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627840|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627841|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627842|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627843|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627844|NCT00002556|Interferons|interferons|mesh-list
83627845|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
83627846|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
83627847|NCT00002556|Prednisone|prednisone|mesh-list
83627848|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
83627849|NCT00002556|Melphalan|melphalan|mesh-list
83627850|NCT00002556|Carmustine|carmustine|mesh-list
83627851|NCT00002556|Vincristine|vincristine|mesh-list
83627852|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627853|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
83627854|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627855|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627856|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627857|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
83627858|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627859|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627860|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83627861|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83627862|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
83627863|NCT00002556|Hormones|hormones|mesh-ancestor
83627864|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627865|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83627866|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
83627867|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627868|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627869|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
83627870|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
83627871|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
83627872|NCT00002562|Paclitaxel|paclitaxel|mesh-list
83627873|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627874|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627875|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83627876|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83627877|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83627878|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627879|NCT00002568|Paclitaxel|paclitaxel|mesh-list
83627880|NCT00002568|Cisplatin|cisplatin|mesh-list
83627881|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627882|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627883|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
83627884|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
83627885|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
83627886|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627887|NCT00002574|Interferons|interferons|mesh-list
83627888|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
83627889|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
83627890|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627891|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
83627892|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627893|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
83627894|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627895|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627896|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83627897|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627898|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627899|NCT00002580|Tamoxifen|tamoxifen|mesh-list
83627900|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
83627901|NCT00002580|Fluorouracil|fluorouracil|mesh-list
83627902|NCT00002580|Methotrexate|methotrexate|mesh-list
83627903|NCT00002580|Leuprolide|leuprolide|mesh-list
83627904|NCT00002580|Goserelin|goserelin|mesh-list
83627905|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627906|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
83627907|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627908|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627909|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627910|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
83627911|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627912|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627913|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83627914|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
83627915|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83627916|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83627917|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
83627918|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83627919|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
83627920|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627921|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83627922|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627923|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83627924|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
83627925|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83627926|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83627927|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83627928|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83627929|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83627930|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83627931|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
83627932|NCT00002586|Vitamin E|vitamin e|mesh-list
83627933|NCT00002586|Tocopherols|tocopherols|mesh-list
83627934|NCT00002586|Tocotrienols|tocotrienols|mesh-list
83627935|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
83627936|NCT00002586|Tretinoin|tretinoin|mesh-list
83627937|NCT00002586|Isotretinoin|isotretinoin|mesh-list
83627938|NCT00002586|Vitamins|vitamins|mesh-ancestor
83627939|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
83627940|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627941|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
83627942|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627943|NCT00002586|Protective Agents|protective agents|mesh-ancestor
83627944|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627945|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
83627946|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
83627947|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
83627948|NCT00002592|Busulfan|busulfan|mesh-list
83627949|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627950|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
83627951|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627952|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627953|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627954|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
83627955|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627956|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627957|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83627958|NCT00002598|Interferons|interferons|mesh-list
83627960|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
83627961|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
83627962|NCT00002598|Methotrexate|methotrexate|mesh-list
83627963|NCT00002598|Etoposide|etoposide|mesh-list
83627964|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
83627965|NCT00002598|Sargramostim|sargramostim|mesh-list
83627966|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83627967|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
83627968|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83627969|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83627970|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627971|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
83627972|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627973|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627974|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83627975|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83627976|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
83627977|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83627978|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83627979|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
83627980|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
83627981|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627982|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83627983|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83627984|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83627985|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83627986|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83627987|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
83627988|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83627989|NCT00002598|Analgesics|analgesics|mesh-ancestor
83627990|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
83627991|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83627992|NCT00002604|Carmustine|carmustine|mesh-list
83627993|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83627994|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83627995|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
83627996|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83627997|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83627998|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83627999|NCT00002610|Dactinomycin|dactinomycin|mesh-list
83628000|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
83628001|NCT00002610|Carboplatin|carboplatin|mesh-list
83628002|NCT00002610|Doxorubicin|doxorubicin|mesh-list
83628003|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83628004|NCT00002610|Etoposide|etoposide|mesh-list
83628005|NCT00002610|Vincristine|vincristine|mesh-list
83628006|NCT00002610|Lenograstim|lenograstim|mesh-list
83628007|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628008|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
83628009|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628010|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628011|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628012|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
83628013|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628014|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628015|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628016|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628017|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628018|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628019|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628020|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628021|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83628022|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628023|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628024|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628025|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628026|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628027|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83628028|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628029|NCT00002616|Aldesleukin|aldesleukin|mesh-list
83628030|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
83628032|NCT00002616|Carboplatin|carboplatin|mesh-list
83628033|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628034|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
83628035|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628036|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628037|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628038|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
83628039|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628040|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628041|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628042|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83628043|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83628044|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
83628045|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628046|NCT00002634|Cobalt|cobalt|mesh-list
83628047|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
83628048|NCT00002634|Doxorubicin|doxorubicin|mesh-list
83628049|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83628050|NCT00002634|Etoposide|etoposide|mesh-list
83628051|NCT00002634|Vincristine|vincristine|mesh-list
83628052|NCT00002634|Antibodies|antibodies|mesh-list
83628053|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83628054|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628055|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
83628056|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628057|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628058|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628059|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
83628060|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628061|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628062|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628063|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628064|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628065|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628066|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628067|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628068|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628069|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628070|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628071|NCT00002634|Trace Elements|trace elements|mesh-ancestor
83628072|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
83628073|NCT00002646|Tamoxifen|tamoxifen|mesh-list
83628074|NCT00002646|Fenretinide|fenretinide|mesh-list
83628075|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83628076|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83628077|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628078|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628079|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628080|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628081|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83628082|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83628083|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83628084|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83628085|NCT00002646|Protective Agents|protective agents|mesh-ancestor
83628086|NCT00002652|Suramin|suramin|mesh-list
83628087|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
83628088|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
83628089|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83628090|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628091|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628092|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83628093|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83628094|NCT00002658|Cytarabine|cytarabine|mesh-list
83628095|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
83628096|NCT00002658|Etoposide|etoposide|mesh-list
83628097|NCT00002658|Daunorubicin|daunorubicin|mesh-list
83628098|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
83628099|NCT00002658|Idarubicin|idarubicin|mesh-list
83628100|NCT00002658|Tretinoin|tretinoin|mesh-list
83628101|NCT00002658|Thioguanine|thioguanine|mesh-list
83628102|NCT00002658|Amsacrine|amsacrine|mesh-list
83628103|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628104|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
83628105|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628106|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628107|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628108|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
83628109|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628110|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628111|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628112|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628113|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628114|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628115|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628116|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628117|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
83628118|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
83628119|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628120|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628121|NCT00002658|Analgesics|analgesics|mesh-ancestor
83628122|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
83628123|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628124|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
83628125|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628126|NCT00002664|Sargramostim|sargramostim|mesh-list
83628127|NCT00002664|Edrecolomab|edrecolomab|mesh-list
83628128|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
83628129|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628130|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83628131|NCT00002670|Cobalt|cobalt|mesh-list
83628132|NCT00002670|Trace Elements|trace elements|mesh-ancestor
83628133|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
83628134|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628135|NCT00002676|Cobalt|cobalt|mesh-list
83628136|NCT00002676|Cytarabine|cytarabine|mesh-list
83628137|NCT00002676|Dexamethasone|dexamethasone|mesh-list
83628138|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
83628139|NCT00002676|Carmustine|carmustine|mesh-list
83628140|NCT00002676|Doxorubicin|doxorubicin|mesh-list
83628141|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83628142|NCT00002676|Methotrexate|methotrexate|mesh-list
83628143|NCT00002676|Vincristine|vincristine|mesh-list
83628144|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628145|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
83628146|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628147|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628148|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628149|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
83628150|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628151|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628152|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628153|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83628154|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
83628155|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
83628156|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628157|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628158|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
83628159|NCT00002676|Hormones|hormones|mesh-ancestor
83628160|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628161|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628162|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628163|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628164|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628165|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628166|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83628167|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
83628168|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83628169|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628170|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
83628171|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628172|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83628173|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628174|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
83628175|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628176|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628177|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628178|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
82782428|NCT00989352|Rituximab|rituximab|mesh-list
83628179|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628180|NCT00002676|Trace Elements|trace elements|mesh-ancestor
83628181|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
83628182|NCT00002682|Amoxicillin|amoxicillin|mesh-list
83628183|NCT00002682|Metronidazole|metronidazole|mesh-list
83628184|NCT00002682|Clarithromycin|clarithromycin|mesh-list
83628185|NCT00002682|Tetracycline|tetracycline|mesh-list
83628186|NCT00002682|Omeprazole|omeprazole|mesh-list
83628187|NCT00002682|Bismuth|bismuth|mesh-list
83628188|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83628189|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628190|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628191|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83628192|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83628193|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83628194|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628195|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83628196|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628197|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628198|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83628199|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83628200|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83628201|NCT00002682|Antacids|antacids|mesh-ancestor
83628202|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
83628203|NCT00002688|Cyclosporine|cyclosporine|mesh-list
83628204|NCT00002688|Etoposide|etoposide|mesh-list
83628205|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
83628206|NCT00002688|Cyclosporins|cyclosporins|mesh-list
83628207|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628208|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628209|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628210|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628211|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628212|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628213|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628214|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
83628215|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628216|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
83628217|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628218|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628219|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628220|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83628221|NCT00002688|Analgesics|analgesics|mesh-ancestor
83628222|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
83628223|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628224|NCT00002700|Leucovorin|leucovorin|mesh-list
83628225|NCT00002700|Cytarabine|cytarabine|mesh-list
83628226|NCT00002700|Dexamethasone|dexamethasone|mesh-list
83628227|NCT00002700|Prednisone|prednisone|mesh-list
83628228|NCT00002700|Prednisolone|prednisolone|mesh-list
83628229|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
83628230|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83628231|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83628232|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82782495|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
82782496|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782497|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82782498|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782499|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782500|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782501|NCT01589419|Capecitabine|capecitabine|mesh-list
82782502|NCT01589419|Veliparib|veliparib|mesh-list
82782503|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82782504|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
82782505|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782506|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782507|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82782508|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782509|NCT00676403|Pregabalin|pregabalin|mesh-list
82782510|NCT00676403|Analgesics|analgesics|mesh-ancestor
82782511|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
82782512|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782513|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782514|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
82782515|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82782516|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83628233|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
83628234|NCT00002700|Doxorubicin|doxorubicin|mesh-list
83628235|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83628236|NCT00002700|Methotrexate|methotrexate|mesh-list
83628237|NCT00002700|Vincristine|vincristine|mesh-list
83628238|NCT00002700|Daunorubicin|daunorubicin|mesh-list
83628239|NCT00002700|Asparaginase|asparaginase|mesh-list
83628240|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
83628241|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
83628242|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
83628243|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628244|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
83628245|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628246|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628247|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628248|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
83628249|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628250|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628251|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628252|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83628253|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
83628254|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
83628255|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628256|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628257|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
83628258|NCT00002700|Hormones|hormones|mesh-ancestor
83628259|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628260|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628261|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628262|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628263|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628264|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628265|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83628266|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
83628267|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83628268|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628269|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
83628270|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628271|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83628272|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628273|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
83628274|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628275|NCT00002700|Antidotes|antidotes|mesh-ancestor
83628276|NCT00002700|Protective Agents|protective agents|mesh-ancestor
83628277|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
83628278|NCT00002700|Vitamins|vitamins|mesh-ancestor
83628279|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
83628280|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628281|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628282|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628283|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628284|NCT00002700|Analgesics|analgesics|mesh-ancestor
83628285|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
83628286|NCT00002718|Cytarabine|cytarabine|mesh-list
83628287|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
83628288|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
83628289|NCT00002718|Thiotepa|thiotepa|mesh-list
83628290|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83628291|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628292|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
83628293|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628294|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628295|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628296|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
83628297|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628298|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628299|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628300|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628301|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
83628302|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
83628303|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628304|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83628305|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
83628306|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
83628307|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628308|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628309|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
83628310|NCT00002718|Hormones|hormones|mesh-ancestor
83628311|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628312|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83628313|NCT00002718|Protective Agents|protective agents|mesh-ancestor
83628314|NCT00002730|Melphalan|melphalan|mesh-list
83628315|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
83628316|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628317|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
83628318|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628319|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628320|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628321|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628322|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
83628323|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628324|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
83628325|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628326|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628327|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83628328|NCT00002730|Protective Agents|protective agents|mesh-ancestor
83628329|NCT00002742|Amphotericin B|amphotericin b|mesh-list
83628330|NCT00002742|Nystatin|nystatin|mesh-list
83628331|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83628332|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
83628333|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
83628334|NCT00002742|Amebicides|amebicides|mesh-ancestor
83628335|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83628336|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83628337|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628338|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628339|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
83628340|NCT00002742|Ionophores|ionophores|mesh-ancestor
83628341|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83628342|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628343|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83628344|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628345|NCT00002748|Interleukin-2|interleukin-2|mesh-list
83628346|NCT00002748|Vaccines|vaccines|mesh-list
83628347|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628348|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83628349|NCT00002748|Analgesics|analgesics|mesh-ancestor
83628350|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
83628351|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628352|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628353|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
83628354|NCT00002754|Antibodies|antibodies|mesh-list
83628355|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83628356|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
83628357|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628358|NCT00002760|Ketoconazole|ketoconazole|mesh-list
83628359|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
83628360|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83628361|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83628362|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83628363|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
83628364|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83628365|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
83628366|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628367|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83628368|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83628369|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628370|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628371|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83628372|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
83628373|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628374|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628375|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83628376|NCT00002772|Tamoxifen|tamoxifen|mesh-list
83628377|NCT00002772|Paclitaxel|paclitaxel|mesh-list
83628378|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
83628379|NCT00002772|Carboplatin|carboplatin|mesh-list
83628380|NCT00002772|Doxorubicin|doxorubicin|mesh-list
83628381|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83628382|NCT00002772|Thiotepa|thiotepa|mesh-list
83628383|NCT00002772|Carmustine|carmustine|mesh-list
83628384|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628385|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628386|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628387|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628388|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628389|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628390|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628391|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
83628392|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628393|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628394|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628395|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
83628396|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628397|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628398|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628399|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628400|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628401|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83628402|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83628403|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628404|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628405|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83628406|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83628407|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83628408|NCT00002778|Sargramostim|sargramostim|mesh-list
83628409|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
83628410|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628411|NCT00002784|Tamoxifen|tamoxifen|mesh-list
83628412|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
83628413|NCT00002784|Doxorubicin|doxorubicin|mesh-list
83628414|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83628415|NCT00002784|Fluorouracil|fluorouracil|mesh-list
83628416|NCT00002784|Methotrexate|methotrexate|mesh-list
83628417|NCT00002784|Epirubicin|epirubicin|mesh-list
83628418|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628419|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
83628420|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628421|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628422|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628423|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
83628424|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628425|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628426|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628427|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628428|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628429|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628430|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628431|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
83628432|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628433|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83628434|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
83628435|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83628436|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628437|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83628438|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628439|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83628440|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
83628441|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628442|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628443|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83628444|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83628445|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83628446|NCT00002790|Cyclosporine|cyclosporine|mesh-list
83628447|NCT00002790|Sirolimus|sirolimus|mesh-list
83628448|NCT00002790|Methotrexate|methotrexate|mesh-list
83628449|NCT00002790|Cyclosporins|cyclosporins|mesh-list
83628450|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83628451|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
83628452|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83628453|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628454|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628455|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
83628456|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628457|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628458|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628459|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628460|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83628461|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628462|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
83628463|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628464|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628465|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
83628466|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628467|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83628468|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628469|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628470|NCT05752110|Ketamine|ketamine|mesh-list
83628471|NCT05752110|Analgesics|analgesics|mesh-ancestor
83628472|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
83628473|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628474|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628475|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83628476|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83628477|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
83628478|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
83628479|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628480|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83628481|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83628482|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83628483|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628484|NCT05751876|Dienogest|dienogest|mesh-list
83628485|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83628486|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
83628487|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83628488|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628489|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83628490|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83628491|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83628492|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83628493|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
83628494|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628495|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628496|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628497|NCT05751252|Ganirelix|ganirelix|mesh-list
83628498|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83628499|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628500|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628501|NCT00002628|Paclitaxel|paclitaxel|mesh-list
83628502|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
83628503|NCT00002628|Carboplatin|carboplatin|mesh-list
83628504|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628505|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628506|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628507|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628508|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628509|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628510|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628511|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
83628512|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628513|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628514|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628515|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
83628516|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628517|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83628518|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
83628519|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83628520|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83628521|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628522|NCT05749614|Lidocaine|lidocaine|mesh-list
83628523|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
83628524|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
83628525|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628526|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628527|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
83628528|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628529|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83628530|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83628531|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83628532|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83628533|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628534|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83628535|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
83628536|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782796|NCT00982202|Pioglitazone|pioglitazone|mesh-list
83628537|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83628538|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83628539|NCT05748990|Insulin|insulin|mesh-list
83628540|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
83628541|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83628542|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628543|NCT05677698|Peppermint oil|peppermint oil|mesh-list
83628544|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
83628545|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
83628546|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628547|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628548|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628549|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
83628550|NCT05588388|Bevacizumab|bevacizumab|mesh-list
83628551|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628552|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628553|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83628554|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83628555|NCT05588388|Growth Substances|growth substances|mesh-ancestor
83628556|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628557|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
83628558|NCT05543850|Pancrelipase|pancrelipase|mesh-list
83628559|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628560|NCT05516628|Bevacizumab|bevacizumab|mesh-list
83628561|NCT05516628|Atezolizumab|atezolizumab|mesh-list
83628562|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628563|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628564|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83628565|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83628566|NCT05516628|Growth Substances|growth substances|mesh-ancestor
83628567|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628568|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
83628569|NCT05516628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83628570|NCT05516628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628571|NCT05497674|Rifampin|rifampin|mesh-list
83628572|NCT05497674|Probenecid|probenecid|mesh-list
83628573|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83628574|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
83628575|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628576|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628577|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
83628578|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628579|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628580|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628581|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83628582|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83628583|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83628584|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83628585|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83628586|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83628587|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
83628588|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
83628589|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628590|NCT05408910|Rifaximin|rifaximin|mesh-list
83628591|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628592|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628593|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628594|NCT05360628|Allopurinol|allopurinol|mesh-list
83628595|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
83628596|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628597|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628598|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
83628599|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628600|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83628601|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
83628602|NCT05360628|Protective Agents|protective agents|mesh-ancestor
83628603|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628604|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
83628605|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628606|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83628607|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628608|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628609|NCT05312112|Venetoclax|venetoclax|mesh-list
83628610|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628611|NCT05296278|Lenvatinib|lenvatinib|mesh-list
83628612|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628613|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83628614|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628615|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628616|NCT05218668|Fasudil|fasudil|mesh-list
83628617|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83628618|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83628619|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628620|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83628621|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628622|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
83628623|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83628624|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628625|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
83628626|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628627|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628628|NCT05182164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83628629|NCT05182164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628630|NCT05048940|Vaccines|vaccines|mesh-list
83628631|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
83628632|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628633|NCT04836780|Dexamethasone|dexamethasone|mesh-list
83628634|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83628635|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
83628636|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
83628637|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628638|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628639|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83628640|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
83628641|NCT04836780|Hormones|hormones|mesh-ancestor
83628642|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628643|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628644|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628645|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
83628646|NCT04740294|Analgesics|analgesics|mesh-ancestor
83628647|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
83628648|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628649|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628650|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
83628651|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628652|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83628653|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
83628654|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83628655|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83628656|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628657|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83628658|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
83628659|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83628660|NCT04705818|Durvalumab|durvalumab|mesh-list
83628661|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628662|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628663|NCT04610736|Temozolomide|temozolomide|mesh-list
83628664|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628665|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
83628666|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628667|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628668|NCT04529538|Vaccines|vaccines|mesh-list
83628669|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
83628670|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628671|NCT04521114|Leronlimab|leronlimab|mesh-list
83628672|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
83628673|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83628674|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83628675|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628676|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83628677|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83628678|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
83628679|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628680|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
83628681|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628682|NCT04519164|Eplerenone|eplerenone|mesh-list
83628683|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
83628684|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83628685|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
82782942|NCT05537402|Growth Substances|growth substances|mesh-ancestor
83628686|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628687|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628688|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83628689|NCT04519164|Diuretics|diuretics|mesh-ancestor
83628690|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
83628691|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83628692|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83628693|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83628694|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628695|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
83628696|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628697|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628698|NCT04471974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83628699|NCT04471974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628700|NCT04360824|Enoxaparin|enoxaparin|mesh-list
83628701|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
83628702|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83628703|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83628704|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628705|NCT04331652|Anesthetics|anesthetics|mesh-list
83628706|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628707|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628708|NCT04168710|Bupivacaine|bupivacaine|mesh-list
83628709|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
83628710|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
83628711|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628712|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628713|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
83628714|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628715|NCT04016142|Paclitaxel|paclitaxel|mesh-list
83628716|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83628717|NCT04016142|Carboplatin|carboplatin|mesh-list
83628718|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628719|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628720|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628721|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628722|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628723|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628724|NCT03915678|Atezolizumab|atezolizumab|mesh-list
83628725|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83628726|NCT03915678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83628727|NCT03915678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628728|NCT03915678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628729|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628730|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
83628731|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628732|NCT03915366|Valganciclovir|valganciclovir|mesh-list
83628733|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
83628734|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
83628735|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628736|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628737|NCT03874338|Colchicine|colchicine|mesh-list
83628738|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
83628739|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628740|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628741|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628742|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628743|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628744|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628745|NCT03846570|Beclomethasone|beclomethasone|mesh-list
83628746|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
83628747|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83628748|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
83628749|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628750|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628751|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83628752|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
83628753|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83628754|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83628755|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83628756|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
83628757|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83628758|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628759|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83628760|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
83628761|NCT03846570|Hormones|hormones|mesh-ancestor
83628762|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628763|NCT03838848|Carboplatin|carboplatin|mesh-list
83628764|NCT03838848|Pemetrexed|pemetrexed|mesh-list
83628765|NCT03838848|Antibodies|antibodies|mesh-list
83628766|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
83628767|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
83628768|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628769|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628770|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628771|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628772|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83628773|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628774|NCT03787602|Avelumab|avelumab|mesh-list
83628775|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628776|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628777|NCT03782376|Ustekinumab|ustekinumab|mesh-list
83628778|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628779|NCT03745170|Capecitabine|capecitabine|mesh-list
83628780|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
83628781|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628782|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
83628783|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628784|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628785|NCT03737370|Docetaxel|docetaxel|mesh-list
83628786|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628787|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628788|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628789|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628790|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628791|NCT03701490|Progesterone|progesterone|mesh-list
83628792|NCT03701490|Progestins|progestins|mesh-ancestor
83628793|NCT03701490|Hormones|hormones|mesh-ancestor
83628794|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628795|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628796|NCT03691974|Fasinumab|fasinumab|mesh-list
83628797|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83628798|NCT03691974|Analgesics|analgesics|mesh-ancestor
83628799|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
83628800|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628801|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628802|NCT03662022|Rifampin|rifampin|mesh-list
83628803|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83628804|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
83628805|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628806|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628807|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
83628808|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83628809|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628810|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628811|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83628812|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83628813|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83628814|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83628815|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83628816|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83628817|NCT03652428|Paclitaxel|paclitaxel|mesh-list
83628818|NCT03652428|Gemcitabine|gemcitabine|mesh-list
83628819|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628820|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628821|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628822|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628823|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628824|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628825|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628826|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
83628827|NCT03580044|Aztreonam|aztreonam|mesh-list
83628828|NCT03580044|Avibactam|avibactam|mesh-list
83628829|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83628830|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628831|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83628832|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628833|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628835|NCT03459222|Ipilimumab|ipilimumab|mesh-list
83628836|NCT03459222|Relatlimab|relatlimab|mesh-list
83628837|NCT03459222|Linrodostat|linrodostat|mesh-list
83628838|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628839|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628840|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83628841|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628842|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628843|NCT03351348|Bupivacaine|bupivacaine|mesh-list
83628844|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
83628845|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
83628846|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628847|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628848|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
83628849|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628850|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
83628851|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628852|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628853|NCT02972034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83628854|NCT02972034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628855|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83628856|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83628857|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628858|NCT02829918|Nivolumab|nivolumab|mesh-list
83628859|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83628860|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628861|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83628862|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628863|NCT02795988|Fluorouracil|fluorouracil|mesh-list
83628864|NCT02795988|Capecitabine|capecitabine|mesh-list
83628865|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
83628866|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628867|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
83628868|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628869|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628870|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628871|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
83628872|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628873|NCT02782104|Esketamine|esketamine|mesh-list
83628874|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
83628875|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83628876|NCT01821690|Buspirone|buspirone|mesh-list
83628877|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83628878|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83628879|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628880|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628881|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83628882|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83628883|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
83628884|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83628885|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628886|NCT01394016|Fulvestrant|fulvestrant|mesh-list
83628887|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83628888|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628889|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83628890|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83628891|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
83628892|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83628893|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628894|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
83628895|NCT01096368|Cisplatin|cisplatin|mesh-list
83628896|NCT01096368|Carboplatin|carboplatin|mesh-list
83628897|NCT01096368|Etoposide|etoposide|mesh-list
83628898|NCT01096368|Vincristine|vincristine|mesh-list
83628899|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
83628900|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
83628901|NCT01096368|Lenograstim|lenograstim|mesh-list
83628902|NCT01096368|Mesna|mesna|mesh-list
83628903|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628904|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
83628905|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628906|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628907|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628908|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
83628909|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628910|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628911|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628912|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83628913|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628914|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83628915|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628916|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83628917|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83628918|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83628919|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83628920|NCT01096368|Protective Agents|protective agents|mesh-ancestor
83628921|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
83628922|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
83628923|NCT00978822|Clevidipine|clevidipine|mesh-list
83628924|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83628925|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83628926|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628927|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83628928|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628929|NCT00577200|Midazolam|midazolam|mesh-list
83628930|NCT00577200|Sufentanil|sufentanil|mesh-list
83628931|NCT00577200|Propofol|propofol|mesh-list
83628932|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83628933|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83628934|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628935|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83628936|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
83628937|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
83628938|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83628939|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83628940|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83628941|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83628942|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
83628943|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
83628944|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83628945|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628946|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83628947|NCT00577200|Narcotics|narcotics|mesh-ancestor
83628948|NCT00577200|Analgesics|analgesics|mesh-ancestor
83628949|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
83628950|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628951|NCT00002796|Interferons|interferons|mesh-list
83628952|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
83628953|NCT00002796|Indomethacin|indomethacin|mesh-list
83628954|NCT00002796|Fluorouracil|fluorouracil|mesh-list
83628955|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83628956|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
83628957|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628958|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83628959|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628960|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628961|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
83628962|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628963|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
83628964|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83628965|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83628966|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83628967|NCT00002796|Analgesics|analgesics|mesh-ancestor
83628968|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
83628969|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83628970|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83628971|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628972|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
83628973|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
83628974|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83628975|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83628976|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83628977|NCT00002802|Cobalt|cobalt|mesh-list
83628978|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
83628979|NCT00002802|Melphalan|melphalan|mesh-list
83628980|NCT00002802|Ifosfamide|ifosfamide|mesh-list
83628981|NCT00002802|Dacarbazine|dacarbazine|mesh-list
83628982|NCT00002802|Carboplatin|carboplatin|mesh-list
83628983|NCT00002802|Doxorubicin|doxorubicin|mesh-list
83628984|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83628985|NCT00002802|Etoposide|etoposide|mesh-list
83628986|NCT00002802|Vincristine|vincristine|mesh-list
83628987|NCT00002802|Vindesine|vindesine|mesh-list
83628988|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83628989|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
83628990|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83628991|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83628992|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83628993|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
83628994|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83628995|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83628996|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83628997|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83628998|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83628999|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629000|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629001|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629002|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629003|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629004|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629005|NCT00002802|Trace Elements|trace elements|mesh-ancestor
83629006|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
83629007|NCT00002814|Paclitaxel|paclitaxel|mesh-list
83629008|NCT00002814|Topotecan|topotecan|mesh-list
83629009|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629010|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629011|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629012|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629013|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629014|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629015|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83629016|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629017|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629018|NCT00002832|Cyclosporine|cyclosporine|mesh-list
83629019|NCT00002832|Decitabine|decitabine|mesh-list
83629020|NCT00002832|Cyclosporins|cyclosporins|mesh-list
83629021|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
83629022|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629023|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629024|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629025|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629026|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
83629027|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629028|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
83629029|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629030|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83629031|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629032|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
83629033|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629034|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
83629035|NCT00002838|Fludarabine|fludarabine|mesh-list
83629036|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
83629037|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629038|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
83629039|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629040|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629041|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629042|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
83629043|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629044|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629045|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629046|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629047|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
83629048|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
83629049|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629050|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
83629051|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629052|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629053|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629054|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
83629055|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629056|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629057|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629058|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
83629059|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629060|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629061|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629062|NCT00002880|Etoposide|etoposide|mesh-list
83629063|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
83629064|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629065|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629066|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629067|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629068|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629069|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629070|NCT00002892|Interferons|interferons|mesh-list
83629071|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
83629072|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629073|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
83629074|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629075|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
83629076|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629077|NCT00002898|Dactinomycin|dactinomycin|mesh-list
83629078|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
83629079|NCT00002898|Ifosfamide|ifosfamide|mesh-list
83629080|NCT00002898|Carboplatin|carboplatin|mesh-list
83629081|NCT00002898|Etoposide|etoposide|mesh-list
83629082|NCT00002898|Vincristine|vincristine|mesh-list
83629083|NCT00002898|Epirubicin|epirubicin|mesh-list
83629084|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629085|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
83629086|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629087|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629088|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629089|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
83629090|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629091|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629092|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629093|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629094|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629095|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629096|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629097|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629098|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629099|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629100|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629101|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83629102|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629103|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83629104|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83629105|NCT00002904|Trabectedin|trabectedin|mesh-list
83629106|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629107|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
83629108|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629109|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629110|NCT00002928|Paclitaxel|paclitaxel|mesh-list
83629111|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629112|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629113|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629114|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629115|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629116|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629117|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
83629118|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629119|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
83629120|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629121|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629122|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83629123|NCT00002946|Penclomedine|penclomedine|mesh-list
83629124|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629125|NCT00002952|Interleukin-12|interleukin-12|mesh-list
83629126|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83629127|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
83629128|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629129|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83629130|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83629131|NCT00002952|Growth Substances|growth substances|mesh-ancestor
83629132|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
83629133|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629134|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83629135|NCT00002964|Trioxsalen|trioxsalen|mesh-list
83629136|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629137|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
83629138|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83629140|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
83629141|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83629142|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83629143|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83629144|NCT00002970|Methotrexate|methotrexate|mesh-list
83629145|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83629146|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
83629147|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83629148|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629149|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629150|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
83629151|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629152|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629153|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
83629154|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629155|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83629156|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629157|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
83629158|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629159|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83629160|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
83629161|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629162|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83629163|NCT00002976|Estrogens|estrogens|mesh-list
83629164|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83629165|NCT00002976|Hormones|hormones|mesh-ancestor
83629166|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83629167|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629168|NCT00002982|Cytarabine|cytarabine|mesh-list
83629169|NCT00002982|Carboplatin|carboplatin|mesh-list
83629170|NCT00002982|Etoposide|etoposide|mesh-list
83629171|NCT00002982|Melphalan|melphalan|mesh-list
83629172|NCT00002982|Ifosfamide|ifosfamide|mesh-list
83629173|NCT00002982|Carmustine|carmustine|mesh-list
83629174|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629175|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629176|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629177|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629178|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629179|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629180|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629181|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
83629182|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
83629183|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629184|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629185|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
83629186|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629187|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629188|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
83629189|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629190|NCT00002988|Irinotecan|irinotecan|mesh-list
83629191|NCT00002988|Carmustine|carmustine|mesh-list
83629192|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83629193|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629194|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629195|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629196|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629197|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629198|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
83629199|NCT00002994|Interleukin-2|interleukin-2|mesh-list
83629200|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629201|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83629202|NCT00002994|Analgesics|analgesics|mesh-ancestor
83629203|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
83629204|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83629205|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629206|NCT00003000|Fentanyl|fentanyl|mesh-list
83629207|NCT00003000|Morphine|morphine|mesh-list
83629208|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83629209|NCT00003000|Narcotics|narcotics|mesh-ancestor
83629210|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83629211|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629212|NCT00003000|Analgesics|analgesics|mesh-ancestor
83629213|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
83629214|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83629215|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83629216|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83629217|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
83629218|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
83629219|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
83629220|NCT00003012|Fluorouracil|fluorouracil|mesh-list
83629221|NCT00003012|Methotrexate|methotrexate|mesh-list
83629222|NCT00003012|Epirubicin|epirubicin|mesh-list
83629223|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629224|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
83629225|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629226|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629227|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629228|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
83629229|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629230|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629231|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629232|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
83629233|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629234|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83629235|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
83629236|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83629237|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
83629238|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629239|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83629240|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83629241|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629242|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629243|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629244|NCT00003048|Amifostine|amifostine|mesh-list
83629245|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83629246|NCT00003048|Protective Agents|protective agents|mesh-ancestor
83629247|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629248|NCT00003054|Paclitaxel|paclitaxel|mesh-list
83629249|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629250|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629251|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629252|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629253|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629254|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629255|NCT00003060|Cyclosporine|cyclosporine|mesh-list
83629256|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
83629257|NCT00003060|Busulfan|busulfan|mesh-list
83629258|NCT00003060|Methotrexate|methotrexate|mesh-list
83629259|NCT00003060|Cyclosporins|cyclosporins|mesh-list
83629260|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629261|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
83629262|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629263|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629264|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629265|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
83629266|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629267|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629268|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629269|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83629270|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
83629271|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83629272|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629273|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
83629274|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
83629275|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629276|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83629277|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83629278|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
83629279|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629280|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83629281|NCT00003066|Docetaxel|docetaxel|mesh-list
83629282|NCT00003066|Estramustine|estramustine|mesh-list
83629283|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629284|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629285|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629286|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629287|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629288|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629289|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
83629290|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83629292|NCT00003072|Carboplatin|carboplatin|mesh-list
83629293|NCT00003072|Amifostine|amifostine|mesh-list
83629294|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629295|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629296|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629297|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629298|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629299|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629300|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83629301|NCT00003072|Protective Agents|protective agents|mesh-ancestor
83629302|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629303|NCT00003078|Fluorouracil|fluorouracil|mesh-list
83629304|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629305|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
83629306|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629307|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629308|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629309|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
83629310|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629311|NCT00003084|Ketoconazole|ketoconazole|mesh-list
83629312|NCT00003084|Paclitaxel|paclitaxel|mesh-list
83629313|NCT00003084|Etoposide|etoposide|mesh-list
83629314|NCT00003084|Vinblastine|vinblastine|mesh-list
83629315|NCT00003084|Doxorubicin|doxorubicin|mesh-list
83629316|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83629317|NCT00003084|Estramustine|estramustine|mesh-list
83629318|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629319|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629320|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629321|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629322|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629323|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629324|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629325|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629326|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629327|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629328|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
83629329|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629330|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83629331|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83629332|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83629333|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
83629334|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83629335|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629336|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83629337|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629338|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
83629339|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83629340|NCT00003090|Aldesleukin|aldesleukin|mesh-list
83629341|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629342|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83629343|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83629344|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
83629345|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629346|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
83629347|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629348|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83629349|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
83629350|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629351|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
83629352|NCT00003114|Lomustine|lomustine|mesh-list
83629353|NCT00003114|Etoposide|etoposide|mesh-list
83629354|NCT00003114|Procarbazine|procarbazine|mesh-list
83629355|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629356|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
83629357|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629358|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629359|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629360|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
83629361|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629362|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629363|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629364|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629365|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629366|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629367|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629368|NCT00003120|Paclitaxel|paclitaxel|mesh-list
83629369|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629370|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629371|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629372|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629373|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629374|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629375|NCT00003126|Aldesleukin|aldesleukin|mesh-list
83629376|NCT00003126|Interleukin-2|interleukin-2|mesh-list
83629377|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629378|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83629379|NCT00003126|Analgesics|analgesics|mesh-ancestor
83629380|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
83629381|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83629382|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629383|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83629384|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83629385|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
83629386|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629387|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
83629388|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629389|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83629390|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
83629391|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629392|NCT00003144|Gemcitabine|gemcitabine|mesh-list
83629393|NCT00003144|Amifostine|amifostine|mesh-list
83629394|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629395|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629396|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
83629397|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629398|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83629399|NCT00003144|Protective Agents|protective agents|mesh-ancestor
83629400|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629401|NCT00003150|Prednisone|prednisone|mesh-list
83629402|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
83629403|NCT00003150|Rituximab|rituximab|mesh-list
83629404|NCT00003150|Doxorubicin|doxorubicin|mesh-list
83629405|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83629406|NCT00003150|Vincristine|vincristine|mesh-list
83629407|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629408|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
83629409|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629410|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629411|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629412|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
83629413|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629414|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629415|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629416|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83629417|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629418|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629419|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629420|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629421|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83629422|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
83629423|NCT00003150|Hormones|hormones|mesh-ancestor
83629424|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83629425|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83629426|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629427|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629428|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629429|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629430|NCT00003156|Topotecan|topotecan|mesh-list
83629431|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83629432|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629433|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629434|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629435|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629436|NCT00003174|Cladribine|cladribine|mesh-list
83629437|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
83629438|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629439|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629440|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
83629441|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629442|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83629444|NCT00003018|Fluorouracil|fluorouracil|mesh-list
83629445|NCT00003018|Mitomycins|mitomycins|mesh-list
83629446|NCT00003018|Mitomycin|mitomycin|mesh-list
83629447|NCT00003018|Dipyridamole|dipyridamole|mesh-list
83629448|NCT00003018|Calcium|calcium|mesh-list
83629449|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
83629450|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83629451|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629452|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
83629453|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629454|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629455|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629456|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629457|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
83629458|NCT00003018|Antidotes|antidotes|mesh-ancestor
83629459|NCT00003018|Protective Agents|protective agents|mesh-ancestor
83629460|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
83629461|NCT00003018|Vitamins|vitamins|mesh-ancestor
83629462|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
83629463|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629464|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
83629465|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83629466|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629467|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83629468|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83629469|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
83629470|NCT00003198|Topotecan|topotecan|mesh-list
83629471|NCT00003198|Ifosfamide|ifosfamide|mesh-list
83629472|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83629473|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629474|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629475|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629476|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629477|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629478|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
83629479|NCT00003204|Prednisone|prednisone|mesh-list
83629480|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
83629481|NCT00003204|Rituximab|rituximab|mesh-list
83629482|NCT00003204|Fludarabine|fludarabine|mesh-list
83629483|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
83629484|NCT00003204|Vincristine|vincristine|mesh-list
83629485|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629486|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
83629487|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629488|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629489|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629490|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
83629491|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629492|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629493|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629494|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83629495|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83629496|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
83629497|NCT00003204|Hormones|hormones|mesh-ancestor
83629498|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83629499|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83629500|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629501|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
83629502|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629503|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629504|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629505|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629506|NCT00003210|Interleukin-12|interleukin-12|mesh-list
83629507|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83629508|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
83629509|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629510|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83629511|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83629512|NCT00003210|Growth Substances|growth substances|mesh-ancestor
83629513|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
83629514|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629515|NCT00003216|Gemcitabine|gemcitabine|mesh-list
83629516|NCT00003216|Fluorouracil|fluorouracil|mesh-list
83629517|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629518|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
83629519|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629520|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629521|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629522|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
83629523|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629524|NCT00003234|Vinorelbine|vinorelbine|mesh-list
83629525|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629526|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629527|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629528|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629529|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629530|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629531|NCT00003240|Vinorelbine|vinorelbine|mesh-list
83629532|NCT00003240|Ifosfamide|ifosfamide|mesh-list
83629533|NCT00003240|Mitomycins|mitomycins|mesh-list
83629534|NCT00003240|Mitomycin|mitomycin|mesh-list
83629535|NCT00003240|Vinblastine|vinblastine|mesh-list
83629536|NCT00003240|Vindesine|vindesine|mesh-list
83629537|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629538|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629539|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629540|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629541|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629542|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629543|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629544|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
83629545|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629546|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83629547|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629548|NCT00003252|Amifostine|amifostine|mesh-list
83629549|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83629550|NCT00003252|Protective Agents|protective agents|mesh-ancestor
83629551|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629552|NCT00003264|Gemcitabine|gemcitabine|mesh-list
83629553|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629554|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629555|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
83629556|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629557|NCT00003276|Irinotecan|irinotecan|mesh-list
83629558|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83629559|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629560|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629561|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629562|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629563|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
83629564|NCT00003288|Tirapazamine|tirapazamine|mesh-list
83629565|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629566|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
83629567|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629568|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629569|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629570|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
83629571|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629572|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629573|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629574|NCT00003294|Paclitaxel|paclitaxel|mesh-list
83629575|NCT00003294|Carboplatin|carboplatin|mesh-list
83629576|NCT00003294|Amifostine|amifostine|mesh-list
83629577|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629578|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629579|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629580|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629581|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629582|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629583|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629584|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83629585|NCT00003294|Protective Agents|protective agents|mesh-ancestor
83629586|NCT00003330|Interleukin-12|interleukin-12|mesh-list
83629587|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83629588|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
83629589|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629590|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83629591|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83629592|NCT00003330|Growth Substances|growth substances|mesh-ancestor
83629593|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83629594|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629595|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
83629596|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
83629597|NCT00003336|Melphalan|melphalan|mesh-list
83629598|NCT00003336|Busulfan|busulfan|mesh-list
83629599|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83629600|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629601|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
83629602|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629603|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629604|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629605|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
83629606|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629607|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629608|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629609|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83629610|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
83629611|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
83629612|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83629613|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83629614|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
83629615|NCT00003336|Hormones|hormones|mesh-ancestor
83629616|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83629617|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83629618|NCT00003336|Protective Agents|protective agents|mesh-ancestor
83629619|NCT00003342|Paclitaxel|paclitaxel|mesh-list
83629620|NCT00003342|Carboplatin|carboplatin|mesh-list
83629621|NCT00003342|Gemcitabine|gemcitabine|mesh-list
83629622|NCT00003342|Doxorubicin|doxorubicin|mesh-list
83629623|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83629624|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629625|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518720|NCT00002349|Stavudine|stavudine|mesh-list
83629626|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629627|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629628|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629629|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629630|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629631|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
83629632|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629633|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629634|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629635|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629636|NCT00003348|Carmustine|carmustine|mesh-list
83629637|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83629638|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629639|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
83629640|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629641|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629642|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629643|NCT00003360|Antibodies|antibodies|mesh-list
83629644|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83629645|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
83629646|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629647|NCT00003372|Topotecan|topotecan|mesh-list
83629648|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83629649|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629650|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629651|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629652|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629653|NCT00003378|Paclitaxel|paclitaxel|mesh-list
83629654|NCT00003378|Carboplatin|carboplatin|mesh-list
83629655|NCT00003378|Gemcitabine|gemcitabine|mesh-list
83629656|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629657|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629658|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629659|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629660|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629661|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629662|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629663|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
83629664|NCT00003390|Irofulven|irofulven|mesh-list
83629665|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629666|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
83629667|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629668|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629669|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
83629670|NCT00003396|Melphalan|melphalan|mesh-list
83629671|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83629672|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629673|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
83629674|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629675|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629676|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629677|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
83629678|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629679|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629680|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629682|NCT00003402|Paclitaxel|paclitaxel|mesh-list
83629683|NCT00003402|Etoposide|etoposide|mesh-list
83629684|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
83629685|NCT00003402|Melphalan|melphalan|mesh-list
83629686|NCT00003402|Carmustine|carmustine|mesh-list
83629687|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629688|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629689|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629690|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629691|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629692|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629693|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629694|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
83629695|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629696|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629697|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629698|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
83629699|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629700|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83629701|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
83629702|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
83629703|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83629704|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83629705|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
83629706|NCT00003402|Hormones|hormones|mesh-ancestor
83629707|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83629708|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83629709|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629710|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629711|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629712|NCT00003408|Interferons|interferons|mesh-list
83629713|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
83629714|NCT00003408|Aldesleukin|aldesleukin|mesh-list
83629715|NCT00003408|Sargramostim|sargramostim|mesh-list
83629716|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629717|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
83629718|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629719|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
83629720|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629721|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83629722|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83629723|NCT00003414|Interferons|interferons|mesh-list
83629724|NCT00003414|Aldesleukin|aldesleukin|mesh-list
83629725|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
83629726|NCT00003414|Cyclosporine|cyclosporine|mesh-list
83629727|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
83629728|NCT00003414|Busulfan|busulfan|mesh-list
83629729|NCT00003414|Cyclosporins|cyclosporins|mesh-list
83629730|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629731|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
83629732|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629733|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629734|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629735|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
83629736|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629737|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629738|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629739|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
83629740|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83629741|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629742|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
83629743|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
83629744|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82783995|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
83629745|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83629746|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83629747|NCT00003426|Gemcitabine|gemcitabine|mesh-list
83629748|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629749|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
83629750|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629751|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629753|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
83629754|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629755|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629756|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
83629757|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629758|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629759|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629760|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629761|NCT00003528|Raltitrexed|raltitrexed|mesh-list
83629762|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629763|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
83629764|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629765|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629766|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83629767|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629768|NCT00003540|Gemcitabine|gemcitabine|mesh-list
83629769|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629770|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
83629771|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629772|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629773|NCT00003546|Gemcitabine|gemcitabine|mesh-list
83629774|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629775|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
83629776|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629777|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629778|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
83629779|NCT00003552|Fludarabine|fludarabine|mesh-list
83629780|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83629781|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629782|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
83629783|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629784|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629785|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629786|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
83629787|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629788|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629789|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629790|NCT00003558|Leucovorin|leucovorin|mesh-list
83629791|NCT00003558|Paclitaxel|paclitaxel|mesh-list
83629792|NCT00003558|Etoposide|etoposide|mesh-list
83629793|NCT00003558|Carboplatin|carboplatin|mesh-list
83629794|NCT00003558|Fluorouracil|fluorouracil|mesh-list
83629795|NCT00003558|Calcium|calcium|mesh-list
83629796|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
83629797|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629798|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629799|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629800|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629801|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629802|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629803|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83629804|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629805|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
83629806|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629807|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629808|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
83629809|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629810|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629811|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629812|NCT00003558|Antidotes|antidotes|mesh-ancestor
83629813|NCT00003558|Protective Agents|protective agents|mesh-ancestor
83629814|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
83629815|NCT00003558|Vitamins|vitamins|mesh-ancestor
83629816|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
83629817|NCT00003564|Procarbazine|procarbazine|mesh-list
83629818|NCT00003564|Isotretinoin|isotretinoin|mesh-list
83629819|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629820|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
83629821|NCT00003576|Fluorouracil|fluorouracil|mesh-list
83629822|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629823|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
83629824|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629825|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629826|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629827|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
83629828|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629829|NCT00003582|Paclitaxel|paclitaxel|mesh-list
83629830|NCT00003582|Fluorouracil|fluorouracil|mesh-list
83629831|NCT00003582|Amifostine|amifostine|mesh-list
83629832|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629833|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629834|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629835|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629836|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629837|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629838|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
83629839|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629840|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629841|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
83629842|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629843|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83629844|NCT00003582|Protective Agents|protective agents|mesh-ancestor
83629845|NCT00003594|Leucovorin|leucovorin|mesh-list
83629846|NCT00003594|Fluorouracil|fluorouracil|mesh-list
83629847|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
83629848|NCT00003594|Irinotecan|irinotecan|mesh-list
83629849|NCT00003594|Calcium|calcium|mesh-list
83629850|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
83629851|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83629852|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629853|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
83629854|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83518955|NCT00381537|Analgesics|analgesics|mesh-ancestor
83629855|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629856|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629857|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629858|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
83629859|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83629860|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629861|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629862|NCT00003594|Antidotes|antidotes|mesh-ancestor
83629863|NCT00003594|Protective Agents|protective agents|mesh-ancestor
83629864|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
83629865|NCT00003594|Vitamins|vitamins|mesh-ancestor
83629866|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
83629867|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
83629868|NCT00003600|Hematinics|hematinics|mesh-ancestor
83629869|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
83629870|NCT00003606|Etoposide|etoposide|mesh-list
83629871|NCT00003606|Epirubicin|epirubicin|mesh-list
83629872|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629873|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
83629874|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629875|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629876|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629877|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
83629878|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629879|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629880|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629881|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629882|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629883|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629884|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629885|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629886|NCT00003612|Paclitaxel|paclitaxel|mesh-list
83629887|NCT00003612|Carboplatin|carboplatin|mesh-list
83629888|NCT00003612|Trastuzumab|trastuzumab|mesh-list
83629889|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629890|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629891|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629892|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629893|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629894|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629895|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83629896|NCT00003624|Paclitaxel|paclitaxel|mesh-list
83629897|NCT00003624|Amifostine|amifostine|mesh-list
83629898|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629899|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629900|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629901|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629902|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629903|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629904|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83629905|NCT00003624|Protective Agents|protective agents|mesh-ancestor
83629906|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629908|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629909|NCT00003636|Carboplatin|carboplatin|mesh-list
83629910|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629911|NCT00003642|Fluorouracil|fluorouracil|mesh-list
83629912|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629913|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
83629914|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629915|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83629916|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629917|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
83629918|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629919|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83629920|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83629921|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629922|NCT00003666|Irofulven|irofulven|mesh-list
83629923|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629924|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
83629925|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629926|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629927|NCT00003678|Tamoxifen|tamoxifen|mesh-list
83629928|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83629929|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
83629930|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83629931|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629932|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83629933|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629934|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83629935|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83629936|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83629937|NCT00003684|Theophylline|theophylline|mesh-list
83629938|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83629939|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
83629940|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83629941|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629942|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83629943|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
83629944|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83629945|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629946|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629947|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
83629948|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83629949|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83629950|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
83629951|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83629952|NCT00003690|Carboplatin|carboplatin|mesh-list
83629953|NCT00003690|Alvocidib|alvocidib|mesh-list
83629954|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629955|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
83629956|NCT00003690|Growth Substances|growth substances|mesh-ancestor
83629957|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629958|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83629959|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629960|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629961|NCT00003696|Paclitaxel|paclitaxel|mesh-list
83629962|NCT00003696|Etoposide|etoposide|mesh-list
83629963|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
83629964|NCT00003696|Carboplatin|carboplatin|mesh-list
83629965|NCT00003696|Doxorubicin|doxorubicin|mesh-list
83629966|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83629967|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83629968|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629969|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
83629970|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
83629971|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
83629972|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629973|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83629974|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
83629975|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629976|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83629977|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629978|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
83629979|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83629980|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83629981|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83629982|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83629983|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83629984|NCT00003708|Temozolomide|temozolomide|mesh-list
83629985|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83629986|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
83629987|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83629988|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629989|NCT00003714|NSC 366140|nsc 366140|mesh-list
83629990|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629991|NCT00003720|Semaxinib|semaxinib|mesh-list
83629992|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83629993|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83629994|NCT00003720|Growth Substances|growth substances|mesh-ancestor
83629995|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83629996|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
83629997|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83629998|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83629999|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630000|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630001|NCT00003732|Paclitaxel|paclitaxel|mesh-list
83630002|NCT00003732|Carboplatin|carboplatin|mesh-list
83630003|NCT00003732|Topotecan|topotecan|mesh-list
83630004|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630005|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630006|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630007|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630008|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630009|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630010|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83630011|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630012|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630013|NCT00003744|Gemcitabine|gemcitabine|mesh-list
83630014|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630015|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
83630016|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630017|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630018|NCT00003762|Gemcitabine|gemcitabine|mesh-list
83630019|NCT00003762|Docetaxel|docetaxel|mesh-list
83630020|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630021|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
83630022|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630023|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630024|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630025|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630026|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630027|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
83630028|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630029|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630030|NCT00003780|Gemcitabine|gemcitabine|mesh-list
83630031|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630032|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
83630033|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630034|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630035|NCT00003786|Irofulven|irofulven|mesh-list
83630036|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630037|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
83630038|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630039|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630040|NCT00003792|Lenograstim|lenograstim|mesh-list
83630041|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630042|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
83630043|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630044|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
83630045|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630046|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83630047|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83630048|NCT00003804|Dactinomycin|dactinomycin|mesh-list
83630049|NCT00003804|Vincristine|vincristine|mesh-list
83630050|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630051|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630052|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630053|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630054|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630055|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630056|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83630057|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630058|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630059|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83630060|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630061|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83630062|NCT00003828|Vinorelbine|vinorelbine|mesh-list
83630063|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630064|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630065|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630066|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630067|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630068|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630069|NCT00003834|Leucovorin|leucovorin|mesh-list
83630070|NCT00003834|Fluorouracil|fluorouracil|mesh-list
83630071|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
83630072|NCT00003834|Calcium|calcium|mesh-list
83630073|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
83630074|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83630075|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630076|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
83630077|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630078|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630079|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630080|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630081|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
83630082|NCT00003834|Antidotes|antidotes|mesh-ancestor
83630083|NCT00003834|Protective Agents|protective agents|mesh-ancestor
83630084|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
83630085|NCT00003834|Vitamins|vitamins|mesh-ancestor
83630086|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
83630087|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
83630088|NCT00003846|Thiotepa|thiotepa|mesh-list
83630089|NCT00003846|Carboplatin|carboplatin|mesh-list
83630090|NCT00003846|Vincristine|vincristine|mesh-list
83630091|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630092|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
83630093|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630094|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630095|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630096|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
83630097|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630098|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630099|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630100|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630101|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630102|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630103|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630104|NCT00003852|Paclitaxel|paclitaxel|mesh-list
83630105|NCT00003852|Etoposide|etoposide|mesh-list
83630106|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
83630107|NCT00003852|Carboplatin|carboplatin|mesh-list
83630108|NCT00003852|Epirubicin|epirubicin|mesh-list
83630109|NCT00003852|Ifosfamide|ifosfamide|mesh-list
83630110|NCT00003852|Thiotepa|thiotepa|mesh-list
83630111|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630112|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630113|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630114|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630115|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630116|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630117|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630118|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
83630119|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630120|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630121|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630122|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
83630123|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630124|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630125|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630126|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630127|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630128|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
83630129|NCT00003858|Analgesics|analgesics|mesh-ancestor
83630130|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
83630131|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630132|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630133|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630134|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630135|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630136|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630137|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630138|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
83630139|NCT00003870|Methotrexate|methotrexate|mesh-list
83630140|NCT00003870|Antibodies|antibodies|mesh-list
83630141|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83630142|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630143|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
83630144|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630145|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630146|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630147|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
83630148|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630149|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630150|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630151|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83630152|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
83630153|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83630154|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630155|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
83630156|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
83630157|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630158|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83630159|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83630160|NCT00003876|Carmustine|carmustine|mesh-list
83630161|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630162|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
83630163|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630164|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630165|NCT00003888|Docetaxel|docetaxel|mesh-list
83630166|NCT00003888|Fluorouracil|fluorouracil|mesh-list
83630167|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630168|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630169|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630170|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630171|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630172|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
83630173|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630174|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630175|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
83630176|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630177|NCT00003894|Thalidomide|thalidomide|mesh-list
83630178|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630179|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
83630180|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630181|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
83630182|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83630183|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630184|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83630185|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83630186|NCT00003894|Growth Substances|growth substances|mesh-ancestor
83630187|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
83630188|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630189|NCT00003900|Docetaxel|docetaxel|mesh-list
83630190|NCT00003900|Irinotecan|irinotecan|mesh-list
83630191|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630192|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630193|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630194|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630195|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630196|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83630197|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630198|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630199|NCT00003906|Tamoxifen|tamoxifen|mesh-list
83630200|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83630201|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83630202|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
83630203|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630204|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630205|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630206|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630207|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83630208|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83630209|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83630210|NCT00003912|Carboplatin|carboplatin|mesh-list
83630211|NCT00003912|Doxorubicin|doxorubicin|mesh-list
83630212|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83630213|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630214|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630215|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630216|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630217|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630218|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630219|NCT00003924|Interferons|interferons|mesh-list
83630220|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
83630221|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630222|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
83630223|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630224|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
83630225|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630226|NCT00003930|Paclitaxel|paclitaxel|mesh-list
83630227|NCT00003930|Gemcitabine|gemcitabine|mesh-list
83630228|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630229|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630230|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630231|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630232|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630233|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630234|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630235|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
83630236|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
83630237|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630238|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
83630239|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630240|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630241|NCT00003954|Cyclosporine|cyclosporine|mesh-list
83630242|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
83630243|NCT00003954|Melphalan|melphalan|mesh-list
83630244|NCT00003954|Cyclosporins|cyclosporins|mesh-list
83630245|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630246|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630247|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630248|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
83630249|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630250|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
83630251|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630252|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
83630253|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630254|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83630255|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630256|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630257|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83630258|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
83630259|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83630260|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630261|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
83630262|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630263|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
83630264|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83630265|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83630266|NCT00003960|Prednisolone|prednisolone|mesh-list
83630267|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
83630268|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
83630269|NCT00003960|Busulfan|busulfan|mesh-list
83630270|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83630271|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
83630272|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630273|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
83630274|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630275|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630276|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630277|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
83630278|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630279|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630280|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630281|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83630282|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
83630283|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
83630284|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630285|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83630286|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
83630287|NCT00003960|Hormones|hormones|mesh-ancestor
83630288|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630289|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83630290|NCT00003960|Protective Agents|protective agents|mesh-ancestor
83630291|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630292|NCT00003966|Defibrotide|defibrotide|mesh-list
83630293|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83630294|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83630295|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630296|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83630297|NCT00003972|Tamoxifen|tamoxifen|mesh-list
83630298|NCT00003972|Paclitaxel|paclitaxel|mesh-list
83630299|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
83630300|NCT00003972|Carboplatin|carboplatin|mesh-list
83630301|NCT00003972|Melphalan|melphalan|mesh-list
83630302|NCT00003972|Busulfan|busulfan|mesh-list
83630303|NCT00003972|Thiotepa|thiotepa|mesh-list
83630304|NCT00003972|Sargramostim|sargramostim|mesh-list
83630305|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630306|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630307|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630308|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630309|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630310|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630311|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630312|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
83630313|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630314|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630315|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630316|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
83630317|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630318|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83630319|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
83630320|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630321|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630322|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83630323|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83630324|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83630325|NCT00003984|Lintuzumab|lintuzumab|mesh-list
83630326|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83630327|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630328|NCT00003996|Etoposide|etoposide|mesh-list
83630329|NCT00003996|Carmustine|carmustine|mesh-list
83630330|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630331|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630332|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630333|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630334|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630335|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630336|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630337|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
83630338|NCT00004002|Bortezomib|bortezomib|mesh-list
83630339|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630340|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
83630341|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630342|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
83630343|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630344|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630345|NCT00004014|Doxorubicin|doxorubicin|mesh-list
83630346|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83630347|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630348|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630349|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630350|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630351|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630352|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630354|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
83630355|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630356|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
83630357|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630358|NCT00004050|Interleukin-2|interleukin-2|mesh-list
83630359|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630360|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83630361|NCT00004050|Analgesics|analgesics|mesh-ancestor
83630362|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
83630363|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630364|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630365|NCT00004056|Cytarabine|cytarabine|mesh-list
83630366|NCT00004056|Thioguanine|thioguanine|mesh-list
83630367|NCT00004056|Melphalan|melphalan|mesh-list
83630368|NCT00004056|Daunorubicin|daunorubicin|mesh-list
83630369|NCT00004056|Asparaginase|asparaginase|mesh-list
83630370|NCT00004056|Lenograstim|lenograstim|mesh-list
83630371|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630372|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
83630373|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630374|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630375|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
83630376|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630377|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630378|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
83630379|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630380|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630381|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630382|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
83630383|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630384|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630385|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630386|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630387|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630388|NCT00004062|Azacitidine|azacitidine|mesh-list
83630389|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630390|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
83630391|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630392|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630393|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630394|NCT00004068|Irinotecan|irinotecan|mesh-list
83630395|NCT00004068|Temozolomide|temozolomide|mesh-list
83630396|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83630397|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630398|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630399|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630400|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630401|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630402|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
83630403|NCT00004074|Carboplatin|carboplatin|mesh-list
83630404|NCT00004074|Trastuzumab|trastuzumab|mesh-list
83630405|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83630406|NCT00004074|Interleukin-12|interleukin-12|mesh-list
83630407|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630408|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83630409|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630410|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
83630411|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630412|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83630413|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83630414|NCT00004074|Growth Substances|growth substances|mesh-ancestor
83630415|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
83630416|NCT00004086|Cytarabine|cytarabine|mesh-list
83630417|NCT00004086|Etoposide|etoposide|mesh-list
83630418|NCT00004086|Ifosfamide|ifosfamide|mesh-list
83630419|NCT00004086|Epratuzumab|epratuzumab|mesh-list
83630420|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630421|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630422|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630423|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630424|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630425|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630426|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630427|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
83630428|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
83630429|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630430|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630431|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
83630432|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630433|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630434|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
83630435|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83630436|NCT00004104|Interferons|interferons|mesh-list
83630437|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
83630438|NCT00004104|Interleukin-2|interleukin-2|mesh-list
83630439|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630440|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
83630441|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630442|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
83630443|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630444|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83630445|NCT00004104|Analgesics|analgesics|mesh-ancestor
83630446|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
83630447|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630448|NCT00004110|Etoposide|etoposide|mesh-list
83630449|NCT00004110|Isotretinoin|isotretinoin|mesh-list
83630450|NCT00004110|Antibodies|antibodies|mesh-list
83630451|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83630452|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
83630453|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630454|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630455|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630456|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630457|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630458|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630459|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630460|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
83630461|NCT00004122|Interferons|interferons|mesh-list
83630462|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
83630463|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
83630464|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630465|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
83630466|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630467|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
83630468|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630469|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630470|NCT00004128|Cytarabine|cytarabine|mesh-list
83630471|NCT00004128|Aldesleukin|aldesleukin|mesh-list
83630472|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
83630473|NCT00004128|Busulfan|busulfan|mesh-list
83630474|NCT00004128|Etoposide|etoposide|mesh-list
83630475|NCT00004128|Daunorubicin|daunorubicin|mesh-list
83630476|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630477|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
83630478|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630479|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630480|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630481|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
83630482|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630483|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630484|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630485|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630486|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630487|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630488|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630489|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630490|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
83630491|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
83630492|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630493|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630494|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83630495|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83630496|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83630497|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83630498|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630499|NCT00004158|Melphalan|melphalan|mesh-list
83630500|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630501|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
83630502|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630503|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630504|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630505|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630506|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
83630507|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630508|NCT00004164|Leucovorin|leucovorin|mesh-list
83630509|NCT00004164|Docetaxel|docetaxel|mesh-list
83630510|NCT00004164|Fluorouracil|fluorouracil|mesh-list
83630511|NCT00004164|Calcium|calcium|mesh-list
83630512|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
83630513|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630514|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630515|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630516|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630517|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630518|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83630519|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630520|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
83630521|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630522|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630523|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
83630524|NCT00004164|Antidotes|antidotes|mesh-ancestor
83630525|NCT00004164|Protective Agents|protective agents|mesh-ancestor
83630526|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
83630527|NCT00004164|Vitamins|vitamins|mesh-ancestor
83630528|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
83630529|NCT00004176|Etoposide|etoposide|mesh-list
83630530|NCT00004176|Amifostine|amifostine|mesh-list
83630531|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630532|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630533|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630534|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630535|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630536|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630537|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83630538|NCT00004176|Protective Agents|protective agents|mesh-ancestor
83630539|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630540|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
83630541|NCT00004188|Melphalan|melphalan|mesh-list
83630542|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
83630543|NCT00004188|Cisplatin|cisplatin|mesh-list
83630544|NCT00004188|Carboplatin|carboplatin|mesh-list
83630545|NCT00004188|Doxorubicin|doxorubicin|mesh-list
83630546|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83630547|NCT00004188|Etoposide|etoposide|mesh-list
83630548|NCT00004188|Vincristine|vincristine|mesh-list
83630549|NCT00004188|Topotecan|topotecan|mesh-list
83630550|NCT00004188|Isotretinoin|isotretinoin|mesh-list
83630551|NCT00004188|Lenograstim|lenograstim|mesh-list
83630552|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630553|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
83630554|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630555|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630556|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630557|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
83630558|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630559|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630560|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630561|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630562|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630563|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630564|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630565|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630566|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630567|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630568|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630569|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630570|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83630571|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83630572|NCT00004194|Fludarabine|fludarabine|mesh-list
83630573|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
83630574|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630575|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630576|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
83630577|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630578|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630579|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
83630580|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630581|NCT00004200|Temozolomide|temozolomide|mesh-list
83630582|NCT00004200|Prinomastat|prinomastat|mesh-list
82784855|NCT00771641|Cobalt|cobalt|mesh-list
83630583|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630584|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
83630585|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630586|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630587|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
83630588|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
83630589|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630590|NCT00004206|Leucovorin|leucovorin|mesh-list
83630591|NCT00004206|Fluorouracil|fluorouracil|mesh-list
83630592|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
83630593|NCT00004206|Calcium|calcium|mesh-list
83630594|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
83630595|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83630596|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630597|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
83630598|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630599|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630600|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630601|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630602|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
83630603|NCT00004206|Antidotes|antidotes|mesh-ancestor
83630604|NCT00004206|Protective Agents|protective agents|mesh-ancestor
83630605|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
83630606|NCT00004206|Vitamins|vitamins|mesh-ancestor
83630607|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
83630608|NCT00004212|Exatecan|exatecan|mesh-list
83630609|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83630610|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630611|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630612|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630613|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630614|NCT00004218|Prednisolone|prednisolone|mesh-list
83630615|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
83630616|NCT00004218|Chlorambucil|chlorambucil|mesh-list
83630617|NCT00004218|Doxorubicin|doxorubicin|mesh-list
83630618|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83630619|NCT00004218|Fludarabine|fludarabine|mesh-list
83630620|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
83630621|NCT00004218|Vincristine|vincristine|mesh-list
83630622|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630623|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
83630624|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630625|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630626|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630627|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
83630628|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630629|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630630|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630631|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630632|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630633|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630634|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630635|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630636|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
83630637|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630638|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630639|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630640|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630641|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83630642|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
83630643|NCT00004218|Hormones|hormones|mesh-ancestor
83630644|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630645|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630646|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
83630647|NCT00004224|Etoposide|etoposide|mesh-list
83630648|NCT00004224|Vincristine|vincristine|mesh-list
83630649|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630650|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
83630651|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630652|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630653|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630654|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
83630655|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630656|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630657|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630658|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83630659|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630660|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630661|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630662|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630663|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630664|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630665|NCT00004236|Doxorubicin|doxorubicin|mesh-list
83630666|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83630667|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630668|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630669|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630670|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630671|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630672|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630673|NCT00004242|Gemcitabine|gemcitabine|mesh-list
83630674|NCT00004242|Fluorouracil|fluorouracil|mesh-list
83630675|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
83630676|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630677|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
83630678|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630679|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630680|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630681|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
83630682|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630683|NCT00004248|Aldesleukin|aldesleukin|mesh-list
83630684|NCT00004248|Doxorubicin|doxorubicin|mesh-list
83630685|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83630686|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83630687|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630688|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83630689|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83630690|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630691|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630692|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83630693|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83630694|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
83630695|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630696|NCT00004254|Raltitrexed|raltitrexed|mesh-list
83630697|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630698|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
83630699|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630700|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630701|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83630702|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630703|NCT00004260|Rituximab|rituximab|mesh-list
83630704|NCT00004260|Interleukin-12|interleukin-12|mesh-list
83630705|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83630706|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630707|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
83630708|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630709|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630710|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630711|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83630712|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83630713|NCT00004260|Growth Substances|growth substances|mesh-ancestor
83630714|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
83630715|NCT00004266|Lisinopril|lisinopril|mesh-list
83630716|NCT00004266|Nifedipine|nifedipine|mesh-list
83630717|NCT00004266|Simvastatin|simvastatin|mesh-list
83630718|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83630719|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83630720|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
83630721|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630722|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83630723|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83630724|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630725|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83630726|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83630727|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83630728|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630729|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
83630730|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
83630731|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83630732|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83630733|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
83630734|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82785040|NCT00539006|Xhance|xhance|mesh-list
83630735|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83630736|NCT00004266|Protective Agents|protective agents|mesh-ancestor
83630737|NCT00004278|Ganciclovir|ganciclovir|mesh-list
83630738|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83630739|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
83630740|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630741|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83630742|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630743|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630744|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
83630745|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
83630746|NCT00004284|Diuretics|diuretics|mesh-ancestor
83630747|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
83630748|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630749|NCT00004284|Expectorants|expectorants|mesh-ancestor
83630750|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
83630751|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
83630752|NCT00004284|Protective Agents|protective agents|mesh-ancestor
83630754|NCT00004344|Testosterone|testosterone|mesh-list
83630755|NCT00004344|Androgens|androgens|mesh-ancestor
83630756|NCT00004344|Hormones|hormones|mesh-ancestor
83630757|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630758|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630759|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630760|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630761|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83630762|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
83630763|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83630764|NCT00004368|Colchicine|colchicine|mesh-list
83630765|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
83630766|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630767|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83630768|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83630769|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83630770|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630771|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630772|NCT00004380|Methocarbamol|methocarbamol|mesh-list
83630773|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83630774|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630775|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83630776|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630777|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83630778|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630779|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630780|NCT00004404|Clotrimazole|clotrimazole|mesh-list
83630781|NCT00004404|Miconazole|miconazole|mesh-list
83630782|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
83630783|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630784|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
83630785|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630786|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630787|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83630788|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83630789|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630790|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
83630791|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83630792|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83630793|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83630794|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
83630795|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630796|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630797|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83630798|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83630799|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83630800|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
83630801|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630802|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83630803|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83630804|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
83630805|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83630806|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83630807|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83630808|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83630809|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630810|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
83630811|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83630812|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630813|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83630814|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630815|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
83630816|NCT00004422|Antibodies|antibodies|mesh-list
83630817|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
83630818|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83630819|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83630820|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
83630821|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630822|NCT00004440|Ibuprofen|ibuprofen|mesh-list
83630823|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83630824|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83630825|NCT00004440|Analgesics|analgesics|mesh-ancestor
83630826|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
83630827|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630828|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630829|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83630830|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630831|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83630832|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630833|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630834|NCT00004446|Fluoxetine|fluoxetine|mesh-list
83630835|NCT00004446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83630836|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83630837|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83630838|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630839|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83630840|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
83630841|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630842|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83630843|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
83630844|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83630845|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83630846|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83630847|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630848|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
83630849|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630850|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
83630851|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630852|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630853|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83630854|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
83630855|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630856|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630857|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83630858|NCT00004482|Cyclosporine|cyclosporine|mesh-list
83630859|NCT00004482|Prednisone|prednisone|mesh-list
83630860|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
83630861|NCT00004482|Cyclosporins|cyclosporins|mesh-list
83630862|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
83630863|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83630864|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
83630865|NCT00004482|Hormones|hormones|mesh-ancestor
83630866|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630867|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630868|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630869|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630870|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630871|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630872|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630873|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
83630874|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
83630875|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630876|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
83630877|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630878|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83630879|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
83630880|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
83630881|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630882|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83630883|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83630885|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
83630886|NCT00004488|Vitamin D|vitamin d|mesh-list
83630887|NCT00004488|Alendronate|alendronate|mesh-list
83630888|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
83630889|NCT00004488|Calcium|calcium|mesh-list
83630890|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83630891|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630892|NCT00004488|Vitamins|vitamins|mesh-ancestor
83630893|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
83630894|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83630895|NCT00004488|Antacids|antacids|mesh-ancestor
83630896|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630897|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83630898|NCT00004554|Naltrexone|naltrexone|mesh-list
83630899|NCT00004554|Sertraline|sertraline|mesh-list
83630900|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83630901|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83630902|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630903|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
83630904|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630905|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
83630906|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83630907|NCT00004554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83630908|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83630909|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83630910|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630911|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83630912|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
83630913|NCT00004578|Ritonavir|ritonavir|mesh-list
83630914|NCT00004578|Lopinavir|lopinavir|mesh-list
83630915|NCT00004578|Lamivudine|lamivudine|mesh-list
83630916|NCT00004578|Stavudine|stavudine|mesh-list
83630917|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83630918|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83630919|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
83630920|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630921|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630922|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83630923|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83630924|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
83630925|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630926|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83630927|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83630928|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83630929|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83630930|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
83630931|NCT00004644|Acyclovir|acyclovir|mesh-list
83630932|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
83630933|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83630934|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83630935|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
83630936|NCT00004650|Estrogens|estrogens|mesh-list
83630937|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83630938|NCT00004650|Hormones|hormones|mesh-ancestor
83630939|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630940|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630941|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83630942|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83630943|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83630944|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
83630945|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83630946|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83630947|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83630948|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83630949|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630950|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630951|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83630952|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83630953|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
83630954|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630955|NCT00004686|Prednisone|prednisone|mesh-list
83630956|NCT00004686|Methotrexate|methotrexate|mesh-list
83630957|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83630958|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
83630959|NCT00004686|Hormones|hormones|mesh-ancestor
83630960|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83630961|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630962|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83630963|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83630964|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83630965|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
83630966|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83630967|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83630968|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
83630969|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630970|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
83630971|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630972|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83630973|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83630974|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
83630975|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630976|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83630977|NCT00004728|Aspirin|aspirin|mesh-list
83630978|NCT00004728|Warfarin|warfarin|mesh-list
83630979|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83630980|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83630981|NCT00004728|Analgesics|analgesics|mesh-ancestor
83630982|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
83630983|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83630984|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83630985|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83630986|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83630987|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83630988|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83630989|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83630990|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83630991|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83630992|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83630993|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
83630994|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
83630995|NCT00004734|Folic Acid|folic acid|mesh-list
83630996|NCT00004734|Pyridoxine|pyridoxine|mesh-list
83630997|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
83630998|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
83630999|NCT00004734|Hematinics|hematinics|mesh-ancestor
83631000|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
83631001|NCT00004734|Vitamins|vitamins|mesh-ancestor
83631002|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
83631003|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631004|NCT00004740|Isoniazid|isoniazid|mesh-list
83631005|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
83631006|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631007|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631008|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83631009|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83631010|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
83631011|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631012|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83631013|NCT00004758|Pyridoxine|pyridoxine|mesh-list
83631014|NCT00004758|Carbamazepine|carbamazepine|mesh-list
83631015|NCT00004758|Valproic Acid|valproic acid|mesh-list
83631016|NCT00004758|Nitrazepam|nitrazepam|mesh-list
83631017|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83631018|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
83631019|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631020|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631021|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
83631022|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631023|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631024|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
83631025|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83631026|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83631027|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83631028|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83631029|NCT00004758|Analgesics|analgesics|mesh-ancestor
83631030|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
83631031|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631032|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83631033|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83631034|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83631035|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83631036|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
83631037|NCT00004758|Vitamins|vitamins|mesh-ancestor
83631038|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
83631039|NCT00004758|Hormones|hormones|mesh-ancestor
83631040|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631041|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83631042|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83631043|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
83631044|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
83631045|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
83631046|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631047|NCT00004770|Protective Agents|protective agents|mesh-ancestor
83631048|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631049|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
83631050|NCT00004770|Vitamins|vitamins|mesh-ancestor
83631051|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
83631052|NCT00004776|Topiramate|topiramate|mesh-list
83631053|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
83631054|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83631055|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631056|NCT00004794|Cidofovir|cidofovir|mesh-list
83631057|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
83631058|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631059|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631060|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631061|NCT00004800|Vaccines|vaccines|mesh-list
83631062|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
83631063|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631064|NCT00004842|Budesonide|budesonide|mesh-list
83631065|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631066|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83631067|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
83631068|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631069|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631070|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83631071|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
83631072|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
83631073|NCT00004842|Hormones|hormones|mesh-ancestor
83631074|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631075|NCT00004854|Carvedilol|carvedilol|mesh-list
83631076|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83631077|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83631078|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
83631079|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631080|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631081|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631082|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83631083|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
83631084|NCT00004854|Protective Agents|protective agents|mesh-ancestor
83631085|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83631086|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83631087|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83631088|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
83631089|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83631090|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83631091|NCT00004866|Exatecan|exatecan|mesh-list
83631092|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83631093|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631094|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631095|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631096|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631097|NCT00004872|Endostatins|endostatins|mesh-list
83631098|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631099|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83631100|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83631101|NCT00004872|Growth Substances|growth substances|mesh-ancestor
83631102|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631103|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
83631104|NCT00004878|Cytarabine|cytarabine|mesh-list
83631105|NCT00004878|Methotrexate|methotrexate|mesh-list
83631106|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
83631107|NCT00004878|Fludarabine|fludarabine|mesh-list
83631108|NCT00004878|Idarubicin|idarubicin|mesh-list
83631109|NCT00004878|Tacrolimus|tacrolimus|mesh-list
83631110|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83631111|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
83631112|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83631113|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631114|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631115|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
83631116|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631117|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631118|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
83631119|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631120|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83631121|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631122|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
83631123|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631124|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83631125|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
83631126|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631127|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83631128|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83631129|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83631130|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631131|NCT00004884|Gemcitabine|gemcitabine|mesh-list
83631132|NCT00004884|Docetaxel|docetaxel|mesh-list
83631133|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631134|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631135|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
83631136|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631137|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
83631138|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
83631139|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631140|NCT00004890|Aldesleukin|aldesleukin|mesh-list
83631141|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631142|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631143|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631144|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
83631145|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631146|NCT00004920|Raltitrexed|raltitrexed|mesh-list
83631147|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631148|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631149|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
83631150|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631151|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83631152|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631153|NCT00004926|Vitamin D|vitamin d|mesh-list
83631154|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
83631155|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
83631156|NCT00004926|Vitamins|vitamins|mesh-ancestor
83631157|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
83631158|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631159|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83631160|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83631161|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631162|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
83631163|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631164|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83631165|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631166|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631167|NCT00004938|Fluconazole|fluconazole|mesh-list
83631168|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
83631169|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631170|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83631171|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83631172|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631173|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631174|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83631175|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
83631176|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631177|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631178|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83631179|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83631180|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
83631181|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83631182|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631183|NCT00004992|Metformin|metformin|mesh-list
83631184|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83631185|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631186|NCT00004998|Lamivudine|lamivudine|mesh-list
83631187|NCT00004998|Zidovudine|zidovudine|mesh-list
83631188|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83631189|NCT00004998|Capravirine|capravirine|mesh-list
83631190|NCT00004998|Nelfinavir|nelfinavir|mesh-list
83631191|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83631192|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83631193|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631194|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631195|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
83631196|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631197|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631198|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631199|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
83631200|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83631201|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83631202|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631203|NCT00005010|Irbesartan|irbesartan|mesh-list
83631204|NCT00005010|Pravastatin|pravastatin|mesh-list
83631205|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83631206|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83631207|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
83631208|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631209|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83631210|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83631211|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631212|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83631213|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83631214|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83631215|NCT00005022|Etoposide|etoposide|mesh-list
83631216|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631217|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631218|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83631219|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631220|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631221|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631222|NCT00005028|Paclitaxel|paclitaxel|mesh-list
83631223|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
83631224|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631225|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631226|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83631227|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83631228|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631229|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631230|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83631231|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
83631232|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631233|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
83631234|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631235|NCT00005046|Paclitaxel|paclitaxel|mesh-list
83631236|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631237|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631238|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
83631239|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
83631240|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631241|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631242|NCT00005064|Bortezomib|bortezomib|mesh-list
83631243|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631244|NCT00005070|Irofulven|irofulven|mesh-list
83631245|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83631246|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
83631247|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631248|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631249|NCT00005076|Irinotecan|irinotecan|mesh-list
83631250|NCT00005076|Cetuximab|cetuximab|mesh-list
83631251|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83631252|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631253|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631254|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631255|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631256|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83631257|NCT00005088|Cisplatin|cisplatin|mesh-list
83631258|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631259|NCT00005094|Celecoxib|celecoxib|mesh-list
83631260|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83631261|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83631262|NCT00005094|Analgesics|analgesics|mesh-ancestor
83631263|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
83631264|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631265|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631266|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631267|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631268|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83631269|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83631270|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631271|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631272|NCT00005106|Lamivudine|lamivudine|mesh-list
83631273|NCT00005106|Zidovudine|zidovudine|mesh-list
83631274|NCT00005106|Abacavir|abacavir|mesh-list
83631275|NCT00005106|Stavudine|stavudine|mesh-list
83631276|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83631277|NCT00005106|Nelfinavir|nelfinavir|mesh-list
83631278|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83631279|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83631280|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631281|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631282|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
83631283|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631284|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631285|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631286|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
83631287|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83631288|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83631289|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631290|NCT00005118|Ritonavir|ritonavir|mesh-list
83631291|NCT00005118|Indinavir|indinavir|mesh-list
83631292|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83631293|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83631294|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631295|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631296|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631297|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631298|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631299|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
83631300|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631301|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83631302|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83631303|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83631304|NCT00005520|Candesartan|candesartan|mesh-list
83631305|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83631306|NCT00005520|Diuretics|diuretics|mesh-ancestor
83631307|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
83631308|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631309|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83631310|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83631311|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631312|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83631313|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83631314|NCT00005574|Gentamicins|gentamicins|mesh-list
83631315|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631316|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631317|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83631318|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631319|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631320|NCT00005580|Fludarabine|fludarabine|mesh-list
83631321|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
83631322|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
83631323|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631324|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631325|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
83631326|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631327|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631328|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
83631329|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631330|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83631331|NCT00005586|Leucovorin|leucovorin|mesh-list
83631332|NCT00005586|Fluorouracil|fluorouracil|mesh-list
83631333|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
83631334|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
83631335|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631336|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631337|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631338|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631339|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
83631340|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631341|NCT00005586|Antidotes|antidotes|mesh-ancestor
83631342|NCT00005586|Protective Agents|protective agents|mesh-ancestor
83631343|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
83631344|NCT00005586|Vitamins|vitamins|mesh-ancestor
83631345|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
83631346|NCT00005592|Rituximab|rituximab|mesh-list
83631347|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83631348|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83631349|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631350|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
83631351|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631352|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631353|NCT00005598|Azacitidine|azacitidine|mesh-list
83631354|NCT00005598|Amifostine|amifostine|mesh-list
83631355|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631356|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
83631357|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631358|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631359|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631360|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83631361|NCT00005598|Protective Agents|protective agents|mesh-ancestor
83631362|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631363|NCT00005604|Aldesleukin|aldesleukin|mesh-list
83631364|NCT00005604|Interleukin-2|interleukin-2|mesh-list
83631365|NCT00005604|Interleukin-12|interleukin-12|mesh-list
83631366|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631367|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83631368|NCT00005604|Analgesics|analgesics|mesh-ancestor
83631369|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
83631370|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631371|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631372|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631373|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631374|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
83631375|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631376|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83631377|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
83631378|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83631379|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83631380|NCT00005604|Growth Substances|growth substances|mesh-ancestor
83631381|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83631382|NCT00005610|Sargramostim|sargramostim|mesh-list
83631383|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
83631384|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631385|NCT00005616|Antibodies|antibodies|mesh-list
83631386|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83631387|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
83631388|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631389|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
83631390|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631391|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
83631392|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631393|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631394|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83631395|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
83631396|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631397|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631398|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83631399|NCT00005634|Vorinostat|vorinostat|mesh-list
83631400|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631401|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83631402|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631403|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631404|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83631405|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83631406|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631407|NCT00005646|Paclitaxel|paclitaxel|mesh-list
83631408|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631409|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631410|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
83631411|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
83631412|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631413|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631414|NCT00005652|Rituximab|rituximab|mesh-list
83631415|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83631416|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631417|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
83631418|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631419|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631420|NCT00005658|Glycine|glycine|mesh-list
83631421|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
83631422|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631423|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631424|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631425|NCT00005796|Vincristine|vincristine|mesh-list
83631426|NCT00005796|Lomustine|lomustine|mesh-list
83631427|NCT00005796|Procarbazine|procarbazine|mesh-list
83361914|NCT02694978|Hematinics|hematinics|mesh-ancestor
83631428|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631429|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631430|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83631431|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83631432|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631433|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631434|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83631435|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
83631436|NCT00005802|Cytarabine|cytarabine|mesh-list
83631437|NCT00005802|Aldesleukin|aldesleukin|mesh-list
83631438|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
83631439|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83631440|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83631441|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83631442|NCT00005802|Methotrexate|methotrexate|mesh-list
83631443|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
83631444|NCT00005802|Fludarabine|fludarabine|mesh-list
83631445|NCT00005802|Etoposide|etoposide|mesh-list
83631446|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
83631447|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83631448|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
83631449|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83631450|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631451|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631452|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
83631453|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631454|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631455|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
83631456|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631457|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83631458|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631459|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
83631460|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631461|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83631462|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631463|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83631464|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631465|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
83631466|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631467|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631468|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631469|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631470|NCT00005802|Analgesics|analgesics|mesh-ancestor
83631471|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
83631472|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631473|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
83631474|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83631475|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
83631476|NCT00005814|Cetuximab|cetuximab|mesh-list
83631477|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631478|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83631479|NCT00354900|Aprotinin|aprotinin|mesh-list
83631480|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
83631481|NCT00354900|Coagulants|coagulants|mesh-ancestor
83631482|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83631483|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83631484|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631485|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631486|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631487|NCT00355290|Vitamin K|vitamin k|mesh-list
83631488|NCT00355290|Vitamins|vitamins|mesh-ancestor
83631489|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
83631490|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631491|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83631492|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83631493|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631494|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
83631495|NCT00355290|Coagulants|coagulants|mesh-ancestor
83631496|NCT00355446|Bimatoprost|bimatoprost|mesh-list
83631497|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83631499|NCT00355524|Darunavir|darunavir|mesh-list
83631500|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83631501|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83631502|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631503|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631504|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631505|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631506|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631507|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
83631508|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631509|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83631510|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83631511|NCT00355602|Metronidazole|metronidazole|mesh-list
83631512|NCT00355602|Vancomycin|vancomycin|mesh-list
83631513|NCT00355602|Clarithromycin|clarithromycin|mesh-list
83631514|NCT00355602|Doxycycline|doxycycline|mesh-list
83631515|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
83631516|NCT00355602|Rifaximin|rifaximin|mesh-list
83631517|NCT00355602|Cefuroxime|cefuroxime|mesh-list
83631518|NCT00355602|Neomycin|neomycin|mesh-list
83631519|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83631520|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83631521|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631522|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631523|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83631524|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83631525|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83631526|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631527|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631528|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83631529|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83631530|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
83631531|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83631532|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631533|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631534|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83631535|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83631536|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83631537|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83631538|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83631539|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83631540|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83631541|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83631542|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631543|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
83631544|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631545|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631546|NCT00356226|Clonidine|clonidine|mesh-list
83631547|NCT00356226|Analgesics|analgesics|mesh-ancestor
83631548|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
83631549|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631550|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631551|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83631552|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
83631553|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
83631554|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83631555|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83631556|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83631557|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83631558|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631559|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631560|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83631561|NCT00356460|Antibodies|antibodies|mesh-list
83631562|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
83631563|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83631564|NCT00356460|Mitogens|mitogens|mesh-list
83631565|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
83631566|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631567|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631568|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631569|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631570|NCT00356616|Tenofovir|tenofovir|mesh-list
83631571|NCT00356616|Abacavir|abacavir|mesh-list
83631572|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
83631573|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631574|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83631575|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83631576|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631577|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631578|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631579|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631580|NCT00356772|Azithromycin|azithromycin|mesh-list
83631581|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631582|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631583|NCT00356850|Azithromycin|azithromycin|mesh-list
83631584|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631585|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631586|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
83631587|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631588|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
83631589|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631590|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631591|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83631592|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
83631593|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631594|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631595|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83631596|NCT00357084|Prednisone|prednisone|mesh-list
83631597|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
83631598|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83631599|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83631600|NCT00357084|Prednisolone|prednisolone|mesh-list
83631601|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
83631602|NCT00357084|Methotrexate|methotrexate|mesh-list
83631603|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83631604|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
83631605|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631606|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
83631607|NCT00357084|Hormones|hormones|mesh-ancestor
83631608|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631609|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631610|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83631611|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631612|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83631613|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
83631614|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83631615|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631616|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
83631617|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631618|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
83631619|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631620|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83631621|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631622|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
83631623|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631624|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83631625|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
83631626|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
83631627|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631628|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83631629|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83631630|NCT00357084|Protective Agents|protective agents|mesh-ancestor
83631631|NCT00357240|Ritonavir|ritonavir|mesh-list
83631632|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83631633|NCT00357240|Omeprazole|omeprazole|mesh-list
83631634|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83631635|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83631636|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631637|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631638|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631639|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631640|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631641|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
83631642|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631643|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83631644|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83631645|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83631646|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83631647|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83631649|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83631650|NCT00357318|Sunitinib|sunitinib|mesh-list
83631651|NCT00357318|Antibodies|antibodies|mesh-list
83631652|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
83631653|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83631654|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631655|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83631656|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83631657|NCT00357318|Growth Substances|growth substances|mesh-ancestor
83631658|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631659|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
83631660|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
83631661|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83631662|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631663|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631664|NCT00357474|Ethanol|ethanol|mesh-list
83631665|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83631666|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631667|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83631668|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631669|NCT00357630|Gemcitabine|gemcitabine|mesh-list
83631670|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631671|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
83631672|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631673|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631674|NCT00357708|Decitabine|decitabine|mesh-list
83631675|NCT00357708|Azacitidine|azacitidine|mesh-list
83631676|NCT00357708|Vorinostat|vorinostat|mesh-list
83631677|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631678|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
83631679|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631680|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631681|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631682|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83631683|NCT00357864|Carbachol|carbachol|mesh-list
83631684|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83631685|NCT00357864|Miotics|miotics|mesh-ancestor
83631686|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
83631687|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631688|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631689|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83631690|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
83631691|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631692|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631693|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83631694|NCT00357864|Analgesics|analgesics|mesh-ancestor
83631695|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
83631696|NCT00357864|Protective Agents|protective agents|mesh-ancestor
83631697|NCT00357942|Morphine|morphine|mesh-list
83631698|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83631699|NCT00357942|Narcotics|narcotics|mesh-ancestor
83631700|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83631701|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631702|NCT00357942|Analgesics|analgesics|mesh-ancestor
83631703|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
83631704|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631705|NCT00358020|Thalidomide|thalidomide|mesh-list
83631706|NCT00358020|Bortezomib|bortezomib|mesh-list
83631707|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631708|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631709|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
83631710|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631711|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
83631712|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631713|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631714|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83631715|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83631716|NCT00358020|Growth Substances|growth substances|mesh-ancestor
83631717|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
83631718|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
83631719|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83631720|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83631721|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631722|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83631723|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631724|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83631725|NCT00358410|Casopitant|casopitant|mesh-list
83631726|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
83631727|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
83631728|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631729|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631730|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83631731|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83631732|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631733|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631734|NCT00358488|Albuterol|albuterol|mesh-list
83631735|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83631736|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83631737|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
83520835|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
83631738|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631739|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631740|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83631741|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
83631742|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83631743|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83631744|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83631745|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
83631746|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631747|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631748|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
83631749|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83631750|NCT00358566|Gemcitabine|gemcitabine|mesh-list
83631751|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631752|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
83631753|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631754|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631755|NCT00359112|Metformin|metformin|mesh-list
83631756|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83631757|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631758|NCT00359190|Lapatinib|lapatinib|mesh-list
83631759|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631760|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83631761|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631762|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631763|NCT00359658|Cyclosporine|cyclosporine|mesh-list
83631764|NCT00359658|Prednisolone|prednisolone|mesh-list
83631765|NCT00359658|Cyclosporins|cyclosporins|mesh-list
83631766|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631767|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631768|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631769|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
83631770|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631771|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
83631772|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631773|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
83631774|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631775|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83631776|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631777|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
83631778|NCT00359658|Hormones|hormones|mesh-ancestor
83631779|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631780|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83631781|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631782|NCT00359814|Cyclosporine|cyclosporine|mesh-list
83631783|NCT00359814|Cyclosporins|cyclosporins|mesh-list
83631784|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631785|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631786|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631787|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
83631788|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631789|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
83631790|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631791|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83631792|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631793|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83631794|NCT00359892|Obatoclax|obatoclax|mesh-list
83631795|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631796|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631797|NCT00359970|Azithromycin|azithromycin|mesh-list
83631798|NCT00359970|Loperamide|loperamide|mesh-list
83631799|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
83631800|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631801|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631802|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83631803|NCT00360048|Oxytocin|oxytocin|mesh-list
83631804|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
83631805|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83631806|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631807|NCT00360438|Rasburicase|rasburicase|mesh-list
83631808|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
83631809|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631810|NCT00360594|Acamprosate|acamprosate|mesh-list
83631811|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83631812|NCT00360750|Cytarabine|cytarabine|mesh-list
83631813|NCT00360750|Carboplatin|carboplatin|mesh-list
83631814|NCT00360750|Etoposide|etoposide|mesh-list
83631815|NCT00360750|Vincristine|vincristine|mesh-list
83631816|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631817|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631818|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83631819|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631820|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631821|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631822|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83631823|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
83631824|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
83631825|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631826|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631827|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
83631828|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631829|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83631830|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83631831|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631832|NCT00360984|Insulin|insulin|mesh-list
83631833|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83631834|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
83631835|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83631836|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631837|NCT00361452|Epinephrine|epinephrine|mesh-list
83631838|NCT00361452|Albuterol|albuterol|mesh-list
83631839|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83631840|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83631841|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
83631842|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631843|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631844|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631845|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83631846|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83631847|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
83631848|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631849|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83631850|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
83631851|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
83631852|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
83631853|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83631854|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
83631855|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83631856|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83631857|NCT00361686|Tramadol|tramadol|mesh-list
83631858|NCT00361686|Remifentanil|remifentanil|mesh-list
83631859|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83631860|NCT00361686|Narcotics|narcotics|mesh-ancestor
83631861|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83631862|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631863|NCT00361686|Analgesics|analgesics|mesh-ancestor
83631864|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
83631865|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631866|NCT00361920|Prednisone|prednisone|mesh-list
83631867|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631868|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
83631869|NCT00361920|Hormones|hormones|mesh-ancestor
83631870|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631871|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631872|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83631873|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631874|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
83631875|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83631876|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631877|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83631878|NCT00362310|Indinavir|indinavir|mesh-list
83631879|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83631880|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83631881|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631882|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631883|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631884|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83631885|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83631886|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
83631887|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631888|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83631889|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
83631890|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631891|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83631892|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83631893|NCT00362700|Clevudine|clevudine|mesh-list
83631894|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
83631895|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83631896|NCT00362778|Insulin|insulin|mesh-list
83631897|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83631898|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631899|NCT00362934|Atorvastatin|atorvastatin|mesh-list
83631900|NCT00362934|Simvastatin|simvastatin|mesh-list
83631901|NCT00362934|Fenofibrate|fenofibrate|mesh-list
83631902|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83631903|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83631904|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
83631905|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631906|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83631907|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83631908|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631909|NCT00363090|Prednisone|prednisone|mesh-list
83631910|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
83631911|NCT00363090|Doxorubicin|doxorubicin|mesh-list
83631912|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83631913|NCT00363090|Vincristine|vincristine|mesh-list
83631914|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
83631915|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631916|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
83631917|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631918|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631919|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83631920|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
83631921|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631922|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631923|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83631924|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83631925|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83631926|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83631927|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631928|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631929|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
83631930|NCT00363090|Hormones|hormones|mesh-ancestor
83631931|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631932|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83631933|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83631934|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
83631935|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
83631936|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
83631937|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83631938|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
83631939|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
83631940|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83631941|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83631942|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631943|NCT00363948|Incretins|incretins|mesh-ancestor
83631944|NCT00363948|Hormones|hormones|mesh-ancestor
83631945|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83631946|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83631947|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
83631948|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631949|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631950|NCT00364026|Darusentan|darusentan|mesh-list
83631951|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83631952|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631953|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
83631954|NCT00364260|Hematinics|hematinics|mesh-ancestor
83631955|NCT00364572|Etanercept|etanercept|mesh-list
83631956|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83631957|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83631958|NCT00364572|Analgesics|analgesics|mesh-ancestor
83631959|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
83631960|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631961|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631962|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631963|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83631964|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83631965|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83631966|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
83631967|NCT00364806|Metoclopramide|metoclopramide|mesh-list
83631968|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
83631969|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
83631970|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
83631971|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631972|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631973|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83631974|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83631975|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83631976|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
83631977|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83631978|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631979|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83631980|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83631981|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83631982|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83631983|NCT00365040|Mitomycins|mitomycins|mesh-list
83631984|NCT00365040|Mitomycin|mitomycin|mesh-list
83631985|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83631986|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83631987|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
83631988|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83631989|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83631990|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83631991|NCT00365586|Ketoprofen|ketoprofen|mesh-list
83631992|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83631993|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83631994|NCT00365586|Analgesics|analgesics|mesh-ancestor
83631995|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
83631996|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83631997|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83631998|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83631999|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632000|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83632001|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632002|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632003|NCT00365742|Simvastatin|simvastatin|mesh-list
83632004|NCT00365742|Red yeast rice|red yeast rice|mesh-list
83632005|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83632006|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83632007|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
83632008|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632009|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83632010|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83632011|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632012|NCT00365820|Tegaserod|tegaserod|mesh-list
83632013|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83632014|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
83632015|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632016|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632017|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632018|NCT00365898|Hydromorphone|hydromorphone|mesh-list
83632019|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83632020|NCT00365898|Narcotics|narcotics|mesh-ancestor
83632021|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786311|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
83632022|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632023|NCT00365898|Analgesics|analgesics|mesh-ancestor
83632024|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
83632025|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632026|NCT00366834|Dexamethasone|dexamethasone|mesh-list
83632027|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
83632028|NCT00366834|Ondansetron|ondansetron|mesh-list
83632030|NCT00366834|BB 1101|bb 1101|mesh-list
83632031|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632032|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
83632033|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
83632034|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632035|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632036|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632037|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
83632038|NCT00366834|Hormones|hormones|mesh-ancestor
83632039|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83521132|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
83632040|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83632041|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632042|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
83632043|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632044|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632045|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
83632046|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83632047|NCT00366834|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83632048|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83632049|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
83632050|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632051|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83632052|NCT00367068|Baclofen|baclofen|mesh-list
83632053|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83632054|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632055|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83632056|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632057|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83632058|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
83632059|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
83632060|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632061|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632062|NCT00367302|Buprenorphine|buprenorphine|mesh-list
83632063|NCT00367302|Methadone|methadone|mesh-list
83632064|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83632065|NCT00367302|Narcotics|narcotics|mesh-ancestor
83632066|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632067|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632068|NCT00367302|Analgesics|analgesics|mesh-ancestor
83632069|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
83632070|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632071|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83632072|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
83632073|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
83632074|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
83632075|NCT00367536|Estrogens|estrogens|mesh-list
83632076|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83632077|NCT00367536|Hormones|hormones|mesh-ancestor
83632078|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632079|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632080|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83632081|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83632082|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
83632083|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83632084|NCT00367614|Pantoprazole|pantoprazole|mesh-list
83632085|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83632086|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632087|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83632088|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632089|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632090|NCT00368160|Eszopiclone|eszopiclone|mesh-list
83632091|NCT00368160|Zopiclone|zopiclone|mesh-list
83632092|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83632093|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632094|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632095|NCT00368238|Aspirin|aspirin|mesh-list
83632096|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
83632097|NCT00368238|Clopidogrel|clopidogrel|mesh-list
83632098|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83632099|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83632100|NCT00368238|Analgesics|analgesics|mesh-ancestor
83632101|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
83632102|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632103|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632104|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632105|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632106|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83632107|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83632108|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632109|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83632110|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83632111|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632112|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
83632113|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83632114|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83632115|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83632116|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
83632117|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632118|NCT00368238|Hematinics|hematinics|mesh-ancestor
83632119|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
83632120|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83632121|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632122|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
83632123|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83632124|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83632125|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83632126|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
83632127|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632128|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632129|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632130|NCT00368706|Urological Agents|urological agents|mesh-ancestor
83632131|NCT00368862|Memantine|memantine|mesh-list
83632132|NCT00368862|Escitalopram|escitalopram|mesh-list
83632133|NCT00368862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83632134|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83632135|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632136|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632137|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632138|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
83632139|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632140|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83632141|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83632142|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
83632143|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83632144|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83632145|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83632146|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83632147|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83632148|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
83632149|NCT00369096|Bemiparin|bemiparin|mesh-list
83632150|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
83632151|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
83632152|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83632153|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632154|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
83632155|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83632156|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632157|NCT00369408|Naltrexone|naltrexone|mesh-list
83632158|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83632159|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83632160|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632161|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
83632162|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632163|NCT00369798|Rolipram|rolipram|mesh-list
83632164|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
83632165|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632166|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83632167|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83632168|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632169|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632170|NCT00369954|Carboplatin|carboplatin|mesh-list
83632171|NCT00369954|Gemcitabine|gemcitabine|mesh-list
83632172|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632173|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83632174|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
83632175|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632176|NCT00370188|Topiramate|topiramate|mesh-list
83632177|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
83632178|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83632179|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632180|NCT00370266|Triamcinolone|triamcinolone|mesh-list
83632181|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632182|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
83632183|NCT00370266|Hormones|hormones|mesh-ancestor
83632184|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632185|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632186|NCT00370422|Triamcinolone|triamcinolone|mesh-list
83632187|NCT00370422|Bevacizumab|bevacizumab|mesh-list
83632188|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83632189|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632190|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83632191|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83632192|NCT00370422|Growth Substances|growth substances|mesh-ancestor
83632193|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632194|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
83632195|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632196|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
83632197|NCT00370422|Hormones|hormones|mesh-ancestor
83632198|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632199|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83632200|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
83632201|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632202|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83632203|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83632204|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632205|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632206|NCT00370656|Pregabalin|pregabalin|mesh-list
83632207|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83632208|NCT00370656|Amitriptyline|amitriptyline|mesh-list
83632209|NCT00370656|Analgesics|analgesics|mesh-ancestor
83632210|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
83632211|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632212|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632213|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
83632214|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83632215|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632216|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632217|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83632218|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83632219|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83632220|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632221|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632222|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83632223|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83632224|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632225|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
83632226|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
83632227|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83632228|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83632229|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83632230|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
83632231|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
83632232|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83632233|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83632234|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83632235|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632236|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632237|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
83632238|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632239|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632240|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83632241|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632242|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
83632243|NCT00370968|Astringents|astringents|mesh-ancestor
83632244|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632245|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
83632246|NCT00371124|Atropine|atropine|mesh-list
83632247|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83632248|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83632249|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83632250|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83632251|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83632252|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
83632253|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632254|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632255|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83632256|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
83632257|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
83632258|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
83632259|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83632260|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83632261|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
83632262|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632263|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632264|NCT00371592|Acyclovir|acyclovir|mesh-list
83632265|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
83632266|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632267|NCT00371904|Rituximab|rituximab|mesh-list
83632268|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83632269|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632270|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
83632271|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632272|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632273|NCT00372138|Thrombin|thrombin|mesh-list
83632274|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
83632275|NCT00372138|Coagulants|coagulants|mesh-ancestor
83632276|NCT00372216|Clopidogrel|clopidogrel|mesh-list
83632277|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83632278|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83632279|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83632280|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83632281|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
83632282|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632283|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632284|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632285|NCT00372294|Clindamycin|clindamycin|mesh-list
83632286|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
83632287|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
83632288|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
83632289|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
83632290|NCT00372294|Dexamethasone|dexamethasone|mesh-list
83632291|NCT00372294|Prednisolone|prednisolone|mesh-list
83632292|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632293|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
83632294|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
83632295|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632296|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632297|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632298|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
83632299|NCT00372294|Hormones|hormones|mesh-ancestor
83632300|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632301|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83632302|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632303|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83632304|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632305|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83632306|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632307|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632308|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
83632309|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83632310|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83632311|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83632312|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
83632313|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
83632314|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83632315|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632316|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632317|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83632318|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632319|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83632320|NCT00372762|Furosemide|furosemide|mesh-list
83632321|NCT00372762|Bumetanide|bumetanide|mesh-list
83632322|NCT00372762|Diuretics|diuretics|mesh-ancestor
83632323|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
83632324|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632325|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83632326|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632327|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632329|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83632330|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83632331|NCT00373464|Analgesics|analgesics|mesh-ancestor
83632332|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
83632333|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632334|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632335|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632336|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632337|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83632338|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83632339|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632340|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632341|NCT00373620|Paclitaxel|paclitaxel|mesh-list
83632342|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83632343|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632344|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
83632345|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
83632346|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
83632347|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632348|NCT00373776|Miltefosine|miltefosine|mesh-list
83632349|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
83632350|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632351|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632352|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83632353|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83632354|NCT00374478|Scopolamine|scopolamine|mesh-list
83632355|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83632356|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83632357|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
83632358|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
83632359|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632360|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632361|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632362|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
83632363|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83632364|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
83632365|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632366|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632367|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83632368|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
83632369|NCT00373542|Ropinirole|ropinirole|mesh-list
83632370|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83632371|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83632372|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
83632373|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
83632374|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632375|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632376|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632377|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
83632378|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83632379|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83632380|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632381|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
83632382|NCT00375258|Coagulants|coagulants|mesh-ancestor
83632383|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
83632384|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83632385|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632386|NCT00376038|Metformin|metformin|mesh-list
83632387|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83632388|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632389|NCT00376272|Valsartan|valsartan|mesh-list
83632390|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83632391|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83632392|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83632393|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632394|NCT00376428|Gentamicins|gentamicins|mesh-list
82786626|NCT00073021|Mesalamine|mesalamine|mesh-list
82786685|NCT00395512|Incretins|incretins|mesh-ancestor
83632395|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83632396|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632397|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83632398|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632399|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632400|NCT00376584|Niacin|niacin|mesh-list
83632401|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83632402|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
83632403|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632404|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83632405|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
83632406|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
83632407|NCT00376584|Vitamins|vitamins|mesh-ancestor
83632408|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
83632409|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632410|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
83632411|NCT00376662|Hormones|hormones|mesh-list
83632412|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632413|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632414|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83632415|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
83632416|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83632417|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632418|NCT00376818|Hormones|hormones|mesh-list
83632419|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632420|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632421|NCT00377052|Gemcitabine|gemcitabine|mesh-list
83632422|NCT00377052|Bortezomib|bortezomib|mesh-list
83632423|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83632424|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
83632425|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632426|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632427|NCT00377442|Simvastatin|simvastatin|mesh-list
83632428|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83632429|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83632430|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
83632431|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632432|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83632433|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83632434|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632435|NCT00377910|Lidocaine|lidocaine|mesh-list
83632436|NCT00377910|Polidocanol|polidocanol|mesh-list
83632437|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
83632438|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
83632439|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632440|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632441|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
83632442|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632443|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83632444|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83632445|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83632446|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632447|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632448|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83632449|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83632450|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
83632451|NCT00377988|Norgestimate|norgestimate|mesh-list
83632452|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
83632453|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83632454|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632455|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83632456|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83632457|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83632458|NCT00378066|Bevacizumab|bevacizumab|mesh-list
83632459|NCT00378066|Capecitabine|capecitabine|mesh-list
83632460|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
83632461|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83632462|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632463|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83632464|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83632465|NCT00378066|Growth Substances|growth substances|mesh-ancestor
83632466|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632467|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
83632468|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83632469|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
83632470|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632471|NCT00378144|Acetaminophen|acetaminophen|mesh-list
83632472|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
83632473|NCT00378144|Ephedrine|ephedrine|mesh-list
83632474|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83632475|NCT00378144|Analgesics|analgesics|mesh-ancestor
83632476|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
83632477|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632478|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632479|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
83632480|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83632481|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
83632482|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83632483|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83632484|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
83632485|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83632486|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83632487|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
83632488|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
83632489|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632490|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632491|NCT00378456|Vitamins|vitamins|mesh-list
83632492|NCT00378456|Leucovorin|leucovorin|mesh-list
83632493|NCT00378456|Folic Acid|folic acid|mesh-list
83632494|NCT00378456|Vitamin A|vitamin a|mesh-list
83632495|NCT00378456|Zinc|zinc|mesh-list
83632496|NCT00378456|Selenium|selenium|mesh-list
83632497|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
83632498|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
83632499|NCT00378456|Antioxidants|antioxidants|mesh-list
83632500|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
83632501|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632502|NCT00378456|Trace Elements|trace elements|mesh-ancestor
83632503|NCT00378456|Antidotes|antidotes|mesh-ancestor
83632504|NCT00378456|Protective Agents|protective agents|mesh-ancestor
83632505|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
83632506|NCT00378456|Hematinics|hematinics|mesh-ancestor
83632507|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632508|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83632509|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632510|NCT00378612|Sirolimus|sirolimus|mesh-list
83632511|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83632512|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632513|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83632514|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632515|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
83632516|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83632517|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
83632518|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632519|NCT00378690|Leuprolide|leuprolide|mesh-list
83632520|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83632521|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
83632522|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83632523|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632524|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83632525|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632526|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83632527|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
83632528|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632529|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83632530|NCT00379158|Micronutrients|micronutrients|mesh-list
83632531|NCT00379158|Trace Elements|trace elements|mesh-list
83632532|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632533|NCT00379626|Hormones|hormones|mesh-list
83632534|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632535|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632536|NCT00380406|Leuprolide|leuprolide|mesh-list
83632537|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83632538|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
83632539|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83632540|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632541|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83632542|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632543|NCT00380484|Budesonide|budesonide|mesh-list
83632544|NCT00380484|Montelukast|montelukast|mesh-list
83632545|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632546|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83632547|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
83632548|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632549|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632550|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83632551|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
83632552|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
83632553|NCT00380484|Hormones|hormones|mesh-ancestor
83632554|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632555|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83632556|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
83632557|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83632558|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83632559|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632560|NCT00380640|Trimethoprim|trimethoprim|mesh-list
83632561|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83632562|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632563|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
83632564|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83632565|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83632566|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83632567|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632568|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632569|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83632570|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83632571|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83632572|NCT00381030|Carvedilol|carvedilol|mesh-list
83632573|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83632574|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83632575|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
83632576|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632577|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632578|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632579|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83632580|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
83632581|NCT00381030|Protective Agents|protective agents|mesh-ancestor
83632582|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83632583|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632584|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83632585|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
83632586|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83632587|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83632588|NCT00381264|Nabilone|nabilone|mesh-list
83632589|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
83632590|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
83632591|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632592|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632593|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632594|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83632595|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83632596|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632597|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632598|NCT00381342|Exenatide|exenatide|mesh-list
83632599|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83632600|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632601|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83632602|NCT00381342|Incretins|incretins|mesh-ancestor
83632603|NCT00381342|Hormones|hormones|mesh-ancestor
83632604|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632605|NCT00381654|MP 412|mp 412|mesh-list
83632606|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632607|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83632608|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786832|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786833|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82786834|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82786835|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82786836|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
82786837|NCT00066469|Hormones|hormones|mesh-ancestor
82786838|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786839|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82786840|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
82786841|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
82786842|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632609|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632610|NCT00381732|Tadalafil|tadalafil|mesh-list
83632611|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
83632612|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83632613|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83632614|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632615|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632616|NCT00381732|Urological Agents|urological agents|mesh-ancestor
83632617|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
83632618|NCT00382044|Hematinics|hematinics|mesh-ancestor
83632619|NCT00382356|Dutasteride|dutasteride|mesh-list
83632620|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83632621|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83632622|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632623|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632624|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
83632625|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632626|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632627|NCT00382668|Dasatinib|dasatinib|mesh-list
83632628|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632629|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83632630|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632631|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632632|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83632633|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83632634|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
83632635|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632636|NCT00382980|Antacids|antacids|mesh-ancestor
83632637|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632638|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632639|NCT00383136|Tirofiban|tirofiban|mesh-list
83632640|NCT00383136|Abciximab|abciximab|mesh-list
83632641|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
83632642|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83632643|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83632644|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83632645|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632646|NCT00383214|Epratuzumab|epratuzumab|mesh-list
83632647|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83632648|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632649|NCT00383370|Aflibercept|aflibercept|mesh-list
83632650|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83632651|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83632652|NCT00383370|Growth Substances|growth substances|mesh-ancestor
83632653|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632654|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83632655|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632656|NCT00383526|Vaccines|vaccines|mesh-list
83632657|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
83632658|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632659|NCT00383682|Mexiletine|mexiletine|mesh-list
83632660|NCT00383682|Morphine|morphine|mesh-list
83632661|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83632662|NCT00383682|Narcotics|narcotics|mesh-ancestor
83632663|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632664|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632665|NCT00383682|Analgesics|analgesics|mesh-ancestor
83632666|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
83632667|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632668|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83632669|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83632670|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83632671|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632672|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632673|NCT00383916|Pantoprazole|pantoprazole|mesh-list
83632674|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83632675|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632676|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83632677|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632678|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632679|NCT00383994|Rituximab|rituximab|mesh-list
83632680|NCT00383994|Sargramostim|sargramostim|mesh-list
83632681|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83632682|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632683|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
83632684|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632685|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632686|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
83632687|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83632688|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83632689|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
83632690|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632691|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632692|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83632693|NCT00384306|Prednisolone|prednisolone|mesh-list
83632694|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632695|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
83632696|NCT00384306|Hormones|hormones|mesh-ancestor
83632697|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632698|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632699|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83632700|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632701|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
83632702|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632703|NCT00384540|Dobutamine|dobutamine|mesh-list
83632704|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83632705|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
83632706|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
83632707|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632708|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632709|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83632710|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83632711|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83632712|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
83632713|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632714|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632715|NCT00384540|Protective Agents|protective agents|mesh-ancestor
83632716|NCT00384618|Vitamin E|vitamin e|mesh-list
83632717|NCT00384618|Pravastatin|pravastatin|mesh-list
83632718|NCT00384618|Vitamins|vitamins|mesh-ancestor
83632719|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
83632720|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632721|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
83632722|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632723|NCT00384618|Protective Agents|protective agents|mesh-ancestor
83632724|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83632725|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83632726|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
83632727|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83632728|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83632729|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632730|NCT00384696|Nicotine|nicotine|mesh-list
83632731|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83632732|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
83632733|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632734|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632735|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83632736|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83632737|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
83632738|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632739|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632740|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83632741|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632742|NCT00385398|Temozolomide|temozolomide|mesh-list
83632743|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83632744|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83632745|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
83632746|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632747|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632748|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83632749|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632750|NCT00385554|UC-781|uc-781|mesh-list
83632751|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83632752|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
83632753|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632754|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83632755|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
83632756|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632757|NCT00385710|Valproic Acid|valproic acid|mesh-list
83632758|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
83632759|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632760|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632762|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632763|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632764|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
83632765|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83632766|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632767|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632768|NCT00386178|Vitamin E|vitamin e|mesh-list
83632769|NCT00386178|Tocopherols|tocopherols|mesh-list
83632770|NCT00386178|Tocotrienols|tocotrienols|mesh-list
83632771|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
83632772|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
83632773|NCT00386178|Vitamins|vitamins|mesh-ancestor
83632774|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
83632775|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632776|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
83632777|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632778|NCT00386178|Protective Agents|protective agents|mesh-ancestor
83632779|NCT00421824|Capecitabine|capecitabine|mesh-list
83632780|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
83632781|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83632782|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
83632783|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632784|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632785|NCT00421980|Etanercept|etanercept|mesh-list
83632786|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83632787|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83632788|NCT00421980|Analgesics|analgesics|mesh-ancestor
83632789|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
83632790|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632791|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632792|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632793|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632794|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632795|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83632796|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
83632797|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83632798|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
83632799|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632800|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83632801|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83632802|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632803|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632804|NCT00422526|Progesterone|progesterone|mesh-list
83632805|NCT00422526|Progestins|progestins|mesh-ancestor
83632806|NCT00422526|Hormones|hormones|mesh-ancestor
83632807|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632808|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632809|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
83632810|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83632811|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83632812|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
83632813|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632814|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632815|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83632816|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
83632817|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
83632818|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83632819|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
83632820|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632821|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632822|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83632823|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83632824|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83632825|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
83632826|NCT00422682|Paclitaxel|paclitaxel|mesh-list
83632827|NCT00422682|Carboplatin|carboplatin|mesh-list
83632828|NCT00422682|Gemcitabine|gemcitabine|mesh-list
83632829|NCT00422682|Temozolomide|temozolomide|mesh-list
83632830|NCT00422682|Topotecan|topotecan|mesh-list
83632831|NCT00422682|Iniparib|iniparib|mesh-list
83632832|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83632833|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632834|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
83632836|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
83632837|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632838|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83632839|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
83632840|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83632841|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
83632842|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83632843|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83632844|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632845|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83632846|NCT00422994|Ropinirole|ropinirole|mesh-list
83632847|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83632848|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83632849|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
83632850|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
83632851|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83521971|NCT02219581|BB 1101|bb 1101|mesh-list
83632852|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632853|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632854|NCT00423228|Donepezil|donepezil|mesh-list
83632855|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83632856|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632857|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632858|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
83632859|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632860|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632861|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
83632862|NCT01799616|Pamidronate|pamidronate|mesh-list
83632863|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83632864|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632865|NCT01799850|Pioglitazone|pioglitazone|mesh-list
83632866|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83632867|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632868|NCT01792050|Paclitaxel|paclitaxel|mesh-list
83632869|NCT01792050|Docetaxel|docetaxel|mesh-list
83632870|NCT01792050|Tryptophan|tryptophan|mesh-list
83632871|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83632872|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632873|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
83632874|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
83632875|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
83632876|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632877|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83632878|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
83632879|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632880|NCT01790100|Ribavirin|ribavirin|mesh-list
83632881|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
83632882|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632883|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
83632884|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632885|NCT01799460|Cyclosporine|cyclosporine|mesh-list
83632886|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
83632887|NCT01799460|Tacrolimus|tacrolimus|mesh-list
83632888|NCT01799460|Cyclosporins|cyclosporins|mesh-list
83632889|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83632890|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
83632891|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
83632892|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632893|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632894|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83632895|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
83632896|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632897|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632898|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83632899|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83632900|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632901|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
83632902|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632903|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83632904|NCT01799460|Hormones|hormones|mesh-ancestor
83632905|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83632906|NCT02999724|Gabapentin|gabapentin|mesh-list
83632907|NCT02999724|Analgesics|analgesics|mesh-ancestor
83632908|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
83632909|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632910|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632911|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
83632912|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83632913|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83632914|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632915|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83632916|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83632917|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83632918|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632919|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632920|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
83632921|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83632922|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83632923|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632925|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632926|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83632927|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83632928|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632929|NCT02998398|Infliximab|infliximab|mesh-list
83632930|NCT02998398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83632931|NCT02998398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83632932|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
83632933|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83632934|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632935|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83632936|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83632937|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83632938|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
83632939|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83632940|NCT02996916|Amlodipine|amlodipine|mesh-list
83632941|NCT02996916|Olmesartan|olmesartan|mesh-list
83632942|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83632943|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83632944|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83632945|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632946|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83632947|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632948|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
83632949|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83632950|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83632951|NCT02996214|Paclitaxel|paclitaxel|mesh-list
83632952|NCT02996214|Gemcitabine|gemcitabine|mesh-list
83632953|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83632954|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632955|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
83632956|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
83632957|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
83632958|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632959|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83632960|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
83632961|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
83632962|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83632963|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632964|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632965|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83632966|NCT02996058|Analgesics|analgesics|mesh-ancestor
83632967|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
83632968|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632969|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83632970|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83632971|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83632972|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
83632973|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83632974|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632975|NCT02995512|Colchicine|colchicine|mesh-list
83632976|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
83632977|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83632978|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
83632979|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
83632980|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
83632981|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83632982|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632983|NCT02994888|Cetuximab|cetuximab|mesh-list
83632984|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83632985|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83632986|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
83632987|NCT02993718|Propofol|propofol|mesh-list
83632988|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83632989|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83632990|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83632991|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83632992|NCT02993718|Analgesics|analgesics|mesh-ancestor
83632993|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
83632994|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83632995|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83632996|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83632997|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83632998|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
83632999|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633000|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633001|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83633002|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
83633003|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
83633004|NCT02993640|Vasopressins|vasopressins|mesh-list
83633005|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
83633006|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
83633007|NCT02993640|Coagulants|coagulants|mesh-ancestor
83633008|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83633009|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83633010|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
83633011|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633012|NCT02993094|Carboplatin|carboplatin|mesh-list
83633013|NCT02993094|Ixazomib|ixazomib|mesh-list
83633014|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633015|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83633016|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633017|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633018|NCT02992938|Acetazolamide|acetazolamide|mesh-list
83633019|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
83633020|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83633021|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633022|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633023|NCT02992938|Diuretics|diuretics|mesh-ancestor
83633024|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
83633025|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633026|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83633027|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
83633028|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633029|NCT02992548|Pravastatin|pravastatin|mesh-list
83633030|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83633031|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83633032|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
83633033|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633034|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83633035|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83633036|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633037|NCT02992392|Dextrans|dextrans|mesh-list
83633038|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
83633039|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
83633040|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
83633041|NCT02991768|Budesonide|budesonide|mesh-list
83633042|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633043|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83633044|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
83633045|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633046|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633047|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83633048|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
83633049|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
83633050|NCT02991768|Hormones|hormones|mesh-ancestor
83633051|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633052|NCT02991612|Rifaximin|rifaximin|mesh-list
83633053|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83633054|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633055|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633056|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
83633057|NCT02990286|Rituximab|rituximab|mesh-list
83633058|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633059|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633060|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
83633061|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633062|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633063|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83633064|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83633065|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
83633066|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83633067|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633068|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633069|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633070|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
83633071|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
83633072|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
83633073|NCT02999958|Antioxidants|antioxidants|mesh-list
83633074|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83633075|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633076|NCT02999958|Protective Agents|protective agents|mesh-ancestor
83633077|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633078|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
83633079|NCT02999958|Vitamins|vitamins|mesh-ancestor
83633080|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
83633081|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
83633082|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
83633083|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633084|NCT02999958|Expectorants|expectorants|mesh-ancestor
83633085|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
83633086|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83633087|NCT02999958|Antidotes|antidotes|mesh-ancestor
83633088|NCT02995746|Dexamethasone|dexamethasone|mesh-list
83633089|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633090|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
83633091|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
83633092|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633093|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633094|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633095|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
83633096|NCT02995746|Hormones|hormones|mesh-ancestor
83633097|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633098|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83633099|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633100|NCT02990364|Lidocaine|lidocaine|mesh-list
83633101|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
83633102|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83633103|NCT02990364|Anesthetics|anesthetics|mesh-list
83633104|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633105|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633106|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
83633107|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633108|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83633109|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83633110|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83633111|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633112|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633113|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83633114|NCT01270074|Azithromycin|azithromycin|mesh-list
83633115|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83633116|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633117|NCT01270308|Lansoprazole|lansoprazole|mesh-list
83633118|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
83633119|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83633120|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633121|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83633122|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633123|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633124|NCT01270386|Apatinib|apatinib|mesh-list
83633125|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633126|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83633127|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633128|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633129|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
83633130|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83633131|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83633132|NCT01270932|Dexamethasone|dexamethasone|mesh-list
83633133|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
83633134|NCT01270932|Lenalidomide|lenalidomide|mesh-list
83633136|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633137|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
83633138|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
83633139|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633140|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633141|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633142|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
83633143|NCT01270932|Hormones|hormones|mesh-ancestor
83633144|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633145|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83633146|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633147|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
83633148|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633149|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633150|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
83633151|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83633152|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83633153|NCT01270932|Growth Substances|growth substances|mesh-ancestor
83633154|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
83633155|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
83633156|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83633157|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
83633158|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633159|NCT01271088|Expectorants|expectorants|mesh-ancestor
83633160|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
83633161|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83633162|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
83633163|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633164|NCT01271088|Protective Agents|protective agents|mesh-ancestor
83633165|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633166|NCT01271088|Antidotes|antidotes|mesh-ancestor
83633167|NCT01271166|Leucovorin|leucovorin|mesh-list
83633168|NCT01271166|Bevacizumab|bevacizumab|mesh-list
83633169|NCT01271166|Fluorouracil|fluorouracil|mesh-list
83633170|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
83633171|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
83633172|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633173|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633174|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83633175|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83633176|NCT01271166|Growth Substances|growth substances|mesh-ancestor
83633177|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633178|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
83633179|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
83633180|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633181|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83633182|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633183|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
83633184|NCT01271166|Antidotes|antidotes|mesh-ancestor
83633185|NCT01271166|Protective Agents|protective agents|mesh-ancestor
83633186|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
83633187|NCT01271166|Vitamins|vitamins|mesh-ancestor
83633188|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
83633189|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83633190|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633191|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83633192|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
83633193|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
83633194|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633195|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633196|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83633197|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
83633198|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83633199|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83633200|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83633201|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
83633202|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633203|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633204|NCT01272258|Leronlimab|leronlimab|mesh-list
83633205|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83633206|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83633207|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633208|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83633209|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82787449|NCT00801905|Nepafenac|nepafenac|mesh-list
83633210|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
83633211|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633212|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
83633213|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83633214|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83633215|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83633216|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633217|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633218|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
83633219|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633220|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633221|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83633222|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633223|NCT01273506|Tapentadol|tapentadol|mesh-list
83633224|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83633225|NCT01273506|Narcotics|narcotics|mesh-ancestor
83633226|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633227|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633228|NCT01273506|Analgesics|analgesics|mesh-ancestor
83633229|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
83633230|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633231|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83633232|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83633233|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633234|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633235|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
83633236|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633237|NCT01273662|Axitinib|axitinib|mesh-list
83633238|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633239|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83633240|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633241|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633242|NCT01273974|Vaccines|vaccines|mesh-list
83633243|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
83633244|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633245|NCT01274130|Metformin|metformin|mesh-list
83633246|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83633247|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633248|NCT01276080|Donepezil|donepezil|mesh-list
83633249|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83633250|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633251|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633252|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
83633253|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633254|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633255|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
83633256|NCT01276548|Carboplatin|carboplatin|mesh-list
83633257|NCT01276548|genexol-PM|genexol-pm|mesh-list
83633258|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633259|NCT01276548|Tubulin Modulators|tubulin modulators|mesh-ancestor
83633260|NCT01276548|Antimitotic Agents|antimitotic agents|mesh-ancestor
83633261|NCT01276548|Mitosis Modulators|mitosis modulators|mesh-ancestor
83633262|NCT01276548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633263|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
83633264|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
83633265|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83633266|NCT01276704|Estrogens|estrogens|mesh-ancestor
83633267|NCT01276704|Hormones|hormones|mesh-ancestor
83633268|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633269|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633270|NCT01277172|Rituximab|rituximab|mesh-list
83633271|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83633272|NCT01277172|Antibodies|antibodies|mesh-list
83633273|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
83633274|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83633275|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
83633276|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633277|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633278|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633279|NCT01277640|Dapivirine|dapivirine|mesh-list
83633280|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83633281|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83633282|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
83633283|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633284|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
83633285|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83633286|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83633287|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83633288|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633289|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633290|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
83633291|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633292|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633293|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83633294|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633295|NCT01279434|Vitamins|vitamins|mesh-list
83633296|NCT01279434|Vitamin E|vitamin e|mesh-list
83633297|NCT01279434|Tocopherols|tocopherols|mesh-list
83633298|NCT01279434|Tocotrienols|tocotrienols|mesh-list
83633299|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
83633300|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
83633301|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633302|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
83633303|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633304|NCT01279434|Protective Agents|protective agents|mesh-ancestor
83633305|NCT01279512|Metformin|metformin|mesh-list
83633306|NCT01279512|Acarbose|acarbose|mesh-list
83633307|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83633308|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633309|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83633310|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633311|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633312|NCT01279668|Montelukast|montelukast|mesh-list
83633313|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83633314|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
83633315|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83633316|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
83633317|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633318|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633319|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83633320|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83633321|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633322|NCT01279902|Rituximab|rituximab|mesh-list
83633323|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633324|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633325|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
83633326|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633327|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633328|NCT01278342|Octreotide|octreotide|mesh-list
83633329|NCT01278342|Cabergoline|cabergoline|mesh-list
83633330|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633331|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83633332|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633333|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83633334|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83633335|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
83633336|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
83633337|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633338|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633339|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633340|NCT01277718|Rabeprazole|rabeprazole|mesh-list
83633341|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83633342|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633343|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83633344|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633345|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633346|NCT01276236|Maraviroc|maraviroc|mesh-list
83633347|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83633348|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83633349|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633350|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83633351|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83633352|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
83633353|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633354|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83633355|NCT01275222|Everolimus|everolimus|mesh-list
83633356|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
83633357|NCT01275222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83633358|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83633359|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834855|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633360|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633361|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633362|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
83633363|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633364|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633365|NCT01275144|Lorazepam|lorazepam|mesh-list
83633366|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
83633367|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
83633368|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
83633369|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633370|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633371|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633372|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83633373|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633374|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83633375|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83633376|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83633377|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
83633378|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
83633379|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633380|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633381|NCT01272180|Vaccines|vaccines|mesh-list
83633382|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
83633383|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633384|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
83633385|NCT01271010|Rituximab|rituximab|mesh-list
83633386|NCT01271010|Fludarabine|fludarabine|mesh-list
83633387|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633388|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
83633389|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633390|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633391|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83633392|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
83633393|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633394|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633395|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83633396|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633397|NCT01270620|Propofol|propofol|mesh-list
83633398|NCT01270620|Desflurane|desflurane|mesh-list
83633399|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83633400|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633401|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633402|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83633403|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
83633404|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
83633405|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83633406|NCT01270464|Reslizumab|reslizumab|mesh-list
83633407|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83633408|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
83633409|NCT01279590|Atorvastatin|atorvastatin|mesh-list
83633410|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83633411|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83633412|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
83633413|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633414|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83633415|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83633416|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633417|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83633418|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
83633419|NCT01271790|Ribavirin|ribavirin|mesh-list
83633420|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
83633421|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633422|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
83633423|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633424|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
83633425|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633426|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
83633427|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
83633428|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633429|NCT01270152|Protective Agents|protective agents|mesh-ancestor
83633430|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633431|NCT01270152|Vitamins|vitamins|mesh-ancestor
83633432|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
83633433|NCT01274988|Methadone|methadone|mesh-list
83633434|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83633435|NCT01274988|Narcotics|narcotics|mesh-ancestor
83633436|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633437|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633438|NCT01274988|Analgesics|analgesics|mesh-ancestor
83633439|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
83633440|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633441|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
83633442|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
83633443|NCT01278498|Escitalopram|escitalopram|mesh-list
83633444|NCT01278498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83633445|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83633446|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633447|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633448|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633449|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
83633450|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633451|NCT01279980|Anesthetics|anesthetics|mesh-list
83633452|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
83633453|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633454|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633455|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
83633456|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633457|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83633458|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83633459|NCT00249834|Hormones|hormones|mesh-ancestor
83633460|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633461|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633462|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83633463|NCT00249444|Mirtazapine|mirtazapine|mesh-list
83633464|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
83633465|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83633466|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83633467|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
83633468|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
83633469|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633470|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633471|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633472|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83633473|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83633474|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633475|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83633476|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83633477|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83633478|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
83633479|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83633480|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83633481|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
83633482|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83633483|NCT00249288|Folic Acid|folic acid|mesh-list
83633484|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
83633485|NCT00249288|Hematinics|hematinics|mesh-ancestor
83633486|NCT00249288|Vitamins|vitamins|mesh-ancestor
83633487|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
83633488|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633489|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
83633490|NCT00247962|Etanercept|etanercept|mesh-list
83633491|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83633492|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83633493|NCT00247962|Analgesics|analgesics|mesh-ancestor
83633494|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
83633495|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633496|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633497|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633498|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633499|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633500|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633501|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
83633502|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633503|NCT00247416|Dexamethasone|dexamethasone|mesh-list
83633504|NCT00247416|Carboplatin|carboplatin|mesh-list
83633505|NCT00247416|Gemcitabine|gemcitabine|mesh-list
83633506|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633507|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
83633508|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
83633509|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633510|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633511|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633512|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
83633513|NCT00247416|Hormones|hormones|mesh-ancestor
83633514|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633515|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83633516|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633517|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83633518|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
83633519|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633520|NCT00246012|Dacarbazine|dacarbazine|mesh-list
83633521|NCT00246012|Intetumumab|intetumumab|mesh-list
83633522|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83633523|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
83633524|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633525|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633526|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633527|NCT00245856|Dalteparin|dalteparin|mesh-list
83633528|NCT00245856|Tinzaparin|tinzaparin|mesh-list
83633529|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83633530|NCT00245856|Warfarin|warfarin|mesh-list
83633531|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
83633532|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83633533|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83633534|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633535|NCT00242580|Triamcinolone|triamcinolone|mesh-list
83633536|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83633537|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83633538|NCT00242580|Verteporfin|verteporfin|mesh-list
83633539|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83633540|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633541|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
83633542|NCT00242580|Hormones|hormones|mesh-ancestor
83633543|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633544|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633545|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633546|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
83633547|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633548|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633549|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83633550|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
83633551|NCT00241644|Vaccines|vaccines|mesh-list
83633552|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
83633553|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633554|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83633555|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83633556|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83633557|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633558|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633559|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
83633560|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633561|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633562|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83633563|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633564|NCT03804840|Dronabinol|dronabinol|mesh-list
83633565|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
83633566|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633567|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83633568|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83633569|NCT03804840|Analgesics|analgesics|mesh-ancestor
83633570|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
83633571|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633572|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83633573|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83633574|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633575|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633576|NCT03804840|Hormones|hormones|mesh-ancestor
83633577|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633578|NCT03804372|Tenofovir|tenofovir|mesh-list
83633579|NCT03804372|Rituximab|rituximab|mesh-list
83633580|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633581|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633582|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
83633583|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633584|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633585|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
83633586|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633587|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83633588|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83633589|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633590|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633591|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83633592|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83633593|NCT03803124|Tolvaptan|tolvaptan|mesh-list
83633594|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83633595|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633596|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
83633597|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633598|NCT03802032|Lidocaine|lidocaine|mesh-list
83633599|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
83633600|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
83633601|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633602|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633603|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
83633604|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633605|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83633606|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83633607|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83633608|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633609|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633610|NCT03801252|Azithromycin|azithromycin|mesh-list
83633611|NCT03801252|Cefazolin|cefazolin|mesh-list
83633612|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83633613|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633614|NCT03800550|Clarithromycin|clarithromycin|mesh-list
83633615|NCT03800550|Bedaquiline|bedaquiline|mesh-list
83633616|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83633617|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633618|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83633619|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633620|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633621|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83633622|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83633623|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
83633624|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83633625|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
83633626|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633627|NCT05742750|Apatinib|apatinib|mesh-list
83633628|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633629|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83633630|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633631|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633632|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
83633633|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83633634|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633635|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
83633636|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83633637|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83633638|NCT05338398|Benzydamine|benzydamine|mesh-list
83633639|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633640|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
83633641|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633642|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633643|NCT05119296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83633644|NCT05119296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633645|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83633646|NCT04581408|Ivacaftor|ivacaftor|mesh-list
83633647|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83633648|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633649|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633650|NCT04295772|Islatravir|islatravir|mesh-list
83633651|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
83633652|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633653|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633654|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633655|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83633656|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82787887|NCT00809939|Progesterone|progesterone|mesh-list
83633657|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83633658|NCT04151940|Immunomodulating Agents|immunomodulating agents|mesh-list
83633659|NCT04151940|Immunologic Factors|immunologic factors|mesh-ancestor
83633660|NCT04151940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633661|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83633662|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633663|NCT04096638|Atezolizumab|atezolizumab|mesh-list
83633664|NCT04096638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83633665|NCT04096638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633666|NCT04096638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633667|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633668|NCT03467256|Cytarabine|cytarabine|mesh-list
83633669|NCT03467256|Dexamethasone|dexamethasone|mesh-list
83633670|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
83633671|NCT03467256|Fludarabine|fludarabine|mesh-list
83633672|NCT03467256|Etoposide|etoposide|mesh-list
83633673|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633674|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
83633675|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633676|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633677|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83633678|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
83633679|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633680|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633681|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83633682|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633683|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
83633684|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
83633685|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633686|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633687|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
83633688|NCT03467256|Hormones|hormones|mesh-ancestor
83633689|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633690|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83633691|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83633692|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
83633693|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83633694|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83633695|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83633696|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633697|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
83633698|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633699|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
83633700|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83633701|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633702|NCT03265080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83633703|NCT03265080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633704|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83633705|NCT02458014|Blinatumomab|blinatumomab|mesh-list
83633706|NCT02458014|Antibodies|antibodies|mesh-list
83633707|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
83633708|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83633709|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
83633710|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83633711|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
83633712|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633713|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633714|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633715|NCT02017704|Leucovorin|leucovorin|mesh-list
83633716|NCT02017704|Fluorouracil|fluorouracil|mesh-list
83633717|NCT02017704|Capecitabine|capecitabine|mesh-list
83633718|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
83633719|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
83633720|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633721|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83633722|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633723|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633724|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
83633725|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633726|NCT02017704|Antidotes|antidotes|mesh-ancestor
83633727|NCT02017704|Protective Agents|protective agents|mesh-ancestor
83633728|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
83633729|NCT02017704|Vitamins|vitamins|mesh-ancestor
83633730|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
83633731|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
83633732|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83633733|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
83633734|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
83633735|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633736|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633737|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83633738|NCT01622322|Analgesics|analgesics|mesh-ancestor
83633739|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
83633740|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633741|NCT05313282|Apatinib|apatinib|mesh-list
83633742|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633743|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83633744|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633745|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633746|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
83633747|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83633748|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
83633749|NCT05311722|Ketamine|ketamine|mesh-list
83633750|NCT05311722|Tramadol|tramadol|mesh-list
83633751|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83633752|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633753|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633754|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83633755|NCT05311722|Analgesics|analgesics|mesh-ancestor
83633756|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
83633757|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633758|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83633759|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83633760|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83633761|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
83633762|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633763|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633764|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83633765|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83633766|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
83633767|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
83633768|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83633769|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83633770|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83633771|NCT05311722|Narcotics|narcotics|mesh-ancestor
83633772|NCT05311254|Fosfomycin|fosfomycin|mesh-list
83633773|NCT05311254|Calcium|calcium|mesh-list
83633774|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83633775|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633776|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83633777|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633778|NCT03215940|Dronabinol|dronabinol|mesh-list
83633779|NCT03215940|Cannabidiol|cannabidiol|mesh-list
83633780|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
83633781|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
83633782|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633783|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83633784|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83633785|NCT03215940|Analgesics|analgesics|mesh-ancestor
83633786|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
83633787|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633788|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83633789|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83633790|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633791|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633792|NCT03215940|Hormones|hormones|mesh-ancestor
83633793|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633794|NCT03219528|Rifaximin|rifaximin|mesh-list
83633795|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83633796|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633797|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83633798|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83633799|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633800|NCT03218514|Dalteparin|dalteparin|mesh-list
83633801|NCT03218514|Tinzaparin|tinzaparin|mesh-list
83633802|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83633803|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
83633804|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83633805|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83633806|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633807|NCT03218124|Remifentanil|remifentanil|mesh-list
83633808|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83633809|NCT03218124|Narcotics|narcotics|mesh-ancestor
83633810|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633811|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633812|NCT03218124|Analgesics|analgesics|mesh-ancestor
83633813|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
83633814|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633815|NCT03217734|Adalimumab|adalimumab|mesh-list
83633816|NCT03217734|Methotrexate|methotrexate|mesh-list
83633817|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83633818|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
83633819|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83633820|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633821|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83633822|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
83633823|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633824|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633825|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
83633826|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633827|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83633828|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633829|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
83633830|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633831|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83633832|NCT03217734|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83633833|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633834|NCT03216876|Ursolic acid|ursolic acid|mesh-list
83633835|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633836|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83633837|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633838|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83633839|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633840|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633841|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83633842|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83633843|NCT03216876|Analgesics|analgesics|mesh-ancestor
83633844|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
83633845|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633846|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633847|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633848|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633849|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83633850|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83633851|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
83633852|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83633853|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83633854|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83633855|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633856|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633857|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
83633858|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633859|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633860|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83633861|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633862|NCT03216564|Vitamin D|vitamin d|mesh-list
83633863|NCT03216564|Calcitriol|calcitriol|mesh-list
83633864|NCT03216564|Vitamins|vitamins|mesh-ancestor
83633865|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
83633866|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633867|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83633868|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83633869|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83633870|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633871|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633872|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83633873|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83633874|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83633875|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
83633876|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83633877|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633878|NCT03214536|Ropivacaine|ropivacaine|mesh-list
83633879|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
83633880|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633881|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633882|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
83633883|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
83633884|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633885|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
83633886|NCT03214770|Calcium|calcium|mesh-list
83633887|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83633888|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633889|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83633890|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83633891|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83633892|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83633893|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633894|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
83633895|NCT03213444|Fluorouracil|fluorouracil|mesh-list
83633896|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633897|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
83633898|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633899|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83633900|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633901|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
83633902|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633903|NCT03212820|Methamphetamine|methamphetamine|mesh-list
83633904|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83633905|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633906|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
83633907|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
83633908|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633909|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
83633910|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83633911|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633912|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
83633913|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83633914|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83633915|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633916|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83633917|NCT03211728|Pregabalin|pregabalin|mesh-list
83633918|NCT03211728|Analgesics|analgesics|mesh-ancestor
83633919|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
83633920|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633921|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633922|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
83633923|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83633924|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83633925|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633926|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83633927|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83633928|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83633929|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83633930|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83633931|NCT03211572|Tamoxifen|tamoxifen|mesh-list
83633932|NCT03211572|Anastrozole|anastrozole|mesh-list
83633933|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83633934|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
83633935|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633936|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633937|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83633938|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633939|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83633940|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83633941|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83633942|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83633943|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83633944|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633945|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633946|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
83633947|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83633948|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
83633949|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633950|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
83633951|NCT03211650|Protective Agents|protective agents|mesh-ancestor
83633952|NCT03211104|Curcumin|curcumin|mesh-list
83633953|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82788189|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83633954|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83633955|NCT03211104|Analgesics|analgesics|mesh-ancestor
83633956|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
83633957|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83633958|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633959|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83633960|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83633961|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83633962|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633963|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633964|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83633965|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83633966|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83633967|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
83633968|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83633969|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633970|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83633971|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83633972|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83633973|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83633974|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83633975|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83633976|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83633977|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83633978|NCT03210324|Mifepristone|mifepristone|mesh-list
83633979|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83633980|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
83633981|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83633982|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83633983|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83633984|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83633985|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83633986|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
83633987|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83633988|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83633989|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
83633990|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83633991|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
83633992|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83633993|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83633994|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
83633995|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
83633996|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83633997|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83633998|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83633999|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
83634000|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83634001|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634002|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634003|NCT01831674|Metformin|metformin|mesh-list
83634004|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83634005|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634006|NCT01832922|Rituximab|rituximab|mesh-list
83634007|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83634008|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83634009|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634010|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
83634011|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634012|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634013|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83634014|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
83634015|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634016|NCT01833312|Meperidine|meperidine|mesh-list
83634017|NCT01833312|Buspirone|buspirone|mesh-list
83634018|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83634019|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83634020|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634021|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634022|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83634023|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83634024|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
83834856|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
83634025|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634026|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634027|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83634028|NCT01833312|Narcotics|narcotics|mesh-ancestor
83634029|NCT01833312|Analgesics|analgesics|mesh-ancestor
83634030|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
83634031|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634032|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83634033|NCT01834014|Bevacizumab|bevacizumab|mesh-list
83634034|NCT01834014|Cetuximab|cetuximab|mesh-list
83634035|NCT01834014|Fluorouracil|fluorouracil|mesh-list
83634036|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
83634037|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83634038|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634039|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83634040|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83634041|NCT01834014|Growth Substances|growth substances|mesh-ancestor
83634042|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634043|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
83634044|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
83634045|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634046|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634047|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634048|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
83634049|NCT01834170|Gemcitabine|gemcitabine|mesh-list
83634050|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634051|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
83634052|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634053|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634054|NCT01835184|Vemurafenib|vemurafenib|mesh-list
83634055|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634056|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634057|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634058|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634059|NCT01835340|Anesthetics|anesthetics|mesh-list
83634060|NCT01835340|Propofol|propofol|mesh-list
83634061|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634062|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634063|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83634064|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83634065|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
83634066|NCT01836120|Docetaxel|docetaxel|mesh-list
83634067|NCT01836120|Raltitrexed|raltitrexed|mesh-list
83634068|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634069|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
83634070|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
83634071|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
83634072|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634073|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634074|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
83634075|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83634076|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634077|NCT01836822|Dimercaprol|dimercaprol|mesh-list
83634078|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
83634079|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
83634080|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634081|NCT01836900|Hemostatics|hemostatics|mesh-list
83634082|NCT01836900|Coagulants|coagulants|mesh-ancestor
83634083|NCT01837992|Primaquine|primaquine|mesh-list
83634084|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
83634085|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83634086|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83634087|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634088|NCT01838460|Lobeline|lobeline|mesh-list
83634089|NCT01838460|Nicotine|nicotine|mesh-list
83634090|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83634091|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
83634092|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634093|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634094|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83634095|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83634096|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
83634097|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634098|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634099|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
83634100|NCT01838538|Paclitaxel|paclitaxel|mesh-list
83634101|NCT01838538|Bevacizumab|bevacizumab|mesh-list
83634102|NCT01838538|Carboplatin|carboplatin|mesh-list
83634103|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83634104|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634105|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
83634106|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
83634107|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
83634108|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634109|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83634110|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83634111|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83634112|NCT01838538|Growth Substances|growth substances|mesh-ancestor
83634113|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634114|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
83634115|NCT01838772|Interferons|interferons|mesh-list
83634116|NCT01838772|Ribavirin|ribavirin|mesh-list
83634117|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634118|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
83634119|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634120|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
83634121|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634122|NCT01838928|Bupivacaine|bupivacaine|mesh-list
83634123|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
83634124|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
83634125|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634126|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634127|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
83634128|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634129|NCT01839084|Isoflurane|isoflurane|mesh-list
83634130|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83634131|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
83634132|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
83634133|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634134|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634135|NCT01839240|Cytarabine|cytarabine|mesh-list
83634136|NCT01839240|Azacitidine|azacitidine|mesh-list
83634137|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
83634138|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634139|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
83634140|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634141|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634142|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
83634143|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634144|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634145|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
83634146|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634147|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634148|NCT01839240|Analgesics|analgesics|mesh-ancestor
83634149|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
83634150|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634151|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83634152|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83634153|NCT01839552|Fentanyl|fentanyl|mesh-list
83634154|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83634155|NCT01839552|Narcotics|narcotics|mesh-ancestor
83634156|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634157|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634158|NCT01839552|Analgesics|analgesics|mesh-ancestor
83634159|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
83634160|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634161|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83634162|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83634163|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
83634164|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
83634165|NCT01839630|Sorafenib|sorafenib|mesh-list
83634166|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634167|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634168|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634169|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634170|NCT01839864|Chrysarobin|chrysarobin|mesh-list
83634171|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634172|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634173|NCT01839864|Analgesics|analgesics|mesh-ancestor
83634174|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
83634175|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634176|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634177|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634178|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634179|NCT01834248|Poly I-C|poly i-c|mesh-list
83634180|NCT01834248|Decitabine|decitabine|mesh-list
83634181|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83634182|NCT01834248|Poly ICLC|poly iclc|mesh-list
83634183|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634184|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
83634185|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634186|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634187|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634188|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
83634189|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
83634190|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634191|NCT01834248|Laxatives|laxatives|mesh-ancestor
83634192|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83634193|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
83634194|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634195|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83634196|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83634197|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634198|NCT01836432|Leucovorin|leucovorin|mesh-list
83634199|NCT01836432|Paclitaxel|paclitaxel|mesh-list
83634200|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83634201|NCT01836432|Gemcitabine|gemcitabine|mesh-list
83634202|NCT01836432|Fluorouracil|fluorouracil|mesh-list
83634203|NCT01836432|Capecitabine|capecitabine|mesh-list
83634204|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
83634205|NCT01836432|Irinotecan|irinotecan|mesh-list
83634206|NCT01836432|Folfirinox|folfirinox|mesh-list
83634207|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83634208|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634209|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83634210|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83634211|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83634212|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634213|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634214|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
83634215|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634216|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
83634217|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634218|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83634219|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83634220|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634221|NCT01836432|Antidotes|antidotes|mesh-ancestor
83634222|NCT01836432|Protective Agents|protective agents|mesh-ancestor
83634223|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
83634224|NCT01836432|Vitamins|vitamins|mesh-ancestor
83634225|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
83634226|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83634227|NCT01720056|Verapamil|verapamil|mesh-list
83634228|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634229|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
83634230|NCT01720056|Hormones|hormones|mesh-ancestor
83634231|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634232|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634233|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634234|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
83634235|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634236|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83634237|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83634238|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634239|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83634240|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
83634241|NCT01720212|Mirabegron|mirabegron|mesh-list
83634242|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83634243|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83634244|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83634245|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
83634246|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634247|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634248|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634249|NCT01720212|Urological Agents|urological agents|mesh-ancestor
83634250|NCT01720290|Metformin|metformin|mesh-list
83634251|NCT01720290|Repaglinide|repaglinide|mesh-list
83634252|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83634253|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634254|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83634255|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83634256|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634257|NCT01721382|Incretins|incretins|mesh-ancestor
83634258|NCT01721382|Hormones|hormones|mesh-ancestor
83634259|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634260|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83634261|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
83634262|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634263|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634264|NCT01721616|Azithromycin|azithromycin|mesh-list
83634265|NCT01721616|Cefazolin|cefazolin|mesh-list
83634266|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83634267|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634268|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83634269|NCT01721694|Azithromycin|azithromycin|mesh-list
83634270|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83634271|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634272|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83634273|NCT01722396|Vitamin D|vitamin d|mesh-list
83634274|NCT01722396|Vitamins|vitamins|mesh-ancestor
83634275|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
83634276|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634277|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83634278|NCT01722630|Dopamine|dopamine|mesh-list
83634279|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83634280|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
83634281|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
83634282|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634283|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634284|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
83634285|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634286|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634287|NCT01722630|Protective Agents|protective agents|mesh-ancestor
83634288|NCT01722942|Amiodarone|amiodarone|mesh-list
83634289|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83634290|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
83634291|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83634292|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634293|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634294|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83634295|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83634296|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83634297|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634298|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83634299|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83634300|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83634301|NCT01723800|Carboplatin|carboplatin|mesh-list
83634302|NCT01723800|Pemetrexed|pemetrexed|mesh-list
83634303|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634304|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634305|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634306|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83634307|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83634308|NCT01724190|Vitamin D|vitamin d|mesh-list
83634309|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
83634310|NCT01724190|Vitamins|vitamins|mesh-ancestor
83634311|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
83634312|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634313|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83634314|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83634315|NCT01724268|Prednisolone|prednisolone|mesh-list
83634316|NCT01724268|Methotrexate|methotrexate|mesh-list
83634317|NCT01724268|Methamphetamine|methamphetamine|mesh-list
83634318|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83634319|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
83634320|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83634321|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634322|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634323|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
83634324|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634325|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634326|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
83634327|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634328|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83634329|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634330|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
83634331|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634332|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83634333|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634334|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
83634335|NCT01724268|Hormones|hormones|mesh-ancestor
83634336|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634337|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83634338|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
83634339|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634340|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83634341|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
83634342|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
83634343|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634344|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
83634345|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83634346|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83634347|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634348|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83634349|NCT01724424|Melatonin|melatonin|mesh-list
83634350|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
83634351|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634352|NCT01724424|Protective Agents|protective agents|mesh-ancestor
83634353|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634354|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634355|NCT01724814|Insulin|insulin|mesh-list
83634356|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83634357|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634358|NCT01725048|Mirtazapine|mirtazapine|mesh-list
83634359|NCT01725048|Citalopram|citalopram|mesh-list
83634360|NCT01725048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83634361|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83634362|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634363|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634364|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634365|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
83634366|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634367|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83634368|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
83634369|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83634370|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83634371|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
83634372|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
83634373|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83634374|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83634375|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634376|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83634377|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83634378|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83634379|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83634380|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83634381|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83634382|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83634383|NCT01725204|Dasatinib|dasatinib|mesh-list
83634384|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634385|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634386|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634387|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634388|NCT01725360|Montelukast|montelukast|mesh-list
83634389|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83634390|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
83634391|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83634392|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
83634393|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634394|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634395|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83634396|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83634397|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634398|NCT01725672|Metformin|metformin|mesh-list
83634399|NCT01725672|Glimepiride|glimepiride|mesh-list
83634400|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83634401|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634402|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83634403|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634404|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
83634405|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83634406|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83634407|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634408|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
83634410|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83634411|NCT01726530|Narcotics|narcotics|mesh-ancestor
83634412|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634413|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634414|NCT01726530|Analgesics|analgesics|mesh-ancestor
83634415|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
83523533|NCT02324543|Docetaxel|docetaxel|mesh-list
83634416|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634417|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83634418|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83634419|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
83634420|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
83634421|NCT01726686|Ropivacaine|ropivacaine|mesh-list
83634422|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
83634423|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
83634424|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634425|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634426|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
83634427|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634428|NCT01726764|Metformin|metformin|mesh-list
83634429|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83634430|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634431|NCT01726920|Naproxen|naproxen|mesh-list
83634432|NCT01726920|Naratriptan|naratriptan|mesh-list
83634433|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634434|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634435|NCT01726920|Analgesics|analgesics|mesh-ancestor
83634436|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
83634437|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634438|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634439|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634440|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634441|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
83634442|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83634443|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634444|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634445|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83634446|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83634447|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83634448|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
83634449|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634450|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83634451|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83634452|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634453|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
83634454|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83634455|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634456|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
83634457|NCT01728480|Cisplatin|cisplatin|mesh-list
83634458|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634459|NCT01728948|Sorafenib|sorafenib|mesh-list
83634460|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634461|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634462|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634463|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634464|NCT01729104|Rituximab|rituximab|mesh-list
83634465|NCT01729104|Lenalidomide|lenalidomide|mesh-list
83634466|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83634467|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634468|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
83634469|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634470|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634471|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83634472|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83634473|NCT01729104|Growth Substances|growth substances|mesh-ancestor
83634474|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
83634475|NCT01729260|Mebendazole|mebendazole|mesh-list
83634476|NCT01729260|Piperazine|piperazine|mesh-list
83634477|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
82788717|NCT00480441|Hormones|hormones|mesh-ancestor
83634478|NCT01729260|DMP 777|dmp 777|mesh-list
83634479|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
83634480|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
83634481|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83634482|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634483|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
83634484|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
83634485|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
83634486|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634487|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634488|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634490|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83634491|NCT01729806|Ipilimumab|ipilimumab|mesh-list
83634492|NCT01729806|Antibodies|antibodies|mesh-list
83634493|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
83634494|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83634495|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
83634496|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634497|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634498|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634499|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83634500|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634501|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
83634502|NCT01724658|Testosterone|testosterone|mesh-list
83634503|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
83634504|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
83634505|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83634506|NCT01724658|Androgens|androgens|mesh-ancestor
83634507|NCT01724658|Hormones|hormones|mesh-ancestor
83634508|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634509|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634510|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83634511|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634512|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
83634513|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
83634514|NCT01049334|Analgesics|analgesics|mesh-ancestor
83634515|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
83634516|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634517|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634518|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634519|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634520|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634521|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634522|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83634523|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634524|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634525|NCT01048944|Bupropion|bupropion|mesh-list
83634526|NCT01048944|Nicotine|nicotine|mesh-list
83634527|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83634528|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
83634529|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634530|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634531|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83634532|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83634533|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83634534|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634535|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634536|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83634537|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
83634538|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83634539|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83634540|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83634541|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634542|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
83634543|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83634544|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83634545|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634546|NCT01048866|Acetaminophen|acetaminophen|mesh-list
83634547|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
83634548|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634549|NCT01048866|Analgesics|analgesics|mesh-ancestor
83634550|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
83634551|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634552|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634553|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
83634554|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634555|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634556|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634557|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83634558|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634559|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634561|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83634562|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634563|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
83634564|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634565|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83634566|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634567|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634568|NCT01046682|Analgesics|analgesics|mesh-ancestor
83634569|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
83634570|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634571|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634572|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634573|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634574|NCT01044498|Norinyl|norinyl|mesh-list
83634575|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83634576|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83634577|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83634578|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
83634579|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83634580|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634581|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83634582|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83634583|NCT01042938|Curcumin|curcumin|mesh-list
83634584|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634585|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634586|NCT01042938|Analgesics|analgesics|mesh-ancestor
83634587|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
83634588|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634589|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634590|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634591|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634592|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634593|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634594|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634595|NCT01042158|Ambrisentan|ambrisentan|mesh-list
83634596|NCT01042158|Tadalafil|tadalafil|mesh-list
83634597|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
83634598|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83634599|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83634600|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634601|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634602|NCT01042158|Urological Agents|urological agents|mesh-ancestor
83634603|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83634604|NCT03405870|SMOFlipid|smoflipid|mesh-list
83634605|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83634606|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83634607|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83634608|NCT03409458|Avelumab|avelumab|mesh-list
83634609|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83634610|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634611|NCT03409068|Anesthetics|anesthetics|mesh-list
83634612|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634613|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634614|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
83634615|NCT03408054|Oxytocin|oxytocin|mesh-list
83634616|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
83634617|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83634618|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634619|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
83634620|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
83634621|NCT03407976|Apatinib|apatinib|mesh-list
83634622|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83634623|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634624|NCT03407976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83634625|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634626|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634627|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634629|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83634630|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634631|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83634632|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634633|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
83634634|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83634635|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634636|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634637|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
83634638|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634639|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634640|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
83634641|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83634642|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83634643|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634644|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83634645|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83634646|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634647|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634648|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634649|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83634650|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
83634651|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83634652|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634653|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83634654|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83634655|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83634656|NCT03403452|Apatinib|apatinib|mesh-list
83634657|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634658|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634659|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634660|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634661|NCT03403140|Etanercept|etanercept|mesh-list
83634662|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634663|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634664|NCT03403140|Analgesics|analgesics|mesh-ancestor
83634665|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
83634666|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634667|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634668|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634669|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634670|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83634671|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634672|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
83634673|NCT03402984|Z 338|z 338|mesh-list
83634674|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83634675|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634676|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634677|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
83634678|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634679|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634680|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83634681|NCT03402438|Fulacimstat|fulacimstat|mesh-list
83634682|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634683|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634684|NCT03402204|Ubenimex|ubenimex|mesh-list
83634685|NCT03402204|Simvastatin|simvastatin|mesh-list
83634686|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83634687|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83634688|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
83634689|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634690|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83634691|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83634692|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634693|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83634694|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
83634695|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634696|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83634697|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788944|NCT02473276|Narcotics|narcotics|mesh-ancestor
83634698|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83634699|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634700|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
83634701|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83634702|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83634703|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
83634704|NCT03402048|Carboplatin|carboplatin|mesh-list
83634705|NCT03402048|Gemcitabine|gemcitabine|mesh-list
83634706|NCT03402048|Docetaxel|docetaxel|mesh-list
83634707|NCT03402048|Pemetrexed|pemetrexed|mesh-list
83634708|NCT03402048|Vinorelbine|vinorelbine|mesh-list
83634709|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634710|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634711|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
83634712|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634713|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
83634714|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
83634715|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
83634716|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634717|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83634718|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83634719|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83634720|NCT03401502|Ranolazine|ranolazine|mesh-list
83634721|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83634722|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634723|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634724|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
83634725|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83634726|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
83634727|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
83634728|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634729|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634730|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634731|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634732|NCT03401346|Analgesics|analgesics|mesh-ancestor
83634733|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
83634734|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634735|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
83634736|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83634737|NCT03401268|Antibodies|antibodies|mesh-list
83634738|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
83634739|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634740|NCT03400722|Clomiphene|clomiphene|mesh-list
83634741|NCT03400722|Hormones|hormones|mesh-list
83634742|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634743|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634744|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83634745|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
83634746|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83634747|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
83634748|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83634749|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83634750|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83634751|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
83634752|NCT03400254|Gedatolisib|gedatolisib|mesh-list
83634753|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
83634754|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83634755|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83634756|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634757|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634758|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634759|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634760|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634761|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
83634762|NCT03400020|Vitamins|vitamins|mesh-ancestor
83634763|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
83634764|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634765|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
83634766|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634767|NCT03400020|Protective Agents|protective agents|mesh-ancestor
83634768|NCT00012012|Amifostine|amifostine|mesh-list
83634769|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83634770|NCT00012012|Protective Agents|protective agents|mesh-ancestor
83634771|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634772|NCT02240160|Nabiximols|nabiximols|mesh-list
83634773|NCT02240160|Analgesics|analgesics|mesh-ancestor
83634774|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
83634775|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634776|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634777|NCT02240238|Gemcitabine|gemcitabine|mesh-list
83634778|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634779|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
83634780|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634781|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634782|NCT02241096|Lidocaine|lidocaine|mesh-list
83634783|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
83634784|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
83634785|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634786|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634787|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
83634788|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634789|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83634790|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83634791|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83634792|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634793|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634794|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83634795|NCT02241174|Eusol|eusol|mesh-list
83634796|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
83634797|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634798|NCT02241564|Sirolimus|sirolimus|mesh-list
83634799|NCT02241564|MTOR Inhibitors|mtor inhibitors|mesh-list
83634800|NCT02241564|Temsirolimus|temsirolimus|mesh-list
83634801|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83634802|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634803|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634804|NCT02241564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83634805|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634806|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
83634807|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634808|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634809|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83634810|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634811|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83634812|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
83634813|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
83634814|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83634815|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
83634816|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634817|NCT02241876|Expectorants|expectorants|mesh-ancestor
83634818|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
83634819|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83634820|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
83634821|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634822|NCT02241876|Protective Agents|protective agents|mesh-ancestor
83634823|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634824|NCT02241876|Antidotes|antidotes|mesh-ancestor
83634825|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83634826|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83634827|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
83634828|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83634829|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
83634830|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634831|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634832|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83634833|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
83634834|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
83634835|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83634836|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
83634837|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634838|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634839|NCT02242344|Telmisartan|telmisartan|mesh-list
83634840|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83634841|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83634842|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83634843|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634844|NCT02242656|Opium|opium|mesh-list
83634845|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83634846|NCT02242656|Narcotics|narcotics|mesh-ancestor
83634847|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634848|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634849|NCT02242656|Analgesics|analgesics|mesh-ancestor
83634850|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
83634851|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634852|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
83634853|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83634854|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
83634855|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
83634856|NCT02242812|Metoprolol|metoprolol|mesh-list
83634857|NCT02242812|Telmisartan|telmisartan|mesh-list
83634858|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83634859|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83634860|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83634861|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634862|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83634863|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
83634864|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
83634865|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634866|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634867|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83634868|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83634869|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83634870|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
83634871|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634872|NCT02243124|Dexamethasone|dexamethasone|mesh-list
83634873|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634874|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
83634875|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
83634876|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634877|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634878|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83634879|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
83634880|NCT02243124|Hormones|hormones|mesh-ancestor
83634881|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634882|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83634883|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634884|NCT02243436|Cytarabine|cytarabine|mesh-list
83634885|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
83634886|NCT02243436|Etoposide|etoposide|mesh-list
83634887|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83634888|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634889|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83634890|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83634891|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83634892|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634893|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634894|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634895|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
83634896|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
83634897|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83634898|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634899|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
83634900|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634901|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83634902|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
83634903|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
83634904|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634905|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83634906|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
83634907|NCT02243436|Hormones|hormones|mesh-ancestor
83634908|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83634909|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83634910|NCT02243436|Protective Agents|protective agents|mesh-ancestor
83634911|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83634912|NCT02243436|Immunotoxins|immunotoxins|mesh-ancestor
83634913|NCT02243436|Immunoconjugates|immunoconjugates|mesh-ancestor
83634914|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
83634915|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83634916|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
83634917|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
83634918|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634919|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634920|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634921|NCT02243826|Analgesics|analgesics|mesh-ancestor
83634922|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
83634923|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634924|NCT02244216|Fenoterol|fenoterol|mesh-list
82789171|NCT01049932|Rilpivirine|rilpivirine|mesh-list
83634925|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83634926|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
83634927|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634928|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634929|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83634930|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
83634931|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
83634932|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
83634933|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83634934|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83634935|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83634936|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83634937|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
83634938|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634939|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634941|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83634942|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83634943|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83634944|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
83634945|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634946|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634947|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634948|NCT02244294|Urological Agents|urological agents|mesh-ancestor
83634949|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
83634950|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
83634951|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83634952|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83634953|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83634954|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634955|NCT02244528|Urological Agents|urological agents|mesh-ancestor
83634956|NCT02245464|Telmisartan|telmisartan|mesh-list
83634957|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83634958|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83634959|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83634960|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634961|NCT02246244|Escitalopram|escitalopram|mesh-list
83634962|NCT02246244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83634963|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83634964|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83634965|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634966|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83634967|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
83634968|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634969|NCT02246712|Tramadol|tramadol|mesh-list
83634970|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83634971|NCT02246712|Narcotics|narcotics|mesh-ancestor
83634972|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83634973|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634974|NCT02246712|Analgesics|analgesics|mesh-ancestor
83634975|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
83634976|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83634977|NCT02246868|Factor VIII|factor viii|mesh-list
83634978|NCT02246868|Coagulants|coagulants|mesh-ancestor
83634979|NCT02247258|Azathioprine|azathioprine|mesh-list
83634980|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
83634981|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83634982|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83634983|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83634984|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83634985|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
83634986|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83634987|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83634988|NCT02247414|Aspirin|aspirin|mesh-list
83634989|NCT02247414|Heparin|heparin|mesh-list
83634990|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83634991|NCT02247414|Tinzaparin|tinzaparin|mesh-list
83634992|NCT02247414|Dalteparin|dalteparin|mesh-list
83634993|NCT02247414|Dipyridamole|dipyridamole|mesh-list
83634994|NCT02247414|Warfarin|warfarin|mesh-list
83634995|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83634996|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83634997|NCT02247414|Analgesics|analgesics|mesh-ancestor
83634998|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
82789319|NCT01026363|Vitamin D|vitamin d|mesh-list
83634999|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635000|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635001|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83635002|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83635003|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83635004|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83635005|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635006|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83635007|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83635008|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635009|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
83635010|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
83635011|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83635012|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
83635013|NCT02247648|Tramadol|tramadol|mesh-list
83635014|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83635015|NCT02247648|Narcotics|narcotics|mesh-ancestor
83635016|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635017|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635018|NCT02247648|Analgesics|analgesics|mesh-ancestor
83635019|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
83635020|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635021|NCT02248428|Clarithromycin|clarithromycin|mesh-list
83635022|NCT02248428|Thalidomide|thalidomide|mesh-list
83635023|NCT02248428|Dexamethasone|dexamethasone|mesh-list
83635024|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
83635025|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83635026|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
83635027|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635028|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83635029|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83635030|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
83635031|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635032|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635033|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83635034|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83635035|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
83635036|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
83635037|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635038|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83635039|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
83635040|NCT02248428|Hormones|hormones|mesh-ancestor
83635041|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635042|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83635043|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83635044|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635045|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83635046|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635047|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83635048|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635049|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
83635050|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83635051|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83635052|NCT02248428|Growth Substances|growth substances|mesh-ancestor
83635053|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
83635054|NCT02248506|Clotrimazole|clotrimazole|mesh-list
83635055|NCT02248506|Miconazole|miconazole|mesh-list
83635056|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83635057|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635058|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
83635059|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83635060|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635061|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635062|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635063|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83635064|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
83635065|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635066|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635067|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83635068|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83635069|NCT02248896|Telmisartan|telmisartan|mesh-list
83635070|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
83635071|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83635072|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83635073|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83635074|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83635075|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635076|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
83635077|NCT02249130|Ritonavir|ritonavir|mesh-list
83635078|NCT02249130|Lamivudine|lamivudine|mesh-list
83635079|NCT02249130|Zidovudine|zidovudine|mesh-list
83635080|NCT02249130|Stavudine|stavudine|mesh-list
83635081|NCT02249130|Tipranavir|tipranavir|mesh-list
83635082|NCT02249130|Delavirdine|delavirdine|mesh-list
83635083|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83635084|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83635085|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
83635086|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635087|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635088|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83635089|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83635090|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
83635091|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635092|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83635093|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635094|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83635095|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83635096|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
83635097|NCT02249364|Propofol|propofol|mesh-list
83635098|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83635099|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635100|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635101|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83635102|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
83635103|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
83635104|NCT02249442|Ritonavir|ritonavir|mesh-list
83635105|NCT02249442|Tipranavir|tipranavir|mesh-list
83635106|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83635107|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83635108|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
83635109|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635110|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635111|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83635112|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83635113|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
83635114|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635115|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83635116|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635117|NCT02244762|Hydrocodone|hydrocodone|mesh-list
83635118|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83635119|NCT02244762|Narcotics|narcotics|mesh-ancestor
83635120|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635121|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635122|NCT02244762|Analgesics|analgesics|mesh-ancestor
83635123|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
83635124|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635125|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
83635126|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635127|NCT02242734|Hydrocodone|hydrocodone|mesh-list
83635128|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83635129|NCT02242734|Narcotics|narcotics|mesh-ancestor
83635130|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635131|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635132|NCT02242734|Analgesics|analgesics|mesh-ancestor
83635133|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
83635134|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635135|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
83635136|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635137|NCT02244606|Fluconazole|fluconazole|mesh-list
83635138|NCT02244606|Micafungin|micafungin|mesh-list
83635139|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
83635140|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
83635141|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635142|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83635143|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635144|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635145|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635146|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83635147|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
82789470|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635148|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635149|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635150|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83635151|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83635152|NCT02245308|Bupropion|bupropion|mesh-list
83635153|NCT02245308|Nicotine|nicotine|mesh-list
83635154|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83635155|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
83635156|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635157|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635158|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83635159|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83635160|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
83635161|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635162|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635163|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83635164|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
83635165|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83635166|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83635167|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83635168|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635169|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
83635170|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83635171|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635172|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635173|NCT02243358|Gemcitabine|gemcitabine|mesh-list
83635174|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83635175|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
83635176|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635177|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635178|NCT00559962|Atorvastatin|atorvastatin|mesh-list
83635179|NCT00559962|Ezetimibe|ezetimibe|mesh-list
83635180|NCT00559962|Fenofibrate|fenofibrate|mesh-list
83635181|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83635182|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83635183|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
83635184|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635185|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83635186|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83635187|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635188|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
83635189|NCT00559104|Carmustine|carmustine|mesh-list
83635190|NCT00559104|Etoposide|etoposide|mesh-list
83635191|NCT00559104|Lenograstim|lenograstim|mesh-list
83635192|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83635193|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
83635194|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635195|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83635196|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83635197|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
83635198|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635199|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635200|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83635201|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83635202|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83635203|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83635204|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635205|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83635206|NCT00558636|Paclitaxel|paclitaxel|mesh-list
83635207|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83635208|NCT00558636|Carboplatin|carboplatin|mesh-list
83635209|NCT00558636|Sorafenib|sorafenib|mesh-list
83635210|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83635211|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635212|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
83635213|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
83635214|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
83635215|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635216|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83635217|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635218|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
83635219|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83635220|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
83635221|NCT00558558|Hormones|hormones|mesh-ancestor
83635222|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635223|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635224|NCT00557622|Paroxetine|paroxetine|mesh-list
83635225|NCT00557622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83635226|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83635227|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635228|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635229|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635230|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
83635231|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635232|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83635233|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
83635234|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83635235|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83635236|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635237|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635238|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
83635239|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83635240|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
83635241|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635242|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635243|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83635244|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635245|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83635246|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83635247|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83635248|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635249|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635250|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635251|NCT00557310|Teriparatide|teriparatide|mesh-list
83635252|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83635253|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635254|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83635255|NCT00555438|PENTA|penta|mesh-list
83635256|NCT00555438|Fondaparinux|fondaparinux|mesh-list
83635257|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83635258|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
83635259|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83635260|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
83635261|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635262|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635263|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
83635264|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83635265|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83635266|NCT00553644|Lenalidomide|lenalidomide|mesh-list
83635267|NCT00553644|Bortezomib|bortezomib|mesh-list
83635268|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
83635269|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635270|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83635271|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83635272|NCT00553644|Growth Substances|growth substances|mesh-ancestor
83635273|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
83635274|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635275|NCT00552240|Ritonavir|ritonavir|mesh-list
83635276|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83635277|NCT00552240|Tenofovir|tenofovir|mesh-list
83635278|NCT00552240|Emtricitabine|emtricitabine|mesh-list
83635279|NCT00552240|Nevirapine|nevirapine|mesh-list
83635280|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83635281|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83635282|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83635283|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635284|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635285|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83635286|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83635287|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
83635288|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635289|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83635290|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635291|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83635292|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83635293|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83834857|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
83635294|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83635295|NCT00550836|Gemcitabine|gemcitabine|mesh-list
83635296|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83635297|NCT00550836|Panitumumab|panitumumab|mesh-list
83635298|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83635299|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
83635300|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635301|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635302|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83635303|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635304|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83635305|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
83635306|NCT00550680|Hematinics|hematinics|mesh-ancestor
83635308|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83635309|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83635310|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635311|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635312|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635313|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635314|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83635315|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
83635316|NCT00556920|Protective Agents|protective agents|mesh-ancestor
83635317|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83635318|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635319|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83635320|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
83635321|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83635322|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83635323|NCT00552708|Lisinopril|lisinopril|mesh-list
83635324|NCT00552708|Carvedilol|carvedilol|mesh-list
83635325|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83635326|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
83635327|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635328|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635329|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83635330|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83635331|NCT00552708|Protective Agents|protective agents|mesh-ancestor
83635332|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635333|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83635334|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83635335|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635336|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635337|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
83635338|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83635339|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635340|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83635341|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
83635342|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83635343|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83635344|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
83635345|NCT00556374|Denosumab|denosumab|mesh-list
83635346|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83635347|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83635348|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635349|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83635350|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635351|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635352|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83635353|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
83635354|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635355|NCT03028350|Ifetroban|ifetroban|mesh-list
83635356|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83635357|NCT03029676|Fentanyl|fentanyl|mesh-list
83635358|NCT03029676|Midazolam|midazolam|mesh-list
83635359|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
83635360|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635361|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635362|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83635363|NCT03029676|Narcotics|narcotics|mesh-ancestor
83635364|NCT03029676|Analgesics|analgesics|mesh-ancestor
83635365|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
83635366|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635367|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83635368|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83635369|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
83635370|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83635371|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83635372|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83635373|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83635374|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
83635375|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
83635376|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635377|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635378|NCT04270344|Valsartan|valsartan|mesh-list
83635379|NCT04270344|Pitavastatin|pitavastatin|mesh-list
83635380|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83635381|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83635382|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83635383|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635384|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83635385|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83635386|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83635387|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
83635388|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635389|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83635390|NCT04278846|Bupivacaine|bupivacaine|mesh-list
83635391|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
83635392|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
83635393|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635394|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635395|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
83635396|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635397|NCT03839550|Apatinib|apatinib|mesh-list
83635398|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635399|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83635400|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635401|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635402|NCT03839160|Morphine|morphine|mesh-list
83635403|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83635404|NCT03839160|Narcotics|narcotics|mesh-ancestor
83635405|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635406|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635407|NCT03839160|Analgesics|analgesics|mesh-ancestor
83635408|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
83635409|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635410|NCT03838926|Trichostatin A|trichostatin a|mesh-list
83635411|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
83635412|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635413|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83635414|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635415|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635416|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83635417|NCT03834012|Beclomethasone|beclomethasone|mesh-list
83635418|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83635419|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
83635420|NCT03834012|Hormones|hormones|mesh-ancestor
83635421|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635422|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635423|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83635424|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635425|NCT03833466|Metformin|metformin|mesh-list
83635426|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83635427|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635428|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83635429|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83635430|NCT03830034|Iron|iron|mesh-list
83635431|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
83635432|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
83635433|NCT03830034|Trace Elements|trace elements|mesh-ancestor
83635434|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
83635435|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635436|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
83635437|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
83635438|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635439|NCT03838068|Anesthetics|anesthetics|mesh-list
83635440|NCT03838068|Procaine|procaine|mesh-list
83635441|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
83635442|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635443|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635445|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635446|NCT05440734|Melatonin|melatonin|mesh-list
83635447|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
83635448|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635449|NCT05440734|Protective Agents|protective agents|mesh-ancestor
83635450|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635451|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635452|NCT05447208|Hormones|hormones|mesh-list
83635453|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635454|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635455|NCT05444556|Repaglinide|repaglinide|mesh-list
83635456|NCT05444556|Quinidine|quinidine|mesh-list
83635457|NCT05444556|Digoxin|digoxin|mesh-list
83635458|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
83635459|NCT05444556|Omeprazole|omeprazole|mesh-list
83635460|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83635461|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83635462|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83635463|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
83635464|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635465|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83635466|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83635467|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635468|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83635469|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83635470|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83635471|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83635472|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83635473|NCT05444556|Protective Agents|protective agents|mesh-ancestor
83635474|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635475|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
83635476|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635477|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83635478|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83635479|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635480|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83635481|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83635482|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83635483|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635484|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
83635485|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83635486|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83635487|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635488|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83635489|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83635490|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83635491|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83635492|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83635493|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635494|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83635495|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83635496|NCT05445804|Cannabidiol|cannabidiol|mesh-list
83635497|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
83635498|NCT05440578|Bevacizumab|bevacizumab|mesh-list
83635499|NCT05440578|Olaparib|olaparib|mesh-list
83635500|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83635501|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635502|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83635503|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83635504|NCT05440578|Growth Substances|growth substances|mesh-ancestor
83635505|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635506|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
83635507|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83635508|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635509|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635510|NCT01689558|Endostatins|endostatins|mesh-list
83635511|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635512|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83635513|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83635514|NCT01689558|Growth Substances|growth substances|mesh-ancestor
83635515|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635516|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
83635517|NCT01689870|Ipilimumab|ipilimumab|mesh-list
83635518|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83635519|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635520|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83635521|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635522|NCT05768542|Metoprolol|metoprolol|mesh-list
83635523|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83635524|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83635525|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
83635526|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
83635527|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635528|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635529|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83635530|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83635531|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83635532|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635533|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635534|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635535|NCT05768464|Axitinib|axitinib|mesh-list
83635536|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635537|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83635538|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635539|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635540|NCT05768334|Lubiprostone|lubiprostone|mesh-list
83635541|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83635542|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635543|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635544|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
83635545|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83635546|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
83635547|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635548|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
83635549|NCT05768243|Protective Agents|protective agents|mesh-ancestor
83635550|NCT05768230|Simendan|simendan|mesh-list
83635551|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83635552|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
83635553|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83635554|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83635555|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635556|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635557|NCT05768230|Protective Agents|protective agents|mesh-ancestor
83635558|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635559|NCT05768204|Prednisolone|prednisolone|mesh-list
83635560|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83635561|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
83635562|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83635563|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
83635564|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83635565|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
83635566|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83635567|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
83635568|NCT05768204|Hormones|hormones|mesh-ancestor
83635569|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635570|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635571|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83635572|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635573|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
83635574|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
83635575|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635576|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83635577|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83635578|NCT05768204|Protective Agents|protective agents|mesh-ancestor
83635579|NCT05768126|Rivastigmine|rivastigmine|mesh-list
83635580|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83635581|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635582|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635583|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
83635584|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635585|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635586|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83635587|NCT05768126|Protective Agents|protective agents|mesh-ancestor
83635588|NCT05767827|Lidocaine|lidocaine|mesh-list
83635589|NCT05767827|Epinephrine|epinephrine|mesh-list
83635590|NCT05767827|Racepinephrine|racepinephrine|mesh-list
83635591|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
83635592|NCT05767827|Ropivacaine|ropivacaine|mesh-list
83635593|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
83635594|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
83635595|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
83635596|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635597|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635598|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
83635599|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635600|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83635601|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83635602|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83635603|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635604|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635605|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83635606|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83635607|NCT05767827|Analgesics|analgesics|mesh-ancestor
83635608|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83635609|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83635610|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83635611|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635612|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635613|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83635614|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83635615|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
83635616|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83635617|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635618|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
83635619|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
83635620|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83635621|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83635622|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83635623|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83635624|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
83635625|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635626|NCT05767723|Aspirin|aspirin|mesh-list
83635627|NCT05767723|Ticagrelor|ticagrelor|mesh-list
83635628|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83635629|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83635630|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83635631|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83635632|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83635633|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
83635634|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635635|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635636|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635637|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83635638|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83635639|NCT05767723|Analgesics|analgesics|mesh-ancestor
83635640|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
83635641|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635642|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83635643|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83635644|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83635645|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83635646|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83635647|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635648|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
83635649|NCT05767684|Nivolumab|nivolumab|mesh-list
83635650|NCT05767684|Lenvatinib|lenvatinib|mesh-list
83635651|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83635652|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635653|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83635654|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635655|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83635656|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635657|NCT05767671|Dimercaprol|dimercaprol|mesh-list
83635658|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
83635659|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
83635660|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635661|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
83635662|NCT05767632|Mirabegron|mirabegron|mesh-list
83635663|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83635664|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83635665|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
83635666|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789931|NCT01027923|Cytarabine|cytarabine|mesh-list
83635667|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635668|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635669|NCT05767632|Urological Agents|urological agents|mesh-ancestor
83635670|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83635671|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83635672|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83635673|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635674|NCT05767515|Inositol|inositol|mesh-list
83635675|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
83635676|NCT05767515|Metformin|metformin|mesh-list
83635677|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83635678|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635679|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
83635680|NCT05767515|Vitamins|vitamins|mesh-ancestor
83635681|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
83635682|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
83635683|NCT05767346|Metoprolol|metoprolol|mesh-list
83635684|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83635685|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83635686|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
83635687|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
83635688|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635689|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635690|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83635691|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83635692|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83635693|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635694|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635695|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635696|NCT05767255|Insulin|insulin|mesh-list
83635697|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83635698|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
83635699|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
83635700|NCT05767255|Liraglutide|liraglutide|mesh-list
83635701|NCT05767255|Xultophy|xultophy|mesh-list
83635702|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83635703|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635704|NCT05767255|Incretins|incretins|mesh-ancestor
83635705|NCT05767255|Hormones|hormones|mesh-ancestor
83635706|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635707|NCT05767229|Carvedilol|carvedilol|mesh-list
83635708|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83635709|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83635710|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635711|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635712|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635713|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635714|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83635715|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
83635716|NCT05767229|Protective Agents|protective agents|mesh-ancestor
83635717|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83635718|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635719|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83635720|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
83635721|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83635722|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83635723|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83635724|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
83635725|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635726|NCT05761431|Octreotide|octreotide|mesh-list
83635727|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83635728|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83635729|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635730|NCT05755789|Cefoxitin|cefoxitin|mesh-list
83635731|NCT05755789|Cefotaxime|cefotaxime|mesh-list
83635732|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83635733|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635734|NCT05753267|Mesalamine|mesalamine|mesh-list
83635735|NCT05753267|Fenofibrate|fenofibrate|mesh-list
83635736|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83635737|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
83635738|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635739|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83635740|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83635741|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83635742|NCT05753267|Analgesics|analgesics|mesh-ancestor
83635743|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
83635744|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635745|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635746|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83635747|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83635748|NCT05751343|Bevacizumab|bevacizumab|mesh-list
83635749|NCT05751343|Atezolizumab|atezolizumab|mesh-list
83635750|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83635751|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635752|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83635753|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83635754|NCT05751343|Growth Substances|growth substances|mesh-ancestor
83635755|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635756|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
83635757|NCT05751343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83635758|NCT05751343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635759|NCT05653050|Insulin|insulin|mesh-list
83635760|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83635761|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635762|NCT05647681|Acetaminophen|acetaminophen|mesh-list
83635763|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83635764|NCT05647681|Analgesics|analgesics|mesh-ancestor
83635765|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
83635766|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635767|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635768|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
83635769|NCT05644145|Vaccines|vaccines|mesh-list
83635770|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
83635771|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635772|NCT05642416|Ropivacaine|ropivacaine|mesh-list
83635773|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
83635774|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
83635775|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635776|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635777|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
83635778|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635779|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
83635780|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83635781|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635782|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635783|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83635784|NCT05631028|Analgesics|analgesics|mesh-ancestor
83635785|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
83635786|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635787|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83635788|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83635789|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83635790|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635791|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635792|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635793|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
83635794|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83635795|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
83635796|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635797|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635798|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83635799|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635800|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83635801|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
83635802|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635803|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635804|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83635805|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
83635806|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
83635807|NCT05612074|Protective Agents|protective agents|mesh-ancestor
83635808|NCT05604599|Fentanyl|fentanyl|mesh-list
83635809|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
83635810|NCT05604599|Propofol|propofol|mesh-list
83635811|NCT05604599|Isoflurane|isoflurane|mesh-list
83635812|NCT05604599|Atracurium|atracurium|mesh-list
83635813|NCT05604599|Cisatracurium|cisatracurium|mesh-list
83635814|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83635815|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635816|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635817|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83635818|NCT05604599|Analgesics|analgesics|mesh-ancestor
83635819|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
83635820|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635821|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83635822|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83635823|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83635824|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
83635825|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635826|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635827|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83635828|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
83635829|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
83635830|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83635831|NCT05604599|Narcotics|narcotics|mesh-ancestor
83635832|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83635833|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83635834|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83635835|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83635836|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83635837|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83635838|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83635839|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
83635840|NCT05602636|Midazolam|midazolam|mesh-list
83635841|NCT05602636|Bupivacaine|bupivacaine|mesh-list
83635842|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
83635843|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
83635844|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83635845|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635846|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
83635847|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635848|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83635849|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83635850|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83635851|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83635852|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83635853|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83635854|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
83635855|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
83635856|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
83635857|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635858|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635859|NCT05543837|Capsaicin|capsaicin|mesh-list
83635860|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
83635861|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
83635862|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
83635863|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635864|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635865|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83635866|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83635867|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83635868|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83635869|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83635870|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635871|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635872|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635873|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635874|NCT05486026|Analgesics|analgesics|mesh-ancestor
83635875|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
83635876|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635877|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
83635878|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83635879|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
83635880|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83635881|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83635882|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
83635883|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
83635884|NCT05468099|Povidone|povidone|mesh-list
83635885|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83635886|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83635887|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
83635888|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
83635889|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
83635890|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
83635891|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
83635892|NCT05451940|Hematinics|hematinics|mesh-list
83635893|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635894|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
83635895|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83635896|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635897|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83635899|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83635900|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635901|NCT05411107|Iloprost|iloprost|mesh-list
83635902|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83635903|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
83635904|NCT05379686|Glucagon|glucagon|mesh-list
83635905|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83635906|NCT05379686|Hormones|hormones|mesh-ancestor
83635907|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635908|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635909|NCT05337540|Hylan|hylan|mesh-list
83635910|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
83635911|NCT05337540|Protective Agents|protective agents|mesh-ancestor
83635912|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635913|NCT05334472|Ofatumumab|ofatumumab|mesh-list
83635914|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635915|NCT05332067|Omalizumab|omalizumab|mesh-list
83635916|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83635917|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83635918|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83635919|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
83635920|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
83635921|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635922|NCT05323890|Tislelizumab|tislelizumab|mesh-list
83635923|NCT05323890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83635924|NCT05323890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635925|NCT05301608|Psilocybin|psilocybin|mesh-list
83635926|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83635927|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
83635928|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635929|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83635930|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83635931|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
83635932|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635933|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635934|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83635935|NCT05284019|Erenumab|erenumab|mesh-list
83635936|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83635937|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83635938|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83635939|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635940|NCT05284019|Analgesics|analgesics|mesh-ancestor
83635941|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
83635942|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635943|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635944|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83635945|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83635946|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83635947|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
83635948|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83635949|NCT05271162|Empagliflozin|empagliflozin|mesh-list
83635950|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83635951|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635952|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83635953|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635954|NCT05257083|Dexamethasone|dexamethasone|mesh-list
83635955|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
83635956|NCT05257083|Fludarabine|fludarabine|mesh-list
83635957|NCT05257083|Lenalidomide|lenalidomide|mesh-list
83635958|NCT05257083|Bortezomib|bortezomib|mesh-list
83635959|NCT05257083|Daratumumab|daratumumab|mesh-list
83635960|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83635961|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
83635962|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635963|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83635964|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83635965|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
83635966|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83635967|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83635968|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83635969|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790222|NCT03862716|Incretins|incretins|mesh-ancestor
83635970|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
83635971|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
83635972|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83635973|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83635974|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
83635975|NCT05257083|Hormones|hormones|mesh-ancestor
83635976|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635977|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83635978|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83635979|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83635980|NCT05257083|Growth Substances|growth substances|mesh-ancestor
83635981|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
83635982|NCT05249634|Testosterone|testosterone|mesh-list
83635983|NCT05249634|Androgens|androgens|mesh-ancestor
83635984|NCT05249634|Hormones|hormones|mesh-ancestor
83635985|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83635986|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635987|NCT05217342|Diuretics|diuretics|mesh-list
83635988|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
83635989|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635990|NCT05199714|Pramlintide|pramlintide|mesh-list
83635991|NCT05199714|Pancrelipase|pancrelipase|mesh-list
83635992|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83635993|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83635994|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83635995|NCT05193370|Vasopressins|vasopressins|mesh-list
83635996|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
83635997|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
83635998|NCT05193370|Giapreza|giapreza|mesh-list
83635999|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
83636000|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
83636001|NCT05193370|Coagulants|coagulants|mesh-ancestor
83636002|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83636003|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83636004|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
83636005|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636006|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83636007|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
83636008|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636009|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636010|NCT05172947|Resveratrol|resveratrol|mesh-list
83636011|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
83636012|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636013|NCT05172947|Protective Agents|protective agents|mesh-ancestor
83636014|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636015|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636016|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83636017|NCT05170607|Antibodies|antibodies|mesh-list
83636018|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
83636019|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636020|NCT05147220|Teriflunomide|teriflunomide|mesh-list
83636021|NCT05147220|Remibrutinib|remibrutinib|mesh-list
83636022|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83636023|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83636024|NCT05147220|Analgesics|analgesics|mesh-ancestor
83636025|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
83636026|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636027|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636028|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636029|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636030|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83636031|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
83636032|NCT05147220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83636033|NCT05147220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636034|NCT05147220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636035|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
83636036|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83636037|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
83636038|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636039|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
83636040|NCT05099718|Protective Agents|protective agents|mesh-ancestor
83636041|NCT05078827|Fluorouracil|fluorouracil|mesh-list
83636042|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
83636043|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636044|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83636045|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790300|NCT05254548|Midazolam|midazolam|mesh-list
83636046|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83636047|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
83636048|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636049|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83636050|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83636051|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636052|NCT05065164|Denosumab|denosumab|mesh-list
83636053|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83636054|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636055|NCT05057819|Empagliflozin|empagliflozin|mesh-list
83636056|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83636057|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636058|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636059|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636060|NCT05037812|Ketorolac|ketorolac|mesh-list
83636061|NCT05037812|Clonidine|clonidine|mesh-list
83636062|NCT05037812|Epinephrine|epinephrine|mesh-list
83636063|NCT05037812|Morphine|morphine|mesh-list
83636064|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83636065|NCT05037812|Narcotics|narcotics|mesh-ancestor
83636066|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636067|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636068|NCT05037812|Analgesics|analgesics|mesh-ancestor
83636069|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
83636070|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636071|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83636072|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636073|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636074|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636075|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636076|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83636077|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83636078|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
83636079|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83636080|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
83636081|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
83636082|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
83636083|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83636084|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83636085|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83636086|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636087|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636088|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83636089|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636090|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83636091|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
83636092|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83636093|NCT05019638|Ketorolac|ketorolac|mesh-list
83636094|NCT05019638|Epinephrine|epinephrine|mesh-list
83636095|NCT05019638|Racepinephrine|racepinephrine|mesh-list
83636096|NCT05019638|Morphine|morphine|mesh-list
83636097|NCT05019638|Bupivacaine|bupivacaine|mesh-list
83636098|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
83636099|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
83636100|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
83636101|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636102|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636103|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
83636104|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636105|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83636106|NCT05019638|Narcotics|narcotics|mesh-ancestor
83636107|NCT05019638|Analgesics|analgesics|mesh-ancestor
83636108|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83636109|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636110|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636111|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636112|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636113|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83636114|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83636115|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
83636116|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83636117|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
83636118|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
83636119|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
83636120|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83636121|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83636122|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83636123|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636124|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636125|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83636126|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636127|NCT04997993|Leflunomide|leflunomide|mesh-list
83636128|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636129|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636130|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83636131|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
83636132|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636133|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83636134|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83636135|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83636136|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83636137|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636138|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636139|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636140|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636141|NCT04854512|Metformin|metformin|mesh-list
83636142|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636143|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636144|NCT04806386|Psyllium|psyllium|mesh-list
83636145|NCT04806386|Cathartics|cathartics|mesh-ancestor
83636146|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83636147|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
83636148|NCT04804072|Narcotics|narcotics|mesh-ancestor
83636149|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636150|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636151|NCT04804072|Analgesics|analgesics|mesh-ancestor
83636152|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
83636153|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636154|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
83636155|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83636156|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83636157|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636158|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
83636159|NCT04797156|Coagulants|coagulants|mesh-ancestor
83636160|NCT04772300|Sirolimus|sirolimus|mesh-list
83636161|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83636162|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83636163|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83636164|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636165|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
83636166|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83636167|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
83636168|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636169|NCT04759144|Insulin|insulin|mesh-list
83636170|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83636171|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
83636172|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
83636173|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83636174|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636175|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636176|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83636177|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636178|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636179|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636180|NCT04679376|Atorvastatin|atorvastatin|mesh-list
83636181|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83636182|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83636183|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
83636184|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636185|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83636186|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83636187|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636188|NCT04677959|Fluticasone|fluticasone|mesh-list
83636189|NCT04677959|Xhance|xhance|mesh-list
83636190|NCT04677959|Albuterol|albuterol|mesh-list
83636191|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83636192|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636193|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83636194|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
83636195|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636196|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636197|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83636198|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
83636199|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
83636200|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83636201|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83636202|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83636203|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636204|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636205|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636206|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636207|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
83636208|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83636209|NCT04671043|Caffeine|caffeine|mesh-list
83636210|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83636211|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636212|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83636213|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636214|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636215|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83636216|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83636217|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
83636218|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636219|NCT04641975|Mirabegron|mirabegron|mesh-list
83636220|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83636221|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83636222|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636223|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636224|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636225|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636226|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636227|NCT04641975|Urological Agents|urological agents|mesh-ancestor
83636228|NCT04612920|Acetaminophen|acetaminophen|mesh-list
83636229|NCT04612920|Ibuprofen|ibuprofen|mesh-list
83636230|NCT04612920|Oxycodone|oxycodone|mesh-list
83636231|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83636232|NCT04612920|Analgesics|analgesics|mesh-ancestor
83636233|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
83636234|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636235|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636236|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
83636237|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83636238|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636239|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636240|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83636241|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636242|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636243|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83636244|NCT04612920|Narcotics|narcotics|mesh-ancestor
83636245|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636246|NCT04570293|Lidocaine|lidocaine|mesh-list
83636247|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
83636248|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
83636249|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636250|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636251|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
83636252|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636253|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83636254|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83636255|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83636256|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83636257|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636258|NCT04540705|Nivolumab|nivolumab|mesh-list
83636259|NCT04540705|Axitinib|axitinib|mesh-list
83636260|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636261|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636262|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83636263|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636264|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83636265|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636266|NCT04531462|Empagliflozin|empagliflozin|mesh-list
83636267|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83636268|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636269|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636270|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636271|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
83636272|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83636273|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
83636274|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83636275|NCT04520139|Expectorants|expectorants|mesh-ancestor
83636276|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
83636277|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83636278|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
83636279|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636280|NCT04520139|Protective Agents|protective agents|mesh-ancestor
83636281|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636282|NCT04520139|Antidotes|antidotes|mesh-ancestor
83636283|NCT04512105|Venetoclax|venetoclax|mesh-list
83636284|NCT04512105|Pitavastatin|pitavastatin|mesh-list
83636285|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636286|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83636287|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83636288|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83636289|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
83636290|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636291|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636292|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83636293|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
83636294|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
83636295|NCT04505254|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83636296|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636297|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636298|NCT04505254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83636299|NCT04505254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636300|NCT04505254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636301|NCT04504318|Enoxaparin|enoxaparin|mesh-list
83636302|NCT04504318|Apixaban|apixaban|mesh-list
83636303|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
83636304|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83636305|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83636306|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636307|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83636308|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
83636309|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83636310|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
83636311|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636312|NCT04501120|Azacitidine|azacitidine|mesh-list
83636313|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83636314|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
83636315|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636316|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636317|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636318|NCT04497142|Levetiracetam|levetiracetam|mesh-list
83636319|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
83636320|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
83636321|NCT04477317|Epinephrine|epinephrine|mesh-list
83636322|NCT04477317|Racepinephrine|racepinephrine|mesh-list
83636323|NCT04477317|Nordefrin|nordefrin|mesh-list
83636324|NCT04477317|Carticaine|carticaine|mesh-list
83636325|NCT04477317|Mepivacaine|mepivacaine|mesh-list
83636326|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
83636327|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83636328|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636329|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636330|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636331|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636332|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636333|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83636334|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83636335|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
83636336|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636337|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83636338|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
83636339|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
83636340|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
83636341|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83636342|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
83636343|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
83636344|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636345|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
83636346|NCT04469959|Levodopa|levodopa|mesh-list
83636347|NCT04469959|Carbidopa|carbidopa|mesh-list
83636348|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83636349|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83636350|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83636351|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
83636352|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636353|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636354|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636355|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83636356|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636357|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83636358|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
83636359|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
83636360|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
83636361|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636362|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636363|NCT04344262|Atracurium|atracurium|mesh-list
83636364|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83636365|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83636366|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83636367|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636368|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636369|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83636370|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83636371|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
83636372|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636373|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636374|NCT04330638|Siltuximab|siltuximab|mesh-list
83636375|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83636376|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636377|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636378|NCT04291521|Ketamine|ketamine|mesh-list
83636379|NCT04291521|Propofol|propofol|mesh-list
83636380|NCT04291521|Etomidate|etomidate|mesh-list
83636381|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83636382|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636383|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636384|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83636385|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
83636386|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
83636387|NCT04291521|Analgesics|analgesics|mesh-ancestor
83636388|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
83636389|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636390|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83636391|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83636392|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83636393|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636394|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636395|NCT04288427|Finasteride|finasteride|mesh-list
83636396|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83636397|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83636398|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636399|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636400|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
83636401|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83636402|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636403|NCT04288427|Urological Agents|urological agents|mesh-ancestor
83636404|NCT04280601|Vitamin D|vitamin d|mesh-list
83636405|NCT04280601|Vitamins|vitamins|mesh-ancestor
83636406|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
83636407|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636408|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83636409|NCT04263064|Clonidine|clonidine|mesh-list
83636410|NCT04263064|Analgesics|analgesics|mesh-ancestor
83636411|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
83636412|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636413|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636414|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83636415|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
83636416|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
83636417|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83636418|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83636419|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636420|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636421|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636422|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636423|NCT04189783|Bupivacaine|bupivacaine|mesh-list
83636424|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
83636425|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
83636426|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636427|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636428|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
83636429|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636430|NCT04131309|Dexamethasone|dexamethasone|mesh-list
83636431|NCT04131309|Bortezomib|bortezomib|mesh-list
83636432|NCT04131309|Daratumumab|daratumumab|mesh-list
83636433|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636434|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
83636435|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
83636436|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636437|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636438|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83636439|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
83636440|NCT04131309|Hormones|hormones|mesh-ancestor
83636441|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83636442|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83636443|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636444|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83636445|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
83636446|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83636447|NCT04090567|Olaparib|olaparib|mesh-list
83636448|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83636449|NCT04090567|Cediranib|cediranib|mesh-list
83636450|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636451|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636452|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636453|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83636454|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
83636455|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83636456|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83636457|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
83636458|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83636459|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636460|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636461|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636462|NCT04040959|Niacinamide|niacinamide|mesh-list
83636463|NCT04040959|Niacin|niacin|mesh-list
83636464|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
83636465|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
83636466|NCT04040959|Vitamins|vitamins|mesh-ancestor
83636467|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
83636468|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636469|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83636470|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
83636471|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636472|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83636473|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
83636474|NCT04039464|Bosentan|bosentan|mesh-list
83636475|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
83636476|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
83636477|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83636478|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83636479|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636480|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636481|NCT04039464|Urological Agents|urological agents|mesh-ancestor
83636482|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83636483|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83636484|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
83636485|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83636486|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636487|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636488|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636489|NCT03965689|Paclitaxel|paclitaxel|mesh-list
83636490|NCT03965689|Carboplatin|carboplatin|mesh-list
83636491|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83636492|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83636493|NCT03965689|Pevonedistat|pevonedistat|mesh-list
83636494|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83636495|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636496|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83636497|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83636498|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83636499|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636500|NCT03960008|Doxorubicin|doxorubicin|mesh-list
83636501|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83636502|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83636503|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636504|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83636505|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83636506|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636507|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636508|NCT03959423|Insulin|insulin|mesh-list
83636509|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636510|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636511|NCT03936998|Vancomycin|vancomycin|mesh-list
83636512|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83636513|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83636514|NCT03911505|Miglustat|miglustat|mesh-list
83636515|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636516|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636517|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83636518|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83636519|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
83636520|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83636521|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83636522|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636523|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636524|NCT03835065|Calpastatin|calpastatin|mesh-list
83636525|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83636526|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
83636527|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636528|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636529|NCT03786783|Vitamin A|vitamin a|mesh-list
83636530|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
83636531|NCT03786783|Melphalan|melphalan|mesh-list
83636532|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
83636533|NCT03786783|Thiotepa|thiotepa|mesh-list
83636534|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83636535|NCT03786783|Cisplatin|cisplatin|mesh-list
83636536|NCT03786783|Carboplatin|carboplatin|mesh-list
83636537|NCT03786783|Doxorubicin|doxorubicin|mesh-list
83636538|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83636539|NCT03786783|Etoposide|etoposide|mesh-list
83636540|NCT03786783|Vincristine|vincristine|mesh-list
83636541|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
83636542|NCT03786783|Daunorubicin|daunorubicin|mesh-list
83636543|NCT03786783|Topotecan|topotecan|mesh-list
83636544|NCT03786783|Tretinoin|tretinoin|mesh-list
83636545|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
83636546|NCT03786783|Dinutuximab|dinutuximab|mesh-list
83636547|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
83636548|NCT03786783|Razoxane|razoxane|mesh-list
83636549|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
83636550|NCT03786783|Isotretinoin|isotretinoin|mesh-list
83636551|NCT03786783|Sargramostim|sargramostim|mesh-list
83636552|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83636553|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
83636554|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636555|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636556|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83636557|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
83636558|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636559|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636560|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83636561|NCT03786783|Vitamins|vitamins|mesh-ancestor
83636562|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
83636563|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83636564|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83636565|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83636566|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636567|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83636568|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
83636569|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
83636570|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
83636571|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83636572|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
83636573|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
83636574|NCT03786783|Protective Agents|protective agents|mesh-ancestor
83636575|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83636576|NCT03785587|Bromides|bromides|mesh-list
83636577|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
83636579|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636580|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636581|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83636582|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83636583|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636584|NCT03735875|Venetoclax|venetoclax|mesh-list
83636585|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636586|NCT03670056|Nivolumab|nivolumab|mesh-list
83636587|NCT03670056|Ipilimumab|ipilimumab|mesh-list
83636588|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636589|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636590|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83636591|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636592|NCT03654833|Bevacizumab|bevacizumab|mesh-list
83636593|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
83636594|NCT03654833|Atezolizumab|atezolizumab|mesh-list
83636595|NCT03654833|Niraparib|niraparib|mesh-list
83636596|NCT03654833|Rucaparib|rucaparib|mesh-list
83636597|NCT03654833|Dostarlimab|dostarlimab|mesh-list
83636598|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636599|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636600|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83636601|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83636602|NCT03654833|Growth Substances|growth substances|mesh-ancestor
83636603|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636604|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
83636605|NCT03654833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83636606|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636607|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83636608|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636609|NCT03639935|Nivolumab|nivolumab|mesh-list
83636610|NCT03639935|Rucaparib|rucaparib|mesh-list
83636611|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636612|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636613|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83636614|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636615|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83636616|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636617|NCT03635333|Nicotine|nicotine|mesh-list
83636618|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83636619|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
83636620|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636621|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636622|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83636623|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83636624|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
83636625|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636626|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636627|NCT03634839|Nicotine|nicotine|mesh-list
83636628|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83636629|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
83636630|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636631|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636632|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83636633|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83636634|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
83636635|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636636|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636637|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83636638|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636639|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636640|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83636641|NCT03441061|Immunotoxins|immunotoxins|mesh-ancestor
83636642|NCT03441061|Immunoconjugates|immunoconjugates|mesh-ancestor
83636643|NCT03441061|Immunologic Factors|immunologic factors|mesh-ancestor
83636644|NCT03441061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636645|NCT03426904|Leucovorin|leucovorin|mesh-list
83636646|NCT03426904|Fluorouracil|fluorouracil|mesh-list
83636647|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
83636648|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
83636649|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636650|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83636651|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790897|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
83636652|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83636653|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
83636654|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636656|NCT03426904|Protective Agents|protective agents|mesh-ancestor
83636657|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
83636658|NCT03426904|Vitamins|vitamins|mesh-ancestor
83636659|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
83636660|NCT03383575|Azacitidine|azacitidine|mesh-list
83636661|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83636662|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
83636663|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636664|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636665|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636666|NCT03361072|Immunomodulating Agents|immunomodulating agents|mesh-list
83636667|NCT03361072|Immunologic Factors|immunologic factors|mesh-ancestor
83636668|NCT03361072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636669|NCT03332667|Vorinostat|vorinostat|mesh-list
83636670|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83636671|NCT03332667|Dinutuximab|dinutuximab|mesh-list
83636672|NCT03332667|Sargramostim|sargramostim|mesh-list
83636673|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
83636674|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636675|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636676|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83636677|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636678|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636679|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83636680|NCT03287778|Pyridoxine|pyridoxine|mesh-list
83636681|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
83636682|NCT03287778|Vitamins|vitamins|mesh-ancestor
83636683|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
83636684|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636685|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
83636686|NCT03273413|Pravastatin|pravastatin|mesh-list
83636687|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83636688|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83636689|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
83636690|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636691|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83636692|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83636693|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636694|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83636695|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83636696|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
83636697|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636698|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83636699|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636700|NCT03075527|Durvalumab|durvalumab|mesh-list
83636701|NCT03075527|Tremelimumab|tremelimumab|mesh-list
83636702|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636703|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636704|NCT03074539|Riociguat|riociguat|mesh-list
83636705|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
83636706|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636707|NCT03030131|Durvalumab|durvalumab|mesh-list
83636708|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636709|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636710|NCT03011021|Liraglutide|liraglutide|mesh-list
83636711|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636712|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636713|NCT03011021|Incretins|incretins|mesh-ancestor
83636714|NCT03011021|Hormones|hormones|mesh-ancestor
83636715|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83636716|NCT02995252|Tenofovir|tenofovir|mesh-list
83636717|NCT02995252|Liver Extracts|liver extracts|mesh-list
83636718|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
83636719|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83636720|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83636721|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83636722|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636723|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636724|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83636725|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83636726|NCT02995252|Hematinics|hematinics|mesh-ancestor
83636727|NCT02983578|Durvalumab|durvalumab|mesh-list
83636728|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
83636729|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83636730|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
83636731|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636732|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636733|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
83636734|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636735|NCT02932826|Insulin|insulin|mesh-list
83636736|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636737|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636738|NCT02846623|Atezolizumab|atezolizumab|mesh-list
83636739|NCT02846623|Venetoclax|venetoclax|mesh-list
83636740|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
83636741|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83636742|NCT02846623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83636743|NCT02846623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636744|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636745|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636746|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
83636747|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636748|NCT02834637|Vaccines|vaccines|mesh-list
83636749|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
83636750|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636751|NCT02817360|Losartan|losartan|mesh-list
83636752|NCT02817360|Valsartan|valsartan|mesh-list
83636753|NCT02817360|Carvedilol|carvedilol|mesh-list
83636754|NCT02817360|Candesartan|candesartan|mesh-list
83636755|NCT02817360|Ramipril|ramipril|mesh-list
83636756|NCT02817360|Enalapril|enalapril|mesh-list
83636757|NCT02817360|Lisinopril|lisinopril|mesh-list
83636758|NCT02817360|Irbesartan|irbesartan|mesh-list
83636759|NCT02817360|Nebivolol|nebivolol|mesh-list
83636760|NCT02817360|Bisoprolol|bisoprolol|mesh-list
83636761|NCT02817360|Perindopril|perindopril|mesh-list
83636762|NCT02817360|Captopril|captopril|mesh-list
83636763|NCT02817360|Quinapril|quinapril|mesh-list
83636764|NCT02817360|Trandolapril|trandolapril|mesh-list
83636765|NCT02817360|Fosinopril|fosinopril|mesh-list
83636766|NCT02817360|Eprosartan|eprosartan|mesh-list
83636767|NCT02817360|Zofenopril|zofenopril|mesh-list
83636768|NCT02817360|Spirapril|spirapril|mesh-list
83636769|NCT02817360|Cilazapril|cilazapril|mesh-list
83636770|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83636771|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83636772|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83636773|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83636774|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636775|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83636776|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83636777|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636778|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636779|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636780|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
83636781|NCT02817360|Protective Agents|protective agents|mesh-ancestor
83636782|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83636783|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83636784|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83636785|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
83636786|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83636787|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83636788|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83636789|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
83636790|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636791|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83636792|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83636793|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83636794|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636795|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
83636796|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
83636797|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636798|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83636799|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83636800|NCT02743806|Vedolizumab|vedolizumab|mesh-list
83636801|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83636802|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
83636803|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636804|NCT02689778|Pirfenidone|pirfenidone|mesh-list
82791047|NCT01034787|Tremelimumab|tremelimumab|mesh-list
83636805|NCT02689778|Analgesics|analgesics|mesh-ancestor
83636806|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
83636807|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791124|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636808|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636809|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83636810|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83636811|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636812|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636813|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636814|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83636815|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83636816|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83636817|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636818|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636819|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83636820|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83636821|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636822|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
83636823|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636824|NCT02659384|Aspirin|aspirin|mesh-list
83636825|NCT02659384|Bevacizumab|bevacizumab|mesh-list
83636826|NCT02659384|Atezolizumab|atezolizumab|mesh-list
83636827|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636828|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636829|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83636830|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83636831|NCT02659384|Growth Substances|growth substances|mesh-ancestor
83636832|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636833|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
83636834|NCT02659384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83636835|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636836|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83636837|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83636838|NCT02659384|Analgesics|analgesics|mesh-ancestor
83636839|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
83636840|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636841|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636842|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636843|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83636844|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83636845|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83636846|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83636847|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636848|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
83636849|NCT02659306|Metformin|metformin|mesh-list
83636850|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636851|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636852|NCT02591147|Fluorides|fluorides|mesh-list
83636853|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
83636854|NCT02591147|Protective Agents|protective agents|mesh-ancestor
83636855|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636856|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
83636857|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83636858|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
83636859|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636860|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
83636861|NCT02588872|Protective Agents|protective agents|mesh-ancestor
83636862|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
83636863|NCT02579161|Clindamycin|clindamycin|mesh-list
83636864|NCT02579161|Gentamicins|gentamicins|mesh-list
83636865|NCT02579161|Penicillins|penicillins|mesh-list
83636866|NCT02579161|Ampicillin|ampicillin|mesh-list
83636867|NCT02579161|Cephalosporins|cephalosporins|mesh-list
83636868|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
83636869|NCT02579161|Lincosamides|lincosamides|mesh-list
83636870|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83636871|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83636872|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83636873|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83636874|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636875|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636876|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636877|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83636878|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83636879|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83636880|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83636881|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
83636882|NCT02538510|Vorinostat|vorinostat|mesh-list
83636883|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636884|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636885|NCT02538510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83636886|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636887|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83636888|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636889|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
83636890|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636891|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636892|NCT02419040|Lidocaine|lidocaine|mesh-list
83636893|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
83636894|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
83636895|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636896|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636897|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
83636898|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636899|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83636900|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83636901|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83636902|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83636903|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636904|NCT02387203|Amoxicillin|amoxicillin|mesh-list
83636905|NCT02387203|Clarithromycin|clarithromycin|mesh-list
83636906|NCT02387203|Lansoprazole|lansoprazole|mesh-list
83636907|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83636908|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83636909|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83636910|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636911|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636912|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83636913|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83636914|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83636915|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83636916|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83636917|NCT02381353|Bupivacaine|bupivacaine|mesh-list
83636918|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
83636919|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
83636920|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83636921|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636922|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
83636923|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83636924|NCT02296229|Androgens|androgens|mesh-list
83636925|NCT02296229|Hormones|hormones|mesh-ancestor
83636926|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83636927|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636928|NCT02192398|Guanfacine|guanfacine|mesh-list
83636929|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83636930|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83636931|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83636932|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83636933|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
83636934|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83636935|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636936|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636937|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
83636938|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636939|NCT01992653|Prednisone|prednisone|mesh-list
83636940|NCT01992653|Prednisolone|prednisolone|mesh-list
83636941|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
83636942|NCT01992653|Rituximab|rituximab|mesh-list
83636943|NCT01992653|Doxorubicin|doxorubicin|mesh-list
83636944|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
83636945|NCT01992653|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83636946|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83636947|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
83636948|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636949|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83636950|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83636951|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
83636952|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636953|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636954|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83636955|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791198|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83636956|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83636957|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83636958|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83636959|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636960|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83636961|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
83636962|NCT01992653|Hormones|hormones|mesh-ancestor
83636963|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83636964|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83636965|NCT01992653|Immunoconjugates|immunoconjugates|mesh-ancestor
83636966|NCT01850303|Gemcitabine|gemcitabine|mesh-list
83636967|NCT01850303|Pemetrexed|pemetrexed|mesh-list
83636968|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83636969|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
83636970|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636971|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636972|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83636973|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83636974|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83636975|NCT01763671|Paclitaxel|paclitaxel|mesh-list
83636976|NCT01763671|Docetaxel|docetaxel|mesh-list
83636977|NCT01763671|Bevacizumab|bevacizumab|mesh-list
83636978|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83636979|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83636980|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83636981|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83636982|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83636983|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83636984|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83636985|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83636986|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83636987|NCT01763671|Growth Substances|growth substances|mesh-ancestor
83636988|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636989|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
83636990|NCT01750567|Metformin|metformin|mesh-list
83636991|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83636992|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636993|NCT01696435|Vitamin D|vitamin d|mesh-list
83636994|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
83636995|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
83636996|NCT01696435|Vitamins|vitamins|mesh-list
83636997|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
83636998|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83636999|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83637000|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83637001|NCT01682083|Trametinib|trametinib|mesh-list
83637002|NCT01682083|Dabrafenib|dabrafenib|mesh-list
83637003|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637004|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83637005|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637006|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637007|NCT01681264|Guanfacine|guanfacine|mesh-list
83637008|NCT01681264|Morphine|morphine|mesh-list
83637009|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83637010|NCT01681264|Narcotics|narcotics|mesh-ancestor
83637011|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83637012|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637013|NCT01681264|Analgesics|analgesics|mesh-ancestor
83637014|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
83637015|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637016|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637017|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83637018|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83637019|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83637020|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637021|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637022|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637023|NCT01654276|Febuxostat|febuxostat|mesh-list
83637024|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
83637025|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83637026|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83637027|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
83637028|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637029|NCT00590122|Levodopa|levodopa|mesh-list
83637030|NCT00590122|Carbidopa|carbidopa|mesh-list
83637031|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83637032|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83637033|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83637034|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
83637035|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637036|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637037|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637038|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83637039|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637040|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83637041|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
83637042|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
83637043|NCT00309192|Triamcinolone|triamcinolone|mesh-list
83637044|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83637045|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83637046|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83637047|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637048|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
83637049|NCT00309192|Hormones|hormones|mesh-ancestor
83637050|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637051|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637052|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637053|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
83637054|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637055|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637056|NCT00295893|Paclitaxel|paclitaxel|mesh-list
83637057|NCT00295893|Docetaxel|docetaxel|mesh-list
83637058|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
83637059|NCT00295893|Carboplatin|carboplatin|mesh-list
83637060|NCT00295893|Doxorubicin|doxorubicin|mesh-list
83637061|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83637062|NCT00295893|Trastuzumab|trastuzumab|mesh-list
83637063|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83637064|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637065|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
83637066|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
83637067|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
83637068|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637069|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637070|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
83637071|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637072|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83637073|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83637074|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
83637075|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83637076|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83637077|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83637078|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83637079|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637080|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637081|NCT00110591|Leronlimab|leronlimab|mesh-list
83637082|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83637083|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83637084|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637085|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83637086|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83637087|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
83637088|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637089|NCT01689246|Methylene Blue|methylene blue|mesh-list
83637090|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637091|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637092|NCT01685268|Prednisone|prednisone|mesh-list
83637093|NCT01685268|Prednisolone|prednisolone|mesh-list
83637094|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
83637095|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637096|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
83637097|NCT01685268|Hormones|hormones|mesh-ancestor
83637098|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637099|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637100|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83637101|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637102|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83637103|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637104|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791346|NCT01002768|Insulin|insulin|mesh-list
83637105|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
83637106|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83637107|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83637108|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
83637109|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637110|NCT01683084|Telmisartan|telmisartan|mesh-list
83637111|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637112|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83637113|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83637114|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637115|NCT04823442|Bisoprolol|bisoprolol|mesh-list
83637116|NCT04823442|Mirabegron|mirabegron|mesh-list
83637117|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83637118|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83637119|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83637120|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637121|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637122|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637123|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637124|NCT04823442|Urological Agents|urological agents|mesh-ancestor
83637125|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637126|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
83637127|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
83637128|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637129|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83637130|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83637131|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83637132|NCT01384448|Dobutamine|dobutamine|mesh-list
83637133|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83637134|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
83637135|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
83637136|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637137|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637138|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83637139|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83637140|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83637141|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637142|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637143|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637144|NCT01384448|Protective Agents|protective agents|mesh-ancestor
83637145|NCT01384578|Vitamins|vitamins|mesh-list
83637146|NCT01384578|Vitamin E|vitamin e|mesh-list
83637147|NCT01384578|Tocopherols|tocopherols|mesh-list
83637148|NCT01384578|Tocotrienols|tocotrienols|mesh-list
83637149|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
83637150|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
83637151|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
83637152|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637153|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
83637154|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637155|NCT01384578|Protective Agents|protective agents|mesh-ancestor
83637156|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83637157|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637158|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83637159|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83637160|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
83637161|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83637162|NCT01384643|Propofol|propofol|mesh-list
83637163|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83637164|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83637165|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637166|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83637167|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
83637168|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
83637169|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83637170|NCT01384682|Maraviroc|maraviroc|mesh-list
83637171|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83637172|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83637173|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637174|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83637175|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83637176|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
83637177|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637178|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83637179|NCT01384695|Proflavine|proflavine|mesh-list
83637180|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83637181|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637182|NCT01384708|Proflavine|proflavine|mesh-list
83637183|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83637184|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637185|NCT01384799|Cisplatin|cisplatin|mesh-list
83637186|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637187|NCT01384812|Dinoprostone|dinoprostone|mesh-list
83637188|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
83637189|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83637190|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637191|NCT01384864|Proflavine|proflavine|mesh-list
83637192|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83637193|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637194|NCT01384903|Antithrombins|antithrombins|mesh-list
83637195|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
83637196|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83637197|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
83637198|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637199|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637200|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
83637201|NCT01384994|Folic Acid|folic acid|mesh-list
83637202|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
83637203|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
83637204|NCT01384994|Fluorouracil|fluorouracil|mesh-list
83637205|NCT01384994|Panitumumab|panitumumab|mesh-list
83637206|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637207|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
83637208|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637209|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637210|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637211|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
83637212|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637213|NCT01384994|Hematinics|hematinics|mesh-ancestor
83637214|NCT01384994|Vitamins|vitamins|mesh-ancestor
83637215|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
83637216|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637217|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
83637218|NCT01385020|Red yeast rice|red yeast rice|mesh-list
83637219|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83637220|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
83637221|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637222|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83637223|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83637224|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83637225|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637226|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83637227|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83637228|NCT01385124|Cannabidiol|cannabidiol|mesh-list
83637229|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
83637230|NCT01385228|Prednisone|prednisone|mesh-list
83637231|NCT01385228|Docetaxel|docetaxel|mesh-list
83637232|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637233|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
83637234|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
83637235|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
83637236|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637237|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637238|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
83637239|NCT01385228|Hormones|hormones|mesh-ancestor
83637240|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637241|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637242|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83637243|NCT01385345|Vitamin D|vitamin d|mesh-list
83637244|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
83637245|NCT01385345|Vitamins|vitamins|mesh-ancestor
83637246|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
83637247|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637248|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83637249|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83637250|NCT01385527|Triamcinolone|triamcinolone|mesh-list
83637251|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637252|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
83637253|NCT01385527|Hormones|hormones|mesh-ancestor
83637254|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637255|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637256|NCT01385631|Ezetimibe|ezetimibe|mesh-list
83637257|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82791496|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637258|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83637259|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
83637260|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637261|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83637262|NCT01385683|Clarithromycin|clarithromycin|mesh-list
83637263|NCT01385683|Dabigatran|dabigatran|mesh-list
83637264|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83637265|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637266|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83637267|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637268|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637269|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83637270|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83637271|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
83637272|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83637273|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
83637274|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
83637275|NCT01385735|Rasagiline|rasagiline|mesh-list
83637276|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83637277|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637278|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637279|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83637280|NCT01385735|Protective Agents|protective agents|mesh-ancestor
83637281|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637282|NCT01385826|Antibodies|antibodies|mesh-list
83637283|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83637284|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
83637285|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637286|NCT01385891|Etoposide|etoposide|mesh-list
83637287|NCT01385891|Clofarabine|clofarabine|mesh-list
83637288|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83637289|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637290|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83637291|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83637292|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637293|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637294|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637295|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
83637296|NCT01385956|Gemcitabine|gemcitabine|mesh-list
83637297|NCT01385956|Pasireotide|pasireotide|mesh-list
83637298|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637299|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
83637300|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637301|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637302|NCT01385956|Hormones|hormones|mesh-ancestor
83637303|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637304|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637305|NCT01386086|Aripiprazole|aripiprazole|mesh-list
83637306|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
83637307|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83637308|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83637309|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83637310|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83637311|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637312|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
83637313|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
83637314|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637315|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637316|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83637317|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83637318|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
83637319|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83637320|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83637321|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83637322|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83637323|NCT01386151|Mitogens|mitogens|mesh-list
83637324|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
83637325|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637326|NCT01386164|Vaccines|vaccines|mesh-list
83637327|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
83637328|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637329|NCT01386177|Doxazosin|doxazosin|mesh-list
83637330|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83637331|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
83637332|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637333|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83637334|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
83637335|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637336|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637337|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83637338|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83526457|NCT04341077|Fluzoparib|fluzoparib|mesh-list
83637339|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83637340|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637341|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637342|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83637343|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83637344|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83637345|NCT01386229|Ketamine|ketamine|mesh-list
83637346|NCT01386229|Etomidate|etomidate|mesh-list
83637347|NCT01386229|Analgesics|analgesics|mesh-ancestor
83637348|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
83637349|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637350|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637351|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83637352|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83637353|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
83637354|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
83637355|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83637356|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83637357|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83637358|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637359|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637360|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83637361|NCT01386242|Interferons|interferons|mesh-list
83637362|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637363|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
83637364|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637365|NCT01386255|Baclofen|baclofen|mesh-list
83637366|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83637367|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637368|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83637369|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637370|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83637371|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
83637372|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
83637373|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637374|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637375|NCT01386268|Factor VIII|factor viii|mesh-list
83637376|NCT01386268|Coagulants|coagulants|mesh-ancestor
83637377|NCT01386294|Tenofovir|tenofovir|mesh-list
83637378|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
83637379|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637380|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83637381|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83637382|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637383|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637384|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83637385|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83637386|NCT01386333|Oxytocin|oxytocin|mesh-list
83637387|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
83637388|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83637389|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637390|NCT01386346|Capecitabine|capecitabine|mesh-list
83637391|NCT01386346|Azacitidine|azacitidine|mesh-list
83637392|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
83637393|NCT01386346|Epirubicin|epirubicin|mesh-list
83637394|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637395|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
83637396|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637397|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637398|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637399|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83637400|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83637401|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83637402|NCT01386372|Tolvaptan|tolvaptan|mesh-list
83637403|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83637404|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637405|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
82791647|NCT00626405|Paclitaxel|paclitaxel|mesh-list
83637406|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637407|NCT01386398|Bortezomib|bortezomib|mesh-list
83637408|NCT01386398|Vorinostat|vorinostat|mesh-list
83637409|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637410|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83637411|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637412|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637413|NCT01386502|Pidilizumab|pidilizumab|mesh-list
83637414|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637415|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637416|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
83637417|NCT01386567|Citric Acid|citric acid|mesh-list
83637418|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
83637419|NCT01386567|Enclomiphene|enclomiphene|mesh-list
83637420|NCT01386567|Clomiphene|clomiphene|mesh-list
83637421|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
83637422|NCT01386567|Testosterone|testosterone|mesh-list
83637423|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
83637424|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
83637425|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83637426|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
83637427|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83637428|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
83637429|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
83637430|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637431|NCT01386567|Androgens|androgens|mesh-ancestor
83637432|NCT01386567|Hormones|hormones|mesh-ancestor
83637433|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637434|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637435|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83637436|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637437|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
83637438|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83637439|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
83637440|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83637441|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
83637442|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83637443|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83637444|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83637445|NCT01386580|Doxorubicin|doxorubicin|mesh-list
83637446|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83637447|NCT01386580|Trastuzumab|trastuzumab|mesh-list
83637448|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83637449|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637450|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83637451|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83637452|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637453|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637454|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637455|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
83637456|NCT01386593|Rifampin|rifampin|mesh-list
83637457|NCT01386593|Fluconazole|fluconazole|mesh-list
83637458|NCT01386593|Paroxetine|paroxetine|mesh-list
83637459|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83637460|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637461|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83637462|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83637463|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637464|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637465|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637466|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83637467|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83637468|NCT01386593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83637469|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83637470|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83637471|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637472|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
83637473|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637474|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83637475|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
83637476|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83637477|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83637478|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
83637479|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83637480|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83637481|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
83637482|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637483|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83637484|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83637485|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83637486|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
83637487|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
83637488|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83637489|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83637490|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83637491|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83637492|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83637493|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83637494|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83637495|NCT01386658|Icatibant|icatibant|mesh-list
83637496|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83637497|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83637498|NCT01386658|Analgesics|analgesics|mesh-ancestor
83637499|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
83637500|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637501|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637502|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637503|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83637504|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83637505|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83637506|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637507|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83637508|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637509|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
83637510|NCT01386671|Metformin|metformin|mesh-list
83637511|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83637512|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637513|NCT01386736|Vitamin D|vitamin d|mesh-list
83637514|NCT01386736|Vitamins|vitamins|mesh-ancestor
83637515|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
83637516|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637517|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83637518|NCT01386853|Atorvastatin|atorvastatin|mesh-list
83637519|NCT01386853|Pitavastatin|pitavastatin|mesh-list
83637520|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83637521|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83637522|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
83637523|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637524|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83637525|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83637526|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637527|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
83637528|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83637529|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637530|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637531|NCT01386879|Methylene Blue|methylene blue|mesh-list
83637532|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637533|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637534|NCT01386996|Budesonide|budesonide|mesh-list
83637535|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
83637536|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83637537|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637538|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83637539|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
83637540|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637541|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637542|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83637543|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
83637544|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
83637545|NCT01386996|Hormones|hormones|mesh-ancestor
83637546|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791796|NCT05889338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82791797|NCT05889338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791798|NCT05889338|Immunologic Factors|immunologic factors|mesh-ancestor
82791799|NCT05889338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82791800|NCT05889338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82791802|NCT05889338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637547|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83637549|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83637550|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637551|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637552|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637553|NCT01387048|Adapalene|adapalene|mesh-list
83637554|NCT01387048|Azelaic acid|azelaic acid|mesh-list
83637555|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83637556|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83637557|NCT01387048|Analgesics|analgesics|mesh-ancestor
83637558|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
83637559|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637560|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637561|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637562|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83637563|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
83637564|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637565|NCT01387087|Peficitinib|peficitinib|mesh-list
83637566|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637567|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637568|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637569|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
83637570|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637571|NCT01387191|Epoprostenol|epoprostenol|mesh-list
83637572|NCT01387191|Tezosentan|tezosentan|mesh-list
83637573|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637574|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83637575|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83637576|NCT01387204|Trametinib|trametinib|mesh-list
83637577|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637578|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83637579|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637580|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637581|NCT01387243|Orlistat|orlistat|mesh-list
83637582|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637583|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637584|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83637585|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83637586|NCT01387295|Capecitabine|capecitabine|mesh-list
83637587|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
83637588|NCT01387295|Trastuzumab|trastuzumab|mesh-list
83637589|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637590|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
83637591|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637592|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637593|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637594|NCT01387373|Capecitabine|capecitabine|mesh-list
83637595|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
83637596|NCT01387373|Trastuzumab|trastuzumab|mesh-list
83637597|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637598|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
82791872|NCT05888493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791873|NCT05888493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82791874|NCT05888493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791875|NCT05888493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82791876|NCT05888493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82791877|NCT05888493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82791878|NCT05888493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791879|NCT05888493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791880|NCT05888493|Glucocorticoids|glucocorticoids|mesh-ancestor
82791881|NCT05888493|Hormones|hormones|mesh-ancestor
82791882|NCT05888493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791883|NCT05888493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82791884|NCT05888493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791885|NCT05888493|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791886|NCT05888493|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791887|NCT05888493|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791888|NCT05888493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791889|NCT05888493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791890|NCT05888493|Growth Substances|growth substances|mesh-ancestor
82791891|NCT05888493|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791892|NCT05888350|Beclomethasone|beclomethasone|mesh-list
82791893|NCT05888350|Formoterol Fumarate|formoterol fumarate|mesh-list
83637599|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637600|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637601|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637603|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637604|NCT01387425|Varenicline|varenicline|mesh-list
83637605|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83637606|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83637607|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
83637608|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637609|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637610|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637611|NCT01387568|Lidocaine|lidocaine|mesh-list
83637612|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
83637613|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
83637614|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83637615|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637616|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
83637617|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637618|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83637619|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83637620|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83637621|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83637622|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637623|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
83637624|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83637625|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
83637626|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637627|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
83637628|NCT01387620|Protective Agents|protective agents|mesh-ancestor
83637629|NCT01387880|Everolimus|everolimus|mesh-list
83637630|NCT01387880|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83637631|NCT01387880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83637632|NCT01387880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637633|NCT01387880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637634|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637635|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
83637636|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637637|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637638|NCT01387906|Bimatoprost|bimatoprost|mesh-list
83637639|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637640|NCT01387997|Antibodies|antibodies|mesh-list
83637641|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
83637642|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637643|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
83637644|NCT01388023|Listerine|listerine|mesh-list
83637645|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83637646|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637647|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
83637648|NCT01388036|Esmolol|esmolol|mesh-list
83637649|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83637650|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83637651|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83637652|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637653|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637654|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637655|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637656|NCT01388049|Antibodies|antibodies|mesh-list
83637657|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
83637658|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637659|NCT01388062|Antibodies|antibodies|mesh-list
83637660|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
83637661|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637662|NCT01388075|Rifampin|rifampin|mesh-list
83637663|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83637664|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
83637665|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83637666|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637667|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
83637668|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83637669|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637670|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637671|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83637672|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83637673|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83637674|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83637675|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83637676|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83637677|NCT01388088|Amiloride|amiloride|mesh-list
83637678|NCT01388088|Spironolactone|spironolactone|mesh-list
83637679|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83637680|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
83637681|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637682|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637683|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83637684|NCT01388088|Diuretics|diuretics|mesh-ancestor
83637685|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
83637686|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83637687|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83637688|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83637689|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637690|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83637691|NCT01388101|Antibodies|antibodies|mesh-list
83637692|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
83637693|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637694|NCT01388114|Antibodies|antibodies|mesh-list
83637695|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
83637696|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637697|NCT01388153|Acarbose|acarbose|mesh-list
83637698|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83637699|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637700|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637701|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83637702|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637703|NCT01388270|Heparin|heparin|mesh-list
83637704|NCT01388270|Calcium heparin|calcium heparin|mesh-list
83637705|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
83637706|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83637707|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83637708|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637709|NCT01388322|Enoxaparin|enoxaparin|mesh-list
83637710|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
83637711|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83637712|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83637713|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637714|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83637715|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637716|NCT01388439|Oseltamivir|oseltamivir|mesh-list
83637717|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
83637718|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637719|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637720|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637721|NCT01388517|Vitamin D|vitamin d|mesh-list
83637722|NCT01388517|Calcitriol|calcitriol|mesh-list
83637723|NCT01388517|Petrolatum|petrolatum|mesh-list
83637724|NCT01388517|Tacrolimus|tacrolimus|mesh-list
83637725|NCT01388517|Vitamins|vitamins|mesh-ancestor
83637726|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
83637727|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637728|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83637729|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637730|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
83637731|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83637732|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637733|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637734|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83637735|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83637736|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83637737|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83637738|NCT01388517|Emollients|emollients|mesh-ancestor
83637739|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
83637740|NCT01388582|Copper|copper|mesh-list
83637741|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
83637742|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
83637743|NCT01388582|Etonogestrel|etonogestrel|mesh-list
83637744|NCT01388582|Desogestrel|desogestrel|mesh-list
83637745|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
83637746|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83637747|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637748|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83637749|NCT01388582|Trace Elements|trace elements|mesh-ancestor
83637750|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
83637751|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83637752|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83637753|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83637754|NCT01388582|Progestins|progestins|mesh-ancestor
83637755|NCT01388582|Hormones|hormones|mesh-ancestor
83637756|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637757|NCT01388595|Fluticasone|fluticasone|mesh-list
83637758|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83637759|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637760|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83637761|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
83637762|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637763|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637764|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83637765|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
83637766|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
83637767|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83637768|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83637769|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83637770|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83637771|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637772|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637773|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637774|NCT01388621|Carboplatin|carboplatin|mesh-list
83637775|NCT01388621|Gemcitabine|gemcitabine|mesh-list
83637776|NCT01388621|Doxorubicin|doxorubicin|mesh-list
83637777|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83637778|NCT01388621|Panitumumab|panitumumab|mesh-list
83637779|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637780|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637781|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
83637782|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637783|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83637784|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83637785|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83637786|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637787|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637788|NCT01388660|Clopidogrel|clopidogrel|mesh-list
83637789|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83637790|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83637791|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83637792|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83637793|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
83637794|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637795|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637796|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637797|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
83637798|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83637799|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
83637800|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83637801|NCT01388738|Protective Agents|protective agents|mesh-ancestor
83637802|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637803|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
83637804|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83637805|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
83637806|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637807|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637808|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83637809|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
83637810|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83637811|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
83637812|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637813|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637814|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83637815|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
83637816|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
83637817|NCT01388842|Protective Agents|protective agents|mesh-ancestor
83637818|NCT01388855|Vitamin D|vitamin d|mesh-list
83637819|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
83637820|NCT01388855|Vitamins|vitamins|mesh-ancestor
82792096|NCT05836584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792097|NCT05836584|Immunologic Factors|immunologic factors|mesh-ancestor
82792098|NCT05836584|Antidotes|antidotes|mesh-ancestor
83637821|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
83637822|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637823|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83637824|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83637825|NCT01388959|Rituximab|rituximab|mesh-list
83637826|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637827|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637828|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
83637829|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637830|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83637831|NCT01389063|Maraviroc|maraviroc|mesh-list
83637832|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83637833|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83637834|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637835|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83637836|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83637837|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
83637838|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637839|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83637840|NCT01389167|Naltrexone|naltrexone|mesh-list
83637841|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83637842|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83637843|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637844|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
83637845|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637846|NCT01389193|Ibudilast|ibudilast|mesh-list
83637847|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83637848|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
83637849|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637850|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637851|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83637852|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
83637853|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83637854|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637855|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637856|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83637857|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
83637858|NCT01389206|Bosentan|bosentan|mesh-list
83637859|NCT01389206|Selexipag|selexipag|mesh-list
83637860|NCT01389206|Iloprost|iloprost|mesh-list
83637861|NCT01389206|Macitentan|macitentan|mesh-list
83637862|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83637863|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
83637864|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637865|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83637866|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637867|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83637868|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83637869|NCT01389271|Iloprost|iloprost|mesh-list
83637870|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83637871|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
83637872|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83637873|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83637874|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83637875|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
83637876|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637877|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83637878|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83637879|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637880|NCT01389401|Omeprazole|omeprazole|mesh-list
83637881|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83637882|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83637883|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83637884|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637885|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637886|NCT01389414|Gemcitabine|gemcitabine|mesh-list
83637887|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
83637888|NCT01389414|Panitumumab|panitumumab|mesh-list
83637889|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637890|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
83637891|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637892|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637893|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637894|NCT01389427|Sirolimus|sirolimus|mesh-list
83637895|NCT01389427|Prednisone|prednisone|mesh-list
83637896|NCT01389427|Temsirolimus|temsirolimus|mesh-list
83637897|NCT01389427|MTOR Inhibitors|mtor inhibitors|mesh-list
83637898|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
83637899|NCT01389427|Vincristine|vincristine|mesh-list
83637900|NCT01389427|Rituximab|rituximab|mesh-list
83637901|NCT01389427|Doxorubicin|doxorubicin|mesh-list
83637902|NCT01389427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83637903|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83527050|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
83637904|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637905|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83637906|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
83637907|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637908|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637909|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83637910|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637911|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83637912|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
83637913|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83637914|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83637915|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
83637916|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83637917|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83637918|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
83637919|NCT01389427|Hormones|hormones|mesh-ancestor
83637920|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637921|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83637922|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83637923|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83637924|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83637925|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83637926|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637927|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83637928|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83637929|NCT01389440|Gemcitabine|gemcitabine|mesh-list
83637930|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83637931|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83637932|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
83637933|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637934|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637935|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83637936|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637937|NCT01389505|Bevacizumab|bevacizumab|mesh-list
83637938|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83637939|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83637940|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83637941|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83637942|NCT01389505|Growth Substances|growth substances|mesh-ancestor
83637943|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637944|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
83637945|NCT01389544|Ritonavir|ritonavir|mesh-list
83637946|NCT01389544|Methadone|methadone|mesh-list
83637947|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83637948|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83637949|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
83637950|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83637951|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637952|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83637953|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83637954|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
83637955|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637956|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83637957|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82792251|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82792252|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82792253|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792254|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
82792255|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792256|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792257|NCT05696782|Durvalumab|durvalumab|mesh-list
82792258|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792259|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792260|NCT05696613|Rituximab|rituximab|mesh-list
82792261|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83637958|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83637960|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83637961|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637962|NCT01389544|Analgesics|analgesics|mesh-ancestor
83637963|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
83637964|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83637965|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
83637966|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
83637967|NCT01389557|Piperaquine|piperaquine|mesh-list
83637968|NCT01389557|Primaquine|primaquine|mesh-list
83637969|NCT01389557|Artenimol|artenimol|mesh-list
83637970|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
83637971|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83637972|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83637973|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83637974|NCT01389609|Doxazosin|doxazosin|mesh-list
83637975|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83637976|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83637977|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83637978|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83637979|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83637980|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83637981|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83637982|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637983|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83637984|NCT01389713|Clomiphene|clomiphene|mesh-list
83637985|NCT01389713|Enclomiphene|enclomiphene|mesh-list
83637986|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
83637987|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83637988|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
83637989|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83637990|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83637991|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83637992|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
83637993|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83637994|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83637995|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83637996|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
83637997|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83637998|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
83637999|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83638000|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83638001|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638002|NCT01389778|Metformin|metformin|mesh-list
83638003|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83638004|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638005|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
83638006|NCT01389791|Rocuronium|rocuronium|mesh-list
83638007|NCT01389791|Analgesics|analgesics|mesh-ancestor
83638008|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
83638009|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638010|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638011|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
83638012|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638013|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83638014|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
83638015|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83638016|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638017|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638018|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83638019|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
83638020|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83638021|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83638022|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83638023|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83638024|NCT01389908|Olanzapine|olanzapine|mesh-list
83638025|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
83638026|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
83638027|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638028|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638029|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638030|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83638031|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83638032|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638033|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83638034|NCT01389908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83638035|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83638036|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638037|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638038|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638039|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
83638040|NCT01390012|Dexamethasone|dexamethasone|mesh-list
83638041|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
83638042|NCT01390012|BB 1101|bb 1101|mesh-list
83638043|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638044|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
83638045|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
83638046|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638047|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638048|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638049|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
83638050|NCT01390012|Hormones|hormones|mesh-ancestor
83638051|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638052|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83638053|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638054|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
83638055|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638056|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638057|NCT01390051|Tinzaparin|tinzaparin|mesh-list
83638058|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83638059|NCT01390051|Dalteparin|dalteparin|mesh-list
83638060|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
83638061|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83638062|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83638063|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638064|NCT01390311|Azacitidine|azacitidine|mesh-list
83638065|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83638066|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
83638067|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638068|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638069|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638070|NCT01390324|Naproxen|naproxen|mesh-list
83638071|NCT01390324|Naratriptan|naratriptan|mesh-list
83638072|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83638073|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83638074|NCT01390324|Analgesics|analgesics|mesh-ancestor
83638075|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
83638076|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638077|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638078|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638079|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83638080|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
83638081|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83638082|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638083|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638084|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83638085|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83638086|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83638087|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
83638088|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638089|NCT01390337|Cytarabine|cytarabine|mesh-list
83638090|NCT01390337|Daunorubicin|daunorubicin|mesh-list
83638091|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83638092|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
82792399|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792400|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792401|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82792402|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82792403|NCT05480306|Growth Substances|growth substances|mesh-ancestor
82792404|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792405|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
82792406|NCT05465135|Artenimol|artenimol|mesh-list
82792407|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
82792408|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82792409|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82792410|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792411|NCT05425732|Vaccines|vaccines|mesh-list
82792412|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82792413|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
82792415|NCT05391061|Abrocitinib|abrocitinib|mesh-list
83638093|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638094|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638095|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
83638096|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638097|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638098|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
83638099|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638100|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83638101|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83638102|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83638103|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638104|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
83638105|NCT01390480|Vitamin D|vitamin d|mesh-list
83638106|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83638107|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638108|NCT01390480|Vitamins|vitamins|mesh-ancestor
83638109|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
83638110|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83638111|NCT01390506|Selenious Acid|selenious acid|mesh-list
83638112|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
83638113|NCT01390506|Trace Elements|trace elements|mesh-ancestor
83638114|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
83638115|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638116|NCT01390519|Everolimus|everolimus|mesh-list
83638117|NCT01390519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83638118|NCT01390519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83638119|NCT01390519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638120|NCT01390519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638121|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638122|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
83638123|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638124|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638125|NCT01390571|Temozolomide|temozolomide|mesh-list
83638126|NCT01390571|Olaparib|olaparib|mesh-list
83638127|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83638128|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
83638129|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638130|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638131|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83638132|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638133|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
83638134|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83638135|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638136|NCT01390662|Vitamin D|vitamin d|mesh-list
83638137|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
83638138|NCT01390662|Vitamins|vitamins|mesh-ancestor
83638139|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
83638140|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638141|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83638142|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83638143|NCT01390766|Azathioprine|azathioprine|mesh-list
83638144|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
83638145|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638146|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83638147|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638148|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638149|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
83638150|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638151|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83638152|NCT01390792|Zanamivir|zanamivir|mesh-list
83638153|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
83638154|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638155|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638156|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638157|NCT01390805|Valacyclovir|valacyclovir|mesh-list
83638158|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
83638159|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638160|NCT01390883|PENTA|penta|mesh-list
83638161|NCT01390883|Fondaparinux|fondaparinux|mesh-list
83638162|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83638163|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
83638164|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83638165|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
83638166|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638167|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638168|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
83638169|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83638170|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83638171|NCT01390896|PENTA|penta|mesh-list
83638172|NCT01390896|Fondaparinux|fondaparinux|mesh-list
83638173|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83638174|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
83638175|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83638176|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
83638177|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638178|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638179|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
83638180|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83638181|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83638182|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
83638183|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83638184|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83638185|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83638186|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638187|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638188|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
83638189|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638190|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638191|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83638192|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638193|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83638194|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
83638195|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638196|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638197|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83638198|NCT01390935|Diuretics|diuretics|mesh-ancestor
83638199|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
83638200|NCT01390961|Pheniramine|pheniramine|mesh-list
83638201|NCT01390961|Naphazoline|naphazoline|mesh-list
83638202|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638203|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83638204|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83638205|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83638206|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638207|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638208|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
83638209|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83638210|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
83638211|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83638212|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
83638213|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
83638214|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
83638215|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83638216|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83638217|NCT01391052|Norethindrone|norethindrone|mesh-list
83638218|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
83638219|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83638220|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83638221|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83638222|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
83638223|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83638224|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638225|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83638226|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83638227|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
83638228|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
83638229|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83638230|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83638231|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638232|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638233|NCT01391104|Urological Agents|urological agents|mesh-ancestor
83638234|NCT01391156|Minoxidil|minoxidil|mesh-list
83638235|NCT01391156|Finasteride|finasteride|mesh-list
83638236|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83638237|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
83638238|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83638239|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83638240|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638241|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638242|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
82792554|NCT05050136|Volixibat|volixibat|mesh-list
83834858|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83638243|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638244|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638245|NCT01391156|Urological Agents|urological agents|mesh-ancestor
83638246|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83638247|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83638248|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83638249|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638250|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638251|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638252|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638253|NCT01391221|Analgesics|analgesics|mesh-ancestor
83638254|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
83638255|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638256|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
83638257|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83638258|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
83638259|NCT01391260|Gefitinib|gefitinib|mesh-list
83638260|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638261|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83638262|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638263|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638264|NCT01391377|Niacin|niacin|mesh-list
83638265|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83638266|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
83638267|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638268|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83638269|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
83638270|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
83638271|NCT01391377|Vitamins|vitamins|mesh-ancestor
83638272|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
83638273|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638274|NCT01391390|Melatonin|melatonin|mesh-list
83638275|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
83638276|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638277|NCT01391390|Protective Agents|protective agents|mesh-ancestor
83638278|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638279|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638280|NCT01391403|Artemisinins|artemisinins|mesh-list
83638281|NCT01391403|Artemisinin|artemisinin|mesh-list
83638282|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
83638283|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83638284|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83638285|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638286|NCT01391520|Deferiprone|deferiprone|mesh-list
83638287|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83638288|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
83638289|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
83638290|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638291|NCT01391572|Fluorouracil|fluorouracil|mesh-list
83638292|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638293|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
83638294|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638295|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83638296|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638297|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
83638298|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638299|NCT01391598|Lidocaine|lidocaine|mesh-list
83638300|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
83638301|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
83638302|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638303|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638304|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
83638305|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638306|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83638307|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83638308|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83638309|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638310|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638311|NCT01391624|Mineral Oil|mineral oil|mesh-list
83638312|NCT01391624|Emollients|emollients|mesh-ancestor
83638313|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
83638314|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83638315|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83638316|NCT01391689|Protective Agents|protective agents|mesh-ancestor
83638317|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638318|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638320|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83638321|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638322|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83638323|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638324|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638325|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
83638326|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83638327|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
83638328|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83638329|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638330|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83638331|NCT01392014|Piperaquine|piperaquine|mesh-list
83638332|NCT01392014|Primaquine|primaquine|mesh-list
83638333|NCT01392014|Artenimol|artenimol|mesh-list
83638334|NCT01392014|Artemisinins|artemisinins|mesh-list
83638335|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
83638336|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83638337|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83638338|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638339|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
83638340|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83638341|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638342|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
83638343|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83638344|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
83638345|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638346|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638347|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83638348|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83638349|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83638350|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
83638351|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638352|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638353|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83638354|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
83638355|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
83638356|NCT01392144|Protective Agents|protective agents|mesh-ancestor
83638357|NCT01392157|Copper|copper|mesh-list
83638358|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
83638359|NCT01392157|Trace Elements|trace elements|mesh-ancestor
83638360|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
83638361|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638362|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83638363|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
83638364|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83638365|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83638366|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83638367|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83638368|NCT01392209|Bevacizumab|bevacizumab|mesh-list
83638369|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83638370|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638371|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83638372|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83638373|NCT01392209|Growth Substances|growth substances|mesh-ancestor
83638374|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638375|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
83638376|NCT01392287|Memantine|memantine|mesh-list
83638377|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83638378|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83638379|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
83638380|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638381|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638382|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638383|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83638384|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83638385|NCT01392430|Azithromycin|azithromycin|mesh-list
83638386|NCT01392430|Dapsone|dapsone|mesh-list
83638387|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83638388|NCT01392430|Itraconazole|itraconazole|mesh-list
83638389|NCT01392430|Fluconazole|fluconazole|mesh-list
83638390|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83638391|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638392|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
83638393|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83638394|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83638395|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638396|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638397|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83638398|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
83638399|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638400|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638401|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83638402|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83638403|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83638404|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
83638405|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83638406|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83638407|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83638408|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
83638409|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83638410|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83638411|NCT01392534|Telmisartan|telmisartan|mesh-list
83638412|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83638413|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83638414|NCT01392534|Diuretics|diuretics|mesh-ancestor
83638415|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
83638416|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638417|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83638418|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638419|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638420|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83638421|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83638422|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
83638423|NCT01392612|Hematinics|hematinics|mesh-ancestor
83638424|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
83638425|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
83638426|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83638427|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83638428|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638429|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638430|NCT01392638|Urological Agents|urological agents|mesh-ancestor
83638431|NCT01392716|Rituximab|rituximab|mesh-list
83638432|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83638433|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638434|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
83638435|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638436|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83638437|NCT01392755|Ritonavir|ritonavir|mesh-list
83638438|NCT01392755|Omeprazole|omeprazole|mesh-list
83638439|NCT01392755|Ranitidine|ranitidine|mesh-list
83638440|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83638441|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83638442|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83638443|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
83638444|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638445|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638446|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83638447|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83638448|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
83638449|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638450|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83638451|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83638452|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83638453|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638454|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83638455|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83638456|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
83361949|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
82792773|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82792774|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82792775|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792776|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792777|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82792778|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
82792779|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638457|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
83638458|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638459|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638460|NCT01392768|Levetiracetam|levetiracetam|mesh-list
83638461|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
83638462|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
83638463|NCT01392794|Ramosetron|ramosetron|mesh-list
83638464|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
83638465|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
83638466|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638467|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638468|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638469|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83638470|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
83638471|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638472|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638473|NCT01392807|Naloxegol|naloxegol|mesh-list
83638474|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83638475|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638476|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
83638477|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638478|NCT01392833|Prednisone|prednisone|mesh-list
83638479|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
83638480|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83638481|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83638482|NCT01392833|Prednisolone|prednisolone|mesh-list
83638483|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
83638484|NCT01392833|Azathioprine|azathioprine|mesh-list
83638485|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83638486|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
83638487|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638488|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
83638489|NCT01392833|Hormones|hormones|mesh-ancestor
83638490|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638491|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638492|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83638493|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638494|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
83638495|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
83638496|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638497|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638498|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83638499|NCT01392833|Protective Agents|protective agents|mesh-ancestor
83638500|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
83638501|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638502|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83638503|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638504|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
83638505|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83638506|NCT01392898|Liraglutide|liraglutide|mesh-list
83638507|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83638508|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638509|NCT01392898|Incretins|incretins|mesh-ancestor
83638510|NCT01392898|Hormones|hormones|mesh-ancestor
83638511|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638512|NCT01392911|Rifampin|rifampin|mesh-list
83638513|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83638514|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
83638515|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83638516|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638517|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
83638518|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83638519|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638520|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638521|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83638522|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83638523|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83638524|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83638525|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83638526|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83638527|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
83638528|NCT01393080|Cisplatin|cisplatin|mesh-list
83638529|NCT01393080|Paclitaxel|paclitaxel|mesh-list
83638530|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83638531|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792848|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
83638532|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83638533|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83638534|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83638535|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83638536|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638537|NCT01393145|Fluticasone|fluticasone|mesh-list
83638538|NCT01393145|Xhance|xhance|mesh-list
83638539|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
83638540|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83638541|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83638542|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638543|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83638544|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
83638545|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638546|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638547|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83638548|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
83638549|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83638550|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83638551|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83638552|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83638553|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83638554|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83638555|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638556|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638557|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
83638558|NCT01393145|Hormones|hormones|mesh-ancestor
83638559|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638560|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
83638561|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
83638562|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83638563|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638564|NCT01393288|Lorazepam|lorazepam|mesh-list
83638565|NCT01393288|Ondansetron|ondansetron|mesh-list
83638566|NCT01393288|Aprepitant|aprepitant|mesh-list
83638567|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
83638568|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
83638569|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638570|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638571|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638572|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
83638573|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
83638574|NCT01393288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83638575|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83638576|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
83638577|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638578|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638579|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83638580|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
83638581|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83638582|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638583|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83638584|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83638585|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83638586|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
83638587|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
83638588|NCT01393340|Omalizumab|omalizumab|mesh-list
83638589|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83638590|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83638591|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
83638592|NCT01393548|Brompheniramine|brompheniramine|mesh-list
83638593|NCT01393548|Phenylephrine|phenylephrine|mesh-list
83638594|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
83638595|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
83638596|NCT01393548|Ephedrine|ephedrine|mesh-list
83638597|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83638598|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
83638599|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
83638600|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638601|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638602|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
83638603|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83638604|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
83638605|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
83638606|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83638607|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83638608|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83638609|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
83638610|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638611|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638612|NCT01393548|Protective Agents|protective agents|mesh-ancestor
83638613|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83638614|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83638615|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83638616|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83638617|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
83638618|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
83638619|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83638620|NCT01393574|Melatonin|melatonin|mesh-list
83638621|NCT01393574|Methylphenidate|methylphenidate|mesh-list
83638622|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
83638623|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638624|NCT01393574|Protective Agents|protective agents|mesh-ancestor
83638625|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638626|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638627|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83638628|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83638629|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83638630|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638631|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
83638632|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638633|NCT01393756|Lenalidomide|lenalidomide|mesh-list
83638634|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
83638635|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638636|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83638637|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83638638|NCT01393756|Growth Substances|growth substances|mesh-ancestor
83638639|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
83638640|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638641|NCT01393769|Melphalan|melphalan|mesh-list
83638642|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83638643|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
83638644|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638645|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638646|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83638647|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638648|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
83638649|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638650|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
83638651|NCT01393782|Giapreza|giapreza|mesh-list
83638652|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
83638653|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83638654|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83638655|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
83638656|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638657|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638658|NCT01393795|Capsaicin|capsaicin|mesh-list
83638659|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
83638660|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
83638661|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
83638662|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638663|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638664|NCT01393912|Crenolanib|crenolanib|mesh-list
83638665|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638666|NCT01393925|Parecoxib|parecoxib|mesh-list
83638667|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83638668|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83638669|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638670|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638671|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83638672|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83638673|NCT01393925|Analgesics|analgesics|mesh-ancestor
83638674|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
83638675|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638676|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638677|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638678|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83638679|NCT01394029|Deferasirox|deferasirox|mesh-list
83638680|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83638681|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
83638682|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
83834859|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638683|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638684|NCT01394094|Calcium|calcium|mesh-list
83638685|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83638686|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638687|NCT01394133|Ritonavir|ritonavir|mesh-list
83638688|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83638689|NCT01394133|Tenofovir|tenofovir|mesh-list
83638690|NCT01394133|Emtricitabine|emtricitabine|mesh-list
83638691|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83638692|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83638693|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83638694|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638695|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638696|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83638697|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83638698|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
83638699|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638700|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83638701|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83638702|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83638703|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83638704|NCT01394224|Levetiracetam|levetiracetam|mesh-list
83638705|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
83638706|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
83638707|NCT01394263|Goserelin|goserelin|mesh-list
83638708|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83638709|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638710|NCT01394341|Liraglutide|liraglutide|mesh-list
83638711|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83638712|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638713|NCT01394341|Incretins|incretins|mesh-ancestor
83638714|NCT01394341|Hormones|hormones|mesh-ancestor
83638715|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638716|NCT01394354|Dexamethasone|dexamethasone|mesh-list
83638717|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
83638718|NCT01394354|Doxorubicin|doxorubicin|mesh-list
83638719|NCT01394354|Bortezomib|bortezomib|mesh-list
83638720|NCT01394354|Vorinostat|vorinostat|mesh-list
83638721|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638722|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
83638723|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
83638724|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638725|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638726|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638727|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
83638728|NCT01394354|Hormones|hormones|mesh-ancestor
83638729|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638730|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83638731|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638732|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83638733|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83638734|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83638735|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638736|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638737|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83638738|NCT01394406|Ketamine|ketamine|mesh-list
83638739|NCT01394406|Analgesics|analgesics|mesh-ancestor
83638740|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
83638741|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638742|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638743|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83638744|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83638745|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
83638746|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
83638747|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638748|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83638749|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83638750|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638751|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638752|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
83638753|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83638754|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
83638755|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638756|NCT01394419|Expectorants|expectorants|mesh-ancestor
82793075|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
83638757|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
83638758|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83638759|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
83638760|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638761|NCT01394419|Protective Agents|protective agents|mesh-ancestor
83638762|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638763|NCT01394419|Antidotes|antidotes|mesh-ancestor
83638764|NCT01394445|Physostigmine|physostigmine|mesh-list
83638765|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83638766|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638767|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638768|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83638769|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638770|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638771|NCT01394445|Miotics|miotics|mesh-ancestor
83638772|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
83638773|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638774|NCT01394458|Ethanol|ethanol|mesh-list
83638775|NCT01394458|Heparin|heparin|mesh-list
83638776|NCT01394458|Citric Acid|citric acid|mesh-list
83638777|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
83638778|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
83638779|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83638780|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
83638781|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
83638782|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638783|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83638784|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83638785|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83638786|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638787|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638788|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638789|NCT01394471|Oxytocin|oxytocin|mesh-list
83638790|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
83638791|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83638792|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638793|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
83638794|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
83638795|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638796|NCT01394497|Expectorants|expectorants|mesh-ancestor
83638797|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
83638798|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83638799|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
83638800|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638801|NCT01394497|Protective Agents|protective agents|mesh-ancestor
83638802|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638803|NCT01394640|Vaccines|vaccines|mesh-list
83638804|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
83638805|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638806|NCT01394653|Ramosetron|ramosetron|mesh-list
83638807|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
83638808|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
83638809|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638810|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638811|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638812|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83638813|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
83638814|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638815|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638816|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
83638817|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638818|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
83638819|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
83638820|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638821|NCT01394731|Acetaminophen|acetaminophen|mesh-list
83638822|NCT01394731|Meperidine|meperidine|mesh-list
83638823|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83638824|NCT01394731|Analgesics|analgesics|mesh-ancestor
83638825|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
83638826|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638827|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638828|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
83638829|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82793149|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
83638830|NCT01394731|Narcotics|narcotics|mesh-ancestor
83638831|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638832|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83638833|NCT01394757|Ketamine|ketamine|mesh-list
83638834|NCT01394757|Esketamine|esketamine|mesh-list
82793223|NCT03735563|Narcotics|narcotics|mesh-ancestor
83638835|NCT01394757|Analgesics|analgesics|mesh-ancestor
83638836|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
83638837|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638838|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638839|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83638840|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83638841|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
83638842|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
83638843|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638844|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83638845|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83638846|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638847|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638848|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
83638849|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83638850|NCT01394770|Amlodipine|amlodipine|mesh-list
83638851|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83638852|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83638853|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638854|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638855|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83638856|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638857|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
83638858|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83638859|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
83638860|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638861|NCT01394796|Protective Agents|protective agents|mesh-ancestor
83638862|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638863|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83638864|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83638865|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638866|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83638867|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83638868|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
83638869|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83638870|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83638871|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
83638872|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638873|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638874|NCT01394848|Everolimus|everolimus|mesh-list
83638875|NCT01394848|Clopidogrel|clopidogrel|mesh-list
83638876|NCT01394848|Atorvastatin|atorvastatin|mesh-list
83638877|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83638878|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83638879|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
83638880|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638881|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83638882|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83638883|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638884|NCT01394848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83638885|NCT01394848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83638886|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638887|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
83638888|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638889|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638890|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83638891|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83638892|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83638893|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83638894|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
83638895|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793224|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82793225|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
82793226|NCT03735095|Trioxsalen|trioxsalen|mesh-list
82793227|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793228|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
82793229|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82793230|NCT03715153|Bumetanide|bumetanide|mesh-list
82793231|NCT03715153|Diuretics|diuretics|mesh-ancestor
82793232|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
82793233|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793234|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83638896|NCT01394887|Metformin|metformin|mesh-list
83638897|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83638898|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638899|NCT01394913|Etanercept|etanercept|mesh-list
83638900|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83638901|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83638902|NCT01394913|Analgesics|analgesics|mesh-ancestor
83638903|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
83638904|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638905|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638906|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638907|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83638908|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83638909|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83638910|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
83638911|NCT01395069|Ketorolac|ketorolac|mesh-list
83638912|NCT01395069|Nepafenac|nepafenac|mesh-list
83638913|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83638914|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83638915|NCT01395069|Analgesics|analgesics|mesh-ancestor
83638916|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
83638917|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83638918|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638919|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638920|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83638921|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83638922|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638923|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638924|NCT01395108|Nemonoxacin|nemonoxacin|mesh-list
83638925|NCT01395108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83638926|NCT01395108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638927|NCT01395147|Vortioxetine|vortioxetine|mesh-list
83638928|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
83638929|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83638930|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83638931|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83638932|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83638933|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638934|NCT01395147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83638935|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83638936|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638937|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638938|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638939|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
83638940|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83638941|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83638942|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83638943|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83638944|NCT01395199|Amlodipine|amlodipine|mesh-list
83638945|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83638946|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83638947|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638948|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638949|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83638950|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638951|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
83638952|NCT01395251|Prednisolone|prednisolone|mesh-list
83638953|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
83638954|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83638955|NCT01395251|Hormones|hormones|mesh-ancestor
83638956|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83638957|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638958|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83638959|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638960|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
83638961|NCT01395290|Vitamin D|vitamin d|mesh-list
83638962|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83638963|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638964|NCT01395290|Vitamins|vitamins|mesh-ancestor
83638965|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
83638966|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82793300|NCT03569293|Upadacitinib|upadacitinib|mesh-list
83638967|NCT01395381|Albendazole|albendazole|mesh-list
82793303|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638968|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
83638969|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83638970|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638971|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
83638972|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83638973|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83638974|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
83638975|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
83638976|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
83638977|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638978|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83638980|NCT01395420|Avibactam|avibactam|mesh-list
83638981|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83638982|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83638983|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83638984|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83638985|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638986|NCT01395433|Dexetimide|dexetimide|mesh-list
83638987|NCT01395433|Citalopram|citalopram|mesh-list
83638988|NCT01395433|Escitalopram|escitalopram|mesh-list
83638989|NCT01395433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83638990|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83638991|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83638992|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83638993|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83638994|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
83638995|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83638996|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83638997|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83638998|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
83638999|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
83639000|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639001|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83639002|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83639003|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
83639004|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83639005|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
83639006|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639007|NCT01395485|Brodalumab|brodalumab|mesh-list
83639008|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
83639009|NCT01395589|Vitamin D|vitamin d|mesh-list
83639010|NCT01395589|Vitamins|vitamins|mesh-ancestor
83639011|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
83639012|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639013|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83639014|NCT01395602|Cabergoline|cabergoline|mesh-list
83639015|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83639016|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83639017|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
83639018|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
83639019|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639020|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639021|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639022|NCT01395654|Rifampin|rifampin|mesh-list
83639023|NCT01395654|Isoniazid|isoniazid|mesh-list
83639024|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
83639025|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83639026|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
83639027|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83639028|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639029|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
83639030|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83639031|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639032|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639033|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83639034|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83639035|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83639036|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83639037|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83639038|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83639039|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83639040|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83639041|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
82793431|NCT03039413|Copper|copper|mesh-list
83639042|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83639043|NCT01395667|Leucovorin|leucovorin|mesh-list
83639044|NCT01395667|Fluorouracil|fluorouracil|mesh-list
83639045|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
83639046|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639047|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639048|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
83639049|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639050|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639051|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639052|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
83639053|NCT01395667|Antidotes|antidotes|mesh-ancestor
83639054|NCT01395667|Protective Agents|protective agents|mesh-ancestor
83639055|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
83639056|NCT01395667|Vitamins|vitamins|mesh-ancestor
83639057|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
83639058|NCT01395732|Bosentan|bosentan|mesh-list
83639059|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83639060|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83639061|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639062|NCT01395849|Fluticasone|fluticasone|mesh-list
83639063|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83639064|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83639065|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639066|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83639067|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
83639068|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639069|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639070|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83639071|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
83639072|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83639073|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83639074|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83639075|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83639076|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83639077|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
83639078|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639079|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639080|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
83639081|NCT01395849|Hormones|hormones|mesh-ancestor
83639082|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639083|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
83639084|NCT01395862|Fluticasone|fluticasone|mesh-list
83639085|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83639086|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83639087|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639088|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83639089|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
83639090|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639091|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639092|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83639093|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
83639094|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
83639095|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83639096|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83639097|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83639098|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83639099|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
83639100|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639101|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639102|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
83639103|NCT01395862|Hormones|hormones|mesh-ancestor
83639104|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639105|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
83639106|NCT01395875|Fluticasone|fluticasone|mesh-list
83639108|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83639109|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83639110|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639111|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83639112|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
83639113|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639114|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639115|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83639116|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
83639117|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83639118|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83639119|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83639120|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83639121|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83639122|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
83639123|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639124|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639125|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
83639127|NCT01395927|Rifampin|rifampin|mesh-list
83639128|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83639129|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
83639130|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83639131|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639132|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
83639133|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83639134|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639135|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639136|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83639137|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83639138|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83639139|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83639140|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83639141|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83639142|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83639143|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83639144|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639145|NCT01395953|Buspirone|buspirone|mesh-list
83639146|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83639147|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83639148|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639149|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639150|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639151|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83639152|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
83639153|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639154|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639155|NCT01395992|Asenapine|asenapine|mesh-list
83639156|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83639157|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83639158|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639159|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639160|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639161|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
83639162|NCT01396200|Sirolimus|sirolimus|mesh-list
83639163|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
83639164|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83639165|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83639166|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639167|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639168|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639169|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639170|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83639171|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83639172|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639173|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
83639174|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639175|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
83639176|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639177|NCT01396291|Asenapine|asenapine|mesh-list
83639178|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83639179|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83639180|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639181|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639182|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639183|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83639184|NCT01396304|Calcium|calcium|mesh-list
83639185|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83639186|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639187|NCT01396304|Laxatives|laxatives|mesh-ancestor
83639188|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639189|NCT01396564|Metformin|metformin|mesh-list
83639190|NCT01396564|Pioglitazone|pioglitazone|mesh-list
83639191|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83639192|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639193|NCT01396642|Emollients|emollients|mesh-list
83639194|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
83639195|NCT01396655|Docetaxel|docetaxel|mesh-list
83639196|NCT01396655|Doxorubicin|doxorubicin|mesh-list
83639197|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639198|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83639199|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83639200|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83639201|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639202|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83639203|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83639204|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83639205|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639206|NCT01396668|Gemcitabine|gemcitabine|mesh-list
83639207|NCT01396668|Capecitabine|capecitabine|mesh-list
83639208|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639209|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639210|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
83639211|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639212|NCT01396681|Gemcitabine|gemcitabine|mesh-list
83639213|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639214|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639215|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
83639216|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639217|NCT01396707|Capecitabine|capecitabine|mesh-list
83639218|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
83639219|NCT01396707|Trastuzumab|trastuzumab|mesh-list
83639220|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639221|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
83639222|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639223|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639224|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639225|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
83639226|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83639227|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83639228|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639229|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639230|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639231|NCT01396720|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83639232|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83639233|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83639234|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639235|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639236|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
83639237|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83639238|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
83639239|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83639240|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83639241|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639242|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83639243|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
83639244|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
83639245|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639246|NCT01396733|Protective Agents|protective agents|mesh-ancestor
83639247|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639248|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
83639249|NCT01396733|Vitamins|vitamins|mesh-ancestor
83639250|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
83639251|NCT01397006|Pregabalin|pregabalin|mesh-list
83639252|NCT01397006|Analgesics|analgesics|mesh-ancestor
83639253|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
83639254|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639255|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639256|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
83639257|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83639258|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83639259|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639260|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83639261|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83639262|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83639263|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639264|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639266|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
83639267|NCT01397019|Irinotecan|irinotecan|mesh-list
83639268|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639269|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83639270|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83639271|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639272|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639273|NCT01397019|Antidotes|antidotes|mesh-ancestor
83639274|NCT01397019|Protective Agents|protective agents|mesh-ancestor
83639275|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639276|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
83639277|NCT01397019|Vitamins|vitamins|mesh-ancestor
83639278|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
83639279|NCT01397097|Etonogestrel|etonogestrel|mesh-list
83639280|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83639281|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
83639282|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83639283|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639284|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83639285|NCT01397175|Everolimus|everolimus|mesh-list
83639286|NCT01397175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83639287|NCT01397175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83639288|NCT01397175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639289|NCT01397175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639290|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639291|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
83639292|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639293|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639294|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
83639295|NCT01397214|Megestrol|megestrol|mesh-list
83639296|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83639297|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639298|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
83639299|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83639300|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639301|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83639302|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83639303|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83639304|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
83639305|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83639306|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83639307|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83639308|NCT01397305|Pemetrexed|pemetrexed|mesh-list
83639309|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639310|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639311|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639312|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83639313|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83639314|NCT01397331|Propofol|propofol|mesh-list
83639315|NCT01397331|Isoflurane|isoflurane|mesh-list
83639316|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83639317|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639318|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639319|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83639320|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
83639321|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
83639322|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83639323|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
83639324|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
83639325|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639326|NCT05268835|Clindamycin|clindamycin|mesh-list
83639327|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83639328|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639329|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83639330|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639331|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639332|NCT05268718|Voriconazole|voriconazole|mesh-list
83639333|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83639334|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83639335|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
83639336|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639337|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83639338|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83639339|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639340|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639341|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83639342|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
83639343|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639344|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639345|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83639346|NCT05268627|Liraglutide|liraglutide|mesh-list
83639347|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83639348|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639349|NCT05268627|Incretins|incretins|mesh-ancestor
83639350|NCT05268627|Hormones|hormones|mesh-ancestor
83639351|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639352|NCT05268601|Sotrovimab|sotrovimab|mesh-list
83639353|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
83639354|NCT05268601|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83639355|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
83639356|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639357|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83639358|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
83639359|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639360|NCT05267977|Cephalosporins|cephalosporins|mesh-list
83639361|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83639362|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639363|NCT05186558|Rituximab|rituximab|mesh-list
83639364|NCT05186558|Gemcitabine|gemcitabine|mesh-list
83639365|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
83639366|NCT05186558|Lenalidomide|lenalidomide|mesh-list
83639367|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639368|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639369|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
83639370|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639371|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639372|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639373|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
83639374|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639375|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83639376|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83639377|NCT05186558|Growth Substances|growth substances|mesh-ancestor
83639378|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
83639379|NCT05092698|Vitamin D|vitamin d|mesh-list
83639380|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
83639381|NCT05092698|Vitamins|vitamins|mesh-ancestor
83639382|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
83639383|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639384|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83639385|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83639386|NCT04975269|Acetazolamide|acetazolamide|mesh-list
83639387|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
83639388|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83639389|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639390|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639391|NCT04975269|Diuretics|diuretics|mesh-ancestor
83639392|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
83639393|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639394|NCT04965870|Trifluridine|trifluridine|mesh-list
83639395|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
83639396|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639397|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
83639398|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639399|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83639400|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
83639401|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
83639402|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639403|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639404|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
83639405|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639406|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83639407|NCT04604353|Calcium|calcium|mesh-list
83639408|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83639409|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639410|NCT04500756|Metformin|metformin|mesh-list
83639411|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83639412|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639413|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
83639414|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
83639416|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83639417|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639418|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639419|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639420|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639421|NCT04453449|Midazolam|midazolam|mesh-list
83639422|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83639423|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83639424|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639425|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639426|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83639427|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83639428|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639429|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83639430|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
83639431|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
83639432|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
83639433|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
83639434|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639435|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639436|NCT04415333|Butyric Acid|butyric acid|mesh-list
83639437|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
83639438|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
83639439|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639440|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639441|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639442|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
83639443|NCT04093596|Fludarabine|fludarabine|mesh-list
83639444|NCT04093596|Nirogacestat|nirogacestat|mesh-list
83639445|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639446|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
83639447|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639448|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639449|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83639450|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
83639451|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639452|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639453|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83639454|NCT04093596|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83639455|NCT04093596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639456|NCT03524170|Atezolizumab|atezolizumab|mesh-list
83639457|NCT03524170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83639458|NCT03524170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639459|NCT03524170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639460|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639461|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
83639462|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83639463|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639464|NCT03283813|Inositol|inositol|mesh-list
83639465|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
83639466|NCT03283813|Vitamins|vitamins|mesh-ancestor
83639467|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
83639468|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639469|NCT03283384|Letrozole|letrozole|mesh-list
83639470|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639471|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83639472|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83639473|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639474|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639475|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83639476|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
83639477|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639478|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639479|NCT03245827|Clomiphene|clomiphene|mesh-list
83639480|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83639481|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
82793834|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793835|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82793836|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82793837|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
82793838|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82793839|NCT00423735|Dasatinib|dasatinib|mesh-list
82793840|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639482|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639483|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639484|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83639485|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
83639486|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83639487|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83639488|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83639489|NCT03129321|Econazole|econazole|mesh-list
83639490|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
83639491|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639492|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83639493|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83639494|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639495|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639496|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83639497|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83639498|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639499|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639500|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
83639501|NCT03107611|Tacrolimus|tacrolimus|mesh-list
83639502|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83639503|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83639504|NCT03107611|Analgesics|analgesics|mesh-ancestor
83639505|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
83639506|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639507|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639508|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639509|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639510|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83639511|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639512|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
83639513|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83639514|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639515|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639516|NCT03040726|Palonosetron|palonosetron|mesh-list
83639517|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
83639518|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
83639519|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639520|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639521|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639522|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83639523|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83639524|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
83639525|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639526|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639527|NCT02607956|Dolutegravir|dolutegravir|mesh-list
83639528|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83639529|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83639530|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83639531|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639532|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639533|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83639534|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83639535|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
83639536|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639537|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83639538|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83639539|NCT02564523|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83639540|NCT02564523|Antiviral Agents|antiviral agents|mesh-ancestor
83639541|NCT02564523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639542|NCT02499666|Clopidogrel|clopidogrel|mesh-list
83639543|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83639544|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83639545|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83639546|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83639547|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
83639548|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639549|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639550|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639551|NCT02420912|Nivolumab|nivolumab|mesh-list
83639552|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639554|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83639555|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639556|NCT02094716|Permethrin|permethrin|mesh-list
83639557|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639558|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639559|NCT01460810|Silicon|silicon|mesh-list
83639560|NCT01460810|Trace Elements|trace elements|mesh-ancestor
83639561|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
83639562|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639563|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
83639564|NCT00667329|Rituximab|rituximab|mesh-list
83639565|NCT00667329|Cladribine|cladribine|mesh-list
83639566|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639567|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
83639568|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639569|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639570|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83639571|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
83639572|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639573|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639574|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83639575|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639576|NCT00492167|Antibodies|antibodies|mesh-list
83639577|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83639578|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
83639579|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639580|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
83639581|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639582|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83639583|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639584|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639585|NCT05274191|Maleic acid|maleic acid|mesh-list
83639586|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639587|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639588|NCT05274139|Cytarabine|cytarabine|mesh-list
83639589|NCT05274139|Dexamethasone|dexamethasone|mesh-list
83639590|NCT05274139|Temozolomide|temozolomide|mesh-list
83639591|NCT05274139|Fotemustine|fotemustine|mesh-list
83639592|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639593|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
83639594|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
83639595|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639596|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639597|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639598|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
83639599|NCT05274139|Hormones|hormones|mesh-ancestor
83639600|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639601|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83639602|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639603|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639604|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639605|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
83639606|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
83639607|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639608|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639609|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
83639610|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83639611|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
83639612|NCT05274113|Dexamethasone|dexamethasone|mesh-list
83639613|NCT05274113|Ropivacaine|ropivacaine|mesh-list
83639614|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639615|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
83639616|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
83639617|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639618|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639619|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639620|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
83639621|NCT05274113|Hormones|hormones|mesh-ancestor
83639622|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639623|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83639624|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639625|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
83639626|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
82793985|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639627|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639628|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
83639629|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83639630|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
83639631|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639632|NCT05273944|Doxorubicin|doxorubicin|mesh-list
83639633|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83639634|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83639635|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639636|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83639637|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83639638|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639639|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639640|NCT05273528|Vaccines|vaccines|mesh-list
83639641|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
83639642|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639643|NCT05273398|Diazepam|diazepam|mesh-list
83639644|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83639645|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
83639646|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
83639647|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
83639648|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639649|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639650|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639651|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83639652|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639653|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83639654|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83639655|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83639656|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83639657|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83639658|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83639659|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
83639660|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
83639661|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
83639662|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
83639663|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639664|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639665|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83639666|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639667|NCT05272462|Minoxidil|minoxidil|mesh-list
83639668|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83639669|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
83639670|NCT05272371|Dinutuximab|dinutuximab|mesh-list
83639671|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639672|NCT05271539|Dexamethasone|dexamethasone|mesh-list
83639673|NCT05271539|Ranibizumab|ranibizumab|mesh-list
83639674|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639675|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
83639676|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
83639677|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639678|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639679|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639680|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
83639681|NCT05271539|Hormones|hormones|mesh-ancestor
83639682|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639683|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83639684|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639685|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83639686|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83639687|NCT05271539|Growth Substances|growth substances|mesh-ancestor
83639688|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
83639689|NCT05271370|Leronlimab|leronlimab|mesh-list
83639690|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
83639691|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83639692|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83639693|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639694|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83639695|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83639696|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
83639697|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639698|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
83639699|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639700|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
83639701|NCT05271253|Bupivacaine|bupivacaine|mesh-list
83639702|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
82794090|NCT00824135|Rituximab|rituximab|mesh-list
83639703|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
83639704|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639705|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639706|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
83639707|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639708|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83639709|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83639710|NCT05271253|Analgesics|analgesics|mesh-ancestor
83639711|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83639712|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83639713|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83639714|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83639715|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639716|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639717|NCT05271188|Anesthetics|anesthetics|mesh-list
83639718|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
83639719|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639720|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639721|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
83639722|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639723|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
83639724|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83639725|NCT05271136|Protective Agents|protective agents|mesh-ancestor
83639726|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639727|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
83639728|NCT05271058|Dexamethasone|dexamethasone|mesh-list
83639729|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
83639730|NCT05271058|Triamcinolone|triamcinolone|mesh-list
83639731|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83639732|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83639733|NCT05271058|BB 1101|bb 1101|mesh-list
83639734|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83639735|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639736|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
83639737|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
83639738|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639739|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639740|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639741|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
83639742|NCT05271058|Hormones|hormones|mesh-ancestor
83639743|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639744|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83639745|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639746|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
83639747|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639748|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639749|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639750|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
83639751|NCT05271045|Vitamin D|vitamin d|mesh-list
83639752|NCT05271045|Vitamin A|vitamin a|mesh-list
83639753|NCT05271045|Vitamins|vitamins|mesh-ancestor
83639754|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
83639755|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639756|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83639757|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83639758|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83639759|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639760|NCT05270889|Tislelizumab|tislelizumab|mesh-list
83639761|NCT05270889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639762|NCT05270889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639763|NCT05270824|Immunomodulating Agents|immunomodulating agents|mesh-list
83639764|NCT05270824|Immunologic Factors|immunologic factors|mesh-ancestor
83639765|NCT05270824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639766|NCT05270434|Dipyrone|dipyrone|mesh-list
83639767|NCT05270434|Meperidine|meperidine|mesh-list
83639768|NCT05270434|Morphine|morphine|mesh-list
83639769|NCT05270434|Buprenorphine|buprenorphine|mesh-list
83639770|NCT05270434|Analgesics|analgesics|mesh-list
83639771|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83639772|NCT05270434|Narcotics|narcotics|mesh-ancestor
83639773|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639774|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639775|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
83639776|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639777|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83639778|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83639779|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83639780|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83639781|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639782|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639783|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
83639784|NCT05270421|Furosemide|furosemide|mesh-list
83639785|NCT05270421|Diuretics|diuretics|mesh-ancestor
83639786|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
83639787|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639788|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83639789|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83639790|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639791|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
83639792|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83639793|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639794|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
83639795|NCT05270343|Vitamin D|vitamin d|mesh-list
83639796|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83639797|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639798|NCT05270343|Vitamins|vitamins|mesh-ancestor
83639799|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
83639800|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83639801|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
83639802|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83639803|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
83639804|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639805|NCT05269654|Mannitol|mannitol|mesh-list
83639806|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83639807|NCT05269654|Diuretics|diuretics|mesh-ancestor
83639808|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
83639809|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639810|NCT05253846|Fluorouracil|fluorouracil|mesh-list
83639811|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
83639812|NCT05253846|Irinotecan|irinotecan|mesh-list
83639813|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
83639814|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639815|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639816|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639817|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83639818|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
83639819|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639820|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83639821|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83639822|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639823|NCT05250141|Levodopa|levodopa|mesh-list
83639824|NCT05250141|Carbidopa|carbidopa|mesh-list
83639825|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83639826|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83639827|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
83639828|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639829|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639830|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639831|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83639832|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639833|NCT05248724|Ketorolac|ketorolac|mesh-list
83639834|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83639835|NCT05248724|Epinephrine|epinephrine|mesh-list
83639836|NCT05248724|Racepinephrine|racepinephrine|mesh-list
83639837|NCT05248724|Morphine|morphine|mesh-list
83639838|NCT05248724|Ropivacaine|ropivacaine|mesh-list
83639839|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
83639840|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83639841|NCT05248724|Narcotics|narcotics|mesh-ancestor
83639842|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639843|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639844|NCT05248724|Analgesics|analgesics|mesh-ancestor
83639845|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
83639846|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639847|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
83639848|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
83639849|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83639850|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83639851|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639852|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83639853|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83639854|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639855|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639856|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83639857|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83639858|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
83639859|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639860|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83639861|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83639862|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
83639863|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83639864|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
83639865|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
83639866|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
83639867|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83639868|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
83639869|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639870|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639871|NCT05235737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83639872|NCT05235737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639873|NCT05232006|Niraparib|niraparib|mesh-list
83639874|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83639875|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639876|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639877|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639878|NCT05209841|Heparin|heparin|mesh-list
83639879|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
83639880|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83639881|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83639882|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639883|NCT05173142|Gemcitabine|gemcitabine|mesh-list
83639884|NCT05173142|Docetaxel|docetaxel|mesh-list
83639885|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639886|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83639887|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
83639888|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639889|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
83639890|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
83639891|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
83639892|NCT05166746|Clindamycin|clindamycin|mesh-list
83639893|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
83639894|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
83639895|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83639896|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83639897|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83639898|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639899|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639900|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
83639901|NCT05165875|Lidocaine|lidocaine|mesh-list
83639902|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
83639903|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
83639904|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639905|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639906|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
83639907|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639908|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83639909|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83639910|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83639911|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83639912|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639913|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639914|NCT05162118|Nivolumab|nivolumab|mesh-list
83639915|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639916|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639917|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83639918|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639919|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
83639920|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83639921|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639922|NCT05142267|Oxycodone|oxycodone|mesh-list
83639923|NCT05142267|Naloxone|naloxone|mesh-list
83639924|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83639925|NCT05142267|Narcotics|narcotics|mesh-ancestor
83639926|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83639927|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639928|NCT05142267|Analgesics|analgesics|mesh-ancestor
82794286|NCT02549105|Lidocaine|lidocaine|mesh-list
83639929|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
83639930|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639931|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83639932|NCT05138029|Dexamethasone|dexamethasone|mesh-list
83639933|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
83639934|NCT05138029|Ranibizumab|ranibizumab|mesh-list
83639935|NCT05138029|BB 1101|bb 1101|mesh-list
83639936|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83639937|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
83639938|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
83639939|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83639940|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639941|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639942|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
83639943|NCT05138029|Hormones|hormones|mesh-ancestor
83639944|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83639945|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83639946|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639947|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
83639948|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639949|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639950|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83639951|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83639952|NCT05138029|Growth Substances|growth substances|mesh-ancestor
83639953|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
83639954|NCT05135039|Canagliflozin|canagliflozin|mesh-list
83639955|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83639956|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639957|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83639958|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639959|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
83639960|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83639961|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
83639962|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83639963|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
83639964|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639965|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639966|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
83639967|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
83639968|NCT05088928|Apixaban|apixaban|mesh-list
83639969|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83639970|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
83639971|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83639972|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
83639973|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639974|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639975|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
83639976|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
83639977|NCT05075122|Sargramostim|sargramostim|mesh-list
83639978|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83639979|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83639980|NCT05075122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83639981|NCT05075122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639982|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
83639983|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639984|NCT05067439|Efavirenz|efavirenz|mesh-list
83639985|NCT05067439|Caffeine|caffeine|mesh-list
83639986|NCT05067439|Omeprazole|omeprazole|mesh-list
83639987|NCT05067439|Abrocitinib|abrocitinib|mesh-list
83639988|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83639989|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83639990|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83639991|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83639992|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83639993|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83639994|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83639995|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
83639996|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83639997|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83639998|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83639999|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83640000|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83640001|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83640002|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
83640003|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640004|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83640005|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83640006|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83640007|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83640008|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83640009|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83640010|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640012|NCT05064137|Fluorides|fluorides|mesh-list
83640013|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
83640014|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
83640015|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
83640016|NCT05064137|Protective Agents|protective agents|mesh-ancestor
83640017|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640018|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83640019|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640020|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
83640021|NCT05052528|Rituximab|rituximab|mesh-list
83640022|NCT05052528|Fludarabine|fludarabine|mesh-list
83640023|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
83640024|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83640025|NCT05052528|Antibodies|antibodies|mesh-list
83640026|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
83640027|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83640028|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640029|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
83640030|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640031|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640032|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83640033|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
83640034|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640035|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640036|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83640037|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640038|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
83640039|NCT05051150|Epinephrine|epinephrine|mesh-list
83640040|NCT05051150|Racepinephrine|racepinephrine|mesh-list
83640041|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
83640042|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83640043|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83640044|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640045|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640046|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640047|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640048|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83640049|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83640050|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
83640051|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640052|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83640053|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
83640054|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
83640055|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
83640056|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83640057|NCT05045313|Probenecid|probenecid|mesh-list
83640058|NCT05045313|Digoxin|digoxin|mesh-list
83640059|NCT05045313|Warfarin|warfarin|mesh-list
83640060|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
83640061|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83640062|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83640063|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640064|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640065|NCT05045313|Protective Agents|protective agents|mesh-ancestor
83640066|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640067|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
83640068|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
83640069|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640070|NCT05007561|Naltrexone|naltrexone|mesh-list
83640071|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83640072|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83640073|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640074|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
83640075|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640076|NCT04961801|Methotrexate|methotrexate|mesh-list
83640077|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
83640078|NCT04961801|Tacrolimus|tacrolimus|mesh-list
83640079|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83640080|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
83640081|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83640082|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640083|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640084|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
83640085|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640086|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640087|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
83640088|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640089|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83640090|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640091|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
83640092|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640093|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83640094|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83640095|NCT04919564|Furosemide|furosemide|mesh-list
83640096|NCT04919564|Diuretics|diuretics|mesh-ancestor
83640097|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
83640098|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640099|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83640100|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640101|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640102|NCT04886284|Ertapenem|ertapenem|mesh-list
83640103|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83640104|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640105|NCT04870333|Ciclesonide|ciclesonide|mesh-list
83640106|NCT04870333|Sotrovimab|sotrovimab|mesh-list
83640107|NCT04870333|Niclosamide|niclosamide|mesh-list
83640108|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
83640109|NCT04870333|Hormones|hormones|mesh-ancestor
83640110|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640111|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640112|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83640113|NCT04870333|Antiviral Agents|antiviral agents|mesh-ancestor
83640114|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640115|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
83640116|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83640117|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
83640118|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83640119|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
83640120|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
83640121|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640122|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640123|NCT04835402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83640124|NCT04835402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640125|NCT04801641|Nabilone|nabilone|mesh-list
83640126|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
83640127|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
83640128|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640129|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640130|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640131|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83640132|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83640133|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640134|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83640135|NCT04783376|Insulin|insulin|mesh-list
83640136|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83640137|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83640138|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640139|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
83640140|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83640141|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640142|NCT04760912|Bromides|bromides|mesh-list
83640143|NCT04760912|Anesthetics|anesthetics|mesh-list
83640144|NCT04760912|Rocuronium|rocuronium|mesh-list
83640145|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640146|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640147|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
83640148|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83640149|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83640150|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83640151|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640152|NCT04710641|Sorafenib|sorafenib|mesh-list
83640153|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640154|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640155|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640156|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640157|NCT04706767|Lidocaine|lidocaine|mesh-list
83640158|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
83640159|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640160|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
83640161|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640162|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640163|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
83640164|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640165|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83640166|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83640167|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83640168|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640169|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640170|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83640171|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83640172|NCT04706767|Analgesics|analgesics|mesh-ancestor
83640173|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83640174|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83640175|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83640176|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640177|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640178|NCT04690686|Paclitaxel|paclitaxel|mesh-list
83640179|NCT04690686|Atezolizumab|atezolizumab|mesh-list
83640180|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83640181|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640182|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
83640183|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
83640184|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
83640185|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640186|NCT04690686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83640187|NCT04690686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640188|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
83640189|NCT04682626|Vitamin D|vitamin d|mesh-list
83640190|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83640191|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640192|NCT04682626|Vitamins|vitamins|mesh-ancestor
83640193|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
83640194|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83640195|NCT04604691|Blinatumomab|blinatumomab|mesh-list
83640196|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640197|NCT04580381|Natalizumab|natalizumab|mesh-list
83640198|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
83640199|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640200|NCT04530006|Amantadine|amantadine|mesh-list
83640201|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83640202|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83640203|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
83640204|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640205|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
83640206|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640207|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640208|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640209|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83640210|NCT04530006|Analgesics|analgesics|mesh-ancestor
83640211|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
83640212|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640213|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
83640214|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83640215|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
83640216|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640217|NCT04476745|Vitamin D|vitamin d|mesh-list
83640218|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
83640219|NCT04476745|Vitamins|vitamins|mesh-ancestor
83640220|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
83640221|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640222|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83640223|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83640224|NCT04433390|Naloxegol|naloxegol|mesh-list
83640225|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83640226|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640227|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
83640228|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640229|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
83640230|NCT04399746|Vitamin D|vitamin d|mesh-list
83640231|NCT04399746|Azithromycin|azithromycin|mesh-list
83640232|NCT04399746|Ivermectin|ivermectin|mesh-list
83640233|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83640234|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640236|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
83640237|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83640238|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83640239|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640240|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83640241|NCT04391608|Tenofovir|tenofovir|mesh-list
83640242|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
83640243|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640244|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83640245|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83640246|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640247|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640248|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83640249|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83640250|NCT04368091|Sirolimus|sirolimus|mesh-list
83640251|NCT04368091|Temsirolimus|temsirolimus|mesh-list
83640252|NCT04368091|MTOR Inhibitors|mtor inhibitors|mesh-list
83640253|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83640254|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640255|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83640256|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640257|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
83640258|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640259|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
83640260|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640261|NCT04368091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640262|NCT04368091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640263|NCT04368091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640264|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
83640265|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83640266|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83640267|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640268|NCT04302168|Choline|choline|mesh-list
83640269|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
83640270|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83640271|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
83640272|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640273|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640274|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83640275|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
83640276|NCT04245644|Aspirin|aspirin|mesh-list
83640277|NCT04245644|Metformin|metformin|mesh-list
83640278|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83640279|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83640280|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640281|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83640282|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83640283|NCT04245644|Analgesics|analgesics|mesh-ancestor
83640284|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
83640285|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640286|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83640287|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640288|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83640289|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83640290|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640291|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83640292|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83640293|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640294|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
83640295|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
83640296|NCT04238845|Vitamin A|vitamin a|mesh-list
83640297|NCT04238845|Vitamins|vitamins|mesh-ancestor
83640298|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
83640299|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640300|NCT04223037|Vaccines|vaccines|mesh-list
83640301|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
83640302|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640303|NCT04186663|Fluorides|fluorides|mesh-list
83640304|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
83640305|NCT04186663|Protective Agents|protective agents|mesh-ancestor
83640306|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640307|NCT04108026|Durvalumab|durvalumab|mesh-list
83640308|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640309|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640310|NCT04095104|Topiramate|topiramate|mesh-list
83640311|NCT04095104|Phentermine|phentermine|mesh-list
83640312|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
83640313|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83640314|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640315|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83640316|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
83640317|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83640318|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
83640319|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
83640320|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640321|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640322|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640323|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640324|NCT04074512|Copper|copper|mesh-list
83640325|NCT04074512|Trace Elements|trace elements|mesh-ancestor
83640326|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
83640327|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640328|NCT04044729|Cannabidiol|cannabidiol|mesh-list
83640329|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
83640330|NCT04008082|Lenvatinib|lenvatinib|mesh-list
83640331|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640332|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640333|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640334|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640335|NCT03974243|Chiauranib|chiauranib|mesh-list
83640336|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640337|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640338|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640339|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640340|NCT03967925|Prednisone|prednisone|mesh-list
83640341|NCT03967925|Prednisolone|prednisolone|mesh-list
83640342|NCT03967925|Rituximab|rituximab|mesh-list
83640343|NCT03967925|Belimumab|belimumab|mesh-list
83640344|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640345|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640346|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
83640347|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640348|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640349|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83640350|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
83640351|NCT03967925|Hormones|hormones|mesh-ancestor
83640352|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640353|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83640354|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640355|NCT03954743|Vaccines|vaccines|mesh-list
83640356|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
83640357|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640358|NCT03932318|Azacitidine|azacitidine|mesh-list
83640359|NCT03932318|Venetoclax|venetoclax|mesh-list
83640360|NCT03932318|Lintuzumab|lintuzumab|mesh-list
83640361|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640362|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
83640363|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640364|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640365|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640366|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640367|NCT03883412|Liraglutide|liraglutide|mesh-list
83640368|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83640369|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640370|NCT03883412|Incretins|incretins|mesh-ancestor
83640371|NCT03883412|Hormones|hormones|mesh-ancestor
83640372|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640373|NCT03867682|Venetoclax|venetoclax|mesh-list
83640374|NCT03867682|Lintuzumab|lintuzumab|mesh-list
83640375|NCT03867682|Spironolactone|spironolactone|mesh-list
83640376|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640377|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83640378|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
83640379|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640380|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640381|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83640382|NCT03867682|Diuretics|diuretics|mesh-ancestor
83640383|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
83640384|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640385|NCT03858621|Fentanyl|fentanyl|mesh-list
83640386|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83640387|NCT03858621|Narcotics|narcotics|mesh-ancestor
83640388|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640389|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640391|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
83640392|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640393|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83640394|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83640395|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
83640396|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
83640397|NCT03845270|Docetaxel|docetaxel|mesh-list
83640398|NCT03845270|Trastuzumab|trastuzumab|mesh-list
83640399|NCT03845270|Pertuzumab|pertuzumab|mesh-list
83640400|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640401|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
83640402|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
83640403|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
83640404|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640405|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640406|NCT03777462|Paclitaxel|paclitaxel|mesh-list
83640407|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83640408|NCT03777462|Gemcitabine|gemcitabine|mesh-list
83640409|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83640410|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640411|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83640412|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83640413|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83640414|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640415|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640416|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
83640417|NCT03758170|Dexamethasone|dexamethasone|mesh-list
83640418|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83640419|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
83640420|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
83640421|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640422|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640423|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640424|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
83640425|NCT03758170|Hormones|hormones|mesh-ancestor
83640426|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640427|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83640428|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640429|NCT03733119|TIC10 compound|tic10 compound|mesh-list
83640430|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640431|NCT03705338|Propofol|propofol|mesh-list
83640432|NCT03705338|Anesthetics|anesthetics|mesh-list
83640433|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
83640434|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83640435|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640436|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640437|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83640438|NCT03704285|Propofol|propofol|mesh-list
83640439|NCT03704285|Anesthetics|anesthetics|mesh-list
83640440|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
83640441|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83640442|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640443|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640444|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83640445|NCT03696537|Fludarabine|fludarabine|mesh-list
83640446|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640447|NCT03661996|Lidocaine|lidocaine|mesh-list
83640448|NCT03661996|Epinephrine|epinephrine|mesh-list
83640449|NCT03661996|Capsaicin|capsaicin|mesh-list
83640450|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640451|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
83640452|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640453|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640454|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
83640455|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640456|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83640457|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83640458|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83640459|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640460|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640461|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83640462|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83640463|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640464|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640465|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83640466|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83640467|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
83640468|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83640469|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
83640470|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
83640471|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
83640472|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83640473|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
83640474|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
83640475|NCT03659799|Insulin|insulin|mesh-list
83640476|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83640477|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
83640478|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83640479|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640480|NCT03555877|Letrozole|letrozole|mesh-list
83640481|NCT03555877|Fulvestrant|fulvestrant|mesh-list
83640482|NCT03555877|Anastrozole|anastrozole|mesh-list
83640483|NCT03555877|Exemestane|exemestane|mesh-list
83640484|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640485|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83640486|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83640487|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640488|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640489|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83640490|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
83640491|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640492|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640493|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83640494|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83640495|NCT03410355|Cortisone|cortisone|mesh-list
83640496|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83640497|NCT03399617|Micronutrients|micronutrients|mesh-list
83640498|NCT03399617|Trace Elements|trace elements|mesh-list
83640499|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640500|NCT03386162|Fulvestrant|fulvestrant|mesh-list
83640501|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83640502|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640503|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83640504|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83640505|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
83640506|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640507|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640508|NCT03360214|Bupivacaine|bupivacaine|mesh-list
83640509|NCT03360214|Ropivacaine|ropivacaine|mesh-list
83640510|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640511|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
83640512|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640513|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640514|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
83640515|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640516|NCT03359239|Atezolizumab|atezolizumab|mesh-list
83640517|NCT03359239|Poly ICLC|poly iclc|mesh-list
83640518|NCT03359239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83640519|NCT03359239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640520|NCT03359239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640521|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640522|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
83640523|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
83640524|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640525|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
83640526|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640527|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640528|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640529|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640530|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
83640531|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83640532|NCT03328676|Protective Agents|protective agents|mesh-ancestor
83640533|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640534|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83640535|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83640536|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
83640537|NCT03315039|Annamycin|annamycin|mesh-list
83640538|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83640539|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640540|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
83640541|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83640542|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640543|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640544|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83640545|NCT03289325|Analgesics|analgesics|mesh-ancestor
83640546|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
83640547|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640548|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83640549|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83529750|NCT04335383|Antibodies|antibodies|mesh-list
83640550|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83640551|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640552|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640553|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640554|NCT03276533|Lidocaine|lidocaine|mesh-list
83640555|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
83640556|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640557|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
83640558|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640559|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640560|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
83640561|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640562|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83640563|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83640564|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83640565|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640566|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640567|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83640568|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83640569|NCT03276533|Analgesics|analgesics|mesh-ancestor
83640570|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83640571|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83640572|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83640573|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640574|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640575|NCT03254394|Lidocaine|lidocaine|mesh-list
83640576|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640577|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
83640578|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640579|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640580|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
83640581|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640582|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83640583|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83640584|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83640585|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640586|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640587|NCT03203876|Nivolumab|nivolumab|mesh-list
83640588|NCT03203876|Ipilimumab|ipilimumab|mesh-list
83640589|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640590|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640591|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83640592|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640593|NCT03191240|Vasopressins|vasopressins|mesh-list
83640594|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
83640595|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
83640596|NCT03191240|Coagulants|coagulants|mesh-ancestor
83640597|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83640598|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83640599|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
83640600|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640601|NCT03180294|Bupropion|bupropion|mesh-list
83640602|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83640603|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
83640604|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83640605|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83640606|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83640607|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640608|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640609|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
83640610|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640611|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640612|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83640613|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83640614|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640615|NCT03071601|Lidocaine|lidocaine|mesh-list
83640616|NCT03071601|Epinephrine|epinephrine|mesh-list
83640617|NCT03071601|Prilocaine|prilocaine|mesh-list
83640618|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83640619|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640620|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
83640621|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640622|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640623|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
83640624|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640625|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83640626|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83640627|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83640628|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640629|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640630|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83640631|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83640632|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640633|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640634|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83640635|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83640636|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
83640637|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83640638|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
83640639|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
83640640|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
83640641|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83640642|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83640643|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83640644|NCT03061903|Laxatives|laxatives|mesh-ancestor
83640645|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640646|NCT03061643|Docetaxel|docetaxel|mesh-list
83640647|NCT03061643|Androgens|androgens|mesh-list
83640648|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640649|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83640650|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83640651|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83640652|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640653|NCT03061643|Hormones|hormones|mesh-ancestor
83640654|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640655|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640656|NCT03061630|Gemcitabine|gemcitabine|mesh-list
83640657|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640658|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640659|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
83640660|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640661|NCT03055390|Scopolamine|scopolamine|mesh-list
83640662|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83640663|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83640664|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
83640665|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
83640666|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640667|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640668|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640669|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
83640670|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83640671|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
83640672|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640673|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640674|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83640675|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
83640676|NCT03012672|Cytarabine|cytarabine|mesh-list
83640677|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83640678|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
83640679|NCT03012672|Cladribine|cladribine|mesh-list
83640680|NCT03012672|Lenograstim|lenograstim|mesh-list
83640681|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640682|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
83640683|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640684|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640685|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
83640686|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640687|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640688|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
83640689|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640690|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83640691|NCT03012672|Analgesics|analgesics|mesh-ancestor
83640692|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
83640693|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640694|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83640695|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83640696|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640697|NCT03011775|Aspirin|aspirin|mesh-list
83640698|NCT03011775|Pioglitazone|pioglitazone|mesh-list
83640699|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83640700|NCT03011775|Ramipril|ramipril|mesh-list
83640701|NCT03011775|Bisoprolol|bisoprolol|mesh-list
83640702|NCT03011775|Isosorbide|isosorbide|mesh-list
83640703|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83640704|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83640705|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
83640706|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83640707|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83640708|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640709|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83640710|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83640711|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
83640712|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640713|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83640714|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83640715|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640716|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83640717|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83640718|NCT03011775|Analgesics|analgesics|mesh-ancestor
83640719|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
83640720|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640721|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83640722|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640723|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83640724|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83640725|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83640726|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
83640727|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83640728|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
83640729|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83640730|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
83640731|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
83640732|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83640733|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83640734|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83640735|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83640736|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640737|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83640738|NCT03011775|Diuretics|diuretics|mesh-ancestor
83640739|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
83640740|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83640741|NCT02960997|Sirolimus|sirolimus|mesh-list
83640742|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83640743|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640744|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83640745|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640746|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
83640747|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640748|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
83640749|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640750|NCT02924480|Lidocaine|lidocaine|mesh-list
83640751|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640752|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
83640753|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640754|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640755|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
83640756|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640757|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83640758|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83640759|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83640760|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640761|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640762|NCT02924064|Metformin|metformin|mesh-list
83640763|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83640764|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795115|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
83640766|NCT02889900|Cediranib|cediranib|mesh-list
83640767|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83640768|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640769|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640770|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640771|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640772|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83640773|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
83640774|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83640775|NCT02879942|Growth Substances|growth substances|mesh-ancestor
83640776|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640777|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
83640778|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640779|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
83640780|NCT02873819|Sargramostim|sargramostim|mesh-list
83640781|NCT02873819|Poly ICLC|poly iclc|mesh-list
83640782|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640783|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
83640784|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640785|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640786|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83640787|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
83640788|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640789|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640790|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83640791|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
83640792|NCT02810457|Paclitaxel|paclitaxel|mesh-list
83640793|NCT02810457|Bevacizumab|bevacizumab|mesh-list
83640794|NCT02810457|Carboplatin|carboplatin|mesh-list
83640795|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83640796|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640797|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83640798|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83640799|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83640800|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640801|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640802|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83640803|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83640804|NCT02810457|Growth Substances|growth substances|mesh-ancestor
83640805|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640806|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
83640807|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
83640808|NCT02745535|Velpatasvir|velpatasvir|mesh-list
83640809|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83640810|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
83640811|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640812|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
83640813|NCT02729701|Estrogens|estrogens|mesh-list
83640814|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83640815|NCT02729701|Hormones|hormones|mesh-ancestor
83640816|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640817|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640818|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83640819|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83640820|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
83640821|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83640822|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
83640823|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
83640824|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83640825|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
83640826|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
83640827|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640828|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640829|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640830|NCT02719314|Hormones|hormones|mesh-ancestor
83640831|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640832|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83640833|NCT02719314|Protective Agents|protective agents|mesh-ancestor
83640834|NCT02711826|Acetaminophen|acetaminophen|mesh-list
83640835|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
83640836|NCT02711826|Promethazine|promethazine|mesh-list
83640837|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
83640838|NCT02711826|Everolimus|everolimus|mesh-list
83640839|NCT02711826|Tacrolimus|tacrolimus|mesh-list
83640840|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640841|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
83640842|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640843|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83640844|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83640845|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640846|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83640848|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
83640849|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640850|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
83640851|NCT02711826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83640852|NCT02711826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83640853|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640854|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83640855|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83640856|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
83640857|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83640858|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640859|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83640860|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83640861|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640862|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640863|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
83640864|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
83640865|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
83640866|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640867|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83640868|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
83640869|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
83640870|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83640871|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83640872|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
83640873|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
83640874|NCT02684253|Nivolumab|nivolumab|mesh-list
83640875|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640876|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640877|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83640878|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640879|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83640880|NCT02666794|Sufentanil|sufentanil|mesh-list
83640881|NCT02666794|Morphine|morphine|mesh-list
83640882|NCT02666794|Dsuvia|dsuvia|mesh-list
83640883|NCT02666794|Bupivacaine|bupivacaine|mesh-list
83640884|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
83640885|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
83640886|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83640887|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640888|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
83640889|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640890|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83640891|NCT02666794|Narcotics|narcotics|mesh-ancestor
83640892|NCT02666794|Analgesics|analgesics|mesh-ancestor
83640893|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83640894|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83640895|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
83640896|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
83640897|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
83640898|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640899|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640900|NCT02642094|Sirolimus|sirolimus|mesh-list
83640901|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83640902|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640903|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83640904|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640905|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
83640906|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640907|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
83640908|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640909|NCT02619552|Prednisone|prednisone|mesh-list
83640910|NCT02619552|Budesonide|budesonide|mesh-list
83640911|NCT02619552|Adalimumab|adalimumab|mesh-list
83640912|NCT02619552|Infliximab|infliximab|mesh-list
83640913|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
83640914|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83640915|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
83640916|NCT02619552|Hormones|hormones|mesh-ancestor
83640917|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640918|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640919|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83640920|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640921|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83640922|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
83640923|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83640924|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83640925|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
83640926|NCT02619552|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83640927|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83640928|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
83640929|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83640930|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640931|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
83640932|NCT02578368|Leucovorin|leucovorin|mesh-list
83640933|NCT02578368|Docetaxel|docetaxel|mesh-list
83640934|NCT02578368|Fluorouracil|fluorouracil|mesh-list
83640935|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
83640936|NCT02578368|Trastuzumab|trastuzumab|mesh-list
83640937|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
83640938|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640939|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83640940|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83640941|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83640942|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640943|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640944|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
83640945|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640946|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640947|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
83640948|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640949|NCT02578368|Antidotes|antidotes|mesh-ancestor
83640950|NCT02578368|Protective Agents|protective agents|mesh-ancestor
83640951|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
83640952|NCT02578368|Vitamins|vitamins|mesh-ancestor
83640953|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
83640954|NCT02575963|Cytarabine|cytarabine|mesh-list
83640955|NCT02575963|Lintuzumab|lintuzumab|mesh-list
83640956|NCT02575963|Furosemide|furosemide|mesh-list
83640957|NCT02575963|Spironolactone|spironolactone|mesh-list
83640958|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83640959|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
83640960|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640961|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640962|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
83640963|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83640964|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83640965|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
83640966|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640967|NCT02575963|Diuretics|diuretics|mesh-ancestor
83640968|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
83640969|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83640970|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83640971|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83640972|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
83640973|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640974|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83640975|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640976|NCT02539225|Paclitaxel|paclitaxel|mesh-list
83640977|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
83640978|NCT02539225|Ramucirumab|ramucirumab|mesh-list
83640979|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83640980|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640981|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83640982|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83640983|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83640984|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640985|NCT02535650|Tipifarnib|tipifarnib|mesh-list
83640986|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640987|NCT02526017|Nivolumab|nivolumab|mesh-list
83640988|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83640989|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83640990|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83640991|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83640992|NCT02516657|Liraglutide|liraglutide|mesh-list
83640993|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83640994|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83640995|NCT02516657|Incretins|incretins|mesh-ancestor
83640996|NCT02516657|Hormones|hormones|mesh-ancestor
83640997|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83640998|NCT02427581|Poly I-C|poly i-c|mesh-list
83640999|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83641000|NCT02427581|Poly ICLC|poly iclc|mesh-list
83641001|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
83641002|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
83641003|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641004|NCT02427581|Laxatives|laxatives|mesh-ancestor
83641005|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641006|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
83641007|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641008|NCT02423525|Afatinib|afatinib|mesh-list
83641009|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641010|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641011|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641012|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641013|NCT02369653|Apixaban|apixaban|mesh-list
83641014|NCT02369653|Anticoagulants|anticoagulants|mesh-list
83641015|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83641016|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
83641017|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83641018|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
83641019|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641020|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641021|NCT02293109|Leucovorin|leucovorin|mesh-list
83641022|NCT02293109|Cytarabine|cytarabine|mesh-list
83641023|NCT02293109|Dexamethasone|dexamethasone|mesh-list
83641024|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
83641025|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83641026|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83641027|NCT02293109|Prednisolone|prednisolone|mesh-list
83641028|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
83641029|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
83641030|NCT02293109|Rituximab|rituximab|mesh-list
83641031|NCT02293109|Doxorubicin|doxorubicin|mesh-list
83641032|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83641033|NCT02293109|Methotrexate|methotrexate|mesh-list
83641034|NCT02293109|Vincristine|vincristine|mesh-list
83641035|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83641036|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
83641037|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
83641038|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83641039|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
83641040|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641041|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83641042|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83641043|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
83641044|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641045|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641046|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83641047|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83641048|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641049|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
83641050|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
83641051|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641052|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641053|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
83641054|NCT02293109|Hormones|hormones|mesh-ancestor
83641055|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641056|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83641057|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83641058|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83641059|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83641060|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641061|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83641062|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
83641063|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83641064|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83641065|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
83641066|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
83641067|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83641068|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83641069|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
83641070|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641071|NCT02293109|Antidotes|antidotes|mesh-ancestor
83641072|NCT02293109|Protective Agents|protective agents|mesh-ancestor
83641073|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
83641074|NCT02293109|Vitamins|vitamins|mesh-ancestor
83641075|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
83641076|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83641077|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
83641078|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
83641079|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
83641080|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83641081|NCT02195986|Estradiol|estradiol|mesh-list
83641082|NCT02195986|Estrogens|estrogens|mesh-ancestor
83641083|NCT02195986|Hormones|hormones|mesh-ancestor
83641084|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641085|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641086|NCT02183883|Afatinib|afatinib|mesh-list
83641087|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641088|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641089|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641090|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641091|NCT01982630|Liraglutide|liraglutide|mesh-list
83641092|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641093|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641094|NCT01982630|Incretins|incretins|mesh-ancestor
83641095|NCT01982630|Hormones|hormones|mesh-ancestor
83641096|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641097|NCT01951469|Pemetrexed|pemetrexed|mesh-list
83641098|NCT01951469|Gefitinib|gefitinib|mesh-list
83641099|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641100|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641101|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641102|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83641103|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83641104|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641105|NCT01940809|Nivolumab|nivolumab|mesh-list
83641106|NCT01940809|Ipilimumab|ipilimumab|mesh-list
83641107|NCT01940809|Trametinib|trametinib|mesh-list
83641108|NCT01940809|Dabrafenib|dabrafenib|mesh-list
83641109|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83641110|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641111|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83641112|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641113|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641114|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641115|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83641116|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641117|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641118|NCT01879228|Incretins|incretins|mesh-ancestor
83641119|NCT01879228|Hormones|hormones|mesh-ancestor
83641120|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641121|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83641122|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83641123|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641124|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641125|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
83641126|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83641127|NCT01740297|Ipilimumab|ipilimumab|mesh-list
83641128|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83641129|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83641130|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641131|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83641132|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641133|NCT01729754|Etanercept|etanercept|mesh-list
83641134|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83641135|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83641136|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83641137|NCT01729754|Analgesics|analgesics|mesh-ancestor
83641138|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
83641139|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641140|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641141|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641142|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83641143|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641144|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83641145|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
83641146|NCT01622998|Nicotine|nicotine|mesh-list
82795478|NCT00861419|Trebananib|trebananib|mesh-list
83641147|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83641148|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
83641149|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641150|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641151|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83641152|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83641153|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
83641154|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641155|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641156|NCT01595620|Dronabinol|dronabinol|mesh-list
83641157|NCT01595620|Capsaicin|capsaicin|mesh-list
83641158|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
83641159|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641160|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641161|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83641162|NCT01595620|Analgesics|analgesics|mesh-ancestor
83641163|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
83641164|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641165|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83641166|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83641167|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641168|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641169|NCT01595620|Hormones|hormones|mesh-ancestor
83641170|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641171|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
83641172|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
83641173|NCT01591629|Dronabinol|dronabinol|mesh-list
83641174|NCT01591629|Naloxone|naloxone|mesh-list
83641175|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83641176|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641177|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
83641178|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641179|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
83641180|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641181|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83641182|NCT01591629|Analgesics|analgesics|mesh-ancestor
83641183|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83641184|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83641185|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641186|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641187|NCT01591629|Hormones|hormones|mesh-ancestor
83641188|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641189|NCT01515306|Paclitaxel|paclitaxel|mesh-list
83641190|NCT01515306|Ramucirumab|ramucirumab|mesh-list
83641191|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83641192|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641193|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
83641194|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
83641195|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
83641196|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641197|NCT01513187|Interferons|interferons|mesh-list
83641198|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
83641199|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
83641200|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641201|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
83641202|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641203|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
83641204|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641205|NCT01433965|Lenalidomide|lenalidomide|mesh-list
83641206|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
83641207|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641208|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83641209|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83641210|NCT01433965|Growth Substances|growth substances|mesh-ancestor
83641211|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
83641212|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641213|NCT01360593|Gemcitabine|gemcitabine|mesh-list
83641214|NCT01360593|Capecitabine|capecitabine|mesh-list
83641215|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83641216|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
83641217|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641218|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641219|NCT01354977|Resveratrol|resveratrol|mesh-list
83641220|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
83641221|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641222|NCT01354977|Protective Agents|protective agents|mesh-ancestor
83641223|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641224|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641225|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83641227|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641228|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641229|NCT01226732|Capecitabine|capecitabine|mesh-list
83641230|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83641231|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
83641232|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641233|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641234|NCT00962988|Bupropion|bupropion|mesh-list
83641235|NCT00962988|Nicotine|nicotine|mesh-list
83641236|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83641237|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
83641238|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641239|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641240|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83641241|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83641242|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
83641243|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641244|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641245|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83641246|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
83641247|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641248|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83641249|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83641250|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83641251|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
83641252|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83641253|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83641254|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641255|NCT00785525|Lenograstim|lenograstim|mesh-list
83641256|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83641257|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
83641258|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641259|NCT00768820|Risperidone|risperidone|mesh-list
83641260|NCT00768820|Methylphenidate|methylphenidate|mesh-list
83641261|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83641262|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
83641263|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641264|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641265|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641266|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83641267|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641268|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641269|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641270|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83641271|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
83641272|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83641273|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83641274|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83641275|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83641276|NCT00678730|Dronabinol|dronabinol|mesh-list
83641277|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
83641278|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641279|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641280|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83641281|NCT00678730|Analgesics|analgesics|mesh-ancestor
83641282|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
83641283|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641284|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83641285|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83641286|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641287|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641288|NCT00678730|Hormones|hormones|mesh-ancestor
83641289|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641290|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83641291|NCT00600015|Sorafenib|sorafenib|mesh-list
83641292|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641293|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641294|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641295|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641296|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83641297|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83641298|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641299|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83641300|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83641301|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83641302|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641303|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
83641304|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641306|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
83641307|NCT00447122|Lapatinib|lapatinib|mesh-list
83641308|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83641309|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
83641310|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641311|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641312|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641313|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641314|NCT00430040|Carvedilol|carvedilol|mesh-list
83641315|NCT00430040|Lisinopril|lisinopril|mesh-list
83641316|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83641317|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83641318|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
83641319|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641320|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641321|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641322|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83641323|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
83641324|NCT00430040|Protective Agents|protective agents|mesh-ancestor
83641325|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83641326|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83641327|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83641328|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
83641329|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83641330|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83641331|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83641332|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
83641333|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641334|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83641335|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
83641336|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83641337|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
83641338|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83641339|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641340|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83641341|NCT00066963|Fluorides|fluorides|mesh-list
83641342|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
83641343|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
83641344|NCT00066963|Protective Agents|protective agents|mesh-ancestor
83641345|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641346|NCT01397500|Testosterone|testosterone|mesh-list
83641347|NCT01397500|Androgens|androgens|mesh-ancestor
83641348|NCT01397500|Hormones|hormones|mesh-ancestor
83641349|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641350|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641351|NCT01397513|Aspirin|aspirin|mesh-list
83641352|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83641353|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83641354|NCT01397513|Analgesics|analgesics|mesh-ancestor
83641355|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
83641356|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641357|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641358|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641359|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83641360|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83641361|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83641362|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641363|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83641364|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83641365|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641366|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
83641367|NCT01397630|Oxytocin|oxytocin|mesh-list
83641368|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
83641369|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82795705|NCT02544737|Apatinib|apatinib|mesh-list
83641370|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641371|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
83641372|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641373|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
83641374|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641375|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641376|NCT01397994|Nicorandil|nicorandil|mesh-list
83641377|NCT01397994|Atenolol|atenolol|mesh-list
83641378|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83641379|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83641380|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
83641381|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
83641382|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641383|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641384|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83641385|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83641386|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83641387|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
83641388|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641389|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641390|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
83641391|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
83641392|NCT01397994|Vitamins|vitamins|mesh-ancestor
83641393|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
83641394|NCT01398033|Paclitaxel|paclitaxel|mesh-list
83641395|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83641396|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641397|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83641398|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83641399|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83641400|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641401|NCT01398046|Dasatinib|dasatinib|mesh-list
83641402|NCT01398046|Rabeprazole|rabeprazole|mesh-list
83641403|NCT01398046|Betaine|betaine|mesh-list
83641404|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641405|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641406|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641407|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641408|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83641409|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641410|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83641411|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
83641412|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83641413|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
83641414|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83641415|NCT01398072|Azithromycin|azithromycin|mesh-list
83641416|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
83641417|NCT01398072|Doxycycline|doxycycline|mesh-list
83641418|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641419|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641420|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83641421|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83641422|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641423|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641424|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641425|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
83641426|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83641427|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83641428|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
83641429|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
83641430|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83641431|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
83641432|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641433|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641434|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83641435|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
83641436|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83641437|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83641438|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83641439|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
83641440|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795781|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641441|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641442|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83641443|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83641444|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83641445|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
83641446|NCT01398189|Clozapine|clozapine|mesh-list
83641447|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83641448|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
83641449|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641450|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641451|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641452|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83641453|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641454|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641455|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641456|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
83641457|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
83641458|NCT01398202|Vitamin D|vitamin d|mesh-list
83641459|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
83641460|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83641461|NCT01398202|Calcifediol|calcifediol|mesh-list
83641462|NCT01398202|Vitamins|vitamins|mesh-ancestor
83641463|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
83641464|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641465|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83641466|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83641467|NCT01398267|Lisinopril|lisinopril|mesh-list
83641468|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83641469|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
83641470|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641471|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641472|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83641473|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83641474|NCT01398267|Protective Agents|protective agents|mesh-ancestor
83641475|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641476|NCT01398293|Ritonavir|ritonavir|mesh-list
83641477|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
83641478|NCT01398293|Lactams|lactams|mesh-list
83641479|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83641480|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83641481|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83641482|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
83641483|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641484|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641485|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83641486|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83641487|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
83641488|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641489|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83641490|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83641491|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641492|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83641493|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83641494|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641495|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83641496|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
83641497|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83641498|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641499|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83641500|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83641501|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83641502|NCT01398371|Digoxin|digoxin|mesh-list
83641503|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83641504|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83641505|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641506|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641507|NCT01398371|Protective Agents|protective agents|mesh-ancestor
83641508|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641509|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
83641510|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83641511|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
83641512|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641513|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641514|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83641515|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
83641516|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83641517|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
83641518|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795884|NCT00434577|Vaccines|vaccines|mesh-list
83641519|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641520|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83641521|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
83641522|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
83641523|NCT01398384|Protective Agents|protective agents|mesh-ancestor
83641524|NCT01398501|Sorafenib|sorafenib|mesh-list
83641525|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641526|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641527|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641528|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641529|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83641530|NCT01398592|Vildagliptin|vildagliptin|mesh-list
83641531|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641532|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641533|NCT01398592|Incretins|incretins|mesh-ancestor
83641534|NCT01398592|Hormones|hormones|mesh-ancestor
83641535|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641536|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83641537|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
83641538|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641539|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641540|NCT01398618|Rifampin|rifampin|mesh-list
83641541|NCT01398618|Isoniazid|isoniazid|mesh-list
83641542|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83641543|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
83641544|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641545|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641546|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
83641547|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83641548|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641549|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641550|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83641551|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83641552|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83641553|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83641554|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83641555|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83641556|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83641557|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83641558|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
83641559|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83641560|NCT01398657|Androgens|androgens|mesh-list
83641561|NCT01398657|Hormones|hormones|mesh-ancestor
83641562|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641563|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641564|NCT01398670|Insulin|insulin|mesh-list
83641565|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83641566|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
83641567|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641568|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641569|NCT01398722|Insulin|insulin|mesh-list
83641570|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83641571|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641572|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641573|NCT01398995|Insulin|insulin|mesh-list
83641574|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641575|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641576|NCT01399086|Fulvestrant|fulvestrant|mesh-list
83641577|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83641578|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641579|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83641580|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83641581|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
83641582|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641583|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641584|NCT01399151|Vitamin D|vitamin d|mesh-list
83641585|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
83641586|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
83641587|NCT01399151|Vitamins|vitamins|mesh-list
83641588|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
83641589|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641590|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83641591|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83641592|NCT01399216|Fucoidan|fucoidan|mesh-list
83641593|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83641594|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796006|NCT00617669|Docetaxel|docetaxel|mesh-list
83641595|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
83641596|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641597|NCT01399242|Everolimus|everolimus|mesh-list
83641598|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83641599|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
83641600|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641601|NCT01399242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641602|NCT01399242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641603|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641604|NCT01399242|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83641605|NCT01399242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641606|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
83641607|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641608|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641609|NCT01399346|Insulin|insulin|mesh-list
83641610|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83641611|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
83641612|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
83641613|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83641614|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641615|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641616|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83641617|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83641618|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641619|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641620|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641621|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641622|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83641623|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83641624|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
83641625|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641626|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641627|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83641628|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83641629|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
83641630|NCT01399463|Paclitaxel|paclitaxel|mesh-list
83641631|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83641632|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641633|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
83641634|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
83641635|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
83641636|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641637|NCT01399515|Valproic Acid|valproic acid|mesh-list
83641638|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
83641639|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641640|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641641|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
83641642|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641643|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641644|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
83641645|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641646|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641647|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641648|NCT01399645|Insulin|insulin|mesh-list
83641649|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83641650|NCT01399645|Metformin|metformin|mesh-list
83641651|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
83641652|NCT01399645|Liraglutide|liraglutide|mesh-list
83641653|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641654|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641655|NCT01399645|Incretins|incretins|mesh-ancestor
83641656|NCT01399645|Hormones|hormones|mesh-ancestor
83641657|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641658|NCT01399840|Talazoparib|talazoparib|mesh-list
83641659|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83641660|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641661|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641662|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641663|NCT01399853|Vaccines|vaccines|mesh-list
83641664|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
83641665|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641666|NCT01400009|Vitamin D|vitamin d|mesh-list
83641667|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
83641668|NCT01400009|Vitamins|vitamins|mesh-ancestor
83641669|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
83641670|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641671|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83641672|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83641673|NCT01400022|Cortisone|cortisone|mesh-list
83641674|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641675|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
83641676|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641677|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641678|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641679|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641680|NCT01400100|Octreotide|octreotide|mesh-list
83641681|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83641682|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641683|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83641684|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641685|NCT01400165|Pindolol|pindolol|mesh-list
83641686|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83641687|NCT01400165|Trazodone|trazodone|mesh-list
83641688|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
83641689|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641690|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83641691|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641692|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641693|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641694|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83641695|NCT01400165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83641696|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83641697|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83641698|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641699|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641700|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
83641701|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83641702|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83641703|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83641704|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
83641705|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83641706|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83641707|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
83641708|NCT01400191|Metformin|metformin|mesh-list
83641709|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641710|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641711|NCT01400217|Beclomethasone|beclomethasone|mesh-list
83641712|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641713|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
83641714|NCT01400217|Hormones|hormones|mesh-ancestor
83641715|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641716|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641717|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83641718|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
83641719|NCT01400256|Valsartan|valsartan|mesh-list
83641720|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83641721|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83641722|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83641723|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641724|NCT01400308|Mupirocin|mupirocin|mesh-list
83641725|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641726|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641727|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83641728|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641729|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641730|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
83641731|NCT01400464|Prednisone|prednisone|mesh-list
83641732|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641733|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
83641734|NCT01400464|Hormones|hormones|mesh-ancestor
83641735|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83641736|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641737|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83641738|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641739|NCT01400568|Fluticasone|fluticasone|mesh-list
83641741|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641742|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83641743|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
83641744|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641745|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641746|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83641747|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
83641748|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
83641749|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83641750|NCT01400633|Decitabine|decitabine|mesh-list
83641751|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83641752|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
83641753|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641754|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641755|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641756|NCT01400646|Vitamins|vitamins|mesh-list
83641757|NCT01400646|Vitamin K|vitamin k|mesh-list
83641758|NCT01400646|Warfarin|warfarin|mesh-list
83641759|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
83641760|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
83641761|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641762|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
83641763|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83641764|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
83641765|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83641766|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
83641767|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641768|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641769|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83641770|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83641771|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
83641772|NCT01400646|Coagulants|coagulants|mesh-ancestor
83641773|NCT01400672|Imiquimod|imiquimod|mesh-list
83641774|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83641775|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
83641776|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641777|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641778|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
83641779|NCT01400685|Rituximab|rituximab|mesh-list
83641780|NCT01400685|Lenalidomide|lenalidomide|mesh-list
83641781|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83641782|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83641783|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641784|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
83641785|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641786|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83641787|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83641788|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83641789|NCT01400685|Growth Substances|growth substances|mesh-ancestor
83641790|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
83641791|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83641792|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
83641793|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641794|NCT01400737|Ibuprofen|ibuprofen|mesh-list
83641795|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83641796|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83641797|NCT01400737|Analgesics|analgesics|mesh-ancestor
83641798|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
83641799|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641800|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641801|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641802|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83641803|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83641804|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641805|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641806|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
83641807|NCT01400750|Tobramycin|tobramycin|mesh-list
83641808|NCT01400750|Colistin|colistin|mesh-list
83641809|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641810|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641811|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83641812|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83641813|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641814|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641815|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641816|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83641817|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83641818|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
83641819|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
83641820|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641821|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641822|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
83641823|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641824|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641825|NCT01400828|Desloratadine|desloratadine|mesh-list
83641826|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83641827|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
83641828|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641829|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641830|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641831|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83641832|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83641833|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
83641834|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
83641835|NCT01400867|Vancomycin|vancomycin|mesh-list
83641836|NCT01400867|Clindamycin|clindamycin|mesh-list
83641837|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
83641838|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
83641839|NCT01400867|Cefazolin|cefazolin|mesh-list
83641840|NCT01400867|Linezolid|linezolid|mesh-list
83641841|NCT01400867|Cephalexin|cephalexin|mesh-list
83641842|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83641843|NCT01400867|Aztreonam|aztreonam|mesh-list
83641844|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641845|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641846|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83641847|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641848|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641849|NCT01400945|Pantoprazole|pantoprazole|mesh-list
83641850|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83641851|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641852|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83641853|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641854|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641855|NCT01401036|Umirolimus|umirolimus|mesh-list
83641856|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83641857|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83641858|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
83641859|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641860|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
83641861|NCT01401075|Doxifluridine|doxifluridine|mesh-list
83641862|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641863|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83641864|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83641865|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
83641866|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641867|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83641868|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
83641869|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641870|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83641871|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
83641872|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641873|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
83641874|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83641875|NCT01401179|Clarithromycin|clarithromycin|mesh-list
83641876|NCT01401179|Cefazolin|cefazolin|mesh-list
83641877|NCT01401179|Erythromycin|erythromycin|mesh-list
83641878|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
83641879|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83641880|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
83641881|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641882|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641883|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83641884|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641885|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641886|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83641887|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83641888|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641889|NCT01401192|Cisplatin|cisplatin|mesh-list
83641890|NCT01401192|Gemcitabine|gemcitabine|mesh-list
83641891|NCT01401192|Pemetrexed|pemetrexed|mesh-list
83641892|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641893|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83641894|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
83641895|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641896|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641897|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83641898|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83641900|NCT01401387|Pancrelipase|pancrelipase|mesh-list
83641901|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641902|NCT01401491|Clozapine|clozapine|mesh-list
83641903|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
83641904|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83641905|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
83641906|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641907|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641908|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641909|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83641910|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641911|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641912|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641913|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
83641914|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
83641915|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83641916|NCT01401491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83641917|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83641918|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83641919|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83641920|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
83641921|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83641922|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83641923|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641924|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83641925|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83641926|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83641927|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83641928|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641929|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
83641930|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641931|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641932|NCT01401933|Rifampin|rifampin|mesh-list
83641933|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83641934|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
83641935|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83641936|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83641937|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
83641938|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83641939|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641940|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641941|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83641942|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83641943|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83641944|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83641945|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83641946|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83641947|NCT01402024|Aprepitant|aprepitant|mesh-list
83641948|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
83641949|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
83641950|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83641951|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641952|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83641953|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83641954|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641955|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641956|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
83641957|NCT01402076|Midazolam|midazolam|mesh-list
83641958|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83641959|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83641960|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641961|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641962|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83641963|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641964|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641965|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83641966|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
83641967|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
83641968|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
82796298|NCT00866021|Ritonavir|ritonavir|mesh-list
83641969|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
83641970|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641971|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641972|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83641973|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83641975|NCT01402089|Midazolam|midazolam|mesh-list
83641976|NCT01402089|Caffeine|caffeine|mesh-list
83641977|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83641978|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83641979|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83641980|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83641981|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83641982|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83641983|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83641984|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83641985|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
83641986|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
83641987|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
83641988|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
83641989|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83641990|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83641991|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83641992|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83641993|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83641994|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83641995|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83641996|NCT01402089|Growth Substances|growth substances|mesh-ancestor
83641997|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83641998|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83641999|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83642000|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83642001|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83642002|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
83642003|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
83642004|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83642005|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642006|NCT01402193|Anastrozole|anastrozole|mesh-list
83642007|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83642008|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642009|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83642010|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83642011|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642012|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642013|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83642014|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83642015|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642016|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642017|NCT01402245|Vaccines|vaccines|mesh-list
83642018|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83642019|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
83642020|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642021|NCT01402297|Acetovanillone|acetovanillone|mesh-list
83642022|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83642023|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83642024|NCT01402297|Analgesics|analgesics|mesh-ancestor
83642025|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
83642026|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642027|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642028|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642029|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642030|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
83642031|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642032|NCT01402297|Protective Agents|protective agents|mesh-ancestor
83642033|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642034|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83642035|NCT01402336|Cetrorelix|cetrorelix|mesh-list
83642036|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83642037|NCT01402336|Hormones|hormones|mesh-ancestor
83642038|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642039|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642040|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
83642041|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82796376|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
83642042|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
83642043|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83642044|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83642045|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83642046|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642047|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83642048|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
83642049|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
83642050|NCT01402479|Ramipril|ramipril|mesh-list
83642051|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83642052|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
83642053|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642054|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642055|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83642056|NCT01402583|Ribavirin|ribavirin|mesh-list
83642057|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
83642058|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642059|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
83642060|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642061|NCT01402596|Midazolam|midazolam|mesh-list
83642062|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
83642063|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83642064|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83642065|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642066|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642067|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83642068|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83642069|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83642070|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83642071|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
83642072|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
83642073|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
83642074|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
83642075|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642076|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642077|NCT01402622|Propofol|propofol|mesh-list
83642078|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
83642079|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642080|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642081|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83642082|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83642083|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
83642084|NCT01402674|Phentermine|phentermine|mesh-list
83642085|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83642086|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642087|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
83642088|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83642089|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
83642090|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
83642091|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642092|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
83642093|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642094|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642095|NCT01402843|Valsartan|valsartan|mesh-list
83642096|NCT01402843|Pitavastatin|pitavastatin|mesh-list
83642097|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83642098|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83642099|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83642100|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642101|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83642102|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83642103|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83642104|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
83642105|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642106|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83642107|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
83642108|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83642109|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83642110|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642111|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
83642112|NCT01402882|Coagulants|coagulants|mesh-ancestor
83642113|NCT01403025|Liraglutide|liraglutide|mesh-list
83642114|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642115|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642116|NCT01403025|Incretins|incretins|mesh-ancestor
82796448|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
83642117|NCT01403025|Hormones|hormones|mesh-ancestor
83642118|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642119|NCT01403103|Vitamin D|vitamin d|mesh-list
83642120|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
83642121|NCT01403103|Vitamins|vitamins|mesh-ancestor
83642122|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
83642123|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642124|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83642125|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83642126|NCT01403168|Analgesics|analgesics|mesh-list
83642127|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
83642128|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642129|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642130|NCT01403181|Ribavirin|ribavirin|mesh-list
83642131|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83642132|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
83642133|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642134|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
83642135|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642136|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
83642137|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642138|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
83642139|NCT01403285|Molgramostim|molgramostim|mesh-list
83642140|NCT01403285|Imiquimod|imiquimod|mesh-list
83642141|NCT01403285|Sargramostim|sargramostim|mesh-list
83642142|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642143|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
83642144|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642145|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642146|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83642147|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
83642148|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642149|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642150|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83642151|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83642152|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
83642153|NCT01403363|Fentanyl|fentanyl|mesh-list
83642154|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83642155|NCT01403363|Narcotics|narcotics|mesh-ancestor
83642156|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642157|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642158|NCT01403363|Analgesics|analgesics|mesh-ancestor
83642159|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
83642160|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642161|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83642162|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83642163|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
83642164|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
83642165|NCT01403389|Eculizumab|eculizumab|mesh-list
83642166|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83642167|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642168|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
83642169|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642170|NCT01403415|Sirolimus|sirolimus|mesh-list
83642171|NCT01403415|Dexamethasone|dexamethasone|mesh-list
83642172|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
83642173|NCT01403415|Methotrexate|methotrexate|mesh-list
83642174|NCT01403415|Vincristine|vincristine|mesh-list
83642175|NCT01403415|Temsirolimus|temsirolimus|mesh-list
83642176|NCT01403415|Asparaginase|asparaginase|mesh-list
83642177|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
83642178|NCT01403415|Pegaspargase|pegaspargase|mesh-list
83642179|NCT01403415|MTOR Inhibitors|mtor inhibitors|mesh-list
83642180|NCT01403415|BB 1101|bb 1101|mesh-list
83642181|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642182|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
83642183|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
83642184|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642185|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642186|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83642187|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
83642188|NCT01403415|Hormones|hormones|mesh-ancestor
83642189|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642190|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82796533|NCT05225831|Fludarabine|fludarabine|mesh-list
83642191|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642192|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83642193|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
83642194|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83642195|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83642196|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
83642197|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642198|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
83642199|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642200|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83642201|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642202|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
83642203|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642204|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83642205|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83642206|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
83642207|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
83642208|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
83642209|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642210|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642211|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83642212|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
83642213|NCT01403415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83642214|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
83642215|NCT01403415|Analgesics|analgesics|mesh-ancestor
83642216|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
83642217|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83642218|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83642219|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
83642220|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83642221|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
83642222|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642223|NCT01403506|Expectorants|expectorants|mesh-ancestor
83642224|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
83642225|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83642226|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
83642227|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642228|NCT01403506|Protective Agents|protective agents|mesh-ancestor
83642229|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642230|NCT01403506|Antidotes|antidotes|mesh-ancestor
83642231|NCT01403545|Curcumin|curcumin|mesh-list
83642232|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83642233|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83642234|NCT01403545|Analgesics|analgesics|mesh-ancestor
83642235|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
83642236|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642237|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642238|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642239|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642240|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642241|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642242|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642243|NCT01403662|Minocycline|minocycline|mesh-list
83642244|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642245|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642246|NCT01403740|Cyclosporine|cyclosporine|mesh-list
83642247|NCT01403740|Rituximab|rituximab|mesh-list
83642248|NCT01403740|Azathioprine|azathioprine|mesh-list
83642249|NCT01403740|Cyclosporins|cyclosporins|mesh-list
83642250|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83642251|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642252|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
83642253|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642254|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642255|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642256|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642257|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642258|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
83642259|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642260|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
83642261|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83642262|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
83642263|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83642264|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
83642265|NCT01403818|Mitiglinide|mitiglinide|mesh-list
83642266|NCT01403818|Calcium|calcium|mesh-list
83642267|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83642268|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642269|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84124607|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642270|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642271|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642272|NCT01403844|Carotenoids|carotenoids|mesh-list
83642273|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
83642274|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642275|NCT01403844|Protective Agents|protective agents|mesh-ancestor
83642276|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642277|NCT01403896|Plerixafor|plerixafor|mesh-list
83642278|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83642279|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83642280|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
83642281|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642282|NCT01403948|BI 836826|bi 836826|mesh-list
83642283|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83642284|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642285|NCT01404000|Charcoal|charcoal|mesh-list
83642286|NCT01404000|Antidotes|antidotes|mesh-ancestor
83642287|NCT01404000|Protective Agents|protective agents|mesh-ancestor
83642288|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642289|NCT01404013|Montelukast|montelukast|mesh-list
83642290|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83642291|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83642292|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
83642293|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83642294|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
83642295|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642296|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642297|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83642298|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83642299|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642300|NCT01404104|Sirolimus|sirolimus|mesh-list
83642301|NCT01404104|Temsirolimus|temsirolimus|mesh-list
83642302|NCT01404104|MTOR Inhibitors|mtor inhibitors|mesh-list
83642303|NCT01404104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83642304|NCT01404104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642305|NCT01404104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642306|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642307|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
83642308|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642309|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642310|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642311|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642312|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83642313|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
83642314|NCT01404117|Interferons|interferons|mesh-list
83642315|NCT01404117|Interferon-beta|interferon-beta|mesh-list
83642316|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
83642317|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
83642318|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642319|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
83642320|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642321|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
83642322|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642323|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83642324|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642325|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642326|NCT01404130|Isotretinoin|isotretinoin|mesh-list
83642327|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
83642328|NCT01404156|Leucovorin|leucovorin|mesh-list
83642329|NCT01404156|Paclitaxel|paclitaxel|mesh-list
83642330|NCT01404156|Docetaxel|docetaxel|mesh-list
83642331|NCT01404156|Carboplatin|carboplatin|mesh-list
83642332|NCT01404156|Fluorouracil|fluorouracil|mesh-list
83642333|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
83642334|NCT01404156|Epirubicin|epirubicin|mesh-list
83642335|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83642336|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642337|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
83642338|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
83642339|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
83642340|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642341|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
83642342|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83642343|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642344|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
83642345|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642346|NCT01404156|Antidotes|antidotes|mesh-ancestor
83642347|NCT01404156|Protective Agents|protective agents|mesh-ancestor
83642348|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
83642349|NCT01404156|Vitamins|vitamins|mesh-ancestor
83642350|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
83642351|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83642352|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83642353|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83642354|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642355|NCT01404169|Donepezil|donepezil|mesh-list
83642356|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83642357|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642358|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642359|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
83642360|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642361|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642362|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
83642363|NCT01404182|Vaccines|vaccines|mesh-list
83642364|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
83642365|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642366|NCT01404312|Pyridoxine|pyridoxine|mesh-list
83642367|NCT01404312|Pyridoxal|pyridoxal|mesh-list
83642368|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
83642369|NCT01404312|Isoniazid|isoniazid|mesh-list
83642370|NCT01404312|Rifapentine|rifapentine|mesh-list
83642371|NCT01404312|Vitamins|vitamins|mesh-ancestor
83642372|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
83642373|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642374|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
83642375|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
83642376|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642377|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642378|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83642379|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83642380|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
83642381|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642382|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83642383|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83642384|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
83642385|NCT01404338|Halobetasol|halobetasol|mesh-list
83642386|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83642387|NCT01404364|Triamcinolone|triamcinolone|mesh-list
83642388|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
83642389|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642390|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
83642391|NCT01404364|Hormones|hormones|mesh-ancestor
83642392|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642393|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642394|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642395|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
83642396|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
83642397|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642398|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83642399|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83642400|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83642401|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642402|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83642403|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83642404|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
83642405|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642406|NCT01404377|Ropivacaine|ropivacaine|mesh-list
83642407|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
83642408|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
83642409|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642410|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642411|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
83642412|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642413|NCT01404442|Midazolam|midazolam|mesh-list
83642414|NCT01404442|Ketamine|ketamine|mesh-list
83642415|NCT01404442|Analgesics|analgesics|mesh-ancestor
83642416|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
83642417|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642418|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642419|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83642420|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82796743|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83642421|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
83642422|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
83642423|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642424|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83642425|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83642426|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642427|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642428|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83642429|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83642430|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83642431|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83642432|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83642433|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
83642435|NCT01404468|Lidocaine|lidocaine|mesh-list
83642436|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
83642437|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
83642438|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642439|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642440|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
83642441|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642442|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83642443|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83642444|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83642445|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83642446|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642447|NCT01404507|Abciximab|abciximab|mesh-list
83642448|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
83642449|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83642450|NCT01404598|Naproxen|naproxen|mesh-list
83642451|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
83642452|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83642453|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83642454|NCT01404598|Analgesics|analgesics|mesh-ancestor
83642455|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
83642456|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642457|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642458|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642459|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642460|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
83642461|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83642462|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642463|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642464|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83642465|NCT01404637|Tamsulosin|tamsulosin|mesh-list
83642466|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83642467|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83642468|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83642469|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
83642470|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642471|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642472|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642473|NCT01404637|Urological Agents|urological agents|mesh-ancestor
83642474|NCT01404676|Glimepiride|glimepiride|mesh-list
83642475|NCT01404676|Vildagliptin|vildagliptin|mesh-list
83642476|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83642477|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642478|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642479|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642480|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
83642481|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83642482|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
83642483|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642484|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642485|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
83642486|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83642487|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642488|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642489|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83642490|NCT01404689|Analgesics|analgesics|mesh-ancestor
83642491|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
83642492|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642493|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83642494|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83642495|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796820|NCT00875771|Bevacizumab|bevacizumab|mesh-list
82796892|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642496|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83642497|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642498|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642499|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
83642500|NCT01404702|Aldesleukin|aldesleukin|mesh-list
83642501|NCT01404702|Interleukin-2|interleukin-2|mesh-list
83642502|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642503|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83642504|NCT01404702|Analgesics|analgesics|mesh-ancestor
83642505|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
83642506|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642507|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642508|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83642509|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83642510|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
83642511|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642512|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83642513|NCT01404715|Metformin|metformin|mesh-list
83642514|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
83642515|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642516|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642517|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642518|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83642519|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642520|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642521|NCT01404741|Azacitidine|azacitidine|mesh-list
83642522|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83642523|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
83642524|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642525|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642526|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642527|NCT01404767|Metoprolol|metoprolol|mesh-list
83642528|NCT01404767|Esmolol|esmolol|mesh-list
83642529|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83642530|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83642531|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
83642532|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
83642533|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642534|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642535|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83642536|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83642537|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83642538|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
83642539|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642540|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642541|NCT01404793|Rocuronium|rocuronium|mesh-list
83642542|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83642543|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83642544|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83642545|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642546|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642547|NCT01404806|Dolutegravir|dolutegravir|mesh-list
83642548|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83642549|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83642550|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642551|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642552|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83642553|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83642554|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
83642555|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642556|NCT01404819|Anesthetics|anesthetics|mesh-list
83642557|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642558|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642559|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83642560|NCT01404871|Clomipramine|clomipramine|mesh-list
83642561|NCT01404871|Escitalopram|escitalopram|mesh-list
83642562|NCT01404871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83642563|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83642564|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83642565|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642566|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642567|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
83642568|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642569|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642570|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
83642571|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83642572|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83642573|NCT01404871|Analgesics|analgesics|mesh-ancestor
83642574|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
83642575|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
83642576|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83642577|NCT01405079|Vinorelbine|vinorelbine|mesh-list
83642579|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642580|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83642581|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
83642582|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
83642583|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
83642584|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642585|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83642586|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642587|NCT01405118|Metformin|metformin|mesh-list
83642588|NCT01405118|Tofacitinib|tofacitinib|mesh-list
83642589|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642590|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642591|NCT01405118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83642592|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83642593|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642594|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642595|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
83642596|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83642597|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83642598|NCT01405131|Prednisolone|prednisolone|mesh-list
83642599|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
83642600|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83642601|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
83642602|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642603|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
83642604|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
83642605|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642606|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642607|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83642608|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
83642609|NCT01405131|Hormones|hormones|mesh-ancestor
83642610|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642611|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83642612|NCT01405131|Protective Agents|protective agents|mesh-ancestor
83642613|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83642614|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642615|NCT01405144|Fluorouracil|fluorouracil|mesh-list
83642616|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
83642617|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642618|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83642619|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642620|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642621|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
83642622|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642623|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
83642624|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83642625|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83642626|NCT01405157|Prednisolone|prednisolone|mesh-list
83642627|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
83642628|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83642629|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
83642630|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642631|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
83642632|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
83642633|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642634|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642635|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83642636|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
83642637|NCT01405157|Hormones|hormones|mesh-ancestor
83642638|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642639|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83642640|NCT01405157|Protective Agents|protective agents|mesh-ancestor
83642641|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83642642|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642643|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
83642644|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83642645|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83642646|NCT01405170|Prednisolone|prednisolone|mesh-list
83642647|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
83642648|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83642649|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
83642650|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642651|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
83642652|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
83642653|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642654|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642655|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83642656|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
83642657|NCT01405170|Hormones|hormones|mesh-ancestor
83642658|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642659|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83642660|NCT01405170|Protective Agents|protective agents|mesh-ancestor
83642661|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83642662|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642663|NCT01405235|Paclitaxel|paclitaxel|mesh-list
83642664|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83642665|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83642666|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642667|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
83642668|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
83642669|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
83642670|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642671|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83642672|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83642673|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83642674|NCT01405248|Protective Agents|protective agents|mesh-ancestor
83642675|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642676|NCT01405326|Adalimumab|adalimumab|mesh-list
83642677|NCT01405326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83642678|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642679|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642680|NCT01405339|Budesonide|budesonide|mesh-list
83642681|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642682|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83642683|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
83642684|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642685|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642686|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83642687|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
83642688|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
83642689|NCT01405339|Hormones|hormones|mesh-ancestor
83642690|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642691|NCT01405352|Vitamin A|vitamin a|mesh-list
83642692|NCT01405352|Vitamins|vitamins|mesh-ancestor
83642693|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
83642694|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642695|NCT01405365|Metronidazole|metronidazole|mesh-list
83642696|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642697|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642698|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83642699|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83642700|NCT01405430|Bevacizumab|bevacizumab|mesh-list
83642701|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83642702|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642703|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83642704|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83642705|NCT01405430|Growth Substances|growth substances|mesh-ancestor
83642706|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642707|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
83642708|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
83642709|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83642710|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83642711|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83642712|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83642713|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642714|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
83642715|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642716|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642717|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82797043|NCT01000220|Omeprazole|omeprazole|mesh-list
83642718|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642719|NCT01405573|Sorafenib|sorafenib|mesh-list
83642720|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642721|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83642722|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642723|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642724|NCT01405612|Midazolam|midazolam|mesh-list
83642725|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83642726|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83642727|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642728|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642729|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83642730|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83642731|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83642732|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83642733|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
83642734|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
83642735|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
83642736|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
83642737|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642738|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642739|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
83642740|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83642741|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642742|NCT01405846|Gefitinib|gefitinib|mesh-list
83642743|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642744|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83642745|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642746|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642747|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
83642748|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83642749|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
83642750|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642751|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642752|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
83642753|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642754|NCT01405989|Ketoconazole|ketoconazole|mesh-list
83642755|NCT01405989|Darexaban|darexaban|mesh-list
83642756|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
83642757|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642758|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83642759|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83642760|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642761|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642762|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83642763|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
83642764|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642765|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642766|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83642767|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83642768|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
83642769|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83642770|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
83642771|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
83642772|NCT01406002|Rifampin|rifampin|mesh-list
83642773|NCT01406002|Darexaban|darexaban|mesh-list
83642774|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83642775|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
83642776|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642777|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642778|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
83642779|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83642780|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642781|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642782|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83642783|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83642784|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83642785|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83642786|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83642787|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83642788|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83642789|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
83642790|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83642791|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
83642792|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
83642794|NCT01406080|Tretinoin|tretinoin|mesh-list
83642795|NCT01406080|Emollients|emollients|mesh-list
83642796|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83642797|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83642798|NCT01406080|Analgesics|analgesics|mesh-ancestor
83642799|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
83642800|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642801|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642802|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642803|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642804|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
83642805|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642806|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
83642807|NCT01406132|Peficitinib|peficitinib|mesh-list
83642808|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642809|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642810|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83642811|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
83642812|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642813|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
83642814|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83642815|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83642816|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83642817|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642818|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642819|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642820|NCT01406158|Urological Agents|urological agents|mesh-ancestor
83642821|NCT01406171|Isavuconazole|isavuconazole|mesh-list
83642822|NCT01406171|Midazolam|midazolam|mesh-list
83642823|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83642824|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83642825|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83642826|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642827|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83642828|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83642829|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83642830|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83642831|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
83642832|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
83642833|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
83642834|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
83642835|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642836|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642837|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
83642838|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642839|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
83642840|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
83642841|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642842|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642843|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83642844|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83642845|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642846|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642847|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642848|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642849|NCT01406262|Incretins|incretins|mesh-ancestor
83642850|NCT01406262|Hormones|hormones|mesh-ancestor
83642851|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642852|NCT01406275|Amoxicillin|amoxicillin|mesh-list
83642853|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
83642854|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
83642855|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642856|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642857|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83642858|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642859|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642860|NCT01406301|PENTA|penta|mesh-list
83642861|NCT01406301|Fondaparinux|fondaparinux|mesh-list
83642862|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83642863|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
83642864|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83642865|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
83642866|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642867|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642868|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
83642869|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83642870|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83642872|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83642873|NCT01406392|Misoprostol|misoprostol|mesh-list
83642874|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83642875|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
83642876|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83642877|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642878|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83642879|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83642880|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
83642881|NCT01406431|Valsartan|valsartan|mesh-list
83642882|NCT01406431|Pitavastatin|pitavastatin|mesh-list
83642883|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83642884|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83642885|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83642886|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642887|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83642888|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83642889|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83642890|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
83642891|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642892|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83642893|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
83642894|NCT01406470|Antibodies|antibodies|mesh-list
83642895|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
83642896|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83642897|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83642898|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
83642899|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
83642900|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642901|NCT01406496|Insulin|insulin|mesh-list
83642902|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83642903|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642904|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642905|NCT01406522|Tacrine|tacrine|mesh-list
83642906|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83642907|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642908|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642909|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
83642910|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83642911|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642912|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83642913|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
83642914|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83642915|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
83642916|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83642917|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
83642918|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83642919|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83642920|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642921|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642922|NCT01406535|Urological Agents|urological agents|mesh-ancestor
83642923|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83642924|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83642925|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642926|NCT01406639|Ranibizumab|ranibizumab|mesh-list
83642927|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83642928|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83642929|NCT01406639|Growth Substances|growth substances|mesh-ancestor
83642930|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642931|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
83642932|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642933|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
83642934|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
83642935|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642936|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642937|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
83642938|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642939|NCT01406704|Protective Agents|protective agents|mesh-ancestor
83642940|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
83642941|NCT01406704|Vitamins|vitamins|mesh-ancestor
83642942|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
83642943|NCT01406782|Rituximab|rituximab|mesh-list
83642944|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83642945|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642946|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
83642947|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642948|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83642949|NCT01407016|Metronidazole|metronidazole|mesh-list
83642950|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83642951|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83642952|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83642953|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83642954|NCT01407211|Vitamin A|vitamin a|mesh-list
83642955|NCT01407211|Vitamins|vitamins|mesh-ancestor
83642956|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
83642957|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642958|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
83642959|NCT01407237|Giapreza|giapreza|mesh-list
83642960|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
83642961|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83642962|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83642963|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
83642964|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83642965|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83642966|NCT01407289|Insulin|insulin|mesh-list
83642967|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
83642968|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
83642969|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83642970|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642971|NCT01407432|Folic Acid|folic acid|mesh-list
83642972|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
83642973|NCT01407432|Hematinics|hematinics|mesh-ancestor
83642974|NCT01407432|Vitamins|vitamins|mesh-ancestor
83642975|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
83642976|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642977|NCT01407471|Clobetasol|clobetasol|mesh-list
83642978|NCT01407471|Spironolactone|spironolactone|mesh-list
83642979|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83642980|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
83642981|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642982|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642983|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83642984|NCT01407471|Diuretics|diuretics|mesh-ancestor
83642985|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
83642986|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642987|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
83642988|NCT01407471|Hormones|hormones|mesh-ancestor
83642989|NCT01407484|Prednisone|prednisone|mesh-list
83642990|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83642991|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
83642992|NCT01407484|Hormones|hormones|mesh-ancestor
83642993|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83642994|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83642995|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83642996|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83642997|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83642998|NCT01407679|Alitretinoin|alitretinoin|mesh-list
83642999|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643000|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
83643001|NCT01407822|Cisplatin|cisplatin|mesh-list
83643002|NCT01407822|Gemcitabine|gemcitabine|mesh-list
83643003|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83643004|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643005|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83643006|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
83643007|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643008|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643009|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643010|NCT01407848|Furosemide|furosemide|mesh-list
83643011|NCT01407848|Diuretics|diuretics|mesh-ancestor
83643012|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
83643013|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643014|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83643015|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643016|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643017|NCT01407887|Artesunate|artesunate|mesh-list
83643018|NCT01407887|Amodiaquine|amodiaquine|mesh-list
83643019|NCT01407887|Methylene Blue|methylene blue|mesh-list
83643020|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
83643021|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83643022|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83643023|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643024|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643026|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
83643027|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83643028|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
83643029|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643030|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643031|NCT01408004|Everolimus|everolimus|mesh-list
83643032|NCT01408004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83643033|NCT01408004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643034|NCT01408004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643035|NCT01408004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643036|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643037|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
83643038|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643039|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643040|NCT01408056|Mupirocin|mupirocin|mesh-list
83643041|NCT01408056|Timolol|timolol|mesh-list
83643042|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83643043|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83643044|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
83643045|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643046|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643047|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643048|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83643049|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83643050|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83643051|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643052|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83643053|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643054|NCT01408095|Glimepiride|glimepiride|mesh-list
83643055|NCT01408095|Globalagliatin|globalagliatin|mesh-list
83643056|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83643057|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83643058|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643059|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643060|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
83643061|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
83643062|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643063|NCT01408160|Cytarabine|cytarabine|mesh-list
83643064|NCT01408160|Immunotoxins|immunotoxins|mesh-list
83643065|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83643066|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
83643067|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643068|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643069|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
83643070|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643071|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643072|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
83643073|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643074|NCT01408160|Immunoconjugates|immunoconjugates|mesh-ancestor
83643075|NCT01408173|Caffeine|caffeine|mesh-list
83643076|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
83643077|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643078|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83643079|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643080|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83643081|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643082|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83643083|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83643084|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
83643085|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643086|NCT01408186|Rabeprazole|rabeprazole|mesh-list
83643087|NCT01408186|Famotidine|famotidine|mesh-list
83643088|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83643089|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643090|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83643091|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643092|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643093|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83643094|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
83643095|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
83643096|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643097|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643098|NCT01408199|Lenalidomide|lenalidomide|mesh-list
83643099|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
83643100|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643101|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83643102|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83643103|NCT01408199|Growth Substances|growth substances|mesh-ancestor
83643104|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
83643105|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643106|NCT01408342|Rituximab|rituximab|mesh-list
83643107|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
83643108|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83643109|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643110|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
83643111|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643112|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83643113|NCT01408394|Ecopipam|ecopipam|mesh-list
83643114|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83643115|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83643116|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83643117|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643118|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83643119|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83643120|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
83643121|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643122|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643123|NCT01408446|Menthol|menthol|mesh-list
83643124|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
83643125|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83643126|NCT01408498|Testosterone|testosterone|mesh-list
83643127|NCT01408498|Androgens|androgens|mesh-ancestor
83643128|NCT01408498|Hormones|hormones|mesh-ancestor
83643129|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643130|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643131|NCT01408524|Diltiazem|diltiazem|mesh-list
83643132|NCT01408524|Labetalol|labetalol|mesh-list
83643133|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83643134|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83643135|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643136|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643137|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643138|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643139|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
83643140|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83643141|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83643142|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
83643143|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643144|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
83643145|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
83643146|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643147|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83643148|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83643149|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83643150|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83643151|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83643152|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643153|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643154|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
83643155|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643156|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643157|NCT01408680|Ubiquinone|ubiquinone|mesh-list
83643158|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
83643159|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
83643160|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643161|NCT01408680|Vitamins|vitamins|mesh-ancestor
83643162|NCT01408797|Bortezomib|bortezomib|mesh-list
83643163|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643164|NCT01408810|Infliximab|infliximab|mesh-list
83643165|NCT01408810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83643166|NCT01408810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643167|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83643168|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643169|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83643170|NCT01408836|Prednisolone|prednisolone|mesh-list
83643171|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83643172|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
82797493|NCT05880017|Morphine|morphine|mesh-list
83643173|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83643174|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
83643175|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83643176|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
83643177|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643178|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
83643180|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643181|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643182|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83643183|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643184|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
83643185|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
83643186|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643187|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643188|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83643189|NCT01408836|Protective Agents|protective agents|mesh-ancestor
83643190|NCT01408849|Omeprazole|omeprazole|mesh-list
83643191|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83643192|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643193|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83643194|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643195|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643196|NCT01408927|Aspirin|aspirin|mesh-list
83643197|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83643198|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83643199|NCT01408927|Analgesics|analgesics|mesh-ancestor
83643200|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
83643201|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643202|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643203|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643204|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83643205|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83643206|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83643207|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643208|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83643209|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83643210|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643211|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
83643212|NCT01408953|Bevacizumab|bevacizumab|mesh-list
83643213|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83643214|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643215|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83643216|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83643217|NCT01408953|Growth Substances|growth substances|mesh-ancestor
83643218|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643219|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
83643220|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
83643221|NCT01408979|Analgesics|analgesics|mesh-ancestor
83643222|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
83643223|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643224|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643225|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
83643226|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83643227|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83643228|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
83643229|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83643230|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643231|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643232|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643233|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
83643234|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83643235|NCT01409005|Gemcitabine|gemcitabine|mesh-list
83643236|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83643237|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
83643238|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643239|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643240|NCT01409018|Itraconazole|itraconazole|mesh-list
83643241|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83643242|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
83643243|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643244|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83643245|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82797577|NCT05879237|Vitamin D|vitamin d|mesh-list
83643246|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643247|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643248|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83643249|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
83643250|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643251|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643252|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83643253|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83643255|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83643256|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
83643257|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643258|NCT01409174|Interferons|interferons|mesh-list
83643259|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
83643260|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
83643261|NCT01409174|Aldesleukin|aldesleukin|mesh-list
83643262|NCT01409174|Cisplatin|cisplatin|mesh-list
83643263|NCT01409174|Temozolomide|temozolomide|mesh-list
83643264|NCT01409174|Ipilimumab|ipilimumab|mesh-list
83643265|NCT01409174|Interleukin-2|interleukin-2|mesh-list
83643266|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643267|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
83643268|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643269|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83643270|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
83643271|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643272|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83643273|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83643274|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
83643275|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643276|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83643277|NCT01409174|Analgesics|analgesics|mesh-ancestor
83643278|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
83643279|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643280|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83643281|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83643282|NCT01409187|Interferons|interferons|mesh-list
83643283|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
83643284|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
83643285|NCT01409187|Aldesleukin|aldesleukin|mesh-list
83643286|NCT01409187|Ipilimumab|ipilimumab|mesh-list
83643287|NCT01409187|Interleukin-2|interleukin-2|mesh-list
83643288|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643289|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
83643290|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643291|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83643292|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83643293|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643294|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
83643295|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643296|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83643297|NCT01409187|Analgesics|analgesics|mesh-ancestor
83643298|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
83643299|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643300|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83643301|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83643302|NCT01409278|Ropivacaine|ropivacaine|mesh-list
83643303|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
83643304|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
83643305|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83643306|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643307|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
83643308|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643309|NCT01409369|Charcoal|charcoal|mesh-list
83643310|NCT01409369|Antidotes|antidotes|mesh-ancestor
83643311|NCT01409369|Protective Agents|protective agents|mesh-ancestor
83643312|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643313|NCT01409395|Metformin|metformin|mesh-list
83643314|NCT01409395|Nizatidine|nizatidine|mesh-list
83643315|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83643316|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643317|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83643318|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643319|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83643320|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
83643321|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
83643322|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797640|NCT05875506|Doxycycline|doxycycline|mesh-list
83643323|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643325|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83643326|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83643327|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643328|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643329|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643330|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643331|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
83643332|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83643333|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83643334|NCT01409603|Naproxen|naproxen|mesh-list
83643335|NCT01409603|Darexaban|darexaban|mesh-list
83643336|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83643337|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83643338|NCT01409603|Analgesics|analgesics|mesh-ancestor
83643339|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
83643340|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643341|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643342|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643343|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83643344|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
83643345|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83643346|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643347|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643348|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83643349|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
83643350|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83643351|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
83643352|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
83643353|NCT01409616|Aspirin|aspirin|mesh-list
83643354|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
83643355|NCT01409616|Salicylates|salicylates|mesh-list
83643356|NCT01409616|Darexaban|darexaban|mesh-list
83643357|NCT01409616|Clopidogrel|clopidogrel|mesh-list
83643358|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83643359|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83643360|NCT01409616|Analgesics|analgesics|mesh-ancestor
83643361|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
83643362|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643363|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643364|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643365|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83643366|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83643367|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83643368|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643369|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83643370|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83643371|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643372|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
83643373|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83643374|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83643375|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83643376|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
83643377|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643378|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643379|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
83643380|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
83643381|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
83643382|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83643383|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
83643384|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83643385|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
83643386|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
83643387|NCT01409694|Vitamin D|vitamin d|mesh-list
83643388|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
83643389|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
83643390|NCT01409694|Vitamins|vitamins|mesh-list
83643391|NCT01409694|Memantine|memantine|mesh-list
83643392|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
83643393|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643394|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83643395|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643396|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83643397|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83643398|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
83643399|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643400|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643401|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83643402|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83643403|NCT01409733|Doxorubicin|doxorubicin|mesh-list
83643404|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83643405|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643406|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83643407|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83643408|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643409|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643410|NCT01409499|Sorafenib|sorafenib|mesh-list
83643411|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643412|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643413|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643414|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643415|NCT01409772|Ethanol|ethanol|mesh-list
83643416|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83643417|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643418|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83643419|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643420|NCT01410162|Tacrolimus|tacrolimus|mesh-list
83643421|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643422|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
83643423|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643424|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83643425|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643426|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643427|NCT01410201|Dexamethasone|dexamethasone|mesh-list
83643428|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
83643429|NCT01410201|BB 1101|bb 1101|mesh-list
83643430|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643431|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
83643432|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
83643433|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643434|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643435|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643436|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
83643437|NCT01410201|Hormones|hormones|mesh-ancestor
83643438|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643439|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83643440|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643441|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
83643442|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643443|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643444|NCT01410214|Cisplatin|cisplatin|mesh-list
83643445|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83643446|NCT01410214|Vinorelbine|vinorelbine|mesh-list
83643447|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643448|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643449|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643450|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643451|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83643452|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
83643453|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
82797790|NCT05844462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82797791|NCT05844462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797792|NCT05844462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797793|NCT05844462|Urological Agents|urological agents|mesh-ancestor
82797794|NCT05838768|Irinotecan|irinotecan|mesh-list
82797795|NCT05838768|Tislelizumab|tislelizumab|mesh-list
82797796|NCT05838768|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82797797|NCT05838768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82797798|NCT05838768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797799|NCT05838768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797800|NCT05838768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797801|NCT05838768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797802|NCT05838573|Metformin|metformin|mesh-list
82797803|NCT05838573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82797804|NCT05838573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797805|NCT05838521|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
82797806|NCT05838521|Immunoconjugates|immunoconjugates|mesh-ancestor
82797809|NCT05835245|Lenvatinib|lenvatinib|mesh-list
83643454|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
83643455|NCT01410370|Endostar protein|endostar protein|mesh-list
83643456|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83643457|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83643458|NCT01410370|Growth Substances|growth substances|mesh-ancestor
83643459|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643460|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83643461|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643462|NCT01410630|Telbivudine|telbivudine|mesh-list
83643463|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
83643464|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643465|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83643466|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643467|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643468|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
83643469|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83643470|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643471|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
83643472|NCT01410708|Dasatinib|dasatinib|mesh-list
83643473|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643474|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643475|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643476|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643477|NCT01410747|Tacrolimus|tacrolimus|mesh-list
83643478|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643479|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
83643480|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643481|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83643482|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643483|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643484|NCT01410916|Eculizumab|eculizumab|mesh-list
83643485|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83643486|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643487|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
83643488|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643489|NCT01410968|Poly ICLC|poly iclc|mesh-list
83643490|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
83643491|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
83643492|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643493|NCT01411072|Gemcitabine|gemcitabine|mesh-list
83643494|NCT01411072|Fluorouracil|fluorouracil|mesh-list
83643495|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83643496|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
83643497|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643498|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643499|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643500|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
83643501|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643502|NCT01411098|Etoposide|etoposide|mesh-list
83643503|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
83643504|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643505|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83643506|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83643507|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83643508|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643509|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643510|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83643511|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83643512|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83643513|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
83643514|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643515|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83643516|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82797869|NCT05814991|Nitroglycerin|nitroglycerin|mesh-list
82797870|NCT05814991|Vasodilator Agents|vasodilator agents|mesh-ancestor
82797871|NCT05814367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82797872|NCT05814367|Lubricant Eye Drops|lubricant eye drops|mesh-list
82797873|NCT05814367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82797883|NCT05809011|Dexamethasone|dexamethasone|mesh-list
82797884|NCT05809011|Prednisone|prednisone|mesh-list
82797885|NCT05809011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82797886|NCT05809011|Antiemetics|antiemetics|mesh-ancestor
82797887|NCT05809011|Autonomic Agents|autonomic agents|mesh-ancestor
82797888|NCT05809011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797889|NCT05809011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643517|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643519|NCT01411124|Promethazine|promethazine|mesh-list
83643520|NCT01411124|Gabapentin|gabapentin|mesh-list
83643521|NCT01411124|Analgesics|analgesics|mesh-ancestor
83643522|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
83643523|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643524|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643525|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
83643526|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83643527|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83643528|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83643529|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83643530|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83643531|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83643532|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643533|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643534|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
83643535|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83643536|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83643537|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
83643538|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
83643539|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
83643540|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
83643541|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643542|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83643543|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
83643544|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
83643545|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83643546|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
83643547|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
83643548|NCT01411176|Menthol|menthol|mesh-list
83643549|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
83643550|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
83643551|NCT01411189|Menthol|menthol|mesh-list
83643552|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
83643553|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83643554|NCT01411202|Doxycycline|doxycycline|mesh-list
83643555|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83643556|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643557|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
83643558|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83643559|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83643560|NCT01411254|Betamethasone|betamethasone|mesh-list
83643561|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
83643562|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83643563|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
83643564|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83643565|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643566|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
83643567|NCT01411254|Hormones|hormones|mesh-ancestor
83643568|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643569|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643570|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83643571|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
83643572|NCT01411280|Methylphenidate|methylphenidate|mesh-list
83643573|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83643574|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643575|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83643576|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83643577|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643578|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797944|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797945|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82797946|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82797947|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
82797948|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797949|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797950|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82797951|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
82797952|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797953|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
82797954|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797955|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643579|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
83643580|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643581|NCT01411410|Paclitaxel|paclitaxel|mesh-list
83643582|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83643583|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643584|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
83643585|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
83643586|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
83643587|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643588|NCT01411423|Sorafenib|sorafenib|mesh-list
83643589|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643590|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643591|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643592|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643593|NCT01411436|Sorafenib|sorafenib|mesh-list
83643594|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643595|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643596|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643597|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643598|NCT01411514|Prednisone|prednisone|mesh-list
83643599|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643600|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
83643601|NCT01411514|Hormones|hormones|mesh-ancestor
83643602|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643603|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643604|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83643605|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643606|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83643607|NCT01411670|Protein C|protein c|mesh-list
83643608|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
83643609|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83643610|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83643611|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643612|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643613|NCT01411735|Enalapril|enalapril|mesh-list
83643614|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83643615|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
83643616|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643617|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643618|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83643619|NCT01411930|Olanzapine|olanzapine|mesh-list
83643620|NCT01411930|Aripiprazole|aripiprazole|mesh-list
83643621|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
83643622|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
83643623|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643624|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643625|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643626|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83643627|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83643628|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83643629|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82798018|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
82798019|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
82798020|NCT05756166|Celecoxib|celecoxib|mesh-list
82798021|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
82798022|NCT05756166|Benzenesulfonamide|benzenesulfonamide|mesh-list
82798023|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798024|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798025|NCT05756166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798026|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798027|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
82798028|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798029|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
82798030|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798031|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82798032|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82798033|NCT05756166|Analgesics|analgesics|mesh-ancestor
82798034|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
82798035|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798036|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82798037|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82798038|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82798039|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82798040|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798041|NCT05756166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83643630|NCT01411930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83643631|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83643632|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643633|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643634|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643635|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
83643636|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
83643637|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
83643638|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
83643639|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83643640|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83643641|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83643642|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83643643|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83643644|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83643645|NCT01411969|Phenylephrine|phenylephrine|mesh-list
83643646|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
83643647|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83643648|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83643649|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
83643650|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643651|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643652|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643653|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
83643654|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
83643655|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643656|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
83643657|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83643658|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
83643659|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83643660|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
83643661|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83643662|NCT01411969|Protective Agents|protective agents|mesh-ancestor
83643663|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
83643664|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83643665|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643666|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643667|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
83643668|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643669|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643670|NCT01412073|Misoprostol|misoprostol|mesh-list
83643671|NCT01412073|Oxytocin|oxytocin|mesh-list
83643672|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
83643673|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83643674|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643675|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83643676|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
83643677|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83643678|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643679|NCT01412294|Capecitabine|capecitabine|mesh-list
83643680|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643681|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83643682|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
83643683|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643684|NCT01412307|Lenalidomide|lenalidomide|mesh-list
83643685|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83643686|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
83643687|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643688|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83643689|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83643690|NCT01412307|Growth Substances|growth substances|mesh-ancestor
82798096|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82798097|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
82798098|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798099|NCT05727371|Hylan|hylan|mesh-list
82798100|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
82798101|NCT05727371|Protective Agents|protective agents|mesh-ancestor
82798102|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798111|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
82798112|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82798113|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
82798114|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798115|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82798116|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83643692|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643693|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83643694|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
83643695|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643696|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
83643697|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83643698|NCT01412385|Antibodies|antibodies|mesh-list
83643699|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
83643700|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83643701|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
83643702|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
83643703|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643704|NCT01412411|Micronutrients|micronutrients|mesh-list
83643705|NCT01412411|Trace Elements|trace elements|mesh-list
83643706|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643707|NCT01412437|Verapamil|verapamil|mesh-list
83643708|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83643709|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83643710|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643711|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643712|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643713|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643714|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
83643715|NCT01412515|Everolimus|everolimus|mesh-list
83643716|NCT01412515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83643717|NCT01412515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643718|NCT01412515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643719|NCT01412515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643720|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643721|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
83643722|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643723|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643724|NCT01412567|Vaccines|vaccines|mesh-list
83643725|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
83643726|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643727|NCT01412632|Remifentanil|remifentanil|mesh-list
83643728|NCT01412632|Propofol|propofol|mesh-list
83643729|NCT01412632|Prilocaine|prilocaine|mesh-list
83643730|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83643731|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83643732|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643733|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83643734|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
83643735|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
83643736|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83643737|NCT01412632|Narcotics|narcotics|mesh-ancestor
83643738|NCT01412632|Analgesics|analgesics|mesh-ancestor
83643739|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
83643740|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643741|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
83643742|NCT01412645|Resveratrol|resveratrol|mesh-list
83643743|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
83643744|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643745|NCT01412645|Protective Agents|protective agents|mesh-ancestor
83643746|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643747|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643748|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83643749|NCT01412658|Caseins|caseins|mesh-list
83643750|NCT01412658|Glycerol|glycerol|mesh-list
83643751|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
83643752|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
83643753|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643754|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83643755|NCT01412658|Protective Agents|protective agents|mesh-ancestor
83643756|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643757|NCT01412671|Sorafenib|sorafenib|mesh-list
83643758|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643759|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643760|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643761|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643762|NCT01412840|Diclofenac|diclofenac|mesh-list
83643763|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83643764|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83643765|NCT01412840|Analgesics|analgesics|mesh-ancestor
83643766|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
83643767|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643768|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643769|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643771|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83643772|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643773|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643774|NCT01412892|Everolimus|everolimus|mesh-list
83643775|NCT01412892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83643776|NCT01412892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643777|NCT01412892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643778|NCT01412892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643779|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643780|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
83643781|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643782|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643783|NCT01413022|Leucovorin|leucovorin|mesh-list
83643784|NCT01413022|Fluorouracil|fluorouracil|mesh-list
83643785|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
83643786|NCT01413022|Irinotecan|irinotecan|mesh-list
83643787|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
83643788|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643789|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83643790|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643791|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643792|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
83643793|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643794|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83643795|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83643796|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643797|NCT01413022|Antidotes|antidotes|mesh-ancestor
83643798|NCT01413022|Protective Agents|protective agents|mesh-ancestor
83643799|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
83643800|NCT01413022|Vitamins|vitamins|mesh-ancestor
83643801|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
83643802|NCT01413048|Carvedilol|carvedilol|mesh-list
83643803|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83643804|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83643805|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83643806|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643807|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643808|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643809|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83643810|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
83643811|NCT01413048|Protective Agents|protective agents|mesh-ancestor
83643812|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83643813|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643814|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643815|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
83643816|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83643817|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83643818|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
83643819|NCT01413230|Vitamin D|vitamin d|mesh-list
83643820|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643821|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643822|NCT01413230|Vitamins|vitamins|mesh-ancestor
83643823|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
83643824|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83643825|NCT01413477|Calcitriol|calcitriol|mesh-list
83643826|NCT01413477|Betamethasone|betamethasone|mesh-list
83643827|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
83643828|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83643829|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
83643830|NCT01413477|Calcipotriene|calcipotriene|mesh-list
83643831|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83643832|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643833|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
83643834|NCT01413477|Hormones|hormones|mesh-ancestor
83643835|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643836|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643837|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83643838|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
83643839|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
82798243|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
83643840|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83643841|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83643842|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83643843|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643844|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83643845|NCT01413477|Vitamins|vitamins|mesh-ancestor
83643846|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
83643847|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83643848|NCT01413490|Rimantadine|rimantadine|mesh-list
83643849|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
83643850|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643851|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83643852|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643853|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643854|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
83643855|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643856|NCT01413620|Vitamins|vitamins|mesh-list
83643857|NCT01413620|Vitamin E|vitamin e|mesh-list
83643858|NCT01413620|Tocopherols|tocopherols|mesh-list
83643859|NCT01413620|Tocotrienols|tocotrienols|mesh-list
83643860|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
83643861|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
83643862|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643863|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
83643864|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643865|NCT01413620|Protective Agents|protective agents|mesh-ancestor
83643866|NCT01413711|Vigabatrin|vigabatrin|mesh-list
83643867|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
83643868|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643869|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643870|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
83643871|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643872|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643873|NCT01413763|Imiquimod|imiquimod|mesh-list
83643874|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83643875|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
83643876|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643877|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643878|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
83643879|NCT01413854|Diclofenac|diclofenac|mesh-list
83643880|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83643881|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83643882|NCT01413854|Analgesics|analgesics|mesh-ancestor
83643883|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
83643884|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643885|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643886|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643887|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83643888|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83643889|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643890|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643891|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
83643892|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83643893|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
83643894|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83643895|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643896|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83643897|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83643898|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83643899|NCT01414231|Cytarabine|cytarabine|mesh-list
83643900|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83643901|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
83643902|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643903|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643904|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
83643905|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643906|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83643907|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
83643908|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643909|NCT01414465|Orlistat|orlistat|mesh-list
83643910|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643911|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643912|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83643913|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83643914|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82798324|NCT05603104|Ketamine|ketamine|mesh-list
83643915|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
83643916|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643918|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
83643919|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83643920|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643921|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83643922|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83643923|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643924|NCT01414556|Incretins|incretins|mesh-ancestor
83643925|NCT01414556|Hormones|hormones|mesh-ancestor
83643926|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643927|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643928|NCT01414569|Dexamethasone|dexamethasone|mesh-list
83643929|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
83643930|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83643931|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
83643932|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
83643933|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643934|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643935|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83643936|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
83643937|NCT01414569|Hormones|hormones|mesh-ancestor
83643938|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643939|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83643940|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643941|NCT01414608|Paclitaxel|paclitaxel|mesh-list
83643942|NCT01414608|Cisplatin|cisplatin|mesh-list
83643943|NCT01414608|Carboplatin|carboplatin|mesh-list
83643944|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83643945|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83643946|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643947|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
83643948|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
83643949|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
83643950|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643951|NCT01414816|Interferons|interferons|mesh-list
83643952|NCT01414816|Interferon-beta|interferon-beta|mesh-list
83643953|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
83643954|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643955|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
83643956|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83643957|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
83643958|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643959|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83643960|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
83643961|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83643962|NCT01414868|Montelukast|montelukast|mesh-list
83643963|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
83643964|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83643965|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
83643966|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
83643967|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83643968|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643969|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83643970|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83643971|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643972|NCT01414881|Mipomersen|mipomersen|mesh-list
83643973|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83643974|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83643975|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
83643976|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643977|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83643978|NCT01414972|Vitamin A|vitamin a|mesh-list
83643979|NCT01414972|Vitamins|vitamins|mesh-ancestor
83643980|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
83643981|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643982|NCT01414998|Nicotine|nicotine|mesh-list
82798391|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
82798392|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82798393|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798396|NCT05580666|Azithromycin|azithromycin|mesh-list
82798397|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82798398|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798405|NCT05567406|Belumosudil|belumosudil|mesh-list
82798411|NCT05556889|Iodine|iodine|mesh-list
83643984|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
83643985|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83643986|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83643987|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83643988|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83643989|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
83643990|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83643991|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643992|NCT01415011|Afatinib|afatinib|mesh-list
83643993|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83643994|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83643995|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83643996|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83643997|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
83643998|NCT01415128|Desipramine|desipramine|mesh-list
83643999|NCT01415128|Omeprazole|omeprazole|mesh-list
83644000|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83644001|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83644002|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83644003|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644004|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644005|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83644006|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644007|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83644008|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
83644009|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644010|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83644011|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644012|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644013|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644014|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644015|NCT01415141|Ribavirin|ribavirin|mesh-list
83644016|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83644017|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
83644018|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644019|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
83644020|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644021|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83644022|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
83644023|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
83644024|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
83644025|NCT01415336|Doxorubicin|doxorubicin|mesh-list
83644026|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83644027|NCT01415336|Capecitabine|capecitabine|mesh-list
83644028|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644029|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
83644030|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644031|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644032|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83644033|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
83644034|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644035|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644036|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83644037|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83644038|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83644039|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83644040|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644041|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83644042|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
83644043|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83644044|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83644045|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83644046|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83644047|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644048|NCT01415505|Valsartan|valsartan|mesh-list
83644049|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83644050|NCT01415505|Nebivolol|nebivolol|mesh-list
83644051|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83644052|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83644053|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82798471|NCT05516914|Cisplatin|cisplatin|mesh-list
82798472|NCT05516914|Gemcitabine|gemcitabine|mesh-list
82798473|NCT05516914|Docetaxel|docetaxel|mesh-list
83644054|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644055|NCT01415505|Diuretics|diuretics|mesh-ancestor
83644056|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
83644057|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644058|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83644059|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644060|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
83644061|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83644062|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83644063|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83644064|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644065|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644066|NCT01415557|Micronutrients|micronutrients|mesh-list
83644067|NCT01415557|Trace Elements|trace elements|mesh-list
83644068|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644069|NCT01415596|Albuterol|albuterol|mesh-list
83644070|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83644071|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
83644072|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644073|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644074|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83644075|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
83644076|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
83644077|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83644078|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83644079|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83644080|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83644081|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644082|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644083|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644084|NCT01415687|Bisacodyl|bisacodyl|mesh-list
83644085|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
83644086|NCT01415687|Citric Acid|citric acid|mesh-list
83644087|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
83644088|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
83644089|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83644090|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
83644091|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
83644092|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644093|NCT01415687|Cathartics|cathartics|mesh-ancestor
83644094|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83644095|NCT01415687|Laxatives|laxatives|mesh-ancestor
83644096|NCT01415713|Leucovorin|leucovorin|mesh-list
83644097|NCT01415713|Gemcitabine|gemcitabine|mesh-list
83644098|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
83644099|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83644100|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
83644101|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644102|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644103|NCT01415713|Antidotes|antidotes|mesh-ancestor
83644104|NCT01415713|Protective Agents|protective agents|mesh-ancestor
83644105|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644106|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
83644107|NCT01415713|Vitamins|vitamins|mesh-ancestor
83644108|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
83644109|NCT01415765|Prednisone|prednisone|mesh-list
83644110|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
83644111|NCT01415765|Rituximab|rituximab|mesh-list
83644112|NCT01415765|Doxorubicin|doxorubicin|mesh-list
83644113|NCT01415765|Etoposide|etoposide|mesh-list
82798543|NCT05453968|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82798544|NCT05453968|Protease Inhibitors|protease inhibitors|mesh-ancestor
82798545|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798546|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798565|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
82798566|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82798567|NCT05440201|Enoxaparin|enoxaparin|mesh-list
82798568|NCT05440201|Anticoagulants|anticoagulants|mesh-list
82798569|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82798570|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82798571|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798592|NCT05422885|Dasatinib|dasatinib|mesh-list
82798593|NCT05422885|Quercetin|quercetin|mesh-list
82798594|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798595|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798596|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798597|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644114|NCT01415765|Vincristine|vincristine|mesh-list
83644115|NCT01415765|Pevonedistat|pevonedistat|mesh-list
83644116|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644117|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
83644118|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644119|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644120|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83644121|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
83644122|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644123|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644124|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83644125|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83644126|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83644127|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83644128|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83644129|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644130|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83644131|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
83644132|NCT01415765|Hormones|hormones|mesh-ancestor
83644133|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644134|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83644135|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83644136|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
83644137|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
83644138|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
83644139|NCT01415778|Bicalutamide|bicalutamide|mesh-list
83644140|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
83644141|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
83644142|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644143|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644144|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644145|NCT01415791|Bicalutamide|bicalutamide|mesh-list
83644146|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
83644147|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
83644148|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644149|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644150|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644151|NCT01415895|Clonidine|clonidine|mesh-list
83644152|NCT01415895|Naltrexone|naltrexone|mesh-list
83644153|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83644154|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83644155|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644156|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
83644157|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644158|NCT01415895|Analgesics|analgesics|mesh-ancestor
83644159|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83644160|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
83644161|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
83644162|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83644163|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83644164|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83644165|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644166|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644167|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644168|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
83644169|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644170|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
83644171|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644172|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644173|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83644174|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
83644175|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798620|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798621|NCT05414500|Immunotoxins|immunotoxins|mesh-ancestor
82798622|NCT05414500|Immunoconjugates|immunoconjugates|mesh-ancestor
82798623|NCT05414500|Immunologic Factors|immunologic factors|mesh-ancestor
82798624|NCT05414500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798625|NCT05411484|Doxycycline|doxycycline|mesh-list
82798626|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82798627|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798628|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
82798629|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82798630|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82798631|NCT05403450|Decitabine|decitabine|mesh-list
83644176|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644178|NCT01416116|Lidocaine|lidocaine|mesh-list
83644179|NCT01416116|Tramadol|tramadol|mesh-list
83644180|NCT01416116|Capsaicin|capsaicin|mesh-list
83644181|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
83644182|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
83644183|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644184|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644185|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
83644186|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644187|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83644188|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83644189|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83644190|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644191|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644192|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83644193|NCT01416116|Narcotics|narcotics|mesh-ancestor
83644194|NCT01416116|Analgesics|analgesics|mesh-ancestor
83644195|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
83644196|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
83644197|NCT01416207|Interferons|interferons|mesh-list
83644198|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
83644199|NCT01416207|Interferon-beta|interferon-beta|mesh-list
83644200|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644201|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
83644202|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644203|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83644204|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
83644205|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644206|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
83644207|NCT01416220|Paroxetine|paroxetine|mesh-list
83644208|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
83644209|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644210|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644211|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644212|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
83644213|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83644214|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644215|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644216|NCT01416220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83644217|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644218|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644219|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644220|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
83644221|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83644222|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83644223|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83644224|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
83644225|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83644226|NCT01416337|Trametinib|trametinib|mesh-list
83644227|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644228|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83644229|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644230|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644231|NCT01416350|Azithromycin|azithromycin|mesh-list
83644232|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83644233|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644234|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83644235|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83644236|NCT01416480|Theobromine|theobromine|mesh-list
83644237|NCT01416480|Dipropizine|dipropizine|mesh-list
82798693|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644238|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83644239|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
83644240|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798694|NCT05321940|Interferons|interferons|mesh-list
82798695|NCT05321940|Vaccines|vaccines|mesh-list
82798696|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
82798697|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798698|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798699|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
82798700|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798701|NCT05316493|Megestrol|megestrol|mesh-list
82798702|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
82798703|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
82798704|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
83644241|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644243|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
83644244|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
83644245|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
83644246|NCT01416558|Paclitaxel|paclitaxel|mesh-list
83644247|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83644248|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644249|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
83644250|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
83644251|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
83644252|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644253|NCT01416649|Exenatide|exenatide|mesh-list
83644254|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83644255|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644256|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83644257|NCT01416649|Incretins|incretins|mesh-ancestor
83644258|NCT01416649|Hormones|hormones|mesh-ancestor
83644259|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644260|NCT01416662|Gemcitabine|gemcitabine|mesh-list
83644261|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83644262|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
83644263|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644264|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644265|NCT01416701|Vitamin D|vitamin d|mesh-list
83644266|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
83644267|NCT01416701|Vitamins|vitamins|mesh-list
83644268|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
83644269|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644270|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644271|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644272|NCT01416870|Bicalutamide|bicalutamide|mesh-list
83644273|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
83644274|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
83644275|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644276|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644277|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644278|NCT01416883|Bicalutamide|bicalutamide|mesh-list
83644279|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
83644280|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
83644281|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644282|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644283|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644284|NCT01416909|Laxatives|laxatives|mesh-list
83644285|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83644286|NCT01416948|Methylphenidate|methylphenidate|mesh-list
83644287|NCT01416948|Galantamine|galantamine|mesh-list
83644288|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83644289|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644290|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83644291|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644292|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644293|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644294|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
83644295|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644296|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83644297|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644298|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
83644299|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83644300|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
83644301|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644302|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
83644303|NCT01416961|Etoposide|etoposide|mesh-list
83644304|NCT01416961|Cisplatin|cisplatin|mesh-list
83644305|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
83644306|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83644307|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644308|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83644309|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83644310|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644311|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644312|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
83644313|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644314|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
83644315|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644316|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644317|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83644318|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
83644319|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644320|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644321|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83644322|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83644323|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
83644324|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83644325|NCT01417065|Sirolimus|sirolimus|mesh-list
83644326|NCT01417065|Temsirolimus|temsirolimus|mesh-list
83644327|NCT01417065|MTOR Inhibitors|mtor inhibitors|mesh-list
83644328|NCT01417065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83644329|NCT01417065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644330|NCT01417065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644331|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644332|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
83644333|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644334|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644335|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83644336|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644337|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83644338|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
83644339|NCT01417169|Micafungin|micafungin|mesh-list
83533629|NCT03198221|Antacids|antacids|mesh-ancestor
83644340|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
83644341|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644342|NCT01417273|Vitamin A|vitamin a|mesh-list
83644343|NCT01417273|Vitamins|vitamins|mesh-ancestor
83644344|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
83644345|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644346|NCT01417351|Vitamin D|vitamin d|mesh-list
83644347|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
83644348|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
83644349|NCT01417351|Vitamins|vitamins|mesh-list
83644350|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
83644351|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644352|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644353|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644354|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
83644355|NCT01417364|Testosterone|testosterone|mesh-list
83644356|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
83644357|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
83644358|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83644359|NCT01417364|Androgens|androgens|mesh-ancestor
83644360|NCT01417364|Hormones|hormones|mesh-ancestor
83644361|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644362|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644363|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83644364|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644365|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
83644366|NCT01417390|Cisplatin|cisplatin|mesh-list
83644367|NCT01417390|Gemcitabine|gemcitabine|mesh-list
83644368|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644369|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83644370|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
83644371|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644372|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
83644373|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
83644374|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83644375|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83644376|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644377|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644378|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644379|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644380|NCT01417429|Galantamine|galantamine|mesh-list
83644381|NCT01417429|Nicotine|nicotine|mesh-list
83644382|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83644383|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
83644384|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644385|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644386|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83644387|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83644388|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
83644389|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644390|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644391|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83644392|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644393|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83644394|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
83644395|NCT01417494|Leucovorin|leucovorin|mesh-list
83644396|NCT01417494|Bevacizumab|bevacizumab|mesh-list
83644397|NCT01417494|Fluorouracil|fluorouracil|mesh-list
83644398|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
83644399|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83644400|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644401|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83644402|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83644403|NCT01417494|Growth Substances|growth substances|mesh-ancestor
83644404|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644405|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
83644406|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
83644407|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644408|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83644409|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644410|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
83644411|NCT01417494|Antidotes|antidotes|mesh-ancestor
83644412|NCT01417494|Protective Agents|protective agents|mesh-ancestor
83644413|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
83644414|NCT01417494|Vitamins|vitamins|mesh-ancestor
83644415|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
83644416|NCT01417572|Lidocaine|lidocaine|mesh-list
83644417|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
83644418|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
83644419|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644420|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644421|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
83644422|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644423|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83644424|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83644425|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83644426|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644427|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644428|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83644429|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83644430|NCT01417754|Toremifene|toremifene|mesh-list
83644431|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83644432|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644433|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83644434|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83644435|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
83644436|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644437|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644438|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644439|NCT01417767|Decitabine|decitabine|mesh-list
83644440|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83644441|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
83644442|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644443|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644444|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644445|NCT01417806|Topotecan|topotecan|mesh-list
83644446|NCT01417806|Pasireotide|pasireotide|mesh-list
83644447|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83644448|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83644449|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644450|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644451|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644452|NCT01417806|Hormones|hormones|mesh-ancestor
82798922|NCT05205252|Pomalidomide|pomalidomide|mesh-list
82798923|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
82798924|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82798925|NCT05205252|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82798926|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82798927|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
82798928|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
82798929|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798930|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798931|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82798932|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
82798933|NCT05205252|Hormones|hormones|mesh-ancestor
82798934|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798945|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
83644453|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644455|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83644456|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83644457|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83644458|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83644459|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83644460|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644461|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644462|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644463|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644464|NCT01417897|Insulin|insulin|mesh-list
83644465|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83644466|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
83644467|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
83644468|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83644469|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644470|NCT01417923|Vitamin D|vitamin d|mesh-list
83644471|NCT01417923|Vitamins|vitamins|mesh-ancestor
83644472|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
83644473|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644474|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644475|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83644476|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
83644477|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644478|NCT01418118|Dobutamine|dobutamine|mesh-list
83644479|NCT01418118|Epinephrine|epinephrine|mesh-list
83644480|NCT01418118|Norepinephrine|norepinephrine|mesh-list
83644481|NCT01418118|Dopexamine|dopexamine|mesh-list
83644482|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83644483|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83644484|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644485|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644486|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644487|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644488|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83644489|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83644490|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
83644491|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644492|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83644493|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
83644494|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
83644495|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
83644496|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83644497|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83644498|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83644499|NCT01418118|Protective Agents|protective agents|mesh-ancestor
83644500|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
83644501|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
83644502|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
83644503|NCT01418131|Tacrolimus|tacrolimus|mesh-list
83644504|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83644505|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644506|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
83644507|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644508|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644509|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644510|NCT01418144|Ropivacaine|ropivacaine|mesh-list
83644511|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
83644512|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
83644513|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644514|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644515|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
83644516|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644517|NCT01418157|Acetazolamide|acetazolamide|mesh-list
83644518|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
83644519|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83361963|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
82799000|NCT05158517|Vedolizumab|vedolizumab|mesh-list
82799001|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82799002|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
82799003|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82799004|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799005|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83644520|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644521|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644522|NCT01418157|Diuretics|diuretics|mesh-ancestor
83644523|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
83644524|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644525|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
83644526|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
83644527|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
83644528|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644529|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644530|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
83644531|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644532|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83644533|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83644534|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
83644535|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644536|NCT01418274|Ritonavir|ritonavir|mesh-list
83644537|NCT01418274|Escitalopram|escitalopram|mesh-list
83644538|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83644539|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83644540|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
83644541|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644542|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644543|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83644544|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83644545|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
83644546|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644547|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83644548|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83644549|NCT01418274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83644550|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644551|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644552|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644553|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
83644554|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644555|NCT01418417|Pantoprazole|pantoprazole|mesh-list
83644556|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83644557|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83644558|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83644559|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644560|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644561|NCT01418430|Daclizumab|daclizumab|mesh-list
83644562|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644563|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
83644564|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644565|NCT01418443|Pantoprazole|pantoprazole|mesh-list
83644566|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83644567|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83644568|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83644569|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644570|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644571|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83644572|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644573|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82799068|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
82799091|NCT05078866|Vaccines|vaccines|mesh-list
82799092|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
82799093|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799100|NCT05065970|Felzartamab|felzartamab|mesh-list
82799101|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799102|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
82799103|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799104|NCT05063552|Bevacizumab|bevacizumab|mesh-list
82799105|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82799106|NCT05063552|Cetuximab|cetuximab|mesh-list
82799107|NCT05063552|Atezolizumab|atezolizumab|mesh-list
82799108|NCT05063552|Cisplatin|cisplatin|mesh-list
82799109|NCT05063552|Carboplatin|carboplatin|mesh-list
82799110|NCT05063552|Docetaxel|docetaxel|mesh-list
82799111|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
82799112|NCT05063552|Antibodies|antibodies|mesh-list
82799113|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
82799114|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82799115|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
82799116|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799117|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82799118|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83644574|NCT01418534|Isosorbide|isosorbide|mesh-list
83644575|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83644576|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83644577|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83644578|NCT01418534|Diuretics|diuretics|mesh-ancestor
83644579|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
83644580|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644581|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
83644582|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83644583|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644584|NCT01418547|Isosorbide|isosorbide|mesh-list
83644585|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83644586|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83644587|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83644588|NCT01418547|Diuretics|diuretics|mesh-ancestor
83644589|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
83644590|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644591|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
83644592|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83644593|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644594|NCT01418586|Alfuzosin|alfuzosin|mesh-list
83644595|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83644596|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83644597|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83644598|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644599|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644600|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644601|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644602|NCT01418586|Urological Agents|urological agents|mesh-ancestor
83644603|NCT01418599|Alfuzosin|alfuzosin|mesh-list
83644604|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83644605|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83644606|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83644607|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
83644608|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644609|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644610|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644611|NCT01418599|Urological Agents|urological agents|mesh-ancestor
83644612|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83644613|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83644614|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644615|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644616|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644617|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644618|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644619|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83644620|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
83644621|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644622|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83644623|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83644624|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644625|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644626|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644627|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644628|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644629|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83644630|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
83644631|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644632|NCT01418651|Milnacipran|milnacipran|mesh-list
83644633|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83644634|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644635|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644636|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644637|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644638|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644639|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83644640|NCT01418651|Analgesics|analgesics|mesh-ancestor
83644641|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
83644642|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644643|NCT01418729|Pravastatin|pravastatin|mesh-list
83644644|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83644645|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83644646|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
83644647|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644648|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83644649|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83644650|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644651|NCT01418742|Doxycycline|doxycycline|mesh-list
83644652|NCT01418742|Panitumumab|panitumumab|mesh-list
83644653|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83644654|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644655|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
83644656|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83644657|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83644658|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83644659|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644660|NCT01418794|Sirolimus|sirolimus|mesh-list
83644661|NCT01418794|Temsirolimus|temsirolimus|mesh-list
83644662|NCT01418794|MTOR Inhibitors|mtor inhibitors|mesh-list
83644663|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83644664|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644665|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83644666|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644667|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
83644668|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644669|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
83644670|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644671|NCT01418794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83644672|NCT01418794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644673|NCT01418794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644674|NCT01419041|Crizotinib|crizotinib|mesh-list
83644675|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644676|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83644677|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644678|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644679|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
83644680|NCT01419119|Vitamin D|vitamin d|mesh-list
83644681|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83644682|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644683|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644684|NCT01419119|Vitamins|vitamins|mesh-ancestor
83644685|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
83644686|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644687|NCT01419132|Furosemide|furosemide|mesh-list
83644688|NCT01419132|Diuretics|diuretics|mesh-list
83644689|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
83644690|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644691|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83644692|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644693|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644694|NCT01419262|Vitamin D|vitamin d|mesh-list
83644695|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
83644696|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
83644697|NCT01419262|Vitamins|vitamins|mesh-list
83644698|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
83644699|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644700|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644701|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644702|NCT01419340|Donepezil|donepezil|mesh-list
83644703|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83644704|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644705|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644706|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
83644707|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644708|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644709|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
82799222|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
82799223|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82799224|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799225|NCT04988295|Carboplatin|carboplatin|mesh-list
82799226|NCT04988295|Pemetrexed|pemetrexed|mesh-list
82799227|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
82799228|NCT04988295|Lazertinib|lazertinib|mesh-list
82799229|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799230|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799231|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799232|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83644710|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83644711|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83644712|NCT01419353|Estradiol|estradiol|mesh-list
83644713|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83644714|NCT01419353|Estrogens|estrogens|mesh-ancestor
83644715|NCT01419353|Hormones|hormones|mesh-ancestor
83644716|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644717|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644718|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83644719|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
83644720|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83644721|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83644722|NCT01419366|Donepezil|donepezil|mesh-list
83644723|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83644724|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644725|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644726|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
83644727|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644728|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644729|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
83644730|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
83644731|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644732|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
83644733|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83644734|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83644735|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644736|NCT01419392|Urological Agents|urological agents|mesh-ancestor
83644737|NCT01419405|Pregabalin|pregabalin|mesh-list
83644738|NCT01419405|Remifentanil|remifentanil|mesh-list
83644739|NCT01419405|Analgesics|analgesics|mesh-ancestor
83644740|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
83644741|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644742|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644743|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
83644744|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83644745|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644746|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644747|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644748|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83644749|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83644750|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644751|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644752|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83644753|NCT01419405|Narcotics|narcotics|mesh-ancestor
83644754|NCT01419457|Favipiravir|favipiravir|mesh-list
83644755|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
83644756|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644757|NCT01419548|Paclitaxel|paclitaxel|mesh-list
83644758|NCT01419548|Carboplatin|carboplatin|mesh-list
82799298|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799299|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
82799300|NCT04931355|Cetrorelix|cetrorelix|mesh-list
82799301|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799302|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799303|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82799304|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
82799305|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82799306|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
82799307|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
82799308|NCT04924374|Atezolizumab|atezolizumab|mesh-list
82799309|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82799310|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799311|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799312|NCT04924374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799313|NCT04924374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799314|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
82799315|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799343|NCT04918147|Acetaminophen|acetaminophen|mesh-list
82799344|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
82799345|NCT04918147|Promethazine|promethazine|mesh-list
82799346|NCT04918147|Prednisone|prednisone|mesh-list
82799347|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
82799348|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82799349|NCT04918147|Elotuzumab|elotuzumab|mesh-list
82799350|NCT04918147|Famotidine|famotidine|mesh-list
82799353|NCT04918147|Hormones|hormones|mesh-ancestor
82799375|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
83644759|NCT01419548|Veliparib|veliparib|mesh-list
83644760|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83644761|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644762|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
83644763|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
83644764|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
83644765|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644766|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83644767|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644768|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83644769|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644770|NCT01419691|Auranofin|auranofin|mesh-list
83644771|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644772|NCT01419730|Vitamin D|vitamin d|mesh-list
83644773|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
83644774|NCT01419730|Vitamins|vitamins|mesh-ancestor
83644775|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
83644776|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644777|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644778|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644779|NCT01419821|Vitamin D|vitamin d|mesh-list
83644780|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
83644781|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
83644782|NCT01419821|Vitamins|vitamins|mesh-list
83644783|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
83644784|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644785|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83644786|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644787|NCT01419847|Ciclopirox|ciclopirox|mesh-list
83644788|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
83644789|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644790|NCT01419873|Insulin|insulin|mesh-list
83644791|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83644792|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83644793|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644794|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83644795|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83644796|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644797|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644798|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
83644799|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644800|NCT01420094|Aspirin|aspirin|mesh-list
83644801|NCT01420094|Acetaminophen|acetaminophen|mesh-list
83644802|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83644803|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83644804|NCT01420094|Analgesics|analgesics|mesh-ancestor
83644805|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
83644806|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644807|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644808|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83644809|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644810|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83644811|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83644812|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644813|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83644814|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83644815|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644816|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
83644817|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
83644818|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83644819|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
83644820|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
83644821|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644822|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644823|NCT01420302|Insulin|insulin|mesh-list
83644824|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83644825|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82799376|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799377|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799378|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82799379|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
82799380|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
82799383|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
83644826|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644827|NCT01420328|Simvastatin|simvastatin|mesh-list
83644828|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83644829|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83644830|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83644831|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
83644832|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644833|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83644834|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83644835|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644836|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83644837|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83644838|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644839|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83644840|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
83644841|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83644842|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83644843|NCT01420367|Metronidazole|metronidazole|mesh-list
83644844|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644845|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83644846|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83644847|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83644849|NCT01420406|Vitamins|vitamins|mesh-ancestor
83644850|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
83644851|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644852|NCT01420471|Triamcinolone|triamcinolone|mesh-list
83644853|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83644854|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83644855|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83644856|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83644857|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
83644858|NCT01420471|Hormones|hormones|mesh-ancestor
83644859|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644860|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644861|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644862|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
83644863|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644864|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644865|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
83644866|NCT01420523|Maraviroc|maraviroc|mesh-list
83644867|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83644868|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83644869|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
83644870|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83644871|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83644872|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83644873|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644874|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644875|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83644876|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83644877|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83644878|NCT01420575|Olanzapine|olanzapine|mesh-list
83644879|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
83644880|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
83644881|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644882|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644883|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83644884|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83644885|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83644886|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644887|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644888|NCT01420575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83644889|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83644890|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644891|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644892|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644893|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
83644894|NCT01420666|Acetaminophen|acetaminophen|mesh-list
82799448|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799449|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799450|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799451|NCT04805775|Desflurane|desflurane|mesh-list
82799452|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82799453|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
83644895|NCT01420666|Ibuprofen|ibuprofen|mesh-list
82799521|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644896|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83644897|NCT01420666|Analgesics|analgesics|mesh-ancestor
83644898|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
83644899|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644900|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644901|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
83644902|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83644903|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83644904|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644905|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83644906|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644907|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644908|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
83644909|NCT01420692|Gliclazide|gliclazide|mesh-list
83644910|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83644911|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644912|NCT01420822|Fluticasone|fluticasone|mesh-list
83644913|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83644914|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83644915|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
83644916|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644917|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644918|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83644919|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
83644920|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
83644921|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83644922|NCT01420900|Tacrine|tacrine|mesh-list
83644923|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83644924|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644925|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644926|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
83644927|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644928|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644929|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83644930|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
83644931|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644932|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
83644933|NCT01420913|Pregabalin|pregabalin|mesh-list
83644934|NCT01420913|Analgesics|analgesics|mesh-ancestor
83644935|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
83644936|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644937|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644938|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
83644939|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83644940|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83644941|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644942|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83644943|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83644944|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83644945|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644946|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644947|NCT01421043|Triazolam|triazolam|mesh-list
83644948|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83644949|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83644950|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83644951|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83644952|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644953|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83644954|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
83644955|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
83644956|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83644957|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644958|NCT01421121|Vaccines|vaccines|mesh-list
83644959|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
83644960|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644961|NCT01421160|Citric Acid|citric acid|mesh-list
82799522|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82799523|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799524|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82799525|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82799526|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
82799527|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799528|NCT04677972|Protective Agents|protective agents|mesh-ancestor
83644962|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
83644963|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
83644964|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83644965|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
83644966|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
83644967|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644968|NCT01421173|Dexamethasone|dexamethasone|mesh-list
83644969|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
83644970|NCT01421173|Rituximab|rituximab|mesh-list
83644971|NCT01421173|Gemcitabine|gemcitabine|mesh-list
83644972|NCT01421173|Melphalan|melphalan|mesh-list
83644973|NCT01421173|Busulfan|busulfan|mesh-list
83644974|NCT01421173|Vorinostat|vorinostat|mesh-list
83644975|NCT01421173|BB 1101|bb 1101|mesh-list
83644976|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83644977|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83644978|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
83644979|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83644980|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83644981|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83644982|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
83644983|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
83644984|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83644985|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83644986|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
83644987|NCT01421173|Hormones|hormones|mesh-ancestor
83644988|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83644989|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83644990|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83644991|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
83644992|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83644993|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83644994|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
83644995|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83644996|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83644997|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83644998|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83644999|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
83645000|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
83645001|NCT01421212|Antibodies|antibodies|mesh-list
83645002|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
83645003|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83645004|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83645005|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
83645006|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
83645007|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645008|NCT01421368|Tenofovir|tenofovir|mesh-list
83645009|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83645010|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
83645011|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
83645012|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
83645013|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
83645014|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645015|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83645016|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83645017|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645018|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645019|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83645020|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83645021|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83645022|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645023|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83645024|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83645025|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83645026|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83645027|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83645028|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83645029|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645030|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
83645031|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
83645032|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83645033|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82799595|NCT04630145|Clarithromycin|clarithromycin|mesh-list
82799596|NCT04630145|Rifampin|rifampin|mesh-list
82799597|NCT04630145|Ethambutol|ethambutol|mesh-list
83645034|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83645035|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83645036|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83645038|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645039|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645040|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645041|NCT01421706|Clarithromycin|clarithromycin|mesh-list
83645042|NCT01421706|Sibutramine|sibutramine|mesh-list
83645043|NCT01421706|Clopidogrel|clopidogrel|mesh-list
83645044|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83645045|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83645046|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83645047|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83645048|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
83645049|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645050|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645051|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645052|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83645053|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645054|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83645055|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645056|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83645057|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83645058|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
83645059|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83645060|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
83645061|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83645062|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
83645063|NCT01421901|Ertapenem|ertapenem|mesh-list
83645064|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83645065|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645066|NCT01421914|Bupivacaine|bupivacaine|mesh-list
83645067|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
83645068|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
83645069|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645070|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645071|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
83645072|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645073|NCT01421927|Lenalidomide|lenalidomide|mesh-list
83645074|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
83645075|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645076|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83645077|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83645078|NCT01421927|Growth Substances|growth substances|mesh-ancestor
83645079|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
83645080|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645081|NCT01421940|Udenafil|udenafil|mesh-list
83645082|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83645083|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83645084|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645085|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645086|NCT01421979|Caffeine|caffeine|mesh-list
83645087|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83645088|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645089|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83645090|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645091|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645092|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83645093|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83645094|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
83645095|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645096|NCT01421992|Methylphenidate|methylphenidate|mesh-list
83645097|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83645098|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645099|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83645100|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83645101|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645102|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645103|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
83645104|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645105|NCT01422018|Bevacizumab|bevacizumab|mesh-list
83645106|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83645107|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645108|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83645109|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83645110|NCT01422018|Growth Substances|growth substances|mesh-ancestor
83645111|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645112|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
83645114|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83645115|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
83645116|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83645117|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645118|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83645119|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645120|NCT01422109|Aspirin|aspirin|mesh-list
83645121|NCT01422109|Clopidogrel|clopidogrel|mesh-list
83645122|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83645123|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83645124|NCT01422109|Analgesics|analgesics|mesh-ancestor
83645125|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
83645126|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645127|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645128|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645129|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645130|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83645131|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83645132|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645133|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83645134|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83645135|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645136|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
83645137|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83645138|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83645139|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83645140|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
83645141|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645142|NCT01422122|Vitamin D|vitamin d|mesh-list
83645143|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
83645144|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
83645145|NCT01422122|Vitamins|vitamins|mesh-list
83645146|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
83645147|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645148|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83645149|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83645150|NCT01422291|Acetaminophen|acetaminophen|mesh-list
83645151|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83645152|NCT01422291|Morphine|morphine|mesh-list
83645153|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83645154|NCT01422291|Narcotics|narcotics|mesh-ancestor
83645155|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645156|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645157|NCT01422291|Analgesics|analgesics|mesh-ancestor
83645158|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
83645159|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645160|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83645161|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
83645162|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83645163|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645164|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645165|NCT01422317|Tocopherols|tocopherols|mesh-list
83645166|NCT01422317|Vitamin E|vitamin e|mesh-list
83645167|NCT01422317|Tocotrienols|tocotrienols|mesh-list
83645168|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
83645169|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
83645170|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645171|NCT01422317|Protective Agents|protective agents|mesh-ancestor
83645172|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645173|NCT01422317|Vitamins|vitamins|mesh-ancestor
83645174|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
83645175|NCT01422330|Etravirine|etravirine|mesh-list
83645176|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82799742|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799743|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799744|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799745|NCT04545736|Metformin|metformin|mesh-list
82799746|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82799747|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799748|NCT04542824|Prednisone|prednisone|mesh-list
82799749|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
83645177|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83645178|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645179|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645180|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
83645181|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645182|NCT01422460|Mitogens|mitogens|mesh-list
83645183|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83645184|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645185|NCT01422499|Vorinostat|vorinostat|mesh-list
83645186|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645187|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83645188|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645189|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645190|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83645191|NCT01422590|Mitiglinide|mitiglinide|mesh-list
83645192|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83645193|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645194|NCT01422590|Incretins|incretins|mesh-ancestor
83645195|NCT01422590|Hormones|hormones|mesh-ancestor
83645196|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645197|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83645198|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
83645199|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645200|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645201|NCT01422603|Clofarabine|clofarabine|mesh-list
83645202|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83645203|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
83645204|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645205|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645206|NCT01422616|Metoprolol|metoprolol|mesh-list
83645207|NCT01422616|Clonidine|clonidine|mesh-list
83645208|NCT01422616|Labetalol|labetalol|mesh-list
83645209|NCT01422616|Hydralazine|hydralazine|mesh-list
83645210|NCT01422616|Nicardipine|nicardipine|mesh-list
83645211|NCT01422616|Phentolamine|phentolamine|mesh-list
83645212|NCT01422616|Urapidil|urapidil|mesh-list
83645213|NCT01422616|Enalaprilat|enalaprilat|mesh-list
83645214|NCT01422616|Enalapril|enalapril|mesh-list
83645215|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83645216|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
83645217|NCT01422616|Esmolol|esmolol|mesh-list
83645218|NCT01422616|Glycerol|glycerol|mesh-list
83645219|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83645220|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83645221|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
83645222|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
83645223|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645224|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645225|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83645226|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83645227|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83645228|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
83645229|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645230|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645231|NCT01422616|Analgesics|analgesics|mesh-ancestor
83645232|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
83645233|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83645234|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83645235|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83645236|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83645237|NCT01422616|Protective Agents|protective agents|mesh-ancestor
82799834|NCT04521686|Gemcitabine|gemcitabine|mesh-list
82799835|NCT04521686|Durvalumab|durvalumab|mesh-list
82799836|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799837|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799838|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
82799839|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799840|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799841|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82799842|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
82799843|NCT04510051|Fludarabine|fludarabine|mesh-list
82799844|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82799845|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
83645238|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
83645239|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83645240|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83645241|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
83645242|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83645243|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83645244|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83645245|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645246|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83645247|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83645248|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
83645249|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83645250|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
83645251|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645252|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
83645253|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645254|NCT01422733|Dexamethasone|dexamethasone|mesh-list
83645255|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
83645256|NCT01422733|Cosyntropin|cosyntropin|mesh-list
83645257|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645258|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
83645259|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
83645260|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645261|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645262|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83645263|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
83645264|NCT01422733|Hormones|hormones|mesh-ancestor
83645265|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645266|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83645267|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645268|NCT01422785|Clindamycin|clindamycin|mesh-list
83645269|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
83645270|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
83645271|NCT01422785|Tretinoin|tretinoin|mesh-list
83645272|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83645273|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83645274|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645275|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83645276|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645277|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645278|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83645279|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645280|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
83645281|NCT01422954|Chloroquine|chloroquine|mesh-list
83645282|NCT01422954|Mefloquine|mefloquine|mesh-list
83645283|NCT01422954|Proguanil|proguanil|mesh-list
83645284|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83645285|NCT01422954|Amebicides|amebicides|mesh-ancestor
83645286|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83645287|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83645288|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645289|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
83645290|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645291|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
83645292|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645293|NCT01423019|Synephrine|synephrine|mesh-list
83645294|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83645295|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83645296|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83645297|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645298|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645299|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645300|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
83645301|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
83645302|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645303|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83645304|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
83645305|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
83645306|NCT01423032|Fludarabine|fludarabine|mesh-list
82799891|NCT04478279|Alkylating Agents|alkylating agents|mesh-ancestor
82799892|NCT04478279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799893|NCT04478279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799894|NCT04471428|Docetaxel|docetaxel|mesh-list
82799895|NCT04471428|Atezolizumab|atezolizumab|mesh-list
82799896|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799897|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799898|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799899|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799900|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645307|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83645308|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645309|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645310|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83645311|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
83645312|NCT01423123|Paclitaxel|paclitaxel|mesh-list
83645313|NCT01423123|Trastuzumab|trastuzumab|mesh-list
83645314|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83645315|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645316|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
83645317|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
83645318|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
83645319|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645320|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83645321|NCT01423175|Clofarabine|clofarabine|mesh-list
83645322|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83645323|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
83645324|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645325|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645326|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83645327|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83645328|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83645329|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645330|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645331|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83645332|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83645333|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83645334|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83645335|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83645336|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645337|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645338|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83645339|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83645340|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
83645341|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83645342|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83645343|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
83645344|NCT01423292|Bupivacaine|bupivacaine|mesh-list
83645345|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
83645346|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
83645347|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645348|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645349|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
83645350|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645351|NCT01423305|Budesonide|budesonide|mesh-list
83645352|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
83645353|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83645354|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645355|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83645356|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
83645357|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645358|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645359|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83645360|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
83645361|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
83645362|NCT01423305|Hormones|hormones|mesh-ancestor
83645363|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645364|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83645365|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83645366|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83645367|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
83645368|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645369|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645370|NCT01423370|Tadalafil|tadalafil|mesh-list
83645371|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
83645372|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83645373|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83645374|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645375|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645376|NCT01423370|Urological Agents|urological agents|mesh-ancestor
83645377|NCT01423435|Beraprost|beraprost|mesh-list
83645378|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83645379|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
83645380|NCT01423487|Metformin|metformin|mesh-list
83645381|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83645382|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645383|NCT01423500|Fludarabine|fludarabine|mesh-list
83645384|NCT01423500|Etoposide|etoposide|mesh-list
83645385|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
83645386|NCT01423500|Thiotepa|thiotepa|mesh-list
83645387|NCT01423500|Treosulfan|treosulfan|mesh-list
83645388|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645389|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645390|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83645391|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
83645392|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645393|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83645394|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83645395|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83645396|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645397|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83645398|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
83645399|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83645400|NCT01423539|Rituximab|rituximab|mesh-list
83645401|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83645402|NCT01423539|Navitoclax|navitoclax|mesh-list
83645403|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83645404|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645405|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
83645406|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645407|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645408|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83645409|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
83645410|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645411|NCT01423591|Infliximab|infliximab|mesh-list
83645412|NCT01423591|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83645413|NCT01423591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645414|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
83645415|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83645416|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645417|NCT01423695|Paclitaxel|paclitaxel|mesh-list
83645418|NCT01423695|Trastuzumab|trastuzumab|mesh-list
83645419|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83645420|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645421|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83645422|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83645423|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83645424|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645425|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83645426|NCT01423708|Everolimus|everolimus|mesh-list
83645427|NCT01423708|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83645428|NCT01423708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800041|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800042|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800043|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82800044|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82800045|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
82800046|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800047|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800048|NCT04302025|Atezolizumab|atezolizumab|mesh-list
82800049|NCT04302025|Vemurafenib|vemurafenib|mesh-list
82800050|NCT04302025|Pralsetinib|pralsetinib|mesh-list
82800051|NCT04302025|Entrectinib|entrectinib|mesh-list
82800052|NCT04302025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800053|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800054|NCT04302025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800055|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800056|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800057|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800058|NCT04301934|Estradiol|estradiol|mesh-list
82800059|NCT04301934|Estrogens|estrogens|mesh-list
82800060|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82800061|NCT04301934|Hormones|hormones|mesh-ancestor
82800062|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800063|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800106|NCT04281017|Anesthetics|anesthetics|mesh-list
82800107|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82800108|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645429|NCT01423708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645430|NCT01423708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645431|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83645432|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
83645433|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645434|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645435|NCT01423747|Fludarabine|fludarabine|mesh-list
83645436|NCT01423747|Etoposide|etoposide|mesh-list
83645437|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
83645438|NCT01423747|Thiotepa|thiotepa|mesh-list
83645439|NCT01423747|Treosulfan|treosulfan|mesh-list
83645440|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645441|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645442|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83645443|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
83645444|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645445|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83645446|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83645447|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83645448|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645449|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83645450|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
83645451|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83645452|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
83645453|NCT01423838|Oxybutynin|oxybutynin|mesh-list
83645454|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83645455|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83645456|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
83645457|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645458|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645459|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645460|NCT01423838|Urological Agents|urological agents|mesh-ancestor
83645461|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
83645462|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
83645463|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645464|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83645465|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83645466|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
83645467|NCT01423864|Prednisolone|prednisolone|mesh-list
83645468|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
83645469|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83645470|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83645471|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
83645472|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645473|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
83645474|NCT01423864|Hormones|hormones|mesh-ancestor
83645475|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645476|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645477|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83645478|NCT01423864|Protective Agents|protective agents|mesh-ancestor
83645479|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800119|NCT04261439|Tislelizumab|tislelizumab|mesh-list
82800120|NCT04261439|Spartalizumab|spartalizumab|mesh-list
82800121|NCT04261439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800122|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800123|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800124|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800125|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
82800126|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
82800127|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800128|NCT04261036|Protective Agents|protective agents|mesh-ancestor
82800129|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800130|NCT04261036|Vitamins|vitamins|mesh-ancestor
82800131|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
82800132|NCT04256707|Docetaxel|docetaxel|mesh-list
82800133|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
82800134|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800135|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
82800136|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
82800137|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
82800138|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800139|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800140|NCT04256707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800175|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
83645480|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645481|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
83645482|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
83645483|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645484|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83645485|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
83645486|NCT01423955|Hematinics|hematinics|mesh-ancestor
83645487|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
83645488|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83645489|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645490|NCT01424111|Escitalopram|escitalopram|mesh-list
83645491|NCT01424111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83645492|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83645493|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645494|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645495|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645496|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
83645497|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645498|NCT01424124|Montelukast|montelukast|mesh-list
83645499|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83645500|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
83645501|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83645502|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
83645503|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645504|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645505|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83645506|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83645507|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645508|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83645509|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83645510|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
83645511|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645512|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645513|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83645514|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
83645515|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
83645516|NCT01424137|Hormones|hormones|mesh-ancestor
83645517|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645518|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
83645519|NCT01424176|Pramipexole|pramipexole|mesh-list
83645520|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
83645521|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645522|NCT01424176|Protective Agents|protective agents|mesh-ancestor
83645523|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645524|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83645525|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83645526|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
83645527|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
83645528|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645529|NCT01424241|Octreotide|octreotide|mesh-list
83645530|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83645531|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83645532|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645533|NCT01424319|Atrasentan|atrasentan|mesh-list
83645534|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645535|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83645536|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83645537|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800217|NCT04095832|Anesthetics|anesthetics|mesh-list
82800218|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82800219|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800220|NCT04083365|Capecitabine|capecitabine|mesh-list
82800221|NCT04083365|Durvalumab|durvalumab|mesh-list
82800222|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82800223|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
82800224|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800225|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800226|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800238|NCT04072068|Edoxaban|edoxaban|mesh-list
82800239|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82800240|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
82800241|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82800242|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
83645539|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
83645540|NCT01424332|Salicylates|salicylates|mesh-list
83645541|NCT01424332|Darexaban|darexaban|mesh-list
83645542|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83645543|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83645544|NCT01424332|Analgesics|analgesics|mesh-ancestor
83645545|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
83645546|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645547|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645548|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645549|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645550|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83645551|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83645552|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645553|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83645554|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83645555|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645556|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
83645557|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645558|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
83645559|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
83645560|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
83645561|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83645562|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
83645563|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83645564|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
83645565|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
83645566|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83645567|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
83645568|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645569|NCT01424384|Citalopram|citalopram|mesh-list
83645570|NCT01424384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83645571|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83645572|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645573|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645574|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645575|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
83645576|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645577|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83645578|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
83645579|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83645580|NCT01424449|Aripiprazole|aripiprazole|mesh-list
83645581|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
83645582|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83645583|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83645584|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83645585|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645586|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645587|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
83645588|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
83645589|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645590|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645591|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83645592|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83645593|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
83645594|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83645595|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83645596|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83645597|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83645598|NCT01424618|Leuprolide|leuprolide|mesh-list
83645599|NCT01424618|Ganirelix|ganirelix|mesh-list
83645600|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83645601|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
83645602|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83645603|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645604|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83645605|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645606|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
83645607|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645608|NCT01424709|Cisplatin|cisplatin|mesh-list
83645609|NCT01424709|Gemcitabine|gemcitabine|mesh-list
83645610|NCT01424709|Docetaxel|docetaxel|mesh-list
83645611|NCT01424709|Irinotecan|irinotecan|mesh-list
83645612|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645613|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83645614|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
83645615|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645616|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83645617|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83645618|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83645619|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83645620|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83645621|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645622|NCT01424761|Ubiquinone|ubiquinone|mesh-list
83645623|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
83645624|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
83645625|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645626|NCT01424761|Vitamins|vitamins|mesh-ancestor
83645627|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
83645628|NCT01424826|Rifampin|rifampin|mesh-list
83645629|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83645630|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83645631|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
83645632|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645633|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83645634|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83645635|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645636|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645637|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83645638|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
83645639|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83645640|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
83645641|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83645642|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83645643|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83645644|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83645645|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83645646|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83645647|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83645648|NCT01424839|Cisplatin|cisplatin|mesh-list
83645649|NCT01424839|Carboplatin|carboplatin|mesh-list
83645650|NCT01424839|Etoposide|etoposide|mesh-list
83645651|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
83645652|NCT01424839|Ifosfamide|ifosfamide|mesh-list
83645653|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
83645654|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645655|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83645656|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83645657|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83645658|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645659|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645660|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83645661|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
83645662|NCT01424891|Simvastatin|simvastatin|mesh-list
83645663|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83645664|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83645665|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
83645666|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645667|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83645668|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83645669|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645670|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
83645671|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83645672|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645673|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83645674|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83645675|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645676|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82800346|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800347|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800348|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800351|NCT03916627|Cemiplimab|cemiplimab|mesh-list
82800352|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800353|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800354|NCT03912064|Ipilimumab|ipilimumab|mesh-list
82800355|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800356|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800357|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83645677|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
83645678|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83645679|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83645680|NCT01425099|Dolutegravir|dolutegravir|mesh-list
83645681|NCT01425099|Prednisone|prednisone|mesh-list
83645682|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645683|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
83645684|NCT01425099|Hormones|hormones|mesh-ancestor
83645685|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645686|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645687|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83645688|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645689|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83645690|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83645691|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645692|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645693|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83645694|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83645695|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
83645696|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645697|NCT01425125|Tolvaptan|tolvaptan|mesh-list
83645698|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83645699|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645700|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
83645701|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645702|NCT01425164|Carvedilol|carvedilol|mesh-list
83645703|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83645704|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83645705|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
83645706|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645707|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645708|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645709|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83645710|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
83645711|NCT01425164|Protective Agents|protective agents|mesh-ancestor
83645712|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83645713|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645714|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83645715|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
83645716|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83645717|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83645718|NCT01425216|Sorafenib|sorafenib|mesh-list
83645719|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645720|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83645721|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645722|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645723|NCT01425242|Amlodipine|amlodipine|mesh-list
83645724|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83645725|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83645726|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645727|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645728|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83645729|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645730|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
83645731|NCT01425320|Dapsone|dapsone|mesh-list
83645732|NCT01425320|Adapalene|adapalene|mesh-list
83645733|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83645734|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83645735|NCT01425320|Analgesics|analgesics|mesh-ancestor
83645736|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
83645737|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645738|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645739|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800422|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82800423|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800424|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82800425|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82800426|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82800427|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
82800428|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800429|NCT03781219|Vemurafenib|vemurafenib|mesh-list
82800430|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645740|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645741|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
83645742|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645743|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
83645744|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83645745|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83645746|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83645747|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645748|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645749|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
83645750|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83645751|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83645752|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83645753|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83645754|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
83645755|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645756|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83645757|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83645758|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645759|NCT01425411|Valsartan|valsartan|mesh-list
83645760|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83645761|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83645762|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83645763|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645764|NCT01425424|Vitamin D|vitamin d|mesh-list
83645765|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
83645766|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
83645767|NCT01425424|Vitamins|vitamins|mesh-list
83645768|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
83645769|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645770|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83645771|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83645772|NCT01425476|Vitamin D|vitamin d|mesh-list
83645773|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
83645774|NCT01425476|Celecoxib|celecoxib|mesh-list
83645775|NCT01425476|Vitamins|vitamins|mesh-ancestor
83645776|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
83645777|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645778|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83645779|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83645780|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83645781|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83645782|NCT01425476|Analgesics|analgesics|mesh-ancestor
83645783|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
83645784|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645785|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645786|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645787|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83645788|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83645789|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645790|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645791|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83645792|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83645793|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83645794|NCT01425580|Metformin|metformin|mesh-list
83645795|NCT01425580|Liraglutide|liraglutide|mesh-list
83645796|NCT01425580|Glimepiride|glimepiride|mesh-list
83645797|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83645798|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645799|NCT01425580|Incretins|incretins|mesh-ancestor
83645800|NCT01425580|Hormones|hormones|mesh-ancestor
83645801|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645802|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83645803|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83645804|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
83645805|NCT01425619|Lidocaine|lidocaine|mesh-list
83645806|NCT01425619|Prilocaine|prilocaine|mesh-list
83645807|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
83645808|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
83645809|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645810|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645811|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
83645812|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645813|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83645814|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83645815|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83645816|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645817|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645818|NCT01425658|Clonidine|clonidine|mesh-list
83645819|NCT01425658|Fentanyl|fentanyl|mesh-list
83645820|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83645821|NCT01425658|Narcotics|narcotics|mesh-ancestor
83645822|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645823|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645824|NCT01425658|Analgesics|analgesics|mesh-ancestor
83645825|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
83645826|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645827|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83645828|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83645829|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
83645830|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
83645831|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83645832|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
83645833|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
83645834|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83645835|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83645836|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83645837|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
83645838|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645839|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645840|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
83645841|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83645842|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83645843|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645844|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
83645845|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
83645846|NCT01425736|Cisplatin|cisplatin|mesh-list
83645847|NCT01425736|Docetaxel|docetaxel|mesh-list
83645848|NCT01425736|Fluorouracil|fluorouracil|mesh-list
83645849|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
83645850|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645851|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
83645852|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
83645853|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
83645854|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645855|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
83645856|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83645857|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83645858|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
83645859|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645860|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83645861|NCT01425775|Vitamin D|vitamin d|mesh-list
83645862|NCT01425775|Vitamins|vitamins|mesh-ancestor
83645863|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
83645864|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645865|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83645866|NCT05386446|Interferons|interferons|mesh-list
83645867|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
83645868|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645869|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
83645870|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645871|NCT05386433|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83645872|NCT05386433|Antiviral Agents|antiviral agents|mesh-ancestor
83645873|NCT05386433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645874|NCT05386290|Infliximab|infliximab|mesh-list
83645875|NCT05386290|Mesalamine|mesalamine|mesh-list
83645876|NCT05386290|Ustekinumab|ustekinumab|mesh-list
83645877|NCT05386290|Vedolizumab|vedolizumab|mesh-list
83645878|NCT05386290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83645879|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645880|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
83645881|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83645882|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645883|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83645884|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83645885|NCT05386290|Analgesics|analgesics|mesh-ancestor
83645886|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
83645887|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645888|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645889|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83645890|NCT05386186|Glimepiride|glimepiride|mesh-list
83645891|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83645892|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82800649|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83645893|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645894|NCT05386186|Incretins|incretins|mesh-ancestor
83645896|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645897|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
83645898|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645899|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645900|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83645901|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83645902|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
83645903|NCT05386160|Ranibizumab|ranibizumab|mesh-list
83645904|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83645905|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83645906|NCT05386160|Growth Substances|growth substances|mesh-ancestor
83645907|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645908|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
83645909|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645910|NCT05386121|Fentanyl|fentanyl|mesh-list
83645911|NCT05386121|Meperidine|meperidine|mesh-list
83645912|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83645913|NCT05386121|Narcotics|narcotics|mesh-ancestor
83645914|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645915|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645916|NCT05386121|Analgesics|analgesics|mesh-ancestor
83645917|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
83645918|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645919|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83645920|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83645921|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
83645922|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
83645923|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
83645924|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83645925|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645926|NCT05386056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83645927|NCT05386056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645928|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
83645929|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645930|NCT05385887|Metronidazole|metronidazole|mesh-list
83645931|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
83645932|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83645933|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83645934|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83645935|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83645936|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83645937|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83645938|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645939|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645940|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645941|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83645942|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83645943|NCT05385861|Carboplatin|carboplatin|mesh-list
83645944|NCT05385861|Irinotecan|irinotecan|mesh-list
83645945|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645946|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83645947|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83645948|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645949|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645950|NCT05385744|Teriflunomide|teriflunomide|mesh-list
83645951|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83645952|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83645953|NCT05385744|Analgesics|analgesics|mesh-ancestor
83645954|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
83645955|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645956|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645957|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83645958|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83645959|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83645960|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
83645961|NCT05385185|Endostatins|endostatins|mesh-list
83645962|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800650|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645963|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83645964|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83645965|NCT05385185|Growth Substances|growth substances|mesh-ancestor
83645966|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645967|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
83645969|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83645970|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83645971|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645972|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645973|NCT05385068|Niraparib|niraparib|mesh-list
83645974|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83645975|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83645976|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645977|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83645978|NCT05385029|Carbimazole|carbimazole|mesh-list
83645979|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
83645980|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
83645981|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83645982|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645983|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
83645984|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83645985|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83645986|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83645987|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83645988|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83645989|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
83645990|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83645991|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83645992|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83645993|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83645994|NCT05379374|Morphine|morphine|mesh-list
83645995|NCT05379374|Bupivacaine|bupivacaine|mesh-list
83645996|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
83645997|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
83645998|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83645999|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646000|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
83646001|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646002|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83646003|NCT05379374|Narcotics|narcotics|mesh-ancestor
83646004|NCT05379374|Analgesics|analgesics|mesh-ancestor
83646005|NCT05375708|Bevacizumab|bevacizumab|mesh-list
83646006|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646007|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646008|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83646009|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83646010|NCT05375708|Growth Substances|growth substances|mesh-ancestor
83646011|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646012|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
83646013|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83646014|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83646015|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83646016|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646017|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646018|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83646019|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83646020|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646021|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
83646022|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646023|NCT05176379|Fluconazole|fluconazole|mesh-list
83646024|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
83646025|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83646026|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83646027|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83646028|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646029|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646030|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83646031|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
83646032|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646033|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646034|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83646035|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83646036|NCT05113615|Bromides|bromides|mesh-list
83646037|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
83646038|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83646039|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
83646040|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646041|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646042|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83646043|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
83646044|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
83646045|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83646046|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
83646047|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646048|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646049|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
83646051|NCT04850378|Tinzaparin|tinzaparin|mesh-list
83646052|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83646053|NCT04850378|Apixaban|apixaban|mesh-list
83646054|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83646055|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
83646056|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83646057|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646058|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646059|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646060|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
83646061|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83646062|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83646063|NCT04809103|Cisplatin|cisplatin|mesh-list
83646064|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646065|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83646066|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83646067|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646068|NCT04765371|Dexamethasone|dexamethasone|mesh-list
83646069|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
83646070|NCT04765371|Prednisolone|prednisolone|mesh-list
83646071|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83646072|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
83646073|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83646074|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
83646075|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83646076|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
83646077|NCT04765371|BB 1101|bb 1101|mesh-list
83646078|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646079|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
83646080|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
83646081|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646082|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646083|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646084|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
83646085|NCT04765371|Hormones|hormones|mesh-ancestor
83646086|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646087|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646088|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646089|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646090|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646091|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646092|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83646093|NCT04765371|Protective Agents|protective agents|mesh-ancestor
83646094|NCT04744363|Ustekinumab|ustekinumab|mesh-list
83646095|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
83646096|NCT04729517|Azelastine|azelastine|mesh-list
83646097|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83646098|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
83646099|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646100|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646101|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83646102|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
83646103|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83646104|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646105|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646106|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83646107|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83646108|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83646109|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
83646110|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
83646111|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646112|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
83646113|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83646114|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83646115|NCT04673162|Prednisolone|prednisolone|mesh-list
83646116|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
83646117|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83646118|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
83646119|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646120|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
83646121|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
83646122|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646123|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646124|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646125|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
83646126|NCT04673162|Hormones|hormones|mesh-ancestor
83646127|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646128|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83646129|NCT04673162|Protective Agents|protective agents|mesh-ancestor
83646130|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646131|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646132|NCT04638660|Phentolamine|phentolamine|mesh-list
83646133|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83646134|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83646135|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83646136|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83646137|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
83646138|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646139|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646140|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646141|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83646142|NCT04622020|Anesthetics|anesthetics|mesh-list
83646143|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646144|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646145|NCT04560556|Antibodies|antibodies|mesh-list
83646146|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
83646147|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646148|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
83646149|NCT04425902|Metoprolol|metoprolol|mesh-list
83646150|NCT04425902|Digoxin|digoxin|mesh-list
83646151|NCT04425902|Midazolam|midazolam|mesh-list
83646152|NCT04425902|Caffeine|caffeine|mesh-list
83646153|NCT04425902|Omeprazole|omeprazole|mesh-list
83646154|NCT04425902|Pravastatin|pravastatin|mesh-list
83646155|NCT04425902|Montelukast|montelukast|mesh-list
83646156|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83646157|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83646158|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646159|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646160|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83646161|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83646162|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83646163|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83646164|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
83646165|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
82800873|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82800874|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800900|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
82800901|NCT03146962|Vitamins|vitamins|mesh-ancestor
82800902|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
82800903|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800904|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
82800905|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800906|NCT03146962|Protective Agents|protective agents|mesh-ancestor
82800907|NCT03110978|Nivolumab|nivolumab|mesh-list
82800908|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800909|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800910|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800911|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800912|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
82800913|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800914|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800915|NCT03089606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800916|NCT03089606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800917|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
82800918|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
82800919|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800920|NCT03077451|Nelfinavir|nelfinavir|mesh-list
83646166|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
83646167|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
83646168|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646169|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646170|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83646171|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83646172|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646173|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83646174|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83646175|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
83646176|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83646177|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646178|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83646179|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83646180|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
83646181|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83646182|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
83646183|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646184|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83646185|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83646186|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83646187|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83646188|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
83646189|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
83646190|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646191|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83646192|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83646193|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83646194|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83646195|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83646196|NCT04425902|Protective Agents|protective agents|mesh-ancestor
83646197|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83646198|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83646199|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
83646200|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83646201|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83646202|NCT04425902|Analgesics|analgesics|mesh-ancestor
83646203|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
83646204|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83646205|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83646206|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646207|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646208|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83646209|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83646210|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646211|NCT04311762|Cisplatin|cisplatin|mesh-list
83646212|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646213|NCT04203472|Budesonide|budesonide|mesh-list
83646214|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646215|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83646216|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
83646217|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646218|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646219|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83646220|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
83646221|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
83646222|NCT04203472|Hormones|hormones|mesh-ancestor
83646223|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646224|NCT04166071|Naltrexone|naltrexone|mesh-list
83646225|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83646226|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83646227|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646228|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
83646229|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646230|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83646231|NCT04072146|Varenicline|varenicline|mesh-list
82800948|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
82800949|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800950|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800951|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82800952|NCT02947685|Trastuzumab|trastuzumab|mesh-list
82800953|NCT02947685|Pertuzumab|pertuzumab|mesh-list
82800954|NCT02947685|Letrozole|letrozole|mesh-list
82800955|NCT02947685|Fulvestrant|fulvestrant|mesh-list
82800956|NCT02947685|Palbociclib|palbociclib|mesh-list
82800957|NCT02947685|Anastrozole|anastrozole|mesh-list
83646233|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83646234|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
83646235|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646236|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646237|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646238|NCT03945084|Niraparib|niraparib|mesh-list
83646239|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83646240|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646241|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646242|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646243|NCT03882463|Insulin|insulin|mesh-list
83646244|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83646245|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646246|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
83646247|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83646248|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
83646249|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646250|NCT03821649|Naloxone|naloxone|mesh-list
83646251|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83646252|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646253|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
83646254|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646255|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
83646256|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
83646257|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
83646258|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646259|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646260|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
83646261|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646262|NCT03771612|Naproxen|naproxen|mesh-list
83646263|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83646264|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83646265|NCT03771612|Analgesics|analgesics|mesh-ancestor
83646266|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
83646267|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646268|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646269|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646270|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646271|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
83646272|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83646273|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646274|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646275|NCT03734211|Evolocumab|evolocumab|mesh-list
83646276|NCT03734211|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83646277|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83646278|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83646279|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
83646280|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646281|NCT03734211|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83646282|NCT03734211|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646283|NCT03734211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646284|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83646285|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
83646286|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83646287|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83646288|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646289|NCT03708198|Bupivacaine|bupivacaine|mesh-list
83646290|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
83646291|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
82801027|NCT02813135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801028|NCT02813135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801029|NCT02813135|Antiemetics|antiemetics|mesh-ancestor
82801030|NCT02813135|Autonomic Agents|autonomic agents|mesh-ancestor
82801031|NCT02813135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801032|NCT02813135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801033|NCT02813135|Glucocorticoids|glucocorticoids|mesh-ancestor
82801034|NCT02813135|Hormones|hormones|mesh-ancestor
82801035|NCT02813135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801036|NCT02813135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801037|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801038|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82801039|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83646292|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646293|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646295|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646296|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
83646297|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83646298|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646299|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646300|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83646301|NCT03444753|Nivolumab|nivolumab|mesh-list
83646302|NCT03444753|Ipilimumab|ipilimumab|mesh-list
83646303|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646304|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646305|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83646306|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646307|NCT03142035|Dienogest|dienogest|mesh-list
83646308|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83646309|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
83646310|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83646311|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646312|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83646313|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83646314|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83646315|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83646316|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
83646317|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646318|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646319|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646320|NCT02786875|Vitamin D|vitamin d|mesh-list
83646321|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
83646322|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
83646323|NCT02786875|Vitamins|vitamins|mesh-list
83646324|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
83646325|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646326|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83646327|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83646328|NCT02767882|Dexamethasone|dexamethasone|mesh-list
83646329|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646330|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
83646331|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
83646332|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646333|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646334|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646335|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
83646336|NCT02767882|Hormones|hormones|mesh-ancestor
82801103|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
82801104|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801105|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82801106|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801107|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
82801108|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801109|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82801110|NCT02764762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82801111|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801112|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801113|NCT02732288|Melatonin|melatonin|mesh-list
82801114|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
82801115|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801116|NCT02732288|Protective Agents|protective agents|mesh-ancestor
82801117|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801118|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801119|NCT02687958|Everolimus|everolimus|mesh-list
82801120|NCT02687958|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82801121|NCT02687958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801122|NCT02687958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801123|NCT02687958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801124|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801125|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
82801126|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801127|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801128|NCT02659930|Doxorubicin|doxorubicin|mesh-list
82801129|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82801130|NCT02659930|Pomalidomide|pomalidomide|mesh-list
83646337|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646338|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646339|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646340|NCT02547662|Dexamethasone|dexamethasone|mesh-list
83646341|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
83646342|NCT02547662|Pomalidomide|pomalidomide|mesh-list
83646344|NCT02547662|Ichthammol|ichthammol|mesh-list
83646345|NCT02547662|BB 1101|bb 1101|mesh-list
83646346|NCT02547662|Glycine|glycine|mesh-list
83646347|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646348|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
83646349|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
83646350|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646351|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646352|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646353|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
83646354|NCT02547662|Hormones|hormones|mesh-ancestor
83646355|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646356|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646357|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646358|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646359|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646360|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646361|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
83646362|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83646363|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83646364|NCT02547662|Growth Substances|growth substances|mesh-ancestor
83646365|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
83646366|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83646367|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
83646368|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646369|NCT02246257|Metformin|metformin|mesh-list
83646370|NCT02246257|Losartan|losartan|mesh-list
83646371|NCT02246257|Simvastatin|simvastatin|mesh-list
83646372|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83646373|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646374|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83646375|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83646376|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
83646377|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646378|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83646379|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83646380|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646381|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83646382|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83646383|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83646384|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83646385|NCT02197221|Bortezomib|bortezomib|mesh-list
83646386|NCT02197221|Melphalan|melphalan|mesh-list
83646387|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646388|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83646389|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
83646390|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646391|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83646392|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83646393|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
83646394|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646395|NCT02010385|Octreotide|octreotide|mesh-list
83646396|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646397|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646398|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646399|NCT01949714|Epinephrine|epinephrine|mesh-list
83646400|NCT01949714|Racepinephrine|racepinephrine|mesh-list
83646401|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
83646402|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83646403|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83646404|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
83646405|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801179|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801180|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82801181|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82801182|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801183|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801184|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
83646406|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646407|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646408|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83646409|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83646410|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
83646411|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646412|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83646413|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
83646414|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
83646415|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
83646416|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83646417|NCT00223145|Goserelin|goserelin|mesh-list
83646418|NCT00223145|Bicalutamide|bicalutamide|mesh-list
83646419|NCT00223145|Androgens|androgens|mesh-list
83646420|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646421|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646422|NCT00223145|Hormones|hormones|mesh-ancestor
83646423|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646424|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646425|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
83646426|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
83646427|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83646428|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83646429|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83646430|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83646431|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646432|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646433|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646434|NCT01425827|Analgesics|analgesics|mesh-ancestor
83646435|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
83646436|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646437|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
83646438|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83646439|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
83646440|NCT01425840|Lidocaine|lidocaine|mesh-list
83646441|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
83646442|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
83646443|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646444|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646445|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
83646446|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646447|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83646448|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83646449|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83646450|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83646451|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646452|NCT01425996|Camptothecin|camptothecin|mesh-list
83646453|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83646454|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646455|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83646456|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83646457|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646458|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646459|NCT01426022|Ethanol|ethanol|mesh-list
83646460|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83646461|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83646462|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646463|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646464|NCT01426074|Bevacizumab|bevacizumab|mesh-list
83646465|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646466|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646467|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83646468|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83646469|NCT01426074|Growth Substances|growth substances|mesh-ancestor
83646470|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646471|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
83646472|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83646473|NCT01426087|Somatostatin|somatostatin|mesh-list
83646474|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83646475|NCT01426087|Hormones|hormones|mesh-ancestor
83646476|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646477|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646478|NCT01426100|Telmisartan|telmisartan|mesh-list
83646479|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83646480|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83646481|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83646482|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646483|NCT01426126|genexol-PM|genexol-pm|mesh-list
83646484|NCT01426126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646485|NCT01426126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83646486|NCT01426126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83646487|NCT01426126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83646488|NCT01426126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646489|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
83646490|NCT01426165|Analgesics|analgesics|mesh-ancestor
83646491|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
83646492|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646493|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646494|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
83646495|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646496|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83646497|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
83646498|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83646499|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83646500|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646501|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83646502|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
83646503|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83646504|NCT01426256|Vitamin D|vitamin d|mesh-list
83646505|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
83646506|NCT01426256|Vitamins|vitamins|mesh-ancestor
83646507|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
83646508|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646509|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83646510|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83646511|NCT01426334|Cyclosporine|cyclosporine|mesh-list
83646512|NCT01426334|Dasatinib|dasatinib|mesh-list
83646513|NCT01426334|Cyclosporins|cyclosporins|mesh-list
83646514|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646515|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646516|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83646517|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
83646518|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646519|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
83646520|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83646521|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
83646522|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646523|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83646524|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646525|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83646526|NCT01426399|Metformin|metformin|mesh-list
83646527|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83646528|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646529|NCT01426464|Latanoprost|latanoprost|mesh-list
83646530|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83646531|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83646532|NCT01426490|Vitamins|vitamins|mesh-list
83646533|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
83646534|NCT01426490|Folic Acid|folic acid|mesh-list
83646535|NCT01426490|Pyridoxine|pyridoxine|mesh-list
83646536|NCT01426490|Pyridoxal|pyridoxal|mesh-list
83646537|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
83646538|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
83646539|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
83646540|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646541|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
83646542|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646543|NCT01426490|Protective Agents|protective agents|mesh-ancestor
83646544|NCT01426490|Hematinics|hematinics|mesh-ancestor
83646545|NCT01426542|Topiramate|topiramate|mesh-list
83646546|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
83646547|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83646548|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646549|NCT01426633|Gemcitabine|gemcitabine|mesh-list
83646550|NCT01426633|Trabectedin|trabectedin|mesh-list
83646551|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83646552|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
83646553|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646554|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646555|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83646557|NCT01426646|Cisplatin|cisplatin|mesh-list
83646558|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646559|NCT01426737|Vildagliptin|vildagliptin|mesh-list
83646560|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83646561|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646562|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83646563|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646564|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646565|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646566|NCT01426802|Vildagliptin|vildagliptin|mesh-list
83646567|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83646568|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646569|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83646570|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646571|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646572|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646573|NCT01426815|Golimumab|golimumab|mesh-list
83646574|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83646575|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646576|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83646577|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
83646578|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646579|NCT01426880|Paclitaxel|paclitaxel|mesh-list
83646580|NCT01426880|Carboplatin|carboplatin|mesh-list
83646581|NCT01426880|Lapatinib|lapatinib|mesh-list
83646582|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83646583|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646584|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
83646585|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
83646586|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
83646587|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646588|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83646589|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646590|NCT01426906|Rifampin|rifampin|mesh-list
83646591|NCT01426906|Ketoconazole|ketoconazole|mesh-list
83646592|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83646593|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
83646594|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83646595|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83646596|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
83646597|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83646598|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646599|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646600|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83646601|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83646602|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83646603|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83646604|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83646605|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83646606|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
83646607|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83646608|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83646609|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83646610|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
83646611|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646612|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646613|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83646614|NCT01426971|Ibuprofen|ibuprofen|mesh-list
83646615|NCT01426971|Caffeine|caffeine|mesh-list
83646616|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83646617|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83646618|NCT01426971|Analgesics|analgesics|mesh-ancestor
83646619|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
83646620|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646621|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646622|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646623|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646624|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83646625|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646626|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646627|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83646628|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83646629|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83646630|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83646632|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646633|NCT01426984|Methylphenidate|methylphenidate|mesh-list
83646634|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83646635|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646636|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83646637|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83646638|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83646639|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646640|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
83646641|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646642|NCT01427114|Prednisolone|prednisolone|mesh-list
83646643|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
83646644|NCT01427114|Rituximab|rituximab|mesh-list
83646645|NCT01427114|Vincristine|vincristine|mesh-list
83646646|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83646647|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
83646648|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646649|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646650|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83646651|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
83646652|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646653|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646654|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83646655|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646656|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83646657|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
83646658|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
83646659|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
83646660|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646661|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
83646662|NCT01427114|Hormones|hormones|mesh-ancestor
83646663|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646664|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646665|NCT01427127|Ramosetron|ramosetron|mesh-list
83646666|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
83646667|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
83646668|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646669|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646670|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83536260|NCT05888207|Serotonin Agents|serotonin agents|mesh-ancestor
83646671|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83646672|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
83646673|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646674|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646675|NCT01427192|Acetazolamide|acetazolamide|mesh-list
83646676|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
83646677|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83646678|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646679|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646680|NCT01427192|Diuretics|diuretics|mesh-ancestor
83646681|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
83646682|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646683|NCT01427205|Cetuximab|cetuximab|mesh-list
83646684|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646685|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646686|NCT01427244|Trastuzumab|trastuzumab|mesh-list
83646687|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646688|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646689|NCT01427270|Oxycodone|oxycodone|mesh-list
83646690|NCT01427270|Naloxone|naloxone|mesh-list
83646691|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83646692|NCT01427270|Narcotics|narcotics|mesh-ancestor
83646693|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646694|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646695|NCT01427270|Analgesics|analgesics|mesh-ancestor
83646696|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
83646697|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646698|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83646699|NCT01427283|Oxycodone|oxycodone|mesh-list
83646700|NCT01427283|Naloxone|naloxone|mesh-list
83646701|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83646702|NCT01427283|Narcotics|narcotics|mesh-ancestor
83646704|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646705|NCT01427283|Analgesics|analgesics|mesh-ancestor
83646706|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
83646707|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646708|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83646709|NCT01427322|Lapatinib|lapatinib|mesh-list
83646710|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646711|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83646712|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646713|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646714|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
83646715|NCT01427335|Calcium|calcium|mesh-list
83646716|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83646717|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646718|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83646719|NCT01427387|Linaclotide|linaclotide|mesh-list
83646720|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83646721|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
83646722|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646723|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646724|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
83646725|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83646726|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83646727|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83646728|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83646729|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646730|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
83646731|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646732|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646733|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83646734|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646735|NCT01427478|Afatinib|afatinib|mesh-list
83646736|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646737|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83646738|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646739|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646740|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83646741|NCT01427491|Laxatives|laxatives|mesh-ancestor
83646742|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646743|NCT01427582|Trabectedin|trabectedin|mesh-list
83646744|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83646745|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
83536332|NCT05857514|Indomethacin|indomethacin|mesh-list
83646746|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646747|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646748|NCT01427686|Dobutamine|dobutamine|mesh-list
83646749|NCT01427686|Dopamine|dopamine|mesh-list
83646750|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83646751|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
83646752|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
83646753|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646754|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646755|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83646756|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83646757|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83646758|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
83646759|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646760|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646761|NCT01427686|Protective Agents|protective agents|mesh-ancestor
83646762|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
83646763|NCT01427699|Antibodies|antibodies|mesh-list
83646764|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
83646765|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646766|NCT01427842|Vancomycin|vancomycin|mesh-list
83646767|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83646768|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83646769|NCT01427868|Maleic acid|maleic acid|mesh-list
83646770|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646771|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646772|NCT01427946|Everolimus|everolimus|mesh-list
83646773|NCT01427946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83646774|NCT01427946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83646775|NCT01427946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801562|NCT00861705|Doxorubicin|doxorubicin|mesh-list
83646776|NCT01427946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646777|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83646778|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
83646779|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646780|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646782|NCT01427985|Fentanyl|fentanyl|mesh-list
83646783|NCT01427985|Mivacurium|mivacurium|mesh-list
83646784|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83646785|NCT01427985|Narcotics|narcotics|mesh-ancestor
83646786|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646787|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646788|NCT01427985|Analgesics|analgesics|mesh-ancestor
83646789|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
83646790|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646791|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83646792|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83646793|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
83646794|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
83646795|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83646796|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83646797|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
83646798|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83646799|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
83646800|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
83646801|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
83646802|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83646803|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83646804|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
83646805|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646806|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646807|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83646808|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83646809|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83646810|NCT01428037|Misoprostol|misoprostol|mesh-list
83646811|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83646812|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
83646813|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83646814|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646815|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83646816|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646817|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
83646818|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83646819|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
83646820|NCT01428154|Hematinics|hematinics|mesh-ancestor
83646821|NCT01428180|Ibuprofen|ibuprofen|mesh-list
83646822|NCT01428180|Indomethacin|indomethacin|mesh-list
83646823|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83646824|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83646825|NCT01428180|Analgesics|analgesics|mesh-ancestor
83646826|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
83646827|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646828|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646829|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646830|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646831|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83646832|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646833|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646834|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
83646835|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
83646836|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83646837|NCT01428284|Canagliflozin|canagliflozin|mesh-list
83646838|NCT01428284|Probenecid|probenecid|mesh-list
83646839|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83646840|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646841|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83646842|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646843|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
83646844|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
83646845|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646846|NCT01428375|Acetaminophen|acetaminophen|mesh-list
83646847|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83646848|NCT01428375|Analgesics|analgesics|mesh-ancestor
83646849|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
83646850|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801638|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646851|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646852|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
83646853|NCT01428388|Bevacizumab|bevacizumab|mesh-list
83646854|NCT01428388|Ranibizumab|ranibizumab|mesh-list
83646855|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646856|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646857|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83646858|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83646859|NCT01428388|Growth Substances|growth substances|mesh-ancestor
83646860|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646861|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
83646862|NCT01428414|Paclitaxel|paclitaxel|mesh-list
83646863|NCT01428414|Carboplatin|carboplatin|mesh-list
83646864|NCT01428414|Trastuzumab|trastuzumab|mesh-list
83646865|NCT01428414|Epirubicin|epirubicin|mesh-list
83646866|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83646867|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646868|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
83646869|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
83646870|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
83646871|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646872|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646873|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83646874|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83646875|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83646876|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646877|NCT01428427|Gemcitabine|gemcitabine|mesh-list
83646878|NCT01428427|Trametinib|trametinib|mesh-list
83646879|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83646880|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
83646881|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646882|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646883|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83646884|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646885|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83646886|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
83646887|NCT01428492|Dexamethasone|dexamethasone|mesh-list
83646888|NCT01428492|Bortezomib|bortezomib|mesh-list
83646889|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83646890|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
83646891|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
83646892|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646893|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646894|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83646895|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
83646896|NCT01428492|Hormones|hormones|mesh-ancestor
83646897|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83646898|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83646899|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646900|NCT01428518|Lamotrigine|lamotrigine|mesh-list
83646901|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
83646902|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83646903|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83646904|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646905|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83646906|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646907|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83646908|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83646909|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646910|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83646911|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83646912|NCT01428531|PENTA|penta|mesh-list
83646913|NCT01428531|Fondaparinux|fondaparinux|mesh-list
83646914|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83646915|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
83646916|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83646917|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646918|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646919|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646920|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
83646921|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83646922|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83646923|NCT01428544|PENTA|penta|mesh-list
83646924|NCT01428544|Fondaparinux|fondaparinux|mesh-list
83646925|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83646926|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
83646927|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83646928|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
83646929|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83646930|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646931|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
83646932|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83646933|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83646934|NCT01428622|Olodaterol|olodaterol|mesh-list
83646935|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83646936|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
83646937|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646938|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646939|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83646940|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
83646941|NCT01428817|Carbetocin|carbetocin|mesh-list
83646942|NCT01428817|Oxytocin|oxytocin|mesh-list
83646943|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
83646944|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83646945|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646946|NCT01428908|Vaccines|vaccines|mesh-list
83646947|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
83646948|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646949|NCT01428986|Maraviroc|maraviroc|mesh-list
83646950|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83646951|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83646952|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646953|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83646954|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83646955|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
83646956|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83646957|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83646958|NCT01429025|Rituximab|rituximab|mesh-list
83646959|NCT01429025|Lenalidomide|lenalidomide|mesh-list
83646960|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83646961|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83646962|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83646963|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
83646964|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646965|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83646966|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83646967|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83646968|NCT01429025|Growth Substances|growth substances|mesh-ancestor
83646969|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
83646970|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83646971|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
83646972|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646973|NCT01429090|Methantheline|methantheline|mesh-list
83646974|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83646975|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83646976|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
83646977|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646978|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646979|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646980|NCT01429129|Nicotine|nicotine|mesh-list
83646981|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83646982|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
83646983|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646984|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646985|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83646986|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83646987|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
83646988|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83646989|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83646990|NCT01429181|Methadone|methadone|mesh-list
83646991|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83646992|NCT01429181|Narcotics|narcotics|mesh-ancestor
83646993|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83646994|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83646995|NCT01429181|Analgesics|analgesics|mesh-ancestor
83646996|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
83646997|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83646998|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
83646999|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647000|NCT01429337|Midostaurin|midostaurin|mesh-list
83647001|NCT01429337|Staurosporine|staurosporine|mesh-list
83647002|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647003|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83647004|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647005|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647006|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
83647007|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83647008|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83647009|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83647010|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83647011|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647012|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
83647013|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647014|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647015|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83647016|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647017|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
83647019|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
83647020|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647021|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647022|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
83647023|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647024|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83647025|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
83647026|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83647027|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83647028|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647029|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83647030|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
83647031|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83647032|NCT01429545|Nifedipine|nifedipine|mesh-list
83647033|NCT01429545|Vasotocin|vasotocin|mesh-list
83647034|NCT01429545|Atosiban|atosiban|mesh-list
83647035|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83647036|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83647037|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647038|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83647039|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647040|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
83647041|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
83647042|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83647043|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83647044|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647045|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
83647046|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83647047|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83647048|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647049|NCT01429610|Cytarabine|cytarabine|mesh-list
83647050|NCT01429610|Rituximab|rituximab|mesh-list
83647051|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83647052|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647053|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
83647054|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647055|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647056|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83647057|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
83647058|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647059|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
83647060|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647061|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647062|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
83647063|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83647064|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647065|NCT01429701|Gentamicins|gentamicins|mesh-list
83647066|NCT01429701|Polymyxins|polymyxins|mesh-list
83647067|NCT01429701|Polymyxin B|polymyxin b|mesh-list
83647068|NCT01429701|Prednisolone|prednisolone|mesh-list
83647069|NCT01429701|Betamethasone|betamethasone|mesh-list
83647070|NCT01429701|Benzocaine|benzocaine|mesh-list
83647071|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647072|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
83647073|NCT01429701|Hormones|hormones|mesh-ancestor
83647074|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647075|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647076|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83647077|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647078|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647079|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83647080|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647081|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83647082|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647083|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83647084|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647085|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647086|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
83647087|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
83647088|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647089|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
83647090|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
83647091|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83647092|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83647093|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647094|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647095|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647096|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647097|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
83647098|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
83647099|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647100|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
83647101|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83647102|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647103|NCT01429818|Metformin|metformin|mesh-list
83647104|NCT01429818|Glimepiride|glimepiride|mesh-list
83647105|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83647106|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647107|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83647108|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647109|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
83647110|NCT01429831|Aripiprazole|aripiprazole|mesh-list
83647111|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
83647112|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83647113|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83647114|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83647115|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647116|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647117|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
83647118|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
83647119|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647120|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647121|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83647122|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83647123|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
83647124|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83647125|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83647126|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83647127|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83647128|NCT01429844|Cyclosporine|cyclosporine|mesh-list
83647129|NCT01429844|Tacrolimus|tacrolimus|mesh-list
83647130|NCT01429844|Cyclosporins|cyclosporins|mesh-list
83647131|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647132|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
83647133|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647134|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83647135|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647136|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647137|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
83647138|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647139|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647140|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647141|NCT01429870|Triamcinolone|triamcinolone|mesh-list
83647142|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647143|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
83647144|NCT01429870|Hormones|hormones|mesh-ancestor
83647145|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647146|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647147|NCT01429935|Ibuprofen|ibuprofen|mesh-list
83647148|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83647149|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83647150|NCT01429935|Analgesics|analgesics|mesh-ancestor
83647151|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
83647152|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647153|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647154|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647155|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647156|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83647157|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647158|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647159|NCT01430013|Endostar protein|endostar protein|mesh-list
83647160|NCT01430013|Endostatins|endostatins|mesh-list
83647161|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83647162|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83647163|NCT01430013|Growth Substances|growth substances|mesh-ancestor
83647164|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647165|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
83647166|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647167|NCT01430052|Gemcitabine|gemcitabine|mesh-list
83647168|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83647169|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
83647170|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647171|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647173|NCT01430065|Peficitinib|peficitinib|mesh-list
83647174|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647175|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
83647176|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647177|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83647178|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647179|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647180|NCT01430078|Niacinamide|niacinamide|mesh-list
83647181|NCT01430078|Peficitinib|peficitinib|mesh-list
83647182|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647183|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647184|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647185|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
83647186|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647187|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
83647188|NCT01430078|Vitamins|vitamins|mesh-ancestor
83647189|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
83647190|NCT01430195|Afamelanotide|afamelanotide|mesh-list
83647191|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647192|NCT01430234|Pancreatin|pancreatin|mesh-list
83647193|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647194|NCT01430260|Ciclesonide|ciclesonide|mesh-list
83647195|NCT01430260|Cetirizine|cetirizine|mesh-list
83647196|NCT01430260|Levocetirizine|levocetirizine|mesh-list
83647197|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
83647198|NCT01430260|Hormones|hormones|mesh-ancestor
83647199|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647200|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647201|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83647202|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83647203|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83647204|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
83647205|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
83647206|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647207|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647208|NCT01430312|Azelaic acid|azelaic acid|mesh-list
83647209|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647210|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647211|NCT01430520|Escitalopram|escitalopram|mesh-list
83647212|NCT01430520|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83647213|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83647214|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83647215|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647216|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647217|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
83647218|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647219|NCT01430533|Azelaic acid|azelaic acid|mesh-list
83647220|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647221|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647222|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
83647223|NCT01430650|Urological Agents|urological agents|mesh-ancestor
83647224|NCT01430689|Vaccines|vaccines|mesh-list
83647225|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
83647226|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647227|NCT01430793|Vitamin D|vitamin d|mesh-list
83647228|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
83647229|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
83647230|NCT01430793|Vitamins|vitamins|mesh-list
83647231|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
83647232|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647233|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83647234|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83647235|NCT01430806|Dronedarone|dronedarone|mesh-list
83647236|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83647237|NCT01430910|Ceftazidime|ceftazidime|mesh-list
83647238|NCT01430910|Avibactam|avibactam|mesh-list
83647239|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83647240|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647241|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83647242|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647243|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647244|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83647245|NCT01430923|Latanoprost|latanoprost|mesh-list
83647246|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83647247|NCT01431053|Aspirin|aspirin|mesh-list
83647248|NCT01431053|Exemestane|exemestane|mesh-list
83647249|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83647250|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83647251|NCT01431053|Analgesics|analgesics|mesh-ancestor
83647252|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
83647253|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647254|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647255|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647256|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647257|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83647258|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83647259|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647260|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83647261|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83647262|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647263|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
83647264|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647265|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83647266|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83647267|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83647268|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83647269|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647270|NCT01431092|Melatonin|melatonin|mesh-list
83647271|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
83647272|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647273|NCT01431092|Protective Agents|protective agents|mesh-ancestor
83647274|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647275|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647276|NCT01431118|Camphor|camphor|mesh-list
83647277|NCT01431118|Salicylates|salicylates|mesh-list
83647278|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
83647279|NCT01431118|Menthol|menthol|mesh-list
83647280|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83647281|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647282|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
83647283|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647284|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83647285|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83647286|NCT01431118|Analgesics|analgesics|mesh-ancestor
83647287|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
83647288|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647289|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647290|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647291|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647292|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83647293|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647294|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647295|NCT01431326|Vancomycin|vancomycin|mesh-list
83647296|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
83647297|NCT01431326|Tazobactam|tazobactam|mesh-list
83647298|NCT01431326|Piperacillin|piperacillin|mesh-list
83647299|NCT01431326|Tobramycin|tobramycin|mesh-list
83647300|NCT01431326|Amikacin|amikacin|mesh-list
83647301|NCT01431326|Cefepime|cefepime|mesh-list
83647302|NCT01431326|Fosfomycin|fosfomycin|mesh-list
83647303|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83647304|NCT01431326|Nafcillin|nafcillin|mesh-list
83647305|NCT01431326|Cidofovir|cidofovir|mesh-list
83647306|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
83647307|NCT01431326|Bosentan|bosentan|mesh-list
83647308|NCT01431326|Labetalol|labetalol|mesh-list
83647309|NCT01431326|Nifedipine|nifedipine|mesh-list
83647310|NCT01431326|Spironolactone|spironolactone|mesh-list
83647311|NCT01431326|Pentobarbital|pentobarbital|mesh-list
83647312|NCT01431326|Oxycodone|oxycodone|mesh-list
83647313|NCT01431326|Alfentanil|alfentanil|mesh-list
83647314|NCT01431326|Haloperidol|haloperidol|mesh-list
83647315|NCT01431326|Zolpidem|zolpidem|mesh-list
83647316|NCT01431326|Ziprasidone|ziprasidone|mesh-list
83647317|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83647318|NCT01431326|Clozapine|clozapine|mesh-list
83647319|NCT01431326|Molindone|molindone|mesh-list
83647320|NCT01431326|Warfarin|warfarin|mesh-list
83647321|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
83647322|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
83647323|NCT01431326|Rocuronium|rocuronium|mesh-list
83647324|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
83647325|NCT01431326|Sevelamer|sevelamer|mesh-list
83647326|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647327|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
83647328|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
83647329|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647330|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647331|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647332|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
83647333|NCT01431326|Hormones|hormones|mesh-ancestor
83647334|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647335|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83647336|NCT01431326|Protective Agents|protective agents|mesh-ancestor
83647337|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647338|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83647339|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83647340|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647341|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
83647342|NCT01431326|Coagulants|coagulants|mesh-ancestor
83647343|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83647344|NCT01431326|Narcotics|narcotics|mesh-ancestor
83647345|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647346|NCT01431326|Analgesics|analgesics|mesh-ancestor
83647347|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
83647348|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
83647349|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83647350|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647351|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83647352|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83647353|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83647354|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83647355|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83647356|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647357|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83647358|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83647359|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83647360|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
83647361|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83647362|NCT01431326|Diuretics|diuretics|mesh-ancestor
83647363|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
83647364|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83647365|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83647366|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83647367|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
83647368|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
83647369|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83647370|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83647371|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83647372|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83647373|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83647374|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83647375|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
83647376|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647377|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83647378|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83647379|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83647380|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83647381|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
83647382|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
83647383|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83647384|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
83647385|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83647386|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83647387|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
83647388|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
83647389|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83647390|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83647391|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83647392|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647393|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83647394|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83647395|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
83647396|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83647397|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
83647398|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83647399|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83647400|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
83647401|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
83647402|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
83647403|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83647404|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83647405|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
83647406|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83647407|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
83647408|NCT01431352|Letrozole|letrozole|mesh-list
83647409|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647410|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83647411|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83647412|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647413|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647414|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83647415|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
83647416|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647417|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647418|NCT01431404|Etanercept|etanercept|mesh-list
83647419|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83647420|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83647421|NCT01431404|Analgesics|analgesics|mesh-ancestor
83647422|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
83647423|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647424|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647425|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647426|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647427|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647428|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647429|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
83647430|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
83647431|NCT01431430|Vitamin D|vitamin d|mesh-list
83647432|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83647433|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647434|NCT01431430|Vitamins|vitamins|mesh-ancestor
83647435|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
83647436|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83647437|NCT01431443|Theobromine|theobromine|mesh-list
83647438|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83647439|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
83647440|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647441|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647442|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83647443|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647444|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
83647445|NCT01431456|Nadroparin|nadroparin|mesh-list
83647446|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
83647447|NCT01431456|Dabigatran|dabigatran|mesh-list
83647448|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83647449|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
83647450|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83647451|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
83647452|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647453|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647454|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
83647455|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83647456|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83647457|NCT01431495|Clopidogrel|clopidogrel|mesh-list
83647458|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83647459|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83647460|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83647461|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82802260|NCT04895306|Hormones|hormones|mesh-ancestor
83647462|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
83647463|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647464|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647465|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647466|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83647467|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
83647468|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647469|NCT01431612|Phenylephrine|phenylephrine|mesh-list
83647470|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
83647471|NCT01431612|Esmolol|esmolol|mesh-list
83647472|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83647473|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
83647474|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
83647475|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647476|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647477|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
83647478|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83647479|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
83647480|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647481|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83647482|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83647483|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83647484|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647485|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647486|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647487|NCT01431612|Protective Agents|protective agents|mesh-ancestor
83647488|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83647489|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83647490|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83647491|NCT01431690|Warfarin|warfarin|mesh-list
83647492|NCT01431690|Anticoagulants|anticoagulants|mesh-list
83647493|NCT01431729|Propolis|propolis|mesh-list
83647494|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647495|NCT01431742|Buprenorphine|buprenorphine|mesh-list
83647496|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83647497|NCT01431742|Narcotics|narcotics|mesh-ancestor
83647498|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647499|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647500|NCT01431742|Analgesics|analgesics|mesh-ancestor
83647501|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
83647502|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647503|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83647504|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83647505|NCT01431781|Somatostatin|somatostatin|mesh-list
83647506|NCT01431781|Hormones|hormones|mesh-ancestor
83647507|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647508|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647509|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
83647510|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83647511|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647512|NCT01431924|Fluticasone|fluticasone|mesh-list
83647513|NCT01431924|Xhance|xhance|mesh-list
83647514|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83647515|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647516|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83647517|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
83647518|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647519|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647520|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83647521|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647522|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647523|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83647524|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83647525|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83647526|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83647527|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647528|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647529|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647530|NCT01432028|Drospirenone|drospirenone|mesh-list
83647531|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83647532|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83647533|NCT01432028|Estradiol|estradiol|mesh-list
83647534|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83647535|NCT01432028|Progesterone|progesterone|mesh-list
83647536|NCT01432028|Estrogens|estrogens|mesh-ancestor
83647537|NCT01432028|Hormones|hormones|mesh-ancestor
83834860|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647538|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647539|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647540|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83647541|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
83647542|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83647543|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83647544|NCT01432028|Progestins|progestins|mesh-ancestor
83647545|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83647546|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
83647547|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83647548|NCT01432028|Diuretics|diuretics|mesh-ancestor
83647549|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
83647550|NCT01432080|Azithromycin|azithromycin|mesh-list
83647551|NCT01432080|Prednisone|prednisone|mesh-list
83647552|NCT01432080|Budesonide|budesonide|mesh-list
83647553|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
83647554|NCT01432080|Montelukast|montelukast|mesh-list
83647555|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83647556|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647557|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
83647558|NCT01432080|Hormones|hormones|mesh-ancestor
83647559|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647560|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647561|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83647562|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647563|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83647564|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
83647565|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647566|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83647567|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647568|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83647569|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647570|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83647571|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83647572|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83647573|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647574|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647575|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647576|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83647577|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83647578|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83537160|NCT05630781|Suvorexant|suvorexant|mesh-list
83647579|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83647580|NCT01432106|Valsartan|valsartan|mesh-list
83647581|NCT01432106|Ramipril|ramipril|mesh-list
83647582|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83647583|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83647584|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83647585|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647586|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83647587|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83647588|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647589|NCT01432119|Cetuximab|cetuximab|mesh-list
83647590|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83647591|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83647592|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647593|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83647594|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647595|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647596|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83647597|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
83647598|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647599|NCT01432223|Paclitaxel|paclitaxel|mesh-list
83647600|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83647601|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647602|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
83647603|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
83647604|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
83647605|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647606|NCT01432249|Etanercept|etanercept|mesh-list
83647607|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83647608|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83647609|NCT01432249|Analgesics|analgesics|mesh-ancestor
82802393|NCT00889733|Cisplatin|cisplatin|mesh-list
83647610|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
83647611|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647612|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647613|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647614|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647615|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647616|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647617|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
83647619|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
83647620|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83647621|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647622|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
83647623|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647624|NCT01432496|Ropivacaine|ropivacaine|mesh-list
83647625|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
83647626|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
83647627|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647628|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647629|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
83647630|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647631|NCT01432522|Epinephrine|epinephrine|mesh-list
83647632|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83647633|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83647634|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647635|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647636|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647637|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647638|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83647639|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83647640|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
83647641|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647642|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83647643|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
83647644|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
83647645|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
83647646|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83647647|NCT01432587|Diflunisal|diflunisal|mesh-list
83647648|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83647649|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83647650|NCT01432587|Analgesics|analgesics|mesh-ancestor
83647651|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
83647652|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647653|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647654|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647655|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83647656|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83647657|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647658|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647659|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
83647660|NCT01432665|Testosterone|testosterone|mesh-list
83647661|NCT01432665|Androgens|androgens|mesh-ancestor
83647662|NCT01432665|Hormones|hormones|mesh-ancestor
83647663|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647664|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647665|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
83647666|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83647667|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83647668|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647669|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647670|NCT01432665|Urological Agents|urological agents|mesh-ancestor
83647671|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
83647672|NCT01432704|Vitamin D|vitamin d|mesh-list
83647673|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83647674|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647675|NCT01432704|Vitamins|vitamins|mesh-ancestor
83647676|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
83647677|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83647678|NCT01432717|Luspatercept|luspatercept|mesh-list
83647679|NCT01432717|Hematinics|hematinics|mesh-ancestor
83647680|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
83647681|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83647682|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83647683|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83647684|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83647685|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647686|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
83647687|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647688|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647689|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83647690|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647691|NCT01432821|Apomorphine|apomorphine|mesh-list
83647692|NCT01432821|Emetics|emetics|mesh-ancestor
83647693|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647694|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
83647695|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647696|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647697|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
83647698|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
83647699|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647700|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647701|NCT01432873|Selenium|selenium|mesh-list
83647702|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
83647703|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647704|NCT01432873|Protective Agents|protective agents|mesh-ancestor
83647705|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647706|NCT01432873|Trace Elements|trace elements|mesh-ancestor
83647707|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
83647708|NCT01432977|Acetaminophen|acetaminophen|mesh-list
83647709|NCT01432977|Droperidol|droperidol|mesh-list
83647710|NCT01432977|Ondansetron|ondansetron|mesh-list
83647711|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83647712|NCT01432977|Analgesics|analgesics|mesh-ancestor
83647713|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
83647714|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647715|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647716|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
83647717|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
83647718|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
83647719|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647720|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
83647721|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647722|NCT01432977|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83647723|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83647724|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
83647725|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647726|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647727|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83647728|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83647729|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83647730|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647731|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83647732|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83647733|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83647734|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
83647735|NCT01433445|Panobinostat|panobinostat|mesh-list
83647736|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647737|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83647738|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647739|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647740|NCT01433614|Paclitaxel|paclitaxel|mesh-list
83647741|NCT01433614|Capecitabine|capecitabine|mesh-list
83647742|NCT01433614|Epirubicin|epirubicin|mesh-list
83647743|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83647744|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647745|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
83647746|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
83647747|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
83647748|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647749|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83647750|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
83647751|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83647752|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83647753|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83647754|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647755|NCT01433627|Hirudins|hirudins|mesh-list
83647756|NCT01433627|Bivalirudin|bivalirudin|mesh-list
83647757|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
83647758|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83647759|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
83647760|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802539|NCT04017845|Tribenoside|tribenoside|mesh-list
83647761|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647762|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
83647763|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83647764|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83647765|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
83647766|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83647767|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647768|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647769|NCT01433705|Regadenoson|regadenoson|mesh-list
83647770|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647771|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83647772|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83647773|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
83647774|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
83647775|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647776|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647777|NCT01433757|Ampicillin|ampicillin|mesh-list
83647778|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83647779|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647780|NCT01433770|Alefacept|alefacept|mesh-list
83647781|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647782|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
83647783|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647784|NCT01433887|Ribavirin|ribavirin|mesh-list
83647785|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83647786|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
83647787|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647788|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
83647789|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647790|NCT01433900|Latanoprost|latanoprost|mesh-list
83647791|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83647792|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83647793|NCT01433952|Thiamine|thiamine|mesh-list
83647794|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
83647795|NCT01433952|Vitamins|vitamins|mesh-ancestor
83647796|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
83647797|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647798|NCT01434017|Dexamethasone|dexamethasone|mesh-list
83647799|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
83647800|NCT01434017|Droperidol|droperidol|mesh-list
83647801|NCT01434017|Ondansetron|ondansetron|mesh-list
83647802|NCT01434017|BB 1101|bb 1101|mesh-list
83647803|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83647804|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
83647805|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
83647806|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647807|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647808|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647809|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
83647810|NCT01434017|Hormones|hormones|mesh-ancestor
83647811|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647812|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83647813|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647814|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
83647815|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647816|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647817|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
83647818|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
83647819|NCT01434017|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83647820|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83647821|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
83647822|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647823|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83647824|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83647825|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83647826|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83647827|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83647828|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83647829|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83647830|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
83647831|NCT01434069|Leucovorin|leucovorin|mesh-list
83647832|NCT01434069|Fluorouracil|fluorouracil|mesh-list
83647833|NCT01434069|Pasireotide|pasireotide|mesh-list
83647834|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
83647835|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647836|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83647837|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647838|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83647839|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
83647840|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647841|NCT01434069|Antidotes|antidotes|mesh-ancestor
83647842|NCT01434069|Protective Agents|protective agents|mesh-ancestor
83647843|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
83647844|NCT01434069|Vitamins|vitamins|mesh-ancestor
83647845|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
83647846|NCT01434069|Hormones|hormones|mesh-ancestor
83647847|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83647848|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
83647849|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83647850|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
83647851|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647852|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647853|NCT01434134|Metoprolol|metoprolol|mesh-list
83647854|NCT01434134|Candesartan|candesartan|mesh-list
83647855|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83647856|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83647857|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
83647858|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
83647859|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83647860|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647861|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83647862|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83647863|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83647864|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647865|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647866|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647867|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83647868|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83647869|NCT01434147|Bevacizumab|bevacizumab|mesh-list
83647870|NCT01434147|Capecitabine|capecitabine|mesh-list
83647871|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
83647872|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83647873|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647874|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83647875|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83647876|NCT01434147|Growth Substances|growth substances|mesh-ancestor
83647877|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647878|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
83647879|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83647880|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
83647881|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647882|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
83647883|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83647884|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
83647885|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83647886|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647887|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83647888|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83647889|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83647890|NCT01434173|Amoxicillin|amoxicillin|mesh-list
83647891|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
83647892|NCT01434173|Clarithromycin|clarithromycin|mesh-list
83647893|NCT01434173|Doxycycline|doxycycline|mesh-list
83647894|NCT01434173|Levofloxacin|levofloxacin|mesh-list
83647895|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
83647896|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
83647897|NCT01434173|Cefuroxime|cefuroxime|mesh-list
83647898|NCT01434173|Telithromycin|telithromycin|mesh-list
83647899|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83647900|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83647901|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647902|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83647903|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83647904|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647905|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647906|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647907|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83647908|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
83647909|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83647910|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647911|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82802691|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
83647912|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83647913|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83647914|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83647915|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83647916|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83647917|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
83647918|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83647919|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83647920|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83647921|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83647922|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83647923|NCT01434212|Interferons|interferons|mesh-list
83647924|NCT01434212|Ribavirin|ribavirin|mesh-list
83647925|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
83647926|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
83647927|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647928|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
83647929|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83647930|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
83647931|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647932|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
83647933|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647934|NCT01434225|Bumetanide|bumetanide|mesh-list
83647935|NCT01434225|Diuretics|diuretics|mesh-ancestor
83647936|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
83647937|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647938|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83647939|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83647940|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647941|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
83647942|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83647943|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83647944|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83647945|NCT01434303|Trastuzumab|trastuzumab|mesh-list
83647946|NCT01434303|Lapatinib|lapatinib|mesh-list
83647947|NCT01434303|Entinostat|entinostat|mesh-list
83647948|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83647949|NCT01434303|Antibodies|antibodies|mesh-list
83647950|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
83647951|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83647952|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83647953|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
83647954|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647955|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647956|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83647957|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83647958|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647959|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83647960|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83647961|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
83647962|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647963|NCT01434381|Antacids|antacids|mesh-ancestor
83647964|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647965|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83647966|NCT01434394|Cetuximab|cetuximab|mesh-list
83647967|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83647968|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647969|NCT01434459|Gemcitabine|gemcitabine|mesh-list
83647970|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83647971|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
83647972|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647973|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83647974|NCT01434849|Timolol|timolol|mesh-list
83647975|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647976|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83647977|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83647978|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647979|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647980|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647981|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83647982|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83647983|NCT01434862|Pramlintide|pramlintide|mesh-list
83647984|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83647985|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83647986|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83647987|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
83647988|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83647989|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83647990|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647991|NCT01434888|Timolol|timolol|mesh-list
83647992|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83647993|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83647994|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83647995|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83647996|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
83647997|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83647998|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83647999|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648000|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83648001|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83648002|NCT01434901|Bethanechol|bethanechol|mesh-list
83648003|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83648004|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
83648005|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648006|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648007|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83648008|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83648009|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
83648010|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648011|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648012|NCT01434914|Octenidine|octenidine|mesh-list
83648013|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648014|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83648015|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83648016|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
83648017|NCT01435083|Coagulants|coagulants|mesh-ancestor
83648018|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83648019|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
83648020|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648021|NCT01435161|Telmisartan|telmisartan|mesh-list
83648022|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
83648023|NCT01435161|Nifedipine|nifedipine|mesh-list
83648024|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83648025|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83648026|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648027|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83648028|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648029|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83648030|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648031|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
83648032|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
83648033|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83648034|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83648035|NCT01435200|Hematinics|hematinics|mesh-ancestor
83648036|NCT01435213|Insulin|insulin|mesh-list
83648037|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83648038|NCT01435213|Ketamine|ketamine|mesh-list
83648039|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83648040|NCT01435213|Atipamezole|atipamezole|mesh-list
83648041|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648042|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648043|NCT01435213|Analgesics|analgesics|mesh-ancestor
83648044|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
83648045|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648046|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83648047|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83648048|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
83648049|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
83648050|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648051|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83648052|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83648053|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648054|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648055|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83648056|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83648057|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648058|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83648059|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83648060|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83648061|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83648062|NCT01435252|Cetuximab|cetuximab|mesh-list
83648063|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648064|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648065|NCT01435291|Tacrolimus|tacrolimus|mesh-list
83648066|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648067|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
83648068|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648069|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83648070|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648071|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648072|NCT01435343|Cytarabine|cytarabine|mesh-list
83648073|NCT01435343|Plerixafor|plerixafor|mesh-list
83648074|NCT01435343|Fludarabine|fludarabine|mesh-list
83648075|NCT01435343|Idarubicin|idarubicin|mesh-list
83648076|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648077|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83648078|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
83648079|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648080|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648081|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
83648082|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648083|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
83648084|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648085|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83648086|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83648087|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83648088|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648089|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83648090|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83648091|NCT01435395|Bevacizumab|bevacizumab|mesh-list
83648092|NCT01435395|Temozolomide|temozolomide|mesh-list
83648093|NCT01435395|Bortezomib|bortezomib|mesh-list
83648094|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648095|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648096|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83648097|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83648098|NCT01435395|Growth Substances|growth substances|mesh-ancestor
83648099|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648100|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
83648101|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83648102|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
83648103|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648104|NCT01435486|Caffeine|caffeine|mesh-list
83648105|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
83648106|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648107|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83648108|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648109|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83648110|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648111|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83648112|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83648113|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
83648114|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648115|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
83648116|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648117|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
83648118|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648119|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648120|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83648121|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
83648122|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648123|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648124|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83648125|NCT01435707|Triamcinolone|triamcinolone|mesh-list
83648126|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83648127|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83648128|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83648129|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648130|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
83648131|NCT01435707|Hormones|hormones|mesh-ancestor
83648132|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648133|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648134|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648135|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
83648136|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648137|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648138|NCT01435837|Caffeine|caffeine|mesh-list
83648139|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83648140|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648141|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83648142|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648143|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648144|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83648145|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83648146|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
83648147|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648148|NCT01435915|Ropinirole|ropinirole|mesh-list
83648149|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83648150|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83648151|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
83648152|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
83648153|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648154|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648155|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648156|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83648157|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83648158|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83648159|NCT01435941|Analgesics|analgesics|mesh-ancestor
83648160|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
83648161|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648162|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648163|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648164|NCT01435954|Doxazosin|doxazosin|mesh-list
83648165|NCT01435954|Tamsulosin|tamsulosin|mesh-list
83648166|NCT01435954|Finasteride|finasteride|mesh-list
83648167|NCT01435954|Silodosin|silodosin|mesh-list
83648168|NCT01435954|Terazosin|terazosin|mesh-list
83648169|NCT01435954|Alfuzosin|alfuzosin|mesh-list
83648170|NCT01435954|Dutasteride|dutasteride|mesh-list
83648171|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83648172|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83648173|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83648174|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
83648175|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648176|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648177|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648178|NCT01435954|Urological Agents|urological agents|mesh-ancestor
83648179|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83648180|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83648181|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648182|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
83648183|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648184|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83648185|NCT01435980|Exenatide|exenatide|mesh-list
83648186|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648187|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648188|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83648189|NCT01435980|Incretins|incretins|mesh-ancestor
83648190|NCT01435980|Hormones|hormones|mesh-ancestor
83648191|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648192|NCT01436123|Everolimus|everolimus|mesh-list
83648193|NCT01436123|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83648194|NCT01436123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83648195|NCT01436123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648196|NCT01436123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648197|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648198|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
83648199|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648200|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648201|NCT01436188|Ibuprofen|ibuprofen|mesh-list
83648202|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83648203|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83648204|NCT01436188|Analgesics|analgesics|mesh-ancestor
83648205|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
83648206|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648207|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648208|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648209|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834861|NCT00101426|Ranirestat|ranirestat|mesh-list
83648210|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83648211|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648212|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648214|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
83648215|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648216|NCT01435902|Fluticasone|fluticasone|mesh-list
83648217|NCT01435902|Xhance|xhance|mesh-list
83648218|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648219|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83648220|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
83648221|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648222|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648223|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83648224|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
83648225|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
83648226|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83648227|NCT01436474|Varenicline|varenicline|mesh-list
83648228|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83648229|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83648230|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
83648231|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648232|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648233|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648234|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83648235|NCT01436513|Estrogens|estrogens|mesh-ancestor
83648236|NCT01436513|Hormones|hormones|mesh-ancestor
83648237|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648238|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648239|NCT01436539|Adefovir|adefovir|mesh-list
83648240|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83648241|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
83648242|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
83648243|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648244|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83648245|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83648246|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648247|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648248|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83648249|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
83648250|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83648251|NCT01436578|Posaconazole|posaconazole|mesh-list
83648252|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
83648253|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648254|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83648255|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83648256|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83648257|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83648258|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83648259|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648260|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648261|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83648262|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
83648263|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648264|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648265|NCT01436825|Factor VIII|factor viii|mesh-list
83648266|NCT01436825|Coagulants|coagulants|mesh-ancestor
83648267|NCT01436838|Interferons|interferons|mesh-list
83648268|NCT01436838|Interferon-beta|interferon-beta|mesh-list
83648269|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
83648270|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648271|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
83648272|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648273|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
83648274|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648275|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83648276|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
83648277|NCT01436916|Vitamin D|vitamin d|mesh-list
83648278|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83648279|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648280|NCT01436916|Vitamins|vitamins|mesh-ancestor
83648281|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
83648282|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82803065|NCT01057498|RNS60|rns60|mesh-list
83648283|NCT01436929|Silymarin|silymarin|mesh-list
83648284|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
82803142|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83648285|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648286|NCT01436929|Protective Agents|protective agents|mesh-ancestor
83648287|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648288|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
83648289|NCT01436994|Carbimazole|carbimazole|mesh-list
83648290|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
83648291|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648292|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
83648293|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
83648294|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648295|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648296|NCT01437007|TKM-080301|tkm-080301|mesh-list
83648297|NCT01437007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83648298|NCT01437007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648299|NCT01437007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648300|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83648301|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
83648302|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648303|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83648304|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83648305|NCT01437046|Doxazosin|doxazosin|mesh-list
83648306|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83648307|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83648308|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83648309|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83648310|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
83648311|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648312|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648313|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648314|NCT01437189|Sertraline|sertraline|mesh-list
83648315|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
83648316|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83648317|NCT01437189|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83648318|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83648319|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648320|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537905|NCT05351801|Dronabinol|dronabinol|mesh-list
83648321|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648322|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
83648323|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648324|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
83648325|NCT01437228|Povidone|povidone|mesh-list
83648326|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
83648327|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
83648328|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83648329|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648330|NCT01437293|Carbidopa|carbidopa|mesh-list
83648331|NCT01437293|Entacapone|entacapone|mesh-list
83648332|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83648333|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83648334|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
83648335|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648336|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648337|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648338|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83648339|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648340|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83648341|NCT01437306|Lofexidine|lofexidine|mesh-list
83648342|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83648343|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83648344|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648345|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
83648346|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648347|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83648348|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83648349|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83648350|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83648351|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648352|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648353|NCT01437371|Ramipril|ramipril|mesh-list
83648354|NCT01437371|Enalapril|enalapril|mesh-list
83648355|NCT01437371|Lisinopril|lisinopril|mesh-list
83648356|NCT01437371|Captopril|captopril|mesh-list
83648357|NCT01437371|Trandolapril|trandolapril|mesh-list
83648359|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83648360|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
83648361|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648362|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83648363|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83648364|NCT01437371|Protective Agents|protective agents|mesh-ancestor
83648365|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648366|NCT01437462|Propofol|propofol|mesh-list
83648367|NCT01437462|Sevoflurane|sevoflurane|mesh-list
83648368|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83648369|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648370|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648371|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83648372|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
83648373|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
83648374|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83648375|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83648376|NCT01437566|Fulvestrant|fulvestrant|mesh-list
83648377|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83648378|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648379|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83648380|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83648381|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
83648382|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648383|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648384|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
83648385|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83648386|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648387|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648388|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
83648389|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648390|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648391|NCT01437592|Insulin|insulin|mesh-list
83648392|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648393|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648394|NCT01437618|Bevacizumab|bevacizumab|mesh-list
83648395|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648396|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648397|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83648398|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83648399|NCT01437618|Growth Substances|growth substances|mesh-ancestor
83648400|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648401|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
83648402|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
83648403|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83648404|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648405|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648406|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
83648407|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648408|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648409|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
83648410|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83648411|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83648412|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
83648413|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648414|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648415|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648416|NCT01437670|Urological Agents|urological agents|mesh-ancestor
83648417|NCT01437696|Vitamin D|vitamin d|mesh-list
83648418|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
83648419|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
83648420|NCT01437696|Vitamins|vitamins|mesh-list
83648421|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
83648422|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648423|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83648424|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83648425|NCT01437748|Bromides|bromides|mesh-list
83648426|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
83648427|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83648428|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
83648429|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648430|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648431|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83648432|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
83648433|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
83648434|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83648435|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
83648436|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648437|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648438|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
83648439|NCT01437800|Metformin|metformin|mesh-list
83648440|NCT01437800|Glimepiride|glimepiride|mesh-list
83648441|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648442|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648443|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83648444|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648445|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
83648446|NCT01437813|Metformin|metformin|mesh-list
83648447|NCT01437813|Glimepiride|glimepiride|mesh-list
83648448|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648449|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648450|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83648451|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648452|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
83648453|NCT01437826|Selenium|selenium|mesh-list
83648454|NCT01437826|Antioxidants|antioxidants|mesh-list
83648455|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648456|NCT01437826|Protective Agents|protective agents|mesh-ancestor
83648457|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648458|NCT01437826|Trace Elements|trace elements|mesh-ancestor
83648459|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
83648460|NCT01437839|Apixaban|apixaban|mesh-list
83648461|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83648462|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
83648463|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83648464|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83648465|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648466|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648467|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
83648468|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83648469|NCT01437982|Prednisolone|prednisolone|mesh-list
83648470|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83648471|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
83648472|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83648473|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
83648474|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83648475|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
83648476|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648477|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
83648478|NCT01437982|Hormones|hormones|mesh-ancestor
83648479|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648480|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648481|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83648482|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648483|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
83648484|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
83648485|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648486|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83648487|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83648488|NCT01437982|Protective Agents|protective agents|mesh-ancestor
83648489|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83648490|NCT01438021|Methotrexate|methotrexate|mesh-list
83648491|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83648492|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
83648493|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83648494|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648495|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83648496|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
83648497|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648498|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648499|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
83648500|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648501|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83648502|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648503|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
83648504|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648505|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83648506|NCT01438086|Mecasermin|mecasermin|mesh-list
83648507|NCT01438086|Growth Substances|growth substances|mesh-ancestor
83648508|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648509|NCT01438112|Interferons|interferons|mesh-list
83648510|NCT01438112|Gemcitabine|gemcitabine|mesh-list
83648511|NCT01438112|Mitomycins|mitomycins|mesh-list
83648512|NCT01438112|Mitomycin|mitomycin|mesh-list
83648513|NCT01438112|Valrubicin|valrubicin|mesh-list
83648514|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83648515|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
83648516|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648517|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648518|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
83648519|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648520|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83648521|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
83648522|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83648523|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648524|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83648525|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83648526|NCT01438190|Metformin|metformin|mesh-list
83648527|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648528|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648529|NCT01438320|Quercetin|quercetin|mesh-list
83648530|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
83648531|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648532|NCT01438320|Protective Agents|protective agents|mesh-ancestor
83648533|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648534|NCT05578859|Sotorasib|sotorasib|mesh-list
83648535|NCT05578859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83648536|NCT05578859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648537|NCT05578859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648538|NCT05578859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648539|NCT05554393|Cytarabine|cytarabine|mesh-list
83648540|NCT05554393|Azacitidine|azacitidine|mesh-list
83648541|NCT05554393|Daunorubicin|daunorubicin|mesh-list
83648542|NCT05554393|Venetoclax|venetoclax|mesh-list
83648543|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83648544|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
83648545|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648546|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648547|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
83648548|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648549|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648550|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
83648551|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648552|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648553|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83648554|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83648555|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83648556|NCT05525013|Simvastatin|simvastatin|mesh-list
83648557|NCT05525013|Calcium|calcium|mesh-list
83648558|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83648559|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648560|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83648561|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83648562|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
83648563|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648564|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83648565|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83648566|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648567|NCT05465174|Nivolumab|nivolumab|mesh-list
83648568|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648569|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648570|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83648571|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648572|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
83648573|NCT05418088|Fludarabine|fludarabine|mesh-list
83648574|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
83648575|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648576|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
83648577|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648578|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648579|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83648580|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
83648581|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648582|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648583|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83648584|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83648585|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
83648586|NCT05387525|Diclofenac|diclofenac|mesh-list
83648587|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
83648588|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83648589|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83648590|NCT05387525|Analgesics|analgesics|mesh-ancestor
83648591|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
83648592|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648593|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648594|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648595|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648596|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83648597|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648598|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648599|NCT05382312|Bedaquiline|bedaquiline|mesh-list
83648600|NCT05382312|GSK656|gsk656|mesh-list
83648601|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
83648602|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83648603|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648604|NCT05371275|Palbociclib|palbociclib|mesh-list
83648605|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648606|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83648607|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648608|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648609|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83648610|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83648611|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648612|NCT05343507|Ketamine|ketamine|mesh-list
83648613|NCT05343507|Analgesics|analgesics|mesh-ancestor
83648614|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
83648615|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648616|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648617|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83648618|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83648619|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
83648620|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
83648621|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83538217|NCT05190770|Hormones|hormones|mesh-ancestor
83648622|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83648623|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83648624|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648625|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648626|NCT05213832|Isoflurane|isoflurane|mesh-list
83648627|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83648628|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
83648629|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
83648630|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648631|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648632|NCT05164159|Propofol|propofol|mesh-list
83648633|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83648634|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648635|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648636|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83648637|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
83648638|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
83648639|NCT05164146|Propofol|propofol|mesh-list
83648640|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83648641|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648642|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648643|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83648644|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
83648645|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
83648646|NCT05153070|Cyclosporine|cyclosporine|mesh-list
83648647|NCT05153070|Cyclosporins|cyclosporins|mesh-list
83648648|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648649|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648650|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648651|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
83648652|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648653|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
83648654|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648655|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
83648656|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648657|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83648658|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
83648659|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83648660|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648661|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648662|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83648663|NCT05111431|Analgesics|analgesics|mesh-ancestor
83648664|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
83648665|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648666|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83648667|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83648668|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83648669|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
83648670|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648671|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648672|NCT04965298|Lansoprazole|lansoprazole|mesh-list
83648673|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
83648674|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83648675|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83648676|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83648677|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648678|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648679|NCT04956939|Levodopa|levodopa|mesh-list
83648680|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83648681|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83648682|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
83648683|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648684|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648685|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648686|NCT04955470|Midazolam|midazolam|mesh-list
83648687|NCT04955470|Ketamine|ketamine|mesh-list
83648688|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83648689|NCT04955470|Analgesics|analgesics|mesh-ancestor
83648690|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
83648691|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648692|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648693|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83648694|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83648695|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
83648696|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
83648697|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648698|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83648699|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83648700|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648701|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648702|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83648703|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83648704|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83648705|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83648706|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83648707|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
83648708|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
83648709|NCT04938557|Insulin|insulin|mesh-list
83648710|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83648711|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648712|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648713|NCT04922567|Prednisone|prednisone|mesh-list
83648714|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
83648715|NCT04922567|Doxorubicin|doxorubicin|mesh-list
83648716|NCT04922567|Vincristine|vincristine|mesh-list
83648717|NCT04922567|Lenalidomide|lenalidomide|mesh-list
83648718|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648719|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
83648720|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648721|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648722|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83648723|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
83648724|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648725|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648726|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83648727|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83648728|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83648729|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83648730|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648731|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648732|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
83648733|NCT04922567|Hormones|hormones|mesh-ancestor
83834862|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648734|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648735|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83648736|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83648737|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83648738|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83648739|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83648740|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83648741|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83648742|NCT04922567|Growth Substances|growth substances|mesh-ancestor
83648743|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
83648744|NCT04906278|Oxytocin|oxytocin|mesh-list
83648745|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
83648746|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83648747|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648748|NCT04850222|Fluoxetine|fluoxetine|mesh-list
83648749|NCT04850222|Calcium|calcium|mesh-list
83648750|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83648751|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648752|NCT04850222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83648753|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83648754|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648755|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648756|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648757|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
83648758|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83648759|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
83648760|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83648761|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83648762|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83648763|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648764|NCT04800692|Verapamil|verapamil|mesh-list
83648765|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83648766|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83648767|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648768|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648769|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83648770|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648771|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
83648772|NCT04787848|Bromides|bromides|mesh-list
83648773|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
83648774|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
83648775|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83648776|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648777|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
83648778|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648779|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
83648780|NCT04660799|Promethazine|promethazine|mesh-list
83648781|NCT04660799|Prednisone|prednisone|mesh-list
83648782|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
83648783|NCT04660799|Rituximab|rituximab|mesh-list
83648784|NCT04660799|Doxorubicin|doxorubicin|mesh-list
83648785|NCT04660799|Vincristine|vincristine|mesh-list
83648786|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83648787|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
83648788|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648789|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
83648790|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648791|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648792|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83648793|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
83648794|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648795|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648796|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83648797|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648798|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83648799|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83648800|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83648801|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648802|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648803|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
83648804|NCT04660799|Hormones|hormones|mesh-ancestor
83648805|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83648806|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803607|NCT00509262|Glipizide|glipizide|mesh-list
83648807|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83648808|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
83648809|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
83648810|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
83648811|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
83648812|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648813|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83648814|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83648815|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648816|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
83648817|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
83648818|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
83648819|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
83648820|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83648821|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
83648822|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648823|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83648824|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
83648825|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83648826|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
83648827|NCT04636632|Aprepitant|aprepitant|mesh-list
83648828|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
83648829|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
83648830|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648831|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648832|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83648833|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83648834|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648835|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648836|NCT04597372|Tamsulosin|tamsulosin|mesh-list
83648837|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83648838|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83648839|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83648840|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
83648841|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648842|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648843|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648844|NCT04597372|Urological Agents|urological agents|mesh-ancestor
83648845|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83648846|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
83648847|NCT04585542|Laxatives|laxatives|mesh-ancestor
83648848|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83648849|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
83648850|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
83648851|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648852|NCT04545060|Sotrovimab|sotrovimab|mesh-list
83648853|NCT04545060|Antiviral Agents|antiviral agents|mesh-ancestor
83648854|NCT04545060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648855|NCT04502602|Niraparib|niraparib|mesh-list
83648856|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83648857|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648858|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648859|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648860|NCT04375202|Colchicine|colchicine|mesh-list
83648861|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
83648862|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648863|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
83648864|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
83648865|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
83648866|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648867|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648868|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
83648869|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83648870|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83648871|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648872|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
83648873|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83648874|NCT04343885|Docetaxel|docetaxel|mesh-list
83648875|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
83648876|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648877|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83648878|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83648879|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803674|NCT00508872|Antidotes|antidotes|mesh-ancestor
83648880|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648881|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83648882|NCT04332393|Metformin|metformin|mesh-list
83648883|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648884|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648885|NCT04329572|Azithromycin|azithromycin|mesh-list
83648886|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
83648887|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83648888|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648889|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
83648890|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83648891|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83648892|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648893|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648894|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648895|NCT04322552|Apatinib|apatinib|mesh-list
83648896|NCT04322552|Digoxin|digoxin|mesh-list
83648897|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648898|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83648899|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648900|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648901|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83648902|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83648903|NCT04322552|Protective Agents|protective agents|mesh-ancestor
83648904|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648905|NCT04322305|Pregabalin|pregabalin|mesh-list
83648906|NCT04322305|Analgesics|analgesics|mesh-ancestor
83648907|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
83648908|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648909|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648910|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
83648911|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83648912|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83648913|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648914|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83648915|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83648916|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83648917|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648918|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83648919|NCT04234061|Tisagenlecleucel|tisagenlecleucel|mesh-list
83648920|NCT04234061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648921|NCT04234061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648922|NCT04189848|Dulaglutide|dulaglutide|mesh-list
83648923|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648924|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648925|NCT04156334|Anesthetics|anesthetics|mesh-list
83648926|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83648927|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648928|NCT04078906|SMOFlipid|smoflipid|mesh-list
83648929|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83648930|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83648931|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83648932|NCT03980171|Lenalidomide|lenalidomide|mesh-list
83648933|NCT03980171|Venetoclax|venetoclax|mesh-list
83648934|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
83648935|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
83648936|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648937|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83648938|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83648939|NCT03980171|Growth Substances|growth substances|mesh-ancestor
83648940|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
83648941|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648942|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648943|NCT03979365|Tacrolimus|tacrolimus|mesh-list
83648944|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83648945|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
83648946|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648947|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83648948|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648949|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648950|NCT03860077|Nicotine|nicotine|mesh-list
83648951|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83648952|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
83648953|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648954|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648955|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83648956|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83648957|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
83648958|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648959|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648961|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83648962|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83648963|NCT03671746|Analgesics|analgesics|mesh-ancestor
83648964|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
83648965|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83648966|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648967|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83648968|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83648969|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83648970|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648971|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648972|NCT03558724|Bevacizumab|bevacizumab|mesh-list
83648973|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648974|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648975|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83648976|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83648977|NCT03558724|Growth Substances|growth substances|mesh-ancestor
83648978|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648979|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
83648980|NCT03512496|Caffeine|caffeine|mesh-list
83648981|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83648982|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648983|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83648984|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83648985|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83648986|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83648987|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83648988|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
83648989|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83648990|NCT03416127|Metformin|metformin|mesh-list
83648991|NCT03416127|Propolis|propolis|mesh-list
83648992|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83648993|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83648994|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83648995|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
83648996|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83648997|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83648998|NCT03293069|Deferiprone|deferiprone|mesh-list
83648999|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83649000|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
83649001|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
83649002|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649003|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
83649004|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649005|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649006|NCT03255018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83649007|NCT03255018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649008|NCT03250975|Azithromycin|azithromycin|mesh-list
83649009|NCT03250975|Budesonide|budesonide|mesh-list
83649010|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83649011|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83649012|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
83649013|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649014|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649015|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83649016|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83649017|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
83649018|NCT03250975|Hormones|hormones|mesh-ancestor
83649019|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649020|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83649021|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649022|NCT03232346|Buprenorphine|buprenorphine|mesh-list
83649023|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83649024|NCT03232346|Narcotics|narcotics|mesh-ancestor
83649025|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649026|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649027|NCT03232346|Analgesics|analgesics|mesh-ancestor
83649028|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
83649029|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649030|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83649031|NCT03227731|Tenofovir|tenofovir|mesh-list
83649032|NCT03227731|Emtricitabine|emtricitabine|mesh-list
83649033|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83649034|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
83649035|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649036|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83649037|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83649038|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649039|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649040|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83649041|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83649042|NCT03200015|Metformin|metformin|mesh-list
83649043|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649044|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649045|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
83649046|NCT03193281|Dasatinib|dasatinib|mesh-list
83649047|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649048|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83649049|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649050|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649051|NCT03149640|Amikacin|amikacin|mesh-list
83649052|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83649053|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649054|NCT03098355|Interleukin-2|interleukin-2|mesh-list
83649055|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649056|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83649057|NCT03098355|Analgesics|analgesics|mesh-ancestor
83649058|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
83649059|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649060|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649061|NCT02986334|Naproxen|naproxen|mesh-list
83649062|NCT02986334|Omeprazole|omeprazole|mesh-list
83649063|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83649064|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83649065|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83649066|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649067|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649068|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83649069|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83649070|NCT02986334|Analgesics|analgesics|mesh-ancestor
83649071|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
83649072|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649073|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649074|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83649075|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83649076|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
83649077|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83649078|NCT02668289|Anesthetics|anesthetics|mesh-list
83649079|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649080|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649081|NCT02655315|Deferiprone|deferiprone|mesh-list
83649082|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83649083|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
83649084|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
83649085|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649086|NCT02572843|Durvalumab|durvalumab|mesh-list
83649087|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649088|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649089|NCT02436733|Pemetrexed|pemetrexed|mesh-list
83649090|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649091|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649092|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649093|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83649094|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83649095|NCT02426502|Cyclosporine|cyclosporine|mesh-list
83649096|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
83649097|NCT02426502|Prednisone|prednisone|mesh-list
83649098|NCT02426502|Azathioprine|azathioprine|mesh-list
83649099|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
83649100|NCT02426502|Cyclosporins|cyclosporins|mesh-list
83649101|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83649102|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
83649103|NCT02426502|Hormones|hormones|mesh-ancestor
83649104|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649105|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649106|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803902|NCT00514020|Fluorouracil|fluorouracil|mesh-list
83649107|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649108|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649109|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649110|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83649111|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
83649112|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
83649113|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649114|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
83649115|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83649116|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83649117|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83649118|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83649119|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
83649120|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83649121|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
83649122|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83649123|NCT02275156|Evolocumab|evolocumab|mesh-list
83649124|NCT02275156|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83649125|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83649126|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83649127|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
83649128|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649129|NCT02275156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83649130|NCT02275156|Protease Inhibitors|protease inhibitors|mesh-ancestor
83649131|NCT02275156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649132|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83649133|NCT02124902|Carboplatin|carboplatin|mesh-list
83649134|NCT02124902|Docetaxel|docetaxel|mesh-list
83649135|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649136|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
83649137|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
83649138|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649139|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649140|NCT02067182|Dabigatran|dabigatran|mesh-list
83649141|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
83649142|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83649143|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
83649144|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649145|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649146|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
83649147|NCT01877837|Fludarabine|fludarabine|mesh-list
83649148|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
83649149|NCT01877837|Melphalan|melphalan|mesh-list
83649150|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
83649151|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649152|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83649153|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
83649154|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649155|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83649156|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
83649157|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649158|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83649159|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
83649160|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83649161|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649162|NCT01781468|Modafinil|modafinil|mesh-list
83649163|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83649164|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649165|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83649166|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83649167|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83649168|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649169|NCT01624142|Evolocumab|evolocumab|mesh-list
83649170|NCT01624142|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83649171|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83649172|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83649173|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
83649174|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649175|NCT01624142|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83649176|NCT01624142|Protease Inhibitors|protease inhibitors|mesh-ancestor
83649177|NCT01624142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649178|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83649179|NCT01375764|Ezetimibe|ezetimibe|mesh-list
83361975|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649180|NCT01375764|Evolocumab|evolocumab|mesh-list
83649181|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83649182|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83649183|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83649184|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
83649185|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649186|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83649187|NCT01375764|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83649188|NCT01375764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83649189|NCT01375764|Protease Inhibitors|protease inhibitors|mesh-ancestor
83649190|NCT01375764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649191|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
83649192|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649193|NCT00523341|Denosumab|denosumab|mesh-list
83649194|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83649195|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649196|NCT00364013|Panitumumab|panitumumab|mesh-list
83649197|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649198|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649199|NCT00345839|Cinacalcet|cinacalcet|mesh-list
83649200|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83649201|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649202|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83649203|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
83649204|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649205|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
83649206|NCT00330759|Denosumab|denosumab|mesh-list
83649207|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83649208|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649209|NCT00113763|Panitumumab|panitumumab|mesh-list
83649210|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649211|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649212|NCT01438359|Furosemide|furosemide|mesh-list
83649213|NCT01438359|Diuretics|diuretics|mesh-ancestor
83649214|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
83649215|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649216|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83649217|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83538809|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
83649218|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649219|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83649220|NCT01438372|Hematinics|hematinics|mesh-ancestor
83649221|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
83649222|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83649223|NCT01438515|Doxycycline|doxycycline|mesh-list
83649224|NCT01438515|Rifampin|rifampin|mesh-list
83649225|NCT01438515|Mupirocin|mupirocin|mesh-list
83649226|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83649227|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649228|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
83649229|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
83649230|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83649231|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
83649232|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83649233|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83649234|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83649235|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
83649236|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
83649237|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83649238|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649239|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649240|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83649241|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83649242|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83649243|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83649244|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83649245|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83649246|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83649247|NCT01438554|Trametinib|trametinib|mesh-list
83649248|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649249|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83649250|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649251|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649252|NCT01438567|Oxycodone|oxycodone|mesh-list
83649253|NCT01438567|Naloxone|naloxone|mesh-list
83649254|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83649255|NCT01438567|Narcotics|narcotics|mesh-ancestor
83649256|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649257|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649258|NCT01438567|Analgesics|analgesics|mesh-ancestor
83649259|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
83649260|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649261|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83649262|NCT01438580|Aspirin|aspirin|mesh-list
83649263|NCT01438580|Warfarin|warfarin|mesh-list
83649264|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83649265|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83649266|NCT01438580|Analgesics|analgesics|mesh-ancestor
83649267|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
83649268|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649269|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649270|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83649271|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83649272|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83649273|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83649274|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649275|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83649276|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83649277|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649278|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
83649279|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
83649280|NCT01438632|Insulin|insulin|mesh-list
83649281|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649282|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649283|NCT01438723|Metformin|metformin|mesh-list
83649284|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649285|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649286|NCT01438736|Etonogestrel|etonogestrel|mesh-list
83649287|NCT01438736|Desogestrel|desogestrel|mesh-list
83649288|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83649289|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
83649290|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83649291|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649292|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83649293|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83649294|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83649295|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83649296|NCT01438736|Progestins|progestins|mesh-ancestor
83649297|NCT01438736|Hormones|hormones|mesh-ancestor
83649298|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649299|NCT01438749|Diazepam|diazepam|mesh-list
83649300|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83649301|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
83649302|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
83649303|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
83649304|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649305|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649306|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83649307|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83649308|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649309|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83649310|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83649311|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83649312|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83649313|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83649314|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83649315|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
83649316|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
83649317|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
83649318|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
83649319|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649320|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649321|NCT01438866|Fluorides|fluorides|mesh-list
83649322|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
83649323|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
83649324|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
83649325|NCT01438866|Protective Agents|protective agents|mesh-ancestor
83649326|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649327|NCT01438944|Nicotine|nicotine|mesh-list
83649328|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83649329|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
83649330|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649331|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649332|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83649333|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83649334|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83649335|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649336|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649337|NCT01439100|Oxycodone|oxycodone|mesh-list
83649338|NCT01439100|Naloxone|naloxone|mesh-list
83649339|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83649340|NCT01439100|Narcotics|narcotics|mesh-ancestor
83649341|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649342|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649343|NCT01439100|Analgesics|analgesics|mesh-ancestor
83649344|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
83649345|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649346|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83649347|NCT01439152|Maytansine|maytansine|mesh-list
83649348|NCT01439152|Anetumab ravtansine|anetumab ravtansine|mesh-list
83649349|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
83649350|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
83649351|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649352|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83649353|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649354|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
83649355|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
83649356|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649357|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649358|NCT01439178|Bevacizumab|bevacizumab|mesh-list
83649359|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649360|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649361|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83649362|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83649363|NCT01439178|Growth Substances|growth substances|mesh-ancestor
83649364|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649365|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
83649366|NCT01439191|Vinorelbine|vinorelbine|mesh-list
83649367|NCT01439191|Antibodies|antibodies|mesh-list
83649368|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
83649369|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649370|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83649371|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649372|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
83649373|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
83649374|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649375|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649376|NCT01439230|Donepezil|donepezil|mesh-list
83649377|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83649378|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649379|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649380|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
83649381|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649382|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649383|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
83649384|NCT01439243|Donepezil|donepezil|mesh-list
83649385|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83649386|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649387|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649388|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
83649389|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649390|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649391|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
83649392|NCT01439399|Lidocaine|lidocaine|mesh-list
83649393|NCT01439399|Ketamine|ketamine|mesh-list
83649394|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
83649395|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
83649396|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649397|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649398|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
83649399|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649400|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83649401|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83649402|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83649403|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83649404|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649405|NCT01439399|Analgesics|analgesics|mesh-ancestor
83649406|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83649407|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83649408|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
83649409|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83649410|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83649411|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649412|NCT01439438|Topiramate|topiramate|mesh-list
83649413|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
83649414|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649415|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649416|NCT01439542|Hormones|hormones|mesh-list
83649417|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83649418|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649419|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649420|NCT01439750|Rituximab|rituximab|mesh-list
83649421|NCT01439750|Bortezomib|bortezomib|mesh-list
83649422|NCT01439750|Cladribine|cladribine|mesh-list
83649423|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649424|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649425|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
83649426|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649427|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83649428|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83649429|NCT01439984|Clomipramine|clomipramine|mesh-list
83649430|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83649431|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
83649432|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83649433|NCT01439984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83649434|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83649435|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83649436|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649437|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649438|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
83649439|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649440|NCT01440062|Vitamin D|vitamin d|mesh-list
83649441|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
83649442|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
83649443|NCT01440062|Vitamins|vitamins|mesh-list
83649444|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
83649445|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649446|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83649447|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83649448|NCT01440088|Doxorubicin|doxorubicin|mesh-list
83649449|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83649450|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83649451|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649452|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83649453|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83649454|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649455|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649456|NCT01440114|Fentanyl|fentanyl|mesh-list
83649457|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83649458|NCT01440114|Narcotics|narcotics|mesh-ancestor
83649459|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649460|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649461|NCT01440114|Analgesics|analgesics|mesh-ancestor
83649462|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
83649463|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649464|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83649465|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83649466|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
83649467|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
83649468|NCT01440127|Metformin|metformin|mesh-list
83649469|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649470|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649471|NCT01440140|Insulin|insulin|mesh-list
83649472|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649473|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649474|NCT01440270|Cetuximab|cetuximab|mesh-list
83649475|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649476|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649477|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83649478|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83649479|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83649480|NCT01440335|Fenoterol|fenoterol|mesh-list
83649481|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83649482|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
83649483|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649484|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649485|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83649486|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
83649487|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
83649488|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
83649489|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83649490|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83649491|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83649492|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83649493|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
83649494|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649495|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649497|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83649498|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
83649499|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649500|NCT01440400|Anesthetics|anesthetics|mesh-list
83649501|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649502|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649503|NCT01440439|Insulin|insulin|mesh-list
83649504|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83649505|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
83649506|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
83649507|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649508|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649509|NCT01440582|Dexamethasone|dexamethasone|mesh-list
83649510|NCT01440582|Lenalidomide|lenalidomide|mesh-list
83649511|NCT01440582|Bortezomib|bortezomib|mesh-list
83649512|NCT01440582|Panobinostat|panobinostat|mesh-list
83649513|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83649514|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
83649515|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
83649516|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649517|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649518|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83649519|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
83649520|NCT01440582|Hormones|hormones|mesh-ancestor
83539110|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
83649521|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649522|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83649523|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649524|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
83649525|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83649526|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83649527|NCT01440582|Growth Substances|growth substances|mesh-ancestor
83649528|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
83649529|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83649530|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649531|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649532|NCT01440608|Albendazole|albendazole|mesh-list
83649533|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
83649534|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83649535|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649536|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
83649537|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83649538|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83649539|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
83649540|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
83649541|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649542|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649543|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649544|NCT01440621|Pyridoxine|pyridoxine|mesh-list
83649545|NCT01440621|Modafinil|modafinil|mesh-list
83649546|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83649547|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649548|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83649549|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83649550|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83649551|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649552|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
83649553|NCT01440621|Vitamins|vitamins|mesh-ancestor
83649554|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
83649555|NCT01440673|Aprepitant|aprepitant|mesh-list
83649556|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
83649557|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
83649558|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649559|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649560|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82804416|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83649561|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83649562|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649563|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649564|NCT01440725|Mitogens|mitogens|mesh-list
83649565|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649566|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649567|NCT01440751|Mitomycins|mitomycins|mesh-list
83649568|NCT01440751|Mitomycin|mitomycin|mesh-list
83649569|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83649570|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649571|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
83649572|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649573|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83649574|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649575|NCT01440790|Vitamins|vitamins|mesh-list
83649576|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
83649577|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
83649578|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649579|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
83649580|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649581|NCT01440790|Protective Agents|protective agents|mesh-ancestor
83649582|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
83649583|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83649584|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83649585|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649586|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649587|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649588|NCT01440842|Insulin|insulin|mesh-list
83649589|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83649590|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649591|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649592|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
83649593|NCT01440933|Analgesics|analgesics|mesh-ancestor
83649594|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
83649595|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649596|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649597|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
83649598|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649599|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83649600|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
83649601|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83649602|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83649603|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649604|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83649605|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
83649606|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83649607|NCT01440985|Nicotine|nicotine|mesh-list
83649608|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83649609|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
83649610|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649611|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649612|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83649613|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83649614|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
83649615|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649616|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649617|NCT01440998|Paclitaxel|paclitaxel|mesh-list
83649618|NCT01440998|Carboplatin|carboplatin|mesh-list
83649619|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83649620|NCT01440998|Dasatinib|dasatinib|mesh-list
83649621|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83649622|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649623|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83649624|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83649625|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649626|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649627|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83649628|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649629|NCT01441128|Crizotinib|crizotinib|mesh-list
83649630|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649631|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83649632|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649633|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649634|NCT01441193|Vaccines|vaccines|mesh-list
83649635|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
83649636|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649637|NCT01441206|Rifampin|rifampin|mesh-list
83649638|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83649639|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
83649640|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83649641|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649642|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
83649643|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83649644|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649645|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649646|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83649647|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83649648|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83649649|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83649650|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83649651|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83649652|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83649653|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83649654|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649655|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649656|NCT01441232|Incretins|incretins|mesh-ancestor
83649657|NCT01441232|Hormones|hormones|mesh-ancestor
83649658|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649659|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83649660|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
83649661|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649662|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649663|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83649664|NCT01441284|Pramipexole|pramipexole|mesh-list
83649665|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
83649666|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649667|NCT01441284|Protective Agents|protective agents|mesh-ancestor
83649668|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649669|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83649670|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83649671|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
83649672|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
83649673|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649674|NCT01441297|Nintedanib|nintedanib|mesh-list
83649675|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649676|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83649677|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649678|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649679|NCT01441388|Bevacizumab|bevacizumab|mesh-list
83649680|NCT01441388|Sunitinib|sunitinib|mesh-list
83649681|NCT01441388|Sorafenib|sorafenib|mesh-list
83649682|NCT01441388|Axitinib|axitinib|mesh-list
83649683|NCT01441388|Crizotinib|crizotinib|mesh-list
83649684|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649685|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649686|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83649687|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83649688|NCT01441388|Growth Substances|growth substances|mesh-ancestor
83649689|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649690|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
83649691|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83649692|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649693|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649694|NCT01441427|Lenograstim|lenograstim|mesh-list
83649695|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83649696|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
83649697|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649698|NCT01441505|Midazolam|midazolam|mesh-list
83649699|NCT01441505|Ketamine|ketamine|mesh-list
83649700|NCT01441505|Analgesics|analgesics|mesh-ancestor
83649701|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
83649702|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649703|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649704|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83649705|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83649706|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
83649707|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
83649708|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649709|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83649710|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83649711|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649712|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649713|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83649714|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83649715|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83649716|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83649717|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83649718|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
83649719|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
83649720|NCT01441531|Gabapentin|gabapentin|mesh-list
83649721|NCT01441531|Analgesics|analgesics|mesh-ancestor
83649722|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
83649723|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649724|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649725|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
83649726|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83649727|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83649728|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649729|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83649730|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83649731|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83649732|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649733|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649734|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
83649735|NCT01441557|Amifampridine|amifampridine|mesh-list
83649736|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83649737|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649738|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649739|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83649740|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83649741|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649742|NCT01441700|Anesthetics|anesthetics|mesh-list
83649743|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649744|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649745|NCT01441804|Ribavirin|ribavirin|mesh-list
83649746|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83649747|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
83649748|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
83649749|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649750|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
83649751|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649752|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
83649753|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649754|NCT01441869|Metformin|metformin|mesh-list
83649755|NCT01441869|Saxagliptin|saxagliptin|mesh-list
83649756|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649757|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649758|NCT01441869|Incretins|incretins|mesh-ancestor
83649759|NCT01441869|Hormones|hormones|mesh-ancestor
83649760|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649761|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83649762|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
83649763|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649764|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649765|NCT01441908|Pravastatin|pravastatin|mesh-list
83649766|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83649767|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83649768|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
83649769|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649770|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83649771|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83649772|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649773|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
83649774|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649775|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
83649776|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83649777|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83649778|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649779|NCT01441934|Urological Agents|urological agents|mesh-ancestor
83649780|NCT01441986|Amantadine|amantadine|mesh-list
83649781|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
83649782|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
83649783|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
83649784|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83649785|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83649786|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649787|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649788|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649789|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83649790|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83649791|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
83649792|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649793|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
83649794|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83649795|NCT01441986|Analgesics|analgesics|mesh-ancestor
83649796|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
83649797|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649798|NCT01442025|Infliximab|infliximab|mesh-list
83649799|NCT01442025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83649800|NCT01442025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83649801|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
83649802|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83649803|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83649804|NCT01442168|Atovaquone|atovaquone|mesh-list
83649805|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649806|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
83649807|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83649808|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83649809|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649810|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649811|NCT01442272|Calcifediol|calcifediol|mesh-list
83649812|NCT01442272|Vitamins|vitamins|mesh-ancestor
83649813|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
83649814|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649815|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83649816|NCT01442311|Interferons|interferons|mesh-list
83649817|NCT01442311|Ribavirin|ribavirin|mesh-list
83649818|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
83649819|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
83649820|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83649821|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649822|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
83649823|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649824|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
83649825|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649826|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
83649827|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649828|NCT01442428|Dexamethasone|dexamethasone|mesh-list
83649829|NCT01442428|Naproxen|naproxen|mesh-list
83649830|NCT01442428|Atorvastatin|atorvastatin|mesh-list
83649831|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83649832|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
83649833|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
83649834|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649835|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649836|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83649837|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
83649838|NCT01442428|Hormones|hormones|mesh-ancestor
83649839|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83649840|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83649841|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649842|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83649843|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83649844|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
83649845|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649846|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83649847|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83649848|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649849|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83649850|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83649851|NCT01442428|Analgesics|analgesics|mesh-ancestor
83649852|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
83649853|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83649854|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
82804660|NCT01057966|Vitamins|vitamins|mesh-list
83649855|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83649856|NCT01442519|Mitomycins|mitomycins|mesh-list
83649857|NCT01442519|Mitomycin|mitomycin|mesh-list
83649858|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
83649859|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83649860|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649861|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
83649862|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649863|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83649864|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649865|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83649866|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
83649867|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649868|NCT01442532|Midazolam|midazolam|mesh-list
83649869|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83649870|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83649871|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649872|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649873|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83649874|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83649875|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83649876|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83649877|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
83649878|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
83649879|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
83649880|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
83649881|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649882|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649883|NCT01442558|Bupivacaine|bupivacaine|mesh-list
83649884|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
83649885|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
83649886|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649887|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649888|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
83649889|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649890|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
83649891|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83649892|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
83649893|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649894|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
83649895|NCT01442571|Protective Agents|protective agents|mesh-ancestor
83649896|NCT01442610|Rasagiline|rasagiline|mesh-list
83649897|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83649898|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649899|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649900|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83649901|NCT01442610|Protective Agents|protective agents|mesh-ancestor
83649902|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649903|NCT01442662|Gemcitabine|gemcitabine|mesh-list
83649904|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83649905|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
83649906|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649907|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649908|NCT01442701|Triclosan|triclosan|mesh-list
83649909|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83649910|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83649911|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83649912|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83649913|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
83649914|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649915|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83649916|NCT01442727|Selenium|selenium|mesh-list
83649917|NCT01442727|Selenious Acid|selenious acid|mesh-list
83649918|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
83649919|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
83649920|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649921|NCT01442727|Protective Agents|protective agents|mesh-ancestor
83649922|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649923|NCT01442727|Trace Elements|trace elements|mesh-ancestor
83649924|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
83649925|NCT01442766|Donepezil|donepezil|mesh-list
83649926|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83649927|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649928|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649929|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
83649930|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83649931|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649932|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
83649934|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83649935|NCT01442818|Narcotics|narcotics|mesh-ancestor
83649936|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83649937|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649938|NCT01442818|Analgesics|analgesics|mesh-ancestor
83649939|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
83649940|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83649941|NCT01442870|Metformin|metformin|mesh-list
83649942|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83649943|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649944|NCT01442909|Docetaxel|docetaxel|mesh-list
83649945|NCT01442909|Pemetrexed|pemetrexed|mesh-list
83649946|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649947|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
83649948|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
83649949|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649950|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649951|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649952|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83649953|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83649954|NCT01442935|Leucovorin|leucovorin|mesh-list
83649955|NCT01442935|Folic Acid|folic acid|mesh-list
83649956|NCT01442935|Bevacizumab|bevacizumab|mesh-list
83649957|NCT01442935|Cetuximab|cetuximab|mesh-list
83649958|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
83649959|NCT01442935|Irinotecan|irinotecan|mesh-list
83649960|NCT01442935|Fluorouracil|fluorouracil|mesh-list
83649961|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
83649962|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83649963|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649964|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83649965|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83649966|NCT01442935|Growth Substances|growth substances|mesh-ancestor
83649967|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83649968|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
83649969|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83649970|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83649971|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83649972|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649973|NCT01442935|Antidotes|antidotes|mesh-ancestor
83649974|NCT01442935|Protective Agents|protective agents|mesh-ancestor
83649975|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
83649976|NCT01442935|Vitamins|vitamins|mesh-ancestor
83649977|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
83649978|NCT01442935|Hematinics|hematinics|mesh-ancestor
83649979|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
83649980|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83649981|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83649982|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
83649983|NCT01442974|Paclitaxel|paclitaxel|mesh-list
83649984|NCT01442974|Gemcitabine|gemcitabine|mesh-list
83649985|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83649986|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83649987|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
83649988|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
83649989|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
83649990|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649991|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83649992|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
83649993|NCT01442987|Irbesartan|irbesartan|mesh-list
83649994|NCT01442987|Atorvastatin|atorvastatin|mesh-list
83649995|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83649996|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83649997|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
83649998|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83649999|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650000|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83650001|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650002|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650003|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83650004|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83650005|NCT01443065|Leucovorin|leucovorin|mesh-list
83650006|NCT01443065|Folic Acid|folic acid|mesh-list
83650007|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
83650008|NCT01443065|Panitumumab|panitumumab|mesh-list
83650009|NCT01443065|Fluorouracil|fluorouracil|mesh-list
83650010|NCT01443065|Rilotumumab|rilotumumab|mesh-list
83650011|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
83650012|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650013|NCT01443065|Antidotes|antidotes|mesh-ancestor
83650014|NCT01443065|Protective Agents|protective agents|mesh-ancestor
83650015|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650016|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
83650017|NCT01443065|Vitamins|vitamins|mesh-ancestor
83650018|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
83650019|NCT01443065|Hematinics|hematinics|mesh-ancestor
83650020|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650021|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
83650022|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650023|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83650024|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650025|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
83650026|NCT01443104|Sirolimus|sirolimus|mesh-list
83650027|NCT01443104|Everolimus|everolimus|mesh-list
83650028|NCT01443104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83650029|NCT01443104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83650030|NCT01443104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650031|NCT01443104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650032|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650033|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
83650034|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650035|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650036|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83650037|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650038|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83650039|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
83650040|NCT01443117|Vaccines|vaccines|mesh-list
83650041|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
83650042|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650043|NCT01443169|Pregabalin|pregabalin|mesh-list
83650044|NCT01443169|Analgesics|analgesics|mesh-ancestor
83650045|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
83650046|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650047|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650048|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
83650049|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83650050|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83650051|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650052|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83650053|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83650054|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83650055|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650056|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650058|NCT01443195|Trace Elements|trace elements|mesh-ancestor
83650059|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
83650060|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650061|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83650062|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83650063|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83650064|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83650065|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650066|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650067|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650068|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
83650069|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650070|NCT01443221|Metformin|metformin|mesh-list
83650071|NCT01443221|Mitiglinide|mitiglinide|mesh-list
83650072|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83650073|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650074|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
83650075|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83650076|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83650077|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
83650078|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650079|NCT01443325|Lidocaine|lidocaine|mesh-list
83650080|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
83650081|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
83650082|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650083|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650084|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
83650085|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650086|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83650087|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83650088|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83650089|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83650090|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650091|NCT01443338|Acitretin|acitretin|mesh-list
83650092|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
83650093|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
83650094|NCT01443377|Panitumumab|panitumumab|mesh-list
83650095|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650096|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650097|NCT01443416|Vaccines|vaccines|mesh-list
83650098|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83650099|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
83650100|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650101|NCT01443429|Beraprost|beraprost|mesh-list
83650102|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83650103|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
83650104|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83650105|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83650106|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83650107|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83650108|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83650109|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650110|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650111|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650112|NCT01443520|Analgesics|analgesics|mesh-ancestor
83650113|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
83650114|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650115|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
83650116|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650117|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
83650118|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83650119|NCT01443572|Anesthetics|anesthetics|mesh-list
83650120|NCT01443572|Sevoflurane|sevoflurane|mesh-list
83650121|NCT01443572|Desflurane|desflurane|mesh-list
83650122|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650123|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650124|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83650125|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83650126|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
83650127|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83650128|NCT01443624|Hematinics|hematinics|mesh-ancestor
83650129|NCT01443650|Alirocumab|alirocumab|mesh-list
83650130|NCT01443650|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83650131|NCT01443650|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650132|NCT01443650|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650133|NCT01443650|Antimetabolites|antimetabolites|mesh-ancestor
83650134|NCT01443650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650135|NCT01443650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83650136|NCT01443650|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650137|NCT01443650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650138|NCT01443650|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650139|NCT01443676|Bevacizumab|bevacizumab|mesh-list
83650140|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650141|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650142|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83650143|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83650144|NCT01443676|Growth Substances|growth substances|mesh-ancestor
83650145|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650146|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
83650147|NCT01443741|Insulin|insulin|mesh-list
83650148|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83650149|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83650150|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650151|NCT01443780|Selenium|selenium|mesh-list
83650152|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
83650153|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650154|NCT01443780|Protective Agents|protective agents|mesh-ancestor
83650155|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650156|NCT01443780|Trace Elements|trace elements|mesh-ancestor
83650157|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
83650158|NCT01443806|Oseltamivir|oseltamivir|mesh-list
83650159|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
83650160|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650161|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650162|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650163|NCT01443897|Vitamin D|vitamin d|mesh-list
83650164|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
83650165|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
83650166|NCT01443897|Vitamins|vitamins|mesh-list
83650167|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
83650168|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650169|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83650170|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83650171|NCT01443988|Travoprost|travoprost|mesh-list
83650172|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650173|NCT01444001|Vaccines|vaccines|mesh-list
83650174|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83650175|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
83650176|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650177|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
83650178|NCT01444118|Vaccines|vaccines|mesh-list
83650179|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83650180|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
83650181|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650182|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650183|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650184|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83650185|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
83650186|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650187|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650188|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83650189|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83650190|NCT01444131|Nicotine|nicotine|mesh-list
83650191|NCT01444131|Varenicline|varenicline|mesh-list
83650192|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83650193|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
83650194|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650195|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650196|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83650197|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83650198|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
83650199|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650200|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650201|NCT01444196|Desloratadine|desloratadine|mesh-list
83650202|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83650203|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
83650204|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650205|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650206|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650207|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83650208|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83650209|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
83650210|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
83650211|NCT01444248|Metformin|metformin|mesh-list
83650212|NCT01444248|Glimepiride|glimepiride|mesh-list
83650213|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83650214|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650215|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83650216|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650217|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
83650218|NCT01444339|Vaccines|vaccines|mesh-list
83650219|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83650220|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
83650221|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650222|NCT01444352|Vaccines|vaccines|mesh-list
83650223|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83650224|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
83650225|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650226|NCT01444469|Azithromycin|azithromycin|mesh-list
83650227|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83650228|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650229|NCT01444521|Irinotecan|irinotecan|mesh-list
83650230|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650231|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83650232|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83650233|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650234|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650235|NCT01444547|Paclitaxel|paclitaxel|mesh-list
83650236|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83650237|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83650238|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650239|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
83650240|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
83650241|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
83650242|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650243|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
83650244|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83650245|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
83650246|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83650247|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650248|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650249|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650250|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
83650251|NCT01444612|Heparin|heparin|mesh-list
83650252|NCT01444612|Calcium heparin|calcium heparin|mesh-list
83650253|NCT01444612|Enoxaparin|enoxaparin|mesh-list
83650254|NCT01444612|Dalteparin|dalteparin|mesh-list
83650255|NCT01444612|Tinzaparin|tinzaparin|mesh-list
83650256|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83650257|NCT01444612|PENTA|penta|mesh-list
83650258|NCT01444612|Fondaparinux|fondaparinux|mesh-list
83650259|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
83650260|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83650261|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83650262|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650263|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83650264|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
83650265|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83650266|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650267|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650268|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
83650269|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650270|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83650271|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83650272|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650273|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650274|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
83650275|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83650276|NCT01444807|Sorafenib|sorafenib|mesh-list
83650277|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650278|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83650279|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650280|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650281|NCT01444833|Candesartan|candesartan|mesh-list
83650282|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650283|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83650284|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83650285|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650286|NCT01444846|Ebselen|ebselen|mesh-list
83650287|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83650288|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83650289|NCT01444846|Analgesics|analgesics|mesh-ancestor
83650290|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
83650291|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650292|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650293|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83650294|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650295|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83650296|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83650297|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
83650298|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650299|NCT01444846|Protective Agents|protective agents|mesh-ancestor
83650300|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83650301|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650302|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83650303|NCT01444885|Amlodipine|amlodipine|mesh-list
83650304|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
83650305|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650306|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83650307|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83650308|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650309|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83650310|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650311|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
83650312|NCT01444976|Midazolam|midazolam|mesh-list
83650313|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
83650314|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650315|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650316|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83650317|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83650318|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83650319|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83650320|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650321|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83650322|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
83650323|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
83650324|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
83650325|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650326|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650327|NCT01445106|Nelfinavir|nelfinavir|mesh-list
83650328|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83650329|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83650330|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650331|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650332|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650333|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83650334|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83650335|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
83650336|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650337|NCT01445119|Carboplatin|carboplatin|mesh-list
83650338|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650339|NCT01445210|Ropivacaine|ropivacaine|mesh-list
83650340|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
83650341|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
83650342|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650343|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650344|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
83650345|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650346|NCT01445223|Ritonavir|ritonavir|mesh-list
83650347|NCT01445223|Lopinavir|lopinavir|mesh-list
83650348|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83650349|NCT01445223|Efavirenz|efavirenz|mesh-list
83650350|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83650351|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83650352|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650353|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650354|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650355|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83650356|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83650357|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
83650358|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650359|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83650360|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83650361|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83650362|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83650363|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83650364|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83650365|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83650366|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83650367|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83650368|NCT01445236|Cyclosporine|cyclosporine|mesh-list
83650369|NCT01445236|Tacrolimus|tacrolimus|mesh-list
83650370|NCT01445236|Cyclosporins|cyclosporins|mesh-list
83650371|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650372|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
83650373|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650374|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83650375|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650376|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650377|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
83650378|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650379|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
83650380|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650381|NCT01445262|Levocetirizine|levocetirizine|mesh-list
83650382|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83650383|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83650384|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
82805160|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83650385|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
83650386|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650387|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650388|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650389|NCT01445340|Romidepsin|romidepsin|mesh-list
83650390|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83650391|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650392|NCT01445340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83650393|NCT01445340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650394|NCT01445340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650395|NCT01445379|Ipilimumab|ipilimumab|mesh-list
83650396|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650397|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650398|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83650399|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650400|NCT01445392|Pemetrexed|pemetrexed|mesh-list
83650401|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83650402|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650403|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650404|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650405|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83650406|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83650407|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
83650408|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650409|NCT01445405|Cetuximab|cetuximab|mesh-list
83650410|NCT01445405|Bortezomib|bortezomib|mesh-list
83650411|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650412|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650413|NCT01445418|Carboplatin|carboplatin|mesh-list
83650414|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650415|NCT01445431|Mineral Oil|mineral oil|mesh-list
83650416|NCT01445431|Emollients|emollients|mesh-ancestor
83650417|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
83650418|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
83650419|NCT01445522|Veliparib|veliparib|mesh-list
83650420|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650421|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
83650422|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650423|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650424|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83650425|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
83650426|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650427|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650428|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83650429|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83650430|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650431|NCT01445561|Interleukin-2|interleukin-2|mesh-list
83650432|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650433|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83650434|NCT01445561|Analgesics|analgesics|mesh-ancestor
83650435|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
83650436|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650437|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650438|NCT01445587|Bortezomib|bortezomib|mesh-list
83650439|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650440|NCT01445600|Retapamulin|retapamulin|mesh-list
83650441|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83650442|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650443|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
83650444|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83650445|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650446|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650447|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83650448|NCT01445639|Analgesics|analgesics|mesh-ancestor
83650449|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
83650450|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650451|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83650452|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83650453|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83650454|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
83650455|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650456|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650457|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83650458|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83650459|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83650460|NCT01445743|Vaccines|vaccines|mesh-list
83650461|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
83650462|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650463|NCT01445756|Lidocaine|lidocaine|mesh-list
83650464|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
83650465|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
83650466|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650467|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650468|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
83650469|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650470|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83650471|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83650472|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83650473|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83650474|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650475|NCT01445860|Simvastatin|simvastatin|mesh-list
83650476|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650477|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650478|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
83650479|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650480|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650481|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83650482|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650483|NCT01445938|Lumefantrine|lumefantrine|mesh-list
83650484|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
83650485|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83650486|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83650487|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650488|NCT01445964|Atenolol|atenolol|mesh-list
83650489|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83650490|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650491|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
83650492|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
83650493|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650494|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650495|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83650496|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83650497|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83650498|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
83650499|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650500|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650501|NCT01446094|Regadenoson|regadenoson|mesh-list
83650502|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83650503|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83650504|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
83650505|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
83650506|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650507|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650508|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650509|NCT01446107|Fluorides|fluorides|mesh-list
83650510|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
83650511|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
83650512|NCT01446107|Protective Agents|protective agents|mesh-ancestor
83650513|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650514|NCT01446120|Insulin|insulin|mesh-list
83650515|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83650516|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
83650517|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
83650518|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
83650519|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83650520|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650521|NCT01446211|Gusperimus|gusperimus|mesh-list
83650522|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
83650523|NCT01446211|Methotrexate|methotrexate|mesh-list
83650524|NCT01446211|Azathioprine|azathioprine|mesh-list
83650525|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
83650526|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650527|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
83650528|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650529|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650530|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83650531|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
83650532|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650533|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650534|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83650535|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83650536|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
83650537|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83650538|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83650539|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
83650540|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
83650541|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650542|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83650543|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83650544|NCT01446211|Hormones|hormones|mesh-ancestor
83650545|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83650546|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83650547|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83650548|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83650549|NCT01446211|Protective Agents|protective agents|mesh-ancestor
83650550|NCT01446276|Resveratrol|resveratrol|mesh-list
83650551|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
83650552|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650553|NCT01446276|Protective Agents|protective agents|mesh-ancestor
83650554|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650555|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650556|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83650557|NCT01446328|Olanzapine|olanzapine|mesh-list
83650558|NCT01446328|Aripiprazole|aripiprazole|mesh-list
83650559|NCT01446328|Amisulpride|amisulpride|mesh-list
83650560|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
83650561|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
83650562|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650563|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650564|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83650565|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83650566|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83650567|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650568|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650569|NCT01446328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83650570|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83650571|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83650572|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650573|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650574|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
83650575|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
83650576|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
83650577|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
83650578|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83650579|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83650580|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83650581|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83650582|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83650583|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83650584|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83650585|NCT01446445|Valganciclovir|valganciclovir|mesh-list
83650586|NCT01446445|Ganciclovir|ganciclovir|mesh-list
83650587|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83650588|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
83650589|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650590|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83650591|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650592|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650593|NCT01446458|Folfirinox|folfirinox|mesh-list
83650594|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650595|NCT01446484|Cyclosporine|cyclosporine|mesh-list
83650596|NCT01446484|Sirolimus|sirolimus|mesh-list
83650597|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
83650598|NCT01446484|Everolimus|everolimus|mesh-list
83650599|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
83650600|NCT01446484|Tacrolimus|tacrolimus|mesh-list
83650601|NCT01446484|Cyclosporins|cyclosporins|mesh-list
83650602|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650603|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
83650604|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650605|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83650606|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650607|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650608|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
83650609|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650610|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83650611|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650612|NCT01446484|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83650613|NCT01446484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83650614|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650615|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83650616|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83650617|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
83650618|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83650619|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650621|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83650622|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83650623|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83650624|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
83650625|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650626|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650627|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650628|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83650629|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650630|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83650631|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83650632|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83650633|NCT01446523|Lactulose|lactulose|mesh-list
83650634|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83650635|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83650636|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
83650637|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650638|NCT01446679|Atorvastatin|atorvastatin|mesh-list
83650639|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650640|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650641|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
83650642|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650643|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650644|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83650645|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650646|NCT01446731|Docetaxel|docetaxel|mesh-list
83650647|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650648|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
83650649|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
83650650|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
83650651|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650652|NCT01446783|Mecasermin|mecasermin|mesh-list
83650653|NCT01446783|Growth Substances|growth substances|mesh-ancestor
83650654|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650655|NCT01446900|Rituximab|rituximab|mesh-list
83650656|NCT01446900|Cladribine|cladribine|mesh-list
83650657|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650658|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650659|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
83650660|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650661|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650662|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83650663|NCT01446926|Vaccines|vaccines|mesh-list
83650664|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83650665|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
83650666|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650667|NCT01446952|Vitamin E|vitamin e|mesh-list
83650668|NCT01446952|Tocopherols|tocopherols|mesh-list
83650669|NCT01446952|Tocotrienols|tocotrienols|mesh-list
83650670|NCT01446952|Vitamins|vitamins|mesh-ancestor
83650671|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
83650672|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650673|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
83650674|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650675|NCT01446952|Protective Agents|protective agents|mesh-ancestor
83650676|NCT01446978|Vaccines|vaccines|mesh-list
83650677|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
83650678|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650679|NCT01447043|Ranibizumab|ranibizumab|mesh-list
83650680|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83650681|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83650682|NCT01447043|Growth Substances|growth substances|mesh-ancestor
83650683|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650684|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
83650685|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650686|NCT01447069|Albuterol|albuterol|mesh-list
83650687|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83650688|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
83650689|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650690|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650691|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83650692|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
83650693|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
83650694|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83650695|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83650696|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83650697|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83650698|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
83650699|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650700|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650701|NCT01447095|Epoprostenol|epoprostenol|mesh-list
83650702|NCT01447095|Tezosentan|tezosentan|mesh-list
83650703|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650704|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83650705|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
83650706|NCT01447160|Cortisone|cortisone|mesh-list
83650707|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83650708|NCT01447173|Vitamin D|vitamin d|mesh-list
83650709|NCT01447173|Vitamins|vitamins|mesh-ancestor
83650710|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
83650711|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650712|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83650713|NCT01447212|Hydromorphone|hydromorphone|mesh-list
83650714|NCT01447212|Heroin|heroin|mesh-list
83650715|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83650716|NCT01447212|Narcotics|narcotics|mesh-ancestor
83650717|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650718|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650719|NCT01447212|Analgesics|analgesics|mesh-ancestor
83650720|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
83650721|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650722|NCT01447355|Vitamin D|vitamin d|mesh-list
83650723|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
83650724|NCT01447355|Vitamins|vitamins|mesh-ancestor
83650725|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
83650726|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650727|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83650728|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83650729|NCT01447368|Cinacalcet|cinacalcet|mesh-list
83650730|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83650731|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650732|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83650733|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
83650734|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83650735|NCT01447394|Interferons|interferons|mesh-list
83650736|NCT01447394|Ribavirin|ribavirin|mesh-list
83650737|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
83650738|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
83650739|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83650740|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650741|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
83650742|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650743|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
83650744|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650745|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
83650746|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650747|NCT01447485|Valsartan|valsartan|mesh-list
83650748|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650749|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83650750|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83650751|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650752|NCT01447550|Bosentan|bosentan|mesh-list
83650753|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650754|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83650755|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650756|NCT01447563|Clopidogrel|clopidogrel|mesh-list
83650757|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83650758|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83650759|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83650760|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83650761|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
83650762|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650763|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650764|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650765|NCT01447589|Nelfinavir|nelfinavir|mesh-list
83650766|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83650767|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83650768|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650769|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650770|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650771|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83650772|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83650773|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
83650774|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650775|NCT01447654|Losartan|losartan|mesh-list
83650776|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83650777|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650778|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83650779|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83650780|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650781|NCT01447797|Irbesartan|irbesartan|mesh-list
83650782|NCT01447797|Atorvastatin|atorvastatin|mesh-list
83650783|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650784|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650785|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
83650786|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650787|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650788|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83650789|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650790|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83650791|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83650792|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83650793|NCT01447862|Ibutilide|ibutilide|mesh-list
83650794|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83650795|NCT01447875|Propofol|propofol|mesh-list
83650796|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83650797|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650798|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650799|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83650800|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
83650801|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
83650802|NCT01447979|Pancrelipase|pancrelipase|mesh-list
83650803|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83650804|NCT01448018|Ranibizumab|ranibizumab|mesh-list
83650805|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83650806|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83650807|NCT01448018|Growth Substances|growth substances|mesh-ancestor
83650808|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650809|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
83650810|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650811|NCT01448031|Esomeprazole|esomeprazole|mesh-list
83650812|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83650813|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83650814|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83650815|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650816|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650817|NCT01448070|Insulin|insulin|mesh-list
83650818|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83650819|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83650820|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650821|NCT01448096|Rituximab|rituximab|mesh-list
83650822|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83650823|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650824|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
83650825|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650826|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650827|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
83650828|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83650829|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83650830|NCT01448174|Atorvastatin|atorvastatin|mesh-list
83650831|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650832|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650833|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
83650834|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650835|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650836|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83650837|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650838|NCT01448239|Alirocumab|alirocumab|mesh-list
83650839|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83650840|NCT01448239|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83650841|NCT01448239|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650842|NCT01448239|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650844|NCT01448239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650845|NCT01448239|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83650846|NCT01448239|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650847|NCT01448239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650848|NCT01448239|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650849|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
83650850|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650851|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83650852|NCT01448291|Etonogestrel|etonogestrel|mesh-list
83650853|NCT01448291|NuvaRing|nuvaring|mesh-list
83650854|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
83650855|NCT01448291|Estradiol|estradiol|mesh-list
83650856|NCT01448291|Estrogens|estrogens|mesh-ancestor
83650857|NCT01448291|Hormones|hormones|mesh-ancestor
83650858|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83650859|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650860|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83650861|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83650862|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83650863|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83650864|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83650865|NCT01448304|Alirocumab|alirocumab|mesh-list
83650866|NCT01448304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83650867|NCT01448304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650868|NCT01448304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650869|NCT01448304|Antimetabolites|antimetabolites|mesh-ancestor
83650870|NCT01448304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650871|NCT01448304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83650872|NCT01448304|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650873|NCT01448304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650874|NCT01448304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650875|NCT01448317|Alirocumab|alirocumab|mesh-list
83650876|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83650877|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83650878|NCT01448317|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83650879|NCT01448317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650880|NCT01448317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650881|NCT01448317|Antimetabolites|antimetabolites|mesh-ancestor
83650882|NCT01448317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650883|NCT01448317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83650884|NCT01448317|Protease Inhibitors|protease inhibitors|mesh-ancestor
83650885|NCT01448317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650886|NCT01448317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650887|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
83650888|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650889|NCT01448330|Aspirin|aspirin|mesh-list
83650890|NCT01448330|Clopidogrel|clopidogrel|mesh-list
83650891|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83650892|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83650893|NCT01448330|Analgesics|analgesics|mesh-ancestor
83650894|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
83650895|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650896|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650897|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83650898|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83650899|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83650900|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83650901|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650902|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83650903|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83650904|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650905|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
83650906|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83650907|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83650908|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83650909|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
83650910|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650911|NCT01448395|Avibactam|avibactam|mesh-list
83650912|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83650913|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650914|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650915|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83650916|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650917|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
83650918|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83650919|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83650920|NCT01448499|Clozapine|clozapine|mesh-list
83650921|NCT01448499|Amisulpride|amisulpride|mesh-list
83650922|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83650923|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
83650924|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650925|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650926|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650927|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83650928|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83650929|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650930|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650931|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
83650932|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
83650933|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83650934|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
83650935|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83650936|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
83650937|NCT01448642|Atorvastatin|atorvastatin|mesh-list
83650938|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83650939|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83650940|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
83650941|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650942|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83650943|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83650944|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650945|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83650946|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83650947|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83650948|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83650949|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650950|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650951|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83650952|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83650953|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
83650954|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650955|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650956|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83650957|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83650958|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
83650959|NCT01448733|Clindamycin|clindamycin|mesh-list
83650960|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
83650961|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
83650962|NCT01448733|Tretinoin|tretinoin|mesh-list
83650963|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83650964|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83650965|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83650966|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83650967|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83650968|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650969|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
83650970|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83650971|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
83650972|NCT01448746|Heparin|heparin|mesh-list
83650973|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83650974|NCT01448746|Tinzaparin|tinzaparin|mesh-list
83650975|NCT01448746|Dalteparin|dalteparin|mesh-list
83650976|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
83650977|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83650978|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83650979|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650980|NCT01448772|Dronabinol|dronabinol|mesh-list
83650981|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
83650982|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83650983|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83650984|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83650985|NCT01448772|Analgesics|analgesics|mesh-ancestor
83650986|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
83650987|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83650988|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83650989|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83650990|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83650991|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83650993|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83650994|NCT01448798|Thrombin|thrombin|mesh-list
83650995|NCT01448798|Hemostatics|hemostatics|mesh-list
83650996|NCT01448798|Coagulants|coagulants|mesh-ancestor
83650997|NCT01448837|Timolol|timolol|mesh-list
83650998|NCT01448837|Bimatoprost|bimatoprost|mesh-list
83650999|NCT01448837|Latanoprost|latanoprost|mesh-list
83651000|NCT01448837|Cloprostenol|cloprostenol|mesh-list
83651001|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83651002|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83651003|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
83651004|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651005|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651006|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651007|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83651008|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83651009|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83651010|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83651011|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
83651012|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83651013|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
83651014|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83651015|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83651016|NCT01448993|Azithromycin|azithromycin|mesh-list
83651017|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651018|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651019|NCT01449045|Lumefantrine|lumefantrine|mesh-list
83651020|NCT01449045|Artemether|artemether|mesh-list
83651021|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83651022|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
83651023|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83651024|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83651025|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651026|NCT01449110|Resveratrol|resveratrol|mesh-list
83651027|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
83651028|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651029|NCT01449110|Protective Agents|protective agents|mesh-ancestor
83651030|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651031|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651032|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83651033|NCT01449123|Mannitol|mannitol|mesh-list
83651034|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83651035|NCT01449123|Diuretics|diuretics|mesh-ancestor
83651036|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
83651037|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651038|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83651039|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651040|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
83651041|NCT01449188|Ondansetron|ondansetron|mesh-list
83651042|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651043|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651044|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83651045|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83651046|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651047|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651048|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651049|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651050|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
83651051|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
83651052|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651053|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83651054|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
83651055|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83651056|NCT01449188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83651057|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83651058|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
83651059|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651060|NCT01449253|Bosentan|bosentan|mesh-list
83651061|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
83651062|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83651063|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83651064|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83651065|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651066|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651067|NCT01449253|Urological Agents|urological agents|mesh-ancestor
83651068|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83651069|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83651070|NCT01449344|Cytarabine|cytarabine|mesh-list
83651071|NCT01449344|Dexamethasone|dexamethasone|mesh-list
83651072|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
83651073|NCT01449344|Rituximab|rituximab|mesh-list
83651074|NCT01449344|Bortezomib|bortezomib|mesh-list
83651075|NCT01449344|BB 1101|bb 1101|mesh-list
83651076|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83651077|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651078|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
83651079|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651080|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83651081|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651082|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
83651083|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
83651084|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651085|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83651086|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
83651087|NCT01449344|Hormones|hormones|mesh-ancestor
83651088|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651089|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83651090|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
83651091|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651092|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651093|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83651094|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
83651095|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
83651096|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651097|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83651098|NCT01449357|Zalutumumab|zalutumumab|mesh-list
83651099|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83651100|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651101|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
83651102|NCT01449435|Miotics|miotics|mesh-ancestor
83651103|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
83651104|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651105|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651106|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83651107|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83651108|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83651109|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83651110|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83651111|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
83651112|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651113|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651114|NCT01449448|Triamcinolone|triamcinolone|mesh-list
83651115|NCT01449448|Ketorolac|ketorolac|mesh-list
83651116|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651117|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
83651118|NCT01449448|Hormones|hormones|mesh-ancestor
83651119|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651120|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651121|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651122|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651123|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83651124|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83651125|NCT01449448|Analgesics|analgesics|mesh-ancestor
83651126|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
83651127|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651128|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83651129|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83651130|NCT01447992|Pancrelipase|pancrelipase|mesh-list
83651131|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83651132|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
83651133|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83651134|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83651135|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651136|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
83651137|NCT01449552|Coagulants|coagulants|mesh-ancestor
83651138|NCT01449565|Naltrexone|naltrexone|mesh-list
83651139|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83651140|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83651141|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651142|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
83651143|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651144|NCT01449578|Pramipexole|pramipexole|mesh-list
83651145|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
83651146|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651147|NCT01449578|Protective Agents|protective agents|mesh-ancestor
83651148|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651149|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83651150|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83651151|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
83651152|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
83651153|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651154|NCT01449617|Aspirin|aspirin|mesh-list
83651155|NCT01449617|Clopidogrel|clopidogrel|mesh-list
83651156|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83651157|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83651158|NCT01449617|Analgesics|analgesics|mesh-ancestor
83651159|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
83651160|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651161|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651162|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651163|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83651164|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83651165|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83651166|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651167|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83651168|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83651169|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651170|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
83651171|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83651172|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83651173|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83651174|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
83651175|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651176|NCT01449799|Fluticasone|fluticasone|mesh-list
83651177|NCT01449799|Xhance|xhance|mesh-list
83651178|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651179|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83651180|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
83651181|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651182|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651183|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83651184|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83651185|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83651186|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83651187|NCT01449825|Bevacizumab|bevacizumab|mesh-list
83651188|NCT01449825|Sunitinib|sunitinib|mesh-list
83651189|NCT01449825|Sorafenib|sorafenib|mesh-list
83651190|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83651191|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651192|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83651193|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83651194|NCT01449825|Growth Substances|growth substances|mesh-ancestor
83651195|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651196|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
83651197|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83651198|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651199|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651200|NCT01449877|Trimethoprim|trimethoprim|mesh-list
83651201|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83651202|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
83651203|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83651204|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651205|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
83651206|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83651207|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83651208|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83651209|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651210|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651211|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83651212|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83651213|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83651214|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651215|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
83651216|NCT01450163|Pregabalin|pregabalin|mesh-list
83651217|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651218|NCT01450163|Analgesics|analgesics|mesh-ancestor
83651219|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
83651220|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651221|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651222|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
83651223|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83651224|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651225|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651226|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651227|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83651228|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83651229|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651230|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83651231|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83651232|NCT01450995|Sumatriptan|sumatriptan|mesh-list
83651233|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83651234|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83651235|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83651236|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
83651237|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651238|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651239|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651240|NCT01451320|Plasminogen|plasminogen|mesh-list
83651241|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83651242|NCT01451320|Streptokinase|streptokinase|mesh-list
83651243|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83651244|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83651245|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651246|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
83651247|NCT01451489|Tacrolimus|tacrolimus|mesh-list
83651248|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83651249|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
83651250|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651251|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83651252|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83651253|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
83651254|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651255|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651256|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83651257|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83651258|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651259|NCT01451853|Ebselen|ebselen|mesh-list
83651260|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83651261|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83651262|NCT01451853|Analgesics|analgesics|mesh-ancestor
83651263|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
83651264|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651265|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651266|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651267|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83651268|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83651269|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83651270|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
83651271|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651272|NCT01451853|Protective Agents|protective agents|mesh-ancestor
83651273|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83651274|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651275|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83651276|NCT01452243|Vitamin D|vitamin d|mesh-list
83651277|NCT01452243|Calcium|calcium|mesh-list
83651278|NCT01452243|Vitamins|vitamins|mesh-ancestor
83651279|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
83651280|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651281|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651282|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83651283|NCT01452256|Propofol|propofol|mesh-list
83651284|NCT01452256|Desflurane|desflurane|mesh-list
83651285|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83651286|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651287|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651288|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83651289|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
83651290|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
83651291|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83651292|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83651293|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83651294|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
83651295|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806130|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83651296|NCT01452607|Ebselen|ebselen|mesh-list
83651297|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83651298|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83651299|NCT01452607|Analgesics|analgesics|mesh-ancestor
83651300|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
83651301|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651302|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651303|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651304|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83651305|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83651306|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83651307|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
83651308|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651309|NCT01452607|Protective Agents|protective agents|mesh-ancestor
83651310|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83651311|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651312|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83651313|NCT01453062|Ofatumumab|ofatumumab|mesh-list
83651314|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651315|NCT01453283|Trabectedin|trabectedin|mesh-list
83651316|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83651317|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
83651318|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651319|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651320|NCT01454700|Insulin|insulin|mesh-list
83651321|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83651322|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651323|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651324|NCT01454869|Heparin|heparin|mesh-list
83651325|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
83651326|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83651327|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83651328|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651329|NCT01455350|Lidocaine|lidocaine|mesh-list
83651330|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
83651331|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
83651332|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651333|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651334|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
83651335|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651336|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83651337|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83651338|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83651339|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651340|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651341|NCT01455636|Micronutrients|micronutrients|mesh-list
83651342|NCT01455636|Trace Elements|trace elements|mesh-list
83651343|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
83651344|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651345|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83651346|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651347|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
83651348|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83651349|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83651350|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651351|NCT01456507|Naltrexone|naltrexone|mesh-list
83651352|NCT01456507|Oxycodone|oxycodone|mesh-list
83651353|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83651354|NCT01456507|Narcotics|narcotics|mesh-ancestor
83651355|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651356|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651357|NCT01456507|Analgesics|analgesics|mesh-ancestor
83651358|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
83651359|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651360|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83651361|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83651362|NCT01456585|Gemcitabine|gemcitabine|mesh-list
83651363|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83651364|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
83651365|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651366|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651367|NCT01456650|Glyburide|glyburide|mesh-list
83651368|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651369|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651370|NCT01457040|Etoposide|etoposide|mesh-list
83651372|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83651373|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651374|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83651375|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83651376|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651377|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651378|NCT01457508|Edetic Acid|edetic acid|mesh-list
83651379|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
83651380|NCT01457508|Antidotes|antidotes|mesh-ancestor
83651381|NCT01457508|Protective Agents|protective agents|mesh-ancestor
83651382|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651383|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
83651384|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
83651385|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651386|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83651387|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
83651388|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83651389|NCT01458431|Anesthetics|anesthetics|mesh-list
83651390|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
83651391|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
83651392|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651393|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651394|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
83651395|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651396|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
83651397|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83651398|NCT01459445|Metformin|metformin|mesh-list
83651399|NCT01459445|Drospirenone|drospirenone|mesh-list
83651400|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83651401|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651402|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651403|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83651404|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83651405|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83651406|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
83651407|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83651408|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83651409|NCT01459445|Estrogens|estrogens|mesh-ancestor
83651410|NCT01459445|Hormones|hormones|mesh-ancestor
83651411|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651412|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83651413|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
83651414|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83651415|NCT01459445|Diuretics|diuretics|mesh-ancestor
83651416|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
83651417|NCT01460030|Cinacalcet|cinacalcet|mesh-list
83651418|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651419|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651420|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83651421|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
83651422|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651423|NCT01460069|Liraglutide|liraglutide|mesh-list
83651424|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651425|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651426|NCT01460069|Incretins|incretins|mesh-ancestor
83651427|NCT01460069|Hormones|hormones|mesh-ancestor
83651428|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651429|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83651430|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
83651431|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651432|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
83651433|NCT01460212|Citalopram|citalopram|mesh-list
83651434|NCT01460212|Fluoxetine|fluoxetine|mesh-list
83651435|NCT01460212|Paroxetine|paroxetine|mesh-list
83651436|NCT01460212|Sertraline|sertraline|mesh-list
83651437|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
83651438|NCT01460212|Escitalopram|escitalopram|mesh-list
83651439|NCT01460212|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83651440|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83651441|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651442|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651443|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651444|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
83651445|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651446|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83651447|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83651448|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83651449|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83651450|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651451|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83651452|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83651453|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651454|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83651455|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83651456|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
83651457|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83651458|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83651459|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83651460|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651461|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651462|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
83651463|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651464|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651465|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83651466|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651467|NCT01460420|Lenalidomide|lenalidomide|mesh-list
83651468|NCT01460420|Bortezomib|bortezomib|mesh-list
83651469|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
83651470|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651471|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83651472|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83651473|NCT01460420|Growth Substances|growth substances|mesh-ancestor
83651474|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
83651475|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651476|NCT01460498|Azacitidine|azacitidine|mesh-list
83651477|NCT01460498|Decitabine|decitabine|mesh-list
83651478|NCT01460498|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83651479|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83651480|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
83651481|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651482|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651483|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651484|NCT01460498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83651485|NCT01460537|Gemcitabine|gemcitabine|mesh-list
83651486|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651487|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83651488|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
83651489|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651490|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
83651491|NCT01460563|Analgesics|analgesics|mesh-ancestor
83651492|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
83651493|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651494|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651495|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
83651496|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651497|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83651498|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
83651499|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83651500|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651501|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651502|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651503|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
83651504|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83651505|NCT01460602|Rituximab|rituximab|mesh-list
83651506|NCT01460602|Bortezomib|bortezomib|mesh-list
83651507|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83651508|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651509|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
83651510|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651511|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83651512|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
83651513|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651514|NCT01460667|Acetaminophen|acetaminophen|mesh-list
83651515|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83651516|NCT01460667|Analgesics|analgesics|mesh-ancestor
83651517|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
83651518|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806286|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
83651519|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651520|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
83651521|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
83651522|NCT01460693|Dasatinib|dasatinib|mesh-list
83651523|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651524|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83651525|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651526|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651527|NCT01460706|Edotreotide|edotreotide|mesh-list
83651528|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83651529|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651530|NCT01460797|Metformin|metformin|mesh-list
83651531|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651532|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651533|NCT01460836|Tobramycin|tobramycin|mesh-list
83651534|NCT01460836|Aztreonam|aztreonam|mesh-list
83651535|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651536|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651537|NCT01460888|Olaparib|olaparib|mesh-list
83651538|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83651539|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651540|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651541|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651542|NCT01460979|Sirolimus|sirolimus|mesh-list
83651543|NCT01460979|Temsirolimus|temsirolimus|mesh-list
83651544|NCT01460979|MTOR Inhibitors|mtor inhibitors|mesh-list
83651545|NCT01460979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83651546|NCT01460979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651547|NCT01460979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651548|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83651549|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
83651550|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651551|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651552|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651553|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651554|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83651555|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
83651556|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
83651557|NCT01461018|Antibodies|antibodies|mesh-list
83651558|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
83651559|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83651560|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83651561|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
83651562|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651563|NCT01461031|Nefopam|nefopam|mesh-list
83651564|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83651565|NCT01461031|Analgesics|analgesics|mesh-ancestor
83651566|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
83651567|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651568|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651569|NCT01461174|Memantine|memantine|mesh-list
83651570|NCT01461174|Modafinil|modafinil|mesh-list
83651571|NCT01461174|Donepezil|donepezil|mesh-list
83651572|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83651573|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651574|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651575|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
83651576|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651577|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651578|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
83651579|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83651580|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83651581|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
83651582|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83651583|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83651584|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83651585|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83651586|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83651587|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83651588|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
83651589|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
83651590|NCT01461460|Tedizolid|tedizolid|mesh-list
83651591|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
83651592|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651593|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651594|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83651595|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83651596|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651597|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651598|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651599|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83651600|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
83651601|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651602|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651603|NCT01461616|Insulin|insulin|mesh-list
83651604|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83651605|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
83651606|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
83651607|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651608|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651609|NCT01461746|Docetaxel|docetaxel|mesh-list
83651610|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651611|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
83651612|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
83651613|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
83651614|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651615|NCT01461759|Cisplatin|cisplatin|mesh-list
83651616|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651617|NCT01461772|Carboplatin|carboplatin|mesh-list
83651618|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651619|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83651620|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
83651621|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651622|NCT01462006|Sirolimus|sirolimus|mesh-list
83651623|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651624|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651625|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83651626|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651627|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
83651628|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83651629|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
83651630|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651631|NCT01462058|Vitamin D|vitamin d|mesh-list
83651632|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
83651633|NCT01462058|Vitamins|vitamins|mesh-ancestor
83651634|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
83651635|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651636|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83651637|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651638|NCT01462149|Carboplatin|carboplatin|mesh-list
83651639|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651640|NCT01462214|Everolimus|everolimus|mesh-list
83651641|NCT01462214|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83651642|NCT01462214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83651643|NCT01462214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651644|NCT01462214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651645|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83651646|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
83651647|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651648|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651649|NCT01462422|Misoprostol|misoprostol|mesh-list
83651650|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83651651|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
83651652|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83651653|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651654|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83651655|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83651656|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
83651657|NCT01462474|Cisplatin|cisplatin|mesh-list
83651658|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651659|NCT01462487|Zanamivir|zanamivir|mesh-list
83651660|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
83651661|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651662|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651663|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651664|NCT01462500|Miltefosine|miltefosine|mesh-list
83651665|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
83651666|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651667|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651668|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82806434|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651669|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83651670|NCT01462617|Nemiralisib|nemiralisib|mesh-list
83651671|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83651672|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651673|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651675|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
83651676|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651677|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651678|NCT01462903|Immunomodulating Agents|immunomodulating agents|mesh-list
83651679|NCT01462903|Immunologic Factors|immunologic factors|mesh-ancestor
83651680|NCT01462903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651681|NCT01462968|Heparin|heparin|mesh-list
83651682|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
83651683|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83651684|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83651685|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651686|NCT01463046|Cytarabine|cytarabine|mesh-list
83651687|NCT01463046|Daunorubicin|daunorubicin|mesh-list
83651688|NCT01463046|Panobinostat|panobinostat|mesh-list
83651689|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83651690|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
83651691|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651692|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651693|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
83651694|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651695|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83651696|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
83651697|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651698|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83651699|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83651700|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83651701|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651702|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83651703|NCT01463150|Clopidogrel|clopidogrel|mesh-list
83651704|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83651705|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83651706|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83651707|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83651708|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83651709|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
83651710|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651711|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651712|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651713|NCT01463163|Ticagrelor|ticagrelor|mesh-list
83651714|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83651715|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83651716|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83651717|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83651718|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83651719|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
83651720|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651721|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651722|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651723|NCT01463215|Ambroxol|ambroxol|mesh-list
83651724|NCT01463215|Expectorants|expectorants|mesh-ancestor
83651725|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
83651726|NCT01463228|Metformin|metformin|mesh-list
83651727|NCT01463228|Canagliflozin|canagliflozin|mesh-list
83651728|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651729|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651730|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83651731|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651732|NCT01463280|Lidocaine|lidocaine|mesh-list
83651733|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
83651734|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
83651735|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651736|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651737|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
83651738|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651739|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83651740|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83651741|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83651742|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651743|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651744|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
83651745|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83651746|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651747|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651748|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83651749|NCT01463332|Analgesics|analgesics|mesh-ancestor
83651750|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
83651751|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651752|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83651753|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83651754|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83651755|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
83651756|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651757|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651758|NCT01463371|Azithromycin|azithromycin|mesh-list
83651759|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651760|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651762|NCT01463592|Interferons|interferons|mesh-list
83651763|NCT01463592|Ribavirin|ribavirin|mesh-list
83651764|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
83651765|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
83651766|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
83651767|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651768|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
83651769|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651770|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
83651771|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651772|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
83651773|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651774|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83651775|NCT01463592|Trace Elements|trace elements|mesh-ancestor
83651776|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
83651777|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
83651778|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83651779|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651780|NCT01463735|Vitamin E|vitamin e|mesh-list
83651781|NCT01463735|Vitamins|vitamins|mesh-ancestor
83651782|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
83651783|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651784|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
83651785|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651786|NCT01463735|Protective Agents|protective agents|mesh-ancestor
83651787|NCT01463774|Metformin|metformin|mesh-list
83651788|NCT01463774|Canagliflozin|canagliflozin|mesh-list
83651789|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651790|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651791|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83651792|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651793|NCT01463813|Vitamin D|vitamin d|mesh-list
83651794|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
83651795|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
83651796|NCT01463813|Vitamins|vitamins|mesh-list
83651797|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
83651798|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651799|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83651800|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651801|NCT01463852|Vincristine|vincristine|mesh-list
83651802|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83651803|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651804|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
83651805|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
83651806|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
83651807|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651808|NCT01463865|Ropivacaine|ropivacaine|mesh-list
83651809|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
83651810|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
83651811|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83651812|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651813|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
83651814|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651815|NCT01463956|Interferons|interferons|mesh-list
83651816|NCT01463956|Ribavirin|ribavirin|mesh-list
83651817|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651818|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
83651819|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651820|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
82806586|NCT00492284|Hormones|hormones|mesh-ancestor
83651821|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651822|NCT01464008|Interferons|interferons|mesh-list
83651823|NCT01464008|Ribavirin|ribavirin|mesh-list
83651824|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
83651825|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
83651826|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83651827|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651828|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
83651829|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651830|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
83651831|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651832|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
83651833|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651834|NCT01464060|Amoxicillin|amoxicillin|mesh-list
83651835|NCT01464060|Metronidazole|metronidazole|mesh-list
83651836|NCT01464060|Clarithromycin|clarithromycin|mesh-list
83651837|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651838|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651839|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83651840|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83651841|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83651842|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651843|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651844|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83651845|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83651846|NCT01464099|Insulin|insulin|mesh-list
83651847|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83651848|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
83651849|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
83651850|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83651851|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83651852|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651853|NCT01464112|Dexamethasone|dexamethasone|mesh-list
83651854|NCT01464112|Bortezomib|bortezomib|mesh-list
83651855|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651856|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
83651857|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
83651858|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651859|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651860|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83651861|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
83651862|NCT01464112|Hormones|hormones|mesh-ancestor
83651863|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651864|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83651865|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651866|NCT01464125|Azithromycin|azithromycin|mesh-list
83651867|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
83651868|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651869|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651870|NCT01464138|Clindamycin|clindamycin|mesh-list
83651871|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
83651872|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
83651873|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
83651874|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651875|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651876|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83651877|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651878|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651879|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83651880|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
83651881|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83651882|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651883|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651884|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83651885|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83651886|NCT01464242|Protective Agents|protective agents|mesh-ancestor
83651887|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651888|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
83651889|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83651890|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
83651891|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83651892|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83651893|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651894|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83651895|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
83651896|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651897|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
83651898|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83651899|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
83651900|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83651901|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
83651902|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651903|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651904|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
83651906|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83651907|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83651908|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83651909|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651910|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651911|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651912|NCT01464489|Atropine|atropine|mesh-list
83651913|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83651914|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83651915|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83651916|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
83651917|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651918|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651919|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83651920|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
83651921|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
83651922|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
83651923|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83651924|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83651925|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
83651926|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651927|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651928|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83651929|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83651930|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83651931|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
83651932|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651933|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83651934|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83651935|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651936|NCT01466712|Beclomethasone|beclomethasone|mesh-list
83651937|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
83651938|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
83651939|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83651940|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
83651941|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83651942|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651943|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83651944|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
83651945|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83651946|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83651947|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83651948|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
83651949|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83651950|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651951|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
83651952|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83651953|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
83651954|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651955|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
83651956|NCT01466712|Hormones|hormones|mesh-ancestor
83651957|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651958|NCT01466829|Hormones|hormones|mesh-list
83651959|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
83651960|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83651961|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651962|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83651963|NCT01466855|Topotecan|topotecan|mesh-list
83651964|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83651965|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83651966|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651967|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651968|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651969|NCT01466959|Acetic Acid|acetic acid|mesh-list
82806740|NCT00500370|Exenatide|exenatide|mesh-list
82806809|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83651970|NCT01466959|Retinol acetate|retinol acetate|mesh-list
83651971|NCT01466959|Citric Acid|citric acid|mesh-list
83651972|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
83651973|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
83651974|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83651975|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
83651976|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
83651977|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651978|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83651979|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651980|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651981|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83651982|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
83651983|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83651984|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83651985|NCT01466959|Protective Agents|protective agents|mesh-ancestor
83651986|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651987|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
83651988|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83651989|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83651990|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83651991|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
83651992|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83651993|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83651994|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83651995|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83651996|NCT01467115|Leucovorin|leucovorin|mesh-list
83651997|NCT01467115|Docetaxel|docetaxel|mesh-list
83651998|NCT01467115|Fluorouracil|fluorouracil|mesh-list
83651999|NCT01467115|Cetuximab|cetuximab|mesh-list
83652000|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
83652001|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
83652002|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652003|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
83652004|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
83652005|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
83652006|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652007|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
83652008|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652009|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83652010|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
83652011|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652012|NCT01467115|Antidotes|antidotes|mesh-ancestor
83652013|NCT01467115|Protective Agents|protective agents|mesh-ancestor
83652014|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
83652015|NCT01467115|Vitamins|vitamins|mesh-ancestor
83652016|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
83652017|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83652018|NCT01467115|Hematinics|hematinics|mesh-ancestor
83652019|NCT01467141|Insulin|insulin|mesh-list
83652020|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83652021|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
83652022|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
83652023|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
83652024|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
83652025|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652026|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652027|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83652028|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83652029|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652030|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83652031|NCT01467258|Amantadine|amantadine|mesh-list
83652032|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83652033|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83652034|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
83652035|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652036|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
83652037|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652038|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652039|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652040|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83652041|NCT01467258|Analgesics|analgesics|mesh-ancestor
83652042|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
83652043|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652044|NCT01467297|Levofloxacin|levofloxacin|mesh-list
83652045|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83652046|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652047|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83652048|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83652049|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83652050|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652051|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652052|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652053|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83652054|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83652055|NCT01467310|Trametinib|trametinib|mesh-list
83652056|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652057|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652058|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652059|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652060|NCT01467323|Insulin|insulin|mesh-list
83652061|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83652062|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
83652063|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
83652064|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652065|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652066|NCT01467362|Desonide|desonide|mesh-list
83652067|NCT01467362|V0034CR|v0034cr|mesh-list
83652068|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652069|NCT01467362|Emollients|emollients|mesh-ancestor
83652070|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
83652071|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
83652072|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
83652073|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652074|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652075|NCT01467401|Insulin|insulin|mesh-list
83652076|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83652077|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
83652078|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
83652079|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652080|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652081|NCT01467414|Insulin|insulin|mesh-list
83652082|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652083|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652084|NCT01467518|Dolutegravir|dolutegravir|mesh-list
83652085|NCT01467518|Methadone|methadone|mesh-list
83652086|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83652087|NCT01467518|Narcotics|narcotics|mesh-ancestor
83652088|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83652089|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652090|NCT01467518|Analgesics|analgesics|mesh-ancestor
83652091|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
83652092|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652093|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
83652094|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
83652095|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83652096|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83652097|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652098|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652099|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83652100|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83652101|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
83652102|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652103|NCT01467531|Dolutegravir|dolutegravir|mesh-list
83652104|NCT01467531|Cabotegravir|cabotegravir|mesh-list
83652105|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83652106|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83652107|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652108|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652109|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83652110|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83652111|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
83652112|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652113|NCT01467596|Lidocaine|lidocaine|mesh-list
83652114|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
83652115|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
83652116|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
83652117|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83652118|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652119|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
83652120|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652121|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83652122|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83652123|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83652124|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652125|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652127|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83652128|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652129|NCT01467687|Verapamil|verapamil|mesh-list
83652130|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83652131|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83652132|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652133|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652134|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83652135|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652136|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
83652137|NCT01467804|Sertraline|sertraline|mesh-list
83652138|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
83652139|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83652140|NCT01467804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83652141|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83652142|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652143|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652144|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652145|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
83652146|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652147|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
83652148|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652149|NCT01467986|Sirolimus|sirolimus|mesh-list
83652150|NCT01467986|Irinotecan|irinotecan|mesh-list
83652151|NCT01467986|Temozolomide|temozolomide|mesh-list
83652152|NCT01467986|Dasatinib|dasatinib|mesh-list
83652153|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83652154|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83652155|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652156|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652157|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652158|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83652159|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
83652160|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83652161|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652162|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83652163|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
83652164|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83652165|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
83652166|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652167|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652168|NCT01468025|Naproxen|naproxen|mesh-list
83652169|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83652170|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83652171|NCT01468025|Analgesics|analgesics|mesh-ancestor
83652172|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
83652173|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652174|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652175|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652176|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652177|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
83652178|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83652179|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652180|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652181|NCT01468038|Trazodone|trazodone|mesh-list
83652182|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83652183|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83652184|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83652185|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652186|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83652187|NCT01468038|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83652188|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83652189|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652190|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652191|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652192|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
83652193|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83652194|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
83652195|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83652196|NCT01468051|Vaccines|vaccines|mesh-list
83652197|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
83652198|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652199|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83652200|NCT01468051|Antacids|antacids|mesh-ancestor
83652201|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652202|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83652203|NCT01468155|Dabigatran|dabigatran|mesh-list
83652204|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
83652205|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83652206|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
83652207|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652208|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652209|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
83652210|NCT01468259|Droxidopa|droxidopa|mesh-list
83652211|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83652212|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83652213|NCT01468272|Beclomethasone|beclomethasone|mesh-list
83652214|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
83652215|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83652216|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
83652217|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652218|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652219|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83652220|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
83652221|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83652222|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83652223|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83652224|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
83652225|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652226|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652227|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652228|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
83652229|NCT01468272|Hormones|hormones|mesh-ancestor
83652230|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652231|NCT01468285|Betahistine|betahistine|mesh-list
83652232|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
83652233|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
83652234|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
83652235|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652236|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652237|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652238|NCT01468389|Capecitabine|capecitabine|mesh-list
83652239|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652240|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
83652241|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652242|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652243|NCT01468415|Phenol|phenol|mesh-list
83652244|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83652245|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652246|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
83652247|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83652248|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83652249|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83652250|NCT01468441|Cetrorelix|cetrorelix|mesh-list
83652251|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
83652252|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83652253|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
83652254|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83652255|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652256|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83652257|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83652258|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652259|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83652260|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
83652261|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
83652262|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652263|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
83652264|NCT01468480|Calcium|calcium|mesh-list
83652265|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83652266|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652267|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83652268|NCT01468519|Insulin|insulin|mesh-list
83652269|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83652270|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652271|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652272|NCT01468545|Iloprost|iloprost|mesh-list
83652273|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83652274|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
83652275|NCT01468571|Spironolactone|spironolactone|mesh-list
83652276|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83652277|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
83652278|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652279|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652280|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83652281|NCT01468571|Diuretics|diuretics|mesh-ancestor
83652282|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
83652283|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83652284|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83652285|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83652286|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652287|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652288|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652289|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652290|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
83652291|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83652292|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
83652293|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652294|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652295|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652296|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652297|NCT01468714|Ketoconazole|ketoconazole|mesh-list
83652298|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
83652299|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652300|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83652301|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83652302|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652303|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652304|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83652305|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
83652306|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652307|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652308|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83652309|NCT01468740|Prednisone|prednisone|mesh-list
83652310|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
83652311|NCT01468740|Dacarbazine|dacarbazine|mesh-list
83652312|NCT01468740|Doxorubicin|doxorubicin|mesh-list
83652313|NCT01468740|Etoposide|etoposide|mesh-list
83652314|NCT01468740|Vincristine|vincristine|mesh-list
83652315|NCT01468740|Bleomycin|bleomycin|mesh-list
83652316|NCT01468740|Vinblastine|vinblastine|mesh-list
83652317|NCT01468740|Procarbazine|procarbazine|mesh-list
83652318|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83652319|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
83652320|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652321|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652322|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83652323|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
83652324|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652325|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652326|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83652327|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83652328|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83652329|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83652330|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652331|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652332|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
83652333|NCT01468740|Hormones|hormones|mesh-ancestor
83652334|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652335|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83652336|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83652337|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
83652338|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
83652339|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
83652340|NCT01469143|Insulin|insulin|mesh-list
83652341|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83652342|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
83652343|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
83652344|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83652345|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652346|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652348|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83652349|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
83652350|NCT01469338|Prednisone|prednisone|mesh-list
83652351|NCT01469338|Octreotide|octreotide|mesh-list
83652352|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652353|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
83652354|NCT01469338|Hormones|hormones|mesh-ancestor
83652355|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652356|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652357|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83652358|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652359|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83652360|NCT01469351|Liraglutide|liraglutide|mesh-list
83652361|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652362|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652363|NCT01469351|Incretins|incretins|mesh-ancestor
83652364|NCT01469351|Hormones|hormones|mesh-ancestor
83652365|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652366|NCT01469416|Clopidogrel|clopidogrel|mesh-list
83652367|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83652368|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83652369|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83652370|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83652371|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83652372|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
83652373|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652374|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652375|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652376|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83652377|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83652378|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
83652379|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83652380|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83652381|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652382|NCT01469468|Simvastatin|simvastatin|mesh-list
83652383|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83652384|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83652385|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
83652386|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652387|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83652388|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83652389|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652390|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
83652391|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652392|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652393|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
83652394|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83652395|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
83652396|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652397|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
83652398|NCT01469507|Protective Agents|protective agents|mesh-ancestor
83652399|NCT01469520|Lamivudine|lamivudine|mesh-list
83652400|NCT01469520|Zidovudine|zidovudine|mesh-list
83652401|NCT01469520|Nevirapine|nevirapine|mesh-list
83652402|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83652403|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83652404|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652405|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652406|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
83652407|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652408|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83652409|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83652410|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
83652411|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83652412|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83652413|NCT01469559|Insulin|insulin|mesh-list
83652414|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652415|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652416|NCT01469572|Everolimus|everolimus|mesh-list
83652417|NCT01469572|Pasireotide|pasireotide|mesh-list
83652418|NCT01469572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82807185|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
83652419|NCT01469572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652420|NCT01469572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652421|NCT01469572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652422|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83652423|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
83652424|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652425|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652426|NCT01469572|Hormones|hormones|mesh-ancestor
83652427|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652428|NCT01469598|Gemcitabine|gemcitabine|mesh-list
83652429|NCT01469598|Docetaxel|docetaxel|mesh-list
83652430|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652431|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
83652432|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652433|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652434|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
83652435|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
83652436|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
83652437|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
83652438|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83652439|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652440|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652441|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83652442|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83652443|NCT01469624|Protective Agents|protective agents|mesh-ancestor
83652444|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652445|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
83652446|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83652447|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
83652448|NCT01469650|Vitamin D|vitamin d|mesh-list
83652449|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
83652450|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
83652451|NCT01469650|Vitamins|vitamins|mesh-list
83652452|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
83652453|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652454|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83652455|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83652456|NCT01469702|Azithromycin|azithromycin|mesh-list
83652457|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83652458|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652459|NCT01469884|Cyclosporine|cyclosporine|mesh-list
83652460|NCT01469884|Everolimus|everolimus|mesh-list
83652461|NCT01469884|Tacrolimus|tacrolimus|mesh-list
83652462|NCT01469884|Cyclosporins|cyclosporins|mesh-list
83652463|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83652464|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
83652465|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652466|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83652467|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652468|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652469|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
83652470|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652471|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
83652472|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652473|NCT01469884|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83652474|NCT01469884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652475|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652476|NCT01469975|Edetic Acid|edetic acid|mesh-list
83652477|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
83652478|NCT01469975|Antidotes|antidotes|mesh-ancestor
83652479|NCT01469975|Protective Agents|protective agents|mesh-ancestor
83652480|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652481|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
83652482|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
83652483|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652484|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83652485|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
83652486|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83652487|NCT01469988|Testosterone|testosterone|mesh-list
83652488|NCT01469988|Androgens|androgens|mesh-ancestor
83652489|NCT01469988|Hormones|hormones|mesh-ancestor
83652490|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652491|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652492|NCT01470040|Aspirin|aspirin|mesh-list
83362009|NCT02664922|Sevoflurane|sevoflurane|mesh-list
83652493|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83652494|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83652495|NCT01470040|Analgesics|analgesics|mesh-ancestor
83652496|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
83652497|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652498|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652499|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652500|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652501|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83652502|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83652503|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652504|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83652505|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83652506|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652507|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
83652508|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
83652509|NCT01470053|Azelastine|azelastine|mesh-list
83652510|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652511|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
83652512|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83652513|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83652514|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
83652515|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652516|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652517|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83652518|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83652519|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83652520|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652521|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652522|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83652523|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83652524|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
83652525|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
83652526|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652527|NCT01470092|Tibolone|tibolone|mesh-list
83652528|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
83652529|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
83652530|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652531|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652532|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83652533|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83652534|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652535|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83652536|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
83652537|NCT01470092|Hormones|hormones|mesh-ancestor
83652538|NCT01470157|Ketamine|ketamine|mesh-list
83652539|NCT01470157|Analgesics|analgesics|mesh-ancestor
83652540|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
83652541|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652542|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652543|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83652544|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83652545|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
83652546|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
83652547|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83652548|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83652549|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83652550|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652551|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652552|NCT01470209|Everolimus|everolimus|mesh-list
83652553|NCT01470209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83652554|NCT01470209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652555|NCT01470209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652556|NCT01470209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652557|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83652558|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
83652559|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652560|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652561|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
83652562|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83652563|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83652564|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
83652565|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652566|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652567|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83652568|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83652569|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83652570|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83652571|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652572|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652573|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652574|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652575|NCT01470339|Analgesics|analgesics|mesh-ancestor
83652576|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
83652577|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652578|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83652579|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83652580|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
83652581|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83652582|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83652583|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83652584|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652585|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652586|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652587|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652588|NCT01470352|Analgesics|analgesics|mesh-ancestor
83652589|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
83652590|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652591|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
83652592|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83652593|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
83652594|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
83652595|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652596|NCT01470456|Rituximab|rituximab|mesh-list
83652597|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83652598|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652599|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
83652600|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652601|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652602|NCT01470495|Sorafenib|sorafenib|mesh-list
83652603|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652604|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652605|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652606|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652607|NCT01470690|Omeprazole|omeprazole|mesh-list
83652608|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83652609|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83652610|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83652611|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652612|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652613|NCT01470742|Capecitabine|capecitabine|mesh-list
83652614|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652615|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
83652616|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652617|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652618|NCT01470794|Flucytosine|flucytosine|mesh-list
83652619|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
83652620|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652621|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
83652622|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652623|NCT01470807|Pancrelipase|pancrelipase|mesh-list
83652624|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83652625|NCT01470937|Acarbose|acarbose|mesh-list
83652626|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83652627|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652628|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652629|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652630|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652631|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
83652632|NCT01471067|Rituximab|rituximab|mesh-list
83652633|NCT01471067|Fludarabine|fludarabine|mesh-list
83652634|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
83652635|NCT01471067|Melphalan|melphalan|mesh-list
83652636|NCT01471067|Busulfan|busulfan|mesh-list
83652637|NCT01471067|Clofarabine|clofarabine|mesh-list
83652638|NCT01471067|Tacrolimus|tacrolimus|mesh-list
83652639|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
83652640|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83652641|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83652642|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652643|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
83652644|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652645|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652646|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652647|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
83652648|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652649|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83652650|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652651|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83652652|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652653|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83652654|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83652655|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
83652656|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83652657|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83652658|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
83652659|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83652660|NCT01471132|Paclitaxel|paclitaxel|mesh-list
83652661|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
83652662|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83652663|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652664|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
83652665|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
83652666|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
83652667|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652668|NCT01471145|Naltrexone|naltrexone|mesh-list
83652669|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83652670|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83652671|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542276|NCT00060346|Hormones|hormones|mesh-ancestor
83652672|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
83652673|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652674|NCT01471158|Timolol|timolol|mesh-list
83652675|NCT01471158|Dorzolamide|dorzolamide|mesh-list
83652676|NCT01471158|Maleic acid|maleic acid|mesh-list
83652677|NCT01471158|Brinzolamide|brinzolamide|mesh-list
83652678|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652679|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652680|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83652681|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83652682|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83652683|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652684|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652685|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83652686|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83652687|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83652688|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83652689|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83652690|NCT01471262|Liver Extracts|liver extracts|mesh-list
83652691|NCT01471262|Hematinics|hematinics|mesh-ancestor
83652692|NCT01471275|Metformin|metformin|mesh-list
83652693|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652694|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652695|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83652696|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83652697|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652698|NCT01471470|Bevacizumab|bevacizumab|mesh-list
83652699|NCT01471470|Docetaxel|docetaxel|mesh-list
83652700|NCT01471470|Capecitabine|capecitabine|mesh-list
83652701|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83652702|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652703|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83652704|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83652705|NCT01471470|Growth Substances|growth substances|mesh-ancestor
83652706|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652707|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
83652708|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
83652709|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
83652710|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
83652711|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652712|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652713|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
83652714|NCT01471535|Interferons|interferons|mesh-list
83652715|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
83652716|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
83652717|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83652718|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652719|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
83652720|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652721|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
83652722|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652723|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
83652724|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
83652725|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83652726|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652727|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652728|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
83652729|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83652730|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83652731|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652732|NCT01471678|Tamsulosin|tamsulosin|mesh-list
83652733|NCT01471678|Dutasteride|dutasteride|mesh-list
83652734|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83652735|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83652736|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83652737|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
83652738|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83652739|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652740|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652741|NCT01471678|Urological Agents|urological agents|mesh-ancestor
83652742|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83652743|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83652744|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652745|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
83652746|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652747|NCT01471704|Verapamil|verapamil|mesh-list
83652748|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83652749|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83652750|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83652751|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652752|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83652753|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652754|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
83652755|NCT01471730|Thrombin|thrombin|mesh-list
83652756|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
83652757|NCT01471730|Coagulants|coagulants|mesh-ancestor
83652758|NCT01471808|Metformin|metformin|mesh-list
83652759|NCT01471808|Pioglitazone|pioglitazone|mesh-list
83652760|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83652761|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652762|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652763|NCT01471808|Incretins|incretins|mesh-ancestor
83652764|NCT01471808|Hormones|hormones|mesh-ancestor
83652765|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652766|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83652767|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
83652768|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858597|NCT05841381|Paclitaxel|paclitaxel|mesh-list
83008016|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008091|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83008198|NCT03426657|Durvalumab|durvalumab|mesh-list
83008317|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652769|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652770|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83652771|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
83008850|NCT04904549|Vaccines|vaccines|mesh-list
83652772|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652773|NCT01471847|Capecitabine|capecitabine|mesh-list
83652774|NCT01471847|Trastuzumab|trastuzumab|mesh-list
83652775|NCT01471847|Lapatinib|lapatinib|mesh-list
83652776|NCT01471847|Dactolisib|dactolisib|mesh-list
83009446|NCT03600974|Rabeprazole|rabeprazole|mesh-list
83652777|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652778|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
83009974|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010121|NCT03648684|Caffeine|caffeine|mesh-list
83652779|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010349|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
83010423|NCT03578042|Diuretics|diuretics|mesh-ancestor
83010491|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
83652780|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010799|NCT02881567|Daclizumab|daclizumab|mesh-list
83652781|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011327|NCT03067610|Paclitaxel|paclitaxel|mesh-list
83011548|NCT05708534|Abatacept|abatacept|mesh-list
83652782|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83012008|NCT01317433|Doxycycline|doxycycline|mesh-list
83652783|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652784|NCT01471886|Ketorolac|ketorolac|mesh-list
83012902|NCT05654090|Cefoperazone|cefoperazone|mesh-list
83652785|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83652786|NCT01471886|Naproxen|naproxen|mesh-list
83013502|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
83013574|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013649|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83013725|NCT02061644|Anesthetics|anesthetics|mesh-list
83013812|NCT03614832|Ticagrelor|ticagrelor|mesh-list
83013887|NCT02061878|Bexarotene|bexarotene|mesh-list
83013952|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
83652787|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83014178|NCT03613428|Vincristine|vincristine|mesh-list
83652788|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014323|NCT01351597|Docetaxel|docetaxel|mesh-list
83652789|NCT01471886|Analgesics|analgesics|mesh-ancestor
83652790|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
83652791|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652792|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652793|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652794|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652795|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83652796|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652797|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652798|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
83652799|NCT01471899|Ketorolac|ketorolac|mesh-list
83652800|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83652801|NCT01471899|Naproxen|naproxen|mesh-list
83652802|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83652803|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83652804|NCT01471899|Analgesics|analgesics|mesh-ancestor
83652805|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
83652806|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83652807|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652808|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83652809|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83652810|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83014469|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
83014929|NCT01352663|Insulin|insulin|mesh-list
83652811|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015127|NCT01318655|Naloxegol|naloxegol|mesh-list
83015354|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
83015581|NCT02940548|Amlodipine|amlodipine|mesh-list
83015654|NCT01359059|Pregabalin|pregabalin|mesh-list
83015731|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
83015800|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
83016336|NCT01218555|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83016410|NCT01372111|Cisplatin|cisplatin|mesh-list
83016968|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83017272|NCT03634111|Morphine|morphine|mesh-list
83017415|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
83017627|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83017704|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
83017779|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83018152|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
83018375|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83018544|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83018620|NCT02260544|Doxorubicin|doxorubicin|mesh-list
83018693|NCT02125682|Atorvastatin|atorvastatin|mesh-list
83018838|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
83019067|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019141|NCT05812430|Paclitaxel|paclitaxel|mesh-list
83019356|NCT05705427|Tenofovir|tenofovir|mesh-list
83019393|NCT05654454|Carboplatin|carboplatin|mesh-list
83019469|NCT05466734|Cilostazol|cilostazol|mesh-list
83019610|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652812|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652813|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
83652814|NCT01471925|Esomeprazole|esomeprazole|mesh-list
83652815|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83652816|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83020594|NCT03405090|Narcotics|narcotics|mesh-ancestor
83652817|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83652818|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021515|NCT02133638|Propofol|propofol|mesh-list
83021590|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83652819|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022125|NCT02238210|Ipratropium|ipratropium|mesh-list
83022351|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
83652820|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83022594|NCT01364519|Xhance|xhance|mesh-list
83022729|NCT01365923|Remifentanil|remifentanil|mesh-list
83652821|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023027|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023100|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
83023257|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
83023337|NCT00109850|Irinotecan|irinotecan|mesh-list
83652822|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83023558|NCT02143934|Artemether|artemether|mesh-list
83023637|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
83652823|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023783|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024081|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024151|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83024223|NCT01368887|Niacinamide|niacinamide|mesh-list
83024594|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024749|NCT05385562|Triamcinolone|triamcinolone|mesh-list
83024817|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83024890|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
83652824|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025035|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025490|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
83652825|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
83025569|NCT03631615|Antibodies|antibodies|mesh-list
83652826|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83652827|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83652828|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
83025929|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026021|NCT03103763|Warfarin|warfarin|mesh-list
83026081|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
83026165|NCT05253131|Durvalumab|durvalumab|mesh-list
83026304|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
83652829|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83652830|NCT01471990|Protective Agents|protective agents|mesh-ancestor
83026524|NCT04455815|Gabexate|gabexate|mesh-list
83026599|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
83652831|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652832|NCT01471990|Growth Substances|growth substances|mesh-ancestor
83652833|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027052|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652834|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652835|NCT01472016|Docetaxel|docetaxel|mesh-list
83652836|NCT01472016|Cetuximab|cetuximab|mesh-list
83027526|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
83027745|NCT04113083|Vitamins|vitamins|mesh-ancestor
83652837|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83652838|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652839|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
83027819|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
83652840|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
83027891|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
83027964|NCT03542006|Brinzolamide|brinzolamide|mesh-list
83652841|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
83028188|NCT01377415|Bupivacaine|bupivacaine|mesh-list
83652842|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652843|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83028562|NCT04553133|Fulvestrant|fulvestrant|mesh-list
83028634|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028789|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
83652844|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652845|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652846|NCT01472029|Leucovorin|leucovorin|mesh-list
83652847|NCT01472029|Docetaxel|docetaxel|mesh-list
83029163|NCT03697239|Vitamins|vitamins|mesh-ancestor
83652848|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
83652849|NCT01472029|Trastuzumab|trastuzumab|mesh-list
83029488|NCT03624231|Durvalumab|durvalumab|mesh-list
83652850|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652851|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
83029803|NCT02178488|Vitamin D|vitamin d|mesh-list
83652852|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
83652853|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
83652854|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652855|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83652856|NCT01472029|Antidotes|antidotes|mesh-ancestor
83652857|NCT01472029|Protective Agents|protective agents|mesh-ancestor
83652858|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652859|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
83652860|NCT01472029|Vitamins|vitamins|mesh-ancestor
83652861|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
83652862|NCT01472055|Fludarabine|fludarabine|mesh-list
83652863|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652864|NCT01472146|Doxorubicin|doxorubicin|mesh-list
83652865|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652866|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83652867|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83030149|NCT02182778|Cisplatin|cisplatin|mesh-list
83030292|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
83652868|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83030440|NCT03684837|Vitamin D|vitamin d|mesh-list
83652869|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030587|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652870|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652871|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
83652872|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83030883|NCT02193698|Dexamethasone|dexamethasone|mesh-list
83031109|NCT02188550|Everolimus|everolimus|mesh-list
83652873|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031252|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
83652874|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031464|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
83652875|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83652876|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83652877|NCT01472263|Protective Agents|protective agents|mesh-ancestor
83031848|NCT02202200|Palbociclib|palbociclib|mesh-list
83652878|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652879|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
83032440|NCT01370538|Esomeprazole|esomeprazole|mesh-list
83032592|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652880|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83652881|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
83033224|NCT02258204|Ketamine|ketamine|mesh-list
83652882|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83652883|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
83652884|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83652885|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83033942|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
83652886|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83034094|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
83652887|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
83034254|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83652888|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83652889|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034487|NCT02262650|Telmisartan|telmisartan|mesh-list
83652890|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83034621|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034852|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
83652891|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83652892|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83035295|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652893|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83652894|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652895|NCT01472406|Pancrelipase|pancrelipase|mesh-list
83035527|NCT04504240|Famotidine|famotidine|mesh-list
83035668|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652896|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035829|NCT01133990|Antidotes|antidotes|mesh-ancestor
83652897|NCT01472497|Pioglitazone|pioglitazone|mesh-list
83652898|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036416|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036493|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652899|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652900|NCT01472510|Ranibizumab|ranibizumab|mesh-list
83652901|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83652902|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83652903|NCT01472510|Growth Substances|growth substances|mesh-ancestor
83036719|NCT01941875|Progesterone|progesterone|mesh-list
83652904|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652905|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
83652906|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652907|NCT01472640|Liraglutide|liraglutide|mesh-list
83652908|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037080|NCT03629717|Calcium|calcium|mesh-list
83652909|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652910|NCT01472640|Incretins|incretins|mesh-ancestor
83652911|NCT01472640|Hormones|hormones|mesh-ancestor
83037448|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83684423|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684424|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684425|NCT01662037|Bosentan|bosentan|mesh-list
83684426|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83038281|NCT03065933|Clonidine|clonidine|mesh-list
83038424|NCT00136903|Prednisone|prednisone|mesh-list
83038564|NCT04470908|Rifabutin|rifabutin|mesh-list
83038656|NCT00486512|Antacids|antacids|mesh-ancestor
83652912|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039163|NCT03187509|Torsemide|torsemide|mesh-list
83652913|NCT01472653|Cetuximab|cetuximab|mesh-list
83039320|NCT01318915|Sirolimus|sirolimus|mesh-list
83039761|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83652914|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652915|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040069|NCT00359450|Taxane|taxane|mesh-list
83652916|NCT01472666|Caseins|caseins|mesh-list
83040292|NCT01067469|Bevacizumab|bevacizumab|mesh-list
83652917|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
83652918|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
83040670|NCT03956446|Doxycycline|doxycycline|mesh-list
83040815|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
83040967|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
83652919|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652920|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83652921|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
83041495|NCT05122780|Acetylcholine|acetylcholine|mesh-list
83041564|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83652922|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041721|NCT02741570|Cisplatin|cisplatin|mesh-list
83041804|NCT03528824|Diclofenac|diclofenac|mesh-list
83652923|NCT01472770|Gemcitabine|gemcitabine|mesh-list
83652924|NCT01472770|Capecitabine|capecitabine|mesh-list
83652925|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83652926|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
83652927|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652928|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652929|NCT01472783|Veliparib|veliparib|mesh-list
83652930|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83652931|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652932|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652933|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652934|NCT01472796|Vitamin D|vitamin d|mesh-list
83652935|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
83652936|NCT01472796|Vitamins|vitamins|mesh-ancestor
83041941|NCT04693468|Crizotinib|crizotinib|mesh-list
83652937|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
83042008|NCT03956368|Atorvastatin|atorvastatin|mesh-list
83042078|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
83652938|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652939|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83652940|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83652941|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83652942|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
82807710|NCT01021488|Enoxaparin|enoxaparin|mesh-list
83652943|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83652944|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
83652945|NCT01472913|Coagulants|coagulants|mesh-ancestor
83652946|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83652947|NCT01472926|Plasminogen|plasminogen|mesh-list
83652948|NCT01472926|Tenecteplase|tenecteplase|mesh-list
83652949|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83652950|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83652951|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652952|NCT01472978|Metronidazole|metronidazole|mesh-list
83652953|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652954|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83652955|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83652956|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83652957|NCT01473043|Axitinib|axitinib|mesh-list
83652958|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042585|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
83042741|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
83042833|NCT02136030|Amphotericin B|amphotericin b|mesh-list
83652959|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83652960|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652961|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652962|NCT01473069|Ketoconazole|ketoconazole|mesh-list
83652963|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
83652964|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83652965|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83652966|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83652967|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652968|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652969|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83652970|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
83652971|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652972|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652973|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83652974|NCT01473147|Exenatide|exenatide|mesh-list
83652975|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83652976|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652977|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83652978|NCT01473147|Incretins|incretins|mesh-ancestor
83652979|NCT01473147|Hormones|hormones|mesh-ancestor
83652980|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83652981|NCT01473173|Esomeprazole|esomeprazole|mesh-list
83043058|NCT05221879|Enoxaparin|enoxaparin|mesh-list
83043110|NCT05705635|Docetaxel|docetaxel|mesh-list
83652982|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83652983|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83652984|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83652985|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83652986|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83652987|NCT01473251|Bevacizumab|bevacizumab|mesh-list
83652988|NCT01473251|Ranibizumab|ranibizumab|mesh-list
83652989|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83652990|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83652991|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83652992|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83652993|NCT01473251|Growth Substances|growth substances|mesh-ancestor
83652994|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83652995|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
83652996|NCT01473277|Triamcinolone|triamcinolone|mesh-list
83652997|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83652998|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83652999|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83653000|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83653001|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83653002|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
83653003|NCT01473277|Hormones|hormones|mesh-ancestor
83653004|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653005|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653006|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83653007|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
83653008|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653009|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043323|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
83043378|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83043451|NCT02969655|Hematinics|hematinics|mesh-ancestor
83653010|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83043756|NCT03648333|Niacin|niacin|mesh-list
83653011|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653012|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
83653013|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653014|NCT01473303|Leucovorin|leucovorin|mesh-list
83653015|NCT01473303|Fluorouracil|fluorouracil|mesh-list
83653016|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
83653017|NCT01473303|Irinotecan|irinotecan|mesh-list
83653018|NCT01473303|Calcium|calcium|mesh-list
83653019|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
83653020|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653021|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653022|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
83653023|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653024|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83653025|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653026|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83653027|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
83653028|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83653029|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83653030|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653031|NCT01473303|Antidotes|antidotes|mesh-ancestor
83653032|NCT01473303|Protective Agents|protective agents|mesh-ancestor
83653033|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
83653034|NCT01473303|Vitamins|vitamins|mesh-ancestor
83653035|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
83653036|NCT01473316|Ketoconazole|ketoconazole|mesh-list
83653037|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
83653038|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653039|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83653040|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83653041|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653042|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653043|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83653044|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
83653045|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653046|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653047|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83653048|NCT01473472|Tenofovir|tenofovir|mesh-list
83653049|NCT01473472|Emtricitabine|emtricitabine|mesh-list
83653050|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83653051|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
83653052|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653053|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83653054|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83653055|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684427|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83653056|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653057|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83653058|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83653059|NCT01473537|Calcium|calcium|mesh-list
83653060|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653061|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653062|NCT01473797|Cladribine|cladribine|mesh-list
83653063|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653064|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83653065|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
83653066|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653067|NCT01473810|Endocine|endocine|mesh-list
83044162|NCT03294694|Fulvestrant|fulvestrant|mesh-list
83044281|NCT02028364|Everolimus|everolimus|mesh-list
83044428|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653068|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83653069|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
83044582|NCT04481724|Analgesics|analgesics|mesh-ancestor
83044652|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
83653070|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045261|NCT05827523|Cisplatin|cisplatin|mesh-list
83653071|NCT01473901|Temozolomide|temozolomide|mesh-list
83653072|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83653073|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
83045689|NCT05171166|Fluorouracil|fluorouracil|mesh-list
83046522|NCT01716806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046682|NCT00109668|Hormones|hormones|mesh-ancestor
83653074|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046817|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83046905|NCT03519152|Diclofenac|diclofenac|mesh-list
83653075|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653076|NCT01473914|Vitamins|vitamins|mesh-list
83047207|NCT05891171|Leucovorin|leucovorin|mesh-list
83047277|NCT05891119|GABA Agents|gaba agents|mesh-ancestor
83653077|NCT01473914|Vitamin E|vitamin e|mesh-list
83653078|NCT01473914|Tocopherols|tocopherols|mesh-list
83047424|NCT05890495|Lidocaine|lidocaine|mesh-list
83047498|NCT05874570|Metronidazole|metronidazole|mesh-list
83653079|NCT01473914|Tocotrienols|tocotrienols|mesh-list
83653080|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
83653081|NCT01473914|Zinc|zinc|mesh-list
83653082|NCT01473914|Selenium|selenium|mesh-list
83653083|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
83048731|NCT03158129|Cisplatin|cisplatin|mesh-list
83048873|NCT02650986|Decitabine|decitabine|mesh-list
83653084|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049018|NCT01430572|Everolimus|everolimus|mesh-list
83653085|NCT01473914|Trace Elements|trace elements|mesh-ancestor
83653086|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
83049319|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
83049696|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
83049784|NCT03388190|Leucovorin|leucovorin|mesh-list
83653087|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050084|NCT04435210|Nifedipine|nifedipine|mesh-list
83653088|NCT01473914|Protective Agents|protective agents|mesh-ancestor
83653089|NCT01474174|Vaccines|vaccines|mesh-list
83653090|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
83653091|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653092|NCT01474187|Capecitabine|capecitabine|mesh-list
83653093|NCT01474187|Irinotecan|irinotecan|mesh-list
83653094|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83653095|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
83653096|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653097|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653098|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83653099|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83050350|NCT02315690|Piperaquine|piperaquine|mesh-list
83653100|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653102|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83653103|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83051097|NCT03756961|Analgesics|analgesics|mesh-ancestor
83653104|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
83051396|NCT02254824|Atorvastatin|atorvastatin|mesh-list
83051549|NCT03887624|Ethosuximide|ethosuximide|mesh-list
83653105|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051791|NCT02768298|Enalapril|enalapril|mesh-list
83653106|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051996|NCT02773368|Insulin|insulin|mesh-list
83052078|NCT02157792|Irinotecan|irinotecan|mesh-list
83653107|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052299|NCT02520921|Analgesics|analgesics|mesh-ancestor
83653108|NCT01474304|Acetaminophen|acetaminophen|mesh-list
83653109|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653110|NCT01474304|Analgesics|analgesics|mesh-ancestor
83653111|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
83653112|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653113|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653114|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
83653115|NCT01474330|Pomalidomide|pomalidomide|mesh-list
83653116|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
83653117|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053789|NCT02634580|Ezetimibe|ezetimibe|mesh-list
83053938|NCT03604575|Insulin|insulin|mesh-list
83054082|NCT02165046|Budesonide|budesonide|mesh-list
83054162|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
83054231|NCT04983160|Allopurinol|allopurinol|mesh-list
83054458|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653118|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83054762|NCT03587025|Amitriptyline|amitriptyline|mesh-list
83054829|NCT02035527|Docetaxel|docetaxel|mesh-list
83653119|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83653120|NCT01474330|Growth Substances|growth substances|mesh-ancestor
83653121|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83055509|NCT04774237|Miotics|miotics|mesh-ancestor
83653122|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653123|NCT01474382|Phentolamine|phentolamine|mesh-list
83056101|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
83056247|NCT04116112|Labetalol|labetalol|mesh-list
83056329|NCT03063190|Vitamin D|vitamin d|mesh-list
83056403|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
83056478|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056625|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83653124|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83056805|NCT02187822|Taxane|taxane|mesh-list
83056922|NCT03700801|Incretins|incretins|mesh-ancestor
83057147|NCT02183610|Incretins|incretins|mesh-ancestor
83057382|NCT02184312|Nevirapine|nevirapine|mesh-list
83653125|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83653126|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
83057591|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
83057738|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83653127|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058252|NCT03690739|Trabectedin|trabectedin|mesh-list
83058414|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
83653128|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653129|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058862|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
83058936|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059010|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83653130|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83653131|NCT01474460|Vitamin K|vitamin k|mesh-list
83653132|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
83653133|NCT01474460|Vitamins|vitamins|mesh-ancestor
83653134|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
83059476|NCT01291004|Estradiol|estradiol|mesh-list
83059531|NCT03131882|Protective Agents|protective agents|mesh-ancestor
83653135|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653136|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83059770|NCT03482180|Calcium|calcium|mesh-list
83059994|NCT03473210|Hormones|hormones|mesh-ancestor
83653137|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83060368|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
83060760|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83060982|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83061135|NCT04908982|Aspirin|aspirin|mesh-list
83061507|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83061578|NCT02809053|Rituximab|rituximab|mesh-list
83061651|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
83653138|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653139|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
83653140|NCT01474460|Coagulants|coagulants|mesh-ancestor
83653141|NCT01474473|Calpastatin|calpastatin|mesh-list
83062189|NCT02052687|Imiquimod|imiquimod|mesh-list
83653142|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83653143|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
83653144|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653145|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653146|NCT01474499|Sorbitol|sorbitol|mesh-list
83653147|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83653148|NCT01474499|Glycerol|glycerol|mesh-list
83653149|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83063389|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
83653150|NCT01474499|Protective Agents|protective agents|mesh-ancestor
83063539|NCT05252988|Loperamide|loperamide|mesh-list
83653151|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063676|NCT04842838|Paclitaxel|paclitaxel|mesh-list
83063830|NCT03036826|Meropenem|meropenem|mesh-list
83653152|NCT01474499|Cathartics|cathartics|mesh-ancestor
83653153|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83064511|NCT01336686|Colchicine|colchicine|mesh-list
83653154|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
83653155|NCT01474642|Capecitabine|capecitabine|mesh-list
83653156|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064746|NCT02267304|Morphine|morphine|mesh-list
83653157|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83653158|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
83064882|NCT03462212|Carboplatin|carboplatin|mesh-list
83064978|NCT03464552|Celecoxib|celecoxib|mesh-list
83065196|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
83065267|NCT00879762|Antiviral Agents|antiviral agents|mesh-ancestor
83065708|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83065853|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83065931|NCT02602288|Nicotine|nicotine|mesh-list
83653159|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653160|NCT01474902|Enoxaparin|enoxaparin|mesh-list
83653161|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
83653162|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83653163|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83653164|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653165|NCT01474967|Metformin|metformin|mesh-list
83653166|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83653167|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653168|NCT01475006|AMG 595|amg 595|mesh-list
83653169|NCT01475006|Immunoconjugates|immunoconjugates|mesh-ancestor
83066222|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
82807963|NCT00402285|Lycopene|lycopene|mesh-list
83066306|NCT03443492|Vitamins|vitamins|mesh-ancestor
83066453|NCT00829530|Ramipril|ramipril|mesh-list
83066521|NCT00646542|Vildagliptin|vildagliptin|mesh-list
83653170|NCT01475006|Immunologic Factors|immunologic factors|mesh-ancestor
83066739|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066896|NCT02069145|Sorafenib|sorafenib|mesh-list
83653171|NCT01475006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653172|NCT01475019|Orlistat|orlistat|mesh-list
83653173|NCT01475019|Sibutramine|sibutramine|mesh-list
83653174|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067564|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
83067711|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
83067861|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83068697|NCT02090829|Oxytocin|oxytocin|mesh-list
83653175|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653176|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83068986|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83069172|NCT03419624|Hormones|hormones|mesh-ancestor
83069248|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83069468|NCT05816668|Tranexamic Acid|tranexamic acid|mesh-list
83653177|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83069541|NCT05803434|Cannabidiol|cannabidiol|mesh-list
83069628|NCT05688579|Diuretics|diuretics|mesh-ancestor
83069696|NCT05599789|Docetaxel|docetaxel|mesh-list
83653178|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
83069920|NCT05225558|Vancomycin|vancomycin|mesh-list
83653179|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83070146|NCT04680286|Narcotics|narcotics|mesh-ancestor
83653180|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
83653181|NCT01475032|Beclomethasone|beclomethasone|mesh-list
83653182|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
83070938|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653183|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83071172|NCT01546987|Flutamide|flutamide|mesh-list
83653184|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
83072147|NCT03399032|Caspofungin|caspofungin|mesh-list
83072221|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
83072314|NCT03126188|Sertraline|sertraline|mesh-list
83072450|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
83653185|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653186|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653187|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83072904|NCT01330017|Loratadine|loratadine|mesh-list
83072981|NCT02118051|Progesterone|progesterone|mesh-list
83653188|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
83653189|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83073358|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
83073453|NCT00004584|Ritonavir|ritonavir|mesh-list
83073506|NCT02124525|Antidotes|antidotes|mesh-ancestor
83073586|NCT03529032|Methadone|methadone|mesh-list
83653190|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83653191|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83653192|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
83073957|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
83653193|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074108|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83074187|NCT05699746|Capecitabine|capecitabine|mesh-list
83074331|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074413|NCT05230758|Metformin|metformin|mesh-list
83653194|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653195|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83653196|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
83653197|NCT01475032|Hormones|hormones|mesh-ancestor
83074931|NCT05577273|Trimethoprim|trimethoprim|mesh-list
83075005|NCT05541328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684428|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684429|NCT01662089|Zinc|zinc|mesh-list
83684430|NCT01662089|Trace Elements|trace elements|mesh-ancestor
83684431|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
83075759|NCT02144025|Cyclosporine|cyclosporine|mesh-list
83075823|NCT00972309|Vaccines|vaccines|mesh-list
83076065|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
83076135|NCT02289378|Docetaxel|docetaxel|mesh-list
83684432|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684433|NCT01662128|Capecitabine|capecitabine|mesh-list
83076393|NCT05172518|Taxane|taxane|mesh-list
83076504|NCT03387098|Fluorouracil|fluorouracil|mesh-list
83076581|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83076814|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
83076968|NCT03382886|Bevacizumab|bevacizumab|mesh-list
83077121|NCT02148783|Methylphenidate|methylphenidate|mesh-list
83077192|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
83684434|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83684435|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
83077727|NCT02158221|Growth Substances|growth substances|mesh-ancestor
83077946|NCT03124082|Lidocaine|lidocaine|mesh-list
83078020|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
83078088|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83078167|NCT03370328|Peppermint oil|peppermint oil|mesh-list
83078540|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078689|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83078840|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078916|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
83078990|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
83684436|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079148|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
83684437|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684438|NCT01662180|Hormones|hormones|mesh-list
83079350|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653198|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653199|NCT01475227|Zinc|zinc|mesh-list
83653200|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
83079811|NCT02319018|Vitamins|vitamins|mesh-ancestor
83653201|NCT01475227|Trace Elements|trace elements|mesh-ancestor
83653202|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
83080105|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
83653203|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653204|NCT01475227|Astringents|astringents|mesh-ancestor
83653205|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
83653206|NCT01475266|Apaziquone|apaziquone|mesh-list
83080862|NCT02509052|Leflunomide|leflunomide|mesh-list
83081240|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653207|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081490|NCT02502344|Metformin|metformin|mesh-list
83653208|NCT01475279|Warfarin|warfarin|mesh-list
83081568|NCT02499614|Crizotinib|crizotinib|mesh-list
83653209|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
83653210|NCT01475318|Letrozole|letrozole|mesh-list
83653211|NCT01475318|Misoprostol|misoprostol|mesh-list
83081841|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
83081918|NCT02497118|Vinorelbine|vinorelbine|mesh-list
83653212|NCT01475318|Mifepristone|mifepristone|mesh-list
83653213|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653214|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83082589|NCT03319784|Hormones|hormones|mesh-ancestor
83361880|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082972|NCT02181309|Meloxicam|meloxicam|mesh-list
83083194|NCT02486510|Maraviroc|maraviroc|mesh-list
83083339|NCT02184117|Adenosine|adenosine|mesh-list
83653215|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83653216|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653217|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653218|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83653219|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
83083809|NCT05437094|Itraconazole|itraconazole|mesh-list
83684439|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83653220|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653221|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780399|NCT04475835|Heparin|heparin|mesh-list
83653222|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82780707|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
83653223|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
83653224|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83653225|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82781366|NCT00097591|Clopidogrel|clopidogrel|mesh-list
83653226|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653227|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
82781664|NCT00969176|Analgesics|analgesics|mesh-ancestor
82781738|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83653228|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82781891|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781969|NCT00679211|Immunotoxins|immunotoxins|mesh-ancestor
82782124|NCT00973154|Prednisone|prednisone|mesh-list
82782264|NCT03388632|Nivolumab|nivolumab|mesh-list
83653229|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83653230|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82782695|NCT00977444|Hormones|hormones|mesh-ancestor
83653231|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83653232|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
82783291|NCT00748787|Psyllium|psyllium|mesh-list
82783733|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
82783822|NCT04003844|Aspirin|aspirin|mesh-list
82783966|NCT01088893|Everolimus|everolimus|mesh-list
82784032|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784127|NCT00762671|Ebselen|ebselen|mesh-list
82784256|NCT00402688|Levofloxacin|levofloxacin|mesh-list
82784488|NCT02558153|Paclitaxel|paclitaxel|mesh-list
82784707|NCT00068419|Analgesics|analgesics|mesh-ancestor
82784800|NCT00398632|Analgesics|analgesics|mesh-ancestor
82785081|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785308|NCT05290220|Lenvatinib|lenvatinib|mesh-list
82785744|NCT00778115|Simethicone|simethicone|mesh-list
82785897|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
83653233|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82786043|NCT00782405|Mirtazapine|mirtazapine|mesh-list
83653234|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82786192|NCT00782951|Analgesics|analgesics|mesh-ancestor
83653235|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
83653236|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83653237|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83653238|NCT01475552|Abciximab|abciximab|mesh-list
83653239|NCT01475552|Clopidogrel|clopidogrel|mesh-list
82787034|NCT00385684|Analgesics|analgesics|mesh-ancestor
83653240|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787577|NCT00803309|Ribavirin|ribavirin|mesh-list
82787709|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
82787932|NCT00651755|Rituximab|rituximab|mesh-list
82787937|NCT00651755|Aprepitant|aprepitant|mesh-list
82788007|NCT02552459|Sufentanil|sufentanil|mesh-list
82788315|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82788620|NCT02688790|Dalbavancin|dalbavancin|mesh-list
82788697|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
83653241|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788919|NCT00382720|Docetaxel|docetaxel|mesh-list
83653242|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82789141|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
83653243|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82789456|NCT00457821|Ivacaftor|ivacaftor|mesh-list
82789520|NCT00815399|Metformin|metformin|mesh-list
82789597|NCT00647699|Riboflavin|riboflavin|mesh-list
82808013|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
82789679|NCT01024179|Sirolimus|sirolimus|mesh-list
82789750|NCT01022229|Vitamins|vitamins|mesh-list
83653244|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82789819|NCT00457665|Efavirenz|efavirenz|mesh-list
82790115|NCT04400994|Rituximab|rituximab|mesh-list
82790343|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83653245|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83653246|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
83653247|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653248|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
82791013|NCT00441441|Xhance|xhance|mesh-list
83653249|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
83653250|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
82791398|NCT01003158|Paclitaxel|paclitaxel|mesh-list
83653251|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82791859|NCT05888493|Cyclophosphamide|cyclophosphamide|mesh-list
83653252|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83653253|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
82792386|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
82792639|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792717|NCT04682158|Paclitaxel|paclitaxel|mesh-list
82792798|NCT04575857|Atorvastatin|atorvastatin|mesh-list
82792960|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
82793034|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82793184|NCT03764098|Guanfacine|guanfacine|mesh-list
82793273|NCT03665207|Insulin|insulin|mesh-list
83653254|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793437|NCT03026790|Naloxone|naloxone|mesh-list
82793517|NCT02735707|Valsartan|valsartan|mesh-list
82793859|NCT00357994|Levodopa|levodopa|mesh-list
82793908|NCT02407509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83653255|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653256|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653257|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
82794594|NCT00356122|Docetaxel|docetaxel|mesh-list
82794729|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83653258|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
82795053|NCT00845819|Iodine|iodine|mesh-list
83653259|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
83653260|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
83653261|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
83653262|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
83653263|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
83653264|NCT01475617|Calcium|calcium|mesh-list
82795559|NCT00857597|Omeprazole|omeprazole|mesh-list
83653265|NCT01475617|Vitamins|vitamins|mesh-ancestor
83653266|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
82795629|NCT00857987|Expectorants|expectorants|mesh-list
82795710|NCT00526656|Sunitinib|sunitinib|mesh-list
82795777|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653267|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795935|NCT04732182|Donepezil|donepezil|mesh-list
83653268|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82796072|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82796155|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
83653269|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82796443|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
83653270|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
82796597|NCT00867737|Hormones|hormones|mesh-ancestor
82796676|NCT00420303|Etanercept|etanercept|mesh-list
83653271|NCT01475617|Hematinics|hematinics|mesh-ancestor
83653272|NCT01475656|Levetiracetam|levetiracetam|mesh-list
83653273|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
83653274|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
83653275|NCT01475708|Doxycycline|doxycycline|mesh-list
83653276|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82797489|NCT05880030|Micronutrients|micronutrients|mesh-ancestor
82798131|NCT05706259|Vitamin D|vitamin d|mesh-list
83653277|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798275|NCT05628623|Cytarabine|cytarabine|mesh-list
83653278|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
83653279|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82798529|NCT05490134|Naloxone|naloxone|mesh-list
83653280|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83653281|NCT01475760|Chitosan|chitosan|mesh-list
83653282|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83653283|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82799193|NCT04998786|Hormones|hormones|mesh-ancestor
83653284|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
82799446|NCT04810078|Nivolumab|nivolumab|mesh-list
82799558|NCT04657081|Decitabine|decitabine|mesh-list
82799632|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
82799796|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800306|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653285|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653286|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83653287|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
83653288|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
82801656|NCT00885443|Sevoflurane|sevoflurane|mesh-list
82801734|NCT00530270|Hormones|hormones|mesh-ancestor
83653289|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
83653290|NCT01475760|Coagulants|coagulants|mesh-ancestor
83653291|NCT01475877|Bromfenac|bromfenac|mesh-list
82803166|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82803241|NCT00524030|Analgesics|analgesics|mesh-ancestor
83653292|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83653293|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653294|NCT01475877|Analgesics|analgesics|mesh-ancestor
82803632|NCT00344968|Hormones|hormones|mesh-ancestor
83653295|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
82803846|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
83653296|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804001|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653297|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804164|NCT00892307|Adenosine|adenosine|mesh-list
82804223|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
83653298|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804469|NCT00903227|Xhance|xhance|mesh-list
83653299|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653300|NCT01475890|Vitamin D|vitamin d|mesh-list
83653301|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
83653302|NCT01475890|Vitamins|vitamins|mesh-ancestor
82805099|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
83653303|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
82805176|NCT00929591|Tamoxifen|tamoxifen|mesh-list
82805526|NCT00930839|Niacin|niacin|mesh-list
83653304|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805623|NCT00936689|Estrogens|estrogens|mesh-ancestor
82805842|NCT03045653|Tamoxifen|tamoxifen|mesh-list
82805991|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
82806376|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82806780|NCT00503984|Prednisone|prednisone|mesh-list
82806906|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806981|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
82807204|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
82807279|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
82807663|NCT00496470|Hormones|hormones|mesh-ancestor
82807957|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82808153|NCT00331630|Paclitaxel|paclitaxel|mesh-list
82808266|NCT00466440|Hormones|hormones|mesh-ancestor
82808341|NCT00464490|Analgesics|analgesics|mesh-ancestor
82808417|NCT00412113|Amlodipine|amlodipine|mesh-list
83653305|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82808862|NCT00385593|Budesonide|budesonide|mesh-list
82808873|NCT00385593|Hormones|hormones|mesh-ancestor
82808932|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82809008|NCT00494780|Prednisone|prednisone|mesh-list
82809080|NCT00946673|Vorinostat|vorinostat|mesh-list
82809153|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
83653306|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82809303|NCT04364555|Clobetasol|clobetasol|mesh-list
83653307|NCT01476007|Vitamins|vitamins|mesh-list
83653308|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
82809520|NCT00467142|Calcium|calcium|mesh-list
82809600|NCT01065610|Oxytocin|oxytocin|mesh-list
83653309|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
83653310|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
83653311|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
82810351|NCT00297778|Protective Agents|protective agents|mesh-ancestor
83653312|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653313|NCT01476007|Hematinics|hematinics|mesh-ancestor
82810577|NCT00441168|Bortezomib|bortezomib|mesh-list
82810655|NCT00373113|Sunitinib|sunitinib|mesh-list
83653314|NCT01476124|Morphine|morphine|mesh-list
82810796|NCT00959075|Thiamine|thiamine|mesh-list
83653315|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83653316|NCT01476124|Narcotics|narcotics|mesh-ancestor
82811320|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811411|NCT00325468|Denosumab|denosumab|mesh-list
83653317|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82811544|NCT00974441|Valproic Acid|valproic acid|mesh-list
83653318|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808087|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83653319|NCT01476124|Analgesics|analgesics|mesh-ancestor
82811772|NCT03923933|Bumetanide|bumetanide|mesh-list
82812295|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82812365|NCT00379899|Vitamin D|vitamin d|mesh-list
82812514|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83653320|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
82812737|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
82812811|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
82812889|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
82813182|NCT00282412|Cyclosporine|cyclosporine|mesh-list
82813330|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
83653321|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653322|NCT01476137|Trametinib|trametinib|mesh-list
83653323|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653324|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82813788|NCT01070524|Hormones|hormones|mesh-ancestor
83653325|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814001|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82814077|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82814227|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
82814760|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82814835|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815213|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
82815287|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815435|NCT03986073|Incretins|incretins|mesh-ancestor
82815509|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
82815660|NCT01034124|Vitamin K|vitamin k|mesh-list
82815814|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
82816038|NCT01055379|Protective Agents|protective agents|mesh-ancestor
82816210|NCT00531947|Selegiline|selegiline|mesh-list
82816258|NCT01005095|Vitamin D|vitamin d|mesh-list
82816409|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
83653326|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653327|NCT01476176|Acetaminophen|acetaminophen|mesh-list
83653328|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653329|NCT01476176|Analgesics|analgesics|mesh-ancestor
82817313|NCT00420342|Diuretics|diuretics|mesh-ancestor
82817826|NCT00449150|Cetrorelix|cetrorelix|mesh-list
83653330|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
82818364|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
82818437|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
82818513|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
83653331|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818741|NCT00427700|Clomiphene|clomiphene|mesh-list
83653332|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819027|NCT01041066|Nicardipine|nicardipine|mesh-list
83653333|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
83653334|NCT01476189|Acetaminophen|acetaminophen|mesh-list
82819479|NCT03982173|Durvalumab|durvalumab|mesh-list
82819548|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819746|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82819818|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83653335|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653336|NCT01476189|Analgesics|analgesics|mesh-ancestor
83653337|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
82820275|NCT00413660|Tofacitinib|tofacitinib|mesh-list
82820350|NCT00429416|Cytarabine|cytarabine|mesh-list
82820510|NCT00386100|Metformin|metformin|mesh-list
82820574|NCT00385944|Clopidogrel|clopidogrel|mesh-list
82820661|NCT01044810|Efavirenz|efavirenz|mesh-list
83653338|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820970|NCT00207142|Ritonavir|ritonavir|mesh-list
83653339|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653340|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
83653341|NCT01476215|Acetaminophen|acetaminophen|mesh-list
82821477|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
82821938|NCT03715166|Bumetanide|bumetanide|mesh-list
82822093|NCT00395018|Entecavir|entecavir|mesh-list
83653342|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82822469|NCT00255034|Ribavirin|ribavirin|mesh-list
83653343|NCT01476215|Analgesics|analgesics|mesh-ancestor
82822693|NCT01048554|Bevacizumab|bevacizumab|mesh-list
82823070|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
83653344|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
83653345|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823286|NCT00349752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823438|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
82823535|NCT00394082|Paclitaxel|paclitaxel|mesh-list
83653346|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653347|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
83653348|NCT01476280|Palonosetron|palonosetron|mesh-list
82823974|NCT01071369|Betamethasone|betamethasone|mesh-list
83653349|NCT01476280|Ramosetron|ramosetron|mesh-list
83653350|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
82824195|NCT00390416|Antidotes|antidotes|mesh-ancestor
82824273|NCT00370292|Pemetrexed|pemetrexed|mesh-list
83653351|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
82824881|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
83653352|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653353|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825103|NCT01057212|Bevacizumab|bevacizumab|mesh-list
82825413|NCT00135694|Prednisone|prednisone|mesh-list
82825495|NCT00335556|Dactinomycin|dactinomycin|mesh-list
82825567|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
82825716|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
82825794|NCT04726085|Ibuprofen|ibuprofen|mesh-list
82826028|NCT00231777|Ondansetron|ondansetron|mesh-list
82826095|NCT00110890|Cinacalcet|cinacalcet|mesh-list
83653354|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826172|NCT00322374|Epirubicin|epirubicin|mesh-list
82826623|NCT00099268|Levodopa|levodopa|mesh-list
83653355|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83653356|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82826924|NCT00504725|Ketamine|ketamine|mesh-list
83653357|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
82827070|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653358|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827147|NCT00381680|Leucovorin|leucovorin|mesh-list
82827222|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827378|NCT00504257|Bevacizumab|bevacizumab|mesh-list
82827456|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827685|NCT00507455|Tamsulosin|tamsulosin|mesh-list
82827773|NCT00503009|Xhance|xhance|mesh-list
82827827|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
82827976|NCT00376688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828049|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
82828277|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653359|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653360|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82828579|NCT01058720|Vitamin D|vitamin d|mesh-list
82828724|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83653361|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83653362|NCT01476358|Vitamin A|vitamin a|mesh-list
83653363|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
82829030|NCT00314808|Analgesics|analgesics|mesh-ancestor
83653364|NCT01476358|Vitamins|vitamins|mesh-ancestor
82829179|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
82829331|NCT00150969|Vitamin K|vitamin k|mesh-list
82829406|NCT00331682|Docetaxel|docetaxel|mesh-list
82829718|NCT01060826|Hormones|hormones|mesh-ancestor
83653365|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
82830085|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830236|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830350|NCT00289848|Hormones|hormones|mesh-ancestor
82830398|NCT01065246|Catumaxomab|catumaxomab|mesh-list
82830476|NCT01064570|Tretinoin|tretinoin|mesh-list
82830775|NCT00496769|Aspirin|aspirin|mesh-list
82830852|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
82830997|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
82831458|NCT02532192|Hormones|hormones|mesh-ancestor
82831533|NCT01065662|Sirolimus|sirolimus|mesh-list
82831606|NCT00296816|Growth Substances|growth substances|mesh-ancestor
82831693|NCT00251004|Everolimus|everolimus|mesh-list
83653366|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653367|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
82831983|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82832206|NCT00465179|Sunitinib|sunitinib|mesh-list
82832374|NCT00068692|Leucovorin|leucovorin|mesh-list
82832740|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82832901|NCT00087490|Vancomycin|vancomycin|mesh-list
82833053|NCT00065260|Cyclosporine|cyclosporine|mesh-list
82833196|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82833421|NCT00291668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82833872|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834025|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82834182|NCT00044512|Sorafenib|sorafenib|mesh-list
83653368|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834564|NCT03953950|Losartan|losartan|mesh-list
83653369|NCT01476358|Protective Agents|protective agents|mesh-ancestor
82835091|NCT03995147|Hormones|hormones|mesh-ancestor
82835316|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
82835396|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
83653370|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83653371|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653372|NCT01476410|Doxorubicin|doxorubicin|mesh-list
83653373|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82836244|NCT00231842|Ifosfamide|ifosfamide|mesh-list
83653374|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83653375|NCT01476410|Dacarbazine|dacarbazine|mesh-list
83653376|NCT01476410|Vinblastine|vinblastine|mesh-list
83653377|NCT01476410|Antibodies|antibodies|mesh-list
82836990|NCT01108042|Docetaxel|docetaxel|mesh-list
82837062|NCT01109134|Tirofiban|tirofiban|mesh-list
83653378|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
83653379|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83653380|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
82837521|NCT01110304|Analgesics|analgesics|mesh-list
82837595|NCT01117636|Aspirin|aspirin|mesh-list
82837773|NCT01119196|Icodextrin|icodextrin|mesh-list
83653381|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82837972|NCT01218022|Losartan|losartan|mesh-list
82838044|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
83653382|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
82838278|NCT00162266|Abatacept|abatacept|mesh-list
83653383|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838423|NCT03932578|Atropine|atropine|mesh-list
82838499|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
83653384|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82839490|NCT02685826|Durvalumab|durvalumab|mesh-list
82839644|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
83653385|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839948|NCT01238224|Tadalafil|tadalafil|mesh-list
83653386|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82840401|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
82840489|NCT00230178|Allopurinol|allopurinol|mesh-list
82840780|NCT01254994|Entecavir|entecavir|mesh-list
83653387|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82840855|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
83653388|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841079|NCT03899506|Midazolam|midazolam|mesh-list
82841149|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83653389|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841318|NCT01153828|Mupirocin|mupirocin|mesh-list
82841526|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
83653390|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82841829|NCT03889288|Analgesics|analgesics|mesh-list
83653391|NCT01476410|Immunotoxins|immunotoxins|mesh-ancestor
83653392|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82842123|NCT01160302|Analgesics|analgesics|mesh-ancestor
82842200|NCT03876574|Dexamethasone|dexamethasone|mesh-list
82842275|NCT01159210|Thrombin|thrombin|mesh-list
82842359|NCT03871972|Sirolimus|sirolimus|mesh-list
82842673|NCT01168492|Ketamine|ketamine|mesh-list
82842918|NCT03868852|Apatinib|apatinib|mesh-list
83653393|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83653394|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
82843622|NCT01286194|Rabeprazole|rabeprazole|mesh-list
82843713|NCT00149994|Prednisone|prednisone|mesh-list
82843924|NCT03739528|Hormones|hormones|mesh-ancestor
82844150|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844303|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
82844376|NCT01187212|Sorafenib|sorafenib|mesh-list
82844458|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
82844534|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
82844681|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845403|NCT01199224|Veliparib|veliparib|mesh-list
82845464|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845540|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82845618|NCT05667376|Curcumin|curcumin|mesh-list
82845691|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82845765|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82845854|NCT01299220|Acitretin|acitretin|mesh-list
82845996|NCT05623852|Fucoidan|fucoidan|mesh-list
83653395|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83653396|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
83653397|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
82846448|NCT01560442|Analgesics|analgesics|mesh-ancestor
82846598|NCT00110214|Prednisone|prednisone|mesh-list
82847128|NCT03790384|Mitomycin|mitomycin|mesh-list
83653398|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
83653399|NCT01476488|Tacrolimus|tacrolimus|mesh-list
83653400|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847458|NCT00418691|Modafinil|modafinil|mesh-list
82847603|NCT02043587|Antidotes|antidotes|mesh-ancestor
83653401|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
82847818|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653402|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848272|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82848352|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
83653403|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83653404|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848498|NCT03383458|Nivolumab|nivolumab|mesh-list
82848647|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848876|NCT01075880|Interferon-beta|interferon-beta|mesh-list
83653405|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849182|NCT00131352|Hylan|hylan|mesh-list
82849413|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
82849490|NCT05459974|Colchicine|colchicine|mesh-list
82849593|NCT04539262|Remdesivir|remdesivir|mesh-list
83653406|NCT01476592|Resveratrol|resveratrol|mesh-list
83653407|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
82849795|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653408|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653409|NCT01476592|Protective Agents|protective agents|mesh-ancestor
82850349|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
82850425|NCT04052620|Analgesics|analgesics|mesh-ancestor
82850507|NCT04018612|Analgesics|analgesics|mesh-ancestor
82850587|NCT03996694|Oxycodone|oxycodone|mesh-list
83653410|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850909|NCT03965546|Sorafenib|sorafenib|mesh-list
82850983|NCT00094172|Atorvastatin|atorvastatin|mesh-list
83653411|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851147|NCT00403481|Olmesartan|olmesartan|mesh-list
82851276|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82851352|NCT00390689|Protective Agents|protective agents|mesh-ancestor
83653412|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83653413|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
83653414|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83653415|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82852198|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
82852310|NCT03739294|Xhance|xhance|mesh-list
83653416|NCT01476683|Racecadotril|racecadotril|mesh-list
82852799|NCT03605212|Febuxostat|febuxostat|mesh-list
83653417|NCT01476683|Thiorphan|thiorphan|mesh-list
83653418|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
82853213|NCT00079040|Growth Substances|growth substances|mesh-ancestor
82853363|NCT01091012|Urological Agents|urological agents|mesh-ancestor
83653419|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653420|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
83653421|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853739|NCT03721900|Ketamine|ketamine|mesh-list
82853813|NCT05782192|Alogliptin|alogliptin|mesh-list
82853889|NCT05869760|Carotenoids|carotenoids|mesh-list
82854189|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
82854265|NCT05609578|Pemetrexed|pemetrexed|mesh-list
82854346|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
82854449|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653422|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854999|NCT03560934|Hormones|hormones|mesh-ancestor
83653423|NCT01476774|Buprenorphine|buprenorphine|mesh-list
82855071|NCT03236857|Venetoclax|venetoclax|mesh-list
82855219|NCT02446600|Paclitaxel|paclitaxel|mesh-list
82855307|NCT05657470|Tenecteplase|tenecteplase|mesh-list
83653424|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83653425|NCT01476774|Narcotics|narcotics|mesh-ancestor
82855793|NCT04712903|Etoposide|etoposide|mesh-list
82855844|NCT04642287|Emollients|emollients|mesh-ancestor
82855917|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855999|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
83653426|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82856623|NCT00072410|Antibodies|antibodies|mesh-list
82856798|NCT01094210|Fluorides|fluorides|mesh-list
82856871|NCT00098787|Vitamins|vitamins|mesh-ancestor
82857002|NCT03956966|Hormones|hormones|mesh-ancestor
83653427|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653428|NCT01476774|Analgesics|analgesics|mesh-ancestor
82857233|NCT00060944|Hormones|hormones|mesh-ancestor
82857458|NCT01100372|Gemcitabine|gemcitabine|mesh-list
82857551|NCT03449758|Amebicides|amebicides|mesh-ancestor
82857611|NCT03722290|Metformin|metformin|mesh-list
82857689|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
82857833|NCT00377429|Catumaxomab|catumaxomab|mesh-list
82857910|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653429|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
82858134|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653430|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653431|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83653432|NCT01476787|Rituximab|rituximab|mesh-list
83653433|NCT01476787|Lenalidomide|lenalidomide|mesh-list
83653434|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83653435|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83653436|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653437|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
83653438|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653439|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653440|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83653441|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83653442|NCT01476787|Growth Substances|growth substances|mesh-ancestor
83653443|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
83653444|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83653445|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
83653446|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653447|NCT01476800|Ketoconazole|ketoconazole|mesh-list
83653448|NCT01476800|Mirabegron|mirabegron|mesh-list
83653449|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
83653450|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653451|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83653452|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83653453|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653454|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653455|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83653456|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
83653457|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653458|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653459|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83653460|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83653461|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83653462|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83653463|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
83653464|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653465|NCT01476800|Urological Agents|urological agents|mesh-ancestor
83653466|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
83653467|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83653468|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83653469|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83653470|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
83653471|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653472|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653473|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653474|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
83653475|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83653476|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
83653477|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653478|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653479|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83653480|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
83653481|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653482|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653483|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83653484|NCT01477034|Vitamin D|vitamin d|mesh-list
83653485|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
83653486|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
83653487|NCT01477034|Vitamins|vitamins|mesh-list
83653488|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
83653489|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653490|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83653491|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653492|NCT01477060|Metformin|metformin|mesh-list
83653493|NCT01477060|Lapatinib|lapatinib|mesh-list
83653494|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83653495|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653496|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653497|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83653498|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653499|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653500|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83653501|NCT01477073|Hormones|hormones|mesh-ancestor
83653502|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653503|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653504|NCT01477112|Beta Carotene|beta carotene|mesh-list
83653505|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653506|NCT01477112|Provitamins|provitamins|mesh-ancestor
83653507|NCT01477112|Vitamins|vitamins|mesh-ancestor
83653508|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
83653509|NCT01477151|Anesthetics|anesthetics|mesh-list
83653510|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83653511|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653512|NCT01477190|Morphine|morphine|mesh-list
83653513|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83653514|NCT01477190|Narcotics|narcotics|mesh-ancestor
83653515|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83653516|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653517|NCT01477190|Analgesics|analgesics|mesh-ancestor
83653518|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
83653519|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653520|NCT01477203|Escitalopram|escitalopram|mesh-list
83653521|NCT01477203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83653522|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83653523|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653524|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653525|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653526|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
83653527|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653528|NCT01477242|Ondansetron|ondansetron|mesh-list
83653529|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
83653530|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
83653531|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653532|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653533|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653534|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
83653535|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83653536|NCT01477242|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83653537|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83653538|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
83653539|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653540|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653541|NCT01477268|Sertraline|sertraline|mesh-list
83653542|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
83653543|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83653544|NCT01477268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83653545|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83653546|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653547|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653548|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653549|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
83653550|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653552|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83653553|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653554|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83653555|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653556|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653557|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83653558|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83653559|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
83653560|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653561|NCT01477385|Fluorides|fluorides|mesh-list
83653562|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
83653563|NCT01477385|Protective Agents|protective agents|mesh-ancestor
83653564|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653565|NCT01477411|Digoxin|digoxin|mesh-list
83653566|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83653567|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83653568|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653569|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653570|NCT01477411|Protective Agents|protective agents|mesh-ancestor
83653571|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653572|NCT01477424|Warfarin|warfarin|mesh-list
83653573|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
83653574|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83653575|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653576|NCT01477489|Veliparib|veliparib|mesh-list
83653577|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83653578|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653579|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653580|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653581|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83653582|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83653583|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
83653584|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653585|NCT01477580|Antacids|antacids|mesh-ancestor
83653586|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653587|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653588|NCT01477606|Cytarabine|cytarabine|mesh-list
83653589|NCT01477606|Daunorubicin|daunorubicin|mesh-list
83653590|NCT01477606|Midostaurin|midostaurin|mesh-list
83653591|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83653592|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
83653593|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653594|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653595|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
83653596|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653597|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83653598|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
83653599|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653600|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83653601|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83653602|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83653603|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653604|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83653605|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83653606|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83653607|NCT01477632|Norethindrone|norethindrone|mesh-list
83653608|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
83653609|NCT01477632|Estradiol|estradiol|mesh-list
83653610|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83653611|NCT01477632|Estrogens|estrogens|mesh-ancestor
83653612|NCT01477632|Hormones|hormones|mesh-ancestor
83653613|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653614|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653615|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83653616|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
83653617|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83653618|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83653619|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83653620|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82808383|NCT01044225|Cetuximab|cetuximab|mesh-list
82808384|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808385|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653621|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83653622|NCT01477736|Oxybutynin|oxybutynin|mesh-list
83653623|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
83653624|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83653625|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83653626|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83653627|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653628|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653629|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
83653630|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653631|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653632|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83653633|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653634|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
83653635|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
83653636|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83653637|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83653638|NCT01477736|Urological Agents|urological agents|mesh-ancestor
83653639|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
83653640|NCT01477801|Vitamin D|vitamin d|mesh-list
83653641|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653642|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653643|NCT01477801|Vitamins|vitamins|mesh-ancestor
83653644|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
83653645|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83653646|NCT01477840|Misoprostol|misoprostol|mesh-list
83653647|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83653648|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
83653649|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83653650|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653651|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83653652|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653653|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
83653654|NCT01477931|Bupropion|bupropion|mesh-list
83653655|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83653656|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
83653657|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83653658|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83653659|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83653660|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653661|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653662|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
83653663|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653664|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653665|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83653666|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83653667|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653668|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83653669|NCT01477983|Flecainide|flecainide|mesh-list
83653670|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83653671|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83653672|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653673|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653674|NCT01478022|Ibuprofen|ibuprofen|mesh-list
83653675|NCT01478022|Isosorbide|isosorbide|mesh-list
83653676|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83653677|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83653678|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83653679|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653680|NCT01478022|Analgesics|analgesics|mesh-ancestor
83653681|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
83653682|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653683|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653684|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83653685|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83653686|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83653687|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653688|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653689|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83653690|NCT01478022|Diuretics|diuretics|mesh-ancestor
83653691|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
83653692|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
83653693|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83653694|NCT01478074|Cytarabine|cytarabine|mesh-list
83653695|NCT01478074|Fludarabine|fludarabine|mesh-list
83653696|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653697|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83653698|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
83653699|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653700|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83653701|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
83653702|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653703|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
83653704|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653705|NCT01478165|Palonosetron|palonosetron|mesh-list
83653706|NCT01478165|Anesthetics|anesthetics|mesh-list
83653707|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83653708|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653709|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
83653710|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
83653711|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653712|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653713|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83653714|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83653715|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
83653716|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653717|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653718|NCT01478230|Nicotine|nicotine|mesh-list
83653719|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83653720|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
83653721|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653722|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653723|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83653724|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83653725|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
83653726|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653727|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653728|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
83653729|NCT01478282|Dabigatran|dabigatran|mesh-list
83653730|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83653731|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
83653732|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83653733|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
83653734|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653735|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653736|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
83653737|NCT01478308|Metformin|metformin|mesh-list
83653738|NCT01478308|Prednisone|prednisone|mesh-list
83653739|NCT01478308|Docetaxel|docetaxel|mesh-list
83653740|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83653741|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653742|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653743|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83653744|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83653745|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83653746|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653747|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83653748|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
83653749|NCT01478308|Hormones|hormones|mesh-ancestor
83653750|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653751|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83653752|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
83653753|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83653754|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
83653755|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653756|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
83653757|NCT01478386|Protective Agents|protective agents|mesh-ancestor
83653758|NCT01478490|Metoprolol|metoprolol|mesh-list
83653759|NCT01478490|Mirabegron|mirabegron|mesh-list
83653760|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83653761|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83653762|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
83653763|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
83653764|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653765|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653766|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83653767|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83653768|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83653769|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
82808545|NCT00945347|Miglustat|miglustat|mesh-list
83653770|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808608|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
83653771|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653772|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83653773|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83653774|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83653775|NCT01478490|Urological Agents|urological agents|mesh-ancestor
83653776|NCT01478503|Mirabegron|mirabegron|mesh-list
83653777|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83653778|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83653779|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83653780|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83653781|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653782|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653783|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653784|NCT01478503|Urological Agents|urological agents|mesh-ancestor
83653785|NCT01478529|Mirabegron|mirabegron|mesh-list
83653786|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83653787|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83653788|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83653789|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
83653790|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653791|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653792|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653793|NCT01478529|Urological Agents|urological agents|mesh-ancestor
83653794|NCT01478568|Desipramine|desipramine|mesh-list
83653795|NCT01478568|Mirabegron|mirabegron|mesh-list
83653796|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83653797|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83653798|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83653799|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
83653800|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653801|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653802|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653803|NCT01478568|Urological Agents|urological agents|mesh-ancestor
83653804|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83653805|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
83653806|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83653807|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653808|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83653809|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83653810|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653811|NCT01478607|Capsaicin|capsaicin|mesh-list
83653812|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
83653813|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
83653814|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
83653815|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653816|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653817|NCT01478633|Galantamine|galantamine|mesh-list
83653818|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83653819|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653820|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653821|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
83653822|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653823|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653824|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83653825|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
83653826|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653827|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
83653828|NCT01478685|Paclitaxel|paclitaxel|mesh-list
83653829|NCT01478685|Carboplatin|carboplatin|mesh-list
83653830|NCT01478685|Azacitidine|azacitidine|mesh-list
83653831|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83653832|NCT01478685|Cc-486|cc-486|mesh-list
83653833|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83653834|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653835|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
83653836|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
83653837|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
83653838|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653839|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83653840|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
83653841|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653842|NCT01478724|Caseins|caseins|mesh-list
83653843|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
83653844|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
83653845|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653846|NCT01478737|Dexamethasone|dexamethasone|mesh-list
83653847|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
83653848|NCT01478737|BB 1101|bb 1101|mesh-list
83653849|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83653850|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
83653851|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
83653852|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653853|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653854|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653855|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
83653856|NCT01478737|Hormones|hormones|mesh-ancestor
83653857|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653858|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83653859|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653860|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
83653861|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653862|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653863|NCT01478997|Acetaminophen|acetaminophen|mesh-list
83653864|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83653865|NCT01478997|Analgesics|analgesics|mesh-ancestor
83653866|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
83653867|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653868|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653869|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
83653870|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83653871|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
83653872|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653873|NCT01479036|Docetaxel|docetaxel|mesh-list
83653874|NCT01479036|Epirubicin|epirubicin|mesh-list
83653875|NCT01479036|Endostatins|endostatins|mesh-list
83653876|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653877|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
83653878|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
83653879|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
83653880|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653881|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83653882|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83653883|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83653884|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653885|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83653886|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83653887|NCT01479036|Growth Substances|growth substances|mesh-ancestor
83653888|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653889|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
83653890|NCT01479088|Cinacalcet|cinacalcet|mesh-list
83653891|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653892|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653893|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83653894|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
83653895|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83653896|NCT01479114|Lenograstim|lenograstim|mesh-list
83653897|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83653898|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
83653899|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653900|NCT01479179|Trastuzumab|trastuzumab|mesh-list
83653901|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83653902|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653903|NCT01479192|Fenretinide|fenretinide|mesh-list
83653904|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653905|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83653906|NCT01479192|Protective Agents|protective agents|mesh-ancestor
83653907|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653908|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
83653909|NCT01479231|Lansoprazole|lansoprazole|mesh-list
83653910|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83653911|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83653912|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83653913|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653914|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653915|NCT01479244|Molgramostim|molgramostim|mesh-list
83653916|NCT01479244|Sargramostim|sargramostim|mesh-list
83653917|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
83653918|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653919|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808686|NCT01043211|Lidocaine|lidocaine|mesh-list
83653920|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83653921|NCT01479283|Cefazolin|cefazolin|mesh-list
83653922|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83653923|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653924|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
83653925|NCT01479296|Vaccines|vaccines|mesh-list
83653926|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
83653927|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653928|NCT01479361|Atovaquone|atovaquone|mesh-list
83653929|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653930|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
83653931|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83653932|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83653933|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653934|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653935|NCT01479504|Cisplatin|cisplatin|mesh-list
83653936|NCT01479504|Docetaxel|docetaxel|mesh-list
83653937|NCT01479504|Nedaplatin|nedaplatin|mesh-list
83653938|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83653939|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
83653940|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
83653941|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
83653942|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653943|NCT01479556|Pregabalin|pregabalin|mesh-list
83653944|NCT01479556|Analgesics|analgesics|mesh-ancestor
83653945|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
83653946|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653947|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653948|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
83653949|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83653950|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653951|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653952|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653953|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83653954|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83653955|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83653956|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83653957|NCT01479634|Efavirenz|efavirenz|mesh-list
83653958|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83653959|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83653960|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83653961|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653962|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
83653963|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83653964|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83653965|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83653966|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83653967|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83653968|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83653969|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83653970|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
83653971|NCT01479751|Ketamine|ketamine|mesh-list
83653972|NCT01479751|Rocuronium|rocuronium|mesh-list
83653973|NCT01479751|Analgesics|analgesics|mesh-ancestor
83653974|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
83653975|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83653976|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83653977|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83653978|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83653979|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
83653980|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
83653981|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83653982|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83653983|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83653984|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83653985|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83653986|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83653987|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
83653988|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83653989|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83653990|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83653991|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
83653992|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83653993|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83653994|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83653995|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83653996|NCT01479881|Cyclosporine|cyclosporine|mesh-list
83653997|NCT01479881|Simeprevir|simeprevir|mesh-list
83653998|NCT01479881|Tacrolimus|tacrolimus|mesh-list
83653999|NCT01479881|Cyclosporins|cyclosporins|mesh-list
83654000|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654001|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
83654002|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654003|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83654004|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654005|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654006|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
83654007|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654008|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
83654009|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654010|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
83654011|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
83654012|NCT01479920|Fluoxetine|fluoxetine|mesh-list
83654013|NCT01479920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83654014|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83654015|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654016|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654017|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654018|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
83654019|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654020|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83654021|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
83654022|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83654023|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83654024|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83654025|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654026|NCT01479933|Vitamin D|vitamin d|mesh-list
83654027|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
83654028|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
83654029|NCT01479933|Vitamins|vitamins|mesh-list
83654030|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
83654031|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654032|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83654033|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83654034|NCT01480050|Temozolomide|temozolomide|mesh-list
83654035|NCT01480050|Mibefradil|mibefradil|mesh-list
83654036|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83654037|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
83654038|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654039|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654040|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83654041|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83654042|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654043|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83654044|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654045|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
83654046|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83654047|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83654048|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654049|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
83654050|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83654051|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654052|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654053|NCT01480141|Afatinib|afatinib|mesh-list
83654054|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654055|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654056|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654057|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654058|NCT01480323|Aldesleukin|aldesleukin|mesh-list
83654059|NCT01480323|Ipilimumab|ipilimumab|mesh-list
83654060|NCT01480323|Interleukin-2|interleukin-2|mesh-list
83654061|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83654062|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654063|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83654064|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654065|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83654066|NCT01480323|Analgesics|analgesics|mesh-ancestor
83654067|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
83654068|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654069|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654070|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83654071|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83654072|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
83654073|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654075|NCT01480336|Ranolazine|ranolazine|mesh-list
83654076|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83654077|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
83654078|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83654079|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654080|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654081|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83654082|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83654083|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83654084|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654085|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83654086|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83654087|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83654088|NCT01480492|Telbivudine|telbivudine|mesh-list
83654089|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
83654090|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654091|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83654092|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654093|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654094|NCT01480531|Clevidipine|clevidipine|mesh-list
83654095|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83654096|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654097|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654098|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83654099|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654100|NCT01480609|Ezogabine|ezogabine|mesh-list
83654101|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
83654102|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654103|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654104|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
83654105|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83654106|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
83654107|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654108|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83654109|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
83654110|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83654111|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83654112|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
83654113|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654114|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83654115|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83654116|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654117|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654118|NCT01480752|Lornoxicam|lornoxicam|mesh-list
83654119|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83654120|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83654121|NCT01480752|Analgesics|analgesics|mesh-ancestor
83654122|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
83654123|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654124|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654125|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654126|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654127|NCT01480765|Pregabalin|pregabalin|mesh-list
83654128|NCT01480765|Ketamine|ketamine|mesh-list
83654129|NCT01480765|Analgesics|analgesics|mesh-ancestor
83654130|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
83654131|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654132|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654133|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83654134|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83654135|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
83654136|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
83654137|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654138|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83654139|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83654140|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654141|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654142|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
83654143|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83654144|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654145|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83654146|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83654147|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83654148|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83654149|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83654150|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83654151|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83654152|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83654153|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
83654154|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83654155|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654156|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83654157|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83654158|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83654159|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83654160|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83654161|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83654162|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83654163|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83654164|NCT01480791|Diuretics|diuretics|mesh-ancestor
83654165|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
83654166|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654167|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83654168|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654169|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654170|NCT01480817|Sorafenib|sorafenib|mesh-list
83654171|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654172|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654173|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654174|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654175|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
83654176|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
83654177|NCT01480869|Vitamin D|vitamin d|mesh-list
83654178|NCT01480869|Calcium|calcium|mesh-list
83654179|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83654180|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654181|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83654182|NCT01480869|Vitamins|vitamins|mesh-ancestor
83654183|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
83654184|NCT01480986|Irinotecan|irinotecan|mesh-list
83654185|NCT01480986|Octreotide|octreotide|mesh-list
83654186|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654187|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83654188|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83654189|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654190|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654191|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654192|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83654193|NCT01481194|Dexamethasone|dexamethasone|mesh-list
83654194|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
83654195|NCT01481194|Doxorubicin|doxorubicin|mesh-list
83654196|NCT01481194|Lenalidomide|lenalidomide|mesh-list
83654197|NCT01481194|Bortezomib|bortezomib|mesh-list
83654198|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654199|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
83654200|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654201|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654202|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83654203|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
83654204|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654205|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654206|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83654207|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654208|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
83654209|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
83654210|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654211|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654212|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
83654213|NCT01481194|Hormones|hormones|mesh-ancestor
83654214|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654215|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83654216|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83654217|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83654218|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83654219|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654220|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83654221|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83654222|NCT01481194|Growth Substances|growth substances|mesh-ancestor
83654223|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
83654224|NCT01481233|Colchicine|colchicine|mesh-list
83654225|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
83654226|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654227|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
83654228|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
83654229|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
83654230|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654231|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654232|NCT01481259|Pemetrexed|pemetrexed|mesh-list
83654233|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654234|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654235|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654236|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83654237|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83654238|NCT01481311|Bromides|bromides|mesh-list
83654239|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
83654240|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
83654241|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
83654242|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83654243|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83654244|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654245|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654246|NCT01481350|Urological Agents|urological agents|mesh-ancestor
83654247|NCT01481389|Theobromine|theobromine|mesh-list
83654248|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83654249|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
83654250|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654251|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654252|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83654253|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
83654254|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
83654255|NCT01481454|Vaccines|vaccines|mesh-list
83654256|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
83654257|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654258|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
83654259|NCT01481519|Dexamethasone|dexamethasone|mesh-list
83654260|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
83654261|NCT01481519|Povidone|povidone|mesh-list
83654262|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
83654263|NCT01481519|BB 1101|bb 1101|mesh-list
83654264|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654265|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
83654266|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
83654267|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654268|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654269|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654270|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
83654271|NCT01481519|Hormones|hormones|mesh-ancestor
83654272|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654273|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83654274|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654275|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
83654276|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654277|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654278|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
83654279|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
83654280|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83654281|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654282|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83654283|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83654284|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
83654285|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
83654286|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654287|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654288|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654289|NCT01481610|Diclofenac|diclofenac|mesh-list
83654290|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
83654291|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83654292|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83654293|NCT01481610|Analgesics|analgesics|mesh-ancestor
83654294|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
83654295|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654296|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654297|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654298|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654299|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83654300|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654301|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654302|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83654303|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
83654304|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654305|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
83654306|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
83654307|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
83654308|NCT01481714|Citric Acid|citric acid|mesh-list
83654309|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
83654310|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83654311|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
83654312|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
83654313|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654314|NCT01481714|Cathartics|cathartics|mesh-ancestor
83654315|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654316|NCT01481714|Antacids|antacids|mesh-ancestor
83654317|NCT01481831|Palonosetron|palonosetron|mesh-list
83654318|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
83654319|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
83390572|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
83654320|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654321|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654322|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654323|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83654324|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83654325|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
83654326|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654327|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654328|NCT01481844|Amoxicillin|amoxicillin|mesh-list
83654329|NCT01481844|Metronidazole|metronidazole|mesh-list
83654330|NCT01481844|Clarithromycin|clarithromycin|mesh-list
83654331|NCT01481844|Tetracycline|tetracycline|mesh-list
83654332|NCT01481844|Tinidazole|tinidazole|mesh-list
83654333|NCT01481844|Lansoprazole|lansoprazole|mesh-list
83654334|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
83654335|NCT01481844|Bismuth|bismuth|mesh-list
83654336|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83654337|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83654338|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654339|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83654340|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83654341|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83654342|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654343|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654344|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83654345|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83654346|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83654347|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654348|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83654349|NCT01481844|Antacids|antacids|mesh-ancestor
83654350|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
83654351|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83654352|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
83654353|NCT01481870|Sorafenib|sorafenib|mesh-list
83654354|NCT01481870|Sunitinib|sunitinib|mesh-list
83654355|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654356|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654357|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654358|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654359|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83654360|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83654361|NCT01481870|Growth Substances|growth substances|mesh-ancestor
83654362|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654363|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
83654364|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83654365|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83654366|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
83654367|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654368|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654369|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83654370|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83654371|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83654373|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
83654374|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654375|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83654376|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83654377|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83654378|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
83654379|NCT01482117|Cilostazol|cilostazol|mesh-list
83654380|NCT01482117|Clopidogrel|clopidogrel|mesh-list
83654381|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83654382|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83654383|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83654384|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83654385|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
83654386|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654387|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654388|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654389|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83654390|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
83654391|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654392|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83654393|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
83654394|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83654395|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83654396|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
83654397|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83654398|NCT01482117|Protective Agents|protective agents|mesh-ancestor
83654399|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83654400|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83654401|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654402|NCT01482156|Everolimus|everolimus|mesh-list
83654403|NCT01482156|Dactolisib|dactolisib|mesh-list
83654404|NCT01482156|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83654405|NCT01482156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654406|NCT01482156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654407|NCT01482156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654408|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654409|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
83654410|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654411|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654412|NCT01482299|Everolimus|everolimus|mesh-list
83654413|NCT01482299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83654414|NCT01482299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654415|NCT01482299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654416|NCT01482299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654417|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654418|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
83654419|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654420|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654421|NCT01482338|Drospirenone|drospirenone|mesh-list
83654422|NCT01482338|Desogestrel|desogestrel|mesh-list
83654423|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83654424|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
83654425|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654426|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654427|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83654428|NCT01482338|Diuretics|diuretics|mesh-ancestor
83654429|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
83654430|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83654431|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83654432|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83654433|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
83654434|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83654435|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83654436|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83654437|NCT01482338|Progestins|progestins|mesh-ancestor
83654438|NCT01482338|Hormones|hormones|mesh-ancestor
83654439|NCT01482377|Cetuximab|cetuximab|mesh-list
83654440|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83654441|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83654442|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654443|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654444|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654445|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654447|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83654448|NCT01482416|Hormones|hormones|mesh-ancestor
83654449|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654450|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654451|NCT01482442|Sorafenib|sorafenib|mesh-list
83654452|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654453|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654454|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654455|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654456|NCT01482468|Palonosetron|palonosetron|mesh-list
83654457|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
83654458|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
83654459|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654460|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654461|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654462|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83654463|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83654464|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
83654465|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654466|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654467|NCT01482559|Dopamine|dopamine|mesh-list
83654468|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83654469|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
83654470|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
83654471|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654472|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654473|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
83654474|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654475|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654476|NCT01482559|Protective Agents|protective agents|mesh-ancestor
83654477|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
83654478|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83654479|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
83654480|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654481|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
83654482|NCT01482624|Protective Agents|protective agents|mesh-ancestor
83654483|NCT01482728|Dasatinib|dasatinib|mesh-list
83654484|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654485|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654486|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654487|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654488|NCT01482754|Rituximab|rituximab|mesh-list
83654489|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83654490|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654491|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
83654492|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654493|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654494|NCT01482897|Prednisolone|prednisolone|mesh-list
83654495|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83654496|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
83654497|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83654498|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
83654499|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83654500|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
83654501|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654502|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
83654503|NCT01482897|Hormones|hormones|mesh-ancestor
83654504|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654505|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654506|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83654507|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654508|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
83654509|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
83654510|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654511|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654512|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83654513|NCT01482897|Protective Agents|protective agents|mesh-ancestor
83654514|NCT01482936|Oxycodone|oxycodone|mesh-list
83654515|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83654516|NCT01482936|Narcotics|narcotics|mesh-ancestor
83654517|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654518|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654519|NCT01482936|Analgesics|analgesics|mesh-ancestor
83654520|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
83654521|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654522|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
83654523|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654524|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654525|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654526|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654527|NCT01483053|Agomelatine|agomelatine|mesh-list
83654528|NCT01483053|Escitalopram|escitalopram|mesh-list
83654529|NCT01483053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83654530|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83654531|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654532|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654533|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654534|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
83654535|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654536|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83654537|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654538|NCT01483248|Interferons|interferons|mesh-list
83654539|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83654540|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654541|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
83654542|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654543|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83654544|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654545|NCT01483274|Vaccines|vaccines|mesh-list
83654546|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
83654547|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654548|NCT01483300|Cisplatin|cisplatin|mesh-list
83654549|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654550|NCT01483365|Progesterone|progesterone|mesh-list
83654551|NCT01483365|Progestins|progestins|mesh-ancestor
83654552|NCT01483365|Hormones|hormones|mesh-ancestor
83654553|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654554|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654555|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
83654556|NCT01483508|Procyanidin|procyanidin|mesh-list
83654557|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
83654558|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654559|NCT01483508|Protective Agents|protective agents|mesh-ancestor
83654560|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654561|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83654562|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83654563|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654564|NCT01483638|Axitinib|axitinib|mesh-list
83654565|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654566|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654567|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654568|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654569|NCT01483729|Ritonavir|ritonavir|mesh-list
83654570|NCT01483729|Lactams|lactams|mesh-list
83654571|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83654572|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83654573|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
83654574|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654575|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654576|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83654577|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83654578|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
83654579|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654580|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83654581|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83654582|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83654583|NCT01483781|Canagliflozin|canagliflozin|mesh-list
83654584|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83654585|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654586|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83654587|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654588|NCT01483859|Liver Extracts|liver extracts|mesh-list
83654589|NCT01483859|Hematinics|hematinics|mesh-ancestor
83654590|NCT01483911|Gontivimab|gontivimab|mesh-list
83654591|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
83654592|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654594|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83654595|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654596|NCT01484080|Paclitaxel|paclitaxel|mesh-list
83654597|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83654598|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83654599|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654600|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83654601|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83654602|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83654603|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654604|NCT01484145|Terbinafine|terbinafine|mesh-list
83654605|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
83654606|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654607|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654608|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654609|NCT01484171|Idarubicin|idarubicin|mesh-list
83654610|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83654611|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654612|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83654613|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83654614|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654615|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654616|NCT01484184|Levodopa|levodopa|mesh-list
83654617|NCT01484184|Buspirone|buspirone|mesh-list
83654618|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83654619|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83654620|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
83654621|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654622|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654623|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654624|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83654625|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83654626|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654627|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83654628|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83654629|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
83654630|NCT01484262|Liraglutide|liraglutide|mesh-list
83654631|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83654632|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654633|NCT01484262|Incretins|incretins|mesh-ancestor
83654634|NCT01484262|Hormones|hormones|mesh-ancestor
83654635|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654636|NCT01484327|Carvedilol|carvedilol|mesh-list
83654637|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83654638|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83654639|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
83654640|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654641|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654642|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654643|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83654644|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
83654645|NCT01484327|Protective Agents|protective agents|mesh-ancestor
83654646|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83654647|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654648|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83654649|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
83654650|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83654651|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83654652|NCT01484457|Pancrelipase|pancrelipase|mesh-list
83654653|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654654|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83654655|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
83654656|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654657|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83654658|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83654659|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
83654660|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83654661|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654662|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83654663|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83654664|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83654665|NCT01484717|Nicotine|nicotine|mesh-list
83654666|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83654667|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
83654668|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654669|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654670|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83654671|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83654672|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
83654673|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654674|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654675|NCT01484756|Micronutrients|micronutrients|mesh-list
83654676|NCT01484756|Trace Elements|trace elements|mesh-list
83654677|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654678|NCT01484964|Peficitinib|peficitinib|mesh-list
83654679|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654680|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654681|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654682|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
83654683|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654684|NCT01484990|Levodopa|levodopa|mesh-list
83654685|NCT01484990|Carbidopa|carbidopa|mesh-list
83654686|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83654687|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83654688|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83654689|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
83654690|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654691|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654692|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390974|NCT04355949|Vitamin D|vitamin d|mesh-list
83654693|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83654694|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654695|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83654696|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
83654697|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
83654698|NCT01485003|Natalizumab|natalizumab|mesh-list
83654699|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
83654700|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654701|NCT01485068|Paclitaxel|paclitaxel|mesh-list
83654702|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83654703|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654704|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
83654705|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
83654706|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
83654707|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654708|NCT01485081|Paclitaxel|paclitaxel|mesh-list
83654709|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83654710|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654711|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
83654712|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
83654713|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
83654714|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654715|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83654716|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83654717|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
83654718|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654719|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83654720|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654721|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83654722|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654723|NCT01485185|Gabapentin|gabapentin|mesh-list
83654724|NCT01485185|Donepezil|donepezil|mesh-list
83654725|NCT01485185|Analgesics|analgesics|mesh-ancestor
83654726|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
83654727|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654728|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654729|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
83654730|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83654731|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83654732|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654733|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83654734|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83654735|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83654736|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654737|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654738|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
83654739|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83654740|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654741|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
83654742|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
83654743|NCT01485198|Acetaminophen|acetaminophen|mesh-list
83654744|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83654745|NCT01485198|Analgesics|analgesics|mesh-ancestor
83654746|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
83654747|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654748|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654749|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
83654750|NCT01485211|Riboflavin|riboflavin|mesh-list
83654751|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
83654752|NCT01485211|Vitamins|vitamins|mesh-ancestor
83654753|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
83654754|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654755|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83654756|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
83654757|NCT01485224|Thalidomide|thalidomide|mesh-list
83654758|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654759|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
83654760|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654761|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
83654762|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83654763|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654764|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83654765|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83654766|NCT01485224|Growth Substances|growth substances|mesh-ancestor
83654767|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
83654768|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654769|NCT01485315|Mannitol|mannitol|mesh-list
83654770|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83654771|NCT01485315|Diuretics|diuretics|mesh-ancestor
83654772|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
83654773|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654774|NCT01485367|Adapalene|adapalene|mesh-list
83654775|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83654776|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83654777|NCT01485367|Analgesics|analgesics|mesh-ancestor
83654778|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
83654779|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654780|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654781|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654782|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654783|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
83654784|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83654785|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
83654786|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654787|NCT01485445|Fluticasone|fluticasone|mesh-list
83654788|NCT01485445|Xhance|xhance|mesh-list
83654789|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654790|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83654791|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
83654792|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654793|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654794|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83654795|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
83654796|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
83654797|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83654798|NCT01485562|Misoprostol|misoprostol|mesh-list
83654799|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83654800|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
83654801|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83654802|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654803|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83654804|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654805|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
83654806|NCT01485653|Mepivacaine|mepivacaine|mesh-list
83654807|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
83654808|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
83654809|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654810|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654811|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
83654812|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654813|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
83654814|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
83654815|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654816|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
83654817|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654818|NCT01485692|Promethazine|promethazine|mesh-list
83654819|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
83654820|NCT01485692|Midazolam|midazolam|mesh-list
83654821|NCT01485692|Haloperidol|haloperidol|mesh-list
83654822|NCT01485692|Olanzapine|olanzapine|mesh-list
83654823|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
83654824|NCT01485692|Ziprasidone|ziprasidone|mesh-list
83654825|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83654826|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83654827|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654828|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654829|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83654830|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83654831|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83654832|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83654833|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
83654834|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
83654835|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
83654836|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
83654837|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83654838|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654839|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
83654840|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
83654841|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654842|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654843|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83654844|NCT01485692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83654845|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83654846|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654847|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
83654848|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83654849|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
83654850|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83654851|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83654852|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
83654853|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
83654854|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83654855|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
83654856|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
83654857|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83654858|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83654859|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
83654860|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
83654861|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83654862|NCT01485718|Cathartics|cathartics|mesh-ancestor
83654863|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654864|NCT01485731|Nelfinavir|nelfinavir|mesh-list
83654865|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83654866|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83654867|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
83654868|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654869|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654870|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83654871|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83654872|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
83654873|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654874|NCT01485744|Leucovorin|leucovorin|mesh-list
83654875|NCT01485744|Fluorouracil|fluorouracil|mesh-list
83654876|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
83654877|NCT01485744|Irinotecan|irinotecan|mesh-list
83654878|NCT01485744|Folfirinox|folfirinox|mesh-list
83654879|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
83654880|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654881|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83654882|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654883|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654884|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
83654885|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654886|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83654887|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83654888|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654889|NCT01485744|Antidotes|antidotes|mesh-ancestor
83654890|NCT01485744|Protective Agents|protective agents|mesh-ancestor
83654891|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
83654892|NCT01485744|Vitamins|vitamins|mesh-ancestor
83654893|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
83654894|NCT01485822|Travoprost|travoprost|mesh-list
83654895|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83654896|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83654897|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83654898|NCT01485835|Dexamethasone|dexamethasone|mesh-list
83654899|NCT01485835|Bortezomib|bortezomib|mesh-list
83654900|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654901|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
83654902|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
83654903|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654904|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654905|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654906|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
83654907|NCT01485835|Hormones|hormones|mesh-ancestor
83654908|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83654909|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83654910|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654911|NCT01485848|Paclitaxel|paclitaxel|mesh-list
83654912|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83654913|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654914|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
83654915|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
83654916|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
83654917|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654918|NCT01485926|Carboplatin|carboplatin|mesh-list
83654919|NCT01485926|Docetaxel|docetaxel|mesh-list
83654920|NCT01485926|Trastuzumab|trastuzumab|mesh-list
83654921|NCT01485926|Lapatinib|lapatinib|mesh-list
83654922|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654923|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
83654924|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
83654925|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
83654926|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654927|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83654928|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654929|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654930|NCT01485939|Lidocaine|lidocaine|mesh-list
83654931|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
83654932|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
83654933|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83654934|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654935|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
83654936|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654937|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83654938|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83654939|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83654940|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83654941|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654942|NCT01485978|Ramipril|ramipril|mesh-list
83654943|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83654944|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
83654945|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654946|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654947|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83654948|NCT01486004|Simeprevir|simeprevir|mesh-list
83654949|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
83654950|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654951|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
83654952|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654953|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654954|NCT01486017|Peficitinib|peficitinib|mesh-list
83654955|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654956|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654957|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83654958|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
83654959|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654960|NCT01486082|Amoxicillin|amoxicillin|mesh-list
83654961|NCT01486082|Clarithromycin|clarithromycin|mesh-list
83654962|NCT01486082|Omeprazole|omeprazole|mesh-list
83654963|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83654964|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83654965|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83654966|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83654967|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83654968|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654969|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654970|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83654971|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83654972|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83654973|NCT01485809|Gefitinib|gefitinib|mesh-list
83654974|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654975|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654976|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654977|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654978|NCT01486251|Axitinib|axitinib|mesh-list
83654979|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83654980|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83654981|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83654982|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83654983|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
83654984|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
83654985|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83654986|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83654987|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654988|NCT01486433|Aspirin|aspirin|mesh-list
83654989|NCT01486433|Simvastatin|simvastatin|mesh-list
83654990|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83654991|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83654992|NCT01486433|Analgesics|analgesics|mesh-ancestor
83654993|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
83654994|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83654995|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83654996|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83654997|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83654998|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83654999|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83655000|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655001|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83655002|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83655003|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655004|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
83655005|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83655006|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83655007|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
83655008|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83655009|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83655010|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
83655011|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
83655012|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83655013|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655014|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655015|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
83655016|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83655017|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655018|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655019|NCT01486485|Nafamostat|nafamostat|mesh-list
83655020|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655021|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655022|NCT01486485|Analgesics|analgesics|mesh-ancestor
83655023|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
83655024|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655025|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655026|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655027|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655028|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
83655029|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
83655030|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655031|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655032|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83655033|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83655034|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83655035|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655036|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
83655037|NCT01486511|Liver Extracts|liver extracts|mesh-list
83655038|NCT01486511|Hematinics|hematinics|mesh-ancestor
83655039|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83655040|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
83655041|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
83655042|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83655043|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
83655044|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
83655045|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82809797|NCT00953303|Torsemide|torsemide|mesh-list
83655046|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
83655047|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
83655048|NCT01486602|Paclitaxel|paclitaxel|mesh-list
83655049|NCT01486602|Carboplatin|carboplatin|mesh-list
83655050|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83655051|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655052|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
83655053|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
83655054|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
83655055|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655056|NCT01486706|Gabapentin|gabapentin|mesh-list
83655057|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
83655058|NCT01486706|Analgesics|analgesics|mesh-ancestor
83655059|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
83655060|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655061|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655062|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
83655063|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83655064|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83655065|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655066|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83655067|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83655068|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83655069|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655070|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655071|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
83655072|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83655073|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83655074|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
83655075|NCT01486706|Urological Agents|urological agents|mesh-ancestor
83655076|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83655077|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
83655078|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655079|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
83655080|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
83655081|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83655082|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655083|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655084|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
83655085|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
83655086|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83655087|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655088|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655089|NCT01486888|Insulin|insulin|mesh-list
83655090|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83655091|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655092|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655093|NCT01486901|Insulin|insulin|mesh-list
83655094|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83655095|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
83655096|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
83655097|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
83655098|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655099|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655100|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
83655101|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655102|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655103|NCT01486940|Insulin|insulin|mesh-list
83655104|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83655105|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
83655106|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
83655107|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
83655108|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
83655109|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
83655110|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655111|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655112|NCT01486953|Sevoflurane|sevoflurane|mesh-list
83655113|NCT01486953|Desflurane|desflurane|mesh-list
83655114|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83655115|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83655116|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
83655117|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
83655118|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655119|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655120|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83655121|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83655122|NCT01486979|Estradiol|estradiol|mesh-list
83655123|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83655124|NCT01486979|Estrogens|estrogens|mesh-ancestor
83655125|NCT01486979|Hormones|hormones|mesh-ancestor
83655126|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83655127|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655128|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83655129|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
83655130|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83655131|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83655132|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
83655133|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83655134|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655135|NCT01487096|Teriflunomide|teriflunomide|mesh-list
83655136|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655137|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655138|NCT01487096|Analgesics|analgesics|mesh-ancestor
83655139|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
83655140|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655141|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655142|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655143|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655144|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655145|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
83655146|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
83655147|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83655148|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655149|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83655150|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83655151|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655152|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655153|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655154|NCT01487226|Paclitaxel|paclitaxel|mesh-list
83655155|NCT01487226|Cisplatin|cisplatin|mesh-list
83655156|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83655157|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655158|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
83655159|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
83655160|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
83655161|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655162|NCT01487278|Misoprostol|misoprostol|mesh-list
83655163|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83655164|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
83655165|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83655166|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655167|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83655168|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83655169|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
83655170|NCT01487304|Hormones|hormones|mesh-list
83655171|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83655172|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655173|NCT01487317|Rivastigmine|rivastigmine|mesh-list
83655174|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83655175|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655176|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655177|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
83655178|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655179|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655180|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83655181|NCT01487317|Protective Agents|protective agents|mesh-ancestor
83655182|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
83655183|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655184|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655185|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
83655186|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655187|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655188|NCT01487395|Donepezil|donepezil|mesh-list
83655189|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83655190|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655191|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655192|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
83655193|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655194|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655195|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
83655196|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
83655197|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655198|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655200|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83655201|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
83655202|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
83655203|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655204|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655205|NCT01487512|Hydromorphone|hydromorphone|mesh-list
83655206|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83655207|NCT01487512|Narcotics|narcotics|mesh-ancestor
83655208|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655209|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655210|NCT01487512|Analgesics|analgesics|mesh-ancestor
83655211|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
83655212|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655213|NCT01487564|Hydromorphone|hydromorphone|mesh-list
83655214|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83655215|NCT01487564|Narcotics|narcotics|mesh-ancestor
83655216|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655217|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655218|NCT01487564|Analgesics|analgesics|mesh-ancestor
83655219|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
83655220|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655221|NCT01487629|Bevacizumab|bevacizumab|mesh-list
83655222|NCT01487629|Ranibizumab|ranibizumab|mesh-list
83655223|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83655224|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655225|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83655226|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83655227|NCT01487629|Growth Substances|growth substances|mesh-ancestor
83655228|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655229|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
83655230|NCT01487785|Gemcitabine|gemcitabine|mesh-list
83655231|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83655232|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
83655233|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655234|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655235|NCT01487798|Insulin|insulin|mesh-list
83655236|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83655237|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
83655238|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
83655239|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83655240|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655241|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655242|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
83655243|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
83655244|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83655245|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655246|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655247|NCT01487993|Metformin|metformin|mesh-list
83655248|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655249|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655250|NCT01488136|Diazoxide|diazoxide|mesh-list
83655251|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83655252|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
83655253|NCT01488201|Brodalumab|brodalumab|mesh-list
83655254|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
83655255|NCT01488227|Vitamin D|vitamin d|mesh-list
83655256|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
83655257|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
83655258|NCT01488227|Vitamins|vitamins|mesh-list
83655259|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
83655260|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655261|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83655262|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83655263|NCT01488253|Sirolimus|sirolimus|mesh-list
83655264|NCT01488253|Temsirolimus|temsirolimus|mesh-list
83655265|NCT01488253|MTOR Inhibitors|mtor inhibitors|mesh-list
83655266|NCT01488253|Tacrolimus|tacrolimus|mesh-list
83655267|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655268|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
83655269|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655270|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83655271|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655272|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655273|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83655274|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655275|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83655276|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655277|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
83655278|NCT01488253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83655279|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83655280|NCT01488266|Milnacipran|milnacipran|mesh-list
83655281|NCT01488266|Aripiprazole|aripiprazole|mesh-list
83655282|NCT01488266|Mirtazapine|mirtazapine|mesh-list
83655283|NCT01488266|Bupropion|bupropion|mesh-list
83655284|NCT01488266|Fluoxetine|fluoxetine|mesh-list
83655285|NCT01488266|Paroxetine|paroxetine|mesh-list
83655286|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83655287|NCT01488266|Sertraline|sertraline|mesh-list
83655288|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
83655289|NCT01488266|Escitalopram|escitalopram|mesh-list
83655290|NCT01488266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83655291|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83655292|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83655293|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655294|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655295|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
83655296|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655297|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655298|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83655299|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83655300|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83655301|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
83655302|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83655303|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83655304|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655305|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83655306|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83655307|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655308|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
83655309|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83655310|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83655311|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83655312|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83655313|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83655314|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83655315|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83655316|NCT01488266|Analgesics|analgesics|mesh-ancestor
83655317|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
83655318|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83655319|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
83655320|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
83655321|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83655322|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83655323|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83655324|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83655325|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
83655326|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83655327|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655328|NCT01488305|Micronutrients|micronutrients|mesh-list
83655329|NCT01488305|Trace Elements|trace elements|mesh-list
83655330|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655331|NCT01488344|Nintedanib|nintedanib|mesh-list
83655332|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655333|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83655334|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655335|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655336|NCT01488396|Cyclosporine|cyclosporine|mesh-list
83655337|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83655338|NCT01488396|Cyclosporins|cyclosporins|mesh-list
83655339|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655340|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655341|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655342|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
83655343|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655344|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
83655345|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655346|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810108|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
83655347|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655348|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83655349|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83655350|NCT01488526|Tenofovir|tenofovir|mesh-list
83655351|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
83655352|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655353|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83655354|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83655355|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655356|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655357|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83655358|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83655359|NCT01488552|Metformin|metformin|mesh-list
83655360|NCT01488552|Paclitaxel|paclitaxel|mesh-list
83655361|NCT01488552|Gemcitabine|gemcitabine|mesh-list
83655362|NCT01488552|Folfirinox|folfirinox|mesh-list
83655363|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83655364|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655365|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
83655366|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
83655367|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
83655368|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655369|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83655370|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
83655371|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655372|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655373|NCT01488565|Azacitidine|azacitidine|mesh-list
83391632|NCT03898037|Metformin|metformin|mesh-list
83655374|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83655375|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
83655376|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655377|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655378|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655379|NCT01488656|Vitamin D|vitamin d|mesh-list
83655380|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83655381|NCT01488656|Antioxidants|antioxidants|mesh-list
83655382|NCT01488656|Vitamins|vitamins|mesh-ancestor
83655383|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
83655384|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655385|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83655386|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655387|NCT01488656|Protective Agents|protective agents|mesh-ancestor
83655388|NCT01488734|Vitamin D|vitamin d|mesh-list
83655389|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
83655390|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
83655391|NCT01488734|Vitamins|vitamins|mesh-list
83655392|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
83655393|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655394|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83655395|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83655396|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83655397|NCT01488773|Montelukast|montelukast|mesh-list
83655398|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83655399|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
83655400|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655401|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655402|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83655403|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
83655404|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83655405|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83655406|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83655407|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
83655408|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655409|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655410|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83655411|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
83655412|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83655413|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83655414|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83655415|NCT01488838|Cisplatin|cisplatin|mesh-list
83655416|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655417|NCT01488955|Fosfomycin|fosfomycin|mesh-list
83655418|NCT01488955|Ibuprofen|ibuprofen|mesh-list
83655419|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655420|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810182|NCT01026714|Fluconazole|fluconazole|mesh-list
83655421|NCT01488955|Analgesics|analgesics|mesh-ancestor
83655422|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
83655423|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655424|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655425|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655426|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655427|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83655428|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655429|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655430|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83655431|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655432|NCT01489033|Immunomodulating Agents|immunomodulating agents|mesh-list
83655433|NCT01489033|Immunologic Factors|immunologic factors|mesh-ancestor
83655434|NCT01489033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655435|NCT01489059|Ipilimumab|ipilimumab|mesh-list
83655436|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83655437|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655438|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83655439|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655440|NCT01489072|Remifentanil|remifentanil|mesh-list
83655441|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83655442|NCT01489072|Narcotics|narcotics|mesh-ancestor
83655443|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655444|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655445|NCT01489072|Analgesics|analgesics|mesh-ancestor
83655446|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
83655447|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655448|NCT01489124|Imipenem|imipenem|mesh-list
83655449|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83655450|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655451|NCT01489137|Remifentanil|remifentanil|mesh-list
83655452|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83655453|NCT01489137|Narcotics|narcotics|mesh-ancestor
83655454|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655455|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655456|NCT01489137|Analgesics|analgesics|mesh-ancestor
83655457|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
83655458|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655459|NCT01489202|Cobalt|cobalt|mesh-list
83655460|NCT01489202|Chromium|chromium|mesh-list
83655461|NCT01489202|Everolimus|everolimus|mesh-list
83655462|NCT01489202|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83655463|NCT01489202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83655464|NCT01489202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655465|NCT01489202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655466|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655467|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
83655468|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655469|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655470|NCT01489202|Trace Elements|trace elements|mesh-ancestor
83655471|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
83655472|NCT01489228|Benzonidazole|benzonidazole|mesh-list
83655473|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655474|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
83655475|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655476|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83655477|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83655478|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83655479|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655480|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83655481|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
83655482|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655483|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655484|NCT01489319|Analgesics|analgesics|mesh-ancestor
83655485|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
83655486|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655487|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655488|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655489|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655490|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83655491|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655492|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655493|NCT01489371|Doxorubicin|doxorubicin|mesh-list
83655494|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83655495|NCT01489371|Interleukin-12|interleukin-12|mesh-list
83655496|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83655497|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655498|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83655499|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83655500|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655501|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655502|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83655503|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
83655504|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655505|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83655506|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83655507|NCT01489371|Growth Substances|growth substances|mesh-ancestor
83655508|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
83655509|NCT01489410|Ethanol|ethanol|mesh-list
83655510|NCT01489410|Doxorubicin|doxorubicin|mesh-list
83655511|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83655512|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
83655513|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83655514|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655515|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83655516|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83655517|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655518|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655519|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83655520|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655521|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655522|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655523|NCT01489488|Riociguat|riociguat|mesh-list
83655524|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
83655525|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655526|NCT01489566|Fluorouracil|fluorouracil|mesh-list
83655527|NCT01489566|Mitomycins|mitomycins|mesh-list
83655528|NCT01489566|Mitomycin|mitomycin|mesh-list
83655529|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
83655530|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655531|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83655532|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655533|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655534|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
83655535|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655536|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83655537|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
83655538|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83655539|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655540|NCT01489592|Turmeric extract|turmeric extract|mesh-list
83655541|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
83655542|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655543|NCT01489592|Protective Agents|protective agents|mesh-ancestor
83655544|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655545|NCT01489631|Sufentanil|sufentanil|mesh-list
83655546|NCT01489631|Gabapentin|gabapentin|mesh-list
83655547|NCT01489631|Bupivacaine|bupivacaine|mesh-list
83655548|NCT01489631|Ropivacaine|ropivacaine|mesh-list
83655549|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
83655550|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
83655551|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655552|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655553|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
83655554|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655555|NCT01489631|Analgesics|analgesics|mesh-ancestor
83655556|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
83655557|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83655558|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83655559|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83655560|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83655561|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83655562|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655563|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655564|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
83655565|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83655566|NCT01489631|Narcotics|narcotics|mesh-ancestor
83655567|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83655568|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83655569|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
83655570|NCT01489644|Metformin|metformin|mesh-list
83655571|NCT01489644|Repaglinide|repaglinide|mesh-list
83655572|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655573|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655574|NCT01489683|Lidocaine|lidocaine|mesh-list
83655575|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
83655576|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
83655577|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655578|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655579|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
83655580|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655581|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83655582|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83655583|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83655584|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83655585|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655586|NCT01489696|Tamsulosin|tamsulosin|mesh-list
83655587|NCT01489696|Mirabegron|mirabegron|mesh-list
83655588|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83655589|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83655590|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83655591|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
83655592|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655593|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655594|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655595|NCT01489696|Urological Agents|urological agents|mesh-ancestor
83655596|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83655597|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83655598|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83655599|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
83655600|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83655601|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83655602|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
83655603|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655604|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655605|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655606|NCT01489709|Urological Agents|urological agents|mesh-ancestor
83655607|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83655608|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83655609|NCT01489852|Estradiol|estradiol|mesh-list
83655610|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83655611|NCT01489852|Estrogens|estrogens|mesh-ancestor
83655612|NCT01489852|Hormones|hormones|mesh-ancestor
83655613|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83655614|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655615|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83655616|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
83655617|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83655618|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83655619|NCT01489865|Fluorouracil|fluorouracil|mesh-list
83655620|NCT01489865|Veliparib|veliparib|mesh-list
83655621|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
83655622|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655623|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83655624|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655625|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655626|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
83655627|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655628|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83655629|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655630|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
83655631|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83655632|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83655633|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83655634|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83655635|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655636|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
83655637|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655638|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655639|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83655640|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655641|NCT01489917|Heparin|heparin|mesh-list
83655642|NCT01489917|Hemostatics|hemostatics|mesh-list
83655643|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
83655644|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83655645|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83655646|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655647|NCT01489917|Coagulants|coagulants|mesh-ancestor
83655648|NCT01489943|Pioglitazone|pioglitazone|mesh-list
82810400|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655650|NCT01489943|Omeprazole|omeprazole|mesh-list
83655651|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83655652|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83655653|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83655654|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655655|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655656|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83655657|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83655658|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83655659|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83655660|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
83655661|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
83655662|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
83655663|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
83655664|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655665|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655666|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83655667|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83655668|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
83655669|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83655670|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83655671|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655672|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655673|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83655674|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83655675|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83655676|NCT01489982|Zopiclone|zopiclone|mesh-list
83655677|NCT01489982|Doxepin|doxepin|mesh-list
83655678|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83655679|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655680|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655681|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83655682|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83655683|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
83655684|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83655685|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
83655686|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
83655687|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655688|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655689|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
83655690|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
83655691|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655692|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655693|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655694|NCT01490047|Etanercept|etanercept|mesh-list
83655695|NCT01490047|Doxorubicin|doxorubicin|mesh-list
83655696|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83655697|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83655698|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655699|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83655700|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83655701|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655702|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655703|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655704|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655705|NCT01490047|Analgesics|analgesics|mesh-ancestor
83655706|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
83655707|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655708|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655709|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655710|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655711|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83655712|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655713|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
83655714|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
83655715|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655716|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655717|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
83655718|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655719|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655720|NCT01490203|Edetic Acid|edetic acid|mesh-list
83655721|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
83655722|NCT01490203|Antidotes|antidotes|mesh-ancestor
83655723|NCT01490203|Protective Agents|protective agents|mesh-ancestor
83655724|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655725|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
83655726|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
83655727|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655728|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83655729|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
83655730|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83655731|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83655732|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83655733|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655734|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83655735|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83655736|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83655737|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655738|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
83655739|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655740|NCT01490229|Ezetimibe|ezetimibe|mesh-list
83655741|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83655742|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83655743|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
83655744|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655745|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83655746|NCT01490255|Amlodipine|amlodipine|mesh-list
83655747|NCT01490255|Ranolazine|ranolazine|mesh-list
83655748|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83655749|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83655750|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83655751|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655752|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83655753|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655754|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
83655755|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83655756|NCT01490268|Sufentanil|sufentanil|mesh-list
83655757|NCT01490268|Dsuvia|dsuvia|mesh-list
83655758|NCT01490268|Hydromorphone|hydromorphone|mesh-list
83655759|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83655760|NCT01490268|Narcotics|narcotics|mesh-ancestor
83655761|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655762|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655763|NCT01490268|Analgesics|analgesics|mesh-ancestor
83655764|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
83655765|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655766|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83655767|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83655768|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
83655769|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
83655770|NCT01490333|Vitamin D|vitamin d|mesh-list
83655771|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
83655772|NCT01490333|Vitamins|vitamins|mesh-ancestor
83655773|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
83655774|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655775|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83655776|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83655777|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83655778|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
83655779|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655780|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83655781|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83655782|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83655783|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
83655784|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655785|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83655786|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83655787|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655788|NCT01490411|Immunomodulating Agents|immunomodulating agents|mesh-list
83655789|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
83655790|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655791|NCT01490437|Dexamethasone|dexamethasone|mesh-list
83655792|NCT01490437|Pemetrexed|pemetrexed|mesh-list
83655793|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655794|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655795|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
83655796|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
83655797|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655798|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83655799|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
83655800|NCT01490437|Hormones|hormones|mesh-ancestor
83655801|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83655802|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83655803|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655804|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655805|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655806|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83655807|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83655808|NCT01490476|Everolimus|everolimus|mesh-list
83655809|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655810|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655811|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
83655812|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655813|NCT01490476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83655814|NCT01490476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83655815|NCT01490476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655816|NCT01490476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655817|NCT01490567|Donepezil|donepezil|mesh-list
83655818|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83655819|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655820|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655821|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
83655822|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655823|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655824|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
83655825|NCT01490658|Metformin|metformin|mesh-list
83655826|NCT01490658|Repaglinide|repaglinide|mesh-list
83655827|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655828|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655829|NCT01490671|Tenofovir|tenofovir|mesh-list
83655830|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
83655831|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655832|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83655833|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83655834|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655835|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655836|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83655837|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83655838|NCT01490749|Carboplatin|carboplatin|mesh-list
83655839|NCT01490749|Capecitabine|capecitabine|mesh-list
83655840|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
83655841|NCT01490749|Everolimus|everolimus|mesh-list
83655842|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655843|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83655844|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
83655845|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655846|NCT01490749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83655847|NCT01490749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83655848|NCT01490749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655849|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83655850|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
83655851|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655852|NCT01490762|Insulin|insulin|mesh-list
83655853|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83655854|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83655855|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655856|NCT01490905|Ibuprofen|ibuprofen|mesh-list
83655857|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655858|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655859|NCT01490905|Analgesics|analgesics|mesh-ancestor
83655860|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
83655861|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655862|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655863|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655864|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655865|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83655866|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655867|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655868|NCT01490944|Iron|iron|mesh-list
83655869|NCT01490944|Folic Acid|folic acid|mesh-list
83655870|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
83655871|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
83655872|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
82810621|NCT00457626|Valsartan|valsartan|mesh-list
83655873|NCT01490944|Trace Elements|trace elements|mesh-ancestor
83655874|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
83655875|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655876|NCT01490944|Hematinics|hematinics|mesh-ancestor
83655877|NCT01490944|Vitamins|vitamins|mesh-ancestor
83655878|NCT01490996|Curcumin|curcumin|mesh-list
83655879|NCT01490996|Capecitabine|capecitabine|mesh-list
83655880|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83655881|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
83655882|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655883|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655884|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655885|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655886|NCT01490996|Analgesics|analgesics|mesh-ancestor
83655887|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
83655888|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655889|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655890|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83655891|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655892|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655893|NCT01491009|Midazolam|midazolam|mesh-list
83655894|NCT01491009|Remifentanil|remifentanil|mesh-list
83655895|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83655896|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83655897|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83655898|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655899|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83655900|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83655901|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83655902|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83655903|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
83655904|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
83655905|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
83655906|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
83655907|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655908|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655909|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83655910|NCT01491009|Narcotics|narcotics|mesh-ancestor
83655911|NCT01491009|Analgesics|analgesics|mesh-ancestor
83655912|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
83655913|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655914|NCT01491048|Tacrine|tacrine|mesh-list
83655915|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83655916|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655917|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655918|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
83655919|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655920|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655921|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83655922|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
83655923|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655924|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
83655925|NCT01491061|Ranolazine|ranolazine|mesh-list
83655926|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83655927|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83655928|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655929|NCT01491100|Interferons|interferons|mesh-list
83655930|NCT01491100|Interferon-beta|interferon-beta|mesh-list
83655931|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
83655932|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655933|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
83655934|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655935|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
83655936|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655937|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83655938|NCT01491139|Olaparib|olaparib|mesh-list
83655939|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655940|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83655941|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655942|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655943|NCT01491191|Palmidrol|palmidrol|mesh-list
83655944|NCT01491191|Analgesics|analgesics|mesh-ancestor
83655945|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
83655946|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655947|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83655948|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655949|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655950|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810703|NCT00384189|Hormones|hormones|mesh-ancestor
83655951|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83655952|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
83655953|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655954|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83655955|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83655956|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83655957|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655958|NCT01491191|Hormones|hormones|mesh-ancestor
83655959|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83655960|NCT01491204|Paclitaxel|paclitaxel|mesh-list
83655961|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83655962|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655963|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83655964|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83655965|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83655966|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655967|NCT01491217|Paclitaxel|paclitaxel|mesh-list
83655968|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83655969|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83655970|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83655971|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83655972|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83655973|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655974|NCT01491256|Atorvastatin|atorvastatin|mesh-list
83655975|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83655976|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83655977|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
83655978|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655979|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83655980|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83655981|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655982|NCT01491295|Tenofovir|tenofovir|mesh-list
83655983|NCT01491295|Lamivudine|lamivudine|mesh-list
83655984|NCT01491295|Adefovir|adefovir|mesh-list
83655985|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
83655986|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83655987|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83655988|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83655989|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83655990|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83655991|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83655992|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83655993|NCT01491321|Loxoprofen|loxoprofen|mesh-list
83655994|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83655995|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83655996|NCT01491321|Analgesics|analgesics|mesh-ancestor
83655997|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
83655998|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83655999|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656000|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656001|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656002|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83656003|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83656004|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656005|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
83656006|NCT01491503|Cetirizine|cetirizine|mesh-list
83656007|NCT01491503|Montelukast|montelukast|mesh-list
83656008|NCT01491503|Levocetirizine|levocetirizine|mesh-list
83656009|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83656010|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83656011|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83656012|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
83656013|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656014|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656015|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83656016|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83656017|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656018|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83656019|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83656020|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
83656021|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
83656022|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656023|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82810768|NCT00548405|Interferon-beta|interferon-beta|mesh-list
83656024|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83656025|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83656026|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83656027|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
83656028|NCT01491867|Travoprost|travoprost|mesh-list
83656029|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83656030|NCT01492062|Pancrelipase|pancrelipase|mesh-list
83656031|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83656032|NCT01492114|Resveratrol|resveratrol|mesh-list
83656033|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
83656034|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656035|NCT01492114|Protective Agents|protective agents|mesh-ancestor
83656036|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656037|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656038|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83656039|NCT01492153|Insulin|insulin|mesh-list
83656040|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656041|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
83656042|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
83656043|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
83656044|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656045|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656046|NCT01492166|Insulin|insulin|mesh-list
83656047|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656048|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656049|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656050|NCT01492179|Lidocaine|lidocaine|mesh-list
83656051|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
83656052|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
83656053|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656054|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656055|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
83656056|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656057|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83656058|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83656059|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83656060|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656061|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656062|NCT01492205|Insulin|insulin|mesh-list
83656063|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656064|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656065|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656066|NCT01492218|Insulin|insulin|mesh-list
83656067|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656068|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656069|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656070|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83656071|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656072|NCT01492504|Asunaprevir|asunaprevir|mesh-list
83656073|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
83656074|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656075|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656076|NCT01492543|Tegafur|tegafur|mesh-list
83656077|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83656078|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
83656079|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656080|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656081|NCT01492556|Etoposide|etoposide|mesh-list
83656082|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83656083|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656084|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83656085|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83656086|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656087|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656088|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
83656089|NCT01492608|Analgesics|analgesics|mesh-ancestor
83656090|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
83656091|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656092|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656093|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
83656094|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656095|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83656096|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
82810851|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
83656097|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83656098|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656099|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656100|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83656101|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
83656102|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83656103|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83656104|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83656105|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83656106|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656107|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656108|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656109|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656110|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
83656111|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83656112|NCT01492712|Propofol|propofol|mesh-list
83656113|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83656114|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656115|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656116|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83656117|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
83656118|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
83656119|NCT01492725|Plasminogen|plasminogen|mesh-list
83656120|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83656121|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83656122|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83656123|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656124|NCT01492881|Doxorubicin|doxorubicin|mesh-list
83656125|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83656126|NCT01492881|Bortezomib|bortezomib|mesh-list
83656127|NCT01492881|Vorinostat|vorinostat|mesh-list
83656128|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83656129|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656130|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83656131|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83656132|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656133|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656134|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83656135|NCT01492894|Cyclosporine|cyclosporine|mesh-list
83656136|NCT01492894|Sirolimus|sirolimus|mesh-list
83656137|NCT01492894|Tacrolimus|tacrolimus|mesh-list
83656138|NCT01492894|Cyclosporins|cyclosporins|mesh-list
83656139|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656140|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
83656141|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656142|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83656143|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656144|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656145|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
83656146|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656147|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
83656148|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656149|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83656150|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83656151|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656152|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
83656153|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
83656154|NCT01492920|Vitamins|vitamins|mesh-ancestor
83656155|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
83656156|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656157|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
83656158|NCT01492959|Insulin|insulin|mesh-list
83656159|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656160|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656161|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656162|NCT01492985|Vaccines|vaccines|mesh-list
83656163|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
83656164|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656165|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
83656166|NCT01493050|Calcium|calcium|mesh-list
83656167|NCT01493050|Sevelamer|sevelamer|mesh-list
83656168|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83656169|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656170|NCT01493050|Antacids|antacids|mesh-ancestor
83656171|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810918|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
83656172|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83656173|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
83656174|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
83656175|NCT01493102|Vasopressins|vasopressins|mesh-list
83656176|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
83656177|NCT01493102|Norepinephrine|norepinephrine|mesh-list
83656178|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83656179|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83656180|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
83656181|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656182|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656183|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656184|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
83656185|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
83656186|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656187|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83656188|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
83656189|NCT01493102|Coagulants|coagulants|mesh-ancestor
83656190|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83656191|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
83656192|NCT01493115|Insulin|insulin|mesh-list
83656193|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656194|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
83656195|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656196|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656197|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
83656198|NCT01493154|Vaccines|vaccines|mesh-list
83656199|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
83656200|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656201|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656202|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656203|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83656204|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
83656205|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656206|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656207|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83656208|NCT01493310|Paclitaxel|paclitaxel|mesh-list
83656209|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83656210|NCT01493310|Mifepristone|mifepristone|mesh-list
83656211|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83656212|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656213|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
83656214|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
83656215|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
83656216|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656217|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83656218|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
83656219|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83656220|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656221|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83656222|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83656223|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83656224|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
83656225|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83656226|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83656227|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
83656228|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656229|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
83656230|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83656231|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83656232|NCT01493336|Capecitabine|capecitabine|mesh-list
83656233|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83656234|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
83656235|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656236|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656237|NCT01493388|Insulin|insulin|mesh-list
83656238|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656239|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656240|NCT01493440|Atosiban|atosiban|mesh-list
83656241|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
83656242|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656243|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656244|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
83656245|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83656246|NCT01493479|Rituximab|rituximab|mesh-list
83656247|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83656248|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656249|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
83656250|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656251|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656253|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83656254|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656255|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656256|NCT01493622|Minocycline|minocycline|mesh-list
83656257|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83656258|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656259|NCT01493635|Analgesics|analgesics|mesh-list
83656260|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
83656261|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656262|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656263|NCT01493648|Vitamin D|vitamin d|mesh-list
83656264|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
83656265|NCT01493648|Vitamins|vitamins|mesh-ancestor
83656266|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
83656267|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656268|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83656269|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83656270|NCT01493674|Folic Acid|folic acid|mesh-list
83656271|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
83656272|NCT01493674|Hematinics|hematinics|mesh-ancestor
83656273|NCT01493674|Vitamins|vitamins|mesh-ancestor
83656274|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
83656275|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656276|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
83656277|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83656278|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
83656279|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83656280|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656281|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83656282|NCT01493843|Paclitaxel|paclitaxel|mesh-list
83656283|NCT01493843|Bevacizumab|bevacizumab|mesh-list
83656284|NCT01493843|Carboplatin|carboplatin|mesh-list
83656285|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83656286|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656287|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
83656288|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
83656289|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
83656290|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656291|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83656292|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83656293|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83656294|NCT01493843|Growth Substances|growth substances|mesh-ancestor
83656295|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656296|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
83656297|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83656298|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83656299|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83656300|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83656301|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656302|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
83656303|NCT01493973|Hematinics|hematinics|mesh-ancestor
83656304|NCT01493986|Ropivacaine|ropivacaine|mesh-list
83656305|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
83656306|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
83656307|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656308|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656309|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
83656310|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656311|NCT01493999|Clopidogrel|clopidogrel|mesh-list
83656312|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83656313|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83656314|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83656315|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83656316|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83656317|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
83656318|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656319|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656320|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656321|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83656322|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82811068|NCT00963833|Interferons|interferons|mesh-list
83656323|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656324|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83656325|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83656326|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83656327|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
83656328|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656329|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83656330|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83656331|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656332|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
83656333|NCT01494155|Capecitabine|capecitabine|mesh-list
83656334|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83656335|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
83656336|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656337|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656338|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
83656339|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83656340|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83656341|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656342|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656343|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656344|NCT01494259|Epinephrine|epinephrine|mesh-list
83656345|NCT01494259|Bupivacaine|bupivacaine|mesh-list
83656346|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
83656347|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
83656348|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656349|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656350|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
83656351|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656352|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83656353|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83656354|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
83656355|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656356|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656357|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83656358|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83656359|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
83656360|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83656361|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
83656362|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
83656363|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
83656364|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83656365|NCT01494311|Lidocaine|lidocaine|mesh-list
83656366|NCT01494311|Tetracaine|tetracaine|mesh-list
83656367|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
83656368|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
83656369|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656370|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656371|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
83656372|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656373|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83656374|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83656375|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83656376|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656377|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656378|NCT01494363|Leucovorin|leucovorin|mesh-list
83656379|NCT01494363|Fluorouracil|fluorouracil|mesh-list
83656380|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
83656381|NCT01494363|Irinotecan|irinotecan|mesh-list
83656382|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
83656383|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656384|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83656385|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656386|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656387|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
83656388|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656389|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83656390|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83656391|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656392|NCT01494363|Antidotes|antidotes|mesh-ancestor
83656393|NCT01494363|Protective Agents|protective agents|mesh-ancestor
83656394|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
83656395|NCT01494363|Vitamins|vitamins|mesh-ancestor
83656396|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
83656397|NCT01494402|Aspirin|aspirin|mesh-list
83656398|NCT01494402|Esomeprazole|esomeprazole|mesh-list
83656399|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83656400|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83656401|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83656402|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656403|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656404|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83656405|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83656406|NCT01494402|Analgesics|analgesics|mesh-ancestor
83656407|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
83656408|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656409|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656410|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656411|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656412|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83656413|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83656414|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83656415|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83656416|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
83656417|NCT01494415|Paclitaxel|paclitaxel|mesh-list
83656418|NCT01494415|Carboplatin|carboplatin|mesh-list
83656419|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83656420|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656421|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
83656422|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
83656423|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
83656424|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656425|NCT01494597|Cyclosporine|cyclosporine|mesh-list
83656426|NCT01494597|Isavuconazole|isavuconazole|mesh-list
83656427|NCT01494597|Cyclosporins|cyclosporins|mesh-list
83656428|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656429|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656430|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656431|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
83656432|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656433|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
83656434|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656435|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
83656436|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656437|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83656438|NCT01494636|Lidocaine|lidocaine|mesh-list
83656439|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83656440|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
83656441|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
83656442|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656443|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656444|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
83656445|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656446|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83656447|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83656448|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83656449|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656450|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656451|NCT01494688|Paclitaxel|paclitaxel|mesh-list
83656452|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83656453|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656454|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
83656455|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
83656456|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
83656457|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656458|NCT01494714|Petrolatum|petrolatum|mesh-list
83656459|NCT01494714|Emollients|emollients|mesh-ancestor
83656460|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
83656461|NCT01494727|Amlodipine|amlodipine|mesh-list
83656462|NCT01494727|Valsartan|valsartan|mesh-list
83656463|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83656464|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83656465|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83656466|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656467|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656468|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83656469|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656470|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
83656471|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82811232|NCT00969449|Naproxen|naproxen|mesh-list
83656472|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83656473|NCT01494740|Vaccines|vaccines|mesh-list
83656474|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
83656475|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656476|NCT01494805|Ranibizumab|ranibizumab|mesh-list
83656477|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83656478|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83656479|NCT01494805|Growth Substances|growth substances|mesh-ancestor
83656480|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656481|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
83656482|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656483|NCT01494857|Adalimumab|adalimumab|mesh-list
83656484|NCT01494857|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83656485|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656486|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656487|NCT01495026|Tamsulosin|tamsulosin|mesh-list
83656488|NCT01495026|Dutasteride|dutasteride|mesh-list
83656489|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83656490|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83656491|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83656492|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
83656493|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656494|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656495|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656496|NCT01495026|Urological Agents|urological agents|mesh-ancestor
83656497|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83656498|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83656499|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656500|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
83656501|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656502|NCT01495039|Nystatin|nystatin|mesh-list
83656503|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83656504|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656505|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
83656506|NCT01495039|Ionophores|ionophores|mesh-ancestor
83656507|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656508|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656509|NCT01495104|Valproic Acid|valproic acid|mesh-list
83656510|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
83656511|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656512|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656513|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
83656514|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656515|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656516|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
83656517|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83656518|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656519|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83656520|NCT01495117|Iodine|iodine|mesh-list
83656521|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
83656522|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83656523|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
83656524|NCT01495117|Povidone|povidone|mesh-list
83656525|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83656526|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83656527|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656528|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
83656529|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
83656530|NCT01495117|Trace Elements|trace elements|mesh-ancestor
83656531|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
83656532|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656533|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
83656534|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
83656535|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
83656536|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83656537|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83656538|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656539|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656540|NCT01495169|Iloperidone|iloperidone|mesh-list
83656541|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83656542|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83656543|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656544|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656545|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83656546|NCT01495195|Selegiline|selegiline|mesh-list
83656547|NCT01495195|Donepezil|donepezil|mesh-list
83656548|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83656549|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656550|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656551|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
83656552|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656553|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656554|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
83656555|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
83656556|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83656557|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83656558|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83656559|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83656560|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83656561|NCT01495195|Protective Agents|protective agents|mesh-ancestor
83656562|NCT01495208|Aflibercept|aflibercept|mesh-list
83656563|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83656564|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83656565|NCT01495208|Growth Substances|growth substances|mesh-ancestor
83656566|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656567|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
83656568|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656569|NCT01495260|Vitamin E|vitamin e|mesh-list
83656570|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
83656571|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
83656572|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83656573|NCT01495260|Vitamins|vitamins|mesh-ancestor
83656574|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
83656575|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656576|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
83656577|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656578|NCT01495260|Expectorants|expectorants|mesh-ancestor
83656579|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
83656580|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83656581|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
83656582|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656583|NCT01495260|Protective Agents|protective agents|mesh-ancestor
83656584|NCT01495260|Antidotes|antidotes|mesh-ancestor
83656585|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
83656586|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83656587|NCT01495338|Cetirizine|cetirizine|mesh-list
83656588|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83656589|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83656590|NCT01495338|Analgesics|analgesics|mesh-ancestor
83656591|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
83656592|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656593|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656594|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656595|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656596|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83656597|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83656598|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83656599|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
83656600|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
83656601|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656602|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656603|NCT01495351|Bortezomib|bortezomib|mesh-list
83656604|NCT01495351|Veliparib|veliparib|mesh-list
83656605|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656606|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83656607|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656608|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656609|NCT01495377|Remifentanil|remifentanil|mesh-list
83656610|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83656611|NCT01495377|Narcotics|narcotics|mesh-ancestor
83656612|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656613|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656614|NCT01495377|Analgesics|analgesics|mesh-ancestor
83656615|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
83656616|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656617|NCT01495468|Hormones|hormones|mesh-list
83656618|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656619|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656620|NCT01495520|Ranolazine|ranolazine|mesh-list
83656621|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83656622|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656623|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656624|NCT01495624|Dexamethasone|dexamethasone|mesh-list
83656626|NCT01495624|Ropivacaine|ropivacaine|mesh-list
83656627|NCT01495624|Anesthetics|anesthetics|mesh-list
83656628|NCT01495624|BB 1101|bb 1101|mesh-list
83656629|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656630|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
83656631|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
83656632|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656633|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656634|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83656635|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
83656636|NCT01495624|Hormones|hormones|mesh-ancestor
83656637|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656638|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83656639|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656640|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
83656641|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656642|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656643|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
83656644|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656645|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
83656646|NCT01495715|Idebenone|idebenone|mesh-list
83656647|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
83656648|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656649|NCT01495715|Protective Agents|protective agents|mesh-ancestor
83656650|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656651|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83656652|NCT01495806|Cathartics|cathartics|mesh-ancestor
83656653|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83656654|NCT01495845|Clopidogrel|clopidogrel|mesh-list
83656655|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83656656|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83656657|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83656658|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83656659|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
83656660|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656661|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656662|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656663|NCT01495884|Lapatinib|lapatinib|mesh-list
83656664|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656665|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83656666|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656667|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656668|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
83656669|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656670|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83656671|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656672|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656673|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
83656674|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656675|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656676|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83656677|NCT01495949|Thiopental|thiopental|mesh-list
83656678|NCT01495949|Etomidate|etomidate|mesh-list
83656679|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83656680|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656681|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656682|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83656683|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
83656684|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
83656685|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
83656686|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
83656687|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
83656688|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656689|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656690|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
83656691|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83656692|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83656693|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83656694|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656695|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656696|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
83656697|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656698|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656699|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83656700|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656702|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
83656703|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
83656704|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656705|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656706|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
83656707|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656708|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83656709|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83656710|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83656711|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656712|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656713|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
83656714|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83656715|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83656716|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656717|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
83656718|NCT01496196|Coagulants|coagulants|mesh-ancestor
83656719|NCT01496261|Aspirin|aspirin|mesh-list
83656720|NCT01496261|Clopidogrel|clopidogrel|mesh-list
83656721|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83656722|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83656723|NCT01496261|Analgesics|analgesics|mesh-ancestor
83656724|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
83656725|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656726|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656727|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656728|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656729|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83656730|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83656731|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656732|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83656733|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83656734|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656735|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
83656736|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83656737|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83656738|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83656739|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
83656740|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656741|NCT01496326|Ibuprofen|ibuprofen|mesh-list
83656742|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83656743|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83656744|NCT01496326|Analgesics|analgesics|mesh-ancestor
83656745|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
83656746|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656747|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656748|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656749|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656750|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83656751|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656752|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656753|NCT01496417|Abatacept|abatacept|mesh-list
83656754|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83656755|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656756|NCT01496417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83656757|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656758|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656759|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
83656760|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656761|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656762|NCT01496443|Glimepiride|glimepiride|mesh-list
83656763|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83656764|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656765|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656766|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656767|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
83656768|NCT01496521|Aspirin|aspirin|mesh-list
83656769|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82811520|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
83656770|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83656771|NCT01496521|Analgesics|analgesics|mesh-ancestor
83656772|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
83656773|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656774|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656775|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656776|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656777|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83656778|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83656779|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656780|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83656781|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83656782|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656783|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
83656784|NCT01496534|Carboplatin|carboplatin|mesh-list
83656785|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656786|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
83656787|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83656788|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656789|NCT01496690|Pregabalin|pregabalin|mesh-list
83656790|NCT01496690|Analgesics|analgesics|mesh-ancestor
83656791|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
83656792|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656793|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656794|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
83656795|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83656796|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656797|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656798|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83656799|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83656800|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83656801|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656802|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83656803|NCT01496742|Paclitaxel|paclitaxel|mesh-list
83656804|NCT01496742|Bevacizumab|bevacizumab|mesh-list
83656805|NCT01496742|Carboplatin|carboplatin|mesh-list
83656806|NCT01496742|Pemetrexed|pemetrexed|mesh-list
83656807|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83656808|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656809|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
83656810|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
83656811|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
83656812|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656813|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83656814|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83656815|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83656816|NCT01496742|Growth Substances|growth substances|mesh-ancestor
83656817|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656818|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
83656819|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656820|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83656821|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83656822|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
83656823|NCT01496911|Levocetirizine|levocetirizine|mesh-list
83656824|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83656825|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83656826|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
83656827|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
83656828|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656829|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656830|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656831|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
83656832|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
83656833|NCT01496989|Interleukin-12|interleukin-12|mesh-list
83656834|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83656835|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
83656836|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656837|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83656838|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83656839|NCT01496989|Growth Substances|growth substances|mesh-ancestor
83656840|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
83656841|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656842|NCT01497002|Cytarabine|cytarabine|mesh-list
83656843|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811591|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
83656844|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
83656845|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656846|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656847|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
83656848|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656849|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656850|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
83656851|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656852|NCT01497041|Docetaxel|docetaxel|mesh-list
83656853|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
83656854|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656855|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83656856|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83656857|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83656858|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656859|NCT01497093|Thalidomide|thalidomide|mesh-list
83656860|NCT01497093|Dexamethasone|dexamethasone|mesh-list
83656861|NCT01497093|Bortezomib|bortezomib|mesh-list
83656862|NCT01497093|Pomalidomide|pomalidomide|mesh-list
83656863|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83656864|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
83656865|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
83656866|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656867|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656868|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83656869|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
83656870|NCT01497093|Hormones|hormones|mesh-ancestor
83656871|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83656872|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83656873|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656874|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
83656875|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83656876|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83656877|NCT01497093|Growth Substances|growth substances|mesh-ancestor
83656878|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
83656879|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656880|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
83656881|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83656882|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656883|NCT01497132|Vitamin D|vitamin d|mesh-list
83656884|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
83656885|NCT01497132|Vitamins|vitamins|mesh-ancestor
83656886|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
83656887|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656888|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83656889|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83656890|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
83656891|NCT01497145|Hematinics|hematinics|mesh-ancestor
83656892|NCT01497288|Fentanyl|fentanyl|mesh-list
83656893|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83656894|NCT01497288|Narcotics|narcotics|mesh-ancestor
83656895|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83656896|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656897|NCT01497288|Analgesics|analgesics|mesh-ancestor
83656898|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
83656899|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83656900|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83656901|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83656902|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
83656903|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
83656904|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
83656905|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
83656906|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656907|NCT01497431|Selenium|selenium|mesh-list
83656908|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
83656909|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
83656910|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656911|NCT01497431|Protective Agents|protective agents|mesh-ancestor
83656912|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656913|NCT01497431|Trace Elements|trace elements|mesh-ancestor
83656914|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
83656915|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83656916|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656917|NCT01497444|Sorafenib|sorafenib|mesh-list
83656918|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656919|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83656920|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656921|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656923|NCT01497470|Carboplatin|carboplatin|mesh-list
83656924|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83656925|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656926|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
83656927|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
83656928|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
83656929|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656930|NCT01497483|Cyclosporine|cyclosporine|mesh-list
83656931|NCT01497483|Pravastatin|pravastatin|mesh-list
83656932|NCT01497483|Cyclosporins|cyclosporins|mesh-list
83656933|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656934|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656935|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83656936|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
83656937|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656938|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
83656939|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83656940|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
83656941|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83656942|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83656943|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83656944|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83656945|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
83656946|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83656947|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83656948|NCT01497522|Vildagliptin|vildagliptin|mesh-list
83656949|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656950|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656951|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83656952|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
83656953|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83656954|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656955|NCT01497535|Insulin|insulin|mesh-list
83656956|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656957|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
83656958|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
83656959|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656960|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656961|NCT01497548|Methylphenidate|methylphenidate|mesh-list
83656962|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83656963|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656964|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83656965|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83656966|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83656967|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83656968|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
83656969|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83656970|NCT01497561|Insulin|insulin|mesh-list
83656971|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656972|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
83656973|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
83656974|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
83656975|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
83656976|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656977|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656978|NCT01497574|Insulin|insulin|mesh-list
83656979|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656980|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
83656981|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
83656982|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656983|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656984|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
83656985|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656986|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656987|NCT01497600|Insulin|insulin|mesh-list
83656988|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83656989|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
83656990|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
83656991|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
83656992|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
83656993|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83656994|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83656995|NCT01497626|Bortezomib|bortezomib|mesh-list
83656996|NCT01497626|Lapatinib|lapatinib|mesh-list
82811737|NCT00979589|Analgesics|analgesics|mesh-ancestor
83656997|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83656998|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657000|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657001|NCT01497652|Rasagiline|rasagiline|mesh-list
83657002|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83657003|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657004|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657005|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83657006|NCT01497652|Protective Agents|protective agents|mesh-ancestor
83657007|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657008|NCT01497717|Adalimumab|adalimumab|mesh-list
83657009|NCT01497717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83657010|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657011|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657012|NCT01497873|Topotecan|topotecan|mesh-list
83657013|NCT01497873|Belotecan|belotecan|mesh-list
83657014|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83657015|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83657016|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657017|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657018|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657019|NCT01497912|Atorvastatin|atorvastatin|mesh-list
83657020|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83657021|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83657022|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
83657023|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657024|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83657025|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83657026|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657027|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
83657028|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83657029|NCT01497977|Estrogens|estrogens|mesh-ancestor
83657030|NCT01497977|Hormones|hormones|mesh-ancestor
83657031|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657032|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657033|NCT01497990|Ertapenem|ertapenem|mesh-list
83657034|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657035|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657036|NCT01498003|Tirofiban|tirofiban|mesh-list
83657037|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83657038|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83657039|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657040|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83657041|NCT01498016|Busulfan|busulfan|mesh-list
83657042|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
83657043|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657044|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83657045|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
83657046|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657047|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83657048|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657049|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83657050|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
83657051|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83657052|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
83657053|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657054|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657055|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83657056|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
83657057|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
83657058|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83657059|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
83657060|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657061|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657062|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
83657063|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83657064|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83657065|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657066|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83657067|NCT01498380|Analgesics|analgesics|mesh-ancestor
83657068|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
83657069|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657070|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83657071|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83657072|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83657073|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
83657074|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657075|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657076|NCT01498406|Vitamin D|vitamin d|mesh-list
83657077|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
83657078|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
83657079|NCT01498406|Vitamins|vitamins|mesh-list
83657080|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
83657081|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657082|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83657083|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83657084|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83657085|NCT01498562|Gefitinib|gefitinib|mesh-list
83657086|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
83657087|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657088|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657089|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657090|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657091|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83657092|NCT01498718|Vaccines|vaccines|mesh-list
83657093|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
83657094|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657095|NCT01498783|Fluorouracil|fluorouracil|mesh-list
83657096|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
83657097|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657098|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83657099|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657100|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83657101|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
83657102|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657103|NCT01498796|Ketorolac|ketorolac|mesh-list
83657104|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83657105|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83657106|NCT01498796|Analgesics|analgesics|mesh-ancestor
83657107|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
83657108|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657109|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657110|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657111|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657112|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83657113|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657114|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657115|NCT01498809|Midodrine|midodrine|mesh-list
83657116|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
83657117|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
83657118|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657119|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657120|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83657121|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83657122|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83657123|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83657124|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
83657125|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657126|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657127|NCT01498835|Sunitinib|sunitinib|mesh-list
83657128|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657129|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83657130|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83657131|NCT01498835|Growth Substances|growth substances|mesh-ancestor
83657132|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657133|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
83657134|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657135|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657136|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657137|NCT01498861|Dolutegravir|dolutegravir|mesh-list
83657138|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
83657139|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83657140|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83657141|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83657142|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657143|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657144|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83657146|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
83657147|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657148|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657149|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83657150|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83657151|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657152|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83657153|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
83657154|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657155|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657156|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83657157|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83657158|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83657159|NCT01498900|Repaglinide|repaglinide|mesh-list
83657160|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657161|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657162|NCT01498913|Repaglinide|repaglinide|mesh-list
83657163|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657164|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657165|NCT01498926|Insulin|insulin|mesh-list
83657166|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83657167|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
83657168|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657169|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657170|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
83657171|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657172|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657173|NCT01499004|Tofacitinib|tofacitinib|mesh-list
83657174|NCT01499004|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83657175|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657176|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657177|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657178|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
83657179|NCT01499069|Fesoterodine|fesoterodine|mesh-list
83657180|NCT01499069|Propiverine|propiverine|mesh-list
83657181|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83657182|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83657183|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
83657184|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657185|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657186|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657187|NCT01499069|Urological Agents|urological agents|mesh-ancestor
83657188|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
83657189|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
83657190|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657191|NCT01499108|Liraglutide|liraglutide|mesh-list
83657192|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657193|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657194|NCT01499108|Incretins|incretins|mesh-ancestor
83657195|NCT01499108|Hormones|hormones|mesh-ancestor
83657196|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657197|NCT01499121|Sunitinib|sunitinib|mesh-list
83657198|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657199|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83657200|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83657201|NCT01499121|Growth Substances|growth substances|mesh-ancestor
83657202|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657203|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
83657204|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657205|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657206|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657207|NCT01499225|Doxycycline|doxycycline|mesh-list
83657208|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657209|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657210|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
83657211|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83657212|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83657213|NCT01499251|Temozolomide|temozolomide|mesh-list
83657214|NCT01499251|Macitentan|macitentan|mesh-list
83657215|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83657216|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
83657217|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657218|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657219|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83657220|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83657221|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83657222|NCT01499407|Abciximab|abciximab|mesh-list
83657223|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
83657224|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83657225|NCT01499433|Caspofungin|caspofungin|mesh-list
83657226|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
83657227|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657228|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657229|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657230|NCT01499446|Fluticasone|fluticasone|mesh-list
83657231|NCT01499446|Xhance|xhance|mesh-list
83657232|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657233|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83657234|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
83657235|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657236|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657237|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83657238|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
83657239|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83657240|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83657241|NCT01499485|Acetazolamide|acetazolamide|mesh-list
83657242|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
83657243|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83657244|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657245|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657246|NCT01499485|Diuretics|diuretics|mesh-ancestor
83657247|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
83657248|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657249|NCT01499589|Anesthetics|anesthetics|mesh-list
83657250|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83657251|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657252|NCT01499602|Norethindrone|norethindrone|mesh-list
83657253|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
83657254|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83657255|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
83657256|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657257|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657258|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83657259|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83657260|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83657261|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83657262|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
83657263|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83657264|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83657265|NCT01499641|Prednisolone|prednisolone|mesh-list
83657266|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
83657267|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83657268|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
83657269|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657270|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
83657271|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
83657272|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657273|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657274|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83657275|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
83657276|NCT01499641|Hormones|hormones|mesh-ancestor
83657277|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657278|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83657279|NCT01499641|Protective Agents|protective agents|mesh-ancestor
83657280|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83657281|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657282|NCT01499693|Pantoprazole|pantoprazole|mesh-list
83657283|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83657284|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83657285|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83657286|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657287|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657288|NCT01499758|Atorvastatin|atorvastatin|mesh-list
83657289|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83657290|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83657291|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
83657292|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657293|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83657294|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83657295|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657297|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83657298|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83657299|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
83657300|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657301|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83657302|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83657303|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657304|NCT01499875|Penicillin V|penicillin v|mesh-list
83657305|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657306|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657307|NCT01500005|Vitamin D|vitamin d|mesh-list
83657308|NCT01500005|Vitamins|vitamins|mesh-ancestor
83657309|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
83657310|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657311|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83657312|NCT01500018|Phentermine|phentermine|mesh-list
83657313|NCT01500018|Ketamine|ketamine|mesh-list
83657314|NCT01500018|Analgesics|analgesics|mesh-ancestor
83657315|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
83657316|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657317|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657318|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83657319|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83657320|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
83657321|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
83657322|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83657323|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83657324|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83657325|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657326|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657327|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83657328|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
83657329|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83657330|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
83657331|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
83657332|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
83657333|NCT01500070|Everolimus|everolimus|mesh-list
83657334|NCT01500070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83657335|NCT01500070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657336|NCT01500070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657337|NCT01500070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657338|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83657339|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
83657340|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657341|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657342|NCT01500161|Cytarabine|cytarabine|mesh-list
83657343|NCT01500161|Fludarabine|fludarabine|mesh-list
83657344|NCT01500161|Etoposide|etoposide|mesh-list
83657345|NCT01500161|Melphalan|melphalan|mesh-list
83657346|NCT01500161|Busulfan|busulfan|mesh-list
83657347|NCT01500161|Carmustine|carmustine|mesh-list
83657348|NCT01500161|Clofarabine|clofarabine|mesh-list
83657349|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657350|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83657351|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
83657352|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657353|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83657354|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
83657355|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657356|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83657357|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83657358|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83657359|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657360|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
83657361|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657362|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83657363|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
83657364|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83657365|NCT01500408|Interferons|interferons|mesh-list
83657366|NCT01500408|Interferon-beta|interferon-beta|mesh-list
83657367|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
83657368|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657369|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
83657370|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657371|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
83657372|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657373|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83657374|NCT01500473|Desogestrel|desogestrel|mesh-list
83657375|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83657376|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83657377|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83657378|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
83657379|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657380|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657381|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83657382|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83657383|NCT01500473|Progestins|progestins|mesh-ancestor
83657385|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657386|NCT01500538|Vorinostat|vorinostat|mesh-list
83657387|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657388|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83657389|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657390|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657391|NCT01500577|Nimesulide|nimesulide|mesh-list
83657392|NCT01500577|Simvastatin|simvastatin|mesh-list
83657393|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83657394|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83657395|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
83657396|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657397|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83657398|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83657399|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657400|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83657401|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83657402|NCT01500577|Analgesics|analgesics|mesh-ancestor
83657403|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
83657404|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657405|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657406|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657407|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657408|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83657409|NCT01500590|Ramipril|ramipril|mesh-list
83657410|NCT01500590|Irbesartan|irbesartan|mesh-list
83657411|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83657412|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
83657413|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657414|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657415|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83657416|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83657417|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83657418|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
83657419|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
83657420|NCT01500785|Simendan|simendan|mesh-list
83657421|NCT01500785|Vitamins|vitamins|mesh-ancestor
83657422|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
83657423|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657424|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
83657425|NCT01500785|Hematinics|hematinics|mesh-ancestor
83657426|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83657427|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
83657428|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83657429|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83657430|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657431|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657432|NCT01500785|Protective Agents|protective agents|mesh-ancestor
83657433|NCT01500824|Crizotinib|crizotinib|mesh-list
83657434|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657435|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657436|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657437|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657438|NCT01500837|Levofloxacin|levofloxacin|mesh-list
83657439|NCT01500837|Ofloxacin|ofloxacin|mesh-list
83657440|NCT01500837|Rifampin|rifampin|mesh-list
83657441|NCT01500837|Clindamycin|clindamycin|mesh-list
83657442|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
83657443|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
83657444|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83657445|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657446|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657447|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83657448|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83657449|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657450|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657451|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657452|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83657453|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83657454|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83657455|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
83657456|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
83657457|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83657458|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83657459|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83657460|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83657461|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83657462|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83657463|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83657464|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83657466|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83657467|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
83657468|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
83657469|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
83657470|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
83657471|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
83657472|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657473|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657474|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83657475|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83657476|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83657477|NCT01500863|Estradiol|estradiol|mesh-list
83657478|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83657479|NCT01500863|Progesterone|progesterone|mesh-list
83657480|NCT01500863|Estrogens|estrogens|mesh-ancestor
83657481|NCT01500863|Hormones|hormones|mesh-ancestor
83657482|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657483|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657484|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83657485|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
83657486|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657487|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83657488|NCT01500863|Progestins|progestins|mesh-ancestor
83657489|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
83657490|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83657491|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657492|NCT01500915|Ranibizumab|ranibizumab|mesh-list
83657493|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83657494|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83657495|NCT01500915|Growth Substances|growth substances|mesh-ancestor
83657496|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657497|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
83657498|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657499|NCT01500928|Insulin|insulin|mesh-list
83657500|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657501|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657502|NCT01500980|Chloroquine|chloroquine|mesh-list
83657503|NCT01500980|Primaquine|primaquine|mesh-list
83657504|NCT01500980|Amebicides|amebicides|mesh-ancestor
83657505|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83657506|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83657507|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657508|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
83657509|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657510|NCT01500993|Fluorouracil|fluorouracil|mesh-list
83657511|NCT01500993|Capecitabine|capecitabine|mesh-list
83657512|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
83657513|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657514|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83657515|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657516|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83657517|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
83657518|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657519|NCT01501032|Pancrelipase|pancrelipase|mesh-list
83657520|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83657521|NCT01501084|Exenatide|exenatide|mesh-list
82812266|NCT00988403|Levan|levan|mesh-list
83657522|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83657523|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657524|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83657525|NCT01501084|Incretins|incretins|mesh-ancestor
83657526|NCT01501084|Hormones|hormones|mesh-ancestor
83657527|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657528|NCT01501123|Midazolam|midazolam|mesh-list
83657529|NCT01501123|Haloperidol|haloperidol|mesh-list
83657530|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
83657531|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83657532|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83657533|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83657534|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657535|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83657536|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83657537|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83657538|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83657539|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
83657540|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
83657541|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
83657542|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
83657543|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657544|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657545|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
83657546|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
83657547|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657548|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83657549|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83657550|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83657551|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
83657552|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83657553|NCT01501136|Dexamethasone|dexamethasone|mesh-list
83657554|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
83657555|NCT01501136|Cisplatin|cisplatin|mesh-list
83657556|NCT01501136|Gemcitabine|gemcitabine|mesh-list
83657557|NCT01501136|Etoposide|etoposide|mesh-list
83657558|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
83657559|NCT01501136|Ifosfamide|ifosfamide|mesh-list
83657560|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
83657561|NCT01501136|Pegaspargase|pegaspargase|mesh-list
83657562|NCT01501136|Asparaginase|asparaginase|mesh-list
83657563|NCT01501136|BB 1101|bb 1101|mesh-list
83657564|NCT01501136|Mesna|mesna|mesh-list
83657565|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657566|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
83657567|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
83657568|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657569|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657570|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83657571|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
83657572|NCT01501136|Hormones|hormones|mesh-ancestor
83657573|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657574|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83657575|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657576|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
83657577|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657578|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657579|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83657580|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
83657581|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83657582|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83657583|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83657584|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83657585|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
83657586|NCT01501136|Protective Agents|protective agents|mesh-ancestor
83657587|NCT01501149|Dexamethasone|dexamethasone|mesh-list
83657588|NCT01501149|Gemcitabine|gemcitabine|mesh-list
83657589|NCT01501149|Etoposide|etoposide|mesh-list
83657590|NCT01501149|Pegaspargase|pegaspargase|mesh-list
83657591|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657592|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
83657593|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
83657594|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657595|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657596|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83657597|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
83657598|NCT01501149|Hormones|hormones|mesh-ancestor
83657599|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657600|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83657601|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657602|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83657604|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657605|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83657606|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83657607|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83657608|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657609|NCT01501214|Atosiban|atosiban|mesh-list
83657610|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
83657611|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657612|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657613|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
83657614|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657615|NCT01501253|Amlodipine|amlodipine|mesh-list
83657616|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83657617|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83657618|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83657619|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657620|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83657621|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657622|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83657623|NCT01501344|Calcium|calcium|mesh-list
83657624|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83657625|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657626|NCT01501370|Dexamethasone|dexamethasone|mesh-list
83657627|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
83657628|NCT01501370|Lenalidomide|lenalidomide|mesh-list
83657629|NCT01501370|Vorinostat|vorinostat|mesh-list
83657630|NCT01501370|BB 1101|bb 1101|mesh-list
83657631|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657632|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
83657633|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
83657634|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657635|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657636|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83657637|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
83657638|NCT01501370|Hormones|hormones|mesh-ancestor
83657639|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657640|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83657641|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657642|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
83657643|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657644|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657645|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
83657646|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83657647|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83657648|NCT01501370|Growth Substances|growth substances|mesh-ancestor
83657649|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83657650|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83657651|NCT01501396|Megestrol|megestrol|mesh-list
83657652|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
83657653|NCT01501396|Mirtazapine|mirtazapine|mesh-list
83657654|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
83657655|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83657656|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83657657|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
83657658|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
83657659|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657660|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657661|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657662|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83657663|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83657664|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83657665|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83657666|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83657667|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83657668|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
83657669|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83657670|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83657671|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
83657672|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83657673|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83657674|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83657675|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83657676|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
83657677|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657678|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83657679|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83657680|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83657681|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657682|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
83657683|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83657684|NCT01501422|Estrogens|estrogens|mesh-list
83657685|NCT01501422|Hormones|hormones|mesh-ancestor
83657686|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657687|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657688|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
83657689|NCT01501435|Fenofibrate|fenofibrate|mesh-list
83657690|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83657691|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83657692|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
83657693|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657694|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83657695|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83657696|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83657697|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
83657698|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83657699|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83657700|NCT01501448|Estradiol|estradiol|mesh-list
83657701|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83657702|NCT01501448|Estrogens|estrogens|mesh-ancestor
83657703|NCT01501448|Hormones|hormones|mesh-ancestor
83657704|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657705|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657706|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83657707|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
83657708|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657709|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83657710|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83657711|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83657712|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83657713|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83657714|NCT01501487|Paclitaxel|paclitaxel|mesh-list
83657715|NCT01501487|Docetaxel|docetaxel|mesh-list
83657716|NCT01501487|Trastuzumab|trastuzumab|mesh-list
83657717|NCT01501487|Pertuzumab|pertuzumab|mesh-list
83657718|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83657719|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657720|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
83657721|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
83657722|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
83657723|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657724|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83657725|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83657726|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83657727|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657728|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657729|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83657730|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83657731|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657732|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
83657733|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657734|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
83657735|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
83657736|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
83657737|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83657738|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
83657739|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
83657740|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657741|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657742|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657743|NCT01501669|Capecitabine|capecitabine|mesh-list
83657744|NCT01501669|Irinotecan|irinotecan|mesh-list
83657745|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83657746|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
83657747|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657748|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657749|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83657750|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83657751|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657752|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
83657753|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83657754|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83657755|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83657756|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657757|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83657758|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83657759|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
83657760|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657761|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657762|NCT01501708|Voriconazole|voriconazole|mesh-list
83657763|NCT01501708|Amphotericin B|amphotericin b|mesh-list
83657764|NCT01501708|Caspofungin|caspofungin|mesh-list
83657765|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
83657766|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657767|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83657768|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83657769|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657770|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657771|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83657772|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
83657773|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657774|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657775|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83657776|NCT01501708|Amebicides|amebicides|mesh-ancestor
83657777|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83657778|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83657779|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657780|NCT01501747|Acetaminophen|acetaminophen|mesh-list
83657781|NCT01501747|Cephalexin|cephalexin|mesh-list
83657782|NCT01501747|Ibuprofen|ibuprofen|mesh-list
83657783|NCT01501747|Caffeine|caffeine|mesh-list
83657784|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83657785|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83657786|NCT01501747|Analgesics|analgesics|mesh-ancestor
83657787|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
83657788|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657789|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657790|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657791|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657792|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83657793|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657794|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657795|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
83657796|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83657797|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83657798|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83657799|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83657800|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
83657801|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657802|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657803|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657804|NCT01501760|Bevacizumab|bevacizumab|mesh-list
83657805|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83657806|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657807|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83657808|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83657809|NCT01501760|Growth Substances|growth substances|mesh-ancestor
83657810|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657811|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
83657812|NCT01501786|Ketamine|ketamine|mesh-list
83657813|NCT01501786|Propofol|propofol|mesh-list
83657814|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83657815|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83657816|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657817|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83657818|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
83657819|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
83657820|NCT01501786|Analgesics|analgesics|mesh-ancestor
83657821|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
83657822|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657823|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83657824|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83657825|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83657826|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657827|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657828|NCT01501799|Adapalene|adapalene|mesh-list
83657829|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83657830|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83657831|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83657832|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83657833|NCT01501799|Analgesics|analgesics|mesh-ancestor
83657834|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
83657835|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657836|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657837|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83657838|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657839|NCT01501890|Algestone|algestone|mesh-list
83657840|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83657841|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83657842|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83657843|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
83657844|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657845|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657846|NCT01501890|Progestins|progestins|mesh-ancestor
83657847|NCT01501890|Hormones|hormones|mesh-ancestor
83657848|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83657849|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83657850|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83657851|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
83657852|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83657853|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83657854|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83657855|NCT01501916|Vitamin D|vitamin d|mesh-list
83657856|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
83657857|NCT01501916|Vitamins|vitamins|mesh-ancestor
83657858|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
83657859|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657860|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83657861|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83657862|NCT01501942|Glycine|glycine|mesh-list
83657863|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
83657864|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657865|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657866|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657867|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
83657868|NCT01501968|Colistin|colistin|mesh-list
83657869|NCT01501968|Vitamins|vitamins|mesh-ancestor
83657870|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
83657871|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657872|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
83657873|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657874|NCT01501968|Protective Agents|protective agents|mesh-ancestor
83657875|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657876|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657877|NCT01502020|Imiquimod|imiquimod|mesh-list
83657878|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83657879|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
83657880|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657881|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657882|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
83657883|NCT01502046|Dronabinol|dronabinol|mesh-list
83657884|NCT01502046|Cannabidiol|cannabidiol|mesh-list
83657885|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
83657886|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
83657887|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657888|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83657889|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83657890|NCT01502046|Analgesics|analgesics|mesh-ancestor
83657891|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
83657892|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83657893|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83657894|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83657895|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83657896|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657897|NCT01502046|Hormones|hormones|mesh-ancestor
82812636|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
83657898|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83657899|NCT01502202|Pemetrexed|pemetrexed|mesh-list
83657900|NCT01502202|Gefitinib|gefitinib|mesh-list
83657901|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657902|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657903|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657904|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83657905|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83657906|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83657907|NCT01502241|Temozolomide|temozolomide|mesh-list
83657908|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83657909|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
83657910|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657911|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657912|NCT01502267|Rituximab|rituximab|mesh-list
83657913|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83657914|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83657915|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657916|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
83657917|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657918|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657919|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
83657920|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83657921|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
83657922|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657923|NCT01502280|Protective Agents|protective agents|mesh-ancestor
83657924|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657925|NCT01502280|Vitamins|vitamins|mesh-ancestor
83657926|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
83657927|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83657928|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
83657929|NCT01502358|Vaccines|vaccines|mesh-list
83657930|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
83657931|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657932|NCT01502592|Ipilimumab|ipilimumab|mesh-list
83657933|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83657934|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657935|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83657936|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657937|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83657938|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83657939|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83657940|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
83657941|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83657942|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
83657943|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657944|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657945|NCT01502774|Cyclosporine|cyclosporine|mesh-list
83657946|NCT01502774|Cyclosporins|cyclosporins|mesh-list
83657947|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657948|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657949|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83657950|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
83657951|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657952|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
83657953|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657954|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
83657955|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83657956|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83657957|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
83657958|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657959|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83657960|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83657961|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657962|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657963|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
83657964|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
83657965|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
83657966|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657967|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657968|NCT01502904|Sirolimus|sirolimus|mesh-list
83657969|NCT01502904|Pravastatin|pravastatin|mesh-list
83657970|NCT01502904|Pitavastatin|pitavastatin|mesh-list
83657971|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83657972|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83657973|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83657974|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83657975|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
83657976|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83657977|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
83657978|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83657979|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657980|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657981|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83657982|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83657983|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
83657984|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83657985|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83657986|NCT01502943|Atorvastatin|atorvastatin|mesh-list
83657987|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83657988|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83657989|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83657990|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83657991|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
83657992|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83657993|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83657994|NCT01503008|Metformin|metformin|mesh-list
83657995|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83657996|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83657997|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83657998|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83657999|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658000|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658001|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658002|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
83658003|NCT01503060|Lidocaine|lidocaine|mesh-list
83658004|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
83658005|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
83658006|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658007|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658008|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
83658009|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658010|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83658011|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83658012|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83658013|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658014|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658015|NCT01503216|Vitamin D|vitamin d|mesh-list
83658016|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
83658017|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
83658018|NCT01503216|Vitamins|vitamins|mesh-ancestor
83658019|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
83658020|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658021|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83658022|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83658023|NCT01503242|Cyclosporine|cyclosporine|mesh-list
83658024|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
83658025|NCT01503242|Fludarabine|fludarabine|mesh-list
83658026|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
83658027|NCT01503242|Antibodies|antibodies|mesh-list
83658028|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83658029|NCT01503242|Cyclosporins|cyclosporins|mesh-list
83658030|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
83658031|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658032|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658033|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83658034|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
83658035|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658036|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83658037|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658038|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
83658039|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83658040|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83658041|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658042|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83658043|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83658044|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83658045|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
83658046|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83658047|NCT01503359|Glycine|glycine|mesh-list
83658048|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
83658049|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658050|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658051|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658052|NCT01503372|Leucovorin|leucovorin|mesh-list
83658053|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
83658054|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658055|NCT01503372|Antidotes|antidotes|mesh-ancestor
83658056|NCT01503372|Protective Agents|protective agents|mesh-ancestor
83658057|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658058|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
83658059|NCT01503372|Vitamins|vitamins|mesh-ancestor
83658060|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
83658061|NCT01503385|Celecoxib|celecoxib|mesh-list
83658062|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83658063|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83658064|NCT01503385|Analgesics|analgesics|mesh-ancestor
83658065|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
83658066|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658067|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658068|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83658069|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658070|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83658071|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83658072|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658073|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658074|NCT01503398|Olanzapine|olanzapine|mesh-list
83658075|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
83658076|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
83658077|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658078|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658079|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658080|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83658081|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83658082|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658083|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658084|NCT01503398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83658085|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83658086|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658087|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658088|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658089|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
83658090|NCT01503424|Olanzapine|olanzapine|mesh-list
83658091|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
83658092|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
83658093|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658094|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658095|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658096|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83658097|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83658098|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658099|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658100|NCT01503424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83658101|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83658102|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658103|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658104|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658105|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
83658106|NCT01503437|Olanzapine|olanzapine|mesh-list
83658107|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
83658108|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
83658109|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658110|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658111|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658112|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83658113|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83658114|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658115|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658116|NCT01503437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83658117|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83658118|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658119|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658120|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658121|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
83658123|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
83658124|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
83658125|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658126|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658127|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658128|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83658129|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83658130|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658131|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658132|NCT01503450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83658133|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83658134|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658135|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658136|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658137|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
83658138|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
83658139|NCT01503502|Flumatinib|flumatinib|mesh-list
83658140|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658141|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83658142|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658143|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658144|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
83658145|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83658146|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83658147|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83658148|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658149|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658150|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658151|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658152|NCT01503580|Urological Agents|urological agents|mesh-ancestor
83658153|NCT01503593|Calcium|calcium|mesh-list
83658154|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83658155|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658156|NCT01503658|Aspirin|aspirin|mesh-list
83658157|NCT01503658|Clopidogrel|clopidogrel|mesh-list
83658158|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83658159|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83658160|NCT01503658|Analgesics|analgesics|mesh-ancestor
83658161|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
83658162|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658163|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658164|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83658165|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658166|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83658167|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83658168|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658169|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83658170|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83658171|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658172|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
83658173|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83658174|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83658175|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83658176|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
83658177|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658178|NCT01503671|Atorvastatin|atorvastatin|mesh-list
83658179|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83658180|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83658181|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
83658182|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658183|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83658184|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83658185|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658186|NCT01503736|Citric Acid|citric acid|mesh-list
83658187|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
83658188|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
83658189|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
83658190|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83658191|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
83658192|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
83658193|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658194|NCT01503736|Hematinics|hematinics|mesh-ancestor
83658195|NCT01503788|Midazolam|midazolam|mesh-list
83658196|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83658197|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83658198|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658199|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658200|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83658201|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83658202|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658203|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83658204|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
83658206|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
83658207|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
83658208|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658209|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658210|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
83658211|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
83658212|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83658213|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
83658214|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658215|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658216|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83658217|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
83658218|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83658219|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
83658220|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658221|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658222|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
83658223|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
83658224|NCT01503801|Protective Agents|protective agents|mesh-ancestor
83658225|NCT01503905|Tamoxifen|tamoxifen|mesh-list
83658226|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
83658227|NCT01503905|Docetaxel|docetaxel|mesh-list
83658228|NCT01503905|Trastuzumab|trastuzumab|mesh-list
83658229|NCT01503905|Epirubicin|epirubicin|mesh-list
83658230|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83658231|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
83658232|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658233|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658234|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83658235|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
83658236|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658237|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658238|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83658239|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
83658240|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
83658241|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
83658242|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83658243|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83658244|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83658245|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83658246|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658247|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83658248|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
83658249|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658250|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83658251|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83658252|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83658253|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83658254|NCT01503918|Valacyclovir|valacyclovir|mesh-list
83658255|NCT01503918|Acyclovir|acyclovir|mesh-list
83658256|NCT01503918|Valganciclovir|valganciclovir|mesh-list
83658257|NCT01503918|Ganciclovir|ganciclovir|mesh-list
83658258|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83658259|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
83658260|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83658261|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83658262|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658263|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658264|NCT01503983|Capecitabine|capecitabine|mesh-list
83658265|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
83658266|NCT01503983|Trastuzumab|trastuzumab|mesh-list
83658267|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83658268|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
83658269|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658270|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658271|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83658272|NCT01504074|Triamcinolone|triamcinolone|mesh-list
83658273|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83658274|NCT01504074|Levobunolol|levobunolol|mesh-list
83658275|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83658276|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83658277|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
83658278|NCT01504074|Hormones|hormones|mesh-ancestor
83658279|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658280|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658281|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658282|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658283|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83658284|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83658285|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
83658286|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658287|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
83658288|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
83658289|NCT01504126|Propranolol|propranolol|mesh-list
83658290|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83658291|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83658292|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
83658293|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658294|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658295|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658296|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83658297|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83658298|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
83658299|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83658300|NCT01504139|Estradiol|estradiol|mesh-list
83658301|NCT01504139|Progesterone|progesterone|mesh-list
83658302|NCT01504139|Estrogens|estrogens|mesh-ancestor
83658303|NCT01504139|Hormones|hormones|mesh-ancestor
83658304|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658305|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658306|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83658307|NCT01504139|Progestins|progestins|mesh-ancestor
83658308|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83658309|NCT01504178|Levodopa|levodopa|mesh-list
83658310|NCT01504178|Apomorphine|apomorphine|mesh-list
83658311|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83658312|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83658313|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83658314|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658315|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658316|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658317|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658318|NCT01504178|Analgesics|analgesics|mesh-ancestor
83658319|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
83658320|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658321|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
83658322|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658323|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
83658324|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83658325|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83658326|NCT01504178|Emetics|emetics|mesh-ancestor
83658327|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
83658328|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658329|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
83658330|NCT01504256|Leucovorin|leucovorin|mesh-list
83658331|NCT01504256|Docetaxel|docetaxel|mesh-list
83658332|NCT01504256|Fluorouracil|fluorouracil|mesh-list
83658333|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
83658334|NCT01504256|Catumaxomab|catumaxomab|mesh-list
83658335|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83658336|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
83658337|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658338|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
83658339|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
83658340|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
83658341|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658342|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
83658343|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82813088|NCT00266032|Drospirenone|drospirenone|mesh-list
83658344|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83658345|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
83658346|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658347|NCT01504256|Antidotes|antidotes|mesh-ancestor
83658348|NCT01504256|Protective Agents|protective agents|mesh-ancestor
83658349|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
83658350|NCT01504256|Vitamins|vitamins|mesh-ancestor
83658351|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
83658352|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658353|NCT01504282|Mitomycins|mitomycins|mesh-list
83658354|NCT01504282|Mitomycin|mitomycin|mesh-list
83658355|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83658356|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658357|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
83658358|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658359|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83658360|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658361|NCT01504295|Metadoxine|metadoxine|mesh-list
83658362|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83658363|NCT01504321|Moxonidine|moxonidine|mesh-list
83658364|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83658365|NCT01504334|Pirfenidone|pirfenidone|mesh-list
83658366|NCT01504334|Analgesics|analgesics|mesh-ancestor
83658367|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
83658368|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658369|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658370|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83658371|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83658372|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83658373|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658374|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658375|NCT01504347|Vaccines|vaccines|mesh-list
83658376|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
83658377|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658378|NCT01504386|Ropivacaine|ropivacaine|mesh-list
83658379|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
83658380|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
83658381|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658382|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658383|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
83658384|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658385|NCT01504490|Bexarotene|bexarotene|mesh-list
83658386|NCT01504490|Efatutazone|efatutazone|mesh-list
83658387|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658388|NCT01504503|Donepezil|donepezil|mesh-list
83658389|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83658390|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658391|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658392|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658393|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658394|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658395|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
83658396|NCT01504516|Donepezil|donepezil|mesh-list
83658397|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83658398|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658399|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658400|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658401|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658402|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658403|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
83658404|NCT01504542|Vaccines|vaccines|mesh-list
83658405|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
83658406|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658407|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83658408|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
83658409|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83658410|NCT01504620|Insulin|insulin|mesh-list
83658411|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83658412|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658413|NCT01504646|Lyprinol|lyprinol|mesh-list
83658414|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83658415|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83658416|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658417|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658418|NCT01504659|Ketamine|ketamine|mesh-list
83658419|NCT01504659|Analgesics|analgesics|mesh-ancestor
83658420|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
83658421|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658422|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658423|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82813155|NCT00445692|Ichthammol|ichthammol|mesh-list
83658424|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83658425|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
83658426|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
83658427|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658428|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83658429|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83658430|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658431|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658432|NCT01504724|Bevacizumab|bevacizumab|mesh-list
83658433|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83658434|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658435|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83658436|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83658437|NCT01504724|Growth Substances|growth substances|mesh-ancestor
83658438|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658439|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
83658441|NCT01504776|Panobinostat|panobinostat|mesh-list
83658442|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658443|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83658444|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658445|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658446|NCT01504828|Ramipril|ramipril|mesh-list
83658447|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83658448|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
83658449|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658450|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658451|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83658452|NCT01504906|Cyclosporine|cyclosporine|mesh-list
83658453|NCT01504906|Ticagrelor|ticagrelor|mesh-list
83658454|NCT01504906|Cyclosporins|cyclosporins|mesh-list
83658455|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658456|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658457|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83658458|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
83658459|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658460|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
83658461|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83658462|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
83658463|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658464|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83658465|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83658466|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83658467|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83658468|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83658469|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
83658470|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658471|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
83658472|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658473|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83658474|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658475|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658476|NCT01505049|Vaccines|vaccines|mesh-list
83658477|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
83658478|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658479|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83658480|NCT01505088|Dexamethasone|dexamethasone|mesh-list
83658481|NCT01505088|Prednisolone|prednisolone|mesh-list
83658482|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83658483|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
83658484|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83658485|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
83658486|NCT01505088|Citric Acid|citric acid|mesh-list
83658487|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
83658488|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83658489|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83658490|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83658491|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
83658492|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83658493|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83658494|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
83658495|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
83658496|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658497|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658498|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658499|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
83658500|NCT01505088|Hormones|hormones|mesh-ancestor
83658501|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658502|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83658503|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658504|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
83658505|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83658506|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
83658507|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
83658508|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658509|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83658510|NCT01505088|Protective Agents|protective agents|mesh-ancestor
83658511|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83658512|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83658513|NCT01505127|Amoxicillin|amoxicillin|mesh-list
83658514|NCT01505127|Clarithromycin|clarithromycin|mesh-list
83658515|NCT01505127|Lansoprazole|lansoprazole|mesh-list
83658516|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
83658517|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83658518|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83658519|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83658520|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658521|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658522|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83658523|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83658524|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83658525|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658526|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83658527|NCT01505218|Propofol|propofol|mesh-list
83658528|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83658529|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658530|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658531|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83658532|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
83658533|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
83658534|NCT01505231|Vasopressins|vasopressins|mesh-list
83658535|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
83658536|NCT01505231|Norepinephrine|norepinephrine|mesh-list
83658537|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83658538|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83658539|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
83658540|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658541|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658542|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658543|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
83658544|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
83658545|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658546|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83658547|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
83658548|NCT01505231|Coagulants|coagulants|mesh-ancestor
83658549|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83658550|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
83658551|NCT01505283|Lidocaine|lidocaine|mesh-list
83658552|NCT01505283|Sufentanil|sufentanil|mesh-list
83658553|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
83658554|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
83658555|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658556|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658557|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
83658558|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658559|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83658560|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83658561|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83658562|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658563|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658564|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83658565|NCT01505283|Narcotics|narcotics|mesh-ancestor
83658566|NCT01505283|Analgesics|analgesics|mesh-ancestor
83658567|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83658568|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83658569|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
83658570|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83658571|NCT01505413|Gemcitabine|gemcitabine|mesh-list
83658572|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
83658573|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83658574|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83658575|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
83658576|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658577|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658578|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83658579|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658580|NCT01505426|Metformin|metformin|mesh-list
83658581|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
83658582|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83658583|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658584|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83658585|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658586|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
83658587|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83658588|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83658589|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658590|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658591|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658592|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658593|NCT01505439|Urological Agents|urological agents|mesh-ancestor
83658594|NCT01505504|Mirtazapine|mirtazapine|mesh-list
83658595|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
83658596|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658597|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83658598|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
83658599|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
83658600|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658601|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658602|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658603|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83658604|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83658605|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658606|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83658607|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83658608|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83658609|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
83658610|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83658611|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83658612|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
83658613|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83658614|NCT01505777|Mosapride|mosapride|mesh-list
83658615|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658616|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83658617|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
83658618|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658619|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658620|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658621|NCT01505790|Clopidogrel|clopidogrel|mesh-list
83658622|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83658623|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83658624|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83658625|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83658626|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83658627|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
83658628|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658629|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658630|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658631|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83658632|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
83658633|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658634|NCT01505894|BI 409306|bi 409306|mesh-list
83658635|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83658636|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658637|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658638|NCT01505920|Lidocaine|lidocaine|mesh-list
83658639|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
83658640|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
83658641|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658642|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658643|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
83658644|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658645|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82813378|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658646|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83658648|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658649|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658650|NCT01505946|Thrombin|thrombin|mesh-list
83658651|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
83658652|NCT01505946|Coagulants|coagulants|mesh-ancestor
83658653|NCT01505998|Amlodipine|amlodipine|mesh-list
83658654|NCT01505998|Benazepril|benazepril|mesh-list
83658655|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83658656|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83658657|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658658|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658659|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83658660|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658661|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
83658662|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83658663|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83658664|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658665|NCT01506011|Amlodipine|amlodipine|mesh-list
83658666|NCT01506011|Benazepril|benazepril|mesh-list
83658667|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83658668|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83658669|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658670|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658671|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83658672|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658673|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
83658674|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83658675|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
83658676|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658677|NCT01506024|Tacrine|tacrine|mesh-list
83658678|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83658679|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658680|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658681|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658682|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658683|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658684|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83658685|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
83658686|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658687|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
83658688|NCT01506037|Desloratadine|desloratadine|mesh-list
83658689|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83658690|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658691|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658692|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658693|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658694|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83658695|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83658696|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
83658697|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
83658698|NCT01506050|Desloratadine|desloratadine|mesh-list
83658699|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83658700|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658701|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658702|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658703|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658704|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83658705|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83658706|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
83658707|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
83658708|NCT01506063|Levocetirizine|levocetirizine|mesh-list
83658709|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83658710|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83658711|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
83658712|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
83658713|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658714|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658715|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658716|NCT01506076|Levocetirizine|levocetirizine|mesh-list
82813451|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83658717|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83658718|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83658719|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
83658720|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
83658721|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658722|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658723|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658724|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83658725|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
83658726|NCT01506115|Trioxsalen|trioxsalen|mesh-list
83658727|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658728|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
83658729|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83658730|NCT01506167|Leucovorin|leucovorin|mesh-list
83658731|NCT01506167|Folic Acid|folic acid|mesh-list
83658732|NCT01506167|Bevacizumab|bevacizumab|mesh-list
83658733|NCT01506167|Fluorouracil|fluorouracil|mesh-list
83658734|NCT01506167|Capecitabine|capecitabine|mesh-list
83658735|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
83658736|NCT01506167|Irinotecan|irinotecan|mesh-list
83658737|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
83658738|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83658739|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658740|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83658741|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83658742|NCT01506167|Growth Substances|growth substances|mesh-ancestor
83658743|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658744|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83658745|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
83658746|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658747|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83658748|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83658749|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
83658750|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83658751|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83658752|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658753|NCT01506167|Antidotes|antidotes|mesh-ancestor
83658754|NCT01506167|Protective Agents|protective agents|mesh-ancestor
83658755|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
83658756|NCT01506167|Vitamins|vitamins|mesh-ancestor
83658757|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
83658758|NCT01506167|Hematinics|hematinics|mesh-ancestor
83658759|NCT01506336|Sunitinib|sunitinib|mesh-list
83658760|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658761|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83658762|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83658763|NCT01506336|Growth Substances|growth substances|mesh-ancestor
83658764|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658765|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
83658766|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83658767|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658768|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658769|NCT01506388|Misoprostol|misoprostol|mesh-list
83658770|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83658771|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
83658772|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83658773|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658774|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83658775|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658776|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
83658777|NCT01506414|Rituximab|rituximab|mesh-list
83658778|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83658779|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658780|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
83658781|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658782|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658783|NCT01506505|Aspirin|aspirin|mesh-list
83658784|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83658785|NCT01506505|Lisinopril|lisinopril|mesh-list
83658786|NCT01506505|Simvastatin|simvastatin|mesh-list
83658787|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83658788|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83658789|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
82813528|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83658790|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658791|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83658792|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83658793|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658794|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83658795|NCT01506505|Diuretics|diuretics|mesh-ancestor
83658796|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
83658797|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658798|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83658799|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83658800|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83658801|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83658802|NCT01506505|Analgesics|analgesics|mesh-ancestor
83658803|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
83658804|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658805|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83658806|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83658807|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83658808|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83658809|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83658810|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83658811|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
83658812|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83658813|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
83658814|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83658815|NCT01506505|Protective Agents|protective agents|mesh-ancestor
83658816|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
83658817|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658818|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
83658819|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658820|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658821|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83658822|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
83658823|NCT01506557|Vitamin D|vitamin d|mesh-list
83658824|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83658825|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658826|NCT01506557|Vitamins|vitamins|mesh-ancestor
83658827|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
83658828|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83658829|NCT01506570|Vaccines|vaccines|mesh-list
83658830|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
83658831|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658832|NCT01506622|Fentanyl|fentanyl|mesh-list
83658833|NCT01506622|Propofol|propofol|mesh-list
83658834|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83658835|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658836|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658837|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83658838|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
83658839|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
83658840|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83658841|NCT01506622|Narcotics|narcotics|mesh-ancestor
83658842|NCT01506622|Analgesics|analgesics|mesh-ancestor
83658843|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
83658844|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658845|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83658846|NCT01506635|Timolol|timolol|mesh-list
83658847|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83658848|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83658849|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
83658850|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658851|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658852|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658853|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83658854|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83658855|NCT01506713|Clopidogrel|clopidogrel|mesh-list
83658856|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83658857|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83658858|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83658859|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83658860|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
83658861|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658862|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658863|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658864|NCT01506739|Donepezil|donepezil|mesh-list
83658865|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83658866|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658867|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658868|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658869|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658870|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658871|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
83658873|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83658874|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658875|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658876|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658877|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658878|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658879|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
83658880|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
83658881|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83658882|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
83658883|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83658884|NCT01506765|Expectorants|expectorants|mesh-ancestor
83658885|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83658886|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83658887|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
83658888|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658889|NCT01506765|Protective Agents|protective agents|mesh-ancestor
83658890|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658891|NCT01506765|Antidotes|antidotes|mesh-ancestor
83658892|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
83658893|NCT01506791|Ephedrine|ephedrine|mesh-list
83658894|NCT01506791|Desloratadine|desloratadine|mesh-list
83658895|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83658896|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
83658897|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658898|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658899|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658900|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83658901|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83658902|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
83658903|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
83658904|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83658905|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
83658906|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658907|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83658908|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
83658909|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
83658910|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83658911|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83658912|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
83658913|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
83658914|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
83658915|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83658916|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83658917|NCT01506804|Prednisolone|prednisolone|mesh-list
83658918|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
83658919|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83658920|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
83658921|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83658922|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
83658923|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
83658924|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658925|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658926|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658927|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
83658928|NCT01506804|Hormones|hormones|mesh-ancestor
83658929|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658930|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83658931|NCT01506804|Protective Agents|protective agents|mesh-ancestor
83658932|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83658933|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658934|NCT01506895|Darapladib|darapladib|mesh-list
83658935|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83658936|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658937|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658938|NCT01506921|Ketamine|ketamine|mesh-list
83658939|NCT01506921|Esketamine|esketamine|mesh-list
83658940|NCT01506921|Analgesics|analgesics|mesh-ancestor
83658941|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
83658942|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658943|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658944|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83658945|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83658946|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
83658947|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
83658948|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83658949|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83658950|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83658951|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658952|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658953|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
83658954|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83658955|NCT01507064|Sorafenib|sorafenib|mesh-list
83658956|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658957|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83658958|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83658959|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658960|NCT01507077|CKD732|ckd732|mesh-list
83658961|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83658962|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83658963|NCT01507077|Growth Substances|growth substances|mesh-ancestor
83658964|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658965|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
83658966|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83658967|NCT01507194|Ondansetron|ondansetron|mesh-list
83658968|NCT01507194|Vestipitant|vestipitant|mesh-list
83658969|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
83658970|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
83658971|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83658972|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658973|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83658974|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
83658975|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
83658976|NCT01507194|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83658977|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83658978|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
83658979|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83658980|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83658981|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83658982|NCT01507272|Liraglutide|liraglutide|mesh-list
83658983|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83658984|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658985|NCT01507272|Incretins|incretins|mesh-ancestor
83658986|NCT01507272|Hormones|hormones|mesh-ancestor
83658987|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658988|NCT01507285|Liraglutide|liraglutide|mesh-list
83658989|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83658990|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658991|NCT01507285|Incretins|incretins|mesh-ancestor
83658992|NCT01507285|Hormones|hormones|mesh-ancestor
83658993|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83658994|NCT01507311|Liraglutide|liraglutide|mesh-list
83658995|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83658996|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83658997|NCT01507311|Incretins|incretins|mesh-ancestor
83658998|NCT01507311|Hormones|hormones|mesh-ancestor
83658999|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659000|NCT01507337|Liraglutide|liraglutide|mesh-list
83659001|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659002|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659003|NCT01507337|Incretins|incretins|mesh-ancestor
83659004|NCT01507337|Hormones|hormones|mesh-ancestor
83659005|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659006|NCT01507363|Gabapentin|gabapentin|mesh-list
83659007|NCT01507363|Analgesics|analgesics|mesh-ancestor
83659008|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
83659009|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659010|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659011|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
83659012|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83659013|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83659014|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83659015|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83659016|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83659017|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83659018|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659019|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659020|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
83659021|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83659022|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83659023|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659024|NCT01507389|Liraglutide|liraglutide|mesh-list
83659025|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659026|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659027|NCT01507389|Incretins|incretins|mesh-ancestor
83659028|NCT01507389|Hormones|hormones|mesh-ancestor
83659029|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659030|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
83659031|NCT01507428|Misonidazole|misonidazole|mesh-list
83659032|NCT01507428|Paclitaxel|paclitaxel|mesh-list
83659033|NCT01507428|Carboplatin|carboplatin|mesh-list
83659034|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83659035|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83659036|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83659037|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659038|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83659039|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83659040|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83659041|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659042|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83659043|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
83659044|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
83659045|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659046|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83659047|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83659048|NCT01507454|Estradiol|estradiol|mesh-list
83659049|NCT01507454|Estrogens|estrogens|mesh-ancestor
83659050|NCT01507454|Hormones|hormones|mesh-ancestor
83659051|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659052|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659053|NCT01507467|Nimorazole|nimorazole|mesh-list
83659054|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83659055|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83659056|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83659057|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659058|NCT01507480|Bevacizumab|bevacizumab|mesh-list
83659059|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83659060|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659061|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83659062|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83659063|NCT01507480|Growth Substances|growth substances|mesh-ancestor
83659064|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659065|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
83659066|NCT01507519|Sirolimus|sirolimus|mesh-list
83659067|NCT01507519|Temsirolimus|temsirolimus|mesh-list
83659068|NCT01507519|MTOR Inhibitors|mtor inhibitors|mesh-list
83659069|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83659070|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659071|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83659072|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659073|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
83659074|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659075|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
83659076|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659077|NCT01507519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659078|NCT01507519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659079|NCT01507519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659080|NCT01507558|Dexamethasone|dexamethasone|mesh-list
83659081|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
83659082|NCT01507558|BB 1101|bb 1101|mesh-list
83659083|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659084|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
83659085|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
83659086|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659087|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659088|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659089|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
83659090|NCT01507558|Hormones|hormones|mesh-ancestor
83659091|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659092|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83659093|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659094|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
83659095|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659096|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659097|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
83659099|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83659100|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659101|NCT01507597|Hormones|hormones|mesh-ancestor
83659102|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659103|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659104|NCT01507597|Incretins|incretins|mesh-ancestor
83659105|NCT01507701|Clonidine|clonidine|mesh-list
83659106|NCT01507701|Analgesics|analgesics|mesh-ancestor
83659107|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
83659108|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659109|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659110|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83659111|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
83659112|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
83659113|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83659114|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83659115|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83659116|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
83659117|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659118|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659119|NCT01507727|Tolvaptan|tolvaptan|mesh-list
83659120|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83659121|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659122|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
83659123|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659124|NCT01507740|Bevacizumab|bevacizumab|mesh-list
83659125|NCT01507740|Sorafenib|sorafenib|mesh-list
83659126|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83659127|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659128|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83659129|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83659130|NCT01507740|Growth Substances|growth substances|mesh-ancestor
83659131|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659132|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
83659133|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659134|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659135|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659136|NCT01507792|Loratadine|loratadine|mesh-list
83659137|NCT01507792|Omeprazole|omeprazole|mesh-list
83659138|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83659139|NCT01507792|Histamine|histamine|mesh-list
83659140|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83659141|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659142|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659143|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659144|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
83659145|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83659146|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83659147|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83659148|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83659149|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
83659150|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
83659151|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659152|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659153|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
83659154|NCT01507857|Vaccines|vaccines|mesh-list
83659155|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
83659156|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659157|NCT01507922|Fenoverine|fenoverine|mesh-list
83659158|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
83659159|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
83659160|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659161|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659162|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83659163|NCT01507974|Amoxicillin|amoxicillin|mesh-list
83659164|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
83659165|NCT01507974|Cephalexin|cephalexin|mesh-list
83659166|NCT01507974|Cefuroxime|cefuroxime|mesh-list
83659167|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
83659168|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83659169|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82813907|NCT01050699|Narcotics|narcotics|mesh-ancestor
83659170|NCT01507974|Trimethoprim|trimethoprim|mesh-list
83659172|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659173|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
83659174|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83659175|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
83659176|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83659177|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83659178|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83659179|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659180|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659181|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83659182|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83659183|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83659184|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83659185|NCT01508000|Bevacizumab|bevacizumab|mesh-list
83659186|NCT01508000|Panitumumab|panitumumab|mesh-list
83659187|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83659188|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659189|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83659190|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83659191|NCT01508000|Growth Substances|growth substances|mesh-ancestor
83659192|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659193|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
83659194|NCT01508104|Everolimus|everolimus|mesh-list
83659195|NCT01508104|Dactolisib|dactolisib|mesh-list
83659196|NCT01508104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83659197|NCT01508104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659198|NCT01508104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659199|NCT01508104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659200|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659201|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
83659202|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659203|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659204|NCT01507610|Sumatriptan|sumatriptan|mesh-list
83659205|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83659206|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83659207|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83659208|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
83659209|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659210|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659211|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659212|NCT01508143|Misoprostol|misoprostol|mesh-list
83659213|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83659214|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
83659215|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83659216|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659217|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83659218|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659219|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
83659220|NCT01508182|Metformin|metformin|mesh-list
83659221|NCT01508182|Canagliflozin|canagliflozin|mesh-list
83659222|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659223|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659224|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83659225|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659226|NCT01508195|Metformin|metformin|mesh-list
83659227|NCT01508195|Canagliflozin|canagliflozin|mesh-list
83659228|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659229|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659230|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83659231|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659232|NCT01508221|Vitamin E|vitamin e|mesh-list
83659233|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
83659234|NCT01508221|Vitamins|vitamins|mesh-ancestor
83659235|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
83659236|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659237|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
83659238|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659239|NCT01508221|Protective Agents|protective agents|mesh-ancestor
83659240|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83659241|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659242|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83659243|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83659244|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
83659245|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83659246|NCT01508260|Furosemide|furosemide|mesh-list
83659247|NCT01508260|Diuretics|diuretics|mesh-ancestor
83659248|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
83659249|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659250|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83659251|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83659252|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659253|NCT01508286|Ribavirin|ribavirin|mesh-list
83659254|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
83659255|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659256|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
83659257|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659258|NCT01508364|Sorafenib|sorafenib|mesh-list
83659259|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659260|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659261|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659262|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659263|NCT01508429|Misoprostol|misoprostol|mesh-list
83659264|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83659265|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
83659266|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83659267|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659268|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83659269|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659270|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
83659271|NCT01508468|Rituximab|rituximab|mesh-list
83659272|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
83659273|NCT01508468|Giapreza|giapreza|mesh-list
83659274|NCT01508468|Calcium|calcium|mesh-list
83659275|NCT01508468|Diuretics|diuretics|mesh-list
83659276|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83659277|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83659278|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
83659279|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83659280|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83659281|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659282|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
83659283|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659284|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83659285|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83659286|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
83659287|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83659288|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
83659289|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659290|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659291|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83659292|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83659293|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
83659294|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
83659295|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659296|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83659297|NCT01508494|Galantamine|galantamine|mesh-list
83659298|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83659299|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659300|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659301|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
83659302|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659303|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659304|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83659305|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
83659306|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659307|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
83659308|NCT01508572|Bevacizumab|bevacizumab|mesh-list
83659309|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83659310|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659311|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83659312|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83659313|NCT01508572|Growth Substances|growth substances|mesh-ancestor
83659314|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659315|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
83659316|NCT01508611|Fluorides|fluorides|mesh-list
83659317|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
83659318|NCT01508611|Protective Agents|protective agents|mesh-ancestor
83659319|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659320|NCT01508637|Terazosin|terazosin|mesh-list
83659321|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83659322|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83659323|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83659324|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
83659325|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659326|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659327|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659328|NCT01508637|Urological Agents|urological agents|mesh-ancestor
83659329|NCT01508663|Everolimus|everolimus|mesh-list
83659330|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83659331|NCT01508663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83659332|NCT01508663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659333|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659334|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659335|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659336|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
83659337|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659338|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659339|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83659340|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83659341|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83659342|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
83659343|NCT01508806|Liraglutide|liraglutide|mesh-list
83659344|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659345|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659346|NCT01508806|Incretins|incretins|mesh-ancestor
83659347|NCT01508806|Hormones|hormones|mesh-ancestor
83395627|NCT04540666|Propofol|propofol|mesh-list
83659348|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659349|NCT01508845|Vitamin D|vitamin d|mesh-list
83659350|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
83659351|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
83659352|NCT01508845|Vitamins|vitamins|mesh-list
83659353|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
83659354|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659355|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83659356|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83659357|NCT01508858|Liraglutide|liraglutide|mesh-list
83659358|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
83659359|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83659360|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659361|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659362|NCT01508858|Incretins|incretins|mesh-ancestor
83659363|NCT01508858|Hormones|hormones|mesh-ancestor
83659364|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659365|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83659366|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
83659367|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83659368|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83659369|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83659370|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83659371|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83659372|NCT01508858|Estrogens|estrogens|mesh-ancestor
83659373|NCT01508884|Imiquimod|imiquimod|mesh-list
83659374|NCT01508884|Vaccines|vaccines|mesh-list
83659375|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
83659376|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659377|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83659378|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659379|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
83659380|NCT01508897|Liraglutide|liraglutide|mesh-list
83659381|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659382|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659383|NCT01508897|Incretins|incretins|mesh-ancestor
83659384|NCT01508897|Hormones|hormones|mesh-ancestor
83659385|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659386|NCT01508923|Liraglutide|liraglutide|mesh-list
83659387|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659388|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659389|NCT01508923|Incretins|incretins|mesh-ancestor
83659390|NCT01508923|Hormones|hormones|mesh-ancestor
83659391|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659392|NCT01508949|Liraglutide|liraglutide|mesh-list
83659393|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659394|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659395|NCT01508949|Incretins|incretins|mesh-ancestor
83659396|NCT01508949|Hormones|hormones|mesh-ancestor
83659397|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659399|NCT01509001|Glimepiride|glimepiride|mesh-list
83659400|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659401|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659402|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83659403|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659404|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
83659405|NCT01509131|Bisacodyl|bisacodyl|mesh-list
83659406|NCT01509131|Cathartics|cathartics|mesh-ancestor
83659407|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659408|NCT01509131|Laxatives|laxatives|mesh-ancestor
83659409|NCT01509144|Vaccines|vaccines|mesh-list
83659410|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
83659411|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659412|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
83659413|NCT01509209|Ephedrine|ephedrine|mesh-list
83659414|NCT01509209|Levocetirizine|levocetirizine|mesh-list
83659415|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83659416|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83659417|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
83659418|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
83659419|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659420|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659421|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659422|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83659423|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
83659424|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659425|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83659426|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
83659427|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
83659428|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83659429|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83659430|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
83659431|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
83659432|NCT01509261|Lansoprazole|lansoprazole|mesh-list
83659433|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
83659434|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83659435|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659436|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83659437|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659438|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659439|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
83659440|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
83659441|NCT01509300|Rituximab|rituximab|mesh-list
83659442|NCT01509300|Fludarabine|fludarabine|mesh-list
83659443|NCT01509300|Tacrolimus|tacrolimus|mesh-list
83659444|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83659445|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659446|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
83659447|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659448|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83659449|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83659450|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
83659451|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659452|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659453|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83659454|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83659455|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83659456|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659457|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83659458|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83659459|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
83659460|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83659461|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659462|NCT01509365|Clopidogrel|clopidogrel|mesh-list
83659463|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83659464|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83659465|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83659466|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83659467|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
83659468|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659469|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659470|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659471|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83659473|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
83659474|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659475|NCT01509469|Caseins|caseins|mesh-list
83659476|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
83659477|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
83659478|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659479|NCT01509521|Phenylephrine|phenylephrine|mesh-list
83659480|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
83659481|NCT01509521|Ephedrine|ephedrine|mesh-list
83659482|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
83659483|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83659484|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
83659485|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
83659486|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659487|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659488|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
83659489|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83659490|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
83659491|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
83659492|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83659493|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83659494|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83659495|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
83659496|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659497|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659498|NCT01509521|Protective Agents|protective agents|mesh-ancestor
83659499|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83659500|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83659501|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83659502|NCT01509560|Everolimus|everolimus|mesh-list
83659503|NCT01509560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83659504|NCT01509560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659505|NCT01509560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659506|NCT01509560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659507|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659508|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
83659509|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659510|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659511|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
83659512|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83659513|NCT01509742|Liraglutide|liraglutide|mesh-list
83659514|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659515|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659516|NCT01509742|Incretins|incretins|mesh-ancestor
83659517|NCT01509742|Hormones|hormones|mesh-ancestor
83659518|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659519|NCT01509755|Liraglutide|liraglutide|mesh-list
83659520|NCT01509755|Glimepiride|glimepiride|mesh-list
83659521|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659522|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659523|NCT01509755|Incretins|incretins|mesh-ancestor
83659524|NCT01509755|Hormones|hormones|mesh-ancestor
83659525|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659526|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83659527|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659528|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
83659529|NCT01509911|Gemcitabine|gemcitabine|mesh-list
83659530|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83659531|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
83659532|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659533|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659534|NCT01509976|Triclosan|triclosan|mesh-list
83659535|NCT01509976|Triclocarban|triclocarban|mesh-list
83659536|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83659537|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659538|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83659539|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83659540|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
83659541|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659542|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83659543|NCT01510015|Risperidone|risperidone|mesh-list
83659544|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83659545|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
83659546|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814275|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83659547|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659548|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659549|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83659550|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83659551|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83659552|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83659553|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83659554|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
83659555|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
83659556|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659557|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659558|NCT01510132|Timolol|timolol|mesh-list
83659559|NCT01510132|Travoprost|travoprost|mesh-list
83659560|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83659561|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83659562|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
83659563|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659564|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659565|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659566|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83659567|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83659568|NCT01510171|Ticagrelor|ticagrelor|mesh-list
83659569|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83659570|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83659571|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83659572|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83659573|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83659574|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
83659575|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659576|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659577|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659578|NCT01510288|Ipilimumab|ipilimumab|mesh-list
83659579|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83659580|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659581|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83659582|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659583|NCT01510366|Vaccines|vaccines|mesh-list
83659584|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
83659585|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659586|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
83659587|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659588|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
83659589|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659590|NCT01510509|Everolimus|everolimus|mesh-list
83659591|NCT01510509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83659592|NCT01510509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659593|NCT01510509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659594|NCT01510509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659595|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659596|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
83659597|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659598|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659599|NCT01510522|Metformin|metformin|mesh-list
83659600|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659601|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659602|NCT01510548|Adalimumab|adalimumab|mesh-list
83659603|NCT01510548|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83659604|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659605|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83659606|NCT01510561|Gemcitabine|gemcitabine|mesh-list
83659607|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83659608|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83659609|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83659610|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
83659611|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659612|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659613|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
83659614|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
83659615|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
83659616|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659617|NCT01510574|Misoprostol|misoprostol|mesh-list
83659618|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83659619|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
83659620|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83659621|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659622|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83659623|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659624|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
83659625|NCT01510613|Dexamethasone|dexamethasone|mesh-list
83659626|NCT01510613|Pomalidomide|pomalidomide|mesh-list
83659627|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659628|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
83659629|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
83659630|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659631|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659632|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659633|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
83659635|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659636|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83659637|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659638|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
83659639|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83659640|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83659641|NCT01510613|Growth Substances|growth substances|mesh-ancestor
83659642|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
83659643|NCT01510626|Omalizumab|omalizumab|mesh-list
83659644|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83659645|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83659646|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
83659647|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
83659648|NCT01510665|Cathartics|cathartics|mesh-ancestor
83659649|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659650|NCT01510795|Spironolactone|spironolactone|mesh-list
83395913|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
83659651|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83659652|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
83659653|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659654|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659655|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83659656|NCT01510795|Diuretics|diuretics|mesh-ancestor
83659657|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
83659658|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
83659659|NCT01510847|Androgens|androgens|mesh-ancestor
83659660|NCT01510847|Hormones|hormones|mesh-ancestor
83659661|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659662|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659663|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83659664|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83659665|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659666|NCT01510977|Bisacodyl|bisacodyl|mesh-list
83659667|NCT01510977|Cathartics|cathartics|mesh-ancestor
83659668|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659669|NCT01510977|Laxatives|laxatives|mesh-ancestor
83659670|NCT01510990|Gefitinib|gefitinib|mesh-list
83659671|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659672|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659673|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659674|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659675|NCT01511003|Tacrolimus|tacrolimus|mesh-list
83659676|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659677|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
83659678|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659679|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83659680|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659681|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659682|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
83659683|NCT01511029|Pramipexole|pramipexole|mesh-list
83659684|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83659685|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659686|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83659687|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83659688|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659689|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659690|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659691|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659692|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
83659693|NCT01511029|Protective Agents|protective agents|mesh-ancestor
83659694|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83659695|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83659696|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
83659697|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
83659698|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659699|NCT01511146|Gemcitabine|gemcitabine|mesh-list
83659700|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
83659701|NCT01511146|Mitomycins|mitomycins|mesh-list
83659702|NCT01511146|Mitomycin|mitomycin|mesh-list
83659703|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83659704|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
83659705|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659706|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659707|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83659708|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
83659709|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83659710|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659711|NCT01511159|Insulin|insulin|mesh-list
83659712|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83659713|NCT01511159|Liraglutide|liraglutide|mesh-list
83659714|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659715|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659716|NCT01511159|Incretins|incretins|mesh-ancestor
83659717|NCT01511159|Hormones|hormones|mesh-ancestor
83659718|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659719|NCT01511172|Metformin|metformin|mesh-list
83659720|NCT01511172|Liraglutide|liraglutide|mesh-list
83659721|NCT01511172|Glimepiride|glimepiride|mesh-list
83659722|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659723|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659724|NCT01511172|Incretins|incretins|mesh-ancestor
83659725|NCT01511172|Hormones|hormones|mesh-ancestor
83659726|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659727|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83659728|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659729|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
83659730|NCT01511185|Liraglutide|liraglutide|mesh-list
83659731|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659732|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659733|NCT01511185|Incretins|incretins|mesh-ancestor
83659734|NCT01511185|Hormones|hormones|mesh-ancestor
83659735|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659736|NCT01511198|Metformin|metformin|mesh-list
83659737|NCT01511198|Liraglutide|liraglutide|mesh-list
83659738|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659739|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659740|NCT01511198|Incretins|incretins|mesh-ancestor
83659741|NCT01511198|Hormones|hormones|mesh-ancestor
83659742|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659743|NCT01511211|Dexamethasone|dexamethasone|mesh-list
83659744|NCT01511211|Ropivacaine|ropivacaine|mesh-list
83659745|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659746|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
83659747|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
83659748|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659749|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659750|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659751|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
83659752|NCT01511211|Hormones|hormones|mesh-ancestor
83659753|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659754|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83659755|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659756|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
83659757|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
83659758|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83659759|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
83659760|NCT01511237|Lamivudine|lamivudine|mesh-list
83659761|NCT01511237|Zidovudine|zidovudine|mesh-list
83659762|NCT01511237|Nevirapine|nevirapine|mesh-list
83659763|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83659764|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83659765|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659766|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659767|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
83659768|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659769|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83659770|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83659771|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
83659772|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83659773|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83659774|NCT01511263|Amiodarone|amiodarone|mesh-list
83659776|NCT01511263|Diuretics|diuretics|mesh-list
83659777|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
83659778|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659779|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
83659780|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83659781|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83659782|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659783|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83659784|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83659785|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83659786|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659787|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83659788|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83659789|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83659790|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
83659791|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659792|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83659793|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659794|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659795|NCT01511302|Budesonide|budesonide|mesh-list
83659796|NCT01511302|RNS60|rns60|mesh-list
83659797|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659798|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83659799|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
83659800|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659801|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659802|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83659803|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
83659804|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
83659805|NCT01511302|Hormones|hormones|mesh-ancestor
83659806|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659807|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83659808|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83659809|NCT01511302|Analgesics|analgesics|mesh-ancestor
83659810|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
83659811|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83659812|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83659813|NCT01511367|Fluticasone|fluticasone|mesh-list
83659814|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83659815|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83659816|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
83659817|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659818|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659819|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83659820|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
83659821|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
83659822|NCT01511367|Hormones|hormones|mesh-ancestor
83659823|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659824|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
83659825|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659826|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
83659827|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83659828|NCT01511471|Ticagrelor|ticagrelor|mesh-list
83659829|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83659830|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83659831|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83659832|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83659833|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
83659834|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659835|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659836|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659837|NCT01511562|Cytarabine|cytarabine|mesh-list
83659838|NCT01511562|Etoposide|etoposide|mesh-list
83659839|NCT01511562|Thiotepa|thiotepa|mesh-list
83659840|NCT01511562|Carmustine|carmustine|mesh-list
83659841|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83659842|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659843|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83659844|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83659845|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659846|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814582|NCT01053039|Morphine|morphine|mesh-list
83659847|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83659848|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
83659849|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
83659850|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659851|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659852|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
83659853|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659854|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83659855|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
83659856|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83659857|NCT01511627|Anesthetics|anesthetics|mesh-list
83659858|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83659859|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659860|NCT01511692|Liraglutide|liraglutide|mesh-list
83659861|NCT01511692|Glimepiride|glimepiride|mesh-list
83659862|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83659863|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659864|NCT01511692|Incretins|incretins|mesh-ancestor
83659865|NCT01511692|Hormones|hormones|mesh-ancestor
83659866|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659867|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83659868|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83659869|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
83659870|NCT01511705|Ondansetron|ondansetron|mesh-list
83659871|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
83659872|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
83659873|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659874|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659875|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659876|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
83659877|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
83659878|NCT01511705|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83659879|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83659880|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
83659881|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659882|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659883|NCT01511718|Ondansetron|ondansetron|mesh-list
83659884|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
83659885|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
83659886|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659887|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659888|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659889|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
83659890|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
83659891|NCT01511718|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83659892|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83659893|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
83659894|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659895|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659896|NCT01511731|Famotidine|famotidine|mesh-list
83659897|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83659898|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83659899|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83659900|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
83659901|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
83659902|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83659903|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659904|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659905|NCT01511757|Fluconazole|fluconazole|mesh-list
83659906|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
83659907|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659908|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83659909|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83659910|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659911|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659912|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83659913|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
83659914|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659915|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659916|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83659917|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83659918|NCT01511770|Fluconazole|fluconazole|mesh-list
83659919|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
82814654|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83659920|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83659921|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83659922|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83659923|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659924|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659925|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83659926|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
83659927|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659928|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659929|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83659930|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83659931|NCT01511822|Inositol|inositol|mesh-list
83659932|NCT01511822|Drospirenone|drospirenone|mesh-list
83659933|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83659934|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83659935|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83659936|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83659937|NCT01511822|Estradiol|estradiol|mesh-list
83659938|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83659939|NCT01511822|Estrogens|estrogens|mesh-ancestor
83659940|NCT01511822|Hormones|hormones|mesh-ancestor
83659941|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83659942|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659943|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83659944|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
83659945|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83659946|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83396205|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
83659947|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83659948|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83659949|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
83659950|NCT01511822|Vitamins|vitamins|mesh-ancestor
83659951|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
83659952|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83659953|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
83659954|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83659955|NCT01511822|Diuretics|diuretics|mesh-ancestor
83659956|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
83659957|NCT01511835|Folic Acid|folic acid|mesh-list
83659958|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
83659959|NCT01511835|Inositol|inositol|mesh-list
83659960|NCT01511835|Hematinics|hematinics|mesh-ancestor
83659961|NCT01511835|Vitamins|vitamins|mesh-ancestor
83659962|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
83659963|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659964|NCT01511848|Deferasirox|deferasirox|mesh-list
83659965|NCT01511848|Deferiprone|deferiprone|mesh-list
83659966|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83659967|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
83659968|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
83659969|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659970|NCT01511874|Leuprolide|leuprolide|mesh-list
83659971|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83659972|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
83659973|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83659974|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659975|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83659976|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83659977|NCT01511887|Ibuprofen|ibuprofen|mesh-list
83659978|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83659979|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83659980|NCT01511887|Analgesics|analgesics|mesh-ancestor
83659981|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
83659982|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83659983|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659984|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83659985|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83659986|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83659987|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83659988|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83659989|NCT01511991|Sevoflurane|sevoflurane|mesh-list
83659990|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83659991|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83659992|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
83659993|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
83659994|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83659995|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83659997|NCT01512004|Propiverine|propiverine|mesh-list
83659998|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83659999|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83660000|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
83660001|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660002|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660003|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660004|NCT01512004|Urological Agents|urological agents|mesh-ancestor
83660005|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
83660006|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
83660007|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660008|NCT01512017|Petrolatum|petrolatum|mesh-list
83660009|NCT01512017|Emollients|emollients|mesh-ancestor
83660010|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
83660011|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
83660012|NCT01512147|Propofol|propofol|mesh-list
83660013|NCT01512147|Isoflurane|isoflurane|mesh-list
83660014|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83660015|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660016|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660017|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660018|NCT01512147|Analgesics|analgesics|mesh-ancestor
83660019|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
83660020|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660021|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83660022|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83660023|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83660024|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
83660025|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660026|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660027|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83660028|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
83660029|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
83660030|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83660031|NCT01512173|Propranolol|propranolol|mesh-list
83660032|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83660033|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83660034|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83660035|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660036|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660037|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660038|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83660039|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83660040|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
83660041|NCT01512199|Paclitaxel|paclitaxel|mesh-list
83660042|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83660043|NCT01512199|Trastuzumab|trastuzumab|mesh-list
83660044|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83660045|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83660046|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660047|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660048|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660049|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660050|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660051|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83660052|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
83660053|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660054|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
83660055|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83660056|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660057|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660058|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660059|NCT01512355|Analgesics|analgesics|mesh-ancestor
83660060|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
83660061|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660062|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83660063|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83660064|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83660065|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83660066|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660067|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660068|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83660069|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83660070|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83660071|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83660072|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660073|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660074|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660075|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83660076|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
83660077|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83660078|NCT01512485|Clopidogrel|clopidogrel|mesh-list
83660079|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83660080|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83660081|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83660082|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83660083|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
83660084|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660085|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660086|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660087|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
83660088|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83660089|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
83660090|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
83660091|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660092|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660093|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660094|NCT01512511|Analgesics|analgesics|mesh-ancestor
83660095|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
83660096|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660098|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
83660099|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
83660100|NCT01512537|Vitamins|vitamins|mesh-list
83660101|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
83660102|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660103|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83660104|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83660105|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83660106|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
83660107|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
83660108|NCT01512680|Insulin|insulin|mesh-list
83660109|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660110|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660111|NCT01512784|Vaccines|vaccines|mesh-list
83660112|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
83660113|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660114|NCT01512862|Calcitriol|calcitriol|mesh-list
83660115|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83660116|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660117|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83660118|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83660119|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660120|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83660121|NCT01512862|Vitamins|vitamins|mesh-ancestor
83660122|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
83660123|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83660124|NCT01512901|Betamethasone|betamethasone|mesh-list
83660125|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
83660126|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83660127|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
83660128|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83660129|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83660130|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
83660131|NCT01512901|Hormones|hormones|mesh-ancestor
83660132|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660133|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660134|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83660135|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
83660136|NCT01512914|Ropivacaine|ropivacaine|mesh-list
83660137|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
83660138|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
83660139|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660140|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660141|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
83660142|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660144|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
83660145|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83660146|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83660147|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83660148|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660149|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660150|NCT01512966|Aflibercept|aflibercept|mesh-list
83660151|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83660152|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83660153|NCT01512966|Growth Substances|growth substances|mesh-ancestor
83660154|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660155|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
83660156|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660157|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
83660158|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83660159|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660160|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83660161|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
83660162|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660163|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660164|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660165|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660166|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
83660167|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83660168|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660169|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83660170|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
83660171|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660172|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660173|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660174|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660175|NCT01513070|Aspirin|aspirin|mesh-list
83660176|NCT01513070|Isosorbide|isosorbide|mesh-list
83660177|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83660178|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83660179|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83660180|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660181|NCT01513070|Analgesics|analgesics|mesh-ancestor
83660182|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
83660183|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660184|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660185|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83660186|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83660187|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83660188|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83660189|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660190|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83660191|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83660192|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660193|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
83660194|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83660195|NCT01513070|Diuretics|diuretics|mesh-ancestor
83660196|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
83660197|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
83660198|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83660199|NCT01513083|Trastuzumab|trastuzumab|mesh-list
83660200|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83660201|NCT01513083|Maytansine|maytansine|mesh-list
83660202|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83660203|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660204|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83660205|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660206|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660207|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660208|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660209|NCT01513083|Immunotoxins|immunotoxins|mesh-ancestor
83660210|NCT01513083|Immunoconjugates|immunoconjugates|mesh-ancestor
83660211|NCT01513083|Immunologic Factors|immunologic factors|mesh-ancestor
83660212|NCT01513083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660213|NCT01513174|Olaparib|olaparib|mesh-list
83660214|NCT01513174|Gefitinib|gefitinib|mesh-list
83660215|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83660216|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660217|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660218|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660219|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83660220|NCT01513200|Heparin|heparin|mesh-list
83660221|NCT01513200|Calcium heparin|calcium heparin|mesh-list
83660222|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
83660223|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83660224|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83660225|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660226|NCT01513499|Oxytocin|oxytocin|mesh-list
83660227|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
83660228|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83660229|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660230|NCT01513525|Liraglutide|liraglutide|mesh-list
83660231|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660232|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660233|NCT01513525|Incretins|incretins|mesh-ancestor
83660234|NCT01513525|Hormones|hormones|mesh-ancestor
83660235|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660236|NCT01513564|Morphine|morphine|mesh-list
83660237|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660238|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660239|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83660240|NCT01513564|Narcotics|narcotics|mesh-ancestor
83660241|NCT01513564|Analgesics|analgesics|mesh-ancestor
83660242|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
83660243|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660244|NCT01513603|Cytarabine|cytarabine|mesh-list
83660245|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
83660246|NCT01513603|Cladribine|cladribine|mesh-list
83660247|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83660248|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
83660249|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660250|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660251|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
83660252|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660253|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660254|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
83660255|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660256|NCT01513603|Analgesics|analgesics|mesh-ancestor
83660257|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
83660258|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660259|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660260|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660261|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660262|NCT01513668|Acetaminophen|acetaminophen|mesh-list
83660263|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660264|NCT01513668|Analgesics|analgesics|mesh-ancestor
83660265|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
83660266|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660267|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660268|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
83660269|NCT01513681|Lamotrigine|lamotrigine|mesh-list
83660270|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
83660271|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83660272|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83660273|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660274|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83660275|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660276|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83660277|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83660278|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660279|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83660280|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83660281|NCT01513720|Lamotrigine|lamotrigine|mesh-list
83660282|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
83660283|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83660284|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83660285|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660286|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83660287|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660288|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83660289|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83660290|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660291|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83660292|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83660293|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
83660294|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83660295|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660296|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660297|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660298|NCT01513772|Analgesics|analgesics|mesh-ancestor
83660299|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
83660300|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660301|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83660302|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83660303|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83660304|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
83660305|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660306|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660307|NCT01513785|Amoxicillin|amoxicillin|mesh-list
83660308|NCT01513785|Rabeprazole|rabeprazole|mesh-list
83660309|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660310|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660311|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83660312|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83660313|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83660314|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660315|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660316|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83660317|NCT01513863|Metronidazole|metronidazole|mesh-list
83660318|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660319|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660320|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83660321|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83660322|NCT01513941|Interferons|interferons|mesh-list
83660323|NCT01513941|Ribavirin|ribavirin|mesh-list
83660324|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
83660325|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
83660326|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83660327|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660328|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
83660329|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660330|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
83660331|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660332|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
83660333|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660334|NCT01514019|Acebutolol|acebutolol|mesh-list
83660335|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83660336|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83660337|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
83660338|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
83660339|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660340|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660341|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83660342|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83660343|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83660344|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83660345|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660346|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660347|NCT01514110|Paclitaxel|paclitaxel|mesh-list
83660348|NCT01514110|Carboplatin|carboplatin|mesh-list
83660349|NCT01514110|Everolimus|everolimus|mesh-list
83660350|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83660351|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660352|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660353|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660354|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660355|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660356|NCT01514110|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83660357|NCT01514110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83660358|NCT01514110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660359|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660360|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
83660361|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660362|NCT01514123|Bevacizumab|bevacizumab|mesh-list
83660363|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83660364|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660365|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83660366|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83362054|NCT01687283|Xhance|xhance|mesh-list
83660367|NCT01514123|Growth Substances|growth substances|mesh-ancestor
83660368|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660369|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
83660370|NCT01514175|Ibuprofen|ibuprofen|mesh-list
83660371|NCT01514175|Ketorolac|ketorolac|mesh-list
83660372|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83660373|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660374|NCT01514175|Analgesics|analgesics|mesh-ancestor
83660375|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
83660376|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660377|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660378|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83660379|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83660380|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83660381|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660382|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660383|NCT01514188|Doxorubicin|doxorubicin|mesh-list
83660384|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83660385|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660386|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660387|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660388|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660389|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660390|NCT01514227|Aspirin|aspirin|mesh-list
83660391|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83660392|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660393|NCT01514227|Analgesics|analgesics|mesh-ancestor
83660394|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
83660395|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660396|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660397|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83660398|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83660399|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83660400|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83660401|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660402|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83660403|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83660404|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660405|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
83660406|NCT01514266|Curcumin|curcumin|mesh-list
83660407|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83660408|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660409|NCT01514266|Analgesics|analgesics|mesh-ancestor
83660410|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
83660411|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660412|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660413|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83660414|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83660415|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660416|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660417|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660418|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83660419|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83660420|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
83660421|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83660422|NCT01514487|Liraglutide|liraglutide|mesh-list
83660423|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660424|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660425|NCT01514487|Incretins|incretins|mesh-ancestor
83660426|NCT01514487|Hormones|hormones|mesh-ancestor
83660427|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660428|NCT01514695|Fentanyl|fentanyl|mesh-list
83660429|NCT01514695|Midazolam|midazolam|mesh-list
83660430|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83660431|NCT01514695|Narcotics|narcotics|mesh-ancestor
83660432|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660433|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660434|NCT01514695|Analgesics|analgesics|mesh-ancestor
83660435|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
83660436|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660437|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83660438|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83660439|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
83660440|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
82815184|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
83660441|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83660442|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83660443|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83660444|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83660445|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
83660446|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
83660447|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660448|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660449|NCT01514721|Timolol|timolol|mesh-list
83660450|NCT01514721|Travoprost|travoprost|mesh-list
83660451|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660452|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83660453|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83660454|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
83660455|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660456|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660457|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83660458|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83660459|NCT01514812|Digoxin|digoxin|mesh-list
83660460|NCT01514812|Darexaban|darexaban|mesh-list
83660461|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83660462|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83660463|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660464|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660465|NCT01514812|Protective Agents|protective agents|mesh-ancestor
83660466|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660467|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83660468|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
83660469|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83660470|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
83660471|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
83660472|NCT01514825|Darexaban|darexaban|mesh-list
83660473|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83660474|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
83660475|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83660476|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
83660477|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660478|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660479|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
83660480|NCT01514838|Acarbose|acarbose|mesh-list
83660481|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
83660482|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83660483|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660484|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660485|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660486|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660487|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83660488|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
83660489|NCT01514851|Calcium|calcium|mesh-list
83660490|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83660491|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660492|NCT01514851|Antacids|antacids|mesh-ancestor
83660493|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660494|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83660495|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
83660496|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660497|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660498|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660499|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660500|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660501|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660502|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660503|NCT01514942|Folic Acid|folic acid|mesh-list
83660504|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
83660505|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
83660506|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
83660507|NCT01514942|Inositol|inositol|mesh-list
83660508|NCT01514942|Manganese|manganese|mesh-list
83660509|NCT01514942|Hematinics|hematinics|mesh-ancestor
83660510|NCT01514942|Vitamins|vitamins|mesh-ancestor
83660511|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
83660512|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660513|NCT01514942|Trace Elements|trace elements|mesh-ancestor
83660514|NCT01514968|Cyclosporine|cyclosporine|mesh-list
83660515|NCT01514968|Ritonavir|ritonavir|mesh-list
83660516|NCT01514968|Cyclosporins|cyclosporins|mesh-list
83660517|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660518|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660519|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660520|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
83660521|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660522|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
83660523|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660524|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
83660525|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83660526|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83660527|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83660528|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83660529|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
83660530|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83660531|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83660532|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
83660533|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83660534|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83660535|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
83660536|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660537|NCT01515020|Vancomycin|vancomycin|mesh-list
83660538|NCT01515020|Daptomycin|daptomycin|mesh-list
83660539|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660540|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660541|NCT01515228|Paclitaxel|paclitaxel|mesh-list
83660542|NCT01515228|Everolimus|everolimus|mesh-list
83660543|NCT01515228|Cilostazol|cilostazol|mesh-list
83660544|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83660545|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660546|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660547|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660548|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660549|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660550|NCT01515228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83660551|NCT01515228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83660552|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396816|NCT01034553|Bortezomib|bortezomib|mesh-list
83660553|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660554|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
83660555|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660556|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83660557|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
83660558|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660559|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83660560|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
83660561|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83660562|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83660563|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83660564|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
83660565|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83660566|NCT01515228|Protective Agents|protective agents|mesh-ancestor
83660567|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83660568|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83660569|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83660570|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83660571|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660572|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660573|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83660574|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83660575|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660576|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
83660577|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660578|NCT01515397|Polygeline|polygeline|mesh-list
83660579|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
83660580|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
83660581|NCT01515553|Liraglutide|liraglutide|mesh-list
83660582|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660583|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660584|NCT01515553|Incretins|incretins|mesh-ancestor
83660585|NCT01515553|Hormones|hormones|mesh-ancestor
83660586|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660587|NCT01515579|Liraglutide|liraglutide|mesh-list
83660588|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660589|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660590|NCT01515579|Incretins|incretins|mesh-ancestor
83660591|NCT01515579|Hormones|hormones|mesh-ancestor
83660592|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660593|NCT01515592|Liraglutide|liraglutide|mesh-list
83660595|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660596|NCT01515592|Incretins|incretins|mesh-ancestor
83660597|NCT01515592|Hormones|hormones|mesh-ancestor
83660598|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660599|NCT01515683|Anesthetics|anesthetics|mesh-list
83660600|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660601|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660602|NCT01515774|Pramipexole|pramipexole|mesh-list
83660603|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
83660604|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660605|NCT01515774|Protective Agents|protective agents|mesh-ancestor
83660606|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660607|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83660608|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83660609|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
83660610|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
83660611|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660612|NCT01515813|Tenofovir|tenofovir|mesh-list
83660613|NCT01515813|Emtricitabine|emtricitabine|mesh-list
83660614|NCT01515813|Efavirenz|efavirenz|mesh-list
83660615|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83660616|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83660617|NCT01515813|Pravastatin|pravastatin|mesh-list
83660618|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
83660619|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660620|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83660621|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83660622|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660623|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660624|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83660625|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83660626|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83660627|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83660628|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83660629|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83660630|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83660631|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83660632|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83660633|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83660634|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
83660635|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83660636|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83660637|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
83660638|NCT01515826|Dexamethasone|dexamethasone|mesh-list
83660639|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
83660640|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83660641|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83660642|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83660643|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83660644|NCT01515826|BB 1101|bb 1101|mesh-list
83660645|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83660646|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
83660647|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
83660648|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660649|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660650|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83660651|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
83660652|NCT01515826|Hormones|hormones|mesh-ancestor
83660653|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660654|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83660655|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660656|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
83660657|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660658|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660659|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660660|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660661|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660662|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660663|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83660664|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
82815401|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660666|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83660667|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83660668|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83660669|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
83660670|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
83660671|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
83660672|NCT01515839|Vinpocetine|vinpocetine|mesh-list
83660673|NCT01515839|Huperzine A|huperzine a|mesh-list
83660674|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
83660675|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660676|NCT01515839|Protective Agents|protective agents|mesh-ancestor
83660677|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660678|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
83660679|NCT01515839|Vitamins|vitamins|mesh-ancestor
83660680|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
83660681|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
83660682|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83660683|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660684|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
83660685|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660686|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83660687|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
83660688|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660689|NCT01515839|Expectorants|expectorants|mesh-ancestor
83660690|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
83660691|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83660692|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83660693|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
83660694|NCT01515852|Anesthetics|anesthetics|mesh-list
83660695|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660696|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660697|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83660698|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
83660699|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83660700|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660701|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83660702|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660703|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660704|NCT01516060|Efavirenz|efavirenz|mesh-list
83660705|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83660706|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83660707|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660708|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660709|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
83660710|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660711|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83660712|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83660713|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83660714|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83660715|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83660716|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83660717|NCT01516138|Insulin|insulin|mesh-list
83660718|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660719|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660720|NCT01516255|Liraglutide|liraglutide|mesh-list
83660721|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
83660722|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660723|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660724|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660725|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660726|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660727|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660728|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660729|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660730|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660731|NCT01516255|Incretins|incretins|mesh-ancestor
83660732|NCT01516255|Hormones|hormones|mesh-ancestor
83660733|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660734|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
83660735|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
83660736|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83660737|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83660738|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660739|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660741|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
83660742|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83660743|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660744|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660745|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660746|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660747|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660748|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660749|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660750|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83660751|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
83660752|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83660753|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660754|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83660755|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83660756|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83660757|NCT01516450|Belimumab|belimumab|mesh-list
83660758|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660759|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
83660760|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660761|NCT01516463|Bacitracin|bacitracin|mesh-list
83660762|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83660763|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660764|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660765|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
83660766|NCT01516554|Testosterone|testosterone|mesh-list
83660767|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
83660768|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
83660769|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83660770|NCT01516554|Androgens|androgens|mesh-ancestor
83660771|NCT01516554|Hormones|hormones|mesh-ancestor
83660772|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660773|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660774|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83660775|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660776|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
83660777|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
83660778|NCT01516567|Rituximab|rituximab|mesh-list
83660779|NCT01516567|Doxorubicin|doxorubicin|mesh-list
83660780|NCT01516567|Etoposide|etoposide|mesh-list
83660781|NCT01516567|Vincristine|vincristine|mesh-list
83660782|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660783|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
83660784|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660785|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83660786|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83660787|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
83660788|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660789|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660790|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83660791|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83660792|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83660793|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660794|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660795|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660796|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83660797|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660798|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660799|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660800|NCT01516580|Cytarabine|cytarabine|mesh-list
83660801|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
83660802|NCT01516580|Rituximab|rituximab|mesh-list
83660803|NCT01516580|Doxorubicin|doxorubicin|mesh-list
83660804|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83660805|NCT01516580|Methotrexate|methotrexate|mesh-list
83660806|NCT01516580|Vincristine|vincristine|mesh-list
83660807|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660808|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
83660809|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660810|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83660811|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82815551|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
83660812|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
83660813|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660814|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660815|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83660816|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83660817|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83660818|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83660819|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83660820|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660821|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83660822|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
83660823|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83660824|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83660825|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
83660826|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
83660827|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83660828|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83660829|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
83660830|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660831|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83660832|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660833|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660834|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660836|NCT01516710|Hematinics|hematinics|mesh-ancestor
83660837|NCT01516723|Sirolimus|sirolimus|mesh-list
83660838|NCT01516723|Everolimus|everolimus|mesh-list
83660839|NCT01516723|MTOR Inhibitors|mtor inhibitors|mesh-list
83660840|NCT01516723|Temsirolimus|temsirolimus|mesh-list
83660841|NCT01516723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83660842|NCT01516723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660843|NCT01516723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660844|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83660845|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
83660846|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660847|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660848|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660849|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660850|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83660851|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
83660852|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83660853|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660854|NCT01516814|Heparin|heparin|mesh-list
83660855|NCT01516814|Calcium heparin|calcium heparin|mesh-list
83660856|NCT01516814|Warfarin|warfarin|mesh-list
83660857|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
83660858|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
83660859|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83660860|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83660861|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660862|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83660863|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
83660864|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83660865|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
83660866|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660867|NCT01516840|Heparin|heparin|mesh-list
83660868|NCT01516840|Calcium heparin|calcium heparin|mesh-list
83660869|NCT01516840|Warfarin|warfarin|mesh-list
83660870|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
83660871|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
83660872|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83660873|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83660874|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660875|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83660876|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
83660877|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83660878|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
83660879|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660880|NCT01516866|Listerine|listerine|mesh-list
83660881|NCT01516866|Fluorides|fluorides|mesh-list
83660882|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
83660883|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
83660884|NCT01516866|Protective Agents|protective agents|mesh-ancestor
83660885|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660886|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83660887|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660888|NCT01516996|Docetaxel|docetaxel|mesh-list
83660889|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
83660890|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660891|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660892|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660893|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660894|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660895|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83660896|NCT01517009|Docetaxel|docetaxel|mesh-list
83660897|NCT01517009|Capecitabine|capecitabine|mesh-list
83660898|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660899|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83660900|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83660901|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83660902|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660903|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83660904|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
83660905|NCT01517022|Nicotine|nicotine|mesh-list
83660906|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83660907|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
83660908|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660909|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660910|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83660911|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83660912|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
83660913|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660914|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660915|NCT01517165|Pioglitazone|pioglitazone|mesh-list
83660916|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660917|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660918|NCT01517308|Interferons|interferons|mesh-list
83660919|NCT01517308|Ribavirin|ribavirin|mesh-list
83660920|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
83660921|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
83660922|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83660923|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660924|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
83660925|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660926|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
83660927|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660928|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
83660929|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660930|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83660931|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660932|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660933|NCT01517321|Incretins|incretins|mesh-ancestor
83660934|NCT01517321|Hormones|hormones|mesh-ancestor
83660935|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83660936|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83660937|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
83660938|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660939|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660940|NCT01517334|Minocycline|minocycline|mesh-list
83660941|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83660942|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83660943|NCT01517347|Interleukin-2|interleukin-2|mesh-list
83660944|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83660945|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83660946|NCT01517347|Analgesics|analgesics|mesh-ancestor
83660947|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
83660948|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83660949|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660950|NCT01517360|Oxytocin|oxytocin|mesh-list
83660951|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
83660952|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83660953|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660954|NCT01517399|Vitamin K|vitamin k|mesh-list
83660955|NCT01517399|Digoxin|digoxin|mesh-list
83660956|NCT01517399|Midazolam|midazolam|mesh-list
83660957|NCT01517399|Caffeine|caffeine|mesh-list
83660958|NCT01517399|Omeprazole|omeprazole|mesh-list
83660959|NCT01517399|Warfarin|warfarin|mesh-list
83660960|NCT01517399|Vitamins|vitamins|mesh-ancestor
83660961|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
83660962|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660963|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83660964|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83660965|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83660966|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83660967|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83660968|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83660969|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83660970|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
83660971|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
83660972|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
83660973|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
83660974|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83660975|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83660976|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
83660977|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83660978|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83660979|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83660980|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83660981|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83660982|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
83660983|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83660984|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83660985|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83660986|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83660987|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83660988|NCT01517399|Protective Agents|protective agents|mesh-ancestor
83660989|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83660990|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83660991|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
83660992|NCT01517399|Coagulants|coagulants|mesh-ancestor
83660993|NCT01517490|Insulin|insulin|mesh-list
83660994|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83660995|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83660996|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83660997|NCT01517555|Acetaminophen|acetaminophen|mesh-list
83660998|NCT01517555|Liraglutide|liraglutide|mesh-list
83660999|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661000|NCT01517555|Analgesics|analgesics|mesh-ancestor
83661001|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
83661002|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661003|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661004|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
83661005|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661006|NCT01517555|Incretins|incretins|mesh-ancestor
83661007|NCT01517555|Hormones|hormones|mesh-ancestor
83661008|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661009|NCT01517568|Liraglutide|liraglutide|mesh-list
83661010|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661011|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661012|NCT01517568|Incretins|incretins|mesh-ancestor
83661013|NCT01517568|Hormones|hormones|mesh-ancestor
83661014|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661015|NCT01517607|Mesalamine|mesalamine|mesh-list
83661016|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83661017|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661018|NCT01517607|Analgesics|analgesics|mesh-ancestor
83661019|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
83661020|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661021|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661022|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83661023|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83661024|NCT01517724|Bortezomib|bortezomib|mesh-list
83661025|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661026|NCT01517815|Tazobactam|tazobactam|mesh-list
83661027|NCT01517815|Piperacillin|piperacillin|mesh-list
83661028|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83661029|NCT01517815|Doripenem|doripenem|mesh-list
83661030|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83661031|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661032|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83661033|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661034|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661035|NCT01517828|Midazolam|midazolam|mesh-list
83661036|NCT01517828|Ketamine|ketamine|mesh-list
83661037|NCT01517828|Analgesics|analgesics|mesh-ancestor
83661038|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
83661039|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661040|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661041|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83661042|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82815783|NCT00332709|Letrozole|letrozole|mesh-list
83661043|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
83661044|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
83661045|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661046|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83661047|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83661048|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661049|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661050|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83661051|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83661052|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83661053|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83661054|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83661055|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
83661056|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
83661057|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
83661058|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
83661059|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83661060|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83661061|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661062|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661063|NCT01517854|Urological Agents|urological agents|mesh-ancestor
83661064|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
83661065|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83661066|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661067|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661068|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661069|NCT01517932|Analgesics|analgesics|mesh-ancestor
83661070|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
83661071|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661072|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83661073|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83661074|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83661075|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
83661076|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661077|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661078|NCT01517997|Paclitaxel|paclitaxel|mesh-list
83661079|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83661080|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661081|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
83661082|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
83661083|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
83661084|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661085|NCT01518062|Estrogens|estrogens|mesh-list
83661086|NCT01518062|Hormones|hormones|mesh-ancestor
83661087|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661088|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661089|NCT01518101|Metformin|metformin|mesh-list
83661090|NCT01518101|Liraglutide|liraglutide|mesh-list
83661091|NCT01518101|Vildagliptin|vildagliptin|mesh-list
83661092|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661093|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661094|NCT01518101|Incretins|incretins|mesh-ancestor
83661095|NCT01518101|Hormones|hormones|mesh-ancestor
83661096|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661097|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83661098|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
83661099|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661100|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661101|NCT01516944|Capecitabine|capecitabine|mesh-list
83661102|NCT01516944|Tegafur|tegafur|mesh-list
83661103|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
83661104|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83661105|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
83661106|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661107|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661108|NCT01518166|Liraglutide|liraglutide|mesh-list
83661109|NCT01518166|Griseofulvin|griseofulvin|mesh-list
83661110|NCT01518166|Digoxin|digoxin|mesh-list
83661111|NCT01518166|Lisinopril|lisinopril|mesh-list
83661112|NCT01518166|Atorvastatin|atorvastatin|mesh-list
83661113|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83661114|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83661115|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
83661116|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661117|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83661118|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83661119|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661120|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661121|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661122|NCT01518166|Incretins|incretins|mesh-ancestor
83661123|NCT01518166|Hormones|hormones|mesh-ancestor
83661124|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661125|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661126|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83661127|NCT01518166|Protective Agents|protective agents|mesh-ancestor
83661128|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83661129|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
83661130|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661131|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
83661132|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661133|NCT01518231|Aspirin|aspirin|mesh-list
83661134|NCT01518231|Edaravone|edaravone|mesh-list
83661135|NCT01518231|Warfarin|warfarin|mesh-list
83661136|NCT01518231|Atorvastatin|atorvastatin|mesh-list
83661137|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83661138|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661139|NCT01518231|Analgesics|analgesics|mesh-ancestor
83661140|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
83661141|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661142|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661143|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83661144|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83661145|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83661146|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83661147|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661148|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83661149|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83661150|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661151|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
83661152|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83661153|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83661154|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
83661155|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83661156|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83661157|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
83661158|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83661159|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
83661160|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83661161|NCT01518231|Protective Agents|protective agents|mesh-ancestor
83661162|NCT01518413|Irinotecan|irinotecan|mesh-list
83661163|NCT01518413|Sorafenib|sorafenib|mesh-list
83661164|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83661165|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83661166|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661167|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661168|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661169|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83661170|NCT01518465|Dexamethasone|dexamethasone|mesh-list
83661171|NCT01518465|Lenalidomide|lenalidomide|mesh-list
83661172|NCT01518465|Dalteparin|dalteparin|mesh-list
83661173|NCT01518465|Tinzaparin|tinzaparin|mesh-list
83661174|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83661175|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83661176|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
83661177|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
83661178|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661179|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661180|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83661181|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
83661182|NCT01518465|Hormones|hormones|mesh-ancestor
83661183|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661184|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83661185|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661186|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
83661187|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83661188|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83661189|NCT01518465|Growth Substances|growth substances|mesh-ancestor
83661190|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
83661191|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
83661192|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83661193|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83661194|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661195|NCT01518569|Urinastatin|urinastatin|mesh-list
83661196|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82815927|NCT00324987|Bevacizumab|bevacizumab|mesh-list
83661197|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83661198|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
83661199|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661200|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661201|NCT01518595|Bosentan|bosentan|mesh-list
83661202|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661203|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83661204|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661205|NCT01518608|Alfentanil|alfentanil|mesh-list
83661206|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83661207|NCT01518608|Narcotics|narcotics|mesh-ancestor
83661208|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661209|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661210|NCT01518608|Analgesics|analgesics|mesh-ancestor
83661211|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
83661212|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661213|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83661214|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
83661215|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
83661216|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83661217|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661218|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83661219|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661220|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661221|NCT01518634|Imipramine|imipramine|mesh-list
83661222|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83661223|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
83661224|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83661225|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83661226|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83661227|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661228|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661229|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83661230|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661231|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661232|NCT01518712|Metformin|metformin|mesh-list
83661233|NCT01518712|Canagliflozin|canagliflozin|mesh-list
83661234|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661235|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661236|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83661237|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661238|NCT01518725|Vitamin D|vitamin d|mesh-list
83661239|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
83661240|NCT01518725|Vitamins|vitamins|mesh-ancestor
83661241|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
83661242|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661243|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83661244|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661245|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83661246|NCT01518790|Laxatives|laxatives|mesh-ancestor
83661247|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83661248|NCT01518855|Amlodipine|amlodipine|mesh-list
83661249|NCT01518855|Nifedipine|nifedipine|mesh-list
83661250|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661251|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83661252|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661253|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661254|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661255|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661256|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
83661257|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
83661258|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83661259|NCT01518933|Silybin|silybin|mesh-list
83661260|NCT01518933|Silymarin|silymarin|mesh-list
83661261|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
83661262|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661263|NCT01518933|Protective Agents|protective agents|mesh-ancestor
83661264|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661265|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83661266|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661267|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
83661268|NCT01518959|Vitamin D|vitamin d|mesh-list
83661269|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661270|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661271|NCT01518959|Vitamins|vitamins|mesh-ancestor
83661272|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
83661273|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83661274|NCT01518998|Amlodipine|amlodipine|mesh-list
83661275|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661276|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83661277|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661278|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661279|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661280|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661281|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
83661282|NCT01519011|Azacitidine|azacitidine|mesh-list
83661283|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83661284|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
83661285|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661286|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661287|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661288|NCT01519037|Cinacalcet|cinacalcet|mesh-list
83661289|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661290|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661291|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83661292|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
83661293|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661294|NCT01519076|Coal Tar|coal tar|mesh-list
83661295|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
83661296|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
83661297|NCT01519102|Hormones|hormones|mesh-list
83661298|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661299|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661300|NCT01519128|Rilpivirine|rilpivirine|mesh-list
83661301|NCT01519128|Digoxin|digoxin|mesh-list
83661302|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661303|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83661304|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661305|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661306|NCT01519128|Protective Agents|protective agents|mesh-ancestor
83661307|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661308|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83661309|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83661310|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
83661311|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661312|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83661313|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83661314|NCT01519154|Ketamine|ketamine|mesh-list
83661315|NCT01519154|Propofol|propofol|mesh-list
83661316|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83661317|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661318|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661319|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83661320|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
83661321|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
83661322|NCT01519154|Analgesics|analgesics|mesh-ancestor
83661323|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
83661324|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661325|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83661326|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83661327|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83661328|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661329|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661330|NCT01519297|Irbesartan|irbesartan|mesh-list
83661331|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661332|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83661333|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83661334|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661335|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83661336|NCT01519310|Metronidazole|metronidazole|mesh-list
83661337|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
83661338|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661339|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83661340|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83661341|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83661342|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83661343|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816077|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83661344|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661345|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661346|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83661347|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83661348|NCT01519336|Ritonavir|ritonavir|mesh-list
83661349|NCT01519336|Darunavir|darunavir|mesh-list
83661350|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83661351|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83661352|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
83661353|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661354|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661355|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83661356|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83661357|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
83661358|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661359|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83661360|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83661361|NCT01519401|Drospirenone|drospirenone|mesh-list
83661362|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83661363|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83661364|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83661365|NCT01519401|Estradiol|estradiol|mesh-list
83661366|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83661367|NCT01519401|Estrogens|estrogens|mesh-ancestor
83661368|NCT01519401|Hormones|hormones|mesh-ancestor
83661369|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661370|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661371|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83661372|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
83661373|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83661374|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83661375|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83661376|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83661377|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83661378|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
83661379|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83661380|NCT01519401|Diuretics|diuretics|mesh-ancestor
83661381|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
83661382|NCT01519544|Acetazolamide|acetazolamide|mesh-list
83661383|NCT01519544|Temazepam|temazepam|mesh-list
83661384|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
83661385|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83661386|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661387|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661388|NCT01519544|Diuretics|diuretics|mesh-ancestor
83661389|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
83661390|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661391|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83661392|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661393|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83661394|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83661395|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83661396|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
83661397|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
83661398|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661399|NCT01519687|Tofisopam|tofisopam|mesh-list
83661400|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
83661401|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83661402|NCT01519726|Midazolam|midazolam|mesh-list
83661403|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83661404|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83661405|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661406|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661407|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83661408|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83661409|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83661410|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83661411|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
83661412|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
83661413|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
83661414|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
83661415|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661416|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661417|NCT01519752|Oxiconazole|oxiconazole|mesh-list
83661418|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
83661419|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661420|NCT01519856|Piribedil|piribedil|mesh-list
83661421|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83661422|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83661423|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
83661424|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
83661425|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661426|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661427|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661428|NCT01519986|Vitamin D|vitamin d|mesh-list
83661429|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
83661430|NCT01519986|Vitamins|vitamins|mesh-ancestor
83661431|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
83661432|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661433|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83661434|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661435|NCT01520012|Esomeprazole|esomeprazole|mesh-list
83661436|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83661437|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83661438|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83661439|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661440|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661441|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83661442|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83661443|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661444|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83661445|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83661446|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83661447|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
83661448|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661449|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83661450|NCT01520103|Everolimus|everolimus|mesh-list
83661451|NCT01520103|Vinorelbine|vinorelbine|mesh-list
83661452|NCT01520103|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83661453|NCT01520103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83661454|NCT01520103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661455|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661456|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83661457|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
83661458|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661459|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661460|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83661461|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
83661462|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
83661463|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
83661464|NCT01520116|Timolol|timolol|mesh-list
83661465|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83661466|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83661467|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
83661468|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661469|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661470|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661471|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661472|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661473|NCT01520181|Lactams|lactams|mesh-list
83661474|NCT01520181|beta-Lactams|beta-lactams|mesh-list
83661475|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83661476|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661477|NCT01520285|Felodipine|felodipine|mesh-list
83661478|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661479|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661480|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83661481|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661482|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661483|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661484|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661485|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
83661486|NCT01520298|Acetaminophen|acetaminophen|mesh-list
83661487|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661488|NCT01520298|Analgesics|analgesics|mesh-ancestor
83661489|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
83661490|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661491|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661492|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
83661493|NCT01520350|Aripiprazole|aripiprazole|mesh-list
83661494|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
83661495|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83661496|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83661497|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83661498|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661499|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661500|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
83661501|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
83661502|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661503|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661504|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83661505|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83661506|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
83661507|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83661508|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83661509|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83661510|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83661511|NCT01520389|Irinotecan|irinotecan|mesh-list
83661512|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83661513|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83661514|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83661515|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661516|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661517|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661518|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
83661519|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661520|NCT01520415|Lidocaine|lidocaine|mesh-list
83661521|NCT01520415|Bupivacaine|bupivacaine|mesh-list
83661522|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
83661523|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
83661524|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661525|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661526|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
83661527|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661528|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661529|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83661530|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83397798|NCT00089843|Androgens|androgens|mesh-ancestor
83661531|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661532|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661533|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83661534|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83661535|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661536|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661537|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83661538|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661539|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661540|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
83661541|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661542|NCT01520467|Anastrozole|anastrozole|mesh-list
83661543|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83661544|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661545|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83661546|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83661547|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661548|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661549|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83661550|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
83661551|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661552|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661553|NCT01520584|Vitamins|vitamins|mesh-list
83661554|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
83661555|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661556|NCT01520753|Insulin|insulin|mesh-list
83661557|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83661558|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
83661559|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
83661560|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83661561|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
83661562|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661563|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661564|NCT01520766|Methamphetamine|methamphetamine|mesh-list
83661565|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83661566|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661568|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
83661569|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661570|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
83661571|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661572|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661573|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
83661574|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83661575|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83661576|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661577|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83661578|NCT01520792|Acetaminophen|acetaminophen|mesh-list
83661579|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661580|NCT01520792|Analgesics|analgesics|mesh-ancestor
83661581|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
83661582|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661583|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661584|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
83661585|NCT01520818|Insulin|insulin|mesh-list
83661586|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83661587|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
83661588|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
83661589|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83661590|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
83661591|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661592|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661593|NCT01520831|Insulin|insulin|mesh-list
83661594|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83661595|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
83661596|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
83661597|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83661598|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
83661599|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83661600|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661601|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661602|NCT01520896|Ketoconazole|ketoconazole|mesh-list
83661603|NCT01520896|Naloxegol|naloxegol|mesh-list
83661604|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
83661605|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661606|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83661607|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83661608|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661609|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661610|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83661611|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
83661612|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661613|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661614|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83661615|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83661616|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
83661617|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661618|NCT01521130|Levetiracetam|levetiracetam|mesh-list
83661619|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
83661620|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
83661621|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
83661622|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661623|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
83661624|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661625|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661626|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83661627|NCT01521312|Saxagliptin|saxagliptin|mesh-list
83661628|NCT01521312|Incretins|incretins|mesh-ancestor
83661629|NCT01521312|Hormones|hormones|mesh-ancestor
83661630|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661631|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661632|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83661633|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
83661634|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661635|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661636|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661637|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83661638|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
82816372|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
83661639|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661640|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
83661641|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83661642|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83661643|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661644|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83661645|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83661646|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661647|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661648|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661649|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83661650|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
83661651|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83661652|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661653|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83661654|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83661655|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83661656|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83661657|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83661658|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
83661659|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661660|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661661|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83661662|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
83661663|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
83661664|NCT01521455|Hormones|hormones|mesh-ancestor
83661665|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661666|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
83661667|NCT01521481|Anesthetics|anesthetics|mesh-list
83661668|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661669|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661670|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83661671|NCT01521520|Hematinics|hematinics|mesh-ancestor
83661672|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83661673|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83661674|NCT01521572|Albuterol|albuterol|mesh-list
83661675|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83661676|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
83661677|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661678|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661679|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83661680|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
83661681|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
83661682|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83661683|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83661684|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83661685|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83661686|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
83661687|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661688|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661689|NCT01521624|Metformin|metformin|mesh-list
83661690|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661691|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661692|NCT01521689|Rituximab|rituximab|mesh-list
83661693|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83661694|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661695|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
83661696|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661697|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83661698|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83661699|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83661700|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83661701|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
83661702|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661703|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661704|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661705|NCT01521767|Urological Agents|urological agents|mesh-ancestor
83661706|NCT01521793|Retinol acetate|retinol acetate|mesh-list
83661707|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83661708|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
83661709|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661710|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83661711|NCT01521793|Protective Agents|protective agents|mesh-ancestor
83661712|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661713|NCT01521819|Ranibizumab|ranibizumab|mesh-list
83661714|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83661715|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83661716|NCT01521819|Growth Substances|growth substances|mesh-ancestor
83661717|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661718|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
83661719|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661720|NCT01521936|Vitamin D|vitamin d|mesh-list
83661721|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
83661722|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
83661723|NCT01521936|Vitamins|vitamins|mesh-list
83661724|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
83661725|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661726|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83661727|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661728|NCT01521962|Alogliptin|alogliptin|mesh-list
83661729|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661730|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661731|NCT01521962|Incretins|incretins|mesh-ancestor
83661732|NCT01521962|Hormones|hormones|mesh-ancestor
83661733|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661734|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83661735|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
83661736|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661737|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661738|NCT01521975|Adefovir|adefovir|mesh-list
83661739|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83661740|NCT01521975|Telbivudine|telbivudine|mesh-list
83661741|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
83661742|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661743|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83661744|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83661745|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661746|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661747|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
83661748|NCT01522040|Analgesics|analgesics|mesh-ancestor
83661749|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
83661750|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661751|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661752|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
83661753|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661754|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661755|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
83661756|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83661757|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661758|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661759|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83661760|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
83661761|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83661762|NCT01522092|Escitalopram|escitalopram|mesh-list
83661763|NCT01522092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83661764|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83661765|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83661766|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661767|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661768|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
83661769|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661770|NCT01522105|Daptomycin|daptomycin|mesh-list
83661771|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83661772|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661773|NCT01522326|Ibuprofen|ibuprofen|mesh-list
83661774|NCT01522326|Metoclopramide|metoclopramide|mesh-list
83661775|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83661776|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661777|NCT01522326|Analgesics|analgesics|mesh-ancestor
83661778|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
83661779|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661780|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661781|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83661782|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83661783|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83661784|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661785|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661786|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
83661787|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
83661788|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83661789|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83661790|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83661791|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
83661792|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661793|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83661794|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661795|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661796|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661797|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83661798|NCT01522534|Morphine|morphine|mesh-list
83661799|NCT01522534|Mepivacaine|mepivacaine|mesh-list
83661800|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83661801|NCT01522534|Narcotics|narcotics|mesh-ancestor
83661802|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661803|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661804|NCT01522534|Analgesics|analgesics|mesh-ancestor
83661805|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
83661806|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661807|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
83661808|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
83661809|NCT01522547|Pomalidomide|pomalidomide|mesh-list
83661810|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
83661811|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661812|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83661813|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83661814|NCT01522547|Growth Substances|growth substances|mesh-ancestor
83661815|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
83661816|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661817|NCT01522612|Leucovorin|leucovorin|mesh-list
83661818|NCT01522612|Fluorouracil|fluorouracil|mesh-list
83661819|NCT01522612|Cetuximab|cetuximab|mesh-list
83661820|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
83661821|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661822|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83661823|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661824|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83661825|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
83661826|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661827|NCT01522612|Antidotes|antidotes|mesh-ancestor
83661828|NCT01522612|Protective Agents|protective agents|mesh-ancestor
83661829|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
83661830|NCT01522612|Vitamins|vitamins|mesh-ancestor
83661831|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
83661832|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83661833|NCT01522625|Tenofovir|tenofovir|mesh-list
83661834|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
83661835|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661836|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83661837|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83661838|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661839|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661840|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83661841|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83661842|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83661843|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83661844|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
83661845|NCT01522729|Fentanyl|fentanyl|mesh-list
83661846|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83661847|NCT01522729|Narcotics|narcotics|mesh-ancestor
83661848|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83661849|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661850|NCT01522729|Analgesics|analgesics|mesh-ancestor
83661851|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
83661852|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661853|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83661854|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83661855|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
83661856|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
83661857|NCT01522820|Sirolimus|sirolimus|mesh-list
83661858|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83661859|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661860|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83661861|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661862|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
83661863|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83661865|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661866|NCT01522846|Heparin|heparin|mesh-list
83661867|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
83661868|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83661869|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83661870|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661871|NCT01522872|Dexamethasone|dexamethasone|mesh-list
83661872|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
83661873|NCT01522872|Bortezomib|bortezomib|mesh-list
83661874|NCT01522872|Pomalidomide|pomalidomide|mesh-list
83661875|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
83661876|NCT01522872|BB 1101|bb 1101|mesh-list
83661877|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83661878|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
83661879|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
83661880|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661881|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661882|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83661883|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
83661884|NCT01522872|Hormones|hormones|mesh-ancestor
83661885|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83661886|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83661887|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661888|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
83661889|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661890|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661891|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
83661892|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83661893|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83661894|NCT01522872|Growth Substances|growth substances|mesh-ancestor
83661895|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
83661896|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83661897|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
83661898|NCT01522989|Fluorouracil|fluorouracil|mesh-list
83661899|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
83661900|NCT01522989|Palbociclib|palbociclib|mesh-list
83661901|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
83661902|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661903|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83661904|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661905|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83661906|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
83661907|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661908|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83661909|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83661910|NCT01523002|Artesunate|artesunate|mesh-list
83661911|NCT01523002|Pyronaridine|pyronaridine|mesh-list
83661912|NCT01523002|Metoprolol|metoprolol|mesh-list
83661913|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661914|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661915|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
83661916|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
83661917|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661918|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661919|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83661920|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83661921|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83661922|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
83661923|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661924|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661925|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
83661926|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83661927|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83661928|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83661929|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661930|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
83661931|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
83661932|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83661933|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
83661934|NCT01523015|Docetaxel|docetaxel|mesh-list
83661935|NCT01523015|Fluorouracil|fluorouracil|mesh-list
83661936|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
83661937|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83661938|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83661939|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83661940|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83661941|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661942|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
83661943|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83661944|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83661945|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
83661946|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661947|NCT01523041|Insulin|insulin|mesh-list
83661948|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83661949|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
83661950|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
83661951|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83661952|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
83661953|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83661954|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661955|NCT01523054|Metoprolol|metoprolol|mesh-list
83661956|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83661957|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83661958|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
83661959|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
83661960|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661961|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661962|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83661963|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83661964|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83661965|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
83661966|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661967|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661968|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
83661969|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
83661970|NCT01523080|Acetaminophen|acetaminophen|mesh-list
83661971|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83661972|NCT01523080|Analgesics|analgesics|mesh-ancestor
83661973|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
83661974|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661975|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661976|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
83661977|NCT01523093|Ondansetron|ondansetron|mesh-list
83661978|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
83661979|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
83661980|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661981|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661982|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83661983|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
83661984|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
83661985|NCT01523093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83661986|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83661987|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
83661988|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83661989|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83661990|NCT01523119|Ondansetron|ondansetron|mesh-list
83661991|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
83661992|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
83661993|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83661994|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83661995|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83661996|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
83661997|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
83661998|NCT01523119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83661999|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83662000|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
83662001|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662002|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662003|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
83662004|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662005|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
83662006|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83662007|NCT01523314|Dexamethasone|dexamethasone|mesh-list
83662008|NCT01523314|Bevacizumab|bevacizumab|mesh-list
83662009|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83662010|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662011|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
83662012|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
83662013|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662014|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662015|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83662016|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
83662018|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662019|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83662020|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662021|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83662022|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83662023|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83662024|NCT01523314|Growth Substances|growth substances|mesh-ancestor
83662025|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
83662026|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83662027|NCT01523327|Uric Acid|uric acid|mesh-list
83662028|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
83662029|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662030|NCT01523327|Protective Agents|protective agents|mesh-ancestor
83662031|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662032|NCT01523379|Parecoxib|parecoxib|mesh-list
83662033|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83662034|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83662035|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662036|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662037|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83662038|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83662039|NCT01523379|Analgesics|analgesics|mesh-ancestor
83662040|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
83662041|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662042|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662043|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662044|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662045|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
83662046|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83662047|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
83662048|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83662049|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
83662050|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662051|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662052|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
83662053|NCT01523431|Leucovorin|leucovorin|mesh-list
83662054|NCT01523431|Fluorouracil|fluorouracil|mesh-list
83662055|NCT01523431|Irinotecan|irinotecan|mesh-list
83662056|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
83662057|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662058|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83662059|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662060|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662061|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
83662062|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662063|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83662064|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83662065|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662066|NCT01523431|Antidotes|antidotes|mesh-ancestor
83662067|NCT01523431|Protective Agents|protective agents|mesh-ancestor
83662068|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
83662069|NCT01523431|Vitamins|vitamins|mesh-ancestor
83662070|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
83662071|NCT01523483|Progesterone|progesterone|mesh-list
83662072|NCT01523483|Progestins|progestins|mesh-ancestor
83662073|NCT01523483|Hormones|hormones|mesh-ancestor
83662074|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662075|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662076|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
83662077|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
83662078|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662079|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
83662080|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662081|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662082|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
83662083|NCT01523574|Vitamin E|vitamin e|mesh-list
83662084|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
83662085|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
83662086|NCT01523574|Calcium|calcium|mesh-list
83662087|NCT01523574|Vitamins|vitamins|mesh-ancestor
83662088|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
83662089|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662090|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82816830|NCT00434304|Ropinirole|ropinirole|mesh-list
83662091|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83662092|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662093|NCT01523574|Analgesics|analgesics|mesh-ancestor
83662094|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
83662095|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662096|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
83662097|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662098|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83662099|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
83662100|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83662101|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662102|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662103|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
83662104|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83662105|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
83662106|NCT01523574|Protective Agents|protective agents|mesh-ancestor
83662108|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662109|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662110|NCT01523678|Paclitaxel|paclitaxel|mesh-list
83662111|NCT01523678|Carboplatin|carboplatin|mesh-list
83662112|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83662113|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662114|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
83662115|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
83662116|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
83662117|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662118|NCT01523847|Doxorubicin|doxorubicin|mesh-list
83662119|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83662120|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662121|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83662122|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83662123|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662124|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662125|NCT01523860|Rituximab|rituximab|mesh-list
83662126|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83662127|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
83662128|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83662129|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662130|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
83662131|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662132|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662133|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83662134|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
83662135|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662136|NCT01523860|Analgesics|analgesics|mesh-ancestor
83662137|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
83662138|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662139|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83662140|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83662141|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662142|NCT01524068|Rituximab|rituximab|mesh-list
83662143|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83662144|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662145|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
83662146|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662147|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662148|NCT01524081|Amoxicillin|amoxicillin|mesh-list
83662149|NCT01524081|Metronidazole|metronidazole|mesh-list
83662150|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
83662151|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
83662152|NCT01524081|Cefuroxime|cefuroxime|mesh-list
83662153|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
83662154|NCT01524081|Fluconazole|fluconazole|mesh-list
83662155|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83662156|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83662157|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662158|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83662159|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83662160|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
83662161|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83662162|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83662163|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662164|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662165|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83662166|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
82816901|NCT00461630|Niacin|niacin|mesh-list
83662167|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662168|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662169|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83662170|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83662171|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83662173|NCT01524094|Fluorouracil|fluorouracil|mesh-list
83662174|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
83662175|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
83662176|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
83662177|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662178|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83662179|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662180|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662181|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
83662182|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662183|NCT01524094|Antidotes|antidotes|mesh-ancestor
83662184|NCT01524094|Protective Agents|protective agents|mesh-ancestor
83662185|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
83662186|NCT01524094|Vitamins|vitamins|mesh-ancestor
83662187|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
83662188|NCT01524237|Ketamine|ketamine|mesh-list
83662189|NCT01524237|Analgesics|analgesics|mesh-ancestor
83662190|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
83662191|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662192|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662193|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83662194|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83662195|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
83662196|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
83662197|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662198|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83662199|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83662200|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662201|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662202|NCT01524315|Vitamins|vitamins|mesh-list
83662203|NCT01524315|Thiamine|thiamine|mesh-list
83662204|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
83662205|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
83662206|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662207|NCT01524354|Anesthetics|anesthetics|mesh-list
83662208|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662209|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662210|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
83662211|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83662212|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662213|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662214|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83662215|NCT01524367|Analgesics|analgesics|mesh-ancestor
83662216|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
83662217|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662218|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83662219|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83662220|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83662221|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
83662222|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662223|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662224|NCT01524432|Clotrimazole|clotrimazole|mesh-list
83662225|NCT01524432|Miconazole|miconazole|mesh-list
83662226|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
83662227|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83662228|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662229|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83662230|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83662231|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662232|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662233|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83662234|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
83662235|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662236|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662237|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83662238|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83662239|NCT01524445|Bortezomib|bortezomib|mesh-list
83662240|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662241|NCT01524497|Trazodone|trazodone|mesh-list
83662242|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83662243|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83662244|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662245|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662246|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83662247|NCT01524497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83662248|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83662249|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662250|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662251|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662252|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
83662253|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83662254|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
83662255|NCT01524575|Gemcitabine|gemcitabine|mesh-list
83662256|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
83662257|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83662258|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
83662259|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662260|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662261|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83662262|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83662263|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83662264|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
83662265|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662266|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83662267|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83662268|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662269|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83662270|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83662271|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83662272|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
83662273|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662274|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83662275|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83662276|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662277|NCT01524705|Insulin|insulin|mesh-list
83662278|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83662279|NCT01524705|Metformin|metformin|mesh-list
83662280|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
83662281|NCT01524705|Exenatide|exenatide|mesh-list
83662282|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83662283|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662284|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662285|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83662286|NCT01524705|Incretins|incretins|mesh-ancestor
83662287|NCT01524705|Hormones|hormones|mesh-ancestor
83662288|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662289|NCT01524731|Dexamethasone|dexamethasone|mesh-list
83662290|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
83662291|NCT01524731|BB 1101|bb 1101|mesh-list
83662292|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662293|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
83662294|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
83662295|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662296|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662297|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83662298|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
83662299|NCT01524731|Hormones|hormones|mesh-ancestor
83662300|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662301|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83662302|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662303|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
83662304|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662305|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662306|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
83662307|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83662308|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83662309|NCT01524744|Analgesics|analgesics|mesh-ancestor
83662310|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
83662311|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662312|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662313|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662314|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662315|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83662316|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662317|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
83662318|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83662319|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662320|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662321|NCT01524757|Pantoprazole|pantoprazole|mesh-list
83662322|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83662323|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83662324|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83662325|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662326|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662327|NCT01524809|Insulin|insulin|mesh-list
83662328|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83662329|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
83662330|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
83662331|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83662332|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
83662333|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83662334|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662335|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662336|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
83662337|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
83662338|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
83662339|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662340|NCT01524861|Protective Agents|protective agents|mesh-ancestor
83662341|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662342|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
83662343|NCT01524861|Vitamins|vitamins|mesh-ancestor
83662344|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
83662345|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
83662346|NCT01524874|Vitamin D|vitamin d|mesh-list
83662347|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
83662348|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
83662349|NCT01524874|Calcitriol|calcitriol|mesh-list
83662350|NCT01524874|Vitamins|vitamins|mesh-list
83662351|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
83662352|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662353|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83662354|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83662355|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83662356|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662357|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662358|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83662359|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
83662360|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83662361|NCT01524939|Antibodies|antibodies|mesh-list
83662362|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
83662363|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
83662364|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662365|NCT01525004|Vaccines|vaccines|mesh-list
83662366|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
83662367|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662368|NCT01525043|Naproxen|naproxen|mesh-list
83662369|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83662370|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83662371|NCT01525043|Analgesics|analgesics|mesh-ancestor
83662372|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
83662373|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662374|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662375|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662376|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662377|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
83662378|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83662379|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662380|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662381|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83662382|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83662383|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83662384|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662385|NCT01525537|Sufentanil|sufentanil|mesh-list
83662386|NCT01525537|Dsuvia|dsuvia|mesh-list
83662387|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83662388|NCT01525537|Narcotics|narcotics|mesh-ancestor
83662389|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662390|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662391|NCT01525537|Analgesics|analgesics|mesh-ancestor
83662392|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
83662393|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662394|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83662395|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83662396|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
83662397|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
83662398|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
83662399|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662400|NCT01525706|Ethanol|ethanol|mesh-list
83662401|NCT01525706|Paclitaxel|paclitaxel|mesh-list
83662402|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83662403|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83662404|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662405|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
83662406|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
83662407|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
83662408|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662409|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83662410|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662411|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662412|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662413|NCT01525719|Everolimus|everolimus|mesh-list
83662414|NCT01525719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83662415|NCT01525719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83662416|NCT01525719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662417|NCT01525719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662418|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662419|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
83662420|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662421|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662422|NCT01525771|Cisplatin|cisplatin|mesh-list
83662423|NCT01525771|Docetaxel|docetaxel|mesh-list
83662424|NCT01525771|Capecitabine|capecitabine|mesh-list
83662425|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662426|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83662427|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83662428|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83662429|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662430|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83662431|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
83662432|NCT01525823|Metformin|metformin|mesh-list
83662433|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662434|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662435|NCT01525836|Rituximab|rituximab|mesh-list
83662436|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83662437|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662438|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
83662439|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662440|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662441|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83662442|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83662443|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83662444|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662445|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83662446|NCT01525914|Dutasteride|dutasteride|mesh-list
83662447|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83662448|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83662449|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662450|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662451|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
83662452|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662453|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662454|NCT01526005|Nicotine|nicotine|mesh-list
83662455|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83662456|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
83662457|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662458|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662459|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83662460|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83662461|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
83662462|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662463|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662464|NCT01526070|Aflibercept|aflibercept|mesh-list
83662465|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83662466|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83662467|NCT01526070|Growth Substances|growth substances|mesh-ancestor
83662468|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662469|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
83662470|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662471|NCT01526083|Lacosamide|lacosamide|mesh-list
83662472|NCT01526083|Warfarin|warfarin|mesh-list
83662473|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
83662474|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
83662475|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83662476|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83662477|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662478|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662479|NCT01526122|Aspirin|aspirin|mesh-list
83662480|NCT01526122|Clopidogrel|clopidogrel|mesh-list
83662481|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83662482|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83662483|NCT01526122|Analgesics|analgesics|mesh-ancestor
83662484|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
83662485|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662486|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662487|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662488|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662489|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83662490|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83662491|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662492|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83662493|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83662494|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662495|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
83662496|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83662497|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83662498|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83662499|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
83662500|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662501|NCT01526161|Fluticasone|fluticasone|mesh-list
83662503|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83662504|NCT01526161|Montelukast|montelukast|mesh-list
83662505|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662506|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83662507|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
83662508|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662509|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662510|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83662511|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
83662512|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
83662513|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83662514|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83662515|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83662516|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83662517|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83662518|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662519|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662520|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83662521|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
83662522|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662523|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83662524|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83662525|NCT01526174|Golimumab|golimumab|mesh-list
83662526|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83662527|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662528|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662529|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
83662530|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662531|NCT01526278|Alendronate|alendronate|mesh-list
83662532|NCT01526278|Calcitriol|calcitriol|mesh-list
83662533|NCT01526278|Maxmarvil|maxmarvil|mesh-list
83662534|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83662535|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662536|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83662537|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83662538|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662539|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662540|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83662541|NCT01526278|Vitamins|vitamins|mesh-ancestor
83662542|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
83662543|NCT01526317|Metformin|metformin|mesh-list
83662544|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83662545|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662546|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662547|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83662548|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83662549|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
83662550|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662551|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83662552|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83662553|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662554|NCT01526369|Paclitaxel|paclitaxel|mesh-list
83662555|NCT01526369|Trastuzumab|trastuzumab|mesh-list
83662556|NCT01526369|Lapatinib|lapatinib|mesh-list
83662557|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83662558|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662559|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83662560|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83662561|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83662562|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662563|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83662564|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83662565|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662566|NCT01526395|Propofol|propofol|mesh-list
83662567|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83662568|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662569|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662570|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83662571|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
83662572|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
83662573|NCT01526460|Atorvastatin|atorvastatin|mesh-list
83662574|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83662575|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83662576|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83662577|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
83662578|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662579|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83662580|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83662581|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662582|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
83662583|NCT01526499|Docetaxel|docetaxel|mesh-list
83662584|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662585|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
83662586|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662587|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662588|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83662589|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
83662590|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662591|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662592|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83662593|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83662594|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83662595|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83662596|NCT01526525|Acetaminophen|acetaminophen|mesh-list
83662597|NCT01526525|Parecoxib|parecoxib|mesh-list
83662598|NCT01526525|Ketamine|ketamine|mesh-list
83662599|NCT01526525|Morphine|morphine|mesh-list
83662600|NCT01526525|Tramadol|tramadol|mesh-list
83662601|NCT01526525|Analgesics|analgesics|mesh-ancestor
83662602|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
83662603|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662604|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662605|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83662606|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83662607|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
83662608|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
83662609|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662610|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83662611|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83662612|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817341|NCT01025882|Gemcitabine|gemcitabine|mesh-list
83662613|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662614|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83662615|NCT01526525|Narcotics|narcotics|mesh-ancestor
83662616|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83662617|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
83662618|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83662619|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83662620|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662621|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83662622|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662623|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662624|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
83662625|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
83662626|NCT01526564|Vitamins|vitamins|mesh-ancestor
83662627|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
83662628|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662629|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
83662630|NCT01526616|Metformin|metformin|mesh-list
83662631|NCT01526616|Spironolactone|spironolactone|mesh-list
83662632|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662633|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662634|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83662635|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
83662636|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662637|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83662638|NCT01526616|Diuretics|diuretics|mesh-ancestor
83662639|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
83662640|NCT01526694|Thalidomide|thalidomide|mesh-list
83662641|NCT01526694|Dexamethasone|dexamethasone|mesh-list
83662642|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83662643|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662644|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
83662645|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
83662646|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662647|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662648|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83662649|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
83662650|NCT01526694|Hormones|hormones|mesh-ancestor
83662651|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662652|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83662653|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662654|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83662655|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
83662656|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662657|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662658|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
83662659|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
83662660|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83662661|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662662|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83662663|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83662664|NCT01526694|Growth Substances|growth substances|mesh-ancestor
83662665|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
83662666|NCT01526837|Bevacizumab|bevacizumab|mesh-list
83662667|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83662668|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662669|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83662670|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83662671|NCT01526837|Growth Substances|growth substances|mesh-ancestor
83662672|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662673|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
83662674|NCT01526850|Cyclosporine|cyclosporine|mesh-list
83662675|NCT01526850|Cyclosporins|cyclosporins|mesh-list
83662676|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
83662677|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662678|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662679|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662680|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
83662681|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662682|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
83662683|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662684|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
83662685|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662686|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83662687|NCT01526850|Hormones|hormones|mesh-ancestor
83662688|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662689|NCT01526876|Clevidipine|clevidipine|mesh-list
83662690|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83662691|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662692|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662693|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83662694|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662695|NCT01526941|Insulin|insulin|mesh-list
83662696|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83662697|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
83662698|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
83662699|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83662700|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
83662701|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83662702|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662703|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662704|NCT01526980|Insulin|insulin|mesh-list
83662705|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83662706|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
83662707|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
83662708|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83662709|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
83662710|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83662711|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662712|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662713|NCT01527019|Cephalosporins|cephalosporins|mesh-list
83662714|NCT01527019|Norfloxacin|norfloxacin|mesh-list
83662715|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83662716|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662717|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83662718|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83662719|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662720|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662721|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662722|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83662723|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83662724|NCT01527032|Thalidomide|thalidomide|mesh-list
83662725|NCT01527032|Dexamethasone|dexamethasone|mesh-list
83662726|NCT01527032|Melphalan|melphalan|mesh-list
83662727|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662728|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
83662729|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
83662730|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662731|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662732|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83662733|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
83662734|NCT01527032|Hormones|hormones|mesh-ancestor
83662735|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662736|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83662737|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662738|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83662739|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
83662740|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662741|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83662742|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662743|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
83662744|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
83662745|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83662746|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662747|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83662748|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83662749|NCT01527032|Growth Substances|growth substances|mesh-ancestor
83662750|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
83662751|NCT01527097|Atorvastatin|atorvastatin|mesh-list
83662752|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83662753|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83662754|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
83662755|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662756|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83662757|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83662758|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662759|NCT01527279|Antazoline|antazoline|mesh-list
83662760|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83662761|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
82817489|NCT00308139|Exenatide|exenatide|mesh-list
83662762|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
83662763|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662764|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662765|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662766|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83662767|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83662768|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83662769|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83662770|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662771|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662772|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83662773|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83662774|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83662775|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
83662776|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662777|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662778|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83662779|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83662780|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
83662781|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
83662782|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83662783|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83662784|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
83662785|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662786|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83662787|NCT01527422|Prednisone|prednisone|mesh-list
83662788|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
83662789|NCT01527422|Doxorubicin|doxorubicin|mesh-list
83662790|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83662791|NCT01527422|Vincristine|vincristine|mesh-list
83662792|NCT01527422|Sargramostim|sargramostim|mesh-list
83662793|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662794|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
83662795|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662796|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662797|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83662798|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
83662799|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662800|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662801|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83662802|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83662803|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83662804|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83662805|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662806|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83662807|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
83662808|NCT01527422|Hormones|hormones|mesh-ancestor
83662809|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83662810|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83662811|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83662812|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
83662813|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
83662814|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
83662815|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83662816|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
83662817|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83662818|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83662819|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83662820|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662821|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662822|NCT01527474|Escitalopram|escitalopram|mesh-list
83662823|NCT01527474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83662824|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83662825|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662826|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662827|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662828|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
83662829|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662830|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
83662831|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
83662832|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83662833|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662834|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662835|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
83662836|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
83662837|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662838|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662839|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
83662840|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
83662841|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662842|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662843|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
83662844|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
83662845|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662846|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662847|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
83662848|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
83662849|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662850|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662851|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
83662852|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
83662853|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83662854|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662855|NCT01527669|Lovastatin|lovastatin|mesh-list
83662856|NCT01527669|L 647318|l 647318|mesh-list
83662857|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
83662858|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83662859|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83662860|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
83662861|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662862|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83662863|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83662864|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662865|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
83662866|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
83662867|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
83662868|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662869|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662870|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
83662871|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662872|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83662873|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662874|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662875|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83662876|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83662877|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83662878|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83662879|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662880|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662881|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662882|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
83662883|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83662884|NCT01527864|Paclitaxel|paclitaxel|mesh-list
83662885|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83662886|NCT01527864|Carboplatin|carboplatin|mesh-list
83662887|NCT01527864|Endostatins|endostatins|mesh-list
83662888|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83662889|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662890|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
83662891|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
83662892|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
83662893|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662894|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83662895|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83662896|NCT01527864|Growth Substances|growth substances|mesh-ancestor
83662897|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662898|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
83662899|NCT01527890|Fentanyl|fentanyl|mesh-list
83662900|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83662901|NCT01527890|Narcotics|narcotics|mesh-ancestor
83662902|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662903|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662904|NCT01527890|Analgesics|analgesics|mesh-ancestor
83662905|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
83662906|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662907|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83662908|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83662909|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
83662910|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
83662911|NCT01527903|Midazolam|midazolam|mesh-list
83662912|NCT01527903|Propofol|propofol|mesh-list
83662913|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83662914|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662915|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662916|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83662917|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
83662918|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
83662919|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83662920|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83662921|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83662922|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83662923|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
83662924|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
83662925|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662926|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662927|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
83662928|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
83662929|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83662930|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83662931|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662932|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
83662933|NCT01527968|Coagulants|coagulants|mesh-ancestor
83662934|NCT01527994|Aprepitant|aprepitant|mesh-list
83662935|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
83662936|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
83662937|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662938|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662939|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83662940|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83662941|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662942|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662943|NCT01528007|Naltrexone|naltrexone|mesh-list
83662944|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83662945|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83662946|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662947|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
83662948|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83662949|NCT01528137|Lactoferrin|lactoferrin|mesh-list
83662950|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
83662951|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83662952|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662953|NCT01528163|Methotrexate|methotrexate|mesh-list
83662954|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83662955|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
83662956|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83662957|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662958|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83662959|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
83662960|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662961|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662962|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
83662963|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662964|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83662965|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83662966|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
83662967|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83662968|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83662969|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
83662970|NCT01528176|Vitamin D|vitamin d|mesh-list
83662971|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83662972|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662973|NCT01528176|Vitamins|vitamins|mesh-ancestor
83662974|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
83662975|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83662976|NCT01528371|Midazolam|midazolam|mesh-list
83662977|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83662978|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83662979|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83662980|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83662981|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83662982|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83662983|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83662984|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83662985|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
83662986|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
83662987|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
83662988|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
83662989|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83662990|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662991|NCT01528501|Panobinostat|panobinostat|mesh-list
83662992|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83662993|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83662994|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83662995|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83662996|NCT01528540|Pregabalin|pregabalin|mesh-list
83662997|NCT01528540|Antioxidants|antioxidants|mesh-list
83662998|NCT01528540|Analgesics|analgesics|mesh-ancestor
83662999|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
83663000|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663001|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663002|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
83663003|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83663004|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663005|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663006|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83663007|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83663008|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83663009|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663010|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83663011|NCT01528540|Protective Agents|protective agents|mesh-ancestor
83663012|NCT01528618|Cisplatin|cisplatin|mesh-list
83663013|NCT01528618|Gemcitabine|gemcitabine|mesh-list
83663014|NCT01528618|Fluorouracil|fluorouracil|mesh-list
83663015|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663016|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83663017|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
83663018|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663019|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663020|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
83663021|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663022|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
83663023|NCT01528644|Iron|iron|mesh-list
83663024|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
83663025|NCT01528644|Calcium|calcium|mesh-list
83663026|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83663027|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663028|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83663029|NCT01528644|Trace Elements|trace elements|mesh-ancestor
83663030|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
83663031|NCT01528644|Hematinics|hematinics|mesh-ancestor
83663032|NCT01528722|Bupivacaine|bupivacaine|mesh-list
83663033|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
83663034|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
83663035|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663036|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663037|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
83663038|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663039|NCT01528800|Vitamin K|vitamin k|mesh-list
83663040|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
83663041|NCT01528800|Vitamins|vitamins|mesh-ancestor
83663042|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
83663043|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663044|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83663045|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83663046|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663047|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
83663048|NCT01528800|Coagulants|coagulants|mesh-ancestor
83663049|NCT01528813|Amorolfine|amorolfine|mesh-list
83663050|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
83663051|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663052|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
83663053|NCT01528826|Vinorelbine|vinorelbine|mesh-list
83663054|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663055|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83663056|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
83663057|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
83663058|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
83663059|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663060|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
83663061|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83663062|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83663063|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663064|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
83663065|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83663067|NCT01528865|Lamivudine|lamivudine|mesh-list
83663068|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
83663069|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663070|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83663071|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83663072|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663073|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663074|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83663075|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83663076|NCT01528930|Amikacin|amikacin|mesh-list
83663077|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663078|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663079|NCT01528943|Epoprostenol|epoprostenol|mesh-list
83663080|NCT01528943|Tezosentan|tezosentan|mesh-list
83663081|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83663082|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83663083|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
83663084|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
83663085|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83663086|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663087|NCT01529125|Lamivudine|lamivudine|mesh-list
83663088|NCT01529125|Zidovudine|zidovudine|mesh-list
83663089|NCT01529125|Nevirapine|nevirapine|mesh-list
83663090|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83663091|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83663092|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663093|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663094|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
83663095|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663096|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83663097|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83663098|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
83663099|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83663100|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83663101|NCT01529138|Sirolimus|sirolimus|mesh-list
83663102|NCT01529138|Temsirolimus|temsirolimus|mesh-list
83663103|NCT01529138|MTOR Inhibitors|mtor inhibitors|mesh-list
83663104|NCT01529138|Axitinib|axitinib|mesh-list
83663105|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83663106|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663107|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663108|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663109|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
83663110|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663111|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663112|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663113|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663114|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83663115|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
83663116|NCT01529164|Leucovorin|leucovorin|mesh-list
83663117|NCT01529164|Fluorouracil|fluorouracil|mesh-list
83663118|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
83663119|NCT01529164|Endostar protein|endostar protein|mesh-list
83663120|NCT01529164|Endostatins|endostatins|mesh-list
83663121|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
83663122|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663123|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83663124|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663125|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663126|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
83663127|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663128|NCT01529164|Antidotes|antidotes|mesh-ancestor
83663129|NCT01529164|Protective Agents|protective agents|mesh-ancestor
83663130|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
83663131|NCT01529164|Vitamins|vitamins|mesh-ancestor
83663132|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
83663133|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83663134|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83663135|NCT01529164|Growth Substances|growth substances|mesh-ancestor
83663136|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
83663137|NCT01529177|Metformin|metformin|mesh-list
83663138|NCT01529177|Citric Acid|citric acid|mesh-list
83663139|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
83663140|NCT01529177|Clomiphene|clomiphene|mesh-list
83663141|NCT01529177|Enclomiphene|enclomiphene|mesh-list
82817868|NCT00419094|Levetiracetam|levetiracetam|mesh-list
83663142|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
83663143|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83663144|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663146|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83663147|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
83663148|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
83663149|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663150|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83663151|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
83663152|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663153|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83663154|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
83663155|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83663156|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83663157|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83663158|NCT01529190|Pregabalin|pregabalin|mesh-list
83663159|NCT01529190|Analgesics|analgesics|mesh-ancestor
83663160|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
83663161|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663162|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663163|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
83663164|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83663165|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663166|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663167|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83663168|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83663169|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83663170|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663171|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83663172|NCT01529229|Prednisolone|prednisolone|mesh-list
83663173|NCT01529229|Betamethasone|betamethasone|mesh-list
83663174|NCT01529229|Desloratadine|desloratadine|mesh-list
83663175|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
83663176|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83663177|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
83663178|NCT01529229|Hormones|hormones|mesh-ancestor
83663179|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663180|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663181|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83663182|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663183|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83663184|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
83663185|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83663186|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663187|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663188|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663189|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83663190|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83663191|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
83663192|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
83663193|NCT01529242|Prednisolone|prednisolone|mesh-list
83663194|NCT01529242|Betamethasone|betamethasone|mesh-list
83663195|NCT01529242|Desloratadine|desloratadine|mesh-list
83663196|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
83663197|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83663198|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
83663199|NCT01529242|Hormones|hormones|mesh-ancestor
83663200|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663201|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663202|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83663203|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663204|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83663205|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
83663206|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83663207|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663208|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663209|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663210|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83663211|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83663212|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
83663213|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
83663214|NCT01529255|Telbivudine|telbivudine|mesh-list
83663215|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
83663216|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663217|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83663218|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663219|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663220|NCT01529294|Iloperidone|iloperidone|mesh-list
83663221|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83663222|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83663223|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663224|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663225|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83663226|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
83663227|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83663228|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83663229|NCT01529320|Prednisolone|prednisolone|mesh-list
83663230|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
83663231|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
83663232|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83663233|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
83663234|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83663235|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
83663236|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
83663237|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663238|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663239|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83663240|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
83663241|NCT01529320|Hormones|hormones|mesh-ancestor
83663242|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663243|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83663244|NCT01529320|Protective Agents|protective agents|mesh-ancestor
83663245|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83663246|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663247|NCT01529437|Immunomodulating Agents|immunomodulating agents|mesh-list
83663248|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
83663249|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663250|NCT01529476|Levofloxacin|levofloxacin|mesh-list
83663251|NCT01529476|Nemonoxacin|nemonoxacin|mesh-list
83663252|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83663253|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663254|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663255|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83663256|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83663257|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663258|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663259|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663260|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83663261|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83663262|NCT01529528|Anagliptin|anagliptin|mesh-list
83663263|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83663264|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
83663265|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663266|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663267|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83663268|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663269|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83663270|NCT01529541|Anagliptin|anagliptin|mesh-list
83663271|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83663272|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663273|NCT01529541|Incretins|incretins|mesh-ancestor
83663274|NCT01529541|Hormones|hormones|mesh-ancestor
83663275|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663276|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83663277|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
83663278|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663279|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663280|NCT01529554|Everolimus|everolimus|mesh-list
83663281|NCT01529554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83663282|NCT01529554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83663283|NCT01529554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663284|NCT01529554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663285|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663286|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
83663287|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663288|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663289|NCT01529619|Rivastigmine|rivastigmine|mesh-list
83663290|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82818090|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663291|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663292|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663293|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663294|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663295|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663296|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83663297|NCT01529619|Protective Agents|protective agents|mesh-ancestor
83663298|NCT01529710|Praziquantel|praziquantel|mesh-list
83663299|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
83663300|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83663301|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663302|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83663303|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83663304|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83663305|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663306|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663307|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83663308|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663309|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663310|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663311|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663312|NCT01529892|Methamphetamine|methamphetamine|mesh-list
83663313|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83663314|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663315|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
83663316|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
83663317|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663318|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
83663319|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663320|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663321|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
83663322|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83663323|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83663324|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663325|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83663326|NCT01529957|Nemonoxacin|nemonoxacin|mesh-list
83663327|NCT01529957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663328|NCT01529957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663329|NCT01530022|Lacosamide|lacosamide|mesh-list
83663330|NCT01530022|Carbamazepine|carbamazepine|mesh-list
83663331|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
83663332|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83663333|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83663334|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663335|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663336|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
83663337|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83663338|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663339|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663340|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83663341|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83663342|NCT01530022|Analgesics|analgesics|mesh-ancestor
83663343|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
83663344|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663345|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83663346|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83663347|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
83663348|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83663349|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663350|NCT01530126|Becaplermin|becaplermin|mesh-list
83663351|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
83663352|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83663353|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83663354|NCT01530126|Growth Substances|growth substances|mesh-ancestor
83663355|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663356|NCT01530152|Lidocaine|lidocaine|mesh-list
83663357|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
83663358|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
83663359|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663360|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663361|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
83663362|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663363|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83663364|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83663365|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83663366|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663367|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663368|NCT01530217|Ibuprofen|ibuprofen|mesh-list
83663369|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83663370|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83663371|NCT01530217|Analgesics|analgesics|mesh-ancestor
83663372|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
83663373|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663374|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663375|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83663376|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83663377|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83663378|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663379|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663380|NCT01530230|Oxytocin|oxytocin|mesh-list
83663381|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
83663382|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83663383|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663384|NCT01530295|Docetaxel|docetaxel|mesh-list
83663385|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663386|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
83663387|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
83663388|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
83663389|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663390|NCT01530308|Dopamine|dopamine|mesh-list
83663391|NCT01530308|Haloperidol|haloperidol|mesh-list
83663392|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
83663393|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
83663394|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
83663395|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
83663396|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
83663397|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663398|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663399|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83663400|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83663401|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663402|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83663403|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
83663404|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663405|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663406|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83663407|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83663408|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
83663409|NCT01530308|Protective Agents|protective agents|mesh-ancestor
83663410|NCT01530386|Lacosamide|lacosamide|mesh-list
83663411|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
83663412|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83663413|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83663414|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663415|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663416|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83663417|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83663418|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663419|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83663420|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
83663421|NCT01530451|Coagulants|coagulants|mesh-ancestor
83663422|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83663423|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
83663424|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663425|NCT01530490|Cabergoline|cabergoline|mesh-list
83663426|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83663427|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
83663428|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
83663429|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83663430|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83663431|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
83663432|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
83663433|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663434|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663435|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663436|NCT01530503|Capecitabine|capecitabine|mesh-list
83663437|NCT01530503|Mitomycins|mitomycins|mesh-list
82818167|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663439|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83663440|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
83663441|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663442|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663443|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83663444|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
83663445|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83663446|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663447|NCT01530542|Oxycodone|oxycodone|mesh-list
83663448|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83663449|NCT01530542|Narcotics|narcotics|mesh-ancestor
83663450|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663451|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663452|NCT01530542|Analgesics|analgesics|mesh-ancestor
83663453|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
83663454|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663455|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
83663456|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
83663457|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663458|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663459|NCT01530594|Lenalidomide|lenalidomide|mesh-list
83663460|NCT01530594|Bortezomib|bortezomib|mesh-list
83663461|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
83663462|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663463|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83663464|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83663465|NCT01530594|Growth Substances|growth substances|mesh-ancestor
83663466|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
83663467|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663468|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
83663469|NCT01530607|Goserelin|goserelin|mesh-list
83663470|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663471|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
83663472|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663473|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83663474|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83663475|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
83663476|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663477|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663478|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83663479|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83663480|NCT01530620|Propiverine|propiverine|mesh-list
83663481|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
83663482|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
83663483|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663484|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663485|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83663486|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83663487|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663488|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663489|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663490|NCT01530620|Urological Agents|urological agents|mesh-ancestor
83663491|NCT01530698|Vaccines|vaccines|mesh-list
83663492|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
83663493|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663494|NCT01530711|Terlipressin|terlipressin|mesh-list
83663495|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83663496|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83663497|NCT01530737|Antithrombins|antithrombins|mesh-list
83663498|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
83663499|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83663500|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
83663501|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663502|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663503|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
83663504|NCT01530763|Amoxicillin|amoxicillin|mesh-list
83663505|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
83663506|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
83663507|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
83663508|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83663509|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83663510|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663511|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663512|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83663513|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663514|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663515|NCT01530815|Bupivacaine|bupivacaine|mesh-list
83663516|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
83663517|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
83663518|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663519|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663520|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
83663521|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663522|NCT01530984|Ipilimumab|ipilimumab|mesh-list
83663523|NCT01530984|Sargramostim|sargramostim|mesh-list
83663524|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83663525|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663526|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83663527|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663528|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
83663529|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663530|NCT01531049|Nicotine|nicotine|mesh-list
83663531|NCT01531049|Varenicline|varenicline|mesh-list
83663532|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83663533|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
83663534|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663535|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663536|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83663537|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83663538|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663539|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663540|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663541|NCT01531114|Ticagrelor|ticagrelor|mesh-list
83663542|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83663543|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83663544|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83663545|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83663546|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83663547|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
83663548|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663549|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663550|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663551|NCT01531140|Bisacodyl|bisacodyl|mesh-list
83663552|NCT01531140|Senna Extract|senna extract|mesh-list
83663553|NCT01531140|Sennosides|sennosides|mesh-list
83663554|NCT01531140|Cathartics|cathartics|mesh-ancestor
83663555|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83663556|NCT01531140|Laxatives|laxatives|mesh-ancestor
83663557|NCT01531166|Interferons|interferons|mesh-list
83663558|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
83663559|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
83663560|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83663561|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663562|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
83663563|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663564|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
83663565|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663566|NCT01531192|Nystatin|nystatin|mesh-list
83663567|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663568|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663569|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
83663570|NCT01531192|Ionophores|ionophores|mesh-ancestor
83663571|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663572|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663573|NCT01531218|Azithromycin|azithromycin|mesh-list
83663574|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663575|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663576|NCT01531244|Dactinomycin|dactinomycin|mesh-list
83663577|NCT01531244|Cactinomycin|cactinomycin|mesh-list
83663578|NCT01531244|Melphalan|melphalan|mesh-list
83663579|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83663580|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
83663581|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663582|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663583|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83663584|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663585|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
83663586|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663587|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663588|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663589|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83663590|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83663591|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663592|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83663593|NCT01531309|Agomelatine|agomelatine|mesh-list
83663594|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83663595|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663596|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663597|NCT01531322|Vaccines|vaccines|mesh-list
83663598|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83663599|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
83663600|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663601|NCT01531361|Sorafenib|sorafenib|mesh-list
83663602|NCT01531361|Vemurafenib|vemurafenib|mesh-list
83663603|NCT01531361|Crizotinib|crizotinib|mesh-list
83663604|NCT01531361|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83663605|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663606|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83663607|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663608|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663609|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
83663610|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663611|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
83663612|NCT01531517|Propolis|propolis|mesh-list
83663613|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
83663614|NCT01531517|Vitamins|vitamins|mesh-ancestor
83663615|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
83663616|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663617|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663618|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
83663619|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
83663620|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83663621|NCT01531569|Estrogens|estrogens|mesh-ancestor
83663622|NCT01531569|Hormones|hormones|mesh-ancestor
83663623|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663624|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663625|NCT01531595|Bevacizumab|bevacizumab|mesh-list
83663626|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
83663627|NCT01531595|Irinotecan|irinotecan|mesh-list
83663628|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83663629|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83399891|NCT05601271|Allopurinol|allopurinol|mesh-list
83663630|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83663631|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83663632|NCT01531595|Growth Substances|growth substances|mesh-ancestor
83663633|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663634|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
83663635|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83663636|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83663637|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663638|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663639|NCT01531647|Ritonavir|ritonavir|mesh-list
83663640|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
83663641|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83663642|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83663643|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
83663644|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663645|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663646|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83663647|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83663648|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
83663649|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663650|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83663651|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83663652|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83663653|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83663654|NCT01531712|Gemcitabine|gemcitabine|mesh-list
83663655|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
83663656|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83663657|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83663658|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
83663659|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663660|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663661|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83663662|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663663|NCT01531764|Vinorelbine|vinorelbine|mesh-list
83663664|NCT01531764|Afatinib|afatinib|mesh-list
83663665|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83663666|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663667|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
83663668|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
83663669|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
83663670|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663671|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83663672|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663673|NCT01531777|Apatinib|apatinib|mesh-list
83663674|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663675|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83663676|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663677|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663678|NCT01531790|Carboplatin|carboplatin|mesh-list
83663679|NCT01531790|Pemetrexed|pemetrexed|mesh-list
83663680|NCT01531790|Endostar protein|endostar protein|mesh-list
83663681|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663682|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663683|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663684|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83663685|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83663686|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83663687|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83663688|NCT01531790|Growth Substances|growth substances|mesh-ancestor
83663689|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663690|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83663691|NCT01531829|Heparin|heparin|mesh-list
83663692|NCT01531829|Plasminogen|plasminogen|mesh-list
83663693|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83663694|NCT01531829|Tinzaparin|tinzaparin|mesh-list
83663695|NCT01531829|Dalteparin|dalteparin|mesh-list
83663696|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83663697|NCT01531829|Nadroparin|nadroparin|mesh-list
83663698|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
83663699|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83663700|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83663701|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663702|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83663703|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663704|NCT01531855|Insulin|insulin|mesh-list
83663705|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
83663706|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
83663707|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83663708|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663709|NCT01531920|Ethanol|ethanol|mesh-list
83663710|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83663711|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663712|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663713|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663714|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83663715|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663716|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83663717|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663718|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663719|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83663720|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
83663721|NCT01532076|Coagulants|coagulants|mesh-ancestor
83663722|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
83663723|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663724|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
83663725|NCT01532115|Opicapone|opicapone|mesh-list
83663726|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663727|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663728|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83663729|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83663730|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663731|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663732|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663733|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83663734|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83663735|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83663736|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
83663737|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83663738|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663739|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663740|NCT01532232|Varenicline|varenicline|mesh-list
83663741|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83663742|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83663743|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663744|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663745|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663746|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663747|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
83663748|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83663749|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83663750|NCT01532466|Rocuronium|rocuronium|mesh-list
83663751|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83663752|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83663753|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83663754|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663755|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663756|NCT01532544|Heparin|heparin|mesh-list
83663757|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83663758|NCT01532544|Tinzaparin|tinzaparin|mesh-list
83663759|NCT01532544|Dalteparin|dalteparin|mesh-list
83663760|NCT01532544|Eptifibatide|eptifibatide|mesh-list
83663761|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
83663762|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83663763|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83663764|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663765|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83663766|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
83663767|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83663768|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83663769|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
83663770|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83663771|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83663772|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663773|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663774|NCT01532804|Bevacizumab|bevacizumab|mesh-list
83663775|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
83663776|NCT01532804|Raltitrexed|raltitrexed|mesh-list
83663777|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83663778|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663779|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83663780|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83663781|NCT01532804|Growth Substances|growth substances|mesh-ancestor
83663782|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663783|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
83663784|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83663785|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
83663786|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663787|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83663788|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663789|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83663790|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
83663791|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663792|NCT01532856|Thalidomide|thalidomide|mesh-list
83663793|NCT01532856|Dexamethasone|dexamethasone|mesh-list
83663794|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
83663795|NCT01532856|Prednisone|prednisone|mesh-list
83663796|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
83663797|NCT01532856|Melphalan|melphalan|mesh-list
83663798|NCT01532856|BB 1101|bb 1101|mesh-list
83663799|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83663800|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
83663801|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663802|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83663803|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83663804|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
83663805|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663806|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83663807|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83663808|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83663809|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
83663810|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
83663811|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663812|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83663813|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
83663814|NCT01532856|Hormones|hormones|mesh-ancestor
83663815|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663816|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83663817|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
83663818|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663819|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
83663820|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83663821|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663822|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83663823|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83663824|NCT01532856|Growth Substances|growth substances|mesh-ancestor
83663825|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
83663826|NCT01532895|Hydromorphone|hydromorphone|mesh-list
83663827|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83663828|NCT01532895|Narcotics|narcotics|mesh-ancestor
83663829|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663830|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663831|NCT01532895|Analgesics|analgesics|mesh-ancestor
83663832|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
83663833|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663834|NCT01532960|Poly ICLC|poly iclc|mesh-list
83663835|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
83663836|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
83663837|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663838|NCT01533090|Bisacodyl|bisacodyl|mesh-list
83663839|NCT01533090|Cathartics|cathartics|mesh-ancestor
83663840|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83663841|NCT01533090|Laxatives|laxatives|mesh-ancestor
83663842|NCT01533129|Testosterone|testosterone|mesh-list
83663843|NCT01533129|Androgens|androgens|mesh-ancestor
83663844|NCT01533129|Hormones|hormones|mesh-ancestor
83663845|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83663846|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663847|NCT01533155|Quinidine|quinidine|mesh-list
83663848|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
83663849|NCT01533155|Morphine|morphine|mesh-list
83663850|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83663851|NCT01533155|Narcotics|narcotics|mesh-ancestor
83663852|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663853|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663854|NCT01533155|Analgesics|analgesics|mesh-ancestor
83663855|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
83663856|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663857|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83663858|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83663859|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
83663860|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663861|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663862|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83663863|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
83663864|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83663865|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83663866|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663867|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663868|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83663869|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83663870|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
83663871|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83663872|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83663873|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83663874|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83663875|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83663876|NCT01533220|Pheniramine|pheniramine|mesh-list
83663877|NCT01533220|Naphazoline|naphazoline|mesh-list
83663878|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663879|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83663880|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83663881|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
83663882|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663883|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663884|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
83663885|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83663886|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
83663887|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
83663888|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
83663889|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83663890|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
83663891|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
83663892|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83663893|NCT01533272|Tenofovir|tenofovir|mesh-list
83663894|NCT01533272|Emtricitabine|emtricitabine|mesh-list
83663895|NCT01533272|Lopinavir|lopinavir|mesh-list
83663897|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
83663898|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663899|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83663900|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83663901|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663902|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663903|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83663904|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83663905|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83663906|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83663907|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
83663908|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83663909|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83663910|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83663911|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83663912|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83663913|NCT01533324|Leucovorin|leucovorin|mesh-list
83663914|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83663915|NCT01533324|Antidotes|antidotes|mesh-ancestor
83663916|NCT01533324|Protective Agents|protective agents|mesh-ancestor
83663917|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663918|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
83663919|NCT01533324|Vitamins|vitamins|mesh-ancestor
83663920|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
83663921|NCT01533376|Timolol|timolol|mesh-list
83663922|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
83663923|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83663924|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83663925|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83663926|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663927|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663928|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663929|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83663930|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83663931|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83663932|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83663933|NCT01533389|Silodosin|silodosin|mesh-list
83663934|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83663935|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83663936|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83663937|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
83663938|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663939|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663940|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663941|NCT01533389|Urological Agents|urological agents|mesh-ancestor
83663942|NCT01533441|Vitamin K|vitamin k|mesh-list
83663943|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
83663944|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
83663945|NCT01533441|Vitamins|vitamins|mesh-ancestor
83663946|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
83663947|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663948|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83663949|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83663950|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663951|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
83663952|NCT01533441|Coagulants|coagulants|mesh-ancestor
83663953|NCT01533506|Stiripentol|stiripentol|mesh-list
83663954|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
83663955|NCT01533545|Epinephrine|epinephrine|mesh-list
83663956|NCT01533545|Mepivacaine|mepivacaine|mesh-list
83663957|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83663958|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83663959|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
83663960|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663961|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663962|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663963|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83663964|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83663965|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
83663966|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663967|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83663968|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
83663969|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
83663970|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
83663971|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83663972|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
83663973|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
83663974|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83663975|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
83663976|NCT01533558|Caspofungin|caspofungin|mesh-list
83663977|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
83663978|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83663979|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83663980|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663981|NCT01533662|Phenylephrine|phenylephrine|mesh-list
83663982|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
83663983|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83663984|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
83663985|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
83663986|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83663987|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83663988|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
83663989|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83663990|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
83663991|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
83663992|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83663993|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83663994|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83663995|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83663996|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83663997|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83663998|NCT01533662|Protective Agents|protective agents|mesh-ancestor
83663999|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83664000|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83664001|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664002|NCT01533740|Leucovorin|leucovorin|mesh-list
83664003|NCT01533740|Folic Acid|folic acid|mesh-list
83664004|NCT01533740|Bevacizumab|bevacizumab|mesh-list
83664005|NCT01533740|Fluorouracil|fluorouracil|mesh-list
83664006|NCT01533740|Irinotecan|irinotecan|mesh-list
83664007|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
83664008|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83664009|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664010|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83664011|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83664012|NCT01533740|Growth Substances|growth substances|mesh-ancestor
83664013|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664014|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
83664015|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
83664016|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664017|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83664018|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664019|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
83664020|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83664021|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83664022|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664023|NCT01533740|Antidotes|antidotes|mesh-ancestor
83664024|NCT01533740|Protective Agents|protective agents|mesh-ancestor
83664025|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
83664026|NCT01533740|Vitamins|vitamins|mesh-ancestor
83664027|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
83664028|NCT01533740|Hematinics|hematinics|mesh-ancestor
83664029|NCT01533818|Amoxicillin|amoxicillin|mesh-list
83664030|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664031|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664032|NCT01533870|Rifampin|rifampin|mesh-list
83664033|NCT01533870|Naloxegol|naloxegol|mesh-list
83664034|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83664035|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
83664036|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664037|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664038|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
83664039|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83664040|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664041|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664042|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83664043|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83664044|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83664045|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83664046|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83664047|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83664048|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83664049|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664050|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
83664051|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664052|NCT01534026|Aspirin|aspirin|mesh-list
83664053|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83664054|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664055|NCT01534026|Analgesics|analgesics|mesh-ancestor
83664056|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
83664057|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664058|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664059|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664060|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664061|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83664062|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83664063|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664064|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83664065|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83664066|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664067|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
83664068|NCT01534169|Dexamethasone|dexamethasone|mesh-list
83664069|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664070|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
83664071|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
83664072|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664073|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664074|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664075|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
83664076|NCT01534169|Hormones|hormones|mesh-ancestor
83664077|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664078|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83664079|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664080|NCT01534247|Metronidazole|metronidazole|mesh-list
83664081|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664082|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664083|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83664084|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83664085|NCT01534312|Mesalamine|mesalamine|mesh-list
83664086|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83664087|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664088|NCT01534312|Analgesics|analgesics|mesh-ancestor
83664089|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
83664090|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664091|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664092|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664093|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664094|NCT01534442|Atropine|atropine|mesh-list
83664095|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83664096|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83664097|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83664098|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
83664099|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664100|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664101|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83664102|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
83664103|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
83664104|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
83664105|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83664106|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83664107|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
83664108|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664109|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664110|NCT01534455|Lapatinib|lapatinib|mesh-list
83664111|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664112|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664113|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664114|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664115|NCT01534494|Psilocybin|psilocybin|mesh-list
83664116|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
83664117|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664118|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83664119|NCT01534546|Capecitabine|capecitabine|mesh-list
83664120|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
83664121|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83664122|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
83664123|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664124|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664126|NCT01534585|Mitogens|mitogens|mesh-list
83664127|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83664128|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664129|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83664130|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83664131|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83664132|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664133|NCT01534702|Cytarabine|cytarabine|mesh-list
83664134|NCT01534702|Clofarabine|clofarabine|mesh-list
83664135|NCT01534702|Idarubicin|idarubicin|mesh-list
83664136|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83664137|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
83664138|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664139|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664140|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
83664141|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664142|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664143|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
83664144|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664145|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83664146|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83664147|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83664148|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664149|NCT01534754|Mesalamine|mesalamine|mesh-list
83664150|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83664151|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664152|NCT01534754|Analgesics|analgesics|mesh-ancestor
83664153|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
83664154|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664155|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664156|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664157|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664158|NCT01534806|Ketorolac|ketorolac|mesh-list
83664159|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83664160|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664161|NCT01534806|Analgesics|analgesics|mesh-ancestor
83664162|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
83664163|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664164|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664165|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664166|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664167|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83664168|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664169|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664170|NCT01534845|Temozolomide|temozolomide|mesh-list
83664171|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83664172|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
83664173|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664174|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664175|NCT01534858|Polihexanide|polihexanide|mesh-list
83664176|NCT01534858|Betaine|betaine|mesh-list
83664177|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664178|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
83664179|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83664180|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
83664181|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664182|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83664183|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
83664184|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664185|NCT01534884|Rituximab|rituximab|mesh-list
83664186|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83664187|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664188|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
83664189|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664190|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664191|NCT01534949|Rituximab|rituximab|mesh-list
83664192|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83664193|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664194|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
83664195|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664196|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664197|NCT01535027|Alendronate|alendronate|mesh-list
82818920|NCT00414908|Pancreatin|pancreatin|mesh-list
83664198|NCT01535027|Teriparatide|teriparatide|mesh-list
83664199|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83664200|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83664201|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664202|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83664203|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83664204|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
83664205|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664206|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83664207|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83664208|NCT01535079|Ibuprofen|ibuprofen|mesh-list
83664209|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83664210|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664211|NCT01535079|Analgesics|analgesics|mesh-ancestor
83664212|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
83664213|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664214|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664215|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664216|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664217|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83664218|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664219|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664220|NCT01535092|Silybin|silybin|mesh-list
83664221|NCT01535092|Protective Agents|protective agents|mesh-ancestor
83664222|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664223|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83664224|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664225|NCT01535157|Ketoconazole|ketoconazole|mesh-list
83664226|NCT01535157|Fenretinide|fenretinide|mesh-list
83664227|NCT01535157|Retinamide|retinamide|mesh-list
83664228|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
83664229|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664230|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83664231|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83664232|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664233|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664234|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83664235|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
83664236|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664237|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664238|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83664239|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664240|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83664241|NCT01535157|Protective Agents|protective agents|mesh-ancestor
83664242|NCT01535170|Lactoferrin|lactoferrin|mesh-list
83664243|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664244|NCT01535183|Irinotecan|irinotecan|mesh-list
83664245|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83664246|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83664247|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664248|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664249|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664250|NCT01535417|Celecoxib|celecoxib|mesh-list
83664251|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83664252|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664253|NCT01535417|Analgesics|analgesics|mesh-ancestor
83664254|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
83664255|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664256|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664257|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664258|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664259|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83664260|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83664261|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664262|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664263|NCT01535469|Fluconazole|fluconazole|mesh-list
83664264|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
83664265|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664266|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83664267|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83664268|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664269|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664270|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83664271|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
83664272|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664273|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664274|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83664275|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83664276|NCT01535495|Propranolol|propranolol|mesh-list
83664277|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83664278|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83664279|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
83664280|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664281|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664282|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664283|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83664284|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83664285|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
83664286|NCT01535547|Isavuconazole|isavuconazole|mesh-list
83664287|NCT01535547|Tacrolimus|tacrolimus|mesh-list
83664288|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664289|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
83664290|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664291|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83664292|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664293|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664294|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
83664295|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664296|NCT01535612|Insulin|insulin|mesh-list
83664297|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664298|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664299|NCT01535677|Metformin|metformin|mesh-list
83664300|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
83664301|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664302|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664303|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83664304|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664305|NCT01535690|Methylene Blue|methylene blue|mesh-list
83664306|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664307|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664308|NCT01535768|Travoprost|travoprost|mesh-list
83664309|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83664310|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83664311|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83664312|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83664313|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83664314|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83664315|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83664316|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
83664317|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664318|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664319|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664320|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
83664321|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83664322|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83664323|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664324|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
83664325|NCT01535781|Coagulants|coagulants|mesh-ancestor
83664326|NCT01535820|Ortho Evra|ortho evra|mesh-list
83664327|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83664328|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
83664329|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83664330|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664331|NCT01535859|Cabergoline|cabergoline|mesh-list
83664332|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83664333|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82819062|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819063|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82819064|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82819065|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82819066|NCT00393042|Amphetamine|amphetamine|mesh-list
82819067|NCT00393042|Adderall|adderall|mesh-list
82819068|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
82819069|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82819070|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819071|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
83664334|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
83664335|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
83664336|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664337|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664338|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664339|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83664340|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83664341|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
83664342|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664343|NCT01535989|Sirolimus|sirolimus|mesh-list
83664344|NCT01535989|Temsirolimus|temsirolimus|mesh-list
83664345|NCT01535989|MTOR Inhibitors|mtor inhibitors|mesh-list
83664346|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83664347|NCT01535989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664348|NCT01535989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664349|NCT01535989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664350|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664351|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
83664352|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664353|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664354|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664355|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664356|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83664357|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
83664358|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83664359|NCT01535989|Immunotoxins|immunotoxins|mesh-ancestor
83664360|NCT01535989|Immunoconjugates|immunoconjugates|mesh-ancestor
83664361|NCT01536002|Propofol|propofol|mesh-list
83664362|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83664363|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83664364|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664365|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83664366|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
83664367|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
83664368|NCT01536028|Insulin|insulin|mesh-list
83664369|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83664370|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
83664371|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
83664372|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83664373|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
83664374|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83664375|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664376|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664377|NCT01536054|Sirolimus|sirolimus|mesh-list
83664378|NCT01536054|Sargramostim|sargramostim|mesh-list
83664379|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664380|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664381|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83664382|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819163|NCT00274846|Aldesleukin|aldesleukin|mesh-list
82819164|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
82819165|NCT00274846|Fludarabine|fludarabine|mesh-list
82819166|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
82819167|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819168|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
82819169|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819170|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819171|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819172|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
82819173|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819174|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819175|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82819176|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819177|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
82819178|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82819179|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82819180|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
82819181|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819182|NCT01072786|Vaccines|vaccines|mesh-list
82819183|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
82819184|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819185|NCT03970798|Midazolam|midazolam|mesh-list
82819186|NCT03970798|Caffeine|caffeine|mesh-list
82819187|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82819188|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83664383|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
83664384|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664385|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
83664386|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664387|NCT01536132|Simendan|simendan|mesh-list
83664388|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83664389|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
83664390|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83664391|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83664392|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664393|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664394|NCT01536132|Protective Agents|protective agents|mesh-ancestor
83664395|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664396|NCT01536158|Acetaminophen|acetaminophen|mesh-list
83664397|NCT01536158|Ibuprofen|ibuprofen|mesh-list
83664398|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83664399|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664400|NCT01536158|Analgesics|analgesics|mesh-ancestor
83664401|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
83664402|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664403|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664404|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664405|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664406|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83664407|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664408|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664409|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
83664410|NCT01536223|Cisplatin|cisplatin|mesh-list
83664411|NCT01536223|Docetaxel|docetaxel|mesh-list
83664412|NCT01536223|Fluorouracil|fluorouracil|mesh-list
83664413|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664414|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
83664415|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
83664416|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
83664417|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664418|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
83664419|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83664420|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664421|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
83664422|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664423|NCT01536249|Pramipexole|pramipexole|mesh-list
83664424|NCT01536249|Cimetidine|cimetidine|mesh-list
83664425|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83664426|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664427|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83664428|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
83664429|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
83664430|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664431|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664432|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664433|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83664434|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83664435|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664436|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
83664437|NCT01536249|Protective Agents|protective agents|mesh-ancestor
83664438|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83664439|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83664440|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
83664441|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
83664442|NCT01536301|Morphine|morphine|mesh-list
83664443|NCT01536301|Oxycodone|oxycodone|mesh-list
83664444|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83664445|NCT01536301|Narcotics|narcotics|mesh-ancestor
83664446|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83664447|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664448|NCT01536301|Analgesics|analgesics|mesh-ancestor
83664449|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
83664450|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664451|NCT01536314|Memantine|memantine|mesh-list
83664452|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83664453|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83664454|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
83664455|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664456|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664457|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664458|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83664459|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83664460|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83664461|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83664462|NCT01536431|Insulin|insulin|mesh-list
83664463|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83664464|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664465|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664466|NCT01536470|Norepinephrine|norepinephrine|mesh-list
83664467|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83664468|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83664469|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
83664470|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664471|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664472|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664473|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
83664474|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
83664475|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664476|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83664477|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
83664478|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
83664479|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83664480|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664481|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664482|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
83664483|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
83664484|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83664485|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664486|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664487|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
83664488|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
83664489|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83664490|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664491|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664492|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
83664493|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
83400794|NCT01266447|Topotecan|topotecan|mesh-list
83664494|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83664495|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664496|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664497|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
83664498|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
83664499|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83664500|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664501|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664502|NCT01536665|Liraglutide|liraglutide|mesh-list
83664503|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664504|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664505|NCT01536665|Incretins|incretins|mesh-ancestor
83664506|NCT01536665|Hormones|hormones|mesh-ancestor
83664507|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664508|NCT01536691|Ondansetron|ondansetron|mesh-list
83664509|NCT01536691|Aprepitant|aprepitant|mesh-list
83664510|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
83664511|NCT01536691|Ramosetron|ramosetron|mesh-list
83664512|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
83664513|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
83664514|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664515|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664516|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664517|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
83664518|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83664519|NCT01536691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83664520|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83664521|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
83664522|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664523|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664524|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83664525|NCT01536717|Carticaine|carticaine|mesh-list
83664526|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
83664527|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
83664528|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83664529|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664530|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
83664531|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664532|NCT01536743|Palbociclib|palbociclib|mesh-list
82819288|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83664533|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664534|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664535|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664536|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664537|NCT01536873|Dolutegravir|dolutegravir|mesh-list
83664538|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83664539|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83664540|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664541|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664542|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83664543|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83664544|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
83664545|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664546|NCT01537055|Amoxicillin|amoxicillin|mesh-list
83664547|NCT01537055|Levofloxacin|levofloxacin|mesh-list
83664548|NCT01537055|Ofloxacin|ofloxacin|mesh-list
83664549|NCT01537055|Lansoprazole|lansoprazole|mesh-list
83664550|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
83664551|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664552|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664553|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83664554|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83664555|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83664556|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664557|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664558|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664559|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83664560|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83664561|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83664562|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664563|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83664564|NCT01537094|Vitamins|vitamins|mesh-list
83664565|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
83664566|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
83664567|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664568|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
83664569|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664570|NCT01537094|Protective Agents|protective agents|mesh-ancestor
83664571|NCT01537107|Sirolimus|sirolimus|mesh-list
83664572|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83664573|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664574|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664575|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83664576|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664577|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
83664578|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664579|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
83664580|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664581|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664582|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83664583|NCT01537146|Ropivacaine|ropivacaine|mesh-list
83664584|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
83664585|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
83664586|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83664587|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664588|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
83664589|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664590|NCT01537250|Levofloxacin|levofloxacin|mesh-list
83664591|NCT01537250|Ofloxacin|ofloxacin|mesh-list
83664592|NCT01537250|Nemonoxacin|nemonoxacin|mesh-list
83664593|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83664594|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664595|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664596|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83664597|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83664598|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664599|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664600|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664601|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83664602|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83664603|NCT01537354|Poractant alfa|poractant alfa|mesh-list
83664604|NCT01537354|Beractant|beractant|mesh-list
83664605|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83664606|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
82819362|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
83664607|NCT01537380|Cefazolin|cefazolin|mesh-list
83664608|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664609|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664610|NCT01537471|Meclizine|meclizine|mesh-list
83664611|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
83664612|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
83664613|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
83664614|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664615|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664616|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664617|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83664618|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
83664619|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
83664620|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664621|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664622|NCT01537471|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83664623|NCT01537471|Cholinergic Agents|cholinergic agents|mesh-ancestor
83664624|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83664625|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
83664626|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83664627|NCT01537575|Antibodies|antibodies|mesh-list
83664628|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
83664629|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83664630|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
83664631|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664632|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83664633|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
83664634|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664635|NCT01537744|Azacitidine|azacitidine|mesh-list
83664636|NCT01537744|Romidepsin|romidepsin|mesh-list
83664637|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83664638|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
83664639|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664640|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664641|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664642|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83664643|NCT01537744|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83664644|NCT01537770|Lidocaine|lidocaine|mesh-list
83664645|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
83664646|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
83664647|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83664648|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664649|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
83664650|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664651|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83664652|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83664653|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83664654|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83664655|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664656|NCT01537809|Vitamin D|vitamin d|mesh-list
83664657|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
83664658|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
83664659|NCT01537809|Vitamins|vitamins|mesh-list
83664660|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
83664661|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664662|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83664663|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83664664|NCT01537861|Thalidomide|thalidomide|mesh-list
83664665|NCT01537861|Dexamethasone|dexamethasone|mesh-list
83664666|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
83664667|NCT01537861|Lenalidomide|lenalidomide|mesh-list
83664668|NCT01537861|Bortezomib|bortezomib|mesh-list
83664669|NCT01537861|Pomalidomide|pomalidomide|mesh-list
83664670|NCT01537861|Lenograstim|lenograstim|mesh-list
83664671|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664672|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
83664673|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664674|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664675|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83664676|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
83664677|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664678|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664679|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83664680|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664681|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
83664682|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
83664683|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664684|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664685|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
83664686|NCT01537861|Hormones|hormones|mesh-ancestor
83664687|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664688|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83664689|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83664690|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83664691|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83664692|NCT01537861|Growth Substances|growth substances|mesh-ancestor
83664693|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83664694|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
83664695|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664696|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664697|NCT01538095|Trebananib|trebananib|mesh-list
83664698|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83664699|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83664700|NCT01538095|Growth Substances|growth substances|mesh-ancestor
83664701|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664702|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
83664703|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664704|NCT01538108|Paclitaxel|paclitaxel|mesh-list
83664705|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83664706|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664707|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
83664708|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
83664709|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
83664710|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664711|NCT01538225|Nabiximols|nabiximols|mesh-list
83664712|NCT01538225|Analgesics|analgesics|mesh-ancestor
83664713|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
83664714|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664715|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664716|NCT01538316|Genistein|genistein|mesh-list
83664717|NCT01538316|Quercetin|quercetin|mesh-list
83664718|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
83664719|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664720|NCT01538316|Protective Agents|protective agents|mesh-ancestor
83664721|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664722|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83664723|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664724|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664725|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664726|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
83664727|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83664728|NCT01538316|Estrogens|estrogens|mesh-ancestor
83664729|NCT01538316|Hormones|hormones|mesh-ancestor
83664730|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664731|NCT01538329|Amantadine|amantadine|mesh-list
83664732|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83664733|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83664734|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
83664735|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664736|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
83664737|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664738|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664739|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664740|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83664741|NCT01538329|Analgesics|analgesics|mesh-ancestor
83664742|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
83664743|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664744|NCT01538381|Afatinib|afatinib|mesh-list
83664745|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664746|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664747|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664748|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664749|NCT01538394|Nicotine|nicotine|mesh-list
83664750|NCT01538394|Varenicline|varenicline|mesh-list
83664751|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83664752|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
83664753|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664754|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664755|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83664756|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83664757|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
82819511|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
83664758|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664759|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664760|NCT01538446|Clopidogrel|clopidogrel|mesh-list
83664761|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83664762|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83664763|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83664764|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83664765|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83664766|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
83664767|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664768|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664769|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664770|NCT01538459|Dexamethasone|dexamethasone|mesh-list
83664771|NCT01538459|Bupivacaine|bupivacaine|mesh-list
83664772|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664773|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
83664774|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
83664775|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664776|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664777|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664778|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
83664779|NCT01538459|Hormones|hormones|mesh-ancestor
83664780|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664781|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83664782|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664783|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
83664784|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
83664785|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83664786|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
83664787|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
83664788|NCT01538485|Vitamin D|vitamin d|mesh-list
83664789|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83664790|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664791|NCT01538485|Vitamins|vitamins|mesh-ancestor
83664792|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
83664793|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83664794|NCT01538511|Insulin|insulin|mesh-list
83664795|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83664796|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
83664797|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
83664798|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83664799|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
83664800|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83664801|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664802|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664803|NCT01538537|ON 01910|on 01910|mesh-list
83664804|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664805|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664806|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664807|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664808|NCT01538563|ON 01910|on 01910|mesh-list
83664809|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664810|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664811|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664812|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664813|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
83664814|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664815|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664816|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
83664817|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83664818|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664819|NCT01538641|Rituximab|rituximab|mesh-list
83664820|NCT01538641|Gemcitabine|gemcitabine|mesh-list
83664821|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
83664822|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83664823|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664824|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
83664825|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664826|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664827|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83664828|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
83664829|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664830|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
83664831|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83664832|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819586|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664833|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83664834|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83664835|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664836|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664837|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664838|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83664839|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83664840|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
83664841|NCT01538693|Dexetimide|dexetimide|mesh-list
83664842|NCT01538693|Citalopram|citalopram|mesh-list
83664843|NCT01538693|Escitalopram|escitalopram|mesh-list
83664844|NCT01538693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83664845|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83664846|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83664847|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664848|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664849|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
83664850|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664851|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83664852|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83664853|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
83664854|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
83664855|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664856|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83664857|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83664858|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
83664859|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83664860|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
83664861|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83664862|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
83664863|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
83664864|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664865|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83664866|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
83664867|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
83664868|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83664869|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83664870|NCT01538732|Alitretinoin|alitretinoin|mesh-list
83664871|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664872|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
83664873|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
83664874|NCT01538771|Hematinics|hematinics|mesh-ancestor
83664875|NCT01538797|Ranitidine|ranitidine|mesh-list
83664876|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83664877|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83664878|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664879|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83664880|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
83664881|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
83664882|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819660|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82819661|NCT01063023|Asunaprevir|asunaprevir|mesh-list
82819662|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
82819663|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819664|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819665|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82819666|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
82819667|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82819668|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819669|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82819670|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82819671|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82819672|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82819673|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819674|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819675|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819676|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819677|NCT01063101|Fucoidan|fucoidan|mesh-list
82819678|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82819679|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819680|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
82819681|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819682|NCT01066689|Rituximab|rituximab|mesh-list
82819683|NCT01066689|Citric Acid|citric acid|mesh-list
82819684|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
83664883|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664885|NCT01538849|Esomeprazole|esomeprazole|mesh-list
83664886|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83664887|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83664888|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83664889|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664890|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664891|NCT01538875|Labetalol|labetalol|mesh-list
83664892|NCT01538875|Hydralazine|hydralazine|mesh-list
83664893|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83664894|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83664895|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
83664896|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664897|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664898|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664899|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83664900|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
83664901|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
83664902|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664903|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83664904|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83664905|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
83664906|NCT01538901|Imiquimod|imiquimod|mesh-list
83664907|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83664908|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
83664909|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664910|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664911|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
83664912|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83664913|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
83664914|NCT01538927|Coagulants|coagulants|mesh-ancestor
83664915|NCT01538940|Vaccines|vaccines|mesh-list
83664916|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
83664917|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401251|NCT01926587|ON 01910|on 01910|mesh-list
83664918|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83664919|NCT01538953|Disinfectants|disinfectants|mesh-list
83664920|NCT01538953|Eusol|eusol|mesh-list
83664921|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664922|NCT01539018|Sorafenib|sorafenib|mesh-list
83664923|NCT01539018|Tegafur|tegafur|mesh-list
83664924|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664925|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83664926|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664927|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664928|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83664929|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
83664930|NCT01539044|Atropine|atropine|mesh-list
83664931|NCT01539044|Neostigmine|neostigmine|mesh-list
83664932|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83664933|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83664934|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83664935|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
83664936|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83664937|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664938|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83664939|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
83664940|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
83664941|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
83664942|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83664943|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83664944|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
83664945|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664946|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664947|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83664948|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664949|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83664950|NCT01539174|Prednisone|prednisone|mesh-list
83664951|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
83664952|NCT01539174|Rituximab|rituximab|mesh-list
83664953|NCT01539174|Doxorubicin|doxorubicin|mesh-list
83664954|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83664955|NCT01539174|Vincristine|vincristine|mesh-list
83664956|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83664957|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
83664958|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664959|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83664960|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83664961|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
83664962|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664963|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83664964|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83664965|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83664966|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83664967|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83664968|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83664969|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664970|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83664971|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
83664973|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664974|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83664975|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83664976|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
83664977|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
83664978|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
83664979|NCT01539265|Silodosin|silodosin|mesh-list
83664980|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83664981|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83664982|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83664983|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
83664984|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83664985|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664986|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664987|NCT01539265|Urological Agents|urological agents|mesh-ancestor
83664988|NCT01539330|Voriconazole|voriconazole|mesh-list
83664989|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
83664990|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83664991|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83664992|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83664993|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83664994|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83664995|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83664996|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
83664997|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83664998|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83664999|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83665000|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
83665001|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83665002|NCT01539408|Misoprostol|misoprostol|mesh-list
83665003|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83665004|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
83665005|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83665006|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665007|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83665008|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665009|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
83665010|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
83665011|NCT01539473|Tedizolid|tedizolid|mesh-list
83665012|NCT01539473|Tyramine|tyramine|mesh-list
83665013|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83665014|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665015|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
83665016|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
83665017|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665018|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665019|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83665020|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83665021|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665022|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665023|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
83665024|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665025|NCT01539564|Minocycline|minocycline|mesh-list
83665026|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83665027|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665028|NCT01539577|Dexamethasone|dexamethasone|mesh-list
83665029|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665030|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
83665031|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
82819870|NCT01067547|Iron|iron|mesh-list
83665032|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665033|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665034|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665035|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
83665036|NCT01539577|Hormones|hormones|mesh-ancestor
83665037|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665038|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83665039|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665040|NCT01539603|Sirolimus|sirolimus|mesh-list
83665041|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83665042|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665043|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83665044|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665045|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
83665046|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83665047|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
83665048|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665049|NCT01539616|Fenofibrate|fenofibrate|mesh-list
83665050|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83665051|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
83665052|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665053|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83665054|NCT01539655|Omeprazole|omeprazole|mesh-list
83665055|NCT01539655|Ranitidine|ranitidine|mesh-list
83665056|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83665057|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83665058|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665059|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83665060|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665061|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665062|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83665063|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
83665064|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
83665065|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665066|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665067|NCT01539681|Sorafenib|sorafenib|mesh-list
83665068|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665069|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83665070|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665071|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665072|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
83665073|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83665074|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83665075|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
83665076|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665077|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665078|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665079|NCT01539707|Urological Agents|urological agents|mesh-ancestor
83665080|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
83665081|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
83665082|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83665083|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
83665084|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83665085|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665086|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83665087|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83665088|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83665089|NCT01539733|Haloperidol|haloperidol|mesh-list
83665090|NCT01539733|Olanzapine|olanzapine|mesh-list
83665091|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
83665092|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
83665093|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
83665094|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665095|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665096|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665097|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83665098|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83665099|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665100|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83665101|NCT01539733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83665102|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83665103|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665104|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819887|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
83665105|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665106|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
83665107|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83665108|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
83665109|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83665110|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83665111|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
83665112|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83665113|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
83665114|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665115|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665116|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83665117|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
83665118|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665119|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665120|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83665121|NCT01540032|Salicylates|salicylates|mesh-list
83665122|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83665123|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665124|NCT01540032|Analgesics|analgesics|mesh-ancestor
83665125|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
83665126|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665127|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665128|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665129|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665130|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83665131|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665132|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665133|NCT01540084|Propofol|propofol|mesh-list
83665134|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83665135|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665136|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665137|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83665138|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
83665139|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
83665140|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
83665141|NCT01540110|Docetaxel|docetaxel|mesh-list
83665142|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83665143|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
83665144|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665145|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665146|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83665147|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
83665148|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665149|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665150|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83665151|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83665152|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83665153|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83665154|NCT01540136|Nedaplatin|nedaplatin|mesh-list
83665155|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665156|NCT01540240|Zidovudine|zidovudine|mesh-list
83665157|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
83665158|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665159|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83665160|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83665161|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665162|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
83665163|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665164|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83665165|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83665166|NCT01540435|Bevacizumab|bevacizumab|mesh-list
83665167|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83665168|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665169|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83665170|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83665171|NCT01540435|Growth Substances|growth substances|mesh-ancestor
83665172|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665173|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
83665174|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
83665175|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83665176|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83665177|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665178|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665179|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83665180|NCT01540500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83665181|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83665182|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665183|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665184|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665185|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
83665186|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83665187|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
83665188|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83665189|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83665190|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665191|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83665192|NCT01540526|Axitinib|axitinib|mesh-list
83665193|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665194|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83665195|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665196|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665197|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83665198|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83665199|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83665200|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83665201|NCT01540682|Cetuximab|cetuximab|mesh-list
83665202|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83665203|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665204|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83665205|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83665206|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
83665207|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665208|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665209|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83665210|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
83665211|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
83665212|NCT01540708|Hormones|hormones|mesh-ancestor
83665213|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665214|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
83665215|NCT01540721|Acetaminophen|acetaminophen|mesh-list
83665216|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665217|NCT01540721|Analgesics|analgesics|mesh-ancestor
83665218|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
83665219|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665220|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665221|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
83665222|NCT01540734|Acetaminophen|acetaminophen|mesh-list
83665223|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665224|NCT01540734|Analgesics|analgesics|mesh-ancestor
83665225|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
83665226|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665227|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665228|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
83665229|NCT01540747|Folic Acid|folic acid|mesh-list
83665230|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
83665231|NCT01540747|Inositol|inositol|mesh-list
83665232|NCT01540747|Melatonin|melatonin|mesh-list
83665233|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
83665234|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665235|NCT01540747|Protective Agents|protective agents|mesh-ancestor
83665236|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665237|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665238|NCT01540747|Hematinics|hematinics|mesh-ancestor
83665239|NCT01540747|Vitamins|vitamins|mesh-ancestor
83665240|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
83665241|NCT01540812|Cytarabine|cytarabine|mesh-list
83665242|NCT01540812|Dexamethasone|dexamethasone|mesh-list
83665243|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
83665244|NCT01540812|Prednisone|prednisone|mesh-list
83665245|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
83665246|NCT01540812|Fludarabine|fludarabine|mesh-list
83665247|NCT01540812|Vincristine|vincristine|mesh-list
83665248|NCT01540812|Daunorubicin|daunorubicin|mesh-list
83665249|NCT01540812|Idarubicin|idarubicin|mesh-list
83665250|NCT01540812|Methotrexate|methotrexate|mesh-list
83665251|NCT01540812|Pegaspargase|pegaspargase|mesh-list
83665252|NCT01540812|Asparaginase|asparaginase|mesh-list
83665253|NCT01540812|BB 1101|bb 1101|mesh-list
83665254|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665255|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
83665256|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
83665257|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665258|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665259|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665260|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
83665261|NCT01540812|Hormones|hormones|mesh-ancestor
83665262|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665263|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83665264|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665265|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
83665266|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665267|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665268|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83665269|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
83665270|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83665271|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
83665272|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
83665273|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665274|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83665275|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83665276|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83665277|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83665278|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83665279|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83665280|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83665281|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83665282|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
83665283|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83665284|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
83665285|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83665286|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665287|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83665288|NCT01540877|Anesthetics|anesthetics|mesh-list
83665289|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83665290|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
83665291|NCT01540877|Capsaicin|capsaicin|mesh-list
83665292|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665293|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665294|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
83665295|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665296|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
83665297|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
83665298|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83665299|NCT01541059|Ropivacaine|ropivacaine|mesh-list
83665300|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
83665301|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
83665302|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665303|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665304|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
83665305|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665306|NCT01541072|Lenograstim|lenograstim|mesh-list
83665307|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83665308|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
83665309|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665310|NCT01541124|Morphine|morphine|mesh-list
83665311|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83665312|NCT01541124|Narcotics|narcotics|mesh-ancestor
83665313|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665314|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665315|NCT01541124|Analgesics|analgesics|mesh-ancestor
83665316|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
83665317|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665318|NCT01541137|Diclofenac|diclofenac|mesh-list
83665319|NCT01541137|Parecoxib|parecoxib|mesh-list
83665320|NCT01541137|Valdecoxib|valdecoxib|mesh-list
83665321|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83665322|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665323|NCT01541137|Analgesics|analgesics|mesh-ancestor
83665324|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
83665325|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665326|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665327|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665328|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665329|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83665330|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665331|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665332|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83665333|NCT01541189|Valsartan|valsartan|mesh-list
83665334|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83665335|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83665336|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83665337|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665338|NCT01541267|Telmisartan|telmisartan|mesh-list
83665339|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83665340|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83665341|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83665342|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665343|NCT01541280|Azacitidine|azacitidine|mesh-list
83665344|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83665345|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
83665346|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665347|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665348|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665349|NCT01541293|Lidocaine|lidocaine|mesh-list
83665350|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
83665351|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
83665352|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665353|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665354|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
83665355|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665356|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83665357|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83665358|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83665359|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665360|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665361|NCT01541332|Dexamethasone|dexamethasone|mesh-list
83665362|NCT01541332|Doxorubicin|doxorubicin|mesh-list
83665363|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83665364|NCT01541332|Pomalidomide|pomalidomide|mesh-list
83665365|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665366|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
83665367|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
83665368|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665369|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665370|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665371|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
83665372|NCT01541332|Hormones|hormones|mesh-ancestor
83665373|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665374|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83665375|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665376|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83665377|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83665378|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83665379|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665380|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665381|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
83665382|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83665383|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83665384|NCT01541332|Growth Substances|growth substances|mesh-ancestor
83665385|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
83665386|NCT01541436|Capsaicin|capsaicin|mesh-list
83665387|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
83665388|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
83665389|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
83665390|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665391|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665392|NCT01541475|Dexetimide|dexetimide|mesh-list
83665393|NCT01541475|Citalopram|citalopram|mesh-list
83665394|NCT01541475|Bupropion|bupropion|mesh-list
83665395|NCT01541475|Escitalopram|escitalopram|mesh-list
83665396|NCT01541475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83665397|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83665398|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665399|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665400|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665401|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
83665402|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665403|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83665404|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83665405|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
82820184|NCT01045980|Vitamins|vitamins|mesh-list
83665406|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
83665407|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665408|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83665409|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83665410|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
83665411|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83665412|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
83665413|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83665414|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83665415|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
83665416|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83665417|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83665418|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665419|NCT01541605|Methylphenidate|methylphenidate|mesh-list
83665420|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83665421|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665422|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83665423|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83665424|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665425|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665426|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
83665427|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665428|NCT01541631|Albendazole|albendazole|mesh-list
83665429|NCT01541631|Praziquantel|praziquantel|mesh-list
83665430|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
83665431|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83665432|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665433|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
83665434|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83665435|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83665436|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
83665437|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
83665438|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
83665439|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665440|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665441|NCT01541670|Antibodies|antibodies|mesh-list
83665442|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
83665443|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665444|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83665445|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83665446|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83665447|NCT01541085|Ritonavir|ritonavir|mesh-list
83665448|NCT01541085|Darunavir|darunavir|mesh-list
83665449|NCT01541085|Efavirenz|efavirenz|mesh-list
83665450|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83665451|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83665452|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
83665453|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665454|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665455|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83665456|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83665457|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
83665458|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665459|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83665460|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83665461|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83665462|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83665463|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83665464|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83665465|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83665466|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83665467|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83665468|NCT01541943|Losartan|losartan|mesh-list
83665469|NCT01541943|Atorvastatin|atorvastatin|mesh-list
82820256|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82820257|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82820258|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
82820259|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
82820260|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820261|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82820262|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82820263|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
83665470|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83665471|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83665472|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
83665473|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665474|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83665475|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83665476|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665477|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83665478|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83665479|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83665480|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83665481|NCT01541956|Metformin|metformin|mesh-list
83665482|NCT01541956|Vildagliptin|vildagliptin|mesh-list
83665483|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665484|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665485|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83665486|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
83665487|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665488|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665489|NCT01542047|Carboplatin|carboplatin|mesh-list
83665490|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665491|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
83665492|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
83665493|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83665494|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665495|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665496|NCT01542099|Remifentanil|remifentanil|mesh-list
83665497|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83665498|NCT01542099|Narcotics|narcotics|mesh-ancestor
83665499|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665500|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665501|NCT01542099|Analgesics|analgesics|mesh-ancestor
83665502|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
83665503|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665504|NCT01542138|Niacinamide|niacinamide|mesh-list
83665505|NCT01542138|Niacin|niacin|mesh-list
83665506|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
83665507|NCT01542138|Desonide|desonide|mesh-list
83665508|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
83665509|NCT01542138|Vitamins|vitamins|mesh-ancestor
83665510|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
83665511|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665512|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83665513|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
83665514|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665515|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83665516|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
83665517|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665518|NCT01542190|Ketorolac|ketorolac|mesh-list
83665519|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83665520|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83665521|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665522|NCT01542190|Analgesics|analgesics|mesh-ancestor
83665523|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
83665524|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665525|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665526|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665527|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665528|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83665529|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665530|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665531|NCT01542242|Liraglutide|liraglutide|mesh-list
83665532|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665533|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665534|NCT01542242|Incretins|incretins|mesh-ancestor
83665535|NCT01542242|Hormones|hormones|mesh-ancestor
83665536|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665537|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
83665538|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83665539|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665540|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665541|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83665542|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83665543|NCT01542268|Protective Agents|protective agents|mesh-ancestor
83665544|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665545|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
82820317|NCT01068405|Methotrexate|methotrexate|mesh-list
83665546|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83665547|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
83665548|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
83665549|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665551|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83665552|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
83665553|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
83665554|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
83665555|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83665556|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665557|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665558|NCT01542437|Afatinib|afatinib|mesh-list
83665559|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665560|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83665561|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665562|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665563|NCT01542450|Insulin|insulin|mesh-list
83665564|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83665565|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
83665566|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
83665567|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
83665568|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
83665569|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665570|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665571|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
83665572|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665573|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665574|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
83665575|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665576|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665577|NCT01542489|Insulin|insulin|mesh-list
83665578|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83665579|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
83665580|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
83665581|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665582|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665583|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
83665584|NCT01542697|Analgesics|analgesics|mesh-ancestor
83665585|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
83665586|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665587|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665588|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
83665589|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665590|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83665591|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
83665592|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83665593|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665594|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665595|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83665596|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
83665597|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83665598|NCT01542710|Timolol|timolol|mesh-list
83665599|NCT01542710|Bimatoprost|bimatoprost|mesh-list
83665600|NCT01542710|Travoprost|travoprost|mesh-list
83665601|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83665602|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83665603|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
83665604|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665605|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665606|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665607|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83665608|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83665609|NCT01542723|Nadroparin|nadroparin|mesh-list
83665610|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
83665611|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83665612|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83665613|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665614|NCT01542762|Nadroparin|nadroparin|mesh-list
83665615|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
83665616|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83665617|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83665618|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665619|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
83665620|NCT01542801|Norfloxacin|norfloxacin|mesh-list
83665621|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83665622|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665623|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83665624|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83665625|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665626|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665627|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665628|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83665629|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83665630|NCT01542827|Analgesics|analgesics|mesh-list
83665631|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
83665632|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665633|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665634|NCT01542918|Rituximab|rituximab|mesh-list
83665635|NCT01542918|Lenalidomide|lenalidomide|mesh-list
83665636|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83665637|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665638|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
83665639|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665640|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665641|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83665642|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83665643|NCT01542918|Growth Substances|growth substances|mesh-ancestor
83665644|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
83665645|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83665646|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
83665647|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665648|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83665649|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83665650|NCT01543139|Valproic Acid|valproic acid|mesh-list
83665651|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
83665652|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665653|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665654|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
83665655|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665656|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665657|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
83665658|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83665659|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665660|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83665661|NCT01543165|Ketorolac|ketorolac|mesh-list
83665662|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83665663|NCT01543165|Morphine|morphine|mesh-list
83665664|NCT01543165|Analgesics|analgesics|mesh-list
83665665|NCT01543165|Nefopam|nefopam|mesh-list
83665666|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83665667|NCT01543165|Narcotics|narcotics|mesh-ancestor
83665668|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665669|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665670|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
83665671|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665672|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83665673|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665674|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665675|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665676|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83665677|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665678|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665679|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
83665680|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83665681|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83665682|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665683|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665684|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
83665685|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665686|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665687|NCT01543347|Temocillin|temocillin|mesh-list
83665688|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83665689|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665690|NCT01543386|Curcumin|curcumin|mesh-list
83665691|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83665692|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665693|NCT01543386|Analgesics|analgesics|mesh-ancestor
83665694|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
83665695|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820467|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
83665696|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665697|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665698|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83665699|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665700|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665701|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665702|NCT01543399|Tibolone|tibolone|mesh-list
83665703|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
83665704|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
83665705|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665706|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665707|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83665708|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83665709|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665710|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83665711|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
83665712|NCT01543399|Hormones|hormones|mesh-ancestor
83665713|NCT01543464|Temozolomide|temozolomide|mesh-list
83665714|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83665715|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
83665716|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665717|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665718|NCT01543555|Atorvastatin|atorvastatin|mesh-list
83665719|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83665720|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83665721|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
83665722|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665723|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83665724|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83665725|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665726|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
83665727|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
83665728|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83665729|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665730|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665731|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
83665732|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83665733|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665734|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665735|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
83665736|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83665737|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
83665738|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665739|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
83665740|NCT01543737|Protective Agents|protective agents|mesh-ancestor
83665741|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
83665742|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83665743|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665744|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665745|NCT01543906|Retinol acetate|retinol acetate|mesh-list
83665746|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83665747|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
83665748|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665749|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83665750|NCT01543906|Protective Agents|protective agents|mesh-ancestor
83665751|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665752|NCT01543932|Clopidogrel|clopidogrel|mesh-list
83665753|NCT01543932|Ticagrelor|ticagrelor|mesh-list
83665754|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83665755|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83665756|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83665757|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83665758|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83665759|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
83665760|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665761|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665762|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665763|NCT01543945|Dexamethasone|dexamethasone|mesh-list
83665764|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
83665765|NCT01543945|Ondansetron|ondansetron|mesh-list
83665766|NCT01543945|Antiemetics|antiemetics|mesh-list
83665767|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
83665768|NCT01543945|BB 1101|bb 1101|mesh-list
82820545|NCT01325571|Tacrolimus|tacrolimus|mesh-list
83665769|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665770|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
83665771|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665772|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665773|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665774|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
83665775|NCT01543945|Hormones|hormones|mesh-ancestor
83665776|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665777|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83665778|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665779|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
83665780|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665781|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665782|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
83665783|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
83665784|NCT01543945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83665785|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83665786|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
83665787|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665788|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83665789|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
83665790|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
83665791|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83665792|NCT01543971|Lenograstim|lenograstim|mesh-list
83665793|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83665794|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
83665795|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665796|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83665797|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
83665798|NCT01544140|Midazolam|midazolam|mesh-list
83665799|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83665800|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83665801|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665802|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665803|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83665804|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83665805|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83665806|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83665807|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
83665808|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
83665809|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
83665810|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
83665811|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665812|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665813|NCT01544192|Tocopherols|tocopherols|mesh-list
83665814|NCT01544192|Vitamin E|vitamin e|mesh-list
83665815|NCT01544192|Tocotrienols|tocotrienols|mesh-list
83665816|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
83665817|NCT01544192|Antioxidants|antioxidants|mesh-list
83665818|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665819|NCT01544192|Protective Agents|protective agents|mesh-ancestor
83665820|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665821|NCT01544192|Vitamins|vitamins|mesh-ancestor
83665822|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
83665823|NCT01544283|Triamcinolone|triamcinolone|mesh-list
83665824|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83665825|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83665826|NCT01544283|Lidocaine|lidocaine|mesh-list
83665827|NCT01544283|Tetracaine|tetracaine|mesh-list
83665828|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83665829|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
83665830|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
83665831|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665832|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665833|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
83665834|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665835|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83665836|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83665837|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83665838|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83665839|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665840|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665841|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
82820611|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665842|NCT01544283|Hormones|hormones|mesh-ancestor
83665843|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665844|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83665845|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
83665846|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665847|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
83665848|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665849|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
83665850|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
83665851|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
83665852|NCT01544504|Norepinephrine|norepinephrine|mesh-list
83665853|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83665854|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83665855|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
83665856|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665857|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665858|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665859|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
83665860|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
83665861|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665862|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83665863|NCT01544517|Amoxicillin|amoxicillin|mesh-list
83665864|NCT01544517|Levofloxacin|levofloxacin|mesh-list
83665865|NCT01544517|Tinidazole|tinidazole|mesh-list
83665866|NCT01544517|Esomeprazole|esomeprazole|mesh-list
83665867|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83665868|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83665869|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665870|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83665871|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83665872|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665873|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665874|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83665875|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83665876|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83665877|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665878|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83665879|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83665880|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
83665881|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83665882|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83665883|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83665884|NCT01544634|Beclomethasone|beclomethasone|mesh-list
83665885|NCT01544634|Propranolol|propranolol|mesh-list
83665886|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83665887|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83665888|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83665889|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83665890|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665891|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665892|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83665893|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83665894|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
83665895|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665896|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
83665897|NCT01544634|Hormones|hormones|mesh-ancestor
83665898|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665899|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83665900|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
83665901|NCT01544673|Linezolid|linezolid|mesh-list
83665902|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83665903|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83665904|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83665905|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665906|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665907|NCT01544725|Ketamine|ketamine|mesh-list
83665908|NCT01544725|Propofol|propofol|mesh-list
83665909|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83665910|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665911|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665912|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83665913|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
83665914|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
83665915|NCT01544725|Analgesics|analgesics|mesh-ancestor
83665916|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
83665917|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665918|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82820682|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82820685|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
83665919|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83665920|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83665922|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665923|NCT01544751|Metformin|metformin|mesh-list
83665924|NCT01544751|Atorvastatin|atorvastatin|mesh-list
83665925|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665926|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665927|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83665928|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83665929|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
83665930|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665931|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83665932|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83665933|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665934|NCT01544829|Theobromine|theobromine|mesh-list
83665935|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83665936|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
83665937|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665938|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665939|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83665940|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
83665941|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
83665942|NCT01544842|Triamcinolone|triamcinolone|mesh-list
83665943|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83665944|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83665945|NCT01544842|Tacrolimus|tacrolimus|mesh-list
83665946|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83665947|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83665948|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
83665949|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665950|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83665951|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83665952|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665953|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83665954|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
83665955|NCT01544842|Hormones|hormones|mesh-ancestor
83665956|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665957|NCT01544881|Insulin|insulin|mesh-list
83665958|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83665959|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665960|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83665961|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
83665962|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83665963|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
83665964|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83665965|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665966|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83665967|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83665968|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83665969|NCT01544907|Paclitaxel|paclitaxel|mesh-list
83665970|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83665971|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83665972|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83665973|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83665974|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83665975|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665976|NCT01544959|Fentanyl|fentanyl|mesh-list
83665977|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83665978|NCT01544959|Esmolol|esmolol|mesh-list
83665979|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83665980|NCT01544959|Narcotics|narcotics|mesh-ancestor
83665981|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83665982|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83665983|NCT01544959|Analgesics|analgesics|mesh-ancestor
83665984|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
83665985|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83665986|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83665987|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83665988|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
83665989|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
83665990|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83665991|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83665992|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820756|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83665993|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83665994|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83665996|NCT01544972|Ibuprofen|ibuprofen|mesh-list
83665997|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83665998|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83665999|NCT01544972|Analgesics|analgesics|mesh-ancestor
83666000|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
83666001|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666002|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666003|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83666004|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666005|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83666006|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666007|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666008|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
83666009|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83666010|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666011|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666012|NCT01545024|Incretins|incretins|mesh-ancestor
83666013|NCT01545024|Hormones|hormones|mesh-ancestor
83666014|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666015|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83666016|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
83666017|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666018|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666019|NCT01545284|Acitretin|acitretin|mesh-list
83666020|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
83666021|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
83666022|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
83666023|NCT01545297|Remifentanil|remifentanil|mesh-list
83666024|NCT01545297|Propofol|propofol|mesh-list
83402390|NCT02728037|Analgesics|analgesics|mesh-ancestor
83666025|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666026|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666027|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666028|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83666029|NCT01545297|Analgesics|analgesics|mesh-ancestor
83666030|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
83666031|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666032|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83666033|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83666034|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83666035|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
83666036|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666037|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666038|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83666039|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
83666040|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
83666041|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83666042|NCT01545297|Narcotics|narcotics|mesh-ancestor
83666043|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
83666044|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666045|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666046|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666047|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666048|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83666049|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
83666050|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666051|NCT01545479|Captopril|captopril|mesh-list
83666052|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83666053|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
83666054|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666055|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666056|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83666057|NCT01545635|Thrombin|thrombin|mesh-list
83666058|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
83666059|NCT01545635|Coagulants|coagulants|mesh-ancestor
83666060|NCT01545778|Oxycodone|oxycodone|mesh-list
83666061|NCT01545778|Tapentadol|tapentadol|mesh-list
83666062|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83666063|NCT01545778|Narcotics|narcotics|mesh-ancestor
82820832|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666064|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666065|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666066|NCT01545778|Analgesics|analgesics|mesh-ancestor
83666067|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
83666068|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666069|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83666070|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83666071|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666072|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666073|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
83666074|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666076|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666077|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666078|NCT01545804|Lenalidomide|lenalidomide|mesh-list
83666079|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
83666080|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666081|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83666082|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83666083|NCT01545804|Growth Substances|growth substances|mesh-ancestor
83666084|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
83666085|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666086|NCT01545830|Vitamin D|vitamin d|mesh-list
83666087|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
83666088|NCT01545830|Vitamins|vitamins|mesh-ancestor
83666089|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
83666090|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666091|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83666092|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83666093|NCT01545856|Levodopa|levodopa|mesh-list
83666094|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83666095|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83666096|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
83666097|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666098|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666099|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666100|NCT01545947|Azacitidine|azacitidine|mesh-list
83666101|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83666102|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83666103|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
83666104|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666105|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666106|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666107|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666108|NCT01546051|BCI-838|bci-838|mesh-list
83666109|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83666110|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83666111|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666112|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666113|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666114|NCT01546090|Alprazolam|alprazolam|mesh-list
83666115|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666116|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666117|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666118|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83666119|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83666120|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83666121|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
83666122|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
83666123|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666124|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666125|NCT01546103|Vitamin D|vitamin d|mesh-list
83666126|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
83666127|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
83666128|NCT01546103|Vitamins|vitamins|mesh-list
83666129|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
83666130|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666131|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83666132|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83666133|NCT01546116|Lamivudine|lamivudine|mesh-list
83666134|NCT01546116|Adefovir|adefovir|mesh-list
83666135|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83666136|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83666137|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83666138|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820904|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820905|NCT00258856|Vaccines|vaccines|mesh-list
82820925|NCT00268983|Iodine|iodine|mesh-list
83666139|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666140|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
83666141|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666142|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83666143|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83666144|NCT01546389|Chloroquine|chloroquine|mesh-list
83666145|NCT01546389|Amebicides|amebicides|mesh-ancestor
83666146|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83666147|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83666148|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666149|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
83666150|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666151|NCT01546558|Metformin|metformin|mesh-list
83666152|NCT01546558|Ranolazine|ranolazine|mesh-list
83666153|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666154|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666155|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83666156|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666157|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666158|NCT01546597|Metformin|metformin|mesh-list
83666159|NCT01546597|Ranolazine|ranolazine|mesh-list
83666160|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666161|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666162|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83666163|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666164|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666165|NCT01546701|Morphine|morphine|mesh-list
83666166|NCT01546701|Buprenorphine|buprenorphine|mesh-list
83666167|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83666168|NCT01546701|Narcotics|narcotics|mesh-ancestor
83666169|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666170|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666171|NCT01546701|Analgesics|analgesics|mesh-ancestor
83666172|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
83666173|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666174|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83666175|NCT01546896|Alprazolam|alprazolam|mesh-list
83666176|NCT01546896|Buspirone|buspirone|mesh-list
83666177|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666178|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666179|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666180|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83666181|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83666182|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83666183|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
83666184|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
83666185|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666186|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666187|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83666188|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
83666189|NCT01546935|Oseltamivir|oseltamivir|mesh-list
83666190|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
83666191|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666192|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666193|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666194|NCT01546961|Chloroquine|chloroquine|mesh-list
83666195|NCT01546961|Amebicides|amebicides|mesh-ancestor
83666196|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83666197|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83666198|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666199|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
83666200|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666201|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
83666202|NCT01547104|Glimepiride|glimepiride|mesh-list
83666203|NCT01547104|Linagliptin|linagliptin|mesh-list
83666204|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83666205|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666206|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666207|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666208|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
83666209|NCT01547104|Incretins|incretins|mesh-ancestor
83666210|NCT01547104|Hormones|hormones|mesh-ancestor
83666211|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666212|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83666213|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
83666214|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820985|NCT00206518|Docetaxel|docetaxel|mesh-list
83666215|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666216|NCT01547143|Cyclosporine|cyclosporine|mesh-list
83666217|NCT01547143|Dexamethasone|dexamethasone|mesh-list
83666218|NCT01547143|Etoposide|etoposide|mesh-list
83666219|NCT01547143|Cyclosporins|cyclosporins|mesh-list
83666220|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
83666221|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83666222|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
83666223|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
83666224|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666225|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666226|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666227|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
83666228|NCT01547143|Hormones|hormones|mesh-ancestor
83666229|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666230|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83666231|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666232|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666233|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666234|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83666235|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83666236|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83666237|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666238|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
83666239|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
83666240|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666241|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83666242|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666243|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83666244|NCT01547169|Insulin|insulin|mesh-list
83666245|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83666246|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
83666247|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666248|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666249|NCT01547221|Clotrimazole|clotrimazole|mesh-list
83666250|NCT01547221|Miconazole|miconazole|mesh-list
83666251|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83666252|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666253|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
83666254|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83666255|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83666256|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666257|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666258|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83666259|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
83666260|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666261|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666262|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83666263|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83666264|NCT01547312|Interferons|interferons|mesh-list
83666265|NCT01547312|Ribavirin|ribavirin|mesh-list
83666266|NCT01547312|Grazoprevir|grazoprevir|mesh-list
83666267|NCT01547312|Liver Extracts|liver extracts|mesh-list
83666268|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666269|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
83666270|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666271|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
83666272|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666273|NCT01547312|Hematinics|hematinics|mesh-ancestor
83666274|NCT01547325|Doxycycline|doxycycline|mesh-list
83666275|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83666276|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666277|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
83666278|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83666279|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83666280|NCT01547377|Zinc|zinc|mesh-list
83666281|NCT01547377|Selenium|selenium|mesh-list
83666282|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83666283|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83666284|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83666285|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
83666286|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666287|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83666288|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82821054|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
82821062|NCT00423332|Cediranib|cediranib|mesh-list
83666289|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666290|NCT01547377|Trace Elements|trace elements|mesh-ancestor
83666291|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
83666292|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666293|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
83666294|NCT01547377|Protective Agents|protective agents|mesh-ancestor
83666296|NCT01547416|Ropivacaine|ropivacaine|mesh-list
83666297|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
83666298|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
83666299|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666300|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666301|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
83666302|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666303|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83666304|NCT01547416|Narcotics|narcotics|mesh-ancestor
83666305|NCT01547416|Analgesics|analgesics|mesh-ancestor
83666306|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83666307|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83666308|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
83666309|NCT01547455|Atorvastatin|atorvastatin|mesh-list
83666310|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83666311|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83666312|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
83666313|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666314|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83666315|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83666316|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666317|NCT01547494|Vitamins|vitamins|mesh-list
83666318|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
83666319|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666320|NCT01547520|Meperidine|meperidine|mesh-list
83666321|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83666322|NCT01547520|Narcotics|narcotics|mesh-ancestor
83666323|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666324|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666325|NCT01547520|Analgesics|analgesics|mesh-ancestor
83666326|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
83666327|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666328|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83666329|NCT01547546|GDC-0084|gdc-0084|mesh-list
83666330|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666331|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666332|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
83666333|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83666334|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666335|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666336|NCT01548001|Methotrexate|methotrexate|mesh-list
83666337|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83666338|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
83666339|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83666340|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666341|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83666342|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
83666343|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666344|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666345|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
83666346|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666347|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83666348|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666349|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
83666350|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666351|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83666352|NCT01548027|Anesthetics|anesthetics|mesh-list
83666353|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
83666354|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666355|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666356|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
83666357|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666358|NCT01548066|Valproic Acid|valproic acid|mesh-list
83666359|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
83666360|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666361|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666362|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
83666363|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666364|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666365|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
83666366|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83666367|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666368|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83666369|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83666370|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83666371|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666372|NCT01548118|Vaccines|vaccines|mesh-list
83666373|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
83666374|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666375|NCT01548144|Pemetrexed|pemetrexed|mesh-list
83666376|NCT01548144|Crizotinib|crizotinib|mesh-list
83666377|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666378|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666379|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666380|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83666381|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83666382|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666383|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83666384|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83666385|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83666386|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
83666387|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666388|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83666389|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83666390|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666391|NCT01548170|Ketoconazole|ketoconazole|mesh-list
83666392|NCT01548170|Sunitinib|sunitinib|mesh-list
83666393|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666394|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83666395|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83666396|NCT01548170|Growth Substances|growth substances|mesh-ancestor
83666397|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666398|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
83666399|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666400|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666401|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666402|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
83666403|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666404|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83666405|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83666406|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83666407|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
83666408|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666409|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83666410|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
83666411|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666412|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666413|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666414|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83666415|NCT01548209|Analgesics|analgesics|mesh-ancestor
83666416|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
83666417|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666418|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83666419|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83666420|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83666421|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
83666422|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666423|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666424|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
83666425|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
83666426|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83666427|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666428|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666429|NCT01548248|Insulin|insulin|mesh-list
83666430|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83666431|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
83666432|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
83666433|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666434|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666435|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
83666436|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83666437|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82821202|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666438|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666439|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83666440|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83666441|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
83666442|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666443|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666444|NCT01548326|Atorvastatin|atorvastatin|mesh-list
83666445|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83666446|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83666447|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
83666448|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666449|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83666450|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83666451|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666452|NCT01548482|Sirolimus|sirolimus|mesh-list
83666453|NCT01548482|Temsirolimus|temsirolimus|mesh-list
83666454|NCT01548482|Trebananib|trebananib|mesh-list
83666455|NCT01548482|MTOR Inhibitors|mtor inhibitors|mesh-list
83666456|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83666457|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666458|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83666459|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666460|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
83666461|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666462|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
83666463|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666464|NCT01548482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666465|NCT01548482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666466|NCT01548482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666467|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83666468|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83666469|NCT01548482|Growth Substances|growth substances|mesh-ancestor
83666470|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
83666471|NCT01548521|Oxytocin|oxytocin|mesh-list
83666472|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
83666473|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83666474|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666475|NCT01548560|Dapivirine|dapivirine|mesh-list
83666476|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83666477|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83666478|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
83666479|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666480|NCT01548612|Nitroprusside|nitroprusside|mesh-list
83666481|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83666482|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
83666483|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83666484|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666485|NCT01548677|Trastuzumab|trastuzumab|mesh-list
83666486|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83666487|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666488|NCT01548703|BCI-838|bci-838|mesh-list
83666489|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83666490|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83666491|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666492|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666493|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666494|NCT01548794|Lidocaine|lidocaine|mesh-list
83666495|NCT01548794|Bupivacaine|bupivacaine|mesh-list
83666496|NCT01548794|Anesthetics|anesthetics|mesh-list
83666497|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
83666498|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666499|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666500|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
83666501|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666502|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83666503|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83666504|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83666505|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666506|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666507|NCT01548807|Everolimus|everolimus|mesh-list
83666508|NCT01548807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83666509|NCT01548807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666510|NCT01548807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666511|NCT01548807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666512|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666513|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
83666514|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666515|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666516|NCT01548859|Midazolam|midazolam|mesh-list
83666517|NCT01548859|Sevoflurane|sevoflurane|mesh-list
83666518|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83666519|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666520|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666521|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666522|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83666523|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83666524|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83666525|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83666526|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
83666527|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
83666528|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
83666529|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
83666530|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666531|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666532|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83666533|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83666534|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
83666535|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83666536|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
83666537|NCT01548911|Calicheamicins|calicheamicins|mesh-list
83666538|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83666539|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666540|NCT01548911|Immunotoxins|immunotoxins|mesh-ancestor
83666541|NCT01548911|Immunoconjugates|immunoconjugates|mesh-ancestor
83666542|NCT01548911|Immunologic Factors|immunologic factors|mesh-ancestor
83666543|NCT01548911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666544|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83666545|NCT01548924|Paclitaxel|paclitaxel|mesh-list
83666546|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83666547|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666548|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
83666549|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
83666550|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
83666551|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666552|NCT01548950|Bosentan|bosentan|mesh-list
83666553|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
83666554|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
83666555|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83666556|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83666557|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666558|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666559|NCT01548950|Urological Agents|urological agents|mesh-ancestor
83666560|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83666561|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83666562|NCT01549093|Carboplatin|carboplatin|mesh-list
83666563|NCT01549093|Gemcitabine|gemcitabine|mesh-list
83666564|NCT01549093|Endostar protein|endostar protein|mesh-list
83666565|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666566|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83666567|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
83666568|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666569|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83666570|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83666571|NCT01549093|Growth Substances|growth substances|mesh-ancestor
83666572|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666573|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
83666574|NCT01549158|Torsemide|torsemide|mesh-list
83666575|NCT01549158|Furosemide|furosemide|mesh-list
83666576|NCT01549158|Diuretics|diuretics|mesh-ancestor
83666577|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
83666578|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666579|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83666580|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666581|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666582|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83666583|NCT01549171|Iloprost|iloprost|mesh-list
83666584|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83666585|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
83666586|NCT01549236|Benzonidazole|benzonidazole|mesh-list
83666587|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666588|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
83666589|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666590|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83666591|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83666592|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83666593|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666594|NCT01549301|Lenograstim|lenograstim|mesh-list
83666595|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83666596|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
83666597|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666598|NCT01549418|Aspirin|aspirin|mesh-list
83666599|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83666600|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83666601|NCT01549418|Analgesics|analgesics|mesh-ancestor
83666602|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
83666603|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666604|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666605|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83666606|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666607|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83666608|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83666609|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666610|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83666611|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83666612|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666613|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
83666614|NCT01549431|Dexamethasone|dexamethasone|mesh-list
83666615|NCT01549431|Panobinostat|panobinostat|mesh-list
83666616|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83666617|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
83666618|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
83666619|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666620|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666621|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666622|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
83666623|NCT01549431|Hormones|hormones|mesh-ancestor
83666624|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666625|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83666626|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666627|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83666628|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666629|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666630|NCT01549496|Amlodipine|amlodipine|mesh-list
83666631|NCT01549496|Diltiazem|diltiazem|mesh-list
83666632|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83666633|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83666634|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666635|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666636|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83666637|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666638|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
83666639|NCT01549548|Ponatinib|ponatinib|mesh-list
83666640|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666641|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666642|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666643|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666644|NCT01549574|Crizotinib|crizotinib|mesh-list
83666645|NCT01549574|Esomeprazole|esomeprazole|mesh-list
83666646|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83666647|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666648|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83666649|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666650|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666651|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666652|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666653|NCT01549600|Psyllium|psyllium|mesh-list
83666654|NCT01549600|Cathartics|cathartics|mesh-ancestor
83666655|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666656|NCT01549691|Alprazolam|alprazolam|mesh-list
83666657|NCT01549691|Zopiclone|zopiclone|mesh-list
83666658|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666659|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666660|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666661|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82821423|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83666662|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83666663|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83666664|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
83666665|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
83666666|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666667|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666668|NCT01549704|Ropivacaine|ropivacaine|mesh-list
83666669|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
83666670|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
83666671|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666672|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666673|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
83666674|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666676|NCT01549743|Rebamipide|rebamipide|mesh-list
83666677|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83666678|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83666679|NCT01549743|Analgesics|analgesics|mesh-ancestor
83666680|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
83666681|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666682|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666683|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83666684|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666685|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83666686|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83666687|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666688|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666689|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83666690|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666691|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
83666692|NCT01549743|Protective Agents|protective agents|mesh-ancestor
83666693|NCT01549795|Capecitabine|capecitabine|mesh-list
83666694|NCT01549795|Liver Extracts|liver extracts|mesh-list
83666695|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83666696|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
83666697|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666698|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666699|NCT01549795|Hematinics|hematinics|mesh-ancestor
83666700|NCT01549847|Piracetam|piracetam|mesh-list
83666701|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83666702|NCT01549847|Protective Agents|protective agents|mesh-ancestor
83666703|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666704|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
83666705|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
83666706|NCT01549938|Vitamin D|vitamin d|mesh-list
83666707|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83666708|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666709|NCT01549938|Vitamins|vitamins|mesh-ancestor
83666710|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
83666711|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83666712|NCT01549990|Sevoflurane|sevoflurane|mesh-list
83666713|NCT01549990|Desflurane|desflurane|mesh-list
83666714|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83666715|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83666716|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
83666717|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
83666718|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666719|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666720|NCT01550055|Irinotecan|irinotecan|mesh-list
83666721|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83666722|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83666723|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666724|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666725|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666726|NCT01550107|Allopurinol|allopurinol|mesh-list
83666727|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
83666728|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666729|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666730|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
83666731|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666732|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83666733|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
83666734|NCT01550107|Protective Agents|protective agents|mesh-ancestor
83666735|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666736|NCT01550146|Dexamethasone|dexamethasone|mesh-list
83666737|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
83666738|NCT01550146|BB 1101|bb 1101|mesh-list
83666739|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821498|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
83666740|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
83666741|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
83666742|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666743|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666744|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666745|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
83666746|NCT01550146|Hormones|hormones|mesh-ancestor
83666747|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666748|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83666749|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666750|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
83666751|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666752|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666753|NCT01550302|Bupivacaine|bupivacaine|mesh-list
83666754|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
83666755|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
83666756|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666757|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666758|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
83666759|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666760|NCT01550354|Alfentanil|alfentanil|mesh-list
83666761|NCT01550354|Propofol|propofol|mesh-list
83666762|NCT01550354|Rocuronium|rocuronium|mesh-list
83666763|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666764|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666765|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666766|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83666767|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
83666768|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
83666769|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83666770|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83666771|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83666772|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83403176|NCT03058536|Hormones|hormones|mesh-ancestor
83666773|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83666774|NCT01550354|Narcotics|narcotics|mesh-ancestor
83666775|NCT01550354|Analgesics|analgesics|mesh-ancestor
83666776|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
83666777|NCT01550419|Atorvastatin|atorvastatin|mesh-list
83666778|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83666779|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83666780|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
83666781|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666782|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83666783|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83666784|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666785|NCT01550445|Prednisolone|prednisolone|mesh-list
83666786|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83666787|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
83666788|NCT01550445|Hormones|hormones|mesh-ancestor
83666789|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666790|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666791|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83666792|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666793|NCT01550640|Remifentanil|remifentanil|mesh-list
83666794|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83666795|NCT01550640|Narcotics|narcotics|mesh-ancestor
83666796|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666797|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666798|NCT01550640|Analgesics|analgesics|mesh-ancestor
83666799|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
83666800|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666801|NCT01550653|Liraglutide|liraglutide|mesh-list
83666802|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666803|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666804|NCT01550653|Incretins|incretins|mesh-ancestor
83666805|NCT01550653|Hormones|hormones|mesh-ancestor
83666806|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666807|NCT01550770|Propofol|propofol|mesh-list
83666808|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666809|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666810|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666811|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83666812|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
82821575|NCT00401258|Analgesics|analgesics|mesh-ancestor
83666813|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
83666814|NCT01550848|Gemcitabine|gemcitabine|mesh-list
83666815|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83666816|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83666818|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666819|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666820|NCT01550900|Metformin|metformin|mesh-list
83666821|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666822|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666823|NCT01550926|Orlistat|orlistat|mesh-list
83666824|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666825|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666826|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83666827|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83666828|NCT01551004|REP 3123|rep 3123|mesh-list
83666829|NCT01551004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83666830|NCT01551004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666831|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
83666832|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
83666833|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83666834|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83666835|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666836|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666837|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666838|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666839|NCT01550458|Mibefradil|mibefradil|mesh-list
83666840|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83666841|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83666842|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666843|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666844|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83666845|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666846|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
83666847|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83666848|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83666849|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666850|NCT01551147|Montelukast|montelukast|mesh-list
83666851|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83666852|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
83666853|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83666854|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
83666855|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666856|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666857|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83666858|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83666859|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666860|NCT01551225|Escitalopram|escitalopram|mesh-list
83666861|NCT01551225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83666862|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83666863|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666864|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666865|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666866|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
83666867|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666868|NCT01551290|Infliximab|infliximab|mesh-list
83666869|NCT01551290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83666870|NCT01551290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83666871|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
83666872|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83666873|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83666874|NCT01551329|Ketamine|ketamine|mesh-list
83666875|NCT01551329|Analgesics|analgesics|mesh-ancestor
83666876|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
83666877|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666878|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666879|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83666880|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83666881|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
83666882|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
83666883|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666884|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83666885|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82821643|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82821645|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83666886|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666887|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666888|NCT01551368|Nimodipine|nimodipine|mesh-list
83666889|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83666890|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83666891|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83666892|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666893|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83666894|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666895|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
83666896|NCT01551394|Gentamicins|gentamicins|mesh-list
83666897|NCT01551394|Meropenem|meropenem|mesh-list
83666898|NCT01551394|Ampicillin|ampicillin|mesh-list
83666899|NCT01551394|Cefotaxime|cefotaxime|mesh-list
83666900|NCT01551394|Cefoxitin|cefoxitin|mesh-list
83666901|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83666902|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666903|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83666904|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666905|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666906|NCT01551459|Sunitinib|sunitinib|mesh-list
83666907|NCT01551459|Dacarbazine|dacarbazine|mesh-list
83666908|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666909|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83666910|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83666911|NCT01551459|Growth Substances|growth substances|mesh-ancestor
83666912|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666913|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
83666914|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83666915|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666916|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666917|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83666918|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
83666919|NCT01551485|Zolpidem|zolpidem|mesh-list
83666920|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83666921|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83666922|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83666923|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666924|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83666925|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
83666926|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
83666927|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666928|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666929|NCT01551511|Dronabinol|dronabinol|mesh-list
83666930|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
83666931|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666932|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83666933|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83666934|NCT01551511|Analgesics|analgesics|mesh-ancestor
83666935|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
83666936|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666937|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83666938|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83666939|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83666940|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666941|NCT01551511|Hormones|hormones|mesh-ancestor
83666942|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83666943|NCT01551589|Docetaxel|docetaxel|mesh-list
83666944|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666945|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
83666946|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
83666947|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83666948|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666949|NCT01551615|Metformin|metformin|mesh-list
83666950|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83666951|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666952|NCT01551628|BCT-100|bct-100|mesh-list
83666953|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666954|NCT01551641|Thalidomide|thalidomide|mesh-list
83666955|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83666956|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
83666957|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666958|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
83666959|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821717|NCT00365976|Eszopiclone|eszopiclone|mesh-list
83666960|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666961|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83666962|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83666963|NCT01551641|Growth Substances|growth substances|mesh-ancestor
83666964|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
83666965|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666966|NCT01551667|Antibodies|antibodies|mesh-list
83666967|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
83666968|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666969|NCT01551680|Iniparib|iniparib|mesh-list
83666970|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83666971|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666972|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666973|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83666974|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83666975|NCT01551719|Vancomycin|vancomycin|mesh-list
83666976|NCT01551719|Linezolid|linezolid|mesh-list
83666977|NCT01551719|Daptomycin|daptomycin|mesh-list
83666978|NCT01551719|Penicillins|penicillins|mesh-list
83666979|NCT01551719|Tigecycline|tigecycline|mesh-list
83666980|NCT01551719|Cephalosporins|cephalosporins|mesh-list
83666981|NCT01551719|Teicoplanin|teicoplanin|mesh-list
83666982|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83666983|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83666984|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83666985|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83666986|NCT01551797|Acetaminophen|acetaminophen|mesh-list
83666987|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83666988|NCT01551797|Analgesics|analgesics|mesh-ancestor
83666989|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
83666990|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83666991|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666992|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
83666993|NCT01551810|Vaccines|vaccines|mesh-list
83666994|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
83666995|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666996|NCT01551823|Vaccines|vaccines|mesh-list
83666997|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
83666998|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83666999|NCT01551836|Acetaminophen|acetaminophen|mesh-list
83667000|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83667001|NCT01551836|Analgesics|analgesics|mesh-ancestor
83667002|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
83667003|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667004|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667005|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
83667006|NCT01552005|Saxagliptin|saxagliptin|mesh-list
83667007|NCT01552005|Incretins|incretins|mesh-ancestor
83667008|NCT01552005|Hormones|hormones|mesh-ancestor
83667009|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667010|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667011|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83667012|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
83667013|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667014|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667015|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83667016|NCT01552018|Saxagliptin|saxagliptin|mesh-list
83667017|NCT01552018|Incretins|incretins|mesh-ancestor
83667018|NCT01552018|Hormones|hormones|mesh-ancestor
83667019|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667020|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667021|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83667022|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
83667023|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667024|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667025|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83667026|NCT01552044|Spironolactone|spironolactone|mesh-list
83667027|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83667028|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667029|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667030|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667031|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83667032|NCT01552044|Diuretics|diuretics|mesh-ancestor
83667033|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
83667034|NCT01552122|Vitamin D|vitamin d|mesh-list
83667035|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
83667036|NCT01552122|Alendronate|alendronate|mesh-list
83667038|NCT01552122|Calcium|calcium|mesh-list
83667039|NCT01552122|Vitamins|vitamins|mesh-ancestor
83667040|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
83667041|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667042|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83667043|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83667044|NCT01552122|Antacids|antacids|mesh-ancestor
83667045|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667046|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667047|NCT01552148|Morphine|morphine|mesh-list
83667048|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83667049|NCT01552148|Narcotics|narcotics|mesh-ancestor
83667050|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667051|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667052|NCT01552148|Analgesics|analgesics|mesh-ancestor
83667053|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
83667054|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667055|NCT01552187|Colchicine|colchicine|mesh-list
83667056|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
83667057|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667058|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
83667059|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
83667060|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
83667061|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667062|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667063|NCT01552330|Artesunate|artesunate|mesh-list
83667064|NCT01552330|Primaquine|primaquine|mesh-list
83667065|NCT01552330|Pyronaridine|pyronaridine|mesh-list
83667066|NCT01552330|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83667067|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
83667068|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83667069|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83667070|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667071|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667072|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
83667073|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
83667074|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83667075|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
83667076|NCT01552629|Cyclosporine|cyclosporine|mesh-list
83667077|NCT01552629|Cyclosporins|cyclosporins|mesh-list
83667078|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667079|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667080|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83667081|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
83667082|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667083|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
83667084|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667085|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83667086|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667087|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83667088|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
83667089|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667090|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667091|NCT01552798|Aspirin|aspirin|mesh-list
83667092|NCT01552798|Acetaminophen|acetaminophen|mesh-list
83667093|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83667094|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83667095|NCT01552798|Analgesics|analgesics|mesh-ancestor
83667096|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
83667097|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667098|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667099|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667100|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667101|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83667102|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83667103|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667104|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83667105|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83667106|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667107|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
83667108|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83667109|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
83667110|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83667111|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82821865|NCT01042028|Everolimus|everolimus|mesh-list
83667112|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83667113|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667114|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667115|NCT01552850|Oxycodone|oxycodone|mesh-list
83667116|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83667117|NCT01552850|Narcotics|narcotics|mesh-ancestor
83667118|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667119|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667120|NCT01552850|Analgesics|analgesics|mesh-ancestor
83667121|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
83667122|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667123|NCT01552863|Oxycodone|oxycodone|mesh-list
83667124|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83667125|NCT01552863|Narcotics|narcotics|mesh-ancestor
83667126|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667127|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667128|NCT01552863|Analgesics|analgesics|mesh-ancestor
83667129|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
83667130|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667131|NCT01552967|Capecitabine|capecitabine|mesh-list
83667132|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83667133|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
83667134|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667135|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667136|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
83667137|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667138|NCT01552993|Acetaminophen|acetaminophen|mesh-list
83667139|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83667140|NCT01552993|Analgesics|analgesics|mesh-ancestor
83667141|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
83667142|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667143|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667144|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
83667145|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
83667146|NCT01553006|Cefditoren|cefditoren|mesh-list
83667147|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667148|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667149|NCT01553019|Gemcitabine|gemcitabine|mesh-list
83667150|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83667151|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
83667152|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667153|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667154|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
83667155|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83667156|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
83667157|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83667158|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667159|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83667160|NCT01553357|Dexamethasone|dexamethasone|mesh-list
83667161|NCT01553357|Lenalidomide|lenalidomide|mesh-list
83667162|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667163|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
83667164|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
83667165|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667166|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667167|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667168|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
83667169|NCT01553357|Hormones|hormones|mesh-ancestor
83667170|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667171|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83667172|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667173|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
83667174|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667175|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667176|NCT01553357|Growth Substances|growth substances|mesh-ancestor
83667177|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667178|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
83667179|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
83667180|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83667181|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83667182|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83667183|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667184|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667185|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821945|NCT01042574|Clevidipine|clevidipine|mesh-list
83667186|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83667187|NCT01553500|Cathartics|cathartics|mesh-ancestor
83667188|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667189|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83667190|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
83667191|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
83667193|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83667194|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83667195|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667196|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667197|NCT01553773|Estradiol|estradiol|mesh-list
83667198|NCT01553773|Estrogens|estrogens|mesh-ancestor
83667199|NCT01553773|Hormones|hormones|mesh-ancestor
83667200|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667201|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667202|NCT01553786|Lenalidomide|lenalidomide|mesh-list
83667203|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
83667204|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667205|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667206|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667207|NCT01553786|Growth Substances|growth substances|mesh-ancestor
83667208|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667209|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667210|NCT01553903|Tamoxifen|tamoxifen|mesh-list
83667211|NCT01553903|Letrozole|letrozole|mesh-list
83667212|NCT01553903|Anastrozole|anastrozole|mesh-list
83667213|NCT01553903|Exemestane|exemestane|mesh-list
83667214|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667215|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83667216|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83667217|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667218|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667219|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83667220|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667221|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667222|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667223|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83667224|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83667225|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83667226|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83667227|NCT01553942|Pemetrexed|pemetrexed|mesh-list
83667228|NCT01553942|Afatinib|afatinib|mesh-list
83667229|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667230|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667231|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667232|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83667233|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83667234|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83667235|NCT01553981|Tadalafil|tadalafil|mesh-list
83667236|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
83667237|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83667238|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83667239|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667240|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667241|NCT01553981|Urological Agents|urological agents|mesh-ancestor
83667242|NCT01554059|Bevacizumab|bevacizumab|mesh-list
83667243|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
83667244|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83667245|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667246|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667247|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667248|NCT01554059|Growth Substances|growth substances|mesh-ancestor
83667249|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667250|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667251|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
83667252|NCT01554111|Cathartics|cathartics|mesh-ancestor
83667253|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667254|NCT01554124|Meropenem|meropenem|mesh-list
83667255|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667256|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667257|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83667258|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83667259|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
83667260|NCT01554345|Vitamin E|vitamin e|mesh-list
83667261|NCT01554345|Selenium|selenium|mesh-list
83667262|NCT01554345|Vitamins|vitamins|mesh-ancestor
83667263|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
83667264|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667265|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
83667266|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667267|NCT01554345|Protective Agents|protective agents|mesh-ancestor
83667268|NCT01554345|Trace Elements|trace elements|mesh-ancestor
83667269|NCT01554397|Cisplatin|cisplatin|mesh-list
83667270|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667271|NCT01554540|Treprostinil|treprostinil|mesh-list
83667272|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83667273|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83667274|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83667275|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83667276|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
83667277|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667278|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667279|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83667280|NCT01554631|Acarbose|acarbose|mesh-list
83667281|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83667282|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667283|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667284|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83667285|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667286|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83667287|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83667288|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667289|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
83667290|NCT01554813|Vaccines|vaccines|mesh-list
83667291|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
83667292|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667293|NCT01554826|Vaccines|vaccines|mesh-list
83667294|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
83667295|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667296|NCT01554852|Thalidomide|thalidomide|mesh-list
83667297|NCT01554852|Dexamethasone|dexamethasone|mesh-list
83667298|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
83667299|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
83667300|NCT01554852|Melphalan|melphalan|mesh-list
83667301|NCT01554852|Lenalidomide|lenalidomide|mesh-list
83667302|NCT01554852|Bortezomib|bortezomib|mesh-list
83667303|NCT01554852|Vorinostat|vorinostat|mesh-list
83667304|NCT01554852|BB 1101|bb 1101|mesh-list
83667305|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83667306|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
83667307|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667308|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667309|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83667310|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
83667311|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667312|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667313|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83667314|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667315|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
83667316|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
83667317|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667318|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667319|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
83667320|NCT01554852|Hormones|hormones|mesh-ancestor
83667321|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667322|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83667323|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
83667324|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667325|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667326|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667327|NCT01554852|Growth Substances|growth substances|mesh-ancestor
83667328|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667329|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
83667330|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667331|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667332|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83667333|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
83667334|NCT01554930|Mannitol|mannitol|mesh-list
83667335|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
82822087|NCT01043744|Artemether|artemether|mesh-list
83667336|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667337|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
83667338|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
83667339|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667340|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667341|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667342|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
83667343|NCT01554930|Hormones|hormones|mesh-ancestor
83667344|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667345|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83667346|NCT01554930|Protective Agents|protective agents|mesh-ancestor
83667347|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
83667348|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83667349|NCT01554930|Diuretics|diuretics|mesh-ancestor
83667350|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
83667351|NCT01554969|Capecitabine|capecitabine|mesh-list
83667352|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83667353|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
83667354|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667355|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667356|NCT01554995|Linezolid|linezolid|mesh-list
83667357|NCT01554995|Delpazolid|delpazolid|mesh-list
83667358|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667359|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667360|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83667361|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667362|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667363|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83667364|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83667365|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667366|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83667367|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667368|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
83667369|NCT01555060|Hematinics|hematinics|mesh-ancestor
83667370|NCT01555099|Budesonide|budesonide|mesh-list
83667371|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667372|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83667373|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
83667374|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667375|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667376|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83667377|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
83667378|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
83667379|NCT01555099|Hormones|hormones|mesh-ancestor
83667380|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667381|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
83667382|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83667383|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
83667384|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667385|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667386|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83667387|NCT01555112|Protective Agents|protective agents|mesh-ancestor
83667388|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83667389|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83667390|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667391|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667392|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
83667393|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667394|NCT01555190|Folic Acid|folic acid|mesh-list
83667395|NCT01555190|Inositol|inositol|mesh-list
83667396|NCT01555190|Hematinics|hematinics|mesh-ancestor
83667397|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
83667398|NCT01555190|Vitamins|vitamins|mesh-ancestor
83667399|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
83667400|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667401|NCT01555216|Ropivacaine|ropivacaine|mesh-list
83667402|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
83667403|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
83667404|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667405|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667406|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
83667407|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667408|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
83667409|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83667410|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83667411|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
83667412|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667413|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83667414|NCT01555476|Ibuprofen|ibuprofen|mesh-list
83667415|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83667416|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83667417|NCT01555476|Analgesics|analgesics|mesh-ancestor
83667418|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
83667419|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667420|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667421|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667422|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667423|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83667424|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667425|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667426|NCT01555580|Molgramostim|molgramostim|mesh-list
83667427|NCT01555580|Sargramostim|sargramostim|mesh-list
83667428|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
83667429|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667430|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667431|NCT01555632|Atorvastatin|atorvastatin|mesh-list
83667432|NCT01555632|Calcium|calcium|mesh-list
83667433|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83667434|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667435|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83667436|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83667437|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
83667438|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667439|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83667440|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83667441|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667442|NCT01555658|Heparin|heparin|mesh-list
83667443|NCT01555658|Bivalirudin|bivalirudin|mesh-list
83667444|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
83667445|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83667446|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83667447|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667448|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
83667449|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83667450|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
83667451|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667452|NCT01555710|Carboplatin|carboplatin|mesh-list
83667453|NCT01555710|Etoposide|etoposide|mesh-list
83667454|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
83667455|NCT01555710|Ifosfamide|ifosfamide|mesh-list
83667456|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667457|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83667458|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83667459|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83667460|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667461|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667462|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83667463|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
83667464|NCT01555788|Pancrelipase|pancrelipase|mesh-list
83667465|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667466|NCT01555814|Amisulpride|amisulpride|mesh-list
83667467|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83667468|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83667469|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667470|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667471|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83667472|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83667473|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
83667474|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667475|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667476|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83667477|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
83667478|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83667479|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667480|NCT01555866|Isavuconazole|isavuconazole|mesh-list
83667481|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
83667482|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667483|NCT01555879|Abatacept|abatacept|mesh-list
83667484|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83667485|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667486|NCT01555879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83667487|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667488|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83667489|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
83667490|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667491|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667492|NCT01555918|Isavuconazole|isavuconazole|mesh-list
83667493|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
83667494|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667495|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
83667496|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83667497|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
83667498|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667499|NCT01555970|Expectorants|expectorants|mesh-ancestor
83667500|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83667501|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83667502|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
83667503|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667504|NCT01555970|Protective Agents|protective agents|mesh-ancestor
83667505|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667506|NCT01555970|Antidotes|antidotes|mesh-ancestor
83667507|NCT01556035|Lenalidomide|lenalidomide|mesh-list
83667508|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
83667509|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667510|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667511|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667512|NCT01556035|Growth Substances|growth substances|mesh-ancestor
83667513|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667514|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667515|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83667516|NCT01556191|Fulvestrant|fulvestrant|mesh-list
83667518|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667519|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83667520|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667521|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667522|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83667523|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83667524|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83667525|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667526|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667527|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667528|NCT01556321|Caffeine|caffeine|mesh-list
83667529|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83667530|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667531|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83667532|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667533|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667534|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83667535|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83667536|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
83667537|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667538|NCT01556334|Azithromycin|azithromycin|mesh-list
83667539|NCT01556334|Erythromycin|erythromycin|mesh-list
83667540|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
83667541|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83667542|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
83667543|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667544|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667545|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667546|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83667547|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667548|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667549|NCT01556477|Lenalidomide|lenalidomide|mesh-list
83667550|NCT01556477|Azacitidine|azacitidine|mesh-list
83667551|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
83667552|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667553|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667554|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667555|NCT01556477|Growth Substances|growth substances|mesh-ancestor
83667556|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667557|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667558|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83667559|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
83667560|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667561|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667562|NCT01556529|Unithiol|unithiol|mesh-list
83667563|NCT01556529|Antidotes|antidotes|mesh-ancestor
83667564|NCT01556529|Protective Agents|protective agents|mesh-ancestor
83667565|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667566|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
83667567|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
83667568|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667569|NCT01556542|Paclitaxel|paclitaxel|mesh-list
83667570|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83667571|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667572|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83667573|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83667574|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83667575|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667576|NCT05847660|Cetrorelix|cetrorelix|mesh-list
83667577|NCT05847660|Progesterone|progesterone|mesh-list
83667578|NCT05847660|Dydrogesterone|dydrogesterone|mesh-list
83667579|NCT05847660|Progestins|progestins|mesh-ancestor
83667580|NCT05847660|Hormones|hormones|mesh-ancestor
83667581|NCT05847660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667582|NCT05847660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667583|NCT05847660|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83667584|NCT05847660|Fertility Agents|fertility agents|mesh-ancestor
83667585|NCT05847660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83667586|NCT05847660|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667587|NCT05847452|Benralizumab|benralizumab|mesh-list
83667588|NCT05847452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83667589|NCT05847452|Respiratory System Agents|respiratory system agents|mesh-ancestor
83667590|NCT05847413|Verapamil|verapamil|mesh-list
83667591|NCT05847413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83667592|NCT05847413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83667593|NCT05847413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83667594|NCT05847413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667595|NCT05847413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83403958|NCT02755597|Bortezomib|bortezomib|mesh-list
83667596|NCT05847413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667597|NCT05847413|Vasodilator Agents|vasodilator agents|mesh-ancestor
83667598|NCT05847348|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83667599|NCT05847348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83667600|NCT05847348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667601|NCT05847322|Azithromycin|azithromycin|mesh-list
83667602|NCT05847322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667603|NCT05847322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667604|NCT05847257|Ubiquinone|ubiquinone|mesh-list
83667605|NCT05847257|Coenzyme Q10|coenzyme q10|mesh-list
83667606|NCT05847257|Letrozole|letrozole|mesh-list
83667607|NCT05847257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667608|NCT05847257|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83667609|NCT05847257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83667610|NCT05847257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667611|NCT05847257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667612|NCT05847257|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83667613|NCT05847257|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667614|NCT05847257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667615|NCT05847257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667616|NCT05847257|Micronutrients|micronutrients|mesh-ancestor
83667617|NCT05847257|Vitamins|vitamins|mesh-ancestor
83667618|NCT05847244|Metformin|metformin|mesh-list
83667619|NCT05847244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83667620|NCT05847244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667621|NCT05847205|Hirudins|hirudins|mesh-list
83667622|NCT05847205|Antithrombins|antithrombins|mesh-ancestor
83667623|NCT05847205|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83667624|NCT05847205|Protease Inhibitors|protease inhibitors|mesh-ancestor
83667625|NCT05847205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667626|NCT05847205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667627|NCT05847205|Anticoagulants|anticoagulants|mesh-ancestor
83667628|NCT05847205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83667629|NCT05847205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83667630|NCT05847088|Dexamethasone|dexamethasone|mesh-list
83667631|NCT05847088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667632|NCT05847088|Antiemetics|antiemetics|mesh-ancestor
83667633|NCT05847088|Autonomic Agents|autonomic agents|mesh-ancestor
83667634|NCT05847088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667635|NCT05847088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667636|NCT05847088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667637|NCT05847088|Glucocorticoids|glucocorticoids|mesh-ancestor
83667638|NCT05847088|Hormones|hormones|mesh-ancestor
83667639|NCT05847088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667640|NCT05847088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83667641|NCT05847088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667643|NCT05847049|Aflibercept|aflibercept|mesh-list
83667644|NCT05847049|Eplerenone|eplerenone|mesh-list
83667645|NCT05847049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667646|NCT05847049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667647|NCT05847049|Growth Substances|growth substances|mesh-ancestor
83667648|NCT05847049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667649|NCT05847049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667650|NCT05847049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667651|NCT05847049|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83667652|NCT05847049|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667653|NCT05847049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667654|NCT05847049|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83667655|NCT05847049|Diuretics|diuretics|mesh-ancestor
83667656|NCT05847049|Natriuretic Agents|natriuretic agents|mesh-ancestor
83667657|NCT05847049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83667658|NCT05847049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83667659|NCT05847049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83667660|NCT05847049|Analgesics|analgesics|mesh-ancestor
83667661|NCT05847049|Sensory System Agents|sensory system agents|mesh-ancestor
83667662|NCT05847049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667663|NCT05847049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667664|NCT05847049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667665|NCT05846880|Vitamin D|vitamin d|mesh-list
83667666|NCT05846880|Ergocalciferols|ergocalciferols|mesh-list
83667667|NCT05846880|Cholecalciferol|cholecalciferol|mesh-list
83667668|NCT05846880|Vitamins|vitamins|mesh-list
83667669|NCT05846880|Lenalidomide|lenalidomide|mesh-list
83667670|NCT05846880|Micronutrients|micronutrients|mesh-ancestor
83667671|NCT05846880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667672|NCT05846880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83667673|NCT05846880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83667674|NCT05846880|Immunologic Factors|immunologic factors|mesh-ancestor
83667675|NCT05846880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83667676|NCT05846880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83667677|NCT05846880|Growth Substances|growth substances|mesh-ancestor
83667678|NCT05846880|Growth Inhibitors|growth inhibitors|mesh-ancestor
83667679|NCT05846880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667680|NCT05846867|Leucovorin|leucovorin|mesh-list
83667681|NCT05846867|Fluorouracil|fluorouracil|mesh-list
83667682|NCT05846867|Oxaliplatin|oxaliplatin|mesh-list
83667683|NCT05846867|Irinotecan|irinotecan|mesh-list
83667684|NCT05846867|Calcium|calcium|mesh-list
83667685|NCT05846867|Levoleucovorin|levoleucovorin|mesh-list
83667686|NCT05846867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83667687|NCT05846867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667688|NCT05846867|Antimetabolites|antimetabolites|mesh-ancestor
83667689|NCT05846867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667690|NCT05846867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83667691|NCT05846867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667692|NCT05846867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83667693|NCT05846867|Immunologic Factors|immunologic factors|mesh-ancestor
83667694|NCT05846867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83667695|NCT05846867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83667696|NCT05846867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667697|NCT05846867|Antidotes|antidotes|mesh-ancestor
83667698|NCT05846867|Protective Agents|protective agents|mesh-ancestor
83667699|NCT05846867|Vitamin B Complex|vitamin b complex|mesh-ancestor
83667700|NCT05846867|Vitamins|vitamins|mesh-ancestor
83667701|NCT05846867|Micronutrients|micronutrients|mesh-ancestor
83667702|NCT05845736|Antihypertensive Agents|antihypertensive agents|mesh-list
83667703|NCT05840744|Antithrombins|antithrombins|mesh-list
83667704|NCT05840744|Thrombin|thrombin|mesh-list
83667705|NCT05840744|Hemostatics|hemostatics|mesh-ancestor
83667706|NCT05840744|Coagulants|coagulants|mesh-ancestor
83667707|NCT05840744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83667708|NCT05840744|Protease Inhibitors|protease inhibitors|mesh-ancestor
83667709|NCT05840744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667710|NCT05840744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667711|NCT05840744|Anticoagulants|anticoagulants|mesh-ancestor
83667712|NCT05840692|Escitalopram|escitalopram|mesh-list
83667713|NCT05840692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83667714|NCT05840692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83667715|NCT05840692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83667716|NCT05840692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667717|NCT05840692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667718|NCT05840692|Serotonin Agents|serotonin agents|mesh-ancestor
83667719|NCT05840692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667720|NCT05840653|Psychotropic Drugs|psychotropic drugs|mesh-list
83667721|NCT05840640|Lenograstim|lenograstim|mesh-list
83667722|NCT05840640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83667723|NCT05840640|Immunologic Factors|immunologic factors|mesh-ancestor
83667724|NCT05840640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667725|NCT05840588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83667726|NCT05840588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667727|NCT05840536|Chlorothiazide|chlorothiazide|mesh-list
83667729|NCT05840536|Diuretics|diuretics|mesh-ancestor
83667730|NCT05840536|Natriuretic Agents|natriuretic agents|mesh-ancestor
83667731|NCT05840536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667732|NCT05840536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83667733|NCT05840536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83667734|NCT05840536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667735|NCT05840536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83667736|NCT05840536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83667737|NCT05840406|Acetaminophen|acetaminophen|mesh-list
83667738|NCT05840406|Ibuprofen|ibuprofen|mesh-list
83667739|NCT05840406|Ketoprofen|ketoprofen|mesh-list
83667740|NCT05840406|Dexmedetomidine|dexmedetomidine|mesh-list
83667741|NCT05840406|Tramadol|tramadol|mesh-list
83667742|NCT05840406|Levobupivacaine|levobupivacaine|mesh-list
83667743|NCT05840406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83667744|NCT05840406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667745|NCT05840406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667746|NCT05840406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83667747|NCT05840406|Analgesics|analgesics|mesh-ancestor
83667748|NCT05840406|Sensory System Agents|sensory system agents|mesh-ancestor
83667749|NCT05840406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667750|NCT05840406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83667751|NCT05840406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83667752|NCT05840406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83667753|NCT05840406|Adrenergic Agents|adrenergic agents|mesh-ancestor
83667754|NCT05840406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667755|NCT05840406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667756|NCT05840406|Antipyretics|antipyretics|mesh-ancestor
83667757|NCT05840406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83667758|NCT05840406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667759|NCT05840406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83667760|NCT05840406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83667761|NCT05840406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667762|NCT05840406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83667763|NCT05840406|Narcotics|narcotics|mesh-ancestor
83667764|NCT05840406|Anesthetics, Local|anesthetics, local|mesh-ancestor
83667765|NCT05840406|Anesthetics|anesthetics|mesh-ancestor
83667766|NCT05840328|Dexmedetomidine|dexmedetomidine|mesh-list
83667767|NCT05840328|Bupivacaine|bupivacaine|mesh-list
83667768|NCT05840328|Anesthetics, Local|anesthetics, local|mesh-ancestor
83667769|NCT05840328|Anesthetics|anesthetics|mesh-ancestor
83667770|NCT05840328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667771|NCT05840328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667772|NCT05840328|Sensory System Agents|sensory system agents|mesh-ancestor
83667773|NCT05840328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667774|NCT05840328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83667775|NCT05840328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83667776|NCT05840328|Analgesics|analgesics|mesh-ancestor
83667777|NCT05840328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83667778|NCT05840328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83667779|NCT05840328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83667780|NCT05840328|Adrenergic Agents|adrenergic agents|mesh-ancestor
83667781|NCT05840328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667782|NCT05840328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667783|NCT05840172|Benzocaine|benzocaine|mesh-list
83667784|NCT05840172|Anesthetics, Local|anesthetics, local|mesh-ancestor
83667785|NCT05840172|Anesthetics|anesthetics|mesh-ancestor
83667786|NCT05840172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667787|NCT05840172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667788|NCT05840172|Sensory System Agents|sensory system agents|mesh-ancestor
83667789|NCT05840172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667790|NCT05840159|Doxycycline|doxycycline|mesh-list
82822544|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
83667791|NCT05840159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667792|NCT05840159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667793|NCT05840159|Antimalarials|antimalarials|mesh-ancestor
83667794|NCT05840159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83667795|NCT05840159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83667796|NCT05840094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83667797|NCT05840094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83667798|NCT05840094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667799|NCT05840016|Carboplatin|carboplatin|mesh-list
83667800|NCT05840016|Tislelizumab|tislelizumab|mesh-list
83667801|NCT05840016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667802|NCT05840016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83667803|NCT05839899|Misoprostol|misoprostol|mesh-list
83667804|NCT05839899|Mifepristone|mifepristone|mesh-list
83667805|NCT05839899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83667806|NCT05839899|Abortifacient Agents|abortifacient agents|mesh-ancestor
83667807|NCT05839899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83667808|NCT05839899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667809|NCT05839899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83667810|NCT05839899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83667811|NCT05839899|Oxytocics|oxytocics|mesh-ancestor
83667812|NCT05839899|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83667813|NCT05839899|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83667814|NCT05839899|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83667815|NCT05839899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83667816|NCT05839899|Contraceptive Agents|contraceptive agents|mesh-ancestor
83667817|NCT05839899|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83667818|NCT05839899|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83667819|NCT05839899|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667820|NCT05839899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667821|NCT05839899|Luteolytic Agents|luteolytic agents|mesh-ancestor
83667822|NCT05839899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83667823|NCT05839899|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83667824|NCT05839652|Midodrine|midodrine|mesh-list
83667825|NCT05839652|Droxidopa|droxidopa|mesh-list
83667826|NCT05839652|Sympathomimetics|sympathomimetics|mesh-ancestor
83667827|NCT05839652|Autonomic Agents|autonomic agents|mesh-ancestor
83667828|NCT05839652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667829|NCT05839652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667830|NCT05839652|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83667831|NCT05839652|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83667832|NCT05839652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83667833|NCT05839652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83667834|NCT05839652|Adrenergic Agents|adrenergic agents|mesh-ancestor
83667835|NCT05839652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667836|NCT05839652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667837|NCT05839652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83667838|NCT05839652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83667839|NCT05839574|Letrozole|letrozole|mesh-list
83667840|NCT05839574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667841|NCT05839574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83667842|NCT05839574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83667843|NCT05839574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667844|NCT05839574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667845|NCT05839574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83667846|NCT05839574|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667847|NCT05839574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667848|NCT05839574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667849|NCT05839561|Letrozole|letrozole|mesh-list
83667850|NCT05839561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667851|NCT05839561|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83667852|NCT05839561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83667853|NCT05839561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667854|NCT05839561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667855|NCT05839561|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83667856|NCT05839561|Hormone Antagonists|hormone antagonists|mesh-ancestor
83667857|NCT05839561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83667858|NCT05839561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667859|NCT05839548|Epinephrine|epinephrine|mesh-list
83667860|NCT05839548|Racepinephrine|racepinephrine|mesh-list
83667861|NCT05839548|Carticaine|carticaine|mesh-list
83667862|NCT05839548|Mepivacaine|mepivacaine|mesh-list
83667863|NCT05839548|Epinephryl borate|epinephryl borate|mesh-list
83667864|NCT05839548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82822618|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83667865|NCT05839548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83667866|NCT05839548|Adrenergic Agents|adrenergic agents|mesh-ancestor
83667867|NCT05839548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667868|NCT05839548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667869|NCT05839548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667870|NCT05839548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83667871|NCT05839548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83667872|NCT05839548|Autonomic Agents|autonomic agents|mesh-ancestor
83667873|NCT05839548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667874|NCT05839548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83667875|NCT05839548|Respiratory System Agents|respiratory system agents|mesh-ancestor
83667876|NCT05839548|Mydriatics|mydriatics|mesh-ancestor
83667877|NCT05839548|Sympathomimetics|sympathomimetics|mesh-ancestor
83667878|NCT05839548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83667879|NCT05839548|Anesthetics, Local|anesthetics, local|mesh-ancestor
83667880|NCT05839548|Anesthetics|anesthetics|mesh-ancestor
83667881|NCT05839548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667882|NCT05839548|Sensory System Agents|sensory system agents|mesh-ancestor
83667883|NCT05839522|Antibodies|antibodies|mesh-list
83667884|NCT05839522|Immunoglobulins|immunoglobulins|mesh-list
83667885|NCT05839522|HIV Antibodies|hiv antibodies|mesh-list
83667886|NCT05839522|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
83667887|NCT05839522|Immunologic Factors|immunologic factors|mesh-ancestor
83667888|NCT05839522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667889|NCT05839509|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83667890|NCT05839509|Hallucinogens|hallucinogens|mesh-ancestor
83667891|NCT05839509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667892|NCT05839509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83667893|NCT05839509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83667894|NCT05839509|Serotonin Agents|serotonin agents|mesh-ancestor
83667895|NCT05839509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667896|NCT05839509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667897|NCT05839509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83667898|NCT05839470|Leucovorin|leucovorin|mesh-list
83667899|NCT05839470|Oxaliplatin|oxaliplatin|mesh-list
83667900|NCT05839470|Irinotecan|irinotecan|mesh-list
83667901|NCT05839470|Levoleucovorin|levoleucovorin|mesh-list
83667902|NCT05839470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667903|NCT05839470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83667904|NCT05839470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83667905|NCT05839470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667906|NCT05839470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667907|NCT05839470|Antidotes|antidotes|mesh-ancestor
83667908|NCT05839470|Protective Agents|protective agents|mesh-ancestor
83667909|NCT05839470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667910|NCT05839470|Vitamin B Complex|vitamin b complex|mesh-ancestor
83667911|NCT05839470|Vitamins|vitamins|mesh-ancestor
83667912|NCT05839470|Micronutrients|micronutrients|mesh-ancestor
83667913|NCT05839366|Remifentanil|remifentanil|mesh-list
83667914|NCT05839366|Propofol|propofol|mesh-list
83667915|NCT05839366|Esketamine|esketamine|mesh-list
83667916|NCT05839366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83667917|NCT05839366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667918|NCT05839366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667919|NCT05839366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83667920|NCT05839366|Anesthetics, General|anesthetics, general|mesh-ancestor
83667921|NCT05839366|Anesthetics|anesthetics|mesh-ancestor
83667922|NCT05839366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83667923|NCT05839366|Narcotics|narcotics|mesh-ancestor
83667924|NCT05839366|Analgesics|analgesics|mesh-ancestor
83667925|NCT05839366|Sensory System Agents|sensory system agents|mesh-ancestor
83667926|NCT05839366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667927|NCT05839366|Antidepressive Agents|antidepressive agents|mesh-ancestor
83667928|NCT05839366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83667929|NCT05839236|Atorvastatin|atorvastatin|mesh-list
83667930|NCT05839236|Calcium|calcium|mesh-list
83667931|NCT05839236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83667932|NCT05839236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667933|NCT05839236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83667934|NCT05839236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83667935|NCT05839236|Antimetabolites|antimetabolites|mesh-ancestor
83667936|NCT05839236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667937|NCT05839236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83667938|NCT05839236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83667939|NCT05839236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667940|NCT05839197|Apatinib|apatinib|mesh-list
83667941|NCT05839197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667942|NCT05839197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83667943|NCT05839197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667944|NCT05839197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667945|NCT05839158|Mupirocin|mupirocin|mesh-list
83667946|NCT05839158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83667947|NCT05839158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83667948|NCT05839158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83667949|NCT05839158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667950|NCT05839158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667951|NCT05839119|Gemcitabine|gemcitabine|mesh-list
83667952|NCT05839119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83667953|NCT05839119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83667954|NCT05839119|Antimetabolites|antimetabolites|mesh-ancestor
83667955|NCT05839119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667956|NCT05839054|Methamphetamine|methamphetamine|mesh-list
83667957|NCT05839054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83667958|NCT05839054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667959|NCT05839054|Sympathomimetics|sympathomimetics|mesh-ancestor
83667960|NCT05839054|Autonomic Agents|autonomic agents|mesh-ancestor
83667961|NCT05839054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667962|NCT05839054|Dopamine Agents|dopamine agents|mesh-ancestor
83667963|NCT05839054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667964|NCT05839054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667965|NCT05839054|Adrenergic Agents|adrenergic agents|mesh-ancestor
83667966|NCT05839054|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83667967|NCT05839054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83667968|NCT05839054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83667969|NCT05839054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83667970|NCT05838846|Milrinone|milrinone|mesh-list
83667971|NCT05838846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83667972|NCT05838846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83667973|NCT05838846|Vasodilator Agents|vasodilator agents|mesh-ancestor
83667974|NCT05838846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83667975|NCT05838846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83667976|NCT05838846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83667977|NCT05838846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667978|NCT05838846|Protective Agents|protective agents|mesh-ancestor
83667979|NCT05838846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667980|NCT05837403|Nitroglycerin|nitroglycerin|mesh-list
83667981|NCT05837403|Vasodilator Agents|vasodilator agents|mesh-ancestor
83667982|NCT05836610|Hydrocortisone|hydrocortisone|mesh-list
83667983|NCT05836610|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83667984|NCT05836610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83667985|NCT05833529|Cocaine|cocaine|mesh-list
83667986|NCT05833529|Anesthetics, Local|anesthetics, local|mesh-ancestor
83667987|NCT05833529|Anesthetics|anesthetics|mesh-ancestor
83667988|NCT05833529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83667989|NCT05833529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83667990|NCT05833529|Sensory System Agents|sensory system agents|mesh-ancestor
83667991|NCT05833529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83667992|NCT05833529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83667993|NCT05833529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83667994|NCT05833529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83667995|NCT05833529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83667996|NCT05833529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83667997|NCT05833529|Dopamine Agents|dopamine agents|mesh-ancestor
83667998|NCT05833529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83667999|NCT05830630|Bupivacaine|bupivacaine|mesh-list
83668000|NCT05830630|Methylene Blue|methylene blue|mesh-list
83668001|NCT05830630|Anesthetics, Local|anesthetics, local|mesh-ancestor
83668002|NCT05830630|Anesthetics|anesthetics|mesh-ancestor
83668003|NCT05830630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668004|NCT05830630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668005|NCT05830630|Sensory System Agents|sensory system agents|mesh-ancestor
83668006|NCT05830630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668007|NCT05830630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668008|NCT05830630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668009|NCT05823753|Cannabidiol|cannabidiol|mesh-list
83668010|NCT05823753|Anticonvulsants|anticonvulsants|mesh-ancestor
83668011|NCT05823311|Cisplatin|cisplatin|mesh-list
83668012|NCT05823311|Gemcitabine|gemcitabine|mesh-list
83668013|NCT05823311|Lenvatinib|lenvatinib|mesh-list
83668014|NCT05823311|Tislelizumab|tislelizumab|mesh-list
83668015|NCT05823311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822766|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822770|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
83668016|NCT05823311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83668017|NCT05823311|Antimetabolites|antimetabolites|mesh-ancestor
83668018|NCT05823311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668019|NCT05823311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83668020|NCT05823311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668021|NCT05823311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668022|NCT05813158|Bupivacaine|bupivacaine|mesh-list
83668023|NCT05813158|Anesthetics, Local|anesthetics, local|mesh-ancestor
83668024|NCT05813158|Anesthetics|anesthetics|mesh-ancestor
83668025|NCT05813158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668026|NCT05813158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668027|NCT05813158|Sensory System Agents|sensory system agents|mesh-ancestor
83668028|NCT05813158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668029|NCT05805683|Calcitonin|calcitonin|mesh-list
83668030|NCT05805683|Salmon calcitonin|salmon calcitonin|mesh-list
83668031|NCT05805683|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83668032|NCT05805683|Katacalcin|katacalcin|mesh-list
83668033|NCT05805683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83668034|NCT05805683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668035|NCT05805683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83668036|NCT05805683|Vasodilator Agents|vasodilator agents|mesh-ancestor
83668037|NCT05799079|Decitabine|decitabine|mesh-list
83668038|NCT05799079|Venetoclax|venetoclax|mesh-list
83668039|NCT05799079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83668040|NCT05799079|Antimetabolites|antimetabolites|mesh-ancestor
83668041|NCT05799079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668042|NCT05799079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668043|NCT05799079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668044|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
83668045|NCT05782361|Tepotinib|tepotinib|mesh-list
83668046|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668047|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668048|NCT05782361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668049|NCT05782361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668050|NCT05780801|Glycerol|glycerol|mesh-list
83668051|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83668052|NCT05780801|Protective Agents|protective agents|mesh-ancestor
83668053|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668054|NCT05753670|Tamsulosin|tamsulosin|mesh-list
83668055|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83668056|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83668057|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83668058|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668059|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668060|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668061|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668062|NCT05753670|Urological Agents|urological agents|mesh-ancestor
83668063|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
83668064|NCT05753059|Amiloride|amiloride|mesh-list
83668065|NCT05753059|Diuretics|diuretics|mesh-ancestor
83668066|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
83668067|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668068|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83668069|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83668070|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83668071|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668072|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83668073|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83668074|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83668075|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83668076|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83668077|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
83668078|NCT05729139|Cemiplimab|cemiplimab|mesh-list
83668079|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
83668080|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668081|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668082|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668083|NCT05726032|Empagliflozin|empagliflozin|mesh-list
83668084|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83668085|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668086|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83668087|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668088|NCT05711940|Psilocybin|psilocybin|mesh-list
82822842|NCT01050036|Busulfan|busulfan|mesh-list
83668089|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
83668090|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668091|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83668092|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
83668093|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83668094|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83668095|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668096|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
83668097|NCT05686005|Coagulants|coagulants|mesh-ancestor
83668098|NCT05671991|Empagliflozin|empagliflozin|mesh-list
83668099|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83668100|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668101|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83668102|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668103|NCT05660681|Glycerol|glycerol|mesh-list
83668104|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83668105|NCT05660681|Protective Agents|protective agents|mesh-ancestor
83668106|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668107|NCT05624268|Psilocybin|psilocybin|mesh-list
83668108|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
83668109|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668110|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83668111|NCT05600114|Cannabidiol|cannabidiol|mesh-list
83668112|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83668113|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
83668114|NCT05585151|Evolocumab|evolocumab|mesh-list
83668115|NCT05585151|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83668116|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83668117|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83668118|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
83668119|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668120|NCT05585151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83668121|NCT05585151|Protease Inhibitors|protease inhibitors|mesh-ancestor
83668122|NCT05585151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668123|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83668124|NCT05585112|Lidocaine|lidocaine|mesh-list
83668125|NCT05585112|Carticaine|carticaine|mesh-list
83668126|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
83668127|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
83668128|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668129|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668130|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
83668131|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668132|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83668133|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83668134|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83668135|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83668136|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668137|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
83668138|NCT05565105|Melphalan|melphalan|mesh-list
83668139|NCT05565105|Busulfan|busulfan|mesh-list
83668140|NCT05565105|Thiotepa|thiotepa|mesh-list
83668141|NCT05565105|Fludarabine|fludarabine|mesh-list
83668142|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668143|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
83668144|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668145|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83668146|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83668147|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
83668148|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668149|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668150|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83668151|NCT05552508|Benralizumab|benralizumab|mesh-list
83668152|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83668153|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
83668154|NCT05552443|Hydromorphone|hydromorphone|mesh-list
83668155|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83668156|NCT05552443|Narcotics|narcotics|mesh-ancestor
83668157|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668158|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668159|NCT05552443|Analgesics|analgesics|mesh-ancestor
83668160|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
83668161|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668162|NCT05550337|Trifarotene|trifarotene|mesh-list
83668163|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
83668164|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83668165|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83668166|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668167|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668168|NCT05528588|Furosemide|furosemide|mesh-list
83668169|NCT05528588|Diuretics|diuretics|mesh-ancestor
83668170|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
83668171|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668172|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83668173|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83668174|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668175|NCT05527483|Listerine|listerine|mesh-list
83668176|NCT05527483|Fluorides|fluorides|mesh-list
83668177|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
83668178|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
83668179|NCT05527483|Protective Agents|protective agents|mesh-ancestor
83668180|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668181|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83668182|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668183|NCT05527470|Cisplatin|cisplatin|mesh-list
83668184|NCT05527470|Gemcitabine|gemcitabine|mesh-list
83668185|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668186|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83668187|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
83668188|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668189|NCT05481736|Psilocybin|psilocybin|mesh-list
83668190|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
83668191|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668192|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83668193|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83668194|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
83668195|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668196|NCT05458102|Voriconazole|voriconazole|mesh-list
83668197|NCT05458102|Cobicistat|cobicistat|mesh-list
83668198|NCT05458102|Rifabutin|rifabutin|mesh-list
83668199|NCT05458102|Vesatolimod|vesatolimod|mesh-list
83668200|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
83668201|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668202|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83668203|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83668204|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668205|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668206|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83668207|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
83668208|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668209|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668210|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83668211|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83668212|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83668213|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
83668214|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83668215|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83668216|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
83668217|NCT05439356|Colchicine|colchicine|mesh-list
83668218|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
83668219|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83668220|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83668221|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83668222|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83668223|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668224|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668225|NCT05416320|Calcipotriene|calcipotriene|mesh-list
83668226|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
83668227|NCT05335356|Ustekinumab|ustekinumab|mesh-list
83668228|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
83668229|NCT05323487|Bumetanide|bumetanide|mesh-list
83668230|NCT05323487|Diuretics|diuretics|mesh-ancestor
83668231|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
83668232|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668233|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83668234|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83668235|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668236|NCT05301842|Durvalumab|durvalumab|mesh-list
83668237|NCT05301842|Lenvatinib|lenvatinib|mesh-list
82822992|NCT01053390|Hormones|hormones|mesh-ancestor
83668238|NCT05301842|Tremelimumab|tremelimumab|mesh-list
82822994|NCT00356148|Ampicillin|ampicillin|mesh-list
83668239|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668240|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668242|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668243|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668244|NCT05301322|Vaccines|vaccines|mesh-list
83668245|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
83668246|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668247|NCT05281601|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83668248|NCT05281601|Antiviral Agents|antiviral agents|mesh-ancestor
83668249|NCT05281601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668250|NCT05266807|Vancomycin|vancomycin|mesh-list
83668251|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
83668252|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83668253|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668254|NCT05254418|Dulaglutide|dulaglutide|mesh-list
83668255|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83668256|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668257|NCT05224050|Nicotine|nicotine|mesh-list
83668258|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83668259|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
83668260|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668261|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668262|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83668263|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83668264|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
83668265|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668266|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668267|NCT05174065|Apremilast|apremilast|mesh-list
83668268|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83668269|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83668270|NCT05174065|Analgesics|analgesics|mesh-ancestor
83668271|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
83668272|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668273|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668274|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668275|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83668276|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83668277|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83668278|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668279|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668280|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
83668281|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83668282|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83668283|NCT05150704|Prednisolone|prednisolone|mesh-list
83668284|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
83668285|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83668286|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
83668287|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668288|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
83668289|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
83668290|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668291|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668292|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668293|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
83668294|NCT05150704|Hormones|hormones|mesh-ancestor
83668295|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668296|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83668297|NCT05150704|Protective Agents|protective agents|mesh-ancestor
83668298|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668299|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668300|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83668301|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83668302|NCT05116241|Vaccines|vaccines|mesh-list
83668303|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
83668304|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668305|NCT05095259|Insulin|insulin|mesh-list
83668306|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83668307|NCT05095259|Epinephrine|epinephrine|mesh-list
83668308|NCT05095259|Glucagon|glucagon|mesh-list
83668309|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83668310|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668311|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83668312|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82823065|NCT00252694|Candesartan cilexetil|candesartan cilexetil|mesh-list
83668313|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668314|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668315|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668316|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83668317|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83668318|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
83668319|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668320|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83668321|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
83668322|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
83668323|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
83668324|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83668325|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668326|NCT05095259|Hormones|hormones|mesh-ancestor
83668327|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668328|NCT05085002|Letrozole|letrozole|mesh-list
83668329|NCT05085002|Fulvestrant|fulvestrant|mesh-list
83668330|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668331|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83668332|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83668333|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668334|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668335|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83668336|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
83668337|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668338|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668339|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668340|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83668341|NCT05071053|Ramucirumab|ramucirumab|mesh-list
83668342|NCT05071053|Maytansine|maytansine|mesh-list
83668343|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668344|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83668345|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83668346|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83404713|NCT05874141|Hormones|hormones|mesh-list
83668347|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83668348|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668349|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
83668350|NCT05064280|Lenvatinib|lenvatinib|mesh-list
83668351|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668352|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668353|NCT05064280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668354|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668355|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83668356|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668357|NCT05060315|Treprostinil|treprostinil|mesh-list
83668358|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83668359|NCT05049278|Phenylephrine|phenylephrine|mesh-list
83668360|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
83668361|NCT05049278|Norepinephrine|norepinephrine|mesh-list
83668362|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83668363|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
83668364|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
83668365|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668366|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668367|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
83668368|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83668369|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
83668370|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83668371|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83668372|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83668373|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83668374|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668375|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668376|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668377|NCT05049278|Protective Agents|protective agents|mesh-ancestor
83668378|NCT05040282|Etonogestrel|etonogestrel|mesh-list
83668379|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83668380|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
83668381|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83668382|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668383|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83668384|NCT04982614|Vaccines|vaccines|mesh-list
83668385|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
83668386|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668387|NCT04982354|Fludarabine|fludarabine|mesh-list
83668388|NCT04982354|Melphalan|melphalan|mesh-list
83668389|NCT04982354|Busulfan|busulfan|mesh-list
83668390|NCT04982354|Midostaurin|midostaurin|mesh-list
83668391|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668392|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668393|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668394|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
83668395|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668396|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83668397|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
83668398|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83668399|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83668400|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668401|NCT04953754|Melatonin|melatonin|mesh-list
83668402|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
83668403|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668404|NCT04953754|Protective Agents|protective agents|mesh-ancestor
83668405|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668406|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668407|NCT04932382|Misoprostol|misoprostol|mesh-list
83668408|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83668409|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
83668410|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83668411|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668412|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83668413|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668414|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
83668415|NCT04925284|Bevacizumab|bevacizumab|mesh-list
83668416|NCT04925284|Nivolumab|nivolumab|mesh-list
83668417|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668418|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668419|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83668420|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83668421|NCT04925284|Growth Substances|growth substances|mesh-ancestor
83668422|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668423|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
83668424|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668425|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668426|NCT04909801|Adalimumab|adalimumab|mesh-list
83668427|NCT04909801|Methotrexate|methotrexate|mesh-list
83668428|NCT04909801|Abatacept|abatacept|mesh-list
83668429|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83668430|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
83668431|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83668432|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668433|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83668434|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
83668435|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668436|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668437|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
83668438|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668439|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83668440|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668441|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
83668442|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83668443|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83668444|NCT04909801|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83668445|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668446|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668447|NCT04909801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668448|NCT04901715|Albuterol|albuterol|mesh-list
83668449|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83668450|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
83668451|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668452|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668453|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83668454|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83668455|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
83668456|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83668457|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83668458|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83668459|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83668460|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668461|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668462|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668463|NCT04895592|Dexamethasone|dexamethasone|mesh-list
83668464|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
83668466|NCT04895592|BB 1101|bb 1101|mesh-list
83668467|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668468|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
83668469|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
83668470|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668471|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668472|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668473|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
83668474|NCT04895592|Hormones|hormones|mesh-ancestor
83668475|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668476|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668477|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668478|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
83668479|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668480|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668481|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
83668482|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
83668483|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83668484|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83668485|NCT04873583|Prednisolone|prednisolone|mesh-list
83668486|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
83668487|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83668488|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
83668489|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668490|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
83668491|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
83668492|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668493|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668494|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668495|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
83668496|NCT04873583|Hormones|hormones|mesh-ancestor
83668497|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668498|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83668499|NCT04873583|Protective Agents|protective agents|mesh-ancestor
83668500|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668501|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668502|NCT04861103|Enoxaparin|enoxaparin|mesh-list
83668503|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
83668504|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83668505|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83668506|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668507|NCT04843761|Remdesivir|remdesivir|mesh-list
83668508|NCT04843761|Phentolamine|phentolamine|mesh-list
83668509|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
83668510|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
83668511|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668512|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
83668513|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668514|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83668515|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83668516|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668517|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668518|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668519|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83668520|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668521|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
83668522|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83668523|NCT04843761|Protective Agents|protective agents|mesh-ancestor
83668524|NCT04835129|Dexamethasone|dexamethasone|mesh-list
83668525|NCT04835129|Pomalidomide|pomalidomide|mesh-list
83668526|NCT04835129|Elotuzumab|elotuzumab|mesh-list
83668527|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83668528|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668529|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
83668530|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
83668531|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668532|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668533|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668534|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
83668535|NCT04835129|Hormones|hormones|mesh-ancestor
83668536|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668537|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668538|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668539|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
83668540|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83668541|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83668542|NCT04835129|Growth Substances|growth substances|mesh-ancestor
83668543|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
83668544|NCT04799249|Carboplatin|carboplatin|mesh-list
83668545|NCT04799249|Gemcitabine|gemcitabine|mesh-list
83668546|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668547|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83668548|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
83668549|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668550|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
83668551|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
83668552|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668553|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668554|NCT04719273|Anastrozole|anastrozole|mesh-list
83668555|NCT04719273|Onapristone|onapristone|mesh-list
83668556|NCT04719273|Progesterone|progesterone|mesh-list
83668557|NCT04719273|Estrogens|estrogens|mesh-list
83668558|NCT04719273|Progestins|progestins|mesh-ancestor
83668559|NCT04719273|Hormones|hormones|mesh-ancestor
83668560|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668561|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668562|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668563|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668564|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83668565|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83668566|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668567|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668568|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83668569|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
83668570|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83668571|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
83404948|NCT05870800|Vitamins|vitamins|mesh-ancestor
83668572|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83668573|NCT04710368|Evolocumab|evolocumab|mesh-list
83668574|NCT04710368|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83668575|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83668576|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83668577|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
83668578|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668579|NCT04710368|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83668580|NCT04710368|Protease Inhibitors|protease inhibitors|mesh-ancestor
83668581|NCT04710368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668582|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83668583|NCT04699604|Levocetirizine|levocetirizine|mesh-list
83668584|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83668585|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83668586|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
83668587|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
83668588|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668589|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668590|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668591|NCT04614974|Famotidine|famotidine|mesh-list
83668592|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83668593|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668594|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83668595|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
83668596|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
83668597|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668598|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668599|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668600|NCT04610866|Mitapivat|mitapivat|mesh-list
83668601|NCT04610866|Enzyme Activators|enzyme activators|mesh-ancestor
83668602|NCT04610866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668603|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
83668604|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668605|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668606|NCT04609579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668607|NCT04609579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668608|NCT04603066|Ondansetron|ondansetron|mesh-list
83668609|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
83668610|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
83668611|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668612|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668613|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82823363|NCT00264849|Omalizumab|omalizumab|mesh-list
83668614|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
83668615|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
83668616|NCT04603066|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83668617|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83668618|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
83668619|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668620|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668621|NCT04591431|Nivolumab|nivolumab|mesh-list
83668622|NCT04591431|Trastuzumab|trastuzumab|mesh-list
83668623|NCT04591431|Ipilimumab|ipilimumab|mesh-list
83668624|NCT04591431|Atezolizumab|atezolizumab|mesh-list
83668625|NCT04591431|Pertuzumab|pertuzumab|mesh-list
83668626|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83668627|NCT04591431|Everolimus|everolimus|mesh-list
83668628|NCT04591431|Palbociclib|palbociclib|mesh-list
83668629|NCT04591431|Lapatinib|lapatinib|mesh-list
83668630|NCT04591431|Vemurafenib|vemurafenib|mesh-list
83668631|NCT04591431|Maytansine|maytansine|mesh-list
83668632|NCT04591431|Talazoparib|talazoparib|mesh-list
83668633|NCT04591431|Ponatinib|ponatinib|mesh-list
83668634|NCT04591431|Ipatasertib|ipatasertib|mesh-list
83668635|NCT04591431|Tepotinib|tepotinib|mesh-list
83668636|NCT04591431|Pralsetinib|pralsetinib|mesh-list
83668637|NCT04591431|Entrectinib|entrectinib|mesh-list
83668638|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668639|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668640|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668641|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668642|NCT04591431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83668643|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83668644|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668645|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668646|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
83668647|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668648|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83668649|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
83668650|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
83668651|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
83668652|NCT04591431|Immunotoxins|immunotoxins|mesh-ancestor
83668653|NCT04591431|Immunoconjugates|immunoconjugates|mesh-ancestor
83668654|NCT04591431|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83668655|NCT04571164|Rotigotine|rotigotine|mesh-list
83668656|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
83668657|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
83668658|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668659|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668660|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668661|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
83668662|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83668663|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83668664|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668665|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
83668666|NCT04559880|Coagulants|coagulants|mesh-ancestor
83668667|NCT04542369|Carboplatin|carboplatin|mesh-list
83668668|NCT04542369|Etoposide|etoposide|mesh-list
83668669|NCT04542369|Tislelizumab|tislelizumab|mesh-list
83668670|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668671|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83668672|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83668673|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83668674|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668675|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668676|NCT04542369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668677|NCT04524000|Fulvestrant|fulvestrant|mesh-list
83668678|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668679|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668680|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83668681|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83668682|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
83668683|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668684|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668685|NCT04496596|Suramin|suramin|mesh-list
83668686|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
83668687|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
83668688|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83668689|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823437|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668690|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668691|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83668692|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83668693|NCT04477850|Luspatercept|luspatercept|mesh-list
83668694|NCT04477850|Hematinics|hematinics|mesh-ancestor
83668695|NCT04388163|Gentian Violet|gentian violet|mesh-list
83668696|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83668697|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668698|NCT04346654|Dexamethasone|dexamethasone|mesh-list
83668699|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668700|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
83668701|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
83668702|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668703|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668704|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668705|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
83668706|NCT04346654|Hormones|hormones|mesh-ancestor
83668707|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668708|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83668709|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668710|NCT04339738|Paclitaxel|paclitaxel|mesh-list
83668711|NCT04339738|Nivolumab|nivolumab|mesh-list
83668712|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83668713|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83668714|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668715|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
83668716|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
83668717|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
83668718|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668719|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668720|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668721|NCT04312503|Olanzapine|olanzapine|mesh-list
83668722|NCT04312503|Risperidone|risperidone|mesh-list
83668723|NCT04312503|Aripiprazole|aripiprazole|mesh-list
83668724|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83668725|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83668726|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83668727|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
83668728|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668729|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668730|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668731|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83668732|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83668733|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668734|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83668735|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83668736|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
83668737|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
83668738|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
83668739|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668740|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83668741|NCT04312503|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83668742|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83668743|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83668744|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
83668745|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
83668746|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83668747|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83668748|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83668749|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83668750|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83668751|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83668752|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83668753|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668754|NCT04310540|Edetic Acid|edetic acid|mesh-list
83668755|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83668756|NCT04310540|Chelating Agents|chelating agents|mesh-ancestor
83668757|NCT04310540|Sequestering Agents|sequestering agents|mesh-ancestor
83668758|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668759|NCT04310540|Anticoagulants|anticoagulants|mesh-ancestor
83668760|NCT04310540|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83668761|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83668762|NCT04305444|Everolimus|everolimus|mesh-list
83668763|NCT04305444|Pomalidomide|pomalidomide|mesh-list
83668764|NCT04305444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83668765|NCT04305444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82823514|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
83668766|NCT04305444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668767|NCT04305444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668768|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668769|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
83668770|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668771|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668772|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83668773|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83668774|NCT04305444|Growth Substances|growth substances|mesh-ancestor
83668775|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
83668776|NCT04297332|Nicotine|nicotine|mesh-list
83668777|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83668778|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
83668779|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668780|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668781|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83668782|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83668783|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
83668784|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668785|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668786|NCT04273776|Zolpidem|zolpidem|mesh-list
83668787|NCT04273776|Suvorexant|suvorexant|mesh-list
83668788|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83668789|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83668790|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668791|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668792|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83668793|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
83668794|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
83668795|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668796|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668797|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83668798|NCT04249063|Lidocaine|lidocaine|mesh-list
83668799|NCT04249063|Anesthetics|anesthetics|mesh-list
83668800|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
83668801|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668802|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668803|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
83668804|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668805|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83668806|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83668807|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83668808|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83668809|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668810|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
83668811|NCT04245722|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83668812|NCT04245722|Rituximab|rituximab|mesh-list
83668813|NCT04245722|Fludarabine|fludarabine|mesh-list
83668814|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
83668815|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668816|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
83668817|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668818|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83668819|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83668820|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
83668821|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668822|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668823|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83668824|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668825|NCT04239040|Nivolumab|nivolumab|mesh-list
83668826|NCT04239040|Ipilimumab|ipilimumab|mesh-list
83668827|NCT04239040|Vaccines|vaccines|mesh-list
83668828|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
83668829|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668830|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668831|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668832|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668833|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668834|NCT04205409|Nivolumab|nivolumab|mesh-list
83668835|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668836|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668837|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668838|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668839|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83668840|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
83668841|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83668842|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83668843|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
83668844|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668845|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668846|NCT04198116|Guanfacine|guanfacine|mesh-list
83668847|NCT04198116|Varenicline|varenicline|mesh-list
83668848|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83668849|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83668850|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
83668851|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668852|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668853|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668854|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83668855|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83668856|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83668857|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83668858|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668859|NCT04192955|Salicylates|salicylates|mesh-list
83668860|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83668861|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83668862|NCT04192955|Analgesics|analgesics|mesh-ancestor
83668863|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
83668864|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668865|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668866|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668867|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83668868|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83668869|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668870|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668871|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83668872|NCT04184869|Belinostat|belinostat|mesh-list
83668873|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83668874|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83668875|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
83668876|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668877|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668878|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83668879|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83668880|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
83668881|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83668882|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668883|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83668884|NCT04176705|Triamcinolone|triamcinolone|mesh-list
83668885|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83668886|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83668887|NCT04176705|Lidocaine|lidocaine|mesh-list
83668888|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83668889|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
83668890|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
83668891|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83668892|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668893|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
83668894|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668895|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83668896|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83668897|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83668898|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83668899|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668900|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668901|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
83668902|NCT04176705|Hormones|hormones|mesh-ancestor
83668903|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83668904|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668905|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
83668906|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668907|NCT04175262|Sunitinib|sunitinib|mesh-list
83668908|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668909|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83668910|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83668911|NCT04175262|Growth Substances|growth substances|mesh-ancestor
83668912|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668913|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
83668914|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83668915|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83668916|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668917|NCT04149899|Timolol|timolol|mesh-list
83668918|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83668919|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83668920|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
83668921|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83668922|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668923|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668924|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83668925|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83668926|NCT04140305|Ozanimod|ozanimod|mesh-list
83668927|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83668928|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668929|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668930|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
83668931|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668932|NCT04137536|Antibodies|antibodies|mesh-list
83668933|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83668934|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
83668935|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668936|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
83668937|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668938|NCT04102098|Bevacizumab|bevacizumab|mesh-list
83668939|NCT04102098|Atezolizumab|atezolizumab|mesh-list
83668940|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668941|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668942|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83668943|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83668944|NCT04102098|Growth Substances|growth substances|mesh-ancestor
83668945|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668946|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
83668947|NCT04102098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83668948|NCT04102098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668949|NCT04094311|Tisagenlecleucel|tisagenlecleucel|mesh-list
83668950|NCT04094311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668951|NCT04094311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668952|NCT04087421|Glycerol|glycerol|mesh-list
83668953|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83668954|NCT04087421|Protective Agents|protective agents|mesh-ancestor
83668955|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668956|NCT04085445|Paclitaxel|paclitaxel|mesh-list
83668957|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83668958|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668959|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
83668960|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
83668961|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
83668962|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668963|NCT04080531|Vaccines|vaccines|mesh-list
83668964|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
83668965|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668966|NCT04070378|Daratumumab|daratumumab|mesh-list
83668967|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668968|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
83668969|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83668970|NCT04023071|Rituximab|rituximab|mesh-list
83668971|NCT04023071|Fludarabine|fludarabine|mesh-list
83668972|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
83668973|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83668974|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
83668975|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668976|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83668977|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83668978|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
83668979|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83668980|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668981|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83668982|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668983|NCT04014075|Trastuzumab|trastuzumab|mesh-list
83668984|NCT04014075|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83668985|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83668986|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83668987|NCT04014075|Immunoconjugates|immunoconjugates|mesh-ancestor
83668988|NCT04014075|Immunologic Factors|immunologic factors|mesh-ancestor
82823735|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82823737|NCT01046786|Prednisolone|prednisolone|mesh-list
83668990|NCT04009109|Dexamethasone|dexamethasone|mesh-list
83668991|NCT04009109|Lenalidomide|lenalidomide|mesh-list
83668992|NCT04009109|Daratumumab|daratumumab|mesh-list
83668993|NCT04009109|Ixazomib|ixazomib|mesh-list
83668994|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83668995|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
83668996|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
83668997|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83668998|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83668999|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669000|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
83669001|NCT04009109|Hormones|hormones|mesh-ancestor
83669002|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669003|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669004|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669005|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
83669006|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83669007|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83669008|NCT04009109|Growth Substances|growth substances|mesh-ancestor
83669009|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
83669010|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
83669011|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669012|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669013|NCT03983993|Panitumumab|panitumumab|mesh-list
83669014|NCT03983993|Niraparib|niraparib|mesh-list
83669015|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669016|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669017|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83669018|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669019|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669020|NCT03975647|Tucatinib|tucatinib|mesh-list
83669021|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669022|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669023|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669024|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669025|NCT03964090|Cytarabine|cytarabine|mesh-list
83669026|NCT03964090|Isavuconazole|isavuconazole|mesh-list
83669027|NCT03964090|Methotrexate|methotrexate|mesh-list
83669028|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83669029|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
83669030|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83669031|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669032|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669033|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
83669034|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669035|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669036|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
83669037|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669038|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83669039|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669040|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
83669041|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669042|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83669043|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
83669044|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669045|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
83669046|NCT03944577|Evolocumab|evolocumab|mesh-list
83669047|NCT03944577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83669048|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83669049|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83669050|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
83669051|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669052|NCT03944577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83669053|NCT03944577|Protease Inhibitors|protease inhibitors|mesh-ancestor
83669054|NCT03944577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669055|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83669056|NCT03909152|Anastrozole|anastrozole|mesh-list
83669057|NCT03909152|Onapristone|onapristone|mesh-list
83669058|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669059|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669060|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83669061|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83669062|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823812|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83669063|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669064|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83669065|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
83669066|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669067|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669068|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83669069|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
83669070|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83669071|NCT03800602|Metformin|metformin|mesh-list
83669072|NCT03800602|Nivolumab|nivolumab|mesh-list
83669073|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83669074|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669075|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669076|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669077|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669078|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669079|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83669080|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669081|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83669082|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669083|NCT03790488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669084|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669085|NCT03778424|Rufinamide|rufinamide|mesh-list
83669086|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
83669087|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83669088|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83669089|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83669090|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669091|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83669092|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83669093|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
83669094|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
83669095|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
83669096|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
83669097|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669098|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669099|NCT03776864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669100|NCT03776864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669101|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
83669102|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669103|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83669104|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83669105|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669106|NCT03754933|Fludarabine|fludarabine|mesh-list
83669107|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
83669108|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669109|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669110|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
83669111|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669112|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669113|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
83669114|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669115|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
83669116|NCT03682536|Luspatercept|luspatercept|mesh-list
83669117|NCT03682536|Hematinics|hematinics|mesh-ancestor
83669118|NCT03675412|Caffeine|caffeine|mesh-list
83669119|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83669120|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669121|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83669122|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669123|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669124|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83669125|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83669126|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
83669127|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669128|NCT03664180|Heparin|heparin|mesh-list
83669129|NCT03664180|Calcium heparin|calcium heparin|mesh-list
83669130|NCT03664180|Enoxaparin|enoxaparin|mesh-list
83669131|NCT03664180|Hirudins|hirudins|mesh-list
83669132|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
83669133|NCT03664180|Bivalirudin|bivalirudin|mesh-list
83669134|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
83669135|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82823886|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669136|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83669137|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669138|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
83669139|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83669140|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
83669141|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669142|NCT03652870|Dexetimide|dexetimide|mesh-list
83669143|NCT03652870|Citalopram|citalopram|mesh-list
83669144|NCT03652870|Nortriptyline|nortriptyline|mesh-list
83669145|NCT03652870|Escitalopram|escitalopram|mesh-list
83669146|NCT03652870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83669147|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83669148|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83669149|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669150|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669151|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
83669152|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669153|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83669154|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83669155|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
83669156|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
83669157|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669158|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83669159|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83669160|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
83669161|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83669162|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
83669163|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83669164|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83669165|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83669166|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83669167|NCT03648905|Dopamine|dopamine|mesh-list
83669168|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83669169|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
83669170|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
83669171|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669172|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669173|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
83669174|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669175|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669176|NCT03648905|Protective Agents|protective agents|mesh-ancestor
83669177|NCT03637543|Nivolumab|nivolumab|mesh-list
83669178|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669179|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669180|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669181|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669182|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
83669183|NCT03634852|Dexamethasone|dexamethasone|mesh-list
83669184|NCT03634852|Triamcinolone|triamcinolone|mesh-list
83669185|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83669186|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83669187|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83669188|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83669189|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83669190|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83669191|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
83669192|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
83669193|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669194|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669195|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669196|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
83669197|NCT03634852|Hormones|hormones|mesh-ancestor
83669198|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669199|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669200|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669201|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83669202|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669203|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83669204|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83669205|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669206|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669207|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83669208|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
82823959|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83669209|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83669210|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83669211|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83669212|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83669213|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83669214|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669215|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
83669217|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83669218|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
83669219|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669220|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669221|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83669222|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83669223|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
83669224|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669225|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669226|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83669227|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83669228|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
83669229|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
83669230|NCT03593811|Ondansetron|ondansetron|mesh-list
83669231|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
83669232|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
83669233|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669234|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669235|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669236|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
83669237|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83669238|NCT03593811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83669239|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83669240|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
83669241|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669242|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669243|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83669244|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
83669245|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
83669246|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83669247|NCT03588754|Propranolol|propranolol|mesh-list
83669248|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83669249|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83669250|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
83669251|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669252|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669253|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669254|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83669255|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83669256|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
83669257|NCT03569085|Sevoflurane|sevoflurane|mesh-list
83669258|NCT03569085|Isoflurane|isoflurane|mesh-list
83669259|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83669260|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83669261|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
83669262|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
83669263|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83669264|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669265|NCT03564340|Cemiplimab|cemiplimab|mesh-list
83669266|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669267|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669268|NCT03552575|Valsartan|valsartan|mesh-list
83669269|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83669270|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83669271|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83669272|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83669273|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669274|NCT03528902|Tamoxifen|tamoxifen|mesh-list
83669275|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83669276|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
83669277|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669278|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669279|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82824032|NCT03974685|Niacin|niacin|mesh-list
83669280|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824033|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
83669281|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83669282|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83669283|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83669284|NCT03523156|Azithromycin|azithromycin|mesh-list
83669285|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83669286|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669287|NCT03495388|Oxycodone|oxycodone|mesh-list
83669288|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83669289|NCT03495388|Narcotics|narcotics|mesh-ancestor
83669290|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83669291|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669292|NCT03495388|Analgesics|analgesics|mesh-ancestor
83669293|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
83669294|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669295|NCT03463408|Nivolumab|nivolumab|mesh-list
83669296|NCT03463408|Ipilimumab|ipilimumab|mesh-list
83669297|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669298|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669299|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669300|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669301|NCT03456063|Paclitaxel|paclitaxel|mesh-list
83669302|NCT03456063|Carboplatin|carboplatin|mesh-list
83669303|NCT03456063|Gemcitabine|gemcitabine|mesh-list
83669304|NCT03456063|Pemetrexed|pemetrexed|mesh-list
83669305|NCT03456063|Atezolizumab|atezolizumab|mesh-list
83669306|NCT03456063|Antibodies|antibodies|mesh-list
83669307|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83669308|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669309|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
83669310|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
83669311|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
83669312|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669313|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
83669314|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669315|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669316|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
83669317|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669318|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83669319|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83669320|NCT03456063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669321|NCT03456063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669322|NCT03450343|Azacitidine|azacitidine|mesh-list
83669323|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669324|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
83669325|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669326|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669327|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669328|NCT03420144|Hormones|hormones|mesh-list
83669329|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669330|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669331|NCT03418038|Vitamins|vitamins|mesh-list
83669332|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
83669333|NCT03418038|Cytarabine|cytarabine|mesh-list
83669334|NCT03418038|Dexamethasone|dexamethasone|mesh-list
83669335|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
83669336|NCT03418038|Rituximab|rituximab|mesh-list
83669337|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83669338|NCT03418038|Cisplatin|cisplatin|mesh-list
83669339|NCT03418038|Carboplatin|carboplatin|mesh-list
83669340|NCT03418038|Gemcitabine|gemcitabine|mesh-list
83669341|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
83669342|NCT03418038|Etoposide|etoposide|mesh-list
83669343|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
83669344|NCT03418038|Ifosfamide|ifosfamide|mesh-list
83669345|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
83669346|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
83669347|NCT03418038|Antibodies|antibodies|mesh-list
83669348|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
83669349|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83669350|NCT03418038|BB 1101|bb 1101|mesh-list
83669351|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
83669352|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669353|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
83669354|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669355|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669356|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824116|NCT00262041|Vaccines|vaccines|mesh-list
83669357|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
83669358|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
83669359|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669360|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669361|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
83669362|NCT03418038|Hormones|hormones|mesh-ancestor
83669363|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669364|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669365|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
83669366|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669367|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669368|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669369|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
83669370|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83669371|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83669372|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83669373|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
83669374|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669375|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669376|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
83669377|NCT03418038|Protective Agents|protective agents|mesh-ancestor
83669378|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83669379|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
83669380|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
83669381|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
83669382|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83669383|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83669384|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83669385|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
83669386|NCT03386539|Everolimus|everolimus|mesh-list
83669387|NCT03386539|Tacrolimus|tacrolimus|mesh-list
83669388|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669389|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
83669390|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669391|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83669392|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669393|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669394|NCT03386539|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83669395|NCT03386539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669396|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669397|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83669398|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83669399|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
83669400|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83669401|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669402|NCT03384784|Galantamine|galantamine|mesh-list
83669403|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83669404|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669405|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669406|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
83669407|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669408|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669409|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83669410|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
83669411|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669412|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
83669413|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
83669414|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669415|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669416|NCT03383094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669417|NCT03383094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669418|NCT03366103|Navitoclax|navitoclax|mesh-list
83669419|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669420|NCT03344419|Ketamine|ketamine|mesh-list
83669421|NCT03344419|Analgesics|analgesics|mesh-ancestor
83669422|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
83669423|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669424|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669425|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83669426|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83669427|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
83669428|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
83669429|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83669430|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83669431|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83669432|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669433|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669434|NCT03321526|Norepinephrine|norepinephrine|mesh-list
83669435|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83669436|NCT03321526|Serotonin|serotonin|mesh-list
83669437|NCT03321526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83669438|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
83669439|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83669440|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83669441|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83669442|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83669443|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669444|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83669445|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83669446|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
83669447|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669448|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669449|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
83669450|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
83669451|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669452|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83669453|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83669454|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
83669455|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83669456|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83669457|NCT03297593|Nivolumab|nivolumab|mesh-list
83669458|NCT03297593|Ipilimumab|ipilimumab|mesh-list
83669459|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669460|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669461|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669462|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669463|NCT03263650|Prednisone|prednisone|mesh-list
83669464|NCT03263650|Carboplatin|carboplatin|mesh-list
83669465|NCT03263650|Olaparib|olaparib|mesh-list
83669466|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669467|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83669468|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
83669469|NCT03263650|Hormones|hormones|mesh-ancestor
83669470|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669471|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669472|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669473|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83669474|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669475|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669476|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83669477|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
83669478|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
83669479|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83669480|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
83669481|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83669482|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83669483|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
83669484|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669485|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669486|NCT03217669|Sirolimus|sirolimus|mesh-list
83669487|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83669488|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669489|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83669490|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669491|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
83669492|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669493|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
83669494|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669495|NCT03196427|Vedolizumab|vedolizumab|mesh-list
83669496|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669497|NCT03185819|Midazolam|midazolam|mesh-list
83669498|NCT03185819|Esketamine|esketamine|mesh-list
83669499|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83669500|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83669501|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83669502|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669503|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83669504|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83669505|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83669506|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83669507|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
83669508|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
83669509|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
83669510|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
83669511|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669512|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669513|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
83669514|NCT03153111|Macitentan|macitentan|mesh-list
83669515|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83669516|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83669517|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669518|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83669519|NCT03126435|Gemcitabine|gemcitabine|mesh-list
83669520|NCT03126435|Paclitaxel|paclitaxel|mesh-list
83669521|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669522|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
83669523|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669524|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669525|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83669526|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83669527|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83669528|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83669529|NCT03119584|Linaclotide|linaclotide|mesh-list
83669530|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83669531|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
83669532|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669533|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669534|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
83669535|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669536|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669537|NCT03095781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669538|NCT03095781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669539|NCT03084939|Capecitabine|capecitabine|mesh-list
83669540|NCT03084939|Trastuzumab|trastuzumab|mesh-list
83669541|NCT03084939|Lapatinib|lapatinib|mesh-list
83669542|NCT03084939|Maytansine|maytansine|mesh-list
83669543|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83669544|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669545|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
83669546|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669547|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669548|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669549|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669550|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669551|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83669552|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
83669553|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
83669554|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
83669555|NCT03084939|Immunotoxins|immunotoxins|mesh-ancestor
83669556|NCT03084939|Immunoconjugates|immunoconjugates|mesh-ancestor
83669557|NCT03084939|Immunologic Factors|immunologic factors|mesh-ancestor
83669558|NCT03084939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669559|NCT03047005|Naltrexone|naltrexone|mesh-list
83669560|NCT03047005|Bupropion|bupropion|mesh-list
83669561|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83669562|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83669563|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669564|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
83669565|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669566|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83669567|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
83669568|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83669569|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83669570|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83669571|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83669572|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669573|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
83669574|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669575|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83669576|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83669577|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669578|NCT03020030|Leucovorin|leucovorin|mesh-list
83669579|NCT03020030|Cytarabine|cytarabine|mesh-list
83669580|NCT03020030|Dexamethasone|dexamethasone|mesh-list
83669581|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
83669582|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
83669583|NCT03020030|Doxorubicin|doxorubicin|mesh-list
83669584|NCT03020030|Methotrexate|methotrexate|mesh-list
83669585|NCT03020030|Etoposide|etoposide|mesh-list
83669586|NCT03020030|Vincristine|vincristine|mesh-list
83669587|NCT03020030|Asparaginase|asparaginase|mesh-list
83669588|NCT03020030|Dasatinib|dasatinib|mesh-list
83669589|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
83669590|NCT03020030|Pegaspargase|pegaspargase|mesh-list
83669591|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
83669592|NCT03020030|Razoxane|razoxane|mesh-list
83669593|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
83669594|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669595|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
83669596|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669597|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669598|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83669599|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
83669600|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669601|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669602|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83669603|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83669604|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
83669605|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
83669606|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669607|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669608|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
83669609|NCT03020030|Hormones|hormones|mesh-ancestor
83669610|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669611|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669612|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83669613|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83669614|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83669615|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405994|NCT03780673|Rifaximin|rifaximin|mesh-list
83669616|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83669617|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
83669618|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83669619|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83669620|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
83669621|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
83669622|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83669623|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83669624|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83669625|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
83669626|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669627|NCT03020030|Antidotes|antidotes|mesh-ancestor
83669628|NCT03020030|Protective Agents|protective agents|mesh-ancestor
83669629|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
83669630|NCT03020030|Vitamins|vitamins|mesh-ancestor
83669631|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
83669632|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
83669633|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
83669634|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
83669635|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669636|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83669637|NCT03011684|Tamoxifen|tamoxifen|mesh-list
83669638|NCT03011684|Letrozole|letrozole|mesh-list
83669639|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669640|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83669641|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83669642|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669643|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669644|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83669645|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
83669646|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669647|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669648|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669649|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83669650|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83669651|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83669652|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83669653|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83669654|NCT03007030|Antibodies|antibodies|mesh-list
83669655|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
83669656|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83669657|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
83669658|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
83669659|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669660|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669661|NCT03007030|Immunotoxins|immunotoxins|mesh-ancestor
83669662|NCT02968108|Ustekinumab|ustekinumab|mesh-list
83669663|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
83669664|NCT02947347|Rituximab|rituximab|mesh-list
83669665|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669666|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669667|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
83669668|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669669|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669670|NCT02946996|Metformin|metformin|mesh-list
83669671|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83669672|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669673|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
83669674|NCT02870907|Thiotepa|thiotepa|mesh-list
83669675|NCT02870907|Carboplatin|carboplatin|mesh-list
83669676|NCT02870907|Etoposide|etoposide|mesh-list
83669677|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
83669678|NCT02870907|Vincristine|vincristine|mesh-list
83669679|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669680|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
83669681|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669682|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669683|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83669684|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
83669685|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669686|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669687|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83669688|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83669689|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83669690|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83669691|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669692|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83669693|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83669694|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83669695|NCT02823574|Nivolumab|nivolumab|mesh-list
83669696|NCT02823574|Ipilimumab|ipilimumab|mesh-list
83669697|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669698|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669699|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669700|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669701|NCT02814916|Dalbavancin|dalbavancin|mesh-list
83669702|NCT02814916|Teicoplanin|teicoplanin|mesh-list
83669703|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83669704|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669705|NCT02641028|Aticaprant|aticaprant|mesh-list
83669706|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83669707|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669708|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
83669709|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669710|NCT02584933|Ceritinib|ceritinib|mesh-list
83669711|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669712|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669713|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669714|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669715|NCT02525796|Eplerenone|eplerenone|mesh-list
83669716|NCT02525796|Amiloride|amiloride|mesh-list
83669717|NCT02525796|Cinacalcet|cinacalcet|mesh-list
83669718|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83669719|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
83669720|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669721|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669722|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83669723|NCT02525796|Diuretics|diuretics|mesh-ancestor
83669724|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
83669725|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83669726|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83669727|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83669728|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83669729|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83669730|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83669731|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669732|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83669733|NCT02502786|Antibodies|antibodies|mesh-list
83669734|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
83669735|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669736|NCT02454933|Durvalumab|durvalumab|mesh-list
82824486|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
82824493|NCT04878107|Docetaxel|docetaxel|mesh-list
83669737|NCT02454933|Osimertinib|osimertinib|mesh-list
83669738|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669739|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669740|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669741|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669742|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669743|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
83669744|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83669745|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83669746|NCT02429570|Analgesics|analgesics|mesh-ancestor
83669747|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
83669748|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669749|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669750|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83669751|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669752|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83669753|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669754|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669756|NCT02360280|Ketamine|ketamine|mesh-list
83669757|NCT02360280|Analgesics|analgesics|mesh-ancestor
83669758|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
83669759|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669760|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669761|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83669762|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83669763|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
83669764|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
83669765|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83669766|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83669767|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83669768|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83669769|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669770|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83669771|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83669772|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83669773|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83669774|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83669775|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
83669776|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
83669777|NCT02201251|Topiramate|topiramate|mesh-list
83669778|NCT02201251|Levetiracetam|levetiracetam|mesh-list
83669779|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
83669780|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83669781|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669782|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
83669783|NCT02192021|Doxorubicin|doxorubicin|mesh-list
83669784|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83669785|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83669786|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669787|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83669788|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83669789|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669790|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669791|NCT02174575|Sevoflurane|sevoflurane|mesh-list
83669792|NCT02174575|Desflurane|desflurane|mesh-list
83669793|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83669794|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83669795|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
83669796|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
83669797|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83669798|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669799|NCT01889810|Vitamin D|vitamin d|mesh-list
83669800|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
83669801|NCT01889810|Vitamins|vitamins|mesh-ancestor
83669802|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
83669803|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669804|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83669805|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83669806|NCT01840592|Doxorubicin|doxorubicin|mesh-list
83669807|NCT01840592|Sorafenib|sorafenib|mesh-list
83669808|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83669809|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669810|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83669811|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824566|NCT01074892|Hormones|hormones|mesh-ancestor
83669812|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669813|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669814|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669815|NCT01734694|Vancomycin|vancomycin|mesh-list
83669816|NCT01734694|Linezolid|linezolid|mesh-list
83669817|NCT01734694|Daptomycin|daptomycin|mesh-list
83669818|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83669819|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83669820|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669821|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83669822|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669823|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669824|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83669825|NCT01703949|Nivolumab|nivolumab|mesh-list
83669826|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83669827|NCT01703949|Antibodies|antibodies|mesh-list
83669828|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
83669829|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83669830|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
83669831|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
83669832|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669833|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669834|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669835|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669836|NCT01703949|Immunotoxins|immunotoxins|mesh-ancestor
83669837|NCT01599234|Nabiximols|nabiximols|mesh-list
83669838|NCT01599234|Analgesics|analgesics|mesh-ancestor
83669839|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
83669840|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669841|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669842|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83669843|NCT01468896|Cetuximab|cetuximab|mesh-list
83669844|NCT01468896|Interleukin-12|interleukin-12|mesh-list
83669845|NCT01468896|Antibodies|antibodies|mesh-list
83669846|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
83669847|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83669848|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
83669849|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669850|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669851|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83669852|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83669853|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83669854|NCT01468896|Growth Substances|growth substances|mesh-ancestor
83669855|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
83669856|NCT01274338|Interferons|interferons|mesh-list
83669857|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
83669858|NCT01274338|Interferon alpha-2|interferon alpha-2|mesh-list
83669859|NCT01274338|Ipilimumab|ipilimumab|mesh-list
83669860|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669861|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
83669862|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669863|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83669864|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83669865|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669866|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
83669867|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669868|NCT01251861|Bicalutamide|bicalutamide|mesh-list
83669869|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
83669870|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
83669871|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669872|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669873|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669874|NCT01236560|Bevacizumab|bevacizumab|mesh-list
83669875|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83669876|NCT01236560|Temozolomide|temozolomide|mesh-list
83669877|NCT01236560|Vorinostat|vorinostat|mesh-list
83669878|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
83669879|NCT01236560|Antibodies|antibodies|mesh-list
83669880|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
83669881|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83669882|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
83669883|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669884|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83669885|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83669886|NCT01236560|Growth Substances|growth substances|mesh-ancestor
83669887|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669888|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
83669889|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
83669890|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83669891|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
83669892|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669893|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83669894|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669895|NCT00843882|Lenalidomide|lenalidomide|mesh-list
83669896|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
83669897|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
83669898|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669899|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83669900|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83669901|NCT00843882|Growth Substances|growth substances|mesh-ancestor
83669902|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
83669903|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669904|NCT00843882|Hematinics|hematinics|mesh-ancestor
83669905|NCT00716625|Sunitinib|sunitinib|mesh-list
83669906|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669907|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83669908|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83669909|NCT00716625|Growth Substances|growth substances|mesh-ancestor
83669910|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669911|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
83669912|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83669913|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669914|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669915|NCT00713817|Nabiximols|nabiximols|mesh-list
83669916|NCT00713817|Analgesics|analgesics|mesh-ancestor
83669917|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
83669918|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669919|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669920|NCT00713323|Nabiximols|nabiximols|mesh-list
83669921|NCT00713323|Analgesics|analgesics|mesh-ancestor
83669922|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
83669923|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669924|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669925|NCT00713193|Cyclosporine|cyclosporine|mesh-list
83669926|NCT00713193|Prednisone|prednisone|mesh-list
83669927|NCT00713193|Cyclosporins|cyclosporins|mesh-list
83669928|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83669929|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
83669930|NCT00713193|Hormones|hormones|mesh-ancestor
83669931|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669932|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669933|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669934|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669935|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669936|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669937|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83669938|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
83669939|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
83669940|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83669941|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83669942|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83669943|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83669944|NCT00710554|Nabiximols|nabiximols|mesh-list
83669945|NCT00710554|Analgesics|analgesics|mesh-ancestor
83669946|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
83669947|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669948|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669949|NCT00710424|Nabiximols|nabiximols|mesh-list
83669950|NCT00710424|Analgesics|analgesics|mesh-ancestor
83669951|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
83669952|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669953|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669954|NCT00674609|Nabiximols|nabiximols|mesh-list
83669955|NCT00674609|Analgesics|analgesics|mesh-ancestor
83669956|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
83669957|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669958|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669959|NCT00644228|Dexamethasone|dexamethasone|mesh-list
83669960|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
83669961|NCT00644228|Lenalidomide|lenalidomide|mesh-list
82824710|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669962|NCT00644228|Bortezomib|bortezomib|mesh-list
83669963|NCT00644228|Ichthammol|ichthammol|mesh-list
83669964|NCT00644228|BB 1101|bb 1101|mesh-list
83669965|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83669966|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
83669967|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
83669968|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83669969|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669970|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83669971|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
83669972|NCT00644228|Hormones|hormones|mesh-ancestor
83669973|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83669974|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83669975|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669976|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83669977|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83669978|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83669979|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
83669980|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83669981|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83669982|NCT00644228|Growth Substances|growth substances|mesh-ancestor
83669983|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
83669984|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
83669985|NCT00026312|Vitamin A|vitamin a|mesh-list
83669986|NCT00026312|Aldesleukin|aldesleukin|mesh-list
83669987|NCT00026312|Interleukin-2|interleukin-2|mesh-list
83669988|NCT00026312|Tretinoin|tretinoin|mesh-list
83669989|NCT00026312|Dinutuximab|dinutuximab|mesh-list
83669990|NCT00026312|Isotretinoin|isotretinoin|mesh-list
83669991|NCT00026312|Sargramostim|sargramostim|mesh-list
83669992|NCT00026312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83669993|NCT00026312|Vitamins|vitamins|mesh-ancestor
83669994|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
83669995|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83669996|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83669997|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83669998|NCT00026312|Analgesics|analgesics|mesh-ancestor
83669999|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
83670000|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670001|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
83670002|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83670003|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83670004|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
83670005|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670006|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
83670007|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670008|NCT01556646|Tolvaptan|tolvaptan|mesh-list
83670009|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83670010|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670011|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
83670012|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670013|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
83670014|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
83670015|NCT01556672|Adalimumab|adalimumab|mesh-list
83670016|NCT01556672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83670017|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670018|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670019|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
83670020|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83670021|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
83670022|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670023|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670024|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83670025|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
83670026|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83670027|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
83670028|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670029|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670030|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83670031|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
83670032|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
83670033|NCT01556698|Protective Agents|protective agents|mesh-ancestor
83670034|NCT01556737|Genistein|genistein|mesh-list
83670035|NCT01556737|Daidzein|daidzein|mesh-list
83670036|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83670037|NCT01556737|Protective Agents|protective agents|mesh-ancestor
83670038|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670039|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670040|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670041|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824782|NCT00202839|Ribavirin|ribavirin|mesh-list
82824796|NCT00126490|Antibodies|antibodies|mesh-list
83670042|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670043|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
83670044|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83670045|NCT01556737|Estrogens|estrogens|mesh-ancestor
83670046|NCT01556737|Hormones|hormones|mesh-ancestor
83670047|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670048|NCT01556815|Sorafenib|sorafenib|mesh-list
83670049|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
83670050|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670051|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670052|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670053|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670054|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83670055|NCT01556815|Estrogens|estrogens|mesh-ancestor
83670056|NCT01556815|Hormones|hormones|mesh-ancestor
83670057|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670058|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670059|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83670060|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83670061|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670062|NCT01557075|Atorvastatin|atorvastatin|mesh-list
83670063|NCT01557075|Pravastatin|pravastatin|mesh-list
83670064|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83670065|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83670066|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83670067|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
83670068|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670069|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83670070|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670071|NCT01557114|Ipilimumab|ipilimumab|mesh-list
83670072|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670073|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670074|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83670075|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670076|NCT01557127|Sorafenib|sorafenib|mesh-list
83670077|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670078|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670079|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670080|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670081|NCT01557140|Carvedilol|carvedilol|mesh-list
83670082|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83670083|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83670084|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
83670085|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670086|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670087|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670088|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83670089|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
83670090|NCT01557140|Protective Agents|protective agents|mesh-ancestor
83670091|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83670092|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670093|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83670094|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
83670095|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83670096|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83670097|NCT01557153|Amlodipine|amlodipine|mesh-list
83670098|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83670099|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83670100|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670101|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670102|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83670103|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670104|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
83670105|NCT01557257|Naltrexone|naltrexone|mesh-list
83670106|NCT01557257|Oxycodone|oxycodone|mesh-list
83670107|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83670108|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83670109|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670110|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
83670111|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670112|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83670113|NCT01557257|Narcotics|narcotics|mesh-ancestor
83670114|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670115|NCT01557257|Analgesics|analgesics|mesh-ancestor
83670116|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
83670117|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83670118|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670119|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670120|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83670122|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
83670123|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670124|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83670125|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83670126|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83670127|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
83670128|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670129|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670130|NCT01557335|Aspirin|aspirin|mesh-list
83670131|NCT01557335|Omeprazole|omeprazole|mesh-list
83670132|NCT01557335|Clopidogrel|clopidogrel|mesh-list
83670133|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83670134|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83670135|NCT01557335|Analgesics|analgesics|mesh-ancestor
83670136|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
83670137|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670138|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670139|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670140|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670141|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83670142|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83670143|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670144|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83670145|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83670146|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670147|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
83670148|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83670149|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83670150|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83670151|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
83670152|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670153|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83670154|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670155|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83670156|NCT01557374|Abatacept|abatacept|mesh-list
83670157|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83670158|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670159|NCT01557374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670160|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670161|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83670162|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
83670163|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670164|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670165|NCT01557439|Levocetirizine|levocetirizine|mesh-list
83670166|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83670167|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83670168|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
83670169|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
83670170|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670171|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670172|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670173|NCT01557478|Melatonin|melatonin|mesh-list
83670174|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
83670175|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670176|NCT01557478|Protective Agents|protective agents|mesh-ancestor
83670177|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670178|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670179|NCT01557634|Insulin|insulin|mesh-list
83670180|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83670181|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670182|NCT01557647|Treprostinil|treprostinil|mesh-list
83670183|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83670184|NCT01557660|Treprostinil|treprostinil|mesh-list
83670185|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83670186|NCT01557712|Ketamine|ketamine|mesh-list
83670187|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83670188|NCT01557712|Analgesics|analgesics|mesh-ancestor
83670189|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
82824931|NCT00114166|Topotecan|topotecan|mesh-list
83670190|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670191|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670192|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83670193|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83670194|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
83670195|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
83670196|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670197|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83670198|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83670199|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670200|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670201|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83670202|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83670203|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670204|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83670205|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
83670206|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83670207|NCT01557764|Trastuzumab|trastuzumab|mesh-list
83670208|NCT01557764|Lapatinib|lapatinib|mesh-list
83670209|NCT01557764|Antibodies|antibodies|mesh-list
83670210|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83670211|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
83670212|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670213|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670214|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670215|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670216|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670217|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670218|NCT01557816|Naproxen|naproxen|mesh-list
83670219|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83670220|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83670221|NCT01557816|Analgesics|analgesics|mesh-ancestor
83670222|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
83670223|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670224|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670225|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670226|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670227|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
83670228|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83670229|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670230|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670231|NCT01557829|Silicon|silicon|mesh-list
83670232|NCT01557829|Trace Elements|trace elements|mesh-ancestor
83670233|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
83670234|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670235|NCT01557907|Insulin|insulin|mesh-list
83670236|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83670237|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83670238|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670239|NCT01557985|Bupivacaine|bupivacaine|mesh-list
83670240|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
83670241|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
83670242|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670243|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670244|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
83670245|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670246|NCT01558011|Docetaxel|docetaxel|mesh-list
83670247|NCT01558011|Capecitabine|capecitabine|mesh-list
83670248|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
83670249|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670250|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
83670251|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
83670252|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
83670253|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670254|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83670255|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
83670256|NCT01558167|Rituximab|rituximab|mesh-list
83670257|NCT01558167|Lenalidomide|lenalidomide|mesh-list
83670258|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83670259|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670260|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670261|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
82825009|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
83670262|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670263|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670264|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83670265|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83670266|NCT01558167|Growth Substances|growth substances|mesh-ancestor
83670267|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83670268|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83670269|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
83670270|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670271|NCT01558193|Vitamins|vitamins|mesh-list
83670272|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
83670273|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
83670274|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670275|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83670276|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83670277|NCT01558193|Analgesics|analgesics|mesh-ancestor
83670278|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
83670279|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670280|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670281|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670282|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83670283|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
83670284|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670285|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83670286|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670287|NCT01558245|Kallikreins|kallikreins|mesh-list
83670288|NCT01558245|Coagulants|coagulants|mesh-ancestor
83670289|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83670290|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
83406673|NCT05902533|Mitomycins|mitomycins|mesh-list
83670291|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83670292|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670293|NCT01558310|Ustekinumab|ustekinumab|mesh-list
83670294|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670295|NCT01558336|Praziquantel|praziquantel|mesh-list
83670296|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
83670297|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83670298|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670299|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83670300|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670301|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
83670302|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670303|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
83670304|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
83670305|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83670306|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83670307|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670308|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670309|NCT01558466|Urological Agents|urological agents|mesh-ancestor
83670310|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83670311|NCT01558622|Ketoprofen|ketoprofen|mesh-list
83670312|NCT01558622|Meperidine|meperidine|mesh-list
83670313|NCT01558622|Tramadol|tramadol|mesh-list
83670314|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670315|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670316|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83670317|NCT01558622|Narcotics|narcotics|mesh-ancestor
83670318|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670319|NCT01558622|Analgesics|analgesics|mesh-ancestor
83670320|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
83670321|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670322|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83670323|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83670324|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670325|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670326|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83670327|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83670328|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670329|NCT01558648|Analgesics|analgesics|mesh-list
83670330|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
83670331|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670332|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670333|NCT01558713|Fentanyl|fentanyl|mesh-list
83670334|NCT01558713|Bupivacaine|bupivacaine|mesh-list
83670335|NCT01558713|Ropivacaine|ropivacaine|mesh-list
83670336|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
83670337|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
83670338|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
83670339|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82825091|NCT00337194|Immunotoxins|immunotoxins|mesh-ancestor
83670340|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670341|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
83670342|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670343|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83670344|NCT01558713|Narcotics|narcotics|mesh-ancestor
83670345|NCT01558713|Analgesics|analgesics|mesh-ancestor
83670346|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83670347|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83670348|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
83670349|NCT01558830|Ranolazine|ranolazine|mesh-list
83670350|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83670351|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670352|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670353|NCT01558869|Capecitabine|capecitabine|mesh-list
83670354|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
83670355|NCT01558869|Irinotecan|irinotecan|mesh-list
83670356|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83670357|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
83670358|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670359|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670360|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83670361|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83670362|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670363|NCT01558934|Lofexidine|lofexidine|mesh-list
83670364|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83670365|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83670366|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670367|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
83670368|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670369|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83670370|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83670371|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83670372|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
83670373|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670374|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670375|NCT01558960|Melphalan|melphalan|mesh-list
83670376|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83670377|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
83670378|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670379|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670380|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83670381|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83670382|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
83670383|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670384|NCT01558986|Cefazolin|cefazolin|mesh-list
83670385|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83670386|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670387|NCT01559025|Vildagliptin|vildagliptin|mesh-list
83670388|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83670389|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83670390|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670391|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
83670392|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670393|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670394|NCT01559051|Anesthetics|anesthetics|mesh-list
83670395|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670396|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670397|NCT01559142|Infliximab|infliximab|mesh-list
83670398|NCT01559142|Azathioprine|azathioprine|mesh-list
83670399|NCT01559142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83670400|NCT01559142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670401|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670402|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670403|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670404|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
83670405|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670406|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83670407|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670408|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83670409|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
83670410|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670411|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83670412|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83670413|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82825161|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670414|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670415|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670416|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83670417|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83670418|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83670419|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
83670420|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670421|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670422|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83670423|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83670424|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
83670425|NCT01559285|Ropivacaine|ropivacaine|mesh-list
83670426|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
83670427|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
83670428|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670429|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670430|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
83670431|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670432|NCT01559298|Aspirin|aspirin|mesh-list
83670433|NCT01559298|Clopidogrel|clopidogrel|mesh-list
83670434|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83670435|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83670436|NCT01559298|Analgesics|analgesics|mesh-ancestor
83670437|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
83670438|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670439|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670440|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670441|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670442|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83670443|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83670444|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670445|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83670446|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83670447|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670448|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
83670449|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83670450|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83670451|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83670452|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
83670453|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670454|NCT01559480|Desogestrel|desogestrel|mesh-list
83670455|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83670456|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83670457|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83670458|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
83670459|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83670460|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670461|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83670462|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83670463|NCT01559480|Progestins|progestins|mesh-ancestor
83670464|NCT01559480|Hormones|hormones|mesh-ancestor
83670465|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670466|NCT01559545|Metronidazole|metronidazole|mesh-list
83670467|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670468|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83670469|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83670470|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83670471|NCT01559584|Triamcinolone|triamcinolone|mesh-list
83670472|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83670473|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83670474|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83670475|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670476|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
83670477|NCT01559584|Hormones|hormones|mesh-ancestor
83670478|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670479|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670480|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83670481|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
83670482|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670483|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670484|NCT01559727|Prednisone|prednisone|mesh-list
83670485|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670486|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
82825236|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
83670488|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670489|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670490|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83670491|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670492|NCT01559740|Bupivacaine|bupivacaine|mesh-list
83670493|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
83670494|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
83670495|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670496|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670497|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
83670498|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670499|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83670500|NCT01559753|Amoxicillin|amoxicillin|mesh-list
83670501|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
83670502|NCT01559753|Tobramycin|tobramycin|mesh-list
83670503|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83670504|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
83670505|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
83670506|NCT01559753|Cefotaxime|cefotaxime|mesh-list
83670507|NCT01559753|Cefoxitin|cefoxitin|mesh-list
83670508|NCT01559753|Netilmicin|netilmicin|mesh-list
83670509|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670510|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83670511|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670512|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670513|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83406889|NCT05826574|Rifampin|rifampin|mesh-list
83670514|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
83670515|NCT01559974|Vitamin D|vitamin d|mesh-list
83670516|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83670517|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670518|NCT01559974|Vitamins|vitamins|mesh-ancestor
83670519|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
83670520|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83670521|NCT01560117|Rituximab|rituximab|mesh-list
83670522|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670523|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670524|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
83670525|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670526|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670527|NCT05570669|Simethicone|simethicone|mesh-list
83670528|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
83670529|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
83670530|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670531|NCT05570669|Emollients|emollients|mesh-ancestor
83670532|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670533|NCT05570669|Cathartics|cathartics|mesh-ancestor
83670534|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670535|NCT05570383|Antacids|antacids|mesh-list
83670536|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670537|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670538|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
83670539|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670540|NCT05570084|Tamsulosin|tamsulosin|mesh-list
83670541|NCT05570084|Silodosin|silodosin|mesh-list
83670542|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83670543|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83670544|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83670545|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
83670546|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670547|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670548|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670549|NCT05570084|Urological Agents|urological agents|mesh-ancestor
83670550|NCT05569668|Paclitaxel|paclitaxel|mesh-list
83670551|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83670552|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670553|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83670554|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83670555|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83670556|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670557|NCT05569655|Furosemide|furosemide|mesh-list
83670558|NCT05569655|Tolvaptan|tolvaptan|mesh-list
83670559|NCT05569655|Diuretics|diuretics|mesh-ancestor
83670560|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
83670561|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670562|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83670563|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670564|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670565|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83670566|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83670567|NCT05569590|Propolis|propolis|mesh-list
83670568|NCT05569590|Fluorides|fluorides|mesh-list
83670569|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
83670570|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
83670571|NCT05569590|Protective Agents|protective agents|mesh-ancestor
83670572|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670573|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83670574|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670575|NCT05569577|Estrogens|estrogens|mesh-list
83670576|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
83670577|NCT05569577|Hormones|hormones|mesh-ancestor
83670578|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670579|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670580|NCT05569577|Progestins|progestins|mesh-ancestor
83670581|NCT05569408|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83670582|NCT05569408|Antiviral Agents|antiviral agents|mesh-ancestor
83670583|NCT05569408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670584|NCT05569031|Lofexidine|lofexidine|mesh-list
83670585|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83670586|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83670587|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83670588|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670589|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670590|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670591|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670592|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83670593|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
83670594|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83670595|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83670596|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83670597|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
83670598|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670599|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83670600|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83670601|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83670602|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
83670603|NCT05564741|Norepinephrine|norepinephrine|mesh-list
83670604|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83670605|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83670606|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
83670607|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670608|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670609|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670610|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
83670611|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
83670612|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670613|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83670614|NCT05522582|Methotrexate|methotrexate|mesh-list
83670615|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83670616|NCT05522582|Antibodies|antibodies|mesh-list
83670617|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83670618|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
83670619|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670620|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83670621|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
83670622|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83670623|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83670624|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
83670625|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670626|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670627|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670628|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670629|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83670630|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83670631|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670632|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83670633|NCT05522582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670634|NCT05491304|Dexamethasone|dexamethasone|mesh-list
82825389|NCT00526097|Laxatives|laxatives|mesh-ancestor
83670636|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670637|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
83670638|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
83670639|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670640|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670641|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670642|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
83670643|NCT05491304|Hormones|hormones|mesh-ancestor
83670644|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670645|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83670646|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670647|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83670648|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83670649|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83670650|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670651|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670652|NCT05461794|Docetaxel|docetaxel|mesh-list
83670653|NCT05461794|Irinotecan|irinotecan|mesh-list
83670654|NCT05461794|Tislelizumab|tislelizumab|mesh-list
83670655|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670656|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83670657|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83670658|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83670659|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670660|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83670661|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83670662|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670663|NCT05461794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670664|NCT05391555|Remifentanil|remifentanil|mesh-list
83670665|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83670666|NCT05391555|Narcotics|narcotics|mesh-ancestor
83670667|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670668|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670669|NCT05391555|Analgesics|analgesics|mesh-ancestor
83670670|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
83670671|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670672|NCT05388656|Estradiol|estradiol|mesh-list
83670673|NCT05388656|Progesterone|progesterone|mesh-list
83670674|NCT05388656|Estrogens|estrogens|mesh-ancestor
83670675|NCT05388656|Hormones|hormones|mesh-ancestor
83670676|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670677|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670678|NCT05388656|Progestins|progestins|mesh-ancestor
83670679|NCT05372393|Anesthetics|anesthetics|mesh-list
83670680|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670681|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670682|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
83670683|NCT05219604|Promethazine|promethazine|mesh-list
83670684|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83670685|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83670686|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670687|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670688|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
83670689|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
83670690|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
83670691|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670692|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
83670693|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
83670694|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670695|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83670696|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
83670697|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
83670698|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670699|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670700|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83670701|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
83670702|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670703|NCT05137080|Dexamethasone|dexamethasone|mesh-list
83670704|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670705|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
83670706|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
83670707|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825466|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83670708|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825472|NCT01080352|Vitamins|vitamins|mesh-ancestor
83670709|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670710|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
83670711|NCT05137080|Hormones|hormones|mesh-ancestor
83670712|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670713|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83670714|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670715|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
83670716|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83670717|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670718|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83670719|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83670720|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670721|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670722|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670723|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
83670724|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83670725|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670726|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83670727|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670728|NCT04787731|Lidocaine|lidocaine|mesh-list
83670729|NCT04787731|Bupivacaine|bupivacaine|mesh-list
83670730|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
83670731|NCT04787731|Anesthetics|anesthetics|mesh-list
83670732|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670733|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670734|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
83670735|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670736|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83670737|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83670738|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83670739|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670740|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670741|NCT04713358|Nalmefene|nalmefene|mesh-list
83670742|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83670743|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670744|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
83670745|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670746|NCT04705051|Venglustat|venglustat|mesh-list
83670747|NCT04705051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670748|NCT04705051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670749|NCT04696952|Zopiclone|zopiclone|mesh-list
83670750|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83670751|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670752|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670753|NCT04496999|Midostaurin|midostaurin|mesh-list
83670754|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670755|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670756|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670757|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670758|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
83670759|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83670760|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670761|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83670762|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670763|NCT04464265|Propofol|propofol|mesh-list
83670764|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83670765|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670766|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670767|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83670768|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
83670769|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
83670770|NCT04424511|Azithromycin|azithromycin|mesh-list
83670771|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83670772|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670773|NCT04421079|Resveratrol|resveratrol|mesh-list
83670774|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
83670775|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670776|NCT04421079|Protective Agents|protective agents|mesh-ancestor
83670777|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670778|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670779|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83670780|NCT04410406|Ivermectin|ivermectin|mesh-list
83670781|NCT04410406|Albendazole|albendazole|mesh-list
82825544|NCT00518531|Denosumab|denosumab|mesh-list
83670782|NCT04410406|Moxidectin|moxidectin|mesh-list
83670783|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
83670784|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670785|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83670786|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670787|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
83670788|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
83670789|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83670790|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83670791|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83670792|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83670793|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83670794|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670795|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
83670796|NCT04410406|Filaricides|filaricides|mesh-ancestor
83670797|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83670798|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670799|NCT04393506|Apatinib|apatinib|mesh-list
83670800|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83670801|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670802|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670803|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670804|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670805|NCT04393506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670806|NCT04349826|Azithromycin|azithromycin|mesh-list
83670807|NCT04349826|Cefixime|cefixime|mesh-list
83670808|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83670809|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670810|NCT04298853|Morphine|morphine|mesh-list
83670811|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83670812|NCT04298853|Narcotics|narcotics|mesh-ancestor
83670813|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670814|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670815|NCT04298853|Analgesics|analgesics|mesh-ancestor
83670816|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
83670817|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670818|NCT04232683|Tamsulosin|tamsulosin|mesh-list
83670819|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83670820|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83670821|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83670822|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
83670823|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670824|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670825|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670826|NCT04232683|Urological Agents|urological agents|mesh-ancestor
83670827|NCT04227483|Prednisolone|prednisolone|mesh-list
83670828|NCT04227483|Deflazacort|deflazacort|mesh-list
83670829|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670830|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
83670831|NCT04227483|Hormones|hormones|mesh-ancestor
83670832|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670833|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670834|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83670835|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670836|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83670837|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
83670838|NCT04182672|Triamcinolone|triamcinolone|mesh-list
83670839|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83670840|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83670841|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83670842|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670843|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
83670844|NCT04182672|Hormones|hormones|mesh-ancestor
83670845|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670846|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670847|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83670848|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
83670849|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670850|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670851|NCT04101227|Ondansetron|ondansetron|mesh-list
83670852|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
83670853|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
83670854|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670855|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670856|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83670857|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
83670858|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
83670859|NCT04101227|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83670860|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83670861|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
83670862|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670863|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670864|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83670865|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670866|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670867|NCT04047004|Doxorubicin|doxorubicin|mesh-list
83670868|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670869|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83670870|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83670871|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83670872|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670873|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670874|NCT03893435|Valsartan|valsartan|mesh-list
83670875|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83670876|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83670877|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83670878|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83670879|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670880|NCT03813121|Midazolam|midazolam|mesh-list
83670881|NCT03813121|Ketamine|ketamine|mesh-list
83670882|NCT03813121|Analgesics|analgesics|mesh-ancestor
83670883|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
83670884|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670885|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670886|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83670887|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83670888|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
83670889|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
83670890|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670891|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83670892|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83670893|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670894|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670895|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83670896|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83670897|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83670898|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83670899|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83670900|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
83670901|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
83670902|NCT03710590|Nicotine|nicotine|mesh-list
83670903|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83670904|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
83670905|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670906|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670907|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83670908|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83670909|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
83670910|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670911|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670912|NCT03676725|Lidocaine|lidocaine|mesh-list
83670913|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
83670914|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
83670915|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670916|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670917|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
83670918|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670919|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83670920|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83670921|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83670922|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83670923|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670924|NCT03572049|Itraconazole|itraconazole|mesh-list
83670925|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83670926|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
83670927|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83670928|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83670929|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83670930|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670931|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670932|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83670933|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
83670934|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83670935|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670936|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83670937|NCT03471507|Diclofenac|diclofenac|mesh-list
83670938|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83670939|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83670940|NCT03471507|Analgesics|analgesics|mesh-ancestor
83670941|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
83670942|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670943|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670944|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670945|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670946|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83670947|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670948|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670949|NCT03470922|Nivolumab|nivolumab|mesh-list
83670950|NCT03470922|Relatlimab|relatlimab|mesh-list
83670951|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670952|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670953|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83670954|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670955|NCT03468335|Irinotecan|irinotecan|mesh-list
83670956|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83670957|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83670958|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670959|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670960|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670961|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83670962|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670963|NCT03425279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83670964|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670965|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
83670966|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670967|NCT03205423|Gabapentin|gabapentin|mesh-list
83670968|NCT03205423|Analgesics|analgesics|mesh-ancestor
83670969|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
83670970|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83670971|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83670972|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
83670973|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83670974|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83670975|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83670976|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83670977|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83670978|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83670979|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83670980|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670981|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
83670982|NCT03104400|Adalimumab|adalimumab|mesh-list
83670983|NCT03104400|Upadacitinib|upadacitinib|mesh-list
83670984|NCT03104400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83670985|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83670986|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670987|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83670988|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670989|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670990|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670991|NCT03104374|Upadacitinib|upadacitinib|mesh-list
83670992|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83670993|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83670994|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83670995|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83670996|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83670997|NCT03008369|Lenvatinib|lenvatinib|mesh-list
83670998|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83670999|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83671000|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671001|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671002|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
83671003|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83671004|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83671005|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671006|NCT02965716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83671007|NCT02965716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671008|NCT02918006|Vaccines|vaccines|mesh-list
83671009|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
83671010|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671011|NCT02917772|Nivolumab|nivolumab|mesh-list
83671012|NCT02917772|Ipilimumab|ipilimumab|mesh-list
83671013|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83671014|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671015|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83671016|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671017|NCT02909686|Curcumin|curcumin|mesh-list
83671018|NCT02909686|Resveratrol|resveratrol|mesh-list
83671019|NCT02909686|Pycnogenols|pycnogenols|mesh-list
83671020|NCT02909686|Turmeric extract|turmeric extract|mesh-list
83671021|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83671022|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83671023|NCT02909686|Analgesics|analgesics|mesh-ancestor
83671024|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
83671025|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671026|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671027|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671028|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671029|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671030|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671031|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671032|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
83671033|NCT02909686|Protective Agents|protective agents|mesh-ancestor
83671034|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83671035|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83671036|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
83671037|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83671038|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
83671039|NCT02713373|Cetuximab|cetuximab|mesh-list
83671040|NCT02713373|Antibodies|antibodies|mesh-list
83671041|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
83671042|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83671043|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
83671044|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671045|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671046|NCT02713373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83671047|NCT02713373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671048|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
83671049|NCT02686593|Clofarabine|clofarabine|mesh-list
83671050|NCT02686593|Analgesics|analgesics|mesh-ancestor
83671051|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
83671052|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671053|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671054|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671055|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83671056|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83671057|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671058|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671059|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671060|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
83671061|NCT02658487|Cytarabine|cytarabine|mesh-list
83671062|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671063|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
83671064|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671065|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671066|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
83671067|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671068|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671069|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
83671070|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671071|NCT02583282|Doxycycline|doxycycline|mesh-list
83671072|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83671073|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671074|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
83671075|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83671076|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82825840|NCT00517361|Bevacizumab|bevacizumab|mesh-list
83671077|NCT02553941|Azacitidine|azacitidine|mesh-list
83671078|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671079|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
83671080|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671081|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671082|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671083|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83671084|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83671085|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
83671086|NCT02546492|Hormones|hormones|mesh-ancestor
83671087|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671088|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671089|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671090|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671091|NCT02527564|Suvorexant|suvorexant|mesh-list
83671092|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83671093|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83671094|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671095|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671096|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83671097|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671098|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671099|NCT02339168|Metformin|metformin|mesh-list
83671100|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83671101|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671102|NCT02179749|Mifepristone|mifepristone|mesh-list
83671103|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83671104|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
83671105|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83671106|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671107|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83671108|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83671109|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83671110|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
83671111|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83671112|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83671113|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
83671114|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671115|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
83671116|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83671117|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83671118|NCT02065609|Trastuzumab|trastuzumab|mesh-list
83671119|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83671120|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671121|NCT00700882|Dasatinib|dasatinib|mesh-list
83671122|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671123|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83671124|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671125|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671126|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
83671127|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83671128|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83671129|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
83671130|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
83671131|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671132|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671133|NCT01561482|Metformin|metformin|mesh-list
83671134|NCT01561482|Simvastatin|simvastatin|mesh-list
83671135|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83671136|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671137|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83671138|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83671139|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
83671140|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671141|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83671142|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83671143|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671144|NCT01561586|Cisplatin|cisplatin|mesh-list
83671145|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671146|NCT01562704|Acetaminophen|acetaminophen|mesh-list
83671147|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83671148|NCT01562704|Analgesics|analgesics|mesh-ancestor
82825916|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
83671149|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
83671150|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671151|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671152|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
83671153|NCT01564095|Tryptophan|tryptophan|mesh-list
83671154|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83671155|NCT01564095|Tacrolimus|tacrolimus|mesh-list
83671156|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671157|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
83671158|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671159|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83671160|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671161|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671162|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83671163|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671164|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671165|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
83671166|NCT01564238|Calcium|calcium|mesh-list
83671167|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83671168|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671169|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83671170|NCT01564576|Bromides|bromides|mesh-list
83671171|NCT01564576|Rocuronium|rocuronium|mesh-list
83671172|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
83671173|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83671174|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83671175|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83671176|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671177|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671178|NCT01564823|Metronidazole|metronidazole|mesh-list
83671179|NCT01564823|Adalimumab|adalimumab|mesh-list
83671180|NCT01564823|Azathioprine|azathioprine|mesh-list
83671181|NCT01564823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83671182|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671183|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671184|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671185|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83671186|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83671187|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83671188|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
83671189|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671190|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671191|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671192|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671193|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
83671194|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671195|NCT01565239|Thrombin|thrombin|mesh-list
83671196|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
83671197|NCT01565239|Coagulants|coagulants|mesh-ancestor
83671198|NCT01565265|Cetrorelix|cetrorelix|mesh-list
83671199|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83671200|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83671201|NCT01565265|Hormones|hormones|mesh-ancestor
83671202|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671203|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671204|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83671205|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
83671206|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83671207|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
83671208|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
83671209|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83671210|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83671211|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83671212|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671213|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671214|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
83671215|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671216|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671217|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83671218|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671219|NCT01566422|Vancomycin|vancomycin|mesh-list
83671220|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83671221|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671222|NCT01566760|Fesoterodine|fesoterodine|mesh-list
83671223|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83671224|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83671225|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
83671226|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671227|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671228|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671229|NCT01566760|Urological Agents|urological agents|mesh-ancestor
83671231|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83671232|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83671233|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
83671234|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
83671235|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671236|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671237|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671238|NCT01567072|Ibuprofen|ibuprofen|mesh-list
83671239|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83671240|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83671241|NCT01567072|Analgesics|analgesics|mesh-ancestor
83671242|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
83671243|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671244|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671245|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671246|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671247|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83671248|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671249|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671250|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83671251|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
83671252|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83671253|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83671254|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671255|NCT01568632|Imetelstat|imetelstat|mesh-list
83671256|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
83671257|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671258|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671259|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83671260|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
83671261|NCT01568645|Carvedilol|carvedilol|mesh-list
83671262|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671263|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83671264|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671265|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671266|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83671267|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83671268|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
83671269|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671270|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671271|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83671272|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
83671273|NCT01568645|Protective Agents|protective agents|mesh-ancestor
83671274|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83671275|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671276|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83671277|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
83671278|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83671279|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83671280|NCT01568684|Citalopram|citalopram|mesh-list
83671281|NCT01568684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83671282|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83671283|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671284|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671285|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671286|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
83671287|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671288|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83671289|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671290|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671291|NCT01569685|Sertraline|sertraline|mesh-list
83671292|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83671293|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671294|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671295|NCT01569685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82826072|NCT00254397|Leuprolide|leuprolide|mesh-list
83671296|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83671297|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671298|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671299|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671300|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
83671301|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671302|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83671303|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83671304|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83671305|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83671306|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
83671307|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671308|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671309|NCT01570088|Folic Acid|folic acid|mesh-list
83671310|NCT01570088|Hematinics|hematinics|mesh-ancestor
83671311|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
83671312|NCT01570088|Vitamins|vitamins|mesh-ancestor
83671313|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
83671314|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671315|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83671316|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83671317|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
83671318|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671319|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671320|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83671321|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
83671322|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
83671323|NCT01570478|Hormones|hormones|mesh-ancestor
83671324|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671325|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
83671326|NCT01570504|Ivermectin|ivermectin|mesh-list
83671327|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83671328|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671329|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83671330|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671331|NCT01570569|Losartan|losartan|mesh-list
83671332|NCT01570569|Midazolam|midazolam|mesh-list
83671333|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
83671334|NCT01570569|Caffeine|caffeine|mesh-list
83671335|NCT01570569|Omeprazole|omeprazole|mesh-list
83671336|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83671337|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83671338|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671339|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671340|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83671341|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83671342|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671343|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83671344|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
83671345|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
83671346|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
83671347|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
83671348|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671349|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671350|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83671351|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83671352|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83671353|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83671354|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83671355|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83671356|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671357|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83671358|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83671359|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
83671360|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83671361|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671362|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83671363|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
83671364|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
83671365|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83671366|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83671367|NCT01570582|Paclitaxel|paclitaxel|mesh-list
83671368|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82826142|NCT00322452|Carboplatin|carboplatin|mesh-list
83671369|NCT01570582|Carboplatin|carboplatin|mesh-list
83671371|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83671372|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671373|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83671374|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83671375|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83671376|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671377|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671378|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
83671379|NCT01570608|Ranibizumab|ranibizumab|mesh-list
83671380|NCT01570608|Verteporfin|verteporfin|mesh-list
83671381|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83671382|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83671383|NCT01570608|Growth Substances|growth substances|mesh-ancestor
83671384|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671385|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
83671386|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671387|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83671388|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
83671389|NCT01570660|Pioglitazone|pioglitazone|mesh-list
83671390|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83671391|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671392|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
83671393|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671394|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
83671395|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671396|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671397|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83671398|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
83671399|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671400|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671401|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83671402|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
83671403|NCT01570790|Combretastatin|combretastatin|mesh-list
83671404|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83671405|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671406|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
83671407|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
83671408|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
83671409|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671410|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83671411|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671412|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671413|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83671414|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83671415|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671416|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671417|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83671418|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671419|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671420|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83671421|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83671422|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671423|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671424|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83671425|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671426|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671427|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83671428|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83671429|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671430|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671431|NCT01570985|Triamcinolone|triamcinolone|mesh-list
83671432|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83671433|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83671434|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83671435|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671436|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
83671437|NCT01570985|Hormones|hormones|mesh-ancestor
83671438|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671439|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671440|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671441|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
83671442|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826216|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671443|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671444|NCT01571024|Leucovorin|leucovorin|mesh-list
83671445|NCT01571024|Fluorouracil|fluorouracil|mesh-list
83671446|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
83671447|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
83671448|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671449|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671450|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671451|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671452|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
83671453|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671454|NCT01571024|Antidotes|antidotes|mesh-ancestor
83671455|NCT01571024|Protective Agents|protective agents|mesh-ancestor
83671456|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
83671457|NCT01571024|Vitamins|vitamins|mesh-ancestor
83671458|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
83671459|NCT01571037|Milrinone|milrinone|mesh-list
83671460|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83671461|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83671462|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
83671463|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83671464|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83671465|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671466|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671467|NCT01571037|Protective Agents|protective agents|mesh-ancestor
83671468|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671469|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
83671470|NCT01571050|Antacids|antacids|mesh-ancestor
83671471|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671472|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671473|NCT01571063|Vitamin D|vitamin d|mesh-list
83671474|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
83671475|NCT01571063|Vitamins|vitamins|mesh-ancestor
83671476|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
83671477|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671478|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83671479|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83671480|NCT01571167|Varenicline|varenicline|mesh-list
83671481|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83671482|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83671483|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83671484|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671485|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671486|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671487|NCT01571206|Infliximab|infliximab|mesh-list
83671488|NCT01571206|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83671489|NCT01571206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671490|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
83671491|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671492|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671493|NCT01571219|Infliximab|infliximab|mesh-list
83671494|NCT01571219|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83671495|NCT01571219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671496|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83671497|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671498|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671499|NCT01571323|Misoprostol|misoprostol|mesh-list
83671500|NCT01571323|Oxytocin|oxytocin|mesh-list
83671501|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
83671502|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83671503|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671504|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83671505|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
83671506|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83671507|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671508|NCT01571414|Ritonavir|ritonavir|mesh-list
83671509|NCT01571414|Lopinavir|lopinavir|mesh-list
83671510|NCT01571414|Efavirenz|efavirenz|mesh-list
83671511|NCT01571414|Rifampin|rifampin|mesh-list
83671512|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83671513|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83671514|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
83671515|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671516|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671517|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82826296|NCT00362414|Mitogens|mitogens|mesh-list
83671518|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83671519|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
83671520|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671521|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83671522|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83671523|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83671524|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83671525|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83671526|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83671527|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83671528|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83671529|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83671530|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83671531|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
83671532|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83671533|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
83671534|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83671535|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83671536|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83671538|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
83671539|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671540|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
83671541|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671542|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671543|NCT01571583|Interferons|interferons|mesh-list
83671544|NCT01571583|Ribavirin|ribavirin|mesh-list
83671545|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
83671546|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
83671547|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83671548|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671549|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
83671550|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671551|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
83671552|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671553|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
83671554|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671555|NCT01571609|Insulin|insulin|mesh-list
83671556|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83671557|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671558|NCT01571648|Azacitidine|azacitidine|mesh-list
83671559|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671560|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
83671561|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671562|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671563|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671564|NCT01571687|Antioxidants|antioxidants|mesh-list
83671565|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671566|NCT01571687|Protective Agents|protective agents|mesh-ancestor
83671567|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671568|NCT01571791|Ketorolac|ketorolac|mesh-list
83671569|NCT01571791|Lidocaine|lidocaine|mesh-list
83671570|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
83671571|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
83671572|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671573|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671574|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
83671575|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671576|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83671577|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83671578|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83671579|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671580|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671581|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83671582|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83671583|NCT01571791|Analgesics|analgesics|mesh-ancestor
83671584|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671585|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671586|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83671587|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671588|NCT01571804|Pregabalin|pregabalin|mesh-list
83671589|NCT01571804|Analgesics|analgesics|mesh-ancestor
83671590|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
83671591|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671592|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671594|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83671595|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671596|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671597|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83671598|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83671599|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83671600|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671601|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671602|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
83671603|NCT01571856|Astringents|astringents|mesh-ancestor
83671604|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671605|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
83671606|NCT01571882|Policosanol|policosanol|mesh-list
83671607|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83671608|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83671609|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
83671610|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671611|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83671612|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83671613|NCT01571921|Tocotrienols|tocotrienols|mesh-list
83671614|NCT01571921|Vitamin E|vitamin e|mesh-list
83671615|NCT01571921|Tocopherols|tocopherols|mesh-list
83671616|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
83671617|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671618|NCT01571921|Protective Agents|protective agents|mesh-ancestor
83671619|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671620|NCT01571921|Vitamins|vitamins|mesh-ancestor
83671621|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
83671622|NCT01571960|Vaccines|vaccines|mesh-list
83671623|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
83671624|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671625|NCT01572012|Ondansetron|ondansetron|mesh-list
83671626|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
83671627|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
83671628|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671629|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671630|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671631|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
83671632|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
83671633|NCT01572012|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83671634|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83671635|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
83671636|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671637|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671638|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83671639|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83671640|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
83671641|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671642|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83671643|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671644|NCT01571908|Rocuronium|rocuronium|mesh-list
83671645|NCT01571908|Succinylcholine|succinylcholine|mesh-list
83671646|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83671647|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83671648|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83671649|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671650|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671651|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83671652|NCT01572116|Lidocaine|lidocaine|mesh-list
83671653|NCT01572116|Epinephrine|epinephrine|mesh-list
83671654|NCT01572116|Racepinephrine|racepinephrine|mesh-list
83671655|NCT01572116|Sufentanil|sufentanil|mesh-list
83671656|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
83671657|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
83671658|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
83671659|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671660|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671661|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
83671662|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671663|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83671664|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83671665|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82826437|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671666|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671667|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671668|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83671669|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83671670|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
83671671|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671672|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83671673|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83671674|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
83671675|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83671676|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
83671677|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
83671678|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
83671679|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83671680|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83671681|NCT01572116|Narcotics|narcotics|mesh-ancestor
83671682|NCT01572116|Analgesics|analgesics|mesh-ancestor
83671683|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83671684|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83671685|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
83671686|NCT01572129|Clopidogrel|clopidogrel|mesh-list
83671687|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83671688|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83671689|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83671690|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83671691|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
83671692|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671693|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671694|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671695|NCT01572181|Fludarabine|fludarabine|mesh-list
83671696|NCT01572181|Busulfan|busulfan|mesh-list
83671697|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
83671698|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671699|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671700|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671701|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
83671702|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671703|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
83671704|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83671705|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83671706|NCT01572259|Hormones|hormones|mesh-list
83671707|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671708|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671709|NCT01572285|Dexamethasone|dexamethasone|mesh-list
83671710|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
83671711|NCT01572285|BB 1101|bb 1101|mesh-list
83671712|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671713|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
83671714|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
83671715|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671716|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671717|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671718|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
83671719|NCT01572285|Hormones|hormones|mesh-ancestor
83671720|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671721|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83671722|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671723|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
83671724|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671725|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671726|NCT01572324|Leucovorin|leucovorin|mesh-list
83671727|NCT01572324|Fluorouracil|fluorouracil|mesh-list
83671728|NCT01572324|Capecitabine|capecitabine|mesh-list
83671729|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
83671730|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
83671731|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671732|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671733|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671734|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671735|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
83671736|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671737|NCT01572324|Antidotes|antidotes|mesh-ancestor
83671738|NCT01572324|Protective Agents|protective agents|mesh-ancestor
83671739|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
83671740|NCT01572324|Vitamins|vitamins|mesh-ancestor
83671741|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
83671742|NCT01572350|Triamcinolone|triamcinolone|mesh-list
83671743|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83671744|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83671746|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83671747|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83671748|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671749|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83671750|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83671751|NCT01572350|Growth Substances|growth substances|mesh-ancestor
83671752|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671753|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
83671754|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671755|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
83671756|NCT01572350|Hormones|hormones|mesh-ancestor
83671757|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671758|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671759|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
83671760|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671761|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671762|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
83671763|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
83671764|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83671765|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83671766|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671767|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671768|NCT01572363|Urological Agents|urological agents|mesh-ancestor
83671769|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
83671770|NCT01572454|Remifentanil|remifentanil|mesh-list
83671771|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83671772|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671773|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671774|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83671775|NCT01572454|Analgesics|analgesics|mesh-ancestor
83671776|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
83671777|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671778|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83671779|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83671780|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83671781|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83671782|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671783|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671784|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83671785|NCT01572454|Narcotics|narcotics|mesh-ancestor
83671786|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
83671787|NCT01572545|Denosumab|denosumab|mesh-list
83671788|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83671789|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671790|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
83671791|NCT01572558|Meropenem|meropenem|mesh-list
83671792|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83671793|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671794|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83671795|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83671796|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671797|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671798|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671799|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83671800|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83671801|NCT01572597|Metronidazole|metronidazole|mesh-list
83671802|NCT01572597|Clarithromycin|clarithromycin|mesh-list
83671803|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
83671804|NCT01572597|Rabeprazole|rabeprazole|mesh-list
83671805|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83671806|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83671807|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83671808|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83671809|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83671810|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671811|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83671812|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671813|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671814|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83671815|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82826584|NCT00513695|Paclitaxel|paclitaxel|mesh-list
83671816|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83671817|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
83671818|NCT01572597|Expectorants|expectorants|mesh-ancestor
83671819|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83671820|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83671821|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
83671822|NCT01572597|Protective Agents|protective agents|mesh-ancestor
83671823|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671824|NCT01572623|Clopidogrel|clopidogrel|mesh-list
83671825|NCT01572623|Atorvastatin|atorvastatin|mesh-list
83671826|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83671827|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83671828|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
83671829|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671830|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83671831|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83671832|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671833|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83671834|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83671835|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83671836|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83671837|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
83671838|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671839|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671840|NCT01572649|Lixisenatide|lixisenatide|mesh-list
83671841|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83671842|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671843|NCT01572688|Melphalan|melphalan|mesh-list
83671844|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83671845|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
83671846|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671847|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671848|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83671849|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83671850|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
83671851|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671852|NCT01572805|Melatonin|melatonin|mesh-list
83671853|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
83671854|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671855|NCT01572805|Protective Agents|protective agents|mesh-ancestor
83671856|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671857|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671858|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
83671859|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
83671860|NCT01572831|Protective Agents|protective agents|mesh-ancestor
83671861|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671862|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
83671863|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83671864|NCT01572857|Antibodies|antibodies|mesh-list
83671865|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
83671866|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671867|NCT01572961|Aspirin|aspirin|mesh-list
83671868|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83671869|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83671870|NCT01572961|Analgesics|analgesics|mesh-ancestor
83671871|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
83671872|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671873|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671874|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83671875|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83671876|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83671877|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83671878|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671879|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83671880|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83671881|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671882|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
83671883|NCT01573013|Iron|iron|mesh-list
83671884|NCT01573013|Trace Elements|trace elements|mesh-ancestor
83671885|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
82826659|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671886|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671887|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83671888|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83671889|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83671890|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
83671891|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671892|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83671893|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83671894|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671896|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83671897|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671898|NCT01573286|Hormones|hormones|mesh-ancestor
83671899|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671900|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671901|NCT01573286|Incretins|incretins|mesh-ancestor
83671902|NCT01573338|Carboplatin|carboplatin|mesh-list
83671903|NCT01573338|Etoposide|etoposide|mesh-list
83671904|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671905|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83671906|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83671907|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83671908|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671909|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671910|NCT01573377|Metformin|metformin|mesh-list
83671911|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
83671912|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83671913|NCT01573377|Cyproterone|cyproterone|mesh-list
83671914|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83671915|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671916|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83671917|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83671918|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83671919|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
83671920|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83671921|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83671922|NCT01573377|Estrogens|estrogens|mesh-ancestor
83671923|NCT01573377|Hormones|hormones|mesh-ancestor
83671924|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671925|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
83671926|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
83671927|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671928|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83671929|NCT01573468|Capecitabine|capecitabine|mesh-list
83671930|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83671931|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
83671932|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671933|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83671934|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83671935|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
83671936|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83671937|NCT01573598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83671938|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83671939|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83671940|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671941|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671942|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
83671943|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671944|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83671945|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83671946|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83671947|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83671948|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
83671949|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671950|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671951|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83671952|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83671953|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83671954|NCT01573663|Dipropizine|dipropizine|mesh-list
83671955|NCT01573663|Ambroxol|ambroxol|mesh-list
83671956|NCT01573663|Expectorants|expectorants|mesh-ancestor
83671957|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
83671958|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
83671959|NCT01573715|Cisatracurium|cisatracurium|mesh-list
83671960|NCT01573715|Atracurium|atracurium|mesh-list
83671961|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83671962|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83671963|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671964|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671965|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83671966|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83671967|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83671968|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
83671969|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671970|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671971|NCT01573741|Ketamine|ketamine|mesh-list
83671972|NCT01573741|Analgesics|analgesics|mesh-ancestor
83671973|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
83671974|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83671975|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671976|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83671977|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83671978|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
83671979|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
83671980|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83671981|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83671982|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83671983|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83671984|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671985|NCT01573806|Exenatide|exenatide|mesh-list
83671986|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83671987|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83671988|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83671989|NCT01573806|Incretins|incretins|mesh-ancestor
83671990|NCT01573806|Hormones|hormones|mesh-ancestor
83671991|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83671992|NCT01573975|Clarithromycin|clarithromycin|mesh-list
83671993|NCT01573975|Rabeprazole|rabeprazole|mesh-list
83671994|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83671995|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83671996|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83671997|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83671998|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83671999|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672000|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672001|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83672002|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83672003|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83672004|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
83672005|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672006|NCT01574027|Vitamin D|vitamin d|mesh-list
83672007|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
83672008|NCT01574027|Vitamins|vitamins|mesh-ancestor
83672009|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
83672010|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672011|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83672012|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672013|NCT01574092|Irinotecan|irinotecan|mesh-list
83672014|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672015|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83672016|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83672017|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672018|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672019|NCT01574131|Fenofibrate|fenofibrate|mesh-list
83672020|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83672021|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
83672022|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672023|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83672024|NCT01574261|Inositol|inositol|mesh-list
83672025|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
83672026|NCT01574261|Vitamins|vitamins|mesh-ancestor
83672027|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
83672028|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672029|NCT01574313|Tocopherols|tocopherols|mesh-list
83672030|NCT01574313|Vitamin E|vitamin e|mesh-list
83672031|NCT01574313|Tocotrienols|tocotrienols|mesh-list
83672032|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
83672033|NCT01574313|Niacin|niacin|mesh-list
83672034|NCT01574313|Diphenidol|diphenidol|mesh-list
83672035|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
83672036|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672037|NCT01574313|Protective Agents|protective agents|mesh-ancestor
83672038|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672039|NCT01574313|Vitamins|vitamins|mesh-ancestor
83672040|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
83672041|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83672042|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
83672043|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83672044|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
83672045|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
83672046|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
83672047|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
83672048|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672049|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672050|NCT01574508|Insulin|insulin|mesh-list
83672051|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83672052|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83672053|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672054|NCT01574638|Rifapentine|rifapentine|mesh-list
83672055|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83672056|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
83672057|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672058|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672059|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
83672060|NCT01574742|Minocycline|minocycline|mesh-list
83672061|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672062|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672063|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
83672064|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83672065|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672066|NCT01575158|Citalopram|citalopram|mesh-list
83672067|NCT01575158|Clomipramine|clomipramine|mesh-list
83672068|NCT01575158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83672069|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83672070|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672071|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672072|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672073|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
83672074|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672075|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83672076|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
83672077|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83672078|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83672079|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
83672080|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83672081|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672082|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
83672083|NCT01575301|Liraglutide|liraglutide|mesh-list
83672084|NCT01575301|Exenatide|exenatide|mesh-list
83672085|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83672086|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672087|NCT01575301|Incretins|incretins|mesh-ancestor
83672088|NCT01575301|Hormones|hormones|mesh-ancestor
83672089|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672090|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83672091|NCT01575405|Tenofovir|tenofovir|mesh-list
83672092|NCT01575405|Glycerol|glycerol|mesh-list
83672093|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
83672094|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672095|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83672096|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83672097|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672098|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672099|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83672100|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83672101|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83672102|NCT01575405|Protective Agents|protective agents|mesh-ancestor
83672103|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672104|NCT01575418|Tenofovir|tenofovir|mesh-list
83672105|NCT01575418|Glycerol|glycerol|mesh-list
83672106|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
83672107|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672108|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83672109|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83672110|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672111|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672112|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83672113|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82826883|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672114|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83672116|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672117|NCT01575483|Saxagliptin|saxagliptin|mesh-list
83672118|NCT01575483|Incretins|incretins|mesh-ancestor
83672119|NCT01575483|Hormones|hormones|mesh-ancestor
83672120|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672121|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672122|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83672123|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
83672124|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672125|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672126|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83672127|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83672128|NCT01575613|Lumefantrine|lumefantrine|mesh-list
83672129|NCT01575613|Artemether|artemether|mesh-list
83672130|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83672131|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
83672132|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83672133|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83672134|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672135|NCT01575626|Sevoflurane|sevoflurane|mesh-list
83672136|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83672137|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83672138|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
83672139|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
83672140|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672141|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672142|NCT01575639|Prednisolone|prednisolone|mesh-list
83672143|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672144|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
83672145|NCT01575639|Hormones|hormones|mesh-ancestor
83672146|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672147|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672148|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672149|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672150|NCT01575652|Lisinopril|lisinopril|mesh-list
83672151|NCT01575652|Perindopril|perindopril|mesh-list
83672152|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83672153|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83672154|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
83672155|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672156|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83672157|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83672158|NCT01575652|Protective Agents|protective agents|mesh-ancestor
83672159|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672160|NCT01575678|Melatonin|melatonin|mesh-list
83672161|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
83672162|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672163|NCT01575678|Protective Agents|protective agents|mesh-ancestor
83672164|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672165|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672166|NCT01575717|Vitamin D|vitamin d|mesh-list
83672167|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
83672168|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
83672169|NCT01575717|Vitamins|vitamins|mesh-list
83672170|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
83672171|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672172|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83672173|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672174|NCT01575782|Chloroquine|chloroquine|mesh-list
83672175|NCT01575782|Amebicides|amebicides|mesh-ancestor
83672176|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83672177|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83672178|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672179|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
83672180|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83672181|NCT01575795|Ticagrelor|ticagrelor|mesh-list
83672182|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83672183|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83672184|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83672185|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83672186|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
83672187|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826965|NCT00362180|Mipomersen|mipomersen|mesh-list
83672188|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672189|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672191|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672192|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
83672193|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
83672194|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
83672195|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672196|NCT01576094|Simendan|simendan|mesh-list
83672197|NCT01576094|Milrinone|milrinone|mesh-list
83672198|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83672199|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
83672200|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83672201|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83672202|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672203|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672204|NCT01576094|Protective Agents|protective agents|mesh-ancestor
83672205|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672206|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83672207|NCT01576185|Sorafenib|sorafenib|mesh-list
83672208|NCT01576185|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83672209|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672210|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83672211|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672212|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672213|NCT01576263|Ropivacaine|ropivacaine|mesh-list
83672214|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
83672215|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
83672216|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672217|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672218|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
83672219|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672220|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
83672221|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83672222|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672223|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672224|NCT01576419|Celecoxib|celecoxib|mesh-list
83672225|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83672226|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672227|NCT01576419|Analgesics|analgesics|mesh-ancestor
83672228|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
83672229|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672230|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672231|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672232|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83672233|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83672234|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83672235|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672236|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672237|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83672238|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83672239|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672240|NCT01576627|Zinc|zinc|mesh-list
83672241|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
83672242|NCT01576627|Trace Elements|trace elements|mesh-ancestor
83672243|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
83672244|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672245|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
83672246|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
83672247|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83672248|NCT01576627|Protective Agents|protective agents|mesh-ancestor
83672249|NCT01576640|Bupropion|bupropion|mesh-list
83672250|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83672251|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
83672252|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83672253|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83672254|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83672255|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672256|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672257|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
83672258|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672259|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672260|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82827031|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
83672261|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83672262|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672263|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83672264|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83672265|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83672266|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672268|NCT01576692|Antibodies|antibodies|mesh-list
83672269|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
83672270|NCT01576692|Sargramostim|sargramostim|mesh-list
83672271|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
83672272|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672273|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672274|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83672275|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83672276|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
83672277|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672278|NCT01576731|Tenofovir|tenofovir|mesh-list
83672279|NCT01576731|Emtricitabine|emtricitabine|mesh-list
83672280|NCT01576731|Lopinavir|lopinavir|mesh-list
83672281|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
83672282|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
83672283|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672284|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83672285|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83672286|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672287|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672288|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83672289|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83672290|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83672291|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83672292|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
83672293|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83672294|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83672295|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83672296|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83672297|NCT01576770|Lidocaine|lidocaine|mesh-list
83672298|NCT01576770|Tetracaine|tetracaine|mesh-list
83672299|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
83672300|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
83672301|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
83672302|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672303|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672304|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
83672305|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672306|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83672307|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83672308|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83672309|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672310|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672311|NCT01576848|Caseins|caseins|mesh-list
83672312|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
83672313|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
83672314|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672315|NCT01577017|Letrozole|letrozole|mesh-list
83672316|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83672317|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672318|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83672319|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672320|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672321|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83672322|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
83672323|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672324|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672325|NCT01577043|Racecadotril|racecadotril|mesh-list
83672326|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
83672327|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672328|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
83672329|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672330|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672331|NCT01577121|Indomethacin|indomethacin|mesh-list
82827104|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83672332|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82827105|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672333|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672334|NCT01577121|Analgesics|analgesics|mesh-ancestor
83672335|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
83672336|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672337|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672338|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672339|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83672340|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
83672341|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
83672342|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83672343|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83672344|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672345|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672346|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
83672347|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83672348|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672349|NCT01577199|Clomiphene|clomiphene|mesh-list
83672350|NCT01577199|Enclomiphene|enclomiphene|mesh-list
83672351|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
83672352|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83672353|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
83672354|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672355|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672356|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83672357|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
83672358|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83672359|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83672360|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83672361|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
83672362|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672363|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672364|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83672365|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83672366|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672367|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672368|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672369|NCT01577368|Tazobactam|tazobactam|mesh-list
83672370|NCT01577368|Piperacillin|piperacillin|mesh-list
83672371|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83672372|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672373|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672374|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83672375|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672376|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672377|NCT01577407|Nefopam|nefopam|mesh-list
83672378|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672379|NCT01577407|Analgesics|analgesics|mesh-ancestor
83672380|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
83672381|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672382|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672383|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
83672384|NCT01577459|Tedizolid|tedizolid|mesh-list
83672385|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672386|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672387|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
83672388|NCT01577524|Povidone|povidone|mesh-list
83672389|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
83672390|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
83672391|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83672392|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672393|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83672394|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
83672395|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672396|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83672397|NCT01577589|Cephalosporins|cephalosporins|mesh-list
83672398|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672399|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672400|NCT01577693|Dutasteride|dutasteride|mesh-list
83672401|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83672402|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83672403|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672404|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827179|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672405|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
83672406|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672407|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672408|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83672409|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
83672410|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672411|NCT01577849|Vitamin D|vitamin d|mesh-list
83672412|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
83672413|NCT01577849|Vitamins|vitamins|mesh-ancestor
83672414|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
83672415|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672416|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83672417|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672418|NCT01577862|Rifampin|rifampin|mesh-list
83672419|NCT01577862|Colistin|colistin|mesh-list
83672420|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83672421|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
83672422|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672423|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672424|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
83672425|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83672426|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672427|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672428|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83672429|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83672430|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83672431|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83672432|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83672433|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83672434|NCT01577914|Carvedilol|carvedilol|mesh-list
83672435|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83672436|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83672437|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
83672438|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672439|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672440|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672441|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83672442|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
83672443|NCT01577914|Protective Agents|protective agents|mesh-ancestor
83672444|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83672445|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672446|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672447|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
83672448|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83672449|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83672450|NCT01577940|Ropivacaine|ropivacaine|mesh-list
83672451|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
83672452|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
83672453|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672454|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672455|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
83672456|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672457|NCT01577992|Levodopa|levodopa|mesh-list
83672458|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83672459|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83672460|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
83672461|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672462|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672463|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672464|NCT01578057|Ethanol|ethanol|mesh-list
83672465|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83672466|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672467|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672468|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672469|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
83672470|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672471|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
83672472|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
83672473|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
83672474|NCT01578109|Sorafenib|sorafenib|mesh-list
83672475|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672476|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83672477|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672478|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672479|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
82827259|NCT00360698|Insulin|insulin|mesh-list
83672480|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83672481|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672482|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672483|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672484|NCT01578161|Analgesics|analgesics|mesh-ancestor
83672485|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
83672486|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672487|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83672488|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83672489|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83672490|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83672491|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672492|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672493|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
83672494|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83672495|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672496|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672497|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672498|NCT01578174|Analgesics|analgesics|mesh-ancestor
83672499|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
83672500|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672501|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83672502|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83672503|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83672504|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
83672505|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672506|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672507|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
83672508|NCT01578200|Calcium|calcium|mesh-list
83672509|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672510|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672511|NCT01578200|Antacids|antacids|mesh-ancestor
83672512|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672513|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672514|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
83672515|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672516|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83672517|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672518|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672519|NCT01578252|Ondansetron|ondansetron|mesh-list
83672520|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
83672521|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
83672522|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672523|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672524|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672525|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
83672526|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
83672527|NCT01578252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83672528|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83672529|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
83672530|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672531|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672532|NCT01578265|Ondansetron|ondansetron|mesh-list
83672533|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
83672534|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
83672535|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672536|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672537|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672538|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
83672539|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
83672540|NCT01578265|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83672541|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83672542|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
83672543|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672544|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672545|NCT01578304|Fesoterodine|fesoterodine|mesh-list
83672546|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83672547|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83672548|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
83672549|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672550|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672551|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827379|NCT00504257|Docetaxel|docetaxel|mesh-list
83672552|NCT01578304|Urological Agents|urological agents|mesh-ancestor
83672553|NCT01578343|Dexamethasone|dexamethasone|mesh-list
83672554|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
83672555|NCT01578343|Fludarabine|fludarabine|mesh-list
83672556|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
83672557|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
83672558|NCT01578343|Vorinostat|vorinostat|mesh-list
83672559|NCT01578343|BB 1101|bb 1101|mesh-list
83672560|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672561|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
83672562|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
83672563|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672564|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672565|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672566|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
83672567|NCT01578343|Hormones|hormones|mesh-ancestor
83672568|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672569|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672570|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672571|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
83672572|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672573|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672574|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83672575|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
83672576|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83672577|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
83672578|NCT01578343|Analgesics|analgesics|mesh-ancestor
83672579|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
83672580|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83672581|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83672582|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83672583|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
83672584|NCT01578434|Vitamin D|vitamin d|mesh-list
83672585|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
83672586|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
83672587|NCT01578434|Vitamins|vitamins|mesh-list
83672588|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
83672589|NCT01578434|Calcium|calcium|mesh-list
83672590|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
83672591|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672592|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672593|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83672594|NCT01578434|Antacids|antacids|mesh-ancestor
83672595|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672596|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672597|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83672598|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
83672599|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83672600|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
83672601|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83672602|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672603|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83672604|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83672605|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672606|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672607|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83672608|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83672609|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83672610|NCT01578473|Vitamin D|vitamin d|mesh-list
83672611|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
83672612|NCT01578473|Vitamins|vitamins|mesh-list
83672613|NCT01578473|Vitamin E|vitamin e|mesh-list
83672614|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
83672615|NCT01578473|Testosterone|testosterone|mesh-list
83672616|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
83672617|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
83672618|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83672619|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
83672620|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672621|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83672622|NCT01578473|Androgens|androgens|mesh-ancestor
83672623|NCT01578473|Hormones|hormones|mesh-ancestor
83672624|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672625|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82827412|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
83672626|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672627|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
83672628|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
83672630|NCT01578473|Protective Agents|protective agents|mesh-ancestor
83672631|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672632|NCT01578564|SOR-C13|sor-c13|mesh-list
83672633|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672634|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83672635|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672636|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672637|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672638|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672639|NCT01578603|Calcium|calcium|mesh-list
83672640|NCT01578603|Caseins|caseins|mesh-list
83672641|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83672642|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672643|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
83672644|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
83672645|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672646|NCT01578629|Aspirin|aspirin|mesh-list
83672647|NCT01578629|Vitamin E|vitamin e|mesh-list
83672648|NCT01578629|Tocopherols|tocopherols|mesh-list
83672649|NCT01578629|Tocotrienols|tocotrienols|mesh-list
83672650|NCT01578629|Vitamins|vitamins|mesh-ancestor
83672651|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
83672652|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672653|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83672654|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672655|NCT01578629|Analgesics|analgesics|mesh-ancestor
83672656|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
83672657|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672658|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672659|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83672660|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83672661|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83672662|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672663|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83672664|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83672665|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672666|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
83672667|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
83672668|NCT01578629|Protective Agents|protective agents|mesh-ancestor
83672669|NCT01578668|Pemetrexed|pemetrexed|mesh-list
83672670|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83672671|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672672|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672673|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672674|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83672675|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83672676|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83672677|NCT01578720|Aflibercept|aflibercept|mesh-list
83672678|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83672679|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83672680|NCT01578720|Growth Substances|growth substances|mesh-ancestor
83672681|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672682|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
83672683|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672684|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
83672685|NCT01578824|Miotics|miotics|mesh-ancestor
83672686|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
83672687|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672688|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672689|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83672690|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83672691|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
83672692|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83672693|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83672694|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
83672695|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672696|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672697|NCT01578889|Vaccines|vaccines|mesh-list
83672698|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
83672699|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672700|NCT01578928|Pasireotide|pasireotide|mesh-list
83672701|NCT01578928|Hormones|hormones|mesh-ancestor
82827485|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672702|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672703|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672705|NCT01579019|Ribavirin|ribavirin|mesh-list
83672706|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83672707|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83672708|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83672709|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
83672710|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672711|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672712|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83672713|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83672714|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
83672715|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672716|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83672717|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83672718|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
83672719|NCT01579058|Bisoprolol|bisoprolol|mesh-list
83672720|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83672721|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
83672722|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
83672723|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672724|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672725|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83672726|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83672727|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83672728|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
83672729|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672730|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672731|NCT01579110|Levamisole|levamisole|mesh-list
83672732|NCT01579110|Prednisone|prednisone|mesh-list
83672733|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672734|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
83672735|NCT01579110|Hormones|hormones|mesh-ancestor
83672736|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672737|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672738|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672739|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672740|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83672741|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
83672742|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
83672743|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
83672744|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83672745|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672746|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83672747|NCT01579149|Plerixafor|plerixafor|mesh-list
83672748|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83672749|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83672750|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
83672751|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672752|NCT01579201|Carbetocin|carbetocin|mesh-list
83672753|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
83672754|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83672755|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672756|NCT01579227|Tamoxifen|tamoxifen|mesh-list
83672757|NCT01579227|Tocotrienols|tocotrienols|mesh-list
83672758|NCT01579227|Vitamin E|vitamin e|mesh-list
83672759|NCT01579227|Tocopherols|tocopherols|mesh-list
83672760|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83672761|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
83672762|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672763|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672764|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672765|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672766|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83672767|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83672768|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83672769|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
83672770|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672771|NCT01579227|Protective Agents|protective agents|mesh-ancestor
83672772|NCT01579227|Vitamins|vitamins|mesh-ancestor
83672773|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
83672774|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82827558|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83672775|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83672776|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83672778|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672779|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672780|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672781|NCT01579279|Analgesics|analgesics|mesh-ancestor
83672782|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
83672783|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672784|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
83672785|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83672786|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
83672787|NCT01579383|Sumatriptan|sumatriptan|mesh-list
83672788|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83672789|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83672790|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83672791|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
83672792|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672793|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672794|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672795|NCT01579448|Vaccines|vaccines|mesh-list
83672796|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
83672797|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672798|NCT01579461|Mirabegron|mirabegron|mesh-list
83672799|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83672800|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83672801|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83672802|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
83672803|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672804|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672805|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672806|NCT01579461|Urological Agents|urological agents|mesh-ancestor
83672807|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
83672808|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83672809|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83672810|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83672811|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83672812|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672813|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
83672814|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83672815|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672816|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83672817|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672818|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
83672819|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83672820|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83672821|NCT01579539|Prednisolone|prednisolone|mesh-list
83672822|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
83672823|NCT01579539|Esomeprazole|esomeprazole|mesh-list
83672824|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83672825|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
83672826|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672827|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
83672828|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
83672829|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672830|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672831|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83672832|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
83672833|NCT01579539|Hormones|hormones|mesh-ancestor
83672834|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83672835|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83672836|NCT01579539|Protective Agents|protective agents|mesh-ancestor
83672837|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672838|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672839|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83672840|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83672841|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672842|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672843|NCT01579630|Pemetrexed|pemetrexed|mesh-list
83672844|NCT01579630|Gefitinib|gefitinib|mesh-list
83672845|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672846|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672847|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672848|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83672849|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83672850|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83672851|NCT01579695|Tesamorelin|tesamorelin|mesh-list
83672852|NCT01579695|Growth Substances|growth substances|mesh-ancestor
83672853|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672854|NCT01579760|Aflibercept|aflibercept|mesh-list
83672855|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83672856|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83672857|NCT01579760|Growth Substances|growth substances|mesh-ancestor
83672858|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672859|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
83672860|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672861|NCT01579786|Acetaminophen|acetaminophen|mesh-list
83672862|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672863|NCT01579786|Analgesics|analgesics|mesh-ancestor
83672864|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
83672865|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672866|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672867|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
83672868|NCT01579838|Eculizumab|eculizumab|mesh-list
83672869|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83672870|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83672871|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
83672872|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672873|NCT01579864|Rocuronium|rocuronium|mesh-list
83672874|NCT01579864|Succinylcholine|succinylcholine|mesh-list
83672875|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83672876|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83672877|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83672878|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672879|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672880|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83672881|NCT01579890|Diclofenac|diclofenac|mesh-list
83672882|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83672883|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83672884|NCT01579890|Analgesics|analgesics|mesh-ancestor
83672885|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
83672886|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83672887|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672888|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83672889|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83672890|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83672891|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672892|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672893|NCT01579903|Factor VIII|factor viii|mesh-list
83672894|NCT01579903|Coagulants|coagulants|mesh-ancestor
83672895|NCT01579929|Etoposide|etoposide|mesh-list
83672896|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672897|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83672898|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83672899|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83672900|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672901|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672902|NCT01579994|Crizotinib|crizotinib|mesh-list
83672903|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672904|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83672905|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672906|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672907|NCT01580228|Ofatumumab|ofatumumab|mesh-list
83672908|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672909|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
83672910|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83672911|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83672912|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
83672913|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83672914|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
83672915|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83672916|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672917|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83672918|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83672919|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672920|NCT01581476|Quinapril|quinapril|mesh-list
83672921|NCT01581476|Atorvastatin|atorvastatin|mesh-list
83672922|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83672923|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83672924|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83672925|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
83672926|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672927|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83672928|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83672929|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672930|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
83672931|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83672932|NCT01582321|Cantharidin|cantharidin|mesh-list
83672933|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672934|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672935|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
83672936|NCT01582438|Citric Acid|citric acid|mesh-list
83672937|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
83672938|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
83672939|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83672940|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
83672941|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
83672942|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672943|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
83672944|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83672945|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83672946|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672947|NCT01582438|Urological Agents|urological agents|mesh-ancestor
83672948|NCT01582711|Isoniazid|isoniazid|mesh-list
83672949|NCT01582711|Rifapentine|rifapentine|mesh-list
83672950|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
83672951|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672952|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672953|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83672954|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83672955|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
83672956|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672957|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83672958|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83672959|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
83672960|NCT01583062|Amoxicillin|amoxicillin|mesh-list
83672961|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
83672962|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
83672963|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83672964|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672965|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83672966|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672967|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83672968|NCT01583426|Paclitaxel|paclitaxel|mesh-list
83672969|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83672970|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83672971|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672972|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
83672973|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
83672974|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
83672975|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672976|NCT01583972|Vitamin A|vitamin a|mesh-list
83672977|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
83672978|NCT01583972|Vitamins|vitamins|mesh-ancestor
83672979|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
83672980|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672981|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
83672982|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83672983|NCT01583972|Protective Agents|protective agents|mesh-ancestor
83672984|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83672985|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83672986|NCT01584362|Oxfendazole|oxfendazole|mesh-list
83672987|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
83672988|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83672989|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83672990|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
83672991|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
83672992|NCT01584921|Hematinics|hematinics|mesh-ancestor
83672993|NCT01586013|Propofol|propofol|mesh-list
83672994|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83672995|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83672996|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83672997|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83672998|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
83672999|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
83673000|NCT01586845|Cyclosporine|cyclosporine|mesh-list
83673001|NCT01586845|Tacrolimus|tacrolimus|mesh-list
83673002|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673003|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
83673004|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673005|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83673006|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673007|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673008|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
83673009|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673010|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
83673011|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673012|NCT01587339|Pregabalin|pregabalin|mesh-list
83673013|NCT01587339|Zonisamide|zonisamide|mesh-list
83673014|NCT01587339|Lacosamide|lacosamide|mesh-list
83673015|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83673016|NCT01587339|Ezogabine|ezogabine|mesh-list
83673017|NCT01587339|Analgesics|analgesics|mesh-ancestor
83673018|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
83673019|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673020|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673021|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
83673022|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83673023|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673024|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673025|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83673026|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83673027|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83673028|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673029|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83673030|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83673031|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83673032|NCT01587378|Metformin|metformin|mesh-list
83673033|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673034|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673035|NCT01587482|Paclitaxel|paclitaxel|mesh-list
83673036|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83673037|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673038|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
83673039|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
83673040|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
83673041|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673042|NCT01587625|Oxytocin|oxytocin|mesh-list
83673043|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
83673044|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673045|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673046|NCT01587820|Cisplatin|cisplatin|mesh-list
83673047|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673048|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83673049|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83673050|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673051|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
83673052|NCT01588171|Enoxaparin|enoxaparin|mesh-list
83673053|NCT01588171|Bemiparin|bemiparin|mesh-list
83673054|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
83673055|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83673056|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83673057|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673058|NCT01588873|Desogestrel|desogestrel|mesh-list
83673059|NCT01588873|NuvaRing|nuvaring|mesh-list
83673060|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83673061|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83673062|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83673063|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
83673064|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673065|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673066|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83673067|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83673068|NCT01588873|Progestins|progestins|mesh-ancestor
83673069|NCT01588873|Hormones|hormones|mesh-ancestor
83673070|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673071|NCT01589367|Metformin|metformin|mesh-list
83673072|NCT01589367|Letrozole|letrozole|mesh-list
82827855|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
83673073|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673074|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673075|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673076|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83673077|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83673078|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673079|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673080|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83673081|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
83673082|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673083|NCT01589432|Lidocaine|lidocaine|mesh-list
83673084|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
83673085|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
83673086|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673087|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673088|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
83673089|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673090|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83673091|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83673092|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83673093|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673094|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673095|NCT01589614|Erythromycin|erythromycin|mesh-list
83673096|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
83673097|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83673098|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
83673099|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83673100|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673101|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83673102|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83673103|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673104|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673105|NCT01589861|Lapatinib|lapatinib|mesh-list
83673106|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673107|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83673108|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673109|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673110|NCT01590173|Prednisolone|prednisolone|mesh-list
83673111|NCT01590173|Heparin|heparin|mesh-list
83673112|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673113|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
83673114|NCT01590173|Hormones|hormones|mesh-ancestor
83673115|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673116|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673117|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83673118|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673119|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
83673120|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83673121|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83673122|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673123|NCT01590199|Everolimus|everolimus|mesh-list
83673124|NCT01590199|Pasireotide|pasireotide|mesh-list
83673125|NCT01590199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83673126|NCT01590199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83673127|NCT01590199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673128|NCT01590199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673129|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673130|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
83673131|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673132|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673133|NCT01590199|Hormones|hormones|mesh-ancestor
83673134|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673135|NCT01590225|Ribavirin|ribavirin|mesh-list
83673136|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83673137|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
83673138|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
83673139|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673140|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
83673141|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673142|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
83673143|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673144|NCT01590342|Diclofenac|diclofenac|mesh-list
83673145|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83673146|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82827928|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673147|NCT01590342|Analgesics|analgesics|mesh-ancestor
83673148|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
83673149|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673150|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673151|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673152|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673153|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83673154|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673155|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673156|NCT01590537|Copper|copper|mesh-list
83673157|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
83673158|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83673159|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
83673160|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673161|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673162|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83673163|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83673164|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83673165|NCT01590537|Trace Elements|trace elements|mesh-ancestor
83673166|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
83673167|NCT01590641|Vesatolimod|vesatolimod|mesh-list
83673168|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
83673169|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673170|NCT01590654|Vesatolimod|vesatolimod|mesh-list
83673171|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
83673172|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673173|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
83673174|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83673175|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83673176|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83673177|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673178|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673179|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
83673180|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673181|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673182|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83673183|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673184|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83673185|NCT01590732|Carboplatin|carboplatin|mesh-list
83673186|NCT01590732|Etoposide|etoposide|mesh-list
83673187|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
83673188|NCT01590732|Ifosfamide|ifosfamide|mesh-list
83673189|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
83673190|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
83673191|NCT01590732|Romidepsin|romidepsin|mesh-list
83673192|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673193|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83673194|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83673195|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83673196|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673197|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673198|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673199|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83673200|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
83673201|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
83673202|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
83673203|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
83673204|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
83673205|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
83673206|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83673207|NCT01590732|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83673208|NCT01590823|Dabigatran|dabigatran|mesh-list
83673209|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
83673210|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83673211|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
83673212|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673213|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673214|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
83673215|NCT01590836|Insulin|insulin|mesh-list
83673216|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83673217|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
83673218|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
83673219|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673220|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673221|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
83673222|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
83673223|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83673224|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673225|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673226|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83673227|NCT01590901|Probucol|probucol|mesh-list
83673228|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83673229|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83673230|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
83673231|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673232|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83673233|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
83673234|NCT01590901|Protective Agents|protective agents|mesh-ancestor
83673235|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673236|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
83673237|NCT01590966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83673238|NCT01590966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673239|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673240|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
83673241|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673242|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673243|NCT01591031|Sevoflurane|sevoflurane|mesh-list
83673244|NCT01591031|Rocuronium|rocuronium|mesh-list
83673245|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83673246|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83673247|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
83673248|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
83673249|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673250|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673251|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83673252|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83673253|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83673254|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673255|NCT01591070|Tacrolimus|tacrolimus|mesh-list
83673256|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673257|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
83673258|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673259|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83673260|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673261|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673262|NCT01591083|Esomeprazole|esomeprazole|mesh-list
83673263|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83673264|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83673265|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83673266|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673267|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673268|NCT01591122|Prednisone|prednisone|mesh-list
83673269|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
83673270|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673271|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
83673272|NCT01591122|Hormones|hormones|mesh-ancestor
83673273|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673274|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673275|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83673276|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673277|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83673278|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673279|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673280|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
83673281|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83673282|NCT01591135|Paclitaxel|paclitaxel|mesh-list
83673283|NCT01591135|Fluorouracil|fluorouracil|mesh-list
83673284|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83673285|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673286|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
83673287|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
83673288|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
83673289|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673290|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
83673291|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83673292|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673293|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
83673294|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673295|NCT01591148|Propofol|propofol|mesh-list
83673296|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83673297|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673298|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673299|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83673300|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
83673301|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
83673302|NCT01591226|Mannitol|mannitol|mesh-list
83673303|NCT01591226|Caffeine|caffeine|mesh-list
83673304|NCT01591226|Citric Acid|citric acid|mesh-list
83673305|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
83673306|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
83673307|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83673308|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
83673309|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
83673310|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673311|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83673312|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673313|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83673314|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673315|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83673316|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83673317|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
83673318|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673319|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83673320|NCT01591226|Diuretics|diuretics|mesh-ancestor
83673321|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
83673322|NCT01591421|Panitumumab|panitumumab|mesh-list
83673323|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83673324|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673325|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83673326|NCT01591434|Laxatives|laxatives|mesh-ancestor
83673327|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83673328|NCT01591551|Natalizumab|natalizumab|mesh-list
83673329|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
83673330|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673331|NCT01591668|Vesatolimod|vesatolimod|mesh-list
83673332|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
83673333|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673334|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83673335|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
83673336|NCT01591850|Ritonavir|ritonavir|mesh-list
83673337|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83673338|NCT01591850|Rifampin|rifampin|mesh-list
83673339|NCT01591850|Ketoconazole|ketoconazole|mesh-list
83673340|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83673341|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83673342|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83673343|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673344|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673345|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83673346|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83673347|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
83673348|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673349|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83673350|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83673351|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83673352|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
83673353|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83673354|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
83673355|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83673356|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83673357|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83673358|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83673359|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83673360|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83673361|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83673362|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
83673363|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83673364|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83673365|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
83673366|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673367|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673368|NCT01591889|Tinidazole|tinidazole|mesh-list
83673369|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
83673370|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673371|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83673372|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673373|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83673374|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83673375|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83673376|NCT01591902|Tesamorelin|tesamorelin|mesh-list
83673377|NCT01591902|Growth Substances|growth substances|mesh-ancestor
83673378|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673379|NCT01591980|Pregabalin|pregabalin|mesh-list
83673380|NCT01591980|Analgesics|analgesics|mesh-ancestor
83673381|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
83673382|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673383|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673384|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
83673385|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83673386|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673387|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673388|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83673389|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83673390|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83673391|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673392|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83673393|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83673394|NCT01592019|Diclofenac|diclofenac|mesh-list
83673395|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83673396|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83673397|NCT01592019|Analgesics|analgesics|mesh-ancestor
83673398|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
83673399|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673400|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673401|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673402|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673403|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83673404|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673405|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673406|NCT01592032|Vancomycin|vancomycin|mesh-list
83673407|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83673408|NCT01592032|Linezolid|linezolid|mesh-list
83673409|NCT01592032|Daptomycin|daptomycin|mesh-list
83673410|NCT01592032|Tigecycline|tigecycline|mesh-list
83673411|NCT01592032|Teicoplanin|teicoplanin|mesh-list
83673412|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
83673413|NCT01592032|Heparin|heparin|mesh-list
83673414|NCT01592032|Calcium heparin|calcium heparin|mesh-list
83673415|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83673416|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
83673417|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83673418|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83673419|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673420|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83673421|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673422|NCT01592136|Ponatinib|ponatinib|mesh-list
83673423|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673424|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83673425|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673426|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673427|NCT01592162|Remifentanil|remifentanil|mesh-list
83673428|NCT01592162|Propofol|propofol|mesh-list
83673429|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83673430|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673431|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673432|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83673433|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
83673434|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
83673435|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83673436|NCT01592162|Narcotics|narcotics|mesh-ancestor
83673437|NCT01592162|Analgesics|analgesics|mesh-ancestor
83673438|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
83673439|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673440|NCT01592201|Olanzapine|olanzapine|mesh-list
83673441|NCT01592201|Risperidone|risperidone|mesh-list
83673442|NCT01592201|Aripiprazole|aripiprazole|mesh-list
83673443|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
83673444|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83673445|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
83673446|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673447|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673448|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673449|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83673450|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673451|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83673452|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83673453|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
83673455|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
83673456|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673457|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83673458|NCT01592201|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83673459|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83673460|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673461|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
83673462|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
83673463|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83673464|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83673465|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83673466|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83673467|NCT01592214|Benzocaine|benzocaine|mesh-list
83673468|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
83673469|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
83673470|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673471|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673472|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
83673473|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673474|NCT01592227|Acetaminophen|acetaminophen|mesh-list
83673475|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83673476|NCT01592227|Analgesics|analgesics|mesh-ancestor
83673477|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
83673478|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673479|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673480|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
83673481|NCT01592253|Sirolimus|sirolimus|mesh-list
83673482|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83673483|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673484|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83673485|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673486|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
83673487|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673488|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
83673489|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673490|NCT01592279|Liraglutide|liraglutide|mesh-list
83673491|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673492|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673493|NCT01592279|Incretins|incretins|mesh-ancestor
83673494|NCT01592279|Hormones|hormones|mesh-ancestor
83673495|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673496|NCT01592305|Ritonavir|ritonavir|mesh-list
83673497|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83673498|NCT01592305|Tenofovir|tenofovir|mesh-list
83673499|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83673500|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83673501|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
83673502|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673503|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673504|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83673505|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83673506|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
83673507|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673508|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83673509|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83673510|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83673511|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83673512|NCT01592318|Ritonavir|ritonavir|mesh-list
83673513|NCT01592318|Lactams|lactams|mesh-list
83673514|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83673515|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83673516|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
83673517|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673518|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673519|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83673520|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83673521|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
83673522|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673523|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83673524|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83673525|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828303|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
83673526|NCT01592526|Nicotine|nicotine|mesh-list
83673527|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83673528|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
83673529|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673530|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673531|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83673532|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83673533|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
83673534|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673535|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673536|NCT01592630|Ropivacaine|ropivacaine|mesh-list
83673537|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
83673538|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
83673539|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673540|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673541|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
83673542|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673543|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
83673544|NCT01592981|Rituximab|rituximab|mesh-list
83673545|NCT01592981|Fludarabine|fludarabine|mesh-list
83673546|NCT01592981|Bortezomib|bortezomib|mesh-list
83673547|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673548|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
83673549|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673550|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673551|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83673552|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
83673553|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673554|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673555|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83673556|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83673557|NCT01593033|Micronutrients|micronutrients|mesh-list
83673558|NCT01593033|Trace Elements|trace elements|mesh-list
83673559|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673560|NCT01593046|Cabotegravir|cabotegravir|mesh-list
83673561|NCT01593046|Rilpivirine|rilpivirine|mesh-list
83673562|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83673563|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83673564|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673565|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673566|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83673567|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83673568|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
83673569|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673570|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83673571|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83673572|NCT01593124|Imiquimod|imiquimod|mesh-list
83673573|NCT01593124|Nonoxynol|nonoxynol|mesh-list
83673574|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83673575|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
83673576|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673577|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673578|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
83673579|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83673580|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83673581|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83673582|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
83673583|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673584|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83673585|NCT01593137|Metformin|metformin|mesh-list
83673586|NCT01593137|Liraglutide|liraglutide|mesh-list
83673587|NCT01593137|Glimepiride|glimepiride|mesh-list
83673588|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673589|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673590|NCT01593137|Incretins|incretins|mesh-ancestor
83673591|NCT01593137|Hormones|hormones|mesh-ancestor
83673592|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673593|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83673594|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673595|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
83673596|NCT01593150|Dabigatran|dabigatran|mesh-list
83673597|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
83673598|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83673599|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
83673600|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673601|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673602|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
83673603|NCT01593163|Ibuprofen|ibuprofen|mesh-list
83673604|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83673605|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83673606|NCT01593163|Analgesics|analgesics|mesh-ancestor
83673607|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
83673608|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673609|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673610|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673611|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673612|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83673613|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673614|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673615|NCT01593280|Morphine|morphine|mesh-list
83673616|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83673617|NCT01593280|Narcotics|narcotics|mesh-ancestor
83673618|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673619|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673620|NCT01593280|Analgesics|analgesics|mesh-ancestor
83673621|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
83673622|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673623|NCT01593293|Pemetrexed|pemetrexed|mesh-list
83673624|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673625|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673626|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673627|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83673628|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83673629|NCT01593306|Paclitaxel|paclitaxel|mesh-list
83673630|NCT01593306|Cisplatin|cisplatin|mesh-list
83673631|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83673632|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673633|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
83673634|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
83673635|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
83673636|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673637|NCT01593319|Ropivacaine|ropivacaine|mesh-list
83673638|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
83673639|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
83673640|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673641|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673642|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
83673643|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673644|NCT01593332|Rituximab|rituximab|mesh-list
83673645|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83673646|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673647|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
83673648|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673649|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673650|NCT01593371|Metformin|metformin|mesh-list
83673651|NCT01593371|Pioglitazone|pioglitazone|mesh-list
83673652|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673653|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673654|NCT01593397|Fentanyl|fentanyl|mesh-list
83673655|NCT01593397|Propofol|propofol|mesh-list
83673656|NCT01593397|Anesthetics|anesthetics|mesh-list
83673657|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83673658|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673659|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673660|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83673661|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
83673662|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83673663|NCT01593397|Narcotics|narcotics|mesh-ancestor
83673664|NCT01593397|Analgesics|analgesics|mesh-ancestor
83673665|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
83673666|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673667|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83673668|NCT01593410|Dexamethasone|dexamethasone|mesh-list
83673669|NCT01593410|Lenalidomide|lenalidomide|mesh-list
83673670|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673671|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
83673672|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
83673673|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673674|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673675|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83673676|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
82828452|NCT00329238|Dabigatran|dabigatran|mesh-list
82828468|NCT00328926|Hormones|hormones|mesh-list
83673677|NCT01593410|Hormones|hormones|mesh-ancestor
83673678|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673679|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83673680|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673681|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
83673682|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83673683|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83673684|NCT01593410|Growth Substances|growth substances|mesh-ancestor
83673685|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
83673686|NCT01593501|Vitamin D|vitamin d|mesh-list
83673687|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
83673688|NCT01593501|Vitamins|vitamins|mesh-ancestor
83673689|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
83673690|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673691|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83673692|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83673693|NCT01593514|Lactitol|lactitol|mesh-list
83673694|NCT01593514|Vaccines|vaccines|mesh-list
83673695|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
83673696|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673697|NCT01593514|Cathartics|cathartics|mesh-ancestor
83673698|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83673699|NCT01593566|Bupivacaine|bupivacaine|mesh-list
83673700|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
83673701|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
83673702|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673703|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673704|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
83673705|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673706|NCT01593605|Resveratrol|resveratrol|mesh-list
83673707|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
83673708|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673709|NCT01593605|Protective Agents|protective agents|mesh-ancestor
83673710|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673711|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673712|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83673713|NCT01593644|Adenosine|adenosine|mesh-list
83673714|NCT01593644|Dipyridamole|dipyridamole|mesh-list
83673715|NCT01593644|Analgesics|analgesics|mesh-ancestor
83673716|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
83673717|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673718|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673719|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83673720|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
83673721|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83673722|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
83673723|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
83673724|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673725|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673726|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83673727|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673728|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83673729|NCT01593774|Melatonin|melatonin|mesh-list
83673730|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
83673731|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673732|NCT01593774|Protective Agents|protective agents|mesh-ancestor
83673733|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673734|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673735|NCT01593826|Budesonide|budesonide|mesh-list
83673736|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
83673737|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83673738|NCT01593826|Charcoal|charcoal|mesh-list
83673739|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673740|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83673741|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
83673742|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673743|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673744|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83673745|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
83673746|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
83673747|NCT01593826|Hormones|hormones|mesh-ancestor
83673748|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673749|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83673750|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83673751|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83673752|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
82828525|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
83673753|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673754|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673755|NCT01593826|Antidotes|antidotes|mesh-ancestor
83673756|NCT01593826|Protective Agents|protective agents|mesh-ancestor
83673757|NCT01593930|Lidocaine|lidocaine|mesh-list
83673758|NCT01593930|Carticaine|carticaine|mesh-list
83673759|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
83673760|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
83673761|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673762|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673763|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
83673764|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673765|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83673766|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83673767|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83673768|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673769|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673770|NCT01593995|Mitogens|mitogens|mesh-list
83673771|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
83673772|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673773|NCT01594047|Ketamine|ketamine|mesh-list
83673774|NCT01594047|Methadone|methadone|mesh-list
83673775|NCT01594047|Analgesics|analgesics|mesh-ancestor
83673776|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
83673777|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673778|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673779|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83673780|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83673781|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
83673782|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
83673783|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83673784|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83673785|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83673786|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673787|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673788|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83673789|NCT01594047|Narcotics|narcotics|mesh-ancestor
83673790|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
83673791|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83673792|NCT01594060|Insulin|insulin|mesh-list
83673793|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83673794|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
83673795|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
83673796|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673797|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673798|NCT01594099|Paclitaxel|paclitaxel|mesh-list
83673799|NCT01594099|Cisplatin|cisplatin|mesh-list
83673800|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83673801|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673802|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
83673803|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
83673804|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
83673805|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673806|NCT01594177|Paclitaxel|paclitaxel|mesh-list
83673807|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
83673808|NCT01594177|Trastuzumab|trastuzumab|mesh-list
83673809|NCT01594177|Epirubicin|epirubicin|mesh-list
83673810|NCT01594177|Afatinib|afatinib|mesh-list
83673811|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83673812|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673813|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83673814|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83673815|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83673816|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673817|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673818|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
83673819|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673820|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673821|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83673822|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
83673823|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83673824|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83673825|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83673826|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83673827|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83673828|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673829|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83673831|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83673832|NCT01594229|Venetoclax|venetoclax|mesh-list
83673833|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83673834|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673835|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
83673836|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673837|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83673838|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83673839|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
83673840|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673841|NCT01594242|Bortezomib|bortezomib|mesh-list
83673842|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673843|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
83673844|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83673845|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673846|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83673847|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83673848|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673849|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673850|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673851|NCT01594268|Everolimus|everolimus|mesh-list
83673852|NCT01594268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83673853|NCT01594268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83673854|NCT01594268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673855|NCT01594268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673856|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673857|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
83673858|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673859|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673860|NCT01594346|Vitamin E|vitamin e|mesh-list
83673861|NCT01594346|Tocopherols|tocopherols|mesh-list
83673862|NCT01594346|Tocotrienols|tocotrienols|mesh-list
83673863|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
83673864|NCT01594346|Vitamins|vitamins|mesh-ancestor
83673865|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
83673866|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673867|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
83673868|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673869|NCT01594346|Protective Agents|protective agents|mesh-ancestor
83673870|NCT01594489|Aminophylline|aminophylline|mesh-list
83673871|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83673872|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
83673873|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673874|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673875|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83673876|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
83673877|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83673878|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83673879|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673880|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673881|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83673882|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83673883|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
83673884|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673885|NCT01594489|Protective Agents|protective agents|mesh-ancestor
83673886|NCT01594502|Dutasteride|dutasteride|mesh-list
83673887|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83673888|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83673889|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673890|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673891|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
83673892|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673893|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673894|NCT01594619|Diltiazem|diltiazem|mesh-list
83673895|NCT01594619|Naloxegol|naloxegol|mesh-list
83673896|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83673897|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83673898|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673899|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673900|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83673901|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673902|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
83673903|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83673904|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
83673905|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673906|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
83673907|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83673908|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83673909|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673910|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
83673911|NCT01594671|Coagulants|coagulants|mesh-ancestor
83673912|NCT01594697|Metformin|metformin|mesh-list
83673913|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83673914|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673915|NCT01594775|Oxytocin|oxytocin|mesh-list
83673916|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
83673917|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673918|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673919|NCT01594866|Dexetimide|dexetimide|mesh-list
83673920|NCT01594866|Citalopram|citalopram|mesh-list
83673921|NCT01594866|Escitalopram|escitalopram|mesh-list
83673922|NCT01594866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83673923|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83673924|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83673925|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673926|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673927|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
83673928|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673929|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83673930|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83673931|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
83673932|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
83673933|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673934|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83673935|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83673936|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
83673937|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83673938|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
83673939|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83673940|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
83673941|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83673942|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
83673943|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673944|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673945|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83673946|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83673947|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83673948|NCT01594905|Tenofovir|tenofovir|mesh-list
83673949|NCT01594905|Entecavir|entecavir|mesh-list
83673950|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
83673951|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83673952|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83673953|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83673954|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673955|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673956|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83673957|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83673958|NCT01594918|Prednisone|prednisone|mesh-list
83673959|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
83673960|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83673961|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
83673962|NCT01594918|Hormones|hormones|mesh-ancestor
83673963|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83673964|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673965|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83673966|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673967|NCT01594918|Analgesics|analgesics|mesh-ancestor
83673968|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
83673969|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83673970|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83673971|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83673972|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673973|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673974|NCT01595009|Everolimus|everolimus|mesh-list
83673975|NCT01595009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83673976|NCT01595009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83673977|NCT01595009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83673978|NCT01595009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673979|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83673980|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
83673981|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673982|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83673983|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
83673984|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
83673985|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83673986|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673987|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83673988|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83673989|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83673990|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83673991|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
83673992|NCT01595152|Fesoterodine|fesoterodine|mesh-list
83673993|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83673994|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83673995|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
83673996|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83673997|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83673998|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83673999|NCT01595152|Urological Agents|urological agents|mesh-ancestor
83674000|NCT01595334|Cetrorelix|cetrorelix|mesh-list
83674001|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83674002|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
83674003|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674004|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674005|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
83674006|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674007|NCT01595399|Atropine|atropine|mesh-list
83674008|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83674009|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83674010|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83674011|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
83674012|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674013|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674014|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83674015|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
83674016|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
83410442|NCT02058693|Adderall|adderall|mesh-list
83674017|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
83674018|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83674019|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83674020|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
83674021|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674022|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674023|NCT01595425|Esomeprazole|esomeprazole|mesh-list
83674024|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83674025|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674026|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83674027|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674028|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674029|NCT01595594|Doxycycline|doxycycline|mesh-list
83674030|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83674031|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674032|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
83674033|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83674034|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83674035|NCT01595633|Tenofovir|tenofovir|mesh-list
83674036|NCT01595633|Adefovir|adefovir|mesh-list
83674037|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
83674038|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674039|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83674040|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83674041|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674042|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674043|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83674044|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83674045|NCT01595685|Entecavir|entecavir|mesh-list
83674046|NCT01595685|Telbivudine|telbivudine|mesh-list
83674047|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
83674048|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674049|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83674050|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674051|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674052|NCT01595724|Dienogest|dienogest|mesh-list
82828824|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83674053|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83674054|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
83674055|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674056|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674057|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83674058|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83674059|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83674060|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83674061|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
83674062|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674063|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83674064|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674065|NCT01595737|Simendan|simendan|mesh-list
83674066|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83674067|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
83674068|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83674069|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83674070|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674071|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674072|NCT01595737|Protective Agents|protective agents|mesh-ancestor
83674073|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674074|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
83674075|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83674076|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83674077|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674078|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
83674079|NCT01595763|Coagulants|coagulants|mesh-ancestor
83674080|NCT01595789|Liraglutide|liraglutide|mesh-list
83674081|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83674082|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674083|NCT01595789|Incretins|incretins|mesh-ancestor
83674084|NCT01595789|Hormones|hormones|mesh-ancestor
83674085|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674086|NCT01595815|Calcium|calcium|mesh-list
83674087|NCT01595815|Ionophores|ionophores|mesh-list
83674088|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
83674089|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83674090|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674091|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83674092|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674093|NCT01595828|Pitavastatin|pitavastatin|mesh-list
83674094|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83674095|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83674096|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83674097|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
83674098|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674099|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674100|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83674101|NCT01595867|Naltrexone|naltrexone|mesh-list
83674102|NCT01595867|Morphine|morphine|mesh-list
83674103|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83674104|NCT01595867|Narcotics|narcotics|mesh-ancestor
83674105|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674106|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674107|NCT01595867|Analgesics|analgesics|mesh-ancestor
83674108|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
83674109|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674110|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83674111|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83674112|NCT01595880|Metformin|metformin|mesh-list
83674113|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83674114|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674115|NCT01595893|Vitamin D|vitamin d|mesh-list
83674116|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
83674117|NCT01595893|Vitamins|vitamins|mesh-ancestor
83674118|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
83674119|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674120|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83674121|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83674122|NCT01595958|Cyclosporine|cyclosporine|mesh-list
83674123|NCT01595958|Cyclosporins|cyclosporins|mesh-list
83674124|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674125|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674126|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828904|NCT01063842|Acetaminophen|acetaminophen|mesh-list
83674127|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
83674128|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674129|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
83674130|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674131|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
83674132|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674133|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83674134|NCT01595984|Cyclosporine|cyclosporine|mesh-list
83674135|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
83674136|NCT01595984|Everolimus|everolimus|mesh-list
83674137|NCT01595984|Cyclosporins|cyclosporins|mesh-list
83674138|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674139|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674140|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83674141|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
83674142|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674143|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
83674144|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674145|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
83674146|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674147|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83674148|NCT01595984|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83674149|NCT01595984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83674150|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674151|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83674152|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83674153|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
83674154|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83674155|NCT01596010|Norethindrone|norethindrone|mesh-list
83674156|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
83674157|NCT01596010|Estradiol|estradiol|mesh-list
83674158|NCT01596010|Estrogens|estrogens|mesh-ancestor
83674159|NCT01596010|Hormones|hormones|mesh-ancestor
83674160|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674161|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674162|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83674163|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
83674164|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674165|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83674166|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83674167|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83674168|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83674169|NCT01596075|Cannabidiol|cannabidiol|mesh-list
83674170|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
83674171|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
83674172|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
83674173|NCT01596114|Protective Agents|protective agents|mesh-ancestor
83674174|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674175|NCT01596140|Sirolimus|sirolimus|mesh-list
83674176|NCT01596140|Everolimus|everolimus|mesh-list
83674177|NCT01596140|Temsirolimus|temsirolimus|mesh-list
83674178|NCT01596140|MTOR Inhibitors|mtor inhibitors|mesh-list
83674179|NCT01596140|Vemurafenib|vemurafenib|mesh-list
83674180|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83674181|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674182|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674183|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83674184|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
83674185|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674186|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674187|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83674188|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674189|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83674190|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
83674191|NCT01596166|Ketorolac|ketorolac|mesh-list
83674192|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83674193|NCT01596166|Metoclopramide|metoclopramide|mesh-list
83674194|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83674195|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674196|NCT01596166|Analgesics|analgesics|mesh-ancestor
83674197|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
83674198|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828975|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828980|NCT01057160|Rizatriptan|rizatriptan|mesh-list
83674199|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674200|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674201|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674202|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83674203|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674204|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674205|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
83674206|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
83674207|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674208|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83674209|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83674210|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
83674211|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674212|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83674213|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83674214|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674215|NCT01596218|Immunotoxins|immunotoxins|mesh-ancestor
83674216|NCT01596218|Immunoconjugates|immunoconjugates|mesh-ancestor
83674217|NCT01596218|Immunologic Factors|immunologic factors|mesh-ancestor
83674218|NCT01596218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674219|NCT01596296|Dinoprostone|dinoprostone|mesh-list
83674220|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
83674221|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674222|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674223|NCT01596387|Propofol|propofol|mesh-list
83674224|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83674225|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674226|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674227|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83674228|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
83674229|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
83674230|NCT01596400|Granisetron|granisetron|mesh-list
83674231|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
83674232|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
83674233|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674234|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674235|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674236|NCT01596400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83674237|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83674238|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
83674239|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674240|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674241|NCT01596413|Granisetron|granisetron|mesh-list
83674242|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
83674243|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
83674244|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674245|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674246|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674247|NCT01596413|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83674248|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83674249|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
83674250|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674251|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674252|NCT01596426|Granisetron|granisetron|mesh-list
83674253|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
83674254|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
83674255|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674256|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674257|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674258|NCT01596426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83674259|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83674260|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
83674261|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674262|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674263|NCT01596517|Ribavirin|ribavirin|mesh-list
83674264|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83674265|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
83674266|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
83674267|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674268|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
83674269|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674270|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
83674271|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674272|NCT01596556|Nicotine|nicotine|mesh-list
83674273|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83674274|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
83674275|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674276|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674277|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83674278|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83674280|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674281|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674282|NCT01596634|Lactoferrin|lactoferrin|mesh-list
83674283|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674284|NCT01596647|Diclofenac|diclofenac|mesh-list
83674285|NCT01596647|Midazolam|midazolam|mesh-list
83674286|NCT01596647|Caffeine|caffeine|mesh-list
83674287|NCT01596647|Omeprazole|omeprazole|mesh-list
83674288|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83674289|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83674290|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674291|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674292|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83674293|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83674294|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83674295|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83674296|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
83674297|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
83674298|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
83674299|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
83674300|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674301|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674302|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83674303|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83674304|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674305|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83674306|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83674307|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
83674308|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83674309|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674310|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83674311|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83674312|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674313|NCT01596647|Analgesics|analgesics|mesh-ancestor
83674314|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
83674315|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674316|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674317|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674318|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83674319|NCT01596660|Bupivacaine|bupivacaine|mesh-list
83674320|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
83674321|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
83674322|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674323|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674324|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
83674325|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674326|NCT01596673|Hydrocodone|hydrocodone|mesh-list
83674327|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83674328|NCT01596673|Narcotics|narcotics|mesh-ancestor
83674329|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674330|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674331|NCT01596673|Analgesics|analgesics|mesh-ancestor
83674332|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
83674333|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674334|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
83674335|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
83674336|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
83674337|NCT01596686|Cathartics|cathartics|mesh-ancestor
83674338|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674339|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
83674340|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83674341|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83674342|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674343|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
83674344|NCT01596738|Coagulants|coagulants|mesh-ancestor
83674345|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
83674346|NCT01596764|Naloxone|naloxone|mesh-list
83674347|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
83674348|NCT01596764|Loperamide|loperamide|mesh-list
83674349|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
83674350|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83674351|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674352|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
83674353|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674354|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674355|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674356|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83674357|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674358|NCT01596764|Analgesics|analgesics|mesh-ancestor
83674359|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674360|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674361|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
83674362|NCT01596777|Naltrexone|naltrexone|mesh-list
83674363|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
83674364|NCT01596777|Loperamide|loperamide|mesh-list
83674365|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
83674366|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674367|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674368|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83674369|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674370|NCT01596777|Analgesics|analgesics|mesh-ancestor
83674371|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
83674372|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674373|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674374|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674375|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674376|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83674377|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83674378|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
83674379|NCT01596803|Vitamin E|vitamin e|mesh-list
83674380|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
83674381|NCT01596803|Tocopherols|tocopherols|mesh-list
83674382|NCT01596803|Antioxidants|antioxidants|mesh-list
83674383|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674384|NCT01596803|Protective Agents|protective agents|mesh-ancestor
83674385|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674386|NCT01596803|Vitamins|vitamins|mesh-ancestor
83674387|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
83674388|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
83674389|NCT01596855|Hematinics|hematinics|mesh-ancestor
83674390|NCT01596868|Cisplatin|cisplatin|mesh-list
83674391|NCT01596868|Gemcitabine|gemcitabine|mesh-list
83674392|NCT01596868|Docetaxel|docetaxel|mesh-list
83674393|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674394|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83674395|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
83674396|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674397|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
83674398|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
83674399|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
83674400|NCT01596894|Azithromycin|azithromycin|mesh-list
83674401|NCT01596894|Metronidazole|metronidazole|mesh-list
83674402|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83674403|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674404|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83674405|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83674406|NCT01596907|Ephedrine|ephedrine|mesh-list
83674407|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
83674408|NCT01596907|Caffeine|caffeine|mesh-list
83674409|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83674410|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674411|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83674412|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674413|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674414|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83674415|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83674416|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
83674417|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674418|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
83674419|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
83674420|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674421|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83674422|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
83674423|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83674424|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83674425|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
83674426|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
83674427|NCT01596998|Epinephrine|epinephrine|mesh-list
83674428|NCT01596998|Racepinephrine|racepinephrine|mesh-list
83674429|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
83674430|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
83674431|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82829201|NCT00324038|Acetaminophen|acetaminophen|mesh-list
83674432|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83674433|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
83674434|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674435|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674436|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674437|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83674438|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83674439|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
83674440|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674441|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83674442|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
83674443|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
83674444|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
83674445|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83674446|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
83674447|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
83674448|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674449|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
83674450|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83674451|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
83674452|NCT01597011|Coagulants|coagulants|mesh-ancestor
83674453|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
83674454|NCT01597167|Analgesics|analgesics|mesh-ancestor
83674455|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
83674456|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674457|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674458|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
83674459|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674460|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83674461|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
83674462|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83674463|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83674464|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674465|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83674466|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
83674467|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674468|NCT01597206|Cobalt|cobalt|mesh-list
83674469|NCT01597206|Trace Elements|trace elements|mesh-ancestor
83674470|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
83674471|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674472|NCT01597232|Chrysarobin|chrysarobin|mesh-list
83674473|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83674474|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674475|NCT01597232|Analgesics|analgesics|mesh-ancestor
83674476|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
83674477|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674478|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674479|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674480|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674481|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
83674482|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83674483|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83674484|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674485|NCT01597310|Pramipexole|pramipexole|mesh-list
83674486|NCT01597310|Warfarin|warfarin|mesh-list
83674487|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
83674488|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
83674489|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674490|NCT01597310|Protective Agents|protective agents|mesh-ancestor
83674491|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674492|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83674493|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83674494|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
83674495|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
83674496|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674497|NCT01597336|Plasminogen|plasminogen|mesh-list
83674498|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83674499|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83674500|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83674501|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674502|NCT01597427|Clonidine|clonidine|mesh-list
83674503|NCT01597427|Analgesics|analgesics|mesh-ancestor
83674504|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
83674505|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674506|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829273|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674507|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83674508|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
83674509|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
83674510|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83674511|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83674512|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83674513|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
83674514|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674515|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674516|NCT01597518|Riluzole|riluzole|mesh-list
83674517|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
83674518|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83674519|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83674520|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674521|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674522|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674523|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83674524|NCT01597518|Protective Agents|protective agents|mesh-ancestor
83674525|NCT01597531|Liraglutide|liraglutide|mesh-list
83674526|NCT01597531|Orlistat|orlistat|mesh-list
83674527|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83674528|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674529|NCT01597531|Incretins|incretins|mesh-ancestor
83674530|NCT01597531|Hormones|hormones|mesh-ancestor
83674531|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674532|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674533|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674534|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83674535|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83674536|NCT01597609|Sibutramine|sibutramine|mesh-list
83674537|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
83674538|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83674539|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
83674540|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83674541|NCT01597648|Maraviroc|maraviroc|mesh-list
83674542|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83674543|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83674544|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83674545|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674546|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83674547|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83674548|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
83674549|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674550|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83674551|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83674552|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83674553|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674554|NCT01597661|Bupropion|bupropion|mesh-list
83674555|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
83674556|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83674557|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83674558|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83674559|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83674560|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83674561|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674562|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
83674563|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674564|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674565|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83674566|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83674567|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674568|NCT01597700|Ezetimibe|ezetimibe|mesh-list
83674569|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83674570|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83674571|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
83674572|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674573|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83674574|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
83674575|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83674576|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674577|NCT01597726|Misoprostol|misoprostol|mesh-list
83674578|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83674579|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
83674580|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674581|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829346|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674582|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83674583|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674584|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
83674585|NCT01597765|Vitamins|vitamins|mesh-list
83674586|NCT01597765|Vitamin E|vitamin e|mesh-list
83674587|NCT01597765|Tocopherols|tocopherols|mesh-list
83674588|NCT01597765|Tocotrienols|tocotrienols|mesh-list
83674589|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
83674590|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
83674591|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83674592|NCT01597765|Deferiprone|deferiprone|mesh-list
83674593|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
83674594|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674595|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
83674596|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674597|NCT01597765|Expectorants|expectorants|mesh-ancestor
83674598|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83674599|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83674600|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
83674601|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674602|NCT01597765|Protective Agents|protective agents|mesh-ancestor
83674603|NCT01597765|Antidotes|antidotes|mesh-ancestor
83674604|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83674605|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
83674606|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
83674607|NCT01597817|Chitosan|chitosan|mesh-list
83674608|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83674609|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83674610|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
83674611|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674612|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83674613|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
83674614|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
83674615|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
83674616|NCT01597817|Coagulants|coagulants|mesh-ancestor
83674617|NCT01597895|Maraviroc|maraviroc|mesh-list
83674618|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83674619|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83674620|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674621|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83674622|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83674623|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
83674624|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674625|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83674626|NCT01597934|Tenofovir|tenofovir|mesh-list
83674627|NCT01597934|Entecavir|entecavir|mesh-list
83674628|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83674629|NCT01597934|Adefovir|adefovir|mesh-list
83674630|NCT01597934|Lamivudine|lamivudine|mesh-list
83674631|NCT01597934|Telbivudine|telbivudine|mesh-list
83674632|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
83674633|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674634|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83674635|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83674636|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674637|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674638|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83674639|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83674640|NCT01597986|Isavuconazole|isavuconazole|mesh-list
83674641|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83674642|NCT01597986|Norethindrone|norethindrone|mesh-list
83674643|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
83674644|NCT01597986|Norinyl|norinyl|mesh-list
83674645|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
83674646|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
83674647|NCT01597986|Estradiol|estradiol|mesh-list
83674648|NCT01597986|Estrogens|estrogens|mesh-ancestor
83674649|NCT01597986|Hormones|hormones|mesh-ancestor
83674650|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674651|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674652|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83674653|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674654|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83674655|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83674656|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83674657|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
83674658|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674659|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83674660|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
83674661|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83674662|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674663|NCT01598012|Analgesics|analgesics|mesh-ancestor
83674664|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
83674665|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674666|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674667|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674668|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674669|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83674670|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674671|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674672|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
83674673|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83674674|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
83674675|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83674676|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
83674677|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674678|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674679|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
83674680|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
83674681|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83674682|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
83674683|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83674684|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
83674685|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674686|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674687|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
83674688|NCT01598259|Melatonin|melatonin|mesh-list
83674689|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
83674690|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674691|NCT01598259|Protective Agents|protective agents|mesh-ancestor
83674692|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674693|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674694|NCT01598337|Aspirin|aspirin|mesh-list
83674695|NCT01598337|Tirofiban|tirofiban|mesh-list
83674696|NCT01598337|Clopidogrel|clopidogrel|mesh-list
83674697|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83674698|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83674699|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674700|NCT01598337|Analgesics|analgesics|mesh-ancestor
83674701|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
83674702|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674703|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674704|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674705|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674706|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83674707|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83674708|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674709|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83674710|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83674711|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674712|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
83674713|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83674714|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83674715|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83674716|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
83674717|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674718|NCT01598363|Digoxin|digoxin|mesh-list
83674719|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83674720|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83674721|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83674722|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
83674723|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674724|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83674725|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83674726|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674727|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83674728|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83674729|NCT01598363|Protective Agents|protective agents|mesh-ancestor
83674730|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674731|NCT01598402|Amoxicillin|amoxicillin|mesh-list
83674732|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
83674733|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
83674734|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82829495|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674735|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674736|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674737|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674738|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83674739|NCT01598441|Iloprost|iloprost|mesh-list
83674740|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83674741|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
83674742|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
83674743|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83674744|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83674745|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83674746|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
83674747|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83674748|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83674749|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83674750|NCT01598558|Rituximab|rituximab|mesh-list
83674751|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83674752|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674753|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
83674754|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674755|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674756|NCT01598584|Gemcitabine|gemcitabine|mesh-list
83674757|NCT01598584|Mirtazapine|mirtazapine|mesh-list
83674758|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83674759|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
83674760|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674761|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674762|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
83674763|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83674764|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83674765|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
83674766|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
83674767|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674768|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674769|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83674770|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83674771|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674772|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83674773|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83674774|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83674775|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83674776|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83674777|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83674778|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
83674779|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83674780|NCT01598623|Oxytocin|oxytocin|mesh-list
83674781|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
83674782|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83674783|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674784|NCT01598649|Mannitol|mannitol|mesh-list
83674785|NCT01598649|Caseins|caseins|mesh-list
83674786|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83674787|NCT01598649|Diuretics|diuretics|mesh-ancestor
83674788|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
83674789|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674790|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
83674791|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
83674792|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674793|NCT01598675|Methamphetamine|methamphetamine|mesh-list
83674794|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83674795|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674796|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
83674797|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
83674798|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674799|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
83674800|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674801|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674802|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
83674803|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83674804|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83674805|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83674806|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83674807|NCT01598883|Heparin|heparin|mesh-list
83674808|NCT01598883|Calcium heparin|calcium heparin|mesh-list
83674809|NCT01598883|Antithrombins|antithrombins|mesh-list
83674810|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
83674811|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83674812|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83674813|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674814|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83674815|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
83674816|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674818|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83674819|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83674820|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
83674821|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674822|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83674823|NCT01599000|Lumefantrine|lumefantrine|mesh-list
83674824|NCT01599000|Artemether|artemether|mesh-list
83674825|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83674826|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
83674827|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83674828|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83674829|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674830|NCT01599013|Carboplatin|carboplatin|mesh-list
83674831|NCT01599013|Gemcitabine|gemcitabine|mesh-list
83674832|NCT01599013|Vinblastine|vinblastine|mesh-list
83674833|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674834|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83674835|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
83674836|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674837|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83674838|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83674839|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83674840|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83674841|NCT01599078|Paclitaxel|paclitaxel|mesh-list
83674842|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83674843|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674844|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
83674845|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
83674846|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
83674847|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674848|NCT01599117|Udenafil|udenafil|mesh-list
83674849|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83674850|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83674851|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674852|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674853|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83674854|NCT01599130|Entecavir|entecavir|mesh-list
83674855|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
83674856|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674857|NCT01599273|Triamcinolone|triamcinolone|mesh-list
83674858|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674859|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
83674860|NCT01599273|Hormones|hormones|mesh-ancestor
83674861|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674862|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674863|NCT01599312|Cobalt|cobalt|mesh-list
83674864|NCT01599312|Trace Elements|trace elements|mesh-ancestor
83674865|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
83674866|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674867|NCT01599338|Liraglutide|liraglutide|mesh-list
83674868|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83674869|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674870|NCT01599338|Incretins|incretins|mesh-ancestor
83674871|NCT01599338|Hormones|hormones|mesh-ancestor
83674872|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674873|NCT01599364|Ritonavir|ritonavir|mesh-list
83674874|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83674875|NCT01599364|Lamivudine|lamivudine|mesh-list
83674876|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83674877|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83674878|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
83674879|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674880|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674881|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83674882|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83674883|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
83674884|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83674885|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83674886|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83674887|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83674889|NCT01599377|Tofacitinib|tofacitinib|mesh-list
83674890|NCT01599377|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83674891|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83674892|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674893|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674894|NCT05691088|Acetaminophen|acetaminophen|mesh-list
83674895|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83674896|NCT05691088|Analgesics|analgesics|mesh-ancestor
83674897|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
83674898|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674899|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674900|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
83674901|NCT05691010|Paclitaxel|paclitaxel|mesh-list
83674902|NCT05691010|Carboplatin|carboplatin|mesh-list
83674903|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83674904|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674905|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83674906|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83674907|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83674908|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674909|NCT05690802|Palonosetron|palonosetron|mesh-list
83674910|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
83674911|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
83674912|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674913|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674914|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674915|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83674916|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83674917|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
83674918|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83674919|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674920|NCT05690321|Opium|opium|mesh-list
83674921|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83674922|NCT05690321|Narcotics|narcotics|mesh-ancestor
83674923|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83674924|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674925|NCT05690321|Analgesics|analgesics|mesh-ancestor
83674926|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
83674927|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674928|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
83674929|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83674930|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
83674931|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
83674932|NCT05690191|Rituximab|rituximab|mesh-list
83674933|NCT05690191|Lenalidomide|lenalidomide|mesh-list
83674934|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83674935|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674936|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
83674937|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674938|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83674939|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83674940|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83674941|NCT05690191|Growth Substances|growth substances|mesh-ancestor
83674942|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
83674943|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83674944|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83674945|NCT05689983|Budesonide|budesonide|mesh-list
83674946|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
83674947|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83674948|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83674949|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
83674950|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674951|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674952|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83674953|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
83674954|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
83674955|NCT05689983|Hormones|hormones|mesh-ancestor
83674956|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83674957|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83674958|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83674959|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83674960|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
83674961|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829729|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
83674962|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674963|NCT05689957|Rocuronium|rocuronium|mesh-list
83674964|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83674965|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83674966|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83674967|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83674968|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674969|NCT05689671|Paclitaxel|paclitaxel|mesh-list
83674970|NCT05689671|Carboplatin|carboplatin|mesh-list
83674971|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
83674972|NCT05689671|Pemetrexed|pemetrexed|mesh-list
83674973|NCT05689671|Atezolizumab|atezolizumab|mesh-list
83674974|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83674975|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674976|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83674977|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83674978|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83674979|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83674980|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83674981|NCT05689671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83674982|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83674983|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83674984|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83674985|NCT05689632|Vitamin D|vitamin d|mesh-list
83674986|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
83674987|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
83674988|NCT05689632|Vitamins|vitamins|mesh-list
83674989|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
83674990|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674991|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83674992|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83674993|NCT05689619|Silybin|silybin|mesh-list
83674994|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83674995|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83674996|NCT05689619|Protective Agents|protective agents|mesh-ancestor
83674997|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83674998|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
83674999|NCT05689242|Nalbuphine|nalbuphine|mesh-list
83675000|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83675001|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675002|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675003|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83675004|NCT05689242|Analgesics|analgesics|mesh-ancestor
83675005|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
83675006|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675007|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83675008|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83675009|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83675010|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
83675011|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675012|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675013|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83675014|NCT05689242|Narcotics|narcotics|mesh-ancestor
83675015|NCT05689229|Colistin|colistin|mesh-list
83675016|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675017|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675018|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83675019|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83675020|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675021|NCT05688046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675022|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675023|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83675024|NCT05688046|Growth Substances|growth substances|mesh-ancestor
83675025|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675026|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
83675027|NCT05646563|Eculizumab|eculizumab|mesh-list
83675028|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83675029|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675030|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
83675031|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675032|NCT05618132|Acetylcholine|acetylcholine|mesh-list
83675033|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675034|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83675035|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
83675036|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675037|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675038|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675039|NCT05553808|Docetaxel|docetaxel|mesh-list
83675040|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675041|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675042|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675043|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675044|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675045|NCT05540184|Allopurinol|allopurinol|mesh-list
83675046|NCT05540184|Trimetazidine|trimetazidine|mesh-list
83675047|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
83675048|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675049|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675050|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
83675051|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675052|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83675053|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
83675054|NCT05540184|Protective Agents|protective agents|mesh-ancestor
83675055|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675056|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675057|NCT05493761|Denosumab|denosumab|mesh-list
83675058|NCT05493761|Alendronate|alendronate|mesh-list
83675059|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83675060|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675061|NCT05473195|Isoniazid|isoniazid|mesh-list
83675062|NCT05473195|Ethionamide|ethionamide|mesh-list
83675063|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
83675064|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675065|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675066|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83675067|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83675068|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
83675069|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675070|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83675071|NCT05442216|Azacitidine|azacitidine|mesh-list
83675072|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83675073|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
83675074|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675075|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675076|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675077|NCT05422053|Insulin|insulin|mesh-list
83675078|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83675079|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675080|NCT05414240|Ibudilast|ibudilast|mesh-list
83675081|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83675082|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
83675083|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675084|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675085|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83675086|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
83675087|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83675088|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675089|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675090|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83675091|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675092|NCT05344911|Remifentanil|remifentanil|mesh-list
83675093|NCT05344911|Alfentanil|alfentanil|mesh-list
83675094|NCT05344911|Propofol|propofol|mesh-list
83675095|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83675096|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675097|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675098|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83675099|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
83675100|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
83675101|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83675102|NCT05344911|Narcotics|narcotics|mesh-ancestor
83675103|NCT05344911|Analgesics|analgesics|mesh-ancestor
83675104|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
83675105|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675106|NCT05344417|Iodine|iodine|mesh-list
83675107|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83675108|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675109|NCT05344417|Trace Elements|trace elements|mesh-ancestor
83675110|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
83675111|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675112|NCT05338021|Vancomycin|vancomycin|mesh-list
83675113|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675114|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675115|NCT05338008|Vancomycin|vancomycin|mesh-list
83675116|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675117|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675118|NCT05281328|Octreotide|octreotide|mesh-list
83675119|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83675120|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83675121|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675122|NCT05265208|Capecitabine|capecitabine|mesh-list
83675123|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83675124|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
83675125|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675126|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675127|NCT05251376|Morphine|morphine|mesh-list
83675128|NCT05251376|Methadone|methadone|mesh-list
83675129|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83675130|NCT05251376|Narcotics|narcotics|mesh-ancestor
83675131|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675132|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675133|NCT05251376|Analgesics|analgesics|mesh-ancestor
83675134|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
83675135|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675136|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
83675137|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
83675138|NCT05191797|Atezolizumab|atezolizumab|mesh-list
83675139|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
83675140|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83675141|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
83675142|NCT05191797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675143|NCT05191797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675144|NCT05191797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675145|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675146|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
83675147|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675148|NCT05191446|Ethanol|ethanol|mesh-list
83675149|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83675150|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675151|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675152|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675153|NCT05189483|Paclitaxel|paclitaxel|mesh-list
83675154|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83675155|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83675156|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675157|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675158|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675159|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675160|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675161|NCT05188820|Cortisone|cortisone|mesh-list
83675162|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83675163|NCT05177055|Methamphetamine|methamphetamine|mesh-list
83675164|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83675165|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675166|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
83675167|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
83675168|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675169|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
83675170|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675171|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675172|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
83675173|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83675174|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83675175|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83675176|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83675177|NCT05156281|Teriflunomide|teriflunomide|mesh-list
83675178|NCT05156281|Remibrutinib|remibrutinib|mesh-list
83675179|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83675180|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83675181|NCT05156281|Analgesics|analgesics|mesh-ancestor
83675182|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
83675183|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675184|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675185|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83675186|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675187|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675188|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
83675189|NCT05156281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675190|NCT05156281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675191|NCT05156281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675192|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83675193|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
83675194|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675195|NCT05121974|Azithromycin|azithromycin|mesh-list
83675196|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
83675197|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675198|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675199|NCT05106192|Triamcinolone|triamcinolone|mesh-list
83675200|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83675201|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83675202|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
83675203|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83675205|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83675206|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83675207|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
83675208|NCT05106192|Hormones|hormones|mesh-ancestor
83675209|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83675210|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675211|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675212|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
83675213|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675214|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675215|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
83675216|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83675217|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675218|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
83675219|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675220|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675221|NCT05070247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675222|NCT05070247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675223|NCT05064878|Fenfluramine|fenfluramine|mesh-list
83675224|NCT05064878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83675225|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83675226|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83675227|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675228|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675229|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
83675230|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675231|NCT04969250|Vaccines|vaccines|mesh-list
83675232|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
83675233|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675234|NCT04965077|Antibodies|antibodies|mesh-list
83675235|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83675236|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
83675237|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675238|NCT04950426|Propranolol|propranolol|mesh-list
83675239|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83675240|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83675241|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
83675242|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675243|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675244|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675245|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83675246|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83675247|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675248|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
83675249|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675250|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675251|NCT04938609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675252|NCT04938609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675253|NCT04873557|Copper|copper|mesh-list
83675254|NCT04873557|Trace Elements|trace elements|mesh-ancestor
83675255|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
83675256|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675257|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
83675258|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82830024|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83675259|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675260|NCT04789616|Maraviroc|maraviroc|mesh-list
82830025|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675261|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83675262|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83675263|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675264|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83675265|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83675266|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
83675267|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675268|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83675269|NCT04785300|Dasatinib|dasatinib|mesh-list
83675270|NCT04785300|Quercetin|quercetin|mesh-list
83675271|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675272|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675273|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675274|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675275|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
83675276|NCT04785300|Protective Agents|protective agents|mesh-ancestor
83675277|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675278|NCT04753216|Bevacizumab|bevacizumab|mesh-list
83675279|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83675280|NCT04753216|Irinotecan|irinotecan|mesh-list
83675281|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
83675282|NCT04753216|Antibodies|antibodies|mesh-list
83675283|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
83675284|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83675285|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
83675286|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675287|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83675288|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83675289|NCT04753216|Growth Substances|growth substances|mesh-ancestor
83675290|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675291|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
83675292|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
83675293|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83675294|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83675295|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675296|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675297|NCT04742634|Decitabine|decitabine|mesh-list
83675298|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83675299|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
83675300|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675301|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675302|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675303|NCT04734990|Azacitidine|azacitidine|mesh-list
83675304|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83675305|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
83675306|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675307|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675308|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675309|NCT04714619|Letrozole|letrozole|mesh-list
83675310|NCT04714619|Anastrozole|anastrozole|mesh-list
83675311|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675312|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83675313|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83675314|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675315|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675316|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83675317|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
83675318|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83675319|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675320|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83675321|NCT04690855|Atezolizumab|atezolizumab|mesh-list
83675322|NCT04690855|Talazoparib|talazoparib|mesh-list
83675323|NCT04690855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675324|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675325|NCT04690855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675326|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675327|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83675328|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675329|NCT04689945|Morphine|morphine|mesh-list
83675330|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83675331|NCT04689945|Narcotics|narcotics|mesh-ancestor
83675332|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675333|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830100|NCT00307736|Growth Substances|growth substances|mesh-ancestor
83675334|NCT04689945|Analgesics|analgesics|mesh-ancestor
83675335|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
83675336|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675337|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83675339|NCT04643574|Fludarabine|fludarabine|mesh-list
83675340|NCT04643574|Interleukin-2|interleukin-2|mesh-list
83675341|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675342|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
83675343|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675344|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675345|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83675346|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
83675347|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675348|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675349|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83675350|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83675351|NCT04643574|Analgesics|analgesics|mesh-ancestor
83675352|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
83675353|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675354|NCT04583501|Omalizumab|omalizumab|mesh-list
83675355|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83675356|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83675357|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
83675358|NCT04563494|Dexamethasone|dexamethasone|mesh-list
83675359|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83675360|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
83675361|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
83675362|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675363|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675364|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83675365|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
83675366|NCT04563494|Hormones|hormones|mesh-ancestor
83675367|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83675368|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83675369|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675370|NCT04552288|Benralizumab|benralizumab|mesh-list
83675371|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83675372|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83675373|NCT04541173|Bevacizumab|bevacizumab|mesh-list
83675374|NCT04541173|Atezolizumab|atezolizumab|mesh-list
83675375|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675376|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675377|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83675378|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83675379|NCT04541173|Growth Substances|growth substances|mesh-ancestor
83675380|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675381|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
83675382|NCT04541173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675383|NCT04541173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675384|NCT04530747|Metformin|metformin|mesh-list
83675385|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83675386|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675387|NCT04464174|Carboplatin|carboplatin|mesh-list
83675388|NCT04464174|Gemcitabine|gemcitabine|mesh-list
83675389|NCT04464174|Capecitabine|capecitabine|mesh-list
83675390|NCT04464174|Ipatasertib|ipatasertib|mesh-list
83675391|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675392|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83675393|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
83675394|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675395|NCT04464174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675396|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675397|NCT04463498|Methamphetamine|methamphetamine|mesh-list
83675398|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83675399|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675400|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
83675401|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
83675402|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675403|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
83675404|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675405|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675406|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
82830170|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675407|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82830172|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83675408|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83675409|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83675410|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83675411|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
83675412|NCT04456296|Testosterone|testosterone|mesh-list
83675413|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
83675414|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
83675415|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83675416|NCT04456296|Androgens|androgens|mesh-ancestor
83675417|NCT04456296|Hormones|hormones|mesh-ancestor
83675418|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83675419|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675420|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83675421|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675422|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
83675423|NCT04408118|Paclitaxel|paclitaxel|mesh-list
83675424|NCT04408118|Atezolizumab|atezolizumab|mesh-list
83675425|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83675426|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675427|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675428|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675429|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675430|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675431|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675432|NCT04408118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675433|NCT04403321|Tacrolimus|tacrolimus|mesh-list
83675434|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675435|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
83675436|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675437|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83675438|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675439|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675440|NCT04332744|Talazoparib|talazoparib|mesh-list
83675441|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83675442|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675443|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675444|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675445|NCT04265755|Erenumab|erenumab|mesh-list
83675446|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83675447|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675448|NCT04265755|Analgesics|analgesics|mesh-ancestor
83675449|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
83675450|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675451|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675452|NCT04246372|Tofacitinib|tofacitinib|mesh-list
83675453|NCT04246372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83675454|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675455|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675456|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675457|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
83675458|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83675459|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83675460|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
83675461|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
83675462|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675463|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675464|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
83675465|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675466|NCT04182334|TEMPO|tempo|mesh-list
83675467|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
83675468|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675469|NCT04182334|Protective Agents|protective agents|mesh-ancestor
83675470|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675471|NCT04123444|Iloprost|iloprost|mesh-list
83675472|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83675473|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675474|NCT04098250|Erenumab|erenumab|mesh-list
83675475|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83675476|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675477|NCT04098250|Analgesics|analgesics|mesh-ancestor
83675478|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
83675479|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830249|NCT00302952|Lovastatin|lovastatin|mesh-list
83675480|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675481|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
83675482|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
83675483|NCT04002115|Busulfan|busulfan|mesh-list
83675484|NCT04002115|Fludarabine|fludarabine|mesh-list
83675485|NCT04002115|Clofarabine|clofarabine|mesh-list
83675486|NCT04002115|Tacrolimus|tacrolimus|mesh-list
83675487|NCT04002115|Lenograstim|lenograstim|mesh-list
83675488|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675489|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
83675490|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675491|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675492|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83675493|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
83675494|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675495|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675496|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83675497|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83675498|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
83675499|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83675500|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675501|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83675502|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83675503|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
83675504|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675505|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675506|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83675507|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83675508|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
83675509|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675510|NCT03967197|Lidocaine|lidocaine|mesh-list
83675511|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
83675512|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
83675513|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675514|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675515|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
83675516|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675517|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83675518|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83675519|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83675520|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83675521|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675522|NCT03935646|Adderall|adderall|mesh-list
83675523|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83675524|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675525|NCT03875573|Durvalumab|durvalumab|mesh-list
83675526|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675527|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675528|NCT03871153|Paclitaxel|paclitaxel|mesh-list
83675529|NCT03871153|Carboplatin|carboplatin|mesh-list
83675530|NCT03871153|Durvalumab|durvalumab|mesh-list
83675531|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83675532|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675533|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675534|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675535|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675536|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675537|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675538|NCT03547999|Nivolumab|nivolumab|mesh-list
83675539|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675540|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675541|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675542|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675543|NCT03536728|Eflornithine|eflornithine|mesh-list
83675544|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675545|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83675546|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83675547|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83675548|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675549|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83675550|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675551|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675552|NCT03517423|Brivaracetam|brivaracetam|mesh-list
83675553|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
82830316|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675554|NCT03470675|Ketamine|ketamine|mesh-list
83675555|NCT03470675|Morphine|morphine|mesh-list
83675556|NCT03470675|Analgesics|analgesics|mesh-ancestor
83675557|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
83675558|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675559|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675560|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83675561|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83675562|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
83675563|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
83675564|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675565|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83675566|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83675567|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675568|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675569|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83675570|NCT03470675|Narcotics|narcotics|mesh-ancestor
83675571|NCT03462251|Paclitaxel|paclitaxel|mesh-list
83675572|NCT03462251|Bevacizumab|bevacizumab|mesh-list
83675573|NCT03462251|Capecitabine|capecitabine|mesh-list
83675574|NCT03462251|Fulvestrant|fulvestrant|mesh-list
83675575|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83675576|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83675577|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675578|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675579|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675580|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675581|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675582|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675583|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83675584|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83675585|NCT03462251|Growth Substances|growth substances|mesh-ancestor
83675586|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675587|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
83675588|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83675589|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
83675590|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83675591|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83675592|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83675593|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
83675594|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83675595|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83675596|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675597|NCT03404778|Cimetidine|cimetidine|mesh-list
83675598|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83675599|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83675600|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83675601|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
83675602|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
83675603|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675604|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675605|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675606|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83675607|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83675608|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675609|NCT03392246|Osimertinib|osimertinib|mesh-list
83675610|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675611|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675612|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675613|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675614|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
83675615|NCT03340766|Blinatumomab|blinatumomab|mesh-list
83675616|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675617|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675618|NCT03340766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675619|NCT03340766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675620|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
83675621|NCT03294954|Fludarabine|fludarabine|mesh-list
83675622|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675623|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
83675624|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675625|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675626|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82830392|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675627|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
83675628|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675629|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675630|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83675631|NCT03274414|Cisplatin|cisplatin|mesh-list
83675632|NCT03274414|Etoposide|etoposide|mesh-list
83675633|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675634|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83675635|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83675636|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83675637|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675638|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675639|NCT03272685|Nicotine|nicotine|mesh-list
83675640|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83675641|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
83675642|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675643|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675644|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83675645|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83675646|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
83675647|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675648|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675649|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
83675650|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675651|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675652|NCT03272334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675653|NCT03272334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675654|NCT03258281|Evolocumab|evolocumab|mesh-list
83675655|NCT03258281|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83675656|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83675657|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83675658|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
83675659|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675660|NCT03258281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83675661|NCT03258281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83675662|NCT03258281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675663|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83675664|NCT05705492|Olanzapine|olanzapine|mesh-list
83675665|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
83675666|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
83675667|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675668|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675669|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83675670|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83675671|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83675672|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675673|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83675674|NCT05705492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83675675|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83675676|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83675677|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675678|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675679|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
83675680|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
83675681|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675682|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675683|NCT05705466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675684|NCT05705466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675685|NCT05705388|Liraglutide|liraglutide|mesh-list
83675686|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83675687|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675688|NCT05705388|Incretins|incretins|mesh-ancestor
83675689|NCT05705388|Hormones|hormones|mesh-ancestor
83675690|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83675691|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
83675692|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83675693|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83675694|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675695|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
83675696|NCT05705336|Coagulants|coagulants|mesh-ancestor
83675697|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
83675698|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82830466|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82830469|NCT03978494|Tacrolimus|tacrolimus|mesh-list
83675699|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
83675700|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675701|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675702|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675703|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
83675704|NCT05704959|Povidone|povidone|mesh-list
83675705|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
83675706|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
83675707|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83675708|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675709|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
83675710|NCT05704894|Hematinics|hematinics|mesh-ancestor
83675711|NCT05704816|Anesthetics|anesthetics|mesh-list
83675712|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675713|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675714|NCT05704634|Cemiplimab|cemiplimab|mesh-list
83675715|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675716|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675717|NCT05704595|Diuretics|diuretics|mesh-list
83675718|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
83675719|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675720|NCT05704400|Rituximab|rituximab|mesh-list
83675721|NCT05704400|Daratumumab|daratumumab|mesh-list
83675722|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675723|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675724|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
83675725|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675726|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675727|NCT05704114|Tazarotene|tazarotene|mesh-list
83675728|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
83675729|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
83675730|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
83675731|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83675732|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675733|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83675734|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675735|NCT05703997|Atezolizumab|atezolizumab|mesh-list
83675736|NCT05703997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675737|NCT05703997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675738|NCT05703997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675739|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675740|NCT05703984|Metformin|metformin|mesh-list
83675741|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83675742|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675743|NCT05703659|Sulfalene|sulfalene|mesh-list
83675744|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675745|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83675746|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
83675747|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83675748|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83675749|NCT05703555|Maytansine|maytansine|mesh-list
83675750|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83675751|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675752|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675753|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675754|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675755|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675756|NCT05703373|Micronutrients|micronutrients|mesh-list
83675757|NCT05703373|Trace Elements|trace elements|mesh-list
83675758|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675759|NCT05702190|Opium|opium|mesh-list
83675760|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83675761|NCT05702190|Narcotics|narcotics|mesh-ancestor
83675762|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83675763|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675764|NCT05702190|Analgesics|analgesics|mesh-ancestor
83675765|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
83675766|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675767|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
83675768|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83675769|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
83675770|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
83675771|NCT05701124|Ranibizumab|ranibizumab|mesh-list
83675772|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83675773|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83675774|NCT05701124|Growth Substances|growth substances|mesh-ancestor
83675775|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675776|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
83675777|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675778|NCT05688085|Amlodipine|amlodipine|mesh-list
83675779|NCT05688085|Irbesartan|irbesartan|mesh-list
83675780|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83675781|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83675782|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83675783|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675784|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83675785|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675786|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675787|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83675788|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83675789|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
83675790|NCT05645380|Carboplatin|carboplatin|mesh-list
83675791|NCT05645380|Docetaxel|docetaxel|mesh-list
83675792|NCT05645380|Doxorubicin|doxorubicin|mesh-list
83675793|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
83675794|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675795|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
83675796|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675797|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675798|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83675799|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
83675800|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675801|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675802|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83675803|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675804|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675805|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675806|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83675807|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83675808|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83675809|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675810|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675811|NCT05645380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675812|NCT05641246|Diclofenac|diclofenac|mesh-list
83675813|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83675814|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83675815|NCT05641246|Analgesics|analgesics|mesh-ancestor
83675816|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
83675817|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83675818|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675819|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83675820|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675821|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83675822|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675823|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675824|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
83675825|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
83675826|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675827|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
83675828|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
83675829|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83675830|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675831|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675832|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
83675833|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
83675834|NCT05476939|Everolimus|everolimus|mesh-list
83675835|NCT05476939|TIC10 compound|tic10 compound|mesh-list
83675836|NCT05476939|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83675837|NCT05476939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675838|NCT05476939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675839|NCT05476939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675840|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675841|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
83675842|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675843|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675844|NCT05458232|Tadalafil|tadalafil|mesh-list
83675845|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
83675846|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83675847|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83675848|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675849|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830630|NCT00284934|Prednisone|prednisone|mesh-list
83675850|NCT05458232|Urological Agents|urological agents|mesh-ancestor
83675852|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83675853|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675854|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
83675855|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83675856|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83675857|NCT05271799|Gepotidacin|gepotidacin|mesh-list
83675858|NCT05271799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83675859|NCT05271799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675860|NCT05271799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675861|NCT05271799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675862|NCT05270733|Ustekinumab|ustekinumab|mesh-list
83675863|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
83675864|NCT05253417|Cannabidiol|cannabidiol|mesh-list
83675865|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
83675866|NCT05184803|Docetaxel|docetaxel|mesh-list
83675867|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
83675868|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675869|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
83675870|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
83675871|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
83675872|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675873|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
83675874|NCT05030506|Lenvatinib|lenvatinib|mesh-list
83675875|NCT05030506|Belzutifan|belzutifan|mesh-list
83675876|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675877|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675878|NCT05030506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675879|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675880|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675881|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675882|NCT04911621|Temozolomide|temozolomide|mesh-list
83675883|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83675884|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
83675885|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675886|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675887|NCT04877522|Niacinamide|niacinamide|mesh-list
83675888|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
83675889|NCT04877522|Dasatinib|dasatinib|mesh-list
83675890|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675891|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675892|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675893|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675894|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
83675895|NCT04877522|Vitamins|vitamins|mesh-ancestor
83675896|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
83675897|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675898|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
83675899|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
83675900|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83675901|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83675902|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
83675903|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675904|NCT04764643|Expectorants|expectorants|mesh-ancestor
83675905|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
83675906|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83675907|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
83675908|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675909|NCT04764643|Protective Agents|protective agents|mesh-ancestor
83675910|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675911|NCT04764643|Antidotes|antidotes|mesh-ancestor
83675912|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
83675913|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675914|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
83675915|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
83675916|NCT04706429|Trientine|trientine|mesh-list
83675917|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
83675918|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
83675919|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675920|NCT04625803|Apatinib|apatinib|mesh-list
83675921|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675922|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830693|NCT00298272|Hormones|hormones|mesh-ancestor
83675923|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675924|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675925|NCT04558892|Enoxaparin|enoxaparin|mesh-list
83675926|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
83675927|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83675928|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83675929|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675930|NCT04551885|Aldesleukin|aldesleukin|mesh-list
83675931|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
83675932|NCT04551885|Fludarabine|fludarabine|mesh-list
83675933|NCT04551885|Avelumab|avelumab|mesh-list
83675934|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675935|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
83675936|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675937|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675938|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83675939|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
83675940|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675941|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675942|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83675943|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83675944|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83675945|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
83675946|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675947|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675948|NCT04304820|Cyclosporine|cyclosporine|mesh-list
83675949|NCT04304820|Cyclosporins|cyclosporins|mesh-list
83675950|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83675951|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675952|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675953|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675954|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
83675955|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675956|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
83675957|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675958|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
83675959|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83675960|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83675961|NCT04199728|Liraglutide|liraglutide|mesh-list
83675962|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83675963|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675964|NCT04199728|Incretins|incretins|mesh-ancestor
83675965|NCT04199728|Hormones|hormones|mesh-ancestor
83675966|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83675967|NCT04166435|Temozolomide|temozolomide|mesh-list
83675968|NCT04166435|Olaparib|olaparib|mesh-list
83675969|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83675970|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
83675971|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675972|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675973|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83675974|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675975|NCT04162015|Carboplatin|carboplatin|mesh-list
83675976|NCT04162015|Nivolumab|nivolumab|mesh-list
83675977|NCT04162015|Pemetrexed|pemetrexed|mesh-list
83675978|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675979|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83675980|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83675981|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83675982|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675983|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83675984|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83675985|NCT04077515|Sirolimus|sirolimus|mesh-list
83675986|NCT04077515|Temsirolimus|temsirolimus|mesh-list
83675987|NCT04077515|MTOR Inhibitors|mtor inhibitors|mesh-list
83675988|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83675989|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83675990|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83675991|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83675992|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
83675993|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83675994|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
83675995|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83675996|NCT04077515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83675997|NCT04077515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83675998|NCT04077515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830767|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
83675999|NCT04009044|Tamoxifen|tamoxifen|mesh-list
83676000|NCT04009044|Afimoxifene|afimoxifene|mesh-list
83676001|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83676002|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
83676003|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676004|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676005|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83676006|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676007|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83676008|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83676009|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83676010|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
83676011|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676012|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83676013|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676014|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676015|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
83676016|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676017|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676018|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83676019|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83676020|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676021|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
83676022|NCT03936153|Abexinostat|abexinostat|mesh-list
83676023|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83676024|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676025|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676026|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
83676027|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83676028|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
83676029|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83676030|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
83676031|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676032|NCT03841110|Aldesleukin|aldesleukin|mesh-list
83676033|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
83676034|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
83676035|NCT03841110|Nivolumab|nivolumab|mesh-list
83676036|NCT03841110|Fludarabine|fludarabine|mesh-list
83676037|NCT03841110|Atezolizumab|atezolizumab|mesh-list
83676038|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676039|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
83676040|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676041|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676042|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83676043|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
83676044|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676045|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676046|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83676047|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676048|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676049|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83676050|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83676051|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
83676052|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676053|NCT03810313|Aflibercept|aflibercept|mesh-list
83676054|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83676055|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83676056|NCT03810313|Growth Substances|growth substances|mesh-ancestor
83676057|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676058|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
83676059|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676060|NCT03802630|Aflibercept|aflibercept|mesh-list
83676061|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83676062|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83676063|NCT03802630|Growth Substances|growth substances|mesh-ancestor
83676064|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676065|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
83676066|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676067|NCT03785691|Ondansetron|ondansetron|mesh-list
83676068|NCT03785691|Mirtazapine|mirtazapine|mesh-list
83676069|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
83676070|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
83676071|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676072|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676073|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83676074|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
82830842|NCT00296244|Hormones|hormones|mesh-ancestor
82830866|NCT00282048|Axitinib|axitinib|mesh-list
83676075|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83676076|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83676077|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83676078|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
83676079|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676080|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676081|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
83676082|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83676083|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83676084|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
83676085|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
83676086|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83676087|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83676088|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83676089|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83676090|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83676091|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83676092|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
83676093|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83676094|NCT03780829|Cycloserine|cycloserine|mesh-list
83676095|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83676096|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676097|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83676098|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
83676099|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83676100|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
83676101|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676103|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676104|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676105|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676106|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676107|NCT03710564|Aflibercept|aflibercept|mesh-list
83676108|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83676109|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83676110|NCT03710564|Growth Substances|growth substances|mesh-ancestor
83676111|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676112|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
83676113|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676114|NCT03703492|Estradiol|estradiol|mesh-list
83676115|NCT03703492|Estrogens|estrogens|mesh-ancestor
83676116|NCT03703492|Hormones|hormones|mesh-ancestor
83676117|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676118|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676119|NCT03624127|Apremilast|apremilast|mesh-list
83676120|NCT03624127|Deucravacitinib|deucravacitinib|mesh-list
83676121|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83676122|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83676123|NCT03624127|Analgesics|analgesics|mesh-ancestor
83676124|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
83676125|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676126|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676127|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83676128|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676129|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83676130|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83676131|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676132|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676133|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
83676134|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676135|NCT03597568|Resveratrol|resveratrol|mesh-list
83676136|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
83676137|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676138|NCT03597568|Protective Agents|protective agents|mesh-ancestor
83676139|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676140|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676141|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83676142|NCT03499899|Carboplatin|carboplatin|mesh-list
83676143|NCT03499899|Spartalizumab|spartalizumab|mesh-list
83676144|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676145|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676146|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830915|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676148|NCT03481634|Aflibercept|aflibercept|mesh-list
83676149|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83676150|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83676151|NCT03481634|Growth Substances|growth substances|mesh-ancestor
83676152|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676153|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
83676154|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676155|NCT03476642|Epinephrine|epinephrine|mesh-list
83676156|NCT03476642|Ropivacaine|ropivacaine|mesh-list
83676157|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
83676158|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
83676159|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83676160|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676161|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
83676162|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676163|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83676164|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83676165|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83676166|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676167|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676168|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83676169|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83676170|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
83676171|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83676172|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
83676173|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
83676174|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
83676175|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83676176|NCT03460756|Ganaxolone|ganaxolone|mesh-list
83676177|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
83676178|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676179|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676180|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676181|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
83676182|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
83676183|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
83676184|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676185|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676186|NCT03430700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676187|NCT03430700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676188|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83676189|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676190|NCT03291028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676191|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676192|NCT03245151|Everolimus|everolimus|mesh-list
83676193|NCT03245151|Lenvatinib|lenvatinib|mesh-list
83676194|NCT03245151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83676195|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676196|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676197|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676198|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676199|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
83676200|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676201|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676202|NCT03171025|Nivolumab|nivolumab|mesh-list
83676203|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676204|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676205|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676206|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676207|NCT03149003|Bevacizumab|bevacizumab|mesh-list
83676208|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676209|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676210|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83676211|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83676212|NCT03149003|Growth Substances|growth substances|mesh-ancestor
83676213|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676214|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
83676215|NCT03148275|Trametinib|trametinib|mesh-list
83676216|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676217|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676218|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830990|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83676219|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676220|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
83676221|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83676222|NCT03106454|Norethindrone|norethindrone|mesh-list
83676223|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
83676224|NCT03106454|Estradiol|estradiol|mesh-list
83676225|NCT03106454|Estrogens|estrogens|mesh-ancestor
83676226|NCT03106454|Hormones|hormones|mesh-ancestor
83676227|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676228|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676229|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83676230|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
83676231|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83676232|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83676233|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83676234|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83676235|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83676236|NCT03106454|Trace Elements|trace elements|mesh-ancestor
83676237|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
83676238|NCT02990806|Infliximab|infliximab|mesh-list
83676239|NCT02990806|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83676240|NCT02990806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83676241|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
83676242|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83676243|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676244|NCT02965703|Aspirin|aspirin|mesh-list
83676245|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83676246|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83676247|NCT02965703|Analgesics|analgesics|mesh-ancestor
83676248|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
83676249|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676250|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676251|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83676252|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676253|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83676254|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83676255|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676256|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83676257|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83676258|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676259|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
83676260|NCT02938442|Paclitaxel|paclitaxel|mesh-list
83676261|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83676262|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
83676263|NCT02938442|Doxorubicin|doxorubicin|mesh-list
83676264|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83676265|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83676266|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
83676267|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83676268|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676269|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83676270|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83676271|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83676272|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676273|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676274|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
83676275|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676276|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676277|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83676278|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
83676279|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83676280|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83676281|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83676282|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83676283|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676284|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83676285|NCT02890329|Ipilimumab|ipilimumab|mesh-list
83676286|NCT02890329|Decitabine|decitabine|mesh-list
83676287|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676288|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676289|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676290|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676291|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83676292|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
83676293|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676294|NCT02650271|Tenofovir|tenofovir|mesh-list
83676295|NCT02650271|Entecavir|entecavir|mesh-list
83676296|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
83676297|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676298|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83676299|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83676300|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676301|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676302|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83676303|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83676304|NCT02420821|Bevacizumab|bevacizumab|mesh-list
83676305|NCT02420821|Atezolizumab|atezolizumab|mesh-list
83676306|NCT02420821|Sunitinib|sunitinib|mesh-list
83676307|NCT02420821|Antibodies|antibodies|mesh-list
83676308|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83676309|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676310|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676311|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83676312|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83676313|NCT02420821|Growth Substances|growth substances|mesh-ancestor
83676314|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676315|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
83676316|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
83676317|NCT02420821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676318|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676319|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676320|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676321|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
83676322|NCT02811263|Hematinics|hematinics|mesh-ancestor
83676323|NCT02398773|Estradiol|estradiol|mesh-list
83676324|NCT02398773|Estrogens|estrogens|mesh-ancestor
83676325|NCT02398773|Hormones|hormones|mesh-ancestor
83676326|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676327|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676328|NCT02229084|Paclitaxel|paclitaxel|mesh-list
83676329|NCT02229084|Docetaxel|docetaxel|mesh-list
83676330|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
83676331|NCT02229084|Doxorubicin|doxorubicin|mesh-list
83676332|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83676333|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
83676334|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83676335|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676336|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
83676337|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
83676338|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
83676339|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676340|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676341|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
83676342|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676343|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676344|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83676345|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
83676346|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83676347|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83676348|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83676349|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83676350|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676351|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83676352|NCT02188121|Losartan|losartan|mesh-list
83676353|NCT02188121|Simvastatin|simvastatin|mesh-list
83676354|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83676355|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83676356|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
83676357|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676358|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83676359|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83676360|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676361|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83676362|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83676363|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83676364|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83676365|NCT02039063|Quetmolimab|quetmolimab|mesh-list
83676366|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83676367|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676368|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
82831136|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
83676369|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676370|NCT01970410|Teriflunomide|teriflunomide|mesh-list
83676371|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83676372|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83676373|NCT01970410|Analgesics|analgesics|mesh-ancestor
83676374|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
83676375|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676376|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676377|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83676378|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676379|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676380|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
83676381|NCT01861314|Bortezomib|bortezomib|mesh-list
83676382|NCT01861314|Sorafenib|sorafenib|mesh-list
83676383|NCT01861314|Decitabine|decitabine|mesh-list
83676384|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676385|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676386|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676387|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676388|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83676389|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
83676390|NCT01746173|Plerixafor|plerixafor|mesh-list
83676391|NCT01746173|Prednisone|prednisone|mesh-list
83676392|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
83676393|NCT01746173|Melphalan|melphalan|mesh-list
83676394|NCT01746173|Busulfan|busulfan|mesh-list
83676395|NCT01746173|Gemcitabine|gemcitabine|mesh-list
83676396|NCT01746173|Doxorubicin|doxorubicin|mesh-list
83676397|NCT01746173|Etoposide|etoposide|mesh-list
83676398|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
83676399|NCT01746173|Vincristine|vincristine|mesh-list
83676400|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676401|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
83676402|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676403|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676404|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83676405|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
83676406|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676407|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676408|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83676409|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83676410|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
83676411|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83676412|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83676413|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83676414|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676415|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83676416|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
83676417|NCT01746173|Hormones|hormones|mesh-ancestor
83676418|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676419|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83676420|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83676421|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83676422|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83676423|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83676424|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83676425|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83676426|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
83676427|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676428|NCT01694004|Benzocaine|benzocaine|mesh-list
83676429|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
83676430|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
83676431|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83676432|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676433|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
83676434|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676435|NCT01545843|Fluoxetine|fluoxetine|mesh-list
83676436|NCT01545843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83676437|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83676438|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83676439|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676440|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676441|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
83676442|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676443|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83676444|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
82831213|NCT00294554|Memantine|memantine|mesh-list
83676445|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83676446|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83676447|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83676448|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676449|NCT00843791|Pioglitazone|pioglitazone|mesh-list
83676450|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83676451|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83676452|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676453|NCT03187769|Olanzapine|olanzapine|mesh-list
83676454|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
83676455|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
83676456|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676457|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676458|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83676459|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83676460|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83676461|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83676462|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83676463|NCT03187769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83676464|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83676465|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83676466|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676467|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676468|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
83676469|NCT03161353|Tamoxifen|tamoxifen|mesh-list
83676470|NCT03161353|Carboplatin|carboplatin|mesh-list
83676471|NCT03161353|Docetaxel|docetaxel|mesh-list
83676472|NCT03161353|Trastuzumab|trastuzumab|mesh-list
83676473|NCT03161353|Letrozole|letrozole|mesh-list
83676474|NCT03161353|Pertuzumab|pertuzumab|mesh-list
83676475|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676476|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
83676477|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
83676478|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
83676479|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676480|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676481|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83676482|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83676483|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676484|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83676485|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
83676486|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676487|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676488|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83676489|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83676490|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83676491|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83676492|NCT03136731|Antibodies|antibodies|mesh-list
83676493|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
83676494|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676495|NCT03134196|Valacyclovir|valacyclovir|mesh-list
83676496|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
83676497|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676498|NCT02956382|Venetoclax|venetoclax|mesh-list
83676499|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676500|NCT02939573|Dapsone|dapsone|mesh-list
83676501|NCT02939573|Colchicine|colchicine|mesh-list
83676502|NCT02939573|Azathioprine|azathioprine|mesh-list
83676503|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
83676504|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676505|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
83676506|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
83676507|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
83676508|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676509|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676510|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
83676511|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83676512|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676513|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
83676514|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676515|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676516|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
83676517|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83676518|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83676519|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83676520|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831291|NCT00278148|Paclitaxel|paclitaxel|mesh-list
83676521|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
83676522|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83676523|NCT02876107|Paclitaxel|paclitaxel|mesh-list
83676524|NCT02876107|Carboplatin|carboplatin|mesh-list
83676525|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83676526|NCT02876107|Panitumumab|panitumumab|mesh-list
83676527|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83676528|NCT02876107|Antibodies|antibodies|mesh-list
83676529|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
83676530|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83676531|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83676532|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676533|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
83676534|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
83676535|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
83676536|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676537|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
83676538|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676539|NCT02855229|Methylphenidate|methylphenidate|mesh-list
83676540|NCT02855229|Modafinil|modafinil|mesh-list
83676541|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83676542|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676543|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83676544|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83676545|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83676546|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676547|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
83676548|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676549|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83676550|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83676551|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83676552|NCT02829931|Bevacizumab|bevacizumab|mesh-list
83676553|NCT02829931|Nivolumab|nivolumab|mesh-list
83676554|NCT02829931|Ipilimumab|ipilimumab|mesh-list
83676555|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676556|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676557|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83676558|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83676559|NCT02829931|Growth Substances|growth substances|mesh-ancestor
83676560|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676561|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
83676562|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676563|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676564|NCT02815566|Tenofovir|tenofovir|mesh-list
83676565|NCT02815566|Emtricitabine|emtricitabine|mesh-list
83676566|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
83676567|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676568|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83676569|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83676570|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676571|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676572|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83676573|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83676574|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
83676575|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676576|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
83676577|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676578|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676579|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83676580|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
83676581|NCT02727803|Melphalan|melphalan|mesh-list
83676582|NCT02727803|Busulfan|busulfan|mesh-list
83676583|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
83676584|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83676585|NCT02727803|Rituximab|rituximab|mesh-list
83676586|NCT02727803|Fludarabine|fludarabine|mesh-list
83676587|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
83676588|NCT02727803|Clofarabine|clofarabine|mesh-list
83676589|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83676590|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83676591|NCT02727803|Antibodies|antibodies|mesh-list
83676592|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
83676593|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83676594|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676595|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
82831360|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676596|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676597|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676598|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83676599|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
83676600|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676601|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676602|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83676603|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83676605|NCT02702492|Niacin|niacin|mesh-list
83676606|NCT02702492|Nivolumab|nivolumab|mesh-list
83676607|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676608|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676609|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676610|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676611|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83676612|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
83676613|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83676614|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
83676615|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
83676616|NCT02702492|Vitamins|vitamins|mesh-ancestor
83676617|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
83676618|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676619|NCT02652455|Aldesleukin|aldesleukin|mesh-list
83676620|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
83676621|NCT02652455|Nivolumab|nivolumab|mesh-list
83676622|NCT02652455|Fludarabine|fludarabine|mesh-list
83676623|NCT02652455|Interleukin-2|interleukin-2|mesh-list
83676624|NCT02652455|Antibodies|antibodies|mesh-list
83676625|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
83676626|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
83676627|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83676628|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
83676629|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676630|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676631|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83676632|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
83676633|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676634|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676635|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83676636|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676637|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676638|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83676639|NCT02652455|Analgesics|analgesics|mesh-ancestor
83676640|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
83676641|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676642|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83676643|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83676644|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
83676645|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676646|NCT02520791|Antibodies|antibodies|mesh-list
83676647|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83676648|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
83676649|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676650|NCT02491983|Letrozole|letrozole|mesh-list
83676651|NCT02491983|Fulvestrant|fulvestrant|mesh-list
83676652|NCT02491983|Palbociclib|palbociclib|mesh-list
83676653|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676654|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83676655|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83676656|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676657|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676658|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83676659|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
83676660|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676661|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676662|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83676663|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83676664|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676665|NCT02467478|Linagliptin|linagliptin|mesh-list
83676666|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82831433|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82831434|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831435|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831436|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
82831437|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82831440|NCT02532192|Cytarabine|cytarabine|mesh-list
83676667|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676668|NCT02467478|Incretins|incretins|mesh-ancestor
83676669|NCT02467478|Hormones|hormones|mesh-ancestor
83676670|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676671|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83676672|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
83676673|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676674|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676675|NCT02466243|Lenabasum|lenabasum|mesh-list
83676676|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83676677|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83676678|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676679|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676680|NCT02466243|Hormones|hormones|mesh-ancestor
83676681|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676682|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676683|NCT02321098|Amorolfine|amorolfine|mesh-list
83676684|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
83676685|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676686|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83676687|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
83676688|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83676689|NCT02185417|Diuretics|diuretics|mesh-ancestor
83676690|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
83676691|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676692|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83676693|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83676694|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676695|NCT02158234|Cisplatin|cisplatin|mesh-list
83676696|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
83676697|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676698|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676699|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
83676700|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676701|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
83676702|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413138|NCT02935361|Guadecitabine|guadecitabine|mesh-list
83676703|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676704|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83676705|NCT01953926|Trastuzumab|trastuzumab|mesh-list
83676706|NCT01953926|Fulvestrant|fulvestrant|mesh-list
83676707|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676708|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676709|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83676710|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83676711|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83676712|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
83676713|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676714|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676715|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83676716|NCT01859026|Mitogens|mitogens|mesh-list
83676717|NCT01859026|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83676718|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676719|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676720|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676721|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676722|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
83676723|NCT01843374|Tremelimumab|tremelimumab|mesh-list
83676724|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676725|NCT01657591|Vemurafenib|vemurafenib|mesh-list
83676726|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676727|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676728|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676729|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676730|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
83676731|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83676732|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83676733|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676734|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
83676735|NCT01599468|Coagulants|coagulants|mesh-ancestor
83676736|NCT01599572|Zinc|zinc|mesh-list
83676737|NCT01599572|Trace Elements|trace elements|mesh-ancestor
83676738|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
83676739|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676740|NCT01599598|Imidacloprid|imidacloprid|mesh-list
83676741|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
83676742|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676743|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676744|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676745|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83676746|NCT01599702|Hematinics|hematinics|mesh-ancestor
83676747|NCT01599728|Substance P|substance p|mesh-list
83676748|NCT01599728|Neurokinin A|neurokinin a|mesh-list
83676749|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676750|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676751|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676752|NCT01599819|Factor VIII|factor viii|mesh-list
83676753|NCT01599819|BAX 855|bax 855|mesh-list
83676754|NCT01599819|Coagulants|coagulants|mesh-ancestor
83676755|NCT01599858|Omeprazole|omeprazole|mesh-list
83676756|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83676757|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83676758|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83676759|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676760|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676761|NCT01599871|Theophylline|theophylline|mesh-list
83676762|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83676763|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
83676764|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676765|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676766|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83676767|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
83676768|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83676769|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676770|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676771|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83676772|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83676773|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83676774|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
83676775|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676776|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
83676777|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83676778|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
83676779|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676780|NCT01599884|Expectorants|expectorants|mesh-ancestor
83676781|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
83676782|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83676783|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
83676784|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676785|NCT01599884|Protective Agents|protective agents|mesh-ancestor
83676786|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676787|NCT01599884|Antidotes|antidotes|mesh-ancestor
83676788|NCT01599923|Antivenins|antivenins|mesh-list
83676789|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
83676790|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676791|NCT01599936|Antivenins|antivenins|mesh-list
83676792|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
83676793|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676794|NCT01599962|Cinacalcet|cinacalcet|mesh-list
83676795|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83676796|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676797|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83676798|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
83676799|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676800|NCT01599975|Methylphenidate|methylphenidate|mesh-list
83676801|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83676802|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676803|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83676804|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83676805|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83676806|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676807|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
83676808|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676809|NCT01599988|Caseins|caseins|mesh-list
83676810|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
83676811|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
83676812|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676813|NCT01600430|Vitamin D|vitamin d|mesh-list
83676814|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
83676816|NCT01600430|Vitamins|vitamins|mesh-list
83676817|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
83676818|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676819|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83676820|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83676821|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
83676822|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83676823|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83676824|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676825|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
83676826|NCT01600599|Coagulants|coagulants|mesh-ancestor
83676827|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
83676828|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
83676829|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83676830|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83676831|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676832|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676833|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676834|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676835|NCT01602029|Ondansetron|ondansetron|mesh-list
83676836|NCT01602029|Simvastatin|simvastatin|mesh-list
83676837|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83676838|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83676839|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
83676840|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676841|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83676842|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83676843|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676844|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
83676845|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
83676846|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676847|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676848|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83676849|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
83676850|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
83676851|NCT01602029|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83676852|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83676853|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
83676854|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676855|NCT01602874|Metronidazole|metronidazole|mesh-list
83676856|NCT01602874|Clarithromycin|clarithromycin|mesh-list
83676857|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
83676858|NCT01602874|Tigecycline|tigecycline|mesh-list
83676859|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676860|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83676861|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83676862|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83676863|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83676864|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676865|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676866|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83676867|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83676868|NCT01602887|Palbociclib|palbociclib|mesh-list
83676869|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676870|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83676871|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676872|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676873|NCT01603264|Trastuzumab|trastuzumab|mesh-list
83676874|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676875|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676876|NCT01603680|Anesthetics|anesthetics|mesh-list
83676877|NCT01603680|Mepivacaine|mepivacaine|mesh-list
83676878|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
83676879|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83676880|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676881|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
83676882|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676883|NCT01604213|Metformin|metformin|mesh-list
83676884|NCT01604213|Vildagliptin|vildagliptin|mesh-list
83676885|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83676886|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676887|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83676888|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
83676889|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676890|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676891|NCT01605240|Acetaminophen|acetaminophen|mesh-list
83676892|NCT01605240|Ibuprofen|ibuprofen|mesh-list
83676893|NCT01605240|Codeine|codeine|mesh-list
83676894|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83676895|NCT01605240|Analgesics|analgesics|mesh-ancestor
83676896|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
83676897|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676898|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676899|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
83676900|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83676901|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83676902|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83676903|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83676904|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676905|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676906|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83676907|NCT01605240|Narcotics|narcotics|mesh-ancestor
83676908|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83676909|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
83676910|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
83676911|NCT01605279|Dobutamine|dobutamine|mesh-list
83676912|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83676913|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
83676914|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
83676915|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676916|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676917|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83676918|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83676919|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83676920|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
83676921|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676922|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676923|NCT01605279|Protective Agents|protective agents|mesh-ancestor
83676924|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83676925|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
83676926|NCT01606072|Coagulants|coagulants|mesh-ancestor
83676927|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83676928|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
83676929|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676930|NCT01606722|Ritonavir|ritonavir|mesh-list
83676931|NCT01606722|Darunavir|darunavir|mesh-list
83676932|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83676933|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83676934|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
83676935|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83676936|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676937|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83676938|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83676939|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
83676940|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676941|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83676942|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83676943|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
83676944|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83676945|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
83676946|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676947|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676948|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83676949|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
83676950|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83676951|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
83676952|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676953|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676954|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83676955|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
83676956|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
83676957|NCT01607983|Protective Agents|protective agents|mesh-ancestor
83676958|NCT01608217|Acetaminophen|acetaminophen|mesh-list
83676959|NCT01608217|Dronabinol|dronabinol|mesh-list
83676960|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83676961|NCT01608217|Analgesics|analgesics|mesh-ancestor
83676962|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
83676963|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676964|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831730|NCT04357457|Almitrine|almitrine|mesh-list
83676965|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
83676966|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
83676967|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83676968|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83676969|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83676970|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83676971|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676972|NCT01608217|Hormones|hormones|mesh-ancestor
83676973|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83676974|NCT01608594|Ipilimumab|ipilimumab|mesh-list
83676975|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83676976|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83676977|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83676978|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83676979|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83676980|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83676981|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
83676982|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
83676983|NCT01608958|Oxytocin|oxytocin|mesh-list
83676984|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
83676985|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83676986|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676987|NCT01609153|Olanzapine|olanzapine|mesh-list
83676988|NCT01609153|Amisulpride|amisulpride|mesh-list
83676989|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
83676990|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
83676991|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83676992|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83676993|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83676994|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83676995|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83676996|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83676997|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83676998|NCT01609153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83676999|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83677000|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677001|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677002|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677003|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
83677004|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83677005|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
83677006|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83677007|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
83677008|NCT01610141|Warfarin|warfarin|mesh-list
83677009|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
83677010|NCT01610310|Interferon-beta|interferon-beta|mesh-list
83677011|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677012|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
83677013|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677014|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
83677015|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677016|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
83677017|NCT01610362|Antibodies|antibodies|mesh-list
83677018|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
83677019|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83677020|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83677021|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
83677022|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
83677023|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677024|NCT01610401|Metformin|metformin|mesh-list
83677025|NCT01610401|Caffeine|caffeine|mesh-list
83677026|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677027|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677028|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83677029|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83677030|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677031|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677032|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83677033|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83677034|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
83677035|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677036|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
83677037|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677038|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83677039|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82831804|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
83677040|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677041|NCT01610869|Nintedanib|nintedanib|mesh-list
83677042|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677043|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677044|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677045|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677046|NCT01610921|Adenosine|adenosine|mesh-list
83677047|NCT01610921|Analgesics|analgesics|mesh-ancestor
83677048|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
83677049|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677050|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677051|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83677052|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
83677053|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83677054|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
83677055|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
83677056|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677057|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677058|NCT01610934|Liraglutide|liraglutide|mesh-list
83677059|NCT01610934|Glimepiride|glimepiride|mesh-list
83677060|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677061|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677062|NCT01610934|Incretins|incretins|mesh-ancestor
83677063|NCT01610934|Hormones|hormones|mesh-ancestor
83677064|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677065|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83677066|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677067|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
83677068|NCT01610947|Adalimumab|adalimumab|mesh-list
83677069|NCT01610947|Infliximab|infliximab|mesh-list
83677070|NCT01610947|Golimumab|golimumab|mesh-list
83677071|NCT01610947|Etanercept|etanercept|mesh-list
83677072|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83677073|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83677074|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677075|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677076|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677077|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83677078|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83677079|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83677080|NCT01610947|Analgesics|analgesics|mesh-ancestor
83677081|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
83677082|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677083|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677084|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677085|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
83677086|NCT01610999|Plerixafor|plerixafor|mesh-list
83677087|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83677088|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83677089|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
83677090|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677091|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
83677092|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83677093|NCT01611038|Protective Agents|protective agents|mesh-ancestor
83677094|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677095|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677096|NCT01611077|Amlodipine|amlodipine|mesh-list
83677097|NCT01611077|Candesartan|candesartan|mesh-list
83677098|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
83677099|NCT01611077|Olmesartan|olmesartan|mesh-list
83677100|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83677101|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83677102|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83677103|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677104|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677105|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83677106|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677107|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
83677108|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83677109|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83677110|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
83677111|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677112|NCT01611311|BI 409306|bi 409306|mesh-list
83677113|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83677114|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677115|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677116|NCT01611324|Epinephrine|epinephrine|mesh-list
83677117|NCT01611324|Mepivacaine|mepivacaine|mesh-list
83677118|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83677119|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83677120|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
83677121|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677122|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677123|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677124|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83677125|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83677126|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
83677127|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677128|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83677129|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
83677130|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
83677131|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
83677132|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83677133|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
83677134|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
83677135|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677136|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
83677137|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
83677138|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83677139|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677140|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677141|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677142|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
83677143|NCT01611415|Furosemide|furosemide|mesh-list
83677144|NCT01611415|Diuretics|diuretics|mesh-ancestor
83677145|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
83677146|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677147|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83677148|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677149|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677150|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83677151|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677152|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
83677153|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83677154|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677155|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677156|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677157|NCT01611480|Imiquimod|imiquimod|mesh-list
83677158|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83677159|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
83677160|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677161|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677162|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
83677163|NCT01611506|Capecitabine|capecitabine|mesh-list
83677164|NCT01611506|Cetuximab|cetuximab|mesh-list
83677165|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677166|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83677167|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
83677168|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677169|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83677170|NCT01611675|Vemurafenib|vemurafenib|mesh-list
83677171|NCT01611675|Leflunomide|leflunomide|mesh-list
83677172|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677173|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677174|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677175|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677176|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677177|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
83677178|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677179|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83677180|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
83677181|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677182|NCT01611727|Cisplatin|cisplatin|mesh-list
83677183|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677184|NCT01611896|Selenium|selenium|mesh-list
83677185|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
83677186|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677187|NCT01611896|Protective Agents|protective agents|mesh-ancestor
83677188|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677189|NCT01611896|Trace Elements|trace elements|mesh-ancestor
83677190|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
83677192|NCT01611909|Expectorants|expectorants|mesh-ancestor
83677193|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
83677194|NCT01611961|Docetaxel|docetaxel|mesh-list
83677195|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677196|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
83677197|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
83677198|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
83677199|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677200|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83677201|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677202|NCT01612065|Misoprostol|misoprostol|mesh-list
83677203|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83677204|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
83677205|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677206|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677207|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83677208|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83677209|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
83677210|NCT01612078|Droxidopa|droxidopa|mesh-list
83677211|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83677212|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83677213|NCT01612247|Aspirin|aspirin|mesh-list
83677214|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
83677215|NCT01612247|Methotrexate|methotrexate|mesh-list
83677216|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677217|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
83677218|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677219|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677220|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83677221|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
83677222|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677223|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677224|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83677225|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83677226|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
83677227|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677228|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83677229|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
83413665|NCT03045510|Decitabine|decitabine|mesh-list
83677230|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677231|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677232|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83677233|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83677234|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83677235|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83677236|NCT01612247|Analgesics|analgesics|mesh-ancestor
83677237|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
83677238|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677239|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677240|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83677241|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83677242|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83677243|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83677244|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
83677245|NCT01612273|Aspirin|aspirin|mesh-list
83677246|NCT01612273|Triflusal|triflusal|mesh-list
83677247|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83677248|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83677249|NCT01612273|Analgesics|analgesics|mesh-ancestor
83677250|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
83677251|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677252|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677253|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677254|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677255|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83677256|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83677257|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677258|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83677259|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83677260|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677261|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
83677262|NCT01612286|Endostatins|endostatins|mesh-list
83677263|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83677264|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83677265|NCT01612286|Growth Substances|growth substances|mesh-ancestor
82832031|NCT00467597|Levodopa|levodopa|mesh-list
83677266|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677267|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
83677268|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677269|NCT01612299|Everolimus|everolimus|mesh-list
83677270|NCT01612299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83677271|NCT01612299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677272|NCT01612299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677273|NCT01612299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677274|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677275|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
83677276|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677277|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677278|NCT01612377|Prednisone|prednisone|mesh-list
83677279|NCT01612377|Prednisolone|prednisolone|mesh-list
83677280|NCT01612377|Dipyridamole|dipyridamole|mesh-list
83677281|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677282|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
83677283|NCT01612377|Hormones|hormones|mesh-ancestor
83677284|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677285|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677286|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83677287|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677288|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83677289|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677290|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677291|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83677292|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
83677293|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
83677294|NCT01612403|Astringents|astringents|mesh-ancestor
83677295|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677296|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677297|NCT01612468|Liraglutide|liraglutide|mesh-list
83677298|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677299|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677300|NCT01612468|Incretins|incretins|mesh-ancestor
83677301|NCT01612468|Hormones|hormones|mesh-ancestor
83677302|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677303|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83677304|NCT01612507|Cephalosporins|cephalosporins|mesh-list
83677305|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83677306|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677307|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83677308|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83677309|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677310|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677311|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83677312|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
83677313|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677314|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677315|NCT01612741|Acarbose|acarbose|mesh-list
83677316|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83677317|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677318|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677319|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677320|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677321|NCT01612832|Pregabalin|pregabalin|mesh-list
83677322|NCT01612832|Analgesics|analgesics|mesh-ancestor
83677323|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
83677324|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677325|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677326|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
83677327|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83677328|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677329|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677330|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83677331|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83677332|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83677333|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677334|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83677335|NCT01612871|Tamoxifen|tamoxifen|mesh-list
83677336|NCT01612871|Letrozole|letrozole|mesh-list
83677337|NCT01612871|Anastrozole|anastrozole|mesh-list
83677338|NCT01612871|Exemestane|exemestane|mesh-list
82832103|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677339|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677340|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83677341|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83677342|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677343|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677344|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83677345|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
83677346|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677347|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677348|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83677349|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83677350|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83677351|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83677352|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83677353|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83677354|NCT01612910|Protective Agents|protective agents|mesh-ancestor
83677355|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677356|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677357|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83677358|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83677359|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677361|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83677362|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83677363|NCT01612975|Analgesics|analgesics|mesh-ancestor
83677364|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
83677365|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677366|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677367|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677368|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677369|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
83677370|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83677371|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677372|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677373|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
83677374|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83677375|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83677376|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677377|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83677378|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83677379|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677380|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677381|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677382|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83677383|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
83677384|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677385|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677386|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83677387|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83677388|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83677389|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
83677390|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677391|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677392|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677393|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677394|NCT01613079|Methotrexate|methotrexate|mesh-list
83677395|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83677396|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
83677397|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677398|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677399|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83677400|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
83677401|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677402|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677403|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677404|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677405|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83677406|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677407|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
83677408|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677409|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83677410|NCT01613092|Vancomycin|vancomycin|mesh-list
83677411|NCT01613092|Clindamycin|clindamycin|mesh-list
83677412|NCT01613092|Cefazolin|cefazolin|mesh-list
83677413|NCT01613092|Cephalexin|cephalexin|mesh-list
83677414|NCT01613092|Bacitracin|bacitracin|mesh-list
83677415|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83677416|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677417|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83677418|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677419|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677420|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83677421|NCT01613105|Acarbose|acarbose|mesh-list
83677422|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83677423|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677424|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677425|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677426|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677427|NCT01613170|Estrogens|estrogens|mesh-list
83677428|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83677429|NCT01613170|Hormones|hormones|mesh-ancestor
83677430|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677431|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677432|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
83677433|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
83677434|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677435|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
83677436|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677437|NCT01613209|Candesartan|candesartan|mesh-list
83677438|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
83677439|NCT01613209|Olmesartan|olmesartan|mesh-list
83677440|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83677441|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83677442|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83677443|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677444|NCT01613300|Ofatumumab|ofatumumab|mesh-list
83677445|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677446|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
83677447|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83677448|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83677449|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83413887|NCT03042234|Insulin|insulin|mesh-list
83677450|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
83677451|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677452|NCT01613469|Leucovorin|leucovorin|mesh-list
83677453|NCT01613469|Antidotes|antidotes|mesh-ancestor
83677454|NCT01613469|Protective Agents|protective agents|mesh-ancestor
83677455|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677456|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
83677457|NCT01613469|Vitamins|vitamins|mesh-ancestor
83677458|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
83677459|NCT01613482|Trastuzumab|trastuzumab|mesh-list
83677460|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83677461|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677462|NCT01613534|Sucralfate|sucralfate|mesh-list
83677463|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83677464|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83677465|NCT01613547|Amoxicillin|amoxicillin|mesh-list
83677466|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83677467|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677468|NCT01613573|Hormones|hormones|mesh-list
83677469|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677470|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677471|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83677472|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
83677473|NCT01613664|Coagulants|coagulants|mesh-ancestor
83677474|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
83677475|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83677476|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83677477|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83677478|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
83677479|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677480|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677481|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832252|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83677482|NCT01613755|Metformin|metformin|mesh-list
83677483|NCT01613755|Dipyridamole|dipyridamole|mesh-list
83677484|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677485|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832253|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677486|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83677487|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677488|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677489|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83677490|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
83677491|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83677492|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83677493|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83677494|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
83677495|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677496|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83677497|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83677498|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677499|NCT01613807|Insulin|insulin|mesh-list
83677500|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83677501|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
83677502|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
83677503|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
83677504|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677505|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677506|NCT01613820|Scopolamine|scopolamine|mesh-list
83677507|NCT01613820|Ketamine|ketamine|mesh-list
83677508|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83677509|NCT01613820|Analgesics|analgesics|mesh-ancestor
83677510|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
83677511|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677512|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677513|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83677514|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83677515|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
83677516|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
83677517|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677518|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83677519|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83677520|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677521|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677522|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83677523|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
83677524|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
83677525|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83677526|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
83677527|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83677528|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
83677529|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83677530|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
83677531|NCT01613846|Sorafenib|sorafenib|mesh-list
83677532|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677533|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677534|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677535|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677536|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83677537|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677538|NCT01613963|Cyclosporine|cyclosporine|mesh-list
83677539|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
83677540|NCT01613963|Prednisolone|prednisolone|mesh-list
83677541|NCT01613963|Adalimumab|adalimumab|mesh-list
83677542|NCT01613963|Infliximab|infliximab|mesh-list
83677543|NCT01613963|Etanercept|etanercept|mesh-list
83677544|NCT01613963|Methotrexate|methotrexate|mesh-list
83677545|NCT01613963|Azathioprine|azathioprine|mesh-list
83677546|NCT01613963|Cyclosporins|cyclosporins|mesh-list
83677547|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83677548|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677549|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
83677550|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677551|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677552|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83677553|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
83677554|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677555|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83677556|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
83677557|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677558|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677559|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677560|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83677561|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83677562|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
83677563|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677564|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83677565|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83677566|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83677567|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
83677568|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83677569|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677570|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
83677571|NCT01613963|Hormones|hormones|mesh-ancestor
83677572|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677573|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83677574|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677575|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83677576|NCT01613963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83677577|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83677578|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83677579|NCT01613963|Analgesics|analgesics|mesh-ancestor
83677580|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
83677581|NCT01613976|Panobinostat|panobinostat|mesh-list
83677582|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677583|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83677584|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677585|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677586|NCT01614041|Tandospirone|tandospirone|mesh-list
83677587|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83677588|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83677589|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677590|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677591|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83677592|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83677593|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
83677594|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677595|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677596|NCT01614132|Cisplatin|cisplatin|mesh-list
83677597|NCT01614132|Vincristine|vincristine|mesh-list
83677598|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677599|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677600|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83677601|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
83677602|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
83677603|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
83677604|NCT01614197|Cytarabine|cytarabine|mesh-list
83677605|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
83677606|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83677607|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83677608|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83677609|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
83677610|NCT01614197|Methotrexate|methotrexate|mesh-list
83677611|NCT01614197|Etoposide|etoposide|mesh-list
83677612|NCT01614197|Etoposide phosphate|etoposide phosphate|mesh-list
83677613|NCT01614197|Temsirolimus|temsirolimus|mesh-list
83677614|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677615|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
83677616|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677617|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677618|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83677619|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
83677620|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677621|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677622|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83677623|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83677624|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
83677625|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677626|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83677627|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
83677628|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
83677629|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677630|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83677631|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83677632|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83677633|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83677634|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82832404|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677635|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
83677636|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677637|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677638|NCT01614197|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83677639|NCT01614197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677640|NCT01614223|Betamethasone|betamethasone|mesh-list
83677641|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677642|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
83677643|NCT01614223|Hormones|hormones|mesh-ancestor
83677644|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677645|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677646|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83677647|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
83677648|NCT01614236|Pregabalin|pregabalin|mesh-list
83677649|NCT01614236|Analgesics|analgesics|mesh-ancestor
83677650|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
83677651|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677652|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677653|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
83677654|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83677655|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677656|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677657|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83677658|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83677659|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83677660|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677661|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83677662|NCT01614301|Pioglitazone|pioglitazone|mesh-list
83677663|NCT01614301|Sirolimus|sirolimus|mesh-list
83677664|NCT01614301|Etoricoxib|etoricoxib|mesh-list
83677665|NCT01614301|Temsirolimus|temsirolimus|mesh-list
83677666|NCT01614301|MTOR Inhibitors|mtor inhibitors|mesh-list
83677667|NCT01614301|Dacarbazine|dacarbazine|mesh-list
83677668|NCT01614301|Trofosfamide|trofosfamide|mesh-list
83677669|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677670|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677671|NCT01614301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677672|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677673|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677674|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677675|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
83677676|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677677|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83677678|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677679|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83677680|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
83677681|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83677682|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
83677683|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83677684|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83677685|NCT01614301|Analgesics|analgesics|mesh-ancestor
83677686|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
83677687|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677688|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83677689|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83677690|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83677691|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83677692|NCT01614366|Amlodipine|amlodipine|mesh-list
83677693|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83677694|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83677695|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677696|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677697|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83677698|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677699|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
83677700|NCT01614405|Ritonavir|ritonavir|mesh-list
83677701|NCT01614405|Lopinavir|lopinavir|mesh-list
83677702|NCT01614405|Tenofovir|tenofovir|mesh-list
83677703|NCT01614405|Emtricitabine|emtricitabine|mesh-list
83677704|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83677705|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83677706|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83677707|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
83677708|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677709|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677710|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83677711|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83677712|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
83677713|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677714|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83677715|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83677716|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83677717|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83677718|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
83677719|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83677720|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
83677721|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677722|NCT01614431|Expectorants|expectorants|mesh-ancestor
83677723|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
83677724|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83677725|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
83677726|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677727|NCT01614431|Protective Agents|protective agents|mesh-ancestor
83677728|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677729|NCT01614431|Antidotes|antidotes|mesh-ancestor
83677730|NCT01614496|Insulin|insulin|mesh-list
83677731|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677732|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677733|NCT01614535|Remifentanil|remifentanil|mesh-list
83677734|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83677735|NCT01614535|Narcotics|narcotics|mesh-ancestor
83677736|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677737|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677738|NCT01614535|Analgesics|analgesics|mesh-ancestor
83677739|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
83677740|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677741|NCT01614938|Cisplatin|cisplatin|mesh-list
83677742|NCT01614938|Docetaxel|docetaxel|mesh-list
83677743|NCT01614938|Cetuximab|cetuximab|mesh-list
83677744|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677745|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
83677746|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
83677747|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
83677748|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83414191|NCT01418001|Docetaxel|docetaxel|mesh-list
83677749|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83677750|NCT01614964|Lumefantrine|lumefantrine|mesh-list
83677751|NCT01614964|Artemether|artemether|mesh-list
83677752|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83677753|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
83677754|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83677755|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83677756|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677757|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83677758|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83677759|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83677760|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
83677761|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677762|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83677763|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83677764|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677765|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83677766|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
83677767|NCT01615042|Lenalidomide|lenalidomide|mesh-list
83677768|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
83677769|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677770|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83677771|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83677772|NCT01615042|Growth Substances|growth substances|mesh-ancestor
83677773|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
83677774|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677775|NCT01615055|Fluoxetine|fluoxetine|mesh-list
83677776|NCT01615055|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83677777|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83677778|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677779|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677780|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677781|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
83677782|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677783|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83677784|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
83677785|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83677786|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83677787|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83677788|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677790|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677791|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677792|NCT01615107|Oxytocin|oxytocin|mesh-list
83677793|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
83677794|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677795|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677796|NCT01615185|Amisulpride|amisulpride|mesh-list
83677797|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83677798|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83677799|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677800|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677801|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83677802|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83677803|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
83677804|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677805|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677806|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83677807|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
83677808|NCT01615211|Letrozole|letrozole|mesh-list
83677809|NCT01615211|Trilostane|trilostane|mesh-list
83677810|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677811|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83677812|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83677813|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677814|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677815|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83677816|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
83677817|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677818|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677819|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83677820|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
83677821|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677822|NCT01615224|Misoprostol|misoprostol|mesh-list
83677823|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83677824|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
83677825|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677826|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677827|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83677828|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83677829|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
83677830|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83677831|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83677832|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83677833|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83677834|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
83677835|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677836|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677837|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83677838|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83677839|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83677840|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83677841|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83677842|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83677843|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83677844|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83677845|NCT01615393|Ribavirin|ribavirin|mesh-list
83677846|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
83677847|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677848|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
83677849|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677850|NCT01615445|Resveratrol|resveratrol|mesh-list
83677851|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
83677852|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677853|NCT01615445|Protective Agents|protective agents|mesh-ancestor
83677854|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677855|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832628|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83677856|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83677857|NCT01615601|Ritonavir|ritonavir|mesh-list
83677858|NCT01615601|Darunavir|darunavir|mesh-list
83677859|NCT01615601|Etravirine|etravirine|mesh-list
83677860|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83677861|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83677862|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83677863|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
83677864|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677865|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677866|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83677867|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
83677868|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677869|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83677870|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83677871|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83677872|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83677873|NCT01615614|Rilpivirine|rilpivirine|mesh-list
83677874|NCT01615614|Rifabutin|rifabutin|mesh-list
83677875|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83677876|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83677877|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677878|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677879|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
83677880|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677881|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83677882|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83677883|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83677884|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83677885|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
83677886|NCT01615627|Treprostinil|treprostinil|mesh-list
83677887|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83677888|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83677889|NCT01615757|Cytarabine|cytarabine|mesh-list
83677890|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83677891|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
83677892|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677893|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677894|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
83677895|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677896|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677897|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
83677898|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677899|NCT01615796|Gepotidacin|gepotidacin|mesh-list
83677900|NCT01615796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83677901|NCT01615796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677902|NCT01615796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677903|NCT01615796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677904|NCT01615913|Ketoconazole|ketoconazole|mesh-list
83677905|NCT01615913|Terbinafine|terbinafine|mesh-list
83677906|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
83677907|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677908|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83677909|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83677910|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677911|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677912|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83677913|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
83677914|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677915|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677916|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83677917|NCT01615978|Liraglutide|liraglutide|mesh-list
83677918|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83677919|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677920|NCT01615978|Incretins|incretins|mesh-ancestor
83677921|NCT01615978|Hormones|hormones|mesh-ancestor
83677922|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677923|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
83677924|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83677925|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
83677926|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
83677927|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832703|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83677928|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677929|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83677930|NCT01616004|Analgesics|analgesics|mesh-ancestor
83677931|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
83677932|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677933|NCT01616069|Simendan|simendan|mesh-list
83677934|NCT01616069|Epinephrine|epinephrine|mesh-list
83677935|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83677936|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83677937|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
83677938|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83677939|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677940|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677941|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83677942|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83677943|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
83677944|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677945|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83677946|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
83677947|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
83677948|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
83677949|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83677950|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83677951|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
83677952|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83677953|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83677954|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677955|NCT01616069|Protective Agents|protective agents|mesh-ancestor
83677956|NCT01616108|Bupivacaine|bupivacaine|mesh-list
83677957|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
83677958|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
83677959|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83677960|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677961|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
83677962|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83677963|NCT01616186|Everolimus|everolimus|mesh-list
83677964|NCT01616186|Sorafenib|sorafenib|mesh-list
83677965|NCT01616186|Sunitinib|sunitinib|mesh-list
83677966|NCT01616186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83677967|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83677968|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677969|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677970|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83677971|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
83677972|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677973|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83677974|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83677975|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83677976|NCT01616186|Growth Substances|growth substances|mesh-ancestor
83677977|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
83677978|NCT01616225|Hormones|hormones|mesh-list
83677979|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83677980|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677981|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83677982|NCT01616355|Eusol|eusol|mesh-list
83677983|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
83677984|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83677985|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
83677986|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
83677987|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83677988|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83677989|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83677990|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83677991|NCT01616381|Urological Agents|urological agents|mesh-ancestor
83677992|NCT01616407|Methylphenidate|methylphenidate|mesh-list
83677993|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83677994|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83677995|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83677996|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83677997|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83677998|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83677999|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678000|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
83678001|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678002|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
82832781|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
83678003|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678004|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
83678005|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83678006|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678007|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
83678008|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
83678009|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678010|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
83678011|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83678012|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83678013|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678014|NCT01616485|Urological Agents|urological agents|mesh-ancestor
83678015|NCT01616615|Aspirin|aspirin|mesh-list
83678016|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83678017|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83678018|NCT01616615|Analgesics|analgesics|mesh-ancestor
83678019|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
83678020|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678021|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678022|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678023|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678024|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83678025|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83678026|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678027|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83678028|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83678029|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678030|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
83678031|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83678032|NCT01616680|Antibodies|antibodies|mesh-list
83678033|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
83678034|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83678035|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
83678036|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
83678037|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678038|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83678039|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678040|NCT01616680|Immunotoxins|immunotoxins|mesh-ancestor
83678041|NCT01616732|Testosterone|testosterone|mesh-list
83678042|NCT01616732|Androgens|androgens|mesh-ancestor
83678043|NCT01616732|Hormones|hormones|mesh-ancestor
83678044|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678045|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678046|NCT01616784|Insulin|insulin|mesh-list
83678047|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83678048|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
83678049|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678050|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678051|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
83678052|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678053|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83678054|NCT01616875|Cisplatin|cisplatin|mesh-list
83678055|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678056|NCT01616888|Paclitaxel|paclitaxel|mesh-list
83678057|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83678058|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678059|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83678060|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83678061|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83678062|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678063|NCT01616927|Lanreotide|lanreotide|mesh-list
83678064|NCT01616927|Somatostatin|somatostatin|mesh-list
83678065|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678066|NCT01616927|Hormones|hormones|mesh-ancestor
83678067|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678068|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678069|NCT01616966|Remifentanil|remifentanil|mesh-list
83678070|NCT01616966|Propofol|propofol|mesh-list
83678071|NCT01616966|Sevoflurane|sevoflurane|mesh-list
83678072|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83678073|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678074|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678075|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83678076|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
83678077|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
83678078|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82832851|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678079|NCT01616966|Narcotics|narcotics|mesh-ancestor
83678080|NCT01616966|Analgesics|analgesics|mesh-ancestor
83678081|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
83678082|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678083|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83678084|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83678085|NCT01616992|Bupivacaine|bupivacaine|mesh-list
83678086|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
83678087|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
83678088|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678089|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678090|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
83678091|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678092|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
83678093|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83678094|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678096|NCT01617135|Carbidopa|carbidopa|mesh-list
83678097|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83678098|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83678099|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83678100|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
83678101|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678102|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678103|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678104|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83678105|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678106|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83678107|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
83678108|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
83678109|NCT01617200|Olanzapine|olanzapine|mesh-list
83678110|NCT01617200|Asenapine|asenapine|mesh-list
83678111|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
83678112|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
83678113|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678114|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678115|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83678116|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83678117|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83678118|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678119|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678120|NCT01617200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83678121|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83678122|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678123|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678124|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678125|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
83678126|NCT01617213|Lenalidomide|lenalidomide|mesh-list
83678127|NCT01617213|Melphalan|melphalan|mesh-list
83678128|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
83678129|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678130|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83678131|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83678132|NCT01617213|Growth Substances|growth substances|mesh-ancestor
83678133|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
83678134|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678135|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83678136|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
83678137|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678138|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83678139|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678140|NCT01617226|Azacitidine|azacitidine|mesh-list
83678141|NCT01617226|Vorinostat|vorinostat|mesh-list
83678142|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83678143|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
83678144|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678145|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678146|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678147|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83678148|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
83678149|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83678150|NCT01617317|Antibodies|antibodies|mesh-list
83678151|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
83678152|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83678153|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
83678154|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678155|NCT01617356|Lidocaine|lidocaine|mesh-list
83678156|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
83678157|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
83678158|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678159|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678160|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
83678161|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678162|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83678163|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83678164|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83678165|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678166|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678167|NCT01617538|Atorvastatin|atorvastatin|mesh-list
83678168|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83678169|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83678170|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
83678171|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678172|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83678173|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83678174|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678175|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83678176|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678177|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678178|NCT01617564|Bupivacaine|bupivacaine|mesh-list
83678179|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
83678180|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
83678181|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678182|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678183|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
83678184|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678185|NCT01617590|Methotrexate|methotrexate|mesh-list
83678186|NCT01617590|Leflunomide|leflunomide|mesh-list
83678187|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83678188|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
83678189|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83678190|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678191|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83678192|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
83678193|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678194|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678195|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
83678196|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678197|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83678198|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678199|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
83678200|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678201|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83678202|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
83678203|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83678204|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678205|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678206|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83678207|NCT01617694|Analgesics|analgesics|mesh-ancestor
83678208|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
83678209|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678210|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83678211|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83678212|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83678213|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678214|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678215|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678216|NCT01617707|Midazolam|midazolam|mesh-list
83678217|NCT01617707|Propofol|propofol|mesh-list
83678218|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83678219|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678220|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678221|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83678222|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
83678223|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
83678224|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83678225|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82833004|NCT01026467|Carboplatin|carboplatin|mesh-list
83678226|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83678227|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678228|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
83678229|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
83678230|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678231|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678232|NCT01617733|Pasireotide|pasireotide|mesh-list
83678233|NCT01617733|Hormones|hormones|mesh-ancestor
83678234|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678235|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678236|NCT01617746|Bosentan|bosentan|mesh-list
83678237|NCT01617746|Ambrisentan|ambrisentan|mesh-list
83678238|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83678239|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83678240|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678241|NCT01617772|Atorvastatin|atorvastatin|mesh-list
83678242|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83678243|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83678244|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
83678245|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678246|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83678247|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83678248|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678249|NCT01617798|Metolazone|metolazone|mesh-list
83678250|NCT01617798|Furosemide|furosemide|mesh-list
83678251|NCT01617798|Diuretics|diuretics|mesh-ancestor
83678252|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
83678253|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678254|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83678255|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678256|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678257|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83678258|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83678259|NCT01617811|Anesthetics|anesthetics|mesh-list
83678260|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678261|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678262|NCT01617824|Linagliptin|linagliptin|mesh-list
83678263|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678264|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678265|NCT01617824|Incretins|incretins|mesh-ancestor
83678266|NCT01617824|Hormones|hormones|mesh-ancestor
83678267|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678268|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83678269|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
83678270|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678271|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678272|NCT01617928|Paclitaxel|paclitaxel|mesh-list
83678273|NCT01617928|Carboplatin|carboplatin|mesh-list
83678274|NCT01617928|Veliparib|veliparib|mesh-list
83678275|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83678276|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678277|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
83678278|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
83678279|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
83678280|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678281|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83678282|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678283|NCT01618006|Aspirin|aspirin|mesh-list
83678284|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83678285|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83678286|NCT01618006|Analgesics|analgesics|mesh-ancestor
83678287|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
83678288|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678289|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678290|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678291|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678292|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83678293|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83678294|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678295|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83678296|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83678297|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678298|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
83678299|NCT01618253|Sorafenib|sorafenib|mesh-list
83678300|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678301|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83678302|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678303|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678304|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83678305|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678306|NCT01618396|Midazolam|midazolam|mesh-list
83678307|NCT01618396|Propofol|propofol|mesh-list
83678308|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83678309|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678310|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678311|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83678312|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
83678313|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
83678314|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83678315|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83678316|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83678317|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678318|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
83678319|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
83678320|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678321|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678322|NCT01618188|Insulin|insulin|mesh-list
83678323|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83678324|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
83678325|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
83678326|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83678327|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678328|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678329|NCT01618448|Tolvaptan|tolvaptan|mesh-list
83678330|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83678331|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678332|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
83678333|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678334|NCT01618474|Docetaxel|docetaxel|mesh-list
83678335|NCT01618474|Capecitabine|capecitabine|mesh-list
83678336|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678337|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
83678338|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
83678339|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
83678340|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678341|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83678342|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
83678343|NCT01618513|Octreotide|octreotide|mesh-list
83678344|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83678345|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83678346|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678347|NCT01618539|Propofol|propofol|mesh-list
83678348|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83678349|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678350|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678351|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83678352|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
83678353|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
83678354|NCT01618591|Azithromycin|azithromycin|mesh-list
83678355|NCT01618591|Levofloxacin|levofloxacin|mesh-list
83678356|NCT01618591|Rifaximin|rifaximin|mesh-list
83678357|NCT01618591|Loperamide|loperamide|mesh-list
83678358|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
83678359|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83678360|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678361|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83678362|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83678363|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83678364|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678365|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678366|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678367|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83678368|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83678369|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83678370|NCT01618643|Acetic Acid|acetic acid|mesh-list
83678371|NCT01618643|Retinol acetate|retinol acetate|mesh-list
83678372|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833153|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678373|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678374|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83678376|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678377|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83678378|NCT01618643|Protective Agents|protective agents|mesh-ancestor
83678379|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678380|NCT01618760|Risperidone|risperidone|mesh-list
83678381|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83678382|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
83678383|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678384|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678385|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678386|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83678387|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83678388|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678389|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678390|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83678391|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
83678392|NCT01618773|Adapalene|adapalene|mesh-list
83678393|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83678394|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
83678395|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83678396|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83678397|NCT01618773|Analgesics|analgesics|mesh-ancestor
83678398|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
83678399|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678400|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678401|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678402|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678403|NCT01618799|Lamotrigine|lamotrigine|mesh-list
83678404|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
83678405|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83678406|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678407|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678408|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83678409|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678410|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83678411|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83678412|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678413|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678414|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83678415|NCT01618825|Lamotrigine|lamotrigine|mesh-list
83678416|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
83678417|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83678418|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678419|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678420|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83678421|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678422|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83678423|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83678424|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678425|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678426|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83678427|NCT01618877|Levetiracetam|levetiracetam|mesh-list
83678428|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
83678429|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
83678430|NCT01618890|Propranolol|propranolol|mesh-list
83678431|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83678432|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83678433|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678434|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678435|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678436|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678437|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83678438|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83678439|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
83678440|NCT01618903|Levetiracetam|levetiracetam|mesh-list
83678441|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
83678442|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
83678443|NCT01618929|Montelukast|montelukast|mesh-list
83678444|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83678445|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
83678446|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83678447|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
82833226|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678448|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678449|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678450|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83678451|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83678452|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678453|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
83678454|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83678455|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
83678456|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83678457|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83678458|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678459|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678460|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
83678461|NCT01619046|Factor VIII|factor viii|mesh-list
83678462|NCT01619046|Coagulants|coagulants|mesh-ancestor
83678463|NCT01619072|Misoprostol|misoprostol|mesh-list
83678464|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83678465|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
83678466|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83678467|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678468|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83678469|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83678470|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
83678471|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
83678472|NCT01619137|Povidone|povidone|mesh-list
83678473|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
83678474|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
83678475|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83678476|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678477|NCT01619150|Etoricoxib|etoricoxib|mesh-list
83678478|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83678479|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83678480|NCT01619150|Analgesics|analgesics|mesh-ancestor
83678481|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
83678482|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678483|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678484|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678485|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678486|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83678487|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83678488|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678489|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678490|NCT01619163|Prednisolone|prednisolone|mesh-list
83678491|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678492|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
83678493|NCT01619163|Hormones|hormones|mesh-ancestor
83678494|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678495|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678496|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83678497|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678498|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83678499|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83678500|NCT01619176|Methotrexate|methotrexate|mesh-list
83678501|NCT01619176|Leflunomide|leflunomide|mesh-list
83678502|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83678503|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
83678504|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83678505|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678506|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83678507|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
83678508|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678509|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678510|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
83678511|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678512|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83678513|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678514|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
83678515|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678516|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83678517|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83678518|NCT01619176|Analgesics|analgesics|mesh-ancestor
83678519|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
83678520|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833304|NCT00063154|Pertuzumab|pertuzumab|mesh-list
83678521|NCT01619280|Nitroprusside|nitroprusside|mesh-list
83678522|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83678523|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
83678524|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83678525|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678526|NCT01619436|Clonidine|clonidine|mesh-list
83678527|NCT01619436|Analgesics|analgesics|mesh-ancestor
83678528|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
83678529|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678530|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678531|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83678532|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
83678533|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
83678534|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83678535|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83678536|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83678537|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678538|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678539|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678540|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83678541|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
83678542|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678543|NCT01619527|Darunavir|darunavir|mesh-list
83678544|NCT01619527|Cobicistat|cobicistat|mesh-list
83678545|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83678546|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83678547|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
83678548|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678549|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678550|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83678551|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83678552|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
83678553|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678554|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83678555|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83678556|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83678557|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83678558|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83678559|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678560|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678561|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678562|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678563|NCT01619566|Analgesics|analgesics|mesh-ancestor
83678564|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
83678565|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678566|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
83678567|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678568|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
83678569|NCT01619644|Valproic Acid|valproic acid|mesh-list
83678570|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
83678571|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678572|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678573|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
83678574|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678575|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678576|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
83678577|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83678578|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678579|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678580|NCT01619683|Enclomiphene|enclomiphene|mesh-list
83678581|NCT01619683|Clomiphene|clomiphene|mesh-list
83678582|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
83678583|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83678584|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83678585|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678586|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678587|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83678588|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
83678589|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83678590|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83678591|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83678592|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
83678593|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
83678594|NCT01619761|Melphalan|melphalan|mesh-list
83678595|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
83678596|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83678597|NCT01619761|Rituximab|rituximab|mesh-list
83678598|NCT01619761|Fludarabine|fludarabine|mesh-list
83678599|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
83678600|NCT01619761|Lenalidomide|lenalidomide|mesh-list
83678601|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83678602|NCT01619761|Tacrolimus|tacrolimus|mesh-list
83678603|NCT01619761|Antibodies|antibodies|mesh-list
83678604|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
83678605|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83678606|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678607|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
83678608|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678609|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678610|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83678611|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
83678612|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678613|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678614|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83678615|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83678616|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
83678617|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83678618|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678619|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83678620|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83678621|NCT01619761|Growth Substances|growth substances|mesh-ancestor
83678622|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
83678623|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83678624|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83678625|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
83678626|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83678627|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678628|NCT01619813|Prednisone|prednisone|mesh-list
83678629|NCT01619813|Docetaxel|docetaxel|mesh-list
83678630|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678631|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
83678632|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
83678633|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
83678634|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678635|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678636|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
83678637|NCT01619813|Hormones|hormones|mesh-ancestor
83678638|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678639|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678640|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83678641|NCT01619891|Vitamin D|vitamin d|mesh-list
83678642|NCT01619891|Vitamins|vitamins|mesh-ancestor
83678643|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
83678644|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678645|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83678646|NCT01620112|Lidocaine|lidocaine|mesh-list
83678647|NCT01620112|Clonidine|clonidine|mesh-list
83678648|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
83678649|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
83678650|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678651|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678652|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
83678653|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678654|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83678655|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83678656|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83678657|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678658|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678659|NCT01620112|Analgesics|analgesics|mesh-ancestor
83678660|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83678661|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
83678662|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
83678663|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83678664|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83678665|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83678666|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678667|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678668|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83678669|NCT01620229|Antibodies|antibodies|mesh-list
83678670|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
83678671|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83678672|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
83678673|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
83678674|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678675|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83678676|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678677|NCT01620229|Immunotoxins|immunotoxins|mesh-ancestor
83678678|NCT01620268|Leflunomide|leflunomide|mesh-list
83678679|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678680|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678681|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678682|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
83678683|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678684|NCT01620307|Sirolimus|sirolimus|mesh-list
83678685|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83678686|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678687|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83678688|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678689|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
83678690|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678691|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
83678692|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678693|NCT01620320|Dobutamine|dobutamine|mesh-list
83678694|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83678695|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
83678696|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
83678697|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678698|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678699|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83678700|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83678701|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83678702|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678703|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678704|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678705|NCT01620320|Protective Agents|protective agents|mesh-ancestor
83678706|NCT01620333|Insulin|insulin|mesh-list
83678707|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83678708|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
83678709|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
83678710|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83678711|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
83678712|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678713|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678714|NCT01620424|Insulin|insulin|mesh-list
83678715|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83678716|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
83678717|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
83678718|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83678719|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
83678720|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83678721|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678722|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678723|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
83678724|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
83678725|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678726|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678727|NCT01620450|Insulin|insulin|mesh-list
83678728|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83678729|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678730|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678731|NCT01620463|Liraglutide|liraglutide|mesh-list
83678732|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678733|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678734|NCT01620463|Incretins|incretins|mesh-ancestor
83678735|NCT01620463|Hormones|hormones|mesh-ancestor
83678736|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678737|NCT01620476|Liraglutide|liraglutide|mesh-list
83678738|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678739|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678740|NCT01620476|Incretins|incretins|mesh-ancestor
83678741|NCT01620476|Hormones|hormones|mesh-ancestor
83678742|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678743|NCT01620684|Metyrapone|metyrapone|mesh-list
83678744|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
82833525|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
83678745|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678746|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678747|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
83678748|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83678749|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83678750|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
83678751|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678752|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83678753|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83678754|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678755|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678756|NCT01620814|Misoprostol|misoprostol|mesh-list
83678757|NCT01620814|Dinoprostone|dinoprostone|mesh-list
83678758|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83678759|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
83678760|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83678761|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678762|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83678763|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83678764|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
83678765|NCT01620840|Lacosamide|lacosamide|mesh-list
83678766|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
83678767|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83678768|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83678769|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678770|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678771|NCT01620944|Ritonavir|ritonavir|mesh-list
83678772|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83678773|NCT01620944|Tenofovir|tenofovir|mesh-list
83678774|NCT01620944|Lamivudine|lamivudine|mesh-list
83678775|NCT01620944|Emtricitabine|emtricitabine|mesh-list
83678776|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83678777|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83678778|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
83678779|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678780|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678781|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83678782|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83678783|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
83678784|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678785|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83678786|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83678787|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83678788|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83678789|NCT01621022|Bupropion|bupropion|mesh-list
83678790|NCT01621022|Nicotine|nicotine|mesh-list
83678791|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83678792|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
83678793|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678794|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678795|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83678796|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83678797|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
83678798|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678799|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678800|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83678801|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
83678802|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83678803|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83678804|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83678805|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678806|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
83678807|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83678808|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83678809|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678810|NCT01621100|Hydromorphone|hydromorphone|mesh-list
83678811|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83678812|NCT01621100|Narcotics|narcotics|mesh-ancestor
83678813|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678814|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678815|NCT01621100|Analgesics|analgesics|mesh-ancestor
83678816|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
83678817|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833599|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
83678818|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
83678819|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83678820|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83678821|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678822|NCT01621165|Prazosin|prazosin|mesh-list
83678823|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83678824|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83678825|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83678826|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83678827|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678828|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678829|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678830|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678831|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
83678832|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83678833|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
83678834|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83678835|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
83678836|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678837|NCT01621217|Cetuximab|cetuximab|mesh-list
83678838|NCT01621217|Mitomycins|mitomycins|mesh-list
83678839|NCT01621217|Mitomycin|mitomycin|mesh-list
83678840|NCT01621217|Fluorouracil|fluorouracil|mesh-list
83678841|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83678842|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678843|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83678844|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
83678845|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678846|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83678847|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678848|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
83678849|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83678850|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678851|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
83678852|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678853|NCT01621256|Ancrod|ancrod|mesh-list
83678854|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
83678855|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83678856|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83678857|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678858|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83678859|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83678860|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678861|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83678862|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
83678863|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678864|NCT01621308|Insulin|insulin|mesh-list
83678865|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83678866|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678867|NCT01621321|Voriconazole|voriconazole|mesh-list
83678868|NCT01621321|Prednisolone|prednisolone|mesh-list
83678869|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678870|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
83678871|NCT01621321|Hormones|hormones|mesh-ancestor
83678872|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678873|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678874|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83678875|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678876|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
83678877|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678878|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83678879|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83678880|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678881|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678882|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83678883|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83678884|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83678885|NCT01621373|Propofol|propofol|mesh-list
83678886|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83678887|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678888|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678889|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83678890|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
83678891|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
83678892|NCT01621386|Prednisone|prednisone|mesh-list
82833671|NCT00235716|Vitamin E|vitamin e|mesh-list
82833672|NCT00235716|Tocopherols|tocopherols|mesh-list
83678893|NCT01621386|Montelukast|montelukast|mesh-list
83678894|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678895|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
83678897|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83678898|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678899|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83678900|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83678901|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83678902|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
83678903|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83678904|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
83678905|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83678906|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83678907|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678908|NCT01621451|Aspirin|aspirin|mesh-list
83678909|NCT01621451|Clopidogrel|clopidogrel|mesh-list
83678910|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83678911|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83678912|NCT01621451|Analgesics|analgesics|mesh-ancestor
83678913|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
83678914|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678915|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678916|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83678917|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83678918|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83678919|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83678920|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678921|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83678922|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83678923|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83678924|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
83678925|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83678926|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83678927|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83678928|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
83678929|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678930|NCT01621620|Yohimbine|yohimbine|mesh-list
83678931|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
83678932|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
83678933|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678934|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678935|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83678936|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83678937|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83678938|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
83678939|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678940|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678941|NCT01621620|Urological Agents|urological agents|mesh-ancestor
83678942|NCT01621698|Fentanyl|fentanyl|mesh-list
83678943|NCT01621698|Bupivacaine|bupivacaine|mesh-list
83678944|NCT01621698|Propofol|propofol|mesh-list
83678945|NCT01621698|Atracurium|atracurium|mesh-list
83678946|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
83678947|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
83678948|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83678949|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678950|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
83678951|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83678952|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83678953|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83678954|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
83678955|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83678956|NCT01621698|Narcotics|narcotics|mesh-ancestor
83678957|NCT01621698|Analgesics|analgesics|mesh-ancestor
83678958|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83678959|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83678960|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83678961|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83678962|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83678963|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83678964|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
83678965|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678966|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678968|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83678969|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83678970|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83678971|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83678972|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
83678973|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678974|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678975|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678976|NCT01621763|Clopidogrel|clopidogrel|mesh-list
83678977|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83678978|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83678979|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83678980|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83678981|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
83678982|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83678983|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83678984|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678985|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
83678986|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83678987|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83678988|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83678989|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83678990|NCT01621893|Calcium|calcium|mesh-list
83678991|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83678992|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83678993|NCT01621971|Milrinone|milrinone|mesh-list
83678994|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83678995|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83678996|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
83678997|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83678998|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83678999|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679000|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679001|NCT01621971|Protective Agents|protective agents|mesh-ancestor
83679002|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679003|NCT01622075|Paclitaxel|paclitaxel|mesh-list
83679004|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83679005|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83679006|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679007|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
83679008|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
83679009|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
83679010|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679011|NCT01622283|Cetirizine|cetirizine|mesh-list
83679012|NCT01622283|Levocetirizine|levocetirizine|mesh-list
83679013|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83679014|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83679015|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83679016|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
83679017|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
83679018|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679019|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679020|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679021|NCT01622361|Tamoxifen|tamoxifen|mesh-list
83679022|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
83679023|NCT01622361|Docetaxel|docetaxel|mesh-list
83679024|NCT01622361|Doxorubicin|doxorubicin|mesh-list
83679025|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83679026|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679027|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
83679028|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679029|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83679030|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83679031|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
83679032|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679033|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679034|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83679035|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
83679036|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
83679037|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
83679038|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82833818|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83679039|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83679040|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83679041|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679042|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83679043|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
83679044|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679045|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83679046|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83679047|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83679048|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83679049|NCT01622439|Prednisone|prednisone|mesh-list
83679050|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
83679051|NCT01622439|Rituximab|rituximab|mesh-list
83679052|NCT01622439|Doxorubicin|doxorubicin|mesh-list
83679053|NCT01622439|Vincristine|vincristine|mesh-list
83679054|NCT01622439|Valproic Acid|valproic acid|mesh-list
83679055|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679056|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
83679057|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679058|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83679059|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83679060|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
83679061|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679062|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679063|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83679064|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679065|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83679066|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83679067|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83679068|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679069|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679070|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
83679071|NCT01622439|Hormones|hormones|mesh-ancestor
83679072|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679073|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83679074|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83679075|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
83679076|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
83679077|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
83679078|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
83679079|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
83679080|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679081|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
83679082|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83679083|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679084|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83679085|NCT01622504|Naloxone|naloxone|mesh-list
83679086|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83679087|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679088|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
83679089|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679090|NCT01622556|Fludarabine|fludarabine|mesh-list
83679091|NCT01622556|Busulfan|busulfan|mesh-list
83679092|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
83679093|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679094|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679095|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679096|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
83679097|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679098|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
83679099|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83679100|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83679101|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83679102|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83679103|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83679104|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
83679105|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679106|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83679107|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83679108|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679109|NCT01622790|Lamivudine|lamivudine|mesh-list
83679110|NCT01622790|Abacavir|abacavir|mesh-list
82833891|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83679111|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
82833892|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
83679112|NCT01622790|Dolutegravir|dolutegravir|mesh-list
83679113|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83679114|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83679115|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679116|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679117|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
83679118|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679119|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83679120|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83679121|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83679122|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83679123|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
83679124|NCT01622881|Nefopam|nefopam|mesh-list
83679125|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83679126|NCT01622881|Analgesics|analgesics|mesh-ancestor
83679127|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
83679128|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679129|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679130|NCT01622933|Interferons|interferons|mesh-list
83679131|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
83679132|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679133|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
83679134|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679135|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
83679136|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679137|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
83679138|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83679139|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83679140|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679141|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
83679142|NCT01622946|Coagulants|coagulants|mesh-ancestor
83679143|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83679144|NCT01622972|Laxatives|laxatives|mesh-ancestor
83679145|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83679146|NCT01623024|Vitamin D|vitamin d|mesh-list
83679147|NCT01623024|Vitamins|vitamins|mesh-ancestor
83679148|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
83679149|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679150|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83679151|NCT01623102|Bevacizumab|bevacizumab|mesh-list
83679152|NCT01623102|Cisplatin|cisplatin|mesh-list
83679153|NCT01623102|Gemcitabine|gemcitabine|mesh-list
83679154|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679155|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679156|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83679157|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83679158|NCT01623102|Growth Substances|growth substances|mesh-ancestor
83679159|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679160|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83679161|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83679162|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
83679163|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679164|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83679165|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
83679166|NCT01623206|Coagulants|coagulants|mesh-ancestor
83679167|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83679168|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
83679169|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679170|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83679171|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83679172|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679173|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83679174|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83679175|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
83679176|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
83679177|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679178|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
83679179|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679180|NCT01623349|Olaparib|olaparib|mesh-list
83679181|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83679182|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679183|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679184|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679185|NCT01623362|Fluorides|fluorides|mesh-list
82833965|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
83679186|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
83679187|NCT01623362|Protective Agents|protective agents|mesh-ancestor
83679188|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679190|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83679191|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
83679192|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83679193|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679194|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
83679195|NCT01623401|Tedizolid|tedizolid|mesh-list
83679196|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83679197|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679198|NCT01623440|Naltrexone|naltrexone|mesh-list
83679199|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83679200|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83679201|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679202|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
83679203|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679204|NCT01623505|Varenicline|varenicline|mesh-list
83679205|NCT01623505|Nicotine|nicotine|mesh-list
83679206|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83679207|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83679208|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
83679209|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679210|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679211|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679212|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83679213|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
83679214|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679215|NCT01623570|Menotropins|menotropins|mesh-list
83679216|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83679217|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
83679218|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83679219|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679220|NCT01623609|Naloxegol|naloxegol|mesh-list
83679221|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83679222|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679223|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
83679224|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679225|NCT01623635|Ropivacaine|ropivacaine|mesh-list
83679226|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
83679227|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
83679228|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679229|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679230|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
83679231|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679232|NCT01623713|Risperidone|risperidone|mesh-list
83679233|NCT01623713|Iloperidone|iloperidone|mesh-list
83679234|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83679235|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
83679236|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679237|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679238|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679239|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83679240|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83679241|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679242|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83679243|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83679244|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
83679245|NCT01623778|Interferons|interferons|mesh-list
83679246|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
83679247|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
83679248|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679249|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
83679250|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679251|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
83679252|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679253|NCT01623817|Vancomycin|vancomycin|mesh-list
83679254|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83679255|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679256|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
83679257|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83679258|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679259|NCT01623921|Celecoxib|celecoxib|mesh-list
83679260|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83679261|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83679262|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83679263|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
83679264|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679265|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83679266|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83679267|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679268|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83679269|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83679270|NCT01623921|Analgesics|analgesics|mesh-ancestor
83679271|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
83679272|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679273|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679274|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679275|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83679276|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83679277|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83679278|NCT01624025|Docetaxel|docetaxel|mesh-list
83679279|NCT01624025|Epirubicin|epirubicin|mesh-list
83679280|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679281|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
83679282|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
83679283|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
83679284|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679285|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83679286|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83679287|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83679288|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679289|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
83679290|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679291|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
83679292|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679293|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679294|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83679295|NCT01624051|Cisplatin|cisplatin|mesh-list
83679296|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679297|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
83679298|NCT01624064|Enalapril|enalapril|mesh-list
83679299|NCT01624064|Calcium|calcium|mesh-list
83679300|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83679301|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83679302|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83679303|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679304|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83679305|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
83679306|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679307|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83679308|NCT01624103|Lidocaine|lidocaine|mesh-list
83679309|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
83679310|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
83679311|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
83679312|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679313|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679314|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
83679315|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679316|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83679317|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83679318|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83679319|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83679320|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679321|NCT01624116|Metformin|metformin|mesh-list
83679322|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83679323|NCT01624116|Acarbose|acarbose|mesh-list
83679324|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83679325|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679326|NCT01624116|Incretins|incretins|mesh-ancestor
83679327|NCT01624116|Hormones|hormones|mesh-ancestor
83679328|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679329|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83679330|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
83679331|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679332|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679333|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83679334|NCT01624129|Fluticasone|fluticasone|mesh-list
83679335|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679336|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83679337|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
82834114|NCT00276380|Analgesics|analgesics|mesh-ancestor
83679338|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679339|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679340|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83679341|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
83679342|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
83679343|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83679344|NCT01624207|Atorvastatin|atorvastatin|mesh-list
83679345|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83679346|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83679347|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
83679348|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679349|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83679350|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83679351|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679352|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83679353|NCT01624246|Avibactam|avibactam|mesh-list
83679354|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83679355|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679356|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83679357|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679358|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679359|NCT01624337|Piperaquine|piperaquine|mesh-list
83679360|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
83679361|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83679362|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83679363|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679364|NCT01624428|Varenicline|varenicline|mesh-list
83679365|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83679366|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83679367|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
83679368|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679369|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679370|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679371|NCT01624441|Epirubicin|epirubicin|mesh-list
83679372|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83679373|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679374|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83679375|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83679376|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679377|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679378|NCT01624493|Carboplatin|carboplatin|mesh-list
83679379|NCT01624493|Gemcitabine|gemcitabine|mesh-list
83679380|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679381|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83679382|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
83679383|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679384|NCT01624649|Methylphenidate|methylphenidate|mesh-list
83679385|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83679386|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83679387|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679388|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83679389|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83679390|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83679391|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679392|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
83679393|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679394|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83679395|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83679396|NCT01624675|Risperidone|risperidone|mesh-list
83679397|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83679398|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
83679399|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679400|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679401|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679402|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83679403|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83679404|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679405|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83679406|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83679407|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
83679408|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
83679409|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679410|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834194|NCT01096420|Topiramate|topiramate|mesh-list
83679412|NCT01624766|Everolimus|everolimus|mesh-list
83679413|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83679414|NCT01624766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83679415|NCT01624766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83679416|NCT01624766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679417|NCT01624766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679418|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679419|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
83679420|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679421|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679422|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83679423|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83679424|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83679425|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83679426|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83679427|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
83679428|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679429|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83679430|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83679431|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679432|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83679433|NCT01625026|Cathartics|cathartics|mesh-ancestor
83679434|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83679435|NCT01625260|Gemcitabine|gemcitabine|mesh-list
83679436|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83679437|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
83679438|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679439|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679440|NCT01625351|Sirolimus|sirolimus|mesh-list
83679441|NCT01625351|Fludarabine|fludarabine|mesh-list
83679442|NCT01625351|Melphalan|melphalan|mesh-list
83679443|NCT01625351|Busulfan|busulfan|mesh-list
83679444|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
83679445|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
83679446|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679447|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679448|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679449|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
83679450|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679451|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83679452|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679453|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83679454|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
83679455|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83679456|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
83679457|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83679458|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679459|NCT01625429|Paclitaxel|paclitaxel|mesh-list
83679460|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83679461|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679462|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83679463|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83679464|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83679465|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679466|NCT01625494|Amlodipine|amlodipine|mesh-list
83679467|NCT01625494|Irbesartan|irbesartan|mesh-list
83679468|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83679469|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83679470|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83679471|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679472|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83679473|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679474|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
83679475|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83679476|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83679477|NCT01625520|Everolimus|everolimus|mesh-list
83679478|NCT01625520|Pasireotide|pasireotide|mesh-list
83679479|NCT01625520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83679480|NCT01625520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83679481|NCT01625520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679482|NCT01625520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834265|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679483|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679484|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
83679485|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679486|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679488|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679489|NCT01625572|Morphine|morphine|mesh-list
83679490|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83679491|NCT01625572|Narcotics|narcotics|mesh-ancestor
83679492|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679493|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679494|NCT01625572|Analgesics|analgesics|mesh-ancestor
83679495|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
83679496|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679497|NCT01625715|Ketotifen|ketotifen|mesh-list
83679498|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
83679499|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
83679500|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83679501|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
83679502|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
83679503|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679504|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679505|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679506|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83679507|NCT01625741|Rituximab|rituximab|mesh-list
83679508|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679509|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679510|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
83679511|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679512|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83679513|NCT01625793|Interferons|interferons|mesh-list
83679514|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
83679515|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679516|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
83679517|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679518|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
83679519|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679520|NCT01625806|Ketoconazole|ketoconazole|mesh-list
83679521|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
83679522|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679523|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83679524|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83679525|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679526|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679527|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83679528|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
83679529|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679530|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679531|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83679532|NCT01625871|Lumefantrine|lumefantrine|mesh-list
83679533|NCT01625871|Artemether|artemether|mesh-list
83679534|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83679535|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
83679536|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83679537|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83679538|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679539|NCT01625936|Bevacizumab|bevacizumab|mesh-list
83679540|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679541|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679542|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83679543|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83679544|NCT01625936|Growth Substances|growth substances|mesh-ancestor
83679545|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679546|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
83679547|NCT01625156|Sirolimus|sirolimus|mesh-list
83679548|NCT01625156|Temsirolimus|temsirolimus|mesh-list
83679549|NCT01625156|MTOR Inhibitors|mtor inhibitors|mesh-list
83679550|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83679551|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679552|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83679553|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679554|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
83679555|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679556|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
83679557|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834338|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
83679558|NCT01625156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83679559|NCT01625156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679560|NCT01625156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679561|NCT01626222|Everolimus|everolimus|mesh-list
83679562|NCT01626222|Exemestane|exemestane|mesh-list
83679563|NCT01626222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83679564|NCT01626222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83679565|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679566|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679567|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679568|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
83679569|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679570|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679571|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83679572|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83679573|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83679574|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
83679575|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679576|NCT01626339|Bevacizumab|bevacizumab|mesh-list
83679577|NCT01626339|Ranibizumab|ranibizumab|mesh-list
83679578|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679579|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679580|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83679581|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83679582|NCT01626339|Growth Substances|growth substances|mesh-ancestor
83679583|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679584|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83679585|NCT01626443|Folic Acid|folic acid|mesh-list
83679586|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
83679587|NCT01626443|Inositol|inositol|mesh-list
83679588|NCT01626443|Hematinics|hematinics|mesh-ancestor
83679589|NCT01626443|Vitamins|vitamins|mesh-ancestor
83679590|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
83679591|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679592|NCT01626469|Captopril|captopril|mesh-list
83679593|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83679594|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
83679595|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679596|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679597|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83679598|NCT01626534|Clopidogrel|clopidogrel|mesh-list
83679599|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83679600|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83679601|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83679602|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83679603|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
83679604|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679605|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679606|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679607|NCT01626560|Vancomycin|vancomycin|mesh-list
83679608|NCT01626560|Daptomycin|daptomycin|mesh-list
83679609|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83679610|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679611|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
83679612|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83679613|NCT01626651|Ketoconazole|ketoconazole|mesh-list
83679614|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
83679615|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679616|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83679617|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83679618|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679619|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679620|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83679621|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
83679622|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679623|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679624|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83679625|NCT01626911|Heparin|heparin|mesh-list
83679626|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83679627|NCT01626911|Tinzaparin|tinzaparin|mesh-list
83679628|NCT01626911|Dalteparin|dalteparin|mesh-list
83679629|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
83679630|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83679631|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83679632|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679634|NCT01627041|Decitabine|decitabine|mesh-list
83679635|NCT01627041|Daunorubicin|daunorubicin|mesh-list
83679636|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83679637|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
83679638|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679639|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679640|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
83679641|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679642|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83679643|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
83679644|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679645|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83679646|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83679647|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83679648|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679649|NCT01627106|Amiodarone|amiodarone|mesh-list
83679650|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83679651|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
83679652|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83679653|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83679654|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679655|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83679656|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83679657|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83679658|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679659|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83679660|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83679661|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83679662|NCT01627132|Dasatinib|dasatinib|mesh-list
83679663|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679664|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83679665|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679666|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679667|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
83679668|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83679669|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83679670|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83679671|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679672|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679673|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679674|NCT01627145|Urological Agents|urological agents|mesh-ancestor
83679675|NCT01627158|Budesonide|budesonide|mesh-list
83679676|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
83679677|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83679678|NCT01627158|Charcoal|charcoal|mesh-list
83679679|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679680|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83679681|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
83679682|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679683|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679684|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83679685|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
83679686|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
83679687|NCT01627158|Hormones|hormones|mesh-ancestor
83679688|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679689|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83679690|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83679691|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83679692|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83679693|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679694|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679695|NCT01627158|Antidotes|antidotes|mesh-ancestor
83679696|NCT01627158|Protective Agents|protective agents|mesh-ancestor
83679697|NCT01627171|Bisacodyl|bisacodyl|mesh-list
83679698|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
83679699|NCT01627171|Cathartics|cathartics|mesh-ancestor
83679700|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83679701|NCT01627171|Laxatives|laxatives|mesh-ancestor
83679702|NCT01627223|Lamivudine|lamivudine|mesh-list
83679703|NCT01627223|Entecavir|entecavir|mesh-list
83679704|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83679705|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83679706|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679707|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679708|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
83679709|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679710|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83679711|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83679712|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
83679713|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83679714|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83679715|NCT01627236|Prednisolone|prednisolone|mesh-list
83679716|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
83679717|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83679718|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
83679719|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679720|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
83679721|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
83679722|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679723|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679724|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83679725|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
83679726|NCT01627236|Hormones|hormones|mesh-ancestor
83679727|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679728|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83679729|NCT01627236|Protective Agents|protective agents|mesh-ancestor
83679730|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83679731|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679732|NCT01627262|Mesalamine|mesalamine|mesh-list
83679733|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83679734|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83679735|NCT01627262|Analgesics|analgesics|mesh-ancestor
83679736|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
83679737|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679738|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679739|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679740|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83679741|NCT01627353|Dexamethasone|dexamethasone|mesh-list
83679742|NCT01627353|Lidocaine|lidocaine|mesh-list
83679743|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
83679744|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679745|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
83679746|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
83679747|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679748|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679749|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83679750|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
83679751|NCT01627353|Hormones|hormones|mesh-ancestor
83679752|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679753|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83679754|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679755|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679756|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
83679757|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
83679758|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679759|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
83679760|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83679761|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83679762|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83679763|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83679764|NCT01627353|Analgesics|analgesics|mesh-ancestor
83679765|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
83679766|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83679767|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83679768|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
83679769|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83679770|NCT01627379|Panitumumab|panitumumab|mesh-list
83679771|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679772|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83679773|NCT01627431|Aspirin|aspirin|mesh-list
83679774|NCT01627431|Clopidogrel|clopidogrel|mesh-list
83679775|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83679776|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83679777|NCT01627431|Analgesics|analgesics|mesh-ancestor
83679778|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
83679779|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679780|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679781|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83679782|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83679783|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83679784|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83679785|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679786|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83679787|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83679788|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679789|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
83679790|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83679791|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83679792|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83679793|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
83679794|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679795|NCT01627587|Ketoconazole|ketoconazole|mesh-list
83679796|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
83679797|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679798|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83679799|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83679800|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679801|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679802|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83679803|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
83679804|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679805|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679806|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83679807|NCT01627626|Pilocarpine|pilocarpine|mesh-list
83679808|NCT01627626|Miotics|miotics|mesh-ancestor
83679809|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
83679810|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679811|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679812|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83679813|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83679814|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
83679815|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679816|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679817|NCT01627639|Acetazolamide|acetazolamide|mesh-list
83679818|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
83679819|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83679820|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679821|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679822|NCT01627639|Diuretics|diuretics|mesh-ancestor
83679823|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
83679824|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679825|NCT01627678|Molgramostim|molgramostim|mesh-list
83679826|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83679827|NCT01627678|Sargramostim|sargramostim|mesh-list
83679828|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
83679829|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679830|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679831|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83679832|NCT01627678|Antacids|antacids|mesh-ancestor
83679833|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679834|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83679835|NCT01627717|Maraviroc|maraviroc|mesh-list
83679836|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83679837|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83679838|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679839|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83679840|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83679841|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
83679842|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679843|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83679844|NCT01627834|Ropinirole|ropinirole|mesh-list
83679845|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83679846|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83679847|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
83679848|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
83679849|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679850|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679851|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679852|NCT01627847|Ropinirole|ropinirole|mesh-list
83679853|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83679854|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82834640|NCT03969758|Metronidazole|metronidazole|mesh-list
83679856|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
83679857|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679858|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679859|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679860|NCT01627873|Fentanyl|fentanyl|mesh-list
83679861|NCT01627873|Remifentanil|remifentanil|mesh-list
83679862|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83679863|NCT01627873|Narcotics|narcotics|mesh-ancestor
83679864|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679865|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679866|NCT01627873|Analgesics|analgesics|mesh-ancestor
83679867|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
83679868|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679869|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83679870|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83679871|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
83679872|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
83679873|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
83679874|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83679875|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679876|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
83679877|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
83679878|NCT01627938|Razoxane|razoxane|mesh-list
83679879|NCT01627938|Analgesics|analgesics|mesh-ancestor
83679880|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
83679881|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679882|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679883|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679884|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83679885|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83679886|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679887|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679888|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83679889|NCT01627938|Protective Agents|protective agents|mesh-ancestor
83679890|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
83679891|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
83679892|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
83679893|NCT01628055|Antibodies|antibodies|mesh-list
83679894|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
83679895|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83679896|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83679897|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
83679898|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
83679899|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679900|NCT01628341|Insulin|insulin|mesh-list
83679901|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83679902|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679903|NCT01628354|Ranibizumab|ranibizumab|mesh-list
83679904|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83679905|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83679906|NCT01628354|Growth Substances|growth substances|mesh-ancestor
83679907|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679908|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
83679909|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679910|NCT01628445|Liraglutide|liraglutide|mesh-list
83679911|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83679912|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679913|NCT01628445|Incretins|incretins|mesh-ancestor
83679914|NCT01628445|Hormones|hormones|mesh-ancestor
83679915|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679916|NCT01628471|Decitabine|decitabine|mesh-list
83679917|NCT01628471|Genistein|genistein|mesh-list
83679918|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83679919|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
83679920|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679921|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679922|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679923|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83679924|NCT01628471|Protective Agents|protective agents|mesh-ancestor
83679925|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679926|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83679927|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
83679928|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83679929|NCT01628471|Estrogens|estrogens|mesh-ancestor
83679930|NCT01628471|Hormones|hormones|mesh-ancestor
82834722|NCT00039130|Leucovorin|leucovorin|mesh-list
83679931|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83679932|NCT01628562|Remifentanil|remifentanil|mesh-list
83679933|NCT01628562|Esmolol|esmolol|mesh-list
83679934|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83679935|NCT01628562|Narcotics|narcotics|mesh-ancestor
83679936|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83679937|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679938|NCT01628562|Analgesics|analgesics|mesh-ancestor
83679939|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
83679940|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679941|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83679942|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83679943|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83679944|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
83679945|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679946|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679947|NCT01628666|Vancomycin|vancomycin|mesh-list
83679948|NCT01628666|Cefazolin|cefazolin|mesh-list
83679949|NCT01628666|Cephalexin|cephalexin|mesh-list
83679950|NCT01628666|Bacitracin|bacitracin|mesh-list
83679951|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83679952|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83679953|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83679954|NCT01628731|Furosemide|furosemide|mesh-list
83679955|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
83679956|NCT01628731|Diuretics|diuretics|mesh-ancestor
83679957|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
83679958|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679959|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83679960|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83679961|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679962|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83679963|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83679964|NCT01628770|Hematinics|hematinics|mesh-ancestor
83679965|NCT01628783|Escitalopram|escitalopram|mesh-list
83679966|NCT01628783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83679967|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83679968|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83679969|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679970|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679971|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
83679972|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679973|NCT01628952|Curare|curare|mesh-list
83679974|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83679975|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83679976|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83679977|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83679978|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679979|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83679980|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83679981|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
83679982|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83679983|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679984|NCT01629082|Lenalidomide|lenalidomide|mesh-list
83679985|NCT01629082|Clofarabine|clofarabine|mesh-list
83679986|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
83679987|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83679988|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83679989|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83679990|NCT01629082|Growth Substances|growth substances|mesh-ancestor
83679991|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
83679992|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83679993|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83679994|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
83679995|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83679996|NCT01629173|Ethylene|ethylene|mesh-list
83679997|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83679998|NCT01629173|Growth Substances|growth substances|mesh-ancestor
83679999|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680000|NCT01629199|Mitogens|mitogens|mesh-list
83680001|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83680002|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680003|NCT01629212|Octylonium|octylonium|mesh-list
83680004|NCT01629212|Bromides|bromides|mesh-list
82834792|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
83680006|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
83680007|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
83680008|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
83680009|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680010|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680011|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680012|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680013|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680014|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680015|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83680016|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83680017|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83680018|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
83680019|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680020|NCT01629225|Candesartan|candesartan|mesh-list
83680021|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680022|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83680023|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83680024|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680025|NCT01629251|Insulin|insulin|mesh-list
83680026|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83680027|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680028|NCT01629277|Insulin|insulin|mesh-list
83680029|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83680030|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680031|NCT01629368|Carbamazepine|carbamazepine|mesh-list
83680032|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
83680033|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
83680034|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83680035|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680036|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680037|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83680038|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680039|NCT01629368|Analgesics|analgesics|mesh-ancestor
83680040|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
83680041|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680042|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83680043|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680044|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680045|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83680046|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83680047|NCT01629394|Neostigmine|neostigmine|mesh-list
83680048|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83680049|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680050|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680051|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
83680052|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680053|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680054|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83680055|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
83680056|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680057|NCT01629446|Lofexidine|lofexidine|mesh-list
83680058|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680059|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83680060|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680061|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
83680062|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680063|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83680064|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83680065|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83680066|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680067|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680068|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680069|NCT01629511|Gemcitabine|gemcitabine|mesh-list
83680070|NCT01629511|Methotrexate|methotrexate|mesh-list
83680071|NCT01629511|Clofarabine|clofarabine|mesh-list
83680072|NCT01629511|Busulfan|busulfan|mesh-list
83680073|NCT01629511|Tacrolimus|tacrolimus|mesh-list
83680074|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
83680075|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83680076|NCT01629511|Lenograstim|lenograstim|mesh-list
83680077|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680078|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
83680079|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680080|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680081|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83680082|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
83680083|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83680084|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680085|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
83680086|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680087|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83680088|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680089|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
83680090|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680091|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83680092|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83680093|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83680094|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
83680095|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83680096|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83680097|NCT01629628|Adalimumab|adalimumab|mesh-list
83680098|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
83680099|NCT01629628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83680100|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680101|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680102|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
83680103|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680104|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680105|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680106|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680107|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
83680108|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680109|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83680110|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680111|NCT01629680|Moxaverine|moxaverine|mesh-list
83680112|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
83680113|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
83680114|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680115|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680116|NCT01629732|Ribavirin|ribavirin|mesh-list
83680117|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
83680118|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680119|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
83680120|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680121|NCT01629758|Nivolumab|nivolumab|mesh-list
83680122|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680123|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680124|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83680125|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680126|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83680127|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83680128|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83680129|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680130|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680131|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83680132|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680133|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680134|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
83680135|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680136|NCT01630018|Topotecan|topotecan|mesh-list
83680137|NCT01630018|Belotecan|belotecan|mesh-list
83680138|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83680139|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83680140|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680141|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680142|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680143|NCT01630057|Zonisamide|zonisamide|mesh-list
83680144|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
83680145|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680146|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680147|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680148|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680149|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680150|NCT01630070|Paclitaxel|paclitaxel|mesh-list
82834945|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83680151|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83680152|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680153|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
83680154|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
83680155|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
83680156|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680158|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
83680159|NCT01630083|Epirubicin|epirubicin|mesh-list
83680160|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680161|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
83680162|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680163|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680164|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83680165|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83680166|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83680167|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680168|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83680169|NCT01630096|Laxatives|laxatives|mesh-ancestor
83680170|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83680171|NCT01630148|Bemiparin|bemiparin|mesh-list
83680172|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
83680173|NCT01630187|Carbetocin|carbetocin|mesh-list
83680174|NCT01630187|Oxytocin|oxytocin|mesh-list
83680175|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
83680176|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83680177|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680178|NCT01630226|Cisplatin|cisplatin|mesh-list
83680179|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680180|NCT01630278|Ibuprofen|ibuprofen|mesh-list
83680181|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83680182|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680183|NCT01630278|Analgesics|analgesics|mesh-ancestor
83680184|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
83680185|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680186|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680187|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680188|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680189|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83680190|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680191|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680192|NCT01630343|Acetaminophen|acetaminophen|mesh-list
83680193|NCT01630343|Tramadol|tramadol|mesh-list
83680194|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680195|NCT01630343|Analgesics|analgesics|mesh-ancestor
83680196|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
83680197|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680198|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680199|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
83680200|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83680201|NCT01630343|Narcotics|narcotics|mesh-ancestor
83680202|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680203|NCT01630369|Insulin|insulin|mesh-list
83680204|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83680205|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83680206|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680207|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
83680208|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680209|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
83680210|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680211|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680212|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83680213|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
83680214|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680215|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680216|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83680217|NCT01630564|Aldesleukin|aldesleukin|mesh-list
83680218|NCT01630564|Interleukin-2|interleukin-2|mesh-list
83680219|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680220|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680221|NCT01630564|Analgesics|analgesics|mesh-ancestor
83680222|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
83680223|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680224|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680225|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83680226|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83680227|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
83680228|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680229|NCT01630642|Clopidogrel|clopidogrel|mesh-list
83680230|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83680231|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83680232|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83680233|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83680234|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
83680235|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680236|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680237|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680238|NCT01630655|Felodipine|felodipine|mesh-list
83680239|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83680240|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680241|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680242|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680243|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680244|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680245|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680246|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
83680247|NCT01630720|Vitamin D|vitamin d|mesh-list
83680248|NCT01630720|Vitamins|vitamins|mesh-list
83680249|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
83680250|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680251|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83680252|NCT01630733|Docetaxel|docetaxel|mesh-list
83680253|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680254|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
83680255|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
83680256|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
83680257|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680258|NCT01630902|Felodipine|felodipine|mesh-list
83680259|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83680260|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680261|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680262|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680263|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680264|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680265|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680266|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
83680267|NCT01630915|Clopidogrel|clopidogrel|mesh-list
83680268|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83680269|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83680270|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83680271|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83680272|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
83680273|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680274|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680275|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680276|NCT01630941|Denosumab|denosumab|mesh-list
83680277|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83680278|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680279|NCT01631058|Prednisone|prednisone|mesh-list
83680280|NCT01631058|Everolimus|everolimus|mesh-list
83680281|NCT01631058|Lactitol|lactitol|mesh-list
83680282|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680283|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
83680284|NCT01631058|Hormones|hormones|mesh-ancestor
83680285|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83680286|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680287|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83680288|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680289|NCT01631058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83680290|NCT01631058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83680291|NCT01631058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680292|NCT01631058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680293|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680294|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
83680295|NCT01631058|Cathartics|cathartics|mesh-ancestor
83680296|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83680297|NCT01631097|Tivozanib|tivozanib|mesh-list
83680298|NCT01631097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83680299|NCT01631097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680300|NCT01631097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680301|NCT01631136|Cisplatin|cisplatin|mesh-list
83680302|NCT01631136|Gemcitabine|gemcitabine|mesh-list
83680303|NCT01631136|Pemetrexed|pemetrexed|mesh-list
83680304|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680305|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680306|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
83680307|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680308|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680309|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83680310|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83680311|NCT01631201|Azithromycin|azithromycin|mesh-list
83680312|NCT01631201|KRM 1648|krm 1648|mesh-list
83680313|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83680314|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680315|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83680316|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
83680317|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
83680318|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
83680319|NCT01631305|Calcium|calcium|mesh-list
83680320|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680321|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680322|NCT01631305|Antacids|antacids|mesh-ancestor
83680323|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680324|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83680325|NCT01631357|Cisplatin|cisplatin|mesh-list
83680326|NCT01631357|Gemcitabine|gemcitabine|mesh-list
83680327|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680328|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680329|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
83680330|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680331|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
83680332|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83680333|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680334|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680335|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680336|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680337|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680338|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680339|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83680340|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83680341|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680342|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83680343|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83680344|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
83680345|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680346|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680347|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680348|NCT01631383|Analgesics|analgesics|mesh-ancestor
83680349|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
83680350|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680351|NCT01631396|Neostigmine|neostigmine|mesh-list
83680352|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83680353|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680354|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680355|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
83680356|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680357|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680358|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83680359|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
83680360|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680361|NCT01631409|Aspirin|aspirin|mesh-list
83680362|NCT01631409|Atenolol|atenolol|mesh-list
83680363|NCT01631409|Enalapril|enalapril|mesh-list
83680364|NCT01631409|Enalaprilat|enalaprilat|mesh-list
83680365|NCT01631409|Amlodipine|amlodipine|mesh-list
83680366|NCT01631409|Isosorbide|isosorbide|mesh-list
83680367|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83680368|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83680369|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
83680370|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83680371|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680372|NCT01631409|Analgesics|analgesics|mesh-ancestor
83680373|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
83680374|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835232|NCT00435461|Xhance|xhance|mesh-list
83680375|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680376|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680377|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680378|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83680379|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83680380|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680381|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83680382|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83680383|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680385|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83680386|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
83680387|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680388|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83680389|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
83680390|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
83680391|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83680392|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83680393|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83680394|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680395|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680396|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680397|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680398|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680399|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
83680400|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83680401|NCT01631409|Diuretics|diuretics|mesh-ancestor
83680402|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
83680403|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83680404|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83680405|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
83680406|NCT01631448|Coagulants|coagulants|mesh-ancestor
83680407|NCT01631513|Tapentadol|tapentadol|mesh-list
83680408|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83680409|NCT01631513|Narcotics|narcotics|mesh-ancestor
83680410|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680411|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680412|NCT01631513|Analgesics|analgesics|mesh-ancestor
83680413|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
83680414|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680415|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83680416|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83680417|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680418|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680419|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680420|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680421|NCT01631526|Vitamin D|vitamin d|mesh-list
83680422|NCT01631526|Vitamins|vitamins|mesh-ancestor
83680423|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
83680424|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680425|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83680426|NCT01631539|Irinotecan|irinotecan|mesh-list
83680427|NCT01631539|Cetuximab|cetuximab|mesh-list
83680428|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83680429|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83680430|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680431|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680432|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680433|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680434|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
83680435|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83680436|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680437|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680438|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
83680439|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680440|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680441|NCT01631669|Celecoxib|celecoxib|mesh-list
83680442|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83680443|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680444|NCT01631669|Analgesics|analgesics|mesh-ancestor
83680445|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
83680446|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680447|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680448|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680449|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680450|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83680451|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83680452|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680453|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680454|NCT01631838|Tocotrienols|tocotrienols|mesh-list
83680456|NCT01631838|Tocopherols|tocopherols|mesh-list
83680457|NCT01631838|Tocovid|tocovid|mesh-list
83680458|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
83680459|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680460|NCT01631838|Protective Agents|protective agents|mesh-ancestor
83680461|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680462|NCT01631838|Vitamins|vitamins|mesh-ancestor
83680463|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
83680464|NCT01631877|Enoxaparin|enoxaparin|mesh-list
83680465|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
83680466|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
83680467|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83680468|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83680469|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680470|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83680471|NCT01631968|Colistin|colistin|mesh-list
83680472|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680473|NCT01631994|Metoclopramide|metoclopramide|mesh-list
83680474|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
83680475|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
83680476|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680477|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680478|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83680479|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83680480|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83680481|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
83680482|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680483|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680484|NCT01632007|Alogliptin|alogliptin|mesh-list
83680485|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83680486|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680487|NCT01632007|Incretins|incretins|mesh-ancestor
83680488|NCT01632007|Hormones|hormones|mesh-ancestor
83680489|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83680490|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83680491|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83680492|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680493|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680494|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
83680495|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83680496|NCT01632163|Lixisenatide|lixisenatide|mesh-list
83680497|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83416989|NCT00070135|Fludarabine|fludarabine|mesh-list
83680498|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680499|NCT01632189|Varenicline|varenicline|mesh-list
83680500|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83680501|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83680502|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
83680503|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680504|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680505|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680506|NCT01632371|Paclitaxel|paclitaxel|mesh-list
83680507|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83680508|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83680509|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680510|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
83680511|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
83680512|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
83680513|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680514|NCT01632436|Pixantrone|pixantrone|mesh-list
83680515|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83680516|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83680517|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680518|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680519|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680520|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
83680521|NCT01632514|Vitamin D|vitamin d|mesh-list
83680522|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680523|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680524|NCT01632514|Vitamins|vitamins|mesh-ancestor
83680525|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
83680526|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83680527|NCT01632540|Beclomethasone|beclomethasone|mesh-list
83680528|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680529|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
83680530|NCT01632540|Hormones|hormones|mesh-ancestor
83680531|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83680532|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680533|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83680534|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
83680535|NCT01632592|Tesamorelin|tesamorelin|mesh-list
83680536|NCT01632592|Growth Substances|growth substances|mesh-ancestor
83680537|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680538|NCT01632605|Sirolimus|sirolimus|mesh-list
83680539|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83680540|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680541|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83680542|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680543|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
83680544|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680545|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
83680546|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680547|NCT01632722|Bevacizumab|bevacizumab|mesh-list
83680548|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680549|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680550|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83680551|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83680552|NCT01632722|Growth Substances|growth substances|mesh-ancestor
83680553|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680554|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
83680555|NCT01632761|Vitamin D|vitamin d|mesh-list
83680556|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
83680557|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
83680558|NCT01632761|Vitamins|vitamins|mesh-list
83680559|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
83680560|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680561|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83680562|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680563|NCT01632826|Pomalidomide|pomalidomide|mesh-list
83680564|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
83680565|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680566|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83680567|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83680568|NCT01632826|Growth Substances|growth substances|mesh-ancestor
83680569|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
83680570|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680571|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
83680572|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83680573|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
83680574|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680575|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680576|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83680577|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83680578|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83680579|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
83680580|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680581|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680582|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83680583|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
83680584|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
83680585|NCT01633086|Protective Agents|protective agents|mesh-ancestor
83680586|NCT01633099|Decitabine|decitabine|mesh-list
83680587|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680588|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
83680589|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680590|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680591|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680592|NCT01633203|Capecitabine|capecitabine|mesh-list
83680593|NCT01633203|Epirubicin|epirubicin|mesh-list
83680594|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680595|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680596|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
83680597|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680598|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83680599|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83680600|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83680601|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680602|NCT01633294|Gentamicins|gentamicins|mesh-list
83680603|NCT01633294|Ampicillin|ampicillin|mesh-list
83680604|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83680605|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680606|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83680607|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680608|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680609|NCT01633359|Atorvastatin|atorvastatin|mesh-list
83680610|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83680611|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83680612|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83680613|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
83680614|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680615|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83680616|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680617|NCT01633450|Zinc|zinc|mesh-list
83680618|NCT01633450|Trace Elements|trace elements|mesh-ancestor
83680619|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
83680620|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680621|NCT01633476|Valacyclovir|valacyclovir|mesh-list
83680622|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
83680623|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680624|NCT01633593|Donepezil|donepezil|mesh-list
83680625|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83680626|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680627|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680628|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
83680629|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680630|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680631|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
83680632|NCT01633645|Gemcitabine|gemcitabine|mesh-list
83680633|NCT01633645|Bortezomib|bortezomib|mesh-list
83680634|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680635|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680636|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
83680637|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680638|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
83680639|NCT01633658|Vitamin D|vitamin d|mesh-list
83680640|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680641|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680642|NCT01633658|Vitamins|vitamins|mesh-ancestor
83680643|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
83680644|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83680645|NCT01633749|Vaccines|vaccines|mesh-list
83680646|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
83680647|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680648|NCT01633762|Vancomycin|vancomycin|mesh-list
83680649|NCT01633762|Gentamicins|gentamicins|mesh-list
83680650|NCT01633762|Meropenem|meropenem|mesh-list
83680651|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83680652|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680653|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83680654|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680655|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680656|NCT01633957|Warfarin|warfarin|mesh-list
83680657|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
83680658|NCT01633970|Leucovorin|leucovorin|mesh-list
83680659|NCT01633970|Paclitaxel|paclitaxel|mesh-list
83680660|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83680661|NCT01633970|Bevacizumab|bevacizumab|mesh-list
83680662|NCT01633970|Carboplatin|carboplatin|mesh-list
83680663|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
83680664|NCT01633970|Pemetrexed|pemetrexed|mesh-list
83680665|NCT01633970|Atezolizumab|atezolizumab|mesh-list
83680666|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83680667|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680668|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
83680669|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
83680670|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
83680671|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680672|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680673|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83680674|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83680675|NCT01633970|Growth Substances|growth substances|mesh-ancestor
83680676|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680677|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
83680678|NCT01633970|Antidotes|antidotes|mesh-ancestor
82835476|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83680679|NCT01633970|Protective Agents|protective agents|mesh-ancestor
83680680|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
83680682|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
83680683|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680684|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83680685|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83680686|NCT01633970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83680687|NCT01633983|Methotrexate|methotrexate|mesh-list
83680688|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83680689|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
83680690|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83680691|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680692|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680693|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
83680694|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680695|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680696|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
83680697|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680698|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83680699|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680700|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
83680701|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680702|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83680703|NCT01634061|Dactolisib|dactolisib|mesh-list
83680704|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680705|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
83680706|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680707|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
83680708|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680709|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680710|NCT01634295|Niacin|niacin|mesh-list
83680711|NCT01634295|Amlodipine|amlodipine|mesh-list
83680712|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680713|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680714|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680715|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680716|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680717|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680718|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
83680719|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83680720|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
83680721|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83680722|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
83680723|NCT01634295|Vitamins|vitamins|mesh-ancestor
83680724|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
83680725|NCT01634321|Leuprolide|leuprolide|mesh-list
83680726|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83680727|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
83680728|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83680729|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680730|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83680731|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680732|NCT01634347|Propranolol|propranolol|mesh-list
83680733|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83680734|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83680735|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680736|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680737|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680738|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680739|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83680740|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680741|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
83680742|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83680743|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
83680744|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83680745|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83680746|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83680747|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680748|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680749|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83680750|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
83680751|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83680752|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83680753|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82835550|NCT01101412|Protective Agents|protective agents|mesh-ancestor
83680754|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680755|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680756|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83680757|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
83680758|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83680759|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83680760|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83680761|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680762|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680763|NCT01634412|Amitriptyline|amitriptyline|mesh-list
83680764|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
83680765|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83680766|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
83680767|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83680768|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83680769|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680770|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83680771|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680772|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83680773|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680774|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680775|NCT01634412|Analgesics|analgesics|mesh-ancestor
83680776|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
83680777|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83680778|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83680779|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680780|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680781|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680782|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680783|NCT01634438|Heparin|heparin|mesh-list
83680784|NCT01634438|Calcium heparin|calcium heparin|mesh-list
83680785|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
83680786|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83680787|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83680788|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680789|NCT01634594|Nicardipine|nicardipine|mesh-list
83680790|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
83680791|NCT01634594|Remifentanil|remifentanil|mesh-list
83680792|NCT01634594|Sevoflurane|sevoflurane|mesh-list
83680793|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83680794|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680795|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680796|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680797|NCT01634594|Analgesics|analgesics|mesh-ancestor
83680798|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
83680799|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680800|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83680801|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83680802|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83680803|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680804|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680805|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680806|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83680807|NCT01634594|Narcotics|narcotics|mesh-ancestor
83680808|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83680809|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83680810|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
83680811|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
83680812|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680813|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680814|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680815|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680816|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
83680817|NCT01634685|Capecitabine|capecitabine|mesh-list
83680818|NCT01634685|Bavituximab|bavituximab|mesh-list
83680819|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680820|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
83680821|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680822|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680823|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680824|NCT01634698|Vitamin A|vitamin a|mesh-list
83680825|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
83680826|NCT01634698|Vitamins|vitamins|mesh-ancestor
83680827|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
83680828|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680829|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
83680830|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680831|NCT01634698|Protective Agents|protective agents|mesh-ancestor
83680832|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83680833|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680834|NCT01634763|Ceritinib|ceritinib|mesh-list
83680835|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680836|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83680837|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680838|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680839|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
83680840|NCT01634789|Estrogens|estrogens|mesh-list
83680841|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83680842|NCT01634789|Hormones|hormones|mesh-ancestor
83680843|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83680844|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680845|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83680846|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83680847|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
83680848|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83680849|NCT01634880|Panitumumab|panitumumab|mesh-list
83680850|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680851|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680852|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
83680853|NCT01634893|Sorafenib|sorafenib|mesh-list
83680854|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680855|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83680856|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680857|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680858|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
83680859|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83680860|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83680861|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680862|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680863|NCT01634906|Atorvastatin|atorvastatin|mesh-list
83680864|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83680865|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83680866|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83680867|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
83680868|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680869|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83680870|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83680871|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680872|NCT01634932|Iron|iron|mesh-list
83680873|NCT01634932|Trace Elements|trace elements|mesh-ancestor
83680874|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
83680875|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680876|NCT01634945|Amodiaquine|amodiaquine|mesh-list
83680877|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
83680878|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83680879|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83680880|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680881|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83680882|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83680883|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
83680884|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680885|NCT01634958|Antacids|antacids|mesh-ancestor
83680886|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680887|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83680888|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
83680889|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680890|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
83680891|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83680892|NCT01635114|Resveratrol|resveratrol|mesh-list
83680893|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
83680894|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680895|NCT01635114|Protective Agents|protective agents|mesh-ancestor
83680896|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680897|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680898|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83680899|NCT01635205|Anesthetics|anesthetics|mesh-list
83680900|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680901|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680902|NCT01635296|Cytarabine|cytarabine|mesh-list
83680903|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83680904|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
83680905|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680906|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680907|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
83680908|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680909|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680910|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
83680911|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680912|NCT01635400|Irinotecan|irinotecan|mesh-list
83680913|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83680914|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83680915|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83680916|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680917|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680918|NCT01635530|Doxycycline|doxycycline|mesh-list
83680919|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
83680920|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83680921|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680922|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
83680923|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83680924|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83680925|NCT01635608|Acetaminophen|acetaminophen|mesh-list
83680926|NCT01635608|Amoxicillin|amoxicillin|mesh-list
83680927|NCT01635608|Talinolol|talinolol|mesh-list
83680928|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680929|NCT01635608|Analgesics|analgesics|mesh-ancestor
83680930|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
83680931|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680932|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680933|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
83680934|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83680935|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680936|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83680937|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83680938|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
83680939|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83680940|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680941|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83680942|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83680943|NCT01635686|Etanercept|etanercept|mesh-list
83680944|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83680945|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83680946|NCT01635686|Analgesics|analgesics|mesh-ancestor
83680947|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
83680948|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680949|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680950|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83680951|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83680952|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83680953|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83680954|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
83680955|NCT01635751|Pregabalin|pregabalin|mesh-list
83680956|NCT01635751|Analgesics|analgesics|mesh-ancestor
83680957|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
83680958|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83680959|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680960|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
83680961|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83680962|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83680963|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83680964|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83680965|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83680966|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83680967|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83680968|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83680969|NCT01635777|Miltefosine|miltefosine|mesh-list
83680970|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
83680971|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83680972|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680973|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83680974|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83680975|NCT01635790|Bevacizumab|bevacizumab|mesh-list
83680976|NCT01635790|Ranibizumab|ranibizumab|mesh-list
83680977|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680978|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680979|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83680980|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83680981|NCT01635790|Growth Substances|growth substances|mesh-ancestor
83680982|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680983|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83680984|NCT01635803|Bevacizumab|bevacizumab|mesh-list
83680985|NCT01635803|Ranibizumab|ranibizumab|mesh-list
83680986|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83680987|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83680988|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83680989|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83680990|NCT01635803|Growth Substances|growth substances|mesh-ancestor
83680991|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680992|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
83680993|NCT01635816|Vaccines|vaccines|mesh-list
83680994|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
83680995|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83680996|NCT01635829|Carbamazepine|carbamazepine|mesh-list
83680997|NCT01635829|Phenytoin|phenytoin|mesh-list
83680998|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
83680999|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
83681000|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83681001|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681002|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681003|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83681004|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83681005|NCT01635829|Analgesics|analgesics|mesh-ancestor
83681006|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
83681007|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681008|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83681009|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83681010|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681011|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83681012|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83681013|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83681014|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83681015|NCT01635946|Isavuconazole|isavuconazole|mesh-list
83681016|NCT01635946|Atorvastatin|atorvastatin|mesh-list
83681017|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83681018|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83681019|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
83681020|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681021|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83681022|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83681023|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681024|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
83681025|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681026|NCT01635972|Isavuconazole|isavuconazole|mesh-list
83681027|NCT01635972|Bupropion|bupropion|mesh-list
83681028|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83681029|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
83681030|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83681031|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83681032|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83681033|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83681034|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681035|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
83681036|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681037|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681038|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83681039|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83681040|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681041|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
83681042|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681043|NCT01636037|Levodopa|levodopa|mesh-list
83681044|NCT01636037|Carbidopa|carbidopa|mesh-list
83681045|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83681046|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83681047|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83681048|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
83681049|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681050|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681051|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681052|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83681053|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835858|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681054|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83681055|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
83681056|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
83681057|NCT01636128|Eflornithine|eflornithine|mesh-list
83681058|NCT01636128|Sulindac|sulindac|mesh-list
83681059|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681060|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83681061|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83681062|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83681063|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681064|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83681065|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681066|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681067|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83681068|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83681069|NCT01636128|Analgesics|analgesics|mesh-ancestor
83681070|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
83681071|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681072|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681073|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681074|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681075|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83681076|NCT01636141|Dapansutrile|dapansutrile|mesh-list
83681077|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681078|NCT01636180|Clopidogrel|clopidogrel|mesh-list
83681079|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83681080|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83681081|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83681082|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83681083|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
83681084|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681085|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681086|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681087|NCT01636245|Vaccines|vaccines|mesh-list
83681088|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
83681089|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681090|NCT01636271|Darapladib|darapladib|mesh-list
83681091|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83681092|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681093|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681094|NCT01636310|Nicotine|nicotine|mesh-list
83681095|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83681096|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
83681097|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681098|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681099|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83681100|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83681101|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
83681102|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681103|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681104|NCT01636323|Nicotine|nicotine|mesh-list
83681105|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83681106|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
83681107|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681108|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681109|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83681110|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83681111|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
83681112|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681113|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681114|NCT01636336|Nicotine|nicotine|mesh-list
83681115|NCT01636336|Progesterone|progesterone|mesh-list
83681116|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83681117|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
83681118|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681119|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681120|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83681121|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83681122|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
83681123|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681124|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681125|NCT01636336|Progestins|progestins|mesh-ancestor
83681126|NCT01636336|Hormones|hormones|mesh-ancestor
83681127|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681128|NCT01636401|Bromides|bromides|mesh-list
83681129|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
83681130|NCT01636505|Cetrorelix|cetrorelix|mesh-list
83681131|NCT01636505|Buserelin|buserelin|mesh-list
83681132|NCT01636505|Ganirelix|ganirelix|mesh-list
83681133|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83681134|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
83681135|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83681136|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681137|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
83681138|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681139|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83681140|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
83681141|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681142|NCT01636557|Vitamin K|vitamin k|mesh-list
83681143|NCT01636557|Midazolam|midazolam|mesh-list
83681144|NCT01636557|Caffeine|caffeine|mesh-list
83681145|NCT01636557|Omeprazole|omeprazole|mesh-list
83681146|NCT01636557|Warfarin|warfarin|mesh-list
83681147|NCT01636557|Vitamins|vitamins|mesh-ancestor
83681148|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
83681149|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681150|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83681151|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83681152|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681153|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83681154|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83681155|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83681156|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83681157|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
83681158|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
83681159|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
83681160|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
83681161|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681162|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681163|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
83681164|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83681165|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83681166|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681167|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83681168|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83681169|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
83681170|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83681171|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83681172|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83681173|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83681174|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83681175|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
83681176|NCT01636557|Coagulants|coagulants|mesh-ancestor
83681177|NCT01636570|Vitamin D|vitamin d|mesh-list
83681178|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
83681179|NCT01636570|Vitamins|vitamins|mesh-ancestor
83681180|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
83681181|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681182|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83681183|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83681184|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
83681185|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83681186|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681187|NCT01636609|Cytarabine|cytarabine|mesh-list
83681188|NCT01636609|Azacitidine|azacitidine|mesh-list
83681189|NCT01636609|Tosedostat|tosedostat|mesh-list
83681190|NCT01636609|Glycine|glycine|mesh-list
83681191|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83681192|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
83681193|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681194|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681195|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
83681196|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681197|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681198|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
83681199|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681200|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681201|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
83681202|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681203|NCT01636622|Paclitaxel|paclitaxel|mesh-list
83681204|NCT01636622|Carboplatin|carboplatin|mesh-list
83681205|NCT01636622|Vemurafenib|vemurafenib|mesh-list
83681206|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83681207|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681208|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83681209|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83681210|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83681211|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681212|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83681213|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681215|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83681216|NCT01636700|Narcotics|narcotics|mesh-ancestor
83681217|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681218|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681219|NCT01636700|Analgesics|analgesics|mesh-ancestor
83681220|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
83681221|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681222|NCT01635426|Aspirin|aspirin|mesh-list
83681223|NCT01635426|Clopidogrel|clopidogrel|mesh-list
83681224|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83681225|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83681226|NCT01635426|Analgesics|analgesics|mesh-ancestor
83681227|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
83681228|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681229|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681230|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681231|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681232|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83681233|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83681234|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681235|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83681236|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83681237|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681238|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
83681239|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83681240|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83681241|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83681242|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
83681243|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681244|NCT01636869|Bupivacaine|bupivacaine|mesh-list
83681245|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
83681246|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
83681247|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681248|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681249|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
83681250|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681251|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
83681252|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83681253|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
83681254|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
83681255|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83681256|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83681257|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681258|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83681259|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681260|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681261|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83681262|NCT01636908|Everolimus|everolimus|mesh-list
83681263|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83681264|NCT01636908|Sorafenib|sorafenib|mesh-list
83681265|NCT01636908|Sunitinib|sunitinib|mesh-list
83681266|NCT01636908|Dasatinib|dasatinib|mesh-list
83681267|NCT01636908|Lapatinib|lapatinib|mesh-list
83681268|NCT01636908|Vemurafenib|vemurafenib|mesh-list
83681269|NCT01636908|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83681270|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83681271|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681272|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681273|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681274|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
83681275|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681276|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681277|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83681278|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83681279|NCT01636908|Growth Substances|growth substances|mesh-ancestor
83681280|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
83681281|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
82836085|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681282|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83681283|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
83681284|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
83681285|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681286|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681287|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83681288|NCT01636999|Analgesics|analgesics|mesh-ancestor
83681289|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
83681290|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681291|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
83681292|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
83681293|NCT01637025|Coagulants|coagulants|mesh-ancestor
83681294|NCT01637155|Vitamin D|vitamin d|mesh-list
83681295|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
83681296|NCT01637155|Vitamins|vitamins|mesh-ancestor
83681297|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
83681298|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681299|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83681300|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83681301|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83681302|NCT01637194|Cetuximab|cetuximab|mesh-list
83681303|NCT01637194|Everolimus|everolimus|mesh-list
83681304|NCT01637194|Antibodies|antibodies|mesh-list
83681305|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
83681306|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83681307|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
83681308|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681309|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681310|NCT01637194|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83681311|NCT01637194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83681312|NCT01637194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681313|NCT01637194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681314|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681315|NCT01637233|Ritonavir|ritonavir|mesh-list
83681316|NCT01637233|Lopinavir|lopinavir|mesh-list
83681317|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83681318|NCT01637233|Darunavir|darunavir|mesh-list
83681319|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
83681320|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83681321|NCT01637233|Tenofovir|tenofovir|mesh-list
83681322|NCT01637233|Lamivudine|lamivudine|mesh-list
83681323|NCT01637233|Emtricitabine|emtricitabine|mesh-list
83681324|NCT01637233|Zidovudine|zidovudine|mesh-list
83681325|NCT01637233|Maraviroc|maraviroc|mesh-list
83681326|NCT01637233|Abacavir|abacavir|mesh-list
83681327|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
83681328|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83681329|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
83681330|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83681331|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681332|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681333|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681334|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83681335|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
83681336|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681337|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83681338|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83681339|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681340|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
83681341|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83681342|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83681343|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83681344|NCT01637259|Ritonavir|ritonavir|mesh-list
83681345|NCT01637259|Lopinavir|lopinavir|mesh-list
83681346|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83681347|NCT01637259|Darunavir|darunavir|mesh-list
83681348|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
82836159|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
82836160|NCT00023452|Isoniazid|isoniazid|mesh-list
82836161|NCT00023452|Rifapentine|rifapentine|mesh-list
82836162|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
82836163|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836164|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836165|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82836166|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83681349|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83681350|NCT01637259|Tenofovir|tenofovir|mesh-list
83681351|NCT01637259|Lamivudine|lamivudine|mesh-list
83681352|NCT01637259|Emtricitabine|emtricitabine|mesh-list
83681353|NCT01637259|Zidovudine|zidovudine|mesh-list
83681354|NCT01637259|Maraviroc|maraviroc|mesh-list
83681355|NCT01637259|Abacavir|abacavir|mesh-list
83681356|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
83681357|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83681358|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
83681359|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83681360|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681361|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681362|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681363|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83681364|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
83681365|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681366|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83681367|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83681368|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681369|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
83681370|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83681371|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83681372|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83681373|NCT01637376|Temoporfin|temoporfin|mesh-list
83681374|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681375|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83681376|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
83681377|NCT01637454|Terlipressin|terlipressin|mesh-list
83681378|NCT01637454|Norepinephrine|norepinephrine|mesh-list
83681379|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83681380|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83681381|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83681382|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83681383|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83681384|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681385|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681386|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681387|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
83681388|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
83681389|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681390|NCT01637532|Interferons|interferons|mesh-list
83681391|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
83681392|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
83681393|NCT01637532|Carboplatin|carboplatin|mesh-list
83681394|NCT01637532|Doxorubicin|doxorubicin|mesh-list
83681395|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681396|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83681397|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83681398|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83681399|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681400|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681401|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
83681402|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681403|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
83681404|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681405|NCT01637545|Ramosetron|ramosetron|mesh-list
83681406|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
83681407|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
83681408|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681409|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681410|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83681411|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83681412|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
83681413|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681414|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681415|NCT01637558|Ritonavir|ritonavir|mesh-list
83681416|NCT01637558|Lopinavir|lopinavir|mesh-list
83681417|NCT01637558|Nevirapine|nevirapine|mesh-list
83681418|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83681419|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83681420|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
83681421|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681422|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681423|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681424|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83681425|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
83681426|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681427|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83681428|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83681429|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83681430|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681431|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83681432|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83681433|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
83681434|NCT01637571|Lansoprazole|lansoprazole|mesh-list
83681435|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83681436|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83681437|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83681438|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681439|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681440|NCT01637636|Rifampin|rifampin|mesh-list
83681441|NCT01637636|Ketoconazole|ketoconazole|mesh-list
83681442|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83681443|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
83681444|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83681445|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681446|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
83681447|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681448|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681449|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681450|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83681451|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83681452|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83681453|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83681454|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83681455|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83681456|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
83681457|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83681458|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83681459|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83681460|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
83681461|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681462|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681463|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83681464|NCT01637675|Tanshinone|tanshinone|mesh-list
83681465|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
83681466|NCT01637675|Citric Acid|citric acid|mesh-list
83681467|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
83681468|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
83681469|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83681470|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
83681471|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
83681472|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681473|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
83681474|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83681475|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83681476|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681477|NCT01637675|Urological Agents|urological agents|mesh-ancestor
83681478|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681479|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83681480|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83681481|NCT01637675|Analgesics|analgesics|mesh-ancestor
83681482|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
83681483|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681484|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681485|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681486|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681487|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83681488|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681489|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681490|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
83681491|NCT01637753|Carmustine|carmustine|mesh-list
83681492|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83681493|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
83681494|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681495|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681496|NCT01637766|Melphalan|melphalan|mesh-list
83681497|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83681498|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
83681499|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681500|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681501|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83681502|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681503|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
83681504|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836299|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
83681506|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83681507|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83681508|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83681509|NCT01637818|Analgesics|analgesics|mesh-ancestor
83681510|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
83681511|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681512|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681513|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
83681514|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681515|NCT01637844|Telbivudine|telbivudine|mesh-list
83681516|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
83681517|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681518|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681519|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681520|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681521|NCT01637883|Benzydamine|benzydamine|mesh-list
83681522|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681523|NCT01637948|Listerine|listerine|mesh-list
83681524|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83681525|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681526|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83681527|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
83681528|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83681529|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
83681530|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83681531|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681532|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83681533|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83681534|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681535|NCT01638078|Thalidomide|thalidomide|mesh-list
83681536|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681537|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
83681538|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681539|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
83681540|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83681541|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681542|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83681543|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83681544|NCT01638078|Growth Substances|growth substances|mesh-ancestor
83681545|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
83681546|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681547|NCT01638182|Vitamins|vitamins|mesh-list
83681548|NCT01638182|Vitamin K|vitamin k|mesh-list
83681549|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
83681550|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
83681551|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
83681552|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681553|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83681554|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83681555|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681556|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
83681557|NCT01638182|Coagulants|coagulants|mesh-ancestor
83681558|NCT01638234|Melatonin|melatonin|mesh-list
83681559|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
83681560|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681561|NCT01638234|Protective Agents|protective agents|mesh-ancestor
83681562|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681563|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681564|NCT01638247|Tamoxifen|tamoxifen|mesh-list
83681565|NCT01638247|Goserelin|goserelin|mesh-list
83681566|NCT01638247|Exemestane|exemestane|mesh-list
83681567|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83681568|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83681569|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
83681570|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681571|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681572|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83681573|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681574|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83681575|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83681576|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83681577|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83681578|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83681579|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681580|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681581|NCT01638247|Hormones|hormones|mesh-ancestor
83681582|NCT01638260|Liraglutide|liraglutide|mesh-list
83681583|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83681584|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681585|NCT01638260|Incretins|incretins|mesh-ancestor
83681586|NCT01638260|Hormones|hormones|mesh-ancestor
83681587|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681588|NCT01638273|Pregabalin|pregabalin|mesh-list
83681589|NCT01638273|Analgesics|analgesics|mesh-ancestor
83681590|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
83681591|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681592|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681593|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
83681594|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83681595|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83681596|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681597|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83681598|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83681599|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83681600|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681601|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83681602|NCT01638299|Insulin|insulin|mesh-list
83681603|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83681604|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681605|NCT01638325|Insulin|insulin|mesh-list
83681606|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83681607|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
83681608|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83681609|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681610|NCT01638364|Ethanol|ethanol|mesh-list
83681611|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83681612|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681613|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681614|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681615|NCT01638377|Naltrexone|naltrexone|mesh-list
83681616|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83681617|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83681618|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681619|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
83681620|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681621|NCT01638403|Modafinil|modafinil|mesh-list
83681622|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83681623|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681624|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83681625|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83681626|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83681627|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681628|NCT01638442|Tosedostat|tosedostat|mesh-list
83681629|NCT01638442|Glycine|glycine|mesh-list
83681630|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681631|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681632|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
83681633|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681634|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681635|NCT01638624|Propofol|propofol|mesh-list
83681636|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83681637|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83681638|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681639|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83681640|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
83681641|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
83681642|NCT01638650|Ritonavir|ritonavir|mesh-list
83681643|NCT01638650|Saquinavir|saquinavir|mesh-list
83681644|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83681645|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83681646|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83681647|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
83681648|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681649|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681650|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681651|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82836446|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83681652|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
83681653|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681654|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83681655|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83681656|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681657|NCT01638663|Tolvaptan|tolvaptan|mesh-list
83681658|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83681659|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681660|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
83681661|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681662|NCT01638676|Metformin|metformin|mesh-list
83681663|NCT01638676|Vemurafenib|vemurafenib|mesh-list
83681664|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83681665|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681666|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681667|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83681668|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681669|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681670|NCT01638689|Escitalopram|escitalopram|mesh-list
83681671|NCT01638689|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83681672|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83681673|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83681674|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681675|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681676|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
83681677|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681678|NCT01638715|Infliximab|infliximab|mesh-list
83681679|NCT01638715|Rituximab|rituximab|mesh-list
83681680|NCT01638715|Abatacept|abatacept|mesh-list
83681681|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83681682|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681683|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
83681684|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681685|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681686|NCT01638715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83681687|NCT01638715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681688|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
83681689|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83681690|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83681691|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681692|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681693|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
83681694|NCT01638767|NuvaRing|nuvaring|mesh-list
83681695|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
83681696|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83681697|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681698|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83681699|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83681700|NCT01638780|Resveratrol|resveratrol|mesh-list
83681701|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
83681702|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681703|NCT01638780|Protective Agents|protective agents|mesh-ancestor
83681704|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681705|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681706|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83681707|NCT01638858|Ranibizumab|ranibizumab|mesh-list
83681708|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83681709|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83681710|NCT01638858|Growth Substances|growth substances|mesh-ancestor
83681711|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681712|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
83681713|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681714|NCT01638936|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
83681715|NCT01638936|Immunoconjugates|immunoconjugates|mesh-ancestor
83681716|NCT01638936|Immunologic Factors|immunologic factors|mesh-ancestor
83681717|NCT01638936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681718|NCT01638962|Acetaminophen|acetaminophen|mesh-list
83681719|NCT01638962|Aspirin|aspirin|mesh-list
83681720|NCT01638962|Ibuprofen|ibuprofen|mesh-list
83681721|NCT01638962|Celecoxib|celecoxib|mesh-list
83681722|NCT01638962|Diclofenac|diclofenac|mesh-list
83681723|NCT01638962|Naproxen|naproxen|mesh-list
83681724|NCT01638962|Indomethacin|indomethacin|mesh-list
83681725|NCT01638962|Etoricoxib|etoricoxib|mesh-list
83681726|NCT01638962|Meloxicam|meloxicam|mesh-list
83681727|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83681728|NCT01638962|Etodolac|etodolac|mesh-list
83681729|NCT01638962|Lornoxicam|lornoxicam|mesh-list
83681730|NCT01638962|Nabumetone|nabumetone|mesh-list
83681731|NCT01638962|Tenoxicam|tenoxicam|mesh-list
83681732|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
83681733|NCT01638962|Analgesics|analgesics|mesh-list
83681734|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83681735|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
83681736|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681737|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681738|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
83681739|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83681740|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681741|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681742|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83681743|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681744|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681745|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83681746|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
83681747|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83681748|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83681749|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83681750|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
83681751|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83681752|NCT01638988|Metformin|metformin|mesh-list
83681753|NCT01638988|Clomiphene|clomiphene|mesh-list
83681754|NCT01638988|Enclomiphene|enclomiphene|mesh-list
83681755|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
83681756|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83681757|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681758|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83681759|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
83681760|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681761|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83681762|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
83681763|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83681764|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83681765|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83681766|NCT01639027|Drotaverin|drotaverin|mesh-list
83681767|NCT01639027|Analgesics|analgesics|mesh-ancestor
83681768|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
83681769|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681770|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681771|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
83681772|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
83681773|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
83681774|NCT01639066|Tenofovir|tenofovir|mesh-list
83681775|NCT01639066|Entecavir|entecavir|mesh-list
83681776|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
83681777|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681778|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83681779|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681780|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681781|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681782|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681783|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83681784|NCT01639092|Tenofovir|tenofovir|mesh-list
83681785|NCT01639092|Entecavir|entecavir|mesh-list
83681786|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
83681787|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681788|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83681789|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681790|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681791|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681792|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681793|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83681794|NCT01639261|Interferons|interferons|mesh-list
83681795|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
83681796|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681797|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
83681798|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681799|NCT01639326|Irinotecan|irinotecan|mesh-list
83681800|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83681801|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83681802|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681803|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681804|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681805|NCT01639456|Aldesleukin|aldesleukin|mesh-list
83681806|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
82836595|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681807|NCT01639456|Fludarabine|fludarabine|mesh-list
83681808|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681809|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
83681810|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681811|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681812|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83681813|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
83681814|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681815|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681816|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83681817|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83681818|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83681819|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
83681820|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681821|NCT01639521|Gemcitabine|gemcitabine|mesh-list
83681822|NCT01639521|Doxorubicin|doxorubicin|mesh-list
83681823|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83681824|NCT01639521|Methotrexate|methotrexate|mesh-list
83681825|NCT01639521|Vinblastine|vinblastine|mesh-list
83681826|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681827|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83681828|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
83681829|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681830|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83681831|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83681832|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83681833|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681834|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83681835|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
83681836|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83681837|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681838|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
83681839|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83681840|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681841|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
83681842|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681843|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681844|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83681845|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
83681846|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
83681847|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
83681848|NCT01639547|Ribavirin|ribavirin|mesh-list
83681849|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83681850|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
83681851|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681852|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
83681853|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681854|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
83681855|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83681856|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681857|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
83681858|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83681859|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83681860|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
83681861|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681862|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681863|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681864|NCT01639794|Urological Agents|urological agents|mesh-ancestor
83681865|NCT01639807|Latanoprost|latanoprost|mesh-list
83681866|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83681867|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83681868|NCT01639885|Interferons|interferons|mesh-list
83681869|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
83681870|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
83681871|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681872|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
83681873|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681874|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
83681875|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681876|NCT01639898|Dexamethasone|dexamethasone|mesh-list
83681877|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
83681878|NCT01639898|Lenalidomide|lenalidomide|mesh-list
83681879|NCT01639898|BB 1101|bb 1101|mesh-list
83681880|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681881|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
83681882|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
83681883|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681884|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681885|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83681886|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
83681887|NCT01639898|Hormones|hormones|mesh-ancestor
83681888|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681889|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83681890|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681891|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
83681892|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681893|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681894|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
83681895|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83681896|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83681897|NCT01639898|Growth Substances|growth substances|mesh-ancestor
83681898|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
83681899|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
83681900|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83681901|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83681902|NCT01640743|Prednisolone|prednisolone|mesh-list
83681903|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
83681904|NCT01640743|Everolimus|everolimus|mesh-list
83681905|NCT01640743|Tacrolimus|tacrolimus|mesh-list
83681906|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83681907|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
83681908|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681909|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
83681910|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681911|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83681912|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681913|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681914|NCT01640743|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83681915|NCT01640743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83681916|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681917|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83681918|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
83681919|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
83681920|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681921|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83681922|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
83681923|NCT01640743|Hormones|hormones|mesh-ancestor
83681924|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681925|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83681926|NCT01640743|Protective Agents|protective agents|mesh-ancestor
83681927|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83681928|NCT01641016|Efavirenz|efavirenz|mesh-list
83681929|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83681930|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83681931|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681932|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681933|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
83681934|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681935|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83681936|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83681937|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83681938|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83681939|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83681940|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83681941|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83681942|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
83681943|NCT01641718|Coagulants|coagulants|mesh-ancestor
83681944|NCT01642771|Docetaxel|docetaxel|mesh-list
83681945|NCT01642771|Fluorouracil|fluorouracil|mesh-list
83681946|NCT01642771|Capecitabine|capecitabine|mesh-list
83681947|NCT01642771|Epirubicin|epirubicin|mesh-list
83681948|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83681949|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83681950|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83681951|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83681952|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681953|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
83681954|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83681955|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681956|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
83681957|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836754|NCT05527834|Ceftibuten|ceftibuten|mesh-list
83681958|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83681959|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83681960|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83681961|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681962|NCT01642979|Cyclosporine|cyclosporine|mesh-list
83681963|NCT01642979|Levamisole|levamisole|mesh-list
83681964|NCT01642979|Cyclosporins|cyclosporins|mesh-list
83681965|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
83681966|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83681967|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681968|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83681969|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
83681970|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681971|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
83681972|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83681973|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
83681974|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83681975|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83681976|NCT01642979|Hormones|hormones|mesh-ancestor
83681977|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83681978|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83681979|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
83681980|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
83681981|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83681982|NCT01643031|Clopidogrel|clopidogrel|mesh-list
83681983|NCT01643031|Ticagrelor|ticagrelor|mesh-list
83681984|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83681985|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83681986|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83681987|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83681988|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
83681989|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83681990|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83681991|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681992|NCT01643434|Clonidine|clonidine|mesh-list
83681993|NCT01643434|Spironolactone|spironolactone|mesh-list
83681994|NCT01643434|Analgesics|analgesics|mesh-ancestor
83681995|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
83681996|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83681997|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83681998|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83681999|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
83682000|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
83682001|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83682002|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83682003|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83682004|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83682005|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682006|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682007|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83682008|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
83682009|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682010|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83682011|NCT01643434|Diuretics|diuretics|mesh-ancestor
83682012|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
83682013|NCT01643941|Vaccines|vaccines|mesh-list
83682014|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
83682015|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682016|NCT01643980|Progesterone|progesterone|mesh-list
83682017|NCT01643980|Progestins|progestins|mesh-ancestor
83682018|NCT01643980|Hormones|hormones|mesh-ancestor
83682019|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682020|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682021|NCT01645228|Calcium|calcium|mesh-list
83682022|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83682023|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682024|NCT01645839|Cytarabine|cytarabine|mesh-list
83682025|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682026|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
83682027|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682028|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682029|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
83682030|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682031|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836823|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
83682032|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
83682033|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682034|NCT01646437|Aspirin|aspirin|mesh-list
83682035|NCT01646437|Vitamin D|vitamin d|mesh-list
83682036|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
83682037|NCT01646437|Vitamins|vitamins|mesh-ancestor
83682038|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
83682039|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682040|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83682041|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83682042|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83682043|NCT01646437|Analgesics|analgesics|mesh-ancestor
83682044|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
83682045|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682046|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83682047|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83682048|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83682049|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83682050|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682051|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83682052|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83682053|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682054|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
83682055|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83682056|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
83682057|NCT01646619|Analgesics|analgesics|mesh-ancestor
83682058|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
83682059|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682060|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682061|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
83682062|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682063|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83682064|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
83682065|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83682066|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83682067|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682068|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83682069|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
83682070|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83682071|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83682072|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83682073|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682074|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682075|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
83682076|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682077|NCT01648218|Insulin|insulin|mesh-list
83682078|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83682079|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
83682080|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
83682081|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
83682082|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
83682083|NCT01648218|Protamines|protamines|mesh-list
83682084|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83682085|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682086|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
83682087|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682088|NCT01648218|Coagulants|coagulants|mesh-ancestor
83682089|NCT01648465|Everolimus|everolimus|mesh-list
83682090|NCT01648465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83682091|NCT01648465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83682092|NCT01648465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682093|NCT01648465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682094|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682095|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
83682096|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682097|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682098|NCT01648777|Bupivacaine|bupivacaine|mesh-list
83682099|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
83682100|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
83682101|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682102|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682103|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
83682104|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682105|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
83682106|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83682107|NCT01649024|Tremelimumab|tremelimumab|mesh-list
83682108|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682109|NCT01649960|Sirolimus|sirolimus|mesh-list
83682110|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682111|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682112|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83682113|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682114|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
83682115|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682116|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
83682117|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682118|NCT01650012|Eplerenone|eplerenone|mesh-list
83682119|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83682120|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
83682121|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682122|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682123|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83682124|NCT01650012|Diuretics|diuretics|mesh-ancestor
83682125|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
83682126|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83682127|NCT01650090|Cisplatin|cisplatin|mesh-list
83682128|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682129|NCT01650129|Insulin|insulin|mesh-list
83682130|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83682131|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
83682132|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
83682133|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83682134|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682135|NCT01650181|Selenium|selenium|mesh-list
83682136|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
83682137|NCT01650181|Metformin|metformin|mesh-list
83682138|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83682139|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682140|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
83682141|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682142|NCT01650181|Protective Agents|protective agents|mesh-ancestor
83682143|NCT01650181|Trace Elements|trace elements|mesh-ancestor
83682144|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
83682145|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
83682146|NCT01650181|Vitamins|vitamins|mesh-ancestor
83682147|NCT01650272|Minoxidil|minoxidil|mesh-list
83682148|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83682149|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83682150|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
83682151|NCT01650376|Paclitaxel|paclitaxel|mesh-list
83682152|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83682153|NCT01650376|Carboplatin|carboplatin|mesh-list
83682154|NCT01650376|Olaparib|olaparib|mesh-list
83682155|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83682156|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682157|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
83682158|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
83682159|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
83682160|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682161|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83682162|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682163|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
83682164|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83682165|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
83682166|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682167|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
83682168|NCT01650415|Hematinics|hematinics|mesh-ancestor
83682169|NCT01650428|Bevacizumab|bevacizumab|mesh-list
83682170|NCT01650428|Fluorouracil|fluorouracil|mesh-list
83682171|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
83682172|NCT01650428|Irinotecan|irinotecan|mesh-list
83682173|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83682174|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682175|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83682176|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83682177|NCT01650428|Growth Substances|growth substances|mesh-ancestor
83682178|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682179|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
83682180|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
82836970|NCT01104844|Ibuprofen|ibuprofen|mesh-list
83682181|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682182|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682183|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682184|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
83682185|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83682186|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83682187|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682188|NCT01650441|Beclomethasone|beclomethasone|mesh-list
83682189|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
83682190|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83682191|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
83682192|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682193|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682194|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83682195|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
83682196|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83682197|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83682198|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83682199|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
83682200|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682201|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682202|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83682203|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
83682204|NCT01650441|Hormones|hormones|mesh-ancestor
83682205|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682206|NCT01650493|Listerine|listerine|mesh-list
83682207|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
83682208|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
83682209|NCT01650493|Protective Agents|protective agents|mesh-ancestor
83682210|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682211|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83682212|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682213|NCT01650506|Metformin|metformin|mesh-list
83682214|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83682215|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83682216|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682217|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682218|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83682219|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682220|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682221|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
83682222|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682223|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682224|NCT01650649|Lofexidine|lofexidine|mesh-list
83682225|NCT01650649|Clonidine|clonidine|mesh-list
83682226|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83682227|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83682228|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682229|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
83682230|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682231|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83682232|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83682233|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83682234|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83682235|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682236|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682237|NCT01650649|Analgesics|analgesics|mesh-ancestor
83682238|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
83682239|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
83682240|NCT01650662|Cyclosporine|cyclosporine|mesh-list
83682241|NCT01650662|Cyclosporins|cyclosporins|mesh-list
83682242|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682243|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682244|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682245|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
83682246|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682247|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
83682248|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682249|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83682250|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83682251|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83682252|NCT01650727|Rituximab|rituximab|mesh-list
83682253|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83682254|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682255|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
83682256|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682257|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837045|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682258|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83682259|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83682260|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83682261|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83682262|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682263|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682264|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682265|NCT01650740|Analgesics|analgesics|mesh-ancestor
83682266|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
83682267|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682268|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
83682269|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83682270|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
83682272|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682273|NCT01650883|Vitamin D|vitamin d|mesh-list
83682274|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
83682275|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
83682276|NCT01650883|Vitamins|vitamins|mesh-list
83682277|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
83682278|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682279|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83682280|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83682281|NCT01650961|Palonosetron|palonosetron|mesh-list
83682282|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
83682283|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
83682284|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682285|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682286|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682287|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83682288|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83682289|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
83682290|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682291|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682292|NCT01651130|Carbetocin|carbetocin|mesh-list
83682293|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
83682294|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83682295|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682296|NCT01651156|Tolvaptan|tolvaptan|mesh-list
83682297|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83682298|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682299|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
83682300|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682301|NCT01651169|Methylphenidate|methylphenidate|mesh-list
83682302|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83682303|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682304|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83682305|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83682306|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83682307|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682308|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
83682309|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682310|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
83682311|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83682312|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83682313|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682314|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
83682315|NCT01651182|Coagulants|coagulants|mesh-ancestor
83682316|NCT01651312|Mirabegron|mirabegron|mesh-list
83682317|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83682318|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83682319|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83682320|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83682321|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682322|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682323|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682324|NCT01651312|Urological Agents|urological agents|mesh-ancestor
83682325|NCT01651325|Isavuconazole|isavuconazole|mesh-list
83682326|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
83682327|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
83682328|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
83682329|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83682330|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82837118|NCT01111630|Hematinics|hematinics|mesh-ancestor
83682331|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682332|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682333|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682334|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
83682335|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682336|NCT01651364|Cabergoline|cabergoline|mesh-list
83682337|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83682338|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83682339|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
83682340|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
83682341|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682342|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682343|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682344|NCT01651377|Pramipexole|pramipexole|mesh-list
83682345|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
83682346|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682347|NCT01651377|Protective Agents|protective agents|mesh-ancestor
83682348|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682349|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83682350|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83682351|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
83682352|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
83682353|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682354|NCT01651390|Sirolimus|sirolimus|mesh-list
83682355|NCT01651390|Paclitaxel|paclitaxel|mesh-list
83682356|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83682357|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682358|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
83682359|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
83682360|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
83682361|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682362|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682363|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682364|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83682365|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
83682366|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682367|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
83682368|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682369|NCT01651416|Lumefantrine|lumefantrine|mesh-list
83682370|NCT01651416|Artemether|artemether|mesh-list
83682371|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
83682372|NCT01651416|Piperaquine|piperaquine|mesh-list
83682373|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
83682374|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83682375|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83682376|NCT01651416|Amodiaquine|amodiaquine|mesh-list
83682377|NCT01651416|Artenimol|artenimol|mesh-list
83682378|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
83682379|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83682380|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83682381|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682382|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83682383|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682384|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682385|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83682386|NCT01651481|Montelukast|montelukast|mesh-list
83682387|NCT01651481|Levocetirizine|levocetirizine|mesh-list
83682388|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83682389|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
83682390|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83682391|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
83682392|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682393|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682394|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83682395|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83682396|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682397|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83682398|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83682399|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
83682400|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
83682401|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682402|NCT01651520|Flumazenil|flumazenil|mesh-list
83682403|NCT01651520|Antidotes|antidotes|mesh-ancestor
83682404|NCT01651520|Protective Agents|protective agents|mesh-ancestor
83682405|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682406|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
83682407|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
83682408|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682409|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682410|NCT01651572|Rocuronium|rocuronium|mesh-list
83682411|NCT01651572|Cisatracurium|cisatracurium|mesh-list
83682412|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83682413|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83682414|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83682415|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682416|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682417|NCT01651585|Valacyclovir|valacyclovir|mesh-list
83682418|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
83682419|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682420|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83682421|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83682422|NCT01651715|Antibodies|antibodies|mesh-list
83682423|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
83682424|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682425|NCT01651728|Simvastatin|simvastatin|mesh-list
83682426|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83682427|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83682428|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
83682429|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682430|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83682431|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83682432|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682433|NCT01651923|Heparin|heparin|mesh-list
83682434|NCT01651923|Calcium heparin|calcium heparin|mesh-list
83682435|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
83682436|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83682437|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83682438|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682439|NCT01651962|Fentanyl|fentanyl|mesh-list
83682440|NCT01651962|Terbutaline|terbutaline|mesh-list
83682441|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83682442|NCT01651962|Narcotics|narcotics|mesh-ancestor
83682443|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682444|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682445|NCT01651962|Analgesics|analgesics|mesh-ancestor
83682446|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
83682447|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682448|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83682449|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83682450|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
83682451|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
83682452|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83682453|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
83682454|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83682455|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
83682456|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
83682457|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
83682458|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83682459|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83682460|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83682461|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83682462|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
83682463|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682464|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682465|NCT01651988|Propofol|propofol|mesh-list
83682466|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83682467|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682468|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682469|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83682470|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
83682471|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
83682472|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
83682473|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
83682474|NCT01652014|Fludarabine|fludarabine|mesh-list
83682475|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
83682476|NCT01652014|Tacrolimus|tacrolimus|mesh-list
83682477|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682478|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
82837273|NCT01015222|Dasatinib|dasatinib|mesh-list
83682479|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682480|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83682481|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83682482|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
83682483|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682484|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682485|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83682486|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682487|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
83682488|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83682489|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682490|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83682491|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83682492|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
83682493|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682494|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682495|NCT01652118|Clarithromycin|clarithromycin|mesh-list
83682496|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682497|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682498|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83682499|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682500|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682501|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83682502|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83682503|NCT01652157|Pancrelipase|pancrelipase|mesh-list
83682504|NCT01652157|Pancreatin|pancreatin|mesh-list
83682505|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682506|NCT01652183|Acetaminophen|acetaminophen|mesh-list
83682507|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83682508|NCT01652183|Analgesics|analgesics|mesh-ancestor
83682509|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
83682510|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682511|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682512|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
83682513|NCT01652196|Leucovorin|leucovorin|mesh-list
83682514|NCT01652196|Fluorouracil|fluorouracil|mesh-list
83682515|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
83682516|NCT01652196|Aflibercept|aflibercept|mesh-list
83682517|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
83682518|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83682519|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
83682520|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682521|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682522|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682523|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682524|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
83682525|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682526|NCT01652196|Antidotes|antidotes|mesh-ancestor
83682527|NCT01652196|Protective Agents|protective agents|mesh-ancestor
83682528|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
83682529|NCT01652196|Vitamins|vitamins|mesh-ancestor
83682530|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
83682531|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83682532|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83682533|NCT01652196|Growth Substances|growth substances|mesh-ancestor
83682534|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
83682535|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83682536|NCT01652313|Rasagiline|rasagiline|mesh-list
83682537|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83682538|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682539|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682540|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83682541|NCT01652313|Protective Agents|protective agents|mesh-ancestor
83682542|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682543|NCT01652326|Diazepam|diazepam|mesh-list
83682544|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83682545|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
83682546|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
83682547|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
83682548|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682549|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682550|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682551|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83682552|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682553|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83682554|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83682555|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83682556|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83682557|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837347|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
83682558|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83682559|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
83682560|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
83682561|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
83682562|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
83682563|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682564|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682565|NCT01652339|Amlodipine|amlodipine|mesh-list
83682566|NCT01652339|Valsartan|valsartan|mesh-list
83682567|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83682568|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83682569|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83682570|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83682571|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682572|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83682573|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682574|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
83682575|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83682576|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83682577|NCT01652378|Lidocaine|lidocaine|mesh-list
83682578|NCT01652378|Ondansetron|ondansetron|mesh-list
83682579|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
83682580|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
83682581|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682582|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682583|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
83682584|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682585|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83682586|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83682587|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83682588|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83682589|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682590|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
83682591|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
83682592|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682593|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
83682594|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
83682595|NCT01652378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83682596|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83682597|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
83682598|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682599|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
83682600|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83682601|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83682602|NCT01652417|Prednisolone|prednisolone|mesh-list
83682603|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
83682604|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83682605|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
83682606|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83682607|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
83682608|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
83682609|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682610|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682611|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682612|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
83682613|NCT01652417|Hormones|hormones|mesh-ancestor
83682614|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682615|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83682616|NCT01652417|Protective Agents|protective agents|mesh-ancestor
83682617|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83682618|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682619|NCT01652534|Amantadine|amantadine|mesh-list
83682620|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83682621|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83682622|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
83682623|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682624|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
83682625|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682626|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682627|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682628|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83682629|NCT01652534|Analgesics|analgesics|mesh-ancestor
82837424|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682630|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
83682631|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682633|NCT01652547|Somatostatin|somatostatin|mesh-list
83682634|NCT01652547|Hormones|hormones|mesh-ancestor
83682635|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682636|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682637|NCT01652560|Bevacizumab|bevacizumab|mesh-list
83682638|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83682639|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682640|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83682641|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83682642|NCT01652560|Growth Substances|growth substances|mesh-ancestor
83682643|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682644|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
83682645|NCT01652586|Midazolam|midazolam|mesh-list
83682646|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
83682647|NCT01652586|Remifentanil|remifentanil|mesh-list
83682648|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83682649|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682650|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682651|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83682652|NCT01652586|Analgesics|analgesics|mesh-ancestor
83682653|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
83682654|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682655|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83682656|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83682657|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83682658|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
83682659|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682660|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682661|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83682662|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83682663|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83682664|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83682665|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83682666|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
83682667|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
83682668|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
83682669|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
83682670|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83682671|NCT01652586|Narcotics|narcotics|mesh-ancestor
83682672|NCT01652599|Dexamethasone|dexamethasone|mesh-list
83682673|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83682674|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
83682675|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
83682676|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682677|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682678|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682679|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
83682680|NCT01652599|Hormones|hormones|mesh-ancestor
83682681|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682682|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83682683|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682684|NCT01652638|Heparin|heparin|mesh-list
83682685|NCT01652638|Calcium heparin|calcium heparin|mesh-list
83682686|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
83682687|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83682688|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83682689|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682690|NCT01652781|Azacitidine|azacitidine|mesh-list
83682691|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682692|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
83682693|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682694|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682695|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682696|NCT01652794|Carboplatin|carboplatin|mesh-list
83682697|NCT01652794|Gemcitabine|gemcitabine|mesh-list
83682698|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682699|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682700|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
83682701|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682702|NCT01652820|Carboplatin|carboplatin|mesh-list
83682703|NCT01652820|Gemcitabine|gemcitabine|mesh-list
83682704|NCT01652820|Docetaxel|docetaxel|mesh-list
83682705|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682706|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682707|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
83682708|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682709|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
83682710|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
83682711|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
83682712|NCT01652859|Amphotericin B|amphotericin b|mesh-list
83682713|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83682714|NCT01652859|Amebicides|amebicides|mesh-ancestor
83682715|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83682716|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83682717|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682718|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682719|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
83682720|NCT01652898|Esmolol|esmolol|mesh-list
83682721|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83682722|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83682723|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83682724|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
83682725|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682726|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682727|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682728|NCT01652924|Anesthetics|anesthetics|mesh-list
83682729|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83682730|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682731|NCT01653015|Vaccines|vaccines|mesh-list
83682732|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
83682733|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682734|NCT01653041|Everolimus|everolimus|mesh-list
83682735|NCT01653041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83682736|NCT01653041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83682737|NCT01653041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682738|NCT01653041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682739|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682740|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
83682741|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682742|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682743|NCT01653067|Cytarabine|cytarabine|mesh-list
83682744|NCT01653067|Sirolimus|sirolimus|mesh-list
83682745|NCT01653067|Dexamethasone|dexamethasone|mesh-list
83682746|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
83682747|NCT01653067|Rituximab|rituximab|mesh-list
83682748|NCT01653067|Temsirolimus|temsirolimus|mesh-list
83682749|NCT01653067|MTOR Inhibitors|mtor inhibitors|mesh-list
83682750|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83682751|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682752|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
83682753|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682754|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83682755|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83682756|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
83682757|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
83682758|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682759|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682760|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
83682761|NCT01653067|Hormones|hormones|mesh-ancestor
83682762|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682763|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83682764|NCT01653067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682765|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682766|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682767|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
83682768|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
83682769|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682770|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682771|NCT01653067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83682772|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682773|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83682774|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
83682775|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83682776|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83682777|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83682778|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
83682779|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682780|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83682781|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83682782|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682783|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
83682784|NCT01653171|Simethicone|simethicone|mesh-list
83682785|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83682786|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
83682787|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682788|NCT01653171|Expectorants|expectorants|mesh-ancestor
83682789|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
83682790|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83682791|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
83682792|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682793|NCT01653171|Protective Agents|protective agents|mesh-ancestor
83682794|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682795|NCT01653171|Antidotes|antidotes|mesh-ancestor
83682796|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
83682797|NCT01653171|Emollients|emollients|mesh-ancestor
83682798|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
83682799|NCT01653236|Ribavirin|ribavirin|mesh-list
83682800|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83682801|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
83682802|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682803|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
83682804|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682805|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
83682806|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682807|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83682808|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682809|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682810|NCT01653457|Memantine|memantine|mesh-list
83682811|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83682812|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83682813|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
83682814|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682815|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682816|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682817|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83682818|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83682819|NCT01653470|Leucovorin|leucovorin|mesh-list
83682820|NCT01653470|Paclitaxel|paclitaxel|mesh-list
83682821|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83682822|NCT01653470|Carboplatin|carboplatin|mesh-list
83682823|NCT01653470|Fluorouracil|fluorouracil|mesh-list
83682824|NCT01653470|Irinotecan|irinotecan|mesh-list
83682825|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83682826|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682827|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
83682828|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
83682829|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
83682830|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682831|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
83682832|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682833|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682834|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
83682835|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682836|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83682837|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83682838|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682839|NCT01653470|Antidotes|antidotes|mesh-ancestor
83682840|NCT01653470|Protective Agents|protective agents|mesh-ancestor
83682841|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
83682842|NCT01653470|Vitamins|vitamins|mesh-ancestor
83682843|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
83682844|NCT01653522|Doxycycline|doxycycline|mesh-list
83682845|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682846|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682847|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
83682848|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83682849|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83682850|NCT01653561|Apatinib|apatinib|mesh-list
83682851|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682852|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83682853|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682854|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682855|NCT01653639|Factor VIII|factor viii|mesh-list
83682856|NCT01653639|Coagulants|coagulants|mesh-ancestor
82837647|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83682857|NCT01653665|Sargramostim|sargramostim|mesh-list
83682858|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
83682859|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682860|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
83682861|NCT01653717|Fludarabine|fludarabine|mesh-list
83682862|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
83682863|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682864|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
83682865|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682866|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83682867|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83682868|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
83682869|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682870|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682871|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83682872|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682873|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
83682874|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83682875|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
83682876|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83682877|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682878|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682879|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83682880|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83682881|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682882|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682883|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682884|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83682885|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
83682886|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83682887|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682888|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83682889|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83682890|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83682891|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83682892|NCT01654081|Irinotecan|irinotecan|mesh-list
83682893|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83682894|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83682895|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682896|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682897|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682898|NCT01654120|Liraglutide|liraglutide|mesh-list
83682899|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83682900|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682901|NCT01654120|Incretins|incretins|mesh-ancestor
83682902|NCT01654120|Hormones|hormones|mesh-ancestor
83682903|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682904|NCT01654146|Paclitaxel|paclitaxel|mesh-list
83682905|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83682906|NCT01654146|Carboplatin|carboplatin|mesh-list
83682907|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83682908|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682909|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83682910|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83682911|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83682912|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682913|NCT01654185|Letrozole|letrozole|mesh-list
83682914|NCT01654185|Exemestane|exemestane|mesh-list
83682915|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83682916|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682917|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83682918|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682919|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682920|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83682921|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
83682922|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682923|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682924|NCT01654211|Ritonavir|ritonavir|mesh-list
83682925|NCT01654211|Lactams|lactams|mesh-list
83682926|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83682927|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83682928|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
83682929|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682930|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837721|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682931|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83682932|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83682933|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
83682934|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83682935|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83682936|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83682937|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83682938|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
83682939|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83682940|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83682941|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682942|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83682943|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682944|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682945|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83682946|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
83682947|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83682949|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83682950|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
83682951|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
83682952|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83682953|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682954|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682955|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83682956|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83682957|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83682958|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682959|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83682960|NCT01654497|Protective Agents|protective agents|mesh-ancestor
83682961|NCT01654562|Simvastatin|simvastatin|mesh-list
83682962|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83682963|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83682964|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
83682965|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682966|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83682967|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83682968|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682969|NCT01654575|Methotrexate|methotrexate|mesh-list
83682970|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83682971|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
83682972|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83682973|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682974|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83682975|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
83682976|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682977|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682978|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
83682979|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682980|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83682981|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83682982|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
83682983|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83682984|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83682985|NCT01654640|Metformin|metformin|mesh-list
83682986|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83682987|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83682988|NCT01654692|Ipilimumab|ipilimumab|mesh-list
83682989|NCT01654692|Fotemustine|fotemustine|mesh-list
83682990|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83682991|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83682992|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83682993|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83682994|NCT01654705|Pantoprazole|pantoprazole|mesh-list
83682995|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83682996|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83682997|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83682998|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83682999|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683000|NCT01654718|Pantoprazole|pantoprazole|mesh-list
83683001|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83683002|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683003|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83683004|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837792|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837793|NCT02529124|Caseins|caseins|mesh-list
83683005|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683007|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
83683008|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683009|NCT01654913|Chrysarobin|chrysarobin|mesh-list
83683010|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83683011|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683012|NCT01654913|Analgesics|analgesics|mesh-ancestor
83683013|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
83683014|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683015|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683016|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683017|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83683018|NCT01654939|Rifaximin|rifaximin|mesh-list
83683019|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83683020|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683021|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683022|NCT01654965|Topotecan|topotecan|mesh-list
83683023|NCT01654965|Lenograstim|lenograstim|mesh-list
83683024|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83683025|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
83683026|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683027|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83683028|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83683029|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683030|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683031|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683032|NCT01655004|Exemestane|exemestane|mesh-list
83683033|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683034|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83683035|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83683036|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683037|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683038|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83683039|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83683040|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683041|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683042|NCT01655056|Darexaban|darexaban|mesh-list
83683043|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83683044|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
83683045|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83683046|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
83683047|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683048|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683049|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
83683050|NCT01655082|Nicotine|nicotine|mesh-list
83683051|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83683052|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
83683053|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683054|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683055|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83683056|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83683057|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683058|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683059|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683060|NCT01655095|Prucalopride|prucalopride|mesh-list
83683061|NCT01655095|Bisacodyl|bisacodyl|mesh-list
83683062|NCT01655095|Laxatives|laxatives|mesh-ancestor
83683063|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683064|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83683065|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83683066|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
83683067|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683068|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683069|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683070|NCT01655095|Cathartics|cathartics|mesh-ancestor
83683071|NCT01655108|Minoxidil|minoxidil|mesh-list
83683072|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83683073|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
83683074|NCT01655147|Rifampin|rifampin|mesh-list
83683075|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
83683076|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683077|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83683078|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837866|NCT01217086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83683079|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683081|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683082|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683083|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83683084|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83683085|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
83683086|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83683087|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683088|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
83683089|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83683090|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83683091|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83683092|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83683093|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83683094|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83683095|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83683096|NCT01655199|Albuterol|albuterol|mesh-list
83683097|NCT01655199|Ipratropium|ipratropium|mesh-list
83683098|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83683099|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
83683100|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683101|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683102|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83683103|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
83683104|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
83683105|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83683106|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83683107|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83683108|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83683109|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683110|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683111|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683112|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83683113|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683114|NCT01655212|Valganciclovir|valganciclovir|mesh-list
83683115|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
83683116|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683117|NCT01655303|Propranolol|propranolol|mesh-list
83683118|NCT01655303|Metoprolol|metoprolol|mesh-list
83683119|NCT01655303|Verapamil|verapamil|mesh-list
83683120|NCT01655303|Diltiazem|diltiazem|mesh-list
83683121|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83683122|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83683123|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683124|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683125|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683126|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683127|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83683128|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83683129|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
83683130|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
83683131|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
83683132|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683133|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83683134|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83683135|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683136|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683137|NCT01655316|Verapamil|verapamil|mesh-list
83683138|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83683139|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83683140|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683141|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683142|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683143|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683144|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
83683145|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
83683146|NCT01655524|Aminophylline|aminophylline|mesh-list
83683147|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83683148|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
83683149|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683150|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683151|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83683152|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
83683153|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83683154|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83683155|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683156|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683157|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83683158|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83683159|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
83683160|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683161|NCT01655524|Protective Agents|protective agents|mesh-ancestor
83683162|NCT01655628|Cisplatin|cisplatin|mesh-list
83683163|NCT01655628|Gemcitabine|gemcitabine|mesh-list
83683164|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683165|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83683166|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
83683167|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683168|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
83683169|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83683170|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83683171|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683172|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
83683173|NCT01655641|Coagulants|coagulants|mesh-ancestor
83683174|NCT01655706|Aripiprazole|aripiprazole|mesh-list
83683175|NCT01655706|Escitalopram|escitalopram|mesh-list
83683176|NCT01655706|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83683177|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83683178|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683179|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683180|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683181|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
83683182|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683183|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
83683184|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83683185|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83683186|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83683187|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83683188|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
83683189|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
83683190|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83683191|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83419702|NCT00095875|Fluorouracil|fluorouracil|mesh-list
83683192|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83683193|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83683194|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83683195|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83683196|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83683197|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83683198|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683199|NCT01655758|Timolol|timolol|mesh-list
83683200|NCT01655758|Bimatoprost|bimatoprost|mesh-list
83683201|NCT01655758|Travoprost|travoprost|mesh-list
83683202|NCT01655758|Dorzolamide|dorzolamide|mesh-list
83683203|NCT01655758|Latanoprost|latanoprost|mesh-list
83683204|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83683205|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83683206|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683207|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683208|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683209|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683210|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83683211|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83683212|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83683213|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83683214|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83683215|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683216|NCT01655810|Vitamin D|vitamin d|mesh-list
83683217|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
83683218|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
83683219|NCT01655810|Vitamins|vitamins|mesh-list
83683220|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
83683221|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
83683222|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683223|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683224|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82838020|NCT01123408|Haloperidol|haloperidol|mesh-list
83683225|NCT01655810|Antacids|antacids|mesh-ancestor
83683226|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683227|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683228|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
83683229|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83683230|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83683231|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83683232|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683233|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683234|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683235|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683236|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683237|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83683238|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683239|NCT01655875|Plerixafor|plerixafor|mesh-list
83683240|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83683241|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83683242|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
83683243|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683244|NCT01655888|Tremelimumab|tremelimumab|mesh-list
83683245|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683246|NCT01655914|Flumazenil|flumazenil|mesh-list
83683247|NCT01655914|Antidotes|antidotes|mesh-ancestor
83683248|NCT01655914|Protective Agents|protective agents|mesh-ancestor
83683249|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683250|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
83683251|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
83683252|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683253|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683254|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
83683255|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83683256|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83683257|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683258|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
83683259|NCT01655927|Coagulants|coagulants|mesh-ancestor
83683260|NCT01655966|Vitamin D|vitamin d|mesh-list
83683261|NCT01655966|Interferons|interferons|mesh-list
83683262|NCT01655966|Ribavirin|ribavirin|mesh-list
83683263|NCT01655966|Vitamins|vitamins|mesh-ancestor
83683264|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
83683265|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683266|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83683267|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683268|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
83683269|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683270|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
83683271|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683272|NCT01655992|Capecitabine|capecitabine|mesh-list
83683273|NCT01655992|Tegafur|tegafur|mesh-list
83683274|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83683275|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
83683276|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683277|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683278|NCT01656005|Beclomethasone|beclomethasone|mesh-list
83683279|NCT01656005|Carvedilol|carvedilol|mesh-list
83683280|NCT01656005|Bisoprolol|bisoprolol|mesh-list
83683281|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
83683282|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
83683283|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83683284|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
83683285|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683286|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683287|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83683288|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
83683289|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83683290|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83683291|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83683292|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683293|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683294|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683295|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
83683296|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83683297|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683298|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82838091|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82838095|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83683299|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83683300|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83683301|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
83683302|NCT01656005|Protective Agents|protective agents|mesh-ancestor
83683303|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83683304|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683305|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683306|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
83683307|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83683308|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83683309|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
83683310|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83683311|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683312|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
83683313|NCT01656005|Hormones|hormones|mesh-ancestor
83683314|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683315|NCT01656018|Rilpivirine|rilpivirine|mesh-list
83683316|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83683317|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83683318|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683319|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683320|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
83683321|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683322|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83683323|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83683324|NCT01656057|Acetaminophen|acetaminophen|mesh-list
83683325|NCT01656057|Metformin|metformin|mesh-list
83683326|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
83683327|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83683328|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83683329|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683330|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683331|NCT01656057|Analgesics|analgesics|mesh-ancestor
83683332|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
83683333|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683334|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
83683335|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83683336|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83683337|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
83683338|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683339|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83683340|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83683341|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683342|NCT01656070|Vitamin D|vitamin d|mesh-list
83683343|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
83683344|NCT01656070|Vitamins|vitamins|mesh-ancestor
83683345|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
83683346|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683347|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83683348|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683349|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83683350|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83683351|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83683352|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
83683353|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683354|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683355|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83683356|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83683357|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
83683358|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683359|NCT01656122|Abacavir|abacavir|mesh-list
83683360|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83683361|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83683362|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683363|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683364|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
83683365|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683366|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83683367|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83683368|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
83683369|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83683370|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683371|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683372|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
83683373|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82838169|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
83683374|NCT01656226|Protective Agents|protective agents|mesh-ancestor
83683375|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683376|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
83683377|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
83683378|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83683379|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
83683380|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83683381|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
83683382|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683383|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683384|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
83683385|NCT01656512|Vitamin D|vitamin d|mesh-list
83683386|NCT01656512|Diphosphonates|diphosphonates|mesh-list
83683387|NCT01656512|Calcium|calcium|mesh-list
83683388|NCT01656512|Vitamins|vitamins|mesh-ancestor
83683389|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
83683390|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683391|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683392|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83683393|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83683394|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
83683395|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683396|NCT01656538|Paclitaxel|paclitaxel|mesh-list
83683397|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83683398|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683399|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
83683400|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
83683401|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
83683402|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683403|NCT01656616|Antidotes|antidotes|mesh-list
83683404|NCT01656616|Protective Agents|protective agents|mesh-ancestor
83683405|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683406|NCT01656642|Atezolizumab|atezolizumab|mesh-list
83683407|NCT01656642|Vemurafenib|vemurafenib|mesh-list
83683408|NCT01656642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83683409|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683410|NCT01656642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83683411|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683412|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83683413|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683414|NCT01656668|Theobromine|theobromine|mesh-list
83683415|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83683416|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
83683417|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683418|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683419|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83683420|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
83683421|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
83683422|NCT01656720|Methoxamine|methoxamine|mesh-list
83683423|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
83683424|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
83683425|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683426|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683427|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83683428|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83683429|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83683430|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83683431|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683432|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683433|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683434|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
83683435|NCT01656798|Citric Acid|citric acid|mesh-list
83683436|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
83683437|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
83683438|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83683439|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
83683440|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
83683441|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683442|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
83683443|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83683444|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83683445|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683446|NCT01656798|Urological Agents|urological agents|mesh-ancestor
83683447|NCT01656811|Albuterol|albuterol|mesh-list
82838239|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683448|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83683449|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
83683450|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683451|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683452|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83683453|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
83683454|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
83683455|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83683456|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83683457|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83683458|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83683459|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683460|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683461|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683462|NCT01656980|Carmustine|carmustine|mesh-list
83683463|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83683464|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
83683465|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683466|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683467|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
83683468|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
83683469|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
83683470|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683471|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683472|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683473|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83683474|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
83683475|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
83683476|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683477|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683478|NCT01657071|Aspirin|aspirin|mesh-list
83683479|NCT01657071|Clopidogrel|clopidogrel|mesh-list
83683480|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83683481|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683482|NCT01657071|Analgesics|analgesics|mesh-ancestor
83683483|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
83683484|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683485|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683486|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683487|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83683488|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83683489|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83683490|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683491|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83683492|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83683493|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683494|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
83683495|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83683496|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83683497|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83683498|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
83683499|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683500|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
83683501|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83683502|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683503|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83683504|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83683505|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683506|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683507|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683508|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683509|NCT01657201|Voriconazole|voriconazole|mesh-list
83683510|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
83683511|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683512|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83683513|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83683514|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683515|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683516|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83683517|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
83683518|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683519|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683520|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83683522|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83683523|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83683524|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83683525|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683526|NCT01657240|Analgesics|analgesics|mesh-ancestor
83683527|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
83683528|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683529|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683530|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683531|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83683532|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83683533|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83683534|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83683535|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
83683536|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
83683537|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683538|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683539|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83683540|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683541|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83683542|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83683543|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83683544|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
83683545|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683546|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683547|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83683548|NCT01657331|Immunotoxins|immunotoxins|mesh-ancestor
83683549|NCT01657331|Immunoconjugates|immunoconjugates|mesh-ancestor
83683550|NCT01657331|Immunologic Factors|immunologic factors|mesh-ancestor
83683551|NCT01657331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683552|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
83683553|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83683554|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83683555|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83683556|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83683557|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683558|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683559|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683560|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683561|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683562|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83683563|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683564|NCT01657448|Methenamine|methenamine|mesh-list
83683565|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
83683566|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
83683567|NCT01657448|Methylene Blue|methylene blue|mesh-list
83683568|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83683569|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683570|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83683571|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683572|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683573|NCT01657487|Fluticasone|fluticasone|mesh-list
83683574|NCT01657487|Xhance|xhance|mesh-list
83683575|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83683576|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83683577|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683578|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83683579|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
83683580|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683581|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683582|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83683583|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83683584|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
83683585|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83683586|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83683587|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83683588|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83683589|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683590|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683591|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683592|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
83683593|NCT01657487|Hormones|hormones|mesh-ancestor
83683594|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683596|NCT01657578|Omeprazole|omeprazole|mesh-list
83683597|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83683598|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683599|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83683600|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683601|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683602|NCT01657656|Vitamin D|vitamin d|mesh-list
83683603|NCT01657656|Vitamins|vitamins|mesh-ancestor
83683604|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
83683605|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683606|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83683607|NCT01657669|Aflibercept|aflibercept|mesh-list
83683608|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83683609|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83683610|NCT01657669|Growth Substances|growth substances|mesh-ancestor
83683611|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683612|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83683613|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683614|NCT01657682|Crenolanib|crenolanib|mesh-list
83683615|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683616|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83683617|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
83683618|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
83683619|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683620|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683621|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83683622|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83683623|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683624|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683625|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683626|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
83683627|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83683628|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83683629|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683630|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683631|NCT01657812|Analgesics|analgesics|mesh-ancestor
83683632|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
83683633|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683634|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83683635|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83683636|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83683637|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683638|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683639|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683640|NCT01657825|Isavuconazole|isavuconazole|mesh-list
83683641|NCT01657825|Warfarin|warfarin|mesh-list
83683642|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
83683643|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
83683644|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683645|NCT01657838|Ketoconazole|ketoconazole|mesh-list
83683646|NCT01657838|Isavuconazole|isavuconazole|mesh-list
83683647|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
83683648|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683649|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83683650|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83683651|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683652|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683653|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83683654|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
83683655|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683656|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683657|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83683658|NCT01657851|Tamsulosin|tamsulosin|mesh-list
83683659|NCT01657851|Dutasteride|dutasteride|mesh-list
83683660|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83683661|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83683662|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83683663|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683664|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683665|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838463|NCT00224120|Urological Agents|urological agents|mesh-ancestor
83683666|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683668|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83683669|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83683670|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683671|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
83683672|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683673|NCT01657864|Lamotrigine|lamotrigine|mesh-list
83683674|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
83683675|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83683676|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683677|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683678|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683679|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683680|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83683681|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83683682|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83683683|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83683684|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83683685|NCT01657890|Isavuconazole|isavuconazole|mesh-list
83683686|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
83683687|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683688|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83683689|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83683690|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
83683691|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683692|NCT01657929|Antacids|antacids|mesh-ancestor
83683693|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683694|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683695|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83683696|NCT01657955|Chlorambucil|chlorambucil|mesh-list
83683697|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83683698|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
83683699|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683700|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683701|NCT01657513|Adalimumab|adalimumab|mesh-list
83683702|NCT01657513|Infliximab|infliximab|mesh-list
83683703|NCT01657513|Etanercept|etanercept|mesh-list
83683704|NCT01657513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83683705|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683706|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83683707|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
83683708|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683709|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83683710|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683711|NCT01657513|Analgesics|analgesics|mesh-ancestor
83683712|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
83683713|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683714|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683715|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83683716|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
83683717|NCT01657981|Darexaban|darexaban|mesh-list
83683718|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83683719|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
83683720|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83683721|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
83683722|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683723|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683724|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
83683725|NCT01658007|Sirolimus|sirolimus|mesh-list
83683726|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83683727|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683728|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83683729|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683730|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
83683731|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83683732|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
83683733|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683734|NCT01658033|Leucovorin|leucovorin|mesh-list
83683735|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
83683736|NCT01658033|Bevacizumab|bevacizumab|mesh-list
83683737|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683738|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82838538|NCT01226680|Tofacitinib|tofacitinib|mesh-list
83683739|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83683740|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83683741|NCT01658033|Growth Substances|growth substances|mesh-ancestor
83683742|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683743|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
83683744|NCT01658033|Antidotes|antidotes|mesh-ancestor
83683745|NCT01658033|Protective Agents|protective agents|mesh-ancestor
83683746|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
83683747|NCT01658033|Vitamins|vitamins|mesh-ancestor
83683748|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
83683749|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
83683750|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83683751|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83683752|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683753|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
83683754|NCT01658124|Coagulants|coagulants|mesh-ancestor
83683755|NCT01658176|Exemestane|exemestane|mesh-list
83683756|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683757|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83683758|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83683759|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683760|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683761|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83683762|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
83683763|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683764|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683765|NCT01658202|Nicotine|nicotine|mesh-list
83683766|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83683767|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
83683768|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683769|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683770|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83683771|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83683772|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683773|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683774|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683775|NCT01658215|Nicotine|nicotine|mesh-list
83683776|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83683777|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
83683778|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683779|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683780|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83683781|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83683782|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
83683783|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683784|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683785|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
83683786|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83683787|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683788|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
83683789|NCT01658319|Fludarabine|fludarabine|mesh-list
83683790|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
83683791|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683792|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83683793|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
83683794|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683795|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83683796|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
83683797|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683798|NCT01658358|Doxorubicin|doxorubicin|mesh-list
83683799|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83683800|NCT01658358|Lapatinib|lapatinib|mesh-list
83683801|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83683802|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683803|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83683804|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83683805|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683806|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683807|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83683808|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83683809|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83683810|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83683811|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683812|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
83683813|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82838613|NCT01128322|Niacin|niacin|mesh-list
83683814|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
83683815|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683816|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
83683817|NCT01658449|Protective Agents|protective agents|mesh-ancestor
83683818|NCT01658462|Docetaxel|docetaxel|mesh-list
83683819|NCT01658462|Nintedanib|nintedanib|mesh-list
83683820|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683821|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83683822|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83683823|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83683824|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683825|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83683826|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683827|NCT01658527|Bicalutamide|bicalutamide|mesh-list
83683828|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
83683829|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
83683830|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683831|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683832|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683833|NCT01658553|Trametinib|trametinib|mesh-list
83683834|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683835|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83683836|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683837|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683838|NCT01658774|Albendazole|albendazole|mesh-list
83683839|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683840|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
83683841|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83683842|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683843|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
83683844|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83683845|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83683846|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
83683847|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
83683848|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
83683849|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683850|NCT01658852|Metronidazole|metronidazole|mesh-list
83683851|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683852|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83683853|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83683854|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83683855|NCT01658878|Nivolumab|nivolumab|mesh-list
83683856|NCT01658878|Ipilimumab|ipilimumab|mesh-list
83683857|NCT01658878|Sorafenib|sorafenib|mesh-list
83683858|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83683859|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683860|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83683861|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683862|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83683863|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683864|NCT01658891|Beclomethasone|beclomethasone|mesh-list
83683865|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
83683866|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83683867|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
83683868|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683869|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683870|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83683871|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
83683872|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83683873|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83683874|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83683875|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683876|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683877|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683878|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683879|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
83683880|NCT01658891|Hormones|hormones|mesh-ancestor
83683881|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683882|NCT01659008|Estradiol|estradiol|mesh-list
83683883|NCT01659008|Estrogens|estrogens|mesh-ancestor
83683884|NCT01659008|Hormones|hormones|mesh-ancestor
83683885|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683886|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683887|NCT01659047|Idelalisib|idelalisib|mesh-list
82838686|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
83683888|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683889|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683890|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683892|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
83683893|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683894|NCT01659099|Prednisone|prednisone|mesh-list
83683895|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
83683896|NCT01659099|Rituximab|rituximab|mesh-list
83683897|NCT01659099|Doxorubicin|doxorubicin|mesh-list
83683898|NCT01659099|Vincristine|vincristine|mesh-list
83683899|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
83683900|NCT01659099|Bleomycin|bleomycin|mesh-list
83683901|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83683902|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
83683903|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683904|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83683905|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83683906|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
83683907|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683908|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683909|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83683910|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83683911|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83683912|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83683913|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83683914|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683915|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683916|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
83683917|NCT01659099|Hormones|hormones|mesh-ancestor
83683918|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83683919|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83683920|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83683921|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
83683922|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
83683923|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
83683924|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
83683925|NCT01659190|Antacids|antacids|mesh-ancestor
83683926|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683927|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683928|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
83683929|NCT01659242|Methotrexate|methotrexate|mesh-list
83683930|NCT01659242|Leflunomide|leflunomide|mesh-list
83683931|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83683932|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
83683933|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83683934|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683935|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83683936|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
83683937|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683938|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683939|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83683940|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83683941|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83683942|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83683943|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
83683944|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83683945|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83683946|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683947|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83683948|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683949|NCT01659242|Analgesics|analgesics|mesh-ancestor
83683950|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
83683951|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683952|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83683953|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83683954|NCT01659281|Artesunate|artesunate|mesh-list
83683955|NCT01659281|Mefloquine|mefloquine|mesh-list
83683956|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
83683957|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83683958|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83683959|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83683960|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83683961|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
83683962|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
83683963|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82838761|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83683964|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
83683965|NCT01659346|Carvedilol|carvedilol|mesh-list
83683966|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83683967|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83683968|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
83683969|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83683970|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683971|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683972|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83683973|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
83683974|NCT01659346|Protective Agents|protective agents|mesh-ancestor
83683975|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83683976|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683977|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83683978|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
83683979|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83683980|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83683981|NCT01659359|Lidocaine|lidocaine|mesh-list
83683982|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
83683983|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
83683984|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83683985|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83683986|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
83683987|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683988|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83683989|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83683990|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83683991|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83683992|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83683993|NCT01659372|Naproxen|naproxen|mesh-list
83683994|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83683995|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83683996|NCT01659372|Analgesics|analgesics|mesh-ancestor
83683997|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
83683998|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83683999|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684000|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684001|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83684002|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
83684003|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83684004|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684005|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684006|NCT01659437|Clarithromycin|clarithromycin|mesh-list
83684007|NCT01659437|Streptomycin|streptomycin|mesh-list
83684008|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83684009|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684010|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83684011|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684012|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684013|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83684014|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83684015|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
83684016|NCT01659476|Miotics|miotics|mesh-ancestor
83684017|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
83684018|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684019|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684020|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83684021|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83684022|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
83684023|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83684024|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83684025|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
83684026|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684027|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838836|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838837|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
82838838|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838839|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838840|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82838841|NCT01130662|Decitabine|decitabine|mesh-list
82838842|NCT01130662|Midostaurin|midostaurin|mesh-list
82838843|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82838849|NCT03925714|Metformin|metformin|mesh-list
83684028|NCT01659515|Arbekacin|arbekacin|mesh-list
83684029|NCT01659515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83684030|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684031|NCT01659619|Erythromycin|erythromycin|mesh-list
83684032|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
83684033|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83684034|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
83684035|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83684036|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684037|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684038|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83684039|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684040|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684041|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
83684042|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83684043|NCT01659684|Antibodies|antibodies|mesh-list
83684044|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
83684045|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83684046|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
83684047|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684048|NCT01659788|Ubiquinone|ubiquinone|mesh-list
83684049|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
83684050|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
83684051|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684052|NCT01659788|Vitamins|vitamins|mesh-ancestor
83684053|NCT01659827|Bupivacaine|bupivacaine|mesh-list
83684054|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
83684055|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
83684056|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684057|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684058|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
83684059|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684060|NCT01659892|Montelukast|montelukast|mesh-list
83684061|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83684062|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
83684063|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83684064|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684065|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684066|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684067|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83684068|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83684069|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684070|NCT01659905|Montelukast|montelukast|mesh-list
83684071|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83684072|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
83684073|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83684074|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684075|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684076|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684077|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83684078|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83684079|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684080|NCT01659918|Montelukast|montelukast|mesh-list
83684081|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83684082|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
83684083|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83684084|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684085|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684086|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684087|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83684088|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83684089|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684090|NCT01659931|Montelukast|montelukast|mesh-list
83684091|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83684092|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
83684093|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83684094|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684095|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684096|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684097|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83684098|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83684099|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684101|NCT01659944|Eliglustat|eliglustat|mesh-list
83684102|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83684103|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83684104|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
83684105|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
83684106|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684107|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684108|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83684109|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83684110|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83684111|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83684112|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684113|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684114|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684115|NCT01659775|Ondansetron|ondansetron|mesh-list
83684116|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
83684117|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
83684118|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684119|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684120|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684121|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
83684122|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
83684123|NCT01659775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83684124|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83684125|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
83684126|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684127|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684128|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83684129|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
83684130|NCT01660295|Certoparin|certoparin|mesh-list
83684131|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
83684132|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83684133|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83684134|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684135|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83684136|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
83684137|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
83684138|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684139|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684140|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83684141|NCT01660295|Analgesics|analgesics|mesh-ancestor
83684142|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
83684143|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684144|NCT01660373|Tirofiban|tirofiban|mesh-list
83684145|NCT01660373|Ticagrelor|ticagrelor|mesh-list
83684146|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83684147|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83684148|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83684149|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83684150|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
83684151|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684152|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684153|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684154|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83684155|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83684156|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83684157|NCT01660386|Glimepiride|glimepiride|mesh-list
83684158|NCT01660386|Saxagliptin|saxagliptin|mesh-list
83684159|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83684160|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684161|NCT01660386|Incretins|incretins|mesh-ancestor
83684162|NCT01660386|Hormones|hormones|mesh-ancestor
83684163|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684164|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83684165|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
83684166|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684167|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684168|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83684169|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83684170|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
83684171|NCT01660399|Docetaxel|docetaxel|mesh-list
83684172|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684173|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
83684174|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
83684175|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83684176|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684177|NCT01660477|Ritonavir|ritonavir|mesh-list
83684178|NCT01660477|Lopinavir|lopinavir|mesh-list
83684179|NCT01660477|Isavuconazole|isavuconazole|mesh-list
83684180|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83684181|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83684182|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
83684183|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684184|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684185|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83684186|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83684187|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
83684188|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684189|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83684190|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83684191|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
83684192|NCT01660542|Docetaxel|docetaxel|mesh-list
83684193|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684194|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83684195|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83684196|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83684197|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684198|NCT01660594|Calcium|calcium|mesh-list
83684199|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83684200|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684201|NCT01660620|Betaxolol|betaxolol|mesh-list
83684202|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83684203|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
83684204|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
83684205|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684206|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684207|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83684208|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83684209|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83684210|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
83684211|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684212|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684213|NCT01660750|Dexamethasone|dexamethasone|mesh-list
83684214|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
83684215|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83684216|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
83684217|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684218|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83684219|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83684220|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
83684221|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684222|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684223|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83684224|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684225|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
83684226|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
83684227|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684228|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684229|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
83684230|NCT01660750|Hormones|hormones|mesh-ancestor
83684231|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684232|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83684233|NCT01660854|Proguanil|proguanil|mesh-list
83684234|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83684235|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
83684236|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83684237|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83684238|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684239|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
83684240|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684241|NCT01660867|Dexamethasone|dexamethasone|mesh-list
83684242|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684243|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
83684244|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
83684245|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684246|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684247|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684248|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
83684249|NCT01660867|Hormones|hormones|mesh-ancestor
83684250|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684251|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83684253|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83684254|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83684255|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83684256|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
83684257|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684258|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83684259|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83684260|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684261|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83684262|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83684263|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83684264|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
83684265|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684266|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83684267|NCT01660997|Dexamethasone|dexamethasone|mesh-list
83684268|NCT01660997|Ixazomib|ixazomib|mesh-list
83684269|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684270|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
83684271|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
83684272|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684273|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684274|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684275|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
83684276|NCT01660997|Hormones|hormones|mesh-ancestor
83684277|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684278|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83684279|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684280|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
83684281|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684282|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684283|NCT01661101|Omeprazole|omeprazole|mesh-list
83684284|NCT01661101|Dabigatran|dabigatran|mesh-list
83684285|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83684286|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684287|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83684288|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684289|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684290|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
83684291|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83684292|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
83684293|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
83684294|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83684295|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
83684296|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83684297|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83684298|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
83684299|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684300|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684301|NCT01661257|Infliximab|infliximab|mesh-list
83684302|NCT01661257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83684303|NCT01661257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684304|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
83684305|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684306|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83684307|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83684308|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83684309|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83684310|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684311|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
83684312|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83684313|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
83684314|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
83684315|NCT01661309|Vitamins|vitamins|mesh-ancestor
83684316|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
83684317|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684318|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
83684319|NCT01661322|Aspirin|aspirin|mesh-list
83684320|NCT01661322|Clopidogrel|clopidogrel|mesh-list
83684321|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83684322|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83684323|NCT01661322|Analgesics|analgesics|mesh-ancestor
83684324|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
83684325|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684326|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684327|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684328|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83684329|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83684330|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83684331|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684332|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83684333|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83684334|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684335|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
83684336|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83684337|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83684338|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83684339|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
83684340|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684341|NCT01661335|Dexamethasone|dexamethasone|mesh-list
83684342|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
83684343|NCT01661335|Ondansetron|ondansetron|mesh-list
83684344|NCT01661335|Aprepitant|aprepitant|mesh-list
83684345|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
83684346|NCT01661335|BB 1101|bb 1101|mesh-list
83684347|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684348|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
83684349|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
83684350|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684351|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684352|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684353|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
83684354|NCT01661335|Hormones|hormones|mesh-ancestor
83684355|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684356|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83684357|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684358|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
83684359|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684360|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684361|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
83684362|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
83684363|NCT01661335|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83684364|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83684365|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
83684366|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684367|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83684368|NCT01661439|Heparin|heparin|mesh-list
83684369|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83684370|NCT01661439|Tinzaparin|tinzaparin|mesh-list
83684371|NCT01661439|Dalteparin|dalteparin|mesh-list
83684372|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
82858928|NCT05552222|Hormones|hormones|mesh-ancestor
83792092|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
82859065|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
82859142|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82859294|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859481|NCT04348747|Vaccines|vaccines|mesh-list
82859750|NCT03798626|Vitamins|vitamins|mesh-ancestor
82860512|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860594|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
82860679|NCT00063258|Paclitaxel|paclitaxel|mesh-list
82860746|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82860823|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82861049|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
82861277|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82861583|NCT01112540|Morphine|morphine|mesh-list
82861842|NCT03942068|Paclitaxel|paclitaxel|mesh-list
82861894|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82861971|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
82862046|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862118|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862199|NCT01109888|Cetrorelix|cetrorelix|mesh-list
83792093|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792094|NCT00027287|Protective Agents|protective agents|mesh-ancestor
83792095|NCT00055419|Cetuximab|cetuximab|mesh-list
82862660|NCT01124630|Leucovorin|leucovorin|mesh-list
83792096|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82863040|NCT03706300|Ephedrine|ephedrine|mesh-list
82863105|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792097|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792098|NCT00055536|Natalizumab|natalizumab|mesh-list
83792099|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
83792100|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863944|NCT01129934|Morphine|morphine|mesh-list
83792101|NCT00027443|Cyclosporine|cyclosporine|mesh-list
83792102|NCT00027443|Cyclosporins|cyclosporins|mesh-list
82864664|NCT01138904|Irinotecan|irinotecan|mesh-list
82864881|NCT03913442|Colchicine|colchicine|mesh-list
82864969|NCT02143726|Everolimus|everolimus|mesh-list
82865126|NCT01143584|Dopamine|dopamine|mesh-list
83792103|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
82865339|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
83792104|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865580|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82865672|NCT01144676|Dapivirine|dapivirine|mesh-list
82865743|NCT03912740|Narcotics|narcotics|mesh-ancestor
82865813|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865890|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82866050|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866124|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792105|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866699|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
83792106|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792107|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
82866868|NCT01153256|Analgesics|analgesics|mesh-ancestor
83792108|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792109|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
82867244|NCT01154738|Lidocaine|lidocaine|mesh-list
82867319|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792110|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867476|NCT01266512|Docetaxel|docetaxel|mesh-list
82867550|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
82867701|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792111|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
83792112|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792113|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83792114|NCT00055614|Topotecan|topotecan|mesh-list
82868761|NCT01286090|Cisapride|cisapride|mesh-list
82868987|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
82869139|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
82869213|NCT01287260|Nifedipine|nifedipine|mesh-list
83792115|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83792116|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792117|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869592|NCT00061932|Bortezomib|bortezomib|mesh-list
82869670|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869912|NCT01183364|Docetaxel|docetaxel|mesh-list
83792118|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870729|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
83792119|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792120|NCT00027521|Bleomycin|bleomycin|mesh-list
82871262|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
83792121|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82871496|NCT02387996|Nivolumab|nivolumab|mesh-list
82871792|NCT01205516|Morphine|morphine|mesh-list
82872089|NCT01201928|Insulin|insulin|mesh-list
82872718|NCT03979469|Fentanyl|fentanyl|mesh-list
83684440|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684441|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684442|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
82873318|NCT03636178|Daminozide|daminozide|mesh-list
83684443|NCT01662193|Vitamin D|vitamin d|mesh-list
82874154|NCT00262925|Vitamins|vitamins|mesh-ancestor
83684444|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
82874371|NCT03816020|Niacin|niacin|mesh-list
82874453|NCT01301612|Cisplatin|cisplatin|mesh-list
82874531|NCT03812120|Coagulants|coagulants|mesh-ancestor
82874605|NCT03811418|Docetaxel|docetaxel|mesh-list
83684445|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
83684446|NCT01662193|Vitamins|vitamins|mesh-list
82875155|NCT01335334|Omeprazole|omeprazole|mesh-list
83684447|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
82875298|NCT01335646|Analgesics|analgesics|mesh-list
83684448|NCT01662193|Calcium|calcium|mesh-list
83684449|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
83684450|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684451|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82876601|NCT01349764|Vitamins|vitamins|mesh-ancestor
83684452|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83684453|NCT01662193|Antacids|antacids|mesh-ancestor
82877138|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
82877289|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
82877368|NCT02922764|Docetaxel|docetaxel|mesh-list
83792122|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684454|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684455|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82877829|NCT03764462|AD 101|ad 101|mesh-list
83684456|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
83684457|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82878570|NCT02567578|YH12852|yh12852|mesh-list
83684458|NCT01662401|Bupivacaine|bupivacaine|mesh-list
82878723|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
83684459|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
82879013|NCT01359436|Antibodies|antibodies|mesh-list
83684460|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
83792123|NCT00027599|Bevacizumab|bevacizumab|mesh-list
83792124|NCT00027599|Sargramostim|sargramostim|mesh-list
82879546|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
82879694|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
82879844|NCT03783702|Analgesics|analgesics|mesh-ancestor
82880002|NCT01400776|Estradiol|estradiol|mesh-list
83684461|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880403|NCT04103554|Valsartan|valsartan|mesh-list
82880752|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
82880904|NCT03929094|Paclitaxel|paclitaxel|mesh-list
82880987|NCT01229202|Bevacizumab|bevacizumab|mesh-list
82881066|NCT03925428|Entinostat|entinostat|mesh-list
82881366|NCT03917784|Analgesics|analgesics|mesh-ancestor
82881449|NCT01230996|Cisplatin|cisplatin|mesh-list
82881602|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82881926|NCT05848687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82882006|NCT05848102|Dapagliflozin|dapagliflozin|mesh-list
83684462|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882177|NCT05845125|Hormones|hormones|mesh-ancestor
82882253|NCT05844371|Oxaliplatin|oxaliplatin|mesh-list
82882484|NCT05840562|Capsaicin|capsaicin|mesh-list
83684463|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
82882563|NCT05828095|MEDI9197|medi9197|mesh-list
83684464|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684465|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
82882723|NCT05805072|Cytarabine|cytarabine|mesh-list
83684466|NCT01662466|Testosterone|testosterone|mesh-list
82882918|NCT05704673|Nalbuphine|nalbuphine|mesh-list
82883201|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82883275|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
82883439|NCT05262777|Lidocaine|lidocaine|mesh-list
82883710|NCT05114096|Betamethasone|betamethasone|mesh-list
82883932|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82884008|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
82884161|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
82884579|NCT04579510|Vaccines|vaccines|mesh-list
82884878|NCT04323956|Hormones|hormones|mesh-ancestor
82884971|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83684467|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
83684468|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
82885620|NCT03578081|Palonosetron|palonosetron|mesh-list
83684469|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82885859|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
82886011|NCT03234972|Hormones|hormones|mesh-ancestor
82886160|NCT03040973|Gefitinib|gefitinib|mesh-list
83684470|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82886392|NCT02765854|Dexamethasone|dexamethasone|mesh-list
82886772|NCT02123758|Prednisone|prednisone|mesh-list
83684471|NCT01662466|Androgens|androgens|mesh-ancestor
82887309|NCT05795244|Nivolumab|nivolumab|mesh-list
83684472|NCT01662466|Hormones|hormones|mesh-ancestor
83792125|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888006|NCT03777436|Apremilast|apremilast|mesh-list
83792126|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888080|NCT03299309|Vaccines|vaccines|mesh-list
82888158|NCT02581787|Antibodies|antibodies|mesh-list
82888236|NCT01243190|Ofatumumab|ofatumumab|mesh-list
82888501|NCT03790800|Urapidil|urapidil|mesh-list
82888582|NCT00162773|Omalizumab|omalizumab|mesh-list
83792127|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82888726|NCT03099538|Ixekizumab|ixekizumab|mesh-list
83792128|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889107|NCT01237782|Propolis|propolis|mesh-list
83792129|NCT00027599|Growth Substances|growth substances|mesh-ancestor
82889404|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82889560|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
82889862|NCT03897660|Coagulants|coagulants|mesh-ancestor
82889934|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
83792130|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890236|NCT01255956|Sirolimus|sirolimus|mesh-list
82890314|NCT01152372|Insulin|insulin|mesh-list
83792131|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
82890463|NCT01262274|Anastrozole|anastrozole|mesh-list
83792132|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
82890695|NCT01156350|Fludarabine|fludarabine|mesh-list
82891002|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
83792133|NCT00055653|Cyclosporine|cyclosporine|mesh-list
82891369|NCT01269216|Leucovorin|leucovorin|mesh-list
83792134|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
82891525|NCT05835713|Anesthetics|anesthetics|mesh-ancestor
82891824|NCT05753098|Hormones|hormones|mesh-ancestor
82892272|NCT04801849|Vitamins|vitamins|mesh-ancestor
82892372|NCT04361708|Leucovorin|leucovorin|mesh-list
82892500|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
82733749|NCT00877539|Xhance|xhance|mesh-list
83792135|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
82893030|NCT02213913|Hormones|hormones|mesh-ancestor
82893107|NCT01592370|Hormones|hormones|mesh-ancestor
82893262|NCT01167738|Metformin|metformin|mesh-list
82893330|NCT01281852|Paclitaxel|paclitaxel|mesh-list
83792136|NCT00055653|Melphalan|melphalan|mesh-list
83792137|NCT00055653|Busulfan|busulfan|mesh-list
82894082|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
83684473|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684474|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894544|NCT01290276|Ondansetron|ondansetron|mesh-list
82894702|NCT01290432|Folic Acid|folic acid|mesh-list
83792138|NCT00055653|Fludarabine|fludarabine|mesh-list
83684475|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83684476|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896004|NCT05668572|Vaccines|vaccines|mesh-list
83684477|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
83684478|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83684479|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
82896744|NCT00005044|Flutamide|flutamide|mesh-list
83684480|NCT01662518|Dexamethasone|dexamethasone|mesh-list
82896818|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
82897051|NCT03516214|Trametinib|trametinib|mesh-list
83792139|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
83684481|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82897312|NCT01308606|Simeprevir|simeprevir|mesh-list
82897370|NCT03785184|Hormones|hormones|mesh-ancestor
83684482|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
82897678|NCT03783000|BI 425809|bi 425809|mesh-list
83684483|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
82897762|NCT05202496|Vitamins|vitamins|mesh-ancestor
83792140|NCT00055653|Cyclosporins|cyclosporins|mesh-list
83792141|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83684484|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898560|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
82898867|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
82899479|NCT01561950|Clopidogrel|clopidogrel|mesh-list
82899562|NCT05280626|Hormones|hormones|mesh-ancestor
83684485|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899969|NCT04357782|Vitamins|vitamins|mesh-ancestor
82900108|NCT03447262|VX-659|vx-659|mesh-list
82900252|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83684486|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684487|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
83684488|NCT01662518|Hormones|hormones|mesh-ancestor
82900832|NCT04963816|Dexamethasone|dexamethasone|mesh-list
82901121|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83792142|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792143|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
83792144|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792145|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792146|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82902625|NCT03727412|Analgesics|analgesics|mesh-ancestor
82902849|NCT04112589|Cytarabine|cytarabine|mesh-list
83684489|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684490|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82903171|NCT04561648|Heparin|heparin|mesh-list
83684491|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684492|NCT01662622|Sevoflurane|sevoflurane|mesh-list
83684493|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82903737|NCT04491526|Tamsulosin|tamsulosin|mesh-list
82903812|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
82903889|NCT00066807|Tamoxifen|tamoxifen|mesh-list
82904145|NCT03692416|Analgesics|analgesics|mesh-ancestor
83684494|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82904229|NCT03421730|Budesonide|budesonide|mesh-list
83684495|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
83684496|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
83792147|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
82904818|NCT03624166|Ketamine|ketamine|mesh-list
83684497|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684498|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905518|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
82905683|NCT00031551|Etanercept|etanercept|mesh-list
83684499|NCT01662674|Metformin|metformin|mesh-list
83684500|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906040|NCT03007966|Epinephrine|epinephrine|mesh-list
82906658|NCT03415178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82907051|NCT03951051|Olmesartan|olmesartan|mesh-list
83684501|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907263|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
83684502|NCT01662687|Granisetron|granisetron|mesh-list
82907489|NCT01327521|Gemcitabine|gemcitabine|mesh-list
82907648|NCT03650998|Ropivacaine|ropivacaine|mesh-list
83684503|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
83684504|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
82908550|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908628|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908931|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
82909012|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
83684505|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684506|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909537|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
82909626|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
82909768|NCT05252884|Calcitriol|calcitriol|mesh-list
83684507|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82910222|NCT01135641|Cyclosporine|cyclosporine|mesh-list
82910595|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82910676|NCT03445533|Ipilimumab|ipilimumab|mesh-list
83684508|NCT01662687|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82911050|NCT02410317|Analgesics|analgesics|mesh-ancestor
82911366|NCT02859454|Avelumab|avelumab|mesh-list
83684509|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82911427|NCT02862106|Vaccines|vaccines|mesh-list
82911577|NCT02856880|Zinc|zinc|mesh-list
82911805|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
82911886|NCT03602638|Acarbose|acarbose|mesh-list
83684510|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
82912044|NCT03577912|Anesthetics|anesthetics|mesh-list
83684511|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912106|NCT03590626|Dulaglutide|dulaglutide|mesh-list
83684512|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684513|NCT01662700|Artesunate|artesunate|mesh-list
83684514|NCT01662700|Chloroquine|chloroquine|mesh-list
83684515|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
83684516|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83684517|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82912786|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
82913122|NCT03908619|Esomeprazole|esomeprazole|mesh-list
82913338|NCT02527863|Tolvaptan|tolvaptan|mesh-list
82913413|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684518|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913947|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
82914030|NCT01157481|Nifedipine|nifedipine|mesh-list
83684519|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684520|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
82914417|NCT05303324|Choline|choline|mesh-list
83684521|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
82914707|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915316|NCT01165905|ON 01910|on 01910|mesh-list
83684522|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82915456|NCT01166451|Iron|iron|mesh-list
83684523|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
82915844|NCT01173081|Teriparatide|teriparatide|mesh-list
83684524|NCT01662700|Amebicides|amebicides|mesh-ancestor
83684525|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916444|NCT01287741|Hormones|hormones|mesh-ancestor
82916518|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
82916596|NCT01289769|Analgesics|analgesics|mesh-ancestor
83684526|NCT01662804|Interleukin-2|interleukin-2|mesh-list
82917588|NCT03845673|Psyllium|psyllium|mesh-list
83684527|NCT01662804|Antibodies|antibodies|mesh-list
83684528|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82917892|NCT01566669|Parecoxib|parecoxib|mesh-list
83684529|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
82918259|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82918335|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918491|NCT01297803|Mitomycins|mitomycins|mesh-list
82918566|NCT03818919|Narcotics|narcotics|mesh-ancestor
82919321|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919399|NCT02053402|Vitamin D|vitamin d|mesh-list
82919472|NCT01569633|Erythromycin|erythromycin|mesh-list
82919704|NCT05471817|Dabigatran|dabigatran|mesh-list
82919802|NCT01305837|Hormones|hormones|mesh-ancestor
82919856|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
83684530|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920396|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83684531|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684532|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83684533|NCT01662804|Analgesics|analgesics|mesh-ancestor
83684534|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
83684535|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921178|NCT03769935|Etoposide|etoposide|mesh-list
83684536|NCT01662869|Leucovorin|leucovorin|mesh-list
82921548|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
83684537|NCT01662869|Folic Acid|folic acid|mesh-list
83684538|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
82922081|NCT04439253|Crizotinib|crizotinib|mesh-list
82922168|NCT02072746|Zinc|zinc|mesh-list
83684539|NCT01662869|Fluorouracil|fluorouracil|mesh-list
82922715|NCT00187889|Eplerenone|eplerenone|mesh-list
82923067|NCT02094274|Xhance|xhance|mesh-list
82923084|NCT02096926|Ibuprofen|ibuprofen|mesh-list
83684540|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
82923314|NCT04292457|Propofol|propofol|mesh-list
82923447|NCT02101138|Protective Agents|protective agents|mesh-ancestor
83684541|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923593|NCT02106130|Rebamipide|rebamipide|mesh-list
82923901|NCT02119000|Bisacodyl|bisacodyl|mesh-list
83684542|NCT01662869|Antidotes|antidotes|mesh-ancestor
83684543|NCT01662869|Protective Agents|protective agents|mesh-ancestor
82924203|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924278|NCT00179309|Docetaxel|docetaxel|mesh-list
83684544|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924662|NCT02127190|CXA-10|cxa-10|mesh-list
82924730|NCT02125318|Anagrelide|anagrelide|mesh-list
82924802|NCT02126332|Analgesics|analgesics|mesh-ancestor
82924978|NCT00138671|Insulin|insulin|mesh-list
82925046|NCT02252926|Acetaminophen|acetaminophen|mesh-list
82925186|NCT02138500|PF-06372865|pf-06372865|mesh-list
82925273|NCT02252692|Enalapril|enalapril|mesh-list
83684545|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
83684546|NCT01662869|Vitamins|vitamins|mesh-ancestor
83684547|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
82927128|NCT00115037|Naltrexone|naltrexone|mesh-list
83684548|NCT01662869|Hematinics|hematinics|mesh-ancestor
82927203|NCT04949516|Analgesics|analgesics|mesh-ancestor
82927288|NCT03543202|Anesthetics|anesthetics|mesh-list
82927444|NCT02777242|Hormones|hormones|mesh-ancestor
83684549|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
82927507|NCT03183908|Vaccines|vaccines|mesh-list
82927582|NCT03731091|Calcitriol|calcitriol|mesh-list
82928494|NCT02256124|Lamotrigine|lamotrigine|mesh-list
82928562|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
82929515|NCT03535870|Xhance|xhance|mesh-list
82930235|NCT02220400|Analgesics|analgesics|mesh-ancestor
82930248|NCT02205892|Lupeol|lupeol|mesh-list
83684550|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930472|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
82930774|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
82931084|NCT05563480|Cisplatin|cisplatin|mesh-list
82931244|NCT02233816|Vaccines|vaccines|mesh-list
82931536|NCT01091753|Amlodipine|amlodipine|mesh-list
82931887|NCT00043979|Hormones|hormones|mesh-ancestor
82932111|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
82932193|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
82932799|NCT00033371|Analgesics|analgesics|mesh-ancestor
82932952|NCT05464810|Letrozole|letrozole|mesh-list
82933099|NCT04474288|Antibodies|antibodies|mesh-list
82933475|NCT00914602|Levodopa|levodopa|mesh-list
82933930|NCT04464070|Niacin|niacin|mesh-list
83084008|NCT02474420|Deferasirox|deferasirox|mesh-list
82934455|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
82934579|NCT01104883|Iodine|iodine|mesh-list
83684551|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82934832|NCT01776424|Aspirin|aspirin|mesh-list
82935666|NCT02286700|Desonide|desonide|mesh-list
83684552|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83684553|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
82936275|NCT01339988|Busulfan|busulfan|mesh-list
83684554|NCT01662921|Insulin|insulin|mesh-list
82936666|NCT01209715|Hormones|hormones|mesh-ancestor
82936742|NCT02529787|Lansoprazole|lansoprazole|mesh-list
82936829|NCT00002224|Didanosine|didanosine|mesh-list
82936887|NCT02288962|Cabergoline|cabergoline|mesh-list
82936967|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
83684555|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82937183|NCT01212133|Liraglutide|liraglutide|mesh-list
82937414|NCT01216267|Lansoprazole|lansoprazole|mesh-list
82937559|NCT04902040|Nivolumab|nivolumab|mesh-list
83684556|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
82938015|NCT01345604|Ropivacaine|ropivacaine|mesh-list
83684557|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
83684558|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
82938919|NCT05670561|Sufentanil|sufentanil|mesh-list
83684559|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938988|NCT05558280|Dinutuximab|dinutuximab|mesh-list
83684560|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684561|NCT01663038|Aspirin|aspirin|mesh-list
83684562|NCT01663038|Clopidogrel|clopidogrel|mesh-list
82940265|NCT01221025|Analgesics|analgesics|mesh-ancestor
82940337|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82940412|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940489|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
82940561|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940787|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
82940861|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82941010|NCT01348880|Urological Agents|urological agents|mesh-ancestor
82941230|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82941308|NCT02302378|Bupivacaine|bupivacaine|mesh-list
82941469|NCT02302768|Selenium|selenium|mesh-list
83684563|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83684564|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83684565|NCT01663038|Analgesics|analgesics|mesh-ancestor
83684566|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
83684567|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684568|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684569|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684570|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83684571|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83684572|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83684573|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684574|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83684575|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83684576|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684577|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
83684578|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83684579|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83684580|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83684581|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
83684582|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684583|NCT01663077|Clozapine|clozapine|mesh-list
83684584|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83684585|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
83684586|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684587|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684588|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684589|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83684590|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83684591|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684592|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83684593|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
83684594|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
83684595|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83684596|NCT01663090|Hematinics|hematinics|mesh-ancestor
83684597|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83684598|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82941955|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
82942112|NCT01233583|Adalimumab|adalimumab|mesh-list
83684599|NCT01663168|Rifabutin|rifabutin|mesh-list
82942267|NCT01232803|Tenofovir|tenofovir|mesh-list
83684600|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82942635|NCT03508102|Remifentanil|remifentanil|mesh-list
83684601|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943316|NCT03452072|Emollients|emollients|mesh-ancestor
83684602|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82943615|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
82943846|NCT04355728|Heparin|heparin|mesh-list
82944074|NCT03190174|Nivolumab|nivolumab|mesh-list
83684603|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
83684604|NCT01663441|Oprelvekin|oprelvekin|mesh-list
82944230|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
82944301|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944897|NCT02891798|Buprenorphine|buprenorphine|mesh-list
83684605|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684606|NCT01661985|Azithromycin|azithromycin|mesh-list
83684607|NCT01661985|Doxycycline|doxycycline|mesh-list
83684608|NCT01661985|Lymecycline|lymecycline|mesh-list
82945573|NCT03726372|Bromides|bromides|mesh-list
82945804|NCT04635254|Histamine|histamine|mesh-list
82946631|NCT01149499|Valacyclovir|valacyclovir|mesh-list
82946781|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684609|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83684610|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684611|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
82947246|NCT03890341|Hormones|hormones|mesh-ancestor
83684612|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83684613|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83684614|NCT01663558|Imiquimod|imiquimod|mesh-list
83684615|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83684616|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
83684617|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684618|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684619|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
82947453|NCT01157455|Aspirin|aspirin|mesh-list
83684620|NCT01663662|Tolvaptan|tolvaptan|mesh-list
82947678|NCT01155895|Amlodipine|amlodipine|mesh-list
82947905|NCT00057863|Paclitaxel|paclitaxel|mesh-list
82947906|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
82948055|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948132|NCT01159327|Sorafenib|sorafenib|mesh-list
83684621|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83684622|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948514|NCT01163929|Paclitaxel|paclitaxel|mesh-list
83684623|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
82948645|NCT03756883|Xhance|xhance|mesh-list
82948740|NCT00009737|Leucovorin|leucovorin|mesh-list
83684624|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684625|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83684626|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82949738|NCT03134131|TIC10 compound|tic10 compound|mesh-list
83684627|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684628|NCT01663805|Everolimus|everolimus|mesh-list
83684629|NCT01663805|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83684630|NCT01663805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83684631|NCT01663805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950261|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82950413|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950879|NCT01188733|Octreotide|octreotide|mesh-list
83684632|NCT01663805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951018|NCT01101815|Naltrexone|naltrexone|mesh-list
83684633|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83684634|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
82951319|NCT01294735|Temozolomide|temozolomide|mesh-list
82951389|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951967|NCT01190683|Vitamin D|vitamin d|mesh-list
82952250|NCT03716115|Hormones|hormones|mesh-ancestor
82952341|NCT05601895|Sorafenib|sorafenib|mesh-list
83684635|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684636|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684637|NCT01663961|Digoxin|digoxin|mesh-list
83684638|NCT01663961|Mirabegron|mirabegron|mesh-list
83684639|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82953468|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
83684640|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82954075|NCT03441789|Hormones|hormones|mesh-ancestor
82954221|NCT03819127|Metformin|metformin|mesh-list
83684641|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954302|NCT04173338|Pemetrexed|pemetrexed|mesh-list
82954444|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
82954517|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82954668|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955356|NCT05389150|Narcotics|narcotics|mesh-ancestor
82955633|NCT01134341|Vitamins|vitamins|mesh-list
82955807|NCT03921593|Pancrelipase|pancrelipase|mesh-list
82956266|NCT03707457|Nivolumab|nivolumab|mesh-list
82956512|NCT03792295|Ibuprofen|ibuprofen|mesh-list
83684642|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684643|NCT01663961|Protective Agents|protective agents|mesh-ancestor
82956874|NCT03445468|Vaccines|vaccines|mesh-list
83684644|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957175|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
82957262|NCT03437824|Vitamins|vitamins|mesh-ancestor
82957326|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82957564|NCT03784495|Melatonin|melatonin|mesh-list
83684645|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82958115|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
83684646|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82958508|NCT03707808|Nivolumab|nivolumab|mesh-list
82958734|NCT03464968|Leucovorin|leucovorin|mesh-list
82959218|NCT01142843|Propolis|propolis|mesh-list
83684647|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82959370|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
83684648|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83684649|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960379|NCT01321957|Bevacizumab|bevacizumab|mesh-list
82960682|NCT03164655|Vitamins|vitamins|mesh-ancestor
83684650|NCT01663961|Urological Agents|urological agents|mesh-ancestor
83684651|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
82961513|NCT03419650|Hormones|hormones|mesh-ancestor
82962046|NCT03763669|Folic Acid|folic acid|mesh-list
82962419|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82962565|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82962837|NCT03754543|Iron|iron|mesh-list
83684652|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83684653|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83684654|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82963334|NCT05222724|Ibuprofen|ibuprofen|mesh-list
83684655|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82963645|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
83684656|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684657|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
82964244|NCT03263767|Fludarabine|fludarabine|mesh-list
82964331|NCT03066830|Metformin|metformin|mesh-list
83684658|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684659|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684660|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83684661|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684662|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83684663|NCT01664065|Cephalosporins|cephalosporins|mesh-list
82964716|NCT03904745|Atosiban|atosiban|mesh-list
82965005|NCT03896321|Anticoagulants|anticoagulants|mesh-list
83684664|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965077|NCT01257815|Ranibizumab|ranibizumab|mesh-list
82965152|NCT03891095|Oxytocin|oxytocin|mesh-list
82965543|NCT01264133|Adefovir|adefovir|mesh-list
82965829|NCT04292899|Remdesivir|remdesivir|mesh-list
83684665|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684666|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
83684667|NCT01664195|Hematinics|hematinics|mesh-ancestor
83684668|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
83684669|NCT01664221|Hematinics|hematinics|mesh-ancestor
83684670|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
83684671|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83684672|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
83684673|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684674|NCT01664260|Expectorants|expectorants|mesh-ancestor
82968408|NCT01286909|Lycopene|lycopene|mesh-list
82968715|NCT03862079|Nystatin|nystatin|mesh-list
82969031|NCT01285661|Vitamin K|vitamin k|mesh-list
82969168|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
83684675|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969327|NCT03366064|Pemetrexed|pemetrexed|mesh-list
82969545|NCT01188005|Vitamin E|vitamin e|mesh-list
82969769|NCT03738943|Pyridoxine|pyridoxine|mesh-list
83684676|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83684677|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
83684678|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684679|NCT01664260|Protective Agents|protective agents|mesh-ancestor
83684680|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684681|NCT01664260|Antidotes|antidotes|mesh-ancestor
83684682|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
83684683|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83684684|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684685|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684686|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83684687|NCT01664520|Analgesics|analgesics|mesh-ancestor
83684688|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
82970672|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
82970973|NCT03575065|Pamiparib|pamiparib|mesh-list
83684689|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971120|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
83684690|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82971509|NCT02422641|Methotrexate|methotrexate|mesh-list
83684691|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83684692|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83684693|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
83684694|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971942|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684695|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684696|NCT01664650|Genistein|genistein|mesh-list
82972107|NCT03730961|Furosemide|furosemide|mesh-list
82972171|NCT03844217|Tryptophan|tryptophan|mesh-list
82972329|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
82972399|NCT03599089|Analgesics|analgesics|mesh-ancestor
82972476|NCT01202435|Pregabalin|pregabalin|mesh-list
83684697|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83684698|NCT01664650|Protective Agents|protective agents|mesh-ancestor
83684699|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684700|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684701|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83684702|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684703|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684704|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
83684706|NCT01664650|Estrogens|estrogens|mesh-ancestor
83684707|NCT01664650|Hormones|hormones|mesh-ancestor
83684708|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684709|NCT01664676|Liraglutide|liraglutide|mesh-list
83684710|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83684711|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684712|NCT01664676|Incretins|incretins|mesh-ancestor
83684713|NCT01664676|Hormones|hormones|mesh-ancestor
83684714|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684715|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
83684716|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
83684717|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684718|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83684719|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684720|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684721|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684722|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684723|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972700|NCT05222204|Gemcitabine|gemcitabine|mesh-list
83684724|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83684725|NCT01664728|Hormones|hormones|mesh-ancestor
83684726|NCT01664754|Carboplatin|carboplatin|mesh-list
83684727|NCT01664754|Pemetrexed|pemetrexed|mesh-list
83684728|NCT01664754|Exemestane|exemestane|mesh-list
83684729|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684730|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684731|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684732|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83684733|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83684734|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82972746|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972888|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973189|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684735|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83684736|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83684737|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
83684738|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684739|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684740|NCT01664819|Antioxidants|antioxidants|mesh-list
83684741|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973799|NCT03639571|Ibuprofen|ibuprofen|mesh-list
83684742|NCT01664819|Protective Agents|protective agents|mesh-ancestor
83684743|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974093|NCT05864209|Hormones|hormones|mesh-ancestor
82974186|NCT05863845|Cytarabine|cytarabine|mesh-list
83684744|NCT01664845|Metformin|metformin|mesh-list
83684745|NCT01664845|Ribavirin|ribavirin|mesh-list
82974467|NCT05676203|Docetaxel|docetaxel|mesh-list
82974686|NCT05153304|Nivolumab|nivolumab|mesh-list
83684746|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83684747|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684748|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
83684749|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684750|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
83684751|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684752|NCT01664871|Fluorides|fluorides|mesh-list
83684753|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
83684754|NCT01664871|Protective Agents|protective agents|mesh-ancestor
83684755|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975534|NCT01302353|Isoflurane|isoflurane|mesh-list
82975677|NCT03515941|Fluorouracil|fluorouracil|mesh-list
82975758|NCT01300637|Metformin|metformin|mesh-list
82975840|NCT03814733|Ketamine|ketamine|mesh-list
82976213|NCT05014334|Antacids|antacids|mesh-ancestor
83684756|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83684757|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83684758|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684759|NCT01665066|Nicotine|nicotine|mesh-list
83684760|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83684761|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
83684762|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684763|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684764|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83684765|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83684766|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
83684767|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684768|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684769|NCT01665079|Propofol|propofol|mesh-list
83684770|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83684771|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684772|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684773|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83684774|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
83684775|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
83684776|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
83684777|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82976974|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
83684778|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83684779|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684780|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
83684781|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
83684782|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978246|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
83684783|NCT01665209|Morphine|morphine|mesh-list
82978329|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
82978544|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
83684784|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83684785|NCT01665209|Narcotics|narcotics|mesh-ancestor
83684786|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979246|NCT03772067|Insulin|insulin|mesh-list
82979395|NCT01321775|Growth Substances|growth substances|mesh-ancestor
83684787|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684788|NCT01665209|Analgesics|analgesics|mesh-ancestor
83684789|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
82980104|NCT02470546|Metformin|metformin|mesh-list
82980333|NCT03313960|Insulin|insulin|mesh-list
82980414|NCT00703924|Paromomycin|paromomycin|mesh-list
83684790|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980714|NCT04490590|Etoposide|etoposide|mesh-list
83684791|NCT01665222|Morphine|morphine|mesh-list
82980799|NCT01347996|Interleukin-2|interleukin-2|mesh-list
83684792|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83684793|NCT01665222|Narcotics|narcotics|mesh-ancestor
83684794|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684795|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684796|NCT01665222|Analgesics|analgesics|mesh-ancestor
83684797|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
83684798|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684799|NCT01665235|Aspirin|aspirin|mesh-list
83684800|NCT01665235|Amlodipine|amlodipine|mesh-list
83684801|NCT01665235|Clopidogrel|clopidogrel|mesh-list
83684802|NCT01665235|Atorvastatin|atorvastatin|mesh-list
83684803|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82982252|NCT03108274|Midazolam|midazolam|mesh-list
82982325|NCT00395408|Beclomethasone|beclomethasone|mesh-list
82982470|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82982543|NCT00398541|Diuretics|diuretics|mesh-ancestor
82982615|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83684804|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82982844|NCT03291418|Naproxen|naproxen|mesh-list
83684805|NCT01665235|Analgesics|analgesics|mesh-ancestor
82983065|NCT01339065|Ketamine|ketamine|mesh-list
83684806|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
82983364|NCT03267628|Narcotics|narcotics|mesh-ancestor
83684807|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684808|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684809|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984048|NCT01364376|Vitamins|vitamins|mesh-ancestor
83684810|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83684811|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83684812|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82984121|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83684813|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984194|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
83684814|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82984345|NCT01346007|Vaccines|vaccines|mesh-list
83684815|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83684816|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684817|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
82984667|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
83684818|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83684819|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83684820|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
83684821|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82984884|NCT02453932|Donepezil|donepezil|mesh-list
82984954|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82985184|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83684822|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83684823|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83684824|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83684825|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83684826|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
83684827|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684828|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83684829|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83684830|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985406|NCT03222310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684831|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83684832|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
83684833|NCT01665248|Listerine|listerine|mesh-list
83684834|NCT01665248|Fluorides|fluorides|mesh-list
82986311|NCT03198208|Fentanyl|fentanyl|mesh-list
83684835|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
82987002|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
82987079|NCT01194622|Xhance|xhance|mesh-list
83684836|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
82987302|NCT04336982|Venetoclax|venetoclax|mesh-list
83684837|NCT01665248|Protective Agents|protective agents|mesh-ancestor
83684838|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684839|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82987831|NCT03695744|Dexamethasone|dexamethasone|mesh-list
82988188|NCT03182374|Hylan|hylan|mesh-list
82988209|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83684840|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83684841|NCT01665378|Folic Acid|folic acid|mesh-list
83684842|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
83684843|NCT01665378|Micronutrients|micronutrients|mesh-list
82988897|NCT05170464|Caffeine|caffeine|mesh-list
83684844|NCT01665378|Trace Elements|trace elements|mesh-list
83684845|NCT01665378|Hematinics|hematinics|mesh-ancestor
83684846|NCT01665378|Vitamins|vitamins|mesh-ancestor
83684847|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684848|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
82989161|NCT03178396|Melatonin|melatonin|mesh-list
82989300|NCT03770676|Selenium|selenium|mesh-list
83684849|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82989603|NCT01358409|Nebivolol|nebivolol|mesh-list
83684850|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82989742|NCT02930343|Folic Acid|folic acid|mesh-list
83684851|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684852|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684853|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83684854|NCT01665404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83684855|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83684856|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83684857|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684858|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684859|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
82989812|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684860|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82989959|NCT01363089|Ketorolac|ketorolac|mesh-list
83684861|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
83684862|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83684863|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83684864|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990335|NCT02873754|Bupropion|bupropion|mesh-list
82990510|NCT03226418|Cytarabine|cytarabine|mesh-list
83684865|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82991244|NCT03169504|Xhance|xhance|mesh-list
82991375|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
83684866|NCT01665417|Docetaxel|docetaxel|mesh-list
83684867|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684868|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83684869|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83684870|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
82992437|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
83684871|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992588|NCT04102800|Benralizumab|benralizumab|mesh-list
82992667|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
82992744|NCT05173441|Antibodies|antibodies|mesh-list
83684872|NCT01665469|Lycopene|lycopene|mesh-list
82993035|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
83684873|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684874|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
82993562|NCT04908787|Paclitaxel|paclitaxel|mesh-list
82993880|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
82993956|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684875|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684876|NCT01665469|Protective Agents|protective agents|mesh-ancestor
83684877|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684878|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83684879|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82994553|NCT01068860|Troglitazone|troglitazone|mesh-list
82994739|NCT04397354|BB 1101|bb 1101|mesh-list
83684880|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684881|NCT01664507|Epinephrine|epinephrine|mesh-list
83684882|NCT01664507|Racepinephrine|racepinephrine|mesh-list
82994860|NCT03310411|Lasmiditan|lasmiditan|mesh-list
82995304|NCT03333109|Erenumab|erenumab|mesh-list
83684883|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
82995466|NCT02375464|Octreotide|octreotide|mesh-list
82995539|NCT01411267|Cytarabine|cytarabine|mesh-list
83684884|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83684885|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83684886|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
83684887|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83684888|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684889|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995979|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82996128|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996204|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
83684890|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82996362|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
83684891|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83684892|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
82996511|NCT02367118|Prednisone|prednisone|mesh-list
83684893|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996658|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
82997034|NCT03630042|Rituximab|rituximab|mesh-list
83684894|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82997249|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
83684895|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
83684896|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
83684897|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
82997346|NCT02345590|Eplerenone|eplerenone|mesh-list
83684898|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83684899|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
83684900|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82998148|NCT03488225|Cytarabine|cytarabine|mesh-list
82998228|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
82998285|NCT02974868|PF-06700841|pf-06700841|mesh-list
83684901|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684902|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998828|NCT02624128|Cetuximab|cetuximab|mesh-list
82998968|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684903|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999342|NCT03650582|Glucagon|glucagon|mesh-list
83684904|NCT01665586|Analgesics|analgesics|mesh-ancestor
82999564|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999787|NCT03113409|Naltrexone|naltrexone|mesh-list
83000271|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
83000429|NCT05186454|Midazolam|midazolam|mesh-list
83000500|NCT05630339|Vitamin D|vitamin d|mesh-list
83684905|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
83001173|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
83001623|NCT03378635|Hormones|hormones|mesh-ancestor
83001697|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83002147|NCT05214807|Chitosan|chitosan|mesh-list
83684906|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83684907|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83002743|NCT05147376|Analgesics|analgesics|mesh-ancestor
83002888|NCT05309694|Copper|copper|mesh-list
83003048|NCT04731233|Mitogens|mitogens|mesh-list
83003722|NCT03897673|Iron|iron|mesh-list
83003793|NCT03625518|Oxytocin|oxytocin|mesh-list
83004160|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684908|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83004553|NCT04614909|Temozolomide|temozolomide|mesh-list
83684909|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83684910|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
83684911|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004703|NCT03699696|Propofol|propofol|mesh-list
83004918|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
83005143|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83684912|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684913|NCT01665638|Canagliflozin|canagliflozin|mesh-list
83684914|NCT01665638|Somatostatin|somatostatin|mesh-list
83684915|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83684916|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684917|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83684918|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684919|NCT01665638|Hormones|hormones|mesh-ancestor
83684920|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684921|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83684922|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83684923|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684924|NCT01665742|Tocopherols|tocopherols|mesh-list
83684925|NCT01665742|Vitamin E|vitamin e|mesh-list
83684926|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
83684927|NCT01665742|Lycopene|lycopene|mesh-list
83684928|NCT01665742|Vitamins|vitamins|mesh-ancestor
83684929|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
83684930|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684932|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684933|NCT01665742|Protective Agents|protective agents|mesh-ancestor
83684934|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684935|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83684936|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83684937|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83684938|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
83684939|NCT01665781|Hematinics|hematinics|mesh-ancestor
83684940|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83684941|NCT01665846|Hematinics|hematinics|mesh-ancestor
83684942|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83684943|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83684944|NCT01666041|Fenofibrate|fenofibrate|mesh-list
83684945|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83005742|NCT03676140|Ivermectin|ivermectin|mesh-list
83684946|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
83684947|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684948|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83684949|NCT01666067|Simvastatin|simvastatin|mesh-list
83684950|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83684951|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83684952|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83684953|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
83684954|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684955|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83684956|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83684957|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83684958|NCT01666171|Metformin|metformin|mesh-list
83684959|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83684960|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684961|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83684962|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83684963|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83684964|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83684965|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
83684966|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684967|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83684968|NCT01666223|Cathartics|cathartics|mesh-ancestor
83684969|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83684970|NCT01666236|Triamcinolone|triamcinolone|mesh-list
83684971|NCT01666236|Ranibizumab|ranibizumab|mesh-list
83684972|NCT01666236|Verteporfin|verteporfin|mesh-list
83684973|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83684974|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83684975|NCT01666236|Growth Substances|growth substances|mesh-ancestor
83684976|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684977|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
83005801|NCT03675594|Cobalt|cobalt|mesh-list
83362108|NCT00367978|Benazepril|benazepril|mesh-list
83362121|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83006501|NCT03665610|Ozanimod|ozanimod|mesh-list
83006655|NCT03617432|Hormones|hormones|mesh-ancestor
83684978|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006804|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
83684979|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83684980|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
83684981|NCT01666236|Hormones|hormones|mesh-ancestor
83684982|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83684983|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83684984|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
83684985|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
83684986|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83684987|NCT01666249|Antibodies|antibodies|mesh-list
83684988|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
83684989|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684990|NCT01666262|Vaccines|vaccines|mesh-list
83684991|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
83684992|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83684993|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
83684994|NCT01666301|Hematinics|hematinics|mesh-ancestor
83684995|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83684996|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83684997|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83684998|NCT01666379|Fentanyl|fentanyl|mesh-list
83684999|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685000|NCT01666379|Narcotics|narcotics|mesh-ancestor
83685001|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685002|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685003|NCT01666379|Analgesics|analgesics|mesh-ancestor
83685004|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
83685005|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685006|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83685007|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83685008|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
83685009|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
83685010|NCT01666418|Paclitaxel|paclitaxel|mesh-list
83007240|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83685011|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83685012|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685013|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
83685014|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
83685015|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
83685016|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685017|NCT01666431|Lapatinib|lapatinib|mesh-list
83685018|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685019|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685020|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685021|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685022|NCT01666522|Vitamin D|vitamin d|mesh-list
83685023|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
83685024|NCT01666522|Vitamins|vitamins|mesh-ancestor
83685025|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
83685026|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685027|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83685028|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83685029|NCT01666587|Ibuprofen|ibuprofen|mesh-list
83685030|NCT01666587|Antioxidants|antioxidants|mesh-list
83685031|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
83685032|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685033|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685034|NCT01666587|Analgesics|analgesics|mesh-ancestor
83685035|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
83685036|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685037|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007358|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83685038|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007582|NCT04298034|Labetalol|labetalol|mesh-list
83685039|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685040|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83685041|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685042|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685043|NCT01666587|Protective Agents|protective agents|mesh-ancestor
83685044|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
83685045|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685046|NCT01666600|Nintedanib|nintedanib|mesh-list
83685047|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685048|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685049|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685050|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685051|NCT01666665|Metformin|metformin|mesh-list
83685052|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83685053|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685054|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
83685055|NCT01666678|Promethazine|promethazine|mesh-list
83685056|NCT01666678|Naproxen|naproxen|mesh-list
83685057|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685058|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685059|NCT01666678|Analgesics|analgesics|mesh-ancestor
83685060|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
83685061|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685062|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685063|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685064|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685065|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
83685066|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83685067|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685068|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685069|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83685070|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83685071|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685072|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
83084648|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
83685073|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
83685074|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
83685075|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
83685076|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685077|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83685078|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
83685079|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
83685080|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839883|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
83685082|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
83685083|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685084|NCT01666691|CKD732|ckd732|mesh-list
83685085|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83685086|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83685087|NCT01666691|Growth Substances|growth substances|mesh-ancestor
83685088|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685089|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
83685090|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685091|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83685092|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085005|NCT01109004|Dexamethasone|dexamethasone|mesh-list
83685093|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085304|NCT02221401|Metformin|metformin|mesh-list
83685094|NCT01666756|Sorafenib|sorafenib|mesh-list
83685095|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685096|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685097|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685098|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685099|NCT01666769|Micafungin|micafungin|mesh-list
83685100|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
83685101|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685102|NCT01667094|Meropenem|meropenem|mesh-list
83685103|NCT01667094|Tazobactam|tazobactam|mesh-list
83685104|NCT01667094|Piperacillin|piperacillin|mesh-list
83685105|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
83685106|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
83685107|NCT01667094|Ceftazidime|ceftazidime|mesh-list
83685108|NCT01667094|Cefepime|cefepime|mesh-list
83685109|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83685110|NCT01667094|Ticarcillin|ticarcillin|mesh-list
83685111|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
83685112|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685113|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685114|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83685115|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685116|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685117|NCT01667211|Paclitaxel|paclitaxel|mesh-list
83685118|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83685119|NCT01667211|Nedaplatin|nedaplatin|mesh-list
83685120|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83685121|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685122|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
83685123|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
83685124|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
83685125|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685126|NCT01667263|Tretinoin|tretinoin|mesh-list
83685127|NCT01667263|Danazol|danazol|mesh-list
83685128|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685129|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
83685130|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685131|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83685132|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
83685133|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685134|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685135|NCT01667315|Bupivacaine|bupivacaine|mesh-list
83685136|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
83685137|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
83685138|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685139|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685140|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
83685141|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685142|NCT01667445|Morphine|morphine|mesh-list
83086091|NCT05413811|Fluorouracil|fluorouracil|mesh-list
83086400|NCT04541355|Cisplatin|cisplatin|mesh-list
83685143|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685144|NCT01667445|Narcotics|narcotics|mesh-ancestor
83685145|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086787|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
83086860|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
83685146|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685147|NCT01667445|Analgesics|analgesics|mesh-ancestor
83685148|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
83685149|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839959|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
83685150|NCT01667484|Adderall|adderall|mesh-list
83685151|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83685152|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685153|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
82839960|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685154|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83685155|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83685156|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685157|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
83685158|NCT01667523|Capsaicin|capsaicin|mesh-list
83685159|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
83685160|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685161|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
83685162|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685163|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685164|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83685165|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685166|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83685167|NCT01667523|Protective Agents|protective agents|mesh-ancestor
83685168|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83685169|NCT01667575|Amoxicillin|amoxicillin|mesh-list
83087586|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
83685170|NCT01667575|Clarithromycin|clarithromycin|mesh-list
83685171|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83685172|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
83685173|NCT01667575|Esomeprazole|esomeprazole|mesh-list
83685174|NCT01667575|Bismuth|bismuth|mesh-list
83685175|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83088196|NCT03300440|Biotin|biotin|mesh-list
83088200|NCT02236065|Lenograstim|lenograstim|mesh-list
83088350|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
83088432|NCT01379508|Tenofovir|tenofovir|mesh-list
83685176|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685177|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088593|NCT03984591|Diuretics|diuretics|mesh-ancestor
83088743|NCT03223350|Capsaicin|capsaicin|mesh-list
83685178|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
83685179|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83685180|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088895|NCT01204749|Paclitaxel|paclitaxel|mesh-list
83685181|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089110|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685182|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83685183|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83685184|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83685185|NCT01667575|Antacids|antacids|mesh-ancestor
83685186|NCT01667575|Diuretics|diuretics|mesh-ancestor
83685187|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
83685188|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685189|NCT01667575|Expectorants|expectorants|mesh-ancestor
83685190|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
83685191|NCT01667614|Losartan|losartan|mesh-list
83685192|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83685193|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83089481|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
83685194|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83685195|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83685196|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685197|NCT01667692|Azithromycin|azithromycin|mesh-list
83685198|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685199|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685200|NCT01667718|Amoxicillin|amoxicillin|mesh-list
83685201|NCT01667718|Levofloxacin|levofloxacin|mesh-list
83685202|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
83685203|NCT01667718|Lansoprazole|lansoprazole|mesh-list
83685204|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
83685205|NCT01667718|Bismuth|bismuth|mesh-list
83685206|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83685207|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685208|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685209|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685210|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83685211|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83685212|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83685213|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685214|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685215|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83685216|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83685217|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83685218|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685219|NCT01667718|Antacids|antacids|mesh-ancestor
83685220|NCT01667718|Diuretics|diuretics|mesh-ancestor
83685221|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
83685222|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685223|NCT01667718|Expectorants|expectorants|mesh-ancestor
83685224|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
83685225|NCT01667874|Gentamicins|gentamicins|mesh-list
83685226|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685227|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685228|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83685229|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685230|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685231|NCT01668043|UB-421|ub-421|mesh-list
83685232|NCT01668043|Antibodies|antibodies|mesh-list
83685233|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
83089690|NCT03882177|Pyridoxal|pyridoxal|mesh-list
83685234|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685235|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83685236|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
83685237|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685238|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83685239|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83685240|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685241|NCT01668069|Ondansetron|ondansetron|mesh-list
83685242|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
83089759|NCT00869661|Ribavirin|ribavirin|mesh-list
83685243|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
83685244|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685245|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685246|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685247|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
83685248|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685249|NCT01668069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83685250|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83685251|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
83685252|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685253|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685254|NCT01668121|Budesonide|budesonide|mesh-list
83685255|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
83685256|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83685257|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685258|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83685259|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
83089811|NCT02464124|Lactulose|lactulose|mesh-list
83685260|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685261|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685262|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83685263|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83685264|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
83685265|NCT01668121|Hormones|hormones|mesh-ancestor
83685266|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685267|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83685268|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83685269|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83685270|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83685271|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089929|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090076|NCT03108248|Coagulants|coagulants|mesh-ancestor
83090091|NCT04537689|Ixekizumab|ixekizumab|mesh-list
83685272|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685273|NCT01668433|Primaquine|primaquine|mesh-list
83685274|NCT01668433|Methylene Blue|methylene blue|mesh-list
83685275|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
83685276|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83685277|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83090308|NCT04542304|Metolazone|metolazone|mesh-list
83685278|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685279|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685280|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685281|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
83685282|NCT01668446|Estradiol|estradiol|mesh-list
83685283|NCT01668446|Estrogens|estrogens|mesh-ancestor
83685284|NCT01668446|Hormones|hormones|mesh-ancestor
83685285|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685286|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685287|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
83685288|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83685289|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83685290|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090455|NCT00772785|Buprenorphine|buprenorphine|mesh-list
83685291|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685292|NCT01668446|Urological Agents|urological agents|mesh-ancestor
83685293|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83685294|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685295|NCT01668498|Doxycycline|doxycycline|mesh-list
83685296|NCT01668498|Erythromycin|erythromycin|mesh-list
83685297|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
83091492|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
83091860|NCT02280993|Hormones|hormones|mesh-ancestor
83091934|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83092009|NCT05491720|Risperidone|risperidone|mesh-list
83685298|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83685299|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
83092169|NCT03825874|Amikacin|amikacin|mesh-list
83092312|NCT01358968|Gemcitabine|gemcitabine|mesh-list
83092390|NCT00614601|Vaccines|vaccines|mesh-list
83685300|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685301|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092534|NCT00677079|Iniparib|iniparib|mesh-list
83685302|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
83685303|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83685304|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83093433|NCT03234842|Paclitaxel|paclitaxel|mesh-list
83093646|NCT03222206|Analgesics|analgesics|mesh-ancestor
83093722|NCT03232112|Incretins|incretins|mesh-ancestor
83685305|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685306|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82840107|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83685307|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685308|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685309|NCT01668550|AZD-0424|azd-0424|mesh-list
83685310|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685311|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094840|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094914|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83094988|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
83685312|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685313|NCT01668615|Tretinoin|tretinoin|mesh-list
83685314|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685315|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
83685316|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685317|NCT01668680|Celecoxib|celecoxib|mesh-list
83685318|NCT01668680|Capecitabine|capecitabine|mesh-list
83685319|NCT01668680|Methotrexate|methotrexate|mesh-list
83095231|NCT00369317|Cytarabine|cytarabine|mesh-list
83685320|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83685321|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
83685322|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685323|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685324|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83685325|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
83685326|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83685327|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685328|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685329|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685330|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83685331|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83685332|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
83685333|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685334|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83685335|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685336|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685337|NCT01668680|Analgesics|analgesics|mesh-ancestor
83685338|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
83685339|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685340|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685341|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83095362|NCT02447510|Mitogens|mitogens|mesh-list
83095413|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095488|NCT02446652|Paclitaxel|paclitaxel|mesh-list
83685342|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83685343|NCT01668901|Aspirin|aspirin|mesh-list
83685344|NCT01668901|Warfarin|warfarin|mesh-list
83685345|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685346|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685347|NCT01668901|Analgesics|analgesics|mesh-ancestor
83685348|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
83685349|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685350|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685351|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685352|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685353|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83685354|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83685355|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685356|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83685357|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83095630|NCT00282867|Insulin|insulin|mesh-list
83685358|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685359|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
83685360|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
83685361|NCT01668927|Amoxicillin|amoxicillin|mesh-list
83685362|NCT01668927|Metronidazole|metronidazole|mesh-list
83685363|NCT01668927|Tetracycline|tetracycline|mesh-list
83685364|NCT01668927|Furazolidone|furazolidone|mesh-list
83685365|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
83685366|NCT01668927|Lansoprazole|lansoprazole|mesh-list
83685367|NCT01668927|Bismuth|bismuth|mesh-list
83685368|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83685369|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685370|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83095776|NCT04407377|Tolperisone|tolperisone|mesh-list
83685371|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685372|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83685373|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83685374|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83685375|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685376|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685377|NCT01668927|Antacids|antacids|mesh-ancestor
83685378|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82840185|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83685379|NCT01668927|Diuretics|diuretics|mesh-ancestor
83685380|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
83685381|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685382|NCT01668927|Expectorants|expectorants|mesh-ancestor
83685383|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83685384|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83685385|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83685386|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83685387|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83685388|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
83685390|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83685391|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685392|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095840|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685393|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685394|NCT01669044|Analgesics|analgesics|mesh-ancestor
83685395|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
83685396|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095891|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685397|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83685398|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83685399|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83685400|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
83685401|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685402|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685403|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83685404|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
83685405|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
83685406|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
83685407|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685408|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685409|NCT01669135|Anesthetics|anesthetics|mesh-list
83685410|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685411|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685412|NCT01669213|Ondansetron|ondansetron|mesh-list
83685413|NCT01669213|Ramosetron|ramosetron|mesh-list
83685414|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
83685415|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
83685416|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685417|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685418|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685419|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
83685420|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685421|NCT01669213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83685422|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83685423|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
83685424|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685425|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685426|NCT01669226|Taxane|taxane|mesh-list
83685427|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685428|NCT01669239|Doxorubicin|doxorubicin|mesh-list
83685429|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83685430|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83685431|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685432|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83685433|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83685434|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685435|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685436|NCT01669291|Leuprolide|leuprolide|mesh-list
83685437|NCT01669291|Cetrorelix|cetrorelix|mesh-list
83685438|NCT01669291|Menotropins|menotropins|mesh-list
83685439|NCT01669291|Ganirelix|ganirelix|mesh-list
83685440|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83685441|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
83685442|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83685443|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685444|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83685445|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685446|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
83685447|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685448|NCT01669304|Verapamil|verapamil|mesh-list
83685449|NCT01669304|Sertraline|sertraline|mesh-list
83685450|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
83685451|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83685452|NCT01669304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83685453|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83685454|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83685455|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840258|NCT00202644|Anagrelide|anagrelide|mesh-list
83685456|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685458|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685459|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83685460|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83685461|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83685462|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
83685463|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
83096593|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
83097040|NCT02433314|Brexanolone|brexanolone|mesh-list
83685464|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
83685465|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83685466|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685467|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685468|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
83685469|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83097496|NCT04579367|Ezetimibe|ezetimibe|mesh-list
83685470|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097791|NCT02427386|Estradiol|estradiol|mesh-list
83685471|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098324|NCT02767661|Exemestane|exemestane|mesh-list
83685472|NCT01669447|Ranibizumab|ranibizumab|mesh-list
83098559|NCT03174080|Fluorides|fluorides|mesh-list
83098702|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685473|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83098788|NCT02408042|Immunotoxins|immunotoxins|mesh-ancestor
83099014|NCT03133299|Vitamin D|vitamin d|mesh-list
83099077|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099207|NCT02292303|Zinc|zinc|mesh-list
83099230|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099317|NCT02295189|Ketorolac|ketorolac|mesh-list
83685474|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83685475|NCT01669447|Growth Substances|growth substances|mesh-ancestor
83685476|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685477|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
83099750|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
83685478|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100052|NCT03507465|Letrozole|letrozole|mesh-list
83100203|NCT02398994|Hormones|hormones|mesh-ancestor
83685479|NCT01669499|Dexamethasone|dexamethasone|mesh-list
83685480|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
83100750|NCT03943888|Atropine|atropine|mesh-list
83685481|NCT01669499|BB 1101|bb 1101|mesh-list
83101039|NCT05408026|Hormones|hormones|mesh-ancestor
83685482|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101255|NCT02318199|Anesthetics|anesthetics|mesh-list
83685483|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
83101563|NCT03499743|Celecoxib|celecoxib|mesh-list
83101639|NCT03039023|Choline|choline|mesh-list
83685484|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
83101708|NCT03704909|Ephedrine|ephedrine|mesh-list
83101781|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83685485|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685486|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101955|NCT03493503|Albuterol|albuterol|mesh-list
83685487|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685488|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
83102084|NCT03020407|Dopamine|dopamine|mesh-list
83685489|NCT01669499|Hormones|hormones|mesh-ancestor
83685490|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685491|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83102602|NCT03008005|Dronabinol|dronabinol|mesh-list
83685492|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685493|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
83102900|NCT05417386|Antidotes|antidotes|mesh-ancestor
83103056|NCT05577364|Hormones|hormones|mesh-ancestor
83103278|NCT03105830|Acetaminophen|acetaminophen|mesh-list
83685494|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103352|NCT03693833|Cannabidiol|cannabidiol|mesh-list
83103558|NCT03681197|Metformin|metformin|mesh-list
83103660|NCT03680885|Lidocaine|lidocaine|mesh-list
83103730|NCT03486561|Ranolazine|ranolazine|mesh-list
83685495|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685496|NCT01669707|Endostar protein|endostar protein|mesh-list
83103966|NCT03623711|Bupropion|bupropion|mesh-list
83104108|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104197|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685497|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83685498|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83685499|NCT01669707|Growth Substances|growth substances|mesh-ancestor
83685500|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685501|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83685502|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685503|NCT01669824|Aspirin|aspirin|mesh-list
83685504|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685505|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685506|NCT01669824|Analgesics|analgesics|mesh-ancestor
83685507|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
83685508|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104275|NCT05322538|Vitamin D|vitamin d|mesh-list
83104337|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
83685509|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685510|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685511|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104718|NCT04953104|Nivolumab|nivolumab|mesh-list
83104789|NCT05226754|Diacerein|diacerein|mesh-list
83104886|NCT04422028|Hormones|hormones|mesh-ancestor
83685512|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83685513|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83105241|NCT03179475|Analgesics|analgesics|mesh-ancestor
83105399|NCT05170438|Paclitaxel|paclitaxel|mesh-list
83105467|NCT05053750|Paclitaxel|paclitaxel|mesh-list
83685514|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105847|NCT05798533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685515|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83106134|NCT05653193|Miconazole|miconazole|mesh-list
83685516|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83685517|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685518|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
83685519|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83685520|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
83685521|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83685522|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83106568|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685523|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106809|NCT04347720|Acetaminophen|acetaminophen|mesh-list
83685524|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
83685525|NCT01669967|Promethazine|promethazine|mesh-list
83107279|NCT02848131|Dasatinib|dasatinib|mesh-list
83107593|NCT01256398|Dasatinib|dasatinib|mesh-list
83107756|NCT00889876|Metformin|metformin|mesh-list
83685526|NCT01669967|Lidocaine|lidocaine|mesh-list
83685527|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83685528|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
83108129|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
83685529|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840332|NCT01146106|Pravastatin|pravastatin|mesh-list
82840334|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83685530|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685531|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
83685532|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685533|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83685534|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83685535|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83685536|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83685537|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685538|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83685539|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83685540|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
83685541|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
83685542|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685543|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83685544|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
83685545|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
83685546|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108584|NCT02991859|Budesonide|budesonide|mesh-list
83685547|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83685548|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
83685549|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685550|NCT01670149|Rifaximin|rifaximin|mesh-list
83685551|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685552|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685553|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685554|NCT01670370|Gemcitabine|gemcitabine|mesh-list
83685555|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
83685556|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685557|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83685558|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
83685559|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685560|NCT01670552|Naproxen|naproxen|mesh-list
83685561|NCT01670552|Nimesulide|nimesulide|mesh-list
83685562|NCT01670552|Esomeprazole|esomeprazole|mesh-list
83685563|NCT01670552|Pantoprazole|pantoprazole|mesh-list
83685564|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83685565|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685566|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83685567|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685568|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685569|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685570|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685571|NCT01670552|Analgesics|analgesics|mesh-ancestor
83685572|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
83685573|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685574|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685575|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685576|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685577|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
83685578|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83685579|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
83685580|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83685581|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
83685582|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685583|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
83685584|NCT01670578|Protective Agents|protective agents|mesh-ancestor
83685585|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
83685586|NCT01670812|Rituximab|rituximab|mesh-list
83685587|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83685588|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685589|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
83685590|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685591|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685592|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685593|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
83685594|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
83685595|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685596|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685597|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
83685598|NCT01670812|Hormones|hormones|mesh-ancestor
83685599|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685600|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83685601|NCT01670812|Protective Agents|protective agents|mesh-ancestor
83685602|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
82840406|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
82840407|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
83685603|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685604|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83685606|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83685607|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83685608|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685609|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
83685610|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685611|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685612|NCT01672359|Choline|choline|mesh-list
83685613|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
83685614|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83685615|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
83685616|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685617|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685618|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83685619|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
83685620|NCT01673308|Lenalidomide|lenalidomide|mesh-list
83685621|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
83685622|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685623|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83685624|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83685625|NCT01673308|Growth Substances|growth substances|mesh-ancestor
83685626|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
83685627|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685628|NCT01673737|Vemurafenib|vemurafenib|mesh-list
83685629|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685630|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685631|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685632|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685633|NCT01674556|Gemcitabine|gemcitabine|mesh-list
83109308|NCT01069289|Budesonide|budesonide|mesh-list
83109384|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
83685634|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83685635|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
83685636|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685637|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685638|NCT01675115|Aspirin|aspirin|mesh-list
83685639|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685640|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685641|NCT01675115|Analgesics|analgesics|mesh-ancestor
83685642|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
83685643|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685644|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685645|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685646|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685647|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83685648|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83109603|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
83109664|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685649|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685650|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83685651|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83685652|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685653|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
83685654|NCT01675310|Metformin|metformin|mesh-list
83685655|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83685656|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685657|NCT01676649|Paclitaxel|paclitaxel|mesh-list
83110263|NCT03649009|Thiamine|thiamine|mesh-list
83110409|NCT05388123|Rituximab|rituximab|mesh-list
83685658|NCT01676649|Carboplatin|carboplatin|mesh-list
83685659|NCT01676649|Ipilimumab|ipilimumab|mesh-list
83685660|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83685661|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685662|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
83685663|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
83685664|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
83685665|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685666|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83685667|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83685668|NCT01676987|Budesonide|budesonide|mesh-list
83685669|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
83685670|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685671|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83685672|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
83685673|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685674|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685675|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83685676|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
83685677|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
83685678|NCT01676987|Hormones|hormones|mesh-ancestor
83685679|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685680|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83110545|NCT02963935|Liraglutide|liraglutide|mesh-list
83685681|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83685682|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83685683|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
83685684|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685685|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685686|NCT01677039|Ethanol|ethanol|mesh-list
83685687|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83685688|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685689|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685690|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685691|NCT01677065|Oxycodone|oxycodone|mesh-list
83685692|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685693|NCT01677065|Narcotics|narcotics|mesh-ancestor
83685694|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685695|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685696|NCT01677065|Analgesics|analgesics|mesh-ancestor
83685697|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
83685698|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685699|NCT01677247|Glimepiride|glimepiride|mesh-list
83685700|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83685701|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83685702|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685703|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83685704|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
83685705|NCT01677260|Metformin|metformin|mesh-list
83685706|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110749|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
83685707|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685708|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
83685709|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
83685710|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685711|NCT01677650|Methadone|methadone|mesh-list
83685712|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685713|NCT01677650|Narcotics|narcotics|mesh-ancestor
83685714|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685715|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685716|NCT01677650|Analgesics|analgesics|mesh-ancestor
83685717|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
83685718|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685719|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
83685720|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
83685721|NCT01678053|Omeprazole|omeprazole|mesh-list
83685722|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
83685723|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83685724|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83685725|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83685726|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83685727|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83685728|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685729|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
83685730|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685731|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685732|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83685733|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685734|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685735|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83685736|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685737|NCT01678937|Cyclosporine|cyclosporine|mesh-list
83685738|NCT01678937|Sirolimus|sirolimus|mesh-list
83685739|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
83685740|NCT01678937|Temsirolimus|temsirolimus|mesh-list
83685741|NCT01678937|MTOR Inhibitors|mtor inhibitors|mesh-list
83685742|NCT01678937|Tacrolimus|tacrolimus|mesh-list
83685743|NCT01678937|Cyclosporins|cyclosporins|mesh-list
83685744|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83685745|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
83685746|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685747|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83111570|NCT04964128|Insulin|insulin|mesh-list
83685748|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111611|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
83685749|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685750|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
83685751|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112055|NCT04053959|Insulin|insulin|mesh-list
83685752|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685753|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685754|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83685755|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685756|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83685757|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
83685758|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83685759|NCT01678937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685760|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
83685761|NCT01679041|Fludarabine|fludarabine|mesh-list
83685762|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
83685763|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83685764|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
83685765|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685766|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83685767|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83685768|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
83112480|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112637|NCT03421275|Fentanyl|fentanyl|mesh-list
83112709|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83685769|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112786|NCT05384743|Rituximab|rituximab|mesh-list
83685770|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685771|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83685772|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83685773|NCT01679093|Dexamethasone|dexamethasone|mesh-list
83685774|NCT01679093|Droperidol|droperidol|mesh-list
83685775|NCT01679093|Ondansetron|ondansetron|mesh-list
83685776|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685777|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
83685778|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
83685779|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685780|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685781|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83685782|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
83685783|NCT01679093|Hormones|hormones|mesh-ancestor
83112859|NCT02873689|Lansoprazole|lansoprazole|mesh-list
83112922|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113152|NCT03424473|Tucatinib|tucatinib|mesh-list
83685784|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83685785|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83113379|NCT05169801|Paclitaxel|paclitaxel|mesh-list
83113453|NCT02355938|Vancomycin|vancomycin|mesh-list
83685786|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685787|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
83113555|NCT02351024|Naproxen|naproxen|mesh-list
83113683|NCT02359448|Melatonin|melatonin|mesh-list
83685788|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
83685789|NCT01679093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83685790|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83685791|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
83685792|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685793|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685794|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83685795|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83685796|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83685797|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685798|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83685799|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83685800|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83685801|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
83685802|NCT01679743|Trastuzumab|trastuzumab|mesh-list
83685803|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83685804|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685805|NCT01680094|Panobinostat|panobinostat|mesh-list
83113966|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
83114132|NCT05167851|Lazertinib|lazertinib|mesh-list
83685806|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685807|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83685808|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685809|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685810|NCT01680120|Anesthetics|anesthetics|mesh-list
83685811|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685812|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685813|NCT01680198|Vitamin D|vitamin d|mesh-list
83685814|NCT01680198|Vitamins|vitamins|mesh-ancestor
83114711|NCT02476006|Atorvastatin|atorvastatin|mesh-list
83115017|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
83685815|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
83115160|NCT02334488|Everolimus|everolimus|mesh-list
83115237|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
83115836|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83685816|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685817|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83116262|NCT03383367|TEMPO|tempo|mesh-list
83685818|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83685819|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83685820|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685821|NCT05596981|Sorafenib|sorafenib|mesh-list
83116656|NCT03385551|Estrogens|estrogens|mesh-ancestor
83685822|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685823|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685824|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117031|NCT03374007|Antibodies|antibodies|mesh-list
83685825|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685826|NCT05596968|Sorafenib|sorafenib|mesh-list
83117183|NCT03137498|Ketorolac|ketorolac|mesh-list
83117253|NCT05851508|Glucocorticoids|glucocorticoids|mesh-ancestor
83117326|NCT05850546|Immunologic Factors|immunologic factors|mesh-ancestor
83685827|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685828|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117479|NCT05849662|Cytarabine|cytarabine|mesh-list
83685829|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117562|NCT05841134|Capecitabine|capecitabine|mesh-list
83117774|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83117851|NCT05555732|Carboplatin|carboplatin|mesh-list
83685830|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685831|NCT05596890|Paclitaxel|paclitaxel|mesh-list
83685832|NCT05596890|Carboplatin|carboplatin|mesh-list
83685833|NCT05596890|Tislelizumab|tislelizumab|mesh-list
83118301|NCT04997304|Albuterol|albuterol|mesh-list
83685834|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83685835|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685836|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83685837|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83685838|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83685839|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685840|NCT05596890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83685841|NCT05596669|Ketamine|ketamine|mesh-list
83685842|NCT05596669|Morphine|morphine|mesh-list
83685843|NCT05596669|Analgesics|analgesics|mesh-ancestor
83118556|NCT04588233|Melatonin|melatonin|mesh-list
83118707|NCT04340947|Nicotine|nicotine|mesh-list
83118774|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
83685844|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
83118932|NCT03970252|Antidotes|antidotes|mesh-ancestor
83119008|NCT03904251|Immunotoxins|immunotoxins|mesh-ancestor
83119073|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119227|NCT03179904|Paclitaxel|paclitaxel|mesh-list
83119301|NCT02925650|Phenserine|phenserine|mesh-list
83119374|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
83685845|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119595|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
83119747|NCT03372447|Thiamine|thiamine|mesh-list
83119906|NCT03593707|Metformin|metformin|mesh-list
83685846|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120062|NCT02849509|Vitamin K|vitamin k|mesh-list
83120359|NCT03601091|Midazolam|midazolam|mesh-list
83685847|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83120434|NCT03600623|Irinotecan|irinotecan|mesh-list
83685848|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83685849|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
83685850|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
83685851|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685852|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83685853|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83685854|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685855|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685856|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685857|NCT05596669|Narcotics|narcotics|mesh-ancestor
83685858|NCT05596617|Melatonin|melatonin|mesh-list
83685859|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
83685860|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685861|NCT05596617|Protective Agents|protective agents|mesh-ancestor
83685862|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685863|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685864|NCT05596552|Fentanyl|fentanyl|mesh-list
83685865|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
83685866|NCT05596552|Bupivacaine|bupivacaine|mesh-list
83685867|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
83685868|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
83685869|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685870|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685871|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
83685872|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685873|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83685874|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685875|NCT05596552|Analgesics|analgesics|mesh-ancestor
83685876|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83121620|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83685877|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83685878|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83685879|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
83121685|NCT02511639|Anastrozole|anastrozole|mesh-list
83685880|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83685881|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685882|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685883|NCT05596552|Narcotics|narcotics|mesh-ancestor
83685884|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83685885|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83685886|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
83685887|NCT05596227|Fentanyl|fentanyl|mesh-list
83685888|NCT05596227|Narcotics|narcotics|mesh-list
83685889|NCT05596227|Propofol|propofol|mesh-list
83685890|NCT05596227|Anesthetics|anesthetics|mesh-list
83685891|NCT05596227|Sevoflurane|sevoflurane|mesh-list
83685892|NCT05596227|Rocuronium|rocuronium|mesh-list
83685893|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83685894|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685895|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685896|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83685897|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
83685898|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685899|NCT05596227|Analgesics|analgesics|mesh-ancestor
83685900|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
83685901|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685902|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83685903|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82840701|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
82840725|NCT03914092|Hormones|hormones|mesh-ancestor
83685904|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83121814|NCT02510781|Carboplatin|carboplatin|mesh-list
83685905|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83685906|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83685907|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83685909|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83685910|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83685911|NCT05596214|Analgesics|analgesics|mesh-ancestor
83685912|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
83685913|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685914|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685915|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83685916|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122187|NCT02844439|XL647|xl647|mesh-list
83685917|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685918|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685919|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685920|NCT05596149|Listerine|listerine|mesh-list
83685921|NCT05596149|Fluorides|fluorides|mesh-list
83685922|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
83685923|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
83685924|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
83685925|NCT05596149|Protective Agents|protective agents|mesh-ancestor
83685926|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685927|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83685928|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685929|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
83685930|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685931|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83685932|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83685933|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685934|NCT05596071|Sufentanil|sufentanil|mesh-list
83685935|NCT05596071|Dsuvia|dsuvia|mesh-list
83685936|NCT05596071|Ropivacaine|ropivacaine|mesh-list
83685937|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
83685938|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
83685939|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122386|NCT02507583|Insulin|insulin|mesh-list
83122542|NCT04482686|Astringents|astringents|mesh-ancestor
83685940|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685941|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
83685942|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685943|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83685944|NCT05596071|Narcotics|narcotics|mesh-ancestor
83685945|NCT05596071|Analgesics|analgesics|mesh-ancestor
83122984|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123058|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83123209|NCT02498145|Nicotine|nicotine|mesh-list
83123434|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685946|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83123510|NCT05115578|Remifentanil|remifentanil|mesh-list
83123585|NCT03324867|Insulin|insulin|mesh-list
83685947|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83685948|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
83685949|NCT05595824|Molnupiravir|molnupiravir|mesh-list
83685950|NCT05595824|Antiviral Agents|antiviral agents|mesh-ancestor
83123814|NCT03120273|Lansoprazole|lansoprazole|mesh-list
83685951|NCT05595824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685952|NCT05595590|Tislelizumab|tislelizumab|mesh-list
83685953|NCT05595590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83685954|NCT05595590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685955|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
83685956|NCT05595447|Nivolumab|nivolumab|mesh-list
83685957|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83685958|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83685959|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83685960|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83685961|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685962|NCT05595447|Immunotoxins|immunotoxins|mesh-ancestor
83685963|NCT05595447|Immunoconjugates|immunoconjugates|mesh-ancestor
83685964|NCT05595447|Immunologic Factors|immunologic factors|mesh-ancestor
83685965|NCT05595447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685966|NCT05595408|Immunomodulating Agents|immunomodulating agents|mesh-list
83124569|NCT02489019|Fentanyl|fentanyl|mesh-list
83685967|NCT05595408|Immunologic Factors|immunologic factors|mesh-ancestor
83124704|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
83124774|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124850|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83124930|NCT02482857|Aspirin|aspirin|mesh-list
83685968|NCT05595408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125077|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83125149|NCT05713773|Caffeine|caffeine|mesh-list
83125225|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125302|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83685969|NCT05595369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83685970|NCT05595369|Antiviral Agents|antiviral agents|mesh-ancestor
83685971|NCT05595369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83685972|NCT05567822|Esmolol|esmolol|mesh-list
83125546|NCT05870436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83125627|NCT05855395|Prednisone|prednisone|mesh-list
83125860|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83125981|NCT05382338|Mesna|mesna|mesh-list
83126014|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83685973|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83126089|NCT05206773|Venglustat|venglustat|mesh-list
83126164|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
83126239|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126330|NCT04933617|Hormones|hormones|mesh-ancestor
83126466|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
83126544|NCT04411693|Hormones|hormones|mesh-ancestor
83685974|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83685975|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83126854|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
83685976|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
83126928|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
83127085|NCT03519945|Mirikizumab|mirikizumab|mesh-list
83127155|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
83127310|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
83128076|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
83685977|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128301|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83128449|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83128615|NCT00071552|Xhance|xhance|mesh-list
83128758|NCT01674062|Pertuzumab|pertuzumab|mesh-list
83128974|NCT04398914|Paclitaxel|paclitaxel|mesh-list
83129045|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83129195|NCT02415400|Aspirin|aspirin|mesh-list
83129278|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
83685978|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129501|NCT03310593|Cannabidiol|cannabidiol|mesh-list
83685979|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840776|NCT01252342|Oxytocin|oxytocin|mesh-list
83685980|NCT05557253|Anesthetics|anesthetics|mesh-list
83685981|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83685982|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685983|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
83130034|NCT02038621|Paclitaxel|paclitaxel|mesh-list
83685984|NCT05539924|Pregabalin|pregabalin|mesh-list
83685985|NCT05539924|Gabapentin|gabapentin|mesh-list
83685986|NCT05539924|Vitamins|vitamins|mesh-ancestor
83130490|NCT03867110|Ezetimibe|ezetimibe|mesh-list
83685987|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
83130850|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
83131151|NCT03464019|Etripamil|etripamil|mesh-list
83685988|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83685989|NCT05539924|Analgesics|analgesics|mesh-ancestor
83131461|NCT02461329|Polygeline|polygeline|mesh-list
83685990|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
83685991|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83685992|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
83685993|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83131790|NCT02071615|Caffeine|caffeine|mesh-list
83685994|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83685995|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83685996|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83685997|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83685998|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83685999|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686000|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686001|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83686002|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83686003|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686004|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
83686005|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
83686006|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
83686007|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83686008|NCT05514782|Protective Agents|protective agents|mesh-ancestor
83686009|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686010|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83686011|NCT05479370|Vaccines|vaccines|mesh-list
83686012|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
83686013|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686014|NCT05468242|Bevacizumab|bevacizumab|mesh-list
83686015|NCT05468242|Tislelizumab|tislelizumab|mesh-list
83132029|NCT04918069|Capsaicin|capsaicin|mesh-list
83132213|NCT02085655|Hormones|hormones|mesh-ancestor
83132634|NCT05067530|Paclitaxel|paclitaxel|mesh-list
83686016|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686017|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686018|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83686019|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83686020|NCT05468242|Growth Substances|growth substances|mesh-ancestor
83686021|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686022|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83686023|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
83686024|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
83686025|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
83686026|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686027|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686028|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83686029|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83686030|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686031|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686032|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686033|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83686034|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
83686035|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686036|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686037|NCT05423951|Sufentanil|sufentanil|mesh-list
83686038|NCT05423951|Propofol|propofol|mesh-list
83686039|NCT05423951|Rocuronium|rocuronium|mesh-list
83686040|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83686041|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686042|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686043|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83686044|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
83686045|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
83686046|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83686047|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83686048|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83686049|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686050|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83686051|NCT05423951|Narcotics|narcotics|mesh-ancestor
83686052|NCT05423951|Analgesics|analgesics|mesh-ancestor
83686053|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
83686054|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83686055|NCT05405621|Exatecan|exatecan|mesh-list
83686056|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83686058|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686059|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686060|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686061|NCT05350696|Morphine|morphine|mesh-list
83686062|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83686063|NCT05350696|Narcotics|narcotics|mesh-ancestor
83686064|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686065|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686066|NCT05350696|Analgesics|analgesics|mesh-ancestor
83686067|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
83686068|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686069|NCT05291156|Cetuximab|cetuximab|mesh-list
83686070|NCT05291156|Avelumab|avelumab|mesh-list
83686071|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686072|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686073|NCT05253118|Pemetrexed|pemetrexed|mesh-list
83686074|NCT05253118|Tislelizumab|tislelizumab|mesh-list
83686075|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686076|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686077|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686078|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83686079|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83686080|NCT05253118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686081|NCT05226923|Meropenem|meropenem|mesh-list
83686082|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686083|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686084|NCT05098327|Pioglitazone|pioglitazone|mesh-list
83686085|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83686086|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686087|NCT05076838|Diazepam|diazepam|mesh-list
83686088|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83686089|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
83686090|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
83686091|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
83686092|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686093|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686094|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83686095|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83686096|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686097|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83686098|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83686099|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83686100|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686101|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686102|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83686103|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
83686104|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
83686105|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
83686106|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
83686107|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686108|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686109|NCT05057949|Itraconazole|itraconazole|mesh-list
83686110|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83686111|NCT05057949|Rifampin|rifampin|mesh-list
83686112|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
83686113|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686114|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83686115|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83686116|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686117|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686118|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83686119|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
83686120|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686121|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686122|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83686123|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83686124|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
83686125|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686126|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
83686127|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83686128|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83686129|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83686130|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83686131|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83686132|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83686133|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83686135|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686136|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686137|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
83686138|NCT04901312|Narcotics|narcotics|mesh-ancestor
83686139|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686140|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686141|NCT04901312|Analgesics|analgesics|mesh-ancestor
83686142|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
83686143|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686144|NCT04886297|Resveratrol|resveratrol|mesh-list
83686145|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
83686146|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686147|NCT04886297|Protective Agents|protective agents|mesh-ancestor
83686148|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686149|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686150|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83686151|NCT04830410|Levan|levan|mesh-list
83686152|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686153|NCT04810793|Amoxicillin|amoxicillin|mesh-list
83686154|NCT04810793|Levofloxacin|levofloxacin|mesh-list
83686155|NCT04810793|Ofloxacin|ofloxacin|mesh-list
83686156|NCT04810793|Tetracycline|tetracycline|mesh-list
83686157|NCT04810793|Furazolidone|furazolidone|mesh-list
83686158|NCT04810793|Esomeprazole|esomeprazole|mesh-list
83686159|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686160|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686161|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83686162|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83686163|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83686164|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686165|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686166|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83686167|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83686168|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83686169|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686170|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83686171|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83686172|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83686173|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83686174|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83686175|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83686176|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83686177|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83686178|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
83686179|NCT04797832|Hematinics|hematinics|mesh-ancestor
83686180|NCT04684511|Rofecoxib|rofecoxib|mesh-list
83686181|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83686182|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83686183|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686184|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686185|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83686186|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83686187|NCT04684511|Analgesics|analgesics|mesh-ancestor
83686188|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
83686189|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686190|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686191|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686192|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686193|NCT04650841|Naloxone|naloxone|mesh-list
83686194|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83686195|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686196|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
83686197|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686198|NCT04624854|Aspirin|aspirin|mesh-list
83686199|NCT04624854|Clopidogrel|clopidogrel|mesh-list
83686200|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83686201|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83686202|NCT04624854|Analgesics|analgesics|mesh-ancestor
83686203|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
83686204|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686205|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686206|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686207|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686208|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83686209|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83686210|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686211|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83686212|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83686213|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686214|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
83686215|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83686216|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83686217|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83686218|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
83686219|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686220|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
83686221|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686222|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83686223|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686224|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686225|NCT04565171|Yimitasvir|yimitasvir|mesh-list
83686226|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
83686227|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686228|NCT04463368|Nivolumab|nivolumab|mesh-list
83686229|NCT04463368|Ipilimumab|ipilimumab|mesh-list
83686230|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686231|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686232|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83686233|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686234|NCT04452344|Analgesics|analgesics|mesh-list
83686235|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686236|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
83686237|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686238|NCT04450407|Insulin|insulin|mesh-list
83686239|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83686240|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686241|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
83686242|NCT04432506|Fludarabine|fludarabine|mesh-list
83686243|NCT04432506|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83686244|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83686245|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686246|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
83686247|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686248|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686249|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83686250|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
83686251|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686252|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686253|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83686254|NCT04432506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686255|NCT04231838|Nicotine|nicotine|mesh-list
83686256|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83686257|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
83686258|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686259|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686260|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83686261|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83686262|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
83686263|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686264|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686265|NCT04218266|Apixaban|apixaban|mesh-list
83686266|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83686267|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
83686268|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83686269|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
83686270|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686271|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686272|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
83686273|NCT04172363|Octenidine|octenidine|mesh-list
83686274|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686275|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83686276|NCT04074603|Insulin|insulin|mesh-list
83686277|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83686278|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686279|NCT04068246|Metformin|metformin|mesh-list
83686280|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83686281|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686282|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
83686283|NCT04063033|Hematinics|hematinics|mesh-ancestor
83686284|NCT04038255|Nicotine|nicotine|mesh-list
83686285|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83686286|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
83686287|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686288|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686289|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83686290|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83686291|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
83686292|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686293|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686294|NCT04037605|Ketoconazole|ketoconazole|mesh-list
83686295|NCT04037605|Dexamethasone|dexamethasone|mesh-list
83686296|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
83686297|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
83686298|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83686299|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83686300|NCT04037605|Hormones|hormones|mesh-list
83686301|NCT04037605|Cosyntropin|cosyntropin|mesh-list
83686302|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83686303|NCT04037605|BB 1101|bb 1101|mesh-list
83686304|NCT04037605|Ganirelix|ganirelix|mesh-list
83686305|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686306|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
83686307|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
83686308|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686309|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686310|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83686311|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
83686312|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686313|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83686314|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686315|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
83686316|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686317|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686318|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
83686319|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686320|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83686321|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83686322|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83686323|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
83686324|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83686325|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
83686326|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686327|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686328|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686329|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686330|NCT03928093|Pregabalin|pregabalin|mesh-list
83686331|NCT03928093|Analgesics|analgesics|mesh-ancestor
83686332|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
83686333|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686334|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686335|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
83686336|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83686337|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83686338|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686339|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83686340|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83686341|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686342|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686343|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686344|NCT03907800|Paclitaxel|paclitaxel|mesh-list
83686345|NCT03907800|Carboplatin|carboplatin|mesh-list
83686346|NCT03907800|Trastuzumab|trastuzumab|mesh-list
83686347|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83686348|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686349|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686350|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
83686351|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686352|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686353|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686354|NCT03894904|Heparin|heparin|mesh-list
83686355|NCT03894904|Papaverine|papaverine|mesh-list
83686356|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
83686357|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83686358|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83686359|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686360|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83686361|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686362|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
83686363|NCT03894904|Urological Agents|urological agents|mesh-ancestor
83686364|NCT03797833|Anesthetics|anesthetics|mesh-list
83686365|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686366|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686367|NCT03749174|Anesthetics|anesthetics|mesh-list
83686368|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686369|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686370|NCT03722927|Bupivacaine|bupivacaine|mesh-list
83686371|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
83686372|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
83686373|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686374|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686375|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
83686376|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686377|NCT03681652|Azathioprine|azathioprine|mesh-list
83686378|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686379|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
83686380|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686381|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83686382|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686383|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686384|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
83686385|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686386|NCT03578198|Rituximab|rituximab|mesh-list
83686387|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686388|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686389|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
83686390|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686391|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686392|NCT03571308|Prednisolone|prednisolone|mesh-list
83686393|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
83686394|NCT03571308|Doxorubicin|doxorubicin|mesh-list
83686395|NCT03571308|Vincristine|vincristine|mesh-list
83686396|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
83686397|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686398|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
83686399|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686400|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686401|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83686402|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
83686403|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686404|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686405|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83686406|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83686407|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83686408|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83686409|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686410|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83686411|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686412|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83686413|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686414|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686415|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
83686416|NCT03571308|Hormones|hormones|mesh-ancestor
83686417|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686418|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83686419|NCT03554200|Empagliflozin|empagliflozin|mesh-list
83686420|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83686421|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686422|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83686423|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686424|NCT03518086|Mirikizumab|mirikizumab|mesh-list
83686425|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83686426|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83686427|NCT03518086|Analgesics|analgesics|mesh-ancestor
83686428|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
83686429|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686430|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686431|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686432|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686433|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83686434|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83686435|NCT03517176|Paclitaxel|paclitaxel|mesh-list
83686436|NCT03517176|Gemcitabine|gemcitabine|mesh-list
83686437|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83686438|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686439|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686440|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
83686441|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686442|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686443|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83686444|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
83686445|NCT03512964|Tenofovir|tenofovir|mesh-list
83686446|NCT03512964|Emtricitabine|emtricitabine|mesh-list
83686447|NCT03512964|Dolutegravir|dolutegravir|mesh-list
83686448|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83686449|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
83686450|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686451|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83686452|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83686453|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686454|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686455|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83686456|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83686457|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83686458|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83686459|NCT03476109|Omalizumab|omalizumab|mesh-list
83686460|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83686461|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83686462|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
83686463|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
83686464|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83686465|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
83686466|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686467|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
83686468|NCT03463499|Protective Agents|protective agents|mesh-ancestor
83686469|NCT03366974|Clarithromycin|clarithromycin|mesh-list
83686470|NCT03366974|Midazolam|midazolam|mesh-list
83686471|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83686472|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83686473|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686474|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686475|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83686476|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686477|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686478|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83686479|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
83686480|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
83686481|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
83686482|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
83686483|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686484|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686485|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686486|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686487|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83686488|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686489|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83686490|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83686491|NCT03362515|Furosemide|furosemide|mesh-list
83686492|NCT03362515|Diuretics|diuretics|mesh-ancestor
83686493|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
83686494|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686495|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83686496|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83686497|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686498|NCT03340129|Nivolumab|nivolumab|mesh-list
83686499|NCT03340129|Ipilimumab|ipilimumab|mesh-list
83686500|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686501|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686502|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83686503|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686504|NCT03307746|Rituximab|rituximab|mesh-list
83686505|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686506|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686507|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
83686508|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686509|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686510|NCT03294083|Cemiplimab|cemiplimab|mesh-list
83686511|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686512|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686513|NCT03222076|Nivolumab|nivolumab|mesh-list
83686514|NCT03222076|Ipilimumab|ipilimumab|mesh-list
83686515|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686516|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686517|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83686518|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686519|NCT03128398|Domperidone|domperidone|mesh-list
83686520|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
83686521|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
83686522|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686523|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686524|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83686525|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83686526|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
83686527|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686528|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686529|NCT03119038|Ketorolac|ketorolac|mesh-list
83686530|NCT03119038|Clonidine|clonidine|mesh-list
83686531|NCT03119038|Epinephrine|epinephrine|mesh-list
83686532|NCT03119038|Bupivacaine|bupivacaine|mesh-list
83686533|NCT03119038|Ropivacaine|ropivacaine|mesh-list
83686534|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
83686535|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
83686536|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686537|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686538|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
83686539|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686540|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83686541|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83686542|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
83686543|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686544|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686545|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83686546|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83686547|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
83686548|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83686549|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
83686550|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
83686551|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
83686552|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83686553|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83686554|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83686555|NCT03119038|Analgesics|analgesics|mesh-ancestor
83686556|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686557|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686558|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83686559|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686560|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83686561|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
83686562|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83686563|NCT03099265|Leucovorin|leucovorin|mesh-list
83686564|NCT03099265|Fluorouracil|fluorouracil|mesh-list
83686565|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
83686566|NCT03099265|Irinotecan|irinotecan|mesh-list
83686567|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
83686568|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686569|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83686570|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686571|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686572|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
83686573|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686574|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83686575|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83686576|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686577|NCT03099265|Antidotes|antidotes|mesh-ancestor
83686578|NCT03099265|Protective Agents|protective agents|mesh-ancestor
83686579|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
83686580|NCT03099265|Vitamins|vitamins|mesh-ancestor
83686581|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
83686582|NCT03063749|Sirolimus|sirolimus|mesh-list
82841385|NCT00224874|Etanercept|etanercept|mesh-list
83686583|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686584|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686585|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83686586|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686587|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
83686588|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686589|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
83686590|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686591|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
83686592|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83686593|NCT03007589|Protective Agents|protective agents|mesh-ancestor
83686594|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686595|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
83686596|NCT02975037|Clarithromycin|clarithromycin|mesh-list
83686597|NCT02975037|Itraconazole|itraconazole|mesh-list
83686598|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
83686599|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
83686600|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83686601|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83686602|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686603|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686604|NCT02975037|Urological Agents|urological agents|mesh-ancestor
83686605|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686606|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686607|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83686608|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83686609|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83686610|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
83686611|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83686612|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83686613|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
83686614|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686615|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686616|NCT02931890|Paclitaxel|paclitaxel|mesh-list
83686617|NCT02931890|Docetaxel|docetaxel|mesh-list
83686618|NCT02931890|Carboplatin|carboplatin|mesh-list
83686619|NCT02931890|Capecitabine|capecitabine|mesh-list
83686620|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
83686621|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83686622|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132764|NCT03993717|Vaccines|vaccines|mesh-list
83686623|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686624|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83686625|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686626|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686627|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83686628|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
83686629|NCT02914405|Nivolumab|nivolumab|mesh-list
83686630|NCT02914405|Dinutuximab|dinutuximab|mesh-list
83686631|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
83686632|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
83686633|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686634|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686635|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83686636|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686637|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
83686638|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686639|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
83686640|NCT02812862|Olodaterol|olodaterol|mesh-list
83686641|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83686642|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
83686643|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686644|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686645|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83686646|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
83686647|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
83686648|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83686649|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
83686650|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686651|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686652|NCT02587312|Nicotine|nicotine|mesh-list
83686653|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83686654|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
83686655|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686656|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686657|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82841454|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686658|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83686659|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
83686660|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686661|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686662|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
83686663|NCT02549677|Docetaxel|docetaxel|mesh-list
83686664|NCT02549677|Epirubicin|epirubicin|mesh-list
83686665|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686666|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
83686667|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686668|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686669|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83686670|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
83686671|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686672|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686673|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83686674|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686675|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
83686676|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686677|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83686678|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83686679|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83686680|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686681|NCT02536300|Idelalisib|idelalisib|mesh-list
83686682|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686683|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686684|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686685|NCT02450253|Tadalafil|tadalafil|mesh-list
83686686|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83686687|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83686688|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83686689|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686690|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686691|NCT02450253|Urological Agents|urological agents|mesh-ancestor
83686692|NCT02257970|Ketoprofen|ketoprofen|mesh-list
83686693|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83686694|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83686695|NCT02257970|Analgesics|analgesics|mesh-ancestor
83686696|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
83686697|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686698|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686699|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686700|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83686701|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83686702|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686703|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686704|NCT05838729|Pembrolizumab|pembrolizumab|mesh-list
83686705|NCT05838729|Nivolumab|nivolumab|mesh-list
83686706|NCT05838729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83686707|NCT05838729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686708|NCT05838729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686709|NCT05838729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686710|NCT05838716|Vitamin D|vitamin d|mesh-list
83686711|NCT05838716|Ergocalciferols|ergocalciferols|mesh-list
83686712|NCT05838716|Cholecalciferol|cholecalciferol|mesh-list
83686713|NCT05838716|Vitamins|vitamins|mesh-list
83686714|NCT05838716|Micronutrients|micronutrients|mesh-ancestor
83686715|NCT05838716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686716|NCT05838716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83686717|NCT05838716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83686718|NCT05838599|Imiquimod|imiquimod|mesh-list
83686719|NCT05838599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83686720|NCT05838599|Immunologic Factors|immunologic factors|mesh-ancestor
83686721|NCT05838599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686722|NCT05838599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686723|NCT05838599|Interferon Inducers|interferon inducers|mesh-ancestor
83686724|NCT05838391|Fluorouracil|fluorouracil|mesh-list
83686725|NCT05838391|Capecitabine|capecitabine|mesh-list
83686726|NCT05838391|Mitomycins|mitomycins|mesh-list
83686727|NCT05838391|Mitomycin|mitomycin|mesh-list
83686728|NCT05838391|Antimetabolites|antimetabolites|mesh-ancestor
83686729|NCT05838391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686730|NCT05838391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83686731|NCT05838391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686732|NCT05838391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686733|NCT05838391|Immunologic Factors|immunologic factors|mesh-ancestor
83686734|NCT05838391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686735|NCT05838391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83686736|NCT05838391|Alkylating Agents|alkylating agents|mesh-ancestor
83686737|NCT05838391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83686738|NCT05838391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686739|NCT05838248|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83686740|NCT05838248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686741|NCT05838105|Progesterone|progesterone|mesh-list
83686742|NCT05838105|Progestins|progestins|mesh-ancestor
83686743|NCT05838105|Hormones|hormones|mesh-ancestor
83686744|NCT05838105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686745|NCT05838105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686746|NCT05838066|Docetaxel|docetaxel|mesh-list
83686747|NCT05838066|Trastuzumab|trastuzumab|mesh-list
83686748|NCT05838066|Pertuzumab|pertuzumab|mesh-list
83686749|NCT05838066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686750|NCT05838066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686751|NCT05838066|Antimitotic Agents|antimitotic agents|mesh-ancestor
83686752|NCT05838066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686753|NCT05838066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686754|NCT05838066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686755|NCT05838001|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83686756|NCT05838001|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83686757|NCT05838001|beta-Endorphin|beta-endorphin|mesh-list
83686758|NCT05838001|Hormones|hormones|mesh-ancestor
83686759|NCT05838001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686760|NCT05838001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686761|NCT05838001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686762|NCT05838001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686763|NCT05837936|Anesthetics|anesthetics|mesh-list
83686764|NCT05837936|Sevoflurane|sevoflurane|mesh-list
83686765|NCT05837936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686766|NCT05837936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686767|NCT05837936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83686768|NCT05837936|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83686769|NCT05837936|Anesthetics, General|anesthetics, general|mesh-ancestor
83686770|NCT05837845|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83686771|NCT05837845|Hallucinogens|hallucinogens|mesh-ancestor
83686772|NCT05837845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686773|NCT05837845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686774|NCT05837845|Serotonin Agents|serotonin agents|mesh-ancestor
83686775|NCT05837845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686776|NCT05837845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686777|NCT05837845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83686778|NCT05837845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83686779|NCT05837845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83686780|NCT05837845|Adrenergic Agents|adrenergic agents|mesh-ancestor
83686781|NCT05837806|Tislelizumab|tislelizumab|mesh-list
83686782|NCT05837806|Disitamab vedotin|disitamab vedotin|mesh-list
83686783|NCT05837806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686784|NCT05837806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686785|NCT05837806|Immunoconjugates|immunoconjugates|mesh-ancestor
83686786|NCT05837806|Immunologic Factors|immunologic factors|mesh-ancestor
83686787|NCT05837806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686788|NCT05837689|Blinatumomab|blinatumomab|mesh-list
83686789|NCT05837689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686790|NCT05837455|Anastrozole|anastrozole|mesh-list
83686791|NCT05837455|Taxane|taxane|mesh-list
83686792|NCT05837455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83686793|NCT05837455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686794|NCT05837455|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83686795|NCT05837455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83686796|NCT05837455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686797|NCT05837455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686798|NCT05837455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83686799|NCT05837455|Hormone Antagonists|hormone antagonists|mesh-ancestor
83686800|NCT05837455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686801|NCT05837455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686802|NCT05837286|Cortisone|cortisone|mesh-list
83686803|NCT05837286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83686804|NCT05837091|Sodium Oxybate|sodium oxybate|mesh-list
83686805|NCT05837091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686806|NCT05837091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82841603|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
83686807|NCT05837091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83686808|NCT05837091|Anesthetics, General|anesthetics, general|mesh-ancestor
83686810|NCT05837091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686811|NCT05836857|Cannabidiol|cannabidiol|mesh-list
83686812|NCT05836857|Anticonvulsants|anticonvulsants|mesh-ancestor
83686813|NCT05836831|Tranexamic Acid|tranexamic acid|mesh-list
83686814|NCT05836831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83686815|NCT05836831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83686816|NCT05836831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686817|NCT05836831|Hemostatics|hemostatics|mesh-ancestor
83686818|NCT05836831|Coagulants|coagulants|mesh-ancestor
83686819|NCT05836753|Sarecycline|sarecycline|mesh-list
83686820|NCT05836753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686821|NCT05836753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686822|NCT05836753|Dermatologic Agents|dermatologic agents|mesh-ancestor
83686823|NCT05836545|Midazolam|midazolam|mesh-list
83686824|NCT05836545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83686825|NCT05836545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83686826|NCT05836545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686827|NCT05836545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686828|NCT05836545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83686829|NCT05836545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686830|NCT05836545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686831|NCT05836545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83686832|NCT05836545|Anesthetics, General|anesthetics, general|mesh-ancestor
83686833|NCT05836545|Anesthetics|anesthetics|mesh-ancestor
83686834|NCT05836545|GABA Modulators|gaba modulators|mesh-ancestor
83686835|NCT05836545|GABA Agents|gaba agents|mesh-ancestor
83686836|NCT05836545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686837|NCT05836545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686838|NCT05836441|Tacrolimus|tacrolimus|mesh-list
83686839|NCT05836441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686840|NCT05836441|Immunologic Factors|immunologic factors|mesh-ancestor
83686841|NCT05836441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686842|NCT05836441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83686843|NCT05836441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686844|NCT05836441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686845|NCT05836233|Vasodilator Agents|vasodilator agents|mesh-list
83686846|NCT05835999|Everolimus|everolimus|mesh-list
83686847|NCT05835999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83686848|NCT05835999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83686849|NCT05835999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686850|NCT05835999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686851|NCT05835999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83686852|NCT05835999|Immunologic Factors|immunologic factors|mesh-ancestor
83686853|NCT05835999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686854|NCT05835999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686855|NCT05835726|Daratumumab|daratumumab|mesh-list
83686856|NCT05835726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686857|NCT05834049|Midazolam|midazolam|mesh-list
83686858|NCT05834049|Anesthetics|anesthetics|mesh-ancestor
83686859|NCT05834049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686860|NCT05834049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686861|NCT05834049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83686862|NCT05834049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83686863|NCT05834049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83686864|NCT05834049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686865|NCT05834049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686866|NCT05834049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83686867|NCT05834049|Anesthetics, General|anesthetics, general|mesh-ancestor
83686868|NCT05834049|GABA Modulators|gaba modulators|mesh-ancestor
83686869|NCT05834049|GABA Agents|gaba agents|mesh-ancestor
83686870|NCT05834049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686871|NCT05834049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686872|NCT05833217|Insulin|insulin|mesh-list
83686873|NCT05833217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83686874|NCT05833217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686875|NCT05814744|Dexmedetomidine|dexmedetomidine|mesh-list
83686876|NCT05814744|Bupivacaine|bupivacaine|mesh-list
83686877|NCT05814744|Anesthetics, Local|anesthetics, local|mesh-ancestor
83686878|NCT05814744|Anesthetics|anesthetics|mesh-ancestor
83686879|NCT05814744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686880|NCT05814744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686881|NCT05814744|Sensory System Agents|sensory system agents|mesh-ancestor
83686882|NCT05814744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83686883|NCT05814744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83686884|NCT05814744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83686885|NCT05814744|Analgesics|analgesics|mesh-ancestor
83686886|NCT05814744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83686887|NCT05814744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83686888|NCT05814744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83686889|NCT05814744|Adrenergic Agents|adrenergic agents|mesh-ancestor
83686890|NCT05814744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686891|NCT05814744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686892|NCT05797558|Eplerenone|eplerenone|mesh-list
83686893|NCT05797558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83686894|NCT05797558|Mineralocorticoids|mineralocorticoids|mesh-list
83686895|NCT05797558|Hormone Antagonists|hormone antagonists|mesh-ancestor
83686896|NCT05797558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83686897|NCT05797558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686898|NCT05797558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83686899|NCT05797558|Diuretics|diuretics|mesh-ancestor
83686900|NCT05797558|Natriuretic Agents|natriuretic agents|mesh-ancestor
83686901|NCT05797558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83686902|NCT05797558|Hormones|hormones|mesh-ancestor
83686903|NCT05786820|Pycnogenols|pycnogenols|mesh-list
83686904|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83686905|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
83686906|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686907|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
83686908|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686909|NCT05786820|Protective Agents|protective agents|mesh-ancestor
83686910|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83686911|NCT05781308|Paclitaxel|paclitaxel|mesh-list
83686912|NCT05781308|Bevacizumab|bevacizumab|mesh-list
83686913|NCT05781308|Atezolizumab|atezolizumab|mesh-list
83686914|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83686915|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686916|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686917|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83686918|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686919|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686920|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686921|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83686922|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83686923|NCT05781308|Growth Substances|growth substances|mesh-ancestor
83686924|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686925|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
83686926|NCT05781308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83686927|NCT05772156|Methylergonovine|methylergonovine|mesh-list
83686928|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
83686929|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83686930|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686931|NCT05769868|Esmolol|esmolol|mesh-list
83686932|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83686933|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83686934|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83686935|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
83686936|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686937|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686938|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686939|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
83686940|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83686941|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686942|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83686943|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686944|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
83686945|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83686946|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83686947|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83686948|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
83686949|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686950|NCT05715229|Paclitaxel|paclitaxel|mesh-list
83686951|NCT05715229|Carboplatin|carboplatin|mesh-list
83686952|NCT05715229|Nivolumab|nivolumab|mesh-list
83686953|NCT05715229|Pemetrexed|pemetrexed|mesh-list
83686954|NCT05715229|Ipilimumab|ipilimumab|mesh-list
83686955|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83686956|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841750|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83686957|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
83686959|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
83686960|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686961|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83686962|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83686963|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686964|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83686965|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83686966|NCT05685615|Polymyxins|polymyxins|mesh-list
83686967|NCT05685615|Polymyxin B|polymyxin b|mesh-list
83686968|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686969|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686970|NCT05652764|Immunomodulating Agents|immunomodulating agents|mesh-list
83686971|NCT05652764|Immunologic Factors|immunologic factors|mesh-ancestor
83686972|NCT05652764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686973|NCT05650996|Calpastatin|calpastatin|mesh-list
83686974|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83686975|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
83686976|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686977|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686978|NCT05633147|Clarithromycin|clarithromycin|mesh-list
83686979|NCT05633147|Midazolam|midazolam|mesh-list
83686980|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83686981|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83686982|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83686983|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83686984|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83686985|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83686986|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83686987|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83686988|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
83686989|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
83686990|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
83686991|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
83686992|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83686993|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83686994|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83686995|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83686996|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83686997|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83686998|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83686999|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83687000|NCT05610085|Levetiracetam|levetiracetam|mesh-list
83687001|NCT05610085|Phenobarbital|phenobarbital|mesh-list
83687002|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
83687003|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
83687004|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83687005|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687006|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687007|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83687008|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83687009|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687010|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687011|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
83687012|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
83687013|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83687014|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83687015|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83687016|NCT05597254|Niacin|niacin|mesh-list
83687017|NCT05597254|Niacinamide|niacinamide|mesh-list
83687018|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
83687019|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83687020|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
83687021|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687022|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83687023|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
83687024|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
83687025|NCT05597254|Vitamins|vitamins|mesh-ancestor
83687026|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
83687027|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687028|NCT05576415|Varenicline|varenicline|mesh-list
83687029|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83687030|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83687031|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
83687032|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687033|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687034|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687035|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
83687036|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
83687037|NCT05395052|Nivolumab|nivolumab|mesh-list
83687038|NCT05395052|Trastuzumab|trastuzumab|mesh-list
83687039|NCT05395052|Fludarabine|fludarabine|mesh-list
83687040|NCT05395052|Cetuximab|cetuximab|mesh-list
83687041|NCT05395052|Atezolizumab|atezolizumab|mesh-list
83687042|NCT05395052|Interleukin-2|interleukin-2|mesh-list
83687043|NCT05395052|Avelumab|avelumab|mesh-list
83687044|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83687045|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687046|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
83687047|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687048|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687049|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83687050|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
83687051|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687052|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687053|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83687054|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687055|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687056|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83687057|NCT05395052|Analgesics|analgesics|mesh-ancestor
83687058|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
83687059|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687060|NCT05324761|Pregabalin|pregabalin|mesh-list
83687061|NCT05324761|Gabapentin|gabapentin|mesh-list
83687062|NCT05324761|Analgesics|analgesics|mesh-ancestor
83687063|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
83687064|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687065|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687066|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
83687067|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83687068|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83687069|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687070|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83687071|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83687072|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83687073|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687074|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83687075|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83687076|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83687077|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687078|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
83687079|NCT05317403|Cytarabine|cytarabine|mesh-list
83687080|NCT05317403|Fludarabine|fludarabine|mesh-list
83687081|NCT05317403|Venetoclax|venetoclax|mesh-list
83687082|NCT05317403|Vorinostat|vorinostat|mesh-list
83687083|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687084|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687085|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
83687086|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687087|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687088|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
83687089|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687090|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
83687091|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687092|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83687093|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687094|NCT05312242|Folic Acid|folic acid|mesh-list
83687095|NCT05312242|Micronutrients|micronutrients|mesh-list
83687096|NCT05312242|Trace Elements|trace elements|mesh-list
83687097|NCT05312242|Hematinics|hematinics|mesh-ancestor
83687098|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
83687099|NCT05312242|Vitamins|vitamins|mesh-ancestor
83687100|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687101|NCT05300048|Paclitaxel|paclitaxel|mesh-list
83687102|NCT05300048|Serabelisib|serabelisib|mesh-list
83687103|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83687104|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687105|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
83687106|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
83687107|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
83687108|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687109|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687110|NCT05288829|Ravulizumab|ravulizumab|mesh-list
83687111|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83687112|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687113|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
83687114|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687116|NCT05233566|Analgesics|analgesics|mesh-ancestor
83687117|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
83687118|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687119|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687120|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83687121|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83687122|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
83687123|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
83687124|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687125|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83687126|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83687127|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687128|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687129|NCT05232344|Estradiol|estradiol|mesh-list
83687130|NCT05232344|Progesterone|progesterone|mesh-list
83687131|NCT05232344|Estrogens|estrogens|mesh-ancestor
83687132|NCT05232344|Hormones|hormones|mesh-ancestor
83687133|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687134|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687135|NCT05232344|Progestins|progestins|mesh-ancestor
83687136|NCT05210517|Empagliflozin|empagliflozin|mesh-list
83687137|NCT05210517|Benzbromarone|benzbromarone|mesh-list
83687138|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83687139|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687140|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83687141|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687142|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
83687143|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
83687144|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687145|NCT05180994|Infliximab|infliximab|mesh-list
83687146|NCT05180994|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83687147|NCT05180994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83687148|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
83687149|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83687150|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687151|NCT05132699|Cannabidiol|cannabidiol|mesh-list
83687152|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83687153|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
83687154|NCT05118685|Estrogens|estrogens|mesh-list
83687155|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83687156|NCT05118685|Hormones|hormones|mesh-ancestor
83687157|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687158|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687159|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83687160|NCT05109650|Antibodies|antibodies|mesh-list
83687161|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
83687162|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
83687163|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687164|NCT05108259|Adalimumab|adalimumab|mesh-list
83687165|NCT05108259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83687166|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83687167|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687168|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
83687169|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687170|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687171|NCT05082610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687172|NCT05082610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687173|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
83687174|NCT05069935|Fludarabine|fludarabine|mesh-list
83687175|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83687176|NCT05069935|Antibodies|antibodies|mesh-list
83687177|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
83687178|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83687179|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687180|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
83687181|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687182|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687183|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83687184|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
83687185|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687186|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687187|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83687188|NCT05040217|Mitogens|mitogens|mesh-list
83687189|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83687190|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687191|NCT05032118|Ketamine|ketamine|mesh-list
83687192|NCT05032118|Propofol|propofol|mesh-list
83687193|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83687194|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687195|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687196|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83687197|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
83687198|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
83687199|NCT05032118|Analgesics|analgesics|mesh-ancestor
83687200|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
83687201|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687202|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83687203|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83687204|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83687205|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687206|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687207|NCT04977908|Insulin|insulin|mesh-list
83687208|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83687209|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687210|NCT04954599|Carboplatin|carboplatin|mesh-list
83687211|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
83687212|NCT04954599|Nivolumab|nivolumab|mesh-list
83687213|NCT04954599|Ipilimumab|ipilimumab|mesh-list
83687214|NCT04954599|Atezolizumab|atezolizumab|mesh-list
83687215|NCT04954599|Durvalumab|durvalumab|mesh-list
83687216|NCT04954599|Avelumab|avelumab|mesh-list
83687217|NCT04954599|Cemiplimab|cemiplimab|mesh-list
83687218|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83687219|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687220|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687221|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687222|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
83687223|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687224|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687225|NCT04896697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687226|NCT04896697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687227|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
83687228|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
83687229|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687230|NCT04862234|Dulaglutide|dulaglutide|mesh-list
83687231|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83687232|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687233|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
83687234|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
83687235|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687236|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
83687237|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687238|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
83687239|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83687240|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
83687241|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687242|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
83687243|NCT04614636|Fludarabine|fludarabine|mesh-list
83687244|NCT04614636|Daratumumab|daratumumab|mesh-list
83687245|NCT04614636|Elotuzumab|elotuzumab|mesh-list
83687246|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687247|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
83687248|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687249|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687250|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83687251|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
83687252|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687253|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687254|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83687255|NCT04573920|Atrasentan|atrasentan|mesh-list
83687256|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687257|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83687258|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83687259|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687260|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
83687261|NCT04505878|Vitamins|vitamins|mesh-ancestor
83687262|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
83687263|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687264|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
83687265|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687266|NCT04505878|Protective Agents|protective agents|mesh-ancestor
83687267|NCT04505189|Psilocybin|psilocybin|mesh-list
83687268|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
83687269|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687270|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83687271|NCT04404881|Bevacizumab|bevacizumab|mesh-list
83687272|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687273|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687274|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83687275|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83687276|NCT04404881|Growth Substances|growth substances|mesh-ancestor
83687277|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687278|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
83687279|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
83687280|NCT04370509|Axitinib|axitinib|mesh-list
83687281|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687282|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687283|NCT04370509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687284|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687285|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687286|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687288|NCT04335058|Lactoferrin|lactoferrin|mesh-list
83687289|NCT04335058|Trace Elements|trace elements|mesh-ancestor
83687290|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
83687291|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687292|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687293|NCT04319224|Nivolumab|nivolumab|mesh-list
83687294|NCT04319224|Ipilimumab|ipilimumab|mesh-list
83687295|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687296|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687297|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687298|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687299|NCT04280562|Acetaminophen|acetaminophen|mesh-list
83687300|NCT04280562|Analgesics|analgesics|mesh-list
83687301|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83687302|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
83687303|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687304|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687305|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
83687306|NCT04257448|Paclitaxel|paclitaxel|mesh-list
83687307|NCT04257448|Gemcitabine|gemcitabine|mesh-list
83687308|NCT04257448|Lenalidomide|lenalidomide|mesh-list
83687309|NCT04257448|Azacitidine|azacitidine|mesh-list
83687310|NCT04257448|Durvalumab|durvalumab|mesh-list
83687311|NCT04257448|Romidepsin|romidepsin|mesh-list
83687312|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83687313|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687314|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
83687315|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
83687316|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83687317|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687318|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687319|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
83687320|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
83687321|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687322|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83687323|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83687324|NCT04257448|Growth Substances|growth substances|mesh-ancestor
83687325|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
83687326|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687327|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687328|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83687329|NCT04257448|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83687330|NCT04256317|Azacitidine|azacitidine|mesh-list
83687331|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687332|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
83687333|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687334|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842132|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
83687335|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687336|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83687337|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687338|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83687339|NCT04075136|Triamcinolone|triamcinolone|mesh-list
83687340|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83687341|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83687342|NCT04075136|Ranibizumab|ranibizumab|mesh-list
83687343|NCT04075136|Verteporfin|verteporfin|mesh-list
83687344|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83687345|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83687346|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83687347|NCT04075136|Growth Substances|growth substances|mesh-ancestor
83687348|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687349|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
83687350|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687351|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83687352|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
83687354|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687355|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687356|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
83687357|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687358|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687359|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83687360|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
83687361|NCT04024436|Fulvestrant|fulvestrant|mesh-list
83687362|NCT04024436|Futibatinib|futibatinib|mesh-list
83687363|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83687364|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687365|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83687366|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83687367|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
83687368|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687369|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687370|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
83687371|NCT03959566|Bedaquiline|bedaquiline|mesh-list
83687372|NCT03959566|Midazolam|midazolam|mesh-list
83687373|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83687374|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83687375|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687376|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687377|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83687378|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83687379|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83687380|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83687381|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
83687382|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
83687383|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
83687384|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
83687385|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687386|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687387|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687388|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687389|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83687390|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83687391|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687392|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687393|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
83687394|NCT03909529|Digoxin|digoxin|mesh-list
83687395|NCT03909529|Spironolactone|spironolactone|mesh-list
83687396|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83687397|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
83687398|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687399|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687400|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83687401|NCT03909529|Diuretics|diuretics|mesh-ancestor
83687402|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
83687403|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83687404|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83687405|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687406|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687407|NCT03909529|Protective Agents|protective agents|mesh-ancestor
83687408|NCT03875755|Inositol|inositol|mesh-list
83687409|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
83687410|NCT03875755|Vitamins|vitamins|mesh-ancestor
83687411|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
83687412|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687413|NCT03752684|Calcium|calcium|mesh-list
83687414|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83687415|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687416|NCT03677154|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83687417|NCT03677154|Immunoconjugates|immunoconjugates|mesh-ancestor
83687418|NCT03677154|Immunologic Factors|immunologic factors|mesh-ancestor
83687419|NCT03677154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687420|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
83687421|NCT03519997|Bavituximab|bavituximab|mesh-list
83687422|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687423|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687424|NCT03519997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687425|NCT03519997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687426|NCT03380546|Insulin|insulin|mesh-list
83687427|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83687428|NCT03380546|Acarbose|acarbose|mesh-list
83687429|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
83687430|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83687431|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687432|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83687433|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687434|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687435|NCT03318094|Nitroprusside|nitroprusside|mesh-list
83687436|NCT03318094|Phentolamine|phentolamine|mesh-list
83687437|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83687438|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
83687439|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83687440|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
83687441|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83687442|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687443|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83687444|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687445|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687446|NCT03268499|Cisplatin|cisplatin|mesh-list
83687447|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687448|NCT03250624|Ivermectin|ivermectin|mesh-list
83687449|NCT03250624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83687450|NCT03250624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687451|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
83687452|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83687453|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83687454|NCT03190915|Trametinib|trametinib|mesh-list
83687455|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687456|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687457|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687458|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687459|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83687460|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83687461|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687462|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83687463|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83687464|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83687465|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687466|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
83687467|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687468|NCT03122717|Gefitinib|gefitinib|mesh-list
83687469|NCT03122717|Osimertinib|osimertinib|mesh-list
83687470|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687471|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687472|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687473|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687474|NCT03069326|Thalidomide|thalidomide|mesh-list
83687475|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687476|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
83687477|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687478|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
83687479|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687480|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687481|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83687482|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83687483|NCT03069326|Growth Substances|growth substances|mesh-ancestor
83687484|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
83687485|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687486|NCT03015740|Nivolumab|nivolumab|mesh-list
83687487|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82842273|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687488|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687489|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687490|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687491|NCT02953457|Durvalumab|durvalumab|mesh-list
83687492|NCT02953457|Ipilimumab|ipilimumab|mesh-list
83687493|NCT02953457|Olaparib|olaparib|mesh-list
83687494|NCT02953457|Tremelimumab|tremelimumab|mesh-list
83687495|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83687496|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
83687497|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83687498|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
83687499|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687500|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687501|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
83687502|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687503|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687504|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687505|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687506|NCT02881242|Trametinib|trametinib|mesh-list
83687507|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687508|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687509|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687510|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687511|NCT02861417|Vidarabine|vidarabine|mesh-list
83687512|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
83687513|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
83687514|NCT02861417|Busulfan|busulfan|mesh-list
83687515|NCT02861417|Thiotepa|thiotepa|mesh-list
83687516|NCT02861417|Fludarabine|fludarabine|mesh-list
83687517|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
83687518|NCT02861417|Tacrolimus|tacrolimus|mesh-list
83687519|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687520|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
83687521|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687522|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687523|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83687524|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
83687525|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687526|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687527|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83687528|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687529|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
83687530|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
83687531|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687532|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83687533|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687534|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83687535|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83687536|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
83687537|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687538|NCT02720068|Leucovorin|leucovorin|mesh-list
83687539|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
83687540|NCT02720068|Fluorouracil|fluorouracil|mesh-list
83687541|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
83687542|NCT02720068|Irinotecan|irinotecan|mesh-list
83687543|NCT02720068|Lenvatinib|lenvatinib|mesh-list
83687544|NCT02720068|Calcium|calcium|mesh-list
83687545|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
83687546|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687547|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687548|NCT02720068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687549|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687550|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83687551|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687552|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
83687553|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687554|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687555|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
83687556|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83687557|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83687558|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687559|NCT02720068|Antidotes|antidotes|mesh-ancestor
83687560|NCT02720068|Protective Agents|protective agents|mesh-ancestor
83687561|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
83687562|NCT02720068|Vitamins|vitamins|mesh-ancestor
83687563|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
82842349|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83687564|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687566|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
83687567|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687568|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687569|NCT02638519|Xenon|xenon|mesh-list
83687570|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83687571|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
83687572|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
83687573|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687574|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687575|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
83687576|NCT02615184|Lansoprazole|lansoprazole|mesh-list
83687577|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83687578|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83687579|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83687580|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687581|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687582|NCT02563002|Bevacizumab|bevacizumab|mesh-list
83687583|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
83687584|NCT02563002|Cetuximab|cetuximab|mesh-list
83687585|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687586|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687587|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83687588|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83687589|NCT02563002|Growth Substances|growth substances|mesh-ancestor
83687590|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687591|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
83687592|NCT02563002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687593|NCT02563002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687594|NCT02408549|Lacosamide|lacosamide|mesh-list
83687595|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
83687596|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83687597|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83687598|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83687599|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687600|NCT02376699|Paclitaxel|paclitaxel|mesh-list
83687601|NCT02376699|Gemcitabine|gemcitabine|mesh-list
83687602|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
83687603|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83687604|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687605|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
83687606|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
83687607|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
83687608|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687609|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687610|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
83687611|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687612|NCT02376699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687613|NCT02141542|Tremelimumab|tremelimumab|mesh-list
83687614|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687615|NCT01930955|Amoxicillin|amoxicillin|mesh-list
83687616|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687617|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687618|NCT01458327|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83687619|NCT01458327|Hallucinogens|hallucinogens|mesh-ancestor
83687620|NCT01458327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687621|NCT01458327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83687622|NCT01458327|Serotonin Agents|serotonin agents|mesh-ancestor
83687623|NCT01458327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687624|NCT01458327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687625|NCT01458327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83687626|NCT01458327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83687627|NCT01458327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83687628|NCT01458327|Adrenergic Agents|adrenergic agents|mesh-ancestor
83687629|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
83687630|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
83687631|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83687632|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82842425|NCT01587430|Analgesics|analgesics|mesh-ancestor
82842426|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
82842427|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842428|NCT03874000|Metformin|metformin|mesh-list
82842429|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83687633|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687634|NCT01241708|Bortezomib|bortezomib|mesh-list
83687635|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687636|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83687637|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687638|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687639|NCT02098512|Immunotoxins|immunotoxins|mesh-ancestor
83687640|NCT02098512|Immunoconjugates|immunoconjugates|mesh-ancestor
83687641|NCT02098512|Immunologic Factors|immunologic factors|mesh-ancestor
83687642|NCT02098512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687643|NCT02066636|Nivolumab|nivolumab|mesh-list
83687644|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687645|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687646|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83687647|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687648|NCT02036086|Vemurafenib|vemurafenib|mesh-list
83687649|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687650|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687651|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687652|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687653|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
83687654|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83687655|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83687656|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83687657|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83687658|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687659|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
83687660|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687661|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687662|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83687663|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687664|NCT01299480|Vaccines|vaccines|mesh-list
83687665|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
83687666|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687667|NCT01681446|Interferons|interferons|mesh-list
83687668|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
83687669|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687670|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
83687671|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687672|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
83687673|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687674|NCT01681875|Nicotine|nicotine|mesh-list
83687675|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83687676|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
83687677|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687678|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687679|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83687680|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83687681|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
83687682|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687683|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687684|NCT01682577|Perindopril|perindopril|mesh-list
83687685|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83687686|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
83687687|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687688|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687689|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83687690|NCT01683760|Fluconazole|fluconazole|mesh-list
83687691|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
83687692|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687693|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83687694|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83687695|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687696|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687697|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83687698|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
83687699|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687700|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687701|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83687702|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83687703|NCT01684813|Clopidogrel|clopidogrel|mesh-list
83687704|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83687705|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82842495|NCT03971604|Protective Agents|protective agents|mesh-ancestor
82842496|NCT02531490|Labetalol|labetalol|mesh-list
83687706|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83687707|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83687708|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83687709|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
83687710|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687711|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687712|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687713|NCT01684982|Sirolimus|sirolimus|mesh-list
83687714|NCT01684982|Everolimus|everolimus|mesh-list
83687715|NCT01684982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83687716|NCT01684982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83687717|NCT01684982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687718|NCT01684982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687719|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687720|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
83687721|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687722|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687723|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687724|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687725|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83687726|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
83687727|NCT01685034|Immunomodulating Agents|immunomodulating agents|mesh-list
83687728|NCT01685034|Immunologic Factors|immunologic factors|mesh-ancestor
83687729|NCT01685034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687730|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
83687731|NCT01685489|Docetaxel|docetaxel|mesh-list
83687732|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687733|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83687734|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83687735|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83687736|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687737|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83687738|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
83687739|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687740|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83687741|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
83687742|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687743|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
83687744|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83687745|NCT01685489|Protective Agents|protective agents|mesh-ancestor
83687746|NCT01686386|Dexamethasone|dexamethasone|mesh-list
83687747|NCT01686386|Lenalidomide|lenalidomide|mesh-list
83687748|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83687749|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83687750|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
83687751|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
83687752|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687753|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687754|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83687755|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
83687756|NCT01686386|Hormones|hormones|mesh-ancestor
83687757|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687758|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83687759|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687760|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
83687761|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83687762|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83687763|NCT01686386|Growth Substances|growth substances|mesh-ancestor
83687764|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
83687765|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83687766|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
83687767|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687768|NCT01686594|Methoxsalen|methoxsalen|mesh-list
83687769|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83687770|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
83687771|NCT01687517|Vaccines|vaccines|mesh-list
83687772|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
83687773|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687774|NCT01687751|Midazolam|midazolam|mesh-list
83687775|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
83687776|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83687777|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687778|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687779|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82842575|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
83687780|NCT01687751|Analgesics|analgesics|mesh-ancestor
83687781|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
83687782|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687783|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83687784|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83687785|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83687786|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
83687787|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687788|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687789|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83687790|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83687791|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83687792|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83687793|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83687794|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
83687795|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
83687796|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
83687797|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
83687798|NCT01688362|Dexamethasone|dexamethasone|mesh-list
83687799|NCT01688362|Bupivacaine|bupivacaine|mesh-list
83687800|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83687801|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
83687802|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
83687803|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687804|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687805|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83687806|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
83687807|NCT01688362|Hormones|hormones|mesh-ancestor
83687808|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687809|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83687810|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687811|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
83687812|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
83687813|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687814|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
83687815|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83687816|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83687817|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834863|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834864|NCT00133185|Losartan|losartan|mesh-list
83834865|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83834866|NCT00133185|Telmisartan|telmisartan|mesh-list
83834867|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83834868|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83834869|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83834870|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83834871|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834872|NCT00133185|Diuretics|diuretics|mesh-ancestor
83834873|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
83834874|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834875|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83834876|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83834877|NCT00135603|Amoxicillin|amoxicillin|mesh-list
83834878|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
83834879|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
83834880|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83834881|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834882|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834883|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83834884|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834885|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842645|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
82842646|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
82842647|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82842648|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82842649|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842650|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842651|NCT03971370|Vaccines|vaccines|mesh-list
82842652|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
82842653|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842654|NCT01168336|Betahistine|betahistine|mesh-list
82842655|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
83834886|NCT00133224|Prednisone|prednisone|mesh-list
83834887|NCT00133224|Docetaxel|docetaxel|mesh-list
82842656|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
83687818|NCT01689753|Citric Acid|citric acid|mesh-list
83687819|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
83687820|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
83687821|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83687822|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
83687823|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
83687824|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687825|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
83687826|NCT01690039|Furosemide|furosemide|mesh-list
83687827|NCT01690039|Diuretics|diuretics|mesh-ancestor
83687828|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
83687829|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687830|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83687831|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83687832|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687833|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83687834|NCT01690091|Metformin|metformin|mesh-list
83687835|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83687836|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687837|NCT01690104|Rifampin|rifampin|mesh-list
83687838|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83687839|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
83687840|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687841|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687842|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
83687843|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83687844|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687845|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687846|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83687847|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83687848|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83687849|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83687850|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83687851|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83687852|NCT01690221|Diltiazem|diltiazem|mesh-list
83687853|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83687854|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83687855|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83687856|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687857|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83687858|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687859|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
83687860|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83687861|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
83687862|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687863|NCT01690286|Ketoconazole|ketoconazole|mesh-list
83687864|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
83687865|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687866|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83687867|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83687868|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687869|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687870|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83687871|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
83687872|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83687873|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687874|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83687875|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
83687876|NCT01690325|Bevacizumab|bevacizumab|mesh-list
83687877|NCT01690325|Docetaxel|docetaxel|mesh-list
83687878|NCT01690325|Trastuzumab|trastuzumab|mesh-list
83687879|NCT01690325|Epirubicin|epirubicin|mesh-list
83687880|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687881|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
82842708|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842709|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
82842710|NCT01166542|Paclitaxel|paclitaxel|mesh-list
82842711|NCT01166542|Carboplatin|carboplatin|mesh-list
82842712|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82842713|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842714|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
82842715|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
82842716|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
82842718|NCT00169104|Trastuzumab|trastuzumab|mesh-list
83687882|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687883|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83687884|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83687885|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
83687886|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687887|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687888|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83687889|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83687890|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83687891|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83687892|NCT01690325|Growth Substances|growth substances|mesh-ancestor
83687893|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
83687894|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
83687895|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
83687896|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
83687897|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83687898|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83687899|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83687900|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687902|NCT01690338|Rocuronium|rocuronium|mesh-list
83687903|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
83687904|NCT01690338|Cisatracurium|cisatracurium|mesh-list
83687905|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
83687906|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83687907|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83687908|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83687909|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687910|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687911|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83687912|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83687913|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
83687914|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687915|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687916|NCT01690364|Anesthetics|anesthetics|mesh-list
83687917|NCT01690364|Cisatracurium|cisatracurium|mesh-list
83687918|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
83687919|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83687920|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687921|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83687922|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83687923|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83687924|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83687925|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83687926|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83687927|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
83687928|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83687929|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687930|NCT01690403|Rifapentine|rifapentine|mesh-list
83687931|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83687932|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
83687933|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687934|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687935|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
83687936|NCT01690468|Carboplatin|carboplatin|mesh-list
83687937|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687938|NCT01690507|Cytarabine|cytarabine|mesh-list
83687939|NCT01690507|Decitabine|decitabine|mesh-list
83687940|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
83687941|NCT01690507|Lenograstim|lenograstim|mesh-list
83687942|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687943|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
83687944|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687945|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687946|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
83687947|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687948|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83687949|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
83687950|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842774|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82842775|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
82842776|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842777|NCT03873532|Capecitabine|capecitabine|mesh-list
82842778|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83687951|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687952|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83687953|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83687954|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
83687955|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83687956|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687957|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687958|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83687959|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83687960|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687961|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687962|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687963|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83687964|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
83687965|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83687966|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687967|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83687968|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83687969|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83687970|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
83687971|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83687972|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83687973|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83687974|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83687975|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687976|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687977|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687978|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83687979|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83687980|NCT01690572|Paclitaxel|paclitaxel|mesh-list
83687981|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
83687982|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83687983|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83687984|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
83687985|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
83687986|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
83687987|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687988|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83687989|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
83687990|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83687991|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
83687992|NCT01690572|Protective Agents|protective agents|mesh-ancestor
83687993|NCT01690598|Topotecan|topotecan|mesh-list
83687994|NCT01690598|Veliparib|veliparib|mesh-list
83687995|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83687996|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83687997|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83687998|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83687999|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688000|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83688001|NCT01690637|Oseltamivir|oseltamivir|mesh-list
83688002|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
83688003|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688004|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688005|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688006|NCT01690702|Paclitaxel|paclitaxel|mesh-list
83688007|NCT01690702|Docetaxel|docetaxel|mesh-list
83688008|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
83688009|NCT01690702|Epirubicin|epirubicin|mesh-list
83688010|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83688011|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688012|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
83688013|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
83688014|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
83688015|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688016|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688017|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
83688018|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688019|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688020|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83688021|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
82842844|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688022|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83688023|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83688024|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83688025|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83688026|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688027|NCT01690767|Lidocaine|lidocaine|mesh-list
83688028|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
83688029|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
83688030|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688031|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688032|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
83688033|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688034|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83688035|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83688036|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83688037|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83688038|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688039|NCT01690780|Ibuprofen|ibuprofen|mesh-list
83688040|NCT01690780|Morphine|morphine|mesh-list
83688041|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83688042|NCT01690780|Narcotics|narcotics|mesh-ancestor
83688043|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688044|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688045|NCT01690780|Analgesics|analgesics|mesh-ancestor
83688046|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
83688047|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688048|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83688049|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688050|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688051|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688052|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83688053|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688054|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688055|NCT01690832|Fenoldopam|fenoldopam|mesh-list
83688056|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83688057|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
83688058|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
83688059|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
83688060|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688061|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688062|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688063|NCT01690871|Dactolisib|dactolisib|mesh-list
83688064|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688065|NCT01690884|Adenosine|adenosine|mesh-list
83688066|NCT01690884|Analgesics|analgesics|mesh-ancestor
83688067|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
83688068|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688069|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688070|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83688071|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
83688072|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83688073|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
83688074|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
83688075|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688076|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688077|NCT01690962|Vitamins|vitamins|mesh-list
83688078|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
83688079|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
83688080|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
83688081|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
83688082|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688083|NCT01690962|Hematinics|hematinics|mesh-ancestor
83688084|NCT01690975|Benzonatate|benzonatate|mesh-list
83688085|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
83688086|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688087|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
83688088|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83688089|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688090|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688091|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688092|NCT01691001|Analgesics|analgesics|mesh-ancestor
83688093|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
83688094|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688095|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83688096|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83688097|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82842916|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83688098|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
83688099|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688100|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688101|NCT01691053|Spironolactone|spironolactone|mesh-list
83688102|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83688103|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83688104|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688105|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688106|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83688107|NCT01691053|Diuretics|diuretics|mesh-ancestor
83688108|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
83688109|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
83688110|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
83688111|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688112|NCT01691365|Vitamins|vitamins|mesh-list
83688113|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
83688114|NCT01691365|Antioxidants|antioxidants|mesh-list
83688115|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
83688116|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688117|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688118|NCT01691365|Protective Agents|protective agents|mesh-ancestor
83688119|NCT01691404|Quercetin|quercetin|mesh-list
83688120|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
83688121|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688122|NCT01691404|Protective Agents|protective agents|mesh-ancestor
83688123|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688124|NCT01691456|Montelukast|montelukast|mesh-list
83688125|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83688126|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688127|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83688128|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
83688129|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688130|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688131|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83688132|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83688133|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688134|NCT01691469|Montelukast|montelukast|mesh-list
83688135|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83688136|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688137|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83688138|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
83688139|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688140|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688141|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83688142|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83688143|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688145|NCT01691495|Fondaparinux|fondaparinux|mesh-list
83688146|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83688147|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
83688148|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83688149|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
83688150|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688151|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688152|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
83688153|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83688154|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83688155|NCT01691625|Immunomodulating Agents|immunomodulating agents|mesh-list
83688156|NCT01691625|Immunologic Factors|immunologic factors|mesh-ancestor
83688157|NCT01691625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688158|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
83688159|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83688160|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83688161|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82842991|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
82842992|NCT01284946|Deferasirox|deferasirox|mesh-list
82842993|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82842994|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
82842995|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
82842996|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688162|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82842997|NCT01173562|Mebendazole|mebendazole|mesh-list
82842998|NCT01173562|Piperazine|piperazine|mesh-list
83688163|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688164|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
83688165|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688166|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688167|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83688168|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688170|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688171|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
83688172|NCT01691677|Hormones|hormones|mesh-ancestor
83688173|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688174|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688175|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83688176|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688177|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83688178|NCT01691742|Laxatives|laxatives|mesh-list
83688179|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83688180|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83688181|NCT01691807|Ofatumumab|ofatumumab|mesh-list
83688182|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83688183|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
83688184|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688185|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688186|NCT01691872|Ezogabine|ezogabine|mesh-list
83688187|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
83688188|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83688189|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688190|NCT01691937|Sufentanil|sufentanil|mesh-list
83688191|NCT01691937|Ropivacaine|ropivacaine|mesh-list
83688192|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
83688193|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
83688194|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688195|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688196|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
83688197|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688198|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83688199|NCT01691937|Narcotics|narcotics|mesh-ancestor
83688200|NCT01691937|Analgesics|analgesics|mesh-ancestor
83688201|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83688202|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83688203|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
83688204|NCT01691976|Estrogens|estrogens|mesh-list
83688205|NCT01691976|Hormones|hormones|mesh-ancestor
83688206|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688207|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688208|NCT01692132|Prucalopride|prucalopride|mesh-list
83688209|NCT01692132|Laxatives|laxatives|mesh-ancestor
83688210|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83688211|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83688212|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83688213|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
83688214|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688215|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688216|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688217|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
83688218|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83688219|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688220|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688221|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688222|NCT01692210|Analgesics|analgesics|mesh-ancestor
83688223|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
83688224|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688225|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83688226|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83688227|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83688228|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
83688229|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688230|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688231|NCT01692457|Golimumab|golimumab|mesh-list
83688232|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83688233|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688234|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688235|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
82843059|NCT01164046|Vitamin K|vitamin k|mesh-list
83688236|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688237|NCT01692483|Prednisone|prednisone|mesh-list
83688238|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
83688239|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688240|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
83688241|NCT01692483|Hormones|hormones|mesh-ancestor
83688242|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688243|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688244|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83688245|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688246|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83688247|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688248|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688249|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
83688250|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83688251|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83688252|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83688253|NCT01692678|Dacarbazine|dacarbazine|mesh-list
83688254|NCT01692678|Trabectedin|trabectedin|mesh-list
83688255|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83688256|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
83688257|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688258|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688259|NCT01692704|Gemcitabine|gemcitabine|mesh-list
83688260|NCT01692704|Floxuridine|floxuridine|mesh-list
83688261|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688262|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688263|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
83688264|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688265|NCT01692808|Vitamin D|vitamin d|mesh-list
83688266|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
83688267|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
83688268|NCT01692808|Vitamins|vitamins|mesh-list
83688269|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
83688270|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688271|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83688272|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83688273|NCT01692834|Cyclosporine|cyclosporine|mesh-list
83688274|NCT01692834|Cyclosporins|cyclosporins|mesh-list
83688275|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688276|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688277|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688278|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
83688279|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688280|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
83688281|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688282|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83688283|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688284|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83688285|NCT01692886|Vaccines|vaccines|mesh-list
83688286|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83688287|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
83688288|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688289|NCT01692925|Factor VIII|factor viii|mesh-list
83688290|NCT01692925|Coagulants|coagulants|mesh-ancestor
83688291|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
83688292|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83688293|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
83688294|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688295|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688296|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83688297|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688298|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
83688299|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83688300|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
83688301|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688302|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688303|NCT01693081|Apomorphine|apomorphine|mesh-list
83688304|NCT01693081|Emetics|emetics|mesh-ancestor
83688305|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688306|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
83688307|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688308|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83688309|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
82843153|NCT02526394|Vaccines|vaccines|mesh-list
83688310|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
83688311|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688312|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688313|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
83688314|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
83688315|NCT01693159|Coagulants|coagulants|mesh-ancestor
83688316|NCT01693276|Paclitaxel|paclitaxel|mesh-list
83688317|NCT01693276|Gemcitabine|gemcitabine|mesh-list
83688318|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83688319|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83688320|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688321|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
83688322|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
83688323|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
83688324|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688325|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688326|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
83688327|NCT01693289|Metformin|metformin|mesh-list
83688328|NCT01693289|Letrozole|letrozole|mesh-list
83688329|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83688330|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688331|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688332|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83688333|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83688334|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688335|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688336|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83688337|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
83688338|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688339|NCT01693302|Insulin|insulin|mesh-list
83688340|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83688341|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83688342|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688343|NCT01693328|Fentanyl|fentanyl|mesh-list
83688344|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83688345|NCT01693328|Narcotics|narcotics|mesh-ancestor
83688346|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688347|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688348|NCT01693328|Analgesics|analgesics|mesh-ancestor
83688349|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
83688350|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688351|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83688352|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83688353|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
83688354|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
83688355|NCT01693393|Cyclosporine|cyclosporine|mesh-list
83688356|NCT01693393|Cyclosporins|cyclosporins|mesh-list
83688357|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688358|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688359|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688360|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
83688361|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688362|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
83688363|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688364|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83688365|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688366|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83688367|NCT01693419|Gemcitabine|gemcitabine|mesh-list
83688368|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83688369|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688370|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
83688371|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688372|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688373|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83688374|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688375|NCT01693432|Docetaxel|docetaxel|mesh-list
83688376|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688377|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83688378|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83688379|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83688380|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688381|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
83688382|NCT01693445|Irinotecan|irinotecan|mesh-list
82843210|NCT01172002|Leflunomide|leflunomide|mesh-list
82843211|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
82843213|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688383|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688384|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83688385|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83688386|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688387|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688388|NCT01693601|Panobinostat|panobinostat|mesh-list
83688389|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688390|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83688391|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688392|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688393|NCT01693640|Abatacept|abatacept|mesh-list
83688394|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83688395|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688396|NCT01693640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83688397|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688398|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688399|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
83688400|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688401|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688402|NCT01693679|Lamivudine|lamivudine|mesh-list
83688403|NCT01693679|Adefovir|adefovir|mesh-list
83688404|NCT01693679|Telbivudine|telbivudine|mesh-list
83688405|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83688406|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83688407|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688408|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688409|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
83688410|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688411|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83688412|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83688413|NCT01693718|Fluorouracil|fluorouracil|mesh-list
83688414|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
83688415|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688416|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
83688417|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688418|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688419|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688420|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
83688421|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688422|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
83688423|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688424|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83688425|NCT01693809|Caffeine|caffeine|mesh-list
83688426|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83688427|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688428|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83688429|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688430|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688431|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83688432|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83688433|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
83688434|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688435|NCT01693822|Axitinib|axitinib|mesh-list
83688436|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688437|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83688438|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688439|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688440|NCT01694017|Tenofovir|tenofovir|mesh-list
83688441|NCT01694017|Zidovudine|zidovudine|mesh-list
83688442|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
83688443|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688444|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83688445|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83688446|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688447|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688448|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83688449|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83688450|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
83688451|NCT05288816|Ravulizumab|ravulizumab|mesh-list
83688452|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83688453|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688454|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
83688455|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688456|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
83688457|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83688458|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688459|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688460|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688461|NCT05288738|Analgesics|analgesics|mesh-ancestor
83688462|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
83688463|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688464|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83688465|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83688466|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83688467|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
83688468|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688469|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688470|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83688471|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688472|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
83688474|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688475|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688476|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688477|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
83688478|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
83688479|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83688480|NCT05288465|Protective Agents|protective agents|mesh-ancestor
83688481|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688482|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
83688483|NCT05288374|Celecoxib|celecoxib|mesh-list
83688484|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83688485|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688486|NCT05288374|Analgesics|analgesics|mesh-ancestor
83688487|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
83688488|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688489|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688490|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688491|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688492|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83688493|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83688494|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688495|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688496|NCT05288192|Triamcinolone|triamcinolone|mesh-list
83688497|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83688498|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83688499|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83688500|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688501|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
83688502|NCT05288192|Hormones|hormones|mesh-ancestor
83688503|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688504|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688505|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688506|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
83688507|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688508|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688509|NCT05288179|Pirfenidone|pirfenidone|mesh-list
83688510|NCT05288179|Analgesics|analgesics|mesh-ancestor
83688511|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
83688512|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688513|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688514|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83688515|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688516|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688517|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688518|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688519|NCT05288127|Talazoparib|talazoparib|mesh-list
83688520|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83688521|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688522|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688523|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688524|NCT05291455|Lacosamide|lacosamide|mesh-list
83688525|NCT05291455|Phenobarbital|phenobarbital|mesh-list
83688526|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
83688527|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83688528|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83688529|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843364|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
83688530|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688531|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83688532|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688533|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688534|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83688535|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83688536|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688537|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
83688538|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
83688539|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83688540|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83688541|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83688542|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83688543|NCT05291195|Eusol|eusol|mesh-list
83688544|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
83688545|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688546|NCT05291130|Vitamin E|vitamin e|mesh-list
83688547|NCT05291130|Vitamins|vitamins|mesh-ancestor
83688548|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
83688549|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688550|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
83688551|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688552|NCT05291130|Protective Agents|protective agents|mesh-ancestor
83688553|NCT05291104|Folic Acid|folic acid|mesh-list
83688554|NCT05291104|Choline|choline|mesh-list
83688555|NCT05291104|Hematinics|hematinics|mesh-ancestor
83688556|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
83688557|NCT05291104|Vitamins|vitamins|mesh-ancestor
83688558|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
83688559|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688560|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
83688561|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83688562|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
83688563|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688564|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83688565|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83688566|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
83688567|NCT05291052|Capecitabine|capecitabine|mesh-list
83688568|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
83688569|NCT05291052|Lenvatinib|lenvatinib|mesh-list
83688570|NCT05291052|Tislelizumab|tislelizumab|mesh-list
83688571|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688572|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
83688573|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688574|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688575|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83688576|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688577|NCT05291052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83688578|NCT05290948|Bevacizumab|bevacizumab|mesh-list
83688579|NCT05290948|Acetazolamide|acetazolamide|mesh-list
83688580|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83688581|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688582|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83688583|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83688584|NCT05290948|Growth Substances|growth substances|mesh-ancestor
83688585|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688586|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
83688587|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
83688588|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83688589|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688590|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688591|NCT05290948|Diuretics|diuretics|mesh-ancestor
83688592|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
83688593|NCT05290935|Paclitaxel|paclitaxel|mesh-list
83688594|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83688595|NCT05290935|Antibodies|antibodies|mesh-list
83688596|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83688597|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688598|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83688599|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83688600|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83688601|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688602|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
83688603|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688604|NCT05290857|Hemostatics|hemostatics|mesh-list
82843435|NCT01178320|Vitamins|vitamins|mesh-ancestor
83688605|NCT05290857|Coagulants|coagulants|mesh-ancestor
83688606|NCT05290506|Linagliptin|linagliptin|mesh-list
83688607|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83688608|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83688609|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688610|NCT05290506|Incretins|incretins|mesh-ancestor
83688611|NCT05290506|Hormones|hormones|mesh-ancestor
83688612|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688613|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
83688614|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688615|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688616|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
83688617|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688618|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83688619|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688620|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688621|NCT05290324|Midazolam|midazolam|mesh-list
83688622|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83688623|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83688624|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688625|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688626|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83688627|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83688628|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83688629|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83688630|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
83688631|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
83688632|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
83688633|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
83688634|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688635|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688636|NCT05290090|Rituximab|rituximab|mesh-list
83688637|NCT05290090|Lenalidomide|lenalidomide|mesh-list
83688638|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
83688639|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83688640|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688641|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
83688642|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688643|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688644|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83688645|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83688646|NCT05290090|Growth Substances|growth substances|mesh-ancestor
83688647|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
83688648|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83688649|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688650|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688651|NCT05292742|Capecitabine|capecitabine|mesh-list
83688652|NCT05292742|Trastuzumab|trastuzumab|mesh-list
83688653|NCT05292742|Pertuzumab|pertuzumab|mesh-list
83688654|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688655|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
83688656|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688657|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688658|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83688659|NCT05292677|Anesthetics|anesthetics|mesh-list
83688660|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688661|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688662|NCT05292573|Metformin|metformin|mesh-list
83688663|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83688664|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688665|NCT05291910|Paclitaxel|paclitaxel|mesh-list
83688666|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83688667|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83688668|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688669|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83688670|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83688671|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83688672|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688673|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
83688674|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83688675|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82843509|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82843510|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82843511|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843512|NCT01174888|Cytarabine|cytarabine|mesh-list
82843513|NCT01174888|Etoposide|etoposide|mesh-list
82843514|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
83688676|NCT05291793|Prednisolone|prednisolone|mesh-list
83688677|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
83688678|NCT05291793|Tenoxicam|tenoxicam|mesh-list
83688679|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83688680|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
83688681|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688682|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
83688683|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
83688684|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688685|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688686|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83688687|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
83688688|NCT05291793|Hormones|hormones|mesh-ancestor
83688689|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688690|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83688691|NCT05291793|Protective Agents|protective agents|mesh-ancestor
83688692|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83688693|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688694|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83688695|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688696|NCT05291793|Analgesics|analgesics|mesh-ancestor
83688697|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
83688698|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688699|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83688700|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688701|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688702|NCT05294926|Rocuronium|rocuronium|mesh-list
83688703|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83688704|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83688705|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83688706|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688707|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688708|NCT05294887|Bisoprolol|bisoprolol|mesh-list
83688709|NCT05294887|Diltiazem|diltiazem|mesh-list
83688710|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83688711|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83688712|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
83688713|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688714|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688715|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688716|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83688717|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
83688718|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
83688719|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688720|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83688721|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83688722|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83688723|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83688724|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
83688725|NCT05294822|Insulin|insulin|mesh-list
83688726|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83688727|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688728|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
83688729|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83688730|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
83688731|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688732|NCT05294744|Expectorants|expectorants|mesh-ancestor
83688733|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688734|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83688735|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
83688736|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688737|NCT05294744|Protective Agents|protective agents|mesh-ancestor
83688738|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688739|NCT05294744|Antidotes|antidotes|mesh-ancestor
83688740|NCT05294679|Propofol|propofol|mesh-list
83688741|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82843580|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843581|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843582|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82843583|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82843584|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843585|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843586|NCT01077726|Capecitabine|capecitabine|mesh-list
82843591|NCT01179100|Lidocaine|lidocaine|mesh-list
83688742|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688743|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688744|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83688745|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
83688746|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
83688747|NCT05294666|Cyclosporine|cyclosporine|mesh-list
83688748|NCT05294666|Tacrolimus|tacrolimus|mesh-list
83688749|NCT05294666|Cyclosporins|cyclosporins|mesh-list
83688750|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688751|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
83688752|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688753|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83688754|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688755|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688756|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
83688757|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688758|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
83688759|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688760|NCT05294640|Lidocaine|lidocaine|mesh-list
83688761|NCT05294640|Epinephrine|epinephrine|mesh-list
83688762|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
83688763|NCT05294640|Anesthetics|anesthetics|mesh-list
83688764|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688765|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688766|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
83688767|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688768|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83688769|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83688770|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83688771|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83688772|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688773|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83688774|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83688775|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
83688776|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688777|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83688778|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83688779|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
83688780|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83688781|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688782|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
83688783|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
83688784|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83688785|NCT05294536|Liraglutide|liraglutide|mesh-list
83688786|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83688787|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688788|NCT05294536|Incretins|incretins|mesh-ancestor
83688789|NCT05294536|Hormones|hormones|mesh-ancestor
83688790|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688791|NCT05294484|Indapamide|indapamide|mesh-list
83688792|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83688793|NCT05294484|Diuretics|diuretics|mesh-ancestor
83688794|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
83688795|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688796|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83688797|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83688798|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688799|NCT05294406|Piperaquine|piperaquine|mesh-list
83688800|NCT05294406|Artenimol|artenimol|mesh-list
83688801|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
83688802|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83688803|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83688804|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688805|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
83688806|NCT05294393|Ropivacaine|ropivacaine|mesh-list
83688807|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
83688808|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
83688809|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83688810|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688811|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
83688812|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688813|NCT05294393|Analgesics|analgesics|mesh-ancestor
83688814|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83688815|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
83688816|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83688817|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83834888|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843646|NCT01179412|Trace Elements|trace elements|mesh-ancestor
83688818|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688819|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83688820|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
83688821|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83688822|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83688823|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688824|NCT05293808|Aspirin|aspirin|mesh-list
83688825|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83688826|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688827|NCT05293808|Analgesics|analgesics|mesh-ancestor
83688828|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
83688829|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688830|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688831|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688832|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688833|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83688834|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83688835|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688836|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83688837|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83688838|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688839|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
83688840|NCT05293704|Mizoribine|mizoribine|mesh-list
83688841|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83688842|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688843|NCT05293704|Analgesics|analgesics|mesh-ancestor
83688844|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
83688845|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688846|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688847|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688848|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688849|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83688850|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688851|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83688852|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688853|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
83688854|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83688855|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83688856|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688857|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688858|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688859|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
83688860|NCT05293574|Norethindrone|norethindrone|mesh-list
83688861|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
83688862|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83688863|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83688864|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83688865|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
83688866|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83688867|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688868|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83688869|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83688870|NCT05293132|Ubiquinone|ubiquinone|mesh-list
83688871|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
83688872|NCT05293132|Montelukast|montelukast|mesh-list
83688873|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83688874|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
83688875|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83688876|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
83688877|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83688878|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688879|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83688880|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83688881|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688882|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
83688883|NCT05293132|Vitamins|vitamins|mesh-ancestor
83688884|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
83688885|NCT05293119|Tofacitinib|tofacitinib|mesh-list
83688886|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688887|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
83688888|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83688889|NCT05293119|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83688890|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83688891|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688892|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688893|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83688894|NCT05296863|Minoxidil|minoxidil|mesh-list
83688895|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83688896|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
83688897|NCT05296564|Aldesleukin|aldesleukin|mesh-list
83688898|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
83688899|NCT05296564|Interleukin-2|interleukin-2|mesh-list
83688900|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688901|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
83688902|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688903|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688904|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83688905|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
83688906|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688907|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688908|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83688909|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83688910|NCT05296564|Analgesics|analgesics|mesh-ancestor
83688911|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
83688912|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688913|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83688914|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83688915|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
83688916|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688917|NCT05296369|Folic Acid|folic acid|mesh-list
83688918|NCT05296369|Hematinics|hematinics|mesh-ancestor
83688919|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
83688920|NCT05296369|Vitamins|vitamins|mesh-ancestor
83688921|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
83688922|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688923|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
83688924|NCT05296317|Epirubicin|epirubicin|mesh-list
83688925|NCT05296317|Lenograstim|lenograstim|mesh-list
83688926|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688927|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
83688928|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688929|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688930|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83688931|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
83688932|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688933|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688934|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83688935|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83688936|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83688937|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83688938|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83688939|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83688940|NCT05296005|Leucovorin|leucovorin|mesh-list
83688941|NCT05296005|Docetaxel|docetaxel|mesh-list
83688942|NCT05296005|Fluorouracil|fluorouracil|mesh-list
83688943|NCT05296005|Capecitabine|capecitabine|mesh-list
83688944|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
83688945|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688946|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83688947|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83688948|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83688949|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688950|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
83688951|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83688952|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83688953|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
83688954|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688955|NCT05296005|Antidotes|antidotes|mesh-ancestor
83688956|NCT05296005|Protective Agents|protective agents|mesh-ancestor
83688957|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
83688958|NCT05296005|Vitamins|vitamins|mesh-ancestor
83688959|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
83688960|NCT05295836|Glycerol|glycerol|mesh-list
83688961|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83688962|NCT05295836|Protective Agents|protective agents|mesh-ancestor
83688963|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688964|NCT05294900|Paclitaxel|paclitaxel|mesh-list
83688965|NCT05294900|Carboplatin|carboplatin|mesh-list
83688966|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83688967|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688968|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
83688969|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
83688970|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
83688971|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688972|NCT05280405|Infliximab|infliximab|mesh-list
83688973|NCT05280405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83688974|NCT05280405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688975|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
83688976|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83688977|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688978|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83688979|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83688980|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83688981|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83688982|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83688983|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83688984|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83688985|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
83688986|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83688987|NCT05273242|Artesunate|artesunate|mesh-list
83688988|NCT05273242|Infliximab|infliximab|mesh-list
83688989|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83688990|NCT05273242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83688991|NCT05273242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83688992|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83688993|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83688994|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83688995|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
83688996|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83688997|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83688998|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83688999|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
83689000|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
83689001|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83689002|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
83689003|NCT05269095|Anesthetics|anesthetics|mesh-list
83689004|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689005|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689006|NCT05267938|Lidocaine|lidocaine|mesh-list
83689007|NCT05267938|Epinephrine|epinephrine|mesh-list
83689008|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
83689009|NCT05267938|Anesthetics|anesthetics|mesh-list
83689010|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689011|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689012|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
83689013|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689014|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83689015|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83689016|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83689017|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83689018|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689019|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83689020|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83689021|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
83689022|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689023|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83689024|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83689025|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
83689026|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83689027|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
83689028|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
83689029|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
83689030|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83689031|NCT05267431|Methotrexate|methotrexate|mesh-list
83689032|NCT05267431|Hydroquinone|hydroquinone|mesh-list
83689033|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83689034|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
83689035|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83689036|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689037|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83689038|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
83689039|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689040|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689041|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
83689042|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689043|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83689044|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843872|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
83689045|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
83689046|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689047|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83689049|NCT05267431|Protective Agents|protective agents|mesh-ancestor
83689050|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83689051|NCT05266248|Caffeine|caffeine|mesh-list
83689052|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83689053|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689054|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83689055|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689056|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689057|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83689058|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83689059|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
83689060|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689061|NCT05264896|Leucovorin|leucovorin|mesh-list
83689062|NCT05264896|Docetaxel|docetaxel|mesh-list
83689063|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
83689064|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689065|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
83689066|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
83689067|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
83689068|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689069|NCT05264896|Antidotes|antidotes|mesh-ancestor
83689070|NCT05264896|Protective Agents|protective agents|mesh-ancestor
83689071|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689072|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
83689073|NCT05264896|Vitamins|vitamins|mesh-ancestor
83689074|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
83689075|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
83689076|NCT05264584|Febuxostat|febuxostat|mesh-list
83689077|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83689078|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
83689079|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689080|NCT05264584|Expectorants|expectorants|mesh-ancestor
83689081|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
83689082|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83689083|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
83689084|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689085|NCT05264584|Protective Agents|protective agents|mesh-ancestor
83689086|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689087|NCT05264584|Antidotes|antidotes|mesh-ancestor
83689088|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
83689089|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689090|NCT05262686|Aldesleukin|aldesleukin|mesh-list
83689091|NCT05262686|Interleukin-2|interleukin-2|mesh-list
83689092|NCT05262686|Belimumab|belimumab|mesh-list
83689093|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689094|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83689095|NCT05262686|Analgesics|analgesics|mesh-ancestor
83689096|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
83689097|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689098|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689099|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83689100|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
83689101|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83689102|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83689103|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
83689104|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689105|NCT05238714|Venglustat|venglustat|mesh-list
83689106|NCT05238714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689107|NCT05238714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689108|NCT05238506|Lidocaine|lidocaine|mesh-list
83689109|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
83689110|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
83689111|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689112|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689113|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
83689114|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689115|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83689116|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83689117|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83689118|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843947|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
83689119|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689120|NCT05236608|Nivolumab|nivolumab|mesh-list
83689121|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689122|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689123|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689124|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689125|NCT05225402|Norepinephrine|norepinephrine|mesh-list
83689126|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83689127|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83689128|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
83689129|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689130|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689131|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689132|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
83689133|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
83689134|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689135|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83689136|NCT05220826|Ethanol|ethanol|mesh-list
83689137|NCT05220826|Ethylene|ethylene|mesh-list
83689138|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83689139|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689140|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689141|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689142|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83689143|NCT05220826|Growth Substances|growth substances|mesh-ancestor
83689144|NCT05210413|Spartalizumab|spartalizumab|mesh-list
83689145|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689146|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689147|NCT05210413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689148|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689149|NCT05203705|Enoxaparin|enoxaparin|mesh-list
83689150|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
83689151|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83689152|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83689153|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689154|NCT05202561|Vaccines|vaccines|mesh-list
83689155|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
83689156|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689157|NCT05192629|Midazolam|midazolam|mesh-list
83689158|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
83689159|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83689160|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689161|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689162|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83689163|NCT05192629|Analgesics|analgesics|mesh-ancestor
83689164|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
83689165|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689166|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83689167|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83689168|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83689169|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
83689170|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689171|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689172|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83689173|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83689174|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83689175|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83689176|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83689177|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
83689178|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
83689179|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
83689180|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
83689181|NCT05189444|Amoxicillin|amoxicillin|mesh-list
83689182|NCT05189444|Clarithromycin|clarithromycin|mesh-list
83689183|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
83689184|NCT05189444|Esomeprazole|esomeprazole|mesh-list
83689185|NCT05189444|Bismuth|bismuth|mesh-list
83689186|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689187|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83689188|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689189|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83689190|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689191|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83689192|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689193|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83689194|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83689195|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83689196|NCT05189444|Antacids|antacids|mesh-ancestor
83689197|NCT05189444|Diuretics|diuretics|mesh-ancestor
83689198|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
83689199|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689200|NCT05189444|Expectorants|expectorants|mesh-ancestor
83689201|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
83689202|NCT05175274|Colchicine|colchicine|mesh-list
83689203|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
83689204|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689205|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
83689206|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
83689207|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
83689208|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689209|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689210|NCT05169268|Aripiprazole|aripiprazole|mesh-list
83689211|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
83689212|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
83689213|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83689214|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83689215|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83689216|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689217|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689218|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
83689219|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
83689220|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689221|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689222|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83689223|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83689224|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
83689225|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83689226|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83689227|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83689228|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83689229|NCT05129137|Acetaminophen|acetaminophen|mesh-list
83689230|NCT05129137|Nefopam|nefopam|mesh-list
83689231|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83689232|NCT05129137|Analgesics|analgesics|mesh-ancestor
83689233|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
83689234|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689235|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689236|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
83689237|NCT05110898|Olmesartan|olmesartan|mesh-list
83689238|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83689239|NCT05110898|Indapamide|indapamide|mesh-list
83689240|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83689241|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83689242|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83689243|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689244|NCT05110898|Diuretics|diuretics|mesh-ancestor
83689245|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
83689246|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689247|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83689248|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83689249|NCT05098041|Rifampin|rifampin|mesh-list
83689250|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83689251|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
83689252|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83689253|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689254|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
83689255|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83689256|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689257|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689258|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83689259|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83689260|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83689261|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83689262|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83689263|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83689264|NCT05096325|Insulin|insulin|mesh-list
83689265|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83689266|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689267|NCT05096065|Leuprolide|leuprolide|mesh-list
83689268|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83689269|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
82844108|NCT01184716|Vitamin D|vitamin d|mesh-list
83834889|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
83689270|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83689271|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689272|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83689273|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689274|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83689275|NCT05083572|Rifaximin|rifaximin|mesh-list
83689276|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689277|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689278|NCT05030025|Lamivudine|lamivudine|mesh-list
83689279|NCT05030025|Abacavir|abacavir|mesh-list
83689280|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
83689281|NCT05030025|Dolutegravir|dolutegravir|mesh-list
83689282|NCT05030025|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
83689283|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83689284|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83689285|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689286|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689287|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
83689288|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689289|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83689290|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83689291|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83689292|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83689293|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
83689294|NCT05013567|Ibuprofen|ibuprofen|mesh-list
83689295|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83689296|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83689297|NCT05013567|Analgesics|analgesics|mesh-ancestor
83689298|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
83689299|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689300|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689301|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83689302|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689303|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83689304|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689305|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689306|NCT05008926|Naloxegol|naloxegol|mesh-list
83689307|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83689308|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689309|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
83689310|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689311|NCT04989621|Rituximab|rituximab|mesh-list
83689312|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689313|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689314|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
83689315|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689316|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689317|NCT04989049|Folic Acid|folic acid|mesh-list
83689318|NCT04989049|Hematinics|hematinics|mesh-ancestor
83689319|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
83689320|NCT04989049|Vitamins|vitamins|mesh-ancestor
83689321|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
83689322|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689323|NCT04984044|Vitamin D|vitamin d|mesh-list
83689324|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
83689325|NCT04984044|Vitamins|vitamins|mesh-ancestor
83689326|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
83689327|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689328|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83689329|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83689330|NCT04975802|Caffeine|caffeine|mesh-list
83689331|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83689332|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689333|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83689334|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689335|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689336|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83689337|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83689338|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
83689339|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689340|NCT04964700|Natalizumab|natalizumab|mesh-list
83689341|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
83689342|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689343|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83689344|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
83689345|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83689346|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83689347|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83689348|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689349|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689350|NCT04921527|Paclitaxel|paclitaxel|mesh-list
83689351|NCT04921527|Chiauranib|chiauranib|mesh-list
83689352|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83689353|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689354|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
83689355|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
83689356|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
83689357|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689358|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83689359|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689360|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
83689361|NCT04899843|Astringents|astringents|mesh-ancestor
83689362|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689363|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
83689364|NCT04897802|Exenatide|exenatide|mesh-list
83689365|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83689366|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689367|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83689368|NCT04897802|Incretins|incretins|mesh-ancestor
83689369|NCT04897802|Hormones|hormones|mesh-ancestor
83689370|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83689371|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
83689372|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689373|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
83689374|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
83689375|NCT04882332|Vitamins|vitamins|mesh-ancestor
83689376|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
83689377|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689378|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
83689379|NCT04882332|Hematinics|hematinics|mesh-ancestor
83689380|NCT04882202|Acetaminophen|acetaminophen|mesh-list
83689381|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83689382|NCT04882202|Analgesics|analgesics|mesh-ancestor
83689383|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
83689384|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689385|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689386|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
83689387|NCT04871425|Fentanyl|fentanyl|mesh-list
83689388|NCT04871425|Ketamine|ketamine|mesh-list
83689389|NCT04871425|Analgesics|analgesics|mesh-ancestor
83689390|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
83689391|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689392|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689393|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83689394|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83689395|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
83689396|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
83689397|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689398|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83689399|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83689400|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689401|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689402|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83689403|NCT04871425|Narcotics|narcotics|mesh-ancestor
83689404|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83689405|NCT04869605|Chrysarobin|chrysarobin|mesh-list
83689406|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83689407|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83689408|NCT04869605|Analgesics|analgesics|mesh-ancestor
83689409|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
83689410|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689411|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689412|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83689413|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689414|NCT04835584|Dasatinib|dasatinib|mesh-list
83689415|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689416|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83689417|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689418|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689419|NCT04793867|Xenon|xenon|mesh-list
83689420|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83689421|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
82844251|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
83689422|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
83689423|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689424|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689425|NCT04774315|Omalizumab|omalizumab|mesh-list
83689426|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83689427|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83689428|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
83689429|NCT04767503|Propofol|propofol|mesh-list
83689430|NCT04767503|Desflurane|desflurane|mesh-list
83689431|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83689432|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689433|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689434|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83689435|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
83689436|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
83689437|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83689438|NCT04760496|Oxytocin|oxytocin|mesh-list
83689439|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
83689440|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83689441|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689442|NCT04750967|Lidocaine|lidocaine|mesh-list
83689443|NCT04750967|Amitriptyline|amitriptyline|mesh-list
83689444|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83689445|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
83689446|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689447|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689448|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
83689449|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689450|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83689451|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83689452|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83689453|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83689454|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689455|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83689456|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
83689457|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83689458|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83689459|NCT04750967|Analgesics|analgesics|mesh-ancestor
83689460|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83689461|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83689462|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
83689463|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689464|NCT04722679|Anticoagulants|anticoagulants|mesh-list
83689465|NCT04696380|Nicotine|nicotine|mesh-list
83689466|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83689467|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
83689468|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689469|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689470|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83689471|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83689472|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
83689473|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689474|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689475|NCT04672772|Paclitaxel|paclitaxel|mesh-list
83689476|NCT04672772|Cetuximab|cetuximab|mesh-list
83689477|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83689478|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689479|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83689480|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83689481|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83689482|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689483|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689484|NCT04671082|Tolperisone|tolperisone|mesh-list
83689485|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83689486|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689487|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83689488|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689489|NCT04669587|Palbociclib|palbociclib|mesh-list
83689490|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689491|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83689492|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689493|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689494|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
83689495|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82844335|NCT01184404|Bosentan|bosentan|mesh-list
83689496|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
83834890|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
83689497|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689499|NCT04659382|Atezolizumab|atezolizumab|mesh-list
83689500|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689501|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689502|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83689503|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83689504|NCT04659382|Growth Substances|growth substances|mesh-ancestor
83689505|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689506|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
83689507|NCT04659382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689508|NCT04659382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689509|NCT04658823|Vitamin E|vitamin e|mesh-list
83689510|NCT04658823|Tocopherols|tocopherols|mesh-list
83689511|NCT04658823|Tocotrienols|tocotrienols|mesh-list
83689512|NCT04658823|Tocovid|tocovid|mesh-list
83689513|NCT04658823|Vitamins|vitamins|mesh-ancestor
83689514|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
83689515|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689516|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
83689517|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689518|NCT04658823|Protective Agents|protective agents|mesh-ancestor
83689519|NCT04648241|Vaccines|vaccines|mesh-list
83689520|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
83689521|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689522|NCT04640818|Rituximab|rituximab|mesh-list
83689523|NCT04640818|Cladribine|cladribine|mesh-list
83689524|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
83689525|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689526|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689527|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
83689528|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689529|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689530|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83689531|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
83689532|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83689533|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689534|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83689535|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689536|NCT04602078|Gemcitabine|gemcitabine|mesh-list
83689537|NCT04602078|Atezolizumab|atezolizumab|mesh-list
83689538|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689539|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83689540|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
83689541|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689542|NCT04602078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689543|NCT04602078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689544|NCT04588857|Dexamethasone|dexamethasone|mesh-list
83689545|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83689546|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
83689547|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
83689548|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689549|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689550|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689551|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
83689552|NCT04588857|Hormones|hormones|mesh-ancestor
83689553|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83689554|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83689555|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689556|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
83689557|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
83689558|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689559|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689560|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689561|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
83689562|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
83689563|NCT04562831|Niacinamide|niacinamide|mesh-list
83689564|NCT04562831|Niacin|niacin|mesh-list
83689565|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
83689566|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
83689567|NCT04562831|Vitamins|vitamins|mesh-ancestor
83689568|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
83689569|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844398|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
83689570|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82844402|NCT03849664|Riboflavin|riboflavin|mesh-list
83689571|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
83689572|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689573|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83689574|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
83689575|NCT04545242|Dexamethasone|dexamethasone|mesh-list
83689576|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83689577|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
83689578|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
83689579|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689580|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689581|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689582|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
83689583|NCT04545242|Hormones|hormones|mesh-ancestor
83689584|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83689585|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83689586|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689587|NCT04542980|Autoantibodies|autoantibodies|mesh-list
83689588|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
83689589|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689590|NCT04529499|Favipiravir|favipiravir|mesh-list
83689591|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
83689592|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689593|NCT04523428|Venetoclax|venetoclax|mesh-list
83689594|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
83689595|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689596|NCT04508504|Ropivacaine|ropivacaine|mesh-list
83689597|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
83689598|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
83689599|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689600|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689601|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
83689602|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689603|NCT04490707|Lenalidomide|lenalidomide|mesh-list
83689604|NCT04490707|Azacitidine|azacitidine|mesh-list
83689605|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
83689606|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689607|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83689608|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83689609|NCT04490707|Growth Substances|growth substances|mesh-ancestor
83689610|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83689611|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689612|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83689613|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
83689614|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689615|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689616|NCT04464577|Itraconazole|itraconazole|mesh-list
83689617|NCT04464577|Fluconazole|fluconazole|mesh-list
83689618|NCT04464577|Bupropion|bupropion|mesh-list
83689619|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83689620|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
83689621|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83689622|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83689623|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83689624|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83689625|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689626|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
83689627|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689628|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689629|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83689630|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83689631|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689632|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
83689633|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689634|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83689635|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83689636|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
83689637|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83689638|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83689639|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83689640|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83689641|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
83689642|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689643|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689644|NCT04402658|Albuterol|albuterol|mesh-list
83689645|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83689646|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
83689647|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689648|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689649|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83689650|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
83689651|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
83689652|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83689653|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83689654|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83689655|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83689656|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
83689657|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689658|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689659|NCT04391179|Dipyridamole|dipyridamole|mesh-list
83689660|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83689661|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689662|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689663|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83689664|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
83689665|NCT04375683|Flumatinib|flumatinib|mesh-list
83689666|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83689667|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689668|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689669|NCT04356742|Metformin|metformin|mesh-list
83689670|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
83689671|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83689672|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689673|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83689674|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689675|NCT04353284|Gabexate|gabexate|mesh-list
83689676|NCT04353284|Camostat|camostat|mesh-list
83689677|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
83689678|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689679|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689680|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83689681|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83689682|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
83689683|NCT04348864|Antibodies|antibodies|mesh-list
83689684|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
83689685|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689686|NCT04328012|Losartan|losartan|mesh-list
83689687|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83689688|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83689689|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83689690|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83689691|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689692|NCT04310150|Hemostatics|hemostatics|mesh-list
83689693|NCT04310150|Coagulants|coagulants|mesh-ancestor
83689694|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83689695|NCT04294147|Erenumab|erenumab|mesh-list
83689696|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83689697|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689698|NCT04294147|Analgesics|analgesics|mesh-ancestor
83689699|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
83689700|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689701|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689702|NCT04292873|Vitamin D|vitamin d|mesh-list
83689703|NCT04292873|Vitamins|vitamins|mesh-ancestor
83689704|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
83689705|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689706|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83689707|NCT04264637|Azelastine|azelastine|mesh-list
83689708|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83689709|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
83689710|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689711|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689712|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83689713|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83689714|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83689715|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689716|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689717|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83689718|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82844549|NCT03852160|Bupropion|bupropion|mesh-list
83689719|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83689720|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
83689721|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
83689722|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689723|NCT04262687|Bevacizumab|bevacizumab|mesh-list
83689724|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
83689725|NCT04262687|Capecitabine|capecitabine|mesh-list
83689726|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
83689727|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689728|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689729|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83689730|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83689731|NCT04262687|Growth Substances|growth substances|mesh-ancestor
83689732|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689733|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
83689734|NCT04262687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689735|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689736|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83689737|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
83689738|NCT04238546|Sirolimus|sirolimus|mesh-list
83689739|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83689740|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689741|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83689742|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689743|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
83689744|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83689745|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
83689746|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689747|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83689748|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689749|NCT04233801|Empagliflozin|empagliflozin|mesh-list
83689750|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83689751|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689752|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83689753|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689754|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
83689755|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83689756|NCT04223570|Levulinic acid|levulinic acid|mesh-list
83689757|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83689758|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
83689759|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689760|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689761|NCT04180085|Abatacept|abatacept|mesh-list
83689762|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689763|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689764|NCT04180085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689765|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689766|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83689767|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
83689768|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689769|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689770|NCT04169451|Letrozole|letrozole|mesh-list
83689771|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689772|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83689773|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83689774|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689775|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689776|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83689777|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
83689778|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83689779|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689780|NCT04169438|Petrolatum|petrolatum|mesh-list
83689781|NCT04169438|Emollients|emollients|mesh-ancestor
83689782|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
83689783|NCT04159818|Doxorubicin|doxorubicin|mesh-list
83689784|NCT04159818|Nivolumab|nivolumab|mesh-list
83689785|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689786|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83689787|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83689788|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83689789|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689790|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689791|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689792|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689793|NCT04157881|Rabeprazole|rabeprazole|mesh-list
83689795|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
83689796|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83689797|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
83689798|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689799|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689800|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
83689801|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83689802|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689803|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83689804|NCT04151563|Docetaxel|docetaxel|mesh-list
83689805|NCT04151563|Nivolumab|nivolumab|mesh-list
83689806|NCT04151563|Ipilimumab|ipilimumab|mesh-list
83689807|NCT04151563|Ramucirumab|ramucirumab|mesh-list
83689808|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689809|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
83689810|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
83689811|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
83689812|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689813|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689814|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689815|NCT04136262|Methotrexate|methotrexate|mesh-list
83689816|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83689817|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
83689818|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83689819|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689820|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83689821|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
83689822|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689823|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689824|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
83689825|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689826|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83689827|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83689828|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
83689829|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83689830|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83689831|NCT04133922|Insulin|insulin|mesh-list
83689832|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83689833|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689834|NCT04115059|Dasatinib|dasatinib|mesh-list
83689835|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689836|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83689837|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689838|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689839|NCT04114890|Tenofovir|tenofovir|mesh-list
83689840|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
83689841|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689842|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83689843|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83689844|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689845|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689846|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83689847|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83689848|NCT04096066|Dexamethasone|dexamethasone|mesh-list
83689849|NCT04096066|Lenalidomide|lenalidomide|mesh-list
83689850|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83689851|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
83689852|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
83689853|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689854|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689855|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689856|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
83689857|NCT04096066|Hormones|hormones|mesh-ancestor
83689858|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83689859|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83689860|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689861|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
83689862|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83689863|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83689864|NCT04096066|Growth Substances|growth substances|mesh-ancestor
83689865|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
83689866|NCT04082676|Bupivacaine|bupivacaine|mesh-list
83689867|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
83689868|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
82844704|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
83689869|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689870|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689871|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
83689872|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689873|NCT04012177|Niacinamide|niacinamide|mesh-list
83689874|NCT04012177|Niacin|niacin|mesh-list
83689875|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
83689876|NCT04012177|Azithromycin|azithromycin|mesh-list
83689877|NCT04012177|Choline|choline|mesh-list
83689878|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83689879|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689880|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
83689881|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83689882|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
83689883|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689884|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689885|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83689886|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
83689887|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
83689888|NCT04012177|Vitamins|vitamins|mesh-ancestor
83689889|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
83689890|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689891|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
83689892|NCT04007289|Apixaban|apixaban|mesh-list
83689893|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83689894|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
83689895|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83689896|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
83689897|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689898|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689899|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
83689900|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
83689901|NCT04002518|Cimetidine|cimetidine|mesh-list
83689902|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83689903|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83689904|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83689905|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
83689906|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
83689907|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83689908|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689909|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689910|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83689911|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83689912|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689913|NCT03993249|Nivolumab|nivolumab|mesh-list
83689914|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689915|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689916|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689917|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689918|NCT03990883|Lidocaine|lidocaine|mesh-list
83689919|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
83689920|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
83689921|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83689922|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689923|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
83689924|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83689925|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83689926|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83689927|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83689928|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83689929|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689930|NCT03984890|Vitamin D|vitamin d|mesh-list
83689931|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
83689932|NCT03984890|Vitamins|vitamins|mesh-ancestor
83689933|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
83689934|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689935|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83689936|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83689937|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
83689938|NCT03926091|Docetaxel|docetaxel|mesh-list
83689939|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83689940|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
83689941|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689942|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844776|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834891|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
83689943|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83689945|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689946|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689947|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83689948|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
83689949|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
83689950|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
83689951|NCT03924427|Deucravacitinib|deucravacitinib|mesh-list
83689952|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
83689953|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83689954|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689955|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689956|NCT03922451|Cefazolin|cefazolin|mesh-list
83689957|NCT03922451|Tazobactam|tazobactam|mesh-list
83689958|NCT03922451|Piperacillin|piperacillin|mesh-list
83689959|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83689960|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83689961|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689962|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83689963|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83689964|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689965|NCT05802628|Cetylpyridinium|cetylpyridinium|mesh-list
83689966|NCT05802628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83689967|NCT05802628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689968|NCT05802433|Vitamin D|vitamin d|mesh-list
83689969|NCT05802433|Cholecalciferol|cholecalciferol|mesh-list
83689970|NCT05802433|Vitamins|vitamins|mesh-ancestor
83689971|NCT05802433|Micronutrients|micronutrients|mesh-ancestor
83689972|NCT05802433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689973|NCT05802433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83689974|NCT05802433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83689975|NCT05802303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83689976|NCT05802303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83689977|NCT05802303|Estradiol|estradiol|mesh-list
83689978|NCT05802303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83689979|NCT05802303|Estrogens|estrogens|mesh-ancestor
83689980|NCT05802303|Hormones|hormones|mesh-ancestor
83689981|NCT05802303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83689982|NCT05802303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83689983|NCT05802303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83689984|NCT05802303|Contraceptive Agents|contraceptive agents|mesh-ancestor
83689985|NCT05802303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83689986|NCT05802303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83689987|NCT05802290|Nivolumab|nivolumab|mesh-list
83689988|NCT05802290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83689989|NCT05802290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83689990|NCT05802290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83689991|NCT05802290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83689992|NCT05802264|Amphotericin B|amphotericin b|mesh-list
83689993|NCT05802264|Amebicides|amebicides|mesh-ancestor
83689994|NCT05802264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83689995|NCT05802264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83689996|NCT05802264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83689997|NCT05802264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83689998|NCT05802264|Antifungal Agents|antifungal agents|mesh-ancestor
83689999|NCT05802225|Pertuzumab|pertuzumab|mesh-list
83690000|NCT05802225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690001|NCT05802225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690002|NCT05802212|Metformin|metformin|mesh-list
83690003|NCT05802212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83690004|NCT05802212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690005|NCT05802121|Acetic Acid|acetic acid|mesh-list
83690006|NCT05802121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83690007|NCT05802121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690008|NCT05802108|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83690009|NCT05802108|Evolocumab|evolocumab|mesh-list
83690010|NCT05802108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83690011|NCT05802108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83690012|NCT05802108|Antimetabolites|antimetabolites|mesh-ancestor
83690013|NCT05802108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690014|NCT05802108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690015|NCT05802108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83690016|NCT05802108|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82844853|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690017|NCT05802108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83690018|NCT05802108|Protease Inhibitors|protease inhibitors|mesh-ancestor
83690019|NCT05802082|Anesthetics|anesthetics|mesh-list
83690020|NCT05802082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690021|NCT05802082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690022|NCT05801900|Ibuprofen|ibuprofen|mesh-list
83690023|NCT05801900|Ketorolac|ketorolac|mesh-list
83690024|NCT05801900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690025|NCT05801900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690026|NCT05801900|Analgesics|analgesics|mesh-ancestor
83690027|NCT05801900|Sensory System Agents|sensory system agents|mesh-ancestor
83690028|NCT05801900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690029|NCT05801900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690030|NCT05801900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690031|NCT05801900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690032|NCT05801900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83690033|NCT05801900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690034|NCT05801900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690035|NCT05801835|Cytarabine|cytarabine|mesh-list
83690036|NCT05801835|Daunorubicin|daunorubicin|mesh-list
83690037|NCT05801835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83690038|NCT05801835|Antimetabolites|antimetabolites|mesh-ancestor
83690039|NCT05801835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690040|NCT05801835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690041|NCT05801835|Antiviral Agents|antiviral agents|mesh-ancestor
83690042|NCT05801835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690043|NCT05801835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690044|NCT05801835|Immunologic Factors|immunologic factors|mesh-ancestor
83690045|NCT05801835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690046|NCT05801835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83690047|NCT05801835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83690048|NCT05801835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83690049|NCT05801835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690050|NCT05801523|Ethanol|ethanol|mesh-list
83690051|NCT05801523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83690052|NCT05801523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690053|NCT05801523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690054|NCT05801523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690055|NCT05801484|Linezolid|linezolid|mesh-list
83690056|NCT05801484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83690057|NCT05801484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690058|NCT05801484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83690059|NCT05801484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690060|NCT05801484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690061|NCT05801380|Memantine|memantine|mesh-list
83690062|NCT05801380|Donepezil|donepezil|mesh-list
83690063|NCT05801380|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83690064|NCT05801380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690065|NCT05801380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690066|NCT05801380|Cholinergic Agents|cholinergic agents|mesh-ancestor
83690067|NCT05801380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690068|NCT05801380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690069|NCT05801380|Nootropic Agents|nootropic agents|mesh-ancestor
83690070|NCT05801380|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83690071|NCT05801380|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83690072|NCT05801380|Dopamine Agents|dopamine agents|mesh-ancestor
83690073|NCT05801380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83690074|NCT05801380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83690075|NCT05801367|Allyl sulfide|allyl sulfide|mesh-list
83690076|NCT05801367|Antioxidants|antioxidants|mesh-ancestor
83690077|NCT05801367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690078|NCT05801367|Protective Agents|protective agents|mesh-ancestor
83690079|NCT05801367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690080|NCT05801367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83690081|NCT05801367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690082|NCT05801367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83690083|NCT05801367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690084|NCT05801328|Salicylic Acid|salicylic acid|mesh-list
83690085|NCT05801328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690086|NCT05801328|Antifungal Agents|antifungal agents|mesh-ancestor
83690087|NCT05801328|Keratolytic Agents|keratolytic agents|mesh-ancestor
83690088|NCT05801328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690089|NCT05801315|Glycine|glycine|mesh-list
82844925|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
83690090|NCT05801315|Glycine Agents|glycine agents|mesh-ancestor
83690091|NCT05801315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690092|NCT05801315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690093|NCT05801315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690094|NCT05801289|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83690095|NCT05801289|Antidepressive Agents|antidepressive agents|mesh-ancestor
83690096|NCT05801289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83690097|NCT05801289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83690098|NCT05801289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83690099|NCT05801289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690100|NCT05801289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690101|NCT05801237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83690102|NCT05801237|Antibodies|antibodies|mesh-list
83690103|NCT05801237|Immunoglobulins|immunoglobulins|mesh-list
83690104|NCT05801237|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83690105|NCT05801237|Immunologic Factors|immunologic factors|mesh-ancestor
83690106|NCT05801237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690107|NCT05801237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690108|NCT05801172|Ketoprofen|ketoprofen|mesh-list
83690109|NCT05801172|Lidocaine|lidocaine|mesh-list
83690110|NCT05801172|Anesthetics|anesthetics|mesh-list
83690111|NCT05801172|Anesthetics, Local|anesthetics, local|mesh-ancestor
83690112|NCT05801172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690113|NCT05801172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690114|NCT05801172|Sensory System Agents|sensory system agents|mesh-ancestor
83690115|NCT05801172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690116|NCT05801172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83690117|NCT05801172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83690118|NCT05801172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83690119|NCT05801172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83690120|NCT05801172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690121|NCT05801172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690122|NCT05801172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690123|NCT05801172|Analgesics|analgesics|mesh-ancestor
83690124|NCT05801172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690125|NCT05801172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690126|NCT05801172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83690127|NCT05801172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690128|NCT05801133|Pirfenidone|pirfenidone|mesh-list
83690129|NCT05801133|Analgesics|analgesics|mesh-ancestor
83690130|NCT05801133|Sensory System Agents|sensory system agents|mesh-ancestor
83690131|NCT05801133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690132|NCT05801133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690133|NCT05801133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690134|NCT05801133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690135|NCT05801133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690136|NCT05801133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690137|NCT05801133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690138|NCT05801068|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
83690139|NCT05801068|Antithrombins|antithrombins|mesh-ancestor
83690140|NCT05801068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83690141|NCT05801068|Protease Inhibitors|protease inhibitors|mesh-ancestor
83690142|NCT05801068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690143|NCT05801068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690144|NCT05801068|Anticoagulants|anticoagulants|mesh-ancestor
83690145|NCT05801029|Osimertinib|osimertinib|mesh-list
83690146|NCT05801029|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83690147|NCT05801029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690148|NCT05801029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690149|NCT05801029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690150|NCT05801029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690151|NCT05801029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690152|NCT05800860|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83690153|NCT05800860|Hallucinogens|hallucinogens|mesh-ancestor
83690154|NCT05800860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690155|NCT05800860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83690156|NCT05800860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83690157|NCT05800860|Serotonin Agents|serotonin agents|mesh-ancestor
83690158|NCT05800860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690159|NCT05800860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690160|NCT05800860|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83690161|NCT05800847|Gabapentin|gabapentin|mesh-list
83690162|NCT05800847|Analgesics|analgesics|mesh-ancestor
83690163|NCT05800847|Sensory System Agents|sensory system agents|mesh-ancestor
83690164|NCT05800847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690165|NCT05800847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690167|NCT05800847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83690168|NCT05800847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83690169|NCT05800847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690170|NCT05800847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83690171|NCT05800847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83690172|NCT05800847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83690173|NCT05800847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690174|NCT05800847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690175|NCT05800847|Antimanic Agents|antimanic agents|mesh-ancestor
83690176|NCT05800834|Lidocaine|lidocaine|mesh-list
83690177|NCT05800834|Morphine|morphine|mesh-list
83690178|NCT05800834|Anesthetics, Local|anesthetics, local|mesh-ancestor
83690179|NCT05800834|Anesthetics|anesthetics|mesh-ancestor
83690180|NCT05800834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690181|NCT05800834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690182|NCT05800834|Sensory System Agents|sensory system agents|mesh-ancestor
83690183|NCT05800834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690184|NCT05800834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83690185|NCT05800834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83690186|NCT05800834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83690187|NCT05800834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83690188|NCT05800834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690189|NCT05800834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83690190|NCT05800834|Narcotics|narcotics|mesh-ancestor
83690191|NCT05800834|Analgesics|analgesics|mesh-ancestor
83690192|NCT05800756|Trastuzumab|trastuzumab|mesh-list
83690193|NCT05800756|Letrozole|letrozole|mesh-list
83690194|NCT05800756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690195|NCT05800756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690196|NCT05800756|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83690197|NCT05800756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83690198|NCT05800756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690199|NCT05800756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690200|NCT05800756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83690201|NCT05800756|Hormone Antagonists|hormone antagonists|mesh-ancestor
83690202|NCT05800756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83690203|NCT05800756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690204|NCT05800197|Tamoxifen|tamoxifen|mesh-list
83690205|NCT05800197|Letrozole|letrozole|mesh-list
83690206|NCT05800197|Anastrozole|anastrozole|mesh-list
83690207|NCT05800197|Goserelin|goserelin|mesh-list
83690208|NCT05800197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83690209|NCT05800197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690210|NCT05800197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83690211|NCT05800197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83690212|NCT05800197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690213|NCT05800197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690214|NCT05800197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83690215|NCT05800197|Hormone Antagonists|hormone antagonists|mesh-ancestor
83690216|NCT05800197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83690217|NCT05800197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690218|NCT05800197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83690219|NCT05800197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83690220|NCT05800197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83690221|NCT05800197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83690222|NCT05800197|Luteolytic Agents|luteolytic agents|mesh-ancestor
83690223|NCT05800197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83690224|NCT05800197|Contraceptive Agents|contraceptive agents|mesh-ancestor
83690225|NCT05800197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83690226|NCT05800197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83690227|NCT05798663|Atezolizumab|atezolizumab|mesh-list
83690228|NCT05798663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690229|NCT05798663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690230|NCT05798663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690231|NCT05798663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690232|NCT05797597|Aspirin|aspirin|mesh-list
83690233|NCT05797597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690234|NCT05797597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690235|NCT05797597|Analgesics|analgesics|mesh-ancestor
83690236|NCT05797597|Sensory System Agents|sensory system agents|mesh-ancestor
82845073|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690237|NCT05797597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690238|NCT05797597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690240|NCT05797597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690241|NCT05797597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83690242|NCT05797597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83690243|NCT05797597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690244|NCT05797597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83690245|NCT05797597|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83690246|NCT05797597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690247|NCT05797597|Antipyretics|antipyretics|mesh-ancestor
83690248|NCT05796661|Citric Acid|citric acid|mesh-list
83690249|NCT05796661|Sodium Citrate|sodium citrate|mesh-list
83690250|NCT05796661|Anticoagulants|anticoagulants|mesh-ancestor
83690251|NCT05796661|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83690252|NCT05796661|Chelating Agents|chelating agents|mesh-ancestor
83690253|NCT05796661|Sequestering Agents|sequestering agents|mesh-ancestor
83690254|NCT05796661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690255|NCT05794750|Capecitabine|capecitabine|mesh-list
83690256|NCT05794750|Oxaliplatin|oxaliplatin|mesh-list
83690257|NCT05794750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83690258|NCT05794750|Antimetabolites|antimetabolites|mesh-ancestor
83690259|NCT05794750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690260|NCT05794750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690261|NCT05792293|Atorvastatin|atorvastatin|mesh-list
83690262|NCT05792293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83690263|NCT05792293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83690264|NCT05792293|Antimetabolites|antimetabolites|mesh-ancestor
83690265|NCT05792293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690266|NCT05792293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83690267|NCT05792293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83690268|NCT05792293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690269|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
83690270|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83690271|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690272|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690273|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690274|NCT05785689|Analgesics|analgesics|mesh-ancestor
83690275|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
83690276|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690277|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83690278|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83690279|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83690280|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83690281|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690282|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690283|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
83690284|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83690285|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83690286|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690287|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
83690288|NCT05759156|Coagulants|coagulants|mesh-ancestor
83690289|NCT05753644|Ropivacaine|ropivacaine|mesh-list
83690290|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
83690291|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
83690292|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690293|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690294|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
83690295|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690296|NCT05752201|Vaccines|vaccines|mesh-list
83690297|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
83690298|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690299|NCT05756504|Ketorolac|ketorolac|mesh-list
83690300|NCT05756504|Tramadol|tramadol|mesh-list
83690301|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690302|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690303|NCT05756504|Analgesics|analgesics|mesh-ancestor
83690304|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
83690305|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690306|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690307|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690308|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845145|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845158|NCT04638790|Etoposide|etoposide|mesh-list
83690309|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83690310|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690311|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690312|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83690313|NCT05756504|Narcotics|narcotics|mesh-ancestor
83690314|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690315|NCT05699603|Fluorouracil|fluorouracil|mesh-list
83690316|NCT05699603|Calcipotriene|calcipotriene|mesh-list
83690317|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
83690318|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690319|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83690320|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690321|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690322|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
83690323|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690324|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690325|NCT05697510|Siltuximab|siltuximab|mesh-list
83690326|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690327|NCT05691400|Palbociclib|palbociclib|mesh-list
83690328|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690329|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690330|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690331|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690332|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
83690333|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83690334|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
83690335|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690336|NCT05657925|Ondansetron|ondansetron|mesh-list
83690337|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
83690338|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
83690339|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690340|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690341|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83690342|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
83690343|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690344|NCT05657925|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83690345|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83690346|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
83690347|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690348|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690349|NCT05656508|Vaccines|vaccines|mesh-list
83690350|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
83690351|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690352|NCT05622812|Lidocaine|lidocaine|mesh-list
83690353|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
83690354|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
83690355|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690356|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690357|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
83690358|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690359|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83690360|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83690361|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83690362|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83690363|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690364|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
83690365|NCT05611229|Nivolumab|nivolumab|mesh-list
83690366|NCT05611229|Ipilimumab|ipilimumab|mesh-list
83690367|NCT05611229|Trametinib|trametinib|mesh-list
83690368|NCT05611229|Vemurafenib|vemurafenib|mesh-list
83690369|NCT05611229|Dabrafenib|dabrafenib|mesh-list
83690370|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690371|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690372|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690373|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690374|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690375|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690376|NCT05601154|Listerine|listerine|mesh-list
83690377|NCT05601154|Fluorides|fluorides|mesh-list
83690378|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
83690379|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
83690380|NCT05601154|Protective Agents|protective agents|mesh-ancestor
83690381|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845220|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83690382|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83690383|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690385|NCT05566665|Tazobactam|tazobactam|mesh-list
83690386|NCT05566665|Ceftazidime|ceftazidime|mesh-list
83690387|NCT05566665|Avibactam|avibactam|mesh-list
83690388|NCT05566665|Ceftolozane|ceftolozane|mesh-list
83690389|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83690390|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83690391|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83690392|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690393|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83690394|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690395|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690396|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83690397|NCT05559476|Vaccines|vaccines|mesh-list
83690398|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
83690399|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690400|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83690401|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690402|NCT05534529|Rezafungin|rezafungin|mesh-list
83690403|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
83690404|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690405|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
83690406|NCT05521984|Carmustine|carmustine|mesh-list
83690407|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83690408|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690409|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83690410|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690411|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83690412|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
83690413|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690414|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
83690415|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690416|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83690417|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690418|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690419|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
83690420|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83690421|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690422|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83690423|NCT05497323|Adapalene|adapalene|mesh-list
83690424|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690425|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690426|NCT05497323|Analgesics|analgesics|mesh-ancestor
83690427|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
83690428|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690429|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690430|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690431|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690432|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690433|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83690434|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83690435|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83690436|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690437|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690438|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83690439|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83690440|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690441|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
83690442|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690443|NCT05371886|Midazolam|midazolam|mesh-list
83690444|NCT05371886|Morphine|morphine|mesh-list
83690445|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83690446|NCT05371886|Narcotics|narcotics|mesh-ancestor
83690447|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690448|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690449|NCT05371886|Analgesics|analgesics|mesh-ancestor
83690450|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
83690451|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690452|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83690453|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83690454|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83690455|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83690456|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845294|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83690457|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83690458|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
83690459|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
83690460|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
83690461|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
83690462|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690463|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690464|NCT05345782|Bupivacaine|bupivacaine|mesh-list
83690465|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
83690466|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
83690467|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690468|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690469|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
83690470|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690471|NCT05321420|Pirfenidone|pirfenidone|mesh-list
83690472|NCT05321420|Analgesics|analgesics|mesh-ancestor
83690473|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
83690474|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690475|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690476|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690477|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690478|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690479|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690480|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690481|NCT05309655|Adenosine|adenosine|mesh-list
83690482|NCT05309655|Analgesics|analgesics|mesh-ancestor
83690483|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
83690484|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690485|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690486|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83690487|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
83690488|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83690489|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
83690490|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
83690491|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690492|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690493|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83690494|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
83690495|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690496|NCT05265767|Factor VIII|factor viii|mesh-list
83690497|NCT05265767|Coagulants|coagulants|mesh-ancestor
83690498|NCT05249101|Capecitabine|capecitabine|mesh-list
83690499|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83690500|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
83690501|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690502|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690503|NCT05219799|Propranolol|propranolol|mesh-list
83690504|NCT05219799|Phentolamine|phentolamine|mesh-list
83690505|NCT05219799|Isoproterenol|isoproterenol|mesh-list
83690506|NCT05219799|Norepinephrine|norepinephrine|mesh-list
83690507|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83690508|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83690509|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
83690510|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690511|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690512|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690513|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83690514|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83690515|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
83690516|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83690517|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82845368|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83690518|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
82845369|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
82845370|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845371|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82845372|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82845373|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845374|NCT01202890|Bevacizumab|bevacizumab|mesh-list
82845375|NCT01202890|Lenalidomide|lenalidomide|mesh-list
82845376|NCT01202890|Doxorubicin|doxorubicin|mesh-list
82845377|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82845378|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845379|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845382|NCT01202890|Growth Substances|growth substances|mesh-ancestor
83690519|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
83690520|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690521|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83690522|NCT05219799|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83690523|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83690524|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83690525|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83690526|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83690527|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83690528|NCT05219799|Protective Agents|protective agents|mesh-ancestor
83690529|NCT05215951|Osimertinib|osimertinib|mesh-list
83690530|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690531|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690532|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690533|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690534|NCT05161468|Triamcinolone|triamcinolone|mesh-list
83690535|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83690536|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83690537|NCT05161468|Lidocaine|lidocaine|mesh-list
83690538|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
83690539|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
83690540|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83690541|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
83690542|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
83690543|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690544|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690545|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
83690546|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690547|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83690548|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83690549|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83690550|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83690551|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690552|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
83690553|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690554|NCT05161468|Hormones|hormones|mesh-ancestor
83690555|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83690556|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690557|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
83690558|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690559|NCT05108389|Hemostatics|hemostatics|mesh-list
83690560|NCT05108389|Coagulants|coagulants|mesh-ancestor
83690561|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
83690562|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83690563|NCT05104762|Antibodies|antibodies|mesh-list
83690564|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
83690565|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83690566|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
83690567|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690568|NCT05103358|Sirolimus|sirolimus|mesh-list
83690569|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83690570|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690571|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83690572|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690573|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
83690574|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690575|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
83690576|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690577|NCT05083312|Fluticasone|fluticasone|mesh-list
83690578|NCT05083312|Xhance|xhance|mesh-list
83690579|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690580|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83690581|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
83690582|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690583|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690584|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83690585|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83690586|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690587|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83690588|NCT05027425|Durvalumab|durvalumab|mesh-list
83690589|NCT05027425|Tremelimumab|tremelimumab|mesh-list
83690590|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690591|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690592|NCT05003648|Pramipexole|pramipexole|mesh-list
82845441|NCT01204450|Valproic Acid|valproic acid|mesh-list
82845477|NCT02428270|Trametinib|trametinib|mesh-list
83690593|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
83690594|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690595|NCT05003648|Protective Agents|protective agents|mesh-ancestor
83690596|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690597|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83690598|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83690599|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
83690600|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
83690601|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690602|NCT04991480|Niraparib|niraparib|mesh-list
83690603|NCT04991480|Talazoparib|talazoparib|mesh-list
83690604|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83690605|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690606|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690607|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690608|NCT04892043|Nivolumab|nivolumab|mesh-list
83690609|NCT04892043|Ipilimumab|ipilimumab|mesh-list
83690610|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690611|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690612|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690613|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690614|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
83690615|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83690616|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690617|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83690618|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690619|NCT04880278|Nabilone|nabilone|mesh-list
83690620|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
83690621|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
83690622|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690623|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690624|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83690625|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83690626|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83690627|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690628|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83690629|NCT04858425|Niclosamide|niclosamide|mesh-list
83690630|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
83690631|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83690632|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
83690633|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83690634|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690635|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
83690636|NCT04845035|Cytarabine|cytarabine|mesh-list
83690637|NCT04845035|Methotrexate|methotrexate|mesh-list
83690638|NCT04845035|Dasatinib|dasatinib|mesh-list
83690639|NCT04845035|Ponatinib|ponatinib|mesh-list
83690640|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83690641|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
83690642|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83690643|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690644|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83690645|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
83690646|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690647|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690648|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690649|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690650|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83690651|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690652|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
83690653|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690654|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83690655|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
83690656|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690657|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690658|NCT04835506|Infliximab|infliximab|mesh-list
83690659|NCT04835506|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83690660|NCT04835506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690661|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690662|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83690663|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690664|NCT04824092|Prednisone|prednisone|mesh-list
83690665|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
83690666|NCT04824092|Rituximab|rituximab|mesh-list
82845514|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690667|NCT04824092|Doxorubicin|doxorubicin|mesh-list
82845515|NCT02047474|Antidotes|antidotes|mesh-ancestor
83690668|NCT04824092|Vincristine|vincristine|mesh-list
83690669|NCT04824092|Lenalidomide|lenalidomide|mesh-list
83690670|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690671|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
83690672|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690673|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690674|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83690675|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
83690676|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690677|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690678|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83690679|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690680|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83690681|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83690682|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83690683|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690684|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690685|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
83690686|NCT04824092|Hormones|hormones|mesh-ancestor
83690687|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83690688|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83690689|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83690690|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
83690691|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
83690692|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
83690693|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83690694|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83690695|NCT04824092|Growth Substances|growth substances|mesh-ancestor
83690696|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
83690697|NCT04820179|Atezolizumab|atezolizumab|mesh-list
83690698|NCT04820179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690699|NCT04820179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690700|NCT04820179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690701|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690702|NCT04762758|Naltrexone|naltrexone|mesh-list
83690703|NCT04762758|Baclofen|baclofen|mesh-list
83690704|NCT04762758|Sorbitol|sorbitol|mesh-list
83690705|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83690706|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83690707|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690708|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
83690709|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690710|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83690711|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83690712|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83690713|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
83690714|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
83690715|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690716|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690717|NCT04762758|Cathartics|cathartics|mesh-ancestor
83690718|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83690719|NCT04732065|Dopamine|dopamine|mesh-list
83690720|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83690721|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
83690722|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
83690723|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690724|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690725|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
83690726|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690727|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690728|NCT04732065|Protective Agents|protective agents|mesh-ancestor
83690729|NCT04717908|Linezolid|linezolid|mesh-list
83690730|NCT04717908|Cycloserine|cycloserine|mesh-list
83690731|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
83690732|NCT04717908|Bedaquiline|bedaquiline|mesh-list
83690733|NCT04717908|Clofazimine|clofazimine|mesh-list
83690734|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83690735|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690736|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83690737|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690738|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690739|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83690740|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83690741|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
83690742|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
83690743|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690744|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
83690745|NCT04665895|Fluticasone|fluticasone|mesh-list
83690746|NCT04665895|Xhance|xhance|mesh-list
83690747|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83690748|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83690749|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
83690750|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690751|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690752|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83690753|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
83690754|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690755|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83690756|NCT04594187|Immunomodulating Agents|immunomodulating agents|mesh-list
83690757|NCT04594187|Immunologic Factors|immunologic factors|mesh-ancestor
83690758|NCT04594187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690759|NCT04559230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83690760|NCT04559230|Immunoconjugates|immunoconjugates|mesh-ancestor
83690761|NCT04559230|Immunologic Factors|immunologic factors|mesh-ancestor
83690762|NCT04559230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690763|NCT04549792|Ustekinumab|ustekinumab|mesh-list
83690764|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83690765|NCT04545554|Vitamin D|vitamin d|mesh-list
83690766|NCT04545554|Calcium|calcium|mesh-list
83690767|NCT04545554|Vitamins|vitamins|mesh-ancestor
83690768|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
83690769|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690770|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83690771|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83690772|NCT04530058|Metformin|metformin|mesh-list
83690773|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83690774|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690775|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83690776|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690777|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690778|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690779|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83690780|NCT04500574|Latanoprost|latanoprost|mesh-list
83690781|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83690782|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83690783|NCT04483505|Fulvestrant|fulvestrant|mesh-list
83690784|NCT04483505|Palbociclib|palbociclib|mesh-list
83690785|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83690786|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690787|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83690788|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83690789|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
83690790|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83690791|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690792|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690793|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690794|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690795|NCT04461535|Hormones|hormones|mesh-list
83690796|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83690797|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83690798|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
83690799|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83690800|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690801|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690802|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690803|NCT04459715|Cisplatin|cisplatin|mesh-list
83690804|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690805|NCT04445662|Varenicline|varenicline|mesh-list
83690806|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83690807|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83690808|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
83690809|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690810|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690811|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690812|NCT04416282|Terlipressin|terlipressin|mesh-list
83690813|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83690814|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83690815|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83690816|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83690817|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690818|NCT04375150|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83690819|NCT04375150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845663|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
83690820|NCT04375150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690821|NCT04375150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690822|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83690823|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690824|NCT04323046|Nivolumab|nivolumab|mesh-list
83690825|NCT04323046|Ipilimumab|ipilimumab|mesh-list
83690826|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690827|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690828|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690829|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690830|NCT04170946|Talazoparib|talazoparib|mesh-list
83690831|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83690832|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690833|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690834|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690835|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
83690836|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83690837|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83690838|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690839|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83690840|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690841|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83690842|NCT04112498|Nivolumab|nivolumab|mesh-list
83690843|NCT04112498|Relatlimab|relatlimab|mesh-list
83690844|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690845|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690846|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690847|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690848|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
83690849|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690850|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690851|NCT04104893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690852|NCT04104893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690853|NCT04042051|Trastuzumab|trastuzumab|mesh-list
83690854|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83690855|NCT04042051|Maytansine|maytansine|mesh-list
83690856|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690857|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690858|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83690859|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
83690860|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
83690861|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
83690862|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690863|NCT04042051|Immunotoxins|immunotoxins|mesh-ancestor
83690864|NCT04042051|Immunoconjugates|immunoconjugates|mesh-ancestor
83690865|NCT04042051|Immunologic Factors|immunologic factors|mesh-ancestor
83690866|NCT04042051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690867|NCT04033991|Sunitinib|sunitinib|mesh-list
83690868|NCT04033991|Axitinib|axitinib|mesh-list
83690869|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690870|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83690871|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83690872|NCT04033991|Growth Substances|growth substances|mesh-ancestor
83690873|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690874|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
83690875|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690876|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690877|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690878|NCT03975231|Trametinib|trametinib|mesh-list
83690879|NCT03975231|Dabrafenib|dabrafenib|mesh-list
83690880|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690881|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83690882|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690883|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690884|NCT03961360|Aspirin|aspirin|mesh-list
83690885|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83690886|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690887|NCT03961360|Analgesics|analgesics|mesh-ancestor
83690888|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
83690889|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690890|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690891|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845771|NCT01205932|Enoxaparin|enoxaparin|mesh-list
83690892|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690893|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83690894|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83690895|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690896|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83690897|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83690898|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690899|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
83690900|NCT03924401|Abatacept|abatacept|mesh-list
83690901|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83690902|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690903|NCT03924401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690904|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690905|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690906|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
83690907|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690908|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83690909|NCT03769285|Niacinamide|niacinamide|mesh-list
83690910|NCT03769285|Niacin|niacin|mesh-list
83690911|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
83690912|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
83690913|NCT03769285|Vitamins|vitamins|mesh-ancestor
83690914|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
83690915|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690916|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83690917|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
83690918|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690919|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83690920|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
83690921|NCT03749187|Temozolomide|temozolomide|mesh-list
83690922|NCT03749187|Pamiparib|pamiparib|mesh-list
83690923|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83690924|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83690925|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
83690926|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690927|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690928|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690929|NCT03738553|Trastuzumab|trastuzumab|mesh-list
83690930|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690931|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690932|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
83690933|NCT03705806|Immunomodulating Agents|immunomodulating agents|mesh-list
83690934|NCT03705806|Immunologic Factors|immunologic factors|mesh-ancestor
83690935|NCT03705806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690936|NCT03642132|Bevacizumab|bevacizumab|mesh-list
83690937|NCT03642132|Avelumab|avelumab|mesh-list
83690938|NCT03642132|Talazoparib|talazoparib|mesh-list
83690939|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83690940|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690941|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83690942|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83690943|NCT03642132|Growth Substances|growth substances|mesh-ancestor
83690944|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690945|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
83690946|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83690947|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690948|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690949|NCT03632330|Midazolam|midazolam|mesh-list
83690950|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
83690951|NCT03632330|Propofol|propofol|mesh-list
83690952|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83690953|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83690954|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690955|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83690956|NCT03632330|Analgesics|analgesics|mesh-ancestor
83690957|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
83690958|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83690959|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83690960|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83690961|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83690962|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
83690963|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83690964|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690965|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82845816|NCT05665114|Cytarabine|cytarabine|mesh-list
83690966|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
83690967|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
83690968|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83690969|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83690970|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83690971|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83690972|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
83690973|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
83690974|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
83690975|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83690976|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83690977|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690978|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
83690979|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
83690980|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690981|NCT03572764|Cytarabine|cytarabine|mesh-list
83690982|NCT03572764|Daunorubicin|daunorubicin|mesh-list
83690983|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83690984|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
83690985|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83690986|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83690987|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
83690988|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83690989|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83690990|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
83690991|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690992|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83690993|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83690994|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83690995|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83690996|NCT03560752|Vaccines|vaccines|mesh-list
83690997|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
83690998|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83690999|NCT03506061|Ivacaftor|ivacaftor|mesh-list
83691000|NCT03506061|Elexacaftor|elexacaftor|mesh-list
83691001|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83691002|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83691003|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691004|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
83691005|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83691006|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83691007|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691008|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
83691009|NCT03475342|Coagulants|coagulants|mesh-ancestor
83691010|NCT03466151|Sirolimus|sirolimus|mesh-list
83691011|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83691012|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691013|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83691014|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691015|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
83691016|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691017|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
83691018|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691019|NCT03452930|Benzimidazole|benzimidazole|mesh-list
83691020|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
83691021|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83691022|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691023|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83691024|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83691025|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691026|NCT03253289|Meclizine|meclizine|mesh-list
83691027|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
83691028|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
83691029|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691030|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691031|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691032|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83691033|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
83691034|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
83691035|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691036|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691037|NCT03253289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82845891|NCT01206946|Hormones|hormones|mesh-ancestor
83691038|NCT03253289|Cholinergic Agents|cholinergic agents|mesh-ancestor
83691039|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83691040|NCT03227705|Progesterone|progesterone|mesh-list
83691041|NCT03227705|Progestins|progestins|mesh-ancestor
83691042|NCT03227705|Hormones|hormones|mesh-ancestor
83691043|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691044|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691045|NCT03219268|Margetuximab|margetuximab|mesh-list
83691046|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691047|NCT03188432|Carboplatin|carboplatin|mesh-list
83691048|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691049|NCT03176953|Topiramate|topiramate|mesh-list
83691050|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
83691051|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83691052|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691053|NCT03150004|Cytarabine|cytarabine|mesh-list
83691054|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
83691055|NCT03150004|Cladribine|cladribine|mesh-list
83691056|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691057|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
83691058|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691059|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691060|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
83691061|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691062|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691063|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
83691064|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691065|NCT03150004|Analgesics|analgesics|mesh-ancestor
83691066|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
83691067|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691068|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83691069|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83691070|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691071|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
83691072|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691073|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691074|NCT03149822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691075|NCT03149822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691076|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
83691077|NCT03082534|Cetuximab|cetuximab|mesh-list
83691078|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691079|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691080|NCT03082534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691081|NCT03082534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691082|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
83691083|NCT03056339|Fludarabine|fludarabine|mesh-list
83691084|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
83691085|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691086|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
83691087|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691088|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83691089|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83691090|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
83691091|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691092|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691093|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83691094|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691095|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
83691096|NCT02960230|Nivolumab|nivolumab|mesh-list
83691097|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691098|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691099|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691100|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691101|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
83691102|NCT02816021|Azacitidine|azacitidine|mesh-list
83691103|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691104|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691105|NCT02816021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691106|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691107|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691108|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
83691109|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691110|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
83691111|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691112|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691113|NCT02777385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691114|NCT02777385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691115|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82845965|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
83691116|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83691117|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691118|NCT02682511|Ifetroban|ifetroban|mesh-list
83691119|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83691120|NCT02584634|Avelumab|avelumab|mesh-list
83691121|NCT02584634|Crizotinib|crizotinib|mesh-list
83691122|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691123|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691124|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691125|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691126|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691127|NCT02351869|Midazolam|midazolam|mesh-list
83691128|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
83691129|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83691130|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83691131|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691132|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691133|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83691134|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83691135|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83691136|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83691137|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
83691138|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
83691139|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
83691140|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
83691141|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691142|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691143|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83691144|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83691145|NCT02351869|Analgesics|analgesics|mesh-ancestor
83691146|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
83691147|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691148|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
83691149|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691150|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691151|NCT02311582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691152|NCT02311582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691153|NCT02237820|Dexamethasone|dexamethasone|mesh-list
83691154|NCT02237820|Prednisone|prednisone|mesh-list
83691155|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691156|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
83691157|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
83691158|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691159|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691160|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691161|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
83691162|NCT02237820|Hormones|hormones|mesh-ancestor
83691163|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691164|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691165|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691166|NCT02160353|Prednisolone|prednisolone|mesh-list
83691167|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
83691168|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691169|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
83691170|NCT02160353|Hormones|hormones|mesh-ancestor
83691171|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691172|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691173|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691174|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691175|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83691176|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691177|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691178|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
83691179|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83691180|NCT02152358|Acyclovir|acyclovir|mesh-list
83691181|NCT02152358|Ganciclovir|ganciclovir|mesh-list
83691182|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83691183|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
83691184|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691185|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691186|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691187|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691188|NCT02125461|Durvalumab|durvalumab|mesh-list
83691189|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691190|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691191|NCT01892371|Cytarabine|cytarabine|mesh-list
83691192|NCT01892371|Azacitidine|azacitidine|mesh-list
83691193|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691194|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
83691195|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691196|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691197|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
83691198|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691199|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691200|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
83691201|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691202|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691203|NCT01819064|Atropine|atropine|mesh-list
83691204|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83691205|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83691206|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83691207|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
83691208|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691209|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691210|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83691211|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
83691212|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
83691213|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
83691214|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83691215|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83691216|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
83691217|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691218|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691219|NCT01817751|Sorafenib|sorafenib|mesh-list
83691220|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
83691221|NCT01817751|Valproic Acid|valproic acid|mesh-list
83691222|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691223|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691224|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691225|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691226|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
83691227|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83691228|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83691229|NCT01817751|Urological Agents|urological agents|mesh-ancestor
83691230|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
83691231|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
83691232|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691233|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691234|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
83691235|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83691236|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691237|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83691238|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83691239|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83691240|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691241|NCT01748149|Vemurafenib|vemurafenib|mesh-list
83691242|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691243|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691244|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691245|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691246|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83691247|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83691248|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691249|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
83691250|NCT00812669|Rituximab|rituximab|mesh-list
83691251|NCT00812669|Fludarabine|fludarabine|mesh-list
83691252|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
83691253|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691254|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
83691255|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691256|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83691257|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83691258|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
83691259|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691260|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691261|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83691262|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691263|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82846113|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83691264|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
83691265|NCT00188539|Anesthetics|anesthetics|mesh-list
83691266|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691267|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691268|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83691269|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
83691270|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691271|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83691272|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83691273|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83691274|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
83691275|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691276|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83691277|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83691278|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691279|NCT03870880|Risperidone|risperidone|mesh-list
83691280|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83691281|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
83691282|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691283|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691284|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691285|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83691286|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83691287|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691288|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83691289|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83691290|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
83691291|NCT03861377|Remifentanil|remifentanil|mesh-list
83691292|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83691293|NCT03861377|Narcotics|narcotics|mesh-ancestor
83691294|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691295|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691296|NCT03861377|Analgesics|analgesics|mesh-ancestor
83691297|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
83691298|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691299|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83691300|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83691301|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691302|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
83691303|NCT03836144|Diuretics|diuretics|mesh-ancestor
83691304|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
83691305|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691306|NCT03836144|Expectorants|expectorants|mesh-ancestor
83691307|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83691308|NCT03796416|Misoprostol|misoprostol|mesh-list
83691309|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83691310|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
83691311|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83691312|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691313|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83691314|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691315|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
83691317|NCT03785106|Pyridoxine|pyridoxine|mesh-list
83691318|NCT03785106|Pyridoxal|pyridoxal|mesh-list
83691319|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
83691320|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
83691321|NCT03785106|Isoniazid|isoniazid|mesh-list
83691322|NCT03785106|Rifapentine|rifapentine|mesh-list
83691323|NCT03785106|Rifampin|rifampin|mesh-list
83691324|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
83691325|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691326|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
83691327|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83691328|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691329|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83691330|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83691331|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
83691332|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691333|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83691334|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83691335|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
83691336|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691337|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691338|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83691339|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82846186|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494541|NCT02243618|Rebamipide|rebamipide|mesh-list
83691340|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83691341|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83691342|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83691343|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83691345|NCT03782142|Dolutegravir|dolutegravir|mesh-list
83691346|NCT03782142|Rilpivirine|rilpivirine|mesh-list
83691347|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83691348|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
83691349|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691350|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83691351|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691352|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691353|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691354|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83691355|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83691356|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83691357|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83691358|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
83691359|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83691360|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83691361|NCT03770299|Paclitaxel|paclitaxel|mesh-list
83691362|NCT03770299|Vinorelbine|vinorelbine|mesh-list
83691363|NCT03770299|Docetaxel|docetaxel|mesh-list
83691364|NCT03770299|Carboplatin|carboplatin|mesh-list
83691365|NCT03770299|Gemcitabine|gemcitabine|mesh-list
83691366|NCT03770299|Nivolumab|nivolumab|mesh-list
83691367|NCT03770299|Pemetrexed|pemetrexed|mesh-list
83691368|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83691369|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691370|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
83691371|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
83691372|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
83691373|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691374|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691375|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
83691376|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691377|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691378|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691379|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83691380|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691381|NCT03760835|Dexamethasone|dexamethasone|mesh-list
83691382|NCT03760835|Prednisone|prednisone|mesh-list
83691383|NCT03760835|Prednisolone|prednisolone|mesh-list
83691384|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
83691385|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83691386|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83691387|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83691388|NCT03760835|Cortisone|cortisone|mesh-list
83691389|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
83691390|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691391|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
83691392|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
83691393|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691394|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691395|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691396|NCT03760835|Hormones|hormones|mesh-ancestor
83691397|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691398|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691399|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691400|NCT03759496|Durvalumab|durvalumab|mesh-list
83691401|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691402|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691403|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
83691404|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691405|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691406|NCT03748784|Aflibercept|aflibercept|mesh-list
83691407|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83691408|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83691409|NCT03748784|Growth Substances|growth substances|mesh-ancestor
83691410|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691411|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
82846261|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83691412|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691413|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
83691414|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691415|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691416|NCT03727750|Immunotoxins|immunotoxins|mesh-ancestor
83691417|NCT03727750|Immunoconjugates|immunoconjugates|mesh-ancestor
83691418|NCT03727750|Immunologic Factors|immunologic factors|mesh-ancestor
83691419|NCT03727750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691420|NCT03724409|Octreotide|octreotide|mesh-list
83691421|NCT03724409|Edotreotide|edotreotide|mesh-list
83691422|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691423|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691424|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691425|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83691426|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691427|NCT03715829|PF-06700841|pf-06700841|mesh-list
83691428|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691429|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691430|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691431|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
83691432|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
83691433|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83691434|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83691435|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691436|NCT03704441|Bupivacaine|bupivacaine|mesh-list
83691437|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
83691438|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
83691439|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691440|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691441|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
83691442|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691443|NCT03693677|Paclitaxel|paclitaxel|mesh-list
83691444|NCT03693677|Gemcitabine|gemcitabine|mesh-list
83691445|NCT03693677|Irinotecan|irinotecan|mesh-list
83691446|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83691447|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691448|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
83691449|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
83691450|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
83691451|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691452|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691453|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
83691454|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83691455|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83691456|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691457|NCT03673826|Dexamethasone|dexamethasone|mesh-list
83691458|NCT03673826|Lenalidomide|lenalidomide|mesh-list
83691459|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691460|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
83691461|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
83691462|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691463|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691464|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691465|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
83691466|NCT03673826|Hormones|hormones|mesh-ancestor
83691467|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691468|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691469|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691470|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
83691471|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83691472|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83691473|NCT03673826|Growth Substances|growth substances|mesh-ancestor
83691474|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
83691475|NCT03660839|Artefenomel|artefenomel|mesh-list
83691476|NCT03660839|Ferroquine|ferroquine|mesh-list
83691477|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
83691478|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83691479|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83691480|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691481|NCT03660241|Abrocitinib|abrocitinib|mesh-list
83691482|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691483|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691484|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691485|NCT03651102|Thalidomide|thalidomide|mesh-list
83691486|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
83691487|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691488|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
83691489|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691490|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
83691491|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83691492|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691493|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83691494|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83691496|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83691497|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691498|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
83691499|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691500|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691501|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691502|NCT03649802|Vitamin D|vitamin d|mesh-list
83691503|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
83691504|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
83691505|NCT03649802|Vitamins|vitamins|mesh-list
83691506|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
83691507|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691508|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83691509|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83691510|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83691511|NCT03643198|Metronidazole|metronidazole|mesh-list
83691512|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
83691513|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691514|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83691515|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83691516|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83691517|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83691518|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691519|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691520|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691521|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83691522|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83691523|NCT03606980|Dexamethasone|dexamethasone|mesh-list
83691524|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
83691525|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83691526|NCT03606980|BB 1101|bb 1101|mesh-list
83691527|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691528|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
83691529|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
83691530|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691531|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691532|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691533|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
83691534|NCT03606980|Hormones|hormones|mesh-ancestor
83691535|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691536|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691537|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691538|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
83691539|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691540|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691541|NCT03576417|Nivolumab|nivolumab|mesh-list
83691542|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691543|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691544|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691545|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691546|NCT03573115|Adapalene|adapalene|mesh-list
83691547|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83691548|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
83691549|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83691550|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83691551|NCT03573115|Analgesics|analgesics|mesh-ancestor
83691552|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
83691553|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691554|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691555|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691556|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83691557|NCT03569475|Milnacipran|milnacipran|mesh-list
83691558|NCT03569475|Fluoxetine|fluoxetine|mesh-list
83691559|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
83691560|NCT03569475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83691561|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83691562|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83691563|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846408|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846412|NCT01080612|Pregabalin|pregabalin|mesh-list
83691564|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691566|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691567|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83691568|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
83691569|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83691570|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83691571|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83691572|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691573|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83691574|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83691575|NCT03569475|Analgesics|analgesics|mesh-ancestor
83691576|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
83691577|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691578|NCT03546556|Alovudine|alovudine|mesh-list
83691579|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
83691580|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
83691581|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691582|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
83691583|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691584|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83691585|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691586|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691587|NCT03533712|Folic Acid|folic acid|mesh-list
83691588|NCT03533712|Hematinics|hematinics|mesh-ancestor
83691589|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
83691590|NCT03533712|Vitamins|vitamins|mesh-ancestor
83691591|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
83691592|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691593|NCT03523520|Naltrexone|naltrexone|mesh-list
83691594|NCT03523520|Bromides|bromides|mesh-list
83691595|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
83691596|NCT03523520|Naloxegol|naloxegol|mesh-list
83691597|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
83691598|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83691599|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691600|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
83691601|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691602|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83691603|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
83691604|NCT03518242|Capecitabine|capecitabine|mesh-list
83691605|NCT03518242|Methotrexate|methotrexate|mesh-list
83691606|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691607|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
83691608|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691609|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83691610|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83691611|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
83691612|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691613|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691614|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83691615|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691616|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
83691617|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83691618|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
83691619|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83691620|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83691621|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691622|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83691623|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691624|NCT03500549|Eculizumab|eculizumab|mesh-list
83691625|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83691626|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691627|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
83691628|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691629|NCT03435185|Lidocaine|lidocaine|mesh-list
83691630|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
83691631|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
83691632|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691633|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691634|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
83691635|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691636|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82846483|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691637|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83691638|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83691639|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83691640|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691641|NCT03426293|Heparin|heparin|mesh-list
83691642|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
83691643|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83691644|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83691645|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691646|NCT03383380|Sirolimus|sirolimus|mesh-list
83691647|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83691648|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691649|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83691650|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691651|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
83691652|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691653|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
83691654|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691655|NCT03325439|Brivaracetam|brivaracetam|mesh-list
83691656|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
83691657|NCT03242772|Amphetamine|amphetamine|mesh-list
83691658|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83691659|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691660|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
83691661|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
83691662|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691663|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
83691664|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691665|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691666|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
83691667|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83691668|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83691669|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83691670|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83691671|NCT03236311|Adenosine|adenosine|mesh-list
83691672|NCT03236311|Regadenoson|regadenoson|mesh-list
83691673|NCT03236311|Analgesics|analgesics|mesh-ancestor
83691674|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
83691675|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691676|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691677|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83691678|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
83691679|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83691680|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
83691681|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
83691682|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691683|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691684|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83691685|NCT03234686|Deferiprone|deferiprone|mesh-list
83691686|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83691687|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
83691688|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
83691689|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691690|NCT03223974|Paclitaxel|paclitaxel|mesh-list
83691691|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83691692|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691693|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
83691694|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
83691695|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
83691696|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691697|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
83691698|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83691699|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691700|NCT03190369|Hylan|hylan|mesh-list
83691701|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
83691702|NCT03190369|Protective Agents|protective agents|mesh-ancestor
83691703|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691704|NCT05438342|Immunomodulating Agents|immunomodulating agents|mesh-list
83691705|NCT05438342|Immunologic Factors|immunologic factors|mesh-ancestor
83691706|NCT05438342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691707|NCT05438108|Bevacizumab|bevacizumab|mesh-list
83691708|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691709|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691710|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82846557|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82846560|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
83691711|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83691713|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691714|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
83691715|NCT05437783|Azithromycin|azithromycin|mesh-list
83691716|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83691717|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691718|NCT05437718|Ropivacaine|ropivacaine|mesh-list
83691719|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
83691720|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
83691721|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691722|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691723|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
83691724|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691725|NCT05437497|Propofol|propofol|mesh-list
83691726|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83691727|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691728|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691729|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83691730|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
83691731|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
83691732|NCT05437471|Letrozole|letrozole|mesh-list
83691733|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
83691734|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691735|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83691736|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83691737|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691738|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691739|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83691740|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
83691741|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691742|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691743|NCT05437471|Progestins|progestins|mesh-ancestor
83691744|NCT05437471|Hormones|hormones|mesh-ancestor
83691745|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
83691746|NCT05437432|Methamphetamine|methamphetamine|mesh-list
83691747|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83691748|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691749|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
83691750|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
83691751|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691752|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
83691753|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691754|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691755|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
83691756|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83691757|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83691758|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83691759|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83691760|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
83691761|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83691762|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691763|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
83691764|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83691765|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691766|NCT05437224|Ambrisentan|ambrisentan|mesh-list
83691767|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83691768|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
83691769|NCT05436990|Vactosertib|vactosertib|mesh-list
83691770|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691771|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691772|NCT05436990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691773|NCT05436990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691774|NCT05436990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691775|NCT05436990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691776|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
83691777|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83691778|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691779|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691780|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83691781|NCT05436964|Analgesics|analgesics|mesh-ancestor
83691782|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
83691783|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691784|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83691785|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83691787|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
83691788|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691789|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691790|NCT05426811|Raltitrexed|raltitrexed|mesh-list
83691791|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691792|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
83691793|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691794|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691795|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83691796|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691797|NCT05357859|Vitamin D|vitamin d|mesh-list
83691798|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
83691799|NCT05357859|Vitamins|vitamins|mesh-ancestor
83691800|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
83691801|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691802|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83691803|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83691804|NCT05239169|Capecitabine|capecitabine|mesh-list
83691805|NCT05239169|Durvalumab|durvalumab|mesh-list
83691806|NCT05239169|Tremelimumab|tremelimumab|mesh-list
83691807|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691808|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
83691809|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691810|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691811|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691812|NCT05006079|Morphine|morphine|mesh-list
83691813|NCT05006079|Alprazolam|alprazolam|mesh-list
83691814|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83691815|NCT05006079|Narcotics|narcotics|mesh-ancestor
83691816|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83691817|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691818|NCT05006079|Analgesics|analgesics|mesh-ancestor
83691819|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
83691820|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691821|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83691822|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83691823|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83691824|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83691825|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
83691826|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
83691827|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691828|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691829|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
83691830|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83691831|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
83691832|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83691833|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
83691834|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691835|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691836|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
83691837|NCT04895046|Niraparib|niraparib|mesh-list
83691838|NCT04895046|Dostarlimab|dostarlimab|mesh-list
83691839|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83691840|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691841|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691842|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691843|NCT04765514|Temozolomide|temozolomide|mesh-list
83691844|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83691845|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
83691846|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691847|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691848|NCT04590586|Thalidomide|thalidomide|mesh-list
83691849|NCT04590586|Apremilast|apremilast|mesh-list
83691850|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83691851|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83691852|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83691853|NCT04590586|Analgesics|analgesics|mesh-ancestor
83691854|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
83691855|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691856|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691857|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691858|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846706|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83691859|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83691860|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83691861|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691862|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691863|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83691864|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
83691865|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
83691866|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83691867|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691868|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83691869|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83691870|NCT04590586|Growth Substances|growth substances|mesh-ancestor
83691871|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
83691872|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691873|NCT04312009|Losartan|losartan|mesh-list
83691874|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83691875|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83691876|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83691877|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83691878|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691879|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
83691880|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
83691881|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83691882|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691883|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691884|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
83691885|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
83691886|NCT03850483|PF-06700841|pf-06700841|mesh-list
83691887|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691888|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691889|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691890|NCT03819296|Prednisone|prednisone|mesh-list
83691891|NCT03819296|Infliximab|infliximab|mesh-list
83691892|NCT03819296|Cortisone|cortisone|mesh-list
83691893|NCT03819296|Vedolizumab|vedolizumab|mesh-list
83691894|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
83691895|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
83691896|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83691897|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
83691898|NCT03819296|Hormones|hormones|mesh-ancestor
83691899|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691900|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691901|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691902|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691903|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
83691904|NCT03819296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83691905|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
83691906|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83691907|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83691908|NCT03563742|Tenofovir|tenofovir|mesh-list
83691909|NCT03563742|Lamivudine|lamivudine|mesh-list
83691910|NCT03563742|Rilpivirine|rilpivirine|mesh-list
83691911|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
83691912|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691913|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83691914|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83691915|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691916|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691917|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83691918|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83691919|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
83691920|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691921|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691922|NCT03473925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83691923|NCT03473925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691924|NCT03424122|Rituximab|rituximab|mesh-list
83691925|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83691926|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691927|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691928|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
83691929|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691930|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846782|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83691931|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83691932|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
83691933|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691934|NCT03230097|BI 409306|bi 409306|mesh-list
83691935|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83691936|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691937|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691938|NCT02968940|Avelumab|avelumab|mesh-list
83691939|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83691940|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691941|NCT02663908|Leuprolide|leuprolide|mesh-list
83691942|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83691943|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
83691944|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83691945|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691946|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83691947|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691948|NCT02333292|Ritonavir|ritonavir|mesh-list
83691949|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
83691950|NCT02333292|Grazoprevir|grazoprevir|mesh-list
83691951|NCT02333292|Ledipasvir|ledipasvir|mesh-list
83691952|NCT02333292|Velpatasvir|velpatasvir|mesh-list
83691953|NCT02333292|Simeprevir|simeprevir|mesh-list
83691954|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83691955|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83691956|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
83691957|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691958|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691959|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83691960|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83691961|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
83691962|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691963|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83691964|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83691965|NCT02203773|Posaconazole|posaconazole|mesh-list
83691966|NCT02203773|Azacitidine|azacitidine|mesh-list
83691967|NCT02203773|Decitabine|decitabine|mesh-list
83691968|NCT02203773|Venetoclax|venetoclax|mesh-list
83691969|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83691970|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
83691971|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83691972|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83691973|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83691974|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
83691975|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83691976|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83691977|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83691978|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83691979|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83691980|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83691981|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83691982|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
83691983|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83691984|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691985|NCT02175030|Copper|copper|mesh-list
83691986|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
83691987|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83691988|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
83691989|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83691990|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83691991|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83691992|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83691993|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83691994|NCT02175030|Trace Elements|trace elements|mesh-ancestor
83691995|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
83691996|NCT01734512|Everolimus|everolimus|mesh-list
83691997|NCT01734512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83691998|NCT01734512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83691999|NCT01734512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692000|NCT01734512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692001|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692002|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
83692003|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692004|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692005|NCT01555541|Cytarabine|cytarabine|mesh-list
83692006|NCT01555541|Etoposide|etoposide|mesh-list
83692007|NCT01555541|Ofatumumab|ofatumumab|mesh-list
83692008|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83692009|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692010|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83692011|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83692012|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692013|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692014|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692015|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
83692016|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
83692017|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692018|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692019|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
83692020|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692021|NCT01398852|Riboflavin|riboflavin|mesh-list
83692022|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
83692023|NCT01398852|Vitamins|vitamins|mesh-ancestor
83692024|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
83692025|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692026|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83692027|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692028|NCT01398839|Riboflavin|riboflavin|mesh-list
83692029|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
83692030|NCT01398839|Vitamins|vitamins|mesh-ancestor
83692031|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
83692032|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692033|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83692034|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692035|NCT00496795|Docetaxel|docetaxel|mesh-list
83692036|NCT00496795|Epirubicin|epirubicin|mesh-list
83692037|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692038|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
83692039|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
83692040|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
83692041|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692042|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83692043|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83692044|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83692045|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692046|NCT03164889|Entecavir|entecavir|mesh-list
83692047|NCT03164889|Molgramostim|molgramostim|mesh-list
83692048|NCT03164889|Sargramostim|sargramostim|mesh-list
83692049|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
83692050|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692051|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
83692052|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692053|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692054|NCT03133260|Aspirin|aspirin|mesh-list
83692055|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83692056|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83692057|NCT03133260|Analgesics|analgesics|mesh-ancestor
83692058|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
83692059|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692060|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692061|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692062|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692063|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83692064|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83692065|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692066|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83692067|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83692068|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692069|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
83692070|NCT03096834|Erenumab|erenumab|mesh-list
83692071|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83692072|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692073|NCT03096834|Analgesics|analgesics|mesh-ancestor
83692074|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
83692075|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692076|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692077|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
83692078|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83692079|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
83692080|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692081|NCT03056014|Expectorants|expectorants|mesh-ancestor
83692082|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
82846928|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692083|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83692084|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
83692085|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692086|NCT03056014|Protective Agents|protective agents|mesh-ancestor
83692087|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692088|NCT03056014|Antidotes|antidotes|mesh-ancestor
83692089|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
83692090|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
83692091|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692092|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
83692093|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
83692094|NCT04950270|Coagulants|coagulants|mesh-ancestor
83692095|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83692096|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83692097|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
83692098|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692099|NCT03126812|Paclitaxel|paclitaxel|mesh-list
83692100|NCT03126812|Carboplatin|carboplatin|mesh-list
83692101|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
83692102|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83692103|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692104|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83692105|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83692106|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83692107|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692108|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692109|NCT03126812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692110|NCT03026972|Vaccines|vaccines|mesh-list
83692111|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
83692112|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692113|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
83692114|NCT03012815|Gabapentin|gabapentin|mesh-list
83692115|NCT03012815|Lorazepam|lorazepam|mesh-list
83692116|NCT03012815|Valproic Acid|valproic acid|mesh-list
83692117|NCT03012815|Analgesics|analgesics|mesh-ancestor
83692118|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
83692119|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692120|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692121|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
83692122|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83692123|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83692124|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692125|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83692126|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83692127|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83692128|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692129|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692130|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
83692131|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
83692132|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
83692133|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692134|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83692135|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
83692136|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
83692137|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692138|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83692139|NCT03006432|Leucovorin|leucovorin|mesh-list
83692140|NCT03006432|Folic Acid|folic acid|mesh-list
83692141|NCT03006432|Docetaxel|docetaxel|mesh-list
83692142|NCT03006432|Fluorouracil|fluorouracil|mesh-list
83692143|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
83692144|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
83692145|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692146|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83692147|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83692148|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83692149|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692150|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
83692151|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692152|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692153|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
83692154|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692155|NCT03006432|Antidotes|antidotes|mesh-ancestor
83692156|NCT03006432|Protective Agents|protective agents|mesh-ancestor
83692157|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
83692158|NCT03006432|Vitamins|vitamins|mesh-ancestor
83692159|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
83692160|NCT03006432|Hematinics|hematinics|mesh-ancestor
82847004|NCT01306708|Amitriptyline|amitriptyline|mesh-list
83692161|NCT03003065|Temoporfin|temoporfin|mesh-list
83692162|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692163|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83692164|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692165|NCT03001011|Sevelamer|sevelamer|mesh-list
83692166|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
83692167|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
83692168|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692169|NCT02993757|Vaccines|vaccines|mesh-list
83692170|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
83692171|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692172|NCT02979535|Vaccines|vaccines|mesh-list
83692173|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
83692174|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692175|NCT02978716|Carboplatin|carboplatin|mesh-list
83692176|NCT02978716|Gemcitabine|gemcitabine|mesh-list
83692177|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692178|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692179|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
83692180|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692181|NCT02973321|Metformin|metformin|mesh-list
83692182|NCT02973321|Liraglutide|liraglutide|mesh-list
83692183|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83692184|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692185|NCT02973321|Incretins|incretins|mesh-ancestor
83692186|NCT02973321|Hormones|hormones|mesh-ancestor
83692187|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692188|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83692189|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83692190|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692191|NCT02943785|Edoxaban|edoxaban|mesh-list
83692192|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83692193|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
83692194|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83692195|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
83692196|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692197|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692198|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
83692199|NCT02908334|Sertraline|sertraline|mesh-list
83692200|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
83692201|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83692202|NCT02908334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83692203|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83692204|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83692205|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692206|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692207|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
83692208|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692209|NCT02886286|Fentanyl|fentanyl|mesh-list
83692210|NCT02886286|Morphine|morphine|mesh-list
83692211|NCT02886286|Hydromorphone|hydromorphone|mesh-list
83692212|NCT02886286|Bupivacaine|bupivacaine|mesh-list
83692213|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
83692214|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
83692215|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692216|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692217|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
83692218|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692219|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83692220|NCT02886286|Narcotics|narcotics|mesh-ancestor
83692221|NCT02886286|Analgesics|analgesics|mesh-ancestor
83692222|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83692223|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83692224|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
83692225|NCT02865187|Vitamin D|vitamin d|mesh-list
83692226|NCT02865187|Vitamins|vitamins|mesh-ancestor
83692227|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
83692228|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692229|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83692230|NCT02787551|Metformin|metformin|mesh-list
83692231|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
83692232|NCT02787551|Pioglitazone|pioglitazone|mesh-list
83692233|NCT02787551|Liraglutide|liraglutide|mesh-list
83692234|NCT02787551|Exenatide|exenatide|mesh-list
83692235|NCT02787551|Dulaglutide|dulaglutide|mesh-list
83692236|NCT02787551|Lixisenatide|lixisenatide|mesh-list
83692237|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83692238|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82847077|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83692239|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
83692240|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692241|NCT02787551|Incretins|incretins|mesh-ancestor
83692242|NCT02787551|Hormones|hormones|mesh-ancestor
83834892|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692243|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692244|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83692245|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692246|NCT02735044|Insulin|insulin|mesh-list
83692247|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83692248|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
83692249|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83692250|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692251|NCT02692651|Vancomycin|vancomycin|mesh-list
83692252|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
83692253|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83692254|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692255|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
83692256|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692257|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692258|NCT02674061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692259|NCT02674061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692260|NCT02654314|Melatonin|melatonin|mesh-list
83692261|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
83692262|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692263|NCT02654314|Protective Agents|protective agents|mesh-ancestor
83692264|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692265|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692266|NCT02626962|Nivolumab|nivolumab|mesh-list
83692267|NCT02626962|Ipilimumab|ipilimumab|mesh-list
83692268|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692269|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692270|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692271|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692272|NCT02623998|Metformin|metformin|mesh-list
83692273|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
83692274|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83692275|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83692276|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692277|NCT02623998|Incretins|incretins|mesh-ancestor
83692278|NCT02623998|Hormones|hormones|mesh-ancestor
83692279|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692280|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83692281|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83692282|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692283|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692284|NCT02608684|Gemcitabine|gemcitabine|mesh-list
83692285|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
83692286|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692287|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692288|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
83692289|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692290|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692291|NCT02608684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692292|NCT02587520|Vaccines|vaccines|mesh-list
83692293|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
83692294|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692295|NCT02584829|Interferons|interferons|mesh-list
83132805|NCT01369069|Insulin|insulin|mesh-list
83692296|NCT02584829|Interferon-beta|interferon-beta|mesh-list
83692297|NCT02584829|Avelumab|avelumab|mesh-list
83692298|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83692299|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692300|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
83692301|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692302|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692303|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
83692304|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692305|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
83692306|NCT02559856|Apixaban|apixaban|mesh-list
83692307|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83692308|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
83692309|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83692310|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
83692311|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692312|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692313|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
83692314|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
83692315|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692316|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692317|NCT02557321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692318|NCT02557321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692319|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
83692320|NCT02512172|Azacitidine|azacitidine|mesh-list
83692321|NCT02512172|Romidepsin|romidepsin|mesh-list
83692322|NCT02512172|Cc-486|cc-486|mesh-list
83692323|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692324|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692325|NCT02512172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692326|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692327|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692328|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
83692329|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692330|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83692331|NCT02512172|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83692332|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
83692333|NCT02499367|Doxorubicin|doxorubicin|mesh-list
83692334|NCT02499367|Nivolumab|nivolumab|mesh-list
83692335|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692336|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
83692337|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692338|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692339|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83692340|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
83692341|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692342|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692343|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83692344|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83692345|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83692346|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83692347|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692348|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692349|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692350|NCT02497612|Artefenomel|artefenomel|mesh-list
83692351|NCT02497612|Ferroquine|ferroquine|mesh-list
83692352|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
83692353|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83692354|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83692355|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692356|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83692357|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692358|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692359|NCT02497131|Immunotoxins|immunotoxins|mesh-ancestor
83692360|NCT02497131|Immunoconjugates|immunoconjugates|mesh-ancestor
83692361|NCT02497131|Immunologic Factors|immunologic factors|mesh-ancestor
83692362|NCT02497131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692363|NCT02491333|Metformin|metformin|mesh-list
83692364|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83692365|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692366|NCT02469987|Bevacizumab|bevacizumab|mesh-list
83692367|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692368|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692369|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83692370|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83692371|NCT02469987|Growth Substances|growth substances|mesh-ancestor
83692372|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692373|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
83692374|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83692375|NCT02439307|Rifaximin|rifaximin|mesh-list
83692376|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692377|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692378|NCT02381652|Triamcinolone|triamcinolone|mesh-list
83692379|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83692380|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83692381|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
83692382|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83692383|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692384|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
83692385|NCT02381652|Hormones|hormones|mesh-ancestor
83692386|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692387|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692388|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692389|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
83692390|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692391|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847226|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
83692392|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83692393|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
83692394|NCT02381652|Protective Agents|protective agents|mesh-ancestor
83692395|NCT02368301|Dexamethasone|dexamethasone|mesh-list
83692396|NCT02368301|Lenalidomide|lenalidomide|mesh-list
83692397|NCT02368301|Elotuzumab|elotuzumab|mesh-list
83692398|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692399|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
83692400|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
83692401|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692402|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692403|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692404|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
83692405|NCT02368301|Hormones|hormones|mesh-ancestor
83692406|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692407|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692408|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692409|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
83692410|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83692411|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83692412|NCT02368301|Growth Substances|growth substances|mesh-ancestor
83692413|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
83692414|NCT02367794|Paclitaxel|paclitaxel|mesh-list
83692415|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83692416|NCT02367794|Carboplatin|carboplatin|mesh-list
83692417|NCT02367794|Atezolizumab|atezolizumab|mesh-list
83692418|NCT02367794|Antibodies|antibodies|mesh-list
83692419|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83692420|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692421|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83692422|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83692423|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83692424|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692425|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
83692426|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692427|NCT02367794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83692428|NCT02367794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692429|NCT02363998|Lofexidine|lofexidine|mesh-list
83692430|NCT02363998|Clonidine|clonidine|mesh-list
83692431|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83692432|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83692433|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692434|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
83692435|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692436|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83692437|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83692438|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83692439|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
83692440|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692441|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692442|NCT02363998|Analgesics|analgesics|mesh-ancestor
83692443|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
83692444|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
83692445|NCT02355379|Capecitabine|capecitabine|mesh-list
83692446|NCT02355379|Fluorouracil|fluorouracil|mesh-list
83692447|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692448|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
83692449|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692450|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692451|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692452|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
83692453|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692454|NCT02325466|Aspirin|aspirin|mesh-list
83692455|NCT02325466|Ticagrelor|ticagrelor|mesh-list
83692456|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83692457|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83692458|NCT02325466|Analgesics|analgesics|mesh-ancestor
83692459|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
83692460|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692461|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692462|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692463|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692464|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83692465|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83692466|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692467|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83692468|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83692469|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692470|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
83692471|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83692472|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83692473|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83692474|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
83692475|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692476|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83692477|NCT02323100|Glycerol|glycerol|mesh-list
83692478|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83692479|NCT02323100|Protective Agents|protective agents|mesh-ancestor
83692480|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692481|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692482|NCT02322710|Petrolatum|petrolatum|mesh-list
83692483|NCT02322710|Emollients|emollients|mesh-ancestor
83692484|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692485|NCT02283281|Dronabinol|dronabinol|mesh-list
83692486|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
83692487|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692488|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83692489|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83692490|NCT02283281|Analgesics|analgesics|mesh-ancestor
83692491|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
83692492|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692493|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83692494|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83692495|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692496|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692497|NCT02283281|Hormones|hormones|mesh-ancestor
83692498|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692499|NCT02204241|Dexamethasone|dexamethasone|mesh-list
83692500|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
83692501|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692502|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
83692503|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692504|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692505|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83692506|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
83692507|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692508|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692509|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83692510|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692511|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
83692512|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
83692513|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692514|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692515|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
83692516|NCT02204241|Hormones|hormones|mesh-ancestor
83692517|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692518|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692519|NCT02185820|Dexamethasone|dexamethasone|mesh-list
83692520|NCT02185820|Pomalidomide|pomalidomide|mesh-list
83692521|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692522|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
83692523|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
83692524|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692525|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692526|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692527|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
83692528|NCT02185820|Hormones|hormones|mesh-ancestor
83692529|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692530|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692531|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692532|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
83692533|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83692534|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83692535|NCT02185820|Growth Substances|growth substances|mesh-ancestor
83692536|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83692537|NCT02162563|Leucovorin|leucovorin|mesh-list
83692538|NCT02162563|Bevacizumab|bevacizumab|mesh-list
83692539|NCT02162563|Panitumumab|panitumumab|mesh-list
83692540|NCT02162563|Fluorouracil|fluorouracil|mesh-list
83692541|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
83692542|NCT02162563|Irinotecan|irinotecan|mesh-list
83692543|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
83692544|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83692545|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692546|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83692547|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83692548|NCT02162563|Growth Substances|growth substances|mesh-ancestor
83692549|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692550|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
83692551|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
83692552|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692553|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692554|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692555|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
83692556|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83692557|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83692558|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692559|NCT02162563|Antidotes|antidotes|mesh-ancestor
83692560|NCT02162563|Protective Agents|protective agents|mesh-ancestor
83692561|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
83692562|NCT02162563|Vitamins|vitamins|mesh-ancestor
83692563|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
83692564|NCT02127086|Analgesics|analgesics|mesh-list
83692565|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
83692566|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692567|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692568|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83692569|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83692570|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
83692571|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83692572|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83692573|NCT02106195|Belumosudil|belumosudil|mesh-list
83692574|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83692575|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692576|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692577|NCT02075177|Ketoconazole|ketoconazole|mesh-list
83692578|NCT02075177|Fenretinide|fenretinide|mesh-list
83692579|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
83692580|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692581|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83692582|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83692583|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692584|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692585|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83692586|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
83692587|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692588|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692589|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83692590|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692591|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83692592|NCT02075177|Protective Agents|protective agents|mesh-ancestor
83692593|NCT02050919|Sorafenib|sorafenib|mesh-list
83692594|NCT02050919|Epirubicin|epirubicin|mesh-list
83692595|NCT02050919|Ifosfamide|ifosfamide|mesh-list
83692596|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
83692597|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692598|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83692599|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692600|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692601|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83692602|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83692603|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83692604|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83692605|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
83692606|NCT02040857|Tamoxifen|tamoxifen|mesh-list
83692607|NCT02040857|Letrozole|letrozole|mesh-list
83692608|NCT02040857|Palbociclib|palbociclib|mesh-list
83692609|NCT02040857|Anastrozole|anastrozole|mesh-list
83692610|NCT02040857|Exemestane|exemestane|mesh-list
83692611|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83692612|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692613|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83692614|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692615|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692616|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83692617|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
83692618|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692619|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692620|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692621|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83692622|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83692623|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83692624|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83692626|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83692627|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
83692628|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692629|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692630|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83692631|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83692632|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
83692633|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83692634|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83692635|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83692636|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83692637|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
83692638|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692639|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692640|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
83692641|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83692642|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692643|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692644|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83692645|NCT01976754|Analgesics|analgesics|mesh-ancestor
83692646|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
83692647|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692648|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83692649|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83692650|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83692651|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
83692652|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692653|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692654|NCT01943825|Vaccines|vaccines|mesh-list
83692655|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
83692656|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692657|NCT01916317|Lidocaine|lidocaine|mesh-list
83692658|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
83692659|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
83692660|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692661|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692662|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
83692663|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692664|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83692665|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83692666|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83692667|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83692668|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692669|NCT01913730|Dexamethasone|dexamethasone|mesh-list
83692670|NCT01913730|Bortezomib|bortezomib|mesh-list
83692671|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692672|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
83692673|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
83692674|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692675|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692676|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692677|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
83692678|NCT01913730|Hormones|hormones|mesh-ancestor
83692679|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692680|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692681|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692682|NCT01863186|Lofexidine|lofexidine|mesh-list
83692683|NCT01863186|Clonidine|clonidine|mesh-list
83692684|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83692685|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83692686|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692687|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
83692688|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692689|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83692690|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83692691|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82847531|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847538|NCT00418145|Hormones|hormones|mesh-ancestor
83692692|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
83692693|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692694|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692695|NCT01863186|Analgesics|analgesics|mesh-ancestor
83692696|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
83692697|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
83692698|NCT01828840|Fentanyl|fentanyl|mesh-list
83692699|NCT01828840|Morphine|morphine|mesh-list
83692700|NCT01828840|Methadone|methadone|mesh-list
83692701|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83692702|NCT01828840|Narcotics|narcotics|mesh-ancestor
83692703|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692704|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692705|NCT01828840|Analgesics|analgesics|mesh-ancestor
83692706|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
83692707|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692708|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83692709|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83692710|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
83692711|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
83692712|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
83692713|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
83692714|NCT01817426|Infliximab|infliximab|mesh-list
83692715|NCT01817426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83692716|NCT01817426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692717|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692718|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692719|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692720|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83692721|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83692722|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692723|NCT01741103|Incretins|incretins|mesh-ancestor
83692724|NCT01741103|Hormones|hormones|mesh-ancestor
83692725|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692726|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83692727|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
83692728|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692729|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692730|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83692731|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
83692732|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692733|NCT01630590|Androgens|androgens|mesh-list
83692734|NCT01630590|Hormones|hormones|mesh-ancestor
83692735|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692736|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692737|NCT01619085|Nintedanib|nintedanib|mesh-list
83692738|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692739|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83692740|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692741|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692742|NCT01499095|Insulin|insulin|mesh-list
83692743|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83692744|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
83692745|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83692746|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692747|NCT01499082|Insulin|insulin|mesh-list
83692748|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83692749|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
83692750|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83692751|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692752|NCT01488890|Vaccines|vaccines|mesh-list
83692753|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
83692754|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692755|NCT01436396|Vaccines|vaccines|mesh-list
83692756|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
83692757|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692758|NCT01414777|Ondansetron|ondansetron|mesh-list
83692759|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
83692760|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
83692761|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847608|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
82847609|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83692762|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692763|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692764|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
83692765|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692766|NCT01414777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83692767|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83692768|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
83692769|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83692770|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692771|NCT01411241|Vaccines|vaccines|mesh-list
83692772|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83692773|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
83692774|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692775|NCT01380938|Ribavirin|ribavirin|mesh-list
83692776|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83692777|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
83692778|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
83692779|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692780|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
83692781|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692782|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
83692783|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692784|NCT01374516|Vaccines|vaccines|mesh-list
83692785|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
83692786|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692787|NCT01373281|Vaccines|vaccines|mesh-list
83692788|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
83692789|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692790|NCT01346787|Dexamethasone|dexamethasone|mesh-list
83692791|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
83692792|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692793|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
83692794|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692795|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692796|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83692797|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
83692798|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692799|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692800|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83692801|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692802|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
83692803|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
83692804|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692805|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692806|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
83692807|NCT01346787|Hormones|hormones|mesh-ancestor
83692808|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692809|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692810|NCT01254422|Vaccines|vaccines|mesh-list
83692811|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
83692812|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692813|NCT01204242|Lidocaine|lidocaine|mesh-list
83692814|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
83692815|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
83692816|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692817|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692818|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
83692819|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692820|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83692821|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83692822|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83692823|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83692824|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692825|NCT01187433|Vaccines|vaccines|mesh-list
83692826|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
83692827|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692828|NCT01150045|Leucovorin|leucovorin|mesh-list
83692829|NCT01150045|Celecoxib|celecoxib|mesh-list
83692830|NCT01150045|Fluorouracil|fluorouracil|mesh-list
83692831|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
83692832|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
83692833|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692834|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692835|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692836|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692837|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
83692838|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692839|NCT01150045|Antidotes|antidotes|mesh-ancestor
83692840|NCT01150045|Protective Agents|protective agents|mesh-ancestor
83692841|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
83692842|NCT01150045|Vitamins|vitamins|mesh-ancestor
83692843|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
83692844|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83692845|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83692846|NCT01150045|Analgesics|analgesics|mesh-ancestor
83692847|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
83692848|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692849|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692850|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692851|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83692852|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83692853|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692854|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
83692855|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
83692856|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692857|NCT01098032|Expectorants|expectorants|mesh-ancestor
83692858|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
83692859|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83692860|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
83692861|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692862|NCT01098032|Protective Agents|protective agents|mesh-ancestor
83692863|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692864|NCT01093196|Dexamethasone|dexamethasone|mesh-list
83692865|NCT01093196|Prednisone|prednisone|mesh-list
83692866|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
83692867|NCT01093196|Melphalan|melphalan|mesh-list
83692868|NCT01093196|Lenalidomide|lenalidomide|mesh-list
83692869|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692870|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
83692871|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692872|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692873|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83692874|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
83692875|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692876|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692877|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83692878|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692879|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
83692880|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
83692881|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692882|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692883|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
83692884|NCT01093196|Hormones|hormones|mesh-ancestor
83692885|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692886|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692887|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83692888|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83692889|NCT01093196|Growth Substances|growth substances|mesh-ancestor
83692890|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
83692891|NCT00945009|Dactinomycin|dactinomycin|mesh-list
83692892|NCT00945009|Cactinomycin|cactinomycin|mesh-list
83692893|NCT00945009|Doxorubicin|doxorubicin|mesh-list
83692894|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83692895|NCT00945009|Vincristine|vincristine|mesh-list
83692896|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83692897|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692898|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83692899|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83692900|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692901|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692902|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83692903|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83692904|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83692905|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83692906|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83692907|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692908|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83692909|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83692910|NCT00942877|Cediranib|cediranib|mesh-list
83692911|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692912|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83692913|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692914|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692915|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83692916|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83692917|NCT00896389|Diuretics|diuretics|mesh-ancestor
82847754|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
82847758|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83692918|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
83692919|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692920|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83692921|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83692922|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692924|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
83692925|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692926|NCT00579527|Cyclosporine|cyclosporine|mesh-list
83692927|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
83692928|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
83692929|NCT00579527|Prednisolone|prednisolone|mesh-list
83692930|NCT00579527|Tacrolimus|tacrolimus|mesh-list
83692931|NCT00579527|Cyclosporins|cyclosporins|mesh-list
83692932|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
83692933|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83692934|NCT00579527|Daclizumab|daclizumab|mesh-list
83692935|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
83692936|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83692937|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
83692938|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692939|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83692940|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692941|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692942|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
83692943|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692944|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692945|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83692946|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83692947|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692948|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83692949|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
83692950|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83692951|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83692952|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
83692953|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
83692954|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83692955|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83692956|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
83692957|NCT00579527|Hormones|hormones|mesh-ancestor
83692958|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83692959|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83692960|NCT00579527|Protective Agents|protective agents|mesh-ancestor
83692961|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83692962|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83692963|NCT01904123|Tyrphostins|tyrphostins|mesh-list
83692964|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692965|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83692966|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692967|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
83692968|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83692969|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692970|NCT00531232|Clofarabine|clofarabine|mesh-list
83692971|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83692972|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
83692973|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83692974|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83692975|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
83692976|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83692977|NCT00066950|Fluorides|fluorides|mesh-list
83692978|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
83692979|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
83692980|NCT00066950|Protective Agents|protective agents|mesh-ancestor
83692981|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692982|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83692983|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83692984|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
83692985|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83692986|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83692987|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
83692988|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83692989|NCT01694134|Prednisolone|prednisolone|mesh-list
83692990|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
82847831|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83692991|NCT01694134|Lidocaine|lidocaine|mesh-list
83692992|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83692993|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
83692994|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
83692995|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
83692996|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83692997|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83692998|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
83692999|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693000|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83693001|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83693002|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83693003|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83693004|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693005|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693006|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
83693007|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
83693008|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693009|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
83693010|NCT01694134|Hormones|hormones|mesh-ancestor
83693011|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693012|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83693013|NCT01694134|Protective Agents|protective agents|mesh-ancestor
83693014|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693015|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693016|NCT01694212|Diclofenac|diclofenac|mesh-list
83693017|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83693018|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83693019|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83693020|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83693021|NCT01694212|Analgesics|analgesics|mesh-ancestor
83693022|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
83693023|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693024|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693025|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693026|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83693027|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83693028|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693029|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693030|NCT01694264|Entecavir|entecavir|mesh-list
83693031|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
83693032|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693033|NCT01694355|Vitamin D|vitamin d|mesh-list
83693034|NCT01694355|Vitamins|vitamins|mesh-ancestor
83693035|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
83693036|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693037|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83693038|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83693039|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83693040|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693041|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
83693042|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693043|NCT01694407|Tenofovir|tenofovir|mesh-list
83693044|NCT01694407|Emtricitabine|emtricitabine|mesh-list
83693045|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
83693046|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693047|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83693048|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83693049|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693050|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693051|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83693052|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83693053|NCT01694459|Heparin|heparin|mesh-list
83693054|NCT01694459|Calcium heparin|calcium heparin|mesh-list
83693055|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
83693056|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83693057|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83693058|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693059|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83693060|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
83693061|NCT01694498|Coagulants|coagulants|mesh-ancestor
83693062|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83693063|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
83693064|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693065|NCT01694576|Paclitaxel|paclitaxel|mesh-list
83693066|NCT01694576|Nedaplatin|nedaplatin|mesh-list
82847909|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
83693067|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83693068|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693069|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83693070|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83693071|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83693072|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693073|NCT01694693|Abatacept|abatacept|mesh-list
83693074|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83693075|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693076|NCT01694693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83693077|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693078|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693079|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
83693080|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693081|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83693082|NCT01694732|Varenicline|varenicline|mesh-list
83693083|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83693084|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83693085|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
83693086|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693087|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693088|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693089|NCT01694797|Metoprolol|metoprolol|mesh-list
83693090|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83693091|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83693092|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
83693093|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
83693094|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693095|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693096|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83693097|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83693098|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83693099|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
83693100|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693101|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693102|NCT01695005|Prednisone|prednisone|mesh-list
83693103|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693104|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
83693105|NCT01695005|Hormones|hormones|mesh-ancestor
83693106|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693107|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693108|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693109|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693110|NCT01695057|Vorinostat|vorinostat|mesh-list
83693111|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693112|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83693113|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693114|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693115|NCT01695070|Melatonin|melatonin|mesh-list
83693116|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
83693117|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693118|NCT01695070|Protective Agents|protective agents|mesh-ancestor
83693119|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693120|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693121|NCT01695109|Liraglutide|liraglutide|mesh-list
83693122|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693123|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693124|NCT01695109|Incretins|incretins|mesh-ancestor
83693125|NCT01695109|Hormones|hormones|mesh-ancestor
83693126|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693127|NCT01695122|Valproic Acid|valproic acid|mesh-list
83693128|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
83693129|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693130|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693131|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
83693132|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693133|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693134|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
83693135|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83693136|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693137|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693138|NCT01695148|Carotenoids|carotenoids|mesh-list
83693139|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
83834893|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847979|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83693140|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693141|NCT01695148|Protective Agents|protective agents|mesh-ancestor
83693142|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693143|NCT01695174|Rifaximin|rifaximin|mesh-list
83693144|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83693145|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693146|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693147|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
83693148|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
83693149|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693150|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693151|NCT01695226|Celecoxib|celecoxib|mesh-list
83693152|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83693153|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83693154|NCT01695226|Analgesics|analgesics|mesh-ancestor
83693155|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
83693156|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693157|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693158|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693159|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83693160|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83693161|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83693162|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693163|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693164|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
83693165|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
83693166|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
83693167|NCT01695356|Avobenzone|avobenzone|mesh-list
83693168|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
83693169|NCT01695356|Benzophenone|benzophenone|mesh-list
83693170|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83693171|NCT01695356|Protective Agents|protective agents|mesh-ancestor
83693172|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693173|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
83693174|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83693175|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
83693176|NCT01695460|Vitamins|vitamins|mesh-list
83693177|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
83693178|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693179|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83693180|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83693181|NCT01695707|Pioglitazone|pioglitazone|mesh-list
83693182|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693183|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693184|NCT01695733|Vaccines|vaccines|mesh-list
83693185|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
83693186|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693187|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
83693188|NCT01695759|Hematinics|hematinics|mesh-ancestor
83693189|NCT01695798|Vaccines|vaccines|mesh-list
83693190|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
83693191|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693192|NCT01695824|Warfarin|warfarin|mesh-list
83693193|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
83693194|NCT01695850|Sennosides|sennosides|mesh-list
83693195|NCT01695850|Laxatives|laxatives|mesh-ancestor
83693196|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693197|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
83693198|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83693199|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
83693200|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83693201|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693202|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83693203|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83693204|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83693205|NCT01696110|Heparin|heparin|mesh-list
83693206|NCT01696110|Calcium heparin|calcium heparin|mesh-list
83693207|NCT01696110|Tirofiban|tirofiban|mesh-list
83693208|NCT01696110|Bivalirudin|bivalirudin|mesh-list
83693209|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
82848055|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83693210|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83693211|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82848056|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
83693212|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693213|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
83693214|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83693215|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
83693216|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693217|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83693218|NCT01696240|Udenafil|udenafil|mesh-list
83693219|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83693220|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83693221|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693222|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693223|NCT01696370|Trimetazidine|trimetazidine|mesh-list
83693224|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
83693225|NCT01696383|Timolol|timolol|mesh-list
83693226|NCT01696383|Travoprost|travoprost|mesh-list
83693227|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83693228|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83693229|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
83693230|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693231|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693232|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693233|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83693234|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83693235|NCT01696409|Vitamin D|vitamin d|mesh-list
83693236|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
83693237|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
83693238|NCT01696409|Vitamins|vitamins|mesh-list
83693239|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
83693240|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693241|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83693242|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83693243|NCT01696422|Vaccines|vaccines|mesh-list
83693244|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
83693245|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693246|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
83693247|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
83693248|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693249|NCT01696448|Protective Agents|protective agents|mesh-ancestor
83693250|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693251|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
83693252|NCT01696448|Vitamins|vitamins|mesh-ancestor
83693253|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
83693254|NCT01696461|Plerixafor|plerixafor|mesh-list
83693255|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83693256|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83693257|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
83693258|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693259|NCT01696474|Bortezomib|bortezomib|mesh-list
83693260|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693261|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
83693262|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83693263|NCT01696500|Antibodies|antibodies|mesh-list
83693264|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
83693265|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83693266|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
83693267|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693268|NCT01696526|Vitamin D|vitamin d|mesh-list
83693269|NCT01696526|Vitamins|vitamins|mesh-ancestor
83693270|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
83693271|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693272|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83693273|NCT01696552|Cimetidine|cimetidine|mesh-list
83693274|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83693275|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693276|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83693277|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
83693278|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
83693279|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693280|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693281|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693282|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83693283|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83693284|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693285|NCT01696617|Aripiprazole|aripiprazole|mesh-list
83693286|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
83693287|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693288|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82848129|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693289|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83693290|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693291|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693292|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
83693293|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
83693294|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693295|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693296|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83693297|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83693298|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
83693299|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83693300|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83693301|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83693302|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83693303|NCT01696630|Desflurane|desflurane|mesh-list
83693304|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83693305|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
83693306|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
83693307|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693308|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693309|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83693310|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
83693311|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693312|NCT01696799|Econazole|econazole|mesh-list
83693313|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
83693314|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693315|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83693316|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83693317|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693318|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693319|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83693320|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
83693321|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693322|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693323|NCT01696825|Diazepam|diazepam|mesh-list
83693324|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83693325|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
83693326|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
83693327|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
83693328|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693329|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693330|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693331|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83693332|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693333|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83693334|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83693335|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83693336|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83693337|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693338|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83693339|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
83693340|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
83693341|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
83693342|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
83693343|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693344|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693345|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
83693346|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
83693347|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693348|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83693349|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693350|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693351|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
83693352|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693353|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83693354|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693355|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83693356|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
83693357|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83693358|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83693359|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693360|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693361|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
83693362|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693363|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82848202|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693364|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83693365|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83693366|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83693367|NCT01697059|Amoxicillin|amoxicillin|mesh-list
83693368|NCT01697059|Piperacillin|piperacillin|mesh-list
83693369|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83693370|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83693371|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693372|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83693373|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693374|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693375|NCT01697098|Dexamethasone|dexamethasone|mesh-list
83693376|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
83693377|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
83693378|NCT01697098|BB 1101|bb 1101|mesh-list
83693379|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693380|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
83693381|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
83693382|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693383|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693384|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693385|NCT01697098|Hormones|hormones|mesh-ancestor
83693386|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693387|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693388|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693389|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
83693390|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693391|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693392|NCT01697111|Dienogest|dienogest|mesh-list
83693393|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83693394|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
83693395|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83693396|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693397|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83693398|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83693399|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83693400|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83693401|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
83693402|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693403|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693404|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693405|NCT01697150|Pancrelipase|pancrelipase|mesh-list
83693406|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693407|NCT01697228|Vitamin D|vitamin d|mesh-list
83693408|NCT01697228|Vitamins|vitamins|mesh-ancestor
83693409|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
83693410|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693411|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83693412|NCT01697293|Paclitaxel|paclitaxel|mesh-list
83693413|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
83693414|NCT01697293|Doxorubicin|doxorubicin|mesh-list
83693415|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83693416|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83693417|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83693418|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693419|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
83693420|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
83693421|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
83693422|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693423|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693424|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
83693425|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693426|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83693427|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83693428|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
83693429|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83693430|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83693431|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83693432|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83693433|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693434|NCT01697306|Gemcitabine|gemcitabine|mesh-list
83693435|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
83693436|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83693437|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
83693438|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693439|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693440|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83693441|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
83693442|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693443|NCT01697410|Terlipressin|terlipressin|mesh-list
83693444|NCT01697410|Norepinephrine|norepinephrine|mesh-list
83693445|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83693446|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83693447|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
83693448|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693449|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693450|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693451|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
83693452|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
83693453|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693454|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83693455|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83693456|NCT01697436|Ribavirin|ribavirin|mesh-list
83693457|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
83693458|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693459|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
83693460|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693461|NCT01697605|Infigratinib|infigratinib|mesh-list
83693462|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693463|NCT01697618|Insulin|insulin|mesh-list
83693464|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83693465|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
83693466|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
83693467|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83693468|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693469|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693470|NCT01697631|Insulin|insulin|mesh-list
83693471|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83693472|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
83693473|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
83693474|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83693475|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
83693476|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83693477|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693478|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693479|NCT01697657|Insulin|insulin|mesh-list
83693480|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83693481|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
83693482|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
83693483|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
83693484|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
83693485|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
83693486|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693487|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693488|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83693489|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83693490|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
83693491|NCT01697722|Beclomethasone|beclomethasone|mesh-list
83693492|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693493|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
83693494|NCT01697722|Hormones|hormones|mesh-ancestor
83693495|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693496|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693497|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83693498|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
83693499|NCT01697735|Atorvastatin|atorvastatin|mesh-list
83693500|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83693501|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83693502|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83693503|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
83693504|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693505|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83693506|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83693507|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693508|NCT01697787|Artesunate|artesunate|mesh-list
83693509|NCT01697787|Lumefantrine|lumefantrine|mesh-list
83693510|NCT01697787|Artemether|artemether|mesh-list
83693511|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83693512|NCT01697787|Amodiaquine|amodiaquine|mesh-list
82848351|NCT03762148|Vitamins|vitamins|mesh-list
83693513|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
83693514|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83693515|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83693516|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693517|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693518|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
83693519|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
83693520|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83693521|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
83693522|NCT01697826|Clindamycin|clindamycin|mesh-list
83693523|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
83693524|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
83693525|NCT01697826|Clotrimazole|clotrimazole|mesh-list
83693527|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83693528|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693529|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83693530|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693531|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693532|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83693533|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
83693534|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83693535|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83693536|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83693537|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
83693538|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693539|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693540|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83693541|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83693542|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83693543|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83693544|NCT01698164|Estradiol|estradiol|mesh-list
83693545|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83693546|NCT01698164|Progesterone|progesterone|mesh-list
83693547|NCT01698164|Estrogens|estrogens|mesh-ancestor
83693548|NCT01698164|Hormones|hormones|mesh-ancestor
83693549|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693550|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693551|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83693552|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
83693553|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83693554|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83693555|NCT01698164|Progestins|progestins|mesh-ancestor
83693556|NCT01698177|Vaccines|vaccines|mesh-list
83693557|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
83693558|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693559|NCT01698203|Ropivacaine|ropivacaine|mesh-list
83693560|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
83693561|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
83693562|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693563|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693564|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
83693565|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693566|NCT01698476|Vitamin D|vitamin d|mesh-list
83693567|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
83693568|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83693569|NCT01698476|Vitamins|vitamins|mesh-ancestor
83693570|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
83693571|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693572|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83693573|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83693574|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693575|NCT01698541|Tacrolimus|tacrolimus|mesh-list
83693576|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693577|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
83693578|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693579|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83693580|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693581|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693582|NCT01698567|Antithrombins|antithrombins|mesh-list
83693583|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
83693584|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83693585|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
83693586|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693587|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693588|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
82848426|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83693589|NCT01698593|Epinephrine|epinephrine|mesh-list
83693590|NCT01698593|Bupivacaine|bupivacaine|mesh-list
83693591|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
83693592|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
83693593|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693594|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693595|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
83693596|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693597|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83693598|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83693599|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
83693600|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693601|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693602|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83693603|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83693604|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
83693605|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83693606|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
83693607|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
83693608|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
83693609|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83693610|NCT01698645|Fentanyl|fentanyl|mesh-list
83693611|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83693612|NCT01698645|Narcotics|narcotics|mesh-ancestor
83693613|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693614|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693615|NCT01698645|Analgesics|analgesics|mesh-ancestor
83693616|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
83693617|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693618|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83693619|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83693620|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
83693621|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
83693622|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
83693623|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693624|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693625|NCT01698723|Ribavirin|ribavirin|mesh-list
83693626|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
83693627|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693628|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
83693629|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693630|NCT01698749|Dexamethasone|dexamethasone|mesh-list
83693631|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693632|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
83693633|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
83693634|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693635|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693636|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693637|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
83693638|NCT01698749|Hormones|hormones|mesh-ancestor
83693639|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693640|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693641|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693642|NCT01698788|Dexamethasone|dexamethasone|mesh-list
83693643|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
83693644|NCT01698788|BB 1101|bb 1101|mesh-list
83693645|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693646|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
83693647|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
83693648|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693649|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693650|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693651|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
83693652|NCT01698788|Hormones|hormones|mesh-ancestor
83693653|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693654|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693655|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693656|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
83693657|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693658|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693659|NCT01698931|Glyburide|glyburide|mesh-list
83693660|NCT01698931|Repaglinide|repaglinide|mesh-list
82848501|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83693661|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693662|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693663|NCT01699113|Rabeprazole|rabeprazole|mesh-list
83693664|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83693665|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693666|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83693667|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693668|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693669|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83693670|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83693671|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83693672|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
83693673|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693674|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83693675|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83693676|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693677|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
83693678|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83693679|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
83693680|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693681|NCT01699204|Expectorants|expectorants|mesh-ancestor
83693682|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
83693683|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83693684|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
83693685|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693686|NCT01699204|Protective Agents|protective agents|mesh-ancestor
83693687|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693688|NCT01699204|Antidotes|antidotes|mesh-ancestor
83693689|NCT01699282|Antivitamins K|antivitamins k|mesh-list
83693690|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
83693691|NCT01699347|Picibanil|picibanil|mesh-list
83693692|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693693|NCT01699360|Cyclosporine|cyclosporine|mesh-list
83693694|NCT01699360|Sirolimus|sirolimus|mesh-list
83693695|NCT01699360|Tacrolimus|tacrolimus|mesh-list
83693696|NCT01699360|Cyclosporins|cyclosporins|mesh-list
83693697|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693698|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
83693699|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693700|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83693701|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693702|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693703|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
83693704|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693705|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
83693706|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83693707|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83693708|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83693709|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693710|NCT01699412|Dexamethasone|dexamethasone|mesh-list
83693711|NCT01699412|Clobetasol|clobetasol|mesh-list
83693712|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693713|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
83693714|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
83693715|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693716|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693717|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693718|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
83693719|NCT01699412|Hormones|hormones|mesh-ancestor
83693720|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693721|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693722|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693723|NCT01699438|Mesalamine|mesalamine|mesh-list
83693724|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83693725|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83693726|NCT01699438|Analgesics|analgesics|mesh-ancestor
83693727|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
83693728|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693729|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693730|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693731|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83693732|NCT01699490|Valsartan|valsartan|mesh-list
83693733|NCT01699490|Fluoxetine|fluoxetine|mesh-list
83693734|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83693735|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83693736|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83693737|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693738|NCT01699490|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83693739|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83693740|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83693741|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693742|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
83693743|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693744|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83693745|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
83693746|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693747|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83693748|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83693749|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693750|NCT01699594|Mannitol|mannitol|mesh-list
83693751|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
83693752|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83693753|NCT01699594|Diuretics|diuretics|mesh-ancestor
83693754|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
83693755|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693756|NCT01699594|Miotics|miotics|mesh-ancestor
83693757|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
83693758|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693759|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83693760|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83693761|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
83693762|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83693763|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83693764|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
83693765|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693766|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693767|NCT01699659|Immunomodulating Agents|immunomodulating agents|mesh-list
83693768|NCT01699659|Immunologic Factors|immunologic factors|mesh-ancestor
83693769|NCT01699659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693770|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83693771|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
83693772|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693773|NCT01699711|Protective Agents|protective agents|mesh-ancestor
83693774|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693775|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83693776|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83693777|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693778|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83693779|NCT01699724|Sertraline|sertraline|mesh-list
83693780|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
83693781|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693782|NCT01699724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83693783|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83693784|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83693785|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693786|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693787|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
83693788|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693789|NCT01699776|Digoxin|digoxin|mesh-list
83693790|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83693791|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83693792|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693793|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693794|NCT01699776|Protective Agents|protective agents|mesh-ancestor
83693795|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693796|NCT01699802|Anesthetics|anesthetics|mesh-list
83693797|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693798|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693799|NCT01699828|Buspirone|buspirone|mesh-list
83693800|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83693801|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83693802|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693803|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693804|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693805|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83693806|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
83693807|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693808|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693809|NCT01699854|Capsaicin|capsaicin|mesh-list
83693810|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
83693811|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
83693812|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
83693813|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848649|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83693814|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693816|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
83693817|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
83693818|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693819|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693820|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
83693821|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693822|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83693823|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83693824|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83693825|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83693826|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693827|NCT01699932|Metformin|metformin|mesh-list
83693828|NCT01699932|Glimepiride|glimepiride|mesh-list
83693829|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83693830|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693831|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83693832|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693833|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
83693834|NCT01699997|Oxytocin|oxytocin|mesh-list
83693835|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
83693836|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83693837|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693838|NCT01700010|Paclitaxel|paclitaxel|mesh-list
83693839|NCT01700010|Lapatinib|lapatinib|mesh-list
83693840|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83693841|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693842|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83693843|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83693844|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83693845|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693846|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83693847|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693848|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
83693849|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83693850|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83693851|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693852|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693853|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693854|NCT01700270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83693855|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83693856|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83693857|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693858|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693859|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
83693860|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83693861|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
83693862|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83693863|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83693864|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693865|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83693866|NCT01700322|Clopidogrel|clopidogrel|mesh-list
83693867|NCT01700322|Ticagrelor|ticagrelor|mesh-list
83693868|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83693869|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83693870|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83693871|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83693872|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83693873|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
83693874|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83693875|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693876|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693877|NCT01700400|Bevacizumab|bevacizumab|mesh-list
83693878|NCT01700400|Carboplatin|carboplatin|mesh-list
83693879|NCT01700400|Pemetrexed|pemetrexed|mesh-list
83693880|NCT01700400|Everolimus|everolimus|mesh-list
83693881|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83693882|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693883|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83693884|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83693885|NCT01700400|Growth Substances|growth substances|mesh-ancestor
83693886|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693887|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
83693888|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693889|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693890|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83693891|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83693892|NCT01700400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83693893|NCT01700400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83693894|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83693895|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
83693896|NCT01700413|Idarubicin|idarubicin|mesh-list
83693897|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83693898|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693899|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83693900|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83693901|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693902|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693903|NCT01700426|Vitamins|vitamins|mesh-list
83693904|NCT01700426|Vitamin E|vitamin e|mesh-list
83693905|NCT01700426|Tocopherols|tocopherols|mesh-list
83693906|NCT01700426|Tocotrienols|tocotrienols|mesh-list
83693907|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
83693908|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
83693909|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693910|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
83693911|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693912|NCT01700426|Protective Agents|protective agents|mesh-ancestor
83693913|NCT01700478|Vasopressins|vasopressins|mesh-list
83693914|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
83693915|NCT01700478|Misoprostol|misoprostol|mesh-list
83693916|NCT01700478|Diuretics|diuretics|mesh-list
83693917|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693918|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83693919|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
83693920|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83693921|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83693922|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693923|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
83693924|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
83693925|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
83693926|NCT01700478|Coagulants|coagulants|mesh-ancestor
83693927|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83693928|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83693929|NCT01700491|Ropivacaine|ropivacaine|mesh-list
83693930|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
83693931|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
83693932|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83693933|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693934|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
83693935|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693936|NCT01700504|Gentamicins|gentamicins|mesh-list
83693937|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83693938|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693939|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83693940|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693941|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693942|NCT01700608|Plerixafor|plerixafor|mesh-list
83693943|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83693944|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83693945|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
83693946|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693947|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83693948|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83693949|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693950|NCT01700751|Immunotoxins|immunotoxins|mesh-ancestor
83693951|NCT01700751|Immunoconjugates|immunoconjugates|mesh-ancestor
83693952|NCT01700751|Immunologic Factors|immunologic factors|mesh-ancestor
83693953|NCT01700751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693954|NCT01700790|Ritonavir|ritonavir|mesh-list
83693955|NCT01700790|Lopinavir|lopinavir|mesh-list
83693956|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83693957|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83693958|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
83693959|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83693960|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693961|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82848801|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83693962|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83693963|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
83693964|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693965|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83693966|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83693967|NCT01700803|Iodine|iodine|mesh-list
83693968|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
83693969|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
83693970|NCT01700803|Povidone|povidone|mesh-list
83693971|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83693972|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83693973|NCT01700803|Trace Elements|trace elements|mesh-ancestor
83693974|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
83693975|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693976|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
83693977|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
83693978|NCT01700881|Vitamin E|vitamin e|mesh-list
83693979|NCT01700881|Vitamins|vitamins|mesh-ancestor
83693980|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
83693981|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693982|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
83693983|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83693984|NCT01700881|Protective Agents|protective agents|mesh-ancestor
83693985|NCT01701076|Dexamethasone|dexamethasone|mesh-list
83693986|NCT01701076|Lenalidomide|lenalidomide|mesh-list
83693987|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83693988|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83693989|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
83693990|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
83693991|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83693992|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83693993|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83693994|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
83693995|NCT01701076|Hormones|hormones|mesh-ancestor
83693996|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83693997|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83693998|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83693999|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694000|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
83694001|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83694002|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83694003|NCT01701076|Growth Substances|growth substances|mesh-ancestor
83694004|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
83694005|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83694006|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
83694007|NCT01701089|Selegiline|selegiline|mesh-list
83694008|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
83694009|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83694010|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83694011|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83694012|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83694013|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694014|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694015|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83694016|NCT01701089|Protective Agents|protective agents|mesh-ancestor
83694017|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694018|NCT01701180|Oxytocin|oxytocin|mesh-list
83694019|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
83694020|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83694021|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694022|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83694023|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83694024|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694025|NCT01701232|Rituximab|rituximab|mesh-list
83694026|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694027|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694028|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
83694029|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694030|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83694031|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83694032|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83694033|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694034|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83694035|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
83694036|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83694037|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83694038|NCT01701323|Cytarabine|cytarabine|mesh-list
83694039|NCT01701323|Fludarabine|fludarabine|mesh-list
83694040|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
83694041|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694042|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83694043|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
83694044|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694045|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83694046|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
83694047|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694048|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
83694049|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694050|NCT01701336|Cloricromen|cloricromen|mesh-list
83694051|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83694052|NCT01701349|Paclitaxel|paclitaxel|mesh-list
83694053|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
83694054|NCT01701349|Combretastatin|combretastatin|mesh-list
83694055|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83694056|NCT01701349|Carboplatin|carboplatin|mesh-list
83694057|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83694058|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694059|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
83694060|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
83694061|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
83694062|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694063|NCT01701453|Clopidogrel|clopidogrel|mesh-list
83694064|NCT01701453|Ticagrelor|ticagrelor|mesh-list
83694065|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83694066|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83694067|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83694068|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83694069|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83694070|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
83694071|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694072|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694073|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694074|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83694075|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83694076|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694077|NCT01701479|Aldesleukin|aldesleukin|mesh-list
83694078|NCT01701479|Interleukin-2|interleukin-2|mesh-list
83694079|NCT01701479|Dinutuximab|dinutuximab|mesh-list
83694080|NCT01701479|Isotretinoin|isotretinoin|mesh-list
83694081|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694082|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83694083|NCT01701479|Analgesics|analgesics|mesh-ancestor
83694084|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
83694085|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694086|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694087|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83694088|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83694089|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
83694090|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694091|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
83694092|NCT01701518|Dexamethasone|dexamethasone|mesh-list
83694093|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83694094|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
83694095|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
83694096|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694097|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694098|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83694099|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
83694100|NCT01701518|Hormones|hormones|mesh-ancestor
83694101|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83694102|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83694103|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694104|NCT01701583|Omalizumab|omalizumab|mesh-list
83694105|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83694106|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83694107|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
83694108|NCT01701739|Digoxin|digoxin|mesh-list
83694109|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83694110|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83694111|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694112|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848952|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83494805|NCT02452320|Acetaminophen|acetaminophen|mesh-list
83694113|NCT01701739|Protective Agents|protective agents|mesh-ancestor
82848953|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694114|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694115|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
83694116|NCT01701778|Sevoflurane|sevoflurane|mesh-list
83694117|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
83694118|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83694119|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694120|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694121|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83694122|NCT01701778|Analgesics|analgesics|mesh-ancestor
83694123|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
83694124|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694125|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83694126|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83694127|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83694128|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
83694129|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694130|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694131|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83694132|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83694133|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
83694134|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
83694135|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
83694136|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
83694137|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83694138|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
83694139|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694140|NCT01701843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83694141|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83694142|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83694143|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83694144|NCT01701856|Interferons|interferons|mesh-list
83694145|NCT01701856|Interferon-beta|interferon-beta|mesh-list
83694146|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
83694147|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694148|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
83694149|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694150|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
83694151|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694152|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83694153|NCT01701882|Tenofovir|tenofovir|mesh-list
83694154|NCT01701882|Emtricitabine|emtricitabine|mesh-list
83694155|NCT01701882|Rilpivirine|rilpivirine|mesh-list
83694156|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
83694157|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694158|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83694159|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83694160|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694161|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694162|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83694163|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83694164|NCT01701921|Pregabalin|pregabalin|mesh-list
83694165|NCT01701921|Analgesics|analgesics|mesh-ancestor
83694166|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
83694167|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694168|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694169|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
83694170|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83694171|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83694172|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694173|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83694174|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83694175|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83694176|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694177|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83694178|NCT01702038|Rituximab|rituximab|mesh-list
83694179|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694180|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694181|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
83694182|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694183|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83694184|NCT01702090|Ritonavir|ritonavir|mesh-list
83694185|NCT01702090|Darunavir|darunavir|mesh-list
83694186|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83694187|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83694188|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
83694189|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849027|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83694190|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694191|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83694192|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83694193|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
83694194|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694195|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83694196|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83694197|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
83694198|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83694199|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
83694200|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83694201|NCT01702129|Doxorubicin|doxorubicin|mesh-list
83694202|NCT01702129|Cetuximab|cetuximab|mesh-list
83694203|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83694204|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694205|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83694206|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83694207|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694208|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694209|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694210|NCT01702181|Tacrolimus|tacrolimus|mesh-list
83694211|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83694212|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
83694213|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694214|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83694215|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694216|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694217|NCT01702207|Tacrolimus|tacrolimus|mesh-list
83694218|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83694219|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
83694220|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694221|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83694222|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694223|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694224|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
83694225|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83694226|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694227|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83694228|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83694229|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694230|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694231|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694232|NCT01702389|Remifentanil|remifentanil|mesh-list
83694233|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83694234|NCT01702389|Narcotics|narcotics|mesh-ancestor
83694235|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694236|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694237|NCT01702389|Analgesics|analgesics|mesh-ancestor
83694238|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
83694239|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694240|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
83694241|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83694242|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694243|NCT01702506|Antacids|antacids|mesh-list
83694244|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694245|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83694246|NCT01702610|Temozolomide|temozolomide|mesh-list
83694247|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83694248|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
83694249|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694250|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694251|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
83694252|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
83694253|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83694254|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83694255|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83694256|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694257|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83694258|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83694259|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
83694260|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83694261|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82849101|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
83694262|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694264|NCT01702636|Coagulants|coagulants|mesh-ancestor
83694265|NCT01702649|Biapenem|biapenem|mesh-list
83694266|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694267|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
83694268|NCT01702688|Giapreza|giapreza|mesh-list
83694269|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
83694270|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83694271|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83694272|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
83694273|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694274|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694275|NCT01702701|Fluticasone|fluticasone|mesh-list
83694276|NCT01702701|Montelukast|montelukast|mesh-list
83694277|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83694278|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83694279|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
83694280|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694281|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694282|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83694283|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83694284|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83694285|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83694286|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83694287|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
83694288|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83694289|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83694290|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83694291|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694292|NCT01702714|Paclitaxel|paclitaxel|mesh-list
83694293|NCT01702714|Carboplatin|carboplatin|mesh-list
83694294|NCT01702714|Gemcitabine|gemcitabine|mesh-list
83694295|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83694296|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694297|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
83694298|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
83694299|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
83694300|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694301|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83694302|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
83694303|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83694304|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83694305|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
83694306|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694307|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83694308|NCT01702857|Vaccines|vaccines|mesh-list
83694309|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
83694310|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
83694311|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694312|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83694313|NCT01702857|Antacids|antacids|mesh-ancestor
83694314|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694315|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83694316|NCT01702974|Vitamin D|vitamin d|mesh-list
83694317|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
83694318|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83694319|NCT01702974|Vitamins|vitamins|mesh-ancestor
83694320|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
83694321|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694322|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83694323|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83694324|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694325|NCT01703104|Folic Acid|folic acid|mesh-list
83694326|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
83694327|NCT01703104|Proguanil|proguanil|mesh-list
83694328|NCT01703104|Hematinics|hematinics|mesh-ancestor
83694329|NCT01703104|Vitamins|vitamins|mesh-ancestor
83694330|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
83694331|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694332|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
83694333|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83694334|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83694335|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694336|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
83694337|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694338|NCT01703130|Ropivacaine|ropivacaine|mesh-list
83694339|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
83694340|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
83694341|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694342|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694343|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
83694344|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694346|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83694347|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
83694348|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694349|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694350|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83694351|NCT01703312|Omalizumab|omalizumab|mesh-list
83694352|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83694353|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83694354|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83694355|NCT01703325|Triamcinolone|triamcinolone|mesh-list
83694356|NCT01703325|Clobetasol|clobetasol|mesh-list
83694357|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83694358|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
83694359|NCT01703325|Hormones|hormones|mesh-ancestor
83694360|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83694361|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694362|NCT01703351|Fentanyl|fentanyl|mesh-list
83694363|NCT01703351|Ropivacaine|ropivacaine|mesh-list
83694364|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
83694365|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
83694366|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694367|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694368|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
83694369|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694370|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83694371|NCT01703351|Narcotics|narcotics|mesh-ancestor
83694372|NCT01703351|Analgesics|analgesics|mesh-ancestor
83694373|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83694374|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83694375|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
83694376|NCT01703364|Lenalidomide|lenalidomide|mesh-list
83694377|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
83694378|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694379|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83694380|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83694381|NCT01703364|Growth Substances|growth substances|mesh-ancestor
83694382|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
83694383|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694384|NCT01703390|Cetuximab|cetuximab|mesh-list
83694385|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694386|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694387|NCT01703455|Sorafenib|sorafenib|mesh-list
83694388|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694389|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83694390|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694391|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694392|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
83694393|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
83694394|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83694395|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83694396|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83694397|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694398|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83694399|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83694400|NCT01703559|Phentolamine|phentolamine|mesh-list
83694401|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83694402|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83694403|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83694404|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83694405|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
83694406|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694407|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694408|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694409|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83694410|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
83694411|NCT01703624|Bromides|bromides|mesh-list
83694412|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
82849248|NCT00129974|Gemcitabine|gemcitabine|mesh-list
82849302|NCT00118716|Xhance|xhance|mesh-list
83694413|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83694414|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83694415|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83694416|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
83694417|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694418|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694419|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694420|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83694421|NCT01703637|Vildagliptin|vildagliptin|mesh-list
83694422|NCT01703637|Saxagliptin|saxagliptin|mesh-list
83694423|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83694424|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694425|NCT01703637|Incretins|incretins|mesh-ancestor
83694426|NCT01703637|Hormones|hormones|mesh-ancestor
83694427|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83694428|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83694429|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
83694430|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694431|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694432|NCT01703728|Menotropins|menotropins|mesh-list
83694433|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83694434|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
83694435|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83694436|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694437|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
83694438|NCT01703754|Ifosfamide|ifosfamide|mesh-list
83694439|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83694440|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
83694441|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694442|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694443|NCT01703910|Paclitaxel|paclitaxel|mesh-list
83694444|NCT01703910|Etoposide|etoposide|mesh-list
83694445|NCT01703910|Vinorelbine|vinorelbine|mesh-list
83694446|NCT01703910|Docetaxel|docetaxel|mesh-list
83694447|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83694448|NCT01703910|Cisplatin|cisplatin|mesh-list
83694449|NCT01703910|Gemcitabine|gemcitabine|mesh-list
83694450|NCT01703910|Doxorubicin|doxorubicin|mesh-list
83694451|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83694452|NCT01703910|Fluorouracil|fluorouracil|mesh-list
83694453|NCT01703910|Capecitabine|capecitabine|mesh-list
83694454|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
83694455|NCT01703910|Irinotecan|irinotecan|mesh-list
83694456|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
83694457|NCT01703910|Pemetrexed|pemetrexed|mesh-list
83694458|NCT01703910|Cetuximab|cetuximab|mesh-list
83694459|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83694460|NCT01703910|Sorafenib|sorafenib|mesh-list
83694461|NCT01703910|Topotecan|topotecan|mesh-list
83694462|NCT01703910|Dasatinib|dasatinib|mesh-list
83694463|NCT01703910|Mitomycins|mitomycins|mesh-list
83694464|NCT01703910|Mitomycin|mitomycin|mesh-list
83694465|NCT01703910|Raltitrexed|raltitrexed|mesh-list
83694466|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83694467|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694468|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83694469|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83694470|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83694471|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694472|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83694473|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
83694474|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83694475|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83694476|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83694477|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694478|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83694479|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
83694480|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694481|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83694482|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83694483|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83694484|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694485|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83694486|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
83694487|NCT01704027|Androgens|androgens|mesh-list
82849322|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83694488|NCT01704027|Hormones|hormones|mesh-ancestor
83694489|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834894|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
83694490|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694491|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
83694492|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83694493|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694494|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694495|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83694496|NCT01704092|Analgesics|analgesics|mesh-ancestor
83694497|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
83694498|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694499|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83694500|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83694501|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83694502|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
83694503|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694504|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694505|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83694506|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83694507|NCT01704339|Capsaicin|capsaicin|mesh-list
83694508|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
83694509|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
83694510|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
83694511|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694512|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694513|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
83694514|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
83694515|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83694516|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694517|NCT01704417|Insulin|insulin|mesh-list
83694518|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83694519|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
83694520|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83694521|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694522|NCT01704469|Anesthetics|anesthetics|mesh-list
83694523|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
83694524|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694525|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694526|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
83694527|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694528|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
83694529|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83694530|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
83694531|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694532|NCT01704482|Expectorants|expectorants|mesh-ancestor
83694533|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
83694534|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83694535|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
83694536|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694537|NCT01704482|Protective Agents|protective agents|mesh-ancestor
83694538|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694539|NCT01704482|Antidotes|antidotes|mesh-ancestor
83694540|NCT01704508|Lumefantrine|lumefantrine|mesh-list
83694541|NCT01704508|Artemether|artemether|mesh-list
83694542|NCT01704508|Piperaquine|piperaquine|mesh-list
83694543|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83694544|NCT01704508|Artenimol|artenimol|mesh-list
83694545|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
83694546|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83694547|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83694548|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694549|NCT01704534|Ustekinumab|ustekinumab|mesh-list
83694550|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
83694551|NCT01704612|Ropivacaine|ropivacaine|mesh-list
83694552|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
83694553|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
83694554|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694555|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694556|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
83694557|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694558|NCT01704638|Digoxin|digoxin|mesh-list
83694559|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
82849397|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82849398|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
82849399|NCT00129272|Bupropion|bupropion|mesh-list
82849400|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83694560|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83694561|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83694562|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834895|NCT00133224|Hormones|hormones|mesh-ancestor
83694563|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694564|NCT01704638|Protective Agents|protective agents|mesh-ancestor
83694565|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694566|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83694567|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83694568|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694569|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83694570|NCT01704638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83694571|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83694572|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83694573|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694574|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
83694575|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83694576|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
83694577|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83694578|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83694579|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83694580|NCT01704690|Paclitaxel|paclitaxel|mesh-list
83694581|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83694582|NCT01704690|Cisplatin|cisplatin|mesh-list
83694583|NCT01704690|Fluorouracil|fluorouracil|mesh-list
83694584|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83694585|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694586|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83694587|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83694588|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83694589|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694590|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
83694591|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83694592|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83694593|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
83694594|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694595|NCT01704703|Panitumumab|panitumumab|mesh-list
83694596|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694597|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694598|NCT01704716|Aldesleukin|aldesleukin|mesh-list
83694599|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
83694600|NCT01704716|Melphalan|melphalan|mesh-list
83694601|NCT01704716|Busulfan|busulfan|mesh-list
83694602|NCT01704716|Carboplatin|carboplatin|mesh-list
83694603|NCT01704716|Doxorubicin|doxorubicin|mesh-list
83694604|NCT01704716|Etoposide|etoposide|mesh-list
83694605|NCT01704716|Vincristine|vincristine|mesh-list
83694606|NCT01704716|Interleukin-2|interleukin-2|mesh-list
83694607|NCT01704716|Dinutuximab|dinutuximab|mesh-list
83694608|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83694609|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
83694610|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694611|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83694612|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83694613|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
83694614|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694615|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694616|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83694617|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83694618|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83694619|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83694620|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694621|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83694622|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
83694623|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
83694624|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
83694625|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83694626|NCT01704716|Analgesics|analgesics|mesh-ancestor
83694627|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
83694628|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694629|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83694630|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83694631|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
83694632|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694633|NCT01704794|Folic Acid|folic acid|mesh-list
83694634|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
83694635|NCT01704794|Proguanil|proguanil|mesh-list
83694636|NCT01704794|Hematinics|hematinics|mesh-ancestor
83694637|NCT01704794|Vitamins|vitamins|mesh-ancestor
83694638|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
83694639|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694640|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
83694641|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83694642|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83694643|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694644|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
83694645|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694646|NCT01704872|Dinutuximab|dinutuximab|mesh-list
83694647|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694648|NCT01704898|Efavirenz|efavirenz|mesh-list
83694649|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83694650|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83694651|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694652|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694653|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
83694654|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694655|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83694656|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83694657|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83694658|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83694659|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83694660|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83694661|NCT01705002|Bevacizumab|bevacizumab|mesh-list
83694662|NCT01705002|Capecitabine|capecitabine|mesh-list
83694663|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694664|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694665|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83694666|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83694667|NCT01705002|Growth Substances|growth substances|mesh-ancestor
83694668|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694669|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
83694670|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83694671|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
83694672|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694673|NCT01705041|Liver Extracts|liver extracts|mesh-list
83694674|NCT01705041|Hematinics|hematinics|mesh-ancestor
83694675|NCT01705158|Carboplatin|carboplatin|mesh-list
83694676|NCT01705158|Doxorubicin|doxorubicin|mesh-list
83694677|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83694678|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694679|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83694680|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83694681|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83694682|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694683|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694684|NCT01705223|Vaccines|vaccines|mesh-list
83694685|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
83694686|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694687|NCT01705249|Norethindrone|norethindrone|mesh-list
83694688|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
83694689|NCT01705249|Estradiol|estradiol|mesh-list
83694690|NCT01705249|Estrogens|estrogens|mesh-ancestor
83694691|NCT01705249|Hormones|hormones|mesh-ancestor
83694692|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83694693|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694694|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83694695|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
83694696|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83694697|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83694698|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83694699|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83694700|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83694701|NCT01705314|Vitamin D|vitamin d|mesh-list
83694702|NCT01705314|Vitamins|vitamins|mesh-ancestor
83694703|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
83694704|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694705|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83694706|NCT01705340|Trastuzumab|trastuzumab|mesh-list
83694707|NCT01705340|Lapatinib|lapatinib|mesh-list
83694708|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694709|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694710|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83694711|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694712|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694713|NCT01705379|Lactitol|lactitol|mesh-list
83694714|NCT01705379|Cathartics|cathartics|mesh-ancestor
83694715|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83694716|NCT01705392|Bevacizumab|bevacizumab|mesh-list
83694717|NCT01705392|Dacarbazine|dacarbazine|mesh-list
83694718|NCT01705392|Propranolol|propranolol|mesh-list
83694719|NCT01705392|Enalapril|enalapril|mesh-list
83694720|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83694721|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694722|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83694723|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83694724|NCT01705392|Growth Substances|growth substances|mesh-ancestor
83694725|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694726|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
83694727|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83694728|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83694729|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
83694730|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694731|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694732|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83694733|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83694734|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
83694735|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83694736|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
83694737|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83694738|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
83694739|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694740|NCT01705457|Vitamin A|vitamin a|mesh-list
83694741|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
83694742|NCT01705457|Vitamins|vitamins|mesh-ancestor
83694743|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
83694744|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694745|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
83694746|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694747|NCT01705457|Protective Agents|protective agents|mesh-ancestor
83694748|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83694749|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694750|NCT01705470|Furosemide|furosemide|mesh-list
83694751|NCT01705470|Diuretics|diuretics|mesh-ancestor
83694752|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
83694753|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694754|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83694755|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83694756|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694757|NCT01705483|Paclitaxel|paclitaxel|mesh-list
83694758|NCT01705483|Docetaxel|docetaxel|mesh-list
83694759|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83694760|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694761|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
83694762|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
83694763|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
83694764|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694765|NCT01705639|Melatonin|melatonin|mesh-list
83694766|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
83694767|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694768|NCT01705639|Protective Agents|protective agents|mesh-ancestor
83694769|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694770|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694771|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
83694772|NCT01705743|Sevoflurane|sevoflurane|mesh-list
83694773|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83694774|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83694775|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
83694776|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
83694777|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694778|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694779|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83694780|NCT01705743|Analgesics|analgesics|mesh-ancestor
83694781|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
83694782|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694783|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83694784|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83694785|NCT01705769|Micronutrients|micronutrients|mesh-list
83694786|NCT01705769|Trace Elements|trace elements|mesh-list
83694787|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694788|NCT01705795|Antibodies|antibodies|mesh-list
83694789|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
83694790|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694791|NCT01705808|Protein C|protein c|mesh-list
83694792|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
83694793|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83694794|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83694795|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694796|NCT01705938|Dolcanatide|dolcanatide|mesh-list
83694797|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83694798|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
83694799|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694800|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83694801|NCT01705951|Nicotine|nicotine|mesh-list
83694802|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83694803|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
83694804|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694805|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694806|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83694807|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83694808|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
83694809|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694810|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694811|NCT01706055|Interferons|interferons|mesh-list
83694812|NCT01706055|Interferon-beta|interferon-beta|mesh-list
83694813|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
83694814|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694815|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
83694816|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694817|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
83694818|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694819|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83694820|NCT01706172|Lidocaine|lidocaine|mesh-list
83694821|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
83694822|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
83694823|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694824|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694825|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
83694826|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694827|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83694828|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83694829|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83694830|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83694831|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694832|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
83694833|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83694834|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694835|NCT01706315|Gepotidacin|gepotidacin|mesh-list
83694836|NCT01706315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83694837|NCT01706315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694838|NCT01706315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694839|NCT01706315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694840|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83694841|NCT01706354|Anesthetics|anesthetics|mesh-list
83694842|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
83694843|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694844|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694845|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
83694846|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694847|NCT01706367|Vaccines|vaccines|mesh-list
83694848|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
83694849|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694850|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
83694851|NCT01706471|Everolimus|everolimus|mesh-list
83694852|NCT01706471|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83694853|NCT01706471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83694854|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694855|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694856|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83694857|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
83694858|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694859|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694860|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83694861|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83694862|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
83694863|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83694864|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849701|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
83694865|NCT01706510|Clopidogrel|clopidogrel|mesh-list
83694866|NCT01706510|Ticagrelor|ticagrelor|mesh-list
83694867|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83694868|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83694869|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83694870|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83694871|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
83694872|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694873|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694874|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694875|NCT01706562|Itraconazole|itraconazole|mesh-list
83694876|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
83694877|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694878|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83694879|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83694880|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694881|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694882|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83694883|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
83694884|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83694885|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694886|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83694887|NCT01706627|Melatonin|melatonin|mesh-list
83694888|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
83694889|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694890|NCT01706627|Protective Agents|protective agents|mesh-ancestor
83694891|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694892|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694893|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
83694894|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83694895|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694896|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83694897|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83694898|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694899|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694900|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694901|NCT01706874|Listerine|listerine|mesh-list
83694902|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83694903|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694904|NCT01706887|Amiloride|amiloride|mesh-list
83694905|NCT01706887|Diuretics|diuretics|mesh-ancestor
83694906|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
83694907|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694908|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83694909|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83694910|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83694911|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694912|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83694913|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83694914|NCT01707082|Midazolam|midazolam|mesh-list
83694915|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83694916|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83694917|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83694918|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694919|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83694920|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83694921|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83694922|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83694923|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
83694924|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
83694925|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
83694926|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
83694927|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83694928|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694929|NCT01707134|Insulin|insulin|mesh-list
83694930|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83694931|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
83694932|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
83694933|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
83694934|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
83694935|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83694936|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694937|NCT01707160|Insulin|insulin|mesh-list
82849778|NCT01079754|Morphine|morphine|mesh-list
83694938|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83694939|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
83694940|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
83694941|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83694942|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83694943|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694944|NCT01707199|Artesunate|artesunate|mesh-list
83694945|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
83694946|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
83694947|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83694948|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
83694949|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83694950|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83694951|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694952|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83694953|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
83694954|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
83694955|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83694956|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
83694957|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83694958|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694959|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694960|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83694961|NCT01707251|Ibuprofen|ibuprofen|mesh-list
83694962|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83694963|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83694964|NCT01707251|Analgesics|analgesics|mesh-ancestor
83694965|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
83694966|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83694967|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694968|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83694969|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83694970|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83694971|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694972|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694973|NCT01707316|Canagliflozin|canagliflozin|mesh-list
83694974|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83694975|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694976|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83694977|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694978|NCT01707342|Simeprevir|simeprevir|mesh-list
83694979|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
83694980|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83694981|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
83694982|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694983|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694984|NCT01707394|Apixaban|apixaban|mesh-list
83694985|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83694986|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
83694987|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83694988|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
83694989|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83694990|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83694991|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
83694992|NCT01707407|Ketoconazole|ketoconazole|mesh-list
83694993|NCT01707407|Pomalidomide|pomalidomide|mesh-list
83694994|NCT01707407|Carbamazepine|carbamazepine|mesh-list
83694995|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
83694996|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
83694997|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83694998|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82849851|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
82849852|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
82849853|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849854|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849855|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
82849856|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849857|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82849858|NCT01082744|Narcotics|narcotics|mesh-ancestor
82849859|NCT01082744|Analgesics|analgesics|mesh-ancestor
82849860|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82849861|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82849862|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
82849863|NCT00096356|Vitamins|vitamins|mesh-list
82849864|NCT00096356|Vitamin E|vitamin e|mesh-list
83694999|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83695000|NCT01707407|Growth Substances|growth substances|mesh-ancestor
83695001|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
83695002|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695003|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
83695004|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695005|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83695006|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83695007|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695008|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695009|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83695010|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
83695011|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695012|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83695013|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
83695014|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
83695015|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83695016|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695017|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83695018|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695019|NCT01707407|Analgesics|analgesics|mesh-ancestor
83695020|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
83695021|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695022|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83695023|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695024|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83695025|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83695026|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83695027|NCT01707407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83695028|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83695029|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695030|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
83695031|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83695032|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
83695033|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83695034|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83695036|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
83695037|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695038|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
83695039|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
83695040|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695041|NCT01707615|Protective Agents|protective agents|mesh-ancestor
83695042|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695043|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83695044|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83695045|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695046|NCT01707732|Enoxaparin|enoxaparin|mesh-list
83695047|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
83695048|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83695049|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83695050|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695051|NCT01707745|Bevacizumab|bevacizumab|mesh-list
83695052|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83695053|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695054|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83695055|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83695056|NCT01707745|Growth Substances|growth substances|mesh-ancestor
83695057|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695058|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
83695059|NCT01707823|Aspirin|aspirin|mesh-list
83695060|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83695061|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695062|NCT01707823|Analgesics|analgesics|mesh-ancestor
83695063|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
83695064|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695065|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695066|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695067|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695068|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83695069|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83695070|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695071|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83695072|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83695073|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695074|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
83695075|NCT01707849|Everolimus|everolimus|mesh-list
83695076|NCT01707849|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83695077|NCT01707849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83695078|NCT01707849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695079|NCT01707849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695080|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695081|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
83695082|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695083|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695084|NCT01707940|Ketoconazole|ketoconazole|mesh-list
83695085|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
83695086|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695087|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83695088|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83695089|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695090|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695091|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83695092|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
83695093|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695094|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695095|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83695096|NCT01707953|Midodrine|midodrine|mesh-list
83695097|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
83695098|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
83695099|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695100|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695101|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83695102|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83695103|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83695104|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83695105|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
83695106|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695107|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695108|NCT01708005|Vitamin D|vitamin d|mesh-list
83695109|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
83695110|NCT01708005|Vitamins|vitamins|mesh-ancestor
83695111|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
83695112|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695113|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83695114|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83695115|NCT01708044|Pramlintide|pramlintide|mesh-list
83695116|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83695117|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695118|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
83695119|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83695120|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83695121|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695122|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
83695123|NCT01708239|Coagulants|coagulants|mesh-ancestor
83695124|NCT01708330|Lidocaine|lidocaine|mesh-list
83695125|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
83695126|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
83695127|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695128|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695129|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
83695130|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695131|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83695132|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83695133|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83695134|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695135|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695136|NCT01708369|Aspirin|aspirin|mesh-list
83695137|NCT01708369|Ethanol|ethanol|mesh-list
83695138|NCT01708369|Oseltamivir|oseltamivir|mesh-list
83695139|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83695140|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695141|NCT01708369|Analgesics|analgesics|mesh-ancestor
83695142|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
83695143|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695144|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850003|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695145|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695146|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695147|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83695148|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83695149|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695150|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83695151|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83695152|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695153|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
83695154|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83695155|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695156|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695157|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
83695158|NCT01708447|Lidocaine|lidocaine|mesh-list
83695159|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
83695160|NCT01708447|Anesthetics|anesthetics|mesh-list
83695161|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695162|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695163|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
83695164|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695165|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83695166|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83695167|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83695168|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695169|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695170|NCT01708616|Risperidone|risperidone|mesh-list
83695171|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83695172|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
83695173|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695174|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695175|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695176|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83695177|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83695178|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695179|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83695180|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83695181|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
83695182|NCT01708642|Epinephrine|epinephrine|mesh-list
83695183|NCT01708642|Racepinephrine|racepinephrine|mesh-list
83695184|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
83695185|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83695186|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83695187|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83695188|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695189|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695190|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695191|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83695192|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83695193|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
83695194|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695195|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83695196|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
83695197|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
83695198|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
83695199|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83695200|NCT01708707|Morphine|morphine|mesh-list
83695201|NCT01708707|Buprenorphine|buprenorphine|mesh-list
83695202|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83695203|NCT01708707|Narcotics|narcotics|mesh-ancestor
83695204|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695205|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695206|NCT01708707|Analgesics|analgesics|mesh-ancestor
83695207|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
83695208|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695209|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83695210|NCT01708720|Vaccines|vaccines|mesh-list
83695211|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
83695212|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695213|NCT01708798|Eplerenone|eplerenone|mesh-list
83695214|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83695215|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
83695216|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695217|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695218|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82850079|NCT03748108|Lidocaine|lidocaine|mesh-list
83695219|NCT01708798|Diuretics|diuretics|mesh-ancestor
83695220|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
83695221|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83695222|NCT01708837|Propofol|propofol|mesh-list
83695223|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83695224|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695225|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695226|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83695227|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
83695228|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
83695229|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
83695230|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83695231|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
83695232|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83695233|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83695234|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695235|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695236|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
83695237|NCT01708876|Artesunate|artesunate|mesh-list
83695238|NCT01708876|Chloroquine|chloroquine|mesh-list
83695239|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83695240|NCT01708876|Primaquine|primaquine|mesh-list
83695241|NCT01708876|Mefloquine|mefloquine|mesh-list
83695242|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
83695243|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83695244|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83695245|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695246|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695247|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
83695248|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
83695249|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83695250|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
83695251|NCT01708876|Amebicides|amebicides|mesh-ancestor
83695252|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695253|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83695254|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695255|NCT01708876|Analgesics|analgesics|mesh-ancestor
83695256|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
83695257|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695258|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695259|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695260|NCT01708876|Filaricides|filaricides|mesh-ancestor
83695261|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
83695262|NCT01708993|Docetaxel|docetaxel|mesh-list
83695263|NCT01708993|Pemetrexed|pemetrexed|mesh-list
83695264|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695265|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83695266|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83695267|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83695268|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695269|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695270|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83695271|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83695272|NCT01709019|Vaccines|vaccines|mesh-list
83695273|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
83695274|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695275|NCT01709071|Vaccines|vaccines|mesh-list
83695276|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
83695277|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695278|NCT01709292|Vemurafenib|vemurafenib|mesh-list
83695279|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695280|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83695281|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695282|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695283|NCT01709370|Letrozole|letrozole|mesh-list
83695284|NCT01709370|Palbociclib|palbociclib|mesh-list
83695285|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695286|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83695287|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83695288|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695289|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695290|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83695291|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
83695292|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695293|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695294|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83695295|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
83695296|NCT01709630|Analgesics|analgesics|mesh-ancestor
83695297|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
83695298|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695299|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695301|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695302|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83695303|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
83695304|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83695305|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695306|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695307|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83695308|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
83695309|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695310|NCT01709656|Celecoxib|celecoxib|mesh-list
83695311|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83695312|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695313|NCT01709656|Analgesics|analgesics|mesh-ancestor
83695314|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
83695315|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695316|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695317|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695318|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695319|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83695320|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83695321|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695322|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695323|NCT01709682|Amiodarone|amiodarone|mesh-list
83695324|NCT01709682|Sotalol|sotalol|mesh-list
83695325|NCT01709682|Flecainide|flecainide|mesh-list
83695326|NCT01709682|Propafenone|propafenone|mesh-list
83695327|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83695328|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
83695329|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83695330|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695331|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695332|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83695333|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83695334|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83695335|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695336|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83695337|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83695338|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83695339|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83695340|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83695341|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
83695342|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695343|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695344|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
83695345|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
83695346|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695347|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83695348|NCT01709760|Methotrexate|methotrexate|mesh-list
83695349|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83695350|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
83695351|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695352|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695353|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83695354|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
83695355|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695356|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695357|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
83695358|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695359|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83695360|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695361|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
83695362|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695363|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83695364|NCT01709825|Sulfalene|sulfalene|mesh-list
83695365|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695366|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83695367|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
82850228|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695368|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83695369|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83695370|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
83695371|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83695372|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695373|NCT01709942|Cetrorelix|cetrorelix|mesh-list
83695374|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83695375|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
83695376|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695377|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695378|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
83695379|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695380|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83695381|NCT01709955|Cathartics|cathartics|mesh-ancestor
83695382|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695383|NCT01709994|Aspirin|aspirin|mesh-list
83695384|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83695385|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695386|NCT01709994|Analgesics|analgesics|mesh-ancestor
83695387|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
83695388|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695389|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695390|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695391|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695392|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83695393|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83695394|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695395|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83695396|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83695397|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695398|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
83695399|NCT01710007|Atorvastatin|atorvastatin|mesh-list
83695400|NCT01710007|Pitavastatin|pitavastatin|mesh-list
83695401|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83695402|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83695403|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
83695404|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695405|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83695406|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83695407|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695408|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
83695409|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
83695410|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695411|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695412|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695413|NCT01710072|Aspirin|aspirin|mesh-list
83695414|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83695415|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695416|NCT01710072|Analgesics|analgesics|mesh-ancestor
83695417|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
83695418|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695419|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695420|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695421|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695422|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83695423|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83695424|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695425|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83695426|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83695427|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695428|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
83695429|NCT01710163|Aripiprazole|aripiprazole|mesh-list
83695430|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
83695431|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83695432|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83695433|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83695434|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695435|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695436|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
83695437|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
83695438|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695439|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695440|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83695441|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83695442|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
83695443|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83695444|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83695445|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83695446|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83695447|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
83695448|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695449|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
83695450|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83695451|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83695452|NCT01710228|Prednisolone|prednisolone|mesh-list
83695453|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
83695454|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83695455|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
83695456|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695457|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
83695458|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
83695459|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695460|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695461|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695462|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
83695463|NCT01710228|Hormones|hormones|mesh-ancestor
83695464|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695465|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83695466|NCT01710228|Protective Agents|protective agents|mesh-ancestor
83695467|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83695468|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695469|NCT01710384|Betamethasone|betamethasone|mesh-list
83695470|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695471|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
83695472|NCT01710384|Hormones|hormones|mesh-ancestor
83695473|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695474|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695475|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83695476|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
83695477|NCT01710462|Domperidone|domperidone|mesh-list
83695478|NCT01710462|Pantoprazole|pantoprazole|mesh-list
83695479|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83695480|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695481|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83695482|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695483|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695484|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
83695485|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
83695486|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695487|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695488|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83695489|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
83695490|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695491|NCT01710488|Levofloxacin|levofloxacin|mesh-list
83695492|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
83695493|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83695494|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695495|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83695496|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83695497|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83695498|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695499|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695500|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695501|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83695502|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83695503|NCT01710540|Metformin|metformin|mesh-list
83695504|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83695505|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695506|NCT01710553|Metformin|metformin|mesh-list
83695507|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83695508|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695509|NCT01710566|Misoprostol|misoprostol|mesh-list
83695510|NCT01710566|Oxytocin|oxytocin|mesh-list
83695511|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
83695512|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695513|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695514|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83695515|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
83695516|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83695517|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695518|NCT01710592|Docetaxel|docetaxel|mesh-list
83695519|NCT01710592|Capecitabine|capecitabine|mesh-list
83695520|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
83695521|NCT01710592|Epirubicin|epirubicin|mesh-list
83695522|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695523|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
83695524|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
83695525|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
83695526|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695527|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83695528|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
83695529|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83695530|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83695531|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83695532|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695533|NCT01710631|Eszopiclone|eszopiclone|mesh-list
83695534|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83695535|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695536|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695537|NCT01710670|Ethanol|ethanol|mesh-list
83695538|NCT01710670|Brivaracetam|brivaracetam|mesh-list
83695539|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83695540|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695541|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695542|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695543|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
83695544|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83695545|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83695546|NCT01710696|Estradiol|estradiol|mesh-list
83695547|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83695548|NCT01710696|Estrogens|estrogens|mesh-ancestor
83695549|NCT01710696|Hormones|hormones|mesh-ancestor
83695550|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695551|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695552|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83695553|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
83695554|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695555|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83695556|NCT01710722|Ephedrine|ephedrine|mesh-list
83695557|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
83695558|NCT01710722|Caffeine|caffeine|mesh-list
83695559|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83695560|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695561|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83695562|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695563|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695564|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83695565|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83695566|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
83695567|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695568|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
83695569|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
83695570|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695571|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83695572|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
83695573|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83695574|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83695575|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
83695576|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
83695577|NCT01710748|Everolimus|everolimus|mesh-list
83695578|NCT01710748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83695579|NCT01710748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83695580|NCT01710748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695581|NCT01710748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695582|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695583|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
83695584|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695585|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850452|NCT00095498|Denosumab|denosumab|mesh-list
82850453|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82850454|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850455|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
82850456|NCT04237792|Propofol|propofol|mesh-list
82850457|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83695586|NCT01710826|Venglustat|venglustat|mesh-list
82850458|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695587|NCT01710826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695588|NCT01710826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695589|NCT01710904|Oxycodone|oxycodone|mesh-list
83695590|NCT01710904|Naloxone|naloxone|mesh-list
83695591|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83695592|NCT01710904|Narcotics|narcotics|mesh-ancestor
83695593|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695594|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695595|NCT01710904|Analgesics|analgesics|mesh-ancestor
83695596|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
83695597|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695598|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83695599|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83695600|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83695601|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695602|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695603|NCT01711060|Oxytocin|oxytocin|mesh-list
83695604|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
83695605|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695606|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695607|NCT01711073|Plerixafor|plerixafor|mesh-list
83695608|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83695609|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83695610|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
83695611|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695612|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
83695613|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83695614|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
83695615|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695616|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695617|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83695618|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83695619|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83695620|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83695621|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83695622|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
83695623|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695624|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695625|NCT01711112|Docetaxel|docetaxel|mesh-list
83695626|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695627|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
83695628|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
83695629|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
83695630|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695631|NCT01711125|Baclofen|baclofen|mesh-list
83695632|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83695633|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695634|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83695635|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695636|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83695637|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
83695638|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
83695639|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695640|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695641|NCT01711229|Acetaminophen|acetaminophen|mesh-list
83695642|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695643|NCT01711229|Analgesics|analgesics|mesh-ancestor
83695644|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
83695645|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695646|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695647|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
83695648|NCT01711320|Omeprazole|omeprazole|mesh-list
83695649|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83695650|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695651|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83695652|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695653|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695654|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
83695655|NCT01711437|Simethicone|simethicone|mesh-list
83695656|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
83695657|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
83695658|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82850523|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83695659|NCT01711437|Citric Acid|citric acid|mesh-list
83695660|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
83695661|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83695662|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
83695663|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83695664|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
83695665|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
83695666|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695667|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
83695668|NCT01711437|Protective Agents|protective agents|mesh-ancestor
83695669|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695670|NCT01711437|Vitamins|vitamins|mesh-ancestor
83695671|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
83695672|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
83695673|NCT01711437|Emollients|emollients|mesh-ancestor
83695674|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83695675|NCT01711437|Cathartics|cathartics|mesh-ancestor
83695676|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695677|NCT01711437|Antacids|antacids|mesh-ancestor
83695678|NCT01711437|Laxatives|laxatives|mesh-ancestor
83695679|NCT01711463|Fluticasone|fluticasone|mesh-list
83695680|NCT01711463|Xhance|xhance|mesh-list
83695681|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695682|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83695683|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
83695684|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695685|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695686|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83695687|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83695688|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
83695689|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83695690|NCT01711476|Complement Factor H|complement factor h|mesh-list
83695691|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83695692|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695693|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
83695694|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695695|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
83695696|NCT01711489|Isavuconazole|isavuconazole|mesh-list
83695697|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83695698|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695699|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83695700|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
83695701|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83695702|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695703|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695704|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695705|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
83695706|NCT01711515|Cisplatin|cisplatin|mesh-list
83695707|NCT01711515|Ipilimumab|ipilimumab|mesh-list
83695708|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695709|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83695710|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83695711|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695712|NCT01711528|Dexamethasone|dexamethasone|mesh-list
83695713|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
83695714|NCT01711528|Bortezomib|bortezomib|mesh-list
83695715|NCT01711528|Ichthammol|ichthammol|mesh-list
83695716|NCT01711528|BB 1101|bb 1101|mesh-list
83695717|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695718|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
83695719|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
83695720|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695721|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695722|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695723|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
83695724|NCT01711528|Hormones|hormones|mesh-ancestor
83695725|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695726|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83695727|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695728|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
83695729|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695730|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695731|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
83695732|NCT01711567|Tenofovir|tenofovir|mesh-list
83695733|NCT01711567|Entecavir|entecavir|mesh-list
83695734|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
83695735|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695736|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83695737|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83695738|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695739|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695740|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83695741|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83695742|NCT01711593|Dimercaprol|dimercaprol|mesh-list
83695743|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
83695744|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
83695745|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695746|NCT01711671|Dexamethasone|dexamethasone|mesh-list
83695747|NCT01711671|Lenalidomide|lenalidomide|mesh-list
83695748|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695749|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
83695750|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
83695751|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695752|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695753|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695754|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
83695755|NCT01711671|Hormones|hormones|mesh-ancestor
83695756|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695757|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83695758|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695759|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
83695760|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83695761|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83695762|NCT01711671|Growth Substances|growth substances|mesh-ancestor
83695763|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
83695764|NCT01711697|Paclitaxel|paclitaxel|mesh-list
83695765|NCT01711697|Carboplatin|carboplatin|mesh-list
83695766|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83695767|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695768|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
83695769|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
83695770|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
83695771|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695772|NCT01711723|Darapladib|darapladib|mesh-list
83695773|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83695774|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695775|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695776|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83695777|NCT01711749|Calcium|calcium|mesh-list
83695778|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83695779|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695780|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83695781|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83695782|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
83695783|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695784|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83695785|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83695786|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695787|NCT01711814|Peficitinib|peficitinib|mesh-list
83695788|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695789|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695790|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695791|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
83695792|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695793|NCT01711827|Isavuconazole|isavuconazole|mesh-list
83695794|NCT01711827|Prednisone|prednisone|mesh-list
83695795|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695796|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
83695797|NCT01711827|Hormones|hormones|mesh-ancestor
83695798|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83695799|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695800|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83695801|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695802|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
83695803|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695804|NCT01711905|Vitamin D|vitamin d|mesh-list
83695805|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
83695806|NCT01711905|Vitamins|vitamins|mesh-ancestor
83695807|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
83695808|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695809|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83695810|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83695811|NCT01711931|Everolimus|everolimus|mesh-list
83695812|NCT01711931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82850671|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83695813|NCT01711931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850672|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
83695814|NCT01711931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695815|NCT01711931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695816|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695817|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
83695818|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695819|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695820|NCT01711957|Liver Extracts|liver extracts|mesh-list
83695821|NCT01711957|Hematinics|hematinics|mesh-ancestor
83695823|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83695824|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695825|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
83695826|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
83695827|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
83695828|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695829|NCT01712100|Irbesartan|irbesartan|mesh-list
83695830|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83695831|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83695832|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83695833|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695834|NCT01712113|Irbesartan|irbesartan|mesh-list
83695835|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83695836|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83695837|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83695838|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695839|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83695840|NCT01712126|Irbesartan|irbesartan|mesh-list
83695841|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83695842|NCT01712126|Diuretics|diuretics|mesh-ancestor
83695843|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
83695844|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695845|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83695846|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695847|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695848|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83695849|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83695850|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83695851|NCT01712139|Irbesartan|irbesartan|mesh-list
83695852|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83695853|NCT01712139|Diuretics|diuretics|mesh-ancestor
83695854|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
83695855|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695856|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83695857|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695858|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695859|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83695860|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83695861|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
83695862|NCT01712295|Salicylates|salicylates|mesh-list
83695863|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83695864|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83695865|NCT01712295|Analgesics|analgesics|mesh-ancestor
83695866|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
83695867|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695868|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695869|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83695870|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83695871|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83695872|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695873|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695874|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695875|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
83695876|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
83695877|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
83695878|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83695879|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
83695880|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83695881|NCT01712321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83695882|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83695883|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695884|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695885|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695886|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
83695887|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695888|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83695889|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83695890|NCT01712347|Bevacizumab|bevacizumab|mesh-list
83695891|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83695892|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695893|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83695894|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83695895|NCT01712347|Growth Substances|growth substances|mesh-ancestor
83695896|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695897|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
83695899|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
83695900|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695901|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695902|NCT01712477|Midazolam|midazolam|mesh-list
83695903|NCT01712477|Propofol|propofol|mesh-list
83695904|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83695905|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695906|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695907|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83695908|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
83695909|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
83695910|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83695911|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83695912|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83695913|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83695914|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
83695915|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
83695916|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695917|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695918|NCT01710761|Caffeine|caffeine|mesh-list
83695919|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83695920|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695921|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83695922|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695923|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695924|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83695925|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83695926|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
83695927|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695928|NCT01712568|Ropinirole|ropinirole|mesh-list
83695929|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83695930|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83695931|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
83695932|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
83695933|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695934|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695935|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695936|NCT01712646|Oxytocin|oxytocin|mesh-list
83695937|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
83695938|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83695939|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695940|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
83695941|NCT01712828|Promethazine|promethazine|mesh-list
83695942|NCT01712828|Sirolimus|sirolimus|mesh-list
83695943|NCT01712828|Quinidine|quinidine|mesh-list
83695944|NCT01712828|Lenalidomide|lenalidomide|mesh-list
83695945|NCT01712828|Temsirolimus|temsirolimus|mesh-list
83695946|NCT01712828|MTOR Inhibitors|mtor inhibitors|mesh-list
83695947|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
83695948|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83695949|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83695950|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83695951|NCT01712828|Growth Substances|growth substances|mesh-ancestor
83695952|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
83695953|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695954|NCT01712828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83695955|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83695956|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83695957|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83695958|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83695959|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83695960|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83695961|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
83695962|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83695963|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83695964|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83695965|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
83695966|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
83695967|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
83695968|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83695969|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
83695970|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
83695971|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83695972|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83695973|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
83695974|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
83695975|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83695976|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83695977|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
83695978|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83695979|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83695980|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83695981|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
83695982|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83695983|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
83695984|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83695985|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83695986|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83695987|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83695988|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
83695989|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83695990|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83695991|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83695992|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83695993|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83695995|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83695996|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83695997|NCT01712919|Paclitaxel|paclitaxel|mesh-list
83695998|NCT01712919|Cetuximab|cetuximab|mesh-list
83695999|NCT01712919|Nedaplatin|nedaplatin|mesh-list
83696000|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83696001|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696002|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
83696003|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
83696004|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
83696005|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696006|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696007|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
83696008|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696009|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696010|NCT01712997|Bosentan|bosentan|mesh-list
83696011|NCT01712997|Iloprost|iloprost|mesh-list
83696012|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83696013|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83696014|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696015|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83696016|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
83696017|NCT01713049|Alovudine|alovudine|mesh-list
83696018|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
83696019|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696020|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
83696021|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
83696022|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
83696023|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83696024|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696025|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
82850898|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850899|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850900|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
82850901|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
82850902|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850903|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850904|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82850905|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82850906|NCT00112502|Growth Substances|growth substances|mesh-ancestor
82850907|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
83696026|NCT01713101|Coagulants|coagulants|mesh-ancestor
83696027|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
83696028|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83696029|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83696030|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696031|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83696032|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83696033|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696034|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696035|NCT01713127|Remifentanil|remifentanil|mesh-list
83696036|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83696037|NCT01713127|Narcotics|narcotics|mesh-ancestor
83696038|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696039|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696040|NCT01713127|Analgesics|analgesics|mesh-ancestor
83696041|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
83696042|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696043|NCT01713153|Misoprostol|misoprostol|mesh-list
83696044|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83696045|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
83696046|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83696047|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696048|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83696049|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696050|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
83696051|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
83696052|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83696053|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83696054|NCT01713179|Ambroxol|ambroxol|mesh-list
83696055|NCT01713179|Expectorants|expectorants|mesh-ancestor
83696056|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
83696057|NCT01713218|Gemcitabine|gemcitabine|mesh-list
83696058|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83696059|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
83696060|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696061|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696062|NCT01713231|Vitamin D|vitamin d|mesh-list
83696063|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
83696064|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
83696065|NCT01713231|Vitamins|vitamins|mesh-list
83696066|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
83696067|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696068|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83696069|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83696070|NCT01713309|Lenograstim|lenograstim|mesh-list
83696071|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83696072|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
83696073|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696074|NCT01713361|Enoxaparin|enoxaparin|mesh-list
83696075|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
83696076|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83696077|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83696078|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696079|NCT01713387|Gemcitabine|gemcitabine|mesh-list
83696080|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83696081|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
83696082|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696083|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696084|NCT01713426|Pregabalin|pregabalin|mesh-list
83696085|NCT01713426|Capsaicin|capsaicin|mesh-list
83696086|NCT01713426|Analgesics|analgesics|mesh-ancestor
83696087|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
83696088|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696089|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696090|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
83696091|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83696092|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696093|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696094|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83696095|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83696096|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83696097|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696098|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83696099|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
83696100|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83696101|NCT01713556|Propranolol|propranolol|mesh-list
83696102|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82850970|NCT00094328|Anastrozole|anastrozole|mesh-list
83696103|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83696104|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
83696105|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696106|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696107|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696108|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83696109|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83696110|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
83696111|NCT01713647|Losartan|losartan|mesh-list
83696112|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83696113|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83696114|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83696115|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83696116|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696117|NCT01713725|Omalizumab|omalizumab|mesh-list
83696118|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83696119|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83696120|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
83696121|NCT01713738|Rituximab|rituximab|mesh-list
83696122|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696123|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696124|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
83696125|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696126|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696127|NCT01713777|Lamotrigine|lamotrigine|mesh-list
83696128|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
83696129|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83696130|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696131|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696132|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83696133|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696134|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83696135|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83696136|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696137|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83696138|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83696139|NCT01713803|Buprenorphine|buprenorphine|mesh-list
83696140|NCT01713803|Naloxone|naloxone|mesh-list
83696141|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83696142|NCT01713803|Narcotics|narcotics|mesh-ancestor
83696143|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696144|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696145|NCT01713803|Analgesics|analgesics|mesh-ancestor
83696146|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
83696147|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696148|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83696149|NCT01713920|Amlodipine|amlodipine|mesh-list
83696150|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83696151|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83696152|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696153|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696154|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83696155|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696156|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
83696157|NCT01713972|Dabrafenib|dabrafenib|mesh-list
83696158|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696159|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83696160|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696161|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696162|NCT01714011|Aripiprazole|aripiprazole|mesh-list
83696163|NCT01714011|Ziprasidone|ziprasidone|mesh-list
83696164|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
83696165|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83696166|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83696167|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83696168|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696169|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696170|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
83696171|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
83696172|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696173|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696174|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83696175|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83696176|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
83696177|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83696178|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83696179|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83696180|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83696181|NCT01714037|Gemcitabine|gemcitabine|mesh-list
83696183|NCT01714037|Pemetrexed|pemetrexed|mesh-list
83696184|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696185|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83696186|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
83696187|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696188|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
83696189|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
83696190|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
83696191|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696192|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83696193|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83696194|NCT01714089|Interferons|interferons|mesh-list
83696195|NCT01714089|Interferon-beta|interferon-beta|mesh-list
83696196|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
83696197|NCT01714089|RNS60|rns60|mesh-list
83696198|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696199|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
83696200|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696201|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
83696202|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696203|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83696204|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83696205|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83696206|NCT01714089|Analgesics|analgesics|mesh-ancestor
83696207|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
83696208|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696209|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83696210|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696211|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83696212|NCT01714102|Resveratrol|resveratrol|mesh-list
83696213|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
83696214|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696215|NCT01714102|Protective Agents|protective agents|mesh-ancestor
83696216|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696217|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696218|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83696219|NCT01714115|Aflibercept|aflibercept|mesh-list
83696220|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83696221|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83696222|NCT01714115|Growth Substances|growth substances|mesh-ancestor
83696223|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696224|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
83696225|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696226|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83696227|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83696228|NCT01714128|Estradiol|estradiol|mesh-list
83696229|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83696230|NCT01714128|Estrogens|estrogens|mesh-ancestor
83696231|NCT01714128|Hormones|hormones|mesh-ancestor
83696232|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696233|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696234|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83696235|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
83696236|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83696237|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83696238|NCT01714154|Ritonavir|ritonavir|mesh-list
83696239|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83696240|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83696241|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
83696242|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696243|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696244|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83696245|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83696246|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
83696247|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696248|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83696249|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83696250|NCT01714193|Canagliflozin|canagliflozin|mesh-list
82851140|NCT01087710|Vitamins|vitamins|mesh-list
83696251|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
83696252|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
83696253|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83696254|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696255|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83696256|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696257|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83696258|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83696259|NCT01714206|Canagliflozin|canagliflozin|mesh-list
83696260|NCT01714206|Digoxin|digoxin|mesh-list
83696261|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83696262|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83696263|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696264|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696265|NCT01714206|Protective Agents|protective agents|mesh-ancestor
83696266|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696267|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83696268|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83696269|NCT01714297|Dalteparin|dalteparin|mesh-list
83696270|NCT01714297|Tinzaparin|tinzaparin|mesh-list
83696271|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83696272|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
83696273|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83696274|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83696275|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696276|NCT01714388|Remifentanil|remifentanil|mesh-list
83696277|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83696278|NCT01714388|Narcotics|narcotics|mesh-ancestor
83696279|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696280|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696281|NCT01714388|Analgesics|analgesics|mesh-ancestor
83696282|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
83696283|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696284|NCT01714401|Albuterol|albuterol|mesh-list
83696285|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83696286|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
83696287|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696288|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696289|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83696290|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
83696291|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
83696292|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83696293|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83696294|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83696295|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83696296|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
83696297|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696298|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696299|NCT01714414|Lamivudine|lamivudine|mesh-list
83696300|NCT01714414|Zidovudine|zidovudine|mesh-list
83696301|NCT01714414|Efavirenz|efavirenz|mesh-list
83696302|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83696303|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83696304|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696305|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696306|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
83696307|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696308|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83696309|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83696310|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
83696311|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83696312|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83696313|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83696314|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83696315|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83696316|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83696317|NCT01714427|Dexamethasone|dexamethasone|mesh-list
83696318|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83696319|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
83696320|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
83696321|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696322|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851189|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
82851190|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696323|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696324|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
83696326|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696327|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83696328|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696329|NCT01714557|Tazobactam|tazobactam|mesh-list
83696330|NCT01714557|Piperacillin|piperacillin|mesh-list
83696331|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83696332|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83696333|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696334|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83696335|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696336|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696337|NCT01714570|Tazobactam|tazobactam|mesh-list
83696338|NCT01714570|Piperacillin|piperacillin|mesh-list
83696339|NCT01714570|Imipenem|imipenem|mesh-list
83696340|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83696341|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83696342|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696343|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83696344|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696345|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696346|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83696347|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696348|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83696349|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
83696350|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83696351|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
83696352|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83696353|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696354|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83696355|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83696356|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696357|NCT01714765|Everolimus|everolimus|mesh-list
83696358|NCT01714765|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83696359|NCT01714765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83696360|NCT01714765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696361|NCT01714765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696362|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696363|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
83696364|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696365|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696366|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
83696367|NCT01714817|Prednisone|prednisone|mesh-list
83696368|NCT01714817|Abatacept|abatacept|mesh-list
83696369|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83696370|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
83696371|NCT01714817|Hormones|hormones|mesh-ancestor
83696372|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696373|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696374|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83696375|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696376|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83696377|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83696378|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
83696379|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83696380|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696381|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696382|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696383|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83696384|NCT01714817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696385|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696386|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
83696387|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696388|NCT01714843|Linaclotide|linaclotide|mesh-list
83696389|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83696390|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
83696391|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696392|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696393|NCT01714856|Ropinirole|ropinirole|mesh-list
83696394|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83696395|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83696396|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
83696397|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
83696398|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696399|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696400|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696401|NCT01714895|Insulin|insulin|mesh-list
83696402|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83696403|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83696404|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696405|NCT01714908|Etoposide|etoposide|mesh-list
83696406|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83696407|NCT01714908|Cisplatin|cisplatin|mesh-list
83696408|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83696409|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696410|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83696411|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83696412|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696413|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696414|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83696415|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83696416|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83696417|NCT01715077|Ipilimumab|ipilimumab|mesh-list
83696418|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696419|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696420|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83696421|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696422|NCT01715090|Insulin|insulin|mesh-list
83696423|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83696424|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696425|NCT01715142|Paclitaxel|paclitaxel|mesh-list
83696426|NCT01715142|Gemcitabine|gemcitabine|mesh-list
83696427|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83696428|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83696429|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696430|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
83696431|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
83696432|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
83696433|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696434|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83696435|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
83696436|NCT01715168|Doxorubicin|doxorubicin|mesh-list
83696437|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83696438|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83696439|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696440|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83696441|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83696442|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696443|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696444|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
83696445|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
83696446|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
83696447|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696448|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83696449|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696450|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696451|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
83696452|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696453|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696454|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83696455|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
83696456|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83696457|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
83696458|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696459|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696460|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83696461|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83696462|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
83696463|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83696464|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
83696465|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696466|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696467|NCT01715363|Leucovorin|leucovorin|mesh-list
83696468|NCT01715363|Folic Acid|folic acid|mesh-list
83696469|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
82851338|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
82851339|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696470|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
83696471|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696472|NCT01715363|Antidotes|antidotes|mesh-ancestor
83696473|NCT01715363|Protective Agents|protective agents|mesh-ancestor
83495558|NCT01704521|Ribavirin|ribavirin|mesh-list
83696474|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696475|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
83696476|NCT01715363|Vitamins|vitamins|mesh-ancestor
83696477|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
83696478|NCT01715363|Hematinics|hematinics|mesh-ancestor
83696479|NCT01715441|Irinotecan|irinotecan|mesh-list
83696480|NCT01715441|Sorafenib|sorafenib|mesh-list
83696481|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83696482|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83696483|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696484|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696485|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696486|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83696487|NCT01715493|Muramidase|muramidase|mesh-list
83696488|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696489|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83696490|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
83696491|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83696492|NCT01715519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83696493|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83696494|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696495|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696496|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696497|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
83696498|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696499|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83696500|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83696501|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
83696502|NCT01715584|Sevoflurane|sevoflurane|mesh-list
83696503|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83696504|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83696505|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
83696506|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
83696507|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696508|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696509|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83696510|NCT01715584|Analgesics|analgesics|mesh-ancestor
83696511|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
83696512|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696513|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
83696514|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
83696515|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696516|NCT01715597|Protective Agents|protective agents|mesh-ancestor
83696517|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696518|NCT01715597|Vitamins|vitamins|mesh-ancestor
83696519|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
83696520|NCT01715610|Clindamycin|clindamycin|mesh-list
83696521|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
83696522|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
83696523|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83696524|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83696525|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696526|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83696527|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696528|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696529|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83696530|NCT01715636|Tenofovir|tenofovir|mesh-list
83696531|NCT01715636|Emtricitabine|emtricitabine|mesh-list
83696532|NCT01715636|Rilpivirine|rilpivirine|mesh-list
83696533|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
83696534|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696535|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83696536|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83696537|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696538|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696539|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83696540|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83696541|NCT01715688|Lidocaine|lidocaine|mesh-list
83696542|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
82851413|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83696543|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
83696544|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696545|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696546|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
83696547|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696548|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83696549|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83696550|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83696551|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696552|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696553|NCT01715701|Iodine|iodine|mesh-list
83696554|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83696555|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696556|NCT01715701|Trace Elements|trace elements|mesh-ancestor
83696557|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
83696558|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696559|NCT01715909|Oseltamivir|oseltamivir|mesh-list
83696560|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
83696561|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696562|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696563|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696564|NCT01715922|Fluconazole|fluconazole|mesh-list
83696565|NCT01715922|Flucytosine|flucytosine|mesh-list
83696566|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
83696567|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696568|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83696569|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83696570|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696571|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696572|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83696573|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
83696574|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696575|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696576|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83696577|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83696578|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
83696579|NCT01715935|Everolimus|everolimus|mesh-list
83696580|NCT01715935|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83696581|NCT01715935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83696582|NCT01715935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696583|NCT01715935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696584|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696585|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
83696586|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696587|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696588|NCT01715987|Tenofovir|tenofovir|mesh-list
83696589|NCT01715987|Entecavir|entecavir|mesh-list
83696590|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
83696591|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696592|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83696593|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83696594|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696595|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696596|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83696597|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83696598|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83696599|NCT01716273|Laxatives|laxatives|mesh-ancestor
83696600|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696601|NCT01716338|Glyburide|glyburide|mesh-list
83696602|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83696603|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696604|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83696605|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83696606|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83696607|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696608|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696609|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696610|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696611|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83696612|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
83696613|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83696614|NCT01716416|Cetuximab|cetuximab|mesh-list
83696615|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696616|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696617|NCT01716442|Rituximab|rituximab|mesh-list
83696618|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696619|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696620|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
83696621|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696622|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696623|NCT01716572|Erythromycin|erythromycin|mesh-list
83696624|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
83696625|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83696626|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
83696627|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83696628|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696629|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696630|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83696631|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696632|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696633|NCT01716611|Tolvaptan|tolvaptan|mesh-list
83696634|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83696635|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696636|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
83696637|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696638|NCT01716624|Oxybutynin|oxybutynin|mesh-list
83696639|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
83696640|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83696641|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83696642|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83696643|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696644|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696645|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
83696646|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696647|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696648|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83696649|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696650|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
83696651|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
83696652|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83696653|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83696654|NCT01716624|Urological Agents|urological agents|mesh-ancestor
83696655|NCT01716637|Etanercept|etanercept|mesh-list
83696656|NCT01716637|Curcumin|curcumin|mesh-list
83696657|NCT01716637|Resveratrol|resveratrol|mesh-list
83696658|NCT01716637|Quercetin|quercetin|mesh-list
83696659|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83696660|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83696661|NCT01716637|Analgesics|analgesics|mesh-ancestor
83696662|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
83696663|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696664|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696665|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83696666|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696667|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696668|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696669|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
83696670|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696671|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696672|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696673|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
83696674|NCT01716637|Protective Agents|protective agents|mesh-ancestor
83696675|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83696676|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
83696677|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696678|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
83696679|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696680|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696681|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83696682|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
83696683|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696684|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696685|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83696686|NCT01716767|Analgesics|analgesics|mesh-list
83696687|NCT01716767|Menthol|menthol|mesh-list
83696688|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
83696689|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696690|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696691|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
83696692|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
83696693|NCT01716858|Sulforaphane|sulforaphane|mesh-list
83696694|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83696695|NCT01716858|Protective Agents|protective agents|mesh-ancestor
83696696|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696697|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696698|NCT01716949|Fluorouracil|fluorouracil|mesh-list
83696699|NCT01716949|Capecitabine|capecitabine|mesh-list
83696700|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
83696701|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
83696702|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696703|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83696704|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696705|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696706|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
83696707|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696708|NCT01717027|Oxycodone|oxycodone|mesh-list
83696709|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83696710|NCT01717027|Narcotics|narcotics|mesh-ancestor
83696711|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696712|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696713|NCT01717027|Analgesics|analgesics|mesh-ancestor
83696714|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
83696715|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696716|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
83696717|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83696718|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696719|NCT01717118|Vaccines|vaccines|mesh-list
83696720|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
83696721|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696722|NCT01717157|Fentanyl|fentanyl|mesh-list
83696723|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83696724|NCT01717157|Narcotics|narcotics|mesh-ancestor
83696725|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696726|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696727|NCT01717157|Analgesics|analgesics|mesh-ancestor
83696728|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
83696729|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696730|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83696731|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83696732|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
83696733|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
83696734|NCT01717222|Lidocaine|lidocaine|mesh-list
83696735|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
83696736|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
83696737|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696738|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696739|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
83696740|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696741|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83696742|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83696743|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83696744|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696745|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696746|NCT01717235|Ropinirole|ropinirole|mesh-list
83696747|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83696748|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83696749|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
83696750|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
83696751|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696752|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696753|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696754|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
83696755|NCT01717300|Anacetrapib|anacetrapib|mesh-list
83696756|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83696757|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83696758|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
83696759|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696760|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83696761|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696762|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83696763|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696764|NCT01717404|Mexiletine|mexiletine|mesh-list
83696765|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82851637|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696766|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83696767|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83696768|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696769|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696770|NCT01717599|Diclofenac|diclofenac|mesh-list
83696771|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83696772|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83696773|NCT01717599|Analgesics|analgesics|mesh-ancestor
83696774|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
83696775|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696776|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696777|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83696778|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696779|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83696780|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696781|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696782|NCT01717612|Thrombin|thrombin|mesh-list
83696783|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
83696784|NCT01717612|Coagulants|coagulants|mesh-ancestor
83696785|NCT01717625|Montelukast|montelukast|mesh-list
83696786|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83696787|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
83696788|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83696789|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
83696790|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696791|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696792|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83696793|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83696794|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696795|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
83696796|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83696797|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83696798|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696799|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
83696800|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
83696801|NCT01717729|Iodine|iodine|mesh-list
83696802|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83696803|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696804|NCT01717729|Trace Elements|trace elements|mesh-ancestor
83696805|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
83696806|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696807|NCT01716260|Chloroquine|chloroquine|mesh-list
83696808|NCT01716260|Primaquine|primaquine|mesh-list
83696809|NCT01716260|Amebicides|amebicides|mesh-ancestor
83696810|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83696811|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83696812|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696813|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
83696814|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696815|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83696816|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696817|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83696818|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696819|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696820|NCT01717846|Abatacept|abatacept|mesh-list
83696821|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83696822|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696823|NCT01717846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83696824|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696825|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83696826|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
83696827|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696828|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696829|NCT01717911|Metformin|metformin|mesh-list
83696830|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83696831|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
83696832|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83696833|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696834|NCT01717911|Incretins|incretins|mesh-ancestor
83696835|NCT01717911|Hormones|hormones|mesh-ancestor
83696836|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696837|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83696838|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
83696839|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696840|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851715|NCT00387881|Naproxen|naproxen|mesh-list
83696841|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83696842|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83696843|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
83696844|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696845|NCT01717950|Antacids|antacids|mesh-ancestor
83696846|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696847|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696848|NCT01717963|Naltrexone|naltrexone|mesh-list
83696849|NCT01717963|Buprenorphine|buprenorphine|mesh-list
83696850|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83696851|NCT01717963|Naloxone|naloxone|mesh-list
83696852|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83696853|NCT01717963|Narcotics|narcotics|mesh-ancestor
83696854|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696855|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696856|NCT01717963|Analgesics|analgesics|mesh-ancestor
83696857|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
83696858|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696859|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83696860|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83696861|NCT01718054|Chloroquine|chloroquine|mesh-list
83696862|NCT01718054|Amebicides|amebicides|mesh-ancestor
83696863|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83696864|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83696865|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696866|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
83696867|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696868|NCT01718093|Metformin|metformin|mesh-list
83696869|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83696870|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83696871|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696872|NCT01718093|Incretins|incretins|mesh-ancestor
83696873|NCT01718093|Hormones|hormones|mesh-ancestor
83696874|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83696875|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83696876|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
83696877|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696878|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696879|NCT01718223|Temoporfin|temoporfin|mesh-list
83696880|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696881|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83696882|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
83696883|NCT01718236|Rocuronium|rocuronium|mesh-list
83696884|NCT01718236|Succinylcholine|succinylcholine|mesh-list
83696885|NCT01718236|Neostigmine|neostigmine|mesh-list
83696886|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83696887|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83696888|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83696889|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696890|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696891|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83696892|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696893|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696894|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
83696895|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83696896|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83696897|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
83696898|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83696899|NCT01718288|Aspirin|aspirin|mesh-list
83696900|NCT01718288|Iloprost|iloprost|mesh-list
83696901|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83696902|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83696903|NCT01718288|Analgesics|analgesics|mesh-ancestor
83696904|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
83696905|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696906|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696907|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83696908|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83696909|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83696910|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83696911|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696912|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83696913|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83696914|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696915|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
83696916|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
83696917|NCT01718301|Ribavirin|ribavirin|mesh-list
83696918|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83696919|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83696920|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
83696921|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696922|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
83696923|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696924|NCT01718314|Lidocaine|lidocaine|mesh-list
83696925|NCT01718314|Misoprostol|misoprostol|mesh-list
83696926|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
83696927|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
83696928|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696929|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696930|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
83696931|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696932|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83696933|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83696934|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83696935|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83696936|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696937|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83696938|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
83696939|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83696940|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83696941|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83696942|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
83696943|NCT01718327|Sunitinib|sunitinib|mesh-list
83696944|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696945|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83696946|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83696947|NCT01718327|Growth Substances|growth substances|mesh-ancestor
83696948|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696949|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83696950|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83696951|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696952|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696953|NCT01718340|Metformin|metformin|mesh-list
83696954|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83696955|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696956|NCT01718366|Vitamin D|vitamin d|mesh-list
83696957|NCT01718366|Azacitidine|azacitidine|mesh-list
83696958|NCT01718366|Deferasirox|deferasirox|mesh-list
83696959|NCT01718366|Vitamins|vitamins|mesh-ancestor
83696960|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
83696961|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696962|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83696963|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83696964|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
83696965|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696966|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696967|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696968|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83696969|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
83696970|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
83696971|NCT01718379|Lenalidomide|lenalidomide|mesh-list
83696972|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
83696973|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696974|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83696975|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83696976|NCT01718379|Growth Substances|growth substances|mesh-ancestor
83696977|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
83696978|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83696979|NCT01718496|Morphine|morphine|mesh-list
83696980|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83696981|NCT01718496|Narcotics|narcotics|mesh-ancestor
83696982|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83696983|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83696984|NCT01718496|Analgesics|analgesics|mesh-ancestor
83696985|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
83696986|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83696987|NCT01718587|Lamivudine|lamivudine|mesh-list
83696988|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
82851861|NCT01046279|Bevacizumab|bevacizumab|mesh-list
83696989|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83696990|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82851862|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851866|NCT01046279|Growth Substances|growth substances|mesh-ancestor
83696991|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83696992|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83696993|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83696994|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83696995|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83696996|NCT01718613|Vasopressins|vasopressins|mesh-list
83696997|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
83696998|NCT01718613|Norepinephrine|norepinephrine|mesh-list
83696999|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83697000|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83697001|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
83697002|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697003|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697004|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697005|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
83697006|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
83697007|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697008|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83697009|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
83697010|NCT01718613|Coagulants|coagulants|mesh-ancestor
83697011|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83697012|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
83697013|NCT01718626|Docetaxel|docetaxel|mesh-list
83697014|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697015|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
83697016|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
83697017|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
83697018|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697019|NCT01718652|Canagliflozin|canagliflozin|mesh-list
83697020|NCT01718652|Cyclosporine|cyclosporine|mesh-list
83697021|NCT01718652|Cyclosporins|cyclosporins|mesh-list
83697022|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697023|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697024|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697025|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
83697026|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697027|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
83697028|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697029|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
83697030|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697031|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83697032|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83697033|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83697034|NCT01718678|Melatonin|melatonin|mesh-list
83697035|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
83697036|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697037|NCT01718678|Protective Agents|protective agents|mesh-ancestor
83697038|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697039|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697040|NCT01718717|Morphine|morphine|mesh-list
83697041|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83697042|NCT01718717|Narcotics|narcotics|mesh-ancestor
83697043|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697044|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697045|NCT01718717|Analgesics|analgesics|mesh-ancestor
83697046|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
83697047|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697048|NCT01718808|Capecitabine|capecitabine|mesh-list
83697049|NCT01718808|Cetuximab|cetuximab|mesh-list
83697050|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83697051|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
83697052|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697053|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697054|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83697055|NCT01718834|Vaccines|vaccines|mesh-list
83697056|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
83697057|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697058|NCT01718899|Lenalidomide|lenalidomide|mesh-list
83697059|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
83697060|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697061|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83697062|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83697063|NCT01718899|Growth Substances|growth substances|mesh-ancestor
82851937|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697064|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
83697065|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697066|NCT01718912|Metronidazole|metronidazole|mesh-list
83697068|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697069|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83697070|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83697071|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83697072|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
83697073|NCT01718912|Ionophores|ionophores|mesh-ancestor
83697074|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697075|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697076|NCT01718951|Pamidronate|pamidronate|mesh-list
83697077|NCT01718951|Golimumab|golimumab|mesh-list
83697078|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83697079|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697080|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697081|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
83697082|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697083|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83697084|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
83697085|NCT01718964|Mannitol|mannitol|mesh-list
83697086|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83697087|NCT01718964|Diuretics|diuretics|mesh-ancestor
83697088|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
83697089|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697090|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697091|NCT01719042|Ondansetron|ondansetron|mesh-list
83697092|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
83697093|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
83697094|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697095|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697096|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697097|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
83697098|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
83697099|NCT01719042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83697100|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83697101|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
83697102|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697103|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697104|NCT01719133|Histamine|histamine|mesh-list
83697105|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
83697106|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
83697107|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
83697108|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697109|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697110|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697111|NCT01719159|Rituximab|rituximab|mesh-list
83697112|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83697113|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697114|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
83697115|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697116|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697117|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
83697118|NCT01719185|Phentermine|phentermine|mesh-list
83697119|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83697120|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697121|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
83697122|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83697123|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
83697124|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
83697125|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697126|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
83697127|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697128|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697129|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
83697130|NCT01719185|Vitamins|vitamins|mesh-ancestor
83697131|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
83697132|NCT01719302|Gemcitabine|gemcitabine|mesh-list
83697133|NCT01719302|Docetaxel|docetaxel|mesh-list
83697134|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83697135|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
83697136|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697137|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697138|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
83697139|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
83697140|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
82852009|NCT01326858|Analgesics|analgesics|mesh-ancestor
83697141|NCT01719419|Orlistat|orlistat|mesh-list
83697142|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697143|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697144|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83697145|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83697146|NCT01719588|Tapentadol|tapentadol|mesh-list
83697147|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83697148|NCT01719588|Narcotics|narcotics|mesh-ancestor
83697149|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697150|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697151|NCT01719588|Analgesics|analgesics|mesh-ancestor
83697152|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
83697153|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697154|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83697155|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83697156|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697157|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697158|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
83697159|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697160|NCT01719601|Tapentadol|tapentadol|mesh-list
83697161|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83697162|NCT01719601|Narcotics|narcotics|mesh-ancestor
83697163|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697164|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697165|NCT01719601|Analgesics|analgesics|mesh-ancestor
83697166|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
83697167|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697168|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83697169|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83697170|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697171|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697172|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
83697173|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697174|NCT01719614|Metformin|metformin|mesh-list
83697175|NCT01719614|Rilpivirine|rilpivirine|mesh-list
83697176|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83697177|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697178|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83697179|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83697180|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697181|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697182|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
83697183|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697184|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83697185|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83697186|NCT01719627|Maraviroc|maraviroc|mesh-list
83697187|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83697188|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83697189|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697190|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83697191|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83697192|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
83697193|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697194|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83697195|NCT01719692|Rituximab|rituximab|mesh-list
83697196|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83697197|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697198|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
83697199|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697200|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697201|NCT01719705|Pregabalin|pregabalin|mesh-list
83697202|NCT01719705|Analgesics|analgesics|mesh-ancestor
83697203|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
83697204|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697205|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697206|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
83697207|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83697208|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697209|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697210|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83697211|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83697212|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83697213|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82852084|NCT00091026|Growth Substances|growth substances|mesh-ancestor
82852085|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697214|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83697215|NCT01719770|Rocuronium|rocuronium|mesh-list
83697216|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83697217|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83697218|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83697219|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697220|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697221|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
83697222|NCT01719835|Prednisolone|prednisolone|mesh-list
83697223|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
83697224|NCT01719835|Gemcitabine|gemcitabine|mesh-list
83697225|NCT01719835|Doxorubicin|doxorubicin|mesh-list
83697226|NCT01719835|Vincristine|vincristine|mesh-list
83697227|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697228|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
83697229|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697230|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697231|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83697232|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
83697233|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697234|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697235|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83697236|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83697237|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
83697238|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83697239|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83697240|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83697241|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697242|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83697243|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83697244|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83697245|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83697246|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697247|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
83697248|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
83697249|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697250|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697251|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
83697252|NCT01719835|Hormones|hormones|mesh-ancestor
83697253|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83697254|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83697255|NCT01719835|Protective Agents|protective agents|mesh-ancestor
83697256|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83697257|NCT01719926|Indomethacin|indomethacin|mesh-list
83697258|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697259|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697260|NCT01719926|Analgesics|analgesics|mesh-ancestor
83697261|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
83697262|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697263|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697264|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697265|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697266|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
83697267|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
83697268|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83697269|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83697270|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697271|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697272|NCT01719952|Oxytocin|oxytocin|mesh-list
83697273|NCT01719952|Carbetocin|carbetocin|mesh-list
83697274|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
83697275|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83697276|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697277|NCT01719978|Epinephrine|epinephrine|mesh-list
83697278|NCT01719978|Racepinephrine|racepinephrine|mesh-list
83697279|NCT01719978|Mepivacaine|mepivacaine|mesh-list
83697280|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
83697281|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83697282|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83697283|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
83697284|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697285|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697286|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697287|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83697288|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82852157|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
83697289|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
83697290|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697291|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83697292|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
83697293|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
83697294|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
83697295|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83697296|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
83697297|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
83697298|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697299|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
83697300|NCT01720459|Resveratrol|resveratrol|mesh-list
83697301|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
83697302|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697303|NCT01720459|Protective Agents|protective agents|mesh-ancestor
83697304|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697305|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697306|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83697307|NCT01720537|Bococizumab|bococizumab|mesh-list
83697308|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83697309|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83697310|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83697311|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
83697312|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697313|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83697314|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
83697315|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697316|NCT01720719|Vitamin E|vitamin e|mesh-list
83697317|NCT01720719|Atorvastatin|atorvastatin|mesh-list
83697318|NCT01720719|Vitamins|vitamins|mesh-ancestor
83697319|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
83697320|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697321|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83697322|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83697323|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
83697324|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697325|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83697326|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83697327|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697328|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
83697329|NCT01720719|Protective Agents|protective agents|mesh-ancestor
83697330|NCT01722214|Adalimumab|adalimumab|mesh-list
83697331|NCT01722214|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83697332|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697333|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697334|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
83697335|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83697336|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83697337|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697338|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697339|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697340|NCT01723852|Vitamin D|vitamin d|mesh-list
83697341|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
83697342|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
83697343|NCT01723852|Vitamins|vitamins|mesh-list
83697344|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
83697345|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697346|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83697347|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83697348|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
83697349|NCT01724229|Clotrimazole|clotrimazole|mesh-list
83697350|NCT01724229|Miconazole|miconazole|mesh-list
83697351|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697352|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83697353|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83697354|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83697355|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697356|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697357|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83697358|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
83697359|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83697360|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697361|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83697362|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82852235|NCT01087658|Calcium|calcium|mesh-list
83697363|NCT01724450|Carvedilol|carvedilol|mesh-list
83697364|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83697365|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83697366|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
83697367|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697368|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697369|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697370|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83697371|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
83697372|NCT01724450|Protective Agents|protective agents|mesh-ancestor
83697373|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83697374|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697375|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83697376|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
83697377|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83697378|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83697379|NCT01724723|Entecavir|entecavir|mesh-list
83697380|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
83697381|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697382|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83697383|NCT01724892|Dexamethasone|dexamethasone|mesh-list
83697384|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697385|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
83697386|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
83697387|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697388|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697389|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697390|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
83697391|NCT01724892|Hormones|hormones|mesh-ancestor
83697392|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83697393|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83697394|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697395|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83697396|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83697397|NCT01727427|Aspirin|aspirin|mesh-list
83697398|NCT01727427|Vitamin K|vitamin k|mesh-list
83697399|NCT01727427|Heparin|heparin|mesh-list
83697400|NCT01727427|Enoxaparin|enoxaparin|mesh-list
83697401|NCT01727427|Dalteparin|dalteparin|mesh-list
83697402|NCT01727427|Tinzaparin|tinzaparin|mesh-list
83697403|NCT01727427|PENTA|penta|mesh-list
83697404|NCT01727427|Nadroparin|nadroparin|mesh-list
83697405|NCT01727427|Warfarin|warfarin|mesh-list
83697406|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
83697407|NCT01727427|Dabigatran|dabigatran|mesh-list
83697408|NCT01727427|Apixaban|apixaban|mesh-list
83697409|NCT01727427|Fondaparinux|fondaparinux|mesh-list
83697410|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
83697411|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
83697412|NCT01727427|Bemiparin|bemiparin|mesh-list
83697413|NCT01727427|Vitamins|vitamins|mesh-ancestor
83697414|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
83697415|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697416|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697417|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697418|NCT01727427|Analgesics|analgesics|mesh-ancestor
83697419|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
83697420|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697421|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697422|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697423|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83697424|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83697425|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697426|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83697427|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83697428|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697429|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
83697430|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
83697431|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83697432|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
83697433|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83697434|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
83697435|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82852308|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83697436|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
83697437|NCT01727427|Coagulants|coagulants|mesh-ancestor
83697438|NCT01727778|Antibodies|antibodies|mesh-list
83697439|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
83697440|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
83697441|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697442|NCT01728025|Ranolazine|ranolazine|mesh-list
83697443|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83697444|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697445|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697446|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
83697447|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83697448|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697449|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83697450|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83697451|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697452|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697453|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697454|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83697455|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83697456|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
83697457|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83697458|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697459|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83697460|NCT01730157|Ipilimumab|ipilimumab|mesh-list
83697461|NCT01730157|Antibodies|antibodies|mesh-list
83697462|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
83697463|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83697464|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
83697465|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697466|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697467|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83697468|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697469|NCT01730209|Everolimus|everolimus|mesh-list
83697470|NCT01730209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83697471|NCT01730209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83697472|NCT01730209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697473|NCT01730209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697474|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697475|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
83697476|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697477|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697478|NCT01730222|Paclitaxel|paclitaxel|mesh-list
83697479|NCT01730222|Gemcitabine|gemcitabine|mesh-list
83697480|NCT01730222|Capecitabine|capecitabine|mesh-list
83697481|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83697482|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697483|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
83697484|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
83697485|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
83697486|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697487|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83697488|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
83697489|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
83697490|NCT01730287|Calcium|calcium|mesh-list
83697491|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83697492|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697493|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83697494|NCT01730326|Acetaminophen|acetaminophen|mesh-list
83697495|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83697496|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697497|NCT01730326|Analgesics|analgesics|mesh-ancestor
83697498|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
83697499|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697500|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697501|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
83697502|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697503|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697504|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697505|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83697506|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697507|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697508|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697509|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83697510|NCT01730495|Etanercept|etanercept|mesh-list
83697511|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697512|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697513|NCT01730495|Analgesics|analgesics|mesh-ancestor
83697514|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
83697515|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852383|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697516|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697517|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697518|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697519|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697520|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697521|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
83697522|NCT01730508|Interferons|interferons|mesh-list
83697523|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
83697524|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697525|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
83697526|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697527|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
83697528|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697529|NCT01726400|Interferons|interferons|mesh-list
83697530|NCT01726400|Ribavirin|ribavirin|mesh-list
83697531|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
83697532|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697533|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
83697534|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697535|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
83697536|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697537|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
83697538|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697539|NCT01730612|Histamine|histamine|mesh-list
83697540|NCT01730612|Glycine|glycine|mesh-list
83697541|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
83697542|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
83697543|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697544|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697545|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697546|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
83697547|NCT01730664|Ertapenem|ertapenem|mesh-list
83697548|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83697549|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697550|NCT01730677|Vinorelbine|vinorelbine|mesh-list
83697551|NCT01730677|Lapatinib|lapatinib|mesh-list
83697552|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83697553|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697554|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
83697555|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
83697556|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
83697557|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697558|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83697559|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697560|NCT01730976|Vitamin D|vitamin d|mesh-list
83697561|NCT01730976|Vitamins|vitamins|mesh-list
83697562|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
83697563|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697564|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83697565|NCT01731067|Fexofenadine|fexofenadine|mesh-list
83697566|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
83697567|NCT01731067|Midazolam|midazolam|mesh-list
83697568|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
83697569|NCT01731067|Caffeine|caffeine|mesh-list
83697570|NCT01731067|Bupropion|bupropion|mesh-list
83697571|NCT01731067|Omeprazole|omeprazole|mesh-list
83697572|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83697573|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83697574|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697575|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697576|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83697577|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83697578|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83697579|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83697580|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
83697581|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
83697582|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
83697583|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
83697584|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697585|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697586|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83697587|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83697588|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697589|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83697590|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83697591|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
83697592|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83697593|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697594|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83697595|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83697596|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
83697597|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83697598|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83697599|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697600|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
83697601|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83697602|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83697603|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
83697604|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
83697605|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83697606|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83697607|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83697608|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83697609|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83697610|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
83697611|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
83697612|NCT01731067|Analgesics|analgesics|mesh-ancestor
83697613|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
83697614|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697615|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697616|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697617|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697618|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697619|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83697620|NCT01731132|Copper|copper|mesh-list
83697621|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
83697622|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83697623|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
83697624|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83697625|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697626|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83697627|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83697628|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83697629|NCT01731132|Trace Elements|trace elements|mesh-ancestor
83697630|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
83697631|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
83697632|NCT01731158|Bevacizumab|bevacizumab|mesh-list
83697633|NCT01731158|Sunitinib|sunitinib|mesh-list
83697634|NCT01731158|Everolimus|everolimus|mesh-list
83697635|NCT01731158|Sorafenib|sorafenib|mesh-list
83697636|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83697637|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697638|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83697639|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83697640|NCT01731158|Growth Substances|growth substances|mesh-ancestor
83697641|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697642|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
83697643|NCT01731158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83697644|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83697645|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697646|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697647|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697648|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
83697649|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
83697650|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697651|NCT01731184|Midazolam|midazolam|mesh-list
83697652|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83697653|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83697654|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697655|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697656|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83697657|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83697658|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83697659|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83697660|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
83697661|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
83697662|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
83697663|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
83697664|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697665|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697666|NCT01731275|Quetmolimab|quetmolimab|mesh-list
83697667|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83697668|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852537|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697669|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
83697670|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697671|NCT01731301|Ribavirin|ribavirin|mesh-list
83697672|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
83697673|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697674|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
83697675|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697676|NCT01731327|Tofacitinib|tofacitinib|mesh-list
83697677|NCT01731327|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83697678|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83697679|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697680|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697681|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
83697682|NCT01731340|Calcium|calcium|mesh-list
83697683|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83697684|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697685|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83697686|NCT01731431|Glyburide|glyburide|mesh-list
83697687|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83697688|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697689|NCT01731457|Etanercept|etanercept|mesh-list
83697690|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697691|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697692|NCT01731457|Analgesics|analgesics|mesh-ancestor
83697693|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
83697694|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697695|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697696|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697697|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697698|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697699|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697700|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
83697701|NCT01731561|Rituximab|rituximab|mesh-list
83697702|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83697703|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697704|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
83697705|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697706|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697707|NCT01731574|Dapivirine|dapivirine|mesh-list
83697708|NCT01731574|Miconazole|miconazole|mesh-list
83697709|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83697710|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83697711|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
83697712|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697713|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
83697714|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83697715|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83697716|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697717|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697718|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83697719|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
83792148|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697720|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83697721|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697722|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83697723|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83697724|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
83697725|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83697726|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
83697727|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697728|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697729|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83697730|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
83697731|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697732|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697733|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83697734|NCT01731652|Imiquimod|imiquimod|mesh-list
83697735|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83697736|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
83697737|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697738|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697739|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
83697740|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
83697741|NCT01731756|Salicylates|salicylates|mesh-list
83697742|NCT01731756|Petrolatum|petrolatum|mesh-list
83697743|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697744|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
83697745|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
83697746|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83697747|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697748|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697749|NCT01731756|Analgesics|analgesics|mesh-ancestor
83697750|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
83697751|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697752|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697753|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697754|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697755|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83697756|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697757|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697758|NCT01731756|Emollients|emollients|mesh-ancestor
83697759|NCT01731795|Dexamethasone|dexamethasone|mesh-list
83697760|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
83697761|NCT01731795|BB 1101|bb 1101|mesh-list
83697762|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697763|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
83697764|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
83697765|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697766|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697767|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697768|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
83697769|NCT01731795|Hormones|hormones|mesh-ancestor
83697770|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83697771|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83697772|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697773|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
83697774|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697775|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697776|NCT01731899|Agomelatine|agomelatine|mesh-list
83697777|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83697778|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697779|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697780|NCT01731925|Sunitinib|sunitinib|mesh-list
83697781|NCT01731925|Lanreotide|lanreotide|mesh-list
83697782|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697783|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83697784|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83697785|NCT01731925|Growth Substances|growth substances|mesh-ancestor
83697786|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697787|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
83697788|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83697789|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697790|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697791|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
83697792|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83697793|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83697794|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
83697795|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83697796|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
83697797|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83697798|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697799|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83697800|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83697801|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697802|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83697803|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
83697804|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83697805|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
83697806|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83697807|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697808|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83697809|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83697810|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697811|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
83697812|NCT01732146|Hematinics|hematinics|mesh-ancestor
83697813|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83697814|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
83697815|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697816|NCT01732224|Tenofovir|tenofovir|mesh-list
83697817|NCT01732224|Telbivudine|telbivudine|mesh-list
83697818|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
83697819|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697820|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83697821|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83697822|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697823|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697824|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83697825|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83697826|NCT01732250|Meropenem|meropenem|mesh-list
83697827|NCT01732250|Colistin|colistin|mesh-list
83697828|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83697829|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697830|NCT01732276|Gefitinib|gefitinib|mesh-list
83697831|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697832|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83697833|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697834|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697835|NCT01732328|Vitamin D|vitamin d|mesh-list
83697836|NCT01732328|Calcium|calcium|mesh-list
83697837|NCT01732328|Vitamins|vitamins|mesh-ancestor
83697838|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
83697839|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697840|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83697841|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83697842|NCT01732367|Tenofovir|tenofovir|mesh-list
83697843|NCT01732367|Lamivudine|lamivudine|mesh-list
83697844|NCT01732367|Adefovir|adefovir|mesh-list
83697845|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
83697846|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697847|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83697848|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83697849|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697850|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697851|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83697852|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83697853|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
83697854|NCT01732380|Raltitrexed|raltitrexed|mesh-list
83697855|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697856|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83697857|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
83697858|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697859|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83697860|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697861|NCT01732393|Quercetin|quercetin|mesh-list
83697862|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
83697863|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697864|NCT01732393|Protective Agents|protective agents|mesh-ancestor
83697865|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697866|NCT01732666|Remifentanil|remifentanil|mesh-list
83697867|NCT01732666|Nefopam|nefopam|mesh-list
83697868|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83697869|NCT01732666|Narcotics|narcotics|mesh-ancestor
83697870|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697871|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697872|NCT01732666|Analgesics|analgesics|mesh-ancestor
83697873|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
83697874|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697875|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697876|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83697877|NCT01732744|Eusol|eusol|mesh-list
83697878|NCT01732744|Castor Oil|castor oil|mesh-list
83697879|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83697880|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
83697881|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697882|NCT01732744|Cathartics|cathartics|mesh-ancestor
83697883|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83697884|NCT01732861|Lenalidomide|lenalidomide|mesh-list
83697885|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
83697886|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697887|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83697888|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83697889|NCT01732861|Growth Substances|growth substances|mesh-ancestor
83697890|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83697891|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697892|NCT01733017|Lycopene|lycopene|mesh-list
83697893|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697894|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
83697895|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697896|NCT01733017|Protective Agents|protective agents|mesh-ancestor
83697897|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697898|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83697899|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83697900|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697901|NCT01733030|Cycloserine|cycloserine|mesh-list
83697902|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83697903|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83697904|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83697905|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
83697906|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83697907|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
83697908|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697909|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
83697910|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83697911|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697912|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697913|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697914|NCT01733043|Analgesics|analgesics|mesh-ancestor
83697915|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
83697916|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697917|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83697918|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83697919|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83697920|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83697921|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697922|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697923|NCT01733095|Ambrisentan|ambrisentan|mesh-list
83697924|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83697925|NCT01733108|Canagliflozin|canagliflozin|mesh-list
83697926|NCT01733108|Glyburide|glyburide|mesh-list
83697927|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83697928|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697929|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83697930|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697931|NCT01733134|Tolvaptan|tolvaptan|mesh-list
83697932|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83697933|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697934|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
83697935|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697936|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
83697937|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83697938|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83697939|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83697940|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697941|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697942|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
83697943|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83697944|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697945|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83697946|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697947|NCT01733342|Anesthetics|anesthetics|mesh-list
83697948|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697949|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697950|NCT01733394|Lamotrigine|lamotrigine|mesh-list
83697951|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
83697952|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83697953|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83697954|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697955|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83697956|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697957|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83697958|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83697959|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83697960|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83697961|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83697962|NCT01733459|Metformin|metformin|mesh-list
83697963|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83697964|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697965|NCT01733485|Aspirin|aspirin|mesh-list
83697966|NCT01733485|Indomethacin|indomethacin|mesh-list
83697967|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83697968|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83697969|NCT01733485|Analgesics|analgesics|mesh-ancestor
83697970|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
83697971|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83697972|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697973|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83697974|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83697975|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83697976|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83697977|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697978|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83697979|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83697980|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697981|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
83697982|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
83697983|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
83697984|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83697985|NCT01733589|Etoposide|etoposide|mesh-list
83697986|NCT01733589|Cisplatin|cisplatin|mesh-list
83697987|NCT01733589|Endostatins|endostatins|mesh-list
83697988|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83697989|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83697990|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83697991|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83697992|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83697993|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83697994|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83697995|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83697996|NCT01733589|Growth Substances|growth substances|mesh-ancestor
83697997|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83697998|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
83697999|NCT01733706|Nicotine|nicotine|mesh-list
83698000|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83698001|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
83698002|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698003|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698004|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83698005|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83698006|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
83698007|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698008|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698009|NCT01733823|Nimorazole|nimorazole|mesh-list
83698010|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83698011|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83698012|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83698013|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698014|NCT01733836|Metformin|metformin|mesh-list
83698015|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83698016|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698017|NCT01733966|Amoxicillin|amoxicillin|mesh-list
83698018|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
83698019|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
83698020|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83698021|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
83698022|NCT01733966|Secnidazole|secnidazole|mesh-list
83698023|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83698024|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698025|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698026|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698027|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83698028|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83698029|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83698030|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83698031|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83698032|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698033|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83698034|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83698035|NCT01733979|Iron|iron|mesh-list
83698036|NCT01733979|Trace Elements|trace elements|mesh-ancestor
83698037|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
83698038|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698039|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83698040|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83698041|NCT01734044|Dexamethasone|dexamethasone|mesh-list
83698042|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
83698043|NCT01734044|BB 1101|bb 1101|mesh-list
83698044|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698045|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
83698046|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
83698047|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698048|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698049|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698050|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
83698052|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698053|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83698054|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698055|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
83698056|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698057|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698058|NCT01734057|Dexamethasone|dexamethasone|mesh-list
83698059|NCT01734057|Rituximab|rituximab|mesh-list
83698060|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83698061|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698062|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
83698063|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698064|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698065|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698066|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
83698067|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
83698068|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698069|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698070|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
83698071|NCT01734057|Hormones|hormones|mesh-ancestor
83698072|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698073|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83698074|NCT01734096|Candesartan|candesartan|mesh-list
83698075|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
83698076|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83698077|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83698078|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83698079|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698080|NCT01734252|Argatroban|argatroban|mesh-list
83698081|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
83698082|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83698083|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
83698084|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698085|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698086|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
83698087|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83698088|NCT01734330|Nicotine|nicotine|mesh-list
83698089|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83698090|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
83698091|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698092|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698093|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83698094|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83698095|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
83698096|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698097|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698098|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83698099|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
83698100|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83698101|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
83698102|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698103|NCT01734408|Antacids|antacids|mesh-ancestor
83698104|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698105|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698106|NCT01734473|Caseins|caseins|mesh-list
83698107|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
83698108|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
83698109|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698110|NCT01734564|Poly I-C|poly i-c|mesh-list
83698111|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83698112|NCT01734564|Poly ICLC|poly iclc|mesh-list
83698113|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
83698114|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
83698115|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698116|NCT01734564|Laxatives|laxatives|mesh-ancestor
83698117|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698118|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
83698119|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698120|NCT01734798|Gemcitabine|gemcitabine|mesh-list
83698121|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852986|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83698122|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83698123|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
83698124|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698125|NCT01734824|Denosumab|denosumab|mesh-list
83698126|NCT01734824|Teriparatide|teriparatide|mesh-list
83698127|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
83698128|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83698129|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698130|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83698131|NCT01734915|Iproplatin|iproplatin|mesh-list
83698132|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698133|NCT01734954|Midazolam|midazolam|mesh-list
83698134|NCT01734954|Analgesics|analgesics|mesh-list
83698135|NCT01734954|Anesthetics|anesthetics|mesh-list
83698136|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
83698137|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
83698138|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698139|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698140|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83698141|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83698142|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83698143|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83698144|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83698145|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83698146|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
83698147|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
83698148|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
83698149|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698150|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698151|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
83698152|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698153|NCT01735006|Vaccines|vaccines|mesh-list
83698154|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
83698155|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698156|NCT01735019|Remifentanil|remifentanil|mesh-list
83698157|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83698158|NCT01735019|Narcotics|narcotics|mesh-ancestor
83698159|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698160|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698161|NCT01735019|Analgesics|analgesics|mesh-ancestor
83698162|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
83698163|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698164|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
83698165|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83698166|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
83698167|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698168|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
83698169|NCT01735058|Protective Agents|protective agents|mesh-ancestor
83698170|NCT01735071|Bevacizumab|bevacizumab|mesh-list
83698171|NCT01735071|Carboplatin|carboplatin|mesh-list
83698172|NCT01735071|Trabectedin|trabectedin|mesh-list
83698173|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83698174|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698175|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83698176|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83698177|NCT01735071|Growth Substances|growth substances|mesh-ancestor
83698178|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698179|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
83698180|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83698181|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
83698182|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698183|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83698184|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
83698185|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698186|NCT01735097|Vitamin E|vitamin e|mesh-list
83698187|NCT01735097|Vitamins|vitamins|mesh-ancestor
83698188|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
83698189|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698190|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
83698191|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698192|NCT01735097|Protective Agents|protective agents|mesh-ancestor
83698193|NCT01735123|Caseins|caseins|mesh-list
83698194|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
82853062|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83698195|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
83698196|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698197|NCT01735227|Omeprazole|omeprazole|mesh-list
83698198|NCT01735227|Pantoprazole|pantoprazole|mesh-list
83698199|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83698200|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698201|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83698202|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698203|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698204|NCT01735240|Ketoconazole|ketoconazole|mesh-list
83698205|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
83698206|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698207|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83698208|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83698209|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698210|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698211|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83698212|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
83698213|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698214|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698215|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83698216|NCT01735318|Lisinopril|lisinopril|mesh-list
83698217|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83698218|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
83698219|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698220|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698221|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83698222|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83698223|NCT01735318|Protective Agents|protective agents|mesh-ancestor
83698224|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698225|NCT01735344|Lisinopril|lisinopril|mesh-list
83698226|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83698227|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
83698228|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698229|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698230|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83698231|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83698232|NCT01735344|Protective Agents|protective agents|mesh-ancestor
83698233|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698234|NCT01735370|Etodolac|etodolac|mesh-list
83698235|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83698236|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83698237|NCT01735370|Analgesics|analgesics|mesh-ancestor
83698238|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
83698239|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698240|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698241|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698242|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698243|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83698244|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83698245|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698246|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698247|NCT01735383|Etodolac|etodolac|mesh-list
83698248|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83698249|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83698250|NCT01735383|Analgesics|analgesics|mesh-ancestor
83698251|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
83698252|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698253|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698254|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698255|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698256|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83698257|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83698258|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698259|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698260|NCT01735487|Nicotine|nicotine|mesh-list
83698261|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83698262|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
82853085|NCT03642262|Guaifenesin|guaifenesin|mesh-list
82853086|NCT03642262|Expectorants|expectorants|mesh-ancestor
82853087|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
82853088|NCT03727048|Ketorolac|ketorolac|mesh-list
82853089|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82853090|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82853091|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853092|NCT03727048|Analgesics|analgesics|mesh-ancestor
83698263|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698264|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698265|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83698266|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83698267|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
83698268|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698269|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698270|NCT01735669|Remifentanil|remifentanil|mesh-list
83698271|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
83698272|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83698273|NCT01735669|Narcotics|narcotics|mesh-ancestor
83698274|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698275|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698276|NCT01735669|Analgesics|analgesics|mesh-ancestor
83698277|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
83698278|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698279|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83698280|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
83698281|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
83698282|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83698283|NCT01735747|Vincristine|vincristine|mesh-list
83698284|NCT01735747|Temozolomide|temozolomide|mesh-list
83698285|NCT01735747|Nedaplatin|nedaplatin|mesh-list
83698286|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83698287|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698288|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
83698289|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
83698290|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
83698291|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698292|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83698293|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
83698294|NCT01735864|Indirubin|indirubin|mesh-list
83698295|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83698296|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698297|NCT01735890|Amlodipine|amlodipine|mesh-list
83698298|NCT01735890|Valsartan|valsartan|mesh-list
83698299|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83698300|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83698301|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83698302|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83698303|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698304|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83698305|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698306|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
83698307|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83698308|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83698309|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
83698310|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
83698311|NCT01736020|Ketamine|ketamine|mesh-list
83698312|NCT01736020|Propofol|propofol|mesh-list
83698313|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83698314|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698315|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698316|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83698317|NCT01736020|Analgesics|analgesics|mesh-ancestor
83698318|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
83698319|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698320|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83698321|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83698322|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83698323|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
83698324|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698325|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698326|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83698327|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
83698328|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
83698329|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83698330|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83698331|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83698332|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83698333|NCT01736033|Tamsulosin|tamsulosin|mesh-list
83698334|NCT01736033|Finasteride|finasteride|mesh-list
83698335|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83698336|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83698337|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83698338|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83698339|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698340|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698341|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698342|NCT01736033|Urological Agents|urological agents|mesh-ancestor
83698343|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83698344|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83698345|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698346|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
83698347|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698349|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
83698350|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
83698351|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698352|NCT01736163|Hormones|hormones|mesh-list
83698353|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698354|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698355|NCT01736371|Propofol|propofol|mesh-list
83698356|NCT01736371|Sevoflurane|sevoflurane|mesh-list
83698357|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83698358|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698359|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698360|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83698361|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
83698362|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
83698363|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83698364|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83698365|NCT01736410|Trastuzumab|trastuzumab|mesh-list
83698366|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698367|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83698368|NCT01736423|Ramosetron|ramosetron|mesh-list
83698369|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
83698370|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
83698371|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698372|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698373|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698374|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83698375|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
83698376|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698377|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698378|NCT01736449|Bevacizumab|bevacizumab|mesh-list
83698379|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83698380|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698381|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83698382|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83698383|NCT01736449|Growth Substances|growth substances|mesh-ancestor
83698384|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698385|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
83698386|NCT01736488|Atenolol|atenolol|mesh-list
83698387|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83698388|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83698389|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
83698390|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
83698391|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698392|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698393|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83698394|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83698395|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83698396|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
83698397|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698398|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698399|NCT01736514|Allopurinol|allopurinol|mesh-list
83698400|NCT01736514|Febuxostat|febuxostat|mesh-list
83698401|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
83698402|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698403|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698404|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
83698405|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698406|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83698407|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
83698408|NCT01736514|Protective Agents|protective agents|mesh-ancestor
83698409|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698410|NCT01736670|Triamcinolone|triamcinolone|mesh-list
83698411|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83698412|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83698413|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83698414|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698415|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
83698416|NCT01736670|Hormones|hormones|mesh-ancestor
83698417|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698418|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698419|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83698420|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
83698421|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698422|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698423|NCT01736761|Ritonavir|ritonavir|mesh-list
83698424|NCT01736761|Darunavir|darunavir|mesh-list
83698425|NCT01736761|Rilpivirine|rilpivirine|mesh-list
83698426|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83698427|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83698428|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
83698429|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698430|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698431|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83698432|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83698433|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
83698434|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698435|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83698436|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83698437|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83698438|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83698439|NCT01736800|Temozolomide|temozolomide|mesh-list
83698440|NCT01736800|Topotecan|topotecan|mesh-list
83698441|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83698442|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
83698443|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698444|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698445|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83698446|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83698447|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698448|NCT01736813|Maraviroc|maraviroc|mesh-list
83698449|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83698450|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83698451|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698452|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83698453|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83698454|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
83698455|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698456|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83698457|NCT01736878|Sorafenib|sorafenib|mesh-list
83698458|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698459|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83698460|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698461|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698462|NCT01736891|Rasagiline|rasagiline|mesh-list
83698463|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83698464|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698465|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698466|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83698467|NCT01736891|Protective Agents|protective agents|mesh-ancestor
83698468|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698469|NCT01737008|Cisplatin|cisplatin|mesh-list
83698470|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698471|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
83698472|NCT01737073|Narcotics|narcotics|mesh-ancestor
83698473|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698474|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698475|NCT01737073|Analgesics|analgesics|mesh-ancestor
83698476|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
83698477|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698478|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
83698479|NCT01737086|Astringents|astringents|mesh-ancestor
83698480|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698481|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
83698482|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
83698483|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83698484|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853311|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
83698485|NCT01737177|Rituximab|rituximab|mesh-list
83698487|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83698488|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83698489|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698490|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
83698491|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698492|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698493|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83698494|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83698495|NCT01737177|Growth Substances|growth substances|mesh-ancestor
83698496|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
83698497|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83698498|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
83698499|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698500|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
83698501|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698502|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
83698503|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83698504|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83698505|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698506|NCT01737203|Urological Agents|urological agents|mesh-ancestor
83698507|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
83698508|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83698509|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698510|NCT01737294|Capsaicin|capsaicin|mesh-list
83698511|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
83698512|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
83698513|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
83698514|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698515|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698516|NCT01737307|Fluorides|fluorides|mesh-list
83698517|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
83698518|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
83698519|NCT01737307|Protective Agents|protective agents|mesh-ancestor
83698520|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698521|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83698522|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83698523|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698524|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
83698525|NCT01737346|Lomustine|lomustine|mesh-list
83698526|NCT01737346|Procarbazine|procarbazine|mesh-list
83698527|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83698528|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
83698529|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698530|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698531|NCT01737359|Tenofovir|tenofovir|mesh-list
83698532|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
83698533|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698534|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83698535|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83698536|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698537|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698538|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83698539|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83698540|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
83698541|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83698542|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83698543|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
83698544|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698545|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698546|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698547|NCT01737411|Urological Agents|urological agents|mesh-ancestor
83698548|NCT01737541|Fluoxetine|fluoxetine|mesh-list
83698549|NCT01737541|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83698550|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83698551|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83698552|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698553|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698554|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
83698555|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698556|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82853385|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698557|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
83698558|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83698559|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83698560|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83698561|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698562|NCT01737671|Leucovorin|leucovorin|mesh-list
83698563|NCT01737671|Methotrexate|methotrexate|mesh-list
83698564|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83698565|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
83698566|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83698567|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698568|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83698569|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
83698570|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698571|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698572|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83698573|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698574|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83698575|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83698576|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
83698577|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698578|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83698579|NCT01737671|Antidotes|antidotes|mesh-ancestor
83698580|NCT01737671|Protective Agents|protective agents|mesh-ancestor
83698581|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
83698582|NCT01737671|Vitamins|vitamins|mesh-ancestor
83698583|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
83698584|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
83698585|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83698586|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83698587|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
83698588|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698589|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698590|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698591|NCT01737918|Urological Agents|urological agents|mesh-ancestor
83698592|NCT01738035|Budesonide|budesonide|mesh-list
83698593|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698594|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83698595|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
83698596|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698597|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698598|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83698599|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
83698600|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
83698601|NCT01738035|Hormones|hormones|mesh-ancestor
83698602|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698603|NCT01738087|Fluticasone|fluticasone|mesh-list
83698604|NCT01738087|Xhance|xhance|mesh-list
83698605|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
83698606|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698607|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83698608|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
83698609|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698610|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698611|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83698612|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
83698613|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
83698614|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83698615|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83698616|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83698617|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83698618|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
83698619|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698620|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698621|NCT01738100|Morphine|morphine|mesh-list
83698622|NCT01738100|Clopidogrel|clopidogrel|mesh-list
83698623|NCT01738100|Ticagrelor|ticagrelor|mesh-list
83698624|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83698625|NCT01738100|Narcotics|narcotics|mesh-ancestor
83698626|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698627|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698628|NCT01738100|Analgesics|analgesics|mesh-ancestor
83698629|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
83698630|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853459|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698631|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83698632|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83698633|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83698634|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83698635|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
83698636|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698637|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698638|NCT01738178|Caffeine|caffeine|mesh-list
83698639|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83698640|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698641|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83698642|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698643|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698644|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83698645|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83698646|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
83698647|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698648|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
83698649|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83698650|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
83698651|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698652|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
83698653|NCT01738243|Protective Agents|protective agents|mesh-ancestor
83698654|NCT01738282|Baclofen|baclofen|mesh-list
83698655|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83698656|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698657|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83698658|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698659|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83698660|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
83698661|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
83698662|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698663|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698664|NCT01738295|Donepezil|donepezil|mesh-list
83698665|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83698666|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698667|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698668|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
83698669|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698670|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698671|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
83698672|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
83698673|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698674|NCT01738373|Plerixafor|plerixafor|mesh-list
83698675|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83698676|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83698677|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
83698678|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698679|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
83698680|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
83698681|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698682|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698683|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698684|NCT01738451|Dabrafenib|dabrafenib|mesh-list
83698685|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698686|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83698687|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698688|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698689|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
83698690|NCT01738542|Bosentan|bosentan|mesh-list
83698691|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83698692|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698693|NCT01738724|Goserelin|goserelin|mesh-list
83698694|NCT01738724|Dienogest|dienogest|mesh-list
83698695|NCT01738724|Desogestrel|desogestrel|mesh-list
83698696|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83698697|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698698|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83698699|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
83698700|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83698701|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698702|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83698703|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83698704|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82853533|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83698705|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83698706|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
83698707|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698708|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83698709|NCT01738724|Progestins|progestins|mesh-ancestor
83698711|NCT01738763|Inositol|inositol|mesh-list
83698712|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
83698713|NCT01738763|Vitamins|vitamins|mesh-ancestor
83698714|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
83698715|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698716|NCT01738802|Micronutrients|micronutrients|mesh-list
83698717|NCT01738802|Trace Elements|trace elements|mesh-list
83698718|NCT01738802|Antioxidants|antioxidants|mesh-list
83698719|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698720|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698721|NCT01738802|Protective Agents|protective agents|mesh-ancestor
83698722|NCT01738815|Valproic Acid|valproic acid|mesh-list
83698723|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
83698724|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698725|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698726|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
83698727|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698728|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698729|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
83698730|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83698731|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698732|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83698733|NCT01738867|Naltrexone|naltrexone|mesh-list
83698734|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83698735|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83698736|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698737|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
83698738|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698739|NCT01738893|Gabapentin|gabapentin|mesh-list
83698740|NCT01738893|Analgesics|analgesics|mesh-ancestor
83698741|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
83698742|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698743|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698744|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
83698745|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83698746|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83698747|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698748|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83698749|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83698750|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83698751|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698752|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698753|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
83698754|NCT01738945|Amlodipine|amlodipine|mesh-list
83698755|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83698756|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83698757|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83698758|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698759|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83698760|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698761|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
83698762|NCT01739049|Liraglutide|liraglutide|mesh-list
83698763|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83698764|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698765|NCT01739049|Incretins|incretins|mesh-ancestor
83698766|NCT01739049|Hormones|hormones|mesh-ancestor
83698767|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698768|NCT01739127|Risperidone|risperidone|mesh-list
83698769|NCT01739127|Aripiprazole|aripiprazole|mesh-list
83698770|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83698771|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83698772|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
83698773|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698774|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698775|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698776|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83698777|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83698778|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698779|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83698780|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83698782|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
83698783|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
83698784|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83698785|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83698786|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83698787|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83698788|NCT01739192|Bupropion|bupropion|mesh-list
83698789|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83698790|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
83698791|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83698792|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83698793|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83698794|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83698795|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698796|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
83698797|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698798|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698799|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83698800|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83698801|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698802|NCT01739218|Paclitaxel|paclitaxel|mesh-list
83698803|NCT01739218|Bevacizumab|bevacizumab|mesh-list
83698804|NCT01739218|Carboplatin|carboplatin|mesh-list
83698805|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83698806|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698807|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
83698808|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
83698809|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
83698810|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698811|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83698812|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83698813|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83698814|NCT01739218|Growth Substances|growth substances|mesh-ancestor
83698815|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698816|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
83698817|NCT01739413|Anesthetics|anesthetics|mesh-list
83698818|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698819|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698820|NCT01739439|Gemcitabine|gemcitabine|mesh-list
83698821|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83698822|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
83698823|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698824|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698825|NCT01739504|Anesthetics|anesthetics|mesh-list
83698826|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698827|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698828|NCT01739556|Aspirin|aspirin|mesh-list
83698829|NCT01739556|Ticagrelor|ticagrelor|mesh-list
83698830|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83698831|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83698832|NCT01739556|Analgesics|analgesics|mesh-ancestor
83698833|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
83698834|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698835|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698836|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698837|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698838|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83698839|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83698840|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698841|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83698842|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83698843|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698844|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
83698845|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83698846|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83698847|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83698848|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
83698849|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698850|NCT01739582|Enclomiphene|enclomiphene|mesh-list
83698851|NCT01739582|Clomiphene|clomiphene|mesh-list
83698852|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
83698853|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83698854|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
83698855|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698856|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698857|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83698858|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
83698859|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83698860|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83698861|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83698862|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
83698863|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
83698864|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698866|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
83698867|NCT01739673|Vitamins|vitamins|mesh-ancestor
83698868|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
83698869|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698870|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83698871|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
83698872|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
83698873|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
83698874|NCT01739855|Calcium|calcium|mesh-list
83698875|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83698876|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698877|NCT01739855|Antacids|antacids|mesh-ancestor
83698878|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698879|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698880|NCT01739855|Vitamins|vitamins|mesh-ancestor
83698881|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
83698882|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83698883|NCT01739894|Paclitaxel|paclitaxel|mesh-list
83698884|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83698885|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698886|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
83698887|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
83698888|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
83698889|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698890|NCT01739907|Vitamin D|vitamin d|mesh-list
83698891|NCT01739907|Vitamins|vitamins|mesh-ancestor
83698892|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
83698893|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698894|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83698895|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
83698896|NCT01739920|Povidone|povidone|mesh-list
83698897|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
83698898|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
83698899|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83698900|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698901|NCT01739985|Dexamethasone|dexamethasone|mesh-list
83698902|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
83698903|NCT01739985|Droperidol|droperidol|mesh-list
83698904|NCT01739985|Ondansetron|ondansetron|mesh-list
83698905|NCT01739985|BB 1101|bb 1101|mesh-list
83698906|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698907|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
83698908|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
83698909|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698910|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698911|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83698912|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
83698913|NCT01739985|Hormones|hormones|mesh-ancestor
83698914|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698915|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83698916|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698917|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
83698918|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698919|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698920|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
83698921|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
83698922|NCT01739985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83698923|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83698924|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
82853757|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
83698925|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83698926|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83698927|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83698928|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83698929|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698930|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83698931|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83698932|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83698933|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
83698934|NCT01740245|Biguanides|biguanides|mesh-list
83698935|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
83698936|NCT01740245|Polihexanide|polihexanide|mesh-list
83698937|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83698938|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698939|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
83698940|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83698941|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698942|NCT01740271|Epirubicin|epirubicin|mesh-list
83698943|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83698944|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698945|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83698946|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83698947|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698948|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698949|NCT01740336|Paclitaxel|paclitaxel|mesh-list
83698950|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83698951|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83698952|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83698953|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
83698954|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83698955|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698956|NCT01740453|Ropivacaine|ropivacaine|mesh-list
83698957|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
83698958|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
83698959|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83698960|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698961|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
83698962|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698963|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
83698964|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
83698965|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698966|NCT01740518|Protective Agents|protective agents|mesh-ancestor
83698967|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698968|NCT01740518|Vitamins|vitamins|mesh-ancestor
83698969|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
83698970|NCT01740921|Aspirin|aspirin|mesh-list
83698971|NCT01740921|Liraglutide|liraglutide|mesh-list
83698972|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83698973|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83698974|NCT01740921|Analgesics|analgesics|mesh-ancestor
83698975|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
83698976|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83698977|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83698978|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83698979|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83698980|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83698981|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83698982|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83698983|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83698984|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83698985|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83698986|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
83698987|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83698988|NCT01740921|Incretins|incretins|mesh-ancestor
83698989|NCT01740921|Hormones|hormones|mesh-ancestor
83698990|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83698991|NCT01740947|Amphotericin B|amphotericin b|mesh-list
83698992|NCT01740947|Tobramycin|tobramycin|mesh-list
83698993|NCT01740947|Colistin|colistin|mesh-list
83698994|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83698995|NCT01740947|Amebicides|amebicides|mesh-ancestor
83698996|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83698997|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83698998|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83698999|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83699000|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
83699001|NCT01740960|Dronabinol|dronabinol|mesh-list
83699002|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
82853837|NCT05781854|Analgesics|analgesics|mesh-ancestor
83699003|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699004|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699005|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699006|NCT01740960|Analgesics|analgesics|mesh-ancestor
83699007|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
83699008|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699009|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83699010|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83699011|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699012|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699013|NCT01740960|Hormones|hormones|mesh-ancestor
83699014|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699015|NCT01741038|Cetuximab|cetuximab|mesh-list
83699016|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83699017|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699018|NCT01741077|Folic Acid|folic acid|mesh-list
83699019|NCT01741077|Hematinics|hematinics|mesh-ancestor
83699020|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
83699021|NCT01741077|Vitamins|vitamins|mesh-ancestor
83699022|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
83699023|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699024|NCT01741142|Escitalopram|escitalopram|mesh-list
83699025|NCT01741142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83699026|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83699027|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83699028|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699029|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699030|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
83699031|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699032|NCT01741181|Vitamin D|vitamin d|mesh-list
83699033|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
83699034|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
83699035|NCT01741181|Vitamins|vitamins|mesh-list
83699036|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
83699037|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699038|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83699039|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83699040|NCT01741285|Fluticasone|fluticasone|mesh-list
83699041|NCT01741285|Beclomethasone|beclomethasone|mesh-list
83699042|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699043|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83699044|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
83699045|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699046|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699047|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83699048|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
83699049|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
83699050|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83699051|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
83699052|NCT01741285|Hormones|hormones|mesh-ancestor
83699053|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699054|NCT01741324|Vitamin D|vitamin d|mesh-list
83699055|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
83699056|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
83699057|NCT01741324|Vitamins|vitamins|mesh-list
83699058|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
83699059|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699060|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83699061|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83699062|NCT01741376|Progesterone|progesterone|mesh-list
83699063|NCT01741376|Progestins|progestins|mesh-ancestor
83699064|NCT01741376|Hormones|hormones|mesh-ancestor
83699065|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699066|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699067|NCT01741389|Melatonin|melatonin|mesh-list
83699068|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
83699069|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699070|NCT01741389|Protective Agents|protective agents|mesh-ancestor
83699071|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699072|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699073|NCT01741493|Upadacitinib|upadacitinib|mesh-list
83699074|NCT01741493|Tofacitinib|tofacitinib|mesh-list
83699075|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83699076|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83699077|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699078|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699079|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853906|NCT05869227|Capecitabine|capecitabine|mesh-list
83699080|NCT01741506|Dalteparin|dalteparin|mesh-list
83699081|NCT01741506|Tinzaparin|tinzaparin|mesh-list
83699082|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83699083|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
83699084|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83699085|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83699086|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699087|NCT01741519|Landiolol|landiolol|mesh-list
83699088|NCT01741519|Esmolol|esmolol|mesh-list
83699089|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83699090|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83699091|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83699092|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699093|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699094|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699095|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699096|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83699097|NCT01741558|Riboflavin|riboflavin|mesh-list
83699098|NCT01741558|Methotrexate|methotrexate|mesh-list
83699099|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83699100|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
83699101|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699102|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699103|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83699104|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
83699105|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699106|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699107|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
83699108|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699109|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83699110|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83699111|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
83699112|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699113|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83699114|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
83699115|NCT01741558|Vitamins|vitamins|mesh-ancestor
83699116|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
83699117|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83699118|NCT01741623|Bisoprolol|bisoprolol|mesh-list
83699119|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83699120|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
83699121|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
83699122|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699123|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699124|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83699125|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83699126|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83699127|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699128|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699129|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699130|NCT01741649|Povidone|povidone|mesh-list
83699131|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
83699132|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
83699133|NCT01741727|ABT-414|abt-414|mesh-list
83699134|NCT01741727|Immunoconjugates|immunoconjugates|mesh-ancestor
83699135|NCT01741727|Immunologic Factors|immunologic factors|mesh-ancestor
83699136|NCT01741727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699137|NCT01741753|Prednisone|prednisone|mesh-list
83699138|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699139|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
83699140|NCT01741753|Hormones|hormones|mesh-ancestor
83699141|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699142|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699143|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83699144|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699145|NCT01741831|Darunavir|darunavir|mesh-list
83699146|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83699147|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83699148|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
83699149|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699150|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699151|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83699152|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83699153|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
83699154|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699155|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
83699156|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699157|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699159|NCT01742247|Analgesics|analgesics|mesh-ancestor
83699160|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
83699161|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699162|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699163|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699164|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699165|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699166|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699167|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
83699168|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699169|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83699170|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83699171|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699172|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699173|NCT01742247|Hormones|hormones|mesh-ancestor
83699174|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699175|NCT01742273|Vitamin K|vitamin k|mesh-list
83699176|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
83699177|NCT01742273|Vitamins|vitamins|mesh-ancestor
83699178|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
83699179|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699180|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83699181|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83699182|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699183|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
83699184|NCT01742273|Coagulants|coagulants|mesh-ancestor
83699185|NCT01742338|Prednisone|prednisone|mesh-list
83699186|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
83699187|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83699188|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83699189|NCT01742338|Prednisolone|prednisolone|mesh-list
83699190|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
83699191|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83699192|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
83699193|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699194|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
83699195|NCT01742338|Hormones|hormones|mesh-ancestor
83699196|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699197|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699198|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83699199|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699200|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
83699201|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
83699202|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699203|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699204|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83699205|NCT01742338|Protective Agents|protective agents|mesh-ancestor
83699206|NCT01742390|Risperidone|risperidone|mesh-list
83699207|NCT01742390|Aripiprazole|aripiprazole|mesh-list
83699208|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83699209|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83699210|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
83699211|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699212|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699213|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699214|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83699215|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83699216|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699217|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699218|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83699219|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
83699220|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
83699221|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
83699222|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83699223|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83699224|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83699225|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83699226|NCT01742429|Amoxicillin|amoxicillin|mesh-list
83699227|NCT01742429|Metronidazole|metronidazole|mesh-list
83699228|NCT01742429|Levofloxacin|levofloxacin|mesh-list
83699229|NCT01742429|Tetracycline|tetracycline|mesh-list
83699230|NCT01742429|Bismuth|bismuth|mesh-list
83699231|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83699232|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83699233|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83699234|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699235|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83699236|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83699237|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83699238|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83699239|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83699240|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699241|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699242|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699243|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83699244|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83699245|NCT01742429|Antacids|antacids|mesh-ancestor
83699246|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699247|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83699248|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
83699249|NCT01742533|Hormones|hormones|mesh-list
83699250|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699251|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699252|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
83699253|NCT01742624|Tacrolimus|tacrolimus|mesh-list
83699254|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83699255|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
83699256|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699257|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83699258|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699259|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699260|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83699261|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699262|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83699263|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
83699264|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83699265|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699266|NCT01742637|Adapalene|adapalene|mesh-list
83699267|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83699268|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
83699269|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699270|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699271|NCT01742637|Analgesics|analgesics|mesh-ancestor
83699272|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
83699273|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699274|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699275|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699276|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699277|NCT01742663|Diclofenac|diclofenac|mesh-list
83699278|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699279|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699280|NCT01742663|Analgesics|analgesics|mesh-ancestor
83699281|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
83699282|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699283|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699284|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699285|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699286|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83699287|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699288|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699289|NCT01742676|Tacrolimus|tacrolimus|mesh-list
83699290|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83699291|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
83699292|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699293|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83699294|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699295|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699296|NCT01742689|Indomethacin|indomethacin|mesh-list
83699297|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83699298|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699299|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699300|NCT01742689|Analgesics|analgesics|mesh-ancestor
83699301|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
83699302|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699303|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699304|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699305|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699306|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
83699307|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
83699308|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699309|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83699310|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699311|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699312|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
83699313|NCT01742689|Coagulants|coagulants|mesh-ancestor
83699314|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83699315|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
83699316|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
83699317|NCT01742702|Bisoprolol|bisoprolol|mesh-list
83699318|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
83699319|NCT01742702|Albuterol|albuterol|mesh-list
83699320|NCT01742702|Caseins|caseins|mesh-list
83699321|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83699322|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
83699323|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699324|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699325|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83699326|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
83699327|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
83699328|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699329|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83699330|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83699331|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83699332|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699333|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699334|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699335|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
83699336|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
83699337|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
83699338|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83699339|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
83699340|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83699341|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83699342|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83699343|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699344|NCT01742767|Pemetrexed|pemetrexed|mesh-list
83699345|NCT01742767|Cisplatin|cisplatin|mesh-list
83699346|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699347|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699348|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699349|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83699350|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83699351|NCT01742793|Lenalidomide|lenalidomide|mesh-list
83699352|NCT01742793|Romidepsin|romidepsin|mesh-list
83699353|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
83699354|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699355|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83699356|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83699357|NCT01742793|Growth Substances|growth substances|mesh-ancestor
83699358|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
83699359|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699360|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83699361|NCT01742793|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83699362|NCT01742793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699363|NCT01742793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699364|NCT01742845|Ropivacaine|ropivacaine|mesh-list
83699365|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
83699366|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
83699367|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699368|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699369|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
83699370|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699371|NCT01742988|Rituximab|rituximab|mesh-list
83699372|NCT01742988|Venetoclax|venetoclax|mesh-list
83699373|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83699374|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699375|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
83699376|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699377|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699378|NCT01743014|Ramipril|ramipril|mesh-list
83699379|NCT01743014|Clopidogrel|clopidogrel|mesh-list
83699380|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82854206|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83699381|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83699382|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83699384|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
83699385|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699386|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699387|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699388|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83699389|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
83699390|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699391|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83699392|NCT01743066|Vitamin E|vitamin e|mesh-list
83699393|NCT01743066|Vitamins|vitamins|mesh-ancestor
83699394|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
83699395|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699396|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
83699397|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699398|NCT01743066|Protective Agents|protective agents|mesh-ancestor
83699399|NCT01743079|Lamivudine|lamivudine|mesh-list
83699400|NCT01743079|Telbivudine|telbivudine|mesh-list
83699401|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83699402|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83699403|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699404|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699405|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
83699406|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699407|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83699408|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83699409|NCT01743118|Calcipotriene|calcipotriene|mesh-list
83699410|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83699411|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
83699412|NCT01743144|Analgesics|analgesics|mesh-ancestor
83699413|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
83699414|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699415|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699416|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
83699417|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699418|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83699419|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
83699420|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83699421|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83699422|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699423|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83699424|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
83699425|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699426|NCT01743157|Bevacizumab|bevacizumab|mesh-list
83699427|NCT01743157|Ipilimumab|ipilimumab|mesh-list
83699428|NCT01743157|Interleukin-2|interleukin-2|mesh-list
83699429|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83699430|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699431|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83699432|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83699433|NCT01743157|Growth Substances|growth substances|mesh-ancestor
83699434|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699435|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
83699436|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83699437|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699438|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699439|NCT01743157|Analgesics|analgesics|mesh-ancestor
83699440|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
83699441|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699442|NCT01743235|Buspirone|buspirone|mesh-list
83699443|NCT01743235|Testosterone|testosterone|mesh-list
83699444|NCT01743235|Androgens|androgens|mesh-ancestor
83699445|NCT01743235|Hormones|hormones|mesh-ancestor
83699446|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699447|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699448|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83699449|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82854280|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854281|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854282|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854283|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854284|NCT05518799|Midazolam|midazolam|mesh-list
82854294|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
83699450|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699451|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699452|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83699454|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699455|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699456|NCT01743300|Sunitinib|sunitinib|mesh-list
83699457|NCT01743300|Midazolam|midazolam|mesh-list
83699458|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83699459|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83699460|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699461|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699462|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83699463|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83699464|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699465|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83699466|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
83699467|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
83699468|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
83699469|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
83699470|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699471|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699472|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699473|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83699474|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83699475|NCT01743300|Growth Substances|growth substances|mesh-ancestor
83699476|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
83699477|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83699478|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699479|NCT01743326|Anesthetics|anesthetics|mesh-list
83699480|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699481|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699482|NCT01743365|Afatinib|afatinib|mesh-list
83699483|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699484|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83699485|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699486|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699487|NCT01743378|Ropivacaine|ropivacaine|mesh-list
83699488|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
83699489|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
83699490|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699491|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699492|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
83699493|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699494|NCT01743456|Anesthetics|anesthetics|mesh-list
83699495|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699496|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699497|NCT01743508|Misoprostol|misoprostol|mesh-list
83699498|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83699499|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
83699500|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699501|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699502|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83699503|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699504|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
83699505|NCT01743690|Nystatin|nystatin|mesh-list
83699506|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83699507|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699508|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
83699509|NCT01743690|Hormones|hormones|mesh-ancestor
83699510|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699511|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699512|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82854359|NCT05361720|Nivolumab|nivolumab|mesh-list
82854360|NCT05361720|Ipilimumab|ipilimumab|mesh-list
82854361|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854362|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854363|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854364|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854365|NCT05323396|Metronidazole|metronidazole|mesh-list
82854366|NCT05323396|Albendazole|albendazole|mesh-list
82854367|NCT05323396|Praziquantel|praziquantel|mesh-list
82854368|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
82854369|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854380|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
83699513|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699514|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
83699516|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83699517|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699518|NCT01743755|Dexamethasone|dexamethasone|mesh-list
83699519|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699520|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
83699521|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
83699522|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699523|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699524|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699525|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
83699526|NCT01743755|Hormones|hormones|mesh-ancestor
83699527|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699528|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83699529|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699530|NCT01743794|Ropivacaine|ropivacaine|mesh-list
83699531|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
83699532|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
83699533|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699534|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699535|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
83699536|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699537|NCT01743820|Piperaquine|piperaquine|mesh-list
83699538|NCT01743820|Primaquine|primaquine|mesh-list
83699539|NCT01743820|Artenimol|artenimol|mesh-list
83699540|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
83699541|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83699542|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83699543|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699544|NCT01743885|Propranolol|propranolol|mesh-list
83699545|NCT01743885|Acebutolol|acebutolol|mesh-list
83699546|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83699547|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83699548|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699549|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699550|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699551|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699552|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83699553|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83699554|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
83699555|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
83699556|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
83699557|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699558|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83699559|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
83699560|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83699561|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
83699562|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83699563|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
83699564|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699565|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699566|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
83699567|NCT01743911|Tadalafil|tadalafil|mesh-list
83699568|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
83699569|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83699570|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83699571|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699572|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699573|NCT01743911|Urological Agents|urological agents|mesh-ancestor
83699574|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
83699575|NCT01744106|Ephedrine|ephedrine|mesh-list
83699576|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83699577|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
83699578|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699579|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699580|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83699581|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
83699582|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
83699583|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83699584|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83699585|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
82854430|NCT05168566|Maleic acid|maleic acid|mesh-list
82854431|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699586|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699587|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699588|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699589|NCT01744184|Midazolam|midazolam|mesh-list
83699590|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
83699591|NCT01744184|Entonox|entonox|mesh-list
83699592|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83699593|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83699594|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699595|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699596|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83699597|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83699598|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699599|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83699600|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
83699601|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
83699602|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
83699603|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
83699604|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699605|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699606|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83699607|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699608|NCT01744184|Analgesics|analgesics|mesh-ancestor
83699609|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
83699610|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699611|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83699612|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83699613|NCT01744236|Liraglutide|liraglutide|mesh-list
83699614|NCT01744236|Exenatide|exenatide|mesh-list
83699615|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83699616|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699617|NCT01744236|Incretins|incretins|mesh-ancestor
83699618|NCT01744236|Hormones|hormones|mesh-ancestor
83699619|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699620|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83699621|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
83699622|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699623|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699624|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83699625|NCT01744249|Axitinib|axitinib|mesh-list
83699626|NCT01744249|Octreotide|octreotide|mesh-list
83699627|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699628|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83699629|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699630|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699631|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699632|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83699633|NCT01744288|Clopidogrel|clopidogrel|mesh-list
83699634|NCT01744288|Ticagrelor|ticagrelor|mesh-list
83699635|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83699636|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83699637|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83699638|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83699639|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
83699640|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699641|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699642|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699643|NCT01744314|Indomethacin|indomethacin|mesh-list
83699644|NCT01744314|Pantoprazole|pantoprazole|mesh-list
83699645|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83699646|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699647|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83699648|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699649|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699650|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699651|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699652|NCT01744314|Analgesics|analgesics|mesh-ancestor
83699653|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
83699654|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699655|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699656|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699657|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699658|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
83699659|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
83699660|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699661|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83699663|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83699664|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699665|NCT01744379|Lesinurad|lesinurad|mesh-list
83699666|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
83699667|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699668|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
83699669|NCT01744444|Gabapentin|gabapentin|mesh-list
83699670|NCT01744444|Memantine|memantine|mesh-list
83699671|NCT01744444|Analgesics|analgesics|mesh-ancestor
83699672|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
83699673|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699674|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699675|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
83699676|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83699677|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83699678|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699679|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699680|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83699681|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83699682|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132863|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
83699683|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699684|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
83699685|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83699686|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83699687|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
83699688|NCT01744470|Tacrolimus|tacrolimus|mesh-list
83699689|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83699690|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
83699691|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699692|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83699693|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699694|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699695|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83699696|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
83699697|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699698|NCT01744587|Protective Agents|protective agents|mesh-ancestor
83699699|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699700|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83699701|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83699702|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699703|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83699704|NCT01744262|Anesthetics|anesthetics|mesh-list
83699705|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699706|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699707|NCT01744756|Bevacizumab|bevacizumab|mesh-list
83699708|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83699709|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699710|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83699711|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83699712|NCT01744756|Growth Substances|growth substances|mesh-ancestor
83699713|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699714|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
83699715|NCT01744873|Bisoprolol|bisoprolol|mesh-list
83699716|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83699717|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
83699718|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
83699719|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699720|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699721|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83699722|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83699723|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83699724|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699725|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699726|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699727|NCT01744886|Benzocaine|benzocaine|mesh-list
83699728|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
83699729|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
83699730|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854578|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854579|NCT04635644|Morphine|morphine|mesh-list
82854580|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82854581|NCT04635644|Narcotics|narcotics|mesh-ancestor
82854582|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854588|NCT04631601|Androgens|androgens|mesh-list
83699731|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699732|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
83699733|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699735|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83699736|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699737|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
83699738|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699739|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699740|NCT01744964|Apomorphine|apomorphine|mesh-list
83699741|NCT01744964|Emetics|emetics|mesh-ancestor
83699742|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699743|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
83699744|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699745|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699746|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
83699747|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
83699748|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699749|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699750|NCT01745081|Mannitol|mannitol|mesh-list
83699751|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83699752|NCT01745081|Diuretics|diuretics|mesh-ancestor
83699753|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
83699754|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699755|NCT01745159|Tacrolimus|tacrolimus|mesh-list
83699756|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83699757|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
83699758|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699759|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83699760|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699761|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699762|NCT01745263|Vitamin D|vitamin d|mesh-list
83699763|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
83699764|NCT01745263|Vitamins|vitamins|mesh-ancestor
83699765|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
83699766|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699767|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83699768|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83699769|NCT01745302|Gefitinib|gefitinib|mesh-list
83699770|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699771|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83699772|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699773|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699774|NCT01745328|Amoxicillin|amoxicillin|mesh-list
83699775|NCT01745328|Levofloxacin|levofloxacin|mesh-list
83699776|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83699777|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699778|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83699779|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83699780|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83699781|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699782|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699783|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699784|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83699785|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83699786|NCT01745549|Insulin|insulin|mesh-list
83699787|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83699788|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83699789|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699790|NCT01745562|Alprazolam|alprazolam|mesh-list
83699791|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83699792|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699793|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699794|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83699795|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83699796|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699797|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
83699798|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
83699799|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699800|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699801|NCT01745575|Alprazolam|alprazolam|mesh-list
83699802|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83699803|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699804|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854653|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699806|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83699807|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699808|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
83699809|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
83699810|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699811|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699812|NCT01745601|Dexetimide|dexetimide|mesh-list
83699813|NCT01745601|Citalopram|citalopram|mesh-list
83699814|NCT01745601|Escitalopram|escitalopram|mesh-list
83699815|NCT01745601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83699816|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83699817|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83699818|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699819|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699820|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
83699821|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699822|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83699823|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83699824|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
83699825|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
83699826|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699827|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83699828|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83699829|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
83699830|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83699831|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
83699832|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83699833|NCT01745614|Nimesulide|nimesulide|mesh-list
83699834|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699835|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699836|NCT01745614|Analgesics|analgesics|mesh-ancestor
83699837|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
83699838|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699839|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699840|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699841|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699842|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83699843|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699844|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699845|NCT01745640|Dexamethasone|dexamethasone|mesh-list
83699846|NCT01745640|Pomalidomide|pomalidomide|mesh-list
83699847|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699848|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
83699849|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
83699850|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699851|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699852|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699853|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
83699854|NCT01745640|Hormones|hormones|mesh-ancestor
83699855|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83699856|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83699857|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699858|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
83699859|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83699860|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83699861|NCT01745640|Growth Substances|growth substances|mesh-ancestor
83699862|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
83699863|NCT01745666|Epinephrine|epinephrine|mesh-list
83699864|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83699865|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83699866|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699867|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699868|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699869|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699870|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83699871|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83699872|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
83699873|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699874|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83699875|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
83699876|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
83699877|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
82854725|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83699878|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83699879|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
83699880|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83699881|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699882|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83699883|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83699884|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83699885|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699886|NCT01745770|Mesalamine|mesalamine|mesh-list
83699887|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699888|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699889|NCT01745770|Analgesics|analgesics|mesh-ancestor
83699890|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
83699891|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699892|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699893|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699894|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699895|NCT01745809|Dimercaprol|dimercaprol|mesh-list
83699896|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
83699897|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
83699898|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699899|NCT01745835|Bisacodyl|bisacodyl|mesh-list
83699900|NCT01745835|Cathartics|cathartics|mesh-ancestor
83699901|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83699902|NCT01745835|Laxatives|laxatives|mesh-ancestor
83699903|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
83699904|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
83699905|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83699906|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83699907|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
83699908|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
83699909|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83699910|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83699911|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83699912|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83699913|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699914|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699915|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83699916|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83699917|NCT01746251|Afatinib|afatinib|mesh-list
83699918|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699919|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83699920|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699921|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699922|NCT01746277|Docetaxel|docetaxel|mesh-list
83699923|NCT01746277|Pemetrexed|pemetrexed|mesh-list
83699924|NCT01746277|Gefitinib|gefitinib|mesh-list
83699925|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699926|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
83699927|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
83699928|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
83699929|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699930|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699931|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83699932|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83699933|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83699934|NCT01746485|Treprostinil|treprostinil|mesh-list
83699935|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83699936|NCT01746563|Ranibizumab|ranibizumab|mesh-list
83699937|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83699938|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83699939|NCT01746563|Growth Substances|growth substances|mesh-ancestor
83699940|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699941|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
83699942|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699943|NCT01746602|Timolol|timolol|mesh-list
83699944|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83699945|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83699946|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
83699947|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83699948|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699949|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699950|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83699951|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83699952|NCT01746641|Remifentanil|remifentanil|mesh-list
82854807|NCT03878524|Vitamins|vitamins|mesh-list
83699953|NCT01746641|Propofol|propofol|mesh-list
83699954|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83699955|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83699956|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699957|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83699958|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
83699959|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
83699960|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83699961|NCT01746641|Narcotics|narcotics|mesh-ancestor
83699962|NCT01746641|Analgesics|analgesics|mesh-ancestor
83699963|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
83699964|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699965|NCT01746680|Methotrexate|methotrexate|mesh-list
83699966|NCT01746680|Tacrolimus|tacrolimus|mesh-list
83699967|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83699968|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
83699969|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83699970|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699971|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83699972|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
83699973|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699974|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83699975|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
83699976|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699977|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83699978|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83699979|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
83699980|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699981|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83699982|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83699983|NCT01746719|Etodolac|etodolac|mesh-list
83699984|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83699985|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83699986|NCT01746719|Analgesics|analgesics|mesh-ancestor
83699987|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
83699988|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83699989|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83699990|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83699991|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83699992|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83699993|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83699994|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83699995|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83699996|NCT01746771|Paclitaxel|paclitaxel|mesh-list
83699997|NCT01746771|Trastuzumab|trastuzumab|mesh-list
83699998|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83699999|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700000|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83700001|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83700002|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83700003|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700004|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83700005|NCT01746823|Cyclosporine|cyclosporine|mesh-list
83700006|NCT01746823|Cyclosporins|cyclosporins|mesh-list
83700007|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700008|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700009|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83700010|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
83700011|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700012|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
83700013|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700014|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
83700015|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700016|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83700017|NCT01746875|Aflibercept|aflibercept|mesh-list
83700018|NCT01746875|Verteporfin|verteporfin|mesh-list
83700019|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83700020|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83700021|NCT01746875|Growth Substances|growth substances|mesh-ancestor
83700022|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700023|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
83700024|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700025|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83700026|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83700027|NCT01746992|Prednisone|prednisone|mesh-list
83700028|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
83700029|NCT01746992|Ifosfamide|ifosfamide|mesh-list
83700030|NCT01746992|Doxorubicin|doxorubicin|mesh-list
83700031|NCT01746992|Methotrexate|methotrexate|mesh-list
83700032|NCT01746992|Etoposide|etoposide|mesh-list
83700033|NCT01746992|Vincristine|vincristine|mesh-list
83700034|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
83700035|NCT01746992|Pirarubicin|pirarubicin|mesh-list
83700036|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83700037|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
83700038|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700039|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700040|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83700041|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
83700042|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700043|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700044|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83700045|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83700046|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83700047|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83700048|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700049|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83700050|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
83700051|NCT01746992|Hormones|hormones|mesh-ancestor
83700052|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83700053|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83700054|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83700055|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
83700056|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83700057|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83700058|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
83700059|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
83700060|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83700061|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83700062|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83700063|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83700064|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83700065|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83700066|NCT01747044|Milnacipran|milnacipran|mesh-list
83700067|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
83700068|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83700069|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83700070|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700071|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700072|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700073|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700074|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83700075|NCT01747044|Analgesics|analgesics|mesh-ancestor
83700076|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
83700077|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700078|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
83700079|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83700080|NCT01747083|Metformin|metformin|mesh-list
83700081|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83700082|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700083|NCT01747135|Betadex|betadex|mesh-list
83700084|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
83700085|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700086|NCT01747148|Radavirsen|radavirsen|mesh-list
83700087|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
83700088|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700089|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
83700090|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83700091|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700092|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700093|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83700094|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700095|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700096|NCT01747174|Adenosine|adenosine|mesh-list
83700097|NCT01747174|Nitroprusside|nitroprusside|mesh-list
83700098|NCT01747174|Analgesics|analgesics|mesh-ancestor
83700099|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
83700100|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700101|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700102|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83700103|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
83700104|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83700106|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
83700107|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700108|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700109|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83700110|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83700111|NCT01747226|Fluorides|fluorides|mesh-list
83700112|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
83700113|NCT01747226|Protective Agents|protective agents|mesh-ancestor
83700114|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700115|NCT01747252|Resveratrol|resveratrol|mesh-list
83700116|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
83700117|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700118|NCT01747252|Protective Agents|protective agents|mesh-ancestor
83700119|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700120|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700121|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83700122|NCT01747278|Trimethoprim|trimethoprim|mesh-list
83700123|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
83700124|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83700125|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700126|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
83700127|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83700128|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83700129|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83700130|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700131|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700132|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83700133|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83700134|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83700135|NCT01747564|Mirabegron|mirabegron|mesh-list
83700136|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83700137|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83700138|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83700139|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
83700140|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700141|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700142|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700143|NCT01747564|Urological Agents|urological agents|mesh-ancestor
83700144|NCT01747590|Zolpidem|zolpidem|mesh-list
83700145|NCT01747590|Alprazolam|alprazolam|mesh-list
83700146|NCT01747590|Caffeine|caffeine|mesh-list
83700147|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83700148|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700149|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83700150|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700151|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700152|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83700153|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83700154|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
83700155|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700156|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83700157|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83700158|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700159|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83700160|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
83700161|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
83700162|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83700163|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83700164|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83700165|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
83700166|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
83700167|NCT01747616|Chitosan|chitosan|mesh-list
83700168|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83700169|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83700170|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83700171|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
83700172|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700173|NCT01747616|Expectorants|expectorants|mesh-ancestor
83700174|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
83700175|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83700176|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
83700177|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700178|NCT01747616|Protective Agents|protective agents|mesh-ancestor
83700179|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700180|NCT01747616|Antidotes|antidotes|mesh-ancestor
83700181|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83700182|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83700183|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
83700184|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83700185|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
83700186|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
83700187|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
83700188|NCT01747616|Coagulants|coagulants|mesh-ancestor
83700189|NCT01747642|Sorafenib|sorafenib|mesh-list
83700190|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700191|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83700192|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700193|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700194|NCT01747668|Tocopherols|tocopherols|mesh-list
83700195|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
83700196|NCT01747668|Vitamin E|vitamin e|mesh-list
83700197|NCT01747668|Vitamins|vitamins|mesh-ancestor
83700198|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
83700199|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700200|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
83700201|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700202|NCT01747668|Protective Agents|protective agents|mesh-ancestor
83700203|NCT01747707|Docetaxel|docetaxel|mesh-list
83700204|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700205|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83700206|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83700207|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83700208|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700209|NCT01747720|Vitamin D|vitamin d|mesh-list
83700210|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
83700211|NCT01747720|Vitamins|vitamins|mesh-ancestor
83700212|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
83700213|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700214|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83700215|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83700216|NCT01747746|Enoxaparin|enoxaparin|mesh-list
83700217|NCT01747746|Warfarin|warfarin|mesh-list
83700218|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
83700219|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
83700220|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83700221|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
83700222|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83700223|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
83700224|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700225|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700226|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83700227|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83700228|NCT01747798|Auranofin|auranofin|mesh-list
83700229|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700230|NCT01747993|Tamsulosin|tamsulosin|mesh-list
83700231|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83700232|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83700233|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83700234|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
83700235|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700236|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700237|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700238|NCT01747993|Urological Agents|urological agents|mesh-ancestor
83700239|NCT01748019|Namitecan|namitecan|mesh-list
83700240|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83700241|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700242|NCT01748084|Rituximab|rituximab|mesh-list
83700243|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83700244|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700245|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
83700246|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700247|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700248|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83700249|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
83700250|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83700251|NCT01748123|Diuretics|diuretics|mesh-ancestor
83700252|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
83700253|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700254|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83700255|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700256|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700257|NCT01748253|Amlodipine|amlodipine|mesh-list
83700258|NCT01748253|Telmisartan|telmisartan|mesh-list
83700259|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83700260|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83700261|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83700262|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700263|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700264|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83700265|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700266|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83700267|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83700268|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83700269|NCT01748279|Atorvastatin|atorvastatin|mesh-list
83700270|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
83700271|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83700272|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83700273|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
83700274|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700275|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83700276|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83700277|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700278|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83700279|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
83700280|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700281|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700282|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83700283|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
83700284|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83700285|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83700286|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83700287|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
83700288|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700289|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83700290|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83700291|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700292|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83700293|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
83700294|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83700295|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83700296|NCT01748344|Cetirizine|cetirizine|mesh-list
83700297|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83700298|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83700299|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83700300|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
83700301|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
83700302|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700303|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700304|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700305|NCT01748370|Vitamin D|vitamin d|mesh-list
83700306|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
83700307|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
83700308|NCT01748370|Vitamins|vitamins|mesh-list
83700309|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
83700310|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700311|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83700312|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83700313|NCT01748396|Calcitriol|calcitriol|mesh-list
83700314|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
83700315|NCT01748396|Calcium|calcium|mesh-list
83700316|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83700317|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700318|NCT01748396|Antacids|antacids|mesh-ancestor
83700319|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700320|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83700321|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83700322|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700323|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83700324|NCT01748396|Vitamins|vitamins|mesh-ancestor
83700325|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
83700326|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83700327|NCT01748422|Capsaicin|capsaicin|mesh-list
83700328|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
83700329|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
83700330|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
83700331|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700332|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700333|NCT01748435|Capsaicin|capsaicin|mesh-list
83700334|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
83700335|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83700336|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
83700337|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700338|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700339|NCT01748487|Dexamethasone|dexamethasone|mesh-list
83700340|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
83700341|NCT01748487|BB 1101|bb 1101|mesh-list
83700342|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83700343|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
83700344|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
83700345|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700346|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700347|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83700348|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
83700349|NCT01748487|Hormones|hormones|mesh-ancestor
83700350|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83700351|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83700352|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700353|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
83700354|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700355|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700356|NCT01748500|Pantoprazole|pantoprazole|mesh-list
83700357|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83700358|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83700359|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83700360|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700361|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700362|NCT01748526|Canagliflozin|canagliflozin|mesh-list
83700363|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83700364|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700365|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83700366|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700367|NCT01748539|Brodalumab|brodalumab|mesh-list
83700368|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
83700369|NCT01748630|Fentanyl|fentanyl|mesh-list
83700370|NCT01748630|Midazolam|midazolam|mesh-list
83700371|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
83700372|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83700373|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700374|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700375|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83700376|NCT01748630|Analgesics|analgesics|mesh-ancestor
83700377|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
83700378|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700379|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83700380|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83700381|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83700382|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
83700383|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700384|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700385|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83700386|NCT01748630|Narcotics|narcotics|mesh-ancestor
83700387|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83700388|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83700389|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
83700390|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
83700391|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83700392|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83700393|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83700394|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
83700395|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
83700396|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
83700397|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
83700398|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700399|NCT01748669|Protective Agents|protective agents|mesh-ancestor
83700400|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700401|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83700402|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700403|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83700404|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700405|NCT01748721|Antibodies|antibodies|mesh-list
83700406|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83700407|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
83700408|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700409|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83700410|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83700411|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
83700412|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700413|NCT01748773|Capecitabine|capecitabine|mesh-list
83700414|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
83700415|NCT01748773|Trastuzumab|trastuzumab|mesh-list
83700416|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83700417|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
83700418|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700419|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700420|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83700421|NCT01748838|Mannitol|mannitol|mesh-list
83700422|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83700423|NCT01748838|Diuretics|diuretics|mesh-ancestor
83700424|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
83700425|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700426|NCT01748929|Albendazole|albendazole|mesh-list
83700427|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
83700428|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83700429|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700430|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
83700431|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83700432|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83700433|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
83700434|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
83700435|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
83700436|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700437|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700438|NCT01749072|Vinorelbine|vinorelbine|mesh-list
83700439|NCT01749072|Ifosfamide|ifosfamide|mesh-list
83700440|NCT01749072|Gefitinib|gefitinib|mesh-list
83700441|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83700442|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700443|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
83700444|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
83700445|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
83700446|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700447|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83700448|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
83700449|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83700450|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700451|NCT01749085|Ketoconazole|ketoconazole|mesh-list
83700452|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
83700453|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700454|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83497636|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
83700455|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83700456|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700457|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700458|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83700459|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
83700460|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83700461|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700462|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83700463|NCT01749098|Ketamine|ketamine|mesh-list
83700464|NCT01749098|Analgesics|analgesics|mesh-ancestor
83700465|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
83700466|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700467|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700468|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83700469|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83700470|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
83700471|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
83700472|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700473|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83700474|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83700475|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700476|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700477|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
83700478|NCT01749111|Methotrexate|methotrexate|mesh-list
83700479|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83700480|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855339|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
83700481|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
83700482|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700483|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700484|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83700485|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
83700486|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700487|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700488|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83700489|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83700490|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
83700491|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83700492|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83700493|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
83700494|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
83700495|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700496|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83700497|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83700498|NCT01749150|Ritonavir|ritonavir|mesh-list
83700499|NCT01749150|Ribavirin|ribavirin|mesh-list
83700500|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83700501|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
83700502|NCT01749150|Lactams|lactams|mesh-list
83700503|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83700504|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83700505|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
83700506|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700507|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700508|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83700509|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83700510|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
83700511|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700512|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83700513|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83700514|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
83700515|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
83700516|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700517|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83700518|NCT01749228|Etodolac|etodolac|mesh-list
83700519|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83700520|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83700521|NCT01749228|Analgesics|analgesics|mesh-ancestor
83700522|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
83700523|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700524|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700525|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83700526|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700527|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83700528|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83700529|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700530|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700531|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83700532|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83700533|NCT01749319|Baclofen|baclofen|mesh-list
83700534|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83700535|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700536|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83700537|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700538|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83700539|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
83700540|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
83700541|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700542|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700543|NCT01749371|Vitamins|vitamins|mesh-list
83700544|NCT01749371|Vitamin E|vitamin e|mesh-list
83700545|NCT01749371|Tocopherols|tocopherols|mesh-list
83700546|NCT01749371|Tocotrienols|tocotrienols|mesh-list
83700547|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
83700548|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
83700549|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700550|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
83700551|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700552|NCT01749371|Protective Agents|protective agents|mesh-ancestor
83700553|NCT01749384|Bevacizumab|bevacizumab|mesh-list
83700554|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83700555|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
82855413|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
83700556|NCT01749384|Antibodies|antibodies|mesh-list
83700557|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
83700558|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83700559|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
83700560|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700561|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83700562|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83700563|NCT01749384|Growth Substances|growth substances|mesh-ancestor
83700564|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700565|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
83700566|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
83700567|NCT01749397|Fluorouracil|fluorouracil|mesh-list
83700568|NCT01749397|Floxuridine|floxuridine|mesh-list
83700569|NCT01749397|Veliparib|veliparib|mesh-list
83700570|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
83700571|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
83700572|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700573|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83700574|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700575|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83700576|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
83700577|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700578|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83700579|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700580|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
83700581|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83700582|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83700583|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83700584|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700585|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700586|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
83700587|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700588|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700589|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83700590|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700591|NCT01749475|Midazolam|midazolam|mesh-list
83700592|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83700593|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83700594|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700595|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700596|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83700597|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83700598|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83700599|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83700600|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
83700601|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
83700602|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
83700603|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
83700604|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700605|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700606|NCT01749514|Luspatercept|luspatercept|mesh-list
83700607|NCT01749514|Hematinics|hematinics|mesh-ancestor
83700608|NCT01749540|Luspatercept|luspatercept|mesh-list
83700609|NCT01749540|Hematinics|hematinics|mesh-ancestor
83700610|NCT01749566|Maraviroc|maraviroc|mesh-list
83700611|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83700612|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83700613|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700614|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83700615|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83700616|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
83700617|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700618|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83700619|NCT01749579|Fentanyl|fentanyl|mesh-list
83700620|NCT01749579|Midazolam|midazolam|mesh-list
83700621|NCT01749579|Propofol|propofol|mesh-list
83700622|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83700623|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700624|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700625|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83700626|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
83700627|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
82855489|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700628|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83700629|NCT01749579|Narcotics|narcotics|mesh-ancestor
83700630|NCT01749579|Analgesics|analgesics|mesh-ancestor
83700631|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
83700632|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700633|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83700634|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83700635|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83700636|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83700637|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
83700638|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
83700639|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700640|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700641|NCT01750060|Fentanyl|fentanyl|mesh-list
83700642|NCT01750060|Naltrexone|naltrexone|mesh-list
83700643|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83700644|NCT01750060|Narcotics|narcotics|mesh-ancestor
83700645|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700646|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700647|NCT01750060|Analgesics|analgesics|mesh-ancestor
83700648|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
83700649|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700650|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83700651|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83700652|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
83700653|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
83700654|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83700655|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83700656|NCT01750099|Lidocaine|lidocaine|mesh-list
83700657|NCT01750099|Epinephrine|epinephrine|mesh-list
83700658|NCT01750099|Fentanyl|fentanyl|mesh-list
83700659|NCT01750099|Bupivacaine|bupivacaine|mesh-list
83700660|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
83700661|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
83700662|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700663|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700664|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
83700665|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700666|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83700667|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83700668|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83700669|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700670|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700671|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83700672|NCT01750099|Narcotics|narcotics|mesh-ancestor
83700673|NCT01750099|Analgesics|analgesics|mesh-ancestor
83700674|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83700675|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83700676|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
83700677|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83700678|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83700679|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
83700680|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700681|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83700682|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83700683|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
83700684|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83700685|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
83700686|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
83700687|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
83700688|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83700689|NCT01750359|Curcumin|curcumin|mesh-list
83700690|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83700691|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83700692|NCT01750359|Analgesics|analgesics|mesh-ancestor
83700693|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
83700694|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700695|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700696|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83700697|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700698|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700699|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700700|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855562|NCT05233956|Chrysarobin|chrysarobin|mesh-list
82855563|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82855564|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82855565|NCT05233956|Analgesics|analgesics|mesh-ancestor
82855566|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
82855567|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855568|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855569|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82855570|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700701|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83700702|NCT01750385|Cephalosporins|cephalosporins|mesh-list
83700703|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700704|NCT01750437|Esomeprazole|esomeprazole|mesh-list
83700705|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83700706|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83700707|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83700708|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700709|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700710|NCT01750463|Chrysarobin|chrysarobin|mesh-list
83700711|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83700712|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83700713|NCT01750463|Analgesics|analgesics|mesh-ancestor
83700714|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
83700715|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700716|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700717|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83700718|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83700719|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83700720|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
83700721|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83700722|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
83700723|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83700724|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700725|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83700726|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83700727|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83700728|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83700729|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83700730|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700731|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83700732|NCT01750541|Valproic Acid|valproic acid|mesh-list
83700733|NCT01750541|Haloperidol|haloperidol|mesh-list
83700734|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
83700735|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
83700736|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
83700737|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700738|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700739|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83700740|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83700741|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83700742|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700743|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83700744|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83700745|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
83700746|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700747|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700748|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83700749|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
83700750|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700751|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
83700752|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
83700753|NCT01750580|Ipilimumab|ipilimumab|mesh-list
83700754|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83700755|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700756|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83700757|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700758|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
83700759|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83700760|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700761|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700762|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
83700763|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700764|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700765|NCT01750723|Acetazolamide|acetazolamide|mesh-list
83700766|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
83700767|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83700768|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700769|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700770|NCT01750723|Diuretics|diuretics|mesh-ancestor
83700771|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
83700772|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700773|NCT01750762|Lenalidomide|lenalidomide|mesh-list
83700774|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
82855653|NCT05021991|Pramoxine|pramoxine|mesh-list
83700775|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700776|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83700777|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83700778|NCT01750762|Growth Substances|growth substances|mesh-ancestor
83700779|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
83700780|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700781|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
83700782|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83700783|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
83700784|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83700785|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
83700786|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700787|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700788|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
83700789|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
83700790|NCT01750801|Propolis|propolis|mesh-list
83700791|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83700792|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83700793|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
83700794|NCT01750866|Prednisone|prednisone|mesh-list
83700795|NCT01750866|Lenograstim|lenograstim|mesh-list
83700796|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83700797|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
83700798|NCT01750866|Hormones|hormones|mesh-ancestor
83700799|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83700800|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700801|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83700802|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700803|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83700804|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
83700805|NCT01750983|Lenalidomide|lenalidomide|mesh-list
83700806|NCT01750983|Ipilimumab|ipilimumab|mesh-list
83700807|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
83700808|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700809|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83700810|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83700811|NCT01750983|Growth Substances|growth substances|mesh-ancestor
83700812|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
83700813|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700814|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83700815|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83700816|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700817|NCT01751009|Vitamins|vitamins|mesh-list
83700818|NCT01751009|Vitamin A|vitamin a|mesh-list
83700819|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
83700820|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
83700821|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700822|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
83700823|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700824|NCT01751009|Protective Agents|protective agents|mesh-ancestor
83700825|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83700826|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700827|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83700828|NCT01751074|Darapladib|darapladib|mesh-list
83700829|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83700830|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83700831|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
83700832|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700833|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83700834|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83700835|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700836|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83700837|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
83700838|NCT01751204|Calcium|calcium|mesh-list
83700839|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83700840|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700841|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83700842|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83700843|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700844|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700845|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83700846|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855713|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700847|NCT01751295|Atorvastatin|atorvastatin|mesh-list
83700848|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83700849|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83700850|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
83700851|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700852|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83700853|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83700854|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700855|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83700856|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83700857|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700858|NCT01751321|Incretins|incretins|mesh-ancestor
83700859|NCT01751321|Hormones|hormones|mesh-ancestor
83700860|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83700861|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83700862|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
83700863|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700864|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700865|NCT01751347|Lidocaine|lidocaine|mesh-list
83700866|NCT01751347|Bupivacaine|bupivacaine|mesh-list
83700867|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
83700868|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
83700869|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700870|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700871|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
83700872|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700873|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83700874|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83700875|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83700876|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700877|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700878|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
83700879|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83700880|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83700881|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700882|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700883|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
83700884|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700885|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700886|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83700887|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700888|NCT01751763|Sorafenib|sorafenib|mesh-list
83700889|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700890|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83700891|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700892|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700893|NCT01751828|Sertraline|sertraline|mesh-list
83700894|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
83700895|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83700896|NCT01751828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83700897|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83700898|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700899|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700900|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700901|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
83700902|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700903|NCT01751854|Escitalopram|escitalopram|mesh-list
83700904|NCT01751854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83700905|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83700906|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700907|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700908|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83700909|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
83700910|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700911|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
83700912|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700913|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83700914|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700915|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700916|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
83700917|NCT01752010|Immunomodulating Agents|immunomodulating agents|mesh-list
83700918|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700919|NCT01752075|Lenalidomide|lenalidomide|mesh-list
82855785|NCT04729608|Paclitaxel|paclitaxel|mesh-list
83700920|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
83700921|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700922|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83700923|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83700924|NCT01752075|Growth Substances|growth substances|mesh-ancestor
83700925|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
83700926|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700927|NCT01752153|Silymarin|silymarin|mesh-list
83700928|NCT01752153|Deferoxamine|deferoxamine|mesh-list
83700929|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
83700930|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700931|NCT01752153|Protective Agents|protective agents|mesh-ancestor
83700932|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700933|NCT01752153|Siderophores|siderophores|mesh-ancestor
83700934|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83700935|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
83700936|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
83700937|NCT01752205|Paclitaxel|paclitaxel|mesh-list
83700938|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83700939|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83700940|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700941|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
83700942|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
83700943|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
83700944|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700945|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83700946|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83700947|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
83700948|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83700949|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83700950|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700951|NCT01752244|Vitamins|vitamins|mesh-ancestor
83700952|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
83700953|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
83700954|NCT01752270|Cyproterone|cyproterone|mesh-list
83700955|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83700956|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
83700957|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
83700958|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83700959|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700960|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700961|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83700962|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
83700963|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83700964|NCT01752322|Lidocaine|lidocaine|mesh-list
83700965|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
83700966|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
83700967|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700968|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700969|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
83700970|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83700971|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83700972|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83700973|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83700974|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83700975|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700976|NCT01752517|Vinorelbine|vinorelbine|mesh-list
83700977|NCT01752517|Ifosfamide|ifosfamide|mesh-list
83700978|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83700979|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700980|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
83700981|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
83700982|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
83700983|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700984|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83700985|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
83700986|NCT01752543|Conivaptan|conivaptan|mesh-list
83700987|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83700988|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83700989|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
83700990|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700991|NCT01752686|Carboplatin|carboplatin|mesh-list
83700992|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83700993|NCT01752699|Methadone|methadone|mesh-list
83700994|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83700995|NCT01752699|Narcotics|narcotics|mesh-ancestor
83700996|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83700997|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83700998|NCT01752699|Analgesics|analgesics|mesh-ancestor
83700999|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
83701000|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701001|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
83701002|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
83701003|NCT01752790|Azathioprine|azathioprine|mesh-list
83701004|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701005|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
83701006|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701007|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83701008|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701009|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701010|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
83701011|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701012|NCT01752881|Vaccines|vaccines|mesh-list
83701013|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
83701014|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701015|NCT01752959|Remifentanil|remifentanil|mesh-list
83701016|NCT01752959|Esmolol|esmolol|mesh-list
83701017|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83701018|NCT01752959|Narcotics|narcotics|mesh-ancestor
83701019|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701020|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701021|NCT01752959|Analgesics|analgesics|mesh-ancestor
83701022|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
83701023|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701024|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83701025|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83701026|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83701027|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83701028|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701029|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701030|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
83701031|NCT01752998|Narcotics|narcotics|mesh-ancestor
83701032|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701033|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701034|NCT01752998|Analgesics|analgesics|mesh-ancestor
83701035|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
83701036|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701037|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83701038|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83701039|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
83701040|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701041|NCT01753102|Estradiol|estradiol|mesh-list
83701042|NCT01753102|Estrogens|estrogens|mesh-ancestor
83701043|NCT01753102|Hormones|hormones|mesh-ancestor
83701044|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701045|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701046|NCT01753128|Imipramine|imipramine|mesh-list
83701047|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83701048|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
83701049|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83701050|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83701051|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83701052|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83701053|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701054|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
83701055|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701056|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701057|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83701058|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
83701059|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83701060|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83701061|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83701062|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83701063|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701064|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
83701065|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701066|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701067|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83701068|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701070|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
83701071|NCT01753375|Vitamins|vitamins|mesh-ancestor
83701072|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
83701073|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701074|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83701075|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83701076|NCT01753453|Plerixafor|plerixafor|mesh-list
83701077|NCT01753453|Lenograstim|lenograstim|mesh-list
83701078|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83701079|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
83701080|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701081|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83701082|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83701083|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
83701084|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701085|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83701086|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83701087|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
83701088|NCT01753752|Chitosan|chitosan|mesh-list
83701089|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83701090|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83701091|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83701092|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
83701093|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701094|NCT01753752|Expectorants|expectorants|mesh-ancestor
83701095|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
83701096|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83701097|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
83701098|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701099|NCT01753752|Protective Agents|protective agents|mesh-ancestor
83701100|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701101|NCT01753752|Antidotes|antidotes|mesh-ancestor
83701102|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83701103|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83701104|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
83701105|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83701106|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
83701107|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
83701108|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
83701109|NCT01753752|Coagulants|coagulants|mesh-ancestor
83701110|NCT01753882|Escitalopram|escitalopram|mesh-list
83701111|NCT01753882|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83701112|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83701113|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83701114|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701115|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701116|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
83701117|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701118|NCT01754116|Cabotegravir|cabotegravir|mesh-list
83701119|NCT01754116|Midazolam|midazolam|mesh-list
83701120|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83701121|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83701122|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701123|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701124|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83701125|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83701126|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83701127|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83701128|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
83701129|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
83701130|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
83701131|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
83701132|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701133|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701134|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83701135|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83701136|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701137|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83701138|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83701139|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
83701140|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701141|NCT01754181|Insulin|insulin|mesh-list
83701142|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701143|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701144|NCT01754220|Montelukast|montelukast|mesh-list
83701145|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83701146|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
83701147|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83701148|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
83701149|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701150|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701151|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83701152|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83701153|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701154|NCT01754285|Octreotide|octreotide|mesh-list
83701155|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83701156|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701157|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701158|NCT01754324|Methadone|methadone|mesh-list
83701159|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83701160|NCT01754324|Narcotics|narcotics|mesh-ancestor
83701161|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701162|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701163|NCT01754324|Analgesics|analgesics|mesh-ancestor
83701164|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
83701165|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701166|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
83701167|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
83701168|NCT01754649|Misoprostol|misoprostol|mesh-list
83701169|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83701170|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
83701171|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83701172|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701173|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83701174|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83701175|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
83701177|NCT01754701|Trace Elements|trace elements|mesh-ancestor
83701178|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
83701179|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701180|NCT01754805|Methotrexate|methotrexate|mesh-list
83701181|NCT01754805|Peficitinib|peficitinib|mesh-list
83701182|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83701183|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
83701184|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83701185|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701186|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83701187|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
83701188|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701189|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701190|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
83701191|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701192|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83701193|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701194|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
83701195|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701196|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83701197|NCT01754831|Fluorides|fluorides|mesh-list
83701198|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
83701199|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
83701200|NCT01754831|Protective Agents|protective agents|mesh-ancestor
83701201|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701202|NCT01754844|AZD7624|azd7624|mesh-list
83701203|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83701204|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701205|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701206|NCT01754870|Rituximab|rituximab|mesh-list
83701207|NCT01754870|Lenalidomide|lenalidomide|mesh-list
83701208|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83701209|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83701210|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701211|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
83701212|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701213|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701214|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83701215|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83701216|NCT01754870|Growth Substances|growth substances|mesh-ancestor
83701217|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
83701218|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82856086|NCT03982277|Rifampin|rifampin|mesh-list
83701219|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
83701220|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701221|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
83701222|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
83701223|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83701224|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701225|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701226|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
83701227|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83701228|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701229|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701230|NCT01754961|Vitamin D|vitamin d|mesh-list
83701231|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
83701232|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
83701233|NCT01754961|Vitamins|vitamins|mesh-list
83701234|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
83701235|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701236|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83701237|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83701238|NCT01754974|Ribavirin|ribavirin|mesh-list
83701239|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83701240|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
83701241|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701242|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
83701243|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701244|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
83701245|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
83701246|NCT01755078|Calcium|calcium|mesh-list
83701247|NCT01755078|Sevelamer|sevelamer|mesh-list
83701248|NCT01755078|Calcium acetate|calcium acetate|mesh-list
83701249|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83701250|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701251|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83701252|NCT01755078|Antacids|antacids|mesh-ancestor
83701253|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701254|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83701255|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
83701256|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
83701257|NCT01755117|Ropivacaine|ropivacaine|mesh-list
83701258|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
83701259|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
83701260|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701261|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701262|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
83701263|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701264|NCT01755182|Somatostatin|somatostatin|mesh-list
83701265|NCT01755182|Hormones|hormones|mesh-ancestor
83701266|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701267|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701268|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
83701269|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83701270|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701271|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83701272|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83701273|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701274|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701275|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701276|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83701277|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83701278|NCT01755299|Caffeine|caffeine|mesh-list
83701279|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83701280|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701281|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83701282|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701283|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701284|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83701285|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83701286|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
83701287|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701288|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
83701289|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83701290|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83701291|NCT01755338|Prednisolone|prednisolone|mesh-list
83701292|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
83701293|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82856162|NCT03482024|Tirzepatide|tirzepatide|mesh-list
83701294|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
83701295|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701297|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
83701298|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701299|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701300|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83701301|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
83701302|NCT01755338|Hormones|hormones|mesh-ancestor
83701303|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701304|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83701305|NCT01755338|Protective Agents|protective agents|mesh-ancestor
83701306|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701307|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701308|NCT01755377|Benzonidazole|benzonidazole|mesh-list
83701309|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701310|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
83701311|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701312|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83701313|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83701314|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83701315|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701316|NCT01755403|Benzonidazole|benzonidazole|mesh-list
83701317|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701318|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
83701319|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701320|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83701321|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83701322|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83701323|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701324|NCT01755468|Insulin|insulin|mesh-list
83701325|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83701326|NCT01755468|Metformin|metformin|mesh-list
83701327|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
83701328|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
83701329|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701330|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701331|NCT01755494|Metformin|metformin|mesh-list
83701332|NCT01755494|Saxagliptin|saxagliptin|mesh-list
83701333|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701334|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701335|NCT01755494|Incretins|incretins|mesh-ancestor
83701336|NCT01755494|Hormones|hormones|mesh-ancestor
83701337|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701338|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83701339|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
83701340|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701341|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701342|NCT01755520|Aspirin|aspirin|mesh-list
83701343|NCT01755520|Ticagrelor|ticagrelor|mesh-list
83701344|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83701345|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83701346|NCT01755520|Analgesics|analgesics|mesh-ancestor
83701347|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
83701348|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701349|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701350|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701351|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701352|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83701353|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83701354|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701355|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83701356|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83701357|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701358|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
83701359|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83701360|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83701361|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83701362|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
82856234|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82856235|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
82856236|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
82856237|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856238|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856239|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856241|NCT03057795|Immunotoxins|immunotoxins|mesh-ancestor
83701363|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701364|NCT01755559|Artesunate|artesunate|mesh-list
83701365|NCT01755559|Lumefantrine|lumefantrine|mesh-list
83701366|NCT01755559|Artemether|artemether|mesh-list
83701367|NCT01755559|Piperaquine|piperaquine|mesh-list
83701368|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83701369|NCT01755559|Amodiaquine|amodiaquine|mesh-list
83701370|NCT01755559|Artenimol|artenimol|mesh-list
83701371|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
83701372|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83701373|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83701374|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701375|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701376|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
83701377|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
83701378|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83701379|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
83701380|NCT01755572|Liraglutide|liraglutide|mesh-list
83701381|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701382|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701383|NCT01755572|Incretins|incretins|mesh-ancestor
83701384|NCT01755572|Hormones|hormones|mesh-ancestor
83701385|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701386|NCT01755611|Minocycline|minocycline|mesh-list
83701387|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83701388|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701389|NCT01755663|Metoprolol|metoprolol|mesh-list
83701390|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83701391|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83701392|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
83701393|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
83701394|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701395|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701396|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83701397|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83701398|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83701399|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
83701400|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701401|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701402|NCT01754792|Inositol|inositol|mesh-list
83701403|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
83701404|NCT01754792|Vitamins|vitamins|mesh-ancestor
83701405|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
83701406|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701407|NCT01755676|Orlistat|orlistat|mesh-list
83701408|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701409|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701410|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83701411|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83701412|NCT01755728|Acetaminophen|acetaminophen|mesh-list
83701413|NCT01755728|Ibuprofen|ibuprofen|mesh-list
83701414|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83701415|NCT01755728|Analgesics|analgesics|mesh-ancestor
83701416|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
83701417|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701418|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701419|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
83701420|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83701421|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701422|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701423|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83701424|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701425|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701426|NCT01755845|Paclitaxel|paclitaxel|mesh-list
83701427|NCT01755845|Cisplatin|cisplatin|mesh-list
83701428|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83701429|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701430|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856318|NCT02332850|Dexamethasone|dexamethasone|mesh-list
82856319|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856320|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
82856321|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
82856322|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856323|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856324|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856325|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
82856326|NCT02332850|Hormones|hormones|mesh-ancestor
83701431|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83701432|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83701433|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701434|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83701435|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83701436|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701437|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701438|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
83701439|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701440|NCT01755884|Immunomodulating Agents|immunomodulating agents|mesh-list
83701441|NCT01755884|Immunologic Factors|immunologic factors|mesh-ancestor
83701442|NCT01755884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701443|NCT01755923|Docetaxel|docetaxel|mesh-list
83701444|NCT01755923|Gefitinib|gefitinib|mesh-list
83701445|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701446|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
83701447|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
83701448|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
83701449|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701450|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83701451|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701452|NCT01756040|Lactulose|lactulose|mesh-list
83701453|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83701454|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83701455|NCT01756105|Insulin|insulin|mesh-list
83701456|NCT01756105|Metformin|metformin|mesh-list
83701457|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
83701458|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
83701459|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
83701460|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701461|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701462|NCT01756131|Cabotegravir|cabotegravir|mesh-list
83701463|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83701464|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83701465|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701466|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701467|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83701468|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83701469|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
83701470|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701471|NCT01756170|Paclitaxel|paclitaxel|mesh-list
83701472|NCT01756170|Cisplatin|cisplatin|mesh-list
83701473|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83701474|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701475|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
83701476|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
83701477|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
83701478|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701479|NCT01756183|Paclitaxel|paclitaxel|mesh-list
83701480|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83701481|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701482|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83701483|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83701484|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83701485|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701486|NCT01756261|Aflibercept|aflibercept|mesh-list
83701487|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83701488|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83701489|NCT01756261|Growth Substances|growth substances|mesh-ancestor
83701490|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701491|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
83701492|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701493|NCT01756404|Canagliflozin|canagliflozin|mesh-list
83701494|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83701495|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701496|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701497|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701498|NCT01756417|Metformin|metformin|mesh-list
83701499|NCT01756417|Canagliflozin|canagliflozin|mesh-list
83701500|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701501|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701502|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83701503|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701504|NCT01756430|Carvedilol|carvedilol|mesh-list
83701505|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83701506|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82856386|NCT01996267|Fluorouracil|fluorouracil|mesh-list
83701507|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
83701508|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701509|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701510|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701511|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83701512|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
83701513|NCT01756430|Protective Agents|protective agents|mesh-ancestor
83701514|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83701515|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83701516|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83701517|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
83701518|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83701519|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83701520|NCT01756443|Lidocaine|lidocaine|mesh-list
83701521|NCT01756443|Epinephrine|epinephrine|mesh-list
83701522|NCT01756443|Racepinephrine|racepinephrine|mesh-list
83701523|NCT01756443|Bupivacaine|bupivacaine|mesh-list
83701524|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
83701525|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
83701526|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
83701527|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701528|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701529|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
83701530|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701531|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83701532|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83701533|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83701534|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83701535|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701536|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83701537|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83701538|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
83701539|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701540|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83701541|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83701542|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
83701543|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83701544|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
83701545|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
83701546|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
83701547|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83701548|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
83701549|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83701550|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83701551|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701552|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83701553|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83701554|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792149|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701555|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701556|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701557|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83701558|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
83701559|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83701560|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701561|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83701562|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83701563|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83701564|NCT01756508|Eculizumab|eculizumab|mesh-list
83701565|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83701566|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701567|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
83701568|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701569|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
83701570|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83701571|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701572|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83701573|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83701574|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701575|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701576|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701577|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
83701578|NCT01756547|Diuretics|diuretics|mesh-ancestor
83701579|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
82856476|NCT03721744|Paclitaxel|paclitaxel|mesh-list
83701580|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701581|NCT01756547|Expectorants|expectorants|mesh-ancestor
83701582|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
83701583|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
83701584|NCT01756612|Hematinics|hematinics|mesh-ancestor
83701585|NCT01756638|Prednisolone|prednisolone|mesh-list
83701586|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701587|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
83701588|NCT01756638|Hormones|hormones|mesh-ancestor
83701589|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701590|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701591|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701592|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701593|NCT01756651|Fentanyl|fentanyl|mesh-list
83701594|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83701595|NCT01756651|Narcotics|narcotics|mesh-ancestor
83701596|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701597|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701598|NCT01756651|Analgesics|analgesics|mesh-ancestor
83701599|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
83701600|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701601|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83701602|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83701603|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
83701604|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
83701605|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
83701606|NCT01756664|Petrolatum|petrolatum|mesh-list
83701607|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83701608|NCT01756664|Protective Agents|protective agents|mesh-ancestor
83701609|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701610|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
83701611|NCT01756664|Emollients|emollients|mesh-ancestor
83701612|NCT01756768|Palbociclib|palbociclib|mesh-list
83701613|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701614|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83701615|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701616|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701617|NCT01756781|Palbociclib|palbociclib|mesh-list
83701618|NCT01756781|Midazolam|midazolam|mesh-list
83701619|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83701620|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83701621|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701622|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701623|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83701624|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83701625|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83701626|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83701627|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
83701628|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
83701629|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
83701630|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
83701631|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701632|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701633|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701634|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83701635|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701636|NCT01756989|Thalidomide|thalidomide|mesh-list
83701637|NCT01756989|Celecoxib|celecoxib|mesh-list
83701638|NCT01756989|Etoposide|etoposide|mesh-list
83701639|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
83701640|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83701641|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701642|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83701643|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83701644|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701645|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701646|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83701647|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83701648|NCT01756989|Analgesics|analgesics|mesh-ancestor
83701649|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
83701650|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701651|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701652|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701653|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701654|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83701655|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83701656|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701657|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
83701658|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
83701659|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83701660|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701661|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83701662|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83701663|NCT01756989|Growth Substances|growth substances|mesh-ancestor
83701664|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
83701665|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
83701666|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83701667|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83701668|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83701669|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
83701670|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701671|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701672|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701673|NCT01757106|Sevoflurane|sevoflurane|mesh-list
83701674|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83701675|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83701676|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
83701677|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
83701678|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701679|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701680|NCT01757236|Vancomycin|vancomycin|mesh-list
83701681|NCT01757236|Rifampin|rifampin|mesh-list
83701682|NCT01757236|Clindamycin|clindamycin|mesh-list
83701683|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
83701684|NCT01757236|Linezolid|linezolid|mesh-list
83701685|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83701686|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
83701687|NCT01757236|Trimethoprim|trimethoprim|mesh-list
83701688|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
83701689|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83701690|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701691|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83701692|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
83701693|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
83701694|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83701695|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497723|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
83701696|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701697|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83701698|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83701699|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83701700|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83701701|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83701702|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83701703|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83701704|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83701705|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
83701706|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83701707|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83701708|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83701709|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83701710|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83701711|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83701712|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
83701713|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83701714|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83701715|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
83701716|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83701717|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83701718|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701719|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83701720|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83701721|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83701722|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83701723|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83701724|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83701725|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83701726|NCT01757262|Clopidogrel|clopidogrel|mesh-list
83701727|NCT01757262|Ticagrelor|ticagrelor|mesh-list
83701728|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83701729|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83701730|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83701731|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83701732|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
83701733|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701734|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701735|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701736|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
83701737|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83701738|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701739|NCT01757431|Eculizumab|eculizumab|mesh-list
83701740|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83701741|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701742|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
83701743|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701744|NCT01757457|Abciximab|abciximab|mesh-list
83701745|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
83701746|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83701747|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
83701748|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83701749|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701750|NCT01757587|Insulin|insulin|mesh-list
83701751|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83701752|NCT01757587|Metformin|metformin|mesh-list
83701753|NCT01757587|Vildagliptin|vildagliptin|mesh-list
83701754|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701755|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701756|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83701757|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
83701758|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701759|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701760|NCT01757639|Ipilimumab|ipilimumab|mesh-list
83701761|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83701762|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701763|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83701764|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701765|NCT01757756|Midazolam|midazolam|mesh-list
83701766|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83701767|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83701768|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701769|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701770|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83701771|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83701772|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83701773|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83701774|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
83701775|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
83701776|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
83701777|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
83701778|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701779|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701780|NCT01757769|Silodosin|silodosin|mesh-list
83701781|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83701782|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83701783|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83701784|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
83701785|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701786|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701787|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701788|NCT01757769|Urological Agents|urological agents|mesh-ancestor
83701789|NCT01757795|Otaplimastat|otaplimastat|mesh-list
83701790|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83701791|NCT01757795|Protective Agents|protective agents|mesh-ancestor
83701792|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701793|NCT01757808|Ranolazine|ranolazine|mesh-list
83701794|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83701795|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83701796|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701797|NCT01757860|Vitamin D|vitamin d|mesh-list
83701798|NCT01757860|Vitamins|vitamins|mesh-ancestor
83701799|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
83701800|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701801|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83701802|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
82856686|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856688|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
83701803|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83701804|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83701805|NCT01757899|Prednisolone|prednisolone|mesh-list
83701806|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
83701807|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83701808|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
83701809|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701810|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
83701811|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
83701812|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701813|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701814|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83701815|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
83701816|NCT01757899|Hormones|hormones|mesh-ancestor
83701817|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701818|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83701819|NCT01757899|Protective Agents|protective agents|mesh-ancestor
83701820|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701821|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701822|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
83701823|NCT01758029|Testosterone|testosterone|mesh-list
83701824|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
83701825|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
83701826|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83701827|NCT01758029|Androgens|androgens|mesh-ancestor
83701828|NCT01758029|Hormones|hormones|mesh-ancestor
83701829|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701830|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701831|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701832|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701833|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
83701834|NCT01758094|Testosterone|testosterone|mesh-list
83701835|NCT01758094|Androgens|androgens|mesh-ancestor
83701836|NCT01758094|Hormones|hormones|mesh-ancestor
83701837|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701838|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701839|NCT01758107|Cyclosporine|cyclosporine|mesh-list
83701840|NCT01758107|Cyclosporins|cyclosporins|mesh-list
83701841|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701842|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701843|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701844|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
83701845|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701846|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
83701847|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83701848|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
83701849|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701850|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83701851|NCT01758120|Prednisone|prednisone|mesh-list
83701852|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
83701853|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701854|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
83701855|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701856|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701857|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83701858|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
83701859|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701860|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701861|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83701862|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701863|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
83701864|NCT01758120|Hormones|hormones|mesh-ancestor
83701865|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701866|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701867|NCT01758146|Tamoxifen|tamoxifen|mesh-list
83701868|NCT01758146|Letrozole|letrozole|mesh-list
83701869|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701870|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83701871|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83701872|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701873|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701874|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83701875|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
83701876|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856759|NCT00071006|Axitinib|axitinib|mesh-list
83701877|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701878|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701879|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83701880|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83701881|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83701882|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83701883|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
83701884|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
83701886|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
83701887|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701888|NCT01758198|Methotrexate|methotrexate|mesh-list
83701889|NCT01758198|Abatacept|abatacept|mesh-list
83701890|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83701891|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
83701892|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83701893|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701894|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83701895|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
83701896|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701897|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701898|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
83701899|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701900|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83701901|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701902|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
83701903|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701904|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83701905|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83701906|NCT01758198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83701907|NCT01758263|Metoprolol|metoprolol|mesh-list
83701908|NCT01758263|Nebivolol|nebivolol|mesh-list
83701909|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83701910|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83701911|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
83701912|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
83701913|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701914|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701915|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83701916|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83701917|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83701918|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
83701919|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83701920|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701921|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
83701922|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83701923|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83701924|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83701925|NCT01758367|Decitabine|decitabine|mesh-list
83701926|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83701927|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
83701928|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701929|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701930|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701931|NCT01758380|Metformin|metformin|mesh-list
83701932|NCT01758380|Vildagliptin|vildagliptin|mesh-list
83701933|NCT01758380|Gliclazide|gliclazide|mesh-list
83701934|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701935|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701936|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83701937|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
83701938|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701939|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701940|NCT01758393|Prednisone|prednisone|mesh-list
83701941|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83701942|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
83701943|NCT01758393|Hormones|hormones|mesh-ancestor
83701944|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83701945|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701946|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83701947|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701948|NCT01758471|Acarbose|acarbose|mesh-list
83701949|NCT01758471|Glipizide|glipizide|mesh-list
83701950|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83701952|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701953|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83701954|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701955|NCT01758627|Icodextrin|icodextrin|mesh-list
83701956|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
83701957|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83701958|NCT01758640|Warfarin|warfarin|mesh-list
83701959|NCT01758640|Phenindione|phenindione|mesh-list
83701960|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
83701961|NCT01758666|Leucovorin|leucovorin|mesh-list
83701962|NCT01758666|Methotrexate|methotrexate|mesh-list
83701963|NCT01758666|Calcium|calcium|mesh-list
83701964|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
83701965|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83701966|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701967|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83701968|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
83701969|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83701970|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83701971|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
83701972|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83701973|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83701974|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
83701975|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701976|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83701977|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83701978|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
83701979|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83701980|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83701981|NCT01758666|Antidotes|antidotes|mesh-ancestor
83701982|NCT01758666|Protective Agents|protective agents|mesh-ancestor
83701983|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
83701984|NCT01758666|Vitamins|vitamins|mesh-ancestor
83701985|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
83701986|NCT01758744|Treprostinil|treprostinil|mesh-list
83701987|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83701988|NCT01758809|Bupivacaine|bupivacaine|mesh-list
83701989|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
83701990|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
83701991|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83701992|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83701993|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
83701994|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83701995|NCT01758835|Calpastatin|calpastatin|mesh-list
83701996|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83701997|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
83701998|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83701999|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702000|NCT01758913|Ibuprofen|ibuprofen|mesh-list
83702001|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83702002|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702003|NCT01758913|Analgesics|analgesics|mesh-ancestor
83702004|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
83702005|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702006|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702007|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702008|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702009|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83702010|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702011|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702012|NCT01758978|Hydrocodone|hydrocodone|mesh-list
83702013|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83702014|NCT01758978|Narcotics|narcotics|mesh-ancestor
83702015|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702016|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702017|NCT01758978|Analgesics|analgesics|mesh-ancestor
83702018|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
83702019|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856913|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702020|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
83702021|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
83702022|NCT01759030|Rituximab|rituximab|mesh-list
83702023|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83702024|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702025|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
83702026|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702027|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702028|NCT01759108|Rebamipide|rebamipide|mesh-list
83702029|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83702030|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702031|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
83702032|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702033|NCT01759108|Protective Agents|protective agents|mesh-ancestor
83702034|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702035|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702036|NCT01759394|Maleic acid|maleic acid|mesh-list
83702037|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702038|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702039|NCT01759485|Vitamin D|vitamin d|mesh-list
83702040|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
83702041|NCT01759485|Vitamins|vitamins|mesh-ancestor
83702042|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
83702043|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702044|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83702045|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83702046|NCT01759524|Lidocaine|lidocaine|mesh-list
83702047|NCT01759524|Clonidine|clonidine|mesh-list
83702048|NCT01759524|Bupivacaine|bupivacaine|mesh-list
83702049|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
83702050|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
83702051|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702052|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702053|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
83702054|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702055|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83702056|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83702057|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83702058|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83702059|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702060|NCT01759524|Analgesics|analgesics|mesh-ancestor
83702061|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83702062|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
83702063|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
83702064|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83702065|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83702066|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83702067|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
83702068|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702069|NCT01759576|Canagliflozin|canagliflozin|mesh-list
83702070|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83702071|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702072|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83702073|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702074|NCT01759589|Remifentanil|remifentanil|mesh-list
83702075|NCT01759589|Propofol|propofol|mesh-list
83702076|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83702077|NCT01759589|Anesthetics|anesthetics|mesh-list
83702078|NCT01759589|Sevoflurane|sevoflurane|mesh-list
83702079|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83702080|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702081|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702082|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
83702083|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83702084|NCT01759589|Narcotics|narcotics|mesh-ancestor
83702085|NCT01759589|Analgesics|analgesics|mesh-ancestor
83702086|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
83702087|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702088|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83702089|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83702090|NCT01759706|Dexamethasone|dexamethasone|mesh-list
83702091|NCT01759706|Sufentanil|sufentanil|mesh-list
83702092|NCT01759706|Diazepam|diazepam|mesh-list
83702093|NCT01759706|Ondansetron|ondansetron|mesh-list
83702094|NCT01759706|Anesthetics|anesthetics|mesh-list
83702095|NCT01759706|Ropivacaine|ropivacaine|mesh-list
83702096|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702097|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
83702098|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
83702099|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702100|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856985|NCT01092572|Simvastatin|simvastatin|mesh-list
83702101|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702102|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
83702104|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702105|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83702106|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702107|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702108|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
83702109|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83702110|NCT01759706|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83702111|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83702112|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
83702113|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702114|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702115|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83702116|NCT01759706|Narcotics|narcotics|mesh-ancestor
83702117|NCT01759706|Analgesics|analgesics|mesh-ancestor
83702118|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
83702119|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83702120|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83702121|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
83702122|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
83702123|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
83702124|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83702125|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83702126|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83702127|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83702128|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83702129|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83702130|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
83702131|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
83702132|NCT01759719|Chromium|chromium|mesh-list
83702133|NCT01759719|Trace Elements|trace elements|mesh-ancestor
83702134|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
83702135|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702136|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
83702137|NCT01759732|Fludarabine|fludarabine|mesh-list
83702138|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83702139|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702140|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
83702141|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702142|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702143|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83702144|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
83702145|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702146|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702147|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83702148|NCT01759771|Vitamin D|vitamin d|mesh-list
83702149|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
83702150|NCT01759771|Vitamins|vitamins|mesh-ancestor
83702151|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
83702152|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702153|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83702154|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83702155|NCT01759810|Vaccines|vaccines|mesh-list
83702156|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
83702157|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702158|NCT01759875|Ritonavir|ritonavir|mesh-list
83702159|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83702160|NCT01759875|Rabeprazole|rabeprazole|mesh-list
83702161|NCT01759875|Betaine|betaine|mesh-list
83702162|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83702163|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83702164|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
83702165|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702166|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702167|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83702168|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83702169|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
83702170|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702171|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83702172|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83702173|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83702174|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702175|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82857058|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
83702176|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
83702177|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83702178|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
83702179|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83702181|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
83702182|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
83702183|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702184|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702185|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
83702186|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702187|NCT01760018|Desflurane|desflurane|mesh-list
83702188|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83702189|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
83702190|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
83702191|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702192|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702193|NCT01760096|Cyclosporine|cyclosporine|mesh-list
83702194|NCT01760096|Levamisole|levamisole|mesh-list
83702195|NCT01760096|Cyclosporins|cyclosporins|mesh-list
83702196|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
83702197|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792150|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83702198|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702199|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702200|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
83702201|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702202|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
83702203|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702204|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
83702205|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702206|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83702207|NCT01760096|Hormones|hormones|mesh-ancestor
83702208|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702209|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83702210|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
83702211|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
83702212|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83702213|NCT01760109|Piperacillin|piperacillin|mesh-list
83702214|NCT01760109|Sulbactam|sulbactam|mesh-list
83702215|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702216|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702217|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83702218|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702219|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702220|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83702221|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
83702222|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702223|NCT01760148|Interferons|interferons|mesh-list
83702224|NCT01760148|Ribavirin|ribavirin|mesh-list
83702225|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
83702226|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
83702227|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702228|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
83702229|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702230|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
83702231|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702232|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
83702233|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702234|NCT01760161|Ropivacaine|ropivacaine|mesh-list
83702235|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
83702236|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
83702237|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702238|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702239|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
83702240|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702241|NCT01760174|Bupivacaine|bupivacaine|mesh-list
83702242|NCT01760174|Ropivacaine|ropivacaine|mesh-list
83702243|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
83702244|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
83702245|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702246|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702247|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
83702248|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702249|NCT01760226|Prednisone|prednisone|mesh-list
83702250|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
83702251|NCT01760226|Rituximab|rituximab|mesh-list
82857132|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702252|NCT01760226|Doxorubicin|doxorubicin|mesh-list
83702253|NCT01760226|Methotrexate|methotrexate|mesh-list
83702254|NCT01760226|Etoposide|etoposide|mesh-list
83702255|NCT01760226|Vincristine|vincristine|mesh-list
83702256|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702257|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
83702258|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702259|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702260|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83702261|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
83702262|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702263|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702264|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83702265|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83702266|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83702267|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83702268|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83702269|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702270|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702271|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
83702272|NCT01760226|Hormones|hormones|mesh-ancestor
83792151|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83702273|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702274|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83702275|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83702276|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
83702277|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83702278|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83702279|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
83702280|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
83702281|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83702282|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83702283|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83702284|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
83702285|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
83702286|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
83702287|NCT01760252|Capecitabine|capecitabine|mesh-list
83702288|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
83702289|NCT01760252|Irinotecan|irinotecan|mesh-list
83702290|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83702291|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
83702292|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702293|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702294|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83702295|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83702296|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702297|NCT01760278|Cetrorelix|cetrorelix|mesh-list
83702298|NCT01760278|Hormones|hormones|mesh-list
83702299|NCT01760278|Progesterone|progesterone|mesh-list
83702300|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83702301|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702302|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702303|NCT01760278|Progestins|progestins|mesh-ancestor
83702304|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83702305|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
83702306|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83702307|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
83702308|NCT01760330|Acetaminophen|acetaminophen|mesh-list
83702309|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702310|NCT01760330|Analgesics|analgesics|mesh-ancestor
83702311|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
83702312|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702313|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702314|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
83702315|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
83702316|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
83702317|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83702318|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83702319|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702320|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702321|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702322|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702323|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
83702324|NCT01760460|Anacetrapib|anacetrapib|mesh-list
83702325|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83702326|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83702327|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
83702328|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702329|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83702330|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702332|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702333|NCT01760564|Miglustat|miglustat|mesh-list
83702334|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702335|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702336|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83702337|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83702338|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
83702339|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702340|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83702341|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83702342|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702343|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
83702344|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83702345|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83702346|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
83702347|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83702348|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792152|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
83702349|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702350|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
83702351|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702352|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702353|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83702354|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702355|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83702356|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
83702357|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
83702358|NCT01760577|Protective Agents|protective agents|mesh-ancestor
83702359|NCT01760642|Rifampin|rifampin|mesh-list
83702360|NCT01760642|Ketoconazole|ketoconazole|mesh-list
83702361|NCT01760642|Midazolam|midazolam|mesh-list
83702362|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83702363|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83702364|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702365|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702366|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83702367|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83702368|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83702369|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83702370|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
83702371|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
83702372|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
83702373|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
83702374|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702375|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702376|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83702377|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
83702378|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702379|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702380|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
83702381|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83702382|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702383|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83702384|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83702385|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83702386|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83702387|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83702388|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83702389|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
83702390|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83702391|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83702392|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83702393|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
83702394|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702395|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83702396|NCT01760694|Leucovorin|leucovorin|mesh-list
83702397|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
83702398|NCT01760694|Irinotecan|irinotecan|mesh-list
83702399|NCT01760694|Folfirinox|folfirinox|mesh-list
83702400|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702401|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83702402|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83702403|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857283|NCT03457636|Doxycycline|doxycycline|mesh-list
83702404|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702406|NCT01760694|Protective Agents|protective agents|mesh-ancestor
83702407|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702408|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
83702409|NCT01760694|Vitamins|vitamins|mesh-ancestor
83702410|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
83702411|NCT01760746|Bevacizumab|bevacizumab|mesh-list
83702412|NCT01760746|Ranibizumab|ranibizumab|mesh-list
83702413|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83702414|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702415|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83702416|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83702417|NCT01760746|Growth Substances|growth substances|mesh-ancestor
83702418|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702419|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
83702420|NCT01760798|Teriparatide|teriparatide|mesh-list
83702421|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83702422|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702423|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83702424|NCT01760811|Cetuximab|cetuximab|mesh-list
83702425|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83702426|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702427|NCT01760824|Amoxicillin|amoxicillin|mesh-list
83702428|NCT01760824|Metronidazole|metronidazole|mesh-list
83702429|NCT01760824|Clarithromycin|clarithromycin|mesh-list
83702430|NCT01760824|Tetracycline|tetracycline|mesh-list
83702431|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83702432|NCT01760824|Esomeprazole|esomeprazole|mesh-list
83702433|NCT01760824|Bismuth|bismuth|mesh-list
83702434|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702435|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702436|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83702437|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83702438|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83702439|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702440|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83702441|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702442|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702443|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83702444|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83702445|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83702446|NCT01760824|Antacids|antacids|mesh-ancestor
83702447|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83702448|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702449|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
83702450|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83702451|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702452|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702453|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702454|NCT01760967|Analgesics|analgesics|mesh-ancestor
83702455|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
83702456|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702457|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83702458|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83702459|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83702460|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
83702461|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702462|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702463|NCT01760980|Exemestane|exemestane|mesh-list
83702464|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702465|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83702466|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83702467|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702468|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702469|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83702470|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
83702471|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702472|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702473|NCT01761071|Diclofenac|diclofenac|mesh-list
83702474|NCT01761071|Ketorolac|ketorolac|mesh-list
83702475|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83702476|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702477|NCT01761071|Analgesics|analgesics|mesh-ancestor
82857356|NCT03956888|Protective Agents|protective agents|mesh-ancestor
83702479|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702480|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702481|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702482|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702483|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83702484|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702485|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702486|NCT01761110|Buprenorphine|buprenorphine|mesh-list
83702487|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83702488|NCT01761110|Narcotics|narcotics|mesh-ancestor
83702489|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702490|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702491|NCT01761110|Analgesics|analgesics|mesh-ancestor
83702492|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
83702493|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702494|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83702495|NCT01761149|Remifentanil|remifentanil|mesh-list
83702496|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83702497|NCT01761149|Narcotics|narcotics|mesh-ancestor
83702498|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702499|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702500|NCT01761149|Analgesics|analgesics|mesh-ancestor
83702501|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
83702502|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702503|NCT01761201|Levofloxacin|levofloxacin|mesh-list
83702504|NCT01761201|Ofloxacin|ofloxacin|mesh-list
83702505|NCT01761201|Isoniazid|isoniazid|mesh-list
83702506|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83702507|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702508|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702509|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83702510|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83702511|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702512|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702513|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702514|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83702515|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83702516|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
83702517|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83702518|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83702519|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
83702520|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83702521|NCT01761214|Amoxicillin|amoxicillin|mesh-list
83702522|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
83702523|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
83702524|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
83702525|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83702526|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83702527|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702528|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702529|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83702530|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83702531|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702532|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702533|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702534|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83702535|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83702536|NCT01761318|Liraglutide|liraglutide|mesh-list
83702537|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83702538|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702539|NCT01761318|Incretins|incretins|mesh-ancestor
83702540|NCT01761318|Hormones|hormones|mesh-ancestor
83702541|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702542|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
83702543|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702544|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
83702545|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702546|NCT01761487|Gentamicins|gentamicins|mesh-list
83702547|NCT01761487|Polymyxins|polymyxins|mesh-list
83702548|NCT01761487|Colistin|colistin|mesh-list
83702549|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702550|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702551|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83702552|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702553|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702555|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83702556|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702557|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83702558|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702559|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702560|NCT01761526|Rotigotine|rotigotine|mesh-list
83702561|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
83702562|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
83702563|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702564|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702565|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702566|NCT01761552|Atropine|atropine|mesh-list
83702567|NCT01761552|Neostigmine|neostigmine|mesh-list
83702568|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83702569|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83702570|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83702571|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
83702572|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702573|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702574|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83702575|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
83702576|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
83702577|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
83702578|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83702579|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83702580|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
83702581|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702582|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702583|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83702584|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702585|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83702586|NCT01761656|Atorvastatin|atorvastatin|mesh-list
83702587|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83702588|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83702589|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
83702590|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702591|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83702592|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83702593|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702594|NCT01761669|Vitamin D|vitamin d|mesh-list
83702595|NCT01761669|Vitamins|vitamins|mesh-ancestor
83702596|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
83702597|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702598|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83702599|NCT01761916|Clonidine|clonidine|mesh-list
83702600|NCT01761916|Captopril|captopril|mesh-list
83702601|NCT01761916|Analgesics|analgesics|mesh-ancestor
83702602|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
83702603|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702604|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702605|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83702606|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
83702607|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
83702608|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83702609|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83702610|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83702611|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
83702612|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702613|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702614|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83702615|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
83702616|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702617|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83702618|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83702619|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702620|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702621|NCT01761994|Nafamostat|nafamostat|mesh-list
83702622|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83702623|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702624|NCT01761994|Analgesics|analgesics|mesh-ancestor
83702625|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
82857508|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702626|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702627|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702628|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702629|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702630|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
83702631|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
83702632|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702633|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702634|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83702635|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83702636|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83702637|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702638|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
83702639|NCT01762046|Metformin|metformin|mesh-list
83702640|NCT01762046|Glipizide|glipizide|mesh-list
83702641|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83702642|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702643|NCT01762150|Gemcitabine|gemcitabine|mesh-list
83702644|NCT01762150|Sorafenib|sorafenib|mesh-list
83702645|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702646|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83702647|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
83702648|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702649|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83702650|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702651|NCT01762163|Aspirin|aspirin|mesh-list
83702652|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83702653|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702654|NCT01762163|Analgesics|analgesics|mesh-ancestor
83702655|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
83702656|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702657|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702658|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702659|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702660|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83702661|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83702662|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702663|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83702664|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83702665|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702666|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
83702667|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
83702668|NCT01762202|Fludarabine|fludarabine|mesh-list
83702669|NCT01762202|Ofatumumab|ofatumumab|mesh-list
83702670|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702671|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
83702672|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702673|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702674|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83702675|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
83702676|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702677|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702678|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83702679|NCT01762306|Folic Acid|folic acid|mesh-list
83702680|NCT01762306|Diclofenac|diclofenac|mesh-list
83702681|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83702682|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702683|NCT01762306|Analgesics|analgesics|mesh-ancestor
83702684|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
83702685|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702686|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702687|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702688|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702689|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83702690|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702691|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702692|NCT01762306|Hematinics|hematinics|mesh-ancestor
83702693|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
83702694|NCT01762306|Vitamins|vitamins|mesh-ancestor
83702695|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
83702696|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
83702697|NCT01762319|Pyridoxal|pyridoxal|mesh-list
82857582|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83702698|NCT01762319|Pyridoxine|pyridoxine|mesh-list
83702699|NCT01762319|Misoprostol|misoprostol|mesh-list
83702700|NCT01762319|Vitamins|vitamins|mesh-ancestor
83702701|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
83702702|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702703|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83702704|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
83702705|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83702706|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83702707|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702708|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
83702709|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
83702710|NCT01762332|Remifentanil|remifentanil|mesh-list
83702711|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83702712|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83702713|NCT01762332|Narcotics|narcotics|mesh-ancestor
83702714|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83702715|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702716|NCT01762332|Analgesics|analgesics|mesh-ancestor
83702717|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
83702718|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702719|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83702720|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
83702721|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702722|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702723|NCT01762436|Atenolol|atenolol|mesh-list
83702724|NCT01762436|Bisoprolol|bisoprolol|mesh-list
83702725|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83702726|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83702727|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
83702728|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
83702729|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702730|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702731|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83702732|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83702733|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83702734|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83702735|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702736|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702737|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
83702738|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
83702739|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83702740|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83702741|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702742|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702743|NCT01762475|Urological Agents|urological agents|mesh-ancestor
83702744|NCT01762514|Amifostine|amifostine|mesh-list
83702745|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83702746|NCT01762514|Protective Agents|protective agents|mesh-ancestor
83702747|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702748|NCT01762540|Prednisolone|prednisolone|mesh-list
83702749|NCT01762540|Calcium|calcium|mesh-list
83702750|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
83702751|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83702752|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702753|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702754|NCT01762540|Hormones|hormones|mesh-ancestor
83702755|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702756|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83702757|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702758|NCT01762644|Cyclosporine|cyclosporine|mesh-list
83702759|NCT01762644|Omeprazole|omeprazole|mesh-list
83702760|NCT01762644|Cyclosporins|cyclosporins|mesh-list
83702761|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702762|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702763|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702764|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
83702765|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702766|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
83702767|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702768|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
83702769|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702770|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83702771|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83702772|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702773|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83702774|NCT01762657|Cyclosporine|cyclosporine|mesh-list
83702775|NCT01762657|Lansoprazole|lansoprazole|mesh-list
83702776|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
83702777|NCT01762657|Cyclosporins|cyclosporins|mesh-list
83702778|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702779|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702780|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702781|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
83702782|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702783|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
83702784|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702785|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
83702786|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702787|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83702788|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83702789|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702790|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83702792|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702793|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702794|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83702795|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83702796|NCT01762787|Aspirin|aspirin|mesh-list
83702797|NCT01762787|Prednisolone|prednisolone|mesh-list
83702798|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83702799|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
83702800|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83702801|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
83702802|NCT01762787|Cantharidin|cantharidin|mesh-list
83702803|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83702804|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
83702805|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83702806|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702807|NCT01762787|Analgesics|analgesics|mesh-ancestor
83702808|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
83702809|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702810|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702811|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702812|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702813|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83702814|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83702815|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702816|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83702817|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83702818|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702819|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
83702820|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
83702821|NCT01762787|Hormones|hormones|mesh-ancestor
83702822|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702823|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83702824|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702825|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
83702826|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
83702827|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702828|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83702829|NCT01762787|Protective Agents|protective agents|mesh-ancestor
83702830|NCT01762826|Inositol|inositol|mesh-list
83702831|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
83702832|NCT01762826|Vitamins|vitamins|mesh-ancestor
83702833|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
83702834|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702835|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
83702836|NCT01762839|Oritavancin|oritavancin|mesh-list
83702837|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702838|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702839|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83702840|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83702841|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702842|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702843|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702844|NCT01762852|Belimumab|belimumab|mesh-list
83702845|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83702846|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
83702847|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702848|NCT01762878|Nemiralisib|nemiralisib|mesh-list
83702849|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83702850|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702851|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702852|NCT01762891|Acetaminophen|acetaminophen|mesh-list
83702853|NCT01762891|Celecoxib|celecoxib|mesh-list
83702854|NCT01762891|Rofecoxib|rofecoxib|mesh-list
83702855|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83702856|NCT01762891|Analgesics|analgesics|mesh-ancestor
83702857|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
83702858|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702859|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702860|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
83702861|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83702862|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702863|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83702864|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83702865|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83702866|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702867|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702868|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
83702869|NCT01762995|Dolutegravir|dolutegravir|mesh-list
83702870|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
83702872|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83702873|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702874|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83702875|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83702876|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702877|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702878|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83702879|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83702880|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
83702881|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702882|NCT01762995|Antacids|antacids|mesh-ancestor
83702883|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702884|NCT01762995|Trace Elements|trace elements|mesh-ancestor
83702885|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
83702886|NCT01763021|Rifampin|rifampin|mesh-list
83702887|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83702888|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
83702889|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702890|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702891|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
83702892|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83702893|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702894|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702895|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83702896|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83702897|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83702898|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83702899|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83702900|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83702901|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
83702902|NCT01763281|Hormones|hormones|mesh-ancestor
83702903|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702904|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702905|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83702906|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702907|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83702908|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702909|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702910|NCT01763437|Tetracycline|tetracycline|mesh-list
83702911|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83702912|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83702913|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83702914|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702915|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702916|NCT01763450|Bevacizumab|bevacizumab|mesh-list
83702917|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83702918|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702919|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83702920|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83702921|NCT01763450|Growth Substances|growth substances|mesh-ancestor
83702922|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702923|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
83702924|NCT01763463|Fluticasone|fluticasone|mesh-list
83702925|NCT01763463|Xhance|xhance|mesh-list
83702926|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83702927|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83702928|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
83702929|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702931|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702932|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702933|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83702934|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83702935|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
83702936|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83702937|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83702938|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83702939|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83702940|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
83702941|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83702942|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702943|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
83702944|NCT01763463|Hormones|hormones|mesh-ancestor
83702945|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702946|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
83702947|NCT01763476|Paclitaxel|paclitaxel|mesh-list
83702948|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83702949|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702950|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
83702951|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
83702952|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
83702953|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702954|NCT01763541|Anastrozole|anastrozole|mesh-list
83702955|NCT01763541|Leuprolide|leuprolide|mesh-list
83702956|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83702957|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702958|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83702959|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83702960|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83702961|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702962|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83702963|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
83702964|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702965|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702966|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83702967|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
83702968|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83702969|NCT01763658|Dexamethasone|dexamethasone|mesh-list
83702970|NCT01763658|Prednisolone|prednisolone|mesh-list
83702971|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83702972|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
83702973|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83702974|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
83702975|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83702976|NCT01763658|Antioxidants|antioxidants|mesh-list
83702977|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83702978|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
83702979|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
83702980|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83702981|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83702982|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83702983|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
83702984|NCT01763658|Hormones|hormones|mesh-ancestor
83702985|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83702986|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83702987|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702988|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83702989|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83702990|NCT01763658|Protective Agents|protective agents|mesh-ancestor
83702991|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
83702992|NCT01763710|Paclitaxel|paclitaxel|mesh-list
83702993|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83702994|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83702995|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83702996|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
83702997|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
83702998|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
83702999|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703000|NCT01763749|Clopidogrel|clopidogrel|mesh-list
82857886|NCT00376259|Adefovir|adefovir|mesh-list
83703001|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83703002|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83703003|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83703004|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83703005|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
83703006|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703007|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703008|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703009|NCT01763788|Gemcitabine|gemcitabine|mesh-list
83703010|NCT01763788|Necitumumab|necitumumab|mesh-list
83703011|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703012|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83703013|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
83703014|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703015|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83703016|NCT01764087|Paclitaxel|paclitaxel|mesh-list
83703017|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
83703018|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83703019|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703020|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83703021|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83703022|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83703023|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703024|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703025|NCT01764126|Vaccines|vaccines|mesh-list
83703026|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
83703027|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703028|NCT01764139|Vitamin D|vitamin d|mesh-list
83703029|NCT01764139|Vitamins|vitamins|mesh-ancestor
83703030|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
83703031|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703032|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83703033|NCT01764178|Valsartan|valsartan|mesh-list
83703034|NCT01764178|Pitavastatin|pitavastatin|mesh-list
83703035|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83703036|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83703037|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83703038|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703039|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83703040|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83703041|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83703042|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
83703043|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703044|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83703045|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83703046|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
83703047|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83703048|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
83703049|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83703050|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703051|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83703052|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83703053|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703054|NCT01764295|Olmesartan|olmesartan|mesh-list
83703055|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83703056|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83703057|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83703058|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
83703059|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703060|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83703061|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83703062|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703063|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83703064|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83703065|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83703066|NCT01764451|Simvastatin|simvastatin|mesh-list
83703067|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83703068|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83703069|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
83703070|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703071|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83703072|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83703073|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703075|NCT01763424|Niacinamide|niacinamide|mesh-list
83703076|NCT01763424|Niacin|niacin|mesh-list
83703077|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
83703078|NCT01763424|Calcipotriene|calcipotriene|mesh-list
83703079|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
83703080|NCT01763424|Vitamins|vitamins|mesh-ancestor
83703081|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
83703082|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703083|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83703084|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
83703085|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703086|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83703087|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
83703088|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
83703089|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83703090|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83703091|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703092|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83703093|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83703094|NCT01764555|Acetaminophen|acetaminophen|mesh-list
83703095|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83703096|NCT01764555|Analgesics|analgesics|mesh-ancestor
83703097|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
83703098|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703099|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703100|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
83703101|NCT01764581|Tacrolimus|tacrolimus|mesh-list
83703102|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83703103|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
83703104|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703105|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83703106|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703107|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703108|NCT01764672|Methylphenidate|methylphenidate|mesh-list
83703109|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83703110|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703111|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83703112|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83703113|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703114|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703115|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
83703116|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703117|NCT01764750|Vancomycin|vancomycin|mesh-list
83703118|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703119|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703120|NCT01764828|Gemcitabine|gemcitabine|mesh-list
83703121|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83703122|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
83703123|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703124|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703125|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83703126|NCT01764867|Dexetimide|dexetimide|mesh-list
83703127|NCT01764867|Mirtazapine|mirtazapine|mesh-list
83703128|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
83703129|NCT01764867|Trazodone|trazodone|mesh-list
83703130|NCT01764867|Citalopram|citalopram|mesh-list
83703131|NCT01764867|Bupropion|bupropion|mesh-list
83703132|NCT01764867|Fluoxetine|fluoxetine|mesh-list
83703133|NCT01764867|Paroxetine|paroxetine|mesh-list
83703134|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83703135|NCT01764867|Sertraline|sertraline|mesh-list
83703136|NCT01764867|Escitalopram|escitalopram|mesh-list
83703137|NCT01764867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83703138|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83703139|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703140|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703141|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703142|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
83703143|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703144|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83703145|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83703146|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
82858037|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703147|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
83703148|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703149|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83703151|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
83703152|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83703153|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
83703154|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83498065|NCT02980094|Vitamins|vitamins|mesh-list
83703155|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83703156|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
83703157|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83703158|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83703159|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703160|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83703161|NCT01764867|Analgesics|analgesics|mesh-ancestor
83703162|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
83703163|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83703164|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
83703165|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
83703166|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83703167|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83703168|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703169|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83703170|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83703171|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83703172|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
83703173|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83703174|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83703175|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83703176|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83703177|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83703178|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
83703179|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83703180|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83703181|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
83703182|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703183|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703184|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703185|NCT01764893|Urological Agents|urological agents|mesh-ancestor
83703186|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
83703187|NCT01765010|Vitamin D|vitamin d|mesh-list
83703188|NCT01765010|Calcitriol|calcitriol|mesh-list
83703189|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
83703190|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83703191|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83703192|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703193|NCT01765010|Vitamins|vitamins|mesh-ancestor
83703194|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
83703195|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83703196|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83703197|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703198|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703199|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83703200|NCT01765023|Metformin|metformin|mesh-list
83703201|NCT01765023|Atorvastatin|atorvastatin|mesh-list
83703202|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83703203|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703204|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83703205|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83703206|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
83703207|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703208|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83703209|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83703210|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703211|NCT01765088|Temozolomide|temozolomide|mesh-list
83703212|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83703213|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
83703214|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703215|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703216|NCT01765231|Entecavir|entecavir|mesh-list
83703217|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
83703218|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703219|NCT01765257|Rasagiline|rasagiline|mesh-list
83703220|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83703221|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858117|NCT03439072|Glucagon|glucagon|mesh-list
83703222|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703223|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83703224|NCT01765257|Protective Agents|protective agents|mesh-ancestor
83703225|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703226|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
83792153|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703227|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83703228|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703229|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703230|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
83703231|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703232|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703233|NCT01765374|Rituximab|rituximab|mesh-list
83703234|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83703235|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703236|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
83703237|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703238|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83703239|NCT01765452|Clopidogrel|clopidogrel|mesh-list
83703240|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83703241|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83703242|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83703243|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83703244|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
83703245|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703246|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703247|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703248|NCT01765556|Ketoconazole|ketoconazole|mesh-list
83703249|NCT01765556|Vemurafenib|vemurafenib|mesh-list
83703250|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
83703251|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703252|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83703253|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83703254|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703255|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703256|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83703257|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
83703258|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703259|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703260|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83703261|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703262|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83703263|NCT01765608|Zonisamide|zonisamide|mesh-list
83703264|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
83703265|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83703266|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703267|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703268|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83703269|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703270|NCT01765738|Minocycline|minocycline|mesh-list
83703271|NCT01765738|Rifampin|rifampin|mesh-list
83703272|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703273|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703274|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83703275|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
83703276|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
83703277|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83703278|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703279|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703280|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83703281|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83703282|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83703283|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83703284|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83703285|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83703286|NCT01765790|Antibodies|antibodies|mesh-list
83703287|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
83703288|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
83703289|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703290|NCT01765829|Droperidol|droperidol|mesh-list
83703291|NCT01765829|Haloperidol|haloperidol|mesh-list
83703292|NCT01765829|Pimozide|pimozide|mesh-list
82858189|NCT03389308|Diacerein|diacerein|mesh-list
83703293|NCT01765829|Olanzapine|olanzapine|mesh-list
83703294|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
83703295|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
83703296|NCT01765829|Risperidone|risperidone|mesh-list
83703297|NCT01765829|Aripiprazole|aripiprazole|mesh-list
83703298|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83703299|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83703300|NCT01765829|Ziprasidone|ziprasidone|mesh-list
83703301|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
83703302|NCT01765829|Clozapine|clozapine|mesh-list
83703303|NCT01765829|Asenapine|asenapine|mesh-list
83703304|NCT01765829|Amisulpride|amisulpride|mesh-list
83703305|NCT01765829|Perphenazine|perphenazine|mesh-list
83703306|NCT01765829|Sertindole|sertindole|mesh-list
83703307|NCT01765829|Sulpiride|sulpiride|mesh-list
83703308|NCT01765829|Clopenthixol|clopenthixol|mesh-list
83703309|NCT01765829|Clothiapine|clothiapine|mesh-list
83703310|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83703311|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
83703312|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703313|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703314|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703315|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83703316|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703317|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83703318|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83703319|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
83703320|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
83703321|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
83703322|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703323|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83703324|NCT01765829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83703325|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83703326|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703327|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
83703328|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
83703329|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83703330|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83703331|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83703332|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83703333|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83703334|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
83703335|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
83703336|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83703337|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83703338|NCT01765842|Rituximab|rituximab|mesh-list
83703339|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83703340|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703341|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
83703342|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703343|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83703344|NCT01765855|Betrixaban|betrixaban|mesh-list
83703345|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83703346|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
83703347|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83703348|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83703349|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703350|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703351|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
83703352|NCT01765868|Betrixaban|betrixaban|mesh-list
83703353|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83703354|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
83703355|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83703356|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
83703357|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703358|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703359|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
83703360|NCT01765881|Misoprostol|misoprostol|mesh-list
83703361|NCT01765881|Dinoprostone|dinoprostone|mesh-list
83703362|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83703363|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
83703364|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83703365|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703366|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83703367|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83703368|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
83703369|NCT01765946|Metformin|metformin|mesh-list
83703370|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83703371|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703372|NCT01766063|Interferons|interferons|mesh-list
83703373|NCT01766063|Interferon-beta|interferon-beta|mesh-list
83703374|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
83703375|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703376|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
83703377|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703378|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
83703379|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703380|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83703381|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
83703382|NCT01766089|Remifentanil|remifentanil|mesh-list
83703383|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83703384|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703385|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703386|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83703387|NCT01766089|Analgesics|analgesics|mesh-ancestor
83703388|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
83703389|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703390|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83703391|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83703392|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83703393|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
83703394|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703395|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703396|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83703397|NCT01766089|Narcotics|narcotics|mesh-ancestor
83703398|NCT01766154|Tirofiban|tirofiban|mesh-list
83703399|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83703400|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83703401|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703402|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83703403|NCT01766180|Resveratrol|resveratrol|mesh-list
83703404|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
83703405|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703406|NCT01766180|Protective Agents|protective agents|mesh-ancestor
83703407|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703408|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703409|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83703410|NCT01766258|Carbidopa|carbidopa|mesh-list
83703411|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83703412|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83703413|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
83703414|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703415|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703416|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703417|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83703418|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703419|NCT01766323|Modafinil|modafinil|mesh-list
83703420|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83703421|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703422|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83703423|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83703424|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83703425|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703426|NCT01766375|Cyclosporine|cyclosporine|mesh-list
83703427|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
83703428|NCT01766375|Methotrexate|methotrexate|mesh-list
83703429|NCT01766375|Cyclosporins|cyclosporins|mesh-list
83703430|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83703431|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
83703432|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83703433|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703434|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83703435|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
83703436|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703437|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703438|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
83703439|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703440|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83703441|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83703442|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
83703443|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83703444|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82858333|NCT05513768|Protein C|protein c|mesh-list
83703445|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
83703446|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703447|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83703448|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83703449|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83703450|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
83703451|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703453|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83703454|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83703455|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
83703456|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703457|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83703458|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83703459|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
83703460|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83703461|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703462|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83703463|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
83703464|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703465|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703466|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703467|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703468|NCT01766583|Lenalidomide|lenalidomide|mesh-list
83703469|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
83703470|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703471|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83703472|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83703473|NCT01766583|Growth Substances|growth substances|mesh-ancestor
83703474|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
83703475|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703476|NCT01766609|Triamcinolone|triamcinolone|mesh-list
83703477|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83703478|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83703479|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83703480|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83703481|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
83703482|NCT01766609|Hormones|hormones|mesh-ancestor
83703483|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703484|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703485|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83703486|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
83703487|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703488|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703489|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
83703490|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
83703491|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
83703492|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703493|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83703494|NCT01766843|Charcoal|charcoal|mesh-list
83703495|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83703496|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
83703497|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703498|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703499|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83703500|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83703501|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
83703502|NCT01766843|Hormones|hormones|mesh-ancestor
83703503|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703504|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
83703505|NCT01766843|Antidotes|antidotes|mesh-ancestor
83703506|NCT01766843|Protective Agents|protective agents|mesh-ancestor
83703507|NCT01766960|Morphine|morphine|mesh-list
83703508|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83703509|NCT01766960|Narcotics|narcotics|mesh-ancestor
83703510|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703511|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703512|NCT01766960|Analgesics|analgesics|mesh-ancestor
83703513|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
83703514|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703515|NCT01767025|Oxytocin|oxytocin|mesh-list
83703516|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
83703517|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83703518|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703519|NCT01767090|Leuprolide|leuprolide|mesh-list
83703521|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
83703522|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83703523|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703524|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83703525|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703526|NCT01767259|Valsartan|valsartan|mesh-list
83703527|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83703528|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83703529|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83703530|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83703531|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703532|NCT01767259|Diuretics|diuretics|mesh-ancestor
83703533|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
83703534|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703535|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83703536|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703537|NCT01767272|Fexofenadine|fexofenadine|mesh-list
83703538|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83703539|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83703540|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83703541|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
83703542|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
83703543|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703544|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703545|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703546|NCT01767298|Valsartan|valsartan|mesh-list
83703547|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83703548|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83703549|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83703550|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83703551|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703552|NCT01767298|Diuretics|diuretics|mesh-ancestor
83703553|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
83703554|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703555|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83703556|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703557|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83703558|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
83703559|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83703560|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
83703561|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703562|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703563|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703564|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83703565|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703566|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
83703567|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703568|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83703569|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
83703570|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703571|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703572|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83703573|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703574|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83703575|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
83703576|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703577|NCT01767428|Acetaminophen|acetaminophen|mesh-list
83703578|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83703579|NCT01767428|Analgesics|analgesics|mesh-ancestor
83703580|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
83703581|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703582|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703583|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
83703584|NCT01767454|Ipilimumab|ipilimumab|mesh-list
83703585|NCT01767454|Trametinib|trametinib|mesh-list
83703586|NCT01767454|Dabrafenib|dabrafenib|mesh-list
83703587|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83703588|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703589|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82858482|NCT05842213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83703590|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703591|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83703592|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703594|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703595|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703596|NCT01767545|Dexamethasone|dexamethasone|mesh-list
83703597|NCT01767545|Bevacizumab|bevacizumab|mesh-list
83703598|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83703599|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703600|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83703601|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83703602|NCT01767545|Growth Substances|growth substances|mesh-ancestor
83703603|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703604|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
83703605|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83703606|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
83703607|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
83703608|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703609|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83703610|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
83703611|NCT01767545|Hormones|hormones|mesh-ancestor
83703612|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703613|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83703614|NCT01767571|Cephalexin|cephalexin|mesh-list
83703615|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703616|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703617|NCT01767584|Cephalexin|cephalexin|mesh-list
83703618|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703619|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703620|NCT01767623|Vemurafenib|vemurafenib|mesh-list
83703621|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703622|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83703623|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703624|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703625|NCT01767714|Plerixafor|plerixafor|mesh-list
83703626|NCT01767714|Lenograstim|lenograstim|mesh-list
83703627|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83703628|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
83703629|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703630|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83703631|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83703632|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
83703633|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703634|NCT01767896|Vaccines|vaccines|mesh-list
83703635|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
83703636|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703637|NCT01768039|Vitamin D|vitamin d|mesh-list
83703638|NCT01768039|Vitamins|vitamins|mesh-ancestor
83703639|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
83703640|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703641|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83703642|NCT01767610|Infliximab|infliximab|mesh-list
83703643|NCT01767610|Fenofibrate|fenofibrate|mesh-list
83703644|NCT01767610|Pitavastatin|pitavastatin|mesh-list
83703645|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83703646|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
83703647|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703648|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83703649|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83703650|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83703651|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703652|NCT01767610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83703653|NCT01767610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83703654|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83703655|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83703656|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83703657|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83703658|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83703659|NCT01768078|Betamethasone|betamethasone|mesh-list
83703660|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703661|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
83703662|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83703663|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
83703664|NCT01768078|Hormones|hormones|mesh-ancestor
83703665|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858567|NCT05841472|Pemetrexed|pemetrexed|mesh-list
83703666|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703667|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83703668|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
83703669|NCT01768182|Leucovorin|leucovorin|mesh-list
83703670|NCT01768182|Folic Acid|folic acid|mesh-list
83703671|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
83703672|NCT01768182|Antidotes|antidotes|mesh-ancestor
83703673|NCT01768182|Protective Agents|protective agents|mesh-ancestor
83703674|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703675|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
83703676|NCT01768182|Vitamins|vitamins|mesh-ancestor
83703677|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
83703678|NCT01768182|Hematinics|hematinics|mesh-ancestor
83703679|NCT01768195|Entecavir|entecavir|mesh-list
83703680|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
83703681|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703682|NCT01768208|Saxagliptin|saxagliptin|mesh-list
83703683|NCT01768208|Incretins|incretins|mesh-ancestor
83703684|NCT01768208|Hormones|hormones|mesh-ancestor
83703685|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703686|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703687|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83703688|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
83703689|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703690|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703691|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83703692|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83703693|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83703694|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703695|NCT01768260|Aspirin|aspirin|mesh-list
83703696|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83703697|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83703698|NCT01768260|Analgesics|analgesics|mesh-ancestor
83703699|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
83703700|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703701|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703702|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83703703|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83703704|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83703705|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83703706|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703707|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83703708|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83703709|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703710|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
83703711|NCT01768273|Midazolam|midazolam|mesh-list
83703712|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83703713|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83703714|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703715|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703716|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83703717|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83703718|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83703719|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83703720|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
83703721|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
83703722|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
83703723|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
83703724|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703725|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132899|NCT05066516|Hormones|hormones|mesh-ancestor
83703726|NCT01768299|Misoprostol|misoprostol|mesh-list
83703727|NCT01768299|Mifepristone|mifepristone|mesh-list
83703728|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83703729|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
83703730|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83703731|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703732|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83703733|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83703734|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
83703735|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83703736|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83703737|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83703738|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82858639|NCT05841147|Tirofiban|tirofiban|mesh-list
83703739|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
83703740|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83703741|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83703742|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
83703743|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703744|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
83703745|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83703746|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83703747|NCT01768312|Cyclosporine|cyclosporine|mesh-list
83703748|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83703749|NCT01768312|Cyclosporins|cyclosporins|mesh-list
83703750|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703751|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703752|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83703753|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
83703754|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703755|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
83703756|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703757|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
83703758|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83703759|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83703760|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83703761|NCT01768351|Calcitriol|calcitriol|mesh-list
83703762|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83703763|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703764|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83703765|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703766|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703767|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83703768|NCT01768351|Vitamins|vitamins|mesh-ancestor
83703769|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
83703770|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83703771|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83703772|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83703773|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703774|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83703775|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
83703776|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83703777|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83703778|NCT01768377|Lidocaine|lidocaine|mesh-list
83703779|NCT01768377|Fentanyl|fentanyl|mesh-list
83703780|NCT01768377|Midazolam|midazolam|mesh-list
83703781|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
83703782|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
83703783|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703784|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703785|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
83703786|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703787|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83703788|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83703789|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83703790|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703791|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703792|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83703793|NCT01768377|Narcotics|narcotics|mesh-ancestor
83703794|NCT01768377|Analgesics|analgesics|mesh-ancestor
83703795|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83703796|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83703797|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
83703798|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83703799|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83703800|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83703801|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83703802|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
83703803|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
83703804|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703805|NCT01768390|Fluorides|fluorides|mesh-list
83703806|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
83703807|NCT01768390|Protective Agents|protective agents|mesh-ancestor
83703808|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703809|NCT01768455|Glimepiride|glimepiride|mesh-list
83703810|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83703811|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83703812|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703813|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83703814|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
83703815|NCT01768481|Atorvastatin|atorvastatin|mesh-list
82858707|NCT05840913|Epinephrine|epinephrine|mesh-list
83703816|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83703817|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83703818|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
83703819|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703820|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83703821|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83703822|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703824|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
83703825|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703826|NCT01768507|Protective Agents|protective agents|mesh-ancestor
83703827|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703828|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703829|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83703830|NCT01768663|Itraconazole|itraconazole|mesh-list
83703831|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
83703832|NCT01768663|Rifampin|rifampin|mesh-list
83703833|NCT01768663|Ivacaftor|ivacaftor|mesh-list
83703834|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
83703835|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703836|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83703837|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83703838|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703839|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703840|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83703841|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
83703842|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83703843|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703844|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83703845|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703846|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83703847|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83703848|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703849|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83703850|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83703851|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
83703852|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
83703853|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83703854|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83703855|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83703856|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83703857|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83703858|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83703859|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83703860|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83703861|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703862|NCT01768741|Liver Extracts|liver extracts|mesh-list
83703863|NCT01768741|Hematinics|hematinics|mesh-ancestor
83703864|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
83703865|NCT01768780|Bupivacaine|bupivacaine|mesh-list
83703866|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83703867|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
83703868|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
83703869|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703870|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703871|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
83703872|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703873|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83703874|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83703875|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
82858782|NCT05834023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82858783|NCT05834023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82858784|NCT05834023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82858785|NCT05834023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858811|NCT05804708|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
82858812|NCT05804708|Hallucinogens|hallucinogens|mesh-ancestor
82858813|NCT05804708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858814|NCT05804708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82858815|NCT05804708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82858816|NCT05804708|Serotonin Agents|serotonin agents|mesh-ancestor
82858817|NCT05804708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858818|NCT05804708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703876|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703877|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703878|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
83703879|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83703880|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
83703881|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703882|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703883|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83703884|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
83703885|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83703886|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
83703887|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703888|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703889|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83703890|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
83703891|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
83703892|NCT01768884|Protective Agents|protective agents|mesh-ancestor
83703893|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
83703894|NCT01768897|Cytarabine|cytarabine|mesh-list
83703895|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
83703896|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83703897|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
83703898|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703899|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703900|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
83703901|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703902|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83703903|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
83703904|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703905|NCT01768897|Analgesics|analgesics|mesh-ancestor
83703906|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
83703907|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703908|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83703909|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83703910|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703911|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
83703912|NCT01768897|Protective Agents|protective agents|mesh-ancestor
83703913|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
83703914|NCT01768897|Vitamins|vitamins|mesh-ancestor
83703915|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
83703916|NCT01768988|Pregabalin|pregabalin|mesh-list
83703917|NCT01768988|Analgesics|analgesics|mesh-ancestor
83703918|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
83703919|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703920|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703921|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
83703922|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83703923|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83703924|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703925|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83703926|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83703927|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83703928|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83703929|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83703930|NCT01769040|Rifaximin|rifaximin|mesh-list
83703931|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703932|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703933|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83703934|NCT01769066|Pemetrexed|pemetrexed|mesh-list
83703935|NCT01769066|Gefitinib|gefitinib|mesh-list
83703936|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703937|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703938|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703939|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83703940|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83703941|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83703942|NCT01769079|Isosorbide|isosorbide|mesh-list
83703943|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83703944|NCT01769079|Diuretics|diuretics|mesh-ancestor
83703945|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
83703946|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703947|NCT01769118|Caffeine|caffeine|mesh-list
83703948|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83703949|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703950|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82858858|NCT05707754|Bupivacaine|bupivacaine|mesh-list
83703951|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703952|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703953|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83703954|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83703955|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
83703956|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83703958|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83703959|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83703960|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703961|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703962|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83703963|NCT01769183|Protective Agents|protective agents|mesh-ancestor
83703964|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703965|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83703966|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83703967|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83703968|NCT01769183|Growth Substances|growth substances|mesh-ancestor
83703969|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
83703970|NCT01769235|Clindamycin|clindamycin|mesh-list
83703971|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
83703972|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
83703973|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83703974|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83703975|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83703976|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83703977|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703978|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703979|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83703980|NCT01769482|Udenafil|udenafil|mesh-list
83703981|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83703982|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83703983|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83703984|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83703985|NCT01769625|Vitamin D|vitamin d|mesh-list
83703986|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
83703987|NCT01769625|Celecoxib|celecoxib|mesh-list
83703988|NCT01769625|Vitamins|vitamins|mesh-ancestor
83703989|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
83703990|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83703991|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83703992|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83703993|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83703994|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83703995|NCT01769625|Analgesics|analgesics|mesh-ancestor
83703996|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
83703997|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83703998|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83703999|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704000|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83704001|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83704002|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704003|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704004|NCT01769651|Methadone|methadone|mesh-list
83704005|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83704006|NCT01769651|Narcotics|narcotics|mesh-ancestor
83704007|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704008|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704009|NCT01769651|Analgesics|analgesics|mesh-ancestor
83704010|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
83704011|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704012|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
83704013|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
83704014|NCT01769664|Clindamycin|clindamycin|mesh-list
83704015|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
83704016|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
83704017|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83704018|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704019|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704020|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83704021|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704022|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704023|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
83704024|NCT01769677|Hydrocodone|hydrocodone|mesh-list
82858930|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704026|NCT01769677|Narcotics|narcotics|mesh-ancestor
83704027|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704028|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704029|NCT01769677|Analgesics|analgesics|mesh-ancestor
83704030|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
83704031|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704032|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
83704033|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
83704034|NCT01769703|Dabigatran|dabigatran|mesh-list
83704035|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
83704036|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83704037|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
83704038|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704039|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704040|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
83704041|NCT01769768|Bupropion|bupropion|mesh-list
83704042|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83704043|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
83704044|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83704045|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83704046|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83704047|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704048|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704049|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
83704050|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704051|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704052|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83704053|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83704054|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704055|NCT01769781|Anastrozole|anastrozole|mesh-list
83704056|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704057|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704058|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83704059|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83704060|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704061|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704062|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83704063|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
83704064|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704065|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704066|NCT01769820|Dexamethasone|dexamethasone|mesh-list
83704067|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704068|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
83704069|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
83704070|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704071|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704072|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704073|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
83704074|NCT01769820|Hormones|hormones|mesh-ancestor
83704075|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704076|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704077|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704078|NCT01769833|Interferons|interferons|mesh-list
83704079|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
83704080|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
83704081|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83704082|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704083|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
83704084|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704085|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
83704086|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704087|NCT01769898|Budesonide|budesonide|mesh-list
83704088|NCT01769898|Theophylline|theophylline|mesh-list
83704089|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
83704090|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704091|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83704092|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
83704093|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704094|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704095|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83704096|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83704097|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
83704098|NCT01769898|Hormones|hormones|mesh-ancestor
83704099|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704100|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83704101|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83704102|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83704103|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
83704104|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704105|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704106|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83704107|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704108|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
83704109|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83704110|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83704111|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
83704112|NCT01769911|Cytarabine|cytarabine|mesh-list
83704113|NCT01769911|Etoposide|etoposide|mesh-list
83704114|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
83704115|NCT01769911|Melphalan|melphalan|mesh-list
83704116|NCT01769911|Carmustine|carmustine|mesh-list
83704117|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83704118|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83704119|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704120|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83704121|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83704122|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704123|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704124|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83704125|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
83704126|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
83704127|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704128|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704129|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
83704130|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704131|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83704132|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
83704133|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83704134|NCT01769950|Choline|choline|mesh-list
83704135|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
83704136|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83704137|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
83704138|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704139|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704140|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83704141|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
83704142|NCT01770041|Acetaminophen|acetaminophen|mesh-list
83704143|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83704144|NCT01770041|Analgesics|analgesics|mesh-ancestor
83704145|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
83704146|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704147|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704148|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
83704149|NCT01770080|Peppermint oil|peppermint oil|mesh-list
83704150|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83704151|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
83704152|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
83704153|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704154|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704155|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704156|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
83704157|NCT01770106|Denosumab|denosumab|mesh-list
83704158|NCT01770106|Alendronate|alendronate|mesh-list
83704159|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83704160|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704161|NCT01770132|Gemcitabine|gemcitabine|mesh-list
83704162|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83704163|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
83704164|NCT01770132|Trioxsalen|trioxsalen|mesh-list
83704165|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83704166|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
83704167|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704168|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704169|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
83704170|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83704171|NCT01770171|Paclitaxel|paclitaxel|mesh-list
83704172|NCT01770171|Bevacizumab|bevacizumab|mesh-list
83704173|NCT01770171|Carboplatin|carboplatin|mesh-list
83704174|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83704175|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704176|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
83704177|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
83704178|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
83704179|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704180|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83704181|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83704182|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83704183|NCT01770171|Growth Substances|growth substances|mesh-ancestor
83704184|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704185|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
83704186|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83704187|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83704188|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83704189|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704191|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83704192|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83704193|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
83704194|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704195|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83704196|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83704197|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704198|NCT01770223|Ribavirin|ribavirin|mesh-list
83704199|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83704200|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
83704201|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704202|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
83704203|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704204|NCT01770236|Acetaminophen|acetaminophen|mesh-list
83704205|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83704206|NCT01770236|Analgesics|analgesics|mesh-ancestor
83704207|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
83704208|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704209|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704210|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
83704211|NCT01770301|Paclitaxel|paclitaxel|mesh-list
83704212|NCT01770301|Bevacizumab|bevacizumab|mesh-list
83704213|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83704214|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704215|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
83704216|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
83704217|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
83704218|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704219|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83704220|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83704221|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83704222|NCT01770301|Growth Substances|growth substances|mesh-ancestor
83704223|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704224|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
83704225|NCT01770444|Cytarabine|cytarabine|mesh-list
83704226|NCT01770444|Thioguanine|thioguanine|mesh-list
83704227|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83704228|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
83704229|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704230|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704231|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
83704232|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704233|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704234|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
83704235|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704236|NCT01770470|Chitosan|chitosan|mesh-list
83704237|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83704238|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83704239|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
83704240|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704241|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83704242|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
83704243|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
83704244|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
83704245|NCT01770470|Coagulants|coagulants|mesh-ancestor
83704246|NCT01770600|Risperidone|risperidone|mesh-list
83704247|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83704248|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
83704249|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859155|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83704250|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704251|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704253|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83704254|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704255|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83704256|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83704257|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
83704258|NCT01770769|Cloxacillin|cloxacillin|mesh-list
83704259|NCT01770769|Cephalothin|cephalothin|mesh-list
83704260|NCT01770769|Dalteparin|dalteparin|mesh-list
83704261|NCT01770769|Tinzaparin|tinzaparin|mesh-list
83704262|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83704263|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
83704264|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83704265|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83704266|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704267|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704268|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704269|NCT01770795|Gemcitabine|gemcitabine|mesh-list
83704270|NCT01770795|genexol-PM|genexol-pm|mesh-list
83704271|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83704272|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
83704273|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704274|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704275|NCT01770795|Tubulin Modulators|tubulin modulators|mesh-ancestor
83704276|NCT01770795|Antimitotic Agents|antimitotic agents|mesh-ancestor
83704277|NCT01770795|Mitosis Modulators|mitosis modulators|mesh-ancestor
83704278|NCT01770899|Montelukast|montelukast|mesh-list
83704279|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83704280|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
83704281|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83704282|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
83704283|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704284|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704285|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83704286|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83704287|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704288|NCT01770964|Pregabalin|pregabalin|mesh-list
83704289|NCT01770964|Analgesics|analgesics|mesh-ancestor
83704290|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
83704291|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704292|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704293|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
83704294|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83704295|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704296|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704297|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83704298|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83704299|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83704300|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704301|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83704302|NCT01771081|Ranibizumab|ranibizumab|mesh-list
83704303|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83704304|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83704305|NCT01771081|Growth Substances|growth substances|mesh-ancestor
83704306|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704307|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
83704308|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704309|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
83704310|NCT01771146|Irinotecan|irinotecan|mesh-list
83704311|NCT01771146|Folfirinox|folfirinox|mesh-list
83704312|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704313|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83704314|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83704315|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704316|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704317|NCT01771185|Metformin|metformin|mesh-list
83704318|NCT01771185|Gliclazide|gliclazide|mesh-list
83704319|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83704320|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704321|NCT01771198|Simvastatin|simvastatin|mesh-list
83704322|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83704323|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83704324|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
83704325|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704326|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83704327|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83704328|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704329|NCT01771289|Docetaxel|docetaxel|mesh-list
83704330|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704331|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
83704332|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
83704333|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
83704334|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704335|NCT01771302|Calcium|calcium|mesh-list
83704336|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83704337|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704338|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
83704339|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83704340|NCT01771328|Cortisone|cortisone|mesh-list
83704341|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704342|NCT01771406|Nebivolol|nebivolol|mesh-list
83704343|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83704344|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
83704345|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83704346|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83704347|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83704348|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
83704349|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704350|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704351|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704352|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83704353|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704354|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83704355|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704356|NCT01771458|Tamoxifen|tamoxifen|mesh-list
83704357|NCT01771458|Trastuzumab|trastuzumab|mesh-list
83704358|NCT01771458|Everolimus|everolimus|mesh-list
83704359|NCT01771458|Sorafenib|sorafenib|mesh-list
83704360|NCT01771458|Letrozole|letrozole|mesh-list
83704361|NCT01771458|Dasatinib|dasatinib|mesh-list
83704362|NCT01771458|Lapatinib|lapatinib|mesh-list
83704363|NCT01771458|Vemurafenib|vemurafenib|mesh-list
83704364|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83704365|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704366|NCT01771458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83704367|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83704368|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704369|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704370|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704371|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
83704372|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704373|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83704374|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83704375|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83704376|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
83704377|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704378|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704379|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83704380|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83704381|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83704382|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83704383|NCT05318365|Laxatives|laxatives|mesh-ancestor
83704384|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704385|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83704386|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83704387|NCT01771783|Renin Inhibitors|renin inhibitors|mesh-list
82859306|NCT04779879|Sotrovimab|sotrovimab|mesh-list
83704388|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82859307|NCT04779879|Antiviral Agents|antiviral agents|mesh-ancestor
82859308|NCT04779879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859309|NCT04768101|Corticosterone|corticosterone|mesh-list
82859310|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82859311|NCT04739800|Paclitaxel|paclitaxel|mesh-list
82859312|NCT04739800|Doxorubicin|doxorubicin|mesh-list
82859313|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82859314|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82859315|NCT04739800|Durvalumab|durvalumab|mesh-list
82859316|NCT04739800|Topotecan|topotecan|mesh-list
82859317|NCT04739800|Olaparib|olaparib|mesh-list
82859318|NCT04739800|Cediranib|cediranib|mesh-list
83704389|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704390|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
83704392|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83704393|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83704394|NCT01771822|Analgesics|analgesics|mesh-ancestor
83704395|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
83704396|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704397|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704398|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704399|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704400|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83704401|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704402|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704403|NCT01771874|Bupropion|bupropion|mesh-list
83704404|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83704405|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83704406|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
83704407|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83704408|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83704409|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83704410|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704411|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704412|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
83704413|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704414|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704415|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83704416|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83704417|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704418|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
83704419|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
83704420|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83704421|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
83704422|NCT01771978|Diltiazem|diltiazem|mesh-list
83704423|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83704424|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83704425|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704426|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704427|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83704428|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704429|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
83704430|NCT01772056|Fluticasone|fluticasone|mesh-list
83704431|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704432|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83704433|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
83704434|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704435|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704436|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83704437|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
83704438|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83704439|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83704440|NCT01772212|Terbinafine|terbinafine|mesh-list
83704441|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
83704442|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704443|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704444|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704445|NCT01772238|Amoxicillin|amoxicillin|mesh-list
83704446|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83704447|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
83704448|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
83704449|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704450|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704451|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83704452|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704453|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704454|NCT01772251|Insulin|insulin|mesh-list
83704455|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83704456|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704457|NCT01772290|Itraconazole|itraconazole|mesh-list
83704458|NCT01772290|Fluconazole|fluconazole|mesh-list
83704459|NCT01772290|Rabeprazole|rabeprazole|mesh-list
83704460|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
83704461|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704462|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83704463|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83704464|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704465|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704466|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83704467|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
83704468|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704469|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704470|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83704471|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83704472|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704473|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83704474|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83704475|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83704476|NCT01772381|Dexamethasone|dexamethasone|mesh-list
83704477|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704478|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
83704479|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
83704480|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704481|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704482|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704483|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
83704484|NCT01772381|Hormones|hormones|mesh-ancestor
83704485|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704486|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704487|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704488|NCT01772420|Lenalidomide|lenalidomide|mesh-list
83704489|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
83704490|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704491|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83704492|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83704493|NCT01772420|Growth Substances|growth substances|mesh-ancestor
83704494|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
83704495|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704496|NCT01772563|Itraconazole|itraconazole|mesh-list
83704497|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
83704498|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704499|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83704500|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83704501|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704502|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704503|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83704504|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
83704505|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704506|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704507|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83704508|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
83704509|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
83704510|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
83704511|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
83704512|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704513|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704514|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83704515|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83704516|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704517|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704518|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704519|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83704520|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82859458|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859459|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859460|NCT04478721|Meropenem|meropenem|mesh-list
82859461|NCT04478721|Temocillin|temocillin|mesh-list
82859462|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82859463|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859464|NCT04462328|Durvalumab|durvalumab|mesh-list
82859465|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
82859466|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859467|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859468|NCT04458909|Cisplatin|cisplatin|mesh-list
82859469|NCT04458909|Carboplatin|carboplatin|mesh-list
82859470|NCT04458909|Gemcitabine|gemcitabine|mesh-list
83704521|NCT01772641|Varenicline|varenicline|mesh-list
83704522|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83704523|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83704524|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
83704525|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704526|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704527|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704528|NCT01772797|Ceritinib|ceritinib|mesh-list
83704529|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704530|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83704531|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704532|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704533|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83704534|NCT01772836|Biapenem|biapenem|mesh-list
83704535|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704536|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704537|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704538|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704539|NCT01772940|Ritonavir|ritonavir|mesh-list
83704540|NCT01772940|Lopinavir|lopinavir|mesh-list
83704541|NCT01772940|Tenofovir|tenofovir|mesh-list
83704542|NCT01772940|Lamivudine|lamivudine|mesh-list
83704543|NCT01772940|Emtricitabine|emtricitabine|mesh-list
83704544|NCT01772940|Zidovudine|zidovudine|mesh-list
83704545|NCT01772940|Nevirapine|nevirapine|mesh-list
83704546|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83704547|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83704548|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
83704549|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704550|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704551|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83704552|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83704553|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
83704554|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704555|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83704556|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83704557|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83704558|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83704559|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
83704560|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83704561|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83704562|NCT01772953|Treosulfan|treosulfan|mesh-list
83704563|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83704564|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
83704565|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704566|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704567|NCT01772979|Trabectedin|trabectedin|mesh-list
83704568|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83704569|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
83704570|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704571|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704572|NCT01773005|Acetaminophen|acetaminophen|mesh-list
83704573|NCT01773005|Ibuprofen|ibuprofen|mesh-list
83704574|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83704575|NCT01773005|Analgesics|analgesics|mesh-ancestor
83704576|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
83704577|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704578|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704579|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
83704580|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83704581|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704582|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704583|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83704584|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704585|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704586|NCT01773044|Lidocaine|lidocaine|mesh-list
83704587|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
83704588|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
83704589|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704590|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704591|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
83704592|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704593|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83704594|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82859524|NCT04205968|Antibodies|antibodies|mesh-list
83704595|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83704596|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704597|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704598|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
83704599|NCT01773096|Bisacodyl|bisacodyl|mesh-list
83704600|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83704601|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83704602|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83704603|NCT01773096|Cathartics|cathartics|mesh-ancestor
83704604|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704605|NCT01773096|Laxatives|laxatives|mesh-ancestor
83704606|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83704607|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704608|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
83704609|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704610|NCT01773096|Antacids|antacids|mesh-ancestor
83704611|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704612|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
83704613|NCT01773174|Dabigatran|dabigatran|mesh-list
83704614|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
83704615|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83704616|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
83704617|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704618|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704619|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
83704620|NCT01773408|Cytarabine|cytarabine|mesh-list
83704621|NCT01773408|Daunorubicin|daunorubicin|mesh-list
83704622|NCT01773408|Idarubicin|idarubicin|mesh-list
83704623|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83704624|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
83704625|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704626|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704627|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
83704628|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704629|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704630|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
83704631|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704632|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83704633|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83704634|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83704635|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704636|NCT01773460|Everolimus|everolimus|mesh-list
83704637|NCT01773460|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83704638|NCT01773460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83704639|NCT01773460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704640|NCT01773460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704641|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704642|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
83704643|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704644|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704645|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83704646|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83704647|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83704648|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
83704649|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704650|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83704651|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83704652|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704653|NCT01773538|Rifaximin|rifaximin|mesh-list
83704654|NCT01773538|Lactulose|lactulose|mesh-list
83704655|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704656|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704657|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704658|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
83704659|NCT01773616|Prednisolone|prednisolone|mesh-list
83704660|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83704661|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
83704662|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83704663|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
83704664|NCT01773616|Rituximab|rituximab|mesh-list
83704665|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83704666|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
83704667|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83704668|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704669|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
83704670|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704671|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704672|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83704673|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83704674|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
83704675|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704676|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704677|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704678|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704679|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704680|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
83704681|NCT01773616|Hormones|hormones|mesh-ancestor
83704682|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704683|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704684|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
83704685|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
83704686|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704687|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704688|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83704689|NCT01773616|Protective Agents|protective agents|mesh-ancestor
83704690|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
83704691|NCT01773681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83704692|NCT01773681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704693|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704694|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
83704695|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704696|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704697|NCT01773772|Progesterone|progesterone|mesh-list
83704698|NCT01773772|Progestins|progestins|mesh-ancestor
83704699|NCT01773772|Hormones|hormones|mesh-ancestor
83704700|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704701|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704702|NCT01773798|Insulin|insulin|mesh-list
83704703|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83704704|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
83704705|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
83704706|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83704707|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83704708|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704709|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83704710|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704711|NCT01773837|Methylphenidate|methylphenidate|mesh-list
83704712|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83704713|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704714|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83704715|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83704716|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704717|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704718|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
83704719|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704720|NCT01773876|Micafungin|micafungin|mesh-list
83704721|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
83704722|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704723|NCT01774370|Dabigatran|dabigatran|mesh-list
83704724|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
83704725|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83704726|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
83704727|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859677|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82859678|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859679|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859680|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82859681|NCT03859024|Narcotics|narcotics|mesh-ancestor
82859682|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82859683|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
82859684|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82859685|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82859686|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82859687|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82859688|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82859689|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859690|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
82859691|NCT03841305|Liver Extracts|liver extracts|mesh-list
82859692|NCT03841305|Hematinics|hematinics|mesh-ancestor
82859712|NCT03801902|Durvalumab|durvalumab|mesh-list
82859713|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
82859714|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83704728|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704729|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
83704730|NCT01774396|Lidocaine|lidocaine|mesh-list
83704731|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
83704732|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
83704733|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704734|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704735|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
83704736|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704737|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83704738|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83704739|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83704740|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704741|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704742|NCT01774474|Dexamethasone|dexamethasone|mesh-list
83704743|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
83704744|NCT01774474|Triamcinolone|triamcinolone|mesh-list
83704745|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83704746|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83704747|NCT01774474|Bromfenac|bromfenac|mesh-list
83704748|NCT01774474|Bevacizumab|bevacizumab|mesh-list
83704749|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83704750|NCT01774474|BB 1101|bb 1101|mesh-list
83704751|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83704752|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83704753|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704754|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83704755|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83704756|NCT01774474|Growth Substances|growth substances|mesh-ancestor
83704757|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704758|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
83704759|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704760|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
83704761|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
83704762|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704763|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704764|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
83704765|NCT01774474|Hormones|hormones|mesh-ancestor
83704766|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704767|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704768|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
83704769|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704770|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704771|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83704772|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704773|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
83704774|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83704775|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83704776|NCT01774474|Analgesics|analgesics|mesh-ancestor
83704777|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
83704778|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704779|NCT01774565|Insulin|insulin|mesh-list
83704780|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83704781|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83704782|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704783|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
83704784|NCT01774812|Vitamin D|vitamin d|mesh-list
83704785|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
83704786|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83704787|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83704788|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704789|NCT01774812|Vitamins|vitamins|mesh-ancestor
83704790|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
83704791|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83704792|NCT01774838|Clopidogrel|clopidogrel|mesh-list
83704793|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83704794|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83704795|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83704796|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83704797|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83704798|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
83704799|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704800|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704801|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704802|NCT01774864|Udenafil|udenafil|mesh-list
83704803|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83704804|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83704805|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704806|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704807|NCT01774877|Leflunomide|leflunomide|mesh-list
83704808|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704809|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704810|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704811|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
83704812|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704813|NCT01775098|Allopurinol|allopurinol|mesh-list
83704814|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
83704815|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704816|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704817|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
83704818|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704819|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83704820|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
83704821|NCT01775098|Protective Agents|protective agents|mesh-ancestor
83704822|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704823|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83704824|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
83704825|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704827|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
83704828|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704829|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704830|NCT01775540|Dexamethasone|dexamethasone|mesh-list
83704831|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
83704832|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704833|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
83704834|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
83704835|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704836|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704837|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83704838|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
83704839|NCT01775540|Hormones|hormones|mesh-ancestor
83704840|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704841|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704842|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704843|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83704844|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83704845|NCT01775579|Metformin|metformin|mesh-list
83704846|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83704847|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83704848|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704849|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83704850|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83704851|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
83704852|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704853|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83704854|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83704855|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704856|NCT01775618|Factor VIII|factor viii|mesh-list
83704857|NCT01775618|Coagulants|coagulants|mesh-ancestor
83704858|NCT01775631|Rituximab|rituximab|mesh-list
83704859|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83704860|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704861|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
83704862|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704863|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704864|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
83704865|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83704866|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83704867|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83704868|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83704869|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704870|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704871|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704872|NCT01775839|Aspirin|aspirin|mesh-list
83704873|NCT01775839|Digoxin|digoxin|mesh-list
83704874|NCT01775839|Clopidogrel|clopidogrel|mesh-list
83704875|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83704876|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82859833|NCT03648892|Raclopride|raclopride|mesh-list
83704877|NCT01775839|Analgesics|analgesics|mesh-ancestor
83704878|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
83704879|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704880|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704881|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83704882|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83704883|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83704884|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83704885|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704886|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83704887|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83704888|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704889|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
83704890|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83704891|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83704892|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83704893|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
83704894|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704895|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83704896|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83704897|NCT01775839|Protective Agents|protective agents|mesh-ancestor
83704898|NCT01775891|Flecainide|flecainide|mesh-list
83704899|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83704900|NCT01775891|Propafenone|propafenone|mesh-list
83704901|NCT01775891|Pilsicainide|pilsicainide|mesh-list
83704902|NCT01775891|Lidocaine|lidocaine|mesh-list
83704903|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83704904|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83704905|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83704906|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704907|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
83704908|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
83704909|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704910|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704911|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
83704912|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704913|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83704914|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83704915|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83704916|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
83704917|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83704918|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83704919|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83704920|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
83704921|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83704922|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704923|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83704924|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83704925|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83792154|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
83704926|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83704927|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704928|NCT01776320|Alprostadil|alprostadil|mesh-list
83704929|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83704930|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
83704931|NCT01776320|Urological Agents|urological agents|mesh-ancestor
83704932|NCT01776437|Talazoparib|talazoparib|mesh-list
83704933|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83704934|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704935|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704936|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704937|NCT01776515|Acetaminophen|acetaminophen|mesh-list
83704938|NCT01776515|Tramadol|tramadol|mesh-list
83704939|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83704940|NCT01776515|Analgesics|analgesics|mesh-ancestor
83704941|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
83704942|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704943|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704944|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
83704945|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83704946|NCT01776515|Narcotics|narcotics|mesh-ancestor
83704947|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704948|NCT01776567|Everolimus|everolimus|mesh-list
83704949|NCT01776567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82859908|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704950|NCT01776567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83704951|NCT01776567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704952|NCT01776567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704953|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83704954|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
83704955|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704956|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704957|NCT01776671|Gabapentin|gabapentin|mesh-list
83704958|NCT01776671|Analgesics|analgesics|mesh-ancestor
83704959|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
83704960|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704961|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704962|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
83704963|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83704964|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83704965|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83704966|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83704967|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83704968|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83704969|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83704970|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704971|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
83704972|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83704973|NCT01776684|Gefitinib|gefitinib|mesh-list
83704974|NCT01776684|Afatinib|afatinib|mesh-list
83704975|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704976|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83704977|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83704978|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83704979|NCT01776788|Insulin|insulin|mesh-list
83704980|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83704981|NCT01776788|Exenatide|exenatide|mesh-list
83704982|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
83704983|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83704984|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704985|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83704986|NCT01776788|Incretins|incretins|mesh-ancestor
83704987|NCT01776788|Hormones|hormones|mesh-ancestor
83704988|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83704989|NCT01776853|Levan|levan|mesh-list
83704990|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83704991|NCT01776970|Nabiximols|nabiximols|mesh-list
83704992|NCT01776970|Analgesics|analgesics|mesh-ancestor
83704993|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
83704994|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83704995|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83704996|NCT01777087|Capsaicin|capsaicin|mesh-list
83704997|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
83704998|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
83704999|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
83705000|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705001|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705002|NCT01777100|Sufentanil|sufentanil|mesh-list
83705003|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83705004|NCT01777100|Narcotics|narcotics|mesh-ancestor
83705005|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705006|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705007|NCT01777100|Analgesics|analgesics|mesh-ancestor
83705008|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
83705009|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705010|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83705011|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83705012|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
83705013|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
83705014|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83705015|NCT01777464|Histamine|histamine|mesh-list
83705016|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
83705017|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
83705018|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705019|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705020|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705021|NCT01777477|Chloroquine|chloroquine|mesh-list
83705022|NCT01777477|Gemcitabine|gemcitabine|mesh-list
83705023|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859984|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
83705024|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
83705025|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705026|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705027|NCT01777477|Amebicides|amebicides|mesh-ancestor
83705028|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83705029|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83705030|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705031|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
83705032|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83705033|NCT01777503|Clopidogrel|clopidogrel|mesh-list
83705034|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83705035|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83705036|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83705037|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83705038|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83705039|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
83705040|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705041|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705042|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705043|NCT01777685|Sulpiride|sulpiride|mesh-list
83705044|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83705045|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83705046|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705047|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705048|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83705049|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83705050|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
83705051|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705052|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705053|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83705054|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
83705055|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83705056|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83705057|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705058|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705059|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
83705060|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83705061|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83705062|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
83705063|NCT01777867|Miotics|miotics|mesh-ancestor
83705064|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
83705065|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705066|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705067|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83705068|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83705069|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
83705070|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83705071|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83705072|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
83705073|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705074|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705075|NCT01777919|Copper|copper|mesh-list
83705076|NCT01777919|Temozolomide|temozolomide|mesh-list
83705077|NCT01777919|Disulfiram|disulfiram|mesh-list
83705078|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83705079|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
83705080|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705081|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705082|NCT01777919|Trace Elements|trace elements|mesh-ancestor
83705083|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
83705084|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705085|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83705086|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83705087|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705088|NCT01778075|Acetaminophen|acetaminophen|mesh-list
83705089|NCT01778075|Tramadol|tramadol|mesh-list
83705090|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83705091|NCT01778075|Analgesics|analgesics|mesh-ancestor
83705092|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
83705093|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705094|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705095|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
83705096|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83705097|NCT01778075|Narcotics|narcotics|mesh-ancestor
83705098|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705099|NCT01778101|Lansoprazole|lansoprazole|mesh-list
83705100|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
83705101|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82860060|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
83705103|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83705104|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705105|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705106|NCT01778114|Vitamin D|vitamin d|mesh-list
83705107|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
83705108|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
83705109|NCT01778114|Vitamins|vitamins|mesh-list
83705110|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
83705111|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705112|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83705113|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83705114|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
83705115|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
83705116|NCT01778192|Citric Acid|citric acid|mesh-list
83705117|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
83705118|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
83705119|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83705120|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
83705121|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
83705122|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705123|NCT01778192|Cathartics|cathartics|mesh-ancestor
83705124|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83705125|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
83705126|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
83705127|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705128|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
83705129|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705130|NCT01778244|Metformin|metformin|mesh-list
83705131|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83705132|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705133|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
83705134|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83705135|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
83705136|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83705137|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
83705138|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705139|NCT01778309|Expectorants|expectorants|mesh-ancestor
83705140|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
83705141|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83705142|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
83705143|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705144|NCT01778309|Protective Agents|protective agents|mesh-ancestor
83705145|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705146|NCT01778309|Antidotes|antidotes|mesh-ancestor
83705147|NCT01778400|Ethanol|ethanol|mesh-list
83705148|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83705149|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705150|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705151|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705152|NCT01778413|Tenofovir|tenofovir|mesh-list
83705153|NCT01778413|Emtricitabine|emtricitabine|mesh-list
83705154|NCT01778413|Efavirenz|efavirenz|mesh-list
83705155|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83705156|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
83705157|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705158|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83705159|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83705160|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705161|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705162|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83705163|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83705164|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83705165|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83705166|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83705167|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83705168|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83705169|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83705170|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83705171|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705172|NCT01778686|Pindolol|pindolol|mesh-list
83705173|NCT01778686|Citalopram|citalopram|mesh-list
83705174|NCT01778686|Tryptophan|tryptophan|mesh-list
83705175|NCT01778686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82860133|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83705176|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83705177|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83705178|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705179|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705181|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705182|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83705183|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
83705184|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83705185|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83705186|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83705187|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
83705188|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83705189|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83705190|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
83705191|NCT01778803|Paclitaxel|paclitaxel|mesh-list
83705192|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83705193|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705194|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
83705195|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
83705196|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
83705197|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705198|NCT01778842|Clopidogrel|clopidogrel|mesh-list
83705199|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83705200|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83705201|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83705202|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83705203|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83705204|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
83705205|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705206|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705207|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705208|NCT01779089|Minocycline|minocycline|mesh-list
83705209|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705210|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705211|NCT01779232|Danazol|danazol|mesh-list
83705212|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83705213|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
83705214|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705215|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705216|NCT01779245|Calcium|calcium|mesh-list
83705217|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83705218|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705219|NCT01779258|Desonide|desonide|mesh-list
83705220|NCT01779258|Glycerol|glycerol|mesh-list
83705221|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83705222|NCT01779258|Protective Agents|protective agents|mesh-ancestor
83705223|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705224|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83705225|NCT01779271|Loxoprofen|loxoprofen|mesh-list
83705226|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83705227|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83705228|NCT01779271|Analgesics|analgesics|mesh-ancestor
83705229|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
83705230|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705231|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705232|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83705233|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83705234|NCT01779284|Timolol|timolol|mesh-list
83705235|NCT01779284|Travoprost|travoprost|mesh-list
83705236|NCT01779284|Latanoprost|latanoprost|mesh-list
83705237|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83705238|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83705239|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
83705240|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705241|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705242|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705243|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83705244|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83705245|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83705246|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83705247|NCT01779362|Metformin|metformin|mesh-list
83705248|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
83705249|NCT01779362|Liraglutide|liraglutide|mesh-list
83705250|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83705251|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705252|NCT01779362|Incretins|incretins|mesh-ancestor
83705253|NCT01779362|Hormones|hormones|mesh-ancestor
83705254|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705255|NCT01779401|Aspirin|aspirin|mesh-list
83705256|NCT01779401|Cilostazol|cilostazol|mesh-list
83705257|NCT01779401|Clopidogrel|clopidogrel|mesh-list
83705258|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83705259|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83705260|NCT01779401|Analgesics|analgesics|mesh-ancestor
83705261|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
83705262|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705263|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705264|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83705265|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83705266|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83705267|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83705268|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705269|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83705270|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83705271|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705272|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
83705273|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83705274|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83705275|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83705276|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
83705277|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705278|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83705279|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
83705280|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83705281|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
83705282|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
83705283|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83705284|NCT01779401|Protective Agents|protective agents|mesh-ancestor
83705285|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83705286|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83705287|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83705288|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
83705289|NCT01779466|Coagulants|coagulants|mesh-ancestor
83705290|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83705291|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
83705292|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705293|NCT01779479|Paclitaxel|paclitaxel|mesh-list
83705294|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83705295|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705296|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
83705297|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
83705298|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
83705299|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705300|NCT01779492|Oxycodone|oxycodone|mesh-list
83705301|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83705302|NCT01779492|Narcotics|narcotics|mesh-ancestor
83705303|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705304|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705305|NCT01779492|Analgesics|analgesics|mesh-ancestor
83705306|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
83705307|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705308|NCT01779518|Interferons|interferons|mesh-list
83705309|NCT01779518|Ribavirin|ribavirin|mesh-list
83705310|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
83705311|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705312|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
83705313|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705314|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
83705315|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705316|NCT01779596|Bosentan|bosentan|mesh-list
83705317|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83705318|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83705319|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705320|NCT01779609|Bosentan|bosentan|mesh-list
83705321|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83705322|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83705323|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705324|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
83705325|NCT01779687|Atorvastatin|atorvastatin|mesh-list
83705326|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83705327|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83705328|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
83705329|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705330|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83705331|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83705332|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705333|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83705334|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83705335|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
83705336|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705337|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83705338|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83705339|NCT01779830|Zolpidem|zolpidem|mesh-list
83705340|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83705341|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83705342|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705343|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705344|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83705345|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
83705346|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
83705347|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705348|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705349|NCT01779843|Cytarabine|cytarabine|mesh-list
83705350|NCT01779843|Idarubicin|idarubicin|mesh-list
83705351|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83705352|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
83705353|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705354|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705355|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
83705356|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705357|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83705358|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
83705359|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705360|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83705361|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83705362|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83705363|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705364|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
83705365|NCT01779882|Busulfan|busulfan|mesh-list
83705366|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83705367|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
83705368|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705369|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83705370|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83705371|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
83705372|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705373|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705374|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83705375|NCT01779908|Vitamin D|vitamin d|mesh-list
83705376|NCT01779908|Vitamins|vitamins|mesh-ancestor
83705377|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
83705378|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705379|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83705380|NCT01779921|Thrombin|thrombin|mesh-list
83705381|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
83705382|NCT01779921|Coagulants|coagulants|mesh-ancestor
83705383|NCT01780051|Metformin|metformin|mesh-list
83705384|NCT01780051|Repaglinide|repaglinide|mesh-list
83705385|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83705386|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705387|NCT01780181|Gemcitabine|gemcitabine|mesh-list
83705388|NCT01780181|Docetaxel|docetaxel|mesh-list
83705389|NCT01780181|Vinorelbine|vinorelbine|mesh-list
83705390|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83705391|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
83705392|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705393|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705394|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83705395|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83705396|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83705397|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860356|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860358|NCT00077376|Carboplatin|carboplatin|mesh-list
83705398|NCT01780233|Fentanyl|fentanyl|mesh-list
83705399|NCT01780233|Naltrexone|naltrexone|mesh-list
83705400|NCT01780233|Citric Acid|citric acid|mesh-list
83705401|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
83705402|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83705403|NCT01780233|Narcotics|narcotics|mesh-ancestor
83705404|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705405|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705406|NCT01780233|Analgesics|analgesics|mesh-ancestor
83705407|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
83705408|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705409|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83705410|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83705411|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
83705412|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
83705413|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
83705414|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83705415|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
83705416|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
83705417|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705418|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83705419|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83705420|NCT01780259|Triazolam|triazolam|mesh-list
83705421|NCT01780259|Esketamine|esketamine|mesh-list
83705422|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
83705423|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83705424|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83705425|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83705426|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83705427|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705428|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705429|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
83705430|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
83705431|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705432|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705433|NCT01780311|Sotalol|sotalol|mesh-list
83705434|NCT01780311|Flecainide|flecainide|mesh-list
83705435|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83705436|NCT01780311|Propafenone|propafenone|mesh-list
83705437|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83705438|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83705439|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
83705440|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705441|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705442|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705443|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
83705444|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
83705445|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705446|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83705447|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83705448|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83705449|NCT01780467|Dopamine|dopamine|mesh-list
83705450|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83705451|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
83705452|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
83705453|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705454|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705455|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
83705456|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705457|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705458|NCT01780467|Protective Agents|protective agents|mesh-ancestor
83705459|NCT01780519|Lorazepam|lorazepam|mesh-list
83705460|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
83705461|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
83705462|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
83705463|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705464|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705465|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83705466|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83705467|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705468|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83705469|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83705470|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83705471|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
83705472|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
83705473|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705474|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705475|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83705476|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83705477|NCT01780558|Hormones|hormones|mesh-list
83705478|NCT01780558|Estradiol|estradiol|mesh-list
83705479|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83705480|NCT01780558|Progesterone|progesterone|mesh-list
83705481|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705482|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705483|NCT01780558|Estrogens|estrogens|mesh-ancestor
83705484|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83705485|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
83705486|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83705487|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83705488|NCT01780558|Progestins|progestins|mesh-ancestor
83705489|NCT01780610|Letrozole|letrozole|mesh-list
83705490|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83705491|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83705492|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83705493|NCT01780610|Hormones|hormones|mesh-list
83705494|NCT01780610|Estradiol|estradiol|mesh-list
83705495|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83705496|NCT01780610|Progesterone|progesterone|mesh-list
83705497|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705498|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705499|NCT01780610|Estrogens|estrogens|mesh-ancestor
83705500|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83705501|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
83705502|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83705503|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83705504|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705505|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83705506|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83705507|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705508|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705509|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83705510|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
83705511|NCT01780610|Progestins|progestins|mesh-ancestor
83705512|NCT01780740|Atorvastatin|atorvastatin|mesh-list
83705513|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83705514|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83705515|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
83705516|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705517|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83705518|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83705519|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705520|NCT01780753|Primaquine|primaquine|mesh-list
83705521|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
83705522|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83705523|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83705524|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705525|NCT01780909|Paromomycin|paromomycin|mesh-list
83705526|NCT01780909|Domperidone|domperidone|mesh-list
83705527|NCT01780909|Loperamide|loperamide|mesh-list
83705528|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
83705529|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83705530|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
83705531|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
83705532|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705533|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705534|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83705535|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
83705536|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705537|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705538|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705539|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705540|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83705541|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83705542|NCT01780948|Everolimus|everolimus|mesh-list
83705543|NCT01780948|Atorvastatin|atorvastatin|mesh-list
83705544|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83705545|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83705546|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
83705547|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705548|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83705549|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83705550|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860505|NCT03404518|Analgesics|analgesics|mesh-ancestor
82860506|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
83705551|NCT01780948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83705552|NCT01780948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83705553|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83705554|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
83705555|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705556|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705558|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83705559|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
83705560|NCT01781273|Ethanol|ethanol|mesh-list
83705561|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83705562|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705563|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705564|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705565|NCT01781377|Metoclopramide|metoclopramide|mesh-list
83705566|NCT01781377|Propofol|propofol|mesh-list
83705567|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83705568|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705569|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705570|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83705571|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
83705572|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
83705573|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
83705574|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
83705575|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705576|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83705577|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83705578|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83705579|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
83705580|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705581|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705582|NCT01781442|Sirolimus|sirolimus|mesh-list
83705583|NCT01781442|Temsirolimus|temsirolimus|mesh-list
83705584|NCT01781442|MTOR Inhibitors|mtor inhibitors|mesh-list
83705585|NCT01781442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83705586|NCT01781442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705587|NCT01781442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705588|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83705589|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
83705590|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705591|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705592|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705593|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705594|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83705595|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
83705596|NCT01781507|Cetirizine|cetirizine|mesh-list
83705597|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83705598|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83705599|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83705600|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
83705601|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
83705602|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705603|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705604|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705605|NCT01781663|Petrolatum|petrolatum|mesh-list
83705606|NCT01781663|Emollients|emollients|mesh-ancestor
83705607|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
83705608|NCT01781702|Celecoxib|celecoxib|mesh-list
83705609|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83705610|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83705611|NCT01781702|Analgesics|analgesics|mesh-ancestor
83705612|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
83705613|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705614|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705615|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83705616|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83705617|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83705618|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83705619|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705620|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705621|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83705622|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
83705623|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860582|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82860583|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82860584|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82860585|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83705624|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
83705625|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
83705626|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705627|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705628|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705629|NCT01781897|Mosapride|mosapride|mesh-list
83705630|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83705631|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83705632|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
83705633|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705634|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705635|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705636|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83705637|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83705638|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
83705639|NCT01781936|Hormones|hormones|mesh-ancestor
83705640|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705641|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705642|NCT01781988|Carboplatin|carboplatin|mesh-list
83705643|NCT01781988|Gemcitabine|gemcitabine|mesh-list
83705644|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705645|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83705646|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
83705647|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705648|NCT01782001|Vitamins|vitamins|mesh-list
83705649|NCT01782001|Vitamin A|vitamin a|mesh-list
83705650|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
83705651|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
83705652|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705653|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
83705654|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705655|NCT01782001|Protective Agents|protective agents|mesh-ancestor
83705656|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83705657|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705658|NCT01782261|Liraglutide|liraglutide|mesh-list
83705659|NCT01782261|Saxagliptin|saxagliptin|mesh-list
83705660|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83705661|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705662|NCT01782261|Incretins|incretins|mesh-ancestor
83705663|NCT01782261|Hormones|hormones|mesh-ancestor
83705664|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705665|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83705666|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
83705667|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705668|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705669|NCT01782274|Vaccines|vaccines|mesh-list
83705670|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
83705671|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705672|NCT01782287|Vaccines|vaccines|mesh-list
83705673|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
83705674|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705675|NCT01782300|Vaccines|vaccines|mesh-list
83705676|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
83705677|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705678|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
83705679|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83705680|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705681|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
83705682|NCT01782508|Interferons|interferons|mesh-list
83705683|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
83705684|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705685|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
83705686|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705687|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83705688|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705689|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705690|NCT01782560|Omeprazole|omeprazole|mesh-list
83705691|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83705692|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83705693|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83705694|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705695|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705696|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
83705697|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83705698|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82860652|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705699|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705700|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
83705701|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
83705702|NCT01782599|Nicotine|nicotine|mesh-list
83705703|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83705704|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
83705705|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705706|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705707|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83705708|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83705709|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
83705710|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705711|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705712|NCT01782612|Analgesics|analgesics|mesh-list
83705713|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
83705714|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705715|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705716|NCT01782651|Capecitabine|capecitabine|mesh-list
83705717|NCT01782651|Lapatinib|lapatinib|mesh-list
83705718|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83705719|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
83705720|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705721|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705722|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83705723|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705724|NCT01782781|Epinephrine|epinephrine|mesh-list
83705725|NCT01782781|Ropivacaine|ropivacaine|mesh-list
83705726|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
83705727|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
83705728|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705729|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705730|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
83705731|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705732|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83705733|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83705734|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
83705735|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705736|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705737|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83705738|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83705739|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
83705740|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83705741|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
83705742|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
83705743|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
83705744|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83705745|NCT01782846|Codeine|codeine|mesh-list
83705746|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83705747|NCT01782846|Narcotics|narcotics|mesh-ancestor
83705748|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83705749|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705750|NCT01782846|Analgesics|analgesics|mesh-ancestor
83705751|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
83705752|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705753|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
83705754|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
83705755|NCT01782911|Resveratrol|resveratrol|mesh-list
83705756|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
83705757|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705758|NCT01782911|Protective Agents|protective agents|mesh-ancestor
83705759|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705760|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705761|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83705762|NCT01782924|Brodalumab|brodalumab|mesh-list
83705763|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83705764|NCT01782937|Brodalumab|brodalumab|mesh-list
83705765|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
83705766|NCT01782950|Rifampin|rifampin|mesh-list
83705767|NCT01782950|Isoniazid|isoniazid|mesh-list
83705768|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
83705769|NCT01782950|Ethambutol|ethambutol|mesh-list
83705770|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83705771|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
83705772|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705773|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705774|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
82860730|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
83705775|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83705776|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705777|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705778|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83705779|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83705780|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83705781|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83705782|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83705783|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83705784|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83705785|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83705787|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83705788|NCT01782976|Bevacizumab|bevacizumab|mesh-list
83705789|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83705790|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705791|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83705792|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83705793|NCT01782976|Growth Substances|growth substances|mesh-ancestor
83705794|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705795|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
83705796|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
83705797|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83705798|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705799|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
83705800|NCT01783106|Doxycycline|doxycycline|mesh-list
83705801|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
83705802|NCT01783106|Budesonide|budesonide|mesh-list
83705803|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83705804|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83705805|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
83705806|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705807|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705808|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83705809|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
83705810|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
83705811|NCT01783106|Hormones|hormones|mesh-ancestor
83705812|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705813|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
83705814|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83705815|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83705816|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705817|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705818|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705819|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83705820|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705821|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83705822|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83705823|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705824|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83705825|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83705826|NCT01783197|Paclitaxel|paclitaxel|mesh-list
83705827|NCT01783197|Carboplatin|carboplatin|mesh-list
83705828|NCT01783197|Pemetrexed|pemetrexed|mesh-list
83705829|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83705830|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705831|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83705832|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83705833|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83705834|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705835|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705836|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83705837|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83705838|NCT01783340|Azithromycin|azithromycin|mesh-list
83705839|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705840|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705841|NCT01783379|Micafungin|micafungin|mesh-list
83705842|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
83705843|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705844|NCT01783431|Poly ICLC|poly iclc|mesh-list
83705845|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
83705846|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
83705847|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705848|NCT01783587|Docetaxel|docetaxel|mesh-list
83705849|NCT01783587|Afatinib|afatinib|mesh-list
82860811|NCT05386706|Metformin|metformin|mesh-list
83705850|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705851|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83705852|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83705853|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83705854|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705855|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83705856|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705857|NCT01783717|Exenatide|exenatide|mesh-list
83705858|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83705859|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705860|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83705861|NCT01783717|Incretins|incretins|mesh-ancestor
83705862|NCT01783717|Hormones|hormones|mesh-ancestor
83705863|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705864|NCT01783756|Capecitabine|capecitabine|mesh-list
83705865|NCT01783756|Everolimus|everolimus|mesh-list
83705866|NCT01783756|Lapatinib|lapatinib|mesh-list
83705867|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83705868|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
83705869|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705870|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705871|NCT01783756|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83705872|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83705873|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705874|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83705875|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
83705876|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705877|NCT01783834|Pemetrexed|pemetrexed|mesh-list
83705878|NCT01783834|Gefitinib|gefitinib|mesh-list
83705879|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705880|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705881|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705882|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83705883|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83705884|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83705885|NCT01783925|Aflibercept|aflibercept|mesh-list
83705886|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83705887|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83705888|NCT01783925|Growth Substances|growth substances|mesh-ancestor
83705889|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705890|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
83705891|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705892|NCT01783951|Cisplatin|cisplatin|mesh-list
83705893|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705894|NCT01783964|Cytarabine|cytarabine|mesh-list
83705895|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83705896|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
83705897|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705898|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705899|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
83705900|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705901|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83705902|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
83705903|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705904|NCT01783977|Vaccines|vaccines|mesh-list
83705905|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
83705906|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705907|NCT01784107|Ifosfamide|ifosfamide|mesh-list
83705908|NCT01784107|Belotecan|belotecan|mesh-list
83705909|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83705910|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
83705911|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705912|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705913|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83705914|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83705915|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705916|NCT01784120|Doxorubicin|doxorubicin|mesh-list
83705917|NCT01784120|genexol-PM|genexol-pm|mesh-list
83705918|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83705919|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83705920|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83705921|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83705922|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705923|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705924|NCT01784120|Tubulin Modulators|tubulin modulators|mesh-ancestor
83705925|NCT01784120|Antimitotic Agents|antimitotic agents|mesh-ancestor
83705926|NCT01784120|Mitosis Modulators|mitosis modulators|mesh-ancestor
83705927|NCT01784250|Propranolol|propranolol|mesh-list
83705928|NCT01784250|Clonidine|clonidine|mesh-list
83705929|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83705930|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83705931|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
83705932|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83705933|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705934|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705935|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83705936|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83705937|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
83705938|NCT01784250|Analgesics|analgesics|mesh-ancestor
83705939|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
83705940|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705941|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
83705942|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
83705943|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83705944|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83705945|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83705946|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
83705947|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83705948|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83705949|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
83705950|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705951|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83705952|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83705953|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83705954|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83705955|NCT01784315|Chloroquine|chloroquine|mesh-list
83705956|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83705957|NCT01784315|Primaquine|primaquine|mesh-list
83705958|NCT01784315|Artemisinins|artemisinins|mesh-list
83705959|NCT01784315|Artemisinin|artemisinin|mesh-list
83705960|NCT01784315|Amebicides|amebicides|mesh-ancestor
83705961|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83705962|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83705963|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705964|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
83705965|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83705966|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83705967|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83705968|NCT01784315|Analgesics|analgesics|mesh-ancestor
83705969|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
83705970|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83705971|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705972|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83705973|NCT01784315|Filaricides|filaricides|mesh-ancestor
83705974|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
83705975|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
83705976|NCT01784380|Metformin|metformin|mesh-list
83705977|NCT01784380|Clomiphene|clomiphene|mesh-list
83705978|NCT01784380|Enclomiphene|enclomiphene|mesh-list
83705979|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
83705980|NCT01784380|Menotropins|menotropins|mesh-list
83705981|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83705982|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83705983|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83705984|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83705985|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
83705986|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83705987|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83705988|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
83705989|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83705990|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83705991|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83705992|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
83705993|NCT01784445|Ceftazidime|ceftazidime|mesh-list
83705994|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705995|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705996|NCT01784536|Oritavancin|oritavancin|mesh-list
83705997|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83705998|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83705999|NCT01784549|Gemcitabine|gemcitabine|mesh-list
83706000|NCT01784549|Docetaxel|docetaxel|mesh-list
83706001|NCT01784549|Pemetrexed|pemetrexed|mesh-list
83706002|NCT01784549|Vinorelbine|vinorelbine|mesh-list
82860951|NCT01105286|Calcipotriene|calcipotriene|mesh-list
83706003|NCT01784549|Gefitinib|gefitinib|mesh-list
83706004|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706005|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83706006|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
83706007|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706008|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
83706009|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
83706010|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83706011|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706012|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83706013|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83706014|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83706015|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83706016|NCT01784562|Riociguat|riociguat|mesh-list
83706017|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
83706018|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706019|NCT01784640|Pemetrexed|pemetrexed|mesh-list
83706020|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706021|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706022|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706023|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83706024|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83706025|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83706026|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706027|NCT01784900|Catumaxomab|catumaxomab|mesh-list
83706028|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83706029|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706030|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
83706031|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706032|NCT01784913|Sargramostim|sargramostim|mesh-list
83706033|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
83706034|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706035|NCT01784978|Everolimus|everolimus|mesh-list
83706036|NCT01784978|Sunitinib|sunitinib|mesh-list
83706037|NCT01784978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83706038|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83706039|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706040|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706041|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83706042|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
83706043|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706044|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706045|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83706046|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83706047|NCT01784978|Growth Substances|growth substances|mesh-ancestor
83706048|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83706049|NCT01785004|Vitamin D|vitamin d|mesh-list
83706050|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
83706051|NCT01785004|Vitamins|vitamins|mesh-ancestor
83706052|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
83706053|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706054|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83706055|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83706056|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
83706057|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83706058|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
83706059|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
83706060|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706061|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706062|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706063|NCT01785030|Analgesics|analgesics|mesh-ancestor
83706064|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
83706065|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706066|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83706067|NCT01785043|Liraglutide|liraglutide|mesh-list
83706068|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706069|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706070|NCT01785043|Incretins|incretins|mesh-ancestor
83706071|NCT01785043|Hormones|hormones|mesh-ancestor
83706072|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706073|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83706074|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
83706075|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706076|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706077|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83706078|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
83706079|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706080|NCT01785108|Vitamin D|vitamin d|mesh-list
83706081|NCT01785108|Ibuprofen|ibuprofen|mesh-list
83706082|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
83706083|NCT01785108|Vitamins|vitamins|mesh-ancestor
83706084|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
83706085|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706086|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83706087|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83706088|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706089|NCT01785108|Analgesics|analgesics|mesh-ancestor
83706090|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
83706091|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706092|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706093|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706094|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83706095|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706096|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706097|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83706098|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
83706099|NCT01785290|Haloperidol|haloperidol|mesh-list
83706100|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
83706101|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
83706102|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
83706103|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706104|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706105|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706106|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83706107|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83706108|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706109|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83706110|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83706111|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
83706112|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706113|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706114|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83706115|NCT01785329|Alirocumab|alirocumab|mesh-list
83706116|NCT01785329|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83706117|NCT01785329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83706118|NCT01785329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83706119|NCT01785329|Antimetabolites|antimetabolites|mesh-ancestor
83706120|NCT01785329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706121|NCT01785329|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83706122|NCT01785329|Protease Inhibitors|protease inhibitors|mesh-ancestor
83706123|NCT01785329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706124|NCT01785329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83706125|NCT01785446|Sufentanil|sufentanil|mesh-list
83706126|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
83706127|NCT01785446|Dsuvia|dsuvia|mesh-list
83706128|NCT01785446|Atracurium|atracurium|mesh-list
83706129|NCT01785446|Cisatracurium|cisatracurium|mesh-list
83706130|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83706131|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706132|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706133|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706134|NCT01785446|Analgesics|analgesics|mesh-ancestor
83706135|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
83706136|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706137|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83706138|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83706139|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83706140|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
83706141|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706142|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706143|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83706144|NCT01785446|Narcotics|narcotics|mesh-ancestor
83706145|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83706146|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83706147|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
83706148|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
83706149|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83706150|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83706151|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82861103|NCT03994172|Hormones|hormones|mesh-list
83706152|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83706153|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83706154|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
83706155|NCT01785589|Adenosine|adenosine|mesh-list
83706156|NCT01785589|Analgesics|analgesics|mesh-ancestor
83706157|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
83706158|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706159|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706160|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83706161|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
83706162|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83706163|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
83706164|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
83706165|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706166|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706167|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83706168|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
83706169|NCT01785641|Gentamicins|gentamicins|mesh-list
83706170|NCT01785641|Cefazolin|cefazolin|mesh-list
83706171|NCT01785641|Ceftazidime|ceftazidime|mesh-list
83706172|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83706173|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706174|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
83706175|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83706176|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83706177|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706178|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706179|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706180|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83706181|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83706182|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83706183|NCT01785693|Clonidine|clonidine|mesh-list
83706184|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
83706185|NCT01785693|Analgesics|analgesics|mesh-ancestor
83706186|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
83706187|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706188|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706189|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83706190|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
83706191|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
83706192|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83706193|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83706194|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83706195|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83706196|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706197|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706198|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
83706199|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
83706200|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706201|NCT01785797|Silicon|silicon|mesh-list
83706202|NCT01785797|Trace Elements|trace elements|mesh-ancestor
83706203|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
83706204|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706205|NCT01785836|Dapsone|dapsone|mesh-list
83706206|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706207|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
83706208|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83706209|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83706210|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83706211|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706212|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706213|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
83706214|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83706215|NCT01785862|Ibuprofen|ibuprofen|mesh-list
83706216|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83706217|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706218|NCT01785862|Analgesics|analgesics|mesh-ancestor
83706219|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
83706220|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706221|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706222|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706223|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706224|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83706225|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706226|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706227|NCT01785979|Chloroquine|chloroquine|mesh-list
83706228|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83706229|NCT01785979|Prednisone|prednisone|mesh-list
83706230|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706231|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
83706233|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706234|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706235|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83706236|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706237|NCT01785979|Amebicides|amebicides|mesh-ancestor
83706238|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83706239|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83706240|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706241|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
83706242|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706243|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83706244|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706245|NCT01785979|Analgesics|analgesics|mesh-ancestor
83706246|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
83706247|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706248|NCT01785979|Filaricides|filaricides|mesh-ancestor
83706249|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
83706250|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
83706251|NCT01786018|Cyclosporine|cyclosporine|mesh-list
83706252|NCT01786018|Methotrexate|methotrexate|mesh-list
83706253|NCT01786018|Busulfan|busulfan|mesh-list
83706254|NCT01786018|Thiotepa|thiotepa|mesh-list
83706255|NCT01786018|Cyclosporins|cyclosporins|mesh-list
83706256|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83706257|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
83706258|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706259|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706260|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83706261|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
83706262|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706263|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706264|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
83706265|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706266|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83706267|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83706268|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
83706269|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706270|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83706271|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
83706272|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706273|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83706274|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
83706275|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83706276|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83706277|NCT01786070|Budesonide|budesonide|mesh-list
83706278|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706279|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83706280|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
83706281|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706282|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706283|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83706284|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
83706285|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
83706286|NCT01786070|Hormones|hormones|mesh-ancestor
83792155|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706287|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706288|NCT01786200|Aspirin|aspirin|mesh-list
83706289|NCT01786200|Ibuprofen|ibuprofen|mesh-list
83706290|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83706291|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706292|NCT01786200|Analgesics|analgesics|mesh-ancestor
83706293|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
83706294|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706295|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706296|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706297|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706298|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83706299|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83706300|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706301|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83706302|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83706303|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706304|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
83706305|NCT01786226|Mifepristone|mifepristone|mesh-list
82861253|NCT03942926|Sirolimus|sirolimus|mesh-list
83706306|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83706307|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
83706308|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706309|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706310|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83706311|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83706312|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83706313|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
83706314|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83706315|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83706316|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
83706317|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706318|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
83706319|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83706320|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83706321|NCT01786382|Midazolam|midazolam|mesh-list
83706322|NCT01786382|Omeprazole|omeprazole|mesh-list
83706323|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83706324|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83706325|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706326|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706327|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83706328|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83706329|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83706330|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83706331|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
83706332|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
83706333|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
83706334|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
83706335|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706336|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706337|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83706338|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706339|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83706340|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706341|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
83706342|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83706343|NCT01786538|Leucovorin|leucovorin|mesh-list
83706344|NCT01786538|Fluorouracil|fluorouracil|mesh-list
83706345|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
83706346|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
83706347|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706348|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83706349|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706350|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83706351|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
83706352|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706353|NCT01786538|Antidotes|antidotes|mesh-ancestor
83706354|NCT01786538|Protective Agents|protective agents|mesh-ancestor
83706355|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
83706356|NCT01786538|Vitamins|vitamins|mesh-ancestor
83706357|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
83706358|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
83706359|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83706360|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
83706361|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706362|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706363|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83706364|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
83706365|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83706366|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83706367|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83706368|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
83706369|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706370|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706371|NCT01786655|Epinephrine|epinephrine|mesh-list
83706372|NCT01786655|Bupivacaine|bupivacaine|mesh-list
83706373|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
83706374|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
83706375|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
83706376|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706377|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706378|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
83706379|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861334|NCT03187262|Daratumumab|daratumumab|mesh-list
83706380|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83706381|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83706382|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83706383|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706384|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706385|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83706386|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83706387|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
83706388|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83706389|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83706391|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
83706392|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83706393|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83706394|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83706395|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83706396|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83706397|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83706398|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83706399|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
83706400|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83706401|NCT01787123|Protective Agents|protective agents|mesh-ancestor
83706402|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706403|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
83706404|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
83706405|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
83706406|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
83706407|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83706408|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83706409|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706410|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706411|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706412|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
83706413|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83706414|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83706415|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83706416|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706417|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706418|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
83706419|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706420|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706421|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83706422|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706423|NCT01787357|Canagliflozin|canagliflozin|mesh-list
83706424|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
83706425|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83706426|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706427|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83706428|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83706429|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706430|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706431|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706432|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706433|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83706434|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706435|NCT01787396|Metformin|metformin|mesh-list
83706436|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706437|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706438|NCT01787474|Cytarabine|cytarabine|mesh-list
83706439|NCT01787474|Fludarabine|fludarabine|mesh-list
83706440|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
83706441|NCT01787474|Lenograstim|lenograstim|mesh-list
83706442|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706443|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83706444|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
83706445|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706446|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83706447|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
83706448|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706449|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
83706450|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706451|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83706452|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
83706453|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83706454|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
83706455|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706456|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
83706457|NCT01787630|Protective Agents|protective agents|mesh-ancestor
83706458|NCT01787669|Dexamethasone|dexamethasone|mesh-list
83706459|NCT01787669|Bevacizumab|bevacizumab|mesh-list
83706460|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83706461|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706462|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83706463|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83706464|NCT01787669|Growth Substances|growth substances|mesh-ancestor
83706465|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706466|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83706467|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706468|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
83706469|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
83706470|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706471|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706472|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
83706473|NCT01787669|Hormones|hormones|mesh-ancestor
83706474|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706475|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83706476|NCT01788007|Imiquimod|imiquimod|mesh-list
83706477|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83706478|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
83706479|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706480|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706481|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
83706482|NCT01788072|Oxytocin|oxytocin|mesh-list
83706483|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
83706484|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706485|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706486|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
83706487|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83706488|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706489|NCT01788189|Lenalidomide|lenalidomide|mesh-list
83706490|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
83706491|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706492|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83706493|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83706494|NCT01788189|Growth Substances|growth substances|mesh-ancestor
83706495|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
83706496|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706497|NCT01788254|Talinolol|talinolol|mesh-list
83706498|NCT01788254|Torsemide|torsemide|mesh-list
83706499|NCT01788254|Midazolam|midazolam|mesh-list
83706500|NCT01788254|Codeine|codeine|mesh-list
83706501|NCT01788254|Pravastatin|pravastatin|mesh-list
83706502|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83706503|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83706504|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706505|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706506|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83706507|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83706508|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83706509|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83706510|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
83706511|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
83706512|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
83706513|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
83706514|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706515|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706516|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83706517|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83706518|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
83706519|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83706520|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83706521|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706522|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83706523|NCT01788254|Narcotics|narcotics|mesh-ancestor
83706524|NCT01788254|Analgesics|analgesics|mesh-ancestor
83706525|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
83706526|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706527|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
83706528|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
83706529|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82861498|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
83706530|NCT01788254|Diuretics|diuretics|mesh-ancestor
83706531|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
83706532|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83706533|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706534|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83706535|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83706536|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
83706537|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83706538|NCT01788280|Bevacizumab|bevacizumab|mesh-list
83706539|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83706540|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706541|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83706542|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83706543|NCT01788280|Growth Substances|growth substances|mesh-ancestor
83706544|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706545|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
83706546|NCT01788332|Olaparib|olaparib|mesh-list
83706547|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83706548|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706549|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706550|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706551|NCT01788371|Lamivudine|lamivudine|mesh-list
83706552|NCT01788371|Telbivudine|telbivudine|mesh-list
83706553|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83706554|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83706555|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706556|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706557|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
83706558|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706559|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83706560|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83706561|NCT01788384|Clindamycin|clindamycin|mesh-list
83706562|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
83706563|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
83706564|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83706565|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83706566|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706567|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83706568|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706569|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706570|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
83706571|NCT01788462|Tesamorelin|tesamorelin|mesh-list
83706572|NCT01788462|Growth Substances|growth substances|mesh-ancestor
83706573|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706574|NCT01788501|Cyclosporine|cyclosporine|mesh-list
83706575|NCT01788501|Methotrexate|methotrexate|mesh-list
83706576|NCT01788501|Tacrolimus|tacrolimus|mesh-list
83706577|NCT01788501|Cyclosporins|cyclosporins|mesh-list
83706578|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83706579|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
83706580|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706581|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706582|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83706583|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
83706584|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706585|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706586|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
83706587|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706588|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83706589|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83706590|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
83706591|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706592|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83706593|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83706594|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
83706595|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706596|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83706597|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83706598|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83706599|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83706600|NCT01788605|Ramosetron|ramosetron|mesh-list
83706601|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
83706602|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
83706603|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706604|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706605|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82861553|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83706607|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
83706608|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706609|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706610|NCT01788670|Ethanol|ethanol|mesh-list
83706611|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83706612|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706613|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706614|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706615|NCT01788722|Dienogest|dienogest|mesh-list
83706616|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83706617|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
83706618|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706619|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706620|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83706621|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83706622|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83706623|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83706624|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
83706625|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706626|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83706627|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706628|NCT01788774|Risperidone|risperidone|mesh-list
83706629|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83706630|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
83706631|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706632|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706633|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706634|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83706635|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83706636|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706637|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83706638|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83706639|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
83706640|NCT01788969|Escitalopram|escitalopram|mesh-list
83706641|NCT01788969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83706642|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83706643|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706644|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706645|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706646|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
83706647|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706648|NCT01788982|Nintedanib|nintedanib|mesh-list
83706649|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706650|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83706651|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706652|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706653|NCT01789086|Liraglutide|liraglutide|mesh-list
83706654|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706655|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706656|NCT01789086|Incretins|incretins|mesh-ancestor
83706657|NCT01789086|Hormones|hormones|mesh-ancestor
83706658|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706659|NCT01789099|Sargramostim|sargramostim|mesh-list
83706660|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
83706661|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706662|NCT01789125|Nicotine|nicotine|mesh-list
83706663|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83706664|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
83706665|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706666|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706667|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83706668|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83706669|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
83706670|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861627|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861628|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861629|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861630|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
82861631|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
82861632|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861633|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706671|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706672|NCT01789216|Ketorolac|ketorolac|mesh-list
83706673|NCT01789216|Meloxicam|meloxicam|mesh-list
83706674|NCT01789216|Pregabalin|pregabalin|mesh-list
83706675|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83706676|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706677|NCT01789216|Analgesics|analgesics|mesh-ancestor
83706678|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
83706679|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706680|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706681|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706682|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706683|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83706684|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706685|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706686|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
83706687|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83706688|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706689|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83706690|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83706691|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83706692|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706693|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83706694|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83706695|NCT01789242|Dexamethasone|dexamethasone|mesh-list
83706696|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706697|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
83706698|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
83706699|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706700|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706701|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706702|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
83706703|NCT01789242|Hormones|hormones|mesh-ancestor
83706704|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706705|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83706706|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706707|NCT01789294|Mesalamine|mesalamine|mesh-list
83706708|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83706709|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706710|NCT01789294|Analgesics|analgesics|mesh-ancestor
83706711|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
83706712|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706713|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706714|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706715|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83706716|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
83706717|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83706718|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706719|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706720|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706721|NCT01789385|Analgesics|analgesics|mesh-ancestor
83706722|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
83706723|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706724|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83706725|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83706726|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83706727|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
83706728|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706729|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706730|NCT01789437|Dexamethasone|dexamethasone|mesh-list
83706731|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706732|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
83706733|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
83706734|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706735|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861694|NCT00076310|Docetaxel|docetaxel|mesh-list
82861695|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82861696|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861697|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
82861698|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
82861699|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
82861700|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861701|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82861703|NCT00345683|Vaccines|vaccines|mesh-list
83706736|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706737|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
83706739|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706740|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83706741|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706742|NCT01789619|Tacrolimus|tacrolimus|mesh-list
83706743|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83706744|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
83706745|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706746|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83706747|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706748|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706749|NCT01789710|Bupropion|bupropion|mesh-list
83706750|NCT01789710|Nicotine|nicotine|mesh-list
83706751|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83706752|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
83706753|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706754|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706755|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83706756|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83706757|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
83706758|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83706759|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706760|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83706761|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
83706762|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83706763|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83706764|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83706765|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706766|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
83706767|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83706768|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83706769|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706770|NCT01789723|Leucovorin|leucovorin|mesh-list
83706771|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
83706772|NCT01789723|Antidotes|antidotes|mesh-ancestor
83706773|NCT01789723|Protective Agents|protective agents|mesh-ancestor
83706774|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706775|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
83706776|NCT01789723|Vitamins|vitamins|mesh-ancestor
83706777|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
83706778|NCT01789827|Interleukin-2|interleukin-2|mesh-list
83706779|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706780|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83706781|NCT01789827|Analgesics|analgesics|mesh-ancestor
83706782|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
83706783|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706784|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706785|NCT01789879|Efavirenz|efavirenz|mesh-list
83706786|NCT01789879|Nevirapine|nevirapine|mesh-list
83706787|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
83706788|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83706789|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83706790|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706791|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706792|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
83706793|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706794|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83706795|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83706796|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83706797|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83706798|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83706799|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83706800|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83706801|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
83706802|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706803|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706804|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83706805|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83706806|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83706807|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83706808|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82861749|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
83706809|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
83706810|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83706811|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83706812|NCT01789892|Prednisolone|prednisolone|mesh-list
83706813|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
83706814|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83706815|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
83706816|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83706817|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83706818|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
83706819|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
83706820|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706821|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706822|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83706823|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
83706824|NCT01789892|Hormones|hormones|mesh-ancestor
83706825|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706826|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83706827|NCT01789892|Protective Agents|protective agents|mesh-ancestor
83706828|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83706829|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83706830|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83706831|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706832|NCT01789957|Exenatide|exenatide|mesh-list
83706833|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706834|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706835|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83706836|NCT01789957|Incretins|incretins|mesh-ancestor
83706837|NCT01789957|Hormones|hormones|mesh-ancestor
83706838|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706839|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83706840|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83706841|NCT01792063|Sevoflurane|sevoflurane|mesh-list
83706842|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83706843|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83706844|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
83706845|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
83706846|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706847|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706848|NCT01792570|Darunavir|darunavir|mesh-list
83706849|NCT01792570|Rilpivirine|rilpivirine|mesh-list
83706850|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83706851|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83706852|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
83706853|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706854|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706855|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83706856|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83706857|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
83706858|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706859|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83706860|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83706861|NCT01792804|Vancomycin|vancomycin|mesh-list
83706862|NCT01792804|Clindamycin|clindamycin|mesh-list
83706863|NCT01792804|Cefazolin|cefazolin|mesh-list
83706864|NCT01792804|Linezolid|linezolid|mesh-list
83706865|NCT01792804|Daptomycin|daptomycin|mesh-list
83706866|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83706867|NCT01792804|Floxacillin|floxacillin|mesh-list
83706868|NCT01792804|Cloxacillin|cloxacillin|mesh-list
83706869|NCT01792804|Trimethoprim|trimethoprim|mesh-list
83706870|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
83706871|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83706872|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83706873|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83706874|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706875|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706876|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83706877|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
83706878|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83706879|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83706880|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82861825|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83706881|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83706882|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83706883|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83706884|NCT01793038|Clomiphene|clomiphene|mesh-list
83706885|NCT01793038|Enclomiphene|enclomiphene|mesh-list
83706886|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
83706887|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83706888|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706889|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83706890|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
83706891|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706892|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706893|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83706894|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
83706895|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706896|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83706897|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83706898|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83706899|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706900|NCT01794182|Glyburide|glyburide|mesh-list
83706901|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706902|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706903|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83706904|NCT01794208|Hormones|hormones|mesh-ancestor
83706905|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706906|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706907|NCT01794247|Lidocaine|lidocaine|mesh-list
83706908|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
83706909|NCT01794247|Fentanyl|fentanyl|mesh-list
83706910|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
83706911|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
83706912|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706913|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706914|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
83706915|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706916|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83706917|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83706918|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83706919|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706920|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706921|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83706922|NCT01794247|Narcotics|narcotics|mesh-ancestor
83706923|NCT01794247|Analgesics|analgesics|mesh-ancestor
83706924|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83706925|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83706926|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
83706927|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
83706928|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83706929|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83706930|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
83706931|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706932|NCT01794429|Exenatide|exenatide|mesh-list
83706933|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706934|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706935|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83706936|NCT01794429|Incretins|incretins|mesh-ancestor
83706937|NCT01794429|Hormones|hormones|mesh-ancestor
83706938|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706939|NCT01795248|Liraglutide|liraglutide|mesh-list
83706940|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83706941|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706942|NCT01795248|Incretins|incretins|mesh-ancestor
83706943|NCT01795248|Hormones|hormones|mesh-ancestor
83706944|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706945|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83706946|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
83706947|NCT01796132|Citalopram|citalopram|mesh-list
83706948|NCT01796132|Fluoxetine|fluoxetine|mesh-list
83706949|NCT01796132|Paroxetine|paroxetine|mesh-list
83706950|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83706951|NCT01796132|Sertraline|sertraline|mesh-list
83706952|NCT01796132|Escitalopram|escitalopram|mesh-list
83706953|NCT01796132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83706954|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83706955|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706956|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706957|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861896|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
82861900|NCT01115504|Thiamine|thiamine|mesh-list
83706958|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
83706959|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706960|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706961|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83706962|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
83706963|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83706964|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83706966|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
83706967|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
83706968|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83706969|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83706970|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83706971|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83706972|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83706973|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83706974|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83706975|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83706976|NCT01796418|Beraprost|beraprost|mesh-list
83706977|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83706978|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
83706979|NCT01796522|Nifedipine|nifedipine|mesh-list
83706980|NCT01796522|Progesterone|progesterone|mesh-list
83706981|NCT01796522|Progestins|progestins|mesh-ancestor
83706982|NCT01796522|Hormones|hormones|mesh-ancestor
83706983|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83706984|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706985|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83706986|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83706987|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83706988|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83706989|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
83706990|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
83706991|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83706992|NCT01796730|Bambuterol|bambuterol|mesh-list
83706993|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83706994|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
83706995|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83706996|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83706997|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83706998|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
83706999|NCT01796808|Lidocaine|lidocaine|mesh-list
83707000|NCT01796808|Epinephrine|epinephrine|mesh-list
83707001|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
83707002|NCT01796808|Anesthetics|anesthetics|mesh-list
83707003|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707004|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707005|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
83707006|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707007|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83707008|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83707009|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83707010|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707011|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707012|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83707013|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83707014|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
83707015|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707016|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83707017|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83707018|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
83707019|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83707020|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707021|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
83707022|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
83707023|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83707024|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
83707025|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83707026|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83707027|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707028|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
83707029|NCT01797289|Coagulants|coagulants|mesh-ancestor
83707030|NCT01797718|Letrozole|letrozole|mesh-list
83707031|NCT01797718|Testosterone|testosterone|mesh-list
83707032|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707033|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83707034|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83707035|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707036|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707037|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83707038|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
83707039|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707040|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707041|NCT01797718|Androgens|androgens|mesh-ancestor
83707042|NCT01797718|Hormones|hormones|mesh-ancestor
83707043|NCT01797796|Capsaicin|capsaicin|mesh-list
83707044|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
83707045|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
83707046|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
83707047|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707048|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707049|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83707050|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707051|NCT01798446|Axitinib|axitinib|mesh-list
83707052|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707053|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707054|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707055|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707056|NCT01798680|Vitamin D|vitamin d|mesh-list
83707057|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
83707058|NCT01798680|Vitamins|vitamins|mesh-ancestor
83707059|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
83707060|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707061|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83707062|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83707063|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83707064|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83707065|NCT01798836|Estradiol|estradiol|mesh-list
83707066|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83707067|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83707068|NCT01798836|Estrogens|estrogens|mesh-ancestor
83707069|NCT01798836|Hormones|hormones|mesh-ancestor
83707070|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707071|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707072|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83707073|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
83707074|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83707075|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83707076|NCT01798901|Decitabine|decitabine|mesh-list
83707077|NCT01798901|Azacitidine|azacitidine|mesh-list
83707078|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83707079|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707080|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
83707081|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707082|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707083|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707084|NCT01799863|Ketorolac|ketorolac|mesh-list
83707085|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83707086|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83707087|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
83707088|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83707089|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83707090|NCT01799863|Analgesics|analgesics|mesh-ancestor
83707091|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
83707092|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707093|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707094|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83707095|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707096|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83707097|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707098|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707099|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83707100|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83707101|NCT01799863|Laxatives|laxatives|mesh-ancestor
83707102|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83707103|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
83707104|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83707105|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
83707106|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83707107|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
83707108|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707109|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707111|NCT01800019|Nicotine|nicotine|mesh-list
83707112|NCT01800019|Varenicline|varenicline|mesh-list
83707113|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83707114|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
83707115|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707116|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707117|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83707118|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83707119|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
83707120|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707121|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707122|NCT01800097|Modafinil|modafinil|mesh-list
83707123|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83707124|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707125|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83707126|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83707127|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83707128|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707129|NCT01800227|Metformin|metformin|mesh-list
83707130|NCT01800227|Pioglitazone|pioglitazone|mesh-list
83707131|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83707132|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707133|NCT01800240|Metformin|metformin|mesh-list
83707134|NCT01800240|Pioglitazone|pioglitazone|mesh-list
83498409|NCT01171118|Physostigmine|physostigmine|mesh-list
83707135|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83707136|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707137|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
83707138|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707139|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
83707140|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83707141|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83707142|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707143|NCT01800292|Urological Agents|urological agents|mesh-ancestor
83707144|NCT01800357|Aspirin|aspirin|mesh-list
83707145|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
83707146|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83707147|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83707148|NCT01800357|Analgesics|analgesics|mesh-ancestor
83707149|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
83707150|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707151|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707152|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83707153|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707154|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83707155|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83707156|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707157|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83707158|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83707159|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707160|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
83707161|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83707162|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
83707163|NCT01800396|Caseins|caseins|mesh-list
83707164|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
83707165|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
83707166|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707167|NCT01800422|Progesterone|progesterone|mesh-list
83707168|NCT01800422|Progestins|progestins|mesh-ancestor
83707169|NCT01800422|Hormones|hormones|mesh-ancestor
83707170|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707171|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707172|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
83707173|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
83707174|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83707175|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83707176|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707177|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
83707178|NCT01800435|Coagulants|coagulants|mesh-ancestor
83707179|NCT01800487|Silymarin|silymarin|mesh-list
83707180|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
82862144|NCT01210742|Hylan|hylan|mesh-list
83707181|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707183|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707184|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
83707185|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83707186|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
83707187|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707188|NCT01800526|Expectorants|expectorants|mesh-ancestor
83707189|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707190|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83707191|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
83707192|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707193|NCT01800526|Protective Agents|protective agents|mesh-ancestor
83707194|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707195|NCT01800526|Antidotes|antidotes|mesh-ancestor
83707196|NCT01800630|Gemcitabine|gemcitabine|mesh-list
83707197|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707198|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
83707199|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707200|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707201|NCT01800643|Busulfan|busulfan|mesh-list
83707202|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
83707203|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707204|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707205|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
83707206|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707207|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83707208|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707209|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83707210|NCT01800695|Temozolomide|temozolomide|mesh-list
83707211|NCT01800695|ABT-414|abt-414|mesh-list
83707212|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83707213|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
83707214|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707215|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707216|NCT01800695|Immunoconjugates|immunoconjugates|mesh-ancestor
83707217|NCT01800695|Immunologic Factors|immunologic factors|mesh-ancestor
83707218|NCT01800695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707219|NCT01800708|Prednisolone|prednisolone|mesh-list
83707220|NCT01800708|Triamcinolone|triamcinolone|mesh-list
83707221|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83707222|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83707223|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83707224|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83707225|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
83707226|NCT01800708|Hormones|hormones|mesh-ancestor
83707227|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707228|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707229|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83707230|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707231|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707232|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
83707233|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707234|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707235|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83707236|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707237|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
83707238|NCT01800799|Celecoxib|celecoxib|mesh-list
83707239|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83707240|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83707241|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83707242|NCT01800799|Analgesics|analgesics|mesh-ancestor
83707243|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
83707244|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707245|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707246|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707247|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83707248|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83707249|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707250|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707251|NCT01800825|Clindamycin|clindamycin|mesh-list
83707252|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
82862195|NCT03828539|Analgesics|analgesics|mesh-ancestor
83707253|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
83707254|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707255|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707256|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83707257|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707258|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707259|NCT01800942|Azithromycin|azithromycin|mesh-list
83707260|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707261|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707262|NCT01801046|Cytarabine|cytarabine|mesh-list
83707263|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
83707264|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707265|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
83707266|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707267|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707268|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
83707269|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707270|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707271|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
83707272|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707273|NCT01801046|Analgesics|analgesics|mesh-ancestor
83707274|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
83707275|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707276|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83707277|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83707278|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707279|NCT01801137|Everolimus|everolimus|mesh-list
83707280|NCT01801137|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83707281|NCT01801137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707282|NCT01801137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707283|NCT01801137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707284|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707285|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
83707286|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707287|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707288|NCT01801163|Sorafenib|sorafenib|mesh-list
83707289|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707290|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707291|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707292|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707293|NCT01801228|Eplerenone|eplerenone|mesh-list
83707294|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83707295|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
83707296|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707297|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707298|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83707299|NCT01801228|Diuretics|diuretics|mesh-ancestor
83707300|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
83707301|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83707302|NCT01801410|Misoprostol|misoprostol|mesh-list
83707303|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83707304|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
83707305|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83707306|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707307|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83707308|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83707309|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
83707310|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
83707311|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707312|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
83707313|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707314|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707315|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83707316|NCT01801644|Cisplatin|cisplatin|mesh-list
83707317|NCT01801644|Gemcitabine|gemcitabine|mesh-list
83707318|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707319|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707320|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
83707321|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707322|NCT01801774|Triamcinolone|triamcinolone|mesh-list
83707323|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83707324|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83707325|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83707326|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83707327|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
82862269|NCT00351611|Analgesics|analgesics|mesh-ancestor
83707329|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707330|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707331|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707332|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
83707333|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707334|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707335|NCT01802255|Midazolam|midazolam|mesh-list
83707336|NCT01802255|Sevoflurane|sevoflurane|mesh-list
83707337|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83707338|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83707339|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707340|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707341|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83707342|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83707343|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83707344|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83707345|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
83707346|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
83707347|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
83707348|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
83707349|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707350|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707351|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83707352|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83707353|NCT01802268|Sirolimus|sirolimus|mesh-list
83707354|NCT01802268|Tacrolimus|tacrolimus|mesh-list
83707355|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707356|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
83707357|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707358|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83707359|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707360|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707361|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707362|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707363|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83707364|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707365|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
83707366|NCT01802450|Dasatinib|dasatinib|mesh-list
83707367|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707368|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707369|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707370|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707371|NCT01802476|Palbociclib|palbociclib|mesh-list
83707372|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707373|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707374|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707375|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707376|NCT01802489|Amiloride|amiloride|mesh-list
83707377|NCT01802489|Diuretics|diuretics|mesh-ancestor
83707378|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
83707379|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707380|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83707381|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83707382|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707383|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707384|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83707385|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83707386|NCT01802502|Rifampin|rifampin|mesh-list
83707387|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83707388|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
83707389|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707390|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707391|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
83707392|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83707393|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707394|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707395|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83707396|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83707397|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82862344|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82862345|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862346|NCT03987893|Laxatives|laxatives|mesh-ancestor
83707398|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83707399|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83707400|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83707401|NCT01802593|Methotrexate|methotrexate|mesh-list
83707402|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
83707403|NCT01802593|Azathioprine|azathioprine|mesh-list
83707404|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83707405|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
83707406|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83707407|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707408|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707409|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
83707410|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707411|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707412|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83707413|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707414|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83707415|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707416|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
83707417|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707418|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83707419|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
83707420|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83707421|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
83707422|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707423|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707424|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83707425|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707426|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83707427|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
83707428|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707429|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707430|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83707431|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
83707432|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
83707433|NCT01802619|Protective Agents|protective agents|mesh-ancestor
83707434|NCT01802645|Leucovorin|leucovorin|mesh-list
83707435|NCT01802645|Folic Acid|folic acid|mesh-list
83707436|NCT01802645|Bevacizumab|bevacizumab|mesh-list
83707437|NCT01802645|Cetuximab|cetuximab|mesh-list
83707438|NCT01802645|Fluorouracil|fluorouracil|mesh-list
83707439|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
83707440|NCT01802645|Irinotecan|irinotecan|mesh-list
83707441|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
83707442|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83707443|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707444|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83707445|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83707446|NCT01802645|Growth Substances|growth substances|mesh-ancestor
83707447|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707448|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
83707449|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
83707450|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707451|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707452|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707453|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
83707454|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83707455|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83707456|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707457|NCT01802645|Antidotes|antidotes|mesh-ancestor
83707458|NCT01802645|Protective Agents|protective agents|mesh-ancestor
83707459|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
83707460|NCT01802645|Vitamins|vitamins|mesh-ancestor
83707461|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
83707462|NCT01802645|Hematinics|hematinics|mesh-ancestor
83707463|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
83707464|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83707465|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707466|NCT01802684|Aflibercept|aflibercept|mesh-list
83707467|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83707468|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83707469|NCT01802684|Growth Substances|growth substances|mesh-ancestor
82862419|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707470|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707471|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83707472|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707473|NCT01802814|Epratuzumab|epratuzumab|mesh-list
83707474|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83707475|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707476|NCT01802892|Plerixafor|plerixafor|mesh-list
83707477|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83707478|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83707479|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
83707480|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707481|NCT01802918|Ritonavir|ritonavir|mesh-list
83707482|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
83707483|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83707484|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83707485|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83707486|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707487|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707488|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83707489|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83707490|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
83707491|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707492|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83707493|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83707494|NCT01802931|Ketoconazole|ketoconazole|mesh-list
83707495|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
83707496|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707497|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83707498|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83707499|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707500|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707501|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83707502|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
83707503|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707504|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707505|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83707506|NCT01802944|Insulin|insulin|mesh-list
83707507|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83707508|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707509|NCT01802970|Paclitaxel|paclitaxel|mesh-list
83707510|NCT01802970|Vinorelbine|vinorelbine|mesh-list
83707511|NCT01802970|Capecitabine|capecitabine|mesh-list
83707512|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83707513|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83707514|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707515|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
83707516|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
83707517|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
83707518|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707519|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707520|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
83707521|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707522|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
83707523|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83707524|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
83707525|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707526|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707527|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83707528|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707529|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83707530|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83707531|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83707532|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
83707533|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707534|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707535|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
83707536|NCT01803191|Fosfomycin|fosfomycin|mesh-list
83707537|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707538|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862491|NCT03368170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862492|NCT03368170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862493|NCT01121744|Sirolimus|sirolimus|mesh-list
82862494|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862495|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862496|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82862497|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862498|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
82862499|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707539|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83707540|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83707541|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707542|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707543|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707544|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83707545|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83707546|NCT01803321|Rilonacept|rilonacept|mesh-list
83707547|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83707548|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83707549|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
83707550|NCT01803347|Coagulants|coagulants|mesh-ancestor
83707551|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
83707552|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707553|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707554|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83707555|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83707556|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707557|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707558|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707559|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83707560|NCT01803503|Docetaxel|docetaxel|mesh-list
83707561|NCT01803503|Sunitinib|sunitinib|mesh-list
83707562|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707563|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
83707564|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
83707565|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
83707566|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707567|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83707568|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83707569|NCT01803503|Growth Substances|growth substances|mesh-ancestor
83707570|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707571|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
83707572|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707573|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707574|NCT01803659|Vitamin A|vitamin a|mesh-list
83707575|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
83707576|NCT01803659|Carotenoids|carotenoids|mesh-list
83707577|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
83707578|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707579|NCT01803659|Protective Agents|protective agents|mesh-ancestor
83707580|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707581|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83707582|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707583|NCT01803659|Vitamins|vitamins|mesh-ancestor
83707584|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
83707585|NCT01803763|Omalizumab|omalizumab|mesh-list
83707586|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83707587|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83707588|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707589|NCT01803828|Tadalafil|tadalafil|mesh-list
83707590|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
83707591|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83707592|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83707593|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707594|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707595|NCT01803828|Urological Agents|urological agents|mesh-ancestor
83707596|NCT01804127|Rituximab|rituximab|mesh-list
83707597|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83707598|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707599|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
83707600|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707601|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707602|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
83707603|NCT01804205|Analgesics|analgesics|mesh-ancestor
83707604|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
83707605|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707606|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707607|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
83707608|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707609|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83707610|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
83707611|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83707612|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707613|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707614|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83707616|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83707617|NCT01804218|Nadolol|nadolol|mesh-list
83707618|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83707619|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83707620|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
83707621|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707622|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707623|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707624|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83707625|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83707626|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
83707627|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
83707628|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707629|NCT01804244|Rilpivirine|rilpivirine|mesh-list
83707630|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83707631|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83707632|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707633|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707634|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
83707635|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707636|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83707637|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83707638|NCT01804335|Trifarotene|trifarotene|mesh-list
83707639|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
83707640|NCT01804361|Cyclosporine|cyclosporine|mesh-list
83707641|NCT01804361|Cyclosporins|cyclosporins|mesh-list
83707642|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707643|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707644|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707645|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
83707646|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707647|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
83707648|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707649|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83707650|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707651|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83707652|NCT01804374|Everolimus|everolimus|mesh-list
83707653|NCT01804374|Sorafenib|sorafenib|mesh-list
83707654|NCT01804374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83707655|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707656|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707657|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707658|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707659|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
83707660|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707661|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707662|NCT01804387|Lamivudine|lamivudine|mesh-list
83707663|NCT01804387|Adefovir|adefovir|mesh-list
83707664|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83707665|NCT01804387|Telbivudine|telbivudine|mesh-list
83707666|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83707667|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83707668|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707669|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707670|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
83707671|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707672|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83707673|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83707674|NCT01804400|Montelukast|montelukast|mesh-list
83707675|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83707676|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707677|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83707678|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
83707679|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707680|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707681|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83707682|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83707683|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707684|NCT01804413|Insulin|insulin|mesh-list
83707685|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83707686|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83707687|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707688|NCT01804543|Ranolazine|ranolazine|mesh-list
83707689|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83707690|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707691|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707692|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
83707693|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83707694|NCT01804595|Protective Agents|protective agents|mesh-ancestor
83707695|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707696|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
83707698|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83707699|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707700|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
83707701|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707702|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707703|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83707704|NCT01804777|Amiloride|amiloride|mesh-list
83707705|NCT01804777|Diuretics|diuretics|mesh-ancestor
83707706|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
83707707|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707708|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83707709|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83707710|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707711|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707712|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83707713|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83707714|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83707715|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83707716|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
83707717|NCT01804985|Dasatinib|dasatinib|mesh-list
83707718|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707719|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707720|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707721|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707722|NCT01805115|Misoprostol|misoprostol|mesh-list
83707723|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83707724|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
83707725|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83707726|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707727|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83707728|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83707729|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
83707730|NCT01805232|Artesunate|artesunate|mesh-list
83707731|NCT01805232|Quinine|quinine|mesh-list
83707732|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
83707733|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83707734|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83707735|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707736|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707737|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
83707738|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
83707739|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83707740|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
83707741|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83707742|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707743|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83707744|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707745|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83707746|NCT01805232|Analgesics|analgesics|mesh-ancestor
83707747|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
83707748|NCT01805258|Efavirenz|efavirenz|mesh-list
83707749|NCT01805258|Nevirapine|nevirapine|mesh-list
83707750|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83707751|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83707752|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707753|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707754|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
83707755|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707756|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83707757|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83707758|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83707759|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83707760|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83707761|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83707762|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82862691|NCT01122368|Micafungin|micafungin|mesh-list
83707763|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83707764|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
83707765|NCT01805310|Cathartics|cathartics|mesh-ancestor
83707766|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83707767|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83707768|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707769|NCT01807741|Asenapine|asenapine|mesh-list
83707770|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83707771|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83707772|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707773|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707774|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83707775|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
83707776|NCT01807767|Everolimus|everolimus|mesh-list
83707777|NCT01807767|Tacrolimus|tacrolimus|mesh-list
83707778|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707779|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
83707780|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707781|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83707782|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707783|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707784|NCT01807767|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83707785|NCT01807767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83707786|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707787|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83707788|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83707789|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
83707790|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707791|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707792|NCT01807832|Capsaicin|capsaicin|mesh-list
83707793|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
83707794|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
83707795|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
83707796|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707797|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707798|NCT01807910|Choline|choline|mesh-list
83707799|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
83707800|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83707801|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
83707802|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707803|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83707804|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83707805|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
83707806|NCT01807962|Lidocaine|lidocaine|mesh-list
83707807|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
83707808|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
83707809|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707810|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707811|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
83707812|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707813|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83707814|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83707815|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83707816|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707817|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707818|NCT01808014|Nefopam|nefopam|mesh-list
83707819|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83707820|NCT01808014|Analgesics|analgesics|mesh-ancestor
83707821|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
83707822|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707823|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707824|NCT01808131|Lesinurad|lesinurad|mesh-list
83707825|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
83707826|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707827|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
83707828|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
83707829|NCT01808300|Pregabalin|pregabalin|mesh-list
83707830|NCT01808300|Analgesics|analgesics|mesh-ancestor
83707831|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
83707832|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707833|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707834|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
83707835|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83707836|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707837|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707838|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83707839|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83707840|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83707841|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707842|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83707844|NCT01808300|Protective Agents|protective agents|mesh-ancestor
83707845|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
83707846|NCT01808300|Vitamins|vitamins|mesh-ancestor
83707847|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
83707848|NCT01808469|Antibodies|antibodies|mesh-list
83707849|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83707850|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
83707851|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707852|NCT01808495|Mitomycins|mitomycins|mesh-list
83707853|NCT01808495|Mitomycin|mitomycin|mesh-list
83707854|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83707855|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707856|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
83707857|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707858|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83707859|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707860|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
83707861|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83707862|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
83707863|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707864|NCT01808521|Expectorants|expectorants|mesh-ancestor
83707865|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707866|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83707867|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
83707868|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707869|NCT01808521|Protective Agents|protective agents|mesh-ancestor
83707870|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707871|NCT01808521|Antidotes|antidotes|mesh-ancestor
83707872|NCT01808586|Dexamethasone|dexamethasone|mesh-list
83707873|NCT01808586|Betamethasone|betamethasone|mesh-list
83707874|NCT01808586|Lidocaine|lidocaine|mesh-list
83707875|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83707876|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
83707877|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
83707878|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707879|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707880|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83707881|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
83707882|NCT01808586|Hormones|hormones|mesh-ancestor
83707883|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707884|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83707885|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707886|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
83707887|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
83707888|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707889|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
83707890|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83707891|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83707892|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83707893|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83707894|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707895|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83707896|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
83707897|NCT01808638|Gemcitabine|gemcitabine|mesh-list
83707898|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707899|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
83707900|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707901|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707902|NCT01808768|Alcaftadine|alcaftadine|mesh-list
83707903|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83707904|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
83707905|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
83707906|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707907|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707908|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707909|NCT01808898|Bupivacaine|bupivacaine|mesh-list
83707910|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
83707911|NCT01808898|Mepivacaine|mepivacaine|mesh-list
83707912|NCT01808898|Anesthetics|anesthetics|mesh-list
83707913|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707914|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707915|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
83707916|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707917|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
83707918|NCT01808911|Rituximab|rituximab|mesh-list
83707919|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83707920|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
83707921|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707922|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83707923|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83707924|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
83707925|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707926|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707927|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83707928|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83707929|NCT01809158|Minocycline|minocycline|mesh-list
83707930|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707931|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707932|NCT01809171|Vitamin D|vitamin d|mesh-list
83707933|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
83707934|NCT01809171|Vitamins|vitamins|mesh-ancestor
83707935|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
83707936|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707937|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83707938|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83707939|NCT01809184|Insulin|insulin|mesh-list
83707940|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83707941|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
83707942|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83707943|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707944|NCT01809301|Niacin|niacin|mesh-list
83707945|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
83707946|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83707947|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
83707948|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707949|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83707950|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
83707951|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
83707952|NCT01809301|Vitamins|vitamins|mesh-ancestor
83707953|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
83707954|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707955|NCT01809340|Minocycline|minocycline|mesh-list
83707956|NCT01809340|Ketamine|ketamine|mesh-list
83707957|NCT01809340|Analgesics|analgesics|mesh-ancestor
83707958|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
83707959|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83707960|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707961|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83707962|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83707963|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
83707964|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
83707965|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707966|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83707967|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83707968|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83707969|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707970|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707971|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707972|NCT01809392|Decitabine|decitabine|mesh-list
83707973|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83707974|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
83707975|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83707976|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83707977|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83707978|NCT01809444|Doxycycline|doxycycline|mesh-list
83707979|NCT01809444|Prednisone|prednisone|mesh-list
83707980|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83707981|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
83707982|NCT01809444|Hormones|hormones|mesh-ancestor
83707983|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83707984|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707985|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83707986|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862914|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83707987|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83707988|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83707989|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
83707990|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83707991|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83707992|NCT01809626|Zolpidem|zolpidem|mesh-list
83707993|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83707994|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83707995|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83707996|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83707997|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83707998|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
83707999|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
83708000|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708001|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708002|NCT01809743|Adenosine|adenosine|mesh-list
83708003|NCT01809743|Regadenoson|regadenoson|mesh-list
83708004|NCT01809743|Analgesics|analgesics|mesh-ancestor
83708005|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
83708006|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708007|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708008|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83708009|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
83708010|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83708011|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
83708012|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
83708013|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708014|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708015|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83708016|NCT01809847|Ofatumumab|ofatumumab|mesh-list
83708017|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708018|NCT01809860|Sirolimus|sirolimus|mesh-list
83708019|NCT01809860|Isavuconazole|isavuconazole|mesh-list
83708020|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708021|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708022|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83708023|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708024|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
83708025|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708026|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
83708027|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708028|NCT01809886|Neostigmine|neostigmine|mesh-list
83708029|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83708030|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708031|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708032|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
83708033|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708034|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708035|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83708036|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
83708037|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708038|NCT01809925|Psyllium|psyllium|mesh-list
83708039|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
83708040|NCT01809925|Cathartics|cathartics|mesh-ancestor
83708041|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708042|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
83708043|NCT01810185|Naltrexone|naltrexone|mesh-list
83708044|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83708045|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83708046|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708047|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
83708048|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708049|NCT01810237|Dabigatran|dabigatran|mesh-list
83708050|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
83708051|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83708052|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
83708053|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708054|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708055|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
83708056|NCT01810315|Estradiol|estradiol|mesh-list
83708057|NCT01810315|Estrogens|estrogens|mesh-ancestor
83708058|NCT01810315|Hormones|hormones|mesh-ancestor
83708059|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708060|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708061|NCT01810354|Cefazolin|cefazolin|mesh-list
83708062|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862986|NCT05577988|Analgesics|analgesics|mesh-ancestor
83708063|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862998|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
83708064|NCT01810367|Cisplatin|cisplatin|mesh-list
83708065|NCT01810367|Gemcitabine|gemcitabine|mesh-list
83708067|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708068|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
83792156|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708069|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708070|NCT01810393|Trastuzumab|trastuzumab|mesh-list
83708071|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83708072|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708073|NCT01810458|Acetaminophen|acetaminophen|mesh-list
83708074|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83708075|NCT01810458|Lidocaine|lidocaine|mesh-list
83708076|NCT01810458|Fentanyl|fentanyl|mesh-list
83708077|NCT01810458|Midazolam|midazolam|mesh-list
83708078|NCT01810458|Oxycodone|oxycodone|mesh-list
83708079|NCT01810458|Lorazepam|lorazepam|mesh-list
83708080|NCT01810458|Ondansetron|ondansetron|mesh-list
83708081|NCT01810458|Liver Extracts|liver extracts|mesh-list
83708082|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
83708083|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
83708084|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708085|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708086|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
83708087|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708088|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83708089|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83708090|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83708091|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83708092|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708093|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83708094|NCT01810458|Narcotics|narcotics|mesh-ancestor
83708095|NCT01810458|Analgesics|analgesics|mesh-ancestor
83708096|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83708097|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83708098|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
83708099|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83708100|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83708101|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83708102|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83708103|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
83708104|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
83708105|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708106|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83708107|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
83708108|NCT01810458|Hematinics|hematinics|mesh-ancestor
83708109|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
83708110|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
83708111|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708112|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
83708113|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708114|NCT01810458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83708115|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83708116|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
83708117|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
83708118|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83708119|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708120|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708121|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83708122|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708123|NCT01810601|Progesterone|progesterone|mesh-list
83708124|NCT01810601|Progestins|progestins|mesh-ancestor
83708125|NCT01810601|Hormones|hormones|mesh-ancestor
83708126|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708127|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708128|NCT01810640|Liver Extracts|liver extracts|mesh-list
83708129|NCT01810640|Hematinics|hematinics|mesh-ancestor
83708130|NCT01810731|Vaccines|vaccines|mesh-list
83708131|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
83708132|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708133|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83708134|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708135|NCT01810796|Ranolazine|ranolazine|mesh-list
83708136|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83708137|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83708138|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708139|NCT01810809|Hylan|hylan|mesh-list
82863069|NCT01222442|AZD-3199|azd-3199|mesh-list
83708140|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
83708141|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
83708142|NCT01810809|Protective Agents|protective agents|mesh-ancestor
83708143|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708144|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83708145|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
83708146|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
83708147|NCT01810848|Hylan|hylan|mesh-list
83708148|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83708149|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
83708150|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708151|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
83708152|NCT01810848|Protective Agents|protective agents|mesh-ancestor
83708153|NCT01810887|Ritonavir|ritonavir|mesh-list
83708154|NCT01810887|Darunavir|darunavir|mesh-list
83708155|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83708156|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83708157|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
83708158|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708159|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708160|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83708161|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83708162|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
83708163|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708164|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83708165|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83708166|NCT01810926|Cyclosporine|cyclosporine|mesh-list
83708167|NCT01810926|Rituximab|rituximab|mesh-list
83708168|NCT01810926|Methotrexate|methotrexate|mesh-list
83708169|NCT01810926|Fludarabine|fludarabine|mesh-list
83708170|NCT01810926|Thiotepa|thiotepa|mesh-list
83708171|NCT01810926|Treosulfan|treosulfan|mesh-list
83708172|NCT01810926|Antibodies|antibodies|mesh-list
83708173|NCT01810926|Cyclosporins|cyclosporins|mesh-list
83708174|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
83708175|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708176|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83708177|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708178|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708179|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83708180|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
83708181|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83708182|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708183|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
83708184|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708185|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708186|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708187|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83708188|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708189|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83708190|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
83708191|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708192|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83708193|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83708194|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
83708195|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83708196|NCT01811056|Mifepristone|mifepristone|mesh-list
83708197|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83708198|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
83708199|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83708200|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708201|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83708202|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83708203|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83708204|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
83708205|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83708206|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83708207|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
83708208|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708209|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
83708210|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83708211|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83708212|NCT01811160|Melatonin|melatonin|mesh-list
83708213|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
82863133|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82863135|NCT01220102|Analgesics|analgesics|mesh-ancestor
83708214|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708215|NCT01811160|Protective Agents|protective agents|mesh-ancestor
83708216|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708217|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708218|NCT01811251|Dexamethasone|dexamethasone|mesh-list
83708219|NCT01811251|Pregabalin|pregabalin|mesh-list
83708220|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708221|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
83708222|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
83708223|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708224|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708225|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708226|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
83708227|NCT01811251|Hormones|hormones|mesh-ancestor
83708228|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708229|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83708230|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708231|NCT01811251|Analgesics|analgesics|mesh-ancestor
83708232|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
83708233|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
83708234|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83708235|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83708236|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708237|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83708238|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83708239|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83708240|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708241|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83708242|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
83708243|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708244|NCT01811381|Curcumin|curcumin|mesh-list
83708245|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83708246|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83708247|NCT01811381|Analgesics|analgesics|mesh-ancestor
83708248|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
83708249|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708250|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708251|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708252|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708253|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708254|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708255|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708256|NCT01811459|Haloperidol|haloperidol|mesh-list
83708257|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83708258|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
83708259|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
83708260|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83708261|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83708262|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83708263|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708264|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708265|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
83708266|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
83708267|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708268|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708269|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83708270|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
83708271|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708272|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708273|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83708274|NCT01811615|Ethanol|ethanol|mesh-list
83708275|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83708276|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708277|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708278|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708279|NCT01811667|Sirolimus|sirolimus|mesh-list
83708280|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708281|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708282|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83708283|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708284|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
83708285|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708286|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
83708287|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863206|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708288|NCT01811810|Androgens|androgens|mesh-list
83708289|NCT01811810|Hormones|hormones|mesh-ancestor
83708290|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708291|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708292|NCT01811836|Zinc|zinc|mesh-list
83708293|NCT01811836|Trace Elements|trace elements|mesh-ancestor
83708294|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
83708295|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708296|NCT01811849|Insulin|insulin|mesh-list
83708297|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83708298|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
83708299|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83708300|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708301|NCT01812018|Gemcitabine|gemcitabine|mesh-list
83708302|NCT01812018|Docetaxel|docetaxel|mesh-list
83708303|NCT01812018|Endostar protein|endostar protein|mesh-list
83708304|NCT01812018|Endostatins|endostatins|mesh-list
83708305|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708306|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
83708307|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708308|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708309|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83708310|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83708311|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83708312|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83708313|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83708314|NCT01812018|Growth Substances|growth substances|mesh-ancestor
83708315|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708316|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
83708317|NCT01812096|Bortezomib|bortezomib|mesh-list
83708318|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708319|NCT01812122|Glimepiride|glimepiride|mesh-list
83708320|NCT01812122|Vildagliptin|vildagliptin|mesh-list
83708321|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83708322|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83708323|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708324|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708325|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
83708326|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83708327|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
83708328|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708329|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708330|NCT01812135|Vaccines|vaccines|mesh-list
83708331|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
83708332|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708333|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
83708334|NCT01812200|Dabigatran|dabigatran|mesh-list
83708335|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
83708336|NCT01812200|Ticagrelor|ticagrelor|mesh-list
83708337|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83708338|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83708339|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83708340|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83708341|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
83708342|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708343|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708344|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708345|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83708346|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
83708347|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83708348|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
83708349|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708350|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
83708351|NCT01812239|Progesterone|progesterone|mesh-list
83708352|NCT01812239|Progestins|progestins|mesh-list
83708353|NCT01812239|Hormones|hormones|mesh-ancestor
83708354|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708355|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708356|NCT01812330|Clopidogrel|clopidogrel|mesh-list
83708357|NCT01812330|Ticagrelor|ticagrelor|mesh-list
83708358|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83708359|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83708360|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83708361|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83708362|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
83708363|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708364|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708365|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708366|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
83708367|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83708368|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
83708369|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
83708370|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708371|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708372|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83708373|NCT01812356|Analgesics|analgesics|mesh-ancestor
83708374|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
83708375|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708376|NCT01812369|Gemcitabine|gemcitabine|mesh-list
83708377|NCT01812369|Doxorubicin|doxorubicin|mesh-list
83708378|NCT01812369|Vinblastine|vinblastine|mesh-list
83708379|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708380|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
83708381|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708382|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708383|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83708384|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83708385|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83708386|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708387|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83708388|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83708389|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83708390|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83708391|NCT01812382|Retapamulin|retapamulin|mesh-list
83708392|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708393|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708394|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
83708395|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
83708396|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83708397|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83708398|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708399|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708400|NCT01812434|Urological Agents|urological agents|mesh-ancestor
83708401|NCT01812538|Diclofenac|diclofenac|mesh-list
83708402|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83708403|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83708404|NCT01812538|Analgesics|analgesics|mesh-ancestor
83708405|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
83708406|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708407|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708408|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708409|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708410|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83708411|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708412|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708413|NCT01812551|Alendronate|alendronate|mesh-list
83708414|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83708415|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708416|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
83708417|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83708418|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83708419|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
83708420|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708421|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708422|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708423|NCT01812720|Dexamethasone|dexamethasone|mesh-list
83708424|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708425|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
83708426|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
83708427|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708428|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708429|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708430|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
83708431|NCT01812720|Hormones|hormones|mesh-ancestor
83708432|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708433|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83708434|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708435|NCT01812889|TOL-463|tol-463|mesh-list
83708436|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708437|NCT01812928|Diclofenac|diclofenac|mesh-list
83708438|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83708439|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83708440|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863354|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83708442|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
83708443|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708444|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708445|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708446|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83708447|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708448|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708449|NCT01812954|Cyclosporine|cyclosporine|mesh-list
83708450|NCT01812954|Adalimumab|adalimumab|mesh-list
83708451|NCT01812954|Infliximab|infliximab|mesh-list
83708452|NCT01812954|Etanercept|etanercept|mesh-list
83708453|NCT01812954|Methotrexate|methotrexate|mesh-list
83708454|NCT01812954|Ustekinumab|ustekinumab|mesh-list
83708455|NCT01812954|Acitretin|acitretin|mesh-list
83708456|NCT01812954|Cyclosporins|cyclosporins|mesh-list
83708457|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83708458|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
83708459|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83708460|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708461|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708462|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
83708463|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708464|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708465|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708466|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708467|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83708468|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708469|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
83708470|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708471|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83708472|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
83708473|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708474|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83708475|NCT01812954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83708476|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708477|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708478|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83708479|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83708480|NCT01812954|Analgesics|analgesics|mesh-ancestor
83708481|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
83708482|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708483|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
83708484|NCT01812967|Caseins|caseins|mesh-list
83708485|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
83708486|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
83708487|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708488|NCT01813162|Tenofovir|tenofovir|mesh-list
83708489|NCT01813162|Metronidazole|metronidazole|mesh-list
83708490|NCT01813162|Terconazole|terconazole|mesh-list
83708491|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
83708492|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
83708493|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708494|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83708495|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83708496|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708497|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708498|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83708499|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83708500|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708501|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83708502|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83708503|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83708504|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708505|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
83708506|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
83708507|NCT01813201|Testosterone|testosterone|mesh-list
83708508|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
83708509|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
83708510|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83708511|NCT01813201|Androgens|androgens|mesh-ancestor
82863435|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
83708512|NCT01813201|Hormones|hormones|mesh-ancestor
83708513|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708514|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708515|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83708516|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708517|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
83708518|NCT01813240|Minocycline|minocycline|mesh-list
83708519|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708520|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708521|NCT01813253|Irinotecan|irinotecan|mesh-list
83708522|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
83708523|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83708524|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83708525|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708526|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708527|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708528|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83708529|NCT01813318|Acamprosate|acamprosate|mesh-list
83708530|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83708531|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
83708532|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708533|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708534|NCT01813461|Isavuconazole|isavuconazole|mesh-list
83708535|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
83708536|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708537|NCT01813487|Entecavir|entecavir|mesh-list
83708538|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
83708539|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708540|NCT01813513|Simeprevir|simeprevir|mesh-list
83708541|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
83708542|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708543|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
83708544|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708545|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708546|NCT01813552|Ritonavir|ritonavir|mesh-list
83708547|NCT01813552|Omeprazole|omeprazole|mesh-list
83708548|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83708549|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83708550|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
83708551|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708552|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708553|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83708554|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83708555|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
83708556|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708557|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83708558|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83708559|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83708560|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708561|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83708562|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
83708563|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83708564|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
83708565|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708566|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
83708567|NCT01813565|Protective Agents|protective agents|mesh-ancestor
83708568|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83708569|NCT01813591|Hormones|hormones|mesh-ancestor
83708570|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708571|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708572|NCT01813604|Vaccines|vaccines|mesh-list
83708573|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
83708574|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708575|NCT01813617|Prednisone|prednisone|mesh-list
83708576|NCT01813617|Methotrexate|methotrexate|mesh-list
83708577|NCT01813617|Azathioprine|azathioprine|mesh-list
83708578|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83708579|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708580|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
82863498|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863499|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
82863500|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
82863501|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82863502|NCT01328990|Amodiaquine|amodiaquine|mesh-list
82863503|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
83708581|NCT01813617|Hormones|hormones|mesh-ancestor
82863504|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82863505|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83708582|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708583|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863511|NCT01225094|Curcumin|curcumin|mesh-list
83708584|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83708585|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708586|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83708587|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
83708588|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83708589|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708590|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
83708591|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708592|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708593|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708594|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83708595|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
83708596|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708597|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83708598|NCT01813643|Risperidone|risperidone|mesh-list
83708599|NCT01813643|Aripiprazole|aripiprazole|mesh-list
83708600|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83708601|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
83708602|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708603|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708604|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708605|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83708606|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83708607|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708608|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83708609|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83708610|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
83708611|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
83708612|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
83708613|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83708614|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83708615|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83708616|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83708617|NCT01813656|Aripiprazole|aripiprazole|mesh-list
83708618|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
83708619|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83708620|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83708621|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83708622|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708623|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708624|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
83708625|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
83708626|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708627|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708628|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83708629|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83708630|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
83708631|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83708632|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83708633|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83708634|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83708635|NCT01813773|Aflibercept|aflibercept|mesh-list
83708636|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83708637|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83708638|NCT01813773|Growth Substances|growth substances|mesh-ancestor
83708639|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708640|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
83708641|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708642|NCT01813812|Rebamipide|rebamipide|mesh-list
83708643|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83708644|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708645|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
83708646|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708647|NCT01813812|Protective Agents|protective agents|mesh-ancestor
83708648|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708649|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708650|NCT01813955|Papaverine|papaverine|mesh-list
83708651|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83708652|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708653|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708654|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
83708655|NCT01813955|Urological Agents|urological agents|mesh-ancestor
83708656|NCT01813981|Caffeine|caffeine|mesh-list
83708657|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83708658|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708659|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83708660|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708661|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708662|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83708663|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83708664|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
83708665|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708666|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83708667|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83708668|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83708669|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
83708670|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708671|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708672|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83708673|NCT01814059|Sirolimus|sirolimus|mesh-list
83708674|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708675|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708676|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83708677|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708678|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
83708679|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708680|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
83708681|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708682|NCT01814085|Escitalopram|escitalopram|mesh-list
83708683|NCT01814085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83708684|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83708685|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83708686|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708687|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708688|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
83708689|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708690|NCT01814098|Escitalopram|escitalopram|mesh-list
83708691|NCT01814098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83708692|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83708693|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83708694|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708695|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708696|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
83708697|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708698|NCT01814163|Paclitaxel|paclitaxel|mesh-list
83708699|NCT01814163|Bevacizumab|bevacizumab|mesh-list
83708700|NCT01814163|Carboplatin|carboplatin|mesh-list
83708701|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83708702|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708703|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83708704|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83708705|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83708706|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708707|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83708708|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83708709|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83708710|NCT01814163|Growth Substances|growth substances|mesh-ancestor
83708711|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708712|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
83708713|NCT01814189|Promethazine|promethazine|mesh-list
83708714|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
83708715|NCT01814189|Sumatriptan|sumatriptan|mesh-list
83708716|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83708717|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83708718|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83708719|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
83708720|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708721|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708722|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708723|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
83708724|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708725|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83708726|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
83708727|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
83708728|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83708729|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83708730|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82863659|NCT03928340|Metformin|metformin|mesh-list
83708731|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708732|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
83708733|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
83708734|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
83708735|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708736|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
83708737|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
83708738|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708739|NCT01814319|Probenecid|probenecid|mesh-list
83708740|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
83708741|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
83708742|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708743|NCT01814410|Ethanol|ethanol|mesh-list
83708744|NCT01814410|Nicotine|nicotine|mesh-list
83708745|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83708746|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
83708747|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708748|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708749|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83708750|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83708751|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
83708752|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708753|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708754|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83708755|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708756|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83708757|NCT01814423|Chloroquine|chloroquine|mesh-list
83708758|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83708759|NCT01814423|Amebicides|amebicides|mesh-ancestor
83708760|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83708761|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83708762|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708763|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
83708764|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83708765|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83708766|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83708767|NCT01814423|Analgesics|analgesics|mesh-ancestor
83708768|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
83708769|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708770|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708771|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708772|NCT01814423|Filaricides|filaricides|mesh-ancestor
83708773|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
83708774|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
83708775|NCT01814449|Letrozole|letrozole|mesh-list
83708776|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708777|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83708778|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83708779|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708780|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708781|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83708782|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83708783|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708784|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708785|NCT01814475|Vidarabine|vidarabine|mesh-list
83708786|NCT01814475|Fludarabine|fludarabine|mesh-list
83708787|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
83708788|NCT01814475|Busulfan|busulfan|mesh-list
83708789|NCT01814475|Thiotepa|thiotepa|mesh-list
83708790|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708791|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708792|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
83708793|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708794|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708795|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
83708796|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708797|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
83708798|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708799|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
83708800|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82863716|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82863717|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863718|NCT03740438|Analgesics|analgesics|mesh-ancestor
82863719|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
82863720|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863724|NCT01129154|Panitumumab|panitumumab|mesh-list
83708801|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83708802|NCT01814501|Leucovorin|leucovorin|mesh-list
83708803|NCT01814501|Fluorouracil|fluorouracil|mesh-list
83708804|NCT01814501|Irinotecan|irinotecan|mesh-list
83708805|NCT01814501|Panitumumab|panitumumab|mesh-list
83708806|NCT01814501|Calcium|calcium|mesh-list
83708807|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
83708808|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83708809|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708810|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
83708811|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708812|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708813|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708814|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708815|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
83708816|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83708817|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83708818|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708819|NCT01814501|Antidotes|antidotes|mesh-ancestor
83708820|NCT01814501|Protective Agents|protective agents|mesh-ancestor
83708821|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
83708822|NCT01814501|Vitamins|vitamins|mesh-ancestor
83708823|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
83708824|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83708825|NCT01814514|Timolol|timolol|mesh-list
83708826|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83708827|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83708828|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
83708829|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708830|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708831|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708832|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83708833|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83708834|NCT01814618|Budesonide|budesonide|mesh-list
83708835|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708836|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83708837|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
83708838|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708839|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708840|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83708841|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
83708842|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
83708843|NCT01814618|Hormones|hormones|mesh-ancestor
83708844|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708845|NCT01814683|Primaquine|primaquine|mesh-list
83708846|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
83708847|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83708848|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83708849|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708850|NCT01814709|Itraconazole|itraconazole|mesh-list
83708851|NCT01814709|Rifampin|rifampin|mesh-list
83708852|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
83708853|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708854|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83708855|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83708856|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708857|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708858|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83708859|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
83708860|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708861|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708862|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83708863|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83708864|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
83708865|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708866|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
83708867|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83708868|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83708869|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83708870|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83708871|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83708872|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83708873|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82863786|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83708874|NCT01814826|Azacitidine|azacitidine|mesh-list
83708875|NCT01814826|Pevonedistat|pevonedistat|mesh-list
83708876|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708877|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
83792157|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83708878|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708879|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708880|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708881|NCT01814865|Prednisone|prednisone|mesh-list
83708882|NCT01814865|Anastrozole|anastrozole|mesh-list
83708883|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
83708884|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83708885|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83708886|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
83708887|NCT01814865|Hormones|hormones|mesh-ancestor
83708888|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83708889|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708890|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83708891|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708892|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83708893|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708894|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708895|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83708896|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
83708897|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83708898|NCT01814891|Vitamin A|vitamin a|mesh-list
83708899|NCT01814891|Vitamins|vitamins|mesh-ancestor
83708900|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
83708901|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708902|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
83708903|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708904|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
83708905|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83708906|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708907|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
83708908|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
83708909|NCT01815021|Calcium|calcium|mesh-list
83708910|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83708911|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708912|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83708913|NCT01815021|Antacids|antacids|mesh-ancestor
83708914|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708915|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708916|NCT01815047|Vitamin D|vitamin d|mesh-list
83708917|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
83708918|NCT01815047|Vitamins|vitamins|mesh-ancestor
83708919|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
83708920|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708921|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83708922|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83708923|NCT01815073|Vaccines|vaccines|mesh-list
83708924|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
83708925|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708926|NCT01815125|Ondansetron|ondansetron|mesh-list
83708927|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
83708928|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
83708929|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83708930|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708931|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708932|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
83708933|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708934|NCT01815125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83708935|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83708936|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
83708937|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708938|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708939|NCT01815203|Caffeine|caffeine|mesh-list
83708940|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83708941|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708942|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83708943|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708944|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708945|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83708946|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83708947|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
83708948|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83708949|NCT01815255|Tenofovir|tenofovir|mesh-list
82863859|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83708951|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708952|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83708953|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83708954|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708955|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708956|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83708957|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83708958|NCT01815268|Vaccines|vaccines|mesh-list
83708959|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
83708960|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708961|NCT01815294|Doxorubicin|doxorubicin|mesh-list
83708962|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83708963|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83708964|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708965|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83708966|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83708967|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83708968|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708969|NCT01815307|Gemcitabine|gemcitabine|mesh-list
83708970|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83708971|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
83708972|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83708973|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83708974|NCT01815437|Vitamin D|vitamin d|mesh-list
83708975|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
83708976|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
83708977|NCT01815437|Vitamins|vitamins|mesh-list
83708978|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
83708979|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708980|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83708981|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83708982|NCT01815528|Catumaxomab|catumaxomab|mesh-list
83708983|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83708984|NCT01815541|Teicoplanin|teicoplanin|mesh-list
83708985|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83708986|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708987|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
83708988|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83708989|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83708990|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83708991|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
83708992|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83708993|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
83708994|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708995|NCT01815892|Furosemide|furosemide|mesh-list
83708996|NCT01815892|Diuretics|diuretics|mesh-ancestor
83708997|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
83708998|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83708999|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83709000|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709001|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709002|NCT01815944|Ropivacaine|ropivacaine|mesh-list
83709003|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
83709004|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
83709005|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709006|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709007|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
83709008|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709009|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83709010|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709011|NCT01816035|Trastuzumab|trastuzumab|mesh-list
83709012|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83709013|NCT01816035|Maytansine|maytansine|mesh-list
83709014|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
83709015|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83709016|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709017|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709018|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83709019|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83709020|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83709021|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709022|NCT01816035|Immunotoxins|immunotoxins|mesh-ancestor
83709023|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
82863942|NCT01129934|Promethazine|promethazine|mesh-list
83709024|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709025|NCT01816191|Diltiazem|diltiazem|mesh-list
83709026|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709027|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709028|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709029|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709030|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709031|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709032|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709033|NCT01816321|Ganirelix|ganirelix|mesh-list
83709034|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83709035|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709036|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709037|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
83709038|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83709039|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83709040|NCT01816334|Prednisolone|prednisolone|mesh-list
83709041|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
83709042|NCT01816334|Ketoprofen|ketoprofen|mesh-list
83709043|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83709044|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
83709045|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709046|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
83709047|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
83709048|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709049|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709050|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83709051|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
83709052|NCT01816334|Hormones|hormones|mesh-ancestor
83709053|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709054|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83709055|NCT01816334|Protective Agents|protective agents|mesh-ancestor
83709056|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83709057|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709058|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83709059|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83709060|NCT01816334|Analgesics|analgesics|mesh-ancestor
83709061|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
83709062|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83709063|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83709064|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709065|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709066|NCT01816412|Paclitaxel|paclitaxel|mesh-list
83709067|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709068|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709069|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
83709070|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
83709071|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
83709072|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709073|NCT01816490|Silybin|silybin|mesh-list
83709074|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709075|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709076|NCT01816490|Protective Agents|protective agents|mesh-ancestor
83709077|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709078|NCT01816529|Diltiazem|diltiazem|mesh-list
83709079|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709080|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709081|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709082|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709083|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709084|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709085|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709086|NCT01816555|Vitamin D|vitamin d|mesh-list
83709087|NCT01816555|Vitamins|vitamins|mesh-ancestor
83709088|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
83709089|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709090|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83709091|NCT01816581|Morphine|morphine|mesh-list
83709092|NCT01816581|Naloxone|naloxone|mesh-list
83709093|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83709094|NCT01816581|Narcotics|narcotics|mesh-ancestor
83709095|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709096|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709097|NCT01816581|Analgesics|analgesics|mesh-ancestor
82864011|NCT01227200|Tramadol|tramadol|mesh-list
83709098|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
83709099|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709100|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83709101|NCT01816620|Dexamethasone|dexamethasone|mesh-list
83709102|NCT01816620|Lenalidomide|lenalidomide|mesh-list
83709103|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709104|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
83709105|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
83709106|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709107|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709108|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83709109|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
83709110|NCT01816620|Hormones|hormones|mesh-ancestor
83709111|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709112|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83709113|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709114|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
83709115|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83709116|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83709117|NCT01816620|Growth Substances|growth substances|mesh-ancestor
83709118|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
83709119|NCT01816646|Cidofovir|cidofovir|mesh-list
83709120|NCT01816646|Probenecid|probenecid|mesh-list
83709121|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
83709122|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
83709123|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83709124|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
83709125|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709126|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709127|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709128|NCT01816659|Metformin|metformin|mesh-list
83709129|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709130|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709131|NCT01816789|Buserelin|buserelin|mesh-list
83709132|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83709133|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
83709134|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83709135|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709136|NCT01816958|Ketamine|ketamine|mesh-list
83709137|NCT01816958|Analgesics|analgesics|mesh-ancestor
83709138|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
83709139|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709140|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709141|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83709142|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83709143|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
83709144|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
83709145|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709146|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83709147|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83709148|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709149|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709150|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83709151|NCT01816997|Pravastatin|pravastatin|mesh-list
83709152|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83709153|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83709154|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
83709155|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709156|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83709157|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83709158|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709159|NCT01817023|Cisplatin|cisplatin|mesh-list
83709160|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709161|NCT01817036|Vitamin D|vitamin d|mesh-list
83709162|NCT01817036|Vitamins|vitamins|mesh-ancestor
83709163|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
83709164|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709165|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83709166|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
83709167|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83709168|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83709169|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83709170|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709171|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
83709172|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82864093|NCT03927248|Nivolumab|nivolumab|mesh-list
83709173|NCT01817257|Heparin|heparin|mesh-list
83709175|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83709176|NCT01817257|Tinzaparin|tinzaparin|mesh-list
83709177|NCT01817257|Dalteparin|dalteparin|mesh-list
83709178|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
83709179|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83709180|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83709181|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709182|NCT01817283|Triptolide|triptolide|mesh-list
83709183|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83709184|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709185|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83709186|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
83709187|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83709188|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83709189|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
83709190|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83709191|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
83709192|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709193|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709194|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
83709195|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
83709196|NCT01817322|Prednisolone|prednisolone|mesh-list
83709197|NCT01817322|Deflazacort|deflazacort|mesh-list
83709198|NCT01817322|Basiliximab|basiliximab|mesh-list
83709199|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709200|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
83709201|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
83709202|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709203|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709204|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83709205|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
83709206|NCT01817322|Hormones|hormones|mesh-ancestor
83709207|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709208|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83709209|NCT01817322|Protective Agents|protective agents|mesh-ancestor
83709210|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83709211|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709212|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83709213|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83709214|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
83709215|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83709216|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709217|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709218|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709219|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83709220|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
83709221|NCT01817348|Lidocaine|lidocaine|mesh-list
83709222|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
83709223|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
83709224|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709225|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709226|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
83709227|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709228|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83709229|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83709230|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83709231|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709232|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709233|NCT01817400|Aspirin|aspirin|mesh-list
83709234|NCT01817400|Pioglitazone|pioglitazone|mesh-list
83709235|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83709236|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83709237|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83709238|NCT01817400|Analgesics|analgesics|mesh-ancestor
83709239|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
83709240|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709241|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709242|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709243|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83709244|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83709245|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83709246|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864167|NCT03805100|Ranibizumab|ranibizumab|mesh-list
83709247|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83709248|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83709250|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
83709251|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709252|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83709253|NCT01817439|Amiodarone|amiodarone|mesh-list
83709254|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83709255|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709256|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83709257|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709258|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709259|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83709260|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83709261|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83709262|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709263|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83709264|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83709265|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83709266|NCT01817699|Vitamin D|vitamin d|mesh-list
83709267|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
83709268|NCT01817699|Vitamins|vitamins|mesh-ancestor
83709269|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
83709270|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709271|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83709272|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709273|NCT01817803|Metolazone|metolazone|mesh-list
83709274|NCT01817803|Furosemide|furosemide|mesh-list
83709275|NCT01817803|Spironolactone|spironolactone|mesh-list
83709276|NCT01817803|Diuretics|diuretics|mesh-ancestor
83709277|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
83709278|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709279|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83709280|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709281|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709282|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83709283|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
83709284|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709285|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83709286|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709287|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83709288|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83709289|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83709290|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83709291|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709292|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709293|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83709294|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709295|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709296|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
83709297|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709298|NCT01817829|Acetaminophen|acetaminophen|mesh-list
83709299|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83709300|NCT01817829|Analgesics|analgesics|mesh-ancestor
83709301|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
83709302|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709303|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709304|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
83709305|NCT01817868|Factor VIII|factor viii|mesh-list
83709306|NCT01817868|Coagulants|coagulants|mesh-ancestor
83709307|NCT01817894|Eflornithine|eflornithine|mesh-list
83709308|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709309|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83709310|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83709311|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83709312|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709313|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83709314|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709315|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709316|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
83709317|NCT01817972|Azathioprine|azathioprine|mesh-list
83709318|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
82864237|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709319|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709320|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83709321|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709322|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83709324|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709325|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83709326|NCT01817972|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83709327|NCT01817972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709328|NCT01817985|Velpatasvir|velpatasvir|mesh-list
83709329|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
83709330|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709331|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83709332|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
83709333|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709334|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83709335|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83709336|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709337|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709338|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709339|NCT01818648|Exenatide|exenatide|mesh-list
83709340|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709341|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709342|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83709343|NCT01818648|Incretins|incretins|mesh-ancestor
83709344|NCT01818648|Hormones|hormones|mesh-ancestor
83709345|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709346|NCT01818713|Doxorubicin|doxorubicin|mesh-list
83709347|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83709348|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83709349|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709350|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83709351|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83709352|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709353|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709354|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
83709355|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
83709356|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709357|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
83709358|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709359|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709360|NCT01818856|Ritonavir|ritonavir|mesh-list
83709361|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83709362|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83709363|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83709364|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
83709365|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709366|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709367|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83709368|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83709369|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
83709370|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709371|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83709372|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83709373|NCT01818869|Adenosine|adenosine|mesh-list
83709374|NCT01818869|Analgesics|analgesics|mesh-ancestor
83709375|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
83709376|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709377|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709378|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83709379|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709380|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83709381|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
83709382|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
83709383|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709384|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709385|NCT01818908|Prednisone|prednisone|mesh-list
83709386|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
83709387|NCT01818908|Doxorubicin|doxorubicin|mesh-list
83709388|NCT01818908|Etoposide|etoposide|mesh-list
83709389|NCT01818908|Vincristine|vincristine|mesh-list
83709390|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83709391|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
83709392|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709393|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83709394|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83709395|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
83709396|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709397|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709398|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83709399|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83709400|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83709401|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83709402|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709403|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709404|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
83709406|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709407|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83709408|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709409|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
83709410|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
83709411|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
83709412|NCT01818973|Bevacizumab|bevacizumab|mesh-list
83709413|NCT01818973|Capecitabine|capecitabine|mesh-list
83709414|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
83709415|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83709416|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709417|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83709418|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83709419|NCT01818973|Growth Substances|growth substances|mesh-ancestor
83709420|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709421|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
83709422|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83709423|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
83709424|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709425|NCT01819012|Isoflurane|isoflurane|mesh-list
83709426|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83709427|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
83709428|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
83709429|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709430|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709431|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
83709432|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83709433|NCT01819155|Vaccines|vaccines|mesh-list
83709434|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
83709435|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709436|NCT01819220|Amlodipine|amlodipine|mesh-list
83709437|NCT01819220|Valsartan|valsartan|mesh-list
83709438|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83709439|NCT01819220|Telmisartan|telmisartan|mesh-list
83709440|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83709441|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83709442|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709443|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709444|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709445|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709446|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709447|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709448|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709449|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83709450|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83709451|NCT01819220|Diuretics|diuretics|mesh-ancestor
83709452|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
83709453|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83709454|NCT01819259|Nicotine|nicotine|mesh-list
83709455|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83709456|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
83709457|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709458|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709459|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83709460|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83709461|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
83709462|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709463|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864387|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83709464|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83709466|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709467|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709468|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
83709469|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709470|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83709471|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709472|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709473|NCT01819402|Pioglitazone|pioglitazone|mesh-list
83709474|NCT01819402|Glimepiride|glimepiride|mesh-list
83709475|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709476|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709477|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83709478|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83709479|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
83709480|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83709481|NCT01819441|Perindopril|perindopril|mesh-list
83709482|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709483|NCT01819441|Diuretics|diuretics|mesh-ancestor
83709484|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
83709485|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709486|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83709487|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709488|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709489|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83709490|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
83709491|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709492|NCT01819610|Ketorolac|ketorolac|mesh-list
83709493|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83709494|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83709495|NCT01819610|Analgesics|analgesics|mesh-ancestor
83709496|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
83709497|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709498|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709499|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709500|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83709501|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83709502|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709503|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709504|NCT01819649|Selenium|selenium|mesh-list
83709505|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
83709506|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709507|NCT01819649|Protective Agents|protective agents|mesh-ancestor
83709508|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709509|NCT01819649|Trace Elements|trace elements|mesh-ancestor
83709510|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
83709511|NCT01819701|Ubiquinone|ubiquinone|mesh-list
83709512|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
83709513|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
83709514|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709515|NCT01819701|Vitamins|vitamins|mesh-ancestor
83709516|NCT01819779|Amlodipine|amlodipine|mesh-list
83709517|NCT01819779|Valsartan|valsartan|mesh-list
83709518|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83709519|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709520|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709521|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709522|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709523|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709524|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709525|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
82864463|NCT00369941|Efavirenz|efavirenz|mesh-list
82864464|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
82864465|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82864466|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
82864467|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864468|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82864469|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82864470|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864471|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864472|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82864482|NCT01133444|Finasteride|finasteride|mesh-list
83709526|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83709527|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83709528|NCT01819857|Ondansetron|ondansetron|mesh-list
83709529|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
83709530|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
83709531|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709532|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709533|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83709534|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
83709535|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
83709536|NCT01819857|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83709537|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83709538|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
83709539|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709540|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709541|NCT01819870|Carvedilol|carvedilol|mesh-list
83709542|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83709543|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83709544|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83709545|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709546|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709547|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709548|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709549|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
83709550|NCT01819870|Protective Agents|protective agents|mesh-ancestor
83709551|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709552|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709553|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709554|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709555|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83709556|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83709557|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83709558|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83709559|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83709560|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83709561|NCT01820026|Amoxicillin|amoxicillin|mesh-list
83709562|NCT01820026|Azithromycin|azithromycin|mesh-list
83709563|NCT01820026|Vancomycin|vancomycin|mesh-list
83709564|NCT01820026|Imipenem|imipenem|mesh-list
83709565|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83709566|NCT01820026|Cefotaxime|cefotaxime|mesh-list
83709567|NCT01820026|Cefoxitin|cefoxitin|mesh-list
83709568|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83709569|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709570|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83709571|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709572|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709573|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
83709574|NCT01820091|Antidotes|antidotes|mesh-ancestor
83709575|NCT01820091|Protective Agents|protective agents|mesh-ancestor
83709576|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709577|NCT01820104|Lansoprazole|lansoprazole|mesh-list
83709578|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
83709579|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83709580|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83709581|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83709582|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709583|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709584|NCT01820143|Esomeprazole|esomeprazole|mesh-list
83709585|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83709586|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83709587|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83709588|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709589|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709590|NCT01820299|Vitamin D|vitamin d|mesh-list
83709591|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
83709592|NCT01820299|Vitamins|vitamins|mesh-ancestor
83709593|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
83709594|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709595|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83709596|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709597|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709598|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
82864536|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
82864537|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
82864538|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83709599|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709600|NCT01820299|Protective Agents|protective agents|mesh-ancestor
83709602|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709603|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709604|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
83709605|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
83709606|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
83709607|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709608|NCT01820325|Paclitaxel|paclitaxel|mesh-list
83709609|NCT01820325|Carboplatin|carboplatin|mesh-list
83709610|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709611|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709612|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
83709613|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
83709614|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
83709615|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709616|NCT01820442|Lofexidine|lofexidine|mesh-list
83709617|NCT01820442|Clonidine|clonidine|mesh-list
83709618|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709619|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83709620|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709621|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
83709622|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709623|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83709624|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83709625|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83709626|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83709627|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709628|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709629|NCT01820442|Analgesics|analgesics|mesh-ancestor
83709630|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
83709631|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
83709632|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
83709633|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83709634|NCT01820455|Mupirocin|mupirocin|mesh-list
83709635|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83709636|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709637|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
83709638|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
83709639|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83709640|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83709641|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709642|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709643|NCT01820624|Tretinoin|tretinoin|mesh-list
83709644|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
83709645|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
83709646|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83709647|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709648|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709649|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
83709650|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83709651|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709652|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709653|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709654|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
83709655|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
83709656|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
83709657|NCT01820767|Atorvastatin|atorvastatin|mesh-list
83709658|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83709659|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83709660|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
83709661|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709662|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83709663|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83709664|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709665|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709666|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709667|NCT01820767|Vitamins|vitamins|mesh-ancestor
83709668|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
83709669|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83709670|NCT01820793|Cefoxitin|cefoxitin|mesh-list
83709671|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83709672|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864611|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709674|NCT01820832|Calcitriol|calcitriol|mesh-list
83709675|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709676|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709677|NCT01820832|Vitamins|vitamins|mesh-ancestor
83709678|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
83709679|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83709680|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83709681|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709682|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709683|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83709684|NCT01820897|Trimethoprim|trimethoprim|mesh-list
83709685|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83709686|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
83709687|NCT01820897|Fosfomycin|fosfomycin|mesh-list
83709688|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83709689|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709690|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
83709691|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83709692|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83709693|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83709694|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709695|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709696|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83709697|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83709698|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83709699|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83709700|NCT01820962|Heparin|heparin|mesh-list
83709701|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
83709702|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709703|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83709704|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83709705|NCT01821001|Bromocriptine|bromocriptine|mesh-list
83709706|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83709707|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83709708|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
83709709|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709710|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709711|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
83709712|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
83709713|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709714|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709715|NCT01821027|Canagliflozin|canagliflozin|mesh-list
83709716|NCT01821027|Simvastatin|simvastatin|mesh-list
83709717|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83709718|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83709719|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
83709720|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709721|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83709722|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83709723|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709724|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83709725|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709726|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709727|NCT01821040|Prednisone|prednisone|mesh-list
83709728|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83709729|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
83709730|NCT01821040|Hormones|hormones|mesh-ancestor
83709731|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709732|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709733|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83709734|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709735|NCT01821066|Tamoxifen|tamoxifen|mesh-list
83709736|NCT01821066|Palbociclib|palbociclib|mesh-list
83709737|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83709738|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
83709739|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709740|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709741|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83709742|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709743|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83709744|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83709745|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83709746|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83709747|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709748|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709749|NCT01821170|Methylphenidate|methylphenidate|mesh-list
83709750|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83709751|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709752|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83709753|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83709754|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709755|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709756|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
83709757|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709758|NCT01821235|Gabapentin|gabapentin|mesh-list
83709759|NCT01821235|Analgesics|analgesics|mesh-ancestor
83709760|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
83709761|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709762|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709763|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
83709764|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83709765|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83709766|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709767|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83709768|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83709769|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83709770|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709771|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709772|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
83709773|NCT01821248|Cisplatin|cisplatin|mesh-list
83709774|NCT01821248|Gemcitabine|gemcitabine|mesh-list
83709775|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709776|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83709777|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
83709778|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709779|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
83709780|NCT01821261|Fluorides|fluorides|mesh-list
83709781|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
83709782|NCT01821261|Protective Agents|protective agents|mesh-ancestor
83709783|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709784|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83709785|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709786|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
83709787|NCT01821274|Diltiazem|diltiazem|mesh-list
83709788|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83709789|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709790|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709791|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709792|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709793|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709794|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709795|NCT01821404|Atorvastatin|atorvastatin|mesh-list
83709796|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83709797|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83709798|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
83709799|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709800|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83709801|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83709802|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709803|NCT01821430|Pregabalin|pregabalin|mesh-list
83709804|NCT01821430|Analgesics|analgesics|mesh-ancestor
83709805|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
83709806|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709807|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709808|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
83709809|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709810|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709811|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709812|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709813|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83709814|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83709815|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709816|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82864765|NCT01719640|Insulin|insulin|mesh-list
83709817|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
83709818|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
83709819|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
83709820|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83709821|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83709822|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83709823|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709824|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709825|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83709826|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709827|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709828|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83709829|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709830|NCT01821612|Leucovorin|leucovorin|mesh-list
83709831|NCT01821612|Gemcitabine|gemcitabine|mesh-list
83709832|NCT01821612|Fluorouracil|fluorouracil|mesh-list
83709833|NCT01821612|Capecitabine|capecitabine|mesh-list
83709834|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
83709835|NCT01821612|Irinotecan|irinotecan|mesh-list
83709836|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83709837|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
83709838|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709839|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709840|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83709841|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
83709842|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709843|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83709844|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83709845|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709846|NCT01821612|Antidotes|antidotes|mesh-ancestor
83709847|NCT01821612|Protective Agents|protective agents|mesh-ancestor
83709848|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
83709849|NCT01821612|Vitamins|vitamins|mesh-ancestor
83709850|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
83709851|NCT01821664|Heparin|heparin|mesh-list
83709852|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
83709853|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83709854|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83709855|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709856|NCT01821703|Spironolactone|spironolactone|mesh-list
83709857|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83709858|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
83709859|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709860|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709861|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83709862|NCT01821703|Diuretics|diuretics|mesh-ancestor
83709863|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
83709864|NCT01821846|Liraglutide|liraglutide|mesh-list
83709865|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709866|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709867|NCT01821846|Incretins|incretins|mesh-ancestor
83709868|NCT01821846|Hormones|hormones|mesh-ancestor
83709869|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709870|NCT01821872|Acetaminophen|acetaminophen|mesh-list
83709871|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83709872|NCT01821872|Analgesics|analgesics|mesh-ancestor
83709873|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
83709874|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83709875|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709876|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
83709877|NCT01821989|Lactoferrin|lactoferrin|mesh-list
83709878|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709879|NCT01822028|Miglustat|miglustat|mesh-list
83709880|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
83709881|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709882|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709883|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83709884|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83709885|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
83709886|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709887|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83709888|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83709889|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709890|NCT01822080|Dienogest|dienogest|mesh-list
82864836|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83709891|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83709892|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
83709893|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83709894|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709895|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83709896|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83709897|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83709898|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83709899|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83709900|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83709901|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83709902|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709903|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
83709904|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83709905|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709906|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709907|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
83709908|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709909|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709910|NCT01822405|Tocopherols|tocopherols|mesh-list
83709911|NCT01822405|Vitamin E|vitamin e|mesh-list
83709912|NCT01822405|Tocotrienols|tocotrienols|mesh-list
83709913|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
83709914|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
83709915|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83709916|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709917|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709918|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83709919|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83709920|NCT01822405|Protective Agents|protective agents|mesh-ancestor
83709921|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709922|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709923|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83709924|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
83709925|NCT01822405|Vitamins|vitamins|mesh-ancestor
83709926|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
83709927|NCT01822418|Agomelatine|agomelatine|mesh-list
83709928|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83709929|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709930|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709931|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83709932|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709933|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709934|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709935|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83709936|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
83709937|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83709938|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709939|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83709940|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
83709941|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83709942|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83709943|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709944|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709945|NCT01822600|Omeprazole|omeprazole|mesh-list
83709946|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83709947|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83709948|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83709949|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709950|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709951|NCT01822613|Paclitaxel|paclitaxel|mesh-list
83709952|NCT01822613|Docetaxel|docetaxel|mesh-list
83709953|NCT01822613|Irinotecan|irinotecan|mesh-list
83709954|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83709955|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83709956|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
83709957|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
83709958|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
83709959|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709960|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83709961|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83709962|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709963|NCT01822639|Amlodipine|amlodipine|mesh-list
83709964|NCT01822639|Enalapril|enalapril|mesh-list
83709965|NCT01822639|Enalaprilat|enalaprilat|mesh-list
83709966|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82864910|NCT01142492|Interferon-beta|interferon-beta|mesh-list
83709967|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83709968|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83709969|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709970|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83709971|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709972|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
83709973|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83709974|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83709975|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83709976|NCT01822730|Risperidone|risperidone|mesh-list
83709977|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83709978|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83709979|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
83709980|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83709981|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83709982|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709983|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83709984|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83709985|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83709986|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83709987|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83709988|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
83709989|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83709990|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83709991|NCT01822808|Hydralazine|hydralazine|mesh-list
83709992|NCT01822808|Isosorbide|isosorbide|mesh-list
83709993|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83709994|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83709995|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83709996|NCT01822808|Diuretics|diuretics|mesh-ancestor
83709997|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
83709998|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83709999|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
83710000|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83710001|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710002|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710003|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83710004|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
83710005|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710006|NCT01822860|Diuretics|diuretics|mesh-ancestor
83710007|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
83710008|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710009|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83710010|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710011|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710012|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
83710013|NCT01822951|Donepezil|donepezil|mesh-list
83710014|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83710015|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710016|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710017|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
83710018|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710019|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710020|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
83710021|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83710022|NCT01822951|Protective Agents|protective agents|mesh-ancestor
83710023|NCT01822977|Omeprazole|omeprazole|mesh-list
83710024|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83710025|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710026|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83710027|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710028|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710029|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
83710030|NCT01823029|Hematinics|hematinics|mesh-ancestor
83710031|NCT01822509|Nivolumab|nivolumab|mesh-list
83710032|NCT01822509|Ipilimumab|ipilimumab|mesh-list
83710033|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83710034|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710035|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83710036|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710037|NCT01823042|Azathioprine|azathioprine|mesh-list
83710038|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
82864987|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710039|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710040|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83710041|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710042|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83710043|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
83710044|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710045|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83710046|NCT01823081|Bevacizumab|bevacizumab|mesh-list
83710047|NCT01823081|Fasudil|fasudil|mesh-list
83710048|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83710049|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710050|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83710051|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710052|NCT01823081|Growth Substances|growth substances|mesh-ancestor
83710053|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710054|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710055|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83710056|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710057|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710058|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83710059|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
83710060|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83710061|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710062|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83710063|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83710064|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83710065|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
83710066|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710067|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83710068|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83710069|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710070|NCT01823159|Ezogabine|ezogabine|mesh-list
83710071|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
83710072|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710073|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710074|NCT01823172|Methylene Blue|methylene blue|mesh-list
83710075|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710076|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710077|NCT01823185|Clopidogrel|clopidogrel|mesh-list
83710078|NCT01823185|Ticagrelor|ticagrelor|mesh-list
83710079|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83710080|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83710081|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83710082|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83710083|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83710084|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
83710085|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710086|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710087|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710088|NCT01823393|Heparin|heparin|mesh-list
83710089|NCT01823393|Calcium heparin|calcium heparin|mesh-list
83710090|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
83710091|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83710092|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83710093|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710094|NCT01823523|Clindamycin|clindamycin|mesh-list
83710095|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
83710096|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
83710097|NCT01823523|Cefazolin|cefazolin|mesh-list
83710098|NCT01823523|Cephalexin|cephalexin|mesh-list
83710099|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83710100|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710101|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83710102|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710103|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710104|NCT01823744|Micronutrients|micronutrients|mesh-list
83710105|NCT01823744|Trace Elements|trace elements|mesh-list
83710106|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710107|NCT01823770|Rotigotine|rotigotine|mesh-list
83710108|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
83710109|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
83710110|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710111|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865059|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83710112|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710113|NCT01823809|Adenosine|adenosine|mesh-list
83710114|NCT01823809|Analgesics|analgesics|mesh-ancestor
83710115|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
83710116|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710117|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710118|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83710119|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
83710120|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83710121|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
83710122|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
83710123|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710124|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710125|NCT01823848|Mineral Oil|mineral oil|mesh-list
83710126|NCT01823848|Emollients|emollients|mesh-ancestor
83710127|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
83710128|NCT01823965|Ranibizumab|ranibizumab|mesh-list
83710129|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83710130|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710131|NCT01823965|Growth Substances|growth substances|mesh-ancestor
83710132|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710133|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710134|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710135|NCT01824043|Ranibizumab|ranibizumab|mesh-list
83710136|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83710137|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710138|NCT01824043|Growth Substances|growth substances|mesh-ancestor
83710139|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710140|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710141|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710142|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83710143|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83710144|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710145|NCT01824199|Omeprazole|omeprazole|mesh-list
83710146|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83710147|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710148|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83710149|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710150|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710151|NCT01824225|Aflibercept|aflibercept|mesh-list
83710152|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83710153|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710154|NCT01824225|Growth Substances|growth substances|mesh-ancestor
83710155|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710156|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710157|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710158|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
83710159|NCT01824238|Anacetrapib|anacetrapib|mesh-list
83710160|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83710161|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83710162|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
83710163|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710164|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83710165|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710166|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83710167|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710168|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
83710169|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83710170|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
83710171|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83710172|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
83710173|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710174|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83710175|NCT01824264|Licogliflozin|licogliflozin|mesh-list
83710176|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83710177|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710178|NCT01824264|Incretins|incretins|mesh-ancestor
83710179|NCT01824264|Hormones|hormones|mesh-ancestor
83710180|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83710181|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83710182|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
83710183|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710184|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865132|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865134|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
83710185|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83710186|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
83710187|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83710188|NCT01824420|Oxybutynin|oxybutynin|mesh-list
83710189|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83710190|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83710191|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
83710192|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710193|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710194|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710195|NCT01824420|Urological Agents|urological agents|mesh-ancestor
83710196|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
83710197|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
83710198|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710199|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83710200|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710201|NCT01824433|Fluoxetine|fluoxetine|mesh-list
83710202|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83710203|NCT01824433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83710204|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83710205|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710206|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710207|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710208|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
83710209|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710210|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83710211|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
83710212|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83710213|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83710214|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83710215|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710216|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83710217|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
83710218|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710219|NCT01824524|Hydromorphone|hydromorphone|mesh-list
83710220|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83710221|NCT01824524|Narcotics|narcotics|mesh-ancestor
83710222|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710223|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710224|NCT01824524|Analgesics|analgesics|mesh-ancestor
83710225|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
83710226|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710227|NCT01824615|Sunitinib|sunitinib|mesh-list
83710228|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710229|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83710230|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710231|NCT01824615|Growth Substances|growth substances|mesh-ancestor
83710232|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710233|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710234|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83710235|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710236|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710237|NCT01824758|Lidocaine|lidocaine|mesh-list
83710238|NCT01824758|Rocuronium|rocuronium|mesh-list
83710239|NCT01824758|Esmolol|esmolol|mesh-list
83710240|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
83710241|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
83710242|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710243|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710244|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
83710245|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710246|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83710247|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83710248|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83710249|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710250|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710251|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83710252|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82865204|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865205|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82865206|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
82865207|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865208|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83710253|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83710254|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83710255|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83710256|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83710257|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83710258|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710259|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
83710260|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83710261|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83710262|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83710263|NCT01824992|Interferons|interferons|mesh-list
83710264|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710265|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
83710266|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710267|NCT01825031|Azithromycin|azithromycin|mesh-list
83710268|NCT01825031|Isoniazid|isoniazid|mesh-list
83710269|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
83710270|NCT01825031|Fluconazole|fluconazole|mesh-list
83710271|NCT01825031|Albendazole|albendazole|mesh-list
83710272|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83710273|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710274|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83710275|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83710276|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
83710277|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83710278|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83710279|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710280|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710281|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
83710282|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83710283|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83710284|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83710285|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
83710286|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83710287|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710288|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83710289|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83710290|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
83710291|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83710292|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83710293|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
83710294|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83710295|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
83710296|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83710297|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
83710298|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83710299|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83710300|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
83710301|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
83710302|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
83710303|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710304|NCT01825044|Cyclosporine|cyclosporine|mesh-list
83710305|NCT01825044|Cyclosporins|cyclosporins|mesh-list
83710306|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710307|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710308|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83710309|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
83710310|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710311|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
83710312|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710313|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
83710314|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83710315|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83710316|NCT01825083|Ketamine|ketamine|mesh-list
83710317|NCT01825083|Analgesics|analgesics|mesh-ancestor
83710318|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
83710319|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710320|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710321|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83710322|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83710323|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
83710324|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
83710325|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710326|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83710327|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83710328|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710329|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710330|NCT01825109|Vaccines|vaccines|mesh-list
83710331|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
83710332|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710333|NCT01825395|Amifampridine|amifampridine|mesh-list
83710334|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83710335|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710336|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710337|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83710338|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710339|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710340|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83710341|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710342|NCT01825447|Naltrexone|naltrexone|mesh-list
83710343|NCT01825447|Oxycodone|oxycodone|mesh-list
83710344|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83710345|NCT01825447|Narcotics|narcotics|mesh-ancestor
83710346|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710347|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710348|NCT01825447|Analgesics|analgesics|mesh-ancestor
83710349|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
83710350|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710351|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83710352|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83710353|NCT01825473|Erythromycin|erythromycin|mesh-list
83710354|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
83710355|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83710356|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
83710357|NCT01825473|Phenobarbital|phenobarbital|mesh-list
83710358|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83710359|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710360|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710361|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83710362|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710363|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710364|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
83710365|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83710366|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710367|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710368|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83710369|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83710370|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710371|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
83710372|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
83710373|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83710374|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83710375|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83710376|NCT01825551|Lenograstim|lenograstim|mesh-list
83710377|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83710378|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
83710379|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710380|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
83710381|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83710382|NCT01825603|Cisplatin|cisplatin|mesh-list
83710383|NCT01825603|Gemcitabine|gemcitabine|mesh-list
83710384|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710385|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83710386|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
83710387|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710388|NCT01825616|Vitamin D|vitamin d|mesh-list
83710389|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
83710390|NCT01825616|Vitamins|vitamins|mesh-ancestor
83710391|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
83710392|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710393|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83710394|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83710395|NCT01825720|Insulin|insulin|mesh-list
83710396|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83710397|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710398|NCT01825733|Palonosetron|palonosetron|mesh-list
82865349|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82865350|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
82865351|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82865352|NCT01062191|Laxatives|laxatives|mesh-ancestor
82865353|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82865354|NCT01058759|Enoxaparin|enoxaparin|mesh-list
83710399|NCT01825733|Ramosetron|ramosetron|mesh-list
83710400|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
83710401|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
83710402|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710403|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710404|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710405|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83710406|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83710407|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
83710408|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710409|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710410|NCT01825850|Irbesartan|irbesartan|mesh-list
83710411|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710412|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83710413|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83710414|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710415|NCT01825863|Ropivacaine|ropivacaine|mesh-list
83710416|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
83710417|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
83710418|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710419|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710420|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
83710421|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710422|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83710423|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83710424|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710425|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83710426|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83710427|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83710428|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710429|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710430|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83710431|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83710432|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83710433|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
83710434|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710435|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710436|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83710437|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83710438|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
83710439|NCT01825993|Morphine|morphine|mesh-list
83710440|NCT01825993|Bupivacaine|bupivacaine|mesh-list
83710441|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
83710442|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
83710443|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710444|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710445|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
83710446|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710447|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83710448|NCT01825993|Narcotics|narcotics|mesh-ancestor
83710449|NCT01825993|Analgesics|analgesics|mesh-ancestor
83710450|NCT01826149|Propofol|propofol|mesh-list
83710451|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83710452|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710453|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710454|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83710455|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
83710456|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
83710457|NCT01826175|Clopidogrel|clopidogrel|mesh-list
83710458|NCT01826175|Ticagrelor|ticagrelor|mesh-list
83710459|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83710460|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83710461|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83710462|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82865420|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82865421|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82865422|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82865423|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865424|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865425|NCT02842424|Ramipril|ramipril|mesh-list
82865426|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82865427|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
83710463|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
83710464|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710465|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710466|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710467|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83710468|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
83710469|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
83710470|NCT01826279|Resveratrol|resveratrol|mesh-list
83710471|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
83710472|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710473|NCT01826279|Protective Agents|protective agents|mesh-ancestor
83710474|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710475|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710476|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83710477|NCT01826396|Irinotecan|irinotecan|mesh-list
83710478|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83710479|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83710480|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710481|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710482|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710483|NCT01826526|Taurolidine|taurolidine|mesh-list
83710484|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710485|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83710486|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710487|NCT01826747|Progesterone|progesterone|mesh-list
83710488|NCT01826747|Progestins|progestins|mesh-ancestor
83710489|NCT01826747|Hormones|hormones|mesh-ancestor
83710490|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83710491|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710492|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
83710493|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710494|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710495|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
83710496|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710497|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710498|NCT01826864|Sargramostim|sargramostim|mesh-list
83710499|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
83710500|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710501|NCT01826916|Ecallantide|ecallantide|mesh-list
83710502|NCT01826916|Analgesics|analgesics|mesh-ancestor
83710503|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
83710504|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710505|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710506|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83710507|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83710508|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83710509|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83710510|NCT01827007|Polygeline|polygeline|mesh-list
83710511|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
83710512|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
83710513|NCT01827020|Lidocaine|lidocaine|mesh-list
83710514|NCT01827020|Ketamine|ketamine|mesh-list
83710515|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
83710516|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
83710517|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710518|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710519|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
83710520|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710521|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83710522|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83710523|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83710524|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710525|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710526|NCT01827020|Analgesics|analgesics|mesh-ancestor
83710527|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83710528|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83710529|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
83710530|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83710531|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83710532|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710533|NCT01827059|Bosentan|bosentan|mesh-list
83710534|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710535|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83710536|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710537|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
83710538|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
83710539|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710540|NCT01827124|Oxytocin|oxytocin|mesh-list
83710541|NCT01827124|Carbetocin|carbetocin|mesh-list
83710542|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
83710543|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83710544|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710545|NCT01827137|Lenalidomide|lenalidomide|mesh-list
83710546|NCT01827137|Molgramostim|molgramostim|mesh-list
83710547|NCT01827137|Sargramostim|sargramostim|mesh-list
83710548|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
83710549|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710550|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83710551|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710552|NCT01827137|Growth Substances|growth substances|mesh-ancestor
83710553|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710554|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710555|NCT01827202|Candesartan|candesartan|mesh-list
83710556|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710557|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83710558|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83710559|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710560|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
83710561|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
83710562|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710563|NCT01827280|Vildagliptin|vildagliptin|mesh-list
83710564|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83710565|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710566|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83710567|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
83710568|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710569|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710570|NCT01827293|Promethazine|promethazine|mesh-list
83710571|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
83710572|NCT01827293|Lorazepam|lorazepam|mesh-list
83710573|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
83710574|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
83710575|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
83710576|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710577|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710578|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710579|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83710580|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710581|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83710582|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83710583|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83710584|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
83710585|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
83710586|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710587|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710588|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
83710589|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
83710590|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83710591|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
83710592|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
83710593|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83710594|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83710595|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
83710596|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
83710597|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
83710598|NCT01827345|Vitamin D|vitamin d|mesh-list
83710599|NCT01827345|Vitamins|vitamins|mesh-ancestor
83710600|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
83710601|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710602|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83710603|NCT01827397|Vaccines|vaccines|mesh-list
83710604|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
83710605|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710606|NCT01827540|Dolutegravir|dolutegravir|mesh-list
83710607|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
83710608|NCT01827540|Midazolam|midazolam|mesh-list
83710609|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83710610|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865559|NCT01242410|Trace Elements|trace elements|mesh-ancestor
82865560|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
82865561|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710611|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710612|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710613|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83710614|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83710615|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83710616|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83710617|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
83710619|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
83710620|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
83710621|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710622|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710623|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83710624|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83710625|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710626|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83710627|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83710628|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
83710629|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710630|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83710631|NCT01827618|Sirolimus|sirolimus|mesh-list
83710632|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83710633|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710634|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83710635|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710636|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
83710637|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83710638|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
83710639|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710640|NCT01827722|Dexamethasone|dexamethasone|mesh-list
83710641|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
83710642|NCT01827722|Ranibizumab|ranibizumab|mesh-list
83710643|NCT01827722|BB 1101|bb 1101|mesh-list
83710644|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83710645|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
83710646|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
83710647|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710648|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710649|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710650|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
83710651|NCT01827722|Hormones|hormones|mesh-ancestor
83710652|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83710653|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83710654|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710655|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
83710656|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710657|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710658|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83710659|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710660|NCT01827722|Growth Substances|growth substances|mesh-ancestor
83710661|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710662|NCT01827735|Aldesleukin|aldesleukin|mesh-list
83710663|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710664|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83710665|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83710666|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
83710667|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710668|NCT01827865|Etodolac|etodolac|mesh-list
83710669|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83710670|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83710671|NCT01827865|Analgesics|analgesics|mesh-ancestor
83710672|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
83710673|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710674|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710675|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83710676|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83710677|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82865633|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
82865634|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
82865635|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
82865636|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865637|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865638|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
82865639|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82865640|NCT00316277|Narcotics|narcotics|mesh-ancestor
83710678|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83710679|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710680|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865641|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710681|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83710683|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
83710684|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710685|NCT01827878|Diuretics|diuretics|mesh-ancestor
83710686|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
83710687|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710688|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83710689|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710690|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710691|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83710692|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
83710693|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710694|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83710695|NCT01827878|Protective Agents|protective agents|mesh-ancestor
83710696|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83710697|NCT01828125|Glucagon|glucagon|mesh-list
83710698|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710699|NCT01828125|Hormones|hormones|mesh-ancestor
83710700|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83710701|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710702|NCT01828203|Minocycline|minocycline|mesh-list
83710703|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83710704|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710705|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
83710706|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83710707|NCT01828294|Antibodies|antibodies|mesh-list
83710708|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
83710709|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710710|NCT01828346|Azacitidine|azacitidine|mesh-list
83710711|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83710712|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
83710713|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710714|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710715|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710716|NCT01828359|Losartan|losartan|mesh-list
83710717|NCT01828359|Amlodipine|amlodipine|mesh-list
83710718|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710719|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83710720|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710721|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710722|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83710723|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710724|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
83710725|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83710726|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83710727|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83710728|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
83710729|NCT01828385|Analgesics|analgesics|mesh-ancestor
83710730|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
83710731|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710732|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710733|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
83710734|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710735|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83710736|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
83710737|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83710738|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710739|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710740|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83710741|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
83710742|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83710743|NCT01828437|Pyridoxine|pyridoxine|mesh-list
83710744|NCT01828437|Prednisolone|prednisolone|mesh-list
83710745|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83710746|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
83710747|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83710748|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
83710749|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83710750|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
83710751|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83710752|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
82865694|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710753|NCT01828437|Hormones|hormones|mesh-ancestor
83710754|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83710755|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710756|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83710757|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710759|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
83710760|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710761|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710762|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83710763|NCT01828437|Protective Agents|protective agents|mesh-ancestor
83710764|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
83710765|NCT01828437|Vitamins|vitamins|mesh-ancestor
83710766|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
83710767|NCT01828463|Nitisinone|nitisinone|mesh-list
83710768|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710769|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710770|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
83710771|NCT01828489|Analgesics|analgesics|mesh-ancestor
83710772|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
83710773|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710774|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710775|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710776|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83710777|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83710778|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710779|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710780|NCT01828606|Monensin|monensin|mesh-list
83710781|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
83710782|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710783|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83710784|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83710785|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
83710786|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
83710787|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
83710788|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710789|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710790|NCT01828606|Ionophores|ionophores|mesh-ancestor
83710791|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710792|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
83710793|NCT01828736|Cisplatin|cisplatin|mesh-list
83710794|NCT01828736|Carboplatin|carboplatin|mesh-list
83710795|NCT01828736|Gemcitabine|gemcitabine|mesh-list
83710796|NCT01828736|Trastuzumab|trastuzumab|mesh-list
83710797|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710798|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83710799|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
83710800|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710801|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83710802|NCT01828788|Ropivacaine|ropivacaine|mesh-list
83710803|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
83710804|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
83710805|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83710806|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710807|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
83710808|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710809|NCT01828879|Tacrolimus|tacrolimus|mesh-list
83710810|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83710811|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
83710812|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710813|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83710814|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710815|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710816|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83710817|NCT01828892|Vancomycin|vancomycin|mesh-list
83710818|NCT01828892|Meropenem|meropenem|mesh-list
83710819|NCT01828892|Ceftazidime|ceftazidime|mesh-list
83710820|NCT01828892|Cefotaxime|cefotaxime|mesh-list
83710821|NCT01828892|Cefoxitin|cefoxitin|mesh-list
83710822|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710823|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
83710824|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83710825|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710826|NCT01829178|Cisplatin|cisplatin|mesh-list
83710827|NCT01829178|Docetaxel|docetaxel|mesh-list
82865772|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83710828|NCT01829178|Fluorouracil|fluorouracil|mesh-list
83710829|NCT01829178|Silymarin|silymarin|mesh-list
83710830|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710831|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
83710832|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
83710833|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
83710834|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710835|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
83710836|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83710837|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83710838|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
83710839|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710840|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
83710841|NCT01829178|Protective Agents|protective agents|mesh-ancestor
83710842|NCT01829334|Listerine|listerine|mesh-list
83710843|NCT01829334|Fluorides|fluorides|mesh-list
83710844|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
83710845|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
83710846|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
83710847|NCT01829334|Protective Agents|protective agents|mesh-ancestor
83710848|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710849|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83710850|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710851|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
83710852|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83710853|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
83710854|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710855|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
83710856|NCT01829451|Protective Agents|protective agents|mesh-ancestor
83710857|NCT01829529|Amoxicillin|amoxicillin|mesh-list
83710858|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83710859|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710860|NCT01829659|Ticagrelor|ticagrelor|mesh-list
83710861|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83710862|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83710863|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83710864|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83710865|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
83710866|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710867|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710868|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710869|NCT01829685|Entecavir|entecavir|mesh-list
83710870|NCT01829685|Adefovir|adefovir|mesh-list
83710871|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
83710872|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710873|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83710874|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83710875|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710876|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710877|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83710878|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83710879|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83710880|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
83710881|NCT01829711|Protective Agents|protective agents|mesh-list
83710882|NCT01829711|Immunotoxins|immunotoxins|mesh-ancestor
83710883|NCT01829711|Immunoconjugates|immunoconjugates|mesh-ancestor
83710884|NCT01829711|Immunologic Factors|immunologic factors|mesh-ancestor
83710885|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710886|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710887|NCT01829802|Ritonavir|ritonavir|mesh-list
83710888|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83710889|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
83710890|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83710891|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83710892|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
83710893|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710894|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710895|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83710896|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83710897|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
83710898|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83710899|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83710900|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83710901|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83710902|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83710903|NCT01829841|Sunitinib|sunitinib|mesh-list
83710904|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865841|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710905|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82865846|NCT00321464|Denosumab|denosumab|mesh-list
83710906|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83710907|NCT01829841|Growth Substances|growth substances|mesh-ancestor
83710908|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710909|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
83710910|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83710911|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710912|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710913|NCT01829893|Tamsulosin|tamsulosin|mesh-list
83710914|NCT01829893|Finasteride|finasteride|mesh-list
83710915|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83710916|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83710917|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83710918|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
83710919|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710920|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710921|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710922|NCT01829893|Urological Agents|urological agents|mesh-ancestor
83710923|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83710924|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83710925|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710926|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
83710927|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83710928|NCT01830153|Everolimus|everolimus|mesh-list
83710929|NCT01830153|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83710930|NCT01830153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83710931|NCT01830153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710932|NCT01830153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710933|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83710934|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
83710935|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710936|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710937|NCT01830244|Paclitaxel|paclitaxel|mesh-list
83710938|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83710939|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710940|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
83710941|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
83710942|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
83710943|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710944|NCT01830270|Paclitaxel|paclitaxel|mesh-list
83710945|NCT01830270|Epirubicin|epirubicin|mesh-list
83710946|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83710947|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83710948|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
83710949|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
83710950|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
83710951|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710952|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83710953|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83710954|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83710955|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710956|NCT01830530|Telmisartan|telmisartan|mesh-list
83710957|NCT01830530|Nifedipine|nifedipine|mesh-list
83710958|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83710959|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83710960|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83710961|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710962|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83710963|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83710964|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83710965|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710966|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
83710967|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
83710968|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83710969|NCT01830907|Vitamins|vitamins|mesh-list
82865916|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865917|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865918|NCT03323164|Timolol|timolol|mesh-list
82865919|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82865920|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865921|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82865922|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82865923|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
83710970|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
83710971|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710972|NCT01831050|Vaccines|vaccines|mesh-list
83710973|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
83710974|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710975|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
83710976|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83710977|NCT01832311|Ketorolac|ketorolac|mesh-list
83710978|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83710979|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83710980|NCT01832311|Analgesics|analgesics|mesh-ancestor
83710981|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
83710982|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83710983|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710984|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83710985|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83710986|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83710987|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83710988|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710989|NCT01832350|Quinidine|quinidine|mesh-list
83710990|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
83710991|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
83710992|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
83710993|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83710994|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83710995|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83710996|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83710997|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83710998|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83710999|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83711000|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711001|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83711002|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
83711003|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83711004|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83711005|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711006|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711007|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83711008|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83711009|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
83711010|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83711011|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83711012|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711013|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83711014|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83711015|NCT01833221|Lidocaine|lidocaine|mesh-list
83711016|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711017|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
83711018|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711019|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711020|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
83711021|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711022|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83792158|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711023|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83711024|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83711025|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711026|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711027|NCT01834820|Dexamethasone|dexamethasone|mesh-list
83711028|NCT01834820|Epinephrine|epinephrine|mesh-list
83711029|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711030|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
83711031|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
83711032|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711033|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711034|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711035|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
83711036|NCT01834820|Hormones|hormones|mesh-ancestor
83711037|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711038|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83711039|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711040|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83711041|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82865979|NCT03610438|Immunotoxins|immunotoxins|mesh-ancestor
82865980|NCT03610438|Immunoconjugates|immunoconjugates|mesh-ancestor
83711042|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711043|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711044|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711045|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83711046|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83711047|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83711048|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711049|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
83711050|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
83711051|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83711052|NCT01835197|Abrocitinib|abrocitinib|mesh-list
83711053|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83711054|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711055|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711056|NCT01835418|Amlodipine|amlodipine|mesh-list
83711057|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83711058|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83711059|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711060|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711061|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83711062|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711063|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
83711064|NCT01835678|Linagliptin|linagliptin|mesh-list
83711065|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83711066|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711067|NCT01835678|Incretins|incretins|mesh-ancestor
83711068|NCT01835678|Hormones|hormones|mesh-ancestor
83711069|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711070|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83711071|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
83711072|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711073|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711074|NCT01836614|Lidocaine|lidocaine|mesh-list
83711075|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711076|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
83711077|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711078|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711079|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
83711080|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711081|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83711082|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83711083|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83711084|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711085|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711086|NCT01837251|Bevacizumab|bevacizumab|mesh-list
83711087|NCT01837251|Carboplatin|carboplatin|mesh-list
83711088|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83711089|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711090|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83711091|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83711092|NCT01837251|Growth Substances|growth substances|mesh-ancestor
83711093|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711094|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
83711095|NCT01837290|Midazolam|midazolam|mesh-list
83711096|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
83711097|NCT01837290|Bupivacaine|bupivacaine|mesh-list
83711098|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711099|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
83711100|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711101|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711102|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
83711103|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711104|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83711105|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83711106|NCT01837290|Analgesics|analgesics|mesh-ancestor
83711107|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83711108|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83711109|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83711110|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711111|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711112|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866054|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711113|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83711115|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83711116|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83711117|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83711118|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
83711119|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
83711120|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
83711121|NCT01837433|Prednisone|prednisone|mesh-list
83711122|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
83711123|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711124|NCT01837433|Hormones|hormones|mesh-ancestor
83711125|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711126|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711127|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83711128|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711129|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
83711130|NCT01837446|Promethazine|promethazine|mesh-list
83711131|NCT01837446|Lidocaine|lidocaine|mesh-list
83711132|NCT01837446|Morphine|morphine|mesh-list
83711133|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83711134|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
83711135|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711136|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
83711137|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711138|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711139|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
83711140|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711141|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83711142|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83711143|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83711144|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711145|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711146|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83711147|NCT01837446|Narcotics|narcotics|mesh-ancestor
83711148|NCT01837446|Analgesics|analgesics|mesh-ancestor
83711149|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83711150|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83711151|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
83711152|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
83711153|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711154|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83711155|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
83711156|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
83711157|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711158|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83711159|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
83711160|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83711161|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83711162|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
83711163|NCT01837446|Antacids|antacids|mesh-ancestor
83711164|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83711165|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83711166|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83711167|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83711168|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711169|NCT01839344|Acarbose|acarbose|mesh-list
83711170|NCT01839344|Quercetin|quercetin|mesh-list
83711171|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83711172|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711173|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711174|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83711175|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711176|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
83711177|NCT01839344|Protective Agents|protective agents|mesh-ancestor
83711178|NCT01839578|Heparin|heparin|mesh-list
83711179|NCT01839578|Calcium heparin|calcium heparin|mesh-list
83711180|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
83711181|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711182|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83711183|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83711184|NCT01839994|Androgens|androgens|mesh-list
83711185|NCT01839994|Hormones|hormones|mesh-ancestor
83711186|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711187|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711188|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
82866128|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
83711189|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83711190|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83711191|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83711192|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711193|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
83711194|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83711195|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711196|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711197|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83711198|NCT01840254|Analgesics|analgesics|mesh-ancestor
83711199|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
83711200|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711201|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83711202|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83711203|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83711204|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711205|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711206|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711207|NCT01840384|Micronutrients|micronutrients|mesh-list
83711208|NCT01840384|Trace Elements|trace elements|mesh-list
83711209|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711210|NCT01840423|Levodopa|levodopa|mesh-list
83711211|NCT01840423|Carbidopa|carbidopa|mesh-list
83711212|NCT01840423|Entacapone|entacapone|mesh-list
83711213|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83711214|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83711215|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
83711216|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711217|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711218|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711219|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83711220|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711221|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83711222|NCT01840449|Lanreotide|lanreotide|mesh-list
83711223|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711224|NCT01840683|Heparin|heparin|mesh-list
83711225|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
83711226|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83711227|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83711228|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711229|NCT01840696|Regadenoson|regadenoson|mesh-list
83711230|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83711231|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83711232|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
83711233|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
83711234|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711235|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711236|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711237|NCT01840774|Ketamine|ketamine|mesh-list
83711238|NCT01840774|Analgesics|analgesics|mesh-list
83711239|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
83711240|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711241|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711242|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83711243|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83711244|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
83711245|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
83711246|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711247|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83711248|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83711249|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711250|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711251|NCT01840800|Ropivacaine|ropivacaine|mesh-list
83711252|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711253|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
83711254|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711255|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711256|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
83711257|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711258|NCT01840813|Misoprostol|misoprostol|mesh-list
83711259|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83711260|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
83711261|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83711262|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711263|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83711264|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711265|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
83711266|NCT01841008|Tacrolimus|tacrolimus|mesh-list
83711267|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83711268|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
83711269|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711270|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83711271|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711272|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711273|NCT01841099|Mesalamine|mesalamine|mesh-list
83711274|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83711275|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83711276|NCT01841099|Analgesics|analgesics|mesh-ancestor
83711277|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
83711278|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711279|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711280|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711281|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83711282|NCT01841112|BI 409306|bi 409306|mesh-list
83711283|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83711284|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711285|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711286|NCT01841125|Escitalopram|escitalopram|mesh-list
83711287|NCT01841125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83711288|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83711289|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711290|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711291|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711292|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
83711293|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711294|NCT01841164|Montelukast|montelukast|mesh-list
83711295|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83711296|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711297|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83711298|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
83711299|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711300|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711301|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83711302|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83711303|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711304|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
83711305|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
83711306|NCT01841242|Povidone|povidone|mesh-list
83711307|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83711308|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711309|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
83711310|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
83711311|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
83711312|NCT01841294|Lidocaine|lidocaine|mesh-list
83711313|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711314|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
83711315|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711316|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711317|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
83711318|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711319|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83711320|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83711321|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83711322|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711323|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711324|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
83711325|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83711326|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
83711327|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711328|NCT01841307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83711329|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711330|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83711331|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711332|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83711333|NCT01841320|Methadone|methadone|mesh-list
83711334|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83711335|NCT01841320|Narcotics|narcotics|mesh-ancestor
83711336|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711337|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711338|NCT01841320|Analgesics|analgesics|mesh-ancestor
83711339|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
83711340|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711341|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
83711342|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711343|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
83711344|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711345|NCT01841411|Metronidazole|metronidazole|mesh-list
83711346|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
83711347|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83711348|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711349|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83711350|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83711351|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83711352|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
83711353|NCT01841411|Expectorants|expectorants|mesh-ancestor
83711354|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711355|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83711356|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
83711357|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711358|NCT01841411|Protective Agents|protective agents|mesh-ancestor
83711359|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711360|NCT01841411|Antidotes|antidotes|mesh-ancestor
83711361|NCT01841424|Benzocaine|benzocaine|mesh-list
83711362|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711363|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
83711364|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711365|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711366|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
83711367|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711368|NCT01841463|Vemurafenib|vemurafenib|mesh-list
83711369|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711370|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83711371|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711372|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711373|NCT01841502|Paroxetine|paroxetine|mesh-list
83711374|NCT01841502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83711375|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83711376|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711377|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711378|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711379|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
83711380|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711381|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83711382|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
83711383|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83711384|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83711385|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83711386|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711387|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83711388|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
83711389|NCT01841515|Coagulants|coagulants|mesh-ancestor
83711390|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83711391|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
83711392|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711393|NCT01841658|Folic Acid|folic acid|mesh-list
83711394|NCT01841658|Hematinics|hematinics|mesh-ancestor
83711395|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
83711396|NCT01841658|Vitamins|vitamins|mesh-ancestor
83711397|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
83711398|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711399|NCT01841684|Anacetrapib|anacetrapib|mesh-list
83711400|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83711401|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83711402|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
83711403|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711404|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83711405|NCT01841775|Interferons|interferons|mesh-list
83711406|NCT01841775|Ribavirin|ribavirin|mesh-list
83711407|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711408|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
83711409|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866354|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
82866366|NCT03905486|Pregabalin|pregabalin|mesh-list
83711410|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
83711411|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711412|NCT01841827|Cilostazol|cilostazol|mesh-list
83711413|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83711414|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
83711415|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711416|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711417|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83711418|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711419|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83711420|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83711421|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711422|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83711423|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
83711424|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83711425|NCT01841827|Protective Agents|protective agents|mesh-ancestor
83711426|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83711427|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83711428|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711429|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83711430|NCT01842074|Bortezomib|bortezomib|mesh-list
83711431|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711432|NCT01842087|Iproplatin|iproplatin|mesh-list
83711433|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711434|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83711435|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711436|NCT01842113|Rifaximin|rifaximin|mesh-list
83711437|NCT01842113|Lactulose|lactulose|mesh-list
83711438|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83711439|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711440|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711441|NCT01842139|Poly I-C|poly i-c|mesh-list
83711442|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83711443|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83711444|NCT01842139|Poly ICLC|poly iclc|mesh-list
83711445|NCT01842139|Basiliximab|basiliximab|mesh-list
83711446|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83711447|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
83711448|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711449|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
83711450|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83711451|NCT01842139|Laxatives|laxatives|mesh-ancestor
83711452|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711453|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
83711454|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711455|NCT01842230|Niacin|niacin|mesh-list
83711456|NCT01842230|Amlodipine|amlodipine|mesh-list
83711457|NCT01842230|Telmisartan|telmisartan|mesh-list
83711458|NCT01842230|Atorvastatin|atorvastatin|mesh-list
83711459|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83711460|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83711461|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
83711462|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711463|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83711464|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83711465|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711466|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83711467|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83711468|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711469|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83711470|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711471|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
83711472|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83711473|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83711474|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
83711475|NCT01842230|Vitamins|vitamins|mesh-ancestor
83711476|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
83711477|NCT01842256|Amlodipine|amlodipine|mesh-list
82866427|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866428|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82866429|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866430|NCT00336479|Interferons|interferons|mesh-list
82866431|NCT00336479|Ribavirin|ribavirin|mesh-list
82866432|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
82866433|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
82866434|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82866435|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711478|NCT01842256|Telmisartan|telmisartan|mesh-list
83711479|NCT01842256|Atorvastatin|atorvastatin|mesh-list
83711480|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83711481|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83711482|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
83711483|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711484|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83711485|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83711486|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711487|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83711488|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83711489|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711490|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83711491|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711492|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
83711493|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83711494|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83711495|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
83711496|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83711497|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711498|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83711499|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
83711500|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83711501|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711502|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711503|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711504|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
83711505|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711506|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83711507|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711508|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711509|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83711510|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711511|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711512|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83711513|NCT01842373|Lidocaine|lidocaine|mesh-list
83711514|NCT01842373|Tetracaine|tetracaine|mesh-list
83711515|NCT01842373|Benzocaine|benzocaine|mesh-list
83711516|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711517|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
83711518|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711519|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711520|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
83711521|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711522|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82866487|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
82866488|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82866489|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82866490|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866491|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866492|NCT03905018|Urological Agents|urological agents|mesh-ancestor
82866493|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
82866494|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82866495|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866496|NCT03894800|Fentanyl|fentanyl|mesh-list
82866497|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
82866498|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82866499|NCT03894800|Narcotics|narcotics|mesh-ancestor
82866500|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866501|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866502|NCT03894800|Analgesics|analgesics|mesh-ancestor
82866503|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
82866504|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866505|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82866506|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82866507|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
82866508|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
82866509|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82866510|NCT03900026|Evolocumab|evolocumab|mesh-list
82866511|NCT03900026|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82866512|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82866513|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82866514|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
82866515|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866516|NCT03900026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83711523|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83711524|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83711525|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711526|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711527|NCT01842516|Delpazolid|delpazolid|mesh-list
83711528|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
83711529|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83711530|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711531|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83711532|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711533|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711534|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
83711535|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83711536|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711537|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711538|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
83711539|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711540|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711541|NCT01842893|Fentanyl|fentanyl|mesh-list
83711542|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83711543|NCT01842893|Narcotics|narcotics|mesh-ancestor
83711544|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711545|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711546|NCT01842893|Analgesics|analgesics|mesh-ancestor
83711547|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
83711548|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711549|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83711550|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83711551|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
83711552|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
83711553|NCT01842932|Bromides|bromides|mesh-list
83711554|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83711555|NCT01842932|Cimetropium|cimetropium|mesh-list
83711556|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
83711557|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
83711558|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711559|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711560|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711561|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
83711562|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
83711563|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711564|NCT01843010|Parecoxib|parecoxib|mesh-list
83711565|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83711566|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83711567|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711568|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711569|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83711570|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83711571|NCT01843010|Analgesics|analgesics|mesh-ancestor
83711572|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
83711573|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711574|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711575|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711576|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83711577|NCT01843075|Liraglutide|liraglutide|mesh-list
83711578|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83711579|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711580|NCT01843075|Incretins|incretins|mesh-ancestor
83711581|NCT01843075|Hormones|hormones|mesh-ancestor
83711582|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711583|NCT01843088|Mannitol|mannitol|mesh-list
83711584|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83711585|NCT01843088|Diuretics|diuretics|mesh-ancestor
83711586|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
83711587|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711588|NCT01843127|Exenatide|exenatide|mesh-list
83711589|NCT01843127|Ranolazine|ranolazine|mesh-list
83711590|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83711591|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711592|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83711593|NCT01843127|Incretins|incretins|mesh-ancestor
83711594|NCT01843127|Hormones|hormones|mesh-ancestor
83711595|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866528|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711596|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83711597|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711598|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711599|NCT01843153|Ropivacaine|ropivacaine|mesh-list
83711600|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711601|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
83711602|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711603|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711604|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
83711605|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711606|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83711607|NCT01843166|Estrogens|estrogens|mesh-ancestor
83711608|NCT01843166|Hormones|hormones|mesh-ancestor
83711609|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711610|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711611|NCT01843179|Cytarabine|cytarabine|mesh-list
83711612|NCT01843179|Sulindac|sulindac|mesh-list
83711613|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83711614|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
83711615|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711616|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711617|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
83711618|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711619|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83711620|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
83711621|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711622|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83711623|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83711624|NCT01843179|Analgesics|analgesics|mesh-ancestor
83711625|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
83711626|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711627|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711628|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83711629|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83711630|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711631|NCT01843257|Ethanol|ethanol|mesh-list
83711632|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83711633|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711634|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711635|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711636|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
83711637|NCT01843296|Fentanyl|fentanyl|mesh-list
83711638|NCT01843296|Bupivacaine|bupivacaine|mesh-list
83711639|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711640|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
83711641|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711642|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711643|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
83711644|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711645|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83711646|NCT01843296|Narcotics|narcotics|mesh-ancestor
83711647|NCT01843296|Analgesics|analgesics|mesh-ancestor
83711648|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83711649|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83711650|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
83711651|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83711652|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
83711653|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83711654|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83711655|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711656|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83711657|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
83711658|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83711659|NCT01843309|Spironolactone|spironolactone|mesh-list
83711660|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83711661|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
83711662|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711663|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711664|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83711665|NCT01843309|Diuretics|diuretics|mesh-ancestor
83711666|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
83711667|NCT01843439|Pyridoxine|pyridoxine|mesh-list
83711668|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
83711669|NCT01843439|Vitamins|vitamins|mesh-ancestor
83711670|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
82866602|NCT03899246|Capsaicin|capsaicin|mesh-list
83711671|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711672|NCT01843452|Capecitabine|capecitabine|mesh-list
83711673|NCT01843452|Mitomycins|mitomycins|mesh-list
83711674|NCT01843452|Mitomycin|mitomycin|mesh-list
83711675|NCT01843452|Panitumumab|panitumumab|mesh-list
83711676|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83711677|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
83711678|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711679|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711680|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83711681|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
83711682|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83711683|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711684|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83711685|NCT01843530|Cortisone|cortisone|mesh-list
83711686|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711687|NCT01843647|Cisplatin|cisplatin|mesh-list
83711688|NCT01843647|Vinorelbine|vinorelbine|mesh-list
83711689|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711690|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83711691|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
83711692|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
83711693|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
83711694|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711695|NCT01843699|Topiramate|topiramate|mesh-list
83711696|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
83711697|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83711698|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711699|NCT01843725|Capecitabine|capecitabine|mesh-list
83711700|NCT01843725|Aflibercept|aflibercept|mesh-list
83711701|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83711702|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
83711703|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711704|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711705|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83711706|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83711707|NCT01843725|Growth Substances|growth substances|mesh-ancestor
83711708|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711709|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
83711710|NCT01843738|Vemurafenib|vemurafenib|mesh-list
83711711|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711712|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83711713|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711714|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711715|NCT01843829|Paclitaxel|paclitaxel|mesh-list
83711716|NCT01843829|Carboplatin|carboplatin|mesh-list
83711717|NCT01843829|Capecitabine|capecitabine|mesh-list
83711718|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
83711719|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83711720|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711721|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83711722|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83711723|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83711724|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711725|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83711726|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
83711727|NCT01843868|Prednisolone|prednisolone|mesh-list
83711728|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
83711729|NCT01843868|Doxorubicin|doxorubicin|mesh-list
83711730|NCT01843868|Vincristine|vincristine|mesh-list
83711731|NCT01843868|Lorazepam|lorazepam|mesh-list
83711732|NCT01843868|Ondansetron|ondansetron|mesh-list
83711733|NCT01843868|Aprepitant|aprepitant|mesh-list
83711734|NCT01843868|Palonosetron|palonosetron|mesh-list
83711735|NCT01843868|Metoclopramide|metoclopramide|mesh-list
83711736|NCT01843868|Granisetron|granisetron|mesh-list
83711737|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
82866678|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866679|NCT01254578|Lenalidomide|lenalidomide|mesh-list
82866680|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
82866681|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866684|NCT01254578|Growth Substances|growth substances|mesh-ancestor
83711738|NCT01843868|Tropisetron|tropisetron|mesh-list
83711739|NCT01843868|Antiemetics|antiemetics|mesh-list
83711740|NCT01843868|Emetics|emetics|mesh-list
83711741|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83711742|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
83711743|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711744|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83711745|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83711746|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
83711747|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711748|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711749|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83711750|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83711751|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83711752|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83711753|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711754|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83711755|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
83711756|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
83711757|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
83711758|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711759|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
83711760|NCT01843868|Hormones|hormones|mesh-ancestor
83711761|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83711762|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83711763|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
83711764|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711765|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711766|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
83711767|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83711768|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83711769|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83711770|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
83711771|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711772|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83711773|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83711774|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83711775|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
83711776|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
83711777|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83711778|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711779|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83711780|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83711781|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83711782|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
83711783|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
83711784|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83711785|NCT01843998|Sirolimus|sirolimus|mesh-list
83711786|NCT01843998|Temsirolimus|temsirolimus|mesh-list
83711787|NCT01843998|MTOR Inhibitors|mtor inhibitors|mesh-list
83711788|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83711789|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711790|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83711791|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711792|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
83711793|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83711794|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
83711795|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711796|NCT01843998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83711797|NCT01843998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711798|NCT01843998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711799|NCT01844024|Misoprostol|misoprostol|mesh-list
83711800|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83711801|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
83711802|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83711803|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711804|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83711805|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711806|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
83711807|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
83711808|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866746|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
82866747|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866748|NCT03892070|Mannitol|mannitol|mesh-list
82866749|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82866750|NCT03892070|Diuretics|diuretics|mesh-ancestor
82866751|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
82866752|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866753|NCT01155440|Lidocaine|lidocaine|mesh-list
82866754|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
83711809|NCT01844141|Ethanol|ethanol|mesh-list
83711810|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
83711811|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83711812|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83711813|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711814|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711815|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711816|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
83711817|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
83711818|NCT01844323|Palbociclib|palbociclib|mesh-list
83711819|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711820|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83711821|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711822|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711823|NCT01844401|Albuterol|albuterol|mesh-list
83711824|NCT01844401|Procaterol|procaterol|mesh-list
83711825|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83711826|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
83711827|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711828|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711829|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83711830|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711831|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
83711832|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83711833|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83711834|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83711835|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83711836|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711837|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711838|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711839|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
83711840|NCT01844427|Memantine|memantine|mesh-list
83711841|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83711842|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83711843|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
83711844|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711845|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711846|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711847|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83711848|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83711849|NCT01844622|Domperidone|domperidone|mesh-list
83711850|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
83711851|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
83711852|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711853|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711854|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711855|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83711856|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
83711857|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711858|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711859|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
83711860|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
83711861|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711862|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83711863|NCT01844648|Tropicamide|tropicamide|mesh-list
83711864|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
83711865|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
83711866|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711867|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711868|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83711869|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83711870|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
83711871|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711872|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711873|NCT01844674|Vemurafenib|vemurafenib|mesh-list
83711874|NCT01844674|Tizanidine|tizanidine|mesh-list
83711875|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711876|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83711877|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711878|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711879|NCT01844674|Analgesics|analgesics|mesh-ancestor
83711880|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
83711881|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711882|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711883|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
83711884|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82866795|NCT04480372|Gemcitabine|gemcitabine|mesh-list
82866796|NCT04480372|Atezolizumab|atezolizumab|mesh-list
83711885|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83711886|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
83711888|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83711889|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83711890|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83711891|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711892|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711893|NCT01844791|Pentamidine|pentamidine|mesh-list
83711894|NCT01844791|Gemcitabine|gemcitabine|mesh-list
83711895|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83711896|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
83711897|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711898|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711899|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
83711900|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83711901|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83711902|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83711903|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83711904|NCT01844804|Infliximab|infliximab|mesh-list
83711905|NCT01844804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83711906|NCT01844804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83711907|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
83711908|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711909|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83711910|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
83711911|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83711912|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711913|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83711914|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711915|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711916|NCT01844947|Sorafenib|sorafenib|mesh-list
83711917|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83711918|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83711919|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711920|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711921|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
83711922|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83711923|NCT01845038|Timolol|timolol|mesh-list
83711924|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711925|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83711926|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83711927|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711928|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711929|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711930|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83711931|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83711932|NCT01845064|Kallikreins|kallikreins|mesh-list
83711933|NCT01845064|Coagulants|coagulants|mesh-ancestor
83711934|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83711935|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
83711936|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83711937|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711938|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
83711939|NCT01845090|Calcium|calcium|mesh-list
83711940|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83711941|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711942|NCT01845090|Antacids|antacids|mesh-ancestor
83792159|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
83711943|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711944|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83711945|NCT01845142|Vitamin D|vitamin d|mesh-list
83711946|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
83711947|NCT01845142|Vitamins|vitamins|mesh-ancestor
83711948|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
83711949|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711950|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83711951|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83711952|NCT01845194|Metoprolol|metoprolol|mesh-list
83711953|NCT01845194|Talinolol|talinolol|mesh-list
83711954|NCT01845194|Torsemide|torsemide|mesh-list
83711955|NCT01845194|Midazolam|midazolam|mesh-list
83711956|NCT01845194|Codeine|codeine|mesh-list
83711957|NCT01845194|Caffeine|caffeine|mesh-list
83711958|NCT01845194|Pravastatin|pravastatin|mesh-list
83711959|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83711960|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83711961|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83711962|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83711964|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83711965|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83711966|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83711967|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
83711968|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
83711969|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
83711970|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
83711971|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83711972|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83711973|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83711974|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83711975|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83711976|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83711977|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83711978|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
83711979|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83711980|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83711981|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
83711982|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
83711983|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83711984|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83711985|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83711986|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83711987|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
83711988|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83711989|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83711990|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
83711991|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83711992|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83711993|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83711994|NCT01845194|Narcotics|narcotics|mesh-ancestor
83711995|NCT01845194|Analgesics|analgesics|mesh-ancestor
83711996|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
83711997|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
83711998|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
83711999|NCT01845194|Diuretics|diuretics|mesh-ancestor
83712000|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
83712001|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83712002|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712003|NCT01845246|Colistin|colistin|mesh-list
83712004|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712005|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712006|NCT01845259|Liraglutide|liraglutide|mesh-list
83712007|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83712008|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712009|NCT01845259|Incretins|incretins|mesh-ancestor
83712010|NCT01845259|Hormones|hormones|mesh-ancestor
83712011|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712012|NCT01845272|Amlodipine|amlodipine|mesh-list
83712013|NCT01845272|Candesartan|candesartan|mesh-list
83712014|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
83712015|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83712016|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83712017|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712018|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712019|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83792160|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
83712020|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712021|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
83712022|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83712023|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83712024|NCT01845298|Rifampin|rifampin|mesh-list
83712025|NCT01845298|Rifamycins|rifamycins|mesh-list
83712026|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83712027|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
83712028|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82866944|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82866945|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82866946|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82866947|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866948|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866949|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83712029|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712030|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
83712031|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83712032|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712033|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712034|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83712035|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83712036|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83712037|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83712038|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83712039|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83712040|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
83712041|NCT01845363|Cefazolin|cefazolin|mesh-list
83712042|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83712043|NCT01845376|Anesthetics|anesthetics|mesh-list
83712044|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712045|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712046|NCT01845428|Pravastatin|pravastatin|mesh-list
83712047|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83712048|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83712049|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
83712050|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712051|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83712052|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83712053|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712054|NCT01845493|Sulforaphane|sulforaphane|mesh-list
83712055|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83712056|NCT01845493|Protective Agents|protective agents|mesh-ancestor
83712057|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712058|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712059|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83712060|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
83712061|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
83712062|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712063|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712064|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
83712065|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712066|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83712067|NCT01845558|Wobenzym|wobenzym|mesh-list
83712068|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83712069|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
83712070|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712071|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
83712072|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83712073|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
83712074|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83712075|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
83712076|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712077|NCT01845610|Manganese|manganese|mesh-list
83712078|NCT01845610|Trace Elements|trace elements|mesh-ancestor
83712079|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
83712080|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712081|NCT01845675|Temozolomide|temozolomide|mesh-list
83712082|NCT01845675|Dacarbazine|dacarbazine|mesh-list
83712083|NCT01845675|Endostatins|endostatins|mesh-list
83712084|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83712085|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
83712086|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712087|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712088|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83712089|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83712090|NCT01845675|Growth Substances|growth substances|mesh-ancestor
83712091|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712092|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
83712093|NCT01845701|Artesunate|artesunate|mesh-list
83712094|NCT01845701|Lumefantrine|lumefantrine|mesh-list
82867012|NCT01154504|Protective Agents|protective agents|mesh-ancestor
82867013|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82867014|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82867015|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867016|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867017|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867018|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712096|NCT01845701|Piperaquine|piperaquine|mesh-list
83712097|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83712098|NCT01845701|Amodiaquine|amodiaquine|mesh-list
83712099|NCT01845701|Artenimol|artenimol|mesh-list
83712100|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
83712101|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83712102|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83712103|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712104|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712105|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
83712106|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
83712107|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83712108|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
83712109|NCT01845727|Amphotericin B|amphotericin b|mesh-list
83712110|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83712111|NCT01845727|Amebicides|amebicides|mesh-ancestor
83712112|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83712113|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83712114|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712115|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712116|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
83712117|NCT01845844|Ranibizumab|ranibizumab|mesh-list
83712118|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83712119|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83712120|NCT01845844|Growth Substances|growth substances|mesh-ancestor
83712121|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712122|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
83712123|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712124|NCT01846026|Vitamin D|vitamin d|mesh-list
83712125|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
83712126|NCT01846026|Vitamins|vitamins|mesh-ancestor
83712127|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
83712128|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712129|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83712130|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83712131|NCT01846117|Vitamin D|vitamin d|mesh-list
83712132|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
83712133|NCT01846117|Vitamins|vitamins|mesh-ancestor
83712134|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
83712135|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712136|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83712137|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
83712138|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83712139|NCT01846117|Estrogens|estrogens|mesh-ancestor
83712140|NCT01846117|Hormones|hormones|mesh-ancestor
83712141|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712142|NCT01846143|Poly ICLC|poly iclc|mesh-list
83712143|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
83712144|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712145|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
83712146|NCT01846273|Ranibizumab|ranibizumab|mesh-list
83712147|NCT01846273|Verteporfin|verteporfin|mesh-list
83712148|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83712149|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83712150|NCT01846273|Growth Substances|growth substances|mesh-ancestor
83712151|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712152|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
83712153|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712154|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83712155|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712156|NCT01846325|Vitamin E|vitamin e|mesh-list
83712157|NCT01846325|Vitamins|vitamins|mesh-ancestor
83712158|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
83712159|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712160|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
83712161|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712162|NCT01846325|Protective Agents|protective agents|mesh-ancestor
83712163|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83712164|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83712165|NCT01846364|Protective Agents|protective agents|mesh-ancestor
83712166|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712167|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867078|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867079|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
83712168|NCT01846390|Dexamethasone|dexamethasone|mesh-list
83712169|NCT01846390|Gemcitabine|gemcitabine|mesh-list
83712170|NCT01846390|Romidepsin|romidepsin|mesh-list
83712171|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712172|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
83712173|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
83712174|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712175|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712176|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83712177|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
83712178|NCT01846390|Hormones|hormones|mesh-ancestor
83712179|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712180|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83712181|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712182|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83712183|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
83712184|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712185|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83712186|NCT01846390|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83712187|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712188|NCT01846559|Clopidogrel|clopidogrel|mesh-list
83712189|NCT01846559|Ticagrelor|ticagrelor|mesh-list
83712190|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83712191|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83712192|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83712193|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83712194|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
83712195|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712196|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712197|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712198|NCT01846650|Capecitabine|capecitabine|mesh-list
83712199|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83712200|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
83712201|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712202|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712203|NCT01846806|Rifaximin|rifaximin|mesh-list
83712204|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712205|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712206|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83712207|NCT01846832|Interferons|interferons|mesh-list
83712208|NCT01846832|Ribavirin|ribavirin|mesh-list
83712209|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
83712210|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
83712211|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83712212|NCT01846832|Simeprevir|simeprevir|mesh-list
83712213|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712214|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
83712215|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712216|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
83712217|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712218|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
83712219|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712220|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
83712221|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712222|NCT01846962|Fluticasone|fluticasone|mesh-list
83712223|NCT01846962|Budesonide|budesonide|mesh-list
83712224|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712225|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83712226|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
83712227|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712228|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712229|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83712230|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
83712231|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712232|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83712233|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
83712234|NCT01846962|Hormones|hormones|mesh-ancestor
83712235|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712236|NCT01846975|Abatacept|abatacept|mesh-list
83712237|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83712238|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712239|NCT01846975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83712240|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712241|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83712242|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
83712243|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712244|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712245|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83712246|NCT01847144|Gliclazide|gliclazide|mesh-list
83712247|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83712248|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83712249|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712250|NCT01847144|Incretins|incretins|mesh-ancestor
83712251|NCT01847144|Hormones|hormones|mesh-ancestor
83712252|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712253|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
83712254|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712255|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712256|NCT01847157|Anesthetics|anesthetics|mesh-list
83712257|NCT01847157|Prilocaine|prilocaine|mesh-list
83712258|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712259|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712260|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
83712261|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
83712262|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712263|NCT01847235|Temozolomide|temozolomide|mesh-list
83712264|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83712265|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
83712266|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712267|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712268|NCT01847339|Bupivacaine|bupivacaine|mesh-list
83712269|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
83712270|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
83712271|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712272|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712273|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
83712274|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712275|NCT01847404|Pantoprazole|pantoprazole|mesh-list
83712276|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712277|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712278|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83712279|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83712280|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83712281|NCT01847417|Pantoprazole|pantoprazole|mesh-list
83712282|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83712283|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83712284|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83712285|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712286|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712287|NCT01847456|Insulin|insulin|mesh-list
83712288|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83712289|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83712290|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712291|NCT01847495|Irinotecan|irinotecan|mesh-list
83712292|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83712293|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83712294|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712295|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712296|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712297|NCT01847521|Quercetin|quercetin|mesh-list
83712298|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
83712299|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712300|NCT01847521|Protective Agents|protective agents|mesh-ancestor
83712301|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712302|NCT01847599|Capecitabine|capecitabine|mesh-list
83712303|NCT01847599|Lapatinib|lapatinib|mesh-list
83712304|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83712305|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
83712306|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712307|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712308|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83712309|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712310|NCT01847612|Methylene Blue|methylene blue|mesh-list
83712311|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712312|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712313|NCT01847664|Rifamycins|rifamycins|mesh-list
83712314|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
83712315|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712316|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712317|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712318|NCT01847677|Paclitaxel|paclitaxel|mesh-list
83712319|NCT01847677|Bevacizumab|bevacizumab|mesh-list
83712320|NCT01847677|Carboplatin|carboplatin|mesh-list
82867226|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
83712321|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83712322|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712323|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
83712324|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
83712325|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
83712326|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712327|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83712328|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83712329|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83712330|NCT01847677|Growth Substances|growth substances|mesh-ancestor
83712331|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712332|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
83712333|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
83712334|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712335|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
83712336|NCT01847768|Dimercaprol|dimercaprol|mesh-list
83712337|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
83712338|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
83712339|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712340|NCT01847768|Miotics|miotics|mesh-ancestor
83712341|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
83712342|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712343|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712344|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83712345|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83712346|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
83712347|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83712348|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83712349|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
83712350|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712351|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83712352|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
83712353|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712354|NCT01847872|Vaccines|vaccines|mesh-list
83712355|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
83712356|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712357|NCT01847976|Doxycycline|doxycycline|mesh-list
83712358|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712359|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712360|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
83712361|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83712362|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83712363|NCT01848106|Bivalirudin|bivalirudin|mesh-list
83712364|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
83712365|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83712366|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83712367|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712368|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712369|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
83712370|NCT01848119|Gabapentin|gabapentin|mesh-list
83712371|NCT01848119|Analgesics|analgesics|mesh-ancestor
83712372|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
83712373|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712374|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712375|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
83712376|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83712377|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83712378|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712379|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83712380|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83712381|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83712382|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712383|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712384|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
83712385|NCT01848132|Prednisone|prednisone|mesh-list
83712386|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
83712387|NCT01848132|Rituximab|rituximab|mesh-list
83712388|NCT01848132|Doxorubicin|doxorubicin|mesh-list
83712389|NCT01848132|Vincristine|vincristine|mesh-list
83712390|NCT01848132|Bortezomib|bortezomib|mesh-list
83712391|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83712392|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
83712393|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712394|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712395|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83712396|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
83712397|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867301|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
83712398|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712399|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83712400|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83712401|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83712402|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83712403|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83712404|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712405|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712406|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
83712407|NCT01848132|Hormones|hormones|mesh-ancestor
83712408|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712409|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83712410|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83712411|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
83712412|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
83712413|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
83712414|NCT01848197|Paclitaxel|paclitaxel|mesh-list
83712415|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83712416|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712417|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83712418|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83712419|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83712420|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712421|NCT01848236|Vitamin D|vitamin d|mesh-list
83712422|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
83712423|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
83712424|NCT01848236|Vitamins|vitamins|mesh-list
83712425|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
83712426|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712427|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83712428|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83712429|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83712430|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
83712431|NCT01848301|Acetylcholine|acetylcholine|mesh-list
83712432|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
83712433|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83712434|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
83712435|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712436|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712437|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712438|NCT01848340|Cabotegravir|cabotegravir|mesh-list
83712439|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83712440|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83712441|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712442|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712443|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83712444|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83712445|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
83712446|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712447|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83712448|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712449|NCT01848613|Vinorelbine|vinorelbine|mesh-list
83712450|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83712451|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712452|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
83712453|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
83712454|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
83712455|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712456|NCT01848652|Doxorubicin|doxorubicin|mesh-list
83712457|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83712458|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712459|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83712460|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83712461|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712462|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712463|NCT01848665|Indomethacin|indomethacin|mesh-list
83712464|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83712465|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83712466|NCT01848665|Analgesics|analgesics|mesh-ancestor
83712467|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
83712468|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712469|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712470|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712471|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712472|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
82867375|NCT03883022|Vancomycin|vancomycin|mesh-list
83712473|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
83712474|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83712475|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83712476|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712477|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712478|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
83712479|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
83712480|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712481|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
83712482|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712483|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712484|NCT01848743|Tenofovir|tenofovir|mesh-list
83712485|NCT01848743|Lamivudine|lamivudine|mesh-list
83712486|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
83712487|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712488|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83712489|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83712490|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712491|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712492|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83712493|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83712494|NCT01848769|Beclomethasone|beclomethasone|mesh-list
83712495|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
83712496|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83712497|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
83712498|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712499|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712500|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83712501|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
83712502|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83712503|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83712504|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83712505|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
83712506|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712507|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712508|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712509|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
83712510|NCT01848769|Hormones|hormones|mesh-ancestor
83712511|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712512|NCT01848808|Wobenzym|wobenzym|mesh-list
83712513|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83712514|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
83712515|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712516|NCT01848873|Amlodipine|amlodipine|mesh-list
83712517|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83712518|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83712519|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712520|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712521|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83712522|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712523|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
83712524|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
83712525|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712526|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
83712527|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712528|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712529|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83712530|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
83712531|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83712532|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
83712533|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712534|NCT01849016|Expectorants|expectorants|mesh-ancestor
83712535|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
83712536|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83712537|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
83712538|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712539|NCT01849016|Protective Agents|protective agents|mesh-ancestor
83712540|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712541|NCT01849016|Antidotes|antidotes|mesh-ancestor
83712542|NCT01849042|Donepezil|donepezil|mesh-list
83712543|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83712544|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712545|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867449|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712546|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
83712547|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712548|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712549|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
83712550|NCT01849094|Milrinone|milrinone|mesh-list
83712551|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83712552|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83712553|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
83712554|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83712555|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83712556|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712557|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712558|NCT01849094|Protective Agents|protective agents|mesh-ancestor
83712559|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712560|NCT01849211|Rocuronium|rocuronium|mesh-list
83712561|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83712562|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83712563|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83712564|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712565|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712566|NCT01849406|Budesonide|budesonide|mesh-list
83712567|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712568|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83712569|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
83712570|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712571|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712572|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83712573|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
83712574|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
83712575|NCT01849406|Hormones|hormones|mesh-ancestor
83712576|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712577|NCT01849640|Piperaquine|piperaquine|mesh-list
83712578|NCT01849640|Primaquine|primaquine|mesh-list
83712579|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
83712580|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83712581|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83712582|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712583|NCT01849666|Vemurafenib|vemurafenib|mesh-list
83712584|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
83712585|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712586|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83712587|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712588|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712589|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
83712590|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
83712591|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83712592|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83712593|NCT01849835|Menthol|menthol|mesh-list
83712594|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
83712595|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712596|NCT01849861|Methimazole|methimazole|mesh-list
83712597|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
83712598|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
83712599|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712600|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712601|NCT01849926|Amdinocillin|amdinocillin|mesh-list
83712602|NCT01849926|Ibuprofen|ibuprofen|mesh-list
83712603|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83712604|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83712605|NCT01849926|Analgesics|analgesics|mesh-ancestor
83712606|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
83712607|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712608|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712609|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712610|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712611|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83712612|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712613|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712614|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83712615|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712616|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712617|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83712618|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
83712619|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712620|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
82867524|NCT01160276|Cyclosporine|cyclosporine|mesh-list
83712621|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83712622|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712623|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712624|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83712625|NCT01850017|Analgesics|analgesics|mesh-ancestor
83712626|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
83712627|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712628|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83712629|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83712630|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83712631|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
83712632|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712633|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712634|NCT01850095|Azelaic acid|azelaic acid|mesh-list
83712635|NCT01850095|Estradiol|estradiol|mesh-list
83712636|NCT01850095|Estrogens|estrogens|mesh-ancestor
83712637|NCT01850095|Hormones|hormones|mesh-ancestor
83712638|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712639|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712640|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712641|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712642|NCT01850121|Infliximab|infliximab|mesh-list
83712643|NCT01850121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83712644|NCT01850121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712645|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712646|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83712647|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712648|NCT01850147|Sunitinib|sunitinib|mesh-list
83712649|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712650|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83712651|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83712652|NCT01850147|Growth Substances|growth substances|mesh-ancestor
83712653|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712654|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
83712655|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83712656|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712657|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712658|NCT01850160|Valsartan|valsartan|mesh-list
83712659|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
83712660|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
83712661|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
83712662|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83712663|NCT01850160|Diuretics|diuretics|mesh-list
83712664|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83712665|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83712666|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712667|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
83712668|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712669|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712670|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83712671|NCT01850251|Vitamin D|vitamin d|mesh-list
83712672|NCT01850251|Vitamins|vitamins|mesh-ancestor
83712673|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
83712674|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712675|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83712676|NCT01850277|Amiodarone|amiodarone|mesh-list
83712677|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712678|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83712679|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
83712680|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83712681|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712682|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83712683|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83712684|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83712685|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712686|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83712687|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83712688|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83712689|NCT01850511|Phenylephrine|phenylephrine|mesh-list
83712690|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
83712691|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83712692|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83712693|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83712694|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712695|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712696|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712697|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
83712698|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
83712699|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712700|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
83712701|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83712702|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
83712703|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83712704|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
83712705|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83712706|NCT01850511|Protective Agents|protective agents|mesh-ancestor
83712707|NCT01850628|Paclitaxel|paclitaxel|mesh-list
83712708|NCT01850628|Trastuzumab|trastuzumab|mesh-list
83712709|NCT01850628|Pertuzumab|pertuzumab|mesh-list
83712710|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83712711|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712712|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
83712713|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
83712714|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
83712715|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712716|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83712717|NCT01850680|Folic Acid|folic acid|mesh-list
83712718|NCT01850680|Methotrexate|methotrexate|mesh-list
83712719|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83712720|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
83712721|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83712722|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712723|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83712724|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
83712725|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712726|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712727|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712728|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712729|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83712730|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83712731|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
83712732|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712733|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83712734|NCT01850680|Hematinics|hematinics|mesh-ancestor
83712735|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
83712736|NCT01850680|Vitamins|vitamins|mesh-ancestor
83712737|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
83712738|NCT01850940|Tolvaptan|tolvaptan|mesh-list
83712739|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83712740|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712741|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
83712742|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712743|NCT01850953|Varenicline|varenicline|mesh-list
83712744|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83712745|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83712746|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83712747|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712748|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712749|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712750|NCT01850979|Tacrolimus|tacrolimus|mesh-list
83712751|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83712752|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
83712753|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712754|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83712755|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712756|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712757|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
83712758|NCT01851005|Remifentanil|remifentanil|mesh-list
83712759|NCT01851005|Anesthetics|anesthetics|mesh-list
82867674|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867675|NCT03877562|Olanzapine|olanzapine|mesh-list
82867676|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
82867677|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
82867678|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867679|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867680|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867681|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82867682|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82867684|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83712760|NCT01851005|Propofol|propofol|mesh-list
83712761|NCT01851005|Sevoflurane|sevoflurane|mesh-list
83712762|NCT01851005|Rocuronium|rocuronium|mesh-list
83712763|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712764|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712765|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83712766|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83712767|NCT01851005|Analgesics|analgesics|mesh-ancestor
83712768|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
83712769|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712770|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83712771|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83712772|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83712773|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
83712774|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712775|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712776|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83712777|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
83712778|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83712779|NCT01851005|Narcotics|narcotics|mesh-ancestor
83712780|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83712781|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83712782|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83712783|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83712784|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83712785|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
83712786|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83712787|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
83712788|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712789|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712790|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712791|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83712792|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83712793|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712794|NCT01851200|Immunotoxins|immunotoxins|mesh-ancestor
83712795|NCT01851200|Immunoconjugates|immunoconjugates|mesh-ancestor
83712796|NCT01851200|Immunologic Factors|immunologic factors|mesh-ancestor
83712797|NCT01851200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712798|NCT01851265|Olaparib|olaparib|mesh-list
83712799|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83712800|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712801|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712802|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712803|NCT01851278|Triamcinolone|triamcinolone|mesh-list
83712804|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83712805|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83712806|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83712807|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83712808|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
83712809|NCT01851278|Hormones|hormones|mesh-ancestor
83712810|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83712811|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712812|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83712813|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
83712814|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712815|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712816|NCT01851408|Sirolimus|sirolimus|mesh-list
83712817|NCT01851408|Sorafenib|sorafenib|mesh-list
83712818|NCT01851408|Temsirolimus|temsirolimus|mesh-list
83712819|NCT01851408|MTOR Inhibitors|mtor inhibitors|mesh-list
83712820|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712821|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83712822|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712823|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712824|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83712825|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
83712826|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712827|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712828|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712829|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83712830|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
83712831|NCT01851473|Quinine|quinine|mesh-list
83712832|NCT01851473|Acetazolamide|acetazolamide|mesh-list
83712833|NCT01851473|Cocaine|cocaine|mesh-list
83712834|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
82867739|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83712835|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83712836|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712837|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712838|NCT01851473|Diuretics|diuretics|mesh-ancestor
83712839|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
83712840|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712841|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
83712842|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
83712843|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712844|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
83712845|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712846|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83712847|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83712848|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83712849|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712850|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
83712851|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712852|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
83712853|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83712854|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83712855|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712856|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83712857|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83712858|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83712859|NCT01851473|Analgesics|analgesics|mesh-ancestor
83712860|NCT01851486|Clonidine|clonidine|mesh-list
83712861|NCT01851486|Naloxone|naloxone|mesh-list
83712862|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83712863|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712864|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
83712865|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712866|NCT01851486|Analgesics|analgesics|mesh-ancestor
83712867|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83712868|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
83712869|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
83712870|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83712871|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83712872|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83712873|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
83712874|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712875|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712876|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83712877|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83712878|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712879|NCT01851551|Rituximab|rituximab|mesh-list
83712880|NCT01851551|Vincristine|vincristine|mesh-list
83712881|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83712882|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712883|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
83712884|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712885|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83712886|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83712887|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
83712888|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
83712889|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
83712890|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712891|NCT01851681|Amoxicillin|amoxicillin|mesh-list
83712892|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712893|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712894|NCT01851733|Doxorubicin|doxorubicin|mesh-list
83712895|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83712896|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712897|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83712898|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83712899|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712900|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712901|NCT01851759|Cinepazide|cinepazide|mesh-list
83712902|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
83712903|NCT01851824|Vemurafenib|vemurafenib|mesh-list
83712904|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
83712905|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712906|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83712907|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712908|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712909|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
83712910|NCT01851850|Opicapone|opicapone|mesh-list
83712911|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83712912|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712913|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712914|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83712915|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83712917|NCT01851941|Folic Acid|folic acid|mesh-list
83712918|NCT01851941|Fluorouracil|fluorouracil|mesh-list
83712919|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
83712920|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
83712921|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
83712922|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712923|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83712924|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712925|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83712926|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
83712927|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712928|NCT01851941|Antidotes|antidotes|mesh-ancestor
83712929|NCT01851941|Protective Agents|protective agents|mesh-ancestor
83712930|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
83712931|NCT01851941|Vitamins|vitamins|mesh-ancestor
83712932|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
83712933|NCT01851941|Hematinics|hematinics|mesh-ancestor
83712934|NCT01851954|Clarithromycin|clarithromycin|mesh-list
83712935|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83712936|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712937|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83712938|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83712939|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712940|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83712941|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83712942|NCT01851980|Furosemide|furosemide|mesh-list
83712943|NCT01851980|Diuretics|diuretics|mesh-ancestor
83712944|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
83712945|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712946|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83712947|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712948|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712949|NCT01851993|Ondansetron|ondansetron|mesh-list
83712950|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
83712951|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
83712952|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712953|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712954|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83712955|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
83712956|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712957|NCT01851993|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83712958|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83712959|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
83712960|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712961|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712962|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
83712963|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83712964|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83712965|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83712966|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
83712967|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
83712968|NCT01852266|Vaccines|vaccines|mesh-list
83712969|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
83712970|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712971|NCT01852318|Fexofenadine|fexofenadine|mesh-list
83712972|NCT01852318|Pregabalin|pregabalin|mesh-list
83712973|NCT01852318|Analgesics|analgesics|mesh-ancestor
83712974|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
83712975|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83712976|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712977|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
83712978|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83712979|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83712980|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83712981|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83712982|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83712983|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83712984|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83712985|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83712986|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83712987|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83712988|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83712989|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
83712990|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
83712991|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83712992|NCT01852409|Bevacizumab|bevacizumab|mesh-list
83712993|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83712994|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83712995|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83712996|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83712997|NCT01852409|Growth Substances|growth substances|mesh-ancestor
83712998|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83712999|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
83713000|NCT01852461|Poractant alfa|poractant alfa|mesh-list
83713002|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83713003|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
83713004|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
83713005|NCT01852539|Propofol|propofol|mesh-list
83713006|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713007|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713008|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713009|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83713010|NCT01852539|Analgesics|analgesics|mesh-ancestor
83713011|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
83713012|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713013|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83713014|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83713015|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83713016|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
83713017|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713018|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713019|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713020|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
83713021|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
83713022|NCT01852565|Diltiazem|diltiazem|mesh-list
83713023|NCT01852565|Darapladib|darapladib|mesh-list
83713024|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83713025|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83713026|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83713027|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713028|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713029|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713030|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
83713031|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83713032|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713033|NCT01852604|Interferons|interferons|mesh-list
83713034|NCT01852604|Ritonavir|ritonavir|mesh-list
83713035|NCT01852604|Ribavirin|ribavirin|mesh-list
83713036|NCT01852604|Simeprevir|simeprevir|mesh-list
83713037|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713038|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
83713039|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713040|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83713041|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83713042|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
83713043|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713044|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713045|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83713046|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83713047|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83713048|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83713049|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
83713050|NCT01852630|Imipenem|imipenem|mesh-list
83713051|NCT01852630|Cefepime|cefepime|mesh-list
83713052|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83713053|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713054|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
83713055|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
83713056|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83713057|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83713058|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713059|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83713060|NCT01852903|Vitamins|vitamins|mesh-list
82867963|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713061|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
83713062|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
83713063|NCT01852903|Calcium|calcium|mesh-list
83713064|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
83713065|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713066|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713067|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
83713068|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713069|NCT01852903|Protective Agents|protective agents|mesh-ancestor
83713070|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
83713071|NCT01852994|Testosterone|testosterone|mesh-list
83713072|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
83713073|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
83713074|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83713075|NCT01852994|Androgens|androgens|mesh-ancestor
83713076|NCT01852994|Hormones|hormones|mesh-ancestor
83713077|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713078|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713079|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83713080|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713081|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
83713082|NCT01853111|Aldesleukin|aldesleukin|mesh-list
83713083|NCT01853111|Interleukin-2|interleukin-2|mesh-list
83713084|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713085|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83713086|NCT01853111|Analgesics|analgesics|mesh-ancestor
83713087|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
83713088|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713089|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713090|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83713091|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83713092|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
83713093|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713094|NCT01853306|Veliparib|veliparib|mesh-list
83713095|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83713096|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713097|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713098|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713099|NCT01853423|Sirolimus|sirolimus|mesh-list
83713100|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83713101|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713102|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83713103|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713104|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
83713105|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713106|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
83713107|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713108|NCT01853449|Fentanyl|fentanyl|mesh-list
83713109|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83713110|NCT01853449|Narcotics|narcotics|mesh-ancestor
83713111|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713112|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713113|NCT01853449|Analgesics|analgesics|mesh-ancestor
83713114|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
83713115|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713116|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83713117|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713118|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
83713119|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
83713120|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
83713121|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
83713122|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83713123|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83713124|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713125|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713126|NCT01853540|Urological Agents|urological agents|mesh-ancestor
83713127|NCT01853566|Hormones|hormones|mesh-list
83713128|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713129|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713130|NCT01853709|Bisacodyl|bisacodyl|mesh-list
83713131|NCT01853709|Cathartics|cathartics|mesh-ancestor
83713132|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713133|NCT01853709|Laxatives|laxatives|mesh-ancestor
83713134|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
83713135|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83713136|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82868044|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
83713137|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
83713138|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713139|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713140|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83713141|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
83713142|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83713143|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83713144|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83713145|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83713146|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713147|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713148|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
83713149|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83713150|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
83713151|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83713152|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
83713153|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713154|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713155|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
83713156|NCT01853813|Bevacizumab|bevacizumab|mesh-list
83713157|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83713158|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713159|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83713160|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83713161|NCT01853813|Growth Substances|growth substances|mesh-ancestor
83713162|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713163|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
83713164|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
83713165|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
83713166|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713167|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713168|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713169|NCT01853956|Alprazolam|alprazolam|mesh-list
83713170|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713171|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713172|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713173|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83713174|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83713175|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83713176|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
83713177|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
83713178|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713179|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713180|NCT01854021|Anesthetics|anesthetics|mesh-list
83713181|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713182|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713183|NCT01854073|Scopolamine|scopolamine|mesh-list
83713184|NCT01854073|Bromides|bromides|mesh-list
83713185|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83713186|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
83713187|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83713188|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
83713189|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
83713190|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713191|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713192|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713193|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
83713194|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83713195|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
83713196|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713197|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713198|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83713199|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
83713200|NCT01854086|Diphosphonates|diphosphonates|mesh-list
83713201|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713202|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713203|NCT01854203|Cisplatin|cisplatin|mesh-list
83713204|NCT01854203|Gemcitabine|gemcitabine|mesh-list
83713205|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713206|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82868116|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
83713207|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
83713208|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713209|NCT01854216|Rotigotine|rotigotine|mesh-list
83713210|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
83713211|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
83713212|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713213|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713214|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713215|NCT01854411|Analgesics|analgesics|mesh-list
83713216|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
83713217|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713218|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713219|NCT01854424|Dimercaprol|dimercaprol|mesh-list
83713220|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
83713221|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
83713222|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713223|NCT01854463|Vitamin D|vitamin d|mesh-list
83713224|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
83713225|NCT01854463|Vitamins|vitamins|mesh-ancestor
83713226|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
83713227|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713228|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713229|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713230|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
83713231|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83713232|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83713233|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713234|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
83713235|NCT01854476|Coagulants|coagulants|mesh-ancestor
83713236|NCT01854489|Rifampin|rifampin|mesh-list
83713237|NCT01854489|Buprenorphine|buprenorphine|mesh-list
83713238|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83713239|NCT01854489|Narcotics|narcotics|mesh-ancestor
83713240|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713241|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713242|NCT01854489|Analgesics|analgesics|mesh-ancestor
83713243|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
83713244|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713245|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83713246|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83713247|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
83713248|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83713249|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713250|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
83713251|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83713252|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713253|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713254|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83713255|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83713256|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83713257|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83713258|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83713259|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83713260|NCT01854502|Fluorides|fluorides|mesh-list
83713261|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
83713262|NCT01854502|Protective Agents|protective agents|mesh-ancestor
83713263|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713264|NCT01854515|Dexamethasone|dexamethasone|mesh-list
83713265|NCT01854515|Budesonide|budesonide|mesh-list
83713266|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
83713267|NCT01854515|BB 1101|bb 1101|mesh-list
83713268|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83713269|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
83713270|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
83713271|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713272|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713273|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713274|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
83713275|NCT01854515|Hormones|hormones|mesh-ancestor
83713276|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713277|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83713278|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713279|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83713280|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82868183|NCT01274780|Darunavir|darunavir|mesh-list
82868184|NCT01274780|Tenofovir|tenofovir|mesh-list
82868185|NCT01274780|Emtricitabine|emtricitabine|mesh-list
82868186|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83713281|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
83713282|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868191|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83713283|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713284|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713285|NCT01854606|Everolimus|everolimus|mesh-list
83713286|NCT01854606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83713287|NCT01854606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83713288|NCT01854606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713289|NCT01854606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713290|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713291|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
83713292|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713293|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713294|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
83713295|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83713296|NCT01854723|Insulin|insulin|mesh-list
83713297|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83713298|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
83713299|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
83713300|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
83713301|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
83713302|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83713303|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713304|NCT01854749|Cisplatin|cisplatin|mesh-list
83713305|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713306|NCT01854762|Ritonavir|ritonavir|mesh-list
83713307|NCT01854762|Lopinavir|lopinavir|mesh-list
83713308|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
83713309|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83713310|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83713311|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
83713312|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713313|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713314|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83713315|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83713316|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
83713317|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713318|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83713319|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83713320|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83713321|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83713322|NCT01854970|Esomeprazole|esomeprazole|mesh-list
83713323|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83713324|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713325|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83713326|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713327|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713328|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
83713329|NCT01855009|Vitamin D|vitamin d|mesh-list
83713330|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
83713331|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
83713332|NCT01855009|Calcium|calcium|mesh-list
83713333|NCT01855009|Vitamins|vitamins|mesh-ancestor
83713334|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
83713335|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713336|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713337|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713338|NCT01855009|Antacids|antacids|mesh-ancestor
83713339|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713340|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713341|NCT01855061|Midazolam|midazolam|mesh-list
83713342|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83713343|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713344|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713345|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713346|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83713347|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83713348|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83713349|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713350|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
83713351|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
83713352|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
83713353|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
83713354|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713355|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713356|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
83713357|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83713358|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
83713359|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83713360|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
83713362|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713363|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
83713364|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
83713365|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83713366|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
83713367|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83713368|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
83713369|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713370|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713371|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
83713372|NCT01855256|Oxybutynin|oxybutynin|mesh-list
83713373|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
83713374|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
83713375|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713376|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713377|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83713378|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83713379|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
83713380|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713381|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713382|NCT01855256|Urological Agents|urological agents|mesh-ancestor
83713383|NCT01855321|Vitamin D|vitamin d|mesh-list
83713384|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
83713385|NCT01855321|Vitamins|vitamins|mesh-ancestor
83713386|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
83713387|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713388|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713389|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713390|NCT01855334|Spironolactone|spironolactone|mesh-list
83713391|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83713392|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
83713393|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713394|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713395|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83713396|NCT01855334|Diuretics|diuretics|mesh-ancestor
83713397|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
83713398|NCT01855386|Liver Extracts|liver extracts|mesh-list
83713399|NCT01855386|Hematinics|hematinics|mesh-ancestor
83713400|NCT01855490|Exenatide|exenatide|mesh-list
83713401|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83713402|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713403|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83713404|NCT01855490|Incretins|incretins|mesh-ancestor
83713405|NCT01855490|Hormones|hormones|mesh-ancestor
83713406|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713407|NCT01855516|Heparin|heparin|mesh-list
83713408|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
83713409|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83713410|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83713411|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713412|NCT01855529|Ropivacaine|ropivacaine|mesh-list
83713413|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
83713414|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
83713415|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713416|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713417|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
83713418|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713419|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
83713420|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83713421|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83713422|NCT01855555|Propofol|propofol|mesh-list
83713423|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713424|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713425|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713426|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713427|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
83713428|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
83713429|NCT01855568|Methotrexate|methotrexate|mesh-list
83713430|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83713431|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
83713432|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83713433|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713434|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83713435|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
83713436|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713437|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713438|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
83713439|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713440|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83713441|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713442|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
83713443|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83713444|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83713446|NCT01855581|Propofol|propofol|mesh-list
83713447|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713448|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713449|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713450|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713451|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
83713452|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
83713453|NCT01855581|Analgesics|analgesics|mesh-ancestor
83713454|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
83713455|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713456|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83713457|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83713458|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83713459|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713460|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713461|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
83713462|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
83713463|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83713464|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713465|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713466|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
83713467|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83713468|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713469|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713470|NCT01855711|Alosetron|alosetron|mesh-list
83713471|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713472|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83713473|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
83713474|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713475|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713476|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713477|NCT01855724|Gemcitabine|gemcitabine|mesh-list
83713478|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83713479|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
83713480|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713481|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713482|NCT01855737|Warfarin|warfarin|mesh-list
83713483|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
83713484|NCT01855763|Insulin|insulin|mesh-list
83713485|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83713486|NCT01855763|Metformin|metformin|mesh-list
83713487|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83713488|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713489|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83713490|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
83713491|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713492|NCT01855971|Protective Agents|protective agents|mesh-ancestor
83713493|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713494|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83713495|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83713496|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713497|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83713498|NCT01855984|Tocotrienols|tocotrienols|mesh-list
83713499|NCT01855984|Vitamin E|vitamin e|mesh-list
83713500|NCT01855984|Tocopherols|tocopherols|mesh-list
83713501|NCT01855984|Tocovid|tocovid|mesh-list
83713502|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
83713503|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713504|NCT01855984|Protective Agents|protective agents|mesh-ancestor
83713505|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713506|NCT01855984|Vitamins|vitamins|mesh-ancestor
83713507|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
83713508|NCT01856023|Aldesleukin|aldesleukin|mesh-list
83713509|NCT01856023|Ipilimumab|ipilimumab|mesh-list
83713510|NCT01856023|Interleukin-2|interleukin-2|mesh-list
83713511|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83713512|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713513|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83713514|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713515|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83713516|NCT01856023|Analgesics|analgesics|mesh-ancestor
83713517|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
83713518|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713519|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713520|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83713521|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83713522|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
83713523|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713524|NCT01856062|Dexamethasone|dexamethasone|mesh-list
83713525|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83713526|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
83713527|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
83713528|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713529|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713530|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713531|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
83713532|NCT01856062|Hormones|hormones|mesh-ancestor
83713533|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713534|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83713535|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713536|NCT01856101|Dactolisib|dactolisib|mesh-list
83713537|NCT01856101|MTOR Inhibitors|mtor inhibitors|mesh-list
83713538|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498877|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
83713539|NCT01856101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83713540|NCT01856101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713541|NCT01856101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713542|NCT01856101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713543|NCT01856101|Immunologic Factors|immunologic factors|mesh-ancestor
83713544|NCT01856101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713545|NCT01856127|Sertraline|sertraline|mesh-list
83713546|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83713547|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
83713548|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83713549|NCT01856127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83713550|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83713551|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83713552|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713553|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713554|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
83713555|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713556|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83713557|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83713558|NCT01856166|Sufentanil|sufentanil|mesh-list
83713559|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
83713560|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83713561|NCT01856166|Narcotics|narcotics|mesh-ancestor
83713562|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713563|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713564|NCT01856166|Analgesics|analgesics|mesh-ancestor
83713565|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
83713566|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713567|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83713568|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713569|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
83713570|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
83713571|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
83713572|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
83713573|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83713574|NCT01856205|Antibodies|antibodies|mesh-list
83713575|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
83713576|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83713577|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
83713578|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713579|NCT01856348|Vitamin D|vitamin d|mesh-list
83713580|NCT01856348|Vitamins|vitamins|mesh-ancestor
83713581|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
83713582|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713583|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713584|NCT01856374|Sirolimus|sirolimus|mesh-list
83713585|NCT01856374|Everolimus|everolimus|mesh-list
83713586|NCT01856374|Atorvastatin|atorvastatin|mesh-list
83713587|NCT01856374|Pravastatin|pravastatin|mesh-list
83713588|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83713589|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83713590|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
83713591|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713592|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83713593|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83713594|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713595|NCT01856374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83713596|NCT01856374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83713597|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713598|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
83713599|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713600|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713601|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83713602|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713603|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83713604|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
83713605|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
83713606|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
83713607|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713609|NCT01856517|Analgesics|analgesics|mesh-ancestor
83713610|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
83713611|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713612|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713613|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83713614|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
83713615|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
83713616|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83713617|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83713618|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83713619|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
83713620|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713621|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713622|NCT01856556|Glycine|glycine|mesh-list
83713623|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
83713624|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713625|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713626|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713627|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83713628|NCT01856621|Charcoal|charcoal|mesh-list
83713629|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83713630|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
83713631|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713632|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713633|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83713634|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
83713635|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
83713636|NCT01856621|Hormones|hormones|mesh-ancestor
83713637|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713638|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
83713639|NCT01856621|Antidotes|antidotes|mesh-ancestor
83713640|NCT01856621|Protective Agents|protective agents|mesh-ancestor
83713641|NCT01856738|Rivastigmine|rivastigmine|mesh-list
83713642|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83713643|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713644|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713645|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
83713646|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713647|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713648|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83713649|NCT01856738|Protective Agents|protective agents|mesh-ancestor
83713650|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
83713651|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83713652|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
83713653|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713654|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713655|NCT01856946|Vitamin D|vitamin d|mesh-list
83713656|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
83713657|NCT01856946|Vitamins|vitamins|mesh-ancestor
83713658|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
83713659|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713660|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713661|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713662|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
83713663|NCT01856959|Albuterol|albuterol|mesh-list
83713665|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
83713666|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713667|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713668|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
83713669|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713670|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83713671|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
83713672|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83713673|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83713674|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713675|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713676|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
83713677|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83713678|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83713679|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
83713680|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83713681|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
83713682|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83713683|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83713684|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83713685|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83713686|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713687|NCT01856985|Misoprostol|misoprostol|mesh-list
83713688|NCT01856985|Mifepristone|mifepristone|mesh-list
83713689|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83713690|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
83713691|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83713692|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713693|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83713694|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713695|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
83713696|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83713697|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83713698|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83713699|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83713700|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
83713701|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83713702|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83713703|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
83713704|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713705|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
83713706|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83713707|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83713708|NCT01856998|Propofol|propofol|mesh-list
83713709|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713710|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713711|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713712|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713713|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
83713714|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
83713715|NCT01857011|Iron|iron|mesh-list
83713716|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83713717|NCT01857011|Teferrol|teferrol|mesh-list
83713718|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
83713719|NCT01857011|Trace Elements|trace elements|mesh-ancestor
83713720|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
83713721|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713722|NCT01857011|Hematinics|hematinics|mesh-ancestor
83713723|NCT01857024|Sevelamer|sevelamer|mesh-list
83713724|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
83713725|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
83713726|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713727|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
83713728|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713729|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713730|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713731|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83713732|NCT01857141|Analgesics|analgesics|mesh-ancestor
83713733|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
83713734|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713735|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83713736|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82868630|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713737|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83713738|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
83713739|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713740|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713741|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
83713742|NCT01857154|Vitamin D|vitamin d|mesh-list
83713743|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
83713744|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
83713745|NCT01857154|Calcium|calcium|mesh-list
83713746|NCT01857154|Vitamins|vitamins|mesh-ancestor
83713747|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
83713748|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713749|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713750|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713751|NCT01857154|Antacids|antacids|mesh-ancestor
83713752|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713753|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713754|NCT01857193|Everolimus|everolimus|mesh-list
83713755|NCT01857193|Exemestane|exemestane|mesh-list
83713756|NCT01857193|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83713757|NCT01857193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83713758|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713759|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713760|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713761|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
83713762|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713763|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713764|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83713765|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83713766|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83713767|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83713768|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713769|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83713770|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83713771|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83713772|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713773|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
83713774|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713775|NCT01857349|Ethanol|ethanol|mesh-list
83713776|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
83713777|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83713778|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83713779|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713780|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713781|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713782|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
83713783|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
83713784|NCT01857375|Insulin|insulin|mesh-list
83713785|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83713786|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713787|NCT01857453|Etoposide|etoposide|mesh-list
83713788|NCT01857453|Carboplatin|carboplatin|mesh-list
83713789|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83713790|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713791|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83713792|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83713793|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713794|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713795|NCT01857479|Amphotericin B|amphotericin b|mesh-list
83713796|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83713797|NCT01857479|Budesonide|budesonide|mesh-list
83713798|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83713799|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83713800|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
83713801|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713802|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713803|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83713804|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
83713805|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
83713806|NCT01857479|Hormones|hormones|mesh-ancestor
83713807|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713808|NCT01857479|Amebicides|amebicides|mesh-ancestor
82868704|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868705|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868706|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83713809|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83713810|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83713811|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713812|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83713813|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
83713814|NCT01857544|Aflibercept|aflibercept|mesh-list
83713815|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83713816|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83713817|NCT01857544|Growth Substances|growth substances|mesh-ancestor
83713818|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713819|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
83713820|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713821|NCT01857596|Trazodone|trazodone|mesh-list
83713822|NCT01857596|Bupropion|bupropion|mesh-list
83713823|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83713824|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
83713825|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83713826|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83713827|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83713828|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83713829|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713830|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
83713831|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713832|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713833|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83713834|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83713835|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713836|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83713837|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83713838|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713839|NCT01857596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83713840|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
83713841|NCT01857609|Metformin|metformin|mesh-list
83713842|NCT01857609|Rabeprazole|rabeprazole|mesh-list
83713843|NCT01857609|Pantoprazole|pantoprazole|mesh-list
83713844|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83713845|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713846|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83713847|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83713848|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83713849|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713850|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713851|NCT01857726|Doxorubicin|doxorubicin|mesh-list
83713852|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713853|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83713854|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83713855|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83713856|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713857|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713858|NCT01857752|Temozolomide|temozolomide|mesh-list
83713859|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83713860|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
83713861|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713862|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713863|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83713864|NCT01857804|Amoxicillin|amoxicillin|mesh-list
83713865|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
83713866|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83713867|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83713868|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83713869|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
83713870|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
83713871|NCT01857817|Etodolac|etodolac|mesh-list
83713872|NCT01857817|Propranolol|propranolol|mesh-list
83713873|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83713874|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83713875|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
83713876|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83713877|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713878|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713879|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83713880|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83713881|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
83713882|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83713883|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83713884|NCT01857817|Analgesics|analgesics|mesh-ancestor
83713885|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
83713886|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713887|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83713888|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83713889|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83713890|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83713891|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713892|NCT01857843|Everolimus|everolimus|mesh-list
83713893|NCT01857843|Simvastatin|simvastatin|mesh-list
83713894|NCT01857843|Ezetimibe|ezetimibe|mesh-list
83713895|NCT01857843|Pravastatin|pravastatin|mesh-list
83713896|NCT01857843|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83713897|NCT01857843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83713898|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713899|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713900|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713901|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
83713902|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713903|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713904|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83713905|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83713906|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
83713907|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83713908|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83713909|NCT01857856|Eplerenone|eplerenone|mesh-list
83713910|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83713911|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
83713912|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713913|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713914|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83713915|NCT01857856|Diuretics|diuretics|mesh-ancestor
83713916|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
83713917|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83713918|NCT01857895|Exenatide|exenatide|mesh-list
83713919|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83713920|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713921|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83713922|NCT01857895|Incretins|incretins|mesh-ancestor
83713923|NCT01857895|Hormones|hormones|mesh-ancestor
83713924|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83713925|NCT01857921|Trimetazidine|trimetazidine|mesh-list
83713926|NCT01857921|Atorvastatin|atorvastatin|mesh-list
83713927|NCT01857921|Pravastatin|pravastatin|mesh-list
83713928|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83713929|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83713930|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
83713931|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713932|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83713933|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83713934|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713935|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
83713936|NCT01857999|Losartan|losartan|mesh-list
83713937|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83713938|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83713939|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83713940|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83713941|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713942|NCT01858025|Fluorouracil|fluorouracil|mesh-list
83713943|NCT01858025|Mitomycins|mitomycins|mesh-list
83713944|NCT01858025|Mitomycin|mitomycin|mesh-list
83713945|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
83713946|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713947|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83713948|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713949|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713950|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
83713951|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713952|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83713953|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
83713954|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83713955|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713956|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
83713957|NCT01858051|Vitamin D|vitamin d|mesh-list
83713958|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83713959|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713960|NCT01858051|Vitamins|vitamins|mesh-ancestor
83713961|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
83713962|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83713963|NCT01858077|Everolimus|everolimus|mesh-list
83713964|NCT01858077|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83713965|NCT01858077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83713966|NCT01858077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83713967|NCT01858077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83713968|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83713969|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
83713970|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713971|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83713972|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
83713973|NCT01858090|Promethazine|promethazine|mesh-list
83713974|NCT01858090|Diclofenac|diclofenac|mesh-list
83713975|NCT01858090|Atropine|atropine|mesh-list
83713976|NCT01858090|Ephedrine|ephedrine|mesh-list
83713977|NCT01858090|Fentanyl|fentanyl|mesh-list
83713978|NCT01858090|Sufentanil|sufentanil|mesh-list
83713979|NCT01858090|Meperidine|meperidine|mesh-list
83713980|NCT01858090|Metoclopramide|metoclopramide|mesh-list
83713981|NCT01858090|Propofol|propofol|mesh-list
83713982|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
83713983|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83713984|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83713985|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83713986|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83713987|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
83713988|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
83713989|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83713990|NCT01858090|Narcotics|narcotics|mesh-ancestor
83713991|NCT01858090|Analgesics|analgesics|mesh-ancestor
83713992|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
83713993|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83713994|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83713995|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83713996|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83713997|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83713998|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83713999|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83714000|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714001|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714002|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83714003|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83714004|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
83714005|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83714006|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
83714007|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
83714008|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
83714009|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83714010|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83714011|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
83714012|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714013|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83714014|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
83714015|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
83714016|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83714017|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83714018|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
83714019|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
83714020|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83714021|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
83714022|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714023|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83714024|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83714025|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
83714026|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83714027|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
83714028|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83714029|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714030|NCT01858155|Melatonin|melatonin|mesh-list
83714031|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
83714032|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714033|NCT01858155|Protective Agents|protective agents|mesh-ancestor
83714034|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714035|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868928|NCT01172444|Mesalamine|mesalamine|mesh-list
83714036|NCT01858168|Irinotecan|irinotecan|mesh-list
83714037|NCT01858168|Temozolomide|temozolomide|mesh-list
83714038|NCT01858168|Olaparib|olaparib|mesh-list
83714039|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83714040|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714041|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714042|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714043|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714044|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83714045|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
83714046|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83714047|NCT01858207|Doxorubicin|doxorubicin|mesh-list
83714048|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83714049|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714050|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83714051|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714052|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714053|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714054|NCT01858311|Tocotrienols|tocotrienols|mesh-list
83714056|NCT01858311|Tocopherols|tocopherols|mesh-list
83714057|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
83714058|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714059|NCT01858311|Protective Agents|protective agents|mesh-ancestor
83714060|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714061|NCT01858311|Vitamins|vitamins|mesh-ancestor
83714062|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
83714063|NCT01858402|Acetaminophen|acetaminophen|mesh-list
83714064|NCT01858402|Dipyrone|dipyrone|mesh-list
83714065|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714066|NCT01858402|Analgesics|analgesics|mesh-ancestor
83714067|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
83714068|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714069|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714070|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
83714071|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83714072|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714073|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714074|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
83714075|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714076|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83714077|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714078|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714079|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
83714080|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83714081|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714082|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83714083|NCT01858571|Thalidomide|thalidomide|mesh-list
83714084|NCT01858571|Celecoxib|celecoxib|mesh-list
83714085|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
83714086|NCT01858571|Etoposide|etoposide|mesh-list
83714087|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714088|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
83714089|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714090|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714091|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83714092|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
83714093|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714094|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714095|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83714096|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83714097|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83714098|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714099|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714100|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83714101|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714102|NCT01858571|Analgesics|analgesics|mesh-ancestor
83714103|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
83714104|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714105|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714106|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83714107|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83714108|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
83714109|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714110|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869004|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714112|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83714113|NCT01858571|Growth Substances|growth substances|mesh-ancestor
83714114|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
83714115|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83714116|NCT01858610|Irbesartan|irbesartan|mesh-list
83714117|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83714118|NCT01858610|Diuretics|diuretics|mesh-ancestor
83714119|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
83714120|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714121|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83714122|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714123|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714124|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83714125|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83714126|NCT01858623|Losartan|losartan|mesh-list
83714127|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83714128|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83714129|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83714130|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83714131|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83714132|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714133|NCT01858623|Diuretics|diuretics|mesh-ancestor
83714134|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
83714135|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714136|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83714137|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714138|NCT01858649|Bevacizumab|bevacizumab|mesh-list
83714139|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
83714140|NCT01858649|Irinotecan|irinotecan|mesh-list
83714141|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83714142|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714143|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83714144|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83714145|NCT01858649|Growth Substances|growth substances|mesh-ancestor
83714146|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714147|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
83714148|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83714149|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714150|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714151|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714152|NCT01858662|Leucovorin|leucovorin|mesh-list
83714153|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
83714154|NCT01858662|Irinotecan|irinotecan|mesh-list
83714155|NCT01858662|Cetuximab|cetuximab|mesh-list
83714156|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714157|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83714158|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714159|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714160|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714161|NCT01858662|Antidotes|antidotes|mesh-ancestor
83714162|NCT01858662|Protective Agents|protective agents|mesh-ancestor
83714163|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714164|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
83714165|NCT01858662|Vitamins|vitamins|mesh-ancestor
83714166|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
83714167|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83714168|NCT01858792|Belimumab|belimumab|mesh-list
83714169|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714170|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
83714171|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714172|NCT01858831|Atovaquone|atovaquone|mesh-list
83714173|NCT01858831|Proguanil|proguanil|mesh-list
83714174|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83714175|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714176|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
83714177|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83714178|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83714179|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714180|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714181|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
83714182|NCT01858870|Lacosamide|lacosamide|mesh-list
83714183|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
83714184|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83714185|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83714186|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714187|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714189|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
83714190|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714191|NCT01858909|Protective Agents|protective agents|mesh-ancestor
83714192|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714193|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714194|NCT01858961|Interferons|interferons|mesh-list
83714195|NCT01858961|Ribavirin|ribavirin|mesh-list
83714196|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714197|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
83714198|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714199|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
83714200|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714201|NCT01859234|Bevacizumab|bevacizumab|mesh-list
83714202|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
83714203|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83714204|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714205|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83714206|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83714207|NCT01859234|Growth Substances|growth substances|mesh-ancestor
83714208|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714209|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
83714210|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83714211|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714212|NCT01859377|Ibuprofen|ibuprofen|mesh-list
83714213|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83714214|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714215|NCT01859377|Analgesics|analgesics|mesh-ancestor
83714216|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
83714217|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714218|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714219|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714220|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714221|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83714222|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714223|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714224|NCT01859455|Atorvastatin|atorvastatin|mesh-list
83714225|NCT01859455|Simvastatin|simvastatin|mesh-list
83714226|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83714227|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83714228|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
83714229|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714230|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83714231|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83714232|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714233|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
83714234|NCT01859468|Calcium|calcium|mesh-list
83714235|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83714236|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714237|NCT01859468|Antacids|antacids|mesh-ancestor
83714238|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714239|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83714240|NCT01859481|Eletriptan|eletriptan|mesh-list
83714241|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83714242|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
83714243|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714244|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714245|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714246|NCT01859585|Ketorolac|ketorolac|mesh-list
83714247|NCT01859585|Parecoxib|parecoxib|mesh-list
83714248|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83714249|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714250|NCT01859585|Analgesics|analgesics|mesh-ancestor
83714251|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
83714252|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714253|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714254|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714255|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714256|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83714257|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714258|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714259|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83714260|NCT01859624|Albuterol|albuterol|mesh-list
83714261|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83714262|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
83714263|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714264|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714265|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83714266|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
83714267|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
83714268|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83714269|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83714270|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83714271|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83714272|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714273|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714274|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714275|NCT01859728|Cisplatin|cisplatin|mesh-list
83714276|NCT01859728|Gemcitabine|gemcitabine|mesh-list
83714277|NCT01859728|Irinotecan|irinotecan|mesh-list
83714278|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714279|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83714280|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
83714281|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714282|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83714283|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714284|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714285|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
83714286|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83714287|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83714288|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
83714289|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714290|NCT01859858|Curcumin|curcumin|mesh-list
83714291|NCT01859858|Irinotecan|irinotecan|mesh-list
83714292|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83714293|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714294|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714295|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714296|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714297|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83714298|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714299|NCT01859858|Analgesics|analgesics|mesh-ancestor
83714300|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
83714301|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714302|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714303|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714304|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714305|NCT01860014|Poractant alfa|poractant alfa|mesh-list
83714306|NCT01860014|Beractant|beractant|mesh-list
83714307|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83714308|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
83714309|NCT01860066|Fluticasone|fluticasone|mesh-list
83714310|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83714311|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83714312|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714313|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83714314|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
83714315|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714316|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714317|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83714318|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
83714319|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714320|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83714321|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83714322|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83714323|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83714324|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714325|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714326|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714327|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
83714328|NCT01860066|Hormones|hormones|mesh-ancestor
83714329|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83714330|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
83714331|NCT01860105|Clopidogrel|clopidogrel|mesh-list
83714332|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83714333|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83714334|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83714335|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83714336|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
83714337|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714338|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714339|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714340|NCT01860144|Bevacizumab|bevacizumab|mesh-list
83714341|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83714342|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714343|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83714344|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83714345|NCT01860144|Growth Substances|growth substances|mesh-ancestor
83714346|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714347|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83714348|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
83714349|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83714350|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714351|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83714352|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
83714353|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714354|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714355|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714356|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714357|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83714358|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83714359|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714360|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714361|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83714362|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714363|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714364|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
83714365|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714366|NCT01860235|Anesthetics|anesthetics|mesh-list
83714367|NCT01860235|Benzocaine|benzocaine|mesh-list
83714368|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
83714369|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714370|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714371|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
83714372|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714373|NCT01860300|Amoxicillin|amoxicillin|mesh-list
83714374|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
83714375|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
83714376|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83714377|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714378|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714379|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83714380|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714381|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714382|NCT01860391|Fluorides|fluorides|mesh-list
83714383|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
83714384|NCT01860391|Protective Agents|protective agents|mesh-ancestor
83714385|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714386|NCT01860417|Mepivacaine|mepivacaine|mesh-list
83714387|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
83714388|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
83714389|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714390|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714391|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
83714392|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714393|NCT01860469|Vancomycin|vancomycin|mesh-list
83714394|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714395|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714396|NCT01860482|Rabeprazole|rabeprazole|mesh-list
83714397|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83714398|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83714399|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83714400|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714401|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714402|NCT01860508|Carboplatin|carboplatin|mesh-list
83714403|NCT01860508|Pemetrexed|pemetrexed|mesh-list
83714404|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714405|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714406|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714407|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83714408|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83714410|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83714411|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714412|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714413|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
83714414|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714415|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714416|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
83714417|NCT01860638|Bevacizumab|bevacizumab|mesh-list
83714418|NCT01860638|Temozolomide|temozolomide|mesh-list
83714419|NCT01860638|Lomustine|lomustine|mesh-list
83714420|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83714421|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714422|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83714423|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83714424|NCT01860638|Growth Substances|growth substances|mesh-ancestor
83714425|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714426|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
83714427|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83714428|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
83714429|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714430|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
83714431|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714432|NCT01860690|Methotrexate|methotrexate|mesh-list
83714433|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83714434|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
83714435|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83714436|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714437|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83714438|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
83714439|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714440|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714441|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714442|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714443|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83714444|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714445|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
83714446|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714447|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83714448|NCT01860716|Melatonin|melatonin|mesh-list
83714449|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
83714450|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714451|NCT01860716|Protective Agents|protective agents|mesh-ancestor
83714452|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714453|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714454|NCT01860729|Anacetrapib|anacetrapib|mesh-list
83714455|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83714456|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83714457|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
83714458|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714459|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83714460|NCT01860742|Interferons|interferons|mesh-list
83714461|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
83714462|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
83714463|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83714464|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714465|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
83714466|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714467|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
83714468|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714469|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83714470|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714471|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83714472|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83714473|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83714474|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714475|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714476|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83714477|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82869383|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82869384|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869385|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714478|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83714479|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
83714480|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714481|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714482|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83714483|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83714484|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
83714485|NCT01860833|Ibuprofen|ibuprofen|mesh-list
83714486|NCT01860833|Celecoxib|celecoxib|mesh-list
83714487|NCT01860833|Diclofenac|diclofenac|mesh-list
83714488|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83714489|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714490|NCT01860833|Analgesics|analgesics|mesh-ancestor
83714491|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
83714492|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714493|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714494|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714495|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714496|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83714497|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714498|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714499|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83714500|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83714501|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714502|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714503|NCT01861015|Vasopressins|vasopressins|mesh-list
83714504|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
83714505|NCT01861015|Epinephrine|epinephrine|mesh-list
83714506|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83714507|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83714508|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714509|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714510|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714511|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714512|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83714513|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83714514|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
83714515|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714516|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83714517|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
83714518|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
83714519|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
83714520|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83714521|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
83714522|NCT01861015|Coagulants|coagulants|mesh-ancestor
83714523|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83714524|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
83714525|NCT01861041|Bupivacaine|bupivacaine|mesh-list
83714526|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
83714527|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
83714528|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714529|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714530|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
83714531|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714532|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
83714533|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714534|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714535|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83714536|NCT01861223|Afatinib|afatinib|mesh-list
83714537|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
83714538|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714539|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83714540|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714541|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714542|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83714543|NCT01861340|Dexamethasone|dexamethasone|mesh-list
83714544|NCT01861340|Lenalidomide|lenalidomide|mesh-list
83714545|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714546|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
83714547|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
83714548|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714549|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714550|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83714551|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
83714552|NCT01861340|Hormones|hormones|mesh-ancestor
83714553|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83714554|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83714555|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714556|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
83714557|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83714558|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83714559|NCT01861340|Growth Substances|growth substances|mesh-ancestor
83714560|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
83714561|NCT01861535|Imiquimod|imiquimod|mesh-list
83714562|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83714563|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
83714564|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714565|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714566|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
83714567|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
83714568|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714569|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
83714570|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714571|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714572|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83714573|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
83714574|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714575|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714576|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83714577|NCT01861626|Isotretinoin|isotretinoin|mesh-list
83714578|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714579|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
83714580|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
83714581|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714582|NCT01861951|Doxorubicin|doxorubicin|mesh-list
83714583|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83714584|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714585|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83714586|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714587|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714588|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714589|NCT01861990|Valproic Acid|valproic acid|mesh-list
83714590|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
83714591|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714592|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714593|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
83714594|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714595|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714596|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
83714597|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83714598|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714599|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83714600|NCT01862003|Leucovorin|leucovorin|mesh-list
83714601|NCT01862003|Folic Acid|folic acid|mesh-list
83714602|NCT01862003|Fluorouracil|fluorouracil|mesh-list
83714603|NCT01862003|Irinotecan|irinotecan|mesh-list
83714604|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
83714605|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
83714606|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714607|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83714608|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714609|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714610|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
83714611|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714612|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83714613|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714614|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714615|NCT01862003|Antidotes|antidotes|mesh-ancestor
83714616|NCT01862003|Protective Agents|protective agents|mesh-ancestor
83714617|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
83714618|NCT01862003|Vitamins|vitamins|mesh-ancestor
83714619|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
83714620|NCT01862003|Hematinics|hematinics|mesh-ancestor
83714621|NCT01862081|Paclitaxel|paclitaxel|mesh-list
83714622|NCT01862081|Docetaxel|docetaxel|mesh-list
83714623|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83714624|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714625|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
82869530|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714626|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
82869531|NCT01185236|Atorvastatin|atorvastatin|mesh-list
83714627|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
83714628|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714629|NCT01862120|Interleukin-2|interleukin-2|mesh-list
83714630|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714631|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714632|NCT01862120|Analgesics|analgesics|mesh-ancestor
83714633|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
83714634|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714635|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714636|NCT01862263|Vildagliptin|vildagliptin|mesh-list
83714637|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83714638|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714639|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83714640|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
83714641|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714642|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714643|NCT01862302|Haloperidol|haloperidol|mesh-list
83714644|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
83714645|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
83714646|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
83714647|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714648|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714649|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83714650|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83714651|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83714652|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714653|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83714654|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83714655|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
83714656|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714657|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714658|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83714659|NCT01862354|Anesthetics|anesthetics|mesh-list
83714660|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714661|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714662|NCT01862497|Carvedilol|carvedilol|mesh-list
83714663|NCT01862497|Prazosin|prazosin|mesh-list
83714664|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83714665|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83714666|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714667|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714668|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714669|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714670|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83714671|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
83714672|NCT01862497|Protective Agents|protective agents|mesh-ancestor
83714673|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83714674|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714675|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83714676|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
83714677|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83714678|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83714679|NCT01862523|Capsaicin|capsaicin|mesh-list
83714680|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
83714681|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714682|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
83714683|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714684|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714685|NCT01862835|Anastrozole|anastrozole|mesh-list
83714686|NCT01862835|Testosterone|testosterone|mesh-list
83714687|NCT01862835|Estrogens|estrogens|mesh-list
83714688|NCT01862835|Androgens|androgens|mesh-ancestor
83714689|NCT01862835|Hormones|hormones|mesh-ancestor
83714690|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83714691|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714692|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83714693|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714694|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83714695|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83714696|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714697|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714698|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83714699|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
83714700|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
83714701|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714702|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869606|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714703|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83714704|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83714705|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714706|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714707|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714709|NCT01862926|Rituximab|rituximab|mesh-list
83714710|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714711|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
83714712|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714713|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714714|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83714715|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
83714716|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714717|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714718|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83714719|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83714720|NCT01862978|Heparin|heparin|mesh-list
83714721|NCT01862978|Nadroparin|nadroparin|mesh-list
83714722|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
83714723|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83714724|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83714725|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714726|NCT01863004|Bortezomib|bortezomib|mesh-list
83714727|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714728|NCT01863069|Interferons|interferons|mesh-list
83714729|NCT01863069|Interferon-beta|interferon-beta|mesh-list
83714730|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
83714731|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714732|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
83714733|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714734|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
83714735|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714736|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83714737|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83714738|NCT01863147|Acarbose|acarbose|mesh-list
83714739|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83714740|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714741|NCT01863147|Incretins|incretins|mesh-ancestor
83714742|NCT01863147|Hormones|hormones|mesh-ancestor
83714743|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83714744|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83714745|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83714746|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714747|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714748|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83714749|NCT01863173|Metoprolol|metoprolol|mesh-list
83714750|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83714751|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83714752|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
83714753|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
83714754|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714755|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714756|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83714757|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83714758|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83714759|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714760|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714761|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714762|NCT01863199|Ranibizumab|ranibizumab|mesh-list
83714763|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83714764|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83714765|NCT01863199|Growth Substances|growth substances|mesh-ancestor
83714766|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714767|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
83714768|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714769|NCT01863225|Atorvastatin|atorvastatin|mesh-list
83714770|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83714771|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83714772|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83714773|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
83714774|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714775|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83714776|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83714777|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714778|NCT01863238|Ivacaftor|ivacaftor|mesh-list
83714779|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83714780|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714781|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714782|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83714783|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83714784|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83714785|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792161|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714786|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714787|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714788|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714789|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714790|NCT01863277|Melatonin|melatonin|mesh-list
83714791|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
83714792|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714793|NCT01863277|Protective Agents|protective agents|mesh-ancestor
83714794|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714795|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714796|NCT01863355|Fentanyl|fentanyl|mesh-list
83714797|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83714798|NCT01863355|Narcotics|narcotics|mesh-ancestor
83714799|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714800|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714801|NCT01863355|Analgesics|analgesics|mesh-ancestor
83714802|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
83714803|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714804|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83714805|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83714806|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
83714807|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
83714808|NCT01863407|Metronidazole|metronidazole|mesh-list
83714809|NCT01863407|Dexamethasone|dexamethasone|mesh-list
83714810|NCT01863407|Allantoin|allantoin|mesh-list
83714811|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714812|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
83714813|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
83714814|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714815|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714816|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83714817|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
83714818|NCT01863407|Hormones|hormones|mesh-ancestor
83714819|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83714820|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83714821|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714822|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714823|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714824|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83714825|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83714826|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714827|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83714828|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83714829|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714830|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83714831|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83714832|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714833|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714834|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
83714835|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714836|NCT01863485|Vorolanib|vorolanib|mesh-list
83714837|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83714838|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714839|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714840|NCT01863511|Tolvaptan|tolvaptan|mesh-list
83714841|NCT01863511|Diuretics|diuretics|mesh-list
83714842|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83714843|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
83714844|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714845|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83714846|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714847|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714848|NCT01863589|Adefovir|adefovir|mesh-list
82869754|NCT03854708|Hormones|hormones|mesh-ancestor
82869757|NCT03860870|Clenbuterol|clenbuterol|mesh-list
83714849|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
83714850|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714851|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83714852|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83714853|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714854|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714855|NCT01863602|Lamotrigine|lamotrigine|mesh-list
83714856|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
83714857|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83714858|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714859|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714860|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83714861|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714862|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83714863|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83714864|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714865|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83714866|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83714867|NCT01863615|Isotretinoin|isotretinoin|mesh-list
83714868|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
83714869|NCT01863641|Calcitriol|calcitriol|mesh-list
83714870|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83714871|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714872|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83714873|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714874|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714875|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83714876|NCT01863641|Vitamins|vitamins|mesh-ancestor
83714877|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
83714878|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83714879|NCT01863654|Montelukast|montelukast|mesh-list
83714880|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83714881|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
83714882|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83714883|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
83714884|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83714885|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714886|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83714887|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83714888|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714889|NCT01863706|Misoprostol|misoprostol|mesh-list
83714890|NCT01863706|Oxytocin|oxytocin|mesh-list
83714891|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
83714892|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83714893|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714894|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83714895|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
83714896|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83714897|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83714898|NCT01863719|Colistin|colistin|mesh-list
83714899|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714900|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714901|NCT01863810|Pregabalin|pregabalin|mesh-list
83714902|NCT01863810|Analgesics|analgesics|mesh-ancestor
83714903|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
83714904|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714905|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714906|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
83714907|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83714908|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83714909|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714910|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83714911|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83714912|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83714913|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714914|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83714915|NCT01863823|Amoxicillin|amoxicillin|mesh-list
83714916|NCT01863823|Tetracycline|tetracycline|mesh-list
83714917|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83714918|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83714919|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83714920|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869827|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714921|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714922|NCT01863888|Teriflunomide|teriflunomide|mesh-list
83714923|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
83714924|NCT01863888|Charcoal|charcoal|mesh-list
83714925|NCT01863888|Antidotes|antidotes|mesh-ancestor
83714926|NCT01863888|Protective Agents|protective agents|mesh-ancestor
83714927|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714928|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83714929|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714930|NCT01863888|Analgesics|analgesics|mesh-ancestor
83714931|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
83714932|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714933|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83714934|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83714935|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714936|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
83714937|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83714938|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83714939|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
83714940|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714941|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83714942|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83714943|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83714944|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83714945|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
83714946|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714947|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83714948|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83714949|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714950|NCT01864057|Thiamine|thiamine|mesh-list
83714951|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
83714952|NCT01864057|Vitamins|vitamins|mesh-ancestor
83714953|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
83714954|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714955|NCT01864070|Everolimus|everolimus|mesh-list
83714956|NCT01864070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83714957|NCT01864070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83714958|NCT01864070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83714959|NCT01864070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714960|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83714961|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
83714962|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714963|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83714964|NCT01864083|Fluorides|fluorides|mesh-list
83714965|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
83714966|NCT01864083|Protective Agents|protective agents|mesh-ancestor
83714967|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714968|NCT01864096|Metformin|metformin|mesh-list
83714969|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83714970|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714971|NCT01864161|Iron|iron|mesh-list
83714972|NCT01864161|Trace Elements|trace elements|mesh-ancestor
83714973|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
83714974|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714975|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
83714976|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83714977|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714978|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714979|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83714980|NCT01864187|Analgesics|analgesics|mesh-ancestor
83714981|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
83714982|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83714983|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83714984|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83714985|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83714986|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
83714987|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83714988|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83714989|NCT01864213|Tetracaine|tetracaine|mesh-list
83714990|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
83714991|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
83714992|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83714993|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83714994|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
83714995|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869902|NCT02530632|Propofol|propofol|mesh-list
83714996|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
83714997|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
83714998|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
83714999|NCT01864265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83715000|NCT01864265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715001|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83715002|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
83715003|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715004|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83715005|NCT01864551|Lamotrigine|lamotrigine|mesh-list
83715006|NCT01864551|Olanzapine|olanzapine|mesh-list
83715007|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
83715008|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
83715009|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715010|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715011|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715012|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83715013|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83715014|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715015|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715016|NCT01864551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83715017|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83715018|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715019|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715020|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715021|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
83715022|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
83715023|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83715024|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715025|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83715026|NCT01864616|Vitamin D|vitamin d|mesh-list
83715027|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
83715028|NCT01864616|Vitamins|vitamins|mesh-ancestor
83715029|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
83715030|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715031|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83715032|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715033|NCT01864655|Saracatinib|saracatinib|mesh-list
83715034|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715035|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715036|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715037|NCT01864681|Metformin|metformin|mesh-list
83715038|NCT01864681|Gefitinib|gefitinib|mesh-list
83715039|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715040|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715041|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715042|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83715043|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715044|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715045|NCT01864798|Denosumab|denosumab|mesh-list
83715046|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83715047|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715048|NCT01864824|Vitamins|vitamins|mesh-list
83715049|NCT01864824|Folic Acid|folic acid|mesh-list
83715050|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
83715051|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
83715052|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
83715053|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
83715054|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715055|NCT01864824|Hematinics|hematinics|mesh-ancestor
83715056|NCT01864863|Bosentan|bosentan|mesh-list
83715057|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83715058|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83715059|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715060|NCT01864915|Prucalopride|prucalopride|mesh-list
83715061|NCT01864915|Laxatives|laxatives|mesh-ancestor
83715062|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715063|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83715064|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83715065|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
83715066|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715067|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715068|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869979|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82869980|NCT00054132|Growth Substances|growth substances|mesh-ancestor
83715070|NCT01865175|Trace Elements|trace elements|mesh-ancestor
83715071|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
83715072|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715073|NCT01865188|Amlodipine|amlodipine|mesh-list
83715074|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83715075|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83715076|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83715077|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715078|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715079|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715080|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715081|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
83715082|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83715083|NCT01865201|Mannitol|mannitol|mesh-list
83715084|NCT01865201|Edaravone|edaravone|mesh-list
83715085|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83715086|NCT01865201|Diuretics|diuretics|mesh-ancestor
83715087|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
83715088|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715089|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83715090|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
83715091|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715092|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83715093|NCT01865201|Protective Agents|protective agents|mesh-ancestor
83715094|NCT01865279|Insulin|insulin|mesh-list
83715095|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83715096|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
83715097|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
83715098|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
83715099|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
83715100|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715101|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715102|NCT01865292|Insulin|insulin|mesh-list
83715103|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83715104|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
83715105|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715106|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715107|NCT01865305|Insulin|insulin|mesh-list
83715108|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83715109|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
83715110|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
83715111|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83715112|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
83715113|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83715114|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
83715115|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715116|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715117|NCT01865318|Insulin|insulin|mesh-list
83715118|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715119|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870081|NCT00057876|Gemcitabine|gemcitabine|mesh-list
82870082|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82870083|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
82870084|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870085|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870086|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
82870087|NCT01183910|Calcium|calcium|mesh-list
82870088|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82870089|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870090|NCT01183910|Antacids|antacids|mesh-ancestor
82870091|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870092|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870093|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
82870094|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82870095|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
82870096|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870097|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
82870098|NCT03852914|Protective Agents|protective agents|mesh-ancestor
82870099|NCT05234684|Prednisone|prednisone|mesh-list
82870100|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
82870101|NCT05234684|Vincristine|vincristine|mesh-list
82870102|NCT05234684|Rituximab|rituximab|mesh-list
82870103|NCT05234684|Doxorubicin|doxorubicin|mesh-list
82870104|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870105|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
82870106|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715121|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83715122|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
83715123|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
83715124|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715125|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715126|NCT01865500|Prednisolone|prednisolone|mesh-list
83715127|NCT01865500|Budesonide|budesonide|mesh-list
83715128|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715129|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
83715130|NCT01865500|Hormones|hormones|mesh-ancestor
83715131|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83715132|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715133|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83715134|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715135|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
83715136|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715137|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83715138|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83715139|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
83715140|NCT01865630|Etanercept|etanercept|mesh-list
83715141|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83715142|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83715143|NCT01865630|Analgesics|analgesics|mesh-ancestor
83715144|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
83715145|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715146|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715147|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715148|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83715149|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715150|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83715151|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
83715152|NCT01865669|Oxytocin|oxytocin|mesh-list
83715153|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
83715154|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83715155|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715156|NCT01865721|Entonox|entonox|mesh-list
83715157|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83715158|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
83715159|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715160|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715161|NCT01865760|Octreotide|octreotide|mesh-list
83715162|NCT01865760|Somatostatin|somatostatin|mesh-list
83715163|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715164|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83715165|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715166|NCT01865760|Hormones|hormones|mesh-ancestor
83715167|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83715168|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715169|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
83715170|NCT01865916|Bisacodyl|bisacodyl|mesh-list
83715171|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
83715172|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715173|NCT01865916|Protective Agents|protective agents|mesh-ancestor
83715174|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715175|NCT01865916|Vitamins|vitamins|mesh-ancestor
83715176|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
83715177|NCT01865916|Cathartics|cathartics|mesh-ancestor
83715178|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715179|NCT01865916|Laxatives|laxatives|mesh-ancestor
83715180|NCT01865968|Vaccines|vaccines|mesh-list
83715181|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
83715182|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715183|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83715184|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
83715185|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715186|NCT01866059|Methamphetamine|methamphetamine|mesh-list
83715187|NCT01866059|Calcium|calcium|mesh-list
83715188|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715189|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715190|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83715191|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
83715192|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
83715193|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715194|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
83715195|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870133|NCT03853304|Vitamins|vitamins|mesh-ancestor
83715196|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715197|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
83715198|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83715199|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83715200|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715201|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83715203|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83715204|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
83715205|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83715206|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715207|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83715208|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715209|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
83715210|NCT01866254|Morphine|morphine|mesh-list
83715211|NCT01866254|Hydromorphone|hydromorphone|mesh-list
83715212|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83715213|NCT01866254|Narcotics|narcotics|mesh-ancestor
83715214|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715215|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715216|NCT01866254|Analgesics|analgesics|mesh-ancestor
83715217|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
83715218|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715219|NCT01866267|Maraviroc|maraviroc|mesh-list
83715220|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83715221|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83715222|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715223|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83715224|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83715225|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
83715226|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715227|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83715228|NCT01866397|Cidofovir|cidofovir|mesh-list
83715229|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
83715230|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715231|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715232|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715233|NCT01866488|Misoprostol|misoprostol|mesh-list
83715234|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83715235|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
83715236|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83715237|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715238|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83715239|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715240|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
83715241|NCT01866514|Lidocaine|lidocaine|mesh-list
83715242|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
83715243|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
83715244|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715245|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715246|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
83715247|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715248|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83715249|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83715250|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83715251|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715252|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715253|NCT01866553|Interferons|interferons|mesh-list
83715254|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
83715255|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
83715256|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83715257|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715258|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
83715259|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715260|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
83715261|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715262|NCT01866605|Midazolam|midazolam|mesh-list
83715263|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83715264|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83715265|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715266|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715267|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83715268|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82870207|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
82870209|NCT02459392|Prednisolone|prednisolone|mesh-list
83715269|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715270|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83715271|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
83715272|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
83715273|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
83715274|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
83715275|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715276|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715277|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
83715278|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83715279|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
83715280|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715281|NCT01866644|Expectorants|expectorants|mesh-ancestor
83715282|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
83715283|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83715284|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
83715285|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715286|NCT01866644|Protective Agents|protective agents|mesh-ancestor
83715287|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715288|NCT01866644|Antidotes|antidotes|mesh-ancestor
83715289|NCT01867138|Vancomycin|vancomycin|mesh-list
83715290|NCT01867138|Cefazolin|cefazolin|mesh-list
83715291|NCT01867138|Amikacin|amikacin|mesh-list
83715292|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83715293|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715294|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83715295|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83715296|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83715297|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715298|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715299|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715300|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715301|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83715302|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
83715303|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715304|NCT01867268|Acetazolamide|acetazolamide|mesh-list
83715305|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
83715306|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83715307|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715308|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715309|NCT01867268|Diuretics|diuretics|mesh-ancestor
83715310|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
83715311|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715312|NCT01867281|Aspirin|aspirin|mesh-list
83715313|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83715314|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83715315|NCT01867281|Analgesics|analgesics|mesh-ancestor
83715316|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
83715317|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715318|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715319|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715320|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83715321|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83715322|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83715323|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715324|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83715325|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83715326|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715327|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
83715328|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83715329|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83715330|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
83715331|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715332|NCT01867463|Antacids|antacids|mesh-ancestor
83715333|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715334|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715335|NCT01867502|Metformin|metformin|mesh-list
83715336|NCT01867502|Vildagliptin|vildagliptin|mesh-list
83715337|NCT01867502|Glyburide|glyburide|mesh-list
82870280|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82870281|NCT01193816|Loxapine|loxapine|mesh-list
82870282|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82870283|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83715338|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715339|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870286|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715340|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83715342|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792162|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715343|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715344|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
83715345|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83715346|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715347|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
83715348|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83715349|NCT01867645|Antibodies|antibodies|mesh-list
83715350|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
83715351|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83715352|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
83715353|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715354|NCT01867697|Leucovorin|leucovorin|mesh-list
83715355|NCT01867697|Folic Acid|folic acid|mesh-list
83715356|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
83715357|NCT01867697|Irinotecan|irinotecan|mesh-list
83715358|NCT01867697|Cetuximab|cetuximab|mesh-list
83715359|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
83715360|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
83715361|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715362|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715363|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83715364|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83715365|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715366|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715367|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83715368|NCT01867697|Antidotes|antidotes|mesh-ancestor
83715369|NCT01867697|Protective Agents|protective agents|mesh-ancestor
83715370|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
83715371|NCT01867697|Vitamins|vitamins|mesh-ancestor
83715372|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
83715373|NCT01867697|Hematinics|hematinics|mesh-ancestor
83715374|NCT01867697|Antacids|antacids|mesh-ancestor
83715375|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715376|NCT01867775|Mirtazapine|mirtazapine|mesh-list
83715377|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
83715378|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715379|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83715380|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
83715381|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
83715382|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715383|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715384|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715385|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83715386|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83715387|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715388|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83715389|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83715390|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83715391|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83715392|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83715393|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83715394|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
83715395|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83715396|NCT01867866|Trifluridine|trifluridine|mesh-list
83715397|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
83715398|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715399|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
83715400|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715401|NCT01867892|Leucovorin|leucovorin|mesh-list
83715402|NCT01867892|Gemcitabine|gemcitabine|mesh-list
83715403|NCT01867892|Fluorouracil|fluorouracil|mesh-list
83715404|NCT01867892|Irinotecan|irinotecan|mesh-list
83715405|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
83715406|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83715407|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
83715408|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715409|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870352|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82870353|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715410|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870354|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83715411|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
83715412|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715413|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83715414|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83715415|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715416|NCT01867892|Antidotes|antidotes|mesh-ancestor
83715417|NCT01867892|Protective Agents|protective agents|mesh-ancestor
83715418|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
83715419|NCT01867892|Vitamins|vitamins|mesh-ancestor
83715420|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
83715421|NCT01868048|Nabiximols|nabiximols|mesh-list
83715422|NCT01868048|Analgesics|analgesics|mesh-ancestor
83715423|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
83715424|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715425|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715426|NCT01868113|Fluticasone|fluticasone|mesh-list
83715427|NCT01868113|Xhance|xhance|mesh-list
83715428|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715429|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83715430|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
83715431|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715432|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715433|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83715434|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
83715435|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
83715436|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83715437|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83715438|NCT01868126|Latanoprost|latanoprost|mesh-list
83715439|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83715440|NCT01868191|Thiamine|thiamine|mesh-list
83715441|NCT01868191|Benphothiamine|benphothiamine|mesh-list
83715442|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83715443|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
83715444|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715445|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
83715446|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
83715447|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715448|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
83715449|NCT01868191|Vitamins|vitamins|mesh-ancestor
83715450|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
83715451|NCT01868360|Aflibercept|aflibercept|mesh-list
83715452|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83715453|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83715454|NCT01868360|Growth Substances|growth substances|mesh-ancestor
83715455|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715456|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
83715457|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715458|NCT01868438|Artesunate|artesunate|mesh-list
83715459|NCT01868438|Pyronaridine|pyronaridine|mesh-list
83715460|NCT01868438|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83715461|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
83715462|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83715463|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83715464|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715465|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715466|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
83715467|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
83715468|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83715469|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
83715470|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
83715471|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83715472|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
83715473|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715474|NCT01868529|Insulin|insulin|mesh-list
83715475|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83715476|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
83715477|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715478|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715479|NCT01868555|Insulin|insulin|mesh-list
83715480|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83715481|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
83715482|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
83715483|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83715484|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715485|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715486|NCT01868568|Insulin|insulin|mesh-list
83715487|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82870440|NCT01292174|Ibalizumab|ibalizumab|mesh-list
83715488|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
83715489|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
83715490|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83715491|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
83715492|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83715493|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715494|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715496|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83715497|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
83715498|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
83715499|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715500|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715501|NCT01868750|Calcitriol|calcitriol|mesh-list
83715502|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715503|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715504|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83715505|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715506|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715507|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83715508|NCT01868750|Vitamins|vitamins|mesh-ancestor
83715509|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
83715510|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83715511|NCT01868802|Ketamine|ketamine|mesh-list
83715512|NCT01868802|Analgesics|analgesics|mesh-ancestor
83715513|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
83715514|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715515|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715516|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83715517|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83715518|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
83715519|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
83715520|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715521|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83715522|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83715523|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715524|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715525|NCT01868906|Temozolomide|temozolomide|mesh-list
83715526|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83715527|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
83715528|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715529|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715530|NCT01868945|Vitamin D|vitamin d|mesh-list
83715531|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
83715532|NCT01868945|Calcifediol|calcifediol|mesh-list
83715533|NCT01868945|Vitamins|vitamins|mesh-ancestor
83715534|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
83715535|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715536|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83715537|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715538|NCT01868984|Paclitaxel|paclitaxel|mesh-list
83715539|NCT01868984|Heparin|heparin|mesh-list
83715540|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83715541|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715542|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
83715543|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
83715544|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
83715545|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715546|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
83715547|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83715548|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83715549|NCT01869010|Tenofovir|tenofovir|mesh-list
83715550|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
83715551|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715552|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83715553|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83715554|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715555|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715556|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83715557|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83715558|NCT01869023|Gemcitabine|gemcitabine|mesh-list
83715559|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715560|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83715561|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
83715562|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715563|NCT01869036|Morphine|morphine|mesh-list
83715564|NCT01869036|Anesthetics|anesthetics|mesh-list
82870499|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715565|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715566|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715567|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83715568|NCT01869036|Narcotics|narcotics|mesh-ancestor
83715569|NCT01869036|Analgesics|analgesics|mesh-ancestor
83715570|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
83715571|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715572|NCT01869205|Ivermectin|ivermectin|mesh-list
83715573|NCT01869205|Abamectin|abamectin|mesh-list
83715574|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83715575|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715576|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
83715577|NCT01869257|Triclosan|triclosan|mesh-list
83715578|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83715579|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715580|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83715581|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83715582|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
83715583|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715584|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83715585|NCT01869309|Ticagrelor|ticagrelor|mesh-list
83715586|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83715587|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83715588|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83715589|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83715590|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83715591|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
83715592|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715593|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715594|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715595|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
83715596|NCT01869491|Antacids|antacids|mesh-ancestor
83715597|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715598|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715599|NCT01869556|Oxytocin|oxytocin|mesh-list
83715600|NCT01869556|Carboprost|carboprost|mesh-list
83715601|NCT01869556|Carboprost tromethamine|carboprost tromethamine|mesh-list
83715602|NCT01869556|Ergonovine|ergonovine|mesh-list
83715603|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
83715604|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83715605|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715606|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83715607|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
83715608|NCT01869569|Pregabalin|pregabalin|mesh-list
83715609|NCT01869569|Analgesics|analgesics|mesh-ancestor
83715610|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
83715611|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715612|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715613|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
83715614|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83715615|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715616|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715617|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715618|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83715619|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83715620|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715621|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715622|NCT01869621|Metformin|metformin|mesh-list
83715623|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715624|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715625|NCT01869673|Anesthetics|anesthetics|mesh-list
83715626|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715627|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715628|NCT01869751|Prucalopride|prucalopride|mesh-list
83715629|NCT01869751|Laxatives|laxatives|mesh-ancestor
83715630|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715631|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83715632|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83715633|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
83715634|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715635|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715636|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715637|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
83715638|NCT01869803|Calicheamicins|calicheamicins|mesh-list
83715639|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83715640|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715641|NCT01869803|Immunotoxins|immunotoxins|mesh-ancestor
83715642|NCT01869803|Immunoconjugates|immunoconjugates|mesh-ancestor
83715643|NCT01869803|Immunologic Factors|immunologic factors|mesh-ancestor
83715644|NCT01869803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715645|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83715646|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
83715647|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83715648|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83715649|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715650|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83715651|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83715652|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
83715653|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715654|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715655|NCT01869907|Minocycline|minocycline|mesh-list
83715656|NCT01869907|Amitriptyline|amitriptyline|mesh-list
83715657|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83715658|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715659|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83715660|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
83715661|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715662|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83715663|NCT01869907|Analgesics|analgesics|mesh-ancestor
83715664|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
83715665|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715666|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715667|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83715668|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83715669|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83715670|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715671|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
83715672|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715673|NCT01869946|Ropivacaine|ropivacaine|mesh-list
83715674|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
83715675|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
83715676|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715677|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715678|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
83715679|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715680|NCT01870011|Anesthetics|anesthetics|mesh-list
83715682|NCT01870011|Desflurane|desflurane|mesh-list
83715683|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715684|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715685|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83715686|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83715687|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
83715688|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83715689|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
83715690|NCT01870024|Lorazepam|lorazepam|mesh-list
83715691|NCT01870024|Clonazepam|clonazepam|mesh-list
83715692|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
83715693|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
83715694|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
83715695|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715696|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715697|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715698|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83715699|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715700|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83715701|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83715702|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83715703|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
83715704|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
83715705|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715706|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715707|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83715708|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82870650|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83715709|NCT01870050|Dapsone|dapsone|mesh-list
83715710|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715711|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
82870651|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
82870654|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
83715712|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83715713|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83715714|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83715715|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715716|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715717|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
83715718|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83715719|NCT01870115|Vitamin D|vitamin d|mesh-list
83715720|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
83715721|NCT01870115|Melatonin|melatonin|mesh-list
83715722|NCT01870115|Vitamins|vitamins|mesh-ancestor
83715723|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
83715724|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715725|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83715726|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715727|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83715728|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
83715729|NCT01870115|Protective Agents|protective agents|mesh-ancestor
83715730|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715731|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
83715732|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
83715733|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
83715734|NCT01870128|Methotrexate|methotrexate|mesh-list
83715735|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83715736|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
83715737|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83715738|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715739|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83715740|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
83715741|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715742|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715743|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
83715744|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715745|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83715746|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83715747|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
83715748|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83715749|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83715750|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715751|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
83715752|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
83715753|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715754|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715755|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
83715756|NCT01870128|Hormones|hormones|mesh-ancestor
83715757|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83715758|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83715759|NCT01870128|Protective Agents|protective agents|mesh-ancestor
83715760|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
83715761|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83715762|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83715763|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715764|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83715765|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83715766|NCT01870128|Analgesics|analgesics|mesh-ancestor
83715767|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
83715768|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83715769|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83715770|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83715771|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83715772|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715773|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715774|NCT01870219|Ketamine|ketamine|mesh-list
83715775|NCT01870219|Anesthetics|anesthetics|mesh-list
83715776|NCT01870219|Sevoflurane|sevoflurane|mesh-list
83715777|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83715778|NCT01870219|Analgesics|analgesics|mesh-ancestor
83715779|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
83715780|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715781|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715782|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83715783|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
83715784|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870724|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83715785|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83715786|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83715787|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715788|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715789|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83715790|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83715792|NCT01870284|Ixekizumab|ixekizumab|mesh-list
83715793|NCT01870284|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83715794|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715795|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83715796|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
83715797|NCT01870427|Aflibercept|aflibercept|mesh-list
83715798|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83715799|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83715800|NCT01870427|Growth Substances|growth substances|mesh-ancestor
83715801|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715802|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
83715803|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715804|NCT01868880|Bisoprolol|bisoprolol|mesh-list
83715805|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83715806|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83715807|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
83715808|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715809|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715810|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715811|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83715812|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
83715813|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
83715814|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715815|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83715816|NCT01870440|Dexamethasone|dexamethasone|mesh-list
83715817|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
83715818|NCT01870440|BB 1101|bb 1101|mesh-list
83715819|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715820|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
83715821|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
83715822|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715823|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715824|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715825|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
83715826|NCT01870440|Hormones|hormones|mesh-ancestor
83715827|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83715828|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83715829|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715830|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
83715831|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715832|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715833|NCT01870466|Cilostazol|cilostazol|mesh-list
83715834|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83715835|NCT01870466|Simvastatin|simvastatin|mesh-list
83715836|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83715837|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83715838|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
83715839|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715840|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83715841|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83715842|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715843|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83715844|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
83715845|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715846|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715847|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83715848|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
83715849|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83715850|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83715851|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83715852|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
83715853|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83715854|NCT01870466|Protective Agents|protective agents|mesh-ancestor
83715855|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83715856|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83715857|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83715858|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83715859|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83715860|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715861|NCT01870635|Ondansetron|ondansetron|mesh-list
83715862|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
83715863|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
83715864|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715865|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715866|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715867|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
83715868|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
83715869|NCT01870635|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83715870|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83715871|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
83715872|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715873|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715874|NCT01870648|Ondansetron|ondansetron|mesh-list
83715875|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
83715876|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
83715877|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715878|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715879|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715880|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
83715881|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
83715882|NCT01870648|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83715883|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83715884|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
83715885|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715886|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715887|NCT01870674|Prucalopride|prucalopride|mesh-list
83715888|NCT01870674|YH12852|yh12852|mesh-list
83715889|NCT01870674|Laxatives|laxatives|mesh-ancestor
83715890|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715891|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83715892|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83715893|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
83715894|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715895|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715896|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715897|NCT01870804|Atorvastatin|atorvastatin|mesh-list
83715898|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83715899|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83715900|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83715901|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
83715902|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715903|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83715904|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83715905|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715906|NCT01870895|Ramosetron|ramosetron|mesh-list
83715907|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
83715908|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
83715909|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715910|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715911|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83715912|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83715913|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
83715914|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83715915|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715916|NCT01870908|Tacrolimus|tacrolimus|mesh-list
83715917|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83715918|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
83715919|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715920|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83715921|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715922|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715923|NCT01870986|Adalimumab|adalimumab|mesh-list
83715924|NCT01870986|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83715925|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715926|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83715927|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
83715928|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83715929|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83715930|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715931|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83715932|NCT01871129|Analgesics|analgesics|mesh-ancestor
83715933|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
82870876|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
83715934|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83715935|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83715936|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83715937|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83715938|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
83715939|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792163|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
83715940|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715941|NCT01871363|Capecitabine|capecitabine|mesh-list
83715942|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715943|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83715944|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
83715945|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715946|NCT01871376|Aflibercept|aflibercept|mesh-list
83715947|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83715948|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83715949|NCT01871376|Growth Substances|growth substances|mesh-ancestor
83715950|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715951|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
83715952|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715953|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
83715954|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83715955|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715956|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715957|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83715958|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83715959|NCT01871454|Protective Agents|protective agents|mesh-ancestor
83715960|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715961|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
83715962|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83715963|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
83715964|NCT01871467|Sargramostim|sargramostim|mesh-list
83715965|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
83715966|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715967|NCT01871480|Gefitinib|gefitinib|mesh-list
83715968|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715969|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83715970|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715971|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715972|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
83715973|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83715974|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715975|NCT01871649|Golimumab|golimumab|mesh-list
83715976|NCT01871649|Methotrexate|methotrexate|mesh-list
83715977|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83715978|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
83715979|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83715980|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83715981|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83715982|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
83715983|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83715984|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83715985|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
83715986|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83715987|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83715988|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83715989|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
83715990|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83715991|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83715992|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83715993|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83715994|NCT01871662|Interferons|interferons|mesh-list
83715995|NCT01871662|Ribavirin|ribavirin|mesh-list
83715996|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
83715997|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
83715998|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83715999|NCT01871662|Silybin|silybin|mesh-list
83716000|NCT01871662|Silymarin|silymarin|mesh-list
83716001|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716002|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
83716003|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716004|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
83716005|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716006|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
82870953|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716007|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716008|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
83716009|NCT01871662|Protective Agents|protective agents|mesh-ancestor
83716010|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83716011|NCT01871675|Rituximab|rituximab|mesh-list
83716012|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83716013|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716014|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716015|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
83716016|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716017|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716018|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83716019|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
83716020|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716021|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
83716022|NCT01871701|Dexetimide|dexetimide|mesh-list
83716023|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83716024|NCT01871701|Citalopram|citalopram|mesh-list
83716025|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83716026|NCT01871701|Escitalopram|escitalopram|mesh-list
83716027|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83716028|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716029|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83716030|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83716031|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716032|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716033|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716034|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83716035|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
83716036|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83716037|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716038|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83716039|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83716040|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83716041|NCT01871701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83716042|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83716043|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83716044|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716045|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
83716046|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83716047|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83716048|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
83716049|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
83716050|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716051|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83716052|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83716053|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
83716054|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83716055|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
83716056|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83716057|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83716058|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83716059|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716060|NCT01871740|Folic Acid|folic acid|mesh-list
83716061|NCT01871740|Enalapril|enalapril|mesh-list
83716062|NCT01871740|Enalaprilat|enalaprilat|mesh-list
83716063|NCT01871740|Maleic acid|maleic acid|mesh-list
83716064|NCT01871740|Hematinics|hematinics|mesh-ancestor
83716065|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
83716066|NCT01871740|Vitamins|vitamins|mesh-ancestor
83716067|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
83716068|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716069|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716070|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716071|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83716072|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
83716073|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83716074|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
83716075|NCT01871792|Pitavastatin|pitavastatin|mesh-list
83716076|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83716077|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83716078|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83716079|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
83716080|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716081|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871027|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83716082|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83716083|NCT01871844|Octreotide|octreotide|mesh-list
83716084|NCT01871844|Somatostatin|somatostatin|mesh-list
83716085|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716086|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83716087|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716088|NCT01871844|Hormones|hormones|mesh-ancestor
83716089|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716090|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716091|NCT01871857|Epinephrine|epinephrine|mesh-list
83716092|NCT01871857|Racepinephrine|racepinephrine|mesh-list
83716093|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
83716094|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83716095|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83716096|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
83716097|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716098|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716099|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716100|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83716101|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83716102|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
83716103|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716104|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83716105|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
83716106|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
83716107|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
83716108|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83716109|NCT01871922|Atropine|atropine|mesh-list
83716110|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83716111|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83716112|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83716113|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
83716114|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716115|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716116|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83716117|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
83716118|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
83716119|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
83716120|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83716121|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83716122|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
83716123|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716124|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716125|NCT01871935|Sufentanil|sufentanil|mesh-list
83716126|NCT01871935|Remifentanil|remifentanil|mesh-list
83716127|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83716128|NCT01871935|Narcotics|narcotics|mesh-ancestor
83716129|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716130|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716131|NCT01871935|Analgesics|analgesics|mesh-ancestor
83716132|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
83716133|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716134|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83716135|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83716136|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
83716137|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
83716138|NCT01871961|Methotrexate|methotrexate|mesh-list
83716139|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83716140|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
83716141|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83716142|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716143|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83716144|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
83716145|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716146|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716147|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83716148|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716149|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83716150|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83716151|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
83716152|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716153|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83716154|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83716155|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
83716156|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83716157|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83716159|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716160|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716161|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83716162|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
83716163|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83716164|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83716165|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83716166|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716167|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716168|NCT01872013|ASP7991|asp7991|mesh-list
83716169|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83716170|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
83716171|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716172|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716173|NCT01872026|ASP7991|asp7991|mesh-list
83716174|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83716175|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
83716176|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716177|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716178|NCT01872039|Nicardipine|nicardipine|mesh-list
83716179|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83716180|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83716181|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83716182|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716183|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83716184|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716185|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
83716186|NCT01871311|Cetuximab|cetuximab|mesh-list
83716187|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716188|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716189|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
83716190|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
83716191|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
83716192|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716193|NCT01872351|Protective Agents|protective agents|mesh-ancestor
83716194|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716195|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
83716196|NCT01872351|Vitamins|vitamins|mesh-ancestor
83716197|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
83716198|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
83716199|NCT01872403|Paclitaxel|paclitaxel|mesh-list
83716200|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83716201|NCT01872403|Carboplatin|carboplatin|mesh-list
83716202|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83716203|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716204|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
83716205|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
83716206|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83716207|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716208|NCT01872416|Doxorubicin|doxorubicin|mesh-list
83716209|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83716210|NCT01872416|Ifosfamide|ifosfamide|mesh-list
83716211|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83716212|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716213|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83716214|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83716215|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716216|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716217|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83716218|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
83716219|NCT01872442|Interferons|interferons|mesh-list
83716220|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
83716221|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
83716222|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83716223|NCT01872442|Dasatinib|dasatinib|mesh-list
83716224|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716225|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
83716226|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716227|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
83716228|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716229|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83716230|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871177|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82871184|NCT05064020|Tenofovir|tenofovir|mesh-list
83716231|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716232|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
83716233|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83716234|NCT01872494|Pentazocine|pentazocine|mesh-list
83716235|NCT01872494|Palonosetron|palonosetron|mesh-list
83716236|NCT01872494|Ropivacaine|ropivacaine|mesh-list
83716237|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
83716238|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
83716239|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716240|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716241|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
83716242|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716243|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
83716244|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
83716245|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716246|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83716247|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83716248|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
83716249|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716250|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716251|NCT01872494|Analgesics|analgesics|mesh-ancestor
83716252|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83716253|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83716254|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83716255|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716256|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83716257|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716258|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83716259|NCT01872494|Narcotics|narcotics|mesh-ancestor
83716260|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83716261|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83716262|NCT01872546|Adalimumab|adalimumab|mesh-list
83716263|NCT01872546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83716264|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83716265|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716266|NCT01872702|Piperaquine|piperaquine|mesh-list
83716267|NCT01872702|Primaquine|primaquine|mesh-list
83716268|NCT01872702|Artenimol|artenimol|mesh-list
83716269|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
83716270|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83716271|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83716272|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716273|NCT01872728|Anesthetics|anesthetics|mesh-list
83716274|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716275|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716276|NCT01872754|Remifentanil|remifentanil|mesh-list
83716277|NCT01872754|Propofol|propofol|mesh-list
83716278|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83716279|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716280|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716281|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83716282|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
83716283|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
83716284|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83716285|NCT01872754|Narcotics|narcotics|mesh-ancestor
83716286|NCT01872754|Analgesics|analgesics|mesh-ancestor
83716287|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
83716288|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716289|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
83716290|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83716291|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716292|NCT01872832|Verinurad|verinurad|mesh-list
83716293|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
83716294|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716295|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83716296|NCT01872845|Pravastatin|pravastatin|mesh-list
83716297|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83716298|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83716299|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
83716300|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716301|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82871250|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
83716302|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83716303|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716304|NCT01872858|Aspirin|aspirin|mesh-list
83716305|NCT01872858|Cilostazol|cilostazol|mesh-list
83716306|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83716307|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83716308|NCT01872858|Analgesics|analgesics|mesh-ancestor
83716309|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
83716310|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716311|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716312|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83716313|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716314|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83716315|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83716316|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716317|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83716318|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83716319|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716320|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
83716321|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83716322|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
83716323|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83716324|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
83716325|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
83716326|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83716327|NCT01872858|Protective Agents|protective agents|mesh-ancestor
83716328|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83716329|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83716330|NCT01872871|Acetaminophen|acetaminophen|mesh-list
83716331|NCT01872871|Anesthetics|anesthetics|mesh-list
83716332|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
83716333|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716334|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716335|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83716336|NCT01872871|Analgesics|analgesics|mesh-ancestor
83716337|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
83716338|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716339|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
83716340|NCT01872884|Remifentanil|remifentanil|mesh-list
83716341|NCT01872884|Sevoflurane|sevoflurane|mesh-list
83716342|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83716343|NCT01872884|Narcotics|narcotics|mesh-ancestor
83716344|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716345|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716346|NCT01872884|Analgesics|analgesics|mesh-ancestor
83716347|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
83716348|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716349|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83716350|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83716351|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
83716352|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
83716353|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
83716354|NCT01872897|Antacids|antacids|mesh-ancestor
83716355|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716356|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716357|NCT01872923|Bleomycin|bleomycin|mesh-list
83716358|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83716359|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716360|NCT01872936|Ribavirin|ribavirin|mesh-list
83716361|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
83716362|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716363|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
83716364|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716365|NCT01872962|Cisplatin|cisplatin|mesh-list
83716366|NCT01872962|Gemcitabine|gemcitabine|mesh-list
83716367|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716368|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83716369|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
83716370|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716371|NCT01872988|Tenofovir|tenofovir|mesh-list
83716372|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
83716373|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716374|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83716375|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83716376|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716377|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716378|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83716379|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83716380|NCT01873001|Pioglitazone|pioglitazone|mesh-list
82871322|NCT01202240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83716381|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
83716382|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83716383|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716384|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716385|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83716386|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716387|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716388|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
83716389|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716390|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83716391|NCT01873027|Sirolimus|sirolimus|mesh-list
83716392|NCT01873027|Umirolimus|umirolimus|mesh-list
83716393|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83716394|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83716395|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
83716396|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716397|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83716398|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716399|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83716400|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716401|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
83716402|NCT01873079|Esomeprazole|esomeprazole|mesh-list
83716403|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83716404|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716405|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83716406|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716407|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716408|NCT05855811|Dostarlimab|dostarlimab|mesh-list
83716409|NCT05855811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716410|NCT05855746|Colchicine|colchicine|mesh-list
83716411|NCT05855746|Gout Suppressants|gout suppressants|mesh-ancestor
83716412|NCT05855746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716413|NCT05855746|Tubulin Modulators|tubulin modulators|mesh-ancestor
83716414|NCT05855746|Antimitotic Agents|antimitotic agents|mesh-ancestor
83716415|NCT05855746|Mitosis Modulators|mitosis modulators|mesh-ancestor
83716416|NCT05855746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716417|NCT05855746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716418|NCT05855629|Inositol|inositol|mesh-list
83716419|NCT05855629|Adapalene|adapalene|mesh-list
83716420|NCT05855629|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83716421|NCT05855629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83716422|NCT05855629|Vitamin B Complex|vitamin b complex|mesh-ancestor
83716423|NCT05855629|Vitamins|vitamins|mesh-ancestor
83716424|NCT05855629|Micronutrients|micronutrients|mesh-ancestor
83716425|NCT05855629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716426|NCT05855629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83716427|NCT05855629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83716428|NCT05855629|Analgesics|analgesics|mesh-ancestor
83716429|NCT05855629|Sensory System Agents|sensory system agents|mesh-ancestor
83716430|NCT05855629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716431|NCT05855629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83716432|NCT05855629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716433|NCT05855616|Chlorhexidine|chlorhexidine|mesh-list
83716434|NCT05855616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83716435|NCT05855616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716436|NCT05855616|Disinfectants|disinfectants|mesh-ancestor
83716437|NCT05855590|Tranexamic Acid|tranexamic acid|mesh-list
83716438|NCT05855590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83716439|NCT05855590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83716440|NCT05855590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716441|NCT05855590|Hemostatics|hemostatics|mesh-ancestor
83716442|NCT05855590|Coagulants|coagulants|mesh-ancestor
83716443|NCT05855577|Terazosin|terazosin|mesh-list
83716444|NCT05855577|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83716445|NCT05855577|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83716446|NCT05855577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83716447|NCT05855577|Adrenergic Agents|adrenergic agents|mesh-ancestor
83716448|NCT05855577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716449|NCT05855577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716450|NCT05855577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716451|NCT05855577|Urological Agents|urological agents|mesh-ancestor
83716452|NCT05855486|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83716453|NCT05855486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83716454|NCT05855200|Dostarlimab|dostarlimab|mesh-list
83716455|NCT05855200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716456|NCT05855187|Modafinil|modafinil|mesh-list
83716457|NCT05855187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82871396|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83716458|NCT05855187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716459|NCT05855187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83716460|NCT05855187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83716461|NCT05855187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83716462|NCT05855187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716463|NCT05855070|Verapamil|verapamil|mesh-list
83716464|NCT05855070|Hyaluronic Acid|hyaluronic acid|mesh-list
83716465|NCT05855070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83716466|NCT05855070|Immunologic Factors|immunologic factors|mesh-ancestor
83716467|NCT05855070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716468|NCT05855070|Viscosupplements|viscosupplements|mesh-ancestor
83716469|NCT05855070|Protective Agents|protective agents|mesh-ancestor
83716470|NCT05855070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83716471|NCT05855070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83716472|NCT05855070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83716473|NCT05855070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716474|NCT05855070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83716475|NCT05855070|Vasodilator Agents|vasodilator agents|mesh-ancestor
83716476|NCT05855018|Atropine|atropine|mesh-list
83716477|NCT05855018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83716478|NCT05855018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83716479|NCT05855018|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83716480|NCT05855018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83716481|NCT05855018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83716482|NCT05855018|Autonomic Agents|autonomic agents|mesh-ancestor
83716483|NCT05855018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716484|NCT05855018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716485|NCT05855018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83716486|NCT05855018|Respiratory System Agents|respiratory system agents|mesh-ancestor
83716487|NCT05855018|Mydriatics|mydriatics|mesh-ancestor
83716488|NCT05855018|Parasympatholytics|parasympatholytics|mesh-ancestor
83716489|NCT05855018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83716490|NCT05855018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83716491|NCT05855018|Cholinergic Agents|cholinergic agents|mesh-ancestor
83716492|NCT05855018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716493|NCT05855018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716494|NCT05854992|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
83716495|NCT05854992|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83716496|NCT05854992|Serotonin Agents|serotonin agents|mesh-ancestor
83716497|NCT05854992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716498|NCT05854992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716499|NCT05854992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716500|NCT05854849|Gemcitabine|gemcitabine|mesh-list
83716501|NCT05854849|Apatinib|apatinib|mesh-list
83716502|NCT05854849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716503|NCT05854849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83716504|NCT05854849|Antimetabolites|antimetabolites|mesh-ancestor
83716505|NCT05854849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716506|NCT05854849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83716507|NCT05854849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716508|NCT05854784|Afamelanotide|afamelanotide|mesh-list
83716509|NCT05854784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83716510|NCT05854667|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83716511|NCT05854667|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83716512|NCT05854667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716513|NCT05854667|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83716514|NCT05854667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83716515|NCT05854667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83716516|NCT05854667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716517|NCT05854667|Dopamine Agents|dopamine agents|mesh-ancestor
83716518|NCT05854667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716519|NCT05854537|Lidocaine|lidocaine|mesh-list
83716520|NCT05854537|Bupivacaine|bupivacaine|mesh-list
83716521|NCT05854537|Anesthetics, Local|anesthetics, local|mesh-ancestor
83716522|NCT05854537|Anesthetics|anesthetics|mesh-ancestor
83716523|NCT05854537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716524|NCT05854537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716525|NCT05854537|Sensory System Agents|sensory system agents|mesh-ancestor
83716526|NCT05854537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716527|NCT05854537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83716528|NCT05854537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83716529|NCT05854537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82871471|NCT03841526|Hormones|hormones|mesh-ancestor
83716530|NCT05854537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83716531|NCT05854537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716532|NCT05854511|Sofosbuvir|sofosbuvir|mesh-list
83716533|NCT05854511|Antiviral Agents|antiviral agents|mesh-ancestor
83716534|NCT05854511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716535|NCT05854498|Bevacizumab|bevacizumab|mesh-list
83716536|NCT05854498|Irinotecan|irinotecan|mesh-list
83716537|NCT05854498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716538|NCT05854498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716539|NCT05854498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83716540|NCT05854498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83716541|NCT05854498|Growth Substances|growth substances|mesh-ancestor
83716542|NCT05854498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716543|NCT05854498|Growth Inhibitors|growth inhibitors|mesh-ancestor
83716544|NCT05854498|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83716545|NCT05854498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83716546|NCT05854498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716547|NCT05854498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716548|NCT05854342|Calcium|calcium|mesh-list
83716549|NCT05854342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83716550|NCT05854342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716551|NCT05854251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83716552|NCT05854251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716553|NCT05854225|Thiotepa|thiotepa|mesh-list
83716554|NCT05854225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83716555|NCT05854225|Alkylating Agents|alkylating agents|mesh-ancestor
83716556|NCT05854225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716557|NCT05854225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716558|NCT05854225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83716559|NCT05854225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83716560|NCT05854225|Immunologic Factors|immunologic factors|mesh-ancestor
83716561|NCT05854225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716562|NCT05854082|Lidocaine|lidocaine|mesh-list
83716563|NCT05854082|Anesthetics, Local|anesthetics, local|mesh-ancestor
83716564|NCT05854082|Anesthetics|anesthetics|mesh-ancestor
83716565|NCT05854082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716566|NCT05854082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716567|NCT05854082|Sensory System Agents|sensory system agents|mesh-ancestor
83716568|NCT05854082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716569|NCT05854082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83716570|NCT05854082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83716571|NCT05854082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83716572|NCT05854082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83716573|NCT05854082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716574|NCT05853965|Venetoclax|venetoclax|mesh-list
83716575|NCT05853965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716576|NCT05853718|Tenofovir|tenofovir|mesh-list
83716577|NCT05853718|Antiviral Agents|antiviral agents|mesh-ancestor
83716578|NCT05853718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716579|NCT05853718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83716580|NCT05853718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83716581|NCT05853718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716582|NCT05853718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716583|NCT05853718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83716584|NCT05853718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83716585|NCT05853627|Propranolol|propranolol|mesh-list
83716586|NCT05853627|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83716587|NCT05853627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83716588|NCT05853627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83716589|NCT05853627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716590|NCT05853627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716591|NCT05853627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716592|NCT05853627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83716593|NCT05853627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83716594|NCT05853627|Vasodilator Agents|vasodilator agents|mesh-ancestor
83716595|NCT05853601|Theophylline|theophylline|mesh-list
83716596|NCT05853601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83716597|NCT05853601|Autonomic Agents|autonomic agents|mesh-ancestor
83716598|NCT05853601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716599|NCT05853601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716600|NCT05853601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83716601|NCT05853601|Respiratory System Agents|respiratory system agents|mesh-ancestor
82871545|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
83716602|NCT05853601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83716603|NCT05853601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716604|NCT05853601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716605|NCT05853601|Vasodilator Agents|vasodilator agents|mesh-ancestor
83716606|NCT05853601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83716607|NCT05853601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83716608|NCT05853601|Purinergic Agents|purinergic agents|mesh-ancestor
83716609|NCT05853601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716610|NCT05852730|Promethazine|promethazine|mesh-list
83716611|NCT05852730|Diphenhydramine|diphenhydramine|mesh-list
83716612|NCT05852730|Meclizine|meclizine|mesh-list
83716613|NCT05852730|Scopolamine|scopolamine|mesh-list
83716614|NCT05852730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83716615|NCT05852730|Antiemetics|antiemetics|mesh-ancestor
83716616|NCT05852730|Autonomic Agents|autonomic agents|mesh-ancestor
83716617|NCT05852730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716618|NCT05852730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716619|NCT05852730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716620|NCT05852730|Mydriatics|mydriatics|mesh-ancestor
83716621|NCT05852730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83716622|NCT05852730|Cholinergic Agents|cholinergic agents|mesh-ancestor
83716623|NCT05852730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716624|NCT05852730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716625|NCT05852730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83716626|NCT05852730|Antipruritics|antipruritics|mesh-ancestor
83716627|NCT05852730|Dermatologic Agents|dermatologic agents|mesh-ancestor
83716628|NCT05852730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83716629|NCT05852730|Histamine Antagonists|histamine antagonists|mesh-ancestor
83716630|NCT05852730|Histamine Agents|histamine agents|mesh-ancestor
83716631|NCT05852730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83716632|NCT05852730|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83716633|NCT05852730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83716634|NCT05852730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716635|NCT05852730|Anesthetics, Local|anesthetics, local|mesh-ancestor
83716636|NCT05852730|Anesthetics|anesthetics|mesh-ancestor
83716637|NCT05852730|Sensory System Agents|sensory system agents|mesh-ancestor
83716638|NCT05852041|Fluorides|fluorides|mesh-list
83716639|NCT05852041|Cariostatic Agents|cariostatic agents|mesh-ancestor
83716640|NCT05852041|Protective Agents|protective agents|mesh-ancestor
83716641|NCT05852041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716642|NCT05845489|Anticoagulants|anticoagulants|mesh-list
83716643|NCT05845489|Clopidogrel|clopidogrel|mesh-list
83716644|NCT05845489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83716645|NCT05845489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83716646|NCT05845489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83716647|NCT05845489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83716648|NCT05845489|Purinergic Agents|purinergic agents|mesh-ancestor
83716649|NCT05845489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716650|NCT05845489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716651|NCT05845489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716652|NCT05831774|Vancomycin|vancomycin|mesh-list
83716653|NCT05831774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83716654|NCT05831774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716655|NCT05826873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83716656|NCT05826873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716657|NCT05823532|Infliximab|infliximab|mesh-list
83716658|NCT05823532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83716659|NCT05823532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83716660|NCT05823532|Dermatologic Agents|dermatologic agents|mesh-ancestor
83716661|NCT05823532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716662|NCT05823532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83716663|NCT05815602|Mebeverine|mebeverine|mesh-list
83716664|NCT05815602|Ebastine|ebastine|mesh-list
83716665|NCT05815602|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83716666|NCT05815602|Histamine Antagonists|histamine antagonists|mesh-ancestor
83716667|NCT05815602|Histamine Agents|histamine agents|mesh-ancestor
83716668|NCT05815602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716669|NCT05815602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716670|NCT05815602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716671|NCT05815602|Anticonvulsants|anticonvulsants|mesh-ancestor
83716672|NCT05815602|Parasympatholytics|parasympatholytics|mesh-ancestor
83716673|NCT05815602|Autonomic Agents|autonomic agents|mesh-ancestor
83716674|NCT05815602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716675|NCT05755737|Ondansetron|ondansetron|mesh-list
83716676|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
83716677|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
83716678|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716679|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716680|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716681|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
83716682|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
83716683|NCT05755737|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83716684|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83716685|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
83716686|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716687|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716688|NCT05739292|Vaccines|vaccines|mesh-list
83716689|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
83716690|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716691|NCT05736952|Topotecan|topotecan|mesh-list
83716692|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83716693|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83716694|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716695|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716696|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716697|NCT05732506|Edoxaban|edoxaban|mesh-list
83716698|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83716699|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
83716700|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83716701|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
83716702|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716703|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716704|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
83716705|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83716706|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83716707|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716708|NCT05725798|Incretins|incretins|mesh-ancestor
83716709|NCT05725798|Hormones|hormones|mesh-ancestor
83716710|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716711|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83716712|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
83716713|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716714|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716715|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83716716|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83716717|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
83716718|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716719|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83716720|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716721|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83716722|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716723|NCT05688332|Metformin|metformin|mesh-list
83716724|NCT05688332|Glyburide|glyburide|mesh-list
83716725|NCT05688332|Voglibose|voglibose|mesh-list
83716726|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83716727|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716728|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83716729|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716730|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716731|NCT05674656|Dolutegravir|dolutegravir|mesh-list
83716732|NCT05674656|Rilpivirine|rilpivirine|mesh-list
83716733|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
83716734|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83716735|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83716736|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716737|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716738|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83716739|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83716740|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
83716741|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716742|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83716743|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83716744|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
83716745|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83716746|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
83716747|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716748|NCT05664789|Expectorants|expectorants|mesh-ancestor
83716749|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
83716750|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83716751|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
83716752|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716753|NCT05664789|Protective Agents|protective agents|mesh-ancestor
83716754|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716755|NCT05664789|Antidotes|antidotes|mesh-ancestor
83716756|NCT05656443|Ritonavir|ritonavir|mesh-list
83716757|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83716758|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83716759|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83716760|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716761|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716762|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83716763|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83716764|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
83716765|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716766|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83716767|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83716768|NCT05651633|Lidocaine|lidocaine|mesh-list
83716769|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83716770|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
83716771|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716772|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716773|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
83716774|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716775|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83716776|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83716777|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83716778|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83716779|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716780|NCT05648448|Oseltamivir|oseltamivir|mesh-list
83716781|NCT05648448|Favipiravir|favipiravir|mesh-list
83716782|NCT05648448|Zanamivir|zanamivir|mesh-list
83716783|NCT05648448|Molnupiravir|molnupiravir|mesh-list
83716784|NCT05648448|Peramivir|peramivir|mesh-list
83716785|NCT05648448|Baloxavir|baloxavir|mesh-list
83716786|NCT05648448|Laninamivir|laninamivir|mesh-list
83716787|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
83716788|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716789|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716790|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716791|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
83716792|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83716793|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716794|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716795|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83716796|NCT05641064|Analgesics|analgesics|mesh-ancestor
83716797|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
83716798|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716799|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83716800|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83716801|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83716802|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
83716803|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716804|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716805|NCT05634967|Ofatumumab|ofatumumab|mesh-list
83716806|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716807|NCT05625776|Capsaicin|capsaicin|mesh-list
83716808|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
83716809|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83716810|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
83716811|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716812|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716813|NCT05563558|Carboplatin|carboplatin|mesh-list
83716814|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
83716815|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716816|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716817|NCT05563558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83716818|NCT05563558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716819|NCT05557838|Durvalumab|durvalumab|mesh-list
83716820|NCT05557838|Tremelimumab|tremelimumab|mesh-list
83716821|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716822|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716823|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83716824|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716825|NCT05531994|Montelukast|montelukast|mesh-list
83716826|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83716827|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
83716828|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83716829|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
83716830|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716831|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716832|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83716833|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83716834|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716835|NCT05528718|Midazolam|midazolam|mesh-list
83716836|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
83716837|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83716838|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83716839|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716840|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716841|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83716842|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83716843|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83716844|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83716845|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
83716846|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
83716847|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
83716848|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
83716849|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716850|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716851|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83716852|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83716853|NCT05528718|Analgesics|analgesics|mesh-ancestor
83716854|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
83716855|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716856|NCT05528198|Montelukast|montelukast|mesh-list
83716857|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83716858|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
83716859|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83716860|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
83716861|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716862|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716863|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83716864|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83716865|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716866|NCT05514899|Dronabinol|dronabinol|mesh-list
83716867|NCT05514899|Cannabidiol|cannabidiol|mesh-list
83716868|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
83716869|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
83716870|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716871|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83716872|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83716873|NCT05514899|Analgesics|analgesics|mesh-ancestor
83716874|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
83716875|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716876|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83716877|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83716878|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716879|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716880|NCT05514899|Hormones|hormones|mesh-ancestor
83716881|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716882|NCT05498272|Olaparib|olaparib|mesh-list
83716883|NCT05498272|Leuprolide|leuprolide|mesh-list
83716884|NCT05498272|Goserelin|goserelin|mesh-list
83716885|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83716886|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83716887|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716888|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716889|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716890|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83716891|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
83716892|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83716893|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716894|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83716895|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
83716896|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83716897|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
83716898|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83716899|NCT05458401|Trastuzumab|trastuzumab|mesh-list
83716900|NCT05458401|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83716901|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716902|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716903|NCT05458401|Immunoconjugates|immunoconjugates|mesh-ancestor
83716904|NCT05458401|Immunologic Factors|immunologic factors|mesh-ancestor
83716905|NCT05458401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716906|NCT05458375|Estradiol|estradiol|mesh-list
83716907|NCT05458375|Estrogens|estrogens|mesh-ancestor
83716908|NCT05458375|Hormones|hormones|mesh-ancestor
83716909|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83716910|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716911|NCT05420584|Tislelizumab|tislelizumab|mesh-list
83716912|NCT05420584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716913|NCT05420584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716914|NCT05416580|Metformin|metformin|mesh-list
83716915|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83716916|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83716917|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716918|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83716919|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83716920|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
83716921|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83716922|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83716923|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83716924|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83716925|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716926|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83716927|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83716928|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83716929|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716930|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716931|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83716932|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
83716933|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83716934|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716935|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83716936|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83716937|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83716938|NCT05413551|Isoniazid|isoniazid|mesh-list
83716939|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
83716940|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83716941|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716942|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83716943|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83716944|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
83716945|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716946|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83716947|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
83716948|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83716949|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716950|NCT05394350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83716951|NCT05394350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83716952|NCT05385406|Acetic Acid|acetic acid|mesh-list
83716953|NCT05385406|Retinol acetate|retinol acetate|mesh-list
83716954|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83716955|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716956|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83716957|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
83716958|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716959|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83716960|NCT05385406|Protective Agents|protective agents|mesh-ancestor
83716961|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716962|NCT05375760|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83716963|NCT05375760|Antiviral Agents|antiviral agents|mesh-ancestor
83716964|NCT05375760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83716965|NCT05357547|Buspirone|buspirone|mesh-list
83716966|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83716967|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83716968|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716969|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716970|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83716971|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83716972|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
83716973|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716974|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871920|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83716975|NCT05344833|Lenalidomide|lenalidomide|mesh-list
83716976|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
83716977|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716978|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83716979|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83716980|NCT05344833|Growth Substances|growth substances|mesh-ancestor
83716981|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
83716982|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83716983|NCT05323838|Complement System Proteins|complement system proteins|mesh-list
83716984|NCT05323838|Immunologic Factors|immunologic factors|mesh-ancestor
83716985|NCT05323838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716986|NCT05302999|Gabapentin|gabapentin|mesh-list
83716987|NCT05302999|Analgesics|analgesics|mesh-ancestor
83716988|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
83716989|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83716990|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83716991|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
83716992|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83716993|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83716994|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83716995|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83716996|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83716997|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83716998|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83716999|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717000|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
83717001|NCT05294965|Fenoterol|fenoterol|mesh-list
83717002|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83717003|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
83717004|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717005|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717006|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83717007|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
83717008|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
83717009|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
83717010|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83717011|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83717012|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83717013|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83717014|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
83717015|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717016|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717017|NCT05265806|Oxytocin|oxytocin|mesh-list
83717018|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
83717019|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83717020|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717021|NCT05252585|Everolimus|everolimus|mesh-list
83717022|NCT05252585|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83717023|NCT05252585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83717024|NCT05252585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717025|NCT05252585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717026|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717027|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
83717028|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717029|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717030|NCT05242419|Huperzine A|huperzine a|mesh-list
83717031|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83717032|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717033|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717034|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
83717035|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717036|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717037|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83717038|NCT05242419|Protective Agents|protective agents|mesh-ancestor
83717039|NCT05232227|Primaquine|primaquine|mesh-list
83717040|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
83717041|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83717042|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83717043|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717044|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
83717045|NCT05225363|Fludarabine|fludarabine|mesh-list
83717046|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717047|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
83717048|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717049|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83717050|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83717051|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
83717052|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717053|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717054|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83717055|NCT05221229|Liraglutide|liraglutide|mesh-list
83717056|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83717057|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717058|NCT05221229|Incretins|incretins|mesh-ancestor
83717059|NCT05221229|Hormones|hormones|mesh-ancestor
83717060|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717061|NCT05216432|Fulvestrant|fulvestrant|mesh-list
83717062|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83717063|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717064|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83717065|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83717066|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
83717067|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717068|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717069|NCT05184842|Decitabine|decitabine|mesh-list
83717070|NCT05184842|Venetoclax|venetoclax|mesh-list
83717071|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717072|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
83717073|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717074|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717075|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717076|NCT05139420|Topiramate|topiramate|mesh-list
83717077|NCT05139420|Phentermine|phentermine|mesh-list
83717078|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
83717079|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83717080|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717081|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83717082|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
83717083|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83717084|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
83717085|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
83717086|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717087|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
83717088|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717089|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717090|NCT05135650|Sotrovimab|sotrovimab|mesh-list
83717091|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83717092|NCT05135650|Antibodies|antibodies|mesh-list
83717093|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
83717094|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83717095|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
83717096|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717097|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717098|NCT05135650|Antiviral Agents|antiviral agents|mesh-ancestor
83717099|NCT05135650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717100|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
83717101|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717102|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717103|NCT05117242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717104|NCT05117242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717105|NCT05094336|Docetaxel|docetaxel|mesh-list
83717106|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717107|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83717108|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
83717109|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83717110|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717111|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
83717112|NCT05073822|Tacrolimus|tacrolimus|mesh-list
83717113|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83499743|NCT05543629|Taxane|taxane|mesh-list
83717114|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
83717115|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717116|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83717117|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717118|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717119|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83717120|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717121|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83717122|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
83717123|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83717124|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717125|NCT05047952|Vortioxetine|vortioxetine|mesh-list
83717126|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
83717127|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83717128|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83717129|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83717130|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83717131|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717132|NCT05047952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83717133|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83717134|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83717135|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717136|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717137|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
83717138|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83717139|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83717140|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83717141|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83717142|NCT05001828|Azacitidine|azacitidine|mesh-list
83717143|NCT05001828|Venetoclax|venetoclax|mesh-list
83717144|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717145|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
83717146|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717147|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717148|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717149|NCT04965454|Choline|choline|mesh-list
83717150|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
83717151|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83717152|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
83717153|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717154|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717155|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83717156|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
83717157|NCT04957615|Nivolumab|nivolumab|mesh-list
83717158|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717159|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717160|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717161|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717162|NCT04941287|Atezolizumab|atezolizumab|mesh-list
83717163|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
83717164|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83717165|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
83717166|NCT04941287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717167|NCT04941287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717168|NCT04941287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717169|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717170|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
83717171|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717172|NCT04933552|Siponimod|siponimod|mesh-list
83717173|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83717174|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717175|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717176|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
83717177|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717178|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83717179|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
83717180|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717181|NCT04917484|Octreotide|octreotide|mesh-list
83717182|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83717183|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717184|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83717185|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717186|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83717187|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717188|NCT04916613|Androgens|androgens|mesh-list
83717189|NCT04916613|Hormones|hormones|mesh-ancestor
83717190|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717191|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717192|NCT04893525|Buprenorphine|buprenorphine|mesh-list
83717193|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83717194|NCT04893525|Naloxone|naloxone|mesh-list
83717195|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83717196|NCT04893525|Narcotics|narcotics|mesh-ancestor
83717197|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872145|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717198|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717199|NCT04893525|Analgesics|analgesics|mesh-ancestor
83717200|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
83717201|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717202|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83717203|NCT04865848|Anesthetics|anesthetics|mesh-list
83717204|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83717205|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717206|NCT04859322|Glucagon|glucagon|mesh-list
83717207|NCT04859322|Somatostatin|somatostatin|mesh-list
83717208|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717209|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717210|NCT04859322|Hormones|hormones|mesh-ancestor
83717211|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717212|NCT04839666|Propofol|propofol|mesh-list
83717213|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83717214|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83717215|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717216|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83717217|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
83717218|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
83717219|NCT04804007|Etoposide|etoposide|mesh-list
83717220|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83717221|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717222|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83717223|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83717224|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717225|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717226|NCT04788667|Erenumab|erenumab|mesh-list
83717227|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
83717228|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83717229|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83717230|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717231|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
83717232|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717233|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717234|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83717235|NCT04788667|Analgesics|analgesics|mesh-ancestor
83717236|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
83717237|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717238|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83717239|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
83717240|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717241|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83717242|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83717243|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717244|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717245|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83717246|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83717247|NCT04757584|Propranolol|propranolol|mesh-list
83717248|NCT04757584|Metoprolol|metoprolol|mesh-list
83717249|NCT04757584|Atenolol|atenolol|mesh-list
83717250|NCT04757584|Sotalol|sotalol|mesh-list
83717251|NCT04757584|Nadolol|nadolol|mesh-list
83717252|NCT04757584|Acebutolol|acebutolol|mesh-list
83717253|NCT04757584|Carvedilol|carvedilol|mesh-list
83717254|NCT04757584|Nebivolol|nebivolol|mesh-list
83717255|NCT04757584|Bisoprolol|bisoprolol|mesh-list
83717256|NCT04757584|Labetalol|labetalol|mesh-list
83717257|NCT04757584|Pindolol|pindolol|mesh-list
83717258|NCT04757584|Betaxolol|betaxolol|mesh-list
83717259|NCT04757584|Penbutolol|penbutolol|mesh-list
83717260|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83717261|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83717262|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83717263|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717264|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717265|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717266|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83717267|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83717268|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
83717269|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
83717270|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
82872220|NCT02935894|Analgesics|analgesics|mesh-ancestor
83717271|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717272|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83717273|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
83717274|NCT04757584|Protective Agents|protective agents|mesh-ancestor
83717275|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83717276|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83717277|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83717278|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83717279|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83717280|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83717281|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83717282|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83717283|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
83717284|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83717285|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
83717286|NCT04756791|Anesthetics|anesthetics|mesh-list
83717287|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83717288|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717289|NCT04752475|Furosemide|furosemide|mesh-list
83717290|NCT04752475|Diuretics|diuretics|mesh-ancestor
83717291|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
83717292|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717293|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83717294|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83717295|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717296|NCT04722146|Lenalidomide|lenalidomide|mesh-list
83717297|NCT04722146|Pomalidomide|pomalidomide|mesh-list
83717298|NCT04722146|Bortezomib|bortezomib|mesh-list
83717299|NCT04722146|Daratumumab|daratumumab|mesh-list
83717300|NCT04722146|Nirogacestat|nirogacestat|mesh-list
83717301|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
83717302|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717303|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83717304|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83717305|NCT04722146|Growth Substances|growth substances|mesh-ancestor
83717306|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
83717307|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717308|NCT04722146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83717309|NCT04722146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717310|NCT04722146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717311|NCT04720326|Tacrolimus|tacrolimus|mesh-list
83717312|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717313|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
83717314|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717315|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83717316|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717317|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717318|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
83717319|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83717320|NCT04717362|Testosterone|testosterone|mesh-list
83717321|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
83717322|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
83717323|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83717324|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717325|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
83717326|NCT04717362|Hormones|hormones|mesh-ancestor
83717327|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717328|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717329|NCT04717362|Androgens|androgens|mesh-ancestor
83717330|NCT04708054|Fludarabine|fludarabine|mesh-list
83717331|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
83717332|NCT04708054|Busulfan|busulfan|mesh-list
83717333|NCT04708054|Venetoclax|venetoclax|mesh-list
83717334|NCT04708054|Thiotepa|thiotepa|mesh-list
83717335|NCT04708054|Cladribine|cladribine|mesh-list
83717336|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83717337|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717338|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717339|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
83717340|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717341|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717342|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
83717343|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717344|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
83717345|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83717346|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83717347|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
82872295|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83717348|NCT04700826|Apixaban|apixaban|mesh-list
83717349|NCT04700826|Edoxaban|edoxaban|mesh-list
83717350|NCT04700826|Dabigatran|dabigatran|mesh-list
83717351|NCT04700826|Anticoagulants|anticoagulants|mesh-list
83717352|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83717353|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
83717354|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83717355|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
83717356|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717357|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717358|NCT04648033|Atovaquone|atovaquone|mesh-list
83717359|NCT04648033|Cisplatin|cisplatin|mesh-list
83717360|NCT04648033|Vinorelbine|vinorelbine|mesh-list
83717361|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717362|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83717363|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83717364|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83717365|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83717366|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717367|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717368|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
83717369|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83717370|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83717371|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717372|NCT04604782|Regadenoson|regadenoson|mesh-list
83717373|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83717374|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83717375|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
83717376|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
83717377|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717378|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717379|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717380|NCT04573946|Vitamin D|vitamin d|mesh-list
83717381|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
83717382|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
83717383|NCT04573946|Vitamins|vitamins|mesh-list
83717384|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
83717385|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717386|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83717387|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83717388|NCT04572100|Paclitaxel|paclitaxel|mesh-list
83717389|NCT04572100|Carboplatin|carboplatin|mesh-list
83717390|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83717391|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717392|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
83717393|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
83717394|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
83717395|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717396|NCT04549207|Denosumab|denosumab|mesh-list
83717397|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
83717398|NCT04549207|Pamidronate|pamidronate|mesh-list
83717399|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83717400|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717401|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
83717402|NCT04319328|Cefazolin|cefazolin|mesh-list
83717403|NCT04319328|Ceftazidime|ceftazidime|mesh-list
83717404|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83717405|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717406|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83717407|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83717408|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717409|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717410|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717411|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83717412|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83717413|NCT04306315|Brodalumab|brodalumab|mesh-list
83717414|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
83717415|NCT04305327|Ustekinumab|ustekinumab|mesh-list
83717416|NCT04305327|Brodalumab|brodalumab|mesh-list
83717417|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
83717418|NCT04267926|Ubiquinone|ubiquinone|mesh-list
83717419|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
83717420|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717421|NCT04255160|Estradiol|estradiol|mesh-list
83717422|NCT04255160|Estrogens|estrogens|mesh-ancestor
83717423|NCT04255160|Hormones|hormones|mesh-ancestor
83717424|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872366|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83717425|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717426|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
83717427|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83717428|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
83717429|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
83717430|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717431|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717432|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717433|NCT04141501|Psilocybin|psilocybin|mesh-list
83717434|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
83717435|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717436|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83717437|NCT04098718|Prednisolone|prednisolone|mesh-list
83717438|NCT04098718|Benralizumab|benralizumab|mesh-list
83717439|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83717440|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
83717441|NCT04098718|Hormones|hormones|mesh-ancestor
83717442|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717443|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717444|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83717445|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717446|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83717447|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
83717448|NCT04097730|Riboflavin|riboflavin|mesh-list
83717449|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
83717450|NCT04097730|Difluprednate|difluprednate|mesh-list
83717451|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83717452|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717453|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83717454|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83717455|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717456|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717457|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717458|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717459|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
83717460|NCT04097730|Vitamins|vitamins|mesh-ancestor
83717461|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
83717462|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83717463|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
83717464|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
83717465|NCT04097730|Hormones|hormones|mesh-ancestor
83717466|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717467|NCT04092387|Nicotine|nicotine|mesh-list
83717468|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83717469|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
83717470|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717471|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717472|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83717473|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83717474|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
83717475|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717476|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717477|NCT04074330|Rituximab|rituximab|mesh-list
83717478|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717479|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717480|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
83717481|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717482|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83717483|NCT04069156|Aspirin|aspirin|mesh-list
83717484|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83717485|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83717486|NCT04069156|Analgesics|analgesics|mesh-ancestor
83717487|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
83717488|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717489|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717490|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83717491|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83717492|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83717493|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83717494|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717495|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83717496|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83717497|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717498|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
83717499|NCT04062656|Leucovorin|leucovorin|mesh-list
82872442|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83717500|NCT04062656|Folic Acid|folic acid|mesh-list
83717502|NCT04062656|Fluorouracil|fluorouracil|mesh-list
83717503|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
83717504|NCT04062656|Nivolumab|nivolumab|mesh-list
83717505|NCT04062656|Relatlimab|relatlimab|mesh-list
83717506|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717507|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
83717508|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
83717509|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
83717510|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717511|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
83717512|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717513|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717514|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
83717515|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717516|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717517|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717518|NCT04062656|Antidotes|antidotes|mesh-ancestor
83717519|NCT04062656|Protective Agents|protective agents|mesh-ancestor
83717520|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
83717521|NCT04062656|Vitamins|vitamins|mesh-ancestor
83717522|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
83717523|NCT04062656|Hematinics|hematinics|mesh-ancestor
83717524|NCT04041050|Celecoxib|celecoxib|mesh-list
83717525|NCT04041050|Navitoclax|navitoclax|mesh-list
83717526|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83717527|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83717528|NCT04041050|Analgesics|analgesics|mesh-ancestor
83717529|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
83717530|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717531|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717532|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83717533|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83717534|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83717535|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83717536|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717537|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717538|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717539|NCT04018313|Omalizumab|omalizumab|mesh-list
83717540|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83717541|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83717542|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83717543|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
83717544|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
83717545|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717546|NCT03976518|Atezolizumab|atezolizumab|mesh-list
83717547|NCT03976518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717548|NCT03976518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717549|NCT03976518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717550|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717551|NCT03973203|Niacin|niacin|mesh-list
83717552|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
83717553|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83717554|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
83717555|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717556|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83717557|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
83717558|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
83717559|NCT03973203|Vitamins|vitamins|mesh-ancestor
83717560|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
83717561|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717562|NCT03916926|Fluorides|fluorides|mesh-list
83717563|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
83717564|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
83717565|NCT03916926|Protective Agents|protective agents|mesh-ancestor
82872517|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872518|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872519|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82872520|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
82872521|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
82872522|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872523|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872533|NCT00301067|Calcitriol|calcitriol|mesh-list
82872534|NCT00301067|Temozolomide|temozolomide|mesh-list
82872535|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83717566|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717567|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
83717568|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717569|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717570|NCT03899857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717571|NCT03899857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717572|NCT03879694|Octreotide|octreotide|mesh-list
83717573|NCT03879694|Sargramostim|sargramostim|mesh-list
83717574|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83717575|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
83717576|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
83717577|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717578|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717579|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717580|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83717581|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83717582|NCT03871491|Azithromycin|azithromycin|mesh-list
83717583|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83717584|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717585|NCT03840967|Niraparib|niraparib|mesh-list
83717586|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83717587|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717588|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717589|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717590|NCT03839914|Vancomycin|vancomycin|mesh-list
83717591|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83717592|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717593|NCT03838263|Cisplatin|cisplatin|mesh-list
83717594|NCT03838263|Nivolumab|nivolumab|mesh-list
83717595|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132930|NCT05052008|Erenumab|erenumab|mesh-list
83717596|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717597|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717598|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717599|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
83717600|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83717601|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717602|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83717603|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717604|NCT03792490|Fasudil|fasudil|mesh-list
83717605|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83717606|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83717607|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717608|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83717609|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717610|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
83717611|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83717612|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717613|NCT03783429|Digoxin|digoxin|mesh-list
83717614|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83717615|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83717616|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717617|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717618|NCT03783429|Protective Agents|protective agents|mesh-ancestor
83717619|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717620|NCT03782207|Atezolizumab|atezolizumab|mesh-list
83717621|NCT03782207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717622|NCT03782207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717623|NCT03782207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717624|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717625|NCT03770338|Teriparatide|teriparatide|mesh-list
83717626|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83717627|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717628|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83717629|NCT03721653|Leucovorin|leucovorin|mesh-list
83717630|NCT03721653|Bevacizumab|bevacizumab|mesh-list
83717631|NCT03721653|Atezolizumab|atezolizumab|mesh-list
83717632|NCT03721653|Fluorouracil|fluorouracil|mesh-list
83717633|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
83717634|NCT03721653|Irinotecan|irinotecan|mesh-list
83717635|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
83717636|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717637|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717638|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83717639|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83717640|NCT03721653|Growth Substances|growth substances|mesh-ancestor
82872590|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83717641|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717642|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
83717643|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
83717644|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717645|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717646|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717647|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
83717648|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83717649|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83717650|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717651|NCT03721653|Antidotes|antidotes|mesh-ancestor
83717652|NCT03721653|Protective Agents|protective agents|mesh-ancestor
83717653|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
83717654|NCT03721653|Vitamins|vitamins|mesh-ancestor
83717655|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
83717656|NCT03721653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717657|NCT03713645|Tacrolimus|tacrolimus|mesh-list
83717658|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717659|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
83717660|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717661|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83717662|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717663|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717664|NCT03710824|Nintedanib|nintedanib|mesh-list
83717665|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717666|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83717667|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717668|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717669|NCT03705507|Dexamethasone|dexamethasone|mesh-list
83717670|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83717671|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
83717672|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
83717673|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717674|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717675|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717676|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
83717677|NCT03705507|Hormones|hormones|mesh-ancestor
83717678|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717679|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83717680|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717681|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
83717682|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83717683|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717684|NCT03663504|Metronidazole|metronidazole|mesh-list
83717685|NCT03663504|Neomycin|neomycin|mesh-list
83717686|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717687|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83717688|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83717689|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83717690|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83717691|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717692|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717693|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
83717694|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83717695|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83717696|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83717697|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83717698|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717699|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
83717700|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717701|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717702|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83717703|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717704|NCT03582488|Corticosterone|corticosterone|mesh-list
83717705|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83717706|NCT03554291|Famotidine|famotidine|mesh-list
83717707|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83717708|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717709|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83717710|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
83717711|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
83717712|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717713|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717714|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872669|NCT03954756|Apatinib|apatinib|mesh-list
83717715|NCT03553810|Valsartan|valsartan|mesh-list
83717716|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83717717|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83717718|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83717719|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83717720|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717721|NCT03528694|Durvalumab|durvalumab|mesh-list
83717722|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
83717723|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717724|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717725|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83717726|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
83717727|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717728|NCT03526250|Palbociclib|palbociclib|mesh-list
83717729|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717730|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83717731|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717732|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717733|NCT03476798|Bevacizumab|bevacizumab|mesh-list
83717734|NCT03476798|Rucaparib|rucaparib|mesh-list
83717735|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717736|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717737|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83717738|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83717739|NCT03476798|Growth Substances|growth substances|mesh-ancestor
83717740|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717741|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
83717742|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83717743|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717744|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717745|NCT03404596|Nicotine|nicotine|mesh-list
83717746|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83717747|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
83717748|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717749|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717750|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83717751|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83717752|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
83717753|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717754|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717755|NCT03340220|Itraconazole|itraconazole|mesh-list
83717756|NCT03340220|Antifungal Agents|antifungal agents|mesh-ancestor
83717757|NCT03340220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717758|NCT03340220|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83717759|NCT03340220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83717760|NCT03340220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717761|NCT03340220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717762|NCT03340220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83717763|NCT03340220|Hormone Antagonists|hormone antagonists|mesh-ancestor
83717764|NCT03340220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717765|NCT03340220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717766|NCT03340220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83717767|NCT03334253|Atropine|atropine|mesh-list
83717768|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83717769|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83717770|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83717771|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83717772|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
83717773|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83717774|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717775|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83717776|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
83717777|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
83717778|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
83717779|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83717780|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83717781|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
83717782|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83717783|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717784|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83717785|NCT03317158|Gemcitabine|gemcitabine|mesh-list
82872741|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83717787|NCT03317158|Durvalumab|durvalumab|mesh-list
83717788|NCT03317158|Tremelimumab|tremelimumab|mesh-list
83717789|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83717790|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
83717791|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717792|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
83717793|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717794|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717795|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
83717796|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
83717797|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
83717798|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717799|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
83717800|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717801|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83717802|NCT03202316|Atezolizumab|atezolizumab|mesh-list
83717803|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83717804|NCT03202316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717805|NCT03202316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717806|NCT03202316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717807|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717808|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
83717809|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717810|NCT03147859|Vedolizumab|vedolizumab|mesh-list
83717811|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717812|NCT03131219|Ravulizumab|ravulizumab|mesh-list
83717813|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83717814|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717815|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
83717816|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717817|NCT03036098|Carboplatin|carboplatin|mesh-list
83717818|NCT03036098|Gemcitabine|gemcitabine|mesh-list
83717819|NCT03036098|Nivolumab|nivolumab|mesh-list
83717820|NCT03036098|Ipilimumab|ipilimumab|mesh-list
83717821|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717822|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717823|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
83717824|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717825|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717826|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717827|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83717828|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83717829|NCT02783092|Cannabidiol|cannabidiol|mesh-list
83717830|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
83717831|NCT02713945|Simvastatin|simvastatin|mesh-list
83717832|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83717833|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83717834|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
83717835|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717836|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83717837|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83717838|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717839|NCT02685605|Temozolomide|temozolomide|mesh-list
83717840|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83717841|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
83717842|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717843|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717844|NCT02664935|Docetaxel|docetaxel|mesh-list
83717845|NCT02664935|Durvalumab|durvalumab|mesh-list
83717846|NCT02664935|Palbociclib|palbociclib|mesh-list
83717847|NCT02664935|Osimertinib|osimertinib|mesh-list
83717848|NCT02664935|Crizotinib|crizotinib|mesh-list
83717849|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717850|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83717851|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83717852|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83717853|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717854|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717855|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83717856|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717857|NCT02586207|Cisplatin|cisplatin|mesh-list
83717858|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
82872814|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83717859|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717860|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717861|NCT02586207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717862|NCT02586207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717863|NCT02573324|Temozolomide|temozolomide|mesh-list
83717864|NCT02573324|ABT-414|abt-414|mesh-list
83717865|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83717866|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
83717867|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717868|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717869|NCT02573324|Immunoconjugates|immunoconjugates|mesh-ancestor
83717870|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
83717871|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717872|NCT02553642|Nivolumab|nivolumab|mesh-list
83717873|NCT02553642|Ipilimumab|ipilimumab|mesh-list
83717874|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717875|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717876|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717877|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717878|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83717879|NCT02523092|Hormones|hormones|mesh-ancestor
83717880|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717881|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717882|NCT02450773|Furosemide|furosemide|mesh-list
83717883|NCT02450773|Diuretics|diuretics|mesh-ancestor
83717884|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
83717885|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717886|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83717887|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83717888|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717889|NCT02445248|Tisagenlecleucel|tisagenlecleucel|mesh-list
83717890|NCT02445248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717891|NCT02445248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717892|NCT02412566|SMOFlipid|smoflipid|mesh-list
83717893|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83717894|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83717895|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83717896|NCT02397226|Anesthetics|anesthetics|mesh-list
83717897|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83717898|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717899|NCT02296684|Cisplatin|cisplatin|mesh-list
83717900|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
83717901|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717902|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717903|NCT02296684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717904|NCT02296684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717905|NCT01939275|Copper|copper|mesh-list
83717906|NCT01939275|Trastuzumab|trastuzumab|mesh-list
83717907|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717908|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717909|NCT01939275|Trace Elements|trace elements|mesh-ancestor
83717910|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
83717911|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717912|NCT01900574|Golimumab|golimumab|mesh-list
83717913|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83717914|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83717915|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717916|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
83717917|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717918|NCT01481974|Treprostinil|treprostinil|mesh-list
83717919|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83717920|NCT01342367|Bicalutamide|bicalutamide|mesh-list
83717921|NCT01342367|Finasteride|finasteride|mesh-list
83717922|NCT01342367|Dutasteride|dutasteride|mesh-list
83717923|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
83717924|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
83717925|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83717926|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717927|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717928|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83717929|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83717930|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717931|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717932|NCT01342367|Urological Agents|urological agents|mesh-ancestor
82872887|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872892|NCT00272987|Paclitaxel|paclitaxel|mesh-list
83717933|NCT01185171|Gefitinib|gefitinib|mesh-list
83717934|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717935|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83717936|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717937|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717938|NCT00896493|Cyclosporine|cyclosporine|mesh-list
83717939|NCT00896493|Cyclosporins|cyclosporins|mesh-list
83717940|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83717941|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717942|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717943|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83717944|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
83717945|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717946|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
83717947|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717948|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
83717949|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83717950|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83717951|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
83717952|NCT00813423|Sunitinib|sunitinib|mesh-list
83717953|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717954|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83717955|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83717956|NCT00813423|Growth Substances|growth substances|mesh-ancestor
83717957|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717958|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
83717959|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83717960|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83717961|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717962|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
83717963|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83717964|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83717965|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83717966|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83717967|NCT00790010|Bevacizumab|bevacizumab|mesh-list
83717968|NCT00790010|Ipilimumab|ipilimumab|mesh-list
83717969|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83717970|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83717971|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83717972|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83717973|NCT00790010|Growth Substances|growth substances|mesh-ancestor
83717974|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83717975|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
83717976|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83717977|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83717978|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
83717979|NCT00444093|Loperamide|loperamide|mesh-list
83717980|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83717981|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
83717982|NCT00408005|Leucovorin|leucovorin|mesh-list
83717983|NCT00408005|Folic Acid|folic acid|mesh-list
83717984|NCT00408005|Cytarabine|cytarabine|mesh-list
83717985|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
83717986|NCT00408005|Dexamethasone|dexamethasone|mesh-list
83717987|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
83717988|NCT00408005|Prednisone|prednisone|mesh-list
83717989|NCT00408005|Cortisone|cortisone|mesh-list
83717990|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
83717991|NCT00408005|Doxorubicin|doxorubicin|mesh-list
83717992|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83717993|NCT00408005|Methotrexate|methotrexate|mesh-list
83717994|NCT00408005|Vincristine|vincristine|mesh-list
83717995|NCT00408005|Daunorubicin|daunorubicin|mesh-list
83717996|NCT00408005|Asparaginase|asparaginase|mesh-list
83717997|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
83717998|NCT00408005|Pegaspargase|pegaspargase|mesh-list
83717999|NCT00408005|Thioguanine|thioguanine|mesh-list
83718000|NCT00408005|BB 1101|bb 1101|mesh-list
83718001|NCT00408005|Calcium|calcium|mesh-list
83718002|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
83718003|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
83718004|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718005|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
83718006|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872959|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83718007|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718008|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83718009|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
83718010|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718011|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718012|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83718013|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718014|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
83718015|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
83718016|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718017|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83718018|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
83718019|NCT00408005|Hormones|hormones|mesh-ancestor
83718020|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718021|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83718022|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
83718023|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718024|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83718025|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718026|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718027|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83718028|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83718029|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83718030|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
83718031|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83718032|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83718033|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
83718034|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
83718035|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83718036|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83718037|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
83718038|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718039|NCT00408005|Antidotes|antidotes|mesh-ancestor
83718040|NCT00408005|Protective Agents|protective agents|mesh-ancestor
83718041|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
83718042|NCT00408005|Vitamins|vitamins|mesh-ancestor
83718043|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
83718044|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83718045|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83718046|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83718047|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83718048|NCT00408005|Hematinics|hematinics|mesh-ancestor
83718049|NCT00003042|Tamoxifen|tamoxifen|mesh-list
83718050|NCT00003042|Paclitaxel|paclitaxel|mesh-list
83718051|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
83718052|NCT00003042|Doxorubicin|doxorubicin|mesh-list
83718053|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83718054|NCT00003042|Melphalan|melphalan|mesh-list
83718055|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83718056|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718057|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83718058|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83718059|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83718060|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718061|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718062|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
83718063|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718064|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718065|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83718066|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
83718067|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83718068|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83718069|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718070|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718071|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718072|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83718073|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
83718074|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718075|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83718076|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83718077|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83718078|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83718079|NCT01873144|Epinephrine|epinephrine|mesh-list
83718080|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83718081|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83718082|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83718083|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
83718084|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718085|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873037|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
83718086|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718087|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83718088|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83718089|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
83718090|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718091|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83718092|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83718093|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
83718094|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
83718095|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83718097|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718098|NCT01873222|Sirolimus|sirolimus|mesh-list
83718099|NCT01873222|Umirolimus|umirolimus|mesh-list
83718100|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718101|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718102|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
83718103|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718104|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718105|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718106|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83718107|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718108|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
83718109|NCT01873313|Ropivacaine|ropivacaine|mesh-list
83718110|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
83718111|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
83718112|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718113|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718114|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
83718115|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718116|NCT01873339|Midazolam|midazolam|mesh-list
83718117|NCT01873339|Darapladib|darapladib|mesh-list
83718118|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83718119|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83718120|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718121|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718122|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83718123|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83718124|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83718125|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83718126|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
83718127|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
83718128|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
83718129|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
83718130|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718131|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718132|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83718133|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718134|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83718135|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
83718136|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83718137|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
83718138|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83718139|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718140|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83718141|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83718142|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718143|NCT01873430|Melatonin|melatonin|mesh-list
83718144|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
83718145|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718146|NCT01873430|Protective Agents|protective agents|mesh-ancestor
83718147|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718148|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718149|NCT01873443|Folic Acid|folic acid|mesh-list
83718150|NCT01873443|Rituximab|rituximab|mesh-list
83718151|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83718152|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718153|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
83718154|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718155|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718156|NCT01873443|Hematinics|hematinics|mesh-ancestor
82873108|NCT02795182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873109|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718157|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
83718158|NCT01873443|Vitamins|vitamins|mesh-ancestor
83718159|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
83718160|NCT01873573|Triamcinolone|triamcinolone|mesh-list
83718161|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718162|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
83718163|NCT01873573|Hormones|hormones|mesh-ancestor
83718164|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718165|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718166|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
83718167|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718168|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718169|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718170|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718171|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718172|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718173|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718174|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83718175|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83718176|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
83718177|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
83718178|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83718179|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83718180|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718181|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
83718182|NCT01873768|Coagulants|coagulants|mesh-ancestor
83718183|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
83718184|NCT01873807|Etoposide|etoposide|mesh-list
83718185|NCT01873807|Idarubicin|idarubicin|mesh-list
83718186|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718187|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
83718188|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718189|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718190|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83718191|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
83792164|NCT00055653|Hormones|hormones|mesh-ancestor
83718192|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718193|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718194|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83718195|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83718196|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718197|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718198|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718199|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83718200|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
83718201|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
83718202|NCT01873820|Calcium|calcium|mesh-list
83718203|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83718204|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718205|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
83718206|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718207|NCT01873820|Protective Agents|protective agents|mesh-ancestor
83718208|NCT01873820|Vitamins|vitamins|mesh-ancestor
83718209|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
83718210|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
83718211|NCT01873833|Capecitabine|capecitabine|mesh-list
83718212|NCT01873833|Trastuzumab|trastuzumab|mesh-list
83718213|NCT01873833|Lapatinib|lapatinib|mesh-list
83718214|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718215|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
83718216|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718217|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718218|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83718219|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
83718220|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718221|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718222|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83718223|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83718224|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
83718225|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83718226|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83718227|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718228|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
83718229|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
83718230|NCT01874002|Sirolimus|sirolimus|mesh-list
83718231|NCT01874002|Temsirolimus|temsirolimus|mesh-list
83718232|NCT01874002|MTOR Inhibitors|mtor inhibitors|mesh-list
83718233|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82873179|NCT03290950|Daratumumab|daratumumab|mesh-list
83718234|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718235|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83718236|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718237|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
83718238|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718239|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
83718240|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718241|NCT01874002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83718242|NCT01874002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718243|NCT01874002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718244|NCT01874028|Trientine|trientine|mesh-list
83718245|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
83718246|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
83718247|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718248|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
83718249|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718250|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
83718251|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
83718252|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
83718253|NCT01874080|Metformin|metformin|mesh-list
83718254|NCT01874080|Saxagliptin|saxagliptin|mesh-list
83718255|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83718256|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718257|NCT01874080|Incretins|incretins|mesh-ancestor
83718258|NCT01874080|Hormones|hormones|mesh-ancestor
83718259|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718260|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83718261|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
83718262|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718263|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718264|NCT01874171|Cetuximab|cetuximab|mesh-list
83718265|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718266|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83718267|NCT01874236|Bupivacaine|bupivacaine|mesh-list
83718268|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
83718269|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
83718270|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718271|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718272|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
83718273|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718274|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
83718275|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718276|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718277|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718278|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718279|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718280|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718281|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718282|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
83718283|NCT01874470|Diuretics|diuretics|mesh-list
83718284|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
83718285|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718286|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
83718287|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718288|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718289|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718290|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718291|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718292|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718293|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718294|NCT01874574|Triamcinolone|triamcinolone|mesh-list
83718295|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83718296|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83718297|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83718298|NCT01874574|Hylan|hylan|mesh-list
83718299|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718300|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
83718301|NCT01874574|Hormones|hormones|mesh-ancestor
83718302|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718303|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718304|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718305|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
83718306|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718307|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718308|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
83718309|NCT01874574|Protective Agents|protective agents|mesh-ancestor
83718310|NCT01874639|Hemostatics|hemostatics|mesh-list
82873256|NCT03178942|Permethrin|permethrin|mesh-list
83718312|NCT01874678|Cisplatin|cisplatin|mesh-list
83718313|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718314|NCT01874717|Midazolam|midazolam|mesh-list
83718315|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83718316|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83718317|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718318|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718319|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83718320|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83718321|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83718322|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83718323|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
83718324|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
83718325|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
83718326|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
83718327|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718328|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718329|NCT01874730|Anesthetics|anesthetics|mesh-list
83718330|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718331|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718332|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83718333|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83718334|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83718335|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
83718336|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718337|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83718338|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83718339|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718340|NCT01874847|Melatonin|melatonin|mesh-list
83718341|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
83718342|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718343|NCT01874847|Protective Agents|protective agents|mesh-ancestor
83718344|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718345|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718346|NCT01874964|Methadone|methadone|mesh-list
83718347|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83718348|NCT01874964|Narcotics|narcotics|mesh-ancestor
83718349|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718350|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718351|NCT01874964|Analgesics|analgesics|mesh-ancestor
83718352|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
83718353|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718354|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
83718355|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
83718356|NCT01875107|Insulin|insulin|mesh-list
83718357|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83718358|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718359|NCT01875172|Bupropion|bupropion|mesh-list
83718360|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83718361|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
83718362|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83718363|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83718364|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83718365|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83718366|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718367|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
83718368|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718369|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718370|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83718371|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83718372|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718373|NCT01875185|Aspirin|aspirin|mesh-list
83718374|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83718375|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83718376|NCT01875185|Analgesics|analgesics|mesh-ancestor
83718377|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
83718378|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718379|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718380|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718381|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718382|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83718383|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82873329|NCT01330654|Metoprolol|metoprolol|mesh-list
83718384|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718385|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83718386|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83718388|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
83718389|NCT01875224|Abatacept|abatacept|mesh-list
83718390|NCT01875224|Tacrolimus|tacrolimus|mesh-list
83718391|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718392|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
83718393|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718394|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83718395|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718396|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718397|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83718398|NCT01875224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83718399|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718400|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718401|NCT01875263|Levofloxacin|levofloxacin|mesh-list
83718402|NCT01875263|Cloxacillin|cloxacillin|mesh-list
83718403|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83718404|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718405|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718406|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718407|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718408|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718409|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718410|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718411|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83718412|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83718413|NCT01875653|Molgramostim|molgramostim|mesh-list
83718414|NCT01875653|Sargramostim|sargramostim|mesh-list
83718415|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
83718416|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718417|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718418|NCT01875666|Trastuzumab|trastuzumab|mesh-list
83718419|NCT01875666|Pertuzumab|pertuzumab|mesh-list
83718420|NCT01875666|Lapatinib|lapatinib|mesh-list
83718421|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83718422|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718423|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83718424|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718425|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718426|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
83718427|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718428|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83718429|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718430|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718431|NCT01875757|Vitamin D|vitamin d|mesh-list
83718432|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
83718433|NCT01875757|Vitamins|vitamins|mesh-ancestor
83718434|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
83718435|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718436|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83718437|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83718438|NCT01875822|Curcumin|curcumin|mesh-list
83718439|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83718440|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83718441|NCT01875822|Analgesics|analgesics|mesh-ancestor
83718442|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
83718443|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718444|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718445|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718446|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718447|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718448|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718449|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718450|NCT01875926|Gontivimab|gontivimab|mesh-list
83718451|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
83718452|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718453|NCT01875939|Levonadifloxacin|levonadifloxacin|mesh-list
83718454|NCT01875939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83718455|NCT01875939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718456|NCT01875939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718457|NCT01875939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718458|NCT01875939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718459|NCT01875952|Isoniazid|isoniazid|mesh-list
83718460|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
83718461|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718462|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718463|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83718464|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83718465|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
83718466|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718467|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83718468|NCT01876004|Methotrexate|methotrexate|mesh-list
83718469|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83718470|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
83718471|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83718472|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718473|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83718474|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
83718475|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718476|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718477|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
83718478|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718479|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83718480|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718481|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
83718482|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718483|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83718484|NCT01876108|Amoxicillin|amoxicillin|mesh-list
83718485|NCT01876108|Azithromycin|azithromycin|mesh-list
83718486|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83718487|NCT01876108|Omeprazole|omeprazole|mesh-list
83718488|NCT01876108|Bismuth|bismuth|mesh-list
83718489|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718490|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718491|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83718492|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83718493|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83718494|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718495|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718496|NCT01876108|Antacids|antacids|mesh-ancestor
83718497|NCT01876121|Celecoxib|celecoxib|mesh-list
83718498|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83718499|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83718500|NCT01876121|Analgesics|analgesics|mesh-ancestor
83718501|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
83718502|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718503|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718504|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718505|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718506|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83718507|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83718508|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718509|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718510|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
83718511|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83718512|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83718513|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
83718514|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718515|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718516|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718517|NCT01876186|Urological Agents|urological agents|mesh-ancestor
83718518|NCT01876290|Dexamethasone|dexamethasone|mesh-list
83718519|NCT01876290|Ondansetron|ondansetron|mesh-list
83718520|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718521|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
83718522|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
83718523|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718524|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718525|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83718526|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
83718527|NCT01876290|Hormones|hormones|mesh-ancestor
83718528|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718529|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82873476|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718530|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718531|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
83718532|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
83718533|NCT01876290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83718534|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83718535|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
83718536|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718537|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718538|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
83718539|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718540|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718541|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718542|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718543|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718544|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718545|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718546|NCT01876433|Mirabegron|mirabegron|mesh-list
83718547|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83718548|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83718549|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83718550|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83718551|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718552|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718553|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718554|NCT01876433|Urological Agents|urological agents|mesh-ancestor
83718555|NCT01876550|Mupirocin|mupirocin|mesh-list
83718556|NCT01876550|Calcium|calcium|mesh-list
83718557|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83718558|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718559|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718560|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718561|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83718562|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718563|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718564|NCT01876563|Vitamin D|vitamin d|mesh-list
83718565|NCT01876563|Vitamins|vitamins|mesh-ancestor
83718566|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
83718567|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718568|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83718569|NCT01876615|Diclofenac|diclofenac|mesh-list
83718570|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83718571|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83718572|NCT01876615|Analgesics|analgesics|mesh-ancestor
83718573|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
83718574|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718575|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718576|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718577|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718578|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83718579|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718580|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718581|NCT01876641|Decitabine|decitabine|mesh-list
83718582|NCT01876641|Vemurafenib|vemurafenib|mesh-list
83718583|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83718584|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
83718585|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718586|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718587|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718588|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83718589|NCT01876797|Ticagrelor|ticagrelor|mesh-list
83718590|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83718591|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83718592|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83718593|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83718594|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83718595|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
83718596|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718597|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718598|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718599|NCT01876849|Exenatide|exenatide|mesh-list
83718600|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83718601|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718602|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83718603|NCT01876849|Incretins|incretins|mesh-ancestor
83718604|NCT01876849|Hormones|hormones|mesh-ancestor
82873549|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
83718605|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718606|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83718607|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
83718608|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718609|NCT01876966|Ritonavir|ritonavir|mesh-list
83718610|NCT01876966|Darunavir|darunavir|mesh-list
83718611|NCT01876966|Lumefantrine|lumefantrine|mesh-list
83718612|NCT01876966|Artemether|artemether|mesh-list
83718613|NCT01876966|Etravirine|etravirine|mesh-list
83718614|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83718615|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83718616|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83718617|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
83718618|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718619|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718620|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83718621|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83718622|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
83718623|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718624|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83718625|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83718626|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
83718627|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83718628|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83718629|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83718630|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83718631|NCT01877122|Ibuprofen|ibuprofen|mesh-list
83718632|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83718633|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83718634|NCT01877122|Analgesics|analgesics|mesh-ancestor
83718635|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
83718636|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718637|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718638|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718639|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718640|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83718641|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718642|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718643|NCT01877226|Tapentadol|tapentadol|mesh-list
83718644|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83718645|NCT01877226|Narcotics|narcotics|mesh-ancestor
83718646|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718647|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718648|NCT01877226|Analgesics|analgesics|mesh-ancestor
83718649|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
83718650|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718651|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83718652|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83718653|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83718654|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718655|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83718656|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718657|NCT01877356|Anesthetics|anesthetics|mesh-list
83718658|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718659|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718660|NCT01877512|Hormones|hormones|mesh-list
83718661|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718662|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718663|NCT01877577|Vitamin D|vitamin d|mesh-list
83718664|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
83718665|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
83718666|NCT01877577|Vitamins|vitamins|mesh-list
83718667|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
83718668|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718669|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83718670|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83718671|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
83718672|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
83718673|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718674|NCT01877590|Protective Agents|protective agents|mesh-ancestor
83718675|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718676|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
83718677|NCT01877590|Vitamins|vitamins|mesh-ancestor
83718678|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
82873626|NCT00286091|Denosumab|denosumab|mesh-list
83718680|NCT01877746|Azathioprine|azathioprine|mesh-list
83718681|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718682|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
83718683|NCT01877746|Hormones|hormones|mesh-ancestor
83718684|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718685|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718686|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83718687|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718688|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
83718689|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718690|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83718691|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718692|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
83718693|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718694|NCT01877811|Agerafenib|agerafenib|mesh-list
83718695|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83718696|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718697|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718698|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
83718699|NCT01877889|Canagliflozin|canagliflozin|mesh-list
83718700|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83718701|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718702|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83718703|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718704|NCT01877954|Fluticasone|fluticasone|mesh-list
83718705|NCT01877954|Xhance|xhance|mesh-list
83718706|NCT01877954|Beclomethasone|beclomethasone|mesh-list
83718707|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718708|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83718709|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
83718710|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718711|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718712|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83718713|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
83718714|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
83718715|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83718716|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
83718717|NCT01877954|Hormones|hormones|mesh-ancestor
83718718|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718719|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83718720|NCT01878136|Plasminogen|plasminogen|mesh-list
83718721|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83718722|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83718723|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718724|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
83718725|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83718726|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
83718727|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718728|NCT01878201|Valsartan|valsartan|mesh-list
83718729|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83718730|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83718731|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83718732|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718733|NCT01878227|Fenofibrate|fenofibrate|mesh-list
83718734|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83718735|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
83718736|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718737|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83718738|NCT01878318|Methotrexate|methotrexate|mesh-list
83718739|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83718740|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
83718741|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83718742|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718743|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83718744|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
83718745|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718746|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718747|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83718748|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718749|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83718750|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718751|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
82873699|NCT01341262|Hormones|hormones|mesh-ancestor
83718752|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83718753|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83718754|NCT01878357|Piperaquine|piperaquine|mesh-list
83718755|NCT01878357|Primaquine|primaquine|mesh-list
83718756|NCT01878357|Artenimol|artenimol|mesh-list
83718757|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
83718758|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83718759|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83718760|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718761|NCT01878422|Leucovorin|leucovorin|mesh-list
83718762|NCT01878422|Bevacizumab|bevacizumab|mesh-list
83718763|NCT01878422|Cetuximab|cetuximab|mesh-list
83718764|NCT01878422|Fluorouracil|fluorouracil|mesh-list
83718765|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
83718766|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83718767|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718768|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83718769|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83718770|NCT01878422|Growth Substances|growth substances|mesh-ancestor
83718771|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718772|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
83718773|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
83718774|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718775|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83718776|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718777|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
83718778|NCT01878422|Antidotes|antidotes|mesh-ancestor
83718779|NCT01878422|Protective Agents|protective agents|mesh-ancestor
83718780|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
83718781|NCT01878422|Vitamins|vitamins|mesh-ancestor
83718782|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
83718783|NCT01878513|Risperidone|risperidone|mesh-list
83718784|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83718785|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
83718786|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718787|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718788|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718789|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83718790|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83718791|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718792|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83718793|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83718794|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
83718795|NCT01878539|Anticoagulants|anticoagulants|mesh-list
83718796|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83718797|NCT01878578|Phenytoin|phenytoin|mesh-list
83718798|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
83718799|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83718800|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83718801|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83718802|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718803|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83718804|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83718805|NCT01878643|Vancomycin|vancomycin|mesh-list
83718806|NCT01878643|Gentamicins|gentamicins|mesh-list
83718807|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718808|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718809|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83718810|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718811|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718812|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
83718813|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83718814|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
83718815|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718816|NCT01878695|Expectorants|expectorants|mesh-ancestor
83718817|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
83718818|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83718819|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
83718820|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718821|NCT01878695|Protective Agents|protective agents|mesh-ancestor
83718822|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718823|NCT01878695|Antidotes|antidotes|mesh-ancestor
83718824|NCT01878708|Dexamethasone|dexamethasone|mesh-list
83718825|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
82873777|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718826|NCT01878708|Asparaginase|asparaginase|mesh-list
83718827|NCT01878708|Pegaspargase|pegaspargase|mesh-list
83718828|NCT01878708|BB 1101|bb 1101|mesh-list
83718829|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718830|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
83718831|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
83718832|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718833|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718834|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83718835|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
83718836|NCT01878708|Hormones|hormones|mesh-ancestor
83718837|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718838|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83718839|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718840|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
83718841|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718842|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718843|NCT01878734|Micronutrients|micronutrients|mesh-list
83718844|NCT01878734|Trace Elements|trace elements|mesh-list
83718845|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718846|NCT01878864|Lidocaine|lidocaine|mesh-list
83718847|NCT01878864|Bupivacaine|bupivacaine|mesh-list
83718848|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
83718849|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
83718850|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718851|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718852|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
83718853|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718854|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83718855|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83718856|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83718857|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83718858|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718859|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83718860|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
83718861|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718862|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83718863|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83718864|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
83718865|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718866|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718867|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83718868|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
83718869|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718870|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718871|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83718872|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83718873|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718874|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718875|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718876|NCT01879033|Insulin|insulin|mesh-list
83718877|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83718878|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718879|NCT01879202|Methylphenidate|methylphenidate|mesh-list
83718880|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83718881|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718882|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83718883|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83718884|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83718885|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718886|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
83718887|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83718888|NCT01879293|Metformin|metformin|mesh-list
83718889|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83718890|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718891|NCT01879358|Sirolimus|sirolimus|mesh-list
83718892|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718893|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718894|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83718895|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718896|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
83718897|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83718898|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
83718899|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718900|NCT01879423|Lamotrigine|lamotrigine|mesh-list
83718901|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
83718902|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83718903|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83718904|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718905|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83718906|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718907|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83718908|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83718909|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718910|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83718911|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83718912|NCT01879488|Edetic Acid|edetic acid|mesh-list
83718913|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
83718914|NCT01879488|Antidotes|antidotes|mesh-ancestor
83718915|NCT01879488|Protective Agents|protective agents|mesh-ancestor
83718916|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718917|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
83718918|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
83718919|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718920|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83718921|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
83718922|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83718923|NCT01879514|Prednisone|prednisone|mesh-list
83718924|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718925|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
83718926|NCT01879514|Hormones|hormones|mesh-ancestor
83718927|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718928|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718929|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83718930|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83718931|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83718932|NCT01879527|Amiloride|amiloride|mesh-list
83718933|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
83718934|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83718935|NCT01879527|Diuretics|diuretics|mesh-ancestor
83718936|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
83718937|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718938|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83718939|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83718940|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718941|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83718942|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83718943|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83718944|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83718945|NCT01879605|Bisacodyl|bisacodyl|mesh-list
83718946|NCT01879605|Sorbitol|sorbitol|mesh-list
83718947|NCT01879605|Cathartics|cathartics|mesh-ancestor
83718948|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83718949|NCT01879605|Laxatives|laxatives|mesh-ancestor
83718950|NCT01879748|Rasagiline|rasagiline|mesh-list
83718951|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83718952|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83718953|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718954|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83718955|NCT01879748|Protective Agents|protective agents|mesh-ancestor
83718956|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718957|NCT01879917|Liraglutide|liraglutide|mesh-list
83718958|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83718959|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718960|NCT01879917|Incretins|incretins|mesh-ancestor
83718961|NCT01879917|Hormones|hormones|mesh-ancestor
83718962|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83718963|NCT01879930|Doxycycline|doxycycline|mesh-list
83718964|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718965|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718966|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
83718967|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83718968|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83718969|NCT01880112|Cefazolin|cefazolin|mesh-list
83718970|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83718971|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83718972|NCT01880125|Acetaminophen|acetaminophen|mesh-list
83718973|NCT01880125|Tramadol|tramadol|mesh-list
83718974|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83718975|NCT01880125|Analgesics|analgesics|mesh-ancestor
83718976|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
83718977|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83718978|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718979|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
83718980|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83718982|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718983|NCT01880138|Anesthetics|anesthetics|mesh-list
83718984|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83718985|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83718986|NCT01880216|Enoxaparin|enoxaparin|mesh-list
83718987|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
83718988|NCT01880216|Bemiparin|bemiparin|mesh-list
83718989|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
83718990|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83718991|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83718992|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83718993|NCT01880307|Prednisolone|prednisolone|mesh-list
83718994|NCT01880307|Infliximab|infliximab|mesh-list
83718995|NCT01880307|Azathioprine|azathioprine|mesh-list
83718996|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83718997|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
83718998|NCT01880307|Hormones|hormones|mesh-ancestor
83718999|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719000|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719001|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83719002|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719003|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719004|NCT01880307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83719005|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719006|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719007|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
83719008|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719009|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719010|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719011|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
83719012|NCT01880346|Vitamin D|vitamin d|mesh-list
83719013|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
83719014|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
83719015|NCT01880346|Vitamins|vitamins|mesh-list
83719016|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
83719017|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719018|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83719019|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83719020|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
83719021|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
83719022|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719023|NCT01880372|Protective Agents|protective agents|mesh-ancestor
83719024|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719025|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
83719026|NCT01880372|Vitamins|vitamins|mesh-ancestor
83719027|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
83719028|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
83719029|NCT01880385|Bevacizumab|bevacizumab|mesh-list
83719030|NCT01880385|Docetaxel|docetaxel|mesh-list
83719031|NCT01880385|Fluorouracil|fluorouracil|mesh-list
83719032|NCT01880385|Trastuzumab|trastuzumab|mesh-list
83719033|NCT01880385|Epirubicin|epirubicin|mesh-list
83719034|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719035|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
83719036|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719037|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719038|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83719039|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
83719040|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719041|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719042|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83719043|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83719044|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83719045|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83719046|NCT01880385|Growth Substances|growth substances|mesh-ancestor
83719047|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
83719048|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
83719049|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
83719050|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
83719051|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
83719052|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719053|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82873998|NCT00282347|Prednisone|prednisone|mesh-list
83719054|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83719055|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83719056|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719058|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
83719059|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
83719060|NCT01880463|Vitamins|vitamins|mesh-list
83719061|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
83719062|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719063|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83719064|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83719065|NCT01880619|Tamsulosin|tamsulosin|mesh-list
83719066|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
83719067|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83719068|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83719069|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83719070|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719071|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719072|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719073|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719074|NCT01880619|Urological Agents|urological agents|mesh-ancestor
83719075|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83719076|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83719077|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
83719078|NCT01880658|Capecitabine|capecitabine|mesh-list
83719079|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719080|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
83719081|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719082|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719083|NCT01880749|Everolimus|everolimus|mesh-list
83719084|NCT01880749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83719085|NCT01880749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83719086|NCT01880749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719087|NCT01880749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719088|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719089|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
83719090|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719091|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719092|NCT01880775|Bupivacaine|bupivacaine|mesh-list
83719093|NCT01880775|Prilocaine|prilocaine|mesh-list
83719094|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
83719095|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
83719096|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719097|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719098|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
83719099|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719100|NCT01879241|Rasagiline|rasagiline|mesh-list
83719101|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83719102|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719103|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719104|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83719105|NCT01879241|Protective Agents|protective agents|mesh-ancestor
83719106|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719107|NCT01880931|Remifentanil|remifentanil|mesh-list
83719108|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83719109|NCT01880931|Narcotics|narcotics|mesh-ancestor
83719110|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719111|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719112|NCT01880931|Analgesics|analgesics|mesh-ancestor
83719113|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
83719114|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719115|NCT01881074|Listerine|listerine|mesh-list
83719116|NCT01881074|Triclosan|triclosan|mesh-list
83719117|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
83719118|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
83719119|NCT01881074|Protective Agents|protective agents|mesh-ancestor
83719120|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719121|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83719122|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719123|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83719124|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83719125|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
83719126|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719127|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83719128|NCT01881100|Listerine|listerine|mesh-list
83719129|NCT01881100|Fluorides|fluorides|mesh-list
83719130|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
82874073|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83719131|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
83719132|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
83719133|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
83719134|NCT01881100|Protective Agents|protective agents|mesh-ancestor
83719135|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719136|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83719137|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719138|NCT01881347|Resveratrol|resveratrol|mesh-list
83719139|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
83719140|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719141|NCT01881347|Protective Agents|protective agents|mesh-ancestor
83719142|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719143|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719144|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83719145|NCT01881464|Adalimumab|adalimumab|mesh-list
83719146|NCT01881464|Infliximab|infliximab|mesh-list
83719147|NCT01881464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83719148|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719149|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719150|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719151|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719152|NCT01881503|HBOC 201|hboc 201|mesh-list
83719153|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
83719154|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
83719155|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83719156|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83719157|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719158|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
83719159|NCT01881568|Coagulants|coagulants|mesh-ancestor
83719160|NCT01881919|Quercetin|quercetin|mesh-list
83719161|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
83719162|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719163|NCT01881919|Protective Agents|protective agents|mesh-ancestor
83719164|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719165|NCT01881971|Calcium|calcium|mesh-list
83719166|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83719167|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719168|NCT01881997|Fentanyl|fentanyl|mesh-list
83719169|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83719170|NCT01881997|Narcotics|narcotics|mesh-ancestor
83719171|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719172|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719173|NCT01881997|Analgesics|analgesics|mesh-ancestor
83719174|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
83719175|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719176|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83719177|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83719178|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
83719179|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
83719180|NCT01882010|Sargramostim|sargramostim|mesh-list
83719181|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
83719182|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719183|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83719184|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
83719185|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
83719186|NCT01882127|Dexamethasone|dexamethasone|mesh-list
83719187|NCT01882127|Tretinoin|tretinoin|mesh-list
83719188|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719189|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
83719190|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
83719191|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719192|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719193|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719194|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
83719195|NCT01882127|Hormones|hormones|mesh-ancestor
83719196|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719197|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83719198|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719199|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
83719200|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719201|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
83719202|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83719203|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
83719204|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
83719205|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874151|NCT00262925|Antidotes|antidotes|mesh-ancestor
83719206|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719207|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83719208|NCT01882179|Diuretics|diuretics|mesh-ancestor
83719209|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
83719210|NCT01882179|Hormones|hormones|mesh-ancestor
83719211|NCT01882296|Pantoprazole|pantoprazole|mesh-list
83719212|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83719213|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719214|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83719215|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719216|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719217|NCT01882322|Tacrolimus|tacrolimus|mesh-list
83719218|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719219|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
83719220|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719221|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83719222|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719223|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719224|NCT01882361|Naltrexone|naltrexone|mesh-list
83719225|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83719226|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83719227|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719228|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
83719229|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719230|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83719231|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719232|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
83719233|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83719234|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719235|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
83719236|NCT01882400|Alendronate|alendronate|mesh-list
83719237|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
83719238|NCT01882400|Diphosphonates|diphosphonates|mesh-list
83719239|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83719240|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719241|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83719242|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83719243|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719244|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83719245|NCT01882530|Acetaminophen|acetaminophen|mesh-list
83719246|NCT01882530|Ketoprofen|ketoprofen|mesh-list
83719247|NCT01882530|Morphine|morphine|mesh-list
83719248|NCT01882530|Nefopam|nefopam|mesh-list
83719249|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83719250|NCT01882530|Narcotics|narcotics|mesh-ancestor
83719251|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719252|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719253|NCT01882530|Analgesics|analgesics|mesh-ancestor
83719254|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
83719255|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719256|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719257|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
83719258|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83719259|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719260|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719261|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83719262|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719263|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719264|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
83719265|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83719266|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83719267|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83719268|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83719269|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719270|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83719271|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719272|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719273|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83719274|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719275|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83719276|NCT01883011|Piracetam|piracetam|mesh-list
83719277|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83719278|NCT01883011|Protective Agents|protective agents|mesh-ancestor
83719279|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719280|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
82874224|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719281|NCT01883102|Capsaicin|capsaicin|mesh-list
83719282|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
83719283|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719284|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
83719285|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719286|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719288|NCT01883167|Verinurad|verinurad|mesh-list
83719289|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
83719290|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719291|NCT01883193|Micronutrients|micronutrients|mesh-list
83719292|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719293|NCT01883232|Lidocaine|lidocaine|mesh-list
83719294|NCT01883232|Epinephrine|epinephrine|mesh-list
83719295|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
83719296|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
83719297|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719298|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719299|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
83719300|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719301|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83719302|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83719303|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83719304|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83719305|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719306|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83719307|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83719308|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719309|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719310|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83719311|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83719312|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
83719313|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83719314|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
83719315|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
83719316|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
83719317|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83719318|NCT01883323|Aldesleukin|aldesleukin|mesh-list
83719319|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
83719320|NCT01883323|Fludarabine|fludarabine|mesh-list
83719321|NCT01883323|Interleukin-2|interleukin-2|mesh-list
83719322|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719323|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
83719324|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719325|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719326|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83719327|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
83719328|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719329|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719330|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83719331|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719332|NCT01883323|Analgesics|analgesics|mesh-ancestor
83719333|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
83719334|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719335|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83719336|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83719337|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
83719338|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719339|NCT01883505|Levodopa|levodopa|mesh-list
83719340|NCT01883505|Carbidopa|carbidopa|mesh-list
83719341|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83719342|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83719343|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
83719344|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719345|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719346|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719347|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83719348|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719349|NCT01883518|Vaccines|vaccines|mesh-list
83719350|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
83719351|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719352|NCT01883531|Mannitol|mannitol|mesh-list
83719353|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83719354|NCT01883531|Diuretics|diuretics|mesh-ancestor
83719355|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
83719356|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719357|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
83719358|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83719359|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719360|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
83719361|NCT01883869|Ticagrelor|ticagrelor|mesh-list
83719362|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83719363|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83719364|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83719365|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83719366|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
83719367|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719368|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719369|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719370|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
83719371|NCT01883882|Narcotics|narcotics|mesh-ancestor
83719372|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719373|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719374|NCT01883882|Analgesics|analgesics|mesh-ancestor
83719375|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
83719376|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719377|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
83719378|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83719379|NCT01883921|Antibodies|antibodies|mesh-list
83719380|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
83719381|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719382|NCT01884038|Treprostinil|treprostinil|mesh-list
83719383|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719384|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83719385|NCT01884116|Capsaicin|capsaicin|mesh-list
83719386|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
83719387|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719388|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
83719389|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719390|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719391|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719392|NCT01884116|Analgesics|analgesics|mesh-ancestor
83719393|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719394|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719395|NCT01884168|Immunomodulating Agents|immunomodulating agents|mesh-list
83719396|NCT01884168|Immunologic Factors|immunologic factors|mesh-ancestor
83719397|NCT01884168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719398|NCT01884272|Naproxen|naproxen|mesh-list
83719399|NCT01884272|Indomethacin|indomethacin|mesh-list
83719400|NCT01884272|Lesinurad|lesinurad|mesh-list
83719401|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83719402|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719403|NCT01884272|Analgesics|analgesics|mesh-ancestor
83719404|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
83719405|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719406|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719407|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719408|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719409|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
83719410|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83719411|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719412|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719413|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
83719414|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83719415|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
83719416|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
83719417|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719418|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83719419|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719420|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719421|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
83719422|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719423|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719424|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83719425|NCT01884298|Lidocaine|lidocaine|mesh-list
83719426|NCT01884298|Remifentanil|remifentanil|mesh-list
83719427|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
83719428|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
83719429|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719430|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719431|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
83719432|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719433|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83719434|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83719435|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83719436|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83719437|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719438|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83719439|NCT01884298|Narcotics|narcotics|mesh-ancestor
83719440|NCT01884298|Analgesics|analgesics|mesh-ancestor
83719441|NCT01884402|Ribavirin|ribavirin|mesh-list
83719442|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83719443|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
83719444|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719445|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
83719446|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719447|NCT01884415|Vaccines|vaccines|mesh-list
83719448|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
83719449|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719450|NCT01884428|Prednisolone|prednisolone|mesh-list
83719451|NCT01884428|Gemcitabine|gemcitabine|mesh-list
83719452|NCT01884428|Vinorelbine|vinorelbine|mesh-list
83719453|NCT01884428|Ifosfamide|ifosfamide|mesh-list
83719454|NCT01884428|Panobinostat|panobinostat|mesh-list
83719455|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719456|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
83719457|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719458|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719459|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719460|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
83719461|NCT01884428|Hormones|hormones|mesh-ancestor
83719462|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719463|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719464|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83719465|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83719466|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83719467|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83719468|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83719469|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83719470|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
83719471|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83719472|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719473|NCT01884441|Gemcitabine|gemcitabine|mesh-list
83719474|NCT01884441|Vinorelbine|vinorelbine|mesh-list
83719475|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83719476|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719477|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
83719478|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719479|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719480|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83719481|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83719482|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83719483|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83719484|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83719485|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
83719486|NCT01884467|Gentamicins|gentamicins|mesh-list
83719487|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83719488|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719489|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83719490|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719491|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719492|NCT01884506|Iron|iron|mesh-list
83719493|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
83719494|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83719495|NCT01884506|Trace Elements|trace elements|mesh-ancestor
83719496|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
83719497|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719498|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
83719499|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719500|NCT01884506|Protective Agents|protective agents|mesh-ancestor
83719501|NCT01884506|Vitamins|vitamins|mesh-ancestor
83719502|NCT01884558|Metformin|metformin|mesh-list
83719503|NCT01884558|Isavuconazole|isavuconazole|mesh-list
83719504|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83719505|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719506|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
83719507|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719508|NCT01884623|Methotrexate|methotrexate|mesh-list
83719509|NCT01884623|Cetuximab|cetuximab|mesh-list
83719510|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83719511|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
83719512|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83719513|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500061|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
83719514|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719515|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
83719516|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719517|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719518|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719519|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719520|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83719521|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719522|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
83719523|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719524|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83719525|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83719526|NCT01884636|Isavuconazole|isavuconazole|mesh-list
83719527|NCT01884636|Methotrexate|methotrexate|mesh-list
83719528|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83719529|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
83719530|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83719531|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719532|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719533|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
83719534|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719535|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719536|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719537|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719538|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83719539|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719540|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
83719541|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719542|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83719543|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
83719544|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719545|NCT01884857|Metoprolol|metoprolol|mesh-list
83719546|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83719547|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719548|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
83719549|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
83719550|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719551|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719552|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83719553|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83719554|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83719555|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719556|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719557|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719558|NCT01884896|Metoprolol|metoprolol|mesh-list
83719559|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83719560|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719561|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
83719562|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
83719563|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719564|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719565|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83719566|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83719567|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83719568|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719569|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719570|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719571|NCT01884909|Metoprolol|metoprolol|mesh-list
83719572|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83719573|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719574|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
83719575|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
83719576|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719577|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719578|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83719579|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83719580|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83719581|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
82874525|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82874526|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
82874530|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
83719582|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719583|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719584|NCT01884935|Natalizumab|natalizumab|mesh-list
83719585|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
83719586|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719587|NCT01885013|Metformin|metformin|mesh-list
83719588|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
83719589|NCT01885013|Doxorubicin|doxorubicin|mesh-list
83719590|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719591|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
83719592|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719593|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719594|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83719595|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
83719596|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719597|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719598|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83719599|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83719600|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83719601|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83719602|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83719603|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719604|NCT01885091|Kinetin|kinetin|mesh-list
83719605|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83719606|NCT01885091|Growth Substances|growth substances|mesh-ancestor
83719607|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719608|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
83719609|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83719610|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
83719611|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719612|NCT01885338|Expectorants|expectorants|mesh-ancestor
83719613|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
83719614|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83719615|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
83719616|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719617|NCT01885338|Protective Agents|protective agents|mesh-ancestor
83719618|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719619|NCT01885338|Antidotes|antidotes|mesh-ancestor
83719620|NCT01885364|Remifentanil|remifentanil|mesh-list
83719621|NCT01885364|Propofol|propofol|mesh-list
83719622|NCT01885364|Esmolol|esmolol|mesh-list
83719623|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83719624|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719625|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719626|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83719627|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
83719628|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
83719629|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83719630|NCT01885364|Narcotics|narcotics|mesh-ancestor
83719631|NCT01885364|Analgesics|analgesics|mesh-ancestor
83719632|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
83719633|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719634|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83719635|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83719636|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83719637|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719638|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719639|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719640|NCT01885481|Dexamethasone|dexamethasone|mesh-list
83719641|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
83719642|NCT01885481|Betamethasone|betamethasone|mesh-list
83719643|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
83719644|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83719645|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
83719646|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83719647|NCT01885481|BB 1101|bb 1101|mesh-list
83719648|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719649|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
83719650|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
83719651|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719652|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719653|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719654|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
83719655|NCT01885481|Hormones|hormones|mesh-ancestor
83719656|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719657|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874600|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
83719658|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719659|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
83719660|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719661|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719662|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83719663|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
83719664|NCT01885585|Apixaban|apixaban|mesh-list
83719665|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83719666|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
83719667|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83719668|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
83719669|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719670|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719671|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
83719672|NCT01885598|Apixaban|apixaban|mesh-list
83719673|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83719674|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
83719675|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83719676|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
83719677|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719678|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719679|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
83719680|NCT01885715|Neostigmine|neostigmine|mesh-list
83719681|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83719682|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719683|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719684|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
83719685|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719686|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719687|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83719688|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
83719689|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719690|NCT01885988|Nebivolol|nebivolol|mesh-list
83719691|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719692|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
83719693|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83719694|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83719695|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83719696|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719697|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719698|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719699|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719700|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
83719701|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83719702|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
83719703|NCT01886001|Povidone|povidone|mesh-list
83719704|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83719705|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719706|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
83719707|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719708|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
83719709|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
83719710|NCT01886014|Oxytocin|oxytocin|mesh-list
83719711|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
83719712|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83719713|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719714|NCT01886053|Ertapenem|ertapenem|mesh-list
83719715|NCT01886053|beta-Lactams|beta-lactams|mesh-list
83719716|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83719717|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719718|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
83719719|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83719720|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719721|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719722|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719723|NCT01886079|Analgesics|analgesics|mesh-ancestor
83719724|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
83719725|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719726|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82874674|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874675|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
82874676|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
83719727|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83719728|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83719729|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719730|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874681|NCT05569148|Faricimab|faricimab|mesh-list
83719731|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719732|NCT01886196|Ibuprofen|ibuprofen|mesh-list
83719733|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83719734|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83719735|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719736|NCT01886196|Analgesics|analgesics|mesh-ancestor
83719737|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
83719738|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719739|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719740|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719741|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83719742|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719743|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719744|NCT01886209|Prednisone|prednisone|mesh-list
83719745|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
83719746|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83719747|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83719748|NCT01886209|Prednisolone|prednisolone|mesh-list
83719749|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
83719750|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83719751|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
83719752|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719753|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
83719754|NCT01886209|Hormones|hormones|mesh-ancestor
83719755|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719756|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719757|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83719758|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719759|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
83719760|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
83719761|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719762|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719763|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83719764|NCT01886209|Protective Agents|protective agents|mesh-ancestor
83719765|NCT01886248|Antithrombins|antithrombins|mesh-list
83719766|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
83719767|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83719768|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
83719769|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719770|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719771|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
83719772|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
83719773|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
83719774|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
83719775|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719776|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719777|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
83719778|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719779|NCT01886365|Insulin|insulin|mesh-list
83719780|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83719781|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719782|NCT01886404|Efavirenz|efavirenz|mesh-list
83719783|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83719784|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83719785|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719786|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719787|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
83719788|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719789|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83719790|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83719791|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83719792|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83719793|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83719794|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83719795|NCT01886443|Tocopherols|tocopherols|mesh-list
83719796|NCT01886443|Vitamin E|vitamin e|mesh-list
83719797|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
83719798|NCT01886443|Infliximab|infliximab|mesh-list
83719799|NCT01886443|Epoprostenol|epoprostenol|mesh-list
83719800|NCT01886443|Tezosentan|tezosentan|mesh-list
83719801|NCT01886443|Melatonin|melatonin|mesh-list
83719802|NCT01886443|Antithrombins|antithrombins|mesh-list
83719803|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
83719804|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
82874750|NCT00250835|Analgesics|analgesics|mesh-ancestor
83719805|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83719806|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
83719807|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719808|NCT01886443|Protective Agents|protective agents|mesh-ancestor
83719809|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719810|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719811|NCT01886443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83719812|NCT01886443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83719813|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
83719814|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719815|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83719816|NCT01886443|Hematinics|hematinics|mesh-ancestor
83719817|NCT01886443|Vitamins|vitamins|mesh-ancestor
83719818|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
83719819|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83719820|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83719821|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719822|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
83719823|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719824|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83719825|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
83719826|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83719827|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83719828|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
83719829|NCT01886534|Diuretics|diuretics|mesh-list
83719830|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
83719831|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719832|NCT01886560|Doxycycline|doxycycline|mesh-list
83719833|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83719834|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719835|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
83719836|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83719837|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83719838|NCT01886573|Azacitidine|azacitidine|mesh-list
83719839|NCT01886573|Entinostat|entinostat|mesh-list
83719840|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83719841|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83719842|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
83719843|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719844|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719845|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719846|NCT01886599|Asunaprevir|asunaprevir|mesh-list
83719847|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
83719848|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719849|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719850|NCT01886638|Abacavir|abacavir|mesh-list
83719851|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83719852|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83719853|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719854|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719855|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
83719856|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719857|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83719858|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83719859|NCT01886664|Sevoflurane|sevoflurane|mesh-list
83719860|NCT01886664|Desflurane|desflurane|mesh-list
83719861|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83719862|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83719863|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
83719864|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
83719865|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719866|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719867|NCT01886768|Anesthetics|anesthetics|mesh-list
83719868|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719869|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719870|NCT01887119|Eplerenone|eplerenone|mesh-list
83719871|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83719872|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
83719873|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719874|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719875|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83719876|NCT01887119|Diuretics|diuretics|mesh-ancestor
83719877|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
83719878|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719879|NCT01887158|Bisacodyl|bisacodyl|mesh-list
83719880|NCT01887158|Cathartics|cathartics|mesh-ancestor
83719881|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719882|NCT01887158|Laxatives|laxatives|mesh-ancestor
83719883|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
83719884|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83719885|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719886|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719887|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83719888|NCT01887184|Analgesics|analgesics|mesh-ancestor
83719889|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
83719890|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719891|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83719892|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83719893|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83719894|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719895|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719896|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719897|NCT01887197|Mannitol|mannitol|mesh-list
83719898|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83719899|NCT01887197|Diuretics|diuretics|mesh-ancestor
83719900|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
83719901|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719902|NCT01887223|Timolol|timolol|mesh-list
83719903|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83719904|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83719905|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83719906|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83719907|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83719908|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719909|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719910|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719911|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719912|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83719913|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83719914|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83719915|NCT01887249|Metronidazole|metronidazole|mesh-list
83719916|NCT01887249|Clarithromycin|clarithromycin|mesh-list
83719917|NCT01887249|Esomeprazole|esomeprazole|mesh-list
83719918|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719919|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83719920|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83719921|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83719922|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83719923|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83719924|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83719925|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719926|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719927|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83719928|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83719929|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83719930|NCT01887275|Interferons|interferons|mesh-list
83719931|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719932|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
83719933|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719934|NCT01887340|Carboplatin|carboplatin|mesh-list
83719935|NCT01887340|Etoposide|etoposide|mesh-list
83719936|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719937|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83719938|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83719939|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83719940|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719941|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719942|NCT01887379|Furosemide|furosemide|mesh-list
83719943|NCT01887379|Diuretics|diuretics|mesh-ancestor
83719944|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
83719945|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719946|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83719947|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83719948|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719949|NCT01887405|Epinephrine|epinephrine|mesh-list
83719950|NCT01887405|Racepinephrine|racepinephrine|mesh-list
83719951|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
83719952|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83719953|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83719954|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83719955|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719956|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719957|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719958|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83719959|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83719960|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
83719961|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719962|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83719963|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
83719964|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
83719965|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
83719966|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83719967|NCT01887457|Voriconazole|voriconazole|mesh-list
83719968|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
83719969|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83719970|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83719971|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83719972|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719973|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719974|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83719975|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
83719976|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83719977|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719978|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83719979|NCT01887561|Dasatinib|dasatinib|mesh-list
83719980|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83719981|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83719982|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83719983|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719984|NCT01887613|Gabapentin|gabapentin|mesh-list
83719985|NCT01887613|Analgesics|analgesics|mesh-ancestor
83719986|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
83719987|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83719988|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83719989|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
83719990|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83719991|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83719992|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83719993|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83719994|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83719995|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83719996|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83719997|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83719998|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
83719999|NCT01887626|Ticagrelor|ticagrelor|mesh-list
83720000|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83720001|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83720002|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83720003|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83720004|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
83720005|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720006|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720007|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720008|NCT01887691|Eszopiclone|eszopiclone|mesh-list
83720009|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83720010|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720011|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720012|NCT01887704|Aspirin|aspirin|mesh-list
83720013|NCT01887704|Sirolimus|sirolimus|mesh-list
83720014|NCT01887704|Paclitaxel|paclitaxel|mesh-list
83720015|NCT01887704|Everolimus|everolimus|mesh-list
83720016|NCT01887704|Clopidogrel|clopidogrel|mesh-list
83720017|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83720018|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720019|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
83720020|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
83720021|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83720022|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720023|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83720024|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83720025|NCT01887704|Analgesics|analgesics|mesh-ancestor
83720026|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
83720027|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720028|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720029|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83720030|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83720031|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83720032|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83720033|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83720034|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83720035|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720036|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
83720037|NCT01887704|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83720038|NCT01887704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83720039|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720040|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
83720041|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83720042|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83720043|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83720044|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
83720045|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720046|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83720047|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720048|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83720049|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
83720050|NCT01887743|Pantoprazole|pantoprazole|mesh-list
83720051|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83720052|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720053|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83720054|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720055|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720056|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83720057|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720058|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83720059|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720060|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720061|NCT01887821|Chloroquine|chloroquine|mesh-list
83720062|NCT01887821|Piperaquine|piperaquine|mesh-list
83720063|NCT01887821|Artenimol|artenimol|mesh-list
83720064|NCT01887821|Amebicides|amebicides|mesh-ancestor
83720065|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83720066|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83720067|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720068|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
83720069|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83720070|NCT01887847|Nicotine|nicotine|mesh-list
83720071|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83720072|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
83720073|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720074|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720075|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83720076|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83720077|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
83720078|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720079|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720080|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
83720081|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83720082|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
83720083|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720084|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
83720085|NCT01887873|Protective Agents|protective agents|mesh-ancestor
83720086|NCT01887951|Tramadol|tramadol|mesh-list
83720087|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83720088|NCT01887951|Narcotics|narcotics|mesh-ancestor
83720089|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500080|NCT04569084|Edaravone|edaravone|mesh-list
83720090|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720091|NCT01887951|Analgesics|analgesics|mesh-ancestor
83720092|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
83720093|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720094|NCT01888042|Everolimus|everolimus|mesh-list
83720095|NCT01888042|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83720096|NCT01888042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83720097|NCT01888042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720098|NCT01888042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720099|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720100|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
83720101|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720102|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720103|NCT01888107|Risperidone|risperidone|mesh-list
83720104|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83720105|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
82875046|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83720106|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720107|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720108|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720109|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83720110|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720111|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720112|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720113|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83720114|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
83720115|NCT01888120|Ziconotide|ziconotide|mesh-list
83720116|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83720117|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720118|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720119|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720120|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720121|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83720122|NCT01888120|Protective Agents|protective agents|mesh-ancestor
83720123|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83720124|NCT01888120|Analgesics|analgesics|mesh-ancestor
83720125|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
83720126|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720127|NCT01888224|Isotretinoin|isotretinoin|mesh-list
83720128|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
83720129|NCT01888250|Lamotrigine|lamotrigine|mesh-list
83720130|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
83720131|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83720132|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720133|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720134|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720135|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720136|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83720137|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720138|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720139|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720140|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83720141|NCT01888263|Lamotrigine|lamotrigine|mesh-list
83720142|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
83720143|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83720144|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720145|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720146|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720147|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720148|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83720149|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720150|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720151|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720152|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83720153|NCT01888289|Isotretinoin|isotretinoin|mesh-list
83720154|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
83720155|NCT01888302|Sirolimus|sirolimus|mesh-list
83720156|NCT01888302|Cisplatin|cisplatin|mesh-list
83720157|NCT01888302|Gemcitabine|gemcitabine|mesh-list
83720158|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720159|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83720160|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
83720161|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720162|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83720163|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720164|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83720165|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
83720166|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720167|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
83720168|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720169|NCT01888328|Isotretinoin|isotretinoin|mesh-list
83720170|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83720171|NCT01888341|Isotretinoin|isotretinoin|mesh-list
82875122|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875123|NCT03150862|Pamiparib|pamiparib|mesh-list
82875124|NCT03150862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82875125|NCT03150862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875126|NCT03150862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875127|NCT03150862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875128|NCT01318928|Metronidazole|metronidazole|mesh-list
82875129|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720172|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
83720173|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83720175|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720176|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720177|NCT01888393|Ivacaftor|ivacaftor|mesh-list
83720178|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83720179|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720180|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720181|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
83720182|NCT01888445|Hematinics|hematinics|mesh-ancestor
83720183|NCT01888458|Micafungin|micafungin|mesh-list
83720184|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
83720185|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720186|NCT01888536|Pregabalin|pregabalin|mesh-list
83720187|NCT01888536|Alprostadil|alprostadil|mesh-list
83720188|NCT01888536|Analgesics|analgesics|mesh-ancestor
83720189|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
83720190|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720191|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720192|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
83720193|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83720194|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720195|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720196|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720197|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83720198|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720199|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720200|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720201|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83720202|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
83720203|NCT01888536|Urological Agents|urological agents|mesh-ancestor
83720204|NCT01888562|Ponatinib|ponatinib|mesh-list
83720205|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720206|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83720207|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720208|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720209|NCT01888575|Aspirin|aspirin|mesh-list
83720210|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83720211|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83720212|NCT01888575|Analgesics|analgesics|mesh-ancestor
83720213|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
83720214|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720215|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720216|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83720217|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83720218|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83720219|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83720220|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720221|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83720222|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83720223|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720224|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
83720225|NCT01888718|Fexofenadine|fexofenadine|mesh-list
83720226|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83720227|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83720228|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83720229|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
83720230|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
83720231|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720232|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720233|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720234|NCT01888731|Lamotrigine|lamotrigine|mesh-list
83720235|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
83720236|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83720237|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720238|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720239|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720240|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720241|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83720242|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720243|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720244|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720246|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83720247|NCT01888744|Cetrorelix|cetrorelix|mesh-list
83720248|NCT01888744|Progesterone|progesterone|mesh-list
83720249|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83720250|NCT01888744|Ganirelix|ganirelix|mesh-list
83720251|NCT01888744|Progestins|progestins|mesh-ancestor
83720252|NCT01888744|Hormones|hormones|mesh-ancestor
83720253|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720254|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720255|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83720256|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83720257|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
83720258|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
83720259|NCT01888757|Lamotrigine|lamotrigine|mesh-list
83720260|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
83720261|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83720262|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720263|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720264|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720265|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720266|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83720267|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720268|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720269|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720270|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83720271|NCT01888796|Linagliptin|linagliptin|mesh-list
83720272|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83720273|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720274|NCT01888796|Incretins|incretins|mesh-ancestor
83720275|NCT01888796|Hormones|hormones|mesh-ancestor
83720276|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720277|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83720278|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
83720279|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720280|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720281|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
83720282|NCT01888822|Ampicillin|ampicillin|mesh-list
83720283|NCT01888822|Sulbactam|sulbactam|mesh-list
83720284|NCT01888822|Sultamicillin|sultamicillin|mesh-list
83720285|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83720286|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720287|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83720288|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83720289|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720290|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720291|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720292|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83720293|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83720294|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83720295|NCT01888835|Mirtazapine|mirtazapine|mesh-list
83720296|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
83720297|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720298|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83720299|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
83720300|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
83720301|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720302|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720303|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720304|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83720305|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720306|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720307|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83720308|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83720309|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83720310|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
83720311|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83720312|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83720313|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
83720314|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83720315|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
83720316|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
82875253|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720317|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720318|NCT01888861|Protective Agents|protective agents|mesh-ancestor
83720319|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720320|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
83720321|NCT01888861|Vitamins|vitamins|mesh-ancestor
83720322|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
83720323|NCT01888978|Leucovorin|leucovorin|mesh-list
83720324|NCT01888978|Gemcitabine|gemcitabine|mesh-list
83720325|NCT01888978|Fluorouracil|fluorouracil|mesh-list
83720326|NCT01888978|Docetaxel|docetaxel|mesh-list
83720327|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
83720328|NCT01888978|Irinotecan|irinotecan|mesh-list
83720329|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
83720330|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83720331|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
83720332|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720333|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720334|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
83720335|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
83720336|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
83720337|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720338|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
83720339|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720340|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83720341|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83720342|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720343|NCT01888978|Antidotes|antidotes|mesh-ancestor
83720344|NCT01888978|Protective Agents|protective agents|mesh-ancestor
83720345|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
83720346|NCT01888978|Vitamins|vitamins|mesh-ancestor
83720347|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
83720348|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
83720349|NCT01889004|Propofol|propofol|mesh-list
83720350|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83720351|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720352|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720353|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83720354|NCT01889004|Analgesics|analgesics|mesh-ancestor
83720355|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
83720356|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720357|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83720358|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83720359|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83720360|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
83720361|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720362|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720363|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83720364|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
83720365|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
83720366|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
83720367|NCT01889056|Hematinics|hematinics|mesh-ancestor
83720368|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83720369|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83720370|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720371|NCT01889134|Alendronate|alendronate|mesh-list
83720372|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83720373|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720374|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
83720375|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83720376|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
83720377|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720378|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83720379|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720380|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83720381|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720382|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720383|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720384|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83720385|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720386|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83720387|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720388|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720389|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
83720390|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83720391|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875326|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83720392|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
83720393|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720394|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
83720395|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83720396|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720397|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
83720398|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720399|NCT01889368|Protective Agents|protective agents|mesh-ancestor
83720400|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720401|NCT01889407|Idarubicin|idarubicin|mesh-list
83720402|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83720403|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720404|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83720405|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83720406|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720407|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720408|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83720409|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
83720410|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720411|NCT01889446|Calcium|calcium|mesh-list
83720412|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720413|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720414|NCT01889498|Acetazolamide|acetazolamide|mesh-list
83720415|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
83720416|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83720417|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720418|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720419|NCT01889498|Diuretics|diuretics|mesh-ancestor
83720420|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
83720421|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720422|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
83720423|NCT01889576|Antacids|antacids|mesh-ancestor
83720424|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720425|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720426|NCT01889680|Leucovorin|leucovorin|mesh-list
83720427|NCT01889680|Fluorouracil|fluorouracil|mesh-list
83720428|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
83720429|NCT01889680|Aflibercept|aflibercept|mesh-list
83720430|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
83720431|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
83720432|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720433|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83720434|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720435|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720436|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
83720437|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720438|NCT01889680|Antidotes|antidotes|mesh-ancestor
83720439|NCT01889680|Protective Agents|protective agents|mesh-ancestor
83720440|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
83720441|NCT01889680|Vitamins|vitamins|mesh-ancestor
83720442|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
83720443|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83720444|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83720445|NCT01889680|Growth Substances|growth substances|mesh-ancestor
83720446|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
83720447|NCT01889758|Tacrolimus|tacrolimus|mesh-list
83720448|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720449|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
83720450|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720451|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83720452|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720453|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720454|NCT01889771|Nicotine|nicotine|mesh-list
83720455|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83720456|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
83720457|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720458|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720459|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83720460|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83720461|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
83720462|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875402|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875403|NCT03783338|Vitamin D|vitamin d|mesh-list
83720463|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720464|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83720465|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83720466|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
83720467|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720468|NCT01889914|Insulin|insulin|mesh-list
83720469|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83720470|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83720471|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720472|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
83720473|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
83720474|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83720475|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83720476|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720477|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720478|NCT01889966|Urological Agents|urological agents|mesh-ancestor
83720479|NCT01889979|Tramadol|tramadol|mesh-list
83720480|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83720481|NCT01889979|Narcotics|narcotics|mesh-ancestor
83720482|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720483|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720484|NCT01889979|Analgesics|analgesics|mesh-ancestor
83720485|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
83720486|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720487|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
83720488|NCT01890538|Piracetam|piracetam|mesh-list
83720489|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83720490|NCT01890538|Protective Agents|protective agents|mesh-ancestor
83720491|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720492|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
83720493|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
83720494|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
83720495|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720496|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720497|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83720498|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
83720499|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
83720500|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720501|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720502|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
83720503|NCT01891292|Enalapril|enalapril|mesh-list
83720504|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83720505|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
83720506|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720507|NCT01891292|Expectorants|expectorants|mesh-ancestor
83720508|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
83720509|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83720510|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
83720511|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720512|NCT01891292|Protective Agents|protective agents|mesh-ancestor
83720513|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720514|NCT01891292|Antidotes|antidotes|mesh-ancestor
83720515|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83720516|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
83720517|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720518|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83720519|NCT01891487|Bimatoprost|bimatoprost|mesh-list
83720520|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83720521|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
83720522|NCT01891981|Immunotoxins|immunotoxins|mesh-ancestor
83720523|NCT01891981|Immunoconjugates|immunoconjugates|mesh-ancestor
83720524|NCT01891981|Immunologic Factors|immunologic factors|mesh-ancestor
83720525|NCT01891981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720526|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720527|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
83720528|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83720529|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720530|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
83720531|NCT01893229|Valproic Acid|valproic acid|mesh-list
83720532|NCT01893229|Olanzapine|olanzapine|mesh-list
83720533|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83720534|NCT01893229|Ziprasidone|ziprasidone|mesh-list
83720535|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
83720536|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
83720537|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
83720538|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720539|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720540|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720541|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83720542|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82875475|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
83720543|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720544|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720545|NCT01893229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83720546|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83720547|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720548|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720549|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720550|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
83720551|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
83720552|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720553|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
83720554|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
83720555|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
83720556|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83720557|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83720558|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
83720559|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83720560|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83720561|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83720562|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83720563|NCT01894269|Lamivudine|lamivudine|mesh-list
83720564|NCT01894269|Entecavir|entecavir|mesh-list
83720565|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83720566|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83720567|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720568|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720569|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
83720570|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720571|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83720572|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83720573|NCT01894789|Clopidogrel|clopidogrel|mesh-list
83720574|NCT01894789|Ticagrelor|ticagrelor|mesh-list
83720575|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83720576|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83720577|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83720578|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83720579|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
83720580|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720581|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720582|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720583|NCT01894815|Dexetimide|dexetimide|mesh-list
83720584|NCT01894815|Citalopram|citalopram|mesh-list
83720585|NCT01894815|Escitalopram|escitalopram|mesh-list
83720586|NCT01894815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83720587|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83720588|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720589|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720590|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720591|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
83720592|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720593|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83720594|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83720595|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
83720596|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
83720597|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720598|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83720599|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83720600|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
83720601|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83720602|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
83720603|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720604|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
83720605|NCT01895049|Prednisone|prednisone|mesh-list
82875550|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
82875551|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875552|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875553|NCT01561508|Butyric Acid|butyric acid|mesh-list
82875554|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
82875555|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
82875556|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875557|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875558|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875559|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82875560|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720606|NCT01895049|Everolimus|everolimus|mesh-list
83720607|NCT01895049|Tacrolimus|tacrolimus|mesh-list
83720608|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
83720609|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83720610|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83720611|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
83720612|NCT01895049|Hormones|hormones|mesh-ancestor
83720613|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720614|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720615|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83720616|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720617|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720618|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
83720619|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83720620|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720621|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720622|NCT01895049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83720623|NCT01895049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83720624|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83720625|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83720626|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
83720627|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83720628|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720629|NCT01896622|Ritonavir|ritonavir|mesh-list
83720630|NCT01896622|Cobicistat|cobicistat|mesh-list
83720631|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83720632|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83720633|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
83720634|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720635|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720636|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83720637|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83720638|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
83720639|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720640|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83720641|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83720642|NCT01897051|Rifaximin|rifaximin|mesh-list
83720643|NCT01897051|Propranolol|propranolol|mesh-list
83720644|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83720645|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83720646|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83720647|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720648|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720649|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720650|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83720651|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83720652|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
83720653|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83720654|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720655|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720656|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
83720657|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
83720658|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83720659|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83720660|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720661|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720662|NCT01897740|Urological Agents|urological agents|mesh-ancestor
83720663|NCT01897753|Hormones|hormones|mesh-list
83720664|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720665|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720666|NCT01898065|Misonidazole|misonidazole|mesh-list
83720667|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720668|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83720669|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83720670|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720671|NCT01898221|Ethanol|ethanol|mesh-list
83720672|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83720673|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720674|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720675|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720676|NCT01898338|Daptomycin|daptomycin|mesh-list
83720677|NCT01898338|Fosfomycin|fosfomycin|mesh-list
83720678|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83720679|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720680|NCT01899105|Ivacaftor|ivacaftor|mesh-list
83720681|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83720682|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720683|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720684|NCT01900015|Efavirenz|efavirenz|mesh-list
83720685|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
83720686|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83720687|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83720688|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720689|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720690|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
83720691|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720692|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83720693|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83720694|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83720695|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83720696|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83720697|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83720698|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83720699|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83720700|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83720701|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83720702|NCT01900028|Itraconazole|itraconazole|mesh-list
83720703|NCT01900028|Olaparib|olaparib|mesh-list
83720704|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83720705|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720706|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720707|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720708|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
83720709|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720710|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83720711|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83720712|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83720713|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
83720714|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720715|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720716|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83720717|NCT01900041|Minoxidil|minoxidil|mesh-list
83720718|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83720719|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
83720720|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83720721|NCT01900093|Hormones|hormones|mesh-ancestor
83720722|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720723|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720724|NCT01900106|Ritonavir|ritonavir|mesh-list
83720725|NCT01900106|Darunavir|darunavir|mesh-list
83720726|NCT01900106|Lamivudine|lamivudine|mesh-list
83720727|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
83720728|NCT01900106|Abacavir|abacavir|mesh-list
83720729|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
83720730|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83720731|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83720732|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83720733|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720734|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720735|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83720736|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83720737|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
83720738|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720739|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83720740|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83720741|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83720742|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83720743|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83720744|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83720745|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
83720746|NCT01900158|Cisplatin|cisplatin|mesh-list
83720747|NCT01900158|Gemcitabine|gemcitabine|mesh-list
83720748|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720749|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83720750|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
83720751|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720752|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82875690|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
83720753|NCT01900197|Hematinics|hematinics|mesh-ancestor
83720754|NCT01900301|Scopolamine|scopolamine|mesh-list
83720755|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83720756|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83720757|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
83720758|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
83720759|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720760|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720761|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720762|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
83720763|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83720764|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
83720765|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720766|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720767|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83720768|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
83720769|NCT01900327|Gemcitabine|gemcitabine|mesh-list
83720770|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83720771|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
83720772|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720773|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720774|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
83720775|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83720776|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720777|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720778|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83720779|NCT01900405|Analgesics|analgesics|mesh-ancestor
83720780|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
83720781|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720782|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83720783|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83720784|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83720785|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83720786|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720787|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720788|NCT01900496|Rituximab|rituximab|mesh-list
83720789|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83720790|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83720791|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720792|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
83720793|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720794|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83720795|NCT01900496|Immunotoxins|immunotoxins|mesh-ancestor
83720796|NCT01900496|Immunoconjugates|immunoconjugates|mesh-ancestor
83720797|NCT01900509|Dexamethasone|dexamethasone|mesh-list
83720798|NCT01900509|Etoposide|etoposide|mesh-list
83720799|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
83720800|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83720801|NCT01900509|Clofarabine|clofarabine|mesh-list
83720802|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83720803|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
83720804|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
83720805|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500089|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
83720806|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720807|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720808|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
83720809|NCT01900509|Hormones|hormones|mesh-ancestor
83720810|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720811|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83720812|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720813|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83720814|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83720815|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83720816|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720817|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720818|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83720819|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
83720820|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83720821|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
83720822|NCT01900587|Tapentadol|tapentadol|mesh-list
83720823|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83720824|NCT01900587|Narcotics|narcotics|mesh-ancestor
83720825|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720826|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720827|NCT01900587|Analgesics|analgesics|mesh-ancestor
83720828|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
83720829|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720830|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83720831|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83720832|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83720833|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720834|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
83720835|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720836|NCT01900639|Aspirin|aspirin|mesh-list
83720837|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83720838|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83720839|NCT01900639|Analgesics|analgesics|mesh-ancestor
83720840|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
83720841|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720842|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720843|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83720844|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83720845|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83720846|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83720847|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720848|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83720849|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83720850|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720851|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
83720852|NCT01900717|Leucovorin|leucovorin|mesh-list
83720853|NCT01900717|Bevacizumab|bevacizumab|mesh-list
83720854|NCT01900717|Fluorouracil|fluorouracil|mesh-list
83720855|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
83720856|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83720857|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720858|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83720859|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83720860|NCT01900717|Growth Substances|growth substances|mesh-ancestor
83720861|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720862|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
83720863|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
83720864|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720865|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83720866|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83720867|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
83720868|NCT01900717|Antidotes|antidotes|mesh-ancestor
83720869|NCT01900717|Protective Agents|protective agents|mesh-ancestor
83720870|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
83720871|NCT01900717|Vitamins|vitamins|mesh-ancestor
83720872|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
83720873|NCT01900795|Ibuprofen|ibuprofen|mesh-list
83720874|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83720875|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83720876|NCT01900795|Analgesics|analgesics|mesh-ancestor
83720877|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
83720878|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720879|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720880|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83720881|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83720882|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83720883|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720884|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720885|NCT01900847|Ketamine|ketamine|mesh-list
83720886|NCT01900847|Morphine|morphine|mesh-list
83720887|NCT01900847|Analgesics|analgesics|mesh-ancestor
83720888|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
83720889|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720890|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720891|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83720892|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83720893|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
83720894|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
83720895|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720896|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83720897|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83720898|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720899|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875839|NCT04296890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83720900|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83720901|NCT01900847|Narcotics|narcotics|mesh-ancestor
82875840|NCT04296890|Immunoconjugates|immunoconjugates|mesh-ancestor
83720902|NCT01900860|Vitamin D|vitamin d|mesh-list
83720903|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
83720904|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
83720905|NCT01900860|Vitamins|vitamins|mesh-list
83720906|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
83720907|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720908|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83720909|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83720910|NCT01900886|Ribavirin|ribavirin|mesh-list
83720911|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83720912|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
83720913|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720914|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
83720915|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720916|NCT01900938|Midazolam|midazolam|mesh-list
83720917|NCT01900938|Propofol|propofol|mesh-list
83720918|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83720919|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720920|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720921|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83720922|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
83720923|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
83720924|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83720925|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83720926|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720927|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720928|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
83720929|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
83720930|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720931|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720932|NCT01900951|Temozolomide|temozolomide|mesh-list
83720933|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83720934|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
83720935|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720936|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720937|NCT01901003|Lorazepam|lorazepam|mesh-list
83720938|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
83720939|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
83720940|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
83720941|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83720942|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720943|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720944|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83720945|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83720946|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83720947|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83720948|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83720949|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
83720950|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
83720951|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720952|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720953|NCT01901120|Mirabegron|mirabegron|mesh-list
83720954|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83720955|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83720956|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83720957|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
83720958|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83720959|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720960|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720961|NCT01901120|Urological Agents|urological agents|mesh-ancestor
83720962|NCT01901172|Posaconazole|posaconazole|mesh-list
83720963|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
83720964|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720965|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82875912|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875913|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875914|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82875915|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82875916|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
82875917|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875918|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82875919|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82875921|NCT03902314|Lidocaine|lidocaine|mesh-list
83720966|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83720967|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83720968|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83720969|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83720970|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720971|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720972|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83720973|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
83720974|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83720975|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720976|NCT01901198|Interferons|interferons|mesh-list
83720977|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
83720978|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
83720979|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83720980|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
83720981|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83720982|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
83720983|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83720984|NCT01901276|Omeprazole|omeprazole|mesh-list
83720985|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83720986|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83720987|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83720988|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720989|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720990|NCT01901380|Caseins|caseins|mesh-list
83720991|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
83720992|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
83720993|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720994|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83720995|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83720996|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83720997|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83720998|NCT01901471|Cyclosporine|cyclosporine|mesh-list
83720999|NCT01901471|Cyclosporins|cyclosporins|mesh-list
83721000|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721001|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721002|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721003|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
83721004|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721005|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
83721006|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721007|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
83721008|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83721009|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83721010|NCT01901484|Praziquantel|praziquantel|mesh-list
83721011|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
83721012|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83721013|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721014|NCT01901549|Metoprolol|metoprolol|mesh-list
83721015|NCT01901549|Lisinopril|lisinopril|mesh-list
83721016|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83721017|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83721018|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
83721019|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
83721020|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721021|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721022|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83721023|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83721024|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83721025|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
83721026|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721027|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721028|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83721029|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
83721030|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721031|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83721032|NCT01901549|Protective Agents|protective agents|mesh-ancestor
83721033|NCT01901601|Anesthetics|anesthetics|mesh-list
83721034|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721035|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721036|NCT01901640|Udenafil|udenafil|mesh-list
83721037|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83721038|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83721039|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721040|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721041|NCT01901666|Hormones|hormones|mesh-list
83721042|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83721043|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721044|NCT01901692|Sorafenib|sorafenib|mesh-list
83721045|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721046|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721047|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721048|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721049|NCT01902017|Ketotifen|ketotifen|mesh-list
83721050|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
83721051|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
83721052|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83721053|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
83721054|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
83721055|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721056|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721057|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721058|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83721059|NCT01902108|Clonidine|clonidine|mesh-list
83721060|NCT01902108|Bupivacaine|bupivacaine|mesh-list
83721061|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
83721062|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
83721063|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721064|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721065|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
83721066|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721067|NCT01902108|Analgesics|analgesics|mesh-ancestor
83721068|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83721069|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
83721070|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
83721071|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83721072|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83721073|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83721074|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
83721075|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721076|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721077|NCT01902121|Insulin|insulin|mesh-list
83721078|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83721079|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83721080|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721081|NCT01902160|Sirolimus|sirolimus|mesh-list
83721082|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83721083|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83721084|NCT01902160|Temsirolimus|temsirolimus|mesh-list
83721085|NCT01902160|MTOR Inhibitors|mtor inhibitors|mesh-list
83721086|NCT01902160|Antibodies|antibodies|mesh-list
83721087|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
83721088|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83721089|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
83721090|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
83721091|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721092|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721093|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721094|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721095|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83721096|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
83721097|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721098|NCT01902160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721099|NCT01902160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721100|NCT01902160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721101|NCT01902160|Immunotoxins|immunotoxins|mesh-ancestor
83721102|NCT01902186|Ritonavir|ritonavir|mesh-list
83721103|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83721104|NCT01902186|Tenofovir|tenofovir|mesh-list
83721105|NCT01902186|Emtricitabine|emtricitabine|mesh-list
83721106|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
83721107|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83721108|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83721109|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
83721110|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721111|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721112|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83721113|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83721114|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
83721115|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721116|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83721117|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83721118|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83721119|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83721120|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83721121|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83721122|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83721123|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83721124|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721125|NCT01901861|Incretins|incretins|mesh-ancestor
83721126|NCT01901861|Hormones|hormones|mesh-ancestor
83721127|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83721128|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83721129|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
83721130|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721131|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721132|NCT01902225|Doxorubicin|doxorubicin|mesh-list
83721133|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83721134|NCT01902225|Romidepsin|romidepsin|mesh-list
83721135|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83721136|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721137|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83721138|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721139|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721140|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721141|NCT01902225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83721142|NCT01902238|Ethanol|ethanol|mesh-list
83721143|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
83721144|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83721145|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721146|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721147|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721148|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721149|NCT01902342|Oseltamivir|oseltamivir|mesh-list
83721150|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
83721151|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721152|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721153|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721154|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
83721155|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83721156|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83721157|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721158|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
83721159|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83721160|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
83721161|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83721162|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721163|NCT01902498|Aspirin|aspirin|mesh-list
83721164|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83721165|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83721166|NCT01902498|Analgesics|analgesics|mesh-ancestor
83721167|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
83721168|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721169|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721170|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83721171|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83721172|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83721173|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83721174|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721175|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83721176|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83721177|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721178|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
83721179|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
83721180|NCT01902511|Lenograstim|lenograstim|mesh-list
83721181|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83721182|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
83721183|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721184|NCT01902511|Hematinics|hematinics|mesh-ancestor
83721185|NCT01902524|Fentanyl|fentanyl|mesh-list
83721186|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83721187|NCT01902524|Narcotics|narcotics|mesh-ancestor
83721188|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721189|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721190|NCT01902524|Analgesics|analgesics|mesh-ancestor
82876119|NCT00166504|Simvastatin|simvastatin|mesh-list
83721191|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
82876120|NCT00166504|Ezetimibe|ezetimibe|mesh-list
83721192|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721193|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83721194|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83721195|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
83721196|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
83721197|NCT01902537|Prucalopride|prucalopride|mesh-list
83721198|NCT01902537|Laxatives|laxatives|mesh-ancestor
83721199|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83721200|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83721201|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83721202|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
83721203|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721204|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721205|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721206|NCT01902550|Metoprolol|metoprolol|mesh-list
83721207|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83721208|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83721209|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
83721210|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
83721211|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721212|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721213|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83721214|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83721215|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83721216|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
83721217|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721218|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721219|NCT01902641|Rocuronium|rocuronium|mesh-list
83721220|NCT01902641|Succinylcholine|succinylcholine|mesh-list
83721221|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83721222|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83721223|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83721224|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721225|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721226|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83721227|NCT01902771|Imiquimod|imiquimod|mesh-list
83721228|NCT01902771|Vaccines|vaccines|mesh-list
83721229|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
83721230|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721231|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83721232|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721233|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
83721234|NCT01902810|Propranolol|propranolol|mesh-list
83721235|NCT01902810|Metoprolol|metoprolol|mesh-list
83721236|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83721237|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83721238|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
83721239|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721240|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721241|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721242|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83721243|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83721244|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
83721245|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
83721246|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
83721247|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721248|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83721249|NCT01902862|Rituximab|rituximab|mesh-list
83721250|NCT01902862|Bortezomib|bortezomib|mesh-list
83721251|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83721252|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721253|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
83721254|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721255|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83721256|NCT01902875|Paclitaxel|paclitaxel|mesh-list
83721257|NCT01902875|Cisplatin|cisplatin|mesh-list
83721258|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83721259|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721260|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721261|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721262|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721263|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721264|NCT01903018|Cisplatin|cisplatin|mesh-list
83721265|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721266|NCT01903057|Azithromycin|azithromycin|mesh-list
83721267|NCT01903057|Ivermectin|ivermectin|mesh-list
83721268|NCT01903057|Albendazole|albendazole|mesh-list
82876192|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83721269|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721270|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721271|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83721272|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
83721273|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
83721274|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83721275|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83721276|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721277|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721278|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721279|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721280|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721282|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83721283|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721284|NCT01903070|Incretins|incretins|mesh-ancestor
83721285|NCT01903070|Hormones|hormones|mesh-ancestor
83721286|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83721287|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83721288|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83721289|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721290|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721291|NCT01903083|Gemcitabine|gemcitabine|mesh-list
83721292|NCT01903083|Tadalafil|tadalafil|mesh-list
83721293|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83721294|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
83721295|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721296|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721297|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
83721298|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83721299|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83721300|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721301|NCT01903083|Urological Agents|urological agents|mesh-ancestor
83721302|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
83721303|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83721304|NCT01903109|Cevimeline|cevimeline|mesh-list
83721305|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83721306|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
83721307|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721308|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721309|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83721310|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83721311|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
83721312|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721313|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721314|NCT01903122|Cevimeline|cevimeline|mesh-list
83721315|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83721316|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
83721317|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721318|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721319|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83721320|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83721321|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
83721322|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721323|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721324|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83721325|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
83721326|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83721327|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83721328|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83721329|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721330|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721331|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83721332|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
83721333|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721334|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83721335|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
83721336|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721337|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
83721338|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721339|NCT01903681|Melatonin|melatonin|mesh-list
83721340|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
83721341|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721342|NCT01903681|Protective Agents|protective agents|mesh-ancestor
83721343|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721344|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721345|NCT01903694|Sorafenib|sorafenib|mesh-list
83721346|NCT01903694|Pravastatin|pravastatin|mesh-list
83721347|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721348|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721349|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721350|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721351|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83721352|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83721353|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
83721354|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83721355|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83721356|NCT01903785|Albuterol|albuterol|mesh-list
83721357|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83721358|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
83721359|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721360|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721361|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83721362|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
83721363|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
83721364|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83721365|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83721366|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83721367|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83721368|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83721369|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721370|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721371|NCT01903824|Modafinil|modafinil|mesh-list
83721372|NCT01903824|Donepezil|donepezil|mesh-list
83721373|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83721374|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721375|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721376|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
83721377|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721378|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721379|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
83721380|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83721381|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83721382|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83721383|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83721384|NCT01904045|Tacrolimus|tacrolimus|mesh-list
83721385|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721386|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
83721387|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721388|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83721389|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721390|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721391|NCT01904097|Pregabalin|pregabalin|mesh-list
83721392|NCT01904097|Analgesics|analgesics|mesh-ancestor
83721393|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
83721394|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721395|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721396|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
83721397|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83721398|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83721399|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721400|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83721401|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83721402|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83721403|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721404|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83721405|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
83721406|NCT01904110|Vitamin D|vitamin d|mesh-list
83721407|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
83721408|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
83721409|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83721410|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721411|NCT01904110|Vitamins|vitamins|mesh-ancestor
83721412|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
83721413|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83721414|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83721415|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83721416|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876343|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
83721418|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83721419|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721420|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721421|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83721422|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721423|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721424|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721425|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721426|NCT01904214|Siponimod|siponimod|mesh-list
83721427|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83721428|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721429|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721430|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
83721431|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721432|NCT01904253|Topotecan|topotecan|mesh-list
83721433|NCT01904253|Amrubicin|amrubicin|mesh-list
83721434|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83721435|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721436|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721437|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721438|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721439|NCT01904357|Cefazolin|cefazolin|mesh-list
83721440|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721441|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721442|NCT01904487|Tiagabine|tiagabine|mesh-list
83721443|NCT01904487|Flumazenil|flumazenil|mesh-list
83721444|NCT01904487|Antidotes|antidotes|mesh-ancestor
83721445|NCT01904487|Protective Agents|protective agents|mesh-ancestor
83721446|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721447|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
83721448|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
83721449|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721450|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721451|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
83721452|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83721453|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83721454|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83721455|NCT01904500|Cefazolin|cefazolin|mesh-list
83721456|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721457|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721458|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83721459|NCT01904539|Cathartics|cathartics|mesh-ancestor
83721460|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83721461|NCT01904591|Vitamin E|vitamin e|mesh-list
83721462|NCT01904591|Selenium|selenium|mesh-list
83721463|NCT01904591|Vitamins|vitamins|mesh-ancestor
83721464|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
83721465|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721466|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
83721467|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721468|NCT01904591|Protective Agents|protective agents|mesh-ancestor
83721469|NCT01904591|Trace Elements|trace elements|mesh-ancestor
83721470|NCT01904643|Cytarabine|cytarabine|mesh-list
83721471|NCT01904643|Etoposide|etoposide|mesh-list
83721472|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
83721473|NCT01904643|Lenalidomide|lenalidomide|mesh-list
83721474|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
83721475|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83721476|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721477|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83721478|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721479|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721480|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721481|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83721482|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
83721483|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
83721484|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721485|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721486|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
83721487|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721488|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83721489|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83721490|NCT01904643|Growth Substances|growth substances|mesh-ancestor
83721491|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83721492|NCT01904643|Analgesics|analgesics|mesh-ancestor
83721493|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
83721494|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721495|NCT01904682|ON 01910|on 01910|mesh-list
83721496|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721497|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721498|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721499|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721500|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
83721501|NCT01904695|Diuretics|diuretics|mesh-list
83721502|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83721503|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83721504|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
83721505|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721506|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
83721507|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721508|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721509|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83721510|NCT01904734|Clomiphene|clomiphene|mesh-list
83721511|NCT01904734|Enclomiphene|enclomiphene|mesh-list
83721512|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
83721513|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83721514|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
83721515|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83721516|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721517|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83721518|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
83721519|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83721520|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83721521|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83721522|NCT01904747|Palbociclib|palbociclib|mesh-list
83721523|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721524|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721525|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721526|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721527|NCT01904786|Melatonin|melatonin|mesh-list
83721528|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
83721529|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721530|NCT01904786|Protective Agents|protective agents|mesh-ancestor
83721531|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721532|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721533|NCT01904981|Atenolol|atenolol|mesh-list
83721534|NCT01904981|Valsartan|valsartan|mesh-list
83721535|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83721536|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83721537|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83721538|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83721539|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721540|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83721541|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
83721542|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721543|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721544|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83721545|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
83721546|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
83721547|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721548|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83721549|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83721550|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
83721551|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721552|NCT01905059|Lamivudine|lamivudine|mesh-list
83721553|NCT01905059|Lopinavir|lopinavir|mesh-list
83721554|NCT01905059|Darunavir|darunavir|mesh-list
83721555|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83721556|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
83721557|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83721558|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83721559|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721560|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721561|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
83721562|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721563|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83721564|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83721565|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82876491|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876492|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
83721566|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83721567|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83721568|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
83721569|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83721570|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83721571|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83721572|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83721573|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721574|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
83721575|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721576|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721577|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83721578|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721579|NCT01905150|Leucovorin|leucovorin|mesh-list
83721580|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
83721581|NCT01905150|Gemcitabine|gemcitabine|mesh-list
83721582|NCT01905150|Fluorouracil|fluorouracil|mesh-list
83721583|NCT01905150|Docetaxel|docetaxel|mesh-list
83721584|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
83721585|NCT01905150|Irinotecan|irinotecan|mesh-list
83721586|NCT01905150|Mitomycins|mitomycins|mesh-list
83721587|NCT01905150|Mitomycin|mitomycin|mesh-list
83721588|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
83721589|NCT01905150|Vitamins|vitamins|mesh-ancestor
83721590|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
83721591|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721592|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83721593|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
83721594|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721595|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721596|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721597|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721598|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721599|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721600|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
83721601|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83721602|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721603|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721604|NCT01905150|Antidotes|antidotes|mesh-ancestor
83721605|NCT01905150|Protective Agents|protective agents|mesh-ancestor
83721606|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
83721607|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
83721608|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83721609|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
83721610|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83721611|NCT01905215|Vaccines|vaccines|mesh-list
83721612|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
83721613|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721614|NCT01905371|Amphetamine|amphetamine|mesh-list
83721615|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
83721616|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83721617|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721618|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
83721619|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
83721620|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721621|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
83721622|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721623|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721624|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83721625|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83721626|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83721627|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83721628|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83721629|NCT01905501|Anesthetics|anesthetics|mesh-list
83721630|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721631|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721632|NCT01905566|Clopidogrel|clopidogrel|mesh-list
83721633|NCT01905566|Ticagrelor|ticagrelor|mesh-list
83721634|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83721635|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83721636|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83721637|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83721638|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
82876566|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83721639|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721640|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721642|NCT01905618|Nicotine|nicotine|mesh-list
83721643|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83721644|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
83721645|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721646|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721647|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83721648|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83721649|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
83721650|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721651|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721652|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
83721653|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83721654|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
83721655|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721656|NCT01905696|Expectorants|expectorants|mesh-ancestor
83721657|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
83721658|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83721659|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
83721660|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721661|NCT01905696|Protective Agents|protective agents|mesh-ancestor
83721662|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721663|NCT01905696|Antidotes|antidotes|mesh-ancestor
83721664|NCT01905774|Deferasirox|deferasirox|mesh-list
83721665|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83721666|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
83721667|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
83721668|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721669|NCT01905904|Sevoflurane|sevoflurane|mesh-list
83721670|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83721671|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83721672|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
83721673|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
83721674|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721675|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721676|NCT01906073|Fentanyl|fentanyl|mesh-list
83721677|NCT01906073|Morphine|morphine|mesh-list
83721678|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83721679|NCT01906073|Narcotics|narcotics|mesh-ancestor
83721680|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721681|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721682|NCT01906073|Analgesics|analgesics|mesh-ancestor
83721683|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
83721684|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721685|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83721686|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83721687|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
83721688|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
83721689|NCT01906125|Palbociclib|palbociclib|mesh-list
83721690|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721691|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721692|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721693|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721694|NCT01906216|Sorafenib|sorafenib|mesh-list
83721695|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721696|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721697|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721698|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721699|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
83721700|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83721701|NCT01906242|Eusol|eusol|mesh-list
83721702|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83721703|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721704|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
83721705|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83721706|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721707|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
83721708|NCT01906307|Giapreza|giapreza|mesh-list
83721709|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83721710|NCT01906411|Dopamine|dopamine|mesh-list
83721711|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83721712|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
83721713|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
83721714|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721715|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721716|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
83721717|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721718|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721719|NCT01906411|Protective Agents|protective agents|mesh-ancestor
83721720|NCT01906450|Azithromycin|azithromycin|mesh-list
83721721|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721722|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721723|NCT01906528|Mivacurium|mivacurium|mesh-list
83721724|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83721725|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83721726|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83721727|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721728|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721729|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83721730|NCT01906580|Entecavir|entecavir|mesh-list
83721731|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
83721732|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721733|NCT01906632|Immunomodulating Agents|immunomodulating agents|mesh-list
83721734|NCT01906632|Immunologic Factors|immunologic factors|mesh-ancestor
83721735|NCT01906632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721736|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
83721737|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
83721738|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721739|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83721740|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721741|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721742|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
83721743|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721744|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83721745|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721746|NCT01906749|Colchicine|colchicine|mesh-list
83721747|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
83721748|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83721749|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721750|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721751|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721752|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721753|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721754|NCT01906762|Acetaminophen|acetaminophen|mesh-list
83721755|NCT01906762|Morphine|morphine|mesh-list
83721756|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83721757|NCT01906762|Narcotics|narcotics|mesh-ancestor
83721758|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721759|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721760|NCT01906762|Analgesics|analgesics|mesh-ancestor
83721761|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
83721762|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721763|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83721764|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
83721765|NCT01906788|Lumefantrine|lumefantrine|mesh-list
83721766|NCT01906788|Artemether|artemether|mesh-list
83721767|NCT01906788|Primaquine|primaquine|mesh-list
83721768|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83721769|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
83721770|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83721771|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83721772|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721773|NCT01906801|Diacerein|diacerein|mesh-list
83721774|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83721775|NCT01906814|Carboplatin|carboplatin|mesh-list
83721776|NCT01906814|Etoposide|etoposide|mesh-list
83721777|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
83721778|NCT01906814|Vincristine|vincristine|mesh-list
83721779|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721780|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83721781|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83721782|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721783|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721784|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721785|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721786|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721787|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721788|NCT01906879|Bismuth|bismuth|mesh-list
83721789|NCT01906879|Antacids|antacids|mesh-ancestor
83721790|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721791|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83721792|NCT01906944|Triamcinolone|triamcinolone|mesh-list
83721793|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83721794|NCT01906944|Bupivacaine|bupivacaine|mesh-list
83721795|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
83721796|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
83721797|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721798|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721799|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
83721800|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721801|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83721802|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
83721803|NCT01906944|Hormones|hormones|mesh-ancestor
83721804|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83721805|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721806|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
83721807|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
83721808|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83721809|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
83721810|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83721811|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
83721812|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721813|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721814|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
83721815|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
83721816|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83721817|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
83721818|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721819|NCT01907061|Expectorants|expectorants|mesh-ancestor
83721820|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
83721821|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83721822|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
83721823|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721824|NCT01907061|Protective Agents|protective agents|mesh-ancestor
83721825|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721826|NCT01907061|Antidotes|antidotes|mesh-ancestor
83721827|NCT01907074|Cholic Acids|cholic acids|mesh-list
83721828|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83721829|NCT01907165|Copper|copper|mesh-list
83721830|NCT01907165|Temozolomide|temozolomide|mesh-list
83721831|NCT01907165|Disulfiram|disulfiram|mesh-list
83721832|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83721833|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
83721834|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721835|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721836|NCT01907165|Trace Elements|trace elements|mesh-ancestor
83721837|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
83721838|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721839|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83721840|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83721841|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721842|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
83721843|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83721844|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83721845|NCT01907204|Prednisolone|prednisolone|mesh-list
83721846|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
83721847|NCT01907204|Budesonide|budesonide|mesh-list
83721848|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83721849|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
83721850|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83721851|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
83721852|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
83721853|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721854|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721855|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83721856|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
83721857|NCT01907204|Hormones|hormones|mesh-ancestor
83721858|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83721859|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83721860|NCT01907204|Protective Agents|protective agents|mesh-ancestor
83721861|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83721862|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721863|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83721864|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83721865|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
83721866|NCT01907230|Entecavir|entecavir|mesh-list
83721867|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
83721868|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721869|NCT01907308|Docetaxel|docetaxel|mesh-list
83721870|NCT01907308|Trebananib|trebananib|mesh-list
83721871|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721872|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721873|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721874|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721875|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721876|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83721877|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83721878|NCT01907308|Growth Substances|growth substances|mesh-ancestor
83721879|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721880|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
83721881|NCT01907373|Probenecid|probenecid|mesh-list
83721882|NCT01907373|Olmesartan|olmesartan|mesh-list
83721883|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83721884|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83721885|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83721886|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83721887|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721888|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
83721889|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
83721890|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83721891|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
83721892|NCT01907529|Docetaxel|docetaxel|mesh-list
83721893|NCT01907529|Epirubicin|epirubicin|mesh-list
83721894|NCT01907529|Endostar protein|endostar protein|mesh-list
83721895|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83721896|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
83721897|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721898|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83721899|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83721900|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
83721901|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721902|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721903|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83721904|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721905|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721906|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721907|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83721908|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83721909|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721910|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721911|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83721912|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83500098|NCT04421339|Melatonin|melatonin|mesh-list
83721913|NCT01907529|Growth Substances|growth substances|mesh-ancestor
83721914|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
83721915|NCT01907594|Cycloserine|cycloserine|mesh-list
83721916|NCT01907594|Nicotine|nicotine|mesh-list
83721917|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83721918|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
83721919|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721920|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721921|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83721922|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83721923|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
83721924|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721925|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721926|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83721927|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721928|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83721929|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
83721930|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721931|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
83721932|NCT01907633|Domperidone|domperidone|mesh-list
83721933|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
83721934|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
83721935|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721936|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721937|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83721938|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83721939|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
83721940|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721941|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721942|NCT01907685|Docetaxel|docetaxel|mesh-list
83721943|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721944|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
83721945|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
83721946|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
83721947|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721948|NCT01907724|Simeprevir|simeprevir|mesh-list
83721949|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
83721950|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721951|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
83721952|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721953|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721955|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83721956|NCT01907776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721957|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721958|NCT01907802|Dabrafenib|dabrafenib|mesh-list
83721959|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721960|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83721961|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721962|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721963|NCT01907867|Finafloxacin|finafloxacin|mesh-list
83721964|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83721965|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83721966|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83721967|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83721968|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83721969|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83721970|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721971|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83721972|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
83721973|NCT01907880|Pamidronate|pamidronate|mesh-list
83721974|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83721975|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721976|NCT01907984|Diclofenac|diclofenac|mesh-list
83721977|NCT01907984|Midazolam|midazolam|mesh-list
83721978|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83721979|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83721980|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83721981|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83721982|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83721983|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83721984|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83721985|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83721986|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
83721987|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
83721988|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
83721989|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
83721990|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83721991|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83721992|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83721993|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83721994|NCT01907984|Analgesics|analgesics|mesh-ancestor
83721995|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
83721996|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83721997|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83721998|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83721999|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83722000|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722001|NCT01907997|Lidocaine|lidocaine|mesh-list
83722002|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
83722003|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
83722004|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722005|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722006|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
83722007|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722008|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83722009|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83722010|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83722011|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722012|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722013|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83722014|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83722015|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
83722016|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722017|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876938|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
82876939|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82876940|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
82876941|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
82876942|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
82876943|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
83722018|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83722019|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
83722020|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
83722021|NCT01908075|Hormones|hormones|mesh-ancestor
83722022|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722023|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
83722024|NCT01908114|Vaccines|vaccines|mesh-list
83722025|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
83722026|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722027|NCT01908257|Lesinurad|lesinurad|mesh-list
83722028|NCT01908257|Ranitidine|ranitidine|mesh-list
83722029|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83722030|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83722031|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722032|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83722033|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
83722034|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
83722035|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722036|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722037|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722038|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
83722039|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722040|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
83722041|NCT01908283|Vaccines|vaccines|mesh-list
83722042|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
83722043|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722044|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83722045|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
83500111|NCT04391049|Carboplatin|carboplatin|mesh-list
83722046|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
83722047|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83722048|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83722049|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83722050|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722051|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722052|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83722053|NCT01908296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83722054|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83722055|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722056|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722057|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722058|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
83722059|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83722060|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83722061|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83722062|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722063|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83722064|NCT01908322|Sorafenib|sorafenib|mesh-list
83722065|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722066|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83722067|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722068|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722069|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83722070|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
83722071|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
83722072|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722073|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
83722074|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722075|NCT01908348|Erythritol|erythritol|mesh-list
83722076|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
83722077|NCT01908387|Azacitidine|azacitidine|mesh-list
83722078|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83722079|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
83722080|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722081|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722082|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722083|NCT01908452|Pyridoxine|pyridoxine|mesh-list
83722084|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
83722085|NCT01908452|Vitamins|vitamins|mesh-ancestor
83722086|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
83722087|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722088|NCT01908478|Gemcitabine|gemcitabine|mesh-list
83722089|NCT01908478|Veliparib|veliparib|mesh-list
83722090|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83722091|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
83722092|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877016|NCT00003102|Antibodies|antibodies|mesh-list
83722093|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722094|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83722095|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722096|NCT01908556|Letrozole|letrozole|mesh-list
83722097|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722098|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83722099|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83722100|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722101|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722102|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83722103|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
83722104|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722105|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722106|NCT01908621|Cytarabine|cytarabine|mesh-list
83722107|NCT01908621|Lenograstim|lenograstim|mesh-list
83722108|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83722109|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
83722110|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722111|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83722112|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
83722113|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722114|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722115|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
83722116|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722117|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83722118|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83722119|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
83722120|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722121|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
83722122|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722123|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722124|NCT01909037|Curcumin|curcumin|mesh-list
83722125|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83722126|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83722127|NCT01909037|Analgesics|analgesics|mesh-ancestor
83722128|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
83722129|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722130|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722131|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83722132|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722133|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722134|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722135|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722136|NCT01909063|Vitamin D|vitamin d|mesh-list
83722137|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
83722138|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
83722139|NCT01909063|Vitamins|vitamins|mesh-list
83722140|NCT01909063|Vitamin E|vitamin e|mesh-list
83722141|NCT01909063|Vitamin A|vitamin a|mesh-list
83722142|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
83722143|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722144|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722145|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83722146|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
83722147|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722148|NCT01909063|Protective Agents|protective agents|mesh-ancestor
83722149|NCT01909115|Vitamin D|vitamin d|mesh-list
83722150|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
83722151|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
83722152|NCT01909115|Vitamins|vitamins|mesh-list
83722153|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
83722154|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722155|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83722156|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722157|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
83722158|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
83722159|NCT01909219|Cathartics|cathartics|mesh-ancestor
83722160|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722161|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
83722162|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
83722163|NCT01909557|Vitamins|vitamins|mesh-ancestor
83722164|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
82877091|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
82877092|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722165|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722166|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
83722167|NCT01909622|Vitamin D|vitamin d|mesh-list
83722168|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
83722169|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
83722170|NCT01909622|Vitamins|vitamins|mesh-list
83722171|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
83722172|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722173|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83722174|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722175|NCT01909661|Caseins|caseins|mesh-list
83722176|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
83722177|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
83722178|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722179|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
83722180|NCT01909752|Imiquimod|imiquimod|mesh-list
83722181|NCT01909752|Vaccines|vaccines|mesh-list
83722182|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
83722183|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722184|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83722185|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722186|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83722187|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
83722188|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722189|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722190|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83722191|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83722192|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
83722193|NCT01909830|Gemcitabine|gemcitabine|mesh-list
83722194|NCT01909830|Pemetrexed|pemetrexed|mesh-list
83722195|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83722196|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
83722197|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722198|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722199|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722200|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83722201|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83722202|NCT01909843|Gontivimab|gontivimab|mesh-list
83722203|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
83722204|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722205|NCT01909856|Dexamethasone|dexamethasone|mesh-list
83722206|NCT01909856|Palonosetron|palonosetron|mesh-list
83722207|NCT01909856|Granisetron|granisetron|mesh-list
83722208|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83722209|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
83722210|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
83722211|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722212|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722213|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722214|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
83722215|NCT01909856|Hormones|hormones|mesh-ancestor
83722216|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722217|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83722218|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722219|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83722220|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83722221|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
83722222|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722223|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722224|NCT01910077|Tacrolimus|tacrolimus|mesh-list
83722225|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83722226|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
83722227|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722228|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83722229|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722230|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722231|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
83722232|NCT01910090|Famotidine|famotidine|mesh-list
83722233|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83722234|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722235|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83722236|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
83722237|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
83722238|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722239|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722240|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722241|NCT01910090|Analgesics|analgesics|mesh-ancestor
83722242|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
83722243|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722244|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83722245|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83722246|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83722247|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722248|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83722249|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722250|NCT01910142|Vitamin K|vitamin k|mesh-list
83722251|NCT01910142|Calcium|calcium|mesh-list
83722252|NCT01910142|Vitamins|vitamins|mesh-ancestor
83722253|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
83722254|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722255|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722256|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83722257|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83722258|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722259|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
83722260|NCT01910142|Coagulants|coagulants|mesh-ancestor
83722261|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
83722262|NCT01910155|Dexamethasone|dexamethasone|mesh-list
83722263|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83722264|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
83722265|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
83722266|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722267|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722268|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722269|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
83722270|NCT01910155|Hormones|hormones|mesh-ancestor
83722271|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722272|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83722273|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722274|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83722275|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722276|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83722277|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83722278|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722279|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722280|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83722281|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83722282|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
83722283|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722284|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722285|NCT01910246|Metformin|metformin|mesh-list
83722286|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722287|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722288|NCT01910259|Amiloride|amiloride|mesh-list
83722289|NCT01910259|Riluzole|riluzole|mesh-list
83722290|NCT01910259|Fluoxetine|fluoxetine|mesh-list
83722291|NCT01910259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83722292|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83722293|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722294|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722295|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722296|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
83722297|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722298|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83722299|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
83722300|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83722301|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83722302|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83722303|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722304|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
83722305|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83722306|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83722307|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83722308|NCT01910259|Protective Agents|protective agents|mesh-ancestor
83722309|NCT01910259|Diuretics|diuretics|mesh-ancestor
83722310|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
83722311|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83722312|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83722313|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83722314|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83722315|NCT01910285|Sufentanil|sufentanil|mesh-list
83722316|NCT01910285|Dsuvia|dsuvia|mesh-list
83722317|NCT01910285|Remifentanil|remifentanil|mesh-list
83722318|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83722319|NCT01910285|Narcotics|narcotics|mesh-ancestor
83722320|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722321|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722322|NCT01910285|Analgesics|analgesics|mesh-ancestor
83722323|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
83722324|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722325|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83722326|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83722327|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
83722328|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
83722329|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
83722330|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83722331|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83722332|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83722333|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722334|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722335|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
83722336|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722337|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722338|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83722339|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722340|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
83722341|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83722343|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83722344|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722345|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83722346|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83722347|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722348|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722349|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722350|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83722351|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
83722352|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83722353|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722354|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83722355|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83722356|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83722357|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83722358|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722359|NCT01910428|Asparaginase|asparaginase|mesh-list
83722360|NCT01910428|Eryaspase|eryaspase|mesh-list
83722361|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722362|NCT01910480|Ketoconazole|ketoconazole|mesh-list
83722363|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
83722364|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722365|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83722366|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83722367|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722368|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722369|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83722370|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
83722371|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722372|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722373|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83722374|NCT01910506|Verinurad|verinurad|mesh-list
83722375|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
83722376|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722377|NCT01910532|Clevidipine|clevidipine|mesh-list
83722378|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83722379|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722380|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722381|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722382|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722383|NCT01910545|OTS167|ots167|mesh-list
83722384|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83722385|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722386|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722387|NCT01910610|Bevacizumab|bevacizumab|mesh-list
83722388|NCT01910610|Cetuximab|cetuximab|mesh-list
83722389|NCT01910610|Panitumumab|panitumumab|mesh-list
83722390|NCT01910610|Irinotecan|irinotecan|mesh-list
83722391|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83722392|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722393|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83722394|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83722395|NCT01910610|Growth Substances|growth substances|mesh-ancestor
83722396|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722397|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83722398|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83722399|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83722400|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722401|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722402|NCT01910766|Ubiquinone|ubiquinone|mesh-list
83722403|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
83722404|NCT01910766|Clomiphene|clomiphene|mesh-list
83722405|NCT01910766|Enclomiphene|enclomiphene|mesh-list
83722406|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
83722407|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83722408|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
83722409|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722410|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722411|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83722412|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
83722413|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83722414|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83722415|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83722416|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
83722417|NCT01910766|Vitamins|vitamins|mesh-ancestor
83722418|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
83722419|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83722420|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
83722421|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722422|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722423|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83722424|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
83722425|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722426|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722427|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83722428|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
83722429|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83722430|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
83722431|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722432|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722433|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83722434|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
83722435|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722436|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722437|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83722438|NCT01910883|Finafloxacin|finafloxacin|mesh-list
83722439|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
83722440|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83722441|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83722442|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722443|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83722444|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83722445|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83722446|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722447|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722448|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722449|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83722450|NCT01910987|Dexamethasone|dexamethasone|mesh-list
83722451|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
83722452|NCT01910987|Bortezomib|bortezomib|mesh-list
83722453|NCT01910987|BB 1101|bb 1101|mesh-list
83722454|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83722455|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
83722456|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
83722457|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722458|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722459|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722460|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
83722461|NCT01910987|Hormones|hormones|mesh-ancestor
83722462|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722463|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83722464|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877393|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877420|NCT00023712|Bortezomib|bortezomib|mesh-list
83722465|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
83722466|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722467|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722469|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83722470|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
83722471|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
83722472|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722473|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722474|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
83722475|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83722476|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
83722477|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722478|NCT01911247|Metformin|metformin|mesh-list
83722479|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722480|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722481|NCT01911299|Choline|choline|mesh-list
83722482|NCT01911299|Glycerol|glycerol|mesh-list
83722483|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
83722484|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83722485|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
83722486|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722487|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722488|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83722489|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
83722490|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83722491|NCT01911299|Protective Agents|protective agents|mesh-ancestor
83722492|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722493|NCT01911325|Docetaxel|docetaxel|mesh-list
83722494|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722495|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
83722496|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
83722497|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
83722498|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722499|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
83722500|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83722501|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
83722502|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722503|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722504|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83722505|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
83722506|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
83722507|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83722508|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
83722509|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722510|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722511|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
83722512|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83722513|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83722514|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83722515|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722516|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722517|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
83722518|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722519|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722520|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83722521|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722522|NCT01911455|Acamprosate|acamprosate|mesh-list
83722523|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83722524|NCT01911468|Metformin|metformin|mesh-list
83722525|NCT01911468|Liraglutide|liraglutide|mesh-list
83722526|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83722527|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722528|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722529|NCT01911468|Incretins|incretins|mesh-ancestor
83722530|NCT01911468|Hormones|hormones|mesh-ancestor
83722531|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722532|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
83722533|NCT01911494|Methyldopa|methyldopa|mesh-list
83722534|NCT01911494|Analgesics|analgesics|mesh-ancestor
83722535|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
83722536|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722537|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722538|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
83722539|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877469|NCT03951402|Narcotics|narcotics|mesh-ancestor
83722540|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83722541|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
83722542|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83722543|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722544|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722545|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722546|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
83722547|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83722548|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83722549|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
83722550|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
83722551|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83722552|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83722553|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83722554|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
83722555|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722556|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83722557|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722558|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83722559|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722560|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722561|NCT01911598|Paclitaxel|paclitaxel|mesh-list
83722562|NCT01911598|Carboplatin|carboplatin|mesh-list
83722563|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83722564|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722565|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
83722566|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
83722567|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
83722568|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722569|NCT01911624|Enoxaparin|enoxaparin|mesh-list
83722570|NCT01911624|Dabigatran|dabigatran|mesh-list
83722571|NCT01911624|Argatroban|argatroban|mesh-list
83722572|NCT01911624|Thrombin|thrombin|mesh-list
83722573|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
83722574|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83722575|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83722576|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722577|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
83722578|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83722579|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
83722580|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722581|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
83722582|NCT01911624|Coagulants|coagulants|mesh-ancestor
83722583|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83722584|NCT01911728|Pioglitazone|pioglitazone|mesh-list
83722585|NCT01911728|Midazolam|midazolam|mesh-list
83722586|NCT01911728|Omeprazole|omeprazole|mesh-list
83722587|NCT01911728|Warfarin|warfarin|mesh-list
83722588|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83722589|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83722590|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722591|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722592|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83722593|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83722594|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83722595|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83722596|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
83722597|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
83722598|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
83722599|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
83722600|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722601|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722602|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722603|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
83722604|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83722605|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722606|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83722607|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722608|NCT01911949|Epinephrine|epinephrine|mesh-list
83722609|NCT01911949|Bupivacaine|bupivacaine|mesh-list
83722610|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
83722611|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
83722612|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722613|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722614|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
83722615|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722616|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83722617|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83722618|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
83722619|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722620|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722621|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83722622|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83722623|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
83722624|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83722625|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
83722626|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
83722627|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
83722628|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83722630|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
83722631|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83722632|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83722633|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722634|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722635|NCT01912053|Gemcitabine|gemcitabine|mesh-list
83722636|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722637|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83722638|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
83722639|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722640|NCT01912066|Aceclofenac|aceclofenac|mesh-list
83722641|NCT01912066|Misoprostol|misoprostol|mesh-list
83722642|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83722643|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
83722644|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83722645|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722646|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83722647|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722648|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
83722649|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83722650|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83722651|NCT01912066|Analgesics|analgesics|mesh-ancestor
83722652|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
83722653|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722654|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83722655|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83722656|NCT01912118|Remifentanil|remifentanil|mesh-list
83722657|NCT01912118|Propofol|propofol|mesh-list
83722658|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83722659|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722660|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722661|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83722662|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
83722663|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
83722664|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83722665|NCT01912118|Narcotics|narcotics|mesh-ancestor
83722666|NCT01912118|Analgesics|analgesics|mesh-ancestor
83722667|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
83722668|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722669|NCT01912261|Iron|iron|mesh-list
83722670|NCT01912261|Trace Elements|trace elements|mesh-ancestor
83722671|NCT01912261|Micronutrients|micronutrients|mesh-ancestor
83722672|NCT01912261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722673|NCT01912378|Oxytocin|oxytocin|mesh-list
83722674|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
83722675|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83722676|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722677|NCT01912391|Selegiline|selegiline|mesh-list
83722678|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
83722679|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83722680|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83722681|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83722682|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83722683|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722684|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722685|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83722686|NCT01912391|Protective Agents|protective agents|mesh-ancestor
83722687|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722688|NCT01912443|Bevacizumab|bevacizumab|mesh-list
83722689|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83722690|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722691|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83722692|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83722693|NCT01912443|Growth Substances|growth substances|mesh-ancestor
83722694|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722696|NCT01912534|Valsartan|valsartan|mesh-list
83722697|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83722698|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83722699|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83722700|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722701|NCT01912573|Naloxone|naloxone|mesh-list
83722702|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83722703|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722704|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
83722705|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722706|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
83722707|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
83722708|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83722709|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83722710|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722711|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722712|NCT01912586|Urological Agents|urological agents|mesh-ancestor
83722713|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
83722714|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83722715|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
83722716|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722717|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
83722718|NCT01912638|Protective Agents|protective agents|mesh-ancestor
83722719|NCT01912677|Labetalol|labetalol|mesh-list
83722720|NCT01912677|Methyldopa|methyldopa|mesh-list
83722721|NCT01912677|Nifedipine|nifedipine|mesh-list
83722722|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83722723|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722724|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722725|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722726|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722727|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
83722728|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
83722729|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83722730|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83722731|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83722732|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
83722733|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722734|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83722735|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
83722736|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
83722737|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722738|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83722739|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83722740|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
83722741|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83722742|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83722743|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83722744|NCT01912755|Lidocaine|lidocaine|mesh-list
83722745|NCT01912755|Epinephrine|epinephrine|mesh-list
83722746|NCT01912755|Racepinephrine|racepinephrine|mesh-list
83722747|NCT01912755|Carticaine|carticaine|mesh-list
83722748|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
83722749|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
83722750|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
83722751|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722752|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722753|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
83722754|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722755|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83722756|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83722757|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83722758|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722759|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722760|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83722761|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83722762|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
83722763|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722764|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83722765|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83722766|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
83722767|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83722768|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
83722769|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
83722770|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
83722771|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83722772|NCT01912820|Quercetin|quercetin|mesh-list
83722773|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
83722774|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722775|NCT01912820|Protective Agents|protective agents|mesh-ancestor
83722776|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722777|NCT01912898|Vitamin D|vitamin d|mesh-list
83722778|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
83722779|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
83722780|NCT01912898|Vitamins|vitamins|mesh-list
83722781|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
83722782|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722783|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83722784|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722785|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83722786|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83722787|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
83722788|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83722789|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
83722790|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83722791|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722792|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83722793|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83722794|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722795|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722796|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722797|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722798|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83722799|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722800|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
83722801|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722802|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83722803|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722804|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722805|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
83722806|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722807|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722808|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83722809|NCT01913054|Fentanyl|fentanyl|mesh-list
83722810|NCT01913054|Propofol|propofol|mesh-list
83722811|NCT01913054|Etomidate|etomidate|mesh-list
83722812|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83722813|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722814|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722815|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83722816|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
83722817|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
83722818|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83722819|NCT01913054|Narcotics|narcotics|mesh-ancestor
83722820|NCT01913054|Analgesics|analgesics|mesh-ancestor
83722821|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
83722822|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722823|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83722824|NCT01913106|Valacyclovir|valacyclovir|mesh-list
83722825|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
83722826|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722827|NCT01913119|Romidepsin|romidepsin|mesh-list
83722828|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83722829|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722830|NCT01913119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83722831|NCT01913119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722832|NCT01913119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722833|NCT01913379|Itraconazole|itraconazole|mesh-list
83722834|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
83722835|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
83722836|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722837|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83722838|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83722839|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722840|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877767|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722841|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83722842|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
83722843|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722844|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722845|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83722846|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83722847|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
83722848|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83722849|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83722850|NCT01913431|Entecavir|entecavir|mesh-list
83722851|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
83722852|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722853|NCT01913444|Antithrombins|antithrombins|mesh-list
83722854|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
83722855|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83722856|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
83722857|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722858|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722859|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
83722860|NCT01913691|Ipilimumab|ipilimumab|mesh-list
83722861|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83722862|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722863|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83722864|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722865|NCT01913808|Iron|iron|mesh-list
83722866|NCT01913808|Glycine|glycine|mesh-list
83722867|NCT01913808|Trace Elements|trace elements|mesh-ancestor
83722868|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
83722869|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722870|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
83722871|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722872|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722873|NCT01913834|Teriparatide|teriparatide|mesh-list
83722874|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83722875|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722876|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83722877|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
83722878|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
83722879|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83722880|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83722881|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722882|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722883|NCT01913847|Urological Agents|urological agents|mesh-ancestor
83722884|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83722885|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722886|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
83722887|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
83722888|NCT01913964|Vitamins|vitamins|mesh-ancestor
83722889|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
83722890|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722891|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
83722892|NCT01913990|Dexamethasone|dexamethasone|mesh-list
83722893|NCT01913990|Ondansetron|ondansetron|mesh-list
83722894|NCT01913990|Aprepitant|aprepitant|mesh-list
83722895|NCT01913990|Antiemetics|antiemetics|mesh-list
83722896|NCT01913990|Emetics|emetics|mesh-list
83722897|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83722898|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
83722899|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722900|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722901|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722902|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
83722903|NCT01913990|Hormones|hormones|mesh-ancestor
83722904|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83722905|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83722906|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722907|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
83722908|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
83722909|NCT01913990|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83722910|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83722911|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
83722912|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722913|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722914|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82877843|NCT05460416|Aspirin|aspirin|mesh-list
83722915|NCT01914042|Morphine|morphine|mesh-list
83722916|NCT01914042|Milnacipran|milnacipran|mesh-list
83722917|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
83722918|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83722919|NCT01914042|Narcotics|narcotics|mesh-ancestor
83722920|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722921|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722922|NCT01914042|Analgesics|analgesics|mesh-ancestor
83722923|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
83722924|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722925|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83722926|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83722927|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83722928|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722929|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83722930|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83722931|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
83722932|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83722933|NCT01914081|Resveratrol|resveratrol|mesh-list
83722934|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
83722935|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722936|NCT01914081|Protective Agents|protective agents|mesh-ancestor
83722937|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722938|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722939|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83722940|NCT01914133|Acarbose|acarbose|mesh-list
83722941|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83722942|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722943|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722944|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722945|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722946|NCT01914146|Insulin|insulin|mesh-list
83722947|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83722948|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83722949|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722950|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
83722951|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83722952|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83722953|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722954|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
83722955|NCT01914211|Coagulants|coagulants|mesh-ancestor
83722956|NCT01914237|Castor Oil|castor oil|mesh-list
83722957|NCT01914237|Cathartics|cathartics|mesh-ancestor
83722958|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722959|NCT01914250|Analgesics|analgesics|mesh-list
83722960|NCT01914250|Tetracaine|tetracaine|mesh-list
83722961|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
83722962|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83722963|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722964|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
83722965|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
83722966|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83722967|NCT01914380|Aflibercept|aflibercept|mesh-list
83722968|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83722969|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83722970|NCT01914380|Growth Substances|growth substances|mesh-ancestor
83722971|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722972|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
83722973|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83722974|NCT01914419|Oxytocin|oxytocin|mesh-list
83722975|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
83722976|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83722977|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83722978|NCT01914432|Telmisartan|telmisartan|mesh-list
83722979|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83722980|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83722981|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83722982|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
83722983|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83722984|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83722985|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83722986|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83722987|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83722988|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83722989|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83722990|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83722991|NCT01914562|Cathartics|cathartics|mesh-ancestor
83722992|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83722993|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
83722994|NCT01914627|Salicylates|salicylates|mesh-list
83722995|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83722996|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
83722997|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
83722998|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
83722999|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83723000|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83723001|NCT01914627|Analgesics|analgesics|mesh-ancestor
83723002|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
83723003|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723004|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723005|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83723006|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723007|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83723008|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723009|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723010|NCT01914692|Somatostatin|somatostatin|mesh-list
83723011|NCT01914692|Hormones|hormones|mesh-ancestor
83723012|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723013|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723014|NCT01914718|Rituximab|rituximab|mesh-list
83723015|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723016|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723017|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
83723018|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723019|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723020|NCT01914744|Lamivudine|lamivudine|mesh-list
83723021|NCT01914744|Entecavir|entecavir|mesh-list
83723022|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83723023|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83723024|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723025|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723026|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
83723027|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723028|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83723029|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83723030|NCT01914770|Belimumab|belimumab|mesh-list
83723031|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723032|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
83723033|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723034|NCT01914822|Methylphenidate|methylphenidate|mesh-list
83723035|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83723036|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723037|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83723038|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83723039|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723040|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723041|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
83723042|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723043|NCT01914900|Docetaxel|docetaxel|mesh-list
83723044|NCT01914900|Fluorouracil|fluorouracil|mesh-list
83723045|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723046|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
83723047|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
83723048|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
83723049|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723050|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
83723051|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83723052|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723053|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
83723054|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723055|NCT01914939|Oxytocin|oxytocin|mesh-list
83723056|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
83723057|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83723058|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723059|NCT01914965|Bupropion|bupropion|mesh-list
83723060|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83723061|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
83723062|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83723063|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83723064|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82877997|NCT03754712|Vitamin D|vitamin d|mesh-list
83723065|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723066|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723067|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
83723068|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723069|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723070|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83723071|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83723072|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723073|NCT01915069|Cilostazol|cilostazol|mesh-list
83723074|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83723075|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
83723076|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723077|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723078|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83723079|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
83723080|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83723081|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83723082|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723083|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83723084|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
83723085|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83723086|NCT01915069|Protective Agents|protective agents|mesh-ancestor
83723087|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83723088|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83723089|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723090|NCT01915082|Azithromycin|azithromycin|mesh-list
83723091|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83723092|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723093|NCT01915134|Cisplatin|cisplatin|mesh-list
83723094|NCT01915134|Gemcitabine|gemcitabine|mesh-list
83723095|NCT01915134|Endostatins|endostatins|mesh-list
83723096|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723097|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83723098|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
83723099|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723100|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83723101|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83723102|NCT01915134|Growth Substances|growth substances|mesh-ancestor
83723103|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723104|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
83723105|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83723106|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83723107|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
83723108|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723109|NCT01915264|Metformin|metformin|mesh-list
83723110|NCT01915264|Acarbose|acarbose|mesh-list
83723111|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723112|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723113|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83723114|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723115|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723116|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
83723117|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83723118|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723119|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723120|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83723121|NCT01915277|Analgesics|analgesics|mesh-ancestor
83723122|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
83723123|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723124|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83723125|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83723126|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83723127|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
83723128|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723129|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723130|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
83723131|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83723132|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83723133|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83723134|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723135|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723136|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
83723137|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723138|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723139|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83723140|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723141|NCT01915472|Irinotecan|irinotecan|mesh-list
83723142|NCT01915472|Labetuzumab|labetuzumab|mesh-list
83723143|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
83723144|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
83723145|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723146|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83723147|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83723148|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723149|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723150|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723151|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723152|NCT01915537|Infliximab|infliximab|mesh-list
83723153|NCT01915537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83723154|NCT01915537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83723155|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
83723156|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83723157|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723158|NCT01915550|Insulin|insulin|mesh-list
83723159|NCT01915550|Metformin|metformin|mesh-list
83723160|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83723161|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
83723162|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723163|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723164|NCT01915602|Sorafenib|sorafenib|mesh-list
83723165|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723166|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83723167|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723168|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723169|NCT01915758|Clindamycin|clindamycin|mesh-list
83723170|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
83723171|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
83723172|NCT01915758|Tretinoin|tretinoin|mesh-list
83723173|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83723174|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723175|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83723176|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723177|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723178|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723179|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
83723180|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
83723181|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83723182|NCT01915901|Bismuth|bismuth|mesh-list
83723183|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83723184|NCT01915901|Antacids|antacids|mesh-ancestor
83723185|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723186|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83723187|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
83723188|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723189|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
83723190|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723191|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
83723192|NCT01915979|Betamethasone|betamethasone|mesh-list
83723193|NCT01915979|Mitogens|mitogens|mesh-list
83723194|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
83723195|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723196|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83723197|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
83723198|NCT01915979|Hormones|hormones|mesh-ancestor
83723199|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723200|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723201|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83723202|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
83723203|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83723204|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83723205|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723206|NCT01916174|Insulin|insulin|mesh-list
83723207|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83723208|NCT01916174|Liraglutide|liraglutide|mesh-list
83723209|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
83723210|NCT01916174|Xultophy|xultophy|mesh-list
83723211|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723212|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723213|NCT01916174|Incretins|incretins|mesh-ancestor
83723214|NCT01916174|Hormones|hormones|mesh-ancestor
83723215|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723216|NCT01916187|Imetelstat|imetelstat|mesh-list
83723217|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
83723218|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723219|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723220|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83723221|NCT01916200|Paroxetine|paroxetine|mesh-list
83723222|NCT01916200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83723223|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83723224|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723225|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723226|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723227|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
83723228|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723229|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83723230|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
83723231|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83723232|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83723233|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83723234|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723235|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
83723236|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83723237|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
83723238|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723239|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
83723240|NCT01916213|Protective Agents|protective agents|mesh-ancestor
83723241|NCT01916252|Dexamethasone|dexamethasone|mesh-list
83723242|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
83723243|NCT01916252|Lenalidomide|lenalidomide|mesh-list
83723244|NCT01916252|Bortezomib|bortezomib|mesh-list
83723245|NCT01916252|Melphalan|melphalan|mesh-list
83723246|NCT01916252|Busulfan|busulfan|mesh-list
83723247|NCT01916252|BB 1101|bb 1101|mesh-list
83723248|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83723249|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
83723250|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
83723251|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723252|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723253|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83723254|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
83723255|NCT01916252|Hormones|hormones|mesh-ancestor
83723256|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723257|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83723258|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723259|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
83723260|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83723261|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83723262|NCT01916252|Growth Substances|growth substances|mesh-ancestor
83723263|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
83723264|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83723265|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
83723266|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723267|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83723268|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723269|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
83723270|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723271|NCT01916265|Glucagon|glucagon|mesh-list
83723272|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83723273|NCT01916265|Hormones|hormones|mesh-ancestor
83723274|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723275|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723276|NCT01916382|Nitisinone|nitisinone|mesh-list
83723277|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723278|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723279|NCT01916395|Sumatriptan|sumatriptan|mesh-list
83723280|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83723281|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83723282|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83723283|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
83723284|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723285|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723286|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723287|NCT01916408|Wobenzym|wobenzym|mesh-list
82878215|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83723289|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
83723290|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723291|NCT01916447|Bevacizumab|bevacizumab|mesh-list
83723292|NCT01916447|Irinotecan|irinotecan|mesh-list
83723293|NCT01916447|Camptothecin|camptothecin|mesh-list
83723294|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723295|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723296|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83723297|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83723298|NCT01916447|Growth Substances|growth substances|mesh-ancestor
83723299|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723300|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
83723301|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83723302|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83723303|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723304|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723305|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83723306|NCT01916577|Plerixafor|plerixafor|mesh-list
83723307|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83723308|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83723309|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
83723310|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723311|NCT01916642|Lidocaine|lidocaine|mesh-list
83723312|NCT01916642|Etomidate|etomidate|mesh-list
83723313|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
83723314|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
83723315|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723316|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723317|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
83723318|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723319|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83723320|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83723321|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83723322|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723323|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723324|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83723325|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83723326|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
83723327|NCT01916707|Enoxaparin|enoxaparin|mesh-list
83723328|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
83723329|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83723330|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83723331|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723332|NCT01916720|Darapladib|darapladib|mesh-list
83723333|NCT01916720|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83723334|NCT01916720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723335|NCT01916720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723336|NCT01916733|Insulin|insulin|mesh-list
83723337|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723338|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723339|NCT01916785|Dasatinib|dasatinib|mesh-list
83723340|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723341|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83723342|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723343|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723344|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83723345|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83723346|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83723347|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83723348|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83723349|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83723350|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723351|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723352|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723353|NCT01916863|Canagliflozin|canagliflozin|mesh-list
83723354|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83723355|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82878290|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
82878292|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83723356|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723357|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723358|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723359|NCT01916902|Ticagrelor|ticagrelor|mesh-list
83723360|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83723361|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83723362|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83723363|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83723364|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
83723365|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723366|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723367|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723368|NCT01916915|Tramadol|tramadol|mesh-list
83723369|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
83723370|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83723371|NCT01916915|Narcotics|narcotics|mesh-ancestor
83723372|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723373|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723374|NCT01916915|Analgesics|analgesics|mesh-ancestor
83723375|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
83723376|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723377|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
83723378|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
83723379|NCT01916954|Lumefantrine|lumefantrine|mesh-list
83723380|NCT01916954|Artemether|artemether|mesh-list
83723381|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83723382|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
83723383|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83723384|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83723385|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723386|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
83723387|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83723388|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723389|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723390|NCT01917032|Folic Acid|folic acid|mesh-list
83723391|NCT01917032|Vitamin A|vitamin a|mesh-list
83723392|NCT01917032|Micronutrients|micronutrients|mesh-list
83723393|NCT01917032|Trace Elements|trace elements|mesh-list
83723394|NCT01917032|Tretinoin|tretinoin|mesh-list
83723395|NCT01917032|Vitamins|vitamins|mesh-ancestor
83723396|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723397|NCT01917032|Hematinics|hematinics|mesh-ancestor
83723398|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
83723399|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723400|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
83723401|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
83723402|NCT01917045|Sufentanil|sufentanil|mesh-list
83723403|NCT01917045|Morphine|morphine|mesh-list
83723404|NCT01917045|Dsuvia|dsuvia|mesh-list
83723405|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83723406|NCT01917045|Narcotics|narcotics|mesh-ancestor
83723407|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723408|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723409|NCT01917045|Analgesics|analgesics|mesh-ancestor
83723410|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
83723411|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723412|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83723413|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83723414|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
83723415|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
83723416|NCT01917058|Abatacept|abatacept|mesh-list
83723417|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83723418|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723419|NCT01917058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723420|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723421|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723422|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
83723423|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723424|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723425|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
83723426|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83723427|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723428|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723429|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83723430|NCT01917097|Analgesics|analgesics|mesh-ancestor
82878363|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83723431|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
83723432|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723433|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83723434|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83723435|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83723436|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
83723437|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723438|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723439|NCT01917149|Metoprolol|metoprolol|mesh-list
83723440|NCT01917149|Valsartan|valsartan|mesh-list
83723441|NCT01917149|Benazepril|benazepril|mesh-list
83723442|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83723443|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83723444|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83723445|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723446|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83723447|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
83723448|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
83723449|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723450|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723451|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83723452|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83723453|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83723454|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83723455|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723456|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83723457|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
83723458|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723459|NCT01917279|Docetaxel|docetaxel|mesh-list
83723460|NCT01917279|Capecitabine|capecitabine|mesh-list
83723461|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723462|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
83723463|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
83723464|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
83723465|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723466|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83723467|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
83723468|NCT01917318|Iloperidone|iloperidone|mesh-list
83723469|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83723470|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83723471|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723472|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723473|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83723474|NCT01917331|Beclomethasone|beclomethasone|mesh-list
83723475|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
83723476|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
83723477|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83723478|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
83723479|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723480|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723481|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83723482|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
83723483|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83723484|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83723485|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83723486|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
83723487|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723488|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723489|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83723490|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83723491|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83723492|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
83723493|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83723494|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
83723495|NCT01917331|Hormones|hormones|mesh-ancestor
83723496|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723497|NCT01917448|Morphine|morphine|mesh-list
83723498|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83723499|NCT01917448|Narcotics|narcotics|mesh-ancestor
83723500|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723501|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723502|NCT01917448|Analgesics|analgesics|mesh-ancestor
83723503|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
83723504|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723505|NCT01917578|Paclitaxel|paclitaxel|mesh-list
83723506|NCT01917578|Docetaxel|docetaxel|mesh-list
83723508|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
83723509|NCT01917578|Carboplatin|carboplatin|mesh-list
83723510|NCT01917578|Doxorubicin|doxorubicin|mesh-list
83723511|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83723512|NCT01917578|Fluorouracil|fluorouracil|mesh-list
83723513|NCT01917578|Trastuzumab|trastuzumab|mesh-list
83723514|NCT01917578|Epirubicin|epirubicin|mesh-list
83723515|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83723516|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723517|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83723518|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83723519|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83723520|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723521|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723522|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
83723523|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723524|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723525|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83723526|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
83723527|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83723528|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83723529|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83723530|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83723531|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723532|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
83723533|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83723534|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723535|NCT01917617|Cisplatin|cisplatin|mesh-list
83723536|NCT01917617|Gemcitabine|gemcitabine|mesh-list
83723537|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83723538|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723539|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83723540|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
83723541|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723542|NCT01917708|Abatacept|abatacept|mesh-list
83723543|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83723544|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723545|NCT01917708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723546|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723547|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723548|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
83723549|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723550|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723551|NCT01917721|Doxycycline|doxycycline|mesh-list
83723552|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83723553|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723554|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
83723555|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83723556|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83723557|NCT01917799|Aspirin|aspirin|mesh-list
83723558|NCT01917799|Heparin|heparin|mesh-list
83723559|NCT01917799|Enoxaparin|enoxaparin|mesh-list
83723560|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83723561|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83723562|NCT01917799|Analgesics|analgesics|mesh-ancestor
83723563|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
83723564|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723565|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723566|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83723567|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723568|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83723569|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83723570|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723571|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83723572|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83723573|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723574|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
83723575|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
83723576|NCT01917890|Curcumin|curcumin|mesh-list
83723577|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83723578|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83723579|NCT01917890|Analgesics|analgesics|mesh-ancestor
83723580|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
82878512|NCT03943992|Esomeprazole|esomeprazole|mesh-list
83723581|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723582|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723583|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83723584|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723585|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723586|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723587|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723588|NCT01918098|Oxycodone|oxycodone|mesh-list
83723589|NCT01918098|Naloxone|naloxone|mesh-list
83723590|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83723591|NCT01918098|Narcotics|narcotics|mesh-ancestor
83723592|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723593|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723594|NCT01918098|Analgesics|analgesics|mesh-ancestor
83723595|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
83723596|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723597|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83723598|NCT01918111|Adenosine|adenosine|mesh-list
83723599|NCT01918111|Analgesics|analgesics|mesh-ancestor
83723600|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
83723601|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723602|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723603|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83723604|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
83723605|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83723606|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
83723607|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
83723608|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723609|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723610|NCT01918124|Paclitaxel|paclitaxel|mesh-list
83723611|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
83723612|NCT01918124|Cisplatin|cisplatin|mesh-list
83723613|NCT01918124|Carboplatin|carboplatin|mesh-list
83723614|NCT01918124|Doxorubicin|doxorubicin|mesh-list
83723615|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83723616|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723617|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
83723618|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
83723619|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
83723620|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723621|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723622|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
83723623|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723624|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723625|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83723626|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
83723627|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83723628|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83723629|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83723630|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83723631|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723633|NCT01918150|Chromium|chromium|mesh-list
83723634|NCT01918150|Trace Elements|trace elements|mesh-ancestor
83723635|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
83723636|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723637|NCT01918176|Palbociclib|palbociclib|mesh-list
83723638|NCT01918176|Rabeprazole|rabeprazole|mesh-list
83723639|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723640|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83723641|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723642|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723643|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83723644|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83723645|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83723646|NCT01918241|Lenograstim|lenograstim|mesh-list
83723647|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83723648|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
83723649|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723650|NCT01918254|Paclitaxel|paclitaxel|mesh-list
83723651|NCT01918254|Pertuzumab|pertuzumab|mesh-list
82878584|NCT02432560|Sirolimus|sirolimus|mesh-list
83723652|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83723653|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723654|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
83723655|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
83723656|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
83723657|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723658|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723659|NCT01918358|Valsartan|valsartan|mesh-list
83723660|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83723661|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83723662|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83723663|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
83723664|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723665|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83723666|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83723667|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723668|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83723669|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83723670|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83723671|NCT01918384|Arbekacin|arbekacin|mesh-list
83723672|NCT01918384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83723673|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723674|NCT01918475|Carbetocin|carbetocin|mesh-list
83723675|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
83723676|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83723677|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723678|NCT01918488|Amiloride|amiloride|mesh-list
83723679|NCT01918488|Triamterene|triamterene|mesh-list
83723680|NCT01918488|Diuretics|diuretics|mesh-ancestor
83723681|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
83723682|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723683|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83723684|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83723685|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723686|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723687|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83723688|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83723689|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
83723690|NCT01918514|Analgesics|analgesics|mesh-ancestor
83723691|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
83723692|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723693|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723694|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
83723695|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723696|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83723697|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
83723698|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83723699|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83723700|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723701|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83723702|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
83723703|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83723704|NCT01918631|Tenofovir|tenofovir|mesh-list
83723705|NCT01918631|Entecavir|entecavir|mesh-list
83723706|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
83723707|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723708|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83723709|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83723710|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723711|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723712|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83723713|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83723714|NCT01918709|Valsartan|valsartan|mesh-list
83723715|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83723716|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83723717|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83723718|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
83723719|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723720|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83723721|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83723722|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723723|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83723724|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83723725|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83723726|NCT01918813|Vancomycin|vancomycin|mesh-list
83723727|NCT01918813|Mupirocin|mupirocin|mesh-list
83723728|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83723729|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723730|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82878659|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723731|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723732|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723733|NCT01918852|Bevacizumab|bevacizumab|mesh-list
83723734|NCT01918852|Capecitabine|capecitabine|mesh-list
83723735|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723736|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723737|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83723738|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83723739|NCT01918852|Growth Substances|growth substances|mesh-ancestor
83723740|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723741|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
83723742|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83723743|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
83723744|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723745|NCT01918865|Metformin|metformin|mesh-list
83723746|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723747|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723748|NCT01918878|Aflibercept|aflibercept|mesh-list
83723749|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83723750|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83723751|NCT01918878|Growth Substances|growth substances|mesh-ancestor
83723752|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723753|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
83723754|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723755|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
83723756|NCT01918904|Antidotes|antidotes|mesh-ancestor
83723757|NCT01918904|Protective Agents|protective agents|mesh-ancestor
83723758|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723759|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
83723760|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723761|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
83723762|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83723763|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723764|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
83723765|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
83723766|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
83723767|NCT01918917|Morphine|morphine|mesh-list
83723768|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
83723769|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83723770|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723771|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723772|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83723773|NCT01918917|Analgesics|analgesics|mesh-ancestor
83723774|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
83723775|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723776|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83723777|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83723778|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83723779|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
83723780|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723781|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723782|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83723783|NCT01918917|Narcotics|narcotics|mesh-ancestor
83723784|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
83723785|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
83723786|NCT01918995|Regadenoson|regadenoson|mesh-list
83723787|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83723788|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83723789|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
83723790|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
83723791|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723792|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723793|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723794|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83723795|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
83723796|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83723797|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83723798|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83500519|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
83723799|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723800|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723801|NCT01919047|Mirabegron|mirabegron|mesh-list
83723802|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82878751|NCT03796728|Lidocaine|lidocaine|mesh-list
83723803|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83723804|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83723805|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83723806|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723807|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723808|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723809|NCT01919047|Urological Agents|urological agents|mesh-ancestor
83723810|NCT01919203|Remifentanil|remifentanil|mesh-list
83723811|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83723812|NCT01919203|Narcotics|narcotics|mesh-ancestor
83723813|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723814|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723815|NCT01919203|Analgesics|analgesics|mesh-ancestor
83723816|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
83723817|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723818|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
83723819|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
83723820|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
83723821|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
83723822|NCT01919255|Citric Acid|citric acid|mesh-list
83723823|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
83723824|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83723825|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
83723826|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
83723827|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723828|NCT01919255|Cathartics|cathartics|mesh-ancestor
83723829|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83723830|NCT01919255|Antacids|antacids|mesh-ancestor
83723831|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
83723832|NCT01919294|Testosterone|testosterone|mesh-list
83723833|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
83723834|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
83723835|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83723836|NCT01919294|Androgens|androgens|mesh-ancestor
83723837|NCT01919294|Hormones|hormones|mesh-ancestor
83723838|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723839|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723840|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83723841|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723842|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
83723843|NCT01919346|Eculizumab|eculizumab|mesh-list
83723844|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83723845|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723846|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
83723847|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723848|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
83723849|NCT01919424|Miotics|miotics|mesh-ancestor
83723850|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
83723851|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723852|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723853|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83723854|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83723855|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
83723856|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83723857|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83723858|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
83723859|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723860|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723861|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
83723862|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83723863|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
83723864|NCT01919593|Povidone|povidone|mesh-list
83723865|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83723866|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723867|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
83723868|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83723869|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
83723870|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
83723871|NCT01919788|Insulin|insulin|mesh-list
83723872|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83723873|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723874|NCT01919879|Cetuximab|cetuximab|mesh-list
83723875|NCT01919879|Afatinib|afatinib|mesh-list
83723876|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723877|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723878|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83723879|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723880|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723881|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
83723882|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
83723883|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83723884|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83723885|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723886|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
83723887|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83723888|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83723889|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723890|NCT01919905|Vitamin D|vitamin d|mesh-list
83723891|NCT01919905|Vitamins|vitamins|mesh-ancestor
83723892|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
83723893|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723894|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83723895|NCT01919918|Adenosine|adenosine|mesh-list
83723896|NCT01919918|Analgesics|analgesics|mesh-ancestor
83723897|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
83723898|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723899|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723900|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83723901|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
83723902|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83723903|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
83723904|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
83723905|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723906|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723907|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
83723908|NCT01920022|Mifepristone|mifepristone|mesh-list
83723909|NCT01920022|Etonogestrel|etonogestrel|mesh-list
83723910|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83723911|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723912|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83723913|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
83723914|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83723915|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83723916|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83723917|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83723918|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83723919|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
83723920|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723921|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
83723922|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83723923|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83723924|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
83723925|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
83723926|NCT01920516|Melphalan|melphalan|mesh-list
83723927|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83723928|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
83723929|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723930|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723931|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83723932|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83723933|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
83723934|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723935|NCT01920984|Bevacizumab|bevacizumab|mesh-list
83723936|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83723937|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723938|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83723939|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83723940|NCT01920984|Growth Substances|growth substances|mesh-ancestor
83723941|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723942|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
83723943|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
83723944|NCT01921374|Interferons|interferons|mesh-list
83723945|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
83723946|NCT01921374|Interleukin-2|interleukin-2|mesh-list
83723947|NCT01921374|Interleukin-4|interleukin-4|mesh-list
83723948|NCT01921374|Dinoprostone|dinoprostone|mesh-list
83723949|NCT01921374|Hormones|hormones|mesh-list
83723950|NCT01921374|Estradiol|estradiol|mesh-list
83723951|NCT01921374|Testosterone|testosterone|mesh-list
83723952|NCT01921374|Progesterone|progesterone|mesh-list
83723953|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83723954|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83723955|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83723956|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
83723957|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83723958|NCT01921374|Antibodies|antibodies|mesh-list
83723960|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
83723961|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
83723962|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
83723963|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
83723964|NCT01921374|Uric Acid|uric acid|mesh-list
83723965|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723966|NCT01921374|Vitamins|vitamins|mesh-ancestor
83723967|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
83723968|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83723969|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
83723970|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83723971|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83723972|NCT01921374|Estrogens|estrogens|mesh-ancestor
83723973|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83723974|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
83723975|NCT01921374|Androgens|androgens|mesh-ancestor
83723976|NCT01921374|Progestins|progestins|mesh-ancestor
83723977|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83723978|NCT01921374|Analgesics|analgesics|mesh-ancestor
83723979|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
83723980|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83723981|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
83723982|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723983|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723984|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
83723985|NCT01921374|Protective Agents|protective agents|mesh-ancestor
83723986|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
83723987|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83723988|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83723989|NCT01921972|Memantine|memantine|mesh-list
83723990|NCT01921972|Galantamine|galantamine|mesh-list
83723991|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83723992|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83723993|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
83723994|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83723995|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83723996|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83723997|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83723998|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83723999|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83724000|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724001|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
83724002|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83724003|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
83724004|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724005|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
83724006|NCT01923454|Acetazolamide|acetazolamide|mesh-list
83724007|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
83724008|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83724009|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724010|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724011|NCT01923454|Diuretics|diuretics|mesh-ancestor
83724012|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
83724013|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724014|NCT01923935|Melphalan|melphalan|mesh-list
83724015|NCT01923935|Busulfan|busulfan|mesh-list
83724016|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83724017|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
83724018|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724019|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724020|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83724021|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83724022|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
83724023|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724024|NCT01923974|Melatonin|melatonin|mesh-list
83724025|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
83724026|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724027|NCT01923974|Protective Agents|protective agents|mesh-ancestor
83724028|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724029|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724030|NCT01924013|Vitamin D|vitamin d|mesh-list
83724031|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
83724032|NCT01924013|Vitamins|vitamins|mesh-ancestor
83724033|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
83724034|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724035|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83724036|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83724037|NCT01924676|Oxycodone|oxycodone|mesh-list
83724038|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724039|NCT01924676|Narcotics|narcotics|mesh-ancestor
83724040|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724041|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724042|NCT01924676|Analgesics|analgesics|mesh-ancestor
83724043|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
83724044|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724045|NCT01925066|Vancomycin|vancomycin|mesh-list
83724046|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83724047|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724048|NCT01927640|Cocaine|cocaine|mesh-list
83724049|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
83724050|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83724051|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724052|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724053|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724054|NCT01927640|Analgesics|analgesics|mesh-ancestor
83724055|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
83724056|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724057|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83724058|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83724059|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83724060|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
83724061|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724062|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724063|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
83724064|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
83724065|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83724066|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83724067|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83724068|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83724069|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
83724070|NCT01927679|Vitamin E|vitamin e|mesh-list
83724071|NCT01927679|Antioxidants|antioxidants|mesh-list
83724072|NCT01927679|Vitamins|vitamins|mesh-ancestor
83724073|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
83724074|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724075|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724076|NCT01927679|Protective Agents|protective agents|mesh-ancestor
83724077|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
83724078|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83724079|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
83724080|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724081|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724082|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83724083|NCT01928407|Darunavir|darunavir|mesh-list
83724084|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83724085|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83724086|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
83724087|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724088|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724089|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83724090|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83724091|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
83724092|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724093|NCT01928875|Anesthetics|anesthetics|mesh-list
83724094|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724095|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724096|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
83724097|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724098|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83724099|NCT01929590|Laxatives|laxatives|mesh-ancestor
83724100|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724101|NCT01930019|Thiopental|thiopental|mesh-list
83724102|NCT01930019|Etomidate|etomidate|mesh-list
83724103|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
83724104|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724105|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724106|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83724107|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83724108|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
83724109|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
83724110|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
83724111|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
83724112|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724113|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724114|NCT01930201|Anesthetics|anesthetics|mesh-list
83724115|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724116|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724117|NCT01930292|Paclitaxel|paclitaxel|mesh-list
83724118|NCT01930292|Carboplatin|carboplatin|mesh-list
83724119|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83724120|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724121|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
83724122|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
83724123|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
83724124|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724125|NCT01930318|Parecoxib|parecoxib|mesh-list
83724126|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83724127|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83724128|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724129|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724130|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724131|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724132|NCT01930318|Analgesics|analgesics|mesh-ancestor
83724133|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
83724134|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724135|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724136|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724137|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724138|NCT01930331|Piperaquine|piperaquine|mesh-list
83724139|NCT01930331|Artenimol|artenimol|mesh-list
83724140|NCT01930331|Artemisinins|artemisinins|mesh-list
83724141|NCT01930331|Artemisinin|artemisinin|mesh-list
83724142|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
83724143|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83724144|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83724145|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724146|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83724147|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
83724148|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
83724149|NCT01930396|Heparin|heparin|mesh-list
83724150|NCT01930396|Calcium heparin|calcium heparin|mesh-list
83724151|NCT01930396|Tinzaparin|tinzaparin|mesh-list
83724152|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83724153|NCT01930396|Dalteparin|dalteparin|mesh-list
83724154|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
83724155|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83724156|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83724157|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724158|NCT01930461|Immunomodulating Agents|immunomodulating agents|mesh-list
83724159|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
83724160|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724161|NCT01930552|Leucovorin|leucovorin|mesh-list
83724162|NCT01930552|Fluorouracil|fluorouracil|mesh-list
83724163|NCT01930552|Irinotecan|irinotecan|mesh-list
83724164|NCT01930552|Aflibercept|aflibercept|mesh-list
83724165|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
83724166|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724167|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83724168|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500529|NCT02678182|Trastuzumab|trastuzumab|mesh-list
83724169|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83724170|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
83724171|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724172|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83724173|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83724174|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724175|NCT01930552|Antidotes|antidotes|mesh-ancestor
83724176|NCT01930552|Protective Agents|protective agents|mesh-ancestor
83724177|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
83724178|NCT01930552|Vitamins|vitamins|mesh-ancestor
83724179|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
83724180|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83724181|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83724182|NCT01930552|Growth Substances|growth substances|mesh-ancestor
83724183|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
83724184|NCT01930591|Clopidogrel|clopidogrel|mesh-list
83724185|NCT01930591|Ticagrelor|ticagrelor|mesh-list
82879106|NCT01368328|Vitamins|vitamins|mesh-ancestor
83724186|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83724187|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83724188|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83724189|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83724190|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
83724191|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724192|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724193|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724194|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83724195|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83724196|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83724197|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83724198|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724199|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724200|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83724201|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83724202|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724203|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
83724204|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724205|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83724206|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83724207|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83724208|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83724209|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724210|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83724211|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
83724212|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83724213|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
83724214|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724215|NCT01930734|Dobutamine|dobutamine|mesh-list
83724216|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83724217|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
83724218|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
83724219|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724220|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724221|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83724222|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83724223|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83724224|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
83724225|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724226|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724227|NCT01930734|Protective Agents|protective agents|mesh-ancestor
83724228|NCT01930773|Clopidogrel|clopidogrel|mesh-list
83724229|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83724230|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83724231|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83724232|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83724233|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
83724234|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724235|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724236|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724237|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
83724238|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83724239|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83724240|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83724241|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83724242|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724243|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
83724244|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724245|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724246|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83724247|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724248|NCT01930812|Listerine|listerine|mesh-list
83724249|NCT01930812|Fluorides|fluorides|mesh-list
83724250|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
83724251|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83724252|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
83724253|NCT01930812|Protective Agents|protective agents|mesh-ancestor
83724254|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724255|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83724256|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724257|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83724258|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724259|NCT01930864|Metformin|metformin|mesh-list
83724260|NCT01930864|Irinotecan|irinotecan|mesh-list
82879185|NCT01210482|Sirolimus|sirolimus|mesh-list
83724262|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724263|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83724264|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83724265|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724266|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724267|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724268|NCT01930877|Lidocaine|lidocaine|mesh-list
83724269|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
83724270|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
83724271|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724272|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724273|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
83724274|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724275|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83724276|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83724277|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83724278|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83724279|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724280|NCT01930916|Anticoagulants|anticoagulants|mesh-list
83724281|NCT01930916|Antibodies|antibodies|mesh-list
83724282|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
83724283|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
83724284|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
83724285|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724286|NCT01931085|Triclabendazole|triclabendazole|mesh-list
83724287|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83724288|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
83724289|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83724290|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724291|NCT01931098|Topotecan|topotecan|mesh-list
83724292|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83724293|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83724294|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724295|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724296|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724297|NCT01931137|Insulin|insulin|mesh-list
83724298|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83724299|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724300|NCT01931189|Infliximab|infliximab|mesh-list
83724301|NCT01931189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83724302|NCT01931189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724303|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83724304|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724305|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724306|NCT01931215|Clonidine|clonidine|mesh-list
83724307|NCT01931215|Morphine|morphine|mesh-list
83724308|NCT01931215|Ropivacaine|ropivacaine|mesh-list
83724309|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
83724310|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724311|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724312|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724313|NCT01931215|Narcotics|narcotics|mesh-ancestor
83724314|NCT01931215|Analgesics|analgesics|mesh-ancestor
83724315|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
83724316|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724317|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
83724318|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83724319|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
83724320|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
83724321|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83724322|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83724323|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83724324|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
83724325|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724326|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724327|NCT01931293|Folic Acid|folic acid|mesh-list
83724328|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
83724329|NCT01931293|Vitamins|vitamins|mesh-ancestor
83724330|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
83724331|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724332|NCT01931293|Hematinics|hematinics|mesh-ancestor
83724333|NCT01931306|Afatinib|afatinib|mesh-list
83724334|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724335|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724336|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724337|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724338|NCT01931319|Baclofen|baclofen|mesh-list
83724339|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83724340|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724341|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83724342|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724343|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83724344|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
83724345|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
83724346|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724347|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724348|NCT01931332|Heroin|heroin|mesh-list
83724349|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724350|NCT01931332|Narcotics|narcotics|mesh-ancestor
83724351|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724352|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724353|NCT01931332|Analgesics|analgesics|mesh-ancestor
83724354|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
83724355|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724356|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83724357|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83724358|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724359|NCT01931410|Misoprostol|misoprostol|mesh-list
83724360|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83724361|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
83724362|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83724363|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724364|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83724365|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724366|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
83724367|NCT01931501|Montelukast|montelukast|mesh-list
83724368|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83724369|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
83724370|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83724371|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
83724372|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83724373|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724374|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83724375|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83724376|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724377|NCT01931514|Montelukast|montelukast|mesh-list
83724378|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83724379|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
83724380|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83724381|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
83724382|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83724383|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724384|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83724385|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83724386|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724387|NCT01931592|Gentamicins|gentamicins|mesh-list
83724388|NCT01931592|Colistin|colistin|mesh-list
83724389|NCT01931592|Fosfomycin|fosfomycin|mesh-list
83724390|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83724391|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724392|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83724393|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724394|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724395|NCT01931657|Mifepristone|mifepristone|mesh-list
83724396|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
83724397|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83724398|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
83724399|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83724400|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724401|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83724402|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83724403|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83724404|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
83724405|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83724406|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83724407|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
83724408|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83724409|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
83724410|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83724411|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83724413|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724414|NCT01931683|Narcotics|narcotics|mesh-ancestor
83724415|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724416|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724417|NCT01931683|Analgesics|analgesics|mesh-ancestor
83724418|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
83724419|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724420|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
83724421|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
83724422|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724423|NCT01931787|Protective Agents|protective agents|mesh-ancestor
83724424|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724425|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
83724426|NCT01931787|Vitamins|vitamins|mesh-ancestor
83724427|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
83724428|NCT01931982|Liraglutide|liraglutide|mesh-list
83724429|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83724430|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724431|NCT01931982|Incretins|incretins|mesh-ancestor
83724432|NCT01931982|Hormones|hormones|mesh-ancestor
83724433|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83724434|NCT01932151|Terlipressin|terlipressin|mesh-list
83724435|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83724436|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83724437|NCT01932177|Everolimus|everolimus|mesh-list
83724438|NCT01932177|Sorafenib|sorafenib|mesh-list
83724439|NCT01932177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83724440|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724441|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724442|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724443|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83724444|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
83724445|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724446|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724447|NCT01932203|Aspirin|aspirin|mesh-list
83724448|NCT01932203|Cilostazol|cilostazol|mesh-list
83724449|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724450|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724451|NCT01932203|Analgesics|analgesics|mesh-ancestor
83724452|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
83724453|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724454|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724455|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724456|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724457|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83724458|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83724459|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724460|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83724461|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83724462|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724463|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
83724464|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83724465|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
83724466|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83724467|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
83724468|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
83724469|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83724470|NCT01932203|Protective Agents|protective agents|mesh-ancestor
83724471|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83724472|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83724473|NCT01932229|Afatinib|afatinib|mesh-list
83724474|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724475|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724476|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724477|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724478|NCT01932268|Rifampin|rifampin|mesh-list
83724479|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83724480|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
83724481|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83724482|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879405|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
83724483|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
83724484|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83724486|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724487|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83724488|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83724489|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83724490|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83724491|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83724492|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83724493|NCT01932320|Ketoconazole|ketoconazole|mesh-list
83724494|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
83724495|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724496|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83724497|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83724498|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724499|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724500|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83724501|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
83724502|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83724503|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724504|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83724505|NCT01932372|Etanercept|etanercept|mesh-list
83724506|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
83724507|NCT01932372|Tofacitinib|tofacitinib|mesh-list
83724508|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724509|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724510|NCT01932372|Analgesics|analgesics|mesh-ancestor
83724511|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
83724512|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724513|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724514|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724515|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724516|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83724517|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
83724518|NCT01932372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83724519|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724520|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724521|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724522|NCT01932385|Sorafenib|sorafenib|mesh-list
83724523|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724524|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724525|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724526|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724527|NCT01932424|Propofol|propofol|mesh-list
83724528|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83724529|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724530|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724531|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83724532|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
83724533|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
83724534|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
83724535|NCT01932502|Clobazam|clobazam|mesh-list
83724536|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
83724537|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83724538|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83724539|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724540|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724541|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83724542|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83724543|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
83724544|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
83724545|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724546|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724547|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83724548|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83724549|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83724550|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724551|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724552|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83724553|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82879478|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724554|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83724555|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83724556|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
83724557|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724558|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724559|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83724560|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83724561|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
83724562|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83724563|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83724564|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
83724565|NCT01932554|Ibuprofen|ibuprofen|mesh-list
83724566|NCT01932554|Fentanyl|fentanyl|mesh-list
83724567|NCT01932554|Morphine|morphine|mesh-list
83724568|NCT01932554|Hydromorphone|hydromorphone|mesh-list
83724569|NCT01932554|Narcotics|narcotics|mesh-list
83724570|NCT01932554|Abciximab|abciximab|mesh-list
83724571|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724572|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724573|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724574|NCT01932554|Analgesics|analgesics|mesh-ancestor
83724575|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
83724576|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724577|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83724578|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83724579|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
83724580|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
83724581|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724582|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724583|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724584|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724585|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83724586|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724587|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724588|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
83724589|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83724590|NCT01932580|Docetaxel|docetaxel|mesh-list
83724591|NCT01932580|Fluorouracil|fluorouracil|mesh-list
83724592|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
83724593|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724594|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
83724595|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
83724596|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
83724597|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724598|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
83724599|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83724600|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83724601|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
83724602|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724603|NCT01932918|Ketorolac|ketorolac|mesh-list
83724604|NCT01932918|Morphine|morphine|mesh-list
83724605|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724606|NCT01932918|Narcotics|narcotics|mesh-ancestor
83724607|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724608|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724609|NCT01932918|Analgesics|analgesics|mesh-ancestor
83724610|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
83724611|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724612|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724613|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724614|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724615|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724616|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83724617|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724618|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724619|NCT01932931|Vitamin D|vitamin d|mesh-list
83724620|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
83724621|NCT01932931|Vitamins|vitamins|mesh-ancestor
83724622|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
83724623|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724624|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83724625|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83724626|NCT01933022|Leuprolide|leuprolide|mesh-list
83724627|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83724628|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
83724629|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83724630|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724631|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83724632|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724633|NCT01933061|Paclitaxel|paclitaxel|mesh-list
83724634|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83724635|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83724636|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724637|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
83724638|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
83724639|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
83724640|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724641|NCT01933152|Ranibizumab|ranibizumab|mesh-list
83724642|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83724643|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83724644|NCT01933152|Growth Substances|growth substances|mesh-ancestor
83724645|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724646|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83724647|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724648|NCT01933347|Gefitinib|gefitinib|mesh-list
83724649|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724650|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724651|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724652|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724653|NCT01933360|Misoprostol|misoprostol|mesh-list
83724654|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83724655|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
83724656|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83724657|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724658|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83724659|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724660|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
83724661|NCT01933412|Vaccines|vaccines|mesh-list
83724662|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
83724663|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724664|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
83724665|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83724666|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724667|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83724668|NCT01933503|Cathartics|cathartics|mesh-ancestor
83724669|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724670|NCT01933516|Rituximab|rituximab|mesh-list
83724671|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83724672|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724673|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
83724674|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724675|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724676|NCT01933542|Morphine|morphine|mesh-list
83724677|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
83724678|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724679|NCT01933542|Narcotics|narcotics|mesh-ancestor
83724680|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724681|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724682|NCT01933542|Analgesics|analgesics|mesh-ancestor
83724683|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
83724684|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724685|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83724686|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83724687|NCT01933568|Cisplatin|cisplatin|mesh-list
83724688|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724689|NCT01933698|Amoxicillin|amoxicillin|mesh-list
83724690|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83724691|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724692|NCT01933711|Rituximab|rituximab|mesh-list
83724693|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83724694|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724695|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
83724696|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724697|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724698|NCT01933906|Interferons|interferons|mesh-list
83724699|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
83724700|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
83724701|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83724702|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879631|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
83724703|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
83724704|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724705|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
82879632|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83724706|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724707|NCT01933945|Sorafenib|sorafenib|mesh-list
83724708|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724709|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724710|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724711|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724712|NCT01933971|Lenograstim|lenograstim|mesh-list
83724713|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83724714|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
83724715|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724716|NCT01933997|Pyridoxine|pyridoxine|mesh-list
83724717|NCT01933997|Metadoxine|metadoxine|mesh-list
83724718|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83724719|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
83724720|NCT01933997|Vitamins|vitamins|mesh-ancestor
83724721|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
83724722|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724723|NCT01934023|Varenicline|varenicline|mesh-list
83724724|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83724725|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83724726|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
83724727|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724728|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724729|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724730|NCT01934049|Anesthetics|anesthetics|mesh-list
83724731|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724732|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724733|NCT01934088|Fentanyl|fentanyl|mesh-list
83724734|NCT01934088|Midazolam|midazolam|mesh-list
83724735|NCT01934088|Propofol|propofol|mesh-list
83724736|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83724737|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724738|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724739|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83724740|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
83724741|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
83724742|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83724743|NCT01934088|Narcotics|narcotics|mesh-ancestor
83724744|NCT01934088|Analgesics|analgesics|mesh-ancestor
83724745|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
83724746|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724747|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83724748|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83724749|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83724750|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83724751|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
83724752|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
83724753|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724754|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724755|NCT01934127|Vaccines|vaccines|mesh-list
83724756|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
83724757|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724758|NCT01934166|Nalmefene|nalmefene|mesh-list
83724759|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83724760|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724761|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
83724762|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724763|NCT01934205|Gepotidacin|gepotidacin|mesh-list
83724764|NCT01934205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83724765|NCT01934205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724766|NCT01934205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724767|NCT01934205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724768|NCT01934361|Carboplatin|carboplatin|mesh-list
83724769|NCT01934361|Lomustine|lomustine|mesh-list
83724770|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724771|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83724772|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
83724773|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724774|NCT01934569|Losartan|losartan|mesh-list
83724775|NCT01934569|Midazolam|midazolam|mesh-list
83724776|NCT01934569|Caffeine|caffeine|mesh-list
83724777|NCT01934569|Omeprazole|omeprazole|mesh-list
83724778|NCT01934569|Pravastatin|pravastatin|mesh-list
83724779|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83724780|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83724781|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724782|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724783|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83724784|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83724785|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83724786|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83724787|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
83724788|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
83724789|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
83724790|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
83724791|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724792|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724793|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83724794|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83724795|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83724796|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83724797|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83724798|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83724799|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724800|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83724801|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83724802|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
83724803|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83724804|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724805|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83724806|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83724807|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83724808|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
83724809|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83724810|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83724811|NCT01934634|Paclitaxel|paclitaxel|mesh-list
83724812|NCT01934634|Gemcitabine|gemcitabine|mesh-list
83724813|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83724814|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724815|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83724816|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83724817|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83724818|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724819|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83724820|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
83724821|NCT01934712|Insulin|insulin|mesh-list
83724822|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83724823|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
83724824|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
83724825|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83724826|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83724827|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724828|NCT01934777|Vitamin E|vitamin e|mesh-list
83724829|NCT01934777|Choline|choline|mesh-list
83724830|NCT01934777|Vitamins|vitamins|mesh-ancestor
83724831|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
83724832|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724833|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
83724834|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724835|NCT01934777|Protective Agents|protective agents|mesh-ancestor
83724836|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
83724837|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83724838|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
83724839|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724840|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83724841|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
83724842|NCT01934816|Liraglutide|liraglutide|mesh-list
83724843|NCT01934816|Exenatide|exenatide|mesh-list
83724844|NCT01934816|Glucagon|glucagon|mesh-list
83724845|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83724846|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83724847|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724848|NCT01934816|Incretins|incretins|mesh-ancestor
83724849|NCT01934816|Hormones|hormones|mesh-ancestor
83724850|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83724851|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83724852|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724853|NCT01934829|Sorafenib|sorafenib|mesh-list
83724854|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724855|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724856|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724857|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724858|NCT01934933|Celecoxib|celecoxib|mesh-list
83724859|NCT01934933|Etanercept|etanercept|mesh-list
82879782|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83724860|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724861|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724862|NCT01934933|Analgesics|analgesics|mesh-ancestor
83724863|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
83724864|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724865|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724866|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724867|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724868|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83724869|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83724870|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724871|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724872|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83724873|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83724874|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
83724875|NCT01935063|Lidocaine|lidocaine|mesh-list
83724876|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
83724877|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
83724878|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724879|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724880|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
83724881|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724882|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83724883|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83724884|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83724885|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83724886|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724887|NCT01935089|Interferons|interferons|mesh-list
83724888|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
83724889|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
83724890|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83724891|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724892|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
83724893|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83724894|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
83724895|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724896|NCT01935115|Ketamine|ketamine|mesh-list
83724897|NCT01935115|Propofol|propofol|mesh-list
83724898|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83724899|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83724900|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724901|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83724902|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
83724903|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
83724904|NCT01935115|Analgesics|analgesics|mesh-ancestor
83724905|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
83724906|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724907|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83724908|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83724909|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83724910|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724911|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724912|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
83724913|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83724914|NCT01935141|Growth Substances|growth substances|mesh-ancestor
83724915|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724916|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
83724917|NCT01935193|Analgesics|analgesics|mesh-ancestor
83724918|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
83724919|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724920|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724921|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724922|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724923|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83724924|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83724925|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83724926|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83724927|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724928|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724929|NCT01935206|Naloxone|naloxone|mesh-list
83724930|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83724931|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724932|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
83724933|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879854|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724934|NCT01935310|Imiquimod|imiquimod|mesh-list
83724935|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83724936|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
83724937|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724938|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724939|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
83724940|NCT01935492|Paclitaxel|paclitaxel|mesh-list
83724941|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83724942|NCT01935492|Bevacizumab|bevacizumab|mesh-list
83724943|NCT01935492|Doxorubicin|doxorubicin|mesh-list
83724944|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83724945|NCT01935492|Capecitabine|capecitabine|mesh-list
83724946|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83724947|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83724948|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
83724949|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
83724950|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
83724951|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724952|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83724953|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83724954|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83724955|NCT01935492|Growth Substances|growth substances|mesh-ancestor
83724956|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724957|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
83724958|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83724959|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83724960|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83724961|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724962|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83724963|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
83724964|NCT01935505|Bupropion|bupropion|mesh-list
83724965|NCT01935505|Nicotine|nicotine|mesh-list
83724966|NCT01935505|Varenicline|varenicline|mesh-list
83724967|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83724968|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
83724969|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83724970|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724971|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83724972|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83724973|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
83724974|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83724975|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724976|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83724977|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
83724978|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83724979|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83724980|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83500542|NCT02620865|Folic Acid|folic acid|mesh-list
83724981|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83724982|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
83724983|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83724984|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83724985|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724986|NCT01935518|Fasudil|fasudil|mesh-list
83724987|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83724988|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83724989|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83724990|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83724991|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83724992|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
83724993|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83724994|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83724995|NCT01935531|Diclofenac|diclofenac|mesh-list
83724996|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
83724997|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83724998|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83724999|NCT01935531|Analgesics|analgesics|mesh-ancestor
83725000|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
83725001|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725002|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725003|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725004|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82879928|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82879929|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82879930|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82879931|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725005|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83725007|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725008|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83725009|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
83725010|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
83725011|NCT01935531|Protective Agents|protective agents|mesh-ancestor
83725012|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
83725013|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83725014|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725015|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725016|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
83725017|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725018|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725019|NCT01935557|Heparin|heparin|mesh-list
83725020|NCT01935557|Calcium heparin|calcium heparin|mesh-list
83725021|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
83725022|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83725023|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83725024|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725025|NCT01935596|Ropivacaine|ropivacaine|mesh-list
83725026|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
83725027|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
83725028|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
83725029|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725030|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725031|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
83725032|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725033|NCT01935648|Ropivacaine|ropivacaine|mesh-list
83725034|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
83725035|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
83725036|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725037|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725038|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
83725039|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725040|NCT01935674|Ritonavir|ritonavir|mesh-list
83725041|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83725042|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83725043|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83725044|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
83725045|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725046|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725047|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83725048|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83725049|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
83725050|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725051|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83725052|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83725053|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83725054|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83725055|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
83725056|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83725057|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83725058|NCT01935713|Nicotine|nicotine|mesh-list
83725059|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83725060|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
83725061|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725062|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725063|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83725064|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83725065|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
83725066|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725067|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725068|NCT01935804|Metformin|metformin|mesh-list
83725069|NCT01935804|Pioglitazone|pioglitazone|mesh-list
83725070|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83725071|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725072|NCT01935817|Vitamin E|vitamin e|mesh-list
83725073|NCT01935817|Silybin|silybin|mesh-list
83725074|NCT01935817|Vitamins|vitamins|mesh-ancestor
83725075|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
83725076|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725077|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
83725078|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725079|NCT01935817|Protective Agents|protective agents|mesh-ancestor
83725081|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725082|NCT01935830|Ritonavir|ritonavir|mesh-list
83725083|NCT01935830|Efavirenz|efavirenz|mesh-list
83725084|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83725085|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83725086|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
83725087|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725088|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725089|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83725090|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83725091|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
83725092|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725093|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83725094|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83725095|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83725096|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83725097|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83725098|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83725099|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83725100|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83725101|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83725102|NCT01935869|Petrolatum|petrolatum|mesh-list
83725103|NCT01935869|Emollients|emollients|mesh-ancestor
83725104|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
83725105|NCT01935882|Lumefantrine|lumefantrine|mesh-list
83725106|NCT01935882|Artemether|artemether|mesh-list
83725107|NCT01935882|Primaquine|primaquine|mesh-list
83725108|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83725109|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
83725110|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83725111|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83725112|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725113|NCT01935908|Levetiracetam|levetiracetam|mesh-list
83725114|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
83725115|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
83725116|NCT01935973|Trametinib|trametinib|mesh-list
83500555|NCT02620865|Calcium|calcium|mesh-list
83725117|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725118|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83725119|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725120|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725121|NCT01936012|Lisinopril|lisinopril|mesh-list
83725122|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83725123|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
83725124|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725125|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725126|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83725127|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83725128|NCT01936012|Protective Agents|protective agents|mesh-ancestor
83725129|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725130|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83725131|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
83725132|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83725133|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725134|NCT01936025|Incretins|incretins|mesh-ancestor
83725135|NCT01936025|Hormones|hormones|mesh-ancestor
83725136|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83725137|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83725138|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
83725139|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725140|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725141|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
83725142|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83725143|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83725144|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83725145|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725146|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
83725147|NCT01936064|Epirubicin|epirubicin|mesh-list
83725148|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83725149|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
83725150|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725151|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725152|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83725153|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
83725154|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725155|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725156|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83725157|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83725158|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83725159|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83725160|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725162|NCT01936090|Melphalan|melphalan|mesh-list
83725163|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725164|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83725165|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
83725166|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725167|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83725168|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83725169|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
83725170|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725171|NCT01936103|Atorvastatin|atorvastatin|mesh-list
83725172|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83725173|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83725174|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
83725175|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725176|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83725177|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83725178|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725179|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
83725180|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
83725181|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83725182|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
83725183|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725184|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83725185|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725186|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
83725187|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83725188|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725189|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725190|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725191|NCT01936233|Aspirin|aspirin|mesh-list
83725192|NCT01936233|Lamivudine|lamivudine|mesh-list
83725193|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83725194|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83725195|NCT01936233|Analgesics|analgesics|mesh-ancestor
83725196|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
83725197|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725198|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725199|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725200|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725201|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83725202|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83725203|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725204|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83725205|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83725206|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725207|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
83725208|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83725209|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83725210|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
83725211|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725212|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83725213|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83725214|NCT01936285|Colchicine|colchicine|mesh-list
83725215|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
83725216|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725217|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
83725218|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
83725219|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
83725220|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725221|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725222|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
83725223|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
82880150|NCT05123170|Lidocaine|lidocaine|mesh-list
82880171|NCT01215708|Tamsulosin|tamsulosin|mesh-list
83725224|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83725225|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83725226|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725227|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725229|NCT01936532|Dexamethasone|dexamethasone|mesh-list
83725230|NCT01936532|Lenalidomide|lenalidomide|mesh-list
83725231|NCT01936532|Ixazomib|ixazomib|mesh-list
83725232|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725233|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
83725234|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
83725235|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725236|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725237|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725238|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
83725239|NCT01936532|Hormones|hormones|mesh-ancestor
83725240|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83725241|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83725242|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725243|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
83725244|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83725245|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83725246|NCT01936532|Growth Substances|growth substances|mesh-ancestor
83725247|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
83725248|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
83725249|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725250|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725251|NCT01936545|Propofol|propofol|mesh-list
83725252|NCT01936545|Desflurane|desflurane|mesh-list
83725253|NCT01936545|Liver Extracts|liver extracts|mesh-list
83725254|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83725255|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725256|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725257|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83725258|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
83725259|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
83725260|NCT01936545|Hematinics|hematinics|mesh-ancestor
83725261|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83725262|NCT01936636|Fentanyl|fentanyl|mesh-list
83725263|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83725264|NCT01936636|Narcotics|narcotics|mesh-ancestor
83725265|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725266|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725267|NCT01936636|Analgesics|analgesics|mesh-ancestor
83725268|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
83725269|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725270|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83725271|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83725272|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
83725273|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
83725274|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83725275|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83725276|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83725277|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
83725278|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725279|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83725280|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83725281|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725282|NCT01936961|Antibodies|antibodies|mesh-list
83725283|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
83725284|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725285|NCT01937013|Oxytocin|oxytocin|mesh-list
83725286|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
83725287|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83725288|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725289|NCT01937078|Famotidine|famotidine|mesh-list
83725290|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83725291|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725292|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83725293|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
83725294|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
83725295|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725296|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725297|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725298|NCT01937104|Remifentanil|remifentanil|mesh-list
83725299|NCT01937104|Desflurane|desflurane|mesh-list
83725300|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82880224|NCT01073501|Pregabalin|pregabalin|mesh-list
83725301|NCT01937104|Narcotics|narcotics|mesh-ancestor
83725302|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725303|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725305|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
83725306|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725307|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83725308|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
83725309|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
83725310|NCT01937169|Levodopa|levodopa|mesh-list
83725311|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83725312|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83725313|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
83725314|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725315|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725316|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725317|NCT01937182|Citalopram|citalopram|mesh-list
83725318|NCT01937182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83725319|NCT01937182|Serotonin|serotonin|mesh-list
83725320|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83725321|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725322|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725323|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725324|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
83725325|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725326|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83725327|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
83725328|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725329|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83725330|NCT01937234|Metoclopramide|metoclopramide|mesh-list
83725331|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
83725332|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
83725333|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725334|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725335|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725336|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83725337|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83725338|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
83725339|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725340|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725341|NCT01937325|Ivacaftor|ivacaftor|mesh-list
83725342|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83725343|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725344|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725345|NCT01937338|AZD7624|azd7624|mesh-list
83725346|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83725347|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725348|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725349|NCT01937442|Thalidomide|thalidomide|mesh-list
83725350|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83725351|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
83725352|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725353|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
83725354|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83725355|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725356|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83725357|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83725358|NCT01937442|Growth Substances|growth substances|mesh-ancestor
83725359|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
83725360|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725361|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
83725362|NCT01937494|Histamine|histamine|mesh-list
83725363|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
83725364|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
83725365|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725366|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725367|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725368|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
83725369|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
83725370|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725371|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
83725372|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725373|NCT01937611|Midazolam|midazolam|mesh-list
83725374|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
83725375|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83725376|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725377|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725378|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83725379|NCT01937611|Analgesics|analgesics|mesh-ancestor
83725380|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
83725381|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725382|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83725383|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83725384|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83725385|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
83725386|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725387|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725388|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83725389|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83725390|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83725391|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725392|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83725393|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
83725394|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
83725395|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
83725396|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
83725397|NCT01937650|Metronidazole|metronidazole|mesh-list
83725398|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725399|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83725400|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83725401|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83725402|NCT01937728|Interferons|interferons|mesh-list
83725403|NCT01937728|Ribavirin|ribavirin|mesh-list
83725404|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
83725405|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
83725406|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83725407|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725408|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
83725409|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725410|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
83725411|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725412|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
83725413|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725414|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
83725415|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83725416|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
83725417|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725418|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725419|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83725420|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
83725421|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83725422|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
83725423|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725424|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725425|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83725426|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
83725427|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
83725428|NCT01937754|Protective Agents|protective agents|mesh-ancestor
83725429|NCT01937767|Fentanyl|fentanyl|mesh-list
83725430|NCT01937767|Remifentanil|remifentanil|mesh-list
83725431|NCT01937767|Propofol|propofol|mesh-list
83725432|NCT01937767|Sevoflurane|sevoflurane|mesh-list
83725433|NCT01937767|Rocuronium|rocuronium|mesh-list
83725434|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83725435|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725436|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725437|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83725438|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
83725439|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
83725440|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83725441|NCT01937767|Narcotics|narcotics|mesh-ancestor
83725442|NCT01937767|Analgesics|analgesics|mesh-ancestor
83725443|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
83725444|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725445|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83725446|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83725447|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82880373|NCT04214860|Venetoclax|venetoclax|mesh-list
83725448|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83725449|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83725450|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83725451|NCT01937806|Tenofovir|tenofovir|mesh-list
83725452|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
83725453|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725454|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83725455|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83725456|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725457|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725458|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83725459|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83725460|NCT01937832|Ertapenem|ertapenem|mesh-list
83725461|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83725462|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725463|NCT01938092|Diazepam|diazepam|mesh-list
83725464|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83725465|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
83725466|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
83725467|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
83725468|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725469|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725470|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725471|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83725472|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725473|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83725474|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83725475|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83725476|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83725477|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725478|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83725479|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
83725480|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
83725481|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
83725482|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
83725483|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725484|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725485|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
83725486|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725487|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725488|NCT01938144|Acetaminophen|acetaminophen|mesh-list
83725489|NCT01938144|Ibuprofen|ibuprofen|mesh-list
83725490|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83725491|NCT01938144|Analgesics|analgesics|mesh-ancestor
83725492|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
83725493|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725494|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725495|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
83725496|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83725497|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725498|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725499|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83725500|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725501|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725502|NCT01938183|Metronidazole|metronidazole|mesh-list
83725503|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725504|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83725505|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83725506|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83725507|NCT01938235|Exenatide|exenatide|mesh-list
83725508|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83725509|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725510|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83725511|NCT01938235|Incretins|incretins|mesh-ancestor
83725512|NCT01938235|Hormones|hormones|mesh-ancestor
83725513|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83725514|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
83725515|NCT01938300|Analgesics|analgesics|mesh-ancestor
83725516|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
83725517|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725518|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725519|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
83725520|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725521|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83725522|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
83725523|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82880445|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82880446|NCT05731804|Ritonavir|ritonavir|mesh-list
83725524|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725525|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725526|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83725527|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
83725528|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83725529|NCT01938417|Tobramycin|tobramycin|mesh-list
83725530|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83725531|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725532|NCT01938443|Trametinib|trametinib|mesh-list
83725533|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725534|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83725535|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725536|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725537|NCT01938456|Docetaxel|docetaxel|mesh-list
83725538|NCT01938456|Trametinib|trametinib|mesh-list
83725539|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725540|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
83725541|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
83725542|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83725543|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725544|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83725545|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725546|NCT01938508|Minocycline|minocycline|mesh-list
83725547|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83725548|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725549|NCT01938612|Durvalumab|durvalumab|mesh-list
83725550|NCT01938612|Tremelimumab|tremelimumab|mesh-list
83725551|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725552|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725553|NCT01938729|Dexamethasone|dexamethasone|mesh-list
83725554|NCT01938729|Gemcitabine|gemcitabine|mesh-list
83725555|NCT01938729|Floxuridine|floxuridine|mesh-list
83725556|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725557|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
83725558|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
83725559|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725560|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725561|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725562|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
83725563|NCT01938729|Hormones|hormones|mesh-ancestor
83725564|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83725565|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83725566|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725567|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83725568|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
83725569|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725570|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
83725571|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
83725572|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
83725573|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725574|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725575|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
83725576|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725577|NCT01938781|Entecavir|entecavir|mesh-list
83725578|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
83725579|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725580|NCT01938820|Entecavir|entecavir|mesh-list
83725581|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
83725582|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725583|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83725584|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
83725585|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725586|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83725587|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83725588|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725589|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725590|NCT01938872|Paclitaxel|paclitaxel|mesh-list
83725591|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83725592|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725593|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
83725594|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
83725595|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
83725596|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725597|NCT01938911|Oxytocin|oxytocin|mesh-list
83725598|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
83725599|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83725600|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725601|NCT01939054|Docetaxel|docetaxel|mesh-list
83725602|NCT01939054|Capecitabine|capecitabine|mesh-list
82880524|NCT01127724|Vitamins|vitamins|mesh-list
83725603|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
83725604|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725605|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
83725606|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
83725607|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
83725608|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725609|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83725610|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
83725611|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725612|NCT01939093|Thiamine|thiamine|mesh-list
83725613|NCT01939093|Cinnarizine|cinnarizine|mesh-list
83725614|NCT01939093|Diazepam|diazepam|mesh-list
83725615|NCT01939093|Vitamins|vitamins|mesh-ancestor
83725616|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
83725617|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725618|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
83725619|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83725620|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
83725621|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
83725622|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
83725623|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725624|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725625|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83725626|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725627|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83725628|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83725629|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83725630|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83725631|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725632|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83725633|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
83725634|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
83725635|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
83725636|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
83725637|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725638|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725639|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83725640|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725641|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83725642|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83725643|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
83725644|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
83725645|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
83725646|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
83725647|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725648|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83725649|NCT01939327|Rituximab|rituximab|mesh-list
83725650|NCT01939327|Lenalidomide|lenalidomide|mesh-list
83725651|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725652|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725653|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
83725654|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725655|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725656|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83725657|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83725658|NCT01939327|Growth Substances|growth substances|mesh-ancestor
83725659|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83725660|NCT01939379|Acetaminophen|acetaminophen|mesh-list
83725661|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83725662|NCT01939379|Morphine|morphine|mesh-list
83725663|NCT01939379|Oxycodone|oxycodone|mesh-list
83725664|NCT01939379|Analgesics|analgesics|mesh-list
83725665|NCT01939379|Ropivacaine|ropivacaine|mesh-list
83725666|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83725667|NCT01939379|Narcotics|narcotics|mesh-ancestor
83725668|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725669|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725670|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
83725671|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725672|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
83725673|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
83725674|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83725675|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83725676|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725677|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725678|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
83725679|NCT01939418|Gemcitabine|gemcitabine|mesh-list
83725680|NCT01939418|Everolimus|everolimus|mesh-list
83725681|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725682|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83725683|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
83725684|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725685|NCT01939418|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83725686|NCT01939418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83725687|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725688|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83725689|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
83725690|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725691|NCT01939444|Naloxone|naloxone|mesh-list
83725692|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83725693|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725694|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
83725695|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725696|NCT01939457|Misoprostol|misoprostol|mesh-list
83725697|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83725698|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
83725699|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83725700|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725701|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83725702|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725703|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
83725704|NCT01939483|Irinotecan|irinotecan|mesh-list
83725705|NCT01939483|Camptothecin|camptothecin|mesh-list
83725706|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83725707|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83725708|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725709|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725710|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725711|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83725712|NCT01939509|Atenolol|atenolol|mesh-list
83725713|NCT01939509|Bisoprolol|bisoprolol|mesh-list
83725714|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83725715|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83725716|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
83725717|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
83725718|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725719|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725720|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83725721|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83725722|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83725723|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83725724|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725725|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725726|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83725727|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
83725728|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725729|NCT01939561|Lamotrigine|lamotrigine|mesh-list
83725730|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
83725731|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83725732|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725733|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725734|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83725735|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725736|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83725737|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83725738|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725739|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725740|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83725741|NCT01939574|Bevacizumab|bevacizumab|mesh-list
83725742|NCT01939574|Temozolomide|temozolomide|mesh-list
83725743|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725744|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725745|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83725746|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83725747|NCT01939574|Growth Substances|growth substances|mesh-ancestor
83725748|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725749|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
83725750|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83725751|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
83725752|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725753|NCT01939639|Oxytocin|oxytocin|mesh-list
83725754|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
83725755|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82880668|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725756|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725757|NCT01939691|Prednisolone|prednisolone|mesh-list
83725758|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83725759|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
83725760|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83725761|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
83725762|NCT01939691|Nepafenac|nepafenac|mesh-list
83725763|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83725764|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
83725765|NCT01939691|Difluprednate|difluprednate|mesh-list
83725766|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725767|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
83725768|NCT01939691|Hormones|hormones|mesh-ancestor
83725769|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83725770|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725771|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83725772|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725773|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
83725774|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
83725775|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725776|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725777|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83725778|NCT01939691|Protective Agents|protective agents|mesh-ancestor
83725779|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83725780|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83725781|NCT01939691|Analgesics|analgesics|mesh-ancestor
83725782|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
83725783|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725784|NCT01939730|Rituximab|rituximab|mesh-list
83725785|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725786|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725787|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
83725788|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725789|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725790|NCT01939743|Diclofenac|diclofenac|mesh-list
83725791|NCT01939743|Lidocaine|lidocaine|mesh-list
83725792|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
83725793|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
83725794|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725795|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725796|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
83725797|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725798|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83725799|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83725800|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83725801|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725802|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725803|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83725804|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83725805|NCT01939743|Analgesics|analgesics|mesh-ancestor
83725806|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83725807|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83725808|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83725809|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725810|NCT01939834|Insulin|insulin|mesh-list
83725811|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83725812|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725813|NCT01939886|Artesunate|artesunate|mesh-list
83725814|NCT01939886|Lumefantrine|lumefantrine|mesh-list
83725815|NCT01939886|Artemether|artemether|mesh-list
83725816|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83725817|NCT01939886|Mefloquine|mefloquine|mesh-list
83725818|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
83725819|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83725820|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83725821|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83725822|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725823|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
83725824|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
83725825|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83725826|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
83725827|NCT01939912|Adenosine|adenosine|mesh-list
82880739|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83725828|NCT01939912|Analgesics|analgesics|mesh-ancestor
83725829|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
83725830|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725831|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725832|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83725833|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
83725834|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83725835|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
83725836|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
83725837|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725838|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725839|NCT01939990|Nebivolol|nebivolol|mesh-list
83725840|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83725841|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
83725842|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83725843|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83725844|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83725845|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
83725846|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725847|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725848|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725849|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83725850|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725851|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725852|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725853|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83725854|NCT01940172|Conatumumab|conatumumab|mesh-list
83725855|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725856|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725857|NCT01940224|Pregabalin|pregabalin|mesh-list
83725858|NCT01940224|Morphine|morphine|mesh-list
83725859|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83725860|NCT01940224|Narcotics|narcotics|mesh-ancestor
83725861|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725862|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725863|NCT01940224|Analgesics|analgesics|mesh-ancestor
83725864|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
83725865|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725866|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
83725867|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83725868|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725869|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725870|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83725871|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83725872|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83725873|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83725874|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
83725875|NCT01940250|Analgesics|analgesics|mesh-ancestor
83725876|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
83725877|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83725878|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725879|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
83725880|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83725881|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83725882|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
83725883|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83725884|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725885|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725886|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83725887|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
83725888|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83725889|NCT01940393|Cetirizine|cetirizine|mesh-list
83725890|NCT01940393|Fexofenadine|fexofenadine|mesh-list
83725891|NCT01940393|Desloratadine|desloratadine|mesh-list
83725892|NCT01940393|Ebastine|ebastine|mesh-list
83725893|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83725894|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83725895|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83725896|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
83725897|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
83725898|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725899|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880811|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82880812|NCT03923010|Itraconazole|itraconazole|mesh-list
82880813|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
82880814|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880815|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82880817|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725900|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725901|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83725903|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
83725904|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83725905|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83725906|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725907|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
83725908|NCT01940419|Coagulants|coagulants|mesh-ancestor
83725909|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
83725910|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83725911|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83725912|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725913|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
83725914|NCT01940536|Coagulants|coagulants|mesh-ancestor
83725915|NCT01940601|Lenograstim|lenograstim|mesh-list
83725916|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83725917|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
83725918|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725919|NCT01940627|Ubiquinone|ubiquinone|mesh-list
83725920|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
83725921|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
83725922|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725923|NCT01940627|Vitamins|vitamins|mesh-ancestor
83725924|NCT01940653|Estradiol|estradiol|mesh-list
83725925|NCT01940653|Progesterone|progesterone|mesh-list
83725926|NCT01940653|Estrogens|estrogens|mesh-ancestor
83725927|NCT01940653|Hormones|hormones|mesh-ancestor
83725928|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83725929|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725930|NCT01940653|Progestins|progestins|mesh-ancestor
83725931|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
83725932|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83725933|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83725934|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725935|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
83725936|NCT01940692|Coagulants|coagulants|mesh-ancestor
83725937|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
83725938|NCT01940718|Testosterone|testosterone|mesh-list
83725939|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
83725940|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
83725941|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83725942|NCT01940718|Androgens|androgens|mesh-ancestor
83725943|NCT01940718|Hormones|hormones|mesh-ancestor
83725944|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83725945|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725946|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83725947|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725948|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
83725949|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83725950|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83725951|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83725952|NCT01940796|Immunotoxins|immunotoxins|mesh-ancestor
83725953|NCT01940796|Immunoconjugates|immunoconjugates|mesh-ancestor
83725954|NCT01940796|Immunologic Factors|immunologic factors|mesh-ancestor
83725955|NCT01940796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725956|NCT01940952|Donepezil|donepezil|mesh-list
83725957|NCT01940952|Udenafil|udenafil|mesh-list
83725958|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83725959|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83725960|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725961|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
83725962|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725963|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725964|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
83725965|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83725966|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83725967|NCT01940965|Lixisenatide|lixisenatide|mesh-list
83725968|NCT01940965|Biguanides|biguanides|mesh-list
83725969|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83725970|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725971|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
83725972|NCT01940978|Methylphenidate|methylphenidate|mesh-list
83725973|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83725974|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725975|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83725976|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83725977|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83725978|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725979|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
83725980|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83725981|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
83725982|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
83725983|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83725984|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83725985|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
83725986|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
83725987|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83725988|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
83725989|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83725990|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83725991|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83725992|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83725993|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83725994|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
83725995|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725996|NCT01941056|Vaccines|vaccines|mesh-list
83725997|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
83725998|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83725999|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
83726000|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83726001|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83726002|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
83726003|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
83726004|NCT01941134|Estradiol|estradiol|mesh-list
83726005|NCT01941134|Estrogens|estrogens|mesh-ancestor
83726006|NCT01941134|Hormones|hormones|mesh-ancestor
83726007|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726008|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726009|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83726010|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726011|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83726012|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83726013|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83726014|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83726015|NCT01941173|Leucovorin|leucovorin|mesh-list
83726016|NCT01941173|Fluorouracil|fluorouracil|mesh-list
83726017|NCT01941173|Irinotecan|irinotecan|mesh-list
83726018|NCT01941173|Aflibercept|aflibercept|mesh-list
83726019|NCT01941173|Calcium|calcium|mesh-list
83726020|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
83726021|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
83726022|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83726023|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726024|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
83726025|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726026|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726027|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726028|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83726029|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
83726030|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83726031|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83726032|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726033|NCT01941173|Antidotes|antidotes|mesh-ancestor
83726034|NCT01941173|Protective Agents|protective agents|mesh-ancestor
83726035|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
83726036|NCT01941173|Vitamins|vitamins|mesh-ancestor
83726037|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
83726038|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83726039|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83726040|NCT01941173|Growth Substances|growth substances|mesh-ancestor
83726041|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
83726042|NCT01941199|Metformin|metformin|mesh-list
83726043|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83726044|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726045|NCT01941225|Iloprost|iloprost|mesh-list
83726046|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83726047|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
82880956|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880957|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726048|NCT01941264|Lumefantrine|lumefantrine|mesh-list
82880958|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83726049|NCT01941264|Artemether|artemether|mesh-list
83726050|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83726051|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
83726052|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83726053|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83726054|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726055|NCT01941316|Irinotecan|irinotecan|mesh-list
83726056|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83726057|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83726058|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726059|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726060|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726061|NCT01941329|Ranibizumab|ranibizumab|mesh-list
83726062|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83726063|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83726064|NCT01941329|Growth Substances|growth substances|mesh-ancestor
83726065|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726066|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
83726067|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726068|NCT01941407|Bevacizumab|bevacizumab|mesh-list
83726069|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83726070|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726071|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83726072|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83726073|NCT01941407|Growth Substances|growth substances|mesh-ancestor
83726074|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726075|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
83726076|NCT01941524|Poractant alfa|poractant alfa|mesh-list
83726077|NCT01941524|Beractant|beractant|mesh-list
83726078|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83726079|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
83726080|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83726081|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
83726082|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726083|NCT01941602|Enoxaparin|enoxaparin|mesh-list
83726084|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
83726085|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83726086|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83726087|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726088|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
83726089|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
83726090|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83726091|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83726092|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726093|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726094|NCT01941732|Urological Agents|urological agents|mesh-ancestor
83726095|NCT01941758|Vaccines|vaccines|mesh-list
83726096|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
83726097|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726098|NCT01941771|Capecitabine|capecitabine|mesh-list
83726099|NCT01941771|Vinorelbine|vinorelbine|mesh-list
83726100|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726101|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
83726102|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726103|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726104|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83726105|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83726106|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83726107|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83726108|NCT01941810|Lactoferrin|lactoferrin|mesh-list
83726109|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726110|NCT01941888|Midazolam|midazolam|mesh-list
83726111|NCT01941888|Propofol|propofol|mesh-list
83726112|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83726113|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726114|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726115|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82881028|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82881029|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881030|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881031|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82881032|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82881033|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881034|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726116|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
83726117|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
83726118|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83726119|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83726120|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726121|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726122|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
83726123|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
83726124|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726125|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726126|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
83726127|NCT01941901|Bleomycin|bleomycin|mesh-list
83726128|NCT01941901|Calcium|calcium|mesh-list
83726129|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83726130|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726131|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83726132|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83726133|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726134|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
83726135|NCT01941914|Calcium|calcium|mesh-list
83726136|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83726137|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726138|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83726139|NCT01941953|Metformin|metformin|mesh-list
83726140|NCT01941953|Fluorouracil|fluorouracil|mesh-list
83726141|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83726142|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726143|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
83726144|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726145|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726146|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726147|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83726148|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
83726149|NCT01941966|Capecitabine|capecitabine|mesh-list
83726150|NCT01941966|Mitomycins|mitomycins|mesh-list
83726151|NCT01941966|Mitomycin|mitomycin|mesh-list
83726152|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726153|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
83726154|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726155|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726156|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83726157|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
83726158|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83726159|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726160|NCT01941979|Leucovorin|leucovorin|mesh-list
83726161|NCT01941979|Capecitabine|capecitabine|mesh-list
83726162|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
83726163|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726164|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
83726165|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726166|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726167|NCT01941979|Antidotes|antidotes|mesh-ancestor
83726168|NCT01941979|Protective Agents|protective agents|mesh-ancestor
83726169|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726170|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
83726171|NCT01941979|Vitamins|vitamins|mesh-ancestor
83726172|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
83726173|NCT01942070|Everolimus|everolimus|mesh-list
83726174|NCT01942070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83726175|NCT01942070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83726176|NCT01942070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726177|NCT01942070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726178|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83726179|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
83726180|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726181|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726182|NCT01942109|Torsemide|torsemide|mesh-list
83726183|NCT01942109|Furosemide|furosemide|mesh-list
83726184|NCT01942109|Diuretics|diuretics|mesh-ancestor
83726185|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
83726186|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726187|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83726188|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726189|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726190|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83726191|NCT01942174|Methotrexate|methotrexate|mesh-list
83726192|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83726193|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83726194|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
83726195|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726196|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726197|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726198|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
83726199|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726200|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726201|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
83726202|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726203|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83726204|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83726205|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
83726206|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83726207|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83726208|NCT01942187|Aripiprazole|aripiprazole|mesh-list
83726209|NCT01942187|Bupropion|bupropion|mesh-list
83726210|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83726211|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
83726212|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726213|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83726214|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83726215|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726216|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726217|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
83726218|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726219|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726220|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83726221|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83726222|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726223|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83726224|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726225|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726226|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
83726227|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83726228|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83726229|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
83726230|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83726231|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83726232|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83726233|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83726234|NCT01942291|Niacin|niacin|mesh-list
83726235|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
83726236|NCT01942291|Vitamins|vitamins|mesh-ancestor
83726237|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
83726238|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726239|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
83726240|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83726241|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
83726242|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726243|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83726244|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
83726245|NCT01942304|Calcium|calcium|mesh-list
83726246|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83726247|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726248|NCT01942343|Droperidol|droperidol|mesh-list
83726249|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83726250|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
83726251|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
83726252|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726253|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726254|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83726255|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83726256|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726257|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726258|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726259|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83726260|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83726261|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
83726262|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726263|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726264|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83726265|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
82881168|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881169|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83726266|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83726268|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726269|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726270|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83726271|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83726272|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726273|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83726274|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83726275|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726276|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726277|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726278|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726279|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83726280|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83726281|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
83726282|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726283|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726284|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83726285|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83726286|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
83726287|NCT01942447|Vancomycin|vancomycin|mesh-list
83726288|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83726289|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726290|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83726291|NCT01942460|Hematinics|hematinics|mesh-ancestor
83726292|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83726293|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83726294|NCT01942551|Tadalafil|tadalafil|mesh-list
83726295|NCT01942551|Dutasteride|dutasteride|mesh-list
83726296|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
83726297|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83726298|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83726299|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726300|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726301|NCT01942551|Urological Agents|urological agents|mesh-ancestor
83726302|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83726303|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83726304|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
83726305|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726306|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726307|NCT01942577|Protective Agents|protective agents|mesh-list
83726308|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726309|NCT01942681|Propiverine|propiverine|mesh-list
83726310|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
83726311|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
83726312|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726313|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726314|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83726315|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83726316|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726317|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726318|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726319|NCT01942681|Urological Agents|urological agents|mesh-ancestor
83726320|NCT01942889|Antioxidants|antioxidants|mesh-list
83726321|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726322|NCT01942889|Protective Agents|protective agents|mesh-ancestor
83726323|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726324|NCT01943019|Linagliptin|linagliptin|mesh-list
83726325|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83726326|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726327|NCT01943019|Incretins|incretins|mesh-ancestor
83726328|NCT01943019|Hormones|hormones|mesh-ancestor
83726329|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726330|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83726331|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
83726332|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726333|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726334|NCT01943058|Megestrol|megestrol|mesh-list
83726335|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
83726336|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
83726337|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83726338|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
83726339|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726340|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726341|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83726342|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83726343|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83726344|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83726345|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83726346|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726347|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
83726348|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83726350|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83726351|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726352|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83726353|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726354|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726355|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
83726356|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83726357|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
83726358|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726359|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83726360|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83726361|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
83726362|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726363|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726364|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83726365|NCT01943240|Ropivacaine|ropivacaine|mesh-list
83726366|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
83726367|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
83726368|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726369|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726370|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
83726371|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726372|NCT01943305|Vaccines|vaccines|mesh-list
83726373|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
83726374|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726375|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83726376|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83726377|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83726378|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83726379|NCT01943422|Interferons|interferons|mesh-list
83726380|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
83726381|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
83726382|NCT01943422|Vemurafenib|vemurafenib|mesh-list
83726383|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726384|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
83726385|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726386|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
83726387|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726388|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83726389|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726390|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726391|NCT01943487|Verapamil|verapamil|mesh-list
83726392|NCT01943487|Tamsulosin|tamsulosin|mesh-list
83726393|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
83726394|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83726395|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83726396|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83726397|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
83726398|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726399|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726400|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726401|NCT01943487|Urological Agents|urological agents|mesh-ancestor
83726402|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83726403|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83726404|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726405|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83726406|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83726407|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726408|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83726409|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83726410|NCT01943526|Natalizumab|natalizumab|mesh-list
82881315|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83726411|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
83726412|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726413|NCT01943617|Entecavir|entecavir|mesh-list
83726414|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
83726415|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726416|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
83726417|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83726418|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
83726419|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726420|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726421|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83726422|NCT01943630|Protective Agents|protective agents|mesh-ancestor
83726423|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83726424|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83726425|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726426|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726427|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
83726428|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726429|NCT01943760|Tramadol|tramadol|mesh-list
83726430|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83726431|NCT01943760|Narcotics|narcotics|mesh-ancestor
83726432|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726433|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726434|NCT01943760|Analgesics|analgesics|mesh-ancestor
83726435|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
83726436|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726437|NCT01943786|Cetuximab|cetuximab|mesh-list
83726438|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83726439|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726440|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83726441|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83726442|NCT01943812|Estradiol|estradiol|mesh-list
83726443|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83726444|NCT01943812|Progesterone|progesterone|mesh-list
83726445|NCT01943812|Estrogens|estrogens|mesh-ancestor
83726446|NCT01943812|Hormones|hormones|mesh-ancestor
83726447|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726448|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726449|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83726450|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
83726451|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726452|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83726453|NCT01943812|Progestins|progestins|mesh-ancestor
83726454|NCT01943877|Propolis|propolis|mesh-list
83726455|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726456|NCT01943942|Montelukast|montelukast|mesh-list
83726457|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83726458|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
83726459|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83726460|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
83726461|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726462|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726463|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83726464|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83726465|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726466|NCT01944033|Terbutaline|terbutaline|mesh-list
83726467|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83726468|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
83726469|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726470|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726471|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83726472|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
83726473|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
83726474|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
83726475|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726476|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83726477|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83726478|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83726479|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83726480|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726481|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726482|NCT01944085|Acetaminophen|acetaminophen|mesh-list
82881389|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
83726483|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
83726484|NCT01944085|Ibuprofen|ibuprofen|mesh-list
83726486|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
83726487|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726488|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83726489|NCT01944085|Analgesics|analgesics|mesh-ancestor
83726490|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
83726491|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726492|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
83726493|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83726494|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83726495|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83726496|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83726497|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726498|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726499|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
83726500|NCT01944085|Protective Agents|protective agents|mesh-ancestor
83726501|NCT01944176|Simvastatin|simvastatin|mesh-list
83726502|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83726503|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83726504|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
83726505|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726506|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83726507|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83726508|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726509|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83726510|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
83726511|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83726512|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83726513|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726514|NCT01944215|Caffeine|caffeine|mesh-list
83726515|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83726516|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726517|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83726518|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726519|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726520|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83726521|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83726522|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
83726523|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726524|NCT01944384|Spironolactone|spironolactone|mesh-list
83726525|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83726526|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
83726527|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726528|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726529|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83726530|NCT01944384|Diuretics|diuretics|mesh-ancestor
83726531|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
83726532|NCT01944410|Mitogens|mitogens|mesh-list
83726533|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
83726534|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726535|NCT01944436|Rivastigmine|rivastigmine|mesh-list
83726536|NCT01944436|Donepezil|donepezil|mesh-list
83726537|NCT01944436|Galantamine|galantamine|mesh-list
83726538|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83726539|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726540|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726541|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726542|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726543|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726544|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
83726545|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83726546|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
83726547|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726548|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83726549|NCT01944436|Protective Agents|protective agents|mesh-ancestor
83726550|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
83726551|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83726552|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726553|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83726554|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726555|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
83726556|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726557|NCT01944683|Midazolam|midazolam|mesh-list
82881465|NCT01137084|Hormones|hormones|mesh-ancestor
83726558|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83726559|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83726560|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726561|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726562|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83726563|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726564|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726565|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83726566|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
83726567|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
83726568|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
83726569|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
83726570|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726571|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726572|NCT01944735|Mannitol|mannitol|mesh-list
83726573|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83726574|NCT01944735|Diuretics|diuretics|mesh-ancestor
83726575|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
83726576|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726577|NCT01944852|Icodextrin|icodextrin|mesh-list
83726578|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
83726579|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83726580|NCT01945021|Crizotinib|crizotinib|mesh-list
83726581|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726582|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83726583|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726584|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726585|NCT01945047|Midazolam|midazolam|mesh-list
83726586|NCT01945047|Ketamine|ketamine|mesh-list
83726587|NCT01945047|Analgesics|analgesics|mesh-ancestor
83726588|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
83726589|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726590|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726591|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83726592|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83726593|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
83726594|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
83726595|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726596|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83726597|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83726598|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726599|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726600|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83726601|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83726602|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83726603|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726604|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726605|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
83726606|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
83726607|NCT01945099|Insulin|insulin|mesh-list
83726608|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83726609|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726610|NCT01945268|Vaccines|vaccines|mesh-list
83726611|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
83726612|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726613|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
83726614|NCT01945437|Analgesics|analgesics|mesh-ancestor
83726615|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
83726616|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726617|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726618|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
83726619|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726620|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83726621|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
83726622|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83726623|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726624|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726625|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83726626|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
83726627|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726628|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83726629|NCT01945450|Clindamycin|clindamycin|mesh-list
83726630|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
83726631|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
83726632|NCT01945450|Gentamicins|gentamicins|mesh-list
83726633|NCT01945450|Ampicillin|ampicillin|mesh-list
83726634|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726635|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83726636|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726637|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726638|NCT01945476|Midazolam|midazolam|mesh-list
83726639|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83726640|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83726641|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726642|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726643|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83726644|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726645|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726646|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83726647|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
83726648|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
83726649|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
83726650|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
83726651|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726652|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726653|NCT01945528|Lidocaine|lidocaine|mesh-list
83726654|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
83726655|NCT01945528|Anesthetics|anesthetics|mesh-list
83726656|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726657|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726658|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
83726659|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726660|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83726661|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83726662|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83726663|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726664|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726665|NCT01945554|Bupivacaine|bupivacaine|mesh-list
83726666|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
83726667|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
83726668|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726669|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726670|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
83726671|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726672|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
83726673|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83726674|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83726675|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83726676|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726677|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726678|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726679|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726680|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726681|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83726682|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726683|NCT01945736|Methadone|methadone|mesh-list
83726684|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83726685|NCT01945736|Narcotics|narcotics|mesh-ancestor
83726686|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726687|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726688|NCT01945736|Analgesics|analgesics|mesh-ancestor
83726689|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
83726690|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726691|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
83726692|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
83726693|NCT01945788|Teriparatide|teriparatide|mesh-list
83726694|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83726695|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726696|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83726697|NCT01945801|Furosemide|furosemide|mesh-list
83726698|NCT01945801|Spironolactone|spironolactone|mesh-list
82881619|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82881620|NCT01142778|Growth Substances|growth substances|mesh-ancestor
82881621|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881622|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
82881623|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
82881624|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
82881625|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
82881626|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881637|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
82881670|NCT01234740|Bafetinib|bafetinib|mesh-list
83726700|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
83726701|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726702|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83726703|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726704|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726705|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83726706|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
83726707|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726708|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83726709|NCT05410782|Vitamins|vitamins|mesh-list
83726710|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
83726711|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726712|NCT05410626|Methylphenidate|methylphenidate|mesh-list
83726713|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83726714|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726715|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83726716|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83726717|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726718|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726719|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
83726720|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726721|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83726722|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83726723|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83726724|NCT05410483|Docetaxel|docetaxel|mesh-list
83726725|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726726|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
83726727|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
83726728|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
83726729|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726730|NCT05410314|Inositol|inositol|mesh-list
83726731|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
83726732|NCT05410314|Vitamins|vitamins|mesh-ancestor
83726733|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
83726734|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726735|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
83726736|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83726737|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
83726738|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83726739|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
83726740|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726741|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726742|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
83726743|NCT05410093|Vitamin E|vitamin e|mesh-list
83726744|NCT05410093|Tocopherols|tocopherols|mesh-list
83726745|NCT05410093|Resveratrol|resveratrol|mesh-list
83726746|NCT05410093|Vitamins|vitamins|mesh-ancestor
83726747|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
83726748|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726749|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
83726750|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726751|NCT05410093|Protective Agents|protective agents|mesh-ancestor
83726752|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726753|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83726754|NCT05409820|Anesthetics|anesthetics|mesh-list
83726755|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726756|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726757|NCT05409339|Mannitol|mannitol|mesh-list
83726758|NCT05409339|Caffeine|caffeine|mesh-list
83726759|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83726760|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726761|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83726762|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726763|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726764|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83726765|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83726766|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
83726767|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726768|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83726769|NCT05409339|Diuretics|diuretics|mesh-ancestor
83726770|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
83726771|NCT05273567|Guanfacine|guanfacine|mesh-list
82881693|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83726772|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83726773|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83726774|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83726775|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83726776|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83726777|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726778|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726779|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726780|NCT05155527|Ivermectin|ivermectin|mesh-list
83726781|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83726782|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726783|NCT05151146|Metformin|metformin|mesh-list
83726784|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83726785|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726786|NCT05068063|Bupivacaine|bupivacaine|mesh-list
83726787|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
83726788|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
83726789|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726790|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726791|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
83726792|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726793|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
83726794|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
83726795|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83726796|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726797|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726798|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83726799|NCT04946396|Analgesics|analgesics|mesh-ancestor
83726800|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
83726801|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726802|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83726803|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83726804|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83726805|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
83726806|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726807|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726808|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
83726809|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83726810|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83726811|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83726812|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726813|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726814|NCT04908657|Urological Agents|urological agents|mesh-ancestor
83726815|NCT04887389|Listerine|listerine|mesh-list
83726816|NCT04887389|Fluorides|fluorides|mesh-list
83726817|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
83726818|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
83726819|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
83726820|NCT04887389|Protective Agents|protective agents|mesh-ancestor
83726821|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726822|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83726823|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726824|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
83726825|NCT04773392|Prednisone|prednisone|mesh-list
83726826|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
83726827|NCT04773392|Azathioprine|azathioprine|mesh-list
83726828|NCT04773392|Tacrolimus|tacrolimus|mesh-list
83726829|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
83726830|NCT04773392|Basiliximab|basiliximab|mesh-list
83726831|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83726832|NCT04773392|Antimetabolites|antimetabolites|mesh-list
83726833|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83726834|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
83726835|NCT04773392|Hormones|hormones|mesh-ancestor
83726836|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726837|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726838|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83726839|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726840|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83726841|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
83726842|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83726843|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726844|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726845|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83726846|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82881770|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
83726847|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
83726848|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83726849|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726850|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
83726851|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
83726852|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726853|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83726854|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83726855|NCT04773392|Protective Agents|protective agents|mesh-ancestor
83726856|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726857|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83726858|NCT04724655|Mineral Oil|mineral oil|mesh-list
83726859|NCT04724655|Emollients|emollients|mesh-ancestor
83726860|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
83726861|NCT04722835|Albuterol|albuterol|mesh-list
83726862|NCT04722835|Dimercaprol|dimercaprol|mesh-list
83726863|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83726864|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
83726865|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726866|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726867|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83726868|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
83726869|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
83726870|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83726871|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83726872|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83726873|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83726874|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
83726875|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726876|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726877|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
83726878|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
83726879|NCT04538053|Cefazolin|cefazolin|mesh-list
83726880|NCT04538053|Cephalexin|cephalexin|mesh-list
83726881|NCT04538053|Floxacillin|floxacillin|mesh-list
83726882|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83726883|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726884|NCT04487990|Heparin|heparin|mesh-list
83726885|NCT04487990|Calcium heparin|calcium heparin|mesh-list
83726886|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
83726887|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83726888|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83726889|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726890|NCT04476979|Dexamethasone|dexamethasone|mesh-list
83726891|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83726892|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
83726893|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
83726894|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726895|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726896|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83726897|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
83726898|NCT04476979|Hormones|hormones|mesh-ancestor
83726899|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726900|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83726901|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726902|NCT04411953|Haloperidol|haloperidol|mesh-list
83726903|NCT04411953|Benztropine|benztropine|mesh-list
83726904|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
83726905|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
83726906|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
83726907|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726908|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726909|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83726910|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83726911|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726912|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726913|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726914|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83726915|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
83726916|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726917|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726918|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83726919|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83726920|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
83726921|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83726922|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83726923|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726924|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83726925|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83726926|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726927|NCT04411940|Haloperidol|haloperidol|mesh-list
83726928|NCT04411940|Benztropine|benztropine|mesh-list
83726929|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
83726930|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
83726931|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
83726932|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83726933|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726934|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83726935|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83726936|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83726937|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83726938|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83726939|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83726940|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
83726941|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726942|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726943|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83726944|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83726945|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
83726946|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83726947|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83726948|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726949|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83726950|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83726951|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83726952|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83726953|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83726954|NCT04030429|Crizotinib|crizotinib|mesh-list
83726955|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726956|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83726957|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726958|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726959|NCT03970694|Capecitabine|capecitabine|mesh-list
83726960|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
83726961|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83726962|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
83726963|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726964|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726965|NCT03941132|Ustekinumab|ustekinumab|mesh-list
83726966|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
83726967|NCT03920007|Trimethoprim|trimethoprim|mesh-list
83726968|NCT03920007|Polymyxins|polymyxins|mesh-list
83726969|NCT03920007|Polymyxin B|polymyxin b|mesh-list
83726970|NCT03920007|Prednisone|prednisone|mesh-list
83726971|NCT03920007|Prednisolone|prednisolone|mesh-list
83726972|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83726973|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
83726974|NCT03920007|Hormones|hormones|mesh-ancestor
83726975|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83726976|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726977|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83726978|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83726979|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83726980|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83726981|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
83726982|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83726983|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83726984|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83726985|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83726986|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83726987|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83726988|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83726989|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83726990|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83726991|NCT03873246|Varenicline|varenicline|mesh-list
83726992|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83726993|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83726994|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
83726995|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83726996|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881923|NCT05848687|Autonomic Agents|autonomic agents|mesh-ancestor
82881927|NCT05848687|Glucocorticoids|glucocorticoids|mesh-ancestor
83726997|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83726998|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
83726999|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83727000|NCT03866577|Antibodies|antibodies|mesh-list
83727001|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
83727002|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83727003|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
83727004|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727005|NCT03714880|Mifepristone|mifepristone|mesh-list
83727006|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83727007|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
83727008|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83727009|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727010|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83727011|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83727012|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83727013|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
83727014|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83727015|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83727016|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
83727017|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727018|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
83727019|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83727020|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83727021|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83727022|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83727023|NCT03619850|Hematinics|hematinics|mesh-ancestor
83727024|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83727025|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83727026|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
83727027|NCT03559686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83727028|NCT03559686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727029|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83727030|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
83727031|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727032|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727033|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
83727034|NCT03559660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83727035|NCT03559660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727036|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83727037|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
83727038|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727039|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727040|NCT03532516|Brivaracetam|brivaracetam|mesh-list
83727041|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
83727042|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
83727043|NCT03333005|Clotrimazole|clotrimazole|mesh-list
83727044|NCT03333005|Miconazole|miconazole|mesh-list
83727045|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727046|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83727047|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83727048|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83727049|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727050|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727051|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83727052|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
83727053|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727054|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727055|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83727056|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83727057|NCT03148366|Levofloxacin|levofloxacin|mesh-list
83727058|NCT03148366|Bismuth|bismuth|mesh-list
83727059|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83727060|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727061|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83727062|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82881995|NCT05848492|Hormone Antagonists|hormone antagonists|mesh-ancestor
82881996|NCT05848492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881997|NCT05848492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881998|NCT05848492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82881999|NCT05848492|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82882000|NCT05848336|Caseins|caseins|mesh-list
82882001|NCT05848336|Chelating Agents|chelating agents|mesh-ancestor
82882002|NCT05848336|Sequestering Agents|sequestering agents|mesh-ancestor
83727063|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83727064|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727065|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727066|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727067|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83727068|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83727069|NCT03148366|Antacids|antacids|mesh-ancestor
83727070|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727071|NCT03122496|Durvalumab|durvalumab|mesh-list
83727072|NCT03122496|Tremelimumab|tremelimumab|mesh-list
83727073|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727074|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727075|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
83727076|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83727077|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
83727078|NCT03118232|Povidone|povidone|mesh-list
83727079|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83727080|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727081|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
83727082|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
83727083|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
83727084|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
83727085|NCT03073694|Melphalan|melphalan|mesh-list
83727086|NCT03073694|Mitomycins|mitomycins|mesh-list
83727087|NCT03073694|Mitomycin|mitomycin|mesh-list
83727088|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83727089|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
83727090|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727091|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727092|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83727093|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83727094|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
83727095|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727096|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83727097|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83727098|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727099|NCT03069703|Rituximab|rituximab|mesh-list
83727100|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727101|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727102|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
83727103|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727104|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727105|NCT02955082|Carboplatin|carboplatin|mesh-list
83727106|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727107|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
83727108|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727109|NCT02818738|Levamisole|levamisole|mesh-list
83727110|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83727111|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
83727112|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727113|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
83727114|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
83727115|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83727116|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727117|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727118|NCT02335099|Ticagrelor|ticagrelor|mesh-list
83727119|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83727120|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83727121|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83727122|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83727123|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
83727124|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727125|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727126|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727127|NCT02330562|Bevacizumab|bevacizumab|mesh-list
83727128|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727129|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727130|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82882069|NCT05846399|Clavulanic Acid|clavulanic acid|mesh-list
82882070|NCT05846399|Clavulanic Acids|clavulanic acids|mesh-list
83727131|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82882071|NCT05846399|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82882072|NCT05846399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82882073|NCT05846399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882074|NCT05846399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83727132|NCT02330562|Growth Substances|growth substances|mesh-ancestor
83727133|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727134|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
83727136|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83727137|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83727138|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727139|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
83727140|NCT02053363|Coagulants|coagulants|mesh-ancestor
83727141|NCT01100775|Galantamine|galantamine|mesh-list
83727142|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83727143|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727144|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727145|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
83727146|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727147|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727148|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83727149|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
83727150|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727151|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
83727152|NCT00504712|Testosterone|testosterone|mesh-list
83727153|NCT00504712|Androgens|androgens|mesh-ancestor
83727154|NCT00504712|Hormones|hormones|mesh-ancestor
83727155|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727156|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727157|NCT05413200|Isotretinoin|isotretinoin|mesh-list
83727158|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
83727159|NCT05413096|Propolis|propolis|mesh-list
83727160|NCT05413096|Diclofenac|diclofenac|mesh-list
83727161|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83727162|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83727163|NCT05413096|Analgesics|analgesics|mesh-ancestor
83727164|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
83727165|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727166|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727167|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727168|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727169|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83727170|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727171|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727172|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727173|NCT05412589|Apatinib|apatinib|mesh-list
83727174|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727175|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83727176|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727177|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727178|NCT05412576|Lidocaine|lidocaine|mesh-list
83727179|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
83727180|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
83727181|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727182|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727183|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
83727184|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727185|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83727186|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83727187|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83727188|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83727189|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727190|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
83727191|NCT05412472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83727192|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
83727193|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727194|NCT05412472|Protective Agents|protective agents|mesh-ancestor
83727195|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727196|NCT05412394|Prednisolone|prednisolone|mesh-list
83727197|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727198|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
83727199|NCT05412394|Hormones|hormones|mesh-ancestor
83727200|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727201|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727202|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83727203|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727204|NCT05412173|Molnupiravir|molnupiravir|mesh-list
83727205|NCT05412173|Antiviral Agents|antiviral agents|mesh-ancestor
82882144|NCT05845424|Antimetabolites|antimetabolites|mesh-ancestor
83727206|NCT05412173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727207|NCT05412147|Vitamins|vitamins|mesh-list
83727208|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
83727209|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727210|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83727211|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83727212|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727213|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727214|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83727215|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83727216|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727217|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
83727218|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727219|NCT05411757|Bevacizumab|bevacizumab|mesh-list
83727220|NCT05411757|Lenvatinib|lenvatinib|mesh-list
83727221|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727222|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727223|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83727224|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83727225|NCT05411757|Growth Substances|growth substances|mesh-ancestor
83727226|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727227|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83727228|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83727229|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727230|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727231|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83727232|NCT05411276|Maleic acid|maleic acid|mesh-list
83727233|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727234|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727235|NCT05396781|Proflavine|proflavine|mesh-list
83727236|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83727237|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727238|NCT05384951|Vitamin D|vitamin d|mesh-list
83727239|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
83727240|NCT05384951|Vitamins|vitamins|mesh-ancestor
83727241|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
83727242|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727243|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83727244|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83727245|NCT05303038|Bevacizumab|bevacizumab|mesh-list
83727246|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727247|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727248|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83727249|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83727250|NCT05303038|Growth Substances|growth substances|mesh-ancestor
83727251|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727252|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
83727253|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83727254|NCT05275894|Metronidazole|metronidazole|mesh-list
83727255|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727256|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83727257|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83727258|NCT05167760|Apraclonidine|apraclonidine|mesh-list
83727259|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83727260|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83727261|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83727262|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
83727263|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727264|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727265|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727266|NCT05077800|Losartan|losartan|mesh-list
83727267|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83727268|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83727269|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83727270|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83727271|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727272|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
83727273|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83727274|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83727275|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727276|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
83727277|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882217|NCT05844683|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83727278|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727279|NCT05042674|Ergothioneine|ergothioneine|mesh-list
83727280|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
83727281|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727282|NCT05042674|Protective Agents|protective agents|mesh-ancestor
83727283|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727284|NCT04927585|Vaccines|vaccines|mesh-list
83727285|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
83727286|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727287|NCT04917055|Dexamethasone|dexamethasone|mesh-list
83727288|NCT04917055|Epinephrine|epinephrine|mesh-list
83727289|NCT04917055|Ropivacaine|ropivacaine|mesh-list
83727290|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727291|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
83727292|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
83727293|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727294|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727295|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727296|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
83727297|NCT04917055|Hormones|hormones|mesh-ancestor
83727298|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727299|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83727300|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727301|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
83727302|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
83727303|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727304|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
83727305|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83727306|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83727307|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
83727308|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727309|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727310|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83727311|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83727312|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83727313|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
83727314|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
83727315|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
83727316|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83727317|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
83727318|NCT04898478|Narcotics|narcotics|mesh-ancestor
83727319|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727320|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727321|NCT04898478|Analgesics|analgesics|mesh-ancestor
83727322|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
83727323|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727324|NCT04755244|Azacitidine|azacitidine|mesh-list
83727325|NCT04755244|Venetoclax|venetoclax|mesh-list
83727326|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83727327|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
83727328|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727329|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727330|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727331|NCT04725864|Progesterone|progesterone|mesh-list
83727332|NCT04725864|Progestins|progestins|mesh-ancestor
83727333|NCT04725864|Hormones|hormones|mesh-ancestor
83727334|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727335|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727336|NCT04721821|Tofacitinib|tofacitinib|mesh-list
83727337|NCT04721821|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83727338|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83727339|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727340|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727341|NCT04721353|Prazosin|prazosin|mesh-list
83727342|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83727343|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83727344|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83727345|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83727346|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
83727347|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727348|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727349|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727350|NCT04655391|Decitabine|decitabine|mesh-list
83727351|NCT04655391|Venetoclax|venetoclax|mesh-list
83727352|NCT04655391|Ivosidenib|ivosidenib|mesh-list
83727353|NCT04655391|Maleic acid|maleic acid|mesh-list
83727354|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83727355|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
83727356|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727357|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727358|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727360|NCT04609098|Artenimol|artenimol|mesh-list
83727361|NCT04609098|Tafenoquine|tafenoquine|mesh-list
83727362|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
83727363|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83727364|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83727365|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727366|NCT04605614|Copper|copper|mesh-list
83727367|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
83727368|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727369|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727370|NCT04605614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83727371|NCT04605614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727372|NCT04605614|Trace Elements|trace elements|mesh-ancestor
83727373|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
83727374|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727375|NCT04475016|Paclitaxel|paclitaxel|mesh-list
83727376|NCT04475016|Ifosfamide|ifosfamide|mesh-list
83727377|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83727378|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
83727379|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83727380|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727381|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
83727382|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
83727383|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
83727384|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727385|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83727386|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
83727387|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727388|NCT04321551|Letrozole|letrozole|mesh-list
83727389|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
83727390|NCT04321551|Testosterone|testosterone|mesh-list
83727391|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
83727392|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
83727393|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83727394|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727395|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83727396|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83727397|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727398|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727399|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83727400|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
83727401|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727402|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727403|NCT04321551|Androgens|androgens|mesh-ancestor
83727404|NCT04321551|Hormones|hormones|mesh-ancestor
83727405|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83727406|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
83727407|NCT04302324|Clarithromycin|clarithromycin|mesh-list
83727408|NCT04302324|Dexamethasone|dexamethasone|mesh-list
83727409|NCT04302324|Daratumumab|daratumumab|mesh-list
83727410|NCT04302324|Pomalidomide|pomalidomide|mesh-list
83727411|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727412|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
83727413|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
83727414|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727415|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727416|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727417|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
83727418|NCT04302324|Hormones|hormones|mesh-ancestor
83727419|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727420|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83727421|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727422|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83727423|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727424|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83727425|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727426|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727427|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82882369|NCT05843188|Irinotecan|irinotecan|mesh-list
82882374|NCT05843188|Growth Substances|growth substances|mesh-ancestor
83727428|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83727429|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
83727430|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83727431|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83727432|NCT04302324|Growth Substances|growth substances|mesh-ancestor
83727433|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
83727434|NCT04174781|Immunomodulating Agents|immunomodulating agents|mesh-list
83727435|NCT04174781|Immunologic Factors|immunologic factors|mesh-ancestor
83727436|NCT04174781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727437|NCT04074460|Propofol|propofol|mesh-list
83727438|NCT04074460|Sevoflurane|sevoflurane|mesh-list
83727439|NCT04074460|Desflurane|desflurane|mesh-list
83727440|NCT04074460|Isoflurane|isoflurane|mesh-list
83727441|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83727442|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727443|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727444|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83727445|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
83727446|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
83727447|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83727448|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83727449|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83727450|NCT03817125|Vancomycin|vancomycin|mesh-list
83727451|NCT03817125|Nivolumab|nivolumab|mesh-list
83727452|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727453|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727454|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83727455|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727456|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727457|NCT03703102|KHK4083|khk4083|mesh-list
83727458|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83727459|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83727460|NCT03581370|Cephalosporins|cephalosporins|mesh-list
83727461|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
83727462|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83727463|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727464|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83727465|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83727466|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727467|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727468|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83727469|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83727470|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
83727471|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727472|NCT03539055|Dabigatran|dabigatran|mesh-list
83727473|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
83727474|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83727475|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
83727476|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727477|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727478|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
83727479|NCT03485534|Tenofovir|tenofovir|mesh-list
83727480|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
83727481|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727482|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83727483|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83727484|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727485|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727486|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83727487|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83727488|NCT03427736|Ketorolac|ketorolac|mesh-list
83727489|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83727490|NCT03427736|Ketamine|ketamine|mesh-list
83727491|NCT03427736|Morphine|morphine|mesh-list
83727492|NCT03427736|Oxycodone|oxycodone|mesh-list
83727493|NCT03427736|Hydromorphone|hydromorphone|mesh-list
83727494|NCT03427736|Analgesics|analgesics|mesh-ancestor
83727495|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
83727496|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727497|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727498|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83727499|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83727500|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
83727501|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
83727502|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882444|NCT05842681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727503|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83727504|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83727505|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727506|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727507|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83727508|NCT03427736|Narcotics|narcotics|mesh-ancestor
83727509|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83727510|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83727511|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727512|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727513|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83727514|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727515|NCT03395704|Hepcidins|hepcidins|mesh-list
83727516|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727517|NCT03246503|Bilirubin|bilirubin|mesh-list
83727518|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
83727519|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727520|NCT03246503|Protective Agents|protective agents|mesh-ancestor
83727521|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727522|NCT03091881|Granisetron|granisetron|mesh-list
83727523|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
83727524|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
83727525|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727526|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727527|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727528|NCT03091881|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83727529|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83727530|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
83727531|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727532|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727533|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
83727534|NCT03032406|Everolimus|everolimus|mesh-list
83727535|NCT03032406|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83727536|NCT03032406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83727537|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727538|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727539|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83727540|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
83727541|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727542|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727543|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
83727544|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83727545|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83727546|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727547|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727548|NCT02897063|Midodrine|midodrine|mesh-list
83727549|NCT02897063|Droxidopa|droxidopa|mesh-list
83727550|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
83727551|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
83727552|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727553|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727554|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83727555|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83727556|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83727557|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83727558|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
83727559|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727560|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727561|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83727562|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83727563|NCT02864368|Temozolomide|temozolomide|mesh-list
83727564|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83727565|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
83727566|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727567|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727568|NCT02856698|Midazolam|midazolam|mesh-list
83727569|NCT02856698|Morphine|morphine|mesh-list
83727570|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83727571|NCT02856698|Narcotics|narcotics|mesh-ancestor
83727572|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727573|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727574|NCT02856698|Analgesics|analgesics|mesh-ancestor
83727575|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
83727576|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727577|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83727578|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82882519|NCT05839756|Autonomic Agents|autonomic agents|mesh-ancestor
83727579|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83727580|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83727581|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83727582|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83727583|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
83727584|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
83727585|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
83727586|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
83727587|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727588|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727589|NCT02793375|Montelukast|montelukast|mesh-list
83727590|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83727591|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
83727592|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83727593|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
83727594|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727595|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727596|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83727597|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83727598|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727599|NCT02625610|Leucovorin|leucovorin|mesh-list
83727600|NCT02625610|Fluorouracil|fluorouracil|mesh-list
83727601|NCT02625610|Capecitabine|capecitabine|mesh-list
83727602|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
83727603|NCT02625610|Avelumab|avelumab|mesh-list
83727604|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
83727605|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
83727606|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727607|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83727608|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727609|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83727610|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
83727611|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727612|NCT02625610|Antidotes|antidotes|mesh-ancestor
83727613|NCT02625610|Protective Agents|protective agents|mesh-ancestor
83727614|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
83727615|NCT02625610|Vitamins|vitamins|mesh-ancestor
83727616|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
83727617|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727618|NCT02515591|Dimercaprol|dimercaprol|mesh-list
83727619|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
83727620|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
83727621|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727622|NCT02514447|Topotecan|topotecan|mesh-list
83727623|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83727624|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83727625|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727626|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727627|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727628|NCT02257346|Lidocaine|lidocaine|mesh-list
83727629|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
83727630|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
83727631|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727632|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727633|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
83727634|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727635|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83727636|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83727637|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83727638|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83727639|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727640|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
83727641|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
83727642|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
83727643|NCT01618357|Veliparib|veliparib|mesh-list
83727644|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83727645|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727646|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727647|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727648|NCT00712322|Darifenacin|darifenacin|mesh-list
83727649|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83727650|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83727651|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
83727652|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727653|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727654|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727655|NCT00712322|Urological Agents|urological agents|mesh-ancestor
83727656|NCT00323856|Factor VIII|factor viii|mesh-list
83727657|NCT00323856|Coagulants|coagulants|mesh-ancestor
83727658|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83727659|NCT05415150|Eptifibatide|eptifibatide|mesh-list
83727660|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83727661|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83727662|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727663|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
83727664|NCT05414942|Narcotics|narcotics|mesh-ancestor
83727665|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727666|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727667|NCT05414942|Analgesics|analgesics|mesh-ancestor
83727668|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
83727669|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727670|NCT05414721|Anesthetics|anesthetics|mesh-list
83727671|NCT05414721|Desflurane|desflurane|mesh-list
83727672|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727673|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727674|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83727675|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
83727676|NCT05414669|Allopurinol|allopurinol|mesh-list
83727677|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
83727678|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727679|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727680|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
83727681|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727682|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83727683|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
83727684|NCT05414669|Protective Agents|protective agents|mesh-ancestor
83727685|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727686|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
83727687|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
83727688|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727689|NCT05414474|Protective Agents|protective agents|mesh-ancestor
83727690|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727691|NCT05414474|Vitamins|vitamins|mesh-ancestor
83727692|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
83727693|NCT05414292|Sirolimus|sirolimus|mesh-list
83727694|NCT05414292|Temsirolimus|temsirolimus|mesh-list
83727695|NCT05414292|MTOR Inhibitors|mtor inhibitors|mesh-list
83727696|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83727697|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727698|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83727699|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727700|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
83727701|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83727702|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
83727703|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727704|NCT05414292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83727705|NCT05414292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727706|NCT05414292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727707|NCT05414149|Ranibizumab|ranibizumab|mesh-list
83727708|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83727709|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83727710|NCT05414149|Growth Substances|growth substances|mesh-ancestor
83727711|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727712|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
83727713|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727714|NCT05413902|Acetaminophen|acetaminophen|mesh-list
83727715|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
83727716|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83727717|NCT05413902|Lidocaine|lidocaine|mesh-list
83727718|NCT05413902|Epinephrine|epinephrine|mesh-list
83727719|NCT05413902|Morphine|morphine|mesh-list
83727720|NCT05413902|Narcotics|narcotics|mesh-list
83727721|NCT05413902|Gabapentin|gabapentin|mesh-list
83727722|NCT05413902|Orphenadrine|orphenadrine|mesh-list
83727723|NCT05413902|Bupivacaine|bupivacaine|mesh-list
83727724|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
83727725|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
83727726|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727727|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882669|NCT05806931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727728|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
83727729|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727730|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83727731|NCT05413902|Analgesics|analgesics|mesh-ancestor
83727732|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83727733|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
83727734|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727735|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
83727736|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
83727737|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727738|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
83727739|NCT05413902|Hormones|hormones|mesh-ancestor
83727740|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727741|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83727742|NCT05413902|Protective Agents|protective agents|mesh-ancestor
83727743|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83727744|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83727745|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83727746|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727747|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727748|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83727749|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83727750|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83727751|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
83727752|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
83727753|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
83727754|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83727755|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
83727756|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83727757|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83727758|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83727759|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83727760|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83727761|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
83727762|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83727763|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83727764|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83727765|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83727766|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83727767|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727768|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83727769|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727770|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83727771|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83727772|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83727773|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83727774|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
83727775|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83727776|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83727777|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
83727778|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83727779|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83727780|NCT05413746|Antioxidants|antioxidants|mesh-list
83727781|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727782|NCT05413746|Protective Agents|protective agents|mesh-ancestor
83727783|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727784|NCT05409365|Antibodies|antibodies|mesh-list
83727785|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
83727786|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83727787|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
83727788|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727789|NCT05397587|Vaccines|vaccines|mesh-list
83727790|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
83727791|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727792|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83727793|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727794|NCT05356936|Vitamin D|vitamin d|mesh-list
83727795|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
83727796|NCT05356936|Vitamins|vitamins|mesh-list
83727797|NCT05356936|Vitamin K|vitamin k|mesh-list
83727798|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
82882745|NCT05804032|Bortezomib|bortezomib|mesh-list
82882746|NCT05804032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82882747|NCT05804032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882748|NCT05804032|Antiemetics|antiemetics|mesh-ancestor
82882749|NCT05804032|Autonomic Agents|autonomic agents|mesh-ancestor
82882750|NCT05804032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882751|NCT05804032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882752|NCT05804032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727799|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
83727800|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727801|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83727802|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83727803|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83727804|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83727805|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727806|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
83727807|NCT05356936|Coagulants|coagulants|mesh-ancestor
83727808|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
83727809|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
83727810|NCT05352178|Androgens|androgens|mesh-list
83727811|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83727812|NCT05352178|Hormones|hormones|mesh-ancestor
83727813|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727814|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727815|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
83727816|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727817|NCT05352178|Protective Agents|protective agents|mesh-ancestor
83727818|NCT05352178|Vitamins|vitamins|mesh-ancestor
83727819|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
83727820|NCT05352178|Estrogens|estrogens|mesh-ancestor
83727821|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83727822|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727823|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
83727824|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
83727825|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
83727826|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727827|NCT05328141|Protective Agents|protective agents|mesh-ancestor
83727828|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727829|NCT05328141|Vitamins|vitamins|mesh-ancestor
83727830|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
83727831|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
83727832|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83727833|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83727834|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727835|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727836|NCT05251493|Iron|iron|mesh-list
83727837|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83727838|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83727839|NCT05251493|Trace Elements|trace elements|mesh-ancestor
83727840|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
83727841|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727842|NCT05251493|Hematinics|hematinics|mesh-ancestor
83727843|NCT05233709|Fesoterodine|fesoterodine|mesh-list
83727844|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83727845|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83727846|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
83727847|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83727848|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727849|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727850|NCT05233709|Urological Agents|urological agents|mesh-ancestor
83727851|NCT05173896|Tadalafil|tadalafil|mesh-list
83727852|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
83727853|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83727854|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83727855|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727856|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727857|NCT05173896|Urological Agents|urological agents|mesh-ancestor
83727858|NCT05150236|Nivolumab|nivolumab|mesh-list
83727859|NCT05150236|Ipilimumab|ipilimumab|mesh-list
83727860|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
83727861|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727862|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727863|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83727864|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727865|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83727866|NCT05111821|Deferiprone|deferiprone|mesh-list
83727867|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83727868|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
83727869|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
83727870|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727871|NCT05105282|Anesthetics|anesthetics|mesh-list
83727872|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
83727873|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727874|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727875|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
83727876|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727878|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727879|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727880|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83727881|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83727882|NCT05005455|Growth Substances|growth substances|mesh-ancestor
83727883|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727884|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
83727885|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
83727886|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83727887|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727888|NCT04641234|Aflibercept|aflibercept|mesh-list
83727889|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83727890|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83727891|NCT04641234|Growth Substances|growth substances|mesh-ancestor
83727892|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727893|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
83727894|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727895|NCT04636034|Anesthetics|anesthetics|mesh-list
83727896|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
83727897|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727898|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727899|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
83727900|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727901|NCT04524663|Camostat|camostat|mesh-list
83727902|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83727903|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727904|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727905|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83727906|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83727907|NCT04435795|Ciclesonide|ciclesonide|mesh-list
83727908|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
83727909|NCT04435795|Hormones|hormones|mesh-ancestor
83727910|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83727911|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727912|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83727913|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
83727914|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83727915|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727916|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83727917|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727918|NCT04222283|Emtricitabine|emtricitabine|mesh-list
83727919|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
83727920|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727921|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83727922|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83727923|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727924|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727925|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83727926|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83727927|NCT04131504|Adalimumab|adalimumab|mesh-list
83727928|NCT04131504|Infliximab|infliximab|mesh-list
83727929|NCT04131504|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83727930|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727931|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83727932|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
83727933|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727934|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
83727935|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83727936|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83727937|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83727938|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83727939|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727940|NCT03962998|Lactulose|lactulose|mesh-list
83727941|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727942|NCT03926143|Maytansine|maytansine|mesh-list
83727943|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
83727944|NCT03926143|Anetumab ravtansine|anetumab ravtansine|mesh-list
82882896|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82882897|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82882898|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
82882899|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882900|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882907|NCT05722561|Nicotine|nicotine|mesh-list
82882917|NCT05704673|Morphine|morphine|mesh-list
83727945|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83727946|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727947|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
83727948|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83727949|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727950|NCT03926143|Immunoconjugates|immunoconjugates|mesh-ancestor
83727951|NCT03926143|Immunologic Factors|immunologic factors|mesh-ancestor
83727952|NCT03926143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727953|NCT03859635|Bupivacaine|bupivacaine|mesh-list
83727954|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
83727955|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
83727956|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83727957|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727958|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
83727959|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727960|NCT03783013|Lycopene|lycopene|mesh-list
83727961|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727962|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
83727963|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727964|NCT03783013|Protective Agents|protective agents|mesh-ancestor
83727965|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727966|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83727967|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83727968|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83727969|NCT03762473|Tacrolimus|tacrolimus|mesh-list
83727970|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83727971|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
83727972|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727973|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83727974|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83727975|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83727976|NCT03726229|Cholic Acids|cholic acids|mesh-list
83727977|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727978|NCT03712228|Antibodies|antibodies|mesh-list
83727979|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83727980|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
83727981|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727982|NCT03626922|Folic Acid|folic acid|mesh-list
83727983|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
83727984|NCT03626922|Hydroxocobalamin|hydroxocobalamin|mesh-list
83727985|NCT03626922|Dexamethasone|dexamethasone|mesh-list
83727986|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
83727987|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
83727988|NCT03626922|Pemetrexed|pemetrexed|mesh-list
83727989|NCT03626922|Vitamins|vitamins|mesh-ancestor
83727990|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
83727991|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83727992|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83727993|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
83727994|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
83727995|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83727996|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83727997|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
83727998|NCT03626922|Hormones|hormones|mesh-ancestor
83727999|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728000|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83728001|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728002|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83728003|NCT03626922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83728004|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728005|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728006|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83728007|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83728008|NCT03626922|Hematinics|hematinics|mesh-ancestor
83728009|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
83728010|NCT03600818|Prednisone|prednisone|mesh-list
83728011|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728012|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
83728013|NCT03600818|Hormones|hormones|mesh-ancestor
83728014|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728015|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728016|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82882972|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728017|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728018|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
83728019|NCT03578276|Prednisolone|prednisolone|mesh-list
83728020|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83728022|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83728023|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
83728024|NCT03578276|Bromfenac|bromfenac|mesh-list
83728025|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83728026|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
83728027|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728028|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
83728029|NCT03578276|Hormones|hormones|mesh-ancestor
83728030|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728031|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728032|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83728033|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728034|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
83728035|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
83728036|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728037|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728038|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83728039|NCT03578276|Protective Agents|protective agents|mesh-ancestor
83728040|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83728041|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83728042|NCT03578276|Analgesics|analgesics|mesh-ancestor
83728043|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
83728044|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728045|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728046|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728047|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83728048|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83728049|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83728050|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83728051|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728052|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728053|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83728054|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83728055|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83728056|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83728057|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728058|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728059|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728060|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83728061|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
83728062|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83728063|NCT03491267|Tretinoin|tretinoin|mesh-list
83728064|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728065|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
83728066|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83728067|NCT03174184|Amoxicillin|amoxicillin|mesh-list
83728068|NCT03174184|Rifampin|rifampin|mesh-list
83728069|NCT03174184|Meropenem|meropenem|mesh-list
83728070|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
83728071|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
83728072|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83728073|NCT03174184|Rifamycins|rifamycins|mesh-list
83728074|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728075|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728076|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83728077|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
83728078|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
83728079|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83728080|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728081|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728082|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83728083|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83728084|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83728085|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83728086|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83728087|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83728088|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83728089|NCT03052933|Gemcitabine|gemcitabine|mesh-list
83728090|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83728091|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
82883045|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
82883047|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
83728092|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728093|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728094|NCT02959697|Lidocaine|lidocaine|mesh-list
83728095|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
83728096|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
83728097|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728098|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728099|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
83728100|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728101|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83728102|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83728103|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83728104|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83728105|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728106|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
83728107|NCT02900560|Azacitidine|azacitidine|mesh-list
83728108|NCT02900560|Cc-486|cc-486|mesh-list
83728109|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83728110|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728111|NCT02900560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83728112|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728113|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83728114|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
83728115|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728116|NCT02877550|Venetoclax|venetoclax|mesh-list
83728117|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
83728118|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728119|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83728120|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
83728121|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728122|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83728123|NCT02775812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83728124|NCT02775812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728125|NCT02679170|Crizotinib|crizotinib|mesh-list
83728126|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728127|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83728128|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728129|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728130|NCT02518009|Estrogens|estrogens|mesh-list
83728131|NCT02518009|Androgens|androgens|mesh-list
83728132|NCT02518009|Hormones|hormones|mesh-ancestor
83728133|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728134|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728135|NCT02238496|Sirolimus|sirolimus|mesh-list
83728136|NCT02238496|Temsirolimus|temsirolimus|mesh-list
83728137|NCT02238496|MTOR Inhibitors|mtor inhibitors|mesh-list
83728138|NCT02238496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83728139|NCT02238496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728140|NCT02238496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728141|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728142|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
83728143|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728144|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728145|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728146|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728147|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83728148|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
83728149|NCT02220426|Xenon|xenon|mesh-list
83728150|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83728151|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
83728152|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
83728153|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728154|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728155|NCT02034110|Trametinib|trametinib|mesh-list
83728156|NCT02034110|Dabrafenib|dabrafenib|mesh-list
83728157|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728158|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83728159|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728160|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728161|NCT01968213|Rucaparib|rucaparib|mesh-list
83728162|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83728163|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728164|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883120|NCT05613205|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
83728165|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728167|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
83728168|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728169|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83728170|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728171|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728172|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
83728173|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728174|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83728175|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728176|NCT01498458|Capecitabine|capecitabine|mesh-list
83728177|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83728178|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
83728179|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728180|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728181|NCT01427712|Pancrelipase|pancrelipase|mesh-list
83728182|NCT01427712|Pancreatin|pancreatin|mesh-list
83728183|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728184|NCT01369147|Clevidipine|clevidipine|mesh-list
83728185|NCT01369147|Propofol|propofol|mesh-list
83728186|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83728187|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728188|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728189|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83728190|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
83728191|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
83728192|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83728193|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83728194|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728195|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83728196|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
83728197|NCT01197066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83728198|NCT01197066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728199|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728200|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
83728201|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728202|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728203|NCT01945840|Hormones|hormones|mesh-list
83728204|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728205|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728206|NCT01945879|Heparin|heparin|mesh-list
83728207|NCT01945879|Enoxaparin|enoxaparin|mesh-list
83728208|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83728209|NCT01945879|Tinzaparin|tinzaparin|mesh-list
83728210|NCT01945879|Dalteparin|dalteparin|mesh-list
83728211|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
83728212|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83728213|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83728214|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728215|NCT01945892|Dexamethasone|dexamethasone|mesh-list
83728216|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728217|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
83728218|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
83728219|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728220|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728221|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728222|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
83728223|NCT01945892|Hormones|hormones|mesh-ancestor
83728224|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728225|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83728226|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728227|NCT01945957|Oxytocin|oxytocin|mesh-list
83728228|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
83728229|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83728230|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728231|NCT01945983|Norepinephrine|norepinephrine|mesh-list
83728232|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83728233|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83728234|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
83728235|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728236|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728237|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728238|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
83728239|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
83728240|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728241|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83728242|NCT01946009|Cidofovir|cidofovir|mesh-list
83728243|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
83728244|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728245|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728246|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728247|NCT01946035|Doxazosin|doxazosin|mesh-list
83728248|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83728249|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83728250|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83728251|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83728252|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
83728253|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728254|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728255|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728256|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
83728257|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728258|NCT01946256|Amoxicillin|amoxicillin|mesh-list
83728259|NCT01946256|Erythromycin|erythromycin|mesh-list
83728260|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
83728261|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83728262|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
83728263|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728264|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728265|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728266|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83728267|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728268|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728269|NCT01946295|Famotidine|famotidine|mesh-list
83728270|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83728271|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728272|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83728273|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
83728274|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
83728275|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728276|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728277|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728278|NCT01946386|Betamethasone|betamethasone|mesh-list
83728279|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
83728280|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83728281|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
83728282|NCT01946386|Clobetasol|clobetasol|mesh-list
83728283|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83728284|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728285|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
83728286|NCT01946386|Hormones|hormones|mesh-ancestor
83728287|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728288|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728289|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83728290|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
83728291|NCT01946399|Dexamethasone|dexamethasone|mesh-list
83728292|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728293|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
83728294|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
83728295|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728296|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728297|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728298|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
83728299|NCT01946399|Hormones|hormones|mesh-ancestor
83728300|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728301|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83728302|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728303|NCT01946555|Fentanyl|fentanyl|mesh-list
83728304|NCT01946555|Morphine|morphine|mesh-list
83728305|NCT01946555|Oxycodone|oxycodone|mesh-list
83728306|NCT01946555|Buprenorphine|buprenorphine|mesh-list
83728307|NCT01946555|Methadone|methadone|mesh-list
83728308|NCT01946555|Hydromorphone|hydromorphone|mesh-list
83728309|NCT01946555|Tapentadol|tapentadol|mesh-list
83728310|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83728311|NCT01946555|Narcotics|narcotics|mesh-ancestor
83728312|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728313|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728314|NCT01946555|Analgesics|analgesics|mesh-ancestor
83728315|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
83728316|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728317|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83728318|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83728319|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
83728320|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
83728321|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83728322|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
83728323|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
83728324|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83728325|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83728326|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83728327|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728328|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
83728329|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728330|NCT01946568|Dalbavancin|dalbavancin|mesh-list
83728331|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728332|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728333|NCT01946594|Acetaminophen|acetaminophen|mesh-list
83728334|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83728335|NCT01946594|Analgesics|analgesics|mesh-ancestor
83728336|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
83728337|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728338|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728339|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
83728341|NCT01946607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83728342|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83728343|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83728344|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728345|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728346|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
83728347|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728348|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83728349|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
83728350|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83728351|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
83728352|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83728353|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
83728354|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728355|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728356|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83728357|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
83728358|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83728359|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83728360|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83728361|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
83728362|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728363|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728364|NCT01946906|Rifaximin|rifaximin|mesh-list
83728365|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728366|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728367|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728368|NCT01946971|Lansoprazole|lansoprazole|mesh-list
83728369|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
83728370|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83728371|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728372|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83728373|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728374|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728375|NCT01946984|Diclofenac|diclofenac|mesh-list
83728376|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83728377|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83728378|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83728379|NCT01946984|Analgesics|analgesics|mesh-ancestor
83728380|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
82883340|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82883341|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
82883342|NCT05358938|Nivolumab|nivolumab|mesh-list
82883343|NCT05358938|Ipilimumab|ipilimumab|mesh-list
82883344|NCT05358938|Avelumab|avelumab|mesh-list
82883345|NCT05358938|Cemiplimab|cemiplimab|mesh-list
82883346|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82883347|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883348|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883349|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728381|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728382|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728383|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728384|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728385|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83728386|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728387|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728388|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83728389|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
83728390|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728391|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
83728392|NCT01947062|Cisplatin|cisplatin|mesh-list
83728393|NCT01947062|Etoposide|etoposide|mesh-list
83728394|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
83728395|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728396|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
83728397|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728398|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728399|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83728400|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
83728401|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728402|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728403|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83728404|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83728405|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83728406|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83728407|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728408|NCT01947114|Ketamine|ketamine|mesh-list
83728409|NCT01947114|Remifentanil|remifentanil|mesh-list
83728410|NCT01947114|Propofol|propofol|mesh-list
83728411|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83728412|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728413|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728414|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83728415|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
83728416|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
83728417|NCT01947114|Analgesics|analgesics|mesh-ancestor
83728418|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
83728419|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728420|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83728421|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83728422|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83728423|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728424|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728425|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83728426|NCT01947114|Narcotics|narcotics|mesh-ancestor
83728427|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
83728428|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83728429|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728430|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
83728431|NCT01947205|Acetaminophen|acetaminophen|mesh-list
83728432|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83728433|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83728434|NCT01947205|Analgesics|analgesics|mesh-ancestor
83728435|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
83728436|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728437|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728438|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
83728439|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83728440|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728441|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728442|NCT01947309|Lenalidomide|lenalidomide|mesh-list
83728443|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
83728444|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728445|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83728446|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83728447|NCT01947309|Growth Substances|growth substances|mesh-ancestor
83728448|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
83728449|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728450|NCT01947465|Vaccines|vaccines|mesh-list
83728451|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
83728452|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883415|NCT05283083|Analgesics|analgesics|mesh-ancestor
83728453|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
83728454|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83728455|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728456|NCT01947608|Ceritinib|ceritinib|mesh-list
83728457|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728458|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83728459|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728460|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728461|NCT01947660|Anesthetics|anesthetics|mesh-list
83728462|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728463|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728464|NCT01947699|Glyburide|glyburide|mesh-list
83728465|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83728466|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728467|NCT01947777|Rifampin|rifampin|mesh-list
83728468|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83728469|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
83728470|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728471|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728472|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
83728473|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83728474|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728475|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728476|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83728477|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83728478|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83728479|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83728480|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83728481|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83728482|NCT01947790|Metformin|metformin|mesh-list
83728483|NCT01947790|Pioglitazone|pioglitazone|mesh-list
83728484|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83728485|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728486|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83728487|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83728488|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83728489|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728490|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728491|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83728492|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83728493|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83728494|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
83728495|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728496|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728497|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83728498|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83728499|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
83728500|NCT01947920|Tramadol|tramadol|mesh-list
83728501|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83728502|NCT01947920|Narcotics|narcotics|mesh-ancestor
83728503|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728504|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728505|NCT01947920|Analgesics|analgesics|mesh-ancestor
83728506|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
83728507|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728508|NCT01947933|Mirikizumab|mirikizumab|mesh-list
83728509|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83728510|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83728511|NCT01947933|Analgesics|analgesics|mesh-ancestor
83728512|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
83728513|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728514|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728515|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728516|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728517|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82883488|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82883489|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883490|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82883491|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883492|NCT05229991|Ritonavir|ritonavir|mesh-list
82883493|NCT05229991|Lonafarnib|lonafarnib|mesh-list
82883494|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82883495|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82883496|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
82883497|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883498|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728518|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728519|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
83728520|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83728521|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
83728522|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83728523|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
83728524|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728525|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728526|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
83728527|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
83728528|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83728529|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
83728530|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83728531|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
83728532|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728533|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728534|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
83728535|NCT01947998|Warfarin|warfarin|mesh-list
83728536|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
83728537|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83728538|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
83728539|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83728540|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
83728541|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83728542|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83728543|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728544|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728545|NCT01948011|Racecadotril|racecadotril|mesh-list
83728546|NCT01948011|Thiorphan|thiorphan|mesh-list
83728547|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
83728548|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83728549|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
83728550|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728551|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728552|NCT01948024|Asenapine|asenapine|mesh-list
83728553|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83728554|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83728555|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728556|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728557|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83728558|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
83728559|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83728560|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
83728561|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
83728562|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728563|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728564|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83728565|NCT01948115|Analgesics|analgesics|mesh-ancestor
83728566|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
83728567|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728568|NCT01948128|Vitamin D|vitamin d|mesh-list
83728569|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
83728570|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
83728571|NCT01948128|Vitamins|vitamins|mesh-list
83728572|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
83728573|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728574|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83728575|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83728576|NCT01948232|Perindopril|perindopril|mesh-list
83728577|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83728578|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
83728579|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728580|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728581|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83728582|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
83728583|NCT01948336|Ketamine|ketamine|mesh-list
83728584|NCT01948336|Propofol|propofol|mesh-list
83728585|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83728586|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728587|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728588|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83728589|NCT01948336|Analgesics|analgesics|mesh-ancestor
83728590|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
82883564|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83728591|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728592|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83728593|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83728595|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
83728596|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728597|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728598|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83728599|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
83728600|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
83728601|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83728602|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83728603|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83728604|NCT01948362|Sulforaphane|sulforaphane|mesh-list
83728605|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83728606|NCT01948362|Protective Agents|protective agents|mesh-ancestor
83728607|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728608|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728609|NCT01948401|Prednisolone|prednisolone|mesh-list
83728610|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728611|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
83728612|NCT01948401|Hormones|hormones|mesh-ancestor
83728613|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728614|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728615|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83728616|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728617|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
83728618|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83728619|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
83728620|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728621|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
83728622|NCT01948583|Protective Agents|protective agents|mesh-ancestor
83728623|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83728624|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83728625|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83728626|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
83728627|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728628|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83728629|NCT01948765|Propofol|propofol|mesh-list
83728630|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83728631|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728632|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728633|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83728634|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
83728635|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
83728636|NCT01948804|Letrozole|letrozole|mesh-list
83728637|NCT01948804|Clomiphene|clomiphene|mesh-list
83728638|NCT01948804|Cetrorelix|cetrorelix|mesh-list
83728639|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83728640|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728641|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83728642|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83728643|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728644|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728645|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83728646|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
83728647|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728648|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728649|NCT01948804|Hormones|hormones|mesh-ancestor
83728650|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83728651|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
83728652|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83728653|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83728654|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83728655|NCT01948817|Deferasirox|deferasirox|mesh-list
83728656|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83728657|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
83728658|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
82883637|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883638|NCT05139316|Prednisolone|prednisolone|mesh-list
82883639|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883640|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
82883641|NCT05139316|Hormones|hormones|mesh-ancestor
82883642|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883643|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883644|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82883645|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728659|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728660|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83728661|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83728662|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83728663|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83728664|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728665|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728666|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728667|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
83728668|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83728669|NCT01948921|Meperidine|meperidine|mesh-list
83728670|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83728671|NCT01948921|Narcotics|narcotics|mesh-ancestor
83728672|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728673|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728674|NCT01948921|Analgesics|analgesics|mesh-ancestor
83728675|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
83728676|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728677|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83728678|NCT01948960|Everolimus|everolimus|mesh-list
83728679|NCT01948960|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83728680|NCT01948960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83728681|NCT01948960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728682|NCT01948960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728683|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728684|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
83728685|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728686|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728687|NCT01948999|Anesthetics|anesthetics|mesh-list
83728688|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728689|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728690|NCT01949038|Alprazolam|alprazolam|mesh-list
83728691|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83728692|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728693|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728694|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83728695|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83728696|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83728697|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
83728698|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
83728699|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728700|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728701|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
83728702|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728703|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
83728704|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
83728705|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
83728706|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
83728707|NCT01949129|Busulfan|busulfan|mesh-list
83728708|NCT01949129|Thiotepa|thiotepa|mesh-list
83728709|NCT01949129|Treosulfan|treosulfan|mesh-list
83728710|NCT01949129|Fludarabine|fludarabine|mesh-list
83728711|NCT01949129|Etoposide|etoposide|mesh-list
83728712|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
83728713|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83728714|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
83728715|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728716|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
83728717|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728718|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728719|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83728720|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
83728721|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728722|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728723|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83728724|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83728725|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83728726|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83728727|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728728|NCT01949168|Ribavirin|ribavirin|mesh-list
83728729|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83728730|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
83728731|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728732|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
83728733|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728734|NCT01949233|Doxycycline|doxycycline|mesh-list
83728735|NCT01949233|Irbesartan|irbesartan|mesh-list
83728736|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728737|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728738|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
83728739|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83728740|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83728741|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83728742|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83728743|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83728744|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728745|NCT01949363|Cefixime|cefixime|mesh-list
83728746|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728747|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728748|NCT01949454|Fluorometholone|fluorometholone|mesh-list
83728749|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83728750|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
83728751|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83728752|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728753|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
83728754|NCT01949454|Hormones|hormones|mesh-ancestor
83728755|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728756|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728757|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83728758|NCT01949519|Lycopene|lycopene|mesh-list
83728759|NCT01949519|Docetaxel|docetaxel|mesh-list
83728760|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728761|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
83728762|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
83728763|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
83728764|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728765|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728766|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
83728767|NCT01949519|Protective Agents|protective agents|mesh-ancestor
83728768|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728769|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83728770|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83728771|NCT01949571|Mirtazapine|mirtazapine|mesh-list
83728772|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83728773|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83728774|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83728775|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
83728776|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
83728777|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728778|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728779|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728780|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83728781|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83728782|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728783|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83728784|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83728785|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83728786|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
83728787|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83728788|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83728789|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
83728790|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83728791|NCT01949675|Vaccines|vaccines|mesh-list
83728792|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
83728793|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728794|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83728795|NCT01949766|Glycerol|glycerol|mesh-list
83728796|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83728797|NCT01949766|Protective Agents|protective agents|mesh-ancestor
83728798|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728799|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728800|NCT01948245|Taurolidine|taurolidine|mesh-list
83728801|NCT01948245|Heparin|heparin|mesh-list
83728802|NCT01948245|Calcium heparin|calcium heparin|mesh-list
83728803|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
83728804|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728805|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83728806|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83728807|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883787|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
83728808|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83728809|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728810|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
83728811|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83728812|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
83728813|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728814|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
83728815|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728816|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728817|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83728818|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
83728819|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728821|NCT01949818|Prednisolone|prednisolone|mesh-list
83728822|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
83728823|NCT01949818|Doxorubicin|doxorubicin|mesh-list
83728824|NCT01949818|Vincristine|vincristine|mesh-list
83728825|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728826|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
83728827|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728828|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83728829|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83728830|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
83728831|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728832|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728833|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83728834|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83728835|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83728836|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83728837|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728838|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728839|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
83728840|NCT01949818|Hormones|hormones|mesh-ancestor
83728841|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728842|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83728843|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83728844|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
83728845|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
83728846|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
83728847|NCT01949857|Vaccines|vaccines|mesh-list
83728848|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
83728849|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728850|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
83728851|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83728852|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
83728853|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728854|NCT01949935|Mupirocin|mupirocin|mesh-list
83728855|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83728856|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728857|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83728858|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728859|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728860|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83728861|NCT01949948|Tenecteplase|tenecteplase|mesh-list
83728862|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83728863|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83728864|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728865|NCT01950000|Fentanyl|fentanyl|mesh-list
83728866|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83728867|NCT01950000|Narcotics|narcotics|mesh-ancestor
83728868|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83728869|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728870|NCT01950000|Analgesics|analgesics|mesh-ancestor
83728871|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
83728872|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728873|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83728874|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83728875|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
83728876|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
83728877|NCT01950182|Tamoxifen|tamoxifen|mesh-list
83728878|NCT01950182|Gemcitabine|gemcitabine|mesh-list
83728879|NCT01950182|Capecitabine|capecitabine|mesh-list
83728880|NCT01950182|Trastuzumab|trastuzumab|mesh-list
83728881|NCT01950182|Vinorelbine|vinorelbine|mesh-list
82883861|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
82883862|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728882|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83728883|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83728884|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
83728885|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728886|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728887|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83728888|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83728889|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
83728890|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
83728891|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
83728892|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83728893|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
83728894|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728895|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728896|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83728897|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83728898|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83728899|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83728900|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83728901|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728902|NCT01950195|Ipilimumab|ipilimumab|mesh-list
83728903|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83728904|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728905|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83728906|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728907|NCT01950416|Clopidogrel|clopidogrel|mesh-list
83728908|NCT01950416|Ticagrelor|ticagrelor|mesh-list
83728909|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83728910|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83728911|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83728912|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83728913|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
83728914|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83728915|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728916|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728917|NCT01950481|Ceritinib|ceritinib|mesh-list
83728918|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728919|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83728920|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728921|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728922|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
83728923|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83728924|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728925|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
83728926|NCT01950507|Fluconazole|fluconazole|mesh-list
83728927|NCT01950507|Voriconazole|voriconazole|mesh-list
83728928|NCT01950507|Micafungin|micafungin|mesh-list
83728929|NCT01950507|Budesonide|budesonide|mesh-list
83728930|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728931|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83728932|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
83728933|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83728934|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728935|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83728936|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
83728937|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
83728938|NCT01950507|Hormones|hormones|mesh-ancestor
83728939|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728940|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
83728941|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728942|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83728943|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83728944|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728945|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728946|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83728947|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83728948|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83728949|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83728950|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83728951|NCT01950546|Fluorides|fluorides|mesh-list
83728952|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
83728953|NCT01950546|Protective Agents|protective agents|mesh-ancestor
83728954|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728955|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
82883935|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728956|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728957|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
83728958|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728959|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728960|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83728961|NCT01950611|Bortezomib|bortezomib|mesh-list
83728962|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83728963|NCT01950689|Nimorazole|nimorazole|mesh-list
83728964|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83728965|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83728966|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83728967|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83728968|NCT01950793|Triamcinolone|triamcinolone|mesh-list
83728969|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83728970|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83728971|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
83728972|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83728973|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83728974|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
83728975|NCT01950793|Hormones|hormones|mesh-ancestor
83728976|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83728977|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83728978|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83728979|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
83728980|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728981|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728982|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83728983|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
83728984|NCT01950793|Protective Agents|protective agents|mesh-ancestor
83728985|NCT01950884|Ezetimibe|ezetimibe|mesh-list
83728986|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83728987|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83728988|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
83728989|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728990|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83728991|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
83728992|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83728993|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
83728994|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83728995|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83728996|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83728997|NCT01950923|Urological Agents|urological agents|mesh-ancestor
83728998|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83728999|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
83729000|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
83729001|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83729002|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83729003|NCT01951027|Lenograstim|lenograstim|mesh-list
83729004|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83729005|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
83729006|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729007|NCT01951053|Citalopram|citalopram|mesh-list
83729008|NCT01951053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83729009|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83729010|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729011|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729012|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729013|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
83729014|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729015|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83729016|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
83729017|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83729018|NCT01951079|Digoxin|digoxin|mesh-list
83729019|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83729020|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83729021|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729022|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729023|NCT01951079|Protective Agents|protective agents|mesh-ancestor
83729024|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729025|NCT01951144|Lorazepam|lorazepam|mesh-list
83729026|NCT01951144|PF-06372865|pf-06372865|mesh-list
82884009|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729027|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
82884010|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884071|NCT04885530|Xhance|xhance|mesh-list
83729028|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
83729029|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
83729030|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729031|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729032|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729033|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83729034|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729035|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83729036|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83729037|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83729038|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
83729039|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
83729040|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729041|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729042|NCT01951209|Rifaximin|rifaximin|mesh-list
83729043|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83729044|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729045|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729046|NCT01951404|Allopurinol|allopurinol|mesh-list
83729047|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
83729048|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729049|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729050|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
83729051|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729052|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83729053|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
83729054|NCT01951404|Protective Agents|protective agents|mesh-ancestor
83729055|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729056|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83729057|NCT01951430|Cephalosporins|cephalosporins|mesh-list
83729058|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83729059|NCT01951430|Itraconazole|itraconazole|mesh-list
83729060|NCT01951430|Fluconazole|fluconazole|mesh-list
83729061|NCT01951430|Posaconazole|posaconazole|mesh-list
83729062|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
83729063|NCT01951430|Clotrimazole|clotrimazole|mesh-list
83729064|NCT01951430|Miconazole|miconazole|mesh-list
83729065|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729066|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83729067|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83729068|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729069|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729070|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83729071|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
83729072|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729073|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729074|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83729075|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83729076|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83729077|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83729078|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83729079|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83729080|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83729081|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83729082|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
83729083|NCT01951482|Bevacizumab|bevacizumab|mesh-list
83729084|NCT01951482|Cisplatin|cisplatin|mesh-list
83729085|NCT01951482|Pemetrexed|pemetrexed|mesh-list
83729086|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729087|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729088|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83729089|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83729090|NCT01951482|Growth Substances|growth substances|mesh-ancestor
83729091|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729092|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
83729093|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729094|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729095|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83729096|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83729097|NCT01951508|Methylphenidate|methylphenidate|mesh-list
83729098|NCT01951508|Modafinil|modafinil|mesh-list
83729099|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83729100|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729101|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83729102|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83729103|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729104|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729105|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
83729106|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729107|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83729108|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83729109|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83729110|NCT01951560|Valproic Acid|valproic acid|mesh-list
83729111|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
83729112|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729113|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729114|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
83729115|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729116|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729117|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
83729118|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83729119|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729120|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83729121|NCT01951599|Osimertinib|osimertinib|mesh-list
83729122|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729123|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83729124|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729125|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729126|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83729127|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
83729128|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729129|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83729130|NCT01951677|Antacids|antacids|mesh-ancestor
83729131|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729132|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729133|NCT01951729|Atropine|atropine|mesh-list
83729134|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83729135|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83729136|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83729137|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
83729138|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729139|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729140|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83729141|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
83729142|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
83729143|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
83729144|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83729145|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83729146|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
83729147|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729148|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729149|NCT01951846|Nintedanib|nintedanib|mesh-list
83729150|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729151|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83729152|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729153|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729154|NCT01951872|Caffeine|caffeine|mesh-list
83729155|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83729156|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729157|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83729158|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729159|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729160|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83729161|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83729162|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
83729163|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729164|NCT01951898|Montelukast|montelukast|mesh-list
83729165|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83729166|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83729167|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83729168|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
83729169|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729170|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729171|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83729172|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83729173|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729174|NCT01951911|Ketamine|ketamine|mesh-list
82884159|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
83729175|NCT01951911|Analgesics|analgesics|mesh-ancestor
83729176|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
83729177|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729178|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729179|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83729180|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83729181|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
83729182|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
83729183|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729184|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83729185|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83729186|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729187|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729188|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
83729189|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83729190|NCT01951924|Antibodies|antibodies|mesh-list
83729191|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
83729192|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
83729193|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729194|NCT01952314|Naftopidil|naftopidil|mesh-list
83729195|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83729196|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83729197|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
83729198|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729199|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729200|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729201|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83729202|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83729203|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729204|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83729205|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83729206|NCT01952561|Dapivirine|dapivirine|mesh-list
83729207|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83729208|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83729209|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
83729210|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729211|NCT01952626|Ondansetron|ondansetron|mesh-list
83729212|NCT01952626|Palonosetron|palonosetron|mesh-list
83729213|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
83729214|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
83729215|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729216|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729217|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729218|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
83729219|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
83729220|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83729221|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83729222|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
83729223|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729224|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729225|NCT01952652|Naproxen|naproxen|mesh-list
83729226|NCT01952652|Codeine|codeine|mesh-list
83729227|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83729228|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729229|NCT01952652|Analgesics|analgesics|mesh-ancestor
83729230|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
83729231|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729232|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729233|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729234|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729235|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
83729236|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83729237|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729238|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729239|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83729240|NCT01952652|Narcotics|narcotics|mesh-ancestor
83729241|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729242|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
83729243|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
83729244|NCT01952756|Cilostazol|cilostazol|mesh-list
83729245|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83729246|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
83729247|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729248|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729249|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83729250|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
83729251|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83729252|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83729253|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729254|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83729255|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
83729256|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83729257|NCT01952756|Protective Agents|protective agents|mesh-ancestor
83729258|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83729259|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83729260|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729261|NCT01952769|Pidilizumab|pidilizumab|mesh-list
83729262|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729263|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729264|NCT05876598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83729265|NCT05876598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729266|NCT05876585|Ondansetron|ondansetron|mesh-list
83729267|NCT05876585|Metoclopramide|metoclopramide|mesh-list
83729268|NCT05876585|Antiemetics|antiemetics|mesh-ancestor
83729269|NCT05876585|Autonomic Agents|autonomic agents|mesh-ancestor
83729270|NCT05876585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729271|NCT05876585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729272|NCT05876585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729273|NCT05876585|Antipruritics|antipruritics|mesh-ancestor
83729274|NCT05876585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83729275|NCT05876585|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83729276|NCT05876585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83729277|NCT05876585|Serotonin Agents|serotonin agents|mesh-ancestor
83729278|NCT05876585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729279|NCT05876585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729280|NCT05876585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83729281|NCT05876585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83729282|NCT05876585|Dopamine Agents|dopamine agents|mesh-ancestor
83729283|NCT05876572|Naloxone|naloxone|mesh-list
83729284|NCT05876572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83729285|NCT05876572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729286|NCT05876572|Sensory System Agents|sensory system agents|mesh-ancestor
83729287|NCT05876572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729288|NCT05876481|Psilocybin|psilocybin|mesh-list
83729289|NCT05876481|Hallucinogens|hallucinogens|mesh-ancestor
83729290|NCT05876481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729291|NCT05876481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83729292|NCT05876390|Acetaminophen|acetaminophen|mesh-list
83729293|NCT05876390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729294|NCT05876390|Analgesics|analgesics|mesh-ancestor
83729295|NCT05876390|Sensory System Agents|sensory system agents|mesh-ancestor
83729296|NCT05876390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729297|NCT05876390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729298|NCT05876390|Antipyretics|antipyretics|mesh-ancestor
83729299|NCT05876377|Vaccines|vaccines|mesh-list
83729300|NCT05876377|Immunologic Factors|immunologic factors|mesh-ancestor
83729301|NCT05876377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729302|NCT05876351|Eculizumab|eculizumab|mesh-list
83729303|NCT05876351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83729304|NCT05876351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83729305|NCT05876351|Immunologic Factors|immunologic factors|mesh-ancestor
83729306|NCT05876351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729307|NCT05876195|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83729308|NCT05876195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83729309|NCT05876195|Freund's Adjuvant|freund's adjuvant|mesh-list
83729310|NCT05876195|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83729311|NCT05876195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83729312|NCT05876195|Immunologic Factors|immunologic factors|mesh-ancestor
83729313|NCT05876195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729314|NCT05876195|Antacids|antacids|mesh-ancestor
83729315|NCT05876195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729316|NCT05876195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729317|NCT05876182|Vancomycin|vancomycin|mesh-list
83729318|NCT05876182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83729319|NCT05876182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729320|NCT05876169|Salicylic Acid|salicylic acid|mesh-list
83729321|NCT05876169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729322|NCT05876169|Antifungal Agents|antifungal agents|mesh-ancestor
83729323|NCT05876169|Keratolytic Agents|keratolytic agents|mesh-ancestor
82884308|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729324|NCT05876169|Dermatologic Agents|dermatologic agents|mesh-ancestor
83729325|NCT05876039|Remifentanil|remifentanil|mesh-list
83729326|NCT05876039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83729327|NCT05876039|Narcotics|narcotics|mesh-ancestor
83729328|NCT05876039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729329|NCT05876039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729330|NCT05876039|Analgesics|analgesics|mesh-ancestor
83729331|NCT05876039|Sensory System Agents|sensory system agents|mesh-ancestor
83729332|NCT05876039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729333|NCT05875948|Terlipressin|terlipressin|mesh-list
83729334|NCT05875948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83729335|NCT05875948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83729336|NCT05875714|Apremilast|apremilast|mesh-list
83729337|NCT05875714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83729338|NCT05875714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729339|NCT05875714|Analgesics|analgesics|mesh-ancestor
83729340|NCT05875714|Sensory System Agents|sensory system agents|mesh-ancestor
83729341|NCT05875714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729342|NCT05875714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729343|NCT05875714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729344|NCT05875714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729345|NCT05875714|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83729346|NCT05875714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83729347|NCT05875714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729348|NCT05875714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729349|NCT05875701|Vaccines|vaccines|mesh-list
83729350|NCT05875701|Immunologic Factors|immunologic factors|mesh-ancestor
83729351|NCT05875701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729352|NCT05875675|Pioglitazone|pioglitazone|mesh-list
83729353|NCT05875675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83729354|NCT05875675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729355|NCT05875610|Gabapentin|gabapentin|mesh-list
83729356|NCT05875610|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83729357|NCT05875610|Analgesics|analgesics|mesh-ancestor
83729358|NCT05875610|Sensory System Agents|sensory system agents|mesh-ancestor
83729359|NCT05875610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729360|NCT05875610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729361|NCT05875610|Anticonvulsants|anticonvulsants|mesh-ancestor
83729362|NCT05875610|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83729363|NCT05875610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83729364|NCT05875610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729365|NCT05875610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83729366|NCT05875610|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83729367|NCT05875610|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83729368|NCT05875610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729369|NCT05875610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729370|NCT05875610|Antimanic Agents|antimanic agents|mesh-ancestor
83729371|NCT05875610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83729372|NCT05875610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83729373|NCT05875610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729374|NCT05875610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83729375|NCT05875610|Antidepressive Agents|antidepressive agents|mesh-ancestor
83729376|NCT05875571|Ketorolac|ketorolac|mesh-list
83729377|NCT05875571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83729378|NCT05875571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729379|NCT05875571|Analgesics|analgesics|mesh-ancestor
83729380|NCT05875571|Sensory System Agents|sensory system agents|mesh-ancestor
83729381|NCT05875571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729382|NCT05875571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729383|NCT05875571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729384|NCT05875571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729385|NCT05875571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83729386|NCT05875571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729387|NCT05875571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729388|NCT05875519|Nordefrin|nordefrin|mesh-list
83729389|NCT05875519|Mepivacaine|mepivacaine|mesh-list
83729390|NCT05875519|Anesthetics|anesthetics|mesh-ancestor
83729391|NCT05875519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729392|NCT05875519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729393|NCT05875519|Anesthetics, Local|anesthetics, local|mesh-ancestor
83729394|NCT05875519|Sensory System Agents|sensory system agents|mesh-ancestor
83729395|NCT05875519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729396|NCT05875519|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83729397|NCT05875428|Mitoxantrone|mitoxantrone|mesh-list
83729398|NCT05875428|Analgesics|analgesics|mesh-ancestor
83729399|NCT05875428|Sensory System Agents|sensory system agents|mesh-ancestor
83729400|NCT05875428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729401|NCT05875428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729402|NCT05875428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729403|NCT05875428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83729404|NCT05875428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83729405|NCT05875428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729406|NCT05875428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729407|NCT05875285|Methotrexate|methotrexate|mesh-list
83729408|NCT05875285|Coal Tar|coal tar|mesh-list
83729409|NCT05875285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83729410|NCT05875285|Abortifacient Agents|abortifacient agents|mesh-ancestor
83729411|NCT05875285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83729412|NCT05875285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729413|NCT05875285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83729414|NCT05875285|Antimetabolites|antimetabolites|mesh-ancestor
83729415|NCT05875285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729416|NCT05875285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729417|NCT05875285|Dermatologic Agents|dermatologic agents|mesh-ancestor
83729418|NCT05875285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729419|NCT05875285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83729420|NCT05875285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83729421|NCT05875285|Immunologic Factors|immunologic factors|mesh-ancestor
83729422|NCT05875285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729423|NCT05875285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83729424|NCT05875285|Keratolytic Agents|keratolytic agents|mesh-ancestor
83729425|NCT05875077|Dexmedetomidine|dexmedetomidine|mesh-list
83729426|NCT05875077|Propofol|propofol|mesh-list
83729427|NCT05875077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83729428|NCT05875077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729429|NCT05875077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729430|NCT05875077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729431|NCT05875077|Analgesics|analgesics|mesh-ancestor
83729432|NCT05875077|Sensory System Agents|sensory system agents|mesh-ancestor
83729433|NCT05875077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729434|NCT05875077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83729435|NCT05875077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83729436|NCT05875077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83729437|NCT05875077|Adrenergic Agents|adrenergic agents|mesh-ancestor
83729438|NCT05875077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729439|NCT05875077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729440|NCT05875077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83729441|NCT05875077|Anesthetics, General|anesthetics, general|mesh-ancestor
83729442|NCT05875077|Anesthetics|anesthetics|mesh-ancestor
83729443|NCT05875025|Norflurane|norflurane|mesh-list
83729444|NCT05875025|Anesthetics|anesthetics|mesh-ancestor
83729445|NCT05875025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729446|NCT05875025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729447|NCT05874921|Mitomycins|mitomycins|mesh-list
83729448|NCT05874921|Mitomycin|mitomycin|mesh-list
83729449|NCT05874921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83729450|NCT05874921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729451|NCT05874921|Alkylating Agents|alkylating agents|mesh-ancestor
83729452|NCT05874921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729453|NCT05874921|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83729454|NCT05874921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729455|NCT05874882|Chlorhexidine|chlorhexidine|mesh-list
83729456|NCT05874882|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83729457|NCT05874882|Resveratrol|resveratrol|mesh-list
83729458|NCT05874882|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83729459|NCT05874882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729460|NCT05874882|Disinfectants|disinfectants|mesh-ancestor
83729461|NCT05874882|Dermatologic Agents|dermatologic agents|mesh-ancestor
83729462|NCT05874882|Antioxidants|antioxidants|mesh-ancestor
83729463|NCT05874882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729464|NCT05874882|Protective Agents|protective agents|mesh-ancestor
83729465|NCT05874882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729466|NCT05874882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729467|NCT05874882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83729468|NCT05874778|Prednisone|prednisone|mesh-list
82884458|NCT04658784|Cyclopropane|cyclopropane|mesh-list
83729469|NCT05874778|Cyclophosphamide|cyclophosphamide|mesh-list
83729470|NCT05874778|Vincristine|vincristine|mesh-list
83729471|NCT05874778|Rituximab|rituximab|mesh-list
83729472|NCT05874778|Doxorubicin|doxorubicin|mesh-list
82884459|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
82884460|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729473|NCT05874778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83729474|NCT05874778|Immunologic Factors|immunologic factors|mesh-ancestor
83729475|NCT05874778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729476|NCT05874778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729477|NCT05874778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83729478|NCT05874778|Alkylating Agents|alkylating agents|mesh-ancestor
83729479|NCT05874778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729480|NCT05874778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729481|NCT05874778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83729482|NCT05874778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729483|NCT05874778|Glucocorticoids|glucocorticoids|mesh-ancestor
83729484|NCT05874778|Hormones|hormones|mesh-ancestor
83729485|NCT05874778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729486|NCT05874778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83729487|NCT05874778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83729488|NCT05874778|Tubulin Modulators|tubulin modulators|mesh-ancestor
83729489|NCT05874778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83729490|NCT05874778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83729491|NCT05874778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729492|NCT05874778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83729493|NCT05874778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83729494|NCT05874778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83729495|NCT05874778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729496|NCT05874700|Sivelestat|sivelestat|mesh-list
83729497|NCT05874700|Glycine|glycine|mesh-list
83729498|NCT05874700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83729499|NCT05874700|Protease Inhibitors|protease inhibitors|mesh-ancestor
83729500|NCT05874700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729501|NCT05874700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729502|NCT05874700|Glycine Agents|glycine agents|mesh-ancestor
83729503|NCT05874700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729504|NCT05874700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729505|NCT05874674|Nafamostat|nafamostat|mesh-list
83729506|NCT05874674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83729507|NCT05874674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729508|NCT05874674|Analgesics|analgesics|mesh-ancestor
83729509|NCT05874674|Sensory System Agents|sensory system agents|mesh-ancestor
83729510|NCT05874674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729511|NCT05874674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729512|NCT05874674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729513|NCT05874674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729514|NCT05874674|Anticoagulants|anticoagulants|mesh-ancestor
83729515|NCT05874674|Protease Inhibitors|protease inhibitors|mesh-ancestor
83729516|NCT05874674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729517|NCT05874674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729518|NCT05874674|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83729519|NCT05874674|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83729520|NCT05874674|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83729521|NCT05874674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83729522|NCT05874674|Immunologic Factors|immunologic factors|mesh-ancestor
83729523|NCT05874583|Tranexamic Acid|tranexamic acid|mesh-list
83729524|NCT05874583|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83729525|NCT05874583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83729526|NCT05874583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729527|NCT05874583|Hemostatics|hemostatics|mesh-ancestor
83729528|NCT05874583|Coagulants|coagulants|mesh-ancestor
83729529|NCT05874544|Amoxicillin|amoxicillin|mesh-list
82884539|NCT04588545|Trastuzumab|trastuzumab|mesh-list
82884540|NCT04588545|Pertuzumab|pertuzumab|mesh-list
82884541|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884542|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884543|NCT04586088|Apatinib|apatinib|mesh-list
82884544|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884545|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82884546|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884547|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884560|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
82884561|NCT04579523|Fludarabine|fludarabine|mesh-list
82884562|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
82884563|NCT04579523|Daratumumab|daratumumab|mesh-list
82884564|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82884565|NCT04579523|Antibodies|antibodies|mesh-list
82884566|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
82884567|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82884568|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83729530|NCT05874544|Metronidazole|metronidazole|mesh-list
83729531|NCT05874544|Tetracycline|tetracycline|mesh-list
83729532|NCT05874544|Rifabutin|rifabutin|mesh-list
83729533|NCT05874544|Potassium Citrate|potassium citrate|mesh-list
83729534|NCT05874544|Bismuth|bismuth|mesh-list
83729535|NCT05874544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729536|NCT05874544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83729537|NCT05874544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729538|NCT05874544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83729539|NCT05874544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83729540|NCT05874544|Antacids|antacids|mesh-ancestor
83729541|NCT05874544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729542|NCT05874544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83729543|NCT05874544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729544|NCT05874544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83729545|NCT05874544|Antitubercular Agents|antitubercular agents|mesh-ancestor
83729546|NCT05874544|Diuretics|diuretics|mesh-ancestor
83729547|NCT05874544|Natriuretic Agents|natriuretic agents|mesh-ancestor
83729548|NCT05874544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729549|NCT05874544|Expectorants|expectorants|mesh-ancestor
83729550|NCT05874544|Respiratory System Agents|respiratory system agents|mesh-ancestor
83729551|NCT05874518|Letrozole|letrozole|mesh-list
83729552|NCT05874518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729553|NCT05874518|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83729554|NCT05874518|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83729555|NCT05874518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729556|NCT05874518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729557|NCT05874518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83729558|NCT05874518|Hormone Antagonists|hormone antagonists|mesh-ancestor
83729559|NCT05874518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729560|NCT05874518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729561|NCT05874505|Adalimumab|adalimumab|mesh-list
83729562|NCT05874505|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83729563|NCT05874505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729564|NCT05874505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729565|NCT05872789|Diazepam|diazepam|mesh-list
83729566|NCT05872789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83729567|NCT05872789|Anticonvulsants|anticonvulsants|mesh-ancestor
83729568|NCT05872789|Antiemetics|antiemetics|mesh-ancestor
83729569|NCT05872789|Autonomic Agents|autonomic agents|mesh-ancestor
83729570|NCT05872789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729571|NCT05872789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729572|NCT05872789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729573|NCT05872789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83729574|NCT05872789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729575|NCT05872789|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83729576|NCT05872789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83729577|NCT05872789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83729578|NCT05872789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83729579|NCT05872789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83729580|NCT05872789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83729581|NCT05872789|Anesthetics, General|anesthetics, general|mesh-ancestor
83729582|NCT05872789|Anesthetics|anesthetics|mesh-ancestor
83729583|NCT05872789|GABA Modulators|gaba modulators|mesh-ancestor
83729584|NCT05872789|GABA Agents|gaba agents|mesh-ancestor
83729585|NCT05872789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729586|NCT05872789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729587|NCT05872412|Paclitaxel|paclitaxel|mesh-list
83729588|NCT05872412|Cyclophosphamide|cyclophosphamide|mesh-list
83729589|NCT05872412|Carboplatin|carboplatin|mesh-list
83729590|NCT05872412|Doxorubicin|doxorubicin|mesh-list
83729591|NCT05872412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83729592|NCT05872412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729593|NCT05872412|Tubulin Modulators|tubulin modulators|mesh-ancestor
83729594|NCT05872412|Antimitotic Agents|antimitotic agents|mesh-ancestor
83729595|NCT05872412|Mitosis Modulators|mitosis modulators|mesh-ancestor
83729596|NCT05872412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884609|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82884617|NCT04557735|Ravulizumab|ravulizumab|mesh-list
83729597|NCT05872412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82884618|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82884619|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82884620|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
82884621|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884622|NCT04552223|Nivolumab|nivolumab|mesh-list
82884623|NCT04552223|Relatlimab|relatlimab|mesh-list
83729598|NCT05872412|Immunologic Factors|immunologic factors|mesh-ancestor
83729599|NCT05872412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729600|NCT05872412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729601|NCT05872412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83729602|NCT05872412|Alkylating Agents|alkylating agents|mesh-ancestor
83729603|NCT05872412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83729604|NCT05872412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83729605|NCT05872412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83729606|NCT05872412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83729607|NCT05872412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729608|NCT05871476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83729609|NCT05871476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729611|NCT05864144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729612|NCT05864144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729613|NCT05860439|Polidocanol|polidocanol|mesh-list
83729614|NCT05860439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83729615|NCT05860439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83729616|NCT05849610|Dexamethasone|dexamethasone|mesh-list
83729617|NCT05849610|Lenalidomide|lenalidomide|mesh-list
83729618|NCT05849610|Bortezomib|bortezomib|mesh-list
83729619|NCT05849610|Daratumumab|daratumumab|mesh-list
83729620|NCT05849610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729621|NCT05849610|Antiemetics|antiemetics|mesh-ancestor
83729622|NCT05849610|Autonomic Agents|autonomic agents|mesh-ancestor
83729623|NCT05849610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729624|NCT05849610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729625|NCT05849610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729626|NCT05849610|Glucocorticoids|glucocorticoids|mesh-ancestor
83729627|NCT05849610|Hormones|hormones|mesh-ancestor
83729628|NCT05849610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729629|NCT05849610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83729630|NCT05849610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729631|NCT05849610|Immunologic Factors|immunologic factors|mesh-ancestor
83729632|NCT05849610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83729633|NCT05849610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83729634|NCT05849610|Growth Substances|growth substances|mesh-ancestor
83729635|NCT05849610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83729636|NCT05823675|Methylprednisolone|methylprednisolone|mesh-list
83729637|NCT05823675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83729638|NCT05823675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83729639|NCT05823675|Prednisolone|prednisolone|mesh-list
83729640|NCT05823675|Prednisolone acetate|prednisolone acetate|mesh-list
83729641|NCT05823675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83729642|NCT05823675|Prednisolone phosphate|prednisolone phosphate|mesh-list
83729643|NCT05823675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729644|NCT05823675|Antiemetics|antiemetics|mesh-ancestor
83729645|NCT05823675|Autonomic Agents|autonomic agents|mesh-ancestor
83729646|NCT05823675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729647|NCT05823675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729648|NCT05823675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83729649|NCT05823675|Glucocorticoids|glucocorticoids|mesh-ancestor
83729650|NCT05823675|Hormones|hormones|mesh-ancestor
83729651|NCT05823675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729652|NCT05823675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83729653|NCT05823675|Protective Agents|protective agents|mesh-ancestor
83729654|NCT05823675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83729655|NCT05823675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729656|NCT05874869|Piperaquine|piperaquine|mesh-list
83729657|NCT05874869|Artenimol|artenimol|mesh-list
83729658|NCT05874869|Antimalarials|antimalarials|mesh-ancestor
83729659|NCT05874869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83729660|NCT05874869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83729661|NCT05874869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729662|NCT05822830|Tirzepatide|tirzepatide|mesh-list
83729663|NCT05822830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83729664|NCT05822830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729665|NCT05822830|Incretins|incretins|mesh-ancestor
83729666|NCT05822830|Hormones|hormones|mesh-ancestor
83729667|NCT05822830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729668|NCT05818735|Escitalopram|escitalopram|mesh-list
83729669|NCT05818735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83729670|NCT05818735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83729671|NCT05818735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729672|NCT05818735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884684|NCT04478734|Thiamine|thiamine|mesh-list
82884685|NCT04478734|Biotin|biotin|mesh-list
82884686|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
82884687|NCT04478734|Vitamins|vitamins|mesh-ancestor
83729673|NCT05818735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729674|NCT05818735|Serotonin Agents|serotonin agents|mesh-ancestor
83729675|NCT05818735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729676|NCT05799820|Bevacizumab|bevacizumab|mesh-list
83729677|NCT05799820|Capecitabine|capecitabine|mesh-list
83729678|NCT05799820|Oxaliplatin|oxaliplatin|mesh-list
83729679|NCT05799820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729680|NCT05799820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729681|NCT05799820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83729682|NCT05799820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83729683|NCT05799820|Growth Substances|growth substances|mesh-ancestor
83729684|NCT05799820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729685|NCT05799820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83729686|NCT05799820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83729687|NCT05799820|Antimetabolites|antimetabolites|mesh-ancestor
83729688|NCT05799820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729689|NCT05794958|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83729690|NCT05794958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729691|NCT05794958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729692|NCT05790161|Caffeine|caffeine|mesh-list
83729693|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83729694|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729695|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83729696|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729697|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729698|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83729699|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83729700|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
83729701|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729702|NCT05786040|Rituximab|rituximab|mesh-list
83729703|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83729704|NCT05786040|Antibodies|antibodies|mesh-list
83729705|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
83729706|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83729707|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
83729708|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729709|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729710|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729711|NCT05775809|Serotonin|serotonin|mesh-list
83729712|NCT05775809|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83729713|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83729714|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
83729715|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729716|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729717|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729718|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83729719|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729720|NCT05737628|Rituximab|rituximab|mesh-list
83729721|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729722|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729723|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
83729724|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729725|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729726|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83729727|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83729728|NCT05723601|Estradiol|estradiol|mesh-list
83729729|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83729730|NCT05723601|Estrogens|estrogens|mesh-ancestor
83729731|NCT05723601|Hormones|hormones|mesh-ancestor
83729732|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729733|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729734|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83729735|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
83729736|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83729737|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83729738|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
83729739|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729740|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729741|NCT05701527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83729742|NCT05701527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729743|NCT05698407|Sufentanil|sufentanil|mesh-list
83729744|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
82884763|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884767|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
83729745|NCT05698407|Dsuvia|dsuvia|mesh-list
83729746|NCT05698407|Ropivacaine|ropivacaine|mesh-list
83729747|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83729748|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729749|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729750|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729751|NCT05698407|Analgesics|analgesics|mesh-ancestor
83729752|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
83729753|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729754|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83729755|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83729756|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83729757|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83729758|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729759|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729760|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
83729761|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
83729762|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83729763|NCT05698407|Narcotics|narcotics|mesh-ancestor
83729764|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83729765|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83729766|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
83729767|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
83729768|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
83729769|NCT05696236|Protective Agents|protective agents|mesh-ancestor
83729770|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729771|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83729772|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
83729773|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729774|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
83729775|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729776|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729777|NCT05656235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83729778|NCT05656235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729779|NCT05641467|Methamphetamine|methamphetamine|mesh-list
83729780|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83729781|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729782|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
83729783|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
83729784|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729785|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
83729786|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729787|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729788|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
83729789|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83729790|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83729791|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729792|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83729793|NCT05627245|Belinostat|belinostat|mesh-list
83729794|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729795|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83729796|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729797|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729798|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83729799|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729800|NCT05590624|Phentermine|phentermine|mesh-list
83729801|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83729802|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729803|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
83729804|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83729805|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
83729806|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
83729807|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729808|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
83729809|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729810|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729811|NCT05574712|Leuprolide|leuprolide|mesh-list
83729812|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
82884836|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884837|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
82884838|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884839|NCT04335006|Paclitaxel|paclitaxel|mesh-list
82884840|NCT04335006|Apatinib|apatinib|mesh-list
82884841|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82884849|NCT04323956|Prednisone|prednisone|mesh-list
83729813|NCT05574712|Belzutifan|belzutifan|mesh-list
83729814|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83729815|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
83729816|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83729817|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729818|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83729819|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729820|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83729821|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729822|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729823|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
83729824|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729825|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83729826|NCT05571059|Ifetroban|ifetroban|mesh-list
83729827|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83729828|NCT05568407|Avelumab|avelumab|mesh-list
83729829|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729830|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729831|NCT05510063|Adalimumab|adalimumab|mesh-list
83729832|NCT05510063|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83729833|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729834|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729835|NCT05508815|Methotrexate|methotrexate|mesh-list
83729836|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83729837|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
83729838|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83729839|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729840|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83729841|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
83729842|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729843|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729844|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
83729845|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729846|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83729847|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83729848|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
83729849|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729850|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83729851|NCT05500508|Eflornithine|eflornithine|mesh-list
83729852|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729853|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83729854|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83729855|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83729856|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729857|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83729858|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729859|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729860|NCT05463861|Lemborexant|lemborexant|mesh-list
83729861|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83729862|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83729863|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729864|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83729865|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83729866|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729867|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729868|NCT05374603|Durvalumab|durvalumab|mesh-list
83729869|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729870|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729871|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
83729872|NCT05353439|Topotecan|topotecan|mesh-list
83729873|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729874|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729875|NCT05353439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83729876|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729877|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83729878|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83729879|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884912|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884913|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
82884914|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884915|NCT04301843|Eflornithine|eflornithine|mesh-list
82884916|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884917|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83729880|NCT05346588|Propofol|propofol|mesh-list
83729881|NCT05346588|Anesthetics|anesthetics|mesh-list
83729882|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83729883|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729884|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729885|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83729886|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
83729887|NCT05327530|Avelumab|avelumab|mesh-list
83729888|NCT05327530|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83729889|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729890|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729891|NCT05327530|Immunoconjugates|immunoconjugates|mesh-ancestor
83729892|NCT05327530|Immunologic Factors|immunologic factors|mesh-ancestor
83729893|NCT05327530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729894|NCT05323708|Denosumab|denosumab|mesh-list
83729895|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83729896|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729897|NCT05312645|Diclofenac|diclofenac|mesh-list
83729898|NCT05312645|Petrolatum|petrolatum|mesh-list
83729899|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83729900|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83729901|NCT05312645|Analgesics|analgesics|mesh-ancestor
83729902|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
83729903|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729904|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729905|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83729906|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83729907|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83729908|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729909|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729910|NCT05312645|Emollients|emollients|mesh-ancestor
83729911|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83729912|NCT05285566|Lidocaine|lidocaine|mesh-list
83729913|NCT05285566|Bupivacaine|bupivacaine|mesh-list
83729914|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
83729915|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
83729916|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83729917|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729918|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
83729919|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83729920|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83729921|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83729922|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83729923|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729924|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729925|NCT05184712|Carboplatin|carboplatin|mesh-list
83729926|NCT05184712|Pemetrexed|pemetrexed|mesh-list
83729927|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729928|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729929|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729930|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83729931|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83729932|NCT05129722|Empagliflozin|empagliflozin|mesh-list
83729933|NCT05129722|Eplerenone|eplerenone|mesh-list
83729934|NCT05129722|Bumetanide|bumetanide|mesh-list
83729935|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83729936|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729937|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83729938|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729939|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83729940|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
83729941|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83729942|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83729943|NCT05129722|Diuretics|diuretics|mesh-ancestor
83729944|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
83729945|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83729946|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83729947|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83729948|NCT05127044|Bilirubin|bilirubin|mesh-list
82884988|NCT04214834|Analgesics|analgesics|mesh-ancestor
82884989|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
82884990|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884991|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
82884992|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
83729949|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
83729950|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729951|NCT05127044|Protective Agents|protective agents|mesh-ancestor
83729952|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729953|NCT05053334|Omalizumab|omalizumab|mesh-list
83729954|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83729955|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83729956|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
83729957|NCT05052957|Temozolomide|temozolomide|mesh-list
83729958|NCT05052957|Carmustine|carmustine|mesh-list
83729959|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83729960|NCT05052957|Lenograstim|lenograstim|mesh-list
83729961|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83729962|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
83729963|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729964|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83729965|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
83729966|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729967|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729968|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729969|NCT05044962|Rilpivirine|rilpivirine|mesh-list
83729970|NCT05044962|Cabotegravir|cabotegravir|mesh-list
83729971|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83729972|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
83729973|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
83729974|NCT05044962|Etonogestrel|etonogestrel|mesh-list
83729975|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83729976|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
83729977|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83729978|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83729979|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83729980|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83729981|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83729982|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83729983|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83729984|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83729985|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83729986|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83729987|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83729988|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83729989|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83729990|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
83729991|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83729992|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83729993|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83729994|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83729995|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83729996|NCT05041309|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83729997|NCT05041309|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
83729998|NCT05041309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83729999|NCT05041309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730000|NCT05041101|Halichondrin B|halichondrin b|mesh-list
83730001|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730002|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730003|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730004|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730005|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730006|NCT05027919|Lofexidine|lofexidine|mesh-list
83730007|NCT05027919|Clonidine|clonidine|mesh-list
82885063|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82885064|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82885065|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82885066|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885067|NCT04080804|Nivolumab|nivolumab|mesh-list
82885068|NCT04080804|Ipilimumab|ipilimumab|mesh-list
82885069|NCT04080804|Relatlimab|relatlimab|mesh-list
82885070|NCT04080804|Antibodies|antibodies|mesh-list
82885071|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
82885072|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
82885073|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885074|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885075|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885076|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885077|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885078|NCT04071769|Xenon|xenon|mesh-list
83730008|NCT05027919|Morphine|morphine|mesh-list
83730009|NCT05027919|Naloxone|naloxone|mesh-list
83730010|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83730011|NCT05027919|Narcotics|narcotics|mesh-ancestor
83730012|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83730013|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730014|NCT05027919|Analgesics|analgesics|mesh-ancestor
83730015|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
83730016|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730017|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83730018|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83730019|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83730020|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83730021|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83730022|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83730023|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730024|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730025|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
83730026|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
83730027|NCT04994431|Tamsulosin|tamsulosin|mesh-list
83730028|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83730029|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83730030|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83730031|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
83730032|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730033|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730034|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730035|NCT04994431|Urological Agents|urological agents|mesh-ancestor
83730036|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83730037|NCT04985760|Vaccines|vaccines|mesh-list
83730038|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
83730039|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
83730040|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730041|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83730042|NCT04985760|Antacids|antacids|mesh-ancestor
83730043|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730044|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83730045|NCT04966546|Memantine|memantine|mesh-list
83730046|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83730047|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83730048|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
83730049|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730050|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730051|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730052|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83730053|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83730054|NCT04929041|Paclitaxel|paclitaxel|mesh-list
83730055|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83730056|NCT04929041|Carboplatin|carboplatin|mesh-list
83730057|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
83730058|NCT04929041|Nivolumab|nivolumab|mesh-list
83730059|NCT04929041|Pemetrexed|pemetrexed|mesh-list
83730060|NCT04929041|Ipilimumab|ipilimumab|mesh-list
83730061|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730062|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730063|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730064|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730065|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730066|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730067|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730068|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83730069|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730070|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730071|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730072|NCT04912063|Azacitidine|azacitidine|mesh-list
83730073|NCT04912063|Venetoclax|venetoclax|mesh-list
83730074|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730075|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
83730076|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730077|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730078|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730079|NCT04853446|Dexamethasone|dexamethasone|mesh-list
83730080|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
83730081|NCT04853446|BB 1101|bb 1101|mesh-list
82885139|NCT04028050|Etoposide|etoposide|mesh-list
83730082|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83730083|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
83730084|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
83730085|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730086|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730087|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83730088|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
83730089|NCT04853446|Hormones|hormones|mesh-ancestor
83730090|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730091|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730092|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730093|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
83730094|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730095|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730096|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83730097|NCT04846231|Red yeast rice|red yeast rice|mesh-list
83730098|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83730099|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83730100|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
83730101|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730102|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83730103|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83730104|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730105|NCT04756401|Dexamethasone|dexamethasone|mesh-list
83730106|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
83730107|NCT04756401|Daratumumab|daratumumab|mesh-list
83730108|NCT04756401|Ichthammol|ichthammol|mesh-list
83730109|NCT04756401|BB 1101|bb 1101|mesh-list
83730110|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83730111|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
83730112|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
83730113|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730114|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730115|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83730116|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
83730117|NCT04756401|Hormones|hormones|mesh-ancestor
83730118|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730119|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730120|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730121|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
83730122|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730123|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730124|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
83730125|NCT04705428|Fluorides|fluorides|mesh-list
83730126|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
83730127|NCT04705428|Protective Agents|protective agents|mesh-ancestor
83730128|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730129|NCT04677387|Naloxone|naloxone|mesh-list
83730130|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83730131|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730132|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
83730133|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730134|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
83730135|NCT04664933|Protective Agents|protective agents|mesh-ancestor
83730136|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730137|NCT04663347|Cytarabine|cytarabine|mesh-list
83730138|NCT04663347|Dexamethasone|dexamethasone|mesh-list
83730139|NCT04663347|Prednisone|prednisone|mesh-list
83730140|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
83730141|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83730142|NCT04663347|Ifosfamide|ifosfamide|mesh-list
83730143|NCT04663347|Rituximab|rituximab|mesh-list
83730144|NCT04663347|Carboplatin|carboplatin|mesh-list
83730145|NCT04663347|Gemcitabine|gemcitabine|mesh-list
83730146|NCT04663347|Doxorubicin|doxorubicin|mesh-list
83730147|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83730148|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
83730149|NCT04663347|Etoposide|etoposide|mesh-list
83730150|NCT04663347|Vincristine|vincristine|mesh-list
83730151|NCT04663347|Lenalidomide|lenalidomide|mesh-list
83730152|NCT04663347|Etoposide phosphate|etoposide phosphate|mesh-list
83730153|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730154|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
83730155|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730156|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83730157|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83730158|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
83730159|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885227|NCT03983824|Analgesics|analgesics|mesh-ancestor
83730160|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730161|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83730162|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730163|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83730164|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
83730165|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
83730166|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730167|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83730168|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
83730170|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730171|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730172|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730173|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
83730174|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83730175|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83730176|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730177|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730178|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730179|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
83730180|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730181|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730182|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730183|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730184|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83730185|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83730186|NCT04663347|Growth Substances|growth substances|mesh-ancestor
83730187|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
83730188|NCT04660760|Trifluridine|trifluridine|mesh-list
83730189|NCT04660760|Paclitaxel|paclitaxel|mesh-list
83730190|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83730191|NCT04660760|Ramucirumab|ramucirumab|mesh-list
83730192|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83730193|NCT04660760|Antibodies|antibodies|mesh-list
83730194|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
83730195|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83730196|NCT04660760|Lexatumumab|lexatumumab|mesh-list
83730197|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730198|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730199|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730200|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730201|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730202|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730203|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
83730204|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730205|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
83730206|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
83730207|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730208|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
83730209|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83730210|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83730211|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730212|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
83730213|NCT04650698|Coagulants|coagulants|mesh-ancestor
83730214|NCT04507217|Carboplatin|carboplatin|mesh-list
83730215|NCT04507217|Pemetrexed|pemetrexed|mesh-list
83730216|NCT04507217|Tislelizumab|tislelizumab|mesh-list
83730217|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730218|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730219|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730220|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730221|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730222|NCT04507217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730223|NCT04495452|Fentanyl|fentanyl|mesh-list
83730224|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83730225|NCT04495452|Narcotics|narcotics|mesh-ancestor
83730226|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83730227|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730228|NCT04495452|Analgesics|analgesics|mesh-ancestor
83730229|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
83730230|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730231|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83730232|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83730233|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
83730234|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
83730235|NCT04447846|Cannabidiol|cannabidiol|mesh-list
83730236|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
82885291|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
83730237|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83730238|NCT04405245|Latanoprost|latanoprost|mesh-list
83730239|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83730240|NCT04335968|Melatonin|melatonin|mesh-list
83730241|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
83730242|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730243|NCT04335968|Protective Agents|protective agents|mesh-ancestor
83730244|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730245|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83730246|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
83730247|NCT04318678|Rituximab|rituximab|mesh-list
83730248|NCT04318678|Fludarabine|fludarabine|mesh-list
83730249|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730250|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
83730251|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730252|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83730253|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83730254|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
83730255|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730256|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730257|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83730258|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730259|NCT04262154|Prednisone|prednisone|mesh-list
83730260|NCT04262154|Atezolizumab|atezolizumab|mesh-list
83730261|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83730262|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
83730263|NCT04262154|Hormones|hormones|mesh-ancestor
83730264|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730265|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730266|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730267|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730268|NCT04262154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83730269|NCT04262154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730270|NCT04262154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730271|NCT04262024|Cabergoline|cabergoline|mesh-list
83730272|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83730273|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83730274|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
83730275|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
83730276|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730277|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730278|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730279|NCT04237103|Methotrexate|methotrexate|mesh-list
83730280|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83730281|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
83730282|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83730283|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730284|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730285|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
83730286|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730287|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730288|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
83730289|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730290|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730291|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730292|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
83730293|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83730294|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730295|NCT04226690|Dronabinol|dronabinol|mesh-list
83730296|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
83730297|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730298|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83730299|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83730300|NCT04226690|Analgesics|analgesics|mesh-ancestor
83730301|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
83730302|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730303|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83730304|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83730305|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730306|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730307|NCT04226690|Hormones|hormones|mesh-ancestor
83730308|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885365|NCT03879798|Irinotecan|irinotecan|mesh-list
82885371|NCT03861390|Prednisone|prednisone|mesh-list
83730310|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83730311|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83730312|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730313|NCT04198805|Vitamins|vitamins|mesh-list
83730314|NCT04198805|Vitamin E|vitamin e|mesh-list
83730315|NCT04198805|Tocopherols|tocopherols|mesh-list
83730316|NCT04198805|Tocotrienols|tocotrienols|mesh-list
83730317|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
83730318|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
83730319|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730320|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
83730321|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730322|NCT04198805|Protective Agents|protective agents|mesh-ancestor
83730323|NCT04185883|Docetaxel|docetaxel|mesh-list
83730324|NCT04185883|Bevacizumab|bevacizumab|mesh-list
83730325|NCT04185883|Carboplatin|carboplatin|mesh-list
83730326|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
83730327|NCT04185883|Pemetrexed|pemetrexed|mesh-list
83730328|NCT04185883|Everolimus|everolimus|mesh-list
83730329|NCT04185883|Atezolizumab|atezolizumab|mesh-list
83730330|NCT04185883|Palbociclib|palbociclib|mesh-list
83730331|NCT04185883|Panitumumab|panitumumab|mesh-list
83730332|NCT04185883|Trametinib|trametinib|mesh-list
83730333|NCT04185883|Afatinib|afatinib|mesh-list
83730334|NCT04185883|Sotorasib|sotorasib|mesh-list
83730335|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730336|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730337|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730338|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730339|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730340|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730341|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83730342|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83730343|NCT04185883|Growth Substances|growth substances|mesh-ancestor
83730344|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730345|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
83730346|NCT04185883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83730347|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730348|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730349|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730350|NCT04185883|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83730351|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83730352|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730353|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
83730354|NCT04179890|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83730355|NCT04179890|Gefitinib|gefitinib|mesh-list
83730356|NCT04179890|Osimertinib|osimertinib|mesh-list
83730357|NCT04179890|Afatinib|afatinib|mesh-list
83730358|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730359|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83730360|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730361|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730362|NCT04166331|Dobutamine|dobutamine|mesh-list
83730363|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83730364|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
83730365|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
83730366|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730367|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730368|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83730369|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83730370|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83730371|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
83730372|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730373|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730374|NCT04166331|Protective Agents|protective agents|mesh-ancestor
83730375|NCT04084210|Nicotine|nicotine|mesh-list
83730376|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83730377|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
83730378|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730379|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730380|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83730381|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83730382|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
83730383|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730384|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730385|NCT04030026|Nalbuphine|nalbuphine|mesh-list
83730386|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83730387|NCT04030026|Narcotics|narcotics|mesh-ancestor
83730388|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83730389|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730390|NCT04030026|Analgesics|analgesics|mesh-ancestor
83730391|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
83730392|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730393|NCT04006457|Vaccines|vaccines|mesh-list
83730394|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
83730395|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730396|NCT04006210|Levodopa|levodopa|mesh-list
83730397|NCT04006210|Carbidopa|carbidopa|mesh-list
83730398|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83730399|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83730400|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
83730401|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730402|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730403|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730404|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83730405|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730406|NCT03927274|Topotecan|topotecan|mesh-list
83730407|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83730408|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730409|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730410|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730411|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730412|NCT03923699|Anesthetics|anesthetics|mesh-list
83730413|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83730414|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730415|NCT03918278|Paclitaxel|paclitaxel|mesh-list
83730416|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83730417|NCT03918278|Carboplatin|carboplatin|mesh-list
83730418|NCT03918278|Gemcitabine|gemcitabine|mesh-list
83730419|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
83730420|NCT03918278|Pemetrexed|pemetrexed|mesh-list
83730421|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730422|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730423|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730424|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730425|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730426|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730427|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730428|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
83730429|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730430|NCT03918278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83730431|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730432|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730433|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730434|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83730435|NCT03883880|Capsaicin|capsaicin|mesh-list
83730436|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
83730437|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
83730438|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
83730439|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730440|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730441|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
83730442|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730443|NCT03883880|Protective Agents|protective agents|mesh-ancestor
83730444|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83730445|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83730446|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730447|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83730448|NCT03853798|Mitapivat|mitapivat|mesh-list
83730449|NCT03853798|Enzyme Activators|enzyme activators|mesh-ancestor
83730450|NCT03853798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730451|NCT03832998|Erenumab|erenumab|mesh-list
83730452|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83730453|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83730454|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730455|NCT03832998|Analgesics|analgesics|mesh-ancestor
83730456|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
83730457|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730458|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730459|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
83730460|NCT03801369|Durvalumab|durvalumab|mesh-list
83730461|NCT03801369|Olaparib|olaparib|mesh-list
82885514|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83730462|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83730463|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
83730464|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83730465|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
83730466|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730467|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730468|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
83730469|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730470|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730471|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730472|NCT03798691|Vaccines|vaccines|mesh-list
83730473|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
83730474|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730475|NCT03649659|Fluorides|fluorides|mesh-list
83730476|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
83730477|NCT03649659|Protective Agents|protective agents|mesh-ancestor
83730478|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730479|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
83730480|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
83730481|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730482|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730483|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730484|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
83730485|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
83730486|NCT03563716|Atezolizumab|atezolizumab|mesh-list
83730487|NCT03563716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83730488|NCT03563716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730489|NCT03563716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730490|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730491|NCT03543969|Nivolumab|nivolumab|mesh-list
83730492|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730493|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730494|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83730495|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730496|NCT03493048|Leucovorin|leucovorin|mesh-list
83730497|NCT03493048|Fluorouracil|fluorouracil|mesh-list
83730498|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
83730499|NCT03493048|Irinotecan|irinotecan|mesh-list
83730500|NCT03493048|Cetuximab|cetuximab|mesh-list
83730501|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
83730502|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730503|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730504|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730505|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730506|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
83730507|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730508|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83730509|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730510|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730511|NCT03493048|Antidotes|antidotes|mesh-ancestor
83730512|NCT03493048|Protective Agents|protective agents|mesh-ancestor
83730513|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
83730514|NCT03493048|Vitamins|vitamins|mesh-ancestor
83730515|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
83730516|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730517|NCT03486106|Propofol|propofol|mesh-list
83730518|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83730519|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83730520|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730521|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83730522|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
83730523|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
83730524|NCT03434275|Meloxicam|meloxicam|mesh-list
83730525|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83730526|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83730527|NCT03434275|Analgesics|analgesics|mesh-ancestor
83730528|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
83730529|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730530|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730531|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83730532|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83730533|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83730534|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83730535|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885589|NCT03583255|Ichthammol|ichthammol|mesh-list
83730536|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730537|NCT03354013|Calcium|calcium|mesh-list
83730538|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83730539|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730540|NCT03348423|Fentanyl|fentanyl|mesh-list
83730541|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83730542|NCT03348423|Narcotics|narcotics|mesh-ancestor
83730543|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83730544|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730545|NCT03348423|Analgesics|analgesics|mesh-ancestor
83730546|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
83730547|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730548|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83730549|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83730550|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
83730551|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
83730552|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
83730553|NCT03337087|Leucovorin|leucovorin|mesh-list
83730554|NCT03337087|Folic Acid|folic acid|mesh-list
83730555|NCT03337087|Fluorouracil|fluorouracil|mesh-list
83730556|NCT03337087|Irinotecan|irinotecan|mesh-list
83730557|NCT03337087|Rucaparib|rucaparib|mesh-list
83730558|NCT03337087|Calcium|calcium|mesh-list
83730559|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
83730560|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83730561|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730562|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83730563|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
83730564|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730565|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730566|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730567|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730568|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
83730569|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83730570|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730571|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730572|NCT03337087|Antidotes|antidotes|mesh-ancestor
83501164|NCT04838717|Doxycycline|doxycycline|mesh-list
83730573|NCT03337087|Protective Agents|protective agents|mesh-ancestor
83730574|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
83730575|NCT03337087|Vitamins|vitamins|mesh-ancestor
83730576|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
83730577|NCT03337087|Hematinics|hematinics|mesh-ancestor
83730578|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83730579|NCT03262935|Capecitabine|capecitabine|mesh-list
83730580|NCT03262935|Trastuzumab|trastuzumab|mesh-list
83730581|NCT03262935|Vinorelbine|vinorelbine|mesh-list
83730582|NCT03262935|Lapatinib|lapatinib|mesh-list
83730583|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730584|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
83730585|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730586|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730587|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730588|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730589|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730590|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730591|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730592|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83730593|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730594|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
83730595|NCT03262142|Tazobactam|tazobactam|mesh-list
83730596|NCT03262142|Piperacillin|piperacillin|mesh-list
83730597|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83730598|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83730599|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730600|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83730601|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730602|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730603|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730604|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730605|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83730606|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83730607|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83730608|NCT03150810|Temozolomide|temozolomide|mesh-list
83730609|NCT03150810|Pamiparib|pamiparib|mesh-list
83730610|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83730611|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
83730612|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730613|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730614|NCT03150810|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83730615|NCT03150810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730616|NCT03117998|Volagidemab|volagidemab|mesh-list
83730617|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83730618|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730619|NCT03117751|Cytarabine|cytarabine|mesh-list
83730620|NCT03117751|Dexamethasone|dexamethasone|mesh-list
83730621|NCT03117751|Prednisone|prednisone|mesh-list
83730622|NCT03117751|Prednisolone|prednisolone|mesh-list
83730623|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
83730624|NCT03117751|Doxorubicin|doxorubicin|mesh-list
83730625|NCT03117751|Methotrexate|methotrexate|mesh-list
83730626|NCT03117751|Etoposide|etoposide|mesh-list
83730627|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
83730628|NCT03117751|Vincristine|vincristine|mesh-list
83730629|NCT03117751|Bortezomib|bortezomib|mesh-list
83730630|NCT03117751|Daunorubicin|daunorubicin|mesh-list
83730631|NCT03117751|Asparaginase|asparaginase|mesh-list
83730632|NCT03117751|Dasatinib|dasatinib|mesh-list
83730633|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
83730634|NCT03117751|Vorinostat|vorinostat|mesh-list
83730635|NCT03117751|Idarubicin|idarubicin|mesh-list
83730636|NCT03117751|Clofarabine|clofarabine|mesh-list
83730637|NCT03117751|Pegaspargase|pegaspargase|mesh-list
83730638|NCT03117751|Thioguanine|thioguanine|mesh-list
83730639|NCT03117751|Blinatumomab|blinatumomab|mesh-list
83730640|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
83730641|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730642|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
83730643|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730644|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83730645|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83730646|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
83730647|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730648|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730649|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83730650|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83730651|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
83730652|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
83730653|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730654|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83730655|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
83730656|NCT03117751|Hormones|hormones|mesh-ancestor
83730657|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730658|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730659|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83730660|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83730661|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730662|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730663|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83730664|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
83730665|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83730666|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730667|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
83730668|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
83730669|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730670|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730671|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730672|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
83730673|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730674|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730675|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730676|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730677|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83730678|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83730679|NCT03114865|Dexamethasone|dexamethasone|mesh-list
83730680|NCT03114865|Blinatumomab|blinatumomab|mesh-list
82885739|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82885740|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885741|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
82885742|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885743|NCT03497143|Lamotrigine|lamotrigine|mesh-list
82885744|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
82885745|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82885746|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83730681|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83730682|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83730683|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
83730684|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
83730685|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730686|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730687|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83730688|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
83730689|NCT03114865|Hormones|hormones|mesh-ancestor
83730690|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730691|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730692|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730693|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
83730694|NCT02920008|Guadecitabine|guadecitabine|mesh-list
83730695|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730696|NCT02866747|Durvalumab|durvalumab|mesh-list
83730697|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730698|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730699|NCT02766335|Docetaxel|docetaxel|mesh-list
83730700|NCT02766335|Durvalumab|durvalumab|mesh-list
83730701|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
83730702|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83730703|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
83730704|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730705|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730706|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730707|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730708|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730709|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730710|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
83730711|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730712|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
83730713|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83730714|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
83730715|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730716|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83730717|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730718|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
83730719|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730720|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
83730721|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83730722|NCT02739711|Protective Agents|protective agents|mesh-ancestor
83730723|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
83730724|NCT02607423|Cisplatin|cisplatin|mesh-list
83730725|NCT02607423|Gemcitabine|gemcitabine|mesh-list
83730726|NCT02607423|Docetaxel|docetaxel|mesh-list
83730727|NCT02607423|Pemetrexed|pemetrexed|mesh-list
83730728|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83730729|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730730|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730731|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
83730732|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730733|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730734|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730735|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730736|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730737|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730738|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730739|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83730740|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
83730741|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730742|NCT02577523|Levodopa|levodopa|mesh-list
83730743|NCT02577523|Carbidopa|carbidopa|mesh-list
83730744|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83730745|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83730746|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83730747|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
83730748|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730749|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730750|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730751|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83730752|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730753|NCT02516241|Carboplatin|carboplatin|mesh-list
83730754|NCT02516241|Gemcitabine|gemcitabine|mesh-list
83730755|NCT02516241|Durvalumab|durvalumab|mesh-list
83730756|NCT02516241|Tremelimumab|tremelimumab|mesh-list
83730757|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730758|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730759|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
83730760|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730761|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730762|NCT02499328|Durvalumab|durvalumab|mesh-list
83730763|NCT02499328|Tremelimumab|tremelimumab|mesh-list
83730764|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730765|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730766|NCT02388906|Nivolumab|nivolumab|mesh-list
83730767|NCT02388906|Ipilimumab|ipilimumab|mesh-list
83730768|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730769|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730770|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83730771|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730772|NCT02344810|Leucovorin|leucovorin|mesh-list
83730773|NCT02344810|Fluorouracil|fluorouracil|mesh-list
83730774|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
83730775|NCT02344810|Calcium|calcium|mesh-list
83730776|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
83730777|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83730778|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730779|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
83730780|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730781|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730782|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730783|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730784|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
83730785|NCT02344810|Antidotes|antidotes|mesh-ancestor
83730786|NCT02344810|Protective Agents|protective agents|mesh-ancestor
83730787|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
83730788|NCT02344810|Vitamins|vitamins|mesh-ancestor
83730789|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
83730790|NCT02333565|Everolimus|everolimus|mesh-list
83730791|NCT02333565|Octreotide|octreotide|mesh-list
83730792|NCT02333565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83730793|NCT02333565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83730794|NCT02333565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730795|NCT02333565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730796|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730797|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
83730798|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730799|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730800|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83730801|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730802|NCT02278185|Leuprolide|leuprolide|mesh-list
83730803|NCT02278185|Goserelin|goserelin|mesh-list
83730804|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83730805|NCT02278185|Tryptophan|tryptophan|mesh-list
83730806|NCT02278185|Androgens|androgens|mesh-list
83730807|NCT02278185|Hormones|hormones|mesh-ancestor
83730808|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730809|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730810|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83730811|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
83730812|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83730813|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730814|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730815|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
83730816|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83730817|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
83730818|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83730819|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83730820|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
83730821|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83730822|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83730823|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83730824|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730825|NCT02177695|Gemcitabine|gemcitabine|mesh-list
83730826|NCT02177695|Doxorubicin|doxorubicin|mesh-list
83730827|NCT02177695|Methotrexate|methotrexate|mesh-list
83730828|NCT02177695|Vinblastine|vinblastine|mesh-list
83730829|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730830|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730831|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
83730832|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730833|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82885887|NCT03384641|Bedaquiline|bedaquiline|mesh-list
83730834|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83730835|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730836|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730837|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83730838|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
83730839|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83730840|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730841|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
83730842|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83730843|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730844|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
83730845|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83730846|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730847|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730848|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730849|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730850|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730851|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
83730852|NCT02106572|Mitomycins|mitomycins|mesh-list
83730853|NCT02106572|Mitomycin|mitomycin|mesh-list
83730854|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83730855|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730856|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
83730857|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730858|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83730859|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730860|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83730861|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83730862|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
83730863|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730864|NCT02096601|Levodopa|levodopa|mesh-list
83730865|NCT02096601|Carbidopa|carbidopa|mesh-list
83730866|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83730867|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83730868|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
83730869|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730870|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730871|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730872|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83730873|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730874|NCT02015013|Plerixafor|plerixafor|mesh-list
83730875|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83730876|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83730877|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
83730878|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730879|NCT01840566|Cytarabine|cytarabine|mesh-list
83730880|NCT01840566|Etoposide|etoposide|mesh-list
83730881|NCT01840566|Melphalan|melphalan|mesh-list
83730882|NCT01840566|Carmustine|carmustine|mesh-list
83730883|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730884|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730885|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83730886|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730887|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730888|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730889|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730890|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
83730891|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
83730892|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83730893|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730894|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
83730895|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730896|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83730897|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
83730898|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83730899|NCT01725802|Levodopa|levodopa|mesh-list
83730900|NCT01725802|Carbidopa|carbidopa|mesh-list
83730901|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83730902|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83730903|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
83730904|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83730905|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730906|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730907|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83730908|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730909|NCT01719237|Ropivacaine|ropivacaine|mesh-list
83730910|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
83730911|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
83730912|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
83730913|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885986|NCT03250117|Ropinirole|ropinirole|mesh-list
83730914|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730915|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
83730916|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83730917|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83730918|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730919|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83730920|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730921|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730922|NCT01004731|Carboplatin|carboplatin|mesh-list
83730923|NCT01004731|Gemcitabine|gemcitabine|mesh-list
83730924|NCT01004731|Cetuximab|cetuximab|mesh-list
83730925|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730926|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730927|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
83730928|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730929|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730930|NCT00771017|Leuprolide|leuprolide|mesh-list
83730931|NCT00771017|Goserelin|goserelin|mesh-list
83730932|NCT00771017|Bicalutamide|bicalutamide|mesh-list
83730933|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83730934|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
83730935|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83730936|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730937|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83730938|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730939|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
83730940|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
83730941|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83730942|NCT00707473|Cisplatin|cisplatin|mesh-list
83730943|NCT00707473|Carboplatin|carboplatin|mesh-list
83730944|NCT00707473|Docetaxel|docetaxel|mesh-list
83730945|NCT00707473|Fluorouracil|fluorouracil|mesh-list
83730946|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730947|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730948|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730949|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730950|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730951|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
83730952|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83730953|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730954|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
83730955|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730956|NCT00499291|Paclitaxel|paclitaxel|mesh-list
83730957|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83730958|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83730959|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730960|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730961|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730962|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730963|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730964|NCT00445627|Metformin|metformin|mesh-list
83730965|NCT00445627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83730966|NCT00445627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730967|NCT00318903|Docetaxel|docetaxel|mesh-list
83730968|NCT00318903|Irinotecan|irinotecan|mesh-list
83730969|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730970|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
83730971|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
83730972|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
83730973|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83730974|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83730975|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83730976|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83730977|NCT00129090|Rituximab|rituximab|mesh-list
83730978|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83730979|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83730980|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
83730981|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730982|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83730983|NCT00092222|Interferons|interferons|mesh-list
83730984|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
83730985|NCT00092222|Zidovudine|zidovudine|mesh-list
83730986|NCT00092222|Valganciclovir|valganciclovir|mesh-list
83730987|NCT00092222|Sirolimus|sirolimus|mesh-list
83730988|NCT00092222|Prednisone|prednisone|mesh-list
83730989|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
83730990|NCT00092222|Rituximab|rituximab|mesh-list
83730991|NCT00092222|Doxorubicin|doxorubicin|mesh-list
83730992|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83730993|NCT00092222|Etoposide|etoposide|mesh-list
83730994|NCT00092222|Vincristine|vincristine|mesh-list
83730995|NCT00092222|Bortezomib|bortezomib|mesh-list
83730996|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83730997|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
83730998|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83730999|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83731000|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83731001|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
83731002|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731003|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731004|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83731005|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83731006|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83731007|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83731008|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83731009|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731010|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83731011|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
83731012|NCT00092222|Hormones|hormones|mesh-ancestor
83731013|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731014|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83731015|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83731016|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
83731017|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731018|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731019|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731020|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731021|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83731022|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
83731023|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
83731024|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83731025|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83731026|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83731027|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83731028|NCT00061568|Sirolimus|sirolimus|mesh-list
83731029|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
83731030|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83731031|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731032|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83731033|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731034|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
83731035|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731036|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
83731037|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731038|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83731039|NCT01952886|Ondansetron|ondansetron|mesh-list
83731040|NCT01952886|Granisetron|granisetron|mesh-list
83731041|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
83731042|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
83731043|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731044|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731045|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731046|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
83731047|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
83731048|NCT01952886|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83731049|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83731050|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
83731051|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731052|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731053|NCT01952951|Fluorouracil|fluorouracil|mesh-list
83731054|NCT01952951|Capecitabine|capecitabine|mesh-list
83731055|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
83731056|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
83731057|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731058|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83731059|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731060|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731061|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
83731062|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731063|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
83731064|NCT01953107|Trace Elements|trace elements|mesh-ancestor
83731065|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
82886111|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83731066|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731067|NCT01953172|Tocotrienols|tocotrienols|mesh-list
83731068|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
83731069|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
83731070|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731071|NCT01953172|Protective Agents|protective agents|mesh-ancestor
83731072|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731074|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
83731075|NCT01953367|Tobramycin|tobramycin|mesh-list
83731076|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83731077|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731078|NCT01953406|Fluorouracil|fluorouracil|mesh-list
83731079|NCT01953406|Mitomycins|mitomycins|mesh-list
83731080|NCT01953406|Mitomycin|mitomycin|mesh-list
83731081|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
83731082|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731083|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83731084|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731085|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731086|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
83731087|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731088|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83731089|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
83132998|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
83731090|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83731091|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731092|NCT01953419|Pemetrexed|pemetrexed|mesh-list
83731093|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731094|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731095|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731096|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83731097|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83731098|NCT01953445|Paclitaxel|paclitaxel|mesh-list
83731099|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83731100|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731101|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731102|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731103|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731104|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731105|NCT01953536|Folic Acid|folic acid|mesh-list
83731106|NCT01953536|Paclitaxel|paclitaxel|mesh-list
83731107|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83731108|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83731109|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731110|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731111|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731112|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731113|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731114|NCT01953536|Hematinics|hematinics|mesh-ancestor
83731115|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
83731116|NCT01953536|Vitamins|vitamins|mesh-ancestor
83731117|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
83731118|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731119|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
83731120|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83731121|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
83731122|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731123|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731124|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83731125|NCT01953731|Rifampin|rifampin|mesh-list
83731126|NCT01953731|Palbociclib|palbociclib|mesh-list
83731127|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731128|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83731129|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731130|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731131|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83731132|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
83731133|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83731134|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731135|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
83731136|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83731137|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83731138|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83731139|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83731140|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83731141|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83731142|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83731143|NCT01953744|Fluconazole|fluconazole|mesh-list
83731144|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83731145|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
83731146|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731147|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83731148|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83731149|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731150|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731151|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83731152|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
83731153|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731154|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731155|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83731156|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83731157|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83731158|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83731159|NCT01953757|Vitamins|vitamins|mesh-list
83731160|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
83731161|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
83731162|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
83731163|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
83731164|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731165|NCT01953757|Hematinics|hematinics|mesh-ancestor
83731166|NCT01953770|Cytarabine|cytarabine|mesh-list
83731167|NCT01953770|Prednisone|prednisone|mesh-list
83731168|NCT01953770|Methotrexate|methotrexate|mesh-list
83731169|NCT01953770|Daunorubicin|daunorubicin|mesh-list
83731170|NCT01953770|Asparaginase|asparaginase|mesh-list
83731171|NCT01953770|Pegaspargase|pegaspargase|mesh-list
83731172|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83731173|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
83731174|NCT01953770|Hormones|hormones|mesh-ancestor
83731175|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731176|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731177|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83731178|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731179|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83731180|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
83731181|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731182|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83731183|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
83731184|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731185|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
83731186|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731187|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83731188|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731189|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
83731190|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83731191|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83731192|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
83731193|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731194|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83731195|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83731196|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83731197|NCT01953796|Clomiphene|clomiphene|mesh-list
83731198|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83731199|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
83731200|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731201|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731202|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83731203|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
83731204|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731205|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83731206|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83731207|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83731208|NCT01953835|Simvastatin|simvastatin|mesh-list
83731209|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83731210|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83731211|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
83731212|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731213|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83731214|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83731215|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731217|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
83731218|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83731219|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83731220|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83731221|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731222|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731223|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731224|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731225|NCT01953848|Urological Agents|urological agents|mesh-ancestor
83731226|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83731227|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83731228|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
83731229|NCT01953887|Tamsulosin|tamsulosin|mesh-list
83731230|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
83731231|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83731232|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83731233|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83731234|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731235|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731236|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731237|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731238|NCT01953887|Urological Agents|urological agents|mesh-ancestor
83731239|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83731240|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83731241|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
83731242|NCT01953952|Cisplatin|cisplatin|mesh-list
83731243|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731244|NCT01953978|Acetaminophen|acetaminophen|mesh-list
83731245|NCT01953978|Dexamethasone|dexamethasone|mesh-list
83731246|NCT01953978|Ibuprofen|ibuprofen|mesh-list
83731247|NCT01953978|Morphine|morphine|mesh-list
83731248|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83731249|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
83731250|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
83731251|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731252|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731253|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731254|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
83731255|NCT01953978|Hormones|hormones|mesh-ancestor
83731256|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731257|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83731258|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731259|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83731260|NCT01953978|Narcotics|narcotics|mesh-ancestor
83731261|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731262|NCT01953978|Analgesics|analgesics|mesh-ancestor
83731263|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
83731264|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83731265|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83731266|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83731267|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83731268|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731269|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731270|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
83731271|NCT01954030|Bevacizumab|bevacizumab|mesh-list
83731272|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83731273|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83731274|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731275|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83731276|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83731277|NCT01954030|Growth Substances|growth substances|mesh-ancestor
83731278|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731279|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
83731280|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83731281|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731282|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731283|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83731284|NCT01954043|Rifampin|rifampin|mesh-list
83731285|NCT01954043|Dabrafenib|dabrafenib|mesh-list
83731286|NCT01954043|Rabeprazole|rabeprazole|mesh-list
83731287|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83731288|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731289|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83731290|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731291|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731292|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83731293|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
83731294|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83731295|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731296|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
83731297|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83731298|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83731299|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83731300|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83731301|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83731302|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83731303|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83731304|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731305|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83731306|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
83731307|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83731308|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
83731309|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731310|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
83731311|NCT01954108|Protective Agents|protective agents|mesh-ancestor
83731313|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
83731314|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731315|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731316|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
83731317|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83731318|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
83731319|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83731320|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
83731321|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731322|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731323|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
83731324|NCT01954290|Mannitol|mannitol|mesh-list
83731325|NCT01954290|Conivaptan|conivaptan|mesh-list
83731326|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83731327|NCT01954290|Diuretics|diuretics|mesh-ancestor
83731328|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
83731329|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731330|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83731331|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731332|NCT01954355|Paclitaxel|paclitaxel|mesh-list
83731333|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83731334|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731335|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731336|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731337|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731338|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731339|NCT01954368|Sufentanil|sufentanil|mesh-list
83731340|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83731341|NCT01954368|Narcotics|narcotics|mesh-ancestor
83731342|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731343|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731344|NCT01954368|Analgesics|analgesics|mesh-ancestor
83731345|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
83731346|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731347|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83731348|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83731349|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
83731350|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
83731351|NCT01954693|Everolimus|everolimus|mesh-list
83731352|NCT01954693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83731353|NCT01954693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83731354|NCT01954693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731355|NCT01954693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731356|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731357|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
83731358|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731359|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731360|NCT01954732|Metformin|metformin|mesh-list
83731361|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83731362|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731363|NCT01954784|Cyclosporine|cyclosporine|mesh-list
82886418|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731364|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
83731365|NCT01954784|Fludarabine|fludarabine|mesh-list
83731366|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
83731367|NCT01954784|Lenalidomide|lenalidomide|mesh-list
83731368|NCT01954784|Bortezomib|bortezomib|mesh-list
83731369|NCT01954784|Cyclosporins|cyclosporins|mesh-list
83731370|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731371|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83731372|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
83731373|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731374|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731375|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
83731376|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731377|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731378|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
83731379|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731380|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83731381|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83731382|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83731383|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83731384|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83731385|NCT01954784|Growth Substances|growth substances|mesh-ancestor
83731386|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
83731387|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83731388|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83731389|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
83731390|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83731391|NCT01954914|Plerixafor|plerixafor|mesh-list
83731392|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83731393|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83731394|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
83731395|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731396|NCT01954992|Fluorouracil|fluorouracil|mesh-list
83731397|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
83731398|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731399|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83731400|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731401|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731402|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
83731403|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731404|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
83731405|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
83731406|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731407|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
83731408|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731409|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731410|NCT01955070|Ketamine|ketamine|mesh-list
83731411|NCT01955070|Analgesics|analgesics|mesh-ancestor
83731412|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
83731413|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731414|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731415|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83731416|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83731417|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
83731418|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
83731419|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731420|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83731421|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83731422|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731423|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731424|NCT01955135|Ketamine|ketamine|mesh-list
83731425|NCT01955135|Propofol|propofol|mesh-list
83731426|NCT01955135|Sevoflurane|sevoflurane|mesh-list
83731427|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83731428|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731429|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731430|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83731431|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
83731432|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
83731433|NCT01955135|Analgesics|analgesics|mesh-ancestor
83731434|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
83731435|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731436|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83731437|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83731438|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82886493|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
83731439|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731440|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731441|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83731442|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83731443|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
83731444|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83731445|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731446|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731447|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
83731448|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731449|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731450|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
83731451|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83731452|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83731453|NCT01955187|Prednisolone|prednisolone|mesh-list
83731454|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
83731455|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
83731456|NCT01955187|Rituximab|rituximab|mesh-list
83731457|NCT01955187|Tacrolimus|tacrolimus|mesh-list
83731458|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83731459|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
83731460|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83731461|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
83731462|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731463|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83731464|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83731465|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
83731466|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731467|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731468|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83731469|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83731470|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83731471|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731472|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83731473|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
83731474|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
83731475|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731476|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731477|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
83731478|NCT01955187|Hormones|hormones|mesh-ancestor
83731479|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731480|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83731481|NCT01955187|Protective Agents|protective agents|mesh-ancestor
83731482|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83731483|NCT01955200|Cilostazol|cilostazol|mesh-list
83731484|NCT01955200|Clopidogrel|clopidogrel|mesh-list
83731485|NCT01955200|Ticagrelor|ticagrelor|mesh-list
83731486|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83731487|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83731488|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83731489|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83731490|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
83731491|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731492|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731493|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731494|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83731495|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
83731496|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731497|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83731498|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
83731499|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83731500|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83731501|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
83731502|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83731503|NCT01955200|Protective Agents|protective agents|mesh-ancestor
83731504|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83731505|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83731506|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731507|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
83731508|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83731509|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731510|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
83731511|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731512|NCT01955252|Azithromycin|azithromycin|mesh-list
82886570|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
83731514|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731515|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
83731516|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83731517|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731518|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
83731519|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83731520|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
83731521|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731522|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731523|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731524|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83731525|NCT01955421|Gefitinib|gefitinib|mesh-list
83731526|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731527|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83731528|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731529|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731530|NCT01955577|Vitamin D|vitamin d|mesh-list
83731531|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
83731532|NCT01955577|Vitamins|vitamins|mesh-ancestor
83731533|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
83731534|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731535|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83731536|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83731537|NCT01955642|Clopidogrel|clopidogrel|mesh-list
83731538|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83731539|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83731540|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83731541|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83731542|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
83731543|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731544|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731545|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731546|NCT01955655|Baclofen|baclofen|mesh-list
83731547|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83731548|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731549|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83731550|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731551|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83731552|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
83731553|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
83731554|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731555|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731556|NCT01955694|Eplerenone|eplerenone|mesh-list
83731557|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83731558|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
83731559|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731560|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731561|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83731562|NCT01955694|Diuretics|diuretics|mesh-ancestor
83731563|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
83731564|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83731565|NCT01955759|Amiodarone|amiodarone|mesh-list
83731566|NCT01955759|Bisoprolol|bisoprolol|mesh-list
83731567|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83731568|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83731569|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83731570|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83731571|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
83731572|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731573|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83731574|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83731575|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731576|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83731577|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731578|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731579|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731580|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83731581|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
83731582|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83731583|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731584|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82886641|NCT02312245|Gemcitabine|gemcitabine|mesh-list
83731585|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83731586|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83731587|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83731588|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83731589|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83731590|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83731591|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
83731592|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
83731593|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731594|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83731596|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
83731597|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
83731598|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731599|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731600|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
83731601|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731602|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83731603|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83731604|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83731605|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731606|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731607|NCT01955967|Lidocaine|lidocaine|mesh-list
83731608|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83731609|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
83731610|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731611|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731612|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
83731613|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731614|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83731615|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83731616|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83731617|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731618|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731619|NCT01956006|Milrinone|milrinone|mesh-list
83731620|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83731621|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83731622|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
83731623|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83731624|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83731625|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731626|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731627|NCT01956006|Protective Agents|protective agents|mesh-ancestor
83731628|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731629|NCT01956201|Atorvastatin|atorvastatin|mesh-list
83731630|NCT01956201|Fenofibrate|fenofibrate|mesh-list
83731631|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83731632|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83731633|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
83731634|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731635|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83731636|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83731637|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731638|NCT01956305|Metformin|metformin|mesh-list
83731639|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83731640|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731641|NCT01956474|Riboflavin|riboflavin|mesh-list
83731642|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
83731643|NCT01956474|Vitamins|vitamins|mesh-ancestor
83731644|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
83731645|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731646|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83731647|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
83731648|NCT01956487|Propafenone|propafenone|mesh-list
83731649|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83731650|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83731651|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83731652|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731653|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731654|NCT01956591|Oxybutynin|oxybutynin|mesh-list
83731655|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
82886715|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731656|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
83731657|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731658|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731659|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83731660|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83731661|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
83731662|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731663|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731664|NCT01956591|Urological Agents|urological agents|mesh-ancestor
83731665|NCT01956604|Clonidine|clonidine|mesh-list
83731666|NCT01956604|Analgesics|analgesics|mesh-ancestor
83731667|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
83731668|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731669|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731670|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83731671|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
83731672|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
83731673|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83731674|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83731675|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83731676|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731677|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731678|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731679|NCT01956695|Rituximab|rituximab|mesh-list
83731680|NCT01956695|Lenalidomide|lenalidomide|mesh-list
83731681|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83731682|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731683|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
83731684|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731685|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83731686|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83731687|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83731688|NCT01956695|Growth Substances|growth substances|mesh-ancestor
83731689|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
83731690|NCT01956734|Temozolomide|temozolomide|mesh-list
83731691|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83731692|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
83731693|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731694|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731695|NCT01956786|Amlodipine|amlodipine|mesh-list
83731696|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83731697|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83731698|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731699|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731700|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83731701|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731702|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
83731703|NCT01956864|Vitamin D|vitamin d|mesh-list
83731704|NCT01956864|Vitamins|vitamins|mesh-ancestor
83731705|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
83731706|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731707|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83731708|NCT01956929|Metformin|metformin|mesh-list
83731709|NCT01956929|Lactulose|lactulose|mesh-list
83731710|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83731711|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731712|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731713|NCT01956955|Heparin|heparin|mesh-list
83731714|NCT01956955|Enoxaparin|enoxaparin|mesh-list
83731715|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83731716|NCT01956955|Calcium heparin|calcium heparin|mesh-list
83731717|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
83731718|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83731719|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83731720|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731721|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
83731722|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
83731723|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83731724|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731725|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731726|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83731727|NCT01956981|Analgesics|analgesics|mesh-ancestor
83731728|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
82886790|NCT02115295|Cladribine|cladribine|mesh-list
82886791|NCT02115295|Midostaurin|midostaurin|mesh-list
83731729|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731730|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83731731|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83731732|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83731733|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731734|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731735|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731736|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
83731737|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83731738|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
83731739|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83731740|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83731741|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83731742|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
83731743|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731744|NCT01957007|Docetaxel|docetaxel|mesh-list
83731745|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731746|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731747|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731748|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731749|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731750|NCT01957046|Laxatives|laxatives|mesh-list
83731751|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731752|NCT01957189|Tamsulosin|tamsulosin|mesh-list
83731753|NCT01957189|Dutasteride|dutasteride|mesh-list
83731754|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83731755|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83731756|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83731757|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731758|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731759|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731760|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731761|NCT01957189|Urological Agents|urological agents|mesh-ancestor
83731762|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83731763|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83731764|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731765|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
83731766|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731767|NCT01957293|Albuterol|albuterol|mesh-list
83731768|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83731769|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
83731770|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731771|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731772|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83731773|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
83731774|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
83731775|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731776|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83731777|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83731778|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83731779|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731780|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731781|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731782|NCT01957319|Vitamin E|vitamin e|mesh-list
83731783|NCT01957319|Silybin|silybin|mesh-list
83731784|NCT01957319|Vitamins|vitamins|mesh-ancestor
83731785|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
83731786|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731787|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
83731788|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731789|NCT01957319|Protective Agents|protective agents|mesh-ancestor
83731790|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83731791|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731792|NCT01957436|Docetaxel|docetaxel|mesh-list
83731793|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
83731794|NCT01957436|Androgens|androgens|mesh-list
83731795|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731796|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731797|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731798|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731799|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731800|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83731801|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731802|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886864|NCT01989585|Dabrafenib|dabrafenib|mesh-list
82886865|NCT01989585|Navitoclax|navitoclax|mesh-list
83731803|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731804|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731805|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83731806|NCT01957436|Hormones|hormones|mesh-ancestor
83731807|NCT01957449|Propranolol|propranolol|mesh-list
83731808|NCT01957449|Metoprolol|metoprolol|mesh-list
83731809|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83731810|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83731811|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731812|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731813|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731814|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731815|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83731816|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83731817|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
83731818|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
83731819|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
83731820|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731821|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83731822|NCT01957540|Ticagrelor|ticagrelor|mesh-list
83731823|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83731824|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83731825|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83731826|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83731827|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83731828|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
83731829|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731830|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731831|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731832|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
83731833|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83731834|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83731835|NCT01957631|Prednisolone|prednisolone|mesh-list
83731836|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
83731837|NCT01957631|Bupivacaine|bupivacaine|mesh-list
83731838|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83731839|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
83731840|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
83731841|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
83731842|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731843|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731844|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
83731845|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731846|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83731847|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
83731848|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
83731849|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731850|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
83731851|NCT01957631|Hormones|hormones|mesh-ancestor
83731852|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731853|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83731854|NCT01957631|Protective Agents|protective agents|mesh-ancestor
83731855|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83731856|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731857|NCT01957839|Cabergoline|cabergoline|mesh-list
83731858|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83731859|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83731860|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
83731861|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
83731862|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731863|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731864|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731865|NCT01957852|Thrombin|thrombin|mesh-list
83731866|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
83731867|NCT01957852|Coagulants|coagulants|mesh-ancestor
83731868|NCT01957943|SMOFlipid|smoflipid|mesh-list
83731869|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83731870|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83731871|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83731872|NCT01957995|Docetaxel|docetaxel|mesh-list
83731873|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731874|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731875|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731876|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731877|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731878|NCT01958138|Propofol|propofol|mesh-list
83731879|NCT01958138|Isoflurane|isoflurane|mesh-list
83731880|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83731881|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83731882|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731883|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83731884|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
83731885|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
83731886|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83731887|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83731888|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83731889|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83731890|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83731891|NCT01958372|Etoposide|etoposide|mesh-list
83731892|NCT01958372|Pemetrexed|pemetrexed|mesh-list
83731893|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731894|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83731895|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83731896|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83731897|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731898|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731899|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83731900|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83731901|NCT01958580|Gemcitabine|gemcitabine|mesh-list
83731902|NCT01958580|Docetaxel|docetaxel|mesh-list
83731903|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83731904|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
83731905|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731906|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731907|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
83731908|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
83731909|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
83731911|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
83731912|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83731913|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
83731914|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731915|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731916|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83731917|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83731918|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83731919|NCT01958684|Trace Elements|trace elements|mesh-ancestor
83731920|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
83731921|NCT01958775|Glucagon|glucagon|mesh-list
83731922|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83731923|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83731924|NCT01958775|Hormones|hormones|mesh-ancestor
83731925|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83731926|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731927|NCT01958775|Incretins|incretins|mesh-ancestor
83731928|NCT01958814|Albuterol|albuterol|mesh-list
83731929|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83731930|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
83731931|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731932|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731933|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83731934|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
83731935|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
83731936|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83731937|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83731938|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83731939|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83731940|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731941|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731942|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731943|NCT01958866|Acetaminophen|acetaminophen|mesh-list
83731944|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83731945|NCT01958866|Analgesics|analgesics|mesh-ancestor
83731946|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
83731947|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731948|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731949|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
83731950|NCT01958905|Lumefantrine|lumefantrine|mesh-list
83731951|NCT01958905|Artemether|artemether|mesh-list
83731952|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83731953|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
83731954|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83731955|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83731956|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83731957|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
83731958|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83731959|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
83731960|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83731961|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731962|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83731963|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
83731964|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83731965|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
83731966|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731967|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731968|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83731969|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
83731970|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
83731971|NCT01958944|Protective Agents|protective agents|mesh-ancestor
83731972|NCT01958996|Idarubicin|idarubicin|mesh-list
83731973|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83731974|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731975|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83731976|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83731977|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731978|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731979|NCT01959022|Doxazosin|doxazosin|mesh-list
83731980|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83731981|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83731982|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83731983|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83731984|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
83731985|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83731986|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731987|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83731988|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
83731989|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
83731990|NCT01959061|Raltitrexed|raltitrexed|mesh-list
83731991|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83731992|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83731993|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
83731994|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83731995|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83731996|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83731997|NCT01959074|Aceclofenac|aceclofenac|mesh-list
83731998|NCT01959074|Naftopidil|naftopidil|mesh-list
83731999|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83732000|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732001|NCT01959074|Analgesics|analgesics|mesh-ancestor
83732002|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
83732003|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732004|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732005|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732006|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83732007|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83732008|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83732009|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732010|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732011|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732012|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83732013|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83732014|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732015|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83732016|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83732017|NCT01959100|Azithromycin|azithromycin|mesh-list
83732018|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83732019|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83732020|NCT01959152|Imidacloprid|imidacloprid|mesh-list
83732021|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
83732022|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732023|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732024|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732025|NCT01959191|Aspirin|aspirin|mesh-list
83732026|NCT01959191|Clopidogrel|clopidogrel|mesh-list
82887094|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83732027|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83732029|NCT01959191|Analgesics|analgesics|mesh-ancestor
83732030|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
83732031|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732032|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732033|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732034|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83732035|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83732036|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83732037|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732038|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83732039|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83732040|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732041|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
83732042|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83732043|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83732044|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83732045|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
83732046|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732047|NCT01959386|Trastuzumab|trastuzumab|mesh-list
83732048|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83732049|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732050|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83732051|NCT01959399|Peficitinib|peficitinib|mesh-list
83732052|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83732053|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83732054|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
83732055|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732056|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83732057|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83732058|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732059|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83732060|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
83732061|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732062|NCT01959438|Selenious Acid|selenious acid|mesh-list
83732063|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
83732064|NCT01959438|Trace Elements|trace elements|mesh-ancestor
83732065|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
83732066|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732067|NCT01959451|Clopidogrel|clopidogrel|mesh-list
83732068|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83732069|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83732070|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83732071|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83732072|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83732073|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
83732074|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732075|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732076|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732077|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
83732078|NCT01959477|Busulfan|busulfan|mesh-list
83732079|NCT01959477|Etoposide|etoposide|mesh-list
83732080|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
83732081|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83732082|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
83732083|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732084|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83732085|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83732086|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
83732087|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732088|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732089|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83732090|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83732091|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83732092|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83732093|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732094|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
83732095|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83732096|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
83732097|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732098|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732099|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83732100|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
83732101|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83732102|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
83732103|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732104|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732105|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83732106|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
83732107|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
83732108|NCT01959828|Protective Agents|protective agents|mesh-ancestor
83732109|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83732110|NCT01959854|Laxatives|laxatives|mesh-ancestor
83732111|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83732112|NCT01959971|Alirocumab|alirocumab|mesh-list
83732113|NCT01959971|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83732114|NCT01959971|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83732115|NCT01959971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83732116|NCT01959971|Antimetabolites|antimetabolites|mesh-ancestor
83732117|NCT01959971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732118|NCT01959971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83732119|NCT01959971|Protease Inhibitors|protease inhibitors|mesh-ancestor
83732120|NCT01959971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732121|NCT01959971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83732122|NCT01960023|Cetuximab|cetuximab|mesh-list
83732123|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83732124|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732125|NCT01960049|Ropivacaine|ropivacaine|mesh-list
83732126|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732127|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
83732128|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732129|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732130|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
83732131|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732132|NCT01960153|Tadalafil|tadalafil|mesh-list
83732133|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
83732134|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83732135|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83732136|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732137|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732138|NCT01960153|Urological Agents|urological agents|mesh-ancestor
83732139|NCT01960179|Lixisenatide|lixisenatide|mesh-list
83732140|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83732141|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732142|NCT01960205|Metformin|metformin|mesh-list
83732143|NCT01960205|Saxagliptin|saxagliptin|mesh-list
83732144|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83732145|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732146|NCT01960205|Incretins|incretins|mesh-ancestor
83732147|NCT01960205|Hormones|hormones|mesh-ancestor
83732148|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732149|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83732150|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
83732151|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732152|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732153|NCT01960283|Methotrexate|methotrexate|mesh-list
83732154|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83732155|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
83732156|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83732157|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732158|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83732159|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
83732160|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732161|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732162|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83732163|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732164|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83732165|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83732166|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
83732167|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83732168|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83732169|NCT01960426|Adalimumab|adalimumab|mesh-list
83732170|NCT01960426|Infliximab|infliximab|mesh-list
83732171|NCT01960426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82887243|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732172|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732173|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887246|NCT00254670|Naltrexone|naltrexone|mesh-list
83732174|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83732175|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83732176|NCT01960543|Fentanyl|fentanyl|mesh-list
83732177|NCT01960543|Bupivacaine|bupivacaine|mesh-list
83732178|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
83732179|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732180|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
83732181|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732182|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732183|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
83732184|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732185|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83732186|NCT01960543|Narcotics|narcotics|mesh-ancestor
83732187|NCT01960543|Analgesics|analgesics|mesh-ancestor
83732188|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83732189|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83732190|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
83732191|NCT01960569|Hirudins|hirudins|mesh-list
83732192|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
83732193|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83732194|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
83732195|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732196|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732197|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
83732198|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83732199|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83732200|NCT01960595|Fentanyl|fentanyl|mesh-list
83732201|NCT01960595|Bupivacaine|bupivacaine|mesh-list
83732202|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732203|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
83732204|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732205|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732206|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
83732207|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732208|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83732209|NCT01960595|Narcotics|narcotics|mesh-ancestor
83732210|NCT01960595|Analgesics|analgesics|mesh-ancestor
83732211|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83732212|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83732213|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
83732214|NCT01960647|Paclitaxel|paclitaxel|mesh-list
83732215|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83732216|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732217|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
83732218|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
83732219|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
83732220|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732221|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83732222|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83732223|NCT01960829|Everolimus|everolimus|mesh-list
83732224|NCT01960829|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83732225|NCT01960829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83732226|NCT01960829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732227|NCT01960829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732228|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83732229|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
83732230|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732231|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732232|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83732233|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83732234|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83732235|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
83732236|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83732237|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
83732238|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732239|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732240|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
83732241|NCT01961154|Hormones|hormones|mesh-ancestor
83732242|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732243|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
83732244|NCT01961180|Escitalopram|escitalopram|mesh-list
83732245|NCT01961180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83732246|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83732247|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732248|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887324|NCT05794997|Atenolol|atenolol|mesh-list
83732249|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732250|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
83732251|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732252|NCT01961193|Silicon|silicon|mesh-list
83732253|NCT01961193|Trace Elements|trace elements|mesh-ancestor
83732254|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
83732255|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732256|NCT01961219|Anesthetics|anesthetics|mesh-list
83732257|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732258|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732259|NCT01961336|Testosterone|testosterone|mesh-list
83732260|NCT01961336|Androgens|androgens|mesh-ancestor
83732261|NCT01961336|Hormones|hormones|mesh-ancestor
83732262|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732263|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732264|NCT01961388|Metformin|metformin|mesh-list
83732265|NCT01961388|Acarbose|acarbose|mesh-list
83732266|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83732267|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732268|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83732269|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732270|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732271|NCT01961414|Aflibercept|aflibercept|mesh-list
83732272|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83732273|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83732274|NCT01961414|Growth Substances|growth substances|mesh-ancestor
83732275|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732276|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
83732277|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732278|NCT01961453|Isosorbide|isosorbide|mesh-list
83732279|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83732280|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83732281|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83732282|NCT01961453|Diuretics|diuretics|mesh-ancestor
83732283|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
83732284|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732285|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
83732286|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83732287|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732288|NCT01961635|Cimetidine|cimetidine|mesh-list
83732289|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83732290|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83732291|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83732292|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
83732293|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
83732294|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732295|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732296|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732297|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83732298|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83732299|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732300|NCT01961739|Lidocaine|lidocaine|mesh-list
83732301|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732302|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
83732303|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732304|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732305|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
83732306|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732307|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83732308|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83732309|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83732310|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732311|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732312|NCT01961752|Triamcinolone|triamcinolone|mesh-list
83732313|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83732314|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83732315|NCT01961752|Bupivacaine|bupivacaine|mesh-list
83732316|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83732317|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732318|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
83732319|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732320|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732321|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
83732322|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732323|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732324|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
83732326|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732327|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83732328|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
83732329|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732330|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732331|NCT01961830|Arbekacin|arbekacin|mesh-list
83732332|NCT01961830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83732333|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83732334|NCT01961843|Prednisone|prednisone|mesh-list
83732335|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
83732336|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732337|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
83732338|NCT01961843|Hormones|hormones|mesh-ancestor
83732339|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732340|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732341|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83732342|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732343|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83732344|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732345|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732346|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
83732347|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83732348|NCT01961856|Clopidogrel|clopidogrel|mesh-list
83732349|NCT01961856|Ticagrelor|ticagrelor|mesh-list
83732350|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83732351|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83732352|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83732353|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83732354|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
83732355|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732356|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732357|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732358|NCT01961947|Vaccines|vaccines|mesh-list
83732359|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
83732360|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732361|NCT01962116|Heparin|heparin|mesh-list
83732362|NCT01962116|Calcium heparin|calcium heparin|mesh-list
83732363|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
83732364|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732365|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83732366|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83732367|NCT01962181|Methylphenidate|methylphenidate|mesh-list
83732368|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83732369|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732370|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83732371|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83732372|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732373|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732374|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
83732375|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732376|NCT01962285|Propofol|propofol|mesh-list
83732377|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83732378|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732379|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732380|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83732381|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
83732382|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
83732383|NCT01962363|Tocotrienols|tocotrienols|mesh-list
83732384|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
83732385|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
83732386|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732387|NCT01962363|Protective Agents|protective agents|mesh-ancestor
83732388|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732389|NCT01962363|Vitamins|vitamins|mesh-ancestor
83732390|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
83732391|NCT01962376|Bevacizumab|bevacizumab|mesh-list
83732392|NCT01962376|Capecitabine|capecitabine|mesh-list
83732393|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
83732394|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83732395|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732396|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83732397|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83732398|NCT01962376|Growth Substances|growth substances|mesh-ancestor
83732399|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732400|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
83732401|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83732402|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
83732403|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732404|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
83732405|NCT01962454|Testosterone|testosterone|mesh-list
83732406|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
83732407|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
83732408|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83732409|NCT01962454|Androgens|androgens|mesh-ancestor
83732410|NCT01962454|Hormones|hormones|mesh-ancestor
83732411|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732412|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732413|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83732414|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732415|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
83732416|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
83732417|NCT01962571|Hematinics|hematinics|mesh-ancestor
83732418|NCT01962831|Dinoprostone|dinoprostone|mesh-list
83732419|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
83732420|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83732421|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732422|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83732423|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
83732424|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83732425|NCT01963039|Protective Agents|protective agents|mesh-ancestor
83732426|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732427|NCT01963182|Irinotecan|irinotecan|mesh-list
83732428|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83732429|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83732430|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732431|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732432|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732433|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83732434|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83732435|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732436|NCT01963299|Clonidine|clonidine|mesh-list
83732437|NCT01963299|Ropivacaine|ropivacaine|mesh-list
83732438|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732439|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
83732440|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732441|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732442|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
83732443|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732444|NCT01963299|Analgesics|analgesics|mesh-ancestor
83732445|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83732446|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
83732447|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
83732448|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83732449|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83732450|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83732451|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732452|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732453|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732454|NCT01963325|Paclitaxel|paclitaxel|mesh-list
83732455|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83732456|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83732457|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732458|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
83732459|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
83732460|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
83732461|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732462|NCT01963390|Testosterone|testosterone|mesh-list
83732463|NCT01963390|Androgens|androgens|mesh-ancestor
83732464|NCT01963390|Hormones|hormones|mesh-ancestor
83732465|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732466|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732467|NCT01963416|Micronutrients|micronutrients|mesh-list
83732468|NCT01963416|Trace Elements|trace elements|mesh-list
83732469|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732470|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83732471|NCT01963442|Lactams|lactams|mesh-list
83732472|NCT01963442|beta-Lactams|beta-lactams|mesh-list
83732473|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83732474|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83732475|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83732476|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732477|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732478|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
83732479|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732480|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732481|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83732482|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732483|NCT01963546|Analgesics|analgesics|mesh-ancestor
83732484|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
83732485|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732486|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83732487|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83732488|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83732489|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732490|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732491|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732492|NCT01963559|Lidocaine|lidocaine|mesh-list
83732493|NCT01963559|Prilocaine|prilocaine|mesh-list
83732494|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83732495|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732496|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
83732497|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732498|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732499|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
83732500|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732501|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83732502|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83732503|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83732504|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732505|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732506|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83732507|NCT01963663|Metformin|metformin|mesh-list
83732508|NCT01963663|Pioglitazone|pioglitazone|mesh-list
83732509|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83732510|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732511|NCT01963702|Capecitabine|capecitabine|mesh-list
83732512|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
83732513|NCT01963702|Docetaxel|docetaxel|mesh-list
83732514|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83732515|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
83732516|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732517|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732518|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
83732519|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
83732520|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
83732521|NCT01963741|Histamine|histamine|mesh-list
83732522|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
83732523|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
83732524|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732525|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732526|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732527|NCT01963754|Epinephrine|epinephrine|mesh-list
83732528|NCT01963754|Racepinephrine|racepinephrine|mesh-list
83732529|NCT01963754|Anesthetics|anesthetics|mesh-list
83732530|NCT01963754|Carticaine|carticaine|mesh-list
83732531|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
83732532|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732533|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732534|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83732535|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83732536|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732537|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732538|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732539|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83732540|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83732541|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
83732542|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732543|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83732544|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
83732545|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
83732546|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
82887624|NCT05287256|Analgesics|analgesics|mesh-ancestor
83732547|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83732548|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732549|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
83732551|NCT01963832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83732552|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83732553|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732554|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732555|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732556|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
83732557|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732558|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83732559|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
83732560|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83732561|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83732562|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83732563|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732564|NCT01963910|Mannitol|mannitol|mesh-list
83732565|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83732566|NCT01963910|Diuretics|diuretics|mesh-ancestor
83732567|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
83732568|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732569|NCT01963962|Copper|copper|mesh-list
83732570|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
83732571|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83732572|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
83732573|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83732574|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732575|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83732576|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83732577|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83732578|NCT01963962|Trace Elements|trace elements|mesh-ancestor
83732579|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
83732580|NCT01964001|Vitamins|vitamins|mesh-list
83732581|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
83732582|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
83732583|NCT01964001|Pyridoxal|pyridoxal|mesh-list
83732584|NCT01964001|Pyridoxine|pyridoxine|mesh-list
83732585|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
83732586|NCT01964001|Ubiquinone|ubiquinone|mesh-list
83732587|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
83732588|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732589|NCT01964027|Irinotecan|irinotecan|mesh-list
83732590|NCT01964027|Epirubicin|epirubicin|mesh-list
83732591|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83732592|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83732593|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732594|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732595|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732596|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83732597|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83732598|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
83732599|NCT01964040|Bupivacaine|bupivacaine|mesh-list
83732600|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732601|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
83732602|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732603|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732604|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
83732605|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732606|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83732607|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732608|NCT01964040|Analgesics|analgesics|mesh-ancestor
83732609|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83732610|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83732611|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83732612|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732613|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732614|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732615|NCT01964079|Losartan|losartan|mesh-list
83732616|NCT01964079|Amlodipine|amlodipine|mesh-list
83732617|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83732618|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83732619|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732620|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732621|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82887694|NCT05054725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82887698|NCT05047211|Dextrans|dextrans|mesh-list
83732622|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732623|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
83732624|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83732625|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83732626|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83732627|NCT01964157|Ceritinib|ceritinib|mesh-list
83732628|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732629|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83732630|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732631|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732632|NCT01964170|Goserelin|goserelin|mesh-list
83732633|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83732634|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732635|NCT01964183|Mirabegron|mirabegron|mesh-list
83732636|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83732637|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83732638|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83732639|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83732640|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732641|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732642|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732643|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732644|NCT01964183|Urological Agents|urological agents|mesh-ancestor
83732645|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83732646|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83732647|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
83732648|NCT01964248|Lidocaine|lidocaine|mesh-list
83732649|NCT01964248|Prilocaine|prilocaine|mesh-list
83732650|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83732651|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732652|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
83732653|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732654|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732655|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
83732656|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732657|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83732658|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83732659|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83732660|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732661|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732662|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83732663|NCT01964287|Leucovorin|leucovorin|mesh-list
83732664|NCT01964287|Paclitaxel|paclitaxel|mesh-list
83732665|NCT01964287|Gemcitabine|gemcitabine|mesh-list
83732666|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
83732667|NCT01964287|Irinotecan|irinotecan|mesh-list
83732668|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83732669|NCT01964287|Folfirinox|folfirinox|mesh-list
83732670|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83732671|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732672|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
83732673|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
83732674|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
83732675|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732676|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83732677|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
83732678|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83732679|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83732680|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732681|NCT01964287|Antidotes|antidotes|mesh-ancestor
83732682|NCT01964287|Protective Agents|protective agents|mesh-ancestor
83732683|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732684|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
83732685|NCT01964287|Vitamins|vitamins|mesh-ancestor
83732686|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
83732687|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
83732688|NCT01964365|Fenofibrate|fenofibrate|mesh-list
83732689|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83732690|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82887768|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82887769|NCT04630769|Analgesics|analgesics|mesh-ancestor
82887770|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
83732691|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
83732692|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732693|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83732694|NCT01964391|Paclitaxel|paclitaxel|mesh-list
83732696|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
83732697|NCT01964391|Carboplatin|carboplatin|mesh-list
83732698|NCT01964391|Doxorubicin|doxorubicin|mesh-list
83732699|NCT01964391|Trastuzumab|trastuzumab|mesh-list
83732700|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83732701|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732702|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
83732703|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
83732704|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
83732705|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732706|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83732707|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
83732708|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732709|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83732710|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83732711|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
83732712|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83732713|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83732714|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83732715|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83732716|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732717|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83732718|NCT01964404|Dronabinol|dronabinol|mesh-list
83732719|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
83732720|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732721|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83732722|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732723|NCT01964404|Analgesics|analgesics|mesh-ancestor
83732724|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
83732725|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732726|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83732727|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83732728|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732729|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732730|NCT01964404|Hormones|hormones|mesh-ancestor
83732731|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732732|NCT01964534|Gemcitabine|gemcitabine|mesh-list
83732733|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83732734|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83732735|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
83732736|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732737|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732738|NCT01964573|Rotigotine|rotigotine|mesh-list
83732739|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
83732740|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
83732741|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732742|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732743|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732744|NCT01964586|Lidocaine|lidocaine|mesh-list
83732745|NCT01964586|Epinephrine|epinephrine|mesh-list
83732746|NCT01964586|Racepinephrine|racepinephrine|mesh-list
83732747|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
83732748|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
83732749|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732750|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
83732751|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732752|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732753|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
83732754|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732755|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83732756|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83732757|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83732758|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732759|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732760|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83732761|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732762|NCT01964586|Analgesics|analgesics|mesh-ancestor
83732763|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83732764|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83732765|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83732766|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732767|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732768|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83732769|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83732771|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83732772|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
83732773|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
83732774|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
83732775|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83732776|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
83732777|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732778|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732779|NCT01964781|Epinephrine|epinephrine|mesh-list
83732780|NCT01964781|Racepinephrine|racepinephrine|mesh-list
83732781|NCT01964781|Bupivacaine|bupivacaine|mesh-list
83732782|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
83732783|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
83732784|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732785|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
83732786|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732787|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732788|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
83732789|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732790|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83732791|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83732792|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732793|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
83732794|NCT01964781|Coagulants|coagulants|mesh-ancestor
83732795|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83732796|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83732797|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
83732798|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732799|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83732800|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83732801|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
83732802|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83732803|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
83732804|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
83732805|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
83732806|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83732807|NCT01964846|Curcumin|curcumin|mesh-list
83732808|NCT01964846|Resveratrol|resveratrol|mesh-list
83732809|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83732810|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732811|NCT01964846|Analgesics|analgesics|mesh-ancestor
83732812|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
83732813|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732814|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732815|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732816|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83732817|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732818|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732819|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732820|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
83732821|NCT01964846|Protective Agents|protective agents|mesh-ancestor
83732822|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83732823|NCT01964911|Ropivacaine|ropivacaine|mesh-list
83732824|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732825|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
83732826|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732827|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732828|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
83732829|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732830|NCT01965041|Aflibercept|aflibercept|mesh-list
83732831|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83732832|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83732833|NCT01965041|Growth Substances|growth substances|mesh-ancestor
83732834|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732835|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
83732836|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732837|NCT01965080|Exemestane|exemestane|mesh-list
83732838|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732839|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83732840|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82887917|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887918|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887919|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83732841|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732842|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732843|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83732844|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83732845|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732846|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732847|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83732848|NCT01965275|Gefitinib|gefitinib|mesh-list
83732849|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732850|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83732851|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732852|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732853|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
83732854|NCT01965301|Promethazine|promethazine|mesh-list
83732855|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83732856|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83732857|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732858|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732859|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
83732860|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
83732861|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
83732862|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732863|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
83732864|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
83732865|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83732866|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83732867|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
83732868|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
83732869|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732870|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732871|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83732872|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
83732873|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
83732874|NCT01965353|Dexamethasone|dexamethasone|mesh-list
83732875|NCT01965353|Lenalidomide|lenalidomide|mesh-list
83732876|NCT01965353|Bortezomib|bortezomib|mesh-list
83732877|NCT01965353|Panobinostat|panobinostat|mesh-list
83732878|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732879|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
83732880|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
83732881|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732882|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732883|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83732884|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
83732885|NCT01965353|Hormones|hormones|mesh-ancestor
83732886|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732887|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83732888|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732889|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
83732890|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83732891|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83732892|NCT01965353|Growth Substances|growth substances|mesh-ancestor
83732893|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
83732894|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83732895|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732896|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732897|NCT01965522|Vitamin D|vitamin d|mesh-list
83732898|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
83732899|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
83732900|NCT01965522|Vitamins|vitamins|mesh-list
83732901|NCT01965522|Melatonin|melatonin|mesh-list
83732902|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
83732903|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732904|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83732905|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83732906|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
83732907|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732908|NCT01965522|Protective Agents|protective agents|mesh-ancestor
83732909|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732910|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
83732911|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83732912|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
83732913|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82887993|NCT03784326|Fluorouracil|fluorouracil|mesh-list
82887994|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
82887995|NCT03784326|Atezolizumab|atezolizumab|mesh-list
83732914|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732915|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83732916|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83732917|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83732919|NCT01965626|Dexamethasone|dexamethasone|mesh-list
83732920|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83732921|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
83732922|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
83732923|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732924|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732925|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83732926|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
83732927|NCT01965626|Hormones|hormones|mesh-ancestor
83732928|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83732929|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83732930|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732931|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
83732932|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83732933|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732934|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732935|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
83732936|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83732937|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83732938|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732939|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
83732940|NCT01965730|Coagulants|coagulants|mesh-ancestor
83732941|NCT01965405|Bupropion|bupropion|mesh-list
83732942|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83732943|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
83732944|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83732945|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83732946|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83732947|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83732948|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732949|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
83732950|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83732951|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732952|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83732953|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83732954|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732955|NCT01965925|Modafinil|modafinil|mesh-list
83732956|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83732957|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732958|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83732959|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83732960|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83732961|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732962|NCT01965977|Bortezomib|bortezomib|mesh-list
83732963|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732964|NCT01966055|Solithromycin|solithromycin|mesh-list
83732965|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83732966|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83732967|NCT01966133|Doxorubicin|doxorubicin|mesh-list
83732968|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83732969|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
83732970|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83732971|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83732972|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83732973|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83732974|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732975|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732976|NCT01966172|Acetaminophen|acetaminophen|mesh-list
83732977|NCT01966172|Ibuprofen|ibuprofen|mesh-list
83732978|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83732979|NCT01966172|Morphine|morphine|mesh-list
83732980|NCT01966172|Gabapentin|gabapentin|mesh-list
83732981|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83732982|NCT01966172|Narcotics|narcotics|mesh-ancestor
83732983|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83732984|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83732985|NCT01966172|Analgesics|analgesics|mesh-ancestor
83732986|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
83732987|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83732988|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83732989|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83732990|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83732991|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83732992|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83732993|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83732994|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
83732995|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
83732996|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83732997|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83732998|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83732999|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83733000|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83733001|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733002|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
83733003|NCT01966276|Methylphenidate|methylphenidate|mesh-list
83733004|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83733005|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733006|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83733007|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83733008|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733009|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733010|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
83733011|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733012|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
83733013|NCT01966289|Guadecitabine|guadecitabine|mesh-list
83733014|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
83733015|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733016|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83733017|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733018|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83733019|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
83733020|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733021|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733022|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83733023|NCT01966302|Beraprost|beraprost|mesh-list
83733024|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83733025|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
83733026|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83733027|NCT01966341|Laxatives|laxatives|mesh-list
83733028|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
83733029|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733030|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83733031|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
83733032|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733033|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733034|NCT01966484|Succinylcholine|succinylcholine|mesh-list
83733035|NCT01966484|Mivacurium|mivacurium|mesh-list
83733036|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83733037|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83733038|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83733039|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733040|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733041|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83733042|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83733043|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
83733044|NCT01966575|Progestins|progestins|mesh-list
83733045|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83733046|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83733047|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83733048|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
83733049|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83733050|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733051|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83733052|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83733053|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83733054|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83733055|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733056|NCT01966575|Hormones|hormones|mesh-ancestor
83733057|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733058|NCT01966627|Liver Extracts|liver extracts|mesh-list
83733059|NCT01966627|Hematinics|hematinics|mesh-ancestor
83733060|NCT01966653|Fosfomycin|fosfomycin|mesh-list
83733061|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
83733062|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888146|NCT02693535|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83733063|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733064|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83733065|NCT01966692|Fluticasone|fluticasone|mesh-list
83733066|NCT01966692|Xhance|xhance|mesh-list
83733067|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733068|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83733069|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
83733070|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733071|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733072|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83733073|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
83733074|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
83733075|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83733076|NCT01966783|Budesonide|budesonide|mesh-list
83733077|NCT01966783|Mesalamine|mesalamine|mesh-list
83733078|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733079|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83733080|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
83733081|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733082|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733083|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83733084|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
83733085|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
83733086|NCT01966783|Hormones|hormones|mesh-ancestor
83733087|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733088|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83733089|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83733090|NCT01966783|Analgesics|analgesics|mesh-ancestor
83733091|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
83733092|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733093|NCT01966822|Ritonavir|ritonavir|mesh-list
83733094|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83733095|NCT01966822|Dolutegravir|dolutegravir|mesh-list
83733096|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
83733097|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83733098|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733099|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733100|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83733101|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83733102|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
83733103|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733104|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83733105|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83733106|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83733107|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83733108|NCT01966913|Bevacizumab|bevacizumab|mesh-list
83733109|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83733110|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733111|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733112|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733113|NCT01966913|Growth Substances|growth substances|mesh-ancestor
83733114|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733115|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733116|NCT01967017|Lidocaine|lidocaine|mesh-list
83733117|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
83733118|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
83733119|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733120|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733121|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
83733122|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733123|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83733124|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83733125|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83733126|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733127|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733128|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83733129|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733130|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83733131|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733132|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733133|NCT01967199|Paclitaxel|paclitaxel|mesh-list
83733134|NCT01967199|Everolimus|everolimus|mesh-list
83733135|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82888220|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888225|NCT01295645|Cidofovir|cidofovir|mesh-list
83733136|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733137|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733138|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733139|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733140|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733141|NCT01967199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83733142|NCT01967199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83733143|NCT01967199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733144|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83733145|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
83733146|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733147|NCT01967251|Udenafil|udenafil|mesh-list
83733148|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83733149|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83733150|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733151|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733152|NCT01967264|Udenafil|udenafil|mesh-list
83733153|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83733154|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83733155|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733156|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733157|NCT01967368|Vaccines|vaccines|mesh-list
83733158|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
83733159|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733160|NCT01967381|Methamphetamine|methamphetamine|mesh-list
83733161|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83733162|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733163|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
83733164|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
83733165|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733166|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
83733167|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733168|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733169|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
83733170|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83733171|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83733172|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733173|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83733174|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
83733175|NCT01967459|Vitamin D|vitamin d|mesh-list
83733176|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83733177|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733178|NCT01967459|Vitamins|vitamins|mesh-ancestor
83733179|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
83733180|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83733181|NCT01967472|Artesunate|artesunate|mesh-list
83733182|NCT01967472|Lumefantrine|lumefantrine|mesh-list
83733183|NCT01967472|Artemether|artemether|mesh-list
83733184|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83733185|NCT01967472|Amodiaquine|amodiaquine|mesh-list
83733186|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
83733187|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83733188|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83733189|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733190|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733191|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
83733192|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
83733193|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83733194|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
83733195|NCT01967498|Montelukast|montelukast|mesh-list
83733196|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83733197|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
83733198|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83733199|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
83733200|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733201|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733202|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83733203|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83733204|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733205|NCT01967524|Ropivacaine|ropivacaine|mesh-list
83733206|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83733207|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
83733208|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83733209|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
82888298|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
83733210|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
83733211|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733212|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733213|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
83733214|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733215|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83733216|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733217|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733218|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
83733219|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733220|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83733221|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83733222|NCT01967758|Amoxicillin|amoxicillin|mesh-list
83733223|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83733224|NCT01967758|Trimethoprim|trimethoprim|mesh-list
83733225|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
83733226|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733227|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83733228|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
83733229|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83733230|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83733231|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83733232|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733233|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733234|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83733235|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83733236|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83733237|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83733238|NCT01967823|Aldesleukin|aldesleukin|mesh-list
83733239|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
83733240|NCT01967823|Fludarabine|fludarabine|mesh-list
83733241|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83733242|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
83733243|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733244|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733245|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83733246|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
83733247|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733248|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733249|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83733250|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83733251|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83733252|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
83733253|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733254|NCT01967875|Docetaxel|docetaxel|mesh-list
83733255|NCT01967875|Capecitabine|capecitabine|mesh-list
83733256|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733257|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733258|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733259|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733260|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733261|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83733262|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
83733263|NCT01967927|Imidazole|imidazole|mesh-list
83733264|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733265|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733266|NCT01967979|Itraconazole|itraconazole|mesh-list
83733267|NCT01967979|Fluoxetine|fluoxetine|mesh-list
83733268|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
83733269|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733270|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83733271|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83733272|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733273|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733274|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83733275|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
83733276|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733277|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733278|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83733279|NCT01967979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83733280|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83733281|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733282|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733284|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83733285|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
83733286|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83733287|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83733288|NCT01968005|Etodolac|etodolac|mesh-list
83733289|NCT01968005|Lidocaine|lidocaine|mesh-list
83733290|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
83733291|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
83733292|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733293|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733294|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
83733295|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733296|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83733297|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83733298|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83733299|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733300|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733301|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83733302|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83733303|NCT01968005|Analgesics|analgesics|mesh-ancestor
83733304|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733305|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733306|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83733307|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83733308|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733309|NCT01968018|Acetaminophen|acetaminophen|mesh-list
83733310|NCT01968018|Tramadol|tramadol|mesh-list
83733311|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83733312|NCT01968018|Analgesics|analgesics|mesh-ancestor
83733313|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
83733314|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733315|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733316|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
83733317|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83733318|NCT01968018|Narcotics|narcotics|mesh-ancestor
83733319|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733320|NCT01968044|Linagliptin|linagliptin|mesh-list
83733321|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733322|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733323|NCT01968044|Incretins|incretins|mesh-ancestor
83733324|NCT01968044|Hormones|hormones|mesh-ancestor
83733325|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733326|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83733327|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
83733328|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733329|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733330|NCT01968083|Vaccines|vaccines|mesh-list
83733331|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
83733332|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733333|NCT01968161|Asenapine|asenapine|mesh-list
83733334|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83733335|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83733336|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733337|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733338|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83733339|NCT01968239|Ranibizumab|ranibizumab|mesh-list
83733340|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733341|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733342|NCT01968239|Growth Substances|growth substances|mesh-ancestor
83733343|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733344|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733345|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733346|NCT01968395|Caspofungin|caspofungin|mesh-list
83733347|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
83733348|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733349|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888450|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888451|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82888452|NCT01238952|Carboplatin|carboplatin|mesh-list
82888453|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888454|NCT05158998|Propofol|propofol|mesh-list
82888455|NCT05158998|Sevoflurane|sevoflurane|mesh-list
82888456|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82888459|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83733350|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733351|NCT01968486|Ranibizumab|ranibizumab|mesh-list
83733352|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733353|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733354|NCT01968486|Growth Substances|growth substances|mesh-ancestor
83733355|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733356|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733357|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733358|NCT01968564|Curcumin|curcumin|mesh-list
83733359|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83733360|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83733361|NCT01968564|Analgesics|analgesics|mesh-ancestor
83733362|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
83733363|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733364|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733365|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733366|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733367|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733368|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733369|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733370|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83733371|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83733372|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83733373|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
83733374|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733375|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83733376|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83733377|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733378|NCT01968616|Ranibizumab|ranibizumab|mesh-list
83733379|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733380|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733381|NCT01968616|Growth Substances|growth substances|mesh-ancestor
83733382|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733383|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733384|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733385|NCT01968655|Factor VIII|factor viii|mesh-list
83733386|NCT01968655|Coagulants|coagulants|mesh-ancestor
83733387|NCT01968759|Ramipril|ramipril|mesh-list
83733388|NCT01968759|Irbesartan|irbesartan|mesh-list
83733389|NCT01968759|Sevelamer|sevelamer|mesh-list
83733390|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83733391|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
83733392|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733393|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733394|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83733395|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83733396|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83733397|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
83733398|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
83733399|NCT01968798|Aspirin|aspirin|mesh-list
83733400|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83733401|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83733402|NCT01968798|Analgesics|analgesics|mesh-ancestor
83733403|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
83733404|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733405|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733406|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733407|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733408|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83733409|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82888518|NCT01236144|Plerixafor|plerixafor|mesh-list
82888519|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82888520|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82888521|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
82888522|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888523|NCT02528526|Inositol|inositol|mesh-list
82888524|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
82888525|NCT02528526|Vitamins|vitamins|mesh-ancestor
82888526|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
82888527|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888528|NCT03971279|Dexamethasone|dexamethasone|mesh-list
82888529|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888530|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
82888531|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
82888532|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888535|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
83733410|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733411|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83733412|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83733413|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733414|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
83733415|NCT01968850|Vitamin D|vitamin d|mesh-list
83733416|NCT01968850|Alendronate|alendronate|mesh-list
83733417|NCT01968850|Vitamins|vitamins|mesh-ancestor
83733418|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
83733419|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733420|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83733421|NCT01968915|Paclitaxel|paclitaxel|mesh-list
83733422|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83733423|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733424|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733425|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733426|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733427|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733428|NCT01969006|Bupivacaine|bupivacaine|mesh-list
83733429|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
83733430|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
83733431|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733432|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733433|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
83733434|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733435|NCT01969019|Prednisone|prednisone|mesh-list
83733436|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
83733437|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83733438|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83733439|NCT01969019|Prednisolone|prednisolone|mesh-list
83733440|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
83733441|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83733442|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
83733443|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733444|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
83733445|NCT01969019|Hormones|hormones|mesh-ancestor
83733446|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733447|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733448|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83733449|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733450|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
83733451|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
83733452|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733453|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83733454|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83733455|NCT01969019|Protective Agents|protective agents|mesh-ancestor
83733456|NCT01969032|Paclitaxel|paclitaxel|mesh-list
83733457|NCT01969032|Doxorubicin|doxorubicin|mesh-list
83733458|NCT01969032|Capecitabine|capecitabine|mesh-list
83733459|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
83733460|NCT01969032|Carboplatin|carboplatin|mesh-list
83733461|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83733462|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733463|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733464|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733465|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733466|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733467|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83733468|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83733469|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83733470|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733471|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83733472|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
83733473|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83733474|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
83733475|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733476|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733477|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83733478|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
83733479|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83733480|NCT01969071|Simendan|simendan|mesh-list
83733481|NCT01969071|Dobutamine|dobutamine|mesh-list
83733482|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83733483|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
83733484|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83733485|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83733486|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733487|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733488|NCT01969071|Protective Agents|protective agents|mesh-ancestor
83733489|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733490|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
83733491|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
83733492|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733493|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83733494|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83733495|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83733496|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
83733497|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733498|NCT01969149|Insulin|insulin|mesh-list
83733499|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83733500|NCT01969149|Exenatide|exenatide|mesh-list
83733501|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
83733502|NCT01969149|Incretins|incretins|mesh-list
83733503|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733504|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733505|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83733506|NCT01969149|Hormones|hormones|mesh-ancestor
83733507|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733508|NCT01969318|Metformin|metformin|mesh-list
83733509|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733510|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733511|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83733512|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733513|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733514|NCT01969357|Incretins|incretins|mesh-ancestor
83733515|NCT01969357|Hormones|hormones|mesh-ancestor
83733516|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733517|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83733518|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
83733519|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733520|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733521|NCT01969617|Naltrexone|naltrexone|mesh-list
83733522|NCT01969617|Nalmefene|nalmefene|mesh-list
83733523|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83733524|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733525|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
83733526|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733527|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83733528|NCT01969656|Calcitriol|calcitriol|mesh-list
83733529|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83733530|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733531|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83733532|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733533|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733534|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83733535|NCT01969656|Vitamins|vitamins|mesh-ancestor
83733536|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
83733537|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83733538|NCT01969669|Ketoconazole|ketoconazole|mesh-list
83733539|NCT01969669|Venetoclax|venetoclax|mesh-list
83733540|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733541|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
83733542|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733543|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83733544|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83733545|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733546|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733547|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83733548|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
83733549|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733550|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733551|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83733552|NCT01969682|Rifampin|rifampin|mesh-list
83733553|NCT01969682|Venetoclax|venetoclax|mesh-list
83733554|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733555|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83733556|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
83733557|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83733558|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733559|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
83733560|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82888668|NCT00160199|Hormones|hormones|mesh-ancestor
83733561|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733562|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733563|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83733564|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83733565|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83733566|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83733567|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83733568|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83733569|NCT01969695|Venetoclax|venetoclax|mesh-list
83733570|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733571|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
83733572|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83733573|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83733574|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83733575|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733576|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733577|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
83733578|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733579|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733580|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83733581|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733582|NCT01969877|Cetuximab|cetuximab|mesh-list
83733583|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733584|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83733585|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
83733586|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83733587|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733588|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733589|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83733590|NCT01969903|Analgesics|analgesics|mesh-ancestor
83733591|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
83733592|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733593|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83733594|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83733595|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83733596|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
83733597|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733598|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733599|NCT01969942|Melphalan|melphalan|mesh-list
83733600|NCT01969942|Busulfan|busulfan|mesh-list
83733601|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83733602|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
83733603|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733604|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733605|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83733606|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83733607|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
83733608|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733609|NCT01969955|Paclitaxel|paclitaxel|mesh-list
83733610|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83733611|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83733612|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733613|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733614|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733615|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733616|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733617|NCT01970046|Metformin|metformin|mesh-list
83733618|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733619|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733620|NCT01970059|Metoprolol|metoprolol|mesh-list
83733621|NCT01970059|Carvedilol|carvedilol|mesh-list
83733622|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83733623|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83733624|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
83733625|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
83733626|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733627|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733628|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83733629|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83733630|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83733631|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
82888742|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
82888743|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733632|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733633|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733634|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
83733635|NCT01970059|Protective Agents|protective agents|mesh-ancestor
83733636|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83733637|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733638|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83733639|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
83733640|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83733641|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83733642|NCT01970072|Midazolam|midazolam|mesh-list
83733643|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83733644|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83733645|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733646|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733647|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83733648|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83733649|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83733650|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83733651|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
83733652|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
83733653|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
83733654|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
83733655|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733656|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733657|NCT01970202|Enoxaparin|enoxaparin|mesh-list
83733658|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
83733659|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
83733660|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83733661|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83733662|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733663|NCT01970215|Atorvastatin|atorvastatin|mesh-list
83733664|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83733665|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83733666|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83733667|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
83733668|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733669|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83733670|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83733671|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733672|NCT01970280|Enoxaparin|enoxaparin|mesh-list
83733673|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
83733674|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83733675|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83733676|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733677|NCT01970358|Poly ICLC|poly iclc|mesh-list
83733678|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
83733679|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
83733680|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733681|NCT01970449|Vaccines|vaccines|mesh-list
83733682|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
83733683|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733684|NCT01970553|Gemcitabine|gemcitabine|mesh-list
83733685|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83733686|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
83733687|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733688|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733689|NCT01970579|Paclitaxel|paclitaxel|mesh-list
83733690|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83733691|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733692|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733693|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733694|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733695|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733696|NCT01970748|Propranolol|propranolol|mesh-list
83733697|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83733698|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83733699|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
83733700|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733701|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733702|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733703|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83733704|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83733705|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
82888826|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
83733706|NCT01970800|Hormones|hormones|mesh-list
83733707|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733708|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733709|NCT01970904|Ribavirin|ribavirin|mesh-list
83733710|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83733711|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
83733712|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733713|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
83733714|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733715|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83733716|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83733717|NCT01971034|Metformin|metformin|mesh-list
83733718|NCT01971034|Paclitaxel|paclitaxel|mesh-list
83733719|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83733720|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733721|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733722|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733723|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733724|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733725|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733726|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733727|NCT01971047|Insulin|insulin|mesh-list
83733728|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
83733729|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83733730|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733731|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733732|NCT01971190|Aflibercept|aflibercept|mesh-list
83733733|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733734|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733735|NCT01971190|Growth Substances|growth substances|mesh-ancestor
83733736|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733737|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733738|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733739|NCT01971242|Exenatide|exenatide|mesh-list
83733740|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733741|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733742|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83733743|NCT01971242|Incretins|incretins|mesh-ancestor
83733744|NCT01971242|Hormones|hormones|mesh-ancestor
83733745|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733746|NCT01971268|Cimetidine|cimetidine|mesh-list
83733747|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83733748|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83733749|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83733750|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
83733751|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
83733752|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733753|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733754|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733755|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83733756|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83733757|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733758|NCT01971281|Paclitaxel|paclitaxel|mesh-list
83733759|NCT01971281|Gemcitabine|gemcitabine|mesh-list
83733760|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83733761|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733762|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83733763|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83733764|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83733765|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733766|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83733767|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
83733768|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
83733769|NCT01971411|Vitamin D|vitamin d|mesh-list
83733770|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
83733771|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
83733772|NCT01971411|Vitamins|vitamins|mesh-list
83733773|NCT01971411|Calcium|calcium|mesh-list
83733774|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
83733775|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733776|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83733777|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83733778|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
83733779|NCT01971424|Antacids|antacids|mesh-ancestor
83733780|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733781|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83733782|NCT01971450|Iloprost|iloprost|mesh-list
83733783|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83733784|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
83733785|NCT01971515|Tamoxifen|tamoxifen|mesh-list
83733786|NCT01971515|Trastuzumab|trastuzumab|mesh-list
83733787|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83733788|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733789|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83733790|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
83733791|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733792|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733793|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83733794|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83733795|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83733796|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83733797|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83733798|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83733799|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83733800|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
83733801|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733802|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83733803|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83733804|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733805|NCT01971632|Oxycodone|oxycodone|mesh-list
83733806|NCT01971632|Naloxone|naloxone|mesh-list
83733807|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83733808|NCT01971632|Narcotics|narcotics|mesh-ancestor
83733809|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733810|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733811|NCT01971632|Analgesics|analgesics|mesh-ancestor
83733812|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
83733813|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733814|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83733815|NCT01971658|Thalidomide|thalidomide|mesh-list
83733816|NCT01971658|Dexamethasone|dexamethasone|mesh-list
83733817|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
83733818|NCT01971658|Bortezomib|bortezomib|mesh-list
83733819|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83733820|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
83733821|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733822|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733823|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83733824|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
83733825|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733826|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733827|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83733828|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733829|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
83733830|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
83733831|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733832|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83733833|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
83733834|NCT01971658|Hormones|hormones|mesh-ancestor
83733835|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733836|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83733837|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
83733838|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83733839|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733840|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733841|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733842|NCT01971658|Growth Substances|growth substances|mesh-ancestor
83733843|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733844|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
83733845|NCT01971684|Sirolimus|sirolimus|mesh-list
83733846|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
83733847|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733848|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
83733849|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733850|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83733851|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83733852|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
83733853|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83733854|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83733855|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733856|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888969|NCT01375426|Amoxicillin|amoxicillin|mesh-list
83733857|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
83733858|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83733859|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
83733860|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83733861|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83733862|NCT01971801|Vitamin D|vitamin d|mesh-list
83733863|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
83733864|NCT01971801|Vitamins|vitamins|mesh-ancestor
83733865|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
83733866|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733867|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83733868|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83733869|NCT01971814|Infliximab|infliximab|mesh-list
83733870|NCT01971814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83733871|NCT01971814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733872|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83733873|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83733874|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733875|NCT01971918|Antibodies|antibodies|mesh-list
83733876|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
83733877|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733878|NCT01972113|Vitamins|vitamins|mesh-list
83733879|NCT01972113|Vitamin K|vitamin k|mesh-list
83733880|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
83733881|NCT01972113|Menaquinone 7|menaquinone 7|mesh-list
83733882|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
83733883|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733884|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83733885|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83733886|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733887|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
83733888|NCT01972113|Coagulants|coagulants|mesh-ancestor
83733889|NCT01972230|Remifentanil|remifentanil|mesh-list
83733890|NCT01972230|Sevoflurane|sevoflurane|mesh-list
83733891|NCT01972230|Propofol|propofol|mesh-list
83733892|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83733893|NCT01972230|Narcotics|narcotics|mesh-ancestor
83733894|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733895|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733896|NCT01972230|Analgesics|analgesics|mesh-ancestor
83733897|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
83733898|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733899|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83733900|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83733901|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
83733902|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
83733903|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83733904|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83733905|NCT01972269|Lidocaine|lidocaine|mesh-list
83733906|NCT01972269|Fentanyl|fentanyl|mesh-list
83733907|NCT01972269|Bupivacaine|bupivacaine|mesh-list
83733908|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
83733909|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
83733910|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733911|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733912|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
83733913|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733914|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83733915|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83733916|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83733917|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83733918|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733919|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83733920|NCT01972269|Narcotics|narcotics|mesh-ancestor
83733921|NCT01972269|Analgesics|analgesics|mesh-ancestor
83733922|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83733923|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83733924|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
83733925|NCT01972373|Bevacizumab|bevacizumab|mesh-list
83733926|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83733927|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733928|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733929|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733930|NCT01972373|Growth Substances|growth substances|mesh-ancestor
82889041|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83733931|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733932|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733933|NCT01972490|Bevacizumab|bevacizumab|mesh-list
83733934|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83733935|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733936|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733937|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733938|NCT01972490|Growth Substances|growth substances|mesh-ancestor
83733939|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733940|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733941|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
83733942|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733943|NCT01972620|Bupivacaine|bupivacaine|mesh-list
83733944|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
83733945|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
83733946|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733947|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733948|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
83733949|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733950|NCT01972711|Amisulpride|amisulpride|mesh-list
83733951|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83733952|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83733953|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83733954|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733955|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83733956|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83733957|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
83733958|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83733959|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733960|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83733961|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
83733962|NCT01972763|Ranibizumab|ranibizumab|mesh-list
83733963|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83733964|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83733965|NCT01972763|Growth Substances|growth substances|mesh-ancestor
83733966|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733967|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
83733968|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733969|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83733970|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
83733971|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
83733972|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
83733973|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83733974|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733975|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83733976|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733977|NCT01972906|Ibuprofen|ibuprofen|mesh-list
83733978|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83733979|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83733980|NCT01972906|Analgesics|analgesics|mesh-ancestor
83733981|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
83733982|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83733983|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83733984|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83733985|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83733986|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83733987|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733988|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733989|NCT01972984|Anastrozole|anastrozole|mesh-list
83733990|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83733991|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83733992|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83733993|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83733994|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83733995|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83733996|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83733997|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
83733998|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83733999|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734000|NCT01973010|Ibuprofen|ibuprofen|mesh-list
83734001|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83734002|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83734003|NCT01973010|Analgesics|analgesics|mesh-ancestor
83734004|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
83734005|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734006|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734007|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734008|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83734009|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83734010|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734011|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734012|NCT01973101|Cisplatin|cisplatin|mesh-list
83734013|NCT01973101|Gemcitabine|gemcitabine|mesh-list
83734014|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734015|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83734016|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
83734017|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734018|NCT01973114|Latanoprost|latanoprost|mesh-list
83734019|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83734020|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83734021|NCT01973140|Tolvaptan|tolvaptan|mesh-list
83734022|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83734023|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734024|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
83734025|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734026|NCT01973309|Paclitaxel|paclitaxel|mesh-list
83734027|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83734028|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734029|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
83734030|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
83734031|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
83734032|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734033|NCT01973322|Vaccines|vaccines|mesh-list
83734034|NCT01973322|Complement Factor H|complement factor h|mesh-list
83734035|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
83734036|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734037|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83734038|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83734039|NCT01973400|Tocotrienols|tocotrienols|mesh-list
83734040|NCT01973400|Vitamin E|vitamin e|mesh-list
83734041|NCT01973400|Tocopherols|tocopherols|mesh-list
83734042|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
83734043|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734044|NCT01973400|Protective Agents|protective agents|mesh-ancestor
83734045|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734046|NCT01973400|Vitamins|vitamins|mesh-ancestor
83734047|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
83734048|NCT01973504|Chrysarobin|chrysarobin|mesh-list
83734049|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83734050|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83734051|NCT01973504|Analgesics|analgesics|mesh-ancestor
83734052|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
83734053|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734054|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734055|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734056|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83734057|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83734058|NCT01973517|Hematinics|hematinics|mesh-ancestor
83734059|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83734060|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83734061|NCT01973660|Tamoxifen|tamoxifen|mesh-list
83734062|NCT01973660|Paclitaxel|paclitaxel|mesh-list
83734063|NCT01973660|Trastuzumab|trastuzumab|mesh-list
83734064|NCT01973660|Letrozole|letrozole|mesh-list
83734065|NCT01973660|Lapatinib|lapatinib|mesh-list
83734066|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83734067|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734068|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
83734069|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
83734070|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
83734071|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734072|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83734073|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83734074|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83734075|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734076|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83734077|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
83734078|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734079|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889191|NCT03632590|Antacids|antacids|mesh-ancestor
83734080|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734081|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83734082|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83734083|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83734084|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83734086|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734087|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83734088|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
83734089|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734090|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734091|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83734092|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
83734093|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
83734094|NCT01973751|Hormones|hormones|mesh-ancestor
83734095|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734096|NCT01973790|Z 338|z 338|mesh-list
83734097|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83734098|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734099|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734100|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
83734101|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734102|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734103|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734104|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
83734105|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83734106|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83734107|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83734108|NCT01973816|Estradiol|estradiol|mesh-list
83734109|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83734110|NCT01973816|Cyproterone|cyproterone|mesh-list
83734111|NCT01973816|Estrogens|estrogens|mesh-ancestor
83734112|NCT01973816|Hormones|hormones|mesh-ancestor
83734113|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734114|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734115|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83734116|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
83734117|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83734118|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83734119|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
83734120|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
83734121|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734122|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83734123|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
83734124|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734125|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83734126|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
83734127|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83734128|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
83734129|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83734130|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734131|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83734132|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734133|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734134|NCT01973855|Ribavirin|ribavirin|mesh-list
83734135|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
83734136|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734137|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
83734138|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734139|NCT01973868|Cetuximab|cetuximab|mesh-list
83734140|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83734141|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734142|NCT01973920|Insulin|insulin|mesh-list
83734143|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83734144|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734145|NCT01973933|Metformin|metformin|mesh-list
83734146|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
83734147|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83734148|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734149|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
83734150|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83734151|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83734152|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734153|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83734154|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734155|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734156|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
83734157|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83734158|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83734159|NCT01974024|Prednisolone|prednisolone|mesh-list
83734160|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
83734161|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83734162|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
83734163|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734164|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
83734165|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
83734166|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734167|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734168|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734169|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
83734170|NCT01974024|Hormones|hormones|mesh-ancestor
83734171|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734172|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83734173|NCT01974024|Protective Agents|protective agents|mesh-ancestor
83734174|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734175|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734176|NCT01974037|Capsaicin|capsaicin|mesh-list
83734177|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
83734178|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
83734179|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
83734180|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734181|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734182|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
83734183|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83734184|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
83734185|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83734186|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734187|NCT01974167|Vitamins|vitamins|mesh-ancestor
83734188|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
83734189|NCT01974258|Vemurafenib|vemurafenib|mesh-list
83734190|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734191|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83734192|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734193|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734194|NCT01974297|Atorvastatin|atorvastatin|mesh-list
83734195|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
83734196|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83734197|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83734198|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
83734199|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734200|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83734201|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83734202|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734203|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83734204|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83734205|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734206|NCT01974375|Fluconazole|fluconazole|mesh-list
83734207|NCT01974375|Micafungin|micafungin|mesh-list
83734208|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
83734209|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734210|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83734211|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83734212|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734213|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734214|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83734215|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
83734216|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734217|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734218|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83734219|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83734220|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
83734221|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83734222|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734223|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
83734224|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
83734225|NCT01974518|Rituximab|rituximab|mesh-list
83734226|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83734227|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
83734228|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734229|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83734230|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83734231|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
83734232|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734233|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734234|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83734235|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83734236|NCT01974622|Verteporfin|verteporfin|mesh-list
83734237|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83734238|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
83734239|NCT01974648|Remifentanil|remifentanil|mesh-list
83734240|NCT01974648|Propofol|propofol|mesh-list
83734241|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83734242|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734243|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734244|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83734245|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
83734246|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
83734247|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83734248|NCT01974648|Narcotics|narcotics|mesh-ancestor
83734249|NCT01974648|Analgesics|analgesics|mesh-ancestor
83734250|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
83734251|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734252|NCT01974843|Bupivacaine|bupivacaine|mesh-list
83734253|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
83734254|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
83734255|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
83734256|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734257|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734258|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
83734259|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734260|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83734261|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83734262|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83734263|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734264|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734265|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734266|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734267|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
83734268|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734269|NCT01975012|Rilpivirine|rilpivirine|mesh-list
83734270|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83734271|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83734272|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734273|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734274|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
83734275|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734276|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83734277|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83734278|NCT01975051|Miltefosine|miltefosine|mesh-list
83734279|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
83734280|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734281|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734282|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83734283|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83734284|NCT01975129|Oxytocin|oxytocin|mesh-list
83734285|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
83734286|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83734287|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734288|NCT01975142|Trastuzumab|trastuzumab|mesh-list
83734289|NCT01975142|Maytansine|maytansine|mesh-list
83734290|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83734291|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734292|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83734293|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
83734294|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
83734295|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
83734296|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734297|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83734298|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83734299|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83734300|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
83734301|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734302|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83734303|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82889415|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889419|NCT01148472|Analgesics|analgesics|mesh-ancestor
83734304|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734306|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83734307|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83734308|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734309|NCT01975259|Hormones|hormones|mesh-ancestor
83734310|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734311|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734312|NCT01975259|Incretins|incretins|mesh-ancestor
83734313|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
83734314|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83734315|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734316|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734317|NCT01975363|Curcumin|curcumin|mesh-list
83734318|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83734319|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83734320|NCT01975363|Analgesics|analgesics|mesh-ancestor
83734321|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
83734322|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734323|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734324|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734325|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83734326|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734327|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734328|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734329|NCT01975441|Ivermectin|ivermectin|mesh-list
83734330|NCT01975441|Albendazole|albendazole|mesh-list
83734331|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
83734332|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83734333|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734334|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
83734335|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
83734336|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83734337|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83734338|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83734339|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83734340|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83734341|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734342|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734343|NCT01975441|Filaricides|filaricides|mesh-ancestor
83734344|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
83734345|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83734346|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734347|NCT01975454|Capecitabine|capecitabine|mesh-list
83734348|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
83734349|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83734350|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
83734351|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734352|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734353|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83734354|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83734355|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83734356|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734357|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734358|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734359|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734360|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
83734361|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734362|NCT01975662|Vancomycin|vancomycin|mesh-list
83734363|NCT01975662|Daptomycin|daptomycin|mesh-list
83734364|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83734365|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734366|NCT01975688|Nabiximols|nabiximols|mesh-list
83734367|NCT01975688|Analgesics|analgesics|mesh-ancestor
83734368|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
83734369|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734370|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734371|NCT01975714|Bimatoprost|bimatoprost|mesh-list
83734372|NCT01975714|Latanoprost|latanoprost|mesh-list
83734373|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83734374|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83734375|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83734376|NCT01975727|Dexamethasone|dexamethasone|mesh-list
83734377|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
83734378|NCT01975727|BB 1101|bb 1101|mesh-list
82889496|NCT03914352|Antibodies|antibodies|mesh-list
83734379|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734380|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
83734381|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
83734382|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734383|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734384|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734385|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
83734386|NCT01975727|Hormones|hormones|mesh-ancestor
83734387|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734388|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734389|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734390|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
83734391|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734392|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734393|NCT01975753|Fentanyl|fentanyl|mesh-list
83734394|NCT01975753|Morphine|morphine|mesh-list
83734395|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83734396|NCT01975753|Narcotics|narcotics|mesh-ancestor
83734397|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734398|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734399|NCT01975753|Analgesics|analgesics|mesh-ancestor
83734400|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
83734401|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734402|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83734403|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83734404|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
83734405|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
83734406|NCT01975779|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83734407|NCT01975779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83734408|NCT01975779|Serotonin Agents|serotonin agents|mesh-ancestor
83734409|NCT01975779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734410|NCT01975779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734411|NCT01975779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734412|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
83734413|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83734414|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
83734415|NCT01975805|Povidone|povidone|mesh-list
83734416|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83734417|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734418|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
83734419|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
83734420|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
83734421|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
83734422|NCT01975961|Telmisartan|telmisartan|mesh-list
83734423|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83734424|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83734425|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83734426|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
83734427|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734428|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83734429|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83734430|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734431|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83734432|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83734433|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83734434|NCT01976078|Midazolam|midazolam|mesh-list
83734435|NCT01976078|Esomeprazole|esomeprazole|mesh-list
83734436|NCT01976078|Ranitidine|ranitidine|mesh-list
83734437|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83734438|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83734439|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83734440|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734441|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734442|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83734443|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83734444|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734445|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83734446|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
83734447|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
83734448|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
83734449|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
83734450|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889567|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889568|NCT02874742|Growth Substances|growth substances|mesh-ancestor
83734451|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734452|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83734453|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734454|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83734455|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734456|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83734457|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
83734458|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
83734459|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
83734460|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734461|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83734462|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83734463|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734464|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734465|NCT01976195|Thalidomide|thalidomide|mesh-list
83734466|NCT01976195|Dexamethasone|dexamethasone|mesh-list
83734467|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734468|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
83734469|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
83734470|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734471|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734472|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734473|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
83734474|NCT01976195|Hormones|hormones|mesh-ancestor
83734475|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734476|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734477|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734478|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83734479|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
83734480|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
83734481|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83734482|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734483|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83734484|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83734485|NCT01976195|Growth Substances|growth substances|mesh-ancestor
83734486|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
83734487|NCT01976208|Omalizumab|omalizumab|mesh-list
83734488|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83734489|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83734490|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
83734491|NCT01976520|Vaccines|vaccines|mesh-list
83734492|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
83734493|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734494|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
83734495|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83734496|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83734497|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83734498|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734499|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734500|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
83734501|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734502|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734503|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83734504|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734505|NCT01976676|Folic Acid|folic acid|mesh-list
83734506|NCT01976676|Hematinics|hematinics|mesh-ancestor
83734507|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
83734508|NCT01976676|Vitamins|vitamins|mesh-ancestor
83734509|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
83734510|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734511|NCT01976780|Artesunate|artesunate|mesh-list
83734512|NCT01976780|Lumefantrine|lumefantrine|mesh-list
83734513|NCT01976780|Artemether|artemether|mesh-list
83734514|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83734515|NCT01976780|Mefloquine|mefloquine|mesh-list
83734516|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
83734517|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83734518|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83734519|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734520|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734521|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
83734522|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
83734523|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83734524|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
83734525|NCT01976923|Bevacizumab|bevacizumab|mesh-list
83734526|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83734527|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734528|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83734529|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83734530|NCT01976923|Growth Substances|growth substances|mesh-ancestor
83501264|NCT03009500|Lidocaine|lidocaine|mesh-list
83734531|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734532|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
83734533|NCT01976936|Lovastatin|lovastatin|mesh-list
83734534|NCT01976936|L 647318|l 647318|mesh-list
83734535|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
83734536|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83734537|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83734538|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
83734539|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734540|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83734541|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83734542|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734543|NCT01977118|Streptokinase|streptokinase|mesh-list
83734544|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83734545|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83734546|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734547|NCT01977209|Gossypol|gossypol|mesh-list
83734548|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83734549|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
83734550|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83734551|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734552|NCT01977300|Valproic Acid|valproic acid|mesh-list
83734553|NCT01977300|Olanzapine|olanzapine|mesh-list
83734554|NCT01977300|Risperidone|risperidone|mesh-list
83734555|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
83734556|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83734557|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
83734558|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734559|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734560|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734561|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83734562|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83734563|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734564|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734565|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83734566|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
83734567|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
83734568|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
83734569|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734570|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83734571|NCT01977300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83734572|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83734573|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734574|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
83734575|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734576|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
83734577|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
83734578|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
83734579|NCT01977339|Bupivacaine|bupivacaine|mesh-list
83734580|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
83734581|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
83734582|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734583|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734584|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
83734585|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734586|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83734587|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83734588|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83734589|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83734590|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734591|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734592|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734593|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734594|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83734595|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
83734596|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734597|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83734598|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83734599|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83734600|NCT01977417|Analgesics|analgesics|mesh-ancestor
83734601|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
83734602|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734603|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734604|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734605|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83734606|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83734607|NCT01977430|Furosemide|furosemide|mesh-list
83734608|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83734609|NCT01977430|Diuretics|diuretics|mesh-ancestor
83734610|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
83734611|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734612|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83734613|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734614|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734615|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83734616|NCT01977235|Irinotecan|irinotecan|mesh-list
83734617|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734618|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83734619|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83734620|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734621|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734622|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83734623|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83734624|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83734625|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
83734626|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734627|NCT01977989|Vancomycin|vancomycin|mesh-list
83734628|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83734629|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734630|NCT01978015|Timolol|timolol|mesh-list
83734631|NCT01978015|Bimatoprost|bimatoprost|mesh-list
83734632|NCT01978015|Travoprost|travoprost|mesh-list
83734633|NCT01978015|Dextrans|dextrans|mesh-list
83734634|NCT01978015|Latanoprost|latanoprost|mesh-list
83734635|NCT01978015|Maleic acid|maleic acid|mesh-list
83734636|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734637|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734638|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83734639|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83734640|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
83734641|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734642|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734643|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83734644|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83734645|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83734646|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83734647|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
83734648|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
83734649|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
83734650|NCT01978041|Fluorides|fluorides|mesh-list
83734651|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
83734652|NCT01978041|Protective Agents|protective agents|mesh-ancestor
83734653|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734654|NCT01978301|Triamcinolone|triamcinolone|mesh-list
83734655|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83734656|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83734657|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83734658|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734659|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
83734660|NCT01978301|Hormones|hormones|mesh-ancestor
83734661|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734662|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734663|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83734664|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
83734665|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734666|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734667|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
83734668|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
83734669|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734670|NCT01978405|Protective Agents|protective agents|mesh-ancestor
83734671|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734672|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
83734673|NCT01978405|Vitamins|vitamins|mesh-ancestor
83734674|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
83734675|NCT01978418|Albuterol|albuterol|mesh-list
83734676|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83734677|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
82889789|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83734678|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734679|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734680|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83734681|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
83734682|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
83734683|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83734684|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83734685|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83734686|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83734687|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
83734688|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734689|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734690|NCT01978457|Propranolol|propranolol|mesh-list
83734691|NCT01978457|Cocaine|cocaine|mesh-list
83734692|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83734693|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83734694|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
83734695|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734696|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734697|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734698|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83734699|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83734700|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
83734701|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
83734702|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
83734703|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734704|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
83734705|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734706|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83734707|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83734708|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83734709|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734710|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
83734711|NCT01978483|Denosumab|denosumab|mesh-list
83734712|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83734713|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734714|NCT01978496|Eletriptan|eletriptan|mesh-list
83734715|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83734716|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
83734717|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734718|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734719|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734720|NCT01978665|Prednisone|prednisone|mesh-list
83734721|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734722|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
83734723|NCT01978665|Hormones|hormones|mesh-ancestor
83734724|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734725|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734726|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734727|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734728|NCT01978678|Budesonide|budesonide|mesh-list
83734729|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734730|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83734731|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
83734732|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734733|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734734|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83734735|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
83734736|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
83734737|NCT01978678|Hormones|hormones|mesh-ancestor
83734738|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734739|NCT01978704|Insulin|insulin|mesh-list
83734740|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83734741|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83734742|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734743|NCT01978717|Anesthetics|anesthetics|mesh-list
83734744|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734745|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734746|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
83734747|NCT01978782|Citalopram|citalopram|mesh-list
83734748|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83734749|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83734750|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
83734751|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734752|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83734753|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83734754|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734755|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734756|NCT01978782|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83734757|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83734758|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734759|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734760|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
83734761|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734762|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83734763|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
83734764|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734765|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
83734766|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
83734767|NCT01978873|Androgens|androgens|mesh-list
83734768|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83734769|NCT01978873|Hormones|hormones|mesh-ancestor
83734770|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734771|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734772|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
83734773|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734774|NCT01978873|Protective Agents|protective agents|mesh-ancestor
83734775|NCT01978873|Vitamins|vitamins|mesh-ancestor
83734776|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
83734777|NCT01978873|Estrogens|estrogens|mesh-ancestor
83734778|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734779|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734780|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
83734781|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83734782|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83734783|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734784|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
83734785|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83734786|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
83734787|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83734788|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83734789|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83734790|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734791|NCT01979354|Morphine|morphine|mesh-list
83734792|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83734793|NCT01979354|Narcotics|narcotics|mesh-ancestor
83734794|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734795|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734796|NCT01979354|Analgesics|analgesics|mesh-ancestor
83734797|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
83734798|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734799|NCT01979406|Vaccines|vaccines|mesh-list
83734800|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
83734801|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734802|NCT01979510|Acetaminophen|acetaminophen|mesh-list
83734803|NCT01979510|Etoricoxib|etoricoxib|mesh-list
83734804|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83734805|NCT01979510|Analgesics|analgesics|mesh-ancestor
83734806|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
83734807|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734808|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734809|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
83734810|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83734811|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734812|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83734813|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83734814|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83734815|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734816|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734817|NCT01979653|Midazolam|midazolam|mesh-list
83734818|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
83734819|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83734820|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734821|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734822|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83734823|NCT01979653|Analgesics|analgesics|mesh-ancestor
83734824|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
83734825|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734826|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83734827|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83734828|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82889940|NCT01257048|Hormones|hormones|mesh-ancestor
83734829|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
83734830|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734831|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734832|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83734833|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83734834|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83734835|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734836|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83734837|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
83734838|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
83734839|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
83734840|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
83734841|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83734842|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83734843|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83734844|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734845|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734846|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734847|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83734848|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83734849|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83734850|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
83734851|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734852|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734853|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83734854|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83734855|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
83734856|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83734857|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83734858|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
83734859|NCT01979965|Ranolazine|ranolazine|mesh-list
83734860|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83734861|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83734862|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734863|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
83734864|NCT01980004|Diuretics|diuretics|mesh-ancestor
83734865|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
83734866|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734867|NCT01980004|Expectorants|expectorants|mesh-ancestor
83734868|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
83734869|NCT01980069|Neostigmine|neostigmine|mesh-list
83734870|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83734871|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734872|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734873|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
83734874|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734875|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734876|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83734877|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
83734878|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734879|NCT01980082|Cefazolin|cefazolin|mesh-list
83734880|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83734881|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734882|NCT01980277|Paclitaxel|paclitaxel|mesh-list
83734883|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83734884|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734885|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
83734886|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
83734887|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
83734888|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734889|NCT01980303|Esketamine|esketamine|mesh-list
83734890|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
83734891|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83734892|NCT01980316|Heparin|heparin|mesh-list
83734893|NCT01980316|Calcium heparin|calcium heparin|mesh-list
83734894|NCT01980316|Argatroban|argatroban|mesh-list
83734895|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
83734896|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83734897|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83734898|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734899|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
82890010|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734900|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83734901|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
83734902|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83734903|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83734904|NCT01980329|Maraviroc|maraviroc|mesh-list
83734905|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83734906|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83734907|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734908|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83734909|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83734910|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
83734911|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83734912|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83734913|NCT01980407|Leucovorin|leucovorin|mesh-list
83734914|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83734915|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
83734916|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734917|NCT01980407|Antidotes|antidotes|mesh-ancestor
83734918|NCT01980407|Protective Agents|protective agents|mesh-ancestor
83734919|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734920|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
83734921|NCT01980407|Vitamins|vitamins|mesh-ancestor
83734922|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
83734923|NCT01980472|Paclitaxel|paclitaxel|mesh-list
83734924|NCT01980472|Bevacizumab|bevacizumab|mesh-list
83734925|NCT01980472|Carboplatin|carboplatin|mesh-list
83734926|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83734927|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734928|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83734929|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83734930|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83734931|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734932|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83734933|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83734934|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83734935|NCT01980472|Growth Substances|growth substances|mesh-ancestor
83734936|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734937|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
83734938|NCT01980498|Fentanyl|fentanyl|mesh-list
83734939|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83734940|NCT01980498|Narcotics|narcotics|mesh-ancestor
83734941|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83734942|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734943|NCT01980498|Analgesics|analgesics|mesh-ancestor
83734944|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
83734945|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734946|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83734947|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83734948|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
83734949|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
83734950|NCT01980550|Nicotine|nicotine|mesh-list
83734951|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83734952|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
83734953|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734954|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734955|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83734956|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83734957|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
83734958|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83734959|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734960|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83734961|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83734962|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
83734963|NCT01980667|Cisplatin|cisplatin|mesh-list
83734964|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734965|NCT01980680|Estradiol|estradiol|mesh-list
83734966|NCT01980680|Progesterone|progesterone|mesh-list
83734967|NCT01980680|Estrogens|estrogens|mesh-ancestor
83734968|NCT01980680|Hormones|hormones|mesh-ancestor
83734969|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83734970|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734971|NCT01980680|Progestins|progestins|mesh-ancestor
83734972|NCT01980745|Chloroquine|chloroquine|mesh-list
83734973|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83734974|NCT01980745|Amebicides|amebicides|mesh-ancestor
83734975|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83734976|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83734977|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890099|NCT01255410|Vaccines|vaccines|mesh-list
83734978|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
83734979|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83734980|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83734981|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83734982|NCT01980745|Analgesics|analgesics|mesh-ancestor
83734983|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
83734984|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83734985|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83734986|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83734987|NCT01980745|Filaricides|filaricides|mesh-ancestor
83734988|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
83734989|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
83734990|NCT01980810|Paclitaxel|paclitaxel|mesh-list
83734991|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83734992|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83734993|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83734994|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83734995|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83734996|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83734997|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83734998|NCT01980849|Nadroparin|nadroparin|mesh-list
83734999|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
83735000|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83735001|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83735002|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735003|NCT01980966|Oseltamivir|oseltamivir|mesh-list
83735004|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
83735005|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735006|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735007|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735008|NCT01980979|Treprostinil|treprostinil|mesh-list
83735009|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83735010|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
83735011|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83735012|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735013|NCT01981278|Tapentadol|tapentadol|mesh-list
83735014|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83735015|NCT01981278|Narcotics|narcotics|mesh-ancestor
83735016|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735017|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735018|NCT01981278|Analgesics|analgesics|mesh-ancestor
83735019|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
83735020|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735021|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83735022|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83735023|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735024|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735025|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
83735026|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735027|NCT01981291|Anesthetics|anesthetics|mesh-list
83735028|NCT01981291|Mepivacaine|mepivacaine|mesh-list
83735029|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
83735030|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735031|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735032|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
83735033|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735034|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
83735035|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83735036|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
83735037|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735038|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
83735039|NCT01981330|Protective Agents|protective agents|mesh-ancestor
83735040|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
83735041|NCT01981369|Propofol|propofol|mesh-list
83735042|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83735043|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735044|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735045|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83735046|NCT01981369|Analgesics|analgesics|mesh-ancestor
83735047|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
83735048|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735049|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83735050|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83735051|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83735052|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
83735053|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735054|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890156|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
82890158|NCT03899142|Antibodies|antibodies|mesh-list
83735055|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83735056|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
83735057|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
83735058|NCT01981447|Lacosamide|lacosamide|mesh-list
83735059|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
83735060|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83735061|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83735062|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735063|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735064|NCT01981460|Methylene Blue|methylene blue|mesh-list
83735065|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735066|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735067|NCT01981499|Cetirizine|cetirizine|mesh-list
83735068|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83735069|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83735070|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83735071|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
83735072|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
83735073|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735074|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735075|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735076|NCT01981525|Metformin|metformin|mesh-list
83735077|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83735078|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735079|NCT01981707|Choline|choline|mesh-list
83735080|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
83735081|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83735082|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
83735083|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735084|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735085|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83735086|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
83735087|NCT01981746|Ropivacaine|ropivacaine|mesh-list
83735088|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
83735089|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
83735090|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735091|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735092|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
83735093|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735094|NCT01981811|Aripiprazole|aripiprazole|mesh-list
83735095|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
83735096|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83735097|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83735098|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83735099|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735100|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735101|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
83735102|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
83735103|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735104|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735105|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83735106|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83735107|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
83735108|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83735109|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83735110|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83735111|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83735112|NCT01981889|Prednisone|prednisone|mesh-list
83735113|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735114|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
83735115|NCT01981889|Hormones|hormones|mesh-ancestor
83735116|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735117|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735118|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83735119|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735120|NCT01981941|Gabapentin|gabapentin|mesh-list
83735121|NCT01981941|Analgesics|analgesics|mesh-ancestor
83735122|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
83735123|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735124|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735125|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
83735126|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83735127|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83735128|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735129|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83735130|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83735131|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83735132|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735133|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735135|NCT01982019|Hormones|hormones|mesh-list
83735136|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735137|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735138|NCT01982071|Micafungin|micafungin|mesh-list
83735139|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
83735140|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735141|NCT01982097|Sorafenib|sorafenib|mesh-list
83735142|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735143|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83735144|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735145|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735146|NCT01982201|Lesinurad|lesinurad|mesh-list
83735147|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
83735148|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735149|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
83735150|NCT01982396|Lamivudine|lamivudine|mesh-list
83735151|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83735152|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83735153|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735154|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735155|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
83735156|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735157|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83735158|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83735159|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83735160|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83735161|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83735162|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
83735163|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735164|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83735165|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83735166|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735167|NCT01982578|Genistein|genistein|mesh-list
83735168|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83735169|NCT01982578|Protective Agents|protective agents|mesh-ancestor
83735170|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735171|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735172|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83735173|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735174|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735175|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
83735176|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83735177|NCT01982578|Estrogens|estrogens|mesh-ancestor
83735178|NCT01982578|Hormones|hormones|mesh-ancestor
83735179|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735180|NCT01982734|Curcumin|curcumin|mesh-list
83735181|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83735182|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83735183|NCT01982734|Analgesics|analgesics|mesh-ancestor
83735184|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
83735185|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735186|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735187|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735188|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735189|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735190|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735191|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735192|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83735193|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
83735194|NCT01982760|Coagulants|coagulants|mesh-ancestor
83735195|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83735196|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
83735197|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735198|NCT01982799|Acetaminophen|acetaminophen|mesh-list
83735199|NCT01982799|Ibuprofen|ibuprofen|mesh-list
83735200|NCT01982799|Naproxen|naproxen|mesh-list
83735201|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83735202|NCT01982799|Hydrocodone|hydrocodone|mesh-list
82890306|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83735203|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83735205|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
83735206|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735207|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735208|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
83735209|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83735210|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735211|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735212|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83735213|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735214|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735215|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
83735216|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83735217|NCT01982799|Narcotics|narcotics|mesh-ancestor
83735218|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735219|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
83735220|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83735221|NCT01982864|Gentamicins|gentamicins|mesh-list
83735222|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83735223|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735224|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83735225|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735226|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735227|NCT01982929|Epinephrine|epinephrine|mesh-list
83735228|NCT01982929|Bupivacaine|bupivacaine|mesh-list
83735229|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
83735230|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
83735231|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735232|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735233|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
83735234|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735235|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83735236|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83735237|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83735238|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735239|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735240|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83735241|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83735242|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
83735243|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83735244|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
83735245|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
83735246|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
83735247|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83735248|NCT01983124|Vemurafenib|vemurafenib|mesh-list
83735249|NCT01983124|Fotemustine|fotemustine|mesh-list
83735250|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735251|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83735252|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735253|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735254|NCT01983137|Oxycodone|oxycodone|mesh-list
83735255|NCT01983137|Naloxone|naloxone|mesh-list
83735256|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83735257|NCT01983137|Narcotics|narcotics|mesh-ancestor
83735258|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735259|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735260|NCT01983137|Analgesics|analgesics|mesh-ancestor
83735261|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
83735262|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735263|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83735264|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83735265|NCT01983371|Hematinics|hematinics|mesh-ancestor
83735266|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83735267|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83735268|NCT01983384|Anesthetics|anesthetics|mesh-list
83735269|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735270|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735271|NCT01983449|Dexamethasone|dexamethasone|mesh-list
83735272|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
83735273|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83735274|NCT01983449|BB 1101|bb 1101|mesh-list
83735275|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735276|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
83735277|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
83735278|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735279|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735280|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735281|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
83735282|NCT01983449|Hormones|hormones|mesh-ancestor
83735283|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735284|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83735285|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735286|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
83735287|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735288|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735289|NCT01983475|Denosumab|denosumab|mesh-list
83735290|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83735291|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735292|NCT01983501|Tucatinib|tucatinib|mesh-list
83735293|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735294|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735295|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83735296|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735297|NCT01983514|Oxytocin|oxytocin|mesh-list
83735298|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
83735299|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83735300|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735301|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
83735302|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83735303|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83735304|NCT01983527|Prednisolone|prednisolone|mesh-list
83735305|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
83735306|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83735307|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
83735308|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735309|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
83735310|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
83735311|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735312|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735313|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735314|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
83735315|NCT01983527|Hormones|hormones|mesh-ancestor
83735316|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735317|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83735318|NCT01983527|Protective Agents|protective agents|mesh-ancestor
83735319|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83735320|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735321|NCT01983540|Vaccines|vaccines|mesh-list
83735322|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83735323|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
83735324|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735325|NCT01983657|Molgramostim|molgramostim|mesh-list
83735326|NCT01983657|Sargramostim|sargramostim|mesh-list
83735327|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
83735328|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735329|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735330|NCT01983722|Stiripentol|stiripentol|mesh-list
83735331|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
83735332|NCT01983735|Niacin|niacin|mesh-list
83735333|NCT01983735|Amlodipine|amlodipine|mesh-list
83735334|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83735335|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83735336|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735337|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735338|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83735339|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735340|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
83735341|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83735342|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
83735343|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83735344|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
83735345|NCT01983735|Vitamins|vitamins|mesh-ancestor
83735346|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
83735347|NCT01983761|Vidarabine|vidarabine|mesh-list
83735348|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
83735349|NCT01983761|Fludarabine|fludarabine|mesh-list
83735350|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
83735351|NCT01983761|Melphalan|melphalan|mesh-list
83735352|NCT01983761|Busulfan|busulfan|mesh-list
82890456|NCT01152840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83735353|NCT01983761|Clofarabine|clofarabine|mesh-list
83735354|NCT01983761|Tacrolimus|tacrolimus|mesh-list
83735355|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735357|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735358|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83735359|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
83735360|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735361|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83735362|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
83735363|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735364|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83735365|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735366|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83735367|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83735368|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
83735369|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83735370|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83735371|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
83735372|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83735373|NCT01983800|Midazolam|midazolam|mesh-list
83735374|NCT01983800|Propofol|propofol|mesh-list
83735375|NCT01983800|Isoflurane|isoflurane|mesh-list
83735376|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83735377|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735378|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735379|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83735380|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
83735381|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
83735382|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83735383|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83735384|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83735385|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83735386|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
83735387|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
83735388|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735389|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735390|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83735391|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83735392|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735393|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
83735394|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735395|NCT01983943|Protective Agents|protective agents|mesh-ancestor
83735396|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735397|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83735398|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
83735399|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
83735400|NCT01984008|Citric Acid|citric acid|mesh-list
83735401|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
83735402|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
83735403|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83735404|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
83735405|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
83735406|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735407|NCT01984008|Cathartics|cathartics|mesh-ancestor
83735408|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735409|NCT01984008|Antacids|antacids|mesh-ancestor
83735410|NCT01984073|Niacin|niacin|mesh-list
83735411|NCT01984073|Niacinamide|niacinamide|mesh-list
83735412|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
83735413|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83735414|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
83735415|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735416|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83735417|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
83735418|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
83735419|NCT01984073|Vitamins|vitamins|mesh-ancestor
83735420|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
83735421|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735422|NCT01984086|Albuterol|albuterol|mesh-list
83735423|NCT01984086|Charcoal|charcoal|mesh-list
83735424|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83735425|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
83735426|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735427|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735428|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83735429|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83735430|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
83735431|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83735432|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83735433|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83735434|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83735435|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
83735436|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735437|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735438|NCT01984086|Antidotes|antidotes|mesh-ancestor
83735439|NCT01984086|Protective Agents|protective agents|mesh-ancestor
83735440|NCT01984099|Folic Acid|folic acid|mesh-list
83735441|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
83735442|NCT01984099|Methotrexate|methotrexate|mesh-list
83735443|NCT01984099|Vitamins|vitamins|mesh-ancestor
83735444|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
83735445|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735446|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83735447|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
83735448|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83735449|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83735450|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
83735451|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735452|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735453|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
83735454|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735455|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83735456|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83735457|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
83735458|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735459|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83735460|NCT01984099|Hematinics|hematinics|mesh-ancestor
83735461|NCT01984177|Hormones|hormones|mesh-list
83735462|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83735463|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
83735464|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735465|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735466|NCT01984255|Ipilimumab|ipilimumab|mesh-list
83735467|NCT01984255|Bavituximab|bavituximab|mesh-list
83735468|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83735469|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735470|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83735471|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735472|NCT01984372|Insulin|insulin|mesh-list
83735473|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83735474|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735475|NCT01984463|Fentanyl|fentanyl|mesh-list
83735476|NCT01984463|Morphine|morphine|mesh-list
83735477|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83735478|NCT01984463|Narcotics|narcotics|mesh-ancestor
83735479|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735480|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735481|NCT01984463|Analgesics|analgesics|mesh-ancestor
83735482|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
83735483|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735484|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83735485|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83735486|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
83735487|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
83735488|NCT01984567|Vitamin E|vitamin e|mesh-list
83735489|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
83735490|NCT01984567|Vitamins|vitamins|mesh-ancestor
83735491|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
83735492|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735493|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
83735494|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735495|NCT01984567|Protective Agents|protective agents|mesh-ancestor
83735496|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
83735497|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83735498|NCT01984606|Empagliflozin|empagliflozin|mesh-list
83735499|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83735500|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735501|NCT01984606|Incretins|incretins|mesh-ancestor
83735502|NCT01984606|Hormones|hormones|mesh-ancestor
83735503|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735504|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83735505|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
83735506|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735507|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735508|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83735509|NCT01984749|Febuxostat|febuxostat|mesh-list
83735510|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
83735511|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735512|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
83735513|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83735514|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735515|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83735516|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83735517|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735518|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735519|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735520|NCT01984931|Medazepam|medazepam|mesh-list
83735521|NCT01984931|Metoclopramide|metoclopramide|mesh-list
83735522|NCT01984931|Bromazepam|bromazepam|mesh-list
83735523|NCT01984931|Simethicone|simethicone|mesh-list
83735524|NCT01984931|Trimebutine|trimebutine|mesh-list
83735525|NCT01984931|Mosapride|mosapride|mesh-list
83735526|NCT01984931|Maleic acid|maleic acid|mesh-list
83735527|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735528|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735529|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
83735530|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
83735531|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735532|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735533|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735534|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83735535|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83735536|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
83735537|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735538|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
83735539|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83735540|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
83735541|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
83735542|NCT01984931|Emollients|emollients|mesh-ancestor
83735543|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
83735544|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83735545|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83735546|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735547|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83735548|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
83735549|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
83735550|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
83735551|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83735552|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83735553|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83735554|NCT01985061|Busulfan|busulfan|mesh-list
83735555|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
83735556|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735557|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83735558|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
83735559|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735560|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83735561|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735562|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83735563|NCT01985087|Temozolomide|temozolomide|mesh-list
83735564|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83735565|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
83735566|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735567|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735568|NCT01985152|Choline|choline|mesh-list
83735569|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83735570|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83735571|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83735572|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735573|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
83735574|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83735575|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
83735576|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735577|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83735578|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
83735579|NCT01985256|Flucytosine|flucytosine|mesh-list
83735580|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
82890681|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
82890684|NCT01155102|Anastrozole|anastrozole|mesh-list
83735581|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735582|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
83735583|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735584|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
83735585|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83735586|NCT01985373|Antibodies|antibodies|mesh-list
83735587|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
83735588|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83735589|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
83735590|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735591|NCT01985451|Temozolomide|temozolomide|mesh-list
83735592|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83735593|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
83735594|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735595|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735596|NCT01985477|Dexamethasone|dexamethasone|mesh-list
83735597|NCT01985477|Lenalidomide|lenalidomide|mesh-list
83735598|NCT01985477|Tretinoin|tretinoin|mesh-list
83735599|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735600|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
83735601|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
83735602|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735603|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735604|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735605|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
83735606|NCT01985477|Hormones|hormones|mesh-ancestor
83735607|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735608|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83735609|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735610|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
83735611|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83735612|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83735613|NCT01985477|Growth Substances|growth substances|mesh-ancestor
83735614|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
83735615|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
83735616|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
83735617|NCT01985594|Nifedipine|nifedipine|mesh-list
83735618|NCT01985594|Progesterone|progesterone|mesh-list
83735619|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83735620|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735621|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735622|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83735623|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735624|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
83735625|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
83735626|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83735627|NCT01985594|Progestins|progestins|mesh-ancestor
83735628|NCT01985594|Hormones|hormones|mesh-ancestor
83735629|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735630|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
83735631|NCT01985724|Docetaxel|docetaxel|mesh-list
83735632|NCT01985724|Epirubicin|epirubicin|mesh-list
83735633|NCT01985724|Fluorouracil|fluorouracil|mesh-list
83735634|NCT01985724|Lenograstim|lenograstim|mesh-list
83735635|NCT01985724|Mitogens|mitogens|mesh-list
83735636|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83735637|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
83735638|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735639|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735640|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83735641|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
83735642|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735643|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735644|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83735645|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
83735646|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
83735647|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
83735648|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83735649|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83735650|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83735651|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735652|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
83735653|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83735654|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83735655|NCT01985750|Cycloserine|cycloserine|mesh-list
83735656|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83735657|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735658|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83735659|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
83735660|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83735661|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
83735662|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735663|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
83735665|NCT01985789|Cetirizine|cetirizine|mesh-list
83735666|NCT01985789|Desloratadine|desloratadine|mesh-list
83735667|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83735668|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83735669|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735670|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735671|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
83735672|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
83735673|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
83735674|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735675|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
83735676|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
83735677|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735678|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83735679|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
83735680|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
83735681|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735682|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735683|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83735684|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
83735685|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
83735686|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83735687|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83735688|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
83735689|NCT01985828|Androgens|androgens|mesh-list
83735690|NCT01985828|Hormones|hormones|mesh-ancestor
83735691|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735692|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735693|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
83735694|NCT01985841|Docetaxel|docetaxel|mesh-list
83735695|NCT01985841|Fluorouracil|fluorouracil|mesh-list
83735696|NCT01985841|Epirubicin|epirubicin|mesh-list
83735697|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83735698|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
83735699|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735700|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735701|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83735702|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
83735703|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735704|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735705|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83735706|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
83735707|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
83735708|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
83735709|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
83735710|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83735711|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83735712|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83735713|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83735714|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735715|NCT01985854|Propofol|propofol|mesh-list
83735716|NCT01985854|Desflurane|desflurane|mesh-list
83735717|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83735718|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735719|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735720|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83735721|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
83735722|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
83735723|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83735724|NCT01985893|Trastuzumab|trastuzumab|mesh-list
83735725|NCT01985893|Lapatinib|lapatinib|mesh-list
83735726|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83735727|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735728|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83735729|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735730|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735731|NCT01986036|Calcium|calcium|mesh-list
83735732|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83735733|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735734|NCT01986049|Bupivacaine|bupivacaine|mesh-list
83735735|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
83735736|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
83735737|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735738|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735739|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
83735740|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735741|NCT01986088|Sumatriptan|sumatriptan|mesh-list
83735742|NCT01986088|Eletriptan|eletriptan|mesh-list
83735743|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83735744|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83735745|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83735746|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
83735747|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735748|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735749|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735750|NCT01986127|Adalimumab|adalimumab|mesh-list
83735751|NCT01986127|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83735752|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735753|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735754|NCT01986192|Warfarin|warfarin|mesh-list
83735755|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
83735756|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
83735757|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83735758|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
83735759|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83735760|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
83735761|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735762|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735763|NCT01986218|BMS-986115|bms-986115|mesh-list
83735764|NCT01986218|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83735765|NCT01986218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735766|NCT01986218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735767|NCT01986270|Sumatriptan|sumatriptan|mesh-list
83735768|NCT01986270|Eletriptan|eletriptan|mesh-list
83735769|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83735770|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83735771|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83735772|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
83735773|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735774|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735775|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735776|NCT01986283|Oxycodone|oxycodone|mesh-list
83735777|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83735778|NCT01986283|Narcotics|narcotics|mesh-ancestor
83735779|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735780|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735781|NCT01986283|Analgesics|analgesics|mesh-ancestor
83735782|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
83735783|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735784|NCT01986309|Lidocaine|lidocaine|mesh-list
83735785|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
83735786|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
83735787|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735788|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735789|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
83735790|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735791|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83735792|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83735793|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83735794|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735795|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735796|NCT01986322|Vaccines|vaccines|mesh-list
83735797|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
83735798|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735799|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
83735800|NCT01986426|Ipilimumab|ipilimumab|mesh-list
83735801|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83735802|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735803|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83735804|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735805|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83735806|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
82890902|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82890903|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
82890904|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890905|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890906|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735807|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83735809|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
83735810|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83735811|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
83735812|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735813|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
83735814|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
83735815|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735816|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735817|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735818|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
83735819|NCT01986465|Hormones|hormones|mesh-ancestor
83735820|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735821|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83735822|NCT01986465|Protective Agents|protective agents|mesh-ancestor
83735823|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83735824|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735825|NCT01986556|Lesinurad|lesinurad|mesh-list
83735826|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
83735827|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735828|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
83735829|NCT01986582|Phenylephrine|phenylephrine|mesh-list
83735830|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
83735831|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83735832|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83735833|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
83735834|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735835|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735836|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735837|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
83735838|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
83735839|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735840|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
83735841|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83735842|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
83735843|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83735844|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
83735845|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83735846|NCT01986582|Protective Agents|protective agents|mesh-ancestor
83735847|NCT01986608|Lacosamide|lacosamide|mesh-list
83735848|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
83735849|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83735850|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83735851|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735852|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735853|NCT01986660|Ibuprofen|ibuprofen|mesh-list
83735854|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83735855|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83735856|NCT01986660|Analgesics|analgesics|mesh-ancestor
83735857|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
83735858|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735859|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735860|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735861|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735862|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83735863|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735864|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735865|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
83735866|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
83735867|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83735868|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83735869|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735870|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735871|NCT01986673|Urological Agents|urological agents|mesh-ancestor
83735872|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83735873|NCT01986764|Estradiol|estradiol|mesh-list
83735874|NCT01986764|Estrogens|estrogens|mesh-list
83735875|NCT01986764|Hormones|hormones|mesh-ancestor
83735876|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735877|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735878|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83735879|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83735880|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83735881|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735882|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735883|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
83735884|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735885|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83735886|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83735887|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735888|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83735889|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83735890|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83735891|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735892|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
83735893|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83735894|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
83735895|NCT01986894|Thalidomide|thalidomide|mesh-list
83735896|NCT01986894|Pomalidomide|pomalidomide|mesh-list
83735897|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83735898|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735899|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83735900|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83735901|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735902|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735903|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735904|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735905|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
83735906|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83735907|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83735908|NCT01986894|Growth Substances|growth substances|mesh-ancestor
83735909|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
83735910|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83735911|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
83735912|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
83735913|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83735914|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83735915|NCT01986998|Prednisolone|prednisolone|mesh-list
83735916|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
83735917|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83735918|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
83735919|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735920|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
83735921|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
83735922|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735923|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735924|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83735925|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
83735926|NCT01986998|Hormones|hormones|mesh-ancestor
83735927|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735928|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83735929|NCT01986998|Protective Agents|protective agents|mesh-ancestor
83735930|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83735931|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735932|NCT01987076|Prednisone|prednisone|mesh-list
83735933|NCT01987076|Clobetasol|clobetasol|mesh-list
83735934|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83735935|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
83735936|NCT01987076|Hormones|hormones|mesh-ancestor
83735937|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735938|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735939|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83735940|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735941|NCT01987128|Ropivacaine|ropivacaine|mesh-list
83735942|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
83735943|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
83735944|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83735945|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735946|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
83735947|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83735948|NCT01987154|Caseins|caseins|mesh-list
83735949|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
83735950|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
83735951|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735952|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83735953|NCT01987167|Hormones|hormones|mesh-ancestor
83735954|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83735955|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735956|NCT01987297|Cytarabine|cytarabine|mesh-list
83735957|NCT01987297|Daunorubicin|daunorubicin|mesh-list
83735958|NCT01987297|Idarubicin|idarubicin|mesh-list
83735959|NCT01987297|Tretinoin|tretinoin|mesh-list
83735960|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
83735961|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83735962|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
83735963|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735964|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735965|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
83735966|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83735967|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83735968|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
83735969|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83735970|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83735971|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83735972|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83735973|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735974|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
83735975|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
83735976|NCT01987310|Atorvastatin|atorvastatin|mesh-list
83735977|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83735978|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83735979|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
83735980|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735981|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83735982|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83735983|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735984|NCT01987323|Latanoprost|latanoprost|mesh-list
83735985|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83735986|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83735987|NCT01987375|Cetuximab|cetuximab|mesh-list
83735988|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83735989|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83735990|NCT01987570|Allopurinol|allopurinol|mesh-list
83735991|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
83735992|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83735993|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83735994|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
83735995|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83735996|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83735997|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
83735998|NCT01987570|Protective Agents|protective agents|mesh-ancestor
83735999|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736000|NCT01987739|Zolpidem|zolpidem|mesh-list
83736001|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83736002|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83736003|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736004|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736005|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83736006|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
83736007|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
83736008|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736009|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736010|NCT01987804|Oxytocin|oxytocin|mesh-list
83736011|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
83736012|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736013|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736014|NCT01988077|Ipilimumab|ipilimumab|mesh-list
83736015|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83736016|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736017|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83736018|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736019|NCT01988116|Calcitriol|calcitriol|mesh-list
83736020|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736021|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736022|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83736023|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736024|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736025|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83736026|NCT01988116|Vitamins|vitamins|mesh-ancestor
83736027|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
83736028|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83736029|NCT01988298|Acetaminophen|acetaminophen|mesh-list
83736030|NCT01988298|Ibuprofen|ibuprofen|mesh-list
83736031|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83736032|NCT01988298|Analgesics|analgesics|mesh-ancestor
83736033|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
83736034|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736035|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736036|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
83501476|NCT01337336|Xhance|xhance|mesh-list
83736037|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83736038|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736039|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83736040|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83736041|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736042|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736043|NCT01988311|Psilocybin|psilocybin|mesh-list
83736044|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
83736045|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736046|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83736047|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
83736048|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83736049|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736050|NCT01988506|Interleukin-2|interleukin-2|mesh-list
83736051|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736052|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83736053|NCT01988506|Analgesics|analgesics|mesh-ancestor
83736054|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
83736055|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736056|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736057|NCT01988545|Exenatide|exenatide|mesh-list
83736058|NCT01988545|Glucagon|glucagon|mesh-list
83736059|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83736060|NCT01988545|Incretins|incretins|mesh-ancestor
83736061|NCT01988545|Hormones|hormones|mesh-ancestor
83736062|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736063|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736064|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736065|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83736066|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83736067|NCT01988610|Mifepristone|mifepristone|mesh-list
83736068|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83736069|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
83736070|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736071|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736072|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83736073|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83736074|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83736075|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
83736076|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83736077|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83736078|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
83736079|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736080|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
83736081|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83736082|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83736083|NCT01988649|Oxytocin|oxytocin|mesh-list
83736084|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
83736085|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736086|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736087|NCT01988831|Propranolol|propranolol|mesh-list
83736088|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83736089|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83736090|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
83736091|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736092|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736093|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736094|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83736095|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83736096|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
83736097|NCT01988896|Atezolizumab|atezolizumab|mesh-list
83736098|NCT01988896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83736099|NCT01988896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736100|NCT01988896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83736101|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736102|NCT01988961|Golimumab|golimumab|mesh-list
83736103|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83736104|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82891198|NCT03879486|Povidone|povidone|mesh-list
83736105|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83736106|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
83736107|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736108|NCT01989000|Gemcitabine|gemcitabine|mesh-list
83736110|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83736111|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
83736112|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736113|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736114|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736115|NCT01989052|Lomustine|lomustine|mesh-list
83736116|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83736117|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83736118|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
83736119|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736120|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736121|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83736122|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736123|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736124|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736125|NCT01989078|Losartan|losartan|mesh-list
83736126|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83736127|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83736128|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83736129|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83736130|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736131|NCT01989091|Heparin|heparin|mesh-list
83736132|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
83736133|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83736134|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83736135|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736136|NCT01989312|Lidocaine|lidocaine|mesh-list
83736137|NCT01989312|Epinephrine|epinephrine|mesh-list
83736138|NCT01989312|Midazolam|midazolam|mesh-list
83736139|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
83736140|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
83736141|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
83736142|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736143|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736144|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
83736145|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736146|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83736147|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83736148|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83736149|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736150|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736151|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83736152|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83736153|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83736154|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83736155|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83736156|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83736157|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
83736158|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
83736159|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
83736160|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736161|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83736162|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83736163|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83736164|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83736165|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83736166|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
83736167|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83736168|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83736169|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
83736170|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
83736171|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83736172|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
83736173|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83736174|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83736175|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736176|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
83736177|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
83736178|NCT01989507|Nicotine|nicotine|mesh-list
82891273|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83736179|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83736180|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
83736181|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736182|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736183|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83736184|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83736185|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
83736186|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736187|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736188|NCT01989559|Vaccines|vaccines|mesh-list
83736189|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
83736190|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736191|NCT01989611|Tenofovir|tenofovir|mesh-list
83736192|NCT01989611|Emtricitabine|emtricitabine|mesh-list
83736193|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
83736194|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736195|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83736196|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83736197|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736198|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736199|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83736200|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83736201|NCT01989663|Tenofovir|tenofovir|mesh-list
83736202|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
83736203|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736204|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83736205|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83736206|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736207|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736208|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83736209|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83736210|NCT01989676|Paclitaxel|paclitaxel|mesh-list
83736211|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83736212|NCT01989676|Trastuzumab|trastuzumab|mesh-list
83736213|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83736214|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736215|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83736216|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83736217|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83736218|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736219|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83736220|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
83736221|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83736222|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
83736223|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83736224|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
83736225|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736226|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736227|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
83736228|NCT01989884|IDN 5109|idn 5109|mesh-list
83736229|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736230|NCT01989897|Phenol|phenol|mesh-list
83736231|NCT01989897|Histamine|histamine|mesh-list
83736232|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
83736233|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
83736234|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736235|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736236|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736237|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83736238|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736239|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
83736240|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83736241|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83736242|NCT01989923|Nicotine|nicotine|mesh-list
83736243|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83736244|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
83736245|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736246|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736247|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83736248|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83736249|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
83736250|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736251|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736252|NCT01989936|Eletriptan|eletriptan|mesh-list
83736253|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82891348|NCT01164774|Ramipril|ramipril|mesh-list
83736254|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
83736255|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736256|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736257|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736259|NCT01990079|Nicotine|nicotine|mesh-list
83736260|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83736261|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
83736262|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736263|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736264|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83736265|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83736266|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
83736267|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736268|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736269|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83736270|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
83736271|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83736272|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83736273|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83736274|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736275|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
83736276|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83736277|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83736278|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736279|NCT01990118|Cyclosporine|cyclosporine|mesh-list
83736280|NCT01990118|Cyclosporins|cyclosporins|mesh-list
83736281|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736282|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736283|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83736284|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
83736285|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736286|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
83736287|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736288|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83736289|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83736290|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83736291|NCT01990144|Rituximab|rituximab|mesh-list
83736292|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83736293|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83736294|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736295|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
83736296|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736297|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83736298|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83736299|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
83736300|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736301|NCT01990378|Rabeprazole|rabeprazole|mesh-list
83736302|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83736303|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736304|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83736305|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736306|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736307|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
83736308|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83736309|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
83736310|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
83736311|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736312|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736313|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83736314|NCT01990404|Analgesics|analgesics|mesh-ancestor
83736315|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
83736316|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736317|NCT01990443|Reslizumab|reslizumab|mesh-list
83736318|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83736319|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
83736320|NCT01990586|Rabeprazole|rabeprazole|mesh-list
83736321|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83736322|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736323|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83736324|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736325|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736326|NCT01990690|Antioxidants|antioxidants|mesh-list
82891424|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736327|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736328|NCT01990690|Protective Agents|protective agents|mesh-ancestor
83736329|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736330|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
83736332|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
83736333|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
83736334|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736335|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736336|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736337|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83736338|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83736339|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736340|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83736341|NCT01990755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83736342|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83736343|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736344|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736345|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736346|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
83736347|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
83736348|NCT01990781|Dexamethasone|dexamethasone|mesh-list
83736349|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
83736350|NCT01990781|Lidocaine|lidocaine|mesh-list
83736351|NCT01990781|BB 1101|bb 1101|mesh-list
83736352|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736353|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
83736354|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
83736355|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736356|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736357|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736358|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
83736359|NCT01990781|Hormones|hormones|mesh-ancestor
83736360|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736361|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83736362|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736363|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
83736364|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736365|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736366|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
83736367|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
83736368|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736369|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
83736370|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83736371|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83736372|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83736373|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736374|NCT01990807|Idarubicin|idarubicin|mesh-list
83736375|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83736376|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736377|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83736378|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83736379|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736380|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736381|NCT01990872|Vitamin D|vitamin d|mesh-list
83736382|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
83736383|NCT01990872|Vitamins|vitamins|mesh-ancestor
83736384|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
83736385|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736386|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83736387|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736388|NCT01990937|Midazolam|midazolam|mesh-list
83736389|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83736390|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83736391|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736392|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736393|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83736394|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83736395|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83736396|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83736397|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
83736398|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
83736399|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
83736400|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
82891519|NCT05835713|Propofol|propofol|mesh-list
83736401|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736402|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736403|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83736404|NCT01991054|Vitamin D|vitamin d|mesh-list
83736405|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
83736406|NCT01991054|Vitamins|vitamins|mesh-ancestor
83736407|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
83736408|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736409|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83736410|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736411|NCT01991119|Dronedarone|dronedarone|mesh-list
83736412|NCT01991119|Propafenone|propafenone|mesh-list
83736413|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83736414|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83736415|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83736416|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736417|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736418|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
83736419|NCT01991145|Hematinics|hematinics|mesh-ancestor
83736420|NCT01991158|Dexamethasone|dexamethasone|mesh-list
83736421|NCT01991158|Gemcitabine|gemcitabine|mesh-list
83736422|NCT01991158|Methotrexate|methotrexate|mesh-list
83736423|NCT01991158|Pegaspargase|pegaspargase|mesh-list
83736424|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736425|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
83736426|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
83736427|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736428|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736429|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736430|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
83736431|NCT01991158|Hormones|hormones|mesh-ancestor
83736432|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736433|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83736434|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736435|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83736436|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
83736437|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736438|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83736439|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
83736440|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736441|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
83736442|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736443|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83736444|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83736445|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
83736446|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83736447|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83736448|NCT01991275|Morphine|morphine|mesh-list
83736449|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83736450|NCT01991275|Narcotics|narcotics|mesh-ancestor
83736451|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736452|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736453|NCT01991275|Analgesics|analgesics|mesh-ancestor
83736454|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
83736455|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736456|NCT01991288|Epinephrine|epinephrine|mesh-list
83736457|NCT01991288|Racepinephrine|racepinephrine|mesh-list
83736458|NCT01991288|Bupivacaine|bupivacaine|mesh-list
83736459|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
83736460|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
83736461|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
83736462|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
83736463|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736464|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736465|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
83736466|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736467|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83736468|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83736469|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
83736470|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736471|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736472|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83736473|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82891576|NCT05834777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83736474|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
83736475|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83736476|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83736477|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
83736478|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
83736479|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83736480|NCT01991327|Enclomiphene|enclomiphene|mesh-list
83736482|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
83736483|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83736484|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
83736485|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736486|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736487|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83736488|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
83736489|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736490|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83736491|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83736492|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83736493|NCT01991561|Vaccines|vaccines|mesh-list
83736494|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
83736495|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736496|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83736497|NCT01991561|Antacids|antacids|mesh-ancestor
83736498|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736499|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736500|NCT01991574|Calcium|calcium|mesh-list
83736501|NCT01991574|Calcium acetate|calcium acetate|mesh-list
83736502|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736503|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736504|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
83736505|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
83736506|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736507|NCT01991587|Vaccines|vaccines|mesh-list
83736508|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
83736509|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736510|NCT01991626|Iron|iron|mesh-list
83736511|NCT01991626|Trace Elements|trace elements|mesh-list
83736512|NCT01991626|Micronutrients|micronutrients|mesh-list
83736513|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736514|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
83736515|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736516|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83736517|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83736518|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736519|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736520|NCT01991834|Cefazolin|cefazolin|mesh-list
83736521|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83736522|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736523|NCT01991951|Warfarin|warfarin|mesh-list
83736524|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
83736525|NCT01992133|Vitamin D|vitamin d|mesh-list
83736526|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
83736527|NCT01992133|Vitamins|vitamins|mesh-ancestor
83736528|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
83736529|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736530|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83736531|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736532|NCT01992146|Naloxone|naloxone|mesh-list
83736533|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83736534|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736535|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
83736536|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736537|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
83736538|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83736539|NCT01992198|Metronidazole|metronidazole|mesh-list
83736540|NCT01992198|Meropenem|meropenem|mesh-list
83736541|NCT01992198|Cefoperazone|cefoperazone|mesh-list
83736542|NCT01992198|Sulperazone|sulperazone|mesh-list
83736543|NCT01992198|Somatostatin|somatostatin|mesh-list
83736544|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83736545|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736546|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
83736547|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
83736548|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83736549|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83736550|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83736551|NCT01992198|Hormones|hormones|mesh-ancestor
83736552|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736553|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736554|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83736555|NCT01992211|Metformin|metformin|mesh-list
83736556|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83736557|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83736558|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736559|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83736560|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83736561|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
83736562|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736563|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83736564|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83736565|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736566|NCT01992263|Vitamin D|vitamin d|mesh-list
83736567|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
83736568|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
83736569|NCT01992263|Vitamins|vitamins|mesh-list
83736570|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
83736571|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736572|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83736573|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736574|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
83736575|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83736576|NCT01992328|Antibodies|antibodies|mesh-list
83736577|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
83736578|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
83736579|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83736580|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
83736581|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736582|NCT01992341|Paclitaxel|paclitaxel|mesh-list
83736583|NCT01992341|Trebananib|trebananib|mesh-list
83736584|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83736585|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736586|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
83736587|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
83736588|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
83736589|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736590|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83736591|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83736592|NCT01992341|Growth Substances|growth substances|mesh-ancestor
83736593|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736594|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
83736595|NCT01992562|Ziconotide|ziconotide|mesh-list
83736596|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83736597|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736598|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736599|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736600|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736601|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83736602|NCT01992562|Protective Agents|protective agents|mesh-ancestor
83736603|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83736604|NCT01992562|Analgesics|analgesics|mesh-ancestor
83736605|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
83736606|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736607|NCT01992588|Insulin|insulin|mesh-list
83736608|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83736609|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
83736610|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
83736611|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83736612|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83736613|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736614|NCT01992601|Telmisartan|telmisartan|mesh-list
83736615|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83736616|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83736617|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83736618|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
83736619|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736620|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83736621|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83736622|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736623|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83736624|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83736625|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83736626|NCT01992705|Fluorouracil|fluorouracil|mesh-list
83736627|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
83736628|NCT01992705|Irinotecan|irinotecan|mesh-list
83736629|NCT01992705|Folfirinox|folfirinox|mesh-list
83736630|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
83736631|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736632|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83736633|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736634|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83736635|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
83736636|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736637|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83736638|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83736639|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736640|NCT01992796|Telmisartan|telmisartan|mesh-list
83736641|NCT01992796|Candesartan|candesartan|mesh-list
83736642|NCT01992796|Olmesartan|olmesartan|mesh-list
83736643|NCT01992796|Irbesartan|irbesartan|mesh-list
83736644|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83736645|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83736646|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83736647|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736648|NCT01992900|Piperaquine|piperaquine|mesh-list
83736649|NCT01992900|Artenimol|artenimol|mesh-list
83736650|NCT01992900|Artemisinins|artemisinins|mesh-list
83736651|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
83736652|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83736653|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83736654|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736655|NCT01993134|Cefazolin|cefazolin|mesh-list
83736656|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83736657|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736658|NCT01993173|Vaccines|vaccines|mesh-list
83736659|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
83736660|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736661|NCT01993212|Enclomiphene|enclomiphene|mesh-list
83736662|NCT01993212|Testosterone|testosterone|mesh-list
83736663|NCT01993212|Androgens|androgens|mesh-ancestor
83736664|NCT01993212|Hormones|hormones|mesh-ancestor
83736665|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736666|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736667|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83736668|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
83736669|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83736670|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
83736671|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736672|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83736673|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83736674|NCT01993225|Enclomiphene|enclomiphene|mesh-list
83736675|NCT01993225|Testosterone|testosterone|mesh-list
83736676|NCT01993225|Androgens|androgens|mesh-ancestor
83736677|NCT01993225|Hormones|hormones|mesh-ancestor
83736678|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736679|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736680|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83736681|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
83736682|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83736683|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
83736684|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736685|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83736686|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83736687|NCT01993251|Melatonin|melatonin|mesh-list
83736688|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
83736689|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736690|NCT01993251|Protective Agents|protective agents|mesh-ancestor
83736691|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736692|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736693|NCT01993290|Ropivacaine|ropivacaine|mesh-list
83736694|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83736695|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
83736696|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736697|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736698|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
83736699|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736700|NCT01993459|Midazolam|midazolam|mesh-list
83736701|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83736702|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83736703|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83736704|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736705|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736706|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83736707|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83736708|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83736709|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83736710|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
83736712|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
83736713|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
83736714|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736715|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736716|NCT01993472|Andrographolide|andrographolide|mesh-list
83736717|NCT01993472|Capecitabine|capecitabine|mesh-list
83736718|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83736719|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
83736720|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736721|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736722|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736723|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83736724|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83736725|NCT01993472|Analgesics|analgesics|mesh-ancestor
83736726|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
83736727|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736728|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736729|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83736730|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83736731|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83736732|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736733|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
83736734|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83736735|NCT01993537|Vitamin D|vitamin d|mesh-list
83736736|NCT01993537|Vitamins|vitamins|mesh-ancestor
83736737|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
83736738|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736739|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83736740|NCT01993589|Acetaminophen|acetaminophen|mesh-list
83736741|NCT01993589|Analgesics|analgesics|mesh-list
83736742|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83736743|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
83736744|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736745|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736746|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
83736747|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
83736748|NCT01993680|Bromides|bromides|mesh-list
83736749|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83736750|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
83736751|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83736752|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736753|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736754|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
83736755|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736756|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736757|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736758|NCT01993771|Anesthetics|anesthetics|mesh-list
83736759|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736760|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736761|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
83736762|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83736763|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736764|NCT01993979|Cisplatin|cisplatin|mesh-list
83736765|NCT01993979|Carboplatin|carboplatin|mesh-list
83736766|NCT01993979|Gemcitabine|gemcitabine|mesh-list
83736767|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736768|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83736769|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
83736770|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736771|NCT01994031|Paclitaxel|paclitaxel|mesh-list
83736772|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83736773|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83736774|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736775|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
83736776|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
83736777|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
83736778|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736779|NCT01994070|Procainamide|procainamide|mesh-list
83736780|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83736781|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83736782|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83736783|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83736784|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736785|NCT01994096|Caspofungin|caspofungin|mesh-list
83736786|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
83736787|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736788|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736789|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736790|NCT01994265|Warfarin|warfarin|mesh-list
83736791|NCT01994265|Dabigatran|dabigatran|mesh-list
83736792|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
83736793|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
83736794|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83736795|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
83736796|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736797|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736798|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83736799|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
83736800|NCT01994330|Coagulants|coagulants|mesh-ancestor
83736801|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83736802|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
83736803|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736804|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
83736805|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83736806|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736807|NCT01994460|Linezolid|linezolid|mesh-list
83736808|NCT01994460|Ethambutol|ethambutol|mesh-list
83736809|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83736810|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736811|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83736812|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736813|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736814|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
83736815|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
83736816|NCT01994642|Dexamethasone|dexamethasone|mesh-list
83736817|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
83736818|NCT01994642|BB 1101|bb 1101|mesh-list
83736819|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736820|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
83736821|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
83736822|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736823|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736824|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736825|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
83736826|NCT01994642|Hormones|hormones|mesh-ancestor
83736827|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736828|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83736829|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736830|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
83736831|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736832|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736833|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83736834|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736835|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83736836|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83736837|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83736838|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83736839|NCT01994668|Lorazepam|lorazepam|mesh-list
83736840|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
83736841|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
83736842|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
83736843|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736844|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736845|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736846|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83736847|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736848|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83736849|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83736850|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83736851|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
83736852|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
83736853|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736854|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891950|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83736855|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
83736856|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
83736857|NCT01994733|Calcium|calcium|mesh-list
83736858|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83736859|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736860|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83736861|NCT01994733|Antacids|antacids|mesh-ancestor
83736862|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736863|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736864|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
83736865|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83736866|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736867|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
83736868|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
83736869|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736870|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736871|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736872|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
83736873|NCT01994759|Hormones|hormones|mesh-ancestor
83736874|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736875|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83736876|NCT01994759|Protective Agents|protective agents|mesh-ancestor
83736877|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
83736878|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83736879|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
83736880|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736881|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83736882|NCT01994941|Clopidogrel|clopidogrel|mesh-list
83736883|NCT01994941|Ticagrelor|ticagrelor|mesh-list
83736884|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83736885|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83736886|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83736887|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83736888|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
83736889|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83736890|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736891|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736892|NCT01994967|Bupivacaine|bupivacaine|mesh-list
83736893|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
83736894|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83736895|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
83736896|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736897|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736898|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
83736899|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736900|NCT01995006|Dipyrone|dipyrone|mesh-list
83736901|NCT01995006|Naproxen|naproxen|mesh-list
83736902|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83736903|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83736904|NCT01995006|Analgesics|analgesics|mesh-ancestor
83736905|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
83736906|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736907|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736908|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736909|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83736910|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
83736911|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83736912|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736913|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736914|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
83736915|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
83736916|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83736917|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83736918|NCT01995019|Prednisolone|prednisolone|mesh-list
83736919|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
83736920|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83736921|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
83736922|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736923|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
83736924|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
83736925|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736926|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736927|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83736928|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
83736929|NCT01995019|Hormones|hormones|mesh-ancestor
82892027|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83736930|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736931|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83736933|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83736934|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736935|NCT01995032|Metformin|metformin|mesh-list
83736936|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83736937|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736938|NCT01995058|Prednisone|prednisone|mesh-list
83736939|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
83736940|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83736941|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
83736942|NCT01995058|Hormones|hormones|mesh-ancestor
83736943|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83736944|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736945|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83736946|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736947|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83736948|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736949|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736950|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
83736951|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83736952|NCT01995084|Imidazole|imidazole|mesh-list
83736953|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736954|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736955|NCT01995188|Bevacizumab|bevacizumab|mesh-list
83736956|NCT01995188|Carboplatin|carboplatin|mesh-list
83736957|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83736958|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736959|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83736960|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83736961|NCT01995188|Growth Substances|growth substances|mesh-ancestor
83736962|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736963|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
83736964|NCT01995214|Propofol|propofol|mesh-list
83736965|NCT01995214|Sevoflurane|sevoflurane|mesh-list
83736966|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83736967|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736968|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736969|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83736970|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
83736971|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
83736972|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83736973|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83736974|NCT01995292|Anesthetics|anesthetics|mesh-list
83736975|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
83736976|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83736977|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736978|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
83736979|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83736980|NCT01995331|Cyclosporine|cyclosporine|mesh-list
83736981|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
83736982|NCT01995331|Cyclosporins|cyclosporins|mesh-list
83736983|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83736984|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
83736985|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83736986|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83736987|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83736988|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
83736989|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83736990|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83736991|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83736992|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83736993|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
83736994|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83736995|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
83736996|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83736997|NCT01995370|Aspirin|aspirin|mesh-list
83736998|NCT01995370|Cilostazol|cilostazol|mesh-list
83736999|NCT01995370|Clopidogrel|clopidogrel|mesh-list
83737000|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83737001|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83737002|NCT01995370|Analgesics|analgesics|mesh-ancestor
83737003|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
83737004|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737005|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737006|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737007|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83737008|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83737009|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83737010|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737011|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83737012|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83737013|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737014|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
83737015|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83737016|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83737017|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83737018|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
83737019|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737020|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83737021|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
83737022|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83737023|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
83737024|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
83737025|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83737026|NCT01995370|Protective Agents|protective agents|mesh-ancestor
83737027|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83737028|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83737029|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83737030|NCT01995695|Vaccines|vaccines|mesh-list
83737031|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
83737032|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737033|NCT01995734|Pasireotide|pasireotide|mesh-list
83737034|NCT01995734|Hormones|hormones|mesh-ancestor
83737035|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83737036|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737037|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83737038|NCT01995799|Hematinics|hematinics|mesh-ancestor
83737039|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83737040|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83737041|NCT01995890|Nepafenac|nepafenac|mesh-list
83737042|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83737043|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83737044|NCT01995890|Analgesics|analgesics|mesh-ancestor
83737045|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
83737046|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737047|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737048|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737049|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83737050|NCT01996085|Amlodipine|amlodipine|mesh-list
83737051|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83737052|NCT01996085|Telmisartan|telmisartan|mesh-list
83737053|NCT01996085|Lisinopril|lisinopril|mesh-list
83737054|NCT01996085|Nebivolol|nebivolol|mesh-list
83737055|NCT01996085|Indapamide|indapamide|mesh-list
83737056|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83737057|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83737058|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737059|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737060|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83737061|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737062|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
83737063|NCT01996085|Diuretics|diuretics|mesh-ancestor
83737064|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
83737065|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83737066|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83737067|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83737068|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83737069|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
83737070|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737071|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83737072|NCT01996085|Protective Agents|protective agents|mesh-ancestor
83737073|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83737074|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83737075|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83737076|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892175|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892180|NCT05019703|Atezolizumab|atezolizumab|mesh-list
83737077|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737078|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83737080|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
83737081|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737082|NCT01996189|Insulin|insulin|mesh-list
83737083|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83737084|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737085|NCT01996306|Leucovorin|leucovorin|mesh-list
83737086|NCT01996306|Bevacizumab|bevacizumab|mesh-list
83737087|NCT01996306|Fluorouracil|fluorouracil|mesh-list
83737088|NCT01996306|Capecitabine|capecitabine|mesh-list
83737089|NCT01996306|Irinotecan|irinotecan|mesh-list
83737090|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83737091|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737092|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83737093|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83737094|NCT01996306|Growth Substances|growth substances|mesh-ancestor
83737095|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737096|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
83737097|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
83737098|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737099|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83737100|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83737101|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
83737102|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83737103|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83737104|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737105|NCT01996306|Antidotes|antidotes|mesh-ancestor
83737106|NCT01996306|Protective Agents|protective agents|mesh-ancestor
83737107|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
83737108|NCT01996306|Vitamins|vitamins|mesh-ancestor
83737109|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
83737110|NCT01996358|Rocuronium|rocuronium|mesh-list
83737111|NCT01996358|Succinylcholine|succinylcholine|mesh-list
83737112|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83737113|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83737114|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83737115|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737116|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737117|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83737118|NCT01996384|Lidocaine|lidocaine|mesh-list
83737119|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
83737120|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
83737121|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737122|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737123|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
83737124|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737125|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83737126|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83737127|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83737128|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737129|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737130|NCT01996423|Vitamin D|vitamin d|mesh-list
83737131|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
83737132|NCT01996423|Vitamins|vitamins|mesh-ancestor
83737133|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
83737134|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737135|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83737136|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83737137|NCT01996462|Dexetimide|dexetimide|mesh-list
83737138|NCT01996462|Citalopram|citalopram|mesh-list
83737139|NCT01996462|Escitalopram|escitalopram|mesh-list
83737140|NCT01996462|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83737141|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83737142|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737143|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737144|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737145|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
83737146|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737147|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83737148|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83737149|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
83737150|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
83737151|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737152|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83737153|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83737154|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
83737155|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83737156|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
83737157|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83737158|NCT01996475|Dexetimide|dexetimide|mesh-list
83737159|NCT01996475|Citalopram|citalopram|mesh-list
83737160|NCT01996475|Escitalopram|escitalopram|mesh-list
83737161|NCT01996475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83737162|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83737163|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737164|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737165|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737166|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
83737167|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737168|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83737169|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83737170|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
83737171|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
83737172|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737173|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83737174|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83737175|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
83737176|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83737177|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
83737178|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83737179|NCT01996488|Olanzapine|olanzapine|mesh-list
83737180|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
83737181|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
83737182|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737183|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737184|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83737185|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83737186|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83737187|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737188|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83737189|NCT01996488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83737190|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83737191|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737192|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737193|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737194|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
83737195|NCT01996501|Olanzapine|olanzapine|mesh-list
83737196|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
83737197|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
83737198|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737199|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737200|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83737201|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83737202|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83737203|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737204|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83737205|NCT01996501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83737206|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83737207|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737208|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737209|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737210|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
83737211|NCT01996579|Lactoferrin|lactoferrin|mesh-list
83737212|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737213|NCT01996618|Ranolazine|ranolazine|mesh-list
83737214|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83737215|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737216|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737217|NCT01996683|Deferiprone|deferiprone|mesh-list
83737218|NCT01996683|Deferoxamine|deferoxamine|mesh-list
83737219|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83737220|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
83737221|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
83737222|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737223|NCT01996683|Siderophores|siderophores|mesh-ancestor
83737224|NCT01996696|Metformin|metformin|mesh-list
83737225|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83737226|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892322|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892324|NCT04515836|Olaparib|olaparib|mesh-list
83737228|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83737229|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83737230|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83737231|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83737232|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
83737233|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737234|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737235|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737236|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
83737237|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83737238|NCT01996761|Protective Agents|protective agents|mesh-ancestor
83737239|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737240|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
83737241|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83737242|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
83737243|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83737244|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737245|NCT01997099|Diazepam|diazepam|mesh-list
83737246|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83737247|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
83737248|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
83737249|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
83737250|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737251|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737252|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83737253|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83737254|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737255|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83737256|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83737257|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83737258|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83737259|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83737260|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83737261|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
83737262|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
83737263|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
83737264|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
83737265|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737266|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737267|NCT01997112|Acetaminophen|acetaminophen|mesh-list
83737268|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83737269|NCT01997112|Analgesics|analgesics|mesh-ancestor
83737270|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
83737271|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737272|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737273|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
83737274|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83737275|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83737276|NCT01997164|Aflibercept|aflibercept|mesh-list
83737277|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83737278|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83737279|NCT01997164|Growth Substances|growth substances|mesh-ancestor
83737280|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737281|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
83737282|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737283|NCT01997190|Valacyclovir|valacyclovir|mesh-list
83737284|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
83737285|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737286|NCT01997203|Vitamin D|vitamin d|mesh-list
83737287|NCT01997203|Interferons|interferons|mesh-list
83737288|NCT01997203|Ribavirin|ribavirin|mesh-list
83737289|NCT01997203|Vitamins|vitamins|mesh-ancestor
83737290|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
83737291|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737292|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83737293|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737294|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
83737295|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737296|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
83737297|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737298|NCT01997255|Everolimus|everolimus|mesh-list
83737299|NCT01997255|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82892396|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
82892397|NCT04348006|Lenalidomide|lenalidomide|mesh-list
83737300|NCT01997255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83737301|NCT01997255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737302|NCT01997255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737303|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83737304|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
83737305|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737306|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737308|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83737309|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83737310|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
83737311|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737312|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83737313|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83737314|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737315|NCT01997580|Escitalopram|escitalopram|mesh-list
83737316|NCT01997580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83737317|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83737318|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737319|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737320|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737321|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
83737322|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737323|NCT01997593|Ropivacaine|ropivacaine|mesh-list
83737324|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
83737325|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
83737326|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737327|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737328|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
83737329|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737330|NCT01997632|Vaccines|vaccines|mesh-list
83737331|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
83737332|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737333|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
83737334|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83737335|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83737336|NCT01997658|Prednisolone|prednisolone|mesh-list
83737337|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
83737338|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83737339|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
83737340|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737341|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
83737342|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
83737343|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737344|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737345|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83737346|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
83737347|NCT01997658|Hormones|hormones|mesh-ancestor
83737348|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83737349|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83737350|NCT01997658|Protective Agents|protective agents|mesh-ancestor
83737351|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83737352|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737353|NCT01997762|Resveratrol|resveratrol|mesh-list
83737354|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
83737355|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737356|NCT01997762|Protective Agents|protective agents|mesh-ancestor
83737357|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737358|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737359|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83737360|NCT01997775|Metformin|metformin|mesh-list
83737361|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83737362|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737363|NCT01997788|Morphine|morphine|mesh-list
83737364|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83737365|NCT01997788|Narcotics|narcotics|mesh-ancestor
83737366|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737367|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737368|NCT01997788|Analgesics|analgesics|mesh-ancestor
83737369|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
83737370|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737371|NCT01997801|Ketamine|ketamine|mesh-list
83737372|NCT01997801|Analgesics|analgesics|mesh-ancestor
83737373|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
83737374|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737375|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737376|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83737377|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83737378|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
83737379|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
83737380|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737381|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83737382|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83737383|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737384|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737385|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
83737386|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83737387|NCT01997814|Immunomodulating Agents|immunomodulating agents|mesh-list
83737388|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737389|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83737390|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83737391|NCT01997944|Interferons|interferons|mesh-list
83737392|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
83737393|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
83737394|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83737395|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737396|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
83737397|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737398|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
83737399|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737400|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
83737401|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83737402|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737403|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737404|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
83737405|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737406|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737407|NCT01998061|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83737408|NCT01998061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83737409|NCT01998061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737410|NCT01998061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737411|NCT01998113|Insulin|insulin|mesh-list
83737412|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83737413|NCT01998113|Metformin|metformin|mesh-list
83737414|NCT01998113|Glyburide|glyburide|mesh-list
83737415|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83737416|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737417|NCT01998126|Nivolumab|nivolumab|mesh-list
83737418|NCT01998126|Ipilimumab|ipilimumab|mesh-list
83737419|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83737420|NCT01998126|Crizotinib|crizotinib|mesh-list
83737421|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83737422|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737423|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83737424|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737425|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83737426|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737427|NCT01998165|Remifentanil|remifentanil|mesh-list
83737428|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83737429|NCT01998165|Narcotics|narcotics|mesh-ancestor
83737430|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737431|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737432|NCT01998165|Analgesics|analgesics|mesh-ancestor
83737433|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
83737434|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737435|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
83737436|NCT01998217|Remifentanil|remifentanil|mesh-list
83737437|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83737438|NCT01998217|Narcotics|narcotics|mesh-ancestor
83737439|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737440|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737441|NCT01998217|Analgesics|analgesics|mesh-ancestor
83737442|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
83737443|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737444|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83737445|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83737446|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737447|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83737448|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83737449|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737450|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737452|NCT01998295|Artemether|artemether|mesh-list
83737453|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83737454|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
83737455|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83737456|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83737457|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737458|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
83737459|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83737460|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
83737461|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737462|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
83737463|NCT01998308|Protective Agents|protective agents|mesh-ancestor
83737464|NCT01998347|Paclitaxel|paclitaxel|mesh-list
83737465|NCT01998347|Fluorouracil|fluorouracil|mesh-list
83737466|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83737467|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737468|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83737469|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83737470|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83737471|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737472|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
83737473|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83737474|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83737475|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
83737476|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737477|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83737478|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83737479|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737480|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83737481|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
83737482|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737483|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83737484|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83737485|NCT01998503|Dexamethasone|dexamethasone|mesh-list
83737486|NCT01998503|Bortezomib|bortezomib|mesh-list
83737487|NCT01998503|Melphalan|melphalan|mesh-list
83737488|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737489|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
83737490|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
83737491|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737492|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737493|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83737494|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
83737495|NCT01998503|Hormones|hormones|mesh-ancestor
83737496|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83737497|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83737498|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737499|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
83737500|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83737501|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
83737502|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737503|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83737504|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83737505|NCT01998685|Fentanyl|fentanyl|mesh-list
83737506|NCT01998685|Midazolam|midazolam|mesh-list
83737507|NCT01998685|Remifentanil|remifentanil|mesh-list
83737508|NCT01998685|Propofol|propofol|mesh-list
83737509|NCT01998685|Sevoflurane|sevoflurane|mesh-list
83737510|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83737511|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737512|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737513|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83737514|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
83737515|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
83737516|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83737517|NCT01998685|Narcotics|narcotics|mesh-ancestor
83737518|NCT01998685|Analgesics|analgesics|mesh-ancestor
83737519|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
83737520|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892621|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
83737521|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83737522|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83737523|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83737524|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83737525|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
83737526|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
83737527|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737528|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737529|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83737530|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83737531|NCT01998698|Lidocaine|lidocaine|mesh-list
83737532|NCT01998698|Dipivefrin|dipivefrin|mesh-list
83737533|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
83737534|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83737535|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
83737536|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737537|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737538|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737539|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83737540|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
83737541|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
83737542|NCT01998698|Protective Agents|protective agents|mesh-ancestor
83737543|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
83737544|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
83737545|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737546|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
83737547|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737548|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83737549|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83737550|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83737551|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737552|NCT01998763|Vitamin D|vitamin d|mesh-list
83737553|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
83737554|NCT01998763|Vitamins|vitamins|mesh-ancestor
83737555|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
83737556|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737557|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83737558|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83737559|NCT01998776|Misoprostol|misoprostol|mesh-list
83737560|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83737561|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
83737562|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83737563|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737564|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83737565|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83737566|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
83737567|NCT01998789|Everolimus|everolimus|mesh-list
83737568|NCT01998789|Tacrolimus|tacrolimus|mesh-list
83737569|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83737570|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
83737571|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737572|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83737573|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737574|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737575|NCT01998789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83737576|NCT01998789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83737577|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737578|NCT01999153|Ropivacaine|ropivacaine|mesh-list
83737579|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
83737580|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
83737581|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737582|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737583|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
83737584|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737585|NCT01999270|Bevacizumab|bevacizumab|mesh-list
83737586|NCT01999270|Irinotecan|irinotecan|mesh-list
83737587|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83737588|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737589|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83737590|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83737591|NCT01999270|Growth Substances|growth substances|mesh-ancestor
83737592|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737593|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
83737594|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83737595|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83737596|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737597|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737598|NCT01999309|Simvastatin|simvastatin|mesh-list
83737599|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83737600|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83737601|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
83737602|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737603|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83737604|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83737605|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737606|NCT01999413|Cytarabine|cytarabine|mesh-list
83737607|NCT01999413|Daunorubicin|daunorubicin|mesh-list
83737608|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83737609|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
83737610|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737611|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737612|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
83737613|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737614|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83737615|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
83737616|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737617|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83737618|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83737619|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83737620|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737621|NCT01999647|Ropivacaine|ropivacaine|mesh-list
83737622|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
83737623|NCT01999647|Anesthetics|anesthetics|mesh-list
83737624|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737625|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737626|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
83737627|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737628|NCT01999673|Docetaxel|docetaxel|mesh-list
83737629|NCT01999673|Bavituximab|bavituximab|mesh-list
83737630|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83737631|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737632|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83737633|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83737634|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83737635|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737636|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83737637|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
83737638|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737639|NCT01999686|Metformin|metformin|mesh-list
83737640|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83737641|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737642|NCT01999738|Folic Acid|folic acid|mesh-list
83737643|NCT01999738|Hematinics|hematinics|mesh-ancestor
83737644|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
83737645|NCT01999738|Vitamins|vitamins|mesh-ancestor
83737646|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
83737647|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737648|NCT01999829|Caffeine|caffeine|mesh-list
83737649|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737650|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83737651|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737652|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83737653|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737654|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83737655|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83737656|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
83737657|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737658|NCT01999842|Vaccines|vaccines|mesh-list
83737659|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
83737660|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737661|NCT01999907|Vitamin D|vitamin d|mesh-list
83737662|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
83737663|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
83737664|NCT01999907|Vitamins|vitamins|mesh-list
83737665|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
83737666|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737667|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83737668|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83737669|NCT01999933|Cisplatin|cisplatin|mesh-list
83737670|NCT01999933|Docetaxel|docetaxel|mesh-list
83737671|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737672|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
83737673|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
83737674|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
83737675|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737676|NCT02000102|Aflibercept|aflibercept|mesh-list
83737677|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83737678|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83737679|NCT02000102|Growth Substances|growth substances|mesh-ancestor
83737680|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737681|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83737682|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737684|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83737685|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737686|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83737687|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83737688|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83737689|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83737690|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737691|NCT02000206|Ketamine|ketamine|mesh-list
83737692|NCT02000206|Alfentanil|alfentanil|mesh-list
83737693|NCT02000206|Propofol|propofol|mesh-list
83737694|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83737695|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737696|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737697|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83737698|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
83737699|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
83737700|NCT02000206|Analgesics|analgesics|mesh-ancestor
83737701|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
83737702|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737703|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83737704|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83737705|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83737706|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737707|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737708|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83737709|NCT02000206|Narcotics|narcotics|mesh-ancestor
83737710|NCT02000336|Prednisolone|prednisolone|mesh-list
83737711|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737712|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
83737713|NCT02000336|Hormones|hormones|mesh-ancestor
83737714|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83737715|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737716|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83737717|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737718|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83737719|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83737720|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
83737721|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737722|NCT02000388|Ketorolac|ketorolac|mesh-list
83737723|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83737724|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83737725|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83737726|NCT02000388|Analgesics|analgesics|mesh-ancestor
83737727|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
83737728|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737729|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737730|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737731|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83737732|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83737733|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737734|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737735|NCT02000401|Ketorolac|ketorolac|mesh-list
83737736|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83737737|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83737738|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83737739|NCT02000401|Analgesics|analgesics|mesh-ancestor
83737740|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
83737741|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737742|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737743|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737744|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83737745|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83737746|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737747|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737748|NCT02000414|Daptomycin|daptomycin|mesh-list
83737749|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83737750|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737751|NCT02000674|Rocuronium|rocuronium|mesh-list
83737752|NCT02000674|Succinylcholine|succinylcholine|mesh-list
83737753|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83737754|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83737755|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83737756|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737757|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737758|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83737759|NCT02000700|Canagliflozin|canagliflozin|mesh-list
83737760|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83737761|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737762|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83737763|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737764|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
83737765|NCT02000726|Citalopram|citalopram|mesh-list
83737766|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83737767|NCT02000726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83737768|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83737769|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737770|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737771|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737772|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
83737773|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737774|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83737775|NCT02000765|Gepotidacin|gepotidacin|mesh-list
83737776|NCT02000765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83737777|NCT02000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737778|NCT02000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737779|NCT02000765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737780|NCT02000804|Darapladib|darapladib|mesh-list
83737781|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83737782|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737783|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737784|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83737785|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737786|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737787|NCT02000947|Durvalumab|durvalumab|mesh-list
83737788|NCT02000947|Tremelimumab|tremelimumab|mesh-list
83737789|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83737790|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83737791|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737792|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
83737793|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737794|NCT02001012|Chloroquine|chloroquine|mesh-list
83737795|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83737796|NCT02001012|Lumefantrine|lumefantrine|mesh-list
83737797|NCT02001012|Artemether|artemether|mesh-list
83737798|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83737799|NCT02001012|Amebicides|amebicides|mesh-ancestor
83737800|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83737801|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83737802|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737803|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
83737804|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83737805|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83737806|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83737807|NCT02001012|Analgesics|analgesics|mesh-ancestor
83737808|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
83737809|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737810|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737811|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737812|NCT02001012|Filaricides|filaricides|mesh-ancestor
83737813|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
83737814|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
83737815|NCT02001103|Memantine|memantine|mesh-list
83737816|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83737817|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83737818|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
83737819|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737820|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737821|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737822|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83737823|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83737824|NCT02001168|Docetaxel|docetaxel|mesh-list
83737825|NCT02001168|Pemetrexed|pemetrexed|mesh-list
83737826|NCT02001168|Cisplatin|cisplatin|mesh-list
83737827|NCT02001168|Endostatins|endostatins|mesh-list
83737828|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737829|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
83737830|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
83737831|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
83737832|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737833|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737834|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83737835|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83737836|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83737837|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83737838|NCT02001168|Growth Substances|growth substances|mesh-ancestor
83737839|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737840|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
83737842|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83737843|NCT02001259|Lidocaine|lidocaine|mesh-list
83737844|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
83737845|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
83737846|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737847|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737848|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
83737849|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737850|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83737851|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83737852|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83737853|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737854|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737855|NCT02001272|Paclitaxel|paclitaxel|mesh-list
83737856|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83737857|NCT02001272|Carboplatin|carboplatin|mesh-list
83737858|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83737859|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737860|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
83737861|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
83737862|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
83737863|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737864|NCT02001285|Remifentanil|remifentanil|mesh-list
83737865|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83737866|NCT02001285|Narcotics|narcotics|mesh-ancestor
83737867|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737868|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737869|NCT02001285|Analgesics|analgesics|mesh-ancestor
83737870|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
83737871|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737872|NCT02001298|Nitroprusside|nitroprusside|mesh-list
83737873|NCT02001298|Remifentanil|remifentanil|mesh-list
83737874|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83737875|NCT02001298|Narcotics|narcotics|mesh-ancestor
83737876|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737877|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737878|NCT02001298|Analgesics|analgesics|mesh-ancestor
83737879|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
83737880|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737881|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83737882|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
83737883|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83737884|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737885|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
83737886|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83737887|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83737888|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737889|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
83737890|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83737891|NCT02001363|Liraglutide|liraglutide|mesh-list
83737892|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83737893|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737894|NCT02001363|Incretins|incretins|mesh-ancestor
83737895|NCT02001363|Hormones|hormones|mesh-ancestor
83737896|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83737897|NCT02001428|Piperaquine|piperaquine|mesh-list
83737898|NCT02001428|Artenimol|artenimol|mesh-list
83737899|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
83737900|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83737901|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83737902|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737903|NCT02001506|Docetaxel|docetaxel|mesh-list
83737904|NCT02001506|Epirubicin|epirubicin|mesh-list
83737905|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737906|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
83737907|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
83737908|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
83737909|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737910|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83737911|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83737912|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83737913|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737914|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
83737915|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737916|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83737917|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737918|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737919|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
83737920|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83737921|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737922|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83737923|NCT02001584|Memantine|memantine|mesh-list
83737924|NCT02001584|Baclofen|baclofen|mesh-list
83737925|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83737926|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83737927|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
83737928|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737929|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737930|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737931|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83737932|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83737933|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83737934|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83737935|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737936|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83737937|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
83737938|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
83737939|NCT02001740|Lidocaine|lidocaine|mesh-list
83737940|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
83737941|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
83737942|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83737943|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737944|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
83737945|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737946|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83737947|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83737948|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83737949|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83737950|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737951|NCT02001857|Hemostatics|hemostatics|mesh-list
83737952|NCT02001857|Coagulants|coagulants|mesh-ancestor
83737953|NCT02001883|Policosanol|policosanol|mesh-list
83737954|NCT02001883|Atorvastatin|atorvastatin|mesh-list
83737955|NCT02001883|Simvastatin|simvastatin|mesh-list
83737956|NCT02001883|Red yeast rice|red yeast rice|mesh-list
83737957|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83737958|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83737959|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
83737960|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737961|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83737962|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83737963|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737964|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83737965|NCT02001896|Carboplatin|carboplatin|mesh-list
83737966|NCT02001896|Gemcitabine|gemcitabine|mesh-list
83737967|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83737968|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83737969|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83737970|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
83737971|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737972|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83737973|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737974|NCT02001909|Neomycin|neomycin|mesh-list
83737975|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83737976|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83737977|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82893076|NCT01665794|Dexamethasone|dexamethasone|mesh-list
83737978|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737979|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737980|NCT02001935|Theophylline|theophylline|mesh-list
83737981|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83737982|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
83737983|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83737984|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83737985|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83737986|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
83737987|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83737988|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83737989|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83737990|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
83737991|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83737992|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83737993|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
83737994|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83737996|NCT02001948|Bupivacaine|bupivacaine|mesh-list
83737997|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
83737998|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
83737999|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738000|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738001|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
83738002|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738003|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83738004|NCT02001948|Narcotics|narcotics|mesh-ancestor
83738005|NCT02001948|Analgesics|analgesics|mesh-ancestor
83738006|NCT02001974|Paclitaxel|paclitaxel|mesh-list
83738007|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83738008|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738009|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
83738010|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
83738011|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
83738012|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738013|NCT02002000|Vitamin D|vitamin d|mesh-list
83738014|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
83738015|NCT02002000|Vitamins|vitamins|mesh-ancestor
83738016|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
83738017|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738018|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83738019|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83738020|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
83738021|NCT02002039|Hematinics|hematinics|mesh-ancestor
83738022|NCT02002065|Vaccines|vaccines|mesh-list
83738023|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
83738024|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738025|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83738026|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
83738027|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83738028|NCT02002078|Prednisolone|prednisolone|mesh-list
83738029|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
83738030|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83738031|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
83738032|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738033|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
83738034|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
83738035|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738036|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738037|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738038|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
83738039|NCT02002078|Hormones|hormones|mesh-ancestor
83738040|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738041|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83738042|NCT02002078|Protective Agents|protective agents|mesh-ancestor
83738043|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83738044|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738045|NCT02002156|Vaccines|vaccines|mesh-list
83738046|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83738047|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
83738048|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
83738049|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738050|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83738051|NCT02002195|Leucovorin|leucovorin|mesh-list
83738052|NCT02002195|Fluorouracil|fluorouracil|mesh-list
83738053|NCT02002195|Capecitabine|capecitabine|mesh-list
83738054|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
83738055|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
83738056|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738057|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83738058|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738059|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738060|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
83738061|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738063|NCT02002195|Protective Agents|protective agents|mesh-ancestor
83738064|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
83738065|NCT02002195|Vitamins|vitamins|mesh-ancestor
83738066|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
83738067|NCT02002247|Selenium|selenium|mesh-list
83738068|NCT02002247|Selenious Acid|selenious acid|mesh-list
83738069|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
83738070|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
83738071|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738072|NCT02002247|Protective Agents|protective agents|mesh-ancestor
83738073|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738074|NCT02002247|Trace Elements|trace elements|mesh-ancestor
83738075|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
83738076|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
83738077|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83738078|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
83738079|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
83738080|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83738081|NCT02002260|Estradiol|estradiol|mesh-list
83738082|NCT02002260|Estrogens|estrogens|mesh-ancestor
83738083|NCT02002260|Hormones|hormones|mesh-ancestor
83738084|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738085|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738086|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83738087|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83738088|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83738089|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83738090|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83738091|NCT02002286|Triptolide|triptolide|mesh-list
83738092|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83738093|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738094|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83738095|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
83738096|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83738097|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738098|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
83738099|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83738100|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
83738101|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738102|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738103|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83738104|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
83738105|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
83738106|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738107|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83738108|NCT02002325|Plasminogen|plasminogen|mesh-list
83738109|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83738110|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83738111|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738112|NCT02002377|Aflibercept|aflibercept|mesh-list
83738113|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83738114|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83738115|NCT02002377|Growth Substances|growth substances|mesh-ancestor
83738116|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738117|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
83738118|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738119|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83738120|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83738121|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738122|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738123|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
83738124|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738125|NCT02002403|Danazol|danazol|mesh-list
83738126|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83738127|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
82893232|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
83738128|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738129|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738130|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
83738131|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
83738132|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83738133|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738134|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
83738135|NCT02002598|Dexamethasone|dexamethasone|mesh-list
83738136|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
83738137|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83738138|NCT02002598|BB 1101|bb 1101|mesh-list
83738139|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738140|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
83738141|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
83738142|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738143|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738144|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738145|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
83738146|NCT02002598|Hormones|hormones|mesh-ancestor
83738147|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738148|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83738149|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738150|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
83738151|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738152|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738153|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83738154|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
83738155|NCT02002611|Warfarin|warfarin|mesh-list
83738156|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
83738157|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
83738158|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83738159|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83738160|NCT02002663|Prednisolone|prednisolone|mesh-list
83738161|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
83738162|NCT02002663|Morphine|morphine|mesh-list
83738163|NCT02002663|Ropivacaine|ropivacaine|mesh-list
83738164|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83738165|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
83738166|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83738167|NCT02002663|Narcotics|narcotics|mesh-ancestor
83738168|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738169|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738170|NCT02002663|Analgesics|analgesics|mesh-ancestor
83738171|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
83738172|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738173|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738174|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
83738175|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738176|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
83738177|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
83738178|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738179|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
83738180|NCT02002663|Hormones|hormones|mesh-ancestor
83738181|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738182|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83738183|NCT02002663|Protective Agents|protective agents|mesh-ancestor
83738184|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83738185|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738186|NCT02002715|Budesonide|budesonide|mesh-list
83738187|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738188|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83738189|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
83738190|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738191|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738192|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83738193|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83738194|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
83738195|NCT02002715|Hormones|hormones|mesh-ancestor
83738196|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738197|NCT02002741|Acetaminophen|acetaminophen|mesh-list
83738198|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83738199|NCT02002741|Analgesics|analgesics|mesh-ancestor
83738200|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
83738201|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738202|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738203|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
83738204|NCT02002754|Bambuterol|bambuterol|mesh-list
83738205|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83738206|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
83738207|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738208|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738209|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83738210|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
83738211|NCT02002806|Ethanol|ethanol|mesh-list
83738212|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83738213|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738214|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738215|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738216|NCT02002858|Nicotine|nicotine|mesh-list
83738217|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83738218|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
83738219|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738220|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738221|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83738222|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83738223|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738224|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738225|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738226|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
83738227|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83738228|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738229|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738230|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738231|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738232|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738233|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
83738234|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83738235|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83738236|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83738237|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738238|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738239|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738240|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738241|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738242|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83738243|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738244|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
83738245|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83738246|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738247|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738248|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738249|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738250|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738251|NCT02001818|Interferons|interferons|mesh-list
83738252|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
83738253|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
83738254|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83738255|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
83738256|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738257|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
83738258|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738259|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
83738260|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738261|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83738262|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738263|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738264|NCT02003313|Vaccines|vaccines|mesh-list
83738265|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
83738266|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738267|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83738268|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83738269|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738270|NCT02003495|Vaccines|vaccines|mesh-list
83738271|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
83738272|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738273|NCT02003664|Baclofen|baclofen|mesh-list
83738274|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83738275|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738276|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83738277|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893379|NCT01171170|Paclitaxel|paclitaxel|mesh-list
83738278|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83738279|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
83738280|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
83738281|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738282|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738283|NCT02003677|Insulin|insulin|mesh-list
83738284|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83738285|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
83738286|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
83738287|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83738288|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83738289|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738290|NCT02003768|Propofol|propofol|mesh-list
83738291|NCT02003768|Desflurane|desflurane|mesh-list
83738292|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83738293|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738294|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738295|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83738296|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
83738297|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
83738298|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83738299|NCT02003885|Desflurane|desflurane|mesh-list
83738300|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83738301|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
83738302|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
83738303|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738304|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738305|NCT02004067|Cyclosporine|cyclosporine|mesh-list
83738306|NCT02004067|Castor Oil|castor oil|mesh-list
83738307|NCT02004067|Cyclosporins|cyclosporins|mesh-list
83738308|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738309|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738310|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738311|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
83738312|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738313|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
83738314|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738315|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83738316|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738317|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83738318|NCT02004067|Cathartics|cathartics|mesh-ancestor
83738319|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738320|NCT02004171|Nicotine|nicotine|mesh-list
83738321|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83738322|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
83738323|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738324|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738325|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83738326|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83738327|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738328|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738329|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738330|NCT02004184|Pemetrexed|pemetrexed|mesh-list
83738331|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738332|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738333|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738334|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83738335|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83738336|NCT02004197|Amoxicillin|amoxicillin|mesh-list
83738337|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83738338|NCT02004197|Bismuth|bismuth|mesh-list
83738339|NCT02004197|Ranitidine|ranitidine|mesh-list
83738340|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83738341|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738342|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83738343|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738344|NCT02004197|Antacids|antacids|mesh-ancestor
83738345|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738346|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83738347|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83738348|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
83738349|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
83738350|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738351|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893449|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
83738352|NCT02004301|Diclofenac|diclofenac|mesh-list
83738353|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83738354|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83738355|NCT02004301|Analgesics|analgesics|mesh-ancestor
83738356|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
83738357|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738358|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738359|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738360|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738361|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83738362|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738363|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738364|NCT02004314|Chloroquine|chloroquine|mesh-list
83738365|NCT02004314|Amebicides|amebicides|mesh-ancestor
83738366|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83738367|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83738368|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738369|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
83738370|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738371|NCT02004418|Choline|choline|mesh-list
83738372|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
83738373|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83738374|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
83738375|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738376|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738377|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83738378|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
83738379|NCT02004509|Anticoagulants|anticoagulants|mesh-list
83738380|NCT02004574|Betamethasone|betamethasone|mesh-list
83738381|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
83738382|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83738383|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
83738384|NCT02004574|Calcipotriene|calcipotriene|mesh-list
83738385|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83738386|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738387|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
83738388|NCT02004574|Hormones|hormones|mesh-ancestor
83738389|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738390|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738391|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83738392|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
83738393|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
83738394|NCT02004652|Prucalopride|prucalopride|mesh-list
83738395|NCT02004652|Laxatives|laxatives|mesh-ancestor
83738396|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738397|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83738398|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83738399|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
83738400|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738401|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738402|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738403|NCT02004769|Docetaxel|docetaxel|mesh-list
83738404|NCT02004769|Capecitabine|capecitabine|mesh-list
83738405|NCT02004769|Trastuzumab|trastuzumab|mesh-list
83738406|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738407|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
83738408|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
83738409|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
83738410|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738411|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83738412|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
83738413|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83738414|NCT02004782|Prednisolone|prednisolone|mesh-list
83738415|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738416|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
83738417|NCT02004782|Hormones|hormones|mesh-ancestor
83738418|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738419|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738420|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83738421|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738422|NCT02004860|Ciclopirox|ciclopirox|mesh-list
83738423|NCT02004860|Tacrolimus|tacrolimus|mesh-list
83738424|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738425|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
83738426|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738427|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83738428|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738429|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738430|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
83738431|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738432|NCT02004899|Fentanyl|fentanyl|mesh-list
83738433|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83738434|NCT02004899|Narcotics|narcotics|mesh-ancestor
83738435|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738436|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738437|NCT02004899|Analgesics|analgesics|mesh-ancestor
83738438|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
83738439|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738440|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83738441|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83738442|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
83738443|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
83738444|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83738445|NCT02005068|Cephalosporins|cephalosporins|mesh-list
83738446|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83738447|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738448|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83738449|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83738450|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83738451|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738452|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738453|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738454|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738455|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83738456|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
83738457|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83738458|NCT02005120|Bevacizumab|bevacizumab|mesh-list
83738459|NCT02005120|Endostatins|endostatins|mesh-list
83738460|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83738461|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738462|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83738463|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83738464|NCT02005120|Growth Substances|growth substances|mesh-ancestor
83738465|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738466|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
83738467|NCT02005302|Vitamin D|vitamin d|mesh-list
83738468|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
83738469|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
83738470|NCT02005302|Vitamins|vitamins|mesh-list
83738471|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
83738472|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738473|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83738474|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83738475|NCT02005315|Paclitaxel|paclitaxel|mesh-list
83738476|NCT02005315|Gemcitabine|gemcitabine|mesh-list
83738477|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83738478|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738479|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
83738480|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83738481|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83738482|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738483|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83738484|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
83738485|NCT02005419|Metformin|metformin|mesh-list
83738486|NCT02005419|Gemcitabine|gemcitabine|mesh-list
83738487|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83738488|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
83738489|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738490|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738491|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83738492|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738493|NCT02005523|RNS60|rns60|mesh-list
83738494|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83738495|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83738496|NCT02005523|Analgesics|analgesics|mesh-ancestor
83738497|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
83738498|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738499|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738500|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893601|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
83738501|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738502|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83738503|NCT02005575|Dexamethasone|dexamethasone|mesh-list
83738504|NCT02005575|Bupivacaine|bupivacaine|mesh-list
83738505|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738506|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
83738507|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
83738508|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738509|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738510|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738511|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
83738512|NCT02005575|Hormones|hormones|mesh-ancestor
83738513|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738514|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83738515|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738516|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738517|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
83738518|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738519|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
83738520|NCT02005588|Iron|iron|mesh-list
83738521|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
83738522|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
83738523|NCT02005588|Trace Elements|trace elements|mesh-ancestor
83738524|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
83738525|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738526|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
83738527|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
83738528|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738529|NCT02005653|Doxycycline|doxycycline|mesh-list
83738530|NCT02005653|Albendazole|albendazole|mesh-list
83738531|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
83738532|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83738533|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738534|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
83738535|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83738536|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83738537|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
83738538|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
83738539|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83738540|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
83738541|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
83738542|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
83738543|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738544|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738545|NCT02005653|Filaricides|filaricides|mesh-ancestor
83738546|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
83738547|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83738548|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738549|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
83738550|NCT02005718|Vitamin D|vitamin d|mesh-list
83738551|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83738552|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738553|NCT02005718|Vitamins|vitamins|mesh-ancestor
83738554|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
83738555|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83738556|NCT02005757|Mizoribine|mizoribine|mesh-list
83738557|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83738558|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83738559|NCT02005757|Analgesics|analgesics|mesh-ancestor
83738560|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
83738561|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738562|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738563|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738564|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738565|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83738566|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738567|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83738568|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738569|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
83738570|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83738571|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83738572|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738573|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738574|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738575|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
83738576|NCT02005770|Propofol|propofol|mesh-list
83738577|NCT02005770|Sevoflurane|sevoflurane|mesh-list
83738578|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83738579|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738580|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738581|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83738582|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
83738583|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
83738584|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83738585|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83738586|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
83738587|NCT02005783|Docetaxel|docetaxel|mesh-list
83738588|NCT02005783|Epirubicin|epirubicin|mesh-list
83738589|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738590|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
83738591|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738592|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738593|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83738594|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
83738595|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738596|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738597|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83738598|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
83738599|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
83738600|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
83738601|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83738602|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83738603|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83738604|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738605|NCT02005822|Valganciclovir|valganciclovir|mesh-list
83738606|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
83738607|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738608|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
83738609|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83738610|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
83738611|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738612|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738613|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83738614|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83738615|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83738616|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738617|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83738618|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738619|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738620|NCT02006173|Lidocaine|lidocaine|mesh-list
83738621|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738622|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
83738623|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738624|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738625|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
83738626|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738627|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83738628|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83738629|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83738630|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738631|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738632|NCT02006225|Plerixafor|plerixafor|mesh-list
83738633|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83738634|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83738635|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
83738636|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738637|NCT02006277|Crizotinib|crizotinib|mesh-list
83738638|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83738639|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738640|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83738641|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738642|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738643|NCT02006355|Ropivacaine|ropivacaine|mesh-list
83738644|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738645|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
83738646|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738647|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738648|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
83738649|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738650|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83738651|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83738652|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83738653|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
83738654|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738655|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893750|NCT01174056|Analgesics|analgesics|mesh-ancestor
83738656|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
83738657|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738658|NCT02006498|Silymarin|silymarin|mesh-list
83738659|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
83738660|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738661|NCT02006498|Protective Agents|protective agents|mesh-ancestor
83738662|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738663|NCT02006589|Candesartan|candesartan|mesh-list
83738664|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
83738665|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83738666|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83738667|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83738668|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738669|NCT02006602|Candesartan|candesartan|mesh-list
83738670|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
83738671|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83738672|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83738673|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83738674|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738675|NCT02006745|Ribavirin|ribavirin|mesh-list
83738676|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
83738677|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738678|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
83738679|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738680|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83738681|NCT02006849|Hormones|hormones|mesh-ancestor
83738682|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83738683|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738684|NCT02006914|Chromium|chromium|mesh-list
83738685|NCT02006914|Picolinic acid|picolinic acid|mesh-list
83738686|NCT02006914|Trace Elements|trace elements|mesh-ancestor
83738687|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
83738688|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738689|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83738690|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
83738691|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
83738692|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738693|NCT02006966|Lidocaine|lidocaine|mesh-list
83738694|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738695|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
83738696|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738697|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738698|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
83738699|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738700|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83738701|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83738702|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83738703|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738704|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738705|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
83738706|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738707|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83738708|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83738709|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
83738710|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738711|NCT02007148|Docetaxel|docetaxel|mesh-list
83738712|NCT02007148|Capecitabine|capecitabine|mesh-list
83738713|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738714|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
83738715|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
83738716|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
83738717|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738718|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83738719|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
83738720|NCT02007161|Diclofenac|diclofenac|mesh-list
83738721|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83738722|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83738723|NCT02007161|Analgesics|analgesics|mesh-ancestor
83738724|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
83738725|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738726|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738727|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738728|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82893823|NCT01285596|Mirabegron|mirabegron|mesh-list
83738729|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83738730|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738731|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738732|NCT02007174|Bevacizumab|bevacizumab|mesh-list
83738733|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83738734|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738735|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83738736|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83738737|NCT02007174|Growth Substances|growth substances|mesh-ancestor
83738738|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738739|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
83738740|NCT02007330|Lidocaine|lidocaine|mesh-list
83738741|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738742|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
83738743|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738744|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738745|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
83738746|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738747|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83738748|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83738749|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83738750|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738751|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738752|NCT02007408|Lidocaine|lidocaine|mesh-list
83738753|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738754|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
83738755|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738756|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738757|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
83738758|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738759|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83738760|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83738761|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83738762|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738763|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738764|NCT02007447|Oxytocin|oxytocin|mesh-list
83738765|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
83738766|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83738767|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738768|NCT02007603|Amoxicillin|amoxicillin|mesh-list
83738769|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
83738770|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
83738771|NCT02007603|Ampicillin|ampicillin|mesh-list
83738772|NCT02007603|Sulbactam|sulbactam|mesh-list
83738773|NCT02007603|Sultamicillin|sultamicillin|mesh-list
83738774|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83738775|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738776|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738777|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738778|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83738779|NCT02007629|Riociguat|riociguat|mesh-list
83738780|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
83738781|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738782|NCT02007746|Liver Extracts|liver extracts|mesh-list
83738783|NCT02007746|Hematinics|hematinics|mesh-ancestor
83738784|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
83738785|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83738786|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738787|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738788|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83738789|NCT02007798|Analgesics|analgesics|mesh-ancestor
83738790|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
83738791|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738792|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83738793|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83738794|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83738795|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
83738796|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738797|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738798|NCT02007837|Aspirin|aspirin|mesh-list
83738799|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83738800|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83738801|NCT02007837|Analgesics|analgesics|mesh-ancestor
82893898|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738802|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
83738803|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738804|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738805|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83738806|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83738807|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83738808|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83738809|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738810|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83738811|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83738812|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738813|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
83738814|NCT02007850|Ropivacaine|ropivacaine|mesh-list
83738815|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
83738816|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
83738817|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738818|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738819|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
83738820|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738821|NCT02007915|Pamidronate|pamidronate|mesh-list
83738822|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83738823|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738824|NCT02007928|Olanzapine|olanzapine|mesh-list
83738825|NCT02007928|Risperidone|risperidone|mesh-list
83738826|NCT02007928|Aripiprazole|aripiprazole|mesh-list
83738827|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83738828|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
83738829|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738830|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738831|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738832|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83738833|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83738834|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738835|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83738836|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83738837|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
83738838|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
83738839|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
83738840|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738841|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83738842|NCT02007928|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83738843|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83738844|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738845|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
83738846|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
83738847|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83738848|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83738849|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83738850|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83738851|NCT02008006|Cytarabine|cytarabine|mesh-list
83738852|NCT02008006|Etoposide|etoposide|mesh-list
83738853|NCT02008006|Melphalan|melphalan|mesh-list
83738854|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83738855|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83738856|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738857|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83738858|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83738859|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738860|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738861|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83738862|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
83738863|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
83738864|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83738865|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738866|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
83738867|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738868|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83738869|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
83738870|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83738871|NCT02008019|Everolimus|everolimus|mesh-list
83738872|NCT02008019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83738873|NCT02008019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83738874|NCT02008019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738875|NCT02008019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738876|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83738877|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
83738878|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738879|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738881|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
83738882|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
83738883|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
83738884|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738885|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738886|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738887|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
83738888|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83738889|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738890|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738891|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738892|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738893|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738894|NCT02008162|Bromides|bromides|mesh-list
83738895|NCT02008162|Albuterol|albuterol|mesh-list
83738896|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
83738897|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
83738898|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
83738899|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738900|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738901|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83738902|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
83738903|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
83738904|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83738905|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738906|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738907|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738908|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
83738909|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
83738910|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83738911|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83738912|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83738913|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83738914|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
83738915|NCT02008201|Vitamin D|vitamin d|mesh-list
83738916|NCT02008201|Vitamins|vitamins|mesh-ancestor
83738917|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
83738918|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738919|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83738920|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
83738921|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83738922|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738923|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738924|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83738925|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83738926|NCT02008214|Protective Agents|protective agents|mesh-ancestor
83738927|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738928|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
83738929|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83738930|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
83738931|NCT02008383|Panitumumab|panitumumab|mesh-list
83738932|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83738933|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738934|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
83738935|NCT02008422|Tegafur|tegafur|mesh-list
83738936|NCT02008422|Endostar protein|endostar protein|mesh-list
83738937|NCT02008422|Endostatins|endostatins|mesh-list
83738938|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738939|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83738940|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
83738941|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738942|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83738943|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83738944|NCT02008422|Growth Substances|growth substances|mesh-ancestor
83738945|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738946|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
83738947|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
83738948|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82894047|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738949|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738950|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738951|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
83738952|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83738953|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738954|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
83738955|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83738956|NCT02008578|Antibodies|antibodies|mesh-list
83738957|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
83738958|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738959|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
83738960|NCT02008721|Protective Agents|protective agents|mesh-ancestor
83738961|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738962|NCT02008734|Palbociclib|palbociclib|mesh-list
83738963|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83738964|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83738965|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738966|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738967|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
83738968|NCT02008747|Analgesics|analgesics|mesh-ancestor
83738969|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
83738970|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83738971|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83738972|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
83738973|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83738974|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83738975|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
83738976|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83738977|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83738978|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738979|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83738980|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
83738981|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83738982|NCT02008786|Ramipril|ramipril|mesh-list
83738983|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83738984|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83738985|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83738986|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
83738987|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738988|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83738989|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83738990|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738991|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83738992|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
83738993|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83738994|NCT02008968|Allopurinol|allopurinol|mesh-list
83738995|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
83738996|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83738997|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83738998|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
83738999|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739000|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83739001|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
83739002|NCT02008968|Protective Agents|protective agents|mesh-ancestor
83739003|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739004|NCT02008981|Aspirin|aspirin|mesh-list
83739005|NCT02008981|Turmeric extract|turmeric extract|mesh-list
83739006|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83739007|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83739008|NCT02008981|Analgesics|analgesics|mesh-ancestor
83739009|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
83739010|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739011|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739012|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739013|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739014|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83739015|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83739016|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739017|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83739018|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83739019|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739020|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
83739021|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
83739022|NCT02008981|Protective Agents|protective agents|mesh-ancestor
83739023|NCT02009007|Phenylephrine|phenylephrine|mesh-list
83739024|NCT02009007|Dopamine|dopamine|mesh-list
83739026|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83739027|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
83739028|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
83739029|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739030|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739031|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
83739032|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83739033|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
83739034|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
83739035|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83739036|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83739037|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83739038|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
83739039|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739040|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739041|NCT02009007|Protective Agents|protective agents|mesh-ancestor
83739042|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
83739043|NCT02009098|Cefuroxime|cefuroxime|mesh-list
83739044|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
83739045|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83739046|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739047|NCT02009189|Taurolidine|taurolidine|mesh-list
83739048|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739049|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83739050|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739051|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
83739052|NCT02009202|Cathartics|cathartics|mesh-ancestor
83739053|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739054|NCT02009215|Piperaquine|piperaquine|mesh-list
83739055|NCT02009215|Artenimol|artenimol|mesh-list
83739056|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
83739057|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83739058|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83739059|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739060|NCT05778825|Minoxidil|minoxidil|mesh-list
83739061|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83739062|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
83739063|NCT05778760|Vitamin A|vitamin a|mesh-list
83739064|NCT05778760|Vitamins|vitamins|mesh-ancestor
83739065|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
83739066|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739067|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
83739068|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83739069|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83739070|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739071|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739072|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739073|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
83739074|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83739075|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739076|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739077|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83739078|NCT05778305|Analgesics|analgesics|mesh-ancestor
83739079|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
83739080|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739081|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83739082|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83739083|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83739084|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
83739085|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739086|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739087|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
83739088|NCT05778227|Acetic Acid|acetic acid|mesh-list
83739089|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83739090|NCT05778227|Eusol|eusol|mesh-list
83739091|NCT05778227|Retinol acetate|retinol acetate|mesh-list
83739092|NCT05778227|Ethylene|ethylene|mesh-list
83739093|NCT05778227|Maleic acid|maleic acid|mesh-list
83739094|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83739095|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739096|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83739097|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
82894197|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82894198|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
83739098|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739099|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83739100|NCT05778227|Protective Agents|protective agents|mesh-ancestor
83739101|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739102|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
83739103|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83739104|NCT05778227|Growth Substances|growth substances|mesh-ancestor
83739105|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739106|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739107|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83739108|NCT05778097|Androgens|androgens|mesh-list
83739109|NCT05778097|Hormones|hormones|mesh-ancestor
83739110|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739111|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739112|NCT05778084|Empagliflozin|empagliflozin|mesh-list
83739113|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83739114|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739115|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83739116|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739117|NCT05777902|Ozanimod|ozanimod|mesh-list
83739118|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83739119|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739120|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83739121|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
83739122|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739123|NCT05777824|Antibodies|antibodies|mesh-list
83739124|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
83739125|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739126|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
83739127|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83739128|NCT05777733|Antidotes|antidotes|mesh-ancestor
83739129|NCT05777733|Protective Agents|protective agents|mesh-ancestor
83739130|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739131|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
83739132|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739133|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
83739134|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739135|NCT05777733|Expectorants|expectorants|mesh-ancestor
83739136|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
83739137|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83739138|NCT05777707|Paclitaxel|paclitaxel|mesh-list
83739139|NCT05777707|Carboplatin|carboplatin|mesh-list
83739140|NCT05777707|Nedaplatin|nedaplatin|mesh-list
83739141|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83739142|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739143|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739144|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739145|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739146|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739147|NCT05777694|Anesthetics|anesthetics|mesh-list
83739148|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739149|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739150|NCT05777369|Prednisone|prednisone|mesh-list
83739151|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
83739152|NCT05777369|Rituximab|rituximab|mesh-list
83739153|NCT05777369|Vincristine|vincristine|mesh-list
83739154|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
83739155|NCT05777369|Vindesine|vindesine|mesh-list
83739156|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83739157|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
83739158|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739159|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739160|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83739161|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
83739162|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739163|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739164|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83739165|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739166|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739167|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
83739168|NCT05777369|Hormones|hormones|mesh-ancestor
83739169|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739170|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739171|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83739172|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739173|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739174|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739175|NCT05777369|Analgesics|analgesics|mesh-ancestor
83739176|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
83739177|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739178|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83739179|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83739180|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739181|NCT05777278|Docetaxel|docetaxel|mesh-list
83739182|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739183|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739184|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739185|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739186|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739187|NCT05777122|Lidocaine|lidocaine|mesh-list
83739188|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
83739189|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
83739190|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739191|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739192|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
83739193|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739194|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83739195|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83739196|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83739197|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83739198|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739199|NCT05777109|Denosumab|denosumab|mesh-list
83739200|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83739201|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739202|NCT05753306|Cisplatin|cisplatin|mesh-list
83739203|NCT05753306|Docetaxel|docetaxel|mesh-list
83739204|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739205|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739206|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739207|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739208|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739209|NCT05680129|Metformin|metformin|mesh-list
83739210|NCT05680129|Dulaglutide|dulaglutide|mesh-list
83739211|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83739212|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739213|NCT05616390|Bevacizumab|bevacizumab|mesh-list
83739214|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739215|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739216|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83739217|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83739218|NCT05616390|Growth Substances|growth substances|mesh-ancestor
83739219|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739220|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
83739221|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
83739222|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739223|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739224|NCT05613413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83739225|NCT05613413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739226|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
83739227|NCT05597150|Cathartics|cathartics|mesh-ancestor
83739228|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739229|NCT05595460|Carboplatin|carboplatin|mesh-list
83739230|NCT05595460|Etoposide|etoposide|mesh-list
83739231|NCT05595460|Atezolizumab|atezolizumab|mesh-list
83739232|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739233|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83739234|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83739235|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83739236|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739237|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739238|NCT05595460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83739239|NCT05595460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739240|NCT05587894|Ritonavir|ritonavir|mesh-list
83739241|NCT05587894|Remdesivir|remdesivir|mesh-list
83739242|NCT05587894|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83739243|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83739244|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83739245|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
83739246|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739247|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739248|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82894348|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83739249|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83739250|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
83739251|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739252|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83739253|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83739254|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
83739255|NCT05548270|Scopolamine|scopolamine|mesh-list
83739256|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83739257|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
83739258|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
83739259|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739260|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739261|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739262|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
83739263|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83739264|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
83739265|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739266|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739267|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83739268|NCT05534620|Fludarabine|fludarabine|mesh-list
83739269|NCT05534620|Treosulfan|treosulfan|mesh-list
83739270|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739271|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739272|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83739273|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
83739274|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
83739275|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
83739276|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739277|NCT05514197|Protective Agents|protective agents|mesh-ancestor
83739278|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739279|NCT05514197|Vitamins|vitamins|mesh-ancestor
83739280|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
83739281|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83739282|NCT05499052|Hormones|hormones|mesh-ancestor
83739283|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739284|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739285|NCT05493735|Lidocaine|lidocaine|mesh-list
83739286|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
83739287|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
83739288|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739289|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739290|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
83739291|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739292|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83739293|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83739294|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83739295|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83739296|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739297|NCT05410158|Ketamine|ketamine|mesh-list
83739298|NCT05410158|Analgesics|analgesics|mesh-ancestor
83739299|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
83739300|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739301|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739302|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83739303|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83739304|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
83739305|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
83739306|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739307|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83739308|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83739309|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739310|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739311|NCT05291403|Erythromycin|erythromycin|mesh-list
83739312|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
83739313|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83739314|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
82894422|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82894423|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82894424|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
82894425|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894426|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
82894427|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82894428|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
83739315|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894429|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739316|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739317|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739318|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83739319|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739320|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739321|NCT05279690|Colchicine|colchicine|mesh-list
83739322|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
83739323|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739324|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739325|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739326|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739327|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739328|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739329|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
83739330|NCT05255302|Pemetrexed|pemetrexed|mesh-list
83739331|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739332|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739333|NCT05255302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83739334|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739335|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739336|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83739337|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83739338|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83739339|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
83739340|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739341|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83739342|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
83739343|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739344|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739345|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83739346|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83739347|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83739348|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
83739349|NCT05121168|Bupivacaine|bupivacaine|mesh-list
83739350|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
83739351|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
83739352|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739353|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739354|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
83739355|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739356|NCT05091905|Ropivacaine|ropivacaine|mesh-list
83739357|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
83739358|NCT05091905|Anesthetics|anesthetics|mesh-list
83739359|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739360|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739361|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
83739362|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739363|NCT05085873|Midazolam|midazolam|mesh-list
83739364|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
83739365|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83739366|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83739367|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739368|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739369|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83739370|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83739371|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83739372|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83739373|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
83739374|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
83739375|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
83739376|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
83739377|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739378|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739379|NCT04983589|Pilocarpine|pilocarpine|mesh-list
83739380|NCT04983589|Miotics|miotics|mesh-ancestor
83739381|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
83739382|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739383|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739384|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83739385|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83739386|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
83739387|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739388|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739389|NCT04975334|Naloxone|naloxone|mesh-list
83739390|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83739392|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739393|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739394|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83739395|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
83739396|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739397|NCT04961580|Ceftazidime|ceftazidime|mesh-list
83739398|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83739399|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739400|NCT04886154|Vaccines|vaccines|mesh-list
83739401|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
83739402|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739403|NCT04861922|Heparin|heparin|mesh-list
83739404|NCT04861922|Calcium heparin|calcium heparin|mesh-list
83739405|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
83739406|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83739407|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83739408|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739409|NCT04840472|Panitumumab|panitumumab|mesh-list
83739410|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739411|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739412|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
83739413|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83739414|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739415|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83739416|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739417|NCT04782830|Midodrine|midodrine|mesh-list
83739418|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83739419|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83739420|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83739421|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83739422|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739423|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
83739424|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739425|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739426|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
83739427|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
83739428|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739429|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83739430|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83739431|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83739432|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83739433|NCT04771000|Ambrisentan|ambrisentan|mesh-list
83739434|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83739435|NCT04711109|Denosumab|denosumab|mesh-list
83739436|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83739437|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739438|NCT04686786|PF-06372865|pf-06372865|mesh-list
83739439|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
83739440|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
83739441|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739442|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739443|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739444|NCT04620382|Midodrine|midodrine|mesh-list
83739445|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
83739446|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
83739447|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739448|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739449|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83739450|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83739451|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83739452|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83739453|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
83739454|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739455|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739456|NCT04567420|Fulvestrant|fulvestrant|mesh-list
83739457|NCT04567420|Palbociclib|palbociclib|mesh-list
83739458|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739459|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739460|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83739461|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83739462|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
83739463|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739464|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739465|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83739466|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739467|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739468|NCT04565483|Benralizumab|benralizumab|mesh-list
83739469|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83739470|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
83739471|NCT04495855|Dienogest|dienogest|mesh-list
83739472|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83739473|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
83739474|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83739475|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739476|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83739477|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83739478|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83739479|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83739480|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
83739481|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739482|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739483|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739484|NCT04461587|Pirfenidone|pirfenidone|mesh-list
83739485|NCT04461587|Analgesics|analgesics|mesh-ancestor
83739486|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
83739487|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739488|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739489|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83739490|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83739491|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739492|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739493|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739494|NCT04371107|Azithromycin|azithromycin|mesh-list
83739495|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83739496|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739497|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83739498|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83739499|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83739500|NCT04364984|Renin Inhibitors|renin inhibitors|mesh-list
83739501|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739502|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
83739503|NCT04278833|Dexamethasone|dexamethasone|mesh-list
83739504|NCT04278833|Triamcinolone|triamcinolone|mesh-list
83739505|NCT04278833|Betamethasone|betamethasone|mesh-list
83739506|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739507|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
83739508|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
83739509|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739510|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739511|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739512|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
83739513|NCT04278833|Hormones|hormones|mesh-ancestor
83739514|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739515|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739516|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739517|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83739518|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
83739519|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
83739520|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
83739521|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83739522|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739523|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
83739524|NCT04221087|Dexamethasone|dexamethasone|mesh-list
83739525|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739526|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
83739527|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
83739528|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739529|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739530|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739531|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
83739532|NCT04221087|Hormones|hormones|mesh-ancestor
83739533|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739534|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739535|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739536|NCT04200911|Sirolimus|sirolimus|mesh-list
83739537|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83739538|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739539|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83739540|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739541|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
83739542|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83739543|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
83739544|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739546|NCT04112641|Niacin|niacin|mesh-list
83739547|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
83739548|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
83739549|NCT04112641|Vitamins|vitamins|mesh-ancestor
83739550|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
83739551|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739552|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83739553|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
83739554|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739555|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83739556|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
83739557|NCT04062591|Piroxicam|piroxicam|mesh-list
83739558|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83739559|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83739560|NCT04062591|Analgesics|analgesics|mesh-ancestor
83739561|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
83739562|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739563|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739564|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739565|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739566|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83739567|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739568|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739569|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83739570|NCT04059770|Amphotericin B|amphotericin b|mesh-list
83739571|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
83739572|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739573|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83739574|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83739575|NCT04059770|Amebicides|amebicides|mesh-ancestor
83739576|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83739577|NCT04050280|Cytarabine|cytarabine|mesh-list
83739578|NCT04050280|Cladribine|cladribine|mesh-list
83739579|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
83739580|NCT04050280|Lenograstim|lenograstim|mesh-list
83739581|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83739582|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
83739583|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739584|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739585|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
83739586|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739587|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83739588|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
83739589|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739590|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83739591|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739592|NCT04050280|Immunotoxins|immunotoxins|mesh-ancestor
83739593|NCT04050280|Immunoconjugates|immunoconjugates|mesh-ancestor
83739594|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83739595|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739596|NCT03994731|Acetaminophen|acetaminophen|mesh-list
83739597|NCT03994731|Folic Acid|folic acid|mesh-list
83739598|NCT03994731|Fexofenadine|fexofenadine|mesh-list
83739599|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
83739600|NCT03994731|Methotrexate|methotrexate|mesh-list
83739601|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83739602|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
83739603|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83739604|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739605|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83739606|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
83739607|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739608|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739609|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
83739610|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739611|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83739612|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83739613|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
83739614|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739615|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83739616|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83739618|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
83739619|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739620|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
83739621|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739622|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
83739623|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
83739624|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739625|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
83739626|NCT03994731|Hormones|hormones|mesh-ancestor
83739627|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739628|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83739629|NCT03994731|Protective Agents|protective agents|mesh-ancestor
83739630|NCT03994731|Hematinics|hematinics|mesh-ancestor
83739631|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
83739632|NCT03994731|Vitamins|vitamins|mesh-ancestor
83739633|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
83739634|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83739635|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83739636|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83739637|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
83739638|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
83739639|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739640|NCT03984357|Gemcitabine|gemcitabine|mesh-list
83739641|NCT03984357|Antibodies|antibodies|mesh-list
83739642|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
83739643|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
83739644|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739645|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739646|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83739647|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
83739648|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739649|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
83739650|NCT03829683|Vitamins|vitamins|mesh-ancestor
83739651|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
83739652|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739653|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
83739654|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739655|NCT03829683|Protective Agents|protective agents|mesh-ancestor
83739656|NCT03824522|BAX 855|bax 855|mesh-list
83739657|NCT03824522|Coagulants|coagulants|mesh-ancestor
83739658|NCT03812991|Calcitonin|calcitonin|mesh-list
83739659|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
83739660|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83739661|NCT03812991|Katacalcin|katacalcin|mesh-list
83739662|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83739663|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739664|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83739665|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
83739666|NCT03737968|Durvalumab|durvalumab|mesh-list
83739667|NCT03737968|Tremelimumab|tremelimumab|mesh-list
83739668|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83739669|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739670|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739671|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
83739672|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739673|NCT03725202|Upadacitinib|upadacitinib|mesh-list
83739674|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83739675|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83739676|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739677|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739678|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739679|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
83739680|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83739681|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
83739682|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739683|NCT03652753|Expectorants|expectorants|mesh-ancestor
83739684|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
83739685|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83739686|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
83739687|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739688|NCT03652753|Protective Agents|protective agents|mesh-ancestor
83739689|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739690|NCT03652753|Antidotes|antidotes|mesh-ancestor
83739691|NCT03617458|Metformin|metformin|mesh-list
83739692|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83739693|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739694|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83739695|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83739696|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83739697|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739698|NCT03556202|Mirikizumab|mirikizumab|mesh-list
83739699|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83739700|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83739701|NCT03556202|Analgesics|analgesics|mesh-ancestor
83739702|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
83739703|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739704|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739705|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739706|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739707|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83739708|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739709|NCT03480438|Blinatumomab|blinatumomab|mesh-list
83739710|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739711|NCT03463876|Apatinib|apatinib|mesh-list
83739712|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739713|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83739714|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739715|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739716|NCT03461120|Anesthetics|anesthetics|mesh-list
83739717|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
83739718|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739719|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739720|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
83739721|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739722|NCT03396588|Clonidine|clonidine|mesh-list
83739723|NCT03396588|Morphine|morphine|mesh-list
83739724|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83739725|NCT03396588|Narcotics|narcotics|mesh-ancestor
83739726|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739727|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739728|NCT03396588|Analgesics|analgesics|mesh-ancestor
83739729|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
83739730|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739731|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83739732|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
83739733|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
83739734|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83739735|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83739736|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83739737|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
83739738|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739739|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739740|NCT03361852|Rituximab|rituximab|mesh-list
83739741|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
83739742|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739743|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739744|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
83739745|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739746|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739747|NCT03361852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83739748|NCT03361852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739749|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
83739750|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
83739751|NCT03350516|Calcium|calcium|mesh-list
83739752|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83739753|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739754|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83739755|NCT03350516|Antacids|antacids|mesh-ancestor
83739756|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739757|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739758|NCT03350451|Lumasiran|lumasiran|mesh-list
83739759|NCT03350451|Renal Agents|renal agents|mesh-ancestor
83739760|NCT03329508|Pramipexole|pramipexole|mesh-list
83739761|NCT03329508|Rasagiline|rasagiline|mesh-list
83739762|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
83739763|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894864|NCT03847818|Docetaxel|docetaxel|mesh-list
83739764|NCT03329508|Protective Agents|protective agents|mesh-ancestor
83739765|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739766|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83739767|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82894865|NCT03847818|Trastuzumab|trastuzumab|mesh-list
83739768|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
83739769|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
83739770|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739771|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83739772|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739773|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83739774|NCT03289039|Fulvestrant|fulvestrant|mesh-list
83739775|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739776|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739777|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83739778|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83739779|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
83739780|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739781|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739782|NCT03281304|Tofacitinib|tofacitinib|mesh-list
83739783|NCT03281304|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83739784|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83739785|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739786|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739787|NCT03153319|Adalimumab|adalimumab|mesh-list
83739788|NCT03153319|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83739789|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739790|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739791|NCT03145272|Oxycodone|oxycodone|mesh-list
83739792|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83739793|NCT03145272|Narcotics|narcotics|mesh-ancestor
83739794|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83739795|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739796|NCT03145272|Analgesics|analgesics|mesh-ancestor
83739797|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
83739798|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739799|NCT03127007|Atezolizumab|atezolizumab|mesh-list
83739800|NCT03127007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83739801|NCT03127007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739802|NCT03127007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739803|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739804|NCT03109093|Blinatumomab|blinatumomab|mesh-list
83739805|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739806|NCT02726711|Trimethaphan|trimethaphan|mesh-list
83739807|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
83739808|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83739809|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83739810|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83739811|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
83739812|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739813|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739814|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83739815|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83739816|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
83739817|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739818|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739819|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
83739820|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
83739821|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
83739822|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739823|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739824|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83739825|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83739826|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
83739827|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739828|NCT02649998|Furosemide|furosemide|mesh-list
83739829|NCT02649998|Isosorbide|isosorbide|mesh-list
83739830|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83739831|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83739832|NCT02649998|Diuretics|diuretics|mesh-ancestor
83739833|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
83739834|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739835|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83739836|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83739837|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739838|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83739839|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
83739840|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83739841|NCT02503358|Paclitaxel|paclitaxel|mesh-list
83739842|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83739843|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83739844|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739845|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739846|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739847|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739848|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739850|NCT02432963|Vaccines|vaccines|mesh-list
83739851|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
83739852|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739853|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739854|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739855|NCT02432963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83739856|NCT02432963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739857|NCT02358538|Ganaxolone|ganaxolone|mesh-list
83739858|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
83739859|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83739860|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739861|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739862|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
83739863|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
83739864|NCT02349906|Treosulfan|treosulfan|mesh-list
83739865|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83739866|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
83739867|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739868|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739869|NCT02336087|Metformin|metformin|mesh-list
83739870|NCT02336087|Paclitaxel|paclitaxel|mesh-list
83739871|NCT02336087|Gemcitabine|gemcitabine|mesh-list
83739872|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83739873|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83739874|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739875|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739876|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739877|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739878|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739879|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83739880|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
83739881|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83739882|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739883|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
83739884|NCT02332980|Idelalisib|idelalisib|mesh-list
83739885|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83739886|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739887|NCT02332980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83739888|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739889|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739890|NCT02197234|Osimertinib|osimertinib|mesh-list
83739891|NCT02197234|Simvastatin|simvastatin|mesh-list
83739892|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83739893|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83739894|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
83739895|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739896|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83739897|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83739898|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739899|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739900|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83739901|NCT02087826|Metformin|metformin|mesh-list
83739902|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83739903|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739904|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
83739905|NCT02048813|Rituximab|rituximab|mesh-list
83739906|NCT02048813|Fludarabine|fludarabine|mesh-list
83739907|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
83739908|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83739909|NCT02048813|Antibodies|antibodies|mesh-list
83739910|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
83739911|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83739912|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83739913|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
83739914|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739915|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83739916|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82895016|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
83739917|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
83739918|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739919|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739920|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83739921|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83739922|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
83739923|NCT02048150|Antibodies|antibodies|mesh-list
83739924|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83739925|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
83739926|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739927|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83739928|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
83739929|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83739930|NCT02038452|Prednisolone|prednisolone|mesh-list
83739931|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
83739932|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83739933|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
83739934|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739935|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
83739936|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
83739937|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83739938|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739939|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83739940|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
83739941|NCT02038452|Hormones|hormones|mesh-ancestor
83739942|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739943|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83739944|NCT02038452|Protective Agents|protective agents|mesh-ancestor
83739945|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739946|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739947|NCT01933932|Docetaxel|docetaxel|mesh-list
83739948|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739949|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
83739950|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
83739951|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
83739952|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739953|NCT01748448|Vitamin D|vitamin d|mesh-list
83739954|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
83739955|NCT01748448|Vitamins|vitamins|mesh-ancestor
83739956|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
83739957|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739958|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83739959|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83739960|NCT01476839|Cytarabine|cytarabine|mesh-list
83739961|NCT01476839|Etoposide|etoposide|mesh-list
83739962|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
83739963|NCT01476839|Melphalan|melphalan|mesh-list
83739964|NCT01476839|Carmustine|carmustine|mesh-list
83739965|NCT01476839|Basiliximab|basiliximab|mesh-list
83739966|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83739967|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739968|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83739969|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83739970|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83739971|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83739972|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83739973|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
83739974|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
83739975|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83739976|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83739977|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
83739978|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739979|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83739980|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
83739981|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83739982|NCT01332097|Prednisone|prednisone|mesh-list
83739983|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83739984|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
83739985|NCT01332097|Hormones|hormones|mesh-ancestor
83739986|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83739987|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83739988|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83739989|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739990|NCT01163357|Sirolimus|sirolimus|mesh-list
83739991|NCT01163357|Fludarabine|fludarabine|mesh-list
83739992|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
83739993|NCT01163357|Bortezomib|bortezomib|mesh-list
83739994|NCT01163357|Melphalan|melphalan|mesh-list
83739995|NCT01163357|Tacrolimus|tacrolimus|mesh-list
83739996|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83739997|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83739998|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
83739999|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740000|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740001|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
83740002|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740003|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83740004|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740005|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83740006|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740007|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83740008|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
83740009|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83740010|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
83740011|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83740012|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
83740013|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83740014|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
83740015|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740016|NCT00967005|Expectorants|expectorants|mesh-ancestor
83740017|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
83740018|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83740019|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
83740020|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740021|NCT00967005|Protective Agents|protective agents|mesh-ancestor
83740022|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740023|NCT00967005|Antidotes|antidotes|mesh-ancestor
83740024|NCT00863369|Rituximab|rituximab|mesh-list
83740025|NCT00863369|Gemcitabine|gemcitabine|mesh-list
83740026|NCT00863369|Bortezomib|bortezomib|mesh-list
83740027|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740028|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740029|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
83740030|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740031|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83740032|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83740033|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
83740034|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740035|NCT00600496|Sirolimus|sirolimus|mesh-list
83740036|NCT00600496|Docetaxel|docetaxel|mesh-list
83740037|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83740038|NCT00600496|Temsirolimus|temsirolimus|mesh-list
83740039|NCT00600496|Dacarbazine|dacarbazine|mesh-list
83740040|NCT00600496|MTOR Inhibitors|mtor inhibitors|mesh-list
83740041|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740042|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
83740043|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
83740044|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
83740045|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740046|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83740047|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740048|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740049|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
83740050|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740051|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83740052|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740053|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83740054|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
83740055|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83740056|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
83740057|NCT00538031|Celecoxib|celecoxib|mesh-list
83740058|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
83740059|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740060|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
83740061|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740062|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83740063|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83740064|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
83740065|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740066|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895168|NCT01383148|Pemetrexed|pemetrexed|mesh-list
83740067|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82895180|NCT01192854|Adefovir|adefovir|mesh-list
83740068|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83740070|NCT00538031|Analgesics|analgesics|mesh-ancestor
83740071|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
83740072|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740073|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83740074|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83740075|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83740076|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740077|NCT00203996|Pioglitazone|pioglitazone|mesh-list
83740078|NCT00203996|Leuprolide|leuprolide|mesh-list
83740079|NCT00203996|Estrogens|estrogens|mesh-list
83740080|NCT00203996|Progestins|progestins|mesh-list
83740081|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83740082|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740083|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83740084|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
83740085|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83740086|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83740087|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740088|NCT00203996|Hormones|hormones|mesh-ancestor
83740089|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740090|NCT00099437|Fulvestrant|fulvestrant|mesh-list
83740091|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83740092|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740093|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83740094|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83740095|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
83740096|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740097|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740098|NCT02009280|Anesthetics|anesthetics|mesh-list
83740099|NCT02009280|Propofol|propofol|mesh-list
83740100|NCT02009280|Sevoflurane|sevoflurane|mesh-list
83740101|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740102|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740103|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83740104|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740105|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
83740106|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83740107|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83740108|NCT02009306|Fentanyl|fentanyl|mesh-list
83740109|NCT02009306|Midazolam|midazolam|mesh-list
83740110|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83740111|NCT02009306|Narcotics|narcotics|mesh-ancestor
83740112|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740113|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740114|NCT02009306|Analgesics|analgesics|mesh-ancestor
83740115|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
83740116|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740117|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83740118|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740119|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
83740120|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
83740121|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83740122|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83740123|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83740124|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83740125|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
83740126|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
83740127|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740128|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740129|NCT02009410|Pancrelipase|pancrelipase|mesh-list
83740130|NCT02009410|Pancreatin|pancreatin|mesh-list
83740131|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740132|NCT02009436|Azacitidine|azacitidine|mesh-list
83740133|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83740134|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
83740135|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740136|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740137|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740138|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83740139|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
83740140|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83740141|NCT02009462|Protective Agents|protective agents|mesh-ancestor
83740142|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740143|NCT02009488|Canagliflozin|canagliflozin|mesh-list
83740144|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83740145|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740146|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83740147|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740148|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
83740149|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
83740150|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83740151|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
83740152|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83740153|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83740154|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83740155|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83740156|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740157|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
83740158|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740159|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740160|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83740161|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740162|NCT02009592|Rifaximin|rifaximin|mesh-list
83740163|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83740164|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740165|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740166|NCT02009618|Rifaximin|rifaximin|mesh-list
83740167|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83740168|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740169|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740170|NCT02009631|Veliparib|veliparib|mesh-list
83740171|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83740172|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740173|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740174|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740175|NCT02009709|Riboflavin|riboflavin|mesh-list
83740176|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83740177|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83740178|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
83740179|NCT02009709|Vitamins|vitamins|mesh-ancestor
83740180|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
83740181|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740182|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83740183|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
83740184|NCT02009748|Vitamin D|vitamin d|mesh-list
83740185|NCT02009748|Vitamins|vitamins|mesh-ancestor
83740186|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
83740187|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740188|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83740189|NCT02009787|Vitamin D|vitamin d|mesh-list
83740190|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
83740191|NCT02009787|Vitamins|vitamins|mesh-ancestor
83740192|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
83740193|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740194|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83740195|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83740196|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83740197|NCT02009943|Hematinics|hematinics|mesh-ancestor
83740198|NCT02010164|Ubiquinone|ubiquinone|mesh-list
83740199|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
83740200|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
83740201|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740202|NCT02010164|Vitamins|vitamins|mesh-ancestor
83740203|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83740204|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83740205|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83740206|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
83740207|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740208|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740209|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
83740210|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83740211|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83740212|NCT02010723|Polidocanol|polidocanol|mesh-list
83740213|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83740214|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83740215|NCT02010762|Vitamin D|vitamin d|mesh-list
83740216|NCT02010762|Vitamins|vitamins|mesh-ancestor
83740217|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
83740218|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740219|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83740220|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
83740221|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83740222|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83740223|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83740224|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83740225|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740226|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
83740227|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740228|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740229|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83740230|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740231|NCT02010827|Glucagon|glucagon|mesh-list
83740232|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740233|NCT02010827|Hormones|hormones|mesh-ancestor
83740234|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740235|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740236|NCT02010905|Losartan|losartan|mesh-list
83740237|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83740238|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83740239|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83740240|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83740241|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740242|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
83740243|NCT02010944|Mirabegron|mirabegron|mesh-list
83740244|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83740245|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83740246|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83740247|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740248|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740249|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740250|NCT02010944|Urological Agents|urological agents|mesh-ancestor
83740251|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83740252|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83740253|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83740254|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83740255|NCT02010957|Etomidate|etomidate|mesh-list
83740256|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83740257|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740258|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740259|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740260|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
83740261|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
83740262|NCT02010970|Itraconazole|itraconazole|mesh-list
83740263|NCT02010970|Diltiazem|diltiazem|mesh-list
83740264|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
83740265|NCT02010970|Midazolam|midazolam|mesh-list
83740266|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83740267|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740268|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83740269|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83740270|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740271|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83740272|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83740273|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83740274|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740275|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
83740276|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
83740277|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
83740278|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
83740279|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740280|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740281|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
83740282|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740283|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83740284|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83740285|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740286|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83740287|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
83740288|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740289|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83740290|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83740291|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83740292|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
83740293|NCT02011126|Imetelstat|imetelstat|mesh-list
83740294|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
83740295|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895395|NCT03845322|Analgesics|analgesics|mesh-ancestor
83740296|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740297|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83740298|NCT02011191|Biotin|biotin|mesh-list
83740299|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
83740300|NCT02011191|Vitamins|vitamins|mesh-ancestor
83740301|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
83740302|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740303|NCT02011347|Ketamine|ketamine|mesh-list
83740304|NCT02011347|Analgesics|analgesics|mesh-ancestor
83740305|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
83740306|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740307|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740308|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83740309|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740310|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
83740311|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
83740312|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740313|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83740314|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83740315|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740316|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740317|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
83740318|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740319|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740320|NCT02011620|Isosorbide|isosorbide|mesh-list
83740321|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83740322|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83740323|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83740324|NCT02011620|Diuretics|diuretics|mesh-ancestor
83740325|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
83740326|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740327|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
83740328|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83740329|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740330|NCT02011633|Metformin|metformin|mesh-list
83740331|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83740332|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83740333|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740334|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83740335|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83740336|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
83740337|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740338|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83740339|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83740340|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740341|NCT02011659|Ramosetron|ramosetron|mesh-list
83740342|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
83740343|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
83740344|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740345|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740346|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740347|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83740348|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
83740349|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740350|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740351|NCT02011737|Naftopidil|naftopidil|mesh-list
83740352|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83740353|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83740354|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
83740355|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740356|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740357|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740358|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83740359|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83740360|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83740361|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83740362|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83740363|NCT02011750|Valproic Acid|valproic acid|mesh-list
83740364|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
83740365|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740366|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740367|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
83740368|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740369|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740370|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
83740371|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83740372|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740373|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83740374|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
83740375|NCT02011828|Vitamin D|vitamin d|mesh-list
83740376|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83740377|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740378|NCT02011828|Vitamins|vitamins|mesh-ancestor
83740379|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
83740380|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83740381|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
83740382|NCT02011841|Rifaximin|rifaximin|mesh-list
83740383|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83740384|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740385|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83740386|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83740387|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740388|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740389|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740390|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83740391|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83740392|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740393|NCT02011906|Vitamins|vitamins|mesh-list
83740394|NCT02011906|Vitamin E|vitamin e|mesh-list
83740395|NCT02011906|Tocopherols|tocopherols|mesh-list
83740396|NCT02011906|Tocotrienols|tocotrienols|mesh-list
83740397|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
83740398|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
83740399|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740400|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
83740401|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740402|NCT02011906|Protective Agents|protective agents|mesh-ancestor
83740403|NCT02011958|Amphotericin B|amphotericin b|mesh-list
83740404|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83740405|NCT02011958|Miltefosine|miltefosine|mesh-list
83740406|NCT02011958|Amebicides|amebicides|mesh-ancestor
83740407|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83740408|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83740409|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740410|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83740411|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
83740412|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740413|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83740414|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83740415|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
83740416|NCT02012049|Risperidone|risperidone|mesh-list
83740417|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83740418|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
83740419|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740420|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740421|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740422|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83740423|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83740424|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740425|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83740426|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83740427|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
83740428|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
83740429|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740430|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740431|NCT02012075|Metoprolol|metoprolol|mesh-list
83740432|NCT02012075|Carvedilol|carvedilol|mesh-list
83740433|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83740434|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83740435|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
83740436|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
83740437|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740438|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740439|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83740440|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83740441|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83740442|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
82895544|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83740443|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740444|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740445|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
83740446|NCT02012075|Protective Agents|protective agents|mesh-ancestor
83740447|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83740448|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83740449|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83740450|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
83740451|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83740452|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83740453|NCT02012088|Prednisone|prednisone|mesh-list
83740454|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
83740455|NCT02012088|Rituximab|rituximab|mesh-list
83740456|NCT02012088|Doxorubicin|doxorubicin|mesh-list
83740457|NCT02012088|Vincristine|vincristine|mesh-list
83740458|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740459|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
83740460|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740461|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83740462|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83740463|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
83740464|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740465|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740466|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83740467|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740468|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83740469|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83740470|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83740471|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740472|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83740473|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
83740474|NCT02012088|Hormones|hormones|mesh-ancestor
83740475|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740476|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83740477|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83740478|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83740479|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83740480|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83740481|NCT02012140|Ticagrelor|ticagrelor|mesh-list
83740482|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83740483|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83740484|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83740485|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83740486|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
83740487|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740488|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740489|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740490|NCT02012166|Insulin|insulin|mesh-list
83740491|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83740492|NCT02012166|Octreotide|octreotide|mesh-list
83740493|NCT02012166|Glucagon|glucagon|mesh-list
83740494|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83740495|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740496|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740497|NCT02012166|Hormones|hormones|mesh-ancestor
83740498|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740499|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83740500|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740501|NCT02012244|Fentanyl|fentanyl|mesh-list
83740502|NCT02012244|Anesthetics|anesthetics|mesh-list
83740503|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
83740504|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83740505|NCT02012244|Narcotics|narcotics|mesh-ancestor
83740506|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740507|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740508|NCT02012244|Analgesics|analgesics|mesh-ancestor
83740509|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
83740510|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740511|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83740512|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740513|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
83740514|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83740515|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
83740516|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740517|NCT02012322|Ubiquinone|ubiquinone|mesh-list
83740518|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
83740519|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
82895618|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83740520|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740521|NCT02012322|Vitamins|vitamins|mesh-ancestor
83740522|NCT02012335|Ketamine|ketamine|mesh-list
83740523|NCT02012335|Analgesics|analgesics|mesh-ancestor
83740524|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
83740525|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740526|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740527|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83740528|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740529|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
83740530|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
83740531|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740532|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83740533|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83740534|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740535|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740536|NCT02012387|Omalizumab|omalizumab|mesh-list
83740537|NCT02012387|Vaccines|vaccines|mesh-list
83740538|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83740539|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
83740540|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740541|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83740542|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83740543|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83740544|NCT02012465|Insulin|insulin|mesh-list
83740545|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
83740546|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83740547|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740548|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83740549|NCT02012517|Cefazolin|cefazolin|mesh-list
83740550|NCT02012517|Cephalexin|cephalexin|mesh-list
83740551|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83740552|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740553|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
83740554|NCT02012556|Tesamorelin|tesamorelin|mesh-list
83740555|NCT02012556|Growth Substances|growth substances|mesh-ancestor
83740556|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740557|NCT02012569|Hemostatics|hemostatics|mesh-list
83740558|NCT02012569|Coagulants|coagulants|mesh-ancestor
83740559|NCT02012595|Donepezil|donepezil|mesh-list
83740560|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83740561|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740562|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740563|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
83740564|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740565|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740566|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
83740567|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
83740568|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740569|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
83740570|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740571|NCT02012777|Propranolol|propranolol|mesh-list
83740572|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83740573|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83740574|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
83740575|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740576|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740577|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133036|NCT03099278|Ezetimibe|ezetimibe|mesh-list
83740578|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83740579|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83740580|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
83740581|NCT02012920|Seviteronel|seviteronel|mesh-list
83740582|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740583|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83740584|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740585|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740586|NCT02012933|Amifampridine|amifampridine|mesh-list
83740587|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83740588|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740589|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740590|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83740591|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83740592|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740593|NCT02012946|Simendan|simendan|mesh-list
83740594|NCT02012946|Dobutamine|dobutamine|mesh-list
83740595|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83740596|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
83740597|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83740598|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83740599|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740600|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740601|NCT02012946|Protective Agents|protective agents|mesh-ancestor
83740602|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740603|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
83740604|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
83740605|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740606|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83740607|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83740608|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83740609|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
83740610|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740611|NCT02012998|Vaccines|vaccines|mesh-list
83740612|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
83740613|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740614|NCT02013102|Decitabine|decitabine|mesh-list
83740615|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83740616|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
83740617|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740618|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740619|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740620|NCT02013115|Budesonide|budesonide|mesh-list
83740621|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83740622|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83740623|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
83740624|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740625|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740626|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83740627|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
83740628|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
83740629|NCT02013115|Hormones|hormones|mesh-ancestor
83740630|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740631|NCT02013154|Paclitaxel|paclitaxel|mesh-list
83740632|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
83740633|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83740634|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740635|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83740636|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83740637|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83740638|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740639|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740640|NCT02013154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83740641|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83740642|NCT02013219|Atezolizumab|atezolizumab|mesh-list
83740643|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740644|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83740645|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740646|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740647|NCT02013219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83740648|NCT02013219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740649|NCT02013232|Aripiprazole|aripiprazole|mesh-list
83740650|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
83740651|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83740652|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83740653|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83740654|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740655|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740656|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
83740657|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
83740658|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740659|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740660|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83740661|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83740662|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
83740663|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83740664|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83740665|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83740666|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82895769|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83740667|NCT02013258|Oxytocin|oxytocin|mesh-list
83740668|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
83740669|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83740670|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740671|NCT02013271|Paclitaxel|paclitaxel|mesh-list
83740672|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83740673|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740674|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83740675|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83740676|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83740677|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740678|NCT02013362|Folic Acid|folic acid|mesh-list
83740679|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
83740680|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
83740681|NCT02013362|Vitamins|vitamins|mesh-ancestor
83740682|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
83740683|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740684|NCT02013362|Hematinics|hematinics|mesh-ancestor
83740685|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
83740686|NCT02013453|Paclitaxel|paclitaxel|mesh-list
83740687|NCT02013453|Carboplatin|carboplatin|mesh-list
83740688|NCT02013453|Fluorouracil|fluorouracil|mesh-list
83740689|NCT02013453|Pemetrexed|pemetrexed|mesh-list
83740690|NCT02013453|Omeprazole|omeprazole|mesh-list
83740691|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83740692|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740693|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
83740694|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
83740695|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
83740696|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740697|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
83740698|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83740699|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740700|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
83740701|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740702|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740703|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83740704|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83740705|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83740706|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740707|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83740708|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
83740709|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83740710|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740711|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740712|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83740713|NCT02013570|Analgesics|analgesics|mesh-ancestor
83740714|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
83740715|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740716|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83740717|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83740718|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83740719|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
83740720|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740721|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740722|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
83740723|NCT02013856|Procyanidin|procyanidin|mesh-list
83740724|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
83740725|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740726|NCT02013856|Protective Agents|protective agents|mesh-ancestor
83740727|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740728|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83740729|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83740730|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740731|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
83740732|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83740733|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740734|NCT02013960|Misoprostol|misoprostol|mesh-list
83740735|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83740736|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
83740737|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83740738|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740739|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83740740|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740741|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
83740742|NCT02013986|Midazolam|midazolam|mesh-list
82895840|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740743|NCT02013986|Propofol|propofol|mesh-list
83740744|NCT02013986|Etomidate|etomidate|mesh-list
83740745|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83740746|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740747|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740748|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740749|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
83740750|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
83740751|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83740752|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83740753|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83740754|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83740755|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
83740756|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
83740757|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740758|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740759|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83740760|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83740761|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83740762|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83740763|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740764|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
83740765|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740766|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740767|NCT02013089|Everolimus|everolimus|mesh-list
83740768|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83740769|NCT02013089|Sorafenib|sorafenib|mesh-list
83740770|NCT02013089|Sunitinib|sunitinib|mesh-list
83740771|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
83740772|NCT02013089|Gefitinib|gefitinib|mesh-list
83740773|NCT02013089|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83740774|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83740775|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740776|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740777|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740778|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
83740779|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740780|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740781|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83740782|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83740783|NCT02013089|Growth Substances|growth substances|mesh-ancestor
83740784|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83740785|NCT02014103|Tacrolimus|tacrolimus|mesh-list
83740786|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740787|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
83740788|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740789|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83740790|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740791|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740792|NCT02014337|Mifepristone|mifepristone|mesh-list
83740793|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83740794|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
83740795|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83740796|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740797|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83740798|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83740799|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83740800|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
83740801|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83740802|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83740803|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
83740804|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740805|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
83740806|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83740807|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83740808|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
83740809|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83740810|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
83740811|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740812|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
83740813|NCT02014428|Protective Agents|protective agents|mesh-ancestor
83740814|NCT02014454|Propranolol|propranolol|mesh-list
83740815|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83740816|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83740817|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83740818|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83740820|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740821|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740822|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740823|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83740824|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83740825|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
83740826|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
83740827|NCT02014506|Fludarabine|fludarabine|mesh-list
83740828|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83740829|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740830|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
83740831|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740832|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83740833|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83740834|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
83740835|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740836|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740837|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83740838|NCT02014532|Montelukast|montelukast|mesh-list
83740839|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
83740840|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83740841|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
83740842|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
83740843|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740844|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740845|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83740846|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83740847|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740848|NCT02014545|Lucanthone|lucanthone|mesh-list
83740849|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
83740850|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83740851|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
83740852|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83740853|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740854|NCT02014558|Voriconazole|voriconazole|mesh-list
83740855|NCT02014558|Cephalexin|cephalexin|mesh-list
83740856|NCT02014558|Midazolam|midazolam|mesh-list
83740857|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83740858|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83740859|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740860|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740861|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83740862|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83740863|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83740864|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740865|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
83740866|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
83740867|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
83740868|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
83740869|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740870|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740871|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
83740872|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740873|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83740874|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83740875|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740876|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83740877|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
83740878|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740879|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83740880|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83740881|NCT02014623|Immunomodulating Agents|immunomodulating agents|mesh-list
83740882|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
83740883|NCT02014623|Immunologic Factors|immunologic factors|mesh-ancestor
83740884|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740885|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
83740886|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83740887|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740888|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
83740889|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740890|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895992|NCT05077488|Lidocaine|lidocaine|mesh-list
83740891|NCT02014636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83740892|NCT02014636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740893|NCT02014714|Fentanyl|fentanyl|mesh-list
83740894|NCT02014714|Morphine|morphine|mesh-list
83740895|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83740896|NCT02014714|Narcotics|narcotics|mesh-ancestor
83740897|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740898|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740899|NCT02014714|Analgesics|analgesics|mesh-ancestor
83740900|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
83740901|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740902|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83740903|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83740904|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
83740905|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
83740906|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83740907|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83740908|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
83740909|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740910|NCT02014727|Antacids|antacids|mesh-ancestor
83740911|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740912|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740913|NCT02014753|Cobalt|cobalt|mesh-list
83740914|NCT02014753|Chromium|chromium|mesh-list
83740915|NCT02014753|Everolimus|everolimus|mesh-list
83740916|NCT02014753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83740917|NCT02014753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83740918|NCT02014753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740919|NCT02014753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740920|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83740921|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
83740922|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740923|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740924|NCT02014753|Trace Elements|trace elements|mesh-ancestor
83740925|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
83740926|NCT02014831|Cetuximab|cetuximab|mesh-list
83740927|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740928|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740929|NCT02014922|Vitamin E|vitamin e|mesh-list
83740930|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
83740931|NCT02014922|Tocopherols|tocopherols|mesh-list
83740932|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83740933|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83740934|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
83740935|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83740936|NCT02014922|Laxatives|laxatives|mesh-ancestor
83740937|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83740938|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
83740939|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740940|NCT02014922|Protective Agents|protective agents|mesh-ancestor
83740941|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740942|NCT02014922|Vitamins|vitamins|mesh-ancestor
83740943|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
83740944|NCT02015156|Trastuzumab|trastuzumab|mesh-list
83740945|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83740946|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740947|NCT02015169|Lapatinib|lapatinib|mesh-list
83740948|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740949|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83740950|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740951|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740952|NCT02015182|Bupivacaine|bupivacaine|mesh-list
83740953|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
83740954|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
83740955|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83740956|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740957|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
83740958|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83740959|NCT02015260|Citric Acid|citric acid|mesh-list
83740960|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
83740961|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83740962|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
83740963|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
83740964|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740965|NCT02015299|Linagliptin|linagliptin|mesh-list
83740966|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83740967|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83740968|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740969|NCT02015299|Incretins|incretins|mesh-ancestor
83740970|NCT02015299|Hormones|hormones|mesh-ancestor
83740971|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83740972|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
83740973|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83740974|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740975|NCT02015312|Silicon|silicon|mesh-list
83740976|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83740977|NCT02015312|Mannitol|mannitol|mesh-list
83740978|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83740979|NCT02015312|Diuretics|diuretics|mesh-ancestor
83740980|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
83740981|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83740982|NCT02015312|Trace Elements|trace elements|mesh-ancestor
83740983|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
83740984|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
83740985|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83740986|NCT02015312|Protective Agents|protective agents|mesh-ancestor
83740987|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83740988|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83740989|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83740990|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83740991|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
83740992|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83740993|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
83740994|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83740995|NCT02015403|Expectorants|expectorants|mesh-ancestor
83740996|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
83740997|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83740998|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
83740999|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741000|NCT02015403|Protective Agents|protective agents|mesh-ancestor
83741001|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741002|NCT02015403|Antidotes|antidotes|mesh-ancestor
83741003|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
83741004|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
83741005|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741006|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
83741007|NCT02015494|Coagulants|coagulants|mesh-ancestor
83741008|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
83741009|NCT02015507|Ivacaftor|ivacaftor|mesh-list
83741010|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83741011|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741012|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83741013|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83741014|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741015|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741016|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741017|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83741018|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83741019|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83741020|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741021|NCT02015559|Protective Agents|protective agents|mesh-list
83741022|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741023|NCT02015598|Carbocysteine|carbocysteine|mesh-list
83741024|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83741025|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741026|NCT02015598|Expectorants|expectorants|mesh-ancestor
83741027|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
83741028|NCT02015650|Fluorouracil|fluorouracil|mesh-list
83741029|NCT02015650|Cetuximab|cetuximab|mesh-list
83741030|NCT02015650|Mitomycins|mitomycins|mesh-list
83741031|NCT02015650|Mitomycin|mitomycin|mesh-list
83741032|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
83741033|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741034|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741035|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741036|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741037|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
83741038|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741039|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896139|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741040|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83741041|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
83741042|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83741043|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896144|NCT03719586|Remdesivir|remdesivir|mesh-list
83741045|NCT02015728|Everolimus|everolimus|mesh-list
83741046|NCT02015728|Temozolomide|temozolomide|mesh-list
83741047|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83741048|NCT02015728|Sorafenib|sorafenib|mesh-list
83741049|NCT02015728|Dasatinib|dasatinib|mesh-list
83741050|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83741051|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741052|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83741053|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83741054|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741055|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741056|NCT02015728|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83741057|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83741058|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741059|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
83741060|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741061|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83741062|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
83741063|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83741064|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741065|NCT02015923|Panitumumab|panitumumab|mesh-list
83741066|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83741067|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741068|NCT02015949|Methylphenidate|methylphenidate|mesh-list
83741069|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83741070|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741071|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83741072|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83741073|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741074|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741075|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
83741076|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741077|NCT02015988|Simvastatin|simvastatin|mesh-list
83741078|NCT02015988|Fenofibrate|fenofibrate|mesh-list
83741079|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83741080|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83741081|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
83741082|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741083|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83741084|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83741085|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741086|NCT02016001|Fluorides|fluorides|mesh-list
83741087|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
83741088|NCT02016001|Protective Agents|protective agents|mesh-ancestor
83741089|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741090|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
83741091|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83741092|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741093|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83741094|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83741095|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741096|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741097|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741098|NCT02016196|Rifaximin|rifaximin|mesh-list
83741099|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83741100|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741101|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741102|NCT02016209|Paclitaxel|paclitaxel|mesh-list
83741103|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83741104|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83741105|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741106|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83741107|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83741108|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83741109|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741110|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
83741111|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83741112|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83741113|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741114|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741115|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83741116|NCT02016261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83741117|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83741118|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741119|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741120|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741121|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
83741122|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83741123|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
83741124|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83741125|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83741126|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741127|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83741128|NCT02016274|Paclitaxel|paclitaxel|mesh-list
83741129|NCT02016274|Cisplatin|cisplatin|mesh-list
83741130|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83741131|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741132|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
83741133|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
83741134|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
83741135|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741136|NCT02016287|Paclitaxel|paclitaxel|mesh-list
83741137|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83741138|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741139|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
83741140|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
83741141|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
83741142|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741143|NCT02016365|Doxycycline|doxycycline|mesh-list
83741144|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83741145|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83741146|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741147|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
83741148|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83741149|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83741150|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83741151|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741152|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
83741153|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83741154|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741155|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741156|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83741157|NCT02016391|Analgesics|analgesics|mesh-ancestor
83741158|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
83741159|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741160|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83133045|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
83741161|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83741162|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83741163|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83741164|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741165|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741166|NCT02016417|Cisplatin|cisplatin|mesh-list
83741167|NCT02016417|Gemcitabine|gemcitabine|mesh-list
83741168|NCT02016417|Docetaxel|docetaxel|mesh-list
83741169|NCT02016417|Fluorouracil|fluorouracil|mesh-list
83741170|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741171|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741172|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
83741173|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741174|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83741175|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83741176|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83741177|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741178|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
83741179|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741180|NCT02016443|Tizanidine|tizanidine|mesh-list
83741181|NCT02016443|Analgesics|analgesics|mesh-ancestor
83741182|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
83741183|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741184|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741185|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
83741186|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83741187|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83741188|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
83741189|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
83741190|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83741191|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82896289|NCT01205724|Factor VIII|factor viii|mesh-list
83741192|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83741193|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
83741194|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741195|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741196|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
83741197|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
83741198|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741199|NCT02016495|Protective Agents|protective agents|mesh-ancestor
83741200|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741201|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
83741202|NCT02016495|Vitamins|vitamins|mesh-ancestor
83741203|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
83741204|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83741205|NCT02016547|Abciximab|abciximab|mesh-list
83741206|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83741207|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83741208|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741209|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
83741210|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83741211|NCT02016664|Ketamine|ketamine|mesh-list
83741212|NCT02016664|Analgesics|analgesics|mesh-ancestor
83741213|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
83741214|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741215|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741216|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83741217|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83741218|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
83741219|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
83741220|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741221|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83741222|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83741223|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741224|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741225|NCT02016703|Erythritol|erythritol|mesh-list
83741226|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
83741227|NCT02016729|Trametinib|trametinib|mesh-list
83741228|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741229|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83741230|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741231|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741232|NCT02016807|Sucralfate|sucralfate|mesh-list
83741233|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83741234|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741235|NCT02016820|Omeprazole|omeprazole|mesh-list
83741236|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83741237|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741238|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83741239|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741240|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741241|NCT02016846|Liraglutide|liraglutide|mesh-list
83741242|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83741243|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741244|NCT02016846|Incretins|incretins|mesh-ancestor
83741245|NCT02016846|Hormones|hormones|mesh-ancestor
83741246|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83741247|NCT02016976|Midazolam|midazolam|mesh-list
83741248|NCT02016976|Meperidine|meperidine|mesh-list
83741249|NCT02016976|Analgesics|analgesics|mesh-list
83741250|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
83741251|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741252|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741253|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83741254|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83741255|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741256|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83741257|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83741258|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83741259|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83741260|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
83741261|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
83741262|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
82896364|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741263|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
83741264|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741265|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741266|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83741267|NCT02016976|Narcotics|narcotics|mesh-ancestor
83741268|NCT02017119|Lactulose|lactulose|mesh-list
83741269|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741270|NCT02017197|Warfarin|warfarin|mesh-list
83741271|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
83741272|NCT02017314|Morphine|morphine|mesh-list
83741273|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83741274|NCT02017314|Narcotics|narcotics|mesh-ancestor
83741275|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741276|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741277|NCT02017314|Analgesics|analgesics|mesh-ancestor
83741278|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
83741279|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741280|NCT02017340|Nilvadipine|nilvadipine|mesh-list
83741281|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83741282|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83741283|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741284|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741285|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83741286|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741287|NCT02017392|Lidocaine|lidocaine|mesh-list
83741288|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83741289|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
83741290|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741291|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741292|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
83741293|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741294|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83741295|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83741296|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83741297|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741298|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741299|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
83741300|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83741301|NCT02017405|Antibodies|antibodies|mesh-list
83741302|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
83741303|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741304|NCT02017457|Azacitidine|azacitidine|mesh-list
83741305|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741306|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
83741307|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741308|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741309|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741310|NCT02017561|Metformin|metformin|mesh-list
83741311|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83741312|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741313|NCT02017600|Fluorouracil|fluorouracil|mesh-list
83741314|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741315|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
83741316|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741317|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741318|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741319|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
83741320|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741321|NCT02017613|Tenalisib|tenalisib|mesh-list
83741322|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83741323|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741324|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741325|NCT02017639|Simvastatin|simvastatin|mesh-list
83741326|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83741327|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83741328|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
83741329|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741330|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83741331|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83741332|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741333|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
83741334|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83741335|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741336|NCT02018055|Aspirin|aspirin|mesh-list
83741337|NCT02018055|Clopidogrel|clopidogrel|mesh-list
83741338|NCT02018055|Ticagrelor|ticagrelor|mesh-list
83741339|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82896435|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83741340|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83741341|NCT02018055|Analgesics|analgesics|mesh-ancestor
83741342|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
83741343|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741344|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741345|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83741346|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83741347|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83741348|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83741349|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741350|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83741351|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83741352|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741353|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
83741354|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83741355|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83741356|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83741357|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
83741358|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741359|NCT02018081|Levofloxacin|levofloxacin|mesh-list
83741360|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83741361|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741362|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83741363|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83741364|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83741365|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741366|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741367|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741368|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83741369|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83741370|NCT02018094|Iodine|iodine|mesh-list
83741371|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
83741372|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
83741373|NCT02018094|Metronidazole|metronidazole|mesh-list
83741374|NCT02018094|Clindamycin|clindamycin|mesh-list
83741375|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83741376|NCT02018094|Teicoplanin|teicoplanin|mesh-list
83741377|NCT02018094|Povidone|povidone|mesh-list
83741378|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83741379|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741380|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
83741381|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83741382|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83741383|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83741384|NCT02018094|Trace Elements|trace elements|mesh-ancestor
83741385|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
83741386|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741387|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83741388|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741389|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741390|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
83741391|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
83741392|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83741393|NCT02018133|Vitamin D|vitamin d|mesh-list
83741394|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
83741395|NCT02018133|Vitamins|vitamins|mesh-ancestor
83741396|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
83741397|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741398|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83741399|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83741400|NCT02018159|Menotropins|menotropins|mesh-list
83741401|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83741402|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
83741403|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83741404|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741405|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
83741406|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
83741407|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
83741408|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741409|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741410|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
83741411|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741412|NCT02018276|Lidocaine|lidocaine|mesh-list
83741413|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
83741414|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
83741415|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741416|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741417|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
83741418|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741419|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83741420|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83741421|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83741422|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741423|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741424|NCT02018289|Triclosan|triclosan|mesh-list
83741425|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83741426|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741427|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83741428|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83741429|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
83741430|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741431|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83741432|NCT02018328|Curcumin|curcumin|mesh-list
83741433|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83741434|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83741435|NCT02018328|Analgesics|analgesics|mesh-ancestor
83741436|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
83741437|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502297|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
83741438|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741439|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83741440|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83741441|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741442|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741443|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741444|NCT02018367|Proflavine|proflavine|mesh-list
83741445|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83741446|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741447|NCT02018419|Vaccines|vaccines|mesh-list
83741448|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
83741449|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741450|NCT02018523|Lenalidomide|lenalidomide|mesh-list
83741451|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
83741452|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741453|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83741454|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83741455|NCT02018523|Growth Substances|growth substances|mesh-ancestor
83741456|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
83741457|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741458|NCT02018536|Simeprevir|simeprevir|mesh-list
83741459|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
83741460|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741461|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
83741462|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741463|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741464|NCT02018588|Tryptophan|tryptophan|mesh-list
83741465|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83741466|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
83741467|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83741468|NCT02018601|Acetaminophen|acetaminophen|mesh-list
83741469|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83741470|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83741471|NCT02018601|Analgesics|analgesics|mesh-ancestor
83741472|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
83741473|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741474|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741475|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
83741476|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83741477|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83741478|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83741479|NCT02018731|Metformin|metformin|mesh-list
83741480|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83741481|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741482|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
83741483|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
83741484|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83741485|NCT02018757|Estrogens|estrogens|mesh-ancestor
83741486|NCT02018757|Hormones|hormones|mesh-ancestor
83741487|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83741488|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741489|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82896584|NCT01381432|Azathioprine|azathioprine|mesh-list
82896597|NCT01381354|Niacin|niacin|mesh-list
83741490|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741491|NCT02018783|Listerine|listerine|mesh-list
83741492|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
83741493|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
83741494|NCT02018783|Protective Agents|protective agents|mesh-ancestor
83741495|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741496|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83741497|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741498|NCT02018874|Gemcitabine|gemcitabine|mesh-list
83741499|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741500|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
83741501|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741502|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741503|NCT02018965|Vitamins|vitamins|mesh-list
83741504|NCT02018965|Niacin|niacin|mesh-list
83741505|NCT02018965|Niacinamide|niacinamide|mesh-list
83741506|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
83741507|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
83741508|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
83741509|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741510|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83741511|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
83741512|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741513|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83741514|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
83741515|NCT02018991|Everolimus|everolimus|mesh-list
83741516|NCT02018991|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83741517|NCT02018991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83741518|NCT02018991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741519|NCT02018991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741520|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741521|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
83741522|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741523|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741524|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
83741525|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83741526|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83741527|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83741528|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741529|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741530|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
83741531|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741532|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741533|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83741534|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741535|NCT02019056|Pyridoxine|pyridoxine|mesh-list
83741536|NCT02019056|Metadoxine|metadoxine|mesh-list
83741537|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83741538|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
83741539|NCT02019056|Vitamins|vitamins|mesh-ancestor
83741540|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
83741541|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741542|NCT02019095|Dimercaprol|dimercaprol|mesh-list
83741543|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
83741544|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
83741545|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741546|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
83741547|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83741548|NCT02019160|Fluorides|fluorides|mesh-list
83741549|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
83741550|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
83741551|NCT02019160|Protective Agents|protective agents|mesh-ancestor
83741552|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741553|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83741554|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741555|NCT02019186|Vitamins|vitamins|mesh-list
83741556|NCT02019186|Vitamin E|vitamin e|mesh-list
83741557|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
83741558|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741559|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
83741560|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741561|NCT02019186|Protective Agents|protective agents|mesh-ancestor
83741562|NCT02019290|Midazolam|midazolam|mesh-list
83741563|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83741564|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82896664|NCT03794544|Durvalumab|durvalumab|mesh-list
83741565|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741566|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741567|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83741568|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83741569|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83741570|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83741571|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
83741572|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
83741573|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
83741574|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
83741575|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741576|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741577|NCT02019329|Risperidone|risperidone|mesh-list
83741578|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83741579|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
83741580|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741581|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741582|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741583|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83741584|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83741585|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741586|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83741587|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83741588|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
83741589|NCT02019355|Fluorouracil|fluorouracil|mesh-list
83741590|NCT02019355|Calcipotriene|calcipotriene|mesh-list
83741591|NCT02019355|Petrolatum|petrolatum|mesh-list
83741592|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
83741593|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741594|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741595|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741596|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741597|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
83741598|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741599|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83741600|NCT02019355|Emollients|emollients|mesh-ancestor
83741601|NCT02019381|Vitamin D|vitamin d|mesh-list
83741602|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
83741603|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
83741604|NCT02019381|Vitamins|vitamins|mesh-list
83741605|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
83741606|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741607|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83741608|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83741609|NCT02019394|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83741610|NCT02019394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83741611|NCT02019394|Serotonin Agents|serotonin agents|mesh-ancestor
83741612|NCT02019394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741613|NCT02019394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741614|NCT02019394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741615|NCT02019446|Terbinafine|terbinafine|mesh-list
83741616|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
83741617|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741618|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741619|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741620|NCT02019459|Nicotine|nicotine|mesh-list
83741621|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83741622|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
83741623|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741624|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741625|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83741626|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83741627|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
83741628|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741629|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741630|NCT02019485|Tapentadol|tapentadol|mesh-list
83741631|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83741632|NCT02019485|Narcotics|narcotics|mesh-ancestor
83741633|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741634|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741635|NCT02019485|Analgesics|analgesics|mesh-ancestor
83741636|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
83741637|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741638|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83741639|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83741640|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82896739|NCT04182360|Carbetocin|carbetocin|mesh-list
83741641|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741642|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83741643|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741644|NCT02019524|Folic Acid|folic acid|mesh-list
83741645|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
83741646|NCT02019524|Molgramostim|molgramostim|mesh-list
83741647|NCT02019524|Vaccines|vaccines|mesh-list
83741648|NCT02019524|Sargramostim|sargramostim|mesh-list
83741649|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
83741650|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741651|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741652|NCT02019524|Hematinics|hematinics|mesh-ancestor
83741653|NCT02019524|Vitamins|vitamins|mesh-ancestor
83741654|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
83741655|NCT02019784|Rifaximin|rifaximin|mesh-list
83741656|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83741657|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741658|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741659|NCT02019797|Desflurane|desflurane|mesh-list
83741660|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83741661|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
83741662|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
83741663|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741664|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741665|NCT02019810|Dobutamine|dobutamine|mesh-list
83741666|NCT02019810|Norepinephrine|norepinephrine|mesh-list
83741667|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83741668|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83741669|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
83741670|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741671|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741672|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741673|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
83741674|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
83741675|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741676|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83741677|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83741678|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83741679|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83741680|NCT02019810|Protective Agents|protective agents|mesh-ancestor
83741681|NCT02019836|Vitamin D|vitamin d|mesh-list
83741682|NCT02019836|Vitamins|vitamins|mesh-ancestor
83741683|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
83741684|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741685|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83741686|NCT02020005|Nicotine|nicotine|mesh-list
83741687|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83741688|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
83741689|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741690|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741691|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83741692|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83741693|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
83741694|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741695|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741696|NCT02020122|Pregabalin|pregabalin|mesh-list
83741697|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83741698|NCT02020122|Analgesics|analgesics|mesh-ancestor
83741699|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
83741700|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741701|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741702|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
83741703|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83741704|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741705|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741706|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83741707|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83741708|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83741709|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741710|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83741711|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83741712|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83741713|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502467|NCT01355588|Ketorolac|ketorolac|mesh-list
83741714|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
83741715|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
83741716|NCT02020161|Methotrexate|methotrexate|mesh-list
83741717|NCT02020161|Idarubicin|idarubicin|mesh-list
83741718|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83741719|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
83741720|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83741721|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741722|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741723|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
83741724|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741725|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741726|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
83741727|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741728|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83741729|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741730|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
83741731|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83741732|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83741733|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83741734|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83741735|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83741736|NCT02020200|Methylphenidate|methylphenidate|mesh-list
83741737|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83741738|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741739|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83741740|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83741741|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741742|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741743|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
83741744|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741745|NCT02020213|Posaconazole|posaconazole|mesh-list
83741746|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
83741747|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741748|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83741749|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83741750|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83741751|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83741752|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83741753|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741754|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741755|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83741756|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
83741757|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83741758|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741759|NCT02020330|Lumefantrine|lumefantrine|mesh-list
83741760|NCT02020330|Artemether|artemether|mesh-list
83741761|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83741762|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
83741763|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83741764|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83741765|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741766|NCT02020499|Lanreotide|lanreotide|mesh-list
83741767|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741768|NCT02020551|Lidocaine|lidocaine|mesh-list
83741769|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
83741770|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
83741771|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741772|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741773|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
83741774|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741775|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83741776|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83741777|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83741778|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741779|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741780|NCT02020603|Epinephrine|epinephrine|mesh-list
83741781|NCT02020603|Racepinephrine|racepinephrine|mesh-list
83741782|NCT02020603|Hemostatics|hemostatics|mesh-list
83741783|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
83741784|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83741785|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83741786|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
83741787|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741788|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741789|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741790|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83741791|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83741792|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
83741793|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741794|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83741795|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
83741796|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
83741797|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
83741798|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83741799|NCT02020603|Coagulants|coagulants|mesh-ancestor
83741800|NCT02020629|Lixisenatide|lixisenatide|mesh-list
83741801|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83741802|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741803|NCT02020681|Fluorides|fluorides|mesh-list
83741804|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
83741805|NCT02020681|Protective Agents|protective agents|mesh-ancestor
83741806|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741807|NCT02018796|Misoprostol|misoprostol|mesh-list
83741808|NCT02018796|Mifepristone|mifepristone|mesh-list
83741809|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83741810|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
83741811|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83741812|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741813|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83741814|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741815|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
83741816|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83741817|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83741818|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83741819|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83741820|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
83741821|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83741822|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83741823|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
83741824|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83741825|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
83741826|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83741827|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83741828|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83741829|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83741830|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
83741831|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83741832|NCT02021097|Estradiol|estradiol|mesh-list
83741833|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83741834|NCT02021097|Estrogens|estrogens|mesh-ancestor
83741835|NCT02021097|Hormones|hormones|mesh-ancestor
83741836|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83741837|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741838|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83741839|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
83741840|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83741841|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83741842|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83741843|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83741844|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83741845|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83741846|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83741847|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741848|NCT02021123|Anidulafungin|anidulafungin|mesh-list
83741849|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
83741850|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83741851|NCT02021201|Risperidone|risperidone|mesh-list
83741852|NCT02021201|Sertindole|sertindole|mesh-list
83741853|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83741854|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
83741855|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741856|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741857|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741858|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83741859|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83741860|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741861|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83741862|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82896965|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
83741863|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
82896966|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741864|NCT02021214|Methylphenidate|methylphenidate|mesh-list
83741865|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83741866|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741867|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83741868|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83741869|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741870|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741872|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741873|NCT02021240|Dexamethasone|dexamethasone|mesh-list
83741874|NCT02021240|Ketamine|ketamine|mesh-list
83741875|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83741876|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
83741877|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
83741878|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741879|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741880|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741881|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
83741882|NCT02021240|Hormones|hormones|mesh-ancestor
83741883|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83741884|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83741885|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741886|NCT02021240|Analgesics|analgesics|mesh-ancestor
83741887|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
83741888|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83741889|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83741890|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
83741891|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
83741892|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83741893|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83741894|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83741895|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741896|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741897|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
83741898|NCT02021409|Hematinics|hematinics|mesh-ancestor
83741899|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
83741900|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83741901|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83741902|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83741903|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83741904|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741905|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
83741906|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741907|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741908|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83741909|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741910|NCT02021422|Fluorouracil|fluorouracil|mesh-list
83741911|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
83741912|NCT02021422|Irinotecan|irinotecan|mesh-list
83741913|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83741914|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
83741915|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741916|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83741917|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741918|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83741919|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
83741920|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741921|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83741922|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83741923|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741924|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83741925|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83741926|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741927|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
83741928|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83741929|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741930|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
83741931|NCT02021825|Analgesics|analgesics|mesh-ancestor
83741932|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
83741933|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741934|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741935|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741936|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82897039|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741937|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83741938|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741939|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741941|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
83741942|NCT02021851|Ondansetron|ondansetron|mesh-list
83741943|NCT02021851|Aprepitant|aprepitant|mesh-list
83741944|NCT02021851|BB 1101|bb 1101|mesh-list
83741945|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83741946|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
83741947|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
83741948|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83741949|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741950|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741951|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
83741952|NCT02021851|Hormones|hormones|mesh-ancestor
83741953|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83741954|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83741955|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741956|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
83741957|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83741958|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741959|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
83741960|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83741961|NCT02021851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83741962|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83741963|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
83741964|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83741965|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83741966|NCT02021864|Vitamin D|vitamin d|mesh-list
83741967|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
83741968|NCT02021864|Vitamins|vitamins|mesh-ancestor
83741969|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
83741970|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741971|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83741972|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83741973|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83741974|NCT02022163|Vaccines|vaccines|mesh-list
83741975|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
83741976|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741977|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83741978|NCT02022163|Antacids|antacids|mesh-ancestor
83741979|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83741980|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83741981|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83741982|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83741983|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
83741984|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83741985|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
83741986|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83741987|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741988|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83741989|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83741990|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83741991|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83741992|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
83741993|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83741994|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
83741995|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83741996|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83741997|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83741998|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83741999|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742000|NCT02022254|Metformin|metformin|mesh-list
83742001|NCT02022254|Warfarin|warfarin|mesh-list
83742002|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83742003|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742004|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
83742005|NCT02022293|Atorvastatin|atorvastatin|mesh-list
83742006|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83742007|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83742008|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
83742009|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742010|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83742011|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83742012|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742013|NCT02022358|Leucovorin|leucovorin|mesh-list
83742014|NCT02022358|Folic Acid|folic acid|mesh-list
83742015|NCT02022358|Methotrexate|methotrexate|mesh-list
83742016|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
83742017|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83742018|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
83742019|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83742020|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742021|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742022|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
83742023|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742024|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742025|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83742026|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742027|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83742028|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742029|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
83742030|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742031|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83742032|NCT02022358|Antidotes|antidotes|mesh-ancestor
83742033|NCT02022358|Protective Agents|protective agents|mesh-ancestor
83742034|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
83742035|NCT02022358|Vitamins|vitamins|mesh-ancestor
83742036|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
83742037|NCT02022358|Hematinics|hematinics|mesh-ancestor
83742038|NCT02022475|Vitamin D|vitamin d|mesh-list
83742039|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
83742040|NCT02022475|Vitamins|vitamins|mesh-ancestor
83742041|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
83742042|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742043|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83742044|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83742045|NCT02022488|Midazolam|midazolam|mesh-list
83742046|NCT02022488|Ketamine|ketamine|mesh-list
83742047|NCT02022488|Alfentanil|alfentanil|mesh-list
83742048|NCT02022488|Analgesics|analgesics|mesh-ancestor
83742049|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
83742050|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742051|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742052|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83742053|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83742054|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
83742055|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
83742056|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742057|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83742058|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83742059|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742060|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742061|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83742062|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83742063|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83742064|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83742065|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83742066|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
83742067|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
83742068|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83742069|NCT02022488|Narcotics|narcotics|mesh-ancestor
83742070|NCT02022527|Aspirin|aspirin|mesh-list
83742071|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
83742072|NCT02022527|Salicylates|salicylates|mesh-list
83742073|NCT02022527|Warfarin|warfarin|mesh-list
83742074|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83742075|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82897190|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83742076|NCT02022527|Analgesics|analgesics|mesh-ancestor
83742077|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
82897191|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82897192|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
82897193|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82897194|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897195|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82897196|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82897197|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82897198|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897201|NCT03077698|Hormones|hormones|mesh-ancestor
83742078|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742079|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742080|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742081|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742082|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83742083|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83742084|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742085|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83742086|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83742087|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742089|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
83742090|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742091|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
83742092|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
83742093|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
83742094|NCT02022540|Ranibizumab|ranibizumab|mesh-list
83742095|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83742096|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83742097|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83742098|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83742099|NCT02022540|Growth Substances|growth substances|mesh-ancestor
83742100|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742101|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
83742102|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742103|NCT02022722|Triamcinolone|triamcinolone|mesh-list
83742104|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83742105|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83742106|NCT02022722|Bupivacaine|bupivacaine|mesh-list
83742107|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83742108|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
83742109|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
83742110|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742111|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742112|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
83742113|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742114|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742115|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
83742116|NCT02022722|Hormones|hormones|mesh-ancestor
83742117|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742118|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742119|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
83742120|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742121|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742122|NCT02022761|Laninamivir|laninamivir|mesh-list
83742123|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
83742124|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742125|NCT02022852|Capecitabine|capecitabine|mesh-list
83742126|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742127|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
83742128|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742129|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742130|NCT02022917|Bevacizumab|bevacizumab|mesh-list
83742131|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83742132|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742133|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83742134|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83742135|NCT02022917|Growth Substances|growth substances|mesh-ancestor
83742136|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742137|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
83742138|NCT02022930|Triamcinolone|triamcinolone|mesh-list
83742139|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83742140|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83742141|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83742142|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742143|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
83742144|NCT02022930|Hormones|hormones|mesh-ancestor
83742145|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742146|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742147|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742148|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
83742149|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742150|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742151|NCT02023021|Paclitaxel|paclitaxel|mesh-list
82897265|NCT05764018|Caffeine|caffeine|mesh-list
83742152|NCT02023021|Gemcitabine|gemcitabine|mesh-list
83742153|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83742154|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742155|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83742156|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83742157|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83742158|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742159|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742160|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
83742161|NCT02023047|Nifedipine|nifedipine|mesh-list
83742162|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83742163|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742164|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742165|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83742166|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742167|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742168|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
83742169|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83742170|NCT02023086|Tropicamide|tropicamide|mesh-list
83742171|NCT02023086|Mydriatics|mydriatics|mesh-list
83742172|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
83742173|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742174|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742175|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83742176|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83742177|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
83742178|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742179|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742180|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
83742181|NCT02023164|Promethazine|promethazine|mesh-list
83742182|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83742183|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83742184|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742185|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742186|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
83742187|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
83742188|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
83742189|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742190|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
83742191|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
83742192|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83742193|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83742194|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
83742195|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
83742196|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742197|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742198|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83742199|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
83742200|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
83742201|NCT02023359|Everolimus|everolimus|mesh-list
83742202|NCT02023359|Exemestane|exemestane|mesh-list
83742203|NCT02023359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83742204|NCT02023359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83742205|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742206|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742207|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742208|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
83742209|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742210|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742211|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83742212|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83742213|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83742214|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
83742215|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742216|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
83742217|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
83742218|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83742219|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
83742220|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742221|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742222|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742223|NCT02023450|Ritonavir|ritonavir|mesh-list
83742224|NCT02023450|Saquinavir|saquinavir|mesh-list
83742225|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82897337|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
83742226|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83742227|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
83742228|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742229|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742230|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83742231|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83742232|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
83742233|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742234|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83742235|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83742236|NCT02023554|Azithromycin|azithromycin|mesh-list
83742237|NCT02023554|Theophylline|theophylline|mesh-list
83742238|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742239|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742240|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83742241|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
83742242|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742243|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742244|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83742245|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
83742246|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83742247|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742248|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742249|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742250|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83742251|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83742252|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
83742253|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742254|NCT02023567|Serotonin|serotonin|mesh-list
83742255|NCT02023567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83742256|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83742257|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
83742258|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742259|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742260|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742261|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83742262|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742263|NCT02023684|Lidocaine|lidocaine|mesh-list
83742264|NCT02023684|Ropivacaine|ropivacaine|mesh-list
83742265|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
83742266|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
83742267|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742268|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742269|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
83742270|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742271|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83742272|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83742273|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83742274|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742275|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742276|NCT02023710|Paclitaxel|paclitaxel|mesh-list
83742277|NCT02023710|Bevacizumab|bevacizumab|mesh-list
83742278|NCT02023710|Carboplatin|carboplatin|mesh-list
83742279|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83742280|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742281|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
83742282|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
83742283|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
83742284|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742285|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83742286|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83742287|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83742288|NCT02023710|Growth Substances|growth substances|mesh-ancestor
83742289|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742290|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
83742291|NCT02023840|Metronidazole|metronidazole|mesh-list
83742292|NCT02023840|Erythritol|erythritol|mesh-list
83742293|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742294|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742295|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83742296|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83742297|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742298|NCT02023853|Metronidazole|metronidazole|mesh-list
83742299|NCT02023853|Erythritol|erythritol|mesh-list
83742300|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897414|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82897416|NCT01307592|Growth Substances|growth substances|mesh-ancestor
83742301|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742302|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83742303|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83742304|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742306|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83742307|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83742308|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
83742309|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742310|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83742311|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83742312|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742313|NCT02023931|Sulforaphane|sulforaphane|mesh-list
83742314|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83742315|NCT02023931|Protective Agents|protective agents|mesh-ancestor
83742316|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742317|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742318|NCT02024009|Nelfinavir|nelfinavir|mesh-list
83742319|NCT02024009|Paclitaxel|paclitaxel|mesh-list
83742320|NCT02024009|Gemcitabine|gemcitabine|mesh-list
83742321|NCT02024009|Capecitabine|capecitabine|mesh-list
83742322|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83742323|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742324|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83742325|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83742326|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83742327|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742328|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742329|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
83742330|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83742331|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83742332|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
83742333|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742334|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83742335|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83742336|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
83742337|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742338|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
83742339|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
83742340|NCT02024022|Cathartics|cathartics|mesh-ancestor
83742341|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83742342|NCT02024152|Cetirizine|cetirizine|mesh-list
83742343|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83742344|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83742345|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83742346|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
83742347|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
83742348|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742349|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742350|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742351|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
83742352|NCT02024217|Tegafur|tegafur|mesh-list
83742353|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742354|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742355|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
83742356|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742357|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
83742358|NCT02024256|Analgesics|analgesics|mesh-ancestor
83742359|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
83742360|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742361|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742362|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
83742363|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742364|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83742365|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
83742366|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83742367|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742368|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742369|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83742370|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
83742371|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83742372|NCT02024295|Choline|choline|mesh-list
83742373|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
82897498|NCT03781674|Progesterone|progesterone|mesh-list
83742374|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
83742375|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83742376|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
83742377|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742378|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83742379|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83742380|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
83742381|NCT02024308|Cytarabine|cytarabine|mesh-list
83742382|NCT02024308|Fludarabine|fludarabine|mesh-list
83742383|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742384|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742385|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
83742386|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742387|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742388|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
83742389|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742390|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
83742391|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742392|NCT02024334|Leflunomide|leflunomide|mesh-list
83742393|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742394|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742395|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742396|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
83742397|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742398|NCT02024373|Atorvastatin|atorvastatin|mesh-list
83742399|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83742400|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83742401|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
83742402|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742403|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83742404|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83742405|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742406|NCT02024425|Antioxidants|antioxidants|mesh-list
83742407|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742408|NCT02024425|Protective Agents|protective agents|mesh-ancestor
83742409|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742410|NCT02024555|Azithromycin|azithromycin|mesh-list
83742411|NCT02024555|Levofloxacin|levofloxacin|mesh-list
83742412|NCT02024555|Rifampin|rifampin|mesh-list
83742413|NCT02024555|Ethambutol|ethambutol|mesh-list
83742414|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742415|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742416|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83742417|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83742418|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83742419|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742420|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742421|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742422|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83742423|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83742424|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83742425|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
83742426|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
83742427|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83742428|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83742429|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83742430|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83742431|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83742432|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83742433|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83742434|NCT02024568|Pregabalin|pregabalin|mesh-list
83742435|NCT02024568|Analgesics|analgesics|mesh-ancestor
83742436|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
83742437|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742438|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742439|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
83742440|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83742441|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742442|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742443|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83742444|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83742445|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83742446|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742447|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83742448|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
83742449|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83742450|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
83742451|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
83742452|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742453|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742454|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83742455|NCT02024594|Analgesics|analgesics|mesh-ancestor
83742456|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
83742457|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742458|NCT02024633|Gemcitabine|gemcitabine|mesh-list
83742459|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742460|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
83742461|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742462|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742463|NCT02024659|Budesonide|budesonide|mesh-list
83742464|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742465|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83742466|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
83742467|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742468|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742469|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83742470|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
83742471|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
83742472|NCT02024659|Hormones|hormones|mesh-ancestor
83742473|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742474|NCT02024841|Docetaxel|docetaxel|mesh-list
83742475|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742476|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
83742477|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
83742478|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
83742479|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742480|NCT02024906|Caseins|caseins|mesh-list
83742481|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
83742482|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
83742483|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742484|NCT02024919|Diltiazem|diltiazem|mesh-list
83742485|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83742486|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83742487|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742488|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742489|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83742490|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742491|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742492|NCT02024945|Propiverine|propiverine|mesh-list
83742493|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
83742494|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
83742495|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742496|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742497|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83742498|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83742499|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
83742500|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742501|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742502|NCT02024945|Urological Agents|urological agents|mesh-ancestor
83742503|NCT02024984|Clomiphene|clomiphene|mesh-list
83742504|NCT02024984|Enclomiphene|enclomiphene|mesh-list
83742505|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
83742506|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83742507|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
83742508|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742509|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742510|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83742511|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
83742512|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83742513|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83742514|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83742515|NCT02025023|Triamcinolone|triamcinolone|mesh-list
83742516|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83742517|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83742518|NCT02025023|Fluorouracil|fluorouracil|mesh-list
83742519|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83742520|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
83742521|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897639|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83742523|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742524|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742525|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
83742526|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742527|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742528|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
83742529|NCT02025023|Hormones|hormones|mesh-ancestor
83742530|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742531|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742532|NCT02025140|Anesthetics|anesthetics|mesh-list
83742533|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742534|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742535|NCT02025166|Acetaminophen|acetaminophen|mesh-list
83742536|NCT02025166|Lornoxicam|lornoxicam|mesh-list
83742537|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83742538|NCT02025166|Analgesics|analgesics|mesh-ancestor
83742539|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
83742540|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742541|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742542|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
83742543|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83742544|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742545|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742546|NCT02025192|Capecitabine|capecitabine|mesh-list
83742547|NCT02025192|Trastuzumab|trastuzumab|mesh-list
83742548|NCT02025192|Tucatinib|tucatinib|mesh-list
83742549|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742550|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
83742551|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742552|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742553|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83742554|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83742555|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742556|NCT02025218|Gefitinib|gefitinib|mesh-list
83742557|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742558|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83742559|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742560|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742561|NCT02025348|Metoprolol|metoprolol|mesh-list
83742562|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83742563|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83742564|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
83742565|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
83742566|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742567|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742568|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83742569|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83742570|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83742571|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
83742572|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742573|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742574|NCT02025361|Lidocaine|lidocaine|mesh-list
83742575|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
83742576|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
83742577|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742578|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742579|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
83742580|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742581|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83742582|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83742583|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83742584|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742585|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742586|NCT02025374|Bupivacaine|bupivacaine|mesh-list
83742587|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
83742588|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
83742589|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
82897715|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897716|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
82897717|NCT01019356|Acarbose|acarbose|mesh-list
82897718|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82897719|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897721|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742590|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742591|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742592|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
83742593|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742594|NCT02025465|Metoprolol|metoprolol|mesh-list
83742595|NCT02025465|Diltiazem|diltiazem|mesh-list
83742596|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83742597|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83742598|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
83742599|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
83742600|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742601|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742602|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83742603|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83742604|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83742605|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
83742606|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742607|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742608|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83742609|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83742610|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83742611|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742612|NCT02025491|Amphotericin B|amphotericin b|mesh-list
83742613|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83742614|NCT02025491|Amebicides|amebicides|mesh-ancestor
83742615|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83742616|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83742617|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742618|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742619|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
83742620|NCT02025608|Pramipexole|pramipexole|mesh-list
83742621|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
83742622|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742623|NCT02025608|Protective Agents|protective agents|mesh-ancestor
83742624|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742625|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83742626|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83742627|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
83742628|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
83742629|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742630|NCT02025712|Everolimus|everolimus|mesh-list
83742631|NCT02025712|Exemestane|exemestane|mesh-list
83742632|NCT02025712|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83742633|NCT02025712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83742634|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742635|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742636|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742637|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
83742638|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742639|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742640|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83742641|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83742642|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83742643|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
83742644|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742645|NCT02025803|Capecitabine|capecitabine|mesh-list
83742646|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742647|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
83742648|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742649|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742650|NCT02025855|Methadone|methadone|mesh-list
83742651|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83742652|NCT02025855|Narcotics|narcotics|mesh-ancestor
83742653|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83742654|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742655|NCT02025855|Analgesics|analgesics|mesh-ancestor
83742656|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
83742657|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742658|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
83742659|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
83742660|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
83742661|NCT02025868|Darunavir|darunavir|mesh-list
83742662|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83742663|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83742664|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
82897783|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
83742665|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742666|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83742667|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83742668|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742669|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742670|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83742671|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83742672|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
83742673|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
83742674|NCT02025881|Thiotepa|thiotepa|mesh-list
83742675|NCT02025881|Carboplatin|carboplatin|mesh-list
83742676|NCT02025881|Etoposide|etoposide|mesh-list
83742677|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742678|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
83742679|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742680|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742681|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83742682|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
83742683|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742684|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742685|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83742686|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83742687|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83742688|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83742689|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742690|NCT02025998|Ibudilast|ibudilast|mesh-list
83742691|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83742692|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
83742693|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742694|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742695|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83742696|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
83742697|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83742698|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742699|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742700|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83742701|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742702|NCT02026050|Dexamethasone|dexamethasone|mesh-list
83742703|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
83742704|NCT02026050|BB 1101|bb 1101|mesh-list
83742705|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742706|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
83742707|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
83742708|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742709|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742710|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83742711|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
83742712|NCT02026050|Hormones|hormones|mesh-ancestor
83742713|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742714|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83742715|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742716|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
83742717|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742718|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742719|NCT02026219|Clopidogrel|clopidogrel|mesh-list
83742720|NCT02026219|Ticagrelor|ticagrelor|mesh-list
83742721|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83742722|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83742723|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83742724|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83742725|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
83742726|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742727|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742728|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742729|NCT02026310|Metformin|metformin|mesh-list
83742730|NCT02026310|Glimepiride|glimepiride|mesh-list
83742731|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83742732|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742733|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83742734|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742735|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
83742736|NCT02026479|Dexamethasone|dexamethasone|mesh-list
83742737|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
83742738|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82897863|NCT03779100|Lenvatinib|lenvatinib|mesh-list
83742739|NCT02026479|BB 1101|bb 1101|mesh-list
83742740|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742741|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
83742742|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
83742743|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742744|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742745|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83742746|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
83742747|NCT02026479|Hormones|hormones|mesh-ancestor
83742748|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742749|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83742750|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742751|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
83742752|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742753|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742754|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
83742755|NCT02026492|Miotics|miotics|mesh-ancestor
83742756|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
83742757|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742758|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742759|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83742760|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83742761|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
83742762|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83742763|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83742764|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
83742765|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742766|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742767|NCT02026505|Bortezomib|bortezomib|mesh-list
83742768|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742769|NCT02026518|Vitamin D|vitamin d|mesh-list
83742770|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
83742771|NCT02026518|Vitamins|vitamins|mesh-ancestor
83742772|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
83742773|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742774|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83742775|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83742776|NCT02026583|Simvastatin|simvastatin|mesh-list
83742777|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83742778|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83742779|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
83742780|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742781|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83742782|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83742783|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742784|NCT02026765|Heparin|heparin|mesh-list
83742785|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
83742786|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83742787|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83742788|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742789|NCT02026778|Betahistine|betahistine|mesh-list
83742790|NCT02026778|Ondansetron|ondansetron|mesh-list
83742791|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
83742792|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
83742793|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742794|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742795|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83742796|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
83742797|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
83742798|NCT02026778|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83742799|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83742800|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
83742801|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83742802|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742803|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
83742804|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
83742805|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
83742806|NCT02026817|Metformin|metformin|mesh-list
83742807|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83742808|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83742809|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742810|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83742811|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83742812|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
83742813|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897946|NCT05697328|Ephedrine|ephedrine|mesh-list
83742815|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83742816|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742817|NCT02026856|Selenious Acid|selenious acid|mesh-list
83742818|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
83742819|NCT02026856|Trace Elements|trace elements|mesh-ancestor
83742820|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
83742821|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742822|NCT02026869|Metformin|metformin|mesh-list
83742823|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83742824|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742825|NCT02026921|Carboplatin|carboplatin|mesh-list
83742826|NCT02026921|Docetaxel|docetaxel|mesh-list
83742827|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742828|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83742829|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83742830|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83742831|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742832|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
83742833|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
83742834|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742835|NCT02026973|Fulvestrant|fulvestrant|mesh-list
83742836|NCT02026973|Anastrozole|anastrozole|mesh-list
83742837|NCT02026973|Somatostatin|somatostatin|mesh-list
83742838|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83742839|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742840|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83742841|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83742842|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
83742843|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742844|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742845|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83742846|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83742847|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742848|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742849|NCT02026973|Hormones|hormones|mesh-ancestor
83742850|NCT02027064|Interferons|interferons|mesh-list
83742851|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
83742852|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742853|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
83742854|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742855|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
83742856|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742857|NCT02027103|Metformin|metformin|mesh-list
83742858|NCT02027103|Pioglitazone|pioglitazone|mesh-list
83742859|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83742860|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742861|NCT02027220|Dexamethasone|dexamethasone|mesh-list
83742862|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
83742863|NCT02027220|Bortezomib|bortezomib|mesh-list
83742864|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742865|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
83742866|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742867|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742868|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83742869|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
82898011|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
82898012|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898013|NCT03438526|Protective Agents|protective agents|mesh-ancestor
82898014|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898015|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898016|NCT02575144|Clarithromycin|clarithromycin|mesh-list
82898017|NCT02575144|Dexamethasone|dexamethasone|mesh-list
82898018|NCT02575144|Lenalidomide|lenalidomide|mesh-list
82898019|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898020|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
82898021|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
82898022|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898023|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898024|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82898025|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
82898026|NCT02575144|Hormones|hormones|mesh-ancestor
82898027|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898028|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82898029|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898062|NCT03768882|Acetaminophen|acetaminophen|mesh-list
83742870|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742871|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742872|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83742873|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742874|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
83742875|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
83742876|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742877|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83742878|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
83742879|NCT02027220|Hormones|hormones|mesh-ancestor
83742880|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742881|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83742882|NCT02027298|Abatacept|abatacept|mesh-list
83742883|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83742884|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742885|NCT02027298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83742886|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742887|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742888|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
83742889|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742890|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742891|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
83742892|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
83742893|NCT02027324|Povidone|povidone|mesh-list
83742894|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83742895|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742896|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
83742897|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
83742898|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
83742899|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
83742900|NCT02027337|Drospirenone|drospirenone|mesh-list
83742901|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83742902|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83742903|NCT02027337|Cyproterone|cyproterone|mesh-list
83742904|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83742905|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83742906|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83742907|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83742908|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
83742909|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83742910|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742911|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83742912|NCT02027337|Estrogens|estrogens|mesh-ancestor
83742913|NCT02027337|Hormones|hormones|mesh-ancestor
83742914|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83742915|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83742916|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
83742917|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83742918|NCT02027337|Diuretics|diuretics|mesh-ancestor
83742919|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
83742920|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
83742921|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742922|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83742923|NCT02027363|Capecitabine|capecitabine|mesh-list
83742924|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83742925|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
83742926|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742927|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742928|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
83742929|NCT02027454|Cabotegravir|cabotegravir|mesh-list
83742930|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742931|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742932|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83742933|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83742934|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742935|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742936|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742937|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83742938|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83742939|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83742940|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83742941|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
83742942|NCT02027493|Interferons|interferons|mesh-list
83742943|NCT02027493|Ribavirin|ribavirin|mesh-list
82898088|NCT03771846|Leucovorin|leucovorin|mesh-list
83742945|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
83742946|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83742947|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742948|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
83742949|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742950|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
83742951|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742952|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
83742953|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742954|NCT02027532|Vancomycin|vancomycin|mesh-list
83742955|NCT02027532|Cefazolin|cefazolin|mesh-list
83742956|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742957|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742958|NCT02027675|Micronutrients|micronutrients|mesh-list
83742959|NCT02027675|Trace Elements|trace elements|mesh-list
83742960|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742961|NCT02027753|Metformin|metformin|mesh-list
83742962|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
83742963|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83742964|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83742965|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742966|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
83742967|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742968|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742969|NCT02027792|Diclofenac|diclofenac|mesh-list
83742970|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83742971|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83742972|NCT02027792|Analgesics|analgesics|mesh-ancestor
83742973|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
83742974|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83742975|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742976|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83742977|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83742978|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83742979|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83742980|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83742981|NCT02027870|Sirolimus|sirolimus|mesh-list
83742982|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83742983|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83742984|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83742985|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742986|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
83742987|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83742988|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
83742989|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742990|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
83742991|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
83742992|NCT02027922|Protective Agents|protective agents|mesh-ancestor
83742993|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83742994|NCT02027961|Durvalumab|durvalumab|mesh-list
83742995|NCT02027961|Trametinib|trametinib|mesh-list
83742996|NCT02027961|Dabrafenib|dabrafenib|mesh-list
83742997|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83742998|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83742999|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83743000|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743001|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743002|NCT02027987|Valproic Acid|valproic acid|mesh-list
83743003|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
83743004|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743005|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743006|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
83743007|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743008|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743009|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
83743010|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83743011|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743012|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743013|NCT02028026|Citalopram|citalopram|mesh-list
83743014|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83743015|NCT02028026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83743016|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83743017|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898163|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743018|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743019|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743020|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
83743021|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743022|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83743023|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
83743024|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743025|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83743026|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83743027|NCT02028078|Insulin|insulin|mesh-list
83743028|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83743029|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743030|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743031|NCT02028234|Omeprazole|omeprazole|mesh-list
83743032|NCT02028234|Pantoprazole|pantoprazole|mesh-list
83743033|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83743034|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743035|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83743036|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743037|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743038|NCT02028260|Modafinil|modafinil|mesh-list
83743039|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83743040|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743041|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83743042|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83743043|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83743044|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743045|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83743046|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83743047|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
83743048|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83743049|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83743050|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83743051|NCT02028403|BMS-936559|bms-936559|mesh-list
83743052|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83743053|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83743054|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743055|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
83743056|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743057|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
83743058|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
83743059|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743060|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743061|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
83743062|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
83743063|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83743064|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83743065|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743066|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743067|NCT02028429|Urological Agents|urological agents|mesh-ancestor
83743068|NCT02028494|Capecitabine|capecitabine|mesh-list
83743069|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743070|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
83743071|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743072|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743073|NCT02028507|Capecitabine|capecitabine|mesh-list
83743074|NCT02028507|Fulvestrant|fulvestrant|mesh-list
83743075|NCT02028507|Palbociclib|palbociclib|mesh-list
83743076|NCT02028507|Exemestane|exemestane|mesh-list
83743077|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743078|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
83743079|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743080|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743081|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83743082|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83743083|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83743084|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83743085|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743086|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743087|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83743088|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743089|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83743090|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83743091|NCT02028533|Oxytocin|oxytocin|mesh-list
83743093|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83743094|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743095|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
83743096|NCT02028598|Clomipramine|clomipramine|mesh-list
83743097|NCT02028598|Citric Acid|citric acid|mesh-list
83743098|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
83743099|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
83743100|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83743101|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
83743102|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
83743103|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743104|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
83743105|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83743106|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83743107|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743108|NCT02028598|Urological Agents|urological agents|mesh-ancestor
83743109|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83743110|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
83743111|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743112|NCT02028598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83743113|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83743114|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83743115|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743116|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
83743117|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743118|NCT02028663|Esomeprazole|esomeprazole|mesh-list
83743119|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83743120|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743121|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83743122|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743123|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743124|NCT02028689|Metformin|metformin|mesh-list
83743125|NCT02028689|Lesinurad|lesinurad|mesh-list
83743126|NCT02028689|Furosemide|furosemide|mesh-list
83743127|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743128|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743129|NCT02028689|Diuretics|diuretics|mesh-ancestor
83743130|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
83743131|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83743132|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83743133|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743134|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
83743135|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83743136|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
83743137|NCT02028819|Dolutegravir|dolutegravir|mesh-list
83743138|NCT02028819|Ibalizumab|ibalizumab|mesh-list
83743139|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83743140|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83743141|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743142|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743143|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83743144|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83743145|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
83743146|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743147|NCT02028910|Ondansetron|ondansetron|mesh-list
83743148|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
83743149|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
83743150|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743151|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743152|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743153|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
83743154|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83743155|NCT02028910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83743156|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83743157|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
83743158|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743159|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743160|NCT02028923|Morphine|morphine|mesh-list
83743161|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83743162|NCT02028923|Narcotics|narcotics|mesh-ancestor
83743163|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743164|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898313|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
83743165|NCT02028923|Analgesics|analgesics|mesh-ancestor
83743166|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
83743167|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743168|NCT02028949|Idarubicin|idarubicin|mesh-list
83743169|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83743170|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743171|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83743172|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83743173|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743174|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743175|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
83743176|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83743177|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
83743178|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743179|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
83743180|NCT02029105|Protective Agents|protective agents|mesh-ancestor
83743181|NCT02029118|Aspirin|aspirin|mesh-list
83743182|NCT02029118|Metoprolol|metoprolol|mesh-list
83743183|NCT02029118|Ramipril|ramipril|mesh-list
83743184|NCT02029118|Atorvastatin|atorvastatin|mesh-list
83743185|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83743186|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83743187|NCT02029118|Analgesics|analgesics|mesh-ancestor
83743188|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
83743189|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743190|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743191|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83743192|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83743193|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83743194|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83743195|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743196|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83743197|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83743198|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743199|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
83743200|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83743201|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83743202|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
83743203|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83743204|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83743205|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83743206|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83743207|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
83743208|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
83743209|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83743210|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83743211|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83743212|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
83743213|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743214|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83743215|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
83743216|NCT02029313|Montelukast|montelukast|mesh-list
83743217|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83743218|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
83743219|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83743220|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
83743221|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743222|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743223|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83743224|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83743225|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743226|NCT02029378|Eculizumab|eculizumab|mesh-list
83743227|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83743228|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743229|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
83743230|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743231|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83743232|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83743233|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83743234|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743235|NCT02029482|Ponesimod|ponesimod|mesh-list
83743236|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83743237|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743238|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743239|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
83743240|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743242|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83743243|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83743244|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
83743245|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743246|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83743247|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83743248|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743249|NCT02029573|Temozolomide|temozolomide|mesh-list
83743250|NCT02029573|Atorvastatin|atorvastatin|mesh-list
83743251|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83743252|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83743253|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
83743254|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743255|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83743256|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83743257|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743258|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83743259|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
83743260|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743261|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
83743262|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743263|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83743264|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83743265|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743266|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743267|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
83743268|NCT02029599|Acetaminophen|acetaminophen|mesh-list
83743269|NCT02029599|Methotrexate|methotrexate|mesh-list
83743270|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83743271|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
83743272|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83743273|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743274|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743275|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
83743276|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743277|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743278|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
83743279|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743280|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83743281|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743282|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
83743283|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83743284|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83743285|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83743286|NCT02029599|Analgesics|analgesics|mesh-ancestor
83743287|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
83743288|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743289|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
83743290|NCT02029612|Nicotine|nicotine|mesh-list
83743291|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83743292|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
83743293|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743294|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743295|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83743296|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83743297|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
83743298|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743299|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743300|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83743301|NCT02029625|Ezetimibe|ezetimibe|mesh-list
83743302|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83743303|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83743304|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
83743305|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743306|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83743307|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83743308|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743309|NCT02029794|Acetic Acid|acetic acid|mesh-list
83743310|NCT02029794|Retinol acetate|retinol acetate|mesh-list
83743311|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83743312|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898466|NCT01532310|Belimumab|belimumab|mesh-list
83743314|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
83743315|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743316|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83743317|NCT02029794|Protective Agents|protective agents|mesh-ancestor
83743318|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743319|NCT02029898|Remifentanil|remifentanil|mesh-list
83743320|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83743321|NCT02029898|Narcotics|narcotics|mesh-ancestor
83743322|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743323|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743324|NCT02029898|Analgesics|analgesics|mesh-ancestor
83743325|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
83743326|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743327|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
83743328|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743329|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743330|NCT02029937|Proflavine|proflavine|mesh-list
83743331|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83743332|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743333|NCT02029950|Cytarabine|cytarabine|mesh-list
83743334|NCT02029950|Etoposide|etoposide|mesh-list
83743335|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
83743336|NCT02029950|Daunorubicin|daunorubicin|mesh-list
83743337|NCT02029950|Idarubicin|idarubicin|mesh-list
83743338|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
83743339|NCT02029950|Pomalidomide|pomalidomide|mesh-list
83743340|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83743341|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743342|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83743343|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83743344|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743345|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743346|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743347|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
83743348|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
83743349|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743350|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743351|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
83743352|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743353|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83743354|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83743355|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83743356|NCT02029950|Growth Substances|growth substances|mesh-ancestor
83743357|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
83743358|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
83743359|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83743360|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
83743361|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
83743362|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
83743363|NCT02030561|Trastuzumab|trastuzumab|mesh-list
83743364|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83743365|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743366|NCT02031367|Triamcinolone|triamcinolone|mesh-list
83743367|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83743368|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83743369|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83743370|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83743371|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
83743372|NCT02031367|Hormones|hormones|mesh-ancestor
83743373|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743374|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743375|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743376|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
83743377|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743378|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743379|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
83743380|NCT02031692|Vitamin D|vitamin d|mesh-list
83743381|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
83743382|NCT02031692|Calcium|calcium|mesh-list
83743383|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83743384|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502556|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83743385|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83743386|NCT02031692|Vitamins|vitamins|mesh-ancestor
83743387|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
82898540|NCT05133804|Methylphenidate|methylphenidate|mesh-list
83743388|NCT02031692|Antacids|antacids|mesh-ancestor
83743389|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743390|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743391|NCT02031991|Bevacizumab|bevacizumab|mesh-list
83743392|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83743393|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743394|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83743395|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83743396|NCT02031991|Growth Substances|growth substances|mesh-ancestor
83743397|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743398|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
83743399|NCT02032043|Ivermectin|ivermectin|mesh-list
83743400|NCT02032043|Albendazole|albendazole|mesh-list
83743401|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83743402|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743403|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
83743404|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
83743405|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83743406|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83743407|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
83743408|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
83743409|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
83743410|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743411|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743412|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83743413|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83743414|NCT02032134|Protective Agents|protective agents|mesh-ancestor
83743415|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743416|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83743417|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
83743418|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743419|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
83743420|NCT02032186|Cathartics|cathartics|mesh-ancestor
83743421|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743422|NCT02033356|Lidocaine|lidocaine|mesh-list
83743423|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
83743424|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
83743425|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743426|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743427|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
83743428|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743429|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83743430|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83743431|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83743432|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83743433|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743434|NCT02033733|Cisatracurium|cisatracurium|mesh-list
83743435|NCT02033733|Atracurium|atracurium|mesh-list
83743436|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83743437|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83743438|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743439|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743440|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83743441|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83743442|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83743443|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
83743444|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743445|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743446|NCT02034253|Risperidone|risperidone|mesh-list
83743447|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83743448|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
83743449|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743450|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743451|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743452|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83743453|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83743454|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743455|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743456|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83743457|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
83743458|NCT02035020|Interferons|interferons|mesh-list
83743459|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
83743460|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743461|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
82898616|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83743462|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743463|NCT02035709|Hydromorphone|hydromorphone|mesh-list
83743464|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83743465|NCT02035709|Narcotics|narcotics|mesh-ancestor
83743466|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743467|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743468|NCT02035709|Analgesics|analgesics|mesh-ancestor
83743469|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
83743470|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743471|NCT02035891|Colchicine|colchicine|mesh-list
83743472|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
83743473|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83743474|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
83743475|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
83743476|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
83743477|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743478|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743479|NCT02035956|Vaccines|vaccines|mesh-list
83743480|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
83743481|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743482|NCT02036151|Fluorides|fluorides|mesh-list
83743483|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
83743484|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
83743485|NCT02036151|Protective Agents|protective agents|mesh-ancestor
83743486|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743487|NCT02036255|Taurolidine|taurolidine|mesh-list
83743488|NCT02036255|Heparin|heparin|mesh-list
83743489|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
83743490|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83743491|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83743492|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743493|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743494|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83743495|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743496|NCT02038062|Sevoflurane|sevoflurane|mesh-list
83743497|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83743498|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83743499|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
83743500|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
83743501|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743502|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743503|NCT02039453|Fentanyl|fentanyl|mesh-list
83743504|NCT02039453|Meperidine|meperidine|mesh-list
83743505|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83743506|NCT02039453|Narcotics|narcotics|mesh-ancestor
83743507|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743508|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743509|NCT02039453|Analgesics|analgesics|mesh-ancestor
83743510|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
83743511|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743512|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83743513|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83743514|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
83743515|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
83743516|NCT02039492|Spironolactone|spironolactone|mesh-list
83743517|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83743518|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
83743519|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743520|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743521|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83743522|NCT02039492|Diuretics|diuretics|mesh-ancestor
83743523|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
83743524|NCT02039869|Omeprazole|omeprazole|mesh-list
83743525|NCT02039869|Sucralfate|sucralfate|mesh-list
83743526|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83743527|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83743528|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743529|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743530|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743531|NCT02040064|Gefitinib|gefitinib|mesh-list
83743532|NCT02040064|Tremelimumab|tremelimumab|mesh-list
83743533|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743534|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83743535|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743536|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743537|NCT02040142|Mitomycins|mitomycins|mesh-list
83743538|NCT02040142|Mitomycin|mitomycin|mesh-list
83743539|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83743540|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743541|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
83743542|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743543|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83743544|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743545|NCT02040220|Aflibercept|aflibercept|mesh-list
83743546|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83743547|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83743548|NCT02040220|Growth Substances|growth substances|mesh-ancestor
83743549|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743550|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
83743551|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743552|NCT02040246|Metformin|metformin|mesh-list
83743553|NCT02040246|Repaglinide|repaglinide|mesh-list
83743554|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743555|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743556|NCT02040285|Metoclopramide|metoclopramide|mesh-list
83743557|NCT02040285|Bisacodyl|bisacodyl|mesh-list
83743558|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
83743559|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
83743560|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743561|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743562|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743563|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83743564|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83743565|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
83743566|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743567|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743568|NCT02040285|Cathartics|cathartics|mesh-ancestor
83743569|NCT02040285|Laxatives|laxatives|mesh-ancestor
83743570|NCT02040311|Topiramate|topiramate|mesh-list
83743571|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
83743572|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743573|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743574|NCT02040350|Pralidoxime|pralidoxime|mesh-list
83743575|NCT02040350|Antidotes|antidotes|mesh-ancestor
83743576|NCT02040350|Protective Agents|protective agents|mesh-ancestor
83743577|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743578|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
83743579|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
83743580|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743581|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
83743582|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743583|NCT02040402|Vaccines|vaccines|mesh-list
83743584|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
83743585|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743586|NCT02040415|Eperisone|eperisone|mesh-list
83743587|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
83743588|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83743589|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83743590|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743591|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83743592|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743593|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83743594|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83743595|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743596|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
83743597|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
83743598|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
83743599|NCT02040441|Spironolactone|spironolactone|mesh-list
83743600|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83743601|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
83743602|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743603|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743604|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83743605|NCT02040441|Diuretics|diuretics|mesh-ancestor
83743606|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
83743607|NCT02040454|Paclitaxel|paclitaxel|mesh-list
83743608|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83743609|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743610|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
83743611|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
83743612|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
83743613|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743614|NCT02040571|Insulin|insulin|mesh-list
83743615|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82898762|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
83743616|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743617|NCT02040597|Beclomethasone|beclomethasone|mesh-list
83743618|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
83743619|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
83743620|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83743621|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
83743622|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743623|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743624|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83743625|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83743626|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83743627|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83743628|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83743629|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
83743630|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743631|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743632|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83743633|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83743634|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83743635|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
83743636|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83743637|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
83743638|NCT02040597|Hormones|hormones|mesh-ancestor
83743639|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743640|NCT02040636|Vaccines|vaccines|mesh-list
83743641|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
83743642|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743643|NCT02040649|Midazolam|midazolam|mesh-list
83743644|NCT02040649|Propofol|propofol|mesh-list
83743645|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83743646|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743647|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743648|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83743649|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
83743650|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
83743651|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83743652|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83743653|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83743654|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743655|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
83743656|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
83743657|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743658|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743659|NCT02040662|Morphine|morphine|mesh-list
83743660|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83743661|NCT02040662|Narcotics|narcotics|mesh-ancestor
83743662|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743663|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743664|NCT02040662|Analgesics|analgesics|mesh-ancestor
83743665|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
83743666|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743667|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
83743668|NCT02040818|Tigecycline|tigecycline|mesh-list
83743669|NCT02040818|Heparin|heparin|mesh-list
83743670|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83743671|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
83743672|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83743673|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83743674|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743675|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
83743676|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743677|NCT02040818|Expectorants|expectorants|mesh-ancestor
83743678|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
83743679|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83743680|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
83743681|NCT02040818|Protective Agents|protective agents|mesh-ancestor
83743682|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743683|NCT02040818|Antidotes|antidotes|mesh-ancestor
83743684|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83743685|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83743686|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743687|NCT02040831|Vaccines|vaccines|mesh-list
83743688|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
82898838|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
83743689|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743690|NCT02040883|Olanzapine|olanzapine|mesh-list
82898839|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743691|NCT02040883|Risperidone|risperidone|mesh-list
83743693|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83743694|NCT02040883|Ziprasidone|ziprasidone|mesh-list
83743695|NCT02040883|Tandospirone|tandospirone|mesh-list
83743696|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83743697|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
83743698|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743699|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743700|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743701|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83743702|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83743703|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743704|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743705|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83743706|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
83743707|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
83743708|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
83743709|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743710|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743711|NCT02040883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83743712|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83743713|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83743714|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
83743715|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
83743716|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83743717|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83743718|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83743719|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83743720|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83743721|NCT02040909|Propofol|propofol|mesh-list
83743722|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83743723|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743724|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743725|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83743726|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
83743727|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
83743728|NCT02040935|Trastuzumab|trastuzumab|mesh-list
83743729|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83743730|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743731|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
83743732|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83743733|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743734|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83743735|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83743736|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743737|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743738|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743739|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83743740|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83743741|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83743742|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
83743743|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743744|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83743745|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83743746|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743747|NCT02041143|Caseins|caseins|mesh-list
83743748|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
83743749|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
83743750|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743751|NCT02041273|Palbociclib|palbociclib|mesh-list
83743752|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743753|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83743754|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743755|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743756|NCT02041338|Paclitaxel|paclitaxel|mesh-list
83743757|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83743758|NCT02041338|Carboplatin|carboplatin|mesh-list
83743759|NCT02041338|Epirubicin|epirubicin|mesh-list
83743760|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83743761|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743762|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
83743763|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
83743764|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
82898913|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743765|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743766|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83743767|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83743768|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83743769|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743770|NCT02041351|Docetaxel|docetaxel|mesh-list
83743771|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743772|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
83743773|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
83743774|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
83743775|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743776|NCT02041455|Amitriptyline|amitriptyline|mesh-list
83743777|NCT02041455|Melatonin|melatonin|mesh-list
83743778|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
83743779|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743780|NCT02041455|Protective Agents|protective agents|mesh-ancestor
83743781|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743782|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743783|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83743784|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
83743785|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743786|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83743787|NCT02041455|Analgesics|analgesics|mesh-ancestor
83743788|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
83743789|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743790|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83743791|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83743792|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83743793|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
83743794|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743795|NCT02041481|Leucovorin|leucovorin|mesh-list
83743796|NCT02041481|Fluorouracil|fluorouracil|mesh-list
83743797|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
83743798|NCT02041481|Calcium|calcium|mesh-list
83743799|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
83743800|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83743801|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743802|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
83743803|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743804|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743805|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743806|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743807|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
83743808|NCT02041481|Antidotes|antidotes|mesh-ancestor
83743809|NCT02041481|Protective Agents|protective agents|mesh-ancestor
83743810|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
83743811|NCT02041481|Vitamins|vitamins|mesh-ancestor
83743812|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
83743813|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83743814|NCT02041546|Poractant alfa|poractant alfa|mesh-list
83743815|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
83743816|NCT02041650|Ticagrelor|ticagrelor|mesh-list
83743817|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83743818|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83743819|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83743820|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83743821|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
83743822|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743823|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743824|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743825|NCT02041767|Ertapenem|ertapenem|mesh-list
83743826|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83743827|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743828|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
83743829|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83743830|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743831|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83743832|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
83743833|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743834|NCT02042170|Hormones|hormones|mesh-list
83743835|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743836|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743837|NCT02042196|Cetrorelix|cetrorelix|mesh-list
83743838|NCT02042196|Estradiol|estradiol|mesh-list
82898986|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83743839|NCT02042196|Estrogens|estrogens|mesh-ancestor
83743840|NCT02042196|Hormones|hormones|mesh-ancestor
83743841|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743842|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743843|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83743844|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83743845|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
83743846|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
83743847|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
83743848|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743849|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
83743850|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743851|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743852|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83743853|NCT02042482|Ubiquinone|ubiquinone|mesh-list
83743854|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
83743855|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
83743856|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743857|NCT02042482|Vitamins|vitamins|mesh-ancestor
83743858|NCT02042495|Metformin|metformin|mesh-list
83743859|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743860|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743861|NCT02042573|Sertraline|sertraline|mesh-list
83743862|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
83743863|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83743864|NCT02042573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83743865|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83743866|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83743867|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743868|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83743869|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
83743870|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743871|NCT02042599|Sevoflurane|sevoflurane|mesh-list
83743872|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83743873|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83743874|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
83743875|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
83743876|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743877|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743878|NCT02042612|Sevoflurane|sevoflurane|mesh-list
83743879|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83743880|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83743881|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
83743882|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
83743883|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83743884|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743885|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83743886|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83743887|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743888|NCT02042664|Metformin|metformin|mesh-list
83743889|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743890|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743891|NCT02042690|Dexamethasone|dexamethasone|mesh-list
83743892|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
83743893|NCT02042690|Methotrexate|methotrexate|mesh-list
83743894|NCT02042690|Epirubicin|epirubicin|mesh-list
83743895|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
83743896|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83743897|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
83743898|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743899|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83743900|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83743901|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
83743902|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743903|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743904|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83743905|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83743906|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
83743907|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
83743908|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83743909|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83743910|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
83743911|NCT02042690|Hormones|hormones|mesh-ancestor
83743912|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743913|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83743914|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743915|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83743916|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
83743917|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83743918|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743919|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
83743920|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
83743921|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83743922|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83743923|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83743924|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83743925|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83743926|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83743927|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
83743928|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743929|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
83743930|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743931|NCT02042742|Protective Agents|protective agents|mesh-ancestor
83743932|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743933|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83743934|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83743935|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
83743936|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83743937|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83743938|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743939|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83743940|NCT02043054|Liraglutide|liraglutide|mesh-list
83743941|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83743942|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743943|NCT02043054|Incretins|incretins|mesh-ancestor
83743945|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83743946|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83743947|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
83743948|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83743949|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743950|NCT02043171|Vitamin D|vitamin d|mesh-list
83743951|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
83743952|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
83743953|NCT02043171|Vitamins|vitamins|mesh-list
83743954|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
83743955|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743956|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83743957|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83743958|NCT02043223|Vitamins|vitamins|mesh-list
83743959|NCT02043223|Vitamin A|vitamin a|mesh-list
83743960|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
83743961|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
83743962|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743963|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
83743964|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743965|NCT02043223|Protective Agents|protective agents|mesh-ancestor
83743966|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83743967|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743968|NCT02043288|Gemcitabine|gemcitabine|mesh-list
83743969|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743970|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
83743971|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743972|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743973|NCT02043314|Isoniazid|isoniazid|mesh-list
83743974|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
83743975|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83743976|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83743977|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83743978|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83743979|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
83743980|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743981|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83743982|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
83743983|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
83743984|NCT02043717|Vitamin D|vitamin d|mesh-list
83743985|NCT02043717|Vitamins|vitamins|mesh-ancestor
83743986|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
83743987|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83743988|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83743989|NCT02043730|Paclitaxel|paclitaxel|mesh-list
83743990|NCT02043730|Gemcitabine|gemcitabine|mesh-list
83743991|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83743992|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83743993|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
83743994|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
83743995|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
83743996|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83743997|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83743998|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
83743999|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
83744000|NCT02043756|Analgesics|analgesics|mesh-ancestor
83744001|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
83744002|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744003|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744004|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744005|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83744006|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744007|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744008|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744009|NCT02043821|Capecitabine|capecitabine|mesh-list
83744010|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744011|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
83744012|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744013|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744014|NCT02043886|Acarbose|acarbose|mesh-list
83744015|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83744016|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744017|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744018|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83744019|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744020|NCT02043912|Haloperidol|haloperidol|mesh-list
83744021|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
83744022|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
83744023|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
83744024|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744025|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744026|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83744027|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83744028|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83744029|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83744030|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83744031|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83744032|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
83744033|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744034|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744035|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83744036|NCT02043977|Propofol|propofol|mesh-list
83744037|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83744038|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83744039|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744040|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83744041|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
83744042|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
83744043|NCT02044120|Irinotecan|irinotecan|mesh-list
83744044|NCT02044120|Temozolomide|temozolomide|mesh-list
83744045|NCT02044120|Niraparib|niraparib|mesh-list
83744046|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83744047|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744048|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744049|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744050|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744051|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744052|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
83744053|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83744054|NCT02044133|Vitamin D|vitamin d|mesh-list
83744055|NCT02044133|Vitamins|vitamins|mesh-ancestor
83744056|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
83744057|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744058|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83744059|NCT02044146|Clopidogrel|clopidogrel|mesh-list
83744060|NCT02044146|Ticagrelor|ticagrelor|mesh-list
83744061|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83744062|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83744063|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82899213|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744064|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83744065|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83744066|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
83744067|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744068|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744069|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744070|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
83744071|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83744072|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83744073|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744074|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744075|NCT02044224|Analgesics|analgesics|mesh-ancestor
83744076|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
83744077|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744078|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83744079|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83744080|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83744081|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
83744082|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744083|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744084|NCT02044250|Aspirin|aspirin|mesh-list
83744085|NCT02044250|Clopidogrel|clopidogrel|mesh-list
83744086|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83744087|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744088|NCT02044250|Analgesics|analgesics|mesh-ancestor
83744089|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
83744090|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744091|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744092|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744093|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744094|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83744095|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83744096|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744097|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83744098|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83744099|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744100|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
83744101|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83744102|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83744103|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83744104|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
83744105|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744106|NCT02044354|Docetaxel|docetaxel|mesh-list
83744107|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744108|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
83744109|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
83744110|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
83744111|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744112|NCT02044549|Oxytocin|oxytocin|mesh-list
83744113|NCT02044549|Carbetocin|carbetocin|mesh-list
83744114|NCT02044549|Methylergonovine|methylergonovine|mesh-list
83744115|NCT02044549|Syntometrine|syntometrine|mesh-list
83744116|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
83744117|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744118|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744119|NCT02044601|Paclitaxel|paclitaxel|mesh-list
83744120|NCT02044601|Carboplatin|carboplatin|mesh-list
83744121|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83744122|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83744123|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744124|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
83744125|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
83744126|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
83744127|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744128|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83744129|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744130|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83744131|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83744132|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
83744133|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744134|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83744135|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744136|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83744137|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744138|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
83744139|NCT02044653|Hematinics|hematinics|mesh-ancestor
83744140|NCT02044809|Cannabidiol|cannabidiol|mesh-list
83744141|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
83744142|NCT02044952|Mesalamine|mesalamine|mesh-list
83744143|NCT02044952|Triptolide|triptolide|mesh-list
83744144|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83744145|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744146|NCT02044952|Analgesics|analgesics|mesh-ancestor
83744147|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
83744148|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744149|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744150|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744151|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744152|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744153|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83744154|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83744155|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
83744156|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744157|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744158|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
83744159|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744160|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
83744161|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744162|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83744163|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83744164|NCT02044965|Trimethoprim|trimethoprim|mesh-list
83744165|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
83744166|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744167|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83744168|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
83744169|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83744170|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83744171|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83744172|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744173|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744174|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83744175|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83744176|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83744177|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
83744178|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83744179|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744180|NCT02045017|Dexamethasone|dexamethasone|mesh-list
83744181|NCT02045017|Pomalidomide|pomalidomide|mesh-list
83744182|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744183|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
83744184|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
83744185|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744186|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744187|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83744188|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
83744189|NCT02045017|Hormones|hormones|mesh-ancestor
83744190|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744191|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83744192|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744193|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
83744194|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83744195|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83744196|NCT02045017|Growth Substances|growth substances|mesh-ancestor
83744197|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
83744198|NCT02045030|Aflibercept|aflibercept|mesh-list
83744199|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83744200|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83744201|NCT02045030|Growth Substances|growth substances|mesh-ancestor
83744202|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744203|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
83744204|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744205|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
83744206|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83744207|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
83744208|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744209|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83744210|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83744211|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82899378|NCT03749096|Antibodies|antibodies|mesh-list
83744212|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744213|NCT02045069|Ivermectin|ivermectin|mesh-list
83744214|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83744215|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744216|NCT02045290|Metformin|metformin|mesh-list
83744217|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83744218|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744219|NCT02045368|Methotrexate|methotrexate|mesh-list
83744220|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83744221|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
83744222|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744223|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744224|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744225|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
83744226|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744227|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744228|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
83744229|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744230|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83744231|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744232|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
83744233|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744234|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83744235|NCT02045589|Gemcitabine|gemcitabine|mesh-list
83744236|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83744237|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744238|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
83744239|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744240|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744241|NCT02045602|Gemcitabine|gemcitabine|mesh-list
83744242|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83744243|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744244|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
83744245|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744246|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744247|NCT02045667|Mexiletine|mexiletine|mesh-list
83744248|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83744249|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83744250|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83744251|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83744252|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744253|NCT02045693|Buprenorphine|buprenorphine|mesh-list
83744254|NCT02045693|Methadone|methadone|mesh-list
83744255|NCT02045693|Naloxone|naloxone|mesh-list
83744256|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83744257|NCT02045693|Narcotics|narcotics|mesh-ancestor
83744258|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83744259|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744260|NCT02045693|Analgesics|analgesics|mesh-ancestor
83744261|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
83744262|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744263|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83744264|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
83744265|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
83744266|NCT02045797|Gepotidacin|gepotidacin|mesh-list
83744267|NCT02045797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744268|NCT02045797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744269|NCT02045797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744270|NCT02045797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744271|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
83744272|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
83744273|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
83744274|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83744275|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744276|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
83744277|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744278|NCT02045849|Itraconazole|itraconazole|mesh-list
83744279|NCT02045849|Gepotidacin|gepotidacin|mesh-list
83744280|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
83744281|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744282|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83744283|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83744284|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744285|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744286|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83744287|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
83744288|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744289|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744290|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83744291|NCT02045849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744292|NCT02045849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744293|NCT02045914|Calcium|calcium|mesh-list
83744294|NCT02045914|Ionophores|ionophores|mesh-list
83744295|NCT02045914|Ionomycin|ionomycin|mesh-list
83744296|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
83744297|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83744298|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744299|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83744300|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744301|NCT02045940|GSK2881078|gsk2881078|mesh-list
83744302|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
83744303|NCT02045940|Hormones|hormones|mesh-ancestor
83744304|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744305|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744306|NCT02045953|Albuterol|albuterol|mesh-list
83744307|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83744308|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
83744309|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744310|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744311|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83744312|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
83744313|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
83744314|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744315|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83744316|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83744317|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83744318|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
83744319|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744320|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744321|NCT02045992|Caffeine|caffeine|mesh-list
83744322|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83744323|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744324|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83744325|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744326|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744327|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83744328|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83744329|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
83744330|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744331|NCT02046044|Digoxin|digoxin|mesh-list
83744332|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83744333|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83744334|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744335|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744336|NCT02046044|Protective Agents|protective agents|mesh-ancestor
83744337|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744338|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
83744339|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83744340|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744341|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
83744342|NCT02046187|Temozolomide|temozolomide|mesh-list
83744343|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744344|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
83744345|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744346|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744347|NCT02046304|Gemcitabine|gemcitabine|mesh-list
83744348|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744349|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
83744350|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744351|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744352|NCT02046421|Carboplatin|carboplatin|mesh-list
83744353|NCT02046421|Gemcitabine|gemcitabine|mesh-list
83744354|NCT02046421|Mifepristone|mifepristone|mesh-list
83744355|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744356|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744357|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
83744358|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744359|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83744360|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
83744361|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744362|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744363|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83744364|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83744365|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83744366|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
83744367|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83744368|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83744369|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
83744370|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744371|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
83744372|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83744373|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83744374|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
83744375|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83744376|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83744377|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83744378|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83744379|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
83744380|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744381|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744382|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744383|NCT02046460|Aspirin|aspirin|mesh-list
83744384|NCT02046460|Vitamin K|vitamin k|mesh-list
83744385|NCT02046460|Warfarin|warfarin|mesh-list
83744386|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
83744387|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
83744388|NCT02046460|Vitamins|vitamins|mesh-ancestor
83744389|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
83744390|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744391|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
83744392|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83744393|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744394|NCT02046460|Analgesics|analgesics|mesh-ancestor
83744395|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
83744396|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744397|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744398|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744399|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83744400|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83744401|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744402|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83744403|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83744404|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744405|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
83744406|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83744407|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
83744408|NCT02046460|Coagulants|coagulants|mesh-ancestor
83744409|NCT02046486|Ticagrelor|ticagrelor|mesh-list
83744410|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83744411|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83744412|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83744413|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83744414|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
83744415|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744416|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744417|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744418|NCT02046499|Oxytocin|oxytocin|mesh-list
83744419|NCT02046499|Ergonovine|ergonovine|mesh-list
83744420|NCT02046499|Syntometrine|syntometrine|mesh-list
83744421|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
83744422|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744423|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744424|NCT02046538|Leucovorin|leucovorin|mesh-list
83744425|NCT02046538|Fluorouracil|fluorouracil|mesh-list
83744426|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
83744427|NCT02046538|Irinotecan|irinotecan|mesh-list
83744428|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
83744429|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744430|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744431|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744432|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744433|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
83744434|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744435|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83744436|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744437|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744438|NCT02046538|Antidotes|antidotes|mesh-ancestor
83744439|NCT02046538|Protective Agents|protective agents|mesh-ancestor
83744440|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
83744441|NCT02046538|Vitamins|vitamins|mesh-ancestor
83744442|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
83744443|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83744444|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83744445|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83744446|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83744447|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744448|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
83744449|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744450|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744451|NCT02046577|Vitamin D|vitamin d|mesh-list
83744452|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
83744453|NCT02046577|Vitamins|vitamins|mesh-ancestor
83744454|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
83744455|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744456|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83744457|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83744458|NCT02046629|Teriflunomide|teriflunomide|mesh-list
83744459|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
83744460|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83744461|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744462|NCT02046629|Analgesics|analgesics|mesh-ancestor
83744463|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
83744464|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744465|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744466|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744467|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744468|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744469|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
83744470|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83744471|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83744472|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
83744473|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744474|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83744475|NCT02046668|Spironolactone|spironolactone|mesh-list
83744476|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83744477|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
83744478|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744479|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744480|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83744481|NCT02046668|Diuretics|diuretics|mesh-ancestor
83744482|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
83744483|NCT02046720|Propofol|propofol|mesh-list
83744484|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83744485|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83744486|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744487|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83744488|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
83744489|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
83744490|NCT02046733|Nivolumab|nivolumab|mesh-list
83744491|NCT02046733|Ipilimumab|ipilimumab|mesh-list
83744492|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83744493|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744494|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83744495|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744496|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83744497|NCT02046850|Rifampin|rifampin|mesh-list
83744498|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83744499|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
83744500|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899664|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
82899665|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899666|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899667|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
82899668|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899669|NCT05204524|Temozolomide|temozolomide|mesh-list
82899670|NCT05204524|Epirubicin|epirubicin|mesh-list
82899671|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82899672|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
82899674|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744501|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744502|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
83744503|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83744504|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744505|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744506|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83744507|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83744508|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83744509|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83744510|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83744511|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83744512|NCT02046915|Dexamethasone|dexamethasone|mesh-list
83744513|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
83744514|NCT02046915|Pomalidomide|pomalidomide|mesh-list
83744515|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744516|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
83744517|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744518|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744519|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744520|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
83744521|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744522|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744523|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83744524|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744525|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
83744526|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
83744527|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744528|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83744529|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
83744530|NCT02046915|Hormones|hormones|mesh-ancestor
83744531|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744532|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83744533|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83744534|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83744535|NCT02046915|Growth Substances|growth substances|mesh-ancestor
83744536|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
83744537|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
83744538|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83744539|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
83744540|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83744541|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
83744542|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744543|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744544|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
83744545|NCT02047019|Candesartan|candesartan|mesh-list
83744546|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
83744547|NCT02047019|Nifedipine|nifedipine|mesh-list
83744548|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83744549|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83744550|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83744551|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744552|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83744553|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83744554|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83744555|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744556|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
83744557|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
83744558|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744559|NCT02047136|Histamine|histamine|mesh-list
83744560|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
83744561|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
83744562|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744563|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744564|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744565|NCT02047149|Zileuton|zileuton|mesh-list
83744566|NCT02047149|Dasatinib|dasatinib|mesh-list
83744567|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
83744568|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899733|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
82899734|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
82899735|NCT04439214|Nivolumab|nivolumab|mesh-list
82899736|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899737|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899740|NCT03754062|Haloperidol|haloperidol|mesh-list
83744569|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83744570|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744571|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744572|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83744573|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744574|NCT02047149|Analgesics|analgesics|mesh-ancestor
83744575|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
83744576|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744577|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744578|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744579|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744580|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83744581|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83744582|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
83744583|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744584|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
83744585|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83744586|NCT02047162|Bismuth|bismuth|mesh-list
83744587|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83744588|NCT02047162|Antacids|antacids|mesh-ancestor
83744589|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744590|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83744591|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
83744592|NCT02047175|Niacin|niacin|mesh-list
83744593|NCT02047175|Amlodipine|amlodipine|mesh-list
83744594|NCT02047175|Telmisartan|telmisartan|mesh-list
83744595|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83744596|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83744597|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83744598|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83744599|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744600|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83744601|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744602|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
83744603|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83744604|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83744605|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
83744606|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83744607|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83744608|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744609|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83744610|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83744611|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
83744612|NCT02047175|Vitamins|vitamins|mesh-ancestor
83744613|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
83744614|NCT02047201|Docetaxel|docetaxel|mesh-list
83744615|NCT02047201|Fluorouracil|fluorouracil|mesh-list
83744616|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744617|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
83744618|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
83744619|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
83744620|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744621|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
83744622|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744623|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744624|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
83744625|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744626|NCT02047292|Tacrine|tacrine|mesh-list
83744627|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83744628|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744629|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744630|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
83744631|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744632|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744633|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83744634|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
83744635|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744636|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
83744637|NCT00005823|Cytarabine|cytarabine|mesh-list
83744638|NCT00005823|Etoposide|etoposide|mesh-list
83744639|NCT00005823|Daunorubicin|daunorubicin|mesh-list
83744640|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
83744641|NCT00005823|Idarubicin|idarubicin|mesh-list
83744642|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
82899804|NCT05324358|Analgesics|analgesics|mesh-ancestor
83744643|NCT00005823|Tretinoin|tretinoin|mesh-list
83744644|NCT00005823|Thioguanine|thioguanine|mesh-list
83744645|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83744646|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744647|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83744648|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744649|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744650|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744651|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744652|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
83744653|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
83744654|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744655|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744656|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
83744657|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744658|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83744659|NCT00005823|Analgesics|analgesics|mesh-ancestor
83744660|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
83744661|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744662|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
83744663|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83744664|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
83744665|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
83744666|NCT00005826|Rubitecan|rubitecan|mesh-list
83744667|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744668|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83744669|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744670|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744671|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744672|NCT00005829|Gemcitabine|gemcitabine|mesh-list
83744673|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744674|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
83744675|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744676|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744677|NCT00005832|Tipifarnib|tipifarnib|mesh-list
83744678|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744679|NCT00005838|Paclitaxel|paclitaxel|mesh-list
83744680|NCT00005838|Vinorelbine|vinorelbine|mesh-list
83744681|NCT00005838|Carboplatin|carboplatin|mesh-list
83744682|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83744683|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744684|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
83744685|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
83744686|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
83744687|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744688|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
83744689|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83744690|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
83744691|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744692|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
83744693|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744694|NCT00005850|Gemcitabine|gemcitabine|mesh-list
83744695|NCT00005850|Fluoxetine|fluoxetine|mesh-list
83744696|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744697|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744698|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
83744699|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744700|NCT00005850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83744701|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83744702|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83744703|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744704|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
83744705|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744706|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83744707|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
83744708|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83744709|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83744710|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83744711|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744712|NCT00005853|Etanercept|etanercept|mesh-list
83744713|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83744714|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83744715|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744716|NCT00005853|Analgesics|analgesics|mesh-ancestor
82899877|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744717|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
83744718|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744719|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744720|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744721|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744722|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83744723|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744724|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
83744726|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744727|NCT00005859|Tipifarnib|tipifarnib|mesh-list
83744728|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744729|NCT00005862|Semaxinib|semaxinib|mesh-list
83744730|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83744731|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83744732|NCT00005862|Growth Substances|growth substances|mesh-ancestor
83744733|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744734|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
83744735|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744736|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83744737|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744738|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744739|NCT00005865|Vinorelbine|vinorelbine|mesh-list
83744740|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83744741|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744742|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
83744743|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
83744744|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
83744745|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744746|NCT00005868|Docetaxel|docetaxel|mesh-list
83744747|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744748|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
83744749|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
83744750|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
83744751|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744752|NCT00005871|Fluorouracil|fluorouracil|mesh-list
83744753|NCT00005871|Rubitecan|rubitecan|mesh-list
83744754|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
83744755|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744756|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744757|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744758|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744759|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
83744760|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744761|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83744762|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744763|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744764|NCT00005874|Rubitecan|rubitecan|mesh-list
83744765|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744766|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83744767|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744768|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744769|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744770|NCT00005877|Rubitecan|rubitecan|mesh-list
83744771|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744772|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83744773|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744774|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744775|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744776|NCT00005880|Budesonide|budesonide|mesh-list
83744777|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744778|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83744779|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
83744780|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744781|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744782|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83744783|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
83744784|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
83744785|NCT00005880|Hormones|hormones|mesh-ancestor
83744786|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744787|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
83744788|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744789|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744790|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82899953|NCT03749850|Doxorubicin|doxorubicin|mesh-list
83744791|NCT00005883|Protective Agents|protective agents|mesh-ancestor
83744792|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744793|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744794|NCT00005886|Tamoxifen|tamoxifen|mesh-list
83744795|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83744796|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
83744797|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744798|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744799|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83744800|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744801|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83744802|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83744803|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83744804|NCT00005889|Glucagon|glucagon|mesh-list
83744805|NCT00005889|Glycerol|glycerol|mesh-list
83744806|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744807|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83744808|NCT00005889|Hormones|hormones|mesh-ancestor
83744809|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744810|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83744811|NCT00005889|Protective Agents|protective agents|mesh-ancestor
83744812|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
83744813|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744814|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
83744815|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744816|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744817|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744818|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
83744819|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744820|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744821|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83744822|NCT00005898|Cyclosporine|cyclosporine|mesh-list
83744823|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
83744824|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
83744825|NCT00005898|Fludarabine|fludarabine|mesh-list
83744826|NCT00005898|Cyclosporins|cyclosporins|mesh-list
83744827|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83744828|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744829|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
83744830|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744831|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744832|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744833|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
83744834|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744835|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744836|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83744837|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744838|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
83744839|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744840|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
83744841|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83744842|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744843|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
83744844|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
83744845|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744846|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83744847|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
83744848|NCT00005898|Hormones|hormones|mesh-ancestor
83744849|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744850|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83744851|NCT00005898|Protective Agents|protective agents|mesh-ancestor
83744852|NCT00386412|Valganciclovir|valganciclovir|mesh-list
83744853|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
83744854|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744855|NCT00386529|Aspirin|aspirin|mesh-list
83744856|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83744857|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744858|NCT00386529|Analgesics|analgesics|mesh-ancestor
83744859|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
83744860|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744861|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900027|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83744862|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744863|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900028|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83744864|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83744865|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83744866|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744867|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83744868|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83744869|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744870|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
83744871|NCT00005922|Triamcinolone|triamcinolone|mesh-list
83744872|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83744873|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83744874|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83744875|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83744876|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
83744877|NCT00005922|Hormones|hormones|mesh-ancestor
83744878|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83744879|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744880|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744881|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
83744882|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744883|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744884|NCT00005925|Muscimol|muscimol|mesh-list
83744885|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83744886|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
83744887|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
83744888|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83744889|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744890|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744891|NCT00005928|Ramipril|ramipril|mesh-list
83744892|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83744893|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
83744894|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744895|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744896|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83744897|NCT00005931|Semaxinib|semaxinib|mesh-list
83744898|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83744899|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83744900|NCT00005931|Growth Substances|growth substances|mesh-ancestor
83744901|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744902|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
83744903|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744904|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83744905|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744906|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744907|NCT00005934|Azacitidine|azacitidine|mesh-list
83744908|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744909|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
83744910|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744911|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744912|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744914|NCT00005940|Cyclosporine|cyclosporine|mesh-list
83744915|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
83744916|NCT00005940|Busulfan|busulfan|mesh-list
83744917|NCT00005940|Methotrexate|methotrexate|mesh-list
83744918|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83744919|NCT00005940|Cyclosporins|cyclosporins|mesh-list
83744920|NCT00005940|Antibodies|antibodies|mesh-list
83744921|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
83744922|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83744923|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744924|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
83744925|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744926|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744927|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744928|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
83744929|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744930|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744931|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83744932|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83744933|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
83744934|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83744935|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744936|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
83744937|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
82900101|NCT03745664|Hormones|hormones|mesh-ancestor
83744938|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744939|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83744940|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83744941|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
83744942|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744943|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83744944|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83744945|NCT00005940|Trace Elements|trace elements|mesh-ancestor
83744946|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
83744947|NCT00005943|Aldesleukin|aldesleukin|mesh-list
83744948|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744949|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83744950|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83744951|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
83744952|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744953|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
83744954|NCT00005946|Etoposide|etoposide|mesh-list
83744955|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83744956|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
83744957|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744958|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83744959|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744960|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
83744961|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744962|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744963|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83744964|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83744965|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83744966|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83744967|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83744968|NCT00005949|Aldesleukin|aldesleukin|mesh-list
83744969|NCT00005949|Interleukin-2|interleukin-2|mesh-list
83744970|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744971|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83744972|NCT00005949|Analgesics|analgesics|mesh-ancestor
83744973|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
83744974|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83744975|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83744976|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83744977|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83744978|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
83744979|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83744980|NCT00005952|Temozolomide|temozolomide|mesh-list
83744981|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744982|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
83744983|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744984|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744985|NCT00005955|Temozolomide|temozolomide|mesh-list
83744986|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83744987|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
83744988|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744989|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744990|NCT00005958|Gemcitabine|gemcitabine|mesh-list
83744991|NCT00005958|Docetaxel|docetaxel|mesh-list
83744992|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83744993|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
83744994|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83744995|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83744996|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
83744997|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
83744998|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
83744999|NCT00005961|Carmustine|carmustine|mesh-list
83745000|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83745001|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745002|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
83745003|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745004|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745005|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745006|NCT00005964|Prednisone|prednisone|mesh-list
83745007|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
83745008|NCT00005964|Doxorubicin|doxorubicin|mesh-list
83745009|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83745010|NCT00005964|Etoposide|etoposide|mesh-list
83745011|NCT00005964|Vincristine|vincristine|mesh-list
82900174|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
83745012|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745013|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
83745014|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745015|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745016|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745017|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
83745018|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745019|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745020|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83745021|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83745022|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83745023|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745024|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745025|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745026|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
83745027|NCT00005964|Hormones|hormones|mesh-ancestor
83745028|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745029|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83745030|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745031|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745032|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745033|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745034|NCT00005967|Tipifarnib|tipifarnib|mesh-list
83745035|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745036|NCT00005970|Tamoxifen|tamoxifen|mesh-list
83745037|NCT00005970|Paclitaxel|paclitaxel|mesh-list
83745038|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
83745039|NCT00005970|Doxorubicin|doxorubicin|mesh-list
83745040|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83745041|NCT00005970|Trastuzumab|trastuzumab|mesh-list
83745042|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83745043|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83745044|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83745045|NCT00005970|Antibodies|antibodies|mesh-list
83745046|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
83745047|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83745048|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83745049|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745050|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745051|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745052|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745053|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745054|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745055|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745056|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
83745057|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745058|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745059|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745060|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
83745061|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83745062|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83745063|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83745064|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745065|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745066|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83745067|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
83745068|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745069|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83745070|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83745071|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83745072|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83745073|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83745074|NCT00005976|Carboplatin|carboplatin|mesh-list
83745075|NCT00005976|NSC 366140|nsc 366140|mesh-list
83745076|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745077|NCT00005979|Leucovorin|leucovorin|mesh-list
83745078|NCT00005979|Fluorouracil|fluorouracil|mesh-list
83745079|NCT00005979|Irinotecan|irinotecan|mesh-list
83745080|NCT00005979|Calcium|calcium|mesh-list
83745081|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
83745082|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83745083|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745084|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
83745085|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900251|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745086|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745087|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745088|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745089|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
83745090|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83745091|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745092|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745094|NCT00005979|Protective Agents|protective agents|mesh-ancestor
83745095|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
83745096|NCT00005979|Vitamins|vitamins|mesh-ancestor
83745097|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
83745098|NCT00005985|Cytarabine|cytarabine|mesh-list
83745099|NCT00005985|Dexamethasone|dexamethasone|mesh-list
83745100|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
83745101|NCT00005985|Carmustine|carmustine|mesh-list
83745102|NCT00005985|Etoposide|etoposide|mesh-list
83745103|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
83745104|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745105|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
83745106|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745107|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745108|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745109|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
83745110|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745111|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745112|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83745113|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745114|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
83745115|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
83745116|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745117|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745118|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
83745119|NCT00005985|Hormones|hormones|mesh-ancestor
83745120|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745121|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83745122|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745123|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83745124|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745125|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745126|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745127|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
83745128|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
83745129|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745130|NCT00005985|Analgesics|analgesics|mesh-ancestor
83745131|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
83745132|NCT00005988|Leucovorin|leucovorin|mesh-list
83745133|NCT00005988|Cyclosporine|cyclosporine|mesh-list
83745134|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
83745135|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
83745136|NCT00005988|Methotrexate|methotrexate|mesh-list
83745137|NCT00005988|Cyclosporins|cyclosporins|mesh-list
83745138|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
83745139|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745140|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
83745141|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745142|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745143|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745144|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
83745145|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745146|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745147|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83745148|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83745149|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
83745150|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83745151|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745152|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
83745153|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
83745154|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745155|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83745156|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83745157|NCT00005988|Antidotes|antidotes|mesh-ancestor
83745158|NCT00005988|Protective Agents|protective agents|mesh-ancestor
83745159|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
82900324|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83745160|NCT00005988|Vitamins|vitamins|mesh-ancestor
83745161|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
83745162|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
83745163|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745164|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83745165|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745166|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
83745167|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
83745168|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745169|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745170|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
83745171|NCT00005988|Hormones|hormones|mesh-ancestor
83745172|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745173|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83745174|NCT00005991|Gemcitabine|gemcitabine|mesh-list
83745175|NCT00005991|Doxorubicin|doxorubicin|mesh-list
83745176|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83745177|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745178|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
83745179|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745180|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745181|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83745182|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83745183|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745184|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745185|NCT00005994|Ondansetron|ondansetron|mesh-list
83745186|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
83745187|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
83745188|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745189|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745190|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745191|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
83745192|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
83745193|NCT00005994|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83745194|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83745195|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
83745196|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745197|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745198|NCT00006000|Irinotecan|irinotecan|mesh-list
83745199|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745200|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83745201|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745202|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745203|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745204|NCT00006003|Semaxinib|semaxinib|mesh-list
83745205|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83745206|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83745207|NCT00006003|Growth Substances|growth substances|mesh-ancestor
83745208|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745209|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
83745210|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745211|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83745212|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745213|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745214|NCT00006006|Interferons|interferons|mesh-list
83745215|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
83745216|NCT00006006|Thalidomide|thalidomide|mesh-list
83745217|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745218|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
83745219|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745220|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
83745221|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745222|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745223|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
83745224|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745225|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83745226|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83745227|NCT00006006|Growth Substances|growth substances|mesh-ancestor
83745228|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
83745229|NCT00006009|Visilizumab|visilizumab|mesh-list
83745230|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
83745231|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745232|NCT00006012|Paclitaxel|paclitaxel|mesh-list
83745233|NCT00006012|Etoposide|etoposide|mesh-list
83745234|NCT00006012|Topotecan|topotecan|mesh-list
83745235|NCT00006012|Amifostine|amifostine|mesh-list
83745236|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745237|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745238|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
82900411|NCT02054104|Celecoxib|celecoxib|mesh-list
83745239|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745240|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745241|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745242|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83745243|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745244|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745245|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745246|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83745247|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83745248|NCT00006012|Protective Agents|protective agents|mesh-ancestor
83745249|NCT00006015|Leucovorin|leucovorin|mesh-list
83745250|NCT00006015|Fluorouracil|fluorouracil|mesh-list
83745251|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
83745252|NCT00006015|Trastuzumab|trastuzumab|mesh-list
83745253|NCT00006015|Calcium|calcium|mesh-list
83745254|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
83745255|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83745256|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745257|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
83745258|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745259|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745260|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745261|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745262|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
83745263|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745264|NCT00006015|Antidotes|antidotes|mesh-ancestor
83745265|NCT00006015|Protective Agents|protective agents|mesh-ancestor
83745266|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
83745267|NCT00006015|Vitamins|vitamins|mesh-ancestor
83745268|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
83745269|NCT00006018|Paclitaxel|paclitaxel|mesh-list
83745270|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745271|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745272|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745273|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745274|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745275|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745276|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
83745277|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
83745278|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
83745279|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745280|NCT00006021|Protective Agents|protective agents|mesh-ancestor
83745281|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745282|NCT00006021|Vitamins|vitamins|mesh-ancestor
83745283|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
83745284|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745285|NCT00006024|Temozolomide|temozolomide|mesh-list
83745286|NCT00006024|Lomustine|lomustine|mesh-list
83745287|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745288|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
83745289|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745290|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745291|NCT00006027|Paclitaxel|paclitaxel|mesh-list
83745292|NCT00006027|Cisplatin|cisplatin|mesh-list
83745293|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745294|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745295|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745296|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745297|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745298|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900490|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
82900491|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
82900492|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900493|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
82900494|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900495|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82900496|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900497|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900498|NCT02737306|Leronlimab|leronlimab|mesh-list
82900499|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82900500|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82900501|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900502|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82900503|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82900504|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
82900505|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900506|NCT02728648|Oxycodone|oxycodone|mesh-list
82900507|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83745299|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83745300|NCT00386646|Laxatives|laxatives|mesh-ancestor
83745301|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745302|NCT00386685|Trastuzumab|trastuzumab|mesh-list
83745303|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745304|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745305|NCT00006030|Tamoxifen|tamoxifen|mesh-list
83745306|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83745307|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
83745308|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745309|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745310|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83745311|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745312|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83745313|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83745314|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83745315|NCT00006033|Methotrexate|methotrexate|mesh-list
83745316|NCT00006033|Interleukin-2|interleukin-2|mesh-list
83745317|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83745318|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
83745319|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83745320|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745321|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745322|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
83745323|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745324|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745325|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
83745326|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745327|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83745328|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745329|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
83745330|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745331|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83745332|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83745333|NCT00006033|Analgesics|analgesics|mesh-ancestor
83745334|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
83745335|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745336|NCT00006036|Lurtotecan|lurtotecan|mesh-list
83745337|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745338|NCT00006039|Interferons|interferons|mesh-list
83745339|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
83745340|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745341|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
83745342|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745343|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
83745344|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745345|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
83745346|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
83745347|NCT00006042|Fludarabine|fludarabine|mesh-list
83745348|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
83745349|NCT00006042|Tacrolimus|tacrolimus|mesh-list
83745350|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745351|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
83745352|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745353|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745354|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745355|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
83745356|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745357|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745358|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83745359|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745360|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
83745361|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83745362|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745363|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83745364|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83745365|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
83745366|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745367|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745368|NCT05680974|Antibodies|antibodies|mesh-list
83745369|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
83745370|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745371|NCT05680857|Ubiquinone|ubiquinone|mesh-list
83745372|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
83745373|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
83745374|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745375|NCT05680857|Vitamins|vitamins|mesh-ancestor
83745376|NCT00386763|Lumefantrine|lumefantrine|mesh-list
83745377|NCT00386763|Artemether|artemether|mesh-list
83745378|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83745379|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
83745380|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83745381|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83745382|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745383|NCT05680662|Metformin|metformin|mesh-list
83745384|NCT05680662|Quercetin|quercetin|mesh-list
83745385|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83745386|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745387|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
83745388|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745389|NCT05680662|Protective Agents|protective agents|mesh-ancestor
83745390|NCT05680545|Sevoflurane|sevoflurane|mesh-list
83745391|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83745392|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83745393|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
83745394|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
83745395|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83745396|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745397|NCT05680389|Minocycline|minocycline|mesh-list
83745398|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745399|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745400|NCT05680194|Diphosphonates|diphosphonates|mesh-list
83745401|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83745402|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745403|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
83745404|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745405|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745406|NCT05679921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83745407|NCT05679921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745408|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
83745409|NCT00386802|Clotrimazole|clotrimazole|mesh-list
83745410|NCT00386802|Miconazole|miconazole|mesh-list
83745411|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745412|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83745413|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83745414|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83745415|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745416|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745417|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83745418|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
83745419|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745420|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745421|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83745422|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83745423|NCT00386841|Escitalopram|escitalopram|mesh-list
83745424|NCT00386841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83745425|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83745426|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83745427|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745428|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745429|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
83745430|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745431|NCT05679453|Etodolac|etodolac|mesh-list
83745432|NCT05679453|Lornoxicam|lornoxicam|mesh-list
83745433|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83745434|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83745435|NCT05679453|Analgesics|analgesics|mesh-ancestor
83745436|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
83745437|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745438|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745439|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745440|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745441|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83745442|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83745443|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745444|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745445|NCT05679375|Ketamine|ketamine|mesh-list
83745446|NCT05679375|Analgesics|analgesics|mesh-ancestor
83745447|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
82900623|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83745448|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745449|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745450|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83745451|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83745452|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
83745453|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
83745454|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83745455|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83745456|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83745457|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745458|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745459|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
83745460|NCT05679336|Rituximab|rituximab|mesh-list
83745461|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745462|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
83745463|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745464|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745465|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745466|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
83745467|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745468|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745469|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83745470|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745471|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
83745472|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83745473|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745474|NCT05626725|Insulin|insulin|mesh-list
83745475|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83745476|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745477|NCT05597163|Atropine|atropine|mesh-list
83745478|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83745479|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83745480|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83745481|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
83745482|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745483|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745484|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83745485|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
83745486|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
83745487|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
83745488|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83745489|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83745490|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
83745491|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745492|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745493|NCT05550129|Metformin|metformin|mesh-list
83745494|NCT05550129|Sotorasib|sotorasib|mesh-list
83745495|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83745496|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745497|NCT05550129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83745498|NCT05550129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745499|NCT05550129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745500|NCT05550129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745501|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
83745502|NCT00386958|Povidone|povidone|mesh-list
83745503|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
83745504|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
83745505|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83745506|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745507|NCT00386997|Amphotericin B|amphotericin b|mesh-list
83745508|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83745509|NCT00386997|Amebicides|amebicides|mesh-ancestor
83745510|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83745511|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83745512|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745513|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745514|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
83745515|NCT03940131|Panitumumab|panitumumab|mesh-list
83745516|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745517|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745518|NCT05160597|Edetic Acid|edetic acid|mesh-list
83745519|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83745520|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
83745521|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
83745522|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745523|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
83745524|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83745525|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83745526|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
83745527|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83745528|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745529|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
83745530|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745531|NCT04921722|Sirolimus|sirolimus|mesh-list
83745532|NCT04921722|Temsirolimus|temsirolimus|mesh-list
83745533|NCT04921722|MTOR Inhibitors|mtor inhibitors|mesh-list
83745534|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745535|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745536|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83745537|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745538|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
83745539|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745540|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
83745541|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745542|NCT04921722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83745543|NCT04921722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745544|NCT04921722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745545|NCT04833387|Antibodies|antibodies|mesh-list
83745546|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
83745547|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745549|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
83745550|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745551|NCT04803084|Protective Agents|protective agents|mesh-ancestor
83745552|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745553|NCT04793685|Prazosin|prazosin|mesh-list
83745554|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83745555|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83745556|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83745557|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83745558|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
83745559|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745560|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745561|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745562|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
83745563|NCT04787991|Paclitaxel|paclitaxel|mesh-list
83745564|NCT04787991|Gemcitabine|gemcitabine|mesh-list
83745565|NCT04787991|Nivolumab|nivolumab|mesh-list
83745566|NCT04787991|Ipilimumab|ipilimumab|mesh-list
83745567|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745568|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745569|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745570|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745571|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745572|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745573|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745574|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
83745575|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745576|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83745577|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
83745578|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83745579|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83745580|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745581|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745582|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745583|NCT04552080|Amoxicillin|amoxicillin|mesh-list
83745584|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745585|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745586|NCT03834909|Tenofovir|tenofovir|mesh-list
83745587|NCT03834909|Emtricitabine|emtricitabine|mesh-list
83745588|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83745589|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
83745590|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745591|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83745592|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83745593|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745594|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745595|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83745596|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83745597|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
83745598|NCT04360473|Ketamine|ketamine|mesh-list
83745599|NCT04360473|Anesthetics|anesthetics|mesh-list
83745600|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83745601|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745602|NCT04360473|Analgesics|analgesics|mesh-ancestor
83745603|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
83745604|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745605|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83745606|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83745607|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
83745608|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83745609|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83745610|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745611|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745612|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83745613|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
83745614|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83745615|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83745616|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83745617|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
83745618|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83745619|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83745620|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
83745621|NCT04329975|Coagulants|coagulants|mesh-ancestor
83745622|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83745623|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
83745624|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745625|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
83745626|NCT04305795|Cemiplimab|cemiplimab|mesh-list
83745627|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745628|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745629|NCT04305795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83745630|NCT04305795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745631|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
83745632|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83745633|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745634|NCT04175613|Apremilast|apremilast|mesh-list
83745635|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83745636|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83745637|NCT04175613|Analgesics|analgesics|mesh-ancestor
83745638|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
83745639|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745640|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745641|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745642|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745643|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83745644|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83745645|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745646|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745647|NCT03945357|Clindamycin|clindamycin|mesh-list
83745648|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
83745649|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
83745650|NCT03945357|Gemcitabine|gemcitabine|mesh-list
83745651|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745652|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
83745653|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745654|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745655|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745656|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745657|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83745658|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745659|NCT03913221|Caffeine|caffeine|mesh-list
83745660|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
83745661|NCT03913221|Citric Acid|citric acid|mesh-list
83745662|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
83745663|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
83745664|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83745665|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
83745666|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
83745667|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745668|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83745669|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745670|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83745671|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900852|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
83745672|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83745673|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83745674|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
83745675|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745676|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
83745677|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83745678|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
83745679|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
83745680|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83745681|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745682|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83745683|NCT03869736|Analgesics|analgesics|mesh-ancestor
83745684|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
83745685|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745686|NCT03786081|Bevacizumab|bevacizumab|mesh-list
83745687|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
83745688|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
83745689|NCT03786081|Carboplatin|carboplatin|mesh-list
83745690|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745691|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745692|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83745693|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83745694|NCT03786081|Growth Substances|growth substances|mesh-ancestor
83745695|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745696|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
83745697|NCT03786081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83745698|NCT03786081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745699|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
83745700|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83745701|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745702|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83745703|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745704|NCT03741933|Apremilast|apremilast|mesh-list
83745705|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83745706|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83745707|NCT03741933|Analgesics|analgesics|mesh-ancestor
83745708|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
83745709|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745710|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745711|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745712|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745713|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83745714|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83745715|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745716|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745717|NCT03002259|Dexamethasone|dexamethasone|mesh-list
83745718|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745719|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
83745720|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
83745721|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745722|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745723|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745724|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
83745725|NCT03002259|Hormones|hormones|mesh-ancestor
83745726|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745727|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83745728|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745729|NCT03000387|Nicotine|nicotine|mesh-list
83745730|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83745731|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
83745732|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745733|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745734|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83745735|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83745736|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
83745737|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83745738|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745739|NCT00387504|Fenretinide|fenretinide|mesh-list
83745740|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745741|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83745742|NCT00387504|Protective Agents|protective agents|mesh-ancestor
83745743|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745744|NCT02936505|Cyclosporine|cyclosporine|mesh-list
82900925|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83745745|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
83745747|NCT02936505|Cyclosporins|cyclosporins|mesh-list
83745748|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
83745749|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83745750|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745751|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
83745752|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745753|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83745754|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745755|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745756|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
83745757|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745758|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
83745759|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745760|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83745761|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745762|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83745763|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
83745764|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83745765|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
83745766|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
83745767|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83745768|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745769|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745770|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
83745771|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83745772|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83745773|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745774|NCT02648997|Nivolumab|nivolumab|mesh-list
83745775|NCT02648997|Ipilimumab|ipilimumab|mesh-list
83745776|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745777|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745778|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83745779|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745780|NCT02593110|Telmisartan|telmisartan|mesh-list
83745781|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83745782|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83745783|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83745784|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745785|NCT02373813|Folic Acid|folic acid|mesh-list
83745786|NCT02373813|Etanercept|etanercept|mesh-list
83745787|NCT02373813|Methotrexate|methotrexate|mesh-list
83745788|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83745789|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
83745790|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83745791|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745792|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745793|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
83745794|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745795|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745796|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83745797|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745798|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83745799|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745800|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
83745801|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745802|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83745803|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83745804|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83745805|NCT02373813|Analgesics|analgesics|mesh-ancestor
83745806|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
83745807|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745808|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745809|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745810|NCT02373813|Hematinics|hematinics|mesh-ancestor
83745811|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
83745812|NCT02373813|Vitamins|vitamins|mesh-ancestor
83745813|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
83745814|NCT01959204|Oxycodone|oxycodone|mesh-list
83745815|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83745816|NCT01959204|Narcotics|narcotics|mesh-ancestor
83745817|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83745818|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900999|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745819|NCT01959204|Analgesics|analgesics|mesh-ancestor
83745820|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
83745821|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745822|NCT01853748|Paclitaxel|paclitaxel|mesh-list
83745823|NCT01853748|Maytansine|maytansine|mesh-list
83745824|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83745825|NCT01853748|Trastuzumab|trastuzumab|mesh-list
83745826|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745827|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745828|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745829|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745830|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745831|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745832|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745833|NCT01853748|Immunotoxins|immunotoxins|mesh-ancestor
83745834|NCT01853748|Immunoconjugates|immunoconjugates|mesh-ancestor
83745835|NCT01853748|Immunologic Factors|immunologic factors|mesh-ancestor
83745836|NCT01853748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745837|NCT00006045|Cytarabine|cytarabine|mesh-list
83745838|NCT00006045|Etoposide|etoposide|mesh-list
83745839|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
83745840|NCT00006045|Lintuzumab|lintuzumab|mesh-list
83745841|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745842|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745843|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83745844|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745845|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745846|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745847|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745848|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
83745849|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
83745850|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745851|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745852|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
83745853|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745854|NCT00006045|Analgesics|analgesics|mesh-ancestor
83745855|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
83745856|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745857|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745858|NCT00006048|Gemcitabine|gemcitabine|mesh-list
83745859|NCT00006048|Gefitinib|gefitinib|mesh-list
83745860|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745861|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745862|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
83745863|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745864|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83745865|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745866|NCT00006051|Fluorouracil|fluorouracil|mesh-list
83745867|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745868|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
83745869|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745870|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745871|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745872|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
83745873|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745874|NCT00006054|Cyclosporine|cyclosporine|mesh-list
83745875|NCT00006054|Prednisone|prednisone|mesh-list
83745876|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
83745877|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
83745878|NCT00006054|Busulfan|busulfan|mesh-list
83745879|NCT00006054|Methotrexate|methotrexate|mesh-list
83745880|NCT00006054|Etoposide|etoposide|mesh-list
83745881|NCT00006054|Cyclosporins|cyclosporins|mesh-list
83745882|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83745883|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745884|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
83745885|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745886|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745887|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83745888|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
83745889|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901074|NCT05609656|Calcium|calcium|mesh-list
82901081|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
83745890|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745891|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83745892|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745893|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
83745894|NCT00006054|Hormones|hormones|mesh-ancestor
83745895|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83745896|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83745897|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83745899|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83745900|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745901|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
83745902|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
83745903|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83745904|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83745905|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83745906|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745907|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83745908|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83745909|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
83745910|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745911|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83745912|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
83745913|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
83745914|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83745915|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745916|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83745917|NCT00006054|Protective Agents|protective agents|mesh-ancestor
83745918|NCT00006063|Pancrelipase|pancrelipase|mesh-list
83745919|NCT00006063|Pancreatin|pancreatin|mesh-list
83745920|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83745921|NCT00006066|Aldesleukin|aldesleukin|mesh-list
83745922|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745923|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83745924|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83745925|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
83745926|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745927|NCT00006072|Rituximab|rituximab|mesh-list
83745928|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745929|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745930|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
83745931|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745932|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83745933|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
83745934|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83745935|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83745936|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83745937|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
83745938|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
83745939|NCT00006078|Lycopene|lycopene|mesh-list
83745940|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83745941|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
83745942|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745943|NCT00006078|Protective Agents|protective agents|mesh-ancestor
83745944|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745945|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83745946|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83745947|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745948|NCT00006081|Paclitaxel|paclitaxel|mesh-list
83745949|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
83745950|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745951|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745952|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745953|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745954|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745955|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745956|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83745957|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
83745958|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745959|NCT00006084|Lintuzumab|lintuzumab|mesh-list
83745960|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745961|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745962|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
83745963|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745964|NCT00006096|Cisplatin|cisplatin|mesh-list
83745965|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745966|NCT00006105|Gemcitabine|gemcitabine|mesh-list
83745967|NCT00006105|Amifostine|amifostine|mesh-list
83745968|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745969|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745970|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
83745971|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745972|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83745973|NCT00006105|Protective Agents|protective agents|mesh-ancestor
83745974|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745975|NCT00006108|Paclitaxel|paclitaxel|mesh-list
83745976|NCT00006108|Capecitabine|capecitabine|mesh-list
83745977|NCT00006108|Trastuzumab|trastuzumab|mesh-list
83745978|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745979|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745980|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
83745981|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
83745982|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
83745983|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745984|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745985|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
83745986|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83745987|NCT00006111|Fluorouracil|fluorouracil|mesh-list
83745988|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745989|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
83745990|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83745991|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83745992|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83745993|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
83745994|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83745995|NCT00006114|Vinorelbine|vinorelbine|mesh-list
83745996|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
83745997|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83745998|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83745999|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746000|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746001|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746002|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746003|NCT00006114|Analgesics|analgesics|mesh-ancestor
83746004|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
83746005|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746006|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746007|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746008|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746009|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746010|NCT00006117|Gemcitabine|gemcitabine|mesh-list
83746011|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
83746012|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746013|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
83746014|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746015|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746016|NCT00006120|Paclitaxel|paclitaxel|mesh-list
83746017|NCT00006120|Docetaxel|docetaxel|mesh-list
83746018|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746019|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746020|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746021|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746022|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746023|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746024|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
83746025|NCT00006123|Thiotepa|thiotepa|mesh-list
83746026|NCT00006123|Carmustine|carmustine|mesh-list
83746027|NCT00006123|Carboplatin|carboplatin|mesh-list
83746028|NCT00006123|Trastuzumab|trastuzumab|mesh-list
83746029|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746030|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
83746031|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746032|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746033|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746034|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
83746035|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746036|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746037|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746038|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83746039|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
83746040|NCT00006126|Busulfan|busulfan|mesh-list
83746041|NCT00006126|Fludarabine|fludarabine|mesh-list
83746042|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
82901220|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83746043|NCT00006126|Etoposide|etoposide|mesh-list
83746044|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746045|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
83746046|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746047|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746048|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746049|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
83746050|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746051|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746052|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746053|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746054|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
83746055|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746056|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746057|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746058|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746059|NCT00006129|Testosterone|testosterone|mesh-list
83746060|NCT00006129|Androgens|androgens|mesh-ancestor
83746061|NCT00006129|Hormones|hormones|mesh-ancestor
83746062|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746063|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746064|NCT00006132|Acyclovir|acyclovir|mesh-list
83746065|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
83746066|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746067|NCT00006135|Acyclovir|acyclovir|mesh-list
83746068|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
83746069|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746070|NCT00006144|Ritonavir|ritonavir|mesh-list
83746071|NCT00006144|Lopinavir|lopinavir|mesh-list
83746072|NCT00006144|Emtricitabine|emtricitabine|mesh-list
83746073|NCT00006144|Stavudine|stavudine|mesh-list
83746074|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83746075|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83503212|NCT01263938|Atorvastatin|atorvastatin|mesh-list
83746076|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
83746077|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746078|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746079|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83746080|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83746081|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
83746082|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746083|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83746084|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83746085|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83746086|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746087|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
83746088|NCT00006168|Methotrexate|methotrexate|mesh-list
83746089|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83746090|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
83746091|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83746092|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746093|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746094|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
83746095|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746096|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746097|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746098|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746099|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83746100|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746101|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
83746102|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746103|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746104|NCT00006174|Letrozole|letrozole|mesh-list
83746105|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746106|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83746107|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83746108|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746109|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746110|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83746111|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
83746112|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746113|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746114|NCT00006180|Alendronate|alendronate|mesh-list
83746115|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83746116|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746117|NCT00006195|Olanzapine|olanzapine|mesh-list
83746118|NCT00006195|Risperidone|risperidone|mesh-list
83746119|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83746120|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
83746121|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83746122|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746123|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746124|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83746125|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83746126|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83746127|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83746128|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83746130|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
83746131|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
83746132|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746133|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83746134|NCT00006195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83746135|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83746136|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83746137|NCT00006198|Thalidomide|thalidomide|mesh-list
83746138|NCT00006198|Doxorubicin|doxorubicin|mesh-list
83746139|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746140|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746141|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746142|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746143|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746144|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746145|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746146|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
83746147|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746148|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
83746149|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83746150|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746151|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83746152|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83746153|NCT00006198|Growth Substances|growth substances|mesh-ancestor
83746154|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
83746155|NCT00006204|Naltrexone|naltrexone|mesh-list
83746156|NCT00006204|Fluoxetine|fluoxetine|mesh-list
83746157|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83746158|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83746159|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746160|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
83746161|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746162|NCT00006204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83746163|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83746164|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83746165|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746166|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83746167|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
83746168|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83746169|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
83746170|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83746171|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83746172|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83746173|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746174|NCT00006216|Ganciclovir|ganciclovir|mesh-list
83746175|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83746176|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
83746177|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746178|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746179|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746180|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746181|NCT00006219|Clarithromycin|clarithromycin|mesh-list
83746182|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83746183|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83746184|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746185|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83746186|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746187|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746188|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83746189|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83746190|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83746191|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
82901371|NCT02154490|Talazoparib|talazoparib|mesh-list
83746192|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746193|NCT00387582|Ranibizumab|ranibizumab|mesh-list
83746194|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83746195|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83746196|NCT00387582|Growth Substances|growth substances|mesh-ancestor
83746197|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746198|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
83746199|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746200|NCT00006228|Aldesleukin|aldesleukin|mesh-list
83746201|NCT00006228|Trastuzumab|trastuzumab|mesh-list
83746202|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83746203|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746204|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83746205|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83746206|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
83746207|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746208|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83746209|NCT03751800|Dienogest|dienogest|mesh-list
83746210|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
83746211|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
83746212|NCT03751800|Estradiol|estradiol|mesh-list
83746213|NCT03751800|Estrogens|estrogens|mesh-ancestor
83746214|NCT03751800|Hormones|hormones|mesh-ancestor
83746215|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746216|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746217|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83746218|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
83746219|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83746220|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83746221|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83746222|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83746223|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83746224|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83746225|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83746226|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746227|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
83746228|NCT00006240|Dexamethasone|dexamethasone|mesh-list
83746229|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83746230|NCT00006240|Sargramostim|sargramostim|mesh-list
83746231|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83746232|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
83746233|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
83746234|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746235|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746236|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83746237|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
83746238|NCT00006240|Hormones|hormones|mesh-ancestor
83746239|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746240|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83746241|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746242|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
83746243|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
83746244|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83746245|NCT02972463|Antibodies|antibodies|mesh-list
83746246|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
83746247|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746248|NCT00006243|Sargramostim|sargramostim|mesh-list
83746249|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
83746250|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
83746251|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746252|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83746253|NCT00006246|Busulfan|busulfan|mesh-list
83746254|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
83746255|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746256|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746257|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
83746258|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746259|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746260|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746261|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746262|NCT00006249|Interferons|interferons|mesh-list
83746263|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
83746264|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746265|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
82901453|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
83746266|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746267|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
83746268|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746269|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
83746270|NCT00006252|Fludarabine|fludarabine|mesh-list
83746271|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
83746272|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746273|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
83746274|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746275|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746276|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746277|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
83746278|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746279|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746280|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746281|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746282|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
83746283|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
83746284|NCT00006258|Methotrexate|methotrexate|mesh-list
83746285|NCT00006258|Etoposide|etoposide|mesh-list
83746286|NCT00006258|Vincristine|vincristine|mesh-list
83746287|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746288|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
83746289|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746290|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746291|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746292|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
83746293|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746294|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746295|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746296|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83746297|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
83746298|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83746299|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746300|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
83746301|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746302|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746303|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83746304|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746305|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746306|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746307|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746308|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746309|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746310|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746311|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
83746312|NCT00006261|Docetaxel|docetaxel|mesh-list
83746313|NCT00006261|Doxorubicin|doxorubicin|mesh-list
83746314|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83746315|NCT00006261|Fludarabine|fludarabine|mesh-list
83746316|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
83746317|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746318|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
83746319|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746320|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746321|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746322|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
83746323|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746324|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746325|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746326|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746327|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746328|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746329|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746330|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746331|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746332|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746333|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746334|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
83746335|NCT00006264|Zidovudine|zidovudine|mesh-list
83746336|NCT00006264|Aldesleukin|aldesleukin|mesh-list
83746337|NCT00006264|Ganciclovir|ganciclovir|mesh-list
83746338|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83746339|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
83746340|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746341|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83746342|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746343|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746344|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
83746345|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746346|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83746347|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83746348|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746349|NCT00006267|Rubitecan|rubitecan|mesh-list
83746350|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746351|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83746352|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746353|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746354|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746355|NCT00006270|Cosyntropin|cosyntropin|mesh-list
83746356|NCT00006270|Metyrapone|metyrapone|mesh-list
83746357|NCT00006270|Hormones|hormones|mesh-ancestor
83746358|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746359|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746360|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
83746361|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746362|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746363|NCT00006276|Paclitaxel|paclitaxel|mesh-list
83746364|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746365|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746366|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746367|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746368|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746369|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746370|NCT00006279|Nevirapine|nevirapine|mesh-list
83746371|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83746372|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746373|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746374|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746375|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
83746376|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746377|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83746378|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83746379|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83746380|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83746381|NCT00006291|Aldesleukin|aldesleukin|mesh-list
83746382|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746383|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83746384|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83746385|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
83746386|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746387|NCT00006294|Amlodipine|amlodipine|mesh-list
83746388|NCT00006294|Lisinopril|lisinopril|mesh-list
83746389|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
83746390|NCT00006294|Doxazosin|doxazosin|mesh-list
83746391|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83746392|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83746393|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83746394|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746395|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83746396|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746397|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
83746398|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83746399|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
83746400|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746401|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83746402|NCT00006294|Protective Agents|protective agents|mesh-ancestor
83746403|NCT00006294|Diuretics|diuretics|mesh-ancestor
83746404|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
83746405|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83746406|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83746407|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83746408|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83746409|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
83746410|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83746411|NCT00005818|Irinotecan|irinotecan|mesh-list
83746412|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83746413|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746414|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746415|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746416|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746417|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83746418|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
83746419|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83746420|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
83746421|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83746422|NCT00006324|Estradiol|estradiol|mesh-list
83746423|NCT00006324|Estrogens|estrogens|mesh-ancestor
83746424|NCT00006324|Hormones|hormones|mesh-ancestor
83746425|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746426|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746427|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83746428|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
83746429|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83746430|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83746431|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83746432|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83746433|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83746434|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83746435|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83746436|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746437|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83746438|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
83746439|NCT00005824|Busulfan|busulfan|mesh-list
83746440|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746441|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
83746442|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746443|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746444|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746445|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
83746446|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746447|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746448|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746449|NCT00005827|Genistein|genistein|mesh-list
83746450|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83746451|NCT00005827|Protective Agents|protective agents|mesh-ancestor
83746452|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746453|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746454|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83746455|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746456|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746457|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
83746458|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83746459|NCT00005827|Estrogens|estrogens|mesh-ancestor
83746460|NCT00005827|Hormones|hormones|mesh-ancestor
83746461|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746462|NCT00005830|Doxorubicin|doxorubicin|mesh-list
83746463|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83746464|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746465|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746466|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746467|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746468|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746469|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746470|NCT00005833|Tipifarnib|tipifarnib|mesh-list
83746471|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746472|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
83746473|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746474|NCT00006330|Digoxin|digoxin|mesh-list
83746475|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83746476|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83746477|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746478|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746479|NCT00006330|Protective Agents|protective agents|mesh-ancestor
83746480|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746481|NCT00005839|Capecitabine|capecitabine|mesh-list
83746482|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
83746483|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746484|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
83746485|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746486|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746487|NCT00005842|Trastuzumab|trastuzumab|mesh-list
83746488|NCT00005842|Tipifarnib|tipifarnib|mesh-list
83746489|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83746490|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746491|NCT00005845|Tipifarnib|tipifarnib|mesh-list
83746492|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901672|NCT04716946|Durvalumab|durvalumab|mesh-list
83746493|NCT00005848|Tipifarnib|tipifarnib|mesh-list
83746494|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746495|NCT00005851|Cyclosporine|cyclosporine|mesh-list
83746496|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
83746497|NCT00005851|Fludarabine|fludarabine|mesh-list
83746498|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
83746499|NCT00005851|Cyclosporins|cyclosporins|mesh-list
83746500|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746501|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746502|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
83746503|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746504|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746505|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
83746506|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746507|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746508|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
83746509|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746510|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746511|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746512|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83746513|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746514|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83746515|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
83746516|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83746517|NCT00005854|Cyclosporine|cyclosporine|mesh-list
83746518|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
83746519|NCT00005854|Methotrexate|methotrexate|mesh-list
83746520|NCT00005854|Cyclosporins|cyclosporins|mesh-list
83746521|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746522|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
83746523|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746524|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746525|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746526|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
83746527|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746528|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746529|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746530|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83746531|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
83746532|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83746533|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746534|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
83746535|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746536|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746537|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83746538|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746539|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
83746540|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746541|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83746542|NCT00005857|Docetaxel|docetaxel|mesh-list
83746543|NCT00005857|Trastuzumab|trastuzumab|mesh-list
83746544|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746545|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746546|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746547|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746548|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746549|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83746550|NCT00005860|Leucovorin|leucovorin|mesh-list
83746551|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
83746552|NCT00005860|Floxuridine|floxuridine|mesh-list
83746553|NCT00005860|Calcium|calcium|mesh-list
83746554|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
83746555|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83746556|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746557|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746558|NCT00005860|Antidotes|antidotes|mesh-ancestor
83746559|NCT00005860|Protective Agents|protective agents|mesh-ancestor
83746560|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
83746561|NCT00005860|Vitamins|vitamins|mesh-ancestor
83746562|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
82901747|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
83746563|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746564|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
83746565|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746566|NCT00005863|Cytarabine|cytarabine|mesh-list
83746567|NCT00005863|Fludarabine|fludarabine|mesh-list
83746568|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
83746569|NCT00005863|Etoposide|etoposide|mesh-list
83746571|NCT00005863|Tretinoin|tretinoin|mesh-list
83746572|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746573|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746574|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
83746575|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746576|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746577|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
83746578|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746579|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746580|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746581|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746582|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746583|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
83746584|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746585|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746586|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
83746587|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746588|NCT00005866|Cyclosporine|cyclosporine|mesh-list
83746589|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
83746590|NCT00005866|Busulfan|busulfan|mesh-list
83746591|NCT00005866|Methotrexate|methotrexate|mesh-list
83746592|NCT00005866|Cyclosporins|cyclosporins|mesh-list
83746593|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746594|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
83746595|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746596|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746597|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746598|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
83746599|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746600|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746601|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746602|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83746603|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
83746604|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83746605|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746606|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
83746607|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746608|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746609|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83746610|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746611|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
83746612|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746613|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83746614|NCT00005869|Gemcitabine|gemcitabine|mesh-list
83746615|NCT00005869|Rubitecan|rubitecan|mesh-list
83746616|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746617|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
83746618|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746619|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746620|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83746621|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746622|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746623|NCT00005872|Rubitecan|rubitecan|mesh-list
83746624|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746625|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83746626|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746627|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746628|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746629|NCT00005875|Rubitecan|rubitecan|mesh-list
83746630|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746631|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83746632|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746633|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746634|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746635|NCT00005878|Celecoxib|celecoxib|mesh-list
83746636|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83746637|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83746638|NCT00005878|Analgesics|analgesics|mesh-ancestor
83746639|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
83746640|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746641|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746642|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83746643|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82901820|NCT00043108|Paclitaxel|paclitaxel|mesh-list
83746644|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83746645|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83746646|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746647|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746648|NCT00005884|Eflornithine|eflornithine|mesh-list
83746649|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746650|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83746651|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83746652|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83746653|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746654|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83746655|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746656|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746657|NCT00005887|Efaproxiral|efaproxiral|mesh-list
83746658|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
83746659|NCT00006339|Ritonavir|ritonavir|mesh-list
83746660|NCT00006339|Indinavir|indinavir|mesh-list
83746661|NCT00006339|Stavudine|stavudine|mesh-list
83746662|NCT00006339|Didanosine|didanosine|mesh-list
83746663|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
83746664|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83746665|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83746666|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
83746667|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746668|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746669|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83746670|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83746671|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
83746672|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746673|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83746674|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83746675|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746676|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
83746677|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746678|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
83746679|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83746680|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83746681|NCT00005890|Hormones|hormones|mesh-ancestor
83746682|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746683|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746684|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
83746685|NCT00005893|Busulfan|busulfan|mesh-list
83746686|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83746687|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746688|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
83746689|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746690|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746691|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746692|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
83746693|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746694|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746695|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746696|NCT00005896|Lenograstim|lenograstim|mesh-list
83746697|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83746698|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
83746699|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746700|NCT00386503|Artesunate|artesunate|mesh-list
83746701|NCT00386503|Amodiaquine|amodiaquine|mesh-list
83746702|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
83746703|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83746704|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83746705|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746706|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746707|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
83746708|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
83746709|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83746710|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
83746711|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83746712|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83746713|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83746714|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83746715|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746716|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83746717|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83746718|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746719|NCT00006345|Dexamethasone|dexamethasone|mesh-list
83746720|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
83746721|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83746723|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
83746724|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746725|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746726|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83746727|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
83746728|NCT00006345|Hormones|hormones|mesh-ancestor
83503383|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
83746729|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746730|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83746731|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746732|NCT00005920|Caspofungin|caspofungin|mesh-list
83746733|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
83746734|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746735|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746736|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746737|NCT00005926|Gemcitabine|gemcitabine|mesh-list
83746738|NCT00005926|Trastuzumab|trastuzumab|mesh-list
83746739|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746740|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
83746741|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746742|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746743|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83746744|NCT00005935|Cyclosporine|cyclosporine|mesh-list
83746745|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
83746746|NCT00005935|Cyclosporins|cyclosporins|mesh-list
83746747|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746748|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746749|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746750|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
83746751|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746752|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
83746753|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746754|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746755|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746756|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83746757|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746758|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746759|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83746760|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
83746761|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83746762|NCT00006348|Ondansetron|ondansetron|mesh-list
83746763|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
83746764|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
83746765|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746766|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746767|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83746768|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
83746769|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746770|NCT00006348|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83746771|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83746772|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
83746773|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83746774|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746775|NCT00005938|Exatecan|exatecan|mesh-list
83746776|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83746777|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746778|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746779|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746780|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746781|NCT00005941|Cyclosporine|cyclosporine|mesh-list
83746782|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
83746783|NCT00005941|Fludarabine|fludarabine|mesh-list
83746784|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
83746785|NCT00005941|Cyclosporins|cyclosporins|mesh-list
83746786|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746787|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746788|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
83746789|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746790|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746791|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
83746792|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746793|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746794|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
83746795|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746796|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746797|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746798|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83746799|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746800|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83746801|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
83746802|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83746803|NCT00005944|Leucovorin|leucovorin|mesh-list
83746804|NCT00005944|Fluorouracil|fluorouracil|mesh-list
83746805|NCT00005944|Mitomycins|mitomycins|mesh-list
83746806|NCT00005944|Mitomycin|mitomycin|mesh-list
83746807|NCT00005944|Calcium|calcium|mesh-list
83746808|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
83746809|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83746810|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746811|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
83746812|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746813|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746814|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746815|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746816|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
83746817|NCT00005944|Antidotes|antidotes|mesh-ancestor
83746818|NCT00005944|Protective Agents|protective agents|mesh-ancestor
83746819|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
83746820|NCT00005944|Vitamins|vitamins|mesh-ancestor
83746821|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
83746822|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746823|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
83746824|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746825|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746826|NCT00387699|Bevacizumab|bevacizumab|mesh-list
83746827|NCT00387699|Etoposide|etoposide|mesh-list
83746828|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83746829|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746830|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83746831|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83746832|NCT00387699|Growth Substances|growth substances|mesh-ancestor
83746833|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746834|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
83746835|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746836|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746837|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746838|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746839|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746840|NCT00005959|Prednisone|prednisone|mesh-list
83746841|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
83746842|NCT00005959|Rituximab|rituximab|mesh-list
83746843|NCT00005959|Doxorubicin|doxorubicin|mesh-list
83746844|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83746845|NCT00005959|Vincristine|vincristine|mesh-list
83746846|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746847|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
83746848|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746849|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746850|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746851|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
83746852|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746853|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746854|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746855|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83746856|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746857|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746858|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746859|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746860|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83746861|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
83746862|NCT00005959|Hormones|hormones|mesh-ancestor
83746863|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746864|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83746865|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746866|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746867|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746868|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746869|NCT00387738|Histamine|histamine|mesh-list
83746870|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
83503470|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
83746871|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
83746872|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83746873|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746874|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746875|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
83746876|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746877|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83746878|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
83746879|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746880|NCT00005968|Irofulven|irofulven|mesh-list
83746881|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746882|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
83746883|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746884|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746885|NCT00387777|Buprenorphine|buprenorphine|mesh-list
83746886|NCT00387777|Analgesics|analgesics|mesh-list
83746887|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83746888|NCT00387777|Narcotics|narcotics|mesh-ancestor
83746889|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83746890|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746891|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
83746892|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746893|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83746894|NCT00005971|Alvocidib|alvocidib|mesh-list
83746895|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746896|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
83746897|NCT00005971|Growth Substances|growth substances|mesh-ancestor
83746898|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746899|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83746900|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746901|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746902|NCT00005974|Alvocidib|alvocidib|mesh-list
83746903|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746904|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
83746905|NCT00005974|Growth Substances|growth substances|mesh-ancestor
83746906|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746907|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83746908|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746909|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746910|NCT00005977|Leucovorin|leucovorin|mesh-list
83746911|NCT00005977|Cytarabine|cytarabine|mesh-list
83746912|NCT00005977|Dexamethasone|dexamethasone|mesh-list
83746913|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
83746914|NCT00005977|Ifosfamide|ifosfamide|mesh-list
83746915|NCT00005977|Doxorubicin|doxorubicin|mesh-list
83746916|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83746917|NCT00005977|Methotrexate|methotrexate|mesh-list
83746918|NCT00005977|Etoposide|etoposide|mesh-list
83746919|NCT00005977|Vincristine|vincristine|mesh-list
83746920|NCT00005977|Lenograstim|lenograstim|mesh-list
83746921|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
83746922|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746923|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
83746924|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746925|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746926|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746927|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
83746928|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746929|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746930|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746931|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83746932|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
83746933|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
83746934|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83746935|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83746936|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
83746937|NCT00005977|Hormones|hormones|mesh-ancestor
83746938|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83746939|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83746940|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746941|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746942|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746943|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746944|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83746945|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
83746946|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83746947|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83746948|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
83746949|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
83746950|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83746951|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83746952|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83746953|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
83746954|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746955|NCT00005977|Antidotes|antidotes|mesh-ancestor
83746956|NCT00005977|Protective Agents|protective agents|mesh-ancestor
83746957|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
83746958|NCT00005977|Vitamins|vitamins|mesh-ancestor
83746959|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
83746960|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83746961|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
83746962|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
83746963|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
83746964|NCT00005980|Doxorubicin|doxorubicin|mesh-list
83746965|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83746966|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83746967|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746968|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83746969|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83746970|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83746971|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746972|NCT00005986|Interferons|interferons|mesh-list
83746973|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
83746974|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
83746975|NCT00005986|Busulfan|busulfan|mesh-list
83746976|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746977|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
83746978|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746979|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746980|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83746981|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
83746982|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83746983|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746984|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83746985|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
83746986|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83746987|NCT00005989|Tipifarnib|tipifarnib|mesh-list
83746988|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83746989|NCT00005998|Cytarabine|cytarabine|mesh-list
83746990|NCT00005998|Dexamethasone|dexamethasone|mesh-list
83746991|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
83746992|NCT00005998|Carmustine|carmustine|mesh-list
83746993|NCT00005998|Etoposide|etoposide|mesh-list
83746994|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
83746995|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83746996|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
83746997|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83746998|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83746999|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747000|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
83747001|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747002|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747003|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83747004|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83747005|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
83747006|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
83747007|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747008|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83747009|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
83747010|NCT00005998|Hormones|hormones|mesh-ancestor
83747011|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83747012|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83747013|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747014|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747015|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747016|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747017|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747018|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
83747019|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
82902192|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747020|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747021|NCT00005998|Analgesics|analgesics|mesh-ancestor
83747022|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
83747023|NCT00006351|Gemcitabine|gemcitabine|mesh-list
83747024|NCT00006351|Lonafarnib|lonafarnib|mesh-list
83747025|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747026|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
83747027|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747028|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747029|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747030|NCT00006001|Semaxinib|semaxinib|mesh-list
83747031|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83747032|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83747033|NCT00006001|Growth Substances|growth substances|mesh-ancestor
83747034|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747035|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83747036|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747037|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747038|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747039|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747040|NCT00006007|Gemcitabine|gemcitabine|mesh-list
83747041|NCT00006007|Pemetrexed|pemetrexed|mesh-list
83747042|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747043|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
83747044|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747045|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747046|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747047|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83747048|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747049|NCT00006010|Gemcitabine|gemcitabine|mesh-list
83747050|NCT00006010|Docetaxel|docetaxel|mesh-list
83747051|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747052|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
83747053|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747054|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747055|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83747056|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83747057|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83747058|NCT00006013|Semaxinib|semaxinib|mesh-list
83747059|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83747060|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83747061|NCT00006013|Growth Substances|growth substances|mesh-ancestor
83747062|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747063|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
83747064|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747065|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747066|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747067|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747068|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
83747069|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747070|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747071|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747072|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747073|NCT00006016|Thalidomide|thalidomide|mesh-list
83747074|NCT00006016|Doxorubicin|doxorubicin|mesh-list
83747075|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83747076|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83747077|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747078|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747079|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747080|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747081|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747082|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747083|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
83747084|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747085|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
83747086|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83747087|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747088|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83747089|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83747090|NCT00006016|Growth Substances|growth substances|mesh-ancestor
83747091|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
83747092|NCT00006019|Azacitidine|azacitidine|mesh-list
83747093|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83747094|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747095|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
83747096|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747097|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747098|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747100|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
83747101|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747102|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747103|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747104|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
83747105|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747106|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83747107|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
83747108|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747109|NCT00006025|Irinotecan|irinotecan|mesh-list
83747110|NCT00006025|Temozolomide|temozolomide|mesh-list
83747111|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83747112|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747113|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747114|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747115|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747116|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747117|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
83747118|NCT00386659|Ritonavir|ritonavir|mesh-list
83747119|NCT00386659|Lopinavir|lopinavir|mesh-list
83747120|NCT00386659|Tenofovir|tenofovir|mesh-list
83747121|NCT00386659|Abacavir|abacavir|mesh-list
83747122|NCT00386659|Efavirenz|efavirenz|mesh-list
83747123|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
83747124|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83747125|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83747126|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
83747127|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747128|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747129|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747130|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747131|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
83747132|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747133|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83747134|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83747135|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83747136|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747137|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83747138|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83747139|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83747140|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83747141|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83747142|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
83747143|NCT00006028|Gemcitabine|gemcitabine|mesh-list
83747144|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747145|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747146|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
83747147|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747148|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
83747149|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
83747150|NCT00387933|Vatalanib|vatalanib|mesh-list
83747151|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747152|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747153|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747154|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747155|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
83747156|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747157|NCT00006034|Doxorubicin|doxorubicin|mesh-list
83747158|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83747159|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83747160|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83747161|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747162|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747163|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747164|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747165|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747166|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83747167|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
83747168|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747169|NCT00006037|Fluorouracil|fluorouracil|mesh-list
83747170|NCT00006037|Irinotecan|irinotecan|mesh-list
83747171|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
83747172|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747173|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747174|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747175|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747176|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
83747177|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747178|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83747179|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747180|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747182|NCT00006040|Antibodies|antibodies|mesh-list
83747183|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83747184|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
83747185|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747186|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747187|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747188|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747189|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747190|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747191|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747192|NCT00006363|Cytarabine|cytarabine|mesh-list
83747193|NCT00006363|Aldesleukin|aldesleukin|mesh-list
83747194|NCT00006363|Etoposide|etoposide|mesh-list
83747195|NCT00006363|Daunorubicin|daunorubicin|mesh-list
83747196|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
83747197|NCT00006363|Busulfan|busulfan|mesh-list
83747198|NCT00006363|Interleukin-2|interleukin-2|mesh-list
83747199|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747200|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747201|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747202|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747203|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747204|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747205|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747206|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
83747207|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
83747208|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747209|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747210|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
83747211|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747212|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
83747213|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747214|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83747215|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83747216|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83747217|NCT00006363|Analgesics|analgesics|mesh-ancestor
83747218|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
83747219|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747220|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747221|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747222|NCT05680870|Omeprazole|omeprazole|mesh-list
83747223|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83747224|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83747225|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83747226|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747227|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747228|NCT00006366|Fluorouracil|fluorouracil|mesh-list
83747229|NCT00006366|Irinotecan|irinotecan|mesh-list
83747230|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
83747231|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747232|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747233|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747234|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747235|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
83747236|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747237|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83747238|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747239|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747240|NCT05680792|Ritonavir|ritonavir|mesh-list
83747241|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83747242|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
83747243|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83747244|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83747245|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
83747246|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747247|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747248|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82902416|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83747249|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747250|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
83747251|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747252|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83747253|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83747254|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83747255|NCT00006372|Gemcitabine|gemcitabine|mesh-list
83747256|NCT00006372|Doxorubicin|doxorubicin|mesh-list
83747257|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83747258|NCT00006372|Vinorelbine|vinorelbine|mesh-list
83747259|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747260|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
83747261|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747262|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747263|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83747264|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747265|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747266|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747267|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747268|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83747269|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83747270|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83747271|NCT00006378|Paclitaxel|paclitaxel|mesh-list
83747272|NCT00006378|Carboplatin|carboplatin|mesh-list
83747273|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747274|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747275|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
83747276|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
83747277|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
83747278|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747279|NCT00006381|Celecoxib|celecoxib|mesh-list
83747280|NCT00006381|Trastuzumab|trastuzumab|mesh-list
83747281|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747282|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747283|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83747284|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83747285|NCT00006381|Analgesics|analgesics|mesh-ancestor
83747286|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
83747287|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747288|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747289|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83747290|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83747291|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83747292|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83747293|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747294|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747295|NCT00006384|Interferons|interferons|mesh-list
83747296|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
83747297|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747298|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
83747299|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747300|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
83747301|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747302|NCT00386815|Pemetrexed|pemetrexed|mesh-list
83747303|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747304|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747305|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747306|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83747307|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747308|NCT05679388|Ritonavir|ritonavir|mesh-list
83747309|NCT05679388|Itraconazole|itraconazole|mesh-list
83747310|NCT05679388|Relugolix|relugolix|mesh-list
83747311|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83747312|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83747313|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83747314|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747315|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747316|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747317|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747318|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
83747319|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747320|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83747321|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83747322|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
83747323|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83747324|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83747325|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
83747326|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83747327|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747328|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
83747329|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83747330|NCT05678296|Analgesics|analgesics|mesh-list
83747331|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747332|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
83747333|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747334|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747335|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83747336|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747337|NCT00006396|Zidovudine|zidovudine|mesh-list
83747338|NCT00006396|Nevirapine|nevirapine|mesh-list
83747339|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
83747340|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747341|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83747342|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747343|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747344|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
83747345|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747346|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747347|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747348|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83747349|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83747350|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
83747351|NCT03996148|Remifentanil|remifentanil|mesh-list
83747352|NCT03996148|Propofol|propofol|mesh-list
83747353|NCT03996148|Desflurane|desflurane|mesh-list
83747354|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83747355|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83747356|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747357|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83747358|NCT03996148|Analgesics|analgesics|mesh-ancestor
83747359|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
83747360|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747361|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83747362|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83747363|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83747364|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83747365|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747366|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747367|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83747368|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
83747369|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
83747370|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83747371|NCT03996148|Narcotics|narcotics|mesh-ancestor
83747372|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83747373|NCT00006399|Donepezil|donepezil|mesh-list
83747374|NCT00006399|Progesterone|progesterone|mesh-list
83747375|NCT00006399|Estrogens|estrogens|mesh-list
83747376|NCT00006399|Progestins|progestins|mesh-ancestor
83747377|NCT00006399|Hormones|hormones|mesh-ancestor
83747378|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83747379|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747380|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83747381|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747382|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747383|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
83747384|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747385|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
83747387|NCT05660200|Trace Elements|trace elements|mesh-ancestor
83747388|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
83747389|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747390|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83747391|NCT05656027|Aceclidine|aceclidine|mesh-list
83747392|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83747393|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83747394|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83747395|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83747396|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
83747397|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902566|NCT05462548|Luspatercept|luspatercept|mesh-list
83747398|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747399|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747400|NCT05656027|Miotics|miotics|mesh-ancestor
83747401|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
83747402|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747403|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83747404|NCT05552404|Aminophylline|aminophylline|mesh-list
83747405|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83747406|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
83747407|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747408|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747409|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83747410|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
83747411|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83747412|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83747413|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747414|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747415|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83747416|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83747417|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
83747418|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747419|NCT05552404|Protective Agents|protective agents|mesh-ancestor
83747420|NCT05546320|Aspirin|aspirin|mesh-list
83747421|NCT05546320|Metoprolol|metoprolol|mesh-list
83747422|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
83747423|NCT05546320|Clopidogrel|clopidogrel|mesh-list
83747424|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83747425|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83747426|NCT05546320|Analgesics|analgesics|mesh-ancestor
83747427|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
83747428|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747429|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747430|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83747431|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83747432|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83747433|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83747434|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747435|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83747436|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83747437|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747438|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
83747439|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83747440|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83747441|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83747442|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
83747443|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747444|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83747445|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
83747446|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83747447|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
83747448|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
83747449|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83747450|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83747451|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
83747452|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
83747453|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83747454|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83747455|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83747456|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
83747457|NCT05535595|Perindopril|perindopril|mesh-list
83747458|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83747459|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
83747460|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747461|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747462|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83747463|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
83747464|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83747465|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83747466|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747467|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
83747468|NCT05470816|Coagulants|coagulants|mesh-ancestor
83747469|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83747470|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83747471|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83747472|NCT05431543|Aceclidine|aceclidine|mesh-list
83747473|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82902645|NCT03629184|Oseltamivir|oseltamivir|mesh-list
83747474|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83747475|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83747477|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
83747478|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747479|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747480|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747481|NCT05431543|Miotics|miotics|mesh-ancestor
83747482|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
83747483|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747484|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83747485|NCT05401786|Ipilimumab|ipilimumab|mesh-list
83747486|NCT05401786|Cemiplimab|cemiplimab|mesh-list
83747487|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747488|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747489|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83747490|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747491|NCT05285683|Levodopa|levodopa|mesh-list
83747492|NCT05285683|Carbidopa|carbidopa|mesh-list
83747493|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83747494|NCT05285683|Methylphenidate|methylphenidate|mesh-list
83747495|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83747496|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747497|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83747498|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83747499|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83747500|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747501|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
83747502|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747503|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83747504|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83747505|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83747506|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747507|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83747508|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
83747509|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
83747510|NCT05247970|Midazolam|midazolam|mesh-list
83747511|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83747512|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83747513|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83747514|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747515|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83747516|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83747517|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83747518|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83747519|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
83747520|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
83747521|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
83747522|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
83747523|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747524|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747525|NCT00006441|Lamivudine|lamivudine|mesh-list
83747526|NCT00006441|Zidovudine|zidovudine|mesh-list
83747527|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83747528|NCT00006441|Aldesleukin|aldesleukin|mesh-list
83747529|NCT00006441|Nelfinavir|nelfinavir|mesh-list
83747530|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83747531|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747532|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747533|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747534|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
83747535|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747536|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747537|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747538|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
83747539|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747540|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83747541|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83747542|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
83747543|NCT05147233|Dexamethasone|dexamethasone|mesh-list
83747544|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83747545|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
82902720|NCT03840616|Fluconazole|fluconazole|mesh-list
83747546|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
83747547|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747548|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747549|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83747550|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
83747551|NCT05147233|Hormones|hormones|mesh-ancestor
83747552|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83747553|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83747554|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747555|NCT03926845|Thiamidol|thiamidol|mesh-list
83747556|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747557|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747558|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83747559|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747560|NCT00006453|Carboplatin|carboplatin|mesh-list
83747561|NCT00006453|Gemcitabine|gemcitabine|mesh-list
83747562|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747563|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747564|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
83747565|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747566|NCT00387322|Pemetrexed|pemetrexed|mesh-list
83747567|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83747568|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747569|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747570|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747571|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83747572|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747573|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747574|NCT00006459|Paclitaxel|paclitaxel|mesh-list
83747575|NCT00006459|Gemcitabine|gemcitabine|mesh-list
83747576|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747577|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747578|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
83747579|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
83747580|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
83747581|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747582|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747583|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
83747584|NCT00387400|Everolimus|everolimus|mesh-list
83747585|NCT00387400|Temozolomide|temozolomide|mesh-list
83747586|NCT00387400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83747587|NCT00387400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747588|NCT00387400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747589|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747590|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747591|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
83747592|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747593|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747594|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747595|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
83747596|NCT03876106|LUT014|lut014|mesh-list
83747597|NCT03876106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747598|NCT03876106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747599|NCT03876106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747600|NCT00388011|Morphine|morphine|mesh-list
83747601|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83747602|NCT00388011|Narcotics|narcotics|mesh-ancestor
83747603|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83747604|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747605|NCT00388011|Analgesics|analgesics|mesh-ancestor
83747606|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
83747607|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747608|NCT04852978|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83747609|NCT04852978|Antiviral Agents|antiviral agents|mesh-ancestor
83747610|NCT04852978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747611|NCT00388089|Bortezomib|bortezomib|mesh-list
83747612|NCT00388089|Topotecan|topotecan|mesh-list
83747613|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747614|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83747615|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747616|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747617|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747618|NCT04742023|Insulin|insulin|mesh-list
83747619|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83747620|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747621|NCT00388128|Caffeine|caffeine|mesh-list
83747622|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83747623|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747624|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83747625|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747626|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747627|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83747628|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83747629|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
83747630|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747631|NCT00006462|Gemcitabine|gemcitabine|mesh-list
83747632|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747633|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
83747634|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747635|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747636|NCT00006465|Capecitabine|capecitabine|mesh-list
83747637|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
83747638|NCT00006465|Irinotecan|irinotecan|mesh-list
83747639|NCT00006465|Camptothecin|camptothecin|mesh-list
83747640|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747641|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
83747642|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747643|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747644|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83747645|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747646|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747647|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747648|NCT04575181|Insulin|insulin|mesh-list
83747649|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83747650|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
83747651|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83747652|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747653|NCT00006468|Leucovorin|leucovorin|mesh-list
83747654|NCT00006468|Fluorouracil|fluorouracil|mesh-list
83747655|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
83747656|NCT00006468|Calcium|calcium|mesh-list
83747657|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
83747658|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83747659|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747660|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
83747661|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747662|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747663|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747664|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747665|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
83747666|NCT00006468|Antidotes|antidotes|mesh-ancestor
83747667|NCT00006468|Protective Agents|protective agents|mesh-ancestor
83747668|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
83747669|NCT00006468|Vitamins|vitamins|mesh-ancestor
83747670|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
83747671|NCT00006471|Fenretinide|fenretinide|mesh-list
83747672|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747673|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83747674|NCT00006471|Protective Agents|protective agents|mesh-ancestor
83747675|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747676|NCT00006474|Temozolomide|temozolomide|mesh-list
83747677|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83747678|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747679|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
83747680|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747681|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747682|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747683|NCT04201834|Risperidone|risperidone|mesh-list
83747684|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83747685|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
83747686|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83747687|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747688|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747689|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83747690|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83747691|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902866|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
83747692|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83747693|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82902867|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
83747694|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
83747695|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
83747696|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83747697|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83747698|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747699|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
83747700|NCT04192435|Coagulants|coagulants|mesh-ancestor
83747701|NCT03771157|Vaccines|vaccines|mesh-list
83747702|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
83747703|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747704|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
83747705|NCT03765229|Entinostat|entinostat|mesh-list
83747706|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747707|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747708|NCT03765229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83747709|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747710|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83747711|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747712|NCT03624517|Octreotide|octreotide|mesh-list
83747713|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83747714|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83747715|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747716|NCT00423397|Interferons|interferons|mesh-list
83747717|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
83747718|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
83747719|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83747720|NCT00423397|Gefitinib|gefitinib|mesh-list
83747721|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747722|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
83747723|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747724|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
83747725|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747726|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747727|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747728|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747729|NCT03352765|Rituximab|rituximab|mesh-list
83747730|NCT03352765|Melphalan|melphalan|mesh-list
83747731|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83747732|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747733|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747734|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
83747735|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747736|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83747737|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747738|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
83747739|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747740|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83747741|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747742|NCT03265405|Prednisolone|prednisolone|mesh-list
83747743|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83747744|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
83747745|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83747746|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
83747747|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83747748|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
83747749|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83747750|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
83747751|NCT03265405|Hormones|hormones|mesh-ancestor
83747752|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83747753|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747754|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83747755|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747756|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
83747757|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
83747758|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747759|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83747760|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83747761|NCT03265405|Protective Agents|protective agents|mesh-ancestor
83747762|NCT03808480|Nivolumab|nivolumab|mesh-list
83747763|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747764|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747765|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83747766|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747767|NCT03003325|Aspirin|aspirin|mesh-list
83747768|NCT03003325|Interferons|interferons|mesh-list
83747769|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747770|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
82902940|NCT01670656|Ibuprofen|ibuprofen|mesh-list
83747771|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747772|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83747773|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83747774|NCT03003325|Analgesics|analgesics|mesh-ancestor
83747775|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
83747776|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83747777|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747778|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83747779|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83747780|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83747781|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83747782|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747783|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83747784|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83747785|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747786|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
83747787|NCT02966548|Nivolumab|nivolumab|mesh-list
83747788|NCT02966548|Relatlimab|relatlimab|mesh-list
83747789|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747790|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747791|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83747792|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747793|NCT02890069|Everolimus|everolimus|mesh-list
83747794|NCT02890069|Panobinostat|panobinostat|mesh-list
83747795|NCT02890069|Spartalizumab|spartalizumab|mesh-list
83747796|NCT02890069|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83747797|NCT02890069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83747798|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747799|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747800|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747801|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
83747802|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747803|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747804|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83747805|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83747806|NCT02890069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747807|NCT02425501|Aflibercept|aflibercept|mesh-list
83747808|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83747809|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83747810|NCT02425501|Growth Substances|growth substances|mesh-ancestor
83747811|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747812|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
83747813|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747814|NCT02409238|Metformin|metformin|mesh-list
83747815|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83747816|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747817|NCT00006480|Aldesleukin|aldesleukin|mesh-list
83747818|NCT00006480|Ganciclovir|ganciclovir|mesh-list
83747819|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83747820|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747821|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747822|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747823|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
83747824|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747825|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747826|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747827|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747828|NCT00006483|Sargramostim|sargramostim|mesh-list
83747829|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
83747830|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747831|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83747832|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903014|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82903015|NCT00620464|Progestins|progestins|mesh-ancestor
82903016|NCT00620464|Hormones|hormones|mesh-ancestor
82903017|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903018|NCT00541684|Atenolol|atenolol|mesh-list
82903019|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
82903020|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903021|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903022|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903023|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
82903024|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903025|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82903026|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82903027|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
82903031|NCT00413764|Tibolone|tibolone|mesh-list
83747833|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83747834|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83747835|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747836|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83747837|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747838|NCT00006519|Capravirine|capravirine|mesh-list
83747839|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83747840|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747841|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747842|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747843|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
83747844|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747845|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747846|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747847|NCT00006591|Ritonavir|ritonavir|mesh-list
83747848|NCT00006591|Amprenavir|amprenavir|mesh-list
83747849|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83747850|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83747851|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
83747852|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747853|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747854|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747855|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747856|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
83747857|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747858|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83747859|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83747860|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83747861|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
83747862|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83747863|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
83747864|NCT00006630|Antibodies|antibodies|mesh-list
83747865|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
83747866|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83747867|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83747868|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
83747869|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747870|NCT00006669|Prednisone|prednisone|mesh-list
83747871|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
83747872|NCT00006669|Rituximab|rituximab|mesh-list
83747873|NCT00006669|Doxorubicin|doxorubicin|mesh-list
83747874|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83747875|NCT00006669|Etoposide|etoposide|mesh-list
83747876|NCT00006669|Vincristine|vincristine|mesh-list
83747877|NCT00006669|Sargramostim|sargramostim|mesh-list
83747878|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747879|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
83747880|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747881|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83747882|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747883|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
83747884|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747885|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747886|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83747887|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747888|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83747889|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747890|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747891|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747892|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83747893|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
83747894|NCT00006669|Hormones|hormones|mesh-ancestor
83747895|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83747896|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83747897|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747898|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83747899|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83747900|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83747901|NCT00006708|Rituximab|rituximab|mesh-list
83747902|NCT00006708|Carboplatin|carboplatin|mesh-list
83747903|NCT00006708|Etoposide|etoposide|mesh-list
83747904|NCT00006708|Ifosfamide|ifosfamide|mesh-list
83747905|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747906|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747907|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
82903072|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747908|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747909|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83747910|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747911|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747912|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747913|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747914|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747915|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747916|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
83747917|NCT00006747|Cytarabine|cytarabine|mesh-list
83747918|NCT00006747|Methotrexate|methotrexate|mesh-list
83747919|NCT00006747|Etoposide|etoposide|mesh-list
83747920|NCT00006747|Melphalan|melphalan|mesh-list
83747921|NCT00006747|Carmustine|carmustine|mesh-list
83747922|NCT00006747|Tacrolimus|tacrolimus|mesh-list
83747923|NCT00006747|Sargramostim|sargramostim|mesh-list
83747924|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83747925|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
83747926|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83747927|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747928|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747929|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
83747930|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747931|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747932|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
83747933|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747934|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83747935|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747936|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
83747937|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83747938|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83747939|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83747940|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747941|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747942|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
83747943|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747944|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83747945|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83747946|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
83747947|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83747948|NCT00006786|Leucovorin|leucovorin|mesh-list
83747949|NCT00006786|Bevacizumab|bevacizumab|mesh-list
83747950|NCT00006786|Fluorouracil|fluorouracil|mesh-list
83747951|NCT00006786|Irinotecan|irinotecan|mesh-list
83747952|NCT00006786|Calcium|calcium|mesh-list
83747953|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
83747954|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747955|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747956|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83747957|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83747958|NCT00006786|Growth Substances|growth substances|mesh-ancestor
83747959|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747960|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
83747961|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83747962|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
83747963|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83747964|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83747965|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83747966|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
83747967|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83747968|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747969|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747970|NCT00006786|Antidotes|antidotes|mesh-ancestor
83747971|NCT00006786|Protective Agents|protective agents|mesh-ancestor
83747972|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
83747973|NCT00006786|Vitamins|vitamins|mesh-ancestor
83747974|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
83747975|NCT00006825|Doxorubicin|doxorubicin|mesh-list
83747976|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83747977|NCT00006825|Trastuzumab|trastuzumab|mesh-list
83747978|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83747979|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747980|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83747981|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83747982|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83747983|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903149|NCT04575688|Bupivacaine|bupivacaine|mesh-list
83747984|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83747985|NCT00006864|Aldesleukin|aldesleukin|mesh-list
83747986|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747987|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83747988|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83747989|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
83747990|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83747991|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
83747992|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83747993|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83747994|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
83747995|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83747996|NCT00006981|Immunotoxins|immunotoxins|mesh-list
83747997|NCT00006981|Immunoconjugates|immunoconjugates|mesh-ancestor
83747998|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
83747999|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748000|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
83748001|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748002|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748003|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83748004|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
83748005|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83748006|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748007|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748008|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748009|NCT00387556|Ondansetron|ondansetron|mesh-list
83748010|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
83748011|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
83748012|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748013|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748014|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748015|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
83748016|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
83748017|NCT00387556|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83748018|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83748019|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
83748020|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748021|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748022|NCT03780790|Bupivacaine|bupivacaine|mesh-list
83748023|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
83748024|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
83748025|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83748026|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748027|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
83748028|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748029|NCT00388167|Caspofungin|caspofungin|mesh-list
83748030|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
83748031|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748032|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748033|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748034|NCT00006043|Temozolomide|temozolomide|mesh-list
83748035|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748036|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
83748037|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748038|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748039|NCT00006049|Paclitaxel|paclitaxel|mesh-list
83748040|NCT00006049|Carboplatin|carboplatin|mesh-list
83748041|NCT00006049|Gefitinib|gefitinib|mesh-list
83748042|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748043|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748044|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83748045|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83748046|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83748047|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748048|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83748049|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748050|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
83748051|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748052|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82903223|NCT03615144|Fludarabine|fludarabine|mesh-list
82903224|NCT03615144|Melphalan|melphalan|mesh-list
82903225|NCT03615144|Thiotepa|thiotepa|mesh-list
82903226|NCT03615144|Clofarabine|clofarabine|mesh-list
82903227|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
82903228|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83748053|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903248|NCT03522506|Modafinil|modafinil|mesh-list
83748054|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748055|NCT00006055|Cyclosporine|cyclosporine|mesh-list
83748056|NCT00006055|Prednisone|prednisone|mesh-list
83748057|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
83748058|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
83748059|NCT00006055|Cyclosporins|cyclosporins|mesh-list
83748060|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83748061|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748062|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
83748063|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748064|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748065|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748066|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
83748067|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748068|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748069|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83748070|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83748071|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
83748072|NCT00006055|Hormones|hormones|mesh-ancestor
83748073|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83748074|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83748075|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748076|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
83748077|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748078|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
83748079|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83748080|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
83748081|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
83748082|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748083|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748084|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83748085|NCT00006055|Protective Agents|protective agents|mesh-ancestor
83748086|NCT00006070|Etanercept|etanercept|mesh-list
83748087|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83748088|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83748089|NCT00006070|Analgesics|analgesics|mesh-ancestor
83748090|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
83748091|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748092|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748093|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83748094|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748095|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748096|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748097|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
83748098|NCT00006079|Eflornithine|eflornithine|mesh-list
83748099|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748100|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83748101|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83748102|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83748103|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748104|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83748105|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748106|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748107|NCT00006082|Rubitecan|rubitecan|mesh-list
83748108|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748109|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83748110|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748111|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748112|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748113|NCT00006088|Vinorelbine|vinorelbine|mesh-list
83748114|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748115|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748116|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83748117|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83748118|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83748119|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748120|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
83748121|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748122|NCT00006094|Fluorouracil|fluorouracil|mesh-list
83748123|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
83748124|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
83748125|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748126|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748127|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903293|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83748128|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748130|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748131|NCT00006100|Aldesleukin|aldesleukin|mesh-list
83748132|NCT00006100|Fludarabine|fludarabine|mesh-list
83748133|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
83748134|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748135|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748136|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
83748137|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748138|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748139|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
83748140|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748141|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83748142|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83748143|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
83748144|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748145|NCT00006103|Leucovorin|leucovorin|mesh-list
83748146|NCT00006103|Fluorouracil|fluorouracil|mesh-list
83748147|NCT00006103|Irinotecan|irinotecan|mesh-list
83748148|NCT00006103|Calcium|calcium|mesh-list
83748149|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
83748150|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83748151|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748152|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
83748153|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748154|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748155|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748156|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748157|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
83748158|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83748159|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748160|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748161|NCT00006103|Antidotes|antidotes|mesh-ancestor
83748162|NCT00006103|Protective Agents|protective agents|mesh-ancestor
83748163|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
83748164|NCT00006103|Vitamins|vitamins|mesh-ancestor
83748165|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
83748166|NCT00006106|Fluorouracil|fluorouracil|mesh-list
83748167|NCT00006106|Dl1520|dl1520|mesh-list
83748168|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748169|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
83748170|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748171|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748172|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748173|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
83748174|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748175|NCT00006112|Leucovorin|leucovorin|mesh-list
83748176|NCT00006112|Fluorouracil|fluorouracil|mesh-list
83748177|NCT00006112|Mitomycins|mitomycins|mesh-list
83748178|NCT00006112|Mitomycin|mitomycin|mesh-list
83748179|NCT00006112|Calcium|calcium|mesh-list
83748180|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
83748181|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83748182|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748183|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
83748184|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748185|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748186|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748187|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748188|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
83748189|NCT00006112|Antidotes|antidotes|mesh-ancestor
83748190|NCT00006112|Protective Agents|protective agents|mesh-ancestor
83748191|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
83748192|NCT00006112|Vitamins|vitamins|mesh-ancestor
83748193|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
83748194|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748195|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
83748196|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748197|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748198|NCT00006115|Leucovorin|leucovorin|mesh-list
83748199|NCT00006115|Fluorouracil|fluorouracil|mesh-list
83748200|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
82903367|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903369|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
83748201|NCT00006115|Irinotecan|irinotecan|mesh-list
83748202|NCT00006115|Calcium|calcium|mesh-list
83748203|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
83748204|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83748205|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748206|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
83748207|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748208|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748209|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748210|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748211|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
83748212|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83748213|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748214|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748215|NCT00006115|Antidotes|antidotes|mesh-ancestor
83748216|NCT00006115|Protective Agents|protective agents|mesh-ancestor
83748217|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
83748218|NCT00006115|Vitamins|vitamins|mesh-ancestor
83748219|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
83748220|NCT00006118|Paclitaxel|paclitaxel|mesh-list
83748221|NCT00006118|Gemcitabine|gemcitabine|mesh-list
83748222|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748223|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748224|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83748225|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83748226|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83748227|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748228|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748229|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
83748230|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
83748231|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748232|NCT00006124|Celecoxib|celecoxib|mesh-list
83748233|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83748234|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83748235|NCT00006124|Analgesics|analgesics|mesh-ancestor
83748236|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
83748237|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748238|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748239|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83748240|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748241|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83748242|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83748243|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748244|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748245|NCT00006127|Amifostine|amifostine|mesh-list
83748246|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83748247|NCT00006127|Protective Agents|protective agents|mesh-ancestor
83748248|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748249|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83748250|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83748251|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83748252|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83748253|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
83748254|NCT00006133|Norethindrone|norethindrone|mesh-list
83748255|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
83748256|NCT00006133|Estradiol|estradiol|mesh-list
83748257|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83748258|NCT00006133|Estrogens|estrogens|mesh-ancestor
83748259|NCT00006133|Hormones|hormones|mesh-ancestor
83748260|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83748261|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748262|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83748263|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
82903440|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903441|NCT02843074|Dexamethasone|dexamethasone|mesh-list
82903442|NCT02843074|Lenalidomide|lenalidomide|mesh-list
82903443|NCT02843074|Elotuzumab|elotuzumab|mesh-list
82903444|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903445|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
82903446|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
82903447|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903448|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903449|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903450|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
82903451|NCT02843074|Hormones|hormones|mesh-ancestor
82903452|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903453|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82903454|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903455|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
83748264|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83748265|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83748266|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83748267|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83748268|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83748269|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83748270|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83748271|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748273|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
83748274|NCT00006136|Hematinics|hematinics|mesh-ancestor
83748275|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748276|NCT00006145|Valganciclovir|valganciclovir|mesh-list
83748277|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
83748278|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748279|NCT00006154|Ritonavir|ritonavir|mesh-list
83748280|NCT00006154|Indinavir|indinavir|mesh-list
83748281|NCT00006154|Aldesleukin|aldesleukin|mesh-list
83748282|NCT00006154|Abacavir|abacavir|mesh-list
83748283|NCT00006154|Stavudine|stavudine|mesh-list
83748284|NCT00006154|Didanosine|didanosine|mesh-list
83748285|NCT00006154|Efavirenz|efavirenz|mesh-list
83748286|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83748287|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83748288|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
83748289|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748290|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748291|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83748292|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83748293|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
83748294|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748295|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83748296|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83748297|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748298|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83748299|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748300|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83748301|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83748302|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83748303|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83748304|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83748305|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
83748306|NCT00006157|Desipramine|desipramine|mesh-list
83748307|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83748308|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
83748309|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83748310|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748311|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748312|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83748313|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83748314|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83748315|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
83748316|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748317|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748318|NCT00006190|Lamivudine|lamivudine|mesh-list
83748319|NCT00006190|Efavirenz|efavirenz|mesh-list
83748320|NCT00006190|Stavudine|stavudine|mesh-list
83748321|NCT00006190|Nelfinavir|nelfinavir|mesh-list
83748322|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83748323|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748324|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748325|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748326|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
83748327|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748328|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83748329|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83748330|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83748331|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82903499|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903500|NCT03519854|Bromides|bromides|mesh-list
82903501|NCT03519854|Rocuronium|rocuronium|mesh-list
82903502|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
82903503|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82903504|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82903505|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82903511|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
83748332|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83748333|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83748334|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83748335|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83748336|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83748337|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83748338|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
83748339|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
83748340|NCT00006196|Vitamin D|vitamin d|mesh-list
83748341|NCT00006196|Vitamins|vitamins|mesh-ancestor
83748342|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
83748343|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748344|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83748345|NCT00006199|Topotecan|topotecan|mesh-list
83748346|NCT00006199|Tipifarnib|tipifarnib|mesh-list
83748347|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83748348|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748349|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748350|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748351|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748352|NCT00006205|Topiramate|topiramate|mesh-list
83748353|NCT00006205|Ondansetron|ondansetron|mesh-list
83748354|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
83748355|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
83748356|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748357|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748358|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748359|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
83748360|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
83748361|NCT00006205|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83748362|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83748363|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
83748364|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748365|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748366|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
83748367|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83748368|NCT00006208|Emtricitabine|emtricitabine|mesh-list
83748369|NCT00006208|Efavirenz|efavirenz|mesh-list
83748370|NCT00006208|Stavudine|stavudine|mesh-list
83748371|NCT00006208|Didanosine|didanosine|mesh-list
83748372|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
83748373|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748374|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83748375|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748376|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748377|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748378|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83748379|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83748380|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83748381|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83748382|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83748383|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83748384|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83748385|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83748386|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
83748387|NCT00006211|Nelfinavir|nelfinavir|mesh-list
83748388|NCT00006211|Capravirine|capravirine|mesh-list
83748389|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83748390|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83748391|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
83748392|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748393|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748394|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83748395|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83748396|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
83748397|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748398|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83748399|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748400|NCT00006214|Flutamide|flutamide|mesh-list
83748401|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
83748402|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
83748403|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83748404|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748405|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83748406|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748407|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
83748408|NCT00006220|Tretinoin|tretinoin|mesh-list
83748409|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748410|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
83748411|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
83748412|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
83748413|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83748414|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
83748415|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748416|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83748417|NCT00006223|Protective Agents|protective agents|mesh-ancestor
83748418|NCT03761953|Oritavancin|oritavancin|mesh-list
83748419|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83748420|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748421|NCT00006226|Thalidomide|thalidomide|mesh-list
83748422|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748423|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
83748424|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748425|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
83748426|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83748427|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748428|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83748429|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83748430|NCT00006226|Growth Substances|growth substances|mesh-ancestor
83748431|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
83748432|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748433|NCT00006232|Dexamethasone|dexamethasone|mesh-list
83748434|NCT00006232|Doxorubicin|doxorubicin|mesh-list
83748435|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83748436|NCT00006232|Vincristine|vincristine|mesh-list
83748437|NCT00006232|Idarubicin|idarubicin|mesh-list
83748438|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83748439|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
83748440|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
83748441|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748442|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748443|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748444|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
83748445|NCT00006232|Hormones|hormones|mesh-ancestor
83748446|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83748447|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83748448|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748449|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748450|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748451|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748452|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748453|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748454|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748455|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
83748456|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
83748457|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
83748458|NCT00006235|Carboplatin|carboplatin|mesh-list
83748459|NCT00006235|Doxorubicin|doxorubicin|mesh-list
83748460|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83748461|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748462|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748463|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748464|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748465|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748466|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748467|NCT00006241|Lenograstim|lenograstim|mesh-list
83748468|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83748469|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
83748470|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748471|NCT00006247|Semaxinib|semaxinib|mesh-list
83748472|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83748473|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83748474|NCT00006247|Growth Substances|growth substances|mesh-ancestor
83748475|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748476|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
83748477|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903654|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748478|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83748479|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748480|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748481|NCT00006250|Dexamethasone|dexamethasone|mesh-list
83748482|NCT00006250|Fludarabine|fludarabine|mesh-list
83748483|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
83748484|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
83748485|NCT00006250|Chlorambucil|chlorambucil|mesh-list
83748486|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83748487|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
83748488|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
83748489|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748490|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748491|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748492|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
83748493|NCT00006250|Hormones|hormones|mesh-ancestor
83748494|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83748495|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83748496|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748497|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748498|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
83748499|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748500|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748501|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
83748502|NCT00006250|Analgesics|analgesics|mesh-ancestor
83748503|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
83748504|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748505|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748506|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748507|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748508|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
83748509|NCT00006265|Cytarabine|cytarabine|mesh-list
83748510|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
83748511|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748512|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
83748513|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748514|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748515|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
83748516|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748517|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748518|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
83748519|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748520|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83748521|NCT00006265|Immunotoxins|immunotoxins|mesh-ancestor
83748522|NCT00006265|Immunoconjugates|immunoconjugates|mesh-ancestor
83748523|NCT00007527|Buprenorphine|buprenorphine|mesh-list
83748524|NCT00007527|Naloxone|naloxone|mesh-list
83748525|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83748526|NCT00007527|Narcotics|narcotics|mesh-ancestor
83748527|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83748528|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748529|NCT00007527|Analgesics|analgesics|mesh-ancestor
83748530|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
83748531|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748532|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83748533|NCT00006280|Tobramycin|tobramycin|mesh-list
83748534|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83748535|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748536|NCT00006286|Fluoxetine|fluoxetine|mesh-list
83748537|NCT00006286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83748538|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83748539|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83748540|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748541|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748542|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
83748543|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748544|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83748545|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
83748546|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83748547|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83748548|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83748549|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748550|NCT00007605|Amiodarone|amiodarone|mesh-list
83748551|NCT00007605|Sotalol|sotalol|mesh-list
83748552|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83748553|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
83748554|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83748555|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83748556|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748557|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83748558|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83748559|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83748560|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748561|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83748562|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83748563|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83748564|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83748565|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83748566|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
83748567|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748568|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748569|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
83748570|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
83748571|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748573|NCT00006292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83748574|NCT00006292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83748575|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
83748576|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748577|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748578|NCT03709888|Pregabalin|pregabalin|mesh-list
83748579|NCT03709888|Memantine|memantine|mesh-list
83748580|NCT03709888|Analgesics|analgesics|mesh-ancestor
83748581|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
83748582|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748583|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748584|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
83748585|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83748586|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83748587|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748588|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83748589|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83748590|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83748591|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83748592|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83748593|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83748594|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83748595|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
83748596|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748597|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83748598|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83748599|NCT00007683|Aspirin|aspirin|mesh-list
83748600|NCT00007683|Warfarin|warfarin|mesh-list
83748601|NCT00007683|Clopidogrel|clopidogrel|mesh-list
83748602|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83748603|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83748604|NCT00007683|Analgesics|analgesics|mesh-ancestor
83748605|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
83748606|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748607|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748608|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83748609|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748610|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83748611|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83748612|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748613|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83748614|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83748615|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748616|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
83748617|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83748618|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83748619|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83748620|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
83748621|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748622|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
83748623|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83748624|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
83748625|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748626|NCT00006337|Levodopa|levodopa|mesh-list
83748627|NCT00006337|Istradefylline|istradefylline|mesh-list
83748628|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83748629|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83748630|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
83748631|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903811|NCT03699202|Ziresovir|ziresovir|mesh-list
83748632|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748633|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748634|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83748635|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83748636|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83748637|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
83748638|NCT00006340|Ganciclovir|ganciclovir|mesh-list
83748639|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83748640|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
83748641|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
83748642|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748643|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748644|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748645|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748646|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748647|NCT00006229|Paclitaxel|paclitaxel|mesh-list
83748648|NCT00006229|Carboplatin|carboplatin|mesh-list
83748649|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748650|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748651|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
83748652|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
83748653|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
83748654|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748655|NCT00006343|Interferons|interferons|mesh-list
83748656|NCT00006343|Cytarabine|cytarabine|mesh-list
83748657|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
83748658|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
83748659|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748660|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
83748661|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748662|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748663|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
83748664|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748665|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748666|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
83748667|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748668|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83748669|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748670|NCT00387868|Etoposide|etoposide|mesh-list
83748671|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748672|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748673|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748674|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748675|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748676|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748677|NCT03616717|Modafinil|modafinil|mesh-list
83748678|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83748679|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748680|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83748681|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83748682|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83748683|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748684|NCT00006349|Vitamin E|vitamin e|mesh-list
83748685|NCT00006349|Donepezil|donepezil|mesh-list
83748686|NCT00006349|Vitamins|vitamins|mesh-ancestor
83748687|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
83748688|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748689|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83748690|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748691|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748692|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
83748693|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748694|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
83748695|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
83748696|NCT00006349|Protective Agents|protective agents|mesh-ancestor
83748697|NCT00006352|Antibodies|antibodies|mesh-list
83748698|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83748699|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
83748700|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
83748701|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748702|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83748703|NCT00007878|Leucovorin|leucovorin|mesh-list
83748704|NCT00007878|Fluorouracil|fluorouracil|mesh-list
82903876|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
83748705|NCT00007878|Bortezomib|bortezomib|mesh-list
83748706|NCT00007878|Calcium|calcium|mesh-list
83748708|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83748709|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748710|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
83748711|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748712|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748713|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748714|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748715|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
83748716|NCT00007878|Antidotes|antidotes|mesh-ancestor
83748717|NCT00007878|Protective Agents|protective agents|mesh-ancestor
83748718|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
83748719|NCT00007878|Vitamins|vitamins|mesh-ancestor
83748720|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
83748721|NCT00006355|NSC 366140|nsc 366140|mesh-list
83748722|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748723|NCT00006358|Thalidomide|thalidomide|mesh-list
83748724|NCT00006358|Temozolomide|temozolomide|mesh-list
83748725|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748726|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
83748727|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748728|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748729|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748730|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
83748731|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748732|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
83748733|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83748734|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748735|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83748736|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83748737|NCT00006358|Growth Substances|growth substances|mesh-ancestor
83748738|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
83748739|NCT00006361|Semaxinib|semaxinib|mesh-list
83748740|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83748741|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83748742|NCT00006361|Growth Substances|growth substances|mesh-ancestor
83748743|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748744|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
83748745|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748746|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83748747|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748748|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748749|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
83748750|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748751|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748752|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83748753|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748754|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748755|NCT00007917|Gemcitabine|gemcitabine|mesh-list
83748756|NCT00007917|Alvocidib|alvocidib|mesh-list
83748757|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748758|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
83748759|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748760|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748761|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
83748762|NCT00007917|Growth Substances|growth substances|mesh-ancestor
83748763|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748764|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83748765|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748766|NCT00006367|Cytarabine|cytarabine|mesh-list
83748767|NCT00006367|Busulfan|busulfan|mesh-list
83748768|NCT00006367|Idarubicin|idarubicin|mesh-list
82903949|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
82903950|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
82903951|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
82903952|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903953|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903954|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903955|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82903956|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903957|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82903958|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82903959|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82903960|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82903964|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
83748769|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748770|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
83748771|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748772|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748773|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
83748774|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748775|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748776|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
83748777|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748778|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
83748779|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748780|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83748781|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748782|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748783|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748784|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748785|NCT00006370|Edotreotide|edotreotide|mesh-list
83748786|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83748787|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748788|NCT00007956|Antibodies|antibodies|mesh-list
83748789|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83748790|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
83748791|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748792|NCT00006373|Etoposide|etoposide|mesh-list
83748793|NCT00006373|Topotecan|topotecan|mesh-list
83748794|NCT00006373|Ifosfamide|ifosfamide|mesh-list
83748795|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748796|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748797|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748798|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748799|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748800|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748801|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83748802|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748803|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
83748804|NCT00006376|Tipifarnib|tipifarnib|mesh-list
83748805|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748806|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
83748807|NCT00006379|Fludarabine|fludarabine|mesh-list
83748808|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
83748809|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83748810|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748811|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
83748812|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748813|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748814|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748815|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
83748816|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748817|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748818|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83748819|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748820|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
83748821|NCT00006385|Interferons|interferons|mesh-list
83748822|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
83748823|NCT00006385|Sargramostim|sargramostim|mesh-list
83748824|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
83748825|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748826|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
83748827|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748828|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
83748829|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748830|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83748831|NCT00007995|Interferons|interferons|mesh-list
83748832|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
83748833|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
83748834|NCT00007995|Melphalan|melphalan|mesh-list
83748835|NCT00007995|Busulfan|busulfan|mesh-list
83748836|NCT00007995|Sargramostim|sargramostim|mesh-list
83748837|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748838|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
83748839|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904025|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83748840|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748841|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748842|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
83748843|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748844|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748845|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83748846|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
83748847|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748848|NCT00006388|Tamoxifen|tamoxifen|mesh-list
83748849|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83748850|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
83748851|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83748852|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748853|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83748854|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748855|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83748856|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83748857|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83748858|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
83748859|NCT00008034|Capecitabine|capecitabine|mesh-list
83748860|NCT00008034|Epirubicin|epirubicin|mesh-list
83748861|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748862|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
83748863|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748864|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748865|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748866|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
83748867|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748868|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748869|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83748870|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748871|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
83748872|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748873|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748874|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748875|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748876|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
83748877|NCT00006391|Topotecan|topotecan|mesh-list
83748878|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748879|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83748880|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748881|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748882|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748883|NCT00006394|Hormones|hormones|mesh-list
83748884|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83748885|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748886|NCT00008073|Doxorubicin|doxorubicin|mesh-list
83748887|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83748888|NCT00008073|Octreotide|octreotide|mesh-list
83748889|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748890|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748891|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748892|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83748893|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748894|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748895|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83748896|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83748897|NCT00006397|Ritonavir|ritonavir|mesh-list
83748898|NCT00006397|Indinavir|indinavir|mesh-list
83748899|NCT00006397|Stavudine|stavudine|mesh-list
83748900|NCT00006397|Didanosine|didanosine|mesh-list
83748901|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83748902|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83748903|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
83748904|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748905|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748906|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83748907|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83748908|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
83748909|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748910|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83748911|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83748912|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
83748913|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83748914|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748915|NCT00006412|Fenofibrate|fenofibrate|mesh-list
83748916|NCT00006412|Pravastatin|pravastatin|mesh-list
83748917|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83748918|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
83748919|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748920|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83748921|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83748922|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83748923|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748924|NCT00008112|Cisplatin|cisplatin|mesh-list
83748925|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748926|NCT00006427|Amitriptyline|amitriptyline|mesh-list
83748927|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83748928|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
83748929|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83748930|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83748931|NCT00006427|Analgesics|analgesics|mesh-ancestor
83748932|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
83748933|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748934|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748935|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83748936|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83748937|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83748938|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748939|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
83748940|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83748941|NCT00008151|Cyclosporine|cyclosporine|mesh-list
83748942|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
83748943|NCT00008151|Methotrexate|methotrexate|mesh-list
83748944|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
83748945|NCT00008151|Fludarabine|fludarabine|mesh-list
83748946|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
83748947|NCT00008151|Cyclosporins|cyclosporins|mesh-list
83748948|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83748949|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
83748950|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83748951|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748952|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83748953|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
83748954|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748955|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748956|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
83748957|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83748958|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83748959|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748960|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
83748961|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748962|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83748963|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
83748964|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83748965|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83748966|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83748967|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83748968|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
83748969|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83748970|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83748971|NCT00008151|Immunotoxins|immunotoxins|mesh-ancestor
83748972|NCT00008151|Immunoconjugates|immunoconjugates|mesh-ancestor
83748973|NCT00006448|Methadone|methadone|mesh-list
83748974|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83748975|NCT00006448|Narcotics|narcotics|mesh-ancestor
83748976|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83748977|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748978|NCT00006448|Analgesics|analgesics|mesh-ancestor
83748979|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
83748980|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83748981|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
83748982|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
83748983|NCT00008190|Aldesleukin|aldesleukin|mesh-list
83748984|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
83748985|NCT00008190|Melphalan|melphalan|mesh-list
83748986|NCT00008190|Busulfan|busulfan|mesh-list
83748987|NCT00008190|Etoposide|etoposide|mesh-list
83748988|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83748989|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
82904174|NCT03624244|Letrozole|letrozole|mesh-list
82904175|NCT03624244|Exemestane|exemestane|mesh-list
82904176|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83748990|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83748991|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83748992|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83748993|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
83748994|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83748995|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83748996|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83748997|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83748998|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83748999|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83749000|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749001|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83749002|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83749003|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
83749004|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749005|NCT00006451|Cyclosporine|cyclosporine|mesh-list
83749006|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
83749007|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
83749008|NCT00006451|Methotrexate|methotrexate|mesh-list
83749009|NCT00006451|Cyclosporins|cyclosporins|mesh-list
83749010|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83749011|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749012|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
83749013|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749014|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749015|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749016|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
83749017|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749018|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749019|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749020|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83749021|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
83749022|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83749023|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749024|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
83749025|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
83749026|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749027|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83749028|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83749029|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
83749030|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749031|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83749032|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749033|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
83749034|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
83749035|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749036|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749037|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
83749038|NCT00006451|Hormones|hormones|mesh-ancestor
83749039|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749040|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83749041|NCT00006451|Protective Agents|protective agents|mesh-ancestor
83749042|NCT00006454|Paclitaxel|paclitaxel|mesh-list
83749043|NCT00006454|Carboplatin|carboplatin|mesh-list
83749044|NCT00006454|Topotecan|topotecan|mesh-list
83749045|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749046|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749047|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749048|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749049|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749050|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749051|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83749052|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83749053|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749054|NCT00008229|Melphalan|melphalan|mesh-list
83749055|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
83749056|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749057|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749058|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
83749059|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749060|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749061|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749062|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749063|NCT00006457|Oltipraz|oltipraz|mesh-list
83749064|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
83749065|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749066|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
83749067|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83749068|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
82904245|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
83749069|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83749070|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83749071|NCT00006457|Protective Agents|protective agents|mesh-ancestor
83749072|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749073|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749074|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83749075|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83749076|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749077|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749079|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
83749080|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749081|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749082|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
83749083|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749084|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749085|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749086|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749087|NCT00006463|Trabectedin|trabectedin|mesh-list
83749088|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749089|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
83749090|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749091|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749092|NCT00008307|Cyclosporine|cyclosporine|mesh-list
83749093|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
83749094|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
83749095|NCT00008307|Fludarabine|fludarabine|mesh-list
83749096|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
83749097|NCT00008307|Melphalan|melphalan|mesh-list
83749098|NCT00008307|Cyclosporins|cyclosporins|mesh-list
83749099|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83749100|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749101|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749102|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
83749103|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749104|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749105|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
83749106|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749107|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749108|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
83749109|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749110|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
83749111|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749112|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83749113|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83749114|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83749115|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
83749116|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83749117|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749118|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
83749119|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
83749120|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749121|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749122|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
83749123|NCT00008307|Hormones|hormones|mesh-ancestor
83749124|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749125|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83749126|NCT00008307|Protective Agents|protective agents|mesh-ancestor
83749127|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749128|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
83749129|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749130|NCT00006469|Paclitaxel|paclitaxel|mesh-list
83749131|NCT00006469|Carboplatin|carboplatin|mesh-list
83749132|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749133|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749134|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749135|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749136|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749137|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749138|NCT00006472|Paclitaxel|paclitaxel|mesh-list
83749139|NCT00006472|Carboplatin|carboplatin|mesh-list
83749140|NCT00006472|Fluorouracil|fluorouracil|mesh-list
83749141|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749142|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749143|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749144|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749145|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749146|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749147|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
83749148|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749149|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749150|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
83749151|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749152|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
83749153|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749154|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83749155|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749156|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749157|NCT00008424|Irinotecan|irinotecan|mesh-list
83749158|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83749159|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83749160|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749161|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749162|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749163|NCT00006484|Paclitaxel|paclitaxel|mesh-list
83749164|NCT00006484|Carboplatin|carboplatin|mesh-list
83749165|NCT00006484|Tirapazamine|tirapazamine|mesh-list
83749166|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749167|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749168|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749169|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749170|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749171|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749172|NCT00006487|Etoposide|etoposide|mesh-list
83749173|NCT00006487|Tirapazamine|tirapazamine|mesh-list
83749174|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749175|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749176|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83749177|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83749178|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749179|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749180|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
83749181|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83749182|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749183|NCT00008463|Interferons|interferons|mesh-list
83749184|NCT00008463|Ribavirin|ribavirin|mesh-list
83749185|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
83749186|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
83749187|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83749188|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749189|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
83749190|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749191|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
83749192|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749193|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
83749194|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749195|NCT00006508|Insulin|insulin|mesh-list
83749196|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83749197|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749198|NCT00006682|Docetaxel|docetaxel|mesh-list
83749199|NCT00006682|Vinorelbine|vinorelbine|mesh-list
83749200|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749201|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749202|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749203|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749204|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749205|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749206|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
83749207|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749208|NCT00006760|Vinorelbine|vinorelbine|mesh-list
83749209|NCT00006760|Ifosfamide|ifosfamide|mesh-list
83749210|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749211|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749212|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749213|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749214|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749215|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749216|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749217|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
83749218|NCT00008736|Metoclopramide|metoclopramide|mesh-list
83749219|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
83749220|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
83749221|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749222|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749223|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749224|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83749225|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83749226|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
83749227|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749228|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749229|NCT00006799|Megestrol|megestrol|mesh-list
83749230|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
83749231|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83749232|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83749233|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83749234|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
83749235|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83749236|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749237|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83749238|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83749239|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83749240|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749241|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
83749242|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83749243|NCT00006877|Temozolomide|temozolomide|mesh-list
83749244|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749245|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
83749246|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749247|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749248|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
83749249|NCT00007033|Analgesics|analgesics|mesh-ancestor
83749250|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
83749251|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749252|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749253|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
83749254|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749255|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83749256|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
83749257|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83749258|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83749259|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749260|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83749261|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
83749262|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83749263|NCT00388401|Alvimopan|alvimopan|mesh-list
83749264|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749265|NCT00007189|Celecoxib|celecoxib|mesh-list
83749266|NCT00007189|Naproxen|naproxen|mesh-list
83749267|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83749268|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83749269|NCT00007189|Analgesics|analgesics|mesh-ancestor
83749270|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
83749271|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749272|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749273|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749274|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749275|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83749276|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83749277|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749278|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749279|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
83749280|NCT00388219|Buprenorphine|buprenorphine|mesh-list
83749281|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83749282|NCT00388219|Narcotics|narcotics|mesh-ancestor
83749283|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749284|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749285|NCT00388219|Analgesics|analgesics|mesh-ancestor
83749286|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
83749287|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749288|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83749289|NCT00388258|Alvimopan|alvimopan|mesh-list
83749290|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749291|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
82904472|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83749292|NCT00388336|Hematinics|hematinics|mesh-ancestor
83749293|NCT00007306|Hormones|hormones|mesh-list
83749294|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
83749295|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749296|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749297|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83749298|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
83749299|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83749300|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
83749301|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749302|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83749303|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749304|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
83749305|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749306|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
83749307|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83749308|NCT00007423|Protective Agents|protective agents|mesh-ancestor
83749309|NCT00007735|Doxycycline|doxycycline|mesh-list
83749310|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83749311|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749312|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
83749313|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83749314|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83749315|NCT00007774|Haloperidol|haloperidol|mesh-list
83749316|NCT00007774|Olanzapine|olanzapine|mesh-list
83749317|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
83749318|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
83749319|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
83749320|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749321|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749322|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749323|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83749324|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83749325|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749326|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83749327|NCT00007774|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83749328|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83749329|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83749330|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749331|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749332|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
83749333|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83749334|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
83749335|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83749336|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
83749337|NCT00007813|Carboplatin|carboplatin|mesh-list
83749338|NCT00007813|Etoposide|etoposide|mesh-list
83749339|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749340|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
83749341|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749342|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749343|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749344|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
83749345|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749346|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749347|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749348|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749349|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83749350|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83749351|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749352|NCT00007852|Cytarabine|cytarabine|mesh-list
83749353|NCT00007852|Rituximab|rituximab|mesh-list
83749354|NCT00007852|Etoposide|etoposide|mesh-list
83749355|NCT00007852|Melphalan|melphalan|mesh-list
83749356|NCT00007852|Carmustine|carmustine|mesh-list
83749357|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83749358|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749359|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
83749360|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749361|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749362|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749363|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83749364|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83749365|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749366|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904550|NCT03502070|Tobramycin|tobramycin|mesh-list
83749367|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749368|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
83749369|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
83749370|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749371|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749372|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749373|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
83749374|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749375|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83749376|NCT00007891|Antibodies|antibodies|mesh-list
83749377|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
83749378|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83749379|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
83749380|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749381|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749382|NCT00007969|Verteporfin|verteporfin|mesh-list
83749383|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
83749384|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83749385|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
83749386|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83749387|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
83749388|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749389|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
83749390|NCT00008008|Thiotepa|thiotepa|mesh-list
83749391|NCT00008008|Sargramostim|sargramostim|mesh-list
83749392|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749393|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
83749394|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749395|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749396|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749397|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
83749398|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749399|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749400|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749401|NCT00008047|Paclitaxel|paclitaxel|mesh-list
83749402|NCT00008047|Fluorouracil|fluorouracil|mesh-list
83749403|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
83749404|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749405|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749406|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749407|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749408|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749409|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749410|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
83749411|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749412|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749413|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
83749414|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749415|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
83749416|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749417|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83749418|NCT00008086|Calcitriol|calcitriol|mesh-list
83749419|NCT00008086|Carboplatin|carboplatin|mesh-list
83749420|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749421|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83749422|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749423|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83749424|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83749425|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749426|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83749427|NCT00008086|Vitamins|vitamins|mesh-ancestor
83749428|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
83749429|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83749430|NCT00008125|Carboplatin|carboplatin|mesh-list
83749431|NCT00008125|Gemcitabine|gemcitabine|mesh-list
83749432|NCT00008125|Docetaxel|docetaxel|mesh-list
83749433|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749434|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749435|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
83749436|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749437|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
82904618|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82904619|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82904624|NCT03715322|Tobramycin|tobramycin|mesh-list
83749438|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749439|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749440|NCT00008203|Interferons|interferons|mesh-list
83749441|NCT00008203|Aldesleukin|aldesleukin|mesh-list
83749442|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
83749443|NCT00008203|Cyclosporine|cyclosporine|mesh-list
83749444|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
83749445|NCT00008203|Thiotepa|thiotepa|mesh-list
83749446|NCT00008203|Carboplatin|carboplatin|mesh-list
83749447|NCT00008203|Cyclosporins|cyclosporins|mesh-list
83749448|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749449|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
83749450|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749451|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749452|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83749453|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
83749454|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749455|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749456|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83749457|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
83749458|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749459|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749460|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
83749461|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
83749462|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83749463|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83749464|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83749465|NCT00008242|Thalidomide|thalidomide|mesh-list
83749466|NCT00008242|Dexamethasone|dexamethasone|mesh-list
83749467|NCT00008242|Doxorubicin|doxorubicin|mesh-list
83749468|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83749469|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749470|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
83749471|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
83749472|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749473|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749474|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749475|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
83749476|NCT00008242|Hormones|hormones|mesh-ancestor
83749477|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749478|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83749479|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749480|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83749481|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83749482|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83749483|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749484|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749485|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749486|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
83749487|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
83749488|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83749489|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749490|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83749491|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83749492|NCT00008242|Growth Substances|growth substances|mesh-ancestor
83749493|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83749494|NCT00008281|Leucovorin|leucovorin|mesh-list
83749495|NCT00008281|Fluorouracil|fluorouracil|mesh-list
83749496|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
83749497|NCT00008281|Calcium|calcium|mesh-list
83749498|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
83749499|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83749500|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749501|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
83749502|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749503|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749504|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749505|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83749506|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
83749507|NCT00008281|Antidotes|antidotes|mesh-ancestor
83749508|NCT00008281|Protective Agents|protective agents|mesh-ancestor
83749509|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
83749510|NCT00008281|Vitamins|vitamins|mesh-ancestor
83749511|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
83749512|NCT00008359|Amphotericin B|amphotericin b|mesh-list
83749513|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83749514|NCT00008359|Caspofungin|caspofungin|mesh-list
83749515|NCT00008359|Amebicides|amebicides|mesh-ancestor
83749516|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83749517|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83749518|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749519|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83749520|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
83749521|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749522|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749523|NCT00008398|Sargramostim|sargramostim|mesh-list
83749524|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
83749525|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749526|NCT00008476|Capsaicin|capsaicin|mesh-list
83749527|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
83749528|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
83749529|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
83749530|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749531|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749532|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83749533|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749534|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
83749535|NCT00008515|Hormones|hormones|mesh-ancestor
83749536|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749537|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749538|NCT00008554|Lamivudine|lamivudine|mesh-list
83749539|NCT00008554|Abacavir|abacavir|mesh-list
83749540|NCT00008554|Nelfinavir|nelfinavir|mesh-list
83749541|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
83749542|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83749543|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83749544|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749545|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749546|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
83749547|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749548|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83749549|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83749550|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83749551|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83749552|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
83749553|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
83749554|NCT05636566|Propofol|propofol|mesh-list
83749555|NCT05636566|Sevoflurane|sevoflurane|mesh-list
83749556|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83749557|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749558|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749559|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83749560|NCT05636566|Analgesics|analgesics|mesh-ancestor
83749561|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
83749562|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749563|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83749564|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83749565|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83749566|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
83749567|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749568|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749569|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83749570|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
83749571|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
83749572|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83749573|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83749574|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83749575|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83749576|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749577|NCT05637073|Dienogest|dienogest|mesh-list
83749578|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83749579|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
83749580|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83749581|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749582|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83749583|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83749584|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83749585|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83749586|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
83749587|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749588|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83749589|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749590|NCT05637268|Paclitaxel|paclitaxel|mesh-list
83749591|NCT05637268|Cisplatin|cisplatin|mesh-list
83749592|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83749593|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904765|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
83749594|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
83749595|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
83749596|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
83749597|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749598|NCT05637216|Losartan|losartan|mesh-list
83749599|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83749600|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83749601|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83749602|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83749603|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749604|NCT05638087|Dexamethasone|dexamethasone|mesh-list
83749605|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749606|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
83749607|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
83749608|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749609|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749610|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749611|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
83749612|NCT05638087|Hormones|hormones|mesh-ancestor
83749613|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749614|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83749615|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749616|NCT05638633|Vitamins|vitamins|mesh-list
83749617|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
83749618|NCT05638633|Prednisolone|prednisolone|mesh-list
83749619|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83749620|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
83749621|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83749622|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
83749623|NCT05638633|Corticosterone|corticosterone|mesh-list
83749624|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83749625|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
83749626|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
83749627|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749628|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749629|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
83749630|NCT05638633|Hormones|hormones|mesh-ancestor
83749631|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749632|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83749633|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749634|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
83749635|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
83749636|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749637|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749638|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83749639|NCT05638633|Protective Agents|protective agents|mesh-ancestor
83749640|NCT05638984|Decitabine|decitabine|mesh-list
83749641|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83749642|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
83749643|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749644|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749645|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749646|NCT05639218|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83749647|NCT05639218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83749648|NCT05639218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83749649|NCT05639218|Antimetabolites|antimetabolites|mesh-ancestor
83749650|NCT05639218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749651|NCT05639218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83749652|NCT05639218|Protease Inhibitors|protease inhibitors|mesh-ancestor
83749653|NCT05639218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749654|NCT05639218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83749655|NCT05639257|Mexiletine|mexiletine|mesh-list
83749656|NCT05639257|Lamotrigine|lamotrigine|mesh-list
83749657|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
83749658|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83749659|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83749660|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749661|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83749662|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749663|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83749664|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83749665|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749666|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83749667|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83749668|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83749669|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83749670|NCT00000115|Acetazolamide|acetazolamide|mesh-list
83749671|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
83749672|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83749673|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749674|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749675|NCT00000115|Diuretics|diuretics|mesh-ancestor
83749676|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
83749677|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749678|NCT00000136|Ganciclovir|ganciclovir|mesh-list
83749679|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83749680|NCT00000136|Foscarnet|foscarnet|mesh-list
83749681|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
83749682|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749683|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83749684|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749685|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749686|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83749687|NCT00000139|Acyclovir|acyclovir|mesh-list
83749688|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
83749689|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749690|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83749691|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83749692|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749693|NCT00000142|Cidofovir|cidofovir|mesh-list
83749694|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
83749695|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83749696|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749697|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749698|NCT00000145|Zinc|zinc|mesh-list
83749699|NCT00000145|Antioxidants|antioxidants|mesh-list
83749700|NCT00000145|Trace Elements|trace elements|mesh-ancestor
83749701|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
83749702|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749703|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749704|NCT00000145|Protective Agents|protective agents|mesh-ancestor
83749705|NCT00000151|Aspirin|aspirin|mesh-list
83749706|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83749707|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83749708|NCT00000151|Analgesics|analgesics|mesh-ancestor
83749709|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
83749710|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749711|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749712|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749713|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749714|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83749715|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83749716|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749717|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83749718|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83749719|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749720|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
83749721|NCT00000157|Aspirin|aspirin|mesh-list
83749722|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83749723|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83749724|NCT00000157|Analgesics|analgesics|mesh-ancestor
83749725|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
83749726|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749727|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749728|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749729|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83749730|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83749731|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83749732|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749733|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83749734|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83749735|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749736|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
83749737|NCT00000172|Galantamine|galantamine|mesh-list
83749738|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83749739|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749740|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749741|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
83749742|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749743|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904916|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
83749745|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
83749746|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749747|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
83749748|NCT00000175|Testosterone|testosterone|mesh-list
83749749|NCT00000175|Estrogens|estrogens|mesh-list
83749750|NCT00000175|Androgens|androgens|mesh-ancestor
83749751|NCT00000175|Hormones|hormones|mesh-ancestor
83749752|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749753|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749754|NCT00000187|Ritanserin|ritanserin|mesh-list
83749755|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83749756|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
83749757|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749758|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749759|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749760|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83749761|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83749762|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749763|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83749764|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83749765|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83749766|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
83749767|NCT00000205|Buprenorphine|buprenorphine|mesh-list
83749768|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83749769|NCT00000205|Narcotics|narcotics|mesh-ancestor
83749770|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749771|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749772|NCT00000205|Analgesics|analgesics|mesh-ancestor
83749773|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
83749774|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749775|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83749776|NCT00000214|Buprenorphine|buprenorphine|mesh-list
83749777|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83749778|NCT00000214|Narcotics|narcotics|mesh-ancestor
83749779|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749780|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749781|NCT00000214|Analgesics|analgesics|mesh-ancestor
83749782|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
83749783|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749784|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83749785|NCT00000220|Buprenorphine|buprenorphine|mesh-list
83749786|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83749787|NCT00000220|Narcotics|narcotics|mesh-ancestor
83749788|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749789|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749790|NCT00000220|Analgesics|analgesics|mesh-ancestor
83749791|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
83749792|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749793|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83749794|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
83749795|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83749796|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
83749797|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
83749798|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749799|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749800|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83749801|NCT00000256|Analgesics|analgesics|mesh-ancestor
83749802|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
83749803|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749804|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
83749805|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83749806|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
83749807|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749808|NCT00000421|Prednisone|prednisone|mesh-list
83749809|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83749810|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
83749811|NCT00000421|Hormones|hormones|mesh-ancestor
83749812|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749813|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749814|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83749815|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749816|NCT00000427|Alendronate|alendronate|mesh-list
83749817|NCT00000427|Hormones|hormones|mesh-list
82904992|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83749818|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
83749819|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749820|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749821|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83749822|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83749823|NCT00000457|Bupropion|bupropion|mesh-list
83749824|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83749825|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
83749826|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83749827|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83749828|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83749829|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83749830|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749831|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
83749832|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749833|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749834|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83749835|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83749836|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749837|NCT00388479|Alvimopan|alvimopan|mesh-list
83749838|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83749839|NCT00000463|Warfarin|warfarin|mesh-list
83749840|NCT00000463|Lovastatin|lovastatin|mesh-list
83749841|NCT00000463|L 647318|l 647318|mesh-list
83749842|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
83749843|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
83749844|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
83749845|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83749846|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83749847|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
83749848|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749849|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83749850|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83749851|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83749852|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83749853|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
83749854|NCT00000466|Progesterone|progesterone|mesh-list
83749855|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83749856|NCT00000466|Estrogens|estrogens|mesh-list
83749857|NCT00000466|Progestins|progestins|mesh-ancestor
83749858|NCT00000466|Hormones|hormones|mesh-ancestor
83749859|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83749860|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749861|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83749862|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83749863|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83749864|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
83749865|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83749866|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83749867|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83749868|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83749869|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83749870|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83749871|NCT00000472|Heparin|heparin|mesh-list
83749872|NCT00000472|Plasminogen|plasminogen|mesh-list
83749873|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83749874|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
83749875|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83749876|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83749877|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749878|NCT00000478|Atenolol|atenolol|mesh-list
83749879|NCT00000478|Diltiazem|diltiazem|mesh-list
83749880|NCT00000478|Nifedipine|nifedipine|mesh-list
83749881|NCT00000478|Isosorbide|isosorbide|mesh-list
83749882|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83749883|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83749884|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83749885|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83749886|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749887|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83749888|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749889|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
83749890|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
83749891|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82905068|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83749892|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83749893|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83749894|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
83749895|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
83749896|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749897|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83749898|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83749899|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83749900|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
83749901|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749902|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83749903|NCT00000478|Diuretics|diuretics|mesh-ancestor
83749904|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
83749905|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83749907|NCT00388882|Albuterol|albuterol|mesh-list
83749908|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
83749909|NCT00388882|Ipratropium|ipratropium|mesh-list
83749910|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83749911|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
83749912|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749913|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749914|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83749915|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
83749916|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
83749917|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83749918|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
83749919|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749920|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749921|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
83749922|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
83749923|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83749924|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83749925|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83749926|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83749927|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83749928|NCT00388999|Lectins|lectins|mesh-list
83749929|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
83749930|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
83749931|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749932|NCT00388999|Coagulants|coagulants|mesh-ancestor
83749933|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
83749934|NCT00000487|Diuretics|diuretics|mesh-list
83749935|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
83749936|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749937|NCT00000493|Propranolol|propranolol|mesh-list
83749938|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83749939|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83749940|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
83749941|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749942|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749943|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749944|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83749945|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83749946|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
83749947|NCT00000499|Metoprolol|metoprolol|mesh-list
83749948|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
83749949|NCT00000499|Hydralazine|hydralazine|mesh-list
83749950|NCT00000499|Reserpine|reserpine|mesh-list
83749951|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83749952|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83749953|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
83749954|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
83749955|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749956|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749957|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83749958|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83749959|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83749960|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
83749961|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749962|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749963|NCT00000499|Diuretics|diuretics|mesh-ancestor
83749964|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
83749965|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83749966|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82905143|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
82905150|NCT03910738|Hormones|hormones|mesh-ancestor
83749967|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
83749968|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83749969|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83749970|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749971|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83749972|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83749973|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83749975|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
83749976|NCT00000514|Reserpine|reserpine|mesh-list
83749977|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83749978|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83749979|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
83749980|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
83749981|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83749982|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83749983|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83749984|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83749985|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83749986|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
83749987|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83749988|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83749989|NCT00000514|Diuretics|diuretics|mesh-ancestor
83749990|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
83749991|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83749992|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83749993|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83749994|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83749995|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83749996|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83749997|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83749998|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83749999|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83750000|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750001|NCT05638425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83750002|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750003|NCT00000517|Warfarin|warfarin|mesh-list
83750004|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
83750005|NCT00000520|Aspirin|aspirin|mesh-list
83750006|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
83750007|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83750008|NCT00000520|Antibodies|antibodies|mesh-list
83750009|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
83750010|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83750011|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83750012|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83750013|NCT00000520|Analgesics|analgesics|mesh-ancestor
83750014|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
83750015|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83750016|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750017|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83750018|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83750019|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83750020|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83750021|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750022|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83750023|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83750024|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750025|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
83750026|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
83750027|NCT00000526|Flecainide|flecainide|mesh-list
83750028|NCT00000526|Moricizine|moricizine|mesh-list
83750029|NCT00000526|Encainide|encainide|mesh-list
83750030|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83750031|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83750032|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83750033|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83750034|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750035|NCT00000529|Tamoxifen|tamoxifen|mesh-list
83750036|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83750037|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
83750038|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83750039|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750040|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83750041|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750042|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83750043|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83750044|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83750046|NCT00000553|Simvastatin|simvastatin|mesh-list
83750047|NCT00000553|Antioxidants|antioxidants|mesh-list
83750048|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83750049|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83750050|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
83750051|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750052|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83750053|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83750054|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750055|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
83750056|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
83750057|NCT00000553|Vitamins|vitamins|mesh-ancestor
83750058|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
83750059|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750060|NCT00000553|Protective Agents|protective agents|mesh-ancestor
83750061|NCT00000556|Quinidine|quinidine|mesh-list
83750062|NCT00000556|Digoxin|digoxin|mesh-list
83750063|NCT00000556|Amiodarone|amiodarone|mesh-list
83750064|NCT00000556|Verapamil|verapamil|mesh-list
83750065|NCT00000556|Sotalol|sotalol|mesh-list
83750066|NCT00000556|Flecainide|flecainide|mesh-list
83750067|NCT00000556|Propafenone|propafenone|mesh-list
83750068|NCT00000556|Procainamide|procainamide|mesh-list
83750069|NCT00000556|Moricizine|moricizine|mesh-list
83750070|NCT00000556|Disopyramide|disopyramide|mesh-list
83750071|NCT00000556|Diltiazem|diltiazem|mesh-list
83750072|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83750073|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
83750074|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83750075|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83750076|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750077|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750078|NCT00000556|Protective Agents|protective agents|mesh-ancestor
83750079|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750080|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
83750081|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83750082|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83750083|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83750084|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83750085|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750086|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83750087|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83750088|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750089|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83750090|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83750091|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83750092|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83750093|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83750094|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
83750095|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
83750096|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83750097|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83750098|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83750099|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
83750100|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750101|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750102|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750103|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83750104|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83750105|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83750106|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83750107|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
83750108|NCT00000559|Hormones|hormones|mesh-list
83750109|NCT00000559|Estradiol|estradiol|mesh-list
83750110|NCT00000559|Estrogens|estrogens|mesh-list
83750111|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83750112|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750113|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82905294|NCT03623776|Carboplatin|carboplatin|mesh-list
83750114|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
82905295|NCT03623776|Pemetrexed|pemetrexed|mesh-list
83750115|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83750116|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83750117|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83750118|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83750119|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83750120|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83750121|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83750122|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750124|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83750125|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
83750126|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83750127|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750128|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83750129|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
83750130|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83750131|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
83750132|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83750133|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750134|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
83750135|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750136|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
83750137|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750138|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750139|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750140|NCT00000595|Deferoxamine|deferoxamine|mesh-list
83750141|NCT00000595|Siderophores|siderophores|mesh-ancestor
83750142|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83750143|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
83750144|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
83750145|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750146|NCT00000601|Hormones|hormones|mesh-list
83750147|NCT00000601|Progesterone|progesterone|mesh-list
83750148|NCT00000601|Estrogens|estrogens|mesh-list
83750149|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83750150|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750151|NCT00000601|Progestins|progestins|mesh-ancestor
83750152|NCT00000625|Zidovudine|zidovudine|mesh-list
83750153|NCT00000625|Didanosine|didanosine|mesh-list
83750154|NCT00000625|Zalcitabine|zalcitabine|mesh-list
83750155|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
83750156|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750157|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750158|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750159|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750160|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
83750161|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750162|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750163|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750164|NCT00000637|Zidovudine|zidovudine|mesh-list
83750165|NCT00000637|Didanosine|didanosine|mesh-list
83750166|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
83750167|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750168|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750169|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750170|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750171|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
83750172|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750173|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750174|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750175|NCT00000640|Clindamycin|clindamycin|mesh-list
83750176|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
83750177|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
83750178|NCT00000640|Dapsone|dapsone|mesh-list
83750179|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83750180|NCT00000640|Primaquine|primaquine|mesh-list
83750181|NCT00000640|Trimethoprim|trimethoprim|mesh-list
83750182|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
83750183|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750184|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750185|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83750186|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750187|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750188|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
83750189|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750190|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82905382|NCT03673384|Xhance|xhance|mesh-list
83750191|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83750192|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83750193|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83750194|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83750195|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750196|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
83750198|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83750199|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750200|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750201|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83750202|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83750203|NCT00000646|Protective Agents|protective agents|mesh-ancestor
83750204|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750205|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
83750206|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83750207|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
83750208|NCT00389038|Amitriptyline|amitriptyline|mesh-list
83750209|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83750210|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
83750211|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83750212|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83750213|NCT00389038|Analgesics|analgesics|mesh-ancestor
83750214|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
83750215|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83750216|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750217|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83750218|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83750219|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83750220|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750221|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
83750222|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83750223|NCT00000652|Zidovudine|zidovudine|mesh-list
83750224|NCT00000652|Didanosine|didanosine|mesh-list
83750225|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
83750226|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750227|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750228|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750229|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750230|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
83750231|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750232|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750233|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750234|NCT00000676|Fluconazole|fluconazole|mesh-list
83750235|NCT00000676|Clotrimazole|clotrimazole|mesh-list
83750236|NCT00000676|Miconazole|miconazole|mesh-list
83750237|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
83750238|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750239|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83750240|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750241|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750242|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750243|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83750244|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
83750245|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83750246|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750247|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83750248|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83504659|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
83750249|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83750250|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750251|NCT00000679|Zidovudine|zidovudine|mesh-list
83750252|NCT00000679|Zalcitabine|zalcitabine|mesh-list
83750253|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
83750254|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750255|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750256|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750257|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750258|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
83750259|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750260|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750261|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750262|NCT00000682|Zidovudine|zidovudine|mesh-list
83750263|NCT00000682|Zalcitabine|zalcitabine|mesh-list
83750264|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
83750265|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750266|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750267|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750268|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750269|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
83750270|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750271|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750272|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750273|NCT00000688|Ganciclovir|ganciclovir|mesh-list
83750274|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83750275|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
83750276|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750277|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750278|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750279|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750280|NCT00000712|Zidovudine|zidovudine|mesh-list
83750281|NCT00000712|Acyclovir|acyclovir|mesh-list
83750282|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
83750283|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750284|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750285|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750286|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750287|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
83750288|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750289|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750290|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750291|NCT00000715|Trimethoprim|trimethoprim|mesh-list
83750292|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83750293|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
83750294|NCT00000715|Pentamidine|pentamidine|mesh-list
83750295|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83750296|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750297|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
83750298|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750299|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750300|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83750301|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750302|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750303|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83750304|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83750305|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750306|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
83750307|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83750308|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750309|NCT00000718|Zidovudine|zidovudine|mesh-list
83750310|NCT00000718|Zalcitabine|zalcitabine|mesh-list
83750311|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
83750312|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750313|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750314|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750315|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750316|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
83750317|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750318|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750319|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750320|NCT00000739|Dapsone|dapsone|mesh-list
83750321|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750322|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
83750323|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750324|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750325|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83750326|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750327|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750328|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
83750329|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750330|NCT00000742|Zidovudine|zidovudine|mesh-list
83750331|NCT00000742|Didanosine|didanosine|mesh-list
83750332|NCT00000742|Atevirdine|atevirdine|mesh-list
83750333|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
83750334|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750335|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750336|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750337|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750338|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
83750339|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750340|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750341|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750342|NCT00000745|Vaccines|vaccines|mesh-list
83750343|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
83750344|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750345|NCT00000748|Trimethoprim|trimethoprim|mesh-list
83750346|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83750347|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
83750348|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83750349|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750350|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
83750351|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750352|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750353|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83750354|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750355|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750356|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83750357|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83750358|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750359|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750360|NCT00000751|Zidovudine|zidovudine|mesh-list
83750361|NCT00000751|Immune Sera|immune sera|mesh-list
83750362|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
83750363|NCT00000751|Antibodies|antibodies|mesh-list
83750364|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
83750365|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750366|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750367|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750368|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750369|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
83750370|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750371|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750372|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750373|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
83750374|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750375|NCT00000754|Interferons|interferons|mesh-list
83750376|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
83750377|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
83750378|NCT00000754|Zidovudine|zidovudine|mesh-list
83750379|NCT00000754|Zalcitabine|zalcitabine|mesh-list
83750380|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750381|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
83750382|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750383|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
83750384|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750385|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
83750386|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750387|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750388|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750389|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750390|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750391|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750392|NCT00000760|Zidovudine|zidovudine|mesh-list
83750393|NCT00000760|Didanosine|didanosine|mesh-list
83750394|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
83750395|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750396|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750397|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750398|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750399|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
83750400|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750401|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750402|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750403|NCT00000790|Thalidomide|thalidomide|mesh-list
83750404|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83750405|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
83750406|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750407|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
83750408|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750409|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750410|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82905603|NCT00945724|Vincristine|vincristine|mesh-list
82905604|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83750411|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83750412|NCT00000790|Growth Substances|growth substances|mesh-ancestor
83750413|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83750414|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750416|NCT00000793|Amitriptyline|amitriptyline|mesh-list
83750417|NCT00000793|Benztropine|benztropine|mesh-list
83750418|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83750419|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
83750420|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83750421|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83750422|NCT00000793|Analgesics|analgesics|mesh-ancestor
83750423|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
83750424|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83750425|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750426|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83750427|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83750428|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83750429|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750430|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
83750431|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83750432|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83750433|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83750434|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83750435|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83750436|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83750437|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
83750438|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
83750439|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83750440|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83750441|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
83750442|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83750443|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
83750444|NCT00000799|Cidofovir|cidofovir|mesh-list
83750445|NCT00000799|Probenecid|probenecid|mesh-list
83750446|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
83750447|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
83750448|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83750449|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
83750450|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750451|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750452|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750453|NCT00000817|Amitriptyline|amitriptyline|mesh-list
83750454|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83750455|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
83750456|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83750457|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83750458|NCT00000817|Analgesics|analgesics|mesh-ancestor
83750459|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
83750460|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83750461|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750462|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83750463|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83750464|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83750465|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750466|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
83750467|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83750468|NCT00000820|Aldesleukin|aldesleukin|mesh-list
83750469|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750470|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750471|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750472|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
83750473|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750474|NCT00000826|Clarithromycin|clarithromycin|mesh-list
83750475|NCT00000826|Dapsone|dapsone|mesh-list
83750476|NCT00000826|Rifabutin|rifabutin|mesh-list
83750477|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83750478|NCT00000826|Fluconazole|fluconazole|mesh-list
83750479|NCT00000826|Trimethoprim|trimethoprim|mesh-list
83750480|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
83750481|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750482|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750483|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83750484|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750485|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750486|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750487|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82905676|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83750488|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
83750489|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83750490|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83750491|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
83750492|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83750493|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750494|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83750495|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83750496|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83750497|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
83750498|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750499|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750500|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83750501|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83750502|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83750503|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
83750504|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83750505|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
83750506|NCT00000859|Ritonavir|ritonavir|mesh-list
83750507|NCT00000859|Nelfinavir|nelfinavir|mesh-list
83750508|NCT00000859|Indinavir|indinavir|mesh-list
83750509|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750510|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750511|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750512|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750513|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750514|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750515|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750516|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
83750517|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750518|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750519|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750520|NCT00000877|Indinavir|indinavir|mesh-list
83750521|NCT00000877|Rifabutin|rifabutin|mesh-list
83750522|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750523|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750524|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750525|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750526|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750527|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750528|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750529|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
83750530|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750531|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750532|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83750533|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
83750534|NCT00000883|Azithromycin|azithromycin|mesh-list
83750535|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750536|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750537|NCT00000892|Ritonavir|ritonavir|mesh-list
83750538|NCT00000892|Nelfinavir|nelfinavir|mesh-list
83750539|NCT00000892|Saquinavir|saquinavir|mesh-list
83750540|NCT00000892|Delavirdine|delavirdine|mesh-list
83750541|NCT00000892|Adefovir|adefovir|mesh-list
83750542|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83750543|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750544|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750545|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750546|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750547|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750548|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750549|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750550|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
83750551|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750552|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750553|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750554|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750555|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750556|NCT00000895|Azithromycin|azithromycin|mesh-list
83750557|NCT00000895|Nevirapine|nevirapine|mesh-list
83750558|NCT00000895|Nelfinavir|nelfinavir|mesh-list
83750559|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750560|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750561|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82905748|NCT03020992|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83750562|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750563|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750564|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750565|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
83750566|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750567|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750568|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83750569|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83750570|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750571|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750572|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750573|NCT00000898|Ritonavir|ritonavir|mesh-list
83750574|NCT00000898|Nelfinavir|nelfinavir|mesh-list
83750575|NCT00000898|Saquinavir|saquinavir|mesh-list
83750576|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750577|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750578|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750579|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750580|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750581|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750582|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750583|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
83750584|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750585|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750586|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750587|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
83750588|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83750589|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
83750590|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750591|NCT00389233|Protective Agents|protective agents|mesh-ancestor
83750592|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750593|NCT00389233|Vitamins|vitamins|mesh-ancestor
83750594|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
83750595|NCT00389233|Laxatives|laxatives|mesh-ancestor
83750596|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83750597|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
83750598|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83750599|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
83750600|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750601|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83750602|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750603|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
83750604|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750605|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
83750606|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83750607|NCT00000904|Protective Agents|protective agents|mesh-ancestor
83750608|NCT00000919|Ritonavir|ritonavir|mesh-list
83750609|NCT00000919|Nelfinavir|nelfinavir|mesh-list
83750610|NCT00000919|Indinavir|indinavir|mesh-list
83750611|NCT00000919|Amprenavir|amprenavir|mesh-list
83750612|NCT00000919|Lamivudine|lamivudine|mesh-list
83750613|NCT00000919|Zidovudine|zidovudine|mesh-list
83750614|NCT00000919|Abacavir|abacavir|mesh-list
83750615|NCT00000919|Stavudine|stavudine|mesh-list
83750616|NCT00000919|Didanosine|didanosine|mesh-list
83750617|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83750618|NCT00000919|Efavirenz|efavirenz|mesh-list
83750619|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
83750620|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750621|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750622|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750623|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750624|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750625|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750626|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750627|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
83750628|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750629|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750630|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750631|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750632|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750633|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
83750634|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83750635|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83750636|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82905822|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750637|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83750638|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83750639|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750640|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
83750641|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83750642|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
83750643|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750644|NCT00000922|Lamivudine|lamivudine|mesh-list
83750645|NCT00000922|Efavirenz|efavirenz|mesh-list
83750646|NCT00000922|Nevirapine|nevirapine|mesh-list
83750647|NCT00000922|Abacavir|abacavir|mesh-list
83750648|NCT00000922|Stavudine|stavudine|mesh-list
83750649|NCT00000922|Didanosine|didanosine|mesh-list
83750650|NCT00000922|Nelfinavir|nelfinavir|mesh-list
83750651|NCT00000922|Indinavir|indinavir|mesh-list
83750652|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750653|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750654|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750655|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750656|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
83750657|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750658|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750659|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750660|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83750661|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750662|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83750663|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83750664|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83750665|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83750666|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750667|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750668|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750669|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
83750670|NCT00000940|Ritonavir|ritonavir|mesh-list
83750671|NCT00000940|Amprenavir|amprenavir|mesh-list
83750672|NCT00000940|Lamivudine|lamivudine|mesh-list
83750673|NCT00000940|Abacavir|abacavir|mesh-list
83750674|NCT00000940|Stavudine|stavudine|mesh-list
83750675|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750676|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750677|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750678|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750679|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750680|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750681|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750682|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
83750683|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750684|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750685|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750686|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750687|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750688|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
83750689|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83750690|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
83750691|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750692|NCT00000943|Vaccines|vaccines|mesh-list
83750693|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
83750694|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750695|NCT00000952|Ritonavir|ritonavir|mesh-list
83750696|NCT00000952|Lamivudine|lamivudine|mesh-list
83750697|NCT00000952|Zidovudine|zidovudine|mesh-list
83750698|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750699|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750700|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750701|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750702|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750703|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750704|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750705|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
83750706|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750707|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750708|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750709|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750710|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750711|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
83750712|NCT00000643|Leucovorin|leucovorin|mesh-list
83750713|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
83750714|NCT00000643|Calcium|calcium|mesh-list
82905912|NCT01095939|Benazepril|benazepril|mesh-list
83750715|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
83750716|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83750717|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750718|NCT00000643|Antidotes|antidotes|mesh-ancestor
83750719|NCT00000643|Protective Agents|protective agents|mesh-ancestor
83750720|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
83750721|NCT00000643|Vitamins|vitamins|mesh-ancestor
83750722|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
83750723|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
83750724|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750725|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750726|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750727|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83750728|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750729|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750730|NCT00000970|Ganciclovir|ganciclovir|mesh-list
83750731|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83750732|NCT00000970|Foscarnet|foscarnet|mesh-list
83750733|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83750734|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
83750735|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750736|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750737|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750738|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750739|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750740|NCT00000973|Leucovorin|leucovorin|mesh-list
83750741|NCT00000973|Zidovudine|zidovudine|mesh-list
83750742|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
83750743|NCT00000973|Calcium|calcium|mesh-list
83750744|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
83750745|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83750746|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750747|NCT00000973|Antidotes|antidotes|mesh-ancestor
83750748|NCT00000973|Protective Agents|protective agents|mesh-ancestor
83750749|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
83750750|NCT00000973|Vitamins|vitamins|mesh-ancestor
83750751|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
83750752|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
83750753|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750754|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750755|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750756|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750757|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
83750758|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750759|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750760|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750761|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
83750762|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83750763|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750764|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83750765|NCT00000985|Acyclovir|acyclovir|mesh-list
83750766|NCT00000985|Foscarnet|foscarnet|mesh-list
83750767|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83750768|NCT00000985|Vidarabine|vidarabine|mesh-list
83750769|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
83750770|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750771|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750772|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750773|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750774|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750775|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
83750776|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83750777|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
83750778|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750779|NCT00001003|Zidovudine|zidovudine|mesh-list
83750780|NCT00001003|Pentamidine|pentamidine|mesh-list
83750781|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
83750782|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750783|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750784|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750785|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750786|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
83750787|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750788|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750789|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750790|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
83750791|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82905970|NCT00021255|Trastuzumab|trastuzumab|mesh-list
83750792|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83750793|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83750794|NCT00001030|Clarithromycin|clarithromycin|mesh-list
83750795|NCT00001030|Rifabutin|rifabutin|mesh-list
83750796|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750797|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750798|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83750799|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750800|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750801|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750802|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750803|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83750804|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
83750805|NCT05639127|Prednisolone|prednisolone|mesh-list
83750806|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83750807|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
83750808|NCT05639127|Hormones|hormones|mesh-ancestor
83750809|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83750810|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750811|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83750812|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750813|NCT00001033|Pyridoxine|pyridoxine|mesh-list
83750814|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
83750815|NCT00001033|Levofloxacin|levofloxacin|mesh-list
83750816|NCT00001033|Rifampin|rifampin|mesh-list
83750817|NCT00001033|Isoniazid|isoniazid|mesh-list
83750818|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
83750819|NCT00001033|Ethambutol|ethambutol|mesh-list
83750820|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83750821|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750822|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83750823|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83750824|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83750825|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750826|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750827|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750828|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83750829|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750830|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83750831|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
83750832|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
83750833|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750834|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83750835|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83750836|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83750837|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83750838|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83750839|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83750840|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83750841|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83750842|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
83750843|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83750844|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
83750845|NCT00001033|Vitamins|vitamins|mesh-ancestor
83750846|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
83750847|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750848|NCT00001036|Zidovudine|zidovudine|mesh-list
83750849|NCT00001036|Interleukin-2|interleukin-2|mesh-list
83750850|NCT00001036|Thymalfasin|thymalfasin|mesh-list
83750851|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750852|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83750853|NCT00001036|Analgesics|analgesics|mesh-ancestor
83750854|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
83750855|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83750856|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750857|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
83750858|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750859|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750860|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750861|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750862|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
83750863|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750864|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750865|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750866|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83750867|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
83750868|NCT00001045|Zidovudine|zidovudine|mesh-list
83750869|NCT00001045|Nevirapine|nevirapine|mesh-list
83750870|NCT00001045|Didanosine|didanosine|mesh-list
83750871|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
83750872|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750873|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750874|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750875|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750876|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
83750877|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750878|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750879|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750880|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83750881|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83750882|NCT00001048|Cytarabine|cytarabine|mesh-list
83750883|NCT00001048|Zidovudine|zidovudine|mesh-list
83750884|NCT00001048|Didanosine|didanosine|mesh-list
83750885|NCT00001048|Zalcitabine|zalcitabine|mesh-list
83750886|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83750887|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
83750888|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750889|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750890|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
83750891|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750892|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83750893|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
83750894|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750895|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750896|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750897|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750898|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750899|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750900|NCT00001066|Lamivudine|lamivudine|mesh-list
83750901|NCT00001066|Zidovudine|zidovudine|mesh-list
83750902|NCT00001066|Didanosine|didanosine|mesh-list
83750903|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750904|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750905|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750906|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750907|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
83750908|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750909|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750910|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750911|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
83750912|NCT00001075|Ritonavir|ritonavir|mesh-list
83750913|NCT00001075|Lamivudine|lamivudine|mesh-list
83750914|NCT00001075|Zidovudine|zidovudine|mesh-list
83750915|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750916|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750917|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750918|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750919|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750920|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750921|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750922|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
83750923|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750924|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750925|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750926|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750927|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750928|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
83750929|NCT00001084|Lamivudine|lamivudine|mesh-list
83750930|NCT00001084|Zidovudine|zidovudine|mesh-list
83750931|NCT00001084|Stavudine|stavudine|mesh-list
83750932|NCT00001084|Indinavir|indinavir|mesh-list
83750933|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750934|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750935|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750936|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750937|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
83750938|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750939|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750940|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750941|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
83750942|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82906122|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906123|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
83750943|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750944|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750945|NCT00001087|Ritonavir|ritonavir|mesh-list
83750946|NCT00001087|Nelfinavir|nelfinavir|mesh-list
83750947|NCT00001087|Saquinavir|saquinavir|mesh-list
83750948|NCT00001087|Lamivudine|lamivudine|mesh-list
83750949|NCT00001087|Zidovudine|zidovudine|mesh-list
83750950|NCT00001087|Stavudine|stavudine|mesh-list
83750951|NCT00001087|Didanosine|didanosine|mesh-list
83750952|NCT00001087|Zalcitabine|zalcitabine|mesh-list
83750953|NCT00001087|Efavirenz|efavirenz|mesh-list
83750954|NCT00001087|Adefovir|adefovir|mesh-list
83750955|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83750956|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83750957|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83750958|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
83750959|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750960|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750961|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750962|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750963|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
83750964|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750965|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83750966|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83750967|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750968|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750969|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
83750970|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83750971|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83750972|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83750973|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83750974|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83750975|NCT00001105|Antibodies|antibodies|mesh-list
83750976|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83750977|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
83750978|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83750979|NCT00001111|Zidovudine|zidovudine|mesh-list
83750980|NCT00001111|Nevirapine|nevirapine|mesh-list
83750981|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
83750982|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83750983|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83750984|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83750985|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83750986|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
83750987|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750988|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83750989|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83750990|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83750991|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83750992|NCT00001114|Interferons|interferons|mesh-list
83750993|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
83750994|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
83750995|NCT00001114|Didanosine|didanosine|mesh-list
83750996|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83750997|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
83750998|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83750999|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
83751000|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751001|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
83751002|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751003|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83751004|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83751005|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751006|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83751007|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83751008|NCT00001165|Doxorubicin|doxorubicin|mesh-list
83751009|NCT00001165|Streptozocin|streptozocin|mesh-list
83751010|NCT00001165|Fluorouracil|fluorouracil|mesh-list
83751011|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83751012|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751013|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83751014|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83751015|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751016|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751017|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
83751018|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83751019|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82906197|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83751020|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
83751021|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751022|NCT00001180|Hormones|hormones|mesh-list
83751023|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83751024|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
83751025|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751026|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751027|NCT00389272|Acetaminophen|acetaminophen|mesh-list
83751028|NCT00389272|Ibuprofen|ibuprofen|mesh-list
83751029|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83751030|NCT00389272|Analgesics|analgesics|mesh-ancestor
83751031|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
83751032|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751033|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751034|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
83751035|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83751036|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751037|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83751038|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83751039|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751040|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751041|NCT00389311|Nonoxynol|nonoxynol|mesh-list
83751042|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83751043|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83751044|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751045|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83751046|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
83751047|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83751048|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83751049|NCT00001213|Cysteamine|cysteamine|mesh-list
83751050|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83751051|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751052|NCT00000114|Vitamins|vitamins|mesh-list
83751053|NCT00000114|Vitamin E|vitamin e|mesh-list
83751054|NCT00000114|Vitamin A|vitamin a|mesh-list
83751055|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
83751056|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751057|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
83751058|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751059|NCT00000114|Protective Agents|protective agents|mesh-ancestor
83751060|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
83751061|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83751062|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83751063|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
83751064|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751065|NCT00001267|Zidovudine|zidovudine|mesh-list
83751066|NCT00001267|Didanosine|didanosine|mesh-list
83751067|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
83751068|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751069|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83751070|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83751071|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751072|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
83751073|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751074|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83751075|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83751076|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
83751077|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83751078|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
83751079|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751080|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751081|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83751082|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
83751083|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83751084|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
83751085|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751086|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751087|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83751088|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
83751089|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
83751090|NCT00001303|Protective Agents|protective agents|mesh-ancestor
83751091|NCT00000120|Erythromycin|erythromycin|mesh-list
83751092|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
83751093|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83751094|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
82906270|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906272|NCT00027027|Pertuzumab|pertuzumab|mesh-list
83751095|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
83751096|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83751097|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751098|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83751099|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83751100|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751101|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751102|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83751104|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83751105|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83751106|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751107|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751108|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751109|NCT00001378|Fenretinide|fenretinide|mesh-list
83751110|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751111|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83751112|NCT00001378|Protective Agents|protective agents|mesh-ancestor
83751113|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751114|NCT00001387|Paclitaxel|paclitaxel|mesh-list
83751115|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83751116|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751117|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
83751118|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
83751119|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83751120|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751121|NCT00388557|Ketoconazole|ketoconazole|mesh-list
83751122|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
83751123|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751124|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83751125|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83751126|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751127|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751128|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83751129|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
83751130|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751131|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751132|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83751133|NCT00388635|Prednisone|prednisone|mesh-list
83751134|NCT00388635|Melphalan|melphalan|mesh-list
83751135|NCT00388635|Bortezomib|bortezomib|mesh-list
83751136|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751137|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
83751138|NCT00388635|Hormones|hormones|mesh-ancestor
83751139|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751140|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751141|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83751142|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751143|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83751144|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
83751145|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751146|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83751147|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83751148|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
83751149|NCT00001474|Interleukin-2|interleukin-2|mesh-list
83751150|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751151|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83751152|NCT00001474|Analgesics|analgesics|mesh-ancestor
83751153|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
83751154|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751155|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751156|NCT00001483|Sertraline|sertraline|mesh-list
83751157|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83751158|NCT00001483|Bupropion|bupropion|mesh-list
83751159|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751160|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751161|NCT00001483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83751162|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751163|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751164|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906342|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906343|NCT03720756|Nickel|nickel|mesh-list
82906344|NCT03720756|Trace Elements|trace elements|mesh-ancestor
82906345|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
82906347|NCT00025233|Bevacizumab|bevacizumab|mesh-list
83751165|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751166|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
83751167|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751168|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83751169|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83751170|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83751171|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
83751172|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83751173|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83751174|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751175|NCT00001495|Irinotecan|irinotecan|mesh-list
83751176|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83751177|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83751178|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751179|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751180|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751181|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83751182|NCT00001507|Antibodies|antibodies|mesh-list
83751183|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
83751184|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83751185|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
83751186|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751187|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751188|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
83751189|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751190|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
83751191|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751192|NCT00001576|Leucovorin|leucovorin|mesh-list
83751193|NCT00001576|Melphalan|melphalan|mesh-list
83751194|NCT00001576|Floxuridine|floxuridine|mesh-list
83751195|NCT00001576|Antidotes|antidotes|mesh-ancestor
83751196|NCT00001576|Protective Agents|protective agents|mesh-ancestor
83751197|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751198|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
83751199|NCT00001576|Vitamins|vitamins|mesh-ancestor
83751200|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
83751201|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83751202|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
83751203|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751204|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751205|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83751206|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83751207|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
83751208|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83751209|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
83751210|NCT00000147|Prednisone|prednisone|mesh-list
83751211|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
83751212|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83751213|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83751214|NCT00000147|Prednisolone|prednisolone|mesh-list
83751215|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
83751216|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83751217|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
83751218|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751219|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
83751220|NCT00000147|Hormones|hormones|mesh-ancestor
83751221|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751222|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751223|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83751224|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751225|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
83751226|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
83751227|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906414|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906415|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82906416|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82906417|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82906418|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82906419|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82906420|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82906421|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82906422|NCT00023673|Paclitaxel|paclitaxel|mesh-list
82906423|NCT00023673|Carboplatin|carboplatin|mesh-list
83751228|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83751229|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83751230|NCT00000147|Protective Agents|protective agents|mesh-ancestor
83751231|NCT00001624|Insulin|insulin|mesh-list
83751232|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83751233|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751234|NCT00001666|Methamphetamine|methamphetamine|mesh-list
83751235|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83751236|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751237|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
83751238|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
83751239|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751240|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
83751241|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751242|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751243|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751244|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83751245|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751246|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751247|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83751248|NCT00001669|Mecasermin|mecasermin|mesh-list
83751249|NCT00001669|Growth Substances|growth substances|mesh-ancestor
83751250|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751251|NCT00001693|Celecoxib|celecoxib|mesh-list
83751252|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83751253|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83751254|NCT00001693|Analgesics|analgesics|mesh-ancestor
83751255|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
83751256|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751257|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751258|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751259|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83751260|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83751261|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83751262|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751263|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751264|NCT00001696|Genistein|genistein|mesh-list
83751265|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83751266|NCT00001696|Protective Agents|protective agents|mesh-ancestor
83751267|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751268|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751269|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83751270|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751271|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751272|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
83751273|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83751274|NCT00001696|Estrogens|estrogens|mesh-ancestor
83751275|NCT00001696|Hormones|hormones|mesh-ancestor
83751276|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751277|NCT00389428|Cytarabine|cytarabine|mesh-list
83751278|NCT00389428|Daunorubicin|daunorubicin|mesh-list
83751279|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83751280|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
83751281|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751282|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751283|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
83751284|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751285|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83751286|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
83751287|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751288|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83751289|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83751290|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83751291|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751292|NCT00001720|Alendronate|alendronate|mesh-list
83751293|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83751294|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751295|NCT00001723|Orlistat|orlistat|mesh-list
83751296|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751297|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751298|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83751299|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83751300|NCT00001729|Ribavirin|ribavirin|mesh-list
83751301|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
83751302|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751303|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
82906480|NCT04056754|Hormones|hormones|mesh-ancestor
83751304|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751306|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83751307|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83751308|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83751309|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83751310|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751311|NCT00001777|Sertraline|sertraline|mesh-list
83751312|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751313|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751314|NCT00001777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83751315|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751316|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751317|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751318|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751319|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
83751320|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751321|NCT00000171|Melatonin|melatonin|mesh-list
83751322|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
83751323|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751324|NCT00000171|Protective Agents|protective agents|mesh-ancestor
83751325|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751326|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751327|NCT05641636|Hormones|hormones|mesh-list
83751328|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751329|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751330|NCT00000177|Estrogens|estrogens|mesh-list
83751331|NCT00000177|Hormones|hormones|mesh-ancestor
83751332|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751333|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751334|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
83751335|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83751336|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751337|NCT03444376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83751338|NCT03444376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751339|NCT00000216|Buprenorphine|buprenorphine|mesh-list
83751340|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83751341|NCT00000216|Narcotics|narcotics|mesh-ancestor
83751342|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751343|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751344|NCT00000216|Analgesics|analgesics|mesh-ancestor
83751345|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
83751346|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751347|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83751348|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
83751349|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83751350|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
83751351|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
83751352|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751353|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751354|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83751355|NCT00000252|Analgesics|analgesics|mesh-ancestor
83751356|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
83751357|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751358|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
83751359|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83751360|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751361|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751362|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83751363|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83751364|NCT05640817|Protective Agents|protective agents|mesh-ancestor
83751365|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751366|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
83751367|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83751368|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
83751369|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
83751370|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83751371|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
83751372|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
83751373|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751374|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751375|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906556|NCT03717662|Nicotine|nicotine|mesh-list
83751376|NCT00000255|Analgesics|analgesics|mesh-ancestor
83751377|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
83751378|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751379|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
83751380|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83751381|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
83751382|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
83751383|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751384|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751385|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83751386|NCT00000258|Analgesics|analgesics|mesh-ancestor
83751387|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
83751388|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751389|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
83751390|NCT00389506|Fludarabine|fludarabine|mesh-list
83751391|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
83751392|NCT00389506|Immunotoxins|immunotoxins|mesh-list
83751393|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83751394|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
83751395|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751396|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83751397|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83751398|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
83751399|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751400|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751401|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83751402|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83751403|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
83751404|NCT00389506|Immunoconjugates|immunoconjugates|mesh-ancestor
83751405|NCT00389584|Irinotecan|irinotecan|mesh-list
83751406|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83751407|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83751408|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751409|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751410|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751411|NCT00000324|Tryptophan|tryptophan|mesh-list
83751412|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83751413|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751414|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751415|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
83751416|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83751417|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751418|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751419|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83751420|NCT05640427|Analgesics|analgesics|mesh-ancestor
83751421|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
83751422|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751423|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83751424|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83751425|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83751426|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751427|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751428|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751429|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
83751430|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83751431|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
83751432|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751433|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751434|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751435|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
83751436|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751437|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751438|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751439|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751440|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
83751441|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83751442|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751443|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751444|NCT00000375|Nortriptyline|nortriptyline|mesh-list
83751445|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751446|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751447|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906623|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751448|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751449|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83751450|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83751451|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751452|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751453|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751454|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751455|NCT03295747|Peppermint oil|peppermint oil|mesh-list
83751456|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
83751457|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
83751458|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751459|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751460|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83751461|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
83751462|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
83751463|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751464|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
83751465|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83751466|NCT03575208|Interferons|interferons|mesh-list
83751467|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
83751468|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
83751469|NCT03575208|Antibodies|antibodies|mesh-list
83751470|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
83751471|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83751472|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83751473|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751474|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
83751475|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751476|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
83751477|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751478|NCT03295552|Carboplatin|carboplatin|mesh-list
83751479|NCT03295552|Decitabine|decitabine|mesh-list
83751480|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751481|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83751482|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
83751483|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751484|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751485|NCT05629468|Azithromycin|azithromycin|mesh-list
83751486|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83751487|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83751488|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751489|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
83751490|NCT00000378|Sertraline|sertraline|mesh-list
83751491|NCT00000378|Nortriptyline|nortriptyline|mesh-list
83751492|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751493|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751494|NCT00000378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83751495|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751496|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751497|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751498|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751499|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
83751500|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751501|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83751502|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83751503|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751504|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
83751505|NCT05626621|Azelastine|azelastine|mesh-list
83751506|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751507|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83751508|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83751509|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83751510|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
83751511|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751512|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751513|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83751514|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
83751515|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83751516|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751517|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751518|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83751519|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83751520|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
83751521|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
83751522|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751523|NCT00000381|Fluoxetine|fluoxetine|mesh-list
83751524|NCT00000381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83751525|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751526|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751527|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751528|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751529|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
83751530|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751531|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83751532|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751533|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751534|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83751535|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83751536|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751537|NCT05619172|Cetuximab|cetuximab|mesh-list
83751538|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83751539|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751540|NCT05631925|Propofol|propofol|mesh-list
83751541|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83751542|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751543|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751544|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83751545|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
83751546|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
83751547|NCT00389701|Dexamethasone|dexamethasone|mesh-list
83751548|NCT00389701|Bortezomib|bortezomib|mesh-list
83751549|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751550|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
83751551|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
83751552|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751553|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751554|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83751555|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
83751556|NCT00389701|Hormones|hormones|mesh-ancestor
83751557|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751558|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83751559|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751560|NCT00000420|Norinyl|norinyl|mesh-list
83751561|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83751562|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83751563|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83751564|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
83751565|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83751566|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751567|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83751568|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83751569|NCT00000426|Calcium|calcium|mesh-list
83751570|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83751571|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751572|NCT05551858|Proglumide|proglumide|mesh-list
83751573|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83751574|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83751575|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83751576|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751577|NCT00000456|Naltrexone|naltrexone|mesh-list
83751578|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83751579|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83751580|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751581|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
83751582|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751583|NCT05519683|Escitalopram|escitalopram|mesh-list
83751584|NCT05519683|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83751585|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751586|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751587|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751588|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751589|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
83751590|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751591|NCT05442268|Acetaminophen|acetaminophen|mesh-list
83751592|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83751593|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83751594|NCT05442268|Analgesics|analgesics|mesh-ancestor
83751595|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
83751596|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751597|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751598|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
83751599|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83751600|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751601|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751602|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751603|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751604|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751605|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751606|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
83751607|NCT05448820|Doxorubicin|doxorubicin|mesh-list
83751608|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83751609|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751610|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83751611|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83751612|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751613|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751614|NCT00000468|Plasminogen|plasminogen|mesh-list
83751615|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83751616|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83751617|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83751618|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751619|NCT02972476|Fluticasone|fluticasone|mesh-list
83751620|NCT02972476|Xhance|xhance|mesh-list
83751621|NCT02972476|Budesonide|budesonide|mesh-list
83751622|NCT02972476|Bromides|bromides|mesh-list
83751623|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
83751624|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83751625|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83751626|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751627|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83751628|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
83751629|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751630|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751631|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83751632|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
83751633|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
83751634|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83751635|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
83751636|NCT02972476|Hormones|hormones|mesh-ancestor
83504907|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83751637|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751638|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83751639|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83751640|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83751641|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751642|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751643|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751644|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
83751645|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
83751646|NCT05418868|Cabotegravir|cabotegravir|mesh-list
83751647|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83751648|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83751649|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751650|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751651|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83751652|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83751653|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
83751654|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751655|NCT02972320|Temozolomide|temozolomide|mesh-list
83751656|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83751657|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
83751658|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751659|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751660|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83751661|NCT05349838|Dolutegravir|dolutegravir|mesh-list
83751662|NCT05349838|Rilpivirine|rilpivirine|mesh-list
83751663|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
83751664|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83751665|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83751666|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751667|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751668|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83751669|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83751670|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
83751671|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751672|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82906847|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
83751673|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83751675|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83751676|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
83751677|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751678|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751679|NCT05305456|Vitamins|vitamins|mesh-list
83751680|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
83751681|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
83751682|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751683|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
83751684|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751685|NCT05305456|Protective Agents|protective agents|mesh-ancestor
83751686|NCT00388986|Glyburide|glyburide|mesh-list
83751687|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83751688|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751689|NCT05233696|Paclitaxel|paclitaxel|mesh-list
83751690|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83751691|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
83751692|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83751693|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751694|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
83751695|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
83751696|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
83751697|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751698|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83751699|NCT05233696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83751700|NCT05223673|Trifluridine|trifluridine|mesh-list
83751701|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
83751702|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751703|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
83751704|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751705|NCT00000492|Propranolol|propranolol|mesh-list
83751706|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83751707|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83751708|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751709|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751710|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751711|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751712|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83751713|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83751714|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
83751715|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
83751716|NCT00000504|Flecainide|flecainide|mesh-list
83751717|NCT00000504|Moricizine|moricizine|mesh-list
83751718|NCT00000504|Encainide|encainide|mesh-list
83751719|NCT00000504|Imipramine|imipramine|mesh-list
83751720|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83751721|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83751722|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83751723|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751724|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751725|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83751726|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751727|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751728|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83751729|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751730|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751731|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751732|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751733|NCT00389935|Thalidomide|thalidomide|mesh-list
83751734|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83751735|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
83751736|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751737|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
83751738|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83751739|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751740|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83751741|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83751742|NCT00389935|Growth Substances|growth substances|mesh-ancestor
83751743|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
83751744|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751745|NCT05116930|Atropine|atropine|mesh-list
83751746|NCT05116930|Neostigmine|neostigmine|mesh-list
83751747|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83751748|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83751749|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83751750|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
83751751|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751752|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751753|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83751754|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
83751755|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
83751756|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
83751757|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83751758|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83751759|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
83751760|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751761|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751762|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83751763|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751764|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83751766|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83751767|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751768|NCT00000516|Enalapril|enalapril|mesh-list
83751769|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83751770|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
83751771|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751772|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751773|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83751774|NCT05049616|Nifedipine|nifedipine|mesh-list
83751775|NCT05049616|Diuretics|diuretics|mesh-list
83751776|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83751777|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83751778|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751779|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751780|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83751781|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751782|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
83751783|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
83751784|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83751785|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
83751786|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
83751787|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751788|NCT00000522|Acebutolol|acebutolol|mesh-list
83751789|NCT00000522|Amlodipine|amlodipine|mesh-list
83751790|NCT00000522|Enalapril|enalapril|mesh-list
83751791|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
83751792|NCT00000522|Doxazosin|doxazosin|mesh-list
83751793|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83751794|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83751795|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751796|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751797|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83751798|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751799|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
83751800|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83751801|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
83751802|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751803|NCT00000522|Diuretics|diuretics|mesh-ancestor
83751804|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
83751805|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83751806|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83751807|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83751808|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83751809|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751810|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751811|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83751812|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
83751813|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
83751814|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751815|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83751816|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83751817|NCT03126799|Bevacizumab|bevacizumab|mesh-list
83751818|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83751819|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83751820|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751821|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83751822|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83751823|NCT03126799|Growth Substances|growth substances|mesh-ancestor
83751824|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751825|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
83751826|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83751827|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751828|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751829|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83751830|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
83751831|NCT00000525|Triamterene|triamterene|mesh-list
83751832|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83751833|NCT00000525|Diuretics|diuretics|mesh-ancestor
83751834|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
83751835|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751836|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83751837|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751838|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751839|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83751840|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83751841|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83751842|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
83751843|NCT05020483|Coagulants|coagulants|mesh-ancestor
83751844|NCT00000531|Amiodarone|amiodarone|mesh-list
83751845|NCT00000531|Sotalol|sotalol|mesh-list
83751846|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83751847|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
83751848|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83751849|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751850|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751851|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83751852|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83751853|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83751854|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751855|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83751856|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83751857|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83751858|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83751859|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83751860|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
83751861|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751862|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751863|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
83751864|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
83751865|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751866|NCT00000534|Calcium|calcium|mesh-list
83751867|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83751868|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751869|NCT04935814|Vasopressins|vasopressins|mesh-list
83751870|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
83751871|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
83751872|NCT04935814|Coagulants|coagulants|mesh-ancestor
83751873|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83751874|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83751875|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
83751876|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751877|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83751878|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83751879|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751880|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
83751881|NCT00000555|Vitamin E|vitamin e|mesh-list
83751882|NCT00000555|Hormones|hormones|mesh-list
83751883|NCT00000555|Progesterone|progesterone|mesh-list
83751884|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83751885|NCT00000555|Estrogens|estrogens|mesh-list
83751886|NCT00000555|Vitamins|vitamins|mesh-ancestor
83751887|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
83751888|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751889|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751890|NCT00000555|Progestins|progestins|mesh-ancestor
83751891|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
83751892|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751893|NCT00000555|Protective Agents|protective agents|mesh-ancestor
83751894|NCT04888858|Fentanyl|fentanyl|mesh-list
82907074|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907082|NCT03949101|Atropine|atropine|mesh-list
83751896|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
83751897|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
83751898|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751899|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751900|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
83751901|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751902|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83751903|NCT04888858|Narcotics|narcotics|mesh-ancestor
83751904|NCT04888858|Analgesics|analgesics|mesh-ancestor
83751905|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83751906|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83751907|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
83751908|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83751909|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83751910|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83751911|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83751912|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751913|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751914|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751915|NCT04870957|Analgesics|analgesics|mesh-ancestor
83751916|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
83751917|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751918|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
83751919|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751920|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
83751921|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83751922|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83751923|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751924|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
83751925|NCT04802746|Alprazolam|alprazolam|mesh-list
83751926|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83751927|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83751928|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751929|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83751930|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83751931|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83751932|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
83751933|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
83751934|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83751935|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751936|NCT00000576|Beclomethasone|beclomethasone|mesh-list
83751937|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751938|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
83751939|NCT00000576|Hormones|hormones|mesh-ancestor
83751940|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751941|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751942|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83751943|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
83751944|NCT00000579|Ketoconazole|ketoconazole|mesh-list
83751945|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
83751946|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83751947|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83751948|NCT00000579|Prednisolone|prednisolone|mesh-list
83751949|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
83751950|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83751951|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
83751952|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83751953|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
83751954|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
83751955|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83751956|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751957|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83751958|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
83751959|NCT00000579|Hormones|hormones|mesh-ancestor
83751960|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83751961|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83751962|NCT00000579|Protective Agents|protective agents|mesh-ancestor
83751963|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83751964|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751965|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
83751966|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83751967|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82907148|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83751968|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83751969|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83751970|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751971|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83751972|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
83751973|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83751975|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
83751976|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
83751977|NCT00000588|Vitamins|vitamins|mesh-ancestor
83751978|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
83751979|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751980|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
83751981|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
83751982|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751983|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83751984|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
83751985|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83751986|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83751987|NCT04713514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83751988|NCT04713514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751989|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
83751990|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83751991|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83751992|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
83751993|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83751994|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83751995|NCT00390091|Abetimus|abetimus|mesh-list
83751996|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83751997|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
83751998|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83751999|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83752000|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
83752001|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752002|NCT04650880|Vitamin D|vitamin d|mesh-list
83752003|NCT04650880|Vitamins|vitamins|mesh-ancestor
83752004|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
83752005|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752006|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83752007|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
83752008|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83752009|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
83752010|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752011|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752012|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83752013|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
83752014|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83752015|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
83752016|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752017|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83752018|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83752019|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
83752020|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
83752021|NCT04601077|Protective Agents|protective agents|mesh-ancestor
83752022|NCT00000609|Amiodarone|amiodarone|mesh-list
83752023|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83752024|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
83752025|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83752026|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83752027|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752028|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83752029|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83752030|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752031|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752032|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83752033|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83752034|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83752035|NCT04547530|Vitamin D|vitamin d|mesh-list
83752036|NCT04547530|Vitamins|vitamins|mesh-ancestor
83752037|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
83752038|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752039|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82907221|NCT01103739|Simvastatin|simvastatin|mesh-list
83752040|NCT04544683|Dexamethasone|dexamethasone|mesh-list
83752041|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
83752042|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83752044|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83752045|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
83752046|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
83752047|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752048|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752049|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83752050|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
83752051|NCT04544683|Hormones|hormones|mesh-ancestor
83752052|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752053|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83752054|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752055|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752056|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752057|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752058|NCT00000612|Estrogens|estrogens|mesh-list
83752059|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83752060|NCT00000612|Hormones|hormones|mesh-ancestor
83752061|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752062|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752063|NCT00000639|Itraconazole|itraconazole|mesh-list
83752064|NCT00000639|Fluconazole|fluconazole|mesh-list
83752065|NCT00000639|Amphotericin B|amphotericin b|mesh-list
83752066|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83752067|NCT00000639|Flucytosine|flucytosine|mesh-list
83752068|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
83752069|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752070|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83752071|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752072|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752073|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752074|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83752075|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
83752076|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752077|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752078|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83752079|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83752080|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83752081|NCT00000639|Amebicides|amebicides|mesh-ancestor
83752082|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83752083|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83752084|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83752085|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
83752086|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83752087|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
83752088|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752089|NCT00000645|Hypericin|hypericin|mesh-list
83752090|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
83752091|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83752092|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752093|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
83752094|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752095|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752096|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752097|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83752098|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
83752099|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752100|NCT04495504|Ropivacaine|ropivacaine|mesh-list
83752101|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
83752102|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
83752103|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83752104|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752105|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
83752106|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752107|NCT00390208|Dexamethasone|dexamethasone|mesh-list
83752108|NCT00390208|Ranibizumab|ranibizumab|mesh-list
83752109|NCT00390208|Verteporfin|verteporfin|mesh-list
83752110|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83752111|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
83752112|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
83752113|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752114|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752115|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83752116|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
83752117|NCT00390208|Hormones|hormones|mesh-ancestor
83752118|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752119|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83752120|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752121|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83752122|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83752123|NCT00390208|Growth Substances|growth substances|mesh-ancestor
83752124|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
83752125|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83752126|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
83752127|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83752128|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83752129|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83752130|NCT00389025|Analgesics|analgesics|mesh-ancestor
83752131|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
83752132|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752133|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752134|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83752135|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83752136|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83752137|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83752138|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83752139|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
83752140|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
83752141|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83752142|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752143|NCT00390247|Thalidomide|thalidomide|mesh-list
83752144|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83752145|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
83752146|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752147|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
83752148|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83752149|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752150|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83752151|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83752152|NCT00390247|Growth Substances|growth substances|mesh-ancestor
83752153|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
83752154|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752155|NCT00000651|Zidovudine|zidovudine|mesh-list
83752156|NCT00000651|Zalcitabine|zalcitabine|mesh-list
83752157|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
83752158|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752159|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752160|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752161|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752162|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
83752163|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752164|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752165|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752166|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
83752167|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
83752168|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83752169|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83752170|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752171|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83752172|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752173|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752174|NCT00000672|Didanosine|didanosine|mesh-list
83752175|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
83752176|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752177|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752178|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752179|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752180|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
83752181|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752182|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752183|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752184|NCT04321954|Lenvatinib|lenvatinib|mesh-list
83752185|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752186|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83752187|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752188|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752189|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83752190|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
83752191|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752193|NCT00000678|Zalcitabine|zalcitabine|mesh-list
83752194|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
83752195|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752196|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752197|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752198|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752199|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
83752200|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752201|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752202|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752203|NCT00390403|Acetic Acid|acetic acid|mesh-list
83752204|NCT00390403|Temozolomide|temozolomide|mesh-list
83752205|NCT00390403|Retinol acetate|retinol acetate|mesh-list
83752206|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
83752207|NCT00390403|Gossypol|gossypol|mesh-list
83752208|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83752209|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
83752210|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752211|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752212|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83752213|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752214|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83752215|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
83752216|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752217|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83752218|NCT00390403|Protective Agents|protective agents|mesh-ancestor
83752219|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83752220|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
83752221|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83752222|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83752223|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83752224|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83752225|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83752226|NCT00000681|Zidovudine|zidovudine|mesh-list
83752227|NCT00000681|Doxorubicin|doxorubicin|mesh-list
83752228|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83752229|NCT00000681|Bleomycin|bleomycin|mesh-list
83752230|NCT00000681|Vincristine|vincristine|mesh-list
83752231|NCT00000681|Sargramostim|sargramostim|mesh-list
83752232|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83752233|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752234|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83752235|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83752236|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752237|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752238|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83752239|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
83752240|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
83752241|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
83752242|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
83752243|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752244|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752245|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
83752246|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752247|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752248|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752249|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
83752250|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752251|NCT00000684|Dextrans|dextrans|mesh-list
83752252|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
83752253|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
83752254|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
83752255|NCT00000687|Interferons|interferons|mesh-list
83752256|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
83752257|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
83752258|NCT00000687|Zidovudine|zidovudine|mesh-list
83752259|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752260|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
83752261|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752262|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
83752263|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752264|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
83752265|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752266|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752267|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752268|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752269|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752270|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752272|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
83752273|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
83752274|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
83752275|NCT00000696|Interferons|interferons|mesh-list
83752276|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
83752277|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
83752278|NCT00000696|Zidovudine|zidovudine|mesh-list
83752279|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752280|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
83752281|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752282|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
83752283|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752284|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
83752285|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752286|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752287|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752288|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752289|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752290|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752291|NCT00000705|Zidovudine|zidovudine|mesh-list
83752292|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
83752293|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752294|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752295|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752296|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752297|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
83752298|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752299|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752300|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752301|NCT00000708|Fluconazole|fluconazole|mesh-list
83752302|NCT00000708|Amphotericin B|amphotericin b|mesh-list
83752303|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83752304|NCT00000708|Flucytosine|flucytosine|mesh-list
83752305|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
83752306|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752307|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83752308|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752309|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752310|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752311|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83752312|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
83752313|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752314|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752315|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83752316|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83752317|NCT00000708|Amebicides|amebicides|mesh-ancestor
83752318|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83752319|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83752320|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83752321|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
83752322|NCT00000711|Zidovudine|zidovudine|mesh-list
83752323|NCT00000711|Sargramostim|sargramostim|mesh-list
83752324|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
83752325|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752326|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752327|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752328|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752329|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
83752330|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752331|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752332|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752333|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
83752334|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752335|NCT00000717|Clindamycin|clindamycin|mesh-list
83752336|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
83752337|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
83752338|NCT00000717|Primaquine|primaquine|mesh-list
83752339|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83752340|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752341|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83752342|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752343|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752344|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
83752345|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83752346|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83752347|NCT04169347|Leucovorin|leucovorin|mesh-list
83752348|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
83752349|NCT04169347|Irinotecan|irinotecan|mesh-list
83752350|NCT04169347|Panitumumab|panitumumab|mesh-list
83752351|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752352|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83752353|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83752354|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752355|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752356|NCT04169347|Antidotes|antidotes|mesh-ancestor
83752357|NCT04169347|Protective Agents|protective agents|mesh-ancestor
83752358|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752359|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
83752360|NCT04169347|Vitamins|vitamins|mesh-ancestor
83752361|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
83752362|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83752363|NCT00000720|Zidovudine|zidovudine|mesh-list
83752364|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
83752365|NCT00000720|Antibodies|antibodies|mesh-list
83752366|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
83752367|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752368|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752369|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752370|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752371|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
83752372|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752373|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752374|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752375|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
83752376|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752377|NCT04142983|Vaccines|vaccines|mesh-list
83752378|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
83752379|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752380|NCT00000726|Foscarnet|foscarnet|mesh-list
83752381|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83752382|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
83752383|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752384|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752385|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752386|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752387|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752388|NCT04104139|Trifluridine|trifluridine|mesh-list
83752389|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
83752390|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752391|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
83752392|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752393|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
83752394|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83752395|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83752396|NCT00000741|Prednisolone|prednisolone|mesh-list
83752397|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
83752398|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83752399|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
83752400|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83752401|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
83752402|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
83752403|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752404|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752405|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83752406|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
83752407|NCT00000741|Hormones|hormones|mesh-ancestor
83752408|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752409|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83752410|NCT00000741|Protective Agents|protective agents|mesh-ancestor
83752411|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83752412|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752413|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
83752414|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82907601|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907602|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83752415|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83752416|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83752417|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83752418|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752419|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
83752420|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83752421|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752422|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83752423|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752424|NCT00000744|Fluconazole|fluconazole|mesh-list
83752425|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
83752426|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752427|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83752428|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752429|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752430|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752431|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83752432|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
83752433|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752434|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752435|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83752436|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83752437|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
83752438|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
83752439|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83752440|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752441|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83752442|NCT04038346|Acetaminophen|acetaminophen|mesh-list
83752443|NCT04038346|Naproxen|naproxen|mesh-list
83752444|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83752445|NCT04038346|Analgesics|analgesics|mesh-ancestor
83752446|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
83752447|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752448|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752449|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
83752450|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83752451|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83752452|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83752453|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
83752454|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83752455|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752456|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752457|NCT04020172|Dobutamine|dobutamine|mesh-list
83752458|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83752459|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
83752460|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
83752461|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752462|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752463|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83752464|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83752465|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83752466|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
83752467|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83752468|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752469|NCT04020172|Protective Agents|protective agents|mesh-ancestor
83752470|NCT00000747|Nevirapine|nevirapine|mesh-list
83752471|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752472|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752473|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752474|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752475|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
83752476|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752477|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752478|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752479|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83752480|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83752481|NCT00000753|Zidovudine|zidovudine|mesh-list
83752482|NCT00000753|Didanosine|didanosine|mesh-list
83752483|NCT00000753|Zalcitabine|zalcitabine|mesh-list
83752484|NCT00000753|Atevirdine|atevirdine|mesh-list
83752485|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
83752486|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752487|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752488|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752489|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752490|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
83752491|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752492|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752493|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752494|NCT03991741|Interleukin-2|interleukin-2|mesh-list
83752495|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752496|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83752497|NCT03991741|Analgesics|analgesics|mesh-ancestor
83752498|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
83752499|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752500|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752501|NCT00000768|Ganciclovir|ganciclovir|mesh-list
83752502|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83752503|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
83752504|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752505|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752506|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752507|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752508|NCT00000789|Zidovudine|zidovudine|mesh-list
83752509|NCT00000789|Stavudine|stavudine|mesh-list
83752510|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
83752511|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752512|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752513|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752514|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752515|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
83752516|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752517|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752518|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752519|NCT00000792|Hypericin|hypericin|mesh-list
83752520|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
83752521|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83752522|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752523|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
83752524|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752525|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752526|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752527|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83752528|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
83752529|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752530|NCT03937609|Infliximab|infliximab|mesh-list
83752531|NCT03937609|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83752532|NCT03937609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83752533|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
83752534|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83752535|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83752536|NCT00390520|Vildagliptin|vildagliptin|mesh-list
83752537|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83752538|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752539|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83752540|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752541|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752542|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752543|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
83752544|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83752545|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
83752546|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752547|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83752548|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752549|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
83752550|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752551|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
83752552|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83752553|NCT00000813|Protective Agents|protective agents|mesh-ancestor
83752554|NCT03877549|Dexamethasone|dexamethasone|mesh-list
83752555|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83752556|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
83752557|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
83752558|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752559|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752560|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83752561|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
83752562|NCT03877549|Hormones|hormones|mesh-ancestor
83752563|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752564|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83752565|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752566|NCT00390598|Sennosides|sennosides|mesh-list
83752567|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83752568|NCT00390598|Laxatives|laxatives|mesh-ancestor
83752569|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83752570|NCT00000816|Trimethoprim|trimethoprim|mesh-list
83752571|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83752572|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
83752573|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83752574|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752575|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
83752576|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83752577|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83752578|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83752579|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752580|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752581|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83752582|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83752583|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752584|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83752585|NCT03801031|Lidocaine|lidocaine|mesh-list
83752586|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
83752587|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
83752588|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83752589|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752590|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
83752591|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752592|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83752593|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83752594|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83752595|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83752596|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752597|NCT00000822|Ritonavir|ritonavir|mesh-list
83752598|NCT00000822|Stavudine|stavudine|mesh-list
83752599|NCT00000822|Didanosine|didanosine|mesh-list
83752600|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83752601|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83752602|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752603|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752604|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752605|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752606|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752607|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
83752608|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752609|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83752610|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752611|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
83752612|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752613|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752614|NCT03797560|Pregabalin|pregabalin|mesh-list
83752615|NCT03797560|Analgesics|analgesics|mesh-ancestor
83752616|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
83752617|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752618|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752619|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
83752620|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83752621|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83752622|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752623|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83752624|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83752625|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83752626|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83752627|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83752628|NCT03729271|Rifaximin|rifaximin|mesh-list
83752629|NCT03729271|Lactulose|lactulose|mesh-list
83752630|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83752631|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752632|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83752633|NCT03646123|Doxorubicin|doxorubicin|mesh-list
83752634|NCT03646123|Nivolumab|nivolumab|mesh-list
83752635|NCT03646123|Dacarbazine|dacarbazine|mesh-list
83752636|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83752637|NCT03646123|Vinblastine|vinblastine|mesh-list
83752638|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83752639|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752640|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83752641|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83752642|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752643|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752644|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83752645|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83752646|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83752647|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
83752648|NCT03646123|Immunotoxins|immunotoxins|mesh-ancestor
83752649|NCT03646123|Immunoconjugates|immunoconjugates|mesh-ancestor
83752650|NCT03646123|Immunologic Factors|immunologic factors|mesh-ancestor
83752651|NCT03646123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752652|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83752653|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
83752654|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
83752655|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
83752656|NCT03574402|Carboplatin|carboplatin|mesh-list
83752657|NCT03574402|Gemcitabine|gemcitabine|mesh-list
83752658|NCT03574402|Pemetrexed|pemetrexed|mesh-list
83752659|NCT03574402|Afatinib|afatinib|mesh-list
83752660|NCT03574402|Crizotinib|crizotinib|mesh-list
83752661|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
83752662|NCT03574402|Ensartinib|ensartinib|mesh-list
83752663|NCT03574402|Maleic acid|maleic acid|mesh-list
83752664|NCT03574402|Abivertinib|abivertinib|mesh-list
83752665|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752666|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83752667|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
83752668|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752669|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752670|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83752671|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752672|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83752673|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83752674|NCT03539302|Flecainide|flecainide|mesh-list
83752675|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83752676|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83752677|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83752678|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83752679|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752680|NCT00000831|Lamivudine|lamivudine|mesh-list
83752681|NCT00000831|Zidovudine|zidovudine|mesh-list
83752682|NCT00000831|Stavudine|stavudine|mesh-list
83752683|NCT00000831|Didanosine|didanosine|mesh-list
83752684|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752685|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752686|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752687|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752688|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
83752689|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752690|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752691|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752692|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
83752693|NCT00000849|Aldesleukin|aldesleukin|mesh-list
83752694|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752695|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752696|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752697|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
83752698|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752699|NCT03357952|Daratumumab|daratumumab|mesh-list
83752700|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752701|NCT00000855|Zidovudine|zidovudine|mesh-list
83752702|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
83752703|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752704|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752705|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752706|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752707|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
83752708|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752709|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752710|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752711|NCT03317392|Olaparib|olaparib|mesh-list
83752712|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83752713|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83752714|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752715|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752716|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907896|NCT01207947|Urological Agents|urological agents|mesh-ancestor
83752717|NCT00000867|Memantine|memantine|mesh-list
83752718|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83752719|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83752720|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
83752721|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83752722|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752723|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752724|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83752725|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83752726|NCT00390676|Carboplatin|carboplatin|mesh-list
83752727|NCT00390676|Docetaxel|docetaxel|mesh-list
83752728|NCT00390676|Capecitabine|capecitabine|mesh-list
83752729|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752730|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83752731|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83752732|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83752733|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752734|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83752735|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
83752736|NCT00000870|Lamivudine|lamivudine|mesh-list
83752737|NCT00000870|Zidovudine|zidovudine|mesh-list
83752738|NCT00000870|Stavudine|stavudine|mesh-list
83752739|NCT00000870|Didanosine|didanosine|mesh-list
83752740|NCT00000870|Aldesleukin|aldesleukin|mesh-list
83752741|NCT00000870|Indinavir|indinavir|mesh-list
83752742|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752743|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752744|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752745|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752746|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
83752747|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752748|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752749|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752750|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
83752751|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752752|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83752753|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83752754|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752755|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
83752756|NCT00390832|Hematinics|hematinics|mesh-ancestor
83752757|NCT00390871|Fentanyl|fentanyl|mesh-list
83752758|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
83752759|NCT00390871|Propofol|propofol|mesh-list
83752760|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83752761|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83752762|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752763|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83752764|NCT00390871|Analgesics|analgesics|mesh-ancestor
83752765|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
83752766|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752767|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83752768|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83752769|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83752770|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
83752771|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83752772|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752773|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83752774|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
83752775|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
83752776|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83752777|NCT00390871|Narcotics|narcotics|mesh-ancestor
83752778|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83752779|NCT03211741|Bevacizumab|bevacizumab|mesh-list
83752780|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83752781|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752782|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83752783|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83752784|NCT03211741|Growth Substances|growth substances|mesh-ancestor
83752785|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752786|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
83752787|NCT03206203|Carboplatin|carboplatin|mesh-list
83752788|NCT03206203|Atezolizumab|atezolizumab|mesh-list
83752789|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752790|NCT03206203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83752791|NCT03206203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752792|NCT03206203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83752793|NCT00000882|Lamivudine|lamivudine|mesh-list
83752794|NCT00000882|Zidovudine|zidovudine|mesh-list
83752795|NCT00000882|Stavudine|stavudine|mesh-list
83752796|NCT00000882|Delavirdine|delavirdine|mesh-list
83752797|NCT00000882|Indinavir|indinavir|mesh-list
83752798|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752799|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752800|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752801|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752802|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
83752803|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752804|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752805|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752806|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
83752807|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83752808|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83752809|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752810|NCT00000888|Ritonavir|ritonavir|mesh-list
83752811|NCT00000888|Lamivudine|lamivudine|mesh-list
83752812|NCT00000888|Zidovudine|zidovudine|mesh-list
83752813|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83752814|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83752815|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752816|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752817|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752818|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752819|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752820|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
83752821|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752822|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83752823|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752824|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752825|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752826|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
83752827|NCT00000891|Ritonavir|ritonavir|mesh-list
83752828|NCT00000891|Saquinavir|saquinavir|mesh-list
83752829|NCT00000891|Lamivudine|lamivudine|mesh-list
83752830|NCT00000891|Zidovudine|zidovudine|mesh-list
83752831|NCT00000891|Stavudine|stavudine|mesh-list
83752832|NCT00000891|Didanosine|didanosine|mesh-list
83752833|NCT00000891|Delavirdine|delavirdine|mesh-list
83752834|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83752835|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83752836|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752837|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752838|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752839|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752840|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752841|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
83752842|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752843|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83752844|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752845|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752846|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752847|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
83752848|NCT00000903|Lamivudine|lamivudine|mesh-list
83752849|NCT00000903|Zidovudine|zidovudine|mesh-list
83752850|NCT00000903|Efavirenz|efavirenz|mesh-list
83752851|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83752852|NCT00000903|Nelfinavir|nelfinavir|mesh-list
83752853|NCT00000903|Indinavir|indinavir|mesh-list
83752854|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752855|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752856|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752857|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752858|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
83752859|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752860|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752861|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752862|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
83752863|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83752864|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752865|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83752866|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83752867|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83752868|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83752869|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82908047|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752870|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83752871|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752872|NCT02939365|Abatacept|abatacept|mesh-list
83752873|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83752874|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752875|NCT02939365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83752876|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752877|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83752878|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
83752879|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752880|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83752881|NCT00000906|Ritonavir|ritonavir|mesh-list
83752882|NCT00000906|Saquinavir|saquinavir|mesh-list
83752883|NCT00000906|Methadone|methadone|mesh-list
83752884|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83752885|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83752886|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
83752887|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752888|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752889|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752890|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752891|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
83752892|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752893|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83752894|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752895|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83752896|NCT00000906|Narcotics|narcotics|mesh-ancestor
83752897|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83752898|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752899|NCT00000906|Analgesics|analgesics|mesh-ancestor
83752900|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
83752901|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83752902|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
83752903|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
83752904|NCT02681302|Nivolumab|nivolumab|mesh-list
83752905|NCT02681302|Ipilimumab|ipilimumab|mesh-list
83752906|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83752907|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752908|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83752909|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752910|NCT00000951|Fluconazole|fluconazole|mesh-list
83752911|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
83752912|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752913|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83752914|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752915|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752916|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752917|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83752918|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
83752919|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752920|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752921|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83752922|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83752923|NCT02627443|Carboplatin|carboplatin|mesh-list
83752924|NCT02627443|Gemcitabine|gemcitabine|mesh-list
83752925|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752926|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83752927|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
83752928|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752929|NCT02491099|Afatinib|afatinib|mesh-list
83752930|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752931|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83752932|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83752933|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752934|NCT00000966|Leucovorin|leucovorin|mesh-list
83752935|NCT00000966|Azithromycin|azithromycin|mesh-list
83752936|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
83752937|NCT00000966|Calcium|calcium|mesh-list
83752938|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
83752939|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83752940|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752941|NCT00000966|Antidotes|antidotes|mesh-ancestor
83752942|NCT00000966|Protective Agents|protective agents|mesh-ancestor
83752943|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
83752944|NCT00000966|Vitamins|vitamins|mesh-ancestor
83752945|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
83752947|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752948|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
83752949|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83752950|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83752951|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83752952|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752953|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752954|NCT00000969|Didanosine|didanosine|mesh-list
83752955|NCT00000969|Zalcitabine|zalcitabine|mesh-list
83752956|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
83752957|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133106|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
83752958|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752959|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752960|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752961|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
83752962|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752963|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752964|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752965|NCT00000975|Itraconazole|itraconazole|mesh-list
83752966|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
83752967|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752968|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83752969|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83752970|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752971|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752972|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83752973|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
83752974|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83752975|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83752976|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83752977|NCT00000978|Zidovudine|zidovudine|mesh-list
83752978|NCT00000978|Zalcitabine|zalcitabine|mesh-list
83752979|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
83752980|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752981|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752982|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752983|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752984|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
83752985|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752986|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752987|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752988|NCT00000999|Zidovudine|zidovudine|mesh-list
83752989|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
83752990|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83752991|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83752992|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83752993|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83752994|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
83752995|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83752996|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83752997|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83752998|NCT00001002|Zidovudine|zidovudine|mesh-list
83752999|NCT00001002|Foscarnet|foscarnet|mesh-list
83753000|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83753001|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
83753002|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753003|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753004|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753005|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753006|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
83753007|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753008|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753009|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753010|NCT00005819|Paclitaxel|paclitaxel|mesh-list
83753011|NCT00005819|Fenretinide|fenretinide|mesh-list
83753012|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753013|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753014|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753015|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753016|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753017|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753018|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83753019|NCT00005819|Protective Agents|protective agents|mesh-ancestor
83753020|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753021|NCT00001005|Zidovudine|zidovudine|mesh-list
83753022|NCT00001005|Aldesleukin|aldesleukin|mesh-list
83753023|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
83753024|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753025|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753026|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753027|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753028|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
83753029|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753030|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753031|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753032|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753033|NCT00391105|Remifentanil|remifentanil|mesh-list
83753034|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83753035|NCT00391105|Narcotics|narcotics|mesh-ancestor
83753036|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83753037|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753038|NCT00391105|Analgesics|analgesics|mesh-ancestor
83753039|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
83753040|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753041|NCT00391144|Triamcinolone|triamcinolone|mesh-list
83753042|NCT00391144|Bevacizumab|bevacizumab|mesh-list
83753043|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83753044|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753045|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83753046|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83753047|NCT00391144|Growth Substances|growth substances|mesh-ancestor
83753048|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753049|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83753050|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753051|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
83753052|NCT00391144|Hormones|hormones|mesh-ancestor
83753053|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753054|NCT00005822|Tamoxifen|tamoxifen|mesh-list
83753055|NCT00005822|Doxorubicin|doxorubicin|mesh-list
83753056|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83753057|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753058|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753059|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83753060|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753061|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753062|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753063|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83753064|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
83753065|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753066|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753067|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753068|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83753069|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83753070|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83753071|NCT00391261|Metformin|metformin|mesh-list
83753072|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83753073|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753074|NCT00001008|Zidovudine|zidovudine|mesh-list
83753075|NCT00001008|Methadone|methadone|mesh-list
83753076|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
83753077|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753078|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753079|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753080|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753081|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
83753082|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753083|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753084|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753085|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83753086|NCT00001008|Narcotics|narcotics|mesh-ancestor
83753087|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83753088|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753089|NCT00001008|Analgesics|analgesics|mesh-ancestor
83753090|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
83753091|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753092|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
83753093|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
83753094|NCT01889992|Sirolimus|sirolimus|mesh-list
83753095|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753096|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753097|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83133121|NCT03099122|Hormones|hormones|mesh-ancestor
83753098|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753099|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
83753100|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753101|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
83753102|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753103|NCT00005825|Vinorelbine|vinorelbine|mesh-list
83753104|NCT00005825|Mitomycins|mitomycins|mesh-list
83753105|NCT00005825|Mitomycin|mitomycin|mesh-list
83753106|NCT00005825|Tretinoin|tretinoin|mesh-list
83753107|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753108|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753109|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753110|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753111|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753112|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753113|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753114|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
83753115|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753116|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753117|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
83753118|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
83753119|NCT00001011|Zidovudine|zidovudine|mesh-list
83753120|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
83753121|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753122|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753123|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753124|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753125|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
83753126|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753127|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753128|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753129|NCT00001014|Leucovorin|leucovorin|mesh-list
83753130|NCT00001014|Trimethoprim|trimethoprim|mesh-list
83753131|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83753132|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
83753133|NCT00001014|Trimetrexate|trimetrexate|mesh-list
83753134|NCT00001014|Calcium|calcium|mesh-list
83753135|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
83753136|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83753137|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753138|NCT00001014|Antidotes|antidotes|mesh-ancestor
83753139|NCT00001014|Protective Agents|protective agents|mesh-ancestor
83753140|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
83753141|NCT00001014|Vitamins|vitamins|mesh-ancestor
83753142|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
83753143|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83753144|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753145|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
83753146|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83753147|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83753148|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83753149|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753150|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753151|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83753152|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83753153|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753154|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753155|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
83753156|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83753157|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
83133136|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
83753158|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753159|NCT00005831|Paclitaxel|paclitaxel|mesh-list
83753160|NCT00005831|Carboplatin|carboplatin|mesh-list
83753161|NCT00005831|Gemcitabine|gemcitabine|mesh-list
83753162|NCT00005831|Trastuzumab|trastuzumab|mesh-list
83753163|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753164|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908351|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753165|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753166|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753167|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753168|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753169|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83753170|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
83753171|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83753173|NCT00005834|Dexamethasone|dexamethasone|mesh-list
83753174|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
83753175|NCT00005834|Etoposide|etoposide|mesh-list
83753176|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753177|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
83753178|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753179|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753180|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753181|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
83753182|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753183|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753184|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83753185|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753186|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
83753187|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
83753188|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753189|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83753190|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
83753191|NCT00005834|Hormones|hormones|mesh-ancestor
83753192|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753193|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753194|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753195|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83753196|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753197|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753198|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
83753199|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753200|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753201|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83753202|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83753203|NCT00005834|Growth Substances|growth substances|mesh-ancestor
83753204|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
83753205|NCT00001029|Zidovudine|zidovudine|mesh-list
83753206|NCT00001029|Didanosine|didanosine|mesh-list
83753207|NCT00001029|Zalcitabine|zalcitabine|mesh-list
83753208|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
83753209|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753210|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753211|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753212|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753213|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
83753214|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753215|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753216|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753217|NCT00001032|Zidovudine|zidovudine|mesh-list
83753218|NCT00001032|Zalcitabine|zalcitabine|mesh-list
83753219|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
83753220|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753221|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753222|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753223|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753224|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
83753225|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753226|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753227|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753228|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
83753229|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753230|NCT00001038|Valacyclovir|valacyclovir|mesh-list
83753231|NCT00001038|Acyclovir|acyclovir|mesh-list
83753232|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
83753233|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753234|NCT00005840|Paclitaxel|paclitaxel|mesh-list
83753235|NCT00005840|Cisplatin|cisplatin|mesh-list
83753236|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753237|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753238|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753239|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753240|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753241|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753242|NCT00005843|Tipifarnib|tipifarnib|mesh-list
83753243|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753244|NCT00005849|Paclitaxel|paclitaxel|mesh-list
83753245|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
83753246|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753247|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753248|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753249|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753250|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753251|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753252|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83753253|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
83753254|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753255|NCT00001047|Clarithromycin|clarithromycin|mesh-list
83753256|NCT00001047|Ethambutol|ethambutol|mesh-list
83753257|NCT00001047|Rifabutin|rifabutin|mesh-list
83753258|NCT00001047|Clofazimine|clofazimine|mesh-list
83753259|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753260|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753261|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83753262|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753263|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753264|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83753265|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753266|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
83753267|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83753268|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753269|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
83753270|NCT00005852|Cyclosporine|cyclosporine|mesh-list
83753271|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
83753272|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
83753273|NCT00005852|Cyclosporins|cyclosporins|mesh-list
83753274|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83753275|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
83753276|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753277|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
83753278|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753279|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753280|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753281|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
83753282|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753283|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753284|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83753285|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753286|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
83753287|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753288|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83753289|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83753290|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753291|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
83753292|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
83753293|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753294|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83753295|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
83753296|NCT00005852|Hormones|hormones|mesh-ancestor
83753297|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753298|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83753299|NCT00005852|Protective Agents|protective agents|mesh-ancestor
83753300|NCT00001071|Lenograstim|lenograstim|mesh-list
83753301|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83753302|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
83753303|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753304|NCT00005855|Carmustine|carmustine|mesh-list
83753305|NCT00005855|Efaproxiral|efaproxiral|mesh-list
83753306|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753307|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
83753308|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753309|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753310|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
83753311|NCT00001074|Didanosine|didanosine|mesh-list
83753312|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
83753313|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753314|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
83753315|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753316|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753317|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753318|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
83753319|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82908500|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
83753320|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
82908513|NCT01122615|Sirolimus|sirolimus|mesh-list
83753321|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753322|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753323|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753325|NCT00005858|Immunoconjugates|immunoconjugates|mesh-ancestor
83753326|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
83753327|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753328|NCT00005861|Doxorubicin|doxorubicin|mesh-list
83753329|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83753330|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753331|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753332|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83753333|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753334|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753335|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753336|NCT00001083|Ritonavir|ritonavir|mesh-list
83753337|NCT00001083|Indinavir|indinavir|mesh-list
83753338|NCT00001083|Lamivudine|lamivudine|mesh-list
83753339|NCT00001083|Zidovudine|zidovudine|mesh-list
83753340|NCT00001083|Nevirapine|nevirapine|mesh-list
83753341|NCT00001083|Stavudine|stavudine|mesh-list
83753342|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83753343|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83753344|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
83753345|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753346|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753347|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753348|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753349|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
83753350|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753351|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83753352|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753353|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753354|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753355|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
83753356|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83753357|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83753358|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
83753359|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753360|NCT00001086|Efavirenz|efavirenz|mesh-list
83753361|NCT00001086|Abacavir|abacavir|mesh-list
83753362|NCT00001086|Indinavir|indinavir|mesh-list
83753363|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753364|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753365|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753366|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753367|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
83753368|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753369|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83753370|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753371|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83753372|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83753373|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83753374|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83753375|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753376|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753377|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83753378|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83753379|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
83753380|NCT00700258|Sirolimus|sirolimus|mesh-list
83753381|NCT00700258|Sunitinib|sunitinib|mesh-list
83753382|NCT00700258|Temsirolimus|temsirolimus|mesh-list
83753383|NCT00700258|Axitinib|axitinib|mesh-list
83753384|NCT00700258|MTOR Inhibitors|mtor inhibitors|mesh-list
83753385|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753386|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83753387|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83753388|NCT00700258|Growth Substances|growth substances|mesh-ancestor
83753389|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753390|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
83753391|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83753392|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753393|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753394|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753395|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
82908572|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83753396|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753397|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753398|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753399|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
83753400|NCT00001113|Interferons|interferons|mesh-list
83753401|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
83753402|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
83753404|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753405|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
83753406|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753407|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
83753408|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753409|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
83753410|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753411|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753412|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753413|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753414|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753415|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753416|NCT00005867|Prednisolone|prednisolone|mesh-list
83753417|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
83753418|NCT00005867|Doxorubicin|doxorubicin|mesh-list
83753419|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83753420|NCT00005867|Etoposide|etoposide|mesh-list
83753421|NCT00005867|Vincristine|vincristine|mesh-list
83753422|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
83753423|NCT00005867|Bleomycin|bleomycin|mesh-list
83753424|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753425|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
83753426|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753427|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753428|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753429|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
83753430|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753431|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753432|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83753433|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753434|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83753435|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753436|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753437|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753438|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753439|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753440|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753441|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753442|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
83753443|NCT00005867|Hormones|hormones|mesh-ancestor
83753444|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753445|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753446|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753447|NCT00005867|Analgesics|analgesics|mesh-ancestor
83753448|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
83753449|NCT00005870|Gemcitabine|gemcitabine|mesh-list
83753450|NCT00005870|Fluorouracil|fluorouracil|mesh-list
83753451|NCT00005870|Mitomycins|mitomycins|mesh-list
83753452|NCT00005870|Mitomycin|mitomycin|mesh-list
83753453|NCT00005870|Rubitecan|rubitecan|mesh-list
83753454|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83753455|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
83753456|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753457|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753458|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753459|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
83753460|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753461|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753462|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
83753463|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753464|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753465|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83753466|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753467|NCT00017407|Paclitaxel|paclitaxel|mesh-list
83753468|NCT00017407|Carboplatin|carboplatin|mesh-list
83753469|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753470|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753471|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753472|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
82908649|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83753473|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753474|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753475|NCT00008866|Didanosine|didanosine|mesh-list
83753476|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
83753477|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753478|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
83753479|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753480|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753481|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753482|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
83753483|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753484|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
83753485|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753486|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753487|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753488|NCT00001119|Ritonavir|ritonavir|mesh-list
83753489|NCT00001119|Indinavir|indinavir|mesh-list
83753490|NCT00001119|Amprenavir|amprenavir|mesh-list
83753491|NCT00001119|Lamivudine|lamivudine|mesh-list
83753492|NCT00001119|Zidovudine|zidovudine|mesh-list
83753493|NCT00001119|Abacavir|abacavir|mesh-list
83753494|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83753495|NCT00001119|Efavirenz|efavirenz|mesh-list
83753496|NCT00001119|Vaccines|vaccines|mesh-list
83753497|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
83753498|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753499|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83753500|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83753501|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
83753502|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753503|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753504|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753505|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753506|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
83753507|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753508|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83753509|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753510|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753511|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753512|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
83753513|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83753514|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83753515|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83753516|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83753517|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83753518|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83753519|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
83753520|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753521|NCT00009061|Ritonavir|ritonavir|mesh-list
83753522|NCT00009061|Nelfinavir|nelfinavir|mesh-list
83753523|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
83753524|NCT00009061|Lamivudine|lamivudine|mesh-list
83753525|NCT00009061|Abacavir|abacavir|mesh-list
83753526|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83753527|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83753528|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
83753529|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753530|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753531|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753532|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753533|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
83753534|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753535|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83753536|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753537|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753538|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753539|NCT00005873|Rubitecan|rubitecan|mesh-list
83753540|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753541|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83753542|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753543|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753544|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753545|NCT00009178|Fluoxetine|fluoxetine|mesh-list
83753546|NCT00009178|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82908724|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83753547|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83753548|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83753549|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753550|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83753551|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
83753552|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753553|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83753554|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
83753555|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83753556|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83753557|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753558|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753559|NCT00009217|Haloperidol|haloperidol|mesh-list
83753560|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
83753561|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
83753562|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
83753563|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753564|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753565|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83753566|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83753567|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83753568|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83753569|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83753570|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83753571|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
83753572|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83753573|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753574|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83753575|NCT00005876|Rubitecan|rubitecan|mesh-list
83753576|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753577|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83753578|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753579|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753580|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753581|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83753582|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83753583|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83753584|NCT00009646|Indomethacin|indomethacin|mesh-list
83753585|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83753586|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83753587|NCT00009646|Analgesics|analgesics|mesh-ancestor
83753588|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
83753589|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753590|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753591|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753592|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753593|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
83753594|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
83753595|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83753596|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83753597|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753598|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753599|NCT00009763|Cyclosporine|cyclosporine|mesh-list
83753600|NCT00009763|Paclitaxel|paclitaxel|mesh-list
83753601|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83753602|NCT00009763|Antibodies|antibodies|mesh-list
83753603|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
83753604|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83753605|NCT00009763|Cyclosporins|cyclosporins|mesh-list
83753606|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753607|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753608|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753609|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753610|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753611|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753612|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
83753613|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753614|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753615|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753616|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
83753617|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753618|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
83753619|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753620|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83753621|NCT00009802|Calcitriol|calcitriol|mesh-list
82908857|NCT01221129|Zinc|zinc|mesh-list
83753623|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753624|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753625|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753626|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753627|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753628|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753629|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83753630|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753631|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83753632|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83753633|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83753634|NCT00009802|Vitamins|vitamins|mesh-ancestor
83753635|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
83753636|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83753637|NCT00009841|Mitogens|mitogens|mesh-list
83753638|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753639|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753640|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
83753641|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753642|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
83753643|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753644|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753645|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753646|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
83753647|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753648|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753649|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83753650|NCT00009880|Paclitaxel|paclitaxel|mesh-list
83753651|NCT00009880|Fluorouracil|fluorouracil|mesh-list
83753652|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753653|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753654|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753655|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753656|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753657|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753658|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
83753659|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83753660|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753661|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
83753662|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753663|NCT00009919|Semaxinib|semaxinib|mesh-list
83753664|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83753665|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83753666|NCT00009919|Growth Substances|growth substances|mesh-ancestor
83753667|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753668|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
83753669|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753670|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83753671|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753672|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753673|NCT00009958|Metronidazole|metronidazole|mesh-list
83753674|NCT00009958|Vaccines|vaccines|mesh-list
83753675|NCT00009958|Sargramostim|sargramostim|mesh-list
83753676|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
83753677|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753678|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753679|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753680|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83753681|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83753682|NCT00009997|Tamoxifen|tamoxifen|mesh-list
83753683|NCT00009997|Paclitaxel|paclitaxel|mesh-list
83753684|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
83753685|NCT00009997|Doxorubicin|doxorubicin|mesh-list
83753686|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83753687|NCT00009997|Trastuzumab|trastuzumab|mesh-list
83753688|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83753689|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753690|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753691|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753692|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753693|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908873|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83753694|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753695|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
83753696|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753697|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753698|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753699|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
83753700|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83753701|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753702|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83753703|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753704|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753705|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83753706|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83753707|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
83133179|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83753708|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753709|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753710|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83753711|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83753712|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83753713|NCT00010036|Carboplatin|carboplatin|mesh-list
83753714|NCT00010036|Irinotecan|irinotecan|mesh-list
83753715|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753716|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83753717|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753718|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753719|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753720|NCT00010075|Leucovorin|leucovorin|mesh-list
83753721|NCT00010075|Fluorouracil|fluorouracil|mesh-list
83753722|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
83753723|NCT00010075|Calcium|calcium|mesh-list
83753724|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
83753725|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83753726|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753727|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
83753728|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753729|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83753730|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753731|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753732|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
83753733|NCT00010075|Antidotes|antidotes|mesh-ancestor
83753734|NCT00010075|Protective Agents|protective agents|mesh-ancestor
83753735|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
83753736|NCT00010075|Vitamins|vitamins|mesh-ancestor
83753737|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
83753738|NCT00010075|Analgesics|analgesics|mesh-ancestor
83753739|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
83753740|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753741|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83753742|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753743|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753744|NCT00010153|Fulvestrant|fulvestrant|mesh-list
83753745|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753746|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753747|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83753748|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83753749|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
83753750|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753751|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753752|NCT00010192|Aldesleukin|aldesleukin|mesh-list
83753753|NCT00010192|Rituximab|rituximab|mesh-list
83753754|NCT00010192|Interleukin-2|interleukin-2|mesh-list
83753755|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83753756|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753757|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
83753758|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753759|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753760|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83753761|NCT00010192|Analgesics|analgesics|mesh-ancestor
83753762|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
83753763|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753764|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753765|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753766|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
83753767|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753768|NCT00005912|Voriconazole|voriconazole|mesh-list
82908947|NCT03648034|Ropivacaine|ropivacaine|mesh-list
83753769|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
83753770|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753771|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83753772|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83753773|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753774|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753775|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83753776|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
83753777|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753778|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753779|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83753780|NCT00010231|Calcitriol|calcitriol|mesh-list
83753781|NCT00010231|Dexamethasone|dexamethasone|mesh-list
83753782|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753783|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
83753784|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
83753785|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753786|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753787|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83753788|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
83753789|NCT00010231|Hormones|hormones|mesh-ancestor
83753790|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753791|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753792|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753793|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83753794|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83753795|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83753796|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753797|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83753798|NCT00010231|Vitamins|vitamins|mesh-ancestor
83753799|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
83753800|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83753801|NCT00010270|Immunotoxins|immunotoxins|mesh-list
83753802|NCT00010270|Immunoconjugates|immunoconjugates|mesh-ancestor
83753803|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
83753804|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753805|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
83753806|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753807|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
83753808|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753809|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753810|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753811|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
83753812|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753813|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753814|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83753815|NCT00010426|Cysteamine|cysteamine|mesh-list
83753816|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83753817|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753818|NCT00386516|Fluorouracil|fluorouracil|mesh-list
83753819|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
83753820|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753821|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83753822|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753823|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753824|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
83753825|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753826|NCT00010699|Vitamin E|vitamin e|mesh-list
83753827|NCT00010699|Vitamins|vitamins|mesh-ancestor
83753828|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
83753829|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753830|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
83753831|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753832|NCT00010699|Protective Agents|protective agents|mesh-ancestor
83753833|NCT00386555|Docetaxel|docetaxel|mesh-list
83753834|NCT00386555|Axitinib|axitinib|mesh-list
83753835|NCT00386555|Crenolanib|crenolanib|mesh-list
83753836|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753837|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83753838|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83753839|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83753840|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753841|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83753842|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909019|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753843|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83753844|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83753845|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753846|NCT00001191|Omeprazole|omeprazole|mesh-list
83753847|NCT00001191|Pantoprazole|pantoprazole|mesh-list
83753848|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83753849|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83753850|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83753851|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753852|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753853|NCT00011089|Tenofovir|tenofovir|mesh-list
83753854|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
83753855|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753856|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753857|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753858|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753859|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753860|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753861|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753862|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83753863|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
83753864|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753865|NCT00005921|Caspofungin|caspofungin|mesh-list
83753866|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
83753867|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753868|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753869|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753870|NCT00011362|Dexamethasone|dexamethasone|mesh-list
83753871|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
83753872|NCT00011362|BB 1101|bb 1101|mesh-list
83753873|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753874|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
83753875|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
83753876|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83753877|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753878|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83753879|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
83753880|NCT00011362|Hormones|hormones|mesh-ancestor
83753881|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753882|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753883|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753884|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
83753885|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753886|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753887|NCT00001212|Cyclosporine|cyclosporine|mesh-list
83753888|NCT00001212|Prednisone|prednisone|mesh-list
83753889|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
83753890|NCT00001212|Cyclosporins|cyclosporins|mesh-list
83753891|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753892|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
83753893|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753894|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753895|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753896|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
83753897|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753898|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753899|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83753900|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83753901|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
83753902|NCT00001212|Hormones|hormones|mesh-ancestor
83753903|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753904|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753905|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753906|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
83753907|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753908|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
83753909|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83753910|NCT00011479|Abacavir|abacavir|mesh-list
83753911|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83753912|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83753913|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753914|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753915|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
82909093|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83753916|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753917|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83753918|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83753920|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
83753921|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753922|NCT00011635|Protective Agents|protective agents|mesh-ancestor
83753923|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753924|NCT00001221|Hormones|hormones|mesh-list
83753925|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753926|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753927|NCT00391417|Estradiol|estradiol|mesh-list
83753928|NCT00391417|Estrogens|estrogens|mesh-ancestor
83753929|NCT00391417|Hormones|hormones|mesh-ancestor
83753930|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753931|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753932|NCT00011908|Epratuzumab|epratuzumab|mesh-list
83753933|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83753934|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753935|NCT00012025|Fulvestrant|fulvestrant|mesh-list
83753936|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83753937|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753938|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83753939|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83753940|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
83753941|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83753942|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753943|NCT00005942|Daunorubicin|daunorubicin|mesh-list
83753944|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753945|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753946|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753947|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83753948|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83753949|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753950|NCT00012103|Dimercaprol|dimercaprol|mesh-list
83753951|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
83753952|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
83753953|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753954|NCT00001251|Mafosfamide|mafosfamide|mesh-list
83753955|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83753956|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
83753957|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753958|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753959|NCT00012142|Sirolimus|sirolimus|mesh-list
83753960|NCT00012142|Temsirolimus|temsirolimus|mesh-list
83753961|NCT00012142|MTOR Inhibitors|mtor inhibitors|mesh-list
83753962|NCT00012142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83753963|NCT00012142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753964|NCT00012142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753965|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753966|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
83753967|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753968|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753969|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83753970|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83753971|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83753972|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
83753973|NCT00012181|Alvocidib|alvocidib|mesh-list
83753974|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83753975|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
83753976|NCT00012181|Growth Substances|growth substances|mesh-ancestor
83753977|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753978|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83753979|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83753980|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83753981|NCT00005945|Cytarabine|cytarabine|mesh-list
83753982|NCT00005945|Dexamethasone|dexamethasone|mesh-list
83753983|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
83753984|NCT00005945|Doxorubicin|doxorubicin|mesh-list
83753985|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83753986|NCT00005945|Methotrexate|methotrexate|mesh-list
83753987|NCT00005945|Vincristine|vincristine|mesh-list
82909168|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83753988|NCT00005945|Daunorubicin|daunorubicin|mesh-list
83753989|NCT00005945|Asparaginase|asparaginase|mesh-list
83753990|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
83753991|NCT00005945|Pegaspargase|pegaspargase|mesh-list
83753992|NCT00005945|Thioguanine|thioguanine|mesh-list
83753993|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83753994|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
83753995|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83753996|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83753997|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83753998|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
83753999|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754000|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754001|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754002|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83754003|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
83754004|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
83754005|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754006|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83754007|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
83754008|NCT00005945|Hormones|hormones|mesh-ancestor
83754009|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754010|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83754011|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754012|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754013|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754014|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754015|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83754016|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
83754017|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83754018|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754019|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
83754020|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
83754021|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83754022|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83754023|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
83754024|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754025|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754026|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754027|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754028|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754029|NCT01929811|Metformin|metformin|mesh-list
83754030|NCT01929811|Docetaxel|docetaxel|mesh-list
83754031|NCT01929811|Epirubicin|epirubicin|mesh-list
83754032|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83754033|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754034|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754035|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754036|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754037|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754038|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754039|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754040|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754041|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754042|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754043|NCT00012220|Gemcitabine|gemcitabine|mesh-list
83754044|NCT00012220|Docetaxel|docetaxel|mesh-list
83754045|NCT00012220|Irinotecan|irinotecan|mesh-list
83754046|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754047|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754048|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
83754049|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754050|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754051|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754052|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754053|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754054|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754055|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754056|NCT00012259|Troxacitabine|troxacitabine|mesh-list
83754057|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754058|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754059|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754060|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
83754061|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909243|NCT03646318|Ketanserin|ketanserin|mesh-list
82909244|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83754062|NCT00012337|Gefitinib|gefitinib|mesh-list
83754063|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754064|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83754065|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754066|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754067|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
83754068|NCT00012376|Sargramostim|sargramostim|mesh-list
83754069|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
83754070|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754071|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754072|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83754073|NCT00001266|Suramin|suramin|mesh-list
83754074|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
83754075|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
83754076|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83754077|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754078|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754079|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83754080|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83754081|NCT00005948|Interferons|interferons|mesh-list
83754082|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
83754083|NCT00005948|Aldesleukin|aldesleukin|mesh-list
83754084|NCT00005948|Busulfan|busulfan|mesh-list
83754085|NCT00005948|Sargramostim|sargramostim|mesh-list
83754086|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754087|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
83754088|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754089|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
83754090|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754091|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
83754092|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754093|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754094|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754095|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754096|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754097|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754098|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
83754099|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83754100|NCT00012688|Doxycycline|doxycycline|mesh-list
83754101|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83754102|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754103|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
83754104|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
83754105|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83754106|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
83754107|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83754108|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83754109|NCT00005951|Irinotecan|irinotecan|mesh-list
83754110|NCT00005951|Temozolomide|temozolomide|mesh-list
83754111|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754112|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754113|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754114|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754115|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754116|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754117|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
83754118|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
83754119|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83754120|NCT00001287|Antibodies|antibodies|mesh-list
83754121|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
83754122|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83754123|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
83754124|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754125|NCT00005954|Temozolomide|temozolomide|mesh-list
83754126|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754127|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
83754128|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754129|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754130|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
83754131|NCT00005960|Docetaxel|docetaxel|mesh-list
83754132|NCT00005960|Doxorubicin|doxorubicin|mesh-list
83754133|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83754134|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754135|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
83754136|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754137|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83754138|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754139|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
83754140|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909315|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83754141|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754142|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754143|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754144|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754145|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754146|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754147|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754148|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754149|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754150|NCT00005963|Carboplatin|carboplatin|mesh-list
83754151|NCT00005963|Docetaxel|docetaxel|mesh-list
83754152|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754153|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754154|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754155|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754156|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754157|NCT00013585|Selegiline|selegiline|mesh-list
83754158|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
83754159|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83754160|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83754161|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83754162|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83754163|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754164|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754165|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83754166|NCT00013585|Protective Agents|protective agents|mesh-ancestor
83754167|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754168|NCT00013624|Levodopa|levodopa|mesh-list
83754169|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83754170|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83754171|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
83754172|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754173|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754174|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754175|NCT00013663|Aldesleukin|aldesleukin|mesh-list
83754176|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754177|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754178|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754179|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
83754180|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754181|NCT00013702|Adefovir|adefovir|mesh-list
83754182|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
83754183|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754184|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83754185|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83754186|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754187|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754188|NCT00005966|Interferons|interferons|mesh-list
83754189|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
83754190|NCT00005966|Thalidomide|thalidomide|mesh-list
83754191|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754192|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
83754193|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754194|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
83754195|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754196|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754197|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
83754198|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83754199|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83754200|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83754201|NCT00005966|Growth Substances|growth substances|mesh-ancestor
83754202|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
83754203|NCT00005969|Tretinoin|tretinoin|mesh-list
83754204|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754205|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
83754206|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
83754207|NCT00014014|Lamivudine|lamivudine|mesh-list
83754208|NCT00014014|Zidovudine|zidovudine|mesh-list
83754209|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83754210|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83754211|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83754212|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754213|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754214|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
83754215|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909391|NCT03772041|Tolvaptan|tolvaptan|mesh-list
83754216|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754217|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754218|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
83754219|NCT00014092|Interferons|interferons|mesh-list
83754220|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
83754221|NCT00014092|Aldesleukin|aldesleukin|mesh-list
83754222|NCT00014092|Temozolomide|temozolomide|mesh-list
83754223|NCT00014092|Sargramostim|sargramostim|mesh-list
83754224|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754225|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
83754226|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754227|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754228|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
83754229|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754230|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
83754231|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754232|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754233|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754234|NCT00005972|Gemcitabine|gemcitabine|mesh-list
83754235|NCT00005972|Irinotecan|irinotecan|mesh-list
83754236|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754237|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
83754238|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754239|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754240|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754241|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754242|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754243|NCT00014170|Gefitinib|gefitinib|mesh-list
83754244|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754245|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83754246|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754247|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754248|NCT00014209|Dexamethasone|dexamethasone|mesh-list
83754249|NCT00014209|Gemcitabine|gemcitabine|mesh-list
83754250|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83754251|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
83754252|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
83754253|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754254|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754255|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83754256|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
83754257|NCT00014209|Hormones|hormones|mesh-ancestor
83754258|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754259|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83754260|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754261|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754262|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
83754263|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754264|NCT00014248|Adenosine|adenosine|mesh-list
83754265|NCT00014248|Analgesics|analgesics|mesh-ancestor
83754266|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
83754267|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754268|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754269|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83754270|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
83754271|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83754272|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
83754273|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
83754274|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754275|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754276|NCT00005975|Megestrol|megestrol|mesh-list
83754277|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
83754278|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83754279|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83754280|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83754281|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
83754282|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83754283|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754284|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83754285|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83754286|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83754287|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754288|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
83754289|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82909465|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754290|NCT00014287|Gemcitabine|gemcitabine|mesh-list
83754291|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754292|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
83754293|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754294|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754295|NCT02971930|Factor VIII|factor viii|mesh-list
83754296|NCT02971930|Coagulants|coagulants|mesh-ancestor
83754297|NCT00005978|Carboplatin|carboplatin|mesh-list
83754298|NCT00005978|Etoposide|etoposide|mesh-list
83754299|NCT00005978|Melphalan|melphalan|mesh-list
83754300|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83754301|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754302|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754303|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754304|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754305|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754306|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754307|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
83754308|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754309|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754310|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
83754311|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754312|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754313|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83754314|NCT00014404|Celecoxib|celecoxib|mesh-list
83754315|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83754316|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83754317|NCT00014404|Analgesics|analgesics|mesh-ancestor
83754318|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
83754319|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754320|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754321|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83754322|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83754323|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83754324|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83754325|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754326|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754327|NCT00001332|Cisplatin|cisplatin|mesh-list
83754328|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754329|NCT00014599|Paclitaxel|paclitaxel|mesh-list
83754330|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754331|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754332|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754333|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754334|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754335|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754336|NCT00005981|Carmustine|carmustine|mesh-list
83754337|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83754338|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754339|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
83754340|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754341|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754342|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754343|NCT00014638|Letrozole|letrozole|mesh-list
83754344|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754345|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83754346|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83754347|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754348|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754349|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83754350|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
83754351|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754352|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754353|NCT00001341|Raltitrexed|raltitrexed|mesh-list
83754354|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754355|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
83754356|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754357|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754358|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83754359|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754360|NCT00014677|Interleukin-4|interleukin-4|mesh-list
83754361|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83754362|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
83754363|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754364|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754365|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909538|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83754366|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
83754367|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
83754368|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83754369|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83754370|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83754371|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754372|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83754373|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83754374|NCT00005984|Interferons|interferons|mesh-list
83754375|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
83754376|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
83754377|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754378|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
83754379|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754380|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83754381|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754382|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
83754383|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754384|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754385|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754386|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
83754387|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754388|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
83754389|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83754390|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754391|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83754392|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
83754393|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83754394|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754395|NCT00005987|Interferons|interferons|mesh-list
83754396|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
83754397|NCT00005987|Dexamethasone|dexamethasone|mesh-list
83754398|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
83754399|NCT00005987|Carmustine|carmustine|mesh-list
83754400|NCT00005987|Etoposide|etoposide|mesh-list
83754401|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
83754402|NCT00005987|Sargramostim|sargramostim|mesh-list
83754403|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754404|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
83754405|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754406|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83754407|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754408|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
83754409|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754410|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754411|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754412|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83754413|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
83754414|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
83754415|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754416|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83754417|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
83754418|NCT00005987|Hormones|hormones|mesh-ancestor
83754419|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754420|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83754421|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754422|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754423|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754424|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754425|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
83754426|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754427|NCT00005987|Analgesics|analgesics|mesh-ancestor
83754428|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
83754429|NCT00014755|Prednisone|prednisone|mesh-list
83754430|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
83754431|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83754432|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754433|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
83754434|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754435|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83754436|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754437|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
83754438|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909625|NCT01130805|Capecitabine|capecitabine|mesh-list
83754439|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754440|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754441|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83754442|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
83754443|NCT00014755|Hormones|hormones|mesh-ancestor
83754444|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754445|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83754446|NCT00005990|Topotecan|topotecan|mesh-list
83754447|NCT00005990|Tipifarnib|tipifarnib|mesh-list
83754448|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754449|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754450|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754451|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754452|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754453|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
83754454|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
83754455|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
83754456|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83754457|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83754458|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754459|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754460|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754461|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
83754462|NCT00014989|Analgesics|analgesics|mesh-ancestor
83754463|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
83754464|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754465|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754466|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
83754467|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83754468|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83754469|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
83754470|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83754471|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83754472|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754473|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83754474|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
83754475|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83754476|NCT00005993|Aldesleukin|aldesleukin|mesh-list
83754477|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754478|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754479|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754480|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
83754481|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754482|NCT00015028|Buprenorphine|buprenorphine|mesh-list
83754483|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83754484|NCT00015028|Naloxone|naloxone|mesh-list
83754485|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83754486|NCT00015028|Narcotics|narcotics|mesh-ancestor
83754487|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83754488|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754489|NCT00015028|Analgesics|analgesics|mesh-ancestor
83754490|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
83754491|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754492|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83754493|NCT00015067|Methylphenidate|methylphenidate|mesh-list
83754494|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83754495|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754496|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83754497|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83754498|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83754499|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754500|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
83754501|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754502|NCT00015106|Lamotrigine|lamotrigine|mesh-list
83754503|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
83754504|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83754505|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83754506|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754507|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83754508|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754509|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83754510|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83754511|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83754512|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83754513|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83754514|NCT00005996|Gemcitabine|gemcitabine|mesh-list
83754515|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754516|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754517|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
83754518|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754519|NCT00001359|Penicillins|penicillins|mesh-list
83754520|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83754521|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754522|NCT00015223|Methylphenidate|methylphenidate|mesh-list
83754523|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83754524|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754525|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83754526|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83754527|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83754528|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754529|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
83754530|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754531|NCT00015301|Methylphenidate|methylphenidate|mesh-list
83754532|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83754533|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754534|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83754535|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83754536|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83754537|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754538|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
83754539|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754540|NCT00015340|Buprenorphine|buprenorphine|mesh-list
83754541|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83754542|NCT00015340|Naloxone|naloxone|mesh-list
83754543|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83754544|NCT00015340|Narcotics|narcotics|mesh-ancestor
83754545|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83754546|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754547|NCT00015340|Analgesics|analgesics|mesh-ancestor
83754548|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
83754549|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754550|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83754551|NCT00015652|Ribavirin|ribavirin|mesh-list
83754552|NCT00015652|Aldesleukin|aldesleukin|mesh-list
83754553|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83754554|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
83754555|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754556|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
83754557|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754558|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754559|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754560|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754561|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
83754562|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754563|NCT00015691|Metformin|metformin|mesh-list
83754564|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
83754565|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83754566|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754567|NCT00015769|Levetiracetam|levetiracetam|mesh-list
83754568|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
83754569|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
83754570|NCT00015808|Idebenone|idebenone|mesh-list
83754571|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
83754572|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754573|NCT00015808|Protective Agents|protective agents|mesh-ancestor
83754574|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754575|NCT00015886|Docetaxel|docetaxel|mesh-list
83754576|NCT00015886|Fluorouracil|fluorouracil|mesh-list
83754577|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754578|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754579|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754580|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754581|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754582|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
83754583|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754584|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754585|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
83754586|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754587|NCT00006002|Dexamethasone|dexamethasone|mesh-list
83754588|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909765|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
83754589|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
83754590|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
83754591|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754592|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754593|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83754594|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
83754595|NCT00006002|Hormones|hormones|mesh-ancestor
83754596|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754597|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83754598|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754599|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
83754600|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
83754601|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
83754602|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83754603|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83754604|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754605|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754606|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754607|NCT00015925|Entinostat|entinostat|mesh-list
83754608|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754609|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83754610|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754611|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754612|NCT00006005|Thalidomide|thalidomide|mesh-list
83754613|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754614|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
83754615|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754616|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
83754617|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83754618|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754619|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83754620|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83754621|NCT00006005|Growth Substances|growth substances|mesh-ancestor
83754622|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
83754623|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754624|NCT00015964|Gefitinib|gefitinib|mesh-list
83754625|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754626|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83754627|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754628|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754629|NCT01630213|Vitamin D|vitamin d|mesh-list
83754630|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
83754631|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
83754632|NCT01630213|Vitamins|vitamins|mesh-list
83754633|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
83754634|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754635|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83754636|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83754637|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
83754638|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754639|NCT00016042|Interferons|interferons|mesh-list
83754640|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
83754641|NCT00016042|Fluorouracil|fluorouracil|mesh-list
83754642|NCT00016042|Sargramostim|sargramostim|mesh-list
83754643|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
83754644|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754645|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754646|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754647|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754648|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
83754649|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754650|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
83754651|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754652|NCT00016081|Ribavirin|ribavirin|mesh-list
83754653|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
83754654|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754655|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
83754656|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754657|NCT00016159|Idarubicin|idarubicin|mesh-list
83754658|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
83754659|NCT00016159|Tretinoin|tretinoin|mesh-list
83754660|NCT00016159|Lintuzumab|lintuzumab|mesh-list
83754661|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754662|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754663|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754664|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754665|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754666|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754667|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
83754668|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83754669|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83754671|NCT00016198|Fluorouracil|fluorouracil|mesh-list
83754672|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
83754673|NCT00016198|Calcium|calcium|mesh-list
83754674|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
83754675|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83754676|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754677|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
83754678|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754679|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754680|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754681|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754682|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
83754683|NCT00016198|Antidotes|antidotes|mesh-ancestor
83754684|NCT00016198|Protective Agents|protective agents|mesh-ancestor
83754685|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
83754686|NCT00016198|Vitamins|vitamins|mesh-ancestor
83754687|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
83754688|NCT00016276|Tamoxifen|tamoxifen|mesh-list
83754689|NCT00016276|Paclitaxel|paclitaxel|mesh-list
83754690|NCT00016276|Razoxane|razoxane|mesh-list
83754691|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
83754692|NCT00016276|Doxorubicin|doxorubicin|mesh-list
83754693|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83754694|NCT00016276|Trastuzumab|trastuzumab|mesh-list
83754695|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
83754696|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754697|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754698|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754699|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754700|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754701|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754702|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754703|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
83754704|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754705|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83754706|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754707|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
83754708|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754709|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754710|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754711|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754712|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754713|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83754714|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83754715|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
83754716|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754717|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83754718|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83754719|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83754720|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83754721|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83754722|NCT00016276|Protective Agents|protective agents|mesh-ancestor
83754723|NCT00016315|Paclitaxel|paclitaxel|mesh-list
83754724|NCT00016315|Carboplatin|carboplatin|mesh-list
83754725|NCT00016315|Gemcitabine|gemcitabine|mesh-list
83754726|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754727|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754728|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754729|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754730|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754731|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754732|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754733|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
83754734|NCT00006014|Semaxinib|semaxinib|mesh-list
83754735|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83754736|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83754737|NCT00006014|Growth Substances|growth substances|mesh-ancestor
83754738|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754739|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
83754740|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754741|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83754742|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754743|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754744|NCT00016432|Exemestane|exemestane|mesh-list
83754745|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754746|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83754747|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83754748|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754749|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754750|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83754751|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
83754752|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754753|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754754|NCT00389376|Silymarin|silymarin|mesh-list
83754755|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
83754756|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754757|NCT00389376|Protective Agents|protective agents|mesh-ancestor
83754758|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754759|NCT00016549|Bevacizumab|bevacizumab|mesh-list
83754760|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83754761|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754762|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83754763|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83754764|NCT00016549|Growth Substances|growth substances|mesh-ancestor
83754765|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754766|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
83754767|NCT00006023|Capecitabine|capecitabine|mesh-list
83754768|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754769|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
83754770|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754771|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754772|NCT00016588|Tenofovir|tenofovir|mesh-list
83754773|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
83754774|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83754775|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83754776|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83754777|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754778|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754779|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83754780|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83754781|NCT00006026|Rubitecan|rubitecan|mesh-list
83754782|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754783|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754784|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754785|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754786|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754787|NCT00016666|Propranolol|propranolol|mesh-list
83754788|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83754789|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83754790|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
83754791|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754792|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754793|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754794|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83754795|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83754796|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
83754797|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83754798|NCT00016744|Genistein|genistein|mesh-list
83754799|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754800|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83754801|NCT00016744|Protective Agents|protective agents|mesh-ancestor
83754802|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754803|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83754804|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754805|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754806|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
83754807|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83754808|NCT00016744|Estrogens|estrogens|mesh-ancestor
83754809|NCT00016744|Hormones|hormones|mesh-ancestor
83754810|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83754811|NCT00016861|Irinotecan|irinotecan|mesh-list
82909990|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83754812|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754813|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754814|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754815|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754816|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754818|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754819|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754820|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754821|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754822|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754823|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754824|NCT00016939|Alvocidib|alvocidib|mesh-list
83754825|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754826|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
83754827|NCT00016939|Growth Substances|growth substances|mesh-ancestor
83754828|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754829|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83754830|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754831|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754832|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
83754833|NCT00386672|Vitamin D|vitamin d|mesh-list
83754834|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
83754835|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
83754836|NCT00386672|Vitamins|vitamins|mesh-list
83754837|NCT00386672|Calcium|calcium|mesh-list
83754838|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
83754839|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754840|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83754841|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83754842|NCT00016978|Leucovorin|leucovorin|mesh-list
83754843|NCT00016978|Fluorouracil|fluorouracil|mesh-list
83754844|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
83754845|NCT00016978|Calcium|calcium|mesh-list
83754846|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
83754847|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83754848|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754849|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
83754850|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754851|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754852|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754853|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754854|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
83754855|NCT00016978|Antidotes|antidotes|mesh-ancestor
83754856|NCT00016978|Protective Agents|protective agents|mesh-ancestor
83754857|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
83754858|NCT00016978|Vitamins|vitamins|mesh-ancestor
83754859|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
83754860|NCT00017017|Paclitaxel|paclitaxel|mesh-list
83754861|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83754862|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754863|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754864|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754865|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754866|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754867|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754868|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
83754869|NCT00017095|Docetaxel|docetaxel|mesh-list
83754870|NCT00017095|Fluorouracil|fluorouracil|mesh-list
83754871|NCT00017095|Epirubicin|epirubicin|mesh-list
83754872|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83754873|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
83754874|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754875|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83754876|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754877|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
83754878|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754879|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754880|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83754881|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754882|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754883|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754884|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
83754885|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82910061|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754886|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754887|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82910071|NCT01132911|Bortezomib|bortezomib|mesh-list
83754888|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754889|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754891|NCT00006029|Doxorubicin|doxorubicin|mesh-list
83754892|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83754893|NCT00006029|Vinorelbine|vinorelbine|mesh-list
83754894|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83754895|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
83754896|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754897|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754898|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754899|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754900|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754901|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754902|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754903|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
83754904|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
83754905|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
83754906|NCT00371059|Memantine|memantine|mesh-list
83754907|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83754908|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83754909|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
83754910|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754911|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754912|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754913|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83754914|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83754915|NCT00001482|Lamotrigine|lamotrigine|mesh-list
83754916|NCT00001482|Gabapentin|gabapentin|mesh-list
83754917|NCT00001482|Analgesics|analgesics|mesh-ancestor
83754918|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
83754919|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754920|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754921|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
83754922|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83754923|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83754924|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83754925|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83754926|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83754927|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83754928|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754929|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754930|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
83754931|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83754932|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83754933|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83754934|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83754935|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83754936|NCT00017134|Fenretinide|fenretinide|mesh-list
83754937|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754938|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83754939|NCT00017134|Protective Agents|protective agents|mesh-ancestor
83754940|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754941|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
83754942|NCT04734418|Remifentanil|remifentanil|mesh-list
83754943|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83754944|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83754945|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83754946|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83754947|NCT04734418|Analgesics|analgesics|mesh-ancestor
83754948|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
83754949|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83754950|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83754951|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83754952|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83754953|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
83754954|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83754955|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754956|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83754957|NCT04734418|Narcotics|narcotics|mesh-ancestor
83754958|NCT00006032|Etoposide|etoposide|mesh-list
83754959|NCT00006032|Topotecan|topotecan|mesh-list
83754960|NCT00006032|Ifosfamide|ifosfamide|mesh-list
83754961|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754962|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754963|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754964|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754965|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754966|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754967|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754968|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83754969|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
83754970|NCT00017173|Cisplatin|cisplatin|mesh-list
83754971|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754972|NCT00001509|Tretinoin|tretinoin|mesh-list
83754973|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754974|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
83754975|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
83754976|NCT00006035|Bleomycin|bleomycin|mesh-list
83754977|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83754978|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754979|NCT00017212|Exatecan|exatecan|mesh-list
83754980|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83754981|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754982|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754983|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754984|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754985|NCT00017251|Carboplatin|carboplatin|mesh-list
83754986|NCT00017251|Etoposide|etoposide|mesh-list
83754987|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
83754988|NCT00017251|Oblimersen|oblimersen|mesh-list
83754989|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83754990|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83754991|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83754992|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83754993|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83754994|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83754995|NCT00006038|Leucovorin|leucovorin|mesh-list
83754996|NCT00006038|Docetaxel|docetaxel|mesh-list
83754997|NCT00006038|Fluorouracil|fluorouracil|mesh-list
83754998|NCT00006038|Floxuridine|floxuridine|mesh-list
83754999|NCT00006038|Calcium|calcium|mesh-list
83755000|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
83755001|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755002|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83755003|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83755004|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83755005|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755006|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83755007|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755008|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
83755009|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83755010|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755011|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
83755012|NCT00006038|Antidotes|antidotes|mesh-ancestor
83755013|NCT00006038|Protective Agents|protective agents|mesh-ancestor
83755014|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
83755015|NCT00006038|Vitamins|vitamins|mesh-ancestor
83755016|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
83755017|NCT00017290|Prednisone|prednisone|mesh-list
83755018|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
83755019|NCT00017290|Vincristine|vincristine|mesh-list
83755020|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
83755021|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83755022|NCT00017290|Antibodies|antibodies|mesh-list
83755023|NCT00017290|Sargramostim|sargramostim|mesh-list
83755024|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83755025|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83755026|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755027|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
83755028|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755029|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755030|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83755031|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
83755032|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755033|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755034|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83755035|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83755036|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
82910212|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83755037|NCT00017290|Hormones|hormones|mesh-ancestor
83755038|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755039|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83755040|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83755041|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
83755042|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
83755043|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
83755044|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83755045|NCT00017329|Bortezomib|bortezomib|mesh-list
83755046|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755047|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
83755048|NCT00017368|Melphalan|melphalan|mesh-list
83755049|NCT00017368|Ifosfamide|ifosfamide|mesh-list
83755050|NCT00017368|Thiotepa|thiotepa|mesh-list
83755051|NCT00017368|Carboplatin|carboplatin|mesh-list
83755052|NCT00017368|Doxorubicin|doxorubicin|mesh-list
83755053|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83755054|NCT00017368|Etoposide|etoposide|mesh-list
83755055|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
83755056|NCT00017368|Vincristine|vincristine|mesh-list
83755057|NCT00017368|Isotretinoin|isotretinoin|mesh-list
83755058|NCT00017368|Sargramostim|sargramostim|mesh-list
83755059|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755060|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
83755061|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755062|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755063|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83755064|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
83755065|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755066|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755067|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83755068|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83755069|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83755070|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83755071|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755072|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83755073|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83755074|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83755075|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83755076|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
83755077|NCT00001524|Thalidomide|thalidomide|mesh-list
83755078|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755079|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
83755080|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755081|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
83755082|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755083|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755084|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83755085|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83755086|NCT00001524|Growth Substances|growth substances|mesh-ancestor
83755087|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
83755088|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755089|NCT00006041|Vaccines|vaccines|mesh-list
83755090|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
83755091|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
83755092|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755093|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83755094|NCT00017602|Dexamethasone|dexamethasone|mesh-list
83755095|NCT00017602|Oblimersen|oblimersen|mesh-list
83755096|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83755097|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
83755098|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
83755099|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755100|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755101|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755102|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
83755103|NCT00017602|Hormones|hormones|mesh-ancestor
83755104|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755105|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83755106|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755107|NCT00001533|Cyclosporine|cyclosporine|mesh-list
83755108|NCT00001533|Cyclosporins|cyclosporins|mesh-list
83755109|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755110|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755111|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755112|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
83755113|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755114|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
83755115|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755116|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
83755117|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755118|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83755119|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
83755120|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83755121|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755122|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
83755123|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755124|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755125|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83755126|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
83755127|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755128|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755129|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83755130|NCT00017680|Melphalan|melphalan|mesh-list
83755131|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83755132|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
83755133|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755134|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755135|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83755136|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755137|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
83755138|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755139|NCT00017719|Lamivudine|lamivudine|mesh-list
83755140|NCT00017719|Zidovudine|zidovudine|mesh-list
83755141|NCT00017719|Nevirapine|nevirapine|mesh-list
83755142|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83755143|NCT00017719|Nelfinavir|nelfinavir|mesh-list
83755144|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83755145|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83755146|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755147|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755148|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
83755149|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755150|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83755151|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83755152|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
83755153|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83755154|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83755155|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83755156|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83755157|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755158|NCT00001542|Fluconazole|fluconazole|mesh-list
83755159|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
83755160|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755161|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83755162|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755163|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755164|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755165|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83755166|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
83755167|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755168|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755169|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83755170|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83755171|NCT00017758|Efavirenz|efavirenz|mesh-list
83755172|NCT00017758|Nelfinavir|nelfinavir|mesh-list
83755173|NCT00017758|Atorvastatin|atorvastatin|mesh-list
83755174|NCT00017758|Simvastatin|simvastatin|mesh-list
83755175|NCT00017758|Pravastatin|pravastatin|mesh-list
83755176|NCT00017758|Calcium|calcium|mesh-list
83755177|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83755178|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755179|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83755180|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83755181|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
83755182|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755183|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83755184|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83755185|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755186|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83755187|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83755188|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
83755189|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755190|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83755191|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755192|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83755193|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83755194|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83755195|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83755196|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83755197|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83755198|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755200|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83755201|NCT00017992|Ritonavir|ritonavir|mesh-list
83755202|NCT00017992|Lopinavir|lopinavir|mesh-list
83755203|NCT00017992|Emtricitabine|emtricitabine|mesh-list
83755204|NCT00017992|Stavudine|stavudine|mesh-list
83755205|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83755206|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83755207|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755208|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755209|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755210|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83755211|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83755212|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
83755213|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755214|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83755215|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755216|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83755217|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83755218|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
83755219|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83755220|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755221|NCT04734067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755222|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755223|NCT05680805|Metformin|metformin|mesh-list
83755224|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83755225|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755226|NCT00018148|Nortriptyline|nortriptyline|mesh-list
83755227|NCT00018148|Nicotine|nicotine|mesh-list
83755228|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83755229|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
83755230|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755231|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755232|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83755233|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83755234|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
83755235|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755236|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755237|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83755238|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
83755239|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83755240|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83755241|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83755242|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755243|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83755244|NCT00001563|Rituximab|rituximab|mesh-list
83755245|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755246|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755247|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
83755248|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755249|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755250|NCT00018187|Mecamylamine|mecamylamine|mesh-list
83755251|NCT00018187|Bupropion|bupropion|mesh-list
83755252|NCT00018187|Nicotine|nicotine|mesh-list
83755253|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83755254|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
83755255|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755256|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755257|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83755258|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83755259|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
83755260|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755261|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755262|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83755263|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
83755264|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83755265|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83755266|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83755267|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755268|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
83755269|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83755270|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755271|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755272|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83755273|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83755274|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83755275|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83755276|NCT00018343|Estrogens|estrogens|mesh-list
83755277|NCT00018343|Hormones|hormones|mesh-ancestor
83755278|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755279|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755280|NCT00001566|Indinavir|indinavir|mesh-list
83755281|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83755282|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83755283|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755284|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755285|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755286|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83755287|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83755288|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
83755289|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755290|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
83755291|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83755292|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755293|NCT00018460|Vitamins|vitamins|mesh-list
83755294|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
83755295|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
83755296|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755297|NCT00386750|Lumefantrine|lumefantrine|mesh-list
83755298|NCT00386750|Artemether|artemether|mesh-list
83755299|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83755300|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
83755301|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83755302|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83755303|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755304|NCT00001575|Edetic Acid|edetic acid|mesh-list
83755305|NCT00001575|Calcium|calcium|mesh-list
83755306|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
83755307|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83755308|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755309|NCT00001575|Antidotes|antidotes|mesh-ancestor
83755310|NCT00001575|Protective Agents|protective agents|mesh-ancestor
83755311|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
83755312|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
83755313|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755314|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83755315|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
83755316|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83755317|NCT00001596|Pirfenidone|pirfenidone|mesh-list
83755318|NCT00001596|Analgesics|analgesics|mesh-ancestor
83755319|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
83755320|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755321|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755322|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83755323|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83755324|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83755325|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755326|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755327|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83755328|NCT05576194|Taurolidine|taurolidine|mesh-list
83755329|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83755330|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755331|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755332|NCT00391885|Anesthetics|anesthetics|mesh-list
83755333|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755334|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755335|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83755336|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83755337|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
83755338|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755339|NCT00392002|Esomeprazole|esomeprazole|mesh-list
83755340|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83755341|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755342|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83755343|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755344|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755345|NCT00392080|Naproxen|naproxen|mesh-list
83755346|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83755347|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83755348|NCT00392080|Analgesics|analgesics|mesh-ancestor
83755349|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
83755350|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755351|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755352|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83755353|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755354|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
83755355|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83755356|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755357|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755358|NCT00001644|Lamivudine|lamivudine|mesh-list
83755359|NCT00001644|Zidovudine|zidovudine|mesh-list
83755360|NCT00001644|Nevirapine|nevirapine|mesh-list
83755361|NCT00001644|Indinavir|indinavir|mesh-list
83755362|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83755363|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83755364|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755365|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755366|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
83755367|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755368|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83755369|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83755370|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
83755371|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83755372|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83755373|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83755374|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83755375|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755376|NCT05573386|Lenograstim|lenograstim|mesh-list
83755377|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83755378|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
83755379|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755380|NCT00001656|Olanzapine|olanzapine|mesh-list
83755381|NCT00001656|Clozapine|clozapine|mesh-list
83755382|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
83755383|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
83755384|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755385|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755386|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755387|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83755388|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83755389|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755390|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83755391|NCT00001656|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83755392|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83755393|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755394|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755395|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755396|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
83755397|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83755398|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
83755399|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
83755400|NCT05573191|Lidocaine|lidocaine|mesh-list
83755401|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
83755402|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
83755403|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755404|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755405|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
83755406|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755407|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83755408|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83755409|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83755410|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755411|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755412|NCT05679830|Cannabidiol|cannabidiol|mesh-list
83755413|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
83755414|NCT05572996|Treprostinil|treprostinil|mesh-list
83755415|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82910586|NCT01139463|Haloperidol|haloperidol|mesh-list
82910587|NCT01139463|Olanzapine|olanzapine|mesh-list
83755416|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
83755417|NCT05572723|Remifentanil|remifentanil|mesh-list
83755418|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83755419|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755420|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755421|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83755422|NCT05572723|Analgesics|analgesics|mesh-ancestor
83755423|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
83755424|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755425|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83755426|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83755427|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83755428|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83755429|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755430|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755431|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83755432|NCT05572723|Narcotics|narcotics|mesh-ancestor
83755433|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83755434|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755435|NCT00389415|Vildagliptin|vildagliptin|mesh-list
83755436|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83755437|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755438|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83755439|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755440|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755441|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755442|NCT05465317|Empagliflozin|empagliflozin|mesh-list
83755443|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83755444|NCT05465317|Glucagon|glucagon|mesh-list
83755445|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83755446|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755447|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83755448|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755449|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755450|NCT05465317|Hormones|hormones|mesh-ancestor
83755451|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755452|NCT05465317|Incretins|incretins|mesh-ancestor
83755453|NCT05419921|Lidocaine|lidocaine|mesh-list
83755454|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
83755455|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
83755456|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755457|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755458|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
83755459|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755460|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83755461|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83755462|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83755463|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755464|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755465|NCT00386828|Bevacizumab|bevacizumab|mesh-list
83755466|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755467|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755468|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83755469|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83755470|NCT00386828|Growth Substances|growth substances|mesh-ancestor
83755471|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755472|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
83755473|NCT05367271|Dexamethasone|dexamethasone|mesh-list
83755474|NCT05367271|Cortisone|cortisone|mesh-list
83755475|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83755476|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
83755477|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83755478|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83755479|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
83755480|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
83755481|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755482|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755483|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755484|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
83755485|NCT05367271|Hormones|hormones|mesh-ancestor
83755486|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755487|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83755488|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755489|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82910664|NCT03618316|Cimetidine|cimetidine|mesh-list
83755490|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755491|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755492|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
83755493|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755494|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83755495|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
83755496|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
83755497|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
83755498|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83755499|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83755500|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755501|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755502|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755503|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
83755504|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755505|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755506|NCT05311618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83755507|NCT05311618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755508|NCT00001728|Alendronate|alendronate|mesh-list
83755509|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83755510|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755511|NCT05673629|Docetaxel|docetaxel|mesh-list
83755512|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755513|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
83755514|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
83755515|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
83755516|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755517|NCT00001731|Cyclosporine|cyclosporine|mesh-list
83755518|NCT00001731|Cyclosporins|cyclosporins|mesh-list
83755519|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755520|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505338|NCT02683707|Midazolam|midazolam|mesh-list
83755521|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755522|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
83755523|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755524|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
83755525|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755526|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
83755527|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755528|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83755529|NCT00392158|Anesthetics|anesthetics|mesh-list
83755530|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755531|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755532|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
83755533|NCT00392275|Levofloxacin|levofloxacin|mesh-list
83755534|NCT00392275|Ofloxacin|ofloxacin|mesh-list
83755535|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755536|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755537|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83755538|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83755539|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755540|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755541|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755542|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83755543|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755544|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83755545|NCT00001749|Cyclosporine|cyclosporine|mesh-list
83755546|NCT00001749|Cyclosporins|cyclosporins|mesh-list
83755547|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83755548|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755549|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755550|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755551|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
83755552|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755553|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
83755554|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755555|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83755556|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755557|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83755558|NCT00001752|Estrogens|estrogens|mesh-list
83755559|NCT00001752|Hormones|hormones|mesh-ancestor
83755560|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755561|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755562|NCT05171179|Lidocaine|lidocaine|mesh-list
82910734|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83755563|NCT05171179|Bupivacaine|bupivacaine|mesh-list
83755564|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
83755565|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
83755566|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755567|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755568|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
83755569|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755570|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83755571|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83755572|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83755573|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755574|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755575|NCT05156905|Docetaxel|docetaxel|mesh-list
83755576|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755577|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
83755578|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
83755579|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
83755580|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755581|NCT00001758|Efavirenz|efavirenz|mesh-list
83755582|NCT00001758|Abacavir|abacavir|mesh-list
83755583|NCT00001758|Amprenavir|amprenavir|mesh-list
83755584|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83755585|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83755586|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755587|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755588|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
83755589|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755590|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83755591|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755592|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83755593|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83755594|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83755595|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83755596|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83755597|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83755598|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83755599|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
83755600|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755601|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83755602|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83755603|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755604|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
83755605|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83755606|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755607|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83755608|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
83755609|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755610|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755611|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755612|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755613|NCT04983901|Vancomycin|vancomycin|mesh-list
83755614|NCT04983901|Meropenem|meropenem|mesh-list
83755615|NCT04983901|Linezolid|linezolid|mesh-list
83755616|NCT04983901|Tazobactam|tazobactam|mesh-list
83755617|NCT04983901|Piperacillin|piperacillin|mesh-list
83755618|NCT04983901|Daptomycin|daptomycin|mesh-list
83755619|NCT04983901|Imipenem|imipenem|mesh-list
83755620|NCT04983901|Cefepime|cefepime|mesh-list
83755621|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83755622|NCT04983901|Relebactam|relebactam|mesh-list
83755623|NCT04983901|Cilastatin|cilastatin|mesh-list
83755624|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755625|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755626|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83755627|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755628|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755629|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83755630|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
83755631|NCT04971343|Antibodies|antibodies|mesh-list
83755632|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
83755633|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
83755634|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910810|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755635|NCT04951804|Bupivacaine|bupivacaine|mesh-list
83755636|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
83755637|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
83755638|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755639|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755640|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
83755641|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755642|NCT05620628|Durvalumab|durvalumab|mesh-list
83755643|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755644|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755645|NCT04905121|Psilocybin|psilocybin|mesh-list
83755646|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
83755647|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755648|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83755649|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
83755650|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755651|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
83755652|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755653|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755654|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83755655|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
83755656|NCT04887805|Lenvatinib|lenvatinib|mesh-list
83755657|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755658|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755659|NCT04887805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83755660|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755661|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83755662|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755663|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
83755664|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
83755665|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755666|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
83755667|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755668|NCT00000102|Nifedipine|nifedipine|mesh-list
83755669|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83755670|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755671|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755672|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83755673|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755674|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
83755675|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
83755676|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83755677|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
83755678|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83755679|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83755680|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
83755681|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755682|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755683|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755684|NCT05641506|Niraparib|niraparib|mesh-list
83755685|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83755686|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755687|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755688|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755689|NCT04734730|Prednisone|prednisone|mesh-list
83755690|NCT04734730|Cortisone|cortisone|mesh-list
83755691|NCT04734730|Leuprolide|leuprolide|mesh-list
83755692|NCT04734730|Goserelin|goserelin|mesh-list
83755693|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
83755694|NCT04734730|Bicalutamide|bicalutamide|mesh-list
83755695|NCT04734730|Talazoparib|talazoparib|mesh-list
83755696|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83755697|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
83755698|NCT04734730|Hormones|hormones|mesh-ancestor
83755699|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755700|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755701|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83755702|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755703|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83755704|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
83755705|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83755706|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83755707|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755708|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755709|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
83755710|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755711|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
83755712|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83755713|NCT05555888|Capecitabine|capecitabine|mesh-list
83755714|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
83755715|NCT05555888|Antibodies|antibodies|mesh-list
83755716|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
83755717|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755718|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83755719|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
83755720|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755721|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755722|NCT04619680|Nintedanib|nintedanib|mesh-list
83755723|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755724|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83755725|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755726|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755727|NCT00386867|Misoprostol|misoprostol|mesh-list
83755728|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83755729|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
83755730|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83755731|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755732|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83755733|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755734|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
83755735|NCT04526119|Z 338|z 338|mesh-list
83755736|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83755737|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755738|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755739|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
83755740|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755741|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755742|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755743|NCT04487236|Capecitabine|capecitabine|mesh-list
83755744|NCT04487236|Trastuzumab|trastuzumab|mesh-list
83755745|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83755746|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
83755747|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755748|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755749|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755750|NCT00392431|Amiodarone|amiodarone|mesh-list
83755751|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83755752|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
83755753|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83755754|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755755|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755756|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83755757|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83755758|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83755759|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755760|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83755761|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83755762|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83755763|NCT05495204|Ibalizumab|ibalizumab|mesh-list
83755764|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83755765|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83755766|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83755767|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
83755768|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755769|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
83755770|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755771|NCT00392470|Irinotecan|irinotecan|mesh-list
83755772|NCT00392470|Cetuximab|cetuximab|mesh-list
83755773|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83755774|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83755775|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755776|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755777|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755778|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755779|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
83755780|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755781|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755782|NCT03960151|Dexamethasone|dexamethasone|mesh-list
83755783|NCT03960151|Olanzapine|olanzapine|mesh-list
83755784|NCT03960151|Palonosetron|palonosetron|mesh-list
82910961|NCT04966299|Erythritol|erythritol|mesh-list
82910963|NCT01143987|Cinacalcet|cinacalcet|mesh-list
83755785|NCT03960151|Rolapitant|rolapitant|mesh-list
83755787|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
83755788|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
83755789|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755790|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755791|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755792|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
83755793|NCT03960151|Hormones|hormones|mesh-ancestor
83755794|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755795|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83755796|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755797|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83755798|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83755799|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755800|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83755801|NCT03960151|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83755802|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83755803|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755804|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755805|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755806|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
83755807|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83755808|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83755809|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83755810|NCT04733326|Ketorolac|ketorolac|mesh-list
83755811|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83755812|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83755813|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83755814|NCT04733326|Analgesics|analgesics|mesh-ancestor
83755815|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
83755816|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755817|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755818|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83755819|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83755820|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83755821|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755822|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755823|NCT00386984|Octreotide|octreotide|mesh-list
83755824|NCT00386984|Somatostatin|somatostatin|mesh-list
83755825|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755826|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83755827|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755828|NCT00386984|Hormones|hormones|mesh-ancestor
83755829|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83755830|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755831|NCT03959761|Nivolumab|nivolumab|mesh-list
83755832|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755833|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755834|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83755835|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755836|NCT00387179|Melatonin|melatonin|mesh-list
83755837|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
83755838|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755839|NCT00387179|Protective Agents|protective agents|mesh-ancestor
83755840|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755841|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755842|NCT03959332|Baloxavir|baloxavir|mesh-list
83755843|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
83755844|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755845|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755846|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755847|NCT03959293|Durvalumab|durvalumab|mesh-list
83755848|NCT03959293|Tremelimumab|tremelimumab|mesh-list
83755849|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755850|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755851|NCT04733521|Cisplatin|cisplatin|mesh-list
83755852|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755853|NCT05640726|Leucovorin|leucovorin|mesh-list
83755854|NCT05640726|Bevacizumab|bevacizumab|mesh-list
83755855|NCT05640726|Fluorouracil|fluorouracil|mesh-list
83755856|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
83755857|NCT05640726|Calcium|calcium|mesh-list
83755858|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
82911038|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
83755859|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755860|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755861|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83755862|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83755863|NCT05640726|Growth Substances|growth substances|mesh-ancestor
83755864|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755865|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
83755866|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83755867|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
83755868|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755869|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83755870|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83755871|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
83755872|NCT05640726|Antidotes|antidotes|mesh-ancestor
83755873|NCT05640726|Protective Agents|protective agents|mesh-ancestor
83755874|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
83755875|NCT05640726|Vitamins|vitamins|mesh-ancestor
83755876|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
83755877|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83755878|NCT03959176|Phenylephrine|phenylephrine|mesh-list
83755879|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
83755880|NCT03959176|Tropicamide|tropicamide|mesh-list
83755881|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83755882|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
83755883|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
83755884|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755885|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755886|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
83755887|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83755888|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
83755889|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83755890|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83755891|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83755892|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83755893|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83755894|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755895|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755896|NCT03959176|Protective Agents|protective agents|mesh-ancestor
83755897|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83755898|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83755899|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83755900|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83755901|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
83755902|NCT03958981|Castor Oil|castor oil|mesh-list
83755903|NCT03958981|Cathartics|cathartics|mesh-ancestor
83755904|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755905|NCT03958942|Bupivacaine|bupivacaine|mesh-list
83755906|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
83755907|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
83755908|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755909|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755910|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
83755911|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755912|NCT03958708|Rifaximin|rifaximin|mesh-list
83755913|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755914|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755915|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83755916|NCT05640609|Bevacizumab|bevacizumab|mesh-list
83755917|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83755918|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755919|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83755920|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83755921|NCT05640609|Growth Substances|growth substances|mesh-ancestor
83755922|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755923|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
83755924|NCT05411861|Analgesics|analgesics|mesh-list
83755925|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83755926|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
83755927|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755928|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755929|NCT03958513|Bupivacaine|bupivacaine|mesh-list
83755930|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
82911108|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755931|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
83755932|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755933|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755934|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
83755935|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755936|NCT03958396|Remifentanil|remifentanil|mesh-list
83755937|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83755938|NCT03958396|Narcotics|narcotics|mesh-ancestor
83755939|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755940|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755941|NCT03958396|Analgesics|analgesics|mesh-ancestor
83755942|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
83755943|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755944|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
83755945|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83755946|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83755947|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755948|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83755949|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83755950|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83755951|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755952|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83755953|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83755954|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
83755955|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83755956|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755957|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83755958|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83755959|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83755960|NCT03933865|Ketamine|ketamine|mesh-list
83755961|NCT03933865|Hydromorphone|hydromorphone|mesh-list
83755962|NCT03933865|Analgesics|analgesics|mesh-ancestor
83755963|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
83755964|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755965|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755966|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83755967|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83755968|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
83755969|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
83755970|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83755971|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83755972|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83755973|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755974|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755975|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83755976|NCT03933865|Narcotics|narcotics|mesh-ancestor
83755977|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
83755978|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83755979|NCT03819322|Velpatasvir|velpatasvir|mesh-list
83755980|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
83755981|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83755982|NCT05206175|Methamphetamine|methamphetamine|mesh-list
83755983|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83755984|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83755985|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
83755986|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
83755987|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83755988|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
83755989|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83755990|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83755991|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
83755992|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83755993|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83755994|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83755995|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83755996|NCT00392899|Tegafur|tegafur|mesh-list
83755997|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83755998|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
83755999|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756000|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756001|NCT05638893|Metformin|metformin|mesh-list
83756002|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83756003|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756004|NCT00392938|Docetaxel|docetaxel|mesh-list
83756005|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
83756006|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756007|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
83756008|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
83756009|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
83756010|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756011|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
83756012|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756013|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756014|NCT05637567|Aspirin|aspirin|mesh-list
83756015|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83756016|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756017|NCT05637567|Analgesics|analgesics|mesh-ancestor
83756018|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
83756019|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756020|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756021|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756022|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756023|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83756024|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83756025|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756026|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756027|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83756028|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756029|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
83756030|NCT03432091|Melatonin|melatonin|mesh-list
83756031|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
83756032|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756033|NCT03432091|Protective Agents|protective agents|mesh-ancestor
83756034|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756035|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83756036|NCT05634564|Paclitaxel|paclitaxel|mesh-list
83756037|NCT05634564|Gemcitabine|gemcitabine|mesh-list
83756038|NCT05634564|Tislelizumab|tislelizumab|mesh-list
83756039|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83756040|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756041|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
83756042|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
83756043|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
83756044|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756045|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83756046|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
83756047|NCT05634564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756048|NCT03152149|Fluticasone|fluticasone|mesh-list
83756049|NCT03152149|Xhance|xhance|mesh-list
83756050|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
83756051|NCT03152149|Olodaterol|olodaterol|mesh-list
83756052|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756053|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83756054|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
83756055|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756056|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756057|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83756058|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83756059|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
83756060|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83756061|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
83756062|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83756063|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
83756064|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756065|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756066|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83756067|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83756068|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83756069|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756070|NCT05633472|Vitamin D|vitamin d|mesh-list
83756071|NCT05633472|Vitamins|vitamins|mesh-ancestor
83756072|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
83756073|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756074|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83756075|NCT03151876|Gemcitabine|gemcitabine|mesh-list
83756076|NCT03151876|Busulfan|busulfan|mesh-list
83756077|NCT03151876|Cladribine|cladribine|mesh-list
83756078|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83756079|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
83756080|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756081|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756082|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
83756083|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756084|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
83756085|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756086|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83756087|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83756088|NCT03151720|Loratadine|loratadine|mesh-list
83756089|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
83756090|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
83756091|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83756092|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83756093|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83756094|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
83756095|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
83756096|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756097|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756098|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756099|NCT03151603|Fosfomycin|fosfomycin|mesh-list
83756100|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83756101|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756102|NCT03151525|Infliximab|infliximab|mesh-list
83756103|NCT03151525|Azathioprine|azathioprine|mesh-list
83756104|NCT03151525|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83756105|NCT03151525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756106|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
83756107|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756108|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756109|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
83756110|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756111|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83756112|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756113|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756114|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
83756115|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756116|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
83756117|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
83756118|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83756119|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83756120|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
83756121|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756122|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756123|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756124|NCT00387374|Paclitaxel|paclitaxel|mesh-list
83756125|NCT00387374|Bevacizumab|bevacizumab|mesh-list
83756126|NCT00387374|Carboplatin|carboplatin|mesh-list
83756127|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83756128|NCT00387374|Antibodies|antibodies|mesh-list
83756129|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
83756130|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83756131|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83756132|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756133|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
83756134|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
83756135|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
83756136|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756137|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83756138|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83756139|NCT00387374|Growth Substances|growth substances|mesh-ancestor
83756140|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756141|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
83756142|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
83756143|NCT03151369|Morphine|morphine|mesh-list
83756144|NCT03151369|Analgesics|analgesics|mesh-list
83756145|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83756146|NCT03151369|Narcotics|narcotics|mesh-ancestor
83756147|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83756148|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756149|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
83756150|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756151|NCT04712266|Insulin|insulin|mesh-list
83756152|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83756153|NCT04712266|Glucagon|glucagon|mesh-list
83756154|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83756155|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756156|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756157|NCT04712266|Hormones|hormones|mesh-ancestor
83845097|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756158|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756160|NCT03912818|Gemcitabine|gemcitabine|mesh-list
83756161|NCT03912818|Doxorubicin|doxorubicin|mesh-list
83756162|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83756163|NCT03912818|Methotrexate|methotrexate|mesh-list
83756164|NCT03912818|Durvalumab|durvalumab|mesh-list
83756165|NCT03912818|Daunorubicin|daunorubicin|mesh-list
83756166|NCT03912818|Vinblastine|vinblastine|mesh-list
83756167|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756168|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83756169|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
83756170|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756171|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83756172|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83756173|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83756174|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756175|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83756176|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
83756177|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83756178|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756179|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
83756180|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83756181|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756182|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
83756183|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756184|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83756185|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756186|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83756187|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
83756188|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
83756189|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
83756190|NCT03151213|Pregabalin|pregabalin|mesh-list
83756191|NCT03151213|Analgesics|analgesics|mesh-ancestor
83756192|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
83756193|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756194|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756195|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
83756196|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83756197|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83756198|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756199|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83756200|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83756201|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83756202|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83756203|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83756204|NCT03151174|Vitamin D|vitamin d|mesh-list
83756205|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
83756206|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
83756207|NCT03151174|Vitamins|vitamins|mesh-list
83756208|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
83756209|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756210|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83756211|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83756212|NCT03151096|Riboflavin|riboflavin|mesh-list
83756213|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
83756214|NCT03151096|Vitamins|vitamins|mesh-ancestor
83756215|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
83756216|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756217|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83756218|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
83756219|NCT03906539|Atorvastatin|atorvastatin|mesh-list
83756220|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83756221|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83756222|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
83756223|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756224|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83756225|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83756226|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756227|NCT00389688|Pemetrexed|pemetrexed|mesh-list
83756228|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756229|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756230|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756231|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82911405|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
83756232|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83756233|NCT05605665|Sirolimus|sirolimus|mesh-list
83756234|NCT05605665|Aldesleukin|aldesleukin|mesh-list
83756235|NCT05605665|Interleukin-2|interleukin-2|mesh-list
83756236|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83756237|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756238|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83756239|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756240|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
83756241|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756242|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
83756243|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756244|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756245|NCT05605665|Analgesics|analgesics|mesh-ancestor
83756246|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
83756247|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756248|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83756249|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83756250|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
83756251|NCT03150706|Avelumab|avelumab|mesh-list
83756252|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756253|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756254|NCT03150667|Clopidogrel|clopidogrel|mesh-list
83756255|NCT03150667|Ticagrelor|ticagrelor|mesh-list
83756256|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756257|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83756258|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83756259|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83756260|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
83756261|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756262|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756263|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756264|NCT03150316|Dexamethasone|dexamethasone|mesh-list
83756265|NCT03150316|Lenalidomide|lenalidomide|mesh-list
83756266|NCT03150316|CKD-581|ckd-581|mesh-list
83756267|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756268|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
83756269|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
83756270|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756271|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756272|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756273|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
83756274|NCT03150316|Hormones|hormones|mesh-ancestor
83756275|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756276|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83756277|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756278|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756279|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756280|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
83756281|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83756282|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83756283|NCT03150316|Growth Substances|growth substances|mesh-ancestor
83756284|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
83756285|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83756286|NCT02972125|Lacosamide|lacosamide|mesh-list
83756287|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
83756288|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83756289|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83756290|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83756291|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756292|NCT05597553|Pemetrexed|pemetrexed|mesh-list
83756293|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756294|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756295|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756296|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83756297|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83756298|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
83756299|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83756300|NCT03086044|Velpatasvir|velpatasvir|mesh-list
83756301|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
83756302|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756303|NCT03083665|Brivaracetam|brivaracetam|mesh-list
83756304|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
83756305|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
82911484|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
83756306|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756307|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756308|NCT02977468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83756309|NCT02977468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756310|NCT02866006|Topotecan|topotecan|mesh-list
83756311|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83756312|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83756313|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756314|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756315|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756316|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83756317|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756318|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83756319|NCT02633098|Artesunate|artesunate|mesh-list
83756320|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
83756321|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83756322|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83756323|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756324|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756325|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
83756326|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
83756327|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83756328|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
83756329|NCT00393289|Calcium|calcium|mesh-list
83756330|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83756331|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756332|NCT02285179|Tamoxifen|tamoxifen|mesh-list
83756333|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83756334|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
83756335|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756336|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756337|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83756338|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756339|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83756340|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83756341|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83756342|NCT02250937|Fludarabine|fludarabine|mesh-list
83756343|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
83756344|NCT02250937|Busulfan|busulfan|mesh-list
83756345|NCT02250937|Venetoclax|venetoclax|mesh-list
83756346|NCT02250937|Cladribine|cladribine|mesh-list
83756347|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83756348|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756349|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83756350|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
83756351|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756352|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756353|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
83756354|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756355|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
83756356|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83756357|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83756358|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
83756359|NCT02122081|Methotrexate|methotrexate|mesh-list
83756360|NCT02122081|Tacrolimus|tacrolimus|mesh-list
83756361|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
83756362|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83756363|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
83756364|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756365|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
83756366|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756367|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756368|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83756369|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
83756370|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756371|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756372|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83756373|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83756374|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
83756375|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83756376|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83756377|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
83756378|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
83756379|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756380|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83756381|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83756382|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83756383|NCT04708886|Alendronate|alendronate|mesh-list
83756384|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83756385|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756386|NCT00393328|Ritonavir|ritonavir|mesh-list
83756387|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83756388|NCT00393328|Aripiprazole|aripiprazole|mesh-list
83756389|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83756390|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83756391|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
83756392|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756393|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756394|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83756395|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83756396|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
83756397|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756398|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83756399|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83756400|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
83756401|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83756402|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83756403|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83756404|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83756405|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756406|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
83756407|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
83756408|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756409|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83756410|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83756411|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
83756412|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83756413|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83756414|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83756415|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83756416|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83756417|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756418|NCT01807429|Midazolam|midazolam|mesh-list
83756419|NCT01807429|Ketamine|ketamine|mesh-list
83756420|NCT01807429|Morphine|morphine|mesh-list
83756421|NCT01807429|Analgesics|analgesics|mesh-ancestor
83756422|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
83756423|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756424|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756425|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83756426|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83756427|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
83756428|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
83756429|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83756430|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83756431|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83756432|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756433|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756434|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83756435|NCT01807429|Narcotics|narcotics|mesh-ancestor
83756436|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83756437|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83756438|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83756439|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83756440|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83756441|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
83756442|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
83756443|NCT01807078|Ezetimibe|ezetimibe|mesh-list
83756444|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83756445|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83756446|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
83756447|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756448|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83756449|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
83756450|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83756451|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
83756452|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756453|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756454|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83756455|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
83756456|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83756457|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83756458|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83756459|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
83756460|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756461|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756462|NCT01807000|Prucalopride|prucalopride|mesh-list
83756463|NCT01807000|Laxatives|laxatives|mesh-ancestor
83756464|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756465|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83756466|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83756467|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
83756468|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756469|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756470|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756471|NCT01806805|Zonisamide|zonisamide|mesh-list
83756472|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
83756473|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83756474|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83756475|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756476|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83756477|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756478|NCT00387413|Niacinamide|niacinamide|mesh-list
83756479|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83756480|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83756481|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83756482|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83756483|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756484|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756485|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756486|NCT00387413|Analgesics|analgesics|mesh-ancestor
83756487|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
83756488|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756489|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
83756490|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83756491|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
83756492|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
83756493|NCT00387413|Vitamins|vitamins|mesh-ancestor
83756494|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
83756495|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83756496|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
83756497|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756498|NCT05517291|Paclitaxel|paclitaxel|mesh-list
83756499|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83756500|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756501|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83756502|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83756503|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83756504|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756505|NCT04590248|Adavosertib|adavosertib|mesh-list
83756506|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756507|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756508|NCT01806454|Calcium|calcium|mesh-list
83756509|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83756510|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756511|NCT01806415|Imidazole|imidazole|mesh-list
83756512|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756513|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756514|NCT01806376|Maleic acid|maleic acid|mesh-list
83756515|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756516|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756517|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
83756518|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756519|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756520|NCT01806259|Ketorolac|ketorolac|mesh-list
83756521|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83756522|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83756523|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756524|NCT01806259|Analgesics|analgesics|mesh-ancestor
83756525|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
83756526|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756527|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756528|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756529|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756530|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83756531|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756532|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756533|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
83756534|NCT05482542|Rituximab|rituximab|mesh-list
83756535|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756536|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
83756537|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756538|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756539|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83756540|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
83756541|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756542|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756543|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83756544|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756545|NCT04579757|Tislelizumab|tislelizumab|mesh-list
83756546|NCT04579757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756547|NCT04579757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756548|NCT00393445|Glucagon|glucagon|mesh-list
83756549|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83756550|NCT00393445|Incretins|incretins|mesh-ancestor
83756551|NCT00393445|Hormones|hormones|mesh-ancestor
83756552|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756553|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756554|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756555|NCT00393562|Methylphenidate|methylphenidate|mesh-list
83756556|NCT00393562|Modafinil|modafinil|mesh-list
83756557|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83756558|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756559|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83756560|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83756561|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83756562|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756563|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
83756564|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756565|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83756566|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83756567|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83756568|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
83756569|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83756570|NCT04551131|Dexamethasone|dexamethasone|mesh-list
83756571|NCT04551131|Etoposide|etoposide|mesh-list
83756572|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
83756573|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756574|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
83756575|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
83756576|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756577|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756578|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756579|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
83756580|NCT04551131|Hormones|hormones|mesh-ancestor
83756581|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756582|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83756583|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756584|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83756585|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83756586|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83756587|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756588|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756589|NCT01805908|Pertuzumab|pertuzumab|mesh-list
83756590|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756591|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756592|NCT04527107|Aflibercept|aflibercept|mesh-list
83756593|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83756594|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83756595|NCT04527107|Growth Substances|growth substances|mesh-ancestor
83756596|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756597|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
83756598|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756599|NCT05437887|Fucoidan|fucoidan|mesh-list
83756600|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83756601|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756602|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
83756603|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911788|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
83756604|NCT01805596|Clopidogrel|clopidogrel|mesh-list
83756605|NCT01805596|Ticagrelor|ticagrelor|mesh-list
83756606|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756607|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83756608|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83756609|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83756610|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
83756611|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756612|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756613|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756614|NCT04477343|Nivolumab|nivolumab|mesh-list
83756615|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756616|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756617|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83756618|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756619|NCT04474223|Dexamethasone|dexamethasone|mesh-list
83756620|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756621|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
83756622|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
83756623|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756624|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756625|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756626|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
83756627|NCT04474223|Hormones|hormones|mesh-ancestor
83756628|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756629|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83756630|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756631|NCT01466530|Misoprostol|misoprostol|mesh-list
83756632|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83756633|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
83756634|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83756635|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756636|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83756637|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756638|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
83756639|NCT01466452|Aspirin|aspirin|mesh-list
83756640|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83756641|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756642|NCT01466452|Analgesics|analgesics|mesh-ancestor
83756643|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
83756644|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756645|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756646|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756647|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756648|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83756649|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83756650|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756651|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756652|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83756653|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756654|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
83756655|NCT01466374|Antibodies|antibodies|mesh-list
83756656|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
83756657|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83756658|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
83756659|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756660|NCT01466257|Cetuximab|cetuximab|mesh-list
83756661|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756662|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756663|NCT01466101|Pregabalin|pregabalin|mesh-list
83756664|NCT01466101|Analgesics|analgesics|mesh-ancestor
83756665|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
83756666|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756667|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756668|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
83756669|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83756670|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83756671|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756672|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83756673|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83756674|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83756675|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83756676|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83756677|NCT01465984|Acetaminophen|acetaminophen|mesh-list
83756678|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756679|NCT01465984|Analgesics|analgesics|mesh-ancestor
83756680|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
83756681|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756682|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756683|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
83756684|NCT01465906|Bromides|bromides|mesh-list
83756685|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
83756686|NCT01465906|Tulobuterol|tulobuterol|mesh-list
83756687|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83756688|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
83756689|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756690|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756691|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83756692|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
83756693|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
83756694|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83756695|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
83756696|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756697|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756698|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
83756699|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83756700|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83756701|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
83756702|NCT01465867|Selenium|selenium|mesh-list
83756703|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
83756704|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756705|NCT01465867|Protective Agents|protective agents|mesh-ancestor
83756706|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756707|NCT01465867|Trace Elements|trace elements|mesh-ancestor
83756708|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
83756709|NCT01465828|Clopidogrel|clopidogrel|mesh-list
83756710|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83756711|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756712|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83756713|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83756714|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83756715|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
83756716|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756717|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756718|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756719|NCT01465438|Adalimumab|adalimumab|mesh-list
83756720|NCT01465438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83756721|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756722|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756723|NCT01465399|Mitogens|mitogens|mesh-list
83756724|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83756725|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756726|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83756727|NCT05393505|Amoxicillin|amoxicillin|mesh-list
83756728|NCT05393505|Levofloxacin|levofloxacin|mesh-list
83756729|NCT05393505|Meropenem|meropenem|mesh-list
83756730|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
83756731|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
83756732|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83756733|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756734|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83756735|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83756736|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83756737|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756738|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756739|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756740|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83756741|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83756742|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83756743|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
83756744|NCT04201457|Trametinib|trametinib|mesh-list
83756745|NCT04201457|Dabrafenib|dabrafenib|mesh-list
83756746|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83756747|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
83756748|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83756749|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83756750|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911934|NCT03601624|Hormones|hormones|mesh-ancestor
83756751|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756752|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756753|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756754|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756755|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83756756|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83756757|NCT04201457|Protective Agents|protective agents|mesh-ancestor
83756758|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756759|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83756760|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
83756761|NCT01465009|Aspirin|aspirin|mesh-list
83756762|NCT01465009|Acetaminophen|acetaminophen|mesh-list
83756763|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83756764|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756765|NCT01465009|Analgesics|analgesics|mesh-ancestor
83756766|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
83756767|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756768|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756769|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756770|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756771|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83756772|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83756773|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756774|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756775|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83756776|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756777|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
83756778|NCT00389766|Topotecan|topotecan|mesh-list
83756779|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83756780|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83756781|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83756782|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756783|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756784|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756785|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83756786|NCT01464697|Progesterone|progesterone|mesh-list
83756787|NCT01464697|Progestins|progestins|mesh-ancestor
83756788|NCT01464697|Hormones|hormones|mesh-ancestor
83756789|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756790|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756791|NCT04083950|Aspirin|aspirin|mesh-list
83756792|NCT04083950|Vaccines|vaccines|mesh-list
83756793|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
83756794|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756795|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83756796|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756797|NCT04083950|Analgesics|analgesics|mesh-ancestor
83756798|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
83756799|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756800|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756801|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756802|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83756803|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83756804|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756805|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756806|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83756807|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756808|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
83756809|NCT00393679|Artesunate|artesunate|mesh-list
83756810|NCT00393679|Lumefantrine|lumefantrine|mesh-list
83756811|NCT00393679|Artemether|artemether|mesh-list
83756812|NCT00393679|Piperaquine|piperaquine|mesh-list
83756813|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83756814|NCT00393679|Amodiaquine|amodiaquine|mesh-list
83756815|NCT00393679|Artenimol|artenimol|mesh-list
83756816|NCT00393679|Dapsone|dapsone|mesh-list
83756817|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
83756818|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
83756819|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83756820|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83756821|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756822|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756823|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
83756824|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
83756825|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82912008|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912013|NCT03600064|Misoprostol|misoprostol|mesh-list
83756826|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
83756827|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83756828|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756829|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756830|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
83756831|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83756832|NCT00393835|Azithromycin|azithromycin|mesh-list
83756833|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83756834|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756836|NCT04078568|Prednisolone|prednisolone|mesh-list
83756837|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
83756838|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83756839|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
83756840|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83756841|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83756842|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83756843|NCT04078568|Analgesics|analgesics|mesh-ancestor
83756844|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
83756845|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756846|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756847|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83756848|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756849|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83756850|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83756851|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756852|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756853|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83756854|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756855|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
83756856|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
83756857|NCT04078568|Hormones|hormones|mesh-ancestor
83756858|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756859|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83756860|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756861|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
83756862|NCT01057069|Paclitaxel|paclitaxel|mesh-list
83756863|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83756864|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
83756865|NCT01057069|Carboplatin|carboplatin|mesh-list
83756866|NCT01057069|Doxorubicin|doxorubicin|mesh-list
83756867|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83756868|NCT01057069|Thiotepa|thiotepa|mesh-list
83756869|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83756870|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756871|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
83756872|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
83756873|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
83756874|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756875|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756876|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
83756877|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756878|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756879|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83756880|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
83756881|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83756882|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83756883|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83756884|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83756885|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756886|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83756887|NCT00847834|Irbesartan|irbesartan|mesh-list
83756888|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83756889|NCT00847834|Diuretics|diuretics|mesh-ancestor
83756890|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
83756891|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756892|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83756893|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83756894|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756895|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83756896|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83756897|NCT00847678|Amphotericin B|amphotericin b|mesh-list
83756898|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83756899|NCT00847678|Flucytosine|flucytosine|mesh-list
83756900|NCT00847678|Efungumab|efungumab|mesh-list
83756901|NCT00847678|Amebicides|amebicides|mesh-ancestor
83756902|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82912087|NCT03346070|Rocuronium|rocuronium|mesh-list
83756903|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83756904|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756905|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83756906|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
83756907|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
83756908|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756909|NCT00847639|Lenalidomide|lenalidomide|mesh-list
83756910|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
83756911|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756912|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83756913|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83756914|NCT00847639|Growth Substances|growth substances|mesh-ancestor
83756915|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
83756916|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756917|NCT00847483|Bimatoprost|bimatoprost|mesh-list
83756918|NCT00847483|Travoprost|travoprost|mesh-list
83756919|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83756920|NCT00847483|Latanoprost|latanoprost|mesh-list
83756921|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83756922|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83756923|NCT04034927|Olaparib|olaparib|mesh-list
83756924|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83756925|NCT04034927|Tremelimumab|tremelimumab|mesh-list
83756926|NCT04034927|Ipilimumab|ipilimumab|mesh-list
83756927|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83756928|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756929|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756930|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756931|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
83756932|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756933|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756934|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83756935|NCT00847366|Tamoxifen|tamoxifen|mesh-list
83756936|NCT00847366|Trastuzumab|trastuzumab|mesh-list
83756937|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756938|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756939|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83756940|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
83756941|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83756942|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756943|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83756944|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83756945|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83756946|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83756947|NCT05321160|Ketamine|ketamine|mesh-list
83756948|NCT05321160|Sevoflurane|sevoflurane|mesh-list
83756949|NCT05321160|Esketamine|esketamine|mesh-list
83756950|NCT05321160|Analgesics|analgesics|mesh-ancestor
83756951|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
83756952|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83756953|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756954|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83756955|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83756956|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
83756957|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
83756958|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83756959|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83756960|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83756961|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83756962|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756963|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83756964|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83756965|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
83756966|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83756967|NCT04009343|Lumefantrine|lumefantrine|mesh-list
83756968|NCT04009343|Artemether|artemether|mesh-list
83756969|NCT04009343|Piperaquine|piperaquine|mesh-list
83756970|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83756971|NCT04009343|Artenimol|artenimol|mesh-list
83756972|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
83756973|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83756974|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83756975|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83756976|NCT03969641|Vaccines|vaccines|mesh-list
82912155|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83756977|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
83756978|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756979|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
83756980|NCT00847210|Lansoprazole|lansoprazole|mesh-list
83756981|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83756982|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83756983|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83756984|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83756985|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756986|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
83756987|NCT00847171|Trastuzumab|trastuzumab|mesh-list
83756988|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83756989|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
83756990|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83756991|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83756992|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83756993|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
83756994|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83756995|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83756996|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83756997|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83756998|NCT03940586|Letermovir|letermovir|mesh-list
83756999|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83757000|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757001|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757002|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757003|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
83757004|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757005|NCT00847093|Lidocaine|lidocaine|mesh-list
83757006|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
83757007|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
83757008|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757009|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757010|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
83757011|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757012|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83757013|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83757014|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83757015|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83757016|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757017|NCT00847054|Antibodies|antibodies|mesh-list
83757018|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83757019|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
83757020|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757021|NCT00846976|Bicalutamide|bicalutamide|mesh-list
83757022|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
83757023|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
83757024|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757025|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757026|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757027|NCT00846859|Varenicline|varenicline|mesh-list
83757028|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83757029|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83757030|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
83757031|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757032|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757033|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757034|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
83757035|NCT03885830|Dasatinib|dasatinib|mesh-list
83757036|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757037|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83757038|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757039|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757040|NCT00846703|Dexamethasone|dexamethasone|mesh-list
83757041|NCT00846703|Methotrexate|methotrexate|mesh-list
83757042|NCT00846703|Vincristine|vincristine|mesh-list
83757043|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
83757044|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757045|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
83757046|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
83757047|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757048|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757049|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83757050|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
83757051|NCT00846703|Hormones|hormones|mesh-ancestor
82912228|NCT03573934|Glucagon|glucagon|mesh-list
82912229|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83757052|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757053|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83757054|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757055|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83757056|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
83757057|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83757058|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757059|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
83757060|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757061|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
83757062|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757063|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83757064|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757065|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
83757066|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757067|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83757068|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757069|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757070|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757071|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757073|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83757074|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757075|NCT00846625|Triamcinolone|triamcinolone|mesh-list
83757076|NCT00846625|Ranibizumab|ranibizumab|mesh-list
83757077|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83757078|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83757079|NCT00846625|Growth Substances|growth substances|mesh-ancestor
83757080|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757081|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
83757082|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757083|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757084|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
83757085|NCT00846625|Hormones|hormones|mesh-ancestor
83757086|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757087|NCT00846508|Cisplatin|cisplatin|mesh-list
83757088|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757089|NCT03721172|Apremilast|apremilast|mesh-list
83757090|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83757091|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83757092|NCT03721172|Analgesics|analgesics|mesh-ancestor
83757093|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
83757094|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757095|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757096|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757097|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757098|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83757099|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83757100|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757101|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757102|NCT00846274|Antithrombins|antithrombins|mesh-list
83757103|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
83757104|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83757105|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
83757106|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757107|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757108|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
83757109|NCT00846235|Glycerol|glycerol|mesh-list
83757110|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83757111|NCT00846235|Protective Agents|protective agents|mesh-ancestor
83757112|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757113|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
83757114|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
83757115|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83757116|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83757117|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757118|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83757119|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757120|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83757121|NCT00846118|Pitavastatin|pitavastatin|mesh-list
83757122|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83757123|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83757124|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83757125|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
83757126|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757127|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757128|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83757129|NCT00846079|Regadenoson|regadenoson|mesh-list
83757130|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83757131|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83757132|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
83757133|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
83757134|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757135|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757136|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757137|NCT00845962|Bupivacaine|bupivacaine|mesh-list
83757138|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
83757139|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
83757140|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
83757141|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757142|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757143|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
83757144|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757145|NCT03620942|Phenylephrine|phenylephrine|mesh-list
83757146|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
83757147|NCT03620942|Ephedrine|ephedrine|mesh-list
83757148|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83757149|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83757150|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
83757151|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
83757152|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757153|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757154|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
83757155|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
83757156|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
83757157|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83757158|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83757159|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83757160|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
83757161|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757162|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757163|NCT03620942|Protective Agents|protective agents|mesh-ancestor
83757164|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83757165|NCT00277108|Escitalopram|escitalopram|mesh-list
83757166|NCT00277108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83757167|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83757168|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83757169|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757170|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757171|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
83757172|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757173|NCT00277069|Carboplatin|carboplatin|mesh-list
83757174|NCT00277069|Capecitabine|capecitabine|mesh-list
83757175|NCT00277069|Vinorelbine|vinorelbine|mesh-list
83757176|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757177|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757178|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
83757179|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757180|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757181|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757182|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757183|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757184|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83757185|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
83757186|NCT00276991|Immunomodulating Agents|immunomodulating agents|mesh-list
83757187|NCT00276991|Immunologic Factors|immunologic factors|mesh-ancestor
83757188|NCT00276991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757189|NCT00276874|Aripiprazole|aripiprazole|mesh-list
83757190|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
83757191|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83757192|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83757193|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83757194|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757195|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757196|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
82912379|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82912388|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
83757197|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
83757198|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757199|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757200|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83757201|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83757202|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
83757203|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83757204|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83757205|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83757206|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83757207|NCT00276835|Aldesleukin|aldesleukin|mesh-list
83757208|NCT00276835|Interleukin-2|interleukin-2|mesh-list
83757209|NCT00276835|Genistein|genistein|mesh-list
83757210|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757211|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83757212|NCT00276835|Analgesics|analgesics|mesh-ancestor
83757213|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
83757214|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757215|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757216|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83757217|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83757218|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
83757219|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757220|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83757221|NCT00276835|Protective Agents|protective agents|mesh-ancestor
83757222|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83757223|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757224|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757225|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
83757226|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83757227|NCT00276835|Estrogens|estrogens|mesh-ancestor
83757228|NCT00276835|Hormones|hormones|mesh-ancestor
83757229|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757230|NCT00276796|Paclitaxel|paclitaxel|mesh-list
83757231|NCT00276796|Topotecan|topotecan|mesh-list
83757232|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757233|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757234|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757235|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757236|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757237|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757238|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83757239|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83757240|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757241|NCT00276757|Leucovorin|leucovorin|mesh-list
83757242|NCT00276757|Prednisolone|prednisolone|mesh-list
83757243|NCT00276757|Methotrexate|methotrexate|mesh-list
83757244|NCT00276757|Vinblastine|vinblastine|mesh-list
83757245|NCT00276757|Calcium|calcium|mesh-list
83757246|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
83757247|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83757248|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757249|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83757250|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
83757251|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83757252|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757253|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
83757254|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757255|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757256|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
83757257|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757258|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83757259|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757260|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
83757261|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757262|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83757263|NCT00276757|Antidotes|antidotes|mesh-ancestor
83757264|NCT00276757|Protective Agents|protective agents|mesh-ancestor
83757265|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
83757266|NCT00276757|Vitamins|vitamins|mesh-ancestor
83757267|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
83757268|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757269|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
83757270|NCT00276757|Hormones|hormones|mesh-ancestor
83757271|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757272|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912452|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757273|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757274|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757275|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757276|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757278|NCT00276718|Etoposide|etoposide|mesh-list
83757279|NCT00276718|Bleomycin|bleomycin|mesh-list
83757280|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757281|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757282|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83757283|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83757284|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757285|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757286|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83757287|NCT00276679|Temozolomide|temozolomide|mesh-list
83757288|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83757289|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
83757290|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757291|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757292|NCT00276601|Cytarabine|cytarabine|mesh-list
83757293|NCT00276601|Methotrexate|methotrexate|mesh-list
83757294|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
83757295|NCT00276601|Daunorubicin|daunorubicin|mesh-list
83757296|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
83757297|NCT00276601|Tretinoin|tretinoin|mesh-list
83757298|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83757299|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
83757300|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83757301|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757302|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757303|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
83757304|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757305|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757306|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
83757307|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757308|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83757309|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757310|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
83757311|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757312|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83757313|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
83757314|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757315|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83757316|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83757317|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83757318|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
83757319|NCT00276523|Interferons|interferons|mesh-list
83757320|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
83757321|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
83757322|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83757323|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757324|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
83757325|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757326|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
83757327|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757328|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
83757329|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83757330|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
83757331|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757332|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83757333|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83757334|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757335|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757336|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
83757337|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757338|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757339|NCT00389883|Anesthetics|anesthetics|mesh-list
83757340|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757341|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757342|NCT00389922|Vinorelbine|vinorelbine|mesh-list
83757343|NCT00389922|Lapatinib|lapatinib|mesh-list
83757344|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757345|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757346|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
82912534|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
83757347|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757348|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757349|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757350|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83757351|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757352|NCT00276289|Spironolactone|spironolactone|mesh-list
83757353|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83757354|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
83757355|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757356|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757357|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83757358|NCT00276289|Diuretics|diuretics|mesh-ancestor
83757359|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
83757360|NCT00276250|Abatacept|abatacept|mesh-list
83757361|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83757362|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757363|NCT00276250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757364|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757365|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757366|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
83757367|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757368|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757369|NCT00394186|Solabegron|solabegron|mesh-list
83757370|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83757371|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83757372|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83757373|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
83757374|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757375|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757376|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757377|NCT00276172|Natalizumab|natalizumab|mesh-list
83757378|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
83757379|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757380|NCT00276133|Atorvastatin|atorvastatin|mesh-list
83757381|NCT00276133|Probucol|probucol|mesh-list
83757382|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83757383|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83757384|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
83757385|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757386|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83757387|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83757388|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757389|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
83757390|NCT00276133|Protective Agents|protective agents|mesh-ancestor
83757391|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757392|NCT00276055|Bevacizumab|bevacizumab|mesh-list
83757393|NCT00276055|Gemcitabine|gemcitabine|mesh-list
83757394|NCT00276055|Docetaxel|docetaxel|mesh-list
83757395|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757396|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757397|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83757398|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83757399|NCT00276055|Growth Substances|growth substances|mesh-ancestor
83757400|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757401|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
83757402|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757403|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
83757404|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757405|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757406|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757407|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757408|NCT00275938|Interferons|interferons|mesh-list
83757409|NCT00275938|Ribavirin|ribavirin|mesh-list
83757410|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
83757411|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
83757412|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757413|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
83757414|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757415|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
83757416|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757417|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
83757418|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757419|NCT00275665|Valganciclovir|valganciclovir|mesh-list
83757420|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
83757421|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912604|NCT03708848|Expectorants|expectorants|mesh-ancestor
83757422|NCT00276640|Carboplatin|carboplatin|mesh-list
83757423|NCT00276640|Etoposide|etoposide|mesh-list
83757424|NCT00276640|Vincristine|vincristine|mesh-list
83757425|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757426|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757427|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83757428|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83757429|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757430|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757431|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757432|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757433|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757434|NCT00275548|Ribavirin|ribavirin|mesh-list
83757435|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83757436|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
83757437|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757438|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
83757439|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757440|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
83757441|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757442|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757443|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83757444|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
83757445|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83757446|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757447|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83757448|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83757449|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83757450|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
83757451|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757452|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
83757453|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757454|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757455|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83757456|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
83757457|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757458|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757459|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83757460|NCT05566054|Azacitidine|azacitidine|mesh-list
83757461|NCT05566054|Venetoclax|venetoclax|mesh-list
83757462|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757463|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
83757464|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757465|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757466|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757467|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83757468|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
83757469|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757470|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757471|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757472|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83757473|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83757474|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757475|NCT02979977|Cetuximab|cetuximab|mesh-list
83757476|NCT02979977|Afatinib|afatinib|mesh-list
83757477|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757478|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757479|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83757480|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757481|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757482|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83757483|NCT05424757|Laxatives|laxatives|mesh-ancestor
83757484|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83757485|NCT02921555|Prednisone|prednisone|mesh-list
83757486|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
83757487|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83757488|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83757489|NCT02921555|Prednisolone|prednisolone|mesh-list
83757490|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
83757491|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83757492|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
83757493|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757494|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
82912679|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
83757495|NCT02921555|Hormones|hormones|mesh-ancestor
83845098|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
83757496|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757497|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757498|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83757499|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757500|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
83757501|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
83757502|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757503|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83757504|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83757505|NCT02921555|Protective Agents|protective agents|mesh-ancestor
83757506|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
83757507|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757508|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757509|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83757510|NCT05070585|Protective Agents|protective agents|mesh-ancestor
83757511|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757512|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757513|NCT00387530|Valganciclovir|valganciclovir|mesh-list
83757514|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83757515|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
83757516|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757517|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757518|NCT02687906|Meropenem|meropenem|mesh-list
83757519|NCT02687906|Vaborbactam|vaborbactam|mesh-list
83757520|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83757521|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83757522|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757523|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757524|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757525|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
83757526|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757527|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757528|NCT02680184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83757529|NCT02680184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757530|NCT00390000|Pemetrexed|pemetrexed|mesh-list
83757531|NCT00390000|Vatalanib|vatalanib|mesh-list
83757532|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757533|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757534|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757535|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83757536|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83757537|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83757538|NCT04856176|Paclitaxel|paclitaxel|mesh-list
83757539|NCT04856176|Carboplatin|carboplatin|mesh-list
83757540|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
83757541|NCT04856176|Pemetrexed|pemetrexed|mesh-list
83757542|NCT04856176|Molgramostim|molgramostim|mesh-list
83757543|NCT04856176|Sargramostim|sargramostim|mesh-list
83757544|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757545|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757546|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757547|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757548|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757549|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757550|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757551|NCT04856176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83757552|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757553|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83757554|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83757555|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
83757556|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757557|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83757558|NCT02632760|Hematinics|hematinics|mesh-ancestor
83757559|NCT04732507|Lidocaine|lidocaine|mesh-list
83757560|NCT04732507|Bupivacaine|bupivacaine|mesh-list
83757561|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
83757562|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
83757563|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757564|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757565|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
83757566|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757567|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83757568|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82912753|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82912755|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
83757569|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83757570|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83757571|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757572|NCT05047770|Vaccines|vaccines|mesh-list
83757573|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
83757574|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757575|NCT02453984|Atezolizumab|atezolizumab|mesh-list
83757576|NCT02453984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83757577|NCT02453984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757578|NCT02453984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757579|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757580|NCT04599478|Naltrexone|naltrexone|mesh-list
83757581|NCT04599478|Bupropion|bupropion|mesh-list
83757582|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83757583|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83757584|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757585|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
83757586|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757587|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83757588|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
83757589|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83757590|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83757591|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83757592|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83757593|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757594|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
83757595|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757596|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83757597|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83757598|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757599|NCT04574245|Immunomodulating Agents|immunomodulating agents|mesh-list
83757600|NCT04574245|Immunologic Factors|immunologic factors|mesh-ancestor
83757601|NCT04574245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757602|NCT04556617|Prednisone|prednisone|mesh-list
83757603|NCT04556617|Olaparib|olaparib|mesh-list
83757604|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
83757605|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757606|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
83757607|NCT04556617|Hormones|hormones|mesh-ancestor
83757608|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757609|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757610|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83757611|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757612|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83757613|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757614|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757615|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83757616|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
83757617|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83757618|NCT04554862|Ketorolac|ketorolac|mesh-list
83757619|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83757620|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
83757621|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83757622|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83757623|NCT04554862|Analgesics|analgesics|mesh-ancestor
83757624|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
83757625|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757626|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757627|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757628|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757629|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83757630|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757631|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757632|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
83757633|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757634|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83757635|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
83757636|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83757637|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83757638|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83757639|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
83757640|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83757642|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757643|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757644|NCT02337686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83757645|NCT02337686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757646|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
83757647|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83757648|NCT04230499|Sirolimus|sirolimus|mesh-list
83757649|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83757650|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757651|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83757652|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757653|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
83757654|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757655|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
83757656|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757657|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
83757658|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83757659|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
83757660|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757661|NCT04712435|Expectorants|expectorants|mesh-ancestor
83757662|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83757663|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83757664|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
83757665|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757666|NCT04712435|Protective Agents|protective agents|mesh-ancestor
83757667|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757668|NCT04712435|Antidotes|antidotes|mesh-ancestor
83757669|NCT03977194|Paclitaxel|paclitaxel|mesh-list
83757670|NCT03977194|Carboplatin|carboplatin|mesh-list
83757671|NCT03977194|Atezolizumab|atezolizumab|mesh-list
83757672|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757673|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757674|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757675|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757676|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757677|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757678|NCT03977194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83757679|NCT03977194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83757680|NCT04729465|Propofol|propofol|mesh-list
83757681|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83757682|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757683|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757684|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83757685|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
83757686|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
83757687|NCT04712357|Tenofovir|tenofovir|mesh-list
83757688|NCT04712357|Emtricitabine|emtricitabine|mesh-list
83757689|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
83757690|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757691|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83757692|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83757693|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757694|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757695|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83757696|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83757697|NCT00390039|Morphine|morphine|mesh-list
83757698|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83757699|NCT00390039|Narcotics|narcotics|mesh-ancestor
82912905|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912906|NCT01147731|Warfarin|warfarin|mesh-list
82912907|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
82912908|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
82912909|NCT01147731|Incretins|incretins|mesh-ancestor
82912910|NCT01147731|Hormones|hormones|mesh-ancestor
82912911|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912912|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912913|NCT03912285|Losartan|losartan|mesh-list
82912914|NCT03912285|Amlodipine|amlodipine|mesh-list
82912915|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82912916|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82912917|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82912919|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83757700|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757701|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757702|NCT00390039|Analgesics|analgesics|mesh-ancestor
83757703|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
83757704|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757706|NCT02966665|Vitamin E|vitamin e|mesh-list
83757707|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
83757708|NCT02966665|Fexofenadine|fexofenadine|mesh-list
83757709|NCT02966665|Valsartan|valsartan|mesh-list
83757710|NCT02966665|Nitroprusside|nitroprusside|mesh-list
83757711|NCT02966665|Phentolamine|phentolamine|mesh-list
83757712|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83757713|NCT02966665|Norepinephrine|norepinephrine|mesh-list
83757714|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
83757715|NCT02966665|Giapreza|giapreza|mesh-list
83757716|NCT02966665|Acetylcholine|acetylcholine|mesh-list
83757717|NCT02966665|Ranitidine|ranitidine|mesh-list
83757718|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
83757719|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
83757720|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757721|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83757722|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83757723|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83757724|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757725|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
83757726|NCT02966665|Protective Agents|protective agents|mesh-ancestor
83757727|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83757728|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83757729|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
83757730|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757731|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
83757732|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
83757733|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757734|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83757735|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
83757736|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83757737|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83757738|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83757739|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
83757740|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
83757741|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83757742|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83757743|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83757744|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
83757745|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83757746|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83757747|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
83757748|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757749|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83757750|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
83757751|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83757752|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83757753|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83757754|NCT02832544|Vitamin K|vitamin k|mesh-list
83757755|NCT02832544|Warfarin|warfarin|mesh-list
83757756|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
83757757|NCT02832544|Vitamins|vitamins|mesh-ancestor
83757758|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
83757759|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757760|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
83757761|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83757762|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
82912957|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82912958|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
82912959|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912960|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912961|NCT01239849|Atorvastatin|atorvastatin|mesh-list
82912962|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82912963|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82912964|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
82912965|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912966|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82912967|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82912968|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912969|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
83757763|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83757764|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
83757765|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757766|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757767|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83757768|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83757769|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
83757770|NCT02832544|Coagulants|coagulants|mesh-ancestor
83757771|NCT00006044|Testosterone|testosterone|mesh-list
83757772|NCT00006044|Androgens|androgens|mesh-ancestor
83757773|NCT00006044|Hormones|hormones|mesh-ancestor
83757774|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757775|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757776|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
83757777|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
83757778|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83757779|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757780|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757781|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
83757782|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83757783|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83757784|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757785|NCT02395705|Paclitaxel|paclitaxel|mesh-list
83757786|NCT02395705|Cisplatin|cisplatin|mesh-list
83757787|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757788|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757789|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757790|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757791|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757792|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757793|NCT00006047|Etoposide|etoposide|mesh-list
83757794|NCT00006047|Rubitecan|rubitecan|mesh-list
83757795|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
83757796|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757797|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757798|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83757799|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83757800|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757801|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757802|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83757803|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
83757804|NCT00083824|Estrogens|estrogens|mesh-list
83757805|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83757806|NCT00083824|Hormones|hormones|mesh-ancestor
83757807|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757808|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757809|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83757810|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83757811|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83757812|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
83757813|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83757814|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83757815|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83757816|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83757817|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83757818|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757819|NCT00083902|Thalidomide|thalidomide|mesh-list
83757820|NCT00083902|Dexamethasone|dexamethasone|mesh-list
83757821|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757822|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
83757823|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
83757824|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757825|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757826|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83757827|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
83757828|NCT00083902|Hormones|hormones|mesh-ancestor
83757829|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83757830|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83757831|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757832|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757833|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
83757834|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
83757835|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83757836|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757837|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83757838|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83757839|NCT00083902|Growth Substances|growth substances|mesh-ancestor
83757840|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
83757841|NCT00006050|Leucovorin|leucovorin|mesh-list
82913022|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
83757842|NCT00006050|Fluorouracil|fluorouracil|mesh-list
83757843|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
83757844|NCT00006050|Calcium|calcium|mesh-list
83757845|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
83757846|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83757847|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757848|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
83757849|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757850|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757851|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757852|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757853|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
83757854|NCT00006050|Antidotes|antidotes|mesh-ancestor
83757855|NCT00006050|Protective Agents|protective agents|mesh-ancestor
83757856|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
83757857|NCT00006050|Vitamins|vitamins|mesh-ancestor
83757858|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
83757859|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83757860|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83757861|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83757862|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83757863|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757864|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83757865|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757866|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83757867|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
83757868|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83757869|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
83757870|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83757871|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
83757872|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757873|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
83757874|NCT04893174|Protective Agents|protective agents|mesh-ancestor
83757875|NCT00084019|Ritonavir|ritonavir|mesh-list
83757876|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83757877|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83757878|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83757879|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
83757880|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757881|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757882|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83757883|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83757884|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
83757885|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757886|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83757887|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83757888|NCT00084058|Ritonavir|ritonavir|mesh-list
83757889|NCT00084058|Lopinavir|lopinavir|mesh-list
83757890|NCT00084058|Saquinavir|saquinavir|mesh-list
83757891|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83757892|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83757893|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
83757894|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757895|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757896|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83757897|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83757898|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
83757899|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757900|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83757901|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83757902|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
83757903|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757904|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83757905|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757906|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757907|NCT00084097|Omalizumab|omalizumab|mesh-list
83757908|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83757909|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83757910|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
83757911|NCT00084214|Paclitaxel|paclitaxel|mesh-list
83757912|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757913|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757914|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757915|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757916|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757917|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757918|NCT00006056|Cyclosporine|cyclosporine|mesh-list
83757919|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
83757920|NCT00006056|Busulfan|busulfan|mesh-list
83757921|NCT00006056|Methotrexate|methotrexate|mesh-list
83757922|NCT00006056|Etoposide|etoposide|mesh-list
83757923|NCT00006056|Cyclosporins|cyclosporins|mesh-list
83757924|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83757925|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83757926|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
83757927|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757928|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757929|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83757930|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
83757931|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757932|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757933|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83757934|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83757935|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
83757936|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83757937|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83757938|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
83757939|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83757940|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757941|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83757942|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83757943|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757944|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83757945|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83757946|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
83757947|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83757948|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83757949|NCT00084370|Celecoxib|celecoxib|mesh-list
83757950|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83757951|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83757952|NCT00084370|Analgesics|analgesics|mesh-ancestor
83757953|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
83757954|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757955|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757956|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757957|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757958|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83757959|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83757960|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757961|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757962|NCT00084448|Celecoxib|celecoxib|mesh-list
83757963|NCT00084448|Paclitaxel|paclitaxel|mesh-list
83757964|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757965|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757966|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757967|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757968|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757969|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757970|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83757971|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83757972|NCT00084448|Analgesics|analgesics|mesh-ancestor
83757973|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
83757974|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83757975|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83757976|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83757977|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83757978|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83757979|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83757980|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757981|NCT00084565|Paclitaxel|paclitaxel|mesh-list
83757982|NCT00084565|Topotecan|topotecan|mesh-list
83757983|NCT00084565|Estramustine|estramustine|mesh-list
83757984|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83757985|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83757986|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
83757987|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
83757988|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
83757989|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83757990|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83757991|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83757992|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83757993|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83757994|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
83757995|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83757997|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83757998|NCT00084604|Irinotecan|irinotecan|mesh-list
83757999|NCT00084604|Antibodies|antibodies|mesh-list
83758000|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
83758001|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83758002|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758003|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758004|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758005|NCT00084604|Growth Substances|growth substances|mesh-ancestor
83758006|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758007|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758008|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
83758009|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83758010|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758011|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758012|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758013|NCT00084643|Capecitabine|capecitabine|mesh-list
83758014|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
83758015|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758016|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
83758017|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758018|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758019|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
83758020|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758021|NCT00084721|Celecoxib|celecoxib|mesh-list
83758022|NCT00084721|Irinotecan|irinotecan|mesh-list
83758023|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83758024|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758025|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758026|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758027|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758028|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83758029|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83758030|NCT00084721|Analgesics|analgesics|mesh-ancestor
83758031|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
83758032|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758033|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758034|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83758035|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758036|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83758037|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83758038|NCT00084877|Irinotecan|irinotecan|mesh-list
83758039|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83758040|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758041|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758042|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758043|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758044|NCT00084916|Sirolimus|sirolimus|mesh-list
83758045|NCT00084916|Temsirolimus|temsirolimus|mesh-list
83758046|NCT00084916|MTOR Inhibitors|mtor inhibitors|mesh-list
83758047|NCT00084916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758048|NCT00084916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758049|NCT00084916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758050|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758051|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
83758052|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758053|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758054|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758055|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758056|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758057|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
83758058|NCT00085111|Bevacizumab|bevacizumab|mesh-list
83758059|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83758060|NCT00085111|Antibodies|antibodies|mesh-list
83758061|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
83758062|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83758063|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758064|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758065|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758066|NCT00085111|Growth Substances|growth substances|mesh-ancestor
83758067|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758068|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758069|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
83758070|NCT00085150|Immunotoxins|immunotoxins|mesh-list
83758071|NCT00085150|Immunoconjugates|immunoconjugates|mesh-ancestor
83758072|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
83758073|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758074|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
83758075|NCT00400075|Azathioprine|azathioprine|mesh-list
83758076|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758077|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
83758078|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758079|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758080|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758081|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
83758082|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758083|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758084|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83758085|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
83758086|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758087|NCT00400114|Irinotecan|irinotecan|mesh-list
83758088|NCT00400114|Sunitinib|sunitinib|mesh-list
83758089|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758090|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83758091|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758092|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758093|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758094|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758095|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758096|NCT00400114|Growth Substances|growth substances|mesh-ancestor
83758097|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758098|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758099|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758100|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83758101|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
83758102|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83758103|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
83758104|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758105|NCT00085228|Docetaxel|docetaxel|mesh-list
83758106|NCT00085228|Oblimersen|oblimersen|mesh-list
83758107|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758108|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758109|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758110|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758111|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758112|NCT00085306|Interferons|interferons|mesh-list
83758113|NCT00085306|Interferon-beta|interferon-beta|mesh-list
83758114|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758115|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
83758116|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758117|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
83758118|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758119|NCT00006077|Levodopa|levodopa|mesh-list
83758120|NCT00006077|Domperidone|domperidone|mesh-list
83758121|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83758122|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83758123|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
83758124|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758125|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758126|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758127|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
83758128|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
83758129|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758130|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83758131|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83758132|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
83758133|NCT04729348|Lenvatinib|lenvatinib|mesh-list
83758134|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758135|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758136|NCT04729348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83758137|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758138|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758139|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758140|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
83758141|NCT00085345|Melphalan|melphalan|mesh-list
83758142|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
83758143|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758144|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
83758145|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758146|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758147|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83758148|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758149|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
83758150|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758151|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
83758152|NCT00085345|Protective Agents|protective agents|mesh-ancestor
83758154|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
83758155|NCT00085384|Interferons|interferons|mesh-list
83758156|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
83758157|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
83758158|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83758159|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758160|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
83758161|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758162|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
83758163|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758164|NCT00006080|Fenretinide|fenretinide|mesh-list
83758165|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758166|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83758167|NCT00006080|Protective Agents|protective agents|mesh-ancestor
83758168|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758169|NCT00085462|Aldesleukin|aldesleukin|mesh-list
83758170|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
83758171|NCT00085462|Fludarabine|fludarabine|mesh-list
83758172|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
83758173|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758174|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
83758175|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758176|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758177|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758178|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
83758179|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758180|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758181|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83758182|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758183|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
83758184|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83758185|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83758186|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
83758187|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758188|NCT00085501|Paclitaxel|paclitaxel|mesh-list
83758189|NCT00085501|Carboplatin|carboplatin|mesh-list
83758190|NCT00085501|Cetuximab|cetuximab|mesh-list
83758191|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83758192|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758193|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758194|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758195|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758196|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758197|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758198|NCT00006083|Dalteparin|dalteparin|mesh-list
83758199|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
83758200|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83758201|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83758202|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758203|NCT00085579|Aldesleukin|aldesleukin|mesh-list
83758204|NCT00085579|Sargramostim|sargramostim|mesh-list
83758205|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
83758206|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758207|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758208|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83758209|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83758210|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
83758211|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758212|NCT00085696|Rituximab|rituximab|mesh-list
83758213|NCT00085696|Bortezomib|bortezomib|mesh-list
83758214|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758215|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758216|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
83758217|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758218|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758219|NCT00006086|Carboplatin|carboplatin|mesh-list
82913392|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83758220|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758221|NCT04798638|Osimertinib|osimertinib|mesh-list
83758222|NCT04798638|Complement Factor H|complement factor h|mesh-list
83758223|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758224|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758225|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758226|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758227|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83758228|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758229|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
83758230|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758231|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83758232|NCT00006089|Trastuzumab|trastuzumab|mesh-list
83758233|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83758235|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
83758236|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83758237|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
83758238|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758239|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758240|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83758241|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
83758242|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758243|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83758244|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758245|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758246|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758247|NCT00085969|Exenatide|exenatide|mesh-list
83758248|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83758249|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758250|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83758251|NCT00085969|Incretins|incretins|mesh-ancestor
83758252|NCT00085969|Hormones|hormones|mesh-ancestor
83758253|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83758254|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
83758255|NCT00086086|Hematinics|hematinics|mesh-ancestor
83758256|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
83758257|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758258|NCT00086125|Sirolimus|sirolimus|mesh-list
83758259|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758260|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758261|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758262|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758263|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
83758264|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758265|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
83758266|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758267|NCT00086203|Rituximab|rituximab|mesh-list
83758268|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758269|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758270|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
83758271|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758272|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758273|NCT00006095|Irinotecan|irinotecan|mesh-list
83758274|NCT00006095|Vincristine|vincristine|mesh-list
83758275|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83758276|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758277|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758278|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758279|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758280|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83758281|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758282|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758283|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758284|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83758285|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83758286|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758287|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758288|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758289|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758290|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83758291|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83758292|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
83758293|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913467|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83758294|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758295|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83758296|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83758297|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
83758299|NCT00086359|Lopinavir|lopinavir|mesh-list
83758300|NCT00086359|Lamivudine|lamivudine|mesh-list
83758301|NCT00086359|Zidovudine|zidovudine|mesh-list
83758302|NCT00086359|Abacavir|abacavir|mesh-list
83758303|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83758304|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83758305|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83758306|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
83758307|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758308|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758309|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83758310|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83758311|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
83758312|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758313|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83758314|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83758315|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83758316|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83758317|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
83758318|NCT00006098|Bortezomib|bortezomib|mesh-list
83758319|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758320|NCT00086593|Lamotrigine|lamotrigine|mesh-list
83758321|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
83758322|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83758323|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83758324|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758325|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83758326|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758327|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83758328|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758329|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758330|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758331|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83758332|NCT00387569|Vaccines|vaccines|mesh-list
83758333|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
83758334|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758335|NCT04784637|Insulin|insulin|mesh-list
83758336|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83758337|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758338|NCT00086632|Oregovomab|oregovomab|mesh-list
83758339|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758340|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758341|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
83758342|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83758343|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83758344|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758345|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83758346|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83758347|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
83758348|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758349|NCT00006104|Docetaxel|docetaxel|mesh-list
83758350|NCT00006104|Trastuzumab|trastuzumab|mesh-list
83758351|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758352|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758353|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758354|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758355|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758356|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758357|NCT00086827|Romidepsin|romidepsin|mesh-list
83758358|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758359|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758360|NCT00086827|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83758361|NCT00086827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133229|NCT02250859|Minocycline|minocycline|mesh-list
83758362|NCT00086827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758363|NCT00086944|Rituximab|rituximab|mesh-list
83758364|NCT00086944|Carboplatin|carboplatin|mesh-list
83758365|NCT00086944|Etoposide|etoposide|mesh-list
83758366|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
83758367|NCT00086944|Ifosfamide|ifosfamide|mesh-list
83758368|NCT00086944|Oblimersen|oblimersen|mesh-list
83758369|NCT00086944|Lenograstim|lenograstim|mesh-list
83758370|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758371|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758372|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
83758373|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758374|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758375|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83758376|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83758377|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758378|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758379|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758380|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83758381|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758382|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
83758383|NCT00006107|Docetaxel|docetaxel|mesh-list
83758384|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758385|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758386|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758387|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758388|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758389|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
83758390|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758391|NCT00087100|Pemetrexed|pemetrexed|mesh-list
83758392|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758393|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758394|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758395|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83758396|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83758397|NCT00006113|Interferons|interferons|mesh-list
83758398|NCT00006113|Aldesleukin|aldesleukin|mesh-list
83758399|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
83758400|NCT00006113|Interleukin-4|interleukin-4|mesh-list
83758401|NCT00006113|Sargramostim|sargramostim|mesh-list
83758402|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758403|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
83758404|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758405|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
83758406|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758407|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83758408|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83758409|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83758410|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758411|NCT00087217|Paclitaxel|paclitaxel|mesh-list
83758412|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83758413|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758414|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758415|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758416|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758417|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758418|NCT00087256|Celecoxib|celecoxib|mesh-list
83758419|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83758420|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83758421|NCT00087256|Analgesics|analgesics|mesh-ancestor
83758422|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
83758423|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758424|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758425|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83758426|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758427|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83758428|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83758429|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758430|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758431|NCT00006116|Gemcitabine|gemcitabine|mesh-list
83758432|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758433|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758434|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
83758435|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758436|NCT00087295|Romidepsin|romidepsin|mesh-list
83758437|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758438|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758439|NCT00087295|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83758440|NCT00087295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758441|NCT00087295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758442|NCT04762953|Leucovorin|leucovorin|mesh-list
83758443|NCT04762953|Paclitaxel|paclitaxel|mesh-list
83758444|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82913618|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83758445|NCT04762953|Fluorouracil|fluorouracil|mesh-list
82913619|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83758446|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83758447|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758448|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758449|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758450|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758451|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758452|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
83758453|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758454|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758455|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
83758456|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758457|NCT04762953|Antidotes|antidotes|mesh-ancestor
83758458|NCT04762953|Protective Agents|protective agents|mesh-ancestor
83758459|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
83758460|NCT04762953|Vitamins|vitamins|mesh-ancestor
83758461|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
83758462|NCT00087334|Capecitabine|capecitabine|mesh-list
83758463|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
83758464|NCT00087334|Gefitinib|gefitinib|mesh-list
83758465|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758466|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
83758467|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758468|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758469|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758470|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758471|NCT00087373|Metronidazole|metronidazole|mesh-list
83758472|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758473|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758474|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83758475|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83758476|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
83758477|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758478|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
83758479|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758480|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758481|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83758482|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83758483|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758484|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758485|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758486|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758487|NCT00390078|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83758488|NCT00390078|Antiviral Agents|antiviral agents|mesh-ancestor
83758489|NCT00390078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758490|NCT00006122|Cytarabine|cytarabine|mesh-list
83758491|NCT00006122|Etoposide|etoposide|mesh-list
83758492|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
83758493|NCT00006122|Idarubicin|idarubicin|mesh-list
83758494|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
83758495|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83758496|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758497|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83758498|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758499|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758500|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758501|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758502|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
83758503|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
83758504|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758505|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758506|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
83758507|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758508|NCT00006122|Analgesics|analgesics|mesh-ancestor
83758509|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
83758510|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758511|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758512|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758513|NCT00006122|Immunotoxins|immunotoxins|mesh-ancestor
83758514|NCT00006122|Immunoconjugates|immunoconjugates|mesh-ancestor
83758515|NCT00087802|Paclitaxel|paclitaxel|mesh-list
83758516|NCT00087802|Carboplatin|carboplatin|mesh-list
83758517|NCT00087802|Gemcitabine|gemcitabine|mesh-list
83758518|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
83758519|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82913695|NCT05220410|Psilocybin|psilocybin|mesh-list
83758520|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758521|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758522|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758523|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758524|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758525|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758526|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
83758527|NCT04760613|Cannabidiol|cannabidiol|mesh-list
83758528|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
83758529|NCT00006125|Doxorubicin|doxorubicin|mesh-list
83758530|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83758531|NCT00006125|Topotecan|topotecan|mesh-list
83758532|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758533|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758534|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83758535|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758536|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758537|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758538|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83758539|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83758540|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758541|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758542|NCT00087880|Bupropion|bupropion|mesh-list
83758543|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83758544|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
83758545|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758546|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83758547|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83758548|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83758549|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758550|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
83758551|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758552|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758553|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83758554|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83758555|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758556|NCT00088036|Olanzapine|olanzapine|mesh-list
83758557|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
83758558|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
83758559|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758560|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758561|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83758562|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83758563|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758564|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758565|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758566|NCT00088036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83758567|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83758568|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83758569|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758570|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758571|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
83758572|NCT00088075|Risperidone|risperidone|mesh-list
83758573|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83758574|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
83758575|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758576|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758577|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758578|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83758579|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758580|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758581|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758582|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83758583|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
83758584|NCT00088114|Paclitaxel|paclitaxel|mesh-list
83758585|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83758586|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758587|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758588|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758589|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758590|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758591|NCT00006131|Valacyclovir|valacyclovir|mesh-list
83758592|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
83758593|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758594|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
83758595|NCT00088231|Vatalanib|vatalanib|mesh-list
83758596|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758597|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758598|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758599|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758600|NCT00088270|Leucovorin|leucovorin|mesh-list
83758601|NCT00088270|Fluorouracil|fluorouracil|mesh-list
83758602|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
83758603|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758604|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758605|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758606|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758607|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
83758608|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758609|NCT00088270|Antidotes|antidotes|mesh-ancestor
83758610|NCT00088270|Protective Agents|protective agents|mesh-ancestor
83758611|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
83758612|NCT00088270|Vitamins|vitamins|mesh-ancestor
83758613|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
83758614|NCT00088387|Valproic Acid|valproic acid|mesh-list
83758615|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758616|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758617|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758618|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
83758619|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758620|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758621|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758622|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
83758623|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
83758624|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758625|NCT00088504|Interferons|interferons|mesh-list
83758626|NCT00088504|Ribavirin|ribavirin|mesh-list
83758627|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
83758628|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
83758629|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83758630|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758631|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
83758632|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758633|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
83758634|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758635|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
83758636|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758637|NCT00006137|Enalapril|enalapril|mesh-list
83758638|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83758639|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
83758640|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758641|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758642|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83758643|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
83758644|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83758645|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
83758646|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758647|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758648|NCT00088582|Octreotide|octreotide|mesh-list
83758649|NCT00088582|Pasireotide|pasireotide|mesh-list
83758650|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83758651|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83758652|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758653|NCT00088582|Hormones|hormones|mesh-ancestor
83758654|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83758655|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758656|NCT00088816|Tegafur|tegafur|mesh-list
83758657|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758658|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758659|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
83758660|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758661|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
83758662|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
83758663|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83758664|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83758665|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
83758666|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
83758667|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758668|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913841|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
83758669|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758670|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83758671|NCT00088855|Doxorubicin|doxorubicin|mesh-list
83758672|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83758673|NCT00088855|Bortezomib|bortezomib|mesh-list
83758674|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758675|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758676|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83758677|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83758678|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758679|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758680|NCT00088894|Bevacizumab|bevacizumab|mesh-list
83758681|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83758682|NCT00088894|Gemcitabine|gemcitabine|mesh-list
83758683|NCT00088894|Antibodies|antibodies|mesh-list
83758684|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
83758685|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83758686|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758687|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758688|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758689|NCT00088894|Growth Substances|growth substances|mesh-ancestor
83758690|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758691|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758692|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
83758693|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758694|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
83758695|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758696|NCT00006152|Ritonavir|ritonavir|mesh-list
83758697|NCT00006152|Amprenavir|amprenavir|mesh-list
83758698|NCT00006152|Abacavir|abacavir|mesh-list
83758699|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83758700|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83758701|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
83758702|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758703|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758704|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83758705|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83758706|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
83758707|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758708|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83758709|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83758710|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83758711|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83758712|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83758713|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
83758714|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758715|NCT00088933|Metronidazole|metronidazole|mesh-list
83758716|NCT00088933|Docetaxel|docetaxel|mesh-list
83758717|NCT00088933|Vaccines|vaccines|mesh-list
83758718|NCT00088933|Sargramostim|sargramostim|mesh-list
83758719|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
83758720|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758721|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758722|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
83758723|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
83758724|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
83758725|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758726|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758727|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758728|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83758729|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83758730|NCT00089050|Cyclosporine|cyclosporine|mesh-list
83758731|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
83758732|NCT00089050|Cyclosporins|cyclosporins|mesh-list
83758733|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758734|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758735|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758736|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
83758737|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758738|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
83758739|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758740|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
83758741|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758742|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83758743|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758744|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758745|NCT00089050|Immunotoxins|immunotoxins|mesh-ancestor
83758746|NCT00089050|Immunoconjugates|immunoconjugates|mesh-ancestor
82913917|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
83758747|NCT00006155|Carboplatin|carboplatin|mesh-list
83758748|NCT00006155|Semaxinib|semaxinib|mesh-list
83758749|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758750|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758751|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758752|NCT00006155|Growth Substances|growth substances|mesh-ancestor
83758753|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758754|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758755|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758756|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758757|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758758|NCT00089089|Decitabine|decitabine|mesh-list
83758759|NCT00089089|Azacitidine|azacitidine|mesh-list
83758760|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758761|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
83758762|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758763|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758764|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758765|NCT00089167|Thalidomide|thalidomide|mesh-list
83758766|NCT00089167|Dexamethasone|dexamethasone|mesh-list
83758767|NCT00089167|Melphalan|melphalan|mesh-list
83758768|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83758769|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
83758770|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
83758771|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758772|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758773|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83758774|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
83758775|NCT00089167|Hormones|hormones|mesh-ancestor
83758776|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83758777|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83758778|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758779|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
83758780|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758781|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
83758782|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758783|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83758784|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758785|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
83758786|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758787|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758788|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758789|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758790|NCT00089167|Growth Substances|growth substances|mesh-ancestor
83758791|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758792|NCT00089206|Sargramostim|sargramostim|mesh-list
83758793|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
83758794|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
83758795|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758796|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83758797|NCT00400231|Metformin|metformin|mesh-list
83758798|NCT00400231|Fenofibrate|fenofibrate|mesh-list
83758799|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83758800|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758801|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83758802|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
83758803|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758804|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83758805|NCT00006158|Testosterone|testosterone|mesh-list
83758806|NCT00006158|Androgens|androgens|mesh-ancestor
83758807|NCT00006158|Hormones|hormones|mesh-ancestor
83758808|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83758809|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758810|NCT00423826|Cytarabine|cytarabine|mesh-list
83758811|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
83758812|NCT00423826|Fludarabine|fludarabine|mesh-list
83758813|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
83758814|NCT00423826|Busulfan|busulfan|mesh-list
83758815|NCT00423826|Tacrolimus|tacrolimus|mesh-list
83758816|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758817|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758818|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
83758819|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913992|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
83758820|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758821|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
82913998|NCT01261689|Narcotics|narcotics|mesh-ancestor
83758822|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758823|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
83758824|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758825|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83758826|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758827|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758828|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83758829|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
83758830|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758831|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
83758832|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758833|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83758835|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758836|NCT00423865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83758837|NCT00423865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83758838|NCT00423865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758839|NCT00423865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758840|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758841|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
83758842|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758843|NCT00423982|Vancomycin|vancomycin|mesh-list
83758844|NCT00423982|Rifampin|rifampin|mesh-list
83758845|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83758846|NCT00423982|Cloxacillin|cloxacillin|mesh-list
83758847|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
83758848|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83758849|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
83758850|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
83758851|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83758852|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758853|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758854|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83758855|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83758856|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83758857|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83758858|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83758859|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83758860|NCT02965261|Fluoxetine|fluoxetine|mesh-list
83758861|NCT02965261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83758862|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83758863|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83758864|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758865|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758866|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
83758867|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758868|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83758869|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
83758870|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758871|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83758872|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83758873|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758874|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
83758875|NCT00390156|Bevacizumab|bevacizumab|mesh-list
83758876|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
83758877|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758878|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
83758879|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758880|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83758881|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758882|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
83758883|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758884|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758885|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83758886|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758887|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758888|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758889|NCT00390156|Growth Substances|growth substances|mesh-ancestor
83758890|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758891|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914067|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914068|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758892|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83758893|NCT00089401|Melphalan|melphalan|mesh-list
83758894|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83758895|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
83758896|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758897|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758898|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83758899|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758900|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
83758901|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758902|NCT00089440|Aripiprazole|aripiprazole|mesh-list
83758903|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
83758904|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758905|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83758906|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758907|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758908|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758909|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
83758910|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
83758911|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758912|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758913|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83758914|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83758915|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
83758916|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83758917|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83758918|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83758919|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83758920|NCT00089518|Valsartan|valsartan|mesh-list
83758921|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83758922|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83758923|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83758924|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758925|NCT00089557|Capsaicin|capsaicin|mesh-list
83758926|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
83758927|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
83758928|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
83758929|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758930|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758931|NCT00087451|Sirolimus|sirolimus|mesh-list
83758932|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758933|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758934|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83758935|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758936|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
83758937|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758938|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
83758939|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758940|NCT00089830|Squalamine|squalamine|mesh-list
83758941|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83758942|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83758943|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83758944|NCT00089830|Protective Agents|protective agents|mesh-ancestor
83758945|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758946|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758947|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83758948|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83758949|NCT00089830|Growth Substances|growth substances|mesh-ancestor
83758950|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
83758951|NCT00089869|Olanzapine|olanzapine|mesh-list
83758952|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83758953|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
83758954|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
83758955|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83758956|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758957|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83758958|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83758959|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83758960|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83758961|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83758962|NCT00089869|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83758963|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83758964|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83758965|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758966|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83758967|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
83758968|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83758969|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
83758970|NCT00006167|Oxandrolone|oxandrolone|mesh-list
83758971|NCT00006167|Androgens|androgens|mesh-ancestor
83758972|NCT00006167|Hormones|hormones|mesh-ancestor
83758973|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83758974|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758975|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
83758976|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
83758977|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83758978|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
83758979|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758980|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758981|NCT00090025|Leucovorin|leucovorin|mesh-list
83758982|NCT00090025|Fluorouracil|fluorouracil|mesh-list
83758983|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
83758984|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83758985|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83758986|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758987|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83758988|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
83758989|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83758990|NCT00090025|Antidotes|antidotes|mesh-ancestor
83758991|NCT00090025|Protective Agents|protective agents|mesh-ancestor
83758992|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
83758993|NCT00090025|Vitamins|vitamins|mesh-ancestor
83758994|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
83758995|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
83758996|NCT04633902|Olaparib|olaparib|mesh-list
83758997|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83758998|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83758999|NCT04633902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83759000|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759001|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83759002|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759003|NCT00090727|AQ4N|aq4n|mesh-list
83759004|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759005|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
83759006|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83759007|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759008|NCT00091039|Metronidazole|metronidazole|mesh-list
83759009|NCT00091039|Paclitaxel|paclitaxel|mesh-list
83759010|NCT00091039|Carboplatin|carboplatin|mesh-list
83759011|NCT00091039|Vaccines|vaccines|mesh-list
83759012|NCT00091039|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
83759013|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
83759014|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759015|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759016|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759017|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759018|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759019|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759020|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759021|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759022|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759023|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83759024|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83759025|NCT00091039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83759026|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
83759027|NCT00091078|Oblimersen|oblimersen|mesh-list
83759028|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759029|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759030|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759031|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759032|NCT00091117|Bortezomib|bortezomib|mesh-list
83759033|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759034|NCT00091156|Gefitinib|gefitinib|mesh-list
83759035|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759036|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759037|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759038|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759039|NCT00091195|Romidepsin|romidepsin|mesh-list
83759040|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83759041|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759042|NCT00091195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83759043|NCT00091195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759044|NCT00091195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759045|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
83759046|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83759047|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759048|NCT00091234|Immunotoxins|immunotoxins|mesh-ancestor
83759049|NCT00091234|Immunoconjugates|immunoconjugates|mesh-ancestor
83759050|NCT00091234|Immunologic Factors|immunologic factors|mesh-ancestor
83759051|NCT00091234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759052|NCT00091312|Leucovorin|leucovorin|mesh-list
83759053|NCT00091312|Fluorouracil|fluorouracil|mesh-list
83759054|NCT00091312|Irinotecan|irinotecan|mesh-list
83759055|NCT00091312|Calcium|calcium|mesh-list
83759056|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
83759057|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83759058|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759059|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
83759060|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759061|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759062|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759063|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759064|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
83759065|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83759066|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83759067|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759068|NCT00091312|Antidotes|antidotes|mesh-ancestor
83759069|NCT00091312|Protective Agents|protective agents|mesh-ancestor
83759070|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
83759071|NCT00091312|Vitamins|vitamins|mesh-ancestor
83759072|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
83759073|NCT04619706|Palmidrol|palmidrol|mesh-list
83759074|NCT04619706|Analgesics|analgesics|mesh-ancestor
83759075|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
83759076|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759077|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759078|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83759079|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83759080|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83759081|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759082|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
83759083|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759084|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83759085|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83759086|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759087|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759088|NCT04619706|Hormones|hormones|mesh-ancestor
83759089|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83759090|NCT00091429|Ranolazine|ranolazine|mesh-list
83759091|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83759092|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83759093|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759094|NCT00091468|Nicotine|nicotine|mesh-list
83759095|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83759096|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
83759097|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759098|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759099|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83759100|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83759101|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
83759102|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759103|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759104|NCT00006200|Thalidomide|thalidomide|mesh-list
83759105|NCT00006200|Dacarbazine|dacarbazine|mesh-list
83759106|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759107|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
83759108|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759109|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
83759110|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759111|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759112|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83759113|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83759114|NCT00006200|Growth Substances|growth substances|mesh-ancestor
83759115|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759116|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759117|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83759118|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
83845099|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83759119|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759120|NCT00006203|Naltrexone|naltrexone|mesh-list
83759121|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83759122|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83759123|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759124|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
83759125|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759126|NCT00091624|Lenalidomide|lenalidomide|mesh-list
83759127|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
83759128|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759129|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83759130|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83759131|NCT00091624|Growth Substances|growth substances|mesh-ancestor
83759132|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759133|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759134|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83759135|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759136|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759137|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759138|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759139|NCT00006206|Naltrexone|naltrexone|mesh-list
83759140|NCT00006206|Acamprosate|acamprosate|mesh-list
83759141|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83759142|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83759143|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759144|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
83759145|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759146|NCT00091702|Vaccines|vaccines|mesh-list
83759147|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
83759148|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759149|NCT00091741|Etanercept|etanercept|mesh-list
83759150|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83759151|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83759152|NCT00091741|Analgesics|analgesics|mesh-ancestor
83759153|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
83759154|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759155|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759156|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83759157|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759158|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759159|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759160|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
83759161|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
83759162|NCT00091858|Hematinics|hematinics|mesh-ancestor
83759163|NCT00390195|Everolimus|everolimus|mesh-list
83759164|NCT00390195|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83759165|NCT00390195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759166|NCT00390195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759167|NCT00390195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759168|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759169|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
83759170|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759171|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759172|NCT00091897|Rituximab|rituximab|mesh-list
83759173|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83759174|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759175|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
83759176|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759177|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759178|NCT00006212|Vinblastine|vinblastine|mesh-list
83759179|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759180|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759181|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759182|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759183|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759184|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759185|NCT00091936|Lamivudine|lamivudine|mesh-list
83759186|NCT00091936|Efavirenz|efavirenz|mesh-list
83759187|NCT00091936|Didanosine|didanosine|mesh-list
83759188|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83759189|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83759190|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759191|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914366|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759192|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
83759193|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759194|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83759195|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83759196|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83759197|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83759198|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83759199|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83759200|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83759201|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83759202|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
83759203|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83759204|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83759205|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
83759206|NCT02972346|Hormones|hormones|mesh-ancestor
83759207|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83759208|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759209|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759210|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759211|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
83759212|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
83759213|NCT00092170|Ertapenem|ertapenem|mesh-list
83759214|NCT00092170|Ticarcillin|ticarcillin|mesh-list
83759215|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83759216|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759217|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759218|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759219|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759220|NCT00006215|Docetaxel|docetaxel|mesh-list
83759221|NCT00006215|Vinorelbine|vinorelbine|mesh-list
83759222|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759223|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759224|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759225|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759226|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759227|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759228|NCT00092287|Lanreotide|lanreotide|mesh-list
83759229|NCT00092287|Octreotide|octreotide|mesh-list
83759230|NCT00092287|Somatostatin|somatostatin|mesh-list
83759231|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759232|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759233|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83759234|NCT00092287|Hormones|hormones|mesh-ancestor
83759235|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83759236|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759237|NCT00092326|Acetaminophen|acetaminophen|mesh-list
83759238|NCT00092326|Rofecoxib|rofecoxib|mesh-list
83759239|NCT00092326|Oxycodone|oxycodone|mesh-list
83759240|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83759241|NCT00092326|Analgesics|analgesics|mesh-ancestor
83759242|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
83759243|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759244|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759245|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
83759246|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83759247|NCT00092326|Narcotics|narcotics|mesh-ancestor
83759248|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759249|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83759250|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83759251|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759252|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759253|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83759254|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83759255|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759256|NCT00092365|Celecoxib|celecoxib|mesh-list
83759257|NCT00092365|Rofecoxib|rofecoxib|mesh-list
83759258|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83759259|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83759260|NCT00092365|Analgesics|analgesics|mesh-ancestor
83759261|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
83759262|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759263|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759264|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83759265|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759266|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82914441|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759267|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83759268|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759269|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759270|NCT00092404|Vaccines|vaccines|mesh-list
83759271|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
83759272|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759273|NCT04728880|Remdesivir|remdesivir|mesh-list
83759274|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
83759275|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759276|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
83759277|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759278|NCT00093028|Bortezomib|bortezomib|mesh-list
83759279|NCT00093028|Lenalidomide|lenalidomide|mesh-list
83759280|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759281|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
83759282|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759283|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83759284|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83759285|NCT00093028|Growth Substances|growth substances|mesh-ancestor
83759286|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759287|NCT00093067|Daptomycin|daptomycin|mesh-list
83759288|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759289|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759290|NCT00093184|Anticoagulants|anticoagulants|mesh-list
83759291|NCT00093184|Bivalirudin|bivalirudin|mesh-list
83759292|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
83759293|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83759294|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
83759295|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759296|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759297|NCT00006224|Gemcitabine|gemcitabine|mesh-list
83759298|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759299|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
83759300|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759301|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759302|NCT00093223|Paclitaxel|paclitaxel|mesh-list
83759303|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83759304|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759305|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759306|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759307|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759308|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759309|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759310|NCT00093262|Clevidipine|clevidipine|mesh-list
83759311|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83759312|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83759313|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759314|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83759315|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759316|NCT00093301|Simendan|simendan|mesh-list
83759317|NCT00093301|Dobutamine|dobutamine|mesh-list
83759318|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83759319|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
83759320|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83759321|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83759322|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759323|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759324|NCT00093301|Protective Agents|protective agents|mesh-ancestor
83759325|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759326|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
83759327|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
83759328|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759329|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83759330|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83759331|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83759332|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
83759333|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759334|NCT00093418|Tipifarnib|tipifarnib|mesh-list
83759335|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759336|NCT00387608|Veliparib|veliparib|mesh-list
83759337|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83759338|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759339|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759340|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914518|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
83759341|NCT00093457|Sorafenib|sorafenib|mesh-list
83759342|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759343|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759344|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759345|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759346|NCT00093613|Sorafenib|sorafenib|mesh-list
83759347|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759348|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759349|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759350|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759351|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
83759352|NCT00093652|Gefitinib|gefitinib|mesh-list
83759353|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759354|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759355|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759356|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759357|NCT00006230|Rubitecan|rubitecan|mesh-list
83759358|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759359|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83759360|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83759361|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759362|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759363|NCT00093769|Rituximab|rituximab|mesh-list
83759364|NCT00093769|Bortezomib|bortezomib|mesh-list
83759365|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83759366|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759367|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
83759368|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759369|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759370|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83759371|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759372|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759373|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759374|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759375|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759376|NCT00006233|Cyclosporine|cyclosporine|mesh-list
83759377|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
83759378|NCT00006233|Fludarabine|fludarabine|mesh-list
83759379|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
83759380|NCT00006233|Cyclosporins|cyclosporins|mesh-list
83759381|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759382|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759383|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
83759384|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759385|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759386|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
83759387|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759388|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759389|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
83759390|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759391|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
83759392|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759393|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83759394|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83759395|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83759396|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
83759397|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759398|NCT02964715|Empagliflozin|empagliflozin|mesh-list
83759399|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83759400|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759401|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83759402|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759403|NCT00093886|Clevidipine|clevidipine|mesh-list
83759404|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
83759405|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
83759406|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83759407|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83759408|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759409|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83759410|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759411|NCT00093925|Nicardipine|nicardipine|mesh-list
83759412|NCT00093925|Clevidipine|clevidipine|mesh-list
83759413|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83759414|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83845100|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83759415|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759416|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83759417|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759418|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83759419|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
83759420|NCT00006239|Tretinoin|tretinoin|mesh-list
83759421|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83759422|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759423|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
83759424|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
83759425|NCT00094003|Poly I-C|poly i-c|mesh-list
83759426|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
83759427|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759428|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
83759429|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
83759430|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759431|NCT00094081|Tirapazamine|tirapazamine|mesh-list
83759432|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759433|NCT00094120|Squalamine|squalamine|mesh-list
83759434|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759435|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759436|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83759437|NCT00094120|Protective Agents|protective agents|mesh-ancestor
83759438|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759439|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759440|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83759441|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83759442|NCT00094120|Growth Substances|growth substances|mesh-ancestor
83759443|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759444|NCT00006245|Paclitaxel|paclitaxel|mesh-list
83759445|NCT00006245|Alvocidib|alvocidib|mesh-list
83759446|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759447|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759448|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759449|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759450|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759451|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759452|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759453|NCT00006245|Growth Substances|growth substances|mesh-ancestor
83759454|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759455|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759456|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759457|NCT00094315|Cocaine|cocaine|mesh-list
83759458|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
83759459|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
83759460|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759461|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759462|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
83759463|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759464|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83759465|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83759466|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83759467|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83759468|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759469|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
83759470|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759471|NCT00094432|Aripiprazole|aripiprazole|mesh-list
83759472|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
83759473|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759474|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83759475|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83759476|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759477|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759478|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
83759479|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
83759480|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759481|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759482|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83759483|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83759484|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
83759485|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83759486|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83759487|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83759488|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83759489|NCT00006248|Paclitaxel|paclitaxel|mesh-list
83759490|NCT00006248|Fluorouracil|fluorouracil|mesh-list
83759491|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759492|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759493|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759494|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759495|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759496|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759497|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
83759498|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759499|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759500|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
83759501|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759502|NCT00094549|Valproic Acid|valproic acid|mesh-list
83759503|NCT00094549|Olanzapine|olanzapine|mesh-list
83759504|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
83759505|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
83759506|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759507|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759508|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759509|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83759510|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83759511|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759512|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759513|NCT00094549|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83759514|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83759515|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83759516|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759517|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759518|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
83759519|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
83759520|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759521|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
83759522|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
83759523|NCT00094627|Gaboxadol|gaboxadol|mesh-list
83759524|NCT00094627|Analgesics|analgesics|mesh-ancestor
83759525|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
83759526|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759527|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759528|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
83759529|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
83759530|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
83759531|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759532|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759533|NCT00094666|Gaboxadol|gaboxadol|mesh-list
83759534|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759535|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759536|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759537|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759538|NCT00094666|Analgesics|analgesics|mesh-ancestor
83759539|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
83759540|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
83759541|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
83759542|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
83759543|NCT00006251|Cyclosporine|cyclosporine|mesh-list
83759544|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
83759545|NCT00006251|Fludarabine|fludarabine|mesh-list
83759546|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
83759547|NCT00006251|Cyclosporins|cyclosporins|mesh-list
83759548|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759549|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759550|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
83759551|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759552|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759553|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
83759554|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759555|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759556|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
83759557|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759558|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
83759559|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759560|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83759561|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83759562|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83759563|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
82914743|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
83759564|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759565|NCT00094978|Alvocidib|alvocidib|mesh-list
83759566|NCT00094978|Romidepsin|romidepsin|mesh-list
83759567|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759568|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759569|NCT00094978|Growth Substances|growth substances|mesh-ancestor
83759570|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759571|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759572|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759573|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759574|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83759575|NCT00094978|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83759576|NCT00095134|Risperidone|risperidone|mesh-list
83759577|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83759578|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
83759579|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759580|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759581|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759582|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83759583|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83759584|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759585|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759586|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83759587|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
83759588|NCT00006257|Paclitaxel|paclitaxel|mesh-list
83759589|NCT00006257|Semaxinib|semaxinib|mesh-list
83759590|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759591|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759592|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759593|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759594|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759595|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759596|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83759597|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83759598|NCT00006257|Growth Substances|growth substances|mesh-ancestor
83759599|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759600|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759601|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83759602|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759603|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
83759604|NCT00095251|Lorazepam|lorazepam|mesh-list
83759605|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83759606|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759607|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759608|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83759609|NCT00095251|Analgesics|analgesics|mesh-ancestor
83759610|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
83759611|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759612|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83759613|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83759614|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83759615|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
83759616|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759617|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759618|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
83759619|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
83759620|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
83759621|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759622|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83759623|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83759624|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759625|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
83759626|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
83759627|NCT00006260|Etoposide|etoposide|mesh-list
83759628|NCT00006260|Ifosfamide|ifosfamide|mesh-list
83759629|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759630|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759631|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83759632|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83759633|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759634|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759635|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83759636|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
83759637|NCT00095329|Sirolimus|sirolimus|mesh-list
83759638|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759639|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759640|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83845101|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
83759641|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759642|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
83759643|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759644|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
83759645|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759646|NCT00095368|Amoxicillin|amoxicillin|mesh-list
83759647|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759648|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759649|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
83759650|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83759651|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759652|NCT00006263|Carboplatin|carboplatin|mesh-list
83759653|NCT00006263|Temozolomide|temozolomide|mesh-list
83759654|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759655|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83759656|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
83759657|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759658|NCT00095524|Aripiprazole|aripiprazole|mesh-list
83759659|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
83759660|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759661|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83759662|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83759663|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759664|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759665|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
83759666|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
83759667|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759668|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759669|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83759670|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83759671|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
83759672|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83759673|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83759674|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83759675|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83759676|NCT04492566|Pancrelipase|pancrelipase|mesh-list
83759677|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759678|NCT00095641|Capecitabine|capecitabine|mesh-list
83759679|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759680|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
83759681|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759682|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759683|NCT00006269|Irinotecan|irinotecan|mesh-list
83759684|NCT00006269|Octreotide|octreotide|mesh-list
83759685|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83759686|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83759687|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759688|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759689|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759690|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759691|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83759692|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83759693|NCT04476030|Citalopram|citalopram|mesh-list
83759694|NCT04476030|Sertraline|sertraline|mesh-list
83759695|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83759696|NCT04476030|Escitalopram|escitalopram|mesh-list
83759697|NCT04476030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83759698|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83759699|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83759700|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759701|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759702|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
83759703|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759704|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759705|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83759706|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
83759707|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759708|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83759709|NCT04476030|Analgesics|analgesics|mesh-ancestor
83759710|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
83759711|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
83759712|NCT00095680|Bortezomib|bortezomib|mesh-list
83759713|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759714|NCT00095719|Aripiprazole|aripiprazole|mesh-list
83759715|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
83759716|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759717|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83759718|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83759719|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759720|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759721|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
83759722|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
83759723|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759724|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759725|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83759726|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83759727|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
83759728|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83759729|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83759730|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83759731|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83759732|NCT00095758|Aripiprazole|aripiprazole|mesh-list
83759733|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
83759734|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83759735|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83759736|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83759737|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759738|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759739|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
83759740|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
83759741|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759742|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759743|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83759744|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83759745|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
83759746|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83759747|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83759748|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83759749|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83759750|NCT00095914|Paclitaxel|paclitaxel|mesh-list
83759751|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83759752|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759753|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759754|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759755|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759756|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759757|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759758|NCT04432428|Sufentanil|sufentanil|mesh-list
83759759|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83759760|NCT04432428|Narcotics|narcotics|mesh-ancestor
83759761|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759762|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759763|NCT04432428|Analgesics|analgesics|mesh-ancestor
83759764|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
83759765|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759766|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83759767|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83759768|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
83759769|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
83759770|NCT00096070|Gemcitabine|gemcitabine|mesh-list
83759771|NCT00096070|Fluorouracil|fluorouracil|mesh-list
83759772|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
83759773|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759774|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
83759775|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759776|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759777|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759778|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
83759779|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759780|NCT00006275|Calcitriol|calcitriol|mesh-list
83759781|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83759782|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759783|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83759784|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83759785|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759786|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83759787|NCT00006275|Vitamins|vitamins|mesh-ancestor
83759788|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
83759789|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83759790|NCT00096148|Cytarabine|cytarabine|mesh-list
83759791|NCT00096148|Bevacizumab|bevacizumab|mesh-list
83759792|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83759793|NCT00096148|Idarubicin|idarubicin|mesh-list
83759794|NCT00096148|Antibodies|antibodies|mesh-list
83759795|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
83759796|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83759797|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759798|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83759799|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83759800|NCT00096148|Growth Substances|growth substances|mesh-ancestor
83759801|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759802|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759803|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
83759804|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83759805|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
83759806|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759807|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
83759808|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759809|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83759810|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83759811|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83759812|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83759813|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759814|NCT00096187|Pemetrexed|pemetrexed|mesh-list
83759815|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759816|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759817|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759818|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83759819|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83759820|NCT00096304|Docetaxel|docetaxel|mesh-list
83759821|NCT00096304|Epirubicin|epirubicin|mesh-list
83759822|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759823|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759824|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759825|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759826|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759827|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83759828|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83759829|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83759830|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759831|NCT00096343|Paclitaxel|paclitaxel|mesh-list
83759832|NCT00096343|Carboplatin|carboplatin|mesh-list
83759833|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83759834|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759835|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
83759836|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
83759837|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
83759838|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759839|NCT00096616|Albuterol|albuterol|mesh-list
83759840|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83759841|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
83759842|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759843|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759844|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83759845|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
83759846|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
83759847|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83759848|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83759849|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83759850|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83759851|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
83759852|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83759853|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759854|NCT00096655|Infliximab|infliximab|mesh-list
83759855|NCT00096655|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83759856|NCT00096655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83759857|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
83759858|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759859|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759860|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
83759861|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83759862|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
83759863|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83759864|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915042|NCT02891174|Ibuprofen|ibuprofen|mesh-list
83759865|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83759866|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83759867|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83759868|NCT00006299|Celecoxib|celecoxib|mesh-list
83759869|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83759870|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83759871|NCT00006299|Analgesics|analgesics|mesh-ancestor
83759872|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
83759873|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759874|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759875|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83759876|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83759877|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83759878|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83759879|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759880|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759881|NCT00096811|Entecavir|entecavir|mesh-list
83759882|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
83759883|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759884|NCT00096850|Ritonavir|ritonavir|mesh-list
83759885|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83759886|NCT00096850|Rifampin|rifampin|mesh-list
83759887|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83759888|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83759889|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83759890|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759891|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759892|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83759893|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83759894|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
83759895|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759896|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83759897|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83759898|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83759899|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
83759900|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83759901|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
83759902|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83759903|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83759904|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83759905|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83759906|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83759907|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83759908|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83759909|NCT00096967|Bevacizumab|bevacizumab|mesh-list
83759910|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83759911|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759912|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83759913|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83759914|NCT00096967|Growth Substances|growth substances|mesh-ancestor
83759915|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759916|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
83759917|NCT04340076|Ixekizumab|ixekizumab|mesh-list
83759918|NCT04340076|Brodalumab|brodalumab|mesh-list
83759919|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
83759920|NCT00097045|Interferons|interferons|mesh-list
83759921|NCT00097045|Ribavirin|ribavirin|mesh-list
83759922|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
83759923|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759924|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
83759925|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759926|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
83759927|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759928|NCT00097084|Insulin|insulin|mesh-list
83759929|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83759930|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
83759931|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
83759932|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
83759933|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83759934|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759935|NCT04310709|Nivolumab|nivolumab|mesh-list
83759936|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83759937|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759938|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82915111|NCT01270815|Analgesics|analgesics|mesh-ancestor
83759939|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759940|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
83759941|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83759942|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
83759943|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759944|NCT00097123|Misoprostol|misoprostol|mesh-list
83759945|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83759946|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
83759947|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83759948|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759949|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83759950|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83759951|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
83759952|NCT00097279|Metformin|metformin|mesh-list
83759953|NCT00097279|Pioglitazone|pioglitazone|mesh-list
83759954|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
83759955|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
83759956|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83759957|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759958|NCT00390273|Metformin|metformin|mesh-list
83759959|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83759960|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759961|NCT00097318|Interferons|interferons|mesh-list
83759962|NCT00097318|Interferon-beta|interferon-beta|mesh-list
83759963|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
83759964|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83759965|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
83759966|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759967|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
83759968|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759969|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83759970|NCT00097435|Ribavirin|ribavirin|mesh-list
83759971|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
83759972|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759973|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
83759974|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759975|NCT00006326|Ritonavir|ritonavir|mesh-list
83759976|NCT00006326|Indinavir|indinavir|mesh-list
83759977|NCT00006326|Delavirdine|delavirdine|mesh-list
83759978|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83759979|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83759980|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
83759981|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83759982|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83759983|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83759984|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83759985|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
83759986|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83759987|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83759988|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83759989|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83759990|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83759991|NCT00390312|Morphine|morphine|mesh-list
83759992|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83759993|NCT00390312|Narcotics|narcotics|mesh-ancestor
83759994|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83759995|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83759996|NCT00390312|Analgesics|analgesics|mesh-ancestor
83759997|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
83759998|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83759999|NCT00400387|Riboflavin|riboflavin|mesh-list
83760000|NCT00400387|Thiamine|thiamine|mesh-list
83760001|NCT00400387|Pyridoxine|pyridoxine|mesh-list
83760002|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
83760003|NCT00400387|Folic Acid|folic acid|mesh-list
83760004|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
83760005|NCT00400387|Tocopherols|tocopherols|mesh-list
83760006|NCT00400387|Vitamin E|vitamin e|mesh-list
83760007|NCT00400387|Tocotrienols|tocotrienols|mesh-list
83760008|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
83760009|NCT00400387|Heparin|heparin|mesh-list
83760010|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83760011|NCT00400387|Tinzaparin|tinzaparin|mesh-list
83760012|NCT00400387|Dalteparin|dalteparin|mesh-list
83760013|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760014|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
83760015|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83760016|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83760017|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760018|NCT00400387|Vitamins|vitamins|mesh-ancestor
83760019|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
83760020|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83760021|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760022|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
83760023|NCT00400387|Protective Agents|protective agents|mesh-ancestor
83760024|NCT00400387|Hematinics|hematinics|mesh-ancestor
83760025|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83760026|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
83760027|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
83760028|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760029|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760030|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83760031|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83760032|NCT00006332|Growth Substances|growth substances|mesh-ancestor
83760033|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760034|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
83760035|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760036|NCT00390390|Lansoprazole|lansoprazole|mesh-list
83760037|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
83760038|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83760039|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83760040|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83760041|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760042|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760043|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
83760044|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83760045|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760046|NCT00097903|Camptothecin|camptothecin|mesh-list
83760047|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760048|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760049|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83760050|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83760051|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760052|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760053|NCT00097942|Memantine|memantine|mesh-list
83760054|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83760055|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83760056|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
83760057|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760058|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760059|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760060|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83760061|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83760062|NCT04294836|Curcumin|curcumin|mesh-list
83760063|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83760064|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760065|NCT04294836|Analgesics|analgesics|mesh-ancestor
83760066|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
83760067|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760068|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133247|NCT02101255|Fluorides|fluorides|mesh-list
83760069|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760070|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760071|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760072|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760073|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760074|NCT00098137|Olmesartan|olmesartan|mesh-list
83760075|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83760076|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83760077|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83760078|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760079|NCT00098488|Rituximab|rituximab|mesh-list
83760080|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83760081|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760082|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
83760083|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760084|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760085|NCT00098527|Romidepsin|romidepsin|mesh-list
83760086|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83760087|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760088|NCT00098527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83760089|NCT00098527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760090|NCT00098527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760091|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83760092|NCT00006347|Antibodies|antibodies|mesh-list
83760093|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
82915260|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83760094|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83760095|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
83760096|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760097|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760098|NCT00098605|Lapatinib|lapatinib|mesh-list
83760099|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760100|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83760101|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760102|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760103|NCT04290546|Cetuximab|cetuximab|mesh-list
83760104|NCT04290546|Ipilimumab|ipilimumab|mesh-list
83760105|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83760106|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83760107|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760108|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760109|NCT00098683|Amifostine|amifostine|mesh-list
83760110|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83760111|NCT00098683|Protective Agents|protective agents|mesh-ancestor
83760112|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760113|NCT00098800|Fenretinide|fenretinide|mesh-list
83760114|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760115|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83760116|NCT00098800|Protective Agents|protective agents|mesh-ancestor
83760117|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760118|NCT00098878|Carboplatin|carboplatin|mesh-list
83760119|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760120|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83760121|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83760122|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760123|NCT00098917|Vaccines|vaccines|mesh-list
83760124|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
83760125|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760126|NCT00098995|Tirapazamine|tirapazamine|mesh-list
83760127|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760128|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
83760129|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760130|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83760131|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83760132|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760133|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760134|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
83760135|NCT00099502|Interferons|interferons|mesh-list
83760136|NCT00099502|Interferon-beta|interferon-beta|mesh-list
83760137|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
83760138|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
83760139|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760140|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
83760141|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760142|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
83760143|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760144|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83760145|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760146|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760147|NCT00387920|Sunitinib|sunitinib|mesh-list
83760148|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760149|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83760150|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83760151|NCT00387920|Growth Substances|growth substances|mesh-ancestor
83760152|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760153|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
83760154|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83760155|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760156|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760157|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
83760158|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83760159|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760160|NCT02888067|Bromides|bromides|mesh-list
83760161|NCT02888067|Rocuronium|rocuronium|mesh-list
83760162|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
83760163|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83760164|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83760165|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83760166|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760167|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760168|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
83760169|NCT00006350|Tacrolimus|tacrolimus|mesh-list
83760170|NCT00006350|Daclizumab|daclizumab|mesh-list
83760171|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760172|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
83760173|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760174|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83760175|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760176|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760177|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83760178|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760179|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83760180|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
83760181|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83760182|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760183|NCT00400582|Candesartan|candesartan|mesh-list
83760184|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83760185|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83760186|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83760187|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760188|NCT00400621|Acetaminophen|acetaminophen|mesh-list
83760189|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760190|NCT00400621|Analgesics|analgesics|mesh-ancestor
83760191|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
83760192|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760193|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760194|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
83760195|NCT00006353|Temozolomide|temozolomide|mesh-list
83760196|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760197|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
83760198|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760199|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760200|NCT00400738|Ritonavir|ritonavir|mesh-list
83760201|NCT00400738|Lopinavir|lopinavir|mesh-list
83760202|NCT00400738|Saquinavir|saquinavir|mesh-list
83760203|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83760204|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83760205|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
83760206|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760207|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760208|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83760209|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83760210|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
83760211|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760212|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83760213|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83760214|NCT00006356|Carboplatin|carboplatin|mesh-list
83760215|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760216|NCT00099619|Insulin|insulin|mesh-list
83760217|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83760218|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
83760219|NCT00099619|Exenatide|exenatide|mesh-list
83760220|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83760221|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760222|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83760223|NCT00099619|Incretins|incretins|mesh-ancestor
83760224|NCT00099619|Hormones|hormones|mesh-ancestor
83760225|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760226|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
83760227|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
83760228|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760229|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760230|NCT00099736|Cyclosporine|cyclosporine|mesh-list
83760231|NCT00099736|Cyclosporins|cyclosporins|mesh-list
83760232|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83760233|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
83760234|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760235|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760236|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760237|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760238|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760239|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
83760240|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760241|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760242|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83760243|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83760244|NCT04143711|Paclitaxel|paclitaxel|mesh-list
83760245|NCT04143711|Nivolumab|nivolumab|mesh-list
83760246|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760247|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760248|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760249|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760250|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760251|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760252|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83760253|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83760254|NCT00099775|Caspofungin|caspofungin|mesh-list
83760255|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
83760256|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760257|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760258|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760259|NCT00006362|Bortezomib|bortezomib|mesh-list
83760260|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760261|NCT00099892|Vildagliptin|vildagliptin|mesh-list
83760262|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83760263|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760264|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83760265|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
83760266|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760267|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760268|NCT00099931|Vildagliptin|vildagliptin|mesh-list
83760269|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83760270|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760271|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83760272|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
83760273|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760274|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760275|NCT00099970|Dacarbazine|dacarbazine|mesh-list
83760276|NCT00099970|Volociximab|volociximab|mesh-list
83760277|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760278|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
83760279|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760280|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760281|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83760282|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83760283|NCT00099970|Growth Substances|growth substances|mesh-ancestor
83760284|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760285|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
83760286|NCT00100009|Triamcinolone|triamcinolone|mesh-list
83760287|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83760288|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83760289|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83760290|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760291|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
83760292|NCT00100009|Hormones|hormones|mesh-ancestor
83760293|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760294|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760295|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760296|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
83760297|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760298|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760299|NCT00100126|Amoxicillin|amoxicillin|mesh-list
83760300|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83760301|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760302|NCT00100243|Abarelix|abarelix|mesh-list
83760303|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
83760304|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760305|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760306|NCT04071756|Tazarotene|tazarotene|mesh-list
83760307|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760308|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
83760309|NCT00006368|Edotreotide|edotreotide|mesh-list
83760310|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83760311|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760312|NCT00100477|Etoposide|etoposide|mesh-list
83760313|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
83760314|NCT00100477|Topotecan|topotecan|mesh-list
83760315|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760316|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760317|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82915488|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
83760318|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83760319|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760320|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760321|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83760322|NCT00100477|Analgesics|analgesics|mesh-ancestor
83760323|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
83760324|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760325|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760326|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
83760327|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83760328|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760329|NCT00006371|Ketoconazole|ketoconazole|mesh-list
83760330|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
83760331|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83760332|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83760333|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83760334|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
83760335|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760336|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
83760337|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760338|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83760339|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83760340|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760341|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760342|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83760343|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
83760344|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760345|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760346|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83760347|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83760348|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760349|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83760350|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83760351|NCT04062708|Durvalumab|durvalumab|mesh-list
83760352|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83760353|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760354|NCT00100594|Lamivudine|lamivudine|mesh-list
83760355|NCT00100594|Zidovudine|zidovudine|mesh-list
83760356|NCT00100594|Efavirenz|efavirenz|mesh-list
83760357|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83760358|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83760359|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83760360|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760361|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760362|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
83760363|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760364|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83760365|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83760366|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
83760367|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83760368|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83760369|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83760370|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83760371|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83760372|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83760373|NCT00006374|Paclitaxel|paclitaxel|mesh-list
83760374|NCT00006374|Etoposide|etoposide|mesh-list
83760375|NCT00006374|Topotecan|topotecan|mesh-list
83760376|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760377|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760378|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760379|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760380|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760381|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760382|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83760383|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83760384|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760385|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83760386|NCT00100750|Gemcitabine|gemcitabine|mesh-list
83760387|NCT00100750|Tipifarnib|tipifarnib|mesh-list
83760388|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83760389|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
83760390|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760391|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760392|NCT00006377|Paclitaxel|paclitaxel|mesh-list
83760393|NCT00006377|Carboplatin|carboplatin|mesh-list
83760394|NCT00006377|Doxorubicin|doxorubicin|mesh-list
83760395|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83760396|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760397|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760398|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760399|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760400|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760401|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760402|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83760403|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83760404|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83760405|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760406|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
83760407|NCT01350102|Bacitracin|bacitracin|mesh-list
83760408|NCT01350102|Vitamins|vitamins|mesh-ancestor
83760409|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
83760410|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760411|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
83760412|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760413|NCT01350102|Protective Agents|protective agents|mesh-ancestor
83760414|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83760415|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760416|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83760417|NCT00424060|Sagopilone|sagopilone|mesh-list
83760418|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760419|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83760420|NCT00006380|Antibodies|antibodies|mesh-list
83760421|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
83760422|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83760423|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
83760424|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760425|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760426|NCT00100906|Aldesleukin|aldesleukin|mesh-list
83760427|NCT00100906|Interleukin-2|interleukin-2|mesh-list
83760428|NCT00100906|Tretinoin|tretinoin|mesh-list
83760429|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760430|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760431|NCT00100906|Analgesics|analgesics|mesh-ancestor
83760432|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
83760433|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760434|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760435|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83760436|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83760437|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
83760438|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760439|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
83760440|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760441|NCT00100945|Gefitinib|gefitinib|mesh-list
83760442|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760443|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83760444|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760445|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760446|NCT00006383|Vincristine|vincristine|mesh-list
83760447|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760448|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760449|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760450|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760451|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760452|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760453|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
83760454|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83760455|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83760456|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760457|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83760458|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83760459|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
83760460|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760461|NCT00101062|Celecoxib|celecoxib|mesh-list
82915637|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760462|NCT00101062|Letrozole|letrozole|mesh-list
83760463|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760464|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83760465|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83760466|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845102|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760467|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760468|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83760469|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
83760470|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760471|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760472|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83760473|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760474|NCT00101062|Analgesics|analgesics|mesh-ancestor
83760475|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
83760476|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760477|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760478|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760479|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83760480|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83760481|NCT00006386|Carmustine|carmustine|mesh-list
83760482|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760483|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
83760484|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760485|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760486|NCT00101140|Fludarabine|fludarabine|mesh-list
83760487|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
83760488|NCT00101140|Thiotepa|thiotepa|mesh-list
83760489|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83760490|NCT00101140|Immunomodulating Agents|immunomodulating agents|mesh-list
83760491|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760492|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83760493|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
83760494|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760495|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760496|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
83760497|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760498|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760499|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
83760500|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83760501|NCT00101179|Azacitidine|azacitidine|mesh-list
83760502|NCT00101179|Entinostat|entinostat|mesh-list
83760503|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83760504|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83760505|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
83760506|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760507|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760508|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760509|NCT00400777|Amlodipine|amlodipine|mesh-list
83760510|NCT00400777|Valsartan|valsartan|mesh-list
83760511|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83760512|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83760513|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83760514|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83760515|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760516|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83760517|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760518|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
83760519|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83760520|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83760521|NCT00400777|Diuretics|diuretics|mesh-ancestor
83760522|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
83760523|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83760524|NCT00400816|Temozolomide|temozolomide|mesh-list
83760525|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760526|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
83760527|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760528|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760529|NCT00400855|Fluticasone|fluticasone|mesh-list
83760531|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760532|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83760533|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
83760534|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760535|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760536|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83760537|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
83760538|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915718|NCT01584531|ON 01910|on 01910|mesh-list
83760539|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83760540|NCT00101296|Tipifarnib|tipifarnib|mesh-list
83760541|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760542|NCT00006398|Timolol|timolol|mesh-list
83760543|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760544|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83760545|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83760546|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
83760547|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760548|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760549|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83760550|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83760551|NCT00101335|Celecoxib|celecoxib|mesh-list
83760552|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83760553|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760554|NCT00101335|Analgesics|analgesics|mesh-ancestor
83760555|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
83760556|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760557|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760558|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760559|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760560|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83760561|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83760562|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760563|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760564|NCT00101374|Leflunomide|leflunomide|mesh-list
83760565|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760566|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760567|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760568|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
83760569|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760570|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
83760571|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83760572|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
83760573|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760574|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760575|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83760576|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
83760577|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83760578|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
83760579|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760580|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760581|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83760582|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
83760583|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
83760584|NCT00006401|Protective Agents|protective agents|mesh-ancestor
83760585|NCT00101569|Aripiprazole|aripiprazole|mesh-list
83760586|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
83760587|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83760588|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83760589|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83760590|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83760591|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760592|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
83760593|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
83760594|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760595|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760596|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83760597|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83760598|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
83760599|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83760600|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83760601|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83760602|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83760603|NCT03991884|Prednisone|prednisone|mesh-list
83760604|NCT03991884|Cortisone|cortisone|mesh-list
83760605|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
83760606|NCT03991884|Doxorubicin|doxorubicin|mesh-list
83760607|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83760608|NCT03991884|Etoposide|etoposide|mesh-list
83760609|NCT03991884|Vincristine|vincristine|mesh-list
83760610|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
83760611|NCT03991884|Daunorubicin|daunorubicin|mesh-list
83760612|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
83760613|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82915787|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83760614|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760615|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
83760616|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760617|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760618|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760619|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
83760620|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760621|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760622|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83760623|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83760624|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83760625|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83760626|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760627|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760628|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
83760629|NCT03991884|Hormones|hormones|mesh-ancestor
83760630|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760631|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83760632|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760633|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760634|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760635|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760636|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
83760637|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760638|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83760639|NCT03991884|Immunotoxins|immunotoxins|mesh-ancestor
83760640|NCT03991884|Immunoconjugates|immunoconjugates|mesh-ancestor
83760641|NCT00101764|Triamcinolone|triamcinolone|mesh-list
83760642|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83760643|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83760644|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83760645|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760646|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
83760647|NCT00101764|Hormones|hormones|mesh-ancestor
83760648|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760649|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760650|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760651|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
83760652|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760653|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760654|NCT00101803|Vildagliptin|vildagliptin|mesh-list
83760655|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83760656|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760657|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83760658|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
83760659|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760660|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760661|NCT00101842|Gemcitabine|gemcitabine|mesh-list
83760662|NCT00101842|Pemetrexed|pemetrexed|mesh-list
83760663|NCT00101842|Cisplatin|cisplatin|mesh-list
83760664|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83760665|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
83760666|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760667|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760668|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760669|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83760670|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83760671|NCT00102115|Talaporfin|talaporfin|mesh-list
83760672|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760673|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83760674|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760675|NCT00102154|Gaboxadol|gaboxadol|mesh-list
83760676|NCT00102154|Analgesics|analgesics|mesh-ancestor
83760677|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
83760678|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760679|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760680|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
83760681|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
83760682|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
82915862|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760683|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915863|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915864|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82915865|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
82915866|NCT01284309|Mirabegron|mirabegron|mesh-list
83760684|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760685|NCT00102271|Oxypurinol|oxypurinol|mesh-list
83760686|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760687|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760688|NCT00102310|Z 338|z 338|mesh-list
83760689|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83760690|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760691|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760692|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
83760693|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760694|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760695|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83760696|NCT00102388|Vildagliptin|vildagliptin|mesh-list
83760697|NCT00102388|Gliclazide|gliclazide|mesh-list
83760698|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83760699|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760700|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83760701|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83760702|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760703|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760704|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
83760705|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760706|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83760707|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760708|NCT00102583|Cyclosporine|cyclosporine|mesh-list
83760709|NCT00102583|Cyclosporins|cyclosporins|mesh-list
83760710|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760711|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760712|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760713|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
83760714|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760715|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
83760716|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760717|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760718|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760719|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83760720|NCT00102622|Paclitaxel|paclitaxel|mesh-list
83133251|NCT05063318|Itraconazole|itraconazole|mesh-list
83760721|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760722|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760723|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760724|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760725|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760726|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760727|NCT00006428|Amitriptyline|amitriptyline|mesh-list
83760728|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83760729|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
83760730|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83760731|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760732|NCT00006428|Analgesics|analgesics|mesh-ancestor
83760733|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
83760734|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760735|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760736|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83760737|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83760738|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83760739|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760740|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
83760741|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760742|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
83760743|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83760744|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760745|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
83760746|NCT00102700|Gemcitabine|gemcitabine|mesh-list
83760747|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83760748|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
83760749|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760750|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760751|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760752|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83760753|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83760754|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915932|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760755|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
83760756|NCT00102778|Ritonavir|ritonavir|mesh-list
83760757|NCT00102778|Lopinavir|lopinavir|mesh-list
83760758|NCT00102778|Aplaviroc|aplaviroc|mesh-list
83760759|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83760760|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83760761|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
83760762|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760763|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760764|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83760765|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83760766|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
83760767|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760768|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83760769|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83760770|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83760771|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83760772|NCT00101998|Alvimopan|alvimopan|mesh-list
83760773|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83760774|NCT00102856|Pramipexole|pramipexole|mesh-list
83760775|NCT00102856|Rivastigmine|rivastigmine|mesh-list
83760776|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
83760777|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760778|NCT00102856|Protective Agents|protective agents|mesh-ancestor
83760779|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760780|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83760781|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83760782|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
83760783|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
83760784|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760785|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83760786|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760787|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
83760788|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83760789|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
83760790|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83760791|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83760792|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760793|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83760794|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83760795|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
83760796|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760797|NCT00006443|Lamivudine|lamivudine|mesh-list
83760798|NCT00006443|Stavudine|stavudine|mesh-list
83760799|NCT00006443|Nelfinavir|nelfinavir|mesh-list
83760800|NCT00006443|Indinavir|indinavir|mesh-list
83760801|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83760802|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83760803|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760804|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760805|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
83760806|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760807|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83760808|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83760809|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83760810|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83760811|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83760812|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
83760813|NCT00102973|Carboplatin|carboplatin|mesh-list
83760814|NCT00102973|Doxorubicin|doxorubicin|mesh-list
83760815|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83760816|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760817|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83760818|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83760819|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83760820|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760821|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760822|NCT00103051|Gemcitabine|gemcitabine|mesh-list
83760823|NCT00103051|Gefitinib|gefitinib|mesh-list
83760824|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760825|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83760826|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
83760827|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760828|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83760829|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760830|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
83760831|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760832|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83760833|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760834|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760835|NCT02697474|Vaccines|vaccines|mesh-list
83760836|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
83760837|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760838|NCT00103246|Silicon|silicon|mesh-list
83760839|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
83760840|NCT00103246|Trace Elements|trace elements|mesh-ancestor
83760841|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
83760842|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760843|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
83760844|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83760845|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83760846|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760847|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
83760848|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83760849|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760850|NCT00103324|Lapatinib|lapatinib|mesh-list
83760851|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760852|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83760853|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760854|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760855|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
83760856|NCT00103519|Hormones|hormones|mesh-ancestor
83760857|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83760858|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760859|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
83760860|NCT00103597|Domperidone|domperidone|mesh-list
83760861|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
83760862|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
83760863|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760864|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760865|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83760866|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83760867|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
83760868|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760869|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760870|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760871|NCT00006449|Naltrexone|naltrexone|mesh-list
83760872|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83760873|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83760874|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760875|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
83760876|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834896|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834897|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834898|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83834899|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
83834900|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83834901|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834902|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83834903|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
83834904|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834905|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834906|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834907|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834908|NCT00135681|Nedocromil|nedocromil|mesh-list
83834909|NCT00135681|Budesonide|budesonide|mesh-list
83834910|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834911|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83834912|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
83834913|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834914|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834915|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83834916|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
83834917|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
83834918|NCT00135681|Hormones|hormones|mesh-ancestor
83834919|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834920|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83834921|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
83834922|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83834923|NCT00135720|Etanercept|etanercept|mesh-list
83834924|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834925|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834926|NCT00135720|Analgesics|analgesics|mesh-ancestor
83834927|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
83760878|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83760879|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
83760880|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
83760881|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760882|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
83760883|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760884|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83760885|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
83760886|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
83760887|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
83760888|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760889|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
83760890|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760891|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760892|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760893|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
83760894|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760895|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760896|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83760897|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83760898|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83760899|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
83760900|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83760901|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83760902|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760903|NCT00103948|Donepezil|donepezil|mesh-list
83760904|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83760905|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760906|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760907|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
83760908|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83760909|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760910|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
83760911|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83760912|NCT00006458|Antibodies|antibodies|mesh-list
83760913|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
83760914|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83760915|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
83760916|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760917|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760918|NCT03879408|Acetaminophen|acetaminophen|mesh-list
83760919|NCT03879408|Naproxen|naproxen|mesh-list
83760920|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83760921|NCT03879408|Hydrocodone|hydrocodone|mesh-list
83760922|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760923|NCT03879408|Analgesics|analgesics|mesh-ancestor
83760924|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
83760925|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760926|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760927|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
83760928|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83760929|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83760930|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760931|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
83760932|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83760933|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760934|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760935|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83760936|NCT03879408|Narcotics|narcotics|mesh-ancestor
83760937|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83760938|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
83760939|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
83760940|NCT00104182|Insulin|insulin|mesh-list
83760941|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83760942|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
83760943|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
83760944|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
83760945|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
83760946|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83760947|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760948|NCT00104260|Verapamil|verapamil|mesh-list
83760949|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83760950|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82916152|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
82916169|NCT01174017|Iodine|iodine|mesh-list
83760951|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83760952|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760953|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83760954|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760955|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
83760957|NCT00388076|Carboplatin|carboplatin|mesh-list
83760958|NCT00388076|Lapatinib|lapatinib|mesh-list
83760959|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760960|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760961|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760962|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760963|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760964|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760965|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83760966|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760967|NCT00104689|Capecitabine|capecitabine|mesh-list
83760968|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
83760969|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83760970|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
83760971|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760972|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760973|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
83760974|NCT00006461|Etoposide|etoposide|mesh-list
83760975|NCT00006461|Vincristine|vincristine|mesh-list
83760976|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
83760977|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83760978|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
83760979|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83760980|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83760981|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83760982|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
83760983|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83760984|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83760985|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83760986|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83760987|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83760988|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83760989|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83760990|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
83760991|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
83760992|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
83760993|NCT00104767|Celecoxib|celecoxib|mesh-list
83760994|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83760995|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83760996|NCT00104767|Analgesics|analgesics|mesh-ancestor
83760997|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
83760998|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83760999|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761000|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761001|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761002|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83761003|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83761004|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761005|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761006|NCT02972268|Tamsulosin|tamsulosin|mesh-list
83761007|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
83761008|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83761009|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83761010|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83761011|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
83761012|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761013|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761014|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761015|NCT02972268|Urological Agents|urological agents|mesh-ancestor
83761016|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83761017|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83761018|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
83761019|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
83761020|NCT00104806|Vitamin D|vitamin d|mesh-list
83761021|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
83761022|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83761023|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761024|NCT00104806|Vitamins|vitamins|mesh-ancestor
83761025|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
83761026|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83761027|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761028|NCT00401128|Gemcitabine|gemcitabine|mesh-list
83761029|NCT00401128|Irinotecan|irinotecan|mesh-list
83761030|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761031|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
83761032|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761033|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761034|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83761035|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83761036|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761037|NCT00401167|Memantine|memantine|mesh-list
83761038|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83761039|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83761040|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
83761041|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761042|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761043|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761044|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83761045|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83761046|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83761047|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761048|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83761049|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761050|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761051|NCT00104845|Vaccines|vaccines|mesh-list
83761052|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
83761053|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761054|NCT00104923|Fenretinide|fenretinide|mesh-list
83761055|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761056|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83761057|NCT00104923|Protective Agents|protective agents|mesh-ancestor
83761058|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761059|NCT00104962|Lenalidomide|lenalidomide|mesh-list
83761060|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
83761061|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761062|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83761063|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83761064|NCT00104962|Growth Substances|growth substances|mesh-ancestor
83761065|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83761066|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761067|NCT00006467|Gemcitabine|gemcitabine|mesh-list
83761068|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761069|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
83761070|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761071|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761072|NCT00105040|Levetiracetam|levetiracetam|mesh-list
83761073|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
83761074|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
83761075|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83761076|NCT00006470|Vaccines|vaccines|mesh-list
83761077|NCT00006470|Antibodies|antibodies|mesh-list
83761078|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
83761079|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83761080|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83761081|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
83761082|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761083|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761084|NCT00105352|Glucagon|glucagon|mesh-list
83761085|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83761086|NCT00105352|Hormones|hormones|mesh-ancestor
83761087|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761088|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761089|NCT03862950|Metformin|metformin|mesh-list
83761090|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83761091|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761092|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
83761093|NCT00105547|Tarenflurbil|tarenflurbil|mesh-list
83761094|NCT00105547|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83761095|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761096|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761097|NCT00105547|Analgesics|analgesics|mesh-ancestor
83761098|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
83761099|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761100|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761101|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83761102|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83761103|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761104|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761105|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83761106|NCT00390624|Mannitol|mannitol|mesh-list
83761107|NCT00390624|Ularitide|ularitide|mesh-list
83761108|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83761109|NCT00390624|Diuretics|diuretics|mesh-ancestor
83761110|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
83761111|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761112|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83761113|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
83761114|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761115|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83761116|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
83761117|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
83761118|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761119|NCT00006476|Suramin|suramin|mesh-list
83761120|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
83761121|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
83761122|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83761123|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761124|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761125|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83761126|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83761127|NCT00105937|Fentanyl|fentanyl|mesh-list
83761128|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83761129|NCT00105937|Narcotics|narcotics|mesh-ancestor
83761130|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761131|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761132|NCT00105937|Analgesics|analgesics|mesh-ancestor
83761133|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
83761134|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761135|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83761136|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83761137|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
83761138|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
83761139|NCT00006479|Leucovorin|leucovorin|mesh-list
83761140|NCT00006479|Fluorouracil|fluorouracil|mesh-list
83761141|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
83761142|NCT00006479|Calcium|calcium|mesh-list
83761143|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
83761144|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83761145|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761146|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
83761147|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761148|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761149|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761150|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761151|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
83761152|NCT00006479|Antidotes|antidotes|mesh-ancestor
83761153|NCT00006479|Protective Agents|protective agents|mesh-ancestor
83761154|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
83761155|NCT00006479|Vitamins|vitamins|mesh-ancestor
83761156|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
83761157|NCT00106054|Leucovorin|leucovorin|mesh-list
83761158|NCT00106054|Bevacizumab|bevacizumab|mesh-list
83761159|NCT00106054|Irinotecan|irinotecan|mesh-list
83761160|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83761161|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761162|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83761163|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83761164|NCT00106054|Growth Substances|growth substances|mesh-ancestor
83761165|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761166|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
83761167|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83761168|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83761169|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761170|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761171|NCT00106054|Antidotes|antidotes|mesh-ancestor
83761172|NCT00106054|Protective Agents|protective agents|mesh-ancestor
83761173|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
83761174|NCT00106054|Vitamins|vitamins|mesh-ancestor
83761175|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
83761176|NCT00106132|Triamcinolone|triamcinolone|mesh-list
82916376|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
83761177|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83761178|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83761179|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83761180|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761181|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
83761182|NCT00106132|Hormones|hormones|mesh-ancestor
83761183|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761184|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761185|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761186|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
83761187|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761188|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761189|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83761190|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
83761191|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761192|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
83761193|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83761194|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761195|NCT03815682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83761196|NCT03815682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761197|NCT00106288|Amphotericin B|amphotericin b|mesh-list
83761198|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83761199|NCT00106288|Micafungin|micafungin|mesh-list
83761200|NCT00106288|Amebicides|amebicides|mesh-ancestor
83761201|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83761202|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83761203|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761204|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83761205|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
83761206|NCT00006482|Gemcitabine|gemcitabine|mesh-list
83761207|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761208|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761209|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
83761210|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761211|NCT03809988|Letrozole|letrozole|mesh-list
83761212|NCT03809988|Fulvestrant|fulvestrant|mesh-list
83761213|NCT03809988|Palbociclib|palbociclib|mesh-list
83761214|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761215|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83761216|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83761217|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761218|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761219|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83761220|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
83761221|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761222|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761223|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83761224|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83761225|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83761226|NCT00106366|Insulin|insulin|mesh-list
83761227|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83761228|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
83761229|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
83761230|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
83761231|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83761232|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761233|NCT00106405|Memantine|memantine|mesh-list
83761234|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83761235|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83761236|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
83761237|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761238|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761239|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761240|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83761241|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83761242|NCT00006485|Irinotecan|irinotecan|mesh-list
83761243|NCT00006485|Alvocidib|alvocidib|mesh-list
83761244|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83761245|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83761246|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761247|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761248|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761249|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
83761250|NCT00006485|Growth Substances|growth substances|mesh-ancestor
83761251|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761252|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83761253|NCT00106522|Methotrexate|methotrexate|mesh-list
83761254|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83761255|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
83761256|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83761257|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761258|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761259|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
83761260|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761261|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761262|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
83761263|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761264|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83761265|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761266|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
83761267|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761268|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761269|NCT00106561|Irbesartan|irbesartan|mesh-list
83761270|NCT00106561|Spironolactone|spironolactone|mesh-list
83761271|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83761272|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
83761273|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761274|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761275|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83761276|NCT00106561|Diuretics|diuretics|mesh-ancestor
83761277|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
83761278|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83761279|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83761280|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83761281|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761282|NCT00106600|Pixantrone|pixantrone|mesh-list
83761283|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83761284|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83761285|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761286|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761287|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761288|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
83761289|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83761290|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761291|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761292|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83761293|NCT00401206|Analgesics|analgesics|mesh-ancestor
83761294|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
83761295|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761296|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83761297|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83761298|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83761299|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
83761300|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761301|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761302|NCT00401323|Docetaxel|docetaxel|mesh-list
83761303|NCT00401323|Fluorouracil|fluorouracil|mesh-list
83761304|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761305|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
83761306|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
83761307|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
83761308|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761309|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
83761310|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761311|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761312|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
83761313|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761314|NCT00401362|Naltrexone|naltrexone|mesh-list
83761315|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
83761316|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83761317|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761318|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
83761319|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761320|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83761321|NCT00106834|Infliximab|infliximab|mesh-list
83761322|NCT00106834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83761323|NCT00106834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761324|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83761325|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83761326|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761327|NCT00107107|Pramlintide|pramlintide|mesh-list
83761328|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83761329|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761330|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
83761331|NCT00107263|Letrozole|letrozole|mesh-list
83761332|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761333|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83761334|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83761335|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761336|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761337|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83761338|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
83761339|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761340|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761341|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83761342|NCT02964949|Edoxaban|edoxaban|mesh-list
83761343|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83761344|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
83761345|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83761346|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
83761347|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761348|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761349|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
83761350|NCT00107341|Paclitaxel|paclitaxel|mesh-list
83761351|NCT00107341|Carboplatin|carboplatin|mesh-list
83761352|NCT00107341|Bortezomib|bortezomib|mesh-list
83761353|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83761354|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761355|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
83761356|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
83761357|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
83761358|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761359|NCT00107419|Pemetrexed|pemetrexed|mesh-list
83761360|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761361|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761362|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761363|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83761364|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761365|NCT03683667|Azithromycin|azithromycin|mesh-list
83761366|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83761367|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761368|NCT00006578|Ritonavir|ritonavir|mesh-list
83761369|NCT00006578|Amprenavir|amprenavir|mesh-list
83761370|NCT00006578|Lamivudine|lamivudine|mesh-list
83761371|NCT00006578|Abacavir|abacavir|mesh-list
83761372|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83761373|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83761374|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
83761375|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761376|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761377|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83761378|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83761379|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
83761380|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761381|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83761382|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83761383|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83761384|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761385|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83761386|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
83761387|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83761388|NCT00107458|Valproic Acid|valproic acid|mesh-list
83761389|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
83761390|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761391|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761392|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
83761393|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761394|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761395|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
83761396|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83761397|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761398|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83761399|NCT00006617|Lamivudine|lamivudine|mesh-list
83761400|NCT00006617|Zidovudine|zidovudine|mesh-list
83761401|NCT00006617|Abacavir|abacavir|mesh-list
83761402|NCT00006617|Amprenavir|amprenavir|mesh-list
83761403|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83761404|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761405|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761406|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761407|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
83761408|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761409|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83761410|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83761411|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
83761412|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83761413|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
83761414|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83761415|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83761416|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83761417|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
83761418|NCT00107731|Valproic Acid|valproic acid|mesh-list
83761419|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83761420|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
83761421|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83761422|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83761423|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83761424|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761425|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761426|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761427|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761428|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
83761429|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
83761430|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
83761431|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761432|NCT04712396|Itraconazole|itraconazole|mesh-list
83761433|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
83761434|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761435|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83761436|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83761437|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761438|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761439|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83761440|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
83761441|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761442|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761443|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83761444|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83761445|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761446|NCT00107809|Modafinil|modafinil|mesh-list
83761447|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83761448|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761449|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83761450|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83761451|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83761452|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761453|NCT00006656|Ethanol|ethanol|mesh-list
83761454|NCT00006656|Carmustine|carmustine|mesh-list
83761455|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83761456|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761457|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761458|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761459|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83761460|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
83761461|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761462|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761463|NCT03667482|Cetuximab|cetuximab|mesh-list
83761464|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83761465|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761466|NCT00107848|Modafinil|modafinil|mesh-list
83761467|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83761468|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761469|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83761470|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83761471|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83761472|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761473|NCT00006695|Iodine|iodine|mesh-list
83761474|NCT00006695|Cytarabine|cytarabine|mesh-list
83761475|NCT00006695|Etoposide|etoposide|mesh-list
83761476|NCT00006695|Melphalan|melphalan|mesh-list
83761477|NCT00006695|Carmustine|carmustine|mesh-list
82916685|NCT01587729|Serotonin|serotonin|mesh-list
83761478|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
83761479|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83761480|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761481|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83761482|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83761483|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761484|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761485|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761486|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
83761487|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
83761488|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761489|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761490|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
83761491|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761492|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83761493|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
83761494|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83761495|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83761496|NCT00006695|Trace Elements|trace elements|mesh-ancestor
83761497|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
83761498|NCT00108004|Pramlintide|pramlintide|mesh-list
83761499|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83761500|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761501|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
83761502|NCT00006734|Ifosfamide|ifosfamide|mesh-list
83761503|NCT00006734|Doxorubicin|doxorubicin|mesh-list
83761504|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83761505|NCT00006734|Etoposide|etoposide|mesh-list
83761506|NCT00006734|Vincristine|vincristine|mesh-list
83761507|NCT00006734|Lenograstim|lenograstim|mesh-list
83761508|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761509|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
83761510|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761511|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761512|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83761513|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
83761514|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761515|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761516|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83761517|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83761518|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83761519|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83761520|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761521|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83761522|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83761523|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83761524|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83761525|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83761526|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83761527|NCT00108238|Estradiol|estradiol|mesh-list
83761528|NCT00108238|Progesterone|progesterone|mesh-list
83761529|NCT00108238|Estrogens|estrogens|mesh-ancestor
83761530|NCT00108238|Hormones|hormones|mesh-ancestor
83761531|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761532|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761533|NCT00108238|Progestins|progestins|mesh-ancestor
83761534|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83761535|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
83761536|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83761537|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83761538|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83761539|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
83761540|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83761541|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761542|NCT03625323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83761543|NCT03625323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761544|NCT00108316|Fluoxetine|fluoxetine|mesh-list
83761545|NCT00108316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83761546|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83761547|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83761548|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761549|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916753|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916759|NCT01186497|Rabeprazole|rabeprazole|mesh-list
83761550|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
83761551|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761552|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83761553|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
83761554|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83761555|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83761556|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83761557|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761558|NCT00108394|Pamidronate|pamidronate|mesh-list
83761559|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83761560|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761561|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
83761562|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83761563|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
83761564|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761565|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83761566|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83761567|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83761568|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761569|NCT00401440|Misoprostol|misoprostol|mesh-list
83761570|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83761571|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
83761572|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83761573|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761574|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83761575|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83761576|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
83761577|NCT00108667|Levodopa|levodopa|mesh-list
83761578|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83761579|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83761580|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
83761581|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761582|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761583|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761584|NCT00006773|Bortezomib|bortezomib|mesh-list
83761585|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761586|NCT00108706|Candesartan|candesartan|mesh-list
83761587|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83761588|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83761589|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83761590|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761591|NCT03619551|Busulfan|busulfan|mesh-list
83761592|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
83761593|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761594|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761595|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
83761596|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761597|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83761598|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761599|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83761600|NCT00006812|Capecitabine|capecitabine|mesh-list
83761601|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761602|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
83761603|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761604|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761605|NCT00006890|Thalidomide|thalidomide|mesh-list
83761606|NCT00006890|Prednisone|prednisone|mesh-list
83761607|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761608|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
83761609|NCT00006890|Hormones|hormones|mesh-ancestor
83761610|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761611|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761612|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83761613|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761614|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761615|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
83761616|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
83761617|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83761618|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761619|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83761620|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83761621|NCT00006890|Growth Substances|growth substances|mesh-ancestor
83761622|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
83761623|NCT00108979|Escitalopram|escitalopram|mesh-list
82916826|NCT01180413|Losartan|losartan|mesh-list
83761624|NCT00108979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83761625|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83761626|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83761627|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761628|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761629|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
83761630|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761631|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83761632|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83761633|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83761634|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761635|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761636|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83761637|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83761638|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761639|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
83761640|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761641|NCT00109057|Bevacizumab|bevacizumab|mesh-list
83761642|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83761643|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761644|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83761645|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83761646|NCT00109057|Growth Substances|growth substances|mesh-ancestor
83761647|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761648|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
83761649|NCT00109096|Pemetrexed|pemetrexed|mesh-list
83761650|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761651|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761652|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761653|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83761654|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761655|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83761656|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83761657|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83761658|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761659|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761660|NCT00109135|Hormones|hormones|mesh-ancestor
83761661|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761662|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761663|NCT00006929|Suramin|suramin|mesh-list
83761664|NCT00006929|Paclitaxel|paclitaxel|mesh-list
83761665|NCT00006929|Carboplatin|carboplatin|mesh-list
83761666|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83761667|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761668|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
83761669|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
83761670|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
83761671|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761672|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
83761673|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
83761674|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83761675|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761676|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83761677|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83761678|NCT00006968|Cyclosporine|cyclosporine|mesh-list
83761679|NCT00006968|Pentostatin|pentostatin|mesh-list
83761680|NCT00006968|Cyclosporins|cyclosporins|mesh-list
83761681|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
83761682|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761683|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761684|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761685|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761686|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
83761687|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761688|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
83761689|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761690|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83761691|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761692|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82916900|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82916901|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
83761693|NCT03595917|Prednisone|prednisone|mesh-list
83761694|NCT03595917|Dasatinib|dasatinib|mesh-list
83761695|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761696|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
83761697|NCT03595917|Hormones|hormones|mesh-ancestor
83761698|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761699|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761700|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83761701|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761702|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83761703|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761704|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761705|NCT00109408|Methotrexate|methotrexate|mesh-list
83761706|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83761707|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
83761708|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83761709|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761710|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761711|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
83761712|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761713|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761714|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
83761715|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761716|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83761717|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761718|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
83761719|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761720|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761721|NCT00109564|Acetylcholine|acetylcholine|mesh-list
83761722|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
83761723|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
83761724|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83761725|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
83761726|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761727|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761728|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761729|NCT00109603|Tenofovir|tenofovir|mesh-list
83761730|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
83761731|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761732|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83761733|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761734|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761735|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761736|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83761737|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83761738|NCT00109798|Temozolomide|temozolomide|mesh-list
83761739|NCT00109798|Topotecan|topotecan|mesh-list
83761740|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83761741|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
83761742|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761743|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761744|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83761745|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83761746|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761747|NCT00109954|Cisplatin|cisplatin|mesh-list
83761748|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761749|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
83761750|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83761751|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83761752|NCT00109993|Prednisolone|prednisolone|mesh-list
83761753|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
83761754|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
83761755|NCT00109993|Tacrolimus|tacrolimus|mesh-list
83761756|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83761757|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
83761758|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761759|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
83761760|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761761|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83761762|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761763|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761764|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761765|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
83761766|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
83761767|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761768|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83761770|NCT00109993|Hormones|hormones|mesh-ancestor
83761771|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761772|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83761773|NCT00109993|Protective Agents|protective agents|mesh-ancestor
83761774|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83761775|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761776|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83761777|NCT00110032|Etanidazole|etanidazole|mesh-list
83761778|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761779|NCT00110071|Iodine|iodine|mesh-list
83761780|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
83761781|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83761782|NCT00110071|Fludarabine|fludarabine|mesh-list
83761783|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
83761784|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
83761785|NCT00110071|Antibodies|antibodies|mesh-list
83761786|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
83761787|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83761788|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
83761789|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761790|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761791|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83761792|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
83761793|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761794|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761795|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83761796|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761797|NCT00110071|Trace Elements|trace elements|mesh-ancestor
83761798|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
83761799|NCT00110188|Sirolimus|sirolimus|mesh-list
83761800|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83761801|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761802|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83761803|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761804|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
83761805|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761806|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
83761807|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761808|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83761809|NCT00007202|Stavudine|stavudine|mesh-list
83761810|NCT00007202|Didanosine|didanosine|mesh-list
83761811|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83761812|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83761813|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
83761814|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761815|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761816|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83761817|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83761818|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
83761819|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761820|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
83761821|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83761822|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761823|NCT00110344|Sorafenib|sorafenib|mesh-list
83761824|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761825|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83761826|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761827|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761828|NCT00401479|Solabegron|solabegron|mesh-list
83761829|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83761830|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83761831|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83761832|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83761833|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83761834|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761835|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761836|NCT00110578|Aldesleukin|aldesleukin|mesh-list
83761837|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761838|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83761839|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83761840|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
83761841|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917047|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761842|NCT00388193|Rituximab|rituximab|mesh-list
83761843|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83761844|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761845|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
83761846|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761847|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761848|NCT00110695|Paclitaxel|paclitaxel|mesh-list
83761849|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83761850|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83761851|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761852|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83761853|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83761854|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83761855|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761856|NCT00110734|Lidocaine|lidocaine|mesh-list
83761857|NCT00110734|Tetracaine|tetracaine|mesh-list
83761858|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
83761859|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
83761860|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761861|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761862|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
83761863|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761864|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83761865|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83761866|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83761867|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83761868|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761869|NCT00110773|Lidocaine|lidocaine|mesh-list
83761870|NCT00110773|Tetracaine|tetracaine|mesh-list
83761871|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
83761872|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
83761873|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761874|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761875|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
83761876|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761877|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83761878|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83761879|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83761880|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83761881|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761882|NCT00110851|Metformin|metformin|mesh-list
83761883|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
83761884|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83761885|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761886|NCT00110929|Cinacalcet|cinacalcet|mesh-list
83761887|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83761888|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761889|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83761890|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
83761891|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83761892|NCT00111046|Ibuprofen|ibuprofen|mesh-list
83761893|NCT00111046|Tramadol|tramadol|mesh-list
83761894|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83761895|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83761896|NCT00111046|Analgesics|analgesics|mesh-ancestor
83761897|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
83761898|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761899|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761900|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761901|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761902|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83761903|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761904|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761905|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83761906|NCT00111046|Narcotics|narcotics|mesh-ancestor
83761907|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83761908|NCT00388271|Alfuzosin|alfuzosin|mesh-list
83761909|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83761910|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83761911|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83761912|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
83761913|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917121|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761914|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761915|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761916|NCT00388271|Urological Agents|urological agents|mesh-ancestor
83761917|NCT00111124|Etanercept|etanercept|mesh-list
83761918|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83761919|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83761920|NCT00111124|Analgesics|analgesics|mesh-ancestor
83761921|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
83761922|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761923|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761924|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761925|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761926|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83761927|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761928|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
83761929|NCT00111163|Artesunate|artesunate|mesh-list
83761930|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
83761931|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
83761932|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83761933|NCT00111163|Amodiaquine|amodiaquine|mesh-list
83761934|NCT00111163|Dapsone|dapsone|mesh-list
83761935|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
83761936|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
83761937|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83761938|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83761939|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761940|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761941|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
83761942|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
83761943|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83761944|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
83761945|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83761946|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761947|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761948|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83761949|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
83761950|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83761951|NCT00111280|Etravirine|etravirine|mesh-list
83761952|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83761953|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83761954|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761955|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761956|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
83761957|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761958|NCT00111319|Bortezomib|bortezomib|mesh-list
83761959|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761960|NCT00111397|Interferons|interferons|mesh-list
83761961|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
83761962|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83761963|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
83761964|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83761965|NCT00111436|Etanercept|etanercept|mesh-list
83761966|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83761967|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83761968|NCT00111436|Analgesics|analgesics|mesh-ancestor
83761969|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
83761970|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761971|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761972|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761973|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83761974|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83761975|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83761976|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
83761977|NCT00111631|Metformin|metformin|mesh-list
83761978|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83761979|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83761980|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761981|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
83761982|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761983|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761984|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83761985|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
83761986|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83761987|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83761988|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83761989|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761990|NCT00111748|Thalidomide|thalidomide|mesh-list
83761991|NCT00111748|Dexamethasone|dexamethasone|mesh-list
83761992|NCT00111748|Bortezomib|bortezomib|mesh-list
83761993|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83761994|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
83761995|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
83761996|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83761997|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83761998|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83761999|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
83762000|NCT00111748|Hormones|hormones|mesh-ancestor
83762001|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762002|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83762003|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762004|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762005|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
83762006|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
83762007|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83762008|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762009|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83762010|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83762011|NCT00111748|Growth Substances|growth substances|mesh-ancestor
83762012|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
83762013|NCT00111787|Paclitaxel|paclitaxel|mesh-list
83762014|NCT00111787|Lapatinib|lapatinib|mesh-list
83762015|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762016|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762017|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762018|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762019|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762020|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762021|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83762022|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762023|NCT00111904|Paclitaxel|paclitaxel|mesh-list
83762024|NCT00111904|genexol-PM|genexol-pm|mesh-list
83762025|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762026|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762027|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762028|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762029|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762030|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762031|NCT00111943|Tenofovir|tenofovir|mesh-list
83762032|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
83762033|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762034|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83762035|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83762036|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762037|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762038|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83762039|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83762040|NCT00401596|Omalizumab|omalizumab|mesh-list
83762041|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83762042|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83762043|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
83762044|NCT00401635|Carboplatin|carboplatin|mesh-list
83762045|NCT00401635|Doxorubicin|doxorubicin|mesh-list
83762046|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83762047|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762048|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83762049|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83762050|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762051|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762052|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762053|NCT00401674|Paclitaxel|paclitaxel|mesh-list
83762054|NCT00401674|Carboplatin|carboplatin|mesh-list
83762055|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762056|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762057|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762058|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762059|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762060|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762061|NCT00112021|Pramlintide|pramlintide|mesh-list
83762062|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83762063|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83762064|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762065|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
83762066|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83762067|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83762068|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762070|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762071|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
83762072|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
83762073|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762074|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762075|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762076|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
83762077|NCT00007358|Hormones|hormones|mesh-ancestor
83762078|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762079|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83762080|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762081|NCT00112138|Gabapentin|gabapentin|mesh-list
83762082|NCT00112138|Analgesics|analgesics|mesh-ancestor
83762083|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
83762084|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762085|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762086|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
83762087|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83762088|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83762089|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83762090|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83762091|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83762092|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83762093|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762094|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762095|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
83762096|NCT03330639|Capsaicin|capsaicin|mesh-list
83762097|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
83762098|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762099|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
83762100|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762101|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762102|NCT00007436|Tenofovir|tenofovir|mesh-list
83762103|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
83762104|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762105|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83762106|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83762107|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762108|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762109|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83762110|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83762111|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83762112|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83762113|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
83762114|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762115|NCT00112372|Sirolimus|sirolimus|mesh-list
83762116|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83762117|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762118|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83762119|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762120|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
83762121|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762122|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
83762123|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762124|NCT00112528|Bevacizumab|bevacizumab|mesh-list
83762125|NCT00112528|Gemcitabine|gemcitabine|mesh-list
83762126|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
83762127|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83762128|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762129|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83762130|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83762131|NCT00112528|Growth Substances|growth substances|mesh-ancestor
83762132|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762133|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
83762134|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762135|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
83762136|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762137|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
83762138|NCT00007592|Furosemide|furosemide|mesh-list
83762139|NCT00007592|Diuretics|diuretics|mesh-ancestor
83762140|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
83762141|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917345|NCT01295073|Trientine|trientine|mesh-list
83762142|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83762143|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83762144|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762145|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83762146|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83762147|NCT00007631|Tretinoin|tretinoin|mesh-list
83762148|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762149|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
83762150|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762151|NCT00112567|Fludarabine|fludarabine|mesh-list
83762152|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
83762153|NCT00112567|Thiotepa|thiotepa|mesh-list
83762154|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762155|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762156|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
83762157|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762158|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762159|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
83762160|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762161|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762162|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
83762163|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83762164|NCT00112645|Cyclosporine|cyclosporine|mesh-list
83762165|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
83762166|NCT00112645|Methotrexate|methotrexate|mesh-list
83762167|NCT00112645|Melphalan|melphalan|mesh-list
83762168|NCT00112645|Busulfan|busulfan|mesh-list
83762169|NCT00112645|Cyclosporins|cyclosporins|mesh-list
83762170|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83762171|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83762172|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
83762173|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83762174|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762175|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762176|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
83762177|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762178|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762179|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762180|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762181|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83762182|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762183|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
83762184|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762185|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83762186|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
83762187|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762188|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83762189|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762190|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
83762191|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
83762192|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762193|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762194|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
83762195|NCT00112645|Hormones|hormones|mesh-ancestor
83762196|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762197|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83762198|NCT00112645|Protective Agents|protective agents|mesh-ancestor
83762199|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762200|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
83762201|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83762202|NCT00112684|Alvocidib|alvocidib|mesh-list
83762203|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762204|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83762205|NCT00112684|Growth Substances|growth substances|mesh-ancestor
83762206|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762207|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83762208|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762209|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762210|NCT00007670|Lamotrigine|lamotrigine|mesh-list
83762211|NCT00007670|Carbamazepine|carbamazepine|mesh-list
83762212|NCT00007670|Gabapentin|gabapentin|mesh-list
83762213|NCT00007670|Analgesics|analgesics|mesh-ancestor
83762214|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
83762215|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762216|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762217|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
83762218|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83762219|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83762220|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83762221|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83762222|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83762223|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83762224|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762225|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762226|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
83762227|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83762228|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83762229|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83762230|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83762231|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83762232|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83762233|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83762234|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83762235|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
83762236|NCT00112879|Thalidomide|thalidomide|mesh-list
83762237|NCT00112879|Dexamethasone|dexamethasone|mesh-list
83762238|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
83762240|NCT00112879|Immunomodulating Agents|immunomodulating agents|mesh-list
83762241|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762242|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
83762243|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
83762244|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762245|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762246|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762247|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
83762248|NCT00112879|Hormones|hormones|mesh-ancestor
83762249|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762250|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83762251|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762252|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762253|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762254|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762255|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
83762256|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
83762257|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83762258|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762259|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83762260|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83762261|NCT00112879|Growth Substances|growth substances|mesh-ancestor
83762262|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
83762263|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
83762264|NCT00112879|Protective Agents|protective agents|mesh-ancestor
83762265|NCT00112879|Vitamins|vitamins|mesh-ancestor
83762266|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
83762267|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
83762268|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
83762269|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762270|NCT00112996|Protective Agents|protective agents|mesh-ancestor
83762271|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762272|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
83762273|NCT00112996|Vitamins|vitamins|mesh-ancestor
83762274|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
83762275|NCT00113074|Nicotine|nicotine|mesh-list
83762276|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83762277|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
83762278|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762279|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762280|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83762281|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83762282|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83762283|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762284|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762285|NCT00113113|Rubitecan|rubitecan|mesh-list
83762286|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762287|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83762288|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762289|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762290|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762291|NCT00007787|Cyclosporine|cyclosporine|mesh-list
82917503|NCT01196559|Gemcitabine|gemcitabine|mesh-list
83762292|NCT00007787|Tacrolimus|tacrolimus|mesh-list
83762294|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
83762295|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762296|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
83762297|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762298|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83762299|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762300|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762301|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
83762302|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762303|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762304|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762305|NCT00390897|Interferons|interferons|mesh-list
83762306|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762307|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
83762308|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762309|NCT00113347|Docetaxel|docetaxel|mesh-list
83762310|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83762311|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762312|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762313|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762314|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762315|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762316|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83762317|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762318|NCT00113503|Azathioprine|azathioprine|mesh-list
83762319|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
83762320|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762321|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762322|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762323|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762324|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
83762325|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762326|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762327|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83762328|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
83762329|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
83762330|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762331|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762332|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83762333|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83762334|NCT00113542|Growth Substances|growth substances|mesh-ancestor
83762335|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762336|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
83762337|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762338|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83762339|NCT00007826|Vaccines|vaccines|mesh-list
83762340|NCT00007826|Antibodies|antibodies|mesh-list
83762341|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83762342|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
83762343|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
83762344|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
83762345|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762346|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83762347|NCT00007826|Antacids|antacids|mesh-ancestor
83762348|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762349|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762350|NCT00007865|Rituximab|rituximab|mesh-list
83762351|NCT00007865|Carboplatin|carboplatin|mesh-list
83762352|NCT00007865|Etoposide|etoposide|mesh-list
83762353|NCT00007865|Ifosfamide|ifosfamide|mesh-list
83762354|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83762355|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762356|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
83762357|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762358|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762359|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762360|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83762361|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762362|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762363|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762364|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762365|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
83762366|NCT00113698|Enalapril|enalapril|mesh-list
82917571|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762367|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83762368|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
83762369|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762370|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762371|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83762372|NCT00113737|Fluoxetine|fluoxetine|mesh-list
83762373|NCT00113737|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83762374|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83762375|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83762376|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762377|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762378|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
83762379|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762380|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83762381|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
83762382|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83762383|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83762384|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83762385|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762386|NCT03272295|Fenugreek seed meal|fenugreek seed meal|mesh-list
83762387|NCT03272295|Menthol|menthol|mesh-list
83762388|NCT03272295|Sorbitol|sorbitol|mesh-list
83762389|NCT03272295|Glycerol|glycerol|mesh-list
83762390|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
83762391|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762392|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83762393|NCT03272295|Protective Agents|protective agents|mesh-ancestor
83762394|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762395|NCT03272295|Cathartics|cathartics|mesh-ancestor
83762396|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762397|NCT03272295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83762398|NCT00007904|Tamoxifen|tamoxifen|mesh-list
83762399|NCT00007904|Paclitaxel|paclitaxel|mesh-list
83762400|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
83762401|NCT00007904|Doxorubicin|doxorubicin|mesh-list
83762402|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83762403|NCT00007904|Lenograstim|lenograstim|mesh-list
83762404|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762405|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762406|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762407|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762408|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762409|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762410|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762411|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
83762412|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762413|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762414|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762415|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
83762416|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83762417|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83762418|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83762419|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762420|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762421|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83762422|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83762423|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
83762424|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762425|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83762426|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83762427|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83762428|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83762429|NCT00113815|Topiramate|topiramate|mesh-list
83762430|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
83762431|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83762432|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762433|NCT00113854|Mannitol|mannitol|mesh-list
83762434|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83762435|NCT00113854|Diuretics|diuretics|mesh-ancestor
83762436|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
83762437|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762438|NCT00007943|Gemcitabine|gemcitabine|mesh-list
83762439|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762440|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
82917648|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
83762441|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762442|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762444|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83762445|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762446|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83762447|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83762448|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
83762449|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762450|NCT00114010|Antacids|antacids|mesh-ancestor
83133279|NCT02106559|Trioxsalen|trioxsalen|mesh-list
83762451|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762452|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762453|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
83762454|NCT00007982|Thiotepa|thiotepa|mesh-list
83762455|NCT00007982|Carmustine|carmustine|mesh-list
83762456|NCT00007982|Etoposide|etoposide|mesh-list
83762457|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762458|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
83762459|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762460|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762461|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762462|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
83762463|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762464|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762465|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83762466|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762467|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83762468|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762469|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762470|NCT00114205|Docetaxel|docetaxel|mesh-list
83762471|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762472|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762473|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762474|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762475|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762476|NCT00114283|Lapatinib|lapatinib|mesh-list
83762477|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762478|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83762479|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762480|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762481|NCT00114361|Ribavirin|ribavirin|mesh-list
83762482|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83762483|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
83762484|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762485|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
83762486|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762487|NCT00114400|Vitamins|vitamins|mesh-list
83762488|NCT00114400|Folic Acid|folic acid|mesh-list
83762489|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
83762490|NCT00114400|Hydroxocobalamin|hydroxocobalamin|mesh-list
83762491|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
83762492|NCT00114400|Pyridoxal|pyridoxal|mesh-list
83762493|NCT00114400|Pyridoxine|pyridoxine|mesh-list
83762494|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
83762495|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
83762496|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762497|NCT00114400|Hematinics|hematinics|mesh-ancestor
83762498|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
83762499|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
83762500|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83762501|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762502|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762503|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
83762504|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83762505|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83762506|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762507|NCT00114478|Epinephrine|epinephrine|mesh-list
83762508|NCT00114478|Albuterol|albuterol|mesh-list
83762509|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83762510|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83762511|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
83762512|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762513|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762514|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762515|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83762516|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83762517|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
83762518|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762519|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83762520|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
83762522|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
83762523|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83762524|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
83762525|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83762526|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83762527|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
83762528|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83762529|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762530|NCT00008021|Cyclosporine|cyclosporine|mesh-list
83762531|NCT00008021|Paclitaxel|paclitaxel|mesh-list
83762532|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83762533|NCT00008021|Antibodies|antibodies|mesh-list
83762534|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
83762535|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83762536|NCT00008021|Cyclosporins|cyclosporins|mesh-list
83762537|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762538|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762539|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762540|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762541|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762542|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762543|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
83762544|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762545|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762546|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762547|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
83762548|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762549|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762550|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762551|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83762552|NCT03079440|Capecitabine|capecitabine|mesh-list
83762553|NCT03079440|Temozolomide|temozolomide|mesh-list
83762554|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762555|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
83762556|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762557|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762558|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762559|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
83762560|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83762561|NCT00008060|Leucovorin|leucovorin|mesh-list
83762562|NCT00008060|Fluorouracil|fluorouracil|mesh-list
83762563|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
83762564|NCT00008060|Irinotecan|irinotecan|mesh-list
83762565|NCT00008060|Calcium|calcium|mesh-list
83762566|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
83762567|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83762568|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762569|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
83762570|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762571|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762572|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762573|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762574|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
83762575|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83762576|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762577|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762578|NCT00008060|Antidotes|antidotes|mesh-ancestor
83762579|NCT00008060|Protective Agents|protective agents|mesh-ancestor
83762580|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
83762581|NCT00008060|Vitamins|vitamins|mesh-ancestor
83762582|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
83762583|NCT00114868|Vitamins|vitamins|mesh-list
83762584|NCT00114868|Vitamin A|vitamin a|mesh-list
83762585|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
83762586|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
83762587|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762588|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
83762589|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762590|NCT00114868|Protective Agents|protective agents|mesh-ancestor
83762591|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83762592|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762593|NCT03034200|TIC10 compound|tic10 compound|mesh-list
83762594|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917797|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83762595|NCT00114946|Bevacizumab|bevacizumab|mesh-list
83762596|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83762597|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762598|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83762599|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83762600|NCT00114946|Growth Substances|growth substances|mesh-ancestor
83762601|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762602|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
83762603|NCT00115024|Estradiol|estradiol|mesh-list
83762604|NCT00115024|Estrogens|estrogens|mesh-ancestor
83762605|NCT00115024|Hormones|hormones|mesh-ancestor
83762606|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762607|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762608|NCT00008177|Iodine|iodine|mesh-list
83762609|NCT00008177|Cyclosporine|cyclosporine|mesh-list
83762610|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
83762611|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83762612|NCT00008177|Fludarabine|fludarabine|mesh-list
83762613|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
83762614|NCT00008177|Antibodies|antibodies|mesh-list
83762615|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
83762616|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83762617|NCT00008177|Cyclosporins|cyclosporins|mesh-list
83762618|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
83762619|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762620|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762621|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762622|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
83762623|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762624|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762625|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762626|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
83762627|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762628|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762629|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762630|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83762631|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83762632|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83762633|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
83762634|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83762635|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83762636|NCT00008177|Trace Elements|trace elements|mesh-ancestor
83762637|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
83762638|NCT03007407|Durvalumab|durvalumab|mesh-list
83762639|NCT03007407|Tremelimumab|tremelimumab|mesh-list
83762640|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83762641|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762642|NCT00115102|Fentanyl|fentanyl|mesh-list
83762643|NCT00115102|Ketamine|ketamine|mesh-list
83762644|NCT00115102|Esketamine|esketamine|mesh-list
83762645|NCT00115102|Analgesics|analgesics|mesh-ancestor
83762646|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
83762647|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762648|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762649|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83762650|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83762651|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
83762652|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
83762653|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83762654|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83762655|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83762656|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762657|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762658|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83762659|NCT00115102|Narcotics|narcotics|mesh-ancestor
83762660|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83762661|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
83762662|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83762663|NCT00115219|Etanercept|etanercept|mesh-list
83762664|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83762665|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83762666|NCT00115219|Analgesics|analgesics|mesh-ancestor
83762667|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
83762668|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762669|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762670|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762671|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762672|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762673|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762674|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
83762676|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83762677|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83762678|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83762679|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83762680|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
83762681|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762682|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762683|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762684|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
83762685|NCT00115414|Docetaxel|docetaxel|mesh-list
83762686|NCT00115414|Doxorubicin|doxorubicin|mesh-list
83762687|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762688|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
83762689|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762690|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762691|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762692|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
83762693|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762694|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762695|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83762696|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762697|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762698|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762699|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83762700|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83762701|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762702|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762703|NCT00115492|Fluticasone|fluticasone|mesh-list
83762704|NCT00115492|Xhance|xhance|mesh-list
83762705|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83762706|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83762707|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762708|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83762709|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
83762710|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762711|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762712|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83762713|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
83762714|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762715|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83762716|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83762717|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83762718|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83762719|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
83762720|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762721|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762722|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
83762723|NCT00115492|Hormones|hormones|mesh-ancestor
83762724|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762725|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
83762726|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83762727|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83762728|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
83762729|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762730|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83762731|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762732|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83762733|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762734|NCT00115531|Vaccines|vaccines|mesh-list
83762735|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
83762736|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762737|NCT00115570|Insulin|insulin|mesh-list
83762738|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83762739|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
83762740|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
83762741|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
83762742|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
83762743|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
83762744|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
83762745|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82917946|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82917949|NCT01199367|Letrozole|letrozole|mesh-list
83762746|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762747|NCT00115609|Tenofovir|tenofovir|mesh-list
83762748|NCT00115609|Emtricitabine|emtricitabine|mesh-list
83762749|NCT00115609|Efavirenz|efavirenz|mesh-list
83762750|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
83762751|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762752|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83762753|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83762754|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762755|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762756|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83762757|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83762758|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83762759|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83762760|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83762761|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83762762|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83762763|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83762764|NCT00115648|Zidovudine|zidovudine|mesh-list
83762765|NCT00115648|Nevirapine|nevirapine|mesh-list
83762766|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
83762767|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762768|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83762769|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83762770|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762771|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
83762772|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762773|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83762774|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83762775|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83762776|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83762777|NCT00008294|Leucovorin|leucovorin|mesh-list
83762778|NCT00008294|Dexamethasone|dexamethasone|mesh-list
83762779|NCT00008294|Fluorouracil|fluorouracil|mesh-list
83762780|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
83762781|NCT00008294|Floxuridine|floxuridine|mesh-list
83762782|NCT00008294|Calcium|calcium|mesh-list
83762783|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
83762784|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762785|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
83762786|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
83762787|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762788|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762789|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762790|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
83762791|NCT00008294|Hormones|hormones|mesh-ancestor
83762792|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762793|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83762794|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762795|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83762796|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
83762797|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762798|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762799|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762800|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
83762801|NCT00008294|Antidotes|antidotes|mesh-ancestor
83762802|NCT00008294|Protective Agents|protective agents|mesh-ancestor
83762803|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
83762804|NCT00008294|Vitamins|vitamins|mesh-ancestor
83762805|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
83762806|NCT00115687|Nicotine|nicotine|mesh-list
83762807|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83762808|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
83762809|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762810|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762811|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83762812|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83762813|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
83762814|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83762815|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762816|NCT00115726|Furosemide|furosemide|mesh-list
83762817|NCT00115726|Diuretics|diuretics|mesh-ancestor
83762818|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
83762819|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762820|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83762821|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83762822|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762823|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
83762824|NCT00401869|Hematinics|hematinics|mesh-ancestor
83762825|NCT00008333|Vinorelbine|vinorelbine|mesh-list
83762826|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762827|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762828|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762829|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762830|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762831|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762832|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
83762833|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762834|NCT00115921|Antimalarials|antimalarials|mesh-list
83762835|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83762836|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83762837|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762838|NCT00008411|Docetaxel|docetaxel|mesh-list
83762839|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762840|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762841|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762842|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762843|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762844|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83762845|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83762846|NCT04727671|Cetrorelix|cetrorelix|mesh-list
83762847|NCT04727671|Menotropins|menotropins|mesh-list
83762848|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
83762849|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83762850|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
83762851|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83762852|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762853|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83762854|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83762855|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762856|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83762857|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
83762858|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
83762859|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762860|NCT00008450|Cyclosporine|cyclosporine|mesh-list
83762861|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
83762862|NCT00008450|Cyclosporins|cyclosporins|mesh-list
83762863|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762864|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762865|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762866|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
83762867|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762868|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
83762869|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762870|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
83762871|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762872|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83762873|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83762874|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762875|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83762876|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
83762877|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83762878|NCT00008489|Didanosine|didanosine|mesh-list
83762879|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
83762880|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762881|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83762882|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83762883|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762884|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
83762885|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762886|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83762887|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83762888|NCT00116350|Misoprostol|misoprostol|mesh-list
83762889|NCT00116350|Oxytocin|oxytocin|mesh-list
83762890|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
83762891|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83762892|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762893|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83762894|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
82918096|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
83762895|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83762896|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83762897|NCT00116389|Gemcitabine|gemcitabine|mesh-list
83762898|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83762899|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
83762900|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762901|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762902|NCT00116467|Vaccines|vaccines|mesh-list
83762903|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
83762904|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762905|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
83762906|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83762907|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83762908|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762909|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83762910|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83762911|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
83762912|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83762913|NCT00116506|Bevacizumab|bevacizumab|mesh-list
83762914|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83762915|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83762916|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762917|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83762918|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83762919|NCT00116506|Growth Substances|growth substances|mesh-ancestor
83762920|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762921|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
83762922|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83762923|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762924|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762925|NCT00116545|Troglitazone|troglitazone|mesh-list
83762926|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83762927|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762928|NCT00116623|Indomethacin|indomethacin|mesh-list
83762929|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
83762930|NCT00116623|Analgesics|analgesics|mesh-ancestor
83762931|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
83762932|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762933|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762934|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
83762935|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83762936|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83762937|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
83762938|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83762939|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83762940|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762941|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83762942|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
83762943|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83762944|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83762945|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83762946|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762947|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762948|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
83762949|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83762950|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762951|NCT02909322|Hydromorphone|hydromorphone|mesh-list
83762952|NCT02909322|Bupivacaine|bupivacaine|mesh-list
83762953|NCT02909322|Ropivacaine|ropivacaine|mesh-list
83762954|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
83762955|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
83762956|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83762957|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762958|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
83762959|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83762960|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83762961|NCT02909322|Narcotics|narcotics|mesh-ancestor
83762962|NCT02909322|Analgesics|analgesics|mesh-ancestor
83762963|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
83762964|NCT00116701|Hematinics|hematinics|mesh-ancestor
83762965|NCT00116896|Cisplatin|cisplatin|mesh-list
83762966|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762967|NCT02752815|Prednisone|prednisone|mesh-list
83762968|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
83762969|NCT02752815|Rituximab|rituximab|mesh-list
83762970|NCT02752815|Vincristine|vincristine|mesh-list
83762971|NCT02752815|Epirubicin|epirubicin|mesh-list
82918170|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
83762972|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83762973|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
83762974|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83762975|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83762976|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83762977|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
83762978|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83762979|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762980|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83762981|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83762982|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83762983|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
83762984|NCT02752815|Hormones|hormones|mesh-ancestor
83762985|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83762986|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83762987|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83762988|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
83762989|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
83762990|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
83762991|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83762992|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83762993|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83762994|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762995|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
83762996|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83762997|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83762998|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83762999|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763000|NCT00388388|Losartan|losartan|mesh-list
83763001|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83763002|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83763003|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83763004|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83763005|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83763006|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763007|NCT00388388|Diuretics|diuretics|mesh-ancestor
83763008|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
83763009|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763010|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83763011|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763012|NCT00117013|Topotecan|topotecan|mesh-list
83763013|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83763014|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83763015|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763016|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763017|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763018|NCT02743455|Vaccines|vaccines|mesh-list
83763019|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
83763020|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763021|NCT00117052|Cinacalcet|cinacalcet|mesh-list
83763022|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83763023|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763024|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83763025|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
83763026|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763027|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83763028|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83763029|NCT02972450|Vedolizumab|vedolizumab|mesh-list
83763030|NCT02972450|Vaccines|vaccines|mesh-list
83763031|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
83763032|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763033|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763034|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
83763035|NCT00117130|Hematinics|hematinics|mesh-ancestor
83763036|NCT00117208|Mannitol|mannitol|mesh-list
83763037|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83763038|NCT00117208|Diuretics|diuretics|mesh-ancestor
83763039|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
83763040|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763041|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
83763042|NCT00117247|Hematinics|hematinics|mesh-ancestor
83763043|NCT00388427|Cetuximab|cetuximab|mesh-list
83763044|NCT00388427|Dasatinib|dasatinib|mesh-list
83763045|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763046|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918242|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763047|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83763048|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763049|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763050|NCT00117364|Sacchachitin|sacchachitin|mesh-list
83763051|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
83763052|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763053|NCT00117364|Protective Agents|protective agents|mesh-ancestor
83763054|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763055|NCT00117403|Vitamins|vitamins|mesh-list
83763056|NCT00117403|Vitamin E|vitamin e|mesh-list
83763057|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
83763058|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
83763059|NCT00117403|Ubiquinone|ubiquinone|mesh-list
83763060|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
83763061|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763062|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
83763063|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763064|NCT00117403|Protective Agents|protective agents|mesh-ancestor
83763065|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
83763066|NCT00117442|Paclitaxel|paclitaxel|mesh-list
83763067|NCT00117442|Carboplatin|carboplatin|mesh-list
83763068|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83763069|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763070|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83763071|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83763072|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83763073|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763074|NCT00117520|Caffeine|caffeine|mesh-list
83763075|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83763076|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763077|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83763078|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763079|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763080|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83763081|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83763082|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
83763083|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763084|NCT04727515|Fentanyl|fentanyl|mesh-list
83763085|NCT04727515|Isoflurane|isoflurane|mesh-list
83763086|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83763087|NCT04727515|Narcotics|narcotics|mesh-ancestor
83763088|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83763089|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763090|NCT04727515|Analgesics|analgesics|mesh-ancestor
83763091|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
83763092|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763093|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83763094|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83763095|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
83763096|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
83763097|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83763098|NCT00117754|Terbinafine|terbinafine|mesh-list
83763099|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
83763100|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763101|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763102|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763103|NCT00117832|Azelastine|azelastine|mesh-list
83763104|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83763105|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
83763106|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763107|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763108|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83763109|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
83763110|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83763111|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763112|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763113|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83763114|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83763115|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83763116|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
83763117|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
83763118|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763119|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
82918318|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82918321|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
83763120|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
83763121|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83763122|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
83763123|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83763124|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83763125|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763126|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83763127|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763128|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763129|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83763130|NCT00118066|Calcitriol|calcitriol|mesh-list
83763131|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83763132|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763133|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83763134|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763135|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763136|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83763137|NCT00118066|Vitamins|vitamins|mesh-ancestor
83763138|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
83763139|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83763140|NCT00118105|Bevacizumab|bevacizumab|mesh-list
83763141|NCT00118105|Capecitabine|capecitabine|mesh-list
83763142|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
83763143|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763144|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763145|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83763146|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83763147|NCT00118105|Growth Substances|growth substances|mesh-ancestor
83763148|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763149|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
83763150|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763151|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
83763152|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763153|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83763154|NCT00118183|Cetuximab|cetuximab|mesh-list
83763155|NCT00118183|Docetaxel|docetaxel|mesh-list
83763156|NCT00118183|Bortezomib|bortezomib|mesh-list
83763157|NCT00118183|Antibodies|antibodies|mesh-list
83763158|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
83763159|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83763160|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
83763161|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763162|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763163|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83763164|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83763165|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83763166|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763167|NCT00390975|Tegaserod|tegaserod|mesh-list
83763168|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83763169|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
83763170|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763171|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763172|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763173|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83763174|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
83763175|NCT00118222|Ether|ether|mesh-list
83763176|NCT00118222|Trioxsalen|trioxsalen|mesh-list
83763177|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83763178|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
83763179|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
83763180|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83763181|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763182|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763183|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83763184|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83763185|NCT00118261|Leucovorin|leucovorin|mesh-list
83763186|NCT00118261|Bevacizumab|bevacizumab|mesh-list
83763187|NCT00118261|Fluorouracil|fluorouracil|mesh-list
83763188|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
83763189|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83763190|NCT00118261|Calcium|calcium|mesh-list
83763191|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
83763192|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763193|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763194|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83763195|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82918394|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
83763196|NCT00118261|Growth Substances|growth substances|mesh-ancestor
83763197|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763198|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
83763199|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83763201|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763202|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763203|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763204|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
83763205|NCT00118261|Antidotes|antidotes|mesh-ancestor
83763206|NCT00118261|Protective Agents|protective agents|mesh-ancestor
83763207|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
83763208|NCT00118261|Vitamins|vitamins|mesh-ancestor
83763209|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
83763210|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83763211|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763212|NCT00118300|Capecitabine|capecitabine|mesh-list
83763213|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763214|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
83763215|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763216|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763217|NCT02710734|Doxorubicin|doxorubicin|mesh-list
83763218|NCT02710734|Methotrexate|methotrexate|mesh-list
83763219|NCT02710734|Mitomycins|mitomycins|mesh-list
83763220|NCT02710734|Mitomycin|mitomycin|mesh-list
83763221|NCT02710734|Vinblastine|vinblastine|mesh-list
83763222|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763223|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83763224|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83763225|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83763226|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763227|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763228|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83763229|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
83763230|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83763231|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763232|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763233|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
83763234|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
83763235|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83763236|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763237|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
83763238|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83763239|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83763240|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
83763241|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83763242|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83763243|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83763244|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83763245|NCT00118690|Fluticasone|fluticasone|mesh-list
83763246|NCT00118690|Xhance|xhance|mesh-list
83763247|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83763248|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83763249|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83763250|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
83763251|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763252|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763253|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83763254|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
83763255|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
83763256|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83763257|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83763258|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83763259|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83763260|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
83763261|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763262|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763263|NCT00402142|Vaccines|vaccines|mesh-list
83763264|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
83763265|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763266|NCT00118768|Interferons|interferons|mesh-list
83763267|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
83763268|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763269|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
83763270|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918466|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83763271|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
83763272|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763273|NCT02706873|Methotrexate|methotrexate|mesh-list
83763274|NCT02706873|Upadacitinib|upadacitinib|mesh-list
83763275|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83763276|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
83763277|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83763278|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763279|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763280|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
83763281|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763282|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763283|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
83763284|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763285|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83763286|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763287|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
83763288|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83763289|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83763290|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83763291|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83763292|NCT00118807|Artesunate|artesunate|mesh-list
83763293|NCT00118807|Chloroquine|chloroquine|mesh-list
83763294|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
83763295|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
83763296|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83763297|NCT00118807|Amodiaquine|amodiaquine|mesh-list
83763298|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
83763299|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83763300|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83763301|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763302|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763303|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
83763304|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
83763305|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83763306|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
83763307|NCT00118807|Amebicides|amebicides|mesh-ancestor
83763308|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83763309|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83763310|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763311|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763312|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83763313|NCT00118963|Metformin|metformin|mesh-list
83763314|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
83763315|NCT00118963|Repaglinide|repaglinide|mesh-list
83763316|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83763317|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763318|NCT00119002|Dexamethasone|dexamethasone|mesh-list
83763319|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83763320|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
83763321|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
83763322|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763323|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763324|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763325|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
83763326|NCT00119002|Hormones|hormones|mesh-ancestor
83763327|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763328|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83763329|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763330|NCT00119119|Tocopherols|tocopherols|mesh-list
83763331|NCT00119119|Vitamin E|vitamin e|mesh-list
83763332|NCT00119119|Tocotrienols|tocotrienols|mesh-list
83763333|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
83763334|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
83763335|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763336|NCT00119119|Protective Agents|protective agents|mesh-ancestor
83763337|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763338|NCT00119119|Vitamins|vitamins|mesh-ancestor
83763339|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
83763340|NCT00119236|Irinotecan|irinotecan|mesh-list
83763341|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83763342|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83763343|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763344|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918539|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83763345|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763346|NCT00119314|Gemcitabine|gemcitabine|mesh-list
83763347|NCT00119314|Capecitabine|capecitabine|mesh-list
83763348|NCT00119314|Docetaxel|docetaxel|mesh-list
83763349|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763350|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
83763351|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763352|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763353|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
83763354|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
83763355|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
83763356|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83763357|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83763358|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763359|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
83763360|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763361|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
83763362|NCT00119587|Hematinics|hematinics|mesh-ancestor
83763363|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
83763364|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
83763365|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763366|NCT00119626|Protective Agents|protective agents|mesh-ancestor
83763367|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763368|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
83763369|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83763370|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83763371|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83763372|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763373|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763374|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
83763375|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763376|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763377|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83763378|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763379|NCT02621151|Gemcitabine|gemcitabine|mesh-list
83763380|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
83763381|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763382|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
83763383|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763384|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763385|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763386|NCT02621151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83763387|NCT00120055|Atorvastatin|atorvastatin|mesh-list
83763388|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83763389|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83763390|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
83763391|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763392|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83763393|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83763394|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763395|NCT00120133|Atorvastatin|atorvastatin|mesh-list
83763396|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83763397|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83763398|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
83763399|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763400|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83763401|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83763402|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763403|NCT00120172|Bevacizumab|bevacizumab|mesh-list
83763404|NCT00120172|Capecitabine|capecitabine|mesh-list
83763405|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
83763406|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763407|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763408|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83763409|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83763410|NCT00120172|Growth Substances|growth substances|mesh-ancestor
83763411|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763412|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
83763413|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763414|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
83763415|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763416|NCT00402181|Dexamethasone|dexamethasone|mesh-list
83763417|NCT00402181|Siltuximab|siltuximab|mesh-list
83763418|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83763419|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
83763420|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
83763421|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918638|NCT01301313|Simendan|simendan|mesh-list
83763422|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763423|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763424|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
83763425|NCT00402181|Hormones|hormones|mesh-ancestor
83763426|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763427|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83763428|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763429|NCT04727437|Heparin|heparin|mesh-list
83763430|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83763431|NCT04727437|Tinzaparin|tinzaparin|mesh-list
83763432|NCT04727437|Dalteparin|dalteparin|mesh-list
83763433|NCT04727437|Warfarin|warfarin|mesh-list
83763434|NCT04727437|Anticoagulants|anticoagulants|mesh-list
83763435|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83763436|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83763437|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763438|NCT00120367|Tenofovir|tenofovir|mesh-list
83763439|NCT00120367|Emtricitabine|emtricitabine|mesh-list
83763440|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
83763441|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
83763442|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763443|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83763444|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83763445|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763446|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763447|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83763448|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83763449|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83763450|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83763451|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83763452|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
83763453|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763454|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83763455|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763456|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
83763457|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
83763458|NCT00120484|Vitamins|vitamins|mesh-ancestor
83763459|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
83763460|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763461|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
83763462|NCT00120484|Hematinics|hematinics|mesh-ancestor
83763463|NCT00391014|Amphotericin B|amphotericin b|mesh-list
83763464|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83763465|NCT00391014|Amebicides|amebicides|mesh-ancestor
83763466|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83763467|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83763468|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763469|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83763470|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
83763471|NCT00120601|Naltrexone|naltrexone|mesh-list
83763472|NCT00120601|Acamprosate|acamprosate|mesh-list
83763473|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83763474|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83763475|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763476|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
83763477|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763478|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83763479|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83763480|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83763481|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
83763482|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763483|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763484|NCT00120640|Progestins|progestins|mesh-ancestor
83763485|NCT00120640|Hormones|hormones|mesh-ancestor
83763486|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
83763487|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
83763488|NCT00120679|Hematinics|hematinics|mesh-ancestor
83763489|NCT00120718|Fasudil|fasudil|mesh-list
83763490|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83763491|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763492|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763493|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83763494|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763495|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
83763496|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82918691|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
83763497|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763498|NCT00120757|Alendronate|alendronate|mesh-list
83763499|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83763500|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763501|NCT00120796|Lamivudine|lamivudine|mesh-list
83763502|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83763503|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83763504|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763505|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763506|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
83763507|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763508|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83763509|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83763510|NCT00120835|Interferons|interferons|mesh-list
83763511|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763512|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
83763513|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763514|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
83763515|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83763516|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83763517|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
83763518|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83763519|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763520|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
83763521|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
83763522|NCT00121030|Hematinics|hematinics|mesh-ancestor
83763523|NCT00121069|Escitalopram|escitalopram|mesh-list
83763524|NCT00121069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83763525|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83763526|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763527|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763528|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763529|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
83763530|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763531|NCT00121147|Travoprost|travoprost|mesh-list
83763532|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83763533|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83763534|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83763535|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83763536|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83763537|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
83763538|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763539|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763540|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763541|NCT00121264|Sorafenib|sorafenib|mesh-list
83763542|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763543|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83763544|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763545|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763546|NCT00121303|Cytarabine|cytarabine|mesh-list
83763547|NCT00121303|Daunorubicin|daunorubicin|mesh-list
83763548|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
83763549|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83763550|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
83763551|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763552|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763553|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
83763554|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763555|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763556|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
83763557|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763558|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83763559|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83763560|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83763561|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763562|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763563|NCT00121303|Immunotoxins|immunotoxins|mesh-ancestor
83763564|NCT00121303|Immunoconjugates|immunoconjugates|mesh-ancestor
83763565|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
83763566|NCT00121381|Tacrolimus|tacrolimus|mesh-list
83763567|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83763568|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83763569|NCT00121381|Analgesics|analgesics|mesh-ancestor
83763570|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
83763571|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763572|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763573|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83763574|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83763575|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
83763576|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763577|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
83763578|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83763579|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763580|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763581|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
83763582|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763583|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83763584|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
83763586|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
83763587|NCT00121459|Cathartics|cathartics|mesh-ancestor
83763588|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763589|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
83763590|NCT00121498|Lidocaine|lidocaine|mesh-list
83763591|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
83763592|NCT00121498|Anesthetics|anesthetics|mesh-list
83763593|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83763594|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763595|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
83763596|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763597|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83763598|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83763599|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83763600|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763601|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763602|NCT00121615|Etanercept|etanercept|mesh-list
83763603|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83763604|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83763605|NCT00121615|Analgesics|analgesics|mesh-ancestor
83763606|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
83763607|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763608|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763609|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83763610|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83763611|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763612|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763613|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
83763614|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83763615|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763616|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83763617|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763618|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763619|NCT04711096|Bupivacaine|bupivacaine|mesh-list
83763620|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
83763621|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
83763622|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83763623|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763624|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
83763625|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763626|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
83763627|NCT04705948|Ketamine|ketamine|mesh-list
83763628|NCT04705948|Analgesics|analgesics|mesh-ancestor
83763629|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
83763630|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763631|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763632|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83763633|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83763634|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
83763635|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
83763636|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83763637|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83763638|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83763639|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763640|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763641|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83763642|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
83763643|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83763644|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82918844|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83763645|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83763646|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
83763647|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83763649|NCT00121888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83763650|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83763651|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763652|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763653|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763654|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
83763655|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763656|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83763657|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
83763658|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83763659|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83763660|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83763661|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763662|NCT00121966|Insulin|insulin|mesh-list
83763663|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83763664|NCT00121966|Metformin|metformin|mesh-list
83763665|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
83763666|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
83763667|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
83763668|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
83763669|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
83763670|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83763671|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763672|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
83763673|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83763674|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83763675|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83763676|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83763677|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
83763678|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763679|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763680|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763681|NCT02013492|Propranolol|propranolol|mesh-list
83763682|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83763683|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83763684|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
83763685|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763686|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763687|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763688|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83763689|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83763690|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
83763691|NCT00122356|Alendronate|alendronate|mesh-list
83763692|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83763693|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763694|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83763695|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83763696|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763697|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
83763698|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83763699|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
83763700|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763701|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763702|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83763703|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83763704|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
83763705|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83763706|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
83763707|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763708|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763709|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
83763710|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763711|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83763712|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763713|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763714|NCT00122512|Tenofovir|tenofovir|mesh-list
83763715|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
83763716|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763717|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83763718|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82918921|NCT03804177|Vitamins|vitamins|mesh-ancestor
83763719|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763720|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763721|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83763722|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83763723|NCT01720407|Imiquimod|imiquimod|mesh-list
83763724|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83763725|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
83763726|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763727|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763728|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
83763729|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83763730|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
83763731|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763732|NCT00122590|Ritonavir|ritonavir|mesh-list
83763733|NCT00122590|Lopinavir|lopinavir|mesh-list
83763734|NCT00122590|Nelfinavir|nelfinavir|mesh-list
83763735|NCT00122590|Indinavir|indinavir|mesh-list
83763736|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83763737|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83763738|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
83763739|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763740|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763741|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83763742|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83763743|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
83763744|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763745|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83763746|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83763747|NCT00122629|Interferons|interferons|mesh-list
83763748|NCT00122629|Ribavirin|ribavirin|mesh-list
83763749|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
83763750|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
83763751|NCT00122629|Amantadine|amantadine|mesh-list
83763752|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83763753|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763754|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
83763755|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763756|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
83763757|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763758|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
83763759|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763760|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83763761|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83763762|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
83763763|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763764|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83763765|NCT00122629|Analgesics|analgesics|mesh-ancestor
83763766|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
83763767|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763768|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83763769|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83763770|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
83763771|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83763772|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763773|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763774|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
83763775|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763776|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83763777|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83763778|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83763779|NCT05637164|Norepinephrine|norepinephrine|mesh-list
83763780|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83763781|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83763782|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
83763783|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763784|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763785|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763786|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
83763787|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
83763788|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763789|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83763790|NCT00129337|Bavituximab|bavituximab|mesh-list
82919047|NCT02048020|Paclitaxel|paclitaxel|mesh-list
83763791|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763792|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763793|NCT00129298|Tiagabine|tiagabine|mesh-list
83763794|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
83763795|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83763796|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83763797|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763798|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763799|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
83763800|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763801|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763802|NCT00129181|Levodopa|levodopa|mesh-list
83763803|NCT00129181|Carbidopa|carbidopa|mesh-list
83763804|NCT00129181|Cabergoline|cabergoline|mesh-list
83763805|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83763806|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83763807|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83763808|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
83763809|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763810|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763811|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763812|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83763813|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763814|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
83763815|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83763816|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
83763817|NCT00129142|Toremifene|toremifene|mesh-list
83763818|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83763819|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763820|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83763821|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83763822|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
83763823|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763824|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763825|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83763826|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
83763827|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83763828|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763829|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83763830|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
83763831|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83763832|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763833|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763834|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763835|NCT00819780|Bevacizumab|bevacizumab|mesh-list
83763836|NCT00819780|Panitumumab|panitumumab|mesh-list
83763837|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763838|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763839|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83763840|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83763841|NCT00819780|Growth Substances|growth substances|mesh-ancestor
83763842|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763843|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
83763844|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83763845|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
83763846|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763847|NCT00128791|Nitroprusside|nitroprusside|mesh-list
83763848|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83763849|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
83763850|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83763851|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763852|NCT00128752|Beta Carotene|beta carotene|mesh-list
83763853|NCT00128752|Carotenoids|carotenoids|mesh-list
83763854|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
83763855|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763856|NCT00128752|Protective Agents|protective agents|mesh-ancestor
83763857|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763858|NCT00128752|Provitamins|provitamins|mesh-ancestor
83763859|NCT00128752|Vitamins|vitamins|mesh-ancestor
83763860|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
83763861|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83763862|NCT05638295|Panitumumab|panitumumab|mesh-list
83763863|NCT05638295|Sotorasib|sotorasib|mesh-list
83763864|NCT05638295|Antibodies|antibodies|mesh-list
83763865|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
83763866|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83763867|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
83763868|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763869|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763870|NCT05638295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83763871|NCT05638295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763872|NCT00063414|Alicaforsen|alicaforsen|mesh-list
83763873|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83763874|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83763875|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
83763876|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763877|NCT05638451|Bevacizumab|bevacizumab|mesh-list
83763878|NCT05638451|Temozolomide|temozolomide|mesh-list
83763879|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83763880|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763881|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83763882|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83763883|NCT05638451|Growth Substances|growth substances|mesh-ancestor
83763884|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763885|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
83763886|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83763887|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
83763888|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763889|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83763890|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
83763891|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
83763892|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763893|NCT05638763|Ketoconazole|ketoconazole|mesh-list
83763894|NCT05638763|Dasatinib|dasatinib|mesh-list
83763895|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763896|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83763897|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763898|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763899|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
83763900|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83763901|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83763902|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83763903|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83763904|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
83763905|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763906|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763907|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83763908|NCT00128635|Antibodies|antibodies|mesh-list
83763909|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83763910|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
83763911|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763912|NCT00009048|Levodopa|levodopa|mesh-list
83763913|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83763914|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83763915|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
83763916|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763917|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763918|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763919|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
83763920|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83763921|NCT00128557|Vitamin A|vitamin a|mesh-list
83763922|NCT00128557|Vitamins|vitamins|mesh-ancestor
83763923|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
83763924|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763925|NCT00128518|Perindopril|perindopril|mesh-list
83763926|NCT00128518|Indapamide|indapamide|mesh-list
83763927|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83763928|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
83763929|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83763930|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763931|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83763932|NCT00128518|Diuretics|diuretics|mesh-ancestor
83763933|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
83763934|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763935|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83763936|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763937|NCT00009204|Perphenazine|perphenazine|mesh-list
83763938|NCT00009204|Citalopram|citalopram|mesh-list
83763939|NCT00009204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83763940|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83763941|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83763942|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763943|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763944|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
83763945|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763946|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83763947|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
83763948|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83763949|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83763950|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83763951|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83763952|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83763953|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
83763954|NCT00394459|Anesthetics|anesthetics|mesh-list
83763955|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83763956|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763957|NCT00394498|Lenograstim|lenograstim|mesh-list
83763958|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83763959|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
83763960|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763961|NCT00394537|Labetalol|labetalol|mesh-list
83763962|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83763963|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83763964|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
83763965|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83763966|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83763967|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763968|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83763969|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
83763970|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
83763971|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763972|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83763973|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83763974|NCT00009555|Testosterone|testosterone|mesh-list
83763975|NCT00009555|Androgens|androgens|mesh-ancestor
83763976|NCT00009555|Hormones|hormones|mesh-ancestor
83763977|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763978|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763979|NCT00128479|Mifepristone|mifepristone|mesh-list
83763980|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83763981|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
83763982|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83763983|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83763984|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83763985|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83763986|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83763987|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
83763988|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83763989|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83763990|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
83763991|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83763992|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
83763993|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83763994|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83763995|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
83763996|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83763997|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
83763998|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83763999|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764000|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83764001|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
83764002|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
83764003|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83764004|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
83764005|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83764006|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764007|NCT00128401|Cycloserine|cycloserine|mesh-list
83764008|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83764009|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764010|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83764011|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
83764012|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83764013|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
83764014|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764015|NCT00128323|Nystatin|nystatin|mesh-list
82919218|NCT02049034|Lixisenatide|lixisenatide|mesh-list
83764016|NCT00128323|Gentian Violet|gentian violet|mesh-list
83764017|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83764018|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83764019|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764020|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
83764021|NCT00128323|Ionophores|ionophores|mesh-ancestor
83764022|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83764023|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764024|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83764025|NCT00009672|Morphine|morphine|mesh-list
83764026|NCT00009672|Nortriptyline|nortriptyline|mesh-list
83764027|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83764028|NCT00009672|Narcotics|narcotics|mesh-ancestor
83764029|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83764030|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764031|NCT00009672|Analgesics|analgesics|mesh-ancestor
83764032|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
83764033|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764034|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83764035|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
83764036|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83764037|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83764038|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83764039|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83764040|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764041|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
83764042|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83764043|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83764044|NCT00018694|Cathartics|cathartics|mesh-ancestor
83764045|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83764046|NCT00018733|Paroxetine|paroxetine|mesh-list
83764047|NCT00018733|Desipramine|desipramine|mesh-list
83764048|NCT00018733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83764049|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83764050|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83764051|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764052|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83764053|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
83764054|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764055|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83764056|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
83764057|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83764058|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83764059|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83764060|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764061|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83764062|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83764063|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
83764064|NCT00018850|Haloperidol|haloperidol|mesh-list
83764065|NCT00018850|Ondansetron|ondansetron|mesh-list
83764066|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
83764067|NCT00018850|Nicotine|nicotine|mesh-list
83764068|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83764069|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
83764070|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764071|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764072|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83764073|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83764074|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
83764075|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83764076|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764077|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
83764078|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83764079|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
83764080|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
83764081|NCT00018850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83764082|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83764083|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
83764084|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83764085|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83764086|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83764087|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83764088|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83764089|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
82919292|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
83764090|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83764091|NCT00009750|Cyclosporine|cyclosporine|mesh-list
83764092|NCT00009750|Paclitaxel|paclitaxel|mesh-list
83764093|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83764094|NCT00009750|Antibodies|antibodies|mesh-list
83764095|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
83764096|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83764097|NCT00009750|Cyclosporins|cyclosporins|mesh-list
83764098|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764099|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764100|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764101|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764102|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764103|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764104|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
83764105|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764106|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764107|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764108|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
83764109|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764110|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83764111|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764112|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83764113|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
83764114|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83764115|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
83764116|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764117|NCT00019084|Aldesleukin|aldesleukin|mesh-list
83764118|NCT00019084|Vaccines|vaccines|mesh-list
83764119|NCT00019084|Sargramostim|sargramostim|mesh-list
83764120|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
83764121|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764122|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764123|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83764124|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83764125|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
83764126|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764127|NCT00019123|Thalidomide|thalidomide|mesh-list
83764128|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764129|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
83764130|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764131|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
83764132|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83764133|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764134|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83764135|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83764136|NCT00019123|Growth Substances|growth substances|mesh-ancestor
83764137|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764138|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764139|NCT00019240|Cidofovir|cidofovir|mesh-list
83764140|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
83764141|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764142|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764143|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764144|NCT00019357|Aldesleukin|aldesleukin|mesh-list
83764145|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764146|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83764147|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83764148|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
83764149|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764150|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83764151|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
83764152|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83764153|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
83764154|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764155|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83764156|NCT00019396|Protective Agents|protective agents|mesh-ancestor
83764157|NCT00009828|Leucovorin|leucovorin|mesh-list
83764158|NCT00009828|Paclitaxel|paclitaxel|mesh-list
83764159|NCT00009828|Tegafur|tegafur|mesh-list
83764160|NCT00009828|Calcium|calcium|mesh-list
83764161|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
83764162|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764163|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764164|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764165|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764166|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764167|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764168|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764169|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764170|NCT00009828|Antidotes|antidotes|mesh-ancestor
83764171|NCT00009828|Protective Agents|protective agents|mesh-ancestor
83764172|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764173|NCT00009828|Vitamins|vitamins|mesh-ancestor
83764174|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
83764175|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764176|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
83764177|NCT00019435|Immunotoxins|immunotoxins|mesh-list
83764178|NCT00019435|Immunoconjugates|immunoconjugates|mesh-ancestor
83764179|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
83764180|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764181|NCT00019474|Interferons|interferons|mesh-list
83764182|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
83764183|NCT00019474|Fluorouracil|fluorouracil|mesh-list
83764184|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
83764185|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
83764186|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764187|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764188|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764189|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764190|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
83764191|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764192|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
83764193|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764194|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
83764195|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764196|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83764197|NCT00019513|Leucovorin|leucovorin|mesh-list
83764198|NCT00019513|Gemcitabine|gemcitabine|mesh-list
83764199|NCT00019513|Fluorouracil|fluorouracil|mesh-list
83764200|NCT00019513|Calcium|calcium|mesh-list
83764201|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
83764202|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764203|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
83764204|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764205|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764206|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764207|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764208|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764209|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
83764210|NCT00019513|Antidotes|antidotes|mesh-ancestor
83764211|NCT00019513|Protective Agents|protective agents|mesh-ancestor
83764212|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764213|NCT00019513|Vitamins|vitamins|mesh-ancestor
83764214|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
83764215|NCT00019552|Irofulven|irofulven|mesh-list
83764216|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764217|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
83764218|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764219|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764220|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
83764221|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764222|NCT00019591|Aldesleukin|aldesleukin|mesh-list
83764223|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764224|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83764225|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83764226|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
83764227|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764228|NCT00019630|Doxorubicin|doxorubicin|mesh-list
83764229|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83764230|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83764231|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764232|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83764233|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764234|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764235|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764236|NCT00019669|Aldesleukin|aldesleukin|mesh-list
83764237|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764238|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83764239|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83764240|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
83764241|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764242|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
83764243|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764244|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83764245|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834928|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919442|NCT03809949|Fentanyl|fentanyl|mesh-list
83764246|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764248|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764249|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
83764250|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764251|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764252|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83764253|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764254|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
83764255|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764256|NCT00019825|Decitabine|decitabine|mesh-list
83764257|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764258|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
83764259|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764260|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764261|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764262|NCT00019864|Leucovorin|leucovorin|mesh-list
83764263|NCT00019864|Doxorubicin|doxorubicin|mesh-list
83764264|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83764265|NCT00019864|Methotrexate|methotrexate|mesh-list
83764266|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
83764267|NCT00019864|Razoxane|razoxane|mesh-list
83764268|NCT00019864|Calcium|calcium|mesh-list
83764269|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
83764270|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764271|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83764272|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83764273|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764274|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764275|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764276|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764277|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764278|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83764279|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
83764280|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83764281|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764282|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
83764283|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
83764284|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83764285|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764286|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
83764287|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764288|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83764289|NCT00019864|Antidotes|antidotes|mesh-ancestor
83764290|NCT00019864|Protective Agents|protective agents|mesh-ancestor
83764291|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764292|NCT00019864|Vitamins|vitamins|mesh-ancestor
83764293|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
83764294|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83764295|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764296|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764297|NCT00020176|Cyclosporine|cyclosporine|mesh-list
83764298|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
83764299|NCT00020176|Fludarabine|fludarabine|mesh-list
83764300|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
83764301|NCT00020176|Cyclosporins|cyclosporins|mesh-list
83764302|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764303|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
83764304|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764305|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764306|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764307|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
83764308|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764309|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764310|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83764311|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764312|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
83764313|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764314|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
83764315|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764316|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
83764317|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83764318|NCT00020254|Aldesleukin|aldesleukin|mesh-list
83764319|NCT00020254|Nilutamide|nilutamide|mesh-list
83764320|NCT00020254|Vaccines|vaccines|mesh-list
83764321|NCT00020254|Sargramostim|sargramostim|mesh-list
83764322|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
83764323|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764324|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764325|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83764326|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83764327|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
83764328|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764329|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
83764330|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
83764331|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83764332|NCT00009984|Thalidomide|thalidomide|mesh-list
83764333|NCT00009984|Fludarabine|fludarabine|mesh-list
83764334|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
83764335|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764336|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764337|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
83764338|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764339|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764340|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
83764341|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764342|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
83764343|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83764344|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764345|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83764346|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83764347|NCT00009984|Growth Substances|growth substances|mesh-ancestor
83764348|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764349|NCT00020332|Docetaxel|docetaxel|mesh-list
83764350|NCT00020332|Alvocidib|alvocidib|mesh-list
83764351|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764352|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764353|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764354|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764355|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764356|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764357|NCT00020332|Growth Substances|growth substances|mesh-ancestor
83764358|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764359|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83764360|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764361|NCT00020371|Lenograstim|lenograstim|mesh-list
83764362|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83764363|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
83764364|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764365|NCT00020410|Antibodies|antibodies|mesh-list
83764366|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83764367|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
83764368|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764369|NCT00020449|Paclitaxel|paclitaxel|mesh-list
83764370|NCT00020449|Doxorubicin|doxorubicin|mesh-list
83764371|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83764372|NCT00020449|Interleukin-12|interleukin-12|mesh-list
83764373|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764374|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764375|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764376|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764377|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764378|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764379|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83764380|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83764381|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764382|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764383|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83764384|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
83764385|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764386|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83764387|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83764388|NCT00020449|Growth Substances|growth substances|mesh-ancestor
83764389|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764390|NCT00010023|Capecitabine|capecitabine|mesh-list
83764391|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764392|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764393|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
83764394|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764395|NCT00020488|Leucovorin|leucovorin|mesh-list
83764396|NCT00020488|Fluorouracil|fluorouracil|mesh-list
82919591|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764397|NCT00020488|Irinotecan|irinotecan|mesh-list
83764398|NCT00020488|Calcium|calcium|mesh-list
83764400|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764401|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764402|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
83764403|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764404|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764405|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764406|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764407|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
83764408|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83764409|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764410|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764411|NCT00020488|Antidotes|antidotes|mesh-ancestor
83764412|NCT00020488|Protective Agents|protective agents|mesh-ancestor
83764413|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764414|NCT00020488|Vitamins|vitamins|mesh-ancestor
83764415|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
83764416|NCT00020527|Caspofungin|caspofungin|mesh-list
83764417|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
83764418|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764419|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764420|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764421|NCT00020566|Dactinomycin|dactinomycin|mesh-list
83764422|NCT00020566|Doxorubicin|doxorubicin|mesh-list
83764423|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83764424|NCT00020566|Etoposide|etoposide|mesh-list
83764425|NCT00020566|Vincristine|vincristine|mesh-list
83764426|NCT00020566|Melphalan|melphalan|mesh-list
83764427|NCT00020566|Busulfan|busulfan|mesh-list
83764428|NCT00020566|Ifosfamide|ifosfamide|mesh-list
83764429|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83764430|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764431|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83764432|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764433|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764434|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764435|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764436|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764437|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764438|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764439|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764440|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
83764441|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83764442|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764443|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
83764444|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764445|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83764446|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764447|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83764448|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83764449|NCT00010062|Fluorouracil|fluorouracil|mesh-list
83764450|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
83764451|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764452|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764453|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764454|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764455|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
83764456|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764457|NCT00020605|Naloxone|naloxone|mesh-list
83764458|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83764459|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764460|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
83764461|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764462|NCT00020644|Gemcitabine|gemcitabine|mesh-list
83764463|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764464|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
83764465|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764466|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764467|NCT00020761|Paclitaxel|paclitaxel|mesh-list
83764468|NCT00020761|Irinotecan|irinotecan|mesh-list
83764469|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764470|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919667|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83764471|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764472|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764473|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764474|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764475|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83764476|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764477|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764478|NCT00020800|Rituximab|rituximab|mesh-list
83764479|NCT00020800|Fludarabine|fludarabine|mesh-list
83764480|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
83764481|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83764482|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764483|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
83764484|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764485|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764486|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764487|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
83764488|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764489|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764490|NCT00020839|Temozolomide|temozolomide|mesh-list
83764491|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764492|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
83764493|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764494|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764495|NCT00010140|Tamoxifen|tamoxifen|mesh-list
83764496|NCT00010140|Docetaxel|docetaxel|mesh-list
83764497|NCT00010140|Epirubicin|epirubicin|mesh-list
83764498|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764499|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764500|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764501|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764502|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764503|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83764504|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83764505|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764506|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764507|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83764508|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
83764509|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83764510|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764511|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83764512|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83764513|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83764514|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83764515|NCT00020878|Celecoxib|celecoxib|mesh-list
83764516|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83764517|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83764518|NCT00020878|Analgesics|analgesics|mesh-ancestor
83764519|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
83764520|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764521|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764522|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83764523|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764524|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83764525|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83764526|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764527|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764528|NCT00020917|Leucovorin|leucovorin|mesh-list
83764529|NCT00020917|Fluorouracil|fluorouracil|mesh-list
83764530|NCT00020917|Irinotecan|irinotecan|mesh-list
83764531|NCT00020917|Cetuximab|cetuximab|mesh-list
83764532|NCT00020917|Calcium|calcium|mesh-list
83764533|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
83764534|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764535|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764536|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
83764537|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764538|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764539|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764540|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764541|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
83764542|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83764543|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764544|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764545|NCT00020917|Antidotes|antidotes|mesh-ancestor
82919743|NCT03788733|Protective Agents|protective agents|mesh-ancestor
82919746|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
83764546|NCT00020917|Protective Agents|protective agents|mesh-ancestor
83764547|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764548|NCT00020917|Vitamins|vitamins|mesh-ancestor
83764549|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
83764550|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83764551|NCT00021034|Taurolidine|taurolidine|mesh-list
83764552|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764553|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83764554|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764555|NCT00010179|Lurtotecan|lurtotecan|mesh-list
83764556|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764557|NCT00021073|Leucovorin|leucovorin|mesh-list
83764558|NCT00021073|Fluorouracil|fluorouracil|mesh-list
83764559|NCT00021073|Irinotecan|irinotecan|mesh-list
83764560|NCT00021073|Alvocidib|alvocidib|mesh-list
83764561|NCT00021073|Calcium|calcium|mesh-list
83764562|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
83764563|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764564|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764565|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
83764566|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764567|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764568|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764569|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764570|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
83764571|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83764572|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764573|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764574|NCT00021073|Antidotes|antidotes|mesh-ancestor
83764575|NCT00021073|Protective Agents|protective agents|mesh-ancestor
83764576|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764577|NCT00021073|Vitamins|vitamins|mesh-ancestor
83764578|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
83764579|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764580|NCT00021073|Growth Substances|growth substances|mesh-ancestor
83764581|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83764582|NCT00021112|Etoposide|etoposide|mesh-list
83764583|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764584|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764585|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83764586|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764587|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764588|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764589|NCT00000122|Fluorouracil|fluorouracil|mesh-list
83764590|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
83764591|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764592|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764593|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764594|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764595|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
83764596|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764597|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
83764598|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83764599|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764600|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
83764601|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764602|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
83764603|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764604|NCT00021307|Carboplatin|carboplatin|mesh-list
83764605|NCT00021307|Temozolomide|temozolomide|mesh-list
83764606|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764607|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764608|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
83764609|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764610|NCT00021346|Carboplatin|carboplatin|mesh-list
83764611|NCT00021346|Gemcitabine|gemcitabine|mesh-list
83764612|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764613|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764614|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
83764615|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764616|NCT00021385|Squalamine|squalamine|mesh-list
83764617|NCT00021385|Carboplatin|carboplatin|mesh-list
83764618|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764619|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83764620|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764621|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83764622|NCT00021385|Protective Agents|protective agents|mesh-ancestor
83764623|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764624|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83764625|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83764626|NCT00021385|Growth Substances|growth substances|mesh-ancestor
83764627|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764629|NCT00021463|Zidovudine|zidovudine|mesh-list
83764630|NCT00021463|Efavirenz|efavirenz|mesh-list
83764631|NCT00021463|Nevirapine|nevirapine|mesh-list
83764632|NCT00021463|Abacavir|abacavir|mesh-list
83764633|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
83764634|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83764635|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83764636|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764637|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764638|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
83764639|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764640|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83764641|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83764642|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
83764643|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83764644|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83764645|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83764646|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83764647|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83764648|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83764649|NCT00021502|Chrysarobin|chrysarobin|mesh-list
83764650|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83764651|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83764652|NCT00021502|Analgesics|analgesics|mesh-ancestor
83764653|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
83764654|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764655|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764656|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83764657|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764658|NCT00000134|Ganciclovir|ganciclovir|mesh-list
83764659|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83764660|NCT00000134|Foscarnet|foscarnet|mesh-list
83764661|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
83764662|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764663|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83764664|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764665|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764666|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83764667|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
83764668|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764669|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
83764670|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764671|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764672|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764673|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
83764674|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764675|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764676|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83764677|NCT00010452|Picibanil|picibanil|mesh-list
83764678|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764679|NCT00394693|Interferons|interferons|mesh-list
83764680|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
83764681|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764682|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
83764683|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764684|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83764685|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764686|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764687|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764688|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764689|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764690|NCT00021814|Doxazosin|doxazosin|mesh-list
83764691|NCT00021814|Finasteride|finasteride|mesh-list
83764692|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83764693|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83764694|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764695|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764696|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
82919893|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83764697|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83764698|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764699|NCT00021814|Urological Agents|urological agents|mesh-ancestor
83764700|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83764701|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83764702|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83764703|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83764704|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
83764705|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83764706|NCT00019318|Romidepsin|romidepsin|mesh-list
83764707|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83764708|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764709|NCT00019318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83764710|NCT00019318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764711|NCT00019318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764712|NCT00022009|Gemcitabine|gemcitabine|mesh-list
83764713|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764714|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
83764715|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764716|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764717|NCT00388661|Melatonin|melatonin|mesh-list
83764718|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
83764719|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764720|NCT00388661|Protective Agents|protective agents|mesh-ancestor
83764721|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764722|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83764723|NCT00022048|Bevacizumab|bevacizumab|mesh-list
83764724|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83764725|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764726|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83764727|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83764728|NCT00022048|Growth Substances|growth substances|mesh-ancestor
83764729|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764730|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764731|NCT00022087|Vitamin D|vitamin d|mesh-list
83764732|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
83764733|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
83764734|NCT00022087|Calcium|calcium|mesh-list
83764735|NCT00022087|Vitamins|vitamins|mesh-ancestor
83764736|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
83764737|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764738|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83764739|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83764740|NCT00388700|Leucovorin|leucovorin|mesh-list
83764741|NCT00388700|Bevacizumab|bevacizumab|mesh-list
83764742|NCT00388700|Fluorouracil|fluorouracil|mesh-list
83764743|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83764744|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764745|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83764746|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83764747|NCT00388700|Growth Substances|growth substances|mesh-ancestor
83764748|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764749|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
83764750|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
83764751|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764752|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764753|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764754|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
83764755|NCT00388700|Antidotes|antidotes|mesh-ancestor
83764756|NCT00388700|Protective Agents|protective agents|mesh-ancestor
83764757|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764758|NCT00388700|Vitamins|vitamins|mesh-ancestor
83764759|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
83764760|NCT00022126|Cytarabine|cytarabine|mesh-list
83764761|NCT00022126|Cyclosporine|cyclosporine|mesh-list
83764762|NCT00022126|Dexamethasone|dexamethasone|mesh-list
83764763|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
83764764|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
83764765|NCT00022126|Doxorubicin|doxorubicin|mesh-list
83764766|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83764767|NCT00022126|Methotrexate|methotrexate|mesh-list
83764768|NCT00022126|Vincristine|vincristine|mesh-list
83764769|NCT00022126|Daunorubicin|daunorubicin|mesh-list
83764770|NCT00022126|Asparaginase|asparaginase|mesh-list
83764771|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
83764772|NCT00022126|Pegaspargase|pegaspargase|mesh-list
83764773|NCT00022126|Thioguanine|thioguanine|mesh-list
83764774|NCT00022126|Cyclosporins|cyclosporins|mesh-list
83764775|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83764776|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
83764777|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764778|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764779|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764780|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
83764781|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764782|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764783|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83764784|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83764785|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
83764786|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
83764787|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764788|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83764789|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
83764790|NCT00022126|Hormones|hormones|mesh-ancestor
83764791|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83764792|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83764793|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83764794|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83764795|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83764796|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764797|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83764798|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
83764799|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83764800|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83764801|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
83764802|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
83764803|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83764804|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83764805|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
83764806|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764807|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764808|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764809|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764810|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764811|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
83764812|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83764813|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83764814|NCT00022126|Protective Agents|protective agents|mesh-ancestor
83764815|NCT00022165|Selenium|selenium|mesh-list
83764816|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
83764817|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764818|NCT00022165|Protective Agents|protective agents|mesh-ancestor
83764819|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764820|NCT00022165|Trace Elements|trace elements|mesh-ancestor
83764821|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
83764822|NCT00022204|Vitamin E|vitamin e|mesh-list
83764823|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
83764824|NCT00022204|Vitamins|vitamins|mesh-ancestor
83764825|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
83764826|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764827|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
83764828|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764829|NCT00022204|Protective Agents|protective agents|mesh-ancestor
83764830|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83764831|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764832|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83764833|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83764834|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
83764835|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83764836|NCT00388739|Prednisolone|prednisolone|mesh-list
83764837|NCT00388739|Budesonide|budesonide|mesh-list
83764838|NCT00388739|Albuterol|albuterol|mesh-list
83764839|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83764840|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
83764841|NCT00388739|Hormones|hormones|mesh-ancestor
83764842|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83764843|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764844|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83764845|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764846|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
83764847|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764848|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82920044|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
82920046|NCT03785067|Amlodipine|amlodipine|mesh-list
83764849|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83764850|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
83764851|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
83764852|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83764853|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83764854|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83764855|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83764856|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
83764857|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83764858|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764859|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
83764860|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83764861|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764862|NCT00022321|Immunotoxins|immunotoxins|mesh-ancestor
83764863|NCT00022321|Immunoconjugates|immunoconjugates|mesh-ancestor
83764864|NCT00022321|Immunologic Factors|immunologic factors|mesh-ancestor
83764865|NCT00022321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764866|NCT00022360|Taurolidine|taurolidine|mesh-list
83764867|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764868|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83764869|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764870|NCT00022399|Celecoxib|celecoxib|mesh-list
83764871|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83764872|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83764873|NCT00022399|Analgesics|analgesics|mesh-ancestor
83764874|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
83764875|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764876|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764877|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83764878|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764879|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83764880|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83764881|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764882|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764883|NCT00000143|Ganciclovir|ganciclovir|mesh-list
83764884|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83764885|NCT00000143|Cidofovir|cidofovir|mesh-list
83764886|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
83764887|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764888|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83764889|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764890|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764891|NCT00022438|Aldesleukin|aldesleukin|mesh-list
83764892|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
83764893|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764894|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83764895|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83764896|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
83764897|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83764898|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83764899|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
83764900|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764901|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
83764902|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83764903|NCT00010686|Estrogens|estrogens|mesh-ancestor
83764904|NCT00010686|Hormones|hormones|mesh-ancestor
83764905|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83764906|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764907|NCT00022555|Vincristine|vincristine|mesh-list
83764908|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
83764909|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83764910|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764911|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83764912|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83764913|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83764914|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764915|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83764916|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
83764917|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764918|NCT00000146|Prednisone|prednisone|mesh-list
83764919|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
83764920|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83764921|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83764922|NCT00000146|Prednisolone|prednisolone|mesh-list
83764923|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
83764924|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83764925|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
83764926|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83764927|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
83764928|NCT00000146|Hormones|hormones|mesh-ancestor
83764929|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83764930|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764931|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83764932|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764933|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
83764934|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
83764935|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764936|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83764937|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83764938|NCT00000146|Protective Agents|protective agents|mesh-ancestor
83764939|NCT00010725|Vitamins|vitamins|mesh-list
83764940|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
83764941|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764942|NCT00022594|Lurtotecan|lurtotecan|mesh-list
83764943|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764944|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83764945|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83764946|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83764947|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83764948|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764949|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764950|NCT00022711|Temozolomide|temozolomide|mesh-list
83764951|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83764952|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
83764953|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764954|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764955|NCT00010842|Vitamin E|vitamin e|mesh-list
83764956|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
83764957|NCT00010842|Selenium|selenium|mesh-list
83764958|NCT00010842|Vitamins|vitamins|mesh-ancestor
83764959|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
83764960|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764961|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
83764962|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764963|NCT00010842|Protective Agents|protective agents|mesh-ancestor
83764964|NCT00010842|Trace Elements|trace elements|mesh-ancestor
83764965|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
83764966|NCT00000152|Aspirin|aspirin|mesh-list
83764967|NCT00000152|Beta Carotene|beta carotene|mesh-list
83764968|NCT00000152|Carotenoids|carotenoids|mesh-list
83764969|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83764970|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83764971|NCT00000152|Analgesics|analgesics|mesh-ancestor
83764972|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
83764973|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83764974|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764975|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83764976|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83764977|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83764978|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83764979|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764980|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83764981|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83764982|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83764983|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
83764984|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
83764985|NCT00000152|Protective Agents|protective agents|mesh-ancestor
83764986|NCT00000152|Provitamins|provitamins|mesh-ancestor
83764987|NCT00000152|Vitamins|vitamins|mesh-ancestor
82920192|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82920193|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82920194|NCT01560663|Carboplatin|carboplatin|mesh-list
82920195|NCT01560663|Docetaxel|docetaxel|mesh-list
82920196|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920197|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
82920198|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
82920199|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
82920200|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920201|NCT02059564|Liraglutide|liraglutide|mesh-list
83764988|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
82920202|NCT02059564|Exenatide|exenatide|mesh-list
83764989|NCT00010881|Antioxidants|antioxidants|mesh-list
83764990|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83764991|NCT00010881|Protective Agents|protective agents|mesh-ancestor
83764992|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764993|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
83764994|NCT00022906|Antibodies|antibodies|mesh-list
83764995|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
83764996|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83764997|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83764998|NCT00022945|Prednisone|prednisone|mesh-list
83764999|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
83765000|NCT00022945|Doxorubicin|doxorubicin|mesh-list
83765001|NCT00022945|Vincristine|vincristine|mesh-list
83765002|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
83765003|NCT00022945|Antibodies|antibodies|mesh-list
83765004|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765005|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
83765006|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765007|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765008|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765009|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
83765010|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765011|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765012|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765013|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765014|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765015|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765016|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765017|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83765018|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
83765019|NCT00022945|Hormones|hormones|mesh-ancestor
83765020|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765021|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83765022|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765023|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765024|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765025|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765026|NCT00023218|Ritonavir|ritonavir|mesh-list
83765027|NCT00023218|Lopinavir|lopinavir|mesh-list
83765028|NCT00023218|Efavirenz|efavirenz|mesh-list
83765029|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83765030|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83765031|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
83765032|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765033|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765034|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83765035|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83765036|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
83765037|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765038|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83765039|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83765040|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83765041|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765042|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83765043|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83765044|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83765045|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83765046|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83765047|NCT00394966|Rolapitant|rolapitant|mesh-list
83765048|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83765049|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765050|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765051|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765052|NCT00000170|Atropine|atropine|mesh-list
83765053|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83765054|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83765055|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83765056|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
83765057|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765058|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765059|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83765060|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
83765061|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
83765062|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
83765063|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83765064|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83765065|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
83765066|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765067|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765068|NCT02024607|Leucovorin|leucovorin|mesh-list
83765069|NCT02024607|Bevacizumab|bevacizumab|mesh-list
83765070|NCT02024607|Fluorouracil|fluorouracil|mesh-list
83765071|NCT02024607|Capecitabine|capecitabine|mesh-list
83765072|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
83765073|NCT02024607|Irinotecan|irinotecan|mesh-list
83765074|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83765075|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765076|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765077|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765078|NCT02024607|Growth Substances|growth substances|mesh-ancestor
83765079|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765080|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765081|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
83765082|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765083|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765084|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765085|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
83765086|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83765087|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765088|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765089|NCT02024607|Antidotes|antidotes|mesh-ancestor
83765090|NCT02024607|Protective Agents|protective agents|mesh-ancestor
83765091|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
83765092|NCT02024607|Vitamins|vitamins|mesh-ancestor
83765093|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
83765094|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
83765095|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83765096|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
83765097|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765098|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765099|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83765100|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
83765101|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83765102|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
83765103|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765104|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765105|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83765106|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
83765107|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
83765108|NCT00023296|Protective Agents|protective agents|mesh-ancestor
83765109|NCT00023335|Isoniazid|isoniazid|mesh-list
83765110|NCT00023335|Rifapentine|rifapentine|mesh-list
83765111|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
83765112|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765113|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765114|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83765115|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83765116|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
83765117|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765118|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83765119|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83765120|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
83765121|NCT00000173|Vitamin E|vitamin e|mesh-list
83765122|NCT00000173|Donepezil|donepezil|mesh-list
83765123|NCT00000173|Vitamins|vitamins|mesh-ancestor
83765124|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
83765125|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765126|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83765127|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765128|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765129|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
83765130|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765131|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
83765132|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
83765133|NCT00000173|Protective Agents|protective agents|mesh-ancestor
83765134|NCT00023374|Rifampin|rifampin|mesh-list
83765135|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
83765136|NCT00023374|Ethambutol|ethambutol|mesh-list
83765137|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83765138|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
83765139|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765140|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765141|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
82920332|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
83765142|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765143|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765144|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765145|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83765146|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83765147|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83765148|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83765149|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83765150|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83765151|NCT00023413|Efavirenz|efavirenz|mesh-list
83765152|NCT00023413|Rifabutin|rifabutin|mesh-list
83765153|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83765154|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765155|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765156|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765157|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
83765158|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765159|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83765160|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83765161|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83765162|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83765163|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83765164|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83765165|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765166|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83765167|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
83765168|NCT00023530|Thalidomide|thalidomide|mesh-list
83765169|NCT00023530|Fluconazole|fluconazole|mesh-list
83765170|NCT00023530|Voriconazole|voriconazole|mesh-list
83765171|NCT00023530|Dexamethasone|dexamethasone|mesh-list
83765172|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83765173|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
83765174|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
83765175|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765176|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765177|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83765178|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
83765179|NCT00023530|Hormones|hormones|mesh-ancestor
83765180|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765181|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83765182|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765183|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765184|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
83765185|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
83765186|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765187|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765188|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765189|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765190|NCT00023530|Growth Substances|growth substances|mesh-ancestor
83765191|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765192|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
83765193|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83765194|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83765195|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765196|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765197|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83765198|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
83765199|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83765200|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83765201|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83765202|NCT00000176|Progesterone|progesterone|mesh-list
83765203|NCT00000176|Estrogens|estrogens|mesh-list
83765204|NCT00000176|Progestins|progestins|mesh-ancestor
83765205|NCT00000176|Hormones|hormones|mesh-ancestor
83765206|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765207|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765208|NCT00000179|Haloperidol|haloperidol|mesh-list
83765209|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
83765210|NCT00000179|Trazodone|trazodone|mesh-list
83765211|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
83765212|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
83765213|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765214|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920412|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765215|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83765216|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83765217|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83765218|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83765219|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83765220|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83765221|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
83765222|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765223|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765224|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83765225|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83765226|NCT00000179|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83765227|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83765228|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83765229|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
83765230|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83765231|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
83765232|NCT00023725|Semaxinib|semaxinib|mesh-list
83765233|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765234|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765235|NCT00023725|Growth Substances|growth substances|mesh-ancestor
83765236|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765237|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765238|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765239|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765240|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765241|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765242|NCT00391404|Alendronate|alendronate|mesh-list
83765243|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83765244|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765245|NCT00000191|Carbamazepine|carbamazepine|mesh-list
83765246|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
83765247|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
83765248|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83765249|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83765250|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765251|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83765252|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83765253|NCT00000191|Analgesics|analgesics|mesh-ancestor
83765254|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
83765255|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765256|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83765257|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83765258|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765259|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83765260|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83765261|NCT00023842|Mitomycins|mitomycins|mesh-list
83765262|NCT00023842|Mitomycin|mitomycin|mesh-list
83765263|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
83765264|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765265|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765266|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
83765267|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765268|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765269|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765270|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83765271|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
83765272|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765273|NCT00000221|Buprenorphine|buprenorphine|mesh-list
83765274|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83765275|NCT00000221|Narcotics|narcotics|mesh-ancestor
83765276|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83765277|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765278|NCT00000221|Analgesics|analgesics|mesh-ancestor
83765279|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
83765280|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765281|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83765282|NCT00023881|Bortezomib|bortezomib|mesh-list
83765283|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765284|NCT00023920|Cytarabine|cytarabine|mesh-list
83765285|NCT00023920|Bevacizumab|bevacizumab|mesh-list
83765286|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83765287|NCT00023920|Idarubicin|idarubicin|mesh-list
83765288|NCT00023920|Antibodies|antibodies|mesh-list
82920486|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83765290|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83765291|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765292|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765293|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765294|NCT00023920|Growth Substances|growth substances|mesh-ancestor
83765295|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765296|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765297|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
83765298|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765299|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
83765300|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765301|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
83765302|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765303|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765304|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765305|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765306|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765307|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765308|NCT00023959|Bevacizumab|bevacizumab|mesh-list
83765309|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83765310|NCT00023959|Fluorouracil|fluorouracil|mesh-list
83765311|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
83765312|NCT00023959|Antibodies|antibodies|mesh-list
83765313|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
83765314|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83765315|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765316|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765317|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765318|NCT00023959|Growth Substances|growth substances|mesh-ancestor
83765319|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765320|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765321|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
83765322|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
83765323|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765324|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765325|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765326|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
83765327|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765328|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765329|NCT00023998|Leucovorin|leucovorin|mesh-list
83765330|NCT00023998|Doxorubicin|doxorubicin|mesh-list
83765331|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83765332|NCT00023998|Methotrexate|methotrexate|mesh-list
83765333|NCT00023998|Trastuzumab|trastuzumab|mesh-list
83765334|NCT00023998|Etoposide|etoposide|mesh-list
83765335|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
83765336|NCT00023998|Ifosfamide|ifosfamide|mesh-list
83765337|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
83765338|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765339|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765340|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765341|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765342|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765343|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765344|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765345|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83765346|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
83765347|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83765348|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765349|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
83765350|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
83765351|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83765352|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765353|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
83765354|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920559|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
82920560|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920561|NCT03776409|Vancomycin|vancomycin|mesh-list
82920562|NCT03776409|Tazobactam|tazobactam|mesh-list
82920563|NCT03776409|Piperacillin|piperacillin|mesh-list
82920564|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82920565|NCT03776409|Lactams|lactams|mesh-list
82920566|NCT03776409|beta-Lactams|beta-lactams|mesh-list
82920567|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82920568|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920570|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765355|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765356|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83765357|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765358|NCT00023998|Antidotes|antidotes|mesh-ancestor
83765359|NCT00023998|Protective Agents|protective agents|mesh-ancestor
83765360|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
83765361|NCT00023998|Vitamins|vitamins|mesh-ancestor
83765362|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
83765363|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765364|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
83765365|NCT00024115|Antibodies|antibodies|mesh-list
83765366|NCT00024115|Immunotoxins|immunotoxins|mesh-list
83765367|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
83765368|NCT00024115|Immunomodulating Agents|immunomodulating agents|mesh-list
83765369|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765370|NCT00024115|Immunoconjugates|immunoconjugates|mesh-ancestor
83765371|NCT00024154|Trastuzumab|trastuzumab|mesh-list
83765372|NCT00024154|Gefitinib|gefitinib|mesh-list
83765373|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83765374|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765375|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765376|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765377|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765378|NCT00011076|Pirfenidone|pirfenidone|mesh-list
83765379|NCT00011076|Analgesics|analgesics|mesh-ancestor
83765380|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
83765381|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765382|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765383|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83765384|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83765385|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83765386|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765387|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765388|NCT00000248|Pergolide|pergolide|mesh-list
83765389|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
83765390|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
83765391|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765392|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765393|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765394|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
83765395|NCT00024193|Melphalan|melphalan|mesh-list
83765396|NCT00024193|Busulfan|busulfan|mesh-list
83765397|NCT00024193|Doxorubicin|doxorubicin|mesh-list
83765398|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83765399|NCT00024193|Etoposide|etoposide|mesh-list
83765400|NCT00024193|Vincristine|vincristine|mesh-list
83765401|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765402|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
83765403|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765404|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765405|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765406|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
83765407|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765408|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765409|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765410|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765411|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765412|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765413|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765414|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765415|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765416|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765417|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765418|NCT00024232|Antibodies|antibodies|mesh-list
83765419|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83765420|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
83765421|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765422|NCT00024271|Interferons|interferons|mesh-list
83765423|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
83765424|NCT00024271|Gemcitabine|gemcitabine|mesh-list
83765425|NCT00024271|Doxorubicin|doxorubicin|mesh-list
83765426|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83765427|NCT00024271|Mitomycins|mitomycins|mesh-list
83765428|NCT00024271|Mitomycin|mitomycin|mesh-list
83765429|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765430|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765431|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
83765432|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765433|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765434|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765435|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765436|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765437|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
83765438|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765439|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
83765440|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765441|NCT00024310|Folic Acid|folic acid|mesh-list
83765442|NCT00024310|Paclitaxel|paclitaxel|mesh-list
83765443|NCT00024310|Lometrexol|lometrexol|mesh-list
83765444|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765445|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765446|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765447|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765448|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765449|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765450|NCT00024310|Hematinics|hematinics|mesh-ancestor
83765451|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
83765452|NCT00024310|Vitamins|vitamins|mesh-ancestor
83765453|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
83765454|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765455|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765456|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
83765457|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83765458|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765459|NCT00024349|Fluorouracil|fluorouracil|mesh-list
83765460|NCT00024349|Mitomycins|mitomycins|mesh-list
83765461|NCT00024349|Mitomycin|mitomycin|mesh-list
83765462|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
83765463|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765464|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765465|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765466|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765467|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
83765468|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765469|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765470|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
83765471|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765472|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765473|NCT00000251|Isoflurane|isoflurane|mesh-list
83765474|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83765475|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
83765476|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
83765477|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83765478|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765479|NCT00024388|Paclitaxel|paclitaxel|mesh-list
83765480|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765481|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765482|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765483|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765484|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765485|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765486|NCT00024427|Gemcitabine|gemcitabine|mesh-list
83765487|NCT00024427|Fluorouracil|fluorouracil|mesh-list
83765488|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765489|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
83765490|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765491|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765492|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765493|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
83765494|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765495|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
83765496|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83765497|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
83765498|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
83765499|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83765500|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765501|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83765502|NCT00000257|Analgesics|analgesics|mesh-ancestor
83765503|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
83765504|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765505|NCT00024466|Vaccines|vaccines|mesh-list
82920712|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
83765506|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
83765507|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765508|NCT04733131|Abatacept|abatacept|mesh-list
83765509|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83765510|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765511|NCT04733131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83765512|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765513|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765514|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
83765515|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765516|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765518|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83765519|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
83765520|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765521|NCT00395239|Budesonide|budesonide|mesh-list
83765522|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83765523|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83765524|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
83765525|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765526|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765527|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83765528|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
83765529|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
83765530|NCT00395239|Hormones|hormones|mesh-ancestor
83765531|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765532|NCT00025012|Isotretinoin|isotretinoin|mesh-list
83765533|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
83765534|NCT00025051|Celecoxib|celecoxib|mesh-list
83765535|NCT00025051|Mitogens|mitogens|mesh-list
83765536|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83765537|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83765538|NCT00025051|Analgesics|analgesics|mesh-ancestor
83765539|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
83765540|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765541|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765542|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83765543|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765544|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83765545|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83765546|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765547|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765548|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765549|NCT00025090|Fluorouracil|fluorouracil|mesh-list
83765550|NCT00025090|Mitomycins|mitomycins|mesh-list
83765551|NCT00025090|Mitomycin|mitomycin|mesh-list
83765552|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765553|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
83765554|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765555|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765556|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765557|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
83765558|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765559|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765560|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
83765561|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765562|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765563|NCT00000368|Paroxetine|paroxetine|mesh-list
83765564|NCT00000368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83765565|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83765566|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83765567|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765568|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765569|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
83765570|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765571|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83765572|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
83765573|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83765574|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83765575|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83765576|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765577|NCT00025168|Gemcitabine|gemcitabine|mesh-list
83765578|NCT00025168|Irinotecan|irinotecan|mesh-list
83765579|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765580|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
82920788|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
82920795|NCT01321905|Vitamin D|vitamin d|mesh-list
83765581|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765582|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765583|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83765584|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765585|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765586|NCT00025207|Gefitinib|gefitinib|mesh-list
83765587|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765588|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765589|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765590|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765591|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
83765592|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765593|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765594|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765595|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765596|NCT00025285|Thalidomide|thalidomide|mesh-list
83765597|NCT00025285|Carboplatin|carboplatin|mesh-list
83765598|NCT00025285|Irinotecan|irinotecan|mesh-list
83765599|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765600|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83765601|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765602|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765603|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765604|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765605|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
83765606|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765607|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
83765608|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765609|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765610|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765611|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765612|NCT00025285|Growth Substances|growth substances|mesh-ancestor
83765613|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765614|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
83765615|NCT00025324|Thiotepa|thiotepa|mesh-list
83765616|NCT00025324|Carboplatin|carboplatin|mesh-list
83765617|NCT00025324|Etoposide|etoposide|mesh-list
83765618|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765619|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
83765620|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765621|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765622|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765623|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
83765624|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765625|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765626|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765627|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765628|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765629|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765630|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765631|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
83765632|NCT00025363|Ifosfamide|ifosfamide|mesh-list
83765633|NCT00025363|Doxorubicin|doxorubicin|mesh-list
83765634|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83765635|NCT00025363|Irinotecan|irinotecan|mesh-list
83765636|NCT00025363|Etoposide|etoposide|mesh-list
83765637|NCT00025363|Vincristine|vincristine|mesh-list
83765638|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
83765639|NCT00025363|Tirapazamine|tirapazamine|mesh-list
83765640|NCT00025363|Sargramostim|sargramostim|mesh-list
83765641|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765642|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
83765643|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765644|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765645|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765646|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
83765647|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765648|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765649|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765650|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765651|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765652|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765653|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765654|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83765655|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765656|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765657|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765658|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765659|NCT00025402|Interferons|interferons|mesh-list
83765660|NCT00025402|Cytarabine|cytarabine|mesh-list
83765661|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
83765662|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
83765663|NCT00025402|Busulfan|busulfan|mesh-list
83765664|NCT00025402|Etoposide|etoposide|mesh-list
83765665|NCT00025402|Idarubicin|idarubicin|mesh-list
83765666|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
83765667|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765668|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
83765669|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765670|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765671|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765672|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
83765673|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765674|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765675|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765676|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765677|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765678|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765679|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765680|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
83765681|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765682|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765683|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
83765684|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765685|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
83765686|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765687|NCT00025441|Dactinomycin|dactinomycin|mesh-list
83765688|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
83765689|NCT00025441|Ifosfamide|ifosfamide|mesh-list
83765690|NCT00025441|Carboplatin|carboplatin|mesh-list
83765691|NCT00025441|Doxorubicin|doxorubicin|mesh-list
83765692|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83765693|NCT00025441|Etoposide|etoposide|mesh-list
83765694|NCT00025441|Vincristine|vincristine|mesh-list
83765695|NCT00025441|Epirubicin|epirubicin|mesh-list
83765696|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765697|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
83765698|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765699|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765700|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765701|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
83765702|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765703|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765704|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765705|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765706|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765707|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765708|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765709|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765710|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765711|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765712|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765713|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765714|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765715|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83765716|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765717|NCT00000395|Folic Acid|folic acid|mesh-list
83765718|NCT00000395|Leucovorin|leucovorin|mesh-list
83765719|NCT00000395|Methotrexate|methotrexate|mesh-list
83765720|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
83765721|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83765722|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
83765723|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83765724|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765725|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765726|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
83765727|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765728|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765729|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
83765730|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765731|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83765732|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765733|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
83765734|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765735|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765736|NCT00000395|Hematinics|hematinics|mesh-ancestor
83765737|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
83765738|NCT00000395|Vitamins|vitamins|mesh-ancestor
83765739|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
83765740|NCT00000395|Antidotes|antidotes|mesh-ancestor
83765741|NCT00000395|Protective Agents|protective agents|mesh-ancestor
83765742|NCT00025480|Paclitaxel|paclitaxel|mesh-list
83765743|NCT00025480|Carboplatin|carboplatin|mesh-list
83765744|NCT00025480|Tipifarnib|tipifarnib|mesh-list
83765745|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765746|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765747|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765748|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765749|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765750|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765751|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
83765752|NCT00025519|Thalidomide|thalidomide|mesh-list
83765753|NCT00025519|Fludarabine|fludarabine|mesh-list
83765754|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
83765755|NCT00025519|Tacrolimus|tacrolimus|mesh-list
83765756|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765757|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765758|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
83765759|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765760|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765761|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
83765762|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765763|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83765764|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765765|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765766|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83765767|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
83765768|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765769|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765770|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
83765771|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765772|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765773|NCT00025519|Growth Substances|growth substances|mesh-ancestor
83765774|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765775|NCT00025558|Carboplatin|carboplatin|mesh-list
83765776|NCT00025558|Temozolomide|temozolomide|mesh-list
83765777|NCT00025558|Thiotepa|thiotepa|mesh-list
83765778|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765779|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
83765780|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765781|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765782|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
83765783|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765784|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765785|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765786|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
83765787|NCT00025597|Carboplatin|carboplatin|mesh-list
83765788|NCT00025597|Doxorubicin|doxorubicin|mesh-list
83765789|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83765790|NCT00025597|Etoposide|etoposide|mesh-list
83765791|NCT00025597|Vincristine|vincristine|mesh-list
83765792|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765793|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
83765794|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765795|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765796|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765797|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
83765798|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765799|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765800|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765801|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83765802|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765803|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765804|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765805|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765806|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765807|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765808|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765809|NCT00025636|Cytarabine|cytarabine|mesh-list
83765810|NCT00025636|Dexamethasone|dexamethasone|mesh-list
83765811|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
83765812|NCT00025636|Melphalan|melphalan|mesh-list
83765813|NCT00025636|Carmustine|carmustine|mesh-list
83765815|NCT00025636|Etoposide|etoposide|mesh-list
83765816|NCT00025636|Vincristine|vincristine|mesh-list
83765817|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765818|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
83765819|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765820|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765821|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83765822|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
83765823|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765824|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765825|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83765826|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83765827|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
83765828|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
83765829|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83765830|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83765831|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
83765832|NCT00025636|Hormones|hormones|mesh-ancestor
83765833|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765834|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83765835|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83765836|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
83765837|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83765838|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765839|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
83765840|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
83765841|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765842|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83765843|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83765844|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83765845|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83765846|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83765847|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
83765848|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765849|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765850|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765851|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765852|NCT00025675|Gefitinib|gefitinib|mesh-list
83765853|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765854|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765855|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765856|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765857|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
83765858|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83765859|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765860|NCT00025792|Pramipexole|pramipexole|mesh-list
83765861|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
83765862|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765863|NCT00025792|Protective Agents|protective agents|mesh-ancestor
83765864|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765865|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83765866|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83765867|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
83765868|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
83765869|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83765870|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83765871|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83765872|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83765873|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
83765874|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83765875|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765876|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83765877|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83765878|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83765879|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765880|NCT00000419|Estrogens|estrogens|mesh-ancestor
83765881|NCT00000419|Hormones|hormones|mesh-ancestor
83765882|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765883|NCT00026104|Paclitaxel|paclitaxel|mesh-list
83765884|NCT00026104|Gemcitabine|gemcitabine|mesh-list
83765885|NCT00026104|Tipifarnib|tipifarnib|mesh-list
83765886|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82921096|NCT01561911|Antibodies|antibodies|mesh-list
83765887|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765888|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
83765889|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
83765890|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
83765891|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765892|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765893|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
83765894|NCT00026143|Interferons|interferons|mesh-list
83765895|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
83765896|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
83765897|NCT00026143|Interleukin-12|interleukin-12|mesh-list
83765898|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765899|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
83765900|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765901|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
83765902|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765903|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83765904|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765905|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765906|NCT00026143|Growth Substances|growth substances|mesh-ancestor
83765907|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765908|NCT00026182|Rituximab|rituximab|mesh-list
83765909|NCT00026182|Interleukin-12|interleukin-12|mesh-list
83765910|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83765911|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765912|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
83765913|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765914|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83765915|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83765916|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765917|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765918|NCT00026182|Growth Substances|growth substances|mesh-ancestor
83765919|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765920|NCT00026260|Semaxinib|semaxinib|mesh-list
83765921|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765922|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765923|NCT00026260|Growth Substances|growth substances|mesh-ancestor
83765924|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765925|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765926|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765927|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765928|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765929|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765930|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
83765931|NCT00026299|Gefitinib|gefitinib|mesh-list
83765932|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765933|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765934|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765935|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765936|NCT00026338|Gemcitabine|gemcitabine|mesh-list
83765937|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83765938|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83765939|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
83765940|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765941|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765942|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765943|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765944|NCT00026377|Leuprolide|leuprolide|mesh-list
83765945|NCT00026377|Goserelin|goserelin|mesh-list
83765946|NCT00026377|Flutamide|flutamide|mesh-list
83765947|NCT00026377|Bicalutamide|bicalutamide|mesh-list
83765948|NCT00026377|Semaxinib|semaxinib|mesh-list
83765949|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83765950|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
83765951|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83765952|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765953|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83765954|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765955|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
83765956|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
83765957|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765958|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765959|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765960|NCT00026377|Growth Substances|growth substances|mesh-ancestor
83765961|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
82921159|NCT03770013|Bupivacaine|bupivacaine|mesh-list
83765962|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83765963|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83765964|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83765965|NCT00026416|Interferons|interferons|mesh-list
83765966|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
83765967|NCT00026416|Thalidomide|thalidomide|mesh-list
83765968|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765969|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
83765970|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765971|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
83765972|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765973|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765974|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
83765975|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765976|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765977|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765978|NCT00026416|Growth Substances|growth substances|mesh-ancestor
83765979|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765980|NCT00026533|Thalidomide|thalidomide|mesh-list
83765981|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83765982|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
83765983|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765984|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
83765985|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83765986|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83765987|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83765988|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83765989|NCT00026533|Growth Substances|growth substances|mesh-ancestor
83765990|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
83765991|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83765993|NCT00026962|Progesterone|progesterone|mesh-list
83765994|NCT00026962|Estrogens|estrogens|mesh-ancestor
83765995|NCT00026962|Hormones|hormones|mesh-ancestor
83765996|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83765997|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83765998|NCT00026962|Progestins|progestins|mesh-ancestor
83765999|NCT00027040|Selegiline|selegiline|mesh-list
83766000|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
83766001|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766002|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83766003|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83766004|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83766005|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766006|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766007|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83766008|NCT00027040|Protective Agents|protective agents|mesh-ancestor
83766009|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766010|NCT00027079|Naltrexone|naltrexone|mesh-list
83766011|NCT00027079|Ondansetron|ondansetron|mesh-list
83766012|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83766013|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83766014|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766015|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
83766016|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766017|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
83766018|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
83766019|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83766020|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
83766021|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
83766022|NCT00027079|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83766023|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83766024|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
83766025|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766026|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766027|NCT00011778|Bortezomib|bortezomib|mesh-list
83766028|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766029|NCT00000425|Acetaminophen|acetaminophen|mesh-list
83766030|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83766031|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83766032|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766033|NCT00000425|Analgesics|analgesics|mesh-ancestor
83766034|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
83766035|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766036|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921235|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
83766037|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
83766038|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766039|NCT00000428|Amitriptyline|amitriptyline|mesh-list
83766040|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83766041|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
83766042|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766043|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766044|NCT00000428|Analgesics|analgesics|mesh-ancestor
83766045|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
83766046|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766047|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766048|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83766049|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83766050|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83766051|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766052|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
83766053|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766054|NCT00027391|Albuterol|albuterol|mesh-list
83766055|NCT00027391|Oxandrolone|oxandrolone|mesh-list
83766056|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83766057|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
83766058|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766059|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766060|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83766061|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
83766062|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
83766063|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83766064|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83766065|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83766066|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83766067|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83766068|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766069|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766070|NCT00027391|Androgens|androgens|mesh-ancestor
83766071|NCT00027391|Hormones|hormones|mesh-ancestor
83766072|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766073|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
83766074|NCT00000461|Niacin|niacin|mesh-list
83766075|NCT00000461|Pravastatin|pravastatin|mesh-list
83766076|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
83766077|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
83766078|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83766079|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
83766080|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766081|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83766082|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
83766083|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
83766084|NCT00000461|Vitamins|vitamins|mesh-ancestor
83766085|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
83766086|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766087|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83766088|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83766089|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766090|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83766091|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83766092|NCT00027508|Trabectedin|trabectedin|mesh-list
83766093|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766094|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
83766095|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766096|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766097|NCT00027547|Cytarabine|cytarabine|mesh-list
83766098|NCT00027547|Cyclosporine|cyclosporine|mesh-list
83766099|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
83766100|NCT00027547|Methotrexate|methotrexate|mesh-list
83766101|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
83766102|NCT00027547|Fludarabine|fludarabine|mesh-list
83766103|NCT00027547|Cyclosporins|cyclosporins|mesh-list
83766104|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83766105|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
83766106|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83766107|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766108|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766109|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
83766110|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766111|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766112|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
82921310|NCT03758469|Rifampin|rifampin|mesh-list
83766113|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766114|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83766115|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766116|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
83766117|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766118|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766119|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
83766120|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766121|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
83766122|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83766123|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766124|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83766125|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
83766126|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83766127|NCT00011895|Lamivudine|lamivudine|mesh-list
83766128|NCT00011895|Zidovudine|zidovudine|mesh-list
83766129|NCT00011895|Efavirenz|efavirenz|mesh-list
83766130|NCT00011895|Abacavir|abacavir|mesh-list
83766131|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83766132|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766133|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766134|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766135|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
83766136|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766137|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83766138|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83766139|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
83766140|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83766141|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83766142|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83766143|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83766144|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83766145|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83766146|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
83766147|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766148|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83766149|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766150|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766151|NCT00000464|Quinidine|quinidine|mesh-list
83766152|NCT00000464|Amiodarone|amiodarone|mesh-list
83766153|NCT00000464|Sotalol|sotalol|mesh-list
83766154|NCT00000464|Propafenone|propafenone|mesh-list
83766155|NCT00000464|Mexiletine|mexiletine|mesh-list
83766156|NCT00000464|Procainamide|procainamide|mesh-list
83766157|NCT00000464|Imipramine|imipramine|mesh-list
83766158|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83766159|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
83766160|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83766161|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83766162|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766163|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83766164|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83766165|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83766166|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766167|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83766168|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83766169|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83766170|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83766171|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83766172|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
83766173|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766174|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766175|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
83766176|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
83766177|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766178|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83766179|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
83766180|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766181|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83766182|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83766183|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83766184|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
83766185|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83766186|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82921382|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83766187|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766188|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83766189|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83766190|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
83766191|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83766192|NCT00027625|Temozolomide|temozolomide|mesh-list
83766193|NCT00027625|Gefitinib|gefitinib|mesh-list
83766194|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766195|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
83766196|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766197|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766198|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83766199|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766200|NCT00027664|Interferons|interferons|mesh-list
83766201|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
83766202|NCT00027664|Thalidomide|thalidomide|mesh-list
83766203|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766204|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
83766205|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766206|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
83766207|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766208|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766209|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
83766210|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83766211|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83766212|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83766213|NCT00027664|Growth Substances|growth substances|mesh-ancestor
83766214|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
83766215|NCT00027703|Bevacizumab|bevacizumab|mesh-list
83766216|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83766217|NCT00027703|Gemcitabine|gemcitabine|mesh-list
83766218|NCT00027703|Antibodies|antibodies|mesh-list
83766219|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
83766220|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83766221|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766222|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83766223|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83766224|NCT00027703|Growth Substances|growth substances|mesh-ancestor
83766225|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766226|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
83766227|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
83766228|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766229|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
83766230|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766231|NCT00011934|Interferons|interferons|mesh-list
83766232|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
83766233|NCT00011934|Sargramostim|sargramostim|mesh-list
83766234|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766235|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
83766236|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766237|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
83766238|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766239|NCT00027742|Interferons|interferons|mesh-list
83766240|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
83766241|NCT00027742|Temozolomide|temozolomide|mesh-list
83766242|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766243|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
83766244|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766245|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766246|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
83766247|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766248|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
83766249|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766250|NCT00027820|Cyclosporine|cyclosporine|mesh-list
83766251|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
83766252|NCT00027820|Fludarabine|fludarabine|mesh-list
83766253|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
83766254|NCT00027820|Cyclosporins|cyclosporins|mesh-list
83766255|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766256|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766257|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
83766258|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766259|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766260|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
83766261|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766262|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766263|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
83766264|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766265|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
83766266|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766267|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83766268|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766269|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83766270|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
83766271|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83766273|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766274|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83766275|NCT00011973|Protective Agents|protective agents|mesh-ancestor
83766276|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766277|NCT00027898|Carboplatin|carboplatin|mesh-list
83766278|NCT00027898|Etoposide|etoposide|mesh-list
83766279|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
83766280|NCT00027898|Bortezomib|bortezomib|mesh-list
83766281|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766282|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766283|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83766284|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83766285|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766286|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766287|NCT00027937|Aldesleukin|aldesleukin|mesh-list
83766288|NCT00027937|Paclitaxel|paclitaxel|mesh-list
83766289|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
83766290|NCT00027937|Melphalan|melphalan|mesh-list
83766291|NCT00027937|Busulfan|busulfan|mesh-list
83766292|NCT00027937|Thiotepa|thiotepa|mesh-list
83766293|NCT00027937|Sargramostim|sargramostim|mesh-list
83766294|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766295|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766296|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766297|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766298|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766299|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766300|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766301|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
83766302|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766303|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766304|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766305|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
83766306|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83766307|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83766308|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83766309|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
83766310|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766311|NCT00012051|Cytarabine|cytarabine|mesh-list
83766312|NCT00012051|Dexamethasone|dexamethasone|mesh-list
83766313|NCT00012051|Rituximab|rituximab|mesh-list
83766314|NCT00012051|Methotrexate|methotrexate|mesh-list
83766315|NCT00012051|Etoposide|etoposide|mesh-list
83766316|NCT00012051|Melphalan|melphalan|mesh-list
83766317|NCT00012051|Ifosfamide|ifosfamide|mesh-list
83766318|NCT00012051|Carmustine|carmustine|mesh-list
83766319|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83766320|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766321|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
83766322|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766323|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766324|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766325|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
83766326|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
83766327|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766328|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83766329|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
83766330|NCT00012051|Hormones|hormones|mesh-ancestor
83766331|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766332|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83766333|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83766334|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
83766335|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83766336|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766337|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
83766338|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766339|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
83766340|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766341|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83766342|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766343|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766344|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766345|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83766346|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83766347|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
83766348|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766349|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766350|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
83766351|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83766353|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83766354|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766355|NCT00027976|Analgesics|analgesics|mesh-ancestor
83766356|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
83766357|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766358|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766359|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766360|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766361|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83766362|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83766363|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766364|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766365|NCT00000479|Aspirin|aspirin|mesh-list
83766366|NCT00000479|Vitamin E|vitamin e|mesh-list
83766367|NCT00000479|Vitamins|vitamins|mesh-ancestor
83766368|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
83766369|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766370|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83766371|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766372|NCT00000479|Analgesics|analgesics|mesh-ancestor
83766373|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
83766374|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766375|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766376|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766377|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83766378|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83766379|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766380|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83766381|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83766382|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766383|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
83766384|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
83766385|NCT00000479|Protective Agents|protective agents|mesh-ancestor
83766386|NCT00028132|Tenofovir|tenofovir|mesh-list
83766387|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
83766388|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766389|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83766390|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766391|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766392|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766393|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83766394|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83766395|NCT00028171|Tacrolimus|tacrolimus|mesh-list
83766396|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766397|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
83766398|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766399|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83766400|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766401|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766402|NCT00012090|Goserelin|goserelin|mesh-list
83766403|NCT00012090|Bicalutamide|bicalutamide|mesh-list
83766404|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83766405|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766406|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
83766407|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
83766408|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766409|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766410|NCT00395395|Calcitonin|calcitonin|mesh-list
83766411|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
83766412|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83766413|NCT00395395|Katacalcin|katacalcin|mesh-list
83766414|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83766415|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766416|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83766417|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
83766418|NCT00395434|Bevacizumab|bevacizumab|mesh-list
83766419|NCT00395434|Combretastatin|combretastatin|mesh-list
83766420|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
83766421|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83766422|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766423|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83766424|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83766425|NCT00395434|Growth Substances|growth substances|mesh-ancestor
83766426|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766427|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
83766428|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766429|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766430|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766431|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766432|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766433|NCT00395551|Ranibizumab|ranibizumab|mesh-list
83766434|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83766435|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83766436|NCT00395551|Growth Substances|growth substances|mesh-ancestor
83766437|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766438|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
83766439|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766440|NCT00012129|Annamycin|annamycin|mesh-list
83766441|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766442|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766443|NCT00028288|Daclizumab|daclizumab|mesh-list
83766444|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766445|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
83766446|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766447|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83766448|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83766449|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766450|NCT00000482|Niacin|niacin|mesh-list
83766451|NCT00000482|Clofibrate|clofibrate|mesh-list
83766452|NCT00000482|Estrogens|estrogens|mesh-list
83766453|NCT00000482|Hormones|hormones|mesh-ancestor
83766454|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766455|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766456|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83766457|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
83766458|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766459|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83766460|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
83766461|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
83766462|NCT00000482|Vitamins|vitamins|mesh-ancestor
83766463|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
83766464|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83766465|NCT00028327|Lamivudine|lamivudine|mesh-list
83766466|NCT00028327|Zidovudine|zidovudine|mesh-list
83766467|NCT00028327|Efavirenz|efavirenz|mesh-list
83766468|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83766469|NCT00028327|Nelfinavir|nelfinavir|mesh-list
83766470|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83766471|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766472|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766473|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766474|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
83766475|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766476|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83766477|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83766478|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
83766479|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83766480|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83766481|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83766482|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83766483|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83766484|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83766485|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83766486|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83766487|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
83766488|NCT00028366|Ritonavir|ritonavir|mesh-list
83766489|NCT00028366|Lopinavir|lopinavir|mesh-list
83766490|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
82921684|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921685|NCT03754959|Midazolam|midazolam|mesh-list
83766491|NCT00028366|Tenofovir|tenofovir|mesh-list
83766492|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83766493|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83766494|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
83766495|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766496|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766497|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83766498|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83766499|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
83766500|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766501|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83766502|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83766503|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83766504|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766505|NCT00028405|Talaporfin|talaporfin|mesh-list
83766506|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766507|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83766508|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
83766509|NCT00012207|Aldesleukin|aldesleukin|mesh-list
83766510|NCT00012207|Prednisone|prednisone|mesh-list
83766511|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
83766512|NCT00012207|Vincristine|vincristine|mesh-list
83766513|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766514|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
83766515|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766516|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766517|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766518|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
83766519|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766520|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766521|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83766522|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766523|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
83766524|NCT00012207|Hormones|hormones|mesh-ancestor
83766525|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766526|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83766527|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766528|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766529|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766530|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766531|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83766532|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83766533|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
83766534|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766535|NCT00028483|Docetaxel|docetaxel|mesh-list
83766536|NCT00028483|Doxorubicin|doxorubicin|mesh-list
83766537|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
83766538|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766539|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766540|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766541|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766542|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766543|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766544|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83766545|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83766546|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766547|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
83766548|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766549|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
83766550|NCT00000485|Diuretics|diuretics|mesh-list
83766551|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
83766552|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766553|NCT00028561|Carboplatin|carboplatin|mesh-list
83766554|NCT00028561|Epothilone B|epothilone b|mesh-list
83766555|NCT00028561|Epothilones|epothilones|mesh-list
83766556|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766557|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766558|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766559|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766560|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766561|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
83766562|NCT00028600|Melphalan|melphalan|mesh-list
83766563|NCT00028600|Methotrexate|methotrexate|mesh-list
83766564|NCT00028600|Fludarabine|fludarabine|mesh-list
83766565|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
83766566|NCT00028600|Tacrolimus|tacrolimus|mesh-list
82921760|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766567|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766568|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
83766569|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766570|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766571|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766572|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
83766573|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766574|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766575|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83766576|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83766577|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
83766578|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83766579|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766580|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
83766581|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
83766582|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766583|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83766584|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766585|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83766586|NCT00388778|Doxycycline|doxycycline|mesh-list
83766587|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83766588|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766589|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
83766590|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83766591|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83766592|NCT00012246|Sargramostim|sargramostim|mesh-list
83766593|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
83766594|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
83766595|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766596|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83766598|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
83766599|NCT00028717|Rituximab|rituximab|mesh-list
83766600|NCT00028717|Doxorubicin|doxorubicin|mesh-list
83766601|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83766602|NCT00028717|Vincristine|vincristine|mesh-list
83766603|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766604|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
83766605|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766606|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766607|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766608|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
83766609|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766610|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766611|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83766612|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83766613|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766614|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83766615|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83766616|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766617|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766618|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
83766619|NCT00028717|Hormones|hormones|mesh-ancestor
83766620|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766621|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83766622|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766623|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766624|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766625|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766626|NCT00028756|Gemcitabine|gemcitabine|mesh-list
83766627|NCT00028756|Doxorubicin|doxorubicin|mesh-list
83766628|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83766629|NCT00028756|Methotrexate|methotrexate|mesh-list
83766630|NCT00028756|Vinblastine|vinblastine|mesh-list
83766631|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766632|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766633|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
83766634|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766635|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766636|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83766637|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83766638|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766639|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83766640|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
83766641|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83766642|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766643|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83766644|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83766645|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766646|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
83766647|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766648|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83766649|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766650|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766651|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766652|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766653|NCT00012324|Doxorubicin|doxorubicin|mesh-list
83766654|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83766655|NCT00012324|Nolatrexed|nolatrexed|mesh-list
83766656|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766657|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766658|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83766659|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83766660|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766661|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766662|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766663|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
83766664|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83766665|NCT00028795|Temozolomide|temozolomide|mesh-list
83766666|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766667|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
83766668|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766669|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766670|NCT00012363|Gemcitabine|gemcitabine|mesh-list
83766671|NCT00012363|Irinotecan|irinotecan|mesh-list
83766672|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766673|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
83766674|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766675|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766676|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83766677|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83766678|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766679|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
83766680|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766681|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83766682|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766683|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766684|NCT00028834|Bevacizumab|bevacizumab|mesh-list
83766685|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83766686|NCT00028834|Gemcitabine|gemcitabine|mesh-list
83766687|NCT00028834|Antibodies|antibodies|mesh-list
83766688|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
83766689|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83766690|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766691|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83766692|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83766693|NCT00028834|Growth Substances|growth substances|mesh-ancestor
83766694|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766695|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
83766696|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
83766697|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83766698|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
83766699|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766700|NCT00028873|Paclitaxel|paclitaxel|mesh-list
83766701|NCT00028873|Docetaxel|docetaxel|mesh-list
83766702|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83766703|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766704|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
83766705|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
83766706|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
83766707|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766708|NCT00028912|Carboplatin|carboplatin|mesh-list
83766709|NCT00028912|Bortezomib|bortezomib|mesh-list
83766710|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766711|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83766712|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
83766713|NCT00028951|Coagulants|coagulants|mesh-ancestor
82921910|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921913|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83766714|NCT01803555|Budesonide|budesonide|mesh-list
83766715|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
83766716|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83766717|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766718|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83766719|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
83766720|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766721|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766722|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83766723|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
83766724|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
83766725|NCT01803555|Hormones|hormones|mesh-ancestor
83766726|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766727|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83766728|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83766729|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83766730|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
83766731|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766732|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766733|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
83766734|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83766735|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83766736|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
83766737|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766738|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83766739|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
83766740|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83766741|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766742|NCT00000491|Aspirin|aspirin|mesh-list
83766743|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83766744|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766745|NCT00000491|Analgesics|analgesics|mesh-ancestor
83766746|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
83766747|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766748|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766749|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766750|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766751|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83766752|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83766753|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766754|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83766755|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83766756|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766757|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
83766758|NCT00029380|Cyclosporine|cyclosporine|mesh-list
83766759|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
83766760|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
83766761|NCT00029380|Busulfan|busulfan|mesh-list
83766762|NCT00029380|Cyclosporins|cyclosporins|mesh-list
83766763|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766764|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
83766765|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766766|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766767|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766768|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
83766769|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766770|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766771|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83766772|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766773|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
83766774|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766775|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
83766776|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83766777|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83766778|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83766779|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
83766780|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83766781|NCT00029458|Clozapine|clozapine|mesh-list
83766782|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83766783|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
83766784|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766785|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766786|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766787|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83766788|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83766789|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83766790|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766791|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
83766792|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
83766793|NCT00029497|Amitriptyline|amitriptyline|mesh-list
83766794|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83766795|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
83766796|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766797|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766798|NCT00029497|Analgesics|analgesics|mesh-ancestor
83766799|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
83766800|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766801|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766802|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83766803|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83766804|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83766805|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766806|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
83766807|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766808|NCT00000494|Indomethacin|indomethacin|mesh-list
83766809|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83766810|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766811|NCT00000494|Analgesics|analgesics|mesh-ancestor
83766812|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
83766813|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766814|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766815|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766816|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766817|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
83766818|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
83766819|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83766820|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83766821|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766822|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766823|NCT00012519|Ritonavir|ritonavir|mesh-list
83766824|NCT00012519|Indinavir|indinavir|mesh-list
83766825|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83766826|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83766827|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
83766828|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766829|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766830|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83766831|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83766832|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
83766833|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766834|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83766835|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83766836|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83766837|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83766838|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83766839|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83766840|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766841|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83766842|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766843|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766844|NCT00029770|Acetaminophen|acetaminophen|mesh-list
83766845|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83766846|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83766847|NCT00029770|Codeine|codeine|mesh-list
83766848|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766849|NCT00029770|Analgesics|analgesics|mesh-ancestor
83766850|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
83766851|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766852|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766853|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
83766854|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83766855|NCT00029770|Narcotics|narcotics|mesh-ancestor
83766856|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83766857|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
83766858|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
83766859|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766860|NCT00012558|Inositol|inositol|mesh-list
83766861|NCT00012558|Lamotrigine|lamotrigine|mesh-list
83766862|NCT00012558|Valproic Acid|valproic acid|mesh-list
83766863|NCT00012558|Risperidone|risperidone|mesh-list
83766864|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
83766865|NCT00012558|Bupropion|bupropion|mesh-list
83766866|NCT00012558|Paroxetine|paroxetine|mesh-list
83766867|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83766868|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
83766869|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766870|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766871|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766872|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83766873|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83766874|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83766875|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766876|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83766877|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
83766878|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83766879|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
83766880|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83766881|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83766882|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83766883|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83766884|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83766885|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766886|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
83766887|NCT00012558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83766888|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
83766889|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83766890|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83766891|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83766892|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
83766893|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
83766894|NCT00012558|Vitamins|vitamins|mesh-ancestor
83766895|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
83766896|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83766897|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83766898|NCT00395707|Ranibizumab|ranibizumab|mesh-list
83766899|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83766900|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83766901|NCT00395707|Growth Substances|growth substances|mesh-ancestor
83766902|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766903|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83766904|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766905|NCT00000500|Aspirin|aspirin|mesh-list
83766906|NCT00000500|Carotenoids|carotenoids|mesh-list
83766907|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83766908|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83766909|NCT00000500|Analgesics|analgesics|mesh-ancestor
83766910|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
83766911|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766912|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766913|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83766914|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83766915|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83766916|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83766917|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766918|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83766919|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83766920|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766921|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
83766922|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
83766923|NCT00000500|Protective Agents|protective agents|mesh-ancestor
83766924|NCT00395902|Cinacalcet|cinacalcet|mesh-list
83766925|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83766926|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766927|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83766928|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
83766929|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766930|NCT00029848|Rimonabant|rimonabant|mesh-list
83766931|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83766932|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83766933|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83766934|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766935|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766936|NCT00029848|Hormones|hormones|mesh-ancestor
83766937|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83766938|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922137|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83766940|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
83766941|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
83766942|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83766943|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83766944|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766945|NCT00030004|Midazolam|midazolam|mesh-list
83766946|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83766947|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83766948|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83766949|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766950|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83766951|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83766952|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766953|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83766954|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
83766955|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
83766956|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
83766957|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
83766958|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766959|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766960|NCT00030082|Melphalan|melphalan|mesh-list
83766961|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83766962|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
83766963|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766964|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83766965|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83766966|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83766967|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
83766968|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766969|NCT00000518|Quinidine|quinidine|mesh-list
83766970|NCT00000518|Sotalol|sotalol|mesh-list
83766971|NCT00000518|Mexiletine|mexiletine|mesh-list
83766972|NCT00000518|Procainamide|procainamide|mesh-list
83766973|NCT00000518|Imipramine|imipramine|mesh-list
83766974|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83766975|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83766976|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
83766977|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83766978|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83766979|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83766980|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83766981|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
83766982|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
83766983|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83766984|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83766985|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
83766986|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83766987|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83766988|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83766989|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83766990|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83766991|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
83766992|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83766993|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83766994|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83766995|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83766996|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83766997|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83766998|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
83766999|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83767000|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83767001|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83767002|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83767003|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
83767004|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
83767005|NCT00030238|Calcium|calcium|mesh-list
83767006|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83767007|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767008|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
83767009|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83767010|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767011|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83767012|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922215|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767013|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767014|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
83767015|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767016|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767017|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767018|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767019|NCT00395941|Pioglitazone|pioglitazone|mesh-list
83767020|NCT00395941|Acitretin|acitretin|mesh-list
83767021|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83767022|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767023|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
83767024|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
83767025|NCT00030433|Gemcitabine|gemcitabine|mesh-list
83767026|NCT00030433|Irinotecan|irinotecan|mesh-list
83767027|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767028|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
83767029|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767030|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767031|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83767032|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83767033|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767034|NCT00030472|Doxorubicin|doxorubicin|mesh-list
83767035|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83767036|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83767037|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767038|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83767039|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83767040|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767041|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767042|NCT00000527|Aspirin|aspirin|mesh-list
83767043|NCT00000527|Dipyridamole|dipyridamole|mesh-list
83767044|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83767045|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767046|NCT00000527|Analgesics|analgesics|mesh-ancestor
83767047|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
83767048|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767049|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767050|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767051|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767052|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83767053|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83767054|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767055|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83767056|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83767057|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767058|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
83767059|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83767060|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
83767061|NCT00030511|Fluorouracil|fluorouracil|mesh-list
83767062|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
83767063|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767064|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767065|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767066|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83767067|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
83767068|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767069|NCT00030550|Thalidomide|thalidomide|mesh-list
83767070|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83767071|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
83767072|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767073|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
83767074|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83767075|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767076|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83767077|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83767078|NCT00030550|Growth Substances|growth substances|mesh-ancestor
83767079|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
83767080|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767081|NCT00030589|Bexarotene|bexarotene|mesh-list
83767082|NCT00030589|Methoxsalen|methoxsalen|mesh-list
83767083|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767084|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83767085|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922291|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767086|NCT00000530|Nifedipine|nifedipine|mesh-list
82922310|NCT02801656|Vancomycin|vancomycin|mesh-list
83767087|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83767088|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83767089|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767090|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83767091|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767092|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
83767093|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
83767094|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83767095|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
83767096|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767097|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767098|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767099|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767100|NCT00030745|Gemcitabine|gemcitabine|mesh-list
83767101|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767102|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767103|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
83767104|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767105|NCT00030784|Doxorubicin|doxorubicin|mesh-list
83767106|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83767107|NCT00030784|Ifosfamide|ifosfamide|mesh-list
83767108|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83767109|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767110|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83767111|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83767112|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767113|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767114|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83767115|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
83767116|NCT00030862|Irinotecan|irinotecan|mesh-list
83767117|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767118|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83767119|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83767120|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767121|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767122|NCT00000539|Vitamins|vitamins|mesh-list
83767123|NCT00000539|Vitamin E|vitamin e|mesh-list
83767124|NCT00000539|Beta Carotene|beta carotene|mesh-list
83767125|NCT00000539|Warfarin|warfarin|mesh-list
83767126|NCT00000539|Pravastatin|pravastatin|mesh-list
83767127|NCT00000539|Carotenoids|carotenoids|mesh-list
83767128|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
83767129|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767130|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
83767131|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
83767132|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767133|NCT00000539|Protective Agents|protective agents|mesh-ancestor
83767134|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83767135|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
83767136|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83767137|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83767138|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83767139|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767140|NCT00000539|Provitamins|provitamins|mesh-ancestor
83767141|NCT00030979|Donepezil|donepezil|mesh-list
83767142|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83767143|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767144|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767145|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
83767146|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767147|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767148|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
83767149|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
83767150|NCT00031018|Donepezil|donepezil|mesh-list
83767151|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83767152|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767153|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767154|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
83767155|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767156|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767157|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
83767158|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
83767159|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767160|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767161|NCT00031057|Riboflavin|riboflavin|mesh-list
83767162|NCT00031057|Thiamine|thiamine|mesh-list
83767163|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
83767164|NCT00031057|Vitamins|vitamins|mesh-ancestor
83767165|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
83767166|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767167|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83767168|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
83767169|NCT00000554|Dobutamine|dobutamine|mesh-list
83767170|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83767171|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
83767172|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
83767173|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767174|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767175|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83767176|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83767177|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83767178|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
83767179|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767180|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767181|NCT00000554|Protective Agents|protective agents|mesh-ancestor
83767182|NCT00012909|Hormones|hormones|mesh-list
83767183|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767184|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767185|NCT00031096|Azelaic acid|azelaic acid|mesh-list
83767186|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767187|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
83767188|NCT00031135|Choline|choline|mesh-list
83767189|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
83767190|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83767191|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
83767192|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767193|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83767194|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83767195|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
83767196|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
83767197|NCT00031291|Antibodies|antibodies|mesh-list
83767198|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
83767199|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83767200|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83767201|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
83767202|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767203|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
83767204|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83767205|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767206|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767207|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767208|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83767209|NCT00396058|Methylphenidate|methylphenidate|mesh-list
83767210|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83767211|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767212|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83767213|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83767214|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83767215|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767216|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
83767217|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767218|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83767219|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
83767220|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83767221|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83767222|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83767223|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83767224|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767225|NCT00000563|Dexamethasone|dexamethasone|mesh-list
83767226|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767227|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
83767228|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
83767229|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767230|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767231|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83767232|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
83767233|NCT00000563|Hormones|hormones|mesh-ancestor
83767234|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767235|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83767236|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922440|NCT02082652|Etonogestrel|etonogestrel|mesh-list
83767238|NCT00031564|Interleukin-2|interleukin-2|mesh-list
83767239|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767240|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767241|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767242|NCT00031564|Analgesics|analgesics|mesh-ancestor
83767243|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
83767244|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767245|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83767246|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83767247|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
83767248|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767249|NCT00031642|Rituximab|rituximab|mesh-list
83767250|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83767251|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767252|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
83767253|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767254|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767255|NCT00031681|Irinotecan|irinotecan|mesh-list
83767256|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83767257|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83767258|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83767259|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767260|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767261|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767262|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767263|NCT00031720|Tamoxifen|tamoxifen|mesh-list
83767264|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83767265|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
83767266|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767267|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767268|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83767269|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767270|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83767271|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83767272|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83767273|NCT00000569|Triamcinolone|triamcinolone|mesh-list
83767274|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767275|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
83767276|NCT00000569|Hormones|hormones|mesh-ancestor
83767277|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767278|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767279|NCT00031759|Imiquimod|imiquimod|mesh-list
83767280|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83767281|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
83767282|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767283|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767284|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
83767285|NCT01791816|Phenylephrine|phenylephrine|mesh-list
83767286|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
83767287|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83767288|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83767289|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
83767290|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
83767291|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767292|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767293|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
83767294|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83767295|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
83767296|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
83767297|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83767298|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83767299|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83767300|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
83767301|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767302|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767303|NCT01791816|Protective Agents|protective agents|mesh-ancestor
83767304|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767305|NCT00031798|Methylphenidate|methylphenidate|mesh-list
83767306|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83767307|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767308|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83767309|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83767310|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83767311|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767312|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
83767313|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767314|NCT00031837|Gemcitabine|gemcitabine|mesh-list
83767315|NCT00031837|Dalteparin|dalteparin|mesh-list
83767316|NCT00031837|Tinzaparin|tinzaparin|mesh-list
83767317|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83767318|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767319|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
83767320|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767321|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767322|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
83767323|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83767324|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83767325|NCT00031876|Paclitaxel|paclitaxel|mesh-list
83767326|NCT00031876|Capecitabine|capecitabine|mesh-list
83767327|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83767328|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767329|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
83767330|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
83767331|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
83767332|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767333|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767334|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
83767335|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
83767336|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767337|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767338|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767339|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767340|NCT00031954|Paclitaxel|paclitaxel|mesh-list
83767341|NCT00031954|Carboplatin|carboplatin|mesh-list
83767342|NCT00031954|Gemcitabine|gemcitabine|mesh-list
83767343|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83767344|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767345|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
83767346|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
83767347|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
83767348|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767349|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767350|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
83767351|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83767352|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767353|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767354|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767355|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767356|NCT00000575|Nedocromil|nedocromil|mesh-list
83767357|NCT00000575|Budesonide|budesonide|mesh-list
83767358|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767359|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83767360|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
83767361|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767362|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767363|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83767364|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
83767365|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
83767366|NCT00000575|Hormones|hormones|mesh-ancestor
83767367|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767368|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83767369|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
83767370|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83767371|NCT00032032|Paclitaxel|paclitaxel|mesh-list
83767372|NCT00032032|Carboplatin|carboplatin|mesh-list
83767373|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83767374|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767375|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
83767376|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
83767377|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
83767378|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767379|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83767380|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767381|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767382|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767383|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767384|NCT00032149|Prednisolone|prednisolone|mesh-list
82922594|NCT04397445|Ranitidine|ranitidine|mesh-list
83767385|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
83767387|NCT00032149|Vincristine|vincristine|mesh-list
83767388|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
83767389|NCT00032149|Bleomycin|bleomycin|mesh-list
83767390|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83767391|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
83767392|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767393|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767394|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83767395|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
83767396|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767397|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767398|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83767399|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83767400|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83767401|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83767402|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767403|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83767404|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83767405|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83767406|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767407|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
83767408|NCT00032149|Hormones|hormones|mesh-ancestor
83767409|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767410|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83767411|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767412|NCT00032149|Analgesics|analgesics|mesh-ancestor
83767413|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
83767414|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83767415|NCT00032188|Aldesleukin|aldesleukin|mesh-list
83767416|NCT00032188|Interleukin-2|interleukin-2|mesh-list
83767417|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
83767418|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767419|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767420|NCT00032188|Analgesics|analgesics|mesh-ancestor
83767421|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
83767422|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767423|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767424|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83767425|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83767426|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
83767427|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767428|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83767429|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
83767430|NCT00032305|Visilizumab|visilizumab|mesh-list
83767431|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
83767432|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767433|NCT00000596|Dapsone|dapsone|mesh-list
83767434|NCT00000596|Prednisone|prednisone|mesh-list
83767435|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
83767436|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83767437|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
83767438|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767439|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767440|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83767441|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
83767442|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767443|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767444|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83767445|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767446|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
83767447|NCT00000596|Hormones|hormones|mesh-ancestor
83767448|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767449|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83767450|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767451|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
83767452|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83767453|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83767454|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83767455|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767456|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
82922665|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767457|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83767458|NCT00000599|Niacin|niacin|mesh-list
83767459|NCT00000599|Colestipol|colestipol|mesh-list
83767460|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83767461|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
83767462|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767464|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
83767465|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
83767466|NCT00000599|Vitamins|vitamins|mesh-ancestor
83767467|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
83767468|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767469|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
83767470|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
83767471|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767472|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
83767473|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767474|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767475|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83767476|NCT00032734|Satavaptan|satavaptan|mesh-list
83767477|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83767478|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767479|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
83767480|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767481|NCT00032773|Pentostatin|pentostatin|mesh-list
83767482|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767483|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83767484|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767485|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767486|NCT00032812|Raclopride|raclopride|mesh-list
83767487|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83767488|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83767489|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83767490|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767491|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83767492|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83767493|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
83767494|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767495|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767496|NCT00032890|Celecoxib|celecoxib|mesh-list
83767497|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83767498|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767499|NCT00032890|Analgesics|analgesics|mesh-ancestor
83767500|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
83767501|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767502|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767503|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767504|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767505|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83767506|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83767507|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767508|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767509|NCT00032929|Selegiline|selegiline|mesh-list
83767510|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
83767511|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83767512|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83767513|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83767514|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83767515|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767516|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767517|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83767518|NCT00032929|Protective Agents|protective agents|mesh-ancestor
83767519|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767520|NCT00000611|Vitamin D|vitamin d|mesh-list
83767521|NCT00000611|Calcium|calcium|mesh-list
83767522|NCT00000611|Hormones|hormones|mesh-list
83767523|NCT00000611|Estrogens|estrogens|mesh-list
83767524|NCT00000611|Progestins|progestins|mesh-list
83767525|NCT00000611|Vitamins|vitamins|mesh-ancestor
83767526|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
83767527|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767528|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83767529|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83767530|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767531|NCT00032968|Buprenorphine|buprenorphine|mesh-list
83767532|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83767533|NCT00032968|Naloxone|naloxone|mesh-list
83767534|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83767535|NCT00032968|Narcotics|narcotics|mesh-ancestor
83767536|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83767537|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767538|NCT00032968|Analgesics|analgesics|mesh-ancestor
83767539|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
83767540|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767541|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83767542|NCT00033046|Modafinil|modafinil|mesh-list
83767543|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83767544|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767545|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83767546|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83767547|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83767548|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767549|NCT00033085|Ondansetron|ondansetron|mesh-list
83767550|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
83767551|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
83767552|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767553|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767554|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83767555|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
83767556|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
83767557|NCT00033085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83767558|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83767559|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
83767560|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767561|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767562|NCT00033163|Tenofovir|tenofovir|mesh-list
83767563|NCT00033163|Adefovir|adefovir|mesh-list
83767564|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83767565|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
83767566|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767567|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83767568|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83767569|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767570|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767571|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83767572|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83767573|NCT00033241|Gemcitabine|gemcitabine|mesh-list
83767574|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83767575|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767576|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
83767577|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767578|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767579|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767580|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767581|NCT00000620|Insulin|insulin|mesh-list
83767582|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83767583|NCT00000620|Metformin|metformin|mesh-list
83767584|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
83767585|NCT00000620|Pioglitazone|pioglitazone|mesh-list
83767586|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
83767587|NCT00000620|Glimepiride|glimepiride|mesh-list
83767588|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
83767589|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
83767590|NCT00000620|Acarbose|acarbose|mesh-list
83767591|NCT00000620|Repaglinide|repaglinide|mesh-list
83767592|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83767593|NCT00000620|Metoprolol|metoprolol|mesh-list
83767594|NCT00000620|Felodipine|felodipine|mesh-list
83767595|NCT00000620|Amlodipine|amlodipine|mesh-list
83767596|NCT00000620|Valsartan|valsartan|mesh-list
83767597|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83767598|NCT00000620|Carvedilol|carvedilol|mesh-list
83767599|NCT00000620|Candesartan|candesartan|mesh-list
83767600|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
83767601|NCT00000620|Lisinopril|lisinopril|mesh-list
83767602|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
83767603|NCT00000620|Diltiazem|diltiazem|mesh-list
83767604|NCT00000620|Benazepril|benazepril|mesh-list
83767605|NCT00000620|Hydralazine|hydralazine|mesh-list
83767606|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
83767607|NCT00000620|Reserpine|reserpine|mesh-list
83767608|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
82922812|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83767609|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
83767610|NCT00000620|Triamterene|triamterene|mesh-list
83767611|NCT00000620|Furosemide|furosemide|mesh-list
82922814|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
83767612|NCT00000620|Simvastatin|simvastatin|mesh-list
83767613|NCT00000620|Fenofibrate|fenofibrate|mesh-list
83767614|NCT00000620|Terazosin|terazosin|mesh-list
83767615|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767616|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83767617|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83767618|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767619|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83767620|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
83767621|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83767622|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83767623|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
83767624|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83767625|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83767626|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767627|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83767628|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83767629|NCT00000620|Diuretics|diuretics|mesh-ancestor
83767630|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
83767631|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83767632|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83767633|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83767634|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83767635|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
83767636|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
83767637|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
83767638|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767639|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83767640|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83767641|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83767642|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
83767643|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767644|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
83767645|NCT00000620|Protective Agents|protective agents|mesh-ancestor
83767646|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83767647|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83767648|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83767649|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
83767650|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83767651|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83767652|NCT00000620|Urological Agents|urological agents|mesh-ancestor
83767653|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83767654|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83767655|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83767656|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83767657|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83767658|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83767659|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83767660|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83767661|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83767662|NCT00033280|Temozolomide|temozolomide|mesh-list
83767663|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83767664|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
83767665|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767666|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767667|NCT00033319|Aspirin|aspirin|mesh-list
83767668|NCT00033319|Folic Acid|folic acid|mesh-list
83767669|NCT00033319|Hematinics|hematinics|mesh-ancestor
83767670|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
83767671|NCT00033319|Vitamins|vitamins|mesh-ancestor
83767672|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
83767673|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767674|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83767675|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767676|NCT00033319|Analgesics|analgesics|mesh-ancestor
83767677|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
83767678|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767679|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767680|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767681|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83767682|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83767683|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767684|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83767685|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83767686|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922890|NCT02089048|Auranofin|auranofin|mesh-list
83767687|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
83767688|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83767689|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83767690|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
83767691|NCT00033358|Norgestrel|norgestrel|mesh-list
83767692|NCT00033358|Estradiol|estradiol|mesh-list
83767693|NCT00033358|Estrogens|estrogens|mesh-ancestor
83767694|NCT00033358|Hormones|hormones|mesh-ancestor
83767695|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767696|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133336|NCT05047328|Inolimomab|inolimomab|mesh-list
83767697|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83767698|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
83767699|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83767700|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83767701|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83767702|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83767703|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83767704|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83767705|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83767706|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767707|NCT02971696|Sorafenib|sorafenib|mesh-list
83767708|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767709|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83767710|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767711|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767712|NCT00033436|Niacinamide|niacinamide|mesh-list
83767713|NCT00033436|Niacin|niacin|mesh-list
83767714|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
83767715|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
83767716|NCT00033436|Vitamins|vitamins|mesh-ancestor
83767717|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
83767718|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767719|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83767720|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
83767721|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767722|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83767723|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
83767724|NCT00000635|Trifluridine|trifluridine|mesh-list
83767725|NCT00000635|Polymyxins|polymyxins|mesh-list
83767726|NCT00000635|Bacitracin|bacitracin|mesh-list
83767727|NCT00000635|Polymyxin B|polymyxin b|mesh-list
83767728|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
83767729|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767730|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
83767731|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767732|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83767733|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83767734|NCT00033553|Paclitaxel|paclitaxel|mesh-list
83767735|NCT00033553|Carboplatin|carboplatin|mesh-list
83767736|NCT00033553|Gemcitabine|gemcitabine|mesh-list
83767737|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83767738|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767739|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
83767740|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
83767741|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
83767742|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767743|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767744|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
83767745|NCT00033592|Bupropion|bupropion|mesh-list
83767746|NCT00033592|Nicotine|nicotine|mesh-list
83767747|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83767748|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
83767749|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767750|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767751|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83767752|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83767753|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
83767754|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767755|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767756|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83767757|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
83767758|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83767759|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83767760|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83767761|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83767762|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
83767763|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83767764|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83767765|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767766|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
83767767|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
83767768|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83767769|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
83767770|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83767771|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83767772|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767773|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83767774|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767775|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767776|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83767777|NCT00033709|Thalidomide|thalidomide|mesh-list
83767778|NCT00033709|Temozolomide|temozolomide|mesh-list
83767779|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83767780|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
83767781|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767782|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767783|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83767784|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
83767785|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767786|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
83767787|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83767788|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767789|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83767790|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83767791|NCT00033709|Growth Substances|growth substances|mesh-ancestor
83767792|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
83767793|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83767794|NCT00033748|Antibodies|antibodies|mesh-list
83767795|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
83767796|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83767797|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
83767798|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767799|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767800|NCT00000641|Azithromycin|azithromycin|mesh-list
83767801|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
83767802|NCT00000641|Rifampin|rifampin|mesh-list
83767803|NCT00000641|Amikacin|amikacin|mesh-list
83767804|NCT00000641|Ethambutol|ethambutol|mesh-list
83767805|NCT00000641|Clofazimine|clofazimine|mesh-list
83767806|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83767807|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767808|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83767809|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83767810|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767811|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767812|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767813|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83767814|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83767815|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83767816|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
83767817|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
83767818|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83767819|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83767820|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83767821|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83767822|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83767823|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83767824|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83767825|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767826|NCT00000644|Clarithromycin|clarithromycin|mesh-list
83767827|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83767828|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767829|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83767830|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767831|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767832|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83767833|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83767834|NCT02971423|Imipenem|imipenem|mesh-list
83767835|NCT02971423|Sulbactam|sulbactam|mesh-list
83767836|NCT02971423|Durlobactam|durlobactam|mesh-list
82923036|NCT02250118|Bevacizumab|bevacizumab|mesh-list
82923044|NCT03060772|Pioglitazone|pioglitazone|mesh-list
83767837|NCT02971423|Cilastatin|cilastatin|mesh-list
83767838|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83767839|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767840|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
83767841|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767842|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767843|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83767844|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83767845|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83767846|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
83767847|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767848|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767849|NCT00389090|Temozolomide|temozolomide|mesh-list
83767850|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83767851|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83767852|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
83767853|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767854|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767855|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767856|NCT00033982|Posaconazole|posaconazole|mesh-list
83767857|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
83767858|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767859|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83767860|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83767861|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83767862|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83767863|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83767864|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767865|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767866|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83767867|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
83767868|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83767869|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767870|NCT00034060|Etanercept|etanercept|mesh-list
83767871|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83767872|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767873|NCT00034060|Analgesics|analgesics|mesh-ancestor
83767874|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
83767875|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767876|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767877|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767878|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767879|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83767880|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83767881|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
83767882|NCT00034138|Oregovomab|oregovomab|mesh-list
83767883|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83767884|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767885|NCT00034177|Paclitaxel|paclitaxel|mesh-list
83767886|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83767887|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83767888|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767889|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83767890|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83767891|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83767892|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767893|NCT00389129|Aspirin|aspirin|mesh-list
83767894|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83767895|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767896|NCT00389129|Analgesics|analgesics|mesh-ancestor
83767897|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
83767898|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767899|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767900|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767901|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767902|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83767903|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83767904|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767905|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83767906|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83767907|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767908|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
82923111|NCT02095054|Cetuximab|cetuximab|mesh-list
83767910|NCT00013962|Vitamins|vitamins|mesh-ancestor
83767911|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
83767912|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767913|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83767914|NCT00000665|Ganciclovir|ganciclovir|mesh-list
83767915|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83767916|NCT00000665|Foscarnet|foscarnet|mesh-list
83767917|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83767918|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
83767919|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767920|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83767921|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767922|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767923|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83767924|NCT00034372|Oregovomab|oregovomab|mesh-list
83767925|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83767926|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767927|NCT00014001|Olanzapine|olanzapine|mesh-list
83767928|NCT00014001|Risperidone|risperidone|mesh-list
83767929|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83767930|NCT00014001|Ziprasidone|ziprasidone|mesh-list
83767931|NCT00014001|Clozapine|clozapine|mesh-list
83767932|NCT00014001|Perphenazine|perphenazine|mesh-list
83767933|NCT00014001|Fluphenazine|fluphenazine|mesh-list
83767934|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
83767935|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
83767936|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83767937|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
83767938|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83767939|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767940|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767941|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83767942|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83767943|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83767944|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83767945|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83767946|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
83767947|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
83767948|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
83767949|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767950|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83767951|NCT00014001|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83767952|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83767953|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83767954|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
83767955|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
83767956|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
83767957|NCT00000671|Zidovudine|zidovudine|mesh-list
83767958|NCT00000671|Didanosine|didanosine|mesh-list
83767959|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
83767960|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767961|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83767962|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83767963|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767964|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
83767965|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83767966|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83767967|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83767968|NCT02971540|Dipyrone|dipyrone|mesh-list
83767969|NCT02971540|Tramadol|tramadol|mesh-list
83767970|NCT02971540|Bupivacaine|bupivacaine|mesh-list
83767971|NCT02971540|Ropivacaine|ropivacaine|mesh-list
83767972|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
83767973|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
83767974|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83767975|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83767976|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
83767977|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83767978|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83767979|NCT02971540|Narcotics|narcotics|mesh-ancestor
83767980|NCT02971540|Analgesics|analgesics|mesh-ancestor
83767981|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83767982|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83767983|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83767984|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83767985|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
83767986|NCT00034489|Gemcitabine|gemcitabine|mesh-list
83767987|NCT00034489|Pemetrexed|pemetrexed|mesh-list
83767988|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83767989|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
83767990|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83767991|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83767992|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83767993|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83767994|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83767995|NCT00396487|Fluorouracil|fluorouracil|mesh-list
83767996|NCT00396487|Capecitabine|capecitabine|mesh-list
83767997|NCT00396487|Irinotecan|irinotecan|mesh-list
83767998|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
83767999|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768000|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768001|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768002|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768003|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
83768004|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768005|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83768006|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768007|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768008|NCT00000674|Leucovorin|leucovorin|mesh-list
83768009|NCT00000674|Clindamycin|clindamycin|mesh-list
83768010|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
83768011|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
83768012|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
83768013|NCT00000674|Calcium|calcium|mesh-list
83768014|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
83768015|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83768016|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768017|NCT00000674|Antidotes|antidotes|mesh-ancestor
83768018|NCT00000674|Protective Agents|protective agents|mesh-ancestor
83768019|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
83768020|NCT00000674|Vitamins|vitamins|mesh-ancestor
83768021|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
83768022|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768023|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768024|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83768025|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768026|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768027|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
83768028|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83768029|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83768030|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768031|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
83768032|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83768033|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
83768034|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768035|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768036|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83768037|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
83768038|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83768039|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
83768040|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768041|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768042|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83768043|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
83768044|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
83768045|NCT00014040|Protective Agents|protective agents|mesh-ancestor
83768046|NCT00034528|Prednisone|prednisone|mesh-list
83768047|NCT00034528|Fludarabine|fludarabine|mesh-list
83768048|NCT00034528|Busulfan|busulfan|mesh-list
83768049|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83768050|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
83768051|NCT00034528|Hormones|hormones|mesh-ancestor
83768052|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768053|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768054|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83768055|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768056|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768057|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768058|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
83768059|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
83768060|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83768061|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83768062|NCT00000677|Sch 39304|sch 39304|mesh-list
82923264|NCT02098330|Hormones|hormones|mesh-ancestor
83768063|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
83768064|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768065|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
83768066|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83768067|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
83768068|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768069|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
83768070|NCT04711642|Protective Agents|protective agents|mesh-ancestor
83768071|NCT00034606|Gemcitabine|gemcitabine|mesh-list
83768072|NCT00034606|Pemetrexed|pemetrexed|mesh-list
83768073|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768074|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
83768075|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768076|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768077|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768078|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768079|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768080|NCT00034645|Posaconazole|posaconazole|mesh-list
83768081|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
83768082|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768083|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83768084|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83768085|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83768086|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83768087|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83768088|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768089|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768090|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83768091|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
83768092|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768093|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768094|NCT00034762|Risperidone|risperidone|mesh-list
83768095|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83768096|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
83768097|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768098|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768099|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768100|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83768101|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83768102|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83768103|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83768104|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83768105|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
83768106|NCT00000686|Stavudine|stavudine|mesh-list
83768107|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
83768108|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768109|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768110|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768111|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768112|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
83768113|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768114|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768115|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768116|NCT00034801|Olanzapine|olanzapine|mesh-list
83768117|NCT00034801|Ziprasidone|ziprasidone|mesh-list
83768118|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
83768119|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
83768120|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768121|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768122|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83768123|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83768124|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83768125|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83768126|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83768127|NCT00034801|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83768128|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83768129|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83768130|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768131|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768132|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
83768133|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83768134|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83768135|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
83768136|NCT00014196|Docetaxel|docetaxel|mesh-list
82923347|NCT02099890|Curcumin|curcumin|mesh-list
83768137|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768138|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
83768139|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
83768140|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
83768141|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768142|NCT00034840|Valsartan|valsartan|mesh-list
83768143|NCT00034840|Telmisartan|telmisartan|mesh-list
83768144|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83768145|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83768146|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83768147|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768148|NCT00000689|Leucovorin|leucovorin|mesh-list
83768149|NCT00000689|Cytarabine|cytarabine|mesh-list
83768150|NCT00000689|Dexamethasone|dexamethasone|mesh-list
83768151|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
83768152|NCT00000689|Doxorubicin|doxorubicin|mesh-list
83768153|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83768154|NCT00000689|Methotrexate|methotrexate|mesh-list
83768155|NCT00000689|Vincristine|vincristine|mesh-list
83768156|NCT00000689|Bleomycin|bleomycin|mesh-list
83768157|NCT00000689|Sargramostim|sargramostim|mesh-list
83768158|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
83768159|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768160|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
83768161|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768162|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768163|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83768164|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
83768165|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768166|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768167|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83768168|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83768169|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
83768170|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
83768171|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768172|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83768173|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
83768174|NCT00000689|Hormones|hormones|mesh-ancestor
83768175|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768176|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83768177|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83768178|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83768179|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768180|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768181|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83768182|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
83768183|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83768184|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768185|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
83768186|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768187|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768188|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768189|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
83768190|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768191|NCT00000689|Antidotes|antidotes|mesh-ancestor
83768192|NCT00000689|Protective Agents|protective agents|mesh-ancestor
83768193|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
83768194|NCT00000689|Vitamins|vitamins|mesh-ancestor
83768195|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
83768196|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83768197|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83768198|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83768199|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83768200|NCT00034879|Gefitinib|gefitinib|mesh-list
83768201|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768202|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83768203|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768204|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768205|NCT00000707|Pentamidine|pentamidine|mesh-list
83768206|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
83768207|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768208|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83768209|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82923414|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83768210|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83768211|NCT00014235|Cyclosporine|cyclosporine|mesh-list
83768212|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
83768213|NCT00014235|Fludarabine|fludarabine|mesh-list
83768214|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
83768215|NCT00014235|Cyclosporins|cyclosporins|mesh-list
83768216|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768217|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768218|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
83768219|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768220|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768221|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
83768222|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768223|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768224|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
83768225|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768226|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768227|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768228|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83768229|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83768230|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83768231|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
83768232|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768233|NCT00000710|Didanosine|didanosine|mesh-list
83768234|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
83768235|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768236|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768237|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768238|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768239|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
83768240|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768241|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768242|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768243|NCT00000716|Zidovudine|zidovudine|mesh-list
83768244|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
83768245|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768246|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768247|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768248|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768249|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
83768250|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768251|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768252|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768253|NCT00014274|Carboplatin|carboplatin|mesh-list
83768254|NCT00014274|Gemcitabine|gemcitabine|mesh-list
83768255|NCT00014274|Methotrexate|methotrexate|mesh-list
83768256|NCT00014274|Vinblastine|vinblastine|mesh-list
83768257|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768258|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768259|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
83768260|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768261|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83768262|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
83768263|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83768264|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768265|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768266|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768267|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768268|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768269|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
83768270|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768271|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768272|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83768273|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
83768274|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
83768275|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
83768276|NCT00035035|Gemcitabine|gemcitabine|mesh-list
83768277|NCT00035035|Pemetrexed|pemetrexed|mesh-list
83768278|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768279|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
83768280|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768281|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768282|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768283|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768284|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768285|NCT00000719|Zidovudine|zidovudine|mesh-list
83768286|NCT00000719|Zalcitabine|zalcitabine|mesh-list
83768287|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
82923483|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768288|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768289|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768290|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768292|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
83768293|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768294|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768295|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768296|NCT00014313|Etoposide|etoposide|mesh-list
83768297|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768298|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83768299|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83768300|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768301|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768302|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768303|NCT00035074|Methotrexate|methotrexate|mesh-list
83768304|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83768305|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
83768306|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83768307|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768308|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768309|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
83768310|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768311|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768312|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768313|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768314|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768315|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768316|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
83768317|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768318|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768319|NCT00035113|Epothilones|epothilones|mesh-list
83768320|NCT00035113|Epothilone B|epothilone b|mesh-list
83768321|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
83768322|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
83768323|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
83768324|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768325|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768326|NCT00000722|Pentamidine|pentamidine|mesh-list
83768327|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
83768328|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768329|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83768330|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83768331|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83768332|NCT00035152|Paclitaxel|paclitaxel|mesh-list
83768333|NCT00035152|Carboplatin|carboplatin|mesh-list
83768334|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83768335|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768336|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
83768337|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
83768338|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
83768339|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768340|NCT00014352|Ketoconazole|ketoconazole|mesh-list
83768341|NCT00014352|Docetaxel|docetaxel|mesh-list
83768342|NCT00014352|Doxorubicin|doxorubicin|mesh-list
83768343|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83768344|NCT00014352|Estramustine|estramustine|mesh-list
83768345|NCT00014352|Warfarin|warfarin|mesh-list
83768346|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768347|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83768348|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83768349|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83768350|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768351|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83768352|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83768353|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768354|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768355|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
83768356|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
83768357|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768358|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83768359|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83768360|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83768361|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
83768362|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923561|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83768363|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768364|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83768365|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83768366|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
83768367|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83768368|NCT00035191|Galantamine|galantamine|mesh-list
83768369|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83768370|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768371|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768372|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
83768373|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768374|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768375|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83768376|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
83768377|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768378|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
83768379|NCT00035230|Topiramate|topiramate|mesh-list
83768380|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
83768381|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83768382|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768383|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83768384|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768385|NCT00014391|Ribavirin|ribavirin|mesh-list
83768386|NCT00014391|Palivizumab|palivizumab|mesh-list
83768387|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
83768388|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768389|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
83768390|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768391|NCT00035308|Abetimus|abetimus|mesh-list
83768392|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768393|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
83768394|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768395|NCT00035347|Azithromycin|azithromycin|mesh-list
83768396|NCT00035347|Levofloxacin|levofloxacin|mesh-list
83768397|NCT00035347|Ofloxacin|ofloxacin|mesh-list
83768398|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
83768399|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768400|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768401|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83768402|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83768403|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768404|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768405|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768406|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768407|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83768408|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83768409|NCT00014430|Trastuzumab|trastuzumab|mesh-list
83768410|NCT00014430|Vinorelbine|vinorelbine|mesh-list
83768411|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83768412|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768413|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83768414|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
83768415|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
83768416|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
83768417|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768418|NCT00035425|Vancomycin|vancomycin|mesh-list
83768419|NCT00035425|Linezolid|linezolid|mesh-list
83768420|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768421|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768422|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83768423|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768424|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768425|NCT00000752|Cefuroxime|cefuroxime|mesh-list
83768426|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
83768427|NCT00000752|Beclomethasone|beclomethasone|mesh-list
83768428|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
83768429|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
83768430|NCT00000752|Ephedrine|ephedrine|mesh-list
83768431|NCT00000752|Guaifenesin|guaifenesin|mesh-list
83768432|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83768433|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83768434|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
83768435|NCT00000752|Hormones|hormones|mesh-ancestor
83768436|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768437|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768438|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83768439|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
83768440|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83768441|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
83768442|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768443|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
83768444|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83768445|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83768446|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
83768447|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
83768448|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768449|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768450|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768451|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768452|NCT00000752|Expectorants|expectorants|mesh-ancestor
83768453|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83768454|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83768455|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
83768456|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83768457|NCT00035464|Azimilide|azimilide|mesh-list
83768458|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83768459|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83768460|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83768461|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768462|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83768463|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768464|NCT00014469|Methotrexate|methotrexate|mesh-list
83768465|NCT00014469|Melphalan|melphalan|mesh-list
83768466|NCT00014469|Busulfan|busulfan|mesh-list
83768467|NCT00014469|Tacrolimus|tacrolimus|mesh-list
83768468|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83768469|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
83768470|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83768471|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768472|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768473|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
83768474|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768475|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768476|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768477|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768478|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768479|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768480|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
83768481|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768482|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768483|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83768484|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83768485|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
83768486|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83768487|NCT00000755|Zidovudine|zidovudine|mesh-list
83768488|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
83768489|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768490|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768491|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768492|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768493|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
83768494|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768495|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768496|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768497|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83768498|NCT00035581|Poly I-C|poly i-c|mesh-list
83768499|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
83768500|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768501|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
83768502|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
83768503|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768504|NCT00000758|Fluorouracil|fluorouracil|mesh-list
83768505|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
83768506|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768507|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768508|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768509|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768510|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
83768511|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923705|NCT02937740|Androgens|androgens|mesh-ancestor
83768512|NCT00035620|Lenograstim|lenograstim|mesh-list
83768513|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83768514|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
83768515|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768516|NCT00014547|BBR 3464|bbr 3464|mesh-list
83768517|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768518|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
83768519|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83768520|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
83768521|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768522|NCT02971306|Expectorants|expectorants|mesh-ancestor
83768523|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
83768524|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83768525|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
83768526|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768527|NCT02971306|Protective Agents|protective agents|mesh-ancestor
83768528|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768529|NCT02971306|Antidotes|antidotes|mesh-ancestor
83768530|NCT00000761|Interferons|interferons|mesh-list
83768531|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
83768532|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768533|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
83768534|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768535|NCT00014586|Goserelin|goserelin|mesh-list
83768536|NCT00014586|Bicalutamide|bicalutamide|mesh-list
83768537|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83768538|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768539|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
83768540|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
83768541|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768542|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768543|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
83768544|NCT04732390|Bupivacaine|bupivacaine|mesh-list
83768545|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
83768546|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
83768547|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83768548|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768549|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
83768550|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768551|NCT04732390|Analgesics|analgesics|mesh-ancestor
83768552|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83768553|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
83768554|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83768555|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83768556|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768557|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83768558|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
83768559|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83768560|NCT00035854|Linezolid|linezolid|mesh-list
83768561|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768562|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768563|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83768564|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768565|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768566|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83768567|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83768568|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
83768569|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768570|NCT00000779|Antacids|antacids|mesh-ancestor
83768571|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768572|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83768573|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83768574|NCT00035893|Poly I-C|poly i-c|mesh-list
83768575|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
83768576|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768577|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
83768578|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
83768579|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768580|NCT00035971|Alendronate|alendronate|mesh-list
83768581|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83768582|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83768583|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768584|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83768585|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
83768586|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768587|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82923784|NCT02111434|Testosterone|testosterone|mesh-list
83768588|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83768589|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83768591|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83768592|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768593|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768594|NCT02971345|Iodine|iodine|mesh-list
83768595|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
83768596|NCT02971345|Epirubicin|epirubicin|mesh-list
83768597|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
83768598|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83768599|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768600|NCT02971345|Trace Elements|trace elements|mesh-ancestor
83768601|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
83768602|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768603|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83768604|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768605|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83768606|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768607|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768608|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768609|NCT00036088|Olanzapine|olanzapine|mesh-list
83768610|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
83768611|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
83768612|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768613|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768614|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83768615|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83768616|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83768617|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83768618|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83768619|NCT00036088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83768620|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83768621|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83768622|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768623|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768624|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
83768625|NCT00036127|Aripiprazole|aripiprazole|mesh-list
83768626|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
83768627|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83768628|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83768629|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83768630|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83768631|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768632|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
83768633|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
83768634|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768635|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768636|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83768637|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83768638|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
83768639|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83768640|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83768641|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83768642|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83768643|NCT00000788|Fluconazole|fluconazole|mesh-list
83768644|NCT00000788|Methadone|methadone|mesh-list
83768645|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83768646|NCT00000788|Narcotics|narcotics|mesh-ancestor
83768647|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83768648|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768649|NCT00000788|Analgesics|analgesics|mesh-ancestor
83768650|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
83768651|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768652|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
83768653|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
83768654|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
83768655|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768656|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83768657|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83768658|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768659|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923858|NCT02112292|Analgesics|analgesics|mesh-ancestor
83768660|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83768661|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
83768662|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768663|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83768664|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83768666|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
83768667|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768668|NCT00000794|Leucovorin|leucovorin|mesh-list
83768669|NCT00000794|Clarithromycin|clarithromycin|mesh-list
83768670|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
83768671|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
83768672|NCT00000794|Atovaquone|atovaquone|mesh-list
83768673|NCT00000794|Calcium|calcium|mesh-list
83768674|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
83768675|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83768676|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768677|NCT00000794|Antidotes|antidotes|mesh-ancestor
83768678|NCT00000794|Protective Agents|protective agents|mesh-ancestor
83768679|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
83768680|NCT00000794|Vitamins|vitamins|mesh-ancestor
83768681|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
83768682|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768683|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768684|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83768685|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768686|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768687|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83768688|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83768689|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
83768690|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83768691|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83768692|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768693|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
83768694|NCT00036244|Secretin|secretin|mesh-list
83768695|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83768696|NCT00036244|Hormones|hormones|mesh-ancestor
83768697|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83768698|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768699|NCT00036283|Celecoxib|celecoxib|mesh-list
83768700|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83768701|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83768702|NCT00036283|Analgesics|analgesics|mesh-ancestor
83768703|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
83768704|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768705|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768706|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83768707|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768708|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83768709|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83768710|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768711|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768712|NCT00391638|Interferons|interferons|mesh-list
83768713|NCT00391638|Tenofovir|tenofovir|mesh-list
83768714|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83768715|NCT00391638|Emtricitabine|emtricitabine|mesh-list
83768716|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83768717|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768718|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
83768719|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768720|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768721|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768722|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768723|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768724|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768725|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768726|NCT00036361|Aripiprazole|aripiprazole|mesh-list
83768727|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
83768728|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83768729|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83768730|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83768731|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923928|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83768732|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768733|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
83768734|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
83768735|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83768736|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768737|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83768738|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83768739|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
83768740|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83768741|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83768742|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83768743|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83768744|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
83768745|NCT00036400|Hematinics|hematinics|mesh-ancestor
83768746|NCT00036439|Infliximab|infliximab|mesh-list
83768747|NCT00036439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83768748|NCT00036439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83768749|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768750|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83768751|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768752|NCT00000821|Aldesleukin|aldesleukin|mesh-list
83768753|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768754|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768755|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768756|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
83768757|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768758|NCT00036556|Atrasentan|atrasentan|mesh-list
83768759|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768760|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83768761|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83768762|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768763|NCT00000827|Immune Sera|immune sera|mesh-list
83768764|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
83768765|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768766|NCT00036634|Tenofovir|tenofovir|mesh-list
83768767|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
83768768|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768769|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768770|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768771|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768772|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768773|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768774|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768775|NCT00000851|Stavudine|stavudine|mesh-list
83768776|NCT00000851|Didanosine|didanosine|mesh-list
83768777|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
83768778|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768779|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768780|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768781|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768782|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
83768783|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768784|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768785|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768786|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
83768787|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768788|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83768789|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768790|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768791|NCT00036790|Doxorubicin|doxorubicin|mesh-list
83768792|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83768793|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
83768794|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83768795|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768796|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83768797|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768798|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768799|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768800|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83768801|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768802|NCT00000857|Interleukin-12|interleukin-12|mesh-list
83768803|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83768804|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
83768805|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768806|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83768807|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82924003|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83768808|NCT00000857|Growth Substances|growth substances|mesh-ancestor
83768809|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
83768810|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768811|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
83768812|NCT00036868|Fluorouracil|fluorouracil|mesh-list
83768813|NCT00036868|Methotrexate|methotrexate|mesh-list
83768814|NCT00036868|Trastuzumab|trastuzumab|mesh-list
83768815|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768816|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
83768817|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768818|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768819|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83768820|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
83768821|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768822|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768823|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83768824|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
83768825|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768826|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83768827|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
83768828|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83768829|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768830|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768831|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768832|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768833|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83768834|NCT00036946|Aflibercept|aflibercept|mesh-list
83768835|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83768836|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83768837|NCT00036946|Growth Substances|growth substances|mesh-ancestor
83768838|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768839|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
83768840|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768841|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
83768842|NCT00036985|Doxorubicin|doxorubicin|mesh-list
83768843|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83768844|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768845|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
83768846|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768847|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768848|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83768849|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
83768850|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768851|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768852|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83768853|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83768854|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83768855|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768856|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768857|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
83768859|NCT00037063|Riboflavin|riboflavin|mesh-list
83768860|NCT00037063|Thiamine|thiamine|mesh-list
83768861|NCT00037063|Vitamins|vitamins|mesh-ancestor
83768862|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
83768863|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768864|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
83768865|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768866|NCT00037063|Protective Agents|protective agents|mesh-ancestor
83768867|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
83768868|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83768869|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768870|NCT00000869|Nevirapine|nevirapine|mesh-list
83768871|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768872|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768873|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768874|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768875|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
83768876|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768877|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768878|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768879|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83768880|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83768881|NCT00037102|Interferons|interferons|mesh-list
83768882|NCT00037102|Interferon-beta|interferon-beta|mesh-list
82924083|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
83768884|NCT00037102|Methotrexate|methotrexate|mesh-list
83768885|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83768886|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
83768887|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83768888|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768889|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768890|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
83768891|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768892|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768893|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83768894|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768895|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83768896|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768897|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
83768898|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768899|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768900|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
83768901|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768902|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83768903|NCT00037141|Ethanol|ethanol|mesh-list
83768904|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83768905|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768906|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83768907|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768908|NCT00037180|Leucovorin|leucovorin|mesh-list
83768909|NCT00037180|Celecoxib|celecoxib|mesh-list
83768910|NCT00037180|Fluorouracil|fluorouracil|mesh-list
83768911|NCT00037180|Irinotecan|irinotecan|mesh-list
83768912|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
83768913|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768914|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83768915|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768916|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768917|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
83768918|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768919|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83768920|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83768921|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768922|NCT00037180|Antidotes|antidotes|mesh-ancestor
83768923|NCT00037180|Protective Agents|protective agents|mesh-ancestor
83768924|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
83768925|NCT00037180|Vitamins|vitamins|mesh-ancestor
83768926|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
83768927|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83768928|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83768929|NCT00037180|Analgesics|analgesics|mesh-ancestor
83768930|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
83768931|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83768932|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83768933|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768934|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83768935|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83768936|NCT00037219|Anidulafungin|anidulafungin|mesh-list
83768937|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
83768938|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768939|NCT00000893|Efavirenz|efavirenz|mesh-list
83768940|NCT00000893|Nelfinavir|nelfinavir|mesh-list
83768941|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768942|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768943|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768944|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768945|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
83768946|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768947|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83768948|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83768949|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83768950|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83768951|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83768952|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83768953|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83768954|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82924156|NCT03999710|Durvalumab|durvalumab|mesh-list
83768955|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
83768956|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83768957|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83768958|NCT00396526|Amoxicillin|amoxicillin|mesh-list
83768959|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83768960|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768961|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768962|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83768963|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
83768964|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83768965|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83768966|NCT00037531|Sirolimus|sirolimus|mesh-list
83768967|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83768968|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768969|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83768970|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768971|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
83768972|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768973|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
83768974|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768975|NCT00037570|Pantoprazole|pantoprazole|mesh-list
83768976|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83768977|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83768978|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83768979|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768980|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768981|NCT00000899|Lamivudine|lamivudine|mesh-list
83768982|NCT00000899|Stavudine|stavudine|mesh-list
83768983|NCT00000899|Nelfinavir|nelfinavir|mesh-list
83768984|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
83768985|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83768986|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
83768987|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83768988|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83768989|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83768990|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
83768991|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83768992|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83768993|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83768994|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83768995|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83768996|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83768997|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
83768998|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83768999|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769000|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769001|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83769002|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83769003|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
83769004|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
83769005|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
83769006|NCT00037609|Capecitabine|capecitabine|mesh-list
83769007|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83769008|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
83769009|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769010|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769011|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83769012|NCT00037609|Protective Agents|protective agents|mesh-ancestor
83769013|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769014|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83769015|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769016|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83769017|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83769018|NCT00037609|Analgesics|analgesics|mesh-ancestor
83769019|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
83769020|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769021|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83769022|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769023|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83769024|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769025|NCT00037804|Irinotecan|irinotecan|mesh-list
83769026|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83769027|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82924229|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82924230|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
83769028|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769029|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769030|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769032|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
83769033|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
83769034|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83769035|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769036|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
83769037|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769038|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
83769039|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769040|NCT00037999|Testosterone|testosterone|mesh-list
83769041|NCT00037999|Androgens|androgens|mesh-ancestor
83769042|NCT00037999|Hormones|hormones|mesh-ancestor
83769043|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769044|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769045|NCT00038077|Metoprolol|metoprolol|mesh-list
83769046|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83769047|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83769048|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
83769049|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
83769050|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769051|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769052|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83769053|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83769054|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83769055|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
83769056|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769057|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769058|NCT00038116|Dopamine|dopamine|mesh-list
83769059|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83769060|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
83769061|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
83769062|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769063|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769064|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
83769065|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769066|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769067|NCT00038116|Protective Agents|protective agents|mesh-ancestor
83769068|NCT00038194|Docetaxel|docetaxel|mesh-list
83769069|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
83769070|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769071|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769072|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
83769073|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
83769074|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769075|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83769076|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769077|NCT00038233|Thalidomide|thalidomide|mesh-list
83769078|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769079|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
83769080|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769081|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
83769082|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769083|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769084|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83769085|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83769086|NCT00038233|Growth Substances|growth substances|mesh-ancestor
83769087|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769088|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769089|NCT00000926|Nonoxynol|nonoxynol|mesh-list
83769090|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83769091|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83769092|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769093|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83769094|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
83769095|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83769096|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83769097|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
83769098|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83769099|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769100|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83769101|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
83769102|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769103|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924304|NCT00177671|Analgesics|analgesics|mesh-ancestor
83769104|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769105|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769106|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
83769107|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769108|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
83769109|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769110|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769111|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769112|NCT00000941|Ritonavir|ritonavir|mesh-list
83769113|NCT00000941|Nelfinavir|nelfinavir|mesh-list
83769114|NCT00000941|Saquinavir|saquinavir|mesh-list
83769115|NCT00000941|Atorvastatin|atorvastatin|mesh-list
83769116|NCT00000941|Simvastatin|simvastatin|mesh-list
83769117|NCT00000941|Pravastatin|pravastatin|mesh-list
83769118|NCT00000941|Calcium|calcium|mesh-list
83769119|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83769120|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769121|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83769122|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83769123|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
83769124|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769125|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83769126|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83769127|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769128|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83769129|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83769130|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
83769131|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769132|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769133|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
83769134|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769135|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83769136|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83769137|NCT00014937|Ritonavir|ritonavir|mesh-list
83769138|NCT00014937|Lopinavir|lopinavir|mesh-list
83769139|NCT00014937|Lamivudine|lamivudine|mesh-list
83769140|NCT00014937|Zidovudine|zidovudine|mesh-list
83769141|NCT00014937|Stavudine|stavudine|mesh-list
83769142|NCT00014937|Didanosine|didanosine|mesh-list
83769143|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83769144|NCT00014937|Efavirenz|efavirenz|mesh-list
83769145|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83769146|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83769147|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
83769148|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769149|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769150|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769151|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769152|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
83769153|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769154|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83769155|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83769156|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769157|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769158|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
83769159|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83769160|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83769161|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83769162|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83769163|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83769164|NCT00000959|Pyridoxine|pyridoxine|mesh-list
83769165|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
83769166|NCT00000959|Isoniazid|isoniazid|mesh-list
83769167|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
83769168|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769169|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769170|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83769171|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83769172|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
83769173|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769174|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83769175|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
83769176|NCT00000959|Vitamins|vitamins|mesh-ancestor
83769177|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
82924374|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769178|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769179|NCT00000962|Nevirapine|nevirapine|mesh-list
83769180|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769181|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769183|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769184|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
83769185|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769186|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769187|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769188|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83769189|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83769190|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
83769191|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769192|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
83769193|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769194|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769195|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83769196|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
83769197|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769198|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769199|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83769200|NCT00396721|Sirolimus|sirolimus|mesh-list
83769201|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83769202|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83769203|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769204|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769205|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83769206|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769207|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
83769208|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769209|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
83769210|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769211|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769212|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769213|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83769214|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83769215|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
83769216|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83769217|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
83769218|NCT00000965|Zidovudine|zidovudine|mesh-list
83769219|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
83769220|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769221|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769222|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769223|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769224|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
83769225|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769226|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769227|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769228|NCT00015054|Methylphenidate|methylphenidate|mesh-list
83769229|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83769230|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769231|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83769232|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83769233|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83769234|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769235|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
83769236|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769237|NCT00015132|Sertraline|sertraline|mesh-list
83769238|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
83769239|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83769240|NCT00015132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83769241|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83769242|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83769243|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769244|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769245|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
83769246|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769247|NCT00000971|Zidovudine|zidovudine|mesh-list
83769248|NCT00000971|Didanosine|didanosine|mesh-list
83769249|NCT00000971|Clarithromycin|clarithromycin|mesh-list
83769250|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
82924447|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83769251|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769252|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769253|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769255|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
83769256|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769257|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769258|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769259|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769260|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83769261|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83769262|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83769263|NCT00015171|Buprenorphine|buprenorphine|mesh-list
83769264|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83769265|NCT00015171|Naloxone|naloxone|mesh-list
83769266|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83769267|NCT00015171|Narcotics|narcotics|mesh-ancestor
83769268|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83769269|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769270|NCT00015171|Analgesics|analgesics|mesh-ancestor
83769271|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
83769272|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769273|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83769274|NCT00015210|Nefazodone|nefazodone|mesh-list
83769275|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83769276|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83769277|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83769278|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769279|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769280|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769281|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83769282|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
83769283|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83769284|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83769285|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83769286|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
83769287|NCT00000986|Zidovudine|zidovudine|mesh-list
83769288|NCT00000986|Aldesleukin|aldesleukin|mesh-list
83769289|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
83769290|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769291|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769292|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769293|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769294|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
83769295|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769296|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769297|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769298|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769299|NCT00015249|Amantadine|amantadine|mesh-list
83769300|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83769301|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83769302|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
83769303|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769304|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
83769305|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769306|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769307|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769308|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83769309|NCT00015249|Analgesics|analgesics|mesh-ancestor
83769310|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
83769311|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769312|NCT05195242|Dexamethasone|dexamethasone|mesh-list
83769313|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83769314|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
83769315|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
83769316|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769317|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769318|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83769319|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
83769320|NCT05195242|Hormones|hormones|mesh-ancestor
83769321|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924521|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924522|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769322|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769323|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769324|NCT00015288|Buprenorphine|buprenorphine|mesh-list
83769325|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83769326|NCT00015288|Naloxone|naloxone|mesh-list
83769327|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83769328|NCT00015288|Narcotics|narcotics|mesh-ancestor
83769329|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83769330|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769331|NCT00015288|Analgesics|analgesics|mesh-ancestor
83769332|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
83769333|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769334|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83769335|NCT05083975|Anesthetics|anesthetics|mesh-list
83769336|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
83769337|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83769338|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769339|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
83769340|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769341|NCT00000998|Leucovorin|leucovorin|mesh-list
83769342|NCT00000998|Trimetrexate|trimetrexate|mesh-list
83769343|NCT00000998|Calcium|calcium|mesh-list
83769344|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
83769345|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83769346|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769347|NCT00000998|Antidotes|antidotes|mesh-ancestor
83769348|NCT00000998|Protective Agents|protective agents|mesh-ancestor
83769349|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
83769350|NCT00000998|Vitamins|vitamins|mesh-ancestor
83769351|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
83769352|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
83769353|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769354|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83769355|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
83769356|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769357|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769358|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83769359|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769360|NCT00001001|Zidovudine|zidovudine|mesh-list
83769361|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
83769362|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769363|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769364|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769365|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769366|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
83769367|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769368|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769369|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769370|NCT05076877|Metformin|metformin|mesh-list
83769371|NCT05076877|Midazolam|midazolam|mesh-list
83769372|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83769373|NCT05076877|Lazertinib|lazertinib|mesh-list
83769374|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83769375|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769376|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83769377|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83769378|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83769379|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83769380|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83769381|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83769382|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83769383|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
83769384|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
83769385|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
83769386|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
83769387|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769388|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769389|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83769390|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83769391|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
83769392|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83769393|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83769394|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769395|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83769396|NCT00001004|Interferons|interferons|mesh-list
83769397|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
83769398|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924595|NCT02127034|Mirabegron|mirabegron|mesh-list
83769399|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
83769400|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769401|NCT00396604|Maleic acid|maleic acid|mesh-list
83769402|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769403|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769404|NCT04896541|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83769405|NCT04896541|Antiviral Agents|antiviral agents|mesh-ancestor
83769406|NCT04896541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769407|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
83769408|NCT00396760|Aprotinin|aprotinin|mesh-list
83769409|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83769410|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83769411|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769412|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
83769413|NCT00396760|Coagulants|coagulants|mesh-ancestor
83769414|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83769415|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83769416|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
83769417|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769418|NCT00001007|Zidovudine|zidovudine|mesh-list
83769419|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
83769420|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769421|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769422|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769423|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769424|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
83769425|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769426|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769427|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769428|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
83769429|NCT00396799|Estrogens|estrogens|mesh-list
83769430|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83769431|NCT00396799|Hormones|hormones|mesh-ancestor
83769432|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769433|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769434|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83769435|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83769436|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
83769437|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83769438|NCT01786434|Fentanyl|fentanyl|mesh-list
83769439|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83769440|NCT01786434|Narcotics|narcotics|mesh-ancestor
83769441|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83769442|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769443|NCT01786434|Analgesics|analgesics|mesh-ancestor
83769444|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
83769445|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769446|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83769447|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83769448|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
83769449|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
83769450|NCT00001010|Zidovudine|zidovudine|mesh-list
83769451|NCT00001010|Acyclovir|acyclovir|mesh-list
83769452|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
83769453|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769454|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769455|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769456|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769457|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
83769458|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769459|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769460|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769461|NCT00001013|Leucovorin|leucovorin|mesh-list
83769462|NCT00001013|Trimethoprim|trimethoprim|mesh-list
83769463|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83769464|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
83769465|NCT00001013|Pentamidine|pentamidine|mesh-list
83769466|NCT00001013|Trimetrexate|trimetrexate|mesh-list
83769467|NCT00001013|Calcium|calcium|mesh-list
83769468|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
83769469|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82924671|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
83769470|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769471|NCT00001013|Antidotes|antidotes|mesh-ancestor
83769472|NCT00001013|Protective Agents|protective agents|mesh-ancestor
83769473|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
83769474|NCT00001013|Vitamins|vitamins|mesh-ancestor
83769475|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
83769476|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83769477|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769478|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
83769479|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83769480|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83769481|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83769482|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769483|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769484|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83769485|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83769486|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83769487|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
83769488|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83769489|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769490|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83769491|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
83769492|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769493|NCT04680442|Trastuzumab|trastuzumab|mesh-list
83769494|NCT04680442|Pertuzumab|pertuzumab|mesh-list
83769495|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83769496|NCT04680442|Maytansine|maytansine|mesh-list
83769497|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83769498|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769499|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83769500|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769501|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83769502|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83769503|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769504|NCT04680442|Immunotoxins|immunotoxins|mesh-ancestor
83769505|NCT04680442|Immunoconjugates|immunoconjugates|mesh-ancestor
83769506|NCT04680442|Immunologic Factors|immunologic factors|mesh-ancestor
83769507|NCT04680442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769508|NCT00015834|Cytarabine|cytarabine|mesh-list
83769509|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
83769510|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83769511|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
83769512|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769513|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769514|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
83769515|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769516|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769517|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
83769518|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769519|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83769520|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769521|NCT00001040|Zidovudine|zidovudine|mesh-list
83769522|NCT00001040|Zalcitabine|zalcitabine|mesh-list
83769523|NCT00001040|Saquinavir|saquinavir|mesh-list
83769524|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
83769525|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769526|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769527|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769528|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769529|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
83769530|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769531|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769532|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769533|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83769534|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83769535|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
83769536|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83769537|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83769538|NCT00015873|Cytarabine|cytarabine|mesh-list
83769539|NCT00015873|Prednisolone|prednisolone|mesh-list
83769540|NCT00015873|Methotrexate|methotrexate|mesh-list
83769541|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
83769542|NCT00015873|Vincristine|vincristine|mesh-list
83769543|NCT00015873|Asparaginase|asparaginase|mesh-list
83769544|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83769545|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
83769546|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83769547|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769548|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83769549|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
83769550|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769551|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769552|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
83769553|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769554|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83769555|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769556|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
83769557|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769558|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769559|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
83769560|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769561|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83769562|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769563|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
83769564|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
83769565|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83769566|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
83769567|NCT00015873|Hormones|hormones|mesh-ancestor
83769568|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769569|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769570|NCT00015912|Interferons|interferons|mesh-list
83769571|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
83769572|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
83769573|NCT00015912|Thalidomide|thalidomide|mesh-list
83769574|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769575|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
83769576|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769577|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
83769578|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769579|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769580|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
83769581|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769582|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83769583|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83769584|NCT00015912|Growth Substances|growth substances|mesh-ancestor
83769585|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769586|NCT03668431|Trametinib|trametinib|mesh-list
83769587|NCT03668431|Dabrafenib|dabrafenib|mesh-list
83769588|NCT03668431|Spartalizumab|spartalizumab|mesh-list
83769589|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769590|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83769591|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769592|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769593|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83769594|NCT03668431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83769595|NCT00001073|Isotretinoin|isotretinoin|mesh-list
83769596|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
83769597|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
83769598|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
83769599|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83769600|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83769601|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83769602|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769603|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
83769604|NCT00015951|Cytarabine|cytarabine|mesh-list
83769605|NCT00015951|Bevacizumab|bevacizumab|mesh-list
83769606|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
83769607|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83769608|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769609|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83769610|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83769611|NCT00015951|Growth Substances|growth substances|mesh-ancestor
83769612|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769613|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769614|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83769615|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
83769616|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769617|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
83769618|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769619|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769620|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
83769621|NCT00015951|Analgesics|analgesics|mesh-ancestor
83769622|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
82924818|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
82924819|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
83769623|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769624|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83769625|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83769626|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769627|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
83769628|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83769629|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
83769630|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769631|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83769632|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769633|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
83769634|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769635|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
83769636|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83769637|NCT00001076|Protective Agents|protective agents|mesh-ancestor
83769638|NCT00015990|Thalidomide|thalidomide|mesh-list
83769639|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769640|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
83769641|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769642|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
83769643|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769644|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769645|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83769646|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83769647|NCT00015990|Growth Substances|growth substances|mesh-ancestor
83769648|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769649|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769650|NCT00001085|Lamivudine|lamivudine|mesh-list
83769651|NCT00001085|Zidovudine|zidovudine|mesh-list
83769652|NCT00001085|Amprenavir|amprenavir|mesh-list
83769653|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83769654|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769655|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769656|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769657|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
83769658|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769659|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769660|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769661|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
83769662|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83769663|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
83769664|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769665|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83769666|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83769667|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
83769668|NCT02970916|Aflibercept|aflibercept|mesh-list
83769669|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83769670|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83769671|NCT02970916|Growth Substances|growth substances|mesh-ancestor
83769672|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769673|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769674|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769675|NCT00016068|Valganciclovir|valganciclovir|mesh-list
83769676|NCT00016068|Ganciclovir|ganciclovir|mesh-list
83769677|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83769678|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
83769679|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769680|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769681|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769682|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769683|NCT00016107|Bevacizumab|bevacizumab|mesh-list
83769684|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83769685|NCT00016107|Docetaxel|docetaxel|mesh-list
83769686|NCT00016107|Estramustine|estramustine|mesh-list
83769687|NCT00016107|Antibodies|antibodies|mesh-list
83769688|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
83769689|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83769690|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769691|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83769692|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83769693|NCT00016107|Growth Substances|growth substances|mesh-ancestor
83769694|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769695|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769696|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
83769697|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769698|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
83769699|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
83769700|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769701|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83769702|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
82924895|NCT02131948|Insulin|insulin|mesh-list
83769703|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769705|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83769706|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83769707|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769708|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83769709|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83769710|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
83769711|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769712|NCT00016185|Docetaxel|docetaxel|mesh-list
83769713|NCT00016185|Alvocidib|alvocidib|mesh-list
83769714|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769715|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769716|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
83769717|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
83769718|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769719|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769720|NCT00016185|Growth Substances|growth substances|mesh-ancestor
83769721|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769722|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83769723|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769724|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83769725|NCT00001151|Calcitriol|calcitriol|mesh-list
83769726|NCT00001151|Vitamins|vitamins|mesh-ancestor
83769727|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
83769728|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769729|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83769730|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83769731|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83769732|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83769733|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769734|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83769735|NCT00016224|Thalidomide|thalidomide|mesh-list
83769736|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769737|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
83769738|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769739|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
83769740|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83769741|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769742|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83769743|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83769744|NCT00016224|Growth Substances|growth substances|mesh-ancestor
83769745|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
83769746|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769747|NCT00016263|Dacarbazine|dacarbazine|mesh-list
83769748|NCT00016263|Oblimersen|oblimersen|mesh-list
83769749|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83769750|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
83769751|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769752|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769753|NCT00016302|Leucovorin|leucovorin|mesh-list
83769754|NCT00016302|Cytarabine|cytarabine|mesh-list
83769755|NCT00016302|Dexamethasone|dexamethasone|mesh-list
83769756|NCT00016302|Prednisone|prednisone|mesh-list
83769757|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
83769758|NCT00016302|Doxorubicin|doxorubicin|mesh-list
83769759|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83769760|NCT00016302|Methotrexate|methotrexate|mesh-list
83769761|NCT00016302|Vincristine|vincristine|mesh-list
83769762|NCT00016302|Daunorubicin|daunorubicin|mesh-list
83769763|NCT00016302|Asparaginase|asparaginase|mesh-list
83769764|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
83769765|NCT00016302|Pegaspargase|pegaspargase|mesh-list
83769766|NCT00016302|Thioguanine|thioguanine|mesh-list
83769767|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
83769768|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769769|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
83769770|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769771|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769772|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83769773|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
83769774|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769775|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769776|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83769777|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83769778|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
83769779|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
82924969|NCT03968237|Naloxone|naloxone|mesh-list
83769780|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769781|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83769782|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
83769783|NCT00016302|Hormones|hormones|mesh-ancestor
83769784|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769785|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769786|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83769787|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83769788|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83769789|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769790|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83769791|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
83769792|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83769793|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83769794|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
83769795|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
83769796|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83769797|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83769798|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
83769799|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769800|NCT00016302|Antidotes|antidotes|mesh-ancestor
83769801|NCT00016302|Protective Agents|protective agents|mesh-ancestor
83769802|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
83769803|NCT00016302|Vitamins|vitamins|mesh-ancestor
83769804|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
83769805|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83769806|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769807|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
83769808|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
83769809|NCT00389285|Sorafenib|sorafenib|mesh-list
83769810|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769811|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83769812|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769813|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769814|NCT00016341|Tamoxifen|tamoxifen|mesh-list
83769815|NCT00016341|Paclitaxel|paclitaxel|mesh-list
83769816|NCT00016341|Doxorubicin|doxorubicin|mesh-list
83769817|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83769818|NCT00016341|Megestrol|megestrol|mesh-list
83769819|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
83769820|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83769821|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769822|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
83769823|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
83769824|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
83769825|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769826|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83769827|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83769828|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83769829|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769830|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769831|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83769832|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
83769833|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769834|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769835|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83769836|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83769837|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83769838|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83769839|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83769840|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83769841|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
83769842|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83769843|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83769844|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83769845|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
83769846|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83769847|NCT00001181|Testolactone|testolactone|mesh-list
83769848|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769849|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769850|NCT00016380|Dexamethasone|dexamethasone|mesh-list
83769851|NCT00016380|Ondansetron|ondansetron|mesh-list
83769852|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83769853|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
83769854|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
83769855|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769856|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769857|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83769858|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
83769859|NCT00016380|Hormones|hormones|mesh-ancestor
83769860|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769861|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769862|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769863|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
83769864|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
83769865|NCT00016380|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83769866|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83769867|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
83769868|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769869|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769870|NCT00001190|Deslorelin|deslorelin|mesh-list
83769871|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769872|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769873|NCT00001202|Testolactone|testolactone|mesh-list
83769874|NCT00001202|Spironolactone|spironolactone|mesh-list
83769875|NCT00001202|Deslorelin|deslorelin|mesh-list
83769876|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83769877|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
83769878|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769879|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769880|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83769881|NCT00001202|Diuretics|diuretics|mesh-ancestor
83769882|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
83769883|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769884|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769885|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769886|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769887|NCT00016419|Cyclosporine|cyclosporine|mesh-list
83769888|NCT00016419|Cyclosporins|cyclosporins|mesh-list
83769889|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83769890|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769891|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769892|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769893|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
83769894|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769895|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
83769896|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769897|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
83769898|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769899|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83769900|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
83769901|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83769902|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769903|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
83769904|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769905|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769906|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83769907|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
83769908|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769909|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769910|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83769911|NCT01156545|Afatinib|afatinib|mesh-list
83769912|NCT01156545|Simvastatin|simvastatin|mesh-list
83769913|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83769914|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83769915|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
83769916|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769917|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83769918|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83769919|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769920|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769921|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83769922|NCT01140516|Trimethoprim|trimethoprim|mesh-list
83769923|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83769924|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769925|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
83769926|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83769927|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83769928|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83769930|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769931|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83769932|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83769933|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83769934|NCT02734771|Prednisone|prednisone|mesh-list
83769935|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
83769936|NCT02734771|Rituximab|rituximab|mesh-list
83769937|NCT02734771|Doxorubicin|doxorubicin|mesh-list
83769938|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83769939|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83769940|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
83769941|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769942|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83769943|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83769944|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
83769945|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769946|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83769947|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83769948|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83769949|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83769950|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83769951|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83769952|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769953|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83769954|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
83769955|NCT02734771|Hormones|hormones|mesh-ancestor
83769956|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769957|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83769958|NCT02734771|Immunotoxins|immunotoxins|mesh-ancestor
83769959|NCT02734771|Immunoconjugates|immunoconjugates|mesh-ancestor
83769960|NCT02347111|Sotalol|sotalol|mesh-list
83769961|NCT02347111|Flecainide|flecainide|mesh-list
83769962|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83769963|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83769964|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
83769965|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83769966|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769967|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769968|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83769969|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
83769970|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
83769971|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83769972|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83769973|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83769974|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83769975|NCT00001262|Copper|copper|mesh-list
83769976|NCT00001262|Trace Elements|trace elements|mesh-ancestor
83769977|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
83769978|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769979|NCT00001280|Itraconazole|itraconazole|mesh-list
83769980|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
83769981|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83769982|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83769983|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83769984|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83769985|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83769986|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83769987|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
83769988|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83769989|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83769990|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83769991|NCT00016887|Interferons|interferons|mesh-list
83769992|NCT00016887|Cytarabine|cytarabine|mesh-list
83769993|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
83769994|NCT00016887|Dexamethasone|dexamethasone|mesh-list
83769995|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
83769996|NCT00016887|Melphalan|melphalan|mesh-list
83769997|NCT00016887|Carmustine|carmustine|mesh-list
83769998|NCT00016887|Etoposide|etoposide|mesh-list
83769999|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770000|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
83770001|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770002|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925199|NCT00137111|Doxorubicin|doxorubicin|mesh-list
83770003|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770004|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
83770005|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770006|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770007|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83770008|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83770009|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
83770010|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
83770011|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770012|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83770013|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
83770014|NCT00016887|Hormones|hormones|mesh-ancestor
83770015|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770016|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83770017|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83770018|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83770019|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770020|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770021|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
83770022|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770023|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770024|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
83770025|NCT00038389|Rofecoxib|rofecoxib|mesh-list
83770026|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83770027|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83770028|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770029|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770030|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83770031|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83770032|NCT00038389|Analgesics|analgesics|mesh-ancestor
83770033|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
83770034|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770035|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770036|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83770037|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770038|NCT00038506|Tenofovir|tenofovir|mesh-list
83770039|NCT00038506|Lamivudine|lamivudine|mesh-list
83770040|NCT00038506|Zidovudine|zidovudine|mesh-list
83770041|NCT00038506|Abacavir|abacavir|mesh-list
83770042|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83770043|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
83770044|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770045|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83770046|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83770047|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770048|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770049|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83770050|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83770051|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
83770052|NCT00016926|Capecitabine|capecitabine|mesh-list
83770053|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770054|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
83770055|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770056|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770057|NCT00038545|Paclitaxel|paclitaxel|mesh-list
83770058|NCT00038545|Topotecan|topotecan|mesh-list
83770059|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83770060|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770061|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
83770062|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770063|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770064|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770065|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83770066|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770067|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770068|NCT00038584|Lonafarnib|lonafarnib|mesh-list
83770069|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770070|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770071|NCT00038623|Rituximab|rituximab|mesh-list
83770072|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83770073|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770074|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
83770075|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770076|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770077|NCT00038662|Atrasentan|atrasentan|mesh-list
83770078|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770079|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83770080|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83770081|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770082|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
83770083|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83770084|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770085|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83770086|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83770087|NCT00038701|Growth Substances|growth substances|mesh-ancestor
83770088|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770089|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
83770090|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83770091|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83770092|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83770093|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770094|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770095|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770096|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770097|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83770098|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
83770099|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83770100|NCT00038935|Factor VIII|factor viii|mesh-list
83770101|NCT00038935|Coagulants|coagulants|mesh-ancestor
83770102|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
83770103|NCT00017004|Hematinics|hematinics|mesh-ancestor
83770104|NCT00038974|Ribavirin|ribavirin|mesh-list
83770105|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83770106|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
83770107|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770108|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
83770109|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770110|NCT00039013|Exenatide|exenatide|mesh-list
83770111|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83770112|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770113|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83770114|NCT00039013|Incretins|incretins|mesh-ancestor
83770115|NCT00039013|Hormones|hormones|mesh-ancestor
83770116|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770117|NCT00039052|Interleukin-4|interleukin-4|mesh-list
83770118|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83770119|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
83770120|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770121|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770122|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770123|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
83770124|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770125|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83770126|NCT00039091|Ipilimumab|ipilimumab|mesh-list
83770127|NCT00039091|Antibodies|antibodies|mesh-list
83770128|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
83770129|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83770130|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
83770131|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770132|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770133|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83770134|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770135|NCT00039169|IDN 5109|idn 5109|mesh-list
83770136|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770137|NCT00001304|Vitamin D|vitamin d|mesh-list
83770138|NCT00001304|Calcitriol|calcitriol|mesh-list
83770139|NCT00001304|Calcium|calcium|mesh-list
83770140|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
83770141|NCT00001304|Hormones|hormones|mesh-list
83770142|NCT00001304|Vitamins|vitamins|mesh-ancestor
83770143|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
83770144|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770145|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83770146|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83770147|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770148|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83770149|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770150|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770151|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83770152|NCT00039208|Leucovorin|leucovorin|mesh-list
83770153|NCT00039208|Fluorouracil|fluorouracil|mesh-list
83770154|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
83770156|NCT00039208|Calcium|calcium|mesh-list
83770157|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
83770158|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83770159|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770160|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
83770161|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770162|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770163|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770164|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770165|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
83770166|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83770167|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770168|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770169|NCT00039208|Antidotes|antidotes|mesh-ancestor
83770170|NCT00039208|Protective Agents|protective agents|mesh-ancestor
83770171|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
83770172|NCT00039208|Vitamins|vitamins|mesh-ancestor
83770173|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
83770174|NCT00017121|Sargramostim|sargramostim|mesh-list
83770175|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
83770176|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770177|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83770178|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83770179|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770180|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
83770181|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770182|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770183|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770184|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770185|NCT00039403|Gemcitabine|gemcitabine|mesh-list
83770186|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83770187|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770188|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
83770189|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770190|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770191|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770192|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770193|NCT00039442|Capecitabine|capecitabine|mesh-list
83770194|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770195|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
83770196|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770197|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770198|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
83770199|NCT00039481|Doxorubicin|doxorubicin|mesh-list
83770200|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83770201|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
83770202|NCT00039481|Razoxane|razoxane|mesh-list
83770203|NCT00039481|Oblimersen|oblimersen|mesh-list
83770204|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770205|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
83770206|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770207|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770208|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770209|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
83770210|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770211|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770212|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83770213|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83770214|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83770215|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770216|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770217|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83770218|NCT00039481|Protective Agents|protective agents|mesh-ancestor
83770219|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770220|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770221|NCT00001322|Leuprolide|leuprolide|mesh-list
83770222|NCT00001322|Estradiol|estradiol|mesh-list
83770223|NCT00001322|Progesterone|progesterone|mesh-list
83770224|NCT00001322|Estrogens|estrogens|mesh-ancestor
83770225|NCT00001322|Hormones|hormones|mesh-ancestor
83770226|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770227|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770228|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83770229|NCT00001322|Progestins|progestins|mesh-ancestor
83770230|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83770231|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
83770232|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83770233|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770234|NCT00039520|Sulindac|sulindac|mesh-list
83770235|NCT00039520|Docetaxel|docetaxel|mesh-list
83770236|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770237|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
83770238|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770239|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770240|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770241|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83770242|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83770243|NCT00039520|Analgesics|analgesics|mesh-ancestor
83770244|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
83770245|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770246|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770247|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83770248|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770249|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83770250|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770251|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83770252|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83770253|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83770254|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770255|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770256|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83770257|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770258|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770259|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
83770260|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770261|NCT00001328|Ganciclovir|ganciclovir|mesh-list
83770262|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83770263|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
83770264|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770265|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83770266|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770267|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770268|NCT00017160|Doxorubicin|doxorubicin|mesh-list
83770269|NCT00017160|Ifosfamide|ifosfamide|mesh-list
83770270|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
83770271|NCT00017160|Immunomodulating Agents|immunomodulating agents|mesh-list
83770272|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83770273|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770274|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83770275|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770276|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770277|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770278|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770279|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770280|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
83770281|NCT00039832|Reteplase|reteplase|mesh-list
83770282|NCT00039832|Abciximab|abciximab|mesh-list
83770283|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
83770284|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83770285|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83770286|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83770287|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770288|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
83770289|NCT00039988|Albuterol|albuterol|mesh-list
83770290|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
83770291|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83770292|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
83770293|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770294|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770295|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83770296|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
83770297|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
83770298|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83770299|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83770300|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83770301|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83770302|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
83770303|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925502|NCT02140450|Mannitol|mannitol|mesh-list
83770304|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770305|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83770306|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
83770307|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770308|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770309|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83770310|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
83770311|NCT00040027|Thymalfasin|thymalfasin|mesh-list
83770312|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
83770313|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770314|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
83770315|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770316|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83770317|NCT00001343|Oxandrolone|oxandrolone|mesh-list
83770318|NCT00001343|Androgens|androgens|mesh-ancestor
83770319|NCT00001343|Hormones|hormones|mesh-ancestor
83770320|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770321|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770322|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
83770323|NCT00040066|Cocaine|cocaine|mesh-list
83770324|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
83770325|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
83770326|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83770327|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770328|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
83770329|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770330|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83770331|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83770332|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83770333|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770334|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770335|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
83770336|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770337|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
83770338|NCT00040105|Tipifarnib|tipifarnib|mesh-list
83770339|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770340|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770341|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770342|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770343|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
83770344|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83770345|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83770346|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770347|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770348|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
83770349|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770350|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83770351|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83770352|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83770353|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770354|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770355|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770356|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770357|NCT00040261|Memantine|memantine|mesh-list
83770358|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83770359|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83770360|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
83770361|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770362|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770363|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770364|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83770365|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83770366|NCT00040300|Racivir|racivir|mesh-list
83770367|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
83770368|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770369|NCT00040378|Vitamins|vitamins|mesh-list
83770370|NCT00040378|Vitamin E|vitamin e|mesh-list
83770371|NCT00040378|Tocopherols|tocopherols|mesh-list
83770372|NCT00040378|Tocotrienols|tocotrienols|mesh-list
83770373|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
83770374|NCT00040378|Selenium|selenium|mesh-list
83770375|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
83770376|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925585|NCT02135770|Heparin|heparin|mesh-list
83770377|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
83770378|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770379|NCT00040378|Protective Agents|protective agents|mesh-ancestor
83770380|NCT00040378|Trace Elements|trace elements|mesh-ancestor
83770381|NCT00017199|Bortezomib|bortezomib|mesh-list
83770382|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770383|NCT00040417|Fludarabine|fludarabine|mesh-list
83770384|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
83770385|NCT00040417|Lenograstim|lenograstim|mesh-list
83770386|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770387|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
83770388|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770389|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83770390|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83770391|NCT00040495|Pantoprazole|pantoprazole|mesh-list
83770392|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83770393|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83770394|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83770395|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770396|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770397|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
83770398|NCT00040651|Fludarabine|fludarabine|mesh-list
83770399|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
83770400|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770401|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
83770402|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770403|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770404|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770405|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
83770406|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770407|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770408|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83770409|NCT00040690|Leucovorin|leucovorin|mesh-list
83770410|NCT00040690|Cytarabine|cytarabine|mesh-list
83770411|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
83770412|NCT00040690|Ifosfamide|ifosfamide|mesh-list
83770413|NCT00040690|Doxorubicin|doxorubicin|mesh-list
83770414|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83770415|NCT00040690|Methotrexate|methotrexate|mesh-list
83770416|NCT00040690|Etoposide|etoposide|mesh-list
83770417|NCT00040690|Vincristine|vincristine|mesh-list
83770418|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
83770419|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770420|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
83770421|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770422|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770423|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770424|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
83770425|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770426|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770427|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83770428|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83770429|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83770430|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770431|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770432|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83770433|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
83770434|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83770435|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770436|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
83770437|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
83770438|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83770439|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83770440|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83770441|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
83770442|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770443|NCT00040690|Antidotes|antidotes|mesh-ancestor
83770444|NCT00040690|Protective Agents|protective agents|mesh-ancestor
83770445|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
83770446|NCT00040690|Vitamins|vitamins|mesh-ancestor
83770447|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
83770448|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83770449|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770450|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770451|NCT00040768|Bortezomib|bortezomib|mesh-list
83770452|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770453|NCT00017238|KRN 5500|krn 5500|mesh-list
82925651|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770454|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770455|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83770456|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770457|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770458|NCT00040885|Infliximab|infliximab|mesh-list
83770459|NCT00040885|Docetaxel|docetaxel|mesh-list
83770460|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770461|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83770462|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770463|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770464|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770465|NCT00040885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83770466|NCT00040885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83770467|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83770468|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83770469|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770470|NCT00001421|Methimazole|methimazole|mesh-list
83770471|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
83770472|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
83770473|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770474|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770475|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
83770476|NCT00017277|Hematinics|hematinics|mesh-ancestor
83770477|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
83770478|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770479|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770480|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770481|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770482|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
83770483|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770484|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770485|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770486|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770487|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
83770488|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770489|NCT00041236|Exatecan|exatecan|mesh-list
83770490|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83770491|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770492|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770493|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770494|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770495|NCT00017316|Thalidomide|thalidomide|mesh-list
83770496|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770497|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
83770498|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770499|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
83770500|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83770501|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770502|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83770503|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83770504|NCT00017316|Growth Substances|growth substances|mesh-ancestor
83770505|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
83770506|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770507|NCT00041275|Megestrol|megestrol|mesh-list
83770508|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
83770509|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83770510|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83770511|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83770512|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
83770513|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83770514|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770515|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83770516|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83770517|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83770518|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770519|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
83770520|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83770521|NCT00017355|Lenograstim|lenograstim|mesh-list
83770522|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83770523|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
83770524|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770525|NCT00397072|Sagopilone|sagopilone|mesh-list
83770526|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770527|NCT00017394|Bevacizumab|bevacizumab|mesh-list
83770528|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83770529|NCT00017394|Vinorelbine|vinorelbine|mesh-list
83770530|NCT00017394|Antibodies|antibodies|mesh-list
82925724|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770531|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
83770532|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83770533|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770534|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83770535|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83770536|NCT00017394|Growth Substances|growth substances|mesh-ancestor
83770537|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770538|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
83770539|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
83770540|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83770541|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
83770542|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770543|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770544|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770545|NCT00041431|Hormones|hormones|mesh-list
83770546|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770547|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770548|NCT00001436|Tamoxifen|tamoxifen|mesh-list
83770549|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83770550|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
83770551|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770552|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770553|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83770554|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770555|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83770556|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83770557|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83770558|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
83770559|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83770560|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
83770561|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770562|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770563|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83770564|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
83770565|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83770566|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
83770567|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770568|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770569|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83770570|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
83770571|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
83770572|NCT00041548|Protective Agents|protective agents|mesh-ancestor
83770573|NCT00041587|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83770574|NCT00041587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770575|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
83770576|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770577|NCT00041665|Mitogens|mitogens|mesh-list
83770578|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770579|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770580|NCT00041704|Anidulafungin|anidulafungin|mesh-list
83770581|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
83770582|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770583|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83770584|NCT00017472|Antibodies|antibodies|mesh-list
83770585|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
83770586|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83770587|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
83770588|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770589|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770590|NCT00041782|Dalteparin|dalteparin|mesh-list
83770591|NCT00041782|Tinzaparin|tinzaparin|mesh-list
83770592|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83770593|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
83770594|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83770595|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83770596|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770597|NCT00017511|Cevimeline|cevimeline|mesh-list
83770598|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83770599|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
83770600|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770601|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770602|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83770603|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83770604|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
82925800|NCT02253784|Dexamethasone|dexamethasone|mesh-list
83770605|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770606|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770607|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
83770608|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83770609|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
83770610|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83770611|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770612|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83770613|NCT00041977|Doxycycline|doxycycline|mesh-list
83770614|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83770615|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770616|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
83770617|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83770618|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83770619|NCT00042016|Decitabine|decitabine|mesh-list
83770620|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770621|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
83770622|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770623|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770624|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770625|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83770626|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
83770627|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770628|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770629|NCT00001457|Lamivudine|lamivudine|mesh-list
83770630|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83770631|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83770632|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770633|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770634|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
83770635|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770636|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83770637|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83770638|NCT00042172|Donepezil|donepezil|mesh-list
83770639|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83770640|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770641|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770642|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
83770643|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770644|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770645|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
83770646|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
83770647|NCT00017589|Oblimersen|oblimersen|mesh-list
83770648|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83770649|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770650|NCT00017589|Immunotoxins|immunotoxins|mesh-ancestor
83770651|NCT00017589|Immunoconjugates|immunoconjugates|mesh-ancestor
83770652|NCT00017589|Immunologic Factors|immunologic factors|mesh-ancestor
83770653|NCT00017589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770654|NCT00001475|Thalidomide|thalidomide|mesh-list
83770655|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770656|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
83770657|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770658|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
83770659|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83770660|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770661|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83770662|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83770663|NCT00001475|Growth Substances|growth substances|mesh-ancestor
83770664|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
83770665|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770666|NCT00042328|Valacyclovir|valacyclovir|mesh-list
83770667|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
83770668|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770669|NCT00042367|Mafosfamide|mafosfamide|mesh-list
83770670|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
83770671|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83770672|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
83770673|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770674|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770675|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770676|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770677|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770678|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
83770679|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925879|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
83770680|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83770681|NCT02970643|Olanzapine|olanzapine|mesh-list
83770682|NCT02970643|Palonosetron|palonosetron|mesh-list
83770683|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
83770684|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
83770685|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770686|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770687|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83770688|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83770689|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83770690|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83770691|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83770692|NCT02970643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83770693|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83770694|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770695|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770696|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770697|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
83770698|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83770699|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83770700|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
83770701|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83770702|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83770703|NCT00017628|Prednisolone|prednisolone|mesh-list
83770704|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
83770705|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
83770706|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83770707|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
83770708|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770709|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
83770710|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770711|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770712|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770713|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
83770714|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770715|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770716|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83770717|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83770718|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
83770719|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
83770720|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770721|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83770722|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
83770723|NCT00017628|Hormones|hormones|mesh-ancestor
83770724|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770725|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83770726|NCT00017628|Protective Agents|protective agents|mesh-ancestor
83770727|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83770728|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83770729|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83770730|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83770731|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770732|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770733|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770734|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770735|NCT00042562|Analgesics|analgesics|mesh-ancestor
83770736|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
83770737|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770738|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
83770739|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83770740|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
83770741|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83770742|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83770743|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
83770744|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770745|NCT00042601|Pramlintide|pramlintide|mesh-list
83770746|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83770747|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770748|NCT00042679|Carboplatin|carboplatin|mesh-list
83770749|NCT00042679|Gemcitabine|gemcitabine|mesh-list
83770750|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770751|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770752|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
83770753|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770755|NCT00042718|Azithromycin|azithromycin|mesh-list
83770756|NCT00042718|Levofloxacin|levofloxacin|mesh-list
83770757|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
83770758|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
83770759|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83770760|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83770761|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770762|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83770763|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83770764|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770765|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770766|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770767|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770768|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83770769|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83770770|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83770771|NCT00042796|Decitabine|decitabine|mesh-list
83770772|NCT00042796|Azacitidine|azacitidine|mesh-list
83770773|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770774|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
83770775|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770776|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770777|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770778|NCT00042835|Paclitaxel|paclitaxel|mesh-list
83770779|NCT00042835|Etoposide|etoposide|mesh-list
83770780|NCT00042835|Docetaxel|docetaxel|mesh-list
83770781|NCT00042835|Carboplatin|carboplatin|mesh-list
83770782|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
83770783|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83770784|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83770785|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770786|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83770787|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770788|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770789|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770790|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83770791|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770792|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770793|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770794|NCT00017784|Valganciclovir|valganciclovir|mesh-list
83770795|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
83770796|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770797|NCT00042874|Leucovorin|leucovorin|mesh-list
83770798|NCT00042874|Fluorouracil|fluorouracil|mesh-list
83770799|NCT00042874|Irinotecan|irinotecan|mesh-list
83770800|NCT00042874|Alvocidib|alvocidib|mesh-list
83770801|NCT00042874|Calcium|calcium|mesh-list
83770802|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
83770803|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83770804|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770805|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
83770806|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770807|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770808|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770809|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770810|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
83770811|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83770812|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83770813|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770814|NCT00042874|Antidotes|antidotes|mesh-ancestor
83770815|NCT00042874|Protective Agents|protective agents|mesh-ancestor
83770816|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
83770817|NCT00042874|Vitamins|vitamins|mesh-ancestor
83770818|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
83770819|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
83770820|NCT00042874|Growth Substances|growth substances|mesh-ancestor
83770821|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82925976|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82925977|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925978|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925979|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82925980|NCT04307134|Immunotoxins|immunotoxins|mesh-ancestor
82925981|NCT04307134|Immunoconjugates|immunoconjugates|mesh-ancestor
82925982|NCT04307134|Immunologic Factors|immunologic factors|mesh-ancestor
83770822|NCT00042913|Epratuzumab|epratuzumab|mesh-list
83770823|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83770825|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
83770826|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770827|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83770828|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770829|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770830|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
83770831|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
83770832|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
83770833|NCT00043069|Estrogens|estrogens|mesh-list
83770834|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
83770835|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
83770836|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83770837|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770838|NCT00043069|Vitamins|vitamins|mesh-ancestor
83770839|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
83770840|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83770841|NCT00043069|Hormones|hormones|mesh-ancestor
83770842|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770843|NCT00043069|Antacids|antacids|mesh-ancestor
83770844|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770845|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83770846|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83770847|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770848|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
83770849|NCT00043147|Prednisone|prednisone|mesh-list
83770850|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
83770851|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83770852|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83770853|NCT00043147|Prednisolone|prednisolone|mesh-list
83770854|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
83770855|NCT00043147|Beclomethasone|beclomethasone|mesh-list
83770856|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83770857|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
83770858|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83770859|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
83770860|NCT00043147|Hormones|hormones|mesh-ancestor
83770861|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770862|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770863|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83770864|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770865|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
83770866|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
83770867|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770868|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83770869|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83770870|NCT00043147|Protective Agents|protective agents|mesh-ancestor
83770871|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83770872|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
83770873|NCT00017862|Reslizumab|reslizumab|mesh-list
83770874|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83770875|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
83770876|NCT00043264|Azithromycin|azithromycin|mesh-list
83770877|NCT00043264|Rifampin|rifampin|mesh-list
83770878|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83770879|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770880|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83770881|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
83770882|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
83770883|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83770884|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770885|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770886|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83770887|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83770888|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83770889|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83770890|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83770891|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83770892|NCT00043303|Interferons|interferons|mesh-list
83770893|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
83770894|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770895|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
83770896|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770897|NCT00017940|Mitogens|mitogens|mesh-list
83770898|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770899|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770901|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83770902|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83770903|NCT02970604|Analgesics|analgesics|mesh-ancestor
83770904|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
83770905|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83770906|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770907|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83770908|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83770909|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83770910|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83770911|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770912|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83770913|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83770914|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770915|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
83770916|NCT00043342|Interferons|interferons|mesh-list
83770917|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
83770918|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770919|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
83770920|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770921|NCT00043381|Decitabine|decitabine|mesh-list
83770922|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770923|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
83770924|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770925|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770926|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770927|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
83770928|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83770929|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
83770930|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770931|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
83770932|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83770933|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83770934|NCT00043537|Fluoxetine|fluoxetine|mesh-list
83770935|NCT00043537|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83770936|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83770937|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770938|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770939|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83770940|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
83770941|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770942|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83770943|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
83770944|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83770945|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83770946|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83770947|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83770948|NCT00043576|Calcitriol|calcitriol|mesh-list
83770949|NCT00043576|Docetaxel|docetaxel|mesh-list
83770950|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770951|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83770952|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83770953|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83770954|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770955|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83770956|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770957|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83770958|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83770959|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83770960|NCT00043576|Vitamins|vitamins|mesh-ancestor
83770961|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
83770962|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83770963|NCT00043654|Mifepristone|mifepristone|mesh-list
83770964|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83770965|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
83770966|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83770967|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770968|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83770969|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83770970|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83770971|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
83770972|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83770973|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83770974|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
83770975|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83770976|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
83770977|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83770978|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83770980|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83770981|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770982|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
83770983|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770984|NCT00043810|Fludarabine|fludarabine|mesh-list
83770985|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
83770986|NCT00043810|Busulfan|busulfan|mesh-list
83770987|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
83770988|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83770989|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83770990|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
83770991|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83770992|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83770993|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
83770994|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83770995|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
83770996|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83770997|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83770998|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83770999|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83771000|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771001|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83771002|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
83771003|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771004|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83771005|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83771006|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771007|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771008|NCT00001586|Rituximab|rituximab|mesh-list
83771009|NCT00001586|Fludarabine|fludarabine|mesh-list
83771010|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
83771011|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771012|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771013|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
83771014|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771015|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771016|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83771017|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
83771018|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771019|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771020|NCT00043888|Ritonavir|ritonavir|mesh-list
83771021|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
83771022|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83771023|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83771024|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83771025|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771026|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771027|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771028|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771029|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771030|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
83771031|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771032|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83771033|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771034|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83771035|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83771036|NCT00018018|Zidovudine|zidovudine|mesh-list
83771037|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
83771038|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771039|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83771040|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83771041|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771042|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
82926206|NCT00006256|Paclitaxel|paclitaxel|mesh-list
83771043|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771044|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771045|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771046|NCT00043927|Cisplatin|cisplatin|mesh-list
83771047|NCT00043927|Etoposide|etoposide|mesh-list
83771048|NCT00043927|Topotecan|topotecan|mesh-list
83771049|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771050|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83771051|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83771052|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771053|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771054|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771055|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83771056|NCT00043966|Ritonavir|ritonavir|mesh-list
83771057|NCT00043966|Lopinavir|lopinavir|mesh-list
83771058|NCT00043966|Tenofovir|tenofovir|mesh-list
83771059|NCT00043966|Emtricitabine|emtricitabine|mesh-list
83771060|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83771061|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83771062|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771063|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771064|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771065|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771066|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771067|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
83771068|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771069|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83771070|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771071|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83771072|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83771073|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83771074|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83771075|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
83771076|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771077|NCT04731727|Riboflavin|riboflavin|mesh-list
83771078|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
83771079|NCT04731727|Vitamins|vitamins|mesh-ancestor
83771080|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
83771081|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771082|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83771083|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
83771084|NCT00044278|Lamotrigine|lamotrigine|mesh-list
83771085|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
83771086|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83771087|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771088|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771089|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83771090|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771091|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83771092|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83771093|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771094|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771095|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83771096|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
83771097|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771098|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771099|NCT00044434|Bupropion|bupropion|mesh-list
83771100|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83771101|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
83771102|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771103|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83771104|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83771105|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771106|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771107|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
83771108|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926276|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
82926277|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926278|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82926279|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82926280|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
83771109|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926281|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
82926284|NCT02144662|Ranibizumab|ranibizumab|mesh-list
83771110|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83771111|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771112|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771113|NCT00044473|Levofloxacin|levofloxacin|mesh-list
83771114|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83771115|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771116|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771117|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83771118|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771119|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771120|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771121|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771122|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83771123|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771124|NCT00044551|Taxane|taxane|mesh-list
83771125|NCT00044551|IDN 5109|idn 5109|mesh-list
83771126|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771127|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83771128|NCT00018135|Calcium|calcium|mesh-list
83771129|NCT00018135|Sevelamer|sevelamer|mesh-list
83771130|NCT00018135|Calcium acetate|calcium acetate|mesh-list
83771131|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83771132|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771133|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
83771134|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
83771135|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771136|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83771137|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
83771138|NCT00018135|Antacids|antacids|mesh-ancestor
83771139|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83771140|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83771141|NCT00397384|Cetuximab|cetuximab|mesh-list
83771142|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83771143|NCT00397384|Antibodies|antibodies|mesh-list
83771144|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
83771145|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83771146|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
83771147|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771148|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771149|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771150|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771151|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771152|NCT00397423|Lenograstim|lenograstim|mesh-list
83771153|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83771154|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
83771155|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771156|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
83771157|NCT00397501|Carboplatin|carboplatin|mesh-list
83771158|NCT00397501|Methotrexate|methotrexate|mesh-list
83771159|NCT00397501|Trastuzumab|trastuzumab|mesh-list
83771160|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771161|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83771162|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
83771163|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83771164|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771165|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83771166|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
83771167|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771168|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
83771169|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771170|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83771171|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771172|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
83771173|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771174|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83771175|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771176|NCT00397501|Antidotes|antidotes|mesh-ancestor
83771177|NCT00397501|Protective Agents|protective agents|mesh-ancestor
83771178|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
83771179|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
83771180|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771181|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771182|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
82926349|NCT02148328|Vaccines|vaccines|mesh-list
82926350|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
83771183|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
83771184|NCT00018174|Fluoxetine|fluoxetine|mesh-list
83771185|NCT00018174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83771186|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83771187|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771188|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771189|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771190|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
83771191|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771192|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83771193|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
83771194|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771195|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83771196|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771197|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771198|NCT00044629|Zolpidem|zolpidem|mesh-list
83771199|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83771200|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83771201|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771202|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771203|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83771204|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
83771205|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
83771206|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771207|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771208|NCT00044668|Exenatide|exenatide|mesh-list
83771209|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771210|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771211|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83771212|NCT00044668|Incretins|incretins|mesh-ancestor
83771213|NCT00044668|Hormones|hormones|mesh-ancestor
83771214|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83771215|NCT00044707|Pramlintide|pramlintide|mesh-list
83771216|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771217|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771218|NCT00044746|Tazobactam|tazobactam|mesh-list
83771219|NCT00044746|Piperacillin|piperacillin|mesh-list
83771220|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83771221|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771222|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771223|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83771224|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771225|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771226|NCT00044785|Leucovorin|leucovorin|mesh-list
83771227|NCT00044785|Fluorouracil|fluorouracil|mesh-list
83771228|NCT00044785|Irinotecan|irinotecan|mesh-list
83771229|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
83771230|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771231|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83771232|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771233|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771234|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
83771235|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771236|NCT00044785|Antidotes|antidotes|mesh-ancestor
83771237|NCT00044785|Protective Agents|protective agents|mesh-ancestor
83771238|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
83771239|NCT00044785|Vitamins|vitamins|mesh-ancestor
83771240|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
83771241|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83771242|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771243|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771244|NCT00044824|Fexofenadine|fexofenadine|mesh-list
83771245|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83771246|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83771247|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83771248|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
83771249|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
83771250|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771251|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771252|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771253|NCT00018213|Naltrexone|naltrexone|mesh-list
83771254|NCT00018213|Nicotine|nicotine|mesh-list
83771255|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83771256|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
82926422|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
82926423|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83771257|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771258|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771259|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83771260|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83771261|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
83771262|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771263|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771264|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83771265|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83771266|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
83771267|NCT00044863|Cetuximab|cetuximab|mesh-list
83771268|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771269|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771270|NCT00044902|Epratuzumab|epratuzumab|mesh-list
83771271|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771272|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771273|NCT00045136|Melphalan|melphalan|mesh-list
83771274|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83771275|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
83771276|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771277|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771278|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83771279|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771280|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
83771281|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771282|NCT00001649|Valacyclovir|valacyclovir|mesh-list
83771283|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
83771284|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771285|NCT00018291|Gabapentin|gabapentin|mesh-list
83771286|NCT00018291|Risperidone|risperidone|mesh-list
83771287|NCT00018291|Analgesics|analgesics|mesh-ancestor
83771288|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
83771289|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771290|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771291|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
83771292|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83771293|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83771294|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771295|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771296|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83771297|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83771298|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771299|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771300|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
83771301|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83771302|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
83771303|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83771304|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83771305|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
83771306|NCT00045175|Topotecan|topotecan|mesh-list
83771307|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83771308|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83771309|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771310|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771311|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771312|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771313|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771314|NCT00045292|Valacyclovir|valacyclovir|mesh-list
83771315|NCT00045292|Acyclovir|acyclovir|mesh-list
83771316|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
83771317|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771318|NCT00045370|Interferons|interferons|mesh-list
83771319|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
83771320|NCT00045370|Sirolimus|sirolimus|mesh-list
83771321|NCT00045370|Temsirolimus|temsirolimus|mesh-list
83771322|NCT00045370|MTOR Inhibitors|mtor inhibitors|mesh-list
83771323|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771324|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
83771325|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771326|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
83771327|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771328|NCT00045370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771329|NCT00045370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771330|NCT00045370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926495|NCT02152228|Teriparatide|teriparatide|mesh-list
83771331|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771332|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771333|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83771334|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
83771335|NCT02970682|Tamoxifen|tamoxifen|mesh-list
83771336|NCT02970682|Fulvestrant|fulvestrant|mesh-list
83771337|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83771338|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83771339|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
83771340|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83771341|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771342|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83771343|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771344|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83771345|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83771346|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83771347|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83771348|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83771349|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771350|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771351|NCT00045448|Docetaxel|docetaxel|mesh-list
83771352|NCT00045448|Alvocidib|alvocidib|mesh-list
83771353|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771354|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
83771355|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
83771356|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83771357|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771358|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
83771359|NCT00045448|Growth Substances|growth substances|mesh-ancestor
83771360|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771361|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771362|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771363|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83771364|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771365|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771366|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771367|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771368|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
83771369|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771370|NCT00045604|Irinotecan|irinotecan|mesh-list
83771371|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
83771372|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771373|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83771374|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771375|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771376|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771377|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771378|NCT00045682|Paclitaxel|paclitaxel|mesh-list
83771379|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83771380|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83771381|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83771382|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771383|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
83771384|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
83771385|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
83771386|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771387|NCT00045721|Carmustine|carmustine|mesh-list
83771388|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83771389|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83771390|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
83771391|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771392|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771393|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771394|NCT04731766|Listerine|listerine|mesh-list
83771395|NCT04731766|Fluorides|fluorides|mesh-list
83771396|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
83771397|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
83771398|NCT04731766|Protective Agents|protective agents|mesh-ancestor
83771399|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771400|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83771401|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771402|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83771403|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771404|NCT00018447|Fluorides|fluorides|mesh-list
83771405|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
83771406|NCT00018447|Protective Agents|protective agents|mesh-ancestor
83771407|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771408|NCT00001688|Ritonavir|ritonavir|mesh-list
83771409|NCT00001688|Nevirapine|nevirapine|mesh-list
82926568|NCT02153866|Vaccines|vaccines|mesh-list
83771411|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83771412|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83771413|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771414|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771415|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771416|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771417|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771418|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
83771419|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771420|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83771421|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771422|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83771423|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83771424|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83771425|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83771426|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
83771427|NCT00389402|Ritonavir|ritonavir|mesh-list
83771428|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83771429|NCT00389402|Saquinavir|saquinavir|mesh-list
83771430|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83771431|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83771432|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771433|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771434|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771435|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771436|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771437|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
83771438|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771439|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83771440|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771441|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
83771442|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83771443|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
83771444|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771445|NCT00045799|Omeprazole|omeprazole|mesh-list
83771446|NCT00045799|Cimetidine|cimetidine|mesh-list
83771447|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83771448|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83771449|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83771450|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83771451|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771452|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771453|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83771454|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
83771455|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
83771456|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771457|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771458|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83771459|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771460|NCT04394130|Ropivacaine|ropivacaine|mesh-list
83771461|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
83771462|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
83771463|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771464|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771465|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
83771466|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771467|NCT00045877|Aldesleukin|aldesleukin|mesh-list
83771468|NCT00045877|Rituximab|rituximab|mesh-list
83771469|NCT00045877|Interleukin-2|interleukin-2|mesh-list
83771470|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771471|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771472|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
83771473|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771474|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771475|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83771476|NCT00045877|Analgesics|analgesics|mesh-ancestor
83771477|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
83771478|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771479|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771480|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771481|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
83771482|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771483|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83771484|NCT00045916|Nortriptyline|nortriptyline|mesh-list
83771486|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771487|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771488|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771489|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83771490|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83771491|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771492|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771493|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83771494|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83771495|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83771496|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
83771497|NCT04380207|QPX7728|qpx7728|mesh-list
83771498|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83771499|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771500|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771501|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771502|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771503|NCT00045955|Fexofenadine|fexofenadine|mesh-list
83771504|NCT00045955|Montelukast|montelukast|mesh-list
83771505|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83771506|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
83771507|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83771508|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
83771509|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83771510|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771511|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83771512|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83771513|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771514|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83771515|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83771516|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83771517|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
83771518|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
83771519|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771520|NCT00046033|Ritonavir|ritonavir|mesh-list
83771521|NCT00046033|Lopinavir|lopinavir|mesh-list
83771522|NCT00046033|Saquinavir|saquinavir|mesh-list
83771523|NCT00046033|Amprenavir|amprenavir|mesh-list
83771524|NCT00046033|Tenofovir|tenofovir|mesh-list
83771525|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83771526|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83771527|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771528|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771529|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771530|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771531|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771532|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
83771533|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771534|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83771535|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771536|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83771537|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83771538|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83771539|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
83771540|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771541|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83771542|NCT04369560|Hematinics|hematinics|mesh-ancestor
83771543|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83771544|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83771545|NCT00046111|Topotecan|topotecan|mesh-list
83771546|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83771547|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771548|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771549|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771550|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771551|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
83771552|NCT00001724|Analgesics|analgesics|mesh-ancestor
83771553|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
83771554|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771555|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926720|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
83771556|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83771557|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83771558|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83771559|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771560|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83771561|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771562|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771563|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
83771564|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771565|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771566|NCT00046267|Niacin|niacin|mesh-list
83771567|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83771568|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
83771569|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771570|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83771571|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
83771572|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
83771573|NCT00046267|Vitamins|vitamins|mesh-ancestor
83771574|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
83771575|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771576|NCT00046306|Antioxidants|antioxidants|mesh-list
83771577|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771578|NCT00046306|Protective Agents|protective agents|mesh-ancestor
83771579|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771580|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83771581|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83771582|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83771583|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771584|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771585|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771586|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771587|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771588|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
83771589|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771590|NCT00397657|Niacin|niacin|mesh-list
83771591|NCT00397657|Ezetimibe|ezetimibe|mesh-list
83771592|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83771593|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83771594|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
83771595|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771596|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83771597|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83771598|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
83771599|NCT00397657|Vitamins|vitamins|mesh-ancestor
83771600|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
83771601|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771602|NCT00001763|Interleukin-12|interleukin-12|mesh-list
83771603|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83771604|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
83771605|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771606|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83771607|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83771608|NCT00001763|Growth Substances|growth substances|mesh-ancestor
83771609|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
83771610|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771611|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
83771612|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83771613|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
83771614|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771615|NCT00397735|Expectorants|expectorants|mesh-ancestor
83771616|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83771617|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83771618|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
83771619|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771620|NCT00397735|Protective Agents|protective agents|mesh-ancestor
83771621|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771622|NCT00397735|Antidotes|antidotes|mesh-ancestor
83771623|NCT00046384|Aripiprazole|aripiprazole|mesh-list
83771624|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
83771625|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771626|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83771627|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83771628|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771629|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771630|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
83771631|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
83771632|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771633|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771634|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83771635|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83771636|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
83771637|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83771638|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83771639|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83771640|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83771641|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83771642|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771643|NCT04258410|Quercetin|quercetin|mesh-list
83771644|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
83771645|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771646|NCT04258410|Protective Agents|protective agents|mesh-ancestor
83771647|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771648|NCT00046462|Metformin|metformin|mesh-list
83771649|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
83771650|NCT00046462|Glyburide|glyburide|mesh-list
83771651|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83771652|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771653|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771654|NCT00001766|Ritonavir|ritonavir|mesh-list
83771655|NCT00001766|Nelfinavir|nelfinavir|mesh-list
83771656|NCT00001766|Amprenavir|amprenavir|mesh-list
83771657|NCT00001766|Abacavir|abacavir|mesh-list
83771658|NCT00001766|Efavirenz|efavirenz|mesh-list
83771659|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83771660|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83771661|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771662|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771663|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771664|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83771665|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83771666|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
83771667|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771668|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83771669|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771670|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83771671|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83771672|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83771673|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83771674|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83771675|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83771676|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83771677|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83771678|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
83771679|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771680|NCT00046501|Insulin|insulin|mesh-list
83771681|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
83771682|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83771683|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
83771684|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
83771685|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771686|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771687|NCT00046735|Lenalidomide|lenalidomide|mesh-list
83771688|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
83771689|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771690|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83771691|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83771692|NCT00046735|Growth Substances|growth substances|mesh-ancestor
83771693|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
83771694|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771695|NCT00001784|Mexiletine|mexiletine|mesh-list
83771696|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83771697|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83771698|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83771699|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771700|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771701|NCT00046813|Nicotine|nicotine|mesh-list
83771702|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83771703|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
83771704|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771705|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771706|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82926866|NCT02255266|Incretins|incretins|mesh-ancestor
83771707|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83771708|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
83771709|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771710|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771711|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
83771712|NCT00046852|Melphalan|melphalan|mesh-list
83771713|NCT00046852|Carmustine|carmustine|mesh-list
83771714|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83771715|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771716|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
83771717|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771718|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771719|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83771720|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
83771721|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771722|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771723|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83771724|NCT00046969|Cisplatin|cisplatin|mesh-list
83771725|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771726|NCT00001805|Rituximab|rituximab|mesh-list
83771727|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771728|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771729|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
83771730|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771731|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771732|NCT00047047|Gemcitabine|gemcitabine|mesh-list
83771733|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771734|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83771735|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
83771736|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771737|NCT04733781|Lidocaine|lidocaine|mesh-list
83771738|NCT04733781|Epinephrine|epinephrine|mesh-list
83771739|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
83771740|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
83771741|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771742|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771743|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
83771744|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771745|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83771746|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83771747|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83771748|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771749|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771750|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83771751|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83771752|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
83771753|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771754|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83771755|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83771756|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
83771757|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83771758|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
83771759|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
83771760|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
83771761|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83771762|NCT00047164|Ipilimumab|ipilimumab|mesh-list
83771763|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771764|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771765|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83771766|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771767|NCT00047203|Alvocidib|alvocidib|mesh-list
83771768|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771769|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
83771770|NCT00047203|Growth Substances|growth substances|mesh-ancestor
83771771|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771772|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771773|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771774|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771775|NCT04163874|Pramlintide|pramlintide|mesh-list
83771776|NCT04163874|Pancrelipase|pancrelipase|mesh-list
83771777|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83771778|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771779|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771780|NCT00047242|Irinotecan|irinotecan|mesh-list
82927007|NCT00119015|Xhance|xhance|mesh-list
83771781|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83771782|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83771783|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771784|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771785|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771786|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771787|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83771789|NCT00047281|Celecoxib|celecoxib|mesh-list
83771790|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
83771791|NCT00047281|Etoposide|etoposide|mesh-list
83771792|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771793|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
83771794|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771795|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771796|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83771797|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
83771798|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771799|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771800|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83771801|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83771802|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83771803|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771804|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771805|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83771806|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83771807|NCT00047281|Analgesics|analgesics|mesh-ancestor
83771808|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
83771809|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771810|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83771811|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83771812|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83771813|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
83771814|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771815|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771816|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83771817|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83771818|NCT00047281|Growth Substances|growth substances|mesh-ancestor
83771819|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83771820|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83771821|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83771822|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771823|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83771824|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83771825|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771826|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771827|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
83771828|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771829|NCT00047554|Travoprost|travoprost|mesh-list
83771830|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83771831|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83771832|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83771833|NCT00047632|Interferons|interferons|mesh-list
83771834|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
83771835|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771836|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
83771837|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771838|NCT00047671|Citalopram|citalopram|mesh-list
83771839|NCT00047671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83771840|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83771841|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771842|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771843|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771844|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
83771845|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771846|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83771847|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
83771848|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771849|NCT00047710|Bevacizumab|bevacizumab|mesh-list
83771850|NCT00047710|Capecitabine|capecitabine|mesh-list
83771851|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771852|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771853|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83771854|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83771855|NCT00047710|Growth Substances|growth substances|mesh-ancestor
83771856|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771857|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
83771858|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83771859|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
83771860|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771861|NCT00047749|Ziconotide|ziconotide|mesh-list
83771862|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83771863|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771864|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771865|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83771866|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771867|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83771868|NCT00047749|Protective Agents|protective agents|mesh-ancestor
83771869|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83771870|NCT00047749|Analgesics|analgesics|mesh-ancestor
83771871|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
83771872|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771873|NCT00047827|Amphotericin B|amphotericin b|mesh-list
83771874|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83771875|NCT00047827|Micafungin|micafungin|mesh-list
83771876|NCT00047827|Amebicides|amebicides|mesh-ancestor
83771877|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83771878|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83771879|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83771880|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83771881|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
83771882|NCT00048139|Capecitabine|capecitabine|mesh-list
83771883|NCT00048139|Irinotecan|irinotecan|mesh-list
83771884|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83771885|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
83771886|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771887|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771888|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83771889|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83771890|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771891|NCT00048334|Romidepsin|romidepsin|mesh-list
83771892|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83771893|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771894|NCT00048334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83771895|NCT00048334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771896|NCT00048334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771897|NCT00048373|Etanercept|etanercept|mesh-list
83771898|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83771899|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83771900|NCT00048373|Analgesics|analgesics|mesh-ancestor
83771901|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
83771902|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771903|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771904|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83771905|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83771906|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83771907|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83771908|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
83771909|NCT05641337|Insulin|insulin|mesh-list
83771910|NCT05641337|Metformin|metformin|mesh-list
83771911|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
83771912|NCT05641337|Linagliptin|linagliptin|mesh-list
83771913|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83771914|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771915|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771916|NCT05641337|Incretins|incretins|mesh-ancestor
83771917|NCT05641337|Hormones|hormones|mesh-ancestor
83771918|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83771919|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83771920|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
83771921|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771922|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771923|NCT00048412|Fludarabine|fludarabine|mesh-list
83771924|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
83771925|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771926|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83771927|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
83771928|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83771929|NCT00048607|Aprepitant|aprepitant|mesh-list
83771930|NCT00048607|Paroxetine|paroxetine|mesh-list
83771931|NCT00048607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83771932|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83771933|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771934|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771935|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771936|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
83771937|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771938|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83771939|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
83771940|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771941|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83771942|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83771943|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771944|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
83771945|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
83771946|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771947|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83771948|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83771949|NCT00048646|Progesterone|progesterone|mesh-list
83771950|NCT00048646|Progestins|progestins|mesh-ancestor
83771951|NCT00048646|Hormones|hormones|mesh-ancestor
83771952|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83771953|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771954|NCT00048763|Cilostazol|cilostazol|mesh-list
83771955|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83771956|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
83771957|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771958|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771959|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83771960|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
83771961|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83771962|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83771963|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771964|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83771965|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
83771966|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83771967|NCT00048763|Protective Agents|protective agents|mesh-ancestor
83771968|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83771969|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83771970|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83771971|NCT05576298|Insulin|insulin|mesh-list
83771972|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83771973|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
83771974|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83771975|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771976|NCT00048802|Valproic Acid|valproic acid|mesh-list
83771977|NCT00048802|Olanzapine|olanzapine|mesh-list
83771978|NCT00048802|Risperidone|risperidone|mesh-list
83771979|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83771980|NCT00048802|Ziprasidone|ziprasidone|mesh-list
83771981|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83771982|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
83771983|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83771984|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83771985|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83771986|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83771987|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83771988|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83771989|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83771990|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83771991|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
83771992|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
83771993|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
83771994|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83771995|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83771996|NCT00048802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83771997|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83771998|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83771999|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
83772000|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772001|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
83772002|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
82927167|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
83772003|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
83772004|NCT00048841|Alendronate|alendronate|mesh-list
83772005|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83772006|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772007|NCT00048880|Antibodies|antibodies|mesh-list
83772008|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83772009|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
83772010|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772011|NCT00049075|Fludarabine|fludarabine|mesh-list
83772012|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
83772013|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772014|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772015|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
83772016|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772017|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772018|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
83772019|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772020|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
83772021|NCT00049114|Doxorubicin|doxorubicin|mesh-list
83772022|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83772023|NCT00049114|Tipifarnib|tipifarnib|mesh-list
83772024|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772025|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
83772026|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772027|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772028|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772029|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
83772030|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772031|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772032|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772033|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83772034|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772035|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772036|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772037|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
83772038|NCT00049192|Oblimersen|oblimersen|mesh-list
83772039|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772040|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83772041|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772042|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772043|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
83772044|NCT05576181|Fludarabine|fludarabine|mesh-list
83772045|NCT05576181|Etoposide|etoposide|mesh-list
83772046|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772047|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
83772048|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772049|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772050|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772051|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
83772052|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772053|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772054|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772055|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772056|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772057|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772058|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772059|NCT00049387|Temozolomide|temozolomide|mesh-list
83772060|NCT00049387|Tipifarnib|tipifarnib|mesh-list
83772061|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772062|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
83772063|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772064|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772065|NCT05640791|Paclitaxel|paclitaxel|mesh-list
83772066|NCT05640791|Gemcitabine|gemcitabine|mesh-list
83772067|NCT05640791|Durvalumab|durvalumab|mesh-list
83772068|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772069|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772070|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772071|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772072|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772073|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772074|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772075|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
83772076|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927242|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
83772077|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
83772078|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83772079|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
83772080|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772081|NCT00391911|Expectorants|expectorants|mesh-ancestor
83772082|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
83772083|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83772084|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
83772085|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772086|NCT00391911|Protective Agents|protective agents|mesh-ancestor
83772087|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772088|NCT00391911|Antidotes|antidotes|mesh-ancestor
83772089|NCT02970409|Heparin|heparin|mesh-list
83772090|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
83772091|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83772092|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83772093|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772094|NCT00049582|Decitabine|decitabine|mesh-list
83772095|NCT00049582|Azacitidine|azacitidine|mesh-list
83772096|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772097|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
83772098|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772099|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772100|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772101|NCT00049660|Capecitabine|capecitabine|mesh-list
83772102|NCT00049660|Vinorelbine|vinorelbine|mesh-list
83772103|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772104|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
83772105|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772106|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772107|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772108|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772109|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772110|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772111|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
83772112|NCT05640713|Fludarabine|fludarabine|mesh-list
83772113|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772114|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
83772115|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772116|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772117|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772118|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
83772119|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772120|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772121|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772122|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
83772123|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83772124|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772125|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83772126|NCT00049777|Heparin|heparin|mesh-list
83772127|NCT00049777|Calcium heparin|calcium heparin|mesh-list
83772128|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83772129|NCT00049777|Tinzaparin|tinzaparin|mesh-list
83772130|NCT00049777|Dalteparin|dalteparin|mesh-list
83772131|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
83772132|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83772133|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83772134|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772135|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772136|NCT00392028|Ertapenem|ertapenem|mesh-list
83772137|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772138|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772139|NCT00392067|Calcipotriene|calcipotriene|mesh-list
83772140|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83772141|NCT00389558|Amikacin|amikacin|mesh-list
83772142|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772143|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772144|NCT00049972|Paroxetine|paroxetine|mesh-list
83772145|NCT00049972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83772146|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83772147|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83772148|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772149|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772150|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
83772151|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772152|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83772153|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
83772154|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83772155|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83772156|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83772157|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772158|NCT00389636|Becaplermin|becaplermin|mesh-list
83772159|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
83772160|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83772161|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83772162|NCT00389636|Growth Substances|growth substances|mesh-ancestor
83772163|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772164|NCT00050206|Olanzapine|olanzapine|mesh-list
83772165|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
83772166|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
83772167|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772168|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772169|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83772170|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83772171|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83772172|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772173|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83772174|NCT00050206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83772175|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83772176|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83772177|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772178|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772179|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
83772180|NCT00050245|Rituximab|rituximab|mesh-list
83772181|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83772182|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772183|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
83772184|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772185|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772186|NCT00050362|Rofecoxib|rofecoxib|mesh-list
83772187|NCT00050362|Bupivacaine|bupivacaine|mesh-list
83772188|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
83772189|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
83772190|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772191|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772192|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
83772193|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772194|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83772195|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83772196|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772197|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772198|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83772199|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83772200|NCT00050362|Analgesics|analgesics|mesh-ancestor
83772201|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83772202|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772203|NCT00050401|Vancomycin|vancomycin|mesh-list
83772204|NCT00050401|Tobramycin|tobramycin|mesh-list
83772205|NCT00050401|Meropenem|meropenem|mesh-list
83772206|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772207|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772208|NCT05640362|Benzydamine|benzydamine|mesh-list
83772209|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83772210|NCT00050440|Dexamethasone|dexamethasone|mesh-list
83772211|NCT00050440|Trabectedin|trabectedin|mesh-list
83772212|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83772213|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
83772214|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
83772215|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772216|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772217|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83772218|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
83772219|NCT00050440|Hormones|hormones|mesh-ancestor
83772220|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83772221|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83772222|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772223|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772224|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
83772225|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772226|NCT00050479|Celecoxib|celecoxib|mesh-list
83772227|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927392|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
83772228|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83772229|NCT00050479|Analgesics|analgesics|mesh-ancestor
83772230|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
83772231|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772232|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772233|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83772234|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772235|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83772236|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83772237|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772238|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772239|NCT00050596|Docetaxel|docetaxel|mesh-list
83772240|NCT00050596|Ipilimumab|ipilimumab|mesh-list
83772241|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772242|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772243|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772244|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772245|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772246|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83772247|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83772248|NCT00050635|Octreotide|octreotide|mesh-list
83772249|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83772250|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83772251|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772252|NCT00050674|Lenograstim|lenograstim|mesh-list
83772253|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83772254|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
83772255|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772256|NCT00050713|Sirolimus|sirolimus|mesh-list
83772257|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772258|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772259|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83772260|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772261|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
83772262|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772263|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
83772264|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772265|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
83772266|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
83772267|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
83772268|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772269|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772270|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
83772271|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772272|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772273|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83772274|NCT00050830|Protective Agents|protective agents|mesh-ancestor
83772275|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
83772276|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
83772277|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83772278|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83772279|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83772280|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772281|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83772282|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83772283|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
83772284|NCT00051142|Travoprost|travoprost|mesh-list
83772285|NCT00051142|Latanoprost|latanoprost|mesh-list
83772286|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83772287|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83772288|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83772289|NCT00051181|Travoprost|travoprost|mesh-list
83772290|NCT00051181|Latanoprost|latanoprost|mesh-list
83772291|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83772292|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83772293|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83772294|NCT00051259|Bupropion|bupropion|mesh-list
83772295|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83772296|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
83772297|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83772298|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83772299|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83772300|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927467|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772301|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772302|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
83772303|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772304|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772305|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83772306|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83772307|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772308|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
83772309|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83772310|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772311|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772312|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83772313|NCT05639777|Analgesics|analgesics|mesh-ancestor
83772314|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
83772315|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772316|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83772317|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83772318|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83772319|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
83772320|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772321|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772322|NCT00051298|Olanzapine|olanzapine|mesh-list
83772323|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
83772324|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
83772325|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772326|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772327|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83772328|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83772329|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83772330|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772331|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83772332|NCT00051298|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83772333|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83772334|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83772335|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772336|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772337|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
83772338|NCT00398008|Naltrexone|naltrexone|mesh-list
83772339|NCT00398008|Buprenorphine|buprenorphine|mesh-list
83772340|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83772341|NCT00398008|Narcotics|narcotics|mesh-ancestor
83772342|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772343|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772344|NCT00398008|Analgesics|analgesics|mesh-ancestor
83772345|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
83772346|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772347|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83772348|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83772349|NCT05636189|Anesthetics|anesthetics|mesh-list
83772350|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772351|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772352|NCT00051493|Carboplatin|carboplatin|mesh-list
83772353|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772354|NCT00051532|Seocalcitol|seocalcitol|mesh-list
83772355|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772356|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772357|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
83772358|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772359|NCT00051571|Docetaxel|docetaxel|mesh-list
83772360|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772361|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772362|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772363|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772364|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772365|NCT05573958|Aspirin|aspirin|mesh-list
83772366|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
83772367|NCT05573958|Clopidogrel|clopidogrel|mesh-list
83772368|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83772369|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83772370|NCT05573958|Analgesics|analgesics|mesh-ancestor
83772371|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
83772372|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772373|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772374|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83772375|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772376|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83772377|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83772378|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772379|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83772380|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83772381|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772382|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
83772383|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83772384|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83772385|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83772386|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
83772387|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772388|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83772389|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
83772390|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83772391|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
83772392|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
83772393|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
83772394|NCT00051688|Tezacitabine|tezacitabine|mesh-list
83772395|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772396|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772397|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772398|NCT00051844|Capravirine|capravirine|mesh-list
83772399|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83772400|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83772401|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772402|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772403|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
83772404|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772405|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83772406|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83772407|NCT00052000|Antibodies|antibodies|mesh-list
83772408|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83772409|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
83772410|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772411|NCT00052039|Interferons|interferons|mesh-list
83772412|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
83772413|NCT00052039|Azathioprine|azathioprine|mesh-list
83772414|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772415|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
83772416|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772417|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
83772418|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772419|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772420|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772421|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
83772422|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772423|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772424|NCT00052117|Capravirine|capravirine|mesh-list
83772425|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83772426|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83772427|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772428|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772429|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
83772430|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772431|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83772432|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83772433|NCT00052273|Capecitabine|capecitabine|mesh-list
83772434|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772435|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
83772436|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772437|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772438|NCT00052312|Paclitaxel|paclitaxel|mesh-list
83772439|NCT00052312|Doxorubicin|doxorubicin|mesh-list
83772440|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83772441|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772442|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772443|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772444|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772445|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772446|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772447|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83772448|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772449|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772450|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927620|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
83772451|NCT00052351|Metronidazole|metronidazole|mesh-list
83772452|NCT00052351|Paclitaxel|paclitaxel|mesh-list
83772453|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
83772454|NCT00052351|Doxorubicin|doxorubicin|mesh-list
83772455|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83772456|NCT00052351|Vaccines|vaccines|mesh-list
83772457|NCT00052351|Sargramostim|sargramostim|mesh-list
83772458|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
83772459|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772460|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772461|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772462|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772463|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772464|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772465|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772466|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772467|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772468|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772469|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
83772470|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772471|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83772472|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772473|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772474|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772475|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772476|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772477|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83772478|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83772479|NCT00052390|Bevacizumab|bevacizumab|mesh-list
83772480|NCT00052390|Doxorubicin|doxorubicin|mesh-list
83772481|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83772482|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83772483|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772484|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83772485|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83772486|NCT00052390|Growth Substances|growth substances|mesh-ancestor
83772487|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772488|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
83772489|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83772490|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772491|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772492|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772493|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772494|NCT00052468|Paclitaxel|paclitaxel|mesh-list
83772495|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83772496|NCT00052468|Carboplatin|carboplatin|mesh-list
83772497|NCT00052468|Gemcitabine|gemcitabine|mesh-list
83772498|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772499|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772500|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772501|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772502|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772503|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772504|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772505|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
83772506|NCT00052507|Bortezomib|bortezomib|mesh-list
83772507|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772508|NCT00052585|Leucovorin|leucovorin|mesh-list
83772509|NCT00052585|Fluorouracil|fluorouracil|mesh-list
83772510|NCT00052585|Irinotecan|irinotecan|mesh-list
83772511|NCT00052585|Gefitinib|gefitinib|mesh-list
83772512|NCT00052585|Calcium|calcium|mesh-list
83772513|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
83772514|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83772515|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772516|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
83772517|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772518|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772519|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772520|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772521|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
83772522|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83772523|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772524|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772525|NCT00052585|Antidotes|antidotes|mesh-ancestor
83772526|NCT00052585|Protective Agents|protective agents|mesh-ancestor
83772527|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
83772528|NCT00052585|Vitamins|vitamins|mesh-ancestor
83772529|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
83772530|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83772531|NCT00052780|Temozolomide|temozolomide|mesh-list
83772532|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83772533|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772534|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
83772535|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772536|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772537|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772538|NCT00052936|Prednisone|prednisone|mesh-list
83772539|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
83772540|NCT00052936|Rituximab|rituximab|mesh-list
83772541|NCT00052936|Doxorubicin|doxorubicin|mesh-list
83772542|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83772543|NCT00052936|Vincristine|vincristine|mesh-list
83772544|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772545|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
83772546|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772547|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772548|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772549|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
83772550|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772551|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772552|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772553|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83772554|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83772555|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772556|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772557|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772558|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83772559|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
83772560|NCT00052936|Hormones|hormones|mesh-ancestor
83772561|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83772562|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83772563|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772564|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772565|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772566|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772567|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
83772568|NCT00053092|Rituximab|rituximab|mesh-list
83772569|NCT00053092|Fludarabine|fludarabine|mesh-list
83772570|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
83772571|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772572|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
83772573|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772574|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772575|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772576|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
83772577|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772578|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772579|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772580|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83772581|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772582|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
83772583|NCT00053131|Cytarabine|cytarabine|mesh-list
83772584|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
83772585|NCT00053131|Sargramostim|sargramostim|mesh-list
83772586|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772587|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
83772588|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772589|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772590|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
83772591|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772592|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772593|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
83772594|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772595|NCT00053131|Analgesics|analgesics|mesh-ancestor
83772596|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
83772597|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772598|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772599|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772600|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772601|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
83772602|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
83772603|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772604|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83772605|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772606|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772607|NCT00053287|Thalidomide|thalidomide|mesh-list
83772608|NCT00053287|Carboplatin|carboplatin|mesh-list
83772609|NCT00053287|Fludarabine|fludarabine|mesh-list
83772610|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
83772611|NCT00053287|Topotecan|topotecan|mesh-list
83772612|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772613|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772614|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
83772615|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772616|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772617|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
83772618|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772619|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83772620|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772621|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772622|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
83772623|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772624|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772625|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83772626|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83772627|NCT00053287|Growth Substances|growth substances|mesh-ancestor
83772628|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
83772629|NCT00053326|Fenretinide|fenretinide|mesh-list
83772630|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772631|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83772632|NCT00053326|Protective Agents|protective agents|mesh-ancestor
83772633|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772634|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83772635|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83772636|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
83772637|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772638|NCT00053599|Simvastatin|simvastatin|mesh-list
83772639|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83772640|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83772641|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
83772642|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772643|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83772644|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83772645|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772646|NCT00053638|Tenofovir|tenofovir|mesh-list
83772647|NCT00053638|Lamivudine|lamivudine|mesh-list
83772648|NCT00053638|Efavirenz|efavirenz|mesh-list
83772649|NCT00053638|Abacavir|abacavir|mesh-list
83772650|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
83772651|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772652|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83772653|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83772654|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772655|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772656|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83772657|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83772658|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83772659|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83772660|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83772661|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83772662|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83772663|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83772664|NCT00053716|Alprostadil|alprostadil|mesh-list
83772665|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83772666|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
83772667|NCT00053716|Urological Agents|urological agents|mesh-ancestor
83772668|NCT05626478|Moxifloxacin|moxifloxacin|mesh-list
83772669|NCT05626478|Dexamethasone|dexamethasone|mesh-list
83772670|NCT05626478|Prednisolone|prednisolone|mesh-list
83772671|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83772672|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
83772673|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83772674|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
83772675|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83772676|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82927841|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83772677|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83772678|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
83772679|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83772680|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
83772681|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
83772682|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772683|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772684|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83772685|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
83772686|NCT05626478|Hormones|hormones|mesh-ancestor
83772687|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83772688|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83772689|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772690|NCT05626478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772691|NCT05626478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772692|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83772693|NCT05626478|Protective Agents|protective agents|mesh-ancestor
83772694|NCT05626478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772695|NCT05626478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772696|NCT05626478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772697|NCT05626478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772698|NCT02970175|Terlipressin|terlipressin|mesh-list
83772699|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83772700|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83772701|NCT00053833|Irinotecan|irinotecan|mesh-list
83772702|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83772703|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772704|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772705|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772706|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772707|NCT00053872|Vincristine|vincristine|mesh-list
83772708|NCT00053872|Lomustine|lomustine|mesh-list
83772709|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772710|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772711|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772712|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772713|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772714|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772715|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772716|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
83772717|NCT05624918|Paclitaxel|paclitaxel|mesh-list
83772718|NCT05624918|Gemcitabine|gemcitabine|mesh-list
83772719|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772720|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772721|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772722|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772723|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772724|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772725|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772726|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
83772727|NCT00053911|Tamoxifen|tamoxifen|mesh-list
83772728|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
83772729|NCT00053911|Docetaxel|docetaxel|mesh-list
83772730|NCT00053911|Fluorouracil|fluorouracil|mesh-list
83772731|NCT00053911|Epirubicin|epirubicin|mesh-list
83772732|NCT00053911|Anastrozole|anastrozole|mesh-list
83772733|NCT00053911|Goserelin|goserelin|mesh-list
83772734|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772735|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
83772736|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772737|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772738|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772739|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
83772740|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772741|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772742|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772743|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772744|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772745|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772746|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
83772747|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772748|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83772749|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83772750|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83772751|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772752|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83772753|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
83834929|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927913|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772754|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83772755|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83772756|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83772757|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83772758|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83772759|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83772760|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83772761|NCT00053950|NSC 366140|nsc 366140|mesh-list
83772762|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772763|NCT00054067|Cisplatin|cisplatin|mesh-list
83772764|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772765|NCT00054106|Flutamide|flutamide|mesh-list
83772766|NCT00054106|Buserelin|buserelin|mesh-list
83772767|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
83772768|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
83772769|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83772770|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772771|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83772772|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772773|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83772774|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
83772775|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83772776|NCT00054184|Paclitaxel|paclitaxel|mesh-list
83772777|NCT00054184|Docetaxel|docetaxel|mesh-list
83772778|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83772779|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83772780|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772781|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772782|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772783|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772784|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772785|NCT00054340|Cyclosporine|cyclosporine|mesh-list
83772786|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
83772787|NCT00054340|Busulfan|busulfan|mesh-list
83772788|NCT00054340|Methotrexate|methotrexate|mesh-list
83772789|NCT00054340|Cyclosporins|cyclosporins|mesh-list
83772790|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83772791|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83772792|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
83772793|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772794|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83772795|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83772796|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
83772797|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772798|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772799|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83772800|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83772801|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
83772802|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83772803|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772804|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
83772805|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
83772806|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772807|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83772808|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83772809|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
83772810|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772811|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83772812|NCT00054418|Vitamin D|vitamin d|mesh-list
83772813|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
83772814|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
83772815|NCT00054418|Calcium|calcium|mesh-list
83772816|NCT00054418|Vitamins|vitamins|mesh-ancestor
83772817|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
83772818|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772819|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83772820|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83772821|NCT00054418|Antacids|antacids|mesh-ancestor
83772822|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772823|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83772824|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83772825|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83772826|NCT05560230|Clonidine|clonidine|mesh-list
83772827|NCT05560230|Analgesics|analgesics|mesh-ancestor
83772828|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
83772829|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772831|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83772832|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
83772833|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
83772834|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83772835|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83772836|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83772837|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
83772838|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772839|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772840|NCT00054457|Docetaxel|docetaxel|mesh-list
83772841|NCT00054457|Capecitabine|capecitabine|mesh-list
83772842|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772843|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83772844|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83772845|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83772846|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772847|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772848|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
83772849|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83772850|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772851|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83772852|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772853|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772854|NCT00054535|Aldesleukin|aldesleukin|mesh-list
83772855|NCT00054535|Vaccines|vaccines|mesh-list
83772856|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
83772857|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772858|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772859|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83772860|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83772861|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
83772862|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772863|NCT00054574|Panitumumab|panitumumab|mesh-list
83772864|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83772865|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772866|NCT00054613|Methoxsalen|methoxsalen|mesh-list
83772867|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83772868|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
83772869|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
83772870|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83772871|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772872|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772873|NCT00054886|Sunitinib|sunitinib|mesh-list
83772874|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772875|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83772876|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83772877|NCT00054886|Growth Substances|growth substances|mesh-ancestor
83772878|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772879|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
83772880|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83772881|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772882|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772883|NCT02970097|Fentanyl|fentanyl|mesh-list
83772884|NCT02970097|Midazolam|midazolam|mesh-list
83772885|NCT02970097|Ropivacaine|ropivacaine|mesh-list
83772886|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83772887|NCT02970097|Narcotics|narcotics|mesh-ancestor
83772888|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772889|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772890|NCT02970097|Analgesics|analgesics|mesh-ancestor
83772891|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
83772892|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772893|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83772894|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83772895|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
83772896|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
83772897|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83772898|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83772899|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83772900|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83772901|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
83772902|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
82928067|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83772903|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928070|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83772904|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772905|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
83772906|NCT00398281|Dutasteride|dutasteride|mesh-list
83772907|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83772908|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83772909|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772910|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772911|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
83772912|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83772913|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772915|NCT00055042|Vitamins|vitamins|mesh-ancestor
83772916|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
83772917|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772918|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
83772919|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772920|NCT00055042|Protective Agents|protective agents|mesh-ancestor
83772921|NCT00055120|Ritonavir|ritonavir|mesh-list
83772922|NCT00055120|Lopinavir|lopinavir|mesh-list
83772923|NCT00055120|Tenofovir|tenofovir|mesh-list
83772924|NCT00055120|Emtricitabine|emtricitabine|mesh-list
83772925|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83772926|NCT00055120|Stavudine|stavudine|mesh-list
83772927|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83772928|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83772929|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83772930|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772931|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772932|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83772933|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83772934|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
83772935|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772936|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83772937|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83772938|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83772939|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83772940|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
83772941|NCT05527704|Albuterol|albuterol|mesh-list
83772942|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83772943|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
83772944|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83772945|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772946|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83772947|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
83772948|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
83772949|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83772950|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83772951|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83772952|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83772953|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
83772954|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772955|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772956|NCT00055159|Plasminogen|plasminogen|mesh-list
83772957|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83772958|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83772959|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83772960|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772961|NCT00055198|Daptomycin|daptomycin|mesh-list
83772962|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83772963|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83772964|NCT05525325|Anesthetics|anesthetics|mesh-list
83772965|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83772966|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772967|NCT00055393|Bupropion|bupropion|mesh-list
83772968|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83772969|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
83772970|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83772971|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83772972|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83772973|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83772974|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772975|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
82928140|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
83772976|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772977|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772978|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83772979|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83772980|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772981|NCT00055432|Gemcitabine|gemcitabine|mesh-list
83772982|NCT00055432|Pemetrexed|pemetrexed|mesh-list
83772983|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83772984|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
83772985|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772986|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83772987|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83772988|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83772989|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83772990|NCT00055549|Lorazepam|lorazepam|mesh-list
83772991|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
83772992|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
83772993|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
83772994|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83772995|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83772996|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83772997|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83772998|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83772999|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
83773000|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
83773001|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
83773002|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773003|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83773004|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83773005|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83773006|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83773007|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83773008|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83773009|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
83773010|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
83773011|NCT00055666|Beclomethasone|beclomethasone|mesh-list
83773012|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773013|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
83773014|NCT00055666|Hormones|hormones|mesh-ancestor
83773015|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773016|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773017|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83773018|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
83773019|NCT00055822|Leucovorin|leucovorin|mesh-list
83773020|NCT00055822|Fluorouracil|fluorouracil|mesh-list
83773021|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
83773022|NCT00055822|Oblimersen|oblimersen|mesh-list
83773023|NCT00055822|Calcium|calcium|mesh-list
83773024|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
83773025|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83773026|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773027|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
83773028|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773029|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773030|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773031|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773032|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
83773033|NCT00055822|Antidotes|antidotes|mesh-ancestor
83773034|NCT00055822|Protective Agents|protective agents|mesh-ancestor
83773035|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
83773036|NCT00055822|Vitamins|vitamins|mesh-ancestor
83773037|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
83773038|NCT00055861|Bevacizumab|bevacizumab|mesh-list
83773039|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83773040|NCT00055861|Docetaxel|docetaxel|mesh-list
83773041|NCT00055861|Antibodies|antibodies|mesh-list
83773042|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
83773043|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83773044|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773045|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82928215|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773046|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83773047|NCT00055861|Growth Substances|growth substances|mesh-ancestor
83773048|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773049|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83773050|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
83773051|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773052|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773053|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773054|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773055|NCT00392106|Amiodarone|amiodarone|mesh-list
83773056|NCT00392106|Flecainide|flecainide|mesh-list
83773057|NCT00392106|Propafenone|propafenone|mesh-list
83773058|NCT00392106|Dofetilide|dofetilide|mesh-list
83773059|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83773060|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
83773061|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83773062|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773063|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773064|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83773065|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83773066|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83773067|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773068|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83773069|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83773070|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83773071|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83773072|NCT00055939|Exatecan|exatecan|mesh-list
83773073|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83773074|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773075|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773076|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773077|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773078|NCT00055978|Celecoxib|celecoxib|mesh-list
83773079|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83773080|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83773081|NCT00055978|Analgesics|analgesics|mesh-ancestor
83773082|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
83773083|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773084|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773085|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773086|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773087|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83773088|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83773089|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773090|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773091|NCT00056056|Bexarotene|bexarotene|mesh-list
83773092|NCT00056056|Methoxsalen|methoxsalen|mesh-list
83773093|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773094|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83773095|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83773096|NCT00056095|Cyclosporine|cyclosporine|mesh-list
83773097|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
83773098|NCT00056095|Fludarabine|fludarabine|mesh-list
83773099|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
83773100|NCT00056095|Cyclosporins|cyclosporins|mesh-list
83773101|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773102|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
83773103|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773104|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773105|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83773106|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
83773107|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773108|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773109|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83773110|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773111|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
83773112|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773113|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
83773114|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773115|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
83773116|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83773117|NCT00056329|Vitamin E|vitamin e|mesh-list
83773118|NCT00056329|Tocopherols|tocopherols|mesh-list
83773119|NCT00056329|Vitamins|vitamins|mesh-ancestor
83773120|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
83773121|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773122|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
83773123|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773124|NCT00056329|Protective Agents|protective agents|mesh-ancestor
82928289|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83773125|NCT00056368|Fluconazole|fluconazole|mesh-list
83773126|NCT00056368|Anidulafungin|anidulafungin|mesh-list
83773127|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
83773128|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773129|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83773130|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83773131|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773132|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773133|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83773134|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
83773135|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773136|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773137|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83773138|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83773139|NCT00056446|Vatalanib|vatalanib|mesh-list
83773140|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773141|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773142|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773143|NCT00056641|Ritonavir|ritonavir|mesh-list
83773144|NCT00056641|Lopinavir|lopinavir|mesh-list
83773145|NCT00056641|Saquinavir|saquinavir|mesh-list
83773146|NCT00056641|Amprenavir|amprenavir|mesh-list
83773147|NCT00056641|Tipranavir|tipranavir|mesh-list
83773148|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83773149|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83773150|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
83773151|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773152|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773153|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83773154|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83773155|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
83773156|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773157|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83773158|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83773159|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83773160|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
83773161|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83773162|NCT00398437|Trastuzumab|trastuzumab|mesh-list
83773163|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773164|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773165|NCT05433675|Macitentan|macitentan|mesh-list
83773166|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83773167|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83773168|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773169|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83773170|NCT00423709|Fludarabine|fludarabine|mesh-list
83773171|NCT00423709|Melphalan|melphalan|mesh-list
83773172|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773173|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773174|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773175|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
83773176|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773177|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83773178|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
83773179|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83773180|NCT00056797|Interleukin-2|interleukin-2|mesh-list
83773181|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773182|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83773183|NCT00056797|Analgesics|analgesics|mesh-ancestor
83773184|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
83773185|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773186|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773187|NCT00056836|Ranibizumab|ranibizumab|mesh-list
83773188|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83773189|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83773190|NCT00056836|Growth Substances|growth substances|mesh-ancestor
83773191|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773192|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
83773193|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773194|NCT05495321|Aldesleukin|aldesleukin|mesh-list
83773195|NCT05495321|Interleukin-2|interleukin-2|mesh-list
83773196|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773197|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83773198|NCT05495321|Analgesics|analgesics|mesh-ancestor
83773199|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
83773200|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773201|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773202|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83773203|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83773204|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
83773205|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773206|NCT00056875|Mitogens|mitogens|mesh-list
83773207|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773208|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773209|NCT05410197|Gemcitabine|gemcitabine|mesh-list
83773210|NCT05410197|Lenvatinib|lenvatinib|mesh-list
83773211|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773212|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773213|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
83773214|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773215|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773216|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773217|NCT03262454|Atezolizumab|atezolizumab|mesh-list
83773218|NCT03262454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83773219|NCT03262454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773220|NCT03262454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773221|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773222|NCT00057031|Calcitriol|calcitriol|mesh-list
83773223|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83773224|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773225|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83773226|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773227|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773228|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83773229|NCT00057031|Vitamins|vitamins|mesh-ancestor
83773230|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
83773231|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83773232|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
83773233|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773234|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
83773235|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773236|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773237|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83773238|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
83773239|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773240|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773241|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83773242|NCT00057265|Lamivudine|lamivudine|mesh-list
83773243|NCT00057265|Telbivudine|telbivudine|mesh-list
83773244|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83773245|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83773246|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773247|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773248|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
83773249|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773250|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83773251|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83773252|NCT00057343|Rituximab|rituximab|mesh-list
83773253|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773254|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773255|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
83773256|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773257|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773258|NCT00057382|Doxorubicin|doxorubicin|mesh-list
83773259|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83773260|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773261|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83773262|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773263|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773264|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773265|NCT00057421|Prednisolone|prednisolone|mesh-list
83773266|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773267|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
83773268|NCT00057421|Hormones|hormones|mesh-ancestor
83773269|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773270|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773271|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83773272|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773273|NCT00057616|Lenalidomide|lenalidomide|mesh-list
83773274|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
83773275|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773276|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83773277|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83773278|NCT00057616|Growth Substances|growth substances|mesh-ancestor
83773279|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
83773280|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773282|NCT02969746|Antidotes|antidotes|mesh-ancestor
83773283|NCT02969746|Protective Agents|protective agents|mesh-ancestor
83773284|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773285|NCT00057850|Cisplatin|cisplatin|mesh-list
83773286|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773287|NCT00057889|Ipilimumab|ipilimumab|mesh-list
83773288|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773289|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773290|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83773291|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773292|NCT00057928|Paclitaxel|paclitaxel|mesh-list
83773293|NCT00057928|Gemcitabine|gemcitabine|mesh-list
83773294|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773295|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773296|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773297|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773298|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773299|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773300|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773301|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
83773302|NCT05309304|Cefazolin|cefazolin|mesh-list
83773303|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83773304|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773305|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
83773306|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773307|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773308|NCT00058006|Celecoxib|celecoxib|mesh-list
83773309|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83773310|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83773311|NCT00058006|Analgesics|analgesics|mesh-ancestor
83773312|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
83773313|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773314|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773315|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773316|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773317|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83773318|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83773319|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773320|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773321|NCT00058045|Aldesleukin|aldesleukin|mesh-list
83773322|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773323|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83773324|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83773325|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
83773326|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773327|NCT00058084|Prednisone|prednisone|mesh-list
83773328|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
83773329|NCT00058084|Epothilone B|epothilone b|mesh-list
83773330|NCT00058084|Epothilones|epothilones|mesh-list
83773331|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773332|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
83773333|NCT00058084|Hormones|hormones|mesh-ancestor
83773334|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773335|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773336|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83773337|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773338|NCT00058084|Analgesics|analgesics|mesh-ancestor
83773339|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
83773340|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773341|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83773342|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773343|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773344|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773345|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773346|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773347|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
82928510|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773348|NCT02969629|Apomorphine|apomorphine|mesh-list
83773349|NCT02969629|Emetics|emetics|mesh-ancestor
83773350|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773351|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
83773352|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773353|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83773354|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
83773355|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
83773356|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83773357|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773358|NCT00058201|Leucovorin|leucovorin|mesh-list
83773359|NCT00058201|Gemcitabine|gemcitabine|mesh-list
83773360|NCT00058201|Fluorouracil|fluorouracil|mesh-list
83773361|NCT00058201|Calcium|calcium|mesh-list
83773362|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
83773363|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773364|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
83773365|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773366|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773367|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83773368|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773369|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773370|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
83773371|NCT00058201|Antidotes|antidotes|mesh-ancestor
83773372|NCT00058201|Protective Agents|protective agents|mesh-ancestor
83773373|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
83773374|NCT00058201|Vitamins|vitamins|mesh-ancestor
83773375|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
83773376|NCT00058279|Aldesleukin|aldesleukin|mesh-list
83773377|NCT00058279|Ipilimumab|ipilimumab|mesh-list
83773378|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773379|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773380|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83773381|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773382|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83773383|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83773384|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
83773385|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773386|NCT00058318|Gemcitabine|gemcitabine|mesh-list
83773387|NCT00058318|Capecitabine|capecitabine|mesh-list
83773388|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773389|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
83773390|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773391|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773392|NCT00058357|Lidocaine|lidocaine|mesh-list
83773393|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
83773394|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
83773395|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83773396|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773397|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
83773398|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773399|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83773400|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83773401|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83773402|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773403|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773404|NCT00058435|Abagovomab|abagovomab|mesh-list
83773405|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773406|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773407|NCT00058474|Fluorouracil|fluorouracil|mesh-list
83773408|NCT00058474|Capecitabine|capecitabine|mesh-list
83773409|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
83773410|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
83773411|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773412|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773413|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773414|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773415|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
83773416|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773417|NCT00392262|Amlodipine|amlodipine|mesh-list
83773418|NCT00392262|Valsartan|valsartan|mesh-list
83773419|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83773420|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83773421|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773422|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773423|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83773424|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773426|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83773427|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83773428|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
83773429|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773430|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773431|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773432|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773433|NCT00058903|Sertraline|sertraline|mesh-list
83773434|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
83773435|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83773436|NCT00058903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83773437|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83773438|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773439|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773440|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83773441|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
83773442|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773443|NCT02969473|Cisplatin|cisplatin|mesh-list
83773444|NCT02969473|Docetaxel|docetaxel|mesh-list
83773445|NCT02969473|Fluorouracil|fluorouracil|mesh-list
83773446|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773447|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773448|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773449|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773450|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773451|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
83773452|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773453|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773454|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
83773455|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773456|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
83773457|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773458|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773459|NCT01349907|Asenapine|asenapine|mesh-list
83773460|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83773461|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83773462|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83773463|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773464|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83773465|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83773466|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83773467|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773468|NCT05223582|Prednisone|prednisone|mesh-list
83773469|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
83773470|NCT05223582|Fluzoparib|fluzoparib|mesh-list
83773471|NCT05223582|Androgens|androgens|mesh-list
83773472|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773473|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
83773474|NCT05223582|Hormones|hormones|mesh-ancestor
83773475|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773476|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773477|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83773478|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773479|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83773480|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773481|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773482|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
83773483|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83773484|NCT05223582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83773485|NCT00059722|Gefitinib|gefitinib|mesh-list
83773486|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773487|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773488|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773489|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773490|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
83773491|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
83773492|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
83773493|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83773494|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773495|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
83773496|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928662|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
83773497|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83773498|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773499|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773500|NCT02969239|Phenylephrine|phenylephrine|mesh-list
83773501|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
83773502|NCT02969239|Norepinephrine|norepinephrine|mesh-list
83773503|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83773504|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83773505|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
83773506|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
83773507|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773508|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773509|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
83773510|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
83773511|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
83773512|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83773513|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83773514|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83773515|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
83773516|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83773517|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773518|NCT02969239|Protective Agents|protective agents|mesh-ancestor
83773519|NCT00059761|Irinotecan|irinotecan|mesh-list
83773520|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773521|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83773522|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773523|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773524|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773525|NCT00059800|Boron|boron|mesh-list
83773526|NCT00059800|Trace Elements|trace elements|mesh-ancestor
83773527|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
83773528|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773529|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
83773530|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83773531|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83773532|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773533|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
83773534|NCT03216083|Coagulants|coagulants|mesh-ancestor
83773535|NCT00059878|Interferons|interferons|mesh-list
83773536|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
83773537|NCT00059878|Voriconazole|voriconazole|mesh-list
83773538|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773539|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
83773540|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773541|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
83773542|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83773543|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83773544|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773545|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773546|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83773547|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
83773548|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773549|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773550|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83773551|NCT00059917|Camptothecin|camptothecin|mesh-list
83773552|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773553|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773554|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83773555|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773556|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773557|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773558|NCT00060112|Gemcitabine|gemcitabine|mesh-list
83773559|NCT00060112|Oblimersen|oblimersen|mesh-list
83773560|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773561|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
83773562|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773563|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773564|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83773565|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773566|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773567|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773568|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773569|NCT02968927|Vitamin D|vitamin d|mesh-list
83773570|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
82928741|NCT02182960|Ibuprofen|ibuprofen|mesh-list
83773571|NCT02968927|Rifabutin|rifabutin|mesh-list
83773572|NCT02968927|Everolimus|everolimus|mesh-list
83773573|NCT02968927|Auranofin|auranofin|mesh-list
83773574|NCT02968927|CC-11050|cc-11050|mesh-list
83773575|NCT02968927|Vitamins|vitamins|mesh-ancestor
83773576|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
83773577|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773578|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83773579|NCT02968927|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83773580|NCT02968927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773581|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773582|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773583|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773584|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
83773585|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773586|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83773587|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83773588|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773589|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83773590|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
83773591|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773592|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83773593|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83773594|NCT00398515|Sirolimus|sirolimus|mesh-list
83773595|NCT00398515|Lenalidomide|lenalidomide|mesh-list
83773596|NCT00398515|Temsirolimus|temsirolimus|mesh-list
83773597|NCT00398515|MTOR Inhibitors|mtor inhibitors|mesh-list
83773598|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
83773599|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773600|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83773601|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83773602|NCT00398515|Growth Substances|growth substances|mesh-ancestor
83773603|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
83773604|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773605|NCT00398515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773606|NCT00398515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773607|NCT00398515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773608|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773609|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83773610|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773611|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83773612|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
83773613|NCT05105685|Hormones|hormones|mesh-list
83773614|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773615|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773616|NCT05325164|Morphine|morphine|mesh-list
83773617|NCT05325164|Methadone|methadone|mesh-list
83773618|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83773619|NCT05325164|Narcotics|narcotics|mesh-ancestor
83773620|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83773621|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773622|NCT05325164|Analgesics|analgesics|mesh-ancestor
83773623|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
83773624|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773625|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
83773626|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
83773627|NCT00060385|Prednisone|prednisone|mesh-list
83773628|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
83773629|NCT00060385|Doxorubicin|doxorubicin|mesh-list
83773630|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83773631|NCT00060385|Etoposide|etoposide|mesh-list
83773632|NCT00060385|Vincristine|vincristine|mesh-list
83773633|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773634|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
83773635|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773636|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773637|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83773638|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
83773639|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773640|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773641|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83773642|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82928811|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928816|NCT02183272|Ketamine|ketamine|mesh-list
83773643|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83773644|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773645|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773646|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773647|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
83773649|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773650|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83773651|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773652|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773653|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773654|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773655|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
83773656|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
83773657|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83773658|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773659|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83773660|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83773661|NCT02968693|Vancomycin|vancomycin|mesh-list
83773662|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83773663|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83773664|NCT02968693|Calcium|calcium|mesh-list
83773665|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83773666|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773667|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773668|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
83773669|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
83773670|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83773671|NCT02968693|Protective Agents|protective agents|mesh-ancestor
83773672|NCT00060502|Infliximab|infliximab|mesh-list
83773673|NCT00060502|Gemcitabine|gemcitabine|mesh-list
83773674|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773675|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
83773676|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773677|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773678|NCT00060502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83773679|NCT00060502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773680|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
83773681|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83773682|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773683|NCT05312372|Paclitaxel|paclitaxel|mesh-list
83773684|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773685|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773686|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773687|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773688|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773689|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773690|NCT05038410|Wobenzym|wobenzym|mesh-list
83773691|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83773692|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
83773693|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773694|NCT05030493|Bevacizumab|bevacizumab|mesh-list
83773695|NCT05030493|Panitumumab|panitumumab|mesh-list
83773696|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773697|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773698|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83773699|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83773700|NCT05030493|Growth Substances|growth substances|mesh-ancestor
83773701|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773702|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
83773703|NCT02968498|Methamphetamine|methamphetamine|mesh-list
83773704|NCT02968498|Lactulose|lactulose|mesh-list
83773705|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83773706|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83773707|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773708|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
83773709|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
83773710|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773711|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
83773712|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83773713|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773714|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
83773715|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83773716|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83773717|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773718|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83773719|NCT00060931|Metoprolol|metoprolol|mesh-list
83773720|NCT00060931|Carvedilol|carvedilol|mesh-list
83773721|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83773722|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83773723|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
83773724|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
83773725|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773726|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773727|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83773728|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83773729|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83773730|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
83773731|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83773732|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773733|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
83773734|NCT00060931|Protective Agents|protective agents|mesh-ancestor
83773735|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83773736|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773737|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83773738|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83773739|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83773740|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83773741|NCT00061087|Methylphenidate|methylphenidate|mesh-list
83773742|NCT00061087|Bupropion|bupropion|mesh-list
83773743|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83773744|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773745|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83773746|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83773747|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83773748|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773749|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
83773750|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83773751|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83773752|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
83773753|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83773754|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83773755|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83773756|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773757|NCT00061243|Vaccines|vaccines|mesh-list
83773758|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
83773759|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773760|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83773761|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83773762|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83773763|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83773764|NCT00061321|Nevirapine|nevirapine|mesh-list
83773765|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83773766|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83773767|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773768|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773769|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
83773770|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773771|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83773772|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83773773|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83773774|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83773775|NCT00061360|Cyclosporine|cyclosporine|mesh-list
83773776|NCT00061360|Sirolimus|sirolimus|mesh-list
83773777|NCT00061360|Cyclosporins|cyclosporins|mesh-list
83773778|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773779|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773780|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773781|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
83773782|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773783|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
83773784|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773785|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
83773786|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773787|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83773788|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83773789|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83773790|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773791|NCT00061438|Meropenem|meropenem|mesh-list
83773792|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82928960|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83773793|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83773794|NCT00061477|Gemcitabine|gemcitabine|mesh-list
83773795|NCT00061477|Pemetrexed|pemetrexed|mesh-list
83773796|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83773797|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
83773798|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773799|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773800|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773801|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83773802|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83773803|NCT02968342|Progesterone|progesterone|mesh-list
83773804|NCT02968342|Progestins|progestins|mesh-ancestor
83773805|NCT02968342|Hormones|hormones|mesh-ancestor
83773806|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773807|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773808|NCT02968303|Vemurafenib|vemurafenib|mesh-list
83773809|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773810|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773811|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773812|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773813|NCT00061516|Brinzolamide|brinzolamide|mesh-list
83773814|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83773815|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773816|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773817|NCT00061594|Ranibizumab|ranibizumab|mesh-list
83773818|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83773819|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83773820|NCT00061594|Growth Substances|growth substances|mesh-ancestor
83773821|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773822|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
83773823|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773824|NCT00061711|Hormones|hormones|mesh-list
83773825|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
83773826|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773827|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773828|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83773829|NCT00061711|Estrogens|estrogens|mesh-ancestor
83773830|NCT00061750|Deferasirox|deferasirox|mesh-list
83773831|NCT00061750|Deferoxamine|deferoxamine|mesh-list
83773832|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83773833|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
83773834|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
83773835|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773836|NCT00061750|Siderophores|siderophores|mesh-ancestor
83773837|NCT00061789|Acetylcholine|acetylcholine|mesh-list
83773838|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
83773839|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83773840|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
83773841|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83773842|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773843|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773844|NCT00061867|Doxorubicin|doxorubicin|mesh-list
83773845|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83773846|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83773847|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133369|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
83773848|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83773849|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773850|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773851|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773852|NCT00061906|Celecoxib|celecoxib|mesh-list
83773853|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83773854|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83773855|NCT00061906|Analgesics|analgesics|mesh-ancestor
83773856|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
83773857|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773858|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773859|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773860|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773861|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83773862|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83773863|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773864|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929032|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773865|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
83773866|NCT00398554|Prednisone|prednisone|mesh-list
83773867|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
83773869|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83773870|NCT00398554|Etoposide|etoposide|mesh-list
83773871|NCT00398554|Vincristine|vincristine|mesh-list
83773872|NCT00398554|Vinblastine|vinblastine|mesh-list
83773873|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773874|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
83773875|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773876|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773877|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83773878|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
83773879|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773880|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773881|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83773882|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83773883|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83773884|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773885|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773886|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773887|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
83773888|NCT00398554|Hormones|hormones|mesh-ancestor
83773889|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83773890|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83773891|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773892|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773893|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773894|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773895|NCT04917900|Paclitaxel|paclitaxel|mesh-list
83773896|NCT04917900|Trastuzumab|trastuzumab|mesh-list
83773897|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83773898|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773899|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773900|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773901|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773902|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773903|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773904|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773905|NCT05219435|Nivolumab|nivolumab|mesh-list
83773906|NCT05219435|Ipilimumab|ipilimumab|mesh-list
83773907|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83773908|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773909|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83773910|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773911|NCT00061984|Doxorubicin|doxorubicin|mesh-list
83773912|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83773913|NCT00061984|Ifosfamide|ifosfamide|mesh-list
83773914|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83773915|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773916|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83773917|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773918|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773919|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773920|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83773921|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
83773922|NCT00062023|Aspirin|aspirin|mesh-list
83773923|NCT00062023|Sulindac|sulindac|mesh-list
83773924|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83773925|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83773926|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83773927|NCT00062023|Analgesics|analgesics|mesh-ancestor
83773928|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
83773929|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773930|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773931|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773932|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773933|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83773934|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83773935|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773936|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83773937|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83773938|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773939|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
82929104|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
82929105|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83773940|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83773941|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83773942|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773944|NCT00062062|Carboplatin|carboplatin|mesh-list
83773945|NCT00062062|Gefitinib|gefitinib|mesh-list
83773946|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773947|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773948|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773949|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773950|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773951|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773952|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773953|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773954|NCT00392340|Doxorubicin|doxorubicin|mesh-list
83773955|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83773956|NCT00392340|Vincristine|vincristine|mesh-list
83773957|NCT00392340|Topotecan|topotecan|mesh-list
83773958|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83773959|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773960|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83773961|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83773962|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773963|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773964|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773965|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
83773966|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
83773967|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
83773968|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83773969|NCT00062101|Celecoxib|celecoxib|mesh-list
83773970|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83773971|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773972|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83773973|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83773974|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773975|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83773976|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83773977|NCT00062101|Analgesics|analgesics|mesh-ancestor
83773978|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
83773979|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83773980|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773981|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83773982|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773983|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83773984|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83773985|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
83773986|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83773987|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
83773988|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83773989|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83773990|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83773991|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
83773992|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83773993|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83773994|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83773995|NCT00062179|Celecoxib|celecoxib|mesh-list
83773996|NCT00062179|Paclitaxel|paclitaxel|mesh-list
83773997|NCT00062179|Carboplatin|carboplatin|mesh-list
83773998|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83773999|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774000|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
83774001|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
83774002|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
83774003|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774004|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774005|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774006|NCT00062179|Analgesics|analgesics|mesh-ancestor
83774007|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
83774008|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774009|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774010|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774011|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774012|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82929179|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774013|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83774014|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774015|NCT00062257|Irofulven|irofulven|mesh-list
83774016|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83774017|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
83774018|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774019|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774020|NCT00062296|Rituximab|rituximab|mesh-list
83774021|NCT00062296|Epirubicin|epirubicin|mesh-list
83774022|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774023|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774024|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
83774025|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774026|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774027|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83774028|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83774029|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83774030|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774031|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774032|NCT05183984|Bevacizumab|bevacizumab|mesh-list
83774033|NCT05183984|Niraparib|niraparib|mesh-list
83774034|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774035|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774036|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83774037|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83774038|NCT05183984|Growth Substances|growth substances|mesh-ancestor
83774039|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774040|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
83774041|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83774042|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774043|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774044|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
83774045|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83774046|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
83774047|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774048|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
83774049|NCT02967874|Protective Agents|protective agents|mesh-ancestor
83774050|NCT04733625|Vitamin D|vitamin d|mesh-list
83774051|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
83774052|NCT04733625|Vitamins|vitamins|mesh-ancestor
83774053|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
83774054|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774055|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83774056|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83774057|NCT00062686|Lapatinib|lapatinib|mesh-list
83774058|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774059|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83774060|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774061|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774062|NCT00062803|Heparin|heparin|mesh-list
83774063|NCT00062803|Warfarin|warfarin|mesh-list
83774064|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
83774065|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
83774066|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83774067|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83774068|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774069|NCT00062842|Irinotecan|irinotecan|mesh-list
83774070|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83774071|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83774072|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774073|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774074|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774075|NCT00062881|Mafosfamide|mafosfamide|mesh-list
83774076|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83774077|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
83774078|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774079|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774080|NCT00389909|Doxapram|doxapram|mesh-list
83774081|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83774082|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774083|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
83774084|NCT00063076|Bexarotene|bexarotene|mesh-list
82929252|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
82929261|NCT02185300|Dolutegravir|dolutegravir|mesh-list
83774085|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774086|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83774087|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83774088|NCT00063193|Minocycline|minocycline|mesh-list
83774089|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83774090|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774091|NCT00063310|Leuprolide|leuprolide|mesh-list
83774092|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83774093|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
83774094|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83774095|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774096|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83774097|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774098|NCT00063388|Cetuximab|cetuximab|mesh-list
83774099|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774100|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774101|NCT00063583|Pirfenidone|pirfenidone|mesh-list
83774102|NCT00063583|Analgesics|analgesics|mesh-ancestor
83774103|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
83774104|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774105|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774106|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774107|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774108|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774109|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774110|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774111|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83774112|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774113|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83774114|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774115|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774116|NCT00064012|Docetaxel|docetaxel|mesh-list
83774117|NCT00064012|Bortezomib|bortezomib|mesh-list
83774118|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774119|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
83774120|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83774121|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83774122|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774123|NCT00064051|Gemcitabine|gemcitabine|mesh-list
83774124|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774125|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
83774126|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774127|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774128|NCT02967172|Epinephrine|epinephrine|mesh-list
83774129|NCT02967172|Morphine|morphine|mesh-list
83774130|NCT02967172|Ropivacaine|ropivacaine|mesh-list
83774131|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83774132|NCT02967172|Narcotics|narcotics|mesh-ancestor
83774133|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83774134|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774135|NCT02967172|Analgesics|analgesics|mesh-ancestor
83774136|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
83774137|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774138|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
83774139|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
83774140|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83774141|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83774142|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
83774143|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774144|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774145|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83774146|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83774147|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
83774148|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83774149|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
83774150|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
83774151|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
83774152|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83774153|NCT00064090|Cytarabine|cytarabine|mesh-list
83774154|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774155|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
83774156|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774157|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774158|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
83774159|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774160|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774161|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
83774162|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774163|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
83774164|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774165|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774166|NCT05141357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83774167|NCT05141357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774168|NCT00064129|Ipilimumab|ipilimumab|mesh-list
83774169|NCT00064129|Sargramostim|sargramostim|mesh-list
83774170|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774171|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774172|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83774173|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774174|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
83774175|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774176|NCT00064207|Gemcitabine|gemcitabine|mesh-list
83774177|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774178|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
83774179|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774180|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774181|NCT00064246|Rituximab|rituximab|mesh-list
83774182|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83774183|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774184|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774185|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
83774186|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774187|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774188|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
83774189|NCT00064285|Alvocidib|alvocidib|mesh-list
83774190|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774191|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83774192|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774193|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774194|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
83774195|NCT00064285|Growth Substances|growth substances|mesh-ancestor
83774196|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774197|NCT00392418|Micronutrients|micronutrients|mesh-list
83774198|NCT00392418|Trace Elements|trace elements|mesh-list
83774199|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774200|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
83774201|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
83774202|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83774203|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83774204|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774205|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774206|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774207|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774208|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83774209|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
83774210|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83774211|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83774212|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
83774213|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774214|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774215|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83774216|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
83774217|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83774218|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83774219|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83774220|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
83774221|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774222|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774223|NCT00423748|Ambrisentan|ambrisentan|mesh-list
83774224|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83774225|NCT02967211|Insulin|insulin|mesh-list
83774226|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83774227|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
83774228|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
83774229|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
83774230|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
83774231|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
83774232|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83774233|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774234|NCT00064636|Bortezomib|bortezomib|mesh-list
83774235|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774236|NCT05113394|Immunomodulating Agents|immunomodulating agents|mesh-list
83774237|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
82929401|NCT02187562|Aspirin|aspirin|mesh-list
83774238|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774240|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774241|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
83774242|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774243|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774244|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
83774245|NCT00398749|Hematinics|hematinics|mesh-ancestor
83774246|NCT00398788|Hydromorphone|hydromorphone|mesh-list
83774247|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83774248|NCT00398788|Narcotics|narcotics|mesh-ancestor
83774249|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83774250|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774251|NCT00398788|Analgesics|analgesics|mesh-ancestor
83774252|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
83774253|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774254|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
83774255|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83774256|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83774257|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774258|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774259|NCT00398827|Analgesics|analgesics|mesh-ancestor
83774260|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
83774261|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774262|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83774263|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83774264|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83774265|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
83774266|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774267|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774268|NCT00065455|Vitamin A|vitamin a|mesh-list
83774269|NCT00065455|Vitamins|vitamins|mesh-ancestor
83774270|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
83774271|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774272|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
83774273|NCT04488081|Cyclosporine|cyclosporine|mesh-list
83774274|NCT04488081|Remdesivir|remdesivir|mesh-list
83774275|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
83774276|NCT04488081|Dexamethasone|dexamethasone|mesh-list
83774277|NCT04488081|Celecoxib|celecoxib|mesh-list
83774278|NCT04488081|Apremilast|apremilast|mesh-list
83774279|NCT04488081|Icatibant|icatibant|mesh-list
83774280|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
83774281|NCT04488081|Famotidine|famotidine|mesh-list
83774282|NCT04488081|Cyclosporins|cyclosporins|mesh-list
83774283|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774284|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
83774285|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
83774286|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774287|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774288|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83774289|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
83774290|NCT04488081|Hormones|hormones|mesh-ancestor
83774291|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774292|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83774293|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774294|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774295|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774296|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774297|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
83774298|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
83774299|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774300|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
83774301|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774302|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83774303|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774304|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774305|NCT04488081|Analgesics|analgesics|mesh-ancestor
83774306|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
83774307|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83774308|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83774309|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83774310|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83774311|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83774312|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83774313|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83774314|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
83774315|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
83774316|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774317|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
83774318|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
83774319|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
83774320|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83774321|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83774322|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
83774323|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83774324|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83774325|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83774326|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83774327|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83774328|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83774329|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83774330|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83774331|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83774332|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
83774333|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774334|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774335|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83774336|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83774337|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83774338|NCT00065884|Valproic Acid|valproic acid|mesh-list
83774339|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
83774340|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774341|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774342|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
83774343|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774344|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774345|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
83774346|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83774347|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83774348|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83774349|NCT00065923|Topiramate|topiramate|mesh-list
83774350|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
83774351|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83774352|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774353|NCT00065962|Secretin|secretin|mesh-list
83774354|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83774355|NCT00065962|Hormones|hormones|mesh-ancestor
83774356|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774357|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774358|NCT05083754|Temozolomide|temozolomide|mesh-list
83774359|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83774360|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
83774361|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774362|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774363|NCT00066001|Metronidazole|metronidazole|mesh-list
83774364|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133381|NCT02101567|Carbetocin|carbetocin|mesh-list
83774365|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83774366|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83774367|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83774368|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83774369|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83774370|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83774371|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
83774372|NCT00066157|Estradiol|estradiol|mesh-list
83774373|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83774374|NCT00066157|Estrogens|estrogens|mesh-list
83774375|NCT00066157|Progesterone|progesterone|mesh-list
83774376|NCT00066157|Hormones|hormones|mesh-ancestor
83774377|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774378|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774379|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83774380|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
83774381|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83774382|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83774383|NCT00066157|Progestins|progestins|mesh-ancestor
83774384|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83774385|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83774386|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83774387|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83774388|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82929552|NCT02188654|Metformin|metformin|mesh-list
83774389|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774390|NCT00066196|Dacarbazine|dacarbazine|mesh-list
83774391|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83774392|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
83774393|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774394|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774395|NCT00066274|Leucovorin|leucovorin|mesh-list
83774396|NCT00066274|Fluorouracil|fluorouracil|mesh-list
83774397|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
83774398|NCT00066274|Irinotecan|irinotecan|mesh-list
83774399|NCT00066274|Calcium|calcium|mesh-list
83774400|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
83774401|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83774402|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774403|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
83774404|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774405|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774406|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774407|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774408|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
83774409|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83774410|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83774411|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774412|NCT00066274|Antidotes|antidotes|mesh-ancestor
83774413|NCT00066274|Protective Agents|protective agents|mesh-ancestor
83774414|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
83774415|NCT00066274|Vitamins|vitamins|mesh-ancestor
83774416|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
83774417|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
83774418|NCT04401150|Vitamins|vitamins|mesh-ancestor
83774419|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
83774420|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774421|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
83774422|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774423|NCT04401150|Protective Agents|protective agents|mesh-ancestor
83774424|NCT05077280|Immunomodulating Agents|immunomodulating agents|mesh-list
83774425|NCT05077280|Immunologic Factors|immunologic factors|mesh-ancestor
83774426|NCT05077280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774427|NCT00066352|Bortezomib|bortezomib|mesh-list
83774428|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774429|NCT00066391|Irinotecan|irinotecan|mesh-list
83774430|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774431|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83774432|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83774433|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774434|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774435|NCT04388475|Temozolomide|temozolomide|mesh-list
83774436|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83774437|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
83774438|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774439|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774440|NCT00389987|Tazobactam|tazobactam|mesh-list
83774441|NCT00389987|Piperacillin|piperacillin|mesh-list
83774442|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774443|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83774444|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774445|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83774446|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774447|NCT00066508|Bortezomib|bortezomib|mesh-list
83774448|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774449|NCT00066547|Antibodies|antibodies|mesh-list
83774450|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83774451|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
83774452|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774453|NCT00066586|Exemestane|exemestane|mesh-list
83774454|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774455|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83774456|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83774457|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774458|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774459|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83774460|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
82929628|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83774461|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774462|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774463|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
83774464|NCT00066625|Bortezomib|bortezomib|mesh-list
83774465|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774466|NCT00066859|Sertraline|sertraline|mesh-list
83774467|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
83774468|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83774469|NCT00066859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83774470|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83774471|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83774472|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774473|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774474|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
83774475|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774476|NCT04235673|Melatonin|melatonin|mesh-list
83774477|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
83774478|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774479|NCT04235673|Protective Agents|protective agents|mesh-ancestor
83774480|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774481|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83774482|NCT00067015|Goserelin|goserelin|mesh-list
83774483|NCT00067015|Bicalutamide|bicalutamide|mesh-list
83774484|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83774485|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774486|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
83774487|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
83774488|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774489|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774490|NCT00067093|Vitamin K|vitamin k|mesh-list
83774491|NCT00067093|Heparin|heparin|mesh-list
83774492|NCT00067093|Calcium heparin|calcium heparin|mesh-list
83774493|NCT00067093|Idraparinux|idraparinux|mesh-list
83774494|NCT00067093|Vitamins|vitamins|mesh-ancestor
83774495|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
83774496|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774497|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
83774498|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83774499|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83774500|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774501|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83774502|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
83774503|NCT00067093|Coagulants|coagulants|mesh-ancestor
83774504|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83774505|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
83774506|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83774507|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
83774508|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774509|NCT00398905|Enoxaparin|enoxaparin|mesh-list
83774510|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
83774511|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83774512|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
83774513|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83774514|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
83774515|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774516|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774517|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
83774518|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83774519|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83774520|NCT00067405|Micronutrients|micronutrients|mesh-list
83774521|NCT00067405|Trace Elements|trace elements|mesh-list
83774522|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774523|NCT00067444|Paroxetine|paroxetine|mesh-list
83774524|NCT00067444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83774525|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83774526|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83774527|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774528|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774529|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
83774530|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774531|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83774532|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
83774533|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83774534|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83774535|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83774536|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774537|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83774538|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83774539|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83774540|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83774541|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774542|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774543|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774544|NCT00399022|Analgesics|analgesics|mesh-ancestor
83774545|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
83774546|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774547|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
83774548|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83774549|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
83774550|NCT00065533|Pemetrexed|pemetrexed|mesh-list
83774551|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774552|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774553|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774554|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83774555|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83774556|NCT02967094|Expectorants|expectorants|mesh-list
83774557|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
83774558|NCT00067561|Alosetron|alosetron|mesh-list
83774559|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83774560|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83774561|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
83774562|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774563|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774564|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774565|NCT00067600|Calcium|calcium|mesh-list
83774566|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83774567|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774568|NCT05010707|Spironolactone|spironolactone|mesh-list
83774569|NCT05010707|Hormones|hormones|mesh-list
83774570|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774571|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774572|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83774573|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
83774574|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83774575|NCT05010707|Diuretics|diuretics|mesh-ancestor
83774576|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
83774577|NCT00067756|Butyric Acid|butyric acid|mesh-list
83774578|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
83774579|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
83774580|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774581|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774582|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774583|NCT04091880|Vaccines|vaccines|mesh-list
83774584|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
83774585|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774586|NCT04999241|Infliximab|infliximab|mesh-list
83774587|NCT04999241|Mesalamine|mesalamine|mesh-list
83774588|NCT04999241|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83774589|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774590|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
83774591|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83774592|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774593|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774594|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774595|NCT04999241|Analgesics|analgesics|mesh-ancestor
83774596|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
83774597|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774598|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774599|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83774600|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83774601|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83774602|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83774603|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83774604|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774605|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774606|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774607|NCT00067912|Analgesics|analgesics|mesh-ancestor
83774608|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
83774609|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774610|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
83774611|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83774612|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
83774613|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83774614|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
83774615|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774616|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774617|NCT04074096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83774618|NCT04074096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774619|NCT00067951|Metformin|metformin|mesh-list
83774620|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
83774621|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83774622|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774623|NCT00392457|Ketoconazole|ketoconazole|mesh-list
83774624|NCT00392457|Hormones|hormones|mesh-list
83774625|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774626|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774627|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
83774628|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774629|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83774630|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83774631|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774632|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774633|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83774634|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
83774635|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83774636|NCT00068029|Octreotide|octreotide|mesh-list
83774637|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83774638|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83774639|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774640|NCT00068068|Talaporfin|talaporfin|mesh-list
83774641|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774642|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83774643|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
83774644|NCT00068302|Sirolimus|sirolimus|mesh-list
83774645|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83774646|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774647|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83774648|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774649|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
83774650|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774651|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
83774652|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774653|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
83774654|NCT00068458|Calcium|calcium|mesh-list
83774655|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83774656|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774657|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83774658|NCT00068497|Gefitinib|gefitinib|mesh-list
83774659|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774660|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83774661|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774662|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774663|NCT00068653|Celecoxib|celecoxib|mesh-list
83774664|NCT00068653|Gefitinib|gefitinib|mesh-list
83774665|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774666|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774667|NCT00068653|Analgesics|analgesics|mesh-ancestor
83774668|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
83774669|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774670|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774671|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774672|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774673|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83774674|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83774675|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774676|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774677|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774678|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83774679|NCT00068731|Lycopene|lycopene|mesh-list
83774680|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774681|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
83774682|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774683|NCT00068731|Protective Agents|protective agents|mesh-ancestor
83774684|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774685|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82929854|NCT02201914|Enclomiphene|enclomiphene|mesh-list
83774686|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83774687|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774688|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83774689|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
83774690|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774691|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
83774692|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
83774693|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83774694|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774695|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83774697|NCT00399061|Cyclosporins|cyclosporins|mesh-list
83774698|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774699|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774700|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774701|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
83774702|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774703|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
83774704|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774705|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
83774706|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774707|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83774708|NCT00069355|Propranolol|propranolol|mesh-list
83774709|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83774710|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83774711|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83774712|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774713|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774714|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774715|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83774716|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83774717|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
83774718|NCT04963712|Thymalfasin|thymalfasin|mesh-list
83774719|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83774720|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
83774721|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774722|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
83774723|NCT00069550|Donepezil|donepezil|mesh-list
83774724|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83774725|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774726|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774727|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
83774728|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774729|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774730|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
83774731|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
83774732|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
83774733|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83774734|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83774735|NCT02966587|Durvalumab|durvalumab|mesh-list
83774736|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
83774737|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83774738|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
83774739|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774740|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774741|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
83774742|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774743|NCT04958720|Immunomodulating Agents|immunomodulating agents|mesh-list
83774744|NCT04958720|Immunologic Factors|immunologic factors|mesh-ancestor
83774745|NCT04958720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774746|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83774747|NCT00069706|Latanoprost|latanoprost|mesh-list
83774748|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83774749|NCT00069901|Paclitaxel|paclitaxel|mesh-list
83774750|NCT00069901|Carboplatin|carboplatin|mesh-list
83774751|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83774752|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83774753|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774754|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
83774755|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83774756|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83774757|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929928|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929929|NCT03532906|Bupivacaine|bupivacaine|mesh-list
83774758|NCT00069940|Sargramostim|sargramostim|mesh-list
83774759|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
83774760|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774761|NCT00390026|Bevacizumab|bevacizumab|mesh-list
83774762|NCT00390026|Verteporfin|verteporfin|mesh-list
83774763|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774764|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774765|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83774766|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83774767|NCT00390026|Growth Substances|growth substances|mesh-ancestor
83774768|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774769|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
83774770|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83774771|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83774772|NCT00070057|Celecoxib|celecoxib|mesh-list
83774773|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774774|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774775|NCT00070057|Analgesics|analgesics|mesh-ancestor
83774776|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
83774777|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774778|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774779|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774780|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774781|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83774782|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83133400|NCT02407990|Tislelizumab|tislelizumab|mesh-list
83774783|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774784|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774785|NCT00070174|Cytarabine|cytarabine|mesh-list
83774786|NCT00070174|Cyclosporine|cyclosporine|mesh-list
83774787|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
83774788|NCT00070174|Busulfan|busulfan|mesh-list
83774789|NCT00070174|Methotrexate|methotrexate|mesh-list
83774790|NCT00070174|Etoposide|etoposide|mesh-list
83774791|NCT00070174|Daunorubicin|daunorubicin|mesh-list
83774792|NCT00070174|Asparaginase|asparaginase|mesh-list
83774793|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
83774794|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
83774795|NCT00070174|Cyclosporins|cyclosporins|mesh-list
83774796|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774797|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
83774798|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774799|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774800|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83774801|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
83774802|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774803|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774804|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83774805|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83774806|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
83774807|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83774808|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774809|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
83774810|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
83774811|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774812|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83774813|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83774814|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83774815|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83774816|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83774817|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
83774818|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83774819|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
83774820|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83774821|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83774822|NCT00070174|Analgesics|analgesics|mesh-ancestor
83774823|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
83774824|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774825|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774826|NCT00070174|Immunotoxins|immunotoxins|mesh-ancestor
83774827|NCT00070174|Immunoconjugates|immunoconjugates|mesh-ancestor
83774828|NCT00070213|Leucovorin|leucovorin|mesh-list
83774829|NCT00070213|Fluorouracil|fluorouracil|mesh-list
83774830|NCT00070213|Capecitabine|capecitabine|mesh-list
83774831|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
82930002|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774832|NCT00070213|Calcium|calcium|mesh-list
83774833|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
83774834|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83774835|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774836|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
83774837|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774838|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774839|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774840|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774841|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
83774842|NCT00070213|Antidotes|antidotes|mesh-ancestor
83774843|NCT00070213|Protective Agents|protective agents|mesh-ancestor
83774844|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
83774845|NCT00070213|Vitamins|vitamins|mesh-ancestor
83774846|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
83774847|NCT00070252|Docetaxel|docetaxel|mesh-list
83774848|NCT00070252|Capecitabine|capecitabine|mesh-list
83774849|NCT00070252|Tipifarnib|tipifarnib|mesh-list
83774850|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774851|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
83774852|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
83774853|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
83774854|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774855|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774856|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
83774857|NCT00070447|Prednisone|prednisone|mesh-list
83774858|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
83774859|NCT00070447|Rituximab|rituximab|mesh-list
83774860|NCT00070447|Doxorubicin|doxorubicin|mesh-list
83774861|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83774862|NCT00070447|Vincristine|vincristine|mesh-list
83774863|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774864|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
83774865|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774866|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774867|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83774868|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
83774869|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774870|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774871|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83774872|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83774873|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83774874|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83774875|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83774876|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774877|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774878|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
83774879|NCT00070447|Hormones|hormones|mesh-ancestor
83774880|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774881|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83774882|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83774883|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
83774884|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
83774885|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
83774886|NCT03959865|Glucagon|glucagon|mesh-list
83774887|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83774888|NCT03959865|Incretins|incretins|mesh-ancestor
83774889|NCT03959865|Hormones|hormones|mesh-ancestor
83774890|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774891|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774892|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83774893|NCT00070486|Celecoxib|celecoxib|mesh-list
83774894|NCT00070486|Zileuton|zileuton|mesh-list
83774895|NCT00070486|Carboplatin|carboplatin|mesh-list
83774896|NCT00070486|Gemcitabine|gemcitabine|mesh-list
83774897|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774898|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83774899|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
83774900|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774901|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83774902|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774903|NCT00070486|Analgesics|analgesics|mesh-ancestor
83774904|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
83774905|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774906|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774907|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774908|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83774909|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83774910|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82930074|NCT02221102|Edoxaban|edoxaban|mesh-list
83774911|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774912|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83774913|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83774914|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
83774915|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774916|NCT00070525|Tipifarnib|tipifarnib|mesh-list
83774917|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774918|NCT00070642|Dacarbazine|dacarbazine|mesh-list
83774919|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83774920|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
83774921|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774922|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774923|NCT00070759|Daclizumab|daclizumab|mesh-list
83774924|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774925|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
83774926|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774927|NCT00070837|Antibodies|antibodies|mesh-list
83774928|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83774929|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
83774930|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774931|NCT00071188|Paclitaxel|paclitaxel|mesh-list
83774932|NCT00071188|Carboplatin|carboplatin|mesh-list
83774933|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83774934|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83774935|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
83774936|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
83774937|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
83774938|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774939|NCT00071227|Triamcinolone|triamcinolone|mesh-list
83774940|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83774941|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83774942|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83774943|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83774944|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
83774945|NCT00071227|Hormones|hormones|mesh-ancestor
83774946|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83774947|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774948|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83774949|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
83774950|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774951|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774952|NCT00071266|Niacin|niacin|mesh-list
83774953|NCT00071266|Lovastatin|lovastatin|mesh-list
83774954|NCT00071266|L 647318|l 647318|mesh-list
83774955|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
83774956|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83774957|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
83774958|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774959|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83774960|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
83774961|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
83774962|NCT00071266|Vitamins|vitamins|mesh-ancestor
83774963|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
83774964|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774965|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83774966|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83774967|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83774968|NCT02966743|Midazolam|midazolam|mesh-list
83774969|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
83774970|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83774971|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83774972|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774973|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83774974|NCT02966743|Analgesics|analgesics|mesh-ancestor
83774975|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
83774976|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83774977|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83774978|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83774979|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83774980|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
83774981|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83774982|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83774983|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83774984|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83774985|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83774986|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83774987|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83774988|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
83774990|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
83774991|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
83774992|NCT00071539|Immunotoxins|immunotoxins|mesh-list
83774993|NCT00071539|Immunoconjugates|immunoconjugates|mesh-ancestor
83774994|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
83774995|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83774996|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83774997|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83774998|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83774999|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83775000|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83775001|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775002|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775003|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775004|NCT00071695|Analgesics|analgesics|mesh-ancestor
83775005|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
83775006|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775007|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
83775008|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83775009|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
83775010|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83775011|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
83775012|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775013|NCT00071968|Sirolimus|sirolimus|mesh-list
83775014|NCT00071968|Temsirolimus|temsirolimus|mesh-list
83775015|NCT00071968|MTOR Inhibitors|mtor inhibitors|mesh-list
83775016|NCT00071968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83775017|NCT00071968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775018|NCT00071968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775019|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775020|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
83775021|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775022|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775023|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83775024|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775025|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775026|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
83775027|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
83775028|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83775029|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
83775030|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775031|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775032|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83775033|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
83775034|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83775035|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
83775036|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775037|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775038|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83775039|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
83775040|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
83775041|NCT00390065|Protective Agents|protective agents|mesh-ancestor
83775042|NCT00072007|Prednisone|prednisone|mesh-list
83775043|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
83775044|NCT00072007|Rituximab|rituximab|mesh-list
83775045|NCT00072007|Doxorubicin|doxorubicin|mesh-list
83775046|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83775047|NCT00072007|Vincristine|vincristine|mesh-list
83775048|NCT00072007|Cladribine|cladribine|mesh-list
83775049|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775050|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
83775051|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775052|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775053|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775054|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
83775055|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775056|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775057|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83775058|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775059|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775060|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83775061|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82930224|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775062|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775063|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775064|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
83775065|NCT00072007|Hormones|hormones|mesh-ancestor
83775066|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83775067|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83775068|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83775069|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775070|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775071|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775072|NCT00072046|Interferons|interferons|mesh-list
83775073|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
83775074|NCT00072046|Bevacizumab|bevacizumab|mesh-list
83775075|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775076|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775077|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83775078|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83775079|NCT00072046|Growth Substances|growth substances|mesh-ancestor
83775080|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775081|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
83775082|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
83775083|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775084|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
83775085|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
83775086|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83775087|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775088|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
83775089|NCT04730596|Ketamine|ketamine|mesh-list
83775090|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83775091|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83775092|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775093|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83775094|NCT04730596|Analgesics|analgesics|mesh-ancestor
83775095|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
83775096|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775097|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83775098|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83775099|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83775100|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83775101|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775102|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775103|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83775104|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83775105|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
83775106|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
83775107|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83775108|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83775109|NCT00072085|Aldesleukin|aldesleukin|mesh-list
83775110|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
83775111|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775112|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83775113|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83775114|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
83775115|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775116|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83775117|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
83775118|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775119|NCT04730674|Tetracycline|tetracycline|mesh-list
83775120|NCT04730674|Lidocaine|lidocaine|mesh-list
83775121|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
83775122|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
83775123|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83775124|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775125|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
83775126|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775127|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83775128|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83775129|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83775130|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83775131|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775132|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82930297|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82930298|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
82930299|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
82930300|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775133|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775134|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83775136|NCT03959436|Carbetocin|carbetocin|mesh-list
83775137|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
83775138|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83775139|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775140|NCT00072124|Dacarbazine|dacarbazine|mesh-list
83775141|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775142|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775143|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
83775144|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775145|NCT00072163|Thalidomide|thalidomide|mesh-list
83775146|NCT00072163|Temozolomide|temozolomide|mesh-list
83775147|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775148|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
83775149|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775150|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775151|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775152|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
83775153|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775154|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
83775155|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83775156|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775157|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83775158|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83775159|NCT00072163|Growth Substances|growth substances|mesh-ancestor
83775160|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
83775161|NCT00072319|Paclitaxel|paclitaxel|mesh-list
83775162|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
83775163|NCT00072319|Epirubicin|epirubicin|mesh-list
83775164|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83775165|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775166|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775167|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775168|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775169|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775170|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775171|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
83775172|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775173|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775174|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775175|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
83775176|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83775177|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775178|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83775179|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775180|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775181|NCT03959397|Paclitaxel|paclitaxel|mesh-list
83775182|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83775183|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83775184|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775185|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775186|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775187|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775188|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775189|NCT00072436|Gemcitabine|gemcitabine|mesh-list
83775190|NCT00072436|Alvocidib|alvocidib|mesh-list
83775191|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775192|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
83775193|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775194|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775195|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
83775196|NCT00072436|Growth Substances|growth substances|mesh-ancestor
83775197|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775198|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83775199|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775200|NCT00072553|Leucovorin|leucovorin|mesh-list
83775201|NCT00072553|Celecoxib|celecoxib|mesh-list
83775202|NCT00072553|Fluorouracil|fluorouracil|mesh-list
83775203|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
83775204|NCT00072553|Calcium|calcium|mesh-list
83775205|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
83775206|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83775207|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775208|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
82930367|NCT02258620|Isosorbide|isosorbide|mesh-list
83775209|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775210|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775211|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775212|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775213|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
83775215|NCT00072553|Protective Agents|protective agents|mesh-ancestor
83775216|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
83775217|NCT00072553|Vitamins|vitamins|mesh-ancestor
83775218|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
83775219|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83775220|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83775221|NCT00072553|Analgesics|analgesics|mesh-ancestor
83775222|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
83775223|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775224|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775225|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775226|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83775227|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83775228|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775229|NCT00072592|Rituximab|rituximab|mesh-list
83775230|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775231|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775232|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
83775233|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775234|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775235|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83775236|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775237|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83775238|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775239|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775240|NCT00072670|Trabectedin|trabectedin|mesh-list
83775241|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775242|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
83775243|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775244|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775245|NCT03959358|Lenalidomide|lenalidomide|mesh-list
83775246|NCT03959358|Pomalidomide|pomalidomide|mesh-list
83775247|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
83775248|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775249|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83775250|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83775251|NCT03959358|Growth Substances|growth substances|mesh-ancestor
83775252|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
83775253|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775254|NCT02966704|Caseins|caseins|mesh-list
83775255|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
83775256|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
83775257|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775258|NCT00072748|EKB 569|ekb 569|mesh-list
83775259|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775260|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83775261|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775262|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775263|NCT00072787|Cisplatin|cisplatin|mesh-list
83775264|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775265|NCT00072826|Acetylcholine|acetylcholine|mesh-list
83775266|NCT00072826|Oxypurinol|oxypurinol|mesh-list
83775267|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
83775268|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83775269|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
83775270|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775271|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775272|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775273|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775274|NCT00072865|Carboplatin|carboplatin|mesh-list
83775275|NCT00072865|Pemetrexed|pemetrexed|mesh-list
83775276|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775277|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775278|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775279|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83775280|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83775281|NCT00072904|Repaglinide|repaglinide|mesh-list
83775282|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82930445|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83775283|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775284|NCT00072943|Interferons|interferons|mesh-list
83775285|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
83775286|NCT00072943|Antibodies|antibodies|mesh-list
83775287|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83775288|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
83775289|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775290|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775291|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
83775292|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775293|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
83775294|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775295|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775296|NCT04834349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83775297|NCT04834349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775298|NCT00072982|Borage oil|borage oil|mesh-list
83775299|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775300|NCT03959124|Memantine|memantine|mesh-list
83775301|NCT03959124|Rivastigmine|rivastigmine|mesh-list
83775302|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83775303|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83775304|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
83775305|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775306|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775307|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775308|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83775309|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83775310|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83775311|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775312|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
83775313|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83775314|NCT03959124|Protective Agents|protective agents|mesh-ancestor
83775315|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
83775316|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83775317|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83775318|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775319|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
83775320|NCT02966236|Coagulants|coagulants|mesh-ancestor
83775321|NCT04827953|Paclitaxel|paclitaxel|mesh-list
83775322|NCT04827953|Gemcitabine|gemcitabine|mesh-list
83775323|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83775324|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775325|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775326|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775327|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775328|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775329|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775330|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
83775331|NCT04711291|Tacrolimus|tacrolimus|mesh-list
83775332|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775333|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
83775334|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775335|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83775336|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775337|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775338|NCT00073372|Abciximab|abciximab|mesh-list
83775339|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
83775340|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83775341|NCT04821830|Levodopa|levodopa|mesh-list
83775342|NCT04821830|Carbidopa|carbidopa|mesh-list
83775343|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83775344|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83775345|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83775346|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
83775347|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775348|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775349|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775350|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83775351|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775352|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83775353|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
83775354|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
83775355|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83775356|NCT00073411|Escitalopram|escitalopram|mesh-list
83775357|NCT00073411|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82930519|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
83775358|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83775359|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83775360|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775361|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775362|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
83775363|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775364|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775365|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
83775366|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83775367|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83775368|NCT00073411|Analgesics|analgesics|mesh-ancestor
83775369|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
83775370|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
83775371|NCT02966041|Ondansetron|ondansetron|mesh-list
83775372|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
83775373|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
83775374|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775375|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775376|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775377|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
83775378|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
83775379|NCT02966041|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83775380|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83775381|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
83775382|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775383|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775384|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83775385|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775386|NCT00073840|Albuterol|albuterol|mesh-list
83775387|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83775388|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
83775389|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775390|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775391|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83775392|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
83775393|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
83775394|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83775395|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83775396|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83775397|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83775398|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
83775399|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775400|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775401|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
83775402|NCT00073879|Fludarabine|fludarabine|mesh-list
83775403|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
83775404|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
83775405|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775406|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
83775407|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775408|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775409|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775410|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
83775411|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775412|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775413|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83775414|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775415|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
83775416|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775417|NCT00074074|Infliximab|infliximab|mesh-list
83775418|NCT00074074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83775419|NCT00074074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775420|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
83775421|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775422|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775423|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83775424|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83775425|NCT00392652|Protective Agents|protective agents|mesh-ancestor
83775426|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775427|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775428|NCT00074191|Cytarabine|cytarabine|mesh-list
83775429|NCT00074191|Dexamethasone|dexamethasone|mesh-list
83775430|NCT00074191|Methotrexate|methotrexate|mesh-list
82930592|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82930594|NCT00099359|Lamivudine|lamivudine|mesh-list
83775431|NCT00074191|Lomustine|lomustine|mesh-list
83775432|NCT00074191|Procarbazine|procarbazine|mesh-list
83775433|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775434|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
83775435|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
83775436|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775437|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775438|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775439|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
83775440|NCT00074191|Hormones|hormones|mesh-ancestor
83775441|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83775442|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83775443|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775444|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83775445|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
83775446|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83775447|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775448|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
83775449|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775450|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83775451|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775452|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83775453|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775454|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
83775455|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775456|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83775457|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
83775458|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775459|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775460|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
83775461|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
83775462|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83775463|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
83775464|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775465|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775466|NCT00392691|Rituximab|rituximab|mesh-list
83775467|NCT00392691|Melphalan|melphalan|mesh-list
83775468|NCT00392691|Vinorelbine|vinorelbine|mesh-list
83775469|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775470|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775471|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
83775472|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775473|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775474|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775475|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
83775476|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775477|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83775478|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775479|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83775480|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775481|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775482|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775483|NCT02966080|Heparin|heparin|mesh-list
83775484|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
83775485|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83775486|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83775487|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775488|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
83775489|NCT04767776|Charcoal|charcoal|mesh-list
83775490|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83775491|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
83775492|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83775493|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
83775494|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775495|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775496|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
83775497|NCT04767776|Antidotes|antidotes|mesh-ancestor
83775498|NCT04767776|Protective Agents|protective agents|mesh-ancestor
83775499|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775500|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
83775501|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775502|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775503|NCT04754321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83775504|NCT04754321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930673|NCT00090857|Letrozole|letrozole|mesh-list
83775506|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83775507|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775508|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775509|NCT00074620|Hirudins|hirudins|mesh-list
83775510|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
83775511|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83775512|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
83775513|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775514|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775515|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
83775516|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83775517|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83775518|NCT02972333|Osimertinib|osimertinib|mesh-list
83775519|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775520|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83775521|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775522|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775523|NCT00074737|Cytarabine|cytarabine|mesh-list
83775524|NCT00074737|Idarubicin|idarubicin|mesh-list
83775525|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775526|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
83775527|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775528|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775529|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
83775530|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775531|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775532|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
83775533|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775534|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775535|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83775536|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775537|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775538|NCT00074776|Lamotrigine|lamotrigine|mesh-list
83775539|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83775540|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775541|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83775542|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83775543|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775544|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
83775545|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83775546|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83775547|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83775548|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83775549|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83775550|NCT00075010|Decitabine|decitabine|mesh-list
83775551|NCT00075010|Valproic Acid|valproic acid|mesh-list
83775552|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775553|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
83775554|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775555|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775556|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775557|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
83775558|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
83775559|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775560|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775561|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
83775562|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83775563|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83775564|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83775565|NCT04729595|Tempol|tempol|mesh-list
83775566|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
83775567|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775568|NCT04729595|Protective Agents|protective agents|mesh-ancestor
83775569|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775570|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83775571|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775572|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83775573|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83775574|NCT00075205|Rimonabant|rimonabant|mesh-list
83775575|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83775576|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83775577|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82930741|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83775578|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775579|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775581|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83775582|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775583|NCT00075439|Gefitinib|gefitinib|mesh-list
83775584|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775585|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83775586|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775587|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775588|NCT00075517|Gemcitabine|gemcitabine|mesh-list
83775589|NCT00075517|Docetaxel|docetaxel|mesh-list
83775590|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775591|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
83775592|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775593|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775594|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775595|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775596|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775597|NCT00075556|Capecitabine|capecitabine|mesh-list
83775598|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775599|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
83775600|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775601|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775602|NCT00075595|Leucovorin|leucovorin|mesh-list
83775603|NCT00075595|Fluorouracil|fluorouracil|mesh-list
83775604|NCT00075595|Irinotecan|irinotecan|mesh-list
83775605|NCT00075595|Calcium|calcium|mesh-list
83775606|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
83775607|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83775608|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775609|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
83775610|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775611|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775612|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775613|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775614|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
83775615|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83775616|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775617|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775618|NCT00075595|Antidotes|antidotes|mesh-ancestor
83775619|NCT00075595|Protective Agents|protective agents|mesh-ancestor
83775620|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
83775621|NCT00075595|Vitamins|vitamins|mesh-ancestor
83775622|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
83775623|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
83775624|NCT00075634|Doxorubicin|doxorubicin|mesh-list
83775625|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83775626|NCT00075634|Decitabine|decitabine|mesh-list
83775627|NCT00075634|Azacitidine|azacitidine|mesh-list
83775628|NCT00075634|Lenograstim|lenograstim|mesh-list
83775629|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775630|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
83775631|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775632|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775633|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775634|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
83775635|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775636|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775637|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83775638|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775639|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83775640|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775641|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775642|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83775643|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775644|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
83775645|NCT00075673|Celecoxib|celecoxib|mesh-list
83775646|NCT00075673|Vinorelbine|vinorelbine|mesh-list
83775647|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83775648|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83775649|NCT00075673|Analgesics|analgesics|mesh-ancestor
83775650|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
83775651|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775652|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775653|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775654|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775655|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83775656|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83775657|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775658|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775659|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83775660|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775661|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775662|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775663|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775664|NCT00075712|Paclitaxel|paclitaxel|mesh-list
83775665|NCT00075712|Carboplatin|carboplatin|mesh-list
83775666|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83775667|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775668|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775669|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775670|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775671|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775672|NCT03958500|Methylene Blue|methylene blue|mesh-list
83775673|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775674|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775675|NCT00075751|Carboplatin|carboplatin|mesh-list
83775676|NCT00075751|Gemcitabine|gemcitabine|mesh-list
83775677|NCT00075751|Bortezomib|bortezomib|mesh-list
83775678|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775679|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775680|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
83775681|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775682|NCT00075868|Octreotide|octreotide|mesh-list
83775683|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775684|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83775685|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775686|NCT00075907|Ritonavir|ritonavir|mesh-list
83775687|NCT00075907|Lopinavir|lopinavir|mesh-list
83775688|NCT00075907|Efavirenz|efavirenz|mesh-list
83775689|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83775690|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83775691|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
83775692|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775693|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775694|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83775695|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83775696|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
83775697|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775698|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83775699|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83775700|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83775701|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83775702|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83775703|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83775704|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83775705|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83775706|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83775707|NCT03958383|Nivolumab|nivolumab|mesh-list
83775708|NCT03958383|Ipilimumab|ipilimumab|mesh-list
83775709|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775710|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775711|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83775712|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775713|NCT00076414|Acetylcholine|acetylcholine|mesh-list
83775714|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
83775715|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83775716|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
83775717|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83775718|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775719|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775720|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
83775721|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83775722|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
83775723|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775724|NCT00399256|Expectorants|expectorants|mesh-ancestor
83775725|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83775726|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83775727|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
83834930|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930918|NCT01085981|Niacin|niacin|mesh-list
83775728|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775729|NCT00399256|Protective Agents|protective agents|mesh-ancestor
83775730|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775731|NCT00399256|Antidotes|antidotes|mesh-ancestor
83775732|NCT00399295|Naltrexone|naltrexone|mesh-list
83775733|NCT00399295|Hydromorphone|hydromorphone|mesh-list
83775734|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
83775735|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83775736|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775737|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
83775738|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775739|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83775740|NCT00399295|Narcotics|narcotics|mesh-ancestor
83775741|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83775742|NCT00399295|Analgesics|analgesics|mesh-ancestor
83775743|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
83775744|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83775745|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83775746|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775747|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83775748|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
83775749|NCT00076492|Vitamins|vitamins|mesh-ancestor
83775750|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
83775751|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775752|NCT00076531|Leuprolide|leuprolide|mesh-list
83775753|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83775754|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
83775755|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83775756|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775757|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83775758|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775759|NCT00076609|Capecitabine|capecitabine|mesh-list
83775760|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775761|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
83775762|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775763|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775764|NCT00076726|Infliximab|infliximab|mesh-list
83775765|NCT00076726|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83775766|NCT00076726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775767|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
83775768|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775769|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775770|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83775771|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775772|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775773|NCT00077077|Capecitabine|capecitabine|mesh-list
83775774|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775775|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
83775776|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775777|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775778|NCT00077116|Cytarabine|cytarabine|mesh-list
83775779|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
83775780|NCT00077116|Busulfan|busulfan|mesh-list
83775781|NCT00077116|Idarubicin|idarubicin|mesh-list
83775782|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
83775783|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775784|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
83775785|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775786|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775787|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83775788|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
83775789|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775790|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775791|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83775792|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775793|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
83775794|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
83775795|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775796|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775797|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83775798|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775799|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775800|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775801|NCT00077116|Immunotoxins|immunotoxins|mesh-ancestor
83775802|NCT00077116|Immunoconjugates|immunoconjugates|mesh-ancestor
83775803|NCT03951207|Amlodipine|amlodipine|mesh-list
83775804|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83775805|NCT03951207|Atorvastatin|atorvastatin|mesh-list
83775806|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83775807|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83775808|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
83775809|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775810|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83775811|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83775812|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775813|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83775814|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83775815|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83775816|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83775817|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775818|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
83775819|NCT00077194|Romidepsin|romidepsin|mesh-list
83775820|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775821|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775822|NCT00077194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83775823|NCT00077194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775824|NCT00077194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775825|NCT00077233|Leucovorin|leucovorin|mesh-list
83775826|NCT00077233|Fluorouracil|fluorouracil|mesh-list
83775827|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
83775828|NCT00077233|Irinotecan|irinotecan|mesh-list
83775829|NCT00077233|Cetuximab|cetuximab|mesh-list
83775830|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775831|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
83775832|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775833|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775834|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775835|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775836|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
83775837|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83775838|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775839|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775840|NCT00077233|Antidotes|antidotes|mesh-ancestor
83775841|NCT00077233|Protective Agents|protective agents|mesh-ancestor
83775842|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
83775843|NCT00077233|Vitamins|vitamins|mesh-ancestor
83775844|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
83775845|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775846|NCT02958631|Losartan|losartan|mesh-list
83775847|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83775848|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83775849|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83775850|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83775851|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775852|NCT00077311|Docetaxel|docetaxel|mesh-list
83775853|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
83775854|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
83775855|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775856|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
83775857|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83775858|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
83775859|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775860|NCT00077311|Hematinics|hematinics|mesh-ancestor
83775861|NCT00077311|Protective Agents|protective agents|mesh-ancestor
83775862|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775863|NCT00077350|Gemcitabine|gemcitabine|mesh-list
83775864|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83775865|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
83775866|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775867|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775868|NCT00077389|Carboplatin|carboplatin|mesh-list
83775869|NCT00077389|Doxorubicin|doxorubicin|mesh-list
83775870|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83775871|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775872|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775873|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83775874|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775875|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775876|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775877|NCT00077428|Doxorubicin|doxorubicin|mesh-list
83775878|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82931046|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775879|NCT00077428|Bortezomib|bortezomib|mesh-list
83775880|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83775881|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775882|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83775883|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83775884|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775885|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775886|NCT00077467|Bortezomib|bortezomib|mesh-list
83775887|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775888|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
83775889|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775890|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775891|NCT03832569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83775892|NCT03832569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775893|NCT04551482|Oxytocin|oxytocin|mesh-list
83775894|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
83775895|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83775896|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775897|NCT00077545|Cisplatin|cisplatin|mesh-list
83775898|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775899|NCT00077584|Bosentan|bosentan|mesh-list
83775900|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83775901|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83775902|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775903|NCT00077779|Adalimumab|adalimumab|mesh-list
83775904|NCT00077779|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83775905|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775906|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775907|NCT00077818|Enoxaparin|enoxaparin|mesh-list
83775908|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
83775909|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
83775910|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83775911|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83775912|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775913|NCT00078130|Buprenorphine|buprenorphine|mesh-list
83775914|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83775915|NCT00078130|Naloxone|naloxone|mesh-list
83775916|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83775917|NCT00078130|Narcotics|narcotics|mesh-ancestor
83775918|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83775919|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775920|NCT00078130|Analgesics|analgesics|mesh-ancestor
83775921|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
83775922|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775923|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83775924|NCT00399451|Polidocanol|polidocanol|mesh-list
83775925|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83775926|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83775927|NCT04711213|Dexamethasone|dexamethasone|mesh-list
83775928|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
83775929|NCT04711213|BB 1101|bb 1101|mesh-list
83775930|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775931|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
83775932|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
83775933|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775934|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775935|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775936|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
83775937|NCT04711213|Hormones|hormones|mesh-ancestor
83775938|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83775939|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83775940|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775941|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
83775942|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775943|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775944|NCT00078247|Lamivudine|lamivudine|mesh-list
83775945|NCT00078247|Zidovudine|zidovudine|mesh-list
83775946|NCT00078247|Abacavir|abacavir|mesh-list
83775947|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83775948|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83775949|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775950|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775951|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
83775952|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775953|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83775954|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83775955|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
83775956|NCT00078442|Interferons|interferons|mesh-list
83775957|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
83775958|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
83775959|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83775960|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775961|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
83775962|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83775963|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
83775964|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775965|NCT00078481|Idebenone|idebenone|mesh-list
83775966|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
83775967|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775968|NCT00078481|Protective Agents|protective agents|mesh-ancestor
83775969|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775970|NCT00078598|Rituximab|rituximab|mesh-list
83775971|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
83775972|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83775973|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775974|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
83775975|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775976|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775977|NCT00078793|Etanercept|etanercept|mesh-list
83775978|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83775979|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83775980|NCT00078793|Analgesics|analgesics|mesh-ancestor
83775981|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
83775982|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83775983|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83775984|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83775985|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83775986|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83775987|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83775988|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
83775989|NCT00078832|Anastrozole|anastrozole|mesh-list
83775990|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83775991|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83775992|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83775993|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83775994|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83775995|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83775996|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83775997|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
83775998|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83775999|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776000|NCT01350128|Bromides|bromides|mesh-list
83776001|NCT01350128|Ipratropium|ipratropium|mesh-list
83776002|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
83776003|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83776004|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
83776005|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776006|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776007|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83776008|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
83776009|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83776010|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
83776011|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776012|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776013|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
83776014|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776015|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83776016|NCT00078910|Protective Agents|protective agents|mesh-ancestor
83776017|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776018|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83776019|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776020|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776021|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83776022|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83776023|NCT00078910|Analgesics|analgesics|mesh-ancestor
83776024|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
83776025|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776026|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776027|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776028|NCT00078988|Carboplatin|carboplatin|mesh-list
82931195|NCT01337674|Metoprolol|metoprolol|mesh-list
83776029|NCT00078988|Etoposide|etoposide|mesh-list
83776030|NCT00078988|Thiotepa|thiotepa|mesh-list
83776031|NCT00078988|Isotretinoin|isotretinoin|mesh-list
83776032|NCT00078988|Lenograstim|lenograstim|mesh-list
83776033|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776034|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83776035|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776036|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776037|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776038|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776039|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83776040|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
83776041|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776042|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776043|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
83776044|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776045|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776046|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
83776047|NCT00079027|Doxorubicin|doxorubicin|mesh-list
83776048|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83776049|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83776050|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776051|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776052|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776053|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776054|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776055|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
83776056|NCT03655002|Nivolumab|nivolumab|mesh-list
83776057|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776058|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
83776059|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776060|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776061|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776062|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
83776063|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776064|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776065|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776066|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83776067|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83776068|NCT00079105|Prednisolone|prednisolone|mesh-list
83776069|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
83776070|NCT00079105|Etoposide|etoposide|mesh-list
83776071|NCT00079105|Vincristine|vincristine|mesh-list
83776072|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
83776073|NCT00079105|Bleomycin|bleomycin|mesh-list
83776074|NCT00079105|Vinblastine|vinblastine|mesh-list
83776075|NCT00079105|Procarbazine|procarbazine|mesh-list
83776076|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
83776077|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776078|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
83776079|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776080|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776081|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776082|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
83776083|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776084|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776085|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776086|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83776087|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776088|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776089|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776090|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776091|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776092|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776093|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776094|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
83776095|NCT00079105|Hormones|hormones|mesh-ancestor
83776096|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776097|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776098|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776099|NCT00079105|Analgesics|analgesics|mesh-ancestor
83776100|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
83776101|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83776102|NCT03647124|Lenalidomide|lenalidomide|mesh-list
83776103|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
83776104|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776105|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82931286|NCT02235532|Fluorides|fluorides|mesh-list
83776106|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83776107|NCT03647124|Growth Substances|growth substances|mesh-ancestor
83776108|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
83776109|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776110|NCT00079144|Aldesleukin|aldesleukin|mesh-list
83776111|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
83776112|NCT00079144|Fludarabine|fludarabine|mesh-list
83776113|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
83776114|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
83776115|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776116|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
83776117|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776118|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776119|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776120|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
83776121|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776122|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776123|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776124|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83776125|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
83776126|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83776127|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83776128|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83776129|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
83776130|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776131|NCT00079222|Itraconazole|itraconazole|mesh-list
83776132|NCT00079222|Voriconazole|voriconazole|mesh-list
83776133|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
83776134|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776135|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83776136|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83776137|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776138|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776139|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83776140|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
83776141|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776142|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776143|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83776144|NCT00079261|Prednisone|prednisone|mesh-list
83776145|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
83776146|NCT00079261|Gemcitabine|gemcitabine|mesh-list
83776147|NCT00079261|Doxorubicin|doxorubicin|mesh-list
83776148|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83776149|NCT00079261|Vincristine|vincristine|mesh-list
83776150|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776151|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
83776152|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776153|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776154|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776155|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
83776156|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776157|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776158|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776159|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83776160|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
83776161|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83776162|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776163|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776164|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776165|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776166|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
83776167|NCT00079261|Hormones|hormones|mesh-ancestor
83776168|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776169|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776170|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83776171|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776172|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776173|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776174|NCT00079300|Imiquimod|imiquimod|mesh-list
83776175|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83776176|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
83776177|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776178|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931342|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82931364|NCT01094015|Lidocaine|lidocaine|mesh-list
83776179|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
83776180|NCT00079378|Decitabine|decitabine|mesh-list
83776181|NCT00079378|Azacitidine|azacitidine|mesh-list
83776182|NCT00079378|Valproic Acid|valproic acid|mesh-list
83776183|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83776184|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
83776185|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776186|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776187|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776188|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
83776189|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
83776190|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776191|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776192|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
83776193|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83776194|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776195|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83776196|NCT00079456|Sirolimus|sirolimus|mesh-list
83776197|NCT00079456|Temsirolimus|temsirolimus|mesh-list
83776198|NCT00079456|MTOR Inhibitors|mtor inhibitors|mesh-list
83776199|NCT00079456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83776200|NCT00079456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776201|NCT00079456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776202|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776203|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
83776204|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776205|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776206|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776207|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776208|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83776209|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
83776210|NCT04467086|Propranolol|propranolol|mesh-list
83776211|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83776212|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83776213|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
83776214|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776215|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776216|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776217|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83776218|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83776219|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
83776220|NCT00079612|Sorafenib|sorafenib|mesh-list
83776221|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776222|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83776223|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776224|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776225|NCT03526107|Theobromine|theobromine|mesh-list
83776226|NCT03526107|Caffeine|caffeine|mesh-list
83776227|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83776228|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776229|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83776230|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776231|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776232|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83776233|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83776234|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
83776235|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776236|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83776237|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
83776238|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776239|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83776240|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
83776241|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
83776242|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
83776243|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83776244|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776245|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
83776246|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
83776247|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776248|NCT00079807|Protective Agents|protective agents|mesh-ancestor
83776249|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776250|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
83776251|NCT00079807|Vitamins|vitamins|mesh-ancestor
83776252|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
83776253|NCT00079885|Tigecycline|tigecycline|mesh-list
83776254|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776255|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776256|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83776257|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776258|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776259|NCT00079924|Teriparatide|teriparatide|mesh-list
83776260|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83776261|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83776262|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776263|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83776264|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83776265|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
83776266|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776267|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83776268|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83776269|NCT00079963|Vitamins|vitamins|mesh-list
83776270|NCT00079963|Vitamin E|vitamin e|mesh-list
83776271|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
83776272|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776273|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
83776274|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776275|NCT00079963|Protective Agents|protective agents|mesh-ancestor
83776276|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
83776277|NCT00392886|Temozolomide|temozolomide|mesh-list
83776278|NCT00392886|Thiotepa|thiotepa|mesh-list
83776279|NCT00392886|Carboplatin|carboplatin|mesh-list
83776280|NCT00392886|Methotrexate|methotrexate|mesh-list
83776281|NCT00392886|Etoposide|etoposide|mesh-list
83776282|NCT00392886|Vincristine|vincristine|mesh-list
83776283|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776284|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
83776285|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776286|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776287|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776288|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
83776289|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776290|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776291|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776292|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83776293|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
83776294|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83776295|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83776296|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
83776297|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
83776298|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776299|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83776300|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83776301|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83776302|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776303|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776304|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776305|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776306|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776307|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
83776308|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776309|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83776310|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
83776311|NCT00080080|Docetaxel|docetaxel|mesh-list
83776312|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776313|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776314|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776315|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776316|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776317|NCT00080158|Mirtazapine|mirtazapine|mesh-list
83776318|NCT00080158|Citalopram|citalopram|mesh-list
83776319|NCT00080158|Bupropion|bupropion|mesh-list
83776320|NCT00080158|Fluoxetine|fluoxetine|mesh-list
83776321|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83776322|NCT00080158|Sertraline|sertraline|mesh-list
83776323|NCT00080158|Escitalopram|escitalopram|mesh-list
83776324|NCT00080158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83776325|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83776326|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83776327|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776328|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931490|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
83776329|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
83776330|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776331|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83776332|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
83776333|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83776334|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83776335|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
83776336|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83776337|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83776338|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776339|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83776340|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776341|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83776342|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83776343|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
83776344|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
83776345|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83776346|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83776347|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83776348|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83776349|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83776350|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83776351|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83776352|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83776353|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83776354|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776355|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83776356|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776357|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776358|NCT00080275|Niacin|niacin|mesh-list
83776359|NCT00080275|Simvastatin|simvastatin|mesh-list
83776360|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83776361|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83776362|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
83776363|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776364|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83776365|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83776366|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776367|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
83776368|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
83776369|NCT00080275|Vitamins|vitamins|mesh-ancestor
83776370|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
83776371|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776372|NCT00393003|Anesthetics|anesthetics|mesh-list
83776373|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776374|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776375|NCT00080314|Aripiprazole|aripiprazole|mesh-list
83776376|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
83776377|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83776378|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83776379|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83776380|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776381|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776382|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
83776383|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
83776384|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776385|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776386|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83776387|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83776388|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
83776389|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83776390|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83776391|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83776392|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83776393|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83776394|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83776395|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
83776396|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776397|NCT00080431|Daclizumab|daclizumab|mesh-list
83776398|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776399|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
83776400|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776401|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
83776402|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776403|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776404|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776405|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776406|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776407|NCT03506373|Ixazomib|ixazomib|mesh-list
83776408|NCT03506373|Glycine|glycine|mesh-list
83776409|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776410|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776411|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
83776412|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776413|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
83776414|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776415|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776416|NCT02972411|Acetazolamide|acetazolamide|mesh-list
83776417|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
83776418|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83776419|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776420|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776421|NCT02972411|Diuretics|diuretics|mesh-ancestor
83776422|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
83776423|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776424|NCT00080626|Docetaxel|docetaxel|mesh-list
83776425|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776426|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776427|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776428|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776429|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776430|NCT00080665|Docetaxel|docetaxel|mesh-list
83776431|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
83776432|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776433|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776434|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776435|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776436|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776437|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83776438|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776439|NCT00080743|Tamoxifen|tamoxifen|mesh-list
83776440|NCT00080743|Gefitinib|gefitinib|mesh-list
83776441|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776442|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83776443|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
83776444|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776445|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776446|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776447|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776448|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83776449|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83776450|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83776451|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83776452|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776453|NCT04423367|Dexamethasone|dexamethasone|mesh-list
83776454|NCT04423367|Bortezomib|bortezomib|mesh-list
83776455|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776456|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
83776457|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
83776458|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776459|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776460|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83776461|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
83776462|NCT04423367|Hormones|hormones|mesh-ancestor
83776463|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776464|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776465|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776466|NCT00080782|Celecoxib|celecoxib|mesh-list
83776467|NCT00080782|Doxorubicin|doxorubicin|mesh-list
83776468|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83776469|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83776470|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776471|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776472|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776473|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776474|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776475|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83776476|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83776477|NCT00080782|Analgesics|analgesics|mesh-ancestor
83776478|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
83776479|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776480|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776481|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776482|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776483|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83776484|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83776485|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83776486|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83776487|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776488|NCT00080977|Aldesleukin|aldesleukin|mesh-list
83776489|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776490|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83776491|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83776492|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
83776493|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776494|NCT00081055|Cyclosporine|cyclosporine|mesh-list
83776495|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
83776496|NCT00081055|Busulfan|busulfan|mesh-list
83776497|NCT00081055|Methotrexate|methotrexate|mesh-list
83776498|NCT00081055|Cyclosporins|cyclosporins|mesh-list
83776499|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776500|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
83776501|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776502|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776503|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776504|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
83776505|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776506|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776507|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776508|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83776509|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
83776510|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83776511|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83776512|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
83776513|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
83776514|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776515|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83776516|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83776517|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
83776518|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776519|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83776520|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82931717|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82931718|NCT00064337|Growth Substances|growth substances|mesh-ancestor
82931719|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
82931750|NCT01096121|Enalapril|enalapril|mesh-list
82931751|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82931752|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
82931753|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931754|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931755|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82931756|NCT00064259|Fluorouracil|fluorouracil|mesh-list
82931757|NCT00064259|Oblimersen|oblimersen|mesh-list
82931758|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931759|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
82931760|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931761|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82931762|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931763|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
82931764|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931765|NCT03954197|Hormones|hormones|mesh-list
82931766|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931767|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931768|NCT00044213|Vitamins|vitamins|mesh-list
82931769|NCT00044213|Edetic Acid|edetic acid|mesh-list
82931770|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
82931771|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
82931772|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931773|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
82931774|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82931775|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
82931776|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
82931777|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776521|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83776522|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776523|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
83776524|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
83776525|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776526|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83776527|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776528|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776529|NCT00081172|Antibodies|antibodies|mesh-list
83776530|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83776531|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
83776532|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776533|NCT03187080|Bupivacaine|bupivacaine|mesh-list
83776534|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
83776535|NCT03187080|Anesthetics|anesthetics|mesh-list
83776536|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776537|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776538|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
83776539|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776540|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
83776541|NCT00081484|Hematinics|hematinics|mesh-ancestor
83776542|NCT00390260|Acetaminophen|acetaminophen|mesh-list
83776543|NCT00390260|Rofecoxib|rofecoxib|mesh-list
83776544|NCT00390260|Hydrocodone|hydrocodone|mesh-list
83776545|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83776546|NCT00390260|Analgesics|analgesics|mesh-ancestor
83776547|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
83776548|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776549|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776550|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
83776551|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776552|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
83776553|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83776554|NCT00390260|Narcotics|narcotics|mesh-ancestor
83776555|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776556|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
83776557|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83776558|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83776559|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776560|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83776561|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776562|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776563|NCT00081757|Thalidomide|thalidomide|mesh-list
83776564|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776565|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
83776566|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776567|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
83776568|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776569|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776570|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83776571|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83776572|NCT00081757|Growth Substances|growth substances|mesh-ancestor
83776573|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83776574|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776575|NCT00081796|Capecitabine|capecitabine|mesh-list
83776576|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83776577|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
83776578|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776579|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776580|NCT03152175|Propranolol|propranolol|mesh-list
83776581|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83776582|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83776583|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
83776584|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776585|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776586|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776587|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83776588|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83776589|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
83776590|NCT00399685|Efavirenz|efavirenz|mesh-list
83776591|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
83776592|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83776593|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83776594|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83776595|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776596|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776597|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
83776598|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776599|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83776600|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83776601|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83776602|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83776603|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83776604|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83776605|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776606|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776607|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776608|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776609|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83776610|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
83776611|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83776612|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776613|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83776614|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83776615|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83776616|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
83776617|NCT00081835|Antibodies|antibodies|mesh-list
83776618|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
83776619|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83776620|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83776621|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
83776622|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776623|NCT00081874|Everolimus|everolimus|mesh-list
83776624|NCT00081874|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83776625|NCT00081874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83776626|NCT00081874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776627|NCT00081874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776628|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776629|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
83776630|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776631|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776632|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83776633|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83776634|NCT03152097|Protective Agents|protective agents|mesh-ancestor
83776635|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776636|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776637|NCT00082186|Bosentan|bosentan|mesh-list
83776638|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83776639|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83776640|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776641|NCT00082225|Antibodies|antibodies|mesh-list
83776642|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
83776643|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776644|NCT00082537|Caspofungin|caspofungin|mesh-list
83776645|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83776646|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
83776647|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776648|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776649|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776650|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83776651|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83776652|NCT00082576|Azithromycin|azithromycin|mesh-list
83776653|NCT00082576|Chloroquine|chloroquine|mesh-list
83776654|NCT00082576|Mefloquine|mefloquine|mesh-list
83776655|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776656|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776657|NCT00082576|Amebicides|amebicides|mesh-ancestor
83776658|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83776659|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83776660|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
83776661|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776662|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
83776663|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83776664|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776665|NCT00082966|Bortezomib|bortezomib|mesh-list
83776666|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776667|NCT00083005|Thalidomide|thalidomide|mesh-list
83776668|NCT00083005|Docetaxel|docetaxel|mesh-list
83776669|NCT00083005|Estramustine|estramustine|mesh-list
83776670|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776671|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776672|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776673|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776674|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776675|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776676|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
83776677|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776678|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
83776679|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776680|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776681|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83776682|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83776683|NCT00083005|Growth Substances|growth substances|mesh-ancestor
83776684|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
83776685|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776686|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
83776687|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776689|NCT00083083|Etoposide|etoposide|mesh-list
83776690|NCT00083083|Vinorelbine|vinorelbine|mesh-list
83776691|NCT00083083|Vinblastine|vinblastine|mesh-list
83776692|NCT00083083|Docetaxel|docetaxel|mesh-list
83776693|NCT00083083|Carboplatin|carboplatin|mesh-list
83776694|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83776695|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83776696|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776697|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776698|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776699|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776700|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776701|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776702|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776703|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776704|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83776705|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
83776706|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
83776707|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83776708|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776709|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776710|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83776711|NCT03151863|Analgesics|analgesics|mesh-ancestor
83776712|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
83776713|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776714|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83776715|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83776716|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83776717|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83776718|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776719|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776720|NCT03151863|Narcotics|narcotics|mesh-ancestor
83776721|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
83776722|NCT00083161|Etoposide|etoposide|mesh-list
83776723|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776724|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
83776725|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776726|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776727|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776728|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
83776729|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776730|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776731|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776732|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83776733|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776734|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776735|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776736|NCT00083278|Ipilimumab|ipilimumab|mesh-list
83776737|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83776738|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776739|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83776740|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776741|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
83776742|NCT00083434|Hematinics|hematinics|mesh-ancestor
82931938|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
83776743|NCT00083590|Huperzine A|huperzine a|mesh-list
83776744|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83776745|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776746|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776747|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
83776748|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776749|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776750|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83776751|NCT00083590|Protective Agents|protective agents|mesh-ancestor
83776752|NCT03151746|Gabapentin|gabapentin|mesh-list
83776753|NCT03151746|Analgesics|analgesics|mesh-ancestor
83776754|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
83776755|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776756|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776757|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
83776758|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83776759|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83776760|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776761|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83133416|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83776762|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83776763|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83776764|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776765|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776766|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
83776767|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
83776768|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83776769|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776770|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83776771|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83776772|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83776773|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776774|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776775|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83776776|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83776777|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83776778|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
83776779|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776780|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776781|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83776782|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83776783|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
83776784|NCT00083707|Thalidomide|thalidomide|mesh-list
83776785|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776786|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
83776787|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776788|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
83776789|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776790|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776791|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83776792|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83776793|NCT00083707|Growth Substances|growth substances|mesh-ancestor
83776794|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83776795|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776796|NCT00083785|Talaporfin|talaporfin|mesh-list
83776797|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776798|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83776799|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83776800|NCT03151707|Niacinamide|niacinamide|mesh-list
83776801|NCT03151707|Niacin|niacin|mesh-list
83776802|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
83776803|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
83776804|NCT03151707|Vitamins|vitamins|mesh-ancestor
83776805|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
83776806|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776807|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83776808|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
83776809|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776810|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83776811|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
83776812|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
83776813|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83776814|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776815|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776816|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83776817|NCT03151668|Analgesics|analgesics|mesh-ancestor
83776818|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
83776819|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834931|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932015|NCT02263690|Lidocaine|lidocaine|mesh-list
83776820|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83776821|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83776822|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83776823|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
83776824|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776825|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776827|NCT05568082|Sotorasib|sotorasib|mesh-list
83776828|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
83776829|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776830|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83776831|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83776832|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776833|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776834|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83776835|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
83776836|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776837|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776838|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83776839|NCT05568082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83776840|NCT05568082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83776841|NCT05568082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776842|NCT05567653|Sulfalene|sulfalene|mesh-list
83776843|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776844|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83776845|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
83776846|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83776847|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83776848|NCT04733508|Exenatide|exenatide|mesh-list
83776849|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83776850|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776851|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83776852|NCT04733508|Incretins|incretins|mesh-ancestor
83776853|NCT04733508|Hormones|hormones|mesh-ancestor
83776854|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776855|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83776856|NCT00135304|Vitamin D|vitamin d|mesh-list
83776857|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83776858|NCT00135304|Cinacalcet|cinacalcet|mesh-list
83776859|NCT00135304|Vitamins|vitamins|mesh-ancestor
83776860|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
83776861|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776862|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83776863|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83776864|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83776865|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
83776866|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776867|NCT00135499|Prednisone|prednisone|mesh-list
83776868|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
83776869|NCT00135499|Rituximab|rituximab|mesh-list
83776870|NCT00135499|Doxorubicin|doxorubicin|mesh-list
83776871|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83776872|NCT00135499|Vincristine|vincristine|mesh-list
83776873|NCT00135499|Bleomycin|bleomycin|mesh-list
83776874|NCT00135499|Vindesine|vindesine|mesh-list
83776875|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776876|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
83776877|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776878|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776879|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83776880|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
83776881|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776882|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776883|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83776884|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83776885|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83776886|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83776887|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83776888|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776889|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776890|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
83776891|NCT00135499|Hormones|hormones|mesh-ancestor
83776892|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932087|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776893|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776894|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83776895|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83776896|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83776897|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83776898|NCT03151434|Hydromorphone|hydromorphone|mesh-list
83776899|NCT03151434|Bupivacaine|bupivacaine|mesh-list
83776900|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
83776901|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
83776902|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83776903|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776904|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
83776905|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776906|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83776907|NCT03151434|Narcotics|narcotics|mesh-ancestor
83776908|NCT03151434|Analgesics|analgesics|mesh-ancestor
83776909|NCT00135577|Alvimopan|alvimopan|mesh-list
83776910|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83776911|NCT00135733|Alefacept|alefacept|mesh-list
83776912|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
83776913|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
83776914|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776915|NCT04061798|Heparin|heparin|mesh-list
83776916|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
83776917|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83776918|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83776919|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776920|NCT00135811|Cyclosporine|cyclosporine|mesh-list
83776921|NCT00135811|Dexamethasone|dexamethasone|mesh-list
83776922|NCT00135811|Cyclosporins|cyclosporins|mesh-list
83776923|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776924|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
83776925|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
83776926|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776927|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776928|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83776929|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
83776930|NCT00135811|Hormones|hormones|mesh-ancestor
83776931|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776932|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776933|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776934|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776935|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776936|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83776937|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
83776938|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
83776939|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776940|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83776941|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776942|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83776943|NCT00135928|Lenograstim|lenograstim|mesh-list
83776944|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83776945|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
83776946|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776947|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
83776948|NCT00135967|Prednisone|prednisone|mesh-list
83776949|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
83776950|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83776951|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83776952|NCT00135967|Prednisolone|prednisolone|mesh-list
83776953|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
83776954|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83776955|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
83776956|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83776957|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
83776958|NCT00135967|Hormones|hormones|mesh-ancestor
83776959|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83776960|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776961|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83776962|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776963|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83776964|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83776965|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
82932159|NCT01516918|Ribavirin|ribavirin|mesh-list
83776966|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932165|NCT01508026|Valsartan|valsartan|mesh-list
83776967|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776968|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776969|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776970|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
83776971|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
83776972|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83776973|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83776974|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83776975|NCT00135967|Protective Agents|protective agents|mesh-ancestor
83776976|NCT00136045|Rotigotine|rotigotine|mesh-list
83776977|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
83776978|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
83776979|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83776980|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776981|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776982|NCT00136201|Tigecycline|tigecycline|mesh-list
83776983|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83776984|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83776985|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83776986|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83776987|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83776988|NCT03151239|Niacinamide|niacinamide|mesh-list
83776989|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
83776990|NCT03151239|Vitamins|vitamins|mesh-ancestor
83776991|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
83776992|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776993|NCT00136396|Rituximab|rituximab|mesh-list
83776994|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83776995|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83776996|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
83776997|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83776998|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83776999|NCT00136474|Amifostine|amifostine|mesh-list
83777000|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83777001|NCT00136474|Protective Agents|protective agents|mesh-ancestor
83777002|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777003|NCT00136552|Rituximab|rituximab|mesh-list
83777004|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777005|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777006|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
83777007|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777008|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777009|NCT00136591|Bortezomib|bortezomib|mesh-list
83777010|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777011|NCT03151161|Carboplatin|carboplatin|mesh-list
83777012|NCT03151161|Pemetrexed|pemetrexed|mesh-list
83777013|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777014|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777015|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777016|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83777017|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83777018|NCT00404053|Clopidogrel|clopidogrel|mesh-list
83777019|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83777020|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83777021|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83777022|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83777023|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
83777024|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777025|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777026|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777027|NCT03991130|Nivolumab|nivolumab|mesh-list
83777028|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777029|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777030|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83777031|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777032|NCT00136747|Memantine|memantine|mesh-list
83777033|NCT00136747|Bupropion|bupropion|mesh-list
83777034|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83777035|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
83777036|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777037|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83777038|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83777039|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777040|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777041|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
83777042|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777043|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777044|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83777045|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83777046|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777047|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83777048|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83777049|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83777050|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83777051|NCT00136786|Memantine|memantine|mesh-list
83777052|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83777053|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83777054|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
83777055|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777056|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777057|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777058|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83777059|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83777060|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
83777061|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83777062|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
83777063|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777064|NCT00136825|Expectorants|expectorants|mesh-ancestor
83777065|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
83777066|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83777067|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
83777068|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777069|NCT00136825|Protective Agents|protective agents|mesh-ancestor
83777070|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777071|NCT00136825|Antidotes|antidotes|mesh-ancestor
83777072|NCT00393198|Misoprostol|misoprostol|mesh-list
83777073|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
83777074|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83777075|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
83777076|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83777077|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777078|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83777079|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83777080|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83777081|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83777082|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
83777083|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83777084|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83777085|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
83777086|NCT03968822|Lidocaine|lidocaine|mesh-list
83777087|NCT03968822|Bupivacaine|bupivacaine|mesh-list
83777088|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83777089|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
83777090|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
83777091|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777092|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777093|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
83777094|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777095|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83777096|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83777097|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83777098|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777099|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777100|NCT00136942|Atorvastatin|atorvastatin|mesh-list
83777101|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83777102|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83777103|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
83777104|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777105|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83777106|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83777107|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777108|NCT00136981|Atorvastatin|atorvastatin|mesh-list
83777109|NCT00136981|Torcetrapib|torcetrapib|mesh-list
83777110|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83777111|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83777112|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
83777113|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777114|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83777115|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83777116|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777118|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83777119|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
83777120|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777121|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777122|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777123|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83777124|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83777125|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777126|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777127|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83777128|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
83777129|NCT00137059|Acetaminophen|acetaminophen|mesh-list
83777130|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83777131|NCT00137059|Analgesics|analgesics|mesh-ancestor
83777132|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
83777133|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777134|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777135|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
83777136|NCT00137098|Caffeine|caffeine|mesh-list
83777137|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83777138|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777139|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83777140|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777141|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777142|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83777143|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83777144|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
83777145|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777146|NCT00137254|Insulin|insulin|mesh-list
83777147|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83777148|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777149|NCT03151044|Rituximab|rituximab|mesh-list
83777150|NCT03151044|Epirubicin|epirubicin|mesh-list
83777151|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777152|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777153|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
83777154|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777155|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777156|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83777157|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83777158|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83777159|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777160|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777161|NCT00137410|Celecoxib|celecoxib|mesh-list
83777162|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83777163|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83777164|NCT00137410|Analgesics|analgesics|mesh-ancestor
83777165|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
83777166|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777167|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777168|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83777169|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777170|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83777171|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83777172|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777173|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777174|NCT03151005|Metformin|metformin|mesh-list
83777175|NCT03151005|Liraglutide|liraglutide|mesh-list
83777176|NCT03151005|Exenatide|exenatide|mesh-list
83777177|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
83777178|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
83777179|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83777180|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777181|NCT03151005|Incretins|incretins|mesh-ancestor
83777182|NCT03151005|Hormones|hormones|mesh-ancestor
83777183|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777184|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83777185|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83777186|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83777187|NCT00137527|Anesthetics|anesthetics|mesh-list
83777188|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777189|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777190|NCT00137566|Acetaminophen|acetaminophen|mesh-list
82932388|NCT03953729|Analgesics|analgesics|mesh-ancestor
83777191|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83777192|NCT00137566|Analgesics|analgesics|mesh-ancestor
83777193|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
83777194|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777195|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777196|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
83777197|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83777198|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
83777199|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777200|NCT00137761|Docetaxel|docetaxel|mesh-list
83777201|NCT00137761|Gefitinib|gefitinib|mesh-list
83777202|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777203|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777204|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777205|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777206|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777207|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83777208|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777209|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83777210|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777211|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83777212|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777213|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777214|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
83777215|NCT02858921|Trametinib|trametinib|mesh-list
83777216|NCT02858921|Dabrafenib|dabrafenib|mesh-list
83777217|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777218|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777219|NCT02858921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83777220|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777221|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83777222|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777223|NCT00137995|Cytarabine|cytarabine|mesh-list
83777224|NCT00137995|Dexamethasone|dexamethasone|mesh-list
83777225|NCT00137995|Rituximab|rituximab|mesh-list
83777226|NCT00137995|Etoposide|etoposide|mesh-list
83777227|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
83777228|NCT00137995|Melphalan|melphalan|mesh-list
83777229|NCT00137995|Ifosfamide|ifosfamide|mesh-list
83777230|NCT00137995|Carboplatin|carboplatin|mesh-list
83777231|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777232|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777233|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
83777234|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777235|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777236|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83777237|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
83777238|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
83777239|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777240|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83777241|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
83777242|NCT00137995|Hormones|hormones|mesh-ancestor
83777243|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777244|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83777245|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83777246|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83777247|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83777248|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777249|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777250|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83777251|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
83777252|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
83777253|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777254|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777255|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83777256|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
83777257|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83777258|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
83777259|NCT00138112|Vancomycin|vancomycin|mesh-list
83777260|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777261|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932463|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
83777262|NCT00138229|Aldesleukin|aldesleukin|mesh-list
83777263|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
83777264|NCT00138229|Fludarabine|fludarabine|mesh-list
83777265|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
83777266|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777267|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
83777268|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777269|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777270|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83777271|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
83777272|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777273|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777274|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83777275|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83777276|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
83777277|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83777278|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83777279|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
83777280|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777281|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83777282|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83777283|NCT02826161|Paclitaxel|paclitaxel|mesh-list
83777284|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83777285|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777286|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777287|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777288|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777289|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777290|NCT00138541|Vildagliptin|vildagliptin|mesh-list
83777291|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83777292|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777293|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83777294|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
83777295|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777296|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777297|NCT00138580|Vildagliptin|vildagliptin|mesh-list
83777298|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83777299|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777300|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83777301|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
83777302|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777303|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777304|NCT03150771|Aripiprazole|aripiprazole|mesh-list
83777305|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
83777306|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777307|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83777308|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83777309|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777310|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777311|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
83777312|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
83777313|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777314|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777315|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83777316|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83777317|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
83777318|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83777319|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83777320|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83777321|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83777322|NCT00138619|Vildagliptin|vildagliptin|mesh-list
83777323|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83777324|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777325|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83777326|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
83777327|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777328|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777329|NCT03150732|Nalbuphine|nalbuphine|mesh-list
83777330|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83777331|NCT03150732|Narcotics|narcotics|mesh-ancestor
83777332|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932535|NCT01076764|Calcium heparin|calcium heparin|mesh-list
82932536|NCT01076764|Otamixaban|otamixaban|mesh-list
82932537|NCT01076764|Eptifibatide|eptifibatide|mesh-list
82932538|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
82932539|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82932540|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82932541|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932543|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83777333|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777334|NCT03150732|Analgesics|analgesics|mesh-ancestor
83777335|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
83777336|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777337|NCT03893825|Risperidone|risperidone|mesh-list
83777338|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83777339|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
83777340|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777341|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777342|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777343|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83777344|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83777345|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777346|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777347|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83777348|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
83777349|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
83777350|NCT00138970|Cyclosporine|cyclosporine|mesh-list
83777351|NCT00138970|Prednisolone|prednisolone|mesh-list
83777352|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83777353|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
83777354|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83777355|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
83777356|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83777357|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
83777358|NCT00138970|Daclizumab|daclizumab|mesh-list
83777359|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83777360|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
83777361|NCT00138970|Hormones|hormones|mesh-ancestor
83777362|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777363|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777364|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83777365|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777366|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
83777367|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
83777368|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777369|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83777370|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83777371|NCT00138970|Protective Agents|protective agents|mesh-ancestor
83777372|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83777373|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83777374|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
83777375|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777376|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777377|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777378|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777379|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
83777380|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
83777381|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777382|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
83777383|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777384|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83777385|NCT00139009|Cyclosporine|cyclosporine|mesh-list
83777386|NCT00139009|Cyclosporins|cyclosporins|mesh-list
83777387|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508120|NCT03019887|Analgesics|analgesics|mesh-ancestor
83777388|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777389|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777390|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
83777391|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777392|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
83777393|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777394|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83777395|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777396|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83777397|NCT03890666|Albuterol|albuterol|mesh-list
83777398|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83777399|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
83777400|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777401|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777402|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83777403|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
83777404|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
83777405|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83777406|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83777407|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83777408|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83777409|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
83777410|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777411|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777412|NCT00139165|Budesonide|budesonide|mesh-list
83777413|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83777414|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83777415|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
83777416|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777417|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777418|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83777419|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
83777420|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
83777421|NCT00139165|Hormones|hormones|mesh-ancestor
83777422|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777423|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
83777424|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83777425|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777426|NCT00139243|Leucovorin|leucovorin|mesh-list
83777427|NCT00139243|Fluorouracil|fluorouracil|mesh-list
83777428|NCT00139243|Docetaxel|docetaxel|mesh-list
83777429|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777430|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
83777431|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777432|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83777433|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777434|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
83777435|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777436|NCT00139243|Antidotes|antidotes|mesh-ancestor
83777437|NCT00139243|Protective Agents|protective agents|mesh-ancestor
83777438|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
83777439|NCT00139243|Vitamins|vitamins|mesh-ancestor
83777440|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
83777441|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777442|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777443|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777444|NCT00139282|Squalamine|squalamine|mesh-list
83777445|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777446|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777447|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83777448|NCT00139282|Protective Agents|protective agents|mesh-ancestor
83777449|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777450|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777451|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83777452|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83777453|NCT00139282|Growth Substances|growth substances|mesh-ancestor
83777454|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
83777455|NCT03861767|Metformin|metformin|mesh-list
83777456|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83777457|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777458|NCT00139360|Bevacizumab|bevacizumab|mesh-list
83777459|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777460|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777461|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83777462|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83777463|NCT00139360|Growth Substances|growth substances|mesh-ancestor
83777464|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777465|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
83777466|NCT00139516|Nicotine|nicotine|mesh-list
83777467|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83777468|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
83777469|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777470|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777471|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83777472|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83777473|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83777474|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777475|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777476|NCT00139555|Amlodipine|amlodipine|mesh-list
83777477|NCT00139555|Benazepril|benazepril|mesh-list
83777478|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83777479|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83777480|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777481|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777482|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83777483|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777484|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
83777485|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83777486|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
83777487|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777488|NCT03844412|Lidocaine|lidocaine|mesh-list
83777489|NCT03844412|Nortriptyline|nortriptyline|mesh-list
83777490|NCT03844412|Estradiol|estradiol|mesh-list
83777491|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
83777492|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
83777493|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777494|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777495|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
83777496|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777497|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83777498|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83777499|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83777500|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777501|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777502|NCT03844412|Estrogens|estrogens|mesh-ancestor
83777503|NCT03844412|Hormones|hormones|mesh-ancestor
83777504|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777505|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83777506|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
83777507|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777508|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83777509|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83777510|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
83777511|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777512|NCT00139633|Carboplatin|carboplatin|mesh-list
83777513|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777514|NCT00139711|Docetaxel|docetaxel|mesh-list
83777515|NCT00139711|Irinotecan|irinotecan|mesh-list
83777516|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777517|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777518|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777519|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777520|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777521|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83777522|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83777523|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777524|NCT03837977|Leucovorin|leucovorin|mesh-list
83777525|NCT03837977|Folic Acid|folic acid|mesh-list
83777526|NCT03837977|Docetaxel|docetaxel|mesh-list
83777527|NCT03837977|Fluorouracil|fluorouracil|mesh-list
83777528|NCT03837977|Irinotecan|irinotecan|mesh-list
83777529|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
83777530|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777531|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777532|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777533|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777534|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777535|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
83777536|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83777537|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777538|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
83777539|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777540|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83777541|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83777542|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777543|NCT03837977|Antidotes|antidotes|mesh-ancestor
83777544|NCT03837977|Protective Agents|protective agents|mesh-ancestor
83777545|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
83777546|NCT03837977|Vitamins|vitamins|mesh-ancestor
83777547|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
83777548|NCT03837977|Hematinics|hematinics|mesh-ancestor
83777549|NCT00404326|Hydralazine|hydralazine|mesh-list
83777550|NCT00404326|Valproic Acid|valproic acid|mesh-list
83777551|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
83777552|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777553|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777554|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
83777555|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777556|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777557|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
83777558|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83777559|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777560|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777561|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83777562|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
83777564|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83777565|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83777566|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
83777567|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777568|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777569|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777570|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83777571|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83777572|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
83777573|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777574|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83777575|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83777576|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
83777577|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
83777578|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777579|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777580|NCT03150459|Rifaximin|rifaximin|mesh-list
83777581|NCT03150459|Simvastatin|simvastatin|mesh-list
83777582|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83777583|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83777584|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
83777585|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777586|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83777587|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83777588|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777589|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777590|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777591|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83777592|NCT00140023|Azithromycin|azithromycin|mesh-list
83777593|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777594|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777595|NCT00140062|Latanoprost|latanoprost|mesh-list
83777596|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83777597|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83777598|NCT00140101|Paclitaxel|paclitaxel|mesh-list
83777599|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83777600|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777601|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777602|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777603|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777604|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777605|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
83777606|NCT03150420|Antidotes|antidotes|mesh-ancestor
83777607|NCT03150420|Protective Agents|protective agents|mesh-ancestor
83777608|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777609|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
83777610|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777611|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
83777612|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777613|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777614|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
83777615|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
83777616|NCT00140218|Pramipexole|pramipexole|mesh-list
83777617|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
83777618|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777619|NCT00140218|Protective Agents|protective agents|mesh-ancestor
83777620|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777621|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83777622|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83777623|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
83777624|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
83777625|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777626|NCT00140257|Escitalopram|escitalopram|mesh-list
83777627|NCT00140257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83777628|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83777629|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777630|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777631|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777632|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
83777633|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777634|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
83777635|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83777636|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777637|NCT00140374|Immunomodulating Agents|immunomodulating agents|mesh-list
83777638|NCT00140374|Immunologic Factors|immunologic factors|mesh-ancestor
83777639|NCT00140374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777640|NCT00140452|Thalidomide|thalidomide|mesh-list
83777641|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777642|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
83777643|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777644|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
83777645|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777646|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777647|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83777648|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83777649|NCT00140452|Growth Substances|growth substances|mesh-ancestor
83777650|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
83777651|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777652|NCT00140530|Sirolimus|sirolimus|mesh-list
83777653|NCT00140530|Paclitaxel|paclitaxel|mesh-list
83777654|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83777655|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777656|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777657|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777658|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777659|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777660|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777661|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777662|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83777663|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
83777664|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777665|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
83777666|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777667|NCT00140569|Interferons|interferons|mesh-list
83777668|NCT00140569|Fludarabine|fludarabine|mesh-list
83777669|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777670|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
83777671|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777672|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
83777673|NCT00140647|Ramipril|ramipril|mesh-list
83777674|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83777675|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777676|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83777677|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
83777678|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777679|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777680|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83777681|NCT00140725|Interferons|interferons|mesh-list
83777682|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
83777683|NCT00140725|Lamivudine|lamivudine|mesh-list
83777684|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
83777685|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777686|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
83777687|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777688|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
83777689|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777690|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83777691|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83777692|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777693|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777694|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83777695|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83777696|NCT00140764|Metronidazole|metronidazole|mesh-list
83777697|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777698|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83777699|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83777700|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83777701|NCT00138736|Lectins|lectins|mesh-list
83777702|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
83777703|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
83777704|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777705|NCT00138736|Coagulants|coagulants|mesh-ancestor
83777706|NCT00140920|Diclofenac|diclofenac|mesh-list
83777707|NCT00140920|Rofecoxib|rofecoxib|mesh-list
83777708|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83777709|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83777710|NCT00140920|Analgesics|analgesics|mesh-ancestor
83777711|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
82932907|NCT00906334|ON 01910|on 01910|mesh-list
83777712|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777713|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777714|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83777715|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777716|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83777717|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777718|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777719|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83777720|NCT03136497|Rituximab|rituximab|mesh-list
83777721|NCT03136497|Venetoclax|venetoclax|mesh-list
83777722|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777723|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777724|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
83777725|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777726|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777727|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83777728|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83777729|NCT00140998|Estradiol|estradiol|mesh-list
83777730|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83777731|NCT00140998|Estrogens|estrogens|mesh-ancestor
83777732|NCT00140998|Hormones|hormones|mesh-ancestor
83777733|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777734|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777735|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83777736|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
83777737|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83777738|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83777739|NCT00141154|Celecoxib|celecoxib|mesh-list
83777740|NCT00141154|Loxoprofen|loxoprofen|mesh-list
83777741|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83777742|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83777743|NCT00141154|Analgesics|analgesics|mesh-ancestor
83777744|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
83777745|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777746|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777747|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83777748|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777749|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83777750|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83777751|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777752|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777753|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
83777754|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777755|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777756|NCT03709706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83777757|NCT03709706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777758|NCT00141193|Celecoxib|celecoxib|mesh-list
83777759|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83777760|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83777761|NCT00141193|Analgesics|analgesics|mesh-ancestor
83777762|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
83777763|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777764|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777765|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83777766|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777767|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83777768|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83777769|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777770|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777771|NCT00141232|Atorvastatin|atorvastatin|mesh-list
83777772|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83777773|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83777774|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
83777775|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777776|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83777777|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83777778|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777779|NCT02315534|Temozolomide|temozolomide|mesh-list
83777780|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83777781|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
83777782|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777783|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777784|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
83777785|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777786|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
83777787|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83777788|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83777789|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777790|NCT00141310|Urological Agents|urological agents|mesh-ancestor
83777791|NCT00141388|Pregabalin|pregabalin|mesh-list
83777792|NCT00141388|Analgesics|analgesics|mesh-ancestor
83777793|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
83777794|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777795|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777796|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
83777797|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83777798|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777799|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777800|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83777801|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83777802|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83777803|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777804|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777805|NCT00404404|Paclitaxel|paclitaxel|mesh-list
83777806|NCT00404404|Bevacizumab|bevacizumab|mesh-list
83777807|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83777808|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83777809|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777810|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
83777811|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
83777812|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
83777813|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777814|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777815|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83777816|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83777817|NCT00404404|Growth Substances|growth substances|mesh-ancestor
83777818|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777819|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
83777820|NCT00404482|Cyclosporine|cyclosporine|mesh-list
83777821|NCT00404482|Cyclosporins|cyclosporins|mesh-list
83777822|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777823|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777824|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83777825|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
83777826|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777827|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
83777828|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777829|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
83777830|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777831|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83777832|NCT03073941|Cimetidine|cimetidine|mesh-list
83777833|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83777834|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83777835|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83777836|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
83777837|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
83777838|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777839|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777840|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777841|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83777842|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83777843|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777844|NCT00141427|Pregabalin|pregabalin|mesh-list
83777845|NCT00141427|Analgesics|analgesics|mesh-ancestor
83777846|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
83777847|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777848|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777849|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
83777850|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83777851|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777852|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777853|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83777854|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83777855|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83777856|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83777857|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83777858|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
83777859|NCT00141544|Estrogens|estrogens|mesh-list
83777860|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
83777861|NCT00141544|Estrone|estrone|mesh-list
83777862|NCT00141544|Testosterone|testosterone|mesh-list
83777863|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
83777864|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
83777865|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83777866|NCT00141544|Hormones|hormones|mesh-ancestor
83777867|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777868|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777869|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83777870|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777871|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
83777872|NCT00141544|Androgens|androgens|mesh-ancestor
83777873|NCT00141583|Candesartan|candesartan|mesh-list
83777874|NCT00141583|Enalapril|enalapril|mesh-list
83777875|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83777876|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83777877|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83777878|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777879|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83777880|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83777881|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777882|NCT00141700|Rituximab|rituximab|mesh-list
83777883|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777884|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777885|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
83777886|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777887|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83777888|NCT03555149|Bevacizumab|bevacizumab|mesh-list
83777889|NCT03555149|Atezolizumab|atezolizumab|mesh-list
83777890|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777891|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777892|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83777893|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83777894|NCT03555149|Growth Substances|growth substances|mesh-ancestor
83777895|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777896|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
83777897|NCT03555149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83777898|NCT03555149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777899|NCT00141895|Misoprostol|misoprostol|mesh-list
83777900|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83777901|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
83777902|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83777903|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777904|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83777905|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83777906|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
83777907|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
83777908|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83777909|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
83777910|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777911|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777912|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83777913|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
83777914|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83777915|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
83777916|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777917|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777918|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83777919|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
83777920|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
83777921|NCT00142051|Protective Agents|protective agents|mesh-ancestor
83777922|NCT00142129|Bortezomib|bortezomib|mesh-list
83777923|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777924|NCT02825979|Sotalol|sotalol|mesh-list
83777925|NCT02825979|Flecainide|flecainide|mesh-list
83777926|NCT02825979|Dronedarone|dronedarone|mesh-list
83777927|NCT02825979|Propafenone|propafenone|mesh-list
83777928|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83777929|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83777930|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83777931|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
83777932|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777933|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777934|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777935|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
83777936|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
83777937|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83777938|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83777940|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83777941|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
83777942|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
83777943|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83777944|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
83777945|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83777946|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83777947|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777948|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83777949|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777950|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777951|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83777952|NCT00142246|Amodiaquine|amodiaquine|mesh-list
83777953|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
83777954|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83777955|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83777956|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83777957|NCT00142324|Donepezil|donepezil|mesh-list
83777958|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83777959|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777960|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777961|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
83777962|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83777963|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777964|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
83777965|NCT00142402|Modafinil|modafinil|mesh-list
83777966|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83777967|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777968|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83777969|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83777970|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83777971|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777972|NCT00142480|Bevacizumab|bevacizumab|mesh-list
83777973|NCT00142480|Capecitabine|capecitabine|mesh-list
83777974|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
83777975|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83777976|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777977|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83777978|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83777979|NCT00142480|Growth Substances|growth substances|mesh-ancestor
83777980|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777981|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
83777982|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83777983|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
83777984|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777985|NCT02806050|Letrozole|letrozole|mesh-list
83777986|NCT02806050|Palbociclib|palbociclib|mesh-list
83777987|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83777988|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83777989|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83777990|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83777991|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83777992|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83777993|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83777994|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83777995|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83777996|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83777997|NCT02781792|Temozolomide|temozolomide|mesh-list
83777998|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83777999|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
83778000|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778001|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778002|NCT00142870|Bupropion|bupropion|mesh-list
83778003|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83778004|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
83778005|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83778006|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83778007|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83778008|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83778009|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778010|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
83778011|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778012|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778013|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83778014|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83778015|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778016|NCT00142948|Naltrexone|naltrexone|mesh-list
83778017|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83778018|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83778019|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778020|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
83778021|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778022|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
83778023|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83778024|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778025|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778026|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83778027|NCT02780427|Analgesics|analgesics|mesh-ancestor
83778028|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
83778029|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778030|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83778031|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83778032|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83778033|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
83778034|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778035|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778036|NCT00142987|Tegaserod|tegaserod|mesh-list
83778037|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83778038|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
83778039|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778040|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778041|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778042|NCT00143026|Levodopa|levodopa|mesh-list
83778043|NCT00143026|Carbidopa|carbidopa|mesh-list
83778044|NCT00143026|Entacapone|entacapone|mesh-list
83778045|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83778046|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83778047|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
83778048|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778049|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778050|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778051|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83778052|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778053|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83778054|NCT00404599|Simvastatin|simvastatin|mesh-list
83778055|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83778056|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83778057|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
83778058|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778059|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83778060|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83778061|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778062|NCT00143065|Rituximab|rituximab|mesh-list
83778063|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
83778064|NCT00143065|Fludarabine|fludarabine|mesh-list
83778065|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778066|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778067|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
83778068|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778069|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778070|NCT00143104|Insulin|insulin|mesh-list
83778071|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83778072|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778073|NCT00143143|Pregabalin|pregabalin|mesh-list
83778074|NCT00143143|Analgesics|analgesics|mesh-ancestor
83778075|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
83778076|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778077|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778078|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
83778079|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83778080|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933275|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83778081|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778082|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83778083|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83778084|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83778085|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778086|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83778087|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
83778088|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
83778089|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83778090|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83778091|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778092|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778093|NCT00143221|Urological Agents|urological agents|mesh-ancestor
83778094|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
83778095|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778096|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
83778097|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83778098|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83778099|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778100|NCT00143260|Urological Agents|urological agents|mesh-ancestor
83778101|NCT00143299|Varenicline|varenicline|mesh-list
83778102|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83778103|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83778104|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
83778105|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778106|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778107|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778108|NCT00143338|Insulin|insulin|mesh-list
83778109|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83778110|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778111|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83778112|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83778113|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83778114|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
83778115|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778116|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778117|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778118|NCT00143377|Urological Agents|urological agents|mesh-ancestor
83778119|NCT02972216|Docetaxel|docetaxel|mesh-list
83778120|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778121|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
83778122|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
83778123|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
83778124|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778125|NCT04726345|Fexofenadine|fexofenadine|mesh-list
83778126|NCT04726345|Terfenadine|terfenadine|mesh-list
83778127|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83778128|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83778129|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83778130|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
83778131|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
83778132|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778133|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778134|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778135|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
83778136|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
83778137|NCT00143533|Irinotecan|irinotecan|mesh-list
83778138|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83778139|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83778140|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778141|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778142|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778143|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778144|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778145|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
83778146|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778147|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
83778148|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778149|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778150|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83778151|NCT00393315|Paclitaxel|paclitaxel|mesh-list
83778152|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83778153|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778154|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
82933361|NCT04473820|Lidocaine|lidocaine|mesh-list
83778155|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83778156|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83778157|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778159|NCT00143689|Lopinavir|lopinavir|mesh-list
83778160|NCT00143689|Lamivudine|lamivudine|mesh-list
83778161|NCT00143689|Zidovudine|zidovudine|mesh-list
83778162|NCT00143689|Nevirapine|nevirapine|mesh-list
83778163|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83778164|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83778165|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
83778166|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778167|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778168|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83778169|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83778170|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
83778171|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778172|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83778173|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83778174|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83778175|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83778176|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
83778177|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83778178|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83778179|NCT00143728|Lamivudine|lamivudine|mesh-list
83778180|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83778181|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83778182|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778183|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778184|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
83778185|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778186|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83778187|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83778188|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83778189|NCT00140803|Verteporfin|verteporfin|mesh-list
83778190|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778191|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
83778192|NCT00140803|Hormones|hormones|mesh-ancestor
83778193|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83778194|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778195|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83778196|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
83778197|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83778198|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
83778199|NCT00143806|Cyclosporine|cyclosporine|mesh-list
83778200|NCT00143806|Alefacept|alefacept|mesh-list
83778201|NCT00143806|Cyclosporins|cyclosporins|mesh-list
83778202|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778203|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778204|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83778205|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
83778206|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778207|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
83778208|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778209|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
83778210|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778211|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83778212|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
83778213|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83778214|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778215|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83778216|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83778217|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778218|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
83778219|NCT00144118|Sevoflurane|sevoflurane|mesh-list
83778220|NCT00144118|Isoflurane|isoflurane|mesh-list
83778221|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83778222|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83778223|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
83778224|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
83778225|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778226|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778227|NCT00144157|Zidovudine|zidovudine|mesh-list
83778228|NCT00144157|Nevirapine|nevirapine|mesh-list
83778229|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
83778230|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778231|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83778232|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83778233|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778234|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
83778235|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778236|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83778237|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83778238|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83778239|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83778240|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
83778241|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83778242|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
83778243|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778244|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778245|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83778246|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
83778247|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
83778248|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83778249|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
83778250|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778251|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778252|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83778253|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83778254|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778255|NCT00144274|Ambroxol|ambroxol|mesh-list
83778256|NCT00144274|Expectorants|expectorants|mesh-ancestor
83778257|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
83778258|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
83778259|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
83778260|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83778261|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
83778262|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83778263|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83778264|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778265|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83778266|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778267|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778268|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83778269|NCT00144430|Pentostatin|pentostatin|mesh-list
83778270|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778271|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83778272|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778273|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778274|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83778275|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
83778276|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778277|NCT00404716|Cilostazol|cilostazol|mesh-list
83778278|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83778279|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
83778280|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778281|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778282|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83778283|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
83778284|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83778285|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83778286|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778287|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83778288|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
83778289|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83778290|NCT00404716|Protective Agents|protective agents|mesh-ancestor
83778291|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83778292|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83778293|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778294|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
83778295|NCT00404794|Prednisolone|prednisolone|mesh-list
83778296|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83778297|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
83778298|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83778299|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
83778300|NCT00404794|Tacrolimus|tacrolimus|mesh-list
83778301|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83778302|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
83778303|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83778304|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
83778305|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778306|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83778307|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778308|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778309|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83778310|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778311|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83778312|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
83778313|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778314|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778315|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778316|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
83778317|NCT00404794|Hormones|hormones|mesh-ancestor
83778318|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83778319|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83778320|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
83778321|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
83778322|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778323|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778324|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83778325|NCT00404794|Protective Agents|protective agents|mesh-ancestor
83778326|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
83778327|NCT00404833|Prednisolone|prednisolone|mesh-list
83778328|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83778329|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
83778330|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83778331|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
83778332|NCT00404833|Chlorambucil|chlorambucil|mesh-list
83778333|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83778334|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
83778335|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83778336|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778337|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83778338|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
83778339|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778340|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778341|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778342|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778343|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778344|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
83778345|NCT00404833|Hormones|hormones|mesh-ancestor
83778346|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83778347|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778348|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83778349|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
83778350|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
83778351|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778352|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778353|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83778354|NCT00404833|Protective Agents|protective agents|mesh-ancestor
83778355|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83778356|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
83778357|NCT05595109|Silymarin|silymarin|mesh-list
83778358|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
83778359|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778360|NCT05595109|Protective Agents|protective agents|mesh-ancestor
83778361|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778362|NCT03128021|Milnacipran|milnacipran|mesh-list
83778363|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
83778364|NCT03128021|Escitalopram|escitalopram|mesh-list
83778365|NCT03128021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83778366|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83778367|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83778368|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778369|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778370|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
83778371|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778372|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778373|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
83778374|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83778375|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83778376|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82933571|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83778377|NCT03128021|Analgesics|analgesics|mesh-ancestor
83778378|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
83778379|NCT01919619|Lenalidomide|lenalidomide|mesh-list
83778380|NCT01919619|Ipilimumab|ipilimumab|mesh-list
83778381|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
83778382|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778383|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83778384|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83778385|NCT01919619|Growth Substances|growth substances|mesh-ancestor
83778386|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
83778387|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778388|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778389|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83778390|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778391|NCT01807494|Cimetidine|cimetidine|mesh-list
83778392|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83778393|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778394|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83778395|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
83778396|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
83778397|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778398|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778399|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778400|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83778401|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83778402|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778403|NCT01807455|Lidocaine|lidocaine|mesh-list
83778404|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
83778405|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
83778406|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778407|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778408|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
83778409|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778410|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83778411|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83778412|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83778413|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83778414|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778415|NCT05594017|Scopolamine|scopolamine|mesh-list
83778416|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83778417|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83778418|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
83778419|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
83778420|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778421|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778422|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778423|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
83778424|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83778425|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
83778426|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778427|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778428|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83778429|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
83778430|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
83778431|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
83778432|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83778433|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
83778434|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778435|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778436|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83778437|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
83778438|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778439|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778440|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83778441|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778442|NCT03092453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83778443|NCT01807377|Midazolam|midazolam|mesh-list
83778444|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83778445|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83778446|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778447|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778448|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83778449|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83778450|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933643|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83778451|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83778452|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
83778453|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
83778454|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
83778455|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
83778456|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778457|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778458|NCT03090737|Nivolumab|nivolumab|mesh-list
83778459|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778460|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778461|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83778462|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778463|NCT02972255|Meropenem|meropenem|mesh-list
83778464|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778465|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778466|NCT05468671|Remifentanil|remifentanil|mesh-list
83778467|NCT05468671|Oxycodone|oxycodone|mesh-list
83778468|NCT05468671|Propofol|propofol|mesh-list
83778469|NCT05468671|Rocuronium|rocuronium|mesh-list
83778470|NCT05468671|Flumazenil|flumazenil|mesh-list
83778471|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83778472|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778473|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778474|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83778475|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
83778476|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
83778477|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83778478|NCT05468671|Narcotics|narcotics|mesh-ancestor
83778479|NCT05468671|Analgesics|analgesics|mesh-ancestor
83778480|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
83778481|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778482|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83778483|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83778484|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83778485|NCT05468671|Antidotes|antidotes|mesh-ancestor
83778486|NCT05468671|Protective Agents|protective agents|mesh-ancestor
83778487|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
83778488|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
83778489|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778490|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778491|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
83778492|NCT05461807|Apixaban|apixaban|mesh-list
83778493|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83778494|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
83778495|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83778496|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
83778497|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778498|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778499|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
83778500|NCT03079427|Cisplatin|cisplatin|mesh-list
83778501|NCT03079427|Gemcitabine|gemcitabine|mesh-list
83778502|NCT03079427|Capecitabine|capecitabine|mesh-list
83778503|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778504|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83778505|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
83778506|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778507|NCT00390923|Selegiline|selegiline|mesh-list
83778508|NCT00390923|Nicotine|nicotine|mesh-list
83778509|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83778510|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
83778511|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778512|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778513|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83778514|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83778515|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
83778516|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778517|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778518|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
83778519|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83778520|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83778521|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83778522|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83778523|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778524|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83778525|NCT00390923|Protective Agents|protective agents|mesh-ancestor
83778526|NCT00425425|Fluorouracil|fluorouracil|mesh-list
83778527|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
83778528|NCT00425425|Cetuximab|cetuximab|mesh-list
82933717|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
83778529|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
83778530|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778531|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83778532|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778533|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83778534|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
83778535|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778536|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778537|NCT01806948|Ramosetron|ramosetron|mesh-list
83778538|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
83778539|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
83778540|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778541|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778542|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778543|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83778544|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
83778545|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778546|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778547|NCT05374525|Cabotegravir|cabotegravir|mesh-list
83778548|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83778549|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83778550|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778551|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778552|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83778553|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83778554|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
83778555|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778556|NCT02958163|Doxorubicin|doxorubicin|mesh-list
83778557|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83778558|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778559|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83778560|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83778561|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778562|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778563|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83778564|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83778565|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778566|NCT02985866|Pancrelipase|pancrelipase|mesh-list
83778567|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778568|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
83778569|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
83778570|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
83778571|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83778572|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778573|NCT01806792|Vitamins|vitamins|mesh-ancestor
83778574|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
83778575|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83778576|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83778577|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83778578|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778579|NCT05228431|Capecitabine|capecitabine|mesh-list
83778580|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83778581|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
83778582|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778583|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778584|NCT05227456|Etonogestrel|etonogestrel|mesh-list
83778585|NCT05227456|Desogestrel|desogestrel|mesh-list
83778586|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83778587|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
83778588|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83778589|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778590|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83778591|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83778592|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83778593|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83778594|NCT05227456|Progestins|progestins|mesh-ancestor
83778595|NCT05227456|Hormones|hormones|mesh-ancestor
83778596|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83778597|NCT01806753|Midazolam|midazolam|mesh-list
83778598|NCT01806753|Propofol|propofol|mesh-list
82933793|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
83778599|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83778600|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778601|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778602|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83778603|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
83778604|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
83778605|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83778606|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83778607|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83778608|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83778609|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
83778610|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
83778611|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778612|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778613|NCT05197075|Darunavir|darunavir|mesh-list
83778614|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83778615|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83778616|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
83778617|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778618|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778619|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83778620|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83778621|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
83778622|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778623|NCT05175430|Paroxetine|paroxetine|mesh-list
83778624|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83778625|NCT05175430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83778626|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83778627|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83778628|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778629|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778630|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
83778631|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778632|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83778633|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
83778634|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83778635|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83778636|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83778637|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778638|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
83778639|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83778640|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83778641|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83778642|NCT01806675|Glycine|glycine|mesh-list
83778643|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83778644|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778645|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
83778646|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778647|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778648|NCT02762981|Paclitaxel|paclitaxel|mesh-list
83778649|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83778650|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83778651|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778652|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83778653|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83778654|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83778655|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778656|NCT05065567|Droperidol|droperidol|mesh-list
83778657|NCT05065567|Haloperidol|haloperidol|mesh-list
83778658|NCT05065567|Ondansetron|ondansetron|mesh-list
83778659|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
83778660|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
83778661|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
83778662|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778663|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778664|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778665|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
83778666|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
83778667|NCT05065567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83778668|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83778669|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
83778670|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778671|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778672|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83778673|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83778674|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778675|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933862|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
83778676|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83778677|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
83778678|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83778679|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83778680|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83778681|NCT02739035|Dexamethasone|dexamethasone|mesh-list
83778682|NCT02739035|Celecoxib|celecoxib|mesh-list
83778683|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778684|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
83778685|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
83778686|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778687|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778688|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778689|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
83778690|NCT02739035|Hormones|hormones|mesh-ancestor
83778691|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83778692|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83778693|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778694|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83778695|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83778696|NCT02739035|Analgesics|analgesics|mesh-ancestor
83778697|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
83778698|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778699|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83778700|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83778701|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778702|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778703|NCT04958044|Calcium|calcium|mesh-list
83778704|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83778705|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778706|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
83778707|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83778708|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778709|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778710|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83778711|NCT04871308|Analgesics|analgesics|mesh-ancestor
83778712|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
83778713|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778714|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83778715|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83778716|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83778717|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
83778718|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778719|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778720|NCT04861051|Ketamine|ketamine|mesh-list
83778721|NCT04861051|Analgesics|analgesics|mesh-ancestor
83778722|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
83778723|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778724|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778725|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83778726|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83778727|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
83778728|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
83778729|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778730|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83778731|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83778732|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778733|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778734|NCT01806363|Telmisartan|telmisartan|mesh-list
83778735|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
83778736|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83778737|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83778738|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83778739|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778740|NCT01806363|Diuretics|diuretics|mesh-ancestor
83778741|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
83778742|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778743|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83778744|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83778745|NCT04846855|Anesthetics|anesthetics|mesh-list
83778746|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
83778747|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933945|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
83778748|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778749|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
83778750|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778751|NCT02964403|Indomethacin|indomethacin|mesh-list
83778752|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83778753|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83778754|NCT02964403|Analgesics|analgesics|mesh-ancestor
83778755|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
83778756|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778757|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778758|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778759|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778760|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
83778761|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
83778762|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83778763|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83778764|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778765|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778766|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
83778767|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83778768|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
83778769|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
83778770|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778771|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778772|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83778773|NCT04749043|Analgesics|analgesics|mesh-ancestor
83778774|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
83778775|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778776|NCT00393393|Hylan|hylan|mesh-list
83778777|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
83778778|NCT00393393|Protective Agents|protective agents|mesh-ancestor
83778779|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778780|NCT00405262|Ketorolac|ketorolac|mesh-list
83778781|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83778782|NCT00405262|Bupivacaine|bupivacaine|mesh-list
83778783|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
83778784|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
83778785|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778786|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778787|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
83778788|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778789|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83778790|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83778791|NCT00405262|Analgesics|analgesics|mesh-ancestor
83778792|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778793|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778794|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83778795|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778796|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778797|NCT00405301|Rifampin|rifampin|mesh-list
83778798|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
83778799|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83778800|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
83778801|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778802|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778803|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
83778804|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83778805|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778806|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778807|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83778808|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83778809|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83778810|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83778811|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83778812|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83778813|NCT00405340|Rituximab|rituximab|mesh-list
83778814|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778815|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778816|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
83778817|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778818|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778819|NCT04713319|Calcium|calcium|mesh-list
83778820|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82934012|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778821|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778823|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83778824|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83778825|NCT00393471|Analgesics|analgesics|mesh-ancestor
83778826|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
83778827|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778828|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778829|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83778830|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778831|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83778832|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83778833|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
83778834|NCT02647892|Lidocaine|lidocaine|mesh-list
83778835|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
83778836|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
83778837|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778838|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778839|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
83778840|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778841|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83778842|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83778843|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83778844|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83778845|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778846|NCT02593175|Paclitaxel|paclitaxel|mesh-list
83778847|NCT02593175|Carboplatin|carboplatin|mesh-list
83778848|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83778849|NCT02593175|Panitumumab|panitumumab|mesh-list
83778850|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83778851|NCT02593175|Antibodies|antibodies|mesh-list
83778852|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
83778853|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83778854|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83778855|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778856|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83778857|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83778858|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83778859|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778860|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
83778861|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778862|NCT01806090|Clopidogrel|clopidogrel|mesh-list
83778863|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83778864|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83778865|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83778866|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83778867|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
83778868|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778869|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778870|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778871|NCT02505893|Sirolimus|sirolimus|mesh-list
83778872|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778873|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778874|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83778875|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778876|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
83778877|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83778878|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
83778879|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778880|NCT04341181|Trastuzumab|trastuzumab|mesh-list
83778881|NCT04341181|Atezolizumab|atezolizumab|mesh-list
83778882|NCT04341181|Pertuzumab|pertuzumab|mesh-list
83778883|NCT04341181|Avelumab|avelumab|mesh-list
83778884|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83778885|NCT04341181|Niraparib|niraparib|mesh-list
83778886|NCT04341181|Axitinib|axitinib|mesh-list
83778887|NCT04341181|Vemurafenib|vemurafenib|mesh-list
83778888|NCT04341181|Maytansine|maytansine|mesh-list
83778889|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778890|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778891|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83778892|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778893|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778894|NCT04341181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83778895|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83778896|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83778898|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83778899|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83778900|NCT04341181|Immunotoxins|immunotoxins|mesh-ancestor
83778901|NCT04341181|Immunoconjugates|immunoconjugates|mesh-ancestor
83778902|NCT04341181|Immunologic Factors|immunologic factors|mesh-ancestor
83778903|NCT04341181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778904|NCT01806324|Losartan|losartan|mesh-list
83778905|NCT01806324|Atorvastatin|atorvastatin|mesh-list
83778906|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83778907|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83778908|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
83778909|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778910|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83778911|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83778912|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778913|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83778914|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83778915|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83778916|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83778917|NCT02423876|Hydromorphone|hydromorphone|mesh-list
83778918|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778919|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778920|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
83778921|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83778922|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83778923|NCT02423876|Narcotics|narcotics|mesh-ancestor
83778924|NCT02423876|Analgesics|analgesics|mesh-ancestor
83778925|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
83778926|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778927|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778928|NCT02316002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83778929|NCT02316002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778930|NCT01805895|Minocycline|minocycline|mesh-list
83778931|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778932|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778933|NCT01805856|Cefazolin|cefazolin|mesh-list
83778934|NCT01805856|Piperacillin|piperacillin|mesh-list
83778935|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83778936|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83778937|NCT01805817|Copper|copper|mesh-list
83778938|NCT01805817|Drospirenone|drospirenone|mesh-list
83778939|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
83778940|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83778941|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83778942|NCT01805817|Estradiol|estradiol|mesh-list
83778943|NCT01805817|Estrogens|estrogens|mesh-ancestor
83778944|NCT01805817|Hormones|hormones|mesh-ancestor
83778945|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83778946|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778947|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83778948|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
83778949|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83778950|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83778951|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83778952|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83778953|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83778954|NCT01805817|Trace Elements|trace elements|mesh-ancestor
83778955|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
83778956|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83778957|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
83778958|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83778959|NCT01805817|Diuretics|diuretics|mesh-ancestor
83778960|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
83778961|NCT04206046|Anesthetics|anesthetics|mesh-list
83778962|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83778963|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778964|NCT00405418|Insulin|insulin|mesh-list
83778965|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83778966|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
83778967|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
83778968|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83778969|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778970|NCT02157077|Aflibercept|aflibercept|mesh-list
83778971|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83778972|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83778973|NCT02157077|Growth Substances|growth substances|mesh-ancestor
83778974|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778975|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
83778976|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778977|NCT01805700|Caffeine|caffeine|mesh-list
83778978|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83778979|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778980|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83778981|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83778982|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83778983|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83778984|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83778985|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
83778986|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83778987|NCT04033276|Rituximab|rituximab|mesh-list
83778988|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
83778989|NCT04033276|Antibodies|antibodies|mesh-list
83778990|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
83778991|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83778992|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83778993|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83778994|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83778995|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
83778996|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83778997|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83778998|NCT03969823|Osimertinib|osimertinib|mesh-list
83778999|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779000|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83779001|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779002|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779003|NCT00391157|Dexamethasone|dexamethasone|mesh-list
83779004|NCT00391157|Bortezomib|bortezomib|mesh-list
83779005|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779006|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
83779007|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
83779008|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779009|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779010|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779011|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
83779012|NCT00391157|Hormones|hormones|mesh-ancestor
83779013|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779014|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83779015|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779016|NCT03781063|Fulvestrant|fulvestrant|mesh-list
83779017|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83779018|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779019|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83779020|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83779021|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
83779022|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779023|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779024|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
83779025|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83779026|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
83779027|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83779028|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
83779029|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779030|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779031|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
83779032|NCT01903421|Fentanyl|fentanyl|mesh-list
83779033|NCT01903421|Bupivacaine|bupivacaine|mesh-list
83779034|NCT01903421|Anesthetics|anesthetics|mesh-list
83779035|NCT01903421|Propofol|propofol|mesh-list
83779036|NCT01903421|Sevoflurane|sevoflurane|mesh-list
83779037|NCT01903421|Isoflurane|isoflurane|mesh-list
83779038|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
83779039|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83779040|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779041|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
83779042|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779043|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83779044|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83779045|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
83779046|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83779047|NCT01903421|Narcotics|narcotics|mesh-ancestor
83779049|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83779050|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83779051|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83779052|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
83779053|NCT03734731|Narcotics|narcotics|mesh-ancestor
83779054|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83779055|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779056|NCT03734731|Analgesics|analgesics|mesh-ancestor
83779057|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
83779058|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779059|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
83779060|NCT01723839|Rituximab|rituximab|mesh-list
83779061|NCT01723839|Fludarabine|fludarabine|mesh-list
83779062|NCT01723839|Lenalidomide|lenalidomide|mesh-list
83779063|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779064|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
83779065|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779066|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779067|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779068|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
83779069|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779070|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779071|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83779072|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83779073|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83779074|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83779075|NCT01723839|Growth Substances|growth substances|mesh-ancestor
83779076|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
83779077|NCT03421483|Folic Acid|folic acid|mesh-list
83779078|NCT03421483|Hematinics|hematinics|mesh-ancestor
83779079|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
83779080|NCT03421483|Vitamins|vitamins|mesh-ancestor
83779081|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
83779082|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779083|NCT03363217|Trametinib|trametinib|mesh-list
83779084|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779085|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83779086|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779087|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779088|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
83779089|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83779090|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779091|NCT03341143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83779092|NCT03341143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779093|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83779094|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
83779095|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779096|NCT00405496|Difluprednate|difluprednate|mesh-list
83779097|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
83779098|NCT00405496|Hormones|hormones|mesh-ancestor
83779099|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779100|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779101|NCT00405535|Glycine|glycine|mesh-list
83779102|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
83779103|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779104|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779105|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779106|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83779107|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
83779108|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
83779109|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779110|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779111|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83779112|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83779113|NCT00405574|Growth Substances|growth substances|mesh-ancestor
83779114|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779115|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
83779116|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779117|NCT02993029|Celecoxib|celecoxib|mesh-list
83779118|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83779119|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779120|NCT02993029|Analgesics|analgesics|mesh-ancestor
83779121|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
83779122|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779123|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779124|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779125|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779126|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83779127|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83779128|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779129|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779130|NCT02825641|Oxytocin|oxytocin|mesh-list
83779131|NCT02825641|Dinoprostone|dinoprostone|mesh-list
83779132|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
83779133|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83779134|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779135|NCT01646034|Paclitaxel|paclitaxel|mesh-list
83779136|NCT01646034|Docetaxel|docetaxel|mesh-list
83779137|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
83779138|NCT01646034|Carboplatin|carboplatin|mesh-list
83779139|NCT01646034|Gemcitabine|gemcitabine|mesh-list
83779140|NCT01646034|Doxorubicin|doxorubicin|mesh-list
83779141|NCT01646034|Thiotepa|thiotepa|mesh-list
83779142|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779143|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779144|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779145|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779146|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779147|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779148|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779149|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
83779150|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779151|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779152|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779153|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
83779154|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83779155|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83779156|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
83779157|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83779158|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83779159|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83779160|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779161|NCT01628640|Interferons|interferons|mesh-list
83779162|NCT01628640|Interferon-beta|interferon-beta|mesh-list
83779163|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779164|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
83779165|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779166|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
83779167|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779168|NCT00391313|Chloroquine|chloroquine|mesh-list
83779169|NCT00391313|Amebicides|amebicides|mesh-ancestor
83779170|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83779171|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83779172|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779173|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
83779174|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779175|NCT01466517|Ibuprofen|ibuprofen|mesh-list
83779176|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83779177|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779178|NCT01466517|Analgesics|analgesics|mesh-ancestor
83779179|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
83779180|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779181|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779182|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779183|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779184|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83779185|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779186|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779187|NCT01466478|Calcitriol|calcitriol|mesh-list
83779188|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83779189|NCT01466478|Calcipotriene|calcipotriene|mesh-list
83779190|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83779191|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83779192|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779193|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83779194|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83779195|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779196|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83779197|NCT01466478|Vitamins|vitamins|mesh-ancestor
83779198|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
83779199|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83779200|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779201|NCT00063830|Alicaforsen|alicaforsen|mesh-list
83779202|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779203|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779204|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
83779205|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779206|NCT00062816|Ribavirin|ribavirin|mesh-list
83779207|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
83779208|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779209|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
83779210|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779211|NCT00048113|Alicaforsen|alicaforsen|mesh-list
83779212|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779213|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779214|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
83779215|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779216|NCT01466361|Nicotine|nicotine|mesh-list
83779217|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83779218|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
83779219|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779220|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779221|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83779222|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83779223|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
83779224|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779225|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779226|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
83779227|NCT00001832|Fludarabine|fludarabine|mesh-list
83779228|NCT00001832|Interleukin-2|interleukin-2|mesh-list
83779229|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83779230|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779231|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
83779232|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779233|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779234|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779235|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
83779236|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779237|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779238|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83779239|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779240|NCT00001832|Analgesics|analgesics|mesh-ancestor
83779241|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
83779242|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779243|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83779244|NCT01466244|Cetuximab|cetuximab|mesh-list
83779245|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779246|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83779247|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
83779248|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
83779249|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
83779250|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779251|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779252|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779253|NCT01466127|Oxytocin|oxytocin|mesh-list
83779254|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
83779255|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83779256|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779257|NCT00009191|Sertraline|sertraline|mesh-list
83779258|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
83779259|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83779260|NCT00009191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83779261|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83779262|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83779263|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779264|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779265|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
83779266|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779267|NCT01466088|Donepezil|donepezil|mesh-list
83779268|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83779269|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779270|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779271|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
83779272|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779273|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934490|NCT00003199|Tamoxifen|tamoxifen|mesh-list
83779275|NCT00009230|Celecoxib|celecoxib|mesh-list
83779276|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83779277|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779278|NCT00009230|Analgesics|analgesics|mesh-ancestor
83779279|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
83779280|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779281|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779282|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779283|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779284|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83779285|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83779286|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779287|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779288|NCT00009581|Acetylcholine|acetylcholine|mesh-list
83779289|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
83779290|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83779291|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
83779292|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779293|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779294|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779295|NCT00009620|Phenobarbital|phenobarbital|mesh-list
83779296|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
83779297|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83779298|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83779299|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779300|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83779301|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83779302|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779303|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779304|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
83779305|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
83779306|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83779307|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83779308|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83779309|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
83779310|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83779311|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
83779312|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83779313|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779314|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83779315|NCT00009698|Aldesleukin|aldesleukin|mesh-list
83779316|NCT00009698|Interleukin-2|interleukin-2|mesh-list
83779317|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779318|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779319|NCT00009698|Analgesics|analgesics|mesh-ancestor
83779320|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
83779321|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779322|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779323|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83779324|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83779325|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
83779326|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779327|NCT01465893|Vitamin D|vitamin d|mesh-list
83779328|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
83779329|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
83779330|NCT01465893|Vitamins|vitamins|mesh-list
83779331|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
83779332|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779333|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83779334|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83779335|NCT00009776|Cyclosporine|cyclosporine|mesh-list
83779336|NCT00009776|Paclitaxel|paclitaxel|mesh-list
83779337|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83779338|NCT00009776|Antibodies|antibodies|mesh-list
83779339|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
83779340|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83779341|NCT00009776|Cyclosporins|cyclosporins|mesh-list
83779342|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779343|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779344|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779345|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779346|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779347|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779348|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
83779349|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779350|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779351|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779352|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
83779353|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779354|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83779355|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779356|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83779357|NCT00009815|Leucovorin|leucovorin|mesh-list
83779358|NCT00009815|Etoposide|etoposide|mesh-list
83779359|NCT00009815|Tegafur|tegafur|mesh-list
83779360|NCT00009815|Calcium|calcium|mesh-list
83779361|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
83779362|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83779363|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779364|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779365|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779366|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83779367|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83779368|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779369|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779370|NCT00009815|Antidotes|antidotes|mesh-ancestor
83779371|NCT00009815|Protective Agents|protective agents|mesh-ancestor
83779372|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
83779373|NCT00009815|Vitamins|vitamins|mesh-ancestor
83779374|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
83779375|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83779376|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
83779377|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83779378|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779379|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83779380|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779381|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779382|NCT00009854|Ethanol|ethanol|mesh-list
83779383|NCT00009854|Carmustine|carmustine|mesh-list
83779384|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83779385|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779386|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83779387|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779388|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779389|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
83779390|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779391|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779392|NCT00009893|Leucovorin|leucovorin|mesh-list
83779393|NCT00009893|Gemcitabine|gemcitabine|mesh-list
83779394|NCT00009893|Fluorouracil|fluorouracil|mesh-list
83779395|NCT00009893|Calcium|calcium|mesh-list
83779396|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
83779397|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83779398|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
83779399|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779400|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779401|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83779402|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779403|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779404|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
83779405|NCT00009893|Antidotes|antidotes|mesh-ancestor
83779406|NCT00009893|Protective Agents|protective agents|mesh-ancestor
83779407|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
83779408|NCT00009893|Vitamins|vitamins|mesh-ancestor
83779409|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
83779410|NCT00009971|Fenretinide|fenretinide|mesh-list
83779411|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779412|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83779413|NCT00009971|Protective Agents|protective agents|mesh-ancestor
83779414|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779415|NCT00010010|Exemestane|exemestane|mesh-list
83779416|NCT00010010|Goserelin|goserelin|mesh-list
83779417|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779418|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83779419|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83779420|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779421|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779422|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83779423|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
83779424|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779425|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779426|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83779427|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
83779428|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779429|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83779430|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779431|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779432|NCT00010088|Leucovorin|leucovorin|mesh-list
83779433|NCT00010088|Gemcitabine|gemcitabine|mesh-list
83779434|NCT00010088|Fluorouracil|fluorouracil|mesh-list
83779435|NCT00010088|Calcium|calcium|mesh-list
83779436|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
83779437|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83779438|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
83779439|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779440|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779441|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83779442|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779443|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779444|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
83779445|NCT00010088|Antidotes|antidotes|mesh-ancestor
83779446|NCT00010088|Protective Agents|protective agents|mesh-ancestor
83779447|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
83779448|NCT00010088|Vitamins|vitamins|mesh-ancestor
83779449|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
83779450|NCT01465503|Heparin|heparin|mesh-list
83779451|NCT01465503|Calcium heparin|calcium heparin|mesh-list
83779452|NCT01465503|Hirudins|hirudins|mesh-list
83779453|NCT01465503|Bivalirudin|bivalirudin|mesh-list
83779454|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
83779455|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83779456|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83779457|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779458|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
83779459|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83779460|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
83779461|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779462|NCT00010166|Gemcitabine|gemcitabine|mesh-list
83779463|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83779464|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
83779465|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779466|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779467|NCT01465152|Metformin|metformin|mesh-list
83779468|NCT01465152|Repaglinide|repaglinide|mesh-list
83779469|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83779470|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779471|NCT01465113|Vitamin D|vitamin d|mesh-list
83779472|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
83779473|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
83779474|NCT01465113|Vitamins|vitamins|mesh-list
83779475|NCT01465113|Metformin|metformin|mesh-list
83779476|NCT01465113|Omeprazole|omeprazole|mesh-list
83779477|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
83779478|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779479|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83779480|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83779481|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83779482|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83779483|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779484|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83779485|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779486|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779487|NCT01465074|Nicotine|nicotine|mesh-list
83779488|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83779489|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
83779490|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779491|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779492|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83779493|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83779494|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83779495|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779496|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779497|NCT00010283|Beclomethasone|beclomethasone|mesh-list
83779498|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779499|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
83779500|NCT00010283|Hormones|hormones|mesh-ancestor
83779501|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779502|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779503|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83779504|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
83779505|NCT00010322|Toremifene|toremifene|mesh-list
83779506|NCT00010322|Atamestane|atamestane|mesh-list
83779507|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83779508|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779509|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83779510|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83779511|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
83779512|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779513|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779514|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83779515|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779516|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779517|NCT00010361|Cyclosporine|cyclosporine|mesh-list
83779518|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
83779519|NCT00010361|Fludarabine|fludarabine|mesh-list
83779520|NCT00010361|Cyclosporins|cyclosporins|mesh-list
83779521|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779522|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779523|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779524|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
83779525|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779526|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779527|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
83779528|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779529|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83779530|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779531|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83779532|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83779533|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83779534|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
83779535|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83779536|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
83779537|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779538|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
83779539|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779540|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779541|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779542|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
83779543|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779544|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779545|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83779546|NCT01464840|Azithromycin|azithromycin|mesh-list
83779547|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83779548|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779549|NCT01464801|Resveratrol|resveratrol|mesh-list
83779550|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
83779551|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779552|NCT01464801|Protective Agents|protective agents|mesh-ancestor
83779553|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779554|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779555|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83779556|NCT01464762|Bedaquiline|bedaquiline|mesh-list
83779557|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
83779558|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83779559|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779560|NCT02035358|Immunomodulating Agents|immunomodulating agents|mesh-list
83779561|NCT02035358|Immunologic Factors|immunologic factors|mesh-ancestor
83779562|NCT02035358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779563|NCT01464723|Ranibizumab|ranibizumab|mesh-list
83779564|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83779565|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83779566|NCT01464723|Growth Substances|growth substances|mesh-ancestor
83779567|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779568|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
83779569|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779570|NCT01464606|Dactinomycin|dactinomycin|mesh-list
83779571|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
83779572|NCT01464606|Ifosfamide|ifosfamide|mesh-list
83779573|NCT01464606|Doxorubicin|doxorubicin|mesh-list
83779574|NCT01464606|Vincristine|vincristine|mesh-list
83779575|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779576|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
83779577|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779578|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934773|NCT01334762|Letrozole|letrozole|mesh-list
83779579|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779580|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
83779581|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779582|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779583|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83779584|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83779585|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83779586|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83779587|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779588|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779589|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779590|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779591|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779592|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83779593|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779594|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83779595|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83779596|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
83779597|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83779598|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
83779599|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779600|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
83779601|NCT01464528|Protective Agents|protective agents|mesh-ancestor
83779602|NCT00393744|Amoxicillin|amoxicillin|mesh-list
83779603|NCT00393744|Pristinamycin|pristinamycin|mesh-list
83779604|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83779605|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779606|NCT00011297|Gabapentin|gabapentin|mesh-list
83779607|NCT00011297|Lorazepam|lorazepam|mesh-list
83779608|NCT00011297|Analgesics|analgesics|mesh-ancestor
83779609|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
83779610|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779611|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779612|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
83779613|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83779614|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83779615|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83779616|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83779617|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83779618|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83779619|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779620|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779621|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
83779622|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
83779623|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
83779624|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779625|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83779626|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
83779627|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
83779628|NCT00011375|Rolipram|rolipram|mesh-list
83779629|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
83779630|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83779631|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83779632|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83779633|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779634|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779635|NCT00847938|Neostigmine|neostigmine|mesh-list
83779636|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83779637|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779638|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779639|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
83779640|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779641|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779642|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83779643|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
83779644|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779645|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
83779646|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83779647|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779648|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779649|NCT00847860|Aspirin|aspirin|mesh-list
83779650|NCT00847860|Cilostazol|cilostazol|mesh-list
83779651|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83779652|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779653|NCT00847860|Analgesics|analgesics|mesh-ancestor
83779655|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779656|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779657|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779658|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779659|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83779660|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83779661|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779662|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83779663|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83779664|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779665|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
83779666|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83779667|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
83779668|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83779669|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
83779670|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
83779671|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83779672|NCT00847860|Protective Agents|protective agents|mesh-ancestor
83779673|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83779674|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83779675|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83779676|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
83779677|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83779678|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
83779679|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779680|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779681|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83779682|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83779683|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83779684|NCT00009932|Paclitaxel|paclitaxel|mesh-list
83779685|NCT00009932|Fenretinide|fenretinide|mesh-list
83779686|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779687|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779688|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779689|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779690|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779691|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779692|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83779693|NCT00009932|Protective Agents|protective agents|mesh-ancestor
83779694|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779695|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
83779696|NCT00847587|Etonogestrel|etonogestrel|mesh-list
83779697|NCT00847587|Desogestrel|desogestrel|mesh-list
83779698|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83779699|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779700|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83779701|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83779702|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83779703|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83779704|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83779705|NCT00847587|Progestins|progestins|mesh-ancestor
83779706|NCT00847587|Hormones|hormones|mesh-ancestor
83779707|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779708|NCT00011765|Fluoxetine|fluoxetine|mesh-list
83779709|NCT00011765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83779710|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83779711|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83779712|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779713|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779714|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
83779715|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779716|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83779717|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
83779718|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83779719|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83779720|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83779721|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779722|NCT00011804|Topiramate|topiramate|mesh-list
83779723|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
83779724|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82934921|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
83779725|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779726|NCT00011921|Paclitaxel|paclitaxel|mesh-list
83779727|NCT00011921|Etoposide|etoposide|mesh-list
83779728|NCT00011921|Carboplatin|carboplatin|mesh-list
83779729|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
83779730|NCT00011921|Epirubicin|epirubicin|mesh-list
83779731|NCT00011921|Ifosfamide|ifosfamide|mesh-list
83779732|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779733|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779734|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779735|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779736|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779737|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779738|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83779739|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83779740|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779741|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83779742|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779743|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
83779744|NCT00011960|Paclitaxel|paclitaxel|mesh-list
83779745|NCT00011960|Cisplatin|cisplatin|mesh-list
83779746|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779747|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779748|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779749|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779750|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779751|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779752|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
83779753|NCT00847314|Testosterone|testosterone|mesh-list
83779754|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
83779755|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
83779756|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83779757|NCT00847314|Androgens|androgens|mesh-ancestor
83779758|NCT00847314|Hormones|hormones|mesh-ancestor
83779759|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779760|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779761|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83779762|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779763|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
83779764|NCT00011999|Paclitaxel|paclitaxel|mesh-list
83779765|NCT00011999|Cisplatin|cisplatin|mesh-list
83779766|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779767|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779768|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779769|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779770|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779771|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779772|NCT00012038|Irofulven|irofulven|mesh-list
83779773|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779774|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
83779775|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779776|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779777|NCT00012116|Temozolomide|temozolomide|mesh-list
83779778|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779779|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
83779780|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779781|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779782|NCT00847119|Bevacizumab|bevacizumab|mesh-list
83779783|NCT00847119|Capecitabine|capecitabine|mesh-list
83779784|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83779785|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779786|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83779787|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83779788|NCT00847119|Growth Substances|growth substances|mesh-ancestor
83779789|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779790|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
83779791|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83779792|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
83779793|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779794|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83779795|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83779796|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779797|NCT00847080|Incretins|incretins|mesh-ancestor
83779798|NCT00847080|Hormones|hormones|mesh-ancestor
83834932|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82935008|NCT02276014|Vitamins|vitamins|mesh-ancestor
83779799|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779800|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83779801|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
83779802|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779803|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779804|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83779805|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779806|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83779807|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779808|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779809|NCT01818323|Immunomodulating Agents|immunomodulating agents|mesh-list
83779810|NCT01818323|Immunologic Factors|immunologic factors|mesh-ancestor
83779811|NCT01818323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779812|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
83779813|NCT00012311|Ifosfamide|ifosfamide|mesh-list
83779814|NCT00012311|Thiotepa|thiotepa|mesh-list
83779815|NCT00012311|Carboplatin|carboplatin|mesh-list
83779816|NCT00012311|Docetaxel|docetaxel|mesh-list
83779817|NCT00012311|Doxorubicin|doxorubicin|mesh-list
83779818|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83779819|NCT00012311|Fluorouracil|fluorouracil|mesh-list
83779820|NCT00012311|Methotrexate|methotrexate|mesh-list
83779821|NCT00012311|Etoposide|etoposide|mesh-list
83779822|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779823|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
83779824|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779825|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779826|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83779827|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
83779828|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779829|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779830|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83779831|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
83779832|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83779833|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
83779834|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83779835|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83779836|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83779837|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779838|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
83779839|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83779840|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83779841|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
83779842|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83779843|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83779844|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83779845|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83779846|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83779847|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83779848|NCT00847002|Laxatives|laxatives|mesh-ancestor
83779849|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779850|NCT00012350|Tipifarnib|tipifarnib|mesh-list
83779851|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779852|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83779853|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83779854|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779855|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
83779856|NCT00012389|Irinotecan|irinotecan|mesh-list
83779857|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779858|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83779859|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83779860|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779861|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779862|NCT00846885|Sumatriptan|sumatriptan|mesh-list
83779863|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83779864|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83779865|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83779866|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
83779867|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779868|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779869|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779870|NCT00012467|Interferons|interferons|mesh-list
83779871|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
83779872|NCT00012467|Itraconazole|itraconazole|mesh-list
83779873|NCT00012467|Fluconazole|fluconazole|mesh-list
83779874|NCT00012467|Amphotericin B|amphotericin b|mesh-list
83779875|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83779876|NCT00012467|Flucytosine|flucytosine|mesh-list
83779877|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779878|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
83779879|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83779880|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
83779881|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83779882|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83779883|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779884|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779885|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83779886|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
83779887|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83779888|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779889|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83779890|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83779891|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83779892|NCT00012467|Amebicides|amebicides|mesh-ancestor
83779893|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83779894|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83779895|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83779896|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
83779897|NCT00012506|Etanercept|etanercept|mesh-list
83779898|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83779899|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779900|NCT00012506|Analgesics|analgesics|mesh-ancestor
83779901|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
83779902|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779903|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779904|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83779905|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83779906|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83779907|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83779908|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
83779909|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
83779910|NCT00012584|Methylphenidate|methylphenidate|mesh-list
83779911|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83779912|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779913|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83779914|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83779915|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83779916|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779917|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
83779918|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779919|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83779920|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83779921|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83779922|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83779923|NCT00012584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83779924|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
83779925|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83779926|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
83779927|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83779928|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83779929|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779930|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83779931|NCT00846690|Lidocaine|lidocaine|mesh-list
83779932|NCT00846690|Phenylephrine|phenylephrine|mesh-list
83779933|NCT00846690|Benzocaine|benzocaine|mesh-list
83779934|NCT00846690|Tetracaine|tetracaine|mesh-list
83779935|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
83779936|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
83779937|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83779938|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779939|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
83779940|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779941|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83779942|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83779943|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83779944|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83779945|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935146|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83779946|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83779947|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
83779948|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
83779949|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
83779950|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83779951|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
83779952|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
83779953|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83779954|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83779955|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83779956|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
83779957|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779958|NCT00846690|Protective Agents|protective agents|mesh-ancestor
83779959|NCT00846651|Phenylephrine|phenylephrine|mesh-list
83779960|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
83779961|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83779962|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
83779963|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
83779964|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779965|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779966|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
83779967|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83779968|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
83779969|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
83779970|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83779971|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83779972|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83779973|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83779974|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83779975|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779976|NCT00846651|Protective Agents|protective agents|mesh-ancestor
83779977|NCT00846612|Bevacizumab|bevacizumab|mesh-list
83779978|NCT00846612|Doxorubicin|doxorubicin|mesh-list
83779979|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83779980|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83779981|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83779982|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83779983|NCT00846612|Growth Substances|growth substances|mesh-ancestor
83779984|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779985|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
83779986|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83779987|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83779988|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83779989|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83779990|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83779991|NCT00012857|Acetaminophen|acetaminophen|mesh-list
83779992|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83779993|NCT00012857|Analgesics|analgesics|mesh-ancestor
83779994|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
83779995|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83779996|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83779997|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
83779998|NCT00394056|Paroxetine|paroxetine|mesh-list
83779999|NCT00394056|Vestipitant|vestipitant|mesh-list
83780000|NCT00394056|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83780001|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83780002|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780003|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780004|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780005|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
83780006|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780007|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83780008|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
83780009|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780010|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83780011|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83780012|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780013|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83780014|NCT00846339|Bupropion|bupropion|mesh-list
83780015|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83780016|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83780017|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780018|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83780019|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83780020|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780021|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780022|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
83780023|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780024|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780025|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83780026|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83780027|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780029|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
83780030|NCT00846144|Trace Elements|trace elements|mesh-ancestor
83780031|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
83780032|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780033|NCT00846144|Antidotes|antidotes|mesh-ancestor
83780034|NCT00846144|Protective Agents|protective agents|mesh-ancestor
83780035|NCT00846144|Emetics|emetics|mesh-ancestor
83780036|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
83780037|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780038|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83780039|NCT00845988|Aripiprazole|aripiprazole|mesh-list
83780040|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
83780041|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780042|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83780043|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83780044|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780045|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780046|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
83780047|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
83780048|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780049|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780050|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83780051|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83780052|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
83780053|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83780054|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83780055|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83780056|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83780057|NCT00845910|Bevacizumab|bevacizumab|mesh-list
83780058|NCT00845910|Docetaxel|docetaxel|mesh-list
83780059|NCT00845910|Capecitabine|capecitabine|mesh-list
83780060|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83780061|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780062|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83780063|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83780064|NCT00845910|Growth Substances|growth substances|mesh-ancestor
83780065|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780066|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780067|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780068|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780069|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780070|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780071|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780072|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
83780073|NCT00680628|Enoxaparin|enoxaparin|mesh-list
83780074|NCT00680628|Tenecteplase|tenecteplase|mesh-list
83780075|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
83780076|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
83780077|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83780078|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83780079|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780080|NCT00013520|Lamivudine|lamivudine|mesh-list
83780081|NCT00013520|Zidovudine|zidovudine|mesh-list
83780082|NCT00013520|Efavirenz|efavirenz|mesh-list
83780083|NCT00013520|Nevirapine|nevirapine|mesh-list
83780084|NCT00013520|Abacavir|abacavir|mesh-list
83780085|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
83780086|NCT00013520|Stavudine|stavudine|mesh-list
83780087|NCT00013520|Didanosine|didanosine|mesh-list
83780088|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83780089|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83780090|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83780091|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83780092|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780093|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780094|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
83780095|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780096|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83780097|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83780098|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
83780099|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83780100|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83780101|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83780102|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83780103|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83780104|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83780105|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83780106|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83780107|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
83780108|NCT00013598|Pioglitazone|pioglitazone|mesh-list
83780109|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83780110|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780111|NCT00277017|Interferons|interferons|mesh-list
83780112|NCT00277017|Thalidomide|thalidomide|mesh-list
83780113|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780114|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
83780115|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780116|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780117|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
83780118|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780119|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
83780120|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83780121|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83780122|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83780123|NCT00277017|Growth Substances|growth substances|mesh-ancestor
83780124|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780125|NCT00276978|Aripiprazole|aripiprazole|mesh-list
83780126|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
83780127|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780128|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83780129|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83780130|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780131|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780132|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
83780133|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
83780134|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780135|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780136|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83780137|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83780138|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
83780139|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83780140|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83780141|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83780142|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83780143|NCT00276900|Sertraline|sertraline|mesh-list
83780144|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
83780145|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780146|NCT00276900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83780147|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83780148|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780149|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780150|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780151|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
83780152|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780153|NCT00276861|Gemcitabine|gemcitabine|mesh-list
83780154|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
83780155|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780156|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
83780157|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780158|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780159|NCT00013871|Vaccines|vaccines|mesh-list
83780160|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83780161|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
83780162|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780163|NCT00276783|Pemetrexed|pemetrexed|mesh-list
83780164|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780165|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780166|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780167|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83780168|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82935371|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
83780169|NCT00276705|Thalidomide|thalidomide|mesh-list
83780170|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
83780171|NCT00276705|Doxorubicin|doxorubicin|mesh-list
83780172|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83780173|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780174|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
83780175|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780176|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780177|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780178|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
83780179|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780180|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780181|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83780182|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780183|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780184|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780185|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780186|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
83780187|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83780188|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780189|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83780190|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83780191|NCT00276705|Growth Substances|growth substances|mesh-ancestor
83780192|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780193|NCT00276666|Vincristine|vincristine|mesh-list
83780194|NCT00276666|Lomustine|lomustine|mesh-list
83780195|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780196|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780197|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780198|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780199|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780200|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780201|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780202|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
83780203|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
83780204|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
83780205|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83780206|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
83780207|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780208|NCT00014105|Carboplatin|carboplatin|mesh-list
83780209|NCT00014105|Temozolomide|temozolomide|mesh-list
83780210|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780211|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780212|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
83780213|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780214|NCT00014144|Gefitinib|gefitinib|mesh-list
83780215|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780216|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83780217|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780218|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780219|NCT00276588|Paclitaxel|paclitaxel|mesh-list
83780220|NCT00276588|Carboplatin|carboplatin|mesh-list
83780221|NCT00276588|Gemcitabine|gemcitabine|mesh-list
83780222|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780223|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780224|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780225|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780226|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780227|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780228|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780229|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
83780230|NCT00276549|Gemcitabine|gemcitabine|mesh-list
83780231|NCT00276549|Docetaxel|docetaxel|mesh-list
83780232|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780233|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
83780234|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780235|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780236|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780237|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780238|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780239|NCT00014183|Gefitinib|gefitinib|mesh-list
83780240|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780241|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82935447|NCT03942601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83780242|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834933|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780243|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780244|NCT00014261|Interferons|interferons|mesh-list
83780245|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
83780246|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
83780247|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83780248|NCT00014261|Temozolomide|temozolomide|mesh-list
83780249|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780250|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
83780251|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780252|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780253|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
83780254|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780255|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
83780256|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780257|NCT00014339|Prednisone|prednisone|mesh-list
83780258|NCT00014339|Melphalan|melphalan|mesh-list
83780259|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83780260|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
83780261|NCT00014339|Hormones|hormones|mesh-ancestor
83780262|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780263|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780264|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83780265|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780266|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780267|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
83780268|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780269|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83780270|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780271|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
83780272|NCT00014456|Gemcitabine|gemcitabine|mesh-list
83780273|NCT00014456|Docetaxel|docetaxel|mesh-list
83780274|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780275|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
83780276|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780277|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780278|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780279|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780280|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780281|NCT00276393|Insulin|insulin|mesh-list
83780282|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83780283|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780284|NCT00014534|Gemcitabine|gemcitabine|mesh-list
83780285|NCT00014534|Doxorubicin|doxorubicin|mesh-list
83780286|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83780287|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780288|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780289|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
83780290|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780291|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780292|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780293|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780294|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780295|NCT00014573|Aldesleukin|aldesleukin|mesh-list
83780296|NCT00014573|Paclitaxel|paclitaxel|mesh-list
83780297|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
83780298|NCT00014573|Carmustine|carmustine|mesh-list
83780299|NCT00014573|Sargramostim|sargramostim|mesh-list
83780300|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780301|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780302|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780303|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780304|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780305|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780306|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780307|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
83780308|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780309|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780310|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780311|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
83780312|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83780313|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83780314|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83780315|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
83780316|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780317|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
83780318|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83780319|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83780320|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83780321|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780322|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780323|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
83780324|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780325|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780326|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83780327|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780329|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83780330|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780331|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780332|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780333|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780334|NCT00014651|Vapreotide|vapreotide|mesh-list
83780335|NCT00014651|Analgesics|analgesics|mesh-ancestor
83780336|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
83780337|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780338|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780339|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780340|NCT00014690|Topotecan|topotecan|mesh-list
83780341|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83780342|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780343|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780344|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780345|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780346|NCT00014729|Isotretinoin|isotretinoin|mesh-list
83780347|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
83780348|NCT00276198|Vitamin D|vitamin d|mesh-list
83780349|NCT00276198|Vitamin A|vitamin a|mesh-list
83780350|NCT00276198|Vitamins|vitamins|mesh-ancestor
83780351|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
83780352|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780353|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83780354|NCT00276081|Gabapentin|gabapentin|mesh-list
83780355|NCT00276081|Estrogens|estrogens|mesh-list
83780356|NCT00276081|Analgesics|analgesics|mesh-ancestor
83780357|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
83780358|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780359|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780360|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
83780361|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83780362|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83780363|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780364|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780365|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83780366|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83780367|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780368|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780369|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
83780370|NCT00276081|Hormones|hormones|mesh-ancestor
83780371|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780372|NCT00276003|Gemcitabine|gemcitabine|mesh-list
83780373|NCT00276003|Irinotecan|irinotecan|mesh-list
83780374|NCT00276003|Allopurinol|allopurinol|mesh-list
83780375|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780376|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
83780377|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780378|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780379|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83780380|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780381|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780382|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
83780383|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780384|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83780385|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
83780386|NCT00276003|Protective Agents|protective agents|mesh-ancestor
83780387|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780388|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
83780389|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
83780390|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83780391|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83780392|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780393|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780394|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83780395|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83780396|NCT00015041|Buprenorphine|buprenorphine|mesh-list
83780397|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83780398|NCT00015041|Narcotics|narcotics|mesh-ancestor
83780399|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780400|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780401|NCT00015041|Analgesics|analgesics|mesh-ancestor
83780402|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
83780403|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780404|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83780405|NCT00015080|Naltrexone|naltrexone|mesh-list
83780406|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83780407|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83780408|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780409|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
83780410|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780411|NCT00015236|Amantadine|amantadine|mesh-list
83780412|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83780413|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83780414|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
83780415|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780416|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
83780417|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780418|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780419|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780420|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83780421|NCT00015236|Analgesics|analgesics|mesh-ancestor
83780422|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
83780423|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780424|NCT00015275|Cocaine|cocaine|mesh-list
83780425|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
83780426|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
83780427|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780428|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780429|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
83780430|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780431|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83780432|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83780433|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83780434|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780435|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780436|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
83780437|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780438|NCT00275730|Indomethacin|indomethacin|mesh-list
83780439|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83780440|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83780441|NCT00275730|Analgesics|analgesics|mesh-ancestor
83780442|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
83780443|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780444|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780445|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83780446|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780447|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
83780448|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
83780449|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83780450|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83780451|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780452|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780453|NCT00275652|Lamivudine|lamivudine|mesh-list
83780454|NCT00275652|Telbivudine|telbivudine|mesh-list
83780455|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83780456|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83780457|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780458|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780459|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
83780460|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780461|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83780462|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83780463|NCT00275613|Rituximab|rituximab|mesh-list
83780464|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83780465|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780466|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
82935673|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834934|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
83780467|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780468|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780469|NCT00015548|Olanzapine|olanzapine|mesh-list
83780470|NCT00015548|Risperidone|risperidone|mesh-list
83780471|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83780472|NCT00015548|Citalopram|citalopram|mesh-list
83780473|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83780474|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
83780475|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780476|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780477|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780478|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83780479|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83780480|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780481|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780482|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83780483|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
83780484|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
83780485|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
83780486|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780487|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83780488|NCT00015548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83780489|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83780490|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780491|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
83780492|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83780493|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
83780494|NCT00275535|Sirolimus|sirolimus|mesh-list
83780495|NCT00275535|Prednisone|prednisone|mesh-list
83780496|NCT00275535|Tacrolimus|tacrolimus|mesh-list
83780497|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
83780498|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83780499|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83780500|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
83780501|NCT00275535|Hormones|hormones|mesh-ancestor
83780502|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780503|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780504|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83780505|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780506|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780507|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
83780508|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83780509|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780510|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780511|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780512|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83780513|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
83780514|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83780515|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780516|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
83780517|NCT00015626|Metformin|metformin|mesh-list
83780518|NCT00015626|Pioglitazone|pioglitazone|mesh-list
83780519|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
83780520|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83780521|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780522|NCT00015665|Voriconazole|voriconazole|mesh-list
83780523|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
83780524|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780525|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83780526|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83780527|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780528|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780529|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83780530|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
83780531|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780532|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780533|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83780534|NCT00275457|Pramipexole|pramipexole|mesh-list
83780535|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
83780536|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780537|NCT00275457|Protective Agents|protective agents|mesh-ancestor
83780538|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780539|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83780540|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83780541|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
83780542|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
83780543|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780544|NCT00015704|Aldesleukin|aldesleukin|mesh-list
83780545|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780546|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83780547|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83780548|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
83780549|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780550|NCT00275418|Beta Carotene|beta carotene|mesh-list
83780551|NCT00275418|Carotenoids|carotenoids|mesh-list
83780552|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
83780553|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780554|NCT00275418|Protective Agents|protective agents|mesh-ancestor
83780555|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780556|NCT00275418|Provitamins|provitamins|mesh-ancestor
83780557|NCT00275418|Vitamins|vitamins|mesh-ancestor
83780558|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
83780559|NCT01784159|Aspirin|aspirin|mesh-list
83780560|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83780561|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83780562|NCT01784159|Analgesics|analgesics|mesh-ancestor
83780563|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
83780564|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780565|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780566|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83780567|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780568|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83780569|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83780570|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780571|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83780572|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83780573|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780574|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
83780575|NCT00015821|Thalidomide|thalidomide|mesh-list
83780576|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780577|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
83780578|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780579|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
83780580|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83780581|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780582|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83780583|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83780584|NCT00015821|Growth Substances|growth substances|mesh-ancestor
83780585|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780586|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780587|NCT00275184|Metoclopramide|metoclopramide|mesh-list
83780588|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
83780589|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
83780590|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780591|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780592|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83780593|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83780594|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83780595|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
83780596|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780597|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780598|NCT00015860|Prednisone|prednisone|mesh-list
83780599|NCT00015860|Vincristine|vincristine|mesh-list
83780600|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
83780601|NCT00015860|Daunorubicin|daunorubicin|mesh-list
83780602|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83780603|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
83780604|NCT00015860|Hormones|hormones|mesh-ancestor
83780605|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780606|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780607|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83780608|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780609|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780610|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780611|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780612|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780613|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780614|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83780615|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935823|NCT02287246|Bupivacaine|bupivacaine|mesh-list
83780616|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780617|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780618|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780619|NCT00015899|Lonafarnib|lonafarnib|mesh-list
83780620|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780621|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780622|NCT00275106|Leucovorin|leucovorin|mesh-list
83780623|NCT00275106|Cytarabine|cytarabine|mesh-list
83780624|NCT00275106|Dexamethasone|dexamethasone|mesh-list
83780625|NCT00275106|Prednisolone|prednisolone|mesh-list
83780626|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
83780627|NCT00275106|Doxorubicin|doxorubicin|mesh-list
83780628|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83780629|NCT00275106|Methotrexate|methotrexate|mesh-list
83780630|NCT00275106|Vincristine|vincristine|mesh-list
83780631|NCT00275106|Daunorubicin|daunorubicin|mesh-list
83780632|NCT00275106|Asparaginase|asparaginase|mesh-list
83780633|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
83780634|NCT00275106|Thioguanine|thioguanine|mesh-list
83780635|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
83780636|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780637|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
83780638|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780639|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780640|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780641|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
83780642|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780643|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780644|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83780645|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83780646|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
83780647|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
83780648|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780649|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83780650|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
83780651|NCT00275106|Hormones|hormones|mesh-ancestor
83780652|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780653|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83780654|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780655|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780656|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780657|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780658|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83780659|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
83780660|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83780661|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780662|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
83780663|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83780664|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83780665|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83780666|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
83780667|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780668|NCT00275106|Antidotes|antidotes|mesh-ancestor
83780669|NCT00275106|Protective Agents|protective agents|mesh-ancestor
83780670|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
83780671|NCT00275106|Vitamins|vitamins|mesh-ancestor
83780672|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
83780673|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780674|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780675|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780676|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780677|NCT00015938|Docetaxel|docetaxel|mesh-list
83780678|NCT00015938|Vinorelbine|vinorelbine|mesh-list
83780679|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780680|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780681|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780682|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780683|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780684|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780685|NCT00275067|Temozolomide|temozolomide|mesh-list
83780686|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
83780687|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780688|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
83780689|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780690|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780691|NCT00274989|Rituximab|rituximab|mesh-list
82935898|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83780692|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83780693|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83780694|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780695|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
83780696|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780697|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780698|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780699|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
83780700|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780701|NCT00015977|Interleukin-12|interleukin-12|mesh-list
83780702|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83780703|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
83780704|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780705|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83780706|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83780707|NCT00015977|Growth Substances|growth substances|mesh-ancestor
83780708|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780709|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780710|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
83780711|NCT01678586|Gabapentin|gabapentin|mesh-list
83780712|NCT01678586|Analgesics|analgesics|mesh-ancestor
83780713|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
83780714|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780715|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780716|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
83780717|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83780718|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83780719|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780720|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83780721|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83780722|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83780723|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780724|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780725|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
83780726|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83780727|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83780728|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
83780729|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
83780730|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
83780731|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
83780732|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83780733|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83780734|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
83780735|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
83780736|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83780737|NCT00274950|Carboplatin|carboplatin|mesh-list
83780738|NCT00274950|Etoposide|etoposide|mesh-list
83780739|NCT00274950|Ifosfamide|ifosfamide|mesh-list
83780740|NCT00274950|Bleomycin|bleomycin|mesh-list
83780741|NCT00274950|Vinblastine|vinblastine|mesh-list
83780742|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780743|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780744|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780745|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780746|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780747|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780748|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780749|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
83780750|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780751|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780752|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780753|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780754|NCT00016016|Cytarabine|cytarabine|mesh-list
83780755|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
83780756|NCT00016016|Alvocidib|alvocidib|mesh-list
83780757|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780758|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
83780759|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780760|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780761|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
83780762|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780763|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780764|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
83780765|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780766|NCT00016016|Analgesics|analgesics|mesh-ancestor
83780767|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
83780768|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780769|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780770|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780771|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780772|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780773|NCT00016016|Growth Substances|growth substances|mesh-ancestor
83780774|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83780775|NCT00130455|Escitalopram|escitalopram|mesh-list
83780776|NCT00130455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83780777|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83780778|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83780779|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780780|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780781|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
83780782|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780783|NCT00016055|Temozolomide|temozolomide|mesh-list
83780784|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780785|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
83780786|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780787|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780788|NCT00016094|Bevacizumab|bevacizumab|mesh-list
83780789|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83780790|NCT00016094|Antibodies|antibodies|mesh-list
83780791|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
83780792|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83780793|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780794|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83780795|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83780796|NCT00016094|Growth Substances|growth substances|mesh-ancestor
83780797|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780798|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780799|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
83780800|NCT00130338|Rivastigmine|rivastigmine|mesh-list
83780801|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83780802|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780803|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780804|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
83780805|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780806|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780807|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83780808|NCT00130338|Protective Agents|protective agents|mesh-ancestor
83780809|NCT00016133|Leucovorin|leucovorin|mesh-list
83780810|NCT00016133|Fluorouracil|fluorouracil|mesh-list
83780811|NCT00016133|Vaccines|vaccines|mesh-list
83780812|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
83780813|NCT00016133|Calcium|calcium|mesh-list
83780814|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
83780815|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
83780816|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780817|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83780818|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
83780819|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780820|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780821|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780822|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780823|NCT00016133|Antidotes|antidotes|mesh-ancestor
83780824|NCT00016133|Protective Agents|protective agents|mesh-ancestor
83780825|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
83780826|NCT00016133|Vitamins|vitamins|mesh-ancestor
83780827|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
83780828|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83780829|NCT00016172|Doxorubicin|doxorubicin|mesh-list
83780830|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83780831|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780832|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780833|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780834|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780835|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780836|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780837|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83780838|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780839|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83780840|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780841|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780842|NCT00394368|Fluticasone|fluticasone|mesh-list
83780843|NCT00394368|Xhance|xhance|mesh-list
83780844|NCT00394368|Beclomethasone|beclomethasone|mesh-list
83780845|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
83780846|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83780847|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83780848|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83780849|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
83780850|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780851|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780852|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83780853|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
83780854|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
83780855|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83780856|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83780857|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83780858|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83780859|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
83780860|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780861|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780862|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
83780863|NCT00394368|Hormones|hormones|mesh-ancestor
83780864|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780865|NCT01441349|Simvastatin|simvastatin|mesh-list
83780866|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83780867|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83780868|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
83780869|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780870|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83780871|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83780872|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780873|NCT00394407|Insulin|insulin|mesh-list
83780874|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83780875|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83780876|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780877|NCT00130143|Amifostine|amifostine|mesh-list
83780878|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83780879|NCT00130143|Protective Agents|protective agents|mesh-ancestor
83780880|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780881|NCT00016289|Interleukin-12|interleukin-12|mesh-list
83780882|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83780883|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
83780884|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780885|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83780886|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83780887|NCT00016289|Growth Substances|growth substances|mesh-ancestor
83780888|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
83780889|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780890|NCT00130065|Folic Acid|folic acid|mesh-list
83780891|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
83780892|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
83780893|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83780894|NCT00130065|Hematinics|hematinics|mesh-ancestor
83780895|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
83780896|NCT00130065|Vitamins|vitamins|mesh-ancestor
83780897|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
83780898|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780899|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
83780900|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83780901|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83780902|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780903|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83780904|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780905|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780906|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83780907|NCT00016328|Sirolimus|sirolimus|mesh-list
83780908|NCT00016328|Temsirolimus|temsirolimus|mesh-list
83780909|NCT00016328|MTOR Inhibitors|mtor inhibitors|mesh-list
83780910|NCT00016328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83780911|NCT00016328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780912|NCT00016328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780913|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780914|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
83780915|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780916|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780917|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83780918|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780919|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780920|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
83780921|NCT00130026|Caffeine|caffeine|mesh-list
83780922|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83780923|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780924|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83780925|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780926|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780927|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83780928|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83780929|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
83780930|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780931|NCT00016367|Cisplatin|cisplatin|mesh-list
83780932|NCT00016367|Gemcitabine|gemcitabine|mesh-list
83780933|NCT00016367|Trastuzumab|trastuzumab|mesh-list
83780934|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780935|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83780936|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
83780937|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780938|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83780939|NCT00129948|Troxacitabine|troxacitabine|mesh-list
83780940|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780941|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83780942|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83780943|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
83780944|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83780945|NCT00016406|Paclitaxel|paclitaxel|mesh-list
83780946|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
83780947|NCT00016406|Doxorubicin|doxorubicin|mesh-list
83780948|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83780949|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780950|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83780951|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83780952|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83780953|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780954|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83780955|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
83780956|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780957|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83780958|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83780959|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
83780960|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83780961|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83780962|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83780963|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83780964|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83780965|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
83780966|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780967|NCT00016445|Hormones|hormones|mesh-list
83780968|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83780969|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780970|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
83780971|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83780972|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83780973|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
83780974|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83780975|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
83780976|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83780977|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780978|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83780979|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
83780980|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83780981|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
83780982|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83780983|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83780984|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83780985|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
83780986|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
83780987|NCT00016523|Protective Agents|protective agents|mesh-ancestor
83780988|NCT00129597|Ketamine|ketamine|mesh-list
83780989|NCT00129597|Analgesics|analgesics|mesh-ancestor
83780990|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
83780991|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834935|NCT00101894|Panitumumab|panitumumab|mesh-list
82936196|NCT02083250|Fludarabine|fludarabine|mesh-list
82936197|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
82936198|NCT02083250|Busulfan|busulfan|mesh-list
82936199|NCT02083250|Vorinostat|vorinostat|mesh-list
82936200|NCT02083250|Clofarabine|clofarabine|mesh-list
82936201|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
82936202|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82936222|NCT00315640|Anecortave|anecortave|mesh-list
83780992|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83780993|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83780994|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83780995|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
83780996|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
83780997|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83780998|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83780999|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83781000|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781001|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781002|NCT00016601|Ritonavir|ritonavir|mesh-list
83781003|NCT00016601|Nelfinavir|nelfinavir|mesh-list
83781004|NCT00016601|Indinavir|indinavir|mesh-list
83781005|NCT00016601|Nevirapine|nevirapine|mesh-list
83781006|NCT00016601|Efavirenz|efavirenz|mesh-list
83781007|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83781008|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
83781009|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83781010|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83781011|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
83781012|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781013|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781014|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83781015|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83781016|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
83781017|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781018|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83781019|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83781020|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83781021|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83781022|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83781023|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83781024|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83781025|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83781026|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83781027|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83781028|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83781029|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83781030|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
83781031|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83781032|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781033|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83781034|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83781035|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83781036|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83781037|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781038|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
83781039|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83781040|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781041|NCT00129519|Imiquimod|imiquimod|mesh-list
83781042|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781043|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
83781044|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781045|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781046|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
83781047|NCT00016835|Metronidazole|metronidazole|mesh-list
83781048|NCT00016835|Doxycycline|doxycycline|mesh-list
83781049|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781050|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83781051|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83781052|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83781053|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
83781054|NCT00016874|Paclitaxel|paclitaxel|mesh-list
83781055|NCT00016874|Cisplatin|cisplatin|mesh-list
83781056|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781057|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781058|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781059|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781060|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781061|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781062|NCT00016952|Leucovorin|leucovorin|mesh-list
83781063|NCT00016952|Fluorouracil|fluorouracil|mesh-list
83781064|NCT00016952|Irinotecan|irinotecan|mesh-list
83781065|NCT00016952|Calcium|calcium|mesh-list
83781066|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
83834936|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
83781067|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83781068|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781069|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
83781070|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781071|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781072|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781073|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781074|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
83781075|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83781076|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781077|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781078|NCT00016952|Antidotes|antidotes|mesh-ancestor
83781079|NCT00016952|Protective Agents|protective agents|mesh-ancestor
83781080|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
83781081|NCT00016952|Vitamins|vitamins|mesh-ancestor
83781082|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
83781083|NCT00129363|Carvedilol|carvedilol|mesh-list
83781084|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83781085|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83781086|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
83781087|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781088|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781089|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781090|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83781091|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
83781092|NCT00129363|Protective Agents|protective agents|mesh-ancestor
83781093|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83781094|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83781095|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83781096|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
83781097|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83781098|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83781099|NCT00016991|Gefitinib|gefitinib|mesh-list
83781100|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781101|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83781102|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781103|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781104|NCT00017030|Trabectedin|trabectedin|mesh-list
83781105|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781106|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
83781107|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781108|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781109|NCT00017069|Dexamethasone|dexamethasone|mesh-list
83781110|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
83781111|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83781112|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
83781113|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
83781114|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781115|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781116|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83781117|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
83781118|NCT00017069|Hormones|hormones|mesh-ancestor
83781119|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781120|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83781121|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781122|NCT00129285|Modafinil|modafinil|mesh-list
83781123|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83781124|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781125|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82936340|NCT00116116|Efavirenz|efavirenz|mesh-list
82936341|NCT00116116|Stavudine|stavudine|mesh-list
82936342|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82936343|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82936344|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936345|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936346|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
82936347|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936348|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82936349|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82936356|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
83781126|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83781127|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83781128|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781129|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
83781130|NCT00017108|Chlorambucil|chlorambucil|mesh-list
83781131|NCT00017108|Fludarabine|fludarabine|mesh-list
83781132|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
83781133|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781134|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
83781135|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781136|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781137|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781138|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
83781139|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781140|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781141|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83781142|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781143|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
83781144|NCT00129246|Naltrexone|naltrexone|mesh-list
83781145|NCT00129246|Bupropion|bupropion|mesh-list
83781146|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83781147|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83781148|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781149|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
83781150|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781151|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83781152|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
83781153|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83781154|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83781155|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83781156|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83781157|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781158|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
83781159|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781160|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83781161|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83781162|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781163|NCT00017147|Carmustine|carmustine|mesh-list
83781164|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83781165|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781166|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
83781167|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781168|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781169|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781170|NCT00129207|Bortezomib|bortezomib|mesh-list
83781171|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781172|NCT00129168|Cytarabine|cytarabine|mesh-list
83781173|NCT00129168|Daunorubicin|daunorubicin|mesh-list
83781174|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781175|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
83781176|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781177|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781178|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
83781179|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781180|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781181|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
83781182|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781183|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781184|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781185|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781186|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781187|NCT00017186|Gemcitabine|gemcitabine|mesh-list
83781188|NCT00017186|Epirubicin|epirubicin|mesh-list
83781189|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781190|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
83781191|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781192|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781193|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781194|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781195|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781196|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781197|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
83781198|NCT00017225|Melphalan|melphalan|mesh-list
83781199|NCT00017225|Ifosfamide|ifosfamide|mesh-list
83781200|NCT00017225|Dacarbazine|dacarbazine|mesh-list
83781201|NCT00017225|Carboplatin|carboplatin|mesh-list
83781202|NCT00017225|Doxorubicin|doxorubicin|mesh-list
82936396|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83781203|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83781204|NCT00017225|Etoposide|etoposide|mesh-list
83781205|NCT00017225|Vincristine|vincristine|mesh-list
83781206|NCT00017225|Tretinoin|tretinoin|mesh-list
83781207|NCT00017225|Vindesine|vindesine|mesh-list
83781208|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781209|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
83781210|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781211|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781212|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781213|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
83781214|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781215|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781216|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83781217|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781218|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781219|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781220|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781221|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781222|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781223|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781224|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781225|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
83781226|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
83781227|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
83781228|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83781229|NCT00128934|Estradiol|estradiol|mesh-list
83781230|NCT00128934|Estrogens|estrogens|mesh-ancestor
83781231|NCT00128934|Hormones|hormones|mesh-ancestor
83781232|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781233|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781234|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83781235|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
83781236|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83781237|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83781238|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83781239|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83781240|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83781241|NCT00017264|Atrasentan|atrasentan|mesh-list
83781242|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781243|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83781244|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83781245|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781246|NCT00128895|Azathioprine|azathioprine|mesh-list
83781247|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
83781248|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781249|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781250|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781251|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781252|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
83781253|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781254|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781255|NCT00017303|Paclitaxel|paclitaxel|mesh-list
83781256|NCT00017303|Carboplatin|carboplatin|mesh-list
83781257|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781258|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781259|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781260|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781261|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781262|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781263|NCT00017342|Cytarabine|cytarabine|mesh-list
83781264|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
83781265|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781266|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
83781267|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936471|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
82936472|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936473|NCT01337258|Dutasteride|dutasteride|mesh-list
82936474|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82936475|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82936476|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936477|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936478|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
82936481|NCT02603809|Lisinopril|lisinopril|mesh-list
83781268|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781269|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
83781270|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781271|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781272|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
83781273|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781274|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781276|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83781277|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83781278|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
83781279|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781280|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781281|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83781282|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
83781283|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
83781284|NCT00128739|Hormones|hormones|mesh-ancestor
83781285|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781286|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
83781287|NCT00017381|Rituximab|rituximab|mesh-list
83781288|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83781289|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781290|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
83781291|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781292|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781293|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781294|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
83781295|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781296|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781297|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83781298|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83781299|NCT00128700|Temozolomide|temozolomide|mesh-list
83781300|NCT00128700|Vatalanib|vatalanib|mesh-list
83781301|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781302|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
83781303|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781304|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781305|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83781306|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781307|NCT00017459|Vinorelbine|vinorelbine|mesh-list
83781308|NCT00017459|Tirapazamine|tirapazamine|mesh-list
83781309|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781310|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781311|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781312|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781313|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781314|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781315|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
83781316|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781317|NCT00017498|Gemcitabine|gemcitabine|mesh-list
83781318|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781319|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
83781320|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781321|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781322|NCT00128544|Telbivudine|telbivudine|mesh-list
83781323|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
83781324|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781325|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83781326|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781327|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781328|NCT00128505|Mifepristone|mifepristone|mesh-list
83781329|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83781330|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
83781331|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83781332|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781333|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83781334|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83781335|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83781336|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
83781337|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83781338|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83781339|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
83781340|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781341|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
82936523|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83781342|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83781343|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83781344|NCT00017576|Calcitriol|calcitriol|mesh-list
83781345|NCT00017576|Carboplatin|carboplatin|mesh-list
83781346|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781347|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83781348|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781349|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83781350|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83781351|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781352|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83781353|NCT00017576|Vitamins|vitamins|mesh-ancestor
83781354|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
83781355|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83781356|NCT00017654|Cyclosporine|cyclosporine|mesh-list
83781357|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
83781358|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
83781359|NCT00017654|Cyclosporins|cyclosporins|mesh-list
83781360|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83781361|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781362|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
83781363|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781364|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781365|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781366|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
83781367|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781368|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781369|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83781370|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781371|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
83781372|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781373|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
83781374|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83781375|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83781376|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
83781377|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
83781378|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781379|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83781380|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
83781381|NCT00017654|Hormones|hormones|mesh-ancestor
83781382|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781383|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83781384|NCT00017654|Protective Agents|protective agents|mesh-ancestor
83781385|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
83781386|NCT00394485|Procaterol|procaterol|mesh-list
83781387|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83781388|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
83781389|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781390|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781391|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83781392|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
83781393|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
83781394|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83781395|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
83781396|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781397|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781398|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
83781399|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83781400|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83781401|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83781402|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83781403|NCT00017693|Interleukin-4|interleukin-4|mesh-list
83781404|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781405|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
83781406|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781407|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781408|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781409|NCT00128466|Gentamicins|gentamicins|mesh-list
83781410|NCT00128466|Streptomycin|streptomycin|mesh-list
83781411|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83781412|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781413|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83781414|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781415|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781416|NCT00128427|Colchicine|colchicine|mesh-list
83781417|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
83781418|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781419|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781420|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781421|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781422|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781423|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781424|NCT00006099|Antibodies|antibodies|mesh-list
83781425|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83781426|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
83781427|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781428|NCT00018603|Guanfacine|guanfacine|mesh-list
83781429|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83781430|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83781431|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83781432|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83781433|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
83781434|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781435|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781436|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781437|NCT00018642|Haloperidol|haloperidol|mesh-list
83781438|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83781439|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
83781440|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
83781441|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83781442|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83781443|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83781444|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83781445|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781446|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
83781447|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
83781448|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781449|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83781450|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83781451|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
83781452|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781453|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781454|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83781455|NCT00018083|Efavirenz|efavirenz|mesh-list
83781456|NCT00018083|Isoniazid|isoniazid|mesh-list
83781457|NCT00018083|Rifabutin|rifabutin|mesh-list
83781458|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83781459|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83781460|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781461|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781462|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
83781463|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781464|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83781465|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83781466|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83781467|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83781468|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83781469|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83781470|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
83781471|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83781472|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83781473|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83781474|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
83781475|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83781476|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83781477|NCT00018200|Benztropine|benztropine|mesh-list
83781478|NCT00018200|Fluoxetine|fluoxetine|mesh-list
83781479|NCT00018200|Desipramine|desipramine|mesh-list
83781480|NCT00018200|Clomipramine|clomipramine|mesh-list
83781481|NCT00018200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83781482|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83781483|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83781484|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781485|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781486|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
83781487|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781488|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83781489|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
83781490|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82936669|NCT03740893|Durvalumab|durvalumab|mesh-list
83781491|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83781492|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83781493|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781494|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83781495|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83781496|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
83781497|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83781498|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83781499|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
83781500|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
83781501|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781502|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83781503|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83781504|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
83781505|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83781506|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
83781507|NCT00018759|Paroxetine|paroxetine|mesh-list
83781508|NCT00018759|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83781509|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83781510|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83781511|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781512|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781513|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
83781514|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781515|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83781516|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
83781517|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83781518|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83781519|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83781520|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781521|NCT04734353|Ticagrelor|ticagrelor|mesh-list
83781522|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83781523|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83781524|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83781525|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83781526|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83781527|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
83781528|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781529|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781530|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781531|NCT00018954|Cytarabine|cytarabine|mesh-list
83781532|NCT00018954|Prednisone|prednisone|mesh-list
83781533|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
83781534|NCT00018954|Ifosfamide|ifosfamide|mesh-list
83781535|NCT00018954|Doxorubicin|doxorubicin|mesh-list
83781536|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83781537|NCT00018954|Methotrexate|methotrexate|mesh-list
83781538|NCT00018954|Etoposide|etoposide|mesh-list
83781539|NCT00018954|Vincristine|vincristine|mesh-list
83781540|NCT00018954|Daunorubicin|daunorubicin|mesh-list
83781541|NCT00018954|Asparaginase|asparaginase|mesh-list
83781542|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
83781543|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781544|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
83781545|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781546|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781547|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781548|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
83781549|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781550|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781551|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83781552|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781553|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781554|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781555|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781556|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83781557|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
83781558|NCT00018954|Hormones|hormones|mesh-ancestor
83781559|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781560|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83781561|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83781562|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
83781563|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83781564|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781565|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
83781566|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
83781567|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83781568|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83781569|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781570|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
83781571|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781572|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781573|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781574|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781575|NCT00018278|Donepezil|donepezil|mesh-list
83781576|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83781577|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781578|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781579|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
83781580|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781581|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781582|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
83781583|NCT00019032|Antibodies|antibodies|mesh-list
83781584|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83781585|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
83781586|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781587|NCT00019071|Cladribine|cladribine|mesh-list
83781588|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781589|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781590|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
83781591|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781592|NCT04734119|Anesthetics|anesthetics|mesh-list
83781593|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83781594|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781595|NCT00018356|Testosterone|testosterone|mesh-list
83781596|NCT00018356|Androgens|androgens|mesh-ancestor
83781597|NCT00018356|Hormones|hormones|mesh-ancestor
83781598|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781599|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781600|NCT00019188|Interleukin-12|interleukin-12|mesh-list
83781601|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781602|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
83781603|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781604|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83781605|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83781606|NCT00019188|Growth Substances|growth substances|mesh-ancestor
83781607|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
83781608|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781609|NCT00019227|Calcium|calcium|mesh-list
83781610|NCT00019227|Daclizumab|daclizumab|mesh-list
83781611|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
83781612|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83781613|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781614|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781615|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
83781616|NCT00019227|Antidotes|antidotes|mesh-ancestor
83781617|NCT00019227|Protective Agents|protective agents|mesh-ancestor
83781618|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
83781619|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
83781620|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781621|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83781622|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83781623|NCT00019344|Alvocidib|alvocidib|mesh-list
83781624|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781625|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83781626|NCT00019344|Growth Substances|growth substances|mesh-ancestor
83781627|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781628|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83781629|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781630|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781631|NCT00019383|Aldesleukin|aldesleukin|mesh-list
83781632|NCT00019383|Sargramostim|sargramostim|mesh-list
83781633|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
83781634|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
83781635|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781636|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781637|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83781638|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83781639|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
83781640|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781641|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781643|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781644|NCT00018551|Folic Acid|folic acid|mesh-list
83781645|NCT00018551|Hematinics|hematinics|mesh-ancestor
83781646|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
83781647|NCT00018551|Vitamins|vitamins|mesh-ancestor
83781648|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
83781649|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781650|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83781651|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781652|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83781653|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83781654|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781655|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83781656|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781657|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83781658|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83781659|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
83781660|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781661|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781662|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83781663|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83781664|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83781665|NCT00019539|Thalidomide|thalidomide|mesh-list
83781666|NCT00019539|Bevacizumab|bevacizumab|mesh-list
83781667|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83781668|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781669|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83781670|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83781671|NCT00019539|Growth Substances|growth substances|mesh-ancestor
83781672|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781673|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
83781674|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781675|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
83781676|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
83781677|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83781678|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781679|NCT00019695|Alendronate|alendronate|mesh-list
83781680|NCT00019695|Ketoconazole|ketoconazole|mesh-list
83781681|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
83781682|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781683|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83781684|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83781685|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781686|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781687|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83781688|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
83781689|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781690|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781691|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83781692|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83781693|NCT00019734|Aldesleukin|aldesleukin|mesh-list
83781694|NCT00019734|Vaccines|vaccines|mesh-list
83781695|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
83781696|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781697|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781698|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83781699|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83781700|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
83781701|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781702|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83781703|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
83781704|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781705|NCT00019773|Capecitabine|capecitabine|mesh-list
83781706|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
83781707|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781708|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
83781709|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781710|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781711|NCT03370406|Fluorouracil|fluorouracil|mesh-list
83781712|NCT03370406|Imiquimod|imiquimod|mesh-list
83781713|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
83781714|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936896|NCT03942991|Carticaine|carticaine|mesh-list
83781715|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781716|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781717|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781718|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
83781719|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781720|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781721|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
83781722|NCT00019812|Paclitaxel|paclitaxel|mesh-list
83781723|NCT00019812|Trastuzumab|trastuzumab|mesh-list
83781724|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781725|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781726|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781727|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781728|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781729|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781730|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83781731|NCT03326063|Ifetroban|ifetroban|mesh-list
83781732|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83781733|NCT00019890|Sargramostim|sargramostim|mesh-list
83781734|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
83781735|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781736|NCT00019968|Melphalan|melphalan|mesh-list
83781737|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781738|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
83781739|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781740|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781741|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83781742|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781743|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
83781744|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781745|NCT00020007|Paclitaxel|paclitaxel|mesh-list
83781746|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781747|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781748|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781749|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781750|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781751|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781752|NCT00142454|Imiquimod|imiquimod|mesh-list
83781753|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781754|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
83781755|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781756|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781757|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
83781758|NCT00020046|Thalidomide|thalidomide|mesh-list
83781759|NCT00020046|Docetaxel|docetaxel|mesh-list
83781760|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781761|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781762|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781763|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781764|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781765|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781766|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
83781767|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781768|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
83781769|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83781770|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781771|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83781772|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83781773|NCT00020046|Growth Substances|growth substances|mesh-ancestor
83781774|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
83781775|NCT00020124|Doxorubicin|doxorubicin|mesh-list
83781776|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83781777|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781778|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781779|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781780|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781781|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781782|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781783|NCT00020202|Romidepsin|romidepsin|mesh-list
83781784|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781785|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781786|NCT00020202|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83781787|NCT00020202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781788|NCT00020202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781789|NCT05576675|Sufentanil|sufentanil|mesh-list
83781790|NCT05576675|Dsuvia|dsuvia|mesh-list
83781791|NCT05576675|Hydromorphone|hydromorphone|mesh-list
83781792|NCT05576675|Nalbuphine|nalbuphine|mesh-list
83781793|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83781794|NCT05576675|Narcotics|narcotics|mesh-ancestor
83781795|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83781796|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781797|NCT05576675|Analgesics|analgesics|mesh-ancestor
83781798|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
83781799|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781800|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83781801|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83781802|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
83781803|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
83781804|NCT00020358|Aldesleukin|aldesleukin|mesh-list
83781805|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
83781806|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781807|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83781808|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83781809|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
83781810|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781811|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781812|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
83781813|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781814|NCT00020397|Aldesleukin|aldesleukin|mesh-list
83781815|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781816|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83781817|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83781818|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
83781819|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781820|NCT00020475|Interleukin-2|interleukin-2|mesh-list
83781821|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83781822|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781823|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83781824|NCT00020475|Analgesics|analgesics|mesh-ancestor
83781825|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
83781826|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781827|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781828|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83781829|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
83781830|NCT05576480|Capecitabine|capecitabine|mesh-list
83781831|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
83781832|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781833|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
83781834|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781835|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781836|NCT00020631|Pirfenidone|pirfenidone|mesh-list
83781837|NCT00020631|Analgesics|analgesics|mesh-ancestor
83781838|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
83781839|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781840|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781841|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83781842|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83781843|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83781844|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781845|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781846|NCT05576324|Ivacaftor|ivacaftor|mesh-list
83781847|NCT05576324|Elexacaftor|elexacaftor|mesh-list
83781848|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83781849|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83781850|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781851|NCT00020709|Docetaxel|docetaxel|mesh-list
83781852|NCT00020709|Etoposide|etoposide|mesh-list
83781853|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
83781854|NCT00020709|Gefitinib|gefitinib|mesh-list
83781855|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781856|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781857|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781858|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781859|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781860|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781861|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82937041|NCT03529084|Nazartinib|nazartinib|mesh-list
83781862|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781863|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781864|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83781865|NCT00020748|Irinotecan|irinotecan|mesh-list
83781866|NCT00020748|Epirubicin|epirubicin|mesh-list
83781867|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83781868|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781869|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781870|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781871|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781872|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781873|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781874|NCT00020787|Cisplatin|cisplatin|mesh-list
83781875|NCT00020787|Fluorouracil|fluorouracil|mesh-list
83781876|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781877|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
83781878|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781879|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781880|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781881|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
83781882|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781883|NCT00020865|Levofloxacin|levofloxacin|mesh-list
83781884|NCT00020865|Cefepime|cefepime|mesh-list
83781885|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83781886|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781887|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83781888|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781889|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781890|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781891|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781892|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781893|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83781894|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83781895|NCT00020943|Leucovorin|leucovorin|mesh-list
83781896|NCT00020943|Cytarabine|cytarabine|mesh-list
83781897|NCT00020943|Prednisone|prednisone|mesh-list
83781898|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
83781899|NCT00020943|Carmustine|carmustine|mesh-list
83781900|NCT00020943|Rituximab|rituximab|mesh-list
83781901|NCT00020943|Doxorubicin|doxorubicin|mesh-list
83781902|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83781903|NCT00020943|Methotrexate|methotrexate|mesh-list
83781904|NCT00020943|Etoposide|etoposide|mesh-list
83781905|NCT00020943|Vincristine|vincristine|mesh-list
83781906|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
83781907|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83781908|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
83781909|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781910|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83781911|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83781912|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
83781913|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781914|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781915|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83781916|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83781917|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83781918|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83781919|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83781920|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83781921|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83781922|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
83781923|NCT00020943|Hormones|hormones|mesh-ancestor
83781924|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83781925|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83781926|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83781927|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
83781928|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83781929|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83781930|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
83781931|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
83781932|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83781933|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83781934|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781935|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
83781936|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83781937|NCT00020943|Antidotes|antidotes|mesh-ancestor
83781938|NCT00020943|Protective Agents|protective agents|mesh-ancestor
83781939|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
83781940|NCT00020943|Vitamins|vitamins|mesh-ancestor
82937117|NCT04791176|Lenvatinib|lenvatinib|mesh-list
83781941|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
83781942|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781943|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781944|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781945|NCT00021060|Paclitaxel|paclitaxel|mesh-list
83781946|NCT00021060|Bevacizumab|bevacizumab|mesh-list
83781947|NCT00021060|Carboplatin|carboplatin|mesh-list
83781948|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83781949|NCT00021060|Antibodies|antibodies|mesh-list
83781950|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
83781951|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83781952|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83781953|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781954|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781955|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781956|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781957|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781958|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83781959|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83781960|NCT00021060|Growth Substances|growth substances|mesh-ancestor
83781961|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781962|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
83781963|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
83781964|NCT00021099|Epothilones|epothilones|mesh-list
83781965|NCT00021099|Epothilone B|epothilone b|mesh-list
83781966|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
83781967|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
83781968|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
83781969|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781970|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83781971|NCT05574257|Propofol|propofol|mesh-list
83781972|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83781973|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83781974|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781975|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83781976|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
83781977|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
83781978|NCT05574218|Glycine|glycine|mesh-list
83781979|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
83781980|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781981|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781982|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781983|NCT00021138|Nicotine|nicotine|mesh-list
83781984|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83781985|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
83781986|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83781987|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781988|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83781989|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83781990|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
83781991|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83781992|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83781993|NCT00020670|Vaccines|vaccines|mesh-list
83781994|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
83781995|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83781996|NCT05574179|Midazolam|midazolam|mesh-list
83781997|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
83781998|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83781999|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83782000|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782001|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83782002|NCT05574179|Analgesics|analgesics|mesh-ancestor
83782003|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
83782004|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782005|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83782006|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83782007|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83782008|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
83782009|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782010|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782011|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83782012|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83782013|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83782014|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83782015|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82937186|NCT01212133|Incretins|incretins|mesh-ancestor
83782016|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
83782017|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
83782018|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
83782019|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
83782020|NCT00021216|Bortezomib|bortezomib|mesh-list
83782021|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782022|NCT00021294|Eflornithine|eflornithine|mesh-list
83782023|NCT00021294|Triamcinolone|triamcinolone|mesh-list
83782024|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782025|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
83782026|NCT00021294|Hormones|hormones|mesh-ancestor
83782027|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782028|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782029|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782030|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782031|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782032|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83782033|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83782034|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83782035|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782036|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83782037|NCT00021333|Paclitaxel|paclitaxel|mesh-list
83782038|NCT00021333|Cisplatin|cisplatin|mesh-list
83782039|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782040|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782041|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782042|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782043|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782044|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782045|NCT00021372|Paclitaxel|paclitaxel|mesh-list
83782046|NCT00021372|Estramustine|estramustine|mesh-list
83782047|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782048|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782049|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782050|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782051|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782052|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782053|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782054|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
83782055|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782056|NCT00392093|Estrogens|estrogens|mesh-list
83782057|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83782058|NCT00392093|Hormones|hormones|mesh-ancestor
83782059|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782060|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782061|NCT00018161|Mecamylamine|mecamylamine|mesh-list
83782062|NCT00018161|Nicotine|nicotine|mesh-list
83782063|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83782064|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
83782065|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782066|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782067|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83782068|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83782069|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83782070|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782071|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782072|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83782073|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83782074|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83782075|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83782076|NCT00021450|Goserelin|goserelin|mesh-list
83782077|NCT00021450|Bicalutamide|bicalutamide|mesh-list
83782078|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782079|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782080|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
83782081|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
83782082|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782083|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782084|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
83782085|NCT00021489|Abacavir|abacavir|mesh-list
83782086|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782087|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782088|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83782089|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
83782090|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782091|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782092|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782093|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782094|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83782095|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83782097|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83782098|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83782099|NCT00021528|Mirtazapine|mirtazapine|mesh-list
83782100|NCT00021528|Buspirone|buspirone|mesh-list
83782101|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
83782102|NCT00021528|Sertraline|sertraline|mesh-list
83782103|NCT00021528|Citalopram|citalopram|mesh-list
83782104|NCT00021528|Nortriptyline|nortriptyline|mesh-list
83782105|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
83782106|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83782107|NCT00021528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83782108|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83782109|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83782110|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782111|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782112|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
83782113|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782114|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782115|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83782116|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83782117|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83782118|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83782119|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
83782120|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
83782121|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83782122|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83782123|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83782124|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83782125|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
83782126|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83782127|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83782128|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83782129|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83782130|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83782131|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83782132|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83782133|NCT00021567|Interferons|interferons|mesh-list
83782134|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
83782135|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782136|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
83782137|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782138|NCT00021645|Vitamin E|vitamin e|mesh-list
83782139|NCT00021645|Vitamins|vitamins|mesh-ancestor
83782140|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
83782141|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782142|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
83782143|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782144|NCT00021645|Protective Agents|protective agents|mesh-ancestor
83782145|NCT05573204|Vitamin E|vitamin e|mesh-list
83782146|NCT05573204|Vitamins|vitamins|mesh-ancestor
83782147|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
83782148|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782149|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
83782150|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782151|NCT05573204|Protective Agents|protective agents|mesh-ancestor
83782152|NCT00021996|Valdecoxib|valdecoxib|mesh-list
83782153|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83782154|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83782155|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782156|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782157|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83782158|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83782159|NCT00021996|Analgesics|analgesics|mesh-ancestor
83782160|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
83782161|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782162|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782163|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782164|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782165|NCT00022074|Gabapentin|gabapentin|mesh-list
83782166|NCT00022074|Analgesics|analgesics|mesh-ancestor
83782167|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
82937336|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782168|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782169|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782171|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83782172|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83782173|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83782174|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83782175|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83782176|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83782177|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782178|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782179|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
83782180|NCT00022152|Vinorelbine|vinorelbine|mesh-list
83782181|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782182|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782183|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782184|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782185|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782186|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782187|NCT00022191|Paclitaxel|paclitaxel|mesh-list
83782188|NCT00022191|Gemcitabine|gemcitabine|mesh-list
83782189|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782190|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782191|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782192|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782193|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782194|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782195|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782196|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
83782197|NCT00022230|Aldesleukin|aldesleukin|mesh-list
83782198|NCT00022230|Paclitaxel|paclitaxel|mesh-list
83782199|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
83782200|NCT00022230|Doxorubicin|doxorubicin|mesh-list
83782201|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83782202|NCT00022230|Sargramostim|sargramostim|mesh-list
83782203|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782204|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782205|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782206|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782207|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782208|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782209|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782210|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
83782211|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782212|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782213|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782214|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
83782215|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782216|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782217|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782218|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782219|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782220|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83782221|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83782222|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
83782223|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782224|NCT00022308|Irinotecan|irinotecan|mesh-list
83782225|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782226|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83782227|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782228|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782229|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782230|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
83782231|NCT00022386|Hematinics|hematinics|mesh-ancestor
83782232|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
83782233|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782234|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782235|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782236|NCT00022464|Sirolimus|sirolimus|mesh-list
83782237|NCT00022464|Temsirolimus|temsirolimus|mesh-list
83782238|NCT00022464|MTOR Inhibitors|mtor inhibitors|mesh-list
83782239|NCT00022464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83782240|NCT00022464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782241|NCT00022464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782242|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782243|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
83782244|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782245|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782246|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782247|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782248|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782249|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
83782250|NCT00022542|Epothilones|epothilones|mesh-list
83782251|NCT00022542|Epothilone B|epothilone b|mesh-list
83782252|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782253|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782254|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782255|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782256|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782257|NCT00022581|Thalidomide|thalidomide|mesh-list
83782258|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782259|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
83782260|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782261|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
83782262|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782263|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782264|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83782265|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83782266|NCT00022581|Growth Substances|growth substances|mesh-ancestor
83782267|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
83782268|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782269|NCT05551871|Simvastatin|simvastatin|mesh-list
83782270|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83782271|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83782272|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
83782273|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782274|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83782275|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83782276|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782277|NCT00022620|Paclitaxel|paclitaxel|mesh-list
83782278|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782279|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782280|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782281|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782282|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782283|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782284|NCT00022737|Leucovorin|leucovorin|mesh-list
83782285|NCT00022737|Cytarabine|cytarabine|mesh-list
83782286|NCT00022737|Cyclosporine|cyclosporine|mesh-list
83782287|NCT00022737|Dexamethasone|dexamethasone|mesh-list
83782288|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
83782289|NCT00022737|Ifosfamide|ifosfamide|mesh-list
83782290|NCT00022737|Methotrexate|methotrexate|mesh-list
83782291|NCT00022737|Etoposide|etoposide|mesh-list
83782292|NCT00022737|Vincristine|vincristine|mesh-list
83782293|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
83782294|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
83782295|NCT00022737|Daunorubicin|daunorubicin|mesh-list
83782296|NCT00022737|Asparaginase|asparaginase|mesh-list
83782297|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
83782298|NCT00022737|Pegaspargase|pegaspargase|mesh-list
83782299|NCT00022737|Cyclosporins|cyclosporins|mesh-list
83782300|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
83782301|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782302|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
83782303|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782304|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782305|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782306|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
83782307|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782308|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782309|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782310|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782311|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
83782312|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
83782313|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782314|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83782315|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
83782316|NCT00022737|Hormones|hormones|mesh-ancestor
83782317|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782318|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82937491|NCT01119157|Vaccines|vaccines|mesh-list
83782319|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83782320|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
83782321|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83782322|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782324|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
83782325|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782326|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83782327|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83782328|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782329|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782330|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782331|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
83782332|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782333|NCT00022737|Antidotes|antidotes|mesh-ancestor
83782334|NCT00022737|Protective Agents|protective agents|mesh-ancestor
83782335|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
83782336|NCT00022737|Vitamins|vitamins|mesh-ancestor
83782337|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
83782338|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782339|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782340|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782341|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
83782342|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83782343|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83782344|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782345|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
83782346|NCT00022893|Antibodies|antibodies|mesh-list
83782347|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
83782348|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782349|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782350|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83782351|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
83782352|NCT00022932|Antibodies|antibodies|mesh-list
83782353|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
83782354|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782355|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782356|NCT00022971|Rituximab|rituximab|mesh-list
83782357|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83782358|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782359|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
83782360|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782361|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782362|NCT05512754|Ibuprofen|ibuprofen|mesh-list
83782363|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83782364|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83782365|NCT05512754|Analgesics|analgesics|mesh-ancestor
83782366|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
83782367|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782368|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782369|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782370|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782371|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83782372|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782373|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782374|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
83782375|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
83782376|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
83782377|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83782378|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
83782379|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782380|NCT02971878|Protective Agents|protective agents|mesh-ancestor
83782381|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782382|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
83782383|NCT02971878|Vitamins|vitamins|mesh-ancestor
83782384|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
83782385|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
83782386|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
83782387|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782388|NCT02971878|Expectorants|expectorants|mesh-ancestor
83782389|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
83782390|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83782391|NCT02971878|Antidotes|antidotes|mesh-ancestor
83782392|NCT00023166|Paclitaxel|paclitaxel|mesh-list
83782393|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782394|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782395|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782396|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
82937561|NCT04902040|Durvalumab|durvalumab|mesh-list
83782397|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782398|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782399|NCT00394992|Bevacizumab|bevacizumab|mesh-list
83782400|NCT00394992|Capecitabine|capecitabine|mesh-list
83782401|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
83782402|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83782403|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782404|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83782405|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83782406|NCT00394992|Growth Substances|growth substances|mesh-ancestor
83782407|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782408|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
83782409|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782410|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
83782411|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782412|NCT00395031|Ziprasidone|ziprasidone|mesh-list
83782413|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83782414|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
83782415|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782416|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782417|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782418|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83782419|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83782420|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83782421|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83782422|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83782423|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
83782424|NCT00395070|Temozolomide|temozolomide|mesh-list
83782425|NCT00395070|Dacarbazine|dacarbazine|mesh-list
83782426|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782427|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
83782428|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782429|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782430|NCT00023244|Cyclosporine|cyclosporine|mesh-list
83782431|NCT00023244|Sirolimus|sirolimus|mesh-list
83782432|NCT00023244|Trimethoprim|trimethoprim|mesh-list
83782433|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
83782434|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83782435|NCT00023244|Prednisone|prednisone|mesh-list
83782436|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
83782437|NCT00023244|Tacrolimus|tacrolimus|mesh-list
83782438|NCT00023244|Cyclosporins|cyclosporins|mesh-list
83782439|NCT00023244|Basiliximab|basiliximab|mesh-list
83782440|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782441|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
83782442|NCT00023244|Hormones|hormones|mesh-ancestor
83782443|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782444|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782445|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782446|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782447|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782448|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
83782449|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83782450|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782451|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782452|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
83782453|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782454|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
83782455|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782456|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782457|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782458|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
83782459|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
83782460|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782461|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83782462|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83782463|NCT00023244|Protective Agents|protective agents|mesh-ancestor
83782464|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83782465|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
83782466|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83782467|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83782468|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83782469|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83782470|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83782471|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83782472|NCT00023283|Buprenorphine|buprenorphine|mesh-list
83782473|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83782474|NCT00023283|Narcotics|narcotics|mesh-ancestor
83782475|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83782476|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782477|NCT00023283|Analgesics|analgesics|mesh-ancestor
83782478|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
83782479|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782480|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83782481|NCT00023361|Rifabutin|rifabutin|mesh-list
83782482|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782483|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782484|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83782485|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
83782486|NCT00023400|Nelfinavir|nelfinavir|mesh-list
83782487|NCT00023400|Rifabutin|rifabutin|mesh-list
83782488|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83782489|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83782490|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
83782491|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782492|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782493|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83782494|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83782495|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
83782496|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782497|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782498|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83782499|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
83782500|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
83782501|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83782502|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83782503|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782504|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
83782505|NCT05359172|Coagulants|coagulants|mesh-ancestor
83782506|NCT00023634|Sargramostim|sargramostim|mesh-list
83782507|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
83782508|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782509|NCT00023751|Leucovorin|leucovorin|mesh-list
83782510|NCT00023751|Fluorouracil|fluorouracil|mesh-list
83782511|NCT00023751|Calcium|calcium|mesh-list
83782512|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
83782513|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83782514|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782515|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
83782516|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782517|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782518|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782519|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782520|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
83782521|NCT00023751|Antidotes|antidotes|mesh-ancestor
83782522|NCT00023751|Protective Agents|protective agents|mesh-ancestor
83782523|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
83782524|NCT00023751|Vitamins|vitamins|mesh-ancestor
83782525|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
83782526|NCT00023790|Silicon|silicon|mesh-list
83782527|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
83782528|NCT00023790|Trace Elements|trace elements|mesh-ancestor
83782529|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
83782530|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782531|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
83782532|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83782533|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83782534|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782535|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
83782536|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83782537|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
83782538|NCT02971982|Dexamethasone|dexamethasone|mesh-list
83782539|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
83782540|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
83782541|NCT02971982|Rituximab|rituximab|mesh-list
83782542|NCT02971982|Bortezomib|bortezomib|mesh-list
83782543|NCT02971982|BB 1101|bb 1101|mesh-list
83782544|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782545|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
83782546|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782547|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937711|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782548|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782549|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
83782550|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782551|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782552|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782553|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83782554|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782555|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
83782556|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
83782557|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782558|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83782559|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
83782560|NCT02971982|Hormones|hormones|mesh-ancestor
83782561|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782562|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782563|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
83782564|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782565|NCT00023829|Bicalutamide|bicalutamide|mesh-list
83782566|NCT00023829|Flutamide|flutamide|mesh-list
83782567|NCT00023829|Hormones|hormones|mesh-list
83782568|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782569|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782570|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
83782571|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
83782572|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782573|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782574|NCT00023868|Leucovorin|leucovorin|mesh-list
83782575|NCT00023868|Doxorubicin|doxorubicin|mesh-list
83782576|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83782577|NCT00023868|Fluorouracil|fluorouracil|mesh-list
83782578|NCT00023868|Irinotecan|irinotecan|mesh-list
83782579|NCT00023868|Mitomycins|mitomycins|mesh-list
83782580|NCT00023868|Mitomycin|mitomycin|mesh-list
83782581|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
83782582|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782583|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782584|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782585|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782586|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782587|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782588|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782589|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
83782590|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782591|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782592|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
83782593|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83782594|NCT00023868|Antidotes|antidotes|mesh-ancestor
83782595|NCT00023868|Protective Agents|protective agents|mesh-ancestor
83782596|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
83782597|NCT00023868|Vitamins|vitamins|mesh-ancestor
83782598|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
83782599|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
83782600|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83782601|NCT00023907|Paclitaxel|paclitaxel|mesh-list
83782602|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782603|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782604|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782605|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782606|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782607|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782608|NCT00023946|Epothilones|epothilones|mesh-list
83782609|NCT00023946|Epothilone B|epothilone b|mesh-list
83782610|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782611|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782612|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782613|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782614|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782615|NCT05268185|Vaccines|vaccines|mesh-list
83782616|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
83782617|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782618|NCT00024063|Orantinib|orantinib|mesh-list
83782619|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83782620|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782621|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782622|NCT00024141|Fluorouracil|fluorouracil|mesh-list
83782623|NCT00024141|Irinotecan|irinotecan|mesh-list
83782624|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
83782625|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937786|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83782626|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782627|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782628|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782629|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
83782630|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782631|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83782632|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782633|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782634|NCT05239286|Anesthetics|anesthetics|mesh-list
83782635|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83782636|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782637|NCT00024180|Romidepsin|romidepsin|mesh-list
83782638|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782639|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782640|NCT00024180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83782641|NCT00024180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782642|NCT00024180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782643|NCT00024297|Warfarin|warfarin|mesh-list
83782644|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
83782645|NCT00024336|Tamoxifen|tamoxifen|mesh-list
83782646|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83782647|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
83782648|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782649|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782650|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782651|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782652|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83782653|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83782654|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83782655|NCT00024375|Paclitaxel|paclitaxel|mesh-list
83782656|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782657|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782658|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782659|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782660|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782661|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782662|NCT00024414|Paclitaxel|paclitaxel|mesh-list
83782663|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782664|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782665|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782666|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782667|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782668|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782669|NCT00024453|Teicoplanin|teicoplanin|mesh-list
83782670|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782671|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782672|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
83782673|NCT00024492|Analgesics|analgesics|mesh-ancestor
83782674|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
83782675|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782676|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782677|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782678|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782679|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782680|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782681|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782682|NCT00024531|Atorvastatin|atorvastatin|mesh-list
83782683|NCT00024531|Calcium|calcium|mesh-list
83782684|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83782685|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782686|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83782687|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83782688|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
83782689|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782690|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83782691|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83782692|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782693|NCT00024570|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83782694|NCT00024570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782695|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
83782696|NCT05080049|Hematinics|hematinics|mesh-ancestor
83782697|NCT00024687|Immunotoxins|immunotoxins|mesh-list
83782698|NCT00024687|Immunoconjugates|immunoconjugates|mesh-ancestor
83782699|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
83782700|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782701|NCT05072444|QPX7728|qpx7728|mesh-list
83782702|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83782703|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782704|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782705|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782706|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782707|NCT00025038|Cytarabine|cytarabine|mesh-list
83782708|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
83782709|NCT00025038|Fludarabine|fludarabine|mesh-list
83782710|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
83782711|NCT00025038|Tipifarnib|tipifarnib|mesh-list
83782712|NCT00025038|Isotretinoin|isotretinoin|mesh-list
83782713|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
83782714|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83782715|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
83782716|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782717|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
83782718|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782719|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782720|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782721|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
83782722|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782723|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782724|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782725|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782726|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
83782727|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
83782728|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782729|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
83782730|NCT05055830|Acetaminophen|acetaminophen|mesh-list
83782731|NCT05055830|Methadone|methadone|mesh-list
83782732|NCT05055830|Caffeine|caffeine|mesh-list
83782733|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83782734|NCT05055830|Analgesics|analgesics|mesh-ancestor
83782735|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
83782736|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782737|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782738|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
83782739|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83782740|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83782741|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782742|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782743|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83782744|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83782745|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
83782746|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782747|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83782748|NCT05055830|Narcotics|narcotics|mesh-ancestor
83782749|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83782750|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
83782751|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
83782752|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
83782753|NCT00025077|Thiotepa|thiotepa|mesh-list
83782754|NCT00025077|Carboplatin|carboplatin|mesh-list
83782755|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782756|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
83782757|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782758|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782759|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782760|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
83782761|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782762|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782763|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782764|NCT05051891|Prednisone|prednisone|mesh-list
83782765|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
83782766|NCT05051891|Vincristine|vincristine|mesh-list
83782767|NCT05051891|Rituximab|rituximab|mesh-list
83782768|NCT05051891|Doxorubicin|doxorubicin|mesh-list
83782769|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782770|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
83782771|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782772|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782773|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782774|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
83782775|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782776|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782777|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782778|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782779|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
83782780|NCT05051891|Hormones|hormones|mesh-ancestor
83782781|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782782|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782783|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782784|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782785|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782786|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782787|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83782788|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782789|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782790|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782791|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782792|NCT00025194|Estramustine|estramustine|mesh-list
83782793|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782794|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
83782795|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782796|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782797|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83782798|NCT00025272|Carboplatin|carboplatin|mesh-list
83782799|NCT00025272|Etoposide|etoposide|mesh-list
83782800|NCT00025272|Topotecan|topotecan|mesh-list
83782801|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782802|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782803|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782804|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782805|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782806|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782807|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83782808|NCT05023382|Teduglutide|teduglutide|mesh-list
83782809|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83782810|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83782811|NCT05023382|Protective Agents|protective agents|mesh-ancestor
83782812|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782813|NCT00025311|Topotecan|topotecan|mesh-list
83782814|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83782815|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782816|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782817|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782818|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782819|NCT00025116|Gefitinib|gefitinib|mesh-list
83782820|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782821|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83782822|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782823|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782824|NCT00025350|Gefitinib|gefitinib|mesh-list
83782825|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782826|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83782827|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782828|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782829|NCT00025389|Paclitaxel|paclitaxel|mesh-list
83782830|NCT00025389|Bevacizumab|bevacizumab|mesh-list
83782831|NCT00025389|Carboplatin|carboplatin|mesh-list
83782832|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782833|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782834|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782835|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782836|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782837|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782838|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83782839|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83782840|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83782841|NCT00025389|Growth Substances|growth substances|mesh-ancestor
83782842|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782843|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
83782844|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
83782845|NCT00025428|Carboplatin|carboplatin|mesh-list
83782846|NCT00025428|Doxorubicin|doxorubicin|mesh-list
83782847|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83782848|NCT00025428|Etoposide|etoposide|mesh-list
83782849|NCT00025428|Vincristine|vincristine|mesh-list
82938008|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83782850|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782851|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
83782852|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782853|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782854|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782855|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
83782856|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782857|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782858|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782859|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782860|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782861|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782862|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782863|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782864|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782865|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782866|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782868|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782869|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
83782870|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782871|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
83782872|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83782873|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83782874|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83782875|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83782876|NCT00025467|Growth Substances|growth substances|mesh-ancestor
83782877|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
83782878|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782879|NCT04964414|Budesonide|budesonide|mesh-list
83782880|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
83782881|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83782882|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83782883|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
83782884|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83782885|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782886|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83782887|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
83782888|NCT04964414|Hormones|hormones|mesh-ancestor
83782889|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83782890|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
83782891|NCT00025545|Methotrexate|methotrexate|mesh-list
83782892|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782893|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
83782894|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782895|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782896|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782897|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
83782898|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782899|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782900|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782901|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83782902|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
83782903|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83782904|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782905|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
83782906|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
83782907|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782908|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83782909|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83782910|NCT00025584|Bortezomib|bortezomib|mesh-list
83782911|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782912|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
83782913|NCT00025623|Carboplatin|carboplatin|mesh-list
83782914|NCT00025623|Doxorubicin|doxorubicin|mesh-list
83782915|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83782916|NCT00025623|Etoposide|etoposide|mesh-list
83782917|NCT00025623|Vincristine|vincristine|mesh-list
83782918|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782919|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
83782920|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782921|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83782922|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83782923|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
83782924|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938084|NCT04656652|Docetaxel|docetaxel|mesh-list
83782925|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782926|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83782927|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83782928|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83782929|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83782930|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782931|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83782932|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
83782933|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
83782934|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
83782936|NCT00025740|Paroxetine|paroxetine|mesh-list
83782937|NCT00025740|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83782938|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83782939|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83782940|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782941|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782942|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
83782943|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782944|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83782945|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
83782946|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83782947|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83782948|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83782949|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782950|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
83782951|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
83782952|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
83782953|NCT00025779|Guanfacine|guanfacine|mesh-list
83782954|NCT00025779|Methylphenidate|methylphenidate|mesh-list
83782955|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83782956|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782957|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83782958|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83782959|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83782960|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782961|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
83782962|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782963|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83782964|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83782965|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83782966|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83782967|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
83782968|NCT04876079|Insulin|insulin|mesh-list
83782969|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83782970|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782971|NCT00026052|Riluzole|riluzole|mesh-list
83782972|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
83782973|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83782974|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83782975|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782976|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782977|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782978|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83782979|NCT00026052|Protective Agents|protective agents|mesh-ancestor
83782980|NCT00026091|Fenretinide|fenretinide|mesh-list
83782981|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782982|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83782983|NCT00026091|Protective Agents|protective agents|mesh-ancestor
83782984|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782985|NCT00026130|Gemcitabine|gemcitabine|mesh-list
83782986|NCT00026130|Fluorouracil|fluorouracil|mesh-list
83782987|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83782988|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
83782989|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83782990|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782991|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83782992|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
83782993|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83782994|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
83782995|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83782996|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83782997|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83782998|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938155|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83782999|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83783000|NCT04808414|Polymyxins|polymyxins|mesh-list
83783001|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783002|NCT00026364|Leucovorin|leucovorin|mesh-list
83783003|NCT00026364|Fluorouracil|fluorouracil|mesh-list
83783004|NCT00026364|Irinotecan|irinotecan|mesh-list
83783005|NCT00026364|Gefitinib|gefitinib|mesh-list
83783006|NCT00026364|Calcium|calcium|mesh-list
83783007|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
83783008|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83783009|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783010|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
83783011|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783012|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783013|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783014|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783015|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
83783016|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83783017|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783018|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783019|NCT00026364|Antidotes|antidotes|mesh-ancestor
83783020|NCT00026364|Protective Agents|protective agents|mesh-ancestor
83783021|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
83783022|NCT00026364|Vitamins|vitamins|mesh-ancestor
83783023|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
83783024|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83783025|NCT00026403|Gemcitabine|gemcitabine|mesh-list
83783026|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783027|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783028|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
83783029|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783030|NCT00026442|Capecitabine|capecitabine|mesh-list
83783031|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783032|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
83783033|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783034|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783035|NCT04726280|Ropivacaine|ropivacaine|mesh-list
83783036|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83783037|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
83783038|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
83783039|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783040|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783041|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
83783042|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783043|NCT00026520|Interferons|interferons|mesh-list
83783044|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
83783045|NCT00026520|Thalidomide|thalidomide|mesh-list
83783046|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783047|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
83783048|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783049|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
83783050|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783051|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783052|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
83783053|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83783054|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83783055|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83783056|NCT00026520|Growth Substances|growth substances|mesh-ancestor
83783057|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
83783058|NCT00026637|Sertraline|sertraline|mesh-list
83783059|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
83783060|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83783061|NCT00026637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83783062|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83783063|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83783064|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783065|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783066|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
83783067|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783068|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
83783069|NCT04657094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83783070|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783071|NCT04657094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83783072|NCT04657094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783073|NCT04657094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783074|NCT04610684|Carboplatin|carboplatin|mesh-list
83783075|NCT04610684|Etoposide|etoposide|mesh-list
83783076|NCT04610684|Atezolizumab|atezolizumab|mesh-list
83783077|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783078|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783079|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83783080|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783081|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783082|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783083|NCT04610684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83783084|NCT04610684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783085|NCT00027066|Aspirin|aspirin|mesh-list
83783086|NCT00027066|Warfarin|warfarin|mesh-list
83783087|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83783088|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83783089|NCT00027066|Analgesics|analgesics|mesh-ancestor
83783090|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
83783091|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783092|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783093|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83783094|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783095|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83783096|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83783097|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783098|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83783099|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83783100|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783101|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
83783102|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
83783103|NCT04473950|Naloxone|naloxone|mesh-list
83783104|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83783105|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783106|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
83783107|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783108|NCT04473482|Ethanol|ethanol|mesh-list
83783109|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83783110|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783111|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783112|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783113|NCT00027300|Natalizumab|natalizumab|mesh-list
83783114|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
83783115|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783116|NCT00395382|Alendronate|alendronate|mesh-list
83783117|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83783118|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783119|NCT00027339|Ritonavir|ritonavir|mesh-list
83783120|NCT00027339|Lopinavir|lopinavir|mesh-list
83783121|NCT00027339|Indinavir|indinavir|mesh-list
83783122|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
83783123|NCT00027339|Tenofovir|tenofovir|mesh-list
83783124|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83783125|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83783126|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
83783127|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783128|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783129|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83783130|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83783131|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
83783132|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783133|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83783134|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83783135|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83783136|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783137|NCT04206488|Digoxin|digoxin|mesh-list
83783138|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83783139|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83783140|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783141|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783142|NCT04206488|Protective Agents|protective agents|mesh-ancestor
83783143|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783144|NCT00027495|Curcumin|curcumin|mesh-list
83783145|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83783146|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83783147|NCT00027495|Analgesics|analgesics|mesh-ancestor
83783148|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
83783149|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783150|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783152|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783153|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783154|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783155|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783156|NCT00027534|Metronidazole|metronidazole|mesh-list
83783157|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783158|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83783159|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83783160|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83783161|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
83783162|NCT00027573|Methotrexate|methotrexate|mesh-list
83783163|NCT00027573|Fludarabine|fludarabine|mesh-list
83783164|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
83783165|NCT00027573|Tacrolimus|tacrolimus|mesh-list
83783166|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783167|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
83783168|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783169|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783170|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783171|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
83783172|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783173|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783174|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83783175|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83783176|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
83783177|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83783178|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783179|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
83783180|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
83783181|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783182|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83783183|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783184|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83783185|NCT00027612|Irinotecan|irinotecan|mesh-list
83783186|NCT00027612|Carmustine|carmustine|mesh-list
83783187|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83783188|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783189|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783190|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783191|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783192|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783193|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
83783194|NCT00027690|Gefitinib|gefitinib|mesh-list
83783195|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783196|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83783197|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783198|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783199|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
83783200|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783201|NCT00027807|Aldesleukin|aldesleukin|mesh-list
83783202|NCT00027807|Molgramostim|molgramostim|mesh-list
83783203|NCT00027807|Sargramostim|sargramostim|mesh-list
83783204|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
83783205|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783206|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783207|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83783208|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83783209|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
83783210|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783211|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
83783212|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83783213|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
83783214|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
83783215|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783216|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783217|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83783218|NCT00392522|Analgesics|analgesics|mesh-ancestor
83783219|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
83783220|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783221|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
83783222|NCT00027885|Bevacizumab|bevacizumab|mesh-list
83783223|NCT00027885|Docetaxel|docetaxel|mesh-list
83783224|NCT00027885|Doxorubicin|doxorubicin|mesh-list
83783225|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83783226|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783227|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
83783228|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783229|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783230|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783231|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
83783232|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783233|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783234|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83783235|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783236|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83783237|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83783238|NCT00027885|Growth Substances|growth substances|mesh-ancestor
83783239|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
83783240|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783241|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783242|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783243|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83783244|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83783245|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783246|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783247|NCT00027924|Cyclosporine|cyclosporine|mesh-list
83783248|NCT00027924|Methotrexate|methotrexate|mesh-list
83783249|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
83783250|NCT00027924|Fludarabine|fludarabine|mesh-list
83783252|NCT00027924|Cyclosporins|cyclosporins|mesh-list
83783253|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83783254|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
83783255|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83783256|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783257|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783258|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
83783259|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783260|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783261|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83783262|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783263|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83783264|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783265|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
83783266|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783267|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783268|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
83783269|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783270|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83783271|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
83783272|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783273|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83783274|NCT04022876|Carboplatin|carboplatin|mesh-list
83783275|NCT04022876|Pemetrexed|pemetrexed|mesh-list
83783276|NCT04022876|Topotecan|topotecan|mesh-list
83783277|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783278|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783279|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783280|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83783281|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783282|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83783283|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783284|NCT00027963|Gabapentin|gabapentin|mesh-list
83783285|NCT00027963|Analgesics|analgesics|mesh-ancestor
83783286|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
83783287|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783288|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783289|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
83783290|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83783291|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83783292|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783293|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83783294|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83783295|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83783296|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783297|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783298|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
83783299|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83783300|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
83783301|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783302|NCT00395499|Risperidone|risperidone|mesh-list
83783303|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83783304|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
83783305|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783306|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783307|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783308|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83783309|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83783310|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783311|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83783312|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83783313|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
83783314|NCT03960125|Imipramine|imipramine|mesh-list
83783315|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83783316|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
83783317|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83783318|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83783319|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83783320|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83783321|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783322|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83783323|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783324|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783325|NCT00395655|Hydralazine|hydralazine|mesh-list
83783326|NCT00395655|Valproic Acid|valproic acid|mesh-list
83783327|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
83783328|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783329|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783330|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
83783331|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783332|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783333|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
83783334|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83783335|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783336|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83783337|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83783338|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
83783339|NCT00392561|Vitamin E|vitamin e|mesh-list
83783340|NCT00392561|Selenium|selenium|mesh-list
83783341|NCT00392561|Vitamins|vitamins|mesh-ancestor
83783342|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
83783343|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783344|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
83783345|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783346|NCT00392561|Protective Agents|protective agents|mesh-ancestor
83783347|NCT00392561|Trace Elements|trace elements|mesh-ancestor
83783348|NCT00028275|Interferons|interferons|mesh-list
83783349|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
83783350|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783351|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
83783352|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783353|NCT03959969|Ibuprofen|ibuprofen|mesh-list
83783354|NCT03959969|Oxycodone|oxycodone|mesh-list
83783355|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83783356|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83783357|NCT03959969|Analgesics|analgesics|mesh-ancestor
83783358|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
83783359|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783360|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783361|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83783362|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783363|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83783364|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783365|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783366|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83783367|NCT03959969|Narcotics|narcotics|mesh-ancestor
83783368|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783369|NCT00028314|Ritonavir|ritonavir|mesh-list
83783370|NCT00028314|Lopinavir|lopinavir|mesh-list
83783371|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83783372|NCT00028314|Nevirapine|nevirapine|mesh-list
83783373|NCT00028314|Abacavir|abacavir|mesh-list
83783374|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83783375|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83783376|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
83783377|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783378|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783379|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83783380|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83783381|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
83783382|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783383|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83783384|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83783385|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83783386|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783387|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83783388|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83783389|NCT00028353|Toremifene|toremifene|mesh-list
83783390|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83783391|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783392|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83783393|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83783394|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
83783395|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783396|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783397|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83783398|NCT03959852|Fentanyl|fentanyl|mesh-list
83783399|NCT03959852|Ketamine|ketamine|mesh-list
83783400|NCT03959852|Analgesics|analgesics|mesh-ancestor
83783401|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
83783402|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783403|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783404|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83783405|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83783406|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
83783407|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
83783408|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783409|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83783410|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83783411|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783412|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783413|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83783414|NCT03959852|Narcotics|narcotics|mesh-ancestor
83783415|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83783416|NCT00028431|Ipilimumab|ipilimumab|mesh-list
83783417|NCT00028431|Antibodies|antibodies|mesh-list
83783418|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
83783419|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783420|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783421|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783422|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83783423|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783424|NCT00028587|Paclitaxel|paclitaxel|mesh-list
83783425|NCT00028587|Carboplatin|carboplatin|mesh-list
83783426|NCT00028587|Bortezomib|bortezomib|mesh-list
83783427|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783428|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783429|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783430|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783431|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783432|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783433|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
83783434|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83783435|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83783436|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83783437|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783438|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
83783439|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
83783440|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
83783441|NCT00028665|Carmustine|carmustine|mesh-list
83783442|NCT00028665|Rituximab|rituximab|mesh-list
83783443|NCT00028665|Etoposide|etoposide|mesh-list
83783444|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783445|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
83783446|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783447|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783448|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783449|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
83783450|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783451|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783452|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83783453|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783454|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783455|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83783456|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783457|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783458|NCT03959540|Levodopa|levodopa|mesh-list
83783459|NCT03959540|Opicapone|opicapone|mesh-list
83783460|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83783461|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83783462|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
83783463|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783464|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783465|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783466|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83783467|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783468|NCT00028743|Paclitaxel|paclitaxel|mesh-list
83783469|NCT00028743|Carboplatin|carboplatin|mesh-list
83783470|NCT00028743|Topotecan|topotecan|mesh-list
83783471|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783472|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783473|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783474|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783475|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783476|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783477|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83783478|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783479|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783480|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83783481|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
83783482|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83783483|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783484|NCT03959501|Incretins|incretins|mesh-ancestor
83783485|NCT03959501|Hormones|hormones|mesh-ancestor
83783486|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783487|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83783488|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
83783489|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783490|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783491|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83783492|NCT00028782|Etanidazole|etanidazole|mesh-list
83783493|NCT00028782|Imidazole|imidazole|mesh-list
83783494|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783495|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783496|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783497|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83783498|NCT00028821|Estradiol|estradiol|mesh-list
83783499|NCT00028821|Estrogens|estrogens|mesh-ancestor
83783500|NCT00028821|Hormones|hormones|mesh-ancestor
83783501|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783502|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783503|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783504|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783505|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783506|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783507|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783508|NCT03959384|Poractant alfa|poractant alfa|mesh-list
83783509|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83783510|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
83783511|NCT00028860|Paclitaxel|paclitaxel|mesh-list
83783512|NCT00028860|Carboplatin|carboplatin|mesh-list
83783513|NCT00028860|Gemcitabine|gemcitabine|mesh-list
83783514|NCT00028860|Ifosfamide|ifosfamide|mesh-list
83783515|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783516|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783517|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783518|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783519|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783520|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783521|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783522|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
83783523|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783524|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
83783525|NCT00028899|Cytarabine|cytarabine|mesh-list
82938682|NCT03671044|Docetaxel|docetaxel|mesh-list
83783526|NCT00028899|Asparaginase|asparaginase|mesh-list
83783527|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
83783528|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
83783529|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783530|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
83783531|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783532|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783533|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
83783534|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783535|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783536|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
83783537|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783538|NCT00028899|Analgesics|analgesics|mesh-ancestor
83783539|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
83783540|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783541|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83783542|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783543|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783544|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783545|NCT00028899|Immunotoxins|immunotoxins|mesh-ancestor
83783546|NCT00028899|Immunoconjugates|immunoconjugates|mesh-ancestor
83783547|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83783548|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783549|NCT00028938|Paclitaxel|paclitaxel|mesh-list
83783550|NCT00028938|Carboplatin|carboplatin|mesh-list
83783551|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
83783552|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783553|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783554|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783555|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783556|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783557|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783558|NCT00028938|Hematinics|hematinics|mesh-ancestor
83783559|NCT00029250|Allicin|allicin|mesh-list
83783560|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783561|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83783562|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
83783563|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783564|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83783565|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
83783566|NCT00029250|Protective Agents|protective agents|mesh-ancestor
83783567|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783568|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83783569|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83783570|NCT03959150|Capecitabine|capecitabine|mesh-list
83783571|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783572|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
83783573|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783574|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783575|NCT00029328|Etanercept|etanercept|mesh-list
83783576|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83783577|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83783578|NCT00029328|Analgesics|analgesics|mesh-ancestor
83783579|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
83783580|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783581|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783582|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83783583|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783584|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83783585|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783586|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
83783587|NCT00029523|Cytarabine|cytarabine|mesh-list
83783588|NCT00029523|Methotrexate|methotrexate|mesh-list
83783589|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83783590|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
83783591|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83783592|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783593|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783594|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
83783595|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783596|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783597|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83783598|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783599|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83783600|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783601|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
82938758|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83783602|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783603|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783604|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
83783605|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783606|NCT00392717|Atorvastatin|atorvastatin|mesh-list
83783607|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83783608|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83783609|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
83783610|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783611|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83783612|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83783613|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783614|NCT00029679|Borage oil|borage oil|mesh-list
83783615|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783616|NCT03958799|Vaccines|vaccines|mesh-list
83783617|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
83783618|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783619|NCT00029757|Estrogens|estrogens|mesh-list
83783620|NCT00029757|Hormones|hormones|mesh-ancestor
83783621|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783622|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783623|NCT03958721|Capecitabine|capecitabine|mesh-list
83783624|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783625|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
83783626|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783627|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783628|NCT00029835|Rimonabant|rimonabant|mesh-list
83783629|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83783630|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83783631|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83783632|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783633|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783634|NCT00029835|Hormones|hormones|mesh-ancestor
83783635|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783636|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783637|NCT00395772|Vitamin K|vitamin k|mesh-list
83783638|NCT00395772|Heparin|heparin|mesh-list
83783639|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
83783640|NCT00395772|Vitamins|vitamins|mesh-ancestor
83783641|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
83783642|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783643|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
83783644|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83783645|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83783646|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783647|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83783648|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
83783649|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83783650|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
83783651|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783652|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83783653|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
83783654|NCT00395772|Coagulants|coagulants|mesh-ancestor
83783655|NCT00029874|Minocycline|minocycline|mesh-list
83509381|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
83783656|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83783657|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783658|NCT00030030|Silymarin|silymarin|mesh-list
83783659|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
83783660|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783661|NCT00030030|Protective Agents|protective agents|mesh-ancestor
83783662|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783663|NCT00030069|Calcitriol|calcitriol|mesh-list
83783664|NCT00030069|Dexamethasone|dexamethasone|mesh-list
83783665|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83783666|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
83783667|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
83783668|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783669|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783670|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83783671|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
83783672|NCT00030069|Hormones|hormones|mesh-ancestor
83783673|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783674|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83783675|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783676|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83783677|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83783678|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83783679|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938829|NCT05788835|Estrogens|estrogens|mesh-ancestor
83783680|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83783681|NCT00030069|Vitamins|vitamins|mesh-ancestor
83783682|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
83783683|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83783684|NCT03958097|Antibodies|antibodies|mesh-list
83783685|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
83783686|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783687|NCT00030342|Interferons|interferons|mesh-list
83783688|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
83783689|NCT00030342|Fluorouracil|fluorouracil|mesh-list
83783690|NCT00030342|Sargramostim|sargramostim|mesh-list
83783691|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
83783692|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783693|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783694|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783695|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783696|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
83783697|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783698|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
83783699|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783700|NCT00030381|Esorubicin|esorubicin|mesh-list
83783701|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83783702|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783703|NCT00030420|Celecoxib|celecoxib|mesh-list
83783704|NCT00030420|Docetaxel|docetaxel|mesh-list
83783705|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783706|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783707|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783708|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783709|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783710|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83783711|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83783712|NCT00030420|Analgesics|analgesics|mesh-ancestor
83783713|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
83783714|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783715|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783716|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83783717|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783718|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83783719|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83783720|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783721|NCT00030459|Vinorelbine|vinorelbine|mesh-list
83783722|NCT00030459|Mitomycins|mitomycins|mesh-list
83783723|NCT00030459|Mitomycin|mitomycin|mesh-list
83783724|NCT00030459|Vinblastine|vinblastine|mesh-list
83783725|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783726|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783727|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783728|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783729|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783730|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783731|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83783732|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
83783733|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783734|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783735|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83783736|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783737|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83783738|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783739|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783740|NCT03873857|Venetoclax|venetoclax|mesh-list
83783741|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783742|NCT03866408|Pioglitazone|pioglitazone|mesh-list
83783743|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83783744|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783745|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83783746|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783747|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83783748|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783749|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783750|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83783751|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783752|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83783753|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783754|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783755|NCT00030615|Decitabine|decitabine|mesh-list
83783756|NCT00030615|Azacitidine|azacitidine|mesh-list
83783757|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783758|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
83783759|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783760|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783761|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783762|NCT03857087|Edetic Acid|edetic acid|mesh-list
83783763|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83783764|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
83783765|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
83783766|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783767|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
83783768|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83783769|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83783770|NCT00030654|Ketoconazole|ketoconazole|mesh-list
83783771|NCT00030654|Vinblastine|vinblastine|mesh-list
83783772|NCT00030654|Docetaxel|docetaxel|mesh-list
83783773|NCT00030654|Doxorubicin|doxorubicin|mesh-list
83783774|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83783775|NCT00030654|Bicalutamide|bicalutamide|mesh-list
83783776|NCT00030654|Flutamide|flutamide|mesh-list
83783777|NCT00030654|Estramustine|estramustine|mesh-list
83783778|NCT00030654|Hormones|hormones|mesh-list
83783779|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83783780|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783781|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783782|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783783|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783784|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783785|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83783786|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83783787|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83783788|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783789|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783790|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783791|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
83783792|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783793|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83783794|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83783795|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83783796|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
83783797|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83783798|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
83783799|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83783800|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783801|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
83783802|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
83783803|NCT03852407|Melphalan|melphalan|mesh-list
83783804|NCT03852407|Fludarabine|fludarabine|mesh-list
83783805|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
83783806|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783807|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
83783808|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783809|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783810|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783811|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
83783812|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783813|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783814|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83783815|NCT00030693|Metronidazole|metronidazole|mesh-list
83783816|NCT00030693|Vaccines|vaccines|mesh-list
83783817|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
83783818|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783819|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783820|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83783821|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83783822|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83783823|NCT03823274|Aspirin|aspirin|mesh-list
83783824|NCT03823274|Clopidogrel|clopidogrel|mesh-list
83783825|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83783826|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83783827|NCT03823274|Analgesics|analgesics|mesh-ancestor
83783828|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
83783829|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783830|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783831|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83783832|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783833|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83783834|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83783835|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783836|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83783837|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83783838|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783839|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
83783840|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83783841|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83783842|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83783843|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
83783844|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783845|NCT00030732|Gemcitabine|gemcitabine|mesh-list
83783846|NCT00030732|Capecitabine|capecitabine|mesh-list
83783847|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83783848|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
83783849|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783850|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783851|NCT00030810|Docetaxel|docetaxel|mesh-list
83783852|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783853|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83783854|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83783855|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83783856|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783857|NCT00030849|Interferons|interferons|mesh-list
83783858|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
83783859|NCT00030849|Bexarotene|bexarotene|mesh-list
83783860|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783861|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
83783862|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783863|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
83783864|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783865|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83783866|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783867|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83783868|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783869|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783870|NCT00030966|Natalizumab|natalizumab|mesh-list
83783871|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
83783872|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783873|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
83783874|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783875|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783876|NCT03715205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83783877|NCT03715205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783878|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
83783879|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83783880|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83783881|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783882|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83783883|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83783884|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
83783885|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783886|NCT03698006|Ropivacaine|ropivacaine|mesh-list
83783887|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83783888|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
83783889|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
83783890|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783891|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783892|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
83783893|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783894|NCT00031083|Interferons|interferons|mesh-list
83783895|NCT00031083|Interferon-beta|interferon-beta|mesh-list
83783896|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783897|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
83783898|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783899|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
83783900|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783901|NCT03559985|Acetaminophen|acetaminophen|mesh-list
83783902|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82939050|NCT05487755|Urological Agents|urological agents|mesh-ancestor
83783903|NCT03559985|Analgesics|analgesics|mesh-ancestor
83783904|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
83783905|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783906|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783907|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
83783908|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
83783909|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83783910|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83783911|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783912|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783913|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83783914|NCT04711863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83783915|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83783916|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83783917|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783918|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783919|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
83783920|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83783921|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
83783922|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83783923|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83783924|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783925|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83783926|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
83783927|NCT00392912|Testosterone|testosterone|mesh-list
83783928|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
83783929|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
83783930|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83783931|NCT00392912|Androgens|androgens|mesh-ancestor
83783932|NCT00392912|Hormones|hormones|mesh-ancestor
83783933|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83783934|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783935|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83783936|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783937|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
83783938|NCT04712058|Tenofovir|tenofovir|mesh-list
83783939|NCT04712058|Emtricitabine|emtricitabine|mesh-list
83783940|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83783941|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
83783942|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83783943|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83783944|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83783945|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783946|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783947|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83783948|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83783949|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
83783950|NCT00393107|Rituximab|rituximab|mesh-list
83783951|NCT00393107|Fludarabine|fludarabine|mesh-list
83783952|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83783953|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
83783954|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783955|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83783956|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83783957|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
83783958|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783959|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783960|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83783961|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783962|NCT04711668|Lidocaine|lidocaine|mesh-list
83783963|NCT04711668|Ketamine|ketamine|mesh-list
83783964|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
83783965|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
83783966|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83783967|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783968|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
83783969|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83783970|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83783971|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83783972|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83783973|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83783974|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783975|NCT04711668|Analgesics|analgesics|mesh-ancestor
83783976|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83783977|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83783978|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
82939121|NCT05218629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783979|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83783981|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783982|NCT00031161|Nitisinone|nitisinone|mesh-list
83783983|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83783984|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783985|NCT00031278|Trastuzumab|trastuzumab|mesh-list
83783986|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83783987|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83783988|NCT00031317|Clozapine|clozapine|mesh-list
83783989|NCT00031317|Paroxetine|paroxetine|mesh-list
83783990|NCT00031317|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83783991|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83783992|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83783993|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83783994|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83783995|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
83783996|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83783997|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83783998|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
83783999|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83784000|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83784001|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83784002|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784003|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83784004|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83784005|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83784006|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784007|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
83784008|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
83784009|NCT00396045|Lenalidomide|lenalidomide|mesh-list
83784010|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
83784011|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784012|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83784013|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83784014|NCT00396045|Growth Substances|growth substances|mesh-ancestor
83784015|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
83784016|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784017|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83784018|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83784019|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83784020|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
83784021|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784022|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83784023|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83784024|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784025|NCT00031395|Clonidine|clonidine|mesh-list
83784026|NCT00031395|Methylphenidate|methylphenidate|mesh-list
83784027|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83784028|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784029|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83784030|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83784031|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784032|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784033|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
83784034|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784035|NCT00031395|Analgesics|analgesics|mesh-ancestor
83784036|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
83784037|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784038|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83784039|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
83784040|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
83784041|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83784042|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83784043|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83784044|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784045|NCT00031434|Valganciclovir|valganciclovir|mesh-list
83784046|NCT00031434|Ganciclovir|ganciclovir|mesh-list
83784047|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83784048|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
83784049|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784050|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83784051|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784052|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784053|NCT03152123|Phentermine|phentermine|mesh-list
83784054|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83784055|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784056|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
83784057|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83784058|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
83784059|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
83784060|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784061|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784062|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784063|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784064|NCT00031473|Ribavirin|ribavirin|mesh-list
83784065|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
83784066|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784067|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
83784068|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784069|NCT00031629|Gemcitabine|gemcitabine|mesh-list
83784070|NCT00031629|Docetaxel|docetaxel|mesh-list
83784071|NCT00031629|Lenograstim|lenograstim|mesh-list
83784072|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83784073|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
83784074|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784075|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784076|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784077|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
83784078|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784079|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83784080|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
83784081|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784082|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
83784083|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83784084|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784085|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83784086|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784087|NCT00031707|Megestrol|megestrol|mesh-list
83784088|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
83784089|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83784090|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83784091|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83784092|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
83784093|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83784094|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784095|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83784096|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83784097|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784098|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784099|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
83784100|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83784101|NCT00031746|Caseins|caseins|mesh-list
83784102|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
83784103|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
83784104|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784105|NCT00031785|Megestrol|megestrol|mesh-list
83784106|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
83784107|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83784108|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83784109|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83784110|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
83784111|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83784112|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784113|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83784114|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83784115|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784116|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784117|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
83784118|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83784119|NCT03151772|Metformin|metformin|mesh-list
83784120|NCT03151772|Disulfiram|disulfiram|mesh-list
83784121|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83784122|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784123|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83784124|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83784125|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784126|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784127|NCT02971644|Cobalt|cobalt|mesh-list
83784128|NCT02971644|Trace Elements|trace elements|mesh-ancestor
83784129|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
83784130|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784131|NCT00031824|Cyclosporine|cyclosporine|mesh-list
83784132|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
83784133|NCT00031824|Prednisone|prednisone|mesh-list
83784134|NCT00031824|Tacrolimus|tacrolimus|mesh-list
83784135|NCT00031824|Cyclosporins|cyclosporins|mesh-list
83784136|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784137|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
83784138|NCT00031824|Hormones|hormones|mesh-ancestor
83784139|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784140|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784141|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784142|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784143|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784144|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
83784145|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83784146|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784147|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784148|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
83784149|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784150|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
83784151|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784152|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
83784153|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83784154|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83784155|NCT00031863|Rofecoxib|rofecoxib|mesh-list
83784156|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83784157|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83784158|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784159|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784160|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83784161|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83784162|NCT00031863|Analgesics|analgesics|mesh-ancestor
83784163|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
83784164|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784165|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784166|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784167|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784168|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83784169|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
83784170|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784171|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784172|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784173|NCT00031902|Prednisolone|prednisolone|mesh-list
83784174|NCT00031902|Rituximab|rituximab|mesh-list
83784175|NCT00031902|Vincristine|vincristine|mesh-list
83784176|NCT00031902|Bleomycin|bleomycin|mesh-list
83784177|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83784178|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784179|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
83784180|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784181|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784182|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83784183|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784184|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
83784185|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784186|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939348|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82939349|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82939350|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82939351|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82939352|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
82939353|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
82939354|NCT04600167|Isoniazid|isoniazid|mesh-list
82939355|NCT04600167|Rifapentine|rifapentine|mesh-list
82939356|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
82939357|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82939358|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939359|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82939360|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82939361|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
82939362|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784187|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784188|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
83784189|NCT00031902|Hormones|hormones|mesh-ancestor
83784190|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784191|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784192|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83784193|NCT00031941|Lenalidomide|lenalidomide|mesh-list
83784194|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
83784195|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784196|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83784197|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83784198|NCT00031941|Growth Substances|growth substances|mesh-ancestor
83784199|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
83784200|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784201|NCT00031980|Cyclosporine|cyclosporine|mesh-list
83784202|NCT00031980|Cyclosporins|cyclosporins|mesh-list
83784203|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784204|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784205|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784206|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
83784207|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784208|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
83784209|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784210|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
83784211|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784212|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83784213|NCT03151499|Rifampin|rifampin|mesh-list
83784214|NCT03151499|BI 409306|bi 409306|mesh-list
83784215|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83784216|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
83784217|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83784218|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784219|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
83784220|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83784221|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784222|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784223|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83784224|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83784225|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83784226|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83784227|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83784228|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83784229|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83784230|NCT00032019|Prednisone|prednisone|mesh-list
83784231|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
83784232|NCT00032019|Rituximab|rituximab|mesh-list
83784233|NCT00032019|Doxorubicin|doxorubicin|mesh-list
83784234|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83784235|NCT00032019|Etoposide|etoposide|mesh-list
83784236|NCT00032019|Vincristine|vincristine|mesh-list
83784237|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784238|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
83784239|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784240|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784241|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83784242|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
83784243|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784244|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784245|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83784246|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83784247|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83784248|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83784249|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83784250|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784251|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784252|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
83784253|NCT00032019|Hormones|hormones|mesh-ancestor
83784254|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784255|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784256|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83784257|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784258|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
82939424|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784259|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784260|NCT03151460|Dopamine|dopamine|mesh-list
83784261|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
83784262|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83784263|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
83784264|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
83784265|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784266|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784267|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784268|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784269|NCT03151460|Protective Agents|protective agents|mesh-ancestor
83784270|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
83784271|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784272|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83784273|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
83784274|NCT03151382|Tandospirone|tandospirone|mesh-list
83784275|NCT03151382|Donepezil|donepezil|mesh-list
83784276|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784277|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83784278|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784279|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
83784280|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784281|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784282|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
83784283|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83784284|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83784285|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784286|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83784287|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83784288|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
83784289|NCT00032136|Tamoxifen|tamoxifen|mesh-list
83784290|NCT00032136|Exemestane|exemestane|mesh-list
83784291|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784292|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83784293|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
83784294|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784295|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784296|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784297|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784298|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83784299|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83784300|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83784301|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83784302|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83784303|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784304|NCT03151343|Empagliflozin|empagliflozin|mesh-list
83784305|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83784306|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784307|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83784308|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784309|NCT00032175|Gemcitabine|gemcitabine|mesh-list
83784310|NCT00032175|Capecitabine|capecitabine|mesh-list
83784311|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83784312|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
83784313|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784314|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784315|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
83784316|NCT04712279|Ivermectin|ivermectin|mesh-list
83784317|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
83784318|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83784319|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83784320|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784321|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784322|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784323|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784324|NCT00032292|Visilizumab|visilizumab|mesh-list
83784325|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
83784326|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784327|NCT03150914|Sirolimus|sirolimus|mesh-list
83784328|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83784329|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784330|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83784331|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784332|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
83784333|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784334|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
83784335|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784337|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
83784338|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784339|NCT03150836|Durvalumab|durvalumab|mesh-list
83784340|NCT03150836|Tremelimumab|tremelimumab|mesh-list
83784341|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83784342|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784343|NCT00032838|Yohimbine|yohimbine|mesh-list
83784344|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
83784345|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
83784346|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784347|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784348|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83784349|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83784350|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83784351|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784352|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784353|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784354|NCT00032838|Urological Agents|urological agents|mesh-ancestor
83784355|NCT03150797|Melatonin|melatonin|mesh-list
83784356|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
83784357|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784358|NCT03150797|Protective Agents|protective agents|mesh-ancestor
83784359|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784360|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784361|NCT03150680|Clopidogrel|clopidogrel|mesh-list
83784362|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83784363|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83784364|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83784365|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83784366|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
83784367|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784368|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784369|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784370|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
83784371|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83784372|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
83784373|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784374|NCT00396396|Expectorants|expectorants|mesh-ancestor
83784375|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
83784376|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83784377|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
83784378|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784379|NCT00396396|Protective Agents|protective agents|mesh-ancestor
83784380|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784381|NCT00396396|Antidotes|antidotes|mesh-ancestor
83784382|NCT00032955|Buprenorphine|buprenorphine|mesh-list
83784383|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83784384|NCT00032955|Naloxone|naloxone|mesh-list
83784385|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83784386|NCT00032955|Narcotics|narcotics|mesh-ancestor
83784387|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784388|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784389|NCT00032955|Analgesics|analgesics|mesh-ancestor
83784390|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
83784391|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784392|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83784393|NCT03150524|Verapamil|verapamil|mesh-list
83784394|NCT03150524|Nimodipine|nimodipine|mesh-list
83784395|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82939570|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939571|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
82939572|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82939573|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
82939574|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939575|NCT04155632|Expectorants|expectorants|mesh-ancestor
82939576|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
82939577|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82939578|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
82939579|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939580|NCT04155632|Protective Agents|protective agents|mesh-ancestor
82939581|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939582|NCT04155632|Antidotes|antidotes|mesh-ancestor
82939583|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82939586|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784396|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83784397|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784398|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784399|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83784400|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784401|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
83784402|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83784403|NCT00033033|Reserpine|reserpine|mesh-list
83784404|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83784405|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83784406|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83784407|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784408|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784409|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83784410|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83784411|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83784412|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784413|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784414|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784415|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784416|NCT03150368|Docetaxel|docetaxel|mesh-list
83784417|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784418|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784419|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83784420|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784421|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784422|NCT00033072|Selegiline|selegiline|mesh-list
83784423|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
83784424|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83784425|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83784426|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83784427|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83784428|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784429|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784430|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83784431|NCT00033072|Protective Agents|protective agents|mesh-ancestor
83784432|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784433|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83784434|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83784435|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784436|NCT00033111|Cabergoline|cabergoline|mesh-list
83784437|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83784438|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83784439|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
83784440|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
83784441|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784442|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784443|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784444|NCT00033189|Ubiquinone|ubiquinone|mesh-list
83784445|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
83784446|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
83784447|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784448|NCT00033189|Vitamins|vitamins|mesh-ancestor
83784449|NCT00033267|Sirolimus|sirolimus|mesh-list
83784450|NCT00033267|Temsirolimus|temsirolimus|mesh-list
83784451|NCT00033267|MTOR Inhibitors|mtor inhibitors|mesh-list
83784452|NCT00033267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83784453|NCT00033267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784454|NCT00033267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784455|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784456|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
83784457|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784458|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784459|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83784460|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784461|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83784462|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
83784463|NCT00033306|Irinotecan|irinotecan|mesh-list
83784464|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83784465|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82939645|NCT03875079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939646|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
82939647|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
82939648|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784466|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784467|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784468|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784469|NCT02984384|Aspirin|aspirin|mesh-list
83784470|NCT02984384|Heparin|heparin|mesh-list
83784471|NCT02984384|Enoxaparin|enoxaparin|mesh-list
83784472|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83784473|NCT02984384|Tinzaparin|tinzaparin|mesh-list
83784474|NCT02984384|Dalteparin|dalteparin|mesh-list
83784475|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83784476|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83784477|NCT02984384|Analgesics|analgesics|mesh-ancestor
83784478|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
83784479|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784480|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784481|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784482|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784483|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83784484|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83784485|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784486|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83784487|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83784488|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784489|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
83784490|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
83784491|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
83784492|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83784493|NCT00033345|Protective Agents|protective agents|mesh-ancestor
83784494|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784495|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784496|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
83784497|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83784498|NCT00033423|Rituximab|rituximab|mesh-list
83784499|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83784500|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784501|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
83784502|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784503|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784504|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83784505|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784506|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83784507|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784508|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784509|NCT00393263|Clobetasol|clobetasol|mesh-list
83784510|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
83784511|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784512|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
83784513|NCT00393263|Hormones|hormones|mesh-ancestor
83784514|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784515|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784516|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83784517|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83784518|NCT00393263|Analgesics|analgesics|mesh-ancestor
83784519|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
83784520|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784521|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784522|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
83784523|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784524|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
83784525|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83784526|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784527|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784528|NCT00033618|Epothilones|epothilones|mesh-list
83784529|NCT00033618|Epothilone B|epothilone b|mesh-list
83784530|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784531|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
83784532|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784533|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784534|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784535|NCT00033696|Paclitaxel|paclitaxel|mesh-list
83784536|NCT00033696|Etoposide|etoposide|mesh-list
83784537|NCT00033696|Carboplatin|carboplatin|mesh-list
83784538|NCT00033696|Topotecan|topotecan|mesh-list
83784539|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83784540|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939721|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784541|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784542|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
83784543|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784544|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784545|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83784546|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83784547|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784548|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83784549|NCT02548559|Cannabidiol|cannabidiol|mesh-list
83784550|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
83784551|NCT00033735|Fluorouracil|fluorouracil|mesh-list
83784552|NCT00033735|Irofulven|irofulven|mesh-list
83784553|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
83784554|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784555|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83784556|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784557|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784558|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
83784559|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784560|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83784561|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
83784562|NCT00033813|Oxatomide|oxatomide|mesh-list
83784563|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83784564|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
83784565|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
83784566|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784567|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784568|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784569|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83784570|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83784571|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
83784572|NCT00033891|Infliximab|infliximab|mesh-list
83784573|NCT00033891|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83784574|NCT00033891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784575|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
83784576|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83784577|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83784578|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
83784579|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
83784580|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
83784581|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83784582|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83784583|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784584|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784585|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784586|NCT02149823|Oxytocin|oxytocin|mesh-list
83784587|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
83784588|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83784589|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784590|NCT02971410|Simvastatin|simvastatin|mesh-list
83784591|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83784592|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83784593|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
83784594|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784595|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83784596|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83784597|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784598|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
83784599|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83784600|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83784601|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83784602|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784603|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784604|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
83784605|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784606|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784607|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83784608|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784609|NCT00034047|Nafarelin|nafarelin|mesh-list
83784610|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83784611|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
83784612|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83784613|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784614|NCT00034086|Ritonavir|ritonavir|mesh-list
83784615|NCT00034086|Lopinavir|lopinavir|mesh-list
82939798|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
83784616|NCT00034086|Tenofovir|tenofovir|mesh-list
83784617|NCT00034086|Lamivudine|lamivudine|mesh-list
83784618|NCT00034086|Zidovudine|zidovudine|mesh-list
83784619|NCT00034086|Stavudine|stavudine|mesh-list
83784620|NCT00034086|Didanosine|didanosine|mesh-list
83784621|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83784622|NCT00034086|Vaccines|vaccines|mesh-list
83784623|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83784624|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
83784625|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784626|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83784627|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83784628|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
83784629|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784630|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784631|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83784632|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83784633|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
83784634|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784635|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83784636|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83784637|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83784638|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83784639|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
83784640|NCT00034125|Tamoxifen|tamoxifen|mesh-list
83784641|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83784642|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
83784643|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784644|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784645|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784646|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784647|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83784648|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83784649|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83784650|NCT00034164|Paclitaxel|paclitaxel|mesh-list
83784651|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83784652|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784653|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784654|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
83784655|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784656|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784657|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
83784658|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83784659|NCT00034242|Antibodies|antibodies|mesh-list
83784660|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
83784661|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83784662|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
83784663|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784664|NCT01807325|Pancrelipase|pancrelipase|mesh-list
83784665|NCT01807325|Pancreatin|pancreatin|mesh-list
83784666|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83784667|NCT01807286|Dexamethasone|dexamethasone|mesh-list
83784668|NCT01807286|Melphalan|melphalan|mesh-list
83784669|NCT01807286|Pomalidomide|pomalidomide|mesh-list
83784670|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83784671|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
83784672|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
83784673|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784674|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784675|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83784676|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
83784677|NCT01807286|Hormones|hormones|mesh-ancestor
83784678|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784679|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83784680|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784681|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83784682|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
83784683|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784684|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83784685|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83784686|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
83784687|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83784688|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83784689|NCT01807286|Growth Substances|growth substances|mesh-ancestor
82939871|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939876|NCT03103152|Aspirin|aspirin|mesh-list
83784690|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
83784691|NCT00034359|Lamivudine|lamivudine|mesh-list
83784692|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83784693|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83784694|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784695|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784696|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
83784697|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784698|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83784699|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83784700|NCT00034593|Gemcitabine|gemcitabine|mesh-list
83784701|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83784702|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
83784703|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784704|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784705|NCT00034632|Posaconazole|posaconazole|mesh-list
83784706|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
83784707|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784708|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83784709|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83784710|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83784711|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83784712|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83784713|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784714|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784715|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83784716|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
83784717|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784718|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784719|NCT00034671|Posaconazole|posaconazole|mesh-list
83784720|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
83784721|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784722|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83784723|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83784724|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83784725|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83784726|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83784727|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784728|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784729|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83784730|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
83784731|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784732|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784733|NCT01806857|Quinidine|quinidine|mesh-list
83784734|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
83784735|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
83784736|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
83784737|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83784738|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83784739|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784740|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784741|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784742|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83784743|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83784744|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784745|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83784746|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
83784747|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83784748|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83784749|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784750|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784751|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83784752|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83784753|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
83784754|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83784755|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83784756|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784757|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83784758|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83784759|NCT00034710|Capsaicin|capsaicin|mesh-list
83784760|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
83784761|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
83784762|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
83784763|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784764|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784765|NCT00034749|Risperidone|risperidone|mesh-list
83784766|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83784767|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
83784768|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784769|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784770|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784771|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83784772|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83784773|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784774|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83784775|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83784776|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
83784777|NCT00034788|Becaplermin|becaplermin|mesh-list
83784778|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
83784779|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83784780|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83784781|NCT00034788|Growth Substances|growth substances|mesh-ancestor
83784782|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784783|NCT00034866|Tipranavir|tipranavir|mesh-list
83784784|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83784785|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
83784786|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83784787|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83784788|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
83784789|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784790|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784791|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784792|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83784793|NCT00034905|Risperidone|risperidone|mesh-list
83784794|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83784795|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83784796|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
83784797|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784798|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784799|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784800|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83784801|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83784802|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784803|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83784804|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83784805|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
83784806|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
83784807|NCT01806311|Amlodipine|amlodipine|mesh-list
83784808|NCT01806311|Candesartan|candesartan|mesh-list
83784809|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83784810|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83784811|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784812|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784813|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83784814|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784815|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
83784816|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83784817|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83784818|NCT00034944|Aprepitant|aprepitant|mesh-list
83784819|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
83784820|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
83784821|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784822|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784823|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83784824|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83784825|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784826|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784827|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
83784828|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
83784829|NCT01806272|Vitamins|vitamins|mesh-ancestor
83784830|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
83784831|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784832|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
83784833|NCT01806272|Hematinics|hematinics|mesh-ancestor
83784834|NCT00034983|Aprepitant|aprepitant|mesh-list
83784835|NCT00034983|Paroxetine|paroxetine|mesh-list
83784836|NCT00034983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83784837|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83784838|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784839|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784840|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784841|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
83784842|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784843|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83784844|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
83784845|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83784846|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83784847|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83784848|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784849|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
83784850|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
83784851|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784852|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83784853|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83784854|NCT00035061|Pemetrexed|pemetrexed|mesh-list
83784855|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784856|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784857|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784858|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83784859|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83784860|NCT00393497|Bevacizumab|bevacizumab|mesh-list
83784861|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83784862|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784863|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83784864|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83784865|NCT00393497|Growth Substances|growth substances|mesh-ancestor
83784866|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784867|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
83784868|NCT00035100|Epothilones|epothilones|mesh-list
83784869|NCT00035100|Epothilone B|epothilone b|mesh-list
83784870|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
83784871|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
83784872|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
83784873|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784874|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784875|NCT00035139|Methylphenidate|methylphenidate|mesh-list
83784876|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83784877|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784878|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83784879|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83784880|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784881|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784882|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
83784883|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784884|NCT00035178|Argatroban|argatroban|mesh-list
83784885|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
83784886|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83784887|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
83784888|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784889|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784890|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
83784891|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83784892|NCT00393614|Levetiracetam|levetiracetam|mesh-list
83784893|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
83784894|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
83784895|NCT00035256|Teriparatide|teriparatide|mesh-list
83784896|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83784897|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83784898|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784899|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83784900|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83784901|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
83784902|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83784903|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83784904|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83784905|NCT00035295|Aprepitant|aprepitant|mesh-list
83784906|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
83784907|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
83784908|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784909|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784910|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83784911|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83784912|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784913|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784914|NCT01806116|Decitabine|decitabine|mesh-list
83784915|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83784916|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
83784917|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784918|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83784919|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784920|NCT00035451|Sotalol|sotalol|mesh-list
83784921|NCT00035451|Azimilide|azimilide|mesh-list
83784922|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83784923|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83784924|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784925|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784926|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784927|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784928|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83784929|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
83784930|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
83784931|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784932|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83784933|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784934|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83784935|NCT01805999|Psyllium|psyllium|mesh-list
83784936|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
83784937|NCT01805999|Cathartics|cathartics|mesh-ancestor
83784938|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83784939|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
83784940|NCT00035490|Azimilide|azimilide|mesh-list
83784941|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83784942|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83784943|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83784944|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784945|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83784946|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784947|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
83784948|NCT00035607|Hematinics|hematinics|mesh-ancestor
83784949|NCT02971254|Sevoflurane|sevoflurane|mesh-list
83784950|NCT02971254|Desflurane|desflurane|mesh-list
83784951|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83784952|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83784953|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
83784954|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
83784955|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784956|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784957|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
83784958|NCT01805882|Ledipasvir|ledipasvir|mesh-list
83784959|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
83784960|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83784961|NCT00035802|Topiramate|topiramate|mesh-list
83784962|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
83784963|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83784964|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784965|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
83784966|NCT04732377|Bupivacaine|bupivacaine|mesh-list
83784967|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
83784968|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
83784969|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83784970|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784971|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
83784972|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784973|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83784974|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83784975|NCT04732377|Analgesics|analgesics|mesh-ancestor
83784976|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83784977|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83784978|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83784979|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784980|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784981|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784982|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
83784983|NCT01805726|Alfentanil|alfentanil|mesh-list
83784984|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83784985|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940174|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83784986|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83784987|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83784988|NCT01805726|Analgesics|analgesics|mesh-ancestor
83784989|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
83784990|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83784991|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83784992|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83784993|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83784994|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
83784995|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83784996|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83784997|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83784998|NCT01805726|Narcotics|narcotics|mesh-ancestor
83784999|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83785000|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
83785001|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
83785002|NCT00035958|Prednisone|prednisone|mesh-list
83785003|NCT00035958|Etanercept|etanercept|mesh-list
83785004|NCT00035958|Methotrexate|methotrexate|mesh-list
83785005|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785006|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
83785007|NCT00035958|Hormones|hormones|mesh-ancestor
83785008|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785009|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785010|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83785011|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785012|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83785013|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
83785014|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83785015|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83785016|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
83785017|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785018|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
83785019|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785020|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83785021|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785022|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
83785023|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785024|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83785025|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83785026|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83785027|NCT00035958|Analgesics|analgesics|mesh-ancestor
83785028|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
83785029|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785030|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785031|NCT01805687|Zileuton|zileuton|mesh-list
83785032|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83785033|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83785034|NCT01805687|Analgesics|analgesics|mesh-ancestor
83785035|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
83785036|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785037|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785038|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785039|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785040|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83785041|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785042|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785043|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83785044|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
83785045|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785046|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
83785047|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83785048|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785049|NCT01805570|Ticagrelor|ticagrelor|mesh-list
83785050|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83785051|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83785052|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83785053|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83785054|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83785055|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
83785056|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785057|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785058|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785059|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
83785060|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83785061|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
83785062|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83785063|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
83785064|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785065|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785066|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
83785067|NCT00036114|Aripiprazole|aripiprazole|mesh-list
83785068|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785069|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785070|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83785071|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83785072|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83785073|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785074|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
83785075|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
83785076|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785077|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785078|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83785079|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83785080|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
83785081|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83785082|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83785083|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83785084|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83785085|NCT01805453|Losartan|losartan|mesh-list
83785086|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83785087|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83785088|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83785089|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83785090|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785091|NCT00036153|Methotrexate|methotrexate|mesh-list
83785092|NCT00036153|Tacrolimus|tacrolimus|mesh-list
83785093|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83785094|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
83785095|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83785096|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785097|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83785098|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
83785099|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785100|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785101|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
83785102|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785103|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83785104|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785105|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
83785106|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785107|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83785108|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83785109|NCT00036231|Secretin|secretin|mesh-list
83785110|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785111|NCT00036231|Hormones|hormones|mesh-ancestor
83785112|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785113|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785114|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83785115|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83785116|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83785117|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785118|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785119|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785120|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785121|NCT00036309|Analgesics|analgesics|mesh-ancestor
83785122|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
83785123|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785124|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785125|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785126|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
83785127|NCT00036348|Aripiprazole|aripiprazole|mesh-list
83785128|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785129|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785130|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82940330|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
83785131|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83785132|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83785133|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785134|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
83785135|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
83785136|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785137|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785138|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83785139|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83785140|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
83785141|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83785142|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83785143|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83785144|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83785146|NCT00036387|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83785147|NCT00036387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785148|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
83785149|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785150|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785151|NCT00036426|Immunomodulating Agents|immunomodulating agents|mesh-list
83785152|NCT00036426|Immunologic Factors|immunologic factors|mesh-ancestor
83785153|NCT00036426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785154|NCT01466543|Udenafil|udenafil|mesh-list
83785155|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83785156|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83785157|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785158|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785159|NCT01466465|Vitamin D|vitamin d|mesh-list
83785160|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
83785161|NCT01466465|Vitamins|vitamins|mesh-ancestor
83785162|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
83785163|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785164|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83785165|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83785166|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
83785167|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83785168|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785169|NCT00036543|Atrasentan|atrasentan|mesh-list
83785170|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785171|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83785172|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83785173|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785174|NCT01466231|Everolimus|everolimus|mesh-list
83785175|NCT01466231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83785176|NCT01466231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83785177|NCT01466231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785178|NCT01466231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785179|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785180|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
83785181|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785182|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785183|NCT00036582|Clozapine|clozapine|mesh-list
83785184|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83785185|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
83785186|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785187|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785188|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785189|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83785190|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83785191|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83785192|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785193|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
83785194|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
83785195|NCT01466114|Norethindrone|norethindrone|mesh-list
83785196|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
83785197|NCT01466114|Progestins|progestins|mesh-list
83785198|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83785199|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83785200|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83785201|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
83785202|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83785203|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785204|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83785205|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83785206|NCT01466114|Hormones|hormones|mesh-ancestor
83785207|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785208|NCT00036777|Carboplatin|carboplatin|mesh-list
83785209|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83785210|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785211|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83785212|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785213|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785214|NCT01465919|Mirtazapine|mirtazapine|mesh-list
83785215|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785216|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785217|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83785218|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
83785219|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
83785220|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785221|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785222|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785223|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83785224|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83785225|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83785226|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83785227|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83785228|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83785229|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83785230|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83785231|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83785232|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
83785233|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83785234|NCT00396513|Metformin|metformin|mesh-list
83785235|NCT00396513|Simvastatin|simvastatin|mesh-list
83785236|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83785237|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785238|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83785239|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83785240|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
83785241|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785242|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83785243|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83785244|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785245|NCT00036855|Rituximab|rituximab|mesh-list
83785246|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83785247|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83785248|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785249|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
83785250|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785251|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785252|NCT00036894|Lenalidomide|lenalidomide|mesh-list
83785253|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
83785254|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785255|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83785256|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83785257|NCT00036894|Growth Substances|growth substances|mesh-ancestor
83785258|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
83785259|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785260|NCT01465685|Methylphenidate|methylphenidate|mesh-list
83785261|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83785262|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83785263|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785264|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83785265|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83785266|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785267|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785268|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
83785269|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785270|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
83785271|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785272|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
83785273|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83785274|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
83785275|NCT00037011|Antibodies|antibodies|mesh-list
83785276|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83785277|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
82940472|NCT01224847|Lidocaine|lidocaine|mesh-list
83785278|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785279|NCT00037050|Vancomycin|vancomycin|mesh-list
83785280|NCT00037050|Linezolid|linezolid|mesh-list
83785281|NCT00037050|Oxacillin|oxacillin|mesh-list
83785282|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
83785283|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83785284|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785285|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83785286|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785287|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785288|NCT00037089|Tegafur|tegafur|mesh-list
83785289|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83785290|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
83785291|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785292|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785293|NCT01465568|Denosumab|denosumab|mesh-list
83785294|NCT01465568|Diphosphonates|diphosphonates|mesh-list
83785295|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83785296|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785297|NCT00037206|Anidulafungin|anidulafungin|mesh-list
83785298|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
83785299|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785300|NCT01465412|Adenosine|adenosine|mesh-list
83785301|NCT01465412|Analgesics|analgesics|mesh-ancestor
83785302|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
83785303|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785304|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785305|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83785306|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
83785307|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83785308|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
83785309|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
83785310|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785311|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785312|NCT01465373|Progesterone|progesterone|mesh-list
83785313|NCT01465373|Progestins|progestins|mesh-ancestor
83785314|NCT01465373|Hormones|hormones|mesh-ancestor
83785315|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785316|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785317|NCT01465256|Aspirin|aspirin|mesh-list
83785318|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83785319|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83785320|NCT01465256|Analgesics|analgesics|mesh-ancestor
83785321|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
83785322|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785323|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785324|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785325|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785326|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83785327|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83785328|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785329|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83785330|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83785331|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785332|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
83785333|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
83785334|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83785335|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785336|NCT01464983|Aspirin|aspirin|mesh-list
83785337|NCT01464983|Ibuprofen|ibuprofen|mesh-list
83785338|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83785339|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83785340|NCT01464983|Analgesics|analgesics|mesh-ancestor
83785341|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
83785342|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785343|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785344|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785345|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785346|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83785347|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83785348|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785349|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83785350|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83785351|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785352|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
82940557|NCT01130311|Vitamin D|vitamin d|mesh-list
83785353|NCT00037518|Cinacalcet|cinacalcet|mesh-list
83785354|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83785355|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785356|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83785357|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
83785358|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785359|NCT01464944|Aspirin|aspirin|mesh-list
83785360|NCT01464944|Acetaminophen|acetaminophen|mesh-list
83785361|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83785362|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83785363|NCT01464944|Analgesics|analgesics|mesh-ancestor
83785364|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
83785365|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785366|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785367|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785368|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785369|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83785370|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83785371|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785372|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83785373|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83785374|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785375|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
83785376|NCT00037596|Cytarabine|cytarabine|mesh-list
83785377|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
83785378|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83785379|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
83785380|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785381|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785382|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
83785383|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785384|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785385|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
83785386|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785387|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83785388|NCT00037596|Immunotoxins|immunotoxins|mesh-ancestor
83785389|NCT00037596|Immunoconjugates|immunoconjugates|mesh-ancestor
83785390|NCT00037635|Cinacalcet|cinacalcet|mesh-list
83785391|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83785392|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785393|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83785394|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
83785395|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785396|NCT00037674|Topiramate|topiramate|mesh-list
83785397|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
83785398|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83785399|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785400|NCT00037752|Sibutramine|sibutramine|mesh-list
83785401|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785402|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785403|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
83785404|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83785405|NCT01464671|Heparin|heparin|mesh-list
83785406|NCT01464671|Bivalirudin|bivalirudin|mesh-list
83785407|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
83785408|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83785409|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83785410|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785411|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
83785412|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83785413|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
83785414|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785415|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83785416|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785417|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785418|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785419|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83785420|NCT00393731|Misoprostol|misoprostol|mesh-list
83785421|NCT00393731|Oxytocin|oxytocin|mesh-list
83785422|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
83785423|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83785424|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785425|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83785426|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
83785427|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83785428|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785429|NCT00038025|Pentostatin|pentostatin|mesh-list
83785430|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785431|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83785432|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785433|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785434|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
83785435|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
83785436|NCT00393770|Vitamins|vitamins|mesh-ancestor
83785437|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
83785438|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785439|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
83785440|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
83785441|NCT00038064|Hematinics|hematinics|mesh-ancestor
83785442|NCT00038181|Thalidomide|thalidomide|mesh-list
83785443|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785444|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
83785445|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785446|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
83785447|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83785448|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785449|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83785450|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83785451|NCT00038181|Growth Substances|growth substances|mesh-ancestor
83785452|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
83785453|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785454|NCT00038220|Ritonavir|ritonavir|mesh-list
83785455|NCT00038220|Lopinavir|lopinavir|mesh-list
83785456|NCT00038220|Tenofovir|tenofovir|mesh-list
83785457|NCT00038220|Lamivudine|lamivudine|mesh-list
83785458|NCT00038220|Efavirenz|efavirenz|mesh-list
83785459|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83785460|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83785461|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
83785462|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785463|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785464|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83785465|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83785466|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
83785467|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785468|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83785469|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83785470|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83785471|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83785472|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83785473|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83785474|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83785475|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83785476|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83785477|NCT00038259|Aldesleukin|aldesleukin|mesh-list
83785478|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785479|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83785480|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83785481|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
83785482|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785483|NCT00847418|Esketamine|esketamine|mesh-list
83785484|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785485|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785486|NCT05433597|Cisplatin|cisplatin|mesh-list
83785487|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785488|NCT05433480|Fulvestrant|fulvestrant|mesh-list
83785489|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83785490|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785491|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83785492|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83785493|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
83785494|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785495|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785496|NCT00847262|Amlodipine|amlodipine|mesh-list
83785497|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83785498|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83785499|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785500|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785501|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83785502|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785503|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
83785504|NCT00847223|Tipifarnib|tipifarnib|mesh-list
83785505|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785506|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
83785507|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83785508|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785509|NCT00847106|Daclizumab|daclizumab|mesh-list
83785510|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785511|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
83785512|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785513|NCT00396669|Bupropion|bupropion|mesh-list
83785514|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83785515|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785516|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785517|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83785518|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83785519|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785520|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785521|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
83785522|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785523|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785524|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83785525|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83785526|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785527|NCT00846989|Latanoprost|latanoprost|mesh-list
83785528|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83785529|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83785530|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
83785531|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83785532|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83785533|NCT00396747|Prednisolone|prednisolone|mesh-list
83785534|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
83785535|NCT00396747|Infliximab|infliximab|mesh-list
83785536|NCT00396747|Methotrexate|methotrexate|mesh-list
83785537|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83785538|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
83785539|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83785540|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
83785541|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83785542|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785543|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83785544|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
83785545|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785546|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785547|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
83785548|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785549|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83785550|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785551|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
83785552|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785553|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83785554|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785555|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
83785556|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
83785557|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785558|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785559|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
83785560|NCT00396747|Hormones|hormones|mesh-ancestor
83785561|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785562|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83785563|NCT00396747|Protective Agents|protective agents|mesh-ancestor
83785564|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83785565|NCT00396747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83785566|NCT00846950|Lorazepam|lorazepam|mesh-list
83785567|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
83785568|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
83785569|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
83785570|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
83785571|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785572|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785573|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785574|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83785575|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83785576|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83785577|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83785578|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785579|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
83785580|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
83785581|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785582|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785583|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83785584|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
83785585|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
83785586|NCT05432934|Dexamethasone|dexamethasone|mesh-list
83785587|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785588|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
83785589|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
83785590|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785591|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785592|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785593|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
83785594|NCT05432934|Hormones|hormones|mesh-ancestor
83785595|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785596|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83785597|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785598|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
83785599|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83785600|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83785601|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785602|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83785603|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83785604|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785605|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785606|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785607|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83785608|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
83785609|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83785610|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785611|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83785612|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83785613|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83785614|NCT00846872|Mannitol|mannitol|mesh-list
83785615|NCT00846872|Hormones|hormones|mesh-list
83785616|NCT00846872|Secretagogues|secretagogues|mesh-list
83785617|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785618|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785619|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83785620|NCT00846872|Diuretics|diuretics|mesh-ancestor
83785621|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
83785622|NCT05432778|Letermovir|letermovir|mesh-list
83785623|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83785624|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785625|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785626|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785627|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
83785628|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785629|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
83785630|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
83785631|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785632|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
83785633|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83785634|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785635|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785636|NCT00846716|Pioglitazone|pioglitazone|mesh-list
83785637|NCT00846716|Biguanides|biguanides|mesh-list
83785638|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83785639|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785640|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83785641|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83785642|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785643|NCT00846677|Vitamin D|vitamin d|mesh-list
83785644|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
83785645|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
83785646|NCT00846677|Vitamins|vitamins|mesh-list
83785647|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
83785648|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785649|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83785650|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83785651|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
82940848|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83785652|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785654|NCT05428683|Triamcinolone|triamcinolone|mesh-list
83785655|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83785656|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785657|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83785658|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83785659|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785660|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785661|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785662|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785663|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785664|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
83785665|NCT05428683|Hormones|hormones|mesh-ancestor
83785666|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785667|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83785668|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83785669|NCT00846443|Cisplatin|cisplatin|mesh-list
83785670|NCT00846443|Pemetrexed|pemetrexed|mesh-list
83785671|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785672|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785673|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785674|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83785675|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83785676|NCT00846326|Fluticasone|fluticasone|mesh-list
83785677|NCT00846326|Xhance|xhance|mesh-list
83785678|NCT00846326|Phenylephrine|phenylephrine|mesh-list
83785679|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
83785680|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785681|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83785682|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
83785683|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785684|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785685|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83785686|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
83785687|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83785688|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83785689|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83785690|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83785691|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
83785692|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785693|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785694|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
83785695|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
83785696|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83785697|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83785698|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
83785699|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83785700|NCT00846326|Protective Agents|protective agents|mesh-ancestor
83785701|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
83785702|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83785703|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785704|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83785705|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785706|NCT00846248|Chromium|chromium|mesh-list
83785707|NCT00846248|Trace Elements|trace elements|mesh-ancestor
83785708|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
83785709|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785710|NCT00846131|Sorafenib|sorafenib|mesh-list
83785711|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785712|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83785713|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785714|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785715|NCT05116059|Amphotericin B|amphotericin b|mesh-list
83785716|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83785717|NCT05116059|Amebicides|amebicides|mesh-ancestor
83785718|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83785719|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83785720|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785721|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83785722|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
83785723|NCT00845936|Metformin|metformin|mesh-list
83785724|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83785725|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785726|NCT00277082|Camptothecin|camptothecin|mesh-list
83785727|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83785728|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785729|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83785730|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83785731|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785732|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785733|NCT04888377|Aspirin|aspirin|mesh-list
83785734|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83785735|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83785736|NCT04888377|Analgesics|analgesics|mesh-ancestor
83785737|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
83785738|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785739|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785740|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785741|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785742|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83785743|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83785744|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785745|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83785746|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83785747|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785748|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
83785749|NCT00277043|Paclitaxel|paclitaxel|mesh-list
83785750|NCT00277043|Docetaxel|docetaxel|mesh-list
83785751|NCT00277043|Taxane|taxane|mesh-list
83785752|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83785753|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785754|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
83785755|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
83785756|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
83785757|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785758|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
83785759|NCT00276965|Sertraline|sertraline|mesh-list
83785760|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785761|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785762|NCT00276965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83785763|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83785764|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785765|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785766|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785767|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
83785768|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785769|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785770|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
83785771|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83785772|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83785773|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
83785774|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785775|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83785776|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785777|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785778|NCT00396786|Enoxaparin|enoxaparin|mesh-list
83785779|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
83785780|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83785781|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
83785782|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83785783|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
83785784|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785785|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785786|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
83785787|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83785788|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83785789|NCT00276848|Vidarabine|vidarabine|mesh-list
83785790|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
83785791|NCT00276848|Fludarabine|fludarabine|mesh-list
83785792|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
83785793|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785794|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
83785795|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785796|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785797|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83785798|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
83785799|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785800|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785801|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82940997|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
83785802|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83785804|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
83785805|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785806|NCT00276809|Cytarabine|cytarabine|mesh-list
83785807|NCT00276809|Dexamethasone|dexamethasone|mesh-list
83785808|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
83785809|NCT00276809|Melphalan|melphalan|mesh-list
83785810|NCT00276809|Carmustine|carmustine|mesh-list
83785811|NCT00276809|Fludarabine|fludarabine|mesh-list
83785812|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
83785813|NCT00276809|Etoposide|etoposide|mesh-list
83785814|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
83785815|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785816|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
83785817|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785818|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785819|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83785820|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
83785821|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785822|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785823|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83785824|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785825|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
83785826|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
83785827|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785828|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785829|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
83785830|NCT00276809|Hormones|hormones|mesh-ancestor
83785831|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785832|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83785833|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83785834|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
83785835|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83785836|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83785837|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83785838|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785839|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
83785840|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785841|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83785842|NCT00276770|Fluorides|fluorides|mesh-list
83785843|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
83785844|NCT00276770|Protective Agents|protective agents|mesh-ancestor
83785845|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785846|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
83785847|NCT00276731|Carboplatin|carboplatin|mesh-list
83785848|NCT00276731|Etoposide|etoposide|mesh-list
83785849|NCT00276731|Vincristine|vincristine|mesh-list
83785850|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785851|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
83785852|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785853|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785854|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83785855|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
83785856|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785857|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785858|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83785859|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83785860|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83785861|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83785862|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785863|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
83785864|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
83785865|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
83785866|NCT00276692|Irinotecan|irinotecan|mesh-list
83785867|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83785868|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83785869|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785870|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785871|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785872|NCT00276575|Bevacizumab|bevacizumab|mesh-list
83785873|NCT00276575|Everolimus|everolimus|mesh-list
83785874|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83785875|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83785876|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941069|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
83785877|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83785878|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83785879|NCT00276575|Growth Substances|growth substances|mesh-ancestor
83785880|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785881|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
83785882|NCT00276575|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83785883|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83785884|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785885|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785886|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785887|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
83785888|NCT00276536|Interferons|interferons|mesh-list
83785889|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
83785890|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83785891|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785892|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
83785893|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83785894|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
83785895|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785896|NCT00276497|Pioglitazone|pioglitazone|mesh-list
83785897|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83785898|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785899|NCT04430790|Doxapram|doxapram|mesh-list
83785900|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83785901|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785902|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
83785903|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
83785904|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785905|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83785906|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785907|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785908|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
83785909|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83785910|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785911|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785912|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
83785913|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785914|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785915|NCT00276146|Dipyridamole|dipyridamole|mesh-list
83785916|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83785917|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785918|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785919|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83785920|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
83785921|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83785922|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
83785923|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785924|NCT04201665|Oxytocin|oxytocin|mesh-list
83785925|NCT04201665|Carbetocin|carbetocin|mesh-list
83785926|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
83785927|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83785928|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785929|NCT00276068|Lidocaine|lidocaine|mesh-list
83785930|NCT00276068|Desipramine|desipramine|mesh-list
83785931|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
83785932|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
83785933|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83785934|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785935|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
83785936|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785937|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83785938|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83785939|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83785940|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785941|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785942|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83785943|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
83785944|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83785945|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83785946|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83785947|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83785948|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
83785949|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785950|NCT00276029|Etanercept|etanercept|mesh-list
83785951|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83785952|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83785954|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
83785955|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83785956|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785957|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785958|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83785959|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83785960|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83785961|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
83785962|NCT00397059|Escitalopram|escitalopram|mesh-list
83785963|NCT00397059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83785964|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83785965|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785966|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785967|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785968|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
83785969|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785970|NCT04149210|Fluorometholone|fluorometholone|mesh-list
83785971|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
83785972|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83785973|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83785974|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83785975|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
83785976|NCT04149210|Hormones|hormones|mesh-ancestor
83785977|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83785978|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785979|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83785980|NCT00275951|Cetuximab|cetuximab|mesh-list
83785981|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83785982|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83785983|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
83785984|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
83785985|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83785986|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83785987|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83785988|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785989|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83785990|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83785991|NCT00397098|Amibegron|amibegron|mesh-list
83785992|NCT00397098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83785993|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83785994|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83785995|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83785996|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83785997|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83785998|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83785999|NCT00397098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83786000|NCT00275834|Zonisamide|zonisamide|mesh-list
83786001|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
83786002|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83786003|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83786004|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786005|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83786006|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786007|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83786008|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83786009|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83786010|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83786011|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786012|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786013|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786014|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
83786015|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83786016|NCT00275756|Timolol|timolol|mesh-list
83786017|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83786018|NCT00275756|Dorzolamide|dorzolamide|mesh-list
83786019|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83786020|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83786021|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
83786022|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786023|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786024|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786025|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83786026|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786027|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83786028|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83786029|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83786030|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83786031|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786032|NCT00275639|Losartan|losartan|mesh-list
83786033|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83786034|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786035|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83786036|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83786037|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786038|NCT03957057|Iron|iron|mesh-list
83786039|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83786040|NCT03957057|Trace Elements|trace elements|mesh-ancestor
83786041|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
83786042|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786043|NCT03957057|Hematinics|hematinics|mesh-ancestor
83786044|NCT00275600|Vitamin E|vitamin e|mesh-list
83786045|NCT00275600|Vitamins|vitamins|mesh-ancestor
83786046|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
83786047|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786048|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
83786049|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786050|NCT00275600|Protective Agents|protective agents|mesh-ancestor
83786051|NCT00275522|Sirolimus|sirolimus|mesh-list
83786052|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786053|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786054|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83786055|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786056|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
83786057|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786058|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
83786059|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786060|NCT00275444|Tipranavir|tipranavir|mesh-list
83786061|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83786062|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83786063|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
83786064|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786065|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
83786066|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
83786067|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786068|NCT00275405|Protective Agents|protective agents|mesh-ancestor
83786069|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786070|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83786071|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786072|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83786073|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786074|NCT00275249|Levorphanol|levorphanol|mesh-list
83786075|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83786076|NCT00275249|Narcotics|narcotics|mesh-ancestor
83786077|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786078|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786079|NCT00275249|Analgesics|analgesics|mesh-ancestor
83786080|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
83786081|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786082|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
83786083|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786084|NCT00041535|Miglustat|miglustat|mesh-list
83786085|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786086|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786087|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83786088|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83786089|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
83786090|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786091|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83786092|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83786093|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786094|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
83786095|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83786096|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
83786097|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786098|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941293|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
83786099|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83786100|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
83786101|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83786102|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
83786103|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786104|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786105|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83786106|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
83786107|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
83786108|NCT00041574|Protective Agents|protective agents|mesh-ancestor
83786109|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83786110|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786111|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83786112|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786113|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786115|NCT00275093|Temsirolimus|temsirolimus|mesh-list
83786116|NCT00275093|MTOR Inhibitors|mtor inhibitors|mesh-list
83786117|NCT00275093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83786118|NCT00275093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786119|NCT00275093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786120|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786121|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
83786122|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786123|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786124|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786125|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786126|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83786127|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
83786128|NCT00041652|Labetuzumab|labetuzumab|mesh-list
83786129|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786130|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786131|NCT03430596|Pramipexole|pramipexole|mesh-list
83786132|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
83786133|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
83786134|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786135|NCT03430596|Protective Agents|protective agents|mesh-ancestor
83786136|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786137|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83786138|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83786139|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
83786140|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
83786141|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786142|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83786143|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83786144|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
83786145|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
83786146|NCT00275054|Rituximab|rituximab|mesh-list
83786147|NCT00275054|Fludarabine|fludarabine|mesh-list
83786148|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786149|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
83786150|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786151|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786152|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786153|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
83786154|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786155|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786156|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83786157|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786158|NCT03208179|Azithromycin|azithromycin|mesh-list
83786159|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
83786160|NCT03208179|Piperaquine|piperaquine|mesh-list
83786161|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
83786162|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83786163|NCT03208179|Artenimol|artenimol|mesh-list
83786164|NCT03208179|Artemisinins|artemisinins|mesh-list
83786165|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786166|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786167|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
83786168|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83786169|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83786170|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83786171|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786172|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786173|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83786174|NCT00275015|Cytarabine|cytarabine|mesh-list
82941368|NCT01356680|Prednisone|prednisone|mesh-list
83786175|NCT00275015|Dexamethasone|dexamethasone|mesh-list
83786176|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
83786177|NCT00275015|Melphalan|melphalan|mesh-list
83786178|NCT00275015|Carmustine|carmustine|mesh-list
83786179|NCT00275015|Fludarabine|fludarabine|mesh-list
83786180|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
83786181|NCT00275015|Etoposide|etoposide|mesh-list
83786182|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786183|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
83786184|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786185|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786186|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786187|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
83786188|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786189|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786190|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83786191|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786192|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
83786193|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
83786194|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786195|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83786196|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
83786197|NCT00275015|Hormones|hormones|mesh-ancestor
83786198|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83786199|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83786200|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83786201|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
83786202|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83786203|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83786204|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83786205|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786206|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
83786207|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786208|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
83786209|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786210|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786211|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
83786212|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83786213|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83786214|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786215|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83786216|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786217|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83786218|NCT03062826|Aspirin|aspirin|mesh-list
83786219|NCT03062826|Clopidogrel|clopidogrel|mesh-list
83786220|NCT03062826|Ticagrelor|ticagrelor|mesh-list
83786221|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83786222|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786223|NCT03062826|Analgesics|analgesics|mesh-ancestor
83786224|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
83786225|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786226|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786227|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786228|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786229|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83786230|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83786231|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786232|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83786233|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83786234|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786235|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
83786236|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83786237|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83786238|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83786239|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
83786240|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786241|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
83786242|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83786243|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786244|NCT00130364|Analgesics|analgesics|mesh-ancestor
83786245|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
83786246|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786247|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786248|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786249|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786251|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786252|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
83786253|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83786254|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786255|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786256|NCT00130325|Isoniazid|isoniazid|mesh-list
83786257|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
83786258|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786259|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786260|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83786261|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83786262|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
83786263|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786264|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83786265|NCT00041691|Labetuzumab|labetuzumab|mesh-list
83786266|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786267|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786268|NCT00394394|Enalapril|enalapril|mesh-list
83786269|NCT00394394|Amiloride|amiloride|mesh-list
83786270|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83786271|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
83786272|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786273|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786274|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786275|NCT00394394|Diuretics|diuretics|mesh-ancestor
83786276|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
83786277|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786278|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83786279|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83786280|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83786281|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83786282|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83786283|NCT00130091|Clonidine|clonidine|mesh-list
83786284|NCT00130091|Analgesics|analgesics|mesh-ancestor
83786285|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
83786286|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786287|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786288|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786289|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
83786290|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
83786291|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83786292|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83786293|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83786294|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83786295|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786296|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786297|NCT00130013|Amoxicillin|amoxicillin|mesh-list
83786298|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786299|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786300|NCT00129857|HU 211|hu 211|mesh-list
83786301|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83786302|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
83786303|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
83786304|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786305|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786306|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83786307|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83786308|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83786309|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786310|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786311|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83786312|NCT00129857|Protective Agents|protective agents|mesh-ancestor
83786313|NCT00129818|Famciclovir|famciclovir|mesh-list
83786314|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
83786315|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786316|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83786317|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786318|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786319|NCT00129506|Methotrexate|methotrexate|mesh-list
83786320|NCT00129506|Misoprostol|misoprostol|mesh-list
83786321|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82941518|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
83786322|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
83786323|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83786324|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786325|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83786326|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
83786327|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786328|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786329|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
83786330|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786331|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83786332|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786333|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
83786334|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786335|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83786336|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83786337|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83786338|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
83786339|NCT00129233|Amlodipine|amlodipine|mesh-list
83786340|NCT00129233|Valsartan|valsartan|mesh-list
83786341|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786342|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83786343|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83786344|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786345|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83786346|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786347|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
83786348|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83786349|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83786350|NCT00129155|Treosulfan|treosulfan|mesh-list
83786351|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786352|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
83786353|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786354|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786355|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
83786356|NCT00712881|Docetaxel|docetaxel|mesh-list
83786357|NCT00712881|Doxorubicin|doxorubicin|mesh-list
83786358|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83786359|NCT00712881|Trastuzumab|trastuzumab|mesh-list
83786360|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786361|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
83786362|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786363|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786364|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786365|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
83786366|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786367|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786368|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83786369|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83786370|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83786371|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83786372|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83786373|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83786374|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83786375|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786376|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786377|NCT00042003|Decitabine|decitabine|mesh-list
83786378|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83786379|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
83786380|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786381|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786382|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786383|NCT00129038|Aspirin|aspirin|mesh-list
83786384|NCT00129038|Dipyridamole|dipyridamole|mesh-list
83786385|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83786386|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83786387|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786388|NCT00129038|Analgesics|analgesics|mesh-ancestor
83786389|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
83786390|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786391|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786392|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786393|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786394|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82941593|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
82941594|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786395|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83786396|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786397|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83786398|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83786399|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786400|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
83786401|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83786402|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
83786403|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
83786404|NCT00470223|Doxorubicin|doxorubicin|mesh-list
83786405|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83786406|NCT00470223|Methotrexate|methotrexate|mesh-list
83786407|NCT00470223|Etoposide|etoposide|mesh-list
83786408|NCT00470223|Ifosfamide|ifosfamide|mesh-list
83786409|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786410|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83786411|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83786412|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83786413|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786414|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786415|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83786416|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
83786417|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83786418|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786419|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83786420|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
83786421|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
83786422|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83786423|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786424|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
83786425|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786426|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83786427|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83786428|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786429|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
83786430|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83786431|NCT00103389|Docetaxel|docetaxel|mesh-list
83786432|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786433|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
83786434|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
83786435|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
83786436|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786437|NCT00128921|Bortezomib|bortezomib|mesh-list
83786438|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786439|NCT00128804|Beta Carotene|beta carotene|mesh-list
83786440|NCT00128804|Carotenoids|carotenoids|mesh-list
83786441|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
83786442|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786443|NCT00128804|Protective Agents|protective agents|mesh-ancestor
83786444|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786445|NCT00128804|Provitamins|provitamins|mesh-ancestor
83786446|NCT00128804|Vitamins|vitamins|mesh-ancestor
83786447|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
83786448|NCT00097851|Docetaxel|docetaxel|mesh-list
83786449|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786450|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
83786451|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
83786452|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
83786453|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786454|NCT00038376|Interferons|interferons|mesh-list
83786455|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
83786456|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
83786457|NCT00038376|Isotretinoin|isotretinoin|mesh-list
83786458|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786459|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
83786460|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786461|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
83786462|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786463|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
83786464|NCT00128531|Leuprolide|leuprolide|mesh-list
83786465|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83786466|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
83786467|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83786468|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786469|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83786470|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786471|NCT00038454|Chrysarobin|chrysarobin|mesh-list
83786472|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83786474|NCT00038454|Analgesics|analgesics|mesh-ancestor
83786475|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
83786476|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786477|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786478|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786479|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786480|NCT00128453|Colchicine|colchicine|mesh-list
83786481|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
83786482|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786483|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
83786484|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
83786485|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
83786486|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786487|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786488|NCT00128414|Colchicine|colchicine|mesh-list
83786489|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
83786490|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786491|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
83786492|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
83786493|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
83786494|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786495|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786496|NCT00038493|Temozolomide|temozolomide|mesh-list
83786497|NCT00038493|Lonafarnib|lonafarnib|mesh-list
83786498|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786499|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
83786500|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786501|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786502|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786503|NCT00038532|Ritonavir|ritonavir|mesh-list
83786504|NCT00038532|Saquinavir|saquinavir|mesh-list
83786505|NCT00038532|Amprenavir|amprenavir|mesh-list
83786506|NCT00038532|Efavirenz|efavirenz|mesh-list
83786507|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83786508|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83786509|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
83786510|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786511|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786512|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83786513|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83786514|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
83786515|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786516|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83786517|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83786518|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83786519|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83786520|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83786521|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83786522|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83786523|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83786524|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83786525|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83786526|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
83786527|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786528|NCT00038571|Bortezomib|bortezomib|mesh-list
83786529|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786530|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
83786531|NCT05770687|Empagliflozin|empagliflozin|mesh-list
83786532|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
83786533|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83786534|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
83786535|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786536|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83786537|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786538|NCT05770531|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83786539|NCT05770531|Immunoconjugates|immunoconjugates|mesh-ancestor
83786540|NCT05770531|Immunologic Factors|immunologic factors|mesh-ancestor
83786541|NCT05770531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786542|NCT05770323|Uric Acid|uric acid|mesh-list
83786543|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
83786544|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941743|NCT03132610|Analgesics|analgesics|mesh-ancestor
83786545|NCT05770323|Protective Agents|protective agents|mesh-ancestor
83786546|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786547|NCT05769881|Anesthetics|anesthetics|mesh-list
83786548|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
83786549|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786550|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786551|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
83786552|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786553|NCT05769855|Ropivacaine|ropivacaine|mesh-list
83786554|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
83786555|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
83786556|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786557|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786558|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
83786559|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786560|NCT05769738|Furosemide|furosemide|mesh-list
83786561|NCT05769738|Diuretics|diuretics|mesh-list
83786562|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
83786563|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786564|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83786565|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83786566|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786567|NCT05769725|Docetaxel|docetaxel|mesh-list
83786568|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786569|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
83786570|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
83786571|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
83786572|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786573|NCT05769660|Temozolomide|temozolomide|mesh-list
83786574|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786575|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
83786576|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786577|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786578|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83786579|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
83786580|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786581|NCT05769309|Fentanyl|fentanyl|mesh-list
83786582|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83786583|NCT05769309|Narcotics|narcotics|mesh-ancestor
83786584|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786585|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786586|NCT05769309|Analgesics|analgesics|mesh-ancestor
83786587|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
83786588|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786589|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83786590|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83786591|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
83786592|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
83786593|NCT05769049|Vaccines|vaccines|mesh-list
83786594|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
83786595|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786596|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
83786597|NCT05768997|Hematinics|hematinics|mesh-ancestor
83786598|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83786599|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
83786600|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786601|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786602|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83786603|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786604|NCT05765305|Chromium|chromium|mesh-list
83786605|NCT05765305|Letrozole|letrozole|mesh-list
83786606|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786607|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83786608|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83786609|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786610|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786611|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83786612|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
83786613|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83786614|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786615|NCT05765305|Trace Elements|trace elements|mesh-ancestor
83786616|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
83786617|NCT05762146|Perphenazine|perphenazine|mesh-list
83786618|NCT05762146|Riociguat|riociguat|mesh-list
83786619|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
83786620|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
82941814|NCT02301676|Sevoflurane|sevoflurane|mesh-list
83786621|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786622|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83786623|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83786624|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786625|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786626|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83786627|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83786629|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786630|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
83786631|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
83786632|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
83786633|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83786634|NCT05760612|Trastuzumab|trastuzumab|mesh-list
83786635|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786636|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786637|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83786638|NCT05760144|Etonogestrel|etonogestrel|mesh-list
83786639|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83786640|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
83786641|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83786642|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786643|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83786644|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83786645|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83786646|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786647|NCT05744674|Ropivacaine|ropivacaine|mesh-list
83786648|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
83786649|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
83786650|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786651|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786652|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
83786653|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786654|NCT05736978|Azacitidine|azacitidine|mesh-list
83786655|NCT05736978|Venetoclax|venetoclax|mesh-list
83786656|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83786657|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
83786658|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786659|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786660|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786661|NCT05736965|Azacitidine|azacitidine|mesh-list
83786662|NCT05736965|Venetoclax|venetoclax|mesh-list
83786663|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83786664|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
83786665|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786666|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786667|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786668|NCT05706727|Phenylephrine|phenylephrine|mesh-list
83786669|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
83786670|NCT05706727|Mephentermine|mephentermine|mesh-list
83786671|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83786672|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
83786673|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
83786674|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786675|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786676|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
83786677|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83786678|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
83786679|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
83786680|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83786681|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83786682|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83786683|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83786684|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786685|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786686|NCT05706727|Protective Agents|protective agents|mesh-ancestor
83786687|NCT05697783|Fentanyl|fentanyl|mesh-list
83786688|NCT05697783|Methadone|methadone|mesh-list
83786689|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83786690|NCT05697783|Narcotics|narcotics|mesh-ancestor
83786691|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786692|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786693|NCT05697783|Analgesics|analgesics|mesh-ancestor
83786694|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
83786695|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786696|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83786697|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83786698|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
83786699|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
83786700|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
83786701|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
83786702|NCT05686408|Tianeptine|tianeptine|mesh-list
83786703|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83786704|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
83786705|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83786706|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
83786707|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83786708|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786709|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786710|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786711|NCT05672225|Analgesics|analgesics|mesh-ancestor
83786712|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
83786713|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786714|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83786715|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83786716|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83786717|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
83786718|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786719|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786720|NCT05663580|Rilpivirine|rilpivirine|mesh-list
83786721|NCT05663580|Cabotegravir|cabotegravir|mesh-list
83786722|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83786723|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83786724|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786725|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786726|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
83786727|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786728|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83786729|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83786730|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83786731|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83786732|NCT05657860|Guanfacine|guanfacine|mesh-list
83786733|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786734|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83786735|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83786736|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83786737|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
83786738|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786739|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786740|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786741|NCT05644626|Tislelizumab|tislelizumab|mesh-list
83786742|NCT05644626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786743|NCT05644626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786744|NCT05642962|Pancrelipase|pancrelipase|mesh-list
83786745|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83786746|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
83786747|NCT05619627|Anesthetics|anesthetics|mesh-list
83786748|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
83786749|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83786750|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786751|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786752|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786753|NCT05619627|Analgesics|analgesics|mesh-ancestor
83786754|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
83786755|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786756|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83786757|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83786758|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83786759|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83786760|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786761|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786762|NCT05615818|Gemcitabine|gemcitabine|mesh-list
83786763|NCT05615818|Trastuzumab|trastuzumab|mesh-list
83786764|NCT05615818|Niraparib|niraparib|mesh-list
83786765|NCT05615818|Ivosidenib|ivosidenib|mesh-list
83786766|NCT05615818|Futibatinib|futibatinib|mesh-list
83786767|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786768|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83786769|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
83786770|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786771|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786772|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83786773|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786774|NCT05595603|Gentamicins|gentamicins|mesh-list
83786775|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83786776|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786777|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786778|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83786779|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786780|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786781|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
83786782|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83786783|NCT05595603|Protective Agents|protective agents|mesh-ancestor
83786784|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786785|NCT05568940|Tibolone|tibolone|mesh-list
83786786|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
83786787|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
83786788|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83786789|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786790|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786791|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83786792|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786793|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83786794|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
83786795|NCT05568940|Hormones|hormones|mesh-ancestor
83786796|NCT05562973|Psilocybin|psilocybin|mesh-list
83786797|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
83786798|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786799|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83786800|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
83786801|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
83786802|NCT05543785|Ketorolac|ketorolac|mesh-list
83786803|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83786804|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786805|NCT05543785|Analgesics|analgesics|mesh-ancestor
83786806|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
83786807|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786808|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786809|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786810|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786811|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83786812|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786813|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786814|NCT05457465|Cannabidiol|cannabidiol|mesh-list
83786815|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
83786816|NCT05453955|Propofol|propofol|mesh-list
83786817|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83786818|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786819|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786820|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83786821|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
83786822|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
83786823|NCT05447559|Cefazolin|cefazolin|mesh-list
83786824|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786825|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786826|NCT05427786|Nicorandil|nicorandil|mesh-list
83786827|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83786828|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83786829|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
83786830|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
83786831|NCT05427786|Vitamins|vitamins|mesh-ancestor
83786832|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
83786833|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786834|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83786835|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
83786836|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
83786837|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786838|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
83786839|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83786840|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786841|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83786842|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786843|NCT05402553|Ondansetron|ondansetron|mesh-list
83786844|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
82942043|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
83786845|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
83786846|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786847|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786848|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83786849|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
83786850|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
83786851|NCT05402553|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83786852|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83786853|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
83786854|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83786855|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786856|NCT05379322|Adalimumab|adalimumab|mesh-list
83786857|NCT05379322|Golimumab|golimumab|mesh-list
83786858|NCT05379322|Etanercept|etanercept|mesh-list
83786859|NCT05379322|Upadacitinib|upadacitinib|mesh-list
83786860|NCT05379322|Tofacitinib|tofacitinib|mesh-list
83786861|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83786862|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83786863|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786864|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786865|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83786866|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786867|NCT05379322|Analgesics|analgesics|mesh-ancestor
83786868|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
83786869|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786870|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786871|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83786872|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786873|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
83786874|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83786875|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786876|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786877|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
83786878|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83786879|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786880|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786881|NCT05313243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83786882|NCT05313243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786883|NCT05313243|Immunotoxins|immunotoxins|mesh-ancestor
83786884|NCT05313243|Immunoconjugates|immunoconjugates|mesh-ancestor
83786885|NCT05313243|Immunologic Factors|immunologic factors|mesh-ancestor
83786886|NCT05313243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786887|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83786888|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83786889|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786890|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
83786891|NCT05298696|Cilostazol|cilostazol|mesh-list
83786892|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83786893|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
83786894|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786895|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786896|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83786897|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
83786898|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83786899|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83786900|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786901|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83786902|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
83786903|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83786904|NCT05298696|Protective Agents|protective agents|mesh-ancestor
83786905|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83786906|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83786907|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786908|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
83786909|NCT05287425|Gentamicins|gentamicins|mesh-list
83786910|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83786911|NCT05287425|Povidone|povidone|mesh-list
83786912|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83786913|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786914|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83786915|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83786916|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786917|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786918|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786919|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83786920|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83786921|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83786922|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
83786923|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
83786924|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83786925|NCT05276492|Prednisone|prednisone|mesh-list
83786926|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786927|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
83786928|NCT05276492|Hormones|hormones|mesh-ancestor
83786929|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83786930|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786931|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83786932|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786933|NCT05258721|Fluorides|fluorides|mesh-list
83786934|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
83786935|NCT05258721|Protective Agents|protective agents|mesh-ancestor
83786936|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786937|NCT05232032|Nociceptin|nociceptin|mesh-list
83786938|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
83786939|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
83786940|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83786941|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
83786942|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786944|NCT05215730|Trace Elements|trace elements|mesh-ancestor
83786945|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
83786946|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786947|NCT05209074|Ivosidenib|ivosidenib|mesh-list
83786948|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786949|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786950|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786951|NCT05192850|Metformin|metformin|mesh-list
83786952|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83786953|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786954|NCT05111717|Desflurane|desflurane|mesh-list
83786955|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83786956|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
83786957|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
83786958|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83786959|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786960|NCT05105919|Aspirin|aspirin|mesh-list
83786961|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83786962|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83786963|NCT05105919|Analgesics|analgesics|mesh-ancestor
83786964|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
83786965|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83786966|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786967|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83786968|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786969|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83786970|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83786971|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786972|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83786973|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83786974|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83786975|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
83786976|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
83786977|NCT05077527|Fludarabine|fludarabine|mesh-list
83786978|NCT05077527|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83786979|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83786980|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
83786981|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83786982|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83786983|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83786984|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
83786985|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83786986|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786987|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83786988|NCT05077527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83786989|NCT05070364|Interferons|interferons|mesh-list
83786990|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786991|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
83786992|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83786993|NCT05054439|Paclitaxel|paclitaxel|mesh-list
83786994|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83786995|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83786996|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
83786997|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
83786998|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
83786999|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787000|NCT05049603|Atorvastatin|atorvastatin|mesh-list
83787001|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83787002|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83787003|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
83787004|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787005|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83787006|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83787007|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787008|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
83787009|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83787010|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83787011|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787012|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
83787013|NCT05037162|Coagulants|coagulants|mesh-ancestor
83787014|NCT05032157|Remibrutinib|remibrutinib|mesh-list
83787015|NCT05032157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83787016|NCT05032157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787017|NCT05032157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787018|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
83787019|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787020|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787021|NCT05024318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787022|NCT05024318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787023|NCT05022654|Irinotecan|irinotecan|mesh-list
83787024|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83787025|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83787026|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787027|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787028|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787029|NCT05020457|Paclitaxel|paclitaxel|mesh-list
83787030|NCT05020457|Docetaxel|docetaxel|mesh-list
83787031|NCT05020457|Cisplatin|cisplatin|mesh-list
83787032|NCT05020457|Pemetrexed|pemetrexed|mesh-list
83787033|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83787034|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787035|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83787036|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83787037|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83787038|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787039|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787040|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83787041|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787042|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
83787043|NCT05020444|Fludarabine|fludarabine|mesh-list
83787044|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787045|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
83787046|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787047|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787048|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83787049|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
83787050|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787051|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787052|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83787053|NCT05012189|Oseltamivir|oseltamivir|mesh-list
83787054|NCT05012189|Baloxavir|baloxavir|mesh-list
83787055|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
83787056|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787057|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787058|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787059|NCT05006573|Benralizumab|benralizumab|mesh-list
83787060|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83787061|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
83787062|NCT04985721|Tislelizumab|tislelizumab|mesh-list
83787063|NCT04985721|Pamiparib|pamiparib|mesh-list
83787064|NCT04985721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787065|NCT04985721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787066|NCT04985721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83787067|NCT04985721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787068|NCT04985721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787069|NCT04952610|Etripamil|etripamil|mesh-list
83787070|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83787071|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83787072|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787073|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83787074|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787075|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
83787076|NCT04921189|Thiamine|thiamine|mesh-list
83787077|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
83787078|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
83787079|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787080|NCT04921189|Protective Agents|protective agents|mesh-ancestor
83787081|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787082|NCT04921189|Vitamins|vitamins|mesh-ancestor
83787083|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
83787084|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
83787085|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787086|NCT04902911|Antibodies|antibodies|mesh-list
83787087|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
83787088|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
83787089|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787090|NCT04864366|Tenofovir|tenofovir|mesh-list
83787091|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
83787092|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787093|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83787094|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787095|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787096|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787097|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83787098|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83787099|NCT04859296|Dronabinol|dronabinol|mesh-list
83787100|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
83787101|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787102|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83787103|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83787104|NCT04859296|Analgesics|analgesics|mesh-ancestor
83787105|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
83787106|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787107|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83787108|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83787109|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83787110|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787111|NCT04859296|Hormones|hormones|mesh-ancestor
83787112|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787113|NCT04857684|Bevacizumab|bevacizumab|mesh-list
83787114|NCT04857684|Atezolizumab|atezolizumab|mesh-list
83787115|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787116|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787117|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83787118|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83787119|NCT04857684|Growth Substances|growth substances|mesh-ancestor
83787120|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787121|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83787122|NCT04857684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787123|NCT04857684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787124|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
83787125|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83787126|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787127|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787128|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
83787129|NCT04846348|Promethazine|promethazine|mesh-list
83787130|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
83787131|NCT04846348|Salicylates|salicylates|mesh-list
83787132|NCT04846348|Emollients|emollients|mesh-list
83787133|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83787134|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83787135|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787136|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787137|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
83787138|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
83787139|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
83787140|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787141|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
83787142|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
83787143|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942344|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942345|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
83787144|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83787145|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
83787147|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83787148|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787149|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83787150|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
83787151|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
83787152|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83787153|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83787154|NCT04846348|Analgesics|analgesics|mesh-ancestor
83787155|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787156|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787157|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83787158|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787159|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83787160|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
83787161|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83787162|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
83787163|NCT04844918|Tirzepatide|tirzepatide|mesh-list
83787164|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83787165|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787166|NCT04844918|Incretins|incretins|mesh-ancestor
83787167|NCT04844918|Hormones|hormones|mesh-ancestor
83787168|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787169|NCT04777201|Faricimab|faricimab|mesh-list
83787170|NCT04777201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83787171|NCT04777201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83787172|NCT04777201|Growth Substances|growth substances|mesh-ancestor
83787173|NCT04777201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787174|NCT04777201|Growth Inhibitors|growth inhibitors|mesh-ancestor
83787175|NCT04777201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787176|NCT04771520|Piperazine|piperazine|mesh-list
83787177|NCT04771520|Mebendazole|mebendazole|mesh-list
83787178|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
83787179|NCT04771520|DMP 777|dmp 777|mesh-list
83787180|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
83787181|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
83787182|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83787183|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787184|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
83787185|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
83787186|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
83787187|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787188|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787189|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787190|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
83787191|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83787192|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
83787193|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787194|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
83787195|NCT04769453|Protective Agents|protective agents|mesh-ancestor
83787196|NCT04765709|Carboplatin|carboplatin|mesh-list
83787197|NCT04765709|Pemetrexed|pemetrexed|mesh-list
83787198|NCT04765709|Durvalumab|durvalumab|mesh-list
83787199|NCT04765709|Vinorelbine|vinorelbine|mesh-list
83787200|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83787201|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787202|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787203|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787204|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83787205|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787206|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787207|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
83787208|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787209|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83787210|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83787211|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83787212|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83787213|NCT04742699|Lemborexant|lemborexant|mesh-list
83787214|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83787215|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83787216|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787217|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83787218|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83787219|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787220|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787222|NCT04654689|Resveratrol|resveratrol|mesh-list
83787223|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83787224|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83787225|NCT04654689|Analgesics|analgesics|mesh-ancestor
83787226|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
83787227|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787228|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787229|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787230|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787231|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787232|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787233|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787234|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
83787235|NCT04654689|Protective Agents|protective agents|mesh-ancestor
83787236|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83787237|NCT04634838|Copper|copper|mesh-list
83787238|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83787239|NCT04634838|Trace Elements|trace elements|mesh-ancestor
83787240|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
83787241|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787242|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787243|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
83787244|NCT04629534|Vitamin D|vitamin d|mesh-list
83787245|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83787246|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787247|NCT04629534|Vitamins|vitamins|mesh-ancestor
83787248|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
83787249|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83787250|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83787251|NCT04616183|Cetuximab|cetuximab|mesh-list
83787252|NCT04616183|Antibodies|antibodies|mesh-list
83787253|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
83787254|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83787255|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
83787256|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787257|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787258|NCT04602065|Antibodies|antibodies|mesh-list
83787259|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83787260|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
83787261|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787262|NCT04598815|Sirolimus|sirolimus|mesh-list
83787263|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83787264|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787265|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83787266|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787267|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
83787268|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787269|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
83787270|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787271|NCT04584112|Paclitaxel|paclitaxel|mesh-list
83787272|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83787273|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
83787274|NCT04584112|Carboplatin|carboplatin|mesh-list
83787275|NCT04584112|Doxorubicin|doxorubicin|mesh-list
83787276|NCT04584112|Atezolizumab|atezolizumab|mesh-list
83787277|NCT04584112|Molgramostim|molgramostim|mesh-list
83787278|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83787279|NCT04584112|Lenograstim|lenograstim|mesh-list
83787280|NCT04584112|Sargramostim|sargramostim|mesh-list
83787281|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83787282|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787283|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
83787284|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
83787285|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
83787286|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787287|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787288|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
83787289|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787290|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787291|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83787292|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
83787293|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83787294|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82942495|NCT02313220|Incretins|incretins|mesh-ancestor
83787295|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83787296|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83787297|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787298|NCT04584112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787299|NCT04584112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787300|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83787301|NCT04573777|Evolocumab|evolocumab|mesh-list
83787302|NCT04573777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83787303|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83787304|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83787305|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
83787306|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787307|NCT04573777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83787308|NCT04573777|Protease Inhibitors|protease inhibitors|mesh-ancestor
83787309|NCT04573777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787310|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83787311|NCT04507711|Palonosetron|palonosetron|mesh-list
83787312|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
83787313|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
83787314|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787315|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787316|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787317|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83787318|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83787319|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
83787320|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83787321|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787322|NCT04499274|Ondansetron|ondansetron|mesh-list
83787323|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
83787324|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
83787325|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787326|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787327|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787328|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
83787329|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
83787330|NCT04499274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83787331|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83787332|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
83787333|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83787334|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787335|NCT04497961|Lenalidomide|lenalidomide|mesh-list
83787336|NCT04497961|Daratumumab|daratumumab|mesh-list
83787337|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
83787338|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787339|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83787340|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83787341|NCT04497961|Growth Substances|growth substances|mesh-ancestor
83787342|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
83787343|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787344|NCT04488159|Leucovorin|leucovorin|mesh-list
83787345|NCT04488159|Fluorouracil|fluorouracil|mesh-list
83787346|NCT04488159|Capecitabine|capecitabine|mesh-list
83787347|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
83787348|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
83787349|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787350|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83787351|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787352|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787353|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
83787354|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787355|NCT04488159|Antidotes|antidotes|mesh-ancestor
83787356|NCT04488159|Protective Agents|protective agents|mesh-ancestor
83787357|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
83787358|NCT04488159|Vitamins|vitamins|mesh-ancestor
83787359|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
83787360|NCT04449861|Durvalumab|durvalumab|mesh-list
83787361|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787362|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787363|NCT04435691|Azacitidine|azacitidine|mesh-list
83787364|NCT04435691|Venetoclax|venetoclax|mesh-list
83787365|NCT04435691|Magrolimab|magrolimab|mesh-list
83787366|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83787367|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
83787368|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787369|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787370|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787371|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942570|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
83787372|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83787373|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
83787374|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787375|NCT04351555|Carboplatin|carboplatin|mesh-list
83787376|NCT04351555|Pemetrexed|pemetrexed|mesh-list
83787377|NCT04351555|Osimertinib|osimertinib|mesh-list
83787378|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787379|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787380|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787381|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83787382|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787383|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83787384|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
83787385|NCT04321993|Remdesivir|remdesivir|mesh-list
83787386|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83787387|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787388|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
83787389|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787390|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83787391|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787392|NCT04315948|Interferons|interferons|mesh-list
83787393|NCT04315948|Ritonavir|ritonavir|mesh-list
83787394|NCT04315948|Lopinavir|lopinavir|mesh-list
83787395|NCT04315948|Interferon-beta|interferon-beta|mesh-list
83787396|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
83787397|NCT04315948|Remdesivir|remdesivir|mesh-list
83787398|NCT04315948|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83787399|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
83787400|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787401|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
83787402|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787403|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83787404|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83787405|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
83787406|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787407|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787408|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83787409|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83787410|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83787411|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83787412|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
83787413|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83787414|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83787415|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787416|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
83787417|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787418|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83787419|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
83787420|NCT04300127|Pioglitazone|pioglitazone|mesh-list
83787421|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83787422|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787423|NCT04296305|Hydromorphone|hydromorphone|mesh-list
83787424|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83787425|NCT04296305|Narcotics|narcotics|mesh-ancestor
83787426|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787427|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787428|NCT04296305|Analgesics|analgesics|mesh-ancestor
83787429|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
83787430|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787431|NCT04266236|Ropivacaine|ropivacaine|mesh-list
83787432|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
83787433|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787434|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787435|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
83787436|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
83787437|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787438|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
83787439|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787440|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83787441|NCT04256343|Protective Agents|protective agents|mesh-ancestor
83787442|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787443|NCT04243629|Pramlintide|pramlintide|mesh-list
83787444|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
83787445|NCT04243629|Pancrelipase|pancrelipase|mesh-list
83787446|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82942645|NCT03505528|Phenelzine|phenelzine|mesh-list
83787447|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787448|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942656|NCT01234285|Heparin|heparin|mesh-list
83787449|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
83787450|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
83787451|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83787452|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787453|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
83787454|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787455|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787456|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83787457|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
83787458|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787459|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787460|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83787461|NCT04199026|Sirolimus|sirolimus|mesh-list
83787462|NCT04199026|Doxorubicin|doxorubicin|mesh-list
83787463|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83787464|NCT04199026|Daunorubicin|daunorubicin|mesh-list
83787465|NCT04199026|Irinotecan|irinotecan|mesh-list
83787466|NCT04199026|Vincristine|vincristine|mesh-list
83787467|NCT04199026|Everolimus|everolimus|mesh-list
83787468|NCT04199026|Temozolomide|temozolomide|mesh-list
83787469|NCT04199026|Temsirolimus|temsirolimus|mesh-list
83787470|NCT04199026|Ifosfamide|ifosfamide|mesh-list
83787471|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
83787472|NCT04199026|MTOR Inhibitors|mtor inhibitors|mesh-list
83787473|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83787474|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83787475|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787476|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83787477|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83787478|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787479|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787480|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83787481|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83787482|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
83787483|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
83787484|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
83787485|NCT04199026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83787486|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787487|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
83787488|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787489|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83787490|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
83787491|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83787492|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787493|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
83787494|NCT04182997|Dexamethasone|dexamethasone|mesh-list
83787495|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787496|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
83787497|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
83787498|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787499|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787500|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787501|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
83787502|NCT04182997|Hormones|hormones|mesh-ancestor
83787503|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787504|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83787505|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787506|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
83787507|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787508|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787509|NCT04171219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787510|NCT04171219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787511|NCT04167163|Abaloparatide|abaloparatide|mesh-list
83787512|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83787513|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787514|NCT04134936|Lenalidomide|lenalidomide|mesh-list
83787515|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
83787516|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787517|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83787518|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83787519|NCT04134936|Growth Substances|growth substances|mesh-ancestor
83787520|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
83787521|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787522|NCT04115111|Durvalumab|durvalumab|mesh-list
83787523|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787524|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942728|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
83787525|NCT04113109|Icatibant|icatibant|mesh-list
83787526|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83787527|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83787528|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787529|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83787530|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83787531|NCT04113109|Analgesics|analgesics|mesh-ancestor
83787532|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
83787533|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787534|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787535|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787536|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787537|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83787538|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83787539|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83787540|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787541|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
83787542|NCT04107038|Anesthetics|anesthetics|mesh-list
83787543|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787544|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787545|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83787546|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83787547|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83787548|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
83787549|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787550|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83787551|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83787552|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787553|NCT04042233|Vancomycin|vancomycin|mesh-list
83787554|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83787555|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787556|NCT03984565|Cannabidiol|cannabidiol|mesh-list
83787557|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
83787558|NCT03982693|Edetic Acid|edetic acid|mesh-list
83787559|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
83787560|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
83787561|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83787562|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
83787563|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
83787564|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787565|NCT03982693|Antidotes|antidotes|mesh-ancestor
83787566|NCT03982693|Protective Agents|protective agents|mesh-ancestor
83787567|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787568|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83787569|NCT03965195|Vaccines|vaccines|mesh-list
83787570|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
83787571|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787572|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
83787573|NCT03942653|Goserelin|goserelin|mesh-list
83787574|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787575|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787576|NCT03942653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787577|NCT03942653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787578|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83787579|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
83787580|NCT03941262|Avelumab|avelumab|mesh-list
83787581|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787582|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787583|NCT03941262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787584|NCT03941262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787585|NCT03928314|Paclitaxel|paclitaxel|mesh-list
83787586|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83787587|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787588|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
83787589|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
83787590|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
83787591|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787592|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
83787593|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83787594|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787595|NCT03878082|Acetaminophen|acetaminophen|mesh-list
83787596|NCT03878082|Propacetamol|propacetamol|mesh-list
83787597|NCT03878082|Analgesics|analgesics|mesh-ancestor
83787598|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
83787599|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787600|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787601|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83787602|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83787603|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787604|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787605|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
83787606|NCT03862859|Warfarin|warfarin|mesh-list
83787607|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
83787608|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
83787609|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83787610|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787611|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787612|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787613|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787614|NCT03846310|Carboplatin|carboplatin|mesh-list
83787615|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
83787616|NCT03846310|Pemetrexed|pemetrexed|mesh-list
83787617|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787618|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787619|NCT03846310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787620|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787621|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787622|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83787623|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787624|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
83787625|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83787626|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787627|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
83787628|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
83787629|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787630|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787631|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787632|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
83787633|NCT03818737|Hormones|hormones|mesh-ancestor
83787634|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787635|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83787636|NCT03818737|Protective Agents|protective agents|mesh-ancestor
83787637|NCT03814941|Anesthetics|anesthetics|mesh-list
83787638|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787639|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787640|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
83787641|NCT03759938|Apixaban|apixaban|mesh-list
83787642|NCT03759938|Edoxaban|edoxaban|mesh-list
83787643|NCT03759938|Dabigatran|dabigatran|mesh-list
83787644|NCT03759938|Anticoagulants|anticoagulants|mesh-list
83787645|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83787646|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
83787647|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83787648|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
83787649|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787650|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787651|NCT03737240|Insulin|insulin|mesh-list
83787652|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83787653|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
83787654|NCT03737240|Liraglutide|liraglutide|mesh-list
83787655|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
83787656|NCT03737240|Xultophy|xultophy|mesh-list
83787657|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83787658|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787659|NCT03737240|Incretins|incretins|mesh-ancestor
83787660|NCT03737240|Hormones|hormones|mesh-ancestor
83787661|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787662|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
83787663|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787664|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787665|NCT03732950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787666|NCT03732950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787667|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
83787668|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787669|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787670|NCT03658447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787671|NCT03658447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787672|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
83787673|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787674|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787675|NCT03647163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787676|NCT03647163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787678|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787679|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83787680|NCT03596164|Protective Agents|protective agents|mesh-ancestor
83787681|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787682|NCT03556332|Dexamethasone|dexamethasone|mesh-list
83787683|NCT03556332|Lenalidomide|lenalidomide|mesh-list
83787684|NCT03556332|Daratumumab|daratumumab|mesh-list
83787685|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787686|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
83787687|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
83787688|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787689|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787690|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787691|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
83787692|NCT03556332|Hormones|hormones|mesh-ancestor
83787693|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787694|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83787695|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787696|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
83787697|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83787698|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83787699|NCT03556332|Growth Substances|growth substances|mesh-ancestor
83787700|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
83787701|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83787702|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83787703|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787704|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787705|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787706|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
83787707|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787708|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83787709|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83787710|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
83787711|NCT03539900|Naltrexone|naltrexone|mesh-list
83787712|NCT03539900|Bupropion|bupropion|mesh-list
83787713|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83787714|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83787715|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787716|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
83787717|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787718|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83787719|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
83787720|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83787721|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83787722|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83787723|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83787724|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787725|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
83787726|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83787727|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83787728|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83787729|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787730|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83787731|NCT03525873|Methylphenidate|methylphenidate|mesh-list
83787732|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83787733|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787734|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83787735|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83787736|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83787737|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787738|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
83787739|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83787740|NCT03492125|Rituximab|rituximab|mesh-list
83787741|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
83787742|NCT03492125|Venetoclax|venetoclax|mesh-list
83787743|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
83787744|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787745|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787746|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
83787747|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787748|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787749|NCT03427463|Morphine|morphine|mesh-list
83787750|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83787751|NCT03427463|Narcotics|narcotics|mesh-ancestor
83787752|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787753|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787754|NCT03427463|Analgesics|analgesics|mesh-ancestor
83787755|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
83787756|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787757|NCT03363867|Bevacizumab|bevacizumab|mesh-list
83787758|NCT03363867|Atezolizumab|atezolizumab|mesh-list
83787759|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787760|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787761|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83787762|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83787763|NCT03363867|Growth Substances|growth substances|mesh-ancestor
83787764|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787765|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
83787766|NCT03363867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787767|NCT03363867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787768|NCT03356873|Vitamin D|vitamin d|mesh-list
83787769|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
83787770|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
83787771|NCT03356873|Vitamins|vitamins|mesh-list
83787772|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
83787773|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787774|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83787775|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83787776|NCT03308578|Atorvastatin|atorvastatin|mesh-list
83787777|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83787778|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83787779|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
83787780|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787781|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83787782|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83787783|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787784|NCT03305341|Molgramostim|molgramostim|mesh-list
83787785|NCT03305341|Sargramostim|sargramostim|mesh-list
83787786|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
83787787|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787788|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787789|NCT03255473|Dexamethasone|dexamethasone|mesh-list
83787790|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
83787791|NCT03255473|Prednisone|prednisone|mesh-list
83787792|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83787793|NCT03255473|BB 1101|bb 1101|mesh-list
83787794|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787795|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
83787796|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
83787797|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787798|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787799|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787800|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
83787801|NCT03255473|Hormones|hormones|mesh-ancestor
83787802|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787803|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83787804|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787805|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
83787806|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787807|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787808|NCT03176277|Venetoclax|venetoclax|mesh-list
83787809|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787810|NCT03173560|Everolimus|everolimus|mesh-list
83787811|NCT03173560|Lenvatinib|lenvatinib|mesh-list
83787812|NCT03173560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83787813|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83787814|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787815|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787816|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787817|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
83787818|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787819|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943024|NCT03300518|Ganirelix|ganirelix|mesh-list
83787820|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
83787821|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83787822|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83787824|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
83787825|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83787826|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
83787827|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787828|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
83787829|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
83787830|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787831|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787832|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83787833|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
83787834|NCT03098225|Hormones|hormones|mesh-ancestor
83787835|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83787836|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83787837|NCT03098225|Protective Agents|protective agents|mesh-ancestor
83787838|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83787839|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787840|NCT03017131|Aldesleukin|aldesleukin|mesh-list
83787841|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
83787842|NCT03017131|Decitabine|decitabine|mesh-list
83787843|NCT03017131|Interleukin-2|interleukin-2|mesh-list
83787844|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83787845|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
83787846|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787847|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787848|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83787849|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
83787850|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787851|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787852|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83787853|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83787854|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
83787855|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787856|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83787857|NCT03017131|Analgesics|analgesics|mesh-ancestor
83787858|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
83787859|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787860|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83787861|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83787862|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
83787863|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787864|NCT02990468|Cisplatin|cisplatin|mesh-list
83787865|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787866|NCT02940301|Nivolumab|nivolumab|mesh-list
83787867|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787868|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787869|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787870|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787871|NCT02927769|Nivolumab|nivolumab|mesh-list
83787872|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83787873|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83787874|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787875|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787876|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787877|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787878|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83787879|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
83787880|NCT02927769|Immunotoxins|immunotoxins|mesh-ancestor
83787881|NCT02927769|Immunoconjugates|immunoconjugates|mesh-ancestor
83787882|NCT02927769|Immunologic Factors|immunologic factors|mesh-ancestor
83787883|NCT02927769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787884|NCT02899299|Carboplatin|carboplatin|mesh-list
83787885|NCT02899299|Nivolumab|nivolumab|mesh-list
83787886|NCT02899299|Pemetrexed|pemetrexed|mesh-list
83787887|NCT02899299|Ipilimumab|ipilimumab|mesh-list
83787888|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787889|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787890|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787891|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787892|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787893|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83787894|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83787895|NCT02882100|Vaccines|vaccines|mesh-list
83787896|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
83787897|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787898|NCT02855944|Paclitaxel|paclitaxel|mesh-list
83787899|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83787901|NCT02855944|Carboplatin|carboplatin|mesh-list
83787902|NCT02855944|Gemcitabine|gemcitabine|mesh-list
83787903|NCT02855944|Rucaparib|rucaparib|mesh-list
83787904|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83787905|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787906|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
83787907|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
83787908|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
83787909|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787910|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83787911|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
83787912|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83787913|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787914|NCT02733185|Vitamins|vitamins|mesh-list
83787915|NCT02733185|Edetic Acid|edetic acid|mesh-list
83787916|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
83787917|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
83787918|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787919|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
83787920|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83787921|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
83787922|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
83787923|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787924|NCT02733185|Antidotes|antidotes|mesh-ancestor
83787925|NCT02733185|Protective Agents|protective agents|mesh-ancestor
83787926|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83787927|NCT02663518|Rituximab|rituximab|mesh-list
83787928|NCT02663518|Nivolumab|nivolumab|mesh-list
83787929|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
83787930|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83787931|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787932|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
83787933|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787934|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787935|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83787936|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787937|NCT02603848|Ibuprofen|ibuprofen|mesh-list
83787938|NCT02603848|Morphine|morphine|mesh-list
83787939|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83787940|NCT02603848|Narcotics|narcotics|mesh-ancestor
83787941|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787942|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787943|NCT02603848|Analgesics|analgesics|mesh-ancestor
83787944|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
83787945|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83787946|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83787947|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83787948|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83787949|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83787950|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83787951|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787952|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787953|NCT02512887|Anesthetics|anesthetics|mesh-list
83787954|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83787955|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787956|NCT02484261|Bortezomib|bortezomib|mesh-list
83787957|NCT02484261|Pravastatin|pravastatin|mesh-list
83787958|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787959|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83787960|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83787961|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
83787962|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787963|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83787964|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83787965|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787966|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
83787967|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787968|NCT02471430|Interferons|interferons|mesh-list
83787969|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
83787970|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
83787971|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83787972|NCT02471430|Panobinostat|panobinostat|mesh-list
83787973|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787974|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
83787975|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83787976|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
83787977|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83787978|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83787979|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787980|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787981|NCT02451943|Doxorubicin|doxorubicin|mesh-list
83787982|NCT02451943|Olaratumab|olaratumab|mesh-list
83787983|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83787984|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83787985|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83787986|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83787987|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787988|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787989|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
83787990|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83787991|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83787992|NCT02409342|Carboplatin|carboplatin|mesh-list
83787993|NCT02409342|Gemcitabine|gemcitabine|mesh-list
83787994|NCT02409342|Pemetrexed|pemetrexed|mesh-list
83787995|NCT02409342|Atezolizumab|atezolizumab|mesh-list
83787996|NCT02409342|Antibodies|antibodies|mesh-list
83787997|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83787998|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
83787999|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788000|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788001|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83788002|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
83788003|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788004|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788005|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83788006|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83788007|NCT02409342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83788008|NCT02409342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788009|NCT02399085|Lenalidomide|lenalidomide|mesh-list
83788010|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
83788011|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788012|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83788013|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83788014|NCT02399085|Growth Substances|growth substances|mesh-ancestor
83788015|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
83788016|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788017|NCT02255409|Vaccines|vaccines|mesh-list
83788018|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
83788019|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788020|NCT02213757|Estrogens|estrogens|mesh-list
83788021|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83788022|NCT02213757|Hormones|hormones|mesh-ancestor
83788023|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788024|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788025|NCT02120404|Esmolol|esmolol|mesh-list
83788026|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83788027|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83788028|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83788029|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
83788030|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788031|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788032|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788033|NCT02102243|Insulin|insulin|mesh-list
83788034|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83788035|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83788036|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788037|NCT01998971|Acetaminophen|acetaminophen|mesh-list
83788038|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
83788039|NCT01998971|Promethazine|promethazine|mesh-list
83788040|NCT01998971|Thalidomide|thalidomide|mesh-list
83788041|NCT01998971|Dexamethasone|dexamethasone|mesh-list
83788042|NCT01998971|Prednisone|prednisone|mesh-list
83788043|NCT01998971|Lenalidomide|lenalidomide|mesh-list
83788044|NCT01998971|Melphalan|melphalan|mesh-list
83788045|NCT01998971|Bortezomib|bortezomib|mesh-list
83788046|NCT01998971|Daratumumab|daratumumab|mesh-list
83788047|NCT01998971|Pomalidomide|pomalidomide|mesh-list
83788048|NCT01998971|Montelukast|montelukast|mesh-list
83788049|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83788050|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
83788051|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
83788052|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788053|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788054|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83788055|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
83788056|NCT01998971|Hormones|hormones|mesh-ancestor
83788057|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788058|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83788059|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788060|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
83788061|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83788062|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83788063|NCT01998971|Growth Substances|growth substances|mesh-ancestor
83788064|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
83788065|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83788066|NCT01998971|Analgesics|analgesics|mesh-ancestor
83788067|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
83788068|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
83788069|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83788070|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
83788071|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788072|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83788073|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788074|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
83788075|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83788076|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788077|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83788078|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
83788079|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83788080|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
83788081|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83788082|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83788083|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83788084|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83788085|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788086|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
83788087|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
83788088|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83788089|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
83788090|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
83788091|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788092|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83788093|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
83788094|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788095|NCT01969227|Ketamine|ketamine|mesh-list
83788096|NCT01969227|Analgesics|analgesics|mesh-ancestor
83788097|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
83788098|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788099|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788100|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83788101|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83788102|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
83788103|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
83788104|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788105|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83788106|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83788107|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788108|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788109|NCT01885949|Tivozanib|tivozanib|mesh-list
83788110|NCT01885949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83788111|NCT01885949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788112|NCT01885949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788113|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
83788114|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788115|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788116|NCT01604135|Riboflavin|riboflavin|mesh-list
83788117|NCT01604135|Dextrans|dextrans|mesh-list
83788118|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
83788119|NCT01604135|Vitamins|vitamins|mesh-ancestor
83788120|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
83788121|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788122|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83788123|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788124|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
83788125|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
83788126|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
82943317|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788128|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83788129|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
83788130|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788131|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788132|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
83788133|NCT00630032|Docetaxel|docetaxel|mesh-list
83788134|NCT00630032|Fluorouracil|fluorouracil|mesh-list
83788135|NCT00630032|Epirubicin|epirubicin|mesh-list
83788136|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788137|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
83788138|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788139|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788140|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83788141|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
83788142|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788143|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788144|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83788145|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
83788146|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
83788147|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
83788148|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
83788149|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83788150|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83788151|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83788152|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83788153|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788154|NCT00465517|Ganaxolone|ganaxolone|mesh-list
83788155|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
83788156|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788157|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788158|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788159|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
83788160|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
83788161|NCT00289952|Valproic Acid|valproic acid|mesh-list
83788162|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
83788163|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788164|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788165|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
83788166|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788167|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788168|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
83788169|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83788170|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788171|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83788172|NCT05772871|Levamisole|levamisole|mesh-list
83788173|NCT05772871|Prednisone|prednisone|mesh-list
83788174|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83788175|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
83788176|NCT05772871|Hormones|hormones|mesh-ancestor
83788177|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788178|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788179|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83788180|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788181|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83788182|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
83788183|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
83788184|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
83788185|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83788186|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788187|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788188|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
83788189|NCT05772832|Remifentanil|remifentanil|mesh-list
83788190|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83788191|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788192|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509585|NCT03078075|Naltrexone|naltrexone|mesh-list
83788193|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83788194|NCT05772832|Analgesics|analgesics|mesh-ancestor
83788195|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
83788196|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788197|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83788198|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83788199|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83788200|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
82943392|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
83788201|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788202|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788203|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83788205|NCT05772728|Azacitidine|azacitidine|mesh-list
83788206|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
83788207|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83788208|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
83788209|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788210|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788211|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788212|NCT05772728|Analgesics|analgesics|mesh-ancestor
83788213|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
83788214|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788215|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788216|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83788217|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83788218|NCT05772676|Aprepitant|aprepitant|mesh-list
83788219|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
83788220|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
83788221|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788222|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788223|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83788224|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83788225|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788226|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788227|NCT05772624|Nivolumab|nivolumab|mesh-list
83788228|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788229|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788230|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83788231|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788232|NCT05772546|Maleic acid|maleic acid|mesh-list
83788233|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788234|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788235|NCT05772377|Carboplatin|carboplatin|mesh-list
83788236|NCT05772377|Cisplatin|cisplatin|mesh-list
83788237|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788238|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
83788239|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788240|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788241|NCT05772039|Listerine|listerine|mesh-list
83788242|NCT05772039|Fluorides|fluorides|mesh-list
83788243|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
83788244|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
83788245|NCT05772039|Protective Agents|protective agents|mesh-ancestor
83788246|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788247|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83788248|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788249|NCT05772013|Azithromycin|azithromycin|mesh-list
83788250|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83788251|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788252|NCT05771779|Vaccines|vaccines|mesh-list
83788253|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
83788254|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788255|NCT05771675|Simvastatin|simvastatin|mesh-list
83788256|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83788257|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83788258|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
83788259|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788260|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83788261|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83788262|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788263|NCT05771584|Sargramostim|sargramostim|mesh-list
83788264|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
83788265|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788266|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
83788267|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83788268|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83788269|NCT05771181|Vitamin E|vitamin e|mesh-list
83788270|NCT05771181|Tislelizumab|tislelizumab|mesh-list
83788271|NCT05771181|Vitamins|vitamins|mesh-ancestor
83788272|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
83788273|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788274|NCT05771181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788275|NCT05771181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788276|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
82943468|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
83788277|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788278|NCT05771181|Protective Agents|protective agents|mesh-ancestor
83788279|NCT05771038|Alendronate|alendronate|mesh-list
83788280|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83788281|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788282|NCT05771012|Cyclosporine|cyclosporine|mesh-list
83788283|NCT05771012|Cyclosporins|cyclosporins|mesh-list
83788284|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788285|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788286|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788287|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
83788288|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788289|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
83788290|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788291|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788292|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788293|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83788294|NCT05770960|Codeine|codeine|mesh-list
83788295|NCT05770960|Naloxegol|naloxegol|mesh-list
83788296|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83788297|NCT05770960|Narcotics|narcotics|mesh-ancestor
83788298|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788299|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788300|NCT05770960|Analgesics|analgesics|mesh-ancestor
83788301|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
83788302|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788303|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
83788304|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
83788305|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83788306|NCT05769946|Hemay005|hemay005|mesh-list
83788307|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788308|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83788309|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83788310|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788311|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788312|NCT05768282|Prednisolone|prednisolone|mesh-list
83788313|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83788314|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
83788315|NCT05768282|Hormones|hormones|mesh-ancestor
83788316|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788317|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788318|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83788319|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788320|NCT05766800|Paclitaxel|paclitaxel|mesh-list
83788321|NCT05766800|Carboplatin|carboplatin|mesh-list
83788322|NCT05766800|Pemetrexed|pemetrexed|mesh-list
83788323|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83788324|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788325|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
83788326|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
83788327|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
83788328|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788329|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788330|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83788331|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83788332|NCT05766410|Letrozole|letrozole|mesh-list
83788333|NCT05766410|Palbociclib|palbociclib|mesh-list
83788334|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788335|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83788336|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83788337|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788338|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788339|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83788340|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
83788341|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788342|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788343|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83788344|NCT05757011|Bupivacaine|bupivacaine|mesh-list
83788345|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
83788346|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
83788347|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788348|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788349|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
83788350|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943561|NCT05158309|Capsaicin|capsaicin|mesh-list
83788351|NCT05750875|Loratadine|loratadine|mesh-list
83788352|NCT05750875|Gabapentin|gabapentin|mesh-list
83788353|NCT05750875|Analgesics|analgesics|mesh-ancestor
83788354|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
83788355|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788356|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788357|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
83788358|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83788359|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83788360|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788361|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83788362|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83788363|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83788364|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788365|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788366|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
83788367|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
83788368|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788369|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83788370|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83788371|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83788372|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
83788373|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
83788374|NCT05734794|Rituximab|rituximab|mesh-list
83788375|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788376|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788377|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
83788378|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788379|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788380|NCT05715073|Caffeine|caffeine|mesh-list
83788381|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83788382|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788383|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83788384|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788385|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788386|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83788387|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83788388|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
83788389|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788390|NCT05702463|Aspirin|aspirin|mesh-list
83788391|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83788392|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83788393|NCT05702463|Analgesics|analgesics|mesh-ancestor
83788394|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
83788395|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788396|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788397|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83788398|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788399|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83788400|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83788401|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788402|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83788403|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83788404|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788405|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
83788406|NCT05696795|Abrocitinib|abrocitinib|mesh-list
83788407|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83788408|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788409|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788410|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
83788411|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
83788412|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83788413|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83788414|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788415|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788416|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788417|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788418|NCT05680584|Melatonin|melatonin|mesh-list
83788419|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
83788420|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
83788421|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788422|NCT05680584|Protective Agents|protective agents|mesh-ancestor
83788423|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788424|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788425|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
83788426|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788427|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83788428|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
83788429|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
83788430|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788432|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83788433|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788434|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788435|NCT05646992|Azathioprine|azathioprine|mesh-list
83788436|NCT05646992|Tacrolimus|tacrolimus|mesh-list
83788437|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788438|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
83788439|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788440|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83788441|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788442|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788443|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
83788444|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83788445|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788446|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788447|NCT05637606|Etilefrine|etilefrine|mesh-list
83788448|NCT05637606|Norepinephrine|norepinephrine|mesh-list
83788449|NCT05637606|Ephedrine|ephedrine|mesh-list
83788450|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
83788451|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83788452|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83788453|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
83788454|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788455|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788456|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788457|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
83788458|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
83788459|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788460|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83788461|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83788462|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83788463|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83788464|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
83788465|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
83788466|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83788467|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83788468|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83788469|NCT05637606|Protective Agents|protective agents|mesh-ancestor
83788470|NCT05549206|Vaccines|vaccines|mesh-list
83788471|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
83788472|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788473|NCT05533684|Gabapentin|gabapentin|mesh-list
83788474|NCT05533684|Analgesics|analgesics|mesh-ancestor
83788475|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
83788476|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788477|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788478|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
83788479|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83788480|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83788481|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788482|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83788483|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83788484|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83788485|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788486|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788487|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
83788488|NCT05458479|Fluoxetine|fluoxetine|mesh-list
83788489|NCT05458479|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83788490|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83788491|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83788492|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788493|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788494|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
83788495|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788496|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83788497|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
83788498|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83788499|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83788500|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83788501|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788502|NCT05433961|Xenon|xenon|mesh-list
83788503|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83788504|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
83788505|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
83788506|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788507|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788508|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83788509|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83788510|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788511|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788512|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
83788513|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788514|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
83788515|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83788516|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
83788517|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788518|NCT05408247|Expectorants|expectorants|mesh-ancestor
83788519|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
83788520|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83788521|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
83788522|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788523|NCT05408247|Protective Agents|protective agents|mesh-ancestor
83788524|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788525|NCT05408247|Antidotes|antidotes|mesh-ancestor
83788526|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
83788527|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83788528|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
83788529|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788530|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788531|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788532|NCT05375942|Infliximab|infliximab|mesh-list
83788533|NCT05375942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83788534|NCT05375942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83788535|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788536|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83788537|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788538|NCT05209308|Rituximab|rituximab|mesh-list
83788539|NCT05209308|Venetoclax|venetoclax|mesh-list
83788540|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788541|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788542|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
83788543|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788544|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788545|NCT05153317|Ivacaftor|ivacaftor|mesh-list
83788546|NCT05153317|Elexacaftor|elexacaftor|mesh-list
83788547|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83788548|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83788549|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788550|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83788551|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788552|NCT05112848|Vaccines|vaccines|mesh-list
83788553|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
83788554|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788555|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83788556|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
83788557|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83788558|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
83788559|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83788560|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788561|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83788562|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83788563|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788564|NCT05010122|Decitabine|decitabine|mesh-list
83788565|NCT05010122|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83788566|NCT05010122|Venetoclax|venetoclax|mesh-list
83788567|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83788568|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
83788569|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788570|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788571|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788572|NCT04916418|Ropivacaine|ropivacaine|mesh-list
83788573|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
83788574|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
83788575|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788576|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788577|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
83788578|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788579|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83788580|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83788581|NCT04893096|Felzartamab|felzartamab|mesh-list
83788582|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788583|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
83788584|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788585|NCT04892511|Nitroprusside|nitroprusside|mesh-list
83788587|NCT04892511|Urapidil|urapidil|mesh-list
83788588|NCT04892511|Phenylephrine|phenylephrine|mesh-list
83788589|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83788590|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
83788591|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
83788592|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788593|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788594|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
83788595|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83788596|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
83788597|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
83788598|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83788599|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83788600|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83788601|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83788602|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788603|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788604|NCT04892511|Protective Agents|protective agents|mesh-ancestor
83788605|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83788606|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
83788607|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83788608|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83788609|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83788610|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83788611|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83788612|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83788613|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
83788614|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83788615|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788616|NCT04855695|Venetoclax|venetoclax|mesh-list
83788617|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
83788618|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
83788619|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788620|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788621|NCT04855136|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
83788622|NCT04855136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788623|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788624|NCT04785118|Scopolamine|scopolamine|mesh-list
83788625|NCT04785118|Ondansetron|ondansetron|mesh-list
83788626|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83788627|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
83788628|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
83788629|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788630|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788631|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83788632|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
83788633|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788634|NCT04785118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83788635|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83788636|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
83788637|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788638|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788639|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83788640|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
83788641|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83788642|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
83788643|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83788644|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
83788645|NCT04752163|Leucovorin|leucovorin|mesh-list
83788646|NCT04752163|Cytarabine|cytarabine|mesh-list
83788647|NCT04752163|Voriconazole|voriconazole|mesh-list
83788648|NCT04752163|Posaconazole|posaconazole|mesh-list
83788649|NCT04752163|Dexamethasone|dexamethasone|mesh-list
82943849|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82943852|NCT01693783|Ipilimumab|ipilimumab|mesh-list
83788650|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
83788651|NCT04752163|Prednisone|prednisone|mesh-list
83788652|NCT04752163|Cortisone|cortisone|mesh-list
83788653|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
83788654|NCT04752163|Rituximab|rituximab|mesh-list
83788655|NCT04752163|Methotrexate|methotrexate|mesh-list
83788656|NCT04752163|Vincristine|vincristine|mesh-list
83788657|NCT04752163|Azacitidine|azacitidine|mesh-list
83788658|NCT04752163|Venetoclax|venetoclax|mesh-list
83788659|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83788660|NCT04752163|Antibodies|antibodies|mesh-list
83788661|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
83788662|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83788663|NCT04752163|Lenograstim|lenograstim|mesh-list
83788664|NCT04752163|BB 1101|bb 1101|mesh-list
83788665|NCT04752163|Mesna|mesna|mesh-list
83788666|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788667|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
83788668|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788669|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788670|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83788671|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
83788672|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788673|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788674|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83788675|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83788676|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
83788677|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
83788678|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788679|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83788680|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
83788681|NCT04752163|Hormones|hormones|mesh-ancestor
83788682|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788683|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83788684|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
83788685|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788686|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83788687|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
83788688|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83788689|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83788690|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
83788691|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788692|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83788693|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83788694|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
83788695|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788696|NCT04752163|Antidotes|antidotes|mesh-ancestor
83788697|NCT04752163|Protective Agents|protective agents|mesh-ancestor
83788698|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
83788699|NCT04752163|Vitamins|vitamins|mesh-ancestor
83788700|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
83788701|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83788702|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83788703|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83788704|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83788705|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83788706|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
83788707|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83788708|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83788709|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83788710|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
83788711|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83788712|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83788713|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83788714|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83788715|NCT04735926|Calcifediol|calcifediol|mesh-list
83788716|NCT04735926|Vitamins|vitamins|mesh-ancestor
83788717|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
83788718|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788719|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83788720|NCT04720768|Palbociclib|palbociclib|mesh-list
83788721|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788722|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83788723|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788724|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788725|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
83788726|NCT04702256|Prednisone|prednisone|mesh-list
83788727|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
83788728|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83788729|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83788731|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
83788732|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
83788733|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83788734|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
83788735|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
83788736|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83788737|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
83788738|NCT04702256|Hormones|hormones|mesh-ancestor
83788739|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788740|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788741|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83788742|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788743|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83788744|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83788745|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
83788746|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83788747|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83788748|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788749|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788750|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
83788751|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
83788752|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788753|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83788754|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83788755|NCT04702256|Protective Agents|protective agents|mesh-ancestor
83788756|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788757|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83788758|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
83788759|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
83788760|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788761|NCT04671966|Cetrorelix|cetrorelix|mesh-list
83788762|NCT04671966|Estradiol|estradiol|mesh-list
83788763|NCT04671966|Estrogens|estrogens|mesh-ancestor
83788764|NCT04671966|Hormones|hormones|mesh-ancestor
83788765|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788766|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788767|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83788768|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83788769|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
83788770|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
83788771|NCT04641702|Atropine|atropine|mesh-list
83788772|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83788773|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83788774|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83788775|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
83788776|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788777|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788778|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83788779|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
83788780|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
83788781|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
83788782|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83788783|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83788784|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
83788785|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788786|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788787|NCT04624750|Mexiletine|mexiletine|mesh-list
83788788|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83788789|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83788790|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83788791|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83788792|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788793|NCT04622553|Mexiletine|mexiletine|mesh-list
83788794|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83788795|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83788796|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83788797|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83788798|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788799|NCT04616807|Mexiletine|mexiletine|mesh-list
83788800|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83788801|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82944001|NCT00807859|Paclitaxel|paclitaxel|mesh-list
83788802|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83788803|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83788804|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788805|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
83788806|NCT04608630|Denosumab|denosumab|mesh-list
83788807|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83788808|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788809|NCT04603183|Paclitaxel|paclitaxel|mesh-list
83788810|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83788811|NCT04603183|Letrozole|letrozole|mesh-list
83788812|NCT04603183|Fulvestrant|fulvestrant|mesh-list
83788813|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83788814|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788815|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83788816|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83788817|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83788818|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788819|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83788820|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83788821|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788822|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83788823|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
83788824|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788825|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788826|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83788827|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83788828|NCT04580134|Risperidone|risperidone|mesh-list
83788829|NCT04580134|Clozapine|clozapine|mesh-list
83788830|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83788831|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
83788832|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788833|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788834|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788835|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83788836|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83788837|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788838|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83788839|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83788840|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
83788841|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
83788842|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
83788843|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
83788844|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788845|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788846|NCT04541108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83788847|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788848|NCT04529954|Valproic Acid|valproic acid|mesh-list
83788849|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
83788850|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788851|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788852|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
83788853|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788854|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788855|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
83788856|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83788857|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83788858|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83788859|NCT04525755|Nicotine|nicotine|mesh-list
83788860|NCT04525755|Varenicline|varenicline|mesh-list
83788861|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83788862|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
83788863|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788864|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788865|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83788866|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83788867|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
83788868|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788869|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788870|NCT04512079|Enoxaparin|enoxaparin|mesh-list
83788871|NCT04512079|Apixaban|apixaban|mesh-list
83788872|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
83788873|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83788874|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82944075|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788875|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788876|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83788877|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
83788878|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83788879|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
83788880|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788881|NCT04508725|Mitogens|mitogens|mesh-list
83788882|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
83788883|NCT04508725|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83788884|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
83788885|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788886|NCT04508725|Growth Substances|growth substances|mesh-ancestor
83788887|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788888|NCT04508725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83788889|NCT04508725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788890|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83788891|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
83788892|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788893|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
83788894|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788895|NCT04437485|Norepinephrine|norepinephrine|mesh-list
83788896|NCT04437485|Bupropion|bupropion|mesh-list
83788897|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
83788898|NCT04437485|Serotonin|serotonin|mesh-list
83788899|NCT04437485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83788900|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83788901|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83788902|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83788903|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83788904|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83788905|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788906|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
83788907|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788908|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788909|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83788910|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83788911|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788912|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83788913|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83788914|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83788915|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
83788916|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
83788917|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788918|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83788919|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83788920|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
83788921|NCT04421560|Rituximab|rituximab|mesh-list
83788922|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
83788923|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788924|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788925|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
83788926|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788927|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788928|NCT04421560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83788929|NCT04421560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788930|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
83788931|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83788932|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
83788933|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
83788934|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83788935|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788936|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788937|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83788938|NCT04406649|Analgesics|analgesics|mesh-ancestor
83788939|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
83788940|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788941|NCT04392622|Cisplatin|cisplatin|mesh-list
83788942|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788943|NCT04332341|Niacinamide|niacinamide|mesh-list
83788944|NCT04332341|Niacin|niacin|mesh-list
83788945|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
83788946|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
83788947|NCT04332341|Vitamins|vitamins|mesh-ancestor
83788948|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
83788949|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788950|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83788951|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
83788952|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788954|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
83788955|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
83788956|NCT04323657|Fludarabine|fludarabine|mesh-list
83788957|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83788958|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
83788959|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788960|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83788961|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83788962|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
83788963|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788964|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788965|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83788966|NCT04318691|Dimercaprol|dimercaprol|mesh-list
83788967|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
83788968|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
83788969|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788970|NCT04278092|Paclitaxel|paclitaxel|mesh-list
83788971|NCT04278092|Cetuximab|cetuximab|mesh-list
83788972|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83788973|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788974|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
83788975|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
83788976|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
83788977|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788978|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83788979|NCT04240106|Niraparib|niraparib|mesh-list
83788980|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83788981|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83788982|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83788983|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83788984|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83788985|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83788986|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83788987|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
83788988|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83788989|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788990|NCT04220489|Ketamine|ketamine|mesh-list
83788991|NCT04220489|Analgesics|analgesics|mesh-ancestor
83788992|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
83788993|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83788994|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83788995|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83788996|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83788997|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
83788998|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
83788999|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789000|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83789001|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83789002|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789003|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789004|NCT04201262|Ravulizumab|ravulizumab|mesh-list
83789005|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83789006|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789007|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
83789008|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789009|NCT04189107|Dexamethasone|dexamethasone|mesh-list
83789010|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
83789011|NCT04189107|BB 1101|bb 1101|mesh-list
83789012|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83789013|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
83789014|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
83789015|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789016|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789017|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83789018|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
83789019|NCT04189107|Hormones|hormones|mesh-ancestor
83789020|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83789021|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83789022|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789023|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
83789024|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789025|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789027|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789028|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789029|NCT04123314|Psilocybin|psilocybin|mesh-list
83789030|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
83789031|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789032|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83789033|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
83789034|NCT04004221|Tislelizumab|tislelizumab|mesh-list
83789035|NCT04004221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789036|NCT04004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789037|NCT03934567|Abexinostat|abexinostat|mesh-list
83789038|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83789039|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789040|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789041|NCT03872388|Capecitabine|capecitabine|mesh-list
83789042|NCT03872388|Atorvastatin|atorvastatin|mesh-list
83789043|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789044|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
83789045|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789046|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789047|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83789048|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83789049|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83789050|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83789051|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789052|NCT03865940|Lidocaine|lidocaine|mesh-list
83789053|NCT03865940|Guanfacine|guanfacine|mesh-list
83789054|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
83789055|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
83789056|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789057|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789058|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
83789059|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789060|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83789061|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83789062|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83789063|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83789064|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789065|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83789066|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83789067|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83789068|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83789069|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
83789070|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789071|NCT03844997|Palbociclib|palbociclib|mesh-list
83789072|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789073|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789074|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789075|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789076|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83789077|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83789078|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83789079|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789080|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789081|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
83789082|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509612|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
83789083|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789084|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789085|NCT03776071|Temozolomide|temozolomide|mesh-list
83789086|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789087|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
83789088|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789089|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789090|NCT03671811|Megestrol|megestrol|mesh-list
83789091|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
83789092|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83789093|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83789094|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83789095|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
83789096|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83789097|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789098|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83789099|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83789100|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83789101|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789102|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
83789103|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83789104|NCT03625388|Dasatinib|dasatinib|mesh-list
83789105|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789106|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789107|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789108|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789109|NCT03589729|Cytarabine|cytarabine|mesh-list
83789110|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83789111|NCT03589729|Idarubicin|idarubicin|mesh-list
83789112|NCT03589729|Cladribine|cladribine|mesh-list
83789113|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
83789114|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
83789115|NCT03589729|Razoxane|razoxane|mesh-list
83789116|NCT03589729|Calicheamicins|calicheamicins|mesh-list
83789117|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789118|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
83789119|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789120|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789121|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
83789122|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789123|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789124|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
83789125|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789126|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83789127|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83789128|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83789129|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789130|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789131|NCT03589729|Immunotoxins|immunotoxins|mesh-ancestor
83789132|NCT03589729|Immunoconjugates|immunoconjugates|mesh-ancestor
83789133|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83789134|NCT03589729|Protective Agents|protective agents|mesh-ancestor
83789135|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789136|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789137|NCT03585686|Cytarabine|cytarabine|mesh-list
83789138|NCT03585686|Vemurafenib|vemurafenib|mesh-list
83789139|NCT03585686|Cladribine|cladribine|mesh-list
83789140|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789141|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
83789142|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789143|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789144|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
83789145|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789146|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789147|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
83789148|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789149|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789150|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789151|NCT03479307|Ketotifen|ketotifen|mesh-list
83789152|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83789153|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83789154|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
83789155|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
83789156|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83789157|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
83789158|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
83789159|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789160|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789161|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789162|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83789163|NCT03467867|Rituximab|rituximab|mesh-list
83789164|NCT03467867|Venetoclax|venetoclax|mesh-list
83789165|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789166|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789167|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
83789168|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789169|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789170|NCT03452111|ST 1435|st 1435|mesh-list
83789171|NCT03452111|Testosterone|testosterone|mesh-list
82944376|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789172|NCT03452111|Androgens|androgens|mesh-ancestor
83789173|NCT03452111|Hormones|hormones|mesh-ancestor
83789174|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83789175|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789176|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83789177|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
83789178|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83789179|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83789180|NCT03390933|Fluoxetine|fluoxetine|mesh-list
83789181|NCT03390933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83789182|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83789183|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83789184|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789185|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789186|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
83789187|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789188|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83789189|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
83789190|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83789191|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83789192|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83789193|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789194|NCT03387787|Insulin|insulin|mesh-list
83789195|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83789196|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789197|NCT03364036|Cladribine|cladribine|mesh-list
83789198|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789199|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789200|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
83789201|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789202|NCT03338790|Prednisone|prednisone|mesh-list
83789203|NCT03338790|Docetaxel|docetaxel|mesh-list
83789204|NCT03338790|Nivolumab|nivolumab|mesh-list
83789205|NCT03338790|Rucaparib|rucaparib|mesh-list
83789206|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789207|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
83789208|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789209|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789210|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789211|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83789212|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
83789213|NCT03338790|Hormones|hormones|mesh-ancestor
83789214|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83789215|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789216|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83789217|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789218|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83789219|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83789220|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789221|NCT03323463|Carboplatin|carboplatin|mesh-list
83789222|NCT03323463|Fluorouracil|fluorouracil|mesh-list
83789223|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789224|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
83789225|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789226|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789227|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789228|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
83789229|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789230|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
83789231|NCT03315897|Hematinics|hematinics|mesh-ancestor
83789232|NCT03299660|Fluorouracil|fluorouracil|mesh-list
83789233|NCT03299660|Capecitabine|capecitabine|mesh-list
83789234|NCT03299660|Avelumab|avelumab|mesh-list
83789235|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
83789236|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789237|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789238|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789239|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789240|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
83789241|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789242|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789243|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
83789244|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83789245|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83789246|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
82944453|NCT02323516|Aspirin|aspirin|mesh-list
83789247|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
83789248|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789249|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789250|NCT03243058|Aldesleukin|aldesleukin|mesh-list
83789251|NCT03243058|Interleukin-2|interleukin-2|mesh-list
83789252|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789253|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83789254|NCT03243058|Analgesics|analgesics|mesh-ancestor
83789255|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
83789256|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789257|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789258|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789259|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789260|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
83789261|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789262|NCT03140358|Atropine|atropine|mesh-list
83789263|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83789264|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83789265|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83789266|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
83789267|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789268|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789269|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83789270|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
83789271|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
83789272|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
83789273|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83789274|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83789275|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
83789276|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789277|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789278|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
83789279|NCT02954536|Fluorouracil|fluorouracil|mesh-list
83789280|NCT02954536|Capecitabine|capecitabine|mesh-list
83789281|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
83789282|NCT02954536|Trastuzumab|trastuzumab|mesh-list
83789283|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789284|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789285|NCT02954536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83789286|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789287|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
83789288|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789289|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789290|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
83789291|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789292|NCT02899611|Valproic Acid|valproic acid|mesh-list
83789293|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
83789294|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789295|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789296|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
83789297|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789298|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789299|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
83789300|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83789301|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789302|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83789303|NCT02750202|Vaccines|vaccines|mesh-list
83789304|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
83789305|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789306|NCT02645266|Aflibercept|aflibercept|mesh-list
83789307|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83789308|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83789309|NCT02645266|Growth Substances|growth substances|mesh-ancestor
83789310|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789311|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
83789312|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789313|NCT02634294|Interferons|interferons|mesh-list
83789314|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
83789315|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
83789316|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83789317|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789318|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
83789319|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789320|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
83789321|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789322|NCT02586831|Exenatide|exenatide|mesh-list
83789323|NCT02586831|Aldesleukin|aldesleukin|mesh-list
83789324|NCT02586831|Adalimumab|adalimumab|mesh-list
83789325|NCT02586831|Interleukin-2|interleukin-2|mesh-list
83789326|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
83789327|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83789328|NCT02586831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83789329|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83789330|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789331|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789332|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83789333|NCT02586831|Analgesics|analgesics|mesh-ancestor
83789334|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
83789335|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789336|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789337|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789338|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789339|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
83789340|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789341|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83789342|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83789343|NCT02586831|Incretins|incretins|mesh-ancestor
83789344|NCT02586831|Hormones|hormones|mesh-ancestor
83789345|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83789346|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
83789347|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789348|NCT02575677|Oxycodone|oxycodone|mesh-list
83789349|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83789350|NCT02575677|Narcotics|narcotics|mesh-ancestor
83789351|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789352|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789353|NCT02575677|Analgesics|analgesics|mesh-ancestor
83789354|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
83789355|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789356|NCT02573831|Oxycodone|oxycodone|mesh-list
83789357|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83789358|NCT02573831|Narcotics|narcotics|mesh-ancestor
83789359|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789360|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789361|NCT02573831|Analgesics|analgesics|mesh-ancestor
83789362|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
83789363|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789364|NCT02571881|Oxycodone|oxycodone|mesh-list
83789365|NCT02571881|Naloxone|naloxone|mesh-list
83789366|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83789367|NCT02571881|Narcotics|narcotics|mesh-ancestor
83789368|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789369|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789370|NCT02571881|Analgesics|analgesics|mesh-ancestor
83789371|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
83789372|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789373|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83789374|NCT02571179|Fentanyl|fentanyl|mesh-list
83789375|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83789376|NCT02571179|Narcotics|narcotics|mesh-ancestor
83789377|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789378|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789379|NCT02571179|Analgesics|analgesics|mesh-ancestor
83789380|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
83789381|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789382|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83789383|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83789384|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
83789385|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
83789386|NCT02511418|Simvastatin|simvastatin|mesh-list
83789387|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83789388|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83789389|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
83789390|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789391|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83789392|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83789393|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789394|NCT02278250|Carboplatin|carboplatin|mesh-list
83789395|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789396|NCT02250326|Paclitaxel|paclitaxel|mesh-list
83789397|NCT02250326|Azacitidine|azacitidine|mesh-list
83789398|NCT02250326|Cc-486|cc-486|mesh-list
83789399|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789400|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789401|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83789402|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789403|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789404|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789405|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789406|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
83789407|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789409|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
83789410|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83789411|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789412|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
83789413|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83789414|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789415|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83789416|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789417|NCT02101905|Lapatinib|lapatinib|mesh-list
83789418|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789419|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789420|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789421|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789422|NCT02081404|Esomeprazole|esomeprazole|mesh-list
83789423|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83789424|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83789425|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83789426|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789427|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789428|NCT01526603|Carboplatin|carboplatin|mesh-list
83789429|NCT01526603|Etoposide|etoposide|mesh-list
83789430|NCT01526603|Melphalan|melphalan|mesh-list
83789431|NCT01526603|Tretinoin|tretinoin|mesh-list
83789432|NCT01526603|Isotretinoin|isotretinoin|mesh-list
83789433|NCT01526603|Lenograstim|lenograstim|mesh-list
83789434|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789435|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789436|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83789437|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83789438|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789439|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789440|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789441|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
83789442|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83789443|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789444|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
83789445|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789446|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83789447|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
83789448|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83789449|NCT00038766|Semapimod|semapimod|mesh-list
83789450|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83789451|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83789452|NCT00038766|Analgesics|analgesics|mesh-ancestor
83789453|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
83789454|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789455|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789456|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83789457|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789458|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789459|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
83789460|NCT00070070|Sargramostim|sargramostim|mesh-list
83789461|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
83789462|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
83789463|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789464|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83789465|NCT02573909|Oxycodone|oxycodone|mesh-list
83789466|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83789467|NCT02573909|Narcotics|narcotics|mesh-ancestor
83789468|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789469|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789470|NCT02573909|Analgesics|analgesics|mesh-ancestor
83789471|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
83789472|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789473|NCT00042315|Vinorelbine|vinorelbine|mesh-list
83789474|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789475|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789476|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
82944678|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
83789477|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789478|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789479|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789480|NCT00018668|Olanzapine|olanzapine|mesh-list
83789481|NCT00018668|Risperidone|risperidone|mesh-list
83789482|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83789483|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83789484|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
83789485|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789486|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789487|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789488|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83789489|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83789490|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83789491|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83789492|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83789493|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
83789494|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
83789495|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
83789496|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789497|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83789498|NCT00018668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83789499|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83789500|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83789501|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
83789502|NCT00042354|Clofarabine|clofarabine|mesh-list
83789503|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789504|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
83789505|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789506|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789507|NCT00042393|Adefovir|adefovir|mesh-list
83789508|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83789509|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
83789510|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789511|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83789512|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83789513|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789514|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789515|NCT00042471|Pramlintide|pramlintide|mesh-list
83789516|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83789517|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83789518|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789519|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
83789520|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83789521|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83789522|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789523|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83789524|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83789525|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83789526|NCT00042588|Antibodies|antibodies|mesh-list
83789527|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83789528|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
83789529|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789530|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
83789531|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789532|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789533|NCT00038805|Immunotoxins|immunotoxins|mesh-ancestor
83789534|NCT00038805|Immunoconjugates|immunoconjugates|mesh-ancestor
83789535|NCT00038805|Immunologic Factors|immunologic factors|mesh-ancestor
83789536|NCT00038805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789537|NCT00018824|Naltrexone|naltrexone|mesh-list
83789538|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83789539|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83789540|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789541|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
83789542|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789543|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
83789544|NCT00038844|Rituximab|rituximab|mesh-list
83789545|NCT00038844|Fludarabine|fludarabine|mesh-list
83789546|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
83789547|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
83789548|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789549|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
83789550|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789551|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789552|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789553|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
83834937|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789554|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789555|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789556|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83789557|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789558|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789559|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
83789560|NCT00018863|Methylphenidate|methylphenidate|mesh-list
83789561|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83789562|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789563|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83789564|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83789565|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83789566|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789567|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
83789568|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789569|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
83789570|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789571|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789572|NCT00018902|Fluoxetine|fluoxetine|mesh-list
83789573|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83789574|NCT00018902|Citalopram|citalopram|mesh-list
83789575|NCT00018902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83789576|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83789577|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83789578|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789579|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789580|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
83789581|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789582|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83789583|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
83789584|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83789585|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83789586|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83789587|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789588|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83789589|NCT00038922|Oprelvekin|oprelvekin|mesh-list
83789590|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789591|NCT00018941|Aldesleukin|aldesleukin|mesh-list
83789592|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789593|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789594|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789595|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
83789596|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789597|NCT00038961|PENTA|penta|mesh-list
83789598|NCT00038961|Fondaparinux|fondaparinux|mesh-list
83789599|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83789600|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
83789601|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83789602|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
83789603|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789604|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789605|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
83789606|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83789607|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83789608|NCT00019019|Paclitaxel|paclitaxel|mesh-list
83789609|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
83789610|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789611|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789612|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
83789613|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789614|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789615|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789616|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83789617|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83789618|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83789619|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789620|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
83789621|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
83789622|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789623|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
83789624|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789625|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789626|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83789627|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83789628|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83789629|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83789630|NCT00019058|Protective Agents|protective agents|mesh-ancestor
83789631|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789632|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
83789633|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83789635|NCT00039039|Paclitaxel|paclitaxel|mesh-list
83789636|NCT00039039|Carboplatin|carboplatin|mesh-list
83789637|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789638|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789639|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
83789640|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789641|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789642|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789643|NCT00019097|Melphalan|melphalan|mesh-list
83789644|NCT00019097|Sargramostim|sargramostim|mesh-list
83789645|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83789646|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789647|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
83789648|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789649|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789650|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83789651|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789652|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
83789653|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789654|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83789655|NCT00019136|Aldesleukin|aldesleukin|mesh-list
83789656|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789657|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789658|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789659|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
83789660|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789661|NCT00039117|Cytarabine|cytarabine|mesh-list
83789662|NCT00039117|Daunorubicin|daunorubicin|mesh-list
83789663|NCT00039117|Oblimersen|oblimersen|mesh-list
83789664|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789665|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
83789666|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789667|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789668|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
83789669|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789670|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789671|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
83789672|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789673|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83789674|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83789675|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83789676|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789677|NCT00019175|Aldesleukin|aldesleukin|mesh-list
83789678|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789679|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789680|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789681|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
83789682|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789683|NCT00039156|IDN 5109|idn 5109|mesh-list
83789684|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789685|NCT00019214|Aldesleukin|aldesleukin|mesh-list
83789686|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789687|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789688|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789689|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
83789690|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789691|NCT00039234|Aldesleukin|aldesleukin|mesh-list
83789692|NCT00039234|Histamine|histamine|mesh-list
83789693|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
83789694|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789695|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789696|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789697|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
83789698|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789699|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
83789700|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
82944894|NCT02891798|Dexamethasone|dexamethasone|mesh-list
82944896|NCT02891798|Clonidine|clonidine|mesh-list
83789701|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789702|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789703|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789704|NCT00019331|Aldesleukin|aldesleukin|mesh-list
83789705|NCT00019331|Sargramostim|sargramostim|mesh-list
83789706|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
83789707|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789708|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789709|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789710|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789711|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
83789712|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789713|NCT00039273|Panitumumab|panitumumab|mesh-list
83789714|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83789715|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789716|NCT00019409|Cytarabine|cytarabine|mesh-list
83789717|NCT00019409|Prednisone|prednisone|mesh-list
83789718|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
83789719|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83789720|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83789721|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83789722|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
83789723|NCT00019409|Methotrexate|methotrexate|mesh-list
83789724|NCT00019409|Vincristine|vincristine|mesh-list
83789725|NCT00019409|Daunorubicin|daunorubicin|mesh-list
83789726|NCT00019409|Asparaginase|asparaginase|mesh-list
83789727|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
83789728|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789729|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
83789730|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789731|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789732|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789733|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
83789734|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789735|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789736|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83789737|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83789738|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
83789739|NCT00019409|Hormones|hormones|mesh-ancestor
83789740|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83789741|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83789742|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83789743|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
83789744|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83789745|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789746|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
83789747|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
83789748|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789749|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83789750|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83789751|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
83789752|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789753|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789754|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
83789755|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789756|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789757|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83789758|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83789759|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83789760|NCT00019448|Interleukin-2|interleukin-2|mesh-list
83789761|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789762|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83789763|NCT00019448|Analgesics|analgesics|mesh-ancestor
83789764|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
83789765|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789766|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789767|NCT00019487|Aldesleukin|aldesleukin|mesh-list
83789768|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
83789769|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789770|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789771|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789772|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
83789773|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789774|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83789775|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
83789776|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789777|NCT00039351|Prednisone|prednisone|mesh-list
83789778|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
83789779|NCT00039351|Vincristine|vincristine|mesh-list
83789780|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789781|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
83789782|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789783|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789784|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789785|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
83789786|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789787|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789788|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83789789|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83789790|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
83789791|NCT00039351|Hormones|hormones|mesh-ancestor
83789792|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83789793|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83789794|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789795|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
83789796|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789797|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789798|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83789799|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83789800|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789801|NCT00039390|Capecitabine|capecitabine|mesh-list
83789802|NCT00039390|Gefitinib|gefitinib|mesh-list
83789803|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789804|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
83789805|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789806|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789807|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789808|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789809|NCT00019721|Aldesleukin|aldesleukin|mesh-list
83789810|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
83789811|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789812|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789813|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789814|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
83789815|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789816|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83789817|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
83789818|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789819|NCT00019760|Leucovorin|leucovorin|mesh-list
83789820|NCT00019760|Melphalan|melphalan|mesh-list
83789821|NCT00019760|Floxuridine|floxuridine|mesh-list
83789822|NCT00019760|Calcium|calcium|mesh-list
83789823|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
83789824|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83789825|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789826|NCT00019760|Antidotes|antidotes|mesh-ancestor
83789827|NCT00019760|Protective Agents|protective agents|mesh-ancestor
83789828|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
83789829|NCT00019760|Vitamins|vitamins|mesh-ancestor
83789830|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
83789831|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789832|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
83789833|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789834|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789835|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83789836|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789837|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
83789838|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789839|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
83789840|NCT00039468|Thalidomide|thalidomide|mesh-list
83789841|NCT00039468|Irinotecan|irinotecan|mesh-list
83789842|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83789843|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83789844|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789845|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789846|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789847|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789848|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
83789849|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789850|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
83789851|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83789852|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789853|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83789854|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83789855|NCT00039468|Growth Substances|growth substances|mesh-ancestor
83789856|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
83789857|NCT00019838|Fludarabine|fludarabine|mesh-list
83789858|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
83789859|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83789860|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789861|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789862|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
83789863|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789864|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789865|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
83789866|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789867|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789868|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789869|NCT00019916|Aldesleukin|aldesleukin|mesh-list
83789870|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789871|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789872|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789873|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
83789874|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789875|NCT00039546|Paclitaxel|paclitaxel|mesh-list
83789876|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
83789877|NCT00039546|Gemcitabine|gemcitabine|mesh-list
83789878|NCT00039546|Epirubicin|epirubicin|mesh-list
83789879|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83789880|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789881|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
83789882|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
83789883|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
83789884|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789885|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83789886|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
83789887|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789888|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789889|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789890|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
83789891|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83789892|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83789893|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
83789894|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83789895|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83789896|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83789897|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789898|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
83789899|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789900|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789901|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789902|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789903|NCT00019994|Aldesleukin|aldesleukin|mesh-list
83789904|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
83789905|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789906|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789907|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789908|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
83789909|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789910|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83789911|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
83789912|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789913|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
83789914|NCT00039663|Pravastatin|pravastatin|mesh-list
83789915|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
83789916|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83789917|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789918|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83789919|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83789920|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
83789921|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789922|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83789923|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83789924|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789925|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83789926|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83789927|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
83789928|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945121|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789929|NCT00020150|Temozolomide|temozolomide|mesh-list
83789930|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83789931|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83789932|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
83789933|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789934|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789935|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789936|NCT00039858|Argatroban|argatroban|mesh-list
83789937|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
83789938|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83789939|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
83789940|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789941|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789942|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
83789943|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83789944|NCT00020189|Aspirin|aspirin|mesh-list
83789945|NCT00020189|Alvocidib|alvocidib|mesh-list
83789946|NCT00020189|Clopidogrel|clopidogrel|mesh-list
83789947|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83789948|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83789949|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83789950|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83789951|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
83789952|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83789953|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789954|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789955|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83789956|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83789957|NCT00020189|Analgesics|analgesics|mesh-ancestor
83789958|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
83789959|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789960|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83789961|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83789962|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83789963|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83789964|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83789965|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789966|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
83789967|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789968|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
83789969|NCT00020189|Growth Substances|growth substances|mesh-ancestor
83789970|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83789971|NCT00039975|Ritonavir|ritonavir|mesh-list
83789972|NCT00039975|Indinavir|indinavir|mesh-list
83789973|NCT00039975|Amlodipine|amlodipine|mesh-list
83789974|NCT00039975|Diltiazem|diltiazem|mesh-list
83789975|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83789976|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83789977|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
83789978|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83789979|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83789980|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83789981|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83789982|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
83789983|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83789984|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83789985|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83789986|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83789987|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83789988|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83789989|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83789990|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83789991|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
83789992|NCT00020267|Interleukin-2|interleukin-2|mesh-list
83789993|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83789994|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83789995|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83789996|NCT00020267|Analgesics|analgesics|mesh-ancestor
83789997|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
83789998|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83789999|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790000|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83790001|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
83790002|NCT00040014|Exemestane|exemestane|mesh-list
83790003|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790004|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83790005|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82945195|NCT03486496|Gefitinib|gefitinib|mesh-list
83790006|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790007|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790008|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83790009|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
83790010|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790011|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790012|NCT00020345|Gemcitabine|gemcitabine|mesh-list
83790013|NCT00020345|Fluorouracil|fluorouracil|mesh-list
83790014|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790015|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
83790016|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790017|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790018|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790019|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
83790020|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790021|NCT00040053|Ondansetron|ondansetron|mesh-list
83790022|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
83790023|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
83790024|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790025|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790026|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790027|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
83790028|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
83790029|NCT00040053|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83790030|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83790031|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
83790032|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83790033|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790034|NCT00020462|Aldesleukin|aldesleukin|mesh-list
83790035|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790036|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83790037|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83790038|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
83790039|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790040|NCT00020501|Leucovorin|leucovorin|mesh-list
83790041|NCT00020501|Fluorouracil|fluorouracil|mesh-list
83790042|NCT00020501|Floxuridine|floxuridine|mesh-list
83790043|NCT00020501|Irinotecan|irinotecan|mesh-list
83790044|NCT00020501|Melphalan|melphalan|mesh-list
83790045|NCT00020501|Calcium|calcium|mesh-list
83790046|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
83790047|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83790048|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790049|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
83790050|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790051|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790052|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790053|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790054|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
83790055|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83790056|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790057|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790058|NCT00020501|Antidotes|antidotes|mesh-ancestor
83790059|NCT00020501|Protective Agents|protective agents|mesh-ancestor
83790060|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
83790061|NCT00020501|Vitamins|vitamins|mesh-ancestor
83790062|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
83790063|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790064|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
83790065|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83790066|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
83790067|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83790068|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
83790069|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790070|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83790071|NCT00020540|Protective Agents|protective agents|mesh-ancestor
83790072|NCT00020579|Entinostat|entinostat|mesh-list
83790073|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790074|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83790075|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790076|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790077|NCT00040209|Levodopa|levodopa|mesh-list
83790078|NCT00040209|Apomorphine|apomorphine|mesh-list
83790079|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83790080|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83790081|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
83790082|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834938|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790083|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790084|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790086|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
83790087|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790088|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790089|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
83790090|NCT00040248|Daclizumab|daclizumab|mesh-list
83790091|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790092|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
83790093|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790094|NCT00020618|Morphine|morphine|mesh-list
83790095|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83790096|NCT00020618|Narcotics|narcotics|mesh-ancestor
83790097|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83790098|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790099|NCT00020618|Analgesics|analgesics|mesh-ancestor
83790100|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
83790101|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790102|NCT00020657|Ondansetron|ondansetron|mesh-list
83790103|NCT00020657|Granisetron|granisetron|mesh-list
83790104|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
83790105|NCT00020657|Dolasetron|dolasetron|mesh-list
83790106|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
83790107|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
83790108|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790109|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790110|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790111|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
83790112|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
83790113|NCT00020657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83790114|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83790115|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
83790116|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83790117|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790118|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83790119|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83790120|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83790121|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83790122|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83790123|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
83790124|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
83790125|NCT00020696|Tirapazamine|tirapazamine|mesh-list
83790126|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790127|NCT02970630|Everolimus|everolimus|mesh-list
83790128|NCT02970630|Tacrolimus|tacrolimus|mesh-list
83790129|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790130|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
83790131|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790132|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83790133|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790134|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790135|NCT02970630|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83790136|NCT02970630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790137|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790138|NCT00020735|Toremifene|toremifene|mesh-list
83790139|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83790140|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790141|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83790142|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83790143|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
83790144|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790145|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790146|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83790147|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
83790148|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790149|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
83790150|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790151|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790152|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790153|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
83790154|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790155|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790156|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82945341|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790157|NCT00020774|Gemcitabine|gemcitabine|mesh-list
83790158|NCT00020774|Lonafarnib|lonafarnib|mesh-list
83790159|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790160|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
83790161|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790162|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790163|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790164|NCT00040521|Oprelvekin|oprelvekin|mesh-list
83790165|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790166|NCT00040599|Labetuzumab|labetuzumab|mesh-list
83790167|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790168|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790169|NCT00020930|Cetuximab|cetuximab|mesh-list
83790170|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790171|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790172|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
83790173|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790174|NCT00040794|Paclitaxel|paclitaxel|mesh-list
83790175|NCT00040794|Carboplatin|carboplatin|mesh-list
83790176|NCT00040794|Gefitinib|gefitinib|mesh-list
83790177|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790178|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790179|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790180|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790181|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790182|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790183|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790184|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790185|NCT00021047|Carboplatin|carboplatin|mesh-list
83790186|NCT00021047|Capecitabine|capecitabine|mesh-list
83790187|NCT00021047|Epirubicin|epirubicin|mesh-list
83790188|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790189|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790190|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
83790191|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790192|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83790193|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83790194|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790195|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790196|NCT00021164|Aldesleukin|aldesleukin|mesh-list
83790197|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
83790198|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790199|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83790200|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83790201|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
83790202|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790203|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83790204|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
83790205|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790206|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
83790207|NCT00040872|Thiotepa|thiotepa|mesh-list
83790208|NCT00040872|Carboplatin|carboplatin|mesh-list
83790209|NCT00040872|Doxorubicin|doxorubicin|mesh-list
83790210|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83790211|NCT00040872|Etoposide|etoposide|mesh-list
83790212|NCT00040872|Vincristine|vincristine|mesh-list
83790213|NCT00040872|Topotecan|topotecan|mesh-list
83790214|NCT00040872|Isotretinoin|isotretinoin|mesh-list
83790215|NCT00040872|Antibodies|antibodies|mesh-list
83790216|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83790217|NCT00040872|Sargramostim|sargramostim|mesh-list
83790218|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790219|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
83790220|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790221|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790222|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790223|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
83790224|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790225|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790226|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83790227|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83790228|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83790229|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790230|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790231|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790232|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790233|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790234|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790235|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83790237|NCT00021242|Docetaxel|docetaxel|mesh-list
83790238|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790239|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790240|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790241|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790242|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790243|NCT00040950|Rituximab|rituximab|mesh-list
83790244|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790245|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790246|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
83790247|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790248|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790249|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83790250|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790251|NCT00021281|Leucovorin|leucovorin|mesh-list
83790252|NCT00021281|Fluorouracil|fluorouracil|mesh-list
83790253|NCT00021281|Irinotecan|irinotecan|mesh-list
83790254|NCT00021281|Calcium|calcium|mesh-list
83790255|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
83790256|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83790257|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790258|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
83790259|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790260|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790261|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790262|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790263|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
83790264|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83790265|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790266|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790267|NCT00021281|Antidotes|antidotes|mesh-ancestor
83790268|NCT00021281|Protective Agents|protective agents|mesh-ancestor
83790269|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
83790270|NCT00021281|Vitamins|vitamins|mesh-ancestor
83790271|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
83790272|NCT00041106|Gemcitabine|gemcitabine|mesh-list
83790273|NCT00041106|Gefitinib|gefitinib|mesh-list
83790274|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790275|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790276|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
83790277|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790278|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790279|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790280|NCT00021320|Paclitaxel|paclitaxel|mesh-list
83790281|NCT00021320|Fluorouracil|fluorouracil|mesh-list
83790282|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790283|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790284|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790285|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790286|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790287|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790288|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
83790289|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790290|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790291|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
83790292|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790293|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
83790294|NCT00041223|Procyanidin|procyanidin|mesh-list
83790295|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
83790296|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790297|NCT00041223|Protective Agents|protective agents|mesh-ancestor
83790298|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790299|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83790300|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83790301|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790302|NCT00021359|Dexamethasone|dexamethasone|mesh-list
83790303|NCT00021359|Isotretinoin|isotretinoin|mesh-list
83790304|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83790305|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
83790306|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
82945489|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790307|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790308|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790309|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790310|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
83790311|NCT00021359|Hormones|hormones|mesh-ancestor
83790312|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790313|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83790314|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790315|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83790316|NCT00041262|Fluorouracil|fluorouracil|mesh-list
83790317|NCT00041262|Epirubicin|epirubicin|mesh-list
83790318|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790319|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
83790320|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790321|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790322|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790323|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
83790324|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790325|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83790326|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83790327|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790328|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790329|NCT00021398|Leucovorin|leucovorin|mesh-list
83790330|NCT00021398|Fluorouracil|fluorouracil|mesh-list
83790331|NCT00021398|Calcium|calcium|mesh-list
83790332|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
83790333|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83790334|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790335|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
83790336|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790337|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790338|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790339|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790340|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
83790341|NCT00021398|Antidotes|antidotes|mesh-ancestor
83790342|NCT00021398|Protective Agents|protective agents|mesh-ancestor
83790343|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
83790344|NCT00021398|Vitamins|vitamins|mesh-ancestor
83790345|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
83790346|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83790347|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
83790348|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790349|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
83790350|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83790351|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83790352|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790353|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83790354|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83790355|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
83790356|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790357|NCT00049023|Octreotide|octreotide|mesh-list
83790358|NCT00049023|Edotreotide|edotreotide|mesh-list
83790359|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790360|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83790361|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790362|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83790363|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790364|NCT00021671|Metronidazole|metronidazole|mesh-list
83790365|NCT00021671|Nevirapine|nevirapine|mesh-list
83790366|NCT00021671|Erythromycin|erythromycin|mesh-list
83790367|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
83790368|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83790369|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
83790370|NCT00021671|Ampicillin|ampicillin|mesh-list
83790371|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790372|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790373|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83790374|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83790375|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83790376|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83790377|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790378|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790379|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
83790380|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83790381|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83790382|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83790383|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83790384|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790385|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83790386|NCT00049062|Gefitinib|gefitinib|mesh-list
83790387|NCT00049062|Anastrozole|anastrozole|mesh-list
83790388|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790389|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790390|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790391|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790392|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83790393|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83790394|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83790395|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83790396|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
83790397|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790398|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790399|NCT00049101|Leucovorin|leucovorin|mesh-list
83790400|NCT00049101|Fluorouracil|fluorouracil|mesh-list
83790401|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
83790402|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83790403|NCT00049101|Calcium|calcium|mesh-list
83790404|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
83790405|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83790406|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790407|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
83790408|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790409|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790410|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790411|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790412|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
83790413|NCT00049101|Antidotes|antidotes|mesh-ancestor
83790414|NCT00049101|Protective Agents|protective agents|mesh-ancestor
83790415|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
83790416|NCT00049101|Vitamins|vitamins|mesh-ancestor
83790417|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
83790418|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790419|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790420|NCT00394628|Temozolomide|temozolomide|mesh-list
83790421|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790422|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
83790423|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790424|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790425|NCT00049179|Cytarabine|cytarabine|mesh-list
83790426|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
83790427|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790428|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
83790429|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790430|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790431|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
83790432|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790433|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790434|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
83790435|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790436|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790437|NCT00049179|Immunotoxins|immunotoxins|mesh-ancestor
83790438|NCT00049179|Immunoconjugates|immunoconjugates|mesh-ancestor
83790439|NCT00394745|Valsartan|valsartan|mesh-list
83790440|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83790441|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83790442|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83790443|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790444|NCT00049218|Carboplatin|carboplatin|mesh-list
83790445|NCT00049218|Etoposide|etoposide|mesh-list
83790446|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790447|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790448|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83790449|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790450|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790451|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790452|NCT00049296|Thalidomide|thalidomide|mesh-list
83790453|NCT00049296|Docetaxel|docetaxel|mesh-list
83790454|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790455|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790456|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790457|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790458|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790459|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790460|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
83790461|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945640|NCT02876510|Fludarabine|fludarabine|mesh-list
82945665|NCT03380455|Cimetidine|cimetidine|mesh-list
83790462|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
83790463|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790464|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790465|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83790466|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83790467|NCT00049296|Growth Substances|growth substances|mesh-ancestor
83790468|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
83790470|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
83790471|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
83790472|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790473|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790474|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83790475|NCT00049335|Capecitabine|capecitabine|mesh-list
83790476|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790477|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
83790478|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790479|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790480|NCT00049374|Thalidomide|thalidomide|mesh-list
83790481|NCT00049374|Dexamethasone|dexamethasone|mesh-list
83790482|NCT00049374|Oblimersen|oblimersen|mesh-list
83790483|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83790484|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
83790485|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
83790486|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790487|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790488|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790489|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
83790490|NCT00049374|Hormones|hormones|mesh-ancestor
83790491|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790492|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83790493|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790494|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790495|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
83790496|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
83790497|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790498|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790499|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83790500|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83790501|NCT00049374|Growth Substances|growth substances|mesh-ancestor
83790502|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
83790503|NCT00021983|Immunotoxins|immunotoxins|mesh-list
83790504|NCT00021983|Immunoconjugates|immunoconjugates|mesh-ancestor
83790505|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
83790506|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790507|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
83790508|NCT00049413|Rituximab|rituximab|mesh-list
83790509|NCT00049413|Pentostatin|pentostatin|mesh-list
83790510|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790511|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
83790512|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790513|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790514|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790515|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
83790516|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790517|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790518|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83790519|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790520|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83790521|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790522|NCT00022022|Docetaxel|docetaxel|mesh-list
83790523|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790524|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790525|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790526|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790527|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790528|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
83790529|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83790530|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790531|NCT00022139|Paclitaxel|paclitaxel|mesh-list
83790532|NCT00022139|Carboplatin|carboplatin|mesh-list
83790533|NCT00022139|Fluorouracil|fluorouracil|mesh-list
83790534|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82945715|NCT01310712|Urological Agents|urological agents|mesh-ancestor
83790535|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790536|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790537|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790538|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790539|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790540|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
83790541|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790542|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790543|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
83790544|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790545|NCT00049569|Leucovorin|leucovorin|mesh-list
83790546|NCT00049569|Cytarabine|cytarabine|mesh-list
83790547|NCT00049569|Prednisone|prednisone|mesh-list
83790548|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
83790549|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83790550|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83790551|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83790552|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
83790553|NCT00049569|Doxorubicin|doxorubicin|mesh-list
83790554|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83790555|NCT00049569|Methotrexate|methotrexate|mesh-list
83790556|NCT00049569|Etoposide|etoposide|mesh-list
83790557|NCT00049569|Vincristine|vincristine|mesh-list
83790558|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
83790559|NCT00049569|Asparaginase|asparaginase|mesh-list
83790560|NCT00049569|Pegaspargase|pegaspargase|mesh-list
83790561|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
83790562|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790563|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
83790564|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790565|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790566|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790567|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
83790568|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790569|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790570|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83790571|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83790572|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83790573|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790574|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790575|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83790576|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
83790577|NCT00049569|Hormones|hormones|mesh-ancestor
83790578|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790579|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83790580|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83790581|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
83790582|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83790583|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790584|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
83790585|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
83790586|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83790587|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83790588|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790589|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
83790590|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790591|NCT00049569|Antidotes|antidotes|mesh-ancestor
83790592|NCT00049569|Protective Agents|protective agents|mesh-ancestor
83790593|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
83790594|NCT00049569|Vitamins|vitamins|mesh-ancestor
83790595|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
83790596|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790597|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790598|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790599|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790600|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
83790601|NCT00022178|Doxorubicin|doxorubicin|mesh-list
83790602|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83790603|NCT00022178|Fluorouracil|fluorouracil|mesh-list
83790604|NCT00022178|Vincristine|vincristine|mesh-list
83790605|NCT00022178|Epirubicin|epirubicin|mesh-list
83790606|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790607|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
83790608|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790609|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790610|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790611|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
83790612|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790613|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790614|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83790615|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83790616|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83790617|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790618|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790619|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
83790620|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790621|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790622|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790623|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790624|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790625|NCT00049608|Gemcitabine|gemcitabine|mesh-list
83790626|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790627|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
83790628|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790629|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790630|NCT00022217|Paclitaxel|paclitaxel|mesh-list
83790631|NCT00022217|Carboplatin|carboplatin|mesh-list
83790632|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790633|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790634|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790635|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790636|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790637|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790638|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
83790639|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790640|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83790641|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
83790642|NCT00049725|Daclizumab|daclizumab|mesh-list
83790643|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790644|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
83790645|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790646|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83790647|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790648|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
83790649|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83790650|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83790651|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
83790652|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
83790653|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83790654|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790655|NCT00397761|Paclitaxel|paclitaxel|mesh-list
83790656|NCT00397761|Capecitabine|capecitabine|mesh-list
83790657|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83790658|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83790659|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790660|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83790661|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790662|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790663|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790664|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790665|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
83790666|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83790667|NCT00022412|Vitamins|vitamins|mesh-ancestor
83790668|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
83790669|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790670|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83790671|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
83790672|NCT00397800|Rituximab|rituximab|mesh-list
83790673|NCT00397800|Fludarabine|fludarabine|mesh-list
83790674|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
83790675|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790676|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
83790677|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790678|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790679|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790680|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
83790681|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790682|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790683|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83790684|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790685|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790686|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
82945863|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790687|NCT00022451|Tipifarnib|tipifarnib|mesh-list
83790688|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790689|NCT00022529|Trastuzumab|trastuzumab|mesh-list
83790690|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790691|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790692|NCT00022607|Thalidomide|thalidomide|mesh-list
83790693|NCT00022607|Bevacizumab|bevacizumab|mesh-list
83790694|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790695|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790696|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83790697|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83790698|NCT00022607|Growth Substances|growth substances|mesh-ancestor
83790699|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790700|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
83790701|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790702|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
83790703|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
83790704|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790705|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790706|NCT00049998|Topotecan|topotecan|mesh-list
83790707|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83790708|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83790709|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790710|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790711|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790712|NCT00022646|Gemcitabine|gemcitabine|mesh-list
83790713|NCT00022646|Pemetrexed|pemetrexed|mesh-list
83790714|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790715|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
83790716|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790717|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790718|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790719|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83790720|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83790721|NCT00022685|Epratuzumab|epratuzumab|mesh-list
83790722|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83790723|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790724|NCT00022724|Sirolimus|sirolimus|mesh-list
83790725|NCT00022724|Temsirolimus|temsirolimus|mesh-list
83790726|NCT00022724|MTOR Inhibitors|mtor inhibitors|mesh-list
83790727|NCT00022724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790728|NCT00022724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790729|NCT00022724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790730|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790731|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
83790732|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790733|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790734|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790735|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790736|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83790737|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
83790738|NCT00050154|Tipifarnib|tipifarnib|mesh-list
83790739|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790740|NCT00022841|Pamidronate|pamidronate|mesh-list
83790741|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83790742|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790743|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
83790744|NCT00022880|Antibodies|antibodies|mesh-list
83790745|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
83790746|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790747|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790748|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
83790749|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
83790750|NCT00050271|Vitamins|vitamins|mesh-ancestor
83790751|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
83790752|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790753|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
83790754|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
83790755|NCT00022958|Antibodies|antibodies|mesh-list
83790756|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
83790757|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790758|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790759|NCT00050349|Epothilones|epothilones|mesh-list
83790760|NCT00050349|Epothilone B|epothilone b|mesh-list
83790761|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
82945937|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
82945939|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
83790762|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
83790763|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
83790764|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790765|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790766|NCT00050427|Trabectedin|trabectedin|mesh-list
83790767|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83790768|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
83790769|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790770|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790772|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83790773|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
83790774|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790775|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83790776|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83790777|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790778|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790779|NCT00050505|Vaccines|vaccines|mesh-list
83790780|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
83790781|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790782|NCT00050661|Daclizumab|daclizumab|mesh-list
83790783|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790784|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
83790785|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790786|NCT00050817|Clopidogrel|clopidogrel|mesh-list
83790787|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83790788|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83790789|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83790790|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83790791|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
83790792|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83790793|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790794|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790795|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
83790796|NCT00023231|Sirolimus|sirolimus|mesh-list
83790797|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83790798|NCT00023231|Ganciclovir|ganciclovir|mesh-list
83790799|NCT00023231|Prednisone|prednisone|mesh-list
83790800|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
83790801|NCT00023231|Atorvastatin|atorvastatin|mesh-list
83790802|NCT00023231|Daclizumab|daclizumab|mesh-list
83790803|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83790804|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
83790805|NCT00023231|Hormones|hormones|mesh-ancestor
83790806|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83790807|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790808|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83790809|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790810|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83790811|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83790812|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
83790813|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790814|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790815|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790816|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790817|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
83790818|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790819|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
83790820|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
83790821|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
83790822|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790823|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83790824|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83790825|NCT00023231|Protective Agents|protective agents|mesh-ancestor
83790826|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83790827|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83790828|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
83790829|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83790830|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83790831|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
83790832|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83790833|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
83790834|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83790835|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83790836|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
83790837|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83790838|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82946024|NCT01248871|Sufentanil|sufentanil|mesh-list
83790839|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790840|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83790841|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83790842|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
83790843|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790845|NCT00023348|Rifabutin|rifabutin|mesh-list
83790846|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
83790847|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790848|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790849|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83790850|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83790851|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
83790852|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790853|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83790854|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83790855|NCT00050895|Ritonavir|ritonavir|mesh-list
83790856|NCT00050895|Lopinavir|lopinavir|mesh-list
83790857|NCT00050895|Tenofovir|tenofovir|mesh-list
83790858|NCT00050895|Lamivudine|lamivudine|mesh-list
83790859|NCT00050895|Zidovudine|zidovudine|mesh-list
83790860|NCT00050895|Stavudine|stavudine|mesh-list
83790861|NCT00050895|Efavirenz|efavirenz|mesh-list
83790862|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83790863|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83790864|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
83790865|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790866|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790867|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83790868|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83790869|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
83790870|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790871|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83790872|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83790873|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83790874|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83790875|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
83790876|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83790877|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83790878|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83790879|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83790880|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83790881|NCT00023387|Isoniazid|isoniazid|mesh-list
83790882|NCT00023387|Rifapentine|rifapentine|mesh-list
83790883|NCT00023387|Rifampin|rifampin|mesh-list
83790884|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
83790885|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790886|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790887|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83790888|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83790889|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
83790890|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790891|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83790892|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83790893|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
83790894|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83790895|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790896|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83790897|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83790898|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83790899|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83790900|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83790901|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83790902|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
83790903|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
83790904|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83790905|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83790906|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83790907|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790908|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83790909|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83790910|NCT00023426|Rifapentine|rifapentine|mesh-list
82946085|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946086|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790911|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83790912|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
83790913|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83790914|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790915|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
83790916|NCT00050973|Bexarotene|bexarotene|mesh-list
83790917|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790918|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83790919|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
83790920|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790921|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
83790922|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
83790923|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
83790924|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83790925|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790926|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
83790927|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790928|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790929|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83790930|NCT00051051|Protective Agents|protective agents|mesh-ancestor
83790931|NCT00051090|Lamivudine|lamivudine|mesh-list
83790932|NCT00051090|Efavirenz|efavirenz|mesh-list
83790933|NCT00051090|Abacavir|abacavir|mesh-list
83790934|NCT00051090|Didanosine|didanosine|mesh-list
83790935|NCT00051090|Telbivudine|telbivudine|mesh-list
83790936|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83790937|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83790938|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790939|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790940|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
83790941|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83790942|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83790943|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83790944|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83790945|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83790946|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83790947|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83790948|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83790949|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83790950|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
83790951|NCT00023621|Celecoxib|celecoxib|mesh-list
83790952|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83790953|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83790954|NCT00023621|Analgesics|analgesics|mesh-ancestor
83790955|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
83790956|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790957|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790958|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83790959|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790960|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83790961|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83790962|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790963|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790964|NCT00023660|Celecoxib|celecoxib|mesh-list
83790965|NCT00023660|Fluorouracil|fluorouracil|mesh-list
83790966|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790967|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
83790968|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790969|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83790970|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83790971|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
83790972|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790973|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83790974|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83790975|NCT00023660|Analgesics|analgesics|mesh-ancestor
83790976|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
83790977|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83790978|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83790979|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83790980|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83790981|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83790982|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790983|NCT00051285|Enoximone|enoximone|mesh-list
82946168|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
83790984|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83790985|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
83790986|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83790987|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83790988|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790989|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790990|NCT00051285|Protective Agents|protective agents|mesh-ancestor
83790991|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83790992|NCT00023699|Gefitinib|gefitinib|mesh-list
83790993|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83790994|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83790995|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83790996|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83790997|NCT00051441|Benzydamine|benzydamine|mesh-list
83790998|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83790999|NCT00023738|Doxorubicin|doxorubicin|mesh-list
83791000|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83791001|NCT00023738|Ifosfamide|ifosfamide|mesh-list
83791002|NCT00023738|Dacarbazine|dacarbazine|mesh-list
83791003|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791004|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791005|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791006|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791007|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791008|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791009|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791010|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
83791011|NCT00397917|Folic Acid|folic acid|mesh-list
83791012|NCT00397917|Hematinics|hematinics|mesh-ancestor
83791013|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
83791014|NCT00397917|Vitamins|vitamins|mesh-ancestor
83791015|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
83791016|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791017|NCT00397956|Ertapenem|ertapenem|mesh-list
83791018|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83791019|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791020|NCT00023777|Cytarabine|cytarabine|mesh-list
83791021|NCT00023777|Daunorubicin|daunorubicin|mesh-list
83791022|NCT00023777|Sargramostim|sargramostim|mesh-list
83791023|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791024|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
83791025|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791026|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791027|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
83791028|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791029|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791030|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
83791031|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791032|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791033|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791034|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791035|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791036|NCT00023816|Carbendazim|carbendazim|mesh-list
83791037|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
83791038|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
83791039|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83791040|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791041|NCT00398034|Testosterone|testosterone|mesh-list
83791042|NCT00398034|Androgens|androgens|mesh-ancestor
83791043|NCT00398034|Hormones|hormones|mesh-ancestor
83791044|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83791045|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791046|NCT00023855|Doxorubicin|doxorubicin|mesh-list
83791047|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83791048|NCT00023855|Bortezomib|bortezomib|mesh-list
83791049|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791050|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791051|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791052|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791053|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791054|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791055|NCT00023894|Alvocidib|alvocidib|mesh-list
83791056|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791057|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791058|NCT00023894|Growth Substances|growth substances|mesh-ancestor
83791059|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791060|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83791061|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791062|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791064|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83791065|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
83791066|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791067|NCT00051597|Antibodies|antibodies|mesh-list
83791068|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83791069|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
83791070|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791071|NCT00023972|Gemcitabine|gemcitabine|mesh-list
83791072|NCT00023972|Exatecan|exatecan|mesh-list
83791073|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791074|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
83791075|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791076|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791077|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83791078|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791079|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791080|NCT00024011|Bortezomib|bortezomib|mesh-list
83791081|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791082|NCT00051753|Amoxicillin|amoxicillin|mesh-list
83791083|NCT00051753|Levofloxacin|levofloxacin|mesh-list
83791084|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
83791085|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
83791086|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83791087|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83791088|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791089|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83791090|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791091|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791092|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791093|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791094|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791095|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83791096|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83791097|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83791098|NCT00024050|Cyclosporine|cyclosporine|mesh-list
83791099|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
83791100|NCT00024050|Busulfan|busulfan|mesh-list
83791101|NCT00024050|Methotrexate|methotrexate|mesh-list
83791102|NCT00024050|Cyclosporins|cyclosporins|mesh-list
83791103|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791104|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
83791105|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791106|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791107|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791108|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
83791109|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791110|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791111|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791112|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83791113|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
83791114|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83791115|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791116|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
83791117|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
83791118|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791119|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83791120|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83791121|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
83791122|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791123|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83791124|NCT00024089|Gefitinib|gefitinib|mesh-list
83791125|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791126|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83791127|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791128|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791129|NCT00051831|Ritonavir|ritonavir|mesh-list
83791130|NCT00051831|Saquinavir|saquinavir|mesh-list
83791131|NCT00051831|Tenofovir|tenofovir|mesh-list
83791132|NCT00051831|Emtricitabine|emtricitabine|mesh-list
83791133|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
83791134|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83791135|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83791136|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
83791137|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791138|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791139|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83791140|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83791141|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
83791142|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791143|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83791144|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83791145|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83791146|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83791147|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83791148|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83791149|NCT00024128|Cyclosporine|cyclosporine|mesh-list
83791150|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
83791151|NCT00024128|Cyclosporins|cyclosporins|mesh-list
83791152|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83791153|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791154|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
83791155|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791156|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791157|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791158|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
83791159|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791160|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791161|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791162|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791163|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
83791164|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791165|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
83791166|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83791167|NCT00024206|Orantinib|orantinib|mesh-list
83791168|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83791169|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791170|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791171|NCT00024245|Probenecid|probenecid|mesh-list
83791172|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
83791173|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
83791174|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791175|NCT00051987|Bortezomib|bortezomib|mesh-list
83791176|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791177|NCT00024284|Carboplatin|carboplatin|mesh-list
83791178|NCT00024284|Irinotecan|irinotecan|mesh-list
83791179|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791180|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83791181|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791182|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791183|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791184|NCT00052026|Carvedilol|carvedilol|mesh-list
83791185|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83791186|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83791187|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
83791188|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83791189|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791190|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791191|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83791192|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
83791193|NCT00052026|Protective Agents|protective agents|mesh-ancestor
83791194|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83791195|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83791196|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83791197|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
83791198|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83791199|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83791200|NCT00024323|Cisplatin|cisplatin|mesh-list
83791201|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791202|NCT00024362|BBR 3464|bbr 3464|mesh-list
83791203|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791204|NCT00024401|Paclitaxel|paclitaxel|mesh-list
83791205|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791206|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791207|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791208|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791209|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791210|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791211|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
83791212|NCT00024440|Fludarabine|fludarabine|mesh-list
83791213|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
83791214|NCT00024440|Oblimersen|oblimersen|mesh-list
83791215|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791216|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
83791217|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791218|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791219|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791220|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
83791221|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791222|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791223|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791224|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791225|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
83791226|NCT00024518|Interferons|interferons|mesh-list
83791227|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
83791228|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791229|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
83791230|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791231|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
83791232|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791233|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
83791234|NCT00052221|Hematinics|hematinics|mesh-ancestor
83791235|NCT00024557|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83791236|NCT00024557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791237|NCT00052299|Cytarabine|cytarabine|mesh-list
83791238|NCT00052299|Etoposide|etoposide|mesh-list
83791239|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
83791240|NCT00052299|Idarubicin|idarubicin|mesh-list
83791241|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
83791242|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791243|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791244|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791245|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791246|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791247|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791248|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791249|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
83791250|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
83791251|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791252|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791253|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
83791254|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791255|NCT00052299|Analgesics|analgesics|mesh-ancestor
83791256|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
83791257|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791258|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791259|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83791260|NCT00052299|Immunotoxins|immunotoxins|mesh-ancestor
83791261|NCT00052299|Immunoconjugates|immunoconjugates|mesh-ancestor
83791262|NCT00052338|Carboplatin|carboplatin|mesh-list
83791263|NCT00052338|Gemcitabine|gemcitabine|mesh-list
83791264|NCT00052338|Bortezomib|bortezomib|mesh-list
83791265|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791266|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791267|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
83791268|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791269|NCT04733066|Teduglutide|teduglutide|mesh-list
83791270|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83791271|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83791272|NCT04733066|Protective Agents|protective agents|mesh-ancestor
83791273|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791274|NCT00052377|Aldesleukin|aldesleukin|mesh-list
83791275|NCT00052377|Interleukin-2|interleukin-2|mesh-list
83791276|NCT00052377|Interleukin-12|interleukin-12|mesh-list
83791277|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791278|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83791279|NCT00052377|Analgesics|analgesics|mesh-ancestor
83791280|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
83791281|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791282|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791283|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83791284|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83791285|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
83791286|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791287|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83791288|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
83791289|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83791290|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83791291|NCT00052377|Growth Substances|growth substances|mesh-ancestor
83791292|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791293|NCT00052416|Thalidomide|thalidomide|mesh-list
83791294|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791295|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
83791296|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791297|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
83791298|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83791299|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791300|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83791301|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83791302|NCT00052416|Growth Substances|growth substances|mesh-ancestor
83791303|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791304|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791305|NCT00052455|Vincristine|vincristine|mesh-list
83791306|NCT00052455|Temozolomide|temozolomide|mesh-list
83791307|NCT00052455|Lomustine|lomustine|mesh-list
83791308|NCT00052455|Procarbazine|procarbazine|mesh-list
83791309|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83133521|NCT05035472|Phenylephrine|phenylephrine|mesh-list
83791310|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791311|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791312|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791313|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791314|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791315|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791316|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
83791317|NCT00052494|Irinotecan|irinotecan|mesh-list
83791318|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
83791319|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791320|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83791321|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791322|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791323|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791324|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83791325|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
83791326|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
83791327|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
83791328|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791329|NCT00395174|Coagulants|coagulants|mesh-ancestor
83791330|NCT00395213|Norepinephrine|norepinephrine|mesh-list
83791331|NCT00395213|Serotonin|serotonin|mesh-list
83791332|NCT00395213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83791333|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83791334|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83791335|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83791336|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83791337|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791338|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791339|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
83791340|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
83791341|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791342|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83791343|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83791344|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
83791345|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83791346|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83791347|NCT00052611|Celecoxib|celecoxib|mesh-list
83791348|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83791349|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83791350|NCT00052611|Analgesics|analgesics|mesh-ancestor
83791351|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
83791352|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791353|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791354|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791355|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791356|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83791357|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83791358|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791359|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791360|NCT00395252|Gemcitabine|gemcitabine|mesh-list
83791361|NCT00395252|Cetuximab|cetuximab|mesh-list
83791362|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791363|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
83791364|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791365|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946557|NCT03101462|Vaccines|vaccines|mesh-list
83791366|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83791368|NCT00052689|Bortezomib|bortezomib|mesh-list
83791369|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791370|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
83791371|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791372|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791373|NCT00052728|Tamoxifen|tamoxifen|mesh-list
83791374|NCT00052728|Tipifarnib|tipifarnib|mesh-list
83791375|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83791376|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
83791377|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83791378|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791379|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83791380|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791381|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83791382|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83791383|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83791384|NCT00395369|Aprotinin|aprotinin|mesh-list
83791385|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
83791386|NCT00395369|Coagulants|coagulants|mesh-ancestor
83791387|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83791388|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83791389|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
83791390|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791391|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791392|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
83791393|NCT00052845|Docetaxel|docetaxel|mesh-list
83791394|NCT00052845|Estramustine|estramustine|mesh-list
83791395|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791396|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791397|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791398|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791399|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791400|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791401|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
83791402|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83791403|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83791404|NCT00052845|Protective Agents|protective agents|mesh-ancestor
83791405|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791406|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83791407|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791408|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83791409|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83791410|NCT00052845|Analgesics|analgesics|mesh-ancestor
83791411|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
83791412|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791413|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791414|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791415|NCT00024986|Tenofovir|tenofovir|mesh-list
83791416|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
83791417|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791418|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83791419|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83791420|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791421|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791422|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83791423|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83791424|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
83791425|NCT00052923|Carmustine|carmustine|mesh-list
83791426|NCT00052923|Rituximab|rituximab|mesh-list
83791427|NCT00052923|Etoposide|etoposide|mesh-list
83791428|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791429|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
83791430|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791431|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791432|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791433|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
83791434|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791435|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791436|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791437|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83791438|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791439|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791441|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791442|NCT00025064|Prednisolone|prednisolone|mesh-list
83791443|NCT00025064|Doxorubicin|doxorubicin|mesh-list
83791444|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83791445|NCT00025064|Etoposide|etoposide|mesh-list
83791446|NCT00025064|Vincristine|vincristine|mesh-list
83791447|NCT00025064|Melphalan|melphalan|mesh-list
83791448|NCT00025064|Ifosfamide|ifosfamide|mesh-list
83791449|NCT00025064|Dacarbazine|dacarbazine|mesh-list
83791450|NCT00025064|Bleomycin|bleomycin|mesh-list
83791451|NCT00025064|Vinblastine|vinblastine|mesh-list
83791452|NCT00025064|Procarbazine|procarbazine|mesh-list
83791453|NCT00025064|Chlorambucil|chlorambucil|mesh-list
83791454|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791455|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791456|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791457|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791458|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791459|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791460|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791461|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791462|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791463|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791464|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791465|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
83791466|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791467|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791468|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
83791469|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791470|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791471|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
83791472|NCT00025064|Hormones|hormones|mesh-ancestor
83791473|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83791474|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83791475|NCT00053001|Thalidomide|thalidomide|mesh-list
83791476|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
83791477|NCT00053001|Hematinics|hematinics|mesh-ancestor
83791478|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791479|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
83791480|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791481|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
83791482|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83791483|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791484|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83791485|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83791486|NCT00053001|Growth Substances|growth substances|mesh-ancestor
83791487|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791488|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791489|NCT00025103|Dactinomycin|dactinomycin|mesh-list
83791490|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
83791491|NCT00025103|Melphalan|melphalan|mesh-list
83791492|NCT00025103|Carboplatin|carboplatin|mesh-list
83791493|NCT00025103|Doxorubicin|doxorubicin|mesh-list
83791494|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83791495|NCT00025103|Etoposide|etoposide|mesh-list
83791496|NCT00025103|Vincristine|vincristine|mesh-list
83791497|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791498|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
83791499|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791500|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791501|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791502|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
83791503|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791504|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791505|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791506|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791507|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791508|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791509|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791510|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791511|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
82946682|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
83791512|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791513|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791514|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83791515|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791516|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83791517|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83791518|NCT00053040|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83791519|NCT00053040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791520|NCT00025142|Leucovorin|leucovorin|mesh-list
83791521|NCT00025142|Fluorouracil|fluorouracil|mesh-list
83791522|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
83791523|NCT00025142|Gefitinib|gefitinib|mesh-list
83791524|NCT00025142|Calcium|calcium|mesh-list
83791525|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
83791526|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83791527|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791528|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
83791529|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791530|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791531|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791532|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791533|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
83791534|NCT00025142|Antidotes|antidotes|mesh-ancestor
83791535|NCT00025142|Protective Agents|protective agents|mesh-ancestor
83791536|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
83791537|NCT00025142|Vitamins|vitamins|mesh-ancestor
83791538|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
83791539|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83791540|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791541|NCT00053118|Carboplatin|carboplatin|mesh-list
83791542|NCT00053118|Etoposide|etoposide|mesh-list
83791543|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791544|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791545|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791546|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791547|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791548|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791549|NCT00025181|Ipilimumab|ipilimumab|mesh-list
83791550|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
83791551|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83791552|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791553|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83791554|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791555|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83791556|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
83791557|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791558|NCT00025220|Thalidomide|thalidomide|mesh-list
83791559|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791560|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
83791561|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791562|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
83791563|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83791564|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791565|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83791566|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83791567|NCT00025220|Growth Substances|growth substances|mesh-ancestor
83791568|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791569|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791570|NCT00053157|Sargramostim|sargramostim|mesh-list
83791571|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
83791572|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791573|NCT00025298|Paclitaxel|paclitaxel|mesh-list
83791574|NCT00025298|Carboplatin|carboplatin|mesh-list
83791575|NCT00025298|Amifostine|amifostine|mesh-list
83791576|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791577|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791578|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791579|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791580|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791581|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791582|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83791583|NCT00025298|Protective Agents|protective agents|mesh-ancestor
83791584|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791585|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
83791586|NCT00053196|Methotrexate|methotrexate|mesh-list
83791587|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
83791588|NCT00053196|Fludarabine|fludarabine|mesh-list
83791589|NCT00053196|Busulfan|busulfan|mesh-list
83791590|NCT00053196|Allopurinol|allopurinol|mesh-list
83791591|NCT00053196|Tacrolimus|tacrolimus|mesh-list
83791592|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83791593|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83791594|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
83791595|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83791596|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791597|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791598|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
83791599|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791600|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791601|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
83791602|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791603|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83791604|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791605|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
83791606|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791607|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83791608|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83791609|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791610|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83791611|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
83791612|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83791613|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791614|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
83791615|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791616|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791617|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
83791618|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83791620|NCT00053196|Protective Agents|protective agents|mesh-ancestor
83791621|NCT00025337|Leucovorin|leucovorin|mesh-list
83791622|NCT00025337|Bevacizumab|bevacizumab|mesh-list
83791623|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83791624|NCT00025337|Fluorouracil|fluorouracil|mesh-list
83791625|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
83791626|NCT00025337|Antibodies|antibodies|mesh-list
83791627|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
83791628|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83791629|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
83791630|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791631|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83791632|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83791633|NCT00025337|Growth Substances|growth substances|mesh-ancestor
83791634|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791635|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791636|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
83791637|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
83791638|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791639|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791640|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791641|NCT00025337|Antidotes|antidotes|mesh-ancestor
83791642|NCT00025337|Protective Agents|protective agents|mesh-ancestor
83791643|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
83791644|NCT00025337|Vitamins|vitamins|mesh-ancestor
83791645|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
83791646|NCT00025376|Bortezomib|bortezomib|mesh-list
83791647|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791648|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
83791649|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791650|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83791651|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791652|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791653|NCT00025454|Tipifarnib|tipifarnib|mesh-list
83791654|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791655|NCT00025493|Docetaxel|docetaxel|mesh-list
83791656|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791657|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791658|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791659|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791660|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791661|NCT00025532|Antibodies|antibodies|mesh-list
83791662|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83791663|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
83791664|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791665|NCT00053430|Thalidomide|thalidomide|mesh-list
83791666|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791667|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
83791668|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791669|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
83791670|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82946830|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
83791671|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791672|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83791673|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83791674|NCT00053430|Growth Substances|growth substances|mesh-ancestor
83791675|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791676|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791677|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
83791678|NCT00025610|Carboplatin|carboplatin|mesh-list
83791679|NCT00025610|Doxorubicin|doxorubicin|mesh-list
83791680|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83791681|NCT00025610|Etoposide|etoposide|mesh-list
83791682|NCT00025610|Vincristine|vincristine|mesh-list
83791683|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791684|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
83791685|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791686|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791687|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791688|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
83791689|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791690|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791691|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791692|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791693|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791694|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791695|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791696|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791697|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791698|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791699|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791700|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
83791701|NCT00025649|Melphalan|melphalan|mesh-list
83791702|NCT00025649|Busulfan|busulfan|mesh-list
83791703|NCT00025649|Carboplatin|carboplatin|mesh-list
83791704|NCT00025649|Doxorubicin|doxorubicin|mesh-list
83791705|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83791706|NCT00025649|Etoposide|etoposide|mesh-list
83791707|NCT00025649|Vincristine|vincristine|mesh-list
83791708|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791709|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
83791710|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791711|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791712|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791713|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
83791714|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791715|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791716|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83791717|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83791718|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83791719|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791720|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791721|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791722|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791723|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791724|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791725|NCT00025688|Paclitaxel|paclitaxel|mesh-list
83791726|NCT00025688|Carboplatin|carboplatin|mesh-list
83791727|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791728|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791729|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791730|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791731|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791732|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791733|NCT00025727|Ritonavir|ritonavir|mesh-list
83791734|NCT00025727|Lopinavir|lopinavir|mesh-list
83791735|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
83791736|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83791737|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83791738|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
83791739|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791740|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946907|NCT03101930|Liraglutide|liraglutide|mesh-list
83791741|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83791742|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83791743|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
83791744|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791745|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83791746|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83791747|NCT00053820|Interferons|interferons|mesh-list
83791748|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
83791749|NCT00053820|Aldesleukin|aldesleukin|mesh-list
83791750|NCT00053820|Fluorouracil|fluorouracil|mesh-list
83791751|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
83791752|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791753|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791754|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791755|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791756|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
83791757|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791758|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
83791759|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791760|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83791761|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83791762|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83791763|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
83791764|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83791765|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791766|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
83791767|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83791768|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791769|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791770|NCT00053937|Pirfenidone|pirfenidone|mesh-list
83791771|NCT00053937|Analgesics|analgesics|mesh-ancestor
83791772|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
83791773|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791774|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791775|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83791776|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83791777|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791778|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791779|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791780|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
83791781|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83791782|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83791783|NCT00053976|Prednisolone|prednisolone|mesh-list
83791784|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
83791785|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83791786|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
83791787|NCT00053976|Daclizumab|daclizumab|mesh-list
83791788|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791789|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
83791790|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
83791791|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791792|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791793|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83791794|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
83791795|NCT00053976|Hormones|hormones|mesh-ancestor
83791796|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83791797|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83791798|NCT00053976|Protective Agents|protective agents|mesh-ancestor
83791799|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83791800|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791801|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791802|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
83791803|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
83791804|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791805|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
83791806|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
83791807|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
83791808|NCT00054054|Docetaxel|docetaxel|mesh-list
83791809|NCT00054054|Fluorouracil|fluorouracil|mesh-list
83791810|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791811|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791812|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791813|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791814|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791815|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
83791816|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791817|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791818|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
83791819|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791820|NCT00026078|Docetaxel|docetaxel|mesh-list
83791821|NCT00026078|Ifosfamide|ifosfamide|mesh-list
83791822|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791823|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791824|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791826|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791827|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83791828|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
83791829|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83791830|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83791831|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791832|NCT00026156|Docetaxel|docetaxel|mesh-list
83791833|NCT00026156|Vinorelbine|vinorelbine|mesh-list
83791834|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791835|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791836|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791837|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791838|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791839|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791840|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83791841|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83791842|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
83791843|NCT00026195|Irinotecan|irinotecan|mesh-list
83791844|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83791845|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791846|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791847|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791848|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791849|NCT00054210|Paclitaxel|paclitaxel|mesh-list
83791850|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83791851|NCT00054210|Carboplatin|carboplatin|mesh-list
83791852|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83791853|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83791854|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791855|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
83791856|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
83791857|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
83791858|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791859|NCT00026234|Dexamethasone|dexamethasone|mesh-list
83791860|NCT00026234|Capecitabine|capecitabine|mesh-list
83791861|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
83791862|NCT00026234|Floxuridine|floxuridine|mesh-list
83791863|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791864|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
83791865|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
83791866|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791867|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791868|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83791869|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
83791870|NCT00026234|Hormones|hormones|mesh-ancestor
83791871|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83791872|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83791873|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791874|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791875|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
83791876|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791877|NCT00054288|Gemcitabine|gemcitabine|mesh-list
83791878|NCT00054288|Irinotecan|irinotecan|mesh-list
83791879|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791880|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
83791881|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791882|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791883|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83791884|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791885|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791886|NCT00026273|Leucovorin|leucovorin|mesh-list
83791887|NCT00026273|Fluorouracil|fluorouracil|mesh-list
83791888|NCT00026273|Irinotecan|irinotecan|mesh-list
83791889|NCT00026273|Calcium|calcium|mesh-list
83791890|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
83791891|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83791892|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791893|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
83791894|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791895|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83791896|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791897|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83791898|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
83791899|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83791900|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791902|NCT00026273|Antidotes|antidotes|mesh-ancestor
83791903|NCT00026273|Protective Agents|protective agents|mesh-ancestor
83791904|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
83791905|NCT00026273|Vitamins|vitamins|mesh-ancestor
83791906|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
83791907|NCT00054405|Aldesleukin|aldesleukin|mesh-list
83791908|NCT00054405|Interleukin-2|interleukin-2|mesh-list
83791909|NCT00054405|Interleukin-12|interleukin-12|mesh-list
83791910|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791911|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83791912|NCT00054405|Analgesics|analgesics|mesh-ancestor
83791913|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
83791914|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791915|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791916|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83791917|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83791918|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
83791919|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83791920|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83791921|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
83791922|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83791923|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83791924|NCT00054405|Growth Substances|growth substances|mesh-ancestor
83791925|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83791926|NCT00026351|Rituximab|rituximab|mesh-list
83791927|NCT00026351|Pentostatin|pentostatin|mesh-list
83791928|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83791929|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791930|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
83791931|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791932|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791933|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83791934|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791935|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791936|NCT00054444|Topotecan|topotecan|mesh-list
83791937|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791938|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83791939|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83791940|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791941|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791942|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
83791943|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791944|NCT00054483|Bortezomib|bortezomib|mesh-list
83791945|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791946|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
83791947|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791948|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83791949|NCT00026468|Protective Agents|protective agents|mesh-ancestor
83791950|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791951|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83791952|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83791953|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791954|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83791955|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83791956|NCT00026468|Analgesics|analgesics|mesh-ancestor
83791957|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
83791958|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791959|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791960|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83791961|NCT00054522|Calcitriol|calcitriol|mesh-list
83791962|NCT00054522|Dexamethasone|dexamethasone|mesh-list
83791963|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83791964|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
83791965|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
83791966|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83791967|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791968|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83791969|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
83791970|NCT00054522|Hormones|hormones|mesh-ancestor
83791971|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83791972|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83791973|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791974|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83791975|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83791976|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83791977|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83791978|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83791979|NCT00054522|Vitamins|vitamins|mesh-ancestor
83791980|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
83791981|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83791982|NCT00026585|Tamoxifen|tamoxifen|mesh-list
83791983|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83791984|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
83791985|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83791986|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791987|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83791988|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83791989|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83791990|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83791991|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83791992|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83791993|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83791994|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
83791995|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83791996|NCT00054600|Methoxsalen|methoxsalen|mesh-list
83791997|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83791998|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
83791999|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
83792000|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792001|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83792002|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
83792003|NCT00026819|Rofecoxib|rofecoxib|mesh-list
83792004|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83792005|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83792006|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792007|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792008|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83792009|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83792010|NCT00026819|Analgesics|analgesics|mesh-ancestor
83792011|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
83792012|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792013|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792014|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83792015|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792016|NCT00054834|Epratuzumab|epratuzumab|mesh-list
83792017|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83792018|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792019|NCT00054873|Fluorouracil|fluorouracil|mesh-list
83792020|NCT00054873|Tezacitabine|tezacitabine|mesh-list
83792021|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
83792022|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792023|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792024|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792025|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792026|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
83792027|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792028|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792029|NCT00398385|Gemcitabine|gemcitabine|mesh-list
83792030|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792031|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792032|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
83792033|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792034|NCT00027014|Fentanyl|fentanyl|mesh-list
83792035|NCT00027014|Oxycodone|oxycodone|mesh-list
83792036|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83792037|NCT00027014|Narcotics|narcotics|mesh-ancestor
83792038|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792039|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792040|NCT00027014|Analgesics|analgesics|mesh-ancestor
83792041|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
83792042|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792043|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83792044|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83792045|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
83792046|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
83792047|NCT00398424|Cisplatin|cisplatin|mesh-list
83792048|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792049|NCT00027053|Trazodone|trazodone|mesh-list
83792050|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83792051|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83792052|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792053|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792054|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792055|NCT00027053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83792056|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83792057|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792058|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792059|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792060|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
83792061|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83792062|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
83792063|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
83792064|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83792065|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792066|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
83792067|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
83792068|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792069|NCT00055302|Anastrozole|anastrozole|mesh-list
83792070|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83792071|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792072|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83792073|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83792074|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792075|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792076|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83792077|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
83792078|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792079|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792080|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
83792081|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792082|NCT00055341|Ribavirin|ribavirin|mesh-list
83792083|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83792084|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
83792085|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792086|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
83792087|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792088|NCT00027287|Vitamin E|vitamin e|mesh-list
83792089|NCT00027287|Vitamins|vitamins|mesh-ancestor
83792090|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
83792091|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792165|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792166|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83792167|NCT00055653|Protective Agents|protective agents|mesh-ancestor
83792168|NCT00055770|Docetaxel|docetaxel|mesh-list
83792169|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83792170|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792171|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792172|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792173|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792174|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792175|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792176|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792177|NCT00027638|Thalidomide|thalidomide|mesh-list
83792178|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792179|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
83792180|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792181|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
83792182|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83792183|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792184|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792185|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792186|NCT00027638|Growth Substances|growth substances|mesh-ancestor
83792187|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792188|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792189|NCT00055809|Interferons|interferons|mesh-list
83792190|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
83792191|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
83792192|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83792193|NCT00055809|Bevacizumab|bevacizumab|mesh-list
83792194|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83792195|NCT00055809|Antibodies|antibodies|mesh-list
83792196|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
83792197|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83792198|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792199|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792200|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792201|NCT00055809|Growth Substances|growth substances|mesh-ancestor
83792202|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792203|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792204|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
83792205|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
83792206|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792207|NCT00027677|Halofuginone|halofuginone|mesh-list
83792208|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792209|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
83792210|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83792211|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83792212|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792213|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83792214|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792215|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792216|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792217|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792218|NCT00027677|Growth Substances|growth substances|mesh-ancestor
83792219|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792220|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792221|NCT00027716|Bortezomib|bortezomib|mesh-list
83792222|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792223|NCT00055887|Paclitaxel|paclitaxel|mesh-list
83792224|NCT00055887|Vinorelbine|vinorelbine|mesh-list
83792225|NCT00055887|Carboplatin|carboplatin|mesh-list
83792226|NCT00055887|Gemcitabine|gemcitabine|mesh-list
83792227|NCT00055887|Efaproxiral|efaproxiral|mesh-list
83792228|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83792229|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792230|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792231|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792232|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792233|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792234|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792235|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
83792236|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
83792237|NCT00026039|Estrogens|estrogens|mesh-list
83792238|NCT00026039|Hormones|hormones|mesh-ancestor
83792239|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792240|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792241|NCT00027404|Fluoxetine|fluoxetine|mesh-list
83792242|NCT00027404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83792243|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83792244|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792245|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792246|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792247|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
83792248|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792249|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83792250|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
83792251|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792252|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83792253|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83792254|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792255|NCT00055965|Carboplatin|carboplatin|mesh-list
83792256|NCT00055965|Gemcitabine|gemcitabine|mesh-list
83792257|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792258|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792259|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
83792260|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792261|NCT00027833|Leucovorin|leucovorin|mesh-list
83792262|NCT00027833|Fluorouracil|fluorouracil|mesh-list
83792263|NCT00027833|Irinotecan|irinotecan|mesh-list
83792264|NCT00027833|Calcium|calcium|mesh-list
83792265|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
83792266|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83792267|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792268|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
83792269|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792270|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792271|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792272|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792273|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
83792274|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83792275|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792276|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947432|NCT03430986|Lidocaine|lidocaine|mesh-list
82947433|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
83792277|NCT00027833|Antidotes|antidotes|mesh-ancestor
83792278|NCT00027833|Protective Agents|protective agents|mesh-ancestor
83792279|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
83792280|NCT00027833|Vitamins|vitamins|mesh-ancestor
83792281|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
83792282|NCT00027872|Tipifarnib|tipifarnib|mesh-list
83792283|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792284|NCT00027911|Sargramostim|sargramostim|mesh-list
83792285|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
83792286|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792287|NCT00027989|Gemcitabine|gemcitabine|mesh-list
83792288|NCT00027989|Doxorubicin|doxorubicin|mesh-list
83792289|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83792290|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792291|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
83792292|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792293|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792294|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83792295|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83792296|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792297|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792298|NCT00056004|Zileuton|zileuton|mesh-list
83792299|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83792300|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83792301|NCT00056004|Analgesics|analgesics|mesh-ancestor
83792302|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
83792303|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792304|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792305|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83792306|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792307|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83792308|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792309|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792310|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83792311|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83792312|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792313|NCT00028028|Sirolimus|sirolimus|mesh-list
83792314|NCT00028028|Temsirolimus|temsirolimus|mesh-list
83792315|NCT00028028|MTOR Inhibitors|mtor inhibitors|mesh-list
83792316|NCT00028028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792317|NCT00028028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792318|NCT00028028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792319|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792320|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
83792321|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792322|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792323|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83792324|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792325|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83792326|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
83792327|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83792328|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792329|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792330|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792331|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83792332|NCT00056082|Celecoxib|celecoxib|mesh-list
83792333|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83792334|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83792335|NCT00056082|Analgesics|analgesics|mesh-ancestor
83792336|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
83792337|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792338|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792339|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83792340|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792341|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83792342|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83792343|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792344|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792345|NCT04730973|Evolocumab|evolocumab|mesh-list
83792346|NCT04730973|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83792347|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83792348|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83792349|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
83792350|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792351|NCT04730973|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83792352|NCT04730973|Protease Inhibitors|protease inhibitors|mesh-ancestor
83792353|NCT04730973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792354|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83792355|NCT00028418|Clofarabine|clofarabine|mesh-list
83792356|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792357|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
83792358|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792359|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792360|NCT00028496|Metronidazole|metronidazole|mesh-list
83792361|NCT00028496|Molgramostim|molgramostim|mesh-list
83792362|NCT00028496|Vaccines|vaccines|mesh-list
83792363|NCT00028496|Sargramostim|sargramostim|mesh-list
83792364|NCT00028496|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
83792365|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
83792366|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792367|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792368|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792369|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83792370|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83792371|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83792372|NCT00028496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83792373|NCT00028535|Paclitaxel|paclitaxel|mesh-list
83792374|NCT00028535|Trastuzumab|trastuzumab|mesh-list
83792375|NCT00028535|Interleukin-12|interleukin-12|mesh-list
83792376|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83792377|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792378|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792379|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792380|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792381|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792382|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83792383|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83792384|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
83792385|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792386|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792387|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792388|NCT00028535|Growth Substances|growth substances|mesh-ancestor
83792389|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792390|NCT00056277|Lamotrigine|lamotrigine|mesh-list
83792391|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
83792392|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83792393|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792394|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792395|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83792396|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792397|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83792398|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83792399|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792400|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792401|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83792402|NCT00028574|Gabapentin|gabapentin|mesh-list
83792403|NCT00028574|Analgesics|analgesics|mesh-ancestor
83792404|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
83792405|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792406|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792407|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
83792408|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83792409|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83792410|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792411|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792412|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83792413|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83792414|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792415|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792416|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
83792417|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
83792418|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
83792419|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
83792420|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83792421|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83792422|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792423|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792424|NCT00056433|Urological Agents|urological agents|mesh-ancestor
83792425|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792426|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
83792427|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83792429|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83792430|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
83792431|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792432|NCT00028652|Interleukin-12|interleukin-12|mesh-list
83792433|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83792434|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
83792435|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792436|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792437|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792438|NCT00028652|Growth Substances|growth substances|mesh-ancestor
83792439|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792440|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792441|NCT00028691|Chlorambucil|chlorambucil|mesh-list
83792442|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83792443|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
83792444|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792445|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792446|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
83792447|NCT00028730|Thiotepa|thiotepa|mesh-list
83792448|NCT00028730|Fludarabine|fludarabine|mesh-list
83792449|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
83792450|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83792451|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792452|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
83792453|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792454|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792455|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83792456|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
83792457|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792458|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792459|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83792460|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792461|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
83792462|NCT00028847|Cytarabine|cytarabine|mesh-list
83792463|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
83792464|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792465|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
83792466|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792467|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792468|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
83792469|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792470|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792471|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
83792472|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792473|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792474|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792475|NCT00028886|Interferons|interferons|mesh-list
83792476|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
83792477|NCT00028886|Thalidomide|thalidomide|mesh-list
83792478|NCT00028886|Dexamethasone|dexamethasone|mesh-list
83792479|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
83792480|NCT00028886|Melphalan|melphalan|mesh-list
83792481|NCT00028886|Doxorubicin|doxorubicin|mesh-list
83792482|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83792483|NCT00028886|Vincristine|vincristine|mesh-list
83792484|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792485|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
83792486|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792487|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792488|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83792489|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
83792490|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792491|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792492|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83792493|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83792494|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
83792495|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
83792496|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792497|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83792498|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
83792499|NCT00028886|Hormones|hormones|mesh-ancestor
83792500|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792501|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83792502|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83792503|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83792504|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792505|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792506|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
83792507|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792508|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83792509|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792510|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792511|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792512|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
83792513|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83792514|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792515|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792516|NCT00028886|Growth Substances|growth substances|mesh-ancestor
83792517|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792518|NCT00028925|Carboplatin|carboplatin|mesh-list
83792520|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792521|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83792522|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792523|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792524|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792525|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
83792526|NCT00398463|Tirofiban|tirofiban|mesh-list
83792527|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83792528|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83792529|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792530|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83792531|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83792532|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
83792533|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792534|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83792535|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792536|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
83792537|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792538|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
83792539|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83792540|NCT00398463|Protective Agents|protective agents|mesh-ancestor
83792541|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
83792542|NCT00028964|Doxorubicin|doxorubicin|mesh-list
83792543|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83792544|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792545|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
83792546|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792547|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792548|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83792549|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
83792550|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792551|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792552|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83792553|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83792554|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83792555|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792556|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792557|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83792558|NCT00423501|Incretins|incretins|mesh-ancestor
83792559|NCT00423501|Hormones|hormones|mesh-ancestor
83792560|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792561|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792562|NCT00029003|Gefitinib|gefitinib|mesh-list
83792563|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792564|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792565|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792566|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792567|NCT00029042|Infliximab|infliximab|mesh-list
83792568|NCT00029042|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83792569|NCT00029042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83792570|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
83792571|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83792572|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792573|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
83792574|NCT00423540|Analgesics|analgesics|mesh-ancestor
83792575|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
83792576|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792577|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947730|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83792578|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
83792579|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792580|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83792581|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
83792582|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83792583|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792584|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792585|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83792586|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
83792587|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83792588|NCT00029159|Estrogens|estrogens|mesh-list
83792589|NCT00029159|Androgens|androgens|mesh-list
83792590|NCT00029159|Hormones|hormones|mesh-ancestor
83792591|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792592|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792593|NCT00423696|Leucovorin|leucovorin|mesh-list
83792594|NCT00423696|Bevacizumab|bevacizumab|mesh-list
83792595|NCT00423696|Fluorouracil|fluorouracil|mesh-list
83792596|NCT00423696|Capecitabine|capecitabine|mesh-list
83792597|NCT00423696|Irinotecan|irinotecan|mesh-list
83792598|NCT00423696|Calcium|calcium|mesh-list
83792599|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
83792600|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83792601|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792602|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792603|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792604|NCT00423696|Growth Substances|growth substances|mesh-ancestor
83792605|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792606|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792607|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83792608|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
83792609|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792610|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792611|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792612|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
83792613|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83792614|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792615|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792616|NCT00423696|Antidotes|antidotes|mesh-ancestor
83792617|NCT00423696|Protective Agents|protective agents|mesh-ancestor
83792618|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
83792619|NCT00423696|Vitamins|vitamins|mesh-ancestor
83792620|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
83792621|NCT00029315|Plasminogen|plasminogen|mesh-list
83792622|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83792623|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83792624|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83792625|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792626|NCT00056823|Ranibizumab|ranibizumab|mesh-list
83792627|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792628|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792629|NCT00056823|Growth Substances|growth substances|mesh-ancestor
83792630|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792631|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792632|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792633|NCT00029627|Yohimbine|yohimbine|mesh-list
83792634|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
83792635|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
83792636|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792637|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792638|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83792639|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83792640|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83792641|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83792642|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792643|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792644|NCT00029627|Urological Agents|urological agents|mesh-ancestor
83792645|NCT02970084|Vitamin K|vitamin k|mesh-list
83792646|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
83792647|NCT02970084|Vitamins|vitamins|mesh-ancestor
83792648|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
83792649|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792650|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83792651|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83792652|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792653|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
83792654|NCT02970084|Coagulants|coagulants|mesh-ancestor
83792655|NCT00056979|Fludarabine|fludarabine|mesh-list
83792656|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
83173256|NCT02359552|Protective Agents|protective agents|mesh-ancestor
83792657|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792658|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83792659|NCT00029822|Alfuzosin|alfuzosin|mesh-list
83792660|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83792661|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83792662|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83792663|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
83792664|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792665|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792666|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792667|NCT00029822|Urological Agents|urological agents|mesh-ancestor
83792668|NCT00395681|Propofol|propofol|mesh-list
83792669|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83792670|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792671|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792672|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83792673|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
83792674|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
83792675|NCT00395720|Vaccines|vaccines|mesh-list
83792676|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
83792677|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792678|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
83792679|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83792680|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83792681|NCT00395915|Aripiprazole|aripiprazole|mesh-list
83792682|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
83792683|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792684|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83792685|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83792686|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792687|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792688|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
83792689|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
83792690|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792691|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792692|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83792693|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83792694|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
83792695|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83792696|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83792697|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83792698|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83792699|NCT00029861|Rimonabant|rimonabant|mesh-list
83792700|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83792701|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83792702|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83792703|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792704|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792705|NCT00029861|Hormones|hormones|mesh-ancestor
83792706|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792707|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792708|NCT00057369|Dalbavancin|dalbavancin|mesh-list
83792709|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83792710|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792711|NCT00057408|Olanzapine|olanzapine|mesh-list
83792712|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
83792713|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
83792714|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
83792715|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792716|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792717|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83792718|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83792719|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792720|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792721|NCT00057408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83792722|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83792723|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792724|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792725|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792726|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
83792727|NCT00030056|Molgramostim|molgramostim|mesh-list
83792728|NCT00030056|Sargramostim|sargramostim|mesh-list
83792729|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
83792730|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792731|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792733|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
83792734|NCT00057447|Rituximab|rituximab|mesh-list
83792735|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83792736|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792737|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
83792738|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792739|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792740|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
83792741|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792742|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83792743|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792744|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792745|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792746|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792747|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792748|NCT00030173|Epothilones|epothilones|mesh-list
83792749|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
83792750|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792751|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792752|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792753|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792754|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792755|NCT00057564|Thalidomide|thalidomide|mesh-list
83792756|NCT00057564|Dexamethasone|dexamethasone|mesh-list
83792757|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
83792758|NCT00057564|BB 1101|bb 1101|mesh-list
83792759|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83792760|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
83792761|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
83792762|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792763|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792764|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83792765|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
83792766|NCT00057564|Hormones|hormones|mesh-ancestor
83792767|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83792768|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83792769|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792770|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
83792771|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792772|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792773|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792774|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
83792775|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
83792776|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83792777|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83792778|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83792779|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83792780|NCT00057564|Growth Substances|growth substances|mesh-ancestor
83792781|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792782|NCT00030368|Paclitaxel|paclitaxel|mesh-list
83792783|NCT00030368|Bortezomib|bortezomib|mesh-list
83792784|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83792785|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792786|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792787|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792788|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792789|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792790|NCT00030407|Celecoxib|celecoxib|mesh-list
83792791|NCT00030407|Docetaxel|docetaxel|mesh-list
83792792|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792793|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792794|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792795|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792796|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792797|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83792798|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83792799|NCT00030407|Analgesics|analgesics|mesh-ancestor
83792800|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
82947961|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83792801|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792802|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792803|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83792804|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792805|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83792806|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83792807|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792808|NCT00057642|Sertraline|sertraline|mesh-list
83792809|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83792810|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
83792811|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792812|NCT00057642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83792813|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83792814|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792815|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792816|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792817|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
83792818|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792819|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83792820|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83792821|NCT00030446|Carboplatin|carboplatin|mesh-list
83792822|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83792823|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792824|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792825|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792826|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792827|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83792828|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792829|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792830|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792831|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792832|NCT00057720|Doxorubicin|doxorubicin|mesh-list
83792833|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83792834|NCT00057720|Topotecan|topotecan|mesh-list
83792835|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83792836|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792837|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83792838|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792839|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792840|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792841|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83792842|NCT00030524|Gefitinib|gefitinib|mesh-list
83792843|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792844|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792845|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792846|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792847|NCT00030563|Irinotecan|irinotecan|mesh-list
83792848|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83792849|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792850|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792851|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792852|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792853|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
83792854|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83792855|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
83792856|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792857|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
83792858|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792859|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
83792860|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83792861|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83792862|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792863|NCT00057759|Urological Agents|urological agents|mesh-ancestor
83792864|NCT00030641|Docetaxel|docetaxel|mesh-list
83792865|NCT00030641|Oblimersen|oblimersen|mesh-list
83792866|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792867|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792868|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792869|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792870|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792871|NCT00057798|Gemcitabine|gemcitabine|mesh-list
83792872|NCT00057798|Vinorelbine|vinorelbine|mesh-list
83792873|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792874|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
83792875|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792876|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792877|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83792878|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792879|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792880|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792881|NCT02969733|Lidocaine|lidocaine|mesh-list
83792882|NCT02969733|Ketamine|ketamine|mesh-list
83792883|NCT02969733|Analgesics|analgesics|mesh-ancestor
83792884|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
83792885|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83792886|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792887|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83792888|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83792889|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
83792890|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
83792891|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83792892|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83792893|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83792894|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792895|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792896|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
83792897|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83792898|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83792899|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83792900|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792901|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
83792902|NCT00030719|Melphalan|melphalan|mesh-list
83792903|NCT00030719|Busulfan|busulfan|mesh-list
83792904|NCT00030719|Carboplatin|carboplatin|mesh-list
83792905|NCT00030719|Etoposide|etoposide|mesh-list
83792906|NCT00030719|Vincristine|vincristine|mesh-list
83792907|NCT00030719|Dinutuximab|dinutuximab|mesh-list
83792908|NCT00030719|Isotretinoin|isotretinoin|mesh-list
83792909|NCT00030719|Antibodies|antibodies|mesh-list
83792910|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83792911|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792912|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
83792913|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792914|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792915|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83792916|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
83792917|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792918|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792919|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83792920|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83792921|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83792922|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792923|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792924|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
83792925|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
83792926|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
83792927|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
83792928|NCT00030758|Lenograstim|lenograstim|mesh-list
83792929|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83792930|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
83792931|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792932|NCT04730895|Tretinoin|tretinoin|mesh-list
83792933|NCT04730895|Isotretinoin|isotretinoin|mesh-list
83792934|NCT04730895|Vaccines|vaccines|mesh-list
83792935|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
83792936|NCT04730895|Paraproteins|paraproteins|mesh-list
83792937|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
83792938|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792939|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792940|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
83792941|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
83792942|NCT00030797|Irinotecan|irinotecan|mesh-list
83792943|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83792944|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83792945|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792946|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792947|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792948|NCT00030875|Bortezomib|bortezomib|mesh-list
83792949|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792950|NCT00058071|Amifostine|amifostine|mesh-list
83792951|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83792952|NCT00058071|Protective Agents|protective agents|mesh-ancestor
83792953|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792954|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83792955|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83792956|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
83792957|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83792958|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83792959|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83792960|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792961|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83792962|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792963|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83792964|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
83792965|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83792966|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83792967|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83792968|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83792969|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
83792970|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83792971|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83792972|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83792973|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83792974|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83792975|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792976|NCT00058149|Gemcitabine|gemcitabine|mesh-list
83792977|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
83792978|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792979|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
83792980|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792981|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792982|NCT00058227|Rituximab|rituximab|mesh-list
83792983|NCT00058227|Fludarabine|fludarabine|mesh-list
83792984|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
83792985|NCT00058227|Alvocidib|alvocidib|mesh-list
83792986|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83792987|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83792988|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
83792989|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83792990|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83792991|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83792992|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
83792993|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83792994|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83792995|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
83792996|NCT00058227|Growth Substances|growth substances|mesh-ancestor
83792997|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83792998|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83792999|NCT00031070|Cyclosporine|cyclosporine|mesh-list
83793000|NCT00031070|Lamivudine|lamivudine|mesh-list
83793001|NCT00031070|Zidovudine|zidovudine|mesh-list
83793002|NCT00031070|Efavirenz|efavirenz|mesh-list
83793003|NCT00031070|Abacavir|abacavir|mesh-list
83793004|NCT00031070|Vaccines|vaccines|mesh-list
83793005|NCT00031070|Cyclosporins|cyclosporins|mesh-list
83793006|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83793007|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
83793008|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793009|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793010|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793011|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793012|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
83793013|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793014|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
83793015|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793016|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83793017|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83793018|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83793019|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
83793020|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83793021|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83793022|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
83793023|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83793024|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83793025|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83793026|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83793027|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82948199|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
83793029|NCT00058305|Vincristine|vincristine|mesh-list
83793030|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
83793031|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793032|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793033|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793034|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793035|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793036|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793037|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83793038|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
83793039|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793040|NCT00058461|Cytarabine|cytarabine|mesh-list
83793041|NCT00058461|Rituximab|rituximab|mesh-list
83793042|NCT00058461|Carboplatin|carboplatin|mesh-list
83793043|NCT00058461|Methotrexate|methotrexate|mesh-list
83793044|NCT00058461|Etoposide|etoposide|mesh-list
83793045|NCT00058461|Ifosfamide|ifosfamide|mesh-list
83793046|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793047|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793048|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
83793049|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793050|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793051|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83793052|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
83793053|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83793054|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793055|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
83793056|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793057|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
83793058|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793059|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83793060|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793061|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83793062|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793063|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793064|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793065|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
83793066|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793067|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83793068|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
83793069|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
83793070|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793071|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
83793072|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793073|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793074|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83793075|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
83793076|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793077|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793078|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83793079|NCT04711889|Urinastatin|urinastatin|mesh-list
83793080|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83793081|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83793082|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
83793083|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793084|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793085|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83793086|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83793087|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
83793088|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793089|NCT00031109|Antacids|antacids|mesh-ancestor
83793090|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793091|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83793092|NCT00031148|Mitogens|mitogens|mesh-list
83793093|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793094|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793095|NCT00031187|Docetaxel|docetaxel|mesh-list
83793096|NCT00031187|Doxorubicin|doxorubicin|mesh-list
83793097|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
83793098|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793099|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793100|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793101|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
82948275|NCT01156909|Rituximab|rituximab|mesh-list
83793102|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793103|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83793104|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793105|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793106|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793107|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
83793108|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793109|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83793110|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
83793111|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793112|NCT00058890|Gabapentin|gabapentin|mesh-list
83793113|NCT00058890|Analgesics|analgesics|mesh-ancestor
83793114|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
83793115|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793116|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793117|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
83793118|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83793119|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83793120|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83793121|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83793122|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83793123|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83793124|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793125|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793126|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
83793127|NCT00058929|Treprostinil|treprostinil|mesh-list
83793128|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83793129|NCT00396071|Vildagliptin|vildagliptin|mesh-list
83793130|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83793131|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793132|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83793133|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
83793134|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793135|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793136|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83793137|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83793138|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83793139|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83793140|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793141|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793142|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793143|NCT00058968|Analgesics|analgesics|mesh-ancestor
83793144|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
83793145|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793146|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
83793147|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83793148|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
83793149|NCT00396227|Pioglitazone|pioglitazone|mesh-list
83793150|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
83793151|NCT00396227|Vildagliptin|vildagliptin|mesh-list
83793152|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83793153|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83793154|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793155|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83793156|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
83793157|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793158|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793159|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
83793160|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83793161|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83793162|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83793163|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83793164|NCT00031499|Azithromycin|azithromycin|mesh-list
83793165|NCT00031499|Doxycycline|doxycycline|mesh-list
83793166|NCT00031499|Penicillins|penicillins|mesh-list
83793167|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83793168|NCT00031499|Penicillin G|penicillin g|mesh-list
83793169|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
83793170|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83793171|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793172|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
83793173|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83793174|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83793175|NCT00059358|Interferons|interferons|mesh-list
83793176|NCT00059358|Ribavirin|ribavirin|mesh-list
83793177|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
83793178|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
83793179|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83793180|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793181|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
83793182|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793183|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
83793184|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793185|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
83793186|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793187|NCT00031577|Paclitaxel|paclitaxel|mesh-list
83793188|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793189|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793190|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793191|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793192|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793193|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793194|NCT00031616|Brivudine|brivudine|mesh-list
83793195|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
83793196|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
83793197|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793198|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793199|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793200|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83793201|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
83793202|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793203|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
83793204|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793205|NCT00031655|Cyclosporine|cyclosporine|mesh-list
83793206|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
83793207|NCT00031655|Fludarabine|fludarabine|mesh-list
83793208|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
83793209|NCT00031655|Cyclosporins|cyclosporins|mesh-list
83793210|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793211|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793212|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
83793213|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793214|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793215|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
83793216|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793217|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793218|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
83793219|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793220|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
83793221|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793222|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83793223|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83793224|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83793225|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
83793226|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83793227|NCT00059592|Valacyclovir|valacyclovir|mesh-list
83793228|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
83793229|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793230|NCT00031733|Interleukin-12|interleukin-12|mesh-list
83793231|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83793232|NCT00031733|Sargramostim|sargramostim|mesh-list
83793233|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
83793234|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
83793235|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
83793236|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793237|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793238|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83793239|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83793240|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83793241|NCT00031733|Growth Substances|growth substances|mesh-ancestor
83793242|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
83793243|NCT00031733|Antacids|antacids|mesh-ancestor
83793244|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793245|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83793246|NCT02969265|Amlodipine|amlodipine|mesh-list
83793247|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
83793248|NCT02969265|Candesartan|candesartan|mesh-list
83793249|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83793250|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83793251|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83793252|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793253|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83793254|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793255|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
83793256|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83793257|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83793258|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83793259|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83793260|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
83793261|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793262|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793263|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83793264|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83793265|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83793266|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83793267|NCT00031850|Goserelin|goserelin|mesh-list
83793268|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83793269|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793270|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83793271|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
83793272|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793273|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793274|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83793275|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83793276|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83793277|NCT00059631|Bortezomib|bortezomib|mesh-list
83793278|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
83793279|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793280|NCT00059631|Analgesics|analgesics|mesh-ancestor
83793281|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
83793282|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793283|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793284|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793285|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793286|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793287|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793288|NCT00031889|Exemestane|exemestane|mesh-list
83793289|NCT00031889|Bicalutamide|bicalutamide|mesh-list
83793290|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793291|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83793292|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83793293|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793294|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793295|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83793296|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
83793297|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793298|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793299|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
83793300|NCT00031928|Mafosfamide|mafosfamide|mesh-list
83793301|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83793302|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
83793303|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793304|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793305|NCT00031967|Melatonin|melatonin|mesh-list
83793306|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
83793307|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793308|NCT00031967|Protective Agents|protective agents|mesh-ancestor
83793309|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793310|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83793311|NCT00059826|Interferons|interferons|mesh-list
83793312|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
83793313|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
83793314|NCT00059826|Fluorouracil|fluorouracil|mesh-list
83793315|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793316|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
83793317|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793318|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793319|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793320|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
83793321|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793322|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
83793323|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793324|NCT00032045|Ipilimumab|ipilimumab|mesh-list
83793325|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
83793326|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793327|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793328|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83793329|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793330|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83793331|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
83793332|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793333|NCT00059865|Gemcitabine|gemcitabine|mesh-list
83793334|NCT00059865|Pemetrexed|pemetrexed|mesh-list
83793335|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793336|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
83793337|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793338|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793339|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793340|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83793341|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83793342|NCT00032084|Bupropion|bupropion|mesh-list
83793343|NCT00032084|Nicotine|nicotine|mesh-list
83793344|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83793345|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
83793346|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793347|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793348|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83793349|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83793350|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
83793351|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793352|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793353|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83793354|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
83793355|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83793356|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83793357|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83793358|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83793359|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
83793360|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83793361|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83793362|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793363|NCT00059904|Aldesleukin|aldesleukin|mesh-list
83793364|NCT00059904|Rituximab|rituximab|mesh-list
83793365|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793366|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793367|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
83793368|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793369|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793370|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83793371|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83793372|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
83793373|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793374|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83793375|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793376|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83793377|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793378|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793379|NCT00059943|Docetaxel|docetaxel|mesh-list
83793380|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793381|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793382|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793383|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793384|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793385|NCT00032162|Carboplatin|carboplatin|mesh-list
83793386|NCT00032162|Doxorubicin|doxorubicin|mesh-list
83793387|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83793388|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793389|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83793390|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793391|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793392|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793393|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793394|NCT00032279|Visilizumab|visilizumab|mesh-list
83793395|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
83793396|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793397|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
83793398|NCT00060138|Antibodies|antibodies|mesh-list
83793399|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83793400|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
83793401|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793402|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83793403|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83793404|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83793405|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
83793406|NCT00032396|Hormones|hormones|mesh-ancestor
83793407|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793408|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793409|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
83793410|NCT00060255|Melphalan|melphalan|mesh-list
83793411|NCT00060255|Busulfan|busulfan|mesh-list
83793412|NCT00060255|Thiotepa|thiotepa|mesh-list
83793413|NCT00060255|Carmustine|carmustine|mesh-list
83793414|NCT00060255|Carboplatin|carboplatin|mesh-list
83793415|NCT00060255|Etoposide|etoposide|mesh-list
83793416|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793417|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
83793418|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793419|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793420|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83793421|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
83793422|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793423|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793424|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83793425|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793426|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793427|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793428|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793429|NCT00060294|Rituximab|rituximab|mesh-list
83793430|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793431|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793432|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
83793433|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793434|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793435|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83793436|NCT00060372|Ipilimumab|ipilimumab|mesh-list
83793437|NCT00060372|Antibodies|antibodies|mesh-list
83793438|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
83793439|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83793440|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
83793441|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793442|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793443|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83793444|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793445|NCT00060411|Leucovorin|leucovorin|mesh-list
83793446|NCT00060411|Bevacizumab|bevacizumab|mesh-list
83793447|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83793448|NCT00060411|Fluorouracil|fluorouracil|mesh-list
83793449|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
83793450|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83793451|NCT00060411|Antibodies|antibodies|mesh-list
83793452|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
83793453|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83793454|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
83793455|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793456|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83793457|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83793458|NCT00060411|Growth Substances|growth substances|mesh-ancestor
83793459|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793460|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
83793461|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
83793462|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
83793463|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793464|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793465|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793466|NCT00060411|Antidotes|antidotes|mesh-ancestor
83793467|NCT00060411|Protective Agents|protective agents|mesh-ancestor
83793468|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
83793469|NCT00060411|Vitamins|vitamins|mesh-ancestor
83793470|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
83793471|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83793472|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793473|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
83793474|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83793475|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
83793476|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793477|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793478|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83793479|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
83793480|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83542178|NCT00104884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793482|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793483|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793484|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83793485|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
83793486|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
83793487|NCT00060450|Protective Agents|protective agents|mesh-ancestor
83793488|NCT00032747|Vasopressins|vasopressins|mesh-list
83793489|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
83793490|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
83793491|NCT00032747|Coagulants|coagulants|mesh-ancestor
83793492|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83793493|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83793494|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
83793495|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793496|NCT00032786|Natalizumab|natalizumab|mesh-list
83793497|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
83793498|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793499|NCT02968719|Donepezil|donepezil|mesh-list
83793500|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83793501|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793502|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793503|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
83793504|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793505|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793506|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
83793507|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83793508|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
83793509|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83793510|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83793511|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83793512|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83793513|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793514|NCT00032825|Ketoconazole|ketoconazole|mesh-list
83793515|NCT00032825|Docetaxel|docetaxel|mesh-list
83793516|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793517|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793518|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793519|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793520|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793521|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
83793522|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793523|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83793524|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83793525|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793526|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83793527|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
83793528|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793529|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793530|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83793531|NCT00060645|Sirolimus|sirolimus|mesh-list
83793532|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83793533|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793534|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83793535|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793536|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
83793537|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793538|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
83793539|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793540|NCT00060684|Dexamethasone|dexamethasone|mesh-list
83793541|NCT00060684|Rituximab|rituximab|mesh-list
83793542|NCT00060684|Fludarabine|fludarabine|mesh-list
83793543|NCT00060684|Pixantrone|pixantrone|mesh-list
83793544|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793545|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793546|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
83793547|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793548|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793549|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83793550|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
83793551|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
83793552|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793553|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83793554|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
83793555|NCT00060684|Hormones|hormones|mesh-ancestor
83793556|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793557|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83793558|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793559|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793560|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793561|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793562|NCT02971475|Analgesics|analgesics|mesh-list
83793563|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
83793564|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793565|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793566|NCT00032942|Lofexidine|lofexidine|mesh-list
83793567|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83793568|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83793569|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793570|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
83793571|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793572|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83793573|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83793574|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83793575|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
83793576|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793577|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793578|NCT00033059|Tolcapone|tolcapone|mesh-list
83793579|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83793580|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83793581|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83793582|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793583|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793584|NCT00060918|Metoprolol|metoprolol|mesh-list
83793585|NCT00060918|Carvedilol|carvedilol|mesh-list
83793586|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83793587|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83793588|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
83793589|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
83793590|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793591|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793592|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83793593|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83793594|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83793595|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83793596|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793597|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793598|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
83793599|NCT00060918|Protective Agents|protective agents|mesh-ancestor
83793600|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83793601|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83793602|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83793603|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
83793604|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83793605|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83793606|NCT00033098|Metyrapone|metyrapone|mesh-list
83793607|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
83793608|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793609|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793610|NCT02968641|Ritonavir|ritonavir|mesh-list
83793611|NCT02968641|Lonafarnib|lonafarnib|mesh-list
83793612|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83793613|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83793614|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
83793615|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793616|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793617|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83793618|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83793619|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
83793620|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793621|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83793622|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83793623|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
83793624|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
83793625|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793626|NCT00033176|Protective Agents|protective agents|mesh-ancestor
83793627|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948792|NCT01164709|Nelfinavir|nelfinavir|mesh-list
83793628|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
83793629|NCT00033176|Vitamins|vitamins|mesh-ancestor
83793630|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
83793631|NCT00033215|S 3304|s 3304|mesh-list
83793632|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
83793633|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
83793634|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793635|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793636|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
83793637|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83793638|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83793639|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83793640|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83793641|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793642|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
83793643|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793644|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793645|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83793646|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793647|NCT00060996|Treprostinil|treprostinil|mesh-list
83793648|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83793649|NCT00033254|Thalidomide|thalidomide|mesh-list
83793650|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793651|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
83793652|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793653|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
83793654|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83793655|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793656|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83793657|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83793658|NCT00033254|Growth Substances|growth substances|mesh-ancestor
83793659|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
83793660|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793661|NCT00061074|Nicotine|nicotine|mesh-list
83793662|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83793663|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
83793664|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793665|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793666|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83793667|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83793668|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83793669|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793670|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793671|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
83793672|NCT00033332|Pamidronate|pamidronate|mesh-list
83793673|NCT00033332|Thalidomide|thalidomide|mesh-list
83793674|NCT00033332|Dexamethasone|dexamethasone|mesh-list
83793675|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83793676|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
83793677|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
83793678|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793679|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793680|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83793681|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
83793682|NCT00033332|Hormones|hormones|mesh-ancestor
83793683|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793684|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83793685|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793686|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793687|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
83793688|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
83793689|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83793690|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793691|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83793692|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83793693|NCT00033332|Growth Substances|growth substances|mesh-ancestor
83793694|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
83793695|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83793696|NCT00033410|Paclitaxel|paclitaxel|mesh-list
83793697|NCT00033410|Carboplatin|carboplatin|mesh-list
83793698|NCT00033410|Tirapazamine|tirapazamine|mesh-list
83793699|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793700|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793701|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
82948876|NCT01281787|Losartan|losartan|mesh-list
83793702|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793703|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793704|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793705|NCT00061113|Fluoxetine|fluoxetine|mesh-list
83793706|NCT00061113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83793707|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83793708|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83793709|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793710|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793711|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
83793712|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793713|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83793714|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
83793715|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83793716|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83793717|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83793718|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793719|NCT00033449|Gefitinib|gefitinib|mesh-list
83793720|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793721|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83793722|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793723|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793724|NCT00061152|Capsaicin|capsaicin|mesh-list
83793725|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
83793726|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83793727|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
83793728|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793729|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793730|NCT00033566|S 3304|s 3304|mesh-list
83793731|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
83793732|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
83793733|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793734|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793735|NCT00033605|Octreotide|octreotide|mesh-list
83793736|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83793737|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83793738|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793739|NCT00033644|Doxorubicin|doxorubicin|mesh-list
83793740|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83793741|NCT00033644|Mitomycins|mitomycins|mesh-list
83793742|NCT00033644|Mitomycin|mitomycin|mesh-list
83793743|NCT00033644|Dacarbazine|dacarbazine|mesh-list
83793744|NCT00033644|Sargramostim|sargramostim|mesh-list
83793745|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793746|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83793747|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793748|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793749|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793750|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793751|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
83793752|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793753|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
83793754|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83793755|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83793756|NCT00033683|Tamoxifen|tamoxifen|mesh-list
83793757|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
83793758|NCT00033683|Docetaxel|docetaxel|mesh-list
83793759|NCT00033683|Fluorouracil|fluorouracil|mesh-list
83793760|NCT00033683|Methotrexate|methotrexate|mesh-list
83793761|NCT00033683|Epirubicin|epirubicin|mesh-list
83793762|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793763|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
83793764|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793765|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83793766|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83793767|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
83793768|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793769|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793770|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83793771|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793772|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793773|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793774|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
83793775|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793776|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83793777|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
83793778|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83793779|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
83793780|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793781|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83793782|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83793783|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83793784|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793785|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793786|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83793787|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83793788|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793789|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83793790|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83793791|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83793792|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83793793|NCT00061308|Gemcitabine|gemcitabine|mesh-list
83793794|NCT00061308|Topotecan|topotecan|mesh-list
83793795|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793796|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
83793797|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793798|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793799|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83793800|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793801|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793802|NCT00033722|Folic Acid|folic acid|mesh-list
83793803|NCT00033722|Lometrexol|lometrexol|mesh-list
83793804|NCT00033722|Hematinics|hematinics|mesh-ancestor
83793805|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
83793806|NCT00033722|Vitamins|vitamins|mesh-ancestor
83793807|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
83793808|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793809|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793810|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
83793811|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793812|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793813|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83793814|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793815|NCT00061425|Epratuzumab|epratuzumab|mesh-list
83793816|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793817|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793818|NCT00061464|Gemcitabine|gemcitabine|mesh-list
83793819|NCT00061464|Pemetrexed|pemetrexed|mesh-list
83793820|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793821|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
83793822|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793823|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793824|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793825|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83793826|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83793827|NCT00061503|Travoprost|travoprost|mesh-list
83793828|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83793829|NCT00061542|Timolol|timolol|mesh-list
83793830|NCT00061542|Betaxolol|betaxolol|mesh-list
83793831|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83793832|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83793833|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83793834|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793835|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793836|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793837|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83793838|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83793839|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
83793840|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
83793841|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793842|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83793843|NCT00061620|Tezacitabine|tezacitabine|mesh-list
83793844|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793845|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793846|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793847|NCT00034151|Paclitaxel|paclitaxel|mesh-list
83793848|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793849|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793850|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793851|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793852|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
83834939|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83793853|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793854|NCT00034190|Paclitaxel|paclitaxel|mesh-list
83793855|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793856|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793857|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793858|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793859|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793860|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793861|NCT00034229|Felbamate|felbamate|mesh-list
83793862|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
83793863|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83793864|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83793865|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793866|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793867|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793868|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
83793869|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83793870|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793871|NCT00061776|Capsaicin|capsaicin|mesh-list
83793872|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
83793873|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83793874|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
83793875|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793876|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793877|NCT00034346|Paclitaxel|paclitaxel|mesh-list
83793878|NCT00034346|Carboplatin|carboplatin|mesh-list
83793879|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793880|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793881|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793882|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793883|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793884|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793885|NCT00034385|Valganciclovir|valganciclovir|mesh-list
83793886|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
83793887|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793888|NCT00034463|Folic Acid|folic acid|mesh-list
83793889|NCT00034463|Vitamins|vitamins|mesh-ancestor
83793890|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
83793891|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793892|NCT00034463|Hematinics|hematinics|mesh-ancestor
83793893|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
83793894|NCT02971397|Cytarabine|cytarabine|mesh-list
83793895|NCT02971397|Daunorubicin|daunorubicin|mesh-list
83793896|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793897|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
83793898|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793899|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793900|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
83793901|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793902|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793903|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
83793904|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793905|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83793906|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83793907|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793908|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793909|NCT00396500|Vitamin A|vitamin a|mesh-list
83793910|NCT00396500|Albendazole|albendazole|mesh-list
83793911|NCT00396500|Vitamins|vitamins|mesh-ancestor
83793912|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
83793913|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793914|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793915|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793916|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
83793917|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83793918|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793919|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
83793920|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83173310|NCT03134573|Interferons|interferons|mesh-list
83793921|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83793922|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793923|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793924|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793925|NCT00034502|Irinotecan|irinotecan|mesh-list
83793926|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83793927|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83793928|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834940|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793929|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793930|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793932|NCT00034541|Carboplatin|carboplatin|mesh-list
83793933|NCT00034541|Cetuximab|cetuximab|mesh-list
83793934|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83793935|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793936|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
83793937|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
83793938|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
83793939|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793940|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793941|NCT00034580|Olanzapine|olanzapine|mesh-list
83793942|NCT00034580|Risperidone|risperidone|mesh-list
83793943|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83793944|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
83793945|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83793946|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793947|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793948|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83793949|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83793950|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83793951|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83793952|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83793953|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
83793954|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
83793955|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
83793956|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83793957|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83793958|NCT00034580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83793959|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83793960|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83793961|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
83793962|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793963|NCT00061815|Leucovorin|leucovorin|mesh-list
83793964|NCT00061815|Fluorouracil|fluorouracil|mesh-list
83793965|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
83793966|NCT00061815|Cetuximab|cetuximab|mesh-list
83793967|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
83793968|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793969|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83793970|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793971|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83793972|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
83793973|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793974|NCT00061815|Antidotes|antidotes|mesh-ancestor
83793975|NCT00061815|Protective Agents|protective agents|mesh-ancestor
83793976|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
83793977|NCT00061815|Vitamins|vitamins|mesh-ancestor
83793978|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
83793979|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83793980|NCT00061854|Soblidotin|soblidotin|mesh-list
83793981|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83793982|NCT00034658|Posaconazole|posaconazole|mesh-list
83793983|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
83793984|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83793985|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83793986|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83793987|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83793988|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83793989|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83793990|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83793991|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83793992|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83793993|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
83793994|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83793995|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83793996|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
83793997|NCT00398580|Testosterone|testosterone|mesh-list
83793998|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
83793999|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
83794000|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83794001|NCT00398580|Dutasteride|dutasteride|mesh-list
83794002|NCT00398580|Androgens|androgens|mesh-ancestor
83794003|NCT00398580|Hormones|hormones|mesh-ancestor
82949171|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
83794004|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794005|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794006|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83794007|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794008|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
83794009|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83794010|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83794011|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794012|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794013|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
83794014|NCT00034697|Temozolomide|temozolomide|mesh-list
83794015|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83794016|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
83794017|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794018|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794019|NCT00034736|Levofloxacin|levofloxacin|mesh-list
83794020|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83794021|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794022|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794023|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83794024|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794025|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794026|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794027|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794028|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83794029|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83794030|NCT02967939|Tenofovir|tenofovir|mesh-list
83794031|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
83794032|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794033|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83794034|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83794035|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794036|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794037|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83794038|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83794039|NCT00034775|Risperidone|risperidone|mesh-list
83794040|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83794041|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
83794042|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794043|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794044|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794045|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83794046|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83794047|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83794048|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794049|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83794050|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
83794051|NCT00062127|Thalidomide|thalidomide|mesh-list
83794052|NCT00062127|Irinotecan|irinotecan|mesh-list
83794053|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83794054|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794055|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794056|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794057|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794058|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794059|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
83794060|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794061|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
83794062|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794063|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794064|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83794065|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83794066|NCT00062127|Growth Substances|growth substances|mesh-ancestor
83794067|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
83794068|NCT00034853|Naproxen|naproxen|mesh-list
83794069|NCT00034853|Meloxicam|meloxicam|mesh-list
83794070|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83794071|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83794072|NCT00034853|Analgesics|analgesics|mesh-ancestor
83794073|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
83794074|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794075|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949249|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83794076|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794077|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794078|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
83794079|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83794080|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794081|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794082|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83794083|NCT00034892|Olanzapine|olanzapine|mesh-list
83794084|NCT00034892|Risperidone|risperidone|mesh-list
83794085|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83794086|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
83794087|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794088|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794089|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794090|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83794091|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83794092|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83794093|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794094|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83794095|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
83794096|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
83794097|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
83794098|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794099|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794100|NCT00034892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83794101|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83794102|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794103|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
83794104|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794105|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83794106|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794107|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794108|NCT00062244|Oblimersen|oblimersen|mesh-list
83794109|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794110|NCT00035009|Aprepitant|aprepitant|mesh-list
83794111|NCT00035009|Paroxetine|paroxetine|mesh-list
83794112|NCT00035009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83794113|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83794114|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794115|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794116|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794117|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
83794118|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794119|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83794120|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
83794121|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794122|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83794123|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83794124|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794125|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
83794126|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
83794127|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794128|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794129|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83794130|NCT00062283|Alanosine|alanosine|mesh-list
83794131|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83794132|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794133|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
83794134|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
83794135|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794136|NCT00035048|Aprepitant|aprepitant|mesh-list
83794137|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
83794138|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
83794139|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794140|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794141|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794142|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83794143|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794144|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794145|NCT00035087|Epothilones|epothilones|mesh-list
83794146|NCT00035087|Epothilone B|epothilone b|mesh-list
83794147|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794148|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794149|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794150|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794151|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794152|NCT00062322|Irinotecan|irinotecan|mesh-list
83794153|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794154|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83794155|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794156|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794157|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794158|NCT00035126|Epothilones|epothilones|mesh-list
83794159|NCT00035126|Epothilone B|epothilone b|mesh-list
83794160|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794161|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794162|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794163|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794164|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794165|NCT00035165|Epothilones|epothilones|mesh-list
83794166|NCT00035165|Epothilone B|epothilone b|mesh-list
83794167|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794168|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794169|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794170|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794171|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794172|NCT00035204|Galantamine|galantamine|mesh-list
83794173|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83794174|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794175|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794176|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
83794177|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794178|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794179|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83794180|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
83794181|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794182|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
83794183|NCT00062478|Camptothecin|camptothecin|mesh-list
83794184|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83794185|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794186|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83794187|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794188|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794189|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794190|NCT00035243|Epothilones|epothilones|mesh-list
83794191|NCT00035243|Epothilone B|epothilone b|mesh-list
83794192|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794193|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794194|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794195|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794196|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794197|NCT00035282|Aprepitant|aprepitant|mesh-list
83794198|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
83794199|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
83794200|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794201|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794202|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794203|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83794204|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794205|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794206|NCT00062556|Niacin|niacin|mesh-list
83794207|NCT00062556|Lovastatin|lovastatin|mesh-list
83794208|NCT00062556|L 647318|l 647318|mesh-list
83794209|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
83794210|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83794211|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
83794212|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794213|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83794214|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
83794215|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
83794216|NCT00062556|Vitamins|vitamins|mesh-ancestor
83794217|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
82949399|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949400|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
82949401|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949402|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
82949403|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82949404|NCT01285141|Protective Agents|protective agents|mesh-ancestor
82949405|NCT01285219|Lenograstim|lenograstim|mesh-list
82949406|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83794218|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794219|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83794220|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83794221|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794223|NCT00035321|Fluoxetine|fluoxetine|mesh-list
83794224|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
83794225|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
83794226|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794227|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794228|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794229|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83794230|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83794231|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83794232|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794233|NCT00035321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83794234|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83794235|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794236|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794237|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794238|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
83794239|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83794240|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
83794241|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83794242|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83794243|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794244|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
83794245|NCT00062595|Vitamin K|vitamin k|mesh-list
83794246|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83794247|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83794248|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794249|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
83794250|NCT00062595|Coagulants|coagulants|mesh-ancestor
83794251|NCT00062595|Vitamins|vitamins|mesh-ancestor
83794252|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
83794253|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794254|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83794255|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
83794256|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794257|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83794258|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83794259|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83794260|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794261|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794262|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794263|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794264|NCT00062673|Analgesics|analgesics|mesh-ancestor
83794265|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
83794266|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794267|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
83794268|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794269|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
83794270|NCT00035477|Azimilide|azimilide|mesh-list
83794271|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83794272|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83794273|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794274|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794275|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83794276|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794277|NCT00062712|Sirolimus|sirolimus|mesh-list
83794278|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83794279|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794280|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794281|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83794282|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794283|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
83794284|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794285|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
83794286|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794287|NCT00062790|Dutasteride|dutasteride|mesh-list
83794288|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83794289|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83794290|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794291|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794292|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
83794293|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794294|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794295|NCT00035516|Epothilones|epothilones|mesh-list
83794296|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794297|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794298|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794299|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794300|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794301|NCT00062946|Fallypride|fallypride|mesh-list
83794302|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83794303|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83794304|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
83794305|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794306|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794307|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794308|NCT00063024|Calcium|calcium|mesh-list
83794309|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83794310|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794311|NCT00035984|Exenatide|exenatide|mesh-list
83794312|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83794313|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794314|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83794315|NCT00035984|Incretins|incretins|mesh-ancestor
83794316|NCT00035984|Hormones|hormones|mesh-ancestor
83794317|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794318|NCT00063141|Irinotecan|irinotecan|mesh-list
83794319|NCT00063141|Cetuximab|cetuximab|mesh-list
83794320|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83794321|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794322|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794323|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794324|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794325|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83794326|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
83794327|NCT00036023|Hematinics|hematinics|mesh-ancestor
83794328|NCT00036062|Sivelestat|sivelestat|mesh-list
83794329|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83794330|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
83794331|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794332|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794333|NCT00036101|Aripiprazole|aripiprazole|mesh-list
83794334|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
83794335|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794336|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83794337|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83794338|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83794339|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794340|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
83794341|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
83794342|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794343|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794344|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83794345|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83794346|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
83794347|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83794348|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83794349|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83794350|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83794351|NCT00036179|Micafungin|micafungin|mesh-list
83794352|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
83794353|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794354|NCT00036218|Ropinirole|ropinirole|mesh-list
83794355|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83794356|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83794357|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
83794358|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
83794359|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794360|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794361|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794362|NCT00063453|Vitamins|vitamins|mesh-list
82949549|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82949556|NCT01178203|Naproxen|naproxen|mesh-list
83794363|NCT00063453|Vitamin E|vitamin e|mesh-list
83794364|NCT00063453|Tocopherols|tocopherols|mesh-list
83794365|NCT00063453|Tocotrienols|tocotrienols|mesh-list
83794366|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
83794367|NCT00063453|Selenium|selenium|mesh-list
83794368|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
83794369|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794370|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
83794371|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794372|NCT00063453|Protective Agents|protective agents|mesh-ancestor
83794373|NCT00063453|Trace Elements|trace elements|mesh-ancestor
83794374|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83794375|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83794376|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83794377|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794378|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794379|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794380|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794381|NCT00036335|Analgesics|analgesics|mesh-ancestor
83794382|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
83794383|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794384|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
83794385|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794386|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
83794387|NCT00036374|Infliximab|infliximab|mesh-list
83794388|NCT00036374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83794389|NCT00036374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794390|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
83794391|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794392|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794393|NCT00036452|Ritonavir|ritonavir|mesh-list
83794394|NCT00036452|Lopinavir|lopinavir|mesh-list
83794395|NCT00036452|Tenofovir|tenofovir|mesh-list
83794396|NCT00036452|Emtricitabine|emtricitabine|mesh-list
83794397|NCT00036452|Stavudine|stavudine|mesh-list
83794398|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83794399|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83794400|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
83794401|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794402|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794403|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83794404|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83794405|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
83794406|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794407|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83794408|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83794409|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83794410|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83794411|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
83794412|NCT02967276|Metformin|metformin|mesh-list
83794413|NCT02967276|Dexamethasone|dexamethasone|mesh-list
83794414|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794415|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
83794416|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
83794417|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794418|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794419|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794420|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
83794421|NCT02967276|Hormones|hormones|mesh-ancestor
83794422|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794423|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83794424|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794425|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83794426|NCT00036491|Rituximab|rituximab|mesh-list
83794427|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83794428|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794429|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
83794430|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794431|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794432|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
83794433|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83794434|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794435|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
83794436|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83794437|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794438|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82949622|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83794439|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794440|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83794441|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794442|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794444|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794445|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794446|NCT00036764|Epothilones|epothilones|mesh-list
83794447|NCT00036764|Epothilone B|epothilone b|mesh-list
83794448|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794449|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794450|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794451|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794452|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794453|NCT00063726|Bortezomib|bortezomib|mesh-list
83794454|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794455|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
83794456|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794457|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
83794458|NCT00036881|Astringents|astringents|mesh-ancestor
83794459|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794460|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
83794461|NCT00063804|Ritonavir|ritonavir|mesh-list
83794462|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83794463|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83794464|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
83794465|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794466|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794467|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83794468|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83794469|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
83794470|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794471|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83794472|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83794473|NCT02967432|Mupirocin|mupirocin|mesh-list
83794474|NCT02967432|Petrolatum|petrolatum|mesh-list
83794475|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794476|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794477|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83794478|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794479|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794480|NCT02967432|Emollients|emollients|mesh-ancestor
83794481|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
83794482|NCT00063960|Irinotecan|irinotecan|mesh-list
83794483|NCT00063960|Floxuridine|floxuridine|mesh-list
83794484|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83794485|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794486|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794487|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794488|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794489|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83794490|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
83794491|NCT00064116|Rituximab|rituximab|mesh-list
83173325|NCT04232033|Mitogens|mitogens|mesh-list
83794492|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83794493|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794494|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
83794495|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794496|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794497|NCT00037037|Sargramostim|sargramostim|mesh-list
83794498|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
83794499|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794500|NCT00064194|Vitamin E|vitamin e|mesh-list
83794501|NCT00064194|Selenium|selenium|mesh-list
83794502|NCT00064194|Vitamins|vitamins|mesh-ancestor
83794503|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
83794504|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794505|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
83794506|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794507|NCT00064194|Protective Agents|protective agents|mesh-ancestor
83794508|NCT00064194|Trace Elements|trace elements|mesh-ancestor
83794509|NCT00064233|Dasatinib|dasatinib|mesh-list
83794510|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794511|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83794512|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949697|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
83794513|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949701|NCT03349710|Nivolumab|nivolumab|mesh-list
83794514|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
83794515|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83794516|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794517|NCT00037115|Interferons|interferons|mesh-list
83794518|NCT00037115|Interferon-beta|interferon-beta|mesh-list
83794519|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
83794520|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
83794521|NCT00037115|Methotrexate|methotrexate|mesh-list
83794522|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83794523|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
83794524|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83794525|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794526|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83794527|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
83794528|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794529|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794530|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
83794531|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794532|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83794533|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794534|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
83794535|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794536|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83794537|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
83794538|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794539|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794540|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
83794541|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
83794542|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794543|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794544|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
83794545|NCT00037115|Hormones|hormones|mesh-ancestor
83794546|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794547|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83794548|NCT00037115|Protective Agents|protective agents|mesh-ancestor
83794549|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83794550|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
83794551|NCT00037154|Urological Agents|urological agents|mesh-ancestor
83794552|NCT00064389|Albuterol|albuterol|mesh-list
83794553|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83794554|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
83794555|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794556|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794557|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83794558|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
83794559|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
83794560|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83794561|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83794562|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83794563|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83794564|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
83794565|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794566|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794567|NCT00064428|PENTA|penta|mesh-list
83794568|NCT00064428|Fondaparinux|fondaparinux|mesh-list
83794569|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83794570|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
83794571|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83794572|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
83794573|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794574|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794575|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
83794576|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83794577|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83794578|NCT00064467|Bupropion|bupropion|mesh-list
83794579|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83794580|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
83794581|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83794582|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83794583|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83794584|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794585|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794586|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
82949780|NCT01105871|Naloxone|naloxone|mesh-list
83794587|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794588|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794589|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83794590|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83794591|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794592|NCT00064623|Capsaicin|capsaicin|mesh-list
83794593|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
83794594|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83794595|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
83794596|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794597|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794598|NCT00064779|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83794599|NCT00064779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794600|NCT00037544|Factor VIII|factor viii|mesh-list
83794601|NCT00037544|Coagulants|coagulants|mesh-ancestor
83794602|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
83794603|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83794604|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794605|NCT00037583|Immunotoxins|immunotoxins|mesh-ancestor
83794606|NCT00037583|Immunoconjugates|immunoconjugates|mesh-ancestor
83794607|NCT00037583|Immunologic Factors|immunologic factors|mesh-ancestor
83794608|NCT00037583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794609|NCT00064857|Pycnogenols|pycnogenols|mesh-list
83794610|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83794611|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
83794612|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794613|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
83794614|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794615|NCT00064857|Protective Agents|protective agents|mesh-ancestor
83794616|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83794617|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
83794618|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83794619|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83794620|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794621|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794622|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
83794623|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794624|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83794625|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83794626|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83794627|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83794628|NCT04730622|Mitogens|mitogens|mesh-list
83794629|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794630|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794631|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83794632|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794633|NCT00064974|Lenalidomide|lenalidomide|mesh-list
83794634|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
83794635|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794636|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83794637|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83794638|NCT00064974|Growth Substances|growth substances|mesh-ancestor
83794639|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
83794640|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794641|NCT00037817|Celecoxib|celecoxib|mesh-list
83794642|NCT00037817|Decitabine|decitabine|mesh-list
83794643|NCT00037817|Romidepsin|romidepsin|mesh-list
83794644|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83794645|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83794646|NCT00037817|Analgesics|analgesics|mesh-ancestor
83794647|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
83794648|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794649|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794650|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794651|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794652|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83794653|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83794654|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794655|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794656|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83794657|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
83794658|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794659|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83794660|NCT00037817|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83794661|NCT00065130|Insulin|insulin|mesh-list
83794662|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82949845|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794663|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
83794664|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
83794665|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
83794666|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
83794667|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83794668|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794669|NCT00065169|Celecoxib|celecoxib|mesh-list
83794670|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83794671|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83794672|NCT00065169|Analgesics|analgesics|mesh-ancestor
83794673|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
83794674|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794675|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794676|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794677|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794678|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83794679|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83794680|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794681|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794682|NCT00038012|Carboplatin|carboplatin|mesh-list
83794683|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794684|NCT00038051|Lintuzumab|lintuzumab|mesh-list
83794685|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83794686|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794687|NCT00038090|Thalidomide|thalidomide|mesh-list
83794688|NCT00038090|Dexamethasone|dexamethasone|mesh-list
83794689|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794690|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
83794691|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
83794692|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794693|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794694|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794695|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
83794696|NCT00038090|Hormones|hormones|mesh-ancestor
83794697|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794698|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83794699|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794700|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794701|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
83794702|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
83794703|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794704|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794705|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83794706|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83794707|NCT00038090|Growth Substances|growth substances|mesh-ancestor
83794708|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
83794709|NCT00065325|Fulvestrant|fulvestrant|mesh-list
83794710|NCT00065325|Exemestane|exemestane|mesh-list
83794711|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83794712|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794713|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83794714|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83794715|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
83794716|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794717|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794718|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83794719|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83794720|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794721|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794722|NCT00038168|Paclitaxel|paclitaxel|mesh-list
83794723|NCT00038168|Estramustine|estramustine|mesh-list
83794724|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83794725|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794726|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794727|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794728|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794729|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794730|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83794731|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
83794732|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83794733|NCT00398658|Clindamycin|clindamycin|mesh-list
83794734|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
83794735|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
83794736|NCT00398658|Gentamicins|gentamicins|mesh-list
82949921|NCT03859375|Disinfectants|disinfectants|mesh-list
83794737|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794738|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794739|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83794740|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794741|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794742|NCT00038207|Vincristine|vincristine|mesh-list
83794743|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83794744|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794745|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794746|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794747|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794748|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794749|NCT00398697|Gemcitabine|gemcitabine|mesh-list
83794750|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83794751|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
83794752|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794753|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794754|NCT00038246|Thalidomide|thalidomide|mesh-list
83794755|NCT00038246|Paclitaxel|paclitaxel|mesh-list
83794756|NCT00038246|Estramustine|estramustine|mesh-list
83794757|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83794758|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794759|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794760|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794761|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794762|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794763|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794764|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
83794765|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794766|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
83794767|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794768|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794769|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83794770|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83794771|NCT00038246|Growth Substances|growth substances|mesh-ancestor
83794772|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
83794773|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83794774|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
83794775|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83794776|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83794777|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794778|NCT00398814|Sorafenib|sorafenib|mesh-list
83794779|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794780|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83794781|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794782|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794783|NCT00065559|Celecoxib|celecoxib|mesh-list
83794784|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83794785|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83794786|NCT00065559|Analgesics|analgesics|mesh-ancestor
83794787|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
83794788|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794789|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794790|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794791|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794792|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83794793|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83794794|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794795|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794796|NCT00065637|Teriparatide|teriparatide|mesh-list
83794797|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83794798|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794799|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83794800|NCT00396578|Vancomycin|vancomycin|mesh-list
83794801|NCT00396578|Gentamicins|gentamicins|mesh-list
83794802|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794803|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794804|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83794805|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794806|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794807|NCT00398853|Chromium|chromium|mesh-list
82949996|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83794808|NCT00398853|Picolinic acid|picolinic acid|mesh-list
83794809|NCT00398853|Trace Elements|trace elements|mesh-ancestor
83794810|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
83794811|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794812|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83794813|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
83794814|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
83794815|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794816|NCT05433896|Dasatinib|dasatinib|mesh-list
83794817|NCT05433896|Omeprazole|omeprazole|mesh-list
83794818|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83794819|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794820|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83794821|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794822|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794823|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794824|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83794825|NCT00069888|Docetaxel|docetaxel|mesh-list
83794826|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794827|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794828|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794829|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794830|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794831|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83794832|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
83794833|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83794834|NCT00069927|Methylphenidate|methylphenidate|mesh-list
83794835|NCT00069927|Amphetamine|amphetamine|mesh-list
83794836|NCT00069927|Adderall|adderall|mesh-list
83794837|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
83794838|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83794839|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794840|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83794841|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83794842|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794843|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794844|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
83794845|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794846|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
83794847|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
83794848|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794849|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
83794850|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83794851|NCT00069966|Cytarabine|cytarabine|mesh-list
83794852|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
83794853|NCT00069966|Rituximab|rituximab|mesh-list
83794854|NCT00069966|Pixantrone|pixantrone|mesh-list
83794855|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83794856|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794857|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
83794858|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794859|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794860|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83794861|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
83794862|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794863|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
83794864|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794865|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794866|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794867|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
83794868|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
83794869|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83794870|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83794871|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
83794872|NCT00069966|Hormones|hormones|mesh-ancestor
83794873|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794874|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83794875|NCT00069966|Protective Agents|protective agents|mesh-ancestor
83794876|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83794877|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794878|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794879|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
83794880|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83794881|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794882|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
83794883|NCT00065949|Analgesics|analgesics|mesh-ancestor
83794884|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
83794885|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950067|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83794886|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794887|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
83794888|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83794889|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83794890|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
83794891|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83794892|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83794893|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794894|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83794895|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
83794896|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83794897|NCT00066027|Doxycycline|doxycycline|mesh-list
83794898|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83794899|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83794900|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
83794901|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83794902|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83794903|NCT00396734|Topiramate|topiramate|mesh-list
83794904|NCT00396734|Modafinil|modafinil|mesh-list
83794905|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
83794906|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83794907|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794908|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83794909|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83794910|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83794911|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83794912|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794913|NCT00070083|Prednisone|prednisone|mesh-list
83794914|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
83794915|NCT00070083|Rituximab|rituximab|mesh-list
83794916|NCT00070083|Doxorubicin|doxorubicin|mesh-list
83794917|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83794918|NCT00070083|Vincristine|vincristine|mesh-list
83794919|NCT00070083|Oblimersen|oblimersen|mesh-list
83794920|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794921|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
83794922|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794923|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794924|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83794925|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
83794926|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794927|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794928|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83794929|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83794930|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83794931|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83794932|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794933|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794934|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83794935|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
83794936|NCT00070083|Hormones|hormones|mesh-ancestor
83794937|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83794938|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83794939|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83794940|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83794941|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83794942|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83794943|NCT00070122|Leucovorin|leucovorin|mesh-list
83794944|NCT00070122|Bevacizumab|bevacizumab|mesh-list
83794945|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83794946|NCT00070122|Fluorouracil|fluorouracil|mesh-list
83794947|NCT00070122|Capecitabine|capecitabine|mesh-list
83794948|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
83794949|NCT00070122|Antibodies|antibodies|mesh-list
83794950|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
83794951|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83794952|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
83794953|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794954|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83794955|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83794956|NCT00070122|Growth Substances|growth substances|mesh-ancestor
83794957|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794958|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
83794959|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
83794960|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
83794961|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794962|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83794963|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794965|NCT00070122|Protective Agents|protective agents|mesh-ancestor
83794966|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
83794967|NCT00070122|Vitamins|vitamins|mesh-ancestor
83794968|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
83794969|NCT00070161|Donepezil|donepezil|mesh-list
83794970|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83794971|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794972|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794973|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83794974|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83794975|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794976|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
83794977|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
83794978|NCT00070200|Melphalan|melphalan|mesh-list
83794979|NCT00070200|Doxorubicin|doxorubicin|mesh-list
83794980|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83794981|NCT00070200|Etoposide|etoposide|mesh-list
83794982|NCT00070200|Vincristine|vincristine|mesh-list
83794983|NCT00070200|Topotecan|topotecan|mesh-list
83794984|NCT00070200|Isotretinoin|isotretinoin|mesh-list
83794985|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83794986|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
83794987|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83794988|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83794989|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83794990|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
83794991|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83794992|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83794993|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83794994|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83794995|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83794996|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83794997|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83794998|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83794999|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795000|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795001|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795002|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83795003|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
83795004|NCT00066339|Gefitinib|gefitinib|mesh-list
83795005|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795006|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795007|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795008|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795009|NCT00070239|Alvocidib|alvocidib|mesh-list
83795010|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83795011|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83795012|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795013|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795014|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795015|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
83795016|NCT00070239|Growth Substances|growth substances|mesh-ancestor
83795017|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795018|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795019|NCT00070278|Paclitaxel|paclitaxel|mesh-list
83795020|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
83795021|NCT00070278|Gemcitabine|gemcitabine|mesh-list
83795022|NCT00070278|Epirubicin|epirubicin|mesh-list
83795023|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83795024|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795025|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795026|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795027|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795028|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795029|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795030|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
83795031|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795032|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795033|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83795034|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
83795035|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83795036|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795037|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
82950219|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
83795038|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83795039|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83795040|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83795041|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795043|NCT00066378|Anastrozole|anastrozole|mesh-list
83795044|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795045|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795046|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795047|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795048|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83795049|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83795050|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83795051|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83795052|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
83795053|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795054|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795055|NCT00066417|Cyclosporine|cyclosporine|mesh-list
83795056|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
83795057|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
83795058|NCT00066417|Thiotepa|thiotepa|mesh-list
83795059|NCT00066417|Fludarabine|fludarabine|mesh-list
83795060|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
83795061|NCT00066417|Cyclosporins|cyclosporins|mesh-list
83795062|NCT00066417|Immunomodulating Agents|immunomodulating agents|mesh-list
83795063|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795064|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
83795065|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795066|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795067|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83795068|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
83795069|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795070|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795071|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83795072|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795073|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
83795074|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795075|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
83795076|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795077|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
83795078|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83795079|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83795080|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
83795081|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
83795082|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795083|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83795084|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
83795085|NCT00066417|Hormones|hormones|mesh-ancestor
83795086|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795087|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83795088|NCT00066417|Protective Agents|protective agents|mesh-ancestor
83795089|NCT00066456|Docetaxel|docetaxel|mesh-list
83795090|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795091|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795092|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795093|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795094|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795095|NCT00070434|Leucovorin|leucovorin|mesh-list
83795096|NCT00070434|Pyridoxine|pyridoxine|mesh-list
83795097|NCT00070434|Fluorouracil|fluorouracil|mesh-list
83795098|NCT00070434|Capecitabine|capecitabine|mesh-list
83795099|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
83795100|NCT00070434|Irinotecan|irinotecan|mesh-list
83795101|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
83795102|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795103|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
83795104|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795105|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795106|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795107|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795108|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
83795109|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83795110|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83795111|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795112|NCT00070434|Antidotes|antidotes|mesh-ancestor
83795113|NCT00070434|Protective Agents|protective agents|mesh-ancestor
82950294|NCT03368664|Interferons|interferons|mesh-list
83795114|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
83795116|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
83795117|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
83795118|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
83795119|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83795120|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795121|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795122|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
83795123|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83795124|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795125|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795126|NCT00070473|Pemetrexed|pemetrexed|mesh-list
83795127|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795128|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795129|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795130|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83795131|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83795132|NCT00066612|Irinotecan|irinotecan|mesh-list
83795133|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83795134|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83795135|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795136|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795137|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795138|NCT00070551|Cytarabine|cytarabine|mesh-list
83795139|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795140|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
83795141|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795142|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795143|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
83795144|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795145|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795146|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
83795147|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795148|NCT00070629|Paclitaxel|paclitaxel|mesh-list
83795149|NCT00070629|Docetaxel|docetaxel|mesh-list
83795150|NCT00070629|Cisplatin|cisplatin|mesh-list
83795151|NCT00070629|Carboplatin|carboplatin|mesh-list
83795152|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83795153|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795154|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795155|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795156|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795157|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795158|NCT01349595|Bortezomib|bortezomib|mesh-list
83795159|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795160|NCT05184920|Nicotine|nicotine|mesh-list
83795161|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83795162|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
83795163|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795164|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795165|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83795166|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83795167|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
83795168|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795169|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795170|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
83795171|NCT02958501|Vitamin D|vitamin d|mesh-list
83795172|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83795173|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795174|NCT02958501|Vitamins|vitamins|mesh-ancestor
83795175|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
83795176|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83795177|NCT00066651|Immunotoxins|immunotoxins|mesh-list
83795178|NCT00066651|Immunoconjugates|immunoconjugates|mesh-ancestor
83795179|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
83795180|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795181|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
83795182|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
83795183|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795184|NCT00398892|Protective Agents|protective agents|mesh-ancestor
83795185|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795186|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
83795187|NCT00398892|Vitamins|vitamins|mesh-ancestor
83795188|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
82950386|NCT03857581|Olanzapine|olanzapine|mesh-list
83795189|NCT05019794|Infigratinib|infigratinib|mesh-list
83795190|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795191|NCT00066768|Suramin|suramin|mesh-list
83795192|NCT00066768|Gemcitabine|gemcitabine|mesh-list
83795193|NCT00066768|Docetaxel|docetaxel|mesh-list
83795194|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795195|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
83795196|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795197|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795198|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795199|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795200|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795201|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
83795202|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
83795203|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83795204|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795205|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83795206|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83795207|NCT00066846|Leucovorin|leucovorin|mesh-list
83795208|NCT00066846|Bevacizumab|bevacizumab|mesh-list
83795209|NCT00066846|Fluorouracil|fluorouracil|mesh-list
83795210|NCT00066846|Calcium|calcium|mesh-list
83795211|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
83795212|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83795213|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795214|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83795215|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83795216|NCT00066846|Growth Substances|growth substances|mesh-ancestor
83795217|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795218|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
83795219|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83795220|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
83795221|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795222|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795223|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795224|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
83795225|NCT00066846|Antidotes|antidotes|mesh-ancestor
83795226|NCT00066846|Protective Agents|protective agents|mesh-ancestor
83795227|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
83795228|NCT00066846|Vitamins|vitamins|mesh-ancestor
83795229|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
83795230|NCT00066885|Calcitriol|calcitriol|mesh-list
83795231|NCT00066885|Docetaxel|docetaxel|mesh-list
83795232|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795233|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795234|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795235|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795236|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795237|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83795238|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795239|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83795240|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83795241|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83795242|NCT00066885|Vitamins|vitamins|mesh-ancestor
83795243|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
83795244|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83795245|NCT04941521|Exenatide|exenatide|mesh-list
83795246|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83795247|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795248|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83795249|NCT04941521|Incretins|incretins|mesh-ancestor
83795250|NCT04941521|Hormones|hormones|mesh-ancestor
83795251|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795252|NCT02966457|Colistin|colistin|mesh-list
83795253|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83795254|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795255|NCT00067041|Treprostinil|treprostinil|mesh-list
83795256|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83795257|NCT04732364|Bupivacaine|bupivacaine|mesh-list
83795258|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
83795259|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
83795260|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795261|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795262|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
83795263|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795264|NCT04732598|Paclitaxel|paclitaxel|mesh-list
83795265|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83795266|NCT04732598|Bevacizumab|bevacizumab|mesh-list
83795267|NCT04732598|Atezolizumab|atezolizumab|mesh-list
83795268|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83795269|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795270|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795271|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795272|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795273|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795274|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83795275|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83795276|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83795277|NCT04732598|Growth Substances|growth substances|mesh-ancestor
83795278|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795279|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
83795280|NCT04732598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83795281|NCT00067080|Deferasirox|deferasirox|mesh-list
83795282|NCT00067080|Deferoxamine|deferoxamine|mesh-list
83795283|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83795284|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
83795285|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
83795286|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795287|NCT00067080|Siderophores|siderophores|mesh-ancestor
83795288|NCT00396851|Metformin|metformin|mesh-list
83795289|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83795290|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795291|NCT00067119|Dipyridamole|dipyridamole|mesh-list
83795292|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83795293|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795294|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83795295|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795296|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83795297|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
83795298|NCT00396929|Paclitaxel|paclitaxel|mesh-list
83795299|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83795300|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795301|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795302|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795303|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795304|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795305|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83795306|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83795307|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
83795308|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
83795309|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795310|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83795311|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
83795312|NCT00399165|Testosterone|testosterone|mesh-list
83795313|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
83795314|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
83795315|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83795316|NCT00399165|Dutasteride|dutasteride|mesh-list
83795317|NCT00399165|Androgens|androgens|mesh-ancestor
83795318|NCT00399165|Hormones|hormones|mesh-ancestor
84048358|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795319|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795320|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795321|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83795322|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795323|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
83795324|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83795325|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83795326|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795327|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795328|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
83795329|NCT00067158|Nicotine|nicotine|mesh-list
83795330|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83795331|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
83795332|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795333|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795334|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83795335|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83795336|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83795337|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795338|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795339|NCT00071097|Darunavir|darunavir|mesh-list
83795340|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83795341|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82950542|NCT01290211|Ritonavir|ritonavir|mesh-list
83795342|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
83795343|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795344|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795345|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83795346|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83795347|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
83795348|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795349|NCT00067353|Fluorides|fluorides|mesh-list
83795350|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
83795351|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
83795352|NCT00067353|Protective Agents|protective agents|mesh-ancestor
83795353|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795354|NCT00071136|Gemcitabine|gemcitabine|mesh-list
83795355|NCT00071136|Pemetrexed|pemetrexed|mesh-list
83795356|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795357|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
83795358|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795359|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795360|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795361|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83795362|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83795363|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
83795364|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83795365|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
83795366|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83795367|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
83795368|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795369|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795370|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
83795371|NCT00067431|Valproic Acid|valproic acid|mesh-list
83795372|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
83795373|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795374|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795375|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
83795376|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795377|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795378|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
83795379|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83795380|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795381|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83795382|NCT00067509|Progesterone|progesterone|mesh-list
83795383|NCT00067509|Estrogens|estrogens|mesh-list
83795384|NCT00067509|Progestins|progestins|mesh-ancestor
83795385|NCT00067509|Hormones|hormones|mesh-ancestor
83795386|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795387|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795388|NCT01349673|Budesonide|budesonide|mesh-list
83795389|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83795390|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83795391|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
83795392|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795393|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795394|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83795395|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
83795396|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
83795397|NCT01349673|Hormones|hormones|mesh-ancestor
83795398|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795399|NCT00071253|Valproic Acid|valproic acid|mesh-list
83795400|NCT00071253|Olanzapine|olanzapine|mesh-list
83795401|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
83795402|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
83795403|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795404|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795405|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83795406|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83795407|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83795408|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795409|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83795410|NCT00071253|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83795411|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83795412|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83795413|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795414|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795415|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
83795416|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
82950596|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795417|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795419|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
83795420|NCT00067548|EKB 569|ekb 569|mesh-list
83795421|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795422|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795423|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795424|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795425|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
83795426|NCT03338621|Rifampin|rifampin|mesh-list
83795427|NCT03338621|Isoniazid|isoniazid|mesh-list
83795428|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
83795429|NCT03338621|Ethambutol|ethambutol|mesh-list
83795430|NCT03338621|Bedaquiline|bedaquiline|mesh-list
83795431|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83795432|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795433|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83795434|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83795435|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795436|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795437|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795438|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83795439|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
83795440|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
83795441|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83795442|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83133568|NCT02107807|Lactitol|lactitol|mesh-list
83795443|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83795444|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83795445|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83795446|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83795447|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83795448|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83795449|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83795450|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
83795451|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83795452|NCT00071331|Tolvaptan|tolvaptan|mesh-list
83795453|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83795454|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795455|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
83795456|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795457|NCT00067626|Chromium|chromium|mesh-list
83795458|NCT00067626|Trace Elements|trace elements|mesh-ancestor
83795459|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
83795460|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795461|NCT00067743|Lenalidomide|lenalidomide|mesh-list
83795462|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
83795463|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795464|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83795465|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83795466|NCT00067743|Growth Substances|growth substances|mesh-ancestor
83795467|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
83795468|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795469|NCT00396968|Plerixafor|plerixafor|mesh-list
83795470|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83795471|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83795472|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
83795473|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795474|NCT00067860|Hormones|hormones|mesh-list
83795475|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795476|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795477|NCT00071448|Insulin|insulin|mesh-list
83795478|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83795479|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
83795480|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
83795481|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83795482|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795483|NCT02599324|Paclitaxel|paclitaxel|mesh-list
83795484|NCT02599324|Docetaxel|docetaxel|mesh-list
83795485|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
83795486|NCT02599324|Cetuximab|cetuximab|mesh-list
83795487|NCT02599324|Everolimus|everolimus|mesh-list
83795488|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83795489|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795490|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795491|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795492|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795493|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795494|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83795495|NCT02599324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83795496|NCT02599324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83795497|NCT02599324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795498|NCT02599324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795499|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795500|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
83795501|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795502|NCT01331018|Plerixafor|plerixafor|mesh-list
83795503|NCT01331018|Prednisone|prednisone|mesh-list
83795504|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
83795505|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83795506|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83795507|NCT01331018|Prednisolone|prednisolone|mesh-list
83795508|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
83795509|NCT01331018|Cortisone|cortisone|mesh-list
83795510|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83795511|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
83795512|NCT01331018|Lenograstim|lenograstim|mesh-list
83795513|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83795514|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
83795515|NCT01331018|Hormones|hormones|mesh-ancestor
83795516|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795517|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795518|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83795519|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795520|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83795521|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
83795522|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
83795523|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
83795524|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795525|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83795526|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83795527|NCT01331018|Protective Agents|protective agents|mesh-ancestor
83795528|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83795529|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83795530|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
83795531|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795532|NCT00067899|Vitamins|vitamins|mesh-list
83795533|NCT00067899|Vitamin E|vitamin e|mesh-list
83795534|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
83795535|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795536|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
83795537|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795538|NCT00067899|Protective Agents|protective agents|mesh-ancestor
83795539|NCT00067938|Lamotrigine|lamotrigine|mesh-list
83795540|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
83795541|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83795542|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83795543|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795544|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83795545|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795546|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83795547|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83795548|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795549|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83795550|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83795551|NCT02358187|Poly ICLC|poly iclc|mesh-list
83795552|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
83795553|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
83795554|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795555|NCT01809808|Hormones|hormones|mesh-list
83795556|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795557|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795558|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
83795559|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83795560|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83795561|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
83795562|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795563|NCT01406197|Progesterone|progesterone|mesh-list
83795564|NCT01406197|Progestins|progestins|mesh-ancestor
83795565|NCT01406197|Hormones|hormones|mesh-ancestor
83795566|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795567|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950744|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795568|NCT00038402|Paclitaxel|paclitaxel|mesh-list
83795569|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
83795570|NCT00038402|Fluorouracil|fluorouracil|mesh-list
83795571|NCT00038402|Trastuzumab|trastuzumab|mesh-list
83795572|NCT00038402|Epirubicin|epirubicin|mesh-list
83795573|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83795574|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795575|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795576|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795577|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795578|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795579|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795580|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
83795581|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795582|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795583|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83795584|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
83795585|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83795586|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
83795587|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795588|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83795589|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83795590|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83795591|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83795592|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795593|NCT00144703|Sirolimus|sirolimus|mesh-list
83795594|NCT00144703|Tacrolimus|tacrolimus|mesh-list
83795595|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795596|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
83795597|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795598|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83795599|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795600|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795601|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83795602|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795603|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83795604|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795605|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
83795606|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
83795607|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83795608|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
83795609|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795610|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
83795611|NCT00144820|Protective Agents|protective agents|mesh-ancestor
83795612|NCT00071643|Escitalopram|escitalopram|mesh-list
83795613|NCT00071643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83795614|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83795615|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83795616|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795617|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795618|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
83795619|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795620|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83795621|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795622|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795623|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795624|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795625|NCT00038480|Ritonavir|ritonavir|mesh-list
83795626|NCT00038480|Lopinavir|lopinavir|mesh-list
83795627|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83795628|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83795629|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
83795630|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795631|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795632|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83795633|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83795634|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
83795635|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795636|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83795637|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83795638|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
83795639|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
83795640|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83795641|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795642|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950825|NCT01183663|Leucovorin|leucovorin|mesh-list
83795644|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83795645|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795646|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795647|NCT00038519|Ritonavir|ritonavir|mesh-list
83795648|NCT00038519|Saquinavir|saquinavir|mesh-list
83795649|NCT00038519|Amprenavir|amprenavir|mesh-list
83795650|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83795651|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83795652|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
83795653|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795654|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795655|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83795656|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83795657|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
83795658|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795659|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83795660|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83795661|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83795662|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
83795663|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83795664|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83795665|NCT00202345|Hematinics|hematinics|mesh-ancestor
83795666|NCT00202423|Nabiximols|nabiximols|mesh-list
83795667|NCT00202423|Analgesics|analgesics|mesh-ancestor
83795668|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
83795669|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795670|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795671|NCT00202462|Testosterone|testosterone|mesh-list
83795672|NCT00202462|Androgens|androgens|mesh-ancestor
83795673|NCT00202462|Hormones|hormones|mesh-ancestor
83795674|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795675|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795676|NCT00038558|Doxorubicin|doxorubicin|mesh-list
83795677|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83795678|NCT00038558|Bleomycin|bleomycin|mesh-list
83795679|NCT00038558|Dacarbazine|dacarbazine|mesh-list
83795680|NCT00038558|Vinblastine|vinblastine|mesh-list
83795681|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83795682|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795683|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83795684|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83795685|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795686|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795687|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83795688|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
83795689|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83795690|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795691|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795692|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795693|NCT00038597|Lonafarnib|lonafarnib|mesh-list
83795694|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795695|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795696|NCT00202618|Amlodipine|amlodipine|mesh-list
83795697|NCT00202618|Valsartan|valsartan|mesh-list
83795698|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83795699|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83795700|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83795701|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795702|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83795703|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795704|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
83795705|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83795706|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83795707|NCT00202696|Nalmefene|nalmefene|mesh-list
83795708|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83795709|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795710|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
83795711|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795712|NCT00038636|Ritonavir|ritonavir|mesh-list
82950896|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795713|NCT00038636|Lopinavir|lopinavir|mesh-list
83795714|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83795715|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83795716|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
83795717|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795718|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795719|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83795720|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83795721|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
83795722|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795723|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83795724|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83795725|NCT00071838|Daclizumab|daclizumab|mesh-list
83795726|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795727|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
83795728|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795729|NCT00202852|Infliximab|infliximab|mesh-list
83795730|NCT00202852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83795731|NCT00202852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83795732|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83795733|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83795734|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795735|NCT00202891|Sisomicin|sisomicin|mesh-list
83795736|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83795737|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795738|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83795739|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795740|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795741|NCT00202969|Cisplatin|cisplatin|mesh-list
83795742|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795743|NCT00203125|Rasagiline|rasagiline|mesh-list
83795744|NCT00203125|Tyramine|tyramine|mesh-list
83795745|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83795746|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795747|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795748|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83795749|NCT00203125|Protective Agents|protective agents|mesh-ancestor
83795750|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795751|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
83795752|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
83795753|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795754|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83795755|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83795756|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83795757|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83795758|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795759|NCT00203164|Rasagiline|rasagiline|mesh-list
83795760|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83795761|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795762|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795763|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83795764|NCT00203164|Protective Agents|protective agents|mesh-ancestor
83795765|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795766|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
83795767|NCT00203281|Tacrolimus|tacrolimus|mesh-list
83795768|NCT00203281|Daclizumab|daclizumab|mesh-list
83795769|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
83795770|NCT00203281|Antibodies|antibodies|mesh-list
83795771|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
83795772|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83795773|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83795774|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795775|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
83795776|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795777|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83795778|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795779|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795780|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83795781|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795782|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83795783|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
83795784|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83795785|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795786|NCT00203320|Etanercept|etanercept|mesh-list
83795787|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83795788|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83795789|NCT00203320|Analgesics|analgesics|mesh-ancestor
83795790|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
83133590|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83795791|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795792|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795793|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83795794|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795795|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83795796|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795797|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
83795798|NCT00038792|Mitogens|mitogens|mesh-list
83795799|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795800|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795801|NCT00203359|Etanercept|etanercept|mesh-list
83795802|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83795803|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83795804|NCT00203359|Analgesics|analgesics|mesh-ancestor
83795805|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
83795806|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795807|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795808|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83795809|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795810|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83795811|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795812|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
83795813|NCT00410644|Hydromorphone|hydromorphone|mesh-list
83795814|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83795815|NCT00410644|Narcotics|narcotics|mesh-ancestor
83795816|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795817|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795818|NCT00410644|Analgesics|analgesics|mesh-ancestor
83795819|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
83795820|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795821|NCT00038831|Fludarabine|fludarabine|mesh-list
83795822|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
83795823|NCT00038831|Melphalan|melphalan|mesh-list
83795824|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
83795825|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83795826|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
83795827|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795828|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795829|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
83795830|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795831|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795832|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
83795833|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795834|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83795835|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
83795836|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83795837|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83795838|NCT00038831|Immunotoxins|immunotoxins|mesh-ancestor
83795839|NCT00038831|Immunoconjugates|immunoconjugates|mesh-ancestor
83795840|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
83795841|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83795842|NCT00071955|Antibodies|antibodies|mesh-list
83795843|NCT00071955|Sargramostim|sargramostim|mesh-list
83795844|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83795845|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
83133606|NCT03095222|Ketamine|ketamine|mesh-list
83795846|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795847|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83795848|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83795849|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83795850|NCT00203554|Protective Agents|protective agents|mesh-ancestor
83795851|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795852|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
83795853|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83795854|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795855|NCT00071994|Gefitinib|gefitinib|mesh-list
83795856|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795857|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795858|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795859|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795860|NCT00203788|Risperidone|risperidone|mesh-list
83795861|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83795862|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
83795863|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795864|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795865|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795866|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83795867|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82951043|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
83795868|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795869|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83795870|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83795871|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
83795872|NCT00072033|Docetaxel|docetaxel|mesh-list
83795873|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795874|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83795875|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83795876|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83795877|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795878|NCT00203905|Bevacizumab|bevacizumab|mesh-list
83795879|NCT00203905|Fluorouracil|fluorouracil|mesh-list
83795880|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
83795881|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83795882|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795883|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83795884|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83795885|NCT00203905|Growth Substances|growth substances|mesh-ancestor
83795886|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795887|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
83795888|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
83795889|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795890|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795891|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795892|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
83795893|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
83795894|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795895|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83795896|NCT00072072|Celecoxib|celecoxib|mesh-list
83795897|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83795898|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795899|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83795900|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795901|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795902|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83795903|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83795904|NCT00072072|Analgesics|analgesics|mesh-ancestor
83795905|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
83795906|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83795907|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795908|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83795909|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795910|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83795911|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83795912|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
83795913|NCT00204022|Azathioprine|azathioprine|mesh-list
83795914|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83795915|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795916|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83795917|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
82951117|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951118|NCT03854617|Vinorelbine|vinorelbine|mesh-list
82951119|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82951120|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951121|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
82951122|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
82951123|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
82951124|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951125|NCT01186549|Lidocaine|lidocaine|mesh-list
82951126|NCT01186549|Ephedrine|ephedrine|mesh-list
82951127|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
82951128|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
82951129|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
82951130|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951131|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951132|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
82951133|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951134|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82951135|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82951136|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82951137|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82951138|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951139|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82951140|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
83795918|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83795919|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83795920|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795921|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795922|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
83795923|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83795924|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795925|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
83795926|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795927|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795929|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83795930|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83795931|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83795932|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795933|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83795934|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83795935|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
83795936|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83795937|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795938|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83795939|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
83795940|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
83795941|NCT02966652|Testosterone|testosterone|mesh-list
83795942|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
83795943|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
83795944|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83795945|NCT02966652|Androgens|androgens|mesh-ancestor
83795946|NCT02966652|Hormones|hormones|mesh-ancestor
83795947|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795948|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133637|NCT05025098|Azacitidine|azacitidine|mesh-list
83795949|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83795950|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795951|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
83795952|NCT00039026|Exenatide|exenatide|mesh-list
83795953|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83795954|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795955|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83795956|NCT00039026|Incretins|incretins|mesh-ancestor
83795957|NCT00039026|Hormones|hormones|mesh-ancestor
83795958|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795959|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83795960|NCT00204256|Hematinics|hematinics|mesh-ancestor
83795961|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83795962|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83795963|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
83795964|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83795965|NCT00204451|Estradiol|estradiol|mesh-list
83795966|NCT00204451|Estrogens|estrogens|mesh-ancestor
83795967|NCT00204451|Hormones|hormones|mesh-ancestor
83795968|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83795969|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795970|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83795971|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
83795972|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83795973|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83795974|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83795975|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83795976|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83795977|NCT00204529|Interferons|interferons|mesh-list
83795978|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
83795979|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
83795980|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83795981|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795982|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
83795983|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951202|NCT03362190|Ranibizumab|ranibizumab|mesh-list
82951203|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82951204|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82951205|NCT03362190|Growth Substances|growth substances|mesh-ancestor
82951206|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951207|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
82951208|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951209|NCT01292785|Hormones|hormones|mesh-list
82951211|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795985|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795986|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
83795987|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83795988|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83795989|NCT00204568|Doxorubicin|doxorubicin|mesh-list
83795990|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83795991|NCT00204568|Trofosfamide|trofosfamide|mesh-list
83795992|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83795993|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83795994|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83795995|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83795996|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83795997|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83795998|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83795999|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
83796000|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796001|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796002|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
83796003|NCT00072150|Bortezomib|bortezomib|mesh-list
83796004|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796005|NCT00204646|Carboplatin|carboplatin|mesh-list
83796006|NCT00204646|Etoposide|etoposide|mesh-list
83796007|NCT00204646|Doxorubicin|doxorubicin|mesh-list
83796008|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83796009|NCT00204646|Ifosfamide|ifosfamide|mesh-list
83796010|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796011|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83796012|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83796013|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796014|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796015|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796016|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83796017|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796018|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
83796019|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83796020|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796021|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83796022|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796023|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796024|NCT00410878|Hydromorphone|hydromorphone|mesh-list
83796025|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83796026|NCT00410878|Narcotics|narcotics|mesh-ancestor
83796027|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796028|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796029|NCT00410878|Analgesics|analgesics|mesh-ancestor
83796030|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
83796031|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796032|NCT00410995|Naproxen|naproxen|mesh-list
83796033|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83796034|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83796035|NCT00410995|Analgesics|analgesics|mesh-ancestor
83796036|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
83796037|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796038|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796039|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796040|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796041|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
83796042|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83796043|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796044|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796045|NCT00039338|Cisplatin|cisplatin|mesh-list
83796046|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796047|NCT00072228|Gemcitabine|gemcitabine|mesh-list
83796048|NCT00072228|Soblidotin|soblidotin|mesh-list
83796049|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796050|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
83796051|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796052|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796053|NCT00204919|Vitamin D|vitamin d|mesh-list
83796054|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
83796055|NCT00204919|Vitamins|vitamins|mesh-ancestor
83796056|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
83796057|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796058|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83796059|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83796061|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83796062|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83796063|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796064|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796065|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796066|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796067|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83796068|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
83796069|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796070|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83796071|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796072|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796073|NCT00072345|Thalidomide|thalidomide|mesh-list
83796074|NCT00072345|Temozolomide|temozolomide|mesh-list
83796075|NCT00072345|Lomustine|lomustine|mesh-list
83796076|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796077|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
83796078|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796079|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796080|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796081|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
83796082|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796083|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
83796084|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83796085|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796086|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83796087|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83796088|NCT00072345|Growth Substances|growth substances|mesh-ancestor
83796089|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
83796090|NCT00039455|Trastuzumab|trastuzumab|mesh-list
83796091|NCT00039455|Alvocidib|alvocidib|mesh-list
83796092|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83796093|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796094|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
83796095|NCT00039455|Growth Substances|growth substances|mesh-ancestor
83796096|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796097|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83796098|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796099|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796100|NCT00205231|Etanercept|etanercept|mesh-list
83796101|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83796102|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83796103|NCT00205231|Analgesics|analgesics|mesh-ancestor
83796104|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
83796105|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796106|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796107|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796108|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796109|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83796110|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796111|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
83796112|NCT00072462|Tamoxifen|tamoxifen|mesh-list
83796113|NCT00072462|Anastrozole|anastrozole|mesh-list
83796114|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796115|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83796116|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
83796117|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796118|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796119|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83796120|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796121|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83796122|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83796123|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83796124|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83796125|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83796126|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796127|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83796128|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
83796129|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796130|NCT00039494|Temozolomide|temozolomide|mesh-list
82951345|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
83796131|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83796132|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796133|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
83796134|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796135|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133646|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
83796136|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83796137|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796138|NCT00205738|Olanzapine|olanzapine|mesh-list
83796139|NCT00205738|Risperidone|risperidone|mesh-list
83796140|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83796141|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
83796142|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796143|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796144|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796145|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83796146|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83796147|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796148|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796149|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83796150|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
83796151|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
83796152|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
83796153|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796154|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83796155|NCT00205738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83796156|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796157|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796158|NCT00205816|Tigecycline|tigecycline|mesh-list
83796159|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83796160|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796161|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83796162|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796163|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796164|NCT00072540|Celecoxib|celecoxib|mesh-list
83796165|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83796166|NCT00072540|Mitogens|mitogens|mesh-list
83796167|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83796168|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83796169|NCT00072540|Analgesics|analgesics|mesh-ancestor
83796170|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
83796171|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796172|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796173|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796174|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796175|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83796176|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83796177|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796178|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796179|NCT00206050|Esomeprazole|esomeprazole|mesh-list
83796180|NCT00206050|Pantoprazole|pantoprazole|mesh-list
83796181|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83796182|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83796183|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83796184|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796185|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796186|NCT00206089|Ximelagatran|ximelagatran|mesh-list
83796187|NCT00206089|Melagatran|melagatran|mesh-list
82951420|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82951421|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
82951422|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
82951423|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951424|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951425|NCT03850561|Ubiquinone|ubiquinone|mesh-list
82951426|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
82951427|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
82951428|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951429|NCT03850561|Vitamins|vitamins|mesh-ancestor
82951449|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
82951450|NCT01190137|Vitamin D|vitamin d|mesh-list
82951451|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
82951452|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82951453|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951454|NCT01190137|Vitamins|vitamins|mesh-ancestor
82951455|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
82951456|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83796188|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
83796189|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83796190|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
83796191|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796192|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796193|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
83796194|NCT00072579|Sargramostim|sargramostim|mesh-list
83796195|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
83796196|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796197|NCT04732247|Oxytocin|oxytocin|mesh-list
83796198|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
83796199|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83796200|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796201|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83796202|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796203|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796204|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83796205|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83796206|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796207|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796208|NCT00206167|Budesonide|budesonide|mesh-list
83796209|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
83796210|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796211|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83796212|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
83796213|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796214|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796215|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83796216|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83796217|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
83796218|NCT00206167|Hormones|hormones|mesh-ancestor
83796219|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796220|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83796221|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83796222|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83796223|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83796224|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796225|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796226|NCT00039611|Leucovorin|leucovorin|mesh-list
83796227|NCT00039611|Fluorouracil|fluorouracil|mesh-list
83796228|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
83796229|NCT00039611|Calcium|calcium|mesh-list
83796230|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
83796231|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83796232|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796233|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
83796234|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796235|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796236|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796237|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796238|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
83796239|NCT00039611|Antidotes|antidotes|mesh-ancestor
83796240|NCT00039611|Protective Agents|protective agents|mesh-ancestor
83796241|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
83796242|NCT00039611|Vitamins|vitamins|mesh-ancestor
83796243|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
83796244|NCT00068289|Bortezomib|bortezomib|mesh-list
83796245|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796246|NCT00039767|Lepirudin|lepirudin|mesh-list
83796247|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
83796248|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83796249|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
83796250|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796251|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796252|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
83796253|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83796254|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83796255|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
83796256|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796257|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83796258|NCT00072618|Protective Agents|protective agents|mesh-ancestor
83796259|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796260|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83796261|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796262|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796263|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83796264|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83796266|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
83796267|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796268|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796269|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796270|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
83796271|NCT00039884|Hematinics|hematinics|mesh-ancestor
83796272|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
83796273|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83796274|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796275|NCT00399204|Metformin|metformin|mesh-list
83796276|NCT00399204|Pioglitazone|pioglitazone|mesh-list
83796277|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83796278|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796279|NCT00411034|Hydromorphone|hydromorphone|mesh-list
83796280|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83796281|NCT00411034|Narcotics|narcotics|mesh-ancestor
83796282|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796283|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796284|NCT00411034|Analgesics|analgesics|mesh-ancestor
83796285|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
83796286|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796287|NCT00411073|Darapladib|darapladib|mesh-list
83796288|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83796289|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796290|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796291|NCT00411190|Acetaminophen|acetaminophen|mesh-list
83796292|NCT00411190|Ibuprofen|ibuprofen|mesh-list
83796293|NCT00411190|Atorvastatin|atorvastatin|mesh-list
83796294|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83796295|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83796296|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
83133686|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83796297|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796298|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83796299|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83796300|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796301|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83796302|NCT00411190|Analgesics|analgesics|mesh-ancestor
83796303|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
83796304|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796305|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796306|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
83796307|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83796308|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796309|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796310|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83796311|NCT00411229|Capecitabine|capecitabine|mesh-list
83796312|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
83796313|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796314|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
83796315|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796316|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796317|NCT00411268|Hydromorphone|hydromorphone|mesh-list
83796318|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83796319|NCT00411268|Narcotics|narcotics|mesh-ancestor
83796320|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796321|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796322|NCT00411268|Analgesics|analgesics|mesh-ancestor
83796323|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
83796324|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796325|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83796326|NCT00039962|Thymalfasin|thymalfasin|mesh-list
83796327|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
83796328|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796329|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83796330|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
83796331|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796332|NCT00424333|Insulin|insulin|mesh-list
83796333|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83796334|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83796335|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796336|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83796337|NCT00206557|Estradiol|estradiol|mesh-list
83796338|NCT00206557|Estrogens|estrogens|mesh-ancestor
83796339|NCT00206557|Hormones|hormones|mesh-ancestor
83796340|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796341|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796342|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83796343|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
83796344|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83796345|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83796346|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83796347|NCT00068484|Bortezomib|bortezomib|mesh-list
83796348|NCT00068484|Topotecan|topotecan|mesh-list
83796349|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796350|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83796351|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796352|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796353|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796354|NCT00206596|Sargramostim|sargramostim|mesh-list
83796355|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
83796356|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796357|NCT00206635|Interferons|interferons|mesh-list
83796358|NCT00206635|Interferon-beta|interferon-beta|mesh-list
83796359|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
83796360|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796361|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
83796362|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796363|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
83796364|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796365|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83796366|NCT00206674|Sargramostim|sargramostim|mesh-list
83796367|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
83796368|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796369|NCT00206713|Sargramostim|sargramostim|mesh-list
83796370|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
83796371|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796372|NCT00040040|Bupropion|bupropion|mesh-list
83796373|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83796374|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796375|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796376|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83796377|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796378|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796379|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796380|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
83796381|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796382|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796383|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83796384|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83796385|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796386|NCT00068523|Cyclosporine|cyclosporine|mesh-list
83796387|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
83796388|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
83796389|NCT00068523|Fludarabine|fludarabine|mesh-list
83796390|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
83796391|NCT00068523|Cyclosporins|cyclosporins|mesh-list
83796392|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83796393|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796394|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
83796395|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796396|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796397|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796398|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
83796399|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796400|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796401|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83796402|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796403|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
83796404|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796405|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
83796406|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796407|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83796408|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83796409|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796410|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
83796411|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
83796412|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796413|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83796414|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
83796415|NCT00068523|Hormones|hormones|mesh-ancestor
83834941|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796416|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796417|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83796418|NCT00068523|Protective Agents|protective agents|mesh-ancestor
83796419|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
83796420|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83796421|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83796422|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796423|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796424|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
83796425|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796426|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83796427|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83796428|NCT00206947|Ziprasidone|ziprasidone|mesh-list
83796429|NCT00206947|Donepezil|donepezil|mesh-list
83796430|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83796431|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796432|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796433|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
83796434|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796435|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796436|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
83796437|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83796438|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
83796439|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83796440|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83796441|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796442|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796443|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83796444|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
83796445|NCT00068757|Paclitaxel|paclitaxel|mesh-list
83796446|NCT00068757|Trastuzumab|trastuzumab|mesh-list
83796447|NCT00068757|Lonafarnib|lonafarnib|mesh-list
83796448|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83796449|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796450|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796451|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796452|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796453|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796454|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83796455|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796456|NCT00206986|Clonidine|clonidine|mesh-list
83796457|NCT00206986|Analgesics|analgesics|mesh-ancestor
83796458|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
83796459|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796460|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796461|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83796462|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
83796463|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
83796464|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83796465|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83796466|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83796467|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
83796468|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796469|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796470|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83796471|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796472|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796473|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83796474|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83796475|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796476|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796477|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
83796478|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83796479|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83796480|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796481|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796482|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
83796483|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796484|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83796485|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83796486|NCT00072852|Irinotecan|irinotecan|mesh-list
83796487|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83796488|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82951720|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83796489|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796490|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796491|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796493|NCT00207532|Hematinics|hematinics|mesh-ancestor
83796494|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
83796495|NCT00207532|Vitamins|vitamins|mesh-ancestor
83796496|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
83796497|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796498|NCT00040391|Leucovorin|leucovorin|mesh-list
83796499|NCT00040391|Fluorouracil|fluorouracil|mesh-list
83796500|NCT00040391|Irinotecan|irinotecan|mesh-list
83796501|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
83796502|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796503|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796504|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796505|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796506|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
83796507|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796508|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83796509|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796510|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796511|NCT00040391|Antidotes|antidotes|mesh-ancestor
83796512|NCT00040391|Protective Agents|protective agents|mesh-ancestor
83796513|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
83796514|NCT00040391|Vitamins|vitamins|mesh-ancestor
83796515|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
83796516|NCT00207688|Infliximab|infliximab|mesh-list
83796517|NCT00207688|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83796518|NCT00207688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796519|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
83796520|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83796521|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796522|NCT00207766|Infliximab|infliximab|mesh-list
83796523|NCT00207766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83796524|NCT00207766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796525|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
83796526|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83796527|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796528|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
83796529|NCT00040469|Busulfan|busulfan|mesh-list
83796530|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
83796531|NCT00040469|Phenytoin|phenytoin|mesh-list
83796532|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796533|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
83796534|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796535|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796536|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796537|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
83796538|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796539|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796540|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83796541|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83796542|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
83796543|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83796544|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83796545|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796546|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83796547|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83796548|NCT00207844|Selenium|selenium|mesh-list
83796549|NCT00207844|Selenious Acid|selenious acid|mesh-list
83796550|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
83796551|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
83796552|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796553|NCT00207844|Protective Agents|protective agents|mesh-ancestor
83796554|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796555|NCT00207844|Trace Elements|trace elements|mesh-ancestor
83796556|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
83796557|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
83796558|NCT00072930|Prednisone|prednisone|mesh-list
83796559|NCT00072930|Docetaxel|docetaxel|mesh-list
83796560|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796561|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796562|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796563|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796564|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796565|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796566|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
83796567|NCT00072930|Hormones|hormones|mesh-ancestor
83796568|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796569|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796570|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83796571|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83796572|NCT00411307|Hydromorphone|hydromorphone|mesh-list
83796573|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83796574|NCT00411307|Narcotics|narcotics|mesh-ancestor
83796575|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796576|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796577|NCT00411307|Analgesics|analgesics|mesh-ancestor
83796578|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
83796579|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796581|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83796582|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796583|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83796584|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796585|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
83796586|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796587|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
83796588|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796589|NCT00424411|Insulin|insulin|mesh-list
83796590|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83796591|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83796592|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796593|NCT00072969|Daclizumab|daclizumab|mesh-list
83796594|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796595|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
83796596|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796597|NCT00424606|Docetaxel|docetaxel|mesh-list
83796598|NCT00424606|Epirubicin|epirubicin|mesh-list
83796599|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796600|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796601|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796602|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796603|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796604|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83796605|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83796606|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796607|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796608|NCT00208039|Calfactant|calfactant|mesh-list
83796609|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83796610|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83796611|NCT02962921|Insulin|insulin|mesh-list
83796612|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83796613|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
83796614|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83796615|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796616|NCT00040586|Interleukin-2|interleukin-2|mesh-list
83796617|NCT00040586|Antibodies|antibodies|mesh-list
83796618|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83796619|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
83796620|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796621|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796622|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83796623|NCT00040586|Analgesics|analgesics|mesh-ancestor
83796624|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
83796625|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796626|NCT00208117|Sertraline|sertraline|mesh-list
83796627|NCT00208117|Simvastatin|simvastatin|mesh-list
83796628|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83796629|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83796630|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
83796631|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796632|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83796633|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83796634|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796635|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796636|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796637|NCT00208117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83796638|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796639|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796640|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796641|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
83796642|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796643|NCT00208156|Mifepristone|mifepristone|mesh-list
83796644|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83796645|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
83796646|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83796647|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796648|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83796649|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83796650|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83796651|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
83796652|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83796653|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83796654|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048359|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796655|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796656|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
83796657|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83796658|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83796659|NCT00040625|Pemetrexed|pemetrexed|mesh-list
83796660|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796661|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796662|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796663|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83796664|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83796665|NCT00208195|Valproic Acid|valproic acid|mesh-list
83796666|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
83796667|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796668|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796669|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
83796670|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796671|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796672|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
83796673|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83796674|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796675|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796676|NCT00208234|Omalizumab|omalizumab|mesh-list
83796677|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83796678|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83796679|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83796680|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
83796681|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
83796682|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796683|NCT00208273|Letrozole|letrozole|mesh-list
83796684|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796685|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83796686|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83796687|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796688|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796689|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83796690|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
83796691|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796692|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796693|NCT00208312|Adenosine|adenosine|mesh-list
83796694|NCT00208312|Regadenoson|regadenoson|mesh-list
83796695|NCT00208312|Analgesics|analgesics|mesh-ancestor
83796696|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
83796697|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796698|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796699|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83796700|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
83796701|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83796702|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
83796703|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
83796704|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796705|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796706|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83796707|NCT00040781|Gefitinib|gefitinib|mesh-list
83796708|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796709|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83796710|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796711|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796712|NCT00068952|Temozolomide|temozolomide|mesh-list
83796713|NCT00068952|Carmustine|carmustine|mesh-list
83796714|NCT00068952|Lomustine|lomustine|mesh-list
83796715|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796716|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
82951941|NCT03480243|Anticonvulsants|anticonvulsants|mesh-ancestor
83796717|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796718|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796719|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
83796720|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796721|NCT00208546|Bevacizumab|bevacizumab|mesh-list
83796722|NCT00208546|Cetuximab|cetuximab|mesh-list
83796723|NCT00208546|Capecitabine|capecitabine|mesh-list
83796724|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
83796725|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83796726|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796727|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83796728|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83796729|NCT00208546|Growth Substances|growth substances|mesh-ancestor
83796730|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796731|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
83796732|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796733|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
83796734|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796735|NCT00208585|Sertraline|sertraline|mesh-list
83796736|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796737|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796738|NCT00208585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83796739|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796740|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796741|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796742|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796743|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
83796744|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796745|NCT00040859|Capecitabine|capecitabine|mesh-list
83796746|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
83796747|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796748|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
83796749|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796750|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796751|NCT00208702|Sertraline|sertraline|mesh-list
83796752|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796753|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796754|NCT00208702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83796755|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796756|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796757|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796758|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796759|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
83796760|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796761|NCT00208741|Tiagabine|tiagabine|mesh-list
83796762|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
83796763|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83796764|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796765|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796766|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796767|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
83796768|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796769|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796770|NCT00399048|Hydromorphone|hydromorphone|mesh-list
83796771|NCT00399048|Oxycodone|oxycodone|mesh-list
83796772|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83796773|NCT00399048|Narcotics|narcotics|mesh-ancestor
83796774|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796775|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796776|NCT00399048|Analgesics|analgesics|mesh-ancestor
83796777|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
83796778|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796779|NCT00208819|Valproic Acid|valproic acid|mesh-list
83796780|NCT00208819|Olanzapine|olanzapine|mesh-list
83796781|NCT00208819|Risperidone|risperidone|mesh-list
83796782|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83796783|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83796784|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
83796785|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796786|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796787|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796788|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83796789|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83796790|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796791|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796792|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83796793|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
83796794|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
83796795|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
83796796|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796797|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83796798|NCT00208819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83796799|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796800|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796801|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796802|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
83796803|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796804|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
83796805|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
83796806|NCT00208858|Topiramate|topiramate|mesh-list
83796807|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
83796808|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83796809|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796810|NCT00041015|Etoposide|etoposide|mesh-list
83796811|NCT00041015|Topotecan|topotecan|mesh-list
83796812|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796813|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83796814|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83796815|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796816|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796817|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796818|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83796819|NCT00073047|Daclizumab|daclizumab|mesh-list
83796820|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796821|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
83796822|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796823|NCT00208897|Fluoxetine|fluoxetine|mesh-list
83796824|NCT00208897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83796825|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83796826|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83796827|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796828|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83796829|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
83796830|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796831|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83796832|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
83796833|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83796834|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83796835|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83796836|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796837|NCT00208936|Fluorouracil|fluorouracil|mesh-list
83796838|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796839|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
83796840|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796841|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796842|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796843|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
83796844|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796845|NCT00209014|Thalidomide|thalidomide|mesh-list
83796846|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796847|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
83796848|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796849|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
83796850|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83796851|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796852|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83796853|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83796854|NCT00209014|Growth Substances|growth substances|mesh-ancestor
83796855|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
83796856|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796857|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
83796858|NCT00041054|Carboplatin|carboplatin|mesh-list
83796859|NCT00041054|Etoposide|etoposide|mesh-list
83796860|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796861|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83796862|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83796863|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82952090|NCT01209845|Analgesics|analgesics|mesh-ancestor
83796864|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796865|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796866|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83796867|NCT00041054|Protective Agents|protective agents|mesh-ancestor
83796868|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796869|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83796870|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83796871|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83796872|NCT00041054|Analgesics|analgesics|mesh-ancestor
83796873|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
83796874|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83796875|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796876|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796877|NCT00209209|Interferons|interferons|mesh-list
83796878|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
83796879|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
83796880|NCT00209209|Prednisone|prednisone|mesh-list
83796881|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
83796882|NCT00209209|Rituximab|rituximab|mesh-list
83796883|NCT00209209|Doxorubicin|doxorubicin|mesh-list
83796884|NCT00209209|Fludarabine|fludarabine|mesh-list
83796885|NCT00209209|Vincristine|vincristine|mesh-list
83796886|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796887|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
83796888|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796889|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83796890|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83796891|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
83796892|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796893|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796894|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83796895|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83796896|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83796897|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83796898|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796899|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796900|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796901|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
83796902|NCT00209209|Hormones|hormones|mesh-ancestor
83796903|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796904|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83796905|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
83796906|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796907|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83796908|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796909|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796910|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796911|NCT00041093|Docetaxel|docetaxel|mesh-list
83796912|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796913|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796914|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796915|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796916|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796917|NCT00399087|Prednisone|prednisone|mesh-list
83796918|NCT00399087|Docetaxel|docetaxel|mesh-list
83796919|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796920|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796921|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796922|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796923|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796924|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83796925|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
83796926|NCT00399087|Hormones|hormones|mesh-ancestor
83796927|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83796928|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796929|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83796930|NCT00209482|Metformin|metformin|mesh-list
83796931|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83796932|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796933|NCT00041171|Docetaxel|docetaxel|mesh-list
83796934|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796935|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796936|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796937|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796938|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952168|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
83796939|NCT00209521|Propofol|propofol|mesh-list
83796941|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83796942|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83796943|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796944|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83796945|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
83796946|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
83796947|NCT00209638|Irinotecan|irinotecan|mesh-list
83796948|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83796949|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83796950|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796951|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796952|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796953|NCT00399126|Paclitaxel|paclitaxel|mesh-list
83796954|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83796955|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796956|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796957|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796958|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796959|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796960|NCT00209677|Gemcitabine|gemcitabine|mesh-list
83796961|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796962|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
83796963|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796964|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796965|NCT00209716|Cisplatin|cisplatin|mesh-list
83796966|NCT00209716|Docetaxel|docetaxel|mesh-list
83796967|NCT00209716|Fluorouracil|fluorouracil|mesh-list
83796968|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83796969|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
83796970|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
83796971|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
83796972|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796973|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
83796974|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83796975|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83796976|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
83796977|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83796978|NCT00209755|Ribavirin|ribavirin|mesh-list
83796979|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
83796980|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796981|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
83796982|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796983|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
83796984|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
83796985|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83796986|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
83796987|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83796988|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83796989|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83796990|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83796991|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83796992|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83796993|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83796994|NCT00209833|Cytarabine|cytarabine|mesh-list
83796995|NCT00209833|Fludarabine|fludarabine|mesh-list
83796996|NCT00209833|Etoposide|etoposide|mesh-list
83796997|NCT00209833|Idarubicin|idarubicin|mesh-list
83796998|NCT00209833|Daunorubicin|daunorubicin|mesh-list
83796999|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797000|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797001|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
83797002|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797003|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83797004|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
83797005|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797006|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83797007|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83797008|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83797009|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797010|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
83797011|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797012|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83797013|NCT00041210|Prednisone|prednisone|mesh-list
83797014|NCT00041210|Doxorubicin|doxorubicin|mesh-list
82952238|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83797015|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83797016|NCT00041210|Bleomycin|bleomycin|mesh-list
83797017|NCT00041210|Etoposide|etoposide|mesh-list
83797018|NCT00041210|Vincristine|vincristine|mesh-list
83797019|NCT00041210|Dacarbazine|dacarbazine|mesh-list
83797020|NCT00041210|Vinblastine|vinblastine|mesh-list
83797021|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
83797022|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83797023|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797024|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83797025|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83797026|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797027|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797028|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83797029|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
83797030|NCT00041210|Hormones|hormones|mesh-ancestor
83797031|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797032|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797033|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83797034|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83797035|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
83797036|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
83797037|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
83797038|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83797039|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
83797040|NCT00209872|Lidocaine|lidocaine|mesh-list
83797041|NCT00209872|Ketamine|ketamine|mesh-list
83797042|NCT00209872|Gabapentin|gabapentin|mesh-list
83797043|NCT00209872|Esketamine|esketamine|mesh-list
83797044|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
83797045|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
83797046|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797047|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797048|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
83797049|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797050|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83797051|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83797052|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83797053|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797054|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797055|NCT00209872|Analgesics|analgesics|mesh-ancestor
83797056|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83797057|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83797058|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
83797059|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83797060|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83797061|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797062|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
83797063|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83797064|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797065|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797066|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
83797067|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
83797068|NCT00209950|Gaboxadol|gaboxadol|mesh-list
83797069|NCT00209950|Analgesics|analgesics|mesh-ancestor
83797070|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
83797071|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797072|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797073|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
83797074|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
83797075|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
83797076|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797077|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797078|NCT00209989|Tipifarnib|tipifarnib|mesh-list
83797079|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797080|NCT00210028|Tamoxifen|tamoxifen|mesh-list
83797081|NCT00210028|Tipifarnib|tipifarnib|mesh-list
83797082|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82952314|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797083|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
83797084|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797085|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952315|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952316|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952317|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952318|NCT01211327|Cyclosporine|cyclosporine|mesh-list
83797086|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83797087|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797088|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83797089|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83797090|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83797091|NCT00041288|Cyclosporine|cyclosporine|mesh-list
83797092|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
83797093|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
83797094|NCT00041288|Methotrexate|methotrexate|mesh-list
83797095|NCT00041288|Fludarabine|fludarabine|mesh-list
83797096|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
83797097|NCT00041288|Tacrolimus|tacrolimus|mesh-list
83797098|NCT00041288|Cyclosporins|cyclosporins|mesh-list
83797099|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83797100|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
83797101|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797102|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797103|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83797104|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
83797105|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797106|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797107|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83797108|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83797109|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
83797110|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83797111|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797112|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
83797113|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
83797114|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797115|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83797116|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83797117|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83797118|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
83797119|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797120|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83797121|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83797122|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
83797123|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83797124|NCT00073164|Valproic Acid|valproic acid|mesh-list
83797125|NCT00073164|Olanzapine|olanzapine|mesh-list
83797126|NCT00073164|Risperidone|risperidone|mesh-list
83797127|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83797128|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
83797129|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797130|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797131|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797132|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83797133|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797134|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797135|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797136|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83797137|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
83797138|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
83797139|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
83797140|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797141|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83797142|NCT00073164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83797143|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83797144|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797145|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
83797146|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797147|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
83797148|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
83797149|NCT00210301|Modafinil|modafinil|mesh-list
83797150|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83797151|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797152|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83797153|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83797154|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83797155|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797156|NCT00210340|Rituximab|rituximab|mesh-list
83797157|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83797158|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797159|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
83797160|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797161|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797162|NCT00411541|Dexamethasone|dexamethasone|mesh-list
83797163|NCT00411541|Vincristine|vincristine|mesh-list
83797164|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83797165|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
83797166|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
83797167|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797168|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797169|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83797170|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
83797171|NCT00411541|Hormones|hormones|mesh-ancestor
83797172|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797173|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83797174|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797175|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83797176|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
83797177|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
83797178|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
83797179|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797180|NCT00210379|Rituximab|rituximab|mesh-list
83797181|NCT00210379|Methotrexate|methotrexate|mesh-list
83797182|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83797183|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797184|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
83797185|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797186|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797187|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83797188|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
83797189|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83797190|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797191|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
83797192|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797193|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
83797194|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797195|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83797196|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83797197|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83797198|NCT00041327|Interferons|interferons|mesh-list
83797199|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
83797200|NCT00041327|Lamivudine|lamivudine|mesh-list
83797201|NCT00041327|Zidovudine|zidovudine|mesh-list
83797202|NCT00041327|Prednisone|prednisone|mesh-list
83797203|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
83797204|NCT00041327|Doxorubicin|doxorubicin|mesh-list
83797205|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83797206|NCT00041327|Etoposide|etoposide|mesh-list
83797207|NCT00041327|Vincristine|vincristine|mesh-list
83797208|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83797209|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
83797210|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797211|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797212|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83797213|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
83797214|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797215|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797216|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83797217|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83797218|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83797219|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83797220|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797221|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83797222|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
83797223|NCT00041327|Hormones|hormones|mesh-ancestor
83797224|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797225|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83797226|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83797227|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
83797228|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797229|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
83133825|NCT03286959|Calcium|calcium|mesh-list
83797230|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
83797231|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
83797232|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83797233|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83797234|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83797235|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82952463|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
83797236|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
83797237|NCT00210457|Lanreotide|lanreotide|mesh-list
83797238|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797239|NCT00210496|Topiramate|topiramate|mesh-list
83797240|NCT00210496|Almotriptan|almotriptan|mesh-list
83797241|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
83797242|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797243|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797244|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83797245|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
83797246|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797247|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797248|NCT00210535|Topiramate|topiramate|mesh-list
83797249|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
83797250|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797251|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797252|NCT00210574|Topiramate|topiramate|mesh-list
83797253|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
83797254|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797255|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797256|NCT00210691|Risperidone|risperidone|mesh-list
83797257|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83797258|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
83797259|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797260|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797261|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797262|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83797263|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797264|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797265|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797266|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83797267|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
83797268|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
83797269|NCT00210730|Hematinics|hematinics|mesh-ancestor
83797270|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83797271|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83797272|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797273|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797274|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797275|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797276|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83797277|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83797278|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
83797279|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797280|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797281|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83797282|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83797283|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
83797284|NCT00210808|Topiramate|topiramate|mesh-list
83797285|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
83797286|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797287|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797288|NCT00210847|Acetaminophen|acetaminophen|mesh-list
83797289|NCT00210847|Tramadol|tramadol|mesh-list
83797290|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83797291|NCT00210847|Analgesics|analgesics|mesh-ancestor
83797292|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
83797293|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797294|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797295|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
83797296|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83797297|NCT00210847|Narcotics|narcotics|mesh-ancestor
83797298|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797299|NCT00210886|Levofloxacin|levofloxacin|mesh-list
83797300|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83797301|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797302|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83797303|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83797304|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83797305|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797306|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797307|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952537|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797308|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83797309|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83797310|NCT00210925|Topiramate|topiramate|mesh-list
83797311|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
83797312|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797313|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797314|NCT00211003|Doripenem|doripenem|mesh-list
83797315|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83797316|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797317|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
83797318|NCT00211120|Hematinics|hematinics|mesh-ancestor
83797319|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
83797320|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797321|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
83797322|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797323|NCT00211315|Anecortave|anecortave|mesh-list
83797324|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83797325|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83797326|NCT00211315|Growth Substances|growth substances|mesh-ancestor
83797327|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797328|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
83797329|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797330|NCT00211354|Anecortave|anecortave|mesh-list
83797331|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83797332|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83797333|NCT00211354|Growth Substances|growth substances|mesh-ancestor
83797334|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797335|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
83797336|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797337|NCT00211393|Ketoconazole|ketoconazole|mesh-list
83797338|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
83797339|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797340|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83797341|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83797342|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797343|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797344|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83797345|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
83797346|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797347|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797348|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83797349|NCT00211432|Anecortave|anecortave|mesh-list
83797350|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83797351|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83797352|NCT00211432|Growth Substances|growth substances|mesh-ancestor
83797353|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797354|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
83797355|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797356|NCT00211471|Anecortave|anecortave|mesh-list
83797357|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83797358|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83797359|NCT00211471|Growth Substances|growth substances|mesh-ancestor
83797360|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797361|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
83797362|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797363|NCT00211588|Galantamine|galantamine|mesh-list
83797364|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83797365|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797366|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797367|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
83797368|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797369|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797370|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83797371|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
83797372|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797373|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
83797374|NCT00211705|Pravastatin|pravastatin|mesh-list
83797375|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83797376|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83797377|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
83797378|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797379|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83797380|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83797381|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797382|NCT00211744|Topiramate|topiramate|mesh-list
83797383|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
83797384|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797385|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797386|NCT00211939|Atorvastatin|atorvastatin|mesh-list
83797387|NCT00211939|Calcium|calcium|mesh-list
83797388|NCT00211939|Sevelamer|sevelamer|mesh-list
83797389|NCT00211939|Calcium acetate|calcium acetate|mesh-list
83797390|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83797391|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797392|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83797393|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83797394|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
83797395|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797396|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83797397|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83797398|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797399|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
83797400|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
83797401|NCT00211978|Calcium|calcium|mesh-list
83797402|NCT00211978|Calcium acetate|calcium acetate|mesh-list
83797403|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83797404|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797405|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
83797406|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
83797407|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797408|NCT00212017|Voglibose|voglibose|mesh-list
83797409|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797410|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797411|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83797412|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797413|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797414|NCT00212095|Ketoconazole|ketoconazole|mesh-list
83797415|NCT00212095|Docetaxel|docetaxel|mesh-list
83797416|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797417|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83797418|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83797419|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83797420|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797421|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
83797422|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797423|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83797424|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83797425|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797426|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83797427|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
83797428|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797429|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797430|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83797431|NCT00212173|Sibutramine|sibutramine|mesh-list
83797432|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
83797433|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797434|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
83797435|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83797436|NCT00212212|Selenium|selenium|mesh-list
83797437|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
83797438|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797439|NCT00212212|Protective Agents|protective agents|mesh-ancestor
83797440|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797441|NCT00212212|Trace Elements|trace elements|mesh-ancestor
83797442|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
83797443|NCT00212290|Pioglitazone|pioglitazone|mesh-list
83797444|NCT00212290|Nateglinide|nateglinide|mesh-list
83797445|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797446|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797447|NCT00073203|Paroxetine|paroxetine|mesh-list
83797448|NCT00073203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83797449|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83797450|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797451|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797452|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797453|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
83797454|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797455|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83797456|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
83797457|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797458|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83797459|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83797460|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797462|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83797463|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797464|NCT00212602|Aprepitant|aprepitant|mesh-list
83797465|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
83797466|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
83797467|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
83797468|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797469|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797470|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83797471|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83797472|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797473|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797474|NCT00212680|Landiolol|landiolol|mesh-list
83797475|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83797476|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83797477|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797478|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797479|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797480|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797481|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83797482|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
83797483|NCT00212875|Hematinics|hematinics|mesh-ancestor
83797484|NCT00213070|Miglitol|miglitol|mesh-list
83797485|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797486|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797487|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797488|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797489|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83797490|NCT00213109|Miglitol|miglitol|mesh-list
83797491|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797492|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797493|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797494|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797495|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83797496|NCT00213226|Dexamethasone|dexamethasone|mesh-list
83797497|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83797498|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
83797499|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
83797500|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797501|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797502|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83797503|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
83797504|NCT00213226|Hormones|hormones|mesh-ancestor
83797505|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797506|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83797507|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797508|NCT00213265|Vaccines|vaccines|mesh-list
83797509|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83797510|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
83797511|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797512|NCT00213538|Methotrexate|methotrexate|mesh-list
83797513|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83797514|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83797515|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
83797516|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83797517|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797518|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797519|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
83797520|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797521|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797522|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
83797523|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797524|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83797525|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83797526|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
83797527|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797528|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83797529|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
83797530|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83797531|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797532|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797533|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
83797534|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797535|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797536|NCT00213694|Celecoxib|celecoxib|mesh-list
83797537|NCT00213694|Docetaxel|docetaxel|mesh-list
83797538|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797539|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83797540|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
83797541|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83797542|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797543|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83797544|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83797545|NCT00213694|Analgesics|analgesics|mesh-ancestor
83797546|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
83797547|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797548|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797549|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83797550|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797551|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83797552|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83797553|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797554|NCT00214084|Allopurinol|allopurinol|mesh-list
83797555|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
83797556|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797557|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797558|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
83797559|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797560|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83797561|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
83797562|NCT00214084|Protective Agents|protective agents|mesh-ancestor
83797563|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797564|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
83797565|NCT00214240|Antibodies|antibodies|mesh-list
83797566|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
83797567|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83797568|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83797569|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
83133851|NCT02251249|Analgesics|analgesics|mesh-ancestor
83797570|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797571|NCT00214318|Metoprolol|metoprolol|mesh-list
83797572|NCT00214318|Carvedilol|carvedilol|mesh-list
83797573|NCT00214318|Terbutaline|terbutaline|mesh-list
83797574|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83797575|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83797576|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
83797577|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
83797578|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797579|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797580|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83797581|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83797582|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83797583|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797584|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797585|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797586|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
83797587|NCT00214318|Protective Agents|protective agents|mesh-ancestor
83797588|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83797589|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797590|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83797591|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
83797592|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83797593|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83797594|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83797595|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83797596|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
83797597|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
83797598|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
83797599|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83797600|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83797601|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83797602|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83797603|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83797604|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
83797605|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797606|NCT00214552|Rabeprazole|rabeprazole|mesh-list
83797607|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83797608|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83797609|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83797610|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797611|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797612|NCT00069459|Bupropion|bupropion|mesh-list
83797613|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83797614|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
83797615|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797616|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83797617|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83797618|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797619|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797620|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
83797621|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797622|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797623|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83797624|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83797625|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797626|NCT00214630|Atorvastatin|atorvastatin|mesh-list
83797627|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83797628|NCT00214630|Calcium|calcium|mesh-list
83797629|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83797630|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797631|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83797632|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83797633|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
83797634|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797635|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83797636|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83797637|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797638|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83797639|NCT00214825|Eplerenone|eplerenone|mesh-list
83797640|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83797641|NCT00214825|Diuretics|diuretics|mesh-ancestor
83797642|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
83797643|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797644|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83797645|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83797646|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797647|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83797648|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
83797649|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797650|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83797651|NCT00214864|Docetaxel|docetaxel|mesh-list
83797652|NCT00214864|Capecitabine|capecitabine|mesh-list
83797653|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797654|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
83797655|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
83797656|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
83797657|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797658|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797659|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
83797660|NCT00214942|Fentanyl|fentanyl|mesh-list
83797661|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83797662|NCT00214942|Narcotics|narcotics|mesh-ancestor
83797663|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797664|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797665|NCT00214942|Analgesics|analgesics|mesh-ancestor
83797666|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
83797667|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797668|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83797669|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83797670|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
83797671|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
83797672|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83797673|NCT00069498|Mesalamine|mesalamine|mesh-list
83797674|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
83797675|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83797676|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797677|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83797678|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83797679|NCT00069498|Analgesics|analgesics|mesh-ancestor
83797680|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
83797681|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797682|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797683|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83797684|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83797685|NCT00214981|Modafinil|modafinil|mesh-list
83797686|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83797687|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797688|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83797689|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83797690|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83797691|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797692|NCT00397241|Timolol|timolol|mesh-list
83797693|NCT00397241|Dorzolamide|dorzolamide|mesh-list
83797694|NCT00397241|Latanoprost|latanoprost|mesh-list
83797695|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
83797696|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83797697|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83797698|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797699|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797700|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797701|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797702|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83797703|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83797704|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83797705|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83797706|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83797707|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797708|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83797709|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83797710|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797711|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797712|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797713|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797714|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83797715|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83797716|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
83797717|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797718|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797719|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83797720|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83797721|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
83797722|NCT00215176|Modafinil|modafinil|mesh-list
83797723|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83797724|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797725|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83797726|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83797727|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83797728|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797729|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83797730|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
83797731|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797732|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83797733|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797734|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797735|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797736|NCT00041483|Anecortave|anecortave|mesh-list
83797737|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83797738|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83797739|NCT00041483|Growth Substances|growth substances|mesh-ancestor
83797740|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797741|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
83797742|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797743|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
83797744|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83797745|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
83797746|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797747|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797748|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83797749|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
83797750|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83797751|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83797752|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83797753|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797754|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797755|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797756|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
83797757|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83797758|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
83797759|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797760|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797761|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83797762|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
83797763|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83797764|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83797765|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83797766|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797767|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797768|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797769|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
83797770|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83797771|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
83797772|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797773|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797774|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83797775|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
83797776|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83797777|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83797778|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83797779|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797780|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797781|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797782|NCT00215722|Cetuximab|cetuximab|mesh-list
83797783|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83797784|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797785|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83797786|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
83797787|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797788|NCT00215839|Ribavirin|ribavirin|mesh-list
83797789|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
83797790|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797791|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
83797792|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797793|NCT00215956|Topotecan|topotecan|mesh-list
83797794|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83797795|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83797796|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797797|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797798|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797799|NCT00215995|Cisplatin|cisplatin|mesh-list
83797800|NCT00215995|Irinotecan|irinotecan|mesh-list
83797801|NCT00215995|Gefitinib|gefitinib|mesh-list
83797802|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797803|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83797804|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83797805|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797806|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797807|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83797808|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
83797809|NCT00216034|Tegafur|tegafur|mesh-list
83797810|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797811|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
83797812|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797813|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797814|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83797815|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
83797816|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797817|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83797818|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
83797819|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797820|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
83797821|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83797822|NCT00216034|Protective Agents|protective agents|mesh-ancestor
83797823|NCT00216073|Capecitabine|capecitabine|mesh-list
83797824|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
83797825|NCT00216073|Trastuzumab|trastuzumab|mesh-list
83797826|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797827|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
83797828|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797829|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797830|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83797831|NCT00216112|Docetaxel|docetaxel|mesh-list
83797832|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
83797833|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797834|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
83797835|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
83797836|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
83133881|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
83797837|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797838|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83797839|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797840|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
83797841|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83797842|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797843|NCT00216190|Midazolam|midazolam|mesh-list
83797844|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
83797845|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83797846|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797847|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797848|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83797849|NCT00216190|Analgesics|analgesics|mesh-ancestor
83797850|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
83797851|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797852|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83797853|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83797854|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83797855|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797856|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797857|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797858|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83797859|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83797860|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797861|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797862|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83797863|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
83797864|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
83797865|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
83797866|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
83797867|NCT00216268|Ribavirin|ribavirin|mesh-list
83797868|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
83797869|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797870|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
83797871|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797872|NCT00216346|Amphotericin B|amphotericin b|mesh-list
83797873|NCT00216346|Paromomycin|paromomycin|mesh-list
83797874|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83797875|NCT00216346|Amebicides|amebicides|mesh-ancestor
83797876|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83797877|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83797878|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797879|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83797880|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
83797881|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
83797882|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83797883|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797884|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83797885|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83797886|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83797887|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83797888|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797889|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797890|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797891|NCT00216424|Capecitabine|capecitabine|mesh-list
83797892|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83797893|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
83797894|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797895|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797896|NCT00216463|Mipomersen|mipomersen|mesh-list
83797897|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82953136|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
82953137|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797898|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83797899|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
82953138|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82953139|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
82953140|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
82953141|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
82953142|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83834942|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
83797900|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797901|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83797902|NCT00216502|Galantamine|galantamine|mesh-list
83797903|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83797904|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83797905|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797906|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
83797907|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797908|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797909|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83797910|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
83797911|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797912|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
83797913|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
83797914|NCT00216541|Hematinics|hematinics|mesh-ancestor
83797915|NCT00216580|Risperidone|risperidone|mesh-list
83797916|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83797917|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
83797918|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797919|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797920|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797921|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83797922|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83797923|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797924|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83797925|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83797926|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
83797927|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
83797928|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83797929|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
83797930|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797931|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797932|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83797933|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
83797934|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83797935|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
83797936|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797937|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83797938|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83797939|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
83797940|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
83797941|NCT00041561|Protective Agents|protective agents|mesh-ancestor
83797942|NCT00216619|Topiramate|topiramate|mesh-list
83797943|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
83797944|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83797945|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797946|NCT00216658|Fentanyl|fentanyl|mesh-list
83797947|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83797948|NCT00216658|Narcotics|narcotics|mesh-ancestor
83797949|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83797950|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797951|NCT00216658|Analgesics|analgesics|mesh-ancestor
83797952|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
83797953|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797954|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83797955|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83797956|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
83797957|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
83797958|NCT00216697|Bortezomib|bortezomib|mesh-list
83797959|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797960|NCT00216775|Interferons|interferons|mesh-list
83797961|NCT00216775|Ribavirin|ribavirin|mesh-list
83797962|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
83797963|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
83797964|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797965|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
83797966|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83797967|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
83797968|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83797969|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
83797970|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953205|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82953225|NCT01216709|Iron|iron|mesh-list
83797971|NCT00041639|Labetuzumab|labetuzumab|mesh-list
83797972|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83797973|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83797974|NCT00216892|Betamethasone|betamethasone|mesh-list
83797975|NCT00216892|Calcipotriene|calcipotriene|mesh-list
83797976|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83797977|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
83797978|NCT00216892|Hormones|hormones|mesh-ancestor
83797979|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83797980|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797981|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83797982|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
83797983|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
83797984|NCT00216931|Iloprost|iloprost|mesh-list
83797985|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83797986|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83797987|NCT00217009|Furocoumarins|furocoumarins|mesh-list
83797988|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83797989|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83797990|NCT00217048|Yohimbine|yohimbine|mesh-list
83797991|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
83797992|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
83797993|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83797994|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83797995|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83797996|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83797997|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83797998|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83797999|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798000|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798001|NCT00217048|Urological Agents|urological agents|mesh-ancestor
83798002|NCT00217204|Pancrelipase|pancrelipase|mesh-list
83798003|NCT00217204|Pancreatin|pancreatin|mesh-list
83798004|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798005|NCT00412126|Insulin|insulin|mesh-list
83798006|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83798007|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798008|NCT00412204|Bromides|bromides|mesh-list
83798009|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
83798010|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83798011|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
83798012|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798013|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798014|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83798015|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
83798016|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
83798017|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83798018|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
83798019|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798020|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798021|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
83798022|NCT00041678|Aripiprazole|aripiprazole|mesh-list
83798023|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
83798024|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798025|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83798026|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83798027|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798028|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798029|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
83798030|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
83798031|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798032|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798033|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83798034|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83798035|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
83798036|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83798037|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83798038|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83798039|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83798040|NCT00217243|Lidocaine|lidocaine|mesh-list
83798041|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
83798042|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
83798043|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798044|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798045|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
83798046|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798047|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83798048|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83798049|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83798050|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798051|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798052|NCT00217282|Bevacizumab|bevacizumab|mesh-list
83798053|NCT00217282|Gemcitabine|gemcitabine|mesh-list
83798054|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
83798055|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83798056|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798057|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83798058|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83798059|NCT00217282|Growth Substances|growth substances|mesh-ancestor
83798060|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798061|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
83798062|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798063|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
83798064|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798065|NCT00217477|Gemcitabine|gemcitabine|mesh-list
83798066|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798067|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
83798068|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798069|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798070|NCT00217516|Selenium|selenium|mesh-list
83798071|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
83798072|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798073|NCT00217516|Protective Agents|protective agents|mesh-ancestor
83798074|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798075|NCT00217516|Trace Elements|trace elements|mesh-ancestor
83798076|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
83798077|NCT00217555|Gemcitabine|gemcitabine|mesh-list
83798078|NCT00217555|Topotecan|topotecan|mesh-list
83798079|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798080|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
83798081|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798082|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798083|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83798084|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83798085|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798086|NCT00217711|Capecitabine|capecitabine|mesh-list
83798087|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
83798088|NCT00217711|Irinotecan|irinotecan|mesh-list
83798089|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798090|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
83798091|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798092|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798093|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83798094|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83798095|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798096|NCT00217789|Dimercaprol|dimercaprol|mesh-list
83798097|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
83798098|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
83798099|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798100|NCT00217828|Citalopram|citalopram|mesh-list
83798101|NCT00217828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83798102|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798103|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798104|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798105|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798106|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
83798107|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798108|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83798109|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
83798110|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798111|NCT00041990|Decitabine|decitabine|mesh-list
83798112|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798113|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
83798114|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798115|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798116|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798117|NCT00073437|Infliximab|infliximab|mesh-list
83798118|NCT00073437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83798119|NCT00073437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83798120|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83798121|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798122|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83798123|NCT00218101|Buprenorphine|buprenorphine|mesh-list
83798124|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83798125|NCT00218101|Narcotics|narcotics|mesh-ancestor
83798126|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798127|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798128|NCT00218101|Analgesics|analgesics|mesh-ancestor
83798129|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
83798130|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798131|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83798132|NCT00218140|Nicotine|nicotine|mesh-list
83798133|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83798134|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
83798135|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798136|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798137|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83798138|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83798139|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
83798140|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798141|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798142|NCT00042029|Aprepitant|aprepitant|mesh-list
83798143|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
83798144|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
83798145|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798146|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798147|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798148|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83798149|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798150|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798151|NCT00218218|Nicotine|nicotine|mesh-list
83798152|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83798153|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
83798154|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798155|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798156|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83798157|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83798158|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
83798159|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798160|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798161|NCT00218374|Gabapentin|gabapentin|mesh-list
83798162|NCT00218374|Analgesics|analgesics|mesh-ancestor
83798163|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
83798164|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798165|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798166|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
83798167|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83798168|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83798169|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798170|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798171|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83798172|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83798173|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798174|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798175|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
83798176|NCT00218413|Vaccines|vaccines|mesh-list
83798177|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
83798178|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798179|NCT00042068|Meloxicam|meloxicam|mesh-list
83798180|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83798181|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83798182|NCT00042068|Analgesics|analgesics|mesh-ancestor
83798183|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
83798184|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798185|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798186|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83798187|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83798188|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83798189|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83798190|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798191|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798192|NCT00218530|Lofexidine|lofexidine|mesh-list
83798193|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83798194|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83798195|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798196|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
83798197|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798198|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83798199|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83798200|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83798201|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
83798202|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798203|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798205|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83798206|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83798207|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798208|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
83798209|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798210|NCT00218608|Disulfiram|disulfiram|mesh-list
83798211|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83798212|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83798213|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798214|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798215|NCT00042146|Zolpidem|zolpidem|mesh-list
83798216|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83798217|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83798218|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798219|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798220|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83798221|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
83798222|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
83798223|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798224|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798225|NCT00412321|Siltuximab|siltuximab|mesh-list
83798226|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798227|NCT00219232|Rivastigmine|rivastigmine|mesh-list
83798228|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83798229|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798230|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798231|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
83798232|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798233|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798234|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83798235|NCT00219232|Protective Agents|protective agents|mesh-ancestor
83798236|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
83798237|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83798238|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798239|NCT00219310|Famciclovir|famciclovir|mesh-list
83798240|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
83798241|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798242|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83798243|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798244|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798245|NCT00219388|Simendan|simendan|mesh-list
83798246|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83798247|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
83798248|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83798249|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83798250|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798251|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798252|NCT00219388|Protective Agents|protective agents|mesh-ancestor
83798253|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798254|NCT00219466|Zinc|zinc|mesh-list
83798255|NCT00219466|Tocopherols|tocopherols|mesh-list
83798256|NCT00219466|Vitamin E|vitamin e|mesh-list
83798257|NCT00219466|Tocotrienols|tocotrienols|mesh-list
83798258|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
83798259|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
83798260|NCT00219466|Trace Elements|trace elements|mesh-ancestor
83798261|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
83798262|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798263|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
83798264|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798265|NCT00219466|Protective Agents|protective agents|mesh-ancestor
83798266|NCT00219466|Vitamins|vitamins|mesh-ancestor
83798267|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
83798268|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
83798269|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83798270|NCT00042302|Paclitaxel|paclitaxel|mesh-list
83798271|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82953502|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83798272|NCT00042302|Carboplatin|carboplatin|mesh-list
83798273|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83798274|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798275|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
83798276|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
83798277|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
83798278|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798279|NCT00219700|Ibuprofen|ibuprofen|mesh-list
83798280|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83798281|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83798282|NCT00219700|Analgesics|analgesics|mesh-ancestor
83798283|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
83798284|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798285|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798286|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83798287|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83798288|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83798289|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798290|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798291|NCT00219739|Interferons|interferons|mesh-list
83798292|NCT00219739|Cytarabine|cytarabine|mesh-list
83798293|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
83798294|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798295|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
83798296|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798297|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798298|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
83798299|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798300|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83798301|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
83798302|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798303|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83798304|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798305|NCT00219778|Mifepristone|mifepristone|mesh-list
83798306|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83798307|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
83798308|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83798309|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798310|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83798311|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83798312|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83798313|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
83798314|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83798315|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83798316|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
83798317|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83798318|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
83798319|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83798320|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83798321|NCT00219856|Propofol|propofol|mesh-list
83798322|NCT00219856|Desflurane|desflurane|mesh-list
83798323|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83798324|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798325|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798326|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83798327|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
83798328|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
83798329|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83798330|NCT00042458|Pramlintide|pramlintide|mesh-list
83798331|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83798332|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798333|NCT00219895|Ibuprofen|ibuprofen|mesh-list
83798334|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83798335|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83798336|NCT00219895|Analgesics|analgesics|mesh-ancestor
83798337|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
83798338|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798339|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798340|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83798341|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83798342|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83798343|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798344|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798345|NCT00077337|Romidepsin|romidepsin|mesh-list
83798346|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83798347|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953575|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
83798348|NCT00077337|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83798349|NCT00077337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798350|NCT00077337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798351|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83798352|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
83798353|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798355|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
83798356|NCT00220051|Capecitabine|capecitabine|mesh-list
83798357|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
83798358|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798359|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
83798360|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798361|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798362|NCT00077415|Gemcitabine|gemcitabine|mesh-list
83798363|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798364|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
83798365|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798366|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798367|NCT00042536|Naltrexone|naltrexone|mesh-list
83798368|NCT00042536|Yohimbine|yohimbine|mesh-list
83798369|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83798370|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83798371|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798372|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
83798373|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798374|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
83798375|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
83798376|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83798377|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83798378|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83798379|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
83798380|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798381|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798382|NCT00042536|Urological Agents|urological agents|mesh-ancestor
83798383|NCT00220129|Capecitabine|capecitabine|mesh-list
83798384|NCT00220129|Epirubicin|epirubicin|mesh-list
83798385|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798386|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798387|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
83798388|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798389|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83798390|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83798391|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83798392|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798393|NCT00220168|Capecitabine|capecitabine|mesh-list
83798394|NCT00220168|Irinotecan|irinotecan|mesh-list
83798395|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798396|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
83798397|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798398|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798399|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83798400|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83798401|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798402|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83798403|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83798404|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798405|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798406|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798407|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798408|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798409|NCT00042575|Analgesics|analgesics|mesh-ancestor
83798410|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
83798411|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798412|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
83798413|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798414|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
83798415|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83798416|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
83798417|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798418|NCT00077454|Temozolomide|temozolomide|mesh-list
83798419|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83798420|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83798421|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
83798422|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798423|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798424|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83798425|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798426|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83798427|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83798428|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83798429|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83798430|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
83798431|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83798432|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798433|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83798434|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83798435|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83798436|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83798437|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83798438|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83798439|NCT00412555|Oseltamivir|oseltamivir|mesh-list
83798440|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
83798441|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798442|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798443|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798444|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
83798445|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798446|NCT00042653|Cinacalcet|cinacalcet|mesh-list
83798447|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83798448|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798449|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83798450|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
83798451|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83798452|NCT00073593|Heparin|heparin|mesh-list
83798453|NCT00073593|Bivalirudin|bivalirudin|mesh-list
83798454|NCT00073593|Protamines|protamines|mesh-list
83798455|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
83798456|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83798457|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83798458|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798459|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
83798460|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83798461|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
83798462|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798463|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
83798464|NCT00073593|Coagulants|coagulants|mesh-ancestor
83798465|NCT00220480|Escitalopram|escitalopram|mesh-list
83798466|NCT00220480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83798467|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798468|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798469|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798470|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798471|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
83798472|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798473|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
83798474|NCT00220675|Hematinics|hematinics|mesh-ancestor
83798475|NCT00042731|Lycopene|lycopene|mesh-list
83798476|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83798477|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
83133893|NCT04239339|Escitalopram|escitalopram|mesh-list
83798478|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798479|NCT00042731|Protective Agents|protective agents|mesh-ancestor
83798480|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798481|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83798482|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83798483|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798484|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
83798485|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83798486|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798487|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798488|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798489|NCT00077493|Antibodies|antibodies|mesh-list
83798490|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
83798491|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83798492|NCT00077493|Immunotoxins|immunotoxins|mesh-list
83798493|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
83798494|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
82953730|NCT01122641|Vildagliptin|vildagliptin|mesh-list
83798495|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798496|NCT00220831|Vitamin E|vitamin e|mesh-list
83798497|NCT00220831|Vitamins|vitamins|mesh-ancestor
83798498|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
83798499|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798500|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
83798501|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798502|NCT00220831|Protective Agents|protective agents|mesh-ancestor
83798503|NCT00220909|Lansoprazole|lansoprazole|mesh-list
83798504|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
83798505|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83798506|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798507|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83798508|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798509|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798510|NCT00220987|Insulin|insulin|mesh-list
83798511|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83798512|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83798513|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798514|NCT02966067|Anesthetics|anesthetics|mesh-list
83798515|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83798516|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798517|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798518|NCT00221026|Methoxsalen|methoxsalen|mesh-list
83798519|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83798520|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83798521|NCT00042809|Paclitaxel|paclitaxel|mesh-list
83798522|NCT00042809|Trastuzumab|trastuzumab|mesh-list
83798523|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83798524|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83798525|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798526|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
83798527|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
83798528|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
83798529|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798530|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83798531|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83798532|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798533|NCT00073710|Calcitriol|calcitriol|mesh-list
83798534|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83798535|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798536|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83798537|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798538|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798539|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83798540|NCT00073710|Vitamins|vitamins|mesh-ancestor
83798541|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
83133904|NCT05023304|Prednisolone|prednisolone|mesh-list
83798542|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83798543|NCT00042848|Modafinil|modafinil|mesh-list
83798544|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83798545|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798546|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83798547|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83798548|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83798549|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798550|NCT00221260|Anesthetics|anesthetics|mesh-list
83798551|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798552|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798553|NCT00402259|Esomeprazole|esomeprazole|mesh-list
83798554|NCT00402259|Omeprazole|omeprazole|mesh-list
83798555|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83798556|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798557|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83798558|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798559|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798560|NCT02965677|Paclitaxel|paclitaxel|mesh-list
83798561|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83798562|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798563|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
83798564|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
83798565|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
83798566|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953806|NCT03783923|Deflazacort|deflazacort|mesh-list
83798567|NCT00402376|Carvedilol|carvedilol|mesh-list
83798568|NCT00402376|Perindopril|perindopril|mesh-list
83798569|NCT00402376|Pravastatin|pravastatin|mesh-list
83798570|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83798571|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83798572|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83798573|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798574|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798575|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798576|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83798577|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
83798578|NCT00402376|Protective Agents|protective agents|mesh-ancestor
83798579|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83798580|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798581|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83798582|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
83798583|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83798584|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83798585|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83798586|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83798587|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
83798588|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83798589|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83798590|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798591|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83798592|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
83798593|NCT00042887|Mitomycins|mitomycins|mesh-list
83798594|NCT00042887|Mitomycin|mitomycin|mesh-list
83798595|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83798596|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798597|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
83798598|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798599|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83798600|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798601|NCT00122746|Cisplatin|cisplatin|mesh-list
83798602|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798603|NCT00122785|Dexamethasone|dexamethasone|mesh-list
83798604|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83798605|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
83798606|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
83798607|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798608|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798609|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798610|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
83798611|NCT00122785|Hormones|hormones|mesh-ancestor
83798612|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83798613|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83798614|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798615|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83798616|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83798617|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798618|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798619|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798620|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798621|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798622|NCT00122824|Analgesics|analgesics|mesh-ancestor
83798623|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
83798624|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798625|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
83798626|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798627|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
83798628|NCT00077532|Ipilimumab|ipilimumab|mesh-list
83798629|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
83798630|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83798631|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798632|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83798633|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798634|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83798635|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
83798636|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798637|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83798638|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83798639|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798640|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798641|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798642|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798643|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798644|NCT00122863|Analgesics|analgesics|mesh-ancestor
83798645|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
83798646|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798647|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
83798648|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798649|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
83798650|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83798651|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83798652|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798653|NCT00122941|Micronutrients|micronutrients|mesh-list
83798654|NCT00122941|Trace Elements|trace elements|mesh-list
83798655|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798656|NCT00077688|Paclitaxel|paclitaxel|mesh-list
83798657|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83798658|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798659|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
83798660|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
83798661|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
83798662|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798663|NCT00397319|Hormones|hormones|mesh-list
83798664|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83798665|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798666|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
83798667|NCT02965443|Saxagliptin|saxagliptin|mesh-list
83798668|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83798669|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798670|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83798671|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798672|NCT02965443|Incretins|incretins|mesh-ancestor
83798673|NCT02965443|Hormones|hormones|mesh-ancestor
83798674|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83798675|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83798676|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83798677|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798678|NCT00042965|Gemcitabine|gemcitabine|mesh-list
83798679|NCT00042965|Capecitabine|capecitabine|mesh-list
83798680|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798681|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
83798682|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798683|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798684|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83798685|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
83798686|NCT00123175|Progestins|progestins|mesh-list
83798687|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83798688|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83798689|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83798690|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
83798691|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83798692|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798693|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83798694|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83798695|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83798696|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83798697|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798698|NCT00123175|Hormones|hormones|mesh-ancestor
83798699|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83798700|NCT00077727|Galantamine|galantamine|mesh-list
83798701|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83798702|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798703|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798704|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
83798705|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798706|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798707|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83798708|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
83798709|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798710|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
83798711|NCT00123292|Plasminogen|plasminogen|mesh-list
82953953|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953956|NCT01123031|Esomeprazole|esomeprazole|mesh-list
83798712|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
83798713|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83798714|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83798715|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798717|NCT00043004|Bevacizumab|bevacizumab|mesh-list
83798718|NCT00043004|Fluorouracil|fluorouracil|mesh-list
83798719|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
83798720|NCT00043004|Calcium|calcium|mesh-list
83798721|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
83798722|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83798723|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798724|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83798725|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83798726|NCT00043004|Growth Substances|growth substances|mesh-ancestor
83798727|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798728|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
83798729|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83798730|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
83798731|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798732|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798733|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133927|NCT02116231|Cisplatin|cisplatin|mesh-list
83798734|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
83798735|NCT00043004|Antidotes|antidotes|mesh-ancestor
83798736|NCT00043004|Protective Agents|protective agents|mesh-ancestor
83798737|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
83798738|NCT00043004|Vitamins|vitamins|mesh-ancestor
83798739|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
83798740|NCT00123331|Cyclosporine|cyclosporine|mesh-list
83798741|NCT00123331|Sirolimus|sirolimus|mesh-list
83798742|NCT00123331|Cyclosporins|cyclosporins|mesh-list
83798743|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798744|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798745|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83798746|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
83798747|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798748|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
83798749|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798750|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
83798751|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83798752|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83798753|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83798754|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83798755|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798756|NCT00123370|Modafinil|modafinil|mesh-list
83798757|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83798758|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798759|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83798760|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83798761|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83798762|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798763|NCT00043043|Celecoxib|celecoxib|mesh-list
83798764|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83798765|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83798766|NCT00043043|Analgesics|analgesics|mesh-ancestor
83798767|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
83798768|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798769|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798770|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83798771|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83798772|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83798773|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83798774|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798775|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798776|NCT00077805|Enoxaparin|enoxaparin|mesh-list
83798777|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
83798778|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
83798779|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83798780|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83798781|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798782|NCT00043082|Carboplatin|carboplatin|mesh-list
83798783|NCT00043082|Doxorubicin|doxorubicin|mesh-list
83798784|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83798785|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798786|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82954031|NCT03714165|Defensins|defensins|mesh-list
83798787|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83798788|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83798789|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798790|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798791|NCT00123877|Esorubicin|esorubicin|mesh-list
83798792|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83798793|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798794|NCT00123916|Benzonidazole|benzonidazole|mesh-list
83798795|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83798796|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
83798797|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798798|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83798799|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83798800|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83798801|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798802|NCT00073827|Albuterol|albuterol|mesh-list
83798803|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83798804|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
83798805|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798806|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798807|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83798808|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
83798809|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
83798810|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83798811|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83798812|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83798813|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83798814|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
83798815|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798816|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798817|NCT02970539|Paclitaxel|paclitaxel|mesh-list
83798818|NCT02970539|Ramucirumab|ramucirumab|mesh-list
83798819|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83798820|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798821|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
83798822|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
83798823|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
83798824|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798825|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
83798826|NCT00124111|Fluorouracil|fluorouracil|mesh-list
83798827|NCT00124111|Methotrexate|methotrexate|mesh-list
83798828|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83798829|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
83798830|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798831|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83798832|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83798833|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
83798834|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798835|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798836|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83798837|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
83798838|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798839|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83798840|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
83798841|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83798842|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
83798843|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798844|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83798845|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83798846|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
83798847|NCT00124150|Analgesics|analgesics|mesh-ancestor
83798848|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
83798849|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798850|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798851|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
83798852|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83798853|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83798854|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
83798855|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83798856|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798857|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798858|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82954099|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83798859|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
83798860|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83798861|NCT02958046|Domperidone|domperidone|mesh-list
83798862|NCT02958046|Lansoprazole|lansoprazole|mesh-list
83798863|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
83798864|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83798865|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798866|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83798867|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798868|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798869|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
83798870|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
83798871|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798872|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798873|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83798874|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
83798875|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798876|NCT00073905|Gemcitabine|gemcitabine|mesh-list
83798877|NCT00073905|Capecitabine|capecitabine|mesh-list
83798878|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798879|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
83798880|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798881|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798882|NCT00124267|Quinine|quinine|mesh-list
83798883|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
83798884|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83798885|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83798886|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798887|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83798888|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798889|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83798890|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798891|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83798892|NCT00124267|Analgesics|analgesics|mesh-ancestor
83798893|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
83798894|NCT00077844|Enoxaparin|enoxaparin|mesh-list
83798895|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
83798896|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
83798897|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83798898|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83798899|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798900|NCT00043121|Leucovorin|leucovorin|mesh-list
83798901|NCT00043121|Fluorouracil|fluorouracil|mesh-list
83798902|NCT00043121|Capecitabine|capecitabine|mesh-list
83798903|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
83798904|NCT00043121|Calcium|calcium|mesh-list
83798905|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
83798906|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83798907|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798908|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
83798909|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798910|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83798911|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798912|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83798913|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
83798914|NCT00043121|Antidotes|antidotes|mesh-ancestor
83798915|NCT00043121|Protective Agents|protective agents|mesh-ancestor
83798916|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
83798917|NCT00043121|Vitamins|vitamins|mesh-ancestor
83798918|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
83798919|NCT00402415|Sirolimus|sirolimus|mesh-list
83798920|NCT00402415|Sunitinib|sunitinib|mesh-list
83798921|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83798922|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83798923|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83798924|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798925|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
83798926|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83798927|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
83798928|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798929|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83798930|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798931|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798932|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83798933|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83798934|NCT00402415|Growth Substances|growth substances|mesh-ancestor
83798935|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
83798936|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83798937|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83798938|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798939|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83798940|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798941|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798942|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798943|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
83798944|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798945|NCT00124306|Amitriptyline|amitriptyline|mesh-list
83798946|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83798947|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
83798948|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83798949|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83798950|NCT00124306|Analgesics|analgesics|mesh-ancestor
83133939|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83798951|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
83798952|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83798953|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798954|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83798955|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798956|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798957|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798958|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83798959|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798960|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
83798961|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798962|NCT00124384|Modafinil|modafinil|mesh-list
83798963|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83798964|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798965|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83798966|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83798967|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83798968|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798969|NCT00077883|Cisplatin|cisplatin|mesh-list
83798970|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798971|NCT00124540|Misoprostol|misoprostol|mesh-list
83798972|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83798973|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
83798974|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83798975|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798976|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83798977|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83798978|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
83798979|NCT00124696|Cocaethylene|cocaethylene|mesh-list
83798980|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83798981|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83798982|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83798983|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798984|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
83798985|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83798986|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83798987|NCT00043277|Bivalirudin|bivalirudin|mesh-list
83798988|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
83798989|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83798990|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
83798991|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83798992|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83798993|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
83798994|NCT00074022|Docetaxel|docetaxel|mesh-list
83798995|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83798996|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83798997|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83798998|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83798999|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799000|NCT00124813|Thalidomide|thalidomide|mesh-list
83799001|NCT00124813|Idarubicin|idarubicin|mesh-list
83799002|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799003|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
83799004|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799005|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
83799006|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799007|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799008|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83799009|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83799010|NCT00124813|Growth Substances|growth substances|mesh-ancestor
83799011|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
83799012|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799013|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83799014|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83799015|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83799016|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799017|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799019|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
83799020|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
83799021|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799022|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799023|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83799024|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83799025|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83799026|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799027|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799028|NCT00124930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83799029|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83799030|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799031|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799032|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799033|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
83799034|NCT00124969|Amlodipine|amlodipine|mesh-list
83799035|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83799036|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83799037|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799038|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799039|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83799040|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799041|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
83799042|NCT00043316|Interferons|interferons|mesh-list
83799043|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
83799044|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799045|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
83799046|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799047|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
83799048|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799049|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799050|NCT00125008|Vaccines|vaccines|mesh-list
83799051|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
83799052|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799053|NCT00125047|Vaccines|vaccines|mesh-list
83799054|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
83799055|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799056|NCT00078000|Sunitinib|sunitinib|mesh-list
83799057|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799058|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83799059|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83799060|NCT00078000|Growth Substances|growth substances|mesh-ancestor
83799061|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799062|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
83799063|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83799064|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799065|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799066|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83799067|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
83799068|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83799069|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83799070|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83799071|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799072|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799073|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
83799074|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799075|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799076|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83799077|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799078|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83799079|NCT00043355|Interferons|interferons|mesh-list
83799080|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
83799081|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799082|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
83799083|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954322|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
83799084|NCT00125398|Fospropofol|fospropofol|mesh-list
83799085|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83799086|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799087|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799088|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
83799089|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83799090|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
83799091|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83799092|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83799093|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799094|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799095|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
83799096|NCT00125437|Spironolactone|spironolactone|mesh-list
83799097|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83799098|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
83799099|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799100|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799101|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83799102|NCT00125437|Diuretics|diuretics|mesh-ancestor
83799103|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
83799104|NCT00125554|Metyrapone|metyrapone|mesh-list
83799105|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
83799106|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799107|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799108|NCT00043394|Trastuzumab|trastuzumab|mesh-list
83799109|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799110|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799111|NCT00125671|Warfarin|warfarin|mesh-list
83799112|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
83799113|NCT00125827|Clofarabine|clofarabine|mesh-list
83799114|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799115|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
83799116|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799117|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799118|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83799119|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83799120|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83799121|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799122|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799123|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799124|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83799125|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83799126|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
83799127|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799128|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799129|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83799130|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83799131|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
83799132|NCT00125905|Bupropion|bupropion|mesh-list
83799133|NCT00125905|Nicotine|nicotine|mesh-list
83799134|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83799135|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
83799136|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799137|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799138|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83799139|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83799140|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
83799141|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799142|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799143|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83799144|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
83799145|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799146|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83799147|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83799148|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799149|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
83799150|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83799151|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83799152|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799153|NCT00078117|Buprenorphine|buprenorphine|mesh-list
83799154|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83799155|NCT00078117|Narcotics|narcotics|mesh-ancestor
83799156|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799157|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799158|NCT00078117|Analgesics|analgesics|mesh-ancestor
83799159|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
83799160|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799161|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83799162|NCT00125983|Ritonavir|ritonavir|mesh-list
83799163|NCT00125983|Lopinavir|lopinavir|mesh-list
83799164|NCT00125983|Norinyl|norinyl|mesh-list
83799165|NCT00125983|Ortho Evra|ortho evra|mesh-list
83799166|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83799167|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83799168|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
83799169|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799170|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799171|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83799172|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83799173|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
83799174|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799175|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83799176|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83799177|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83799178|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83799179|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83799180|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
83799181|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83799182|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799183|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83799184|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83799185|NCT00126022|Tedisamil|tedisamil|mesh-list
83799186|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83799187|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83799188|NCT00126022|Protective Agents|protective agents|mesh-ancestor
83799189|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799190|NCT00402454|Rifampin|rifampin|mesh-list
83799191|NCT00402454|Isoniazid|isoniazid|mesh-list
83799192|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
83799193|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83799194|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
83799195|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799196|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799197|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
83799198|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799199|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799200|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799201|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83799202|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83799203|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83799204|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83799205|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83799206|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83799207|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83799208|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83799209|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
83799210|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83799211|NCT00402493|Ibuprofen|ibuprofen|mesh-list
83799212|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83799213|NCT00402493|Latanoprost|latanoprost|mesh-list
83799214|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83799215|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799216|NCT00402493|Analgesics|analgesics|mesh-ancestor
83799217|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
83799218|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799219|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799220|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83799221|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799222|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83799223|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799224|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799225|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83799226|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83799227|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83799228|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83799229|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83799230|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83799231|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
82954472|NCT01224353|Protective Agents|protective agents|mesh-ancestor
83799232|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799233|NCT00402532|Everolimus|everolimus|mesh-list
83799234|NCT00402532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83799235|NCT00402532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83799236|NCT00402532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799237|NCT00402532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799238|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799239|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
83799240|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799241|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799242|NCT00126061|Tedisamil|tedisamil|mesh-list
83799243|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83799244|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83799245|NCT00126061|Protective Agents|protective agents|mesh-ancestor
83799246|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799247|NCT00043589|Donepezil|donepezil|mesh-list
83799248|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83799249|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799250|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799251|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
83799252|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799253|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799254|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
83799255|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
83799256|NCT00399399|Azathioprine|azathioprine|mesh-list
83799257|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799258|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
83799259|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799260|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799261|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83799262|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
83799263|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799264|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799265|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83799266|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
83799267|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799268|NCT00126100|Lenograstim|lenograstim|mesh-list
83799269|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83799270|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
83799271|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799272|NCT00123253|Tesamorelin|tesamorelin|mesh-list
83799273|NCT00123253|Growth Substances|growth substances|mesh-ancestor
83799274|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799275|NCT00126139|Abciximab|abciximab|mesh-list
83799276|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
83799277|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83799278|NCT00074100|Amonafide|amonafide|mesh-list
83799279|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799280|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
83799281|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799282|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799283|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799284|NCT00126256|Leucovorin|leucovorin|mesh-list
83799285|NCT00126256|Fluorouracil|fluorouracil|mesh-list
83799286|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
83799287|NCT00126256|Irinotecan|irinotecan|mesh-list
83799288|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
83799289|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799290|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799291|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799292|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799293|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
83799294|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799295|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83799296|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83799297|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799298|NCT00126256|Antidotes|antidotes|mesh-ancestor
83799299|NCT00126256|Protective Agents|protective agents|mesh-ancestor
83799300|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
83799301|NCT00126256|Vitamins|vitamins|mesh-ancestor
83799302|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
83799303|NCT00043667|Daclizumab|daclizumab|mesh-list
83799304|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799305|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
83799306|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954548|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83799307|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
83799308|NCT00074139|Docetaxel|docetaxel|mesh-list
83799309|NCT00074139|Doxorubicin|doxorubicin|mesh-list
83799310|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83799311|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799312|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
83799313|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799314|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799315|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83799316|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
83799317|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799318|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799319|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83799320|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83799321|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83799322|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83799323|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83799324|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83799325|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83799326|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799327|NCT00126373|Bupropion|bupropion|mesh-list
83799328|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83799329|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
83799330|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799331|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83799332|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83799333|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799334|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799335|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
83799336|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799337|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799338|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83799339|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83799340|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799341|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83799342|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799343|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799344|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799345|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83799346|NCT00043706|Antibodies|antibodies|mesh-list
83799347|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83799348|NCT00043706|Mitogens|mitogens|mesh-list
83799349|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
83799350|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799351|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
83799352|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799353|NCT00126451|Vorinostat|vorinostat|mesh-list
83799354|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799355|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83799356|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799357|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799358|NCT00126607|Trastuzumab|trastuzumab|mesh-list
83799359|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799360|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799361|NCT00074178|Cytarabine|cytarabine|mesh-list
83799362|NCT00074178|Dexamethasone|dexamethasone|mesh-list
83799363|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
83799364|NCT00074178|Methotrexate|methotrexate|mesh-list
83799365|NCT00074178|Etoposide|etoposide|mesh-list
83799366|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
83799367|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799368|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
83799369|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799370|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799371|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83799372|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
83799373|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799374|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799375|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83799376|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83799377|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
83799378|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
83799379|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799380|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83799381|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
83799382|NCT00074178|Hormones|hormones|mesh-ancestor
83834943|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799383|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799384|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83799385|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83799386|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
83799387|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83799388|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799389|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
83799390|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
83799391|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799392|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83799393|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799394|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83799395|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83799396|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83799397|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
83799398|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799399|NCT00126646|Antibodies|antibodies|mesh-list
83799400|NCT00126646|Immunotoxins|immunotoxins|mesh-list
83799401|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
83799402|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
83799403|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799404|NCT00126763|Fentanyl|fentanyl|mesh-list
83799405|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83799406|NCT00126763|Narcotics|narcotics|mesh-ancestor
83799407|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799408|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799409|NCT00126763|Analgesics|analgesics|mesh-ancestor
83799410|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
83799411|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799412|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83799413|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83799414|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
83799415|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
83799416|NCT00402571|Acetaminophen|acetaminophen|mesh-list
83799417|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799418|NCT00402571|Analgesics|analgesics|mesh-ancestor
83799419|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
83799420|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799421|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799422|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
83799423|NCT00126880|Lamivudine|lamivudine|mesh-list
83799424|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83799425|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799426|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799427|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799428|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
83799429|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799430|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83799431|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83799432|NCT02965911|Fenofibrate|fenofibrate|mesh-list
83799433|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83799434|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
83799435|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799436|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83799437|NCT00127075|Estradiol|estradiol|mesh-list
83799438|NCT00127075|Estrogens|estrogens|mesh-ancestor
83799439|NCT00127075|Hormones|hormones|mesh-ancestor
83799440|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799441|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799442|NCT00127114|Amantadine|amantadine|mesh-list
83799443|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83799444|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83799445|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
83799446|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799447|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
83799448|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799449|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799450|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799451|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799452|NCT00127114|Analgesics|analgesics|mesh-ancestor
83799453|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
82954697|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799454|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799455|NCT00043784|Enoxaparin|enoxaparin|mesh-list
83799456|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
83799457|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83799458|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83799459|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799460|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83799461|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
83799462|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799463|NCT00399477|Levodopa|levodopa|mesh-list
83799464|NCT00399477|Pramipexole|pramipexole|mesh-list
83799465|NCT00399477|Rasagiline|rasagiline|mesh-list
83799466|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83799467|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83799468|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
83799469|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799470|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799471|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799472|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83799473|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799474|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83799475|NCT00399477|Protective Agents|protective agents|mesh-ancestor
83799476|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
83799477|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
83799478|NCT00127270|Darifenacin|darifenacin|mesh-list
83799479|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83799480|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83799481|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
83799482|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799483|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799484|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799485|NCT00127270|Urological Agents|urological agents|mesh-ancestor
83799486|NCT00043823|Bevacizumab|bevacizumab|mesh-list
83799487|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83799488|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799489|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799490|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83799491|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83799492|NCT00043823|Growth Substances|growth substances|mesh-ancestor
83799493|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799494|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
83799495|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83799496|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799497|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799498|NCT00074334|Immunotoxins|immunotoxins|mesh-list
83799499|NCT00074334|Immunoconjugates|immunoconjugates|mesh-ancestor
83799500|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
83799501|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799502|NCT00127387|Etanercept|etanercept|mesh-list
83799503|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83799504|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799505|NCT00127387|Analgesics|analgesics|mesh-ancestor
83799506|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
83799507|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799508|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799509|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83799510|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799511|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83799512|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799513|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
83799514|NCT00043862|Topotecan|topotecan|mesh-list
83799515|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83799516|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83799517|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799518|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799519|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799520|NCT00127504|Azithromycin|azithromycin|mesh-list
83799521|NCT00127504|Rifampin|rifampin|mesh-list
83799522|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799523|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799524|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83799525|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
83799526|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
83799527|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799528|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799529|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799530|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83799531|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83799532|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83799533|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83799534|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83799535|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83799536|NCT00043901|Lamotrigine|lamotrigine|mesh-list
83799537|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
83799538|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83799539|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799540|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799541|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83799542|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799543|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83799544|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83799545|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799546|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799547|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83799548|NCT00127777|Amantadine|amantadine|mesh-list
83799549|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83799550|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83799551|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
83799552|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799553|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
83799554|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799555|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799556|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799557|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799558|NCT00127777|Analgesics|analgesics|mesh-ancestor
83799559|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
83799560|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799561|NCT00399633|Sumatriptan|sumatriptan|mesh-list
83799562|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83799563|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83799564|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83799565|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
83799566|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799567|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799568|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799569|NCT04727008|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
83799570|NCT04727008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799571|NCT04727008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799572|NCT04726657|Insulin|insulin|mesh-list
83799573|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83799574|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
83799575|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
83799576|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
83799577|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83799578|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799579|NCT00402610|Rifampin|rifampin|mesh-list
83799580|NCT00402610|Isoniazid|isoniazid|mesh-list
83799581|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
83799582|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83799583|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
83799584|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799585|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799586|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
83799587|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799588|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799589|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799590|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83799591|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83799592|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83799593|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83799594|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83799595|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83799596|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83799597|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83799598|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
83799599|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83799600|NCT00402766|Dexamethasone|dexamethasone|mesh-list
83799601|NCT00402766|Cisplatin|cisplatin|mesh-list
83799602|NCT00402766|Pemetrexed|pemetrexed|mesh-list
83799603|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
82954842|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
82954843|NCT04457050|Ledipasvir|ledipasvir|mesh-list
83799604|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83799605|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
83799606|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
83799607|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799608|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799609|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83799610|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
83799611|NCT00402766|Hormones|hormones|mesh-ancestor
83799612|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799613|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83799614|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799615|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799616|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799617|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83799618|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799619|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83799620|NCT00127972|Lamivudine|lamivudine|mesh-list
83799621|NCT00127972|Efavirenz|efavirenz|mesh-list
83799622|NCT00127972|Nevirapine|nevirapine|mesh-list
83799623|NCT00127972|Stavudine|stavudine|mesh-list
83799624|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83799625|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799626|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799627|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799628|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
83799629|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799630|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83799631|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83799632|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83799633|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83799634|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83799635|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83799636|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83799637|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83799638|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
83799639|NCT00043940|Bivalirudin|bivalirudin|mesh-list
83799640|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
83799641|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83799642|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
83799643|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799644|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799645|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
83799646|NCT04711434|Antibodies|antibodies|mesh-list
83799647|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
83799648|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799649|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
83799650|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83799651|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799652|NCT00128245|Analgesics|analgesics|mesh-ancestor
83799653|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
83799654|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799655|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799656|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83799657|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799658|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
83799659|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799660|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
83799661|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83799662|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799663|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799664|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83799665|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83799666|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83799667|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799668|NCT00044135|Clevudine|clevudine|mesh-list
83799669|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
83799670|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799671|NCT05561725|Dexamethasone|dexamethasone|mesh-list
83799672|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83799673|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
83799674|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
83799675|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799676|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799677|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954915|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799678|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
83799679|NCT05561725|Hormones|hormones|mesh-ancestor
83799680|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799681|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83799682|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799683|NCT00078195|Omalizumab|omalizumab|mesh-list
83799684|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
83799685|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
83799686|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83799687|NCT00078195|Immunomodulating Agents|immunomodulating agents|mesh-list
83799688|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799689|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83799690|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83799691|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
83799692|NCT00044291|Toremifene|toremifene|mesh-list
83799693|NCT00044291|Letrozole|letrozole|mesh-list
83799694|NCT00044291|Hormones|hormones|mesh-list
83799695|NCT00044291|Atamestane|atamestane|mesh-list
83799696|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
83799697|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
83799698|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
83799699|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799700|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799701|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799702|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83799703|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83799704|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799705|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799706|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
83799707|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83799708|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83799709|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83799710|NCT00078234|Rituximab|rituximab|mesh-list
83799711|NCT00078234|Fludarabine|fludarabine|mesh-list
83799712|NCT00078234|Oblimersen|oblimersen|mesh-list
83799713|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799714|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799715|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
83799716|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799717|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799718|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
83799719|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799720|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799721|NCT00078351|Hylan|hylan|mesh-list
83799722|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
83799723|NCT00078351|Protective Agents|protective agents|mesh-ancestor
83799724|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799725|NCT00044447|Glimepiride|glimepiride|mesh-list
83799726|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83799727|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83799728|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799729|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799730|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
83799731|NCT00397358|Icodextrin|icodextrin|mesh-list
83799732|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
83799733|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83799734|NCT05519917|Afatinib|afatinib|mesh-list
83799735|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799736|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83799737|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799738|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799739|NCT00078390|S 3304|s 3304|mesh-list
83799740|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
83799741|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
83799742|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799743|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799744|NCT00044486|Posaconazole|posaconazole|mesh-list
83799745|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
83799746|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799747|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83799748|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83799749|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83799750|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82954990|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799751|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83799752|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799753|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799754|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83799755|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
83799756|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799757|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799758|NCT05497336|Cetuximab|cetuximab|mesh-list
83799759|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799760|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799761|NCT00044525|Taxane|taxane|mesh-list
83799762|NCT00044525|IDN 5109|idn 5109|mesh-list
83799763|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799764|NCT00074607|Gemcitabine|gemcitabine|mesh-list
83799765|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799766|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
83799767|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799768|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799769|NCT05305885|Pemetrexed|pemetrexed|mesh-list
83799770|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799771|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799772|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799773|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83799774|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83799775|NCT00044564|IDN 5109|idn 5109|mesh-list
83799776|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799777|NCT00078546|Antibodies|antibodies|mesh-list
83799778|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83799779|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
83799780|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799781|NCT00044642|Lorazepam|lorazepam|mesh-list
83799782|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
83799783|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
83799784|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
83799785|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799786|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799787|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83799788|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83799789|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799790|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83799791|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83799792|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799793|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
83799794|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
83799795|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799796|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799797|NCT00044681|Risperidone|risperidone|mesh-list
83799798|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83799799|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
83799800|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799801|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799802|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799803|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83799804|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83799805|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799806|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799807|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83799808|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
83799809|NCT00044720|Sirolimus|sirolimus|mesh-list
83799810|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799811|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799812|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83799813|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799814|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
83799815|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799816|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
83799817|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799818|NCT04938466|Hormones|hormones|mesh-list
83799819|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799820|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799821|NCT00403000|Dutasteride|dutasteride|mesh-list
83799822|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83799823|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83799824|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799825|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955096|NCT05533281|Hormones|hormones|mesh-ancestor
83799826|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
83799827|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799828|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799829|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
83799830|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83799831|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799832|NCT00403039|Ranibizumab|ranibizumab|mesh-list
83799833|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83799834|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83799835|NCT00403039|Growth Substances|growth substances|mesh-ancestor
83799836|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799837|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83799838|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799839|NCT00078858|Cyclosporine|cyclosporine|mesh-list
83799840|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
83799841|NCT00078858|Fludarabine|fludarabine|mesh-list
83799842|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
83799843|NCT00078858|Cyclosporins|cyclosporins|mesh-list
83799844|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799845|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799846|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
83799847|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799848|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83799849|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
83799850|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799851|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799852|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
83799853|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799854|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
83799855|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799856|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83799857|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83799858|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83799859|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
83799860|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799861|NCT00044759|Tazobactam|tazobactam|mesh-list
83799862|NCT00044759|Piperacillin|piperacillin|mesh-list
83799863|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83799864|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799865|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799866|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83799867|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799868|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799869|NCT00044798|Citalopram|citalopram|mesh-list
83799870|NCT00044798|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83799871|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83799872|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799873|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799874|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799875|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
83799876|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799877|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83799878|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
83799879|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83799880|NCT00074841|Azithromycin|azithromycin|mesh-list
83799881|NCT00074841|Chloroquine|chloroquine|mesh-list
83799882|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83799883|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
83799884|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
83799885|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83799886|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83799887|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83799888|NCT00074841|Amebicides|amebicides|mesh-ancestor
83799889|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83799890|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83799891|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
83799892|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83799893|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83799894|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799895|NCT00074841|Analgesics|analgesics|mesh-ancestor
83799896|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
83799897|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799898|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799899|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83799900|NCT00074841|Filaricides|filaricides|mesh-ancestor
82955137|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
83799901|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
83799902|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
83799903|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83799904|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799905|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799906|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83799908|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799909|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
83799910|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799911|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799912|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83799913|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
83799914|NCT00044837|Estradiol|estradiol|mesh-list
83799915|NCT00044837|Estrogens|estrogens|mesh-ancestor
83799916|NCT00044837|Hormones|hormones|mesh-ancestor
83799917|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83799918|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799919|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83799920|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
83799921|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83799922|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83799923|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83799924|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83799925|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83799926|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83799927|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83799928|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799929|NCT04457557|Ropivacaine|ropivacaine|mesh-list
83799930|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
83799931|NCT04457557|Anesthetics|anesthetics|mesh-list
83799932|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83799933|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799934|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
83799935|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799936|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
83799937|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83799938|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
83799939|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83799940|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799941|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83799942|NCT00079014|Doxorubicin|doxorubicin|mesh-list
83799943|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83799944|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83799945|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799946|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83799947|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83799948|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799949|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799950|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
83799951|NCT00397475|Vitamin D|vitamin d|mesh-list
83799952|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83799953|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799954|NCT00397475|Vitamins|vitamins|mesh-ancestor
83799955|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
83799956|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83799957|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
83799958|NCT04731740|Lenvatinib|lenvatinib|mesh-list
83799959|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83799960|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799961|NCT04731740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83799962|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799963|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83799964|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799965|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
83799966|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83799967|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83799968|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
83799969|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83799970|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799971|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799972|NCT04321408|Ziconotide|ziconotide|mesh-list
83799973|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83799974|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83799975|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799976|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83799977|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83799978|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83799979|NCT04321408|Protective Agents|protective agents|mesh-ancestor
83799980|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83799981|NCT04321408|Analgesics|analgesics|mesh-ancestor
83799982|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
83799983|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83799984|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83799985|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799986|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83799987|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83799988|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799989|NCT04263298|Capecitabine|capecitabine|mesh-list
83799990|NCT04263298|Fulvestrant|fulvestrant|mesh-list
83799991|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83799992|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
83799993|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83799994|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83799995|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83799996|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83799997|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83799998|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
83799999|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800000|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800001|NCT00044954|Cyclosporine|cyclosporine|mesh-list
83800002|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
83800003|NCT00044954|Fludarabine|fludarabine|mesh-list
83800004|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
83800005|NCT00044954|Cyclosporins|cyclosporins|mesh-list
83800006|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800007|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800008|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
83800009|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800010|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800011|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
83800012|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800013|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800014|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
83800015|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800016|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
83800017|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800018|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83800019|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800020|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83800021|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
83800022|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83800023|NCT00079092|Thalidomide|thalidomide|mesh-list
83800024|NCT00079092|Procarbazine|procarbazine|mesh-list
83800025|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800026|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
83800027|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800028|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
83800029|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83800030|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800031|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83800032|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83800033|NCT00079092|Growth Substances|growth substances|mesh-ancestor
83800034|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
83800035|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800037|NCT00044993|Doxorubicin|doxorubicin|mesh-list
83800038|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83800039|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800040|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800041|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800042|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800043|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800044|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800045|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83800046|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82955289|NCT03709719|Blinatumomab|blinatumomab|mesh-list
83800047|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800048|NCT04162210|Dexamethasone|dexamethasone|mesh-list
83800049|NCT04162210|Pomalidomide|pomalidomide|mesh-list
83800050|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800051|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
83800052|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
83800053|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800054|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800055|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800056|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
83800057|NCT04162210|Hormones|hormones|mesh-ancestor
83800058|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800059|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83800060|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800061|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
83800062|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83800063|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83800064|NCT04162210|Growth Substances|growth substances|mesh-ancestor
83800065|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
83800066|NCT00079131|Oblimersen|oblimersen|mesh-list
83800067|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800068|NCT00045149|Aldesleukin|aldesleukin|mesh-list
83800069|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800070|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83800071|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83800072|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
83800073|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800074|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
83800075|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800076|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800077|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800078|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800079|NCT00403156|Ranibizumab|ranibizumab|mesh-list
83800080|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
83800081|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83800082|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83800083|NCT00403156|Growth Substances|growth substances|mesh-ancestor
83800084|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800085|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
83800086|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800087|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800088|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800089|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800090|NCT00045227|Docetaxel|docetaxel|mesh-list
83800091|NCT00045227|Vaccines|vaccines|mesh-list
83800092|NCT00045227|Sargramostim|sargramostim|mesh-list
83800093|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
83800094|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800095|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800096|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800097|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800098|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800099|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800100|NCT00075075|Infliximab|infliximab|mesh-list
83800101|NCT00075075|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83800102|NCT00075075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800103|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
83800104|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800105|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800106|NCT04065451|Epinephrine|epinephrine|mesh-list
83800107|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83800108|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83800109|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
83800110|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800111|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800112|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800113|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83800114|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83800115|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
83800116|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800117|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83800118|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
83800119|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
83800120|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
82955364|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83800121|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83800122|NCT00045266|Aflibercept|aflibercept|mesh-list
83800123|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83800124|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83800125|NCT00045266|Growth Substances|growth substances|mesh-ancestor
83800126|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800127|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
83800128|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800129|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83800130|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
83800131|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
83800132|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800133|NCT03948568|Tamoxifen|tamoxifen|mesh-list
83800134|NCT03948568|Letrozole|letrozole|mesh-list
83800135|NCT03948568|Anastrozole|anastrozole|mesh-list
83800136|NCT03948568|Exemestane|exemestane|mesh-list
83800137|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800138|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83800139|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83800140|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800141|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800142|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83800143|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
83800144|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800145|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800146|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83800147|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83800148|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83800149|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83800150|NCT03928366|Remifentanil|remifentanil|mesh-list
83800151|NCT03928366|Propofol|propofol|mesh-list
83800152|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83800153|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83800154|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800155|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83800156|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
83800157|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
83800158|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83800159|NCT03928366|Narcotics|narcotics|mesh-ancestor
83800160|NCT03928366|Analgesics|analgesics|mesh-ancestor
83800161|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
83800162|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800163|NCT00045422|Interferons|interferons|mesh-list
83800164|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
83800165|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
83800166|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800167|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
83800168|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800169|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
83800170|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800171|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800172|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800173|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800174|NCT00075192|Leuprolide|leuprolide|mesh-list
83800175|NCT00075192|Bicalutamide|bicalutamide|mesh-list
83800176|NCT00075192|Tremelimumab|tremelimumab|mesh-list
83800177|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83800178|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
83800179|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83800180|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800181|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83800182|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800183|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
83800184|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
83800185|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800186|NCT03739411|Temozolomide|temozolomide|mesh-list
83800187|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83800188|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
83800189|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800190|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800191|NCT00045461|Carboplatin|carboplatin|mesh-list
83800192|NCT00045461|Ifosfamide|ifosfamide|mesh-list
83800193|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800194|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83800195|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
83845103|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83800196|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800198|NCT00075231|Lopinavir|lopinavir|mesh-list
83800199|NCT00075231|Lamivudine|lamivudine|mesh-list
83800200|NCT00075231|Zidovudine|zidovudine|mesh-list
83800201|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83800202|NCT00075231|Efavirenz|efavirenz|mesh-list
83800203|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83800204|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83800205|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
83800206|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800207|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800208|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83800209|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83800210|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
83800211|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800212|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83800213|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83800214|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83800215|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83800216|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
83800217|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83800218|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83800219|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83800220|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83800221|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83800222|NCT00403312|Nicotine|nicotine|mesh-list
83800223|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83800224|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
83800225|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800226|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800227|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83800228|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83800229|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
83800230|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800231|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800232|NCT00079170|Docetaxel|docetaxel|mesh-list
83800233|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800234|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800235|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800236|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800237|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800238|NCT00045500|Prednisone|prednisone|mesh-list
83800239|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83800240|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800241|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
83800242|NCT00045500|Hormones|hormones|mesh-ancestor
83800243|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800244|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800245|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83800246|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800247|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800248|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800249|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800250|NCT00045539|Leucovorin|leucovorin|mesh-list
83800251|NCT00045539|Methotrexate|methotrexate|mesh-list
83800252|NCT00045539|Thiotepa|thiotepa|mesh-list
83800253|NCT00045539|Calcium|calcium|mesh-list
83800254|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
83800255|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83800256|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800257|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83800258|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
83800259|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83800260|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800261|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
83800262|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800263|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800264|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
83800265|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800266|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83800267|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82955514|NCT01303549|Amphotericin B|amphotericin b|mesh-list
82955516|NCT01303549|Anidulafungin|anidulafungin|mesh-list
83800268|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
83800269|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800270|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83800271|NCT00045539|Antidotes|antidotes|mesh-ancestor
83800272|NCT00045539|Protective Agents|protective agents|mesh-ancestor
83800273|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
83800274|NCT00045539|Vitamins|vitamins|mesh-ancestor
83800275|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
83800276|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83800277|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
83800278|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83800279|NCT00079248|Progesterone|progesterone|mesh-list
83800280|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83800281|NCT00079248|Estrogens|estrogens|mesh-list
83800282|NCT00079248|Progestins|progestins|mesh-ancestor
83800283|NCT00079248|Hormones|hormones|mesh-ancestor
83800284|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800285|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800286|NCT00045617|Etoposide|etoposide|mesh-list
83800287|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83800288|NCT00045617|Vaccines|vaccines|mesh-list
83800289|NCT00045617|Antibodies|antibodies|mesh-list
83800290|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
83800291|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83800292|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83800293|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
83800294|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800295|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800296|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800297|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83800298|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83800299|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800300|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800301|NCT03442309|Fluorides|fluorides|mesh-list
83800302|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
83800303|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
83800304|NCT03442309|Protective Agents|protective agents|mesh-ancestor
83800305|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800306|NCT03399838|Midazolam|midazolam|mesh-list
83800307|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
83800308|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83800309|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83800310|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800311|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83800312|NCT03399838|Analgesics|analgesics|mesh-ancestor
83800313|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
83800314|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800315|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83800316|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83800317|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83800318|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
83800319|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800320|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800321|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83800322|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83800323|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83800324|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83800325|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83800326|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
83800327|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
83800328|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
83800329|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
83800330|NCT00079287|Paclitaxel|paclitaxel|mesh-list
83800331|NCT00079287|Vinorelbine|vinorelbine|mesh-list
83800332|NCT00079287|Docetaxel|docetaxel|mesh-list
83800333|NCT00079287|Carboplatin|carboplatin|mesh-list
83800334|NCT00079287|Gemcitabine|gemcitabine|mesh-list
83800335|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800336|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800337|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800338|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800339|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800340|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800341|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800342|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
83800343|NCT00045695|Bortezomib|bortezomib|mesh-list
83800344|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800345|NCT00079365|Gemcitabine|gemcitabine|mesh-list
83800346|NCT00079365|Fluorouracil|fluorouracil|mesh-list
83800347|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800348|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
83800349|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800350|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800351|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800352|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
83800353|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800355|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
83800356|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83800357|NCT00045773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83800358|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83800359|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83800360|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800361|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800362|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
83800363|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800364|NCT02839915|Leucovorin|leucovorin|mesh-list
83800365|NCT02839915|Folic Acid|folic acid|mesh-list
83800366|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
83800367|NCT02839915|Antidotes|antidotes|mesh-ancestor
83800368|NCT02839915|Protective Agents|protective agents|mesh-ancestor
83800369|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800370|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
83800371|NCT02839915|Vitamins|vitamins|mesh-ancestor
83800372|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
83800373|NCT02839915|Hematinics|hematinics|mesh-ancestor
83800374|NCT00045812|Ezetimibe|ezetimibe|mesh-list
83800375|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83800376|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83800377|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
83800378|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800379|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83800380|NCT00079443|Rituximab|rituximab|mesh-list
83800381|NCT00079443|Fludarabine|fludarabine|mesh-list
83800382|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
83800383|NCT00079443|Romidepsin|romidepsin|mesh-list
83800384|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83800385|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800386|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
83800387|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800388|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800389|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800390|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
83800391|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800392|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800393|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800394|NCT00079443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83800395|NCT00079443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800396|NCT02599363|Paclitaxel|paclitaxel|mesh-list
83800397|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800398|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800399|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800400|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800401|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800402|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800403|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83800404|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83800405|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83800406|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800407|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800408|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83800409|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83800410|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800411|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
83800412|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800413|NCT00403429|Capecitabine|capecitabine|mesh-list
83800414|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800415|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
83800416|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800417|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800418|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
83800419|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800420|NCT00079560|Dronabinol|dronabinol|mesh-list
83800421|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
83800422|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800423|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83800424|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83800425|NCT00079560|Analgesics|analgesics|mesh-ancestor
83800426|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
83800427|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800428|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83800429|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83800430|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800431|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800432|NCT00079560|Hormones|hormones|mesh-ancestor
83800433|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800434|NCT00046163|Midodrine|midodrine|mesh-list
83800435|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
83800436|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
83800437|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800438|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800439|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83800440|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83800441|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83800442|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83800443|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
83800444|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800445|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800446|NCT01409161|Vitamins|vitamins|mesh-list
83800447|NCT01409161|Vitamin A|vitamin a|mesh-list
83800448|NCT01409161|Tretinoin|tretinoin|mesh-list
83800449|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
83800450|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
83800451|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
83800452|NCT01409161|Calicheamicins|calicheamicins|mesh-list
83800453|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
83800454|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800455|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800456|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
83800457|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
83800458|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
83800459|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800460|NCT01409161|Protective Agents|protective agents|mesh-ancestor
83800461|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83800462|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83800463|NCT01409161|Immunotoxins|immunotoxins|mesh-ancestor
83800464|NCT01409161|Immunoconjugates|immunoconjugates|mesh-ancestor
83800465|NCT01409161|Immunologic Factors|immunologic factors|mesh-ancestor
83800466|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800467|NCT00079638|Niacin|niacin|mesh-list
83800468|NCT00079638|Atorvastatin|atorvastatin|mesh-list
83800469|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83800470|NCT00079638|Simvastatin|simvastatin|mesh-list
83800471|NCT00079638|Ezetimibe|ezetimibe|mesh-list
83800472|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83800473|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83800474|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
83800475|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800476|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83800477|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83800478|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800479|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
83800480|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
83800481|NCT00079638|Vitamins|vitamins|mesh-ancestor
83800482|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
83800483|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800484|NCT00046241|Bupropion|bupropion|mesh-list
83800485|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83800486|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
83800487|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83800488|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83800489|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83800490|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83800491|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800492|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
83800493|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800494|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800495|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83845104|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82955741|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
83800496|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83800497|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800498|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
83800499|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83800500|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800501|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
83800502|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83800503|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
83800504|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800505|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
83800506|NCT00130468|Protective Agents|protective agents|mesh-ancestor
83800507|NCT00130507|Capecitabine|capecitabine|mesh-list
83800508|NCT00130507|Trastuzumab|trastuzumab|mesh-list
83800509|NCT00130507|Vinorelbine|vinorelbine|mesh-list
83800510|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800511|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
83800512|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800513|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800514|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83800515|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800516|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800517|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800518|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800519|NCT00130546|Sirolimus|sirolimus|mesh-list
83800520|NCT00130546|Paclitaxel|paclitaxel|mesh-list
83800521|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800522|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800523|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800524|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800525|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800526|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800527|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83800528|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800529|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800530|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
83800531|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800532|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
83800533|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800534|NCT00130585|Folic Acid|folic acid|mesh-list
83800535|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
83800536|NCT00130585|Hematinics|hematinics|mesh-ancestor
83800537|NCT00130585|Vitamins|vitamins|mesh-ancestor
83800538|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
83800539|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800540|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83800541|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83800542|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800543|NCT00079755|Immunotoxins|immunotoxins|mesh-ancestor
83800544|NCT00079755|Immunoconjugates|immunoconjugates|mesh-ancestor
83800545|NCT00079755|Immunologic Factors|immunologic factors|mesh-ancestor
83800546|NCT00079755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800547|NCT00130702|Gefitinib|gefitinib|mesh-list
83800548|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800549|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800550|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800551|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800552|NCT00130819|Buprenorphine|buprenorphine|mesh-list
83800553|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83800554|NCT00130819|Narcotics|narcotics|mesh-ancestor
83800555|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83800556|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800557|NCT00130819|Analgesics|analgesics|mesh-ancestor
83800558|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
83800559|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800560|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83800561|NCT00130858|Carboplatin|carboplatin|mesh-list
83800562|NCT00130858|Topotecan|topotecan|mesh-list
83800563|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800564|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83800565|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83800566|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800567|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800568|NCT00130897|Sunitinib|sunitinib|mesh-list
83800569|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800570|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83800571|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83800572|NCT00130897|Growth Substances|growth substances|mesh-ancestor
83800573|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800574|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
83800575|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800576|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800577|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800578|NCT00046319|Ambrisentan|ambrisentan|mesh-list
83800579|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83800580|NCT00079833|Esomeprazole|esomeprazole|mesh-list
83800581|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83800582|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800583|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83800584|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800585|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800586|NCT00079872|Pemetrexed|pemetrexed|mesh-list
83800587|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800588|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800589|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800590|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83800591|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83800592|NCT00046358|Ibuprofen|ibuprofen|mesh-list
83800593|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83800594|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83800595|NCT00046358|Analgesics|analgesics|mesh-ancestor
83800596|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
83800597|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800598|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800599|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800600|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800601|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83800602|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800603|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800604|NCT00130936|Carboplatin|carboplatin|mesh-list
83800605|NCT00130936|Capecitabine|capecitabine|mesh-list
83800606|NCT00130936|Epirubicin|epirubicin|mesh-list
83800607|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800608|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800609|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
83800610|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800611|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800612|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83800613|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83800614|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800615|NCT00130975|Candesartan|candesartan|mesh-list
83800616|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83800617|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83800618|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83800619|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800620|NCT00131053|Cytarabine|cytarabine|mesh-list
83800621|NCT00131053|Dexamethasone|dexamethasone|mesh-list
83800622|NCT00131053|Prednisolone|prednisolone|mesh-list
83800623|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
83800624|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
83800625|NCT00131053|Methotrexate|methotrexate|mesh-list
83800626|NCT00131053|Vincristine|vincristine|mesh-list
83800627|NCT00131053|Asparaginase|asparaginase|mesh-list
83800628|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
83800629|NCT00131053|Pirarubicin|pirarubicin|mesh-list
83800630|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800631|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
83800632|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800633|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800634|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83800635|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
83800636|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800637|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800638|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83800639|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800640|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
83800641|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
83800642|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800643|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800644|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
83800645|NCT00131053|Hormones|hormones|mesh-ancestor
83800646|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800647|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83800648|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83800649|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
83800650|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83800651|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83800652|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
83800653|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
83800654|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800655|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83800656|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83800657|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
83800658|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800659|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800660|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800661|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800662|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800663|NCT00079911|Valacyclovir|valacyclovir|mesh-list
83800664|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
83800665|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800667|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800668|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800669|NCT00131326|Hylan|hylan|mesh-list
83800670|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
83800671|NCT00131326|Protective Agents|protective agents|mesh-ancestor
83800672|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800673|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83800674|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83800675|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83800676|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800677|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800678|NCT00131404|Hormones|hormones|mesh-ancestor
83800679|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800680|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800681|NCT00131443|Topiramate|topiramate|mesh-list
83800682|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
83800683|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83800684|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800685|NCT00079989|Tigecycline|tigecycline|mesh-list
83800686|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83800687|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800688|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83800689|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800690|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800691|NCT00131482|Thrombin|thrombin|mesh-list
83800692|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
83800693|NCT00131482|Coagulants|coagulants|mesh-ancestor
83800694|NCT00397709|Rifampin|rifampin|mesh-list
83800695|NCT00397709|Isoniazid|isoniazid|mesh-list
83800696|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83800697|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
83800698|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83800699|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800700|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
83800701|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83800702|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800703|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800704|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83800705|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83800706|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83800707|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83800708|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83800709|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83800710|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83800711|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83800712|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
83800713|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83800714|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
83800715|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
83800716|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800717|NCT00131521|Expectorants|expectorants|mesh-ancestor
83800718|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
83800719|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83800720|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
83800721|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800722|NCT00131521|Protective Agents|protective agents|mesh-ancestor
83800723|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800724|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
83800725|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800726|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83800727|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83800728|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
83800729|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
83800730|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83800731|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
83800732|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83800733|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83800734|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800735|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83800736|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800737|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800738|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83800739|NCT00080145|Risperidone|risperidone|mesh-list
83800740|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83800741|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
83800742|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800743|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800744|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800745|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83800746|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83800747|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83800748|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83800749|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83800750|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
83800751|NCT00403663|Fentanyl|fentanyl|mesh-list
83800752|NCT00403663|Morphine|morphine|mesh-list
83800753|NCT00403663|Bupivacaine|bupivacaine|mesh-list
83800754|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
83800755|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
83800756|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83800757|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800758|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
83800759|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800760|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83800761|NCT00403663|Narcotics|narcotics|mesh-ancestor
83800762|NCT00403663|Analgesics|analgesics|mesh-ancestor
83800763|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83800764|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83800765|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
83800766|NCT00403780|Pregabalin|pregabalin|mesh-list
83800767|NCT00403780|Analgesics|analgesics|mesh-ancestor
83800768|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
83800769|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800770|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800771|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
83800772|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83800773|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83800774|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800775|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83800776|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83800777|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83800778|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83800779|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83800780|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83800781|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800782|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83800783|NCT00403819|Laxatives|laxatives|mesh-ancestor
83800784|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800785|NCT00403858|Lactulose|lactulose|mesh-list
83800786|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83800787|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800788|NCT00403858|Laxatives|laxatives|mesh-ancestor
83800789|NCT00046553|Mifepristone|mifepristone|mesh-list
83800790|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83800791|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
83800792|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83800793|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800794|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83800795|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83800796|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83800797|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
83800798|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83800799|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83800800|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
83800801|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800802|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
83800803|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83800804|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83800805|NCT00131989|Sorafenib|sorafenib|mesh-list
83800806|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800807|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800808|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800809|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800810|NCT00132067|Vorinostat|vorinostat|mesh-list
83800811|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800812|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83800813|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800814|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800815|NCT00132106|Phentolamine|phentolamine|mesh-list
83800816|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83800817|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83800818|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
83800819|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800820|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800821|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800822|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83800823|NCT00080340|Gefitinib|gefitinib|mesh-list
83800824|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800825|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83800826|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800827|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800828|NCT00132184|Vitamin D|vitamin d|mesh-list
83800829|NCT00132184|Vitamins|vitamins|mesh-ancestor
83800830|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
83800831|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800832|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83800833|NCT00132379|Docetaxel|docetaxel|mesh-list
83800834|NCT00132379|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
83800835|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800836|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800837|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800838|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800839|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800840|NCT00132379|Immunoconjugates|immunoconjugates|mesh-ancestor
83800841|NCT00132379|Immunologic Factors|immunologic factors|mesh-ancestor
83800842|NCT00132379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800843|NCT00132418|Etanercept|etanercept|mesh-list
83800844|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83800845|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83800846|NCT00132418|Analgesics|analgesics|mesh-ancestor
83800847|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
83800848|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800849|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800850|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800851|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800852|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800853|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800854|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
83800855|NCT00132535|Chloroquine|chloroquine|mesh-list
83800856|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
83800857|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
83800858|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83800859|NCT00132535|Amebicides|amebicides|mesh-ancestor
83800860|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83800861|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83800862|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800863|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
83800864|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800865|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83800866|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800867|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800868|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83800869|NCT00132613|Bleomycin|bleomycin|mesh-list
83800870|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800871|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800872|NCT00132652|Lamivudine|lamivudine|mesh-list
83800873|NCT00132652|Telbivudine|telbivudine|mesh-list
83800874|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83800875|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83800876|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83800877|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800878|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
83800879|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800880|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83800881|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83800882|NCT00046748|Omalizumab|omalizumab|mesh-list
83800883|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83800884|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83800885|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
83800886|NCT00132886|Tolvaptan|tolvaptan|mesh-list
83800887|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83800888|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800889|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
83800890|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800891|NCT00080418|Paclitaxel|paclitaxel|mesh-list
83800892|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800893|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800894|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800895|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800896|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800897|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800898|NCT00132925|Triamcinolone|triamcinolone|mesh-list
83800899|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800900|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
83800901|NCT00132925|Hormones|hormones|mesh-ancestor
83800902|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83800903|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800904|NCT00133003|Abciximab|abciximab|mesh-list
83800905|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
83800906|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83800907|NCT00046787|Lurtotecan|lurtotecan|mesh-list
83800908|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800909|NCT00133042|Omalizumab|omalizumab|mesh-list
83800910|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83800911|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83800912|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
83800913|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
83800914|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83800915|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800916|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
83800917|NCT00133198|Pramipexole|pramipexole|mesh-list
83800918|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
83800919|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800920|NCT00133198|Protective Agents|protective agents|mesh-ancestor
83800921|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800922|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83800923|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83134026|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800924|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
83800925|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
83800926|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800927|NCT00046826|Thalidomide|thalidomide|mesh-list
83800928|NCT00046826|Docetaxel|docetaxel|mesh-list
83800929|NCT00046826|Estramustine|estramustine|mesh-list
83800930|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800931|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800932|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800933|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800934|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800935|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800936|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
83800937|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800938|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
83800939|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83800940|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800941|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83800942|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83800943|NCT00046826|Growth Substances|growth substances|mesh-ancestor
83800944|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
83800945|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82956199|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
83800946|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
83800947|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83800949|NCT00133237|Paclitaxel|paclitaxel|mesh-list
83800950|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83800951|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800952|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83800953|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83800954|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83800955|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800956|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83800957|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800958|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83800959|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
83800960|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800961|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
83800962|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800963|NCT00399672|Interferons|interferons|mesh-list
83800964|NCT00399672|Ribavirin|ribavirin|mesh-list
83800965|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83800966|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
83800967|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83800968|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
83800969|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800970|NCT00133276|Escitalopram|escitalopram|mesh-list
83800971|NCT00133276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83800972|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83800973|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83800974|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83800975|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83800976|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
83800977|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800978|NCT00131755|Diazoxide|diazoxide|mesh-list
83800979|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83800980|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
83800981|NCT00133315|Adalimumab|adalimumab|mesh-list
83800982|NCT00133315|Infliximab|infliximab|mesh-list
83800983|NCT00133315|Etanercept|etanercept|mesh-list
83800984|NCT00133315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83800985|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83800986|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83800987|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
83800988|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83800989|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83800990|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83800991|NCT00133315|Analgesics|analgesics|mesh-ancestor
83800992|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
83800993|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83800994|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83800995|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83800996|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
83800997|NCT00080496|Imipenem|imipenem|mesh-list
83800998|NCT00080496|Tigecycline|tigecycline|mesh-list
83800999|NCT00080496|Cilastatin|cilastatin|mesh-list
83801000|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801001|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801002|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83801003|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801004|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801005|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
83801006|NCT00133354|Anastrozole|anastrozole|mesh-list
83801007|NCT00133354|Hormones|hormones|mesh-list
83801008|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801009|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801010|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801011|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801012|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83801013|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83801014|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801015|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801016|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83801017|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
83801018|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
83801019|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83801020|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956272|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801021|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801022|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83801023|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83801024|NCT00133393|Protective Agents|protective agents|mesh-ancestor
83801025|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801026|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
83801027|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83801028|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
83801029|NCT00046904|Etanercept|etanercept|mesh-list
83801030|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83801031|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83801032|NCT00046904|Analgesics|analgesics|mesh-ancestor
83801033|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
83801034|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801035|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801036|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801037|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801038|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801039|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801040|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
83801041|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83801042|NCT00403897|Laxatives|laxatives|mesh-ancestor
83801043|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801044|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83801045|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83801046|NCT00046943|Atrasentan|atrasentan|mesh-list
83801047|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801048|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83801049|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83801050|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801051|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83801052|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
83801053|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801054|NCT00080613|Exemestane|exemestane|mesh-list
83801055|NCT00080613|Hormones|hormones|mesh-list
83801056|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801057|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801058|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801059|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83801060|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83801061|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801062|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801063|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83801064|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
83801065|NCT00047021|Cytarabine|cytarabine|mesh-list
83801066|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
83801067|NCT00047021|Sargramostim|sargramostim|mesh-list
83801068|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801069|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
83801070|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801071|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801072|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
83801073|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801074|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801075|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
83801076|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801077|NCT00047021|Analgesics|analgesics|mesh-ancestor
83801078|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
83801079|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801080|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801081|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801082|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801083|NCT00133627|Ketotifen|ketotifen|mesh-list
83801084|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
83801085|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
83801086|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83801087|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
83801088|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
83801089|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801090|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801091|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801092|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83801093|NCT00133744|Folic Acid|folic acid|mesh-list
83801094|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
83801095|NCT00133744|Vitamins|vitamins|mesh-ancestor
83801096|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
83801097|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801098|NCT00133744|Hematinics|hematinics|mesh-ancestor
83801099|NCT00080808|Phentolamine|phentolamine|mesh-list
83801100|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
83801101|NCT00080808|Alprostadil|alprostadil|mesh-list
83801102|NCT00080808|Papaverine|papaverine|mesh-list
83801103|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801104|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
83801105|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83801106|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83801107|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801108|NCT00080808|Urological Agents|urological agents|mesh-ancestor
83801109|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83801110|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83801111|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
83801112|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801113|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801114|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83801115|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83801116|NCT00047099|Tamoxifen|tamoxifen|mesh-list
83801117|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
83801118|NCT00047099|Docetaxel|docetaxel|mesh-list
83801119|NCT00047099|Fluorouracil|fluorouracil|mesh-list
83801120|NCT00047099|Epirubicin|epirubicin|mesh-list
83801121|NCT00047099|Goserelin|goserelin|mesh-list
83801122|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801123|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
83801124|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801125|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801126|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801127|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
83801128|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801129|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801130|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83801131|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801132|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801133|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801134|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
83801135|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801136|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801137|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801138|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801139|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801140|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83801141|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
83801142|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801143|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801144|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83801145|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83801146|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83801147|NCT00133822|Risperidone|risperidone|mesh-list
83801148|NCT00133822|Sertraline|sertraline|mesh-list
83801149|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83801150|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
83801151|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801152|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801153|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801154|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83801155|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83801156|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83801157|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83801158|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83801159|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
83801160|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
83801161|NCT00133822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83801162|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83801163|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83801164|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
83801165|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83801166|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83801167|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801168|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
83801169|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956422|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
83801170|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801171|NCT00134095|Irinotecan|irinotecan|mesh-list
83801172|NCT00134095|Tegafur|tegafur|mesh-list
83801173|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83801174|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801175|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801176|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801177|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801178|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801179|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
83801180|NCT00047138|Dactinomycin|dactinomycin|mesh-list
83801181|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
83801182|NCT00047138|Carboplatin|carboplatin|mesh-list
83801183|NCT00047138|Doxorubicin|doxorubicin|mesh-list
83801184|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83801185|NCT00047138|Etoposide|etoposide|mesh-list
83801186|NCT00047138|Vincristine|vincristine|mesh-list
83801187|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801188|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
83801189|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801190|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801191|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801192|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
83801193|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801194|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801195|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83801196|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801197|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801198|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801199|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801200|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801201|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801202|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801203|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801204|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801205|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801206|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83801207|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83801208|NCT00080847|Prednisone|prednisone|mesh-list
83801209|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
83801210|NCT00080847|Rituximab|rituximab|mesh-list
83801211|NCT00080847|Doxorubicin|doxorubicin|mesh-list
83801212|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83801213|NCT00080847|Vincristine|vincristine|mesh-list
83801214|NCT00080847|Oblimersen|oblimersen|mesh-list
83801215|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801216|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
83801217|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801218|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801219|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801220|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
83801221|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801222|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801223|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83801224|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83801225|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801226|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801227|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801228|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801229|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801230|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
83801231|NCT00080847|Hormones|hormones|mesh-ancestor
83801232|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801233|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801234|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801235|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801236|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801237|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801238|NCT00134173|Atorvastatin|atorvastatin|mesh-list
83801239|NCT00134173|Torcetrapib|torcetrapib|mesh-list
83801240|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83801241|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83801242|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
83801243|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801244|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83801245|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83801246|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801247|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
83801248|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801249|NCT00080886|Cytarabine|cytarabine|mesh-list
83801250|NCT00080886|Rituximab|rituximab|mesh-list
83801251|NCT00080886|Etoposide|etoposide|mesh-list
83801252|NCT00080886|Melphalan|melphalan|mesh-list
83801253|NCT00080886|Carmustine|carmustine|mesh-list
83801254|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83801255|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801256|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
83801257|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801258|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801259|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801260|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801261|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801262|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801263|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801264|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801265|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
83801266|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
83801267|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801268|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801269|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801270|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
83801271|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83801272|NCT00134212|Epinephrine|epinephrine|mesh-list
83801273|NCT00134212|Norepinephrine|norepinephrine|mesh-list
83801274|NCT00134212|Dopexamine|dopexamine|mesh-list
83801275|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83801276|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83801277|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
83801278|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801279|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801280|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801281|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83801282|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83801283|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
83801284|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801285|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83801286|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
83801287|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
83801288|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
83801289|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83801290|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
83801291|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
83801292|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
83801293|NCT00134290|Metformin|metformin|mesh-list
83801294|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83801295|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801296|NCT00047216|Tipifarnib|tipifarnib|mesh-list
83801297|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801298|NCT00080925|Cytarabine|cytarabine|mesh-list
83801299|NCT00080925|Cyclosporine|cyclosporine|mesh-list
83801300|NCT00080925|Prednisone|prednisone|mesh-list
83801301|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
83801302|NCT00080925|Rituximab|rituximab|mesh-list
83801303|NCT00080925|Doxorubicin|doxorubicin|mesh-list
83801304|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83801305|NCT00080925|Fludarabine|fludarabine|mesh-list
83801306|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
83801307|NCT00080925|Etoposide|etoposide|mesh-list
83801308|NCT00080925|Vincristine|vincristine|mesh-list
83801309|NCT00080925|Cyclosporins|cyclosporins|mesh-list
83801310|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801311|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
83801312|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801313|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801314|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801315|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
83801316|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801317|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801318|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83801319|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83801320|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801321|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801322|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801323|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801324|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801325|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
83801326|NCT00080925|Hormones|hormones|mesh-ancestor
83801327|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801328|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801329|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801330|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
83801331|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801332|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
83801333|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801334|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801335|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801336|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801337|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
83801338|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
83801339|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83801340|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83801341|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83801342|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801343|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
83801344|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801345|NCT00047255|Carboplatin|carboplatin|mesh-list
83801346|NCT00047255|Docetaxel|docetaxel|mesh-list
83801347|NCT00047255|Trastuzumab|trastuzumab|mesh-list
83801348|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801349|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801350|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801351|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801352|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801353|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83801354|NCT00134368|Etanercept|etanercept|mesh-list
83801355|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83801356|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83801357|NCT00134368|Analgesics|analgesics|mesh-ancestor
83801358|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
83801359|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801360|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801361|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801362|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801363|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801364|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801365|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
83801366|NCT00134485|Atorvastatin|atorvastatin|mesh-list
83801367|NCT00134485|Torcetrapib|torcetrapib|mesh-list
83801368|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83801369|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83801370|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
83801371|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801372|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83801373|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83801374|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801375|NCT00047294|Thalidomide|thalidomide|mesh-list
83801376|NCT00047294|Celecoxib|celecoxib|mesh-list
83801377|NCT00047294|Temozolomide|temozolomide|mesh-list
83801378|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801379|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
83801380|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801381|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801382|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83801383|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83801384|NCT00047294|Analgesics|analgesics|mesh-ancestor
83801385|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
83801386|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801387|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801388|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801389|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801390|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83801391|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83801392|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801393|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801394|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
83801395|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
83801396|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801397|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801398|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83801399|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83801400|NCT00047294|Growth Substances|growth substances|mesh-ancestor
83801401|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
83801402|NCT00042822|Romidepsin|romidepsin|mesh-list
83801403|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801404|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801405|NCT00042822|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83801406|NCT00042822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801407|NCT00042822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801408|NCT00134641|Gemcitabine|gemcitabine|mesh-list
83801409|NCT00134641|Vinorelbine|vinorelbine|mesh-list
83801410|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801411|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
83801412|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801413|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801414|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801415|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801416|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801417|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801418|NCT00134680|Trastuzumab|trastuzumab|mesh-list
83801419|NCT00134680|Letrozole|letrozole|mesh-list
83801420|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83801421|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801422|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83801423|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83801424|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801425|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801426|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83801427|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
83801428|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801429|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801430|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83801431|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83801432|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801433|NCT00081042|Paclitaxel|paclitaxel|mesh-list
83801434|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83801435|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801436|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801437|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801438|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801439|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801440|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801441|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83801442|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801443|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83801444|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801445|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801446|NCT00134875|Buprenorphine|buprenorphine|mesh-list
83801447|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83801448|NCT00134875|Naloxone|naloxone|mesh-list
83801449|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83801450|NCT00134875|Narcotics|narcotics|mesh-ancestor
83801451|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83801452|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801453|NCT00134875|Analgesics|analgesics|mesh-ancestor
83801454|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
83801455|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801456|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83801457|NCT00134914|Buprenorphine|buprenorphine|mesh-list
83801458|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83801459|NCT00134914|Narcotics|narcotics|mesh-ancestor
83801460|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83801461|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801462|NCT00134914|Analgesics|analgesics|mesh-ancestor
83801463|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
83801464|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801465|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83801466|NCT00134953|Rivastigmine|rivastigmine|mesh-list
83801467|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83801468|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801469|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801470|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83801471|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801472|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956726|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
83801473|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83801474|NCT00134953|Protective Agents|protective agents|mesh-ancestor
83801475|NCT00042861|Leucovorin|leucovorin|mesh-list
83801476|NCT00042861|Fluorouracil|fluorouracil|mesh-list
83801477|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83801478|NCT00042861|Calcium|calcium|mesh-list
83801479|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
83801480|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83801481|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801482|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
83801483|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801484|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801485|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801486|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801487|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
83801488|NCT00042861|Antidotes|antidotes|mesh-ancestor
83801489|NCT00042861|Protective Agents|protective agents|mesh-ancestor
83801490|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
83801491|NCT00042861|Vitamins|vitamins|mesh-ancestor
83801492|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
83801493|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83801494|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801495|NCT00134992|Prednisolone|prednisolone|mesh-list
83801496|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83801497|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
83801498|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83801499|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
83801500|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83801501|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
83801502|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801503|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
83801504|NCT00134992|Hormones|hormones|mesh-ancestor
83801505|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801506|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801507|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801508|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801509|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
83801510|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
83801511|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801512|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801513|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83801514|NCT00134992|Protective Agents|protective agents|mesh-ancestor
83801515|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
83801516|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83801517|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801518|NCT00135187|Dexamethasone|dexamethasone|mesh-list
83801519|NCT00135187|Bortezomib|bortezomib|mesh-list
83801520|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801521|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
83801522|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
83801523|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801524|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801525|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801526|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
83801527|NCT00135187|Hormones|hormones|mesh-ancestor
83801528|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801529|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801530|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801531|NCT00145093|Chromium|chromium|mesh-list
83801532|NCT00145093|Trace Elements|trace elements|mesh-ancestor
83801533|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
83801534|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801535|NCT00047450|Citalopram|citalopram|mesh-list
83801536|NCT00047450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83801537|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83801538|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83801539|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801540|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801541|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
83801542|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801543|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83801544|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
83801545|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83801546|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
83801547|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956810|NCT05313009|Sotorasib|sotorasib|mesh-list
83801548|NCT00145171|Apomorphine|apomorphine|mesh-list
83801549|NCT00145171|Emetics|emetics|mesh-ancestor
83801550|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801551|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
83801552|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801553|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801554|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
83801555|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
83801556|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801557|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801558|NCT00145210|Atenolol|atenolol|mesh-list
83801559|NCT00145210|Nebivolol|nebivolol|mesh-list
83801560|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83801561|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83801562|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
83801563|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
83801564|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801565|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801566|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83801567|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83801568|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83801569|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
83801570|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801571|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801572|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
83801573|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83801574|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83801575|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83801576|NCT00081276|Cisplatin|cisplatin|mesh-list
83801577|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801578|NCT00145405|Octreotide|octreotide|mesh-list
83801579|NCT00145405|Lanreotide|lanreotide|mesh-list
83801580|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801581|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801582|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801583|NCT00145444|Olanzapine|olanzapine|mesh-list
83801584|NCT00145444|Ziprasidone|ziprasidone|mesh-list
83801585|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
83801586|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
83801587|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801588|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801589|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801590|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83801591|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83801592|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83801593|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83801594|NCT00145444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83801595|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83801596|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83801597|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801598|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801599|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
83801600|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83801601|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83801602|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
83801603|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
83801604|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
83801605|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83801606|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83801607|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801608|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801609|NCT00145483|Urological Agents|urological agents|mesh-ancestor
83801610|NCT00145522|Tibolone|tibolone|mesh-list
83801611|NCT00145522|Estradiol|estradiol|mesh-list
83801612|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
83801613|NCT00145522|Estrogens|estrogens|mesh-ancestor
83801614|NCT00145522|Hormones|hormones|mesh-ancestor
83801615|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801616|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801617|NCT00145522|Progestins|progestins|mesh-ancestor
83801618|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
83801619|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
83801620|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83801621|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801622|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801623|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83801624|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
83801625|NCT00081315|Amifostine|amifostine|mesh-list
83801626|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83801627|NCT00081315|Protective Agents|protective agents|mesh-ancestor
83801628|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801629|NCT00145561|Ritonavir|ritonavir|mesh-list
83801630|NCT00145561|Saquinavir|saquinavir|mesh-list
83801631|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83801632|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83801633|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
83801634|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801635|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801636|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83801637|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83801638|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
83801639|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801640|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83801641|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83801642|NCT00145639|Carboplatin|carboplatin|mesh-list
83801643|NCT00145639|Doxorubicin|doxorubicin|mesh-list
83801644|NCT00145639|Ifosfamide|ifosfamide|mesh-list
83801645|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801646|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801647|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801648|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801649|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801650|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801651|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801652|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
83801653|NCT00047567|Zonisamide|zonisamide|mesh-list
83801654|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
83801655|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83801656|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83801657|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801658|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83801659|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801660|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83801661|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
83801662|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801663|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
83801664|NCT00145990|Miotics|miotics|mesh-ancestor
83801665|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
83801666|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801667|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801668|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83801669|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83801670|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
83801671|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83801672|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83801673|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
83801674|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801675|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801676|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
83801677|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83801678|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
83801679|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801680|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801681|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
83801682|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801683|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
83801684|NCT00081471|Hematinics|hematinics|mesh-ancestor
83801685|NCT00047645|Interferons|interferons|mesh-list
83801686|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
83801687|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801688|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
83801689|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801690|NCT00146146|Letrozole|letrozole|mesh-list
83801691|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
83801692|NCT00146146|Dutasteride|dutasteride|mesh-list
83801693|NCT00146146|Testosterone|testosterone|mesh-list
83801694|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
83801695|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
83801696|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83801697|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956952|NCT01308229|Paclitaxel|paclitaxel|mesh-list
83801698|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83801699|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83801700|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801701|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801702|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83801703|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
83801704|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801705|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801707|NCT00146146|Hormones|hormones|mesh-ancestor
83801708|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83801709|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
83801710|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83801711|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
83801712|NCT00146224|Hematinics|hematinics|mesh-ancestor
83801713|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
83801714|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801715|NCT00146341|Telmisartan|telmisartan|mesh-list
83801716|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83801717|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83801718|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83801719|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801720|NCT00146380|Lamivudine|lamivudine|mesh-list
83801721|NCT00146380|Zidovudine|zidovudine|mesh-list
83801722|NCT00146380|Nevirapine|nevirapine|mesh-list
83801723|NCT00146380|Nelfinavir|nelfinavir|mesh-list
83801724|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83801725|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83801726|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801727|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801728|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
83801729|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801730|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83801731|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83801732|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
83801733|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83801734|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83801735|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83801736|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83801737|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
83801738|NCT00081588|Darunavir|darunavir|mesh-list
83801739|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83801740|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83801741|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
83801742|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801743|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801744|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83801745|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83801746|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
83801747|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801748|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83801749|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83801750|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801751|NCT00047723|Minocycline|minocycline|mesh-list
83801752|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801753|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801754|NCT00146497|Budesonide|budesonide|mesh-list
83801755|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83801756|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801757|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83801758|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
83801759|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801760|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801761|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83801762|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
83801763|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
83801764|NCT00146497|Hormones|hormones|mesh-ancestor
83801765|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83801766|NCT02957890|Vaccines|vaccines|mesh-list
83801767|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
83801768|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801769|NCT00146575|Sirolimus|sirolimus|mesh-list
83801770|NCT00146575|Paclitaxel|paclitaxel|mesh-list
83801771|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801772|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801773|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801774|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801775|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801776|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801777|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801778|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801779|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801780|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
83801781|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801782|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
83801783|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801785|NCT00146614|Methotrexate|methotrexate|mesh-list
83801786|NCT00146614|Tacrolimus|tacrolimus|mesh-list
83801787|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83801788|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
83801789|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83801790|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801791|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83801792|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
83801793|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801794|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801795|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
83801796|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801797|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83801798|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801799|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
83801800|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801801|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83801802|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83801803|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801804|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801805|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801806|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
83801807|NCT00047762|Bevacizumab|bevacizumab|mesh-list
83801808|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83801809|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83801810|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801811|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83801812|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83801813|NCT00047762|Growth Substances|growth substances|mesh-ancestor
83801814|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801815|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
83801816|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83801817|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801818|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801819|NCT00042978|Carboplatin|carboplatin|mesh-list
83801820|NCT00042978|Etoposide|etoposide|mesh-list
83801821|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
83801822|NCT00042978|Oblimersen|oblimersen|mesh-list
83801823|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801824|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83801825|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83801826|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83801827|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801828|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801829|NCT00405730|Ketorolac|ketorolac|mesh-list
83801830|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83801831|NCT00405730|Nepafenac|nepafenac|mesh-list
83801832|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83801833|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83801834|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83801835|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83801836|NCT00405730|Analgesics|analgesics|mesh-ancestor
83801837|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
83801838|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801839|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801840|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801841|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801842|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83801843|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801844|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801845|NCT00405769|Red yeast rice|red yeast rice|mesh-list
83801846|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83801847|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83801848|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82957104|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83801849|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
83801850|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801851|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801852|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83801853|NCT00047801|Docetaxel|docetaxel|mesh-list
83801854|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801855|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801856|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801857|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801858|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801859|NCT00146731|Artesunate|artesunate|mesh-list
83801860|NCT00146731|Amodiaquine|amodiaquine|mesh-list
83801861|NCT00146731|Dapsone|dapsone|mesh-list
83801862|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
83801863|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
83801864|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83801865|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83801866|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801867|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801868|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
83801869|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
83801870|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83801871|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
83801872|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83801873|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801874|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801875|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
83801876|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801877|NCT00047840|Docetaxel|docetaxel|mesh-list
83801878|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801879|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
83801880|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
83801881|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
83801882|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801883|NCT00146926|Lidocaine|lidocaine|mesh-list
83801884|NCT00146926|Ephedrine|ephedrine|mesh-list
83801885|NCT00146926|Ketamine|ketamine|mesh-list
83801886|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
83801887|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
83801888|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83801889|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801890|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
83801891|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801892|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83801893|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83801894|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83801895|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83801896|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801897|NCT00146926|Analgesics|analgesics|mesh-ancestor
83801898|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83801899|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83801900|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
83801901|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83801902|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83801903|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801904|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83801905|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
83801906|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
83801907|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83801908|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
83801909|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
83801910|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83801911|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83801912|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83801913|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801914|NCT00147121|Rituximab|rituximab|mesh-list
83801915|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83801916|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801917|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
83801918|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801919|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801920|NCT00147160|Temozolomide|temozolomide|mesh-list
83801921|NCT00147160|Cisplatin|cisplatin|mesh-list
83801922|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83801923|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
82957180|NCT05280444|Idarubicin|idarubicin|mesh-list
83801924|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801925|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801926|NCT04732104|Lidocaine|lidocaine|mesh-list
83801927|NCT04732104|Xylometazoline|xylometazoline|mesh-list
83801928|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
83801929|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
83801930|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
83801931|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83801932|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801933|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
83801934|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801935|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83801936|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83801937|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83801938|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83801939|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801940|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83801941|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
83801942|NCT00147355|Acetaminophen|acetaminophen|mesh-list
83801943|NCT00147355|Ibuprofen|ibuprofen|mesh-list
83801944|NCT00147355|Codeine|codeine|mesh-list
83801945|NCT00147355|Ondansetron|ondansetron|mesh-list
83801946|NCT00147355|Metoclopramide|metoclopramide|mesh-list
83801947|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83801948|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83801949|NCT00147355|Analgesics|analgesics|mesh-ancestor
83801950|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
83801951|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83801952|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801953|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83801954|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801955|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83801956|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801957|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801958|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
83801959|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
83801960|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
83801961|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83801962|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
83801963|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83801964|NCT00147355|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83801965|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83801966|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
83801967|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83801968|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83801969|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83801970|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
83801971|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83801972|NCT00147355|Narcotics|narcotics|mesh-ancestor
83801973|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83801974|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
83801975|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
83801976|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
83801977|NCT00048152|Cyclosporine|cyclosporine|mesh-list
83801978|NCT00048152|Cyclosporins|cyclosporins|mesh-list
83801979|NCT00048152|Daclizumab|daclizumab|mesh-list
83801980|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83801981|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83801982|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83801983|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
83801984|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83801985|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83801986|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83801987|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83801988|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
83801989|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83801990|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83801991|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
83801992|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83801993|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83801994|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83801995|NCT00147394|Risperidone|risperidone|mesh-list
83801996|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83801997|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
83801998|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957251|NCT03437902|Protective Agents|protective agents|mesh-ancestor
82957253|NCT05283499|Analgesics|analgesics|mesh-list
83801999|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802000|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802001|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83802002|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802003|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802004|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802005|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83802006|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
83802007|NCT04725682|Tacrolimus|tacrolimus|mesh-list
83802008|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802009|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
83802010|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802011|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83802012|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802013|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802014|NCT00147511|Linezolid|linezolid|mesh-list
83802015|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802016|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802017|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83802018|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802019|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802020|NCT00043095|Gemcitabine|gemcitabine|mesh-list
83802021|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802022|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
83802023|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802024|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802025|NCT00048230|Bortezomib|bortezomib|mesh-list
83802026|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802027|NCT00147589|Eplerenone|eplerenone|mesh-list
83802028|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83802029|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
83802030|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802031|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802032|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83802033|NCT00147589|Diuretics|diuretics|mesh-ancestor
83802034|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
83802035|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83802036|NCT00397332|Alefacept|alefacept|mesh-list
83802037|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
83802038|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
83802039|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802040|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
83802041|NCT00147628|Citric Acid|citric acid|mesh-list
83802042|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
83802043|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
83802044|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83802045|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
83802046|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
83802047|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802048|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
83802049|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83802050|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83802051|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802052|NCT00147628|Urological Agents|urological agents|mesh-ancestor
83802053|NCT00147667|Erythromycin|erythromycin|mesh-list
83802054|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
83802055|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83802056|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
83802057|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802058|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802059|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83802060|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83802061|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802062|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802063|NCT00147784|Interferons|interferons|mesh-list
83802064|NCT00147784|Ribavirin|ribavirin|mesh-list
83802065|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802066|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
83802067|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802068|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
83802069|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802070|NCT00081744|Tigecycline|tigecycline|mesh-list
83802071|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802072|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802073|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83802074|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845105|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802075|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802076|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
83802077|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83802078|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83802079|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802080|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
83802081|NCT00147862|Coagulants|coagulants|mesh-ancestor
83802082|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
83802083|NCT00147901|Fludarabine|fludarabine|mesh-list
83802084|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
83802085|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802086|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
83802087|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802088|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802089|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83802090|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
83802091|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802092|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802093|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83802094|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83802095|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
83802096|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83802097|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
83802098|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
83802099|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802100|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802101|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83802102|NCT02957851|Analgesics|analgesics|mesh-ancestor
83802103|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
83802104|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802105|NCT00147979|Heparin|heparin|mesh-list
83802106|NCT00147979|Calcium heparin|calcium heparin|mesh-list
83802107|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
83802108|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83802109|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83802110|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802111|NCT00148018|Dexamethasone|dexamethasone|mesh-list
83802112|NCT00148018|Bortezomib|bortezomib|mesh-list
83802113|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83802114|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
83802115|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
83802116|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802117|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802118|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83802119|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
83802120|NCT00148018|Hormones|hormones|mesh-ancestor
83802121|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802122|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83802123|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802124|NCT00081822|Cytarabine|cytarabine|mesh-list
83802125|NCT00081822|Clofarabine|clofarabine|mesh-list
83802126|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802127|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
83802128|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802129|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802130|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
83802131|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802132|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802133|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
83802134|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802135|NCT00048425|Simendan|simendan|mesh-list
83802136|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83802137|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
83802138|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83802139|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83802140|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802141|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802142|NCT00048425|Protective Agents|protective agents|mesh-ancestor
83802143|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802144|NCT00148135|Carboplatin|carboplatin|mesh-list
83802145|NCT00148135|Gemcitabine|gemcitabine|mesh-list
83802146|NCT00148135|Capecitabine|capecitabine|mesh-list
82957400|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802147|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802148|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802149|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
83802150|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802151|NCT00399711|Metformin|metformin|mesh-list
83802152|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
83802153|NCT00399711|Repaglinide|repaglinide|mesh-list
83802154|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83802155|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802156|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
83802157|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83802158|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802159|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83802160|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
83802161|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802162|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802163|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802164|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802165|NCT00148291|Docetaxel|docetaxel|mesh-list
83802166|NCT00148291|Vinorelbine|vinorelbine|mesh-list
83802167|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802168|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83802169|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83802170|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83802171|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802172|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83802173|NCT00148330|Triamcinolone|triamcinolone|mesh-list
83802174|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83802175|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
83802176|NCT00148330|Hormones|hormones|mesh-ancestor
83802177|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802178|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802179|NCT00405808|Rimonabant|rimonabant|mesh-list
83802180|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83802181|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83802182|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83802183|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802184|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802185|NCT00405808|Hormones|hormones|mesh-ancestor
83802186|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802187|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802188|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
83802189|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83802190|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802191|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
83802192|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83802193|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802194|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802195|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83802196|NCT00405847|Analgesics|analgesics|mesh-ancestor
83802197|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
83802198|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802199|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83802200|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83802201|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83802202|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
83802203|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802204|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802205|NCT00148408|Montelukast|montelukast|mesh-list
83802206|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83802207|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
83802208|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83802209|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
83802210|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802211|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802212|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83802213|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83802214|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802215|NCT00048503|Tipifarnib|tipifarnib|mesh-list
83802216|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802217|NCT00148447|Escitalopram|escitalopram|mesh-list
83802218|NCT00148447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82957478|NCT03790345|Pyridoxine|pyridoxine|mesh-list
82957479|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
82957480|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
82957481|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
83802219|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83802220|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802221|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802222|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802223|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
83802224|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802225|NCT00043134|Decitabine|decitabine|mesh-list
83802226|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802227|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
83802228|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802229|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802230|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802231|NCT00148564|Olanzapine|olanzapine|mesh-list
83802232|NCT00148564|Ziprasidone|ziprasidone|mesh-list
83802233|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
83802234|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
83802235|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802236|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802237|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83802238|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83802239|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802240|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802241|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802242|NCT00148564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83802243|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83802244|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802245|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802246|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802247|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
83802248|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83802249|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83802250|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
83802251|NCT00148603|Montelukast|montelukast|mesh-list
83802252|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83802253|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
83802254|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83802255|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
83802256|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802257|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802258|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83802259|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83802260|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802261|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
83802262|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83802263|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802264|NCT00148681|Paclitaxel|paclitaxel|mesh-list
83802265|NCT00148681|Vinorelbine|vinorelbine|mesh-list
83802266|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
83802267|NCT00148681|Doxorubicin|doxorubicin|mesh-list
83802268|NCT00148681|Trastuzumab|trastuzumab|mesh-list
83802269|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83802270|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802271|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
83802272|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
83802273|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
83802274|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802275|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802276|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
83802277|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802278|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802279|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83802280|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
83802281|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83802282|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83802283|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83802284|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83802285|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802286|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83802287|NCT00148720|Capecitabine|capecitabine|mesh-list
83802288|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802289|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
82957562|NCT05076799|Lactulose|lactulose|mesh-list
83802290|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802291|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802293|NCT00148837|Ribavirin|ribavirin|mesh-list
83802294|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
83802295|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
83802296|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83802297|NCT00148837|Prazosin|prazosin|mesh-list
83802298|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802299|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
83802300|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802301|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
83802302|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802303|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
83802304|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802305|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83802306|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83802307|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83802308|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83802309|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
83802310|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802311|NCT00148876|Capecitabine|capecitabine|mesh-list
83802312|NCT00148876|Trastuzumab|trastuzumab|mesh-list
83802313|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802314|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
83802315|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802316|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802317|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83802318|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
83802319|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83802320|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802321|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83802322|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83802323|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83802324|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802325|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802326|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802327|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802328|NCT00149110|Analgesics|analgesics|mesh-ancestor
83802329|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
83802330|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802331|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
83802332|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802333|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
83802334|NCT00149149|Polaprezinc|polaprezinc|mesh-list
83802335|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83802336|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83802337|NCT00149188|Lanreotide|lanreotide|mesh-list
83802338|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802339|NCT00043212|Immunomodulating Agents|immunomodulating agents|mesh-list
83802340|NCT00043212|Immunologic Factors|immunologic factors|mesh-ancestor
83802341|NCT00043212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802342|NCT00048776|Cilostazol|cilostazol|mesh-list
83802343|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83802344|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
83802345|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802346|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802347|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83802348|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
83802349|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83802350|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83802351|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802352|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83802353|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
83802354|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83802355|NCT00048776|Protective Agents|protective agents|mesh-ancestor
83802356|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83802357|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83802358|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802359|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
83802360|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83802361|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802362|NCT00048854|Sertraline|sertraline|mesh-list
83802363|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
83802364|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802365|NCT00048854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83802366|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83802367|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802368|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802369|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802371|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802372|NCT00081978|Etravirine|etravirine|mesh-list
83802373|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83802374|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83802375|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802376|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802377|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
83802378|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802379|NCT00149539|Buprenorphine|buprenorphine|mesh-list
83802380|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83802381|NCT00149539|Naloxone|naloxone|mesh-list
83802382|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83802383|NCT00149539|Narcotics|narcotics|mesh-ancestor
83802384|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802385|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802386|NCT00149539|Analgesics|analgesics|mesh-ancestor
83802387|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
83802388|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802389|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83802390|NCT00149578|Leucovorin|leucovorin|mesh-list
83802391|NCT00149578|Gemcitabine|gemcitabine|mesh-list
83802392|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
83802393|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802394|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
83802395|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802396|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802397|NCT00149578|Antidotes|antidotes|mesh-ancestor
83802398|NCT00149578|Protective Agents|protective agents|mesh-ancestor
83802399|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802400|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
83802401|NCT00149578|Vitamins|vitamins|mesh-ancestor
83802402|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
83802403|NCT00149617|Buspirone|buspirone|mesh-list
83802404|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83802405|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802406|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802407|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802408|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802409|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83802410|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
83802411|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802412|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802413|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
83802414|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
83802415|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802416|NCT00149656|Selenium|selenium|mesh-list
83802417|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
83802418|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802419|NCT00149656|Protective Agents|protective agents|mesh-ancestor
83802420|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802421|NCT00149656|Trace Elements|trace elements|mesh-ancestor
83802422|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
83802423|NCT00082095|Doxorubicin|doxorubicin|mesh-list
83802424|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83802425|NCT00082095|Capecitabine|capecitabine|mesh-list
83802426|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83802427|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802428|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83802429|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83802430|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802431|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802432|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802433|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
83802434|NCT00149851|Tegaserod|tegaserod|mesh-list
83802435|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83802436|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
83802437|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802438|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802439|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802440|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
83802441|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83802442|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802443|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83802444|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
83802445|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802446|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802447|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802448|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802449|NCT00049088|Bevacizumab|bevacizumab|mesh-list
83802450|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83802452|NCT00049088|Antibodies|antibodies|mesh-list
83802453|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
83802454|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83802455|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802456|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83802457|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83802458|NCT00049088|Growth Substances|growth substances|mesh-ancestor
83802459|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802460|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
83802461|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
83802462|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83802463|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83802464|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83802465|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802466|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
83802467|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83802468|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802469|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83802470|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
83802471|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802472|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802473|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802474|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802475|NCT04725448|Paclitaxel|paclitaxel|mesh-list
83802476|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83802477|NCT04725448|Bevacizumab|bevacizumab|mesh-list
83802478|NCT04725448|Carboplatin|carboplatin|mesh-list
83802479|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83802480|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802481|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
83802482|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
83802483|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83802484|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802485|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83802486|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83802487|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83802488|NCT04725448|Growth Substances|growth substances|mesh-ancestor
83802489|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802490|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
83802491|NCT00405925|Lamivudine|lamivudine|mesh-list
83802492|NCT00405925|Zidovudine|zidovudine|mesh-list
83802493|NCT00405925|Abacavir|abacavir|mesh-list
83802494|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83802495|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83802496|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802497|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802498|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
83802499|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802500|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83802501|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83802502|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
83802503|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83802504|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802505|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83802506|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802507|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802508|NCT00082212|Cetuximab|cetuximab|mesh-list
83802509|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83802510|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957784|NCT00114140|Temozolomide|temozolomide|mesh-list
83802511|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
83802512|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83802513|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802514|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83802515|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
83802516|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802517|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802518|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802519|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802521|NCT00150046|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83802522|NCT00150046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83802523|NCT00150046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802524|NCT00150046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802525|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802526|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
83802527|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802528|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802529|NCT00150085|Cyclosporine|cyclosporine|mesh-list
83802530|NCT00150085|Cyclosporins|cyclosporins|mesh-list
83802531|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478408|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83802532|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802533|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802534|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
83802535|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802536|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
83802537|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802538|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
83802539|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802540|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83802541|NCT00082251|Niacin|niacin|mesh-list
83802542|NCT00082251|Simvastatin|simvastatin|mesh-list
83802543|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83802544|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83802545|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
83802546|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802547|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83802548|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83802549|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802550|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
83802551|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
83802552|NCT00082251|Vitamins|vitamins|mesh-ancestor
83802553|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
83802554|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802555|NCT00049244|Capecitabine|capecitabine|mesh-list
83802556|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802557|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
83802558|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802559|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802560|NCT00150124|Methimazole|methimazole|mesh-list
83802561|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
83802562|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
83802563|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802564|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802565|NCT00049283|Docetaxel|docetaxel|mesh-list
83802566|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83802567|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802568|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
83802569|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
83802570|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
83802571|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802572|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83802573|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802574|NCT00150241|Varenicline|varenicline|mesh-list
83802575|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83802576|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83802577|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
83802578|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802579|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802580|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802581|NCT00150280|Ibuprofen|ibuprofen|mesh-list
83802582|NCT00150280|Celecoxib|celecoxib|mesh-list
83802583|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83802584|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83802585|NCT00150280|Analgesics|analgesics|mesh-ancestor
83802586|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
82957859|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
83802587|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802588|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802589|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83802591|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83802592|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802593|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802594|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83802595|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
83802596|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802597|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
83802598|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83802599|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83802600|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802601|NCT00150358|Urological Agents|urological agents|mesh-ancestor
83802602|NCT00049361|Thalidomide|thalidomide|mesh-list
83802603|NCT00049361|Temozolomide|temozolomide|mesh-list
83802604|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83802605|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
83802606|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802607|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802608|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802609|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
83802610|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802611|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
83802612|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802613|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802614|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83802615|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83802616|NCT00049361|Growth Substances|growth substances|mesh-ancestor
83802617|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
83802618|NCT00150436|Pregabalin|pregabalin|mesh-list
83802619|NCT00150436|Analgesics|analgesics|mesh-ancestor
83802620|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
83802621|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802622|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802623|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
83802624|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83802625|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802626|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802627|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83802628|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83802629|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802630|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802631|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802632|NCT00150553|Carbamazepine|carbamazepine|mesh-list
83802633|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
83802634|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
83802635|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802636|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802637|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802638|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802639|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83802640|NCT00150553|Analgesics|analgesics|mesh-ancestor
83802641|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
83802642|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802643|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83802644|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802645|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802646|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83802647|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83802648|NCT00150631|Candesartan|candesartan|mesh-list
83802649|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83802650|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83802651|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83390177|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802652|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802653|NCT00082446|Vaccines|vaccines|mesh-list
83802654|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
83802655|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802656|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
83802657|NCT00049439|Lomustine|lomustine|mesh-list
83802658|NCT00049439|Etoposide|etoposide|mesh-list
83802659|NCT00049439|Procarbazine|procarbazine|mesh-list
83802660|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802661|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
83802662|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802663|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802664|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83802665|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
83802666|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802667|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802668|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83802669|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83802670|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83802671|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83802672|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802673|NCT00150670|Cisplatin|cisplatin|mesh-list
83802674|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802675|NCT00150709|Levetiracetam|levetiracetam|mesh-list
83802676|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
83802677|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
83802678|NCT00150748|Levetiracetam|levetiracetam|mesh-list
83802679|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
83802680|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
83802681|NCT00150787|Levetiracetam|levetiracetam|mesh-list
83802682|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
83802683|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
83802684|NCT00150826|Quinapril|quinapril|mesh-list
83802685|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83802686|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
83802687|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802688|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802689|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83802690|NCT00150865|Ropivacaine|ropivacaine|mesh-list
83802691|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
83802692|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
83802693|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802694|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802695|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
83802696|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802697|NCT00049556|Gefitinib|gefitinib|mesh-list
83802698|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802699|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83802700|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802701|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802702|NCT00150982|Alefacept|alefacept|mesh-list
83802703|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
83802704|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
83802705|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802706|NCT00049634|Cyclosporine|cyclosporine|mesh-list
83802707|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
83802708|NCT00049634|Busulfan|busulfan|mesh-list
83802709|NCT00049634|Methotrexate|methotrexate|mesh-list
83802710|NCT00049634|Cyclosporins|cyclosporins|mesh-list
83802711|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802712|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
83802713|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802714|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802715|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83802716|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
83802717|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802718|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802719|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83802720|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83802721|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
83802722|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83802723|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802724|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
83802725|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
83802726|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802727|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83802728|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83802729|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
83802730|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802731|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83802732|NCT00151060|Paclitaxel|paclitaxel|mesh-list
83802733|NCT00151060|Etoposide|etoposide|mesh-list
83802734|NCT00151060|Estramustine|estramustine|mesh-list
82958010|NCT02949024|Hormones|hormones|mesh-ancestor
83802735|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83802736|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802737|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
83802738|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
83802739|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
83802740|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802741|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83802742|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83802743|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802744|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83802745|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
83802746|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83802747|NCT00151138|Atenolol|atenolol|mesh-list
83802748|NCT00151138|Lisinopril|lisinopril|mesh-list
83802749|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83802750|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
83802751|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802752|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802753|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83802754|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83802755|NCT00151138|Protective Agents|protective agents|mesh-ancestor
83802756|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802757|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83802758|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
83802759|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
83802760|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802761|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83802762|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83802763|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83802764|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
83802765|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802766|NCT00082485|Baclofen|baclofen|mesh-list
83802767|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83802768|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802769|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83802770|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802771|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83802772|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
83802773|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
83802774|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802775|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802776|NCT00151255|Cytarabine|cytarabine|mesh-list
83802777|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
83802778|NCT00151255|Idarubicin|idarubicin|mesh-list
83802779|NCT00151255|Tretinoin|tretinoin|mesh-list
83802780|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83802781|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
83802782|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802783|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802784|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
83802785|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802786|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83802787|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
83802788|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802789|NCT00151255|Analgesics|analgesics|mesh-ancestor
83802790|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
83802791|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802792|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83802793|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83802794|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802795|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82958086|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958087|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958088|NCT03093428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82958089|NCT03093428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802796|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
82958090|NCT02735980|Prexasertib|prexasertib|mesh-list
82958091|NCT02735980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82958092|NCT02735980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958093|NCT02735980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958094|NCT01309789|Prednisone|prednisone|mesh-list
82958095|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
82958096|NCT01309789|Doxorubicin|doxorubicin|mesh-list
82958097|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82958098|NCT01309789|Vincristine|vincristine|mesh-list
83802797|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
83802798|NCT00049751|Adalimumab|adalimumab|mesh-list
83802799|NCT00049751|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83802800|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83802801|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802802|NCT00151294|Dexetimide|dexetimide|mesh-list
83802803|NCT00151294|Citalopram|citalopram|mesh-list
83802804|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
83802805|NCT00151294|Escitalopram|escitalopram|mesh-list
83802806|NCT00151294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83802807|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83802808|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802809|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802810|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802811|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
83802812|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802813|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83802814|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83802815|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
83802816|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
83802817|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802818|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83802819|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83802820|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
83802821|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83802822|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802823|NCT00151450|Pregabalin|pregabalin|mesh-list
83802824|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83802825|NCT00151450|Analgesics|analgesics|mesh-ancestor
83802826|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
83802827|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802828|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802829|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
83802830|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83802831|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802832|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802833|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83802834|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83802835|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802836|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802837|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802838|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83802839|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83802840|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802841|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83802842|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
83802843|NCT00151489|Pregabalin|pregabalin|mesh-list
83802844|NCT00151489|Analgesics|analgesics|mesh-ancestor
83802845|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
83802846|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802847|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802848|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
83802849|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83802850|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802851|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802852|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83802853|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83802854|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802855|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802856|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802857|NCT00049790|Paclitaxel|paclitaxel|mesh-list
83802858|NCT00049790|Carboplatin|carboplatin|mesh-list
83802859|NCT00049790|Angiostatins|angiostatins|mesh-list
83802860|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83802861|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802862|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
83802863|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
83802864|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958163|NCT03787147|Lidocaine|lidocaine|mesh-list
82958164|NCT03787147|Bupivacaine|bupivacaine|mesh-list
82958165|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
82958166|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
82958167|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802865|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802866|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83802867|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83802868|NCT00049790|Growth Substances|growth substances|mesh-ancestor
83802869|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802870|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83802871|NCT00082524|Caspofungin|caspofungin|mesh-list
83802872|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
83802873|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802874|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802875|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802876|NCT00406003|Paroxetine|paroxetine|mesh-list
83802877|NCT00406003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83802878|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83802879|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802880|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802881|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802882|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
83802883|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802884|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83802885|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
83802886|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802887|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83802888|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83802889|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802890|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
83802891|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83802892|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802893|NCT00406042|Prednisolone|prednisolone|mesh-list
83802894|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83802895|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
83802896|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83802897|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
83802898|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83802899|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
83802900|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83802901|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
83802902|NCT00406042|Hormones|hormones|mesh-ancestor
83802903|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83802904|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802905|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83802906|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802907|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
83802908|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
83802909|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802910|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83802911|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83802912|NCT00406042|Protective Agents|protective agents|mesh-ancestor
83802913|NCT00082563|Azithromycin|azithromycin|mesh-list
83802914|NCT00082563|Chloroquine|chloroquine|mesh-list
83802915|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83802916|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83802917|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83802918|NCT00082563|Amebicides|amebicides|mesh-ancestor
83802919|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83802920|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83802921|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
83802922|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83802923|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134139|NCT02251483|Antibodies|antibodies|mesh-list
83802924|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83802925|NCT00082563|Analgesics|analgesics|mesh-ancestor
83802926|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
83802927|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802928|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802929|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83802930|NCT00082563|Filaricides|filaricides|mesh-ancestor
83802931|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
83802932|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
83802933|NCT00151528|Pregabalin|pregabalin|mesh-list
83802934|NCT00151528|Analgesics|analgesics|mesh-ancestor
83802935|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
83802936|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802937|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802938|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
83802939|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82958233|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
83802940|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83802941|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802942|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83802943|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83802944|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83802945|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83802946|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83802947|NCT00397787|Sunitinib|sunitinib|mesh-list
83802948|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802949|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83802950|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83802951|NCT00397787|Growth Substances|growth substances|mesh-ancestor
83802952|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802953|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
83802954|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83802955|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802956|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802957|NCT00082602|Galantamine|galantamine|mesh-list
83802958|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83802959|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802960|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802961|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
83802962|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802963|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802964|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83802965|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
83802966|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83802967|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
83802968|NCT00151567|Tamsulosin|tamsulosin|mesh-list
83802969|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83802970|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83802971|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83802972|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83802973|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83802974|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802975|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83802976|NCT00151567|Urological Agents|urological agents|mesh-ancestor
83802977|NCT00397826|Simvastatin|simvastatin|mesh-list
83802978|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83802979|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83802980|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
83802981|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802982|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83802983|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83802984|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83802985|NCT00151684|Diazoxide|diazoxide|mesh-list
83802986|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83802987|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
83802988|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83802989|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83802990|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83802991|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
83802992|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83802993|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83802994|NCT00151801|Interferons|interferons|mesh-list
83802995|NCT00151801|Interferon-beta|interferon-beta|mesh-list
83802996|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
83802997|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83802998|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
83802999|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803000|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
83803001|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803002|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83803003|NCT04725253|Niacinamide|niacinamide|mesh-list
83803004|NCT04725253|Niacin|niacin|mesh-list
83803005|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
83803006|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
83803007|NCT04725253|Vitamins|vitamins|mesh-ancestor
83803008|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
83803009|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803010|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83803011|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
83803012|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803013|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83803014|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
82958305|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803015|NCT00082719|Interferons|interferons|mesh-list
83803016|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
83803017|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
83803018|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803019|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
83803020|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803021|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
83803022|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803023|NCT00151957|Methylphenidate|methylphenidate|mesh-list
83803024|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83803025|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803026|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83803027|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83803028|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803029|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803030|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
83803031|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803032|NCT00049946|Risperidone|risperidone|mesh-list
83803033|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83803034|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
83803035|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803036|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803037|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803038|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83803039|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83803040|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803041|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803042|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83803043|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
83803044|NCT00152035|Amphetamine|amphetamine|mesh-list
83803045|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
83803046|NCT00152035|Adderall|adderall|mesh-list
83803047|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83803048|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803049|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
83803050|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
83803051|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803052|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
83803053|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803054|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803055|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
83803056|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83803057|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83803058|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803059|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83803060|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
83803061|NCT00049985|Hematinics|hematinics|mesh-ancestor
83803062|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
83803063|NCT00152191|Fluorouracil|fluorouracil|mesh-list
83803064|NCT00152191|Methotrexate|methotrexate|mesh-list
83803065|NCT00152191|Tegafur|tegafur|mesh-list
83803066|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803067|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
83803068|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803069|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803070|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83803071|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
83803072|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803073|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803074|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83803075|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
83803076|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803077|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83803078|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
83803079|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83803080|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83803081|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803082|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83803083|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83803084|NCT00152230|Tegafur|tegafur|mesh-list
83803085|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803086|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
83803087|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803088|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958381|NCT03776851|Hematinics|hematinics|mesh-ancestor
83803090|NCT00152308|Ethanol|ethanol|mesh-list
83803091|NCT00152308|Temsirolimus|temsirolimus|mesh-list
83803092|NCT00152308|MTOR Inhibitors|mtor inhibitors|mesh-list
83803093|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803094|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803095|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83803096|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803097|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
83803098|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803099|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
83803100|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803101|NCT00152308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83803102|NCT00152308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803103|NCT00152308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803104|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83803105|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803106|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
83803107|NCT00152386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83803108|NCT00152386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803109|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803110|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
83803111|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803112|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803113|NCT00082836|Rituximab|rituximab|mesh-list
83803114|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83803115|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803116|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
83803117|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803118|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803119|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
83803120|NCT00152425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83803121|NCT00152425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803122|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803123|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
83803124|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803125|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803126|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
83803127|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83803128|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
83803129|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803130|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803131|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83803132|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
83803133|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83803134|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
83803135|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803136|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803137|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83803138|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
83803139|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
83803140|NCT00152542|Protective Agents|protective agents|mesh-ancestor
83803141|NCT00043680|Celecoxib|celecoxib|mesh-list
83803142|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83803143|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83803144|NCT00043680|Analgesics|analgesics|mesh-ancestor
83803145|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
83803146|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803147|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803148|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803149|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803150|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83803151|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83803152|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803153|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803154|NCT00152581|Interferons|interferons|mesh-list
83803155|NCT00152581|Ribavirin|ribavirin|mesh-list
83803156|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
83803157|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
83803158|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83803159|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803160|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
83803161|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803162|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
83803163|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803164|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
83803165|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803166|NCT00152620|Dexamethasone|dexamethasone|mesh-list
83803167|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
83803168|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83803169|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83803170|NCT00152620|Prednisolone|prednisolone|mesh-list
83803171|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
83803172|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83803173|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
83803174|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803175|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
83803176|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
83803177|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803178|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803179|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83803180|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
83803181|NCT00152620|Hormones|hormones|mesh-ancestor
83803182|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83803183|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83803184|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803185|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83803186|NCT00152620|Protective Agents|protective agents|mesh-ancestor
83803187|NCT00050141|Tipifarnib|tipifarnib|mesh-list
83803188|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803189|NCT04725214|Temozolomide|temozolomide|mesh-list
83803190|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83803191|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
83803192|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803193|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803194|NCT00152698|Irbesartan|irbesartan|mesh-list
83803195|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83134162|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
83803196|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83803197|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83803198|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803199|NCT00050180|Indinavir|indinavir|mesh-list
83803200|NCT00050180|Saquinavir|saquinavir|mesh-list
83803201|NCT00050180|Midazolam|midazolam|mesh-list
83803202|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83803203|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83803204|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803205|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803206|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83803207|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83803208|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803209|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83803210|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
83803211|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
83803212|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
83803213|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
83803214|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803215|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803216|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83803217|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83803218|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
83803219|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803220|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83803221|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83803222|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
83803223|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803224|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83803225|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83803226|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
83803227|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803228|NCT00152815|Vitamin E|vitamin e|mesh-list
83803229|NCT00152815|Antioxidants|antioxidants|mesh-list
83803230|NCT00152815|Vitamins|vitamins|mesh-ancestor
83803231|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
83803232|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803233|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803234|NCT00152815|Protective Agents|protective agents|mesh-ancestor
83803235|NCT00043719|Vitamin D|vitamin d|mesh-list
82958531|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82958538|NCT04673422|Montelukast|montelukast|mesh-list
83803236|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
83803237|NCT00043719|Calcium|calcium|mesh-list
83803238|NCT00043719|Vitamins|vitamins|mesh-ancestor
83803239|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
83803240|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803241|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83803242|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83803243|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
83803244|NCT00152854|Acetaminophen|acetaminophen|mesh-list
83803245|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83803246|NCT00152854|Analgesics|analgesics|mesh-ancestor
83803247|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
83803248|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803249|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803250|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
83803251|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
83803252|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83803253|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803254|NCT00152893|Chromium|chromium|mesh-list
83803255|NCT00152893|Niacin|niacin|mesh-list
83803256|NCT00152893|Trace Elements|trace elements|mesh-ancestor
83803257|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
83803258|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803259|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83803260|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
83803261|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803262|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83803263|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
83803264|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
83803265|NCT00152893|Vitamins|vitamins|mesh-ancestor
83803266|NCT00152932|Dorzolamide|dorzolamide|mesh-list
83803267|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83803268|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83803269|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803270|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803271|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
83803272|NCT00083031|Bevacizumab|bevacizumab|mesh-list
83803273|NCT00083031|Methotrexate|methotrexate|mesh-list
83803274|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803275|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
83803276|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803277|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803278|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83803279|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
83803280|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803281|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803282|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83803283|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83803284|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803285|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803286|NCT00083031|Growth Substances|growth substances|mesh-ancestor
83803287|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803288|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83803289|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
83803290|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83803291|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803292|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
83803293|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
83803294|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803295|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83803296|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83803297|NCT00050336|Lonafarnib|lonafarnib|mesh-list
83803298|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803299|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803300|NCT00043758|Tolvaptan|tolvaptan|mesh-list
83803301|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83803302|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803303|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
83803304|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803305|NCT00050375|Oregovomab|oregovomab|mesh-list
83803306|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83803307|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803308|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83803309|NCT00153049|Telmisartan|telmisartan|mesh-list
83803310|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83803311|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82958613|NCT04943445|Paclitaxel|paclitaxel|mesh-list
83803312|NCT00153049|Diuretics|diuretics|mesh-ancestor
83803313|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
83803314|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803315|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83803316|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803317|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803318|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83803319|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83803320|NCT00153088|Telmisartan|telmisartan|mesh-list
83803321|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83803322|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83803323|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83803324|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803325|NCT00083070|Temozolomide|temozolomide|mesh-list
83803326|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83803327|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
83803328|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803329|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803330|NCT00050414|Dexamethasone|dexamethasone|mesh-list
83803331|NCT00050414|Trabectedin|trabectedin|mesh-list
83803332|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803333|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
83803334|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
83803335|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803336|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803337|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83803338|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
83803339|NCT00050414|Hormones|hormones|mesh-ancestor
83803340|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83803341|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83803342|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803343|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83803344|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
83803345|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803346|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83803347|NCT00153127|Laxatives|laxatives|mesh-ancestor
83803348|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83803349|NCT00083109|Suramin|suramin|mesh-list
83803350|NCT00083109|Fluorouracil|fluorouracil|mesh-list
83803351|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
83803352|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803353|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803354|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803355|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803356|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
83803357|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803358|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
83803359|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
83803360|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83803361|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803362|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83803363|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83803364|NCT00153244|Lamotrigine|lamotrigine|mesh-list
83803365|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
83803366|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83803367|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803368|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803369|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83803370|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803371|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83803372|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83803373|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803374|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803375|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83803376|NCT00153283|Gabapentin|gabapentin|mesh-list
83803377|NCT00153283|Analgesics|analgesics|mesh-ancestor
83803378|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
83803379|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803380|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803381|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
83803382|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83803383|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82958680|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
83803384|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803385|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803386|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83803387|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83803388|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803389|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803390|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
83803391|NCT00050531|Interferons|interferons|mesh-list
83803392|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
83803393|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
83803394|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83803395|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83803396|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
83803397|NCT00050531|Molgramostim|molgramostim|mesh-list
83803398|NCT00050531|Sargramostim|sargramostim|mesh-list
83803399|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803400|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
83803401|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803402|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
83803403|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803404|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83803405|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803406|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803407|NCT00083148|Capecitabine|capecitabine|mesh-list
83803408|NCT00083148|Irinotecan|irinotecan|mesh-list
83803409|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803410|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
83803411|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803412|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803413|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83803414|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83803415|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803416|NCT00153517|Metronidazole|metronidazole|mesh-list
83803417|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803418|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803419|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83803420|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83803421|NCT00153556|Vaccines|vaccines|mesh-list
83803422|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
83803423|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803424|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
83803425|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803426|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
83803427|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803428|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803429|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83803430|NCT00153634|Azithromycin|azithromycin|mesh-list
83803431|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
83803432|NCT00153634|Meropenem|meropenem|mesh-list
83803433|NCT00153634|Tazobactam|tazobactam|mesh-list
83803434|NCT00153634|Piperacillin|piperacillin|mesh-list
83803435|NCT00153634|Tobramycin|tobramycin|mesh-list
83803436|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
83803437|NCT00153634|Amikacin|amikacin|mesh-list
83803438|NCT00153634|Ceftazidime|ceftazidime|mesh-list
83803439|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83803440|NCT00153634|Ticarcillin|ticarcillin|mesh-list
83803441|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
83803442|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803443|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803444|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83803445|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83803446|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803447|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803448|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803449|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83803450|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83803451|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83803452|NCT00050609|Tadalafil|tadalafil|mesh-list
83803453|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
83803454|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83803455|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83803456|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958757|NCT05073744|Narcotics|narcotics|mesh-ancestor
83803457|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803458|NCT00050609|Urological Agents|urological agents|mesh-ancestor
83803459|NCT00153673|Celecoxib|celecoxib|mesh-list
83803460|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83803461|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83803462|NCT00153673|Analgesics|analgesics|mesh-ancestor
83803463|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
83803464|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803465|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803466|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803467|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803468|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83803469|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83803470|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803471|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803472|NCT00050648|Cyclosporine|cyclosporine|mesh-list
83803473|NCT00050648|Cyclosporins|cyclosporins|mesh-list
83803474|NCT00050648|Daclizumab|daclizumab|mesh-list
83803475|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803476|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803477|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803478|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
83803479|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803480|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
83803481|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803482|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
83803483|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803484|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83803485|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
83803486|NCT00153868|Hematinics|hematinics|mesh-ancestor
83803487|NCT00153907|Capecitabine|capecitabine|mesh-list
83803488|NCT00153907|Vinorelbine|vinorelbine|mesh-list
83803489|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803490|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
83803491|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803492|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803493|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83803494|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83803495|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83803496|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83803497|NCT00050726|Interleukin-2|interleukin-2|mesh-list
83803498|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803499|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83803500|NCT00050726|Analgesics|analgesics|mesh-ancestor
83803501|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
83803502|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803503|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803504|NCT00153946|Edaravone|edaravone|mesh-list
83803505|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83803506|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
83803507|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803508|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83803509|NCT00153946|Protective Agents|protective agents|mesh-ancestor
83803510|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803511|NCT00154024|Irbesartan|irbesartan|mesh-list
83803512|NCT00154024|Atorvastatin|atorvastatin|mesh-list
83803513|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83803514|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83803515|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
83803516|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803517|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83803518|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83803519|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803520|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83803521|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83803522|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83803523|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83803524|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
83803525|NCT00154141|Coagulants|coagulants|mesh-ancestor
83803526|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83803527|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83803528|NCT00154180|Estradiol|estradiol|mesh-list
83803529|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83803530|NCT00154180|Estrogens|estrogens|mesh-list
83803531|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83803532|NCT00154180|Progesterone|progesterone|mesh-list
83803533|NCT00154180|Hormones|hormones|mesh-ancestor
82958856|NCT03705780|Fentanyl|fentanyl|mesh-list
83803534|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83803535|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803536|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83803537|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
83803538|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83803539|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83803540|NCT00154180|Progestins|progestins|mesh-ancestor
83803541|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
83803542|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83803543|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83803544|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803545|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803546|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83803547|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83803548|NCT00154219|Analgesics|analgesics|mesh-ancestor
83803549|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
83803550|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803551|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803552|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803553|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803554|NCT00043875|Lamotrigine|lamotrigine|mesh-list
83803555|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
83803556|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83803557|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803558|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803559|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83803560|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803561|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83803562|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83803563|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803564|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803565|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83803566|NCT00154258|Clozapine|clozapine|mesh-list
83803567|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83803568|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
83803569|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803570|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803571|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803572|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83803573|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83803574|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803575|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803576|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
83803577|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
83803578|NCT00154336|Methotrexate|methotrexate|mesh-list
83803579|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
83803580|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83803581|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
83803582|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83803583|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803584|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803585|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
83803586|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803587|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803588|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
83803589|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803590|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83803591|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803592|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
83803593|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803594|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83803595|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83803596|NCT00050804|Sertraline|sertraline|mesh-list
83803597|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
83803598|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803599|NCT00050804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83803600|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83803601|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803602|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803603|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803604|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
83803605|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803606|NCT00043914|Lamotrigine|lamotrigine|mesh-list
83803607|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
83803608|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83803609|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803610|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134191|NCT03553537|Hormones|hormones|mesh-ancestor
83803611|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83803612|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803613|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83803614|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83803615|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803616|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803617|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83803618|NCT04705987|Colchicine|colchicine|mesh-list
83803619|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
83803620|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803621|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
83803622|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
83803623|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
83803624|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803625|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803626|NCT04705909|Pitavastatin|pitavastatin|mesh-list
83803627|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83803628|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83803629|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83803630|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
83803631|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803632|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803633|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83803634|NCT00083304|Efaproxiral|efaproxiral|mesh-list
83803635|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
83803636|NCT00050843|Thalidomide|thalidomide|mesh-list
83803637|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803638|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
83803639|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803640|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
83803641|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803642|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803643|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803644|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803645|NCT00050843|Growth Substances|growth substances|mesh-ancestor
83803646|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803647|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803648|NCT00406237|Tigecycline|tigecycline|mesh-list
83803649|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803650|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803651|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83803652|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803653|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803654|NCT00406432|Paroxetine|paroxetine|mesh-list
83803655|NCT00406432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83803656|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83803657|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803658|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803659|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803660|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
83803661|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803662|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83803663|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
83803664|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803665|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82958981|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
82958982|NCT04483973|Ebselen|ebselen|mesh-list
82958983|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82958984|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958985|NCT04483973|Analgesics|analgesics|mesh-ancestor
82958986|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
82958987|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958988|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958989|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82958990|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958991|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82958992|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958993|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
82958994|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958999|NCT04283890|Nivolumab|nivolumab|mesh-list
83803666|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83803667|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803668|NCT00083343|Caspofungin|caspofungin|mesh-list
83803669|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
83803670|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803671|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803672|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803673|NCT00406471|Ranibizumab|ranibizumab|mesh-list
83803674|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803675|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803676|NCT00406471|Growth Substances|growth substances|mesh-ancestor
83803677|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803678|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803679|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803680|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83803681|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83803682|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
83803683|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803685|NCT00154687|Fluorouracil|fluorouracil|mesh-list
83803686|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83803687|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803688|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
83803689|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
83803690|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
83803691|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803692|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
83803693|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83803694|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803695|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
83803696|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803697|NCT00083460|Thalidomide|thalidomide|mesh-list
83803698|NCT00083460|Dexamethasone|dexamethasone|mesh-list
83803699|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803700|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
83803701|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
83803702|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803703|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803704|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83803705|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
83803706|NCT00083460|Hormones|hormones|mesh-ancestor
83803707|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83803708|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83803709|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803710|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803711|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
83803712|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
83803713|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803714|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803715|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803716|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803717|NCT00083460|Growth Substances|growth substances|mesh-ancestor
83803718|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803719|NCT00154726|Paclitaxel|paclitaxel|mesh-list
83803720|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83803721|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803722|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
83803723|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
83803724|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
83803725|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803726|NCT00154804|Paclitaxel|paclitaxel|mesh-list
83803727|NCT00154804|Cisplatin|cisplatin|mesh-list
83803728|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83803729|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803730|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83803731|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83803732|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83803733|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803734|NCT00154843|Lycopene|lycopene|mesh-list
83803735|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803736|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
82959056|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83803737|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803738|NCT00154843|Protective Agents|protective agents|mesh-ancestor
83803739|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803740|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83803741|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83803742|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803743|NCT00043953|Ritonavir|ritonavir|mesh-list
83803744|NCT00043953|Lopinavir|lopinavir|mesh-list
83803745|NCT00043953|Saquinavir|saquinavir|mesh-list
83803746|NCT00043953|Lamivudine|lamivudine|mesh-list
83803747|NCT00043953|Zidovudine|zidovudine|mesh-list
83803748|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83803749|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83803750|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83803751|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
83803752|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803753|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803754|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83803755|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83803756|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
83803757|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803758|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83803759|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83803760|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83803761|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83803762|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
83803763|NCT00154882|Paclitaxel|paclitaxel|mesh-list
83803764|NCT00154882|Cisplatin|cisplatin|mesh-list
83803765|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83803766|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803767|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
83803768|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
83803769|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
83803770|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803771|NCT00051077|Ribavirin|ribavirin|mesh-list
83803772|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83803773|NCT00051077|Adefovir|adefovir|mesh-list
83803774|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83803775|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
83803776|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803777|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
83803778|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803779|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83803780|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83803781|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803782|NCT00155233|Morphine|morphine|mesh-list
83803783|NCT00155233|Nalbuphine|nalbuphine|mesh-list
83803784|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83803785|NCT00155233|Narcotics|narcotics|mesh-ancestor
83803786|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83803787|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803788|NCT00155233|Analgesics|analgesics|mesh-ancestor
83803789|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
83803790|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803791|NCT00051116|Lenalidomide|lenalidomide|mesh-list
83803792|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
83803793|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803794|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803795|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803796|NCT00051116|Growth Substances|growth substances|mesh-ancestor
83803797|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803798|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803799|NCT00155272|Thalidomide|thalidomide|mesh-list
83803800|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803801|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
83803802|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803803|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
83803804|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803805|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803806|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803807|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803808|NCT00155272|Growth Substances|growth substances|mesh-ancestor
83803809|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803810|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803811|NCT00155350|Pioglitazone|pioglitazone|mesh-list
82959128|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803812|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83803813|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803814|NCT00051155|Timolol|timolol|mesh-list
83803815|NCT00051155|Travoprost|travoprost|mesh-list
83803816|NCT00051155|Latanoprost|latanoprost|mesh-list
83803817|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83803818|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83803819|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
83803820|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803821|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803822|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803823|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83803824|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83803825|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83803826|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83803827|NCT00083538|Thalidomide|thalidomide|mesh-list
83803828|NCT00083538|Dexamethasone|dexamethasone|mesh-list
83803829|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
83803830|NCT00083538|Etoposide|etoposide|mesh-list
83803831|NCT00083538|Doxorubicin|doxorubicin|mesh-list
83803832|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83803833|NCT00083538|Cisplatin|cisplatin|mesh-list
83803834|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803835|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
83803836|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803837|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83803838|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83803839|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
83803840|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803841|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803842|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83803843|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83803844|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
83803845|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
83803846|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83803847|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83803848|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
83803849|NCT00083538|Hormones|hormones|mesh-ancestor
83803850|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83803851|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83803852|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83803853|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83803854|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83803855|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803856|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83803857|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
83803858|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803859|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803860|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803861|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803862|NCT00083538|Growth Substances|growth substances|mesh-ancestor
83803863|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803864|NCT00083577|Thalidomide|thalidomide|mesh-list
83803865|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803866|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
83803867|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803868|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
83803869|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803870|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803871|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803872|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803873|NCT00083577|Growth Substances|growth substances|mesh-ancestor
83803874|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803875|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803876|NCT00154414|Liraglutide|liraglutide|mesh-list
83803877|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83803878|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803879|NCT00154414|Incretins|incretins|mesh-ancestor
83803880|NCT00154414|Hormones|hormones|mesh-ancestor
83803881|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83803882|NCT00406744|Bevacizumab|bevacizumab|mesh-list
83803883|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83803884|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803885|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803886|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803887|NCT00406744|Growth Substances|growth substances|mesh-ancestor
83803888|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803889|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803890|NCT00399750|Bevacizumab|bevacizumab|mesh-list
83803891|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
83803892|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83803893|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803894|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803895|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803896|NCT00399750|Growth Substances|growth substances|mesh-ancestor
83803897|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803898|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803900|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803901|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803902|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
83803903|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803904|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83803905|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803906|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803907|NCT00156325|Escitalopram|escitalopram|mesh-list
83803908|NCT00156325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83803909|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83803910|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803911|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803912|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803913|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
83803914|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803915|NCT00156403|Amlodipine|amlodipine|mesh-list
83803916|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83803917|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83803918|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803919|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803920|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83803921|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803922|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
83803923|NCT00051272|Bupropion|bupropion|mesh-list
83803924|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83803925|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
83803926|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803927|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83803928|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83803929|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83803930|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803931|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
83803932|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83803933|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803934|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83803935|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83803936|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803937|NCT00044187|Sibutramine|sibutramine|mesh-list
83803938|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
83803939|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83803940|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
83803941|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83803942|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
83803943|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83803944|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83803945|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803946|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
83803947|NCT00156520|Coagulants|coagulants|mesh-ancestor
83803948|NCT00083694|Thalidomide|thalidomide|mesh-list
83803949|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83803950|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
83803951|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803952|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
83803953|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803954|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803955|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83803956|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83803957|NCT00083694|Growth Substances|growth substances|mesh-ancestor
83803958|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
83803959|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83803960|NCT00051389|Fosinopril|fosinopril|mesh-list
83803961|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83803962|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
83803963|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83803964|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803965|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83803967|NCT00156949|Hematinics|hematinics|mesh-ancestor
83803968|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
83803969|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83803970|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
83803971|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83803972|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83803973|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83803974|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83803975|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
83803976|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83803977|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
83803978|NCT00157066|Vitamin D|vitamin d|mesh-list
83803979|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83803980|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803981|NCT00157066|Vitamins|vitamins|mesh-ancestor
83803982|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
83803983|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83803984|NCT00157105|Factor VIII|factor viii|mesh-list
83803985|NCT00157105|Coagulants|coagulants|mesh-ancestor
83803986|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83803987|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
83803988|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83803989|NCT00157261|Tenecteplase|tenecteplase|mesh-list
83803990|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83803991|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83803992|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83803993|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
83803994|NCT00157300|Hematinics|hematinics|mesh-ancestor
83803995|NCT00157378|Haloperidol|haloperidol|mesh-list
83803996|NCT00157378|Risperidone|risperidone|mesh-list
83803997|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
83803998|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83803999|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
83804000|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804001|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804002|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804003|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83804004|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83804005|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83804006|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804007|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83804008|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
83804009|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
83804010|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
83804011|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804012|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804013|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83804014|NCT00406861|Montelukast|montelukast|mesh-list
83804015|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83134206|NCT03086174|Antibodies|antibodies|mesh-list
83804016|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
83804017|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83804018|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
83804019|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804020|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804021|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83804022|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83804023|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804024|NCT00044265|Ramipril|ramipril|mesh-list
83804025|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83804026|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
83804027|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804028|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804029|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83804030|NCT00398099|Ertapenem|ertapenem|mesh-list
83804031|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83804032|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804033|NCT00406978|Thalidomide|thalidomide|mesh-list
83804034|NCT00406978|Prednisone|prednisone|mesh-list
83804035|NCT00406978|Melphalan|melphalan|mesh-list
83804036|NCT00406978|Defibrotide|defibrotide|mesh-list
83804037|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83804038|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
83804039|NCT00406978|Hormones|hormones|mesh-ancestor
83804040|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804041|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804042|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83804043|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804044|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83804045|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
83804046|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804047|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83804048|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804049|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
83804050|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
83804051|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83804052|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804053|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83804054|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83804055|NCT00406978|Growth Substances|growth substances|mesh-ancestor
83804056|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83804057|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83804058|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83804059|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83804060|NCT00157651|Warfarin|warfarin|mesh-list
83804061|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
83804062|NCT00044343|Lapatinib|lapatinib|mesh-list
83804063|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804064|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804065|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804066|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804067|NCT00157690|Alendronate|alendronate|mesh-list
83804068|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83804069|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804070|NCT00051506|Carboplatin|carboplatin|mesh-list
83804071|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804072|NCT00157729|Pyridoxal|pyridoxal|mesh-list
83804073|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83804074|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83804075|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
83804076|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804077|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804078|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
83804079|NCT00157729|Vitamins|vitamins|mesh-ancestor
83804080|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
83804081|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804082|NCT00051545|Seocalcitol|seocalcitol|mesh-list
83804083|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804084|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804085|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
83804086|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804087|NCT00157885|Artesunate|artesunate|mesh-list
83804088|NCT00157885|Amodiaquine|amodiaquine|mesh-list
83804089|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
83804090|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83804091|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83804092|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804093|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804094|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
83804095|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
83804096|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83804097|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
83804098|NCT00158002|Topiramate|topiramate|mesh-list
83804099|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
83804100|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83804101|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804102|NCT00158041|Amifostine|amifostine|mesh-list
83804103|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83804104|NCT00158041|Protective Agents|protective agents|mesh-ancestor
83804105|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804106|NCT00051584|Gemcitabine|gemcitabine|mesh-list
83804107|NCT00051584|Doxorubicin|doxorubicin|mesh-list
83804108|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
83804109|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83804110|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
83804111|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804112|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804113|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83804114|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83804115|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82959432|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804116|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804117|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
83804118|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804119|NCT00044382|Lenalidomide|lenalidomide|mesh-list
83804120|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
83804121|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804122|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83804123|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83804124|NCT00044382|Growth Substances|growth substances|mesh-ancestor
83804125|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
83804126|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804127|NCT00158158|Nicotine|nicotine|mesh-list
83804128|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83804129|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
83804130|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804131|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804132|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83804133|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83804134|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83804135|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804136|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804137|NCT00051623|Infliximab|infliximab|mesh-list
83804138|NCT00051623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83804139|NCT00051623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83804140|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83804141|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804142|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804143|NCT00158236|Buprenorphine|buprenorphine|mesh-list
83804144|NCT00158236|Hydromorphone|hydromorphone|mesh-list
83804145|NCT00158236|Naloxone|naloxone|mesh-list
83804146|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83804147|NCT00158236|Narcotics|narcotics|mesh-ancestor
83804148|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83804149|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804150|NCT00158236|Analgesics|analgesics|mesh-ancestor
83804151|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
83804152|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804153|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83804154|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
83804155|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804156|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
83804157|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804158|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804159|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
83804160|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83804161|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804162|NCT00158470|Lamivudine|lamivudine|mesh-list
83804163|NCT00158470|Efavirenz|efavirenz|mesh-list
83804164|NCT00158470|Didanosine|didanosine|mesh-list
83804165|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83804166|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83804167|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804168|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804169|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
83804170|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804171|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83804172|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83804173|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83804174|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804175|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83804176|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83804177|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83804178|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83804179|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
83804180|NCT00158509|Valacyclovir|valacyclovir|mesh-list
83804181|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
83804182|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804183|NCT00158548|Artesunate|artesunate|mesh-list
83804184|NCT00158548|Chloroquine|chloroquine|mesh-list
83804185|NCT00158548|Primaquine|primaquine|mesh-list
83804186|NCT00158548|Amodiaquine|amodiaquine|mesh-list
83804187|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
83804188|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83804189|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83804190|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804191|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804192|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
83804193|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
83804194|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83804195|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
83804196|NCT00158548|Amebicides|amebicides|mesh-ancestor
83804197|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804198|NCT00158587|Primaquine|primaquine|mesh-list
83804199|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
83804200|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83804201|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83804202|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804203|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83804204|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
83804205|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804206|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83804207|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83804208|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804209|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804210|NCT00158782|Lapatinib|lapatinib|mesh-list
83804211|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804212|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804213|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804214|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804215|NCT00158821|Tenofovir|tenofovir|mesh-list
83804216|NCT00158821|Lamivudine|lamivudine|mesh-list
83804217|NCT00158821|Efavirenz|efavirenz|mesh-list
83804218|NCT00158821|Stavudine|stavudine|mesh-list
83804219|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
83804220|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804221|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83804222|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83804223|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804224|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804225|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83804226|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83804227|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83804228|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804229|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83804230|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83804231|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83804232|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83804233|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
83804234|NCT05568147|Aspirin|aspirin|mesh-list
83804235|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83804236|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83804237|NCT05568147|Analgesics|analgesics|mesh-ancestor
83804238|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
83804239|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804240|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804241|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83804242|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804243|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83804244|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83804245|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804246|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83804247|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83804248|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804249|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
83804250|NCT00051896|Vanoxerine|vanoxerine|mesh-list
83804251|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83804252|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83804253|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83804254|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804255|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
83804256|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804257|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804258|NCT04724473|Tretinoin|tretinoin|mesh-list
83804259|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804260|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
83804261|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
83804262|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
83804263|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804264|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804265|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804266|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804267|NCT00159094|Vinorelbine|vinorelbine|mesh-list
83804268|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83804269|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804270|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
83804271|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
83804272|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
83804273|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804274|NCT02965053|Sevelamer|sevelamer|mesh-list
83804275|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
83804276|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
83804277|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804278|NCT00159133|Lorazepam|lorazepam|mesh-list
83804279|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
83804280|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
83804281|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
83804282|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
83804283|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804284|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804285|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804286|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83804287|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83804288|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83804289|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83804290|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804291|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
83804292|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
83804293|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804294|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804295|NCT00051974|Bortezomib|bortezomib|mesh-list
83804296|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804297|NCT00159211|Pioglitazone|pioglitazone|mesh-list
83804298|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83804299|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804300|NCT05567718|Anesthetics|anesthetics|mesh-list
83804301|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83804302|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804303|NCT00052013|Vatalanib|vatalanib|mesh-list
83804304|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804305|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804306|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804307|NCT00159445|Gemcitabine|gemcitabine|mesh-list
83804308|NCT00159445|Capecitabine|capecitabine|mesh-list
83804309|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83804310|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
83804311|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804312|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804313|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
83804314|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83804315|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804316|NCT00159484|Celecoxib|celecoxib|mesh-list
83804317|NCT00159484|Epothilone B|epothilone b|mesh-list
83804318|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83804319|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83804320|NCT00159484|Analgesics|analgesics|mesh-ancestor
83804321|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
83804322|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804323|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804324|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83804325|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804326|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83804327|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83804328|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804329|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804330|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804331|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
83804332|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
83804333|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
83804334|NCT00052052|Interferons|interferons|mesh-list
83804335|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
83804336|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804337|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
83804338|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804339|NCT00159679|Pregabalin|pregabalin|mesh-list
83804340|NCT00159679|Analgesics|analgesics|mesh-ancestor
83804341|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
83804342|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804343|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804344|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
83804345|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83804346|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959658|NCT03110510|Leucovorin|leucovorin|mesh-list
83804347|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804348|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83804350|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83804351|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83804352|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804353|NCT00159718|Amlodipine|amlodipine|mesh-list
83804354|NCT00159718|Atorvastatin|atorvastatin|mesh-list
83804355|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83804356|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83804357|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
83804358|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804359|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83390417|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
83804360|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83804361|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804362|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83804363|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83804364|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83804365|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83804366|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804367|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
83804368|NCT00159757|Ziprasidone|ziprasidone|mesh-list
83804369|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83804370|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
83804371|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804372|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804373|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804374|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83804375|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83804376|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83804377|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804378|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83804379|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
83804380|NCT00159835|Atorvastatin|atorvastatin|mesh-list
83804381|NCT00159835|Simvastatin|simvastatin|mesh-list
83804382|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83804383|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83804384|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
83804385|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804386|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83804387|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83804388|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804389|NCT00052169|Docetaxel|docetaxel|mesh-list
83804390|NCT00052169|Gefitinib|gefitinib|mesh-list
83804391|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804392|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
83804393|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
83804394|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
83804395|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804396|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804397|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804398|NCT00159952|Insulin|insulin|mesh-list
83804399|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83804400|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804401|NCT00052208|Gefitinib|gefitinib|mesh-list
83804402|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804403|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804404|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804405|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804406|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
83804407|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
83804408|NCT00407017|Ketorolac|ketorolac|mesh-list
83804409|NCT00407017|Nepafenac|nepafenac|mesh-list
83804410|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
83804411|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83804412|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804413|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83804414|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83804415|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804416|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804417|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804418|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804419|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82959735|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
83804420|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83804421|NCT00407017|Analgesics|analgesics|mesh-ancestor
83804422|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
83804423|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804424|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83804425|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804426|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83804427|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83804428|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83804430|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804431|NCT00160069|Sagopilone|sagopilone|mesh-list
83804432|NCT00160069|Epothilones|epothilones|mesh-list
83804433|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804434|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
83804435|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
83804436|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
83804437|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804438|NCT00052286|Modafinil|modafinil|mesh-list
83804439|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83804440|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804441|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83804442|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83804443|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83804444|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804445|NCT00160186|Pancreatin|pancreatin|mesh-list
83804446|NCT00160186|Pancrelipase|pancrelipase|mesh-list
83804447|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804448|NCT05567484|Itraconazole|itraconazole|mesh-list
83804449|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
83804450|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804451|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83804452|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804453|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804454|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804455|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83804456|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
83804457|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804458|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804459|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83804460|NCT00160264|Vitamin D|vitamin d|mesh-list
83804461|NCT00160264|Lactulose|lactulose|mesh-list
83804462|NCT00160264|Calcium|calcium|mesh-list
83804463|NCT00160264|Vitamins|vitamins|mesh-ancestor
83804464|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
83804465|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804466|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83804467|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83804468|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804469|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
83804470|NCT00160342|Estrogens|estrogens|mesh-list
83804471|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
83804472|NCT00160342|Estrone|estrone|mesh-list
83804473|NCT00160342|Testosterone|testosterone|mesh-list
83804474|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
83804475|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
83804476|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83804477|NCT00160342|Hormones|hormones|mesh-ancestor
83804478|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804479|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804480|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83804481|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804482|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
83804483|NCT00160342|Androgens|androgens|mesh-ancestor
83804484|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
83804485|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804486|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83804487|NCT00052403|Antibodies|antibodies|mesh-list
83804488|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
83804489|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83804490|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
83804491|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
83804492|NCT00052403|Mitogens|mitogens|mesh-list
83804493|NCT00052403|Immunomodulating Agents|immunomodulating agents|mesh-list
83804494|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804495|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804497|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804498|NCT00160498|Lercanidipine|lercanidipine|mesh-list
83804499|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83804500|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83804501|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83804502|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804503|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83804504|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804505|NCT00160537|Levocetirizine|levocetirizine|mesh-list
83804506|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83804507|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83804508|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
83804509|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
83804510|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804511|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804512|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804513|NCT00160576|Levetiracetam|levetiracetam|mesh-list
83804514|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
83804515|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
83804516|NCT00160849|Lopinavir|lopinavir|mesh-list
83804517|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83804518|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83804519|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
83804520|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804521|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804522|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83804523|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83804524|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
83804525|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804526|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83804527|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804528|NCT00160888|Nitroprusside|nitroprusside|mesh-list
83804529|NCT00160888|Acetylcholine|acetylcholine|mesh-list
83804530|NCT00160888|Bradykinin|bradykinin|mesh-list
83804531|NCT00160888|Kininogens|kininogens|mesh-list
83804532|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83804533|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
83804534|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83804535|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804536|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83804537|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
83804538|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804539|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804540|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83804541|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83804542|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804543|NCT00160927|Nitroprusside|nitroprusside|mesh-list
83804544|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83804545|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
83804546|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83804547|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804548|NCT00160966|Cyclosporine|cyclosporine|mesh-list
83804549|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
83804550|NCT00160966|Everolimus|everolimus|mesh-list
83804551|NCT00160966|Tacrolimus|tacrolimus|mesh-list
83804552|NCT00160966|Cyclosporins|cyclosporins|mesh-list
83804553|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804554|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
83804555|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804556|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83804557|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804558|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804559|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
83804560|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804561|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
83804562|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804563|NCT00160966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83804564|NCT00160966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804565|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134236|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804566|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83804567|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83804568|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
83804569|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83804570|NCT00052559|Bevacizumab|bevacizumab|mesh-list
83804571|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83804572|NCT00052559|Fluorouracil|fluorouracil|mesh-list
83804573|NCT00052559|Antibodies|antibodies|mesh-list
83804574|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
83804575|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83804576|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804577|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83804578|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83804579|NCT00052559|Growth Substances|growth substances|mesh-ancestor
83804580|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804581|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
83804582|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
83804583|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
83804584|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804585|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83804586|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804587|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83804588|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83804589|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804590|NCT00044577|Tenofovir|tenofovir|mesh-list
83804591|NCT00044577|Lamivudine|lamivudine|mesh-list
83804592|NCT00044577|Abacavir|abacavir|mesh-list
83804593|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
83804594|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
83804595|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804596|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83804597|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83804598|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804599|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804600|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83804601|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83804602|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
83804603|NCT00161122|Vaccines|vaccines|mesh-list
83804604|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83804605|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
83804606|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804607|NCT00161200|Pantoprazole|pantoprazole|mesh-list
83804608|NCT00161200|Ranitidine|ranitidine|mesh-list
83804609|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83804610|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83804611|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804612|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83804613|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804614|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804615|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83804616|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
83804617|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
83804618|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804619|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804620|NCT00161239|Prednisone|prednisone|mesh-list
83804621|NCT00161239|Methotrexate|methotrexate|mesh-list
83804622|NCT00161239|Asparaginase|asparaginase|mesh-list
83804623|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83804624|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
83804625|NCT00161239|Hormones|hormones|mesh-ancestor
83804626|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804627|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804628|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83804629|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804630|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83804631|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
83804632|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83804633|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83804634|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
83804635|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804636|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
83804637|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804638|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83804639|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804640|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
83804641|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804642|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83804643|NCT00161278|Paclitaxel|paclitaxel|mesh-list
82959960|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
83804644|NCT00161278|Carboplatin|carboplatin|mesh-list
83804645|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83804646|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804647|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83804648|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83804649|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83804650|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804651|NCT00044616|Fluoxetine|fluoxetine|mesh-list
83804652|NCT00044616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83804653|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83804654|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83804655|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804656|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804657|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
83804658|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804659|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83804660|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
83804661|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804662|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83804663|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804664|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804665|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83804666|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
83804667|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804668|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83804669|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83804670|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83804671|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83804672|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804673|NCT00161434|Valacyclovir|valacyclovir|mesh-list
83804674|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
83804675|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804676|NCT00044694|Exenatide|exenatide|mesh-list
83804677|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83804678|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804679|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83804680|NCT00044694|Incretins|incretins|mesh-ancestor
83804681|NCT00044694|Hormones|hormones|mesh-ancestor
83804682|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804683|NCT00052754|Gefitinib|gefitinib|mesh-list
83804684|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804685|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804686|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804687|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804688|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
83804689|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83804690|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804691|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
83804692|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83804693|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804694|NCT00161668|Immunotoxins|immunotoxins|mesh-ancestor
83804695|NCT00161668|Immunoconjugates|immunoconjugates|mesh-ancestor
83804696|NCT00161668|Immunologic Factors|immunologic factors|mesh-ancestor
83804697|NCT00161668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804698|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83804699|NCT00052832|Vitamins|vitamins|mesh-ancestor
83804700|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
83804701|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804702|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83804703|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83390434|NCT04992468|Hormones|hormones|mesh-ancestor
83804704|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
83804705|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83804706|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83804707|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
82960035|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
82960036|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
82960037|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960038|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
82960039|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960040|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960041|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
82960042|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960054|NCT03778645|Epinephrine|epinephrine|mesh-list
82960055|NCT03778645|Racepinephrine|racepinephrine|mesh-list
82960056|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
82960058|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83804708|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804709|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804710|NCT00044538|Taxane|taxane|mesh-list
83804711|NCT00044538|IDN 5109|idn 5109|mesh-list
83804712|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804713|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
83804714|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83804715|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804716|NCT00044733|Immunotoxins|immunotoxins|mesh-ancestor
83804717|NCT00044733|Immunoconjugates|immunoconjugates|mesh-ancestor
83804718|NCT00044733|Immunologic Factors|immunologic factors|mesh-ancestor
83804719|NCT00044733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804720|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
83804721|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804722|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804723|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804724|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804725|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83804726|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
83804727|NCT00161902|Coagulants|coagulants|mesh-ancestor
83804728|NCT00053027|Rituximab|rituximab|mesh-list
83804729|NCT00053027|Cladribine|cladribine|mesh-list
83804730|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83804731|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804732|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
83804733|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804734|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804735|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804736|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83804737|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
83804738|NCT00161980|Coagulants|coagulants|mesh-ancestor
83804739|NCT00162019|Factor VIII|factor viii|mesh-list
83804740|NCT00162019|Coagulants|coagulants|mesh-ancestor
83804741|NCT00162214|Ketoconazole|ketoconazole|mesh-list
83804742|NCT00162214|Dasatinib|dasatinib|mesh-list
83804743|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804744|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83804745|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804746|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804747|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
83804748|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804749|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83804750|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804751|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83804752|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
83804753|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804754|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804755|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83804756|NCT04731116|Cannabidiol|cannabidiol|mesh-list
83804757|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
83804758|NCT00407056|Difluprednate|difluprednate|mesh-list
83804759|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
83804760|NCT00407056|Hormones|hormones|mesh-ancestor
83804761|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804762|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804763|NCT00405457|Cyclosporine|cyclosporine|mesh-list
83804764|NCT00405457|Cyclosporins|cyclosporins|mesh-list
83804765|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804766|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804767|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804768|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
83804769|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804770|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
83804771|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804772|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
83804773|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83804774|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83804775|NCT00053105|Cytarabine|cytarabine|mesh-list
83804776|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
83804777|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83804778|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83804779|NCT00053105|Prednisolone|prednisolone|mesh-list
83804780|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
83804781|NCT00053105|Pixantrone|pixantrone|mesh-list
82960111|NCT05168683|Rasburicase|rasburicase|mesh-list
83804782|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83804783|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
83804784|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804785|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83804786|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
83804787|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804788|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
83804789|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804790|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804791|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
83804792|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804793|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83804794|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
83804795|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
83804796|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804797|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804798|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
83804799|NCT00053105|Hormones|hormones|mesh-ancestor
83804800|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804801|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83804802|NCT00053105|Protective Agents|protective agents|mesh-ancestor
83804803|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83804804|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83804805|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83804806|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804807|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83804808|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83804809|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804810|NCT00162409|Folic Acid|folic acid|mesh-list
83804811|NCT00162409|Hematinics|hematinics|mesh-ancestor
83804812|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
83804813|NCT00162409|Vitamins|vitamins|mesh-ancestor
83804814|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
83804815|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804816|NCT00053144|Cytarabine|cytarabine|mesh-list
83804817|NCT00053144|Irinotecan|irinotecan|mesh-list
83804818|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83804819|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83804820|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804821|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804822|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804823|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83804824|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
83804825|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
83804826|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804827|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804828|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
83804829|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804830|NCT00162487|Albuterol|albuterol|mesh-list
83804831|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83804832|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
83804833|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83804834|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804835|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83804836|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83804837|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
83804838|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83804839|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83804840|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83804841|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83804842|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
83804843|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804844|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804845|NCT00162526|Tocopherols|tocopherols|mesh-list
83804846|NCT00162526|Vitamin E|vitamin e|mesh-list
83804847|NCT00162526|Tocotrienols|tocotrienols|mesh-list
83804848|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
83804849|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
83804850|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804851|NCT00162526|Protective Agents|protective agents|mesh-ancestor
83804852|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804853|NCT00162526|Vitamins|vitamins|mesh-ancestor
83804854|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
83804855|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83804856|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83804857|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
83804858|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960186|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804859|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804860|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804862|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
83804863|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83804864|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804865|NCT00162643|Ritonavir|ritonavir|mesh-list
83804866|NCT00162643|Lopinavir|lopinavir|mesh-list
83804867|NCT00162643|Lamivudine|lamivudine|mesh-list
83804868|NCT00162643|Zidovudine|zidovudine|mesh-list
83804869|NCT00162643|Efavirenz|efavirenz|mesh-list
83804870|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83804871|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83804872|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
83804873|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804874|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804875|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83804876|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83804877|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
83804878|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804879|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83804880|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804881|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83804882|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83804883|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
83804884|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83804885|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83804886|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83804887|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83804888|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83804889|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83804890|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
83804891|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804892|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83804893|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83804894|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83804895|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83804896|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804897|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804898|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390443|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
83804899|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83804900|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
83804901|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804902|NCT00162721|Doxorubicin|doxorubicin|mesh-list
83804903|NCT00162721|Ifosfamide|ifosfamide|mesh-list
83804904|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804905|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83804906|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83804907|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83804908|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804909|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804910|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83804911|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
83804912|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
83804913|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804914|NCT00162760|Thalidomide|thalidomide|mesh-list
83804915|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83804916|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
83804917|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804918|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
83804919|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83804920|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804921|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83804922|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83804923|NCT00162760|Growth Substances|growth substances|mesh-ancestor
83804924|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
83804925|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804926|NCT00162799|Triflusal|triflusal|mesh-list
83804927|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83804928|NCT00044811|Fexofenadine|fexofenadine|mesh-list
83804929|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83804930|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82960258|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
82960262|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83804931|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83804933|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
83804934|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804935|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804936|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804937|NCT00162877|Esomeprazole|esomeprazole|mesh-list
83804938|NCT00162877|Rabeprazole|rabeprazole|mesh-list
83804939|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83804940|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83804941|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83804942|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804943|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804944|NCT00162916|Citalopram|citalopram|mesh-list
83804945|NCT00162916|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83804946|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83804947|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83804948|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804949|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804950|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
83804951|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804952|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83804953|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
83804954|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83804955|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
83804956|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83804957|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83804958|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
83804959|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83804960|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804961|NCT00163111|Amphotericin B|amphotericin b|mesh-list
83804962|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83804963|NCT00163111|Fluconazole|fluconazole|mesh-list
83804964|NCT00163111|Amebicides|amebicides|mesh-ancestor
83804965|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83804966|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83804967|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83804968|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83804969|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
83804970|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83804971|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83804972|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804973|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804974|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83804975|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
83804976|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83804977|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804978|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83804979|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83804980|NCT00163150|Atorvastatin|atorvastatin|mesh-list
83804981|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83804982|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83804983|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
83804984|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804985|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83804986|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83804987|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83804988|NCT00163267|Clopidogrel|clopidogrel|mesh-list
83804989|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83804990|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83804991|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83804992|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83804993|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
83804994|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83804995|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83804996|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83804997|NCT00163306|Pantoprazole|pantoprazole|mesh-list
83804998|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83804999|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805000|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83805001|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960331|NCT05177406|Analgesics|analgesics|mesh-ancestor
83805002|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805003|NCT00044889|Clofarabine|clofarabine|mesh-list
83805004|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805005|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
83805006|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805007|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805008|NCT00163345|Ciclesonide|ciclesonide|mesh-list
83805009|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
83805010|NCT00163345|Hormones|hormones|mesh-ancestor
83805011|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805012|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805013|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83805014|NCT00163384|Ciclesonide|ciclesonide|mesh-list
83805015|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
83805016|NCT00163384|Hormones|hormones|mesh-ancestor
83805017|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805018|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805019|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83805020|NCT00163423|Ciclesonide|ciclesonide|mesh-list
83805021|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
83805022|NCT00163423|Hormones|hormones|mesh-ancestor
83805023|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805024|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805025|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83805026|NCT04731038|Paclitaxel|paclitaxel|mesh-list
83805027|NCT04731038|Carboplatin|carboplatin|mesh-list
83805028|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805029|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805030|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805031|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805032|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805033|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805034|NCT00163462|Ciclesonide|ciclesonide|mesh-list
83805035|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
83805036|NCT00163462|Hormones|hormones|mesh-ancestor
83805037|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805038|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805039|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83805040|NCT00053300|Thalidomide|thalidomide|mesh-list
83805041|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805042|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
83805043|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805044|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
83805045|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805046|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805047|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83805048|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83805049|NCT00053300|Growth Substances|growth substances|mesh-ancestor
83805050|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
83805051|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805052|NCT00163501|Ciclesonide|ciclesonide|mesh-list
83805053|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
83805054|NCT00163501|Hormones|hormones|mesh-ancestor
83805055|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805056|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805057|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83805058|NCT00163540|Formaldehyde|formaldehyde|mesh-list
83805059|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
83805060|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805061|NCT00053339|Tamoxifen|tamoxifen|mesh-list
83805062|NCT00053339|Trastuzumab|trastuzumab|mesh-list
83805063|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83805064|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805065|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83805066|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
83805067|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805068|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805069|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83805070|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83805071|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83805072|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83805073|NCT00163618|Formaldehyde|formaldehyde|mesh-list
83805074|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
83805075|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805076|NCT00053378|Calcium|calcium|mesh-list
83805077|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83805078|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805079|NCT02970383|Narcotics|narcotics|mesh-list
83805080|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83805081|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805082|NCT02970383|Analgesics|analgesics|mesh-ancestor
83805083|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
83805084|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805085|NCT05502900|Melatonin|melatonin|mesh-list
83805086|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
83805087|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805088|NCT05502900|Protective Agents|protective agents|mesh-ancestor
83805089|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805090|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83805091|NCT00163969|Ketamine|ketamine|mesh-list
83805092|NCT00163969|Analgesics|analgesics|mesh-ancestor
83805093|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
83805094|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805095|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805096|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83805097|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83805098|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
83805099|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
83805100|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83805101|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83805102|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83805103|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805104|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805105|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
83805106|NCT00164008|Pamidronate|pamidronate|mesh-list
83805107|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83805108|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805109|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
83805110|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83805111|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
83805112|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
83805113|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83805114|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805115|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83805116|NCT00164047|Analgesics|analgesics|mesh-ancestor
83805117|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
83805118|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805119|NCT00164086|Atorvastatin|atorvastatin|mesh-list
83805120|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83805121|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83805122|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
83805123|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805124|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83805125|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83805126|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805127|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83805128|NCT00164125|Laxatives|laxatives|mesh-ancestor
83805129|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805130|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83805131|NCT00164164|Laxatives|laxatives|mesh-ancestor
83805132|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805133|NCT00164242|Galantamine|galantamine|mesh-list
83805134|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83805135|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805136|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805137|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
83805138|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805139|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805140|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83805141|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
83805142|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805143|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
83805144|NCT00162955|Valsartan|valsartan|mesh-list
83805145|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83805146|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83805147|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83805148|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805149|NCT00164281|Isoniazid|isoniazid|mesh-list
83805150|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
83805151|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805152|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805153|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83805154|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83805155|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
83805156|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805157|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83805158|NCT00044928|Tazobactam|tazobactam|mesh-list
83805159|NCT00044928|Piperacillin|piperacillin|mesh-list
83805160|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83805161|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805162|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805163|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83805164|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805165|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805166|NCT00164359|Artesunate|artesunate|mesh-list
83805167|NCT00164359|Amodiaquine|amodiaquine|mesh-list
83805168|NCT00164359|Dapsone|dapsone|mesh-list
83805169|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
83805170|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
83805171|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83805172|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83805173|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805174|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805175|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
83805176|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
83805177|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83805178|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
83805179|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83805180|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805181|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805182|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
83805183|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805184|NCT00053612|Vitamin A|vitamin a|mesh-list
83805185|NCT00053612|Vitamins|vitamins|mesh-ancestor
83805186|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
83805187|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805188|NCT00045006|Vorinostat|vorinostat|mesh-list
83805189|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805190|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83805191|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805192|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805193|NCT00164710|Artesunate|artesunate|mesh-list
83805194|NCT00164710|Lumefantrine|lumefantrine|mesh-list
83805195|NCT00164710|Artemether|artemether|mesh-list
83805196|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
83805197|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
83805198|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83805199|NCT00164710|Amodiaquine|amodiaquine|mesh-list
83805200|NCT00164710|Dapsone|dapsone|mesh-list
83805201|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
83805202|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
83805203|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83805204|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83805205|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805206|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805207|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
83805208|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
83805209|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83805210|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
83805211|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83805212|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805213|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805214|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83805215|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
83805216|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805217|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83805218|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83805219|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805220|NCT00164749|Curcumin|curcumin|mesh-list
83805221|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83805222|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83805223|NCT00164749|Analgesics|analgesics|mesh-ancestor
83805224|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
83805225|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805226|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805227|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805228|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805229|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805230|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805231|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805232|NCT00164788|Esomeprazole|esomeprazole|mesh-list
83805233|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83805234|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805235|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83805236|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805237|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805238|NCT00053768|Prednisone|prednisone|mesh-list
83805239|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
83805240|NCT00053768|Doxorubicin|doxorubicin|mesh-list
83805241|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83805242|NCT00053768|Etoposide|etoposide|mesh-list
83805243|NCT00053768|Vincristine|vincristine|mesh-list
83805244|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805245|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
83805246|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805247|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805248|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83805249|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
83805250|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805251|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805252|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83805253|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805254|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83805255|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83805256|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805257|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805258|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
83805259|NCT00053768|Hormones|hormones|mesh-ancestor
83805260|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805261|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83805262|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805263|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805264|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805265|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805266|NCT00045123|Tarenflurbil|tarenflurbil|mesh-list
83805267|NCT00045123|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83805268|NCT00045123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805269|NCT00045123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805270|NCT00164866|Omeprazole|omeprazole|mesh-list
83805271|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83805272|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805273|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83805274|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805275|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805276|NCT00407212|Maleic acid|maleic acid|mesh-list
83805277|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805278|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805279|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
83805280|NCT00165139|Melphalan|melphalan|mesh-list
83805281|NCT00165139|Ifosfamide|ifosfamide|mesh-list
83805282|NCT00165139|Carboplatin|carboplatin|mesh-list
83805283|NCT00165139|Etoposide|etoposide|mesh-list
83805284|NCT00165139|Vincristine|vincristine|mesh-list
83805285|NCT00165139|Doxorubicin|doxorubicin|mesh-list
83805286|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83805287|NCT00165139|Lenograstim|lenograstim|mesh-list
83805288|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805289|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
83805290|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805291|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805292|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83805293|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
83805294|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805295|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805296|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83805297|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805298|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83805299|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83805300|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805301|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805302|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805303|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805304|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805305|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83805307|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
83805308|NCT00053807|Aldesleukin|aldesleukin|mesh-list
83805309|NCT00053807|Fluorouracil|fluorouracil|mesh-list
83805310|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
83805311|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805312|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805313|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805314|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805315|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
83805316|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805317|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
83805318|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805319|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83805320|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83805321|NCT00165178|Leucovorin|leucovorin|mesh-list
83805322|NCT00165178|Cytarabine|cytarabine|mesh-list
83805323|NCT00165178|Dexamethasone|dexamethasone|mesh-list
83805324|NCT00165178|Prednisone|prednisone|mesh-list
83805325|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
83805326|NCT00165178|Doxorubicin|doxorubicin|mesh-list
83805327|NCT00165178|Methotrexate|methotrexate|mesh-list
83805328|NCT00165178|Vincristine|vincristine|mesh-list
83805329|NCT00165178|Asparaginase|asparaginase|mesh-list
83805330|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
83805331|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805332|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
83805333|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
83805334|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805335|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805336|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805337|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
83805338|NCT00165178|Hormones|hormones|mesh-ancestor
83805339|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805340|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83805341|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805342|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805343|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83805344|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83805345|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805346|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805347|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83805348|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
83805349|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83805350|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805351|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
83805352|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
83805353|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83805354|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805355|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
83805356|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805357|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83805358|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
83805359|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805360|NCT00165178|Antidotes|antidotes|mesh-ancestor
83805361|NCT00165178|Protective Agents|protective agents|mesh-ancestor
83805362|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
83805363|NCT00165178|Vitamins|vitamins|mesh-ancestor
83805364|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
83805365|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805366|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805367|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805368|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805369|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83805370|NCT00165217|Thalidomide|thalidomide|mesh-list
83805371|NCT00165217|Capecitabine|capecitabine|mesh-list
83805372|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805373|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
83805374|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805375|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805376|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805377|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
83805378|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805379|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
83805380|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82960708|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
83805381|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805382|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83805383|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83805384|NCT00165217|Growth Substances|growth substances|mesh-ancestor
83805385|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
83805386|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
83805387|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805388|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
83805389|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83805390|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83805391|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805392|NCT00165295|Urological Agents|urological agents|mesh-ancestor
83805393|NCT00053885|Vatalanib|vatalanib|mesh-list
83134336|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83805394|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83805395|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805396|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805397|NCT00165334|Cetuximab|cetuximab|mesh-list
83805398|NCT00165334|Vinorelbine|vinorelbine|mesh-list
83805399|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83805400|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805401|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805402|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805403|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805404|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805405|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805406|NCT00165373|Endostatins|endostatins|mesh-list
83805407|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805408|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83805409|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83805410|NCT00165373|Growth Substances|growth substances|mesh-ancestor
83805411|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805412|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
83805413|NCT00165451|Thalidomide|thalidomide|mesh-list
83805414|NCT00165451|Celecoxib|celecoxib|mesh-list
83805415|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
83805416|NCT00165451|Etoposide|etoposide|mesh-list
83805417|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805418|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
83805419|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805420|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805421|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83805422|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
83805423|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805424|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805425|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83805426|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805427|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83805428|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83805429|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805430|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83805431|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83805432|NCT00165451|Analgesics|analgesics|mesh-ancestor
83805433|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
83805434|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805435|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805436|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83805437|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83805438|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
83805439|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805440|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805441|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83805442|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83805443|NCT00165451|Growth Substances|growth substances|mesh-ancestor
83805444|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
83805445|NCT00165490|Irinotecan|irinotecan|mesh-list
83805446|NCT00165490|Cetuximab|cetuximab|mesh-list
83805447|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805448|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83805449|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83805450|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805451|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805452|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83805453|NCT00165568|Bevacizumab|bevacizumab|mesh-list
83805454|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960786|NCT02392559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83805455|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805456|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83805457|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83805458|NCT00165568|Growth Substances|growth substances|mesh-ancestor
83805459|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805460|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
83805461|NCT00165685|Sibutramine|sibutramine|mesh-list
83805462|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
83805463|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83805464|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
83805465|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83805466|NCT00045279|Interferons|interferons|mesh-list
83805467|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
83805468|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
83805469|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83805470|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805471|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
83805472|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805473|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
83805474|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805475|NCT00053963|Romidepsin|romidepsin|mesh-list
83805476|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805477|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805478|NCT00053963|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83805479|NCT00053963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805480|NCT00053963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805481|NCT00165763|Donepezil|donepezil|mesh-list
83805482|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83805483|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805484|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805485|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
83805486|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805487|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805488|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
83805489|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83805490|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805491|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83805492|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805493|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805494|NCT00045318|Exatecan|exatecan|mesh-list
83805495|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83805496|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83805497|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805498|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805499|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805500|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83805501|NCT00054002|Trioxsalen|trioxsalen|mesh-list
83805502|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805503|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
83805504|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83805505|NCT00054041|Vaccines|vaccines|mesh-list
83805506|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
83805507|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805508|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
83805509|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805510|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805511|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83805512|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
83805513|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805514|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805515|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390852|NCT03074136|Eusol|eusol|mesh-list
83805516|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805517|NCT00054197|Paclitaxel|paclitaxel|mesh-list
83805518|NCT00054197|Vinorelbine|vinorelbine|mesh-list
83805519|NCT00054197|Gemcitabine|gemcitabine|mesh-list
83805520|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83805521|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805522|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805523|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805524|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805525|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805526|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805527|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805528|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
83805529|NCT00045396|Tipifarnib|tipifarnib|mesh-list
82960863|NCT03008616|Digoxin|digoxin|mesh-list
83805530|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805531|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
83805532|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805533|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83805534|NCT00166426|Protective Agents|protective agents|mesh-ancestor
83805535|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805536|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83805537|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805538|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805539|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83805540|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83805541|NCT00166426|Analgesics|analgesics|mesh-ancestor
83805542|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
83805543|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805544|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805545|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805546|NCT00166465|Leucovorin|leucovorin|mesh-list
83805547|NCT00166465|Fluorouracil|fluorouracil|mesh-list
83805548|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
83805549|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
83805550|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805551|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805552|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805553|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805554|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
83805555|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805556|NCT00166465|Antidotes|antidotes|mesh-ancestor
83805557|NCT00166465|Protective Agents|protective agents|mesh-ancestor
83805558|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
83805559|NCT00166465|Vitamins|vitamins|mesh-ancestor
83805560|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
83805561|NCT00166621|Buspirone|buspirone|mesh-list
83805562|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83805563|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83805564|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83805565|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805566|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83805567|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83805568|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
83805569|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805570|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805571|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
83805572|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
83805573|NCT00054236|Fludarabine|fludarabine|mesh-list
83805574|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
83805575|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83805576|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805577|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
83805578|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805579|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805580|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83805581|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
83805582|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805583|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805584|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83805585|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805586|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
83805587|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805588|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
83805589|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
83805590|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805591|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805592|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
83805593|NCT00054236|Hormones|hormones|mesh-ancestor
83805594|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805595|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83805596|NCT00054236|Protective Agents|protective agents|mesh-ancestor
83805597|NCT00054392|Paclitaxel|paclitaxel|mesh-list
83805598|NCT00054392|Carboplatin|carboplatin|mesh-list
83805599|NCT00054392|Gemcitabine|gemcitabine|mesh-list
83805600|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805601|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805602|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805603|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805604|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805605|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805606|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805607|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
83805608|NCT00166816|Cyclosporine|cyclosporine|mesh-list
83805609|NCT00166816|Sirolimus|sirolimus|mesh-list
83805610|NCT00166816|Tacrolimus|tacrolimus|mesh-list
83805611|NCT00166816|Cyclosporins|cyclosporins|mesh-list
83805612|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805613|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
83805614|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805615|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83805616|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805617|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805618|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
83805619|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805620|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
83805621|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805622|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805623|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805624|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805625|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
83805626|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83805627|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83805628|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805629|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
83805630|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
83805631|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
83805632|NCT00054431|Decitabine|decitabine|mesh-list
83805633|NCT00054431|Azacitidine|azacitidine|mesh-list
83805634|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805635|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83805636|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805637|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805638|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805639|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
83805640|NCT00054470|Trastuzumab|trastuzumab|mesh-list
83805641|NCT00054470|Tipifarnib|tipifarnib|mesh-list
83805642|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83805643|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805644|NCT00054548|Paclitaxel|paclitaxel|mesh-list
83805645|NCT00054548|Oblimersen|oblimersen|mesh-list
83805646|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805647|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805648|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805649|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805650|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805651|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805652|NCT00045513|Fludarabine|fludarabine|mesh-list
83805653|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
83805654|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83805655|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805656|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805657|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
83805658|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805659|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805660|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
83805661|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805662|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83805663|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805664|NCT00167401|Docetaxel|docetaxel|mesh-list
83805665|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805666|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805667|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805668|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805669|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805670|NCT00167479|Risperidone|risperidone|mesh-list
83805671|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83805672|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
83805673|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805674|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805675|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805676|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83805677|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83805678|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961013|NCT03916679|Fludarabine|fludarabine|mesh-list
83805679|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83805680|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83805681|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
83805683|NCT00054587|Docetaxel|docetaxel|mesh-list
83805684|NCT00054587|Fluorouracil|fluorouracil|mesh-list
83805685|NCT00054587|Trastuzumab|trastuzumab|mesh-list
83805686|NCT00054587|Epirubicin|epirubicin|mesh-list
83805687|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805688|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
83805689|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805690|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805691|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83805692|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
83805693|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805694|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805695|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83805696|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805697|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805698|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805699|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
83805700|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805701|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83805702|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805703|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83805704|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83805705|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805706|NCT00167518|Triamcinolone|triamcinolone|mesh-list
83805707|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805708|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
83805709|NCT00167518|Hormones|hormones|mesh-ancestor
83805710|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805711|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805712|NCT00167557|Interferons|interferons|mesh-list
83805713|NCT00167557|Ribavirin|ribavirin|mesh-list
83805714|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805715|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
83805716|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805717|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
83805718|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805719|NCT00167674|Zidovudine|zidovudine|mesh-list
83805720|NCT00167674|Nevirapine|nevirapine|mesh-list
83805721|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
83805722|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805723|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83805724|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83805725|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805726|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
83805727|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805728|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83805729|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83805730|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83805731|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83805732|NCT00054626|Gemcitabine|gemcitabine|mesh-list
83805733|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805734|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805735|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
83805736|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805737|NCT00167713|Ibuprofen|ibuprofen|mesh-list
83805738|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83805739|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83805740|NCT00167713|Analgesics|analgesics|mesh-ancestor
83805741|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
83805742|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805743|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805744|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805745|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805746|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83805747|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805748|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805749|NCT00167791|Rituximab|rituximab|mesh-list
83805750|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83805751|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805752|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
83805753|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805754|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805755|NCT00045591|Celecoxib|celecoxib|mesh-list
83805756|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83805757|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83805758|NCT00045591|Analgesics|analgesics|mesh-ancestor
83805759|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
83805760|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805761|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805762|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805763|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805764|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83805765|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83805766|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805767|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805768|NCT00167908|Amifostine|amifostine|mesh-list
83805769|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83805770|NCT00167908|Protective Agents|protective agents|mesh-ancestor
83805771|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805772|NCT00167947|Cyclosporine|cyclosporine|mesh-list
83805773|NCT00167947|Sirolimus|sirolimus|mesh-list
83805774|NCT00167947|Cyclosporins|cyclosporins|mesh-list
83805775|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805776|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805777|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805778|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
83805779|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805780|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
83805781|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805782|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
83805783|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805784|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83805785|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805786|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83805787|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805788|NCT00167986|Vancomycin|vancomycin|mesh-list
83805789|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805790|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805791|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
83805792|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83805793|NCT00168025|Antibodies|antibodies|mesh-list
83805794|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
83805795|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805796|NCT00168181|Pilocarpine|pilocarpine|mesh-list
83805797|NCT00168181|Miotics|miotics|mesh-ancestor
83805798|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
83805799|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805800|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805801|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83805802|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83805803|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
83805804|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805805|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805806|NCT00407251|Epothilone B|epothilone b|mesh-list
83805807|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805808|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805809|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805810|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805811|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805812|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
83805813|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805814|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83805815|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805816|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805817|NCT00407290|Neostigmine|neostigmine|mesh-list
83805818|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83805819|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805820|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805821|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
83805822|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805823|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805824|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83805825|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
83805826|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805827|NCT00407407|Carboplatin|carboplatin|mesh-list
83805828|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83805829|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805830|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
83805831|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
83805832|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83805834|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805835|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805836|NCT00407446|Urological Agents|urological agents|mesh-ancestor
83805837|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
83805838|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83805839|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83805840|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83805841|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83805842|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805843|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
83805844|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805845|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805846|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83805847|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805848|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
83805849|NCT00168493|Serotonin|serotonin|mesh-list
83805850|NCT00168493|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83805851|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83805852|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83805853|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
83805854|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805855|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805856|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805857|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83805858|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83805859|NCT00168532|Trimethoprim|trimethoprim|mesh-list
83805860|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83805861|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
83805862|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83805863|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805864|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
83805865|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83805866|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83805867|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83805868|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805869|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805870|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83805871|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83805872|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83805873|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83805874|NCT00168610|Vitamin A|vitamin a|mesh-list
83805875|NCT00168610|Vitamins|vitamins|mesh-ancestor
83805876|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
83805877|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805878|NCT04731948|Vitamins|vitamins|mesh-list
83805879|NCT04731948|Folic Acid|folic acid|mesh-list
83805880|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
83805881|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
83805882|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
83805883|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
83805884|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805885|NCT04731948|Hematinics|hematinics|mesh-ancestor
83805886|NCT00168649|Vitamin A|vitamin a|mesh-list
83805887|NCT00168649|Vitamins|vitamins|mesh-ancestor
83805888|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
83805889|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805890|NCT00168688|Micronutrients|micronutrients|mesh-list
83805891|NCT00168688|Trace Elements|trace elements|mesh-list
83805892|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805893|NCT00168766|Interferons|interferons|mesh-list
83805894|NCT00168766|Interferon-beta|interferon-beta|mesh-list
83805895|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
83805896|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
83805897|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805898|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
83805899|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83805900|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805901|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
83805902|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
83805903|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805904|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961238|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
83805905|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805906|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
83805907|NCT00168766|Hormones|hormones|mesh-ancestor
83805908|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83805909|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83805910|NCT00168766|Protective Agents|protective agents|mesh-ancestor
83805911|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
83805912|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83805914|NCT00168883|Vinorelbine|vinorelbine|mesh-list
83805915|NCT00168883|Carboplatin|carboplatin|mesh-list
83805916|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83805917|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805918|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805919|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805920|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805921|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805922|NCT04731909|Cisplatin|cisplatin|mesh-list
83805923|NCT04731909|Carboplatin|carboplatin|mesh-list
83805924|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805925|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83805926|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83805927|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
83805928|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805929|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805930|NCT00054938|Aspirin|aspirin|mesh-list
83805931|NCT00054938|Ramipril|ramipril|mesh-list
83805932|NCT00054938|Pravastatin|pravastatin|mesh-list
83805933|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805934|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83805935|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83805936|NCT00054938|Analgesics|analgesics|mesh-ancestor
83805937|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
83805938|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805939|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83805940|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83805941|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83805942|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83805943|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805944|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83805945|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83805946|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805947|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
83805948|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83805949|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
83805950|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83805951|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83805952|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83805953|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
83805954|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83805955|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83805956|NCT00169000|Docetaxel|docetaxel|mesh-list
83805957|NCT00169000|Capecitabine|capecitabine|mesh-list
83805958|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805959|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
83805960|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
83805961|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
83805962|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805963|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805964|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
83805965|NCT00045747|Fluorouracil|fluorouracil|mesh-list
83805966|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83805967|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
83805968|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83805969|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83805970|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83805971|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83805972|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
83805973|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805974|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83805975|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83805976|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
83805977|NCT00169039|Clozapine|clozapine|mesh-list
83805978|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83805979|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
83805980|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83805981|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961313|NCT01242605|Gemcitabine|gemcitabine|mesh-list
83805982|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83805983|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83805984|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83805985|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83805986|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83805987|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
83805989|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
83805990|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
83805991|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83805992|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83805993|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83805994|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
83805995|NCT00169078|Chloroquine|chloroquine|mesh-list
83805996|NCT00169078|Amebicides|amebicides|mesh-ancestor
83805997|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83805998|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83805999|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806000|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
83806001|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806002|NCT00054977|Fluorouracil|fluorouracil|mesh-list
83806003|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
83806004|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806005|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806006|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806007|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806008|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
83806009|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806010|NCT00169156|Prednisone|prednisone|mesh-list
83806011|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
83806012|NCT00169156|Rituximab|rituximab|mesh-list
83806013|NCT00169156|Doxorubicin|doxorubicin|mesh-list
83806014|NCT00169156|Vincristine|vincristine|mesh-list
83806015|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806016|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
83806017|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806018|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806019|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83806020|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
83806021|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806022|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806023|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83806024|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806025|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83806026|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83806027|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83806028|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806029|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806030|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
83806031|NCT00169156|Hormones|hormones|mesh-ancestor
83806032|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806033|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83806034|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83806035|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
83806036|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
83806037|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
83806038|NCT00169195|Rituximab|rituximab|mesh-list
83806039|NCT00169195|Gemcitabine|gemcitabine|mesh-list
83806040|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
83806041|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806042|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806043|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
83806044|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806045|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806046|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806047|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
83806048|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806049|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83806050|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
83806051|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806052|NCT00169468|Rituximab|rituximab|mesh-list
83806053|NCT00169468|Bortezomib|bortezomib|mesh-list
83806054|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806055|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806056|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
83806057|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806058|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806059|NCT00169546|Fluticasone|fluticasone|mesh-list
83806060|NCT00169546|Xhance|xhance|mesh-list
83806061|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83806062|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806063|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83806064|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
83806065|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806066|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806067|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83806068|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
83806069|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
83806070|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83806071|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83806072|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83806073|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83806074|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83806075|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806076|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806077|NCT00398372|Rituximab|rituximab|mesh-list
83806078|NCT00398372|Epratuzumab|epratuzumab|mesh-list
83806079|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806080|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806081|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
83806082|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806083|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806084|NCT00169585|Levofloxacin|levofloxacin|mesh-list
83806085|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83806086|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806087|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83806088|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83806089|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83806090|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806091|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806092|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806093|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83806094|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83806095|NCT00169624|Metformin|metformin|mesh-list
83806096|NCT00169624|Gliclazide|gliclazide|mesh-list
83806097|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83806098|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806099|NCT00407641|Heparin|heparin|mesh-list
83806100|NCT00407641|Tinzaparin|tinzaparin|mesh-list
83806101|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83806102|NCT00407641|Dalteparin|dalteparin|mesh-list
83806103|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
83806104|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83806105|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83806106|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806107|NCT00407680|Valsartan|valsartan|mesh-list
83806108|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806109|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83806110|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83806111|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806112|NCT00169819|Abciximab|abciximab|mesh-list
83806113|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
83806114|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83806115|NCT00055133|Paclitaxel|paclitaxel|mesh-list
83806116|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83806117|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806118|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
83806119|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
83806120|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
83806121|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806122|NCT00170053|Sirolimus|sirolimus|mesh-list
83806123|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83806124|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806125|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83806126|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806127|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
83806128|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806129|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
83806130|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806131|NCT00055250|Gemcitabine|gemcitabine|mesh-list
83806132|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806133|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
83806134|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806135|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806137|NCT00170209|Isoniazid|isoniazid|mesh-list
83806138|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83806139|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
83806140|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83806141|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806142|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
83806143|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83806144|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806145|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806146|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83806147|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83806148|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83806149|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83806150|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83806151|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83806152|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83806153|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83806154|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
83806155|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83806156|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
83806157|NCT02964091|Ledipasvir|ledipasvir|mesh-list
83806158|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
83806159|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806160|NCT00170404|Vitamins|vitamins|mesh-list
83806161|NCT00170404|Folic Acid|folic acid|mesh-list
83806162|NCT00170404|Vitamin A|vitamin a|mesh-list
83806163|NCT00170404|Thiamine|thiamine|mesh-list
83806164|NCT00170404|Selenium|selenium|mesh-list
83806165|NCT00170404|Micronutrients|micronutrients|mesh-list
83806166|NCT00170404|Trace Elements|trace elements|mesh-list
83806167|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806168|NCT00170404|Hematinics|hematinics|mesh-ancestor
83806169|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
83806170|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
83806171|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806172|NCT00170404|Protective Agents|protective agents|mesh-ancestor
83806173|NCT00055367|Natalizumab|natalizumab|mesh-list
83806174|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
83806175|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806176|NCT00170677|Topotecan|topotecan|mesh-list
83806177|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83806178|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83806179|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806180|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806181|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806182|NCT00170755|Darifenacin|darifenacin|mesh-list
83806183|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83806184|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83806185|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
83806186|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806187|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806188|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806189|NCT00170755|Urological Agents|urological agents|mesh-ancestor
83806190|NCT00170794|Everolimus|everolimus|mesh-list
83806191|NCT00170794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83806192|NCT00170794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83806193|NCT00170794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806194|NCT00170794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806195|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806196|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
83806197|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806198|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806199|NCT00170833|Everolimus|everolimus|mesh-list
83806200|NCT00170833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83806201|NCT00170833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83806202|NCT00170833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806203|NCT00170833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806204|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806205|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
83806206|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806207|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961534|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83806208|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
83806209|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83806210|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83806211|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806212|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806213|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83806214|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83806215|NCT00170872|Analgesics|analgesics|mesh-ancestor
83806216|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
83806217|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806218|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806219|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806220|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806221|NCT00170989|Valsartan|valsartan|mesh-list
83806222|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83806223|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806224|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83806225|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83806226|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806227|NCT00170989|Diuretics|diuretics|mesh-ancestor
83806228|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
83806229|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806230|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83806231|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806232|NCT00171028|Valsartan|valsartan|mesh-list
83806233|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806234|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83806235|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83806236|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806237|NCT00055484|Zonisamide|zonisamide|mesh-list
83806238|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
83806239|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83806240|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806241|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806242|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83806243|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806244|NCT00171067|Valsartan|valsartan|mesh-list
83806245|NCT00171067|Lisinopril|lisinopril|mesh-list
83806246|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806247|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83806248|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83806249|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806250|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83806251|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
83806252|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806253|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83806254|NCT00171067|Protective Agents|protective agents|mesh-ancestor
83806255|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806256|NCT00171106|Valsartan|valsartan|mesh-list
83806257|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806258|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83806259|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83806260|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806261|NCT00171145|Darifenacin|darifenacin|mesh-list
83806262|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83806263|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83806264|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83806265|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806266|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806267|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806268|NCT00171145|Urological Agents|urological agents|mesh-ancestor
83806269|NCT00171184|Darifenacin|darifenacin|mesh-list
83806270|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83806271|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83806272|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
83806273|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806274|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806275|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806276|NCT00171184|Urological Agents|urological agents|mesh-ancestor
83806277|NCT00055523|Adalimumab|adalimumab|mesh-list
83806278|NCT00055523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83806279|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806281|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
83806282|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83806283|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806284|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83806285|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
83806286|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83806287|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806288|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806289|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806290|NCT00171418|Tegaserod|tegaserod|mesh-list
83806291|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83806292|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
83806293|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806294|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806295|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806296|NCT00171457|Tegaserod|tegaserod|mesh-list
83806297|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83806298|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
83806299|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806300|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806301|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806302|NCT00055562|Lenalidomide|lenalidomide|mesh-list
83806303|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
83806304|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806305|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83806306|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83806307|NCT00055562|Growth Substances|growth substances|mesh-ancestor
83806308|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
83806309|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806310|NCT00171496|Cyclosporine|cyclosporine|mesh-list
83806311|NCT00171496|Tacrolimus|tacrolimus|mesh-list
83806312|NCT00171496|Cyclosporins|cyclosporins|mesh-list
83806313|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806314|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
83806315|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806316|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83806317|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806318|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806319|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
83806320|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806321|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
83806322|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806323|NCT00171535|Amlodipine|amlodipine|mesh-list
83806324|NCT00171535|Valsartan|valsartan|mesh-list
83806325|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806326|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83806327|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806328|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806329|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83806330|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806331|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
83806332|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83806333|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83806334|NCT00171574|Valsartan|valsartan|mesh-list
83806335|NCT00171574|Lisinopril|lisinopril|mesh-list
83806336|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806337|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83806338|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83806339|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806340|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83806341|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
83806342|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806343|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83806344|NCT00171574|Protective Agents|protective agents|mesh-ancestor
83806345|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806346|NCT00171613|Octreotide|octreotide|mesh-list
83806347|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83806348|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83806349|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806350|NCT04920981|Atezolizumab|atezolizumab|mesh-list
83806351|NCT04920981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82961685|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961746|NCT03418090|Xenon|xenon|mesh-list
83806352|NCT04920981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806353|NCT04920981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806354|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806355|NCT00055640|Prednisone|prednisone|mesh-list
83806356|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
83806357|NCT00055640|Rituximab|rituximab|mesh-list
83806358|NCT00055640|Doxorubicin|doxorubicin|mesh-list
83806359|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83806360|NCT00055640|Vincristine|vincristine|mesh-list
83806361|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806362|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
83806363|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806364|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806365|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83806366|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
83806367|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806368|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806369|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83806370|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806371|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83806372|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83806373|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83806374|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806375|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806376|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
83806377|NCT00055640|Hormones|hormones|mesh-ancestor
83806378|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806379|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83806380|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83806381|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
83806382|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
83806383|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
83806384|NCT00171652|Diclofenac|diclofenac|mesh-list
83806385|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83806386|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83806387|NCT00171652|Analgesics|analgesics|mesh-ancestor
83806388|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
83806389|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806390|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806391|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806392|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806393|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83806394|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806395|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806396|NCT00171691|Diclofenac|diclofenac|mesh-list
83806397|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83806398|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83806399|NCT00171691|Analgesics|analgesics|mesh-ancestor
83806400|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
83806401|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806402|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806403|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806404|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806405|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83806406|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806407|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806408|NCT00171769|Certoparin|certoparin|mesh-list
83806409|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
83806410|NCT00171808|Letrozole|letrozole|mesh-list
83806411|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806412|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83806413|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83806414|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806415|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806416|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83806417|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
83806418|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806419|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806420|NCT00171847|Trastuzumab|trastuzumab|mesh-list
83806421|NCT00171847|Letrozole|letrozole|mesh-list
83806422|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806423|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806424|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83806425|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83806426|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806427|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806428|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83806429|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
83806430|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806431|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806432|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
83806434|NCT00055679|Epirubicin|epirubicin|mesh-list
83806435|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806436|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
83806437|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806438|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806439|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83806440|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
83806441|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806442|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806443|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83806444|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
83806445|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806446|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83806447|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83806448|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83806449|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806450|NCT00171886|Octreotide|octreotide|mesh-list
83806451|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83806452|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83806453|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806454|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
83806455|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83806456|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806457|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
83806458|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83806459|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806460|NCT00055718|Silymarin|silymarin|mesh-list
83806461|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
83806462|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806463|NCT00055718|Protective Agents|protective agents|mesh-ancestor
83806464|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806465|NCT00055757|Gemcitabine|gemcitabine|mesh-list
83806466|NCT00055757|Tipifarnib|tipifarnib|mesh-list
83806467|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806468|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806469|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
83806470|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806471|NCT00399867|Simvastatin|simvastatin|mesh-list
83806472|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83806473|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83806474|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
83806475|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806476|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83806477|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83806478|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806479|NCT00055835|Paclitaxel|paclitaxel|mesh-list
83806480|NCT00055835|Carboplatin|carboplatin|mesh-list
83806481|NCT00055835|Gemcitabine|gemcitabine|mesh-list
83806482|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83806483|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806484|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83806485|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83806486|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83806487|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806488|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806489|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
83806490|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
83806491|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806492|NCT00055874|Interferons|interferons|mesh-list
83806493|NCT00055874|Cytarabine|cytarabine|mesh-list
83806494|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
83806495|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
83806496|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
83806497|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806498|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
83806499|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806500|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806501|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
83806502|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806503|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806504|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
83806505|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806506|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83806507|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806508|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
83806509|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83806510|NCT00407719|Bevacizumab|bevacizumab|mesh-list
83806511|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806512|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806513|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83806514|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83806515|NCT00407719|Growth Substances|growth substances|mesh-ancestor
83806516|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806517|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
83806518|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
83806519|NCT04732845|Fludarabine|fludarabine|mesh-list
83806520|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806521|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
83806522|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806523|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806524|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83806525|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
83806526|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806527|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806528|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83806529|NCT00055913|Bevacizumab|bevacizumab|mesh-list
83806530|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83806531|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83806532|NCT00055913|Antibodies|antibodies|mesh-list
83806533|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
83806534|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83806535|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806536|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83806537|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83806538|NCT00055913|Growth Substances|growth substances|mesh-ancestor
83806539|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806540|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
83806541|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
83806542|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83806543|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806544|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806545|NCT00045864|Aldesleukin|aldesleukin|mesh-list
83806546|NCT00045864|Rituximab|rituximab|mesh-list
83806547|NCT00045864|Interleukin-2|interleukin-2|mesh-list
83806548|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806549|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806550|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
83806551|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806552|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806553|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83806554|NCT00045864|Analgesics|analgesics|mesh-ancestor
83806555|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
83806556|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806557|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83806558|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83806559|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
83806560|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806561|NCT00055952|Exatecan|exatecan|mesh-list
83806562|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83806563|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83806564|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806565|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806566|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806567|NCT00055991|Bexarotene|bexarotene|mesh-list
83806568|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806569|NCT04631484|Riboflavin|riboflavin|mesh-list
83806570|NCT04631484|Niacinamide|niacinamide|mesh-list
83806571|NCT04631484|Niacin|niacin|mesh-list
83806572|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
83806573|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
83806574|NCT04631484|Vitamins|vitamins|mesh-ancestor
83806575|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
83806576|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806577|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83806578|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83806579|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83806580|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
83806581|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806582|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83806583|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
83806584|NCT00056030|Leucovorin|leucovorin|mesh-list
83806585|NCT00056030|Fluorouracil|fluorouracil|mesh-list
83806586|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
83806587|NCT00056030|Cetuximab|cetuximab|mesh-list
83806588|NCT00056030|Calcium|calcium|mesh-list
83806589|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
83806590|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83806591|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806592|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
83806593|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806594|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806595|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806596|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806597|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
83806598|NCT00056030|Antidotes|antidotes|mesh-ancestor
83806599|NCT00056030|Protective Agents|protective agents|mesh-ancestor
83806600|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
83806601|NCT00056030|Vitamins|vitamins|mesh-ancestor
83806602|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
83806603|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83806604|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83806605|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83806606|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83806607|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806608|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806609|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806610|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806611|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83806612|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
83806613|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83806614|NCT00173875|Gefitinib|gefitinib|mesh-list
83806615|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806616|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83806617|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806618|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806619|NCT04605081|Naltrexone|naltrexone|mesh-list
83806620|NCT04605081|Bupropion|bupropion|mesh-list
83806621|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83806622|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83806623|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806624|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
83806625|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806626|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83806627|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
83806628|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83806629|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83806630|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83806631|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806632|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806633|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
83806634|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806635|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83806636|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83806637|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806638|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83806639|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83806640|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806641|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83134416|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
83806642|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83806643|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806644|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806645|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
83806646|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806647|NCT00174226|Buspirone|buspirone|mesh-list
83806648|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83806649|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82961984|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83806650|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83806651|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806652|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806653|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83806654|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806655|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806656|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83806657|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83806658|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806659|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83806660|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83806661|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
83806662|NCT00174304|Amlodipine|amlodipine|mesh-list
83806663|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83806664|NCT00174304|Atorvastatin|atorvastatin|mesh-list
83806665|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83806666|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83806667|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
83806668|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806669|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83806670|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83806671|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806672|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83806673|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83806674|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806675|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83806676|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806677|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
83806678|NCT00174343|Exemestane|exemestane|mesh-list
83806679|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806680|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83806681|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83806682|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806683|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806684|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83806685|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
83806686|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806687|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806688|NCT00174499|Nicotine|nicotine|mesh-list
83806689|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83806690|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
83806691|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806692|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806693|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83806694|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83806695|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83806696|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806697|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806698|NCT00174538|Codeine|codeine|mesh-list
83806699|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83806700|NCT00174538|Narcotics|narcotics|mesh-ancestor
83806701|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806702|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806703|NCT00174538|Analgesics|analgesics|mesh-ancestor
83806704|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
83806705|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806706|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
83806707|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
83806708|NCT00174577|Risperidone|risperidone|mesh-list
83806709|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83806710|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
83806711|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806712|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806713|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806714|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83806715|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83806716|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806717|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83806718|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83806719|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
83806720|NCT00046137|Teriparatide|teriparatide|mesh-list
83806721|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83806722|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83806723|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806724|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83806725|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83806726|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
83806727|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806728|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83806729|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83806730|NCT00056225|Vitamins|vitamins|mesh-list
83806731|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
83806732|NCT00056225|Hydroxocobalamin|hydroxocobalamin|mesh-list
83806733|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
83806734|NCT00056225|Pyridoxal|pyridoxal|mesh-list
83806735|NCT00056225|Pyridoxine|pyridoxine|mesh-list
83806736|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
83806737|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
83806738|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806739|NCT00056225|Hematinics|hematinics|mesh-ancestor
83806740|NCT00174616|Capecitabine|capecitabine|mesh-list
83806741|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
83806742|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83806743|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
83806744|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806745|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806746|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
83806747|NCT00174655|Docetaxel|docetaxel|mesh-list
83806748|NCT00174655|Doxorubicin|doxorubicin|mesh-list
83806749|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83806750|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83806751|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
83806752|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806753|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806754|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83806755|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
83806756|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806757|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806758|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83806759|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83806760|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83806761|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83806762|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83806763|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83806764|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83806765|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806766|NCT00174694|Telithromycin|telithromycin|mesh-list
83806767|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83806768|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806769|NCT00174733|Ciclesonide|ciclesonide|mesh-list
83806770|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
83806771|NCT00174733|Hormones|hormones|mesh-ancestor
83806772|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806773|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806774|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83806775|NCT00056264|Infliximab|infliximab|mesh-list
83806776|NCT00056264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83806777|NCT00056264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806778|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
83806779|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83806780|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806781|NCT00174772|Cisplatin|cisplatin|mesh-list
83806782|NCT00174772|Docetaxel|docetaxel|mesh-list
83806783|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806784|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83806785|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83806786|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83806787|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806788|NCT00174811|Telithromycin|telithromycin|mesh-list
83806789|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83806790|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806791|NCT02963779|Apremilast|apremilast|mesh-list
83806792|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83806793|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83806794|NCT02963779|Analgesics|analgesics|mesh-ancestor
83806795|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
82962137|NCT04631536|Vitamins|vitamins|mesh-ancestor
83806796|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806797|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806798|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806799|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83806800|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83806801|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83806802|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806803|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806804|NCT00046176|Lamivudine|lamivudine|mesh-list
83806805|NCT00046176|Abacavir|abacavir|mesh-list
83806806|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
83806807|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83806808|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83806809|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806810|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806811|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
83806812|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806813|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83806814|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83806815|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
83806816|NCT00174928|Lansoprazole|lansoprazole|mesh-list
83806817|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
83806818|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83806819|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83806820|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83806821|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806822|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806823|NCT00175045|Lansoprazole|lansoprazole|mesh-list
83806824|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
83806825|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83806826|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83806827|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83806828|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806829|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806830|NCT00056381|Anidulafungin|anidulafungin|mesh-list
83806831|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
83806832|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806833|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83806834|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83806835|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83806836|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806837|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806838|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83806839|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806840|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806841|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
83806842|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806843|NCT00175357|Methadone|methadone|mesh-list
83806844|NCT00175357|Heroin|heroin|mesh-list
83806845|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83806846|NCT00175357|Narcotics|narcotics|mesh-ancestor
83806847|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806848|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806849|NCT00175357|Analgesics|analgesics|mesh-ancestor
83806850|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
83806851|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806852|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
83806853|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
83806854|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
83806855|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83806856|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806857|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
83806858|NCT00175396|Leuprolide|leuprolide|mesh-list
83806859|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
83806860|NCT00175396|Flutamide|flutamide|mesh-list
83806861|NCT00175396|Bicalutamide|bicalutamide|mesh-list
83806862|NCT00175396|Nilutamide|nilutamide|mesh-list
83806863|NCT00175396|Buserelin|buserelin|mesh-list
83806864|NCT00175396|Androgens|androgens|mesh-list
83806865|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83806866|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83806867|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
83806868|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83806869|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806870|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83806871|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806872|NCT00175396|Hormones|hormones|mesh-ancestor
83806873|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806874|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
83806875|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806876|NCT00175396|Protective Agents|protective agents|mesh-ancestor
83806877|NCT00175396|Vitamins|vitamins|mesh-ancestor
83806878|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
83806879|NCT00175396|Estrogens|estrogens|mesh-ancestor
83806880|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
83806881|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
83806882|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
83806883|NCT00056459|Vatalanib|vatalanib|mesh-list
83806884|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83806885|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806886|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806887|NCT00175435|Vaccines|vaccines|mesh-list
83806888|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
83806889|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806890|NCT00175513|Valacyclovir|valacyclovir|mesh-list
83806891|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
83806892|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806893|NCT00175591|Bupivacaine|bupivacaine|mesh-list
83806894|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83806895|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
83806896|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806897|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806898|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
83806899|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806900|NCT00175630|Bupivacaine|bupivacaine|mesh-list
83806901|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
83806902|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
83806903|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806904|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806905|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
83806906|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806907|NCT00056537|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
83806908|NCT00056537|Immunoconjugates|immunoconjugates|mesh-ancestor
83806909|NCT00056537|Immunologic Factors|immunologic factors|mesh-ancestor
83806910|NCT00056537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806911|NCT00408031|Cycloserine|cycloserine|mesh-list
83806912|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83806913|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83806914|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83806915|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
83806916|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83806917|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
83806918|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806919|NCT00175747|Budesonide|budesonide|mesh-list
83806920|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83806921|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83806922|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
83806923|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806924|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806925|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83806926|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
83806927|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
83806928|NCT00175747|Hormones|hormones|mesh-ancestor
83806929|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83806930|NCT04493619|Carboplatin|carboplatin|mesh-list
83806931|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806932|NCT00056576|Zonisamide|zonisamide|mesh-list
83806933|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
83806934|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83806935|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806936|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806937|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83806938|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806939|NCT00175903|Carbamazepine|carbamazepine|mesh-list
83806940|NCT00175903|Levetiracetam|levetiracetam|mesh-list
83806941|NCT00175903|Valproic Acid|valproic acid|mesh-list
83806942|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
83806943|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
83806944|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806945|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806946|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
83806947|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806948|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962286|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806949|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
83806950|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83806951|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806952|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83806953|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83806954|NCT00175903|Analgesics|analgesics|mesh-ancestor
83806955|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
83806956|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83806957|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83806958|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806959|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83806960|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83806961|NCT00056654|Leuprolide|leuprolide|mesh-list
83806962|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83806963|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
83806964|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83806965|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806966|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83806967|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83806968|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
83806969|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
83806970|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
83806971|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83806972|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83806973|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83806974|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806975|NCT00175981|Urological Agents|urological agents|mesh-ancestor
83806976|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83806977|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83806978|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83806979|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806980|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83806981|NCT00175981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83806982|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83806983|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83806984|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806985|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
83806986|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83806987|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
83134441|NCT03291249|Omeprazole|omeprazole|mesh-list
83806988|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83806989|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83806990|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83806991|NCT04420533|Mirabegron|mirabegron|mesh-list
83806992|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83806993|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83806994|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83806995|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83806996|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83806997|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83806998|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83806999|NCT04420533|Urological Agents|urological agents|mesh-ancestor
83807000|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
83807001|NCT00176020|Niacin|niacin|mesh-list
83807002|NCT00176020|Niacinamide|niacinamide|mesh-list
83807003|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
83807004|NCT00176020|Vitamins|vitamins|mesh-ancestor
83807005|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
83807006|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807007|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83807008|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
83807009|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807010|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83807011|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
83807012|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
83807013|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83807014|NCT00176059|Antibodies|antibodies|mesh-list
83807015|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
83807016|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83807017|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
83807018|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807019|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83807020|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807021|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807022|NCT00176293|Dexamethasone|dexamethasone|mesh-list
83807023|NCT00176293|Doxorubicin|doxorubicin|mesh-list
83807024|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83807025|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
83807026|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
83807027|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807028|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807029|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83807030|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
83807031|NCT00176293|Hormones|hormones|mesh-ancestor
83807032|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807033|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83807034|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807035|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83807036|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83807037|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807038|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807039|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807040|NCT00056693|Sunitinib|sunitinib|mesh-list
83807041|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807042|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83807043|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83807044|NCT00056693|Growth Substances|growth substances|mesh-ancestor
83807045|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807046|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
83807047|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83807048|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807049|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807050|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83807051|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83807052|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83807053|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
83807054|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807055|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83807056|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83807057|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807058|NCT00176449|Bupropion|bupropion|mesh-list
83807059|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83807060|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807061|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807062|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83807063|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807064|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807065|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807066|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
83807067|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807068|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807069|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83807070|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83807071|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807072|NCT00398450|Interferons|interferons|mesh-list
83807073|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
83807074|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
83807075|NCT00398450|Azacitidine|azacitidine|mesh-list
83807076|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807077|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
83807078|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807079|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807080|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
83807081|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807082|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807083|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
83807084|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807085|NCT00046293|Abciximab|abciximab|mesh-list
83807086|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
83807087|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83807088|NCT00176527|Interferons|interferons|mesh-list
83807089|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
83807090|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
83807091|NCT00176527|Docetaxel|docetaxel|mesh-list
83807092|NCT00176527|Estramustine|estramustine|mesh-list
83807093|NCT00176527|Isotretinoin|isotretinoin|mesh-list
83807094|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807095|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
83807096|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
83807097|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
83807098|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807099|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
83807100|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807101|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
83807102|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807103|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
83807104|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83807105|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
83807106|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83807107|NCT00398489|Tamoxifen|tamoxifen|mesh-list
83807108|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
83807109|NCT00398489|Docetaxel|docetaxel|mesh-list
83807110|NCT00398489|Trastuzumab|trastuzumab|mesh-list
83807111|NCT00398489|Epirubicin|epirubicin|mesh-list
83807112|NCT00398489|Anastrozole|anastrozole|mesh-list
83807113|NCT00398489|Goserelin|goserelin|mesh-list
83807114|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807115|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
83807116|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807117|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807118|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83807119|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
83807120|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807121|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807122|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83807123|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83807124|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83807125|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83807126|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807127|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83807128|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83807129|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807130|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807131|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83807132|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
83807133|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807134|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83807135|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83807136|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83807137|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83807138|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83807139|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83807140|NCT00176761|Interleukin-2|interleukin-2|mesh-list
83807141|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807142|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83807143|NCT00176761|Analgesics|analgesics|mesh-ancestor
83807144|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
83807145|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807146|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807147|NCT00176995|Eflornithine|eflornithine|mesh-list
83807148|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807149|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83807150|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83807151|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83807152|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807153|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83807154|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807155|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807156|NCT00423527|Levetiracetam|levetiracetam|mesh-list
83807157|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
83807158|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
83807159|NCT00408148|Rimonabant|rimonabant|mesh-list
83807160|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83807161|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83807162|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83807163|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807164|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807165|NCT00408148|Hormones|hormones|mesh-ancestor
83807166|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807167|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807168|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
83807169|NCT00397566|BMS-707035|bms-707035|mesh-list
83807170|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
83807171|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807172|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807173|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83807174|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83807175|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
83807176|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807177|NCT00177424|Sertraline|sertraline|mesh-list
83807178|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807179|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807180|NCT00177424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83807181|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807182|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807183|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134474|NCT03291093|Flutemetamol|flutemetamol|mesh-list
83807184|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807185|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
83807186|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807187|NCT00177580|Pravastatin|pravastatin|mesh-list
83807188|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83807189|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83807190|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
83807191|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807192|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83807193|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83807194|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807195|NCT04723342|Blinatumomab|blinatumomab|mesh-list
83807196|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807197|NCT00177619|Alendronate|alendronate|mesh-list
83807198|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83807199|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807200|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
83807201|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83807202|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807203|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807204|NCT00177853|Celecoxib|celecoxib|mesh-list
83807205|NCT00177853|Irinotecan|irinotecan|mesh-list
83807206|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83807207|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807208|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807209|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807210|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807211|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83807212|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83807213|NCT00177853|Analgesics|analgesics|mesh-ancestor
83807214|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
83807215|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807216|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807217|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83807218|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807219|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83807220|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83807221|NCT00178048|Paroxetine|paroxetine|mesh-list
83807222|NCT00178048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83807223|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807224|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807225|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807226|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807227|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
83807228|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807229|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83807230|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807231|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807232|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83807233|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83807234|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807235|NCT00056966|Fludarabine|fludarabine|mesh-list
83807236|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
83807237|NCT00056966|Tacrolimus|tacrolimus|mesh-list
83807238|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807239|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807240|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807241|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
83807242|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807243|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83807244|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807245|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807246|NCT00178828|Bupropion|bupropion|mesh-list
83807247|NCT00178828|Sertraline|sertraline|mesh-list
83807248|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82962581|NCT03289533|Avelumab|avelumab|mesh-list
83807249|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807250|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807251|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83807252|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807253|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807254|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807255|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
83807256|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807257|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807258|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83807259|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83807260|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807261|NCT00178828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83807262|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
83807263|NCT00408187|Cyclosporine|cyclosporine|mesh-list
83807264|NCT00408187|Cyclosporins|cyclosporins|mesh-list
83807265|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807266|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807267|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807268|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
83807269|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807270|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
83807271|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807272|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
83807273|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807274|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83807275|NCT00408226|Pemetrexed|pemetrexed|mesh-list
83807276|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807277|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807278|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807279|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83807280|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83807281|NCT02963896|Gentamicins|gentamicins|mesh-list
83807282|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83807283|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807284|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83807285|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807286|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807287|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
83807288|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83807289|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83807290|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83807291|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807292|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807293|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
83807294|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807295|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807296|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83807297|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807298|NCT00397722|Paroxetine|paroxetine|mesh-list
83807299|NCT00397722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83807300|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807301|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807302|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807303|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807304|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
83807305|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807306|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83807307|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807308|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807309|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83807310|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83807311|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807312|NCT00179023|Trimethaphan|trimethaphan|mesh-list
83807313|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
83807314|NCT00179023|Ephedrine|ephedrine|mesh-list
83807315|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
83807316|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83807317|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
83807318|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807319|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962651|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807320|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83807321|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
83807322|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
83807323|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83807324|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83807325|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
83807326|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83807327|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807328|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807329|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83807330|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83807331|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83807332|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83807333|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83807334|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
83807335|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
83807336|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
83807337|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
83807338|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807339|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
83807340|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807341|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807342|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83807343|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
83807344|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807345|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807346|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83807347|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807348|NCT00179062|Olanzapine|olanzapine|mesh-list
83807349|NCT00179062|Risperidone|risperidone|mesh-list
83807350|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83807351|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
83807352|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807353|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807354|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807355|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83807356|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83807357|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807358|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807359|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83807360|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
83807361|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
83807362|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
83807363|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807364|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83807365|NCT00179062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83807366|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807367|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807368|NCT04723459|Ivermectin|ivermectin|mesh-list
83807369|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83807370|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807371|NCT00179257|Sertraline|sertraline|mesh-list
83807372|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807373|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807374|NCT00179257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83807375|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807376|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807377|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807378|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807379|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
82962724|NCT03398044|Dexamethasone|dexamethasone|mesh-list
82962725|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962726|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
82962727|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
82962728|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962729|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962730|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82962731|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
82962732|NCT03398044|Hormones|hormones|mesh-ancestor
82962733|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962734|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82962735|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962736|NCT03389776|Anesthetics|anesthetics|mesh-list
83807380|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807382|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83807383|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83807384|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
83807385|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807386|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83807387|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83807388|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807389|NCT00057122|Rifampin|rifampin|mesh-list
83807390|NCT00057122|Rifapentine|rifapentine|mesh-list
83807391|NCT00057122|Isoniazid|isoniazid|mesh-list
83807392|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83807393|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
83807394|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83807395|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807396|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
83807397|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83807398|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807399|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807400|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83807401|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83807402|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83807403|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83807404|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83807405|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83807406|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83807407|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83807408|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
83807409|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83807410|NCT00179608|Lenalidomide|lenalidomide|mesh-list
83807411|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
83807412|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807413|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83807414|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83807415|NCT00179608|Growth Substances|growth substances|mesh-ancestor
83807416|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
83807417|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807418|NCT00179686|Lenalidomide|lenalidomide|mesh-list
83807419|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
83807420|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807421|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83807422|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83807423|NCT00179686|Growth Substances|growth substances|mesh-ancestor
83807424|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
83807425|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807426|NCT00179725|Doxorubicin|doxorubicin|mesh-list
83807427|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83807428|NCT00179725|Lenalidomide|lenalidomide|mesh-list
83807429|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83807430|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807431|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83807432|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807433|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807434|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807435|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
83807436|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807437|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83807438|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83807439|NCT00179725|Growth Substances|growth substances|mesh-ancestor
83807440|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
83807441|NCT00179764|Busulfan|busulfan|mesh-list
83807442|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
83807443|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807444|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807445|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
83807446|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807447|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83807448|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807449|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83807450|NCT00179881|Thalidomide|thalidomide|mesh-list
83807451|NCT00179881|Carboplatin|carboplatin|mesh-list
83807452|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807453|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82962786|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807455|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807456|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
83807457|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83807458|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807459|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83807460|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83807461|NCT00179881|Growth Substances|growth substances|mesh-ancestor
83807462|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
83807463|NCT00179920|Carboplatin|carboplatin|mesh-list
83807464|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807465|NCT00180037|Ubiquinone|ubiquinone|mesh-list
83807466|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
83807467|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
83807468|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807469|NCT00180037|Vitamins|vitamins|mesh-ancestor
83807470|NCT00180076|Budesonide|budesonide|mesh-list
83807471|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83807472|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83807473|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
83807474|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807475|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807476|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83807477|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
83807478|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
83807479|NCT00180076|Hormones|hormones|mesh-ancestor
83807480|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807481|NCT00180115|Cytarabine|cytarabine|mesh-list
83807482|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807483|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
83807484|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807485|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807486|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
83807487|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807488|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807489|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
83807490|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807491|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83807492|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807493|NCT00180310|Paclitaxel|paclitaxel|mesh-list
83807494|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83807495|NCT00180310|Everolimus|everolimus|mesh-list
83807496|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83807497|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807498|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
83807499|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
83807500|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
83807501|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807502|NCT00180310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83807503|NCT00180310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83807504|NCT00180310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807505|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807506|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
83807507|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807508|NCT00057278|Gabapentin|gabapentin|mesh-list
83807509|NCT00057278|Analgesics|analgesics|mesh-ancestor
83807510|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
83807511|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807512|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807513|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
83807514|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83807515|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83807516|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807517|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807518|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83807519|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83807520|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807521|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807522|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
83807523|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
83807524|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
83807525|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83807526|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
83807527|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807528|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962863|NCT05396690|Sevoflurane|sevoflurane|mesh-list
83807529|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83807530|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
83807531|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83807533|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807534|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807535|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83807536|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
83807537|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
83807538|NCT00180622|Protective Agents|protective agents|mesh-ancestor
83807539|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
83807540|NCT00180895|Rituximab|rituximab|mesh-list
83807541|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807542|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807543|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
83807544|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807545|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807546|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
83807547|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807548|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
83807549|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807550|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807551|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83807552|NCT04729491|Azithromycin|azithromycin|mesh-list
83807553|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
83807554|NCT04729491|Dutasteride|dutasteride|mesh-list
83807555|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83807556|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807557|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83807558|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83807559|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807560|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807561|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
83807562|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807563|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807564|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83807565|NCT00057356|Conivaptan|conivaptan|mesh-list
83807566|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83807567|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807568|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
83807569|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807570|NCT00181012|Lidocaine|lidocaine|mesh-list
83807571|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
83807572|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
83807573|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807574|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807575|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
83807576|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807577|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83807578|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83807579|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83807580|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807581|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807582|NCT00181246|Fentanyl|fentanyl|mesh-list
83807583|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83807584|NCT00181246|Narcotics|narcotics|mesh-ancestor
83807585|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807586|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807587|NCT00181246|Analgesics|analgesics|mesh-ancestor
83807588|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
83807589|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807590|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83807591|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83807592|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
83807593|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
83807594|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
83807595|NCT00181558|Atrasentan|atrasentan|mesh-list
83807596|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83807597|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807598|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807599|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83807600|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82962938|NCT04732260|Letermovir|letermovir|mesh-list
83807601|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807603|NCT00181597|Trilostane|trilostane|mesh-list
83807604|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83807605|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83807606|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
83807607|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83807608|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807609|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807610|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807611|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807612|NCT00181636|Galantamine|galantamine|mesh-list
83807613|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83807614|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807615|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807616|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
83807617|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807618|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807619|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83807620|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
83807621|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807622|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
83807623|NCT00181675|Galantamine|galantamine|mesh-list
83807624|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83807625|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807626|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807627|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
83807628|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807629|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807630|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83807631|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
83807632|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807633|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
83807634|NCT00181870|Carbamazepine|carbamazepine|mesh-list
83807635|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
83807636|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
83807637|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83807638|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807639|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807640|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807641|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83807642|NCT00181870|Analgesics|analgesics|mesh-ancestor
83807643|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
83807644|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807645|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83807646|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807647|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807648|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83807649|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83807650|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83807651|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83807652|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807653|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807654|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807655|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
83807656|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807657|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807658|NCT00181987|Methylphenidate|methylphenidate|mesh-list
83807659|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83807660|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807661|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83807662|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807663|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807664|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807665|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
83807666|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807667|NCT00182104|Warfarin|warfarin|mesh-list
83807668|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
83807669|NCT00182143|Heparin|heparin|mesh-list
83807670|NCT00182143|Calcium heparin|calcium heparin|mesh-list
83807671|NCT00182143|Dalteparin|dalteparin|mesh-list
83807672|NCT00182143|Tinzaparin|tinzaparin|mesh-list
82963015|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
83807673|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83807674|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
83807675|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83807676|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83807677|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807678|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
83807679|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83807680|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83807681|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807682|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
83807683|NCT00182221|Coagulants|coagulants|mesh-ancestor
83807684|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83807685|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807686|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807687|NCT00408538|UC-781|uc-781|mesh-list
83807688|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
83807689|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83807690|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
83807691|NCT00408655|Sirolimus|sirolimus|mesh-list
83807692|NCT00408655|Paclitaxel|paclitaxel|mesh-list
83807693|NCT00408655|Carboplatin|carboplatin|mesh-list
83807694|NCT00408655|Temsirolimus|temsirolimus|mesh-list
83807695|NCT00408655|MTOR Inhibitors|mtor inhibitors|mesh-list
83807696|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83807697|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807698|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83807699|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83807700|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83807701|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807702|NCT00408655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83807703|NCT00408655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807704|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807705|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
83807706|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807707|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83807708|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807709|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83807710|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
83807711|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83807712|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
83807713|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
83807714|NCT00182455|Topiramate|topiramate|mesh-list
83807715|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
83807716|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83807717|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807718|NCT00182494|Metformin|metformin|mesh-list
83807719|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83807720|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807721|NCT00182533|Sertraline|sertraline|mesh-list
83807722|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807723|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807724|NCT00182533|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83807725|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83807726|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83807727|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807728|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807729|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
83807730|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807731|NCT00182572|Naltrexone|naltrexone|mesh-list
83807732|NCT00182572|Buprenorphine|buprenorphine|mesh-list
83807733|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83807734|NCT00182572|Narcotics|narcotics|mesh-ancestor
83807735|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807736|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807737|NCT00182572|Analgesics|analgesics|mesh-ancestor
83807738|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
83807739|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807740|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83807741|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83807742|NCT00182611|Tegafur|tegafur|mesh-list
83807743|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807744|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807745|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
83807746|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807747|NCT00182650|Aldesleukin|aldesleukin|mesh-list
83807748|NCT00182650|Rituximab|rituximab|mesh-list
83807749|NCT00182650|Fludarabine|fludarabine|mesh-list
83807750|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
83807751|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807752|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807753|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
83807754|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807755|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807756|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807757|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
83807758|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807759|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83807760|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83807761|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83807762|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
83807763|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807764|NCT00182806|Gemcitabine|gemcitabine|mesh-list
83807765|NCT00182806|Irinotecan|irinotecan|mesh-list
83807766|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807767|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
83807768|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807769|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807770|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83807771|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807772|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807773|NCT00182845|Donepezil|donepezil|mesh-list
83807774|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83807775|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807776|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807777|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
83807778|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807779|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807780|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
83807781|NCT00182884|Donepezil|donepezil|mesh-list
83807782|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83807783|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807784|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807785|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
83807786|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807787|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807788|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
83807789|NCT00183001|Vitamin K|vitamin k|mesh-list
83807790|NCT00183001|Vitamins|vitamins|mesh-ancestor
83807791|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
83807792|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807793|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83807794|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83807795|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807796|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
83807797|NCT00183001|Coagulants|coagulants|mesh-ancestor
83807798|NCT00183040|Hormones|hormones|mesh-list
83807799|NCT00183040|Testosterone|testosterone|mesh-list
83807800|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807801|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807802|NCT00183040|Androgens|androgens|mesh-ancestor
83807803|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
83807804|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807805|NCT00183235|Aripiprazole|aripiprazole|mesh-list
83807806|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
83807807|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807808|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83807809|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83807810|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83807811|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807812|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
83807813|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
83807814|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83807815|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807816|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83807817|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83807818|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
83807819|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83807820|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83807821|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83807822|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82963162|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83807823|NCT00057512|Masoprocol|masoprocol|mesh-list
83807824|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
83807825|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807826|NCT00057512|Protective Agents|protective agents|mesh-ancestor
83807827|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807828|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83807829|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807830|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83807831|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83807832|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83807833|NCT00057512|Analgesics|analgesics|mesh-ancestor
83807834|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
83807835|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807836|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83807837|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807838|NCT00183742|Docetaxel|docetaxel|mesh-list
83807839|NCT00183742|Doxorubicin|doxorubicin|mesh-list
83807840|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83807841|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807842|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
83807843|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
83807844|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
83807845|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807846|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83807847|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83807848|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807849|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807850|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
83807851|NCT02965248|Leucovorin|leucovorin|mesh-list
83807852|NCT02965248|Capecitabine|capecitabine|mesh-list
83807853|NCT02965248|Raltitrexed|raltitrexed|mesh-list
83807854|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
83807855|NCT02965248|Calcium|calcium|mesh-list
83807856|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
83807857|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83807858|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807859|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83807860|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807861|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
83807862|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807863|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807864|NCT02965248|Antidotes|antidotes|mesh-ancestor
83807865|NCT02965248|Protective Agents|protective agents|mesh-ancestor
83807866|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
83807867|NCT02965248|Vitamins|vitamins|mesh-ancestor
83807868|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
83807869|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83807870|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807871|NCT00183820|Paclitaxel|paclitaxel|mesh-list
83807872|NCT00183820|Gemcitabine|gemcitabine|mesh-list
83807873|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
83807874|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83807875|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807876|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
83807877|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
83807878|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
83807879|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807880|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807881|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
83807882|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
83807883|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
83807884|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83807885|NCT02969720|Protective Agents|protective agents|mesh-ancestor
83807886|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807887|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
83807888|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83807889|NCT00183859|Irinotecan|irinotecan|mesh-list
83807890|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83807891|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807892|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807893|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807894|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807895|NCT00183898|Capecitabine|capecitabine|mesh-list
83807896|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
83807897|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807898|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
83807899|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807900|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807901|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83807902|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83807903|NCT00183937|Docetaxel|docetaxel|mesh-list
83807904|NCT00183937|Bortezomib|bortezomib|mesh-list
83807905|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807906|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83807907|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83807908|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83807909|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807910|NCT00408772|Bevacizumab|bevacizumab|mesh-list
83807911|NCT00408772|Capecitabine|capecitabine|mesh-list
83807912|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
83807913|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807914|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807915|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83807916|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83807917|NCT00408772|Growth Substances|growth substances|mesh-ancestor
83807918|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807919|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
83807920|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83807921|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
83807922|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807923|NCT00408850|Pioglitazone|pioglitazone|mesh-list
83807924|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83807925|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807926|NCT00183976|Rituximab|rituximab|mesh-list
83807927|NCT00183976|Doxorubicin|doxorubicin|mesh-list
83807928|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83807929|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807930|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807931|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
83807932|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807933|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83807934|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83807935|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83807936|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83807937|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807938|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807939|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
83807940|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807941|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807942|NCT00184015|Bevacizumab|bevacizumab|mesh-list
83807943|NCT00184015|Bortezomib|bortezomib|mesh-list
83807944|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83807945|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807946|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83807947|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83807948|NCT00184015|Growth Substances|growth substances|mesh-ancestor
83807949|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807950|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
83807951|NCT00184171|Budesonide|budesonide|mesh-list
83807952|NCT00184171|Bismuth|bismuth|mesh-list
83807953|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83807954|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83807955|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
83807956|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83807957|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807958|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83807959|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
83807960|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
83807961|NCT00184171|Hormones|hormones|mesh-ancestor
83807962|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807963|NCT00184171|Antacids|antacids|mesh-ancestor
83807964|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807965|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83807966|NCT00057707|Modafinil|modafinil|mesh-list
83807967|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83807968|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807969|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83807970|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83807971|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83807972|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807973|NCT00184522|Esomeprazole|esomeprazole|mesh-list
83807974|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83807975|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83807976|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83807977|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83807978|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83807980|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
83807981|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83807982|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807983|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
83807984|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83807985|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807986|NCT00058097|Tipifarnib|tipifarnib|mesh-list
83807987|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83807988|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83807989|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83807990|NCT00184795|Norethindrone|norethindrone|mesh-list
83807991|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
83807992|NCT00184795|Estradiol|estradiol|mesh-list
83807993|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83807994|NCT00184795|Estrogens|estrogens|mesh-ancestor
83807995|NCT00184795|Hormones|hormones|mesh-ancestor
83807996|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83807997|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83807998|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83807999|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
83808000|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808001|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83808002|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83808003|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83808004|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83808005|NCT00058253|Docetaxel|docetaxel|mesh-list
83808006|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808007|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
83808008|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
83808009|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
83808010|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808011|NCT00046800|Lurtotecan|lurtotecan|mesh-list
83808012|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808013|NCT00058292|Cytarabine|cytarabine|mesh-list
83808014|NCT00058292|Rituximab|rituximab|mesh-list
83808015|NCT00058292|Etoposide|etoposide|mesh-list
83808016|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
83808017|NCT00058292|Melphalan|melphalan|mesh-list
83808018|NCT00058292|Carmustine|carmustine|mesh-list
83808019|NCT00058292|Lenograstim|lenograstim|mesh-list
83808020|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83808021|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808022|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
83808023|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808024|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808025|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83808026|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83808027|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83808028|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808029|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808030|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808031|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
83808032|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
83808033|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808034|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808035|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83808036|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83808037|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
83808038|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83808039|NCT03816774|Simethicone|simethicone|mesh-list
83808040|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
83808041|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808042|NCT03816774|Emollients|emollients|mesh-ancestor
83808043|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
83808044|NCT00184912|Caffeine|caffeine|mesh-list
83808045|NCT00184912|Annexin A5|annexin a5|mesh-list
83808046|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83808047|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808048|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83808049|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963388|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808050|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808051|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83808052|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83808053|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
83808054|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808055|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83808056|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83808057|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83808058|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
83808059|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808060|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83808061|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83808062|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808063|NCT00184990|Pimagedine|pimagedine|mesh-list
83808064|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808065|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808066|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
83808067|NCT00058331|Hematinics|hematinics|mesh-ancestor
83808068|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83808069|NCT00185068|Olmesartan|olmesartan|mesh-list
83808070|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83808071|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83808072|NCT00185068|Diuretics|diuretics|mesh-ancestor
83808073|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
83808074|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808075|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83808076|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83808077|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808078|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83808079|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83808080|NCT00185107|Simvastatin|simvastatin|mesh-list
83808081|NCT00185107|Ezetimibe|ezetimibe|mesh-list
83808082|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83808083|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83808084|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83808085|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
83808086|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808087|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83808088|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83808089|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808090|NCT00058448|Docetaxel|docetaxel|mesh-list
83808091|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808092|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
83808093|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
83808094|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83808095|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808096|NCT00185185|Atenolol|atenolol|mesh-list
83808097|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83808098|NCT00185185|Olmesartan|olmesartan|mesh-list
83808099|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83808100|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83808101|NCT00185185|Diuretics|diuretics|mesh-ancestor
83808102|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
83808103|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808104|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83808105|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83808106|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808107|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83808108|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83808109|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83808110|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
83808111|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
83808112|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808113|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83808114|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83808115|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83808116|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
83808117|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808118|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83808119|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83808120|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83808121|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83808122|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
83808123|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808124|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808125|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83808126|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83808127|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83808128|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83808129|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83808130|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83808132|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83808133|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808134|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808135|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808136|NCT03784014|Durvalumab|durvalumab|mesh-list
83808137|NCT03784014|Olaparib|olaparib|mesh-list
83808138|NCT03784014|Palbociclib|palbociclib|mesh-list
83808139|NCT03784014|Lapatinib|lapatinib|mesh-list
83808140|NCT03784014|Trametinib|trametinib|mesh-list
83808141|NCT03784014|Dabrafenib|dabrafenib|mesh-list
83808142|NCT03784014|Ceritinib|ceritinib|mesh-list
83808143|NCT03784014|Futibatinib|futibatinib|mesh-list
83808144|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83808145|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808146|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83808147|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808148|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808149|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83808150|NCT00058487|Thalidomide|thalidomide|mesh-list
83808151|NCT00058487|Epirubicin|epirubicin|mesh-list
83808152|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83808153|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808154|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83808155|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83808156|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134659|NCT03384225|Cladribine|cladribine|mesh-list
83808157|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808158|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808159|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
83808160|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808161|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
83808162|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808163|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808164|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83808165|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83808166|NCT00058487|Growth Substances|growth substances|mesh-ancestor
83808167|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
83808168|NCT00185419|Desogestrel|desogestrel|mesh-list
83808169|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808170|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808171|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83808172|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83808173|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83808174|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
83808175|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83808176|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83808177|NCT00185419|Progestins|progestins|mesh-ancestor
83808178|NCT00185419|Hormones|hormones|mesh-ancestor
83808179|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808180|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83808181|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83808182|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83808183|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83808184|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808185|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808186|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808187|NCT00185575|Analgesics|analgesics|mesh-ancestor
83808188|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
83808189|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808190|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
83808191|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83808192|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
83808193|NCT03731832|Dexamethasone|dexamethasone|mesh-list
83808194|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
83808195|NCT03731832|Pomalidomide|pomalidomide|mesh-list
83808196|NCT03731832|Ixazomib|ixazomib|mesh-list
83808197|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808198|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
83808199|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808200|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808201|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83808202|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
83808203|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808204|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808205|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83808206|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83808207|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
83808208|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
83808209|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808210|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83808211|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
83808212|NCT03731832|Hormones|hormones|mesh-ancestor
83808213|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808214|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83808215|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83808216|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83808217|NCT03731832|Growth Substances|growth substances|mesh-ancestor
83808218|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
83808219|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
83808220|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808221|NCT00185887|Terbutaline|terbutaline|mesh-list
83808222|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83808223|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
83808224|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808225|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808226|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83808227|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
83808228|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
83808229|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
83808230|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808231|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83808232|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83808233|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83808234|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
83808235|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808236|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808237|NCT00186082|Cefoxitin|cefoxitin|mesh-list
83808238|NCT00186082|Cefotetan|cefotetan|mesh-list
83808239|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808240|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808241|NCT00186277|Docetaxel|docetaxel|mesh-list
83808242|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
83808243|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808244|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
83808245|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
83808246|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
83808247|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808248|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83808249|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
83808250|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808251|NCT03611595|Tretinoin|tretinoin|mesh-list
83808252|NCT03611595|Isotretinoin|isotretinoin|mesh-list
83808253|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808254|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
83808255|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
83808256|NCT00058682|Anidulafungin|anidulafungin|mesh-list
83808257|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
83808258|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808259|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83808260|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
83808261|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808262|NCT00186706|Selenium|selenium|mesh-list
83808263|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
83808264|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808265|NCT00186706|Protective Agents|protective agents|mesh-ancestor
83808266|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808267|NCT00186706|Trace Elements|trace elements|mesh-ancestor
82963619|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83808268|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
83808269|NCT00409201|Reboxetine|reboxetine|mesh-list
83808270|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
83808271|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83808272|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83808273|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83808274|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83808275|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808277|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808278|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808279|NCT00046878|Carmustine|carmustine|mesh-list
83808280|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83808281|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83808282|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
83808283|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808284|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808285|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808286|NCT00186745|Tinzaparin|tinzaparin|mesh-list
83808287|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83808288|NCT00186745|Dalteparin|dalteparin|mesh-list
83808289|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
83808290|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83808291|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83808292|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808293|NCT00186823|Antibodies|antibodies|mesh-list
83808294|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
83808295|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808296|NCT00186862|Interleukin-2|interleukin-2|mesh-list
83808297|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808298|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808299|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83808300|NCT00186862|Analgesics|analgesics|mesh-ancestor
83808301|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
83808302|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808303|NCT03551964|Ticagrelor|ticagrelor|mesh-list
83808304|NCT03551964|Cangrelor|cangrelor|mesh-list
83808305|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83808306|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83808307|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83808308|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83808309|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
83808310|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808311|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808312|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808313|NCT00186940|Rasburicase|rasburicase|mesh-list
83808314|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
83808315|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808316|NCT00186979|Cefixime|cefixime|mesh-list
83808317|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
83808318|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
83808319|NCT00186979|Irinotecan|irinotecan|mesh-list
83808320|NCT00186979|Vincristine|vincristine|mesh-list
83808321|NCT00186979|Gefitinib|gefitinib|mesh-list
83808322|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83808323|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83808324|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808325|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808326|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808327|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83808328|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
83808329|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
83808330|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
83808331|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83808332|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808333|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808334|NCT00187057|Cytarabine|cytarabine|mesh-list
83808335|NCT00187057|Dexamethasone|dexamethasone|mesh-list
83808336|NCT00187057|Prednisone|prednisone|mesh-list
83808337|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
83808338|NCT00187057|Doxorubicin|doxorubicin|mesh-list
83808339|NCT00187057|Methotrexate|methotrexate|mesh-list
83808340|NCT00187057|Etoposide|etoposide|mesh-list
83808341|NCT00187057|Vincristine|vincristine|mesh-list
83808342|NCT00187057|Daunorubicin|daunorubicin|mesh-list
83808343|NCT00187057|Asparaginase|asparaginase|mesh-list
83808344|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
83808345|NCT00187057|Vinblastine|vinblastine|mesh-list
83808346|NCT00187057|Procarbazine|procarbazine|mesh-list
83808347|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808348|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
83808349|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808350|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808351|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83808352|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
83808353|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808354|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808355|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83808356|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83808357|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
83808358|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
83808359|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808360|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83808361|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
83808362|NCT00187057|Hormones|hormones|mesh-ancestor
83808363|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808364|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83808365|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83808366|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83808367|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83808368|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808369|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83808370|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
83808371|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808372|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808373|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
83808374|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
83808375|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83808376|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83808377|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83808378|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
83808379|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808380|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
83808381|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
83808382|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
83808383|NCT00046917|Irinotecan|irinotecan|mesh-list
83808384|NCT00046917|Alvocidib|alvocidib|mesh-list
83808385|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808386|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83808387|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83808388|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808389|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808390|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
83808391|NCT00046917|Growth Substances|growth substances|mesh-ancestor
83808392|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808393|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83808394|NCT00187174|Everolimus|everolimus|mesh-list
83808395|NCT00187174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83808396|NCT00187174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83808397|NCT00187174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808398|NCT00187174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808399|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808400|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
83808401|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808402|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808403|NCT03538938|Nicotine|nicotine|mesh-list
83808404|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83808405|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
83808406|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808407|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808408|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83808409|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83808410|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
83808411|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808412|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808413|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
83808414|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83808415|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
83808416|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808417|NCT00187330|Expectorants|expectorants|mesh-ancestor
83808418|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
83808419|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83808420|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
83808421|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808422|NCT00187330|Protective Agents|protective agents|mesh-ancestor
83808423|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963764|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83808425|NCT00187408|Heparin|heparin|mesh-list
83808426|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83808427|NCT00187408|Tinzaparin|tinzaparin|mesh-list
83808428|NCT00187408|Dalteparin|dalteparin|mesh-list
83808429|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
83808430|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83808431|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83808432|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808433|NCT00187447|Indomethacin|indomethacin|mesh-list
83808434|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83808435|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83808436|NCT00187447|Analgesics|analgesics|mesh-ancestor
83808437|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
83808438|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808439|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808440|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83808441|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808442|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
83808443|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
83808444|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808445|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83808446|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134686|NCT05008250|Metoprolol|metoprolol|mesh-list
83808447|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808448|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83808449|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83808450|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808451|NCT00187525|Memantine|memantine|mesh-list
83808452|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83808453|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83808454|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
83808455|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808456|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808457|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808458|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83808459|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83808460|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
83808461|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
83808462|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808463|NCT00187564|Protective Agents|protective agents|mesh-ancestor
83808464|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808465|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
83808466|NCT00187564|Vitamins|vitamins|mesh-ancestor
83808467|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
83808468|NCT00046995|Leucovorin|leucovorin|mesh-list
83808469|NCT00046995|Carboplatin|carboplatin|mesh-list
83808470|NCT00046995|Fluorouracil|fluorouracil|mesh-list
83808471|NCT00046995|Calcium|calcium|mesh-list
83808472|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
83808473|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808474|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83808475|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808476|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
83808477|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808478|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808479|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808480|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
83808481|NCT00046995|Antidotes|antidotes|mesh-ancestor
83808482|NCT00046995|Protective Agents|protective agents|mesh-ancestor
83808483|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
83808484|NCT00046995|Vitamins|vitamins|mesh-ancestor
83808485|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
83808486|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
83808487|NCT00058955|Triazolam|triazolam|mesh-list
83808488|NCT00058955|Pentobarbital|pentobarbital|mesh-list
83808489|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83808490|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83808491|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
83808492|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
83808493|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83808494|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808495|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83808496|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83808497|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83808498|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
83808499|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
83808500|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808501|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808503|NCT00187759|Cephalexin|cephalexin|mesh-list
83808504|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808505|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808506|NCT00187798|Metformin|metformin|mesh-list
83808507|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83808508|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808509|NCT00058994|Anecortave|anecortave|mesh-list
83808510|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83808511|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83808512|NCT00058994|Growth Substances|growth substances|mesh-ancestor
83808513|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808514|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
83808515|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808516|NCT00187915|Cyclosporine|cyclosporine|mesh-list
83808517|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
83808518|NCT00187915|Tacrolimus|tacrolimus|mesh-list
83808519|NCT00187915|Cyclosporins|cyclosporins|mesh-list
83808520|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808521|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
83808522|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808523|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83808524|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808525|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808526|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
83808527|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808528|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
83808529|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808530|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83808531|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808532|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83808533|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
83808534|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808535|NCT00187993|Hormones|hormones|mesh-list
83808536|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808537|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808538|NCT00188071|Acetaminophen|acetaminophen|mesh-list
83808539|NCT00188071|Ketoprofen|ketoprofen|mesh-list
83808540|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83808541|NCT00188071|Analgesics|analgesics|mesh-ancestor
83808542|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
83808543|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808544|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808545|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
83808546|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83808547|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83808548|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808549|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83808550|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808551|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808552|NCT00188227|Midazolam|midazolam|mesh-list
83808553|NCT00188227|Pirinitramide|pirinitramide|mesh-list
83808554|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83808555|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83808556|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83808557|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808558|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83808559|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83808560|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83808561|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83808562|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
83808563|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
83808564|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
83808565|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
83808566|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808567|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808568|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83808569|NCT00188227|Narcotics|narcotics|mesh-ancestor
83808570|NCT00188227|Analgesics|analgesics|mesh-ancestor
83808571|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
83808572|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808573|NCT00188266|Fluorouracil|fluorouracil|mesh-list
83808574|NCT00188266|Cisplatin|cisplatin|mesh-list
83808575|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
82963915|NCT05055908|Atezolizumab|atezolizumab|mesh-list
82963920|NCT01147523|Vitamin E|vitamin e|mesh-list
83808576|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808577|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808578|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808579|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808580|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
83808581|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808582|NCT00047073|Sirolimus|sirolimus|mesh-list
83808583|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808584|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808585|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83808586|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808587|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
83808588|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808589|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
83808590|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808591|NCT00188383|Amantadine|amantadine|mesh-list
83808592|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83808593|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83808594|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
83808595|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808596|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
83808597|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808598|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808599|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808600|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83808601|NCT00188383|Analgesics|analgesics|mesh-ancestor
83808602|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
83808603|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808604|NCT02969447|Oxytocin|oxytocin|mesh-list
83808605|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
83808606|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808607|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808608|NCT00188617|Gefitinib|gefitinib|mesh-list
83808609|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808610|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83808611|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808612|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808613|NCT00047112|Fluorouracil|fluorouracil|mesh-list
83808614|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808615|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
83808616|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808617|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808618|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808619|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
83808620|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808621|NCT00409318|Etanercept|etanercept|mesh-list
83808622|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83808623|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83808624|NCT00409318|Analgesics|analgesics|mesh-ancestor
83808625|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
83808626|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808627|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808628|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83808629|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808630|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83808631|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808632|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
83808633|NCT00409357|Alfuzosin|alfuzosin|mesh-list
83808634|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83808635|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83808636|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83808637|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83808638|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808639|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808640|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808641|NCT00409357|Urological Agents|urological agents|mesh-ancestor
83808642|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83808643|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83134706|NCT03271749|Anesthetics|anesthetics|mesh-list
83808644|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83808645|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808646|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808647|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
83808648|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963991|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808649|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
83808650|NCT00188773|Heparin|heparin|mesh-list
83808651|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83808652|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83808653|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
83808654|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83808655|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83808656|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808657|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
83808658|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808659|NCT00188773|Expectorants|expectorants|mesh-ancestor
83808660|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
83808661|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83808662|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
83808663|NCT00188773|Protective Agents|protective agents|mesh-ancestor
83808664|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808665|NCT00188773|Antidotes|antidotes|mesh-ancestor
83808666|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83808667|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83808668|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83808669|NCT00188812|Donepezil|donepezil|mesh-list
83808670|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83808671|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808672|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808673|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
83808674|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808675|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808676|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
83808677|NCT02963194|Oxytocin|oxytocin|mesh-list
83808678|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
83808679|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808680|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808681|NCT00059306|Aspirin|aspirin|mesh-list
83808682|NCT00059306|Clopidogrel|clopidogrel|mesh-list
83808683|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83808684|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83808685|NCT00059306|Analgesics|analgesics|mesh-ancestor
83808686|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
83808687|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808688|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808689|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83808690|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808691|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83808692|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83808693|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808694|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83808695|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83808696|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808697|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
83808698|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83808699|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83808700|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83808701|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
83808702|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808703|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
83808704|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
83808705|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808706|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
83808707|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808708|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
83808709|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808710|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808711|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83808712|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
83808713|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83808714|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
83808715|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
83808716|NCT00189007|Allopurinol|allopurinol|mesh-list
83808717|NCT00189007|Mannitol|mannitol|mesh-list
83808718|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
83808719|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808720|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808721|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
83808722|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964066|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808723|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83808724|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
83808725|NCT00189007|Protective Agents|protective agents|mesh-ancestor
83808726|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808727|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83808728|NCT00189007|Diuretics|diuretics|mesh-ancestor
83808729|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
83808730|NCT00399945|Tobramycin|tobramycin|mesh-list
83808731|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808732|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808733|NCT00189085|Simvastatin|simvastatin|mesh-list
83808734|NCT00189085|Ezetimibe|ezetimibe|mesh-list
83808735|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83808736|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83808737|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83808738|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
83808739|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808740|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83808741|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83808742|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808743|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83808744|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83808745|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
83808746|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808747|NCT00189163|Pioglitazone|pioglitazone|mesh-list
83808748|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83808749|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808750|NCT00189358|Tamoxifen|tamoxifen|mesh-list
83808751|NCT00189358|Gefitinib|gefitinib|mesh-list
83808752|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83808753|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
83808754|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808755|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808756|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83808757|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808758|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83808759|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83808760|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83808761|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83808762|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808763|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808764|NCT00189397|Azathioprine|azathioprine|mesh-list
83808765|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
83808766|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808767|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808768|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808769|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808770|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
83808771|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808772|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808773|NCT00189514|Pramlintide|pramlintide|mesh-list
83808774|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83808775|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808776|NCT00189553|Paclitaxel|paclitaxel|mesh-list
83808777|NCT00189553|Carboplatin|carboplatin|mesh-list
83808778|NCT00189553|Doxorubicin|doxorubicin|mesh-list
83808779|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83808780|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83808781|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808782|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
83808783|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
83808784|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
83808785|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808786|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83808787|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83808788|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83808789|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808790|NCT00189709|Fluconazole|fluconazole|mesh-list
83808791|NCT00189709|Micafungin|micafungin|mesh-list
83808792|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
83808793|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808794|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83808795|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83808796|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808797|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808798|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83808799|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
83808800|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808801|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808802|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83808803|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83808804|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83808806|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808807|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
83808808|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808809|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83808810|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808811|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808812|NCT00189787|Tacrolimus|tacrolimus|mesh-list
83808813|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808814|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
83808815|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808816|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83808817|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808818|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808819|NCT00059462|Interleukin-2|interleukin-2|mesh-list
83808820|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808821|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83808822|NCT00059462|Analgesics|analgesics|mesh-ancestor
83808823|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
83808824|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808825|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808826|NCT00189826|Tacrolimus|tacrolimus|mesh-list
83808827|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808828|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
83808829|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808830|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83808831|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808832|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808833|NCT00047190|Tipifarnib|tipifarnib|mesh-list
83808834|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808835|NCT00189904|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83808836|NCT00189904|Antiviral Agents|antiviral agents|mesh-ancestor
83808837|NCT00189904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808838|NCT00189943|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83808839|NCT00189943|Antiviral Agents|antiviral agents|mesh-ancestor
83808840|NCT00189943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808841|NCT00189982|Factor VIII|factor viii|mesh-list
83808842|NCT00189982|Coagulants|coagulants|mesh-ancestor
83808843|NCT00190021|Donepezil|donepezil|mesh-list
83808844|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83808845|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808846|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808847|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
83808848|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808849|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808850|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
83808851|NCT00190060|Testosterone|testosterone|mesh-list
83808852|NCT00190060|Androgens|androgens|mesh-ancestor
83808853|NCT00190060|Hormones|hormones|mesh-ancestor
83808854|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808855|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808856|NCT00047229|Doxorubicin|doxorubicin|mesh-list
83808857|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83808858|NCT00047229|Oblimersen|oblimersen|mesh-list
83808859|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83808860|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808861|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83808862|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83808863|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808864|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808865|NCT00190099|Dexamethasone|dexamethasone|mesh-list
83808866|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83808867|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
83808868|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
83808869|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808870|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808871|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83808872|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
83808873|NCT00190099|Hormones|hormones|mesh-ancestor
83391198|NCT04728633|Carmustine|carmustine|mesh-list
83808874|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808875|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83808876|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808877|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
83808878|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83808879|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83808880|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
83808881|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808882|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83808883|NCT00047268|Cytarabine|cytarabine|mesh-list
83808884|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
83808885|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808886|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
83808887|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808888|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808889|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
83808890|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808891|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83808892|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
83808893|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808894|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83808895|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808896|NCT00190294|Misoprostol|misoprostol|mesh-list
83808897|NCT00190294|Mifepristone|mifepristone|mesh-list
83808898|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83808899|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
83808900|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83808901|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808902|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83808903|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83808904|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
83808905|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83808906|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83808907|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83808908|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83808909|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
83808910|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83808911|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83808912|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
83808913|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83808914|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
83808915|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83808916|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83808917|NCT03238365|Nivolumab|nivolumab|mesh-list
83808918|NCT03238365|Tadalafil|tadalafil|mesh-list
83808919|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83808920|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808921|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83808922|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808923|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
83808924|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83808925|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83808926|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808927|NCT03238365|Urological Agents|urological agents|mesh-ancestor
83808928|NCT00059618|Carboplatin|carboplatin|mesh-list
83808929|NCT00059618|Bortezomib|bortezomib|mesh-list
83808930|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808931|NCT00190333|Escitalopram|escitalopram|mesh-list
83808932|NCT00190333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83808933|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83808934|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83808935|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808936|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808937|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
83808938|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964290|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
82964291|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
82964292|NCT04549376|Povidone|povidone|mesh-list
82964293|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82964294|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964295|NCT04549376|Trace Elements|trace elements|mesh-ancestor
82964314|NCT04135495|Ivacaftor|ivacaftor|mesh-list
83808939|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83808940|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83808941|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808942|NCT00190411|Celiprolol|celiprolol|mesh-list
83808943|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83808944|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83808945|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
83808946|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
83808947|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808948|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808949|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
83808950|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83808951|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83808952|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83808953|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
83808954|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808955|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808956|NCT00047307|Gemcitabine|gemcitabine|mesh-list
83808957|NCT00047307|Alvocidib|alvocidib|mesh-list
83808958|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83808959|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
83808960|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808961|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808962|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83808963|NCT00047307|Growth Substances|growth substances|mesh-ancestor
83808964|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808965|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83808966|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83808967|NCT00190489|Docetaxel|docetaxel|mesh-list
83808968|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83808969|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83808970|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83808971|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83808972|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808973|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83808974|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83808975|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83808976|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83808977|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808978|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808979|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808980|NCT00190567|Analgesics|analgesics|mesh-ancestor
83808981|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
83808982|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83808983|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
83808984|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83808985|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
83808986|NCT02969252|Rifamycins|rifamycins|mesh-list
83808987|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
83808988|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83808989|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83808990|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83808991|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83808992|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83808993|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83808994|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83808995|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83808996|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83808997|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83808998|NCT00190606|Analgesics|analgesics|mesh-ancestor
83808999|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
83809000|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809001|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809002|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809003|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
83809004|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83809005|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83809006|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809007|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809008|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809009|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964373|NCT03907163|Hormones|hormones|mesh-ancestor
83809010|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809011|NCT00190645|Analgesics|analgesics|mesh-ancestor
83809012|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
83809013|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809014|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809015|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809016|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
83809017|NCT00190762|Pemetrexed|pemetrexed|mesh-list
83809018|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809019|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809020|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809021|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809022|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809023|NCT00190801|Pemetrexed|pemetrexed|mesh-list
83809024|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809025|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809026|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809027|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809028|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809029|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83809030|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809031|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83809032|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809033|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809034|NCT00190840|Pemetrexed|pemetrexed|mesh-list
83809035|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809036|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809037|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809038|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809039|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809040|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83809041|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83809042|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809043|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809044|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809045|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809046|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809047|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809048|NCT00190918|Pemetrexed|pemetrexed|mesh-list
83809049|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809050|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809051|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809052|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809053|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809054|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83809055|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83809056|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809057|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809058|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809059|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809060|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809061|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809062|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83809063|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83809064|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809065|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809066|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809067|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809068|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809069|NCT00190996|Analgesics|analgesics|mesh-ancestor
83809070|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
83809071|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809072|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809073|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809074|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
83809075|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83809076|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83809077|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809078|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964438|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
83809079|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809080|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809081|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809082|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809084|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83809085|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83809086|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83809087|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809088|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809089|NCT02922894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83809090|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809091|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809092|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809093|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809094|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
83809095|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83809096|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809097|NCT00191230|Carboplatin|carboplatin|mesh-list
83809098|NCT00191230|Gemcitabine|gemcitabine|mesh-list
83809099|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809100|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809101|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
83809102|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809103|NCT00191347|Gemcitabine|gemcitabine|mesh-list
83809104|NCT00191347|Pemetrexed|pemetrexed|mesh-list
83809105|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809106|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
83809107|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809108|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809109|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809110|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809111|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809112|NCT00191425|Teriparatide|teriparatide|mesh-list
83809113|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83809114|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83809115|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809116|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83809117|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83809118|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
83809119|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83809120|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83809121|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83809122|NCT00191464|Insulin|insulin|mesh-list
83809123|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83809124|NCT00191464|Metformin|metformin|mesh-list
83809125|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
83809126|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
83809127|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83809128|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809129|NCT04723030|Paclitaxel|paclitaxel|mesh-list
83809130|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809131|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809132|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809133|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809134|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809135|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809136|NCT00191503|Gemcitabine|gemcitabine|mesh-list
83809137|NCT00191503|Pemetrexed|pemetrexed|mesh-list
83809138|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809139|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
83809140|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809141|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809142|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809143|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809144|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809145|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83809146|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83809147|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809148|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809149|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964521|NCT01255475|Amlodipine|amlodipine|mesh-list
83809150|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809151|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809152|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809153|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83809154|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809155|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83809156|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809157|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809158|NCT00191581|Insulin|insulin|mesh-list
83809159|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
83809160|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83809161|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
83809162|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83809163|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809164|NCT00191620|Gemcitabine|gemcitabine|mesh-list
83809165|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809166|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809167|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
83809168|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809169|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83809170|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83809171|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809172|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809173|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809174|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809175|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809176|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809177|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83809178|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83809179|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809180|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809181|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809182|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809183|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809184|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809185|NCT02470299|Ketorolac|ketorolac|mesh-list
83809186|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83391303|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
83809187|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83809188|NCT02470299|Analgesics|analgesics|mesh-ancestor
83809189|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
83809190|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809191|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809192|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809193|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809194|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83809195|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809196|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809197|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83809198|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83809199|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809200|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809201|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809202|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809203|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809204|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809205|NCT00191893|Teriparatide|teriparatide|mesh-list
83809206|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83809207|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809208|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83809209|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83809210|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83809211|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809212|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809213|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809214|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809215|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809216|NCT00191932|Analgesics|analgesics|mesh-ancestor
83809217|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
83809218|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809219|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809220|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809221|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
83809223|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
83809224|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
83809225|NCT00059813|Oblimersen|oblimersen|mesh-list
83809226|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809227|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
83809228|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809229|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
83809230|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809231|NCT00191971|Gemcitabine|gemcitabine|mesh-list
83809232|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809233|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
83809234|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809235|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809236|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
83809237|NCT00047502|Lonafarnib|lonafarnib|mesh-list
83809238|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809239|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83809240|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809241|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809242|NCT00192049|Gemcitabine|gemcitabine|mesh-list
83809243|NCT00192049|Mitomycins|mitomycins|mesh-list
83809244|NCT00192049|Mitomycin|mitomycin|mesh-list
83809245|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809246|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
83809247|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809248|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809249|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83809250|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
83809251|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809252|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809253|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
83809254|NCT00192088|Pemetrexed|pemetrexed|mesh-list
83809255|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809256|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809257|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809258|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809259|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809260|NCT00059852|Gemcitabine|gemcitabine|mesh-list
83809261|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83809262|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809263|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
83809264|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809265|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809266|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83809267|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809268|NCT00047580|Tizanidine|tizanidine|mesh-list
83809269|NCT00047580|Analgesics|analgesics|mesh-ancestor
83809270|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
83809271|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809272|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809273|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
83809274|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83809275|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83809276|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
83809277|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
83809278|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83809279|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83809280|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83809281|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809282|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809283|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809284|NCT02968901|Tadalafil|tadalafil|mesh-list
83809285|NCT02968901|Macitentan|macitentan|mesh-list
83809286|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
83809287|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83809288|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83809289|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809290|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809291|NCT02968901|Urological Agents|urological agents|mesh-ancestor
82964660|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
82964673|NCT04320745|Hormones|hormones|mesh-ancestor
83809292|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83809293|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83809294|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83809295|NCT00192595|Tenofovir|tenofovir|mesh-list
83809296|NCT00192595|Lamivudine|lamivudine|mesh-list
83809297|NCT00192595|Zidovudine|zidovudine|mesh-list
83809298|NCT00192595|Efavirenz|efavirenz|mesh-list
83809299|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
83809300|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809301|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83809302|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809303|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809304|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809305|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83809306|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83809307|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
83809308|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83809309|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83809310|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83809311|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83809312|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83809313|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83809314|NCT00192634|Tenofovir|tenofovir|mesh-list
83809315|NCT00192634|Lamivudine|lamivudine|mesh-list
83809316|NCT00192634|Emtricitabine|emtricitabine|mesh-list
83809317|NCT00192634|Abacavir|abacavir|mesh-list
83809318|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
83809319|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809320|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83809321|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809322|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809323|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809324|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83809325|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83809326|NCT00192673|Asparaginase|asparaginase|mesh-list
83809327|NCT00192673|Pegaspargase|pegaspargase|mesh-list
83809328|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809329|NCT00192712|Gemcitabine|gemcitabine|mesh-list
83809330|NCT00192712|Irinotecan|irinotecan|mesh-list
83809331|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809332|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
83809333|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809334|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809335|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83809336|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809337|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809338|NCT00047658|Interferons|interferons|mesh-list
83809339|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
83809340|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809341|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
83809342|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809343|NCT00193024|Docetaxel|docetaxel|mesh-list
83809344|NCT00193024|Epirubicin|epirubicin|mesh-list
83809345|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809346|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809347|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809348|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809349|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809350|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83809351|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83809352|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809353|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809354|NCT00193102|Thalidomide|thalidomide|mesh-list
83809355|NCT00193102|Capecitabine|capecitabine|mesh-list
83809356|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809357|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
83809358|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809359|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809360|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809361|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
83809362|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809363|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
83809364|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83809365|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809366|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83809367|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83809368|NCT00193102|Growth Substances|growth substances|mesh-ancestor
83809369|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83809370|NCT00193141|Paclitaxel|paclitaxel|mesh-list
83809371|NCT00193141|Carboplatin|carboplatin|mesh-list
83809372|NCT00193141|Fluorouracil|fluorouracil|mesh-list
83809373|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809374|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809375|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809376|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809377|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809378|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809379|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
83809380|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809381|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809382|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
83809383|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809384|NCT00193297|Paclitaxel|paclitaxel|mesh-list
83809385|NCT00193297|Carboplatin|carboplatin|mesh-list
83809386|NCT00193297|Topotecan|topotecan|mesh-list
83809387|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809388|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809389|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809390|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809391|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809392|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809393|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83809394|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809395|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809396|NCT00193336|Gefitinib|gefitinib|mesh-list
83809397|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809398|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83809399|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809400|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809401|NCT00193531|Paclitaxel|paclitaxel|mesh-list
83809402|NCT00193531|Etoposide|etoposide|mesh-list
83809403|NCT00193531|Carboplatin|carboplatin|mesh-list
83809404|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809405|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809406|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809407|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809408|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809409|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809410|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83809411|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809412|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809413|NCT00193570|Docetaxel|docetaxel|mesh-list
83809414|NCT00193570|Topotecan|topotecan|mesh-list
83809415|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809416|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809417|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809418|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809419|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809420|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83809421|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809422|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809423|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83809424|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809425|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83809426|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809427|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809428|NCT00409591|Ritonavir|ritonavir|mesh-list
83809429|NCT00409591|Lopinavir|lopinavir|mesh-list
83809430|NCT00409591|Zidovudine|zidovudine|mesh-list
83809431|NCT00409591|Nevirapine|nevirapine|mesh-list
83809432|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83809433|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83809434|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
83809435|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809436|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809437|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83809438|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83809439|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
83809440|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809441|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83809442|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83809443|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
83809444|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83809445|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82964807|NCT03191084|Hormones|hormones|mesh-ancestor
83809446|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83809447|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83809448|NCT00409630|Fluticasone|fluticasone|mesh-list
83809449|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809450|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83809451|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
83809452|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809453|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809454|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83809455|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
83809456|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
83809457|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83809458|NCT00060125|Tipifarnib|tipifarnib|mesh-list
83809459|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809460|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
83809461|NCT00193648|Adalimumab|adalimumab|mesh-list
83809462|NCT00193648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83809463|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809464|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809465|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83809466|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809467|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83809468|NCT00193726|Estradiol|estradiol|mesh-list
83809469|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83809470|NCT00193726|Estrogens|estrogens|mesh-ancestor
83809471|NCT00193726|Hormones|hormones|mesh-ancestor
83809472|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83809473|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809474|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83809475|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
83809476|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83809477|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83809478|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83809479|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83809480|NCT00193882|Cisplatin|cisplatin|mesh-list
83809481|NCT00193882|Fluorouracil|fluorouracil|mesh-list
83809482|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809483|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
83809484|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809485|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809486|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809487|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
83809488|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809489|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
83809490|NCT00060242|Combretastatin|combretastatin|mesh-list
83809491|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809492|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809493|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809494|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809495|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809496|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809497|NCT00193921|Cisplatin|cisplatin|mesh-list
83809498|NCT00193921|Gemcitabine|gemcitabine|mesh-list
83809499|NCT00193921|Vinorelbine|vinorelbine|mesh-list
83809500|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809501|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809502|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
83809503|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809504|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809505|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809506|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809507|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809508|NCT00194038|Aripiprazole|aripiprazole|mesh-list
83809509|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809510|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809511|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83809512|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83809513|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83809514|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809515|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
83809516|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
83809517|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809518|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809519|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83809520|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83809521|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
83809522|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83809524|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83809525|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83809526|NCT00060359|Paclitaxel|paclitaxel|mesh-list
83809527|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83809528|NCT00060359|Carboplatin|carboplatin|mesh-list
83809529|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83809530|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809531|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809532|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809533|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809534|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809535|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809536|NCT00194272|Methotrexate|methotrexate|mesh-list
83809537|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83809538|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
83809539|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83809540|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809541|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809542|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
83809543|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809544|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809545|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
83809546|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809547|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809548|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809549|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
83809550|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809551|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809552|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
83809553|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
83809554|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83809555|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
83809556|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809557|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809558|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809559|NCT00194467|Valganciclovir|valganciclovir|mesh-list
83809560|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
83809561|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809562|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
83809563|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83809564|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83809565|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83809566|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809567|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809568|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
83809569|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809570|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809571|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83809572|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809573|NCT00194740|Docetaxel|docetaxel|mesh-list
83809574|NCT00194740|Vinorelbine|vinorelbine|mesh-list
83809575|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809576|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809577|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809578|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809579|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809580|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809581|NCT00194818|Mesalamine|mesalamine|mesh-list
83809582|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83809583|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83809584|NCT00194818|Analgesics|analgesics|mesh-ancestor
83809585|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
83809586|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809587|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809588|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809589|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809590|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
83809591|NCT00194857|Hematinics|hematinics|mesh-ancestor
83809592|NCT00194935|Topotecan|topotecan|mesh-list
83809593|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82964960|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
83809594|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809595|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809596|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809597|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809598|NCT00194974|Clonidine|clonidine|mesh-list
83809599|NCT00194974|Labetalol|labetalol|mesh-list
83809600|NCT00194974|Methyldopa|methyldopa|mesh-list
83809601|NCT00194974|Nifedipine|nifedipine|mesh-list
83809602|NCT00194974|Analgesics|analgesics|mesh-ancestor
83809603|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
83809604|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809605|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809606|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83809607|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
83809608|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
83809609|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83809610|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83809611|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83809612|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
83809613|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809614|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809615|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83809616|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809617|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83809618|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
83809619|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
83809620|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83809621|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83809622|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83809623|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
83809624|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83809625|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83809626|NCT00195208|Pantoprazole|pantoprazole|mesh-list
83809627|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83809628|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83809629|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83809630|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809631|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809632|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83809633|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83809634|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83809635|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
83809636|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809637|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83809638|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83809639|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809640|NCT00195286|Tazobactam|tazobactam|mesh-list
83809641|NCT00195286|Piperacillin|piperacillin|mesh-list
83809642|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83809643|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83809644|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809645|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83809646|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809647|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809648|NCT00084201|Amoxicillin|amoxicillin|mesh-list
83809649|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83809650|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809651|NCT00195364|Etanercept|etanercept|mesh-list
83809652|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83809653|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83809654|NCT00195364|Analgesics|analgesics|mesh-ancestor
83809655|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
83809656|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809657|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809658|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809659|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809660|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83809661|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809662|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
83809663|NCT00195481|Sirolimus|sirolimus|mesh-list
83809664|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83809665|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809666|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83809667|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809668|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
83809669|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809670|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
83809672|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
83809673|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83809674|NCT00195559|Estradiol|estradiol|mesh-list
83809675|NCT00195559|Estrogens|estrogens|mesh-ancestor
83809676|NCT00195559|Hormones|hormones|mesh-ancestor
83809677|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83809678|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809679|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83809680|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
83809681|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83809682|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83809683|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83809684|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83809685|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83809686|NCT00084240|Azithromycin|azithromycin|mesh-list
83809687|NCT00084240|Chloroquine|chloroquine|mesh-list
83809688|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83809689|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
83809690|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
83809691|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83809692|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83809693|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809694|NCT00084240|Amebicides|amebicides|mesh-ancestor
83809695|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83809696|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83809697|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
83809698|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809699|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83809700|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83809701|NCT00084240|Analgesics|analgesics|mesh-ancestor
83809702|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
83809703|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809704|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809705|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809706|NCT00084240|Filaricides|filaricides|mesh-ancestor
83809707|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
83809708|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
83809709|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809710|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809711|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809712|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83809713|NCT00195598|Paroxetine|paroxetine|mesh-list
83809714|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83809715|NCT00195598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83809716|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809717|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809718|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809719|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809720|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
83809721|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809722|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83809723|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809724|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809725|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83809726|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83809727|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809728|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83809729|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
83809730|NCT00195637|Antibodies|antibodies|mesh-list
83809731|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
83809732|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83809733|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83809734|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
83809735|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809736|NCT00195754|Valproic Acid|valproic acid|mesh-list
83809737|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
83809738|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809739|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809740|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
83809741|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809742|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809743|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
83809744|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83809745|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83809746|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809747|NCT00195793|Atorvastatin|atorvastatin|mesh-list
83809748|NCT00195793|Ezetimibe|ezetimibe|mesh-list
83809749|NCT00195793|Fenofibrate|fenofibrate|mesh-list
83809750|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83809751|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83809752|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
83809753|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809754|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83809755|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83809756|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809757|NCT00195871|Cytarabine|cytarabine|mesh-list
83809758|NCT00195871|Prednisone|prednisone|mesh-list
83809759|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
83809760|NCT00195871|Methotrexate|methotrexate|mesh-list
83809761|NCT00195871|Etoposide|etoposide|mesh-list
83809762|NCT00195871|Vincristine|vincristine|mesh-list
83809763|NCT00195871|Daunorubicin|daunorubicin|mesh-list
83809764|NCT00195871|Asparaginase|asparaginase|mesh-list
83809765|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809766|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
83809767|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809768|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809769|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83809770|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
83809771|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809772|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809773|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83809774|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809775|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
83809776|NCT00195871|Hormones|hormones|mesh-ancestor
83809777|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83809778|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83809779|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83809780|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
83809781|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83809782|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809783|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
83809784|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
83809785|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809786|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83809787|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809788|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83809789|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83809790|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809791|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809792|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809793|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
83809794|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
83809795|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809796|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83809797|NCT00195910|Morphine|morphine|mesh-list
83809798|NCT00195910|Hydromorphone|hydromorphone|mesh-list
83809799|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83809800|NCT00195910|Narcotics|narcotics|mesh-ancestor
83809801|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83809802|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809803|NCT00195910|Analgesics|analgesics|mesh-ancestor
83809804|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
83809805|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809806|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
83809807|NCT00195988|Tacrolimus|tacrolimus|mesh-list
83809808|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809809|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
83809810|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809811|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83809812|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809813|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809814|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83809815|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965184|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83809816|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83809817|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
83809818|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83809819|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809820|NCT00060476|Rofecoxib|rofecoxib|mesh-list
83809821|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83809822|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83809823|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809824|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809825|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83809826|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83809827|NCT00060476|Analgesics|analgesics|mesh-ancestor
83809828|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
83809829|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83809830|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809831|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83809832|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809833|NCT00084279|Interferons|interferons|mesh-list
83809834|NCT00084279|Ribavirin|ribavirin|mesh-list
83809835|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
83809836|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
83809837|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
83809838|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809839|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
83809840|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809841|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
83809842|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809843|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
83809844|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809845|NCT00196378|Estrogens|estrogens|mesh-list
83809846|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83809847|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
83809848|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
83809849|NCT00196378|Hormones|hormones|mesh-ancestor
83809850|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83809851|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809852|NCT00196417|Heparin|heparin|mesh-list
83809853|NCT00196417|Certoparin|certoparin|mesh-list
83809854|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
83809855|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83809856|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83809857|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809858|NCT00060554|Heparin|heparin|mesh-list
83809859|NCT00060554|PENTA|penta|mesh-list
83809860|NCT00060554|Fondaparinux|fondaparinux|mesh-list
83809861|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
83809862|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83809863|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83809864|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809865|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83809866|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
83809867|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83809868|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
83809869|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809870|NCT00048087|Docetaxel|docetaxel|mesh-list
83809871|NCT00048087|Gefitinib|gefitinib|mesh-list
83809872|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809873|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83809874|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83809875|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83134788|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
83809876|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809877|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83809878|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809879|NCT00196534|Thrombin|thrombin|mesh-list
83809880|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
83809881|NCT00196534|Coagulants|coagulants|mesh-ancestor
83809882|NCT00048126|Capecitabine|capecitabine|mesh-list
83809883|NCT00048126|Irinotecan|irinotecan|mesh-list
83809884|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83809885|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
83809886|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809887|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809888|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83809889|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809890|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809891|NCT00196612|Emtricitabine|emtricitabine|mesh-list
83809892|NCT00196612|Efavirenz|efavirenz|mesh-list
83809893|NCT00196612|Didanosine|didanosine|mesh-list
83809894|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
83809895|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809896|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82965260|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
83809897|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83809898|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809899|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809900|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83809901|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83809902|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83809903|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83809904|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83809905|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83809906|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83809907|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83809908|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
83809910|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83809911|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809912|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809913|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
83809914|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809915|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809916|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
83809917|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
83809918|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809919|NCT00084396|Letrozole|letrozole|mesh-list
83809920|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809921|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83809922|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83809923|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809924|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809925|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83809926|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
83809927|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83809928|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809929|NCT00196846|Goserelin|goserelin|mesh-list
83809930|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83809931|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809932|NCT00060632|Sirolimus|sirolimus|mesh-list
83809933|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83809934|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809935|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83809936|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134805|NCT05010356|Insulin|insulin|mesh-list
83809937|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
83809938|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83809939|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
83809940|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809941|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
83809942|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83809943|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
83809944|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809945|NCT00196885|Expectorants|expectorants|mesh-ancestor
83809946|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
83809947|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83809948|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
83809949|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809950|NCT00196885|Protective Agents|protective agents|mesh-ancestor
83809951|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809952|NCT00196885|Antidotes|antidotes|mesh-ancestor
83809953|NCT00048204|Paroxetine|paroxetine|mesh-list
83809954|NCT00048204|Vestipitant|vestipitant|mesh-list
83809955|NCT00048204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83809956|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83809957|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83809958|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809959|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809960|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
83809961|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809962|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83809963|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
83809964|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83809965|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83809966|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83809967|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809968|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83809969|NCT00197080|Ropinirole|ropinirole|mesh-list
83809970|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83809971|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83809972|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
83809973|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
83809974|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83809975|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809976|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809977|NCT00060671|Rituximab|rituximab|mesh-list
83809978|NCT00060671|Pixantrone|pixantrone|mesh-list
83809979|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83809980|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83809981|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
83809982|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83809983|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83809984|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83809985|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83809986|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83809987|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809988|NCT00197197|Aplaviroc|aplaviroc|mesh-list
83809989|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83809990|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83809991|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83809992|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83809993|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83809994|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
83809995|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83809996|NCT00409903|Eprosartan|eprosartan|mesh-list
83809997|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83809998|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83809999|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83810000|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810001|NCT00084435|Docetaxel|docetaxel|mesh-list
83810002|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810003|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810004|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810005|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810006|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810007|NCT00197353|Bupivacaine|bupivacaine|mesh-list
83810008|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
83810009|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
83810010|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810011|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810012|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
83810013|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810014|NCT02962999|Ketamine|ketamine|mesh-list
83810015|NCT02962999|Analgesics|analgesics|mesh-ancestor
83810016|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
83810017|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810018|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810019|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83810020|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83810021|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
83810022|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
83810023|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810024|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83810025|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83810026|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810027|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810028|NCT00084513|Trastuzumab|trastuzumab|mesh-list
83810029|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
83810030|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810031|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810032|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810033|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810034|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810035|NCT00084591|Capecitabine|capecitabine|mesh-list
83810036|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810037|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
83810038|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810039|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810040|NCT00197548|Folic Acid|folic acid|mesh-list
83810041|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
83810042|NCT00197548|Vitamins|vitamins|mesh-ancestor
83810043|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
83810044|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810045|NCT00197548|Hematinics|hematinics|mesh-ancestor
83810046|NCT00197587|Nevirapine|nevirapine|mesh-list
83810047|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83810048|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83810049|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810050|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810051|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
83810052|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810053|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83134826|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
83810054|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83810055|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83810056|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83810057|NCT00197743|Vitamin A|vitamin a|mesh-list
83810058|NCT00197743|Beta Carotene|beta carotene|mesh-list
83810059|NCT00197743|Carotenoids|carotenoids|mesh-list
83810060|NCT00197743|Vitamins|vitamins|mesh-ancestor
83810061|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
83810062|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810063|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
83810064|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810065|NCT00197743|Protective Agents|protective agents|mesh-ancestor
83810066|NCT00197743|Provitamins|provitamins|mesh-ancestor
83810067|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
83810068|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810069|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810070|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810071|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810072|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83810073|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
83810074|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810075|NCT00084669|Zolpidem|zolpidem|mesh-list
83810076|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83810077|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83810078|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810079|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810080|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810081|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810082|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810083|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83810084|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810085|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810086|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83810087|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83810088|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810089|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83810090|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
83810091|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
83810092|NCT00060866|Propranolol|propranolol|mesh-list
83810093|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83810094|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83810095|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
83810096|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810097|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810098|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810099|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83810100|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810101|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
83810102|NCT00048360|Bupropion|bupropion|mesh-list
83810103|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83810104|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810105|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810106|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83810107|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810108|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810109|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810110|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
83810111|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810112|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810113|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83810114|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83810115|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810116|NCT00198055|Aripiprazole|aripiprazole|mesh-list
83810117|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810118|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810119|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810120|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810121|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810122|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810123|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
83810124|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
83810125|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810126|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810127|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83810128|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83810129|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
83810130|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83810131|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83810132|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83810133|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83810134|NCT00198094|Alprazolam|alprazolam|mesh-list
83810135|NCT00198094|Sertraline|sertraline|mesh-list
83810136|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810137|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810138|NCT00198094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83810139|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810140|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810141|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810142|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810143|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
83810144|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810145|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83810146|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810147|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83810148|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810149|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
83810150|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
83810151|NCT00198172|Epirubicin|epirubicin|mesh-list
83810152|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810153|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83810154|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83810155|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83810156|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810157|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810158|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83810159|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83810160|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810161|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810162|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810163|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810164|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810165|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83810166|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810167|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810168|NCT00084708|Calcitriol|calcitriol|mesh-list
83810169|NCT00084708|Dexamethasone|dexamethasone|mesh-list
83810170|NCT00084708|Gefitinib|gefitinib|mesh-list
83810171|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810172|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
83810173|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
83810174|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810175|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810176|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810177|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
83810178|NCT00084708|Hormones|hormones|mesh-ancestor
83810179|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83810180|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83810181|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810182|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810183|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810184|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810185|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83810186|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83810187|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810188|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82965565|NCT01264211|Diacerein|diacerein|mesh-list
83810189|NCT00084708|Vitamins|vitamins|mesh-ancestor
83810190|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
83810191|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83810192|NCT00198367|Cisplatin|cisplatin|mesh-list
83810193|NCT00198367|Carboplatin|carboplatin|mesh-list
83810194|NCT00198367|Vinorelbine|vinorelbine|mesh-list
83810195|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810196|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810197|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83810198|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810199|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810200|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810201|NCT00198445|Bromfenac|bromfenac|mesh-list
83810202|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83810203|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83810204|NCT00198445|Analgesics|analgesics|mesh-ancestor
83810205|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
83810206|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810207|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810208|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810209|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83810210|NCT00048399|Fludarabine|fludarabine|mesh-list
83810211|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
83810212|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810213|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810214|NCT00060905|Valproic Acid|valproic acid|mesh-list
83810215|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
83810216|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810217|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810218|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
83810219|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810220|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810221|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
83810222|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810223|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810224|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810225|NCT00198523|Tobramycin|tobramycin|mesh-list
83810226|NCT00198523|Prednisolone|prednisolone|mesh-list
83810227|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83810228|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
83810229|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83810230|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
83810231|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83810232|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
83810233|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810234|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
83810235|NCT00198523|Hormones|hormones|mesh-ancestor
83810236|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83810237|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810238|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83810239|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810240|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
83134845|NCT03078374|Warfarin|warfarin|mesh-list
83810241|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
83810242|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810243|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810244|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83810245|NCT00198523|Protective Agents|protective agents|mesh-ancestor
83810246|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83810247|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810248|NCT00198562|Losartan|losartan|mesh-list
83810249|NCT00198562|Amlodipine|amlodipine|mesh-list
83810250|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
83810251|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83810252|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810253|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810254|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83810255|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810256|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
83810257|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83810258|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83810259|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83810260|NCT00409942|Torsemide|torsemide|mesh-list
83810261|NCT00409942|Furosemide|furosemide|mesh-list
83810262|NCT00409942|Diuretics|diuretics|mesh-ancestor
83810263|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
83810264|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965639|NCT01264367|Clevudine|clevudine|mesh-list
83810265|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83810266|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810267|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810268|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810269|NCT00084786|Docetaxel|docetaxel|mesh-list
83810270|NCT00084786|Gefitinib|gefitinib|mesh-list
83810271|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810272|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810273|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810274|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810275|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810276|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810277|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810278|NCT00409981|Paclitaxel|paclitaxel|mesh-list
83810279|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83810280|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810281|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810282|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810283|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810284|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810285|NCT00198601|Gentamicins|gentamicins|mesh-list
83810286|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83810287|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810288|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83810289|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810290|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810291|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83810292|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810293|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
83810294|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83810295|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810296|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
83810297|NCT00084825|Docetaxel|docetaxel|mesh-list
83810298|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
83810299|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810300|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810301|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810302|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810303|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810304|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810305|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810306|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83810307|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810308|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810309|NCT00199147|Cytarabine|cytarabine|mesh-list
83810310|NCT00199147|Fludarabine|fludarabine|mesh-list
83810311|NCT00199147|Etoposide|etoposide|mesh-list
83810312|NCT00199147|Idarubicin|idarubicin|mesh-list
83810313|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810314|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810315|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
83810316|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810317|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83810318|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
83810319|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810320|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83810321|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83810322|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83810323|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810324|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
83810325|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810326|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83810327|NCT00199186|Cytarabine|cytarabine|mesh-list
83810328|NCT00199186|Dexamethasone|dexamethasone|mesh-list
83810329|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
83810330|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
83810331|NCT00199186|Methotrexate|methotrexate|mesh-list
83810332|NCT00199186|Vincristine|vincristine|mesh-list
83810333|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
83810334|NCT00199186|Idarubicin|idarubicin|mesh-list
83810335|NCT00199186|BB 1101|bb 1101|mesh-list
83810336|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83810337|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
83810338|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810339|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83810340|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82965706|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810341|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
83810342|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810343|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810344|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83810345|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810346|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
83810347|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
83810348|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810349|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810350|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
83810351|NCT00199186|Hormones|hormones|mesh-ancestor
83810352|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83810353|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83810354|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
83810355|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810356|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83810357|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
83810358|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83810359|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810360|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
83810361|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
83810362|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83810363|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83810364|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83810365|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810366|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810367|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810368|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
83810369|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810370|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810371|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83810372|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83810373|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83810374|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
83810375|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83810376|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810377|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83810378|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83810379|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810380|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810381|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810382|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
83810383|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
83810384|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810385|NCT00061022|Protective Agents|protective agents|mesh-ancestor
83810386|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810387|NCT00199264|Albaconazole|albaconazole|mesh-list
83810388|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
83810389|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810390|NCT00199342|Ecromeximab|ecromeximab|mesh-list
83810391|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810392|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810393|NCT00199420|Istradefylline|istradefylline|mesh-list
83810394|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83810395|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83810396|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83810397|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
83810398|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810399|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810400|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810401|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
83810402|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83810403|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83810404|NCT00199576|Prednisolone|prednisolone|mesh-list
83810405|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
83810406|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83810407|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
83810408|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810409|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
83810410|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
83810411|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810412|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810413|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810414|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
83810416|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83810417|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83810418|NCT00199576|Protective Agents|protective agents|mesh-ancestor
83810419|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83810420|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810421|NCT00084942|Gemcitabine|gemcitabine|mesh-list
83810422|NCT00084942|Capecitabine|capecitabine|mesh-list
83810423|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810424|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
83810425|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810426|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810427|NCT02968394|Omalizumab|omalizumab|mesh-list
83810428|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83810429|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83810430|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
83810431|NCT00199771|Dextrans|dextrans|mesh-list
83810432|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
83810433|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
83810434|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
83810435|NCT00084981|Decitabine|decitabine|mesh-list
83810436|NCT00084981|Azacitidine|azacitidine|mesh-list
83810437|NCT00084981|Valproic Acid|valproic acid|mesh-list
83810438|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810439|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
83810440|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810441|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810442|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810443|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
83810444|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
83810445|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810446|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810447|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
83810448|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810449|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810450|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810451|NCT00199966|Valproic Acid|valproic acid|mesh-list
83810452|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
83810453|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810454|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810455|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
83810456|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810457|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810458|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
83810459|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810460|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810461|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810462|NCT00085020|Trastuzumab|trastuzumab|mesh-list
83810463|NCT00085020|Lapatinib|lapatinib|mesh-list
83810464|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810465|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810466|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810467|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810468|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810469|NCT00410215|Bisacodyl|bisacodyl|mesh-list
83810470|NCT00410215|Cathartics|cathartics|mesh-ancestor
83810471|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810472|NCT00410215|Laxatives|laxatives|mesh-ancestor
83810473|NCT00410254|Midazolam|midazolam|mesh-list
83810474|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83810475|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83810476|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810477|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810478|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83810479|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810480|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810481|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83810482|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
83810483|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
83810484|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
83810485|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
83810486|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810487|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810488|NCT00061178|Bevacizumab|bevacizumab|mesh-list
83810489|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810490|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810491|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83810492|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83810493|NCT00061178|Growth Substances|growth substances|mesh-ancestor
83810494|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810495|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
83810496|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83810497|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810498|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810499|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810500|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810502|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810503|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
83810504|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83810505|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83810506|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83810507|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83810508|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810509|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810510|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810511|NCT00200473|Nebivolol|nebivolol|mesh-list
83810512|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810513|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
83810514|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83810515|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83810516|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83810517|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
83810518|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810519|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810520|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810521|NCT02962804|Nivolumab|nivolumab|mesh-list
83810522|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810523|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810524|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83810525|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810526|NCT00048555|Galiximab|galiximab|mesh-list
83810527|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810528|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810529|NCT00200512|Apomorphine|apomorphine|mesh-list
83810530|NCT00200512|Emetics|emetics|mesh-ancestor
83810531|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810532|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
83810533|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810534|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810535|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
83810536|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
83810537|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810538|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810539|NCT00200551|Cyclosporine|cyclosporine|mesh-list
83810540|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
83810541|NCT00200551|Cyclosporins|cyclosporins|mesh-list
83810542|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83810543|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810544|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810545|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83810546|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
83810547|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810548|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
83810549|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810550|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
83810551|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83810552|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83810553|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83810554|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810555|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83810556|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
83810557|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83810558|NCT00061256|Vitamin D|vitamin d|mesh-list
83810559|NCT00061256|Alendronate|alendronate|mesh-list
83810560|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
83810561|NCT00061256|Calcium|calcium|mesh-list
83810562|NCT00061256|Vitamins|vitamins|mesh-ancestor
83810563|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
83810564|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810565|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82965932|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
83810566|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83810568|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810569|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810570|NCT00200590|Acetaminophen|acetaminophen|mesh-list
83810571|NCT00200590|Morphine|morphine|mesh-list
83810572|NCT00200590|Nalbuphine|nalbuphine|mesh-list
83810573|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83810574|NCT00200590|Narcotics|narcotics|mesh-ancestor
83810575|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810576|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810577|NCT00200590|Analgesics|analgesics|mesh-ancestor
83810578|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
83810579|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810580|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83810581|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
83810582|NCT00200629|Adenosine|adenosine|mesh-list
83810583|NCT00200629|Analgesics|analgesics|mesh-ancestor
83810584|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
83810585|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810586|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810587|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83810588|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83810589|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83810590|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
83810591|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
83810592|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810593|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810594|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83810595|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83810596|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810597|NCT00048594|Aprepitant|aprepitant|mesh-list
83810598|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
83810599|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
83810600|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810601|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810602|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810603|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83810604|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810605|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810606|NCT00200941|Topiramate|topiramate|mesh-list
83810607|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
83810608|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83810609|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810610|NCT00201253|Dimercaprol|dimercaprol|mesh-list
83810611|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
83810612|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
83810613|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810614|NCT00201331|Leucovorin|leucovorin|mesh-list
83810615|NCT00201331|Antidotes|antidotes|mesh-ancestor
83810616|NCT00201331|Protective Agents|protective agents|mesh-ancestor
83810617|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810618|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
83810619|NCT00201331|Vitamins|vitamins|mesh-ancestor
83810620|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
83810621|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
83810622|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810623|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810624|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810625|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810626|NCT00201682|Etanercept|etanercept|mesh-list
83810627|NCT00201682|Rituximab|rituximab|mesh-list
83810628|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810629|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810630|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
83810631|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810632|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83810633|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83810634|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83810635|NCT00201682|Analgesics|analgesics|mesh-ancestor
83810636|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
82966007|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
82966008|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810637|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810638|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810639|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810640|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83810641|NCT00410371|Lamotrigine|lamotrigine|mesh-list
83810642|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
83134890|NCT03078062|Dexamethasone|dexamethasone|mesh-list
83810643|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83810644|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810645|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810646|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83810647|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810648|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810649|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810650|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810651|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810652|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83810653|NCT00410449|Tocopherols|tocopherols|mesh-list
83810654|NCT00410449|Vitamin E|vitamin e|mesh-list
83810655|NCT00410449|Tocotrienols|tocotrienols|mesh-list
83810656|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
83810657|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
83810658|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810659|NCT00410449|Protective Agents|protective agents|mesh-ancestor
83810660|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810661|NCT00410449|Vitamins|vitamins|mesh-ancestor
83810662|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
83810663|NCT00061451|Gemcitabine|gemcitabine|mesh-list
83810664|NCT00061451|Pemetrexed|pemetrexed|mesh-list
83810665|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810666|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
83810667|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810668|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810669|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810670|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83810671|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83810672|NCT00410527|Meropenem|meropenem|mesh-list
83810673|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83810674|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810675|NCT00048750|Micafungin|micafungin|mesh-list
83810676|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
83810677|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810678|NCT00221416|Aripiprazole|aripiprazole|mesh-list
83810679|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810680|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810681|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810682|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810683|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810684|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810685|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
83810686|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
83810687|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810688|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810689|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83810690|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83810691|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
83810692|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83810693|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83810694|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83810695|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83810696|NCT00221494|Pindolol|pindolol|mesh-list
83810697|NCT00221494|Citalopram|citalopram|mesh-list
83810698|NCT00221494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83810699|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810700|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810701|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810702|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810703|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
83810704|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810705|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83810706|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810707|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810708|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83810709|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83810710|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
83810711|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810712|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83810713|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
83810714|NCT00221611|Baclofen|baclofen|mesh-list
83810715|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83810716|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810717|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83810718|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810719|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83810720|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
83810721|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
83810722|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810723|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810724|NCT00221650|Ribavirin|ribavirin|mesh-list
83810725|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83810726|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
83810727|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810728|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
83810729|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810730|NCT00221689|Baclofen|baclofen|mesh-list
83810731|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83810732|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810733|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83810734|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810735|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83810736|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
83810737|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
83810738|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810739|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810740|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
83810741|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
83810742|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810743|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810744|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810745|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
83810746|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
83810747|NCT00412789|Epothilone B|epothilone b|mesh-list
83810748|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810749|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810750|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810751|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810752|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810753|NCT00048828|Olanzapine|olanzapine|mesh-list
83810754|NCT00048828|Clozapine|clozapine|mesh-list
83810755|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
83810756|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
83810757|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810758|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810759|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810760|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810761|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810762|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810763|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810764|NCT00048828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83810765|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810766|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810767|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810768|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810769|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
83810770|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83810771|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
83810772|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
83810773|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83810774|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83810775|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83810776|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810777|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83810778|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83810779|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83810780|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
83810781|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810782|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810783|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810784|NCT00221845|Telmisartan|telmisartan|mesh-list
83810785|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810786|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83810787|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82966153|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83810788|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810790|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
83810791|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83810792|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
83810793|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810794|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810795|NCT00221962|Aripiprazole|aripiprazole|mesh-list
83810796|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810797|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810798|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810799|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810800|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810801|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810802|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
83810803|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
83810804|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810805|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810806|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83810807|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83810808|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
83810809|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83810810|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83810811|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83810812|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83810813|NCT02968160|Telmisartan|telmisartan|mesh-list
83810814|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83810815|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83810816|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83810817|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
83810818|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810819|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83810820|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83810821|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810822|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83810823|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83810824|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83810825|NCT00222079|Esomeprazole|esomeprazole|mesh-list
83810826|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83810827|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810828|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83810829|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810830|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810831|NCT00222235|Cycloserine|cycloserine|mesh-list
83810832|NCT00222235|Glycine|glycine|mesh-list
83810833|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83810834|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810835|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83810836|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
83810837|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83810838|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
83810839|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810840|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
83810841|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810842|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810843|NCT00061646|Carboplatin|carboplatin|mesh-list
83810844|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810845|NCT00222469|Bevacizumab|bevacizumab|mesh-list
83810846|NCT00222469|Gemcitabine|gemcitabine|mesh-list
83810847|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
83810848|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83810849|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810850|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83810851|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83810852|NCT00222469|Growth Substances|growth substances|mesh-ancestor
83810853|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810854|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
83810855|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810856|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
83810857|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810858|NCT00222547|Vitamin A|vitamin a|mesh-list
83810859|NCT00222547|Albendazole|albendazole|mesh-list
83810860|NCT00222547|Vitamins|vitamins|mesh-ancestor
82966230|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810861|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
83810862|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810863|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810864|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810865|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
83810866|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83810867|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810868|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
83810869|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83810870|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83810871|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810872|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810873|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810874|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
83810875|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810876|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83810877|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
83810878|NCT02968082|Scopolamine|scopolamine|mesh-list
83810879|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83810880|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83810881|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
83810882|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
83810883|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810884|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810885|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83810886|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
83810887|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83810888|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
83810889|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810890|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810891|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83810892|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
83810893|NCT00222820|Escitalopram|escitalopram|mesh-list
83810894|NCT00222820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83810895|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810896|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810897|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810898|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810899|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
83810900|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810901|NCT00085332|Docetaxel|docetaxel|mesh-list
83810902|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810903|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
83810904|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
83810905|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
83810906|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810907|NCT00222976|Naproxen|naproxen|mesh-list
83810908|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83810909|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83810910|NCT00222976|Analgesics|analgesics|mesh-ancestor
83810911|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
83810912|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83810913|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810914|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83810915|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83810916|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
83810917|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83810918|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810919|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810920|NCT00223015|Tacrolimus|tacrolimus|mesh-list
83810921|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83810922|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
83810923|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810924|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83810925|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810926|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810927|NCT00061763|Deferasirox|deferasirox|mesh-list
83810928|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83810929|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
83810930|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
83810931|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810932|NCT00223054|Cyclosporine|cyclosporine|mesh-list
83810933|NCT00223054|Sirolimus|sirolimus|mesh-list
83810934|NCT00223054|Everolimus|everolimus|mesh-list
83810935|NCT00223054|Tacrolimus|tacrolimus|mesh-list
83810936|NCT00223054|Cyclosporins|cyclosporins|mesh-list
83810937|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83810938|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
83810939|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810940|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83810941|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83810942|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810943|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
83810944|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83810945|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
83810946|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83810947|NCT00223054|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83810948|NCT00223054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83810949|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810950|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83810951|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83810952|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83810953|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810954|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810955|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810956|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810957|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810958|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810959|NCT00061802|Risperidone|risperidone|mesh-list
83810960|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83810961|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83810962|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
83810963|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810964|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810965|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810966|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810967|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810968|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810969|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810970|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83810971|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
83810972|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810973|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83810974|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
83810975|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83810976|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83810977|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83810978|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83810979|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810980|NCT00223288|Escitalopram|escitalopram|mesh-list
83810981|NCT00223288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83810982|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83810983|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83810984|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810985|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83810986|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
83810987|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83810988|NCT00085449|Cyclosporine|cyclosporine|mesh-list
83810989|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
83810990|NCT00085449|Fludarabine|fludarabine|mesh-list
83810991|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
83810992|NCT00085449|Melphalan|melphalan|mesh-list
83810993|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
83810994|NCT00085449|Cyclosporins|cyclosporins|mesh-list
83810995|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83810996|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83810997|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
83810998|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83810999|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811000|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
83811001|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811002|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811003|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
83811004|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811005|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
83811006|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811007|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83811008|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83811009|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82966379|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811010|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
83811011|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83811012|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83811013|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
83811014|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83811015|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83811016|NCT00223561|Methylphenidate|methylphenidate|mesh-list
83811017|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83811018|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811019|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83811020|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83811021|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811022|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811023|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
83811024|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811025|NCT00223639|Topiramate|topiramate|mesh-list
83811026|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
83811027|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83811028|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811029|NCT00223717|Aspirin|aspirin|mesh-list
83811030|NCT00223717|Losartan|losartan|mesh-list
83811031|NCT00223717|Metoprolol|metoprolol|mesh-list
83811032|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83811033|NCT00223717|Clonidine|clonidine|mesh-list
83811034|NCT00223717|Eplerenone|eplerenone|mesh-list
83811035|NCT00223717|Nebivolol|nebivolol|mesh-list
83811036|NCT00223717|Bosentan|bosentan|mesh-list
83811037|NCT00223717|Diltiazem|diltiazem|mesh-list
83811038|NCT00223717|Guanfacine|guanfacine|mesh-list
83811039|NCT00223717|Prazosin|prazosin|mesh-list
83811040|NCT00223717|Hydralazine|hydralazine|mesh-list
83811041|NCT00223717|Captopril|captopril|mesh-list
83811042|NCT00223717|Nifedipine|nifedipine|mesh-list
83811043|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83811044|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
83811045|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
83811046|NCT00223717|Dipyridamole|dipyridamole|mesh-list
83811047|NCT00223717|Carbidopa|carbidopa|mesh-list
83811048|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83811049|NCT00223717|Tamsulosin|tamsulosin|mesh-list
83811050|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83811051|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811052|NCT00223717|Analgesics|analgesics|mesh-ancestor
83811053|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
83811054|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811055|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811056|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83811057|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811058|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83811059|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83811060|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811061|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83811062|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83811063|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811064|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
83811065|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
83811066|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83811067|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83811068|NCT00223717|Urological Agents|urological agents|mesh-ancestor
83811069|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83811070|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83811071|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83811072|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83811073|NCT00223717|Diuretics|diuretics|mesh-ancestor
83811074|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
83811075|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83811076|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811077|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
83811078|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
83811079|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83811080|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83811081|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83811082|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
83811083|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811084|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83811085|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83811086|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82966452|NCT03384862|Folic Acid|folic acid|mesh-list
83811087|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83811088|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83811089|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83811090|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83811091|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
83811092|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83811093|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83811094|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811095|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
83811096|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83811097|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83811098|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
83811099|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811100|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83811101|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83811102|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83811103|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83811104|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
83811105|NCT00223717|Coagulants|coagulants|mesh-ancestor
83811106|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83811107|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83811108|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
83811109|NCT00061919|Thalidomide|thalidomide|mesh-list
83811110|NCT00061919|Carboplatin|carboplatin|mesh-list
83811111|NCT00061919|Etoposide|etoposide|mesh-list
83811112|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
83811113|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811114|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83811115|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83811116|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83811117|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811118|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811119|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811120|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
83811121|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811122|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
83811123|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83811124|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811125|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83811126|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83811127|NCT00061919|Growth Substances|growth substances|mesh-ancestor
83811128|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
83811129|NCT00085527|Romidepsin|romidepsin|mesh-list
83811130|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83811131|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811132|NCT00085527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83811133|NCT00085527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811134|NCT00085527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811135|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
83811136|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811137|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
83811138|NCT00224068|Hematinics|hematinics|mesh-ancestor
83811139|NCT00224146|Oxybutynin|oxybutynin|mesh-list
83811140|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
83811141|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
83811142|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811143|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811144|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83811145|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83811146|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
83811147|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811148|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811149|NCT00224146|Urological Agents|urological agents|mesh-ancestor
83811150|NCT00061997|Inositol|inositol|mesh-list
83811151|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
83811152|NCT00061997|Vitamins|vitamins|mesh-ancestor
83811153|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
83811154|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811155|NCT00224185|Dimercaprol|dimercaprol|mesh-list
83811156|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
83811157|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
83811158|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811159|NCT00062036|Aldesleukin|aldesleukin|mesh-list
83811160|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
83811161|NCT00062036|Fludarabine|fludarabine|mesh-list
83811162|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
82966539|NCT03238911|Hematinics|hematinics|mesh-ancestor
83811163|NCT00062036|Interleukin-2|interleukin-2|mesh-list
83811164|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
83811165|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811166|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
83811167|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811168|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811169|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83811170|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
83811171|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811172|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811173|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83811174|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811175|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
83811176|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83811177|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811178|NCT00062036|Analgesics|analgesics|mesh-ancestor
83811179|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
83811180|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811181|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83811182|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83811183|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
83811184|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811185|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83811186|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83811187|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83811188|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811189|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811190|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811191|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811192|NCT00224302|Analgesics|analgesics|mesh-ancestor
83811193|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
83811194|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134928|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
83811195|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
83811196|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811197|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
83811198|NCT00062075|Romidepsin|romidepsin|mesh-list
83811199|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83811200|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811201|NCT00062075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83811202|NCT00062075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811203|NCT00062075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811204|NCT00224419|Nicotine|nicotine|mesh-list
83811205|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83811206|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
83811207|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811208|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811209|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83811210|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83811211|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
83811212|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811213|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811214|NCT00224458|Efavirenz|efavirenz|mesh-list
83811215|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83811216|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83811217|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83811218|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811219|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811220|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
83811221|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811222|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83811223|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83811224|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83811225|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83811226|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83811227|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83811228|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83811229|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83811230|NCT00062114|Rituximab|rituximab|mesh-list
83811231|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83811232|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811233|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
82966612|NCT03297216|Progestins|progestins|mesh-ancestor
83811235|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811236|NCT00095043|Gaboxadol|gaboxadol|mesh-list
83811237|NCT00095043|Analgesics|analgesics|mesh-ancestor
83811238|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
83811239|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811240|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811241|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
83811242|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
83811243|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
83811244|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811245|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811246|NCT00095082|Insulin|insulin|mesh-list
83811247|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83811248|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
83811249|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
83811250|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
83811251|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83811252|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811253|NCT00062231|Amoxicillin|amoxicillin|mesh-list
83811254|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
83811255|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
83811256|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
83811257|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
83811258|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83811259|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83811260|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83811261|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811262|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83811263|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83811264|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811265|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811266|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811267|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83811268|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
83811269|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83811270|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811271|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83811272|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83811273|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83811274|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83811275|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83811276|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83811277|NCT00224692|Ketamine|ketamine|mesh-list
83811278|NCT00224692|Analgesics|analgesics|mesh-ancestor
83811279|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
83811280|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811281|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811282|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83811283|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83811284|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
83811285|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
83811286|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811287|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83811288|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83811289|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811290|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811291|NCT00224809|Aspirin|aspirin|mesh-list
83811292|NCT00224809|Spironolactone|spironolactone|mesh-list
83811293|NCT00224809|Clopidogrel|clopidogrel|mesh-list
83811294|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83811295|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83811296|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83811297|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83811298|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811299|NCT00224809|Analgesics|analgesics|mesh-ancestor
83811300|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
83811301|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811302|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811303|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83811304|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811305|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83811306|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82966681|NCT02526953|Paclitaxel|paclitaxel|mesh-list
83811307|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811308|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83811309|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83811310|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
83811311|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83811312|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83811313|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83811314|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
83811315|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811316|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83811317|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
83811318|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811319|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83811320|NCT00224809|Diuretics|diuretics|mesh-ancestor
83811321|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
83811322|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
83811323|NCT00062270|Gemcitabine|gemcitabine|mesh-list
83811324|NCT00062270|Docetaxel|docetaxel|mesh-list
83811325|NCT00062270|Gefitinib|gefitinib|mesh-list
83811326|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811327|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811328|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
83811329|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811330|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
83811331|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
83811332|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
83811333|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83811334|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811335|NCT00413023|Casopitant|casopitant|mesh-list
83811336|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
83811337|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
83811338|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811339|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811340|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83811341|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83811342|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811343|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811344|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
83811345|NCT00095277|Hematinics|hematinics|mesh-ancestor
83811346|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
83811347|NCT00413101|Hematinics|hematinics|mesh-ancestor
83811348|NCT00413179|Metformin|metformin|mesh-list
83811349|NCT00413179|Clomiphene|clomiphene|mesh-list
83811350|NCT00413179|Enclomiphene|enclomiphene|mesh-list
83811351|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
83811352|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83811353|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811354|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83811355|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
83811356|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811357|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83811358|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
83811359|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83811360|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83811361|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83811362|NCT00413257|Nefopam|nefopam|mesh-list
83811363|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811364|NCT00413257|Analgesics|analgesics|mesh-ancestor
83811365|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
83811366|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811367|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811368|NCT00095316|Caspofungin|caspofungin|mesh-list
83811369|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
83811370|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811371|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811372|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811373|NCT00225043|Phenylephrine|phenylephrine|mesh-list
83811374|NCT00225043|Epinephrine|epinephrine|mesh-list
83811375|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
83811376|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83811377|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83811378|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83811379|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811380|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811381|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966759|NCT01280669|Sirolimus|sirolimus|mesh-list
83811382|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83811383|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83811384|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
83811385|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811386|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83811387|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
83811388|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
83811389|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
83811390|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83811391|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83811392|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
83811393|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83811394|NCT00225043|Protective Agents|protective agents|mesh-ancestor
83811395|NCT00095355|Valproic Acid|valproic acid|mesh-list
83811396|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811397|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811398|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811399|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
83811400|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83811401|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811402|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811403|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
83811404|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
83811405|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811406|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
83811407|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
83811408|NCT00225160|Vitamins|vitamins|mesh-ancestor
83811409|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
83811410|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811411|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
83811412|NCT00225238|Esomeprazole|esomeprazole|mesh-list
83811413|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83811414|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83811415|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83811416|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811417|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811418|NCT00062426|Leucovorin|leucovorin|mesh-list
83811419|NCT00062426|Bevacizumab|bevacizumab|mesh-list
83811420|NCT00062426|Fluorouracil|fluorouracil|mesh-list
83811421|NCT00062426|Capecitabine|capecitabine|mesh-list
83811422|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
83811423|NCT00062426|Calcium|calcium|mesh-list
83811424|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
83811425|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83811426|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811427|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83811428|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83811429|NCT00062426|Growth Substances|growth substances|mesh-ancestor
83811430|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811431|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
83811432|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811433|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
83811434|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811435|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811436|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811437|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
83811438|NCT00062426|Antidotes|antidotes|mesh-ancestor
83811439|NCT00062426|Protective Agents|protective agents|mesh-ancestor
83811440|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
83811441|NCT00062426|Vitamins|vitamins|mesh-ancestor
83811442|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
83811443|NCT00095433|Ranibizumab|ranibizumab|mesh-list
83811444|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83811445|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83811446|NCT00095433|Growth Substances|growth substances|mesh-ancestor
83811447|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811448|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
83811449|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811450|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
83811451|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83811452|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134946|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
83811453|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83811454|NCT00225433|Ganirelix|ganirelix|mesh-list
83811455|NCT00225433|Hormones|hormones|mesh-ancestor
83811456|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811457|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966835|NCT03387826|Ticagrelor|ticagrelor|mesh-list
83811458|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
83811460|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811461|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811462|NCT02962258|Amlodipine|amlodipine|mesh-list
83811463|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83811464|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83811465|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83811466|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811467|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811468|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811469|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811470|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
83811471|NCT02962258|Diuretics|diuretics|mesh-ancestor
83811472|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
83811473|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83811474|NCT00225511|Milnacipran|milnacipran|mesh-list
83811475|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83811476|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
83811477|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83811478|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83811479|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811480|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811481|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811482|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811483|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83811484|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
83811485|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811486|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811487|NCT00225511|Analgesics|analgesics|mesh-ancestor
83811488|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
83811489|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811490|NCT00095511|Aripiprazole|aripiprazole|mesh-list
83811491|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
83811492|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811493|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83811494|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83811495|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811496|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811497|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
83811498|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
83811499|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811500|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811501|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83811502|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83811503|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
83811504|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83811505|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83811506|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83811507|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83811508|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83811509|NCT00225589|Calcium|calcium|mesh-list
83811510|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811511|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811512|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83811513|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83811514|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
83811515|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811516|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83811517|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83811518|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811519|NCT02967887|Fluorouracil|fluorouracil|mesh-list
83811520|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811521|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
83811522|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811523|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811524|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811525|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
83811526|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811527|NCT00225667|Irbesartan|irbesartan|mesh-list
83811528|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83811529|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83811530|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83811531|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811532|NCT00225706|Ibuprofen|ibuprofen|mesh-list
83811533|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83811534|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811535|NCT00225706|Analgesics|analgesics|mesh-ancestor
83811536|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
83811537|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811538|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811539|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83811540|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811541|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83811542|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811543|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811544|NCT00095667|Lapatinib|lapatinib|mesh-list
83811545|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811546|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83811547|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811548|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811549|NCT00225862|Ropinirole|ropinirole|mesh-list
83811550|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83811551|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83811552|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
83811553|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
83811554|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811555|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811556|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811557|NCT00095706|Bevacizumab|bevacizumab|mesh-list
83811558|NCT00095706|Trastuzumab|trastuzumab|mesh-list
83811559|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83811560|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811561|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83811562|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83811563|NCT00095706|Growth Substances|growth substances|mesh-ancestor
83811564|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811565|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
83811566|NCT00225901|Mitogens|mitogens|mesh-list
83811567|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83811568|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811569|NCT00225979|Octreotide|octreotide|mesh-list
83811570|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83811571|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83811572|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811573|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
83811574|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83811575|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
83811576|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83811577|NCT00095745|Aripiprazole|aripiprazole|mesh-list
83811578|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
83811579|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811580|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83811581|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83811582|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811583|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811584|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
83811585|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
83811586|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811587|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811588|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83811589|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83811590|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
83811591|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83811592|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83811593|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83811594|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83811595|NCT00226096|Metoprolol|metoprolol|mesh-list
83811596|NCT00226096|Clonidine|clonidine|mesh-list
83811597|NCT00226096|Nitroprusside|nitroprusside|mesh-list
83811598|NCT00226096|Labetalol|labetalol|mesh-list
83811599|NCT00226096|Hydralazine|hydralazine|mesh-list
83811600|NCT00226096|Nicardipine|nicardipine|mesh-list
83811601|NCT00226096|Phentolamine|phentolamine|mesh-list
83811602|NCT00226096|Urapidil|urapidil|mesh-list
83811603|NCT00226096|Enalaprilat|enalaprilat|mesh-list
83811604|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
82966984|NCT03383068|Metformin|metformin|mesh-list
83811605|NCT00226096|Esmolol|esmolol|mesh-list
83811606|NCT00226096|Glycerol|glycerol|mesh-list
83811607|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83811608|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83811609|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
83811610|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
83811611|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811612|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811613|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83811614|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83811615|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83811616|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
83811617|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811618|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811619|NCT00226096|Analgesics|analgesics|mesh-ancestor
83811620|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
83811621|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83811622|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83811623|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83811624|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
83811625|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83811626|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83811627|NCT00226096|Protective Agents|protective agents|mesh-ancestor
83811628|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
83811629|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83811630|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83811631|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83811632|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811633|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811634|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83811635|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
83811636|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83811637|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
83811638|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811639|NCT00226135|Lamotrigine|lamotrigine|mesh-list
83811640|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811641|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811642|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83134991|NCT03077516|Meloxicam|meloxicam|mesh-list
83811643|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811644|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811645|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
83811646|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83811647|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811648|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811649|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83811650|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83811651|NCT00400374|Celecoxib|celecoxib|mesh-list
83811652|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83811653|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811654|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83811655|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811656|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811657|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83811658|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811659|NCT00400374|Analgesics|analgesics|mesh-ancestor
83811660|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
83811661|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811662|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811663|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83811664|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811665|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83811666|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83811667|NCT00226330|Pioglitazone|pioglitazone|mesh-list
83811668|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83811669|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811670|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
83811671|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811672|NCT00226408|Interferons|interferons|mesh-list
83811673|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
83811674|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
83811675|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811676|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
83811677|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811678|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
82967063|NCT01165931|Riociguat|riociguat|mesh-list
83811679|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811680|NCT00226447|Interferons|interferons|mesh-list
83811681|NCT00226447|Lamivudine|lamivudine|mesh-list
83811682|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811683|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
83811684|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811685|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83811686|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83811687|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811688|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811689|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83811690|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83811691|NCT00062660|Tipranavir|tipranavir|mesh-list
83811692|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83811693|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83811694|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
83811695|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811696|NCT00413296|Levetiracetam|levetiracetam|mesh-list
83811697|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
83811698|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
83811699|NCT00413452|Etanercept|etanercept|mesh-list
83811700|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83811701|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811702|NCT00413452|Analgesics|analgesics|mesh-ancestor
83811703|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
83811704|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811705|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811706|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83811707|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811708|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83811709|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811710|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
83811711|NCT00095823|Aripiprazole|aripiprazole|mesh-list
83811712|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
83811713|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811714|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83811715|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83811716|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811717|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811718|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
83811719|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
83811720|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811721|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811722|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83811723|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83811724|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
83811725|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83811726|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83811727|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83811728|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83811729|NCT00226564|Alfentanil|alfentanil|mesh-list
83811730|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83811731|NCT00226564|Narcotics|narcotics|mesh-ancestor
83811732|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811733|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811734|NCT00226564|Analgesics|analgesics|mesh-ancestor
83811735|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
83811736|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811737|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83811738|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
83811739|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
83811740|NCT00062699|Calcitriol|calcitriol|mesh-list
83811741|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811742|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811743|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83811744|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811745|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811746|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83811747|NCT00062699|Vitamins|vitamins|mesh-ancestor
83811748|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
83811749|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83811750|NCT00226798|Capecitabine|capecitabine|mesh-list
83811751|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811752|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
83135020|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811753|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811754|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811755|NCT00399243|Sumatriptan|sumatriptan|mesh-list
83811756|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83811757|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83811758|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83811759|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
83811760|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811761|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811762|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811763|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
83811764|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83811765|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
83811766|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
83811767|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811768|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811769|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83811770|NCT00226837|Analgesics|analgesics|mesh-ancestor
83811771|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
83811772|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811773|NCT00226915|Paclitaxel|paclitaxel|mesh-list
83811774|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83811775|NCT00226915|Carboplatin|carboplatin|mesh-list
83811776|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83811777|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811778|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
83811779|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
83811780|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
83811781|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811782|NCT00095862|Interferons|interferons|mesh-list
83811783|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
83811784|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
83811785|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811786|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
83811787|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811788|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811789|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83811790|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
83811791|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811792|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811793|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83811794|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
83811795|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811796|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
83811797|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83811798|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811799|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83811800|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811801|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83811802|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811803|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811804|NCT00095901|Capecitabine|capecitabine|mesh-list
83811805|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811806|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
83811807|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811808|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811809|NCT00227110|Pioglitazone|pioglitazone|mesh-list
83811810|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83811811|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811812|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
83811813|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811814|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83811815|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
83811816|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811817|NCT00096057|Antibodies|antibodies|mesh-list
83811818|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83811819|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
83811820|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811821|NCT00227461|Levetiracetam|levetiracetam|mesh-list
83811822|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
83811823|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
83811824|NCT00227500|Pravastatin|pravastatin|mesh-list
83811825|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83811826|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83811827|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
83811828|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811829|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83811830|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83811831|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811832|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
83811833|NCT00096096|Tacrolimus|tacrolimus|mesh-list
83811834|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83811835|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
83811836|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811837|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83811838|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811839|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811840|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83811841|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811842|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83811843|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
83811844|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83811845|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811846|NCT04721899|Vitamin D|vitamin d|mesh-list
83811847|NCT04721899|Vitamins|vitamins|mesh-ancestor
83811848|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
83811849|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811850|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83811851|NCT00062972|Donepezil|donepezil|mesh-list
83811852|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83811853|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811854|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811855|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
83811856|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811857|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811858|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
83811859|NCT00227656|Interferons|interferons|mesh-list
83811860|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
83811861|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
83811862|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83811863|NCT00227656|Capecitabine|capecitabine|mesh-list
83811864|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811865|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
83811866|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811867|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811868|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
83811869|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83811870|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
83811871|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811872|NCT00227695|Rituximab|rituximab|mesh-list
83811873|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83811874|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811875|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
83811876|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811877|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83811878|NCT00227734|Capecitabine|capecitabine|mesh-list
83811879|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
83811880|NCT00227734|Cetuximab|cetuximab|mesh-list
83811881|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83811882|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
83811883|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811884|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811885|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83811886|NCT00063011|Calcium|calcium|mesh-list
83811887|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83811888|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811889|NCT00227773|Octreotide|octreotide|mesh-list
83811890|NCT00227773|Hormones|hormones|mesh-list
83811891|NCT00227773|Somatostatin|somatostatin|mesh-list
83811892|NCT00227773|Mitogens|mitogens|mesh-list
83811893|NCT00227773|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83811894|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83811895|NCT00227773|Vatalanib|vatalanib|mesh-list
83811896|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811897|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811898|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
83811899|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811900|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83811901|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83811902|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967289|NCT03744949|Narcotics|narcotics|mesh-ancestor
83811903|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83811904|NCT00227812|Bupropion|bupropion|mesh-list
83811905|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83811906|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
83811907|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811908|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83811909|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83811910|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811911|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811912|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
83811913|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811914|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811915|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83811916|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83811917|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811919|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83811920|NCT00096291|Doxorubicin|doxorubicin|mesh-list
83811921|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83811922|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83811923|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811924|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83811925|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83811926|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83811927|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811928|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83811929|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83811930|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83811931|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811932|NCT02967302|Triamcinolone|triamcinolone|mesh-list
83811933|NCT02967302|Morphine|morphine|mesh-list
83811934|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83811935|NCT02967302|Narcotics|narcotics|mesh-ancestor
83811936|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811937|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811938|NCT02967302|Analgesics|analgesics|mesh-ancestor
83811939|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
83811940|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811941|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83811942|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
83811943|NCT02967302|Hormones|hormones|mesh-ancestor
83811944|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811945|NCT00096330|Folic Acid|folic acid|mesh-list
83811946|NCT00096330|Hematinics|hematinics|mesh-ancestor
83811947|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
83811948|NCT00096330|Vitamins|vitamins|mesh-ancestor
83811949|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
83811950|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811951|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
83811952|NCT02962492|Exenatide|exenatide|mesh-list
83811953|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83811954|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811955|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83811956|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811957|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83811958|NCT02962492|Incretins|incretins|mesh-ancestor
83811959|NCT02962492|Hormones|hormones|mesh-ancestor
83811960|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811961|NCT00096369|Tamoxifen|tamoxifen|mesh-list
83811962|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83811963|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
83811964|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83811965|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811966|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83811967|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83811968|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83811969|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83811970|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83811971|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
83811972|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811973|NCT00228046|Valproic Acid|valproic acid|mesh-list
83811974|NCT00228046|Methylphenidate|methylphenidate|mesh-list
83811975|NCT00228046|Amphetamine|amphetamine|mesh-list
83811976|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
83811977|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83811978|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83811979|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83811980|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83811981|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83811982|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83811983|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
83811984|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83811985|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
83811986|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
83811987|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83811988|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
83811989|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83811990|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
83811991|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83811993|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
83811994|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83811995|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83811996|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83811997|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
83811998|NCT00063089|Antibodies|antibodies|mesh-list
83811999|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
83812000|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83812001|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83812002|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
83812003|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812004|NCT00228163|Teriflunomide|teriflunomide|mesh-list
83812005|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83812006|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83812007|NCT00228163|Analgesics|analgesics|mesh-ancestor
83812008|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
83812009|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812010|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812011|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812012|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812013|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812014|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
83812015|NCT00063128|Insulin|insulin|mesh-list
83812016|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83812017|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812018|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812019|NCT00075465|Docetaxel|docetaxel|mesh-list
83812020|NCT00075465|Epirubicin|epirubicin|mesh-list
83812021|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812022|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
83812023|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
83812024|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
83812025|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812026|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812027|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83812028|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83812029|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812030|NCT00228319|Vitamins|vitamins|mesh-list
83812031|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
83812032|NCT00228319|Vitamin E|vitamin e|mesh-list
83812033|NCT00228319|Vitamin A|vitamin a|mesh-list
83812034|NCT00228319|Carboplatin|carboplatin|mesh-list
83812035|NCT00228319|Carotenoids|carotenoids|mesh-list
83812036|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812037|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812038|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
83812039|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812040|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
83812041|NCT00228319|Protective Agents|protective agents|mesh-ancestor
83812042|NCT00096525|Lenalidomide|lenalidomide|mesh-list
83812043|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
83812044|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812045|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83812046|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83812047|NCT00096525|Growth Substances|growth substances|mesh-ancestor
83812048|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
83812049|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812050|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
83812051|NCT00228358|Interleukin-2|interleukin-2|mesh-list
83812052|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
83812053|NCT00228358|Immunotoxins|immunotoxins|mesh-list
83812054|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812055|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
83812056|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812057|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812058|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83812059|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
83812060|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812061|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812062|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83812063|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83812065|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
83812066|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812067|NCT00228358|Immunoconjugates|immunoconjugates|mesh-ancestor
83812068|NCT00228397|Temsirolimus|temsirolimus|mesh-list
83812069|NCT00228397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83812070|NCT00228397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83812071|NCT00228397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812072|NCT00228397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812073|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812074|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
83812075|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812076|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812077|NCT00075543|Docetaxel|docetaxel|mesh-list
83812078|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
83812079|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812080|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83812081|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83812082|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83812083|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812084|NCT00228475|Budesonide|budesonide|mesh-list
83812085|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812086|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83812087|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
83812088|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812089|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812090|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83812091|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
83812092|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
83812093|NCT00228475|Hormones|hormones|mesh-ancestor
83812094|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812095|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83812096|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83812097|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83812098|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
83812099|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812100|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83812101|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83812102|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812103|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
83812104|NCT00228592|Antibodies|antibodies|mesh-list
83812105|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
83812106|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83812107|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83812108|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
83812109|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812110|NCT00075621|Melphalan|melphalan|mesh-list
83812111|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
83812112|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812113|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83812114|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
83812115|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812116|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812117|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83812118|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812119|NCT00228865|Insulin|insulin|mesh-list
83812120|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83812121|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
83812122|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812123|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812124|NCT00228904|Insulin|insulin|mesh-list
83812125|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
83812126|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
83812127|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83812128|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82967516|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
83812129|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812130|NCT00228982|Vancomycin|vancomycin|mesh-list
83812131|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
83812132|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83812133|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812134|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812135|NCT00229060|Doripenem|doripenem|mesh-list
83812136|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812137|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812138|NCT00229138|Tacrolimus|tacrolimus|mesh-list
83812139|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812140|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
83812141|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812142|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83812143|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812144|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812145|NCT00063323|Bupropion|bupropion|mesh-list
83812146|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83812147|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812148|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812149|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83812150|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83812151|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812152|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812153|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
83812154|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812155|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812156|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83812157|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83812158|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812159|NCT00229216|Tinidazole|tinidazole|mesh-list
83812160|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
83812161|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812162|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812163|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812164|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83812165|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83812166|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83812167|NCT02967653|Atorvastatin|atorvastatin|mesh-list
83812168|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83812169|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83812170|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
83812171|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812172|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83812173|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83812174|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812175|NCT00229333|Escitalopram|escitalopram|mesh-list
83812176|NCT00229333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83812177|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83812178|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812179|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812180|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812181|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
83812182|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812183|NCT00229450|Estrogens|estrogens|mesh-list
83812184|NCT00229450|Hormones|hormones|mesh-ancestor
83812185|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812186|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812187|NCT00229528|Paroxetine|paroxetine|mesh-list
83812188|NCT00229528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83812189|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83812190|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812191|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812192|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812193|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
83812194|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812195|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83812196|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812197|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812198|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83812199|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83812200|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812201|NCT00075699|Vincristine|vincristine|mesh-list
83812202|NCT00075699|Vinorelbine|vinorelbine|mesh-list
83812203|NCT00075699|Mitomycins|mitomycins|mesh-list
83812204|NCT00075699|Mitomycin|mitomycin|mesh-list
83812205|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812206|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83812207|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
83812208|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
83812209|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
83812210|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812211|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812212|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
83812213|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83812214|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812215|NCT00229567|Lidocaine|lidocaine|mesh-list
83812216|NCT00229567|Ketamine|ketamine|mesh-list
83812217|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
83812218|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
83812219|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812220|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812221|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
83812222|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812223|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83812224|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83812225|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83812226|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812227|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812228|NCT00229567|Analgesics|analgesics|mesh-ancestor
83812229|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83812230|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83812231|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
83812232|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83812233|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83812234|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812235|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83812236|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812237|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812238|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83812239|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812240|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812241|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812242|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
83812243|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812244|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812245|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83812246|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83812247|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812248|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812249|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812250|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83812251|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83812252|NCT00229684|Pioglitazone|pioglitazone|mesh-list
83812253|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812254|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812255|NCT00096720|Levodopa|levodopa|mesh-list
83812256|NCT00096720|Pramipexole|pramipexole|mesh-list
83812257|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83812258|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83812259|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
83812260|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812261|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812262|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812263|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
83812264|NCT00096720|Protective Agents|protective agents|mesh-ancestor
83812265|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
83812266|NCT00413608|Clopidogrel|clopidogrel|mesh-list
83812267|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83812268|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83812269|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83812270|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83812271|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
83812272|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812273|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812274|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812275|NCT00229918|Triamcinolone|triamcinolone|mesh-list
83812276|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83812277|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83812278|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83812279|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812280|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
83812281|NCT00229918|Hormones|hormones|mesh-ancestor
83812282|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812283|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812284|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812285|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
83812286|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812287|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812288|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83812289|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83812290|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83812291|NCT00229996|Leuprolide|leuprolide|mesh-list
83812292|NCT00229996|Norethindrone|norethindrone|mesh-list
83812293|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
83812294|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
83812295|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
83812296|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83812297|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
83812298|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83812299|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812300|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83812301|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812302|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83812303|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83812304|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83812305|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83812306|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
83812307|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
83812308|NCT00230035|Rituximab|rituximab|mesh-list
83812309|NCT00230035|Methotrexate|methotrexate|mesh-list
83812310|NCT00230035|Azathioprine|azathioprine|mesh-list
83812311|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
83812312|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83812313|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83812314|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
83812315|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83812316|NCT00230035|Leflunomide|leflunomide|mesh-list
83812317|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
83812318|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83812319|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83812320|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812321|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
83812322|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812323|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83135109|NCT03263871|Micronutrients|micronutrients|mesh-list
83812324|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83812325|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
83812326|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83812327|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83812328|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
83812329|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812330|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
83812331|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812332|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83812333|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83812334|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812335|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83812336|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
83812337|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812338|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812339|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812340|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
83812341|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
83812342|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812343|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83812344|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
83812345|NCT00230035|Hormones|hormones|mesh-ancestor
83812346|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812347|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83812348|NCT00230035|Protective Agents|protective agents|mesh-ancestor
83812349|NCT00063401|Paclitaxel|paclitaxel|mesh-list
83812350|NCT00063401|Carboplatin|carboplatin|mesh-list
83812351|NCT00063401|Cetuximab|cetuximab|mesh-list
82967741|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
83812352|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83812353|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812354|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
83812355|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
83812356|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
83812357|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812358|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83812359|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
83812360|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812361|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83812362|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
83812363|NCT00230464|Vildagliptin|vildagliptin|mesh-list
83812364|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812365|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812366|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83812367|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
83812368|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812369|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812370|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
83812371|NCT00096915|Hematinics|hematinics|mesh-ancestor
83812372|NCT00230503|Adefovir|adefovir|mesh-list
83812373|NCT00230503|Pradefovir|pradefovir|mesh-list
83812374|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
83812375|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812376|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83812377|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83812378|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812379|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812380|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83812381|NCT00424723|Pemetrexed|pemetrexed|mesh-list
83812382|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812383|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812384|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812385|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83812386|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83135121|NCT03263715|Hormones|hormones|mesh-ancestor
83812387|NCT00230542|Carboplatin|carboplatin|mesh-list
83812388|NCT00230542|Pemetrexed|pemetrexed|mesh-list
83812389|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812390|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812391|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812392|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83812393|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83812394|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
83812395|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83812396|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812397|NCT00097032|Risperidone|risperidone|mesh-list
83812398|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83812399|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83812400|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
83812401|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812402|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812403|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812404|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83812405|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812406|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812407|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812408|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83812409|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
83812410|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812411|NCT02962336|Amlodipine|amlodipine|mesh-list
83812412|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83812413|NCT02962336|Olmesartan|olmesartan|mesh-list
83812414|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83812415|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83812416|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83812417|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812418|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812419|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83812420|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812421|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
83812422|NCT02962336|Diuretics|diuretics|mesh-ancestor
83812423|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
83812424|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83812425|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83812426|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83812427|NCT00075738|Leucovorin|leucovorin|mesh-list
83812428|NCT00075738|Fluorouracil|fluorouracil|mesh-list
83812429|NCT00075738|Irinotecan|irinotecan|mesh-list
83812430|NCT00075738|Calcium|calcium|mesh-list
83812431|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
83812432|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812433|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83812434|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812435|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
83812436|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812437|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83812438|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812439|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
83812440|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83812441|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83812442|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812443|NCT00075738|Antidotes|antidotes|mesh-ancestor
83812444|NCT00075738|Protective Agents|protective agents|mesh-ancestor
83812445|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
83812446|NCT00075738|Vitamins|vitamins|mesh-ancestor
83812447|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
83812448|NCT00230698|Topiramate|topiramate|mesh-list
83812449|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
83812450|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812451|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812452|NCT00230776|Pregabalin|pregabalin|mesh-list
83812453|NCT00230776|Analgesics|analgesics|mesh-ancestor
83812454|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
83812455|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812456|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812457|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
83812458|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83812459|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812460|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812461|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83812462|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83812463|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812464|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812465|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812466|NCT00075777|Valproic Acid|valproic acid|mesh-list
83812467|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
83812468|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812469|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812470|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
83812471|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812472|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812473|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
83812474|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812475|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812476|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812477|NCT02967614|Timolol|timolol|mesh-list
83812478|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83812479|NCT02967614|Dorzolamide|dorzolamide|mesh-list
83812480|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83812481|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83812482|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83812483|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812484|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812485|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812486|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83812487|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83812488|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83812489|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83812490|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83812491|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83812492|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812493|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83812494|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83812495|NCT00230815|Hormones|hormones|mesh-ancestor
83812496|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812497|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812498|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83812499|NCT00097071|Insulin|insulin|mesh-list
83812500|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83812501|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
83812502|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
83812503|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812504|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812506|NCT02967380|Antidotes|antidotes|mesh-ancestor
83812507|NCT02967380|Protective Agents|protective agents|mesh-ancestor
83812508|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812509|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
83812510|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
83812511|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812512|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83812513|NCT00075855|Testosterone|testosterone|mesh-list
83812514|NCT00075855|Androgens|androgens|mesh-ancestor
83812515|NCT00075855|Hormones|hormones|mesh-ancestor
83812516|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812517|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812518|NCT00063596|Vitamin A|vitamin a|mesh-list
83812519|NCT00063596|Vitamins|vitamins|mesh-ancestor
83812520|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
83812521|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812522|NCT00231244|Sirolimus|sirolimus|mesh-list
83812523|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812524|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812525|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812526|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812527|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
83812528|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812529|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
83812530|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812531|NCT00231322|Praziquantel|praziquantel|mesh-list
83812532|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
83812533|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83812534|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812535|NCT00231517|Morphine|morphine|mesh-list
83812536|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83812537|NCT00231517|Narcotics|narcotics|mesh-ancestor
83812538|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812539|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812540|NCT00231517|Analgesics|analgesics|mesh-ancestor
83812541|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
83812542|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812543|NCT00075894|Alanosine|alanosine|mesh-list
83812544|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812545|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812546|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
83812547|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
83812548|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812549|NCT00231556|Topiramate|topiramate|mesh-list
83812550|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
83812551|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812552|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812553|NCT00231595|Topiramate|topiramate|mesh-list
83812554|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
83812555|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812556|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812557|NCT00231634|Topiramate|topiramate|mesh-list
83812558|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
83812559|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812560|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812561|NCT00231673|Topiramate|topiramate|mesh-list
83812562|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
83812563|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812564|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812565|NCT00097188|Rituximab|rituximab|mesh-list
83812566|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83812567|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812568|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
83812569|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812570|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812571|NCT00231829|Celecoxib|celecoxib|mesh-list
83812572|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83812573|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83812574|NCT00231829|Analgesics|analgesics|mesh-ancestor
83812575|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
83812576|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812577|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967979|NCT03282240|Vaccines|vaccines|mesh-list
83812578|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812579|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812580|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83812581|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83812582|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812583|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812584|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
83812585|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812586|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83812587|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83812588|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812589|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812590|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
83812591|NCT00063713|Bortezomib|bortezomib|mesh-list
83812592|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812593|NCT00232024|Tegaserod|tegaserod|mesh-list
83812594|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83812595|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
83812596|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812597|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812598|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812599|NCT00232063|Cyclosporine|cyclosporine|mesh-list
83812600|NCT00232063|Cyclosporins|cyclosporins|mesh-list
83812601|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812602|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812603|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812604|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
83812605|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812606|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
83812607|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812608|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
83812609|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812610|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83812611|NCT00232102|Tegaserod|tegaserod|mesh-list
83812612|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83812613|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
83812614|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812615|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812616|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812617|NCT00097227|Paclitaxel|paclitaxel|mesh-list
83812618|NCT00097227|Carboplatin|carboplatin|mesh-list
83812619|NCT00097227|Cetuximab|cetuximab|mesh-list
83812620|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83812621|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812622|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83812623|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83812624|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83812625|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812626|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83812627|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83812628|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812629|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812630|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83812631|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812632|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812633|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812634|NCT00232375|Insulin|insulin|mesh-list
83812635|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83812636|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812637|NCT00063791|Bortezomib|bortezomib|mesh-list
83812638|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812639|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83812640|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812641|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812642|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83812643|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812644|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812645|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812646|NCT00232492|Ketamine|ketamine|mesh-list
83812647|NCT00232492|Analgesics|analgesics|mesh-ancestor
83812648|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
83812649|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812650|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812651|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83812652|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83812653|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
83812654|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
83812655|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812656|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83812657|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83812658|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812659|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812660|NCT00075972|Nicotine|nicotine|mesh-list
83812661|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83812662|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
83812663|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812664|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812665|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83812666|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83812667|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
83812668|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812669|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812670|NCT00063869|Etanercept|etanercept|mesh-list
83812671|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83812672|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83812673|NCT00063869|Analgesics|analgesics|mesh-ancestor
83812674|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
83812675|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812676|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812677|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812678|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812679|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83812680|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812681|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
83812682|NCT00232531|Niacin|niacin|mesh-list
83812683|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
83812684|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83812685|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
83812686|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812687|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83812688|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
83812689|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
83812690|NCT00232531|Vitamins|vitamins|mesh-ancestor
83812691|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
83812692|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812693|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83812694|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812695|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812696|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83812697|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812698|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812699|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812700|NCT00097266|Haloperidol|haloperidol|mesh-list
83812701|NCT00097266|Aripiprazole|aripiprazole|mesh-list
83812702|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
83812703|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812704|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812705|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83812706|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812707|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812708|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812709|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
83812710|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
83812711|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812712|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812713|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83812714|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83812715|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
83812716|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83812717|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83812718|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83812719|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83812720|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
83812721|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
83812722|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812723|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83812724|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83812725|NCT00063947|Gemcitabine|gemcitabine|mesh-list
83812726|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83812727|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83812728|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
83812729|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812730|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812731|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83812732|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812733|NCT00232648|Budesonide|budesonide|mesh-list
83812734|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812735|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83812736|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
83812737|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812738|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812739|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83812740|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
83812741|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
83812742|NCT00232648|Hormones|hormones|mesh-ancestor
83812743|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812744|NCT00232687|Aripiprazole|aripiprazole|mesh-list
83812745|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
83812746|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812747|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83812748|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812749|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812750|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812751|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
83812752|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
83812753|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812754|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812755|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83812756|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83812757|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
83812758|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83812759|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83812760|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83812761|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83812762|NCT00232765|Sirolimus|sirolimus|mesh-list
83812763|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812764|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812765|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812766|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812767|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
83812768|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812769|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
83812770|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812771|NCT02958566|Acetaminophen|acetaminophen|mesh-list
83812772|NCT02958566|Ketorolac|ketorolac|mesh-list
83812773|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83812774|NCT02958566|Lidocaine|lidocaine|mesh-list
83812775|NCT02958566|Fentanyl|fentanyl|mesh-list
83812776|NCT02958566|Ketamine|ketamine|mesh-list
83812777|NCT02958566|Morphine|morphine|mesh-list
83812778|NCT02958566|Gabapentin|gabapentin|mesh-list
83812779|NCT02958566|Tramadol|tramadol|mesh-list
83812780|NCT02958566|Methadone|methadone|mesh-list
83812781|NCT02958566|Hydrocodone|hydrocodone|mesh-list
83812782|NCT02958566|Hydromorphone|hydromorphone|mesh-list
83812783|NCT02958566|Orphenadrine|orphenadrine|mesh-list
83812784|NCT02958566|Bupivacaine|bupivacaine|mesh-list
83812785|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
83812786|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
83812787|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812788|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812789|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
83812790|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812791|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83135227|NCT02127775|Lesinurad|lesinurad|mesh-list
83812792|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83812793|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83812794|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812795|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812796|NCT02958566|Analgesics|analgesics|mesh-ancestor
83812797|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83812798|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83812799|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
83812800|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83812801|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83812802|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812803|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83812804|NCT02958566|Narcotics|narcotics|mesh-ancestor
83812805|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83812806|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83812807|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
83812808|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
83812809|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83812810|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83812811|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83812812|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
83812813|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83812814|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812815|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812816|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83812817|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812818|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
83812819|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
83812820|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83812821|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83812822|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83812823|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83812824|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
83812825|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
83812826|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83812827|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83812828|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
83812829|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83812830|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83812831|NCT00097344|Toremifene|toremifene|mesh-list
83812832|NCT00097344|Letrozole|letrozole|mesh-list
83812833|NCT00097344|Hormones|hormones|mesh-list
83812834|NCT00097344|Atamestane|atamestane|mesh-list
83812835|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
83812836|NCT00097344|Estrogens|estrogens|mesh-list
83812837|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
83812838|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
83812839|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812840|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812841|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812842|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83812843|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83812844|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812845|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812846|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
83812847|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83812848|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83812849|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83812850|NCT00232882|Atenolol|atenolol|mesh-list
83812851|NCT00232882|Candesartan|candesartan|mesh-list
83812852|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
83812853|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83812854|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83812855|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83812856|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83812857|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812858|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83812859|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
83812860|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
83812861|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812862|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812863|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83812864|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83812865|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83812866|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83812867|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83812868|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83812869|NCT00232882|Diuretics|diuretics|mesh-ancestor
83812870|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
83812871|NCT00064064|Gemcitabine|gemcitabine|mesh-list
83812872|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83812873|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
83812874|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812875|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812876|NCT00413686|Gemcitabine|gemcitabine|mesh-list
83812877|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83812878|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
83812879|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812880|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968273|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
83812881|NCT00233038|Ethanol|ethanol|mesh-list
83812882|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83812883|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812884|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83812885|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812886|NCT00097383|Epirubicin|epirubicin|mesh-list
83812887|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812888|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812889|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83812890|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83812891|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812892|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812893|NCT00233155|Capsaicin|capsaicin|mesh-list
83812894|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
83812895|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
83812896|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
83812897|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812898|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812899|NCT00064142|Halofuginone|halofuginone|mesh-list
83812900|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812901|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
83812902|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83812903|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83812904|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812905|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83812906|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812907|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812908|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83812909|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83812910|NCT00064142|Growth Substances|growth substances|mesh-ancestor
83812911|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812912|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
83812913|NCT00064181|Leucovorin|leucovorin|mesh-list
83812914|NCT00064181|Celecoxib|celecoxib|mesh-list
83812915|NCT00064181|Fluorouracil|fluorouracil|mesh-list
83812916|NCT00064181|Capecitabine|capecitabine|mesh-list
83812917|NCT00064181|Irinotecan|irinotecan|mesh-list
83812918|NCT00064181|Calcium|calcium|mesh-list
83812919|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
83812920|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83812921|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812922|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
83812923|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812924|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83812925|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812926|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812927|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
83812928|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83812929|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83812930|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812931|NCT00064181|Antidotes|antidotes|mesh-ancestor
83812932|NCT00064181|Protective Agents|protective agents|mesh-ancestor
83812933|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
83812934|NCT00064181|Vitamins|vitamins|mesh-ancestor
83812935|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
83812936|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83812937|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83812938|NCT00064181|Analgesics|analgesics|mesh-ancestor
83812939|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
83812940|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812941|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812942|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83812943|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83812944|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83812945|NCT00233545|Miltefosine|miltefosine|mesh-list
83812946|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
83812947|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812948|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812949|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83812950|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83812951|NCT00233584|Budesonide|budesonide|mesh-list
83812952|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83812953|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83812954|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
83812955|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83812956|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812957|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83812958|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
83812959|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
83812960|NCT00233584|Hormones|hormones|mesh-ancestor
83812961|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83812962|NCT00233623|Leucovorin|leucovorin|mesh-list
83812963|NCT00233623|Fluorouracil|fluorouracil|mesh-list
83812964|NCT00233623|Irinotecan|irinotecan|mesh-list
83812965|NCT00233623|Gefitinib|gefitinib|mesh-list
83812966|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
83812967|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812968|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83812969|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812970|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812971|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
83812972|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812973|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83812974|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83812975|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83812976|NCT00233623|Antidotes|antidotes|mesh-ancestor
83812977|NCT00233623|Protective Agents|protective agents|mesh-ancestor
83812978|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
83812979|NCT00233623|Vitamins|vitamins|mesh-ancestor
83812980|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
83812981|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83812982|NCT00233662|Alefacept|alefacept|mesh-list
83812983|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83812984|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
83812985|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812986|NCT00064220|Soblidotin|soblidotin|mesh-list
83812987|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812988|NCT00233779|Sirolimus|sirolimus|mesh-list
83812989|NCT00233779|Heparin|heparin|mesh-list
83812990|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83812991|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83812992|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83812993|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83812994|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
83812995|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83812996|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
83812997|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83812998|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83812999|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
83813000|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83813001|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83813002|NCT00233818|Sirolimus|sirolimus|mesh-list
83813003|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813004|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813005|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83813006|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813007|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
83813008|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813009|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
83813010|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813011|NCT00076206|Temsirolimus|temsirolimus|mesh-list
83813012|NCT00076206|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83813013|NCT00076206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813014|NCT00076206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813015|NCT00076206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813016|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813017|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
83813018|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813019|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813020|NCT00233896|Beclomethasone|beclomethasone|mesh-list
83813021|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813022|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
83813023|NCT00233896|Hormones|hormones|mesh-ancestor
83813024|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813025|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813026|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83813027|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
83813028|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83813029|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
83813030|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813031|NCT00233935|Protective Agents|protective agents|mesh-ancestor
83813032|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813033|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83813034|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83813035|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813036|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83813037|NCT00234091|Ritonavir|ritonavir|mesh-list
83813038|NCT00234091|Lopinavir|lopinavir|mesh-list
83813039|NCT00234091|Nelfinavir|nelfinavir|mesh-list
83813040|NCT00234091|Lamivudine|lamivudine|mesh-list
83813041|NCT00234091|Zidovudine|zidovudine|mesh-list
83813042|NCT00234091|Nevirapine|nevirapine|mesh-list
83813043|NCT00234091|Abacavir|abacavir|mesh-list
83813044|NCT00234091|Efavirenz|efavirenz|mesh-list
83813045|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83813046|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83813047|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
83813048|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813049|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813050|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83813051|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83813052|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
83813053|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813054|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83813055|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83813056|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83813057|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83813058|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
83813059|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83813060|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83813061|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83813062|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83813063|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83813064|NCT04721704|Amoxicillin|amoxicillin|mesh-list
83813065|NCT04721704|Metronidazole|metronidazole|mesh-list
83813066|NCT04721704|Clarithromycin|clarithromycin|mesh-list
83813067|NCT04721704|Omeprazole|omeprazole|mesh-list
83813068|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813069|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813070|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83813071|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83813072|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83813073|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813074|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83813075|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813076|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813077|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83813078|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83813079|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83813080|NCT00076284|Aplaviroc|aplaviroc|mesh-list
83813081|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83813082|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83813083|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813084|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83813085|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83813086|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
83813087|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813088|NCT00234403|Fulvestrant|fulvestrant|mesh-list
83813089|NCT00234403|Gefitinib|gefitinib|mesh-list
83813090|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83813091|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813092|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83813093|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83813094|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
83135278|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
83813095|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813096|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813097|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813098|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813099|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813100|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
83813101|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83813102|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83813103|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
83813104|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813105|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813106|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83813107|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
83813108|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82968502|NCT03373864|Anesthetics|anesthetics|mesh-list
83813109|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83813110|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83813111|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
83813112|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813113|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813114|NCT00234442|Gefitinib|gefitinib|mesh-list
83813115|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813116|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813117|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813118|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813119|NCT00076323|Primaquine|primaquine|mesh-list
83813120|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
83813121|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83813122|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83813123|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813124|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
83813125|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83813126|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83813127|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813128|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
83813129|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
83813130|NCT00234637|Memantine|memantine|mesh-list
83813131|NCT00234637|Rivastigmine|rivastigmine|mesh-list
83813132|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83813133|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83813134|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
83813135|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813136|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813137|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813138|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83813139|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83813140|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83813141|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813142|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
83813143|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83813144|NCT00234637|Protective Agents|protective agents|mesh-ancestor
83813145|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83813146|NCT00234676|Estrogens|estrogens|mesh-ancestor
83813147|NCT00234676|Hormones|hormones|mesh-ancestor
83813148|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813149|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813150|NCT00076362|Octreotide|octreotide|mesh-list
83813151|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813152|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83813153|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813154|NCT00234871|Verapamil|verapamil|mesh-list
83813155|NCT00234871|Amlodipine|amlodipine|mesh-list
83813156|NCT00234871|Benazepril|benazepril|mesh-list
83813157|NCT00234871|Trandolapril|trandolapril|mesh-list
83813158|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83813159|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83135313|NCT02125201|Fentanyl|fentanyl|mesh-list
83813160|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83813161|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813162|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83813163|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813164|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83813165|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83813166|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83813167|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
83813168|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813169|NCT00234910|Ritonavir|ritonavir|mesh-list
83813170|NCT00234910|Lopinavir|lopinavir|mesh-list
83813171|NCT00234910|Tenofovir|tenofovir|mesh-list
83813172|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83813173|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83813174|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
83813175|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813176|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813177|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83813178|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83813179|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
83813180|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813181|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83813182|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83813183|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83813184|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83813186|NCT00234949|Cefdinir|cefdinir|mesh-list
83813187|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813188|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813189|NCT00234988|Sibutramine|sibutramine|mesh-list
83813190|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
83813191|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813192|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
83813193|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83813194|NCT00400491|Vitamin D|vitamin d|mesh-list
83813195|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
83813196|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
83813197|NCT00400491|Vitamins|vitamins|mesh-list
83813198|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
83813199|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813200|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83813201|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83813202|NCT00235105|Adalimumab|adalimumab|mesh-list
83813203|NCT00235105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83813204|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813205|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83813206|NCT00235144|Sirolimus|sirolimus|mesh-list
83813207|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813208|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813209|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83813210|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813211|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
83813212|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813213|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
83813214|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813215|NCT00400530|Alendronate|alendronate|mesh-list
83813216|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813217|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83813218|NCT00064610|Bortezomib|bortezomib|mesh-list
83813219|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813220|NCT00235222|Stavudine|stavudine|mesh-list
83813221|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
83813222|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813223|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83813224|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83813225|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813226|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
83813227|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813228|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83813229|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83813230|NCT00235261|Dexamethasone|dexamethasone|mesh-list
83813231|NCT00235261|Pregabalin|pregabalin|mesh-list
83813232|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813233|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
83813234|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
83813235|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813236|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813237|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813238|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
83813239|NCT00235261|Hormones|hormones|mesh-ancestor
83813240|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813241|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83813242|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813243|NCT00235261|Analgesics|analgesics|mesh-ancestor
83813244|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
83813245|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
83813246|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83813247|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83813248|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813249|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83813250|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83813251|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813252|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813253|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813254|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
83813255|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83813256|NCT00235300|Basiliximab|basiliximab|mesh-list
83813257|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
83813258|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813259|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813260|NCT00064649|Finasteride|finasteride|mesh-list
83813261|NCT00064649|Alfuzosin|alfuzosin|mesh-list
82968652|NCT01178645|Cytarabine|cytarabine|mesh-list
83813262|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83813263|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83813264|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813265|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813266|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
83813267|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813268|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813269|NCT00064649|Urological Agents|urological agents|mesh-ancestor
83813270|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83813271|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83813272|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83813273|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83813274|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813275|NCT00097734|Ertapenem|ertapenem|mesh-list
83813276|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813277|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813278|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
83813279|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813280|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813281|NCT00235651|Amphotericin B|amphotericin b|mesh-list
83813282|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83813283|NCT00235651|Amebicides|amebicides|mesh-ancestor
83813284|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83813285|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83813286|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813287|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813288|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
83813289|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
83813290|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83813291|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813292|NCT00064766|Doxycycline|doxycycline|mesh-list
83813293|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813294|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813295|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
83813296|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83813297|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83813298|NCT00235729|Lofexidine|lofexidine|mesh-list
83813299|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83813300|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83813301|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813302|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
83813303|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813304|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83813305|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83813306|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83813307|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
83813308|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813309|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813310|NCT00235885|Adalimumab|adalimumab|mesh-list
83813311|NCT00235885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83813312|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813313|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83813314|NCT04728750|Pancrelipase|pancrelipase|mesh-list
83813315|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813316|NCT00235963|Simvastatin|simvastatin|mesh-list
83813317|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83813318|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83813319|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
83813320|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813321|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83813322|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83813323|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813324|NCT00236002|Alendronate|alendronate|mesh-list
83813325|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83813326|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813327|NCT00414037|Eszopiclone|eszopiclone|mesh-list
83813328|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83813329|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813330|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813331|NCT00236275|Telbivudine|telbivudine|mesh-list
83813332|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
83813333|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813334|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82968727|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83813335|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813336|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813337|NCT00236353|Risperidone|risperidone|mesh-list
83813338|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83813339|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
83813340|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813341|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813342|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813343|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83813344|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813345|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813346|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813347|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83813348|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
83813349|NCT00236392|Rabeprazole|rabeprazole|mesh-list
83813350|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83813351|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813352|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83813353|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813354|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813355|NCT00236431|Galantamine|galantamine|mesh-list
83813356|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83813357|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813358|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813359|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
83813360|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813361|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813362|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83813363|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
83813364|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813365|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
83813366|NCT00097929|Vorinostat|vorinostat|mesh-list
83813367|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813368|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83813369|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813370|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813371|NCT00236470|Risperidone|risperidone|mesh-list
83813372|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83813373|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
83813374|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813375|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813376|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813377|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83813378|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813379|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813380|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813381|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83813382|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
83813383|NCT00236509|Topiramate|topiramate|mesh-list
83813384|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
83813385|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813386|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813387|NCT02962141|Paclitaxel|paclitaxel|mesh-list
83813388|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83813389|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813390|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
83813391|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
83813392|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
83813393|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813394|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
83813395|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813396|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83813397|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
83135357|NCT02128243|Leucovorin|leucovorin|mesh-list
83813398|NCT00236548|Risperidone|risperidone|mesh-list
83813399|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83813400|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
83813401|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813402|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813403|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813404|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83813405|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813406|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813407|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813408|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83813409|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
82968801|NCT03372304|Ropivacaine|ropivacaine|mesh-list
83813411|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83813412|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
83813413|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813414|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813415|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813416|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83813417|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813418|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813419|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813420|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83813421|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
83813422|NCT00236626|Topiramate|topiramate|mesh-list
83813423|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
83813424|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813425|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813426|NCT00236665|Topiramate|topiramate|mesh-list
83813427|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
83813428|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813429|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813430|NCT00399282|Vitamin E|vitamin e|mesh-list
83813431|NCT00399282|Vitamins|vitamins|mesh-ancestor
83813432|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
83813433|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813434|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
83813435|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813436|NCT00399282|Protective Agents|protective agents|mesh-ancestor
83813437|NCT00236704|Topiramate|topiramate|mesh-list
83813438|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
83813439|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813440|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813441|NCT00236743|Topiramate|topiramate|mesh-list
83813442|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
83813443|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813444|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813445|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83813446|NCT00236782|Norelgestromin|norelgestromin|mesh-list
83813447|NCT00236782|Estradiol|estradiol|mesh-list
83813448|NCT00236782|Estrogens|estrogens|mesh-ancestor
83813449|NCT00236782|Hormones|hormones|mesh-ancestor
83813450|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813451|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813452|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83813453|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
83813454|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83813455|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83813456|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83813457|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83813458|NCT00097968|Everolimus|everolimus|mesh-list
83813459|NCT00097968|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83813460|NCT00097968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813461|NCT00097968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813462|NCT00097968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813463|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813464|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
83813465|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813466|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813467|NCT00236821|Levofloxacin|levofloxacin|mesh-list
83813468|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83813469|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813470|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813471|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83813472|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83813473|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813474|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813475|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813476|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83813477|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83813478|NCT00236860|Topiramate|topiramate|mesh-list
83813479|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
83813480|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813481|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813482|NCT00065117|Leucovorin|leucovorin|mesh-list
82968875|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83813483|NCT00065117|Fluorouracil|fluorouracil|mesh-list
83813484|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
83813485|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
83813486|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813487|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83813488|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813489|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813490|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
83813491|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813492|NCT00065117|Antidotes|antidotes|mesh-ancestor
83813493|NCT00065117|Protective Agents|protective agents|mesh-ancestor
83813494|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
83813495|NCT00065117|Vitamins|vitamins|mesh-ancestor
83813496|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
83813497|NCT00237016|Doxycycline|doxycycline|mesh-list
83813498|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813499|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813500|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
83813501|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83813502|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83813503|NCT00237133|Letrozole|letrozole|mesh-list
83813504|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813505|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83813506|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83813507|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813508|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813509|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83813510|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
83813511|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813512|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813513|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
83813514|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813515|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813516|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813517|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813518|NCT00237211|Letrozole|letrozole|mesh-list
83813519|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813520|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83813521|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83813522|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813523|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813524|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83813525|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
83813526|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813527|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813528|NCT00098007|Everolimus|everolimus|mesh-list
83813529|NCT00098007|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83813530|NCT00098007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813531|NCT00098007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813532|NCT00098007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813533|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813534|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
83813535|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813536|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813537|NCT00237250|Vildagliptin|vildagliptin|mesh-list
83813538|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813539|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813540|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83813541|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
83813542|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813543|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813544|NCT00237289|Topiramate|topiramate|mesh-list
83813545|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
83813546|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813547|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813548|NCT00237328|Heparin|heparin|mesh-list
83813549|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
83813550|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83813551|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83813552|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813553|NCT00237367|Rabeprazole|rabeprazole|mesh-list
83813554|NCT00237367|Pantoprazole|pantoprazole|mesh-list
83813555|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83813556|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813557|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83813558|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813559|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813560|NCT00098046|Famciclovir|famciclovir|mesh-list
83813562|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813563|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83813564|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813565|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813566|NCT00065273|Olanzapine|olanzapine|mesh-list
83813567|NCT00065273|Risperidone|risperidone|mesh-list
83813568|NCT00065273|Clozapine|clozapine|mesh-list
83813569|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83813570|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
83813571|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813572|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813573|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813574|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83813575|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813576|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813577|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813578|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83813579|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
83813580|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
83813581|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
83813582|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813583|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813584|NCT00065273|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83813585|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83813586|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83813587|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
83813588|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
83813589|NCT00237445|Azithromycin|azithromycin|mesh-list
83813590|NCT00237445|Telithromycin|telithromycin|mesh-list
83813591|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813592|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813593|NCT00237484|Interferons|interferons|mesh-list
83813594|NCT00237484|Ribavirin|ribavirin|mesh-list
83813595|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
83813596|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
83813597|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83813598|NCT00237484|Infliximab|infliximab|mesh-list
83813599|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813600|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
83813601|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813602|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
83813603|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813604|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
83813605|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813606|NCT00237484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83813607|NCT00237484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813608|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83813609|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813610|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83813611|NCT00237523|Iodine|iodine|mesh-list
83813612|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
83813613|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83813614|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813615|NCT00237523|Trace Elements|trace elements|mesh-ancestor
83813616|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
83813617|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813618|NCT00098124|Milnacipran|milnacipran|mesh-list
83813619|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
83813620|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83813621|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83813622|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83813623|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813624|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813625|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813626|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83813627|NCT00098124|Analgesics|analgesics|mesh-ancestor
83813628|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
83813629|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813630|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
83813631|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813632|NCT04710160|Calcium|calcium|mesh-list
83813633|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83813634|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969025|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813635|NCT00065351|Lenalidomide|lenalidomide|mesh-list
83813636|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
83813637|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813638|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83813639|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83813640|NCT00065351|Growth Substances|growth substances|mesh-ancestor
83813641|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
83813642|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813644|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813645|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
83813646|NCT04709770|Emollients|emollients|mesh-ancestor
83813647|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
83813648|NCT04709731|Ponatinib|ponatinib|mesh-list
83813649|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813650|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813651|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813652|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813653|NCT00398684|Nevirapine|nevirapine|mesh-list
83813654|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83813655|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83813656|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813657|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813658|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
83813659|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813660|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83813661|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83813662|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83813663|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83813664|NCT00076440|Leuprolide|leuprolide|mesh-list
83813665|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83813666|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
83813667|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83813668|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813669|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83813670|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813671|NCT00237874|Aripiprazole|aripiprazole|mesh-list
83813672|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
83813673|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813674|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83813675|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813676|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813677|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813678|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
83813679|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
83813680|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813681|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813682|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83813683|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83813684|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
83813685|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83813686|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83813687|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83813688|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83813689|NCT00237913|Olanzapine|olanzapine|mesh-list
83813690|NCT00237913|Risperidone|risperidone|mesh-list
83813691|NCT00237913|Aripiprazole|aripiprazole|mesh-list
83813692|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83813693|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83813694|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
83813695|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813696|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813697|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813698|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83813699|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83813700|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813701|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83813702|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83813703|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
83813704|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
83813705|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
83813706|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813707|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813708|NCT00237913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83813709|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83813711|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
83813712|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
83813713|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83813714|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83813715|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83813716|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83813717|NCT00237952|Chelating Agents|chelating agents|mesh-list
83813718|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
83813719|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813720|NCT00098241|Everolimus|everolimus|mesh-list
83813721|NCT00098241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83813722|NCT00098241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813723|NCT00098241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813724|NCT00098241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813725|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813726|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
83813727|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813728|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813729|NCT04721119|Anesthetics|anesthetics|mesh-list
83813730|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83813731|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813732|NCT00238147|Carboplatin|carboplatin|mesh-list
83813733|NCT00238147|Docetaxel|docetaxel|mesh-list
83813734|NCT00238147|Capecitabine|capecitabine|mesh-list
83813735|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813736|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
83813737|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
83813738|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
83813739|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813740|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83813741|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
83813742|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
83813743|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
83813744|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83813745|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83813746|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813747|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83813748|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813749|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813750|NCT00238225|Calcitriol|calcitriol|mesh-list
83813751|NCT00238225|Ketoconazole|ketoconazole|mesh-list
83813752|NCT00238225|Dexamethasone|dexamethasone|mesh-list
83813753|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813754|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
83813755|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
83813756|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813757|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813758|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813759|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
83813760|NCT00238225|Hormones|hormones|mesh-ancestor
83813761|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813762|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83813763|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813764|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
83813765|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813766|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83813767|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83813768|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813769|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813770|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83813771|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
83813772|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83813773|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83813774|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83813775|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83813776|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83813777|NCT00238225|Vitamins|vitamins|mesh-ancestor
83813778|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
83813779|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83813780|NCT00076518|Fenofibrate|fenofibrate|mesh-list
83813781|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83813782|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
82969178|NCT03370588|Analgesics|analgesics|mesh-ancestor
83813783|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813784|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83813785|NCT00065546|Choline|choline|mesh-list
83813786|NCT00065546|Estrogens|estrogens|mesh-list
83813787|NCT00065546|Hormones|hormones|mesh-ancestor
83813788|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813789|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813790|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
83813791|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83813792|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
83813793|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813794|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83813795|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83813796|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
83813797|NCT00098280|Eculizumab|eculizumab|mesh-list
83813798|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83813799|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83813800|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
83813801|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813802|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83813803|NCT00238459|Vaccines|vaccines|mesh-list
83813804|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
83813805|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813806|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
83813807|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813808|NCT00238498|Vildagliptin|vildagliptin|mesh-list
83813809|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83813810|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813811|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83813812|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
83813813|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813814|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813815|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83813816|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83813817|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83813818|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813819|NCT00098319|Folic Acid|folic acid|mesh-list
83813820|NCT00098319|Hematinics|hematinics|mesh-ancestor
83813821|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
83813822|NCT00098319|Vitamins|vitamins|mesh-ancestor
83813823|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
83813824|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813825|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
83813826|NCT00238732|Estrogens|estrogens|mesh-list
83813827|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83813828|NCT00238732|Hormones|hormones|mesh-ancestor
83813829|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813830|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813831|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83813832|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83813833|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
83813834|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83813835|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
83813836|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813837|NCT00238927|Fluticasone|fluticasone|mesh-list
83813838|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813839|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83813840|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
83135424|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
83813841|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813842|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813843|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83813844|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83813845|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
83813846|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83813847|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
83813848|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
83813849|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813850|NCT00065624|Protective Agents|protective agents|mesh-ancestor
83813851|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813852|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
83813853|NCT00065624|Vitamins|vitamins|mesh-ancestor
83813854|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
83813855|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
83813856|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83813857|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969253|NCT03359746|Grazoprevir|grazoprevir|mesh-list
83813858|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83813859|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
83813860|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813861|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813862|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813863|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813864|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
83813865|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83813866|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813867|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83813868|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
83813869|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813870|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813871|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813872|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813874|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83813875|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83813876|NCT00098358|Analgesics|analgesics|mesh-ancestor
83813877|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
83813878|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813879|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813880|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813881|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83813882|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83813883|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813884|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813885|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83813886|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
83813887|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813888|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
83813889|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83813890|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813891|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83813892|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
83813893|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813894|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813895|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813896|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813897|NCT00239161|Levofloxacin|levofloxacin|mesh-list
83813898|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83813899|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813900|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83813901|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83813902|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83813903|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813904|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813905|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813906|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83813907|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83813908|NCT00239200|Lapatinib|lapatinib|mesh-list
83813909|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813910|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83813911|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813912|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813913|NCT02961829|Niacinamide|niacinamide|mesh-list
83813914|NCT02961829|Dolutegravir|dolutegravir|mesh-list
83813915|NCT02961829|Maraviroc|maraviroc|mesh-list
83813916|NCT02961829|Auranofin|auranofin|mesh-list
83813917|NCT02961829|Vaccines|vaccines|mesh-list
83813918|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83813919|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
83813920|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813921|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83813922|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83813923|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813924|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969328|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969329|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813925|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83813926|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83813927|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
83813928|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813929|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83813930|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83813931|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83813932|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
83813933|NCT02961829|Vitamins|vitamins|mesh-ancestor
83813934|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
83813935|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83813936|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
83813937|NCT00239239|Hematinics|hematinics|mesh-ancestor
83813938|NCT00414349|Analgesics|analgesics|mesh-list
83813939|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
83813940|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813941|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813942|NCT00065741|Silymarin|silymarin|mesh-list
83813943|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
83813944|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813945|NCT00065741|Protective Agents|protective agents|mesh-ancestor
83813946|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813947|NCT00098397|Romidepsin|romidepsin|mesh-list
83813948|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83813949|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813950|NCT00098397|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83813951|NCT00098397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813952|NCT00098397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813953|NCT00239278|Prednisolone|prednisolone|mesh-list
83813954|NCT00239278|Budesonide|budesonide|mesh-list
83813955|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
83813956|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813957|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
83813958|NCT00239278|Hormones|hormones|mesh-ancestor
83813959|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83813960|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813961|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83813962|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813963|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
83813964|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813965|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83813966|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83813967|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83813968|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83813969|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83813970|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83813971|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
83813972|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83813973|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813974|NCT00239395|Meloxicam|meloxicam|mesh-list
83813975|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83813976|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83813977|NCT00239395|Analgesics|analgesics|mesh-ancestor
83813978|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
83813979|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813980|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813981|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83813982|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83813983|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83813984|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83813985|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83813986|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83813987|NCT00076635|Interferons|interferons|mesh-list
83813988|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
83813989|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83813990|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
83813991|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83813992|NCT00239434|Bromides|bromides|mesh-list
83813993|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
83813994|NCT00239434|Ipratropium|ipratropium|mesh-list
83813995|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83813996|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
83813997|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83813998|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83813999|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83814000|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83814001|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
83814002|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83814003|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
83814004|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814005|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814006|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
83814007|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83814008|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
83814009|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83814010|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
83814011|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814012|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814013|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83814014|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
83814015|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
83814016|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83814017|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
83814018|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814019|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814020|NCT00239512|Ibuprofen|ibuprofen|mesh-list
83814021|NCT00239512|Indomethacin|indomethacin|mesh-list
83135467|NCT02126137|Ezetimibe|ezetimibe|mesh-list
83814022|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83814023|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83814024|NCT00239512|Analgesics|analgesics|mesh-ancestor
83814025|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
83814026|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814027|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814028|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83814029|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814030|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83814031|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814032|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814033|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
83814034|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
83814035|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83814036|NCT00076674|Levodopa|levodopa|mesh-list
83814037|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83814038|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83814039|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
83814040|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814041|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814042|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814043|NCT00239551|Lansoprazole|lansoprazole|mesh-list
83814044|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83814045|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814046|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83814047|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814048|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814049|NCT00239629|Teriparatide|teriparatide|mesh-list
83814050|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
83814051|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83814052|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814053|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83814054|NCT00098436|Temozolomide|temozolomide|mesh-list
83814055|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83814056|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
83814057|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814058|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814059|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83814060|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814061|NCT00239707|Incretins|incretins|mesh-ancestor
83814062|NCT00239707|Hormones|hormones|mesh-ancestor
83814063|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814064|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814065|NCT00239746|Ibuprofen|ibuprofen|mesh-list
83814066|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83814067|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83814068|NCT00239746|Analgesics|analgesics|mesh-ancestor
83814069|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
83814070|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814071|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814072|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83814073|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814074|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83814075|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814076|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814077|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83814078|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83814079|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814080|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814081|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
83814082|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814083|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83814084|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83814085|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814086|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814087|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
83814088|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814089|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83814090|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83814091|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814092|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814093|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
83814094|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814095|NCT00239980|Dalteparin|dalteparin|mesh-list
83814096|NCT00239980|Tinzaparin|tinzaparin|mesh-list
83814097|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83814098|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
83814099|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83814100|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83814101|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814102|NCT00240019|Furosemide|furosemide|mesh-list
83814103|NCT00240019|Diuretics|diuretics|mesh-ancestor
83814104|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
83814105|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814106|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83814107|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83814108|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814109|NCT00240058|Phenylephrine|phenylephrine|mesh-list
83814110|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
83814111|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
83814112|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83814113|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
83814114|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
83814115|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814116|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814117|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
83814118|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83814119|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
83814120|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
83814121|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83814122|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83814123|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83814124|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
83814125|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814126|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814127|NCT00240058|Protective Agents|protective agents|mesh-ancestor
83814128|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83814129|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83814130|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83814131|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
83814132|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83814133|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
83814134|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
83814135|NCT00098553|Everolimus|everolimus|mesh-list
83814136|NCT00098553|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83814137|NCT00098553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814138|NCT00098553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814139|NCT00098553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814140|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814141|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
83814142|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814143|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814144|NCT00240214|Sirolimus|sirolimus|mesh-list
83814145|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814146|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814147|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814148|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814149|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
83814150|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814151|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
83814152|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814153|NCT00240253|Pramlintide|pramlintide|mesh-list
83814154|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814155|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814156|NCT00065936|Naltrexone|naltrexone|mesh-list
83814157|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83814158|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83814159|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814160|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
83814161|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814162|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83814163|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83814164|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83814165|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
83814166|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814167|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83814168|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83814169|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814170|NCT00240409|Pramipexole|pramipexole|mesh-list
83814171|NCT00240409|Bromocriptine|bromocriptine|mesh-list
83814172|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
83814173|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814174|NCT00240409|Protective Agents|protective agents|mesh-ancestor
83814175|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814176|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83814177|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83814178|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
83814179|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
83814180|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814181|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
83814182|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814183|NCT00240448|Valsartan|valsartan|mesh-list
83814184|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83814185|NCT00240448|Telmisartan|telmisartan|mesh-list
83814186|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83814187|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83814188|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83814189|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814190|NCT00240448|Diuretics|diuretics|mesh-ancestor
83814191|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
83814192|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814193|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83814194|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83814195|NCT00098631|Lapatinib|lapatinib|mesh-list
83814196|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814197|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814198|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814199|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814200|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
83814201|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814202|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814203|NCT00076791|Tenofovir|tenofovir|mesh-list
83814204|NCT00076791|Emtricitabine|emtricitabine|mesh-list
83814205|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83814206|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
83814207|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814208|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83814209|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83814210|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814211|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814212|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83814213|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83814214|NCT00240682|Cetuximab|cetuximab|mesh-list
83814215|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83814216|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814217|NCT00240721|Topiramate|topiramate|mesh-list
83814218|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
83814219|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814220|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814221|NCT00240760|Memantine|memantine|mesh-list
83814222|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83814223|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83814224|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
83814225|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814226|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814227|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814228|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83814229|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83814230|NCT00066092|Lenograstim|lenograstim|mesh-list
83814231|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83814232|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
83814233|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814234|NCT04720807|Letrozole|letrozole|mesh-list
83814235|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814236|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83814237|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83814238|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814239|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814240|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83814241|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
83814242|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814243|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814244|NCT00240799|Acetaminophen|acetaminophen|mesh-list
83814245|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83814246|NCT00240799|Analgesics|analgesics|mesh-ancestor
83814247|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
83814248|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814249|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814250|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
83814251|NCT00240838|Acetaminophen|acetaminophen|mesh-list
83814252|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83814253|NCT00240838|Analgesics|analgesics|mesh-ancestor
83814254|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
83814255|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814256|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814257|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
83814258|NCT02965404|Vaccines|vaccines|mesh-list
83814259|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
83814260|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814261|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
83814262|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814263|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814264|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83814265|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
83814266|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814267|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814268|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814269|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814270|NCT00241072|Valsartan|valsartan|mesh-list
83814271|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83814272|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83814273|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83814274|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814275|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
83814276|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83814277|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814278|NCT00241150|Valsartan|valsartan|mesh-list
83814279|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83814280|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83814281|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83814282|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814283|NCT00076869|Amphotericin B|amphotericin b|mesh-list
83814284|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83814285|NCT00076869|Caspofungin|caspofungin|mesh-list
83814286|NCT00076869|Amebicides|amebicides|mesh-ancestor
83814287|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83814288|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83814289|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814290|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814291|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
83814292|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814293|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814294|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
83814295|NCT00066248|Megestrol|megestrol|mesh-list
83814296|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
83814297|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83814298|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83814299|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83814300|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
83814301|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83814302|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814303|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83814304|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83814305|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83814306|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814307|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
83814308|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83814309|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
83814310|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
83814311|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814312|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83814313|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
83814314|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
83814315|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135526|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
83814316|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814317|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83814318|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
83814319|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83814320|NCT00241189|Sirolimus|sirolimus|mesh-list
83814321|NCT00241189|Methotrexate|methotrexate|mesh-list
83814322|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83814323|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
83814324|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83814325|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814326|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83814327|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
83814328|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814329|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814330|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83814331|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814332|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83814333|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814334|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
83814335|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814336|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83814337|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814338|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814339|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814340|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
83814341|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
83814342|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814343|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814344|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814345|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814346|NCT00241345|Valganciclovir|valganciclovir|mesh-list
83814347|NCT00241345|Ganciclovir|ganciclovir|mesh-list
83814348|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83814349|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
83814350|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814351|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83814352|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814353|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814354|NCT00241423|Exenatide|exenatide|mesh-list
83814355|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814356|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814357|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83814358|NCT00241423|Incretins|incretins|mesh-ancestor
83814359|NCT00241423|Hormones|hormones|mesh-ancestor
83814360|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814361|NCT00241501|Esomeprazole|esomeprazole|mesh-list
83814362|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83814363|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814364|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83814365|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814366|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814367|NCT00076986|Carmustine|carmustine|mesh-list
83814368|NCT00076986|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83814369|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83814370|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
83814371|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814372|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814373|NCT00241540|Esomeprazole|esomeprazole|mesh-list
83814374|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83814375|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814376|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83814377|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814378|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814379|NCT00066443|Docetaxel|docetaxel|mesh-list
83814380|NCT00066443|Epirubicin|epirubicin|mesh-list
83814381|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814382|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
83814383|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
83814384|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83814385|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814386|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814387|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83814388|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83814389|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814390|NCT00098982|Leucovorin|leucovorin|mesh-list
83814391|NCT00098982|Fluorouracil|fluorouracil|mesh-list
83814392|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
83814393|NCT00098982|Bortezomib|bortezomib|mesh-list
83814394|NCT00098982|Calcium|calcium|mesh-list
83814395|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
83814396|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83814397|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814398|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
83814399|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814400|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83814401|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814402|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814403|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
83814404|NCT00098982|Antidotes|antidotes|mesh-ancestor
83814405|NCT00098982|Protective Agents|protective agents|mesh-ancestor
83814406|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
83814407|NCT00098982|Vitamins|vitamins|mesh-ancestor
83814408|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
83814409|NCT00241618|Interferons|interferons|mesh-list
83814410|NCT00241618|Ribavirin|ribavirin|mesh-list
83814411|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
83814412|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
83814413|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814414|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
83814415|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814416|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
83814417|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814418|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
83814419|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814420|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
83814421|NCT00066482|Cisplatin|cisplatin|mesh-list
83814422|NCT00066482|Etoposide|etoposide|mesh-list
83814423|NCT00066482|Bleomycin|bleomycin|mesh-list
83814424|NCT00066482|Lenograstim|lenograstim|mesh-list
83814425|NCT00066482|Mesna|mesna|mesh-list
83814426|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814427|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
83814428|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814429|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814430|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83814431|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
83814432|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814433|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814434|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83814435|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83814436|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83814437|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83814438|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814439|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83814440|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814441|NCT00066482|Protective Agents|protective agents|mesh-ancestor
83814442|NCT00099060|Lapatinib|lapatinib|mesh-list
83814443|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814444|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814445|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135557|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83814446|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814447|NCT00066599|Voriconazole|voriconazole|mesh-list
83814448|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
83814449|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814450|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83814451|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83814452|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814453|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814454|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83814455|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
83814456|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814457|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814458|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83814459|NCT00242008|Rotigotine|rotigotine|mesh-list
83814460|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
83814461|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
83814462|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814463|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814464|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814465|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
83814466|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83814467|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
83814468|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
83814469|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83814470|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814471|NCT02962024|Morphine|morphine|mesh-list
83814472|NCT02962024|Bupivacaine|bupivacaine|mesh-list
83814473|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
83814474|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
83814475|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83814476|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814477|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
83814478|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814479|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83814480|NCT02962024|Narcotics|narcotics|mesh-ancestor
83814481|NCT02962024|Analgesics|analgesics|mesh-ancestor
83814482|NCT00066638|Romidepsin|romidepsin|mesh-list
83814483|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814484|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814485|NCT00066638|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83814486|NCT00066638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814487|NCT00066638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814488|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
83814489|NCT00242203|Docetaxel|docetaxel|mesh-list
83814490|NCT00242203|Trastuzumab|trastuzumab|mesh-list
83814491|NCT00242203|Epirubicin|epirubicin|mesh-list
83814492|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814493|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
83814494|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
83814495|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
83814496|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814497|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83814498|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814499|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83814500|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83814501|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814502|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83814503|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814504|NCT00077025|Gefitinib|gefitinib|mesh-list
83814505|NCT00077025|Anastrozole|anastrozole|mesh-list
83814506|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814507|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814508|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814509|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135567|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
83814510|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83814511|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83814512|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83814513|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83814514|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
83814515|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814516|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814517|NCT00242359|Omalizumab|omalizumab|mesh-list
83814518|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83814519|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83814520|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
83814521|NCT00066716|Celecoxib|celecoxib|mesh-list
83814522|NCT00066716|Paclitaxel|paclitaxel|mesh-list
83814523|NCT00066716|Carboplatin|carboplatin|mesh-list
83814524|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83814525|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814526|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
83814527|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
83814528|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
83814529|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814530|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83814531|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83814532|NCT00066716|Analgesics|analgesics|mesh-ancestor
83814533|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
83814534|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814535|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814536|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83814537|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814538|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83814539|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83814540|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814541|NCT00077103|Doxorubicin|doxorubicin|mesh-list
83814542|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83814543|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
83814544|NCT00077103|Combretastatin|combretastatin|mesh-list
83814545|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814546|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814547|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83814548|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83814549|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814550|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814551|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83814552|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
83814553|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
83814554|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
83814555|NCT00242437|Thrombin|thrombin|mesh-list
83814556|NCT00242437|Hemostatics|hemostatics|mesh-list
83814557|NCT00242437|Coagulants|coagulants|mesh-ancestor
83814558|NCT00066794|Cytarabine|cytarabine|mesh-list
83814559|NCT00066794|Cyclosporine|cyclosporine|mesh-list
83814560|NCT00066794|Daunorubicin|daunorubicin|mesh-list
83814561|NCT00066794|Cyclosporins|cyclosporins|mesh-list
83814562|NCT00066794|Sargramostim|sargramostim|mesh-list
83814563|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83814564|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
83814565|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814566|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814567|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
83814568|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814569|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814570|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
83814571|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814572|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814573|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
83814574|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
83814575|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814576|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83814577|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814578|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83814579|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83814580|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
83814581|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83814582|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814583|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
83814584|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814585|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814586|NCT00242749|Gefitinib|gefitinib|mesh-list
83814587|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814588|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814589|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814590|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814591|NCT00242788|Capecitabine|capecitabine|mesh-list
83814592|NCT00242788|Gefitinib|gefitinib|mesh-list
83814593|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83814594|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
83814595|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814596|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814597|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814598|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814599|NCT00066872|Imiquimod|imiquimod|mesh-list
83814600|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83814601|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
83814602|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814603|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814605|NCT00242944|Atorvastatin|atorvastatin|mesh-list
83814606|NCT00242944|Pitavastatin|pitavastatin|mesh-list
83814607|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83814608|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83814609|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
83814610|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814611|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83814612|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83814613|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814614|NCT00243100|Gemcitabine|gemcitabine|mesh-list
83814615|NCT00243100|Vorinostat|vorinostat|mesh-list
83814616|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83814617|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
83814618|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814619|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814620|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83814621|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814622|NCT00099216|Rivastigmine|rivastigmine|mesh-list
83814623|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83814624|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814625|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814626|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
83814627|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814628|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814629|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83814630|NCT00099216|Protective Agents|protective agents|mesh-ancestor
83814631|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
83814632|NCT00066989|Antibodies|antibodies|mesh-list
83814633|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
83814634|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83814635|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83814636|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
83814637|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814638|NCT00243178|Clopidogrel|clopidogrel|mesh-list
83814639|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83814640|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83814641|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83814642|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83814643|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
83814644|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814645|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814646|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814647|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
83814648|NCT00243256|Vitamin D|vitamin d|mesh-list
83814649|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83814650|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814651|NCT00243256|Vitamins|vitamins|mesh-ancestor
83814652|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
83814653|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83814654|NCT00243646|Bicalutamide|bicalutamide|mesh-list
83814655|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814656|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814657|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
83814658|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83814659|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814660|NCT00099333|Exenatide|exenatide|mesh-list
83814661|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814662|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814663|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83814664|NCT00099333|Incretins|incretins|mesh-ancestor
83814665|NCT00099333|Hormones|hormones|mesh-ancestor
83814666|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814667|NCT00243724|Esomeprazole|esomeprazole|mesh-list
83814668|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83814669|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814670|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83814671|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814672|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814673|NCT00243880|Lovastatin|lovastatin|mesh-list
83814674|NCT00243880|L 647318|l 647318|mesh-list
83814675|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
83814676|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83814677|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83814678|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
83814679|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814680|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83814681|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83814682|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814684|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814685|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814686|NCT00244153|Dexamethasone|dexamethasone|mesh-list
83814687|NCT00244153|Morphine|morphine|mesh-list
83814688|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83814689|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
83814690|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
83814691|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814692|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814693|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814694|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
83814695|NCT00244153|Hormones|hormones|mesh-ancestor
83814696|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814697|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83814698|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814699|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83814700|NCT00244153|Narcotics|narcotics|mesh-ancestor
83814701|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83814702|NCT00244153|Analgesics|analgesics|mesh-ancestor
83814703|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
83814704|NCT02967029|Remifentanil|remifentanil|mesh-list
83814705|NCT02967029|Esmolol|esmolol|mesh-list
83814706|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83814707|NCT02967029|Narcotics|narcotics|mesh-ancestor
83814708|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83814709|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814710|NCT02967029|Analgesics|analgesics|mesh-ancestor
83814711|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
83814712|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814713|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83814714|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83814715|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83814716|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
83814717|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814718|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814719|NCT00244192|Infliximab|infliximab|mesh-list
83814720|NCT00244192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83814721|NCT00244192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83814722|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
83814723|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814724|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814725|NCT00077181|Cytarabine|cytarabine|mesh-list
83814726|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83814727|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
83814728|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814729|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814730|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
83814731|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814732|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814733|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
83814734|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814735|NCT00244309|Tamsulosin|tamsulosin|mesh-list
83814736|NCT00244309|Dutasteride|dutasteride|mesh-list
83814737|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83814738|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83814739|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83814740|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
83814741|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814742|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814743|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814744|NCT00244309|Urological Agents|urological agents|mesh-ancestor
83814745|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83814746|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83814747|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814748|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
83814749|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814750|NCT00244348|Fluorouracil|fluorouracil|mesh-list
83814751|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
82970158|NCT03636477|Nivolumab|nivolumab|mesh-list
83814752|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
83814753|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814754|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83814755|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814756|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814757|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
83814758|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814759|NCT00077220|Paclitaxel|paclitaxel|mesh-list
83814760|NCT00077220|Carboplatin|carboplatin|mesh-list
83135621|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
83814761|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83814762|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814763|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
83814764|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
83814765|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
83814766|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814767|NCT00244426|Aspirin|aspirin|mesh-list
83814768|NCT00244426|Indobufen|indobufen|mesh-list
83814769|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83814770|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83814771|NCT00244426|Analgesics|analgesics|mesh-ancestor
83814772|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
83814773|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814774|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814775|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83814776|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814777|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83814778|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83814779|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814780|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83814781|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83814782|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814783|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
83814784|NCT00398957|Naltrexone|naltrexone|mesh-list
83814785|NCT00398957|Hydromorphone|hydromorphone|mesh-list
83814786|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
83814787|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83814788|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814789|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
83814790|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814791|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83814792|NCT00398957|Narcotics|narcotics|mesh-ancestor
83814793|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83814794|NCT00398957|Analgesics|analgesics|mesh-ancestor
83814795|NCT00099450|INS 50589|ins 50589|mesh-list
83814796|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83814797|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83814798|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
83814799|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814800|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814801|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814802|NCT00244504|Moxonidine|moxonidine|mesh-list
83814803|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83814804|NCT00099489|Interferons|interferons|mesh-list
83814805|NCT00099489|Interferon-beta|interferon-beta|mesh-list
83814806|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
83814807|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814808|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
83814809|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814810|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
83814811|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814812|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83814813|NCT00067262|Valproic Acid|valproic acid|mesh-list
83814814|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
83814815|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814816|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814817|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
83814818|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814819|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814820|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
83814821|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83814822|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83814823|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83814824|NCT00244738|Castor Oil|castor oil|mesh-list
83814825|NCT00244738|Cathartics|cathartics|mesh-ancestor
83814826|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814827|NCT00077259|Epothilones|epothilones|mesh-list
82970231|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814829|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
83814830|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
83814831|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
83814832|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814833|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814834|NCT00067301|Citalopram|citalopram|mesh-list
83814835|NCT00067301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83814836|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83814837|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83814838|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814839|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814840|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
83814841|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814842|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83814843|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
83814844|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83814845|NCT00244972|Sorafenib|sorafenib|mesh-list
83814846|NCT00244972|Tipifarnib|tipifarnib|mesh-list
83814847|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814848|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83814849|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814850|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814851|NCT00245089|Dactinomycin|dactinomycin|mesh-list
83814852|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
83814853|NCT00245089|Vincristine|vincristine|mesh-list
83814854|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814855|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
83814856|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814857|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83814858|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83814859|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
83814860|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814861|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814862|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83814863|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83814864|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83814865|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83814866|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83814867|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814868|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814869|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814870|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83814871|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814872|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83814873|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
83814874|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83814875|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814876|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
83814877|NCT00245206|Olanzapine|olanzapine|mesh-list
83814878|NCT00245206|Risperidone|risperidone|mesh-list
83814879|NCT00245206|Aripiprazole|aripiprazole|mesh-list
83814880|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83814881|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
83814882|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814883|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814884|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814885|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83814886|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83814887|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83814888|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83814889|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83814890|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
83814891|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
83814892|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
83814893|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814894|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814895|NCT00245206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83814896|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83814897|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83814898|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
83814899|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
82970305|NCT03349684|Acarbose|acarbose|mesh-list
82970306|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83814901|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83814902|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83814903|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83814904|NCT00245245|Factor VIII|factor viii|mesh-list
83814905|NCT00245245|Coagulants|coagulants|mesh-ancestor
83814906|NCT00077298|Bevacizumab|bevacizumab|mesh-list
83814907|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83814908|NCT00077298|Cetuximab|cetuximab|mesh-list
83814909|NCT00077298|Irinotecan|irinotecan|mesh-list
83814910|NCT00077298|Antibodies|antibodies|mesh-list
83814911|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
83814912|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83814913|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814914|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83814915|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83814916|NCT00077298|Growth Substances|growth substances|mesh-ancestor
83814917|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814918|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
83814919|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
83814920|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83814921|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83814922|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814923|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814924|NCT00245401|Sirolimus|sirolimus|mesh-list
83814925|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814926|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814927|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83814928|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814929|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
83814930|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83814931|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
83814932|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814933|NCT00245440|Azithromycin|azithromycin|mesh-list
83814934|NCT00245440|Telithromycin|telithromycin|mesh-list
83814935|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814936|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814937|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83814938|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83814939|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
83814940|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83814941|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814942|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83814943|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
83814944|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
83814945|NCT00400608|Hormones|hormones|mesh-ancestor
83814946|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83814947|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
83814948|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
83814949|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
83814950|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83814951|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83814952|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814953|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814954|NCT00245596|Urological Agents|urological agents|mesh-ancestor
83814955|NCT00245674|Amisulpride|amisulpride|mesh-list
83814956|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83814957|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83814958|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83814959|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814960|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83814961|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83814962|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
83814963|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814964|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814965|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83814966|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
83814967|NCT00245713|Levetiracetam|levetiracetam|mesh-list
83814968|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
83814969|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
83814970|NCT00067457|Alosetron|alosetron|mesh-list
83814971|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814972|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83814973|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
83814974|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83814975|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814976|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814977|NCT00102843|Folic Acid|folic acid|mesh-list
83814978|NCT00102843|Betaine|betaine|mesh-list
83814979|NCT00102843|Hematinics|hematinics|mesh-ancestor
83814980|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
83814981|NCT00102843|Vitamins|vitamins|mesh-ancestor
83814982|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
83814983|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83814984|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83814985|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
83814986|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83814987|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
83814988|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814989|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83814990|NCT00245791|Levofloxacin|levofloxacin|mesh-list
83814991|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83814992|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83814993|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83814994|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83814995|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83814996|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83814997|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83814998|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83814999|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83815000|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83815001|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
83815002|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83815003|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815004|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83815005|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
83815006|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83815007|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815008|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815009|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815010|NCT00245908|Azithromycin|azithromycin|mesh-list
83815011|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83815012|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815013|NCT00067496|Modafinil|modafinil|mesh-list
83815014|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83815015|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815016|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83815017|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83815018|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83815019|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815020|NCT00400725|Clobetasol|clobetasol|mesh-list
83815021|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815022|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
83815023|NCT00400725|Hormones|hormones|mesh-ancestor
83815024|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815025|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815026|NCT00246064|Infliximab|infliximab|mesh-list
83815027|NCT00246064|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83815028|NCT00246064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815029|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
83815030|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815031|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815032|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
83815033|NCT00246103|Fluorouracil|fluorouracil|mesh-list
83815034|NCT00246103|Epirubicin|epirubicin|mesh-list
83815035|NCT00246103|Valproic Acid|valproic acid|mesh-list
83815036|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83815037|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
83815038|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815039|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815040|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83815041|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
83815042|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815043|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815044|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83815045|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
83815046|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83815047|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82970453|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83815048|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83815049|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83815050|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815051|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
83815052|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
83815053|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815054|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
83815055|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83815056|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815057|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815058|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
83815059|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83815060|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83815061|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83815062|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815063|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815064|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
83815065|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815066|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815067|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83815068|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815069|NCT00067535|Cocaine|cocaine|mesh-list
83815070|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
83815071|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
83815072|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815073|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815074|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
83815075|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815076|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83815077|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83815078|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83815079|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815080|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815081|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
83815082|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815083|NCT00102882|Fluticasone|fluticasone|mesh-list
83815084|NCT00102882|Xhance|xhance|mesh-list
83815085|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83815086|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83815087|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815088|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83815089|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
83815090|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815091|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815092|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83815093|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
83815094|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
83815095|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83815096|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83815097|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83815098|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83815099|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83815100|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815101|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815102|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
83815103|NCT00102882|Hormones|hormones|mesh-ancestor
83815104|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815105|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
83815106|NCT00246220|Methylphenidate|methylphenidate|mesh-list
83815107|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83815108|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815109|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83815110|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83815111|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815112|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815113|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
83815114|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815115|NCT00424801|Nicorandil|nicorandil|mesh-list
83815116|NCT00424801|Valsartan|valsartan|mesh-list
83815117|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83815118|NCT00424801|Doxazosin|doxazosin|mesh-list
83815119|NCT00424801|Lercanidipine|lercanidipine|mesh-list
83815120|NCT00424801|Pindolol|pindolol|mesh-list
83815121|NCT00424801|Moxonidine|moxonidine|mesh-list
82970528|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815122|NCT00424801|Amiloride|amiloride|mesh-list
83815123|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83815124|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83815125|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83815126|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815127|NCT00424801|Diuretics|diuretics|mesh-ancestor
83815128|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
83815129|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815130|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83815131|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815132|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83815133|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83815134|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83815135|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83815136|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83815137|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83815138|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83815139|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
83815140|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815141|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83815142|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
83815143|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
83815144|NCT00424801|Vitamins|vitamins|mesh-ancestor
83815145|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
83815146|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83815147|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83815148|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83815149|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83815150|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
83815151|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
83815152|NCT00246298|Hematinics|hematinics|mesh-ancestor
83815153|NCT00246415|Memantine|memantine|mesh-list
83815154|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83815155|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83815156|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
83815157|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815158|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815159|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815160|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83815161|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83815162|NCT00246532|Morphine|morphine|mesh-list
83815163|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83815164|NCT00246532|Narcotics|narcotics|mesh-ancestor
83815165|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815166|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815167|NCT00246532|Analgesics|analgesics|mesh-ancestor
83815168|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
83815169|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815170|NCT00246610|Nelfinavir|nelfinavir|mesh-list
83815171|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83815172|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83815173|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
83815174|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815175|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815176|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83815177|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83815178|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
83815179|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815180|NCT00246688|Sagopilone|sagopilone|mesh-list
83815181|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815182|NCT04728516|Amoxicillin|amoxicillin|mesh-list
83815183|NCT04728516|Pantoprazole|pantoprazole|mesh-list
83815184|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83815185|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815186|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83815187|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815188|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83815189|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815190|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815191|NCT00400998|Fluticasone|fluticasone|mesh-list
83815192|NCT00400998|Xhance|xhance|mesh-list
83815193|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815194|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83815195|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
83815196|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970604|NCT05303727|Methotrexate|methotrexate|mesh-list
83815197|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815198|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83815199|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
83815200|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
83815201|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83815202|NCT00247078|Antivenins|antivenins|mesh-list
83815203|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
83815204|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815205|NCT00247117|Metformin|metformin|mesh-list
83815206|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815207|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815208|NCT00099606|Dasatinib|dasatinib|mesh-list
83815209|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815210|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83815211|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815212|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815213|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
83815214|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83815215|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
83815216|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815217|NCT00247507|Expectorants|expectorants|mesh-ancestor
83815218|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
83815219|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83815220|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
83815221|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815222|NCT00247507|Protective Agents|protective agents|mesh-ancestor
83815223|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815224|NCT00247507|Antidotes|antidotes|mesh-ancestor
83815225|NCT00247585|Ethanol|ethanol|mesh-list
83815226|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83815227|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815228|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815229|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815230|NCT00099645|Mifepristone|mifepristone|mesh-list
83815231|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83815232|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
83815233|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83815234|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815235|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83815236|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83815237|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83815238|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
83815239|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83815240|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83815241|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
83815242|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815243|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
83815244|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83815245|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83815246|NCT00247663|Letrozole|letrozole|mesh-list
83815247|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815248|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83815249|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83815250|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815251|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815252|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83815253|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
83815254|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815255|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815256|NCT00247702|Warfarin|warfarin|mesh-list
83815257|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
83815258|NCT01349660|Bevacizumab|bevacizumab|mesh-list
83815259|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815260|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815261|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83815262|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83815263|NCT01349660|Growth Substances|growth substances|mesh-ancestor
83815264|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815265|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
83815266|NCT00247741|Lidocaine|lidocaine|mesh-list
83815267|NCT00247741|Carticaine|carticaine|mesh-list
83815268|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
83815269|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
83815270|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815271|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815272|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
83815273|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815274|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83815275|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83815276|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83815277|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815278|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815280|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83815281|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83815282|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
83815283|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815284|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83815285|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83815286|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815287|NCT00248053|Curcumin|curcumin|mesh-list
83815288|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83815289|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83815290|NCT00248053|Analgesics|analgesics|mesh-ancestor
83815291|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
83815292|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815293|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815294|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815295|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815296|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815297|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815298|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815299|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83815300|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83815301|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815302|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83815303|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83815304|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815305|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815306|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
83815307|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815308|NCT00248131|Octreotide|octreotide|mesh-list
83815309|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815310|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83815311|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815312|NCT00248209|Bupropion|bupropion|mesh-list
83815313|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83815314|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
83815315|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815316|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83815317|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83815318|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815319|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815320|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
83815321|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815322|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815323|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83815324|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83815325|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815326|NCT00248248|Doxorubicin|doxorubicin|mesh-list
83815327|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83815328|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83815329|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815330|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83815331|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83815332|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815333|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815334|NCT00248443|Dimercaprol|dimercaprol|mesh-list
83815335|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
83815336|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
83815337|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815338|NCT00248482|Cisplatin|cisplatin|mesh-list
83815339|NCT00248482|Irinotecan|irinotecan|mesh-list
83815340|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
83815341|NCT00248482|Camptothecin|camptothecin|mesh-list
83815342|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815343|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83815344|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83815345|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815346|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815347|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83815348|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83815349|NCT00103233|Trastuzumab|trastuzumab|mesh-list
83815350|NCT00103233|Vinorelbine|vinorelbine|mesh-list
83815351|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815352|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815353|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83815354|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
83815355|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
83815356|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
83815357|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815358|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
83815359|NCT00248716|Hematinics|hematinics|mesh-ancestor
83815360|NCT00067925|Calcium|calcium|mesh-list
83815361|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83815362|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815363|NCT00103272|Bortezomib|bortezomib|mesh-list
83815364|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815365|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83815366|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83815367|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
83815368|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815369|NCT00249106|Vaccines|vaccines|mesh-list
83815370|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
83815371|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815372|NCT00068042|Octreotide|octreotide|mesh-list
83815373|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815374|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83815375|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815376|NCT00249145|Risperidone|risperidone|mesh-list
83135741|NCT03260439|Analgesics|analgesics|mesh-ancestor
83815377|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83815378|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
83815379|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815380|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815381|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815382|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83815383|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83815384|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815385|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815386|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83815387|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
83815388|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83815389|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83815390|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815391|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83815392|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
83815393|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815394|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83815395|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83815396|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815397|NCT00068081|Capsaicin|capsaicin|mesh-list
83815398|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
83815399|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
83815400|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
83815401|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815402|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815403|NCT00249223|Risperidone|risperidone|mesh-list
83815404|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83815405|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
83815406|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815407|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815408|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815409|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83815410|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83815411|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815412|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815413|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83815414|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
83815415|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83815416|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815417|NCT02967224|Insulin|insulin|mesh-list
83815418|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83815419|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
83815420|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
83815421|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
83815422|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
83815423|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
83815424|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815425|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815426|NCT00099918|Vildagliptin|vildagliptin|mesh-list
83815427|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815428|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815429|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83815430|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83815431|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815432|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815433|NCT00249574|Buprenorphine|buprenorphine|mesh-list
83815434|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83815435|NCT00249574|Naloxone|naloxone|mesh-list
83815436|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83815437|NCT00249574|Narcotics|narcotics|mesh-ancestor
83815438|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815439|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815440|NCT00249574|Analgesics|analgesics|mesh-ancestor
83815441|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
83815442|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815443|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83815444|NCT00249691|Topiramate|topiramate|mesh-list
83815445|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
83815446|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815447|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815448|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
83815449|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
83815450|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83815451|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83815452|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815453|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815454|NCT00249730|Urological Agents|urological agents|mesh-ancestor
83815455|NCT00249847|Paroxetine|paroxetine|mesh-list
83815456|NCT00249847|Estrogens|estrogens|mesh-list
83815457|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83815458|NCT00249847|Hormones|hormones|mesh-ancestor
83815459|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815460|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815461|NCT00249847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83815462|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83815463|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815464|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815465|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815466|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
83815467|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83815468|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
83815469|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815470|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83815471|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83815472|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815473|NCT00249886|Citalopram|citalopram|mesh-list
83815474|NCT00249886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83815475|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83815476|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815477|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815478|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815479|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
83815480|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815481|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83815482|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
83815483|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815484|NCT00249964|Paclitaxel|paclitaxel|mesh-list
83815485|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83815486|NCT00249964|Carboplatin|carboplatin|mesh-list
83815487|NCT00249964|Temozolomide|temozolomide|mesh-list
83815488|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83815489|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815490|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
83815491|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
83815492|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
83815493|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135767|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
83815494|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83815495|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
83815496|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
83815497|NCT00068276|Vitamin D|vitamin d|mesh-list
83815498|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83815499|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815500|NCT00068276|Vitamins|vitamins|mesh-ancestor
83815501|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
83815502|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83815503|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
83815504|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
83815505|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815506|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83815507|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815508|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815509|NCT00068315|Rituximab|rituximab|mesh-list
83815510|NCT00068315|Fludarabine|fludarabine|mesh-list
83815511|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
83815512|NCT00068315|Bortezomib|bortezomib|mesh-list
83815513|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815514|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815515|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
83815516|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815517|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815518|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83815519|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
83815520|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815521|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83815522|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
83815523|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83815524|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815525|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815526|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
83815527|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815528|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815529|NCT00250120|Camptothecin|camptothecin|mesh-list
83815530|NCT00250120|Rubitecan|rubitecan|mesh-list
83815531|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83815532|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815533|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83815534|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83815535|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815536|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815537|NCT04720573|Neostigmine|neostigmine|mesh-list
83815538|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83815539|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815540|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815541|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83815542|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815543|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815544|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83815545|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
83815546|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815547|NCT00103545|Abagovomab|abagovomab|mesh-list
83815548|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815549|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815550|NCT00068432|Celecoxib|celecoxib|mesh-list
83815551|NCT00068432|Gemcitabine|gemcitabine|mesh-list
83815552|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83815553|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
83815554|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815555|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815556|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83815557|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83815558|NCT00068432|Analgesics|analgesics|mesh-ancestor
83815559|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
83815560|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815561|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815562|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815563|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815564|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82970976|NCT03575065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815565|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83815566|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815567|NCT00250237|Haloperidol|haloperidol|mesh-list
83815568|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
83815569|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
83815570|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
83815571|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815572|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815573|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815574|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83815575|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83815576|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815577|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815578|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83815579|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
83815580|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815581|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815582|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83815583|NCT00099957|Vildagliptin|vildagliptin|mesh-list
83815584|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815585|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815586|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83815587|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
83815588|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815589|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815590|NCT00250315|Dobutamine|dobutamine|mesh-list
83815591|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83815592|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
83815593|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
83815594|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815595|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815596|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83815597|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83815598|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83815599|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
83815600|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815601|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815602|NCT00250315|Protective Agents|protective agents|mesh-ancestor
83815603|NCT00068471|Anidulafungin|anidulafungin|mesh-list
83815604|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
83815605|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815606|NCT00250354|Risperidone|risperidone|mesh-list
83815607|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83815608|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
83815609|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135805|NCT02259803|Amlodipine|amlodipine|mesh-list
83815610|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815611|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815612|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83815613|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83815614|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815615|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815616|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83815617|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
83815618|NCT00250393|Istradefylline|istradefylline|mesh-list
83815619|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83815620|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83815621|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83815622|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
83815623|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815624|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815625|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815626|NCT02961634|Ciclopirox|ciclopirox|mesh-list
83815627|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
83815628|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815629|NCT02966717|Rituximab|rituximab|mesh-list
83815630|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815631|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815632|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
83815633|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815634|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815635|NCT00099996|Ezetimibe|ezetimibe|mesh-list
83815636|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83815637|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83815638|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
83815639|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815640|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83815641|NCT00250744|Gabapentin|gabapentin|mesh-list
83815642|NCT00250744|Aprepitant|aprepitant|mesh-list
83815643|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
83815644|NCT00250744|Analgesics|analgesics|mesh-ancestor
83815645|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
83815646|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815647|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815648|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
83815649|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83815650|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83815651|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815652|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815653|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83815654|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83815655|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815656|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815657|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
83815658|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
83815659|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
83815660|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815661|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83815662|NCT00103623|Abarelix|abarelix|mesh-list
83815663|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
83815664|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815665|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815666|NCT00250861|Aldesleukin|aldesleukin|mesh-list
83815667|NCT00250861|Rituximab|rituximab|mesh-list
83135817|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
83815668|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815669|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815670|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
83815671|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815672|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815673|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83815674|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83815675|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
83815676|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815677|NCT00068549|Gemcitabine|gemcitabine|mesh-list
83815678|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815679|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83815680|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
83815681|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815682|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
83815683|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815684|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83815685|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83815686|NCT04720183|Analgesics|analgesics|mesh-ancestor
83815687|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
83815688|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815689|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815690|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815691|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83815692|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815693|NCT00250978|Bevacizumab|bevacizumab|mesh-list
83815694|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815695|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815696|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83815697|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83815698|NCT00250978|Growth Substances|growth substances|mesh-ancestor
83815699|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815700|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83815701|NCT00068666|Temozolomide|temozolomide|mesh-list
83815702|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83815703|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
83815704|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815705|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815706|NCT00103701|Dasatinib|dasatinib|mesh-list
83815707|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815708|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83815709|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815710|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815711|NCT00251017|Vancomycin|vancomycin|mesh-list
83815712|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83815713|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815714|NCT00251056|Mannitol|mannitol|mesh-list
83815715|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83815716|NCT00251056|Diuretics|diuretics|mesh-ancestor
83815717|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
83815718|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815719|NCT00251095|Paclitaxel|paclitaxel|mesh-list
83815720|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83815721|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815722|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83815723|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83815724|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83815725|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815726|NCT00100074|Lobeline|lobeline|mesh-list
83815727|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83815728|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
83815729|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815730|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815731|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83815732|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83815733|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83815734|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815735|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815736|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
83815737|NCT00068744|Fluorouracil|fluorouracil|mesh-list
83815738|NCT00068744|Mitomycins|mitomycins|mesh-list
83815739|NCT00068744|Mitomycin|mitomycin|mesh-list
83815740|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815741|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
83815742|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815743|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83815744|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83815745|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
83815746|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815747|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83815748|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
83815749|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83815750|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815751|NCT00100113|Vanoxerine|vanoxerine|mesh-list
83815752|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83815753|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83815754|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83815755|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815756|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
83815757|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815758|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815759|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
83815760|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815761|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83815762|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815763|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815764|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
83815765|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815766|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
83815767|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815768|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815769|NCT00251407|Docetaxel|docetaxel|mesh-list
83815770|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815771|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
83815772|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
83815773|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
83815774|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815775|NCT02966522|Thalidomide|thalidomide|mesh-list
83815776|NCT02966522|Dexamethasone|dexamethasone|mesh-list
83815777|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83815778|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
83815779|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
83815780|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135853|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
83815781|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815782|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815783|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
83815784|NCT02966522|Hormones|hormones|mesh-ancestor
83815785|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815786|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83815787|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815788|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83815789|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
83815790|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
83815791|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83815792|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815793|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83815794|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83815795|NCT02966522|Growth Substances|growth substances|mesh-ancestor
83815796|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
83815798|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815799|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815800|NCT00100152|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
83815801|NCT00100152|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83815802|NCT00100152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815803|NCT00100152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815804|NCT00251524|Bevacizumab|bevacizumab|mesh-list
83815805|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
83815806|NCT00251524|Pemetrexed|pemetrexed|mesh-list
83815807|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83815808|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815809|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83815810|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83815811|NCT00251524|Growth Substances|growth substances|mesh-ancestor
83815812|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815813|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
83815814|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815815|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815816|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83815817|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83815818|NCT00068861|Metformin|metformin|mesh-list
83815819|NCT00068861|Clomiphene|clomiphene|mesh-list
83815820|NCT00068861|Enclomiphene|enclomiphene|mesh-list
83815821|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
83815822|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815823|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815824|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83815825|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
83815826|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815827|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83815828|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
83815829|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83815830|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83815831|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83815832|NCT00251602|Propranolol|propranolol|mesh-list
83815833|NCT00251602|Atropine|atropine|mesh-list
83815834|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83815835|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83815836|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
83815837|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815838|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815839|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815840|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83815841|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83135870|NCT04986254|Piperacillin|piperacillin|mesh-list
83815842|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
83815843|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83815844|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83815845|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
83815846|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815847|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83815848|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
83815849|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
83815850|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
83815851|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83815852|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83815853|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
83815854|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
83815855|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83815856|NCT02961166|Antibodies|antibodies|mesh-list
83815857|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
83815858|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815859|NCT00103818|Gaboxadol|gaboxadol|mesh-list
83815860|NCT00103818|Analgesics|analgesics|mesh-ancestor
83815861|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
83815862|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83815863|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971280|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
83815864|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
83815865|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
83815866|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
83815867|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815868|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815869|NCT00251680|Atorvastatin|atorvastatin|mesh-list
83815870|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83815871|NCT00251680|Simvastatin|simvastatin|mesh-list
83815872|NCT00251680|Fenofibrate|fenofibrate|mesh-list
83815873|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83815874|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83815875|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
83815876|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815877|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83815878|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83815879|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815880|NCT00251797|Thalidomide|thalidomide|mesh-list
83815881|NCT00251797|Irinotecan|irinotecan|mesh-list
83815882|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83815883|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83815884|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815885|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815886|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815887|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83815888|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
83815889|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815890|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
83815891|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83815892|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815893|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83815894|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83815895|NCT00251797|Growth Substances|growth substances|mesh-ancestor
83815896|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
83815897|NCT00251914|Esomeprazole|esomeprazole|mesh-list
83815898|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83815899|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815900|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83815901|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815902|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135886|NCT04996160|Bortezomib|bortezomib|mesh-list
83815903|NCT00100269|Antioxidants|antioxidants|mesh-list
83815904|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815905|NCT00100269|Protective Agents|protective agents|mesh-ancestor
83815906|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815907|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
83815908|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
83815909|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83815910|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
83815911|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83815912|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83815913|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815914|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83815915|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815916|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815917|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83815918|NCT00100308|Heparin|heparin|mesh-list
83815919|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
83815920|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83815921|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83815922|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815923|NCT00251953|Metformin|metformin|mesh-list
83815924|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815925|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815926|NCT00251992|Esomeprazole|esomeprazole|mesh-list
83815927|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83815928|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83815929|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83815930|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815931|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815932|NCT00103935|Exenatide|exenatide|mesh-list
83815933|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83815934|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815935|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83815936|NCT00103935|Incretins|incretins|mesh-ancestor
83815937|NCT00103935|Hormones|hormones|mesh-ancestor
83815938|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83815939|NCT00399152|Sunitinib|sunitinib|mesh-list
83815940|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815941|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83815942|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83815943|NCT00399152|Growth Substances|growth substances|mesh-ancestor
83815944|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815945|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83815946|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83815947|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815948|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815950|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83815951|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83815952|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
83815953|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815954|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815955|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815956|NCT04719715|Antibodies|antibodies|mesh-list
83815957|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
83815958|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815959|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83815960|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
83815961|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83815962|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83815963|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83815964|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83815965|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815966|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
83815967|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815968|NCT00252304|Astringents|astringents|mesh-ancestor
83815969|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
83815970|NCT00252343|Amibegron|amibegron|mesh-list
83815971|NCT00252343|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83815972|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83815973|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83815974|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
83815975|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83815976|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815977|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815978|NCT00252343|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83815979|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
83815980|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
83815981|NCT00252655|Sirolimus|sirolimus|mesh-list
83815982|NCT00252655|Tacrolimus|tacrolimus|mesh-list
83815983|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83815984|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
83815985|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83815986|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83815987|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815988|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815989|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83815990|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83815991|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83815992|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815993|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
83815994|NCT00252811|Gefitinib|gefitinib|mesh-list
83815995|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83815996|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83815997|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83815998|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83815999|NCT00069251|Bupropion|bupropion|mesh-list
83816000|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83816001|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
83816002|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816003|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83816004|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83816005|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816006|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816007|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
83816008|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816009|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816010|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83816011|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82971426|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
83816012|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816013|NCT00252889|Doxorubicin|doxorubicin|mesh-list
83816014|NCT00252889|Topotecan|topotecan|mesh-list
83816015|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
83816016|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83816017|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816018|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83816019|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816020|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816021|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816022|NCT00252928|Troclosene|troclosene|mesh-list
83816023|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
83816024|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816025|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
83816026|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
83816027|NCT00253123|Risperidone|risperidone|mesh-list
83816028|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83816029|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
83816030|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816031|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816032|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816033|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83816034|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83816035|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83816036|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816037|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83816038|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
83816039|NCT00253162|Risperidone|risperidone|mesh-list
83816040|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83816041|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
83816042|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816043|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816044|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816045|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83816046|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83816047|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83816048|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816049|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83816050|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
83816051|NCT00253201|Galantamine|galantamine|mesh-list
83816052|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83816053|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816054|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816055|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
83816056|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816057|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816058|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83816059|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
83816060|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816061|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
83816062|NCT00253318|Dexamethasone|dexamethasone|mesh-list
83816063|NCT00253318|Docetaxel|docetaxel|mesh-list
83816064|NCT00253318|Everolimus|everolimus|mesh-list
83816065|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83816066|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
83816067|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
83816068|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816069|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816070|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83816071|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
83816072|NCT00253318|Hormones|hormones|mesh-ancestor
83816073|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816074|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816075|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816076|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816077|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816078|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816079|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816080|NCT00253318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83816081|NCT00253318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816082|NCT00253318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816083|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816084|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
83816085|NCT00100464|Paroxetine|paroxetine|mesh-list
83816086|NCT00100464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83816087|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83816088|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816089|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816090|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816091|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
83816092|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816093|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83816094|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
83816095|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816096|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83816097|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83816098|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816100|NCT00253396|Enoxaparin|enoxaparin|mesh-list
83816101|NCT00253396|Calcium heparin|calcium heparin|mesh-list
83816102|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
83816103|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83816104|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83816105|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816106|NCT00253474|Interferons|interferons|mesh-list
83816107|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
83816108|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
83816109|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83816110|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816111|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
83816112|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816113|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
83816114|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816115|NCT00253552|Cyclosporine|cyclosporine|mesh-list
83816116|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
83816117|NCT00253552|Busulfan|busulfan|mesh-list
83816118|NCT00253552|Methotrexate|methotrexate|mesh-list
83816119|NCT00253552|Etoposide|etoposide|mesh-list
83816120|NCT00253552|Cyclosporins|cyclosporins|mesh-list
83816121|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816122|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
83816123|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816124|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83816125|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83816126|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
83816127|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816128|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816129|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83816130|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83816131|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
83816132|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83816133|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816134|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
83816135|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
83816136|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816137|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83816138|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83816139|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83816140|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83816141|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816142|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
83816143|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816144|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83816145|NCT00253591|Vinorelbine|vinorelbine|mesh-list
83135942|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
83816146|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816147|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83816148|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816149|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816150|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816151|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816152|NCT04719481|Pravastatin|pravastatin|mesh-list
83816153|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83816154|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83816155|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
83816156|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816157|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82971575|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83816158|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83816159|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816160|NCT00253903|SR 46349B|sr 46349b|mesh-list
83816161|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83816162|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83816163|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816164|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83816165|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83816166|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
83816167|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816168|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816169|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
83816170|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816171|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816172|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816173|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816174|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816175|NCT00254020|Citalopram|citalopram|mesh-list
83816176|NCT00254020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83816177|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83816178|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816179|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816180|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816181|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
83816182|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816183|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83816184|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
83816185|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816186|NCT00254137|Capecitabine|capecitabine|mesh-list
83816187|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
83816188|NCT00254137|Irinotecan|irinotecan|mesh-list
83816189|NCT00254137|Cetuximab|cetuximab|mesh-list
83816190|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816191|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
83816192|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816193|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816194|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83816195|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816196|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816197|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83816198|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
83816199|NCT00104169|Hematinics|hematinics|mesh-ancestor
83816200|NCT00415090|Nevirapine|nevirapine|mesh-list
83816201|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83816202|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83816203|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816204|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816205|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
83816206|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816207|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83816208|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83816209|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83816210|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83816211|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
83816212|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83816213|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83816214|NCT00254254|Exenatide|exenatide|mesh-list
83816215|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83816216|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816217|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83816218|NCT00254254|Incretins|incretins|mesh-ancestor
83816219|NCT00254254|Hormones|hormones|mesh-ancestor
83816220|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816221|NCT00254371|Androgens|androgens|mesh-list
83816222|NCT00254371|Hormones|hormones|mesh-ancestor
83816223|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816224|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816225|NCT00254449|Capsaicin|capsaicin|mesh-list
83816226|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
83816227|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
83816228|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
83816229|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816230|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816231|NCT00104286|Troxacitabine|troxacitabine|mesh-list
83816232|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816233|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83816234|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82971646|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816236|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816237|NCT00254800|Exenatide|exenatide|mesh-list
83816238|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83816239|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83816240|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
83816241|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83816242|NCT00254800|Estradiol|estradiol|mesh-list
83816243|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83816244|NCT00254800|Estrogens|estrogens|mesh-ancestor
83816245|NCT00254800|Hormones|hormones|mesh-ancestor
83816246|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816247|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816248|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83816249|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
83816250|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83816251|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83816252|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83816253|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83816254|NCT00254800|Incretins|incretins|mesh-ancestor
83816255|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83816256|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83816257|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83816258|NCT00104403|Dexamethasone|dexamethasone|mesh-list
83816259|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
83816260|NCT00104403|Ondansetron|ondansetron|mesh-list
83816261|NCT00104403|Casopitant|casopitant|mesh-list
83816262|NCT00104403|BB 1101|bb 1101|mesh-list
83816263|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83816264|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
83816265|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
83816266|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816267|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816268|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83816269|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
83816270|NCT00104403|Hormones|hormones|mesh-ancestor
83816271|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816272|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816273|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816274|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
83816275|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816276|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816277|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
83816278|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83816279|NCT00104403|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83816280|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83816281|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
83816282|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816283|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83816284|NCT00069836|Metformin|metformin|mesh-list
83816285|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
83816286|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83816287|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816288|NCT00254878|Methylphenidate|methylphenidate|mesh-list
83816289|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83816290|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816291|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83816292|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83816293|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816294|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816295|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
83816296|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816297|NCT00254917|Vaccines|vaccines|mesh-list
83816298|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
83816299|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816300|NCT00254956|Ciclesonide|ciclesonide|mesh-list
83816301|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
83816302|NCT00254956|Hormones|hormones|mesh-ancestor
83816303|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816304|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816305|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83816306|NCT00255073|Baclofen|baclofen|mesh-list
83816307|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83816308|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816309|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82971723|NCT01193387|Insulin|insulin|mesh-list
83135999|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816310|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816311|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83816312|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
83816313|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
83816314|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816315|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816316|NCT00069875|Gemcitabine|gemcitabine|mesh-list
83816317|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816318|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816319|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
83816320|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816321|NCT00255268|Goserelin|goserelin|mesh-list
83816322|NCT00255268|Bicalutamide|bicalutamide|mesh-list
83816323|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816324|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816325|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
83816326|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
83816327|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816328|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816329|NCT00104442|Rivastigmine|rivastigmine|mesh-list
83816330|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83816331|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816332|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816333|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
83816334|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816335|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816336|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83816337|NCT00104442|Protective Agents|protective agents|mesh-ancestor
83816338|NCT00255385|Micronutrients|micronutrients|mesh-list
83816339|NCT00255385|Trace Elements|trace elements|mesh-list
83816340|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816341|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83816342|NCT00255424|Hematinics|hematinics|mesh-ancestor
83816343|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83816344|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83816345|NCT00069992|Fludarabine|fludarabine|mesh-list
83816346|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
83816347|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816348|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83816349|NCT00255463|Gefitinib|gefitinib|mesh-list
83816350|NCT00255463|Anastrozole|anastrozole|mesh-list
83816351|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816352|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816353|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816354|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816355|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816356|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83816357|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83816358|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83816359|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
83816360|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816361|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816362|NCT00255502|Metoprolol|metoprolol|mesh-list
83816363|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83816364|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83816365|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
83816366|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
83816367|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816368|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816369|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83816370|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83816371|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83816372|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
83816373|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136013|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
83816374|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816375|NCT00255541|Glyburide|glyburide|mesh-list
83816376|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83816377|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816378|NCT00255658|Sirolimus|sirolimus|mesh-list
83816379|NCT00255658|Sorafenib|sorafenib|mesh-list
83816380|NCT00255658|Temsirolimus|temsirolimus|mesh-list
83816381|NCT00255658|MTOR Inhibitors|mtor inhibitors|mesh-list
83816382|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816383|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816384|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816385|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816386|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816387|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
83816388|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816389|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83816390|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816391|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83816392|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
83816394|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
83816395|NCT00070148|Oxandrolone|oxandrolone|mesh-list
83816396|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83816397|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83816398|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83816399|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
83816400|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83816401|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816402|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83816403|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83816404|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816405|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816406|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
83816407|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83816408|NCT00070148|Androgens|androgens|mesh-ancestor
83816409|NCT00070148|Hormones|hormones|mesh-ancestor
83816410|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816411|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
83816412|NCT00100581|Interferons|interferons|mesh-list
83816413|NCT00100581|Ritonavir|ritonavir|mesh-list
83816414|NCT00100581|Tenofovir|tenofovir|mesh-list
83816415|NCT00100581|Ribavirin|ribavirin|mesh-list
83816416|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
83816417|NCT00100581|Lamivudine|lamivudine|mesh-list
83816418|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
83816419|NCT00100581|Efavirenz|efavirenz|mesh-list
83816420|NCT00100581|Lopinavir|lopinavir|mesh-list
83816421|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83816422|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816423|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
83816424|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816425|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83816426|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83816427|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
83816428|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816429|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816430|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83816431|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83816432|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83816433|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83816434|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83816435|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83816436|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
83816437|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
83816438|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816439|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83816440|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83816441|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83816442|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83816443|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83816444|NCT00070187|Interferons|interferons|mesh-list
83816445|NCT00070187|Cytarabine|cytarabine|mesh-list
83816446|NCT00070187|Aldesleukin|aldesleukin|mesh-list
83816447|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
83816448|NCT00070187|Cyclosporine|cyclosporine|mesh-list
83816449|NCT00070187|Etoposide|etoposide|mesh-list
83816450|NCT00070187|Melphalan|melphalan|mesh-list
83816451|NCT00070187|Interleukin-2|interleukin-2|mesh-list
83816452|NCT00070187|Carmustine|carmustine|mesh-list
83816453|NCT00070187|Cyclosporins|cyclosporins|mesh-list
83816454|NCT00070187|Lenograstim|lenograstim|mesh-list
83816455|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83816456|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816457|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83816458|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816459|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816460|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816461|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
83816463|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816464|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
83816465|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816466|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
83816467|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816468|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83816469|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
83816470|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
83816471|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83816472|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83816473|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83816474|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
83816475|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83816476|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83816477|NCT00070187|Analgesics|analgesics|mesh-ancestor
83816478|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
83816479|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816480|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83816481|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83816482|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83816483|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
83816484|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83816485|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
83816486|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83816487|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816488|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83816489|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816490|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816491|NCT00415285|Docetaxel|docetaxel|mesh-list
83816492|NCT00415285|Capecitabine|capecitabine|mesh-list
83816493|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816494|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816495|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816496|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816497|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816498|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816499|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
83816500|NCT00256009|Misoprostol|misoprostol|mesh-list
83816501|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83816502|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
83816503|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83816504|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816505|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83816506|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83816507|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
83816508|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
83816509|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83816510|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816511|NCT00070265|Capecitabine|capecitabine|mesh-list
83816512|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
83816513|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816514|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
83816515|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816516|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816517|NCT00104598|Bupropion|bupropion|mesh-list
83816518|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83816519|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
83816520|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816521|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83816522|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83816523|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816524|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816525|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
83816526|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816527|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816528|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83816529|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83816530|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816531|NCT00256321|Celecoxib|celecoxib|mesh-list
83816532|NCT00256321|Capecitabine|capecitabine|mesh-list
83816533|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
83816534|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816535|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
83816536|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816537|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816538|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83816539|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83816540|NCT00256321|Analgesics|analgesics|mesh-ancestor
83816541|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
83816542|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816543|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816544|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83816545|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83816546|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83816547|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83816548|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816549|NCT00070304|Gemcitabine|gemcitabine|mesh-list
83816550|NCT00070304|Vinorelbine|vinorelbine|mesh-list
83816551|NCT00070304|Lenograstim|lenograstim|mesh-list
83816552|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816553|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
83816554|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816555|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816556|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83816557|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
83816558|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816559|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83816560|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816561|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816562|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816563|NCT00100737|Rituximab|rituximab|mesh-list
83816564|NCT00100737|Interleukin-2|interleukin-2|mesh-list
83816565|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83816566|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816567|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
83816568|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816569|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83816570|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83816571|NCT00100737|Analgesics|analgesics|mesh-ancestor
83816572|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
83816573|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816574|NCT00070343|Dacarbazine|dacarbazine|mesh-list
83816575|NCT00070343|Oblimersen|oblimersen|mesh-list
83816576|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83816577|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
83816578|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816579|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816580|NCT00104715|Docetaxel|docetaxel|mesh-list
83816581|NCT00104715|Goserelin|goserelin|mesh-list
83816582|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
83816583|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816584|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816585|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816586|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816587|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816588|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816589|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
83816590|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816591|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816592|NCT00256711|Vinorelbine|vinorelbine|mesh-list
83816593|NCT00256711|Gefitinib|gefitinib|mesh-list
83816594|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83816595|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816596|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816597|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816598|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816599|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816600|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816601|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816602|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
83816603|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
83816604|NCT00070382|Hematinics|hematinics|mesh-ancestor
83816605|NCT04709380|Sorafenib|sorafenib|mesh-list
83816606|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816607|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816608|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816609|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972022|NCT01199081|Dronedarone|dronedarone|mesh-list
83816610|NCT00256828|Lamivudine|lamivudine|mesh-list
83816611|NCT00256828|Efavirenz|efavirenz|mesh-list
83816612|NCT00256828|Didanosine|didanosine|mesh-list
83816613|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83816614|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83816615|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816616|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816617|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
83816618|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816619|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83816620|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83816621|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83816622|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83816623|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83816624|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83816625|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83816626|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83816627|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
83816628|NCT00100776|Olanzapine|olanzapine|mesh-list
83816629|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
83816630|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
83816631|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816632|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816633|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83816634|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83816635|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83816636|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83816637|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816638|NCT00100776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83816639|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83816640|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816641|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816642|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816643|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
83816644|NCT00070538|Cytarabine|cytarabine|mesh-list
83816645|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816646|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
83816647|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816648|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816649|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
83816650|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816651|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816652|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
83816653|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816654|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83816655|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83816656|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83816657|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83816658|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816659|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816660|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83816661|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83816662|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
83816663|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816664|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816665|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83816666|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83816667|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
83816668|NCT00257062|Levofloxacin|levofloxacin|mesh-list
83816669|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83816670|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816671|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83816672|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83816673|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816674|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816675|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816676|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816677|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83816678|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83816679|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83816680|NCT00100854|Fulvestrant|fulvestrant|mesh-list
83816681|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816682|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816683|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816684|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816685|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816686|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83816687|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83816688|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
83816689|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816690|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816691|NCT00257140|Levofloxacin|levofloxacin|mesh-list
83816692|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83816693|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136068|NCT02129101|Decitabine|decitabine|mesh-list
83816694|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83816695|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83816696|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816697|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816698|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816699|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816700|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83816701|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83816702|NCT00257257|Rimonabant|rimonabant|mesh-list
83816703|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83816704|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83816705|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83816706|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816707|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816708|NCT00257257|Hormones|hormones|mesh-ancestor
83816709|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816710|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816711|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
83816712|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
83816713|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83816714|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816715|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83816716|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816717|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816718|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816719|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816720|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816721|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83816722|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
83816723|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816724|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83816725|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
83816726|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
83816727|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83816728|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
83816729|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816730|NCT00257491|Telmisartan|telmisartan|mesh-list
83816731|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83816732|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83816733|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83816734|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816735|NCT00104793|Carboplatin|carboplatin|mesh-list
83816736|NCT00104793|Irinotecan|irinotecan|mesh-list
83816737|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816738|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83816739|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816740|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816741|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816742|NCT00070655|Vitamin K|vitamin k|mesh-list
83816743|NCT00070655|Warfarin|warfarin|mesh-list
83816744|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
83816745|NCT00070655|Idraparinux|idraparinux|mesh-list
83816746|NCT00070655|Vitamins|vitamins|mesh-ancestor
83816747|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
83816748|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816749|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
83816750|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83816751|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83816752|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816753|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
83816754|NCT00070655|Coagulants|coagulants|mesh-ancestor
83816755|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83816756|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
83816757|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83816758|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
83816759|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816760|NCT00257530|Imiquimod|imiquimod|mesh-list
83816761|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83816762|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
83816763|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816764|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816765|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
83816766|NCT00257569|Cetirizine|cetirizine|mesh-list
83816767|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83816768|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83816769|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83816770|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
83816771|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
83816772|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816773|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816774|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816775|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
83816776|NCT00100893|Procyanidin|procyanidin|mesh-list
83816777|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
83816778|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816779|NCT00100893|Protective Agents|protective agents|mesh-ancestor
83816780|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816781|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83816782|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83816783|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816784|NCT00257803|Oxytocin|oxytocin|mesh-list
83816785|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
83816786|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83816787|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816788|NCT00401115|Sirolimus|sirolimus|mesh-list
83816789|NCT00401115|Temsirolimus|temsirolimus|mesh-list
83816790|NCT00401115|MTOR Inhibitors|mtor inhibitors|mesh-list
83816791|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83816792|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816793|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83816794|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816795|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
83816796|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816797|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
83816798|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816799|NCT00401115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816800|NCT00401115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816801|NCT00401115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816802|NCT00257959|Amiodarone|amiodarone|mesh-list
83816803|NCT00257959|Sotalol|sotalol|mesh-list
83816804|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83816805|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83816806|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83816807|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816808|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816809|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816810|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83816811|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
83816812|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83816813|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816814|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83136096|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816815|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83816816|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83816817|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816818|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83816819|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83816820|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83816821|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
83816822|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
83816823|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816824|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
83816825|NCT00070733|Testosterone|testosterone|mesh-list
83816826|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
83816827|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
83816828|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83816829|NCT00070733|Androgens|androgens|mesh-ancestor
83816830|NCT00070733|Hormones|hormones|mesh-ancestor
83816831|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816832|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816833|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816834|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816835|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
83816836|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
83816837|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83816838|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816839|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83816840|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83816841|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83816842|NCT00258115|Analgesics|analgesics|mesh-ancestor
83816843|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
83816844|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816845|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816846|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83816847|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83816848|NCT00258193|Linaclotide|linaclotide|mesh-list
83816849|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83816850|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
83816851|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816852|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83816853|NCT00100971|Vaccines|vaccines|mesh-list
83816854|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
83816855|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816856|NCT00258232|Celecoxib|celecoxib|mesh-list
83816857|NCT00258232|Capecitabine|capecitabine|mesh-list
83816858|NCT00258232|Irinotecan|irinotecan|mesh-list
83816859|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816860|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
83816861|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816862|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816863|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83816864|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83816865|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816866|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83816867|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83816868|NCT00258232|Analgesics|analgesics|mesh-ancestor
83816869|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
83816870|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816871|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816872|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83816873|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83816874|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83816875|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83816876|NCT00258271|Cytarabine|cytarabine|mesh-list
83816877|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
83816878|NCT00258271|Cladribine|cladribine|mesh-list
83816879|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816880|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
83816881|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816882|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816883|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
83816884|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816885|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816886|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
83816887|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816888|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816889|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816890|NCT00258388|Prednisone|prednisone|mesh-list
83816891|NCT00258388|Docetaxel|docetaxel|mesh-list
83816892|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816893|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816894|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816895|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816896|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816897|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83816898|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
83816899|NCT00258388|Hormones|hormones|mesh-ancestor
83816900|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83816901|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816902|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83816903|NCT00101088|Sirolimus|sirolimus|mesh-list
83816904|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
82972323|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
83816905|NCT00101088|Temsirolimus|temsirolimus|mesh-list
83816906|NCT00101088|MTOR Inhibitors|mtor inhibitors|mesh-list
83816907|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816908|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816909|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816910|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816911|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816912|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
83816913|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816914|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83816915|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83816916|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83816917|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
83816918|NCT00258622|Lidocaine|lidocaine|mesh-list
83816919|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
83816920|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
83816921|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83816922|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816923|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
83816924|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83816925|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83816926|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83816927|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83816928|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83816929|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816930|NCT00423761|Midazolam|midazolam|mesh-list
83816931|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83816932|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83136118|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83816933|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83816934|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816935|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83816936|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83816937|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83816938|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83816939|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
83816940|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
83816941|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
83816942|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
83816943|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83816944|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816945|NCT00104910|Cetuximab|cetuximab|mesh-list
83816946|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816947|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83816948|NCT00415324|Cisplatin|cisplatin|mesh-list
83816949|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816950|NCT00258739|Carboplatin|carboplatin|mesh-list
83816951|NCT00258739|Gemcitabine|gemcitabine|mesh-list
83816952|NCT00258739|Docetaxel|docetaxel|mesh-list
83816953|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816954|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816955|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
83816956|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816957|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816958|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816959|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816960|NCT00104949|Trastuzumab|trastuzumab|mesh-list
83816961|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83816962|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816963|NCT00101127|Gemcitabine|gemcitabine|mesh-list
83816964|NCT00101127|Docetaxel|docetaxel|mesh-list
83816965|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83816966|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
83816967|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816968|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816969|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
83816970|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
83816971|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
83816972|NCT00259051|Omeprazole|omeprazole|mesh-list
83816973|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83816974|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83816975|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83816976|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816977|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816978|NCT00259129|Sorafenib|sorafenib|mesh-list
83816979|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972400|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
83816980|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83816981|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83816982|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816983|NCT00259168|Nateglinide|nateglinide|mesh-list
83816984|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83816985|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816986|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
83816987|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816988|NCT00104988|Thalidomide|thalidomide|mesh-list
83816989|NCT00104988|Temozolomide|temozolomide|mesh-list
83816990|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83816991|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
83816992|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83816993|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83816994|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83816995|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
83816996|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83816997|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
83816998|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83136136|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
83816999|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817000|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83817001|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83817002|NCT00104988|Growth Substances|growth substances|mesh-ancestor
83817003|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
83817004|NCT00415402|Vitamin D|vitamin d|mesh-list
83817005|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
83817006|NCT00415402|Vitamins|vitamins|mesh-ancestor
83817007|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
83817008|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817009|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817010|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83817011|NCT00259402|Fluorouracil|fluorouracil|mesh-list
83817012|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
83817013|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817014|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
83817015|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817016|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817017|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817018|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
83817019|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817020|NCT00259441|Simvastatin|simvastatin|mesh-list
83817021|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83817022|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83817023|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
83817024|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817025|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83817026|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83817027|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817028|NCT00071201|Adefovir|adefovir|mesh-list
83817029|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83817030|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
83817031|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817032|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83817033|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83817034|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817035|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817036|NCT00259636|Zonisamide|zonisamide|mesh-list
83817037|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
83817038|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83136144|NCT03257319|Analgesics|analgesics|mesh-ancestor
83817039|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817040|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817041|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83817042|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817043|NCT00259675|Carboplatin|carboplatin|mesh-list
83817044|NCT00259675|Gemcitabine|gemcitabine|mesh-list
83817045|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817046|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817047|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
83817048|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817049|NCT00105105|Mifepristone|mifepristone|mesh-list
83817050|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83817051|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
83817052|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83817053|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817054|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83817055|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83817056|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83817057|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
83817058|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83817059|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83817060|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
83817061|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817062|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
83817063|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83817064|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83817066|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83817067|NCT00071240|Hormones|hormones|mesh-list
83817068|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817069|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817070|NCT00259792|Budesonide|budesonide|mesh-list
83817071|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
83817072|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817073|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83817074|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
83817075|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817076|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817077|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83817078|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
83817079|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
83817080|NCT00259792|Hormones|hormones|mesh-ancestor
83817081|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817082|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83817083|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83817084|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83817085|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
83817086|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817087|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817088|NCT00105144|Caspofungin|caspofungin|mesh-list
83817089|NCT00105144|Micafungin|micafungin|mesh-list
83817090|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
83817091|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817092|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817093|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817094|NCT00259870|Olanzapine|olanzapine|mesh-list
83817095|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
83817096|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
83817097|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817098|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817099|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817100|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83817101|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83817102|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817103|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83817104|NCT00259870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83817105|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83817106|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817107|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817108|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817109|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
83817110|NCT00071279|Idraparinux|idraparinux|mesh-list
83817111|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83817112|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
83817113|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83817114|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
83817115|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817116|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817117|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
83817118|NCT00259987|Lapatinib|lapatinib|mesh-list
83817119|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817120|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83817121|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817122|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817123|NCT00260026|Docetaxel|docetaxel|mesh-list
83817124|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817125|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
83817126|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
83817127|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
83817128|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817129|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
83817130|NCT00260143|Testosterone|testosterone|mesh-list
83817131|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
83817132|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
83817133|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83817134|NCT00260143|Androgens|androgens|mesh-ancestor
83817135|NCT00260143|Hormones|hormones|mesh-ancestor
83817136|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817137|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817138|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83817139|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817140|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
83817141|NCT00260260|Oxycodone|oxycodone|mesh-list
83817142|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83817143|NCT00260260|Narcotics|narcotics|mesh-ancestor
83817144|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817145|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817146|NCT00260260|Analgesics|analgesics|mesh-ancestor
83817147|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
83817148|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817149|NCT00105300|Adalimumab|adalimumab|mesh-list
83817150|NCT00105300|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83817151|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817152|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817153|NCT00260416|Abciximab|abciximab|mesh-list
83817154|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
83817155|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83817156|NCT00260611|Docetaxel|docetaxel|mesh-list
83817157|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
83817158|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817159|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
83817160|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
83817161|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
83817162|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817163|NCT00424086|Vaccines|vaccines|mesh-list
83817164|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
83817165|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817166|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
83817167|NCT00101205|Etoposide|etoposide|mesh-list
83817168|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
83817169|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817170|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83817171|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83817172|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83817173|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817174|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817175|NCT00261079|Fexofenadine|fexofenadine|mesh-list
83817176|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83817177|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83817178|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83817179|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
83817180|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
83817181|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817182|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817183|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817184|NCT00261118|Rituximab|rituximab|mesh-list
83817185|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83817186|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817187|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
83817188|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817189|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817190|NCT00071747|Lamotrigine|lamotrigine|mesh-list
83817191|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
83817192|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83817193|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817194|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817195|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83817196|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817197|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82972626|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817198|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83817199|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817200|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83817201|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83817202|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
83817203|NCT00261313|Hematinics|hematinics|mesh-ancestor
83817204|NCT00261352|Metformin|metformin|mesh-list
83817205|NCT00261352|Fenofibrate|fenofibrate|mesh-list
83817206|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83817207|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817208|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83817209|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
83817210|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817211|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83817212|NCT00261391|Marimastat|marimastat|mesh-list
83817213|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817214|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817215|NCT00071942|Metronidazole|metronidazole|mesh-list
83817216|NCT00071942|Vaccines|vaccines|mesh-list
83817217|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
83817218|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817219|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817220|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83817221|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83817222|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83817223|NCT00261469|Topiramate|topiramate|mesh-list
83817224|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
83817225|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83817226|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817227|NCT00261508|Risperidone|risperidone|mesh-list
83817228|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83817229|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
83817230|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817231|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817232|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817233|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83817234|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83817235|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817236|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83817237|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83817238|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
83817239|NCT00261547|Rituximab|rituximab|mesh-list
83817240|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83817241|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817242|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
83817243|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817244|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817245|NCT00261586|Aspirin|aspirin|mesh-list
83817246|NCT00261586|Acetaminophen|acetaminophen|mesh-list
83817247|NCT00261586|Ibuprofen|ibuprofen|mesh-list
83817248|NCT00261586|Celecoxib|celecoxib|mesh-list
83817249|NCT00261586|Naproxen|naproxen|mesh-list
83817250|NCT00261586|Rofecoxib|rofecoxib|mesh-list
83817251|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83817252|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83817253|NCT00261586|Analgesics|analgesics|mesh-ancestor
83817254|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
83817255|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817256|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817257|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817258|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817259|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83817260|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83817261|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817262|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83817263|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83817264|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817265|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
83817266|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83817267|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
83817268|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
83817269|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817270|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817271|NCT00261625|Alendronate|alendronate|mesh-list
83817272|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817273|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817274|NCT00261703|Cisplatin|cisplatin|mesh-list
83817275|NCT00261703|Docetaxel|docetaxel|mesh-list
82972699|NCT05222204|Paclitaxel|paclitaxel|mesh-list
83817276|NCT00261703|Fluorouracil|fluorouracil|mesh-list
83817277|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817278|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
83817279|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
83817280|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
83817281|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817282|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
83817283|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817284|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817285|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
83817286|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817287|NCT00261742|Penicillins|penicillins|mesh-list
83817288|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83817289|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817290|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
83817291|NCT00072059|Hematinics|hematinics|mesh-ancestor
83817292|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
83817294|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
83817295|NCT00261820|Prednisolone|prednisolone|mesh-list
83817296|NCT00261820|Tacrolimus|tacrolimus|mesh-list
83817297|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817298|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
83817299|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817300|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83817301|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817302|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817303|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83817304|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817305|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83817306|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
83817307|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83817308|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817309|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
83817310|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817311|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
83817312|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
83817313|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817314|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817315|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
83817316|NCT00261820|Hormones|hormones|mesh-ancestor
83817317|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817318|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83817319|NCT00261820|Protective Agents|protective agents|mesh-ancestor
83817320|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83817321|NCT00072098|Interleukin-12|interleukin-12|mesh-list
83817322|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83817323|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
83817324|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817325|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83817326|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83817327|NCT00072098|Growth Substances|growth substances|mesh-ancestor
83817328|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
83817329|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817330|NCT00261937|Furosemide|furosemide|mesh-list
83817331|NCT00261937|Diuretics|diuretics|mesh-ancestor
83817332|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
83817333|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817334|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83817335|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817336|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817337|NCT00105495|Deferiprone|deferiprone|mesh-list
83817338|NCT00105495|Deferoxamine|deferoxamine|mesh-list
83817339|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83817340|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
83817341|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
83817342|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817343|NCT00105495|Siderophores|siderophores|mesh-ancestor
83817344|NCT00261976|Infliximab|infliximab|mesh-list
83817345|NCT00261976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83817346|NCT00261976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817347|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
83817348|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817349|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817350|NCT00072137|Metronidazole|metronidazole|mesh-list
83817351|NCT00072137|Molgramostim|molgramostim|mesh-list
82972773|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817352|NCT00072137|Vaccines|vaccines|mesh-list
83817353|NCT00072137|Sargramostim|sargramostim|mesh-list
83817354|NCT00072137|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
83817355|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
83817356|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817357|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817358|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817359|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83817360|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83817361|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83817362|NCT00072137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83817363|NCT00262015|Vaccines|vaccines|mesh-list
83817364|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
83817365|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817366|NCT00262054|Heparin|heparin|mesh-list
83817367|NCT00262054|Calcium heparin|calcium heparin|mesh-list
83817368|NCT00262054|Bivalirudin|bivalirudin|mesh-list
83817369|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
83817370|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83817371|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83817372|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817373|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
83817374|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83817375|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
83817376|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817377|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
83817378|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83817379|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817380|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83817381|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
83817382|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83817383|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817384|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817385|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817386|NCT00262210|Prednisolone|prednisolone|mesh-list
83817387|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
83817388|NCT00262210|Etoposide|etoposide|mesh-list
83817389|NCT00262210|Epirubicin|epirubicin|mesh-list
83817390|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817391|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
83817392|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817393|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817394|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83817395|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
83817396|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817397|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817398|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83817399|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83817400|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83817401|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83817402|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817403|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817404|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
83817405|NCT00262210|Hormones|hormones|mesh-ancestor
83817406|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817407|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83817408|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83817409|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83817410|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83817411|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817412|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
83817413|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817414|NCT00262327|Endostatins|endostatins|mesh-list
83817415|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817416|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83817417|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83817418|NCT00262327|Growth Substances|growth substances|mesh-ancestor
83817419|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817420|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83817421|NCT02966288|Ibuprofen|ibuprofen|mesh-list
83817422|NCT02966288|Ketorolac|ketorolac|mesh-list
83817423|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83817424|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83817425|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83817426|NCT02966288|Analgesics|analgesics|mesh-ancestor
83817427|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
83817428|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817429|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817430|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817431|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817432|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83817433|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817434|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817435|NCT00262405|Prednisone|prednisone|mesh-list
83817436|NCT00262405|Zileuton|zileuton|mesh-list
83817437|NCT00262405|Azathioprine|azathioprine|mesh-list
83817438|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817439|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
83817440|NCT00262405|Hormones|hormones|mesh-ancestor
83817441|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817442|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817443|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83817444|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817445|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
83817446|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817447|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817448|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817449|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
83817450|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817451|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83817452|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83817453|NCT00262405|Analgesics|analgesics|mesh-ancestor
83817454|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
83817455|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817456|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83817457|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817458|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83817459|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
83817460|NCT00262483|Ribavirin|ribavirin|mesh-list
83817461|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83817462|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
83817463|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817464|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
83817465|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817466|NCT00262561|Aspirin|aspirin|mesh-list
83817467|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83817468|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83817469|NCT00262561|Analgesics|analgesics|mesh-ancestor
83817470|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
83817471|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817472|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817473|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817474|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817475|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83817476|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83817477|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817478|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83817479|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83817480|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817481|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
83817482|NCT00072215|Paclitaxel|paclitaxel|mesh-list
83817483|NCT00072215|Vinblastine|vinblastine|mesh-list
83817484|NCT00072215|Ifosfamide|ifosfamide|mesh-list
83817485|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83817486|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817487|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
83817488|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
83817489|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
83817490|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817491|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83817492|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
83817493|NCT00262795|Fludarabine|fludarabine|mesh-list
83817494|NCT00262795|Chlorambucil|chlorambucil|mesh-list
83817495|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817496|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817497|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83817498|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
83817499|NCT00072332|Cisplatin|cisplatin|mesh-list
83817500|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817501|NCT00263029|Capecitabine|capecitabine|mesh-list
83817502|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
83817503|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817504|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
83817505|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817506|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817507|NCT00263068|Rotigotine|rotigotine|mesh-list
83817508|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
83817509|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
83817510|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817511|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817512|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817513|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83817514|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83817515|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83817516|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817517|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817518|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83817519|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83817520|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83817521|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
83817522|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817523|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817524|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83817525|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83817526|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
83817527|NCT00263185|Vitamin D|vitamin d|mesh-list
83817528|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
83817529|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
83817530|NCT00263185|Vitamins|vitamins|mesh-list
83817531|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
83817532|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
83817533|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817534|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83817535|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817536|NCT00263185|Antacids|antacids|mesh-ancestor
83817537|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817538|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817539|NCT00263263|Sirolimus|sirolimus|mesh-list
83817540|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83817541|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817542|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83817543|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817544|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
83817545|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817546|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
83817547|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817548|NCT00101673|Vildagliptin|vildagliptin|mesh-list
83817549|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83817550|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817551|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83817552|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
83817553|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817554|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817555|NCT00263302|Dexamethasone|dexamethasone|mesh-list
83817556|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817557|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
83817558|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
83817559|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817560|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817561|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817562|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
83817563|NCT00263302|Hormones|hormones|mesh-ancestor
83817564|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817565|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83817566|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817567|NCT00263458|Buprenorphine|buprenorphine|mesh-list
83817568|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83817569|NCT00263458|Narcotics|narcotics|mesh-ancestor
83817570|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817571|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817572|NCT00263458|Analgesics|analgesics|mesh-ancestor
83817573|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
83817574|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817575|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83817576|NCT00101712|Vildagliptin|vildagliptin|mesh-list
83817577|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83817578|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817579|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83817580|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
83817581|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817582|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817583|NCT00072527|Carboplatin|carboplatin|mesh-list
83817584|NCT00072527|Irinotecan|irinotecan|mesh-list
83817585|NCT00072527|Etoposide|etoposide|mesh-list
83817586|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817587|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83817588|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83817589|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817590|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817591|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83817592|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83817593|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
83817594|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
83817595|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83817596|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817597|NCT00263965|Metformin|metformin|mesh-list
83817598|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83817599|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817600|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
83817601|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817602|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817603|NCT00072683|Tolvaptan|tolvaptan|mesh-list
83817604|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83817605|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817606|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
83817607|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817608|NCT00101790|Pamidronate|pamidronate|mesh-list
83817609|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817610|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817611|NCT00264277|Vitamin K|vitamin k|mesh-list
83817612|NCT00264277|Anticoagulants|anticoagulants|mesh-list
83817613|NCT00264277|Vitamins|vitamins|mesh-ancestor
83817614|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
83817615|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817616|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83817617|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83817618|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817619|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
83817620|NCT00264277|Coagulants|coagulants|mesh-ancestor
83817621|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83817622|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817623|NCT04709029|Dexamethasone|dexamethasone|mesh-list
83817624|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
83817625|NCT04709029|BB 1101|bb 1101|mesh-list
83817626|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817627|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
83817628|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
83817629|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817630|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817631|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817632|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
83817633|NCT04709029|Hormones|hormones|mesh-ancestor
83817634|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817635|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83817636|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817637|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
83817638|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817639|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817640|NCT00072722|Pomalidomide|pomalidomide|mesh-list
83817641|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
83817642|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817643|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83817644|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83817645|NCT00072722|Growth Substances|growth substances|mesh-ancestor
83817646|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
83817647|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817648|NCT00264355|Cyclosporine|cyclosporine|mesh-list
83817649|NCT00264355|Cyclosporins|cyclosporins|mesh-list
83817650|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817651|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817652|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817653|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
83817654|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817655|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
83817656|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817657|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83817658|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817659|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83817660|NCT00264472|Eniluracil|eniluracil|mesh-list
83817661|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817662|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817663|NCT00101829|Rituximab|rituximab|mesh-list
83817664|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83817665|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817666|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
83817667|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817668|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817669|NCT00072839|Teduglutide|teduglutide|mesh-list
83817670|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817671|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83817672|NCT00072839|Protective Agents|protective agents|mesh-ancestor
83817673|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817674|NCT00264628|Casopitant|casopitant|mesh-list
83817675|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
83817676|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
83817677|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817678|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817679|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83817680|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83817681|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817682|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817683|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
83817684|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83817685|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817686|NCT00265018|Doxorubicin|doxorubicin|mesh-list
83817687|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83817688|NCT00265018|Bleomycin|bleomycin|mesh-list
83817689|NCT00265018|Vinblastine|vinblastine|mesh-list
83817690|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83817691|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817692|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83817693|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83817694|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817695|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817696|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83817697|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83817698|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83817699|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83817700|NCT00265135|Siltuximab|siltuximab|mesh-list
83817701|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817702|NCT00106197|Bupropion|bupropion|mesh-list
83817703|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83817704|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
83817705|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83817706|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83817707|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83817708|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817709|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817710|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
83817711|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817712|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817713|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83817714|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83817715|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817716|NCT00265252|Alendronate|alendronate|mesh-list
83817717|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817718|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817719|NCT00265291|Fluoxetine|fluoxetine|mesh-list
83817720|NCT00265291|Desipramine|desipramine|mesh-list
83817721|NCT00265291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83817722|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83817723|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817724|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817725|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817726|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
83817727|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817728|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82973150|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
82973151|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817729|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
83817730|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83817731|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83817732|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83817733|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817734|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83817735|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83817736|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
83817738|NCT00265408|Warfarin|warfarin|mesh-list
83817739|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83817740|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83817741|NCT00265408|Analgesics|analgesics|mesh-ancestor
83817742|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
83817743|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817744|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817745|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817746|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817747|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83817748|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83817749|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817750|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83817751|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83817752|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817753|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
83817754|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
83817755|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
83817756|NCT00265486|Hematinics|hematinics|mesh-ancestor
83817757|NCT00265642|Irbesartan|irbesartan|mesh-list
83817758|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83817759|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83817760|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83817761|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817762|NCT00265876|Gemcitabine|gemcitabine|mesh-list
83817763|NCT00265876|Saracatinib|saracatinib|mesh-list
83817764|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817765|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
83817766|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817767|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817768|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817769|NCT00265915|Rituximab|rituximab|mesh-list
83817770|NCT00265915|Sargramostim|sargramostim|mesh-list
83817771|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83817772|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817773|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
83817774|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817775|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817776|NCT00265993|Enoxaparin|enoxaparin|mesh-list
83817777|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
83817778|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83817779|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83817780|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817781|NCT00266149|Lamotrigine|lamotrigine|mesh-list
83817782|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
83817783|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83817784|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817785|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817786|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83817787|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817788|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83817789|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83817790|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817791|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83817792|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83817793|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83817794|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83817795|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
83817796|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817797|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83817798|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83817799|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817800|NCT00415831|Levodopa|levodopa|mesh-list
83817801|NCT00415831|Carbidopa|carbidopa|mesh-list
83817802|NCT00415831|Entacapone|entacapone|mesh-list
82973224|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817803|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83817804|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83817805|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83817807|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817808|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817809|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817810|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83817811|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817812|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83817813|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83817814|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
83817815|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
83817816|NCT00102141|Drospirenone|drospirenone|mesh-list
83817817|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83817818|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83817819|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83817820|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83817821|NCT00102141|Estradiol|estradiol|mesh-list
83817822|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83817823|NCT00102141|Estrogens|estrogens|mesh-ancestor
83817824|NCT00102141|Hormones|hormones|mesh-ancestor
83817825|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817826|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817827|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83817828|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
83817829|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83817830|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83817831|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83817832|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
83817833|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83817834|NCT00102141|Diuretics|diuretics|mesh-ancestor
83817835|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
83817836|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83817837|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83817838|NCT00266344|Gaboxadol|gaboxadol|mesh-list
83817839|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817840|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817841|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817842|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817843|NCT00266344|Analgesics|analgesics|mesh-ancestor
83817844|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
83817845|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
83817846|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
83817847|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
83817848|NCT00266539|Fentanyl|fentanyl|mesh-list
83817849|NCT00266539|Morphine|morphine|mesh-list
83817850|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83817851|NCT00266539|Narcotics|narcotics|mesh-ancestor
83817852|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83817853|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817854|NCT00266539|Analgesics|analgesics|mesh-ancestor
83817855|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
83817856|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817857|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83817858|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83817859|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
83817860|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
83817861|NCT00266578|Fluticasone|fluticasone|mesh-list
83817862|NCT00266578|Xhance|xhance|mesh-list
83817863|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817864|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83817865|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
83817866|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83817867|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817868|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83817869|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
83817870|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
83817871|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83817872|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
83817873|NCT00266617|Hematinics|hematinics|mesh-ancestor
83817874|NCT00102219|Doxorubicin|doxorubicin|mesh-list
83817875|NCT00102219|Pemetrexed|pemetrexed|mesh-list
83817876|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83817877|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817878|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83817879|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83817880|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817881|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817882|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83817883|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83817884|NCT01349569|Lenalidomide|lenalidomide|mesh-list
83817885|NCT01349569|Vaccines|vaccines|mesh-list
83817886|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
83817887|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817888|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83817889|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83817890|NCT01349569|Growth Substances|growth substances|mesh-ancestor
83817891|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
83817892|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817893|NCT00267163|Donepezil|donepezil|mesh-list
83817894|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83817895|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817896|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817897|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
83817898|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83817899|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817900|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
83817901|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
83817902|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
83817903|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83817904|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
83817905|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817906|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817907|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817908|NCT00073385|Docetaxel|docetaxel|mesh-list
83817909|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817910|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
83817911|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
83817912|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
83817913|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817914|NCT00102258|Hormones|hormones|mesh-list
83817915|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817916|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817917|NCT00267514|Sevelamer|sevelamer|mesh-list
83817918|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
83817919|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
83817920|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817921|NCT00267553|Toremifene|toremifene|mesh-list
83817922|NCT00267553|Letrozole|letrozole|mesh-list
83817923|NCT00267553|Atamestane|atamestane|mesh-list
83817924|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817925|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83817926|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83817927|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817928|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817929|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83817930|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
83817931|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83817932|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817933|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83817934|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83817935|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83817936|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83817937|NCT00106548|Methotrexate|methotrexate|mesh-list
83817938|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83817939|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
83817940|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83817941|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817942|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83817943|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
83817944|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817945|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817946|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
83817947|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817948|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83817949|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83817950|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
83817951|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973373|NCT05199324|Trimethoprim|trimethoprim|mesh-list
83817952|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83817953|NCT00267709|Visilizumab|visilizumab|mesh-list
83817954|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
83817955|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817956|NCT00267826|Rituximab|rituximab|mesh-list
83817957|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83817958|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817959|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
83817960|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817961|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83817962|NCT00425620|Amphotericin B|amphotericin b|mesh-list
83817963|NCT00425620|Amebicides|amebicides|mesh-ancestor
83817964|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83817965|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83817966|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83817967|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83817968|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
83817969|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83817970|NCT00267943|Telmisartan|telmisartan|mesh-list
83817971|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83817972|NCT00267943|Diuretics|diuretics|mesh-ancestor
83817973|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
83817974|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817975|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83817976|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83817977|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817978|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83817979|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83817980|NCT04711265|Vaccines|vaccines|mesh-list
83817981|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
83817982|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817983|NCT00268138|Fluorides|fluorides|mesh-list
83817984|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
83817985|NCT00268138|Protective Agents|protective agents|mesh-ancestor
83817986|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83817987|NCT00102375|Topotecan|topotecan|mesh-list
83817988|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83817989|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83817990|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83817991|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83817992|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83817993|NCT00268177|Fluticasone|fluticasone|mesh-list
83817994|NCT00268177|Xhance|xhance|mesh-list
83817995|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83817996|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83817997|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83817998|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
83817999|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818000|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818001|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818002|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818003|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
83818004|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83818005|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83818006|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83818007|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83818008|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818009|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818010|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818011|NCT00268216|Fluticasone|fluticasone|mesh-list
83818012|NCT00268216|Xhance|xhance|mesh-list
83818013|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83818014|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818015|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83818016|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
83818017|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818018|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818019|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818020|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818021|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
83818022|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83818023|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83818024|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83818025|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82973451|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
83818026|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818027|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818028|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818030|NCT00073580|Anticoagulants|anticoagulants|mesh-list
83818031|NCT00073580|Bivalirudin|bivalirudin|mesh-list
83818032|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
83818033|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83818034|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
83818035|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818036|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818037|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83818038|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83818039|NCT00073658|Risperidone|risperidone|mesh-list
83818040|NCT00073658|Citalopram|citalopram|mesh-list
83818041|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83818042|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
83818043|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818044|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818045|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818046|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83818047|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83818048|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818049|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83818050|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83818051|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
83818052|NCT00073658|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83818053|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83818054|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83818055|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83818056|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
83818057|NCT00268255|Gefitinib|gefitinib|mesh-list
83818058|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83818059|NCT00268255|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83818060|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818061|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83818062|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818063|NCT00102414|Gemcitabine|gemcitabine|mesh-list
83818064|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818065|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
83818066|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818067|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818068|NCT00268333|Leucovorin|leucovorin|mesh-list
83818069|NCT00268333|Fluorouracil|fluorouracil|mesh-list
83818070|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
83818071|NCT00268333|Calcium|calcium|mesh-list
83818072|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
83818073|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83818074|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818075|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
83818076|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818077|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818078|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818079|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818080|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
83818081|NCT00268333|Antidotes|antidotes|mesh-ancestor
83818082|NCT00268333|Protective Agents|protective agents|mesh-ancestor
83818083|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
83818084|NCT00268333|Vitamins|vitamins|mesh-ancestor
83818085|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
83818086|NCT00073697|Dexetimide|dexetimide|mesh-list
83818087|NCT00073697|Citalopram|citalopram|mesh-list
83818088|NCT00073697|Escitalopram|escitalopram|mesh-list
83818089|NCT00073697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83818090|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83818091|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83818092|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818093|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818094|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
83818095|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818096|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83818097|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83818098|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
83818099|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
83818100|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818101|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83818102|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83818103|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
83818104|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83818105|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
83818106|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83818108|NCT00268372|Fluorouracil|fluorouracil|mesh-list
83818109|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818110|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83818111|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83818112|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83818113|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818114|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
83818115|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818116|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818117|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
83818118|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818119|NCT00268411|Gemcitabine|gemcitabine|mesh-list
83818120|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
83818121|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818122|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
83818123|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818124|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818125|NCT00073736|Cytarabine|cytarabine|mesh-list
83818126|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818127|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
83818128|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818129|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818130|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
83818131|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818132|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818133|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
83818134|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818135|NCT00268489|Bevacizumab|bevacizumab|mesh-list
83818136|NCT00268489|Pemetrexed|pemetrexed|mesh-list
83818137|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83818138|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818139|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83818140|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83818141|NCT00268489|Growth Substances|growth substances|mesh-ancestor
83818142|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818143|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
83818144|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818145|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818146|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83818147|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818148|NCT00268528|Methotrexate|methotrexate|mesh-list
83818149|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
83818150|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83818151|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
83818152|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83818153|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818154|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818155|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
83818156|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818157|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818158|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
83818159|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818160|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83818161|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818162|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
83818163|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83818164|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818165|NCT00073814|Albuterol|albuterol|mesh-list
83818166|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83818167|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
83818168|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818169|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818170|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818171|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818172|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
83818173|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83818174|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83818175|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83818176|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83818177|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818178|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818179|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136521|NCT03576053|Lidocaine|lidocaine|mesh-list
83818180|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
83818181|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83818182|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818183|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818184|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83818185|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83818186|NCT00102453|Protective Agents|protective agents|mesh-ancestor
83818187|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818188|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
83818189|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83818190|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
83818191|NCT00268567|Prednisone|prednisone|mesh-list
83818192|NCT00268567|Leflunomide|leflunomide|mesh-list
83818193|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818194|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
83818195|NCT00268567|Hormones|hormones|mesh-ancestor
83818196|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818197|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818198|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83818199|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818200|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818201|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818202|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818203|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
83818204|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
83818205|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83818206|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818207|NCT00268684|Temozolomide|temozolomide|mesh-list
83818208|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83818209|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83818210|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
83818211|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818212|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818213|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83818214|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818215|NCT00106821|Bromides|bromides|mesh-list
83818216|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
83818217|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83818218|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
83818219|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818220|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818221|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818222|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818223|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
83818224|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83818225|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
83818226|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818227|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818228|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
83818229|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
83818230|NCT00073931|Sargramostim|sargramostim|mesh-list
83818231|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
83818232|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818233|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818234|NCT00268723|Albuterol|albuterol|mesh-list
83818235|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83818236|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
83818237|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818238|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818239|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818240|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818241|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
83818242|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83818243|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83818244|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83818245|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83818246|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818247|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818248|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973675|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83818249|NCT00268840|Gemcitabine|gemcitabine|mesh-list
83818250|NCT00268840|Docetaxel|docetaxel|mesh-list
83818251|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818252|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
83818253|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818254|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818255|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
83818256|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
83818257|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
83818258|NCT00268879|Renzapride|renzapride|mesh-list
83818259|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83818260|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
83818261|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818262|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818263|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818264|NCT00268918|Docetaxel|docetaxel|mesh-list
83818265|NCT00268918|Vatalanib|vatalanib|mesh-list
83818266|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818267|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83818268|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83818269|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83818270|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818271|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83818272|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818273|NCT00268957|Sevelamer|sevelamer|mesh-list
83818274|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
83818275|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
83818276|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818277|NCT00073970|Celecoxib|celecoxib|mesh-list
83818278|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83818279|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83818280|NCT00073970|Analgesics|analgesics|mesh-ancestor
83818281|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
83818282|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818283|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818284|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818285|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83818286|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83818287|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83818288|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818289|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818290|NCT00102492|Casopitant|casopitant|mesh-list
83818291|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
83818292|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
83818293|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818294|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818295|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818296|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83818297|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818298|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818299|NCT00269035|Risperidone|risperidone|mesh-list
83818300|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83818301|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
83818302|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818303|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818304|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818305|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83818306|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83818307|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818308|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83818309|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83818310|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
83818311|NCT00074009|Bortezomib|bortezomib|mesh-list
83818312|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818313|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
83818314|NCT00269386|Clarithromycin|clarithromycin|mesh-list
83818315|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83818316|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818317|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83818318|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818319|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818320|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83818321|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83818322|NCT00074087|Doxorubicin|doxorubicin|mesh-list
83818323|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83818324|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83818325|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818326|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83818327|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83818328|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818329|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818330|NCT00269542|Iron|iron|mesh-list
83818331|NCT00269542|Folic Acid|folic acid|mesh-list
83818332|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
83818333|NCT00269542|Trace Elements|trace elements|mesh-ancestor
83818334|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
83818335|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818336|NCT00269542|Hematinics|hematinics|mesh-ancestor
83818337|NCT00269542|Vitamins|vitamins|mesh-ancestor
83818338|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83818339|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83818340|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83818341|NCT00269620|Etonogestrel|etonogestrel|mesh-list
83818342|NCT00269620|NuvaRing|nuvaring|mesh-list
83818343|NCT00269620|Norelgestromin|norelgestromin|mesh-list
83818344|NCT00269620|Ortho Evra|ortho evra|mesh-list
83818345|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
83818346|NCT00269620|Estradiol|estradiol|mesh-list
83818347|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83818348|NCT00269620|Estrogens|estrogens|mesh-ancestor
83818349|NCT00269620|Hormones|hormones|mesh-ancestor
83818350|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818351|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818352|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83818353|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83818354|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83818355|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83818356|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83818357|NCT00074204|Carboplatin|carboplatin|mesh-list
83818358|NCT00074204|Gemcitabine|gemcitabine|mesh-list
83818359|NCT00074204|Docetaxel|docetaxel|mesh-list
83818360|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818361|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818362|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
83818363|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818364|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83818365|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83818366|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83818367|NCT00416143|Prednisone|prednisone|mesh-list
83818368|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818369|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
83818370|NCT00416143|Hormones|hormones|mesh-ancestor
83818371|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818372|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818373|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83818374|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818375|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
83818376|NCT00416221|Escitalopram|escitalopram|mesh-list
83818377|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83818378|NCT00416221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83818379|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83818380|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83818381|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818382|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818383|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
83818384|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818385|NCT00269737|Fentanyl|fentanyl|mesh-list
83818386|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83818387|NCT00269737|Narcotics|narcotics|mesh-ancestor
83818388|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818389|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818390|NCT00269737|Analgesics|analgesics|mesh-ancestor
83818391|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
83818392|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818393|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83818394|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83818395|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
83818396|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
83818397|NCT00269776|Methylphenidate|methylphenidate|mesh-list
82973825|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818398|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83818399|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818400|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83818401|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83818402|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83818403|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818404|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
83818405|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818406|NCT00269815|Methylphenidate|methylphenidate|mesh-list
83818407|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83818408|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818409|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83818410|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83818411|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83818412|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818413|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
83818414|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818415|NCT00269854|Infliximab|infliximab|mesh-list
83818416|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83818417|NCT00269854|Antibodies|antibodies|mesh-list
83818418|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
83818419|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83818420|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
83818421|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818422|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818423|NCT00269854|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83818424|NCT00269854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818425|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
83818426|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818427|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83818428|NCT00269893|Abciximab|abciximab|mesh-list
83818429|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
83818430|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83818431|NCT00074321|Capecitabine|capecitabine|mesh-list
83818432|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
83818433|NCT00074321|Irinotecan|irinotecan|mesh-list
83818434|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818435|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
83818436|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818437|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818438|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83818439|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83818440|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818441|NCT00102609|Dexamethasone|dexamethasone|mesh-list
83818442|NCT00102609|Doxorubicin|doxorubicin|mesh-list
83818443|NCT00102609|Trabectedin|trabectedin|mesh-list
83818444|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818445|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
83818446|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
83818447|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818448|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818449|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818450|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
83818451|NCT00102609|Hormones|hormones|mesh-ancestor
83818452|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818453|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83818454|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818455|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83818456|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83818457|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83818458|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818459|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818460|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83818461|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
83818462|NCT00269932|Levofloxacin|levofloxacin|mesh-list
83818463|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83818464|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818465|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83818466|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83818467|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83818468|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818469|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818470|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818471|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83818472|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83818473|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
83818474|NCT00269971|Hematinics|hematinics|mesh-ancestor
83818475|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
83818476|NCT00270010|Hematinics|hematinics|mesh-ancestor
83818477|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
83818478|NCT00270049|Hematinics|hematinics|mesh-ancestor
83818479|NCT00107016|Letrozole|letrozole|mesh-list
83818480|NCT00107016|Everolimus|everolimus|mesh-list
83818481|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818482|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83818483|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83818484|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818485|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818486|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83818487|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
83818488|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818489|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818490|NCT00107016|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83818491|NCT00107016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83818492|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818493|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
83818494|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
83818495|NCT00270088|Hematinics|hematinics|mesh-ancestor
83818496|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
83818497|NCT00270127|Hematinics|hematinics|mesh-ancestor
83818498|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
83818499|NCT00270166|Hematinics|hematinics|mesh-ancestor
83818500|NCT00074399|Nevirapine|nevirapine|mesh-list
83818501|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83818502|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818503|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818504|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818505|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
83818506|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818507|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83818508|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83818509|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83818510|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83818511|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
83818512|NCT00270283|Hematinics|hematinics|mesh-ancestor
83818513|NCT00270322|Fentanyl|fentanyl|mesh-list
83818514|NCT00270322|Morphine|morphine|mesh-list
83818515|NCT00270322|Bupivacaine|bupivacaine|mesh-list
83818516|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83818517|NCT00270322|Narcotics|narcotics|mesh-ancestor
83818518|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818519|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818520|NCT00270322|Analgesics|analgesics|mesh-ancestor
83818521|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
83818522|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818523|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83818524|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83818525|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
83818526|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
83818527|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
83818528|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83818529|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
83818530|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818531|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
83818532|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
83818533|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
83818534|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818535|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818536|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
83818537|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818538|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83818539|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
83818540|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818541|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83818542|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818543|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
83818544|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
83818545|NCT00270478|Hematinics|hematinics|mesh-ancestor
83818546|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818547|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
83818548|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818549|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136606|NCT03572231|Urological Agents|urological agents|mesh-ancestor
83818550|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818551|NCT00270517|Telithromycin|telithromycin|mesh-list
83818552|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83818553|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818554|NCT00270556|Tenofovir|tenofovir|mesh-list
83818555|NCT00270556|Abacavir|abacavir|mesh-list
83818556|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
83818557|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818558|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83818559|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818560|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818561|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818562|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83818563|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83818564|NCT00074438|Rituximab|rituximab|mesh-list
83818565|NCT00074438|Methotrexate|methotrexate|mesh-list
83818566|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83818567|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818568|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
83818569|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818570|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83818571|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83818572|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
83818573|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83818574|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818575|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
83818576|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818577|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
83818578|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818579|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83818580|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818581|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818582|NCT00270751|Minocycline|minocycline|mesh-list
83818583|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83818584|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818585|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83818586|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
83818587|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818588|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
83818589|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83818590|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818591|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818592|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83818593|NCT04730375|Analgesics|analgesics|mesh-ancestor
83818594|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
83818595|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818596|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83818597|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83818598|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83818599|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818600|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818601|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818602|NCT00270907|Gemcitabine|gemcitabine|mesh-list
83818603|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83818604|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818605|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
83818606|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818607|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818608|NCT00271063|Annamycin|annamycin|mesh-list
83818609|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83818610|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818611|NCT00107523|Cytarabine|cytarabine|mesh-list
83818612|NCT00107523|Idarubicin|idarubicin|mesh-list
83818613|NCT00107523|Pravastatin|pravastatin|mesh-list
83818614|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83818615|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
83818616|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818617|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818618|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
83818619|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818620|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818621|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
83818622|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818623|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83818624|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83818625|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83818626|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818627|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83818629|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83818630|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83818631|NCT00416377|Prednisolone|prednisolone|mesh-list
83818632|NCT00416377|Doxorubicin|doxorubicin|mesh-list
83818633|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83818634|NCT00416377|Bleomycin|bleomycin|mesh-list
83818635|NCT00416377|Vincristine|vincristine|mesh-list
83818636|NCT00416377|Dacarbazine|dacarbazine|mesh-list
83818637|NCT00416377|Vinblastine|vinblastine|mesh-list
83818638|NCT00416377|Procarbazine|procarbazine|mesh-list
83818639|NCT00416377|Chlorambucil|chlorambucil|mesh-list
83818640|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83818641|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818642|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83818643|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83818644|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818645|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818646|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83818647|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
83818648|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
83818649|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
83818650|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818651|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
83818652|NCT00416377|Hormones|hormones|mesh-ancestor
83818653|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818654|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818655|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83818656|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83818657|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
83818658|NCT02965859|Adefovir|adefovir|mesh-list
83818659|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83818660|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
83818661|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818662|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83818663|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818664|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818665|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818666|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
83818667|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83818668|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818669|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818670|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83818671|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83818672|NCT00271336|Protective Agents|protective agents|mesh-ancestor
83818673|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818674|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
83818675|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83818676|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
83818677|NCT00271414|Fentanyl|fentanyl|mesh-list
83818678|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83818679|NCT00271414|Narcotics|narcotics|mesh-ancestor
83818680|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818681|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818682|NCT00271414|Analgesics|analgesics|mesh-ancestor
83818683|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
83818684|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818685|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83818686|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83818687|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
83818688|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
83818689|NCT00271453|Fentanyl|fentanyl|mesh-list
83818690|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83818691|NCT00271453|Narcotics|narcotics|mesh-ancestor
83818692|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818693|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818694|NCT00271453|Analgesics|analgesics|mesh-ancestor
83818695|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
83818696|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818697|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83818698|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83818699|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
83818700|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
83818701|NCT00271492|Atrasentan|atrasentan|mesh-list
83818702|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818703|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83818704|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83818705|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818707|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818708|NCT00107601|Insulin|insulin|mesh-list
83818709|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83818710|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818711|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
83818712|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83818713|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818714|NCT00272116|Vitamins|vitamins|mesh-list
83818715|NCT00272116|Vitamin A|vitamin a|mesh-list
83818716|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
83818717|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
83818718|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818719|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
83818720|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818721|NCT00272116|Protective Agents|protective agents|mesh-ancestor
83818722|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83818723|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818724|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
83818725|NCT00272428|Vitamin E|vitamin e|mesh-list
83818726|NCT00272428|Beta Carotene|beta carotene|mesh-list
83818727|NCT00272428|Selenium|selenium|mesh-list
83818728|NCT00272428|Carotenoids|carotenoids|mesh-list
83818729|NCT00272428|Vitamins|vitamins|mesh-ancestor
83818730|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
83818731|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818732|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
83818733|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818734|NCT00272428|Protective Agents|protective agents|mesh-ancestor
83818735|NCT00272428|Trace Elements|trace elements|mesh-ancestor
83818736|NCT00272428|Provitamins|provitamins|mesh-ancestor
83818737|NCT00272467|Omeprazole|omeprazole|mesh-list
83818738|NCT00272467|Rebamipide|rebamipide|mesh-list
83818739|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83818740|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818741|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83818742|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818743|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818744|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
83818745|NCT00272467|Protective Agents|protective agents|mesh-ancestor
83818746|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818747|NCT00272584|Risperidone|risperidone|mesh-list
83818748|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83818749|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
83818750|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818751|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818752|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818753|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83818754|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83818755|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818756|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83818757|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83818758|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
83818759|NCT00272701|Esomeprazole|esomeprazole|mesh-list
83818760|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83818761|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818762|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83818763|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818764|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818765|NCT00272740|Fulvestrant|fulvestrant|mesh-list
83818766|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83818767|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818768|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83818769|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83818770|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
83818771|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818772|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818773|NCT00074750|Molgramostim|molgramostim|mesh-list
83818774|NCT00074750|Sargramostim|sargramostim|mesh-list
83818775|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
83136669|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83818776|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818777|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818778|NCT00416533|Prednisone|prednisone|mesh-list
83818779|NCT00416533|Docetaxel|docetaxel|mesh-list
83818780|NCT00416533|Doxorubicin|doxorubicin|mesh-list
83818781|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83818782|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818783|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
83818784|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
83818785|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
83818786|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818787|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83818788|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83818789|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83818790|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818791|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818792|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
83818793|NCT00416533|Hormones|hormones|mesh-ancestor
83818794|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818795|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818796|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83818797|NCT00107796|Modafinil|modafinil|mesh-list
83818798|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83818799|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818800|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83818801|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83818802|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83818803|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818804|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
83818805|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818806|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
83818807|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83818808|NCT00272896|Protective Agents|protective agents|mesh-ancestor
83818809|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818810|NCT00272935|Estrogens|estrogens|mesh-list
83818811|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83818812|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
83818813|NCT00272935|Hormones|hormones|mesh-ancestor
83818814|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818815|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818816|NCT00273013|Montelukast|montelukast|mesh-list
83818817|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818818|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818819|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83818820|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
83818821|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818822|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818823|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83818824|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83818825|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818826|NCT00107835|Lidocaine|lidocaine|mesh-list
83818827|NCT00107835|Tetracaine|tetracaine|mesh-list
83818828|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
83818829|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
83818830|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83818831|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818832|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
83818833|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818834|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83818835|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83818836|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83818837|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136687|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83818838|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818839|NCT00107874|Misoprostol|misoprostol|mesh-list
83818840|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83818841|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
83818842|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83818843|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818844|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83818845|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818846|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
83818847|NCT00074828|Enoxaparin|enoxaparin|mesh-list
83818848|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
83818849|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83818850|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83818851|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818852|NCT00273247|Interferons|interferons|mesh-list
83818853|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
83818855|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818856|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
83818857|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818858|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
83818859|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818860|NCT00273442|Timolol|timolol|mesh-list
83818861|NCT00273442|Dorzolamide|dorzolamide|mesh-list
83818862|NCT00273442|Maleic acid|maleic acid|mesh-list
83818863|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818864|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818865|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83818866|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83818867|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818868|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818869|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818870|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83818871|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83818872|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83818873|NCT00401427|Trastuzumab|trastuzumab|mesh-list
83818874|NCT00401427|Vinorelbine|vinorelbine|mesh-list
83818875|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83818876|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818877|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83818878|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83818879|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83818880|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83818881|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818882|NCT00273481|Timolol|timolol|mesh-list
83818883|NCT00273481|Dorzolamide|dorzolamide|mesh-list
83818884|NCT00273481|Latanoprost|latanoprost|mesh-list
83818885|NCT00273481|Maleic acid|maleic acid|mesh-list
83818886|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818887|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818888|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83818889|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83818890|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818891|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818892|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818893|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83818894|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83818895|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83818896|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83818897|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83818898|NCT00273520|Telithromycin|telithromycin|mesh-list
83818899|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83818900|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818901|NCT00273559|Prednisone|prednisone|mesh-list
83818902|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818903|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
83818904|NCT00273559|Hormones|hormones|mesh-ancestor
83818905|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83818906|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818907|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83818908|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83818909|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83818910|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83818911|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818912|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
83818913|NCT00273871|Cyclosporine|cyclosporine|mesh-list
83818914|NCT00273871|Tacrolimus|tacrolimus|mesh-list
83818915|NCT00273871|Cyclosporins|cyclosporins|mesh-list
83818916|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83818917|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
83818918|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818919|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83818920|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818921|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818922|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
83818923|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818924|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
83818925|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83818926|NCT00273949|Lactulose|lactulose|mesh-list
83818927|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83818928|NCT00273988|Nevirapine|nevirapine|mesh-list
83818929|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83818930|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83818931|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818932|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818933|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
83818934|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83818935|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83818936|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83818937|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83818938|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83818939|NCT00274027|Bromides|bromides|mesh-list
83818940|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
83818941|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83818942|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
83818943|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818944|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818945|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818946|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818947|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
83818948|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83818949|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
83818950|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818951|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818952|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
83818953|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83818954|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83818955|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83818956|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818957|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
83818958|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818959|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818960|NCT00274066|Fenoterol|fenoterol|mesh-list
83818961|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
83818962|NCT00274066|Ipratropium|ipratropium|mesh-list
83818963|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83818964|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
83818965|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818966|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818967|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83818968|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
83818969|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
83818970|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83818971|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
83818972|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83818973|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818974|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
83818975|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
83818976|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83818977|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83818978|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83818979|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83818980|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
83818981|NCT00274105|Telmisartan|telmisartan|mesh-list
83818982|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83818983|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83818984|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83818985|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818986|NCT00274144|Telmisartan|telmisartan|mesh-list
83818987|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83818988|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83818989|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83818990|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83818991|NCT00108186|Celecoxib|celecoxib|mesh-list
83818992|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83818993|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83818994|NCT00108186|Analgesics|analgesics|mesh-ancestor
83818995|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
83818996|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83818997|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83818998|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83818999|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819000|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83819001|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82974431|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819002|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819003|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819004|NCT00274339|Lansoprazole|lansoprazole|mesh-list
83819005|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83819006|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83819007|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83819008|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819009|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819010|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83819011|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
83819012|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819013|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83819014|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819015|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83819016|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819017|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819018|NCT00274417|Dutasteride|dutasteride|mesh-list
83136728|NCT02842073|Bupropion|bupropion|mesh-list
83819019|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83819020|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83819021|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819022|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819023|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
83819024|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819025|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819026|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
83819027|NCT00274495|Ribavirin|ribavirin|mesh-list
83819028|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83819029|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
83819030|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819031|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
83819032|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819033|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83819034|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819035|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
83819036|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83819037|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83819038|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
83819039|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819040|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819041|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83819042|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819043|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
83819044|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83819045|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
83819046|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819047|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819048|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83819049|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83819050|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83819051|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
83819052|NCT00274573|Bromides|bromides|mesh-list
83819053|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
83819054|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83819055|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
83819056|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819057|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819058|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83819059|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819060|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
83819061|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83819062|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83819063|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819064|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819065|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
83819066|NCT00274612|Telmisartan|telmisartan|mesh-list
83819067|NCT00274612|Ramipril|ramipril|mesh-list
83819068|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819069|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83819070|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83819071|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819072|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83819073|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
83819074|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819075|NCT00075374|Docetaxel|docetaxel|mesh-list
83819076|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819077|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
83819078|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
83819079|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
83136741|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
83819080|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819081|NCT00274690|Casopitant|casopitant|mesh-list
83819082|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
83819083|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
83819084|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819085|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819086|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83819087|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83819088|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819089|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819090|NCT00274807|Cytarabine|cytarabine|mesh-list
83819091|NCT00274807|Etoposide|etoposide|mesh-list
83819092|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
83819093|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83819094|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819095|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83819096|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83819097|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819098|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819099|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819100|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
83819101|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
83819102|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819103|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819104|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
83819105|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819106|NCT00274807|Analgesics|analgesics|mesh-ancestor
83819107|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
83819108|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819109|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
83819110|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819111|NCT00277225|Abatacept|abatacept|mesh-list
83819112|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83819113|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819114|NCT00277225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83819115|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819116|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819117|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
83819118|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819119|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819120|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
83819121|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83819122|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
83819123|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819124|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819125|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83819126|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819127|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
83819128|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83819129|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
83819130|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819131|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819132|NCT00108420|Prazosin|prazosin|mesh-list
83819133|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819134|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83819135|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83819136|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82974583|NCT05489796|Ketorolac|ketorolac|mesh-list
82974584|NCT05489796|Fentanyl|fentanyl|mesh-list
82974585|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82974586|NCT05489796|Narcotics|narcotics|mesh-ancestor
82974587|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136758|NCT02135887|Antidotes|antidotes|mesh-ancestor
82974588|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974589|NCT05489796|Analgesics|analgesics|mesh-ancestor
82974590|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
82974591|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974592|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82974593|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82974594|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
82974595|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
83819137|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
83819138|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819139|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819140|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819141|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
83819142|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819143|NCT00277342|Insulin|insulin|mesh-list
83819144|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83819145|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819146|NCT00277498|Timolol|timolol|mesh-list
83819147|NCT00277498|Latanoprost|latanoprost|mesh-list
83819148|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83819149|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83819150|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
83819151|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819152|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819153|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819154|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83819155|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819156|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83819157|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83819158|NCT00108498|Mirtazapine|mirtazapine|mesh-list
83819159|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
83819160|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819161|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83819162|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
83819163|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
83819164|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819165|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819166|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819167|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83819168|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819169|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819170|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83819171|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83819172|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83819173|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
83819174|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83819175|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83819176|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
83819177|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83819178|NCT00277537|Mannitol|mannitol|mesh-list
83819179|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83819180|NCT00277537|Diuretics|diuretics|mesh-ancestor
83819181|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
83819182|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819183|NCT00075452|Gemcitabine|gemcitabine|mesh-list
83819184|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
83819185|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819186|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
82974659|NCT05309629|Carboplatin|carboplatin|mesh-list
82974660|NCT05309629|Etoposide|etoposide|mesh-list
82974661|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136765|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
82974662|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82974663|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82974664|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82974665|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974666|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974667|NCT05297565|Nivolumab|nivolumab|mesh-list
82974668|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974669|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974670|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974671|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974672|NCT05209620|Pemetrexed|pemetrexed|mesh-list
82974673|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974674|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974675|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974676|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82974677|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82974678|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
82974679|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82974680|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819187|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819188|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819189|NCT00108537|Bupropion|bupropion|mesh-list
83819190|NCT00108537|Nicotine|nicotine|mesh-list
83819191|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83819192|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
83819193|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819194|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819195|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83819196|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83819197|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
83819198|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819199|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819200|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83819201|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
83819202|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819203|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83819204|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83819205|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83819206|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
83819207|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83819208|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83819209|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819210|NCT00277654|Risperidone|risperidone|mesh-list
83819211|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83819212|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
83819213|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819214|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819215|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819216|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83819217|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819218|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819219|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819220|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83819221|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
83819222|NCT00277693|Spironolactone|spironolactone|mesh-list
83819223|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83819224|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
83819225|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819226|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819227|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83819228|NCT00277693|Diuretics|diuretics|mesh-ancestor
83819229|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
83819230|NCT00108576|Valproic Acid|valproic acid|mesh-list
83819231|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
83819232|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819233|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819234|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
83819235|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819236|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819237|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
83819238|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819239|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819240|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819241|NCT00075491|Fenretinide|fenretinide|mesh-list
83819242|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819243|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83819244|NCT00075491|Protective Agents|protective agents|mesh-ancestor
83819245|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819246|NCT00108615|Metformin|metformin|mesh-list
83819247|NCT00108615|Pioglitazone|pioglitazone|mesh-list
83819248|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83819249|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819250|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
83819251|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83819252|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
83819253|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819254|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819255|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83819256|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819257|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83819258|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
83819259|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974730|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
82974731|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83819260|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819261|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83819262|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
83819263|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
83819264|NCT00278083|Protective Agents|protective agents|mesh-ancestor
83819265|NCT00278122|Paclitaxel|paclitaxel|mesh-list
83819266|NCT00278122|Sargramostim|sargramostim|mesh-list
83819267|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83819268|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819269|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
83819270|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
83819271|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
83819272|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819273|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
83819274|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819275|NCT00075647|Sirolimus|sirolimus|mesh-list
83819276|NCT00075647|Temsirolimus|temsirolimus|mesh-list
83819277|NCT00075647|MTOR Inhibitors|mtor inhibitors|mesh-list
83819278|NCT00075647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83819279|NCT00075647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819280|NCT00075647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819281|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819282|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
83819283|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819284|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819285|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83819286|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819287|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83819288|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
83819289|NCT00278278|Prednisone|prednisone|mesh-list
83819290|NCT00278278|Methotrexate|methotrexate|mesh-list
83819291|NCT00278278|Etoposide|etoposide|mesh-list
83819292|NCT00278278|Vincristine|vincristine|mesh-list
83819293|NCT00278278|Ifosfamide|ifosfamide|mesh-list
83819294|NCT00278278|Lomustine|lomustine|mesh-list
83819295|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819296|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83819297|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
83819298|NCT00278278|Hormones|hormones|mesh-ancestor
83819299|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819300|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819301|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83819302|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83819303|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
83819304|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83819305|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819306|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
83819307|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819308|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83819309|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819310|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83819311|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819312|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
83819313|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819314|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83819315|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83819316|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83819317|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83819318|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83819319|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83819320|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83819321|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83819322|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
83819323|NCT00108771|Fentanyl|fentanyl|mesh-list
83819324|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83819325|NCT00108771|Narcotics|narcotics|mesh-ancestor
83819326|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819327|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819328|NCT00108771|Analgesics|analgesics|mesh-ancestor
83819329|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
83819330|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819331|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82974805|NCT04967495|Estrogens|estrogens|mesh-ancestor
83819332|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83819333|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
83819334|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
83819335|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
83819336|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83819337|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819338|NCT00075686|Gemcitabine|gemcitabine|mesh-list
83819339|NCT00075686|Cetuximab|cetuximab|mesh-list
83819340|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819341|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
83819342|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819343|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136816|NCT02242799|Artesunate|artesunate|mesh-list
83819344|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83819345|NCT00278824|Fentanyl|fentanyl|mesh-list
83819346|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83819347|NCT00278824|Narcotics|narcotics|mesh-ancestor
83819348|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819349|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819350|NCT00278824|Analgesics|analgesics|mesh-ancestor
83819351|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
83819352|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819353|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83819354|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83819355|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
83819356|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
83819357|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83819358|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
83819359|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819360|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83819361|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819362|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819363|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819364|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
83819365|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83819366|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
83819367|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819368|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819369|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83819370|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819371|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
83819372|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83819373|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
83819374|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819375|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819376|NCT00108849|Estradiol|estradiol|mesh-list
83819377|NCT00108849|Estrogens|estrogens|mesh-ancestor
83819378|NCT00108849|Hormones|hormones|mesh-ancestor
83819379|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819380|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819381|NCT00279058|Immunomodulating Agents|immunomodulating agents|mesh-list
83819382|NCT00279058|Immunologic Factors|immunologic factors|mesh-ancestor
83819383|NCT00279058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819384|NCT00279253|Clonidine|clonidine|mesh-list
83819385|NCT00279253|Analgesics|analgesics|mesh-ancestor
83819386|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
83819387|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819388|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819389|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819390|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
83819391|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
83819392|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83819393|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83819394|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83819395|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83819396|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819397|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819398|NCT00109044|Escitalopram|escitalopram|mesh-list
83819399|NCT00109044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83819400|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83819401|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83819402|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819403|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819404|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
83819405|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819406|NCT00279448|Tamoxifen|tamoxifen|mesh-list
83819407|NCT00279448|Exemestane|exemestane|mesh-list
83819408|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83819409|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
82974884|NCT04735354|Valsartan|valsartan|mesh-list
83819410|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819411|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819412|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83819413|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819414|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83819415|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83819416|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83819417|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83819418|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83819419|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819420|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819421|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
83819422|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
83819423|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819424|NCT00075959|Protective Agents|protective agents|mesh-ancestor
83819425|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819426|NCT00279487|Gabapentin|gabapentin|mesh-list
83819427|NCT00279487|Analgesics|analgesics|mesh-ancestor
83819428|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
83819429|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819430|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819431|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
83819432|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83819433|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819434|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819435|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819436|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83819437|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83819438|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819439|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819440|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
83819441|NCT00279565|Interferons|interferons|mesh-list
83819442|NCT00279565|Ribavirin|ribavirin|mesh-list
83819443|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
83819444|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
83819445|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83819446|NCT00279565|Buprenorphine|buprenorphine|mesh-list
83819447|NCT00279565|Methadone|methadone|mesh-list
83819448|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819449|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
83819450|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819451|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
83819452|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819453|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
83819454|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819455|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83819456|NCT00279565|Narcotics|narcotics|mesh-ancestor
83819457|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819458|NCT00279565|Analgesics|analgesics|mesh-ancestor
83819459|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
83819460|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819461|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83819462|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
83819463|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819464|NCT00075998|Interferons|interferons|mesh-list
83819465|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
83819466|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819467|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
83819468|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819469|NCT00109161|Antibodies|antibodies|mesh-list
83819470|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83819471|NCT00109161|Daclizumab|daclizumab|mesh-list
83819472|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
83819473|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819474|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819475|NCT00279760|Abatacept|abatacept|mesh-list
83819476|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83819477|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819478|NCT00279760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83819479|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819480|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819481|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
83819482|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819483|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819484|NCT00109200|Omalizumab|omalizumab|mesh-list
82974951|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
83819486|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83819487|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819488|NCT00416728|Valsartan|valsartan|mesh-list
83819489|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819490|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83819491|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83819492|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819493|NCT00416767|Leucovorin|leucovorin|mesh-list
83819494|NCT00416767|Fluorouracil|fluorouracil|mesh-list
83819495|NCT00416767|Irinotecan|irinotecan|mesh-list
83819496|NCT00416767|Calcium|calcium|mesh-list
83819497|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
83819498|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83819499|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819500|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
83819501|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819502|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819503|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819504|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819505|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
83819506|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83819507|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83819508|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819509|NCT00416767|Antidotes|antidotes|mesh-ancestor
83819510|NCT00416767|Protective Agents|protective agents|mesh-ancestor
83819511|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
83819512|NCT00416767|Vitamins|vitamins|mesh-ancestor
83819513|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
83819514|NCT00076115|Risperidone|risperidone|mesh-list
83819515|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83819516|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
83819517|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136854|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
83819518|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819519|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819520|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83819521|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819522|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819523|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819524|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83819525|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
83819526|NCT00109239|Bevacizumab|bevacizumab|mesh-list
83819527|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83819528|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819529|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83819530|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83819531|NCT00109239|Growth Substances|growth substances|mesh-ancestor
83819532|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819533|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
83819534|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83819535|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83819536|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
83819537|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819538|NCT00280033|Antacids|antacids|mesh-ancestor
83819539|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819540|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83819541|NCT00109278|Vaccines|vaccines|mesh-list
83819542|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
83819543|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819544|NCT00280267|Testosterone|testosterone|mesh-list
83819545|NCT00280267|Androgens|androgens|mesh-ancestor
83819546|NCT00280267|Hormones|hormones|mesh-ancestor
83819547|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819548|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819549|NCT00076232|Acyclovir|acyclovir|mesh-list
83819550|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
83819551|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819552|NCT00280423|Casopitant|casopitant|mesh-list
83819553|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
83819554|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
83819555|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819556|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819557|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83819558|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83819559|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975025|NCT04311489|Ularitide|ularitide|mesh-list
83819560|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819561|NCT00109356|AQ4N|aq4n|mesh-list
83819562|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819563|NCT00280462|Nifedipine|nifedipine|mesh-list
83819564|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83819565|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83819566|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819567|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83819568|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819569|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
83819570|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
83819571|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83819572|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83819573|NCT00280501|Sulpiride|sulpiride|mesh-list
83819574|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
83819575|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819576|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83819577|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819578|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819579|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819580|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83819581|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
83819582|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819583|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819584|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83819585|NCT00280540|Valsartan|valsartan|mesh-list
83819586|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83819587|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819588|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83819589|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83819590|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819591|NCT00280540|Diuretics|diuretics|mesh-ancestor
83819592|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
83819593|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819594|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83819595|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83819596|NCT00076349|Rituximab|rituximab|mesh-list
83819597|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83819598|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83819599|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819600|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
83819601|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819602|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819603|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83819604|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
83819605|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819606|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
83819607|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819608|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83819609|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83819610|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819611|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819612|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
83819613|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819614|NCT00280696|Levetiracetam|levetiracetam|mesh-list
83819615|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
83819616|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
83819617|NCT00076388|Docetaxel|docetaxel|mesh-list
83819618|NCT00076388|Gefitinib|gefitinib|mesh-list
83819619|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819620|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
83819621|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
83819622|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
83819623|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819624|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83819625|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819626|NCT00280774|Memantine|memantine|mesh-list
83819627|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83819628|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83819629|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
83819630|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136880|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83819631|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819632|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819633|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83819634|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83819635|NCT00109551|Folic Acid|folic acid|mesh-list
83819636|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
83819637|NCT00109551|Hematinics|hematinics|mesh-ancestor
83819638|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
83819639|NCT00109551|Vitamins|vitamins|mesh-ancestor
83819640|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
83819641|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819642|NCT00109551|Astringents|astringents|mesh-ancestor
83819643|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
83819644|NCT00280930|Letrozole|letrozole|mesh-list
83819645|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819646|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83819647|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83819648|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819649|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819650|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83819651|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
83819652|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819653|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819654|NCT00280969|Efavirenz|efavirenz|mesh-list
83819655|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83819656|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83819657|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83819658|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819659|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819660|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
83819661|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819662|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83819663|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83819664|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83819665|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83819666|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83819667|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83819668|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83819669|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83819670|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
83819671|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83819672|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83819673|NCT00281008|Mipomersen|mipomersen|mesh-list
83819674|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83819675|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83819676|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
83819677|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819678|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83819679|NCT00281125|Pemetrexed|pemetrexed|mesh-list
83819680|NCT00281125|Vatalanib|vatalanib|mesh-list
83819681|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819682|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819683|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819684|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83819685|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83819686|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83819687|NCT00109746|Chromium|chromium|mesh-list
83819688|NCT00109746|Picolinic acid|picolinic acid|mesh-list
83819689|NCT00109746|Trace Elements|trace elements|mesh-ancestor
83819690|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
83819691|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819692|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83819693|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
83819694|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
83136909|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
83819695|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819696|NCT04730297|Acetaminophen|acetaminophen|mesh-list
83819697|NCT04730297|Ibuprofen|ibuprofen|mesh-list
83819698|NCT04730297|Codeine|codeine|mesh-list
83819699|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83819700|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83819701|NCT04730297|Analgesics|analgesics|mesh-ancestor
83819702|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
83819703|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819704|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819705|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83819706|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819707|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82975191|NCT03997123|Paclitaxel|paclitaxel|mesh-list
83819708|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819709|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819710|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
83819711|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83819712|NCT04730297|Narcotics|narcotics|mesh-ancestor
83819713|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819714|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
83819715|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
83819716|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
83819717|NCT00399269|Hematinics|hematinics|mesh-ancestor
83819718|NCT00281281|Vancomycin|vancomycin|mesh-list
83819719|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83819720|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819721|NCT00109785|Idoxuridine|idoxuridine|mesh-list
83819722|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83819723|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83819724|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819725|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
83819726|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819727|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83819728|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819729|NCT00281476|Simvastatin|simvastatin|mesh-list
83819730|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83819731|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83819732|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
83819733|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819734|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83819735|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83819736|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819737|NCT00416923|Rituximab|rituximab|mesh-list
83819738|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83819739|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819740|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
83819741|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819742|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819743|NCT00416962|Oseltamivir|oseltamivir|mesh-list
83819744|NCT00416962|Amantadine|amantadine|mesh-list
83819745|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
83819746|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819747|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819748|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819749|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83819750|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83819751|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
83819752|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819753|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819754|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83819755|NCT00416962|Analgesics|analgesics|mesh-ancestor
83819756|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
83819757|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819758|NCT00109824|Decitabine|decitabine|mesh-list
83819759|NCT00109824|Azacitidine|azacitidine|mesh-list
83819760|NCT00109824|Valproic Acid|valproic acid|mesh-list
83819761|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819762|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
83819763|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819764|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819765|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819766|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
83819767|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
83819768|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819769|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819770|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
83819771|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819772|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819773|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819774|NCT00281515|Lonafarnib|lonafarnib|mesh-list
83819775|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819776|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819777|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
83819778|NCT00109941|Mitogens|mitogens|mesh-list
83819779|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
83819780|NCT00109941|Narcotics|narcotics|mesh-ancestor
83819781|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819782|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819783|NCT00109941|Analgesics|analgesics|mesh-ancestor
83819784|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
83819785|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819786|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83819787|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819788|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819789|NCT00281593|Telmisartan|telmisartan|mesh-list
83819790|NCT00281593|Ramipril|ramipril|mesh-list
83819791|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819792|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83819793|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83819794|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819795|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83819796|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
83819797|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819798|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
83819799|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83819800|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83819801|NCT00281710|Prednisolone|prednisolone|mesh-list
83819802|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
83819803|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83819804|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
83819805|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83819806|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
83819807|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
83819808|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819809|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819810|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83819811|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
83819812|NCT00281710|Hormones|hormones|mesh-ancestor
83819813|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83819814|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83819815|NCT00281710|Protective Agents|protective agents|mesh-ancestor
83819816|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83819817|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819818|NCT00076544|Ziconotide|ziconotide|mesh-list
83819819|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83819820|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83819821|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136923|NCT02842853|Vaccines|vaccines|mesh-list
83819822|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83819823|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819824|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83819825|NCT00076544|Protective Agents|protective agents|mesh-ancestor
83819826|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83819827|NCT00076544|Analgesics|analgesics|mesh-ancestor
83819828|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
83819829|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819830|NCT00281788|Paclitaxel|paclitaxel|mesh-list
83819831|NCT00281788|Carboplatin|carboplatin|mesh-list
83819832|NCT00281788|Capecitabine|capecitabine|mesh-list
83819833|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83819834|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819835|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
83819836|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
83819837|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
83819838|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819839|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819840|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
83819841|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83819842|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819843|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83819844|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819845|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819846|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
83819847|NCT00281905|Carboplatin|carboplatin|mesh-list
83819848|NCT00281905|Methotrexate|methotrexate|mesh-list
83819849|NCT00281905|Vincristine|vincristine|mesh-list
83819850|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819851|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
83819852|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975326|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
82975327|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975328|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975329|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975330|NCT03203850|Deferasirox|deferasirox|mesh-list
82975331|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83819854|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83819855|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
83819856|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819857|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819858|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83819859|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83819860|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
83819861|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83819862|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819863|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
83819864|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
83819865|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819866|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83819867|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83819868|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83819869|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
83819870|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
83819871|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
83819872|NCT00110058|Interferons|interferons|mesh-list
83819873|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
83819874|NCT00110058|Cyclosporine|cyclosporine|mesh-list
83819875|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
83819876|NCT00110058|Fludarabine|fludarabine|mesh-list
83819877|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
83819878|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
83819879|NCT00110058|Cyclosporins|cyclosporins|mesh-list
83819880|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819881|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819882|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
83819883|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819884|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819885|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
83819886|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819887|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
83819888|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819889|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819890|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
83819891|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
83819892|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819893|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83819894|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83819895|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83819896|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
83819897|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83819898|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83819899|NCT00281944|Leucovorin|leucovorin|mesh-list
83819900|NCT00281944|Fluorouracil|fluorouracil|mesh-list
83819901|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
83819902|NCT00281944|Calcium|calcium|mesh-list
83819903|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
83819904|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83819905|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819906|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
83819907|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819908|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819909|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819910|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819911|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
83819912|NCT00281944|Antidotes|antidotes|mesh-ancestor
83819913|NCT00281944|Protective Agents|protective agents|mesh-ancestor
83819914|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
83819915|NCT00281944|Vitamins|vitamins|mesh-ancestor
83819916|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
83819917|NCT00281983|Cyclosporine|cyclosporine|mesh-list
83819918|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
83819919|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
83819920|NCT00281983|Busulfan|busulfan|mesh-list
83819921|NCT00281983|Rituximab|rituximab|mesh-list
83819922|NCT00281983|Methotrexate|methotrexate|mesh-list
83819923|NCT00281983|Fludarabine|fludarabine|mesh-list
83819924|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
83819925|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
83819926|NCT00281983|Cyclosporins|cyclosporins|mesh-list
82975402|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819927|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83819928|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83819929|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
83819930|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819931|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83819932|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83819933|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
83819934|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819935|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819936|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83819937|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83819938|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83819939|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
83819940|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83819941|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83819942|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
83819943|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
83819944|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819945|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83819946|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83819947|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
83819948|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83819949|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83819950|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83819951|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83819952|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
83819953|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83819954|NCT00282061|Melatonin|melatonin|mesh-list
83819955|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
83819956|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819957|NCT00282061|Protective Agents|protective agents|mesh-ancestor
83819958|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819959|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819960|NCT00282100|Gefitinib|gefitinib|mesh-list
83819961|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83819962|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83819963|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83819964|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819965|NCT00282139|Aripiprazole|aripiprazole|mesh-list
83819966|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
83819967|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83819968|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83819969|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83819970|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819971|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819972|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
83819973|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
83819974|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83819975|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819976|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83819977|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83819978|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
83819979|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83819980|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83819981|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83819982|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83819983|NCT00110253|Lidocaine|lidocaine|mesh-list
83819984|NCT00110253|Tetracaine|tetracaine|mesh-list
83819985|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
83819986|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
83819987|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83819988|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83819989|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
83819990|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83819991|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83819992|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83819993|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83819994|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83819995|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83819996|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83819997|NCT00282178|Candesartan|candesartan|mesh-list
83819998|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83819999|NCT00282178|Diuretics|diuretics|mesh-ancestor
83820000|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
83820001|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975480|NCT05465278|Alirocumab|alirocumab|mesh-list
83820002|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83820003|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820004|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820005|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83820006|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83820007|NCT00282217|Sirolimus|sirolimus|mesh-list
83820008|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83820009|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820010|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83820011|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820012|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
83820013|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820014|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
83820015|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820016|NCT00282451|Insulin|insulin|mesh-list
83820017|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83820018|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
83820019|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
83820020|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83820021|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
83820022|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83820023|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820024|NCT00282607|Udenafil|udenafil|mesh-list
83820025|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83820026|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83820027|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820028|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820029|NCT00282724|Liarozole|liarozole|mesh-list
83820030|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
83820031|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048360|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83820032|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820033|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820034|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
83820035|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820036|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820037|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83820038|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820039|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
83820040|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83820041|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83820042|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83820043|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820044|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820045|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
83820046|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820047|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820048|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83820049|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820050|NCT00282997|Pregabalin|pregabalin|mesh-list
83820051|NCT00282997|Analgesics|analgesics|mesh-ancestor
83820052|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
83820053|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820054|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820055|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
83820056|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83820057|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820058|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820059|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83820060|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83820061|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820062|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820063|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820064|NCT00283036|Irbesartan|irbesartan|mesh-list
83820065|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83820066|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83820067|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83820068|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820069|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
83820070|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83820071|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820072|NCT00283114|Lintuzumab|lintuzumab|mesh-list
83820073|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83820074|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820075|NCT00076856|Temozolomide|temozolomide|mesh-list
83820076|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83820077|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
83820078|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820079|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820080|NCT00283192|Sertraline|sertraline|mesh-list
83820081|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
83820082|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820083|NCT00283192|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83820084|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83820085|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820086|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820087|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820088|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
83820089|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820090|NCT00283309|Riluzole|riluzole|mesh-list
83820091|NCT00283309|Memantine|memantine|mesh-list
83820092|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83820093|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83820094|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
83820095|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820096|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820097|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820098|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83820099|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83820100|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
83820101|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83820102|NCT00283309|Protective Agents|protective agents|mesh-ancestor
83820103|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83820104|NCT00417157|Ganirelix|ganirelix|mesh-list
83820105|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
83820106|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820107|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820108|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83820109|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
83820110|NCT00283465|Hematinics|hematinics|mesh-ancestor
83820111|NCT00283543|Temozolomide|temozolomide|mesh-list
83820112|NCT00283543|Carmustine|carmustine|mesh-list
83820113|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83820114|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
83820115|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820116|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820117|NCT00283621|Doxorubicin|doxorubicin|mesh-list
83820118|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83820119|NCT00283621|Ifosfamide|ifosfamide|mesh-list
83820120|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
83820121|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83820122|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820123|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83820124|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83820125|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820126|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820127|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83820128|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
83820129|NCT00283621|Hematinics|hematinics|mesh-ancestor
83820130|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
83820131|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
83820132|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
83820133|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83820134|NCT00283660|Protective Agents|protective agents|mesh-ancestor
83820135|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820136|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
83820137|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
83820138|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820139|NCT00283699|Albendazole|albendazole|mesh-list
83820140|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
83820141|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83820142|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820143|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
83820144|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83820145|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83820146|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
82975628|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820147|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
83820148|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
83820149|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820150|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820151|NCT00283777|Chromium|chromium|mesh-list
83820152|NCT00283777|Picolinic acid|picolinic acid|mesh-list
83820153|NCT00283777|Trace Elements|trace elements|mesh-ancestor
83820154|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
83820155|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820156|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83820157|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
83820158|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
83820159|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820160|NCT00110448|Aspirin|aspirin|mesh-list
83820161|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83820162|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83820163|NCT00110448|Analgesics|analgesics|mesh-ancestor
83820164|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
83820165|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820166|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820167|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83820168|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83820169|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83820170|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83820171|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820172|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83820173|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83820174|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820175|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
83820176|NCT00284206|Risperidone|risperidone|mesh-list
83820177|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83820178|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
83820179|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820180|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820181|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820182|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83820183|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820184|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820185|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820186|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83820187|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
83820188|NCT00284323|Adenosine|adenosine|mesh-list
83820189|NCT00284323|Analgesics|analgesics|mesh-ancestor
83820190|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
83820191|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820192|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820193|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83820194|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
83820195|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83820196|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
83820197|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
83820198|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820199|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820200|NCT04718701|Paclitaxel|paclitaxel|mesh-list
83820201|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83820202|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820203|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
83820204|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
83820205|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
83820206|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820207|NCT00077168|Tamoxifen|tamoxifen|mesh-list
83820208|NCT00077168|Anastrozole|anastrozole|mesh-list
83820209|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820210|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83820211|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
83820212|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820213|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820214|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83820215|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820216|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83820217|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83820218|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83820219|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83820220|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83820221|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820222|NCT00110604|Folic Acid|folic acid|mesh-list
83820223|NCT00110604|Hematinics|hematinics|mesh-ancestor
83820224|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
83820225|NCT00110604|Vitamins|vitamins|mesh-ancestor
83820226|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
83820227|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820228|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83820229|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820230|NCT00284791|Lamotrigine|lamotrigine|mesh-list
83820231|NCT00284791|Sertraline|sertraline|mesh-list
83820232|NCT00284791|Fluoxetine|fluoxetine|mesh-list
83820233|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
83820234|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820235|NCT00284791|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83820236|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83820237|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820238|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820239|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820240|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
83820241|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820242|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83820243|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83820244|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83820245|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820246|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
83820247|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83820248|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83820249|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83820250|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820251|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820252|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83820253|NCT00284947|Prednisone|prednisone|mesh-list
83820254|NCT00284947|Prednisolone|prednisolone|mesh-list
83820255|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
83820256|NCT00284947|Basiliximab|basiliximab|mesh-list
83820257|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83820258|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
83820259|NCT00284947|Hormones|hormones|mesh-ancestor
83820260|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820261|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820262|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83820263|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820264|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
83820265|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
83820266|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820267|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83820268|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83820269|NCT00284947|Protective Agents|protective agents|mesh-ancestor
83820270|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820271|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
83820272|NCT00110682|Imiquimod|imiquimod|mesh-list
83820273|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83820274|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
83820275|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820276|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820277|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
83820278|NCT00077246|Paclitaxel|paclitaxel|mesh-list
83820279|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83820280|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83820281|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820282|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
83820283|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
83820284|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
83820285|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820286|NCT00110721|Fluorouracil|fluorouracil|mesh-list
83820287|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
83820288|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820289|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83820290|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820291|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820292|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
83820293|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820294|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
83820295|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83820296|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975783|NCT03473197|Diacerein|diacerein|mesh-list
83820298|NCT00425035|Panitumumab|panitumumab|mesh-list
83820299|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83820300|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820301|NCT00110760|Lidocaine|lidocaine|mesh-list
83820302|NCT00110760|Tetracaine|tetracaine|mesh-list
83820303|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
83820304|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
83820305|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820306|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820307|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
83820308|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820309|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83820310|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83820311|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83820312|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820313|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820314|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
83820315|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83820316|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820317|NCT00285181|Simvastatin|simvastatin|mesh-list
83820318|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83820319|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83820320|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
83820321|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820322|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83820323|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83820324|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820325|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
83820326|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83820327|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820328|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820329|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83820330|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83820331|NCT00285298|Protective Agents|protective agents|mesh-ancestor
83820332|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820333|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
83820334|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83820335|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
83820336|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83820337|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
83820338|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820339|NCT00285376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83820340|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83820341|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820342|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820343|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820344|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
83820345|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820346|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83820347|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83820348|NCT00077363|Capecitabine|capecitabine|mesh-list
83820349|NCT00077363|Tipifarnib|tipifarnib|mesh-list
83820350|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83820351|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
83820352|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820353|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820354|NCT00285415|Carboplatin|carboplatin|mesh-list
83820355|NCT00285415|Docetaxel|docetaxel|mesh-list
83820356|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820357|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
83820358|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
83820359|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
83820360|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820361|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83820362|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820363|NCT00285727|Ropinirole|ropinirole|mesh-list
83820364|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83820365|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83820366|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
83820367|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
83820368|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975857|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820369|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820370|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820371|NCT00077402|Fenretinide|fenretinide|mesh-list
83820372|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820373|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83820374|NCT00077402|Protective Agents|protective agents|mesh-ancestor
83820375|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820377|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
83820378|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820379|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83820380|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83820381|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83820382|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820383|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820384|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83820385|NCT00285766|Protective Agents|protective agents|mesh-ancestor
83820386|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820387|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
83820388|NCT00285805|Amiloride|amiloride|mesh-list
83820389|NCT00285805|Furosemide|furosemide|mesh-list
83820390|NCT00285805|Diuretics|diuretics|mesh-ancestor
83820391|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
83820392|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820393|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83820394|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820395|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820396|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83820397|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83820398|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83820399|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83820400|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83820401|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83820402|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83820403|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820404|NCT00077441|Bortezomib|bortezomib|mesh-list
83820405|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820406|NCT00285883|Saquinavir|saquinavir|mesh-list
83820407|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83820408|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83820409|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
83820410|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820411|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820412|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83820413|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83820414|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
83820415|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820416|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83820417|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83820418|NCT00110877|Darunavir|darunavir|mesh-list
83820419|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83820420|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83820421|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
83820422|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820423|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820424|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83820425|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83820426|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
83820427|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820428|NCT00077519|Tipifarnib|tipifarnib|mesh-list
83820429|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820430|NCT00286117|Tamoxifen|tamoxifen|mesh-list
83820431|NCT00286117|Anastrozole|anastrozole|mesh-list
83820432|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83820433|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
83820434|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820435|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820436|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83820437|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820438|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83820439|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83820440|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82975933|NCT05432414|Pomalidomide|pomalidomide|mesh-list
83820441|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83820442|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83820443|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820444|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820445|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83820446|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83820447|NCT00077558|Fludarabine|fludarabine|mesh-list
83820448|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
83820449|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820450|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83820451|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
83820452|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820453|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820454|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
83820455|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820456|NCT00286273|Heparin|heparin|mesh-list
83820457|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83820458|NCT00286273|Tinzaparin|tinzaparin|mesh-list
83820459|NCT00286273|Dalteparin|dalteparin|mesh-list
83820460|NCT00286273|Nadroparin|nadroparin|mesh-list
83820461|NCT00286273|Citric Acid|citric acid|mesh-list
83820462|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
83820463|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
83820464|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83820465|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
83820466|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
83820467|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820468|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83820469|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83820470|NCT00286312|Atorvastatin|atorvastatin|mesh-list
83820471|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83820472|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83820473|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
83820474|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820475|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83820476|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83820477|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820478|NCT00286351|Goserelin|goserelin|mesh-list
83820479|NCT00286351|Anastrozole|anastrozole|mesh-list
83820480|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83820481|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820482|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83820483|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83820484|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820485|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820486|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83820487|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
83820488|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820489|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820490|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
83820491|NCT00110955|Hematinics|hematinics|mesh-ancestor
83820492|NCT00286585|Propofol|propofol|mesh-list
83820493|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83820494|NCT00286585|Anesthetics|anesthetics|mesh-list
83820495|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83820496|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820497|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820498|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
83820499|NCT00111072|Dexamethasone|dexamethasone|mesh-list
83820500|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83820501|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
83820502|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
83820503|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820504|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820505|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83820506|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
83820507|NCT00111072|Hormones|hormones|mesh-ancestor
83820508|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820509|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83820510|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820511|NCT00286624|Cyclosporine|cyclosporine|mesh-list
83820512|NCT00286624|Everolimus|everolimus|mesh-list
83820513|NCT00286624|Cyclosporins|cyclosporins|mesh-list
83820514|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83820515|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820516|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976011|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
83820517|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820518|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
83820519|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820520|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
83820521|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820522|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
83820523|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83820524|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83820525|NCT00286624|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83820526|NCT00286624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83820527|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820528|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
83820529|NCT00077597|Hematinics|hematinics|mesh-ancestor
83820530|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
83820531|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83820532|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820533|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83820534|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
83820535|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83820536|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820537|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83820538|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83820539|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83820540|NCT00111111|Etanercept|etanercept|mesh-list
83820541|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83820542|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83820543|NCT00111111|Analgesics|analgesics|mesh-ancestor
83820544|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
83820545|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820546|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820547|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83820548|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83820549|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83820550|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820551|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
83820552|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83820553|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83820554|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820555|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820556|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820557|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820558|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83820559|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83820560|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
83820561|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820562|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820563|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83820564|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83820565|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
83820566|NCT00111150|Tenofovir|tenofovir|mesh-list
83820567|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
83820568|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820569|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83820570|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83820571|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820572|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820573|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83820574|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83820575|NCT00417430|Fulvestrant|fulvestrant|mesh-list
83820576|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83820577|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820578|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83820579|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83820580|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
83820581|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820582|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820583|NCT00077753|Enoxaparin|enoxaparin|mesh-list
83820584|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
83820585|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
83820586|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83820587|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82976083|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820588|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820589|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83820590|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83820591|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820592|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820593|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820594|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820595|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83820596|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83820597|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
83820598|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820599|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820600|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83820601|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83820602|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
83820603|NCT00077792|Enoxaparin|enoxaparin|mesh-list
83820604|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
83820605|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
83820606|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83820607|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83820608|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820609|NCT00111267|Vitamins|vitamins|mesh-list
83820610|NCT00111267|Folic Acid|folic acid|mesh-list
83820611|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
83820612|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
83820613|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
83820614|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
83820615|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820616|NCT00111267|Hematinics|hematinics|mesh-ancestor
83820617|NCT00286936|Zolpidem|zolpidem|mesh-list
83820618|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83820619|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83820620|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820621|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820622|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83820623|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
83820624|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
83820625|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820626|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820627|NCT00111306|Epratuzumab|epratuzumab|mesh-list
83820628|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83820629|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820630|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
83820631|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
83820632|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820633|NCT00287170|Calcitriol|calcitriol|mesh-list
83820634|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
83820635|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83820636|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820637|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83820638|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820639|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820640|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83820641|NCT00287170|Vitamins|vitamins|mesh-ancestor
83820642|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
83820643|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83820644|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
83820645|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83820646|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820647|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820648|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
83820649|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83820650|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820651|NCT00287209|Amiodarone|amiodarone|mesh-list
83820652|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83820653|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
83820654|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83820655|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820656|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820657|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83820658|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83820659|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83820660|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820661|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83820662|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83820663|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83820664|NCT00077948|Metoprolol|metoprolol|mesh-list
82976165|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
83820665|NCT00077948|Enoximone|enoximone|mesh-list
83820666|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83820667|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83820668|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
83820669|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
83820670|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820671|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820672|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83820673|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83820674|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83820675|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
83820676|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820677|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820678|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83820679|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
83820680|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83820681|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83820682|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820683|NCT00077948|Protective Agents|protective agents|mesh-ancestor
83820684|NCT00111345|Daunorubicin|daunorubicin|mesh-list
83820685|NCT00111345|Idarubicin|idarubicin|mesh-list
83820686|NCT00111345|Cladribine|cladribine|mesh-list
83820687|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83820688|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820689|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83820690|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83820691|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820692|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820693|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820694|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
83820695|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820696|NCT00287326|Clonidine|clonidine|mesh-list
83820697|NCT00287326|Morphine|morphine|mesh-list
83820698|NCT00287326|Bupivacaine|bupivacaine|mesh-list
83820699|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
83820700|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
83820701|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820702|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820703|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
83820704|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820705|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83820706|NCT00287326|Narcotics|narcotics|mesh-ancestor
83820707|NCT00287326|Analgesics|analgesics|mesh-ancestor
83820708|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83820709|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
83820710|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
83820711|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83820712|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83820713|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83820714|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
83820715|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820716|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820717|NCT00287443|Hormones|hormones|mesh-list
83820718|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820719|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820720|NCT00077987|Sunitinib|sunitinib|mesh-list
83820721|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820722|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83820723|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83820724|NCT00077987|Growth Substances|growth substances|mesh-ancestor
83820725|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820726|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
83820727|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83820728|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820729|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820730|NCT00287521|Timolol|timolol|mesh-list
83820731|NCT00287521|Latanoprost|latanoprost|mesh-list
83820732|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820733|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83820734|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83820735|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
83820736|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820737|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820738|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83820739|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83820740|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83820741|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83820743|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83820744|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820745|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820746|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83820747|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
83820748|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
83820749|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
83820750|NCT00111462|Hematinics|hematinics|mesh-ancestor
83820751|NCT00287677|Hormones|hormones|mesh-list
83820752|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820753|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820754|NCT00287794|Diazepam|diazepam|mesh-list
83820755|NCT00287794|Melatonin|melatonin|mesh-list
83820756|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
83820757|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820758|NCT00287794|Protective Agents|protective agents|mesh-ancestor
83820759|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820760|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820761|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83820762|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
83820763|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
83820764|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
83820765|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820766|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83820767|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83820768|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83820769|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83820770|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83820771|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820772|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820773|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83820774|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
83820775|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
83820776|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
83820777|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
83820778|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820779|NCT00287911|Topotecan|topotecan|mesh-list
83820780|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820781|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83820782|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83820783|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820784|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820785|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
83820786|NCT00287950|Carboplatin|carboplatin|mesh-list
83820787|NCT00287950|Etoposide|etoposide|mesh-list
83820788|NCT00287950|Vincristine|vincristine|mesh-list
83820789|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820790|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
83820791|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820792|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83820793|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83820794|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
83820795|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820796|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820797|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83820798|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83820799|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83820800|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83820801|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820802|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
83820803|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
83820804|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
83820805|NCT00288028|Bortezomib|bortezomib|mesh-list
83820806|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820807|NCT00111540|Exenatide|exenatide|mesh-list
83820808|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83820809|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820810|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83820811|NCT00111540|Incretins|incretins|mesh-ancestor
83820812|NCT00111540|Hormones|hormones|mesh-ancestor
83820813|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820814|NCT00288184|Allopurinol|allopurinol|mesh-list
83820815|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
83820816|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820817|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820818|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
83820819|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83820820|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83820822|NCT00288184|Protective Agents|protective agents|mesh-ancestor
83820823|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820824|NCT00288223|Telithromycin|telithromycin|mesh-list
83820825|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83820826|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820827|NCT00288262|Melatonin|melatonin|mesh-list
83820828|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
83820829|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820830|NCT00288262|Protective Agents|protective agents|mesh-ancestor
83820831|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820832|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820833|NCT00288379|Budesonide|budesonide|mesh-list
83820834|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
83820835|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83820836|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83820837|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
83820838|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820839|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820840|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83820841|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
83820842|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
83820843|NCT00288379|Hormones|hormones|mesh-ancestor
83820844|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83820845|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83820846|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83820847|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83820848|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
83820849|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820850|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820851|NCT00078182|Tenofovir|tenofovir|mesh-list
83820852|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
83820853|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820854|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83820855|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83820856|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820857|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820858|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83820859|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83820860|NCT00111618|Vadimezan|vadimezan|mesh-list
83820861|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820862|NCT00399425|Heparin|heparin|mesh-list
83820863|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83820864|NCT00399425|Tinzaparin|tinzaparin|mesh-list
83820865|NCT00399425|Dalteparin|dalteparin|mesh-list
83820866|NCT00399425|Bemiparin|bemiparin|mesh-list
83820867|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
83820868|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83820869|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83820870|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820871|NCT00288535|Sirolimus|sirolimus|mesh-list
83820872|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83820873|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820874|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83820875|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820876|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
83820877|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83820878|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
83820879|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820880|NCT00399464|Alfuzosin|alfuzosin|mesh-list
83820881|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83820882|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83820883|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83820884|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
83820885|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820886|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820887|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820888|NCT00399464|Urological Agents|urological agents|mesh-ancestor
83820889|NCT00288652|Reboxetine|reboxetine|mesh-list
83820890|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
82976384|NCT02496910|Amlodipine|amlodipine|mesh-list
83820891|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820892|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83820893|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83820894|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83820895|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820897|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820898|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820899|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83820900|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
83820901|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820902|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
83820903|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
83820904|NCT00288769|Vitamins|vitamins|mesh-ancestor
83820905|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
83820906|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820907|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
83820908|NCT00288769|Hematinics|hematinics|mesh-ancestor
83820909|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
83820910|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83820911|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83820912|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820913|NCT00289042|Enoxaparin|enoxaparin|mesh-list
83820914|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
83478747|NCT05334654|Enoxaparin|enoxaparin|mesh-list
83820915|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83820916|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83820917|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820918|NCT00111891|Niacin|niacin|mesh-list
83820919|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83820920|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
83820921|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820922|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83820923|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
83820924|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
83820925|NCT00111891|Vitamins|vitamins|mesh-ancestor
83820926|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
83820927|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820928|NCT00289354|Chromium|chromium|mesh-list
83820929|NCT00289354|Biotin|biotin|mesh-list
83820930|NCT00289354|Picolinic acid|picolinic acid|mesh-list
83820931|NCT00289354|Trace Elements|trace elements|mesh-ancestor
83820932|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
83820933|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820934|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
83820935|NCT00289354|Vitamins|vitamins|mesh-ancestor
83820936|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83820937|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
83820938|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
83820939|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820940|NCT00289510|Vaccines|vaccines|mesh-list
83820941|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
83820942|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820943|NCT00289588|Mupirocin|mupirocin|mesh-list
83820944|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83820945|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83820946|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83820947|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820948|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820949|NCT00289627|Ipilimumab|ipilimumab|mesh-list
83820950|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83820951|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820952|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83820953|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820954|NCT00401661|Alfuzosin|alfuzosin|mesh-list
83820955|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83820956|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83820957|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83820958|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
83820959|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976458|NCT03324490|Analgesics|analgesics|mesh-ancestor
82976459|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82976460|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82976461|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82976462|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
82976463|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976465|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83820960|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820961|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820962|NCT00401661|Urological Agents|urological agents|mesh-ancestor
83820964|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83820965|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
83820966|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83820967|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820968|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820969|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83820970|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83820971|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83820972|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83820973|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83820974|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
83820975|NCT00290017|Pemetrexed|pemetrexed|mesh-list
83820976|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820977|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83820978|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820979|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83820980|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83820981|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
83820982|NCT00112008|Hematinics|hematinics|mesh-ancestor
83820983|NCT00112086|Paclitaxel|paclitaxel|mesh-list
83820984|NCT00112086|Carboplatin|carboplatin|mesh-list
83820985|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83820986|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83820987|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
83820988|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
83820989|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
83820990|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83820991|NCT00290173|Ritodrine|ritodrine|mesh-list
83820992|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
83820993|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
83820994|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83820995|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83820996|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
83820997|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83820998|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83820999|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83821000|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83821001|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83821002|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821003|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821004|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
83821005|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821006|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821007|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821008|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821009|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83821010|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821011|NCT00078260|Pemetrexed|pemetrexed|mesh-list
83821012|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821013|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821014|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821015|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83821016|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83821017|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
83821018|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83821019|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83821020|NCT00290602|Prednisolone|prednisolone|mesh-list
83821021|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
83821022|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83821023|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
83821024|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821025|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
83821026|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
83821027|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821028|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821029|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83821030|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
83821031|NCT00290602|Hormones|hormones|mesh-ancestor
83821032|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821033|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83821034|NCT00290602|Protective Agents|protective agents|mesh-ancestor
83821035|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83821036|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821037|NCT00290641|Cyclosporine|cyclosporine|mesh-list
83821038|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
83821039|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
83821040|NCT00290641|Fludarabine|fludarabine|mesh-list
83821041|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
83821042|NCT00290641|Cyclosporins|cyclosporins|mesh-list
83821043|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821044|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
83821045|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821046|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821047|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83821048|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
83821049|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821050|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821051|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83821052|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821053|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
83821054|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821055|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
83821056|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821057|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821058|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83821059|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83821060|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83821061|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
83821062|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821064|NCT00290680|Bortezomib|bortezomib|mesh-list
83821065|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821066|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83821067|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83821068|NCT00290680|Analgesics|analgesics|mesh-ancestor
83821069|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
83821070|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821071|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821072|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821073|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821074|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83821075|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83821076|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821077|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821078|NCT02960815|Imiquimod|imiquimod|mesh-list
83821079|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83821080|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
83821081|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821082|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821083|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
83821084|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83821085|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821086|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821087|NCT00290719|Irinotecan|irinotecan|mesh-list
83821088|NCT00290719|Gefitinib|gefitinib|mesh-list
83821089|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821090|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83821091|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821092|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821093|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821094|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821095|NCT00290836|Thrombin|thrombin|mesh-list
83821096|NCT00290836|Aprotinin|aprotinin|mesh-list
83821097|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
83821098|NCT00290836|Coagulants|coagulants|mesh-ancestor
83821099|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83821100|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83821101|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
83821102|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821103|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821104|NCT04729556|Chitosan|chitosan|mesh-list
83821105|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83821106|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83821107|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
83821108|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821109|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83821110|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
83821111|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
83821112|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
83821113|NCT04729556|Coagulants|coagulants|mesh-ancestor
83821114|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83821115|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
83821116|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821117|NCT00290914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83821118|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821119|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821120|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821121|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821122|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
83821123|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821124|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83821125|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83821126|NCT00290992|Rasburicase|rasburicase|mesh-list
83821127|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
83821128|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821129|NCT00291109|Letrozole|letrozole|mesh-list
83821130|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821131|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83821132|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83821133|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821134|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821135|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83821136|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
83821137|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821138|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821139|NCT00291148|Pregabalin|pregabalin|mesh-list
83821140|NCT00291148|Paroxetine|paroxetine|mesh-list
83821141|NCT00291148|Analgesics|analgesics|mesh-ancestor
83821142|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
83821143|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821144|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821145|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
83821146|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83821147|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821148|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821149|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83821150|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83821151|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83821152|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83821153|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821154|NCT00291148|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83821155|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821156|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821157|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
83821158|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83821159|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
83821160|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83821161|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83821162|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821163|NCT00291382|Fluticasone|fluticasone|mesh-list
83821164|NCT00291382|Xhance|xhance|mesh-list
83821165|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83821166|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821167|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83821168|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
83821169|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821170|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821171|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83821172|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
83821173|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821174|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83821175|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83821176|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83821177|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83821178|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
83821179|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821180|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821181|NCT00112476|Sirolimus|sirolimus|mesh-list
83821182|NCT00112476|Temsirolimus|temsirolimus|mesh-list
83821183|NCT00112476|MTOR Inhibitors|mtor inhibitors|mesh-list
83821185|NCT00112476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821186|NCT00112476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821187|NCT00112476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821188|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821189|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
83821190|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821191|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821192|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821193|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821194|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83821195|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
83821196|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83821197|NCT00291538|Bortezomib|bortezomib|mesh-list
83821198|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821199|NCT00291616|Interferons|interferons|mesh-list
83821200|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
83821201|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
83821202|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83821203|NCT00291616|Thymalfasin|thymalfasin|mesh-list
83821204|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821205|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
83821206|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821207|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
83821208|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821209|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83821210|NCT00078572|Capecitabine|capecitabine|mesh-list
83821211|NCT00078572|Lapatinib|lapatinib|mesh-list
83821212|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821213|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
83821214|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821215|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821216|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821217|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821218|NCT00291733|Levetiracetam|levetiracetam|mesh-list
83821219|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
83821220|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
83821221|NCT00112515|Modafinil|modafinil|mesh-list
83821222|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83821223|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821224|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83821225|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83821226|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83821227|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821228|NCT00291772|Pramlintide|pramlintide|mesh-list
83821229|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83821230|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821231|NCT00078611|Natalizumab|natalizumab|mesh-list
83821232|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
83821233|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821234|NCT00291811|Plerixafor|plerixafor|mesh-list
83821235|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83821236|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83821237|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
83821238|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821239|NCT00291850|Paclitaxel|paclitaxel|mesh-list
83821240|NCT00291850|Cisplatin|cisplatin|mesh-list
83821241|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83821242|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821243|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
83821244|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
83821245|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
83821246|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821247|NCT00112554|Cytarabine|cytarabine|mesh-list
83821248|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821249|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
83821250|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821251|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821252|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
83821253|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821254|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821255|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
83821256|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821257|NCT04718311|Tacrolimus|tacrolimus|mesh-list
83821258|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976761|NCT03327766|Vitamins|vitamins|mesh-ancestor
83821259|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
83821260|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821261|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83821263|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821264|NCT00078689|Daclizumab|daclizumab|mesh-list
83821265|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821266|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
83821267|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821268|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
83821269|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821270|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821271|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821272|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821273|NCT00078845|Amifostine|amifostine|mesh-list
83821274|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83821275|NCT00078845|Protective Agents|protective agents|mesh-ancestor
83821276|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821277|NCT00275314|Valganciclovir|valganciclovir|mesh-list
83821278|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
83821279|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821280|NCT00275275|Pramipexole|pramipexole|mesh-list
83821281|NCT00275275|Ropinirole|ropinirole|mesh-list
83821282|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
83821283|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821284|NCT00275275|Protective Agents|protective agents|mesh-ancestor
83821285|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821286|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83821287|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83821288|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
83821289|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
83821290|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821291|NCT00112710|Carboplatin|carboplatin|mesh-list
83821292|NCT00112710|Gemcitabine|gemcitabine|mesh-list
83821293|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821294|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821295|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
83821296|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821297|NCT00275236|Rotigotine|rotigotine|mesh-list
83821298|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
83821299|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
83821300|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821301|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821302|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821303|NCT00275197|Sertraline|sertraline|mesh-list
83821304|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
83821305|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821306|NCT00275197|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83821307|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821308|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821309|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821310|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821311|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
83821312|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821313|NCT00275119|Gemcitabine|gemcitabine|mesh-list
83821314|NCT00275119|Fluorouracil|fluorouracil|mesh-list
83821315|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
83821316|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821317|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
83821318|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821319|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821320|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821321|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
83821322|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821323|NCT00275080|Decitabine|decitabine|mesh-list
83821324|NCT00275080|Azacitidine|azacitidine|mesh-list
83821325|NCT00275080|Vorinostat|vorinostat|mesh-list
83821326|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821327|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
83821328|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821329|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821330|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821331|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83821332|NCT00078962|Gemcitabine|gemcitabine|mesh-list
83821333|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821334|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
83821335|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821336|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821338|NCT00275041|Cetuximab|cetuximab|mesh-list
83821339|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83821340|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821341|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821342|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821343|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821344|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83821345|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83821346|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
83821347|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83821348|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
83821349|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821350|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821351|NCT00274963|Analgesics|analgesics|mesh-ancestor
83821352|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
83821353|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821354|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821355|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83821356|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821357|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821358|NCT00102765|Fluticasone|fluticasone|mesh-list
83821359|NCT00102765|Xhance|xhance|mesh-list
83821360|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83821361|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83821362|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821363|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83821364|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
83821365|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821366|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821367|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83821368|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83821369|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821370|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83821371|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83821372|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83821373|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83821374|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83821375|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821376|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821377|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
83821378|NCT00102765|Hormones|hormones|mesh-ancestor
83821379|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821380|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
83821381|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
83821382|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83821383|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821384|NCT00079079|Carboplatin|carboplatin|mesh-list
83821385|NCT00079079|Gemcitabine|gemcitabine|mesh-list
83821386|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821387|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821388|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
83821389|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821390|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83821391|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
83821392|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83821393|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
83821394|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821395|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83821396|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83821397|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83821398|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83821399|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821400|NCT00130234|Omalizumab|omalizumab|mesh-list
83821401|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83821402|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83821403|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
83821404|NCT00119301|Leucovorin|leucovorin|mesh-list
83821405|NCT00119301|Trimetrexate|trimetrexate|mesh-list
83821406|NCT00119301|Methotrexate|methotrexate|mesh-list
83821407|NCT00119301|Calcium|calcium|mesh-list
83821408|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
83821409|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83821410|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821411|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83821412|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
83821413|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83821414|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821415|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
83821416|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821417|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821418|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821419|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821420|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83821421|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821422|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
83821423|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821424|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83821426|NCT00119301|Protective Agents|protective agents|mesh-ancestor
83821427|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
83821428|NCT00119301|Vitamins|vitamins|mesh-ancestor
83821429|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
83821430|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
83821431|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821432|NCT00079118|Docetaxel|docetaxel|mesh-list
83821433|NCT00079118|Irinotecan|irinotecan|mesh-list
83821434|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821435|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83821436|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83821437|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83821438|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821439|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83821440|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821441|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821442|NCT00130195|Cytarabine|cytarabine|mesh-list
83821443|NCT00130195|Dexamethasone|dexamethasone|mesh-list
83821444|NCT00130195|Prednisolone|prednisolone|mesh-list
83821445|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
83821446|NCT00130195|Methotrexate|methotrexate|mesh-list
83821447|NCT00130195|Vincristine|vincristine|mesh-list
83821448|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
83821449|NCT00130195|Daunorubicin|daunorubicin|mesh-list
83821450|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821451|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
83821452|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821453|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821454|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83821455|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
83821456|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821457|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821458|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83821459|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821460|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
83821461|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
83821462|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821463|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83821464|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
83821465|NCT00130195|Hormones|hormones|mesh-ancestor
83821466|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821467|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83821468|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83821469|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
83821470|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83821471|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821472|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
83821473|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821474|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821475|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83821476|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83821477|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
83821478|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821479|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83821480|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
83821481|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
83821482|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
83821483|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821484|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83821485|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83821486|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821487|NCT00394303|Insulin|insulin|mesh-list
83821488|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83821489|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821490|NCT00119340|Cyclosporine|cyclosporine|mesh-list
83821491|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
83821492|NCT00119340|Fludarabine|fludarabine|mesh-list
83821493|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
83821494|NCT00119340|Cyclosporins|cyclosporins|mesh-list
83821495|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821496|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821497|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
83821498|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821499|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821500|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
83821501|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821502|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821503|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
83821504|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821505|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821506|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821507|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83821508|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83821509|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83821510|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
83821511|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821512|NCT00130156|Doxazosin|doxazosin|mesh-list
83821513|NCT00130156|Bunazosin|bunazosin|mesh-list
83821514|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83821515|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83821516|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83821517|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83821518|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
83821519|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821520|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821521|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821522|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
83821523|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
83821524|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83821525|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83821526|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048361|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
83821527|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83821528|NCT00079157|Sargramostim|sargramostim|mesh-list
83821529|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
83821530|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
83821531|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821532|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83821533|NCT00130000|Eculizumab|eculizumab|mesh-list
83821534|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83821535|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821536|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
83821537|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821538|NCT00079235|Sirolimus|sirolimus|mesh-list
83821539|NCT00079235|Temsirolimus|temsirolimus|mesh-list
83821540|NCT00079235|MTOR Inhibitors|mtor inhibitors|mesh-list
83821541|NCT00079235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821542|NCT00079235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821543|NCT00079235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821544|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821545|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
83821546|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821547|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821548|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821549|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821550|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83821551|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
83821552|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
83821553|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821554|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83821555|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821556|NCT00129805|Aspirin|aspirin|mesh-list
83821557|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
83821558|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82977060|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82977061|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977064|NCT03326674|Capecitabine|capecitabine|mesh-list
83821559|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83821560|NCT00129805|Analgesics|analgesics|mesh-ancestor
83821561|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
83821562|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821563|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821564|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821565|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821566|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83821567|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83821568|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821569|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83821570|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83821571|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821572|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
83821573|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83821574|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
83821575|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821576|NCT00129727|Paclitaxel|paclitaxel|mesh-list
83821577|NCT00129727|Bevacizumab|bevacizumab|mesh-list
83821578|NCT00129727|Carboplatin|carboplatin|mesh-list
83821579|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83821580|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821581|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
83821582|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
83821583|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
83821584|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821585|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83821586|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83821587|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83821588|NCT00129727|Growth Substances|growth substances|mesh-ancestor
83821589|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821590|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
83821591|NCT00129688|Amikacin|amikacin|mesh-list
83821592|NCT00129688|Cloxacillin|cloxacillin|mesh-list
83821593|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821594|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821595|NCT00079352|Gemcitabine|gemcitabine|mesh-list
83821596|NCT00079352|Irinotecan|irinotecan|mesh-list
83821597|NCT00079352|Alvocidib|alvocidib|mesh-list
83821598|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83821599|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
83821600|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821601|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821602|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83821603|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821604|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821605|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
83821606|NCT00079352|Growth Substances|growth substances|mesh-ancestor
83821607|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821608|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83821609|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
83821610|NCT00119496|Beclomethasone|beclomethasone|mesh-list
83821611|NCT00119496|Theophylline|theophylline|mesh-list
83821612|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821613|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821614|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83821615|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821616|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821617|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
83821618|NCT00119496|Hormones|hormones|mesh-ancestor
83821619|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821620|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83821621|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
83821622|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83821623|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
83821624|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821625|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83821626|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
83821627|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83821628|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83821629|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
83821630|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977132|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
83821631|NCT00298285|Enoxaparin|enoxaparin|mesh-list
83821632|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
83821633|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83821634|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83821635|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821636|NCT00298324|Cyclosporine|cyclosporine|mesh-list
83821637|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
83821638|NCT00298324|Prednisone|prednisone|mesh-list
83821639|NCT00298324|Cyclosporins|cyclosporins|mesh-list
83821640|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821641|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
83821642|NCT00298324|Hormones|hormones|mesh-ancestor
83821643|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821644|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821645|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83821646|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821647|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821648|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821649|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821650|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
83821651|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
83821652|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821653|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
83821654|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821655|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83821656|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83821657|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83821658|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
83821659|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821660|NCT00079430|Paclitaxel|paclitaxel|mesh-list
83821661|NCT00079430|Bevacizumab|bevacizumab|mesh-list
83821662|NCT00079430|Carboplatin|carboplatin|mesh-list
84048362|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
83821663|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83821664|NCT00079430|Antibodies|antibodies|mesh-list
83821665|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
83821666|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83821667|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83821668|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821669|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
83821670|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
83821671|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
83821672|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821673|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83821674|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83821675|NCT00079430|Growth Substances|growth substances|mesh-ancestor
83821676|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821677|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
83821678|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
83821679|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
83821680|NCT00298597|Hematinics|hematinics|mesh-ancestor
83821681|NCT00298636|Adenosine|adenosine|mesh-list
83821682|NCT00298636|Analgesics|analgesics|mesh-ancestor
83821683|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
83821684|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821685|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821686|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83821687|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
83821688|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83821689|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
83821690|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
83821691|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821692|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821693|NCT00086112|Risperidone|risperidone|mesh-list
83821694|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83821695|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
83821696|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821697|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821698|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821699|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83821700|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83821701|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83821702|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821703|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83821704|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
83821705|NCT00079469|Bupropion|bupropion|mesh-list
83821706|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83821707|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
83821708|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821709|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83821710|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821711|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821712|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821713|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
83821714|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821715|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821716|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83821717|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83821718|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821719|NCT00298675|Irinotecan|irinotecan|mesh-list
83821720|NCT00298675|Iniparib|iniparib|mesh-list
83821721|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83821722|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821723|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821724|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821725|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821726|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83821727|NCT00298714|Losartan|losartan|mesh-list
83821728|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83821729|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83821730|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83821731|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83821732|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821733|NCT00079508|Bivalirudin|bivalirudin|mesh-list
83821734|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
83821735|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83821736|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
83821737|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821738|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821739|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
83821740|NCT00298870|Isoniazid|isoniazid|mesh-list
83821741|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
83821742|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821743|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821744|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83821745|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83821746|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
83821747|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821748|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83821749|NCT00298909|Niacin|niacin|mesh-list
83821750|NCT00298909|Niacinamide|niacinamide|mesh-list
83821751|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
83821752|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83821753|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
83821754|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821755|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83821756|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
83821757|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
83821758|NCT00298909|Vitamins|vitamins|mesh-ancestor
83821759|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
83821760|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821761|NCT00299026|Paclitaxel|paclitaxel|mesh-list
83821762|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83821763|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821764|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
83821765|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
83821766|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
83821767|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821768|NCT00299065|Zileuton|zileuton|mesh-list
83821769|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83821770|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83821771|NCT00299065|Analgesics|analgesics|mesh-ancestor
83821772|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
83821773|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821774|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821775|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821776|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821777|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83821778|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821779|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821780|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83821781|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
83821782|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821783|NCT00079586|Heparin|heparin|mesh-list
83821785|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
83821786|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83821787|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83821788|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821789|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
83821790|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83821791|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
83821792|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821793|NCT00418132|Thalidomide|thalidomide|mesh-list
83821794|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83821795|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
83821796|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821797|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
83821798|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821799|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821800|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83821801|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83821802|NCT00418132|Growth Substances|growth substances|mesh-ancestor
83821803|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
83821804|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821805|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
83821806|NCT00119613|Hematinics|hematinics|mesh-ancestor
83821807|NCT00299377|Abciximab|abciximab|mesh-list
83821808|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
83821809|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83821810|NCT00299455|Amoxicillin|amoxicillin|mesh-list
83821811|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
83821812|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
83821813|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83821814|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83821815|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821816|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83821817|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821818|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821819|NCT00299572|Alendronate|alendronate|mesh-list
83821820|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83821821|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821822|NCT00299611|Levetiracetam|levetiracetam|mesh-list
83821823|NCT00299611|Sertraline|sertraline|mesh-list
83821824|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
83821825|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821826|NCT00299611|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83821827|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821828|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821829|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821830|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821831|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
83821832|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821833|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
83821834|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
83821835|NCT00299650|Cisatracurium|cisatracurium|mesh-list
83821836|NCT00299650|Atracurium|atracurium|mesh-list
83821837|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83821838|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83821839|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821840|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821841|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83821842|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83821843|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83821844|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
83821845|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821846|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821847|NCT04727853|Irinotecan|irinotecan|mesh-list
83821848|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83821849|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821850|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821851|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821852|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821853|NCT00299845|Lansoprazole|lansoprazole|mesh-list
83821854|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
83821855|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83821856|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83821857|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82977358|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83821858|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821859|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821860|NCT00299884|Atorvastatin|atorvastatin|mesh-list
83821861|NCT00299884|Ezetimibe|ezetimibe|mesh-list
83821862|NCT00299884|Fenofibrate|fenofibrate|mesh-list
83821863|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83821864|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83821865|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
83821866|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821867|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83821868|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83821869|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821870|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83821871|NCT00119652|Paroxetine|paroxetine|mesh-list
83821872|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
83821873|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821874|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83821875|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83821876|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83821877|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821878|NCT00119652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83821879|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821880|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821881|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821882|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821883|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
83821884|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83821885|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83821886|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83821887|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821888|NCT00299923|Ribavirin|ribavirin|mesh-list
83821889|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83821890|NCT00299923|Amantadine|amantadine|mesh-list
83821891|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
83821892|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821893|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
83821894|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821895|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83821896|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83821897|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
83821898|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821899|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821900|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83821901|NCT00299923|Analgesics|analgesics|mesh-ancestor
83821902|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
83821903|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821904|NCT00299962|Interferons|interferons|mesh-list
83821905|NCT00299962|Interferon-beta|interferon-beta|mesh-list
83821906|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821907|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
83821908|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83821909|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
83821910|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821911|NCT00418171|Olanzapine|olanzapine|mesh-list
83821912|NCT00418171|Ziprasidone|ziprasidone|mesh-list
83821913|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
83821914|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
83821915|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821916|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821917|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83821918|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83821919|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83821920|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83821921|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83821922|NCT00418171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83821923|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821924|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821925|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821926|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821927|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
83821928|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83821929|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83821930|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
83821931|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83821932|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
83821933|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821934|NCT00300040|Chrysarobin|chrysarobin|mesh-list
83821935|NCT00300040|HBOC 201|hboc 201|mesh-list
83821936|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83821937|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83821938|NCT00300040|Analgesics|analgesics|mesh-ancestor
83821939|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
83821940|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821941|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821942|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821943|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821944|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
83821945|NCT00079820|Vaccines|vaccines|mesh-list
83821946|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
83821947|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821948|NCT00300079|Brinzolamide|brinzolamide|mesh-list
83821949|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83821950|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821951|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821952|NCT00300118|Budesonide|budesonide|mesh-list
83821953|NCT00300118|Mesalamine|mesalamine|mesh-list
83821954|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83821955|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83821956|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
83821957|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821958|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821959|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83821960|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
83821961|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
83821962|NCT00300118|Hormones|hormones|mesh-ancestor
83821963|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821964|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83821965|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83821966|NCT00300118|Analgesics|analgesics|mesh-ancestor
83821967|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
83821968|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821969|NCT00119730|Rituximab|rituximab|mesh-list
83821970|NCT00119730|Fludarabine|fludarabine|mesh-list
83821971|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
83821972|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83821973|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83821974|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
83821975|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821976|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83821977|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821978|NCT00119730|Analgesics|analgesics|mesh-ancestor
83821979|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
83821980|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83821981|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83821982|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83821983|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83821984|NCT00300196|Ancrod|ancrod|mesh-list
83821985|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
83821986|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83821987|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84048363|NCT04181359|Protective Agents|protective agents|mesh-ancestor
83821988|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821989|NCT00119769|Hormones|hormones|mesh-list
83821990|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83821991|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83821992|NCT00300313|Escitalopram|escitalopram|mesh-list
83821993|NCT00300313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83821994|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83821995|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83821996|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83821997|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83821998|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
83821999|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822000|NCT00399659|Tegaserod|tegaserod|mesh-list
83822001|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83822002|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
83822003|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822004|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822005|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822006|NCT00300352|Folic Acid|folic acid|mesh-list
83822007|NCT00300352|Hematinics|hematinics|mesh-ancestor
83822008|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
83822010|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
83822011|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822012|NCT00300508|Anastrozole|anastrozole|mesh-list
83822013|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83822014|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822015|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83822016|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83822017|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822018|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822019|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83822020|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
83822021|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822022|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822023|NCT00086463|Iloprost|iloprost|mesh-list
83822024|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83822025|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
83822026|NCT00079976|Tigecycline|tigecycline|mesh-list
83822027|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822028|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822029|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83822030|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822031|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822032|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
83822033|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822034|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822035|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822036|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822037|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
83822038|NCT00086268|Carboplatin|carboplatin|mesh-list
83822039|NCT00086268|Docetaxel|docetaxel|mesh-list
83822040|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822041|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
83822042|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
83822043|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
83822044|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822045|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83822046|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822047|NCT00300586|Gemcitabine|gemcitabine|mesh-list
83822048|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83822049|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822050|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
83822051|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822052|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822053|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822054|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822055|NCT00086541|Interferons|interferons|mesh-list
83822056|NCT00086541|Ribavirin|ribavirin|mesh-list
83822057|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
83822058|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822059|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
83822060|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822061|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
83822062|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822063|NCT00300664|Hormones|hormones|mesh-list
83822064|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822065|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822066|NCT04718038|Cetuximab|cetuximab|mesh-list
83822067|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822068|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822069|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
83822070|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822071|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83822072|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
83822073|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
83822074|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
83822075|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83822076|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83822077|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822078|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822079|NCT04718233|Urological Agents|urological agents|mesh-ancestor
83822080|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
82977585|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83822081|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83822082|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83822083|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822084|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
83822085|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822086|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822087|NCT00300937|Ubiquinone|ubiquinone|mesh-list
83822088|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
83822089|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
83822090|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822091|NCT00300937|Vitamins|vitamins|mesh-ancestor
83822092|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
83822093|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83822094|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
83822095|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822096|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822097|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83822098|NCT00418249|Protective Agents|protective agents|mesh-ancestor
83822099|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83822100|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83822101|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822102|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822103|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
83822104|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822105|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
83822106|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
83822107|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83822108|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
83822109|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83822110|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83822111|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822112|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83822113|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822114|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822115|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83822116|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
83822117|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822118|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822119|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822120|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822121|NCT00301171|Fluticasone|fluticasone|mesh-list
83822122|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822123|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83822124|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
83822125|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822126|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822127|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83822128|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
83822129|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
83822130|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83822131|NCT00301210|Tramadol|tramadol|mesh-list
83822132|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83822133|NCT00301210|Narcotics|narcotics|mesh-ancestor
84048364|NCT04129502|Carboplatin|carboplatin|mesh-list
83822134|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83822135|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822136|NCT00301210|Analgesics|analgesics|mesh-ancestor
83822137|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
83822138|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822139|NCT00080327|Aripiprazole|aripiprazole|mesh-list
83822140|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
83822141|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83822142|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83822143|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83822144|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83822145|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822146|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
83822147|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
83822148|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822149|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822150|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83822151|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83822152|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
83822153|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83822154|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83822155|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83822156|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83822157|NCT00301405|Thalidomide|thalidomide|mesh-list
83822158|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822159|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
83822160|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822161|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
83822162|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822163|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822164|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83822165|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83822166|NCT00301405|Growth Substances|growth substances|mesh-ancestor
83822167|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83822168|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822169|NCT00301483|Chrysarobin|chrysarobin|mesh-list
83822170|NCT00301483|HBOC 201|hboc 201|mesh-list
83822171|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83822172|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83822173|NCT00301483|Analgesics|analgesics|mesh-ancestor
83822174|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
83822175|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822176|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822177|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822178|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822179|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
83822180|NCT00301522|Paclitaxel|paclitaxel|mesh-list
83822181|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83822182|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822183|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
83822184|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
83822185|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
83822186|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822187|NCT00080405|Bortezomib|bortezomib|mesh-list
83822188|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822189|NCT00292123|Methadone|methadone|mesh-list
83822190|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83822191|NCT00292123|Narcotics|narcotics|mesh-ancestor
83822192|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048365|NCT04129502|Pemetrexed|pemetrexed|mesh-list
83822193|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822194|NCT00292123|Analgesics|analgesics|mesh-ancestor
83822195|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
83822196|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822197|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
83822198|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
83822199|NCT00080444|Dexamethasone|dexamethasone|mesh-list
83822200|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
83822201|NCT00080444|Ondansetron|ondansetron|mesh-list
83822202|NCT00080444|Aprepitant|aprepitant|mesh-list
83822203|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
83822204|NCT00080444|BB 1101|bb 1101|mesh-list
83822205|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822206|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
83822207|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
83822208|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822209|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822210|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83822211|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
83822212|NCT00080444|Hormones|hormones|mesh-ancestor
83822213|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822214|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83822215|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822216|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
83822217|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822218|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822219|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
83822220|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
83822221|NCT00080444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83822222|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83822223|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
83822224|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822225|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83822226|NCT00086736|Eflornithine|eflornithine|mesh-list
83822227|NCT00086736|Bicalutamide|bicalutamide|mesh-list
83822228|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
83822229|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
83822230|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822231|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822232|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822233|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83822234|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83822235|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83822236|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822237|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83822238|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822239|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822240|NCT00292201|Atorvastatin|atorvastatin|mesh-list
83822241|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83822242|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83822243|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
83822244|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822245|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83822246|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83822247|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822248|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83822249|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83822250|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83822251|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83822252|NCT00080522|Ritonavir|ritonavir|mesh-list
83822253|NCT00080522|Lopinavir|lopinavir|mesh-list
83822254|NCT00080522|Lamivudine|lamivudine|mesh-list
83822255|NCT00080522|Zidovudine|zidovudine|mesh-list
83822256|NCT00080522|Stavudine|stavudine|mesh-list
83822257|NCT00080522|Didanosine|didanosine|mesh-list
83822258|NCT00080522|Efavirenz|efavirenz|mesh-list
83822259|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83822260|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83822261|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
83822262|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822263|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822264|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83822265|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83822266|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
83822267|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822268|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83822269|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83822270|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83822271|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83822272|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
83822273|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83822274|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83822275|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83822276|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83822277|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83822278|NCT00086775|Rituximab|rituximab|mesh-list
83822279|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
83822280|NCT00086775|Fludarabine|fludarabine|mesh-list
83822281|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
83822282|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822283|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822284|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
83822285|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822286|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822287|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822288|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
83822289|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822290|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822291|NCT00086892|Carboplatin|carboplatin|mesh-list
83822292|NCT00086892|Cetuximab|cetuximab|mesh-list
83822293|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822294|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822295|NCT00292708|Cefmetazole|cefmetazole|mesh-list
83822296|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822297|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822298|NCT00086931|Capecitabine|capecitabine|mesh-list
83822299|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
83822300|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822301|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
83822302|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822303|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822304|NCT00292747|Ibuprofen|ibuprofen|mesh-list
83822305|NCT00292747|Drotaverin|drotaverin|mesh-list
83822306|NCT00292747|Papaverine|papaverine|mesh-list
83822307|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83822308|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83822309|NCT00292747|Analgesics|analgesics|mesh-ancestor
83822310|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
83822311|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822312|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822313|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822314|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822315|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83822316|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822317|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822318|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
83822319|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
83822320|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
83822321|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83822322|NCT00292747|Urological Agents|urological agents|mesh-ancestor
83822323|NCT00120003|Candesartan|candesartan|mesh-list
83822324|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
83822325|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83822326|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83822327|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83822328|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822329|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
83822330|NCT00201721|Rituximab|rituximab|mesh-list
83822331|NCT00201721|Pentostatin|pentostatin|mesh-list
83822332|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822333|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
83822334|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822335|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822336|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83822337|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
83822338|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822339|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822340|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83822341|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822342|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83822343|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822344|NCT00201799|Infliximab|infliximab|mesh-list
83822345|NCT00201799|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83822346|NCT00201799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822347|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83822348|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83822349|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822350|NCT00080678|Docetaxel|docetaxel|mesh-list
83822351|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
83822352|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822353|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
83822354|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
83822355|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
83822356|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822357|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822358|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822359|NCT00086970|Ifosfamide|ifosfamide|mesh-list
83822360|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83822361|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83822362|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
83822363|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822364|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822365|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822366|NCT00201955|Rebamipide|rebamipide|mesh-list
83822367|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83822368|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83822369|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
83822370|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822371|NCT00201955|Protective Agents|protective agents|mesh-ancestor
83822372|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822373|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822374|NCT00080795|Gemcitabine|gemcitabine|mesh-list
83822375|NCT00080795|Doxorubicin|doxorubicin|mesh-list
83822376|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83822377|NCT00080795|Ifosfamide|ifosfamide|mesh-list
83822378|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822379|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822380|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
83822381|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822382|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83822383|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83822384|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822385|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822386|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83822387|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
83822388|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83822389|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83822390|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
83822391|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822392|NCT00120081|Antacids|antacids|mesh-ancestor
83822393|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822394|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83822395|NCT00201994|Tolvaptan|tolvaptan|mesh-list
83822396|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83822397|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822398|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
83822399|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822400|NCT00120120|Lenalidomide|lenalidomide|mesh-list
83822401|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
83822402|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822403|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83822404|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83822405|NCT00120120|Growth Substances|growth substances|mesh-ancestor
83822406|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
83822407|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822408|NCT00202189|Budesonide|budesonide|mesh-list
83822409|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822410|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83822411|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
83822412|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822413|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822414|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83822415|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
83822416|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
83822417|NCT00202189|Hormones|hormones|mesh-ancestor
83822418|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822419|NCT00202228|Riboflavin|riboflavin|mesh-list
83822420|NCT00202228|Thiamine|thiamine|mesh-list
83822421|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
83822422|NCT00202228|Vitamins|vitamins|mesh-ancestor
83822423|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
83822424|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822425|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83822426|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
83822427|NCT00087009|Rituximab|rituximab|mesh-list
83822428|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822429|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822430|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
83822431|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822432|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822433|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
83822434|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822435|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822436|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83822437|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822438|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822439|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822440|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822441|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
83822442|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
83822443|NCT00306358|Vitamins|vitamins|mesh-ancestor
83822444|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
83822445|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822446|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
83822447|NCT00306358|Hematinics|hematinics|mesh-ancestor
83822448|NCT00306397|Sirolimus|sirolimus|mesh-list
83822449|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822450|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822451|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83822452|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822453|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
83822454|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977962|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83822455|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
83822456|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822457|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83822458|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
83822459|NCT00418600|Vitamins|vitamins|mesh-ancestor
83822460|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
83822461|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822462|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83822463|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83822464|NCT00087048|Topotecan|topotecan|mesh-list
83822465|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83822466|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822467|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822468|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822469|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822470|NCT00080951|Leucovorin|leucovorin|mesh-list
83822471|NCT00080951|Fluorouracil|fluorouracil|mesh-list
83822472|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
83822473|NCT00080951|Irinotecan|irinotecan|mesh-list
83822474|NCT00080951|Calcium|calcium|mesh-list
83822475|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
83822476|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83822477|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822478|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
83822479|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822480|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822481|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822482|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822483|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
83822484|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83822485|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822486|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822487|NCT00080951|Antidotes|antidotes|mesh-ancestor
83822488|NCT00080951|Protective Agents|protective agents|mesh-ancestor
83822489|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
83822490|NCT00080951|Vitamins|vitamins|mesh-ancestor
83822491|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
83822492|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
83822493|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83822494|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822495|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83822496|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
83822497|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822498|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822499|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822500|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822501|NCT00301639|Methylphenidate|methylphenidate|mesh-list
83822502|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83822503|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822504|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83822505|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83822506|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83822507|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822508|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
83822509|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822510|NCT00087087|Pemetrexed|pemetrexed|mesh-list
83822511|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822512|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822513|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822514|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83822515|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83822516|NCT00301795|Rituximab|rituximab|mesh-list
83822517|NCT00301795|Oblimersen|oblimersen|mesh-list
83822518|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822519|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822520|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
83822521|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822522|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822523|NCT00080990|Leucovorin|leucovorin|mesh-list
83822524|NCT00080990|Fluorouracil|fluorouracil|mesh-list
83822525|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
83822526|NCT00080990|Alvocidib|alvocidib|mesh-list
83822527|NCT00080990|Calcium|calcium|mesh-list
83822528|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
83822529|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83822530|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822531|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
83822532|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822533|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82978036|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83822534|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822535|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822536|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
83822537|NCT00080990|Antidotes|antidotes|mesh-ancestor
83822538|NCT00080990|Protective Agents|protective agents|mesh-ancestor
83822539|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
83822540|NCT00080990|Vitamins|vitamins|mesh-ancestor
83822541|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
83822542|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
83822543|NCT00080990|Growth Substances|growth substances|mesh-ancestor
83822544|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822545|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822546|NCT00301912|Methotrexate|methotrexate|mesh-list
83822547|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
83822548|NCT00301912|Fludarabine|fludarabine|mesh-list
83822549|NCT00301912|Busulfan|busulfan|mesh-list
83822550|NCT00301912|Tacrolimus|tacrolimus|mesh-list
83822551|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83822552|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
83822553|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83822554|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822555|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822556|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
83822557|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822558|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822559|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
83822560|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822561|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83822562|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822563|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
83822564|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822565|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83822566|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83822567|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
83822568|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83822569|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83822570|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
83822571|NCT00301951|Fludarabine|fludarabine|mesh-list
83822572|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
83822573|NCT00301951|Busulfan|busulfan|mesh-list
83822574|NCT00301951|Tacrolimus|tacrolimus|mesh-list
83822575|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83822576|NCT00301951|Sargramostim|sargramostim|mesh-list
83822577|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822578|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822579|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
83822580|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822581|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822582|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
83822583|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822584|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83822585|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822586|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83822587|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83822588|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
83822589|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822590|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822591|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
83822592|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83822593|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83822594|NCT00301990|Aldesleukin|aldesleukin|mesh-list
83822595|NCT00301990|Bevacizumab|bevacizumab|mesh-list
83822596|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822597|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822598|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83822599|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83822600|NCT00301990|Growth Substances|growth substances|mesh-ancestor
83822601|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822602|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
83822603|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83822604|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83822605|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
83822606|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822607|NCT00120198|Rituximab|rituximab|mesh-list
82978139|NCT01336062|Paclitaxel|paclitaxel|mesh-list
83822608|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822609|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822610|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
83822612|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822613|NCT00302224|Ketoconazole|ketoconazole|mesh-list
83822614|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
83822615|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822616|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83822617|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83822618|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822619|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822620|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83822621|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
83822622|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822623|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822624|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83822625|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
83822626|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822627|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822628|NCT00087165|Prednisone|prednisone|mesh-list
83822629|NCT00087165|Docetaxel|docetaxel|mesh-list
83822630|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822631|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
83822632|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
83822633|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
83822634|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822635|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822636|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
83822637|NCT00087165|Hormones|hormones|mesh-ancestor
83822638|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822639|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822640|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83822641|NCT00302341|Trimethoprim|trimethoprim|mesh-list
83822642|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83822643|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
83822644|NCT00302341|Pafuramidine|pafuramidine|mesh-list
83822645|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822646|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822647|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83822648|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822649|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
83822650|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83822651|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83822652|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83822653|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83822654|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83822655|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83822656|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822657|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83822658|NCT00302419|Streptokinase|streptokinase|mesh-list
83822659|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83822660|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83822661|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822662|NCT00302497|Basiliximab|basiliximab|mesh-list
83822663|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822664|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
83822665|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822666|NCT00081107|Epothilones|epothilones|mesh-list
83822667|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
83822668|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
83822669|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
83822670|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
83822671|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822672|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822673|NCT00302536|Tacrolimus|tacrolimus|mesh-list
83822674|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822675|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
83822676|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822677|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83822678|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822679|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822680|NCT00081224|Celecoxib|celecoxib|mesh-list
83822681|NCT00081224|Capecitabine|capecitabine|mesh-list
83822682|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822683|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
83822684|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822685|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822686|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83822687|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83822688|NCT00081224|Analgesics|analgesics|mesh-ancestor
83822689|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
83822690|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822691|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822692|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822693|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822694|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83822695|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83822696|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822697|NCT00120237|Misoprostol|misoprostol|mesh-list
83822698|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83822699|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
83822700|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83822701|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822702|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83822703|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83822704|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
83822706|NCT00081302|Carboplatin|carboplatin|mesh-list
83822707|NCT00081302|Cetuximab|cetuximab|mesh-list
83822708|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83822709|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822710|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
83822711|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
83822712|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
83822713|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822714|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822715|NCT00302653|Rasburicase|rasburicase|mesh-list
83822716|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
83822717|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822718|NCT00418288|Glucagon|glucagon|mesh-list
83822719|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83822720|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83822721|NCT00418288|Hormones|hormones|mesh-ancestor
83822722|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822723|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822724|NCT00418288|Incretins|incretins|mesh-ancestor
83822725|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83822726|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822727|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822728|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822729|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822730|NCT00087282|Irinotecan|irinotecan|mesh-list
83822731|NCT00087282|Alvocidib|alvocidib|mesh-list
83822732|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83822733|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822734|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822735|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822736|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822737|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
83822738|NCT00087282|Growth Substances|growth substances|mesh-ancestor
83822739|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822740|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822741|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83822742|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83822743|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822744|NCT00418366|Incretins|incretins|mesh-ancestor
83822745|NCT00418366|Hormones|hormones|mesh-ancestor
83822746|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822747|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83822748|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
83822749|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822750|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822751|NCT00120315|Esomeprazole|esomeprazole|mesh-list
83822752|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83822753|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83822754|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83822755|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822756|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822757|NCT00081380|Valproic Acid|valproic acid|mesh-list
83822758|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83822759|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
83822760|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
83822761|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83822762|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83822763|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83822764|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822765|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822766|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822767|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
83822768|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
83822770|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822771|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
83822772|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83822773|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83822774|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822775|NCT00302692|Metoprolol|metoprolol|mesh-list
83822776|NCT00302692|Esmolol|esmolol|mesh-list
83822777|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83822778|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83822779|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
83822780|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
83822781|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822782|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822783|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83822784|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83822785|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83822786|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
83822787|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822788|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822789|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83822790|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
83822791|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83822792|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83822793|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83822794|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83822795|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822796|NCT00081536|Capecitabine|capecitabine|mesh-list
83822797|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822798|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
83822799|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822800|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822801|NCT00303004|Bosentan|bosentan|mesh-list
83822802|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
83822803|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
83822804|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83822805|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83822806|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822807|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822808|NCT00303004|Urological Agents|urological agents|mesh-ancestor
83822809|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83822810|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83822811|NCT00081575|Levofloxacin|levofloxacin|mesh-list
83822812|NCT00081575|Tigecycline|tigecycline|mesh-list
83822813|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83822814|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822815|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822816|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83822817|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822818|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822819|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822820|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822821|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83822822|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83822823|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83822824|NCT00087399|Gabapentin|gabapentin|mesh-list
83822825|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
83822826|NCT00087399|Analgesics|analgesics|mesh-ancestor
83822827|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
83822828|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822829|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822830|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
83822831|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83822832|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83822833|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83822834|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83822835|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83822836|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83822837|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822838|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822839|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
83822840|NCT00081614|Bevacizumab|bevacizumab|mesh-list
83822841|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83822842|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83822843|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822844|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83822845|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83822846|NCT00081614|Growth Substances|growth substances|mesh-ancestor
83822847|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822848|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
83822849|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83822850|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822851|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822852|NCT00303277|Simvastatin|simvastatin|mesh-list
83822853|NCT00303277|Pravastatin|pravastatin|mesh-list
83822854|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83822855|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83822856|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
83822857|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822858|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83822859|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83822860|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822861|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83822862|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822863|NCT00303433|Memantine|memantine|mesh-list
83822864|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83822865|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83822866|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
83822867|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822868|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822869|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822870|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83822871|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83822872|NCT00303550|Linezolid|linezolid|mesh-list
83822873|NCT00303550|Iclaprim|iclaprim|mesh-list
83822874|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822875|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822876|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83822877|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822878|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822879|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83822880|NCT00120354|Lamivudine|lamivudine|mesh-list
83822881|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83822882|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83822883|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822884|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822885|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
83822886|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822887|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83822888|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83822889|NCT00399698|Risperidone|risperidone|mesh-list
83822890|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83822891|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
83822892|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822893|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822894|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822895|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83822896|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83822897|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83822898|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83822899|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83822900|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
83822901|NCT00303589|Lactams|lactams|mesh-list
83822902|NCT00303589|beta-Lactams|beta-lactams|mesh-list
83822903|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822904|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822905|NCT00081848|Metronidazole|metronidazole|mesh-list
83822906|NCT00081848|Celecoxib|celecoxib|mesh-list
83822907|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83822908|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83822909|NCT00081848|Analgesics|analgesics|mesh-ancestor
83822910|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
83822911|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822912|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822913|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822914|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83822915|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83822916|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83822917|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822918|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822919|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83822920|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83822921|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83822922|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83822923|NCT00120432|Phenylephrine|phenylephrine|mesh-list
83822924|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
83822925|NCT00120432|Tropicamide|tropicamide|mesh-list
83822926|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83822927|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
83822928|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
83822929|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83822930|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822931|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
83822932|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83822933|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
83822934|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
83822935|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83822936|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83822937|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83822938|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
83822939|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83822940|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822941|NCT00120432|Protective Agents|protective agents|mesh-ancestor
83822942|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83822943|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83822944|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
83822945|NCT00303745|Capecitabine|capecitabine|mesh-list
83822946|NCT00303745|Irinotecan|irinotecan|mesh-list
83822947|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822948|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
83822949|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822950|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822951|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83822952|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822953|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822954|NCT00303784|Goserelin|goserelin|mesh-list
83822955|NCT00303784|Estradiol|estradiol|mesh-list
83822956|NCT00303784|Estrogens|estrogens|mesh-ancestor
83822957|NCT00303784|Hormones|hormones|mesh-ancestor
83822958|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822959|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822960|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83822961|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822962|NCT00081887|Clofarabine|clofarabine|mesh-list
83822963|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822964|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
83822965|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822966|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822967|NCT00303940|Carboplatin|carboplatin|mesh-list
83822968|NCT00303940|Temozolomide|temozolomide|mesh-list
83822969|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822970|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83822971|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
83822972|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822973|NCT00304018|Prednisone|prednisone|mesh-list
83822974|NCT00304018|Fludarabine|fludarabine|mesh-list
83822975|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
83822976|NCT00304018|Etoposide|etoposide|mesh-list
83822977|NCT00304018|Busulfan|busulfan|mesh-list
83822978|NCT00304018|Tacrolimus|tacrolimus|mesh-list
83822979|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83822980|NCT00304018|Sargramostim|sargramostim|mesh-list
83822981|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83822982|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
83822983|NCT00304018|Hormones|hormones|mesh-ancestor
83822984|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83822985|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83822986|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83822987|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83822988|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83822989|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
83822990|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83822991|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83822992|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
83822993|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83822994|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83822995|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83822996|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83822997|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83822998|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
83822999|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83823000|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83823001|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
83823002|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823003|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83823004|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823005|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823006|NCT00304135|Gemcitabine|gemcitabine|mesh-list
83823007|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
83823008|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823009|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823010|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
83823011|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823012|NCT00304213|Testosterone|testosterone|mesh-list
83823013|NCT00304213|Androgens|androgens|mesh-ancestor
83823014|NCT00304213|Hormones|hormones|mesh-ancestor
83823015|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823016|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823017|NCT00304252|Interferons|interferons|mesh-list
83823018|NCT00304252|Interferon-beta|interferon-beta|mesh-list
83823019|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
83823020|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823021|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
83823022|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823023|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
83823024|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823025|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83823026|NCT00120471|Tenofovir|tenofovir|mesh-list
83823027|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
83823028|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823029|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83823030|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83823031|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823032|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823033|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823034|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823035|NCT00082043|Dutasteride|dutasteride|mesh-list
83823036|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83823037|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83823038|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823039|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823040|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
83823041|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823042|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823043|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
83823044|NCT00304291|Analgesics|analgesics|mesh-ancestor
83823045|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
83823046|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823047|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823048|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823049|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83823050|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83823051|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823052|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823053|NCT00304369|Metronidazole|metronidazole|mesh-list
83823054|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823055|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83823056|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83823057|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83823058|NCT00082082|Thymalfasin|thymalfasin|mesh-list
83823059|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83823060|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
83823061|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823062|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
83823063|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83823064|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823065|NCT00304447|Immunotoxins|immunotoxins|mesh-ancestor
83823066|NCT00304447|Immunoconjugates|immunoconjugates|mesh-ancestor
83823067|NCT00304447|Immunologic Factors|immunologic factors|mesh-ancestor
83823068|NCT00304447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823069|NCT00087711|Gemcitabine|gemcitabine|mesh-list
83823070|NCT00087711|Pemetrexed|pemetrexed|mesh-list
83823071|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823072|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823073|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
83823074|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823075|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823076|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83823077|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83823078|NCT00304642|Dapivirine|dapivirine|mesh-list
83823079|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823080|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823081|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
83823082|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823083|NCT00304681|Methylphenidate|methylphenidate|mesh-list
83823084|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83823085|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823086|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83823087|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83823088|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83823089|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823090|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
83823091|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823092|NCT00304720|Tacrolimus|tacrolimus|mesh-list
83823093|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83823094|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
83823095|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823096|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83823097|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823098|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823099|NCT00082199|Aripiprazole|aripiprazole|mesh-list
83823100|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
83823101|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83823102|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83823103|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83823104|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823105|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823106|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
83823107|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
83823108|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823109|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823110|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83823111|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83823112|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
83823113|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83823114|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83823115|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83823116|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83823117|NCT00120510|Lamivudine|lamivudine|mesh-list
83823118|NCT00120510|Zidovudine|zidovudine|mesh-list
83823119|NCT00120510|Efavirenz|efavirenz|mesh-list
83823120|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83823121|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83823122|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83823123|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823124|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823125|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
83823126|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823127|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823128|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823129|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
83823130|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83823131|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83823132|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83823133|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83823134|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83823135|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83823136|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83823137|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
83823138|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83823139|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83823140|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83823141|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823142|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823143|NCT00304993|Niacin|niacin|mesh-list
83823144|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
83823145|NCT00304993|Fenofibrate|fenofibrate|mesh-list
83823146|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83823147|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823148|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83823149|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
83823150|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823151|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83823152|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83823153|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
83823154|NCT00304993|Vitamins|vitamins|mesh-ancestor
83823155|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
83823156|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
83823157|NCT00082277|Anastrozole|anastrozole|mesh-list
83823158|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83823159|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823160|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83823161|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83823162|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823163|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823164|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83823165|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
83823166|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823167|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823168|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83823169|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83823170|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83823171|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83823172|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
83823173|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
83823174|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823175|NCT00082316|Capsaicin|capsaicin|mesh-list
83823176|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
83823177|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
83823178|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
83823179|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823180|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823181|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83823182|NCT00305383|Taribavirin|taribavirin|mesh-list
83823183|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
83823184|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823185|NCT00305422|Risperidone|risperidone|mesh-list
83823186|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83823187|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83823188|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
83823189|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823190|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823191|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823192|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83823193|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83823194|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823195|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83823196|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83823197|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
83823198|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
83823199|NCT00305461|Ciclesonide|ciclesonide|mesh-list
83823200|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
83823201|NCT00305461|Hormones|hormones|mesh-ancestor
83823202|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823203|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823204|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83823205|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83823206|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83823207|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83823208|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83823209|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
83823210|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823211|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823212|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823213|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823214|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
83823215|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823216|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83823217|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83823218|NCT00305500|Escitalopram|escitalopram|mesh-list
83823219|NCT00305500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83823220|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83823221|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83823222|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823223|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823224|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
83823225|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823226|NCT00305539|Adalimumab|adalimumab|mesh-list
83823227|NCT00305539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83823228|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823229|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83823230|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
83823231|NCT00305734|Gemcitabine|gemcitabine|mesh-list
83823232|NCT00305734|Bortezomib|bortezomib|mesh-list
83823233|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823234|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
83823235|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823236|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823237|NCT00082472|Docetaxel|docetaxel|mesh-list
83823238|NCT00082472|Doxorubicin|doxorubicin|mesh-list
83823239|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83823240|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823241|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83823242|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83823243|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83823244|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823245|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83823246|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83823247|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83823248|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823249|NCT00087867|Bortezomib|bortezomib|mesh-list
83823250|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823251|NCT00305812|Dexamethasone|dexamethasone|mesh-list
83823252|NCT00305812|Lenalidomide|lenalidomide|mesh-list
83823253|NCT00305812|Melphalan|melphalan|mesh-list
83823254|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823255|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
83823256|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
83823257|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823258|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823259|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823260|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
83823261|NCT00305812|Hormones|hormones|mesh-ancestor
83823262|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823263|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83823264|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823265|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
83823266|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83823267|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83823268|NCT00305812|Growth Substances|growth substances|mesh-ancestor
83823269|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
83823270|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83823271|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
83823272|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823273|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83823274|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83823275|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83823276|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83823277|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
83823278|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823279|NCT00306046|Diphosphonates|diphosphonates|mesh-list
82978783|NCT05185284|Remdesivir|remdesivir|mesh-list
83823280|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83823281|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823282|NCT00306124|Levodopa|levodopa|mesh-list
83823283|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83823284|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83823285|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
83823286|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823287|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823288|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823289|NCT00082589|Eplerenone|eplerenone|mesh-list
83823290|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83823291|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
83823292|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823293|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823294|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83823295|NCT00082589|Diuretics|diuretics|mesh-ancestor
83823296|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
83823297|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83823298|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83823299|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83823300|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83823301|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
83823302|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823303|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823304|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823305|NCT00313924|Urological Agents|urological agents|mesh-ancestor
83823306|NCT00306475|Valproic Acid|valproic acid|mesh-list
83823307|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
83823308|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823309|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823310|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
83823311|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823312|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823313|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
83823314|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83823315|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823316|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83823317|NCT00082667|Gefitinib|gefitinib|mesh-list
83823318|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823319|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83823320|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823321|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823322|NCT00306748|Linaclotide|linaclotide|mesh-list
83823323|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83823324|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
83823325|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823326|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823327|NCT00082784|Bortezomib|bortezomib|mesh-list
83823328|NCT00082784|Alvocidib|alvocidib|mesh-list
83823329|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823330|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
83823331|NCT00082784|Growth Substances|growth substances|mesh-ancestor
83823332|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823333|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83823334|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823335|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823336|NCT00306826|Pioglitazone|pioglitazone|mesh-list
83823337|NCT00306826|Simvastatin|simvastatin|mesh-list
83823338|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83823339|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83823340|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
83823341|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823342|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83823343|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83823344|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823345|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83823346|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823347|NCT00082823|Aflibercept|aflibercept|mesh-list
83823348|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83823349|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83823350|NCT00082823|Growth Substances|growth substances|mesh-ancestor
83823351|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823352|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
83823353|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823354|NCT00087945|Lamivudine|lamivudine|mesh-list
83823355|NCT00087945|Zidovudine|zidovudine|mesh-list
83823356|NCT00087945|Abacavir|abacavir|mesh-list
83823357|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
83823358|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83823359|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83823360|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823361|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823362|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
83823363|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823364|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823365|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823366|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
83823367|NCT00082862|Interferons|interferons|mesh-list
83823368|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
83823369|NCT00082862|Gemcitabine|gemcitabine|mesh-list
83823370|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823371|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823372|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
83823373|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823374|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
83823375|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823376|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
83823377|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823378|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83823379|NCT00307099|Meropenem|meropenem|mesh-list
83823380|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823381|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
83823382|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823383|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83823384|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
83823385|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
83823386|NCT00307177|Vaccines|vaccines|mesh-list
83823387|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
83823388|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823389|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
83823390|NCT00120705|Hematinics|hematinics|mesh-ancestor
83823391|NCT00307255|Paclitaxel|paclitaxel|mesh-list
83823392|NCT00307255|Gemcitabine|gemcitabine|mesh-list
83823393|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83823394|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83823395|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823396|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
83823397|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
83823398|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
83823399|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823400|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823401|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
83823402|NCT00307411|Hormones|hormones|mesh-list
83823403|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823404|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823405|NCT00307450|Levetiracetam|levetiracetam|mesh-list
83823406|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
83823407|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
83823408|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83823409|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
83823410|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823411|NCT00120744|Ondansetron|ondansetron|mesh-list
83823412|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
83823413|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
83823414|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823415|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978930|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823416|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82978931|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978932|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82978933|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978934|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978935|NCT02481076|Monensin|monensin|mesh-list
82978936|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
82978937|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978938|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82978939|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82978940|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
82978941|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
82978942|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
83823417|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
83823419|NCT00120744|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83823420|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83823421|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
83823422|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823423|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823424|NCT00083057|Paclitaxel|paclitaxel|mesh-list
83823425|NCT00083057|Gefitinib|gefitinib|mesh-list
83823426|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83823427|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823428|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
83823429|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
83823430|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
83823431|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823432|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83823433|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823434|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
83823435|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83823436|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83823437|NCT00307606|Prednisolone|prednisolone|mesh-list
83823438|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
83823439|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83823440|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
83823441|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823442|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
83823443|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
83823444|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823445|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823446|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823447|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
83823448|NCT00307606|Hormones|hormones|mesh-ancestor
83823449|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823450|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83823451|NCT00307606|Protective Agents|protective agents|mesh-ancestor
83823452|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83823453|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823454|NCT00083096|Temozolomide|temozolomide|mesh-list
83823455|NCT00083096|Lonafarnib|lonafarnib|mesh-list
83823456|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83823457|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
83823458|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823459|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823460|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823461|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
83823462|NCT00307645|Prednisone|prednisone|mesh-list
83823463|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
83823464|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
83823465|NCT00307645|Azathioprine|azathioprine|mesh-list
83823466|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83823467|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
83823468|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823469|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83823470|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83823471|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
83823472|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823473|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823474|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83823475|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823476|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
83823477|NCT00307645|Hormones|hormones|mesh-ancestor
83823478|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823479|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83823480|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83823481|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83823482|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
83823483|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83823484|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823485|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823486|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
83823487|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
83823488|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823489|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823490|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83823491|NCT00307645|Protective Agents|protective agents|mesh-ancestor
83823492|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
83823494|NCT00120783|Ritonavir|ritonavir|mesh-list
83823495|NCT00120783|Indinavir|indinavir|mesh-list
83823496|NCT00120783|Lamivudine|lamivudine|mesh-list
83823497|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83823498|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83823499|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
83823500|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823501|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823502|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823503|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823504|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
83823505|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823506|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83823507|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83823508|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83823509|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83823510|NCT00307723|Bevacizumab|bevacizumab|mesh-list
83823511|NCT00307723|Gemcitabine|gemcitabine|mesh-list
83823512|NCT00307723|Fluorouracil|fluorouracil|mesh-list
83823513|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
83823514|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83823515|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823516|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83823517|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83823518|NCT00307723|Growth Substances|growth substances|mesh-ancestor
83823519|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823520|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
83823521|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823522|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
83823523|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823524|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83823525|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
83823526|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83823527|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823528|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823529|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823530|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83823531|NCT00120822|Folic Acid|folic acid|mesh-list
83823532|NCT00120822|Hematinics|hematinics|mesh-ancestor
83823533|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
83823534|NCT00120822|Vitamins|vitamins|mesh-ancestor
83823535|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
83823536|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823537|NCT00083213|Aflibercept|aflibercept|mesh-list
83823538|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83823539|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83823540|NCT00083213|Growth Substances|growth substances|mesh-ancestor
83823541|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823542|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
83823543|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823544|NCT00307996|Ubiquinone|ubiquinone|mesh-list
83823545|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
83823546|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
83823547|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823548|NCT00307996|Vitamins|vitamins|mesh-ancestor
83823549|NCT00083252|Cisplatin|cisplatin|mesh-list
83823550|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823551|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
83823552|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83823553|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823554|NCT00418678|Nabilone|nabilone|mesh-list
83823555|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
83823556|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
83137162|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
83823557|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823558|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823559|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823560|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83823561|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83823562|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823563|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83823564|NCT00120861|Interferons|interferons|mesh-list
83823565|NCT00120861|Ribavirin|ribavirin|mesh-list
83823566|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823567|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
82979082|NCT04998214|Thrombin|thrombin|mesh-list
83823568|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823569|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
83823570|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823571|NCT05446142|Rabeprazole|rabeprazole|mesh-list
83823572|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83823573|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823574|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83823575|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823576|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823577|NCT00308191|Bromides|bromides|mesh-list
83823578|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
83823579|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
83823580|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83823581|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
83823582|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823583|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823584|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83823585|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
83823586|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83823587|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83823588|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83823589|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83823590|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823591|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823592|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
83137172|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83823593|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83823594|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
83823595|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
83823596|NCT00308269|Folic Acid|folic acid|mesh-list
83823597|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
83823598|NCT00308269|Hematinics|hematinics|mesh-ancestor
83823599|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
83823600|NCT00308269|Vitamins|vitamins|mesh-ancestor
83823601|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
83823602|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823603|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823604|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
83823605|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
83823606|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
83823607|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823608|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
83823609|NCT00308425|Valsartan|valsartan|mesh-list
83823610|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83823611|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823612|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83823613|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
83823614|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83823615|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823616|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823617|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823618|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83823619|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83823620|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83823621|NCT00308503|SR 46349B|sr 46349b|mesh-list
83823622|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83823623|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83823624|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823625|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83823626|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83823627|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
83823628|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823629|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823630|NCT00308542|Dexamethasone|dexamethasone|mesh-list
83823631|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823632|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
83823633|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
83823634|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823635|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823636|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823637|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
83823638|NCT00308542|Hormones|hormones|mesh-ancestor
83823639|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823640|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83823641|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979158|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83823642|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
83823643|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83823644|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823646|NCT00083408|Thalidomide|thalidomide|mesh-list
83823647|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83823648|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
83823649|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823650|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
83823651|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83823652|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823653|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83823654|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83823655|NCT00083408|Growth Substances|growth substances|mesh-ancestor
83823656|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
83823657|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823658|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83823659|NCT00308971|Vitamin E|vitamin e|mesh-list
83823660|NCT00308971|Tocopherols|tocopherols|mesh-list
83823661|NCT00308971|Tocotrienols|tocotrienols|mesh-list
83823662|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
83823663|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
83823664|NCT00308971|Vitamins|vitamins|mesh-ancestor
83823665|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
83823666|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823667|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
83823668|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823669|NCT00308971|Protective Agents|protective agents|mesh-ancestor
83823670|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
83823671|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
83823672|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823673|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83823674|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
83823675|NCT00309049|Epothilones|epothilones|mesh-list
83823676|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83823677|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83823678|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83823679|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823680|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823681|NCT00309088|Tacrolimus|tacrolimus|mesh-list
83823682|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83823683|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
83823684|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823685|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83823686|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823687|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823688|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
83823689|NCT00083486|Hematinics|hematinics|mesh-ancestor
83823690|NCT00120978|Fluticasone|fluticasone|mesh-list
83823691|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83823692|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
83823693|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823694|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823695|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83823696|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
83823697|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823698|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
83823699|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83823700|NCT00309205|Dapivirine|dapivirine|mesh-list
83823701|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823702|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823703|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
83823704|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823705|NCT00309283|Somatostatin|somatostatin|mesh-list
83823706|NCT00309283|Hormones|hormones|mesh-ancestor
83823707|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823708|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823709|NCT00083525|Capecitabine|capecitabine|mesh-list
83823710|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823711|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
83823712|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823713|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823714|NCT00309322|Phentolamine|phentolamine|mesh-list
83823715|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83823716|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83823717|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
82979231|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
83823718|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823719|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823720|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823721|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83823722|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83823723|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83823724|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83823725|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83823726|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823727|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823728|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823729|NCT04727502|Analgesics|analgesics|mesh-ancestor
83823730|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
83823731|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823732|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
83823733|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83823734|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
83823735|NCT00309361|Phentolamine|phentolamine|mesh-list
83823736|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83823737|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83823738|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83823739|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823740|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823741|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823742|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83823743|NCT00088491|Olanzapine|olanzapine|mesh-list
83823744|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
83823745|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
83823746|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823747|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823748|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823749|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83823750|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83823751|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823752|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83823753|NCT00088491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83823754|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83823755|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83823756|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823757|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823758|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
83823759|NCT00309517|Leucovorin|leucovorin|mesh-list
83823760|NCT00309517|Edrecolomab|edrecolomab|mesh-list
83823761|NCT00309517|Antidotes|antidotes|mesh-ancestor
83823762|NCT00309517|Protective Agents|protective agents|mesh-ancestor
83823763|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823764|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
83823765|NCT00309517|Vitamins|vitamins|mesh-ancestor
83823766|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
83823767|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83823768|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
83823769|NCT00121017|Ritonavir|ritonavir|mesh-list
83823770|NCT00121017|Lopinavir|lopinavir|mesh-list
83823771|NCT00121017|Tenofovir|tenofovir|mesh-list
83823772|NCT00121017|Emtricitabine|emtricitabine|mesh-list
83823773|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83823774|NCT00121017|Efavirenz|efavirenz|mesh-list
83823775|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83823776|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83823777|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
83823778|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823779|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823780|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83823781|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83823782|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
83823783|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823784|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83823785|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83823786|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83823787|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83823788|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83823789|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83823790|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83823791|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83823792|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83823793|NCT00309556|Docetaxel|docetaxel|mesh-list
83823794|NCT00309556|Capecitabine|capecitabine|mesh-list
83823795|NCT00309556|Trastuzumab|trastuzumab|mesh-list
83823796|NCT00309556|Epirubicin|epirubicin|mesh-list
83823797|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823798|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
83823799|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
83823800|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
83823801|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823802|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83823803|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
83823804|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83823805|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83823806|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83823807|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83823808|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823809|NCT00402207|Fluticasone|fluticasone|mesh-list
83823810|NCT00402207|Beclomethasone|beclomethasone|mesh-list
83823811|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823812|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83823813|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
83823814|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823815|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823816|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83823817|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
83823818|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
83823819|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83823820|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
83823821|NCT00402207|Hormones|hormones|mesh-ancestor
83823822|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823823|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83823824|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
83823825|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823826|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823827|NCT00309634|Vaccines|vaccines|mesh-list
83823828|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
83823829|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823830|NCT00309712|Simvastatin|simvastatin|mesh-list
83823831|NCT00309712|Fenofibrate|fenofibrate|mesh-list
83823832|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83823833|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83823834|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
83823835|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823836|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83823837|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83823838|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823839|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83823840|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83823841|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
83823842|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
83823843|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83823844|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83823845|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823846|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823847|NCT00309790|Urological Agents|urological agents|mesh-ancestor
83823848|NCT00418873|Risperidone|risperidone|mesh-list
83823849|NCT00418873|Zotepine|zotepine|mesh-list
83823850|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83823851|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
83823852|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823853|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823854|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823855|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83823856|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83823857|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823858|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83137218|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
83823859|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83823860|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
83823861|NCT00088608|Pasireotide|pasireotide|mesh-list
83823862|NCT00088608|Hormones|hormones|mesh-ancestor
82979378|NCT01321775|Trastuzumab|trastuzumab|mesh-list
83823863|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979379|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83823864|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823865|NCT00310024|Bortezomib|bortezomib|mesh-list
83823866|NCT00310024|Vorinostat|vorinostat|mesh-list
83823867|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823868|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83823869|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823870|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823871|NCT00310141|Nicotine|nicotine|mesh-list
83823872|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83823873|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
83823874|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823875|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823876|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83823877|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83823878|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
83823879|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83823880|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823881|NCT00088686|Capsaicin|capsaicin|mesh-list
83823882|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
83823883|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
83823884|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
83823885|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823886|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823887|NCT00083681|Thalidomide|thalidomide|mesh-list
83823888|NCT00083681|Dexamethasone|dexamethasone|mesh-list
83823889|NCT00083681|Etoposide|etoposide|mesh-list
83823890|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
83823891|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823892|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
83823893|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
83823894|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823895|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823896|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823897|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
83823898|NCT00083681|Hormones|hormones|mesh-ancestor
83823899|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823900|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83823901|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823902|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83823903|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83823904|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83823905|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83823906|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823907|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83823908|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
83823909|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83823910|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83823911|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
83823912|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83823913|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
83823914|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83823915|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823916|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83823917|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83823918|NCT00083681|Growth Substances|growth substances|mesh-ancestor
83823919|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83823920|NCT00121095|Docetaxel|docetaxel|mesh-list
83823921|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83823922|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823923|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83823924|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83823925|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83823926|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823927|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83823928|NCT00121095|Analgesics|analgesics|mesh-ancestor
83823929|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
83823930|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823931|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823932|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
83823933|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83823934|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823935|NCT00310336|Interferons|interferons|mesh-list
83823936|NCT00310336|Ribavirin|ribavirin|mesh-list
83823937|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
83823938|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
83823939|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83823940|NCT00310336|Betaine|betaine|mesh-list
83823941|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823942|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
83823943|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83823945|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823946|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
83823947|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823948|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823949|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
83823950|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83823951|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83823952|NCT05568602|Dexamethasone|dexamethasone|mesh-list
83823953|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83823954|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
83823955|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
83823956|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823957|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823958|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83823959|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
83823960|NCT05568602|Hormones|hormones|mesh-ancestor
83823961|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823962|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83823963|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83823964|NCT00310492|Immunomodulating Agents|immunomodulating agents|mesh-list
83823965|NCT00310492|Immunologic Factors|immunologic factors|mesh-ancestor
83823966|NCT00310492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823967|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83823968|NCT00310531|Estradiol|estradiol|mesh-list
83823969|NCT00310531|Estrogens|estrogens|mesh-ancestor
83823970|NCT00310531|Hormones|hormones|mesh-ancestor
83823971|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83823972|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823973|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83823974|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
83823975|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83823976|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83823977|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83823978|NCT00309673|Lidocaine|lidocaine|mesh-list
83823979|NCT00309673|Prilocaine|prilocaine|mesh-list
83823980|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83823981|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
83823982|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
83823983|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83823984|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823985|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
83823986|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823987|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83823988|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83823989|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83823990|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83823991|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83823992|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83823993|NCT00310765|Pregabalin|pregabalin|mesh-list
83823994|NCT00310765|Gabapentin|gabapentin|mesh-list
83823995|NCT00310765|Analgesics|analgesics|mesh-ancestor
83823996|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
83823997|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83823998|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83823999|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
83824000|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83824001|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824002|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824003|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83824004|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83824005|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83824006|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824007|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83824008|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83824009|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83824010|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824011|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
83824012|NCT00310843|Nevirapine|nevirapine|mesh-list
83824013|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83824014|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83824015|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824016|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824017|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
83824018|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824019|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83824020|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83824021|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83824022|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83824023|NCT00310921|Misoprostol|misoprostol|mesh-list
83824024|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83824025|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
83824026|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83824027|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824028|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83824029|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83824030|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
83824031|NCT05568212|Durvalumab|durvalumab|mesh-list
83824032|NCT05568212|Olaparib|olaparib|mesh-list
83824033|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83824034|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824035|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83824036|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824037|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824038|NCT00121329|Lidocaine|lidocaine|mesh-list
83824039|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83824040|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
83824041|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824042|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824043|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
83824044|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824045|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83824046|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83824047|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83824048|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824049|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824050|NCT00311038|Landiolol|landiolol|mesh-list
83824051|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83824052|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83824053|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
83824054|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824055|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824056|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824057|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83824058|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
83824059|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83824060|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824061|NCT00311116|Vitamin E|vitamin e|mesh-list
83824062|NCT00311116|Vitamins|vitamins|mesh-ancestor
83824063|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
83824064|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824065|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
83824066|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824067|NCT00311116|Protective Agents|protective agents|mesh-ancestor
83824068|NCT00088959|Celecoxib|celecoxib|mesh-list
83824069|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83824070|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824071|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83824072|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824073|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824074|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83824075|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83824076|NCT00088959|Analgesics|analgesics|mesh-ancestor
83824077|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
83824078|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824079|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824080|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824081|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824082|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83824083|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83824084|NCT05568017|Edotreotide|edotreotide|mesh-list
83824085|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83824086|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824087|NCT00311389|Timolol|timolol|mesh-list
83824088|NCT00311389|Travoprost|travoprost|mesh-list
82979602|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83824089|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83824090|NCT00311389|Latanoprost|latanoprost|mesh-list
83824091|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83824092|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824093|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83824094|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83824095|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
83824096|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824097|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824098|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83824099|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824100|NCT00088998|Bevacizumab|bevacizumab|mesh-list
83824101|NCT00088998|Docetaxel|docetaxel|mesh-list
83824102|NCT00088998|Capecitabine|capecitabine|mesh-list
83824103|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83824104|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824105|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83824106|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83824107|NCT00088998|Growth Substances|growth substances|mesh-ancestor
83824108|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824109|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
83824110|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824111|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824112|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824113|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824114|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824115|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
83824116|NCT00311467|Interferons|interferons|mesh-list
83824117|NCT00311467|Capecitabine|capecitabine|mesh-list
83824118|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824119|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
83824120|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824121|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824122|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
83824123|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824124|NCT00311545|Siltuximab|siltuximab|mesh-list
83824125|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824126|NCT00089037|Sirolimus|sirolimus|mesh-list
83824127|NCT00089037|Methotrexate|methotrexate|mesh-list
83824128|NCT00089037|Tacrolimus|tacrolimus|mesh-list
83824129|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83824130|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
83824131|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83824132|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824133|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824134|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
83824135|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824136|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824137|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
83824138|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824139|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83824140|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824141|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
83824142|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824143|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83824144|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83824145|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83824146|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824147|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83824148|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
83824149|NCT00311740|Valsartan|valsartan|mesh-list
83824150|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83824151|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824152|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83824153|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83824154|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824155|NCT00311740|Diuretics|diuretics|mesh-ancestor
83824156|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
83824157|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824158|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83824159|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824160|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
83824161|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83824162|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824163|NCT00121407|Verteporfin|verteporfin|mesh-list
83824164|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83824165|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
83824166|NCT00311857|Cetuximab|cetuximab|mesh-list
83824167|NCT00311857|Temozolomide|temozolomide|mesh-list
83824168|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83824169|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824170|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83824171|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
83824172|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824173|NCT00311896|Bemiparin|bemiparin|mesh-list
83824174|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
83824175|NCT00121446|Enoxaparin|enoxaparin|mesh-list
83824176|NCT00121446|Tenecteplase|tenecteplase|mesh-list
83824177|NCT00121446|Clopidogrel|clopidogrel|mesh-list
83824178|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83824179|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83824180|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83824181|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83824182|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
83824183|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824184|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824185|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824186|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
83824187|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83824188|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83824189|NCT00311974|Dihydralazine|dihydralazine|mesh-list
83824190|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824191|NCT00312013|Nadroparin|nadroparin|mesh-list
83824192|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
83824193|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83824194|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83824195|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824196|NCT00121524|Atropine|atropine|mesh-list
83824197|NCT00121524|Amiodarone|amiodarone|mesh-list
83824198|NCT00121524|Epinephrine|epinephrine|mesh-list
83824199|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83824200|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83824201|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
83824202|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824203|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824204|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824205|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83824206|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83824207|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
83824208|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824209|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83824210|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
83824211|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
83824212|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
83824213|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83824214|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83824215|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83824216|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
83824217|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83824218|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83824219|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
83824220|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
83824221|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83824222|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824223|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83824224|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83824225|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83824226|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824227|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83824228|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83824229|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83824230|NCT00312130|Vildagliptin|vildagliptin|mesh-list
83824231|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83824232|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824233|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83824234|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
83824235|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824236|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824237|NCT00089115|Rituximab|rituximab|mesh-list
82979752|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824238|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
83824239|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83824241|NCT00089115|Sargramostim|sargramostim|mesh-list
83824242|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83824243|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83824244|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824245|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
83824246|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824247|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824248|NCT00312325|Prednisolone|prednisolone|mesh-list
83824249|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824250|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
83824251|NCT00312325|Hormones|hormones|mesh-ancestor
83824252|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824253|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824254|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83137250|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
83824255|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824256|NCT05567471|Vaccines|vaccines|mesh-list
83824257|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
83824258|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824259|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83824260|NCT00089154|Antibodies|antibodies|mesh-list
83824261|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
83824262|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83824263|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
83824264|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824265|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824266|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
83824267|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
83824268|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
83824269|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83824270|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824271|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
83824272|NCT00312481|Protective Agents|protective agents|mesh-ancestor
83824273|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824274|NCT00312481|Vitamins|vitamins|mesh-ancestor
83824275|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
83824276|NCT00312481|Cathartics|cathartics|mesh-ancestor
83824277|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83824278|NCT00312481|Laxatives|laxatives|mesh-ancestor
83824279|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
83824280|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83824281|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83824282|NCT00312520|Prednisolone|prednisolone|mesh-list
83824283|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
83824284|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83824285|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
83824286|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824287|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
83824288|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
83824289|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824290|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824291|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83824292|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
83824293|NCT00312520|Hormones|hormones|mesh-ancestor
83824294|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824295|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83824296|NCT00312520|Protective Agents|protective agents|mesh-ancestor
83824297|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83824298|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824299|NCT00089193|Sargramostim|sargramostim|mesh-list
83824300|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
83824301|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
83824302|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824303|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83824304|NCT00293098|Deferiprone|deferiprone|mesh-list
83824305|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83824306|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
83824307|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
83824308|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824309|NCT00293176|Donepezil|donepezil|mesh-list
83824310|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83824311|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824312|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824313|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
83824314|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824315|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824316|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
83824317|NCT00121563|Thalidomide|thalidomide|mesh-list
83824318|NCT00121563|Ibuprofen|ibuprofen|mesh-list
83824319|NCT00121563|Diazepam|diazepam|mesh-list
83824320|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83824321|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83824322|NCT00121563|Analgesics|analgesics|mesh-ancestor
83824323|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
83824324|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824325|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824326|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824327|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824328|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83824329|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824330|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824331|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824332|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
83824333|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
83824334|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83824335|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824336|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83824337|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83824338|NCT00121563|Growth Substances|growth substances|mesh-ancestor
83824339|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
83824340|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824341|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83824342|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
83824343|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
83824344|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
83824345|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83824346|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83824347|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824348|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83824349|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83824350|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83824351|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83824352|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83824353|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83824354|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
83824355|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
83824356|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
83824357|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
83824358|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824359|NCT00293332|Bevacizumab|bevacizumab|mesh-list
83824360|NCT00293332|Carboplatin|carboplatin|mesh-list
83824361|NCT00293332|Docetaxel|docetaxel|mesh-list
83824362|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83824363|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824364|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83824365|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83824366|NCT00293332|Growth Substances|growth substances|mesh-ancestor
83824367|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824368|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
83824369|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824370|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824371|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824372|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824373|NCT00293371|Prednisone|prednisone|mesh-list
83824374|NCT00293371|Docetaxel|docetaxel|mesh-list
82979904|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82979905|NCT02473198|Narcotics|narcotics|mesh-ancestor
82979906|NCT02473198|Analgesics|analgesics|mesh-ancestor
82979907|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82979908|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82979909|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979910|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979911|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82979912|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979913|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979914|NCT03614728|Azacitidine|azacitidine|mesh-list
82979915|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
82979916|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82979921|NCT05069974|Linezolid|linezolid|mesh-list
83824375|NCT00293371|Vatalanib|vatalanib|mesh-list
83824376|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824377|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824378|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824379|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824380|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824381|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824382|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
83824384|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824385|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824386|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83824387|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83824388|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824389|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
83824390|NCT00293410|Clofarabine|clofarabine|mesh-list
83824391|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824392|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
83824393|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824394|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824395|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83824396|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
83824397|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824398|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824399|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83824400|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824401|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
83824402|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
83824403|NCT00121602|Hematinics|hematinics|mesh-ancestor
83824404|NCT00293527|Interferons|interferons|mesh-list
83824405|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
83824406|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
83824407|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824408|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
83824409|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824410|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
83824411|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824412|NCT04711161|Paclitaxel|paclitaxel|mesh-list
83824413|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83824414|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824415|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824416|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824417|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824418|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824419|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
83824420|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
83824421|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
83824422|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824423|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824424|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83824425|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83824426|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
83824427|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
83824428|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824429|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824430|NCT00293761|Travoprost|travoprost|mesh-list
83824431|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824432|NCT00293800|Timolol|timolol|mesh-list
83824433|NCT00293800|Travoprost|travoprost|mesh-list
83824434|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83824435|NCT00293800|Latanoprost|latanoprost|mesh-list
83824436|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83824437|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83824438|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83824439|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
83824440|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824441|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824442|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824443|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83824444|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824445|NCT00423969|Galantamine|galantamine|mesh-list
83824446|NCT00423969|Escitalopram|escitalopram|mesh-list
83824447|NCT00423969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83824448|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83824449|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824450|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824451|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824452|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
83824453|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824455|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824456|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
83824457|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83824458|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824459|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83824460|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
83824461|NCT00293839|Oxybutynin|oxybutynin|mesh-list
83824462|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
83824463|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
83824464|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824465|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824466|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83824467|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83824468|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
83824469|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824470|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824471|NCT00293839|Urological Agents|urological agents|mesh-ancestor
83824472|NCT00293917|Tacrolimus|tacrolimus|mesh-list
83824473|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824474|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
83824475|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824476|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83824477|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824478|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824479|NCT05567081|Triamcinolone|triamcinolone|mesh-list
83824480|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83824481|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83824482|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83824483|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824484|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
83824485|NCT05567081|Hormones|hormones|mesh-ancestor
83824486|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824487|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824488|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824489|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
83824490|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824491|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824492|NCT04710927|Fluorides|fluorides|mesh-list
83824493|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
83824494|NCT04710927|Protective Agents|protective agents|mesh-ancestor
83824495|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824496|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
83824497|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824498|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
83824499|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824500|NCT00417898|Aspirin|aspirin|mesh-list
83824501|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83824502|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83824503|NCT00417898|Analgesics|analgesics|mesh-ancestor
83824504|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
83824505|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824506|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824507|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824508|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824509|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83824510|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83824511|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824512|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83824513|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83824514|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824515|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
83824516|NCT00294190|Topotecan|topotecan|mesh-list
83824517|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83824518|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83824519|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824520|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824521|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824522|NCT02960503|Azithromycin|azithromycin|mesh-list
83824523|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83824524|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824525|NCT04706091|Suvorexant|suvorexant|mesh-list
83824526|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82980052|NCT04409964|Narcotics|narcotics|mesh-ancestor
83824527|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83824528|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824529|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824530|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83824531|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824532|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824533|NCT00294385|Gemcitabine|gemcitabine|mesh-list
83824534|NCT00294385|Docetaxel|docetaxel|mesh-list
83824535|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824536|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
83824537|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824538|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824539|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824540|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824541|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824542|NCT00294463|Tibolone|tibolone|mesh-list
83824543|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83824544|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83824545|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83824546|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
83824547|NCT00294463|Estradiol|estradiol|mesh-list
83824548|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83824549|NCT00294463|Progesterone|progesterone|mesh-list
83824550|NCT00294463|Estrogens|estrogens|mesh-ancestor
83824551|NCT00294463|Hormones|hormones|mesh-ancestor
83824552|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824553|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824554|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83824555|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
83824556|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83824557|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83824558|NCT00294463|Progestins|progestins|mesh-ancestor
83824559|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
83824560|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
83824561|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824562|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83824563|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824564|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83824565|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
83824566|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83824567|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83824568|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83824569|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83824570|NCT00294502|Minocycline|minocycline|mesh-list
83824571|NCT00294502|Gentamicins|gentamicins|mesh-list
83824572|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824573|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83824574|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824575|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83824576|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824577|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83824578|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
83824579|NCT00089349|Methotrexate|methotrexate|mesh-list
83824580|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
83824581|NCT00089349|Antibodies|antibodies|mesh-list
83824582|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
83824583|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83824584|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
83824585|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824586|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824587|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83824588|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
83824589|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83824590|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824591|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
83824592|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824593|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
83824594|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824595|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83824596|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824597|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824598|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83824599|NCT00294580|Maloprim|maloprim|mesh-list
83824600|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
83824601|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82980128|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
83824602|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83824603|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824604|NCT00294619|Hormones|hormones|mesh-list
83824605|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824606|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824607|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83824608|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824609|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83824610|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824611|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824612|NCT00294775|Candesartan|candesartan|mesh-list
83824613|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824614|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83824615|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83824616|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824617|NCT00121680|Lenvatinib|lenvatinib|mesh-list
83824618|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824619|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83824620|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824621|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824622|NCT00294853|Calcium|calcium|mesh-list
83824623|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83824624|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824625|NCT00294892|Nevirapine|nevirapine|mesh-list
83824626|NCT00294892|Carbamazepine|carbamazepine|mesh-list
83824627|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83824628|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83824629|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824630|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824631|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
83824632|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824633|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83824634|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83824635|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83824636|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83824637|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
83824638|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
83824639|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83824640|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824641|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824642|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83824643|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83824644|NCT00294892|Analgesics|analgesics|mesh-ancestor
83824645|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
83824646|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824647|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83824648|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824649|NCT00089427|Temozolomide|temozolomide|mesh-list
83824650|NCT00089427|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83824651|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83824652|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
83824653|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824654|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824655|NCT00294931|Bevacizumab|bevacizumab|mesh-list
83824656|NCT00294931|Carboplatin|carboplatin|mesh-list
83824657|NCT00294931|Irinotecan|irinotecan|mesh-list
83824658|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83824659|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824660|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83824661|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83824662|NCT00294931|Growth Substances|growth substances|mesh-ancestor
83824663|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824664|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
83824665|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83824666|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83824667|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824668|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824669|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
83824670|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83824671|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
83824672|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824673|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824674|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824675|NCT00295165|Sargramostim|sargramostim|mesh-list
83824676|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
83824677|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824678|NCT00295243|Topotecan|topotecan|mesh-list
83824679|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83824680|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83824681|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824682|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824683|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824684|NCT00295282|Antibodies|antibodies|mesh-list
83824685|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83824686|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
83824687|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824688|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83824689|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824690|NCT00089622|Levodopa|levodopa|mesh-list
83824691|NCT00089622|Lisuride|lisuride|mesh-list
83824692|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83824693|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83824694|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
83824695|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824696|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824697|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824698|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83824699|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
83824700|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
83824701|NCT00295555|Doxazosin|doxazosin|mesh-list
83824702|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824703|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83824704|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83824705|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83824706|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
83824707|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824708|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824709|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824710|NCT00295594|Tacrolimus|tacrolimus|mesh-list
83824711|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824712|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
83824713|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824714|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83824715|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824716|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824717|NCT00121875|Hormones|hormones|mesh-list
83824718|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824719|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824720|NCT00295672|Vinorelbine|vinorelbine|mesh-list
83824721|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83824722|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824723|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824724|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824725|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824726|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824727|NCT00295789|Paclitaxel|paclitaxel|mesh-list
83824728|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83824729|NCT00295789|Carboplatin|carboplatin|mesh-list
83824730|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83824731|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824732|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824733|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824734|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824735|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824736|NCT00089700|Ibalizumab|ibalizumab|mesh-list
83824737|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83824738|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83824739|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
83824740|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824741|NCT04718584|Antibodies|antibodies|mesh-list
83824742|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83824743|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
83824744|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824745|NCT00417937|Azelaic acid|azelaic acid|mesh-list
83824746|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824747|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
83824748|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83824749|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
83824750|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
83824751|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
83824752|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824753|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
83824754|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824755|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83824756|NCT00295945|Fentanyl|fentanyl|mesh-list
83824757|NCT00295945|Hydromorphone|hydromorphone|mesh-list
83824758|NCT00295945|Ropivacaine|ropivacaine|mesh-list
83824759|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
83824760|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
83824761|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824762|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824763|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
83824764|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824765|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83824766|NCT00295945|Narcotics|narcotics|mesh-ancestor
83824767|NCT00295945|Analgesics|analgesics|mesh-ancestor
83824768|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83824769|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83824770|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
83824771|NCT00121914|Ethanol|ethanol|mesh-list
83824772|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83824773|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824774|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824775|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824776|NCT00295984|Nicotine|nicotine|mesh-list
83824777|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83824778|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
83824779|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824780|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824781|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83824782|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83824783|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
83824784|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824785|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824786|NCT00296023|Methotrexate|methotrexate|mesh-list
83824787|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
83824788|NCT00296023|Fludarabine|fludarabine|mesh-list
83824789|NCT00296023|Busulfan|busulfan|mesh-list
83824790|NCT00296023|Tacrolimus|tacrolimus|mesh-list
83824791|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83824792|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83824793|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
83824794|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83824795|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824796|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824797|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
83824798|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824799|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824800|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
83824801|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824802|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83824803|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824804|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
83824805|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83824806|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83824807|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83824808|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
83824809|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83824810|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83824811|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
83824812|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83824813|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824814|NCT00296062|Bevacizumab|bevacizumab|mesh-list
83824815|NCT00296062|Capecitabine|capecitabine|mesh-list
83824816|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
83824817|NCT00296062|Irinotecan|irinotecan|mesh-list
83824818|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83824819|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824820|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83824821|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83824822|NCT00296062|Growth Substances|growth substances|mesh-ancestor
83824823|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980368|NCT05262322|Apixaban|apixaban|mesh-list
83824824|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
83824825|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824826|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
83824827|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824828|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83824829|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83824830|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824831|NCT00296179|Zolpidem|zolpidem|mesh-list
83824832|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83824833|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83824834|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824835|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824836|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83824837|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
83824838|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
83824839|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824840|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824841|NCT00296218|Irbesartan|irbesartan|mesh-list
83824842|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83824843|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83824844|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83824845|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824846|NCT00089856|Prednisone|prednisone|mesh-list
83824847|NCT00089856|Docetaxel|docetaxel|mesh-list
83824848|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824849|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
83824850|NCT00089856|Hormones|hormones|mesh-ancestor
83824851|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824852|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824853|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83824854|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824855|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
83824856|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
83824857|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
83824858|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824859|NCT00296257|Rimacalib|rimacalib|mesh-list
83824860|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83824861|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824862|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824863|NCT00296530|Fluticasone|fluticasone|mesh-list
83824865|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83824866|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83824867|NCT00296530|Montelukast|montelukast|mesh-list
83824868|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83824869|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83824870|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
83824871|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824872|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824873|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83824874|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
83824875|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
83824876|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83824877|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83824878|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83824879|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83824880|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
83824881|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824882|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824883|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83824884|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
83824885|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83824886|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83824887|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83824888|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
83824889|NCT00296530|Hormones|hormones|mesh-ancestor
83824890|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
83824891|NCT00090012|Olanzapine|olanzapine|mesh-list
83824892|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83824893|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
83824894|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
83824895|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824896|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824897|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83824898|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83824899|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82980429|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
83824900|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824901|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83824902|NCT00090012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83824903|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83824904|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824905|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824906|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824907|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
83824908|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
83824909|NCT00296608|Leucovorin|leucovorin|mesh-list
83824910|NCT00296608|Fluorouracil|fluorouracil|mesh-list
83824911|NCT00296608|Calcium|calcium|mesh-list
83824912|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
83824913|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83824914|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824915|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
83824916|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824917|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83824918|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824919|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83824920|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
83824921|NCT00296608|Antidotes|antidotes|mesh-ancestor
83824922|NCT00296608|Protective Agents|protective agents|mesh-ancestor
83824923|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
83824924|NCT00296608|Vitamins|vitamins|mesh-ancestor
83824925|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
83824926|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
83824927|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
83824928|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83824929|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824930|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83824931|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83824932|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83824933|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824934|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
83824935|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824936|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
83824937|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83824938|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83824939|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83824940|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83824941|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83824942|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824943|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83824944|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
83824945|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83824946|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83824947|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83824948|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824949|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824950|NCT00296803|Clopidogrel|clopidogrel|mesh-list
83824951|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83824952|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83824953|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83824954|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83824955|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
83824956|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824957|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824958|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824959|NCT00090090|Elsamicin A|elsamicin a|mesh-list
83824960|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83824961|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83824962|NCT00296959|Topiramate|topiramate|mesh-list
83824963|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
83824964|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83824965|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824966|NCT00297076|Aplaviroc|aplaviroc|mesh-list
83824967|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83824968|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83824969|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824970|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83824971|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83824972|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
83824973|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83824974|NCT00297349|Topiramate|topiramate|mesh-list
83824975|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
83824976|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83824977|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824978|NCT00297388|Risperidone|risperidone|mesh-list
83824979|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83824980|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
83824981|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824982|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83824983|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824984|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83824985|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83824986|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83824987|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83824988|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83824989|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
83824990|NCT00297466|Nicotine|nicotine|mesh-list
83824991|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83824992|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
83824993|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83824994|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83824995|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83824996|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83824997|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
83824998|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83824999|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825000|NCT00297505|Citalopram|citalopram|mesh-list
83825001|NCT00297505|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83825002|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83825003|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83825004|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825005|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825006|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
83825007|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825008|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83825009|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
83825010|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83825011|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
83825012|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
83825013|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83825014|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83825015|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825016|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825017|NCT00297544|Urological Agents|urological agents|mesh-ancestor
83825018|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
83825019|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83825020|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825021|NCT00297661|Sirolimus|sirolimus|mesh-list
83825022|NCT00297661|Paclitaxel|paclitaxel|mesh-list
83825023|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83825024|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825025|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825026|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825027|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
83825028|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825029|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83825030|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825031|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83825032|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
83825033|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825034|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
83825035|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825036|NCT00090207|Ondansetron|ondansetron|mesh-list
83825037|NCT00090207|Aprepitant|aprepitant|mesh-list
83825038|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
83825039|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
83825040|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825041|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825042|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83825043|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
83825044|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
83825045|NCT00090207|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83825046|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83825047|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
82980578|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
83825049|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825050|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83825051|NCT00297739|Risperidone|risperidone|mesh-list
83825052|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83825053|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
83825054|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825055|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825056|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825057|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83825058|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83825059|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83825060|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83825061|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83825062|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
83825063|NCT00090246|Ondansetron|ondansetron|mesh-list
83825064|NCT00090246|Aprepitant|aprepitant|mesh-list
83825065|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
83825066|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
83825067|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825068|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825069|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83825070|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
83825071|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
83825072|NCT00090246|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83825073|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83825074|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
83825075|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825076|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825077|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83825078|NCT00297817|Vaccines|vaccines|mesh-list
83825079|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
83825080|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825081|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83825082|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
83825083|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83825084|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83825085|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83825086|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83825087|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825088|NCT00122226|Ritonavir|ritonavir|mesh-list
83825089|NCT00122226|Lopinavir|lopinavir|mesh-list
83825090|NCT00122226|Lamivudine|lamivudine|mesh-list
83825091|NCT00122226|Zidovudine|zidovudine|mesh-list
83825092|NCT00122226|Nevirapine|nevirapine|mesh-list
83825093|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83825094|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83825095|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
83825096|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825097|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825098|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83825099|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83825100|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
83825101|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825102|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83825103|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83825104|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83825105|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83825106|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
83825107|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83825108|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83825109|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
83825110|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83825111|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825112|NCT05200559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83825113|NCT05200559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825114|NCT00298012|Methotrexate|methotrexate|mesh-list
83825115|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83825116|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
83825117|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83825118|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825119|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825120|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
82980653|NCT04296942|Trastuzumab|trastuzumab|mesh-list
83825121|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825122|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825123|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
83825124|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825125|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83825126|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825127|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
83825128|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825129|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83825130|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
83825131|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83825132|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
83825133|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825134|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83825135|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825136|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
83825137|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825138|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
83825139|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83825140|NCT00298168|Protective Agents|protective agents|mesh-ancestor
83825141|NCT00122304|Eculizumab|eculizumab|mesh-list
83825142|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83825143|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825144|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
83825145|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825146|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
83825147|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83825148|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83825149|NCT00322543|Analgesics|analgesics|mesh-ancestor
83825150|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
83825151|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825152|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825153|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825154|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825155|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
83825156|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825157|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
83825158|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83825159|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825160|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825161|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
83825162|NCT00313963|Analgesics|analgesics|mesh-ancestor
83825163|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
83825164|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825165|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825166|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
83825167|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83825168|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83825169|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
83825170|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83825171|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83825172|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825173|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83825174|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
83825175|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83825176|NCT00122343|Sirolimus|sirolimus|mesh-list
83825177|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83825178|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825179|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83825180|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825181|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
83825182|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825183|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
83825184|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825185|NCT00314080|Antitoxins|antitoxins|mesh-list
82980726|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82980727|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82980728|NCT03735420|Growth Substances|growth substances|mesh-ancestor
82980729|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980730|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
82980740|NCT03299842|Fenfluramine|fenfluramine|mesh-list
82980741|NCT03299842|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82980742|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82980745|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825186|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
83825187|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
83825188|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825189|NCT00314158|Timolol|timolol|mesh-list
83825190|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83825191|NCT00314158|Brinzolamide|brinzolamide|mesh-list
83825192|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83825193|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83825194|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83825195|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83825196|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825197|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825198|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825199|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83825200|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83825201|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83825202|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825203|NCT00090480|Vaccines|vaccines|mesh-list
83825204|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
83825205|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825206|NCT00322660|Epinephrine|epinephrine|mesh-list
83825207|NCT00322660|Racepinephrine|racepinephrine|mesh-list
83825208|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
83825209|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83825210|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83825211|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
83825212|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825213|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825214|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825215|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83825216|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83825217|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
83825218|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825219|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83825220|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
83825221|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
83825222|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
83825223|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83825224|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83825225|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
83825226|NCT00322699|Trioxsalen|trioxsalen|mesh-list
83825227|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825228|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
83825229|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83825230|NCT00322972|Azithromycin|azithromycin|mesh-list
83825231|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83825232|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825233|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
83825234|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
83825235|NCT00323011|Leucovorin|leucovorin|mesh-list
83825236|NCT00323011|Folic Acid|folic acid|mesh-list
83825237|NCT00323011|Bevacizumab|bevacizumab|mesh-list
83825238|NCT00323011|Fluorouracil|fluorouracil|mesh-list
83825239|NCT00323011|Irinotecan|irinotecan|mesh-list
83825240|NCT00323011|Dalteparin|dalteparin|mesh-list
83825241|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
83825242|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83825243|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825244|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83825245|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83825246|NCT00323011|Growth Substances|growth substances|mesh-ancestor
83825247|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825248|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
83825249|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
83825250|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825251|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825252|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825253|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
83825254|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83825255|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83825256|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825257|NCT00323011|Antidotes|antidotes|mesh-ancestor
82980801|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
83825258|NCT00323011|Protective Agents|protective agents|mesh-ancestor
83825259|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
83825260|NCT00323011|Vitamins|vitamins|mesh-ancestor
83825261|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
83825262|NCT00323011|Hematinics|hematinics|mesh-ancestor
83825263|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
83825264|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83825265|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83825266|NCT00323206|Interleukin-12|interleukin-12|mesh-list
83825267|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83825268|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
83825269|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825270|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83825271|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83825272|NCT00323206|Growth Substances|growth substances|mesh-ancestor
83825273|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
83825274|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825275|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
83825276|NCT04717531|Docetaxel|docetaxel|mesh-list
83825277|NCT04717531|Trastuzumab|trastuzumab|mesh-list
83825278|NCT04717531|Epirubicin|epirubicin|mesh-list
83825279|NCT04717531|Pertuzumab|pertuzumab|mesh-list
83825280|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825281|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
83825282|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825283|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825284|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83825285|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
83825286|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825287|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825288|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83825289|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825290|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825291|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83825292|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83825293|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83825294|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83825295|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83825296|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825297|NCT00323323|Prednisone|prednisone|mesh-list
83825298|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
83825299|NCT00323323|Doxorubicin|doxorubicin|mesh-list
83825300|NCT00323323|Vincristine|vincristine|mesh-list
83825301|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
83825302|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825303|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
83825304|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825305|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825306|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83825307|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
83825308|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825309|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825310|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83825311|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83825312|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83825313|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83825314|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825315|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825316|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
83825317|NCT00323323|Hormones|hormones|mesh-ancestor
83825318|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825319|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83825320|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83825321|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825322|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825323|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
83825324|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83825325|NCT00122499|Tadalafil|tadalafil|mesh-list
83825326|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
83825327|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83825328|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83825329|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825330|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825331|NCT00122499|Urological Agents|urological agents|mesh-ancestor
83825332|NCT00312598|Aripiprazole|aripiprazole|mesh-list
83825333|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
83825334|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83825335|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83825336|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83825337|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83825338|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825339|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
83825341|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825342|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825343|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83825344|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83825345|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
83825346|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83825347|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83825348|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83825349|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83825350|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83825351|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83825352|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83825353|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
83825354|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825355|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825356|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83825357|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83825358|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
83825359|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825360|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
83825361|NCT00312871|Hematinics|hematinics|mesh-ancestor
83825362|NCT00090675|Gefitinib|gefitinib|mesh-list
83825363|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825364|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83825365|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825366|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825367|NCT00312988|Gemcitabine|gemcitabine|mesh-list
83825368|NCT00312988|Topotecan|topotecan|mesh-list
83825369|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825370|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
83825371|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825372|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825373|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83825374|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83825375|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825376|NCT00122538|Lamivudine|lamivudine|mesh-list
83825377|NCT00122538|Efavirenz|efavirenz|mesh-list
83825378|NCT00122538|Didanosine|didanosine|mesh-list
83825379|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83825380|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83825381|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825382|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825383|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
83825384|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825385|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83825386|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83825387|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83825388|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83825389|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83825390|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83825391|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83825392|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83825393|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
83825394|NCT00313105|Lobeline|lobeline|mesh-list
83825395|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83825396|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
83825397|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825398|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825399|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83825400|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83825401|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
83825402|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825403|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825404|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
83825405|NCT00313183|Pramlintide|pramlintide|mesh-list
83825406|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83825407|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825408|NCT00122577|Ritonavir|ritonavir|mesh-list
83825409|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83825410|NCT00122577|Tenofovir|tenofovir|mesh-list
83825411|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83825412|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82980948|NCT02718898|Ixekizumab|ixekizumab|mesh-list
82980954|NCT05726734|Bismuth|bismuth|mesh-list
83825413|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
83825414|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825415|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825416|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83825417|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83825418|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
83825419|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825420|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83825421|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83825422|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83825423|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83825424|NCT00313261|Clevudine|clevudine|mesh-list
83825425|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
83825426|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825427|NCT00425074|Aspirin|aspirin|mesh-list
83825428|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
83825429|NCT00425074|Salicylates|salicylates|mesh-list
83825430|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825431|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
83825432|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
83825433|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
83825434|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83825435|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83825436|NCT00425074|Analgesics|analgesics|mesh-ancestor
83825437|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
83825438|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825439|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825440|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825441|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825442|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83825443|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825444|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825445|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83825446|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83825447|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83825448|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
83825449|NCT00425152|Leucovorin|leucovorin|mesh-list
83825450|NCT00425152|Levamisole|levamisole|mesh-list
83825451|NCT00425152|Fluorouracil|fluorouracil|mesh-list
83825452|NCT00425152|Calcium|calcium|mesh-list
83825453|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
83825454|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83825455|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825456|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
83825457|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825458|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825459|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825460|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825461|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
83825462|NCT00425152|Antidotes|antidotes|mesh-ancestor
83825463|NCT00425152|Protective Agents|protective agents|mesh-ancestor
83825464|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
83825465|NCT00425152|Vitamins|vitamins|mesh-ancestor
83825466|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
83825467|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83825468|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
83825469|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
83825470|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83825471|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825472|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825473|NCT00314314|Insulin|insulin|mesh-list
83825474|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83825475|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825476|NCT00122616|Ribavirin|ribavirin|mesh-list
83825477|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83825478|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83825479|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
83825480|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825481|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
83825482|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825483|NCT04984070|Metformin|metformin|mesh-list
83825484|NCT04984070|Drospirenone|drospirenone|mesh-list
83825485|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
83825486|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83825487|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
83825488|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83825489|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83825490|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83825491|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825492|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83825493|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83825494|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83825495|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83825496|NCT04984070|Estrogens|estrogens|mesh-ancestor
83825497|NCT04984070|Hormones|hormones|mesh-ancestor
83825498|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825499|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83825500|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
83825501|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83825502|NCT04984070|Diuretics|diuretics|mesh-ancestor
83825503|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
83825504|NCT00314509|Ciclesonide|ciclesonide|mesh-list
83825505|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
83825506|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83825507|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
83825508|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825509|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825510|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83825511|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
83825512|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83825513|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83825514|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83825515|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83825516|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825517|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825518|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
83825519|NCT00314509|Hormones|hormones|mesh-ancestor
83825520|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825521|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83825522|NCT00314548|Epoprostenol|epoprostenol|mesh-list
83825523|NCT00314548|Alprostadil|alprostadil|mesh-list
83825524|NCT00314548|Tezosentan|tezosentan|mesh-list
83825525|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83825526|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
83825527|NCT00314548|Urological Agents|urological agents|mesh-ancestor
83825528|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83825529|NCT00314626|Lamivudine|lamivudine|mesh-list
83825530|NCT00314626|Efavirenz|efavirenz|mesh-list
83825531|NCT00314626|Abacavir|abacavir|mesh-list
83825532|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83825533|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83825534|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825535|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825536|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
83825537|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825538|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83825539|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83825540|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83825541|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83825542|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83825543|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83825544|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83825545|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83825546|NCT00314665|Thalidomide|thalidomide|mesh-list
83825547|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825548|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
83825549|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825550|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
83825551|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83825552|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825553|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83825554|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83825555|NCT00314665|Growth Substances|growth substances|mesh-ancestor
83825556|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
83825557|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825558|NCT00314704|Dopamine|dopamine|mesh-list
83825559|NCT00314704|Norepinephrine|norepinephrine|mesh-list
83825560|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83825561|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83825562|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
83825563|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825564|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981106|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
83825565|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825566|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
83825567|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
83825568|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825569|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83825570|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83825571|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
83825572|NCT00314704|Protective Agents|protective agents|mesh-ancestor
83825573|NCT00090909|Dexamethasone|dexamethasone|mesh-list
83825574|NCT00090909|Gemcitabine|gemcitabine|mesh-list
83825575|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825576|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
83825577|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
83825578|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825579|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825580|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83825581|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
83825582|NCT00090909|Hormones|hormones|mesh-ancestor
83825583|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825584|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83825585|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825586|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825587|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
83825588|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825589|NCT04943627|Gemcitabine|gemcitabine|mesh-list
83825590|NCT04943627|Irinotecan|irinotecan|mesh-list
83825591|NCT04943627|Pemetrexed|pemetrexed|mesh-list
83825592|NCT04943627|Topotecan|topotecan|mesh-list
83825593|NCT04943627|Vinorelbine|vinorelbine|mesh-list
83825594|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825595|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
83825596|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825597|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825598|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83825599|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83825600|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825601|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83825602|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83825603|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83825604|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825605|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825606|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
83825607|NCT00314743|Dexamethasone|dexamethasone|mesh-list
83825608|NCT00314743|Ondansetron|ondansetron|mesh-list
83825609|NCT00314743|Aprepitant|aprepitant|mesh-list
83825610|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825611|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
83825612|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
83825613|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825614|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825615|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83825616|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
83825617|NCT00314743|Hormones|hormones|mesh-ancestor
83825618|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825619|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83825620|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825621|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
83825622|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
83825623|NCT00314743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83825624|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83825625|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
83825626|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825627|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825628|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83825629|NCT00314782|Docetaxel|docetaxel|mesh-list
83825630|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825631|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825632|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825633|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
83137313|NCT02454478|Everolimus|everolimus|mesh-list
83825634|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825635|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83825636|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83825637|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
82981187|NCT03578172|Menotropins|menotropins|mesh-list
83825638|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83825639|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825640|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825641|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
83825642|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825643|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83825644|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83825645|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83825646|NCT00314821|Ropinirole|ropinirole|mesh-list
83825647|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83825648|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83825649|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
83825650|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
83825651|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825652|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825653|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825654|NCT00314860|Ropinirole|ropinirole|mesh-list
83825655|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83825656|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83825657|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
83825658|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
83825659|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825660|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825661|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825662|NCT04928339|Bupivacaine|bupivacaine|mesh-list
83825663|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
83825664|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
83825665|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83825666|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825667|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
83825668|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825669|NCT00091104|Aldesleukin|aldesleukin|mesh-list
83825670|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
83825671|NCT00091104|Fludarabine|fludarabine|mesh-list
83825672|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
83825673|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
83825674|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825675|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
83825676|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825677|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825678|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83825679|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
83825680|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825681|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825682|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83825683|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825684|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
83825685|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83825686|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83825687|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83825688|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
83825689|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825690|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
83825691|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
83825692|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825693|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
83825694|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825695|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825696|NCT00313456|Satraplatin|satraplatin|mesh-list
83825697|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825698|NCT00313534|Masoprocol|masoprocol|mesh-list
83825699|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
83825700|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825701|NCT00313534|Protective Agents|protective agents|mesh-ancestor
83825702|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825703|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83825704|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825705|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83825706|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83825707|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83825708|NCT00313534|Analgesics|analgesics|mesh-ancestor
83825709|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
83825710|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825711|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825712|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825713|NCT00313690|Docetaxel|docetaxel|mesh-list
83825714|NCT00313690|Bortezomib|bortezomib|mesh-list
83825715|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825716|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825717|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825718|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83825719|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825720|NCT00313885|SR 46349B|sr 46349b|mesh-list
83825721|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83825722|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83825723|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825724|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83825725|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83825726|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
83825727|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825728|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825729|NCT00091143|Fludarabine|fludarabine|mesh-list
83825730|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
83825731|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
83825732|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83825733|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825734|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83825735|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
83825736|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825737|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825738|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
83825739|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825740|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83825741|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
83825742|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825743|NCT04635280|Pancrelipase|pancrelipase|mesh-list
83825744|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83825745|NCT00122733|Loxapine|loxapine|mesh-list
83825746|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83825747|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83825748|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83825749|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825750|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83825751|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83825752|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
83825753|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825754|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825755|NCT04432012|Dexamethasone|dexamethasone|mesh-list
83825756|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
83825757|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83825758|NCT04432012|BB 1101|bb 1101|mesh-list
83825759|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825760|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
83825761|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
83825762|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825763|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825764|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83825765|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
83825766|NCT04432012|Hormones|hormones|mesh-ancestor
83825767|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825768|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83825769|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825770|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
83825771|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825772|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825773|NCT00091299|Warfarin|warfarin|mesh-list
83825774|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
83825775|NCT04607603|Cannabidiol|cannabidiol|mesh-list
83825776|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
83825777|NCT00122772|Cisplatin|cisplatin|mesh-list
83825778|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825779|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
83825780|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83825781|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
83825782|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825783|NCT00122811|Perindopril|perindopril|mesh-list
83825784|NCT00122811|Indapamide|indapamide|mesh-list
83825785|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83825786|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
83825787|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825788|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825789|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83825790|NCT00122811|Diuretics|diuretics|mesh-ancestor
83825791|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
82981325|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
83825792|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825793|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83825794|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83825795|NCT04551170|Theophylline|theophylline|mesh-list
83825796|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83825797|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
83825798|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825799|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825800|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83825801|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
83825802|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83825803|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825804|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825805|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
83825806|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83825807|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83825808|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
83825809|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825810|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83825811|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83825812|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83825813|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83825814|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83825815|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825816|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825817|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825818|NCT00122850|Analgesics|analgesics|mesh-ancestor
83825819|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
83825820|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825821|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
83825822|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83825823|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
83825824|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83825825|NCT04542278|Prednisone|prednisone|mesh-list
83825826|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825827|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
83825828|NCT04542278|Hormones|hormones|mesh-ancestor
83825829|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825830|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825831|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83825832|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825833|NCT03975439|Chrysarobin|chrysarobin|mesh-list
83825834|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83825835|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83825836|NCT03975439|Analgesics|analgesics|mesh-ancestor
83825837|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
83825838|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825839|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825840|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825841|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825842|NCT00091377|Paclitaxel|paclitaxel|mesh-list
83825843|NCT00091377|Cisplatin|cisplatin|mesh-list
83825844|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83825845|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825846|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825847|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825848|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
83825849|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825850|NCT03897868|Losartan|losartan|mesh-list
83825851|NCT03897868|Amlodipine|amlodipine|mesh-list
83825852|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83825853|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83825854|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83825855|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825856|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83825857|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825858|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
83825859|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83825860|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83825861|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82981401|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981403|NCT01347294|Bleomycin|bleomycin|mesh-list
83825862|NCT00122889|Allicin|allicin|mesh-list
83825863|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
83825864|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
83825865|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825866|NCT00122889|Protective Agents|protective agents|mesh-ancestor
83825867|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825868|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83825869|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825870|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83825871|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825872|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83825873|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83825874|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
83825875|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83825876|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83825877|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83825878|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
83825879|NCT04729868|Bupivacaine|bupivacaine|mesh-list
83825880|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
83825881|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
83825882|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
83825883|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83825884|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825885|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
83825886|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825887|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83825888|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83825889|NCT04729868|Analgesics|analgesics|mesh-ancestor
83825890|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83825891|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83825892|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83825893|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
83825894|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83825895|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825896|NCT00419887|Vildagliptin|vildagliptin|mesh-list
83825897|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83825898|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825899|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83825900|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
83825901|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825902|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825903|NCT03690544|Apremilast|apremilast|mesh-list
83825904|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83825905|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83825906|NCT03690544|Analgesics|analgesics|mesh-ancestor
83825907|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
83825908|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825909|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825910|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825911|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825912|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83825913|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83825914|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825915|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825916|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
83825917|NCT00314977|Docetaxel|docetaxel|mesh-list
83825918|NCT00314977|Doxorubicin|doxorubicin|mesh-list
83825919|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83825920|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825921|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
83825922|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825923|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825924|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83825925|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
83825926|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825927|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825928|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83825929|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
83825930|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
83825931|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
83825932|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83825933|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83825934|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83825935|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825936|NCT00315016|Eplerenone|eplerenone|mesh-list
83825938|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83825939|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
83825940|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825941|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825942|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83825943|NCT00315016|Diuretics|diuretics|mesh-ancestor
83825944|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
83825945|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83825946|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83825947|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
83825948|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83825949|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825950|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
83825951|NCT00419068|Vitamin D|vitamin d|mesh-list
83825952|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83825953|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825954|NCT00419068|Vitamins|vitamins|mesh-ancestor
83825955|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
83825956|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83825957|NCT00419146|Vitamins|vitamins|mesh-list
83825958|NCT00419146|Vitamin E|vitamin e|mesh-list
83825959|NCT00419146|Tocopherols|tocopherols|mesh-list
83825960|NCT00419146|Tocotrienols|tocotrienols|mesh-list
83825961|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
83825962|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83825963|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
83825964|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825965|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
83825966|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825967|NCT00419146|Protective Agents|protective agents|mesh-ancestor
83825968|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83825969|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83825970|NCT02965196|Dexamethasone|dexamethasone|mesh-list
83825971|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83825972|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
83825973|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
83825974|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825975|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825976|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83825977|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
83825978|NCT02965196|Hormones|hormones|mesh-ancestor
83825979|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83825980|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83825981|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825982|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
83825983|NCT00091611|Fludarabine|fludarabine|mesh-list
83825984|NCT00091611|Interleukin-2|interleukin-2|mesh-list
83825985|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83825986|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
83825987|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83825988|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83825989|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83825990|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
83825991|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83825992|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83825993|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83825994|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83825995|NCT00091611|Analgesics|analgesics|mesh-ancestor
83825996|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
83825997|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83825998|NCT00123201|Dronabinol|dronabinol|mesh-list
83825999|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
82981552|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
82981553|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
82981554|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981555|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
82981556|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981557|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981558|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
82981559|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82981560|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82981561|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981562|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83826000|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826001|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83826002|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826003|NCT00123201|Analgesics|analgesics|mesh-ancestor
83826004|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
83826005|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826006|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83826007|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83826008|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826009|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826010|NCT00123201|Hormones|hormones|mesh-ancestor
83826011|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826012|NCT03031483|Clarithromycin|clarithromycin|mesh-list
83826013|NCT03031483|Lenalidomide|lenalidomide|mesh-list
83826014|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
83826015|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826016|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83826017|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83826018|NCT03031483|Growth Substances|growth substances|mesh-ancestor
83826019|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
83826020|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826021|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826022|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826023|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83826024|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826025|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826026|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83826027|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83826028|NCT00091650|Olanzapine|olanzapine|mesh-list
83826029|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
83826030|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
83826031|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826032|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826033|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83826034|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83826035|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83826036|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826037|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83826038|NCT00091650|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83826039|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83826040|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83826041|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826042|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826043|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
83826044|NCT02645149|Trametinib|trametinib|mesh-list
83826045|NCT02645149|Ceritinib|ceritinib|mesh-list
83826046|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826047|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826048|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826049|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826050|NCT01691833|Vitamin D|vitamin d|mesh-list
83826051|NCT01691833|Vitamins|vitamins|mesh-ancestor
83826052|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
83826053|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826054|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83826055|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83826056|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
83826057|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
83826058|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
83826059|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83826060|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83826061|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826062|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83826063|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83826064|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83826065|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83826066|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83826067|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83826068|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826069|NCT00123279|Plasminogen|plasminogen|mesh-list
83826070|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83826071|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83826072|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826073|NCT00091806|Panitumumab|panitumumab|mesh-list
83826074|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83826075|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826076|NCT01589302|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83826077|NCT01589302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826078|NCT01589302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826079|NCT01589302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826080|NCT00123318|Cisplatin|cisplatin|mesh-list
83826081|NCT00123318|Fluorouracil|fluorouracil|mesh-list
83826082|NCT00123318|Epirubicin|epirubicin|mesh-list
83826083|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826084|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
83826085|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826086|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826087|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826088|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
83826089|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826090|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83826091|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83826092|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83826093|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826094|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
83826095|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
83826096|NCT00327535|Hematinics|hematinics|mesh-ancestor
83826097|NCT00327691|Atorvastatin|atorvastatin|mesh-list
83826098|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83826099|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83826100|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
83826101|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826102|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83826103|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83826104|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826105|NCT03913832|Sirolimus|sirolimus|mesh-list
83826106|NCT03913832|Paclitaxel|paclitaxel|mesh-list
83826107|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83826108|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826109|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
83826110|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
83826111|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
83826112|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826113|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826114|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826115|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83826116|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
83826117|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826118|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
83826119|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826120|NCT00327730|Eperisone|eperisone|mesh-list
83826121|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
83826122|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83826123|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83826124|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826125|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83826126|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826127|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83826128|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83826129|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826130|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
83826131|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
83137324|NCT02359097|Hematinics|hematinics|mesh-ancestor
83826132|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
83826133|NCT04716868|Levan|levan|mesh-list
83826134|NCT04716868|Psyllium|psyllium|mesh-list
83826135|NCT04716868|Cathartics|cathartics|mesh-ancestor
83826136|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83826137|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826138|NCT00327769|Fulvestrant|fulvestrant|mesh-list
83826139|NCT00327769|Anastrozole|anastrozole|mesh-list
83826140|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83826141|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826142|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83826143|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83826144|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
83826145|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826146|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981680|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826147|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83826148|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83826149|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826150|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826151|NCT00092001|Sunitinib|sunitinib|mesh-list
83826152|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826153|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83826154|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83826155|NCT00092001|Growth Substances|growth substances|mesh-ancestor
83826156|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826157|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83826158|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826159|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826160|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826161|NCT03883919|Vitamin D|vitamin d|mesh-list
83826162|NCT03883919|Leucovorin|leucovorin|mesh-list
83826163|NCT03883919|Fluorouracil|fluorouracil|mesh-list
83826164|NCT03883919|Irinotecan|irinotecan|mesh-list
83826165|NCT03883919|Vitamins|vitamins|mesh-ancestor
83826166|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
83826167|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826168|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83826169|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
83826170|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826171|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826172|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826173|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826174|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
83826175|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83826176|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83826177|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826178|NCT03883919|Antidotes|antidotes|mesh-ancestor
83826179|NCT03883919|Protective Agents|protective agents|mesh-ancestor
83826180|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
83826181|NCT00327808|Budesonide|budesonide|mesh-list
83826182|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826183|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83826184|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
83826185|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826186|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826187|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83826188|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
83826189|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
83826190|NCT00327808|Hormones|hormones|mesh-ancestor
83826191|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826192|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
83826193|NCT00092079|Vitamin D|vitamin d|mesh-list
83826194|NCT00092079|Alendronate|alendronate|mesh-list
83826195|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83826196|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826197|NCT00092079|Vitamins|vitamins|mesh-ancestor
83826198|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
83826199|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83826200|NCT00327847|Vitamin D|vitamin d|mesh-list
83826201|NCT00327847|Vitamins|vitamins|mesh-ancestor
83826202|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
83826203|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826204|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83826205|NCT00327925|Antibodies|antibodies|mesh-list
83826206|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
83826207|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826208|NCT03709550|Decitabine|decitabine|mesh-list
83826209|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826210|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
83826211|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826212|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826213|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826214|NCT00315211|Docetaxel|docetaxel|mesh-list
83826215|NCT00315211|Topotecan|topotecan|mesh-list
83826216|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826217|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
83826218|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
83826219|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
83826220|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826221|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83826222|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83826223|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826224|NCT00315367|Donepezil|donepezil|mesh-list
83826225|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83826226|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826227|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826228|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
83826229|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826230|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826231|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
83826232|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
83826233|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
83826234|NCT00315484|Hematinics|hematinics|mesh-ancestor
83826235|NCT00315523|Levocetirizine|levocetirizine|mesh-list
83826236|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83826237|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83826238|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
83826239|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
83826240|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826241|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826242|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826243|NCT00092196|Aprepitant|aprepitant|mesh-list
83826244|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
83826245|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
83826246|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826247|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826248|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83826249|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83826250|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826251|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826252|NCT00315601|Azithromycin|azithromycin|mesh-list
83826253|NCT00315601|Telithromycin|telithromycin|mesh-list
83826254|NCT00315601|Dimercaprol|dimercaprol|mesh-list
83826255|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826256|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826257|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
83826258|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
83826259|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826260|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
83826261|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83826262|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826263|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826264|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83826265|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83826266|NCT00315679|Protective Agents|protective agents|mesh-ancestor
83826267|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826268|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
83826269|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83826270|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
83826271|NCT00092274|Ofatumumab|ofatumumab|mesh-list
83826272|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826273|NCT00315835|Buprenorphine|buprenorphine|mesh-list
83826274|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83826275|NCT00315835|Narcotics|narcotics|mesh-ancestor
83826276|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826277|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826278|NCT00315835|Analgesics|analgesics|mesh-ancestor
83826279|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
83826280|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826281|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83826282|NCT00315874|Buprenorphine|buprenorphine|mesh-list
83826283|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83826284|NCT00315874|Narcotics|narcotics|mesh-ancestor
83826285|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826286|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826287|NCT00315874|Analgesics|analgesics|mesh-ancestor
83826288|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
83826289|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826290|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83826291|NCT00315913|Propranolol|propranolol|mesh-list
83826292|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83826293|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83826294|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
83826295|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826296|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826297|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826298|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82981830|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
83826299|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83826300|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
83826302|NCT00092313|Rofecoxib|rofecoxib|mesh-list
83826303|NCT00092313|Oxycodone|oxycodone|mesh-list
83826304|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826305|NCT00092313|Analgesics|analgesics|mesh-ancestor
83826306|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
83826307|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826308|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826309|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
83826310|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83826311|NCT00092313|Narcotics|narcotics|mesh-ancestor
83826312|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826313|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83826314|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83826315|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826316|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826317|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826318|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826319|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826320|NCT00399971|Immunomodulating Agents|immunomodulating agents|mesh-list
83826321|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
83826322|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826323|NCT00316030|Bexarotene|bexarotene|mesh-list
83826324|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826325|NCT00123552|Artesunate|artesunate|mesh-list
83826326|NCT00123552|Lumefantrine|lumefantrine|mesh-list
83826327|NCT00123552|Artemether|artemether|mesh-list
83826328|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
83826329|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
83826330|NCT00123552|Amodiaquine|amodiaquine|mesh-list
83826331|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83826332|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
83826333|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83826334|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83826335|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826336|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826337|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
83826338|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
83826339|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83826340|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
83826341|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83826342|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826343|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826344|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83826345|NCT03352427|Everolimus|everolimus|mesh-list
83826346|NCT03352427|Dasatinib|dasatinib|mesh-list
83826347|NCT03352427|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83826348|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826349|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826350|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826351|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826352|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
83826353|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826354|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826355|NCT00316420|Gemcitabine|gemcitabine|mesh-list
83826356|NCT00316420|Capecitabine|capecitabine|mesh-list
83826357|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826358|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
83826359|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826360|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826361|NCT00092352|Celecoxib|celecoxib|mesh-list
83826362|NCT00092352|Rofecoxib|rofecoxib|mesh-list
83826363|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826364|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826365|NCT00092352|Analgesics|analgesics|mesh-ancestor
83826366|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
83826367|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826368|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826369|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826370|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826371|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83826372|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83826373|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826374|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826375|NCT00316498|Miglustat|miglustat|mesh-list
83826376|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826377|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826378|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83826379|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83826380|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
83826381|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826382|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83826383|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83826384|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826385|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
83826386|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
83826387|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83826388|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826389|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
83826390|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826391|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826392|NCT00092391|Vaccines|vaccines|mesh-list
83826393|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
83826394|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826395|NCT00316849|Sirolimus|sirolimus|mesh-list
83826396|NCT00316849|Temozolomide|temozolomide|mesh-list
83826397|NCT00316849|Temsirolimus|temsirolimus|mesh-list
83826398|NCT00316849|MTOR Inhibitors|mtor inhibitors|mesh-list
83826399|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83826400|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
83826401|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826402|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826403|NCT00316849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826404|NCT00316849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826405|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826406|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
83826407|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826408|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826409|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826410|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83826411|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
83826412|NCT03272477|Tamoxifen|tamoxifen|mesh-list
83826413|NCT03272477|Paclitaxel|paclitaxel|mesh-list
83826414|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83826415|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
83826416|NCT03272477|Trastuzumab|trastuzumab|mesh-list
83826417|NCT03272477|Letrozole|letrozole|mesh-list
83826418|NCT03272477|Epirubicin|epirubicin|mesh-list
83826419|NCT03272477|Pertuzumab|pertuzumab|mesh-list
83826420|NCT03272477|Anastrozole|anastrozole|mesh-list
83826421|NCT03272477|Exemestane|exemestane|mesh-list
83826422|NCT03272477|Goserelin|goserelin|mesh-list
83826423|NCT03272477|Leuprolide|leuprolide|mesh-list
83826424|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83137328|NCT05284214|Sargramostim|sargramostim|mesh-list
83826425|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826426|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83826427|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83826428|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83826429|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826430|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826431|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
83826432|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826433|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826434|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83826435|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
83826436|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83826437|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83826438|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83826439|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83826440|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826441|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83826442|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
83826443|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826444|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83826445|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83826446|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83826447|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82981984|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
82982007|NCT03619538|Nefopam|nefopam|mesh-list
83826448|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83826449|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83826450|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83826451|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83826452|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
83826453|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83826454|NCT02959957|Cefotaxime|cefotaxime|mesh-list
83826455|NCT02959957|Cefoxitin|cefoxitin|mesh-list
83826456|NCT02959957|Temocillin|temocillin|mesh-list
83826457|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826458|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826459|NCT00316927|Aspirin|aspirin|mesh-list
83826460|NCT00316927|Dexamethasone|dexamethasone|mesh-list
83826461|NCT00316927|Fosfestrol|fosfestrol|mesh-list
83826462|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
83826463|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826464|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
83826465|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
83826466|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826467|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826468|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83826469|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
83826470|NCT00316927|Hormones|hormones|mesh-ancestor
83826471|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826472|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83826473|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826474|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826475|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826476|NCT00316927|Analgesics|analgesics|mesh-ancestor
83826477|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
83826478|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826479|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83826480|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83826481|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826482|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83826483|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83826484|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826485|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
83826486|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83826487|NCT00316927|Estrogens|estrogens|mesh-ancestor
83826488|NCT00123669|Progesterone|progesterone|mesh-list
83826489|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83826490|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83826491|NCT00123669|Progestins|progestins|mesh-ancestor
83826492|NCT00123669|Hormones|hormones|mesh-ancestor
83826493|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826494|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826495|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83826496|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
83826497|NCT00317200|Paclitaxel|paclitaxel|mesh-list
83826498|NCT00317200|Bevacizumab|bevacizumab|mesh-list
83826499|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83826500|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826501|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83826502|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83826503|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83826504|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826505|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83826506|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83826507|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83826508|NCT00317200|Growth Substances|growth substances|mesh-ancestor
83826509|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826510|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
83826511|NCT02960035|Etanercept|etanercept|mesh-list
83826512|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826513|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826514|NCT02960035|Analgesics|analgesics|mesh-ancestor
83826515|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
83826516|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826517|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826518|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826519|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826520|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83826521|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826522|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
83826523|NCT00317434|Lapatinib|lapatinib|mesh-list
83826524|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826525|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826526|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982065|NCT01359228|Rifaximin|rifaximin|mesh-list
83826527|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826528|NCT00328120|Fulvestrant|fulvestrant|mesh-list
83826529|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83826530|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826531|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83826532|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83826533|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
83826534|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826535|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826536|NCT00328393|Pioglitazone|pioglitazone|mesh-list
83826537|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83826538|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826539|NCT00328432|Celecoxib|celecoxib|mesh-list
83826540|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826541|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826542|NCT00328432|Analgesics|analgesics|mesh-ancestor
83826543|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
83826544|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826545|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826546|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826547|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826548|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83826549|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83826550|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826551|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826552|NCT02571725|Olaparib|olaparib|mesh-list
83826553|NCT02571725|Tremelimumab|tremelimumab|mesh-list
83826554|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83826555|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826556|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826557|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826558|NCT00328549|Interferons|interferons|mesh-list
83826559|NCT00328549|Ribavirin|ribavirin|mesh-list
83826560|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826561|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
83826562|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826563|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
83826564|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826565|NCT00092508|Mesalamine|mesalamine|mesh-list
83826566|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826567|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826568|NCT00092508|Analgesics|analgesics|mesh-ancestor
83826569|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
83826570|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826571|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826572|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826573|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826574|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83826575|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
83826576|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83826577|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83826578|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83826579|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826580|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826581|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
83826582|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826583|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826584|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826585|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826586|NCT00420082|Cetirizine|cetirizine|mesh-list
83826587|NCT00420082|Fexofenadine|fexofenadine|mesh-list
83826588|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83826589|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83826590|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83826591|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
83826592|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
83826593|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826594|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826595|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826596|NCT01821833|Paclitaxel|paclitaxel|mesh-list
83826597|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83826598|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826599|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
82982132|NCT05154734|Belimumab|belimumab|mesh-list
83826600|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83826601|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83826602|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826603|NCT00328900|Atropine|atropine|mesh-list
83826604|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83826605|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83826606|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83826607|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
83826608|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826609|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826610|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83826611|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
83826612|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
83826613|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
83826614|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83826615|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83826616|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
83826617|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826618|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826619|NCT00328939|Enoxaparin|enoxaparin|mesh-list
83826620|NCT00328939|PENTA|penta|mesh-list
83826621|NCT00328939|Fondaparinux|fondaparinux|mesh-list
83826622|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
83826623|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83826624|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83826625|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826626|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83826627|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
83826628|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83826629|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
83826630|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826631|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83826632|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
83826633|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83826634|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83826635|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83826636|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826637|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826638|NCT00329095|Bimatoprost|bimatoprost|mesh-list
83826639|NCT00329095|Travoprost|travoprost|mesh-list
83826640|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
83826641|NCT00329095|Latanoprost|latanoprost|mesh-list
83826642|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83826643|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83826644|NCT00329134|Quinine|quinine|mesh-list
83826645|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
83826646|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83826647|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83826648|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826649|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83826650|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826651|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83826652|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826653|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826654|NCT00329134|Analgesics|analgesics|mesh-ancestor
83826655|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
83826656|NCT00329173|Atorvastatin|atorvastatin|mesh-list
83826657|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83826658|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83826659|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83826660|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
83826661|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826662|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83826663|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83826664|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826665|NCT00123825|Gemcitabine|gemcitabine|mesh-list
83826666|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826667|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826668|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
83826669|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826670|NCT00329329|Capecitabine|capecitabine|mesh-list
83826671|NCT00329329|Satraplatin|satraplatin|mesh-list
83826672|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826673|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
83826674|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826675|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982209|NCT01339689|Ganaxolone|ganaxolone|mesh-list
83826676|NCT00329368|Folic Acid|folic acid|mesh-list
83826677|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
83826678|NCT00329368|Interferons|interferons|mesh-list
83826679|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
83826680|NCT00329368|Interleukin-2|interleukin-2|mesh-list
83826681|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83826682|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826683|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
83826684|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826685|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
83826686|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826687|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826688|NCT00329368|Analgesics|analgesics|mesh-ancestor
83826689|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
83826690|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826691|NCT00329368|Hematinics|hematinics|mesh-ancestor
83826692|NCT00329368|Vitamins|vitamins|mesh-ancestor
83826693|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
83826694|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83826695|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83826696|NCT00329446|Escitalopram|escitalopram|mesh-list
83826697|NCT00329446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83826698|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83826699|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048366|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826700|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826701|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826702|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
83826703|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826704|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
83826705|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83826706|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83826707|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83826708|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826709|NCT00092937|Busulfan|busulfan|mesh-list
83826710|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
83826711|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826712|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826713|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
83826714|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826715|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83826716|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826717|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83826718|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83826719|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83826720|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
83826721|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
83826722|NCT04716751|Paclitaxel|paclitaxel|mesh-list
83826723|NCT04716751|Carboplatin|carboplatin|mesh-list
83826724|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83826725|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826726|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83826727|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83826728|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83826729|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826730|NCT00123903|Metoprolol|metoprolol|mesh-list
83826731|NCT00123903|Carvedilol|carvedilol|mesh-list
83826732|NCT00123903|Lisinopril|lisinopril|mesh-list
83826733|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83826734|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83826735|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
83826736|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
83826737|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826738|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826739|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83826740|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83826741|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83826742|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
83826743|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826744|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826745|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
83826746|NCT00123903|Protective Agents|protective agents|mesh-ancestor
83826747|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83826748|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83826749|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82982283|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83826750|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
83826751|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83826752|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83826753|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83826754|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
83826755|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826756|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83826757|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
83826758|NCT00329680|Antioxidants|antioxidants|mesh-list
83826759|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826760|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826761|NCT00329680|Protective Agents|protective agents|mesh-ancestor
83826762|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826763|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826764|NCT00329680|Analgesics|analgesics|mesh-ancestor
83826765|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
83826766|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826767|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826768|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826769|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83826770|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
83826771|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83826772|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
83826773|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83826774|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83826775|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83826776|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
83826777|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826778|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83826779|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83826780|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826781|NCT00329914|Progesterone|progesterone|mesh-list
83826782|NCT00329914|Progestins|progestins|mesh-ancestor
83826783|NCT00329914|Hormones|hormones|mesh-ancestor
83826784|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826785|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826786|NCT00092976|Factor VIII|factor viii|mesh-list
83826787|NCT00092976|Coagulants|coagulants|mesh-ancestor
83826788|NCT00083876|Thalidomide|thalidomide|mesh-list
83826789|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826790|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
83826791|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826792|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
83826793|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826794|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826795|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83826796|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83826797|NCT00083876|Growth Substances|growth substances|mesh-ancestor
83826798|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
83826799|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826800|NCT00330148|Eflornithine|eflornithine|mesh-list
83826801|NCT00330148|Nifurtimox|nifurtimox|mesh-list
83826802|NCT00330148|Melarsoprol|melarsoprol|mesh-list
83826803|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826804|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83826805|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83826806|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83826807|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826808|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83826809|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826810|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826811|NCT00093093|Interferons|interferons|mesh-list
83826812|NCT00093093|Ribavirin|ribavirin|mesh-list
83826813|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
83826814|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
83826815|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83826816|NCT00093093|Taribavirin|taribavirin|mesh-list
83826817|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826818|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
83826819|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826820|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
83826821|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826822|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
82982377|NCT02461888|Ixazomib|ixazomib|mesh-list
83826823|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826824|NCT00330304|Isoniazid|isoniazid|mesh-list
83826825|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83826826|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
83826827|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826828|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826829|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83826830|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83826831|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
84048367|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826832|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826833|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83826834|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83826835|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
83826836|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83826837|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83826838|NCT00330499|Cisplatin|cisplatin|mesh-list
83826839|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826840|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83826841|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
83826842|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83826843|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83826844|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83826845|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826846|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826847|NCT00330577|Timolol|timolol|mesh-list
83826848|NCT00330577|Latanoprost|latanoprost|mesh-list
83826849|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
83826850|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826851|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83826852|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83826853|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
83826854|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826855|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826856|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83826857|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83826858|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83826859|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83826860|NCT00083993|Sirolimus|sirolimus|mesh-list
83826861|NCT00083993|Letrozole|letrozole|mesh-list
83826862|NCT00083993|Temsirolimus|temsirolimus|mesh-list
83826863|NCT00083993|MTOR Inhibitors|mtor inhibitors|mesh-list
83826864|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826865|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83826866|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83826867|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826868|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826869|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83826870|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
83826871|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83826872|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826873|NCT00083993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826874|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83826875|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
83826876|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826877|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826878|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83826879|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
83826880|NCT00323791|Gemcitabine|gemcitabine|mesh-list
83826881|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
83826882|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826883|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
83826884|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826885|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826886|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83826887|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826888|NCT00323830|Capecitabine|capecitabine|mesh-list
83826889|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826890|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83826891|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
83826892|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826893|NCT00317512|Chrysarobin|chrysarobin|mesh-list
83826894|NCT00317512|HBOC 201|hboc 201|mesh-list
83826895|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83826896|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83826897|NCT00317512|Analgesics|analgesics|mesh-ancestor
83826898|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
83826899|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826900|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826901|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83826902|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826903|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
83826904|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83826905|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
83826906|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83826907|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83826908|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83826909|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83826910|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826911|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83826912|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
83826913|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826914|NCT00323947|Methylphenidate|methylphenidate|mesh-list
83826915|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83826916|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826917|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83826918|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83826919|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83826920|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826921|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
83826922|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826923|NCT00323986|Azithromycin|azithromycin|mesh-list
83826924|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826925|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826926|NCT00324025|Efungumab|efungumab|mesh-list
83826927|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
83826928|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826929|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83826930|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
83826931|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83826932|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
83826933|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83826934|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826935|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83826936|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
83826937|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83826938|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
83826939|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826940|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83826941|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83826942|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83826943|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
83826944|NCT00317629|Protective Agents|protective agents|mesh-ancestor
83826945|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83826946|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83826947|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826948|NCT00093249|Clevidipine|clevidipine|mesh-list
83826949|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83826950|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83826951|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826952|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83826953|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826954|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
83826955|NCT00124098|Hematinics|hematinics|mesh-ancestor
83826956|NCT00324142|Tinidazole|tinidazole|mesh-list
83826957|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
83826958|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826959|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826960|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826961|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83826962|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83826963|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83826964|NCT00324298|Etoposide|etoposide|mesh-list
83826965|NCT00324298|Bleomycin|bleomycin|mesh-list
83826966|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83826967|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83826968|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83826969|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83826970|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826971|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826972|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83826973|NCT00124137|Diuretics|diuretics|mesh-list
83826974|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
83826975|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83826976|NCT00324376|Sevelamer|sevelamer|mesh-list
83826977|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
83826978|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
83826979|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826980|NCT00084227|Azithromycin|azithromycin|mesh-list
83826981|NCT00084227|Chloroquine|chloroquine|mesh-list
83826982|NCT00084227|Atovaquone|atovaquone|mesh-list
83826983|NCT00084227|Proguanil|proguanil|mesh-list
83826984|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83826985|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83826986|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83826987|NCT00084227|Amebicides|amebicides|mesh-ancestor
83826988|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83826989|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83826990|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
83826991|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83826992|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83826993|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83826994|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
83826995|NCT00317746|Citalopram|citalopram|mesh-list
83826996|NCT00317746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83826997|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83826998|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83826999|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827000|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827001|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
83827002|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827003|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83827004|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
83827005|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827006|NCT00317785|Cyclosporine|cyclosporine|mesh-list
83827007|NCT00317785|Sirolimus|sirolimus|mesh-list
83827008|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
83827009|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
83827010|NCT00317785|Methotrexate|methotrexate|mesh-list
83827011|NCT00317785|Tacrolimus|tacrolimus|mesh-list
83827012|NCT00317785|Cyclosporins|cyclosporins|mesh-list
83827013|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827014|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
83827015|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827016|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827017|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83827018|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
83827019|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827020|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827021|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83827022|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83827023|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
83827024|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83827025|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827026|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
83827027|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83827028|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827029|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83827030|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83827031|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83827032|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
83827033|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827034|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827035|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83827036|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
83827037|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83827038|NCT00093288|Bupropion|bupropion|mesh-list
83827039|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83827040|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
83827041|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827042|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83827043|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83827044|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827045|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827046|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
83827047|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827048|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827049|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83827050|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83827051|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827052|NCT00324454|Levetiracetam|levetiracetam|mesh-list
83827053|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
83827054|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
83827055|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
83827056|NCT00317902|Hematinics|hematinics|mesh-ancestor
83827057|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83827058|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83827059|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83827060|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827061|NCT00324571|Calcium|calcium|mesh-list
83827062|NCT00324571|Sevelamer|sevelamer|mesh-list
83827063|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827064|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827065|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
83827066|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
83827067|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827068|NCT00084461|Romidepsin|romidepsin|mesh-list
83827069|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827070|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827071|NCT00084461|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83827072|NCT00084461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827073|NCT00084461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827074|NCT00324610|Capecitabine|capecitabine|mesh-list
83827075|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827076|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
83827077|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827078|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827079|NCT00093366|Etanercept|etanercept|mesh-list
83827080|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
83827081|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83827082|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83827083|NCT00093366|Analgesics|analgesics|mesh-ancestor
83827084|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
83827085|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827086|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827087|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827088|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827089|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83827090|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827091|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
83827092|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827093|NCT00324688|Tenofovir|tenofovir|mesh-list
83827094|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
83827095|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827096|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83827097|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83827098|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827099|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827100|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83827101|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83827102|NCT00324727|Melphalan|melphalan|mesh-list
83827103|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83827104|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
83827105|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827106|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827107|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83827108|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827109|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
83827110|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827111|NCT00324766|Simendan|simendan|mesh-list
83827112|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83827113|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
83827114|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83827115|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83827116|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827117|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827118|NCT00324766|Protective Agents|protective agents|mesh-ancestor
83827119|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827120|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
83827121|NCT00084578|Celecoxib|celecoxib|mesh-list
83827122|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83827123|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83827124|NCT00084578|Analgesics|analgesics|mesh-ancestor
83827125|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
83827126|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827127|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827128|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827129|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827130|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83827131|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83827132|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827133|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827134|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83827135|NCT00318175|Bosentan|bosentan|mesh-list
83827136|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83827137|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83827138|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827139|NCT00093444|Doxorubicin|doxorubicin|mesh-list
83827140|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83827141|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827142|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827143|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83827144|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827145|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827146|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827147|NCT00325000|Amitriptyline|amitriptyline|mesh-list
83827148|NCT00325000|Sertraline|sertraline|mesh-list
83827149|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
83827150|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827151|NCT00325000|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83827152|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83827153|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827154|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827155|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827156|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
83827157|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827158|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83827159|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83827160|NCT00325000|Analgesics|analgesics|mesh-ancestor
83827161|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
83827162|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827163|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83827164|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
83827165|NCT00318448|Zolpidem|zolpidem|mesh-list
83827166|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83827167|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83827168|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827169|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827170|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83827171|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
83827172|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
83827173|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827174|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827175|NCT00325117|Vildagliptin|vildagliptin|mesh-list
83827176|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83827177|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827178|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83827179|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
83827180|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827181|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827182|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
83827183|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
83827184|NCT00084695|Melphalan|melphalan|mesh-list
83827185|NCT00084695|Busulfan|busulfan|mesh-list
83827186|NCT00084695|Fludarabine|fludarabine|mesh-list
83827187|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
83827188|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83827189|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827190|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
83827191|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827192|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827193|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83827194|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
83827195|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827196|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827197|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83827198|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827199|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
82982727|NCT02616146|Etonogestrel|etonogestrel|mesh-list
83827200|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827201|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
83827202|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
83827203|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827204|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83827205|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
83827206|NCT00084695|Hormones|hormones|mesh-ancestor
83827207|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827208|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83827209|NCT00084695|Protective Agents|protective agents|mesh-ancestor
83827210|NCT00325351|Carboplatin|carboplatin|mesh-list
83827211|NCT00325351|Sagopilone|sagopilone|mesh-list
83827212|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827213|NCT00093483|Cytarabine|cytarabine|mesh-list
83827214|NCT00093483|Idarubicin|idarubicin|mesh-list
83827215|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
83827216|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827217|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
83827218|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827219|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827220|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
83827221|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827222|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827223|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
83827224|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827225|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827226|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83827227|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827228|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827229|NCT00084734|Docetaxel|docetaxel|mesh-list
83827230|NCT00084734|Capecitabine|capecitabine|mesh-list
83827231|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827232|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83827233|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83827234|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83827235|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827236|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827237|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
83827238|NCT00325390|Clopidogrel|clopidogrel|mesh-list
83827239|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83827240|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83827241|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83827242|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83827243|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
83827244|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827245|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827246|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827247|NCT00325429|Vildagliptin|vildagliptin|mesh-list
83827248|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83827249|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827250|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83827251|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
83827252|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827253|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827254|NCT00093522|Fludarabine|fludarabine|mesh-list
83827255|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
83827256|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83827257|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827258|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827259|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
83827260|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827261|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827262|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
83827263|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827264|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83827265|NCT00084773|Fluorouracil|fluorouracil|mesh-list
83827266|NCT00084773|Cetuximab|cetuximab|mesh-list
83827267|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
83827268|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827269|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827270|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827271|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827272|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
83827273|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827274|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83827275|NCT00325546|Rimonabant|rimonabant|mesh-list
83827276|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83827277|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83827278|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83827279|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827280|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827281|NCT00325546|Hormones|hormones|mesh-ancestor
83827282|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827283|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827284|NCT00084812|Safingol|safingol|mesh-list
83827285|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827286|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827287|NCT02959879|Folfirinox|folfirinox|mesh-list
83827288|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827289|NCT04717609|Ropivacaine|ropivacaine|mesh-list
83827290|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
83827291|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
83827292|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827293|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827294|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
83827295|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827296|NCT00318760|Clonidine|clonidine|mesh-list
83827297|NCT00318760|Analgesics|analgesics|mesh-ancestor
83827298|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
83827299|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827300|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827301|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83827302|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
83827303|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
83827304|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83827305|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83827306|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83827307|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
83827308|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827309|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827310|NCT00093561|Lycopene|lycopene|mesh-list
83827311|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827312|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
83827313|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827314|NCT00093561|Protective Agents|protective agents|mesh-ancestor
83827315|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827316|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83827317|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83827318|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827319|NCT00084890|Carboplatin|carboplatin|mesh-list
83827320|NCT00084890|Docetaxel|docetaxel|mesh-list
83827321|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827322|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83827323|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83827324|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83827325|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827326|NCT00318838|Azimilide|azimilide|mesh-list
83827327|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83827328|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83827329|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827330|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827331|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827332|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827333|NCT00085124|Cytarabine|cytarabine|mesh-list
83827334|NCT00085124|Daunorubicin|daunorubicin|mesh-list
83827335|NCT00085124|Oblimersen|oblimersen|mesh-list
83827336|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827337|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
83827338|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827339|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827340|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
83827341|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827342|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827343|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
83827344|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982876|NCT02884089|Metformin|metformin|mesh-list
83827345|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827346|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83827347|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82982877|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83827349|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
83827350|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83827351|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827352|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827353|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827354|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827355|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83827356|NCT00325858|Tramadol|tramadol|mesh-list
83827357|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83827358|NCT00325858|Narcotics|narcotics|mesh-ancestor
83827359|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827360|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827361|NCT00325858|Analgesics|analgesics|mesh-ancestor
83827362|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
83827363|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827364|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
83827365|NCT00318955|Propofol|propofol|mesh-list
83827366|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83827367|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827368|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827369|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83827370|NCT00318955|Analgesics|analgesics|mesh-ancestor
83827371|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
83827372|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827373|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83827374|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83827375|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83827376|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
83827377|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827378|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827379|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83827380|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
83827381|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
83827382|NCT00325936|Cilnidipine|cilnidipine|mesh-list
83827383|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83827384|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827385|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827386|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827387|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827388|NCT00318994|Meropenem|meropenem|mesh-list
83827389|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83827390|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827391|NCT00093600|Cytarabine|cytarabine|mesh-list
83827392|NCT00093600|Daunorubicin|daunorubicin|mesh-list
83827393|NCT00093600|Midostaurin|midostaurin|mesh-list
83827394|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827395|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
83827396|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827397|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827398|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
83827399|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827400|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827401|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
83827402|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827403|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827404|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83827405|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827406|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827407|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827408|NCT00319033|Bosentan|bosentan|mesh-list
83827409|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83827410|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83827411|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827412|NCT00085163|Leucovorin|leucovorin|mesh-list
83827413|NCT00085163|Celecoxib|celecoxib|mesh-list
83827414|NCT00085163|Fluorouracil|fluorouracil|mesh-list
83827415|NCT00085163|Calcium|calcium|mesh-list
83827416|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
83827417|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827418|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827419|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
83827420|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982952|NCT00089895|Eptifibatide|eptifibatide|mesh-list
83827421|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827422|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827423|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827424|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
83827426|NCT00085163|Protective Agents|protective agents|mesh-ancestor
83827427|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
83827428|NCT00085163|Vitamins|vitamins|mesh-ancestor
83827429|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
83827430|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83827431|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83827432|NCT00085163|Analgesics|analgesics|mesh-ancestor
83827433|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
83827434|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827435|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827436|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827437|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83827438|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83827439|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827440|NCT00319072|Hormones|hormones|mesh-list
83827441|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827442|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827443|NCT00093639|Everolimus|everolimus|mesh-list
83827444|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
83827445|NCT00093639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83827446|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827447|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827448|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827449|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827450|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
83827451|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827452|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827453|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
83827454|NCT00319150|Hematinics|hematinics|mesh-ancestor
83827455|NCT00326053|Budesonide|budesonide|mesh-list
83827456|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
83827457|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827458|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83827459|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
83827460|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827461|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827462|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83827463|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83827464|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
83827465|NCT00326053|Hormones|hormones|mesh-ancestor
83827466|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827467|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83827468|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83827469|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83827470|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
83827471|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827472|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827473|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
83827474|NCT00400088|Paroxetine|paroxetine|mesh-list
83827475|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
83827476|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827477|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827478|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827479|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
83827480|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83827481|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827482|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827483|NCT00400088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83827484|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83827485|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827486|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827487|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
83827488|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83827489|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83827490|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83827491|NCT00326092|Timolol|timolol|mesh-list
83827492|NCT00326092|Brinzolamide|brinzolamide|mesh-list
83827493|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83827494|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83827495|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
83827496|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827497|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827498|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827499|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83827500|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83827501|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83827502|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827504|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827505|NCT00319189|Nateglinide|nateglinide|mesh-list
83827506|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83827507|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827508|NCT00319267|Bosentan|bosentan|mesh-list
83827509|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83827510|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83827511|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827512|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83827513|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827514|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827515|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827516|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827517|NCT00326248|Casopitant|casopitant|mesh-list
83827518|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
83827519|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
83827520|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827521|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827522|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83827523|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83827524|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827525|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827526|NCT00319306|Budesonide|budesonide|mesh-list
83827527|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
83827528|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83827529|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827530|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83827531|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
83827532|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827533|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827534|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83827535|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
83827536|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
83827537|NCT00319306|Hormones|hormones|mesh-ancestor
83827538|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827539|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83827540|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83827541|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83827542|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83827543|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827544|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827545|NCT00085358|Paclitaxel|paclitaxel|mesh-list
83827546|NCT00085358|Docetaxel|docetaxel|mesh-list
83827547|NCT00085358|Bevacizumab|bevacizumab|mesh-list
83827548|NCT00085358|Carboplatin|carboplatin|mesh-list
83827549|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83827550|NCT00085358|Antibodies|antibodies|mesh-list
83827551|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
83827552|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83827553|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83827554|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827555|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83827556|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83827557|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83827558|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827559|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83827560|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83827561|NCT00085358|Growth Substances|growth substances|mesh-ancestor
83827562|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827563|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
83827564|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
83827565|NCT00093678|Celecoxib|celecoxib|mesh-list
83827566|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82983098|NCT03264430|Ketamine|ketamine|mesh-list
83827567|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83827569|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
83827570|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827571|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827572|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827573|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827574|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83827575|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83827576|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827577|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827578|NCT00319345|Mannitol|mannitol|mesh-list
83827579|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83827580|NCT00319345|Diuretics|diuretics|mesh-ancestor
83827581|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
83827582|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827583|NCT00419536|Panobinostat|panobinostat|mesh-list
83827584|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827585|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83827586|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827587|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827588|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83827589|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83827590|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83827591|NCT00326404|Desogestrel|desogestrel|mesh-list
83827592|NCT00326404|Estradiol|estradiol|mesh-list
83827593|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83827594|NCT00326404|Estrogens|estrogens|mesh-ancestor
83827595|NCT00326404|Hormones|hormones|mesh-ancestor
83827596|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827597|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827598|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83827599|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
83827600|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83827601|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83827602|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83827603|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83827604|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83827605|NCT00326404|Progestins|progestins|mesh-ancestor
83827606|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
83827607|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827608|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827609|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827610|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827611|NCT00319618|Docetaxel|docetaxel|mesh-list
83827612|NCT00319618|Gefitinib|gefitinib|mesh-list
83827613|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827614|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
83827615|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
83827616|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
83827617|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827618|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827619|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827620|NCT00124332|Rimonabant|rimonabant|mesh-list
83827621|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83827622|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83827623|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83827624|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827625|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827626|NCT00124332|Hormones|hormones|mesh-ancestor
83827627|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827628|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827629|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83827630|NCT00085553|Tipifarnib|tipifarnib|mesh-list
83827631|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827632|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827633|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827634|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827635|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
83827636|NCT00400335|Testosterone|testosterone|mesh-list
83827637|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
83827638|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
83827639|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83827640|NCT00400335|Dutasteride|dutasteride|mesh-list
83827641|NCT00400335|Androgens|androgens|mesh-ancestor
83827642|NCT00400335|Hormones|hormones|mesh-ancestor
83827643|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827644|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827645|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83827646|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827647|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
83827648|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83827649|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83827650|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827651|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827652|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
83827653|NCT00319852|Vaccines|vaccines|mesh-list
83827654|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
83827655|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827656|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
83827657|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
83827658|NCT00326833|Vitamins|vitamins|mesh-ancestor
83827659|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
83827660|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827661|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
83827662|NCT00326833|Hematinics|hematinics|mesh-ancestor
83827663|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83827664|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83827665|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83827666|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827667|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827668|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827669|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83827670|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83827671|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
83827672|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827673|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827674|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83827675|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83827676|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
83827677|NCT04717102|Desflurane|desflurane|mesh-list
83827678|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83827679|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
83827680|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
83827681|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827682|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827683|NCT00320047|Baclofen|baclofen|mesh-list
83827684|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83827685|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827686|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83827687|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827688|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83827689|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
83827690|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
83827691|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827692|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827693|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
83827694|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827695|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83827696|NCT00085826|Protective Agents|protective agents|mesh-ancestor
83827697|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827698|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83827699|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827700|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827701|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83827702|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83827703|NCT00085826|Analgesics|analgesics|mesh-ancestor
83827704|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
83827705|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827706|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827707|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827708|NCT00320125|Calcium|calcium|mesh-list
83827709|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827710|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827711|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
83827712|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827713|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827714|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983246|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83827715|NCT00320320|Irinotecan|irinotecan|mesh-list
83827716|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83827717|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827718|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827719|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827720|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827721|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
83827722|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83827723|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83827724|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827725|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
83827726|NCT00327106|Coagulants|coagulants|mesh-ancestor
83827727|NCT00320359|Cisplatin|cisplatin|mesh-list
83827728|NCT00320359|Etoposide|etoposide|mesh-list
83827729|NCT00320359|Topotecan|topotecan|mesh-list
83827730|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827731|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83827732|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83827733|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827734|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827735|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827736|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83827737|NCT00093912|Nitroprusside|nitroprusside|mesh-list
83827738|NCT00093912|Clevidipine|clevidipine|mesh-list
83827739|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83827740|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
83827741|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83827742|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827743|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83827744|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827745|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827746|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827747|NCT00327145|Amlodipine|amlodipine|mesh-list
83827748|NCT00327145|Valsartan|valsartan|mesh-list
83827749|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83827750|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83827751|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83827752|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827753|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827754|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83827755|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827756|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
83827757|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83827758|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83827759|NCT00327145|Diuretics|diuretics|mesh-ancestor
83827760|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
83827761|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83827762|NCT00085943|Ritonavir|ritonavir|mesh-list
83827763|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
83827764|NCT00085943|Lamivudine|lamivudine|mesh-list
83827765|NCT00085943|Abacavir|abacavir|mesh-list
83827766|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83827767|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83827768|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
83827769|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827770|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827771|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83827772|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83827773|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
83827774|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827775|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83827776|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83827777|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83827778|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83827779|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
83827780|NCT00093834|Doxorubicin|doxorubicin|mesh-list
83827781|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83827782|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827783|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
83827784|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827785|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827786|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83827787|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
83827788|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827789|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827790|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83827791|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827792|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83827793|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827794|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827795|NCT00327184|PENTA|penta|mesh-list
83827796|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
83827797|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83827798|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83827799|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827800|NCT00419302|Insulin|insulin|mesh-list
83827801|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83827802|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827803|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
83827804|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83827805|NCT00093951|Protective Agents|protective agents|mesh-ancestor
83827806|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827807|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
83827808|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
83827809|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827810|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827811|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
83827812|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
83827813|NCT00320476|Bortezomib|bortezomib|mesh-list
83827814|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827815|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
83827816|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827817|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827818|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827819|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827820|NCT00093990|Tipifarnib|tipifarnib|mesh-list
83827821|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827822|NCT00327379|Aprotinin|aprotinin|mesh-list
83827823|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
83827824|NCT00327379|Coagulants|coagulants|mesh-ancestor
83827825|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83827826|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83827827|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
83827828|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827829|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827830|NCT00327418|Atorvastatin|atorvastatin|mesh-list
83827831|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83827832|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83827833|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
83827834|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827835|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83827836|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83827837|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827838|NCT00094029|Sunitinib|sunitinib|mesh-list
83827839|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827840|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83827841|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83827842|NCT00094029|Growth Substances|growth substances|mesh-ancestor
83827843|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827844|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
83827845|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83827846|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827847|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827848|NCT00086099|Amifostine|amifostine|mesh-list
83827849|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83827850|NCT00086099|Protective Agents|protective agents|mesh-ancestor
83827851|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827852|NCT00320632|Desipramine|desipramine|mesh-list
83827853|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83827854|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
83827855|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827856|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827857|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827858|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83827859|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83827860|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827861|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
83827862|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827863|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983394|NCT01367028|Docetaxel|docetaxel|mesh-list
83827864|NCT00320827|Antibodies|antibodies|mesh-list
83827865|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
83827866|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827867|NCT00320983|Topotecan|topotecan|mesh-list
83827868|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827869|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83827870|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827871|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827872|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827873|NCT00086177|Progesterone|progesterone|mesh-list
83827874|NCT00086177|Progestins|progestins|mesh-ancestor
83827875|NCT00086177|Hormones|hormones|mesh-ancestor
83827876|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827877|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827878|NCT05458765|Tenofovir|tenofovir|mesh-list
83827879|NCT05458765|Emtricitabine|emtricitabine|mesh-list
83827880|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83827881|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83827882|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
83827883|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827884|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83827885|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83827886|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827887|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827888|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83827889|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83827890|NCT00094146|Octreotide|octreotide|mesh-list
83827891|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83827892|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83827893|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827894|NCT00086255|Tiagabine|tiagabine|mesh-list
83827895|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
83827896|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83827897|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83827898|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827899|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827900|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
83827901|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827902|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827903|NCT00321178|Clarithromycin|clarithromycin|mesh-list
83827904|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83827905|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83827906|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83827907|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827908|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827909|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83827910|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83827911|NCT00124527|Capecitabine|capecitabine|mesh-list
83827912|NCT00124527|Irofulven|irofulven|mesh-list
83827913|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83827914|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
83827915|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827916|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827917|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83827918|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
83827919|NCT00086294|Levodopa|levodopa|mesh-list
83827920|NCT00086294|Pimavanserin|pimavanserin|mesh-list
83827921|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83827922|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83827923|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
83827924|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827925|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827926|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827927|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83827928|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83827929|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827930|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827931|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83827932|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83827933|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
83827934|NCT05458492|Sirolimus|sirolimus|mesh-list
83827935|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83827936|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983487|NCT01316757|Paclitaxel|paclitaxel|mesh-list
83827937|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83827938|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827939|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
83827940|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827941|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
83827942|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827943|NCT00086333|Docetaxel|docetaxel|mesh-list
83827944|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827945|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83827946|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83827947|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83827948|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827949|NCT05458180|Prednisone|prednisone|mesh-list
83827950|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
83827951|NCT05458180|Etoposide|etoposide|mesh-list
83827952|NCT05458180|Vincristine|vincristine|mesh-list
83827953|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
83827954|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83827955|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
83827956|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827957|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83827958|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83827959|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
83827960|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827961|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83827962|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83827963|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83827964|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
83827965|NCT05458180|Hormones|hormones|mesh-ancestor
83827966|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83827967|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83827968|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83827969|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83827970|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83827971|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83827972|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
83827973|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
83827974|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
83827975|NCT05458180|Analgesics|analgesics|mesh-ancestor
83827976|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
83827977|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827978|NCT00419653|Haloperidol|haloperidol|mesh-list
83827979|NCT00419653|Olanzapine|olanzapine|mesh-list
83827980|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
83827981|NCT00419653|Amisulpride|amisulpride|mesh-list
83827982|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
83827983|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
83827984|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83827985|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83827986|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83827987|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83827988|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83827989|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83827990|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83827991|NCT00419653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83827992|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83827993|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83827994|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83827995|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83827996|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
83827997|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83827998|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
83827999|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83828000|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83828001|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828002|NCT00094341|Etanercept|etanercept|mesh-list
83828003|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83828004|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83828005|NCT00094341|Analgesics|analgesics|mesh-ancestor
83828006|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
83828007|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828008|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828009|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828010|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983543|NCT01367418|Narcotics|narcotics|mesh-ancestor
83828011|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83828012|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83828013|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
83828014|NCT00086489|Tremelimumab|tremelimumab|mesh-list
83828015|NCT00086489|Ipilimumab|ipilimumab|mesh-list
83828016|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828017|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83828018|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83828019|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828020|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
83828021|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83828022|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
83828023|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828024|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828025|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83828026|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
83828027|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828028|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828029|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83828030|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83828031|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83828032|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828033|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828034|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83828035|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83828036|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828037|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828038|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83828039|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83828040|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828041|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828042|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828043|NCT00321490|Analgesics|analgesics|mesh-ancestor
83828044|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
83828045|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828046|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
83828048|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828049|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83828050|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828051|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828052|NCT05457829|Doxorubicin|doxorubicin|mesh-list
83828053|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83828054|NCT05457829|Irinotecan|irinotecan|mesh-list
83828055|NCT05457829|Vincristine|vincristine|mesh-list
83828056|NCT05457829|Temozolomide|temozolomide|mesh-list
83828057|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828058|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828059|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828060|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828061|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828062|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828063|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83828064|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83828065|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83828066|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83828067|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83828068|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83828069|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
83828070|NCT05457751|Rocuronium|rocuronium|mesh-list
83828071|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83828072|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83828073|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83828074|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828075|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828076|NCT00086606|Omalizumab|omalizumab|mesh-list
83828077|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83828078|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828079|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828080|NCT00124566|Prednisone|prednisone|mesh-list
83828081|NCT00124566|Capecitabine|capecitabine|mesh-list
83828082|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
83828083|NCT00124566|Irofulven|irofulven|mesh-list
83828084|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828085|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
83828086|NCT00124566|Hormones|hormones|mesh-ancestor
83828087|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83828088|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828089|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83828090|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828091|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83828092|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
83828093|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828095|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
83828096|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828097|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828098|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828099|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828100|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83828101|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
83828102|NCT00321724|Cediranib|cediranib|mesh-list
83828103|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828104|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828105|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828106|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83828107|NCT00086645|Dexetimide|dexetimide|mesh-list
83828108|NCT00086645|Citalopram|citalopram|mesh-list
83828109|NCT00086645|Escitalopram|escitalopram|mesh-list
83828110|NCT00086645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83828111|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83828112|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828113|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828114|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828115|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
83828116|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828117|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83828118|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828119|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828120|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83828121|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83828122|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
83828123|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
83828124|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828125|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83828126|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83828127|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
83828128|NCT00321802|Simvastatin|simvastatin|mesh-list
83828129|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83828130|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83828131|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
83828132|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828133|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83828134|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83828135|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828136|NCT00124605|Pamidronate|pamidronate|mesh-list
83828137|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
83828138|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828139|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83828140|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828141|NCT05457361|Azacitidine|azacitidine|mesh-list
83828142|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
83828143|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83828144|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
83828145|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828146|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828147|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828148|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83828149|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83828150|NCT00086801|Gemcitabine|gemcitabine|mesh-list
83828151|NCT00086801|Doxorubicin|doxorubicin|mesh-list
83828152|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83828153|NCT00086801|Vinblastine|vinblastine|mesh-list
83828154|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83828155|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83828156|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
83828157|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983694|NCT01344213|Celecoxib|celecoxib|mesh-list
83828158|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828159|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828160|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828161|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828162|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828163|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83828164|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83828165|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
83828166|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
83828167|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
83828168|NCT05456113|Cannabidiol|cannabidiol|mesh-list
83828169|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
83828170|NCT00124644|Cytarabine|cytarabine|mesh-list
83828171|NCT00124644|Etoposide|etoposide|mesh-list
83828172|NCT00124644|Daunorubicin|daunorubicin|mesh-list
83828173|NCT00124644|Tipifarnib|tipifarnib|mesh-list
83828174|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83828175|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83828176|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828177|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828178|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828179|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828180|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83828181|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
83828182|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
83828183|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828184|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83828185|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
83828186|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828187|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828188|NCT00086840|Sirolimus|sirolimus|mesh-list
83828189|NCT00086840|Temsirolimus|temsirolimus|mesh-list
83828190|NCT00086840|MTOR Inhibitors|mtor inhibitors|mesh-list
83828191|NCT00086840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83828192|NCT00086840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828193|NCT00086840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828194|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83828195|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
83828196|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828197|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828198|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828199|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828200|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828201|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
83828202|NCT00124683|Bupropion|bupropion|mesh-list
83828203|NCT00124683|Nicotine|nicotine|mesh-list
83828204|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83828205|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
83828206|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828207|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828208|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83828209|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83828210|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
83828211|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828212|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828213|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83828214|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828215|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828216|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83828217|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83828218|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828219|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
83828220|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83828221|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83828222|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828223|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83828224|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83828225|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828226|NCT00086879|Temozolomide|temozolomide|mesh-list
83828227|NCT00086879|Carmustine|carmustine|mesh-list
83828228|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83828229|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83828230|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
83828231|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828232|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828233|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83828234|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828235|NCT00124722|Bromides|bromides|mesh-list
83828236|NCT00124722|Rocuronium|rocuronium|mesh-list
83828237|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
83828238|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83828239|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83828240|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83828241|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828242|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828243|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
83828244|NCT00322036|Tarenflurbil|tarenflurbil|mesh-list
83828245|NCT00322036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83828246|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828247|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828248|NCT00322036|Analgesics|analgesics|mesh-ancestor
83828249|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
83828250|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828251|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828252|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83828253|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83828254|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828255|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828256|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83828257|NCT00094614|Atropine|atropine|mesh-list
83828258|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83828259|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83828260|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83828261|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
83828262|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828263|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828264|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828265|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828266|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
83828267|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
83828268|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83828269|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83828270|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
83828271|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828272|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828273|NCT00087035|Docetaxel|docetaxel|mesh-list
83828274|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83828275|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828276|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83828277|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83828278|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83828279|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828280|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83828281|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828282|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
83828283|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83828284|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828285|NCT00322114|Lycopene|lycopene|mesh-list
83828286|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828287|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
83828288|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828289|NCT00322114|Protective Agents|protective agents|mesh-ancestor
83828290|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828291|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83828292|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83828293|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828294|NCT00087074|Sirolimus|sirolimus|mesh-list
83828295|NCT00087074|Temsirolimus|temsirolimus|mesh-list
83828296|NCT00087074|MTOR Inhibitors|mtor inhibitors|mesh-list
83828297|NCT00087074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83828298|NCT00087074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828299|NCT00087074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828300|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83828301|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
83828302|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828303|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828304|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828305|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828306|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828307|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
83828308|NCT00332176|Ribavirin|ribavirin|mesh-list
82983845|NCT02456428|Miglitol|miglitol|mesh-list
82983850|NCT02456428|Phenformin|phenformin|mesh-list
83828309|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83828310|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
83828311|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828312|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
83828313|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828314|NCT00087113|Pemetrexed|pemetrexed|mesh-list
83828315|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828316|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828317|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828318|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83828319|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83828320|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83828321|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828322|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
83828323|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83828324|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83828325|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83828326|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828327|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828328|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828329|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828330|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828331|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828332|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828333|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83828334|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
83828335|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83828336|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828337|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83828338|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83828339|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83828340|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
83828341|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83828342|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83828343|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
83828344|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83828345|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83828346|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83828347|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828348|NCT00094692|Atropine|atropine|mesh-list
83828349|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83828350|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83828351|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83828352|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
83828353|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828354|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828355|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828356|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828357|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
83828358|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
83828359|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83828360|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83828361|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
83828362|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828363|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828364|NCT05181007|Valproic Acid|valproic acid|mesh-list
83828365|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
83828366|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828367|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828368|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
83828369|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828370|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828371|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
83828372|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83828373|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828374|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828375|NCT00124839|Naltrexone|naltrexone|mesh-list
83828376|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83828377|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83828378|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828379|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
83828380|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828381|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82983922|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828382|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828383|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83828384|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828385|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828386|NCT05126836|Cilostazol|cilostazol|mesh-list
83828387|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83828388|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
83828389|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828390|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828391|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828392|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828393|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83828394|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83828395|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828396|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83828397|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
83828398|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83828399|NCT05126836|Protective Agents|protective agents|mesh-ancestor
83828400|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83828401|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83828402|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828403|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83828404|NCT00087347|Hematinics|hematinics|mesh-ancestor
83828405|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83828406|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83828407|NCT04960930|Minocycline|minocycline|mesh-list
83828408|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828409|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828410|NCT00419692|Ropinirole|ropinirole|mesh-list
83828411|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83828412|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83828413|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
83828414|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
83828415|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828416|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828417|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828418|NCT00419731|Naltrexone|naltrexone|mesh-list
83828419|NCT00419731|Bupropion|bupropion|mesh-list
83828420|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83828421|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83828422|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828423|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
83828424|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828425|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83828426|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828427|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828428|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83828429|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83828430|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828431|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828432|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
83828433|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828434|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83828435|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83828436|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828437|NCT00419848|Azithromycin|azithromycin|mesh-list
83828438|NCT00419848|Doxycycline|doxycycline|mesh-list
83828439|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828440|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828441|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
83828442|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83828443|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83828444|NCT00094848|Mapatumumab|mapatumumab|mesh-list
83828445|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828446|NCT00087425|Rituximab|rituximab|mesh-list
83828447|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
83828448|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83828449|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828450|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
83828451|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828452|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828453|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83828454|NCT00330655|Memantine|memantine|mesh-list
83828455|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83828456|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83828457|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
83828458|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828459|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828460|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828461|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83828462|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83828463|NCT00330772|Aspirin|aspirin|mesh-list
83828464|NCT00330772|Clopidogrel|clopidogrel|mesh-list
83828465|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83828466|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83828467|NCT00330772|Analgesics|analgesics|mesh-ancestor
83828468|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
83828469|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828470|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828471|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828472|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828473|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83828474|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83828475|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828476|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83828477|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83828478|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828479|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
83828480|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83828481|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83828482|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83828483|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
83828484|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828485|NCT00094926|Risperidone|risperidone|mesh-list
83828486|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83828487|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
83828488|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828489|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828490|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828491|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83828492|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83828493|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828494|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828495|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83828496|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
83828497|NCT00087464|Tenofovir|tenofovir|mesh-list
83828498|NCT00087464|Emtricitabine|emtricitabine|mesh-list
83828499|NCT00087464|Nevirapine|nevirapine|mesh-list
83828500|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
83828501|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828502|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83828503|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83828504|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828505|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828506|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83828507|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83828508|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83828509|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83828510|NCT00331045|Alvimopan|alvimopan|mesh-list
83828511|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83828512|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83828513|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
83828514|NCT00331084|Dexamethasone|dexamethasone|mesh-list
83828515|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
83828516|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83828517|NCT00331084|BB 1101|bb 1101|mesh-list
83828518|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828519|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
83828520|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
83828521|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828522|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828523|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83828524|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
83828525|NCT00331084|Hormones|hormones|mesh-ancestor
83828526|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83828527|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83828528|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828529|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
83828530|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828531|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828532|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828533|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828534|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828535|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83828536|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
83828537|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83828538|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83828539|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83828540|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83828541|NCT00420355|Ritonavir|ritonavir|mesh-list
83828542|NCT00420355|Lopinavir|lopinavir|mesh-list
83828543|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83828544|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83828545|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83828546|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
83828547|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828548|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828549|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83828550|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83828551|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
83828552|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828553|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83828554|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83828555|NCT00331123|Testosterone|testosterone|mesh-list
83828556|NCT00331123|Androgens|androgens|mesh-ancestor
83828557|NCT00331123|Hormones|hormones|mesh-ancestor
83828558|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83828559|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828560|NCT00087542|Pimavanserin|pimavanserin|mesh-list
83828561|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83828562|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83828563|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83828564|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83828565|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828566|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828567|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828568|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83828569|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83828570|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
83828571|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828572|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828573|NCT00331240|Timolol|timolol|mesh-list
83828574|NCT00331240|Travoprost|travoprost|mesh-list
83828575|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
83828576|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83828577|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83828578|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83828579|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828580|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828581|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828582|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83828583|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83828584|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83828585|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83828586|NCT00124956|Doxorubicin|doxorubicin|mesh-list
83828587|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828588|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828589|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828590|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828591|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828592|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828593|NCT00087581|Cyclosporine|cyclosporine|mesh-list
83828594|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
83828595|NCT00087581|Tacrolimus|tacrolimus|mesh-list
83828596|NCT00087581|Cyclosporins|cyclosporins|mesh-list
83828597|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83828598|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
83828599|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828600|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83828601|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828602|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828603|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
82984147|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83828604|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828605|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
83828606|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828607|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828608|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828609|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83828610|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
83828611|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828613|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828614|NCT00331435|Verteporfin|verteporfin|mesh-list
83828615|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83828616|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83828617|NCT00331513|Vorinostat|vorinostat|mesh-list
83828618|NCT00331513|Idarubicin|idarubicin|mesh-list
83828619|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828620|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83828621|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828622|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828623|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828624|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828625|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828626|NCT00087620|Capecitabine|capecitabine|mesh-list
83828627|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83828628|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
83828629|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828630|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828631|NCT00124995|Terbutaline|terbutaline|mesh-list
83828632|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83828633|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
83828634|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828635|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828636|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828637|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828638|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
83828639|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
83828640|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83828641|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83828642|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83828643|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83828644|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
83828645|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828646|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828647|NCT00331708|Artesunate|artesunate|mesh-list
83828648|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
83828649|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
83828650|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83828651|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
83828652|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83828653|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83828654|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828655|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828656|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
83828657|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
83828658|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83828659|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
83828660|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83828661|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828662|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828663|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83828664|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
83828665|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
83828666|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83828667|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
83828668|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828669|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83828670|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828671|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
83828672|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83828673|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828674|NCT00331786|Aspirin|aspirin|mesh-list
83828675|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
83828676|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
83828677|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83828678|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83828679|NCT00331786|Analgesics|analgesics|mesh-ancestor
83828680|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
83828681|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828683|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828684|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83828685|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83828686|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83828687|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828688|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83828689|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83828690|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828691|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
83828692|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83828693|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
83828694|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828695|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828696|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83828697|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
83828698|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828699|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83828700|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
83828701|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
83828702|NCT00331786|Protective Agents|protective agents|mesh-ancestor
83828703|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83828704|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
83828705|NCT00331825|Olanzapine|olanzapine|mesh-list
83828706|NCT00331825|Risperidone|risperidone|mesh-list
83828707|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83828708|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
83828709|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828710|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828711|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828712|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83828713|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83828714|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828715|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828716|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83828717|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
83828718|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
83828719|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
83828720|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828721|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83828722|NCT00331825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83828723|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83828724|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828725|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
83828726|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83828727|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828728|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83828729|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
83828730|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828731|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828732|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828733|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828734|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83828735|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83828736|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83828737|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828738|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828739|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828740|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828741|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83828742|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828743|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828744|NCT00331981|Amisulpride|amisulpride|mesh-list
83828745|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83828746|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83828747|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828748|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828749|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828750|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83828751|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
83828752|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828753|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828754|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83828755|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828756|NCT00126633|Bevacizumab|bevacizumab|mesh-list
83828757|NCT00126633|Gemcitabine|gemcitabine|mesh-list
83828758|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83828759|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828760|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83828761|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83828762|NCT00126633|Growth Substances|growth substances|mesh-ancestor
83828763|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828764|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
83828765|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83828766|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
83828767|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828768|NCT00332020|Enoxaparin|enoxaparin|mesh-list
83828769|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
83828770|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83828771|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
83828772|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83828773|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
83828774|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828775|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828776|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
83828777|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83828778|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83828779|NCT02965274|Fluoxetine|fluoxetine|mesh-list
83828780|NCT02965274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83828781|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83828782|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828783|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828784|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828785|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
83828786|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828787|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83828788|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
83828789|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83828790|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83828791|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83828792|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828793|NCT00332059|Timolol|timolol|mesh-list
83828794|NCT00332059|Bimatoprost|bimatoprost|mesh-list
83828795|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83828796|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83828797|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
83828798|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828799|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828800|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828801|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83828802|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83828803|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83828804|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83828805|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83828806|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
83828807|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828808|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828809|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828810|NCT00332137|Urological Agents|urological agents|mesh-ancestor
83828811|NCT00126789|Fentanyl|fentanyl|mesh-list
83828812|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83828813|NCT00126789|Narcotics|narcotics|mesh-ancestor
83828814|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828815|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828816|NCT00126789|Analgesics|analgesics|mesh-ancestor
83828817|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
83828818|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828819|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83828820|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83828821|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
83828822|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
83828823|NCT05831969|Lenalidomide|lenalidomide|mesh-list
83828824|NCT05831969|Immunologic Factors|immunologic factors|mesh-ancestor
83828825|NCT05831969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828826|NCT05831969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83828827|NCT05831969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83828828|NCT05831969|Growth Substances|growth substances|mesh-ancestor
83828829|NCT05831969|Growth Inhibitors|growth inhibitors|mesh-ancestor
83828830|NCT05831969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828831|NCT05831761|Lidocaine|lidocaine|mesh-list
83828832|NCT05831761|Analgesics|analgesics|mesh-list
83828833|NCT05831761|Anesthetics, Local|anesthetics, local|mesh-ancestor
83828834|NCT05831761|Anesthetics|anesthetics|mesh-ancestor
83828835|NCT05831761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828836|NCT05831761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828837|NCT05831761|Sensory System Agents|sensory system agents|mesh-ancestor
83828838|NCT05831761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828839|NCT05831761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83828840|NCT05831761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83828841|NCT05831761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83828842|NCT05831761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83828843|NCT05831761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828844|NCT05831566|Budesonide|budesonide|mesh-list
83828845|NCT05831566|Formoterol Fumarate|formoterol fumarate|mesh-list
83828846|NCT05831566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828847|NCT05831566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83828848|NCT05831566|Autonomic Agents|autonomic agents|mesh-ancestor
83828849|NCT05831566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828850|NCT05831566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828851|NCT05831566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828852|NCT05831566|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828853|NCT05831566|Glucocorticoids|glucocorticoids|mesh-ancestor
83828854|NCT05831566|Hormones|hormones|mesh-ancestor
83828855|NCT05831566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83828856|NCT05831566|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83828857|NCT05831566|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83828858|NCT05831566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83828859|NCT05831566|Adrenergic Agents|adrenergic agents|mesh-ancestor
83828860|NCT05831566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828861|NCT05831566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828862|NCT05831462|Ticagrelor|ticagrelor|mesh-list
83828863|NCT05831462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83828864|NCT05831462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83828865|NCT05831462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83828866|NCT05831462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83828867|NCT05831462|Purinergic Agents|purinergic agents|mesh-ancestor
83828868|NCT05831462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828869|NCT05831462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828870|NCT05831462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828871|NCT05831449|Ropivacaine|ropivacaine|mesh-list
83828872|NCT05831449|Anesthetics, Local|anesthetics, local|mesh-list
83828873|NCT05831449|Anesthetics|anesthetics|mesh-list
83828874|NCT05831449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828875|NCT05831449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828876|NCT05831449|Sensory System Agents|sensory system agents|mesh-ancestor
83828877|NCT05831449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828878|NCT05831345|Sufentanil|sufentanil|mesh-list
83828879|NCT05831345|Dsuvia|dsuvia|mesh-list
83828880|NCT05831345|Methadone|methadone|mesh-list
83828881|NCT05831345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83828882|NCT05831345|Narcotics|narcotics|mesh-ancestor
83828883|NCT05831345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828884|NCT05831345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828885|NCT05831345|Analgesics|analgesics|mesh-ancestor
83828886|NCT05831345|Sensory System Agents|sensory system agents|mesh-ancestor
83828887|NCT05831345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828888|NCT05831345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83828889|NCT05831345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83828890|NCT05831345|Anesthetics, General|anesthetics, general|mesh-ancestor
83828891|NCT05831345|Anesthetics|anesthetics|mesh-ancestor
83828892|NCT05831345|Antitussive Agents|antitussive agents|mesh-ancestor
83828893|NCT05831345|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828894|NCT05831267|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83828895|NCT05831267|Hemostatics|hemostatics|mesh-ancestor
83828896|NCT05831267|Coagulants|coagulants|mesh-ancestor
83828897|NCT05831176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83828898|NCT05831176|Immunologic Factors|immunologic factors|mesh-ancestor
83828899|NCT05831176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828900|NCT05831098|Antibodies|antibodies|mesh-list
83828901|NCT05831098|Immunologic Factors|immunologic factors|mesh-ancestor
83828902|NCT05831098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828903|NCT05830916|Antibodies|antibodies|mesh-list
83828904|NCT05830916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
83828905|NCT05830916|Immunologic Factors|immunologic factors|mesh-ancestor
83828906|NCT05830916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828907|NCT05830864|Isoflurane|isoflurane|mesh-list
83828908|NCT05830864|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83828909|NCT05830864|Anesthetics, General|anesthetics, general|mesh-ancestor
83828910|NCT05830864|Anesthetics|anesthetics|mesh-ancestor
83828911|NCT05830864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828912|NCT05830864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828913|NCT05830747|Prednisone|prednisone|mesh-list
83828914|NCT05830747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828915|NCT05830747|Glucocorticoids|glucocorticoids|mesh-ancestor
83828916|NCT05830747|Hormones|hormones|mesh-ancestor
83828917|NCT05830747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83828918|NCT05830747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828919|NCT05830747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83828920|NCT05830747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828921|NCT05830604|Salicylic Acid|salicylic acid|mesh-list
83828922|NCT05830604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828923|NCT05830604|Antifungal Agents|antifungal agents|mesh-ancestor
83828924|NCT05830604|Keratolytic Agents|keratolytic agents|mesh-ancestor
83828925|NCT05830604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83828926|NCT05830136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83828927|NCT05830071|Moxifloxacin|moxifloxacin|mesh-list
83828928|NCT05830071|Beclomethasone|beclomethasone|mesh-list
83828929|NCT05830071|Glycopyrrolate|glycopyrrolate|mesh-list
83828930|NCT05830071|Bromides|bromides|mesh-list
83828931|NCT05830071|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83828932|NCT05830071|Formoterol Fumarate|formoterol fumarate|mesh-list
83828933|NCT05830071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828934|NCT05830071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828935|NCT05830071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83828936|NCT05830071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83828937|NCT05830071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828938|NCT05830071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828939|NCT05830071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828940|NCT05830071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83828941|NCT05830071|Contraceptive Agents|contraceptive agents|mesh-ancestor
83828942|NCT05830071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83828943|NCT05830071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828944|NCT05830071|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83828945|NCT05830071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83828946|NCT05830071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83828947|NCT05830071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83828948|NCT05830071|Autonomic Agents|autonomic agents|mesh-ancestor
83828949|NCT05830071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828950|NCT05830071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83828951|NCT05830071|Respiratory System Agents|respiratory system agents|mesh-ancestor
83828952|NCT05830071|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83828953|NCT05830071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83828954|NCT05830071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83828955|NCT05830071|Adrenergic Agents|adrenergic agents|mesh-ancestor
83828956|NCT05830071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828957|NCT05830071|Anticonvulsants|anticonvulsants|mesh-ancestor
83828958|NCT05830071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83828959|NCT05830071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83828960|NCT05830071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83828961|NCT05830071|Cholinergic Agents|cholinergic agents|mesh-ancestor
83828962|NCT05830071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83828963|NCT05830071|Glucocorticoids|glucocorticoids|mesh-ancestor
83828964|NCT05830071|Hormones|hormones|mesh-ancestor
83828965|NCT05830071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83828966|NCT05828758|Amoxicillin|amoxicillin|mesh-list
83828967|NCT05828758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83828968|NCT05828758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83828969|NCT05821725|Hyaluronic Acid|hyaluronic acid|mesh-list
83828970|NCT05821725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82984523|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82984524|NCT00832455|Montelukast|montelukast|mesh-list
82984525|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82984526|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
82984527|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83828971|NCT05821725|Immunologic Factors|immunologic factors|mesh-ancestor
83828972|NCT05821725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828973|NCT05821725|Viscosupplements|viscosupplements|mesh-ancestor
83828974|NCT05821725|Protective Agents|protective agents|mesh-ancestor
83828976|NCT05820997|Anesthetics, Local|anesthetics, local|mesh-ancestor
83828977|NCT05820997|Anesthetics|anesthetics|mesh-ancestor
83828978|NCT05820997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83828979|NCT05820997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828980|NCT05820997|Sensory System Agents|sensory system agents|mesh-ancestor
83828981|NCT05820997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83828982|NCT05814523|Ganaxolone|ganaxolone|mesh-list
83828983|NCT05814523|Neurosteroids|neurosteroids|mesh-ancestor
83828984|NCT05814523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83828985|NCT05814523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828986|NCT05814523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83828987|NCT05814523|GABA Modulators|gaba modulators|mesh-ancestor
83828988|NCT05814523|GABA Agents|gaba agents|mesh-ancestor
83828989|NCT05807126|Olaparib|olaparib|mesh-list
83828990|NCT05807126|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83828991|NCT05807126|Magrolimab|magrolimab|mesh-list
83828992|NCT05807126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83828993|NCT05807126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83828994|NCT05807126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83828995|NCT05807126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83828996|NCT05803382|Capecitabine|capecitabine|mesh-list
83828997|NCT05803382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83828998|NCT05803382|Antimetabolites|antimetabolites|mesh-ancestor
83828999|NCT05803382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829000|NCT05803382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829001|NCT05793905|Lidocaine|lidocaine|mesh-list
83829002|NCT05793905|Anesthetics, Local|anesthetics, local|mesh-ancestor
83829003|NCT05793905|Anesthetics|anesthetics|mesh-ancestor
83829004|NCT05793905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829005|NCT05793905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829006|NCT05793905|Sensory System Agents|sensory system agents|mesh-ancestor
83829007|NCT05793905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829008|NCT05793905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83829009|NCT05793905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83829010|NCT05793905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83829011|NCT05793905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83829012|NCT05793905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829013|NCT05790252|Buprenorphine|buprenorphine|mesh-list
83829014|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83829015|NCT05790252|Narcotics|narcotics|mesh-ancestor
83829016|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829017|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829018|NCT05790252|Analgesics|analgesics|mesh-ancestor
83829019|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
83829020|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829021|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83829022|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83829023|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83829024|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
83829025|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829026|NCT05776017|Antacids|antacids|mesh-ancestor
83829027|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829028|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83829029|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
83829030|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
83829031|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83829032|NCT05744648|Protective Agents|protective agents|mesh-ancestor
83829033|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829034|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
83829035|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83829036|NCT05735353|Methamphetamine|methamphetamine|mesh-list
83829037|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83829038|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829039|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
83829040|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
82984594|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984595|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82984596|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82984597|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82984598|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
82984599|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82984600|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83829041|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829042|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
83829043|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829044|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829045|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
83829046|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83829047|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83829048|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83829049|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83829050|NCT05715281|Atezolizumab|atezolizumab|mesh-list
83829051|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83829052|NCT05715281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829053|NCT05715281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829054|NCT05715281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829055|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829056|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
83829057|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829058|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
83829059|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829060|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829061|NCT05709821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829062|NCT05709821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829063|NCT05691517|Exatecan|exatecan|mesh-list
83829064|NCT05691517|Camptothecin|camptothecin|mesh-list
83829065|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829066|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829067|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829068|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829069|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829070|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83829071|NCT05687123|Sunitinib|sunitinib|mesh-list
83829072|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83829073|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829074|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83829075|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83829076|NCT05687123|Growth Substances|growth substances|mesh-ancestor
83829077|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829078|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
83829079|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83829080|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829081|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829082|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83829083|NCT05680818|Vitamin D|vitamin d|mesh-list
83829084|NCT05680818|Calcitriol|calcitriol|mesh-list
83829085|NCT05680818|Alfacalcidol|alfacalcidol|mesh-list
83829086|NCT05680818|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83829087|NCT05680818|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3|mesh-list
83829088|NCT05680818|Calcium|calcium|mesh-list
83829089|NCT05680818|Vitamins|vitamins|mesh-ancestor
83829090|NCT05680818|Micronutrients|micronutrients|mesh-ancestor
83829091|NCT05680818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829092|NCT05680818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83829093|NCT05680818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83829094|NCT05680818|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83829095|NCT05680818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83829096|NCT05680818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829097|NCT05680818|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83829098|NCT05680818|Dermatologic Agents|dermatologic agents|mesh-ancestor
83829099|NCT05670379|Exenatide|exenatide|mesh-list
83829100|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83829101|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829102|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83829103|NCT05670379|Incretins|incretins|mesh-ancestor
83829104|NCT05670379|Hormones|hormones|mesh-ancestor
83829105|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829106|NCT05665270|Prednisolone|prednisolone|mesh-list
83829107|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83829108|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
83829109|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83829110|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
83829111|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83829112|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
83829113|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829114|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
83829115|NCT05665270|Hormones|hormones|mesh-ancestor
83829116|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829117|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829118|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83829119|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829120|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
83829121|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
83829122|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829123|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83829124|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83829125|NCT05665270|Protective Agents|protective agents|mesh-ancestor
83829126|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83829127|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
83829128|NCT05660447|Glycerol|glycerol|mesh-list
83829129|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83829130|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83829131|NCT05660447|Protective Agents|protective agents|mesh-ancestor
83829132|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829133|NCT05653973|Acetylcholine|acetylcholine|mesh-list
83829134|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
83829135|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83829136|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
83829137|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829138|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829139|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829140|NCT05646719|Phentolamine|phentolamine|mesh-list
83829141|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83829142|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83829143|NCT05646719|Pilocarpine|pilocarpine|mesh-list
83829144|NCT05646719|Miotics|miotics|mesh-ancestor
83829145|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
83829146|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829147|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829148|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83829149|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83829150|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
83829151|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829152|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829153|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83829154|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83829155|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
83829156|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83829157|NCT05628363|Androgens|androgens|mesh-list
83829158|NCT05628363|Hormones|hormones|mesh-ancestor
83829159|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829160|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829161|NCT05574400|Caffeine|caffeine|mesh-list
83829162|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
83829163|NCT05574400|Citric Acid|citric acid|mesh-list
83829164|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
83829165|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
83829166|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83829167|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
83829168|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
83829169|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829170|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83829171|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829172|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83829173|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829174|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83829175|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83829176|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
83829177|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829178|NCT05555862|Artesunate|artesunate|mesh-list
83829179|NCT05555862|Artenimol|artenimol|mesh-list
83829180|NCT05555862|Artemisinins|artemisinins|mesh-list
83829181|NCT05555862|Artemisinin|artemisinin|mesh-list
83829182|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
83829183|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83829184|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83829185|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829186|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829187|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
83829188|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
83829189|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83829190|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
83829191|NCT05546359|Dexamethasone|dexamethasone|mesh-list
83829192|NCT05546359|Amisulpride|amisulpride|mesh-list
83829193|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829194|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
83829195|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
83829196|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829197|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829198|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83829199|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
83829200|NCT05546359|Hormones|hormones|mesh-ancestor
83829201|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829202|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83829203|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829204|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83829205|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83829206|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829207|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83829208|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83829209|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
83829210|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829211|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829212|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83829213|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
83829214|NCT05510115|Empagliflozin|empagliflozin|mesh-list
83829215|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83829216|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829217|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83829218|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829219|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
83829220|NCT05478837|Fludarabine|fludarabine|mesh-list
83829221|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829222|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
83829223|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829224|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83829225|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83829226|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
83829227|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829228|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829229|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83829230|NCT05422794|Paclitaxel|paclitaxel|mesh-list
83829231|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83829232|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
83829233|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83829234|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829235|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83829236|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83829237|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83829238|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829239|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829240|NCT05422794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829241|NCT05421858|Fluconazole|fluconazole|mesh-list
83829242|NCT05421858|Caspofungin|caspofungin|mesh-list
83829243|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
83829244|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829245|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83829246|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83829247|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829248|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829249|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83829250|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
83829251|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829252|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829253|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83829254|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83829255|NCT05413330|Triamcinolone|triamcinolone|mesh-list
83829256|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83829257|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83829258|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83829259|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829260|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
83829261|NCT05413330|Hormones|hormones|mesh-ancestor
83829262|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829263|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829264|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829265|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
83829266|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829267|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829268|NCT05368558|Cariprazine|cariprazine|mesh-list
83829269|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83829270|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83829271|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829272|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829273|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83829274|NCT05322954|Psilocybin|psilocybin|mesh-list
83829275|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
83829276|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829277|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83829278|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83829279|NCT05271630|Immunomodulating Agents|immunomodulating agents|mesh-list
83829280|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
83829281|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829282|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829283|NCT05271630|Immunologic Factors|immunologic factors|mesh-ancestor
83829284|NCT05271630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829285|NCT05254639|Donepezil|donepezil|mesh-list
83829286|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83829287|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829288|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829289|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
83829290|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829291|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829292|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
83829293|NCT05243940|Lidocaine|lidocaine|mesh-list
83829294|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
83829295|NCT05243940|Ketamine|ketamine|mesh-list
83829296|NCT05243940|Remifentanil|remifentanil|mesh-list
83829297|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
83829298|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
83829299|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829300|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829301|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
83829302|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829303|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83829304|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83829305|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83829306|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83829307|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829308|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83829309|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83829310|NCT05243940|Analgesics|analgesics|mesh-ancestor
83829311|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83829312|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83829313|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83829314|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
83829315|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829316|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83829317|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83829318|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
83829319|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83829320|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83829321|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83829322|NCT05243940|Narcotics|narcotics|mesh-ancestor
83829323|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
83829324|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83829325|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829326|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
83829327|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83829328|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
83829329|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829330|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
83829331|NCT05198544|Protective Agents|protective agents|mesh-ancestor
83829332|NCT05167734|Dextrans|dextrans|mesh-list
83829333|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
83829334|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
83829335|NCT05167734|Hematinics|hematinics|mesh-ancestor
83829336|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
83829337|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
82984895|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
82984900|NCT00700570|Bevacizumab|bevacizumab|mesh-list
83829338|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
83829339|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
83829341|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83829342|NCT05142241|Temozolomide|temozolomide|mesh-list
83829343|NCT05142241|Talazoparib|talazoparib|mesh-list
83829344|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83829345|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
83829346|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829347|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829348|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83829349|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829350|NCT05141474|Aldesleukin|aldesleukin|mesh-list
83829351|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
83829352|NCT05141474|Fludarabine|fludarabine|mesh-list
83829353|NCT05141474|Interleukin-2|interleukin-2|mesh-list
83829354|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829355|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
83829356|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829357|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83829358|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83829359|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
83829360|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829361|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829362|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83829363|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83829364|NCT05141474|Analgesics|analgesics|mesh-ancestor
83829365|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
83829366|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829367|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83829368|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83829369|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
83829370|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829371|NCT05126719|Docetaxel|docetaxel|mesh-list
83829372|NCT05126719|Capecitabine|capecitabine|mesh-list
83829373|NCT05126719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829374|NCT05126719|Tubulin Modulators|tubulin modulators|mesh-ancestor
83829375|NCT05126719|Antimitotic Agents|antimitotic agents|mesh-ancestor
83829376|NCT05126719|Mitosis Modulators|mitosis modulators|mesh-ancestor
83829377|NCT05126719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829378|NCT05126719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83829379|NCT05126719|Antimetabolites|antimetabolites|mesh-ancestor
83829380|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
83829381|NCT05119140|Mesalamine|mesalamine|mesh-list
83829382|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
83829383|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83829384|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83829385|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829386|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829387|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829388|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83829389|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83829390|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83829391|NCT05119140|Analgesics|analgesics|mesh-ancestor
83829392|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
83829393|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829394|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829395|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829396|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
83829397|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83829398|NCT05097261|Ketamine|ketamine|mesh-list
83829399|NCT05097261|Analgesics|analgesics|mesh-ancestor
83829400|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
83829401|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829402|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829403|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83829404|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83829405|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
83829406|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
83829407|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829408|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83829409|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83829410|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829411|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829412|NCT05037032|Naltrexone|naltrexone|mesh-list
83829413|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82984969|NCT04486690|Ketamine|ketamine|mesh-list
83829414|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83829415|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829416|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
83829417|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829419|NCT04981509|Bevacizumab|bevacizumab|mesh-list
83829420|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83829421|NCT04981509|Atezolizumab|atezolizumab|mesh-list
83829422|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
83829423|NCT04981509|Antibodies|antibodies|mesh-list
83829424|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
83829425|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83829426|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
83829427|NCT04981509|Fluorides|fluorides|mesh-list
83829428|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
83829429|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829430|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83829431|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83829432|NCT04981509|Growth Substances|growth substances|mesh-ancestor
83829433|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829434|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
83829435|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
83829436|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829437|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
83829438|NCT04981509|Protective Agents|protective agents|mesh-ancestor
83829439|NCT04981509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829440|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83829441|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829442|NCT04970901|Obinutuzumab|obinutuzumab|mesh-list
83829443|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83829444|NCT04970901|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83829445|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829446|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829447|NCT04970901|Immunoconjugates|immunoconjugates|mesh-ancestor
83829448|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
83829449|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829450|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
83829451|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
83829452|NCT04904588|Melphalan|melphalan|mesh-list
83829453|NCT04904588|Busulfan|busulfan|mesh-list
83829454|NCT04904588|Fludarabine|fludarabine|mesh-list
83829455|NCT04904588|Tacrolimus|tacrolimus|mesh-list
83829456|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829457|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
83829458|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829459|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83829460|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83829461|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
83829462|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829463|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829464|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83829465|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83829466|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829467|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83829468|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83829469|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
83829470|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83829471|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829472|NCT04903197|Lenalidomide|lenalidomide|mesh-list
83829473|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
83829474|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829475|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83829476|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83829477|NCT04903197|Growth Substances|growth substances|mesh-ancestor
83829478|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
83829479|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829480|NCT04876781|Tofacitinib|tofacitinib|mesh-list
83829481|NCT04876781|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83829482|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83829483|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829484|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829485|NCT04870112|Carboplatin|carboplatin|mesh-list
83829486|NCT04870112|Etoposide|etoposide|mesh-list
83829487|NCT04870112|Durvalumab|durvalumab|mesh-list
83829488|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829489|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83829490|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83829491|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829492|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829493|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829494|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829496|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
83829497|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83829498|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
83829499|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
83829500|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83829501|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829502|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829503|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
83829504|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829505|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829506|NCT04856189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829507|NCT04856189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829508|NCT04840199|Letermovir|letermovir|mesh-list
83829509|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83829510|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829511|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829512|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829513|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
83829514|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829515|NCT04800393|Propofol|propofol|mesh-list
83829516|NCT04800393|Sevoflurane|sevoflurane|mesh-list
83829517|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83829518|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829519|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829520|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83829521|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
83829522|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
83829523|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83829524|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83829525|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
83829526|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829527|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829528|NCT04768881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829529|NCT04768881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829530|NCT04768296|Topotecan|topotecan|mesh-list
83829531|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829532|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829533|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829534|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829535|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829536|NCT04718220|Antibodies|antibodies|mesh-list
83829537|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
83829538|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829539|NCT04668300|Durvalumab|durvalumab|mesh-list
83829540|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
83829541|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83829542|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
83829543|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829544|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829545|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
83829546|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829547|NCT04616560|Trastuzumab|trastuzumab|mesh-list
83829548|NCT04616560|Camptothecin|camptothecin|mesh-list
83829549|NCT04616560|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83829550|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
83829551|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829552|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829553|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
83829554|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829555|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83829556|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829557|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829558|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829559|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829560|NCT04572295|Fulvestrant|fulvestrant|mesh-list
83829561|NCT04572295|Exemestane|exemestane|mesh-list
83829562|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83829563|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829564|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83829565|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83829566|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
83829567|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829568|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829569|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83829570|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83829571|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829572|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829573|NCT04557956|Trametinib|trametinib|mesh-list
83829574|NCT04557956|Dabrafenib|dabrafenib|mesh-list
83829575|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83829576|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829577|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83829578|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829579|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829580|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83829581|NCT04557956|Protective Agents|protective agents|mesh-ancestor
83829582|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829583|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83829584|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
83829585|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
83829586|NCT04541017|Magrolimab|magrolimab|mesh-list
83829587|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
83829588|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
83829589|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
83829590|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829591|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829592|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829593|NCT04521868|Sulforaphane|sulforaphane|mesh-list
83829594|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83829595|NCT04521868|Protective Agents|protective agents|mesh-ancestor
83829596|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829597|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829598|NCT04514497|Irinotecan|irinotecan|mesh-list
83829599|NCT04514497|Topotecan|topotecan|mesh-list
83829600|NCT04514497|Camptothecin|camptothecin|mesh-list
83829601|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829602|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829603|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829604|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829605|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829606|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83829607|NCT04514484|Nivolumab|nivolumab|mesh-list
83829608|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829609|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829610|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829611|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829612|NCT04481204|Leucovorin|leucovorin|mesh-list
83829613|NCT04481204|Paclitaxel|paclitaxel|mesh-list
83829614|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83829615|NCT04481204|Cisplatin|cisplatin|mesh-list
83829616|NCT04481204|Gemcitabine|gemcitabine|mesh-list
83829617|NCT04481204|Fluorouracil|fluorouracil|mesh-list
83829618|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
83829619|NCT04481204|Irinotecan|irinotecan|mesh-list
83829620|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83829621|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829622|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83829623|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83829624|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83829625|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829626|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83829627|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
83829628|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829629|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
83829630|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829631|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829632|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829633|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829634|NCT04481204|Antidotes|antidotes|mesh-ancestor
83829635|NCT04481204|Protective Agents|protective agents|mesh-ancestor
83829636|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
83829637|NCT04481204|Vitamins|vitamins|mesh-ancestor
83829638|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
83829639|NCT04442022|Dexamethasone|dexamethasone|mesh-list
83829640|NCT04442022|Rituximab|rituximab|mesh-list
83829641|NCT04442022|Gemcitabine|gemcitabine|mesh-list
83829642|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829643|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829644|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
83829645|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829646|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83829647|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829648|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
83829649|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
83829650|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829651|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83829652|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
83829653|NCT04442022|Hormones|hormones|mesh-ancestor
83829654|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829655|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83829656|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83829657|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
83829658|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829659|NCT04440735|Atezolizumab|atezolizumab|mesh-list
83829660|NCT04440735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829661|NCT04440735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829662|NCT04440735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829663|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829664|NCT04419493|Heparin|heparin|mesh-list
83829665|NCT04419493|Calcium heparin|calcium heparin|mesh-list
83829666|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83829667|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
83829668|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83829669|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83829670|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829671|NCT04401748|Azacitidine|azacitidine|mesh-list
83829672|NCT04401748|Venetoclax|venetoclax|mesh-list
83829673|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83829674|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
83829675|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829676|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829677|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829678|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83829679|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83829680|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
83829681|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83829682|NCT04394975|Sunitinib|sunitinib|mesh-list
83829683|NCT04394975|Axitinib|axitinib|mesh-list
83829684|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829685|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83829686|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83829687|NCT04394975|Growth Substances|growth substances|mesh-ancestor
83829688|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829689|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
83829690|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83829691|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829692|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829693|NCT04381910|Irinotecan|irinotecan|mesh-list
83829694|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829695|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829696|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829697|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829698|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829699|NCT04340843|Decitabine|decitabine|mesh-list
83829700|NCT04340843|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83829701|NCT04340843|Azacitidine|azacitidine|mesh-list
83829702|NCT04340843|Belinostat|belinostat|mesh-list
83829703|NCT04340843|Guadecitabine|guadecitabine|mesh-list
83829704|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83829705|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
83829706|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829707|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829708|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829709|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83829710|NCT04334876|Antibodies|antibodies|mesh-list
83829711|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
83829712|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
83829713|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829714|NCT04302870|Amantadine|amantadine|mesh-list
83829715|NCT04302870|Memantine|memantine|mesh-list
83829716|NCT04302870|Trazodone|trazodone|mesh-list
83829717|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82985283|NCT02821026|Analgesics|analgesics|mesh-ancestor
83829718|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83829719|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83829720|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
83829721|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829722|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829723|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829724|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83829725|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83829726|NCT04302870|Antiviral Agents|antiviral agents|mesh-ancestor
83829727|NCT04302870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829728|NCT04302870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83829730|NCT04302870|Sensory System Agents|sensory system agents|mesh-ancestor
83829731|NCT04302870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829732|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83829733|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83829734|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829735|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83829736|NCT04302870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83829737|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83829738|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83829739|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
83829740|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83829741|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
83829742|NCT04294628|Trastuzumab|trastuzumab|mesh-list
83829743|NCT04294628|Camptothecin|camptothecin|mesh-list
83829744|NCT04294628|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83829745|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
83829746|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829747|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829748|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
83829749|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829750|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83829751|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829752|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829753|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829754|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829755|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
83829756|NCT04231214|Olodaterol|olodaterol|mesh-list
83829757|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83829758|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
83829759|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829760|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829761|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83829762|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
83829763|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
83829764|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83829765|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
83829766|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829767|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829768|NCT04229095|Suvorexant|suvorexant|mesh-list
83829769|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83829770|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83829771|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829772|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829773|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83829774|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829775|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829776|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
83829777|NCT04164069|Leucovorin|leucovorin|mesh-list
83829778|NCT04164069|Folic Acid|folic acid|mesh-list
83829779|NCT04164069|Bevacizumab|bevacizumab|mesh-list
83829780|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83829781|NCT04164069|Fluorouracil|fluorouracil|mesh-list
83829782|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
83829783|NCT04164069|Dasatinib|dasatinib|mesh-list
83829784|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
83829785|NCT04164069|Antibodies|antibodies|mesh-list
83829786|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
83829787|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83829788|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
83829789|NCT04164069|Calcium|calcium|mesh-list
83829790|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
83829791|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829792|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83829793|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83829794|NCT04164069|Growth Substances|growth substances|mesh-ancestor
83829795|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829796|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
83829797|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
83829798|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83829799|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83829800|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
83829801|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829802|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83829803|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829804|NCT04164069|Antidotes|antidotes|mesh-ancestor
83829805|NCT04164069|Protective Agents|protective agents|mesh-ancestor
83829806|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
83829807|NCT04164069|Vitamins|vitamins|mesh-ancestor
83829808|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
83829809|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83829810|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829811|NCT04164069|Hematinics|hematinics|mesh-ancestor
83829812|NCT04098744|Artesunate|artesunate|mesh-list
83829813|NCT04098744|Artemisinins|artemisinins|mesh-list
83829814|NCT04098744|Artemisinin|artemisinin|mesh-list
83829815|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
83829816|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83829817|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83829818|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829819|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829820|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
83829821|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
83829822|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83829823|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
83829824|NCT04088604|Fluorouracil|fluorouracil|mesh-list
83829825|NCT04088604|Irinotecan|irinotecan|mesh-list
83829826|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
83829827|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829828|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83829829|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829830|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829831|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
83829832|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829833|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829834|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829835|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829836|NCT04078152|Durvalumab|durvalumab|mesh-list
83829837|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829838|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829839|NCT04036435|Deucravacitinib|deucravacitinib|mesh-list
83829840|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83829841|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83829842|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829843|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829844|NCT04006288|Aspirin|aspirin|mesh-list
83829845|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
83829846|NCT04006288|Clopidogrel|clopidogrel|mesh-list
83829847|NCT04006288|Ticagrelor|ticagrelor|mesh-list
83829848|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83829849|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83829850|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83829851|NCT04006288|Analgesics|analgesics|mesh-ancestor
83829852|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
83829853|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829854|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829855|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829856|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83829857|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83829858|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83829859|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829860|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83829861|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83829862|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829863|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
83829864|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83829865|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83829866|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83829867|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
83829868|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829869|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83829870|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
83829871|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83829872|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
83829873|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
83829874|NCT03979131|Avelumab|avelumab|mesh-list
83829875|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829876|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829877|NCT03958045|Nivolumab|nivolumab|mesh-list
83829878|NCT03958045|Rucaparib|rucaparib|mesh-list
83829879|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829880|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829881|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829882|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829883|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83829884|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829885|NCT03956680|Nivolumab|nivolumab|mesh-list
83829886|NCT03956680|Ipilimumab|ipilimumab|mesh-list
83829887|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829888|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829889|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829890|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829891|NCT03952273|Sirolimus|sirolimus|mesh-list
83829892|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83829893|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829894|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83829895|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829896|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
83829897|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83829898|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
83829899|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829900|NCT03947827|Minocycline|minocycline|mesh-list
83829901|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83829902|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829903|NCT03927989|Nicotine|nicotine|mesh-list
83829904|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83829905|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
83829906|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829907|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829908|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83829909|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83829910|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
83829911|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83829912|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829913|NCT03923725|Artesunate|artesunate|mesh-list
83829914|NCT03923725|Lumefantrine|lumefantrine|mesh-list
83829915|NCT03923725|Artemether|artemether|mesh-list
83829916|NCT03923725|Piperaquine|piperaquine|mesh-list
83829917|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83829918|NCT03923725|Amodiaquine|amodiaquine|mesh-list
83829919|NCT03923725|Mefloquine|mefloquine|mesh-list
83829920|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
83829921|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83829922|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83829923|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829924|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829925|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
83829926|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
83829927|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83829928|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
83829929|NCT03914300|Nivolumab|nivolumab|mesh-list
83829930|NCT03914300|Ipilimumab|ipilimumab|mesh-list
83829931|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829932|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829933|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829934|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829935|NCT03896503|Topotecan|topotecan|mesh-list
83829936|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83829937|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83829938|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829939|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829940|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829941|NCT03880019|Temozolomide|temozolomide|mesh-list
83829942|NCT03880019|Olaparib|olaparib|mesh-list
83829943|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83829944|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83829945|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
83829946|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829947|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829948|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829949|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
83829950|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83829951|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83829952|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829953|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83829954|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829955|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83829956|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
83829957|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83829958|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829959|NCT03854474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83829960|NCT03854474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829961|NCT03843645|Anesthetics|anesthetics|mesh-list
83829962|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83829963|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829965|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829966|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83829967|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
83829968|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83829969|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829970|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83829971|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
83829972|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
83829973|NCT03803787|Hormones|hormones|mesh-ancestor
83829974|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829975|NCT03765788|Prednisolone|prednisolone|mesh-list
83829976|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83829977|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
83829978|NCT03765788|Hormones|hormones|mesh-ancestor
83829979|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83829980|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829981|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83829982|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83829983|NCT03728881|Vaccines|vaccines|mesh-list
83829984|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
83829985|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83829986|NCT03711253|Tenofovir|tenofovir|mesh-list
83829987|NCT03711253|Emtricitabine|emtricitabine|mesh-list
83829988|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
83829989|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83829990|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83829991|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83829992|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83829993|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83829994|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83829995|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83829996|NCT03643822|Dexamethasone|dexamethasone|mesh-list
83829997|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
83829998|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
83829999|NCT03643822|BB 1101|bb 1101|mesh-list
83830000|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830001|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
83830002|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
83830003|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830004|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830005|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830006|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
83830007|NCT03643822|Hormones|hormones|mesh-ancestor
83830008|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830009|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83830010|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830011|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
83830012|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830013|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830014|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83830015|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83830016|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83830017|NCT03643822|Analgesics|analgesics|mesh-ancestor
83830018|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
83830019|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82985571|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830020|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83830021|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83830022|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
83830023|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830024|NCT03641313|Irinotecan|irinotecan|mesh-list
83830025|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83830026|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83830027|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830028|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830029|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830030|NCT03606967|Poly I-C|poly i-c|mesh-list
83830031|NCT03606967|Paclitaxel|paclitaxel|mesh-list
83830032|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83830033|NCT03606967|Carboplatin|carboplatin|mesh-list
83830034|NCT03606967|Gemcitabine|gemcitabine|mesh-list
83830035|NCT03606967|Durvalumab|durvalumab|mesh-list
83830036|NCT03606967|Tremelimumab|tremelimumab|mesh-list
83830037|NCT03606967|Ipilimumab|ipilimumab|mesh-list
83830038|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83830039|NCT03606967|Vaccines|vaccines|mesh-list
83830040|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
83830041|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830042|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
83830043|NCT03606967|Poly ICLC|poly iclc|mesh-list
83830044|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
83830045|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830046|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830047|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830048|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
83830049|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
83830050|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
83830051|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830052|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830053|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
83830054|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830055|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830056|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
83830057|NCT03606967|Laxatives|laxatives|mesh-ancestor
83830058|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830059|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
83830060|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830061|NCT03603964|Guadecitabine|guadecitabine|mesh-list
83830062|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830063|NCT03575000|Bromocriptine|bromocriptine|mesh-list
83830064|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83830065|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83393946|NCT01030653|Voriconazole|voriconazole|mesh-list
83830066|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830067|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830068|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830069|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
83830070|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
83830071|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830072|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830073|NCT03513952|Atezolizumab|atezolizumab|mesh-list
83830074|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830075|NCT03513952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830076|NCT03513952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830077|NCT03513952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830078|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830079|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
83830080|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830081|NCT03502733|Nivolumab|nivolumab|mesh-list
83830082|NCT03502733|Ipilimumab|ipilimumab|mesh-list
83830083|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830084|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830085|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830086|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830087|NCT03498261|Gabapentin|gabapentin|mesh-list
83830088|NCT03498261|Analgesics|analgesics|mesh-ancestor
83830089|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
83830090|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830091|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830092|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
83830093|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83830094|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83830095|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985647|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
83830096|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83830097|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83830098|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83830099|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830100|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830101|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
83830102|NCT03495921|Irinotecan|irinotecan|mesh-list
83830103|NCT03495921|Camptothecin|camptothecin|mesh-list
83830104|NCT03495921|Temozolomide|temozolomide|mesh-list
83830105|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83830106|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83830107|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830108|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830109|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830110|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83830111|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
83830112|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830113|NCT03475186|Ramipril|ramipril|mesh-list
83830114|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83830115|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
83830116|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830117|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830118|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83830119|NCT03456700|Sirolimus|sirolimus|mesh-list
83830120|NCT03456700|Auranofin|auranofin|mesh-list
83830121|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83830122|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830123|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83830124|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830125|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
83830126|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830127|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
83830128|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830129|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83830130|NCT03321643|Rituximab|rituximab|mesh-list
83830131|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83830132|NCT03321643|Atezolizumab|atezolizumab|mesh-list
83830133|NCT03321643|Gemcitabine|gemcitabine|mesh-list
83830134|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
83830135|NCT03321643|Antibodies|antibodies|mesh-list
83830136|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
83830137|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830138|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
83830139|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830140|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830141|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83830142|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830143|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
83830144|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830145|NCT03321643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830146|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83830147|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
83830148|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830149|NCT03278925|Protective Agents|protective agents|mesh-ancestor
83830150|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830151|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83830152|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83830153|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830154|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83830155|NCT03258567|Nivolumab|nivolumab|mesh-list
83830156|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830157|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830158|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830159|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830160|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83830161|NCT03258554|Cetuximab|cetuximab|mesh-list
83830162|NCT03258554|Durvalumab|durvalumab|mesh-list
83830163|NCT03258554|Antibodies|antibodies|mesh-list
83830164|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
83830165|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830166|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
83830167|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
83830168|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830169|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830170|NCT03212274|Olaparib|olaparib|mesh-list
82985723|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83830171|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83830172|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830173|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830174|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830175|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
83830176|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
83830177|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830178|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830179|NCT03191864|Fluticasone|fluticasone|mesh-list
83830181|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830182|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83830183|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
83830184|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830185|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830186|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83830187|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
83830188|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
83830189|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83830190|NCT03141684|Bevacizumab|bevacizumab|mesh-list
83830191|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83830192|NCT03141684|Atezolizumab|atezolizumab|mesh-list
83830193|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
83830194|NCT03141684|Antibodies|antibodies|mesh-list
83830195|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
83830196|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830197|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
83830198|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830199|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83830200|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83830201|NCT03141684|Growth Substances|growth substances|mesh-ancestor
83830202|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830203|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83830204|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
83830205|NCT03141684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830206|NCT03141684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830207|NCT03123978|Niclosamide|niclosamide|mesh-list
83830208|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
83830209|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83830210|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
83830211|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83830212|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830213|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
83830214|NCT03114072|Methamphetamine|methamphetamine|mesh-list
83830215|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83830216|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830217|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
83830218|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
83830219|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830220|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
83830221|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830222|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830223|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83830224|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83830225|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83830226|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83830227|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83830228|NCT03063619|Tamoxifen|tamoxifen|mesh-list
83830229|NCT03063619|Afimoxifene|afimoxifene|mesh-list
83830230|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83830231|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830232|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830233|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830234|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83830235|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830236|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83830237|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83830238|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83830239|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
83830240|NCT03030378|Interleukin-12|interleukin-12|mesh-list
83830241|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830242|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830243|NCT03030378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830244|NCT03030378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830245|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83830246|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
83830247|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830248|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83830249|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83830250|NCT03030378|Growth Substances|growth substances|mesh-ancestor
83830251|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
83830252|NCT03002103|Paclitaxel|paclitaxel|mesh-list
83830253|NCT03002103|Gemcitabine|gemcitabine|mesh-list
83830254|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830255|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830256|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
83830257|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
83830258|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
83830259|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830260|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830261|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
83830262|NCT02975882|Sirolimus|sirolimus|mesh-list
83830263|NCT02975882|Irinotecan|irinotecan|mesh-list
83830264|NCT02975882|Camptothecin|camptothecin|mesh-list
83830265|NCT02975882|Temozolomide|temozolomide|mesh-list
83830266|NCT02975882|Temsirolimus|temsirolimus|mesh-list
83830267|NCT02975882|MTOR Inhibitors|mtor inhibitors|mesh-list
83830268|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83830269|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83830270|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830271|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830272|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830273|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83830274|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
83830275|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83830276|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830277|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83830278|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
83830279|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830280|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
83830281|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830282|NCT02975882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83830283|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830284|NCT02968810|Simvastatin|simvastatin|mesh-list
83830285|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83830286|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83830287|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
83830288|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830289|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83830290|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83830291|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830292|NCT02935205|Indomethacin|indomethacin|mesh-list
83830293|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83830294|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83830295|NCT02935205|Analgesics|analgesics|mesh-ancestor
83830296|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
83830297|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830298|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830299|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830300|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83830301|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
83830302|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
83830303|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83830304|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83830305|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830306|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830307|NCT02898207|Olaparib|olaparib|mesh-list
83830308|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83830309|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830310|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830311|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830312|NCT02862275|Atezolizumab|atezolizumab|mesh-list
83830313|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830314|NCT02862275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830315|NCT02862275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830316|NCT02862275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82985875|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83830317|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830318|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
83830319|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830320|NCT02849496|Atezolizumab|atezolizumab|mesh-list
83830321|NCT02849496|Olaparib|olaparib|mesh-list
83830322|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83830323|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830324|NCT02849496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830325|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830326|NCT02849496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830327|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830328|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830329|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
83830330|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830331|NCT02807805|Niclosamide|niclosamide|mesh-list
83830332|NCT02807805|Prednisone|prednisone|mesh-list
83830333|NCT02807805|Cortisone|cortisone|mesh-list
83830334|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
83830335|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830336|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
83830337|NCT02807805|Hormones|hormones|mesh-ancestor
83830338|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830339|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830340|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83830341|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830342|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83830343|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830344|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830345|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830346|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83830347|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
83830348|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83830349|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
83830350|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83830351|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830352|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
83830353|NCT02737046|Interferons|interferons|mesh-list
83830354|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
83830355|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
83830356|NCT02737046|Zidovudine|zidovudine|mesh-list
83830357|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83830358|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83830359|NCT02737046|Belinostat|belinostat|mesh-list
83830360|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830361|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
83830362|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830363|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
83830364|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830365|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
83830366|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830367|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83830368|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83830369|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830370|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83830371|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83830372|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83830373|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
83830374|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83830375|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
83830376|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830377|NCT02682485|Metronidazole|metronidazole|mesh-list
83830378|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
83830379|NCT02682485|Neomycin|neomycin|mesh-list
83830380|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830381|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83830382|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83830383|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83830384|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83830385|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83830386|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830387|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830388|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830389|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82985948|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83830390|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83830391|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83830392|NCT02649790|Dexamethasone|dexamethasone|mesh-list
83830393|NCT02649790|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83830394|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830395|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
83830396|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
83830397|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830398|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830399|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830400|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
83830401|NCT02649790|Hormones|hormones|mesh-ancestor
83830402|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830403|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83830404|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830405|NCT02649790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830406|NCT02649790|Antimetabolites|antimetabolites|mesh-ancestor
83830407|NCT02649790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830408|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
83830409|NCT02636725|Axitinib|axitinib|mesh-list
83830410|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830411|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830412|NCT02636725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830413|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830414|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83830415|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830416|NCT02631733|Irinotecan|irinotecan|mesh-list
83830417|NCT02631733|Veliparib|veliparib|mesh-list
83830418|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83830419|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83830420|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83830421|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830422|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830423|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830424|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83830425|NCT02631733|Hematinics|hematinics|mesh-ancestor
83830426|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83830427|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83830428|NCT02595866|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83830429|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
83830430|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830431|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830432|NCT02595866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830433|NCT02595866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830434|NCT02595866|Antiviral Agents|antiviral agents|mesh-ancestor
83830435|NCT02595866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830436|NCT02573493|Paclitaxel|paclitaxel|mesh-list
83830437|NCT02573493|Cisplatin|cisplatin|mesh-list
83830438|NCT02573493|Cetuximab|cetuximab|mesh-list
83830439|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830440|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830441|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
83830442|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
83830443|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
83830444|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830445|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830446|NCT02521493|Cytarabine|cytarabine|mesh-list
83830447|NCT02521493|Etoposide|etoposide|mesh-list
83830448|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
83830449|NCT02521493|Daunorubicin|daunorubicin|mesh-list
83830450|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
83830451|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
83830452|NCT02521493|Asparaginase|asparaginase|mesh-list
83830453|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
83830454|NCT02521493|Thioguanine|thioguanine|mesh-list
83830455|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
83830456|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830457|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830458|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83830459|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83830460|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830461|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830462|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830463|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
83830464|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
83830465|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830466|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830467|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
82986022|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830468|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830469|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83830470|NCT02521493|Analgesics|analgesics|mesh-ancestor
83830471|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
83830472|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830473|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83830474|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
83830475|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
83830476|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
83830477|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
83830478|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
83830479|NCT02502266|Paclitaxel|paclitaxel|mesh-list
83830480|NCT02502266|Doxorubicin|doxorubicin|mesh-list
83830481|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83830482|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83830483|NCT02502266|Topotecan|topotecan|mesh-list
83830484|NCT02502266|Olaparib|olaparib|mesh-list
83830485|NCT02502266|Cediranib|cediranib|mesh-list
83830486|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83830487|NCT02502266|Maleic acid|maleic acid|mesh-list
83830488|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830489|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830490|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
83830491|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
83830492|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
83830493|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830494|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83830495|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83830496|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83830497|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830498|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83830499|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83830500|NCT02498613|Misonidazole|misonidazole|mesh-list
83830501|NCT02498613|Olaparib|olaparib|mesh-list
83830502|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83830503|NCT02498613|Cediranib|cediranib|mesh-list
83830504|NCT02498613|Maleic acid|maleic acid|mesh-list
83830505|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830506|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830507|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830508|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83830509|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83830510|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83830511|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830512|NCT02496208|Nivolumab|nivolumab|mesh-list
83830513|NCT02496208|Ipilimumab|ipilimumab|mesh-list
83830514|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830515|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830516|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830517|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830518|NCT02465268|Molgramostim|molgramostim|mesh-list
83830519|NCT02465268|Sargramostim|sargramostim|mesh-list
83830520|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
83830521|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830522|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830523|NCT02408861|Nivolumab|nivolumab|mesh-list
83830524|NCT02408861|Ipilimumab|ipilimumab|mesh-list
83830525|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830526|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830527|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830528|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830529|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
83830530|NCT02394834|Leucovorin|leucovorin|mesh-list
83830531|NCT02394834|Bevacizumab|bevacizumab|mesh-list
83830532|NCT02394834|Panitumumab|panitumumab|mesh-list
83830533|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
83830534|NCT02394834|Fluorouracil|fluorouracil|mesh-list
83830535|NCT02394834|Calcium|calcium|mesh-list
83830536|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
83830537|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830538|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830539|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83830540|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83830541|NCT02394834|Growth Substances|growth substances|mesh-ancestor
82986097|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83830542|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830543|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
83830544|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83830545|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83830547|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830548|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830549|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830550|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
83830551|NCT02394834|Antidotes|antidotes|mesh-ancestor
83830552|NCT02394834|Protective Agents|protective agents|mesh-ancestor
83830553|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
83830554|NCT02394834|Vitamins|vitamins|mesh-ancestor
83830555|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
83830556|NCT02392429|Cytarabine|cytarabine|mesh-list
83830557|NCT02392429|Alovudine|alovudine|mesh-list
83830558|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830559|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
83830560|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830561|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830562|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
83830563|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830564|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830565|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
83830566|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830567|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
83830568|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830569|NCT02381535|Cisplatin|cisplatin|mesh-list
83830570|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830571|NCT02327078|Nivolumab|nivolumab|mesh-list
83830572|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830573|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830574|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830575|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830576|NCT02314169|Nivolumab|nivolumab|mesh-list
83830577|NCT02314169|Ipilimumab|ipilimumab|mesh-list
83830578|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830579|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830580|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830581|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830582|NCT02304458|Nivolumab|nivolumab|mesh-list
83830583|NCT02304458|Ipilimumab|ipilimumab|mesh-list
83830584|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830585|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830586|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830587|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830588|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
83830589|NCT02298959|Aflibercept|aflibercept|mesh-list
83830590|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
83830591|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83830592|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830593|NCT02298959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83830594|NCT02298959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830595|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83830596|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83830597|NCT02298959|Growth Substances|growth substances|mesh-ancestor
83830598|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830599|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
83830600|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
83830601|NCT02219373|Gabapentin|gabapentin|mesh-list
83830602|NCT02219373|Analgesics|analgesics|mesh-ancestor
83830603|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
83830604|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830605|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830606|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
83830607|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83830608|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83830609|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83830610|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83830611|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83830612|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83830613|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830614|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830615|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
83830616|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83830617|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83830618|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83830619|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83830620|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83830621|NCT02208375|Olaparib|olaparib|mesh-list
83830622|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83830623|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830624|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830625|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830626|NCT02187224|Progesterone|progesterone|mesh-list
83830627|NCT02187224|Progestins|progestins|mesh-ancestor
83830628|NCT02187224|Hormones|hormones|mesh-ancestor
83830629|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830630|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830631|NCT02159066|Infigratinib|infigratinib|mesh-list
83830632|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830633|NCT02099825|Cycloserine|cycloserine|mesh-list
83830634|NCT02099825|Mifepristone|mifepristone|mesh-list
83830635|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83830636|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
83830637|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83830638|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830639|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83830640|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83830641|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83830642|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
83830643|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83830644|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83830645|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830646|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830647|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
83830648|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83830649|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83830650|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83830651|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830652|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83830653|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
83830654|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83830655|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
83830656|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830657|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
83830658|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83830659|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83830660|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830661|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
83830662|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
83830663|NCT02032823|Olaparib|olaparib|mesh-list
83830664|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83830665|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830666|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830667|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830668|NCT01958021|Letrozole|letrozole|mesh-list
83830669|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830670|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83830671|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83830672|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830673|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830674|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83830675|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830676|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830677|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830678|NCT01946477|Dexamethasone|dexamethasone|mesh-list
83830679|NCT01946477|Daratumumab|daratumumab|mesh-list
83830680|NCT01946477|Pomalidomide|pomalidomide|mesh-list
83830681|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830682|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
83830683|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
83830684|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830685|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830686|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830687|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
83830688|NCT01946477|Hormones|hormones|mesh-ancestor
83830689|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830690|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83830691|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830693|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83830694|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83830695|NCT01946477|Growth Substances|growth substances|mesh-ancestor
83830696|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
83830697|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
83830698|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830699|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83830700|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830701|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830702|NCT00856947|Vitamin D|vitamin d|mesh-list
83830703|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
83830704|NCT00856947|Vitamins|vitamins|mesh-ancestor
83830705|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
83830706|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830707|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83830708|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83830709|NCT00655993|Simvastatin|simvastatin|mesh-list
83830710|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83830711|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83830712|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
83830713|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830714|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83830715|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83830716|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830717|NCT00567580|Leuprolide|leuprolide|mesh-list
83830718|NCT00567580|Goserelin|goserelin|mesh-list
83830719|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83830720|NCT00567580|Flutamide|flutamide|mesh-list
83830721|NCT00567580|Bicalutamide|bicalutamide|mesh-list
83830722|NCT00567580|Buserelin|buserelin|mesh-list
83830723|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83830724|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
83830725|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83830726|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830727|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83830728|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830729|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
83830730|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830731|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830732|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
83830733|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83830734|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
83830735|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83830736|NCT00268385|Temozolomide|temozolomide|mesh-list
83830737|NCT00268385|Vorinostat|vorinostat|mesh-list
83830738|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83830739|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
83830740|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830741|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830742|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83830743|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830744|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83830745|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83830746|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830747|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
83830748|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830749|NCT00087815|Dexamethasone|dexamethasone|mesh-list
83830750|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830751|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
83830752|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
83830753|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830754|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830755|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830756|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
83830757|NCT00087815|Hormones|hormones|mesh-ancestor
83830758|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830759|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83830760|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830761|NCT00087854|Amonafide|amonafide|mesh-list
83830762|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830763|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
83830764|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830765|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986322|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
83830766|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830767|NCT04715620|Niraparib|niraparib|mesh-list
83830768|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83830769|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830770|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830771|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830772|NCT00125229|Mannitol|mannitol|mesh-list
83830773|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83830774|NCT00125229|Diuretics|diuretics|mesh-ancestor
83830775|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
83830776|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830777|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
83830778|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
83830779|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
83830780|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83830781|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83830782|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830783|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83830784|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830785|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830786|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83830787|NCT00088049|Olanzapine|olanzapine|mesh-list
83830788|NCT00088049|Aripiprazole|aripiprazole|mesh-list
83830789|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
83830790|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
83830791|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830792|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830793|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830794|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83830795|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83830796|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83830797|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83830798|NCT00088049|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83830799|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83830800|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83830801|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830802|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830803|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
83830804|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
83830805|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
83830806|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
83830807|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83830808|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83830809|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83830810|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83830811|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83830812|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83830813|NCT00088088|Paclitaxel|paclitaxel|mesh-list
83830814|NCT00088088|Carboplatin|carboplatin|mesh-list
83830815|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830816|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830817|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83830818|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83830819|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83830820|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830821|NCT00125307|Tacrolimus|tacrolimus|mesh-list
83830822|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830823|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
83830824|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830825|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83830826|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986396|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82986397|NCT04238780|Narcotics|narcotics|mesh-ancestor
82986398|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986399|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986400|NCT04238780|Analgesics|analgesics|mesh-ancestor
82986401|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
82986402|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986403|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82986404|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82986405|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
82986406|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
82986407|NCT00944216|Emollients|emollients|mesh-list
83830827|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830828|NCT00127023|Vaccines|vaccines|mesh-list
83830829|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
83830830|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830831|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83830832|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83830833|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83830834|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
83830835|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830836|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83830837|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83830838|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83830839|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83830840|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83830841|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830842|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83830843|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830845|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83830846|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83830847|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
83830848|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830849|NCT00333034|Etanercept|etanercept|mesh-list
83830850|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83830851|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83830852|NCT00333034|Analgesics|analgesics|mesh-ancestor
83830853|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
83830854|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830855|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830856|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83830857|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83830858|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830859|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83830860|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
83830861|NCT00088478|Olanzapine|olanzapine|mesh-list
83830862|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
83830863|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
83830864|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830865|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830866|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830867|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83830868|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83830869|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83830870|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83830871|NCT00088478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83830872|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83830873|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83830874|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830875|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830876|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
83830877|NCT00125346|Tobramycin|tobramycin|mesh-list
83830878|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83830879|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830880|NCT00333112|Tamsulosin|tamsulosin|mesh-list
83830881|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
83830882|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83830883|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83137405|NCT02452762|Vitamin D|vitamin d|mesh-list
83830884|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83830885|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
83830886|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830887|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830888|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830889|NCT00333112|Urological Agents|urological agents|mesh-ancestor
83830890|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83830891|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83830892|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
83830893|NCT00333151|Metformin|metformin|mesh-list
83830894|NCT00333151|Liraglutide|liraglutide|mesh-list
83830895|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
83830896|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83830897|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830898|NCT00333151|Incretins|incretins|mesh-ancestor
83830899|NCT00333151|Hormones|hormones|mesh-ancestor
83830900|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830901|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83830902|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
83830904|NCT00088556|Paclitaxel|paclitaxel|mesh-list
83830905|NCT00088556|Carboplatin|carboplatin|mesh-list
83830906|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83830907|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830908|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
83830909|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
83830910|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
83830911|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830912|NCT00127140|Vorinostat|vorinostat|mesh-list
83830913|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830914|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83830915|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830916|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830917|NCT00333307|Methocarbamol|methocarbamol|mesh-list
83830918|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83830919|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830920|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83830921|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830922|NCT00125424|Midazolam|midazolam|mesh-list
83830923|NCT00125424|Fospropofol|fospropofol|mesh-list
83830924|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83830925|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83830926|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83830927|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830928|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83830929|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83830930|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83830931|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83830932|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
83830933|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
83830934|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
83830935|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
83830936|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830937|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830938|NCT00333346|Tramadol|tramadol|mesh-list
83830939|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83830940|NCT00333346|Narcotics|narcotics|mesh-ancestor
83830941|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83830942|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830943|NCT00333346|Analgesics|analgesics|mesh-ancestor
83830944|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
83830945|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830946|NCT00333385|Ceftazidime|ceftazidime|mesh-list
83830947|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83830948|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83830949|NCT00127257|Diazepam|diazepam|mesh-list
83830950|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83830951|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
83830952|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
83830953|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
83830954|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83830955|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830956|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83830957|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83830958|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83830959|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83830960|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83830961|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83830962|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83830963|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83830964|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83830965|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
83830966|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
83830967|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
83830968|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
83830969|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83830970|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830971|NCT00333424|Vaccines|vaccines|mesh-list
83830972|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
83830973|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830974|NCT00125463|Candesartan|candesartan|mesh-list
83830975|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
83830976|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83830977|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83830978|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83830979|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830980|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83830981|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830982|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83830983|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83830984|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830986|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83830987|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
83830988|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83830989|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
83830990|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83830991|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83830992|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83830993|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83830994|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83830995|NCT00421096|Gemcitabine|gemcitabine|mesh-list
83830996|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83830997|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83830998|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
83830999|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831000|NCT00089063|Sargramostim|sargramostim|mesh-list
83831001|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83831002|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
83831003|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
83831004|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831005|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83831006|NCT00333931|Phenytoin|phenytoin|mesh-list
83831007|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
83831008|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83831009|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83831010|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83831011|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831012|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83831013|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83831014|NCT00334048|Ropinirole|ropinirole|mesh-list
83831015|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83831016|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83831017|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
83831018|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
83831019|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831020|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831021|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831022|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83831023|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83831024|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
83831025|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831026|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83831027|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83831028|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831029|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831030|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83831031|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83831032|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
83831033|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831034|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831035|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83831036|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83831037|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
83831038|NCT00089219|Sargramostim|sargramostim|mesh-list
83831039|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
83831040|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
83831041|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831042|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83831043|NCT00334321|Paclitaxel|paclitaxel|mesh-list
83831044|NCT00334321|Carboplatin|carboplatin|mesh-list
83831045|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83831046|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831047|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
83831048|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
83831049|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
83831050|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831052|NCT00334360|Buspirone|buspirone|mesh-list
83831053|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83831054|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831055|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831056|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83831057|NCT00334360|Analgesics|analgesics|mesh-ancestor
83831058|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
83831059|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831060|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83831061|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83831062|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83831063|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
83831064|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831065|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831066|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83831067|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83831068|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831069|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83831070|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
83831071|NCT00334399|Miglitol|miglitol|mesh-list
83831072|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831073|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831074|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83831075|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831076|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83831077|NCT00334438|Rituximab|rituximab|mesh-list
83831078|NCT00334438|Bortezomib|bortezomib|mesh-list
83831079|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83831080|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831081|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831082|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
83831083|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831084|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831085|NCT00334477|Tadalafil|tadalafil|mesh-list
83831086|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
83831087|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83831088|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83831089|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831090|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831091|NCT00334477|Urological Agents|urological agents|mesh-ancestor
83831092|NCT04715269|Alprazolam|alprazolam|mesh-list
83831093|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83831094|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831095|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831096|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83831097|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83831098|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831099|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
83831100|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
83831101|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831102|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831103|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83831104|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83831105|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831106|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
83831107|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831108|NCT00089258|Isotretinoin|isotretinoin|mesh-list
83831109|NCT00089258|Antibodies|antibodies|mesh-list
83831110|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83831111|NCT00089258|Sargramostim|sargramostim|mesh-list
83831112|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
83831113|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831114|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
83831115|NCT00127569|Rituximab|rituximab|mesh-list
83831116|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831117|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831118|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
83831119|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831120|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831121|NCT00334594|Pemetrexed|pemetrexed|mesh-list
83831122|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831123|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831124|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831125|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83831126|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831127|NCT00334672|Cyclosporine|cyclosporine|mesh-list
83831128|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
83831129|NCT00334672|Dexamethasone|dexamethasone|mesh-list
83831130|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
83831131|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83831132|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83831133|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83831134|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
83831135|NCT00334672|Busulfan|busulfan|mesh-list
83831136|NCT00334672|Methotrexate|methotrexate|mesh-list
83831137|NCT00334672|Etoposide|etoposide|mesh-list
83831138|NCT00334672|Cyclosporins|cyclosporins|mesh-list
83831139|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83831140|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831141|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
83831142|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831143|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831144|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83831145|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
83831146|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831147|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831148|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83831149|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831150|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
83831151|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
83831152|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831153|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831154|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
83831155|NCT00334672|Hormones|hormones|mesh-ancestor
83831156|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831157|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83831158|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83831159|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
83831160|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83831161|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83831162|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
83831163|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
83831164|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831165|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83831166|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831167|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83831168|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83831169|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83831170|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
83831171|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831172|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83831173|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831174|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83831175|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
83831176|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83831177|NCT00089453|Dexamethasone|dexamethasone|mesh-list
83831178|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
83831179|NCT00089453|Melphalan|melphalan|mesh-list
83831180|NCT00089453|Fludarabine|fludarabine|mesh-list
83831181|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831182|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
83831183|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831184|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831185|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83831186|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
83831187|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831188|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831189|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83831190|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831191|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
83831192|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
83831193|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831194|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831195|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
83831196|NCT00089453|Hormones|hormones|mesh-ancestor
83831197|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831198|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83831199|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
83831200|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83831201|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83831202|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831203|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83831204|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83831205|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
83831206|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831207|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
83831208|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
83831209|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
83831210|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83831211|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83831212|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831213|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831214|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831215|NCT00334789|Vitamin A|vitamin a|mesh-list
83831216|NCT00334789|Tretinoin|tretinoin|mesh-list
83831217|NCT00334789|Belinostat|belinostat|mesh-list
83831218|NCT00334789|Isotretinoin|isotretinoin|mesh-list
83831219|NCT00334789|Vitamins|vitamins|mesh-ancestor
83831220|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
83831221|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831222|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831223|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
83831224|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
83831225|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831226|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83831227|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831228|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
83831229|NCT00334867|Ifosfamide|ifosfamide|mesh-list
83831230|NCT00334867|Doxorubicin|doxorubicin|mesh-list
83831231|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83831232|NCT00334867|Etoposide|etoposide|mesh-list
83831233|NCT00334867|Vincristine|vincristine|mesh-list
83831234|NCT00334867|Topotecan|topotecan|mesh-list
83831235|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
83831236|NCT00334867|Razoxane|razoxane|mesh-list
83831237|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831238|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
83831239|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831240|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831241|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83831242|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
83831243|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831244|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831245|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83831246|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831247|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83831248|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83831249|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831250|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83831251|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
83831252|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
83831253|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
83831254|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83831255|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83831256|NCT00334867|Protective Agents|protective agents|mesh-ancestor
83831257|NCT04715152|Dexamethasone|dexamethasone|mesh-list
83831258|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
83831259|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
83831260|NCT04715152|BB 1101|bb 1101|mesh-list
83831261|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831262|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
83831263|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
83831264|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831265|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831266|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831267|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
83831268|NCT04715152|Hormones|hormones|mesh-ancestor
83831269|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831270|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83831271|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831272|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
83831273|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831274|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831275|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
83831276|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
83831277|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831278|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
83831279|NCT00334906|Memantine|memantine|mesh-list
83831280|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83831281|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83831282|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
83831283|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831284|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831285|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831286|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83831287|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83831288|NCT00089570|Terlipressin|terlipressin|mesh-list
83831289|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83831290|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83831291|NCT00342862|Alefacept|alefacept|mesh-list
83831292|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
83831293|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
83831294|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831295|NCT00089687|Vanoxerine|vanoxerine|mesh-list
83831296|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83831297|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83831298|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83831299|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831300|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
83831301|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831302|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831303|NCT00127764|Dexamethasone|dexamethasone|mesh-list
83831304|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831305|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
83831306|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
83831307|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831308|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831309|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831310|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
83831311|NCT00127764|Hormones|hormones|mesh-ancestor
83831312|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831313|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83831314|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831315|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
83831316|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831317|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
83831318|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831319|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831320|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83831321|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
83831322|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831323|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831324|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83831325|NCT00343096|Lorazepam|lorazepam|mesh-list
83831326|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
83831327|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
83831328|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
83831329|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831330|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831331|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831332|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83831333|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831334|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83831335|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83831336|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831337|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
83831338|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
83831339|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831340|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831341|NCT00335179|Imiquimod|imiquimod|mesh-list
83831342|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83831343|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
83831344|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831345|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831346|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
83831347|NCT00089765|Ranibizumab|ranibizumab|mesh-list
83831348|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83831349|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83831350|NCT00089765|Growth Substances|growth substances|mesh-ancestor
83831351|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831352|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
83831353|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831354|NCT00343135|Amoxicillin|amoxicillin|mesh-list
83831355|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
83831356|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
83831357|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83831358|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83831359|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831360|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83831361|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831362|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831363|NCT00343174|Ancrod|ancrod|mesh-list
83831364|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
83831365|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83831366|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83831367|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831368|NCT00343369|Cytarabine|cytarabine|mesh-list
83831369|NCT00343369|Dexamethasone|dexamethasone|mesh-list
83831370|NCT00343369|Prednisolone|prednisolone|mesh-list
83831371|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
83831372|NCT00343369|Doxorubicin|doxorubicin|mesh-list
83831373|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83831374|NCT00343369|Methotrexate|methotrexate|mesh-list
83831375|NCT00343369|Vincristine|vincristine|mesh-list
83831376|NCT00343369|Daunorubicin|daunorubicin|mesh-list
83831377|NCT00343369|Asparaginase|asparaginase|mesh-list
83831378|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
83831379|NCT00343369|Pegaspargase|pegaspargase|mesh-list
83831380|NCT00343369|Thioguanine|thioguanine|mesh-list
83831381|NCT00343369|Teniposide|teniposide|mesh-list
83831382|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831383|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
83831384|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831385|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831386|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83831387|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
83831388|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831389|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831390|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83831391|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831392|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
83831393|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
83831394|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831395|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831396|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
83831397|NCT00343369|Hormones|hormones|mesh-ancestor
83831398|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831399|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83831400|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831401|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83831402|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83831403|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831404|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83831405|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
83831406|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83831407|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83831408|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
83831409|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
83831410|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83831411|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831412|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
83831413|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831414|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83831415|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83831416|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83831417|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83831418|NCT00343408|Leucovorin|leucovorin|mesh-list
83831419|NCT00343408|Gemcitabine|gemcitabine|mesh-list
83831420|NCT00343408|Fluorouracil|fluorouracil|mesh-list
83831421|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
83831422|NCT00343408|Cediranib|cediranib|mesh-list
83831423|NCT00343408|Calcium|calcium|mesh-list
83831424|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
83831425|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831426|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83831427|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
83831428|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986982|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83831429|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83831430|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831431|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831432|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
83831433|NCT00343408|Antidotes|antidotes|mesh-ancestor
83831434|NCT00343408|Protective Agents|protective agents|mesh-ancestor
83831435|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
83831436|NCT00343408|Vitamins|vitamins|mesh-ancestor
83831437|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
83831438|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831439|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83831440|NCT02958111|Capecitabine|capecitabine|mesh-list
83831441|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83831442|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
83831443|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831444|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831445|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
83831446|NCT00343447|Rituximab|rituximab|mesh-list
83831447|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831448|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
83831449|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831450|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831451|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83831452|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
83831453|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831454|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831455|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83831456|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831457|NCT00343486|Solabegron|solabegron|mesh-list
83394441|NCT04730531|Epinephrine|epinephrine|mesh-list
83831458|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83831459|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83831460|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83831461|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
83831462|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831463|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831464|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831465|NCT00089804|Abetimus|abetimus|mesh-list
83831466|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831467|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
83831468|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831469|NCT00343525|Bavituximab|bavituximab|mesh-list
83831470|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831471|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831472|NCT00127881|Zanolimumab|zanolimumab|mesh-list
83831473|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831474|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831475|NCT00343720|Bortezomib|bortezomib|mesh-list
83831476|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831477|NCT00343759|Lapatinib|lapatinib|mesh-list
83831478|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831479|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83831480|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831481|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831482|NCT00127920|Bevacizumab|bevacizumab|mesh-list
83831483|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831484|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831485|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83831486|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83831487|NCT00127920|Growth Substances|growth substances|mesh-ancestor
83831488|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831489|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
83831490|NCT00343798|Cyclosporine|cyclosporine|mesh-list
83831491|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
83831492|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
83831493|NCT00343798|Fludarabine|fludarabine|mesh-list
83831494|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
83831495|NCT00343798|Cyclosporins|cyclosporins|mesh-list
83831496|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831497|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
83831498|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831499|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831500|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83831501|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
83831502|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831503|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831504|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83831505|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83831506|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
83831507|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831508|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
83831509|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831510|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83831511|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83831512|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831513|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83831514|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
83831515|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83831516|NCT00343876|Aspirin|aspirin|mesh-list
83831517|NCT00343876|Clopidogrel|clopidogrel|mesh-list
83831518|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83831519|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83831520|NCT00343876|Analgesics|analgesics|mesh-ancestor
83831521|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
83831522|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831523|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831524|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831525|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831526|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83831527|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83831528|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831529|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83831530|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83831531|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831532|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
83831533|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83831534|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83831535|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83831536|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
83831537|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831538|NCT00402636|Sirolimus|sirolimus|mesh-list
83831539|NCT00402636|Temsirolimus|temsirolimus|mesh-list
83831540|NCT00402636|MTOR Inhibitors|mtor inhibitors|mesh-list
83831541|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83831542|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831543|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831544|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831545|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
83831546|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831547|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
83831548|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831549|NCT00402636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83831550|NCT00402636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831551|NCT00402636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831552|NCT00344149|Rituximab|rituximab|mesh-list
83831553|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831554|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831555|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
83831556|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831557|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831558|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
83831559|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83831560|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831561|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831562|NCT00344227|Ranibizumab|ranibizumab|mesh-list
83831563|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83831564|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83831565|NCT00344227|Growth Substances|growth substances|mesh-ancestor
83831566|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831567|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
83831568|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831569|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83831570|NCT00344383|Norgestimate|norgestimate|mesh-list
83831571|NCT00344383|Estradiol|estradiol|mesh-list
83831572|NCT00344383|Estrogens|estrogens|mesh-ancestor
83831573|NCT00344383|Hormones|hormones|mesh-ancestor
83831574|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831575|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831576|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83831577|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
83831578|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83831579|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83831580|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83831581|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83831582|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83831583|NCT00344422|Dexamethasone|dexamethasone|mesh-list
83831584|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
83831585|NCT00344422|Doxorubicin|doxorubicin|mesh-list
83831586|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83831587|NCT00344422|Vincristine|vincristine|mesh-list
83831588|NCT00344422|BB 1101|bb 1101|mesh-list
83831589|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831590|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
83831591|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
83831592|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831593|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831594|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831595|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
83831596|NCT00344422|Hormones|hormones|mesh-ancestor
83831597|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831598|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83831599|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831600|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
83831601|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831602|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831603|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831604|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83831605|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83831606|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83831607|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
83831608|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
83831609|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
83831610|NCT00090038|Rituximab|rituximab|mesh-list
83831611|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831612|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831613|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
83831614|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831615|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831616|NCT00402792|Acetaminophen|acetaminophen|mesh-list
83831617|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83831618|NCT00402792|Hydrocodone|hydrocodone|mesh-list
83831619|NCT00402792|Oxycodone|oxycodone|mesh-list
83831620|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83831621|NCT00402792|Analgesics|analgesics|mesh-ancestor
83831622|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
83831623|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831624|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831625|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
83831626|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83831627|NCT00402792|Narcotics|narcotics|mesh-ancestor
83831628|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831629|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
83831630|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
83831631|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83831632|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831633|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831634|NCT00127959|Tenofovir|tenofovir|mesh-list
83831635|NCT00127959|Emtricitabine|emtricitabine|mesh-list
83831636|NCT00127959|Zidovudine|zidovudine|mesh-list
83831637|NCT00127959|Efavirenz|efavirenz|mesh-list
83831638|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
83831639|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831640|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83831641|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831642|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831643|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831644|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83831645|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83831646|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
83831647|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83831648|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83831649|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83831650|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83831651|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83831652|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83831653|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83831654|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82987210|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83831655|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
83831656|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831657|NCT00344539|Antacids|antacids|mesh-ancestor
83831658|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831659|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831660|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83831661|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83831662|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831663|NCT00344617|Bevacizumab|bevacizumab|mesh-list
83831664|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831665|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831666|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83831667|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83831668|NCT00344617|Growth Substances|growth substances|mesh-ancestor
83831669|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831670|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
83831671|NCT00127998|Artesunate|artesunate|mesh-list
83831672|NCT00127998|Chloroquine|chloroquine|mesh-list
83831673|NCT00127998|Lumefantrine|lumefantrine|mesh-list
83831674|NCT00127998|Artemether|artemether|mesh-list
83831675|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
83831676|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
83831677|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83831678|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83831679|NCT00127998|Amodiaquine|amodiaquine|mesh-list
83831680|NCT00127998|Mefloquine|mefloquine|mesh-list
83831681|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
83831682|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83831683|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83831684|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831685|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831686|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
83831687|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
83831688|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83831689|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
83831690|NCT00127998|Amebicides|amebicides|mesh-ancestor
83831691|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831692|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83831693|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831694|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831695|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83831696|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83831697|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83831698|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83831699|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831700|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831701|NCT00420589|Hormones|hormones|mesh-ancestor
83831702|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831703|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831704|NCT00344695|Bupropion|bupropion|mesh-list
83831705|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83831706|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
83831707|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831708|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83831709|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83831710|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83831711|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831712|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
83831713|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831714|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831715|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83831716|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83831717|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831718|NCT00128037|Mitomycins|mitomycins|mesh-list
83831719|NCT00128037|Mitomycin|mitomycin|mesh-list
83831720|NCT00128037|Vindesine|vindesine|mesh-list
83831721|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831722|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831723|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
83831724|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831725|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831726|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831727|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83831728|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
82987296|NCT02442466|BQ 788|bq 788|mesh-list
83831729|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
83831730|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
83831731|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83831732|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831733|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831734|NCT00344812|Buprenorphine|buprenorphine|mesh-list
83831735|NCT00344812|Methadone|methadone|mesh-list
83831736|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83831737|NCT00344812|Narcotics|narcotics|mesh-ancestor
83831738|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831739|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831740|NCT00344812|Analgesics|analgesics|mesh-ancestor
83831741|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
83831742|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831743|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83831744|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
83831745|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
83831746|NCT00344851|Metformin|metformin|mesh-list
83831747|NCT00344851|Exenatide|exenatide|mesh-list
83831748|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83831749|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831750|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83831751|NCT00344851|Incretins|incretins|mesh-ancestor
83831752|NCT00344851|Hormones|hormones|mesh-ancestor
83831753|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831754|NCT00090155|Ondansetron|ondansetron|mesh-list
83831755|NCT00090155|Aprepitant|aprepitant|mesh-list
83831756|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
83831757|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
83831758|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831759|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831760|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831761|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
83831762|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
83831763|NCT00090155|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83831764|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83831765|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
83831766|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831767|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831768|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83831769|NCT00335413|Spironolactone|spironolactone|mesh-list
83831770|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83831771|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
83831772|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83831773|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831774|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83831775|NCT00335413|Diuretics|diuretics|mesh-ancestor
83831776|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
83831777|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
83831778|NCT00090194|Antibodies|antibodies|mesh-list
83831779|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
83831780|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83831781|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83831782|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
83831783|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831784|NCT00345163|Bevacizumab|bevacizumab|mesh-list
83831785|NCT00345163|Irinotecan|irinotecan|mesh-list
83831786|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831787|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831788|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83831789|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83831790|NCT00345163|Growth Substances|growth substances|mesh-ancestor
83831791|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831792|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
83831793|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83831794|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83831795|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831796|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831797|NCT00345202|Atorvastatin|atorvastatin|mesh-list
83831798|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83831799|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83831800|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
83831801|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831802|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83831803|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83831804|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831805|NCT00335647|Fluphenazine|fluphenazine|mesh-list
83831806|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
83831807|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
83831808|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83831809|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83831810|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831811|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831812|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831813|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83831814|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
83831815|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83831816|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831817|NCT00128154|Chromium|chromium|mesh-list
83831818|NCT00128154|Picolinic acid|picolinic acid|mesh-list
83831819|NCT00128154|Trace Elements|trace elements|mesh-ancestor
83831820|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
83831821|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831822|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83831823|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
83831824|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
83831825|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831826|NCT00335686|Lopinavir|lopinavir|mesh-list
83831827|NCT00335686|Nevirapine|nevirapine|mesh-list
83831828|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83831829|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83831830|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
83831831|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831832|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831833|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83831834|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83831835|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
83831836|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831837|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83831838|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83831839|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83831840|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831841|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83831842|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83831843|NCT00128232|Octreotide|octreotide|mesh-list
83831844|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831845|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83831846|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831847|NCT04708249|Inositol|inositol|mesh-list
83831848|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
83831849|NCT04708249|Vitamins|vitamins|mesh-ancestor
83831850|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
83831851|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831852|NCT00090272|Ertapenem|ertapenem|mesh-list
83831853|NCT00090272|Cefotetan|cefotetan|mesh-list
83831854|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83831855|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831856|NCT00345787|Buprenorphine|buprenorphine|mesh-list
83831857|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83831858|NCT00345787|Narcotics|narcotics|mesh-ancestor
83831859|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831860|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831861|NCT00345787|Analgesics|analgesics|mesh-ancestor
83831862|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
83831863|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831864|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83831865|NCT00128271|Bavituximab|bavituximab|mesh-list
83831866|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831867|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831868|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83831869|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
83831870|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831871|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83831872|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83831873|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831874|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831875|NCT02959762|Vitamins|vitamins|mesh-list
83831876|NCT02959762|Vitamin K|vitamin k|mesh-list
83831877|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
83831878|NCT02959762|Menaquinone 7|menaquinone 7|mesh-list
83831879|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
83831880|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831881|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83831882|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83831883|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831884|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
83831885|NCT02959762|Coagulants|coagulants|mesh-ancestor
83831886|NCT00345826|Dasatinib|dasatinib|mesh-list
83831887|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831888|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83831889|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831890|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831891|NCT00345982|Sertindole|sertindole|mesh-list
83831892|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83831893|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83831894|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83831895|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831896|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83831897|NCT00346099|Capecitabine|capecitabine|mesh-list
83831898|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
83831899|NCT00346099|Panitumumab|panitumumab|mesh-list
83831900|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83831901|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
83831902|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831903|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831904|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831905|NCT00125736|Rabeprazole|rabeprazole|mesh-list
83831906|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83831907|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831908|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83831909|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831910|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831911|NCT00090428|Caseins|caseins|mesh-list
83831912|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
83831913|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
83831914|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831915|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
83831916|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831917|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831918|NCT00346255|Immunotoxins|immunotoxins|mesh-ancestor
83831919|NCT00346255|Immunoconjugates|immunoconjugates|mesh-ancestor
83831920|NCT00346255|Immunologic Factors|immunologic factors|mesh-ancestor
83831921|NCT00346255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831922|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83831923|NCT00346294|Etanercept|etanercept|mesh-list
83831924|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83831925|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83831926|NCT00346294|Analgesics|analgesics|mesh-ancestor
83831927|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
83831928|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83831929|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831930|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83831931|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831932|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83831933|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831934|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
83831935|NCT00346489|Fluorouracil|fluorouracil|mesh-list
83831936|NCT00346489|Mitomycins|mitomycins|mesh-list
83831937|NCT00346489|Mitomycin|mitomycin|mesh-list
83831938|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
83831939|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831940|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83831941|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831942|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83831943|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
83831944|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831945|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83831946|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
83831947|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831948|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831949|NCT00125814|Interferons|interferons|mesh-list
83831950|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
83831951|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
83831952|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831953|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
83831954|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831955|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
83831956|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831957|NCT00346567|Tenofovir|tenofovir|mesh-list
83831958|NCT00346567|Lamivudine|lamivudine|mesh-list
83831959|NCT00346567|Emtricitabine|emtricitabine|mesh-list
83137444|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
83831961|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83831962|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83831963|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
83831964|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831965|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83831966|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831967|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831968|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831969|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83831970|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83831971|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
83831972|NCT00090623|Ranibizumab|ranibizumab|mesh-list
83831973|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83831974|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83831975|NCT00090623|Growth Substances|growth substances|mesh-ancestor
83831976|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831977|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
83831978|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831979|NCT02957994|Tenofovir|tenofovir|mesh-list
83831980|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
83831981|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83831982|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83831983|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83831984|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83831985|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83831986|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83831987|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83831988|NCT00346645|Bortezomib|bortezomib|mesh-list
83831989|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831990|NCT00346684|Rituximab|rituximab|mesh-list
83831991|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83831992|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83831993|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
83831994|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83831995|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83831996|NCT04728932|Simendan|simendan|mesh-list
83831997|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83831998|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
83831999|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83832000|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83832001|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832002|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832003|NCT04728932|Protective Agents|protective agents|mesh-ancestor
83832004|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832005|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83832006|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83832007|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83832008|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83832009|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832010|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832011|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832012|NCT00125892|Analgesics|analgesics|mesh-ancestor
83832013|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
83832014|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832015|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
83832016|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83832017|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
83832018|NCT00346801|Celecoxib|celecoxib|mesh-list
83832019|NCT00346801|Cisplatin|cisplatin|mesh-list
83832020|NCT00346801|Irinotecan|irinotecan|mesh-list
83832021|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832022|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83832023|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83832024|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832025|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832026|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83832027|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832028|NCT00346801|Analgesics|analgesics|mesh-ancestor
83832029|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
83832030|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832031|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832032|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832033|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832034|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83832035|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83832036|NCT00346840|Misoprostol|misoprostol|mesh-list
83832037|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83832038|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
83832039|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83832040|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832041|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83832042|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832043|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
83832044|NCT00346879|PENTA|penta|mesh-list
83832045|NCT00346879|Fondaparinux|fondaparinux|mesh-list
83832046|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83832047|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
83832048|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83832049|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
83832050|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832051|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832052|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
83832053|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83832054|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83832055|NCT00126009|Amisulpride|amisulpride|mesh-list
83832056|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83832057|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83832058|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832059|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832060|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83832061|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83832062|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
83832063|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832064|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832065|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83832066|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
83832067|NCT00346918|Sirolimus|sirolimus|mesh-list
83832068|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832069|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832070|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83832071|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832072|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
83832073|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832074|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
83832075|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832076|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
83832077|NCT00346957|Anecortave|anecortave|mesh-list
83832078|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83832079|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83832080|NCT00346957|Growth Substances|growth substances|mesh-ancestor
83832081|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832082|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
83832083|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832084|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832085|NCT00346996|Insulin|insulin|mesh-list
83832086|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83832087|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
83832088|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
83832089|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
83832090|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
83832091|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83832092|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832093|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
83832094|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832095|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
83832096|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832097|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832098|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83832099|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83832100|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83832101|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83832102|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83832103|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83832104|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832105|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832106|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832107|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832108|NCT00347113|Albendazole|albendazole|mesh-list
83832110|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
83832111|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83832112|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832113|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
83832114|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83832115|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83832116|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
83832117|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
83832118|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
83832119|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832120|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832121|NCT00347152|Valproic Acid|valproic acid|mesh-list
83832122|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
83832123|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832124|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832125|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
83832126|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832127|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832128|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
83832129|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83832130|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832131|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83832132|NCT00090896|Ipilimumab|ipilimumab|mesh-list
83832133|NCT00090896|Antibodies|antibodies|mesh-list
83832134|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83832135|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
83832136|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832137|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832138|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832139|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83832140|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832141|NCT00402558|Aldesleukin|aldesleukin|mesh-list
83832142|NCT00402558|Methotrexate|methotrexate|mesh-list
83832143|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
83832144|NCT00402558|Fludarabine|fludarabine|mesh-list
83832145|NCT00402558|Busulfan|busulfan|mesh-list
83832146|NCT00402558|Interleukin-2|interleukin-2|mesh-list
83832147|NCT00402558|Tacrolimus|tacrolimus|mesh-list
83832148|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
83832149|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83832150|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83832151|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
83832152|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83832153|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832154|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83832155|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
83832156|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832157|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832158|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
83832159|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832160|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83832161|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832162|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
83832163|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832164|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83832165|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
83832166|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832167|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83832168|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
83832169|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83832170|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83832171|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832172|NCT00402558|Analgesics|analgesics|mesh-ancestor
83832173|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
83832174|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832175|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83832176|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83832177|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
83832178|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832179|NCT00347386|Astringents|astringents|mesh-ancestor
83832180|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
83832181|NCT00347425|Olanzapine|olanzapine|mesh-list
83832182|NCT00347425|Risperidone|risperidone|mesh-list
83832183|NCT00347425|Aripiprazole|aripiprazole|mesh-list
82987738|NCT02434822|Vaccines|vaccines|mesh-list
83832184|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83832185|NCT00347425|Ziprasidone|ziprasidone|mesh-list
83832186|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83832187|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
83832188|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832189|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832190|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832191|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83832192|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83832193|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832194|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83832195|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83832196|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
83832197|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
83832198|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
83832199|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832200|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832201|NCT00347425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83832202|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83832203|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83832204|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
83832205|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
83832206|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83832207|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83832208|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83832209|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83832210|NCT00126048|Atorvastatin|atorvastatin|mesh-list
83832211|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83832212|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83832213|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
83832214|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832215|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83832216|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83832217|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832218|NCT00126087|Dopamine|dopamine|mesh-list
83832219|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83832220|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
83832221|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
83832222|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832223|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832224|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
83832225|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832226|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832227|NCT00126087|Protective Agents|protective agents|mesh-ancestor
83832228|NCT00347503|Ketorolac|ketorolac|mesh-list
83832229|NCT00347503|Bromfenac|bromfenac|mesh-list
83832230|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83832231|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832232|NCT00347503|Analgesics|analgesics|mesh-ancestor
83832233|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
83832234|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832235|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832236|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832237|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832238|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83832239|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832240|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832241|NCT00347542|Vitamin D|vitamin d|mesh-list
83832242|NCT00347542|Vitamins|vitamins|mesh-ancestor
83832243|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
83832244|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832245|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83832246|NCT00091052|Sargramostim|sargramostim|mesh-list
83832247|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
83832248|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832249|NCT00347581|Methamphetamine|methamphetamine|mesh-list
83832250|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83832251|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832252|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
83832253|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
83832254|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832255|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
83832256|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832257|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987809|NCT03718507|Narcotics|narcotics|mesh-ancestor
82987812|NCT03718507|Analgesics|analgesics|mesh-ancestor
83832258|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832259|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83832260|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83832261|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83832262|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83832263|NCT00421252|Clopidogrel|clopidogrel|mesh-list
83832264|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83832265|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83832266|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83832267|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83832268|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
83832269|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832270|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832271|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832272|NCT00126204|Doxycycline|doxycycline|mesh-list
83832273|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832274|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832275|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
83832276|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83832277|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83832278|NCT04705402|Mannitol|mannitol|mesh-list
83832279|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83832280|NCT04705402|Diuretics|diuretics|mesh-ancestor
83832281|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
83832282|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832283|NCT00091130|Vaccines|vaccines|mesh-list
83832284|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
83832285|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832286|NCT00126243|Rituximab|rituximab|mesh-list
83832287|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832288|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832289|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
83832290|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832291|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832292|NCT00426439|Chloroquine|chloroquine|mesh-list
83832293|NCT00426439|Lumefantrine|lumefantrine|mesh-list
83832294|NCT00426439|Artemether|artemether|mesh-list
83832295|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83832296|NCT00426439|Amebicides|amebicides|mesh-ancestor
83832297|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83832298|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83832299|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832300|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
83832301|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832302|NCT00426478|Amlodipine|amlodipine|mesh-list
83832303|NCT00426478|Valsartan|valsartan|mesh-list
83832304|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83832305|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83832306|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83832307|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83832308|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832309|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83832310|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832311|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
83832312|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83832313|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83832314|NCT00426478|Diuretics|diuretics|mesh-ancestor
83832315|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
83832316|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83832317|NCT04705519|Paclitaxel|paclitaxel|mesh-list
83832318|NCT04705519|Bevacizumab|bevacizumab|mesh-list
83832319|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83832320|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832321|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
83832322|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
83832323|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
83832324|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832325|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832326|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83832327|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83832328|NCT04705519|Growth Substances|growth substances|mesh-ancestor
82987885|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83832329|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832330|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
83832331|NCT00126282|Cycloserine|cycloserine|mesh-list
83832332|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83832333|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832334|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83832335|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
83832336|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832338|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832339|NCT04705129|Tislelizumab|tislelizumab|mesh-list
83832340|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
83832341|NCT04705129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832342|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832343|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83832344|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832345|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832346|NCT00126321|Cladribine|cladribine|mesh-list
83832347|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832348|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832349|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
83832350|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832351|NCT00426595|Omeprazole|omeprazole|mesh-list
83832352|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83832353|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832354|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83832355|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832356|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832357|NCT00426673|Brivaracetam|brivaracetam|mesh-list
83832358|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
83832359|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83832360|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83832361|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
83832362|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832363|NCT00091247|Tetracycline|tetracycline|mesh-list
83832364|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832365|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832366|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83832367|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832368|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832369|NCT00126360|Anastrozole|anastrozole|mesh-list
83832370|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83832371|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832372|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83832373|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83832374|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832375|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832376|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83832377|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
83832378|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83832379|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832380|NCT01058863|Albuterol|albuterol|mesh-list
83832381|NCT01058863|Procaterol|procaterol|mesh-list
83832382|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83832383|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
83832384|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832385|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832386|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83832387|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
83832388|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
83832389|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83832390|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83832391|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83832392|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83832393|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832394|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832395|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832396|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
83832397|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83832398|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83832399|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
83832400|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832401|NCT00126399|Doxycycline|doxycycline|mesh-list
83832402|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832403|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832404|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
83832405|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83832407|NCT01058395|Minocycline|minocycline|mesh-list
83832408|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832409|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832410|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83832411|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
83832412|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832413|NCT00091325|Protective Agents|protective agents|mesh-ancestor
83832414|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832415|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83832416|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83832417|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832418|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83832419|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
83832420|NCT00126516|Giapreza|giapreza|mesh-list
83832421|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83832422|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
83832423|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83832424|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83832425|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832426|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83832427|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83832428|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
83832429|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83832430|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
83832431|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832432|NCT04050462|Nivolumab|nivolumab|mesh-list
83832433|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832434|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832435|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83832436|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832437|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83832438|NCT01058005|Interferons|interferons|mesh-list
83832439|NCT01058005|Interferon-beta|interferon-beta|mesh-list
83832440|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
83832441|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
83832442|NCT01058005|Natalizumab|natalizumab|mesh-list
83832443|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
83832444|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832445|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
83832446|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832447|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
83832448|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832449|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83832450|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832451|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832452|NCT00091559|Vorinostat|vorinostat|mesh-list
83832453|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832454|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83832455|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832456|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832457|NCT00426829|Bevacizumab|bevacizumab|mesh-list
83832458|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832459|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832460|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83832461|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83832462|NCT00426829|Growth Substances|growth substances|mesh-ancestor
83832463|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832464|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
83832465|NCT00426946|Reboxetine|reboxetine|mesh-list
83832466|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
83832467|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83832468|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83832469|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83832470|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83832471|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832472|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832473|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832474|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832475|NCT00091598|Ambrisentan|ambrisentan|mesh-list
83832476|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83832477|NCT00426985|Ketoprofen|ketoprofen|mesh-list
83832478|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83832479|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832480|NCT00426985|Analgesics|analgesics|mesh-ancestor
83832481|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
83832482|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832483|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832484|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832485|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832486|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83832487|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832488|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832489|NCT00427102|Cisplatin|cisplatin|mesh-list
83832490|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832491|NCT00427414|Daunorubicin|daunorubicin|mesh-list
83832492|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832493|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83832494|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832495|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83832496|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83832497|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832498|NCT03929718|Spironolactone|spironolactone|mesh-list
83832499|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83832500|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
83832501|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83832502|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832503|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83832504|NCT03929718|Diuretics|diuretics|mesh-ancestor
83832505|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
83832506|NCT01056523|Cytarabine|cytarabine|mesh-list
83832507|NCT01056523|Ribavirin|ribavirin|mesh-list
83832508|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83832509|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
83832510|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832511|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832512|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
83832513|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832514|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832515|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
83832516|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832517|NCT00091715|Bosentan|bosentan|mesh-list
83832518|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83832519|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83832520|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832521|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
83832522|NCT00427492|Antacids|antacids|mesh-ancestor
83832523|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832524|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832525|NCT00427570|Fluorouracil|fluorouracil|mesh-list
83832526|NCT00427570|Vincristine|vincristine|mesh-list
83832527|NCT00427570|Semustine|semustine|mesh-list
83832528|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
83832529|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
83832530|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832531|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83832532|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832533|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832534|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
83832535|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832536|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83832537|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
83832538|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
83832539|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
83832540|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83832541|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83832542|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
83832543|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83832544|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832545|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832546|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
83832547|NCT00091910|Hematinics|hematinics|mesh-ancestor
83832548|NCT00427882|Alfuzosin|alfuzosin|mesh-list
83832549|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83832550|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83832551|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83832552|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832553|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832554|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832555|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832556|NCT00427882|Urological Agents|urological agents|mesh-ancestor
83832558|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
83832559|NCT04704622|Ketamine|ketamine|mesh-list
83832560|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83832561|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832562|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832563|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832564|NCT04704622|Analgesics|analgesics|mesh-ancestor
83832565|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
83832566|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832567|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83832568|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83832569|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83832570|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832571|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832572|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832573|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83832574|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83832575|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
83832576|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
83832577|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83832578|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83832579|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83832580|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83832581|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83832582|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83832583|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
83832584|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
83832585|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83832586|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832587|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83832588|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832589|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832590|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
83832591|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832592|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832593|NCT03769467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83832594|NCT03769467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832595|NCT00092183|Ondansetron|ondansetron|mesh-list
83832596|NCT00092183|Aprepitant|aprepitant|mesh-list
83832597|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
83832598|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
83832599|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832600|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832601|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832602|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
83832603|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
83832604|NCT00092183|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83832605|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83832606|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
83832607|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832608|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832609|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83832610|NCT00428272|Interferons|interferons|mesh-list
83832611|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
83832612|NCT00428272|Lexatumumab|lexatumumab|mesh-list
83832613|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83832614|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832615|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
83832616|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832617|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
83832618|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832619|NCT01580254|Latanoprost|latanoprost|mesh-list
83832620|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83832621|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83832622|NCT00428311|Metformin|metformin|mesh-list
83832623|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
83832624|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83832625|NCT00428311|Estradiol|estradiol|mesh-list
83832626|NCT00428311|Cyproterone|cyproterone|mesh-list
83832627|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83832628|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988185|NCT03182296|Incretins|incretins|mesh-ancestor
83832629|NCT00428311|Estrogens|estrogens|mesh-ancestor
83832630|NCT00428311|Hormones|hormones|mesh-ancestor
83832631|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83832632|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83832633|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
83832634|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83832635|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83832636|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83832637|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83832638|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
83832639|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
83832640|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832641|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83832643|NCT00092300|Rofecoxib|rofecoxib|mesh-list
83832644|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83832645|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83832646|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832647|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832648|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83832649|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832650|NCT00092300|Analgesics|analgesics|mesh-ancestor
83832651|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
83832652|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832653|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832654|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832655|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832656|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83832657|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
83832658|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83832659|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83832660|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83832661|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832662|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832663|NCT00428428|Isoproterenol|isoproterenol|mesh-list
83832664|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83832665|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83832666|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832667|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832668|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832669|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832670|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83832671|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
83832672|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832673|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83832674|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
83832675|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83832676|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
83832677|NCT00428428|Protective Agents|protective agents|mesh-ancestor
83832678|NCT00092339|Valdecoxib|valdecoxib|mesh-list
83832679|NCT00092339|Rofecoxib|rofecoxib|mesh-list
83832680|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83832681|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83832682|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832683|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832684|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83832685|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832686|NCT00092339|Analgesics|analgesics|mesh-ancestor
83832687|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
83832688|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832689|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832690|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832691|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832692|NCT00428545|Bevacizumab|bevacizumab|mesh-list
83832693|NCT00428545|Bortezomib|bortezomib|mesh-list
83832694|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83832695|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832696|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83832697|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83832698|NCT00428545|Growth Substances|growth substances|mesh-ancestor
83832699|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832700|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
83832701|NCT00092378|Diclofenac|diclofenac|mesh-list
83832702|NCT00092378|Rofecoxib|rofecoxib|mesh-list
83832703|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83832704|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83832705|NCT00092378|Analgesics|analgesics|mesh-ancestor
83832706|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
83832707|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832708|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832709|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832710|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832711|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83832712|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832713|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832714|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83832715|NCT00092846|Lovastatin|lovastatin|mesh-list
83832716|NCT00092846|L 647318|l 647318|mesh-list
83832717|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
83832718|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83832719|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83832720|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
83832721|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832722|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83832723|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83832724|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832725|NCT00092924|Mapatumumab|mapatumumab|mesh-list
83832726|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832727|NCT00093002|Fulvestrant|fulvestrant|mesh-list
83832728|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83832729|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832730|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83832731|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83832732|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
83832733|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83832734|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832735|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83832736|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832737|NCT00093158|Anticoagulants|anticoagulants|mesh-list
83832738|NCT00093158|Bivalirudin|bivalirudin|mesh-list
83832739|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
83832740|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83832741|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
83832742|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832743|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832744|NCT03501498|Loperamide|loperamide|mesh-list
83832745|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
83832746|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832747|NCT05561049|Thalidomide|thalidomide|mesh-list
83832748|NCT05561049|Dexamethasone|dexamethasone|mesh-list
83832749|NCT05561049|Bortezomib|bortezomib|mesh-list
83832750|NCT05561049|Daratumumab|daratumumab|mesh-list
83832751|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832752|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
83832753|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
83832754|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832755|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832756|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832757|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
83832758|NCT05561049|Hormones|hormones|mesh-ancestor
83832759|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83832760|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83832761|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832762|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832763|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
83832764|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
83832765|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832766|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832767|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83832768|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83832769|NCT05561049|Growth Substances|growth substances|mesh-ancestor
83832770|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83832771|NCT00424034|Ambrisentan|ambrisentan|mesh-list
83832772|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83832773|NCT05561010|Bupivacaine|bupivacaine|mesh-list
83832774|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
83832775|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
83832776|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832777|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832778|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
83832779|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832780|NCT03448107|Fluorides|fluorides|mesh-list
83832781|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
83832782|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
83832783|NCT03448107|Protective Agents|protective agents|mesh-ancestor
83832784|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832785|NCT00093314|Ofatumumab|ofatumumab|mesh-list
83832786|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832787|NCT00093353|Cefixime|cefixime|mesh-list
83832788|NCT00093353|Irinotecan|irinotecan|mesh-list
83832789|NCT00093353|Temozolomide|temozolomide|mesh-list
83832790|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83832791|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83832792|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832793|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832794|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832795|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83832796|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
83832797|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832798|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832799|NCT00093509|Doxorubicin|doxorubicin|mesh-list
83832800|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83832801|NCT00093509|Ifosfamide|ifosfamide|mesh-list
83832802|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
83832803|NCT00093509|Mesna|mesna|mesh-list
83832804|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83832805|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832806|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83832807|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83832808|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832809|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832810|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83832811|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
83832812|NCT00093509|Protective Agents|protective agents|mesh-ancestor
83832813|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832814|NCT00093548|Vaccines|vaccines|mesh-list
83832815|NCT00093548|Sargramostim|sargramostim|mesh-list
83832816|NCT00093548|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
83832817|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
83832818|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832819|NCT00093548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83832820|NCT05549895|Dexamethasone|dexamethasone|mesh-list
83832821|NCT05549895|Bupivacaine|bupivacaine|mesh-list
83832822|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83832823|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
83832824|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
83832825|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832826|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832827|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83832828|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
83832829|NCT05549895|Hormones|hormones|mesh-ancestor
83832830|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83832831|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83832832|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832833|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
83832834|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
83832835|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832836|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
83832837|NCT00093587|Cyclosporine|cyclosporine|mesh-list
83832838|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
83832839|NCT00093587|Busulfan|busulfan|mesh-list
83832840|NCT00093587|Cyclosporins|cyclosporins|mesh-list
83832841|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83832842|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832843|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
83832844|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832845|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832846|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83832847|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
83832848|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832849|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832850|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83832851|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832852|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
83832853|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832854|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
83832855|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83832856|NCT00093626|Sorafenib|sorafenib|mesh-list
83832857|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832858|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83832859|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832860|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832861|NCT05543109|Fentanyl|fentanyl|mesh-list
83832862|NCT05543109|Narcotics|narcotics|mesh-list
83832863|NCT05543109|Propofol|propofol|mesh-list
83832864|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83832865|NCT05543109|Ropivacaine|ropivacaine|mesh-list
83832866|NCT05543109|Anesthetics|anesthetics|mesh-list
83832867|NCT05543109|Sevoflurane|sevoflurane|mesh-list
83832868|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
83832869|NCT05543109|Rocuronium|rocuronium|mesh-list
83832870|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83832871|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83832872|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832873|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
83832874|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
83832875|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83832876|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83832877|NCT05543109|Analgesics|analgesics|mesh-ancestor
83832878|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83832879|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83832880|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83832881|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83832882|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83832883|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83832884|NCT00093665|Fluorouracil|fluorouracil|mesh-list
83832885|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832886|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
83832887|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832888|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83832889|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832890|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
83832891|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832892|NCT00093704|Ganciclovir|ganciclovir|mesh-list
83832893|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83832894|NCT00093704|Bortezomib|bortezomib|mesh-list
83832895|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832896|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
83832897|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832898|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83832899|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832900|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832901|NCT01055314|Dactinomycin|dactinomycin|mesh-list
83832902|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
83832903|NCT01055314|Temozolomide|temozolomide|mesh-list
83832904|NCT01055314|Ifosfamide|ifosfamide|mesh-list
83832905|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
83832906|NCT01055314|Doxorubicin|doxorubicin|mesh-list
83832907|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83832908|NCT01055314|Irinotecan|irinotecan|mesh-list
83832909|NCT01055314|Etoposide|etoposide|mesh-list
83832910|NCT01055314|Vincristine|vincristine|mesh-list
83832911|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
83832912|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
83832913|NCT01055314|Camptothecin|camptothecin|mesh-list
83832914|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83832915|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832916|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
83832917|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832918|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832919|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83832920|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
83832921|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832922|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832923|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83832924|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83832925|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83832926|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83832927|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832928|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83832929|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83832930|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
83832931|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
83832932|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
83832933|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
83832934|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
83832935|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832936|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988488|NCT03119610|Oxytocin|oxytocin|mesh-list
83832937|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83832938|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83832939|NCT00093743|Cyclosporine|cyclosporine|mesh-list
83832940|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
83832941|NCT00093743|Fludarabine|fludarabine|mesh-list
83832942|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
83832943|NCT00093743|Cyclosporins|cyclosporins|mesh-list
83832944|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83832945|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83832946|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
83832947|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832948|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83832949|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
83832950|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832951|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832952|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
83832953|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832954|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
83832955|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83832956|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83832957|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83832958|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83832959|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
83832960|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83832961|NCT00400322|Valganciclovir|valganciclovir|mesh-list
83832962|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
83832963|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832964|NCT00093860|Propranolol|propranolol|mesh-list
83832965|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83832966|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83832967|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
83832968|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83832969|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832970|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832971|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83832972|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83832973|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
83832974|NCT00402909|Nateglinide|nateglinide|mesh-list
83832975|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83832976|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83832977|NCT02823366|Fenofibrate|fenofibrate|mesh-list
83832978|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83832979|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
83832980|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832981|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83832982|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
83832983|NCT00093977|Hematinics|hematinics|mesh-ancestor
83832985|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83832986|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83832987|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832988|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832989|NCT00094367|Lamivudine|lamivudine|mesh-list
83832990|NCT00094367|Abacavir|abacavir|mesh-list
83832991|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83832992|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83832993|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83832994|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83832995|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
83832996|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83832997|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83832998|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83832999|NCT00094406|Dimercaprol|dimercaprol|mesh-list
83833000|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
83833001|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
83833002|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
83833003|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833004|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
83833005|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
83833006|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833007|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833008|NCT00094484|Cinacalcet|cinacalcet|mesh-list
83833009|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83833010|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833011|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82988565|NCT01311739|Vitamins|vitamins|mesh-ancestor
83833012|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
83833013|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833014|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
83833015|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83833016|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83833017|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
83833018|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833019|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833020|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83833021|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83833022|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
83833023|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833024|NCT00428701|Esomeprazole|esomeprazole|mesh-list
83833025|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83833026|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833027|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83833028|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833029|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833030|NCT00428818|Doxycycline|doxycycline|mesh-list
83833031|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83833032|NCT00428818|Trimethoprim|trimethoprim|mesh-list
83833033|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
83833034|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83833035|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833036|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
83833037|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83833038|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83833039|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83833040|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83833041|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833042|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833043|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83833044|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83833045|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83833046|NCT00094640|Olanzapine|olanzapine|mesh-list
83833047|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
83833048|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
83833049|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833050|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396045|NCT03236324|Epinephrine|epinephrine|mesh-list
83833051|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833052|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83833053|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83833054|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83833055|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83833056|NCT00094640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83833057|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83833058|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83833059|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833060|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833061|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
83833062|NCT02415309|Melatonin|melatonin|mesh-list
83833063|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
83833064|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833065|NCT02415309|Protective Agents|protective agents|mesh-ancestor
83833066|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833067|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83833068|NCT05393817|Caffeine|caffeine|mesh-list
83833069|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
83833070|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833071|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83833072|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833073|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83833074|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833075|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83833076|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83833077|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
83833078|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833079|NCT00403338|Sirolimus|sirolimus|mesh-list
83833080|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83833081|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833082|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83833083|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833084|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
83833085|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833086|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
83833087|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833088|NCT00095069|Gaboxadol|gaboxadol|mesh-list
83833089|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833090|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833091|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833092|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833093|NCT00095069|Analgesics|analgesics|mesh-ancestor
83833094|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
83833095|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
83833096|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
83833097|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
83833098|NCT00403533|Atorvastatin|atorvastatin|mesh-list
83833099|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83833100|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83833101|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
83833102|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833103|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83833104|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83833105|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833106|NCT00095225|Bevacizumab|bevacizumab|mesh-list
83833107|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83833108|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833109|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833110|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83833111|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83833112|NCT00095225|Growth Substances|growth substances|mesh-ancestor
83833113|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833114|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
83833115|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833116|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833117|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833118|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
83833119|NCT00095264|Hematinics|hematinics|mesh-ancestor
83833120|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
83833121|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
83833122|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833123|NCT00403611|Praziquantel|praziquantel|mesh-list
83833124|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
83833125|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83833126|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833127|NCT00428896|Gefitinib|gefitinib|mesh-list
83833128|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833129|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833130|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833131|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833132|NCT01990911|Diuretics|diuretics|mesh-list
83833133|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
83833134|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833135|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83833136|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83833137|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83833138|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83833139|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833140|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83833141|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833142|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833143|NCT00095459|Bevacizumab|bevacizumab|mesh-list
83833144|NCT00095459|Sorafenib|sorafenib|mesh-list
83833145|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833146|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833147|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83833148|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83833149|NCT00095459|Growth Substances|growth substances|mesh-ancestor
83833150|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833151|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
83833152|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833153|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833154|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833155|NCT00429208|Nicotine|nicotine|mesh-list
83833156|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83833157|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
83833158|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988730|NCT03698630|Hormones|hormones|mesh-ancestor
83833159|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833160|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83833161|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83833162|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
83833163|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833164|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833165|NCT00429247|Trastuzumab|trastuzumab|mesh-list
83833166|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833167|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833168|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
83833169|NCT00095654|Ramipril|ramipril|mesh-list
83833170|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83833171|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833172|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83833173|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
83833174|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833175|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833176|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83833177|NCT00095693|Sorafenib|sorafenib|mesh-list
83833178|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83833179|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833180|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833181|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833182|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833183|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83833184|NCT01054573|Interferons|interferons|mesh-list
83833185|NCT01054573|Ribavirin|ribavirin|mesh-list
83833186|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833187|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
83833188|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833189|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
83833190|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833191|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
83833192|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833193|NCT00429442|Simvastatin|simvastatin|mesh-list
83833194|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83833195|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83833196|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
83833197|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833198|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83833199|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83833200|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833201|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
83833202|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83833203|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
83833204|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833205|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
83833206|NCT00429520|Protective Agents|protective agents|mesh-ancestor
83833207|NCT00429559|Gemcitabine|gemcitabine|mesh-list
83833208|NCT00429559|Topotecan|topotecan|mesh-list
83833209|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833210|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
83833211|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833212|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833213|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83833214|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83833215|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833216|NCT00095810|Aripiprazole|aripiprazole|mesh-list
83833217|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
83833218|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83833219|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83833220|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83833221|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83833222|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833223|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
83833224|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
83833225|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833226|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833227|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83833228|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83833229|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
83833230|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83833231|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82988792|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
82988794|NCT03683108|Protective Agents|protective agents|mesh-ancestor
83833232|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83833233|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83833234|NCT05234112|Acetic Acid|acetic acid|mesh-list
83833235|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83833236|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833237|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
83833238|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83833239|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833240|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83833241|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833242|NCT00095888|Gemcitabine|gemcitabine|mesh-list
83833243|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833244|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
83833245|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833246|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833247|NCT00429676|Haloperidol|haloperidol|mesh-list
83833248|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
83833249|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
83833250|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
83833251|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833252|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833253|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833254|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83833255|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83833256|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83833257|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83833258|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83833259|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
83833260|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833261|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833262|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83833263|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
83833264|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83833265|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
83833266|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833268|NCT00095927|Carboplatin|carboplatin|mesh-list
83833269|NCT00095927|Amifostine|amifostine|mesh-list
83833270|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83833271|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833272|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
83833273|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
83833274|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
83833275|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833276|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83833277|NCT00095927|Protective Agents|protective agents|mesh-ancestor
83833278|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833279|NCT00429754|Aprepitant|aprepitant|mesh-list
83833280|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
83833281|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
83833282|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833283|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833284|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833285|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83833286|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833287|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833288|NCT00429832|Promethazine|promethazine|mesh-list
83833289|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
83833290|NCT00429832|Ondansetron|ondansetron|mesh-list
83833291|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
83833292|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
83833293|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833294|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833295|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833296|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
83833297|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
83833298|NCT00429832|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83833299|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83833300|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
83833301|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833302|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833303|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83833304|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
83833305|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
83833306|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83833307|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83833308|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83833309|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83833310|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
83833311|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
83833312|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
83833314|NCT00429871|Capecitabine|capecitabine|mesh-list
83833315|NCT00429871|Epirubicin|epirubicin|mesh-list
83833316|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833317|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
83833318|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
83833319|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
83833320|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833321|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833322|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
83833323|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83833324|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83833325|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83833326|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833327|NCT00095966|Gemcitabine|gemcitabine|mesh-list
83833328|NCT00095966|Sorafenib|sorafenib|mesh-list
83833329|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833330|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
83833331|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833332|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833333|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833334|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833335|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
83833336|NCT01803594|Niacin|niacin|mesh-list
83833337|NCT01803594|Niacinamide|niacinamide|mesh-list
83833338|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
83833339|NCT01803594|Vitamins|vitamins|mesh-ancestor
83833340|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
83833341|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833342|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83833343|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
83833344|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833345|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83833346|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
83833347|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
83833348|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833349|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833350|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833351|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833352|NCT00096005|Bortezomib|bortezomib|mesh-list
83833353|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833354|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
83833355|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833356|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
83833357|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833358|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833359|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83833360|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
83833361|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833362|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988940|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988941|NCT02877927|Linezolid|linezolid|mesh-list
82988942|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82988943|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988944|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82988945|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988946|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988947|NCT02706886|Lumasiran|lumasiran|mesh-list
82988948|NCT02706886|Renal Agents|renal agents|mesh-ancestor
82988949|NCT02809131|Levofloxacin|levofloxacin|mesh-list
82988950|NCT02809131|Clindamycin|clindamycin|mesh-list
82988951|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
82988952|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
82988953|NCT02809131|Cephalexin|cephalexin|mesh-list
82988954|NCT02809131|Polymyxins|polymyxins|mesh-list
82988955|NCT02809131|Bacitracin|bacitracin|mesh-list
83833363|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83833364|NCT00430144|Belotecan|belotecan|mesh-list
83833365|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82988956|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82988957|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833366|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83833367|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833368|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833369|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833370|NCT00430261|Sunitinib|sunitinib|mesh-list
83833371|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833372|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83833373|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83833374|NCT00430261|Growth Substances|growth substances|mesh-ancestor
83833375|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833376|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
83833377|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833378|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833379|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833380|NCT00096083|Melphalan|melphalan|mesh-list
83833381|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83833382|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
83833383|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833384|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833385|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83833386|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833387|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
83833388|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833389|NCT01726452|Leucovorin|leucovorin|mesh-list
83833390|NCT01726452|Paclitaxel|paclitaxel|mesh-list
83833391|NCT01726452|Docetaxel|docetaxel|mesh-list
83833392|NCT01726452|Carboplatin|carboplatin|mesh-list
83833393|NCT01726452|Fluorouracil|fluorouracil|mesh-list
83833394|NCT01726452|Capecitabine|capecitabine|mesh-list
83833395|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
83833396|NCT01726452|Epirubicin|epirubicin|mesh-list
83833397|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83833398|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833399|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
83833400|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
83833401|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
83833402|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833403|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
83833404|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833405|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833406|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
83833407|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833408|NCT01726452|Antidotes|antidotes|mesh-ancestor
83833409|NCT01726452|Protective Agents|protective agents|mesh-ancestor
83833410|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
83833411|NCT01726452|Vitamins|vitamins|mesh-ancestor
83833412|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
83833413|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83833414|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83833415|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83833416|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833417|NCT00096317|Ketoconazole|ketoconazole|mesh-list
83833418|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
83833419|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833420|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83833421|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83833422|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833423|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833424|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83833425|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
83833426|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833427|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833428|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83833429|NCT00096395|Gemcitabine|gemcitabine|mesh-list
83833430|NCT00096395|Sorafenib|sorafenib|mesh-list
83833431|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833432|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
83833433|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833434|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833435|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833436|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833437|NCT00096434|Sorafenib|sorafenib|mesh-list
83833438|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833439|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833440|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988998|NCT01442649|Cetuximab|cetuximab|mesh-list
83833441|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833442|NCT00096473|Donepezil|donepezil|mesh-list
83833443|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83833444|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833445|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833446|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
83833447|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833448|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833449|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
83833450|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
83833451|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83833452|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833453|NCT00096512|Sorafenib|sorafenib|mesh-list
83833454|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833455|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833456|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833457|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833458|NCT00096551|Metronidazole|metronidazole|mesh-list
83833459|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833460|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83833461|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83833462|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83833463|NCT00095186|Lactoferrin|lactoferrin|mesh-list
83833464|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833465|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
83833466|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83833467|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83833468|NCT00130572|Analgesics|analgesics|mesh-ancestor
83833469|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
83833470|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833471|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833472|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83833473|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833474|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83833475|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833476|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
83833477|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83833478|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833479|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833480|NCT00096629|Vaccines|vaccines|mesh-list
83833481|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
83833482|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833483|NCT00430651|Carboplatin|carboplatin|mesh-list
83833484|NCT00430651|Docetaxel|docetaxel|mesh-list
83833485|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833486|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
83833487|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
83833488|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
83833489|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833490|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
83833491|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
83833492|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83833493|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83833494|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833495|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833496|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833497|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833498|NCT00096668|Paclitaxel|paclitaxel|mesh-list
83833499|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83833500|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833501|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83833502|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83833503|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83833504|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833505|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83833506|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833507|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833508|NCT00430846|Immunotoxins|immunotoxins|mesh-ancestor
83833509|NCT00430846|Immunoconjugates|immunoconjugates|mesh-ancestor
83833510|NCT00430846|Immunologic Factors|immunologic factors|mesh-ancestor
83833511|NCT00430846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833512|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
83833513|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83833514|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
83833515|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83833516|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
83833517|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833519|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83833520|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
83833521|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833522|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833523|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83833524|NCT00430924|Diuretics|diuretics|mesh-ancestor
83833525|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
83833526|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83833527|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
83833528|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
83833529|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833530|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
83833531|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833532|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83833533|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83833534|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833535|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833536|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83833537|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83833538|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833539|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
83833540|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833541|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83833542|NCT05102409|Lifitegrast|lifitegrast|mesh-list
83833543|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83833544|NCT01053247|Tacrolimus|tacrolimus|mesh-list
83833545|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833546|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
83833547|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833548|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83833549|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833550|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833551|NCT00096863|Haloperidol|haloperidol|mesh-list
83833552|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
83833553|NCT00096863|Ziprasidone|ziprasidone|mesh-list
83833554|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
83833555|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
83833556|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833557|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833558|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833559|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83833560|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83833561|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83833562|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83833563|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83833564|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
83833565|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833566|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833567|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83833568|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83833569|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
83833570|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83833571|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83833572|NCT01052779|Hematinics|hematinics|mesh-ancestor
83833573|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83833574|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83833575|NCT00130767|Finasteride|finasteride|mesh-list
83833576|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83833577|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83833578|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833579|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833580|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
83833581|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833582|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833583|NCT00130767|Urological Agents|urological agents|mesh-ancestor
83833584|NCT00431080|Paclitaxel|paclitaxel|mesh-list
83833585|NCT00431080|Docetaxel|docetaxel|mesh-list
83833586|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
83833587|NCT00431080|Epirubicin|epirubicin|mesh-list
83833588|NCT00431080|Fluorouracil|fluorouracil|mesh-list
83833589|NCT00431080|Lenograstim|lenograstim|mesh-list
83833590|NCT00431080|Mitogens|mitogens|mesh-list
83833591|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83833592|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833593|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83833594|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83833595|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83833596|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833597|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833598|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
83833599|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833600|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833601|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83833602|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
83833603|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83833604|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83833605|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83833606|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83833607|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833608|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
83833609|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833610|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83833611|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
83833612|NCT00431119|Azathioprine|azathioprine|mesh-list
83833613|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83833614|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833615|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83833616|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
83833617|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83833618|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833619|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833620|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833621|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
83833622|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833623|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833624|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
83833625|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833626|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833627|NCT00097019|Bevacizumab|bevacizumab|mesh-list
83833628|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833629|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833630|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83833631|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83833632|NCT00097019|Growth Substances|growth substances|mesh-ancestor
83833633|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833634|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
83833635|NCT00431197|Ketoconazole|ketoconazole|mesh-list
83833636|NCT00431197|Testosterone|testosterone|mesh-list
83833637|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
83833638|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833639|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83833640|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83833641|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833642|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833643|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83833644|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
83833645|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833646|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833647|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83833648|NCT00431197|Androgens|androgens|mesh-ancestor
83833649|NCT00431197|Hormones|hormones|mesh-ancestor
83833650|NCT00431236|Dexamethasone|dexamethasone|mesh-list
83833651|NCT00431236|Ondansetron|ondansetron|mesh-list
83833652|NCT00431236|Casopitant|casopitant|mesh-list
83833653|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83833654|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
83833655|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
83833656|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833657|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833658|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833659|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
83833660|NCT00431236|Hormones|hormones|mesh-ancestor
83833661|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833662|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83833663|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833664|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
83833665|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
82989232|NCT03394027|TIC10 compound|tic10 compound|mesh-list
83833666|NCT00431236|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83833667|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83833668|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
83833669|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833670|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833671|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83833672|NCT00431275|Tremelimumab|tremelimumab|mesh-list
83833673|NCT00431275|Ipilimumab|ipilimumab|mesh-list
83833674|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833675|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833676|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83833677|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833678|NCT00431353|Valganciclovir|valganciclovir|mesh-list
83833679|NCT00431353|Ganciclovir|ganciclovir|mesh-list
83833680|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83833681|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
83833682|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833683|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83833684|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833685|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833686|NCT00130845|Octreotide|octreotide|mesh-list
83833687|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833688|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83833689|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833690|NCT00431392|Atropine|atropine|mesh-list
83833691|NCT00431392|Propranolol|propranolol|mesh-list
83833692|NCT00431392|Phenylephrine|phenylephrine|mesh-list
83833693|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
83833694|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83833695|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83833696|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
83833697|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
83833698|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833699|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833700|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
83833701|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83833702|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
83833703|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
83833704|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83833705|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83833706|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83833707|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
83833708|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137509|NCT05728268|Paclitaxel|paclitaxel|mesh-list
83833709|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833710|NCT00431392|Protective Agents|protective agents|mesh-ancestor
83833711|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83833712|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83833713|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83833714|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83833715|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
83833716|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83833717|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83833718|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
83833719|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83833720|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83833721|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83833722|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
83833723|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833724|NCT00130884|Simendan|simendan|mesh-list
83833725|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83833726|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
83833727|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83833728|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83833729|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833730|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833731|NCT00130884|Protective Agents|protective agents|mesh-ancestor
83833732|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833733|NCT01052662|Memantine|memantine|mesh-list
83833734|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83833735|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83833736|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
83833737|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833738|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833739|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833740|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83833741|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83833742|NCT00097214|Carboplatin|carboplatin|mesh-list
83833743|NCT00097214|Cetuximab|cetuximab|mesh-list
83833744|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833745|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833746|NCT05049057|Erenumab|erenumab|mesh-list
83833747|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83833748|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833749|NCT05049057|Analgesics|analgesics|mesh-ancestor
83833750|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
83833751|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833752|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833753|NCT00431665|Heparin|heparin|mesh-list
83833754|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83833755|NCT00431665|Somatostatin|somatostatin|mesh-list
83833756|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83833757|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833758|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
83833759|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83833760|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83833761|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833762|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83833763|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83833764|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83833765|NCT00431665|Hormones|hormones|mesh-ancestor
83833766|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833767|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834944|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834945|NCT00135759|Naltrexone|naltrexone|mesh-list
83834946|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83834947|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83834948|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834949|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
83834950|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834951|NCT00133341|Parthenolide|parthenolide|mesh-list
83834952|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834953|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834954|NCT00133341|Analgesics|analgesics|mesh-ancestor
83834955|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
83834956|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834957|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834958|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834959|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834960|NCT00135837|Verteporfin|verteporfin|mesh-list
83834961|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83834962|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
83834963|NCT00133380|Atorvastatin|atorvastatin|mesh-list
83834964|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83834965|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83834966|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
83834967|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834968|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83834969|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83834970|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834971|NCT00102167|Gaboxadol|gaboxadol|mesh-list
83834972|NCT00102167|Analgesics|analgesics|mesh-ancestor
83834973|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
83834974|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834975|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834976|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
83834977|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
83834978|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
83834979|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834980|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834981|NCT00135876|Dalteparin|dalteparin|mesh-list
83834982|NCT00135876|Tinzaparin|tinzaparin|mesh-list
83834983|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83834984|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
83834985|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83834986|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83834987|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834988|NCT00102206|Ritonavir|ritonavir|mesh-list
83834989|NCT00102206|Lopinavir|lopinavir|mesh-list
83834990|NCT00102206|Saquinavir|saquinavir|mesh-list
82989378|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83833768|NCT04703608|Ivermectin|ivermectin|mesh-list
83833769|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83833770|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833771|NCT04727073|Spironolactone|spironolactone|mesh-list
83833772|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83833773|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
83833774|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833775|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833776|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83833777|NCT04727073|Diuretics|diuretics|mesh-ancestor
83833778|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
83833779|NCT00432016|Zidovudine|zidovudine|mesh-list
83833780|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
83833781|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833782|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83833783|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83833784|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833785|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
83833786|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833787|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83833788|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83833789|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
83833790|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83833791|NCT00131040|Aprotinin|aprotinin|mesh-list
83833792|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
83833793|NCT00131040|Coagulants|coagulants|mesh-ancestor
83833794|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83833795|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83833796|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
83833797|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833798|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833799|NCT00400478|Rituximab|rituximab|mesh-list
83833800|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833801|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833802|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
83833803|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833804|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833805|NCT01052038|Dexamethasone|dexamethasone|mesh-list
83833806|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
83833807|NCT01052038|BB 1101|bb 1101|mesh-list
83833808|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83833809|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
83833810|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
83833811|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833812|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833813|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833814|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
83833815|NCT01052038|Hormones|hormones|mesh-ancestor
83833816|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833817|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83833818|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833819|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
83833820|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833821|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833822|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
83833823|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83833824|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83833825|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83833826|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83833827|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833828|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
83833829|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833830|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833831|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83833832|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833833|NCT04711044|Menthol|menthol|mesh-list
83833834|NCT04711044|Histamine|histamine|mesh-list
83833835|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
83833836|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
83833837|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
83833838|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
83833839|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833840|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989457|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83833841|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833842|NCT01051960|Ambrisentan|ambrisentan|mesh-list
83833843|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83833844|NCT00432367|Artesunate|artesunate|mesh-list
83833845|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
83833846|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
83833847|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83833848|NCT00432367|Amodiaquine|amodiaquine|mesh-list
83833849|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
83833850|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83833851|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83833852|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833853|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833854|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
83833855|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
83833856|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83833857|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
83833858|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83833859|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833860|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833861|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83833862|NCT00097760|Natalizumab|natalizumab|mesh-list
83833863|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
83833864|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833865|NCT00432406|Infliximab|infliximab|mesh-list
83833866|NCT00432406|Etanercept|etanercept|mesh-list
83833867|NCT00432406|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83833868|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83833869|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
83833870|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833871|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833872|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83833873|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83833874|NCT00432406|Analgesics|analgesics|mesh-ancestor
83833875|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
83833876|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833877|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833878|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833879|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
83833880|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
83833881|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83833882|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833883|NCT02957656|Vaccines|vaccines|mesh-list
83833884|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
83833885|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833886|NCT00097799|Ritonavir|ritonavir|mesh-list
83833887|NCT00097799|Tipranavir|tipranavir|mesh-list
83833888|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83833889|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83833890|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
83833891|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833892|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833893|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83833894|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83833895|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
83833896|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833897|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83833898|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83833899|NCT01051921|Interferons|interferons|mesh-list
83833900|NCT01051921|Ribavirin|ribavirin|mesh-list
83833901|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833902|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
83833903|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833904|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
83833905|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833906|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83833907|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83833908|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83833909|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83833910|NCT00432757|Ketotifen|ketotifen|mesh-list
83833911|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
83833912|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
83833913|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83833914|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
83833915|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
82989527|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82989543|NCT03548064|Vaccines|vaccines|mesh-list
83833916|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833917|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833918|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833919|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83833920|NCT00432796|Dalteparin|dalteparin|mesh-list
83833921|NCT00432796|Tinzaparin|tinzaparin|mesh-list
83833922|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83833923|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
83833924|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83833925|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83833926|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833927|NCT00097877|Insulin|insulin|mesh-list
83833928|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83833929|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
83833930|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
83833931|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
83833932|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83833933|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833934|NCT00097916|Memantine|memantine|mesh-list
83833935|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83833936|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83833937|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
83833938|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83833939|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833940|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833941|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83833942|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83833943|NCT00433069|Pioglitazone|pioglitazone|mesh-list
83833944|NCT00433069|Interferons|interferons|mesh-list
83833945|NCT00433069|Ribavirin|ribavirin|mesh-list
83833946|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
83833947|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
83833948|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833949|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
83833950|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83833951|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
83833952|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833953|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
83833954|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833955|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83833956|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83833957|NCT01580371|CKD-581|ckd-581|mesh-list
83833958|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833959|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833960|NCT00403026|Bevacizumab|bevacizumab|mesh-list
83833961|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83833962|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833963|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83833964|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83833965|NCT00403026|Growth Substances|growth substances|mesh-ancestor
83833966|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833967|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
83833968|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
83833969|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833970|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83833971|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83833972|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833973|NCT00098033|Clofarabine|clofarabine|mesh-list
83833974|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833975|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
83833976|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833977|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833978|NCT00403065|Dexamethasone|dexamethasone|mesh-list
83833979|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83833980|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
83833981|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
83833982|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83833983|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833984|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83833985|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
83833986|NCT00403065|Hormones|hormones|mesh-ancestor
83833987|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83833988|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83833989|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833990|NCT00098111|Azathioprine|azathioprine|mesh-list
83833991|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
83833992|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83833993|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83833994|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83833995|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83833996|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
83833997|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83833998|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83833999|NCT04702906|Trimetazidine|trimetazidine|mesh-list
83834000|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
83834001|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
83834002|NCT00131313|Rituximab|rituximab|mesh-list
83834003|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834004|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
83834005|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834006|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834007|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83834008|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
83834009|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834010|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834011|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83834012|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83834013|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
83834014|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83834015|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834016|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83834017|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
83834018|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834019|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834020|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834021|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834022|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
83834023|NCT00433225|Prednisolone|prednisolone|mesh-list
83834024|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83834025|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
83834026|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83834027|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
83834028|NCT00433225|Ketorolac|ketorolac|mesh-list
83834029|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83834030|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
83834031|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834032|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
83834033|NCT00433225|Hormones|hormones|mesh-ancestor
83834034|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834035|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834036|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83834037|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834038|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
83834039|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
83834040|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834041|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834042|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83834043|NCT00433225|Protective Agents|protective agents|mesh-ancestor
83834044|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834045|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834046|NCT00433225|Analgesics|analgesics|mesh-ancestor
83834047|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
83834048|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834049|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83834050|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834051|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834052|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834053|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834054|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83834055|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83834056|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83834057|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834058|NCT00433342|Floxacillin|floxacillin|mesh-list
83834059|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834060|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834061|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83834062|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83834063|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83834064|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834065|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834066|NCT00131391|Hormones|hormones|mesh-ancestor
83834067|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834068|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834069|NCT00433459|Prednisone|prednisone|mesh-list
83834070|NCT00433459|Prednisolone|prednisolone|mesh-list
83834071|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
83834072|NCT00433459|Dacarbazine|dacarbazine|mesh-list
83834073|NCT00433459|Vincristine|vincristine|mesh-list
83834074|NCT00433459|Procarbazine|procarbazine|mesh-list
83834075|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83834076|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834077|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
83834078|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834079|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834080|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83834081|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
83834082|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834083|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834084|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83834085|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834086|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
83834087|NCT00433459|Hormones|hormones|mesh-ancestor
83834088|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834089|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83834090|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83834091|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
83834092|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
83834093|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
83834094|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83834095|NCT00433498|Carboplatin|carboplatin|mesh-list
83834096|NCT00433498|Etoposide|etoposide|mesh-list
83834097|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
83834098|NCT00433498|Pravastatin|pravastatin|mesh-list
83834099|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834100|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83834101|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83834102|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834103|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834104|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834105|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83834106|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83834107|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
83834108|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83834109|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83834110|NCT00433576|Resveratrol|resveratrol|mesh-list
83834111|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
83834112|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834113|NCT00433576|Protective Agents|protective agents|mesh-ancestor
83834114|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834115|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834116|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83834117|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
83834118|NCT00433615|Hematinics|hematinics|mesh-ancestor
83834119|NCT00098384|Rifaximin|rifaximin|mesh-list
83834120|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834121|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834122|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834123|NCT00433732|Naproxen|naproxen|mesh-list
83834124|NCT00433732|Sumatriptan|sumatriptan|mesh-list
83834125|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834126|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834127|NCT00433732|Analgesics|analgesics|mesh-ancestor
83834128|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
83834129|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834130|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834131|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834132|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834133|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
83834134|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83834135|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834136|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834137|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83834138|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83834139|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83834140|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
83834141|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834142|NCT00098423|Cytarabine|cytarabine|mesh-list
83834143|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83834144|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
83834145|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834146|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834147|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
83834148|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834149|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834150|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
83834151|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834153|NCT01050790|Azacitidine|azacitidine|mesh-list
83834154|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
83834155|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834156|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83834157|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83834158|NCT01050790|Growth Substances|growth substances|mesh-ancestor
83834159|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83834160|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834161|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83834162|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
83834163|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834164|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834165|NCT00433927|Leucovorin|leucovorin|mesh-list
83834166|NCT00433927|Folic Acid|folic acid|mesh-list
83834167|NCT00433927|Bevacizumab|bevacizumab|mesh-list
83834168|NCT00433927|Cetuximab|cetuximab|mesh-list
83834169|NCT00433927|Irinotecan|irinotecan|mesh-list
83834170|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
83834171|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83834172|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834173|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83834174|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83834175|NCT00433927|Growth Substances|growth substances|mesh-ancestor
83834176|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834177|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
83834178|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83834179|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834180|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834181|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834182|NCT00433927|Antidotes|antidotes|mesh-ancestor
83834183|NCT00433927|Protective Agents|protective agents|mesh-ancestor
83834184|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
83834185|NCT00433927|Vitamins|vitamins|mesh-ancestor
83834186|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
83834187|NCT00433927|Hematinics|hematinics|mesh-ancestor
83834188|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83834189|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83834190|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83834191|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834192|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834193|NCT00131430|Hormones|hormones|mesh-ancestor
83834194|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834195|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834196|NCT00098462|Sirolimus|sirolimus|mesh-list
83834197|NCT00098462|Gefitinib|gefitinib|mesh-list
83834198|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834199|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834200|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83834201|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834202|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
83834203|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834204|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
83834205|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834206|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834207|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834208|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834209|NCT00098501|Sirolimus|sirolimus|mesh-list
83834210|NCT00098501|Temsirolimus|temsirolimus|mesh-list
83834211|NCT00098501|MTOR Inhibitors|mtor inhibitors|mesh-list
83834212|NCT00098501|EKB 569|ekb 569|mesh-list
83834213|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834214|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834215|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834216|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834217|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
83834218|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834219|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834220|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834221|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834222|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83834223|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
83834224|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
83834225|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83834226|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
83834227|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834228|NCT00434005|Expectorants|expectorants|mesh-ancestor
83834229|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
83834230|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83834231|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
83834232|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834233|NCT00434005|Protective Agents|protective agents|mesh-ancestor
83834234|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834235|NCT00434005|Antidotes|antidotes|mesh-ancestor
83834236|NCT00434044|Etanercept|etanercept|mesh-list
83834237|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834238|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834239|NCT00434044|Analgesics|analgesics|mesh-ancestor
83834240|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
83834241|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834242|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834243|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834244|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834245|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834246|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834247|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
83834248|NCT00434083|Naproxen|naproxen|mesh-list
83834249|NCT00434083|Sumatriptan|sumatriptan|mesh-list
83834250|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834251|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834252|NCT00434083|Analgesics|analgesics|mesh-ancestor
83834253|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
83834254|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834255|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834256|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834257|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834258|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
83834259|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83834260|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834261|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834262|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83834263|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83834264|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83834265|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
83834266|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834267|NCT00098540|Sorafenib|sorafenib|mesh-list
83834268|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834269|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834270|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834271|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834272|NCT00098579|Doxorubicin|doxorubicin|mesh-list
83834273|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83834274|NCT00098579|Alvocidib|alvocidib|mesh-list
83834275|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83834276|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834277|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83834278|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834279|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834280|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834281|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
83834282|NCT00098579|Growth Substances|growth substances|mesh-ancestor
83834283|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834284|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834285|NCT00098618|Interferons|interferons|mesh-list
83834286|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
83834287|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
83834288|NCT00098618|Sorafenib|sorafenib|mesh-list
83834289|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834290|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
83834291|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834292|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834293|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834294|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834295|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
83834296|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834297|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83834298|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83834299|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834300|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834301|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
83834302|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834303|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
83834304|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83834305|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834306|NCT01059448|Brodalumab|brodalumab|mesh-list
83834307|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83834308|NCT00098891|Entinostat|entinostat|mesh-list
83834309|NCT00098891|Isotretinoin|isotretinoin|mesh-list
83834310|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83834311|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
83834312|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834313|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834314|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834315|NCT00098969|Resveratrol|resveratrol|mesh-list
83834316|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
83834317|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834318|NCT00098969|Protective Agents|protective agents|mesh-ancestor
83834319|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834320|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834321|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83834322|NCT00099008|Genistein|genistein|mesh-list
83834323|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83834324|NCT00099008|Protective Agents|protective agents|mesh-ancestor
83834325|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834326|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834327|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834328|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834329|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834330|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
83834331|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83834332|NCT00099008|Estrogens|estrogens|mesh-ancestor
83834333|NCT00099008|Hormones|hormones|mesh-ancestor
83834334|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834335|NCT00434239|Lenalidomide|lenalidomide|mesh-list
83834336|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
83834337|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834338|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83834339|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83834340|NCT00434239|Growth Substances|growth substances|mesh-ancestor
83834341|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
83834342|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834343|NCT01057147|Rebamipide|rebamipide|mesh-list
83834344|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83834345|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83834346|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83834347|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834348|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
83834349|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834350|NCT01057147|Protective Agents|protective agents|mesh-ancestor
83834351|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834352|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834353|NCT00099125|Irinotecan|irinotecan|mesh-list
83834354|NCT00099125|Temozolomide|temozolomide|mesh-list
83834355|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83834356|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834357|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834358|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834359|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834360|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83834361|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
83834362|NCT00131703|Chloroquine|chloroquine|mesh-list
83834363|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
83834364|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
83834365|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83834366|NCT00131703|Amodiaquine|amodiaquine|mesh-list
82989984|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
83834367|NCT00131703|Amebicides|amebicides|mesh-ancestor
83834368|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83834369|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83834370|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834371|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
83834372|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834373|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83834374|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834375|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834376|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83834377|NCT01051414|Asunaprevir|asunaprevir|mesh-list
83834378|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
83834379|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834380|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834381|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
83834382|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83834383|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834384|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83834385|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83834386|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83834387|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
83834388|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834389|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834390|NCT00099164|Progestins|progestins|mesh-ancestor
83834391|NCT00099164|Hormones|hormones|mesh-ancestor
83834392|NCT00131742|Lamivudine|lamivudine|mesh-list
83834393|NCT00131742|Telbivudine|telbivudine|mesh-list
83834394|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83834395|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83834396|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834397|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834398|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
83834399|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834400|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83834401|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83834402|NCT04621149|Lactoferrin|lactoferrin|mesh-list
83834403|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
83834404|NCT04621149|Famotidine|famotidine|mesh-list
83834405|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83834406|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834407|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83834408|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
83834409|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
83834410|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834411|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834412|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834413|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834414|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
83834415|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
83834416|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
83834417|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
83834418|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83834419|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834420|NCT00099242|Rivastigmine|rivastigmine|mesh-list
83834421|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83834422|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834423|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834424|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
83834425|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834426|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834427|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83834428|NCT00099242|Protective Agents|protective agents|mesh-ancestor
83834429|NCT00099320|Exenatide|exenatide|mesh-list
83834430|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83834431|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834432|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83834433|NCT00099320|Incretins|incretins|mesh-ancestor
83834434|NCT00099320|Hormones|hormones|mesh-ancestor
83834435|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834436|NCT00403650|Iloprost|iloprost|mesh-list
83834437|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83834438|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
83834439|NCT00403728|Cyclosporine|cyclosporine|mesh-list
83834440|NCT00403728|Cyclosporins|cyclosporins|mesh-list
83834441|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834442|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990057|NCT02426164|Epinephrine|epinephrine|mesh-list
83834443|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834444|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
83834445|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834446|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
83834447|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834448|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
83834449|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834450|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83834451|NCT00403806|Dexamethasone|dexamethasone|mesh-list
83834452|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
83834453|NCT00403806|BB 1101|bb 1101|mesh-list
83834454|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834455|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
83834456|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
83834457|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834458|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834459|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834460|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
83834461|NCT00403806|Hormones|hormones|mesh-ancestor
83834462|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834463|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83834464|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834465|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
83834466|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834467|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834468|NCT00400556|Lenograstim|lenograstim|mesh-list
83834469|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83834470|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
83834471|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834472|NCT00400595|Mupirocin|mupirocin|mesh-list
83834473|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834474|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834475|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83834476|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834477|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834478|NCT00099554|Etanercept|etanercept|mesh-list
83834479|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834480|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834481|NCT00099554|Analgesics|analgesics|mesh-ancestor
83834482|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
83834483|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834484|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834485|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834486|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834487|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83834488|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834489|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
83834490|NCT00132054|Irinotecan|irinotecan|mesh-list
83834491|NCT00132054|Amrubicin|amrubicin|mesh-list
83834492|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83834493|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834494|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834495|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834496|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834497|NCT00099710|Curcumin|curcumin|mesh-list
83834498|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834499|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834500|NCT00099710|Analgesics|analgesics|mesh-ancestor
83834501|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
83834502|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834503|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834504|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834505|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834506|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834507|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834508|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834509|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83834510|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83834511|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834512|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834513|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
83834514|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834515|NCT00132093|Eplerenone|eplerenone|mesh-list
83834991|NCT00102206|Tenofovir|tenofovir|mesh-list
82990126|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83834516|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83834517|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83834518|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834519|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834520|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83834521|NCT00132093|Diuretics|diuretics|mesh-ancestor
83834522|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
83834523|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83834524|NCT00099788|Ranolazine|ranolazine|mesh-list
83834525|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83834526|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83834527|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834528|NCT00099866|Metformin|metformin|mesh-list
83834529|NCT00099866|Vildagliptin|vildagliptin|mesh-list
83834530|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83834531|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834532|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83834533|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
83834534|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834535|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834536|NCT00099905|Vildagliptin|vildagliptin|mesh-list
83834537|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83834538|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834539|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83834540|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
83834541|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834542|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834543|NCT00132210|Interferons|interferons|mesh-list
83834544|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834545|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
83834546|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834547|NCT00099944|Glimepiride|glimepiride|mesh-list
83834548|NCT00099944|Vildagliptin|vildagliptin|mesh-list
83834549|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83834550|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83834551|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834552|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834553|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
83834554|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83834555|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
83834556|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834557|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834558|NCT04352166|Buprenorphine|buprenorphine|mesh-list
83834559|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83834560|NCT04352166|Narcotics|narcotics|mesh-ancestor
83834561|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83834562|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834563|NCT04352166|Analgesics|analgesics|mesh-ancestor
83834564|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
83834565|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834566|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83834567|NCT04333914|Avdoralimab|avdoralimab|mesh-list
83834568|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834569|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
83834570|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834571|NCT00100100|Modafinil|modafinil|mesh-list
83834572|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83834573|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834574|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83834575|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83834576|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83834577|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834578|NCT00100139|Paclitaxel|paclitaxel|mesh-list
83834579|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83834580|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83834581|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834582|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83834583|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83834584|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83834585|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834586|NCT00100412|Phenylephrine|phenylephrine|mesh-list
83834587|NCT00100412|Dobutamine|dobutamine|mesh-list
83834588|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
83834589|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82990207|NCT03177850|Acetazolamide|acetazolamide|mesh-list
83834590|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
83834591|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
83834592|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834593|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834594|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
83834595|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83834596|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
83834597|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
83834598|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83834599|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83834600|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83834601|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
83834602|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834603|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834604|NCT00100412|Protective Agents|protective agents|mesh-ancestor
83834605|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83834606|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83834608|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83834609|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83834610|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
83834611|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834612|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
83834613|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83834614|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834615|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834616|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834617|NCT04244058|Analgesics|analgesics|mesh-ancestor
83834618|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
83834619|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834620|NCT00132444|UC-781|uc-781|mesh-list
83834621|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83834622|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
83834623|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834624|NCT00100568|Lamivudine|lamivudine|mesh-list
83834625|NCT00100568|Zidovudine|zidovudine|mesh-list
83834626|NCT00100568|Efavirenz|efavirenz|mesh-list
83834627|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83834628|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83834629|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83834630|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834631|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834632|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
83834633|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834634|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83834635|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83834636|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
83834637|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83834638|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83834639|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83834640|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83834641|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83834642|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83834643|NCT00132561|Artesunate|artesunate|mesh-list
83834644|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
83834645|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
83834646|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
83834647|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83834648|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83834649|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834650|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834651|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
83834652|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
83834653|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83834654|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
83834655|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83834656|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990276|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
82990277|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990278|NCT01881048|Celecoxib|celecoxib|mesh-list
82990279|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82990280|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82990281|NCT01881048|Analgesics|analgesics|mesh-ancestor
83834657|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834658|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83834659|NCT04728659|Desogestrel|desogestrel|mesh-list
83834661|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83834662|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83834663|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83834664|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
83834665|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83834666|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834667|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83834668|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83834669|NCT04728659|Progestins|progestins|mesh-ancestor
83834670|NCT04728659|Hormones|hormones|mesh-ancestor
83834671|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834672|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
83834673|NCT00132600|Bacitracin|bacitracin|mesh-list
83834674|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83834675|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834676|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834677|NCT00132639|Docetaxel|docetaxel|mesh-list
83834678|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834679|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
83834680|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
83834681|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
83834682|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834683|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83834684|NCT04728386|Eusol|eusol|mesh-list
83834685|NCT04728386|Curcumin|curcumin|mesh-list
83834686|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83834687|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83834688|NCT04728386|Analgesics|analgesics|mesh-ancestor
83834689|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
83834690|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83834691|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834692|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83834693|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83834694|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834695|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834696|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834697|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
83834698|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834699|NCT00100646|Ritonavir|ritonavir|mesh-list
83834700|NCT00100646|Lopinavir|lopinavir|mesh-list
83834701|NCT00100646|Lamivudine|lamivudine|mesh-list
83834702|NCT00100646|Stavudine|stavudine|mesh-list
83834703|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83834704|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83834705|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
83834706|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834707|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834708|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83834709|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83834710|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
83834711|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834712|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83834713|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83834714|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83834715|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83834716|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
83834717|NCT00100685|Volociximab|volociximab|mesh-list
83834718|NCT00100685|Antibodies|antibodies|mesh-list
83834719|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83834720|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
83834721|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834722|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83834723|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83834724|NCT00100685|Growth Substances|growth substances|mesh-ancestor
83834725|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
83834726|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834727|NCT00132756|Estramustine|estramustine|mesh-list
83834728|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83834729|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
83834730|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834731|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834732|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83834733|NCT00100880|Lenalidomide|lenalidomide|mesh-list
82990347|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
83834734|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
83834735|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834736|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83834737|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83834738|NCT00100880|Growth Substances|growth substances|mesh-ancestor
83834739|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
83834740|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834741|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
83834742|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83834743|NCT00100958|Protective Agents|protective agents|mesh-ancestor
83834744|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834745|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834746|NCT00101075|Capecitabine|capecitabine|mesh-list
83834747|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
83834748|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83834749|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
83834750|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834751|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834752|NCT00132912|Vorapaxar|vorapaxar|mesh-list
83834753|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83834754|NCT00403182|Letrozole|letrozole|mesh-list
83834755|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834756|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83834757|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83137587|NCT01651780|Heparin|heparin|mesh-list
83834758|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834759|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834760|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83834761|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
83834762|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83834763|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834764|NCT00101114|Interferons|interferons|mesh-list
83834765|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
83834766|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
83834767|NCT00101114|Sorafenib|sorafenib|mesh-list
83834768|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834769|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
83834770|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834771|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83834772|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834773|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834774|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
83834775|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834776|NCT00101153|Cytarabine|cytarabine|mesh-list
83834777|NCT00101153|Daunorubicin|daunorubicin|mesh-list
83834778|NCT00101153|Tipifarnib|tipifarnib|mesh-list
83834779|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83834780|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
83834781|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83834782|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83834783|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
83834784|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834785|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83834786|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
83834787|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834788|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83834789|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83834790|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83834791|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83834792|NCT00132951|Azithromycin|azithromycin|mesh-list
83834793|NCT00132951|Telithromycin|telithromycin|mesh-list
82990419|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
82990420|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990421|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990422|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990423|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990424|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82990425|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990426|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990427|NCT03651206|Niraparib|niraparib|mesh-list
82990428|NCT03651206|Dostarlimab|dostarlimab|mesh-list
82990429|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82990430|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990433|NCT01360437|Ticagrelor|ticagrelor|mesh-list
83834794|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83834795|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834796|NCT00400790|Propofol|propofol|mesh-list
83834798|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83834799|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83834800|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83834801|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83834802|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
83834803|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
83834804|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83834805|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83834806|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83834992|NCT00102206|Lamivudine|lamivudine|mesh-list
83834993|NCT00102206|Emtricitabine|emtricitabine|mesh-list
83834994|NCT00102206|Zidovudine|zidovudine|mesh-list
83834995|NCT00102206|Abacavir|abacavir|mesh-list
83834996|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83834997|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83834998|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
83834999|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835000|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835001|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83835002|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83835003|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
83835004|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835005|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83835006|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835007|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83835008|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83835009|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
83835010|NCT00102284|Levodopa|levodopa|mesh-list
83835011|NCT00102284|Modafinil|modafinil|mesh-list
83835012|NCT00102284|Rivastigmine|rivastigmine|mesh-list
83835013|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83835014|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83835015|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
83835016|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835017|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835018|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835019|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83835020|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83835021|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83835022|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83835023|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83835024|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835025|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
83835026|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83835027|NCT00102284|Protective Agents|protective agents|mesh-ancestor
83835028|NCT00135525|Paroxetine|paroxetine|mesh-list
83835029|NCT00135525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83835030|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83835031|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835032|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835033|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835034|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
83835035|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835036|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83835037|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
83835038|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835039|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83835040|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835041|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835042|NCT00403962|Paroxetine|paroxetine|mesh-list
83835043|NCT00403962|Vestipitant|vestipitant|mesh-list
83835044|NCT00403962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83835045|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83835046|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835047|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835048|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835049|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
83835050|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835051|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83835052|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
83835053|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835054|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83835055|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835056|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835057|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83835058|NCT00102479|Aripiprazole|aripiprazole|mesh-list
83835059|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
83835060|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835061|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83835062|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835063|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835064|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835065|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
83835066|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
83835067|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835068|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835069|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83835070|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83835071|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
83835072|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83835073|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83835074|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83835075|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83835076|NCT00135954|Prednisolone|prednisolone|mesh-list
83835077|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
83835078|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835079|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
83835080|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835081|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835082|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83835083|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
83835084|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835085|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835086|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83835087|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83835088|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
83835089|NCT00135954|Hormones|hormones|mesh-ancestor
83835090|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83835091|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83835092|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
83835093|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
83835094|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83835095|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83835096|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835097|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835098|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835099|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835100|NCT00102635|Fenretinide|fenretinide|mesh-list
83835101|NCT00102635|Lonafarnib|lonafarnib|mesh-list
83835102|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835103|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83835104|NCT00102635|Protective Agents|protective agents|mesh-ancestor
83835105|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835106|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835107|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835108|NCT00133419|Vitamins|vitamins|mesh-list
83835109|NCT00133419|Vitamin A|vitamin a|mesh-list
83835110|NCT00133419|Zinc|zinc|mesh-list
83835111|NCT00133419|Trace Elements|trace elements|mesh-list
83835112|NCT00133419|Micronutrients|micronutrients|mesh-list
83835113|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
83835114|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835115|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
83835116|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835117|NCT00133419|Protective Agents|protective agents|mesh-ancestor
83835118|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83835119|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835120|NCT00102674|Cangrelor|cangrelor|mesh-list
83835121|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83835122|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83835123|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83835124|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83835125|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
83835126|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835127|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835128|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835129|NCT00135993|Rotigotine|rotigotine|mesh-list
83835130|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
83835131|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
83835132|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835133|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835134|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835135|NCT00102713|Valproic Acid|valproic acid|mesh-list
83835136|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
83835137|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835138|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835139|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
83835140|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835141|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835142|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
83835143|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835144|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835145|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835146|NCT00133458|Albendazole|albendazole|mesh-list
83835147|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
83835148|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83835149|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835150|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
83835151|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83835152|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83835153|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
83835154|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
83835155|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
83835156|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835157|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835158|NCT00102752|Gemcitabine|gemcitabine|mesh-list
83835159|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83835160|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
83835161|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835162|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835163|NCT00102830|Trebananib|trebananib|mesh-list
83835164|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83835165|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83835166|NCT00102830|Growth Substances|growth substances|mesh-ancestor
83835167|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835168|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
83835169|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835170|NCT00136110|Valproic Acid|valproic acid|mesh-list
83835171|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
83835172|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835173|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835174|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
83835175|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835176|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835177|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
83835178|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835179|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835180|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835181|NCT00136188|Folic Acid|folic acid|mesh-list
83835182|NCT00136188|Hematinics|hematinics|mesh-ancestor
83835183|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
83835184|NCT00136188|Vitamins|vitamins|mesh-ancestor
83835185|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
83835186|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835187|NCT00102869|Levodopa|levodopa|mesh-list
83835188|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83835189|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83835190|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
83835191|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835192|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835193|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835194|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
83835195|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83835196|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835197|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
83835198|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835199|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83835200|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835201|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835202|NCT00136266|Vitamin D|vitamin d|mesh-list
83835203|NCT00136266|Vitamins|vitamins|mesh-list
83835204|NCT00136266|Vitamin A|vitamin a|mesh-list
83835205|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
82990642|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835206|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
83835207|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835208|NCT00136266|Trace Elements|trace elements|mesh-ancestor
83835209|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83835210|NCT00102947|Daptomycin|daptomycin|mesh-list
83835211|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83835212|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835213|NCT00136344|Levofloxacin|levofloxacin|mesh-list
83835214|NCT00136344|Cefuroxime|cefuroxime|mesh-list
83835215|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
83835216|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83835217|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835218|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83835219|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83835220|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83835221|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835222|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835223|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835224|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83835225|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835226|NCT00102986|Ritonavir|ritonavir|mesh-list
83835227|NCT00102986|Lopinavir|lopinavir|mesh-list
83835228|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83835229|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83835230|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
83835231|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835232|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835233|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83835234|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83835235|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
83835236|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835237|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83835238|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835239|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83835240|NCT00136383|Paroxetine|paroxetine|mesh-list
83835241|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83835242|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83835243|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835244|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835245|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835246|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835247|NCT00136383|Analgesics|analgesics|mesh-ancestor
83835248|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
83835249|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835250|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
83835251|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835252|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
83835253|NCT00136383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83835254|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
83835255|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83835256|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83835257|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835258|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835259|NCT00103103|Leucovorin|leucovorin|mesh-list
83835260|NCT00103103|Fluorouracil|fluorouracil|mesh-list
83835261|NCT00103103|Bortezomib|bortezomib|mesh-list
83835262|NCT00103103|Calcium|calcium|mesh-list
83835263|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
83835264|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83835265|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835266|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
83835267|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835268|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83835269|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835270|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835271|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
83835272|NCT00103103|Antidotes|antidotes|mesh-ancestor
83835273|NCT00103103|Protective Agents|protective agents|mesh-ancestor
83835274|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
83835275|NCT00103103|Vitamins|vitamins|mesh-ancestor
83835276|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
83835277|NCT00133692|Atenolol|atenolol|mesh-list
83835278|NCT00133692|Verapamil|verapamil|mesh-list
83835279|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82990716|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835280|NCT00133692|Trandolapril|trandolapril|mesh-list
83835281|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83835282|NCT00133692|Diuretics|diuretics|mesh-ancestor
83835283|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
83835284|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835285|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83835286|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835287|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835288|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83835289|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
83835290|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
83835291|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835292|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83835293|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83137617|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83835294|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83835295|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
83835296|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835297|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83835298|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83835299|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
83835300|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83835301|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
83835302|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835303|NCT00133731|Heparin|heparin|mesh-list
83835304|NCT00133731|Calcium heparin|calcium heparin|mesh-list
83835305|NCT00133731|Otamixaban|otamixaban|mesh-list
83835306|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
83835307|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83835308|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83835309|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835310|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83835311|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
83835312|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83835313|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
83835314|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835315|NCT00103298|Leucovorin|leucovorin|mesh-list
83835316|NCT00103298|Fluorouracil|fluorouracil|mesh-list
83835317|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
83835318|NCT00103298|Melphalan|melphalan|mesh-list
83835319|NCT00103298|Calcium|calcium|mesh-list
83835320|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
83835321|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83835322|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835323|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
83835324|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835325|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83835326|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835327|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835328|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
83835329|NCT00103298|Antidotes|antidotes|mesh-ancestor
83835330|NCT00103298|Protective Agents|protective agents|mesh-ancestor
83835331|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
83835332|NCT00103298|Vitamins|vitamins|mesh-ancestor
83835333|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
83835334|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83835335|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
83835336|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83835337|NCT00136461|Tretinoin|tretinoin|mesh-list
83835338|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
83835339|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835340|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
83835341|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
83835342|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83835343|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
83835344|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835345|NCT00133770|Pantoprazole|pantoprazole|mesh-list
83835346|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83835347|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83835348|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83835349|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835350|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835351|NCT00133848|Retapamulin|retapamulin|mesh-list
83835352|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83835353|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835354|NCT00133887|Sirolimus|sirolimus|mesh-list
83835355|NCT00133887|Cyclosporine|cyclosporine|mesh-list
83835356|NCT00133887|Tacrolimus|tacrolimus|mesh-list
83835357|NCT00133887|Cyclosporins|cyclosporins|mesh-list
82990800|NCT02915978|Fentanyl|fentanyl|mesh-list
83835358|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835359|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
83835360|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835361|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83835362|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137622|NCT05357612|Pimavanserin|pimavanserin|mesh-list
83835363|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835364|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83835365|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835366|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83835367|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835368|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
83835369|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
83835370|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835371|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
83835372|NCT00136539|Doxorubicin|doxorubicin|mesh-list
83835373|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83835374|NCT00136539|Trastuzumab|trastuzumab|mesh-list
83835375|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835376|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
83835377|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835378|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835379|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83835380|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
83835381|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835382|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835383|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83835384|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83835385|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83835386|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83835387|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835388|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83835389|NCT00103571|Olanzapine|olanzapine|mesh-list
83835390|NCT00103571|Aripiprazole|aripiprazole|mesh-list
83835391|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
83835392|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
83835393|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835394|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835395|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83835396|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83835397|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835398|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835399|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835400|NCT00103571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83835401|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83835402|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835403|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835404|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835405|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
83835406|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83835407|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
83835408|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
83835409|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83835410|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83835411|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83835412|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83835413|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83835414|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83835415|NCT00136578|Carboplatin|carboplatin|mesh-list
83835416|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990868|NCT03175666|Fluorouracil|fluorouracil|mesh-list
82990869|NCT03175666|Capecitabine|capecitabine|mesh-list
82990870|NCT03175666|Avelumab|avelumab|mesh-list
82990871|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82990872|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990873|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
82990874|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
82990875|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
82990876|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990877|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82990878|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
82990879|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990880|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990881|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82990882|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
83835417|NCT00103649|Xaliproden|xaliproden|mesh-list
83835418|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83835419|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83835420|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
83835421|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835422|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835423|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835424|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
83835425|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83835426|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83835427|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835428|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835429|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83835430|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835431|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835432|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
83835433|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
83835434|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835435|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835436|NCT00103727|Risperidone|risperidone|mesh-list
83835437|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83835438|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
83835439|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835440|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835441|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835442|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83835443|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835444|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835445|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835446|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83835447|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
83835448|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83835449|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83835450|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83835451|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835452|NCT00103805|Levodopa|levodopa|mesh-list
83835453|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83835454|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83835455|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
83835456|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835457|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835458|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835459|NCT00404040|Lactulose|lactulose|mesh-list
83835460|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83835461|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83835462|NCT00404040|Laxatives|laxatives|mesh-ancestor
83835463|NCT00103922|Cilomilast|cilomilast|mesh-list
83835464|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83835465|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83835466|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835467|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835468|NCT00134160|Amlodipine|amlodipine|mesh-list
83835469|NCT00134160|Olmesartan|olmesartan|mesh-list
83835470|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83835471|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
83835472|NCT00134160|Calcium|calcium|mesh-list
83835473|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83835474|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835475|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83835476|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835477|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835478|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
83835479|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83835480|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83835481|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83835482|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83835483|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835484|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
83835485|NCT00134199|Sibutramine|sibutramine|mesh-list
83835486|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
83835487|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835488|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
83835489|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82990945|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835491|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83835492|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83835493|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83835494|NCT04729088|Diuretics|diuretics|mesh-ancestor
83835495|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
83835496|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835497|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
83835498|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83835499|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835500|NCT00136734|Methylphenidate|methylphenidate|mesh-list
83835501|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83835502|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835503|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83835504|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83835505|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835506|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835507|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
83835508|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835509|NCT00136773|Amlodipine|amlodipine|mesh-list
83835510|NCT00136773|Benazepril|benazepril|mesh-list
83835511|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83835512|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83835513|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835514|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835515|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83835516|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835517|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
83835518|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83835519|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
83835520|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835521|NCT00136851|Amlodipine|amlodipine|mesh-list
83835522|NCT00136851|Benazepril|benazepril|mesh-list
83835523|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83835524|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83835525|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835526|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835527|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83835528|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835529|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
83835530|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83835531|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
83835532|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835533|NCT00104273|Rasagiline|rasagiline|mesh-list
83835534|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83835535|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835536|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835537|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83835538|NCT00104273|Protective Agents|protective agents|mesh-ancestor
83835539|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835540|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83835541|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83835542|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835543|NCT00134355|Vatalanib|vatalanib|mesh-list
83835544|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83835545|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835546|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835547|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83835548|NCT00104429|Aplaviroc|aplaviroc|mesh-list
83835549|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83835550|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83835551|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835552|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835553|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
83835554|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835555|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83835556|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83835557|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83835558|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83835559|NCT00136968|Voriconazole|voriconazole|mesh-list
83835560|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
83835561|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835562|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83835563|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835564|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835565|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835566|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83835567|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
83835568|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83835569|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835570|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83835571|NCT00104468|Troxacitabine|troxacitabine|mesh-list
83835572|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835573|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83835574|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83835575|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
83835576|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835577|NCT00137007|Azithromycin|azithromycin|mesh-list
83835579|NCT00137007|Sulbactam|sulbactam|mesh-list
83835580|NCT00137007|Sultamicillin|sultamicillin|mesh-list
83835581|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83835582|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835583|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83835584|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835585|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835586|NCT00137085|Ketamine|ketamine|mesh-list
83835587|NCT00137085|Analgesics|analgesics|mesh-ancestor
83835588|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
83835589|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835590|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835591|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83835592|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83835593|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
83835594|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
83835595|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835596|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83835597|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83835598|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835599|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835600|NCT00104546|Vitamin K|vitamin k|mesh-list
83835601|NCT00104546|Vitamins|vitamins|mesh-ancestor
83835602|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
83835603|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835604|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83835605|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83835606|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835607|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
83835608|NCT00104546|Coagulants|coagulants|mesh-ancestor
83835609|NCT00134394|Etanercept|etanercept|mesh-list
83835610|NCT00134394|Tacrolimus|tacrolimus|mesh-list
83835611|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835612|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
83835613|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835614|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83835615|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835616|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835617|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83835618|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83835619|NCT00134394|Analgesics|analgesics|mesh-ancestor
83835620|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
83835621|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835622|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83835623|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835624|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83835625|NCT00104624|Docetaxel|docetaxel|mesh-list
83835626|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835627|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
83835628|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
83835629|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
83835630|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835631|NCT00104663|Quinacrine|quinacrine|mesh-list
83835632|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
83835633|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83835634|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
83835635|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83835636|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835637|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
83835638|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83835639|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
83835640|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835641|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835642|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835643|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83835644|NCT00104741|Flutamide|flutamide|mesh-list
83835645|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
83835646|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83835647|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
83835648|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83835649|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835650|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83835651|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83835652|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835653|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
83835654|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
83835655|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83835656|NCT00134511|Atorvastatin|atorvastatin|mesh-list
83835657|NCT00134511|Torcetrapib|torcetrapib|mesh-list
83835658|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83835659|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83835660|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
83835661|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835662|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83835663|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83835664|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835665|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
83835666|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83835667|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
83835668|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835669|NCT00134550|Atorvastatin|atorvastatin|mesh-list
83835670|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83835671|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83835672|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
83835673|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835674|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83835675|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83835676|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835677|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
83835678|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83835679|NCT00104819|Antibodies|antibodies|mesh-list
83835680|NCT00104819|Sargramostim|sargramostim|mesh-list
83835681|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83835682|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
83835683|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835684|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
83835685|NCT00137202|Promethazine|promethazine|mesh-list
83835686|NCT00137202|Ondansetron|ondansetron|mesh-list
83835687|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
83835688|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
83835689|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835690|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835691|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83835692|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
83835693|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83835694|NCT00137202|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83835695|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83835696|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
83835697|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835698|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835699|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83835700|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83835701|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835702|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
83835703|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
83835704|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
83835705|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83835706|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
83835707|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
83835708|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83835709|NCT00104975|Fludarabine|fludarabine|mesh-list
83835710|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
83835711|NCT00104975|Melphalan|melphalan|mesh-list
82991175|NCT03665441|Vitamins|vitamins|mesh-ancestor
83835713|NCT00104975|Thiotepa|thiotepa|mesh-list
83835714|NCT00104975|Tacrolimus|tacrolimus|mesh-list
83835715|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835716|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83835717|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
83835718|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835719|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835720|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
83835721|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835722|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83835723|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835724|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83835725|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
83835726|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83835727|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83835728|NCT00137358|Amifostine|amifostine|mesh-list
83835729|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83835730|NCT00137358|Protective Agents|protective agents|mesh-ancestor
83835731|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835732|NCT00134667|Verteporfin|verteporfin|mesh-list
83835733|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83835734|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
83835735|NCT00134706|Carboplatin|carboplatin|mesh-list
83835736|NCT00134706|Docetaxel|docetaxel|mesh-list
83835737|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835738|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
83835739|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
83835740|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
83835741|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835742|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83835743|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83835744|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83835745|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
83835746|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835747|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835748|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835749|NCT00137397|Urological Agents|urological agents|mesh-ancestor
83835750|NCT00134745|Estradiol|estradiol|mesh-list
83835751|NCT00134745|Estrogens|estrogens|mesh-ancestor
83835752|NCT00134745|Hormones|hormones|mesh-ancestor
83835753|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83835754|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835755|NCT00105209|Aspirin|aspirin|mesh-list
83835756|NCT00105209|Clopidogrel|clopidogrel|mesh-list
83835757|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83835758|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83835759|NCT00105209|Analgesics|analgesics|mesh-ancestor
83835760|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
83835761|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835762|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835763|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83835764|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835765|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83835766|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83835767|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835768|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83835769|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83835770|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835771|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
83835772|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83835773|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83835774|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83835775|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
83835776|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835777|NCT00105287|Fentanyl|fentanyl|mesh-list
83835778|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83835779|NCT00105287|Narcotics|narcotics|mesh-ancestor
83835780|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835781|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835782|NCT00105287|Analgesics|analgesics|mesh-ancestor
83835783|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
83835784|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835785|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82991248|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83835787|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
83835788|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
83835789|NCT00137514|Chloroquine|chloroquine|mesh-list
83835790|NCT00137514|Amodiaquine|amodiaquine|mesh-list
83835791|NCT00137514|Amebicides|amebicides|mesh-ancestor
83835792|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83835793|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83835794|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835795|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
83835796|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835797|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83835798|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83835799|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835800|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835801|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835802|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835803|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83835804|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83835805|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
83835806|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835807|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835808|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83835809|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83835810|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
83835811|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
83835812|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
83835813|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83835814|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
83835815|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83835816|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83835817|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835818|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83835819|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835820|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835821|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83835822|NCT00105404|Triamcinolone|triamcinolone|mesh-list
83835823|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83835824|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83835825|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83835826|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83835827|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
83835828|NCT00105404|Hormones|hormones|mesh-ancestor
83835829|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83835830|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835831|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83835832|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
83835833|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835834|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835835|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
83835836|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83835837|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
83835838|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835839|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835840|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83835841|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
83835842|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83835843|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83835844|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83835845|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
83835846|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835847|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835848|NCT00135018|Celecoxib|celecoxib|mesh-list
83835849|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83835850|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83835851|NCT00135018|Analgesics|analgesics|mesh-ancestor
83835852|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
83835853|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835854|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835855|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83835856|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83835857|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83835858|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83835859|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835860|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835861|NCT00137709|Lamotrigine|lamotrigine|mesh-list
83835862|NCT00137709|Valproic Acid|valproic acid|mesh-list
83835863|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
83835864|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83835865|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835866|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835867|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83835868|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835869|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83835870|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83835871|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83835872|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83835873|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83835874|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835875|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
83835876|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835877|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
83835878|NCT01054144|Dexamethasone|dexamethasone|mesh-list
83835879|NCT01054144|Prednisone|prednisone|mesh-list
83835880|NCT01054144|Lenalidomide|lenalidomide|mesh-list
83835881|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83835882|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
83835883|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
83835884|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835885|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835886|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83835887|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
83835888|NCT01054144|Hormones|hormones|mesh-ancestor
83835889|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83835890|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83835891|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835892|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
83835893|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83835894|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83835895|NCT01054144|Growth Substances|growth substances|mesh-ancestor
83835896|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83835897|NCT03277495|Nicotine|nicotine|mesh-list
83835898|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83835899|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
83835900|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835901|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835902|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83835903|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83835904|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
83835905|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835906|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835907|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
83835908|NCT00137787|Cefepime|cefepime|mesh-list
83835909|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83835910|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83835911|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83835912|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83835913|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835914|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835915|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835916|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83835917|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83835918|NCT04702048|Aflibercept|aflibercept|mesh-list
83835919|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83835920|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83835921|NCT04702048|Growth Substances|growth substances|mesh-ancestor
83835922|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835923|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
83835924|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835925|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
83835926|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835927|NCT00135057|Insulin|insulin|mesh-list
83835928|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83835929|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
83835930|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
83835931|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83835932|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835933|NCT00434668|Cisplatin|cisplatin|mesh-list
83835934|NCT00434668|Docetaxel|docetaxel|mesh-list
82991400|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83835935|NCT00434668|Vinorelbine|vinorelbine|mesh-list
83835936|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835937|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83835938|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83835939|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83835940|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835941|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83835942|NCT00434746|Fezakinumab|fezakinumab|mesh-list
83835943|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
83835944|NCT00137826|Bevacizumab|bevacizumab|mesh-list
83835945|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83835946|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83835947|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835948|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83835949|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83835950|NCT00137826|Growth Substances|growth substances|mesh-ancestor
83835951|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835952|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
83835953|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83835954|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835955|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835956|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
83835957|NCT00434824|Testosterone|testosterone|mesh-list
83835958|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
83835959|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
83835960|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83835961|NCT00434824|Androgens|androgens|mesh-ancestor
83835963|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83835964|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835965|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83835966|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835967|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
83835968|NCT00105950|Lapatinib|lapatinib|mesh-list
83835969|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835970|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83835971|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83835972|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835973|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
83835974|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83835975|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83835976|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83835977|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83835978|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835979|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
83835980|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83835981|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835982|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83835983|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83835984|NCT00434941|Capecitabine|capecitabine|mesh-list
83835985|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83835986|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
83835987|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835988|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83835989|NCT00135096|Insulin|insulin|mesh-list
83835990|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83835991|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
83835992|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
83835993|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83835994|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83835995|NCT00435058|Timolol|timolol|mesh-list
83835996|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83835997|NCT00435058|Travoprost|travoprost|mesh-list
83835998|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83835999|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83836000|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83836001|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
83836002|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836003|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836004|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83836005|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83836006|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83836007|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82991476|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
83836008|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83836009|NCT00435175|Estradiol|estradiol|mesh-list
83836010|NCT00435175|Estrogens|estrogens|mesh-ancestor
83836011|NCT00435175|Hormones|hormones|mesh-ancestor
83836012|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83836013|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836014|NCT00135135|Carboplatin|carboplatin|mesh-list
83836015|NCT00135135|Doxorubicin|doxorubicin|mesh-list
83836016|NCT00135135|Irinotecan|irinotecan|mesh-list
83836017|NCT00135135|Etoposide|etoposide|mesh-list
83836018|NCT00135135|Melphalan|melphalan|mesh-list
83836019|NCT00135135|Topotecan|topotecan|mesh-list
83836020|NCT00135135|Gefitinib|gefitinib|mesh-list
83836021|NCT00135135|Tretinoin|tretinoin|mesh-list
83836022|NCT00135135|Isotretinoin|isotretinoin|mesh-list
83836023|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836024|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83836025|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83836026|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836027|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836028|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836029|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83836030|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83836031|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83836032|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
83836033|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83836034|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836035|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
83836036|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836037|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83836038|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
83836039|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836040|NCT00435292|Naproxen|naproxen|mesh-list
83836041|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83836042|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83836043|NCT00435292|Analgesics|analgesics|mesh-ancestor
83836044|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
83836045|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836046|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836047|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83836048|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836049|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
83836050|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83836051|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836052|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836053|NCT00435331|Verapamil|verapamil|mesh-list
83836054|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83836055|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83836056|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836057|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836058|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83836059|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836060|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
83836061|NCT00435448|Lonidamine|lonidamine|mesh-list
83836062|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836063|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83836064|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836065|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83836066|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
83836067|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83836068|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83836069|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83836070|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83836071|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836072|NCT00435760|Bromides|bromides|mesh-list
83836073|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
83836074|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83836075|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
83836076|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836077|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836078|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83836079|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
82991551|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
83836080|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
83836081|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83836082|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
83836083|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836084|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836085|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
83836086|NCT00435799|Riboflavin|riboflavin|mesh-list
83836087|NCT00435799|Dextrans|dextrans|mesh-list
83836088|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83836089|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
83836090|NCT00435799|Vitamins|vitamins|mesh-ancestor
83836091|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
83836092|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836093|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83836094|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836095|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83836096|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
83836097|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
83836098|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
83836099|NCT00142467|Bevacizumab|bevacizumab|mesh-list
83836100|NCT00142467|Gemcitabine|gemcitabine|mesh-list
83836101|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
83836102|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83836103|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836104|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83836105|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83836106|NCT00142467|Growth Substances|growth substances|mesh-ancestor
83836107|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836108|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
83836109|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836110|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
83836111|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836112|NCT00435955|Rituximab|rituximab|mesh-list
83836113|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83836114|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836115|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
83836116|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836117|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836118|NCT00436033|Milnacipran|milnacipran|mesh-list
83836119|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
83836120|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83836121|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83836122|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836123|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836124|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836125|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836126|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83836127|NCT00436033|Analgesics|analgesics|mesh-ancestor
83836128|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
83836129|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836130|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
83836131|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83836132|NCT00436072|Irinotecan|irinotecan|mesh-list
83836133|NCT00436072|Cetuximab|cetuximab|mesh-list
83836134|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83836135|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836136|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836137|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836138|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836139|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83836140|NCT03275857|Cisplatin|cisplatin|mesh-list
83836141|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836142|NCT03276052|Bromides|bromides|mesh-list
83836143|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
83836144|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
83836145|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83836146|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
83836147|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83836148|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
83836149|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836150|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836151|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
83836152|NCT04702360|Ivacaftor|ivacaftor|mesh-list
83836153|NCT04702360|Elexacaftor|elexacaftor|mesh-list
83836154|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83836155|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836156|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836157|NCT04702204|Denosumab|denosumab|mesh-list
83836158|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83836159|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836160|NCT00138060|Fluorouracil|fluorouracil|mesh-list
83836161|NCT00138060|Irinotecan|irinotecan|mesh-list
83836162|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
83836163|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836164|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836165|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836166|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836167|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
83836168|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836169|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83836170|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836171|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836172|NCT04702009|Antibodies|antibodies|mesh-list
83836173|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83836174|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
83836175|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836176|NCT00106145|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
83836177|NCT00106145|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83836178|NCT00106145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836179|NCT00106145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836180|NCT00142545|Apomorphine|apomorphine|mesh-list
83836181|NCT00142545|Emetics|emetics|mesh-ancestor
83836182|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836183|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
83836184|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836185|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83836186|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
83836187|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
83836188|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836189|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836190|NCT00106262|Irinotecan|irinotecan|mesh-list
83836191|NCT00106262|Bortezomib|bortezomib|mesh-list
83836192|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83836193|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836194|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836195|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836196|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836197|NCT00106301|Romidepsin|romidepsin|mesh-list
83836198|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83836199|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836200|NCT00106301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83836201|NCT00106301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836202|NCT00106301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836203|NCT00436267|Fluorouracil|fluorouracil|mesh-list
83836204|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
83836205|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836206|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836207|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836208|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836209|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
83836210|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836211|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
83836212|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83836213|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836214|NCT00138099|Dalteparin|dalteparin|mesh-list
83836215|NCT00138099|Tinzaparin|tinzaparin|mesh-list
83836216|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83836217|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
83836218|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83836219|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83836220|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836221|NCT00106379|Tenofovir|tenofovir|mesh-list
83836222|NCT00106379|Emtricitabine|emtricitabine|mesh-list
83836223|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83836224|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
83836225|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836226|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83836227|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83836228|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836229|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836230|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83836231|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82991705|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
83836233|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836234|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
83836235|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836236|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836237|NCT00436579|Sorafenib|sorafenib|mesh-list
83836238|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836239|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83836240|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836241|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836242|NCT00436657|Cisplatin|cisplatin|mesh-list
83836243|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836244|NCT00106418|Romidepsin|romidepsin|mesh-list
83836245|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83836246|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836247|NCT00106418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83836248|NCT00106418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836249|NCT00106418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836250|NCT00436930|Sargramostim|sargramostim|mesh-list
83836251|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
83836252|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836253|NCT00437008|Benphothiamine|benphothiamine|mesh-list
83836254|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83836255|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
83836256|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836257|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
83836258|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
83836259|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836260|NCT00437086|Bortezomib|bortezomib|mesh-list
83836261|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836262|NCT00437164|Insulin|insulin|mesh-list
83836263|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83836264|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83836265|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836266|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83836267|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83836268|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836269|NCT00106496|Tacrolimus|tacrolimus|mesh-list
83836270|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836271|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
83836272|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836273|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83836274|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836275|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836276|NCT00437359|Toremifene|toremifene|mesh-list
83836277|NCT00437359|Anastrozole|anastrozole|mesh-list
83836278|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836279|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83836280|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836281|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83836282|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83836283|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836284|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83836285|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
83836286|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83836287|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836288|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83836289|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83836290|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83836291|NCT00437476|Ribavirin|ribavirin|mesh-list
83836292|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83836293|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83836294|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
83836295|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836296|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
83137686|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836297|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836298|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83836299|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836300|NCT00437554|Glimepiride|glimepiride|mesh-list
83836301|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82991774|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83836302|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83836303|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836304|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836305|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
83836306|NCT00437632|Caffeine|caffeine|mesh-list
83836307|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83836308|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836309|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83836310|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836311|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836312|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83836313|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83836314|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
83836315|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836316|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
83836317|NCT00437671|Antibodies|antibodies|mesh-list
83836318|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
83836319|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83836320|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83836321|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
83836322|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836323|NCT00106613|Romidepsin|romidepsin|mesh-list
83836324|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83836325|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836326|NCT00106613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83836327|NCT00106613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836328|NCT00106613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836329|NCT00401180|Docetaxel|docetaxel|mesh-list
83836330|NCT00401180|Temozolomide|temozolomide|mesh-list
83836331|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836332|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
83836333|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
83836334|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
83836335|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836336|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83836337|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
83836338|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
83836339|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83836340|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836341|NCT03278665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83836342|NCT03278665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836343|NCT00401219|Estrogens|estrogens|mesh-list
83836344|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83836345|NCT00401219|Progestins|progestins|mesh-list
83836346|NCT00401219|Hormones|hormones|mesh-ancestor
83836347|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83836348|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836349|NCT04701463|Calcium|calcium|mesh-list
83836350|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83836351|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836352|NCT00438139|Dronabinol|dronabinol|mesh-list
83836353|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
83836354|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836355|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83836356|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83836357|NCT00438139|Analgesics|analgesics|mesh-ancestor
83836358|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
83836359|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836360|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83836361|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83836362|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836363|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836364|NCT00438139|Hormones|hormones|mesh-ancestor
83836365|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83836366|NCT00438178|Obatoclax|obatoclax|mesh-list
83836367|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836368|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836369|NCT00438217|Leuprolide|leuprolide|mesh-list
83836370|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83836371|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83836372|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83836373|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
83836374|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83836375|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836376|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83836377|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836378|NCT00438217|Hormones|hormones|mesh-ancestor
83836379|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83836380|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
83836381|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83836382|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
83836383|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83836384|NCT03279757|Lidocaine|lidocaine|mesh-list
83836385|NCT03279757|Epinephrine|epinephrine|mesh-list
83836386|NCT03279757|Racepinephrine|racepinephrine|mesh-list
83836387|NCT03279757|Tetracaine|tetracaine|mesh-list
83836388|NCT03279757|Carticaine|carticaine|mesh-list
83836389|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
83836390|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
83836391|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
83836392|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83836393|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836394|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
83836395|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836396|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83836397|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83836398|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83836399|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836400|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836401|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83836402|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83836403|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
83836404|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836405|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83836406|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83836407|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
83836408|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83836409|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
83836410|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
83836411|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
83836412|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83836413|NCT00438568|Insulin|insulin|mesh-list
83836414|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83836415|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83836416|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836417|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
83836418|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83836419|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83836420|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83836421|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
83836422|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836423|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836424|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836425|NCT00106847|Infliximab|infliximab|mesh-list
83836426|NCT00106847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83836427|NCT00106847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83836428|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836429|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83836430|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836431|NCT00106886|Folic Acid|folic acid|mesh-list
83836432|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
83836433|NCT00106886|Pyridoxal|pyridoxal|mesh-list
83836434|NCT00106886|Pyridoxine|pyridoxine|mesh-list
83836435|NCT00106886|Vitamins|vitamins|mesh-ancestor
83836436|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
83836437|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836438|NCT00106886|Hematinics|hematinics|mesh-ancestor
83836439|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
83836440|NCT00438841|Thalidomide|thalidomide|mesh-list
83836441|NCT00438841|Dexamethasone|dexamethasone|mesh-list
83836442|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
83836443|NCT00438841|Bortezomib|bortezomib|mesh-list
83836444|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836445|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
83836446|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836447|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836448|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83836449|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
83836450|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836451|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836452|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83836453|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991921|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
83836454|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
83836455|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
83836456|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836457|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83836458|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
83836459|NCT00438841|Hormones|hormones|mesh-ancestor
83836460|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83836461|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83836462|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
83836463|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83836464|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836465|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83836466|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83836467|NCT00438841|Growth Substances|growth substances|mesh-ancestor
83836468|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
83836469|NCT00438958|Lenograstim|lenograstim|mesh-list
83836470|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83836471|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
83836472|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836473|NCT00107003|Lapatinib|lapatinib|mesh-list
83836474|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836475|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83836476|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836477|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836478|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83836479|NCT00107081|Amoxicillin|amoxicillin|mesh-list
83836480|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
83836481|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836482|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83836483|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836484|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836485|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836486|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836487|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83836488|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83836489|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83836490|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83836491|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83836492|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
83836493|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836494|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836495|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836496|NCT00439192|Urological Agents|urological agents|mesh-ancestor
83836497|NCT00439426|Capecitabine|capecitabine|mesh-list
83836498|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
83836499|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836500|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
83836501|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836502|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836503|NCT00138138|Methylphenidate|methylphenidate|mesh-list
83836504|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83836505|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836506|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83836507|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83836508|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836509|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836510|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
83836511|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836512|NCT00439504|Lobeline|lobeline|mesh-list
83836513|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83836514|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
83836515|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836516|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836517|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83836518|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83836519|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
83836520|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836521|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836522|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83836523|NCT00439543|Iloprost|iloprost|mesh-list
83836524|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83836525|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
82991997|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83836526|NCT00107237|Everolimus|everolimus|mesh-list
83836527|NCT00107237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83836528|NCT00107237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83836529|NCT00107237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836530|NCT00107237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836531|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836532|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
83836533|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836534|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836535|NCT00439699|Memantine|memantine|mesh-list
83836536|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83836537|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83836538|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
83836539|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836540|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836541|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836542|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83836543|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83836544|NCT00439855|Heparin|heparin|mesh-list
83836545|NCT00439855|Enoxaparin|enoxaparin|mesh-list
83836546|NCT00439855|Calcium heparin|calcium heparin|mesh-list
83836547|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
83836548|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83836549|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83836550|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836551|NCT00107354|Cytarabine|cytarabine|mesh-list
83836552|NCT00107354|Aldesleukin|aldesleukin|mesh-list
83836553|NCT00107354|Etoposide|etoposide|mesh-list
83836554|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
83836555|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83836556|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836557|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83836558|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836559|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836560|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836561|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836562|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
83836563|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
83836564|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836565|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836566|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
83836567|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836568|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83836569|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83836570|NCT00107354|Analgesics|analgesics|mesh-ancestor
83836571|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
83836572|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836573|NCT00138177|Leucovorin|leucovorin|mesh-list
83836574|NCT00138177|Fluorouracil|fluorouracil|mesh-list
83836575|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
83836576|NCT00138177|Vorinostat|vorinostat|mesh-list
83836577|NCT00138177|Calcium|calcium|mesh-list
83836578|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
83836579|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83836580|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836581|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
83836582|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836583|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836584|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836585|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836586|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
83836587|NCT00138177|Antidotes|antidotes|mesh-ancestor
83836588|NCT00138177|Protective Agents|protective agents|mesh-ancestor
83836589|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
83836590|NCT00138177|Vitamins|vitamins|mesh-ancestor
83836591|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
83836592|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83836593|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836594|NCT03279601|Capecitabine|capecitabine|mesh-list
83836595|NCT03279601|Temozolomide|temozolomide|mesh-list
83836596|NCT03279601|Dacarbazine|dacarbazine|mesh-list
83836597|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836598|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
83836599|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836600|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992070|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836601|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83836603|NCT00107393|Capecitabine|capecitabine|mesh-list
83836604|NCT00107393|Trastuzumab|trastuzumab|mesh-list
83836605|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836606|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
83836607|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836608|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836609|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83836610|NCT00138216|Irinotecan|irinotecan|mesh-list
83836611|NCT00138216|Vincristine|vincristine|mesh-list
83836612|NCT00138216|Temozolomide|temozolomide|mesh-list
83836613|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83836614|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836615|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836616|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836617|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836618|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83836619|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
83836620|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
83836621|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
83836622|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83836623|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
83836624|NCT00105586|Escitalopram|escitalopram|mesh-list
83836625|NCT00105586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83836626|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83836627|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836628|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836629|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836630|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
83836631|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836632|NCT00107432|Sorafenib|sorafenib|mesh-list
83836633|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836634|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83836635|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836636|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836637|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
83836638|NCT00439972|Ortho Evra|ortho evra|mesh-list
83836639|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83836640|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83836641|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
83836642|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83836643|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836644|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83836645|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836646|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83836647|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836648|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836649|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836650|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836651|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83836652|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83836653|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83836654|NCT00440128|Docetaxel|docetaxel|mesh-list
83836655|NCT00440128|Casopitant|casopitant|mesh-list
83836656|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836657|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
83836658|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
83836659|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
83836660|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836661|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
83836662|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
83836663|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836664|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836665|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83836666|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83836667|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836668|NCT00440167|Gemcitabine|gemcitabine|mesh-list
83836669|NCT00440167|Capecitabine|capecitabine|mesh-list
83836670|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83836671|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836672|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
83836673|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836674|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836675|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83836676|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836678|NCT00107471|Lenograstim|lenograstim|mesh-list
83836679|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83836680|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
83836681|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836682|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83836683|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836684|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836685|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836686|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836687|NCT00404157|Rituximab|rituximab|mesh-list
83836688|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83836689|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836690|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
83836691|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836692|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836693|NCT02957266|Gemcitabine|gemcitabine|mesh-list
83836694|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836695|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836696|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
83836697|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836698|NCT03279562|Nalmefene|nalmefene|mesh-list
83836699|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83836700|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836701|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
83836702|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836703|NCT00404196|Calcipotriene|calcipotriene|mesh-list
83836704|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836705|NCT00107510|Carboplatin|carboplatin|mesh-list
83836706|NCT00107510|Docetaxel|docetaxel|mesh-list
83836707|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836708|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
83836709|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
83836710|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
83836711|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836712|NCT00440245|Albuterol|albuterol|mesh-list
83836713|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83836714|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
83836715|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836716|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836717|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83836718|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
83836719|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
83836720|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83836721|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83836722|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83836723|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83836724|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
83836725|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836726|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836727|NCT00440284|Insulin|insulin|mesh-list
83836728|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83836729|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836730|NCT00142779|Fluoxetine|fluoxetine|mesh-list
83836731|NCT00142779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83836732|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83836733|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836734|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836735|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836736|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
83836737|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836738|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83836739|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
83836740|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83836741|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83836742|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83836743|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836744|NCT00440323|Zolpidem|zolpidem|mesh-list
83836745|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83836746|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83836747|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992222|NCT02397772|Albendazole|albendazole|mesh-list
83836748|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836749|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83836751|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
83836752|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836753|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836754|NCT00440440|Testosterone|testosterone|mesh-list
83836755|NCT00440440|Androgens|androgens|mesh-ancestor
83836756|NCT00440440|Hormones|hormones|mesh-ancestor
83836757|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83836758|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836759|NCT00142896|Morphine|morphine|mesh-list
83836760|NCT00142896|Tramadol|tramadol|mesh-list
83836761|NCT00142896|Naloxone|naloxone|mesh-list
83836762|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83836763|NCT00142896|Narcotics|narcotics|mesh-ancestor
83836764|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83836765|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836766|NCT00142896|Analgesics|analgesics|mesh-ancestor
83836767|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
83836768|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836769|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83836770|NCT00440479|Bortezomib|bortezomib|mesh-list
83836771|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836772|NCT00440635|Bortezomib|bortezomib|mesh-list
83836773|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836774|NCT00440674|Paclitaxel|paclitaxel|mesh-list
83836775|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83836776|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836777|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
83836778|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
83836779|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83836780|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836781|NCT00440713|Aripiprazole|aripiprazole|mesh-list
83836782|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
83836783|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83836784|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83836785|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83836786|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83836787|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836788|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
83836789|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
83836790|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836791|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836792|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83137702|NCT05619848|Etomidate|etomidate|mesh-list
83836793|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83836794|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
83836795|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83836796|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83836797|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83836798|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83836799|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
83836800|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83836801|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
83836802|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836803|NCT00440869|Expectorants|expectorants|mesh-ancestor
83836804|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
83836805|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83836806|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
83836807|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836808|NCT00440869|Protective Agents|protective agents|mesh-ancestor
83836809|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836810|NCT00440869|Antidotes|antidotes|mesh-ancestor
83836811|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
83836812|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83836813|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836814|NCT00441181|Travoprost|travoprost|mesh-list
83836815|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83836816|NCT00441298|Tenofovir|tenofovir|mesh-list
83836817|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
83836818|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836819|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83836820|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83836821|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836822|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836823|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83836824|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83836826|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83836827|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83836828|NCT00441415|Analgesics|analgesics|mesh-ancestor
83836829|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
83836830|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836831|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836832|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83836833|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836834|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836835|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
83836836|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83836837|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83836838|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83836839|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836840|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836841|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
83836842|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836843|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836844|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83836845|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836846|NCT00441532|Lidocaine|lidocaine|mesh-list
83836847|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
83836848|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
83836849|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83836850|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836851|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
83836852|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836853|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83137729|NCT04447352|Leucovorin|leucovorin|mesh-list
83836854|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83836855|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83836856|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836857|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836858|NCT00441649|Methylphenidate|methylphenidate|mesh-list
83836859|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83836860|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836861|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83836862|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83836863|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836864|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836865|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
83836866|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836867|NCT00107822|Lidocaine|lidocaine|mesh-list
83836868|NCT00107822|Tetracaine|tetracaine|mesh-list
83836869|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
83836870|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
83836871|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83836872|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836873|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
83836874|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836875|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83836876|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83836877|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83836878|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836879|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836880|NCT03279328|Petrolatum|petrolatum|mesh-list
83836881|NCT03279328|Emollients|emollients|mesh-ancestor
83836882|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836883|NCT00142974|Tegaserod|tegaserod|mesh-list
83836884|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83836885|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
83836886|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836887|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836888|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836889|NCT00441844|Simvastatin|simvastatin|mesh-list
83836890|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83836891|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83836892|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
83836893|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836894|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83836895|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83836896|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836897|NCT03279133|Ledipasvir|ledipasvir|mesh-list
83836898|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
83836899|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836900|NCT00108017|Timolol|timolol|mesh-list
83836901|NCT00108017|Dorzolamide|dorzolamide|mesh-list
83836902|NCT00108017|Maleic acid|maleic acid|mesh-list
83836903|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836904|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836905|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83836906|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83836907|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
83836908|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836909|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836910|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83836911|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83836912|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83836913|NCT00441922|Docetaxel|docetaxel|mesh-list
83836914|NCT00441922|Vinorelbine|vinorelbine|mesh-list
83836915|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137732|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
83836916|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
83836917|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
83836918|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
83836919|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836920|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83836921|NCT00441961|Methotrexate|methotrexate|mesh-list
83836922|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83836923|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
83836924|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83836925|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836926|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83836927|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
83836928|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836929|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836930|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836931|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836932|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83836933|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83836934|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
83836935|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83836936|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83836937|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
83836938|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83836939|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83836940|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83836941|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83836942|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836943|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836944|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83836945|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83836946|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83836947|NCT00442234|Monteplase|monteplase|mesh-list
83836948|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83836949|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83836950|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836951|NCT00108095|Ondansetron|ondansetron|mesh-list
83836952|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
83836953|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
83836954|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83836955|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836956|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83836957|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
83836958|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
83836959|NCT00108095|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83836960|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83836961|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
83836962|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836963|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836964|NCT03278938|Bupropion|bupropion|mesh-list
83836965|NCT03278938|Citalopram|citalopram|mesh-list
83836966|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83836967|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
83836968|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83836969|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83836970|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83836971|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83836972|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836973|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
83836974|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836975|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836976|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83836977|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83836978|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83836979|NCT03278938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83836980|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
83836981|NCT03278860|Oxytocin|oxytocin|mesh-list
83836982|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
83836983|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83836984|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836985|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83836986|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83836987|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
83836988|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83836989|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83836990|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83836991|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83836992|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83836993|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83836994|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83836995|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83836996|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83836997|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
83836998|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83836999|NCT00442585|Ibuprofen|ibuprofen|mesh-list
83837000|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83837001|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837002|NCT00442585|Analgesics|analgesics|mesh-ancestor
83837003|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
83837004|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837005|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837006|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837007|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837008|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83837009|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837010|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837011|NCT00442741|Epothilone B|epothilone b|mesh-list
83837012|NCT00442741|Epothilones|epothilones|mesh-list
83837013|NCT00442741|Omeprazole|omeprazole|mesh-list
83837014|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83837015|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837016|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83837017|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837018|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837019|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837020|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837021|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837022|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837023|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
83837024|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83837025|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83837026|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83837027|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
83837028|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837029|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837030|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837031|NCT00404586|Fluticasone|fluticasone|mesh-list
83837033|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837034|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83837035|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
83837036|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837037|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837038|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83837039|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
83837040|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
83837041|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82992520|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
83837042|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83837043|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
83837044|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83837045|NCT00442819|Protective Agents|protective agents|mesh-ancestor
83837046|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837047|NCT00108251|Eplerenone|eplerenone|mesh-list
83837048|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83837049|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
83837050|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837051|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837052|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83837053|NCT00108251|Diuretics|diuretics|mesh-ancestor
83837054|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
83837055|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83837056|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
83837057|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
83837058|NCT00443170|Midazolam|midazolam|mesh-list
83837059|NCT00443170|Caffeine|caffeine|mesh-list
83837060|NCT00443170|Omeprazole|omeprazole|mesh-list
83837061|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83837062|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83837063|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83837064|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837065|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83837066|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83837067|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83837068|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83837069|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
83837070|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
83837071|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
83837072|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
83837073|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837074|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837075|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83837076|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83837077|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837078|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83837079|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83837080|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
83837081|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83837082|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837083|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83837084|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83837085|NCT00443170|Analgesics|analgesics|mesh-ancestor
83837086|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
83837087|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837088|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83837089|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837090|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837091|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837092|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83837093|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83837094|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
83837095|NCT00138567|Vildagliptin|vildagliptin|mesh-list
83837096|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83837097|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837098|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83837099|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
83837100|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837101|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837102|NCT00108368|Olanzapine|olanzapine|mesh-list
83837103|NCT00108368|Risperidone|risperidone|mesh-list
83837104|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83837105|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
83837106|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837107|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837108|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837109|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83837110|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83837111|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83837112|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83837113|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83837114|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
83837115|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
83837116|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
83837117|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837118|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837119|NCT00108368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83837120|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83837121|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837122|NCT00108446|Lidocaine|lidocaine|mesh-list
83837123|NCT00108446|Fentanyl|fentanyl|mesh-list
83837124|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
83837125|NCT00108446|Naloxone|naloxone|mesh-list
83837126|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
83837127|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
83837128|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83837129|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837130|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
83837131|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837132|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83837133|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83837134|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83837135|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837136|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837137|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83837138|NCT00108446|Narcotics|narcotics|mesh-ancestor
83837139|NCT00108446|Analgesics|analgesics|mesh-ancestor
83837140|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83837141|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83837142|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
83837143|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83837144|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
83837145|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
83837146|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83837147|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83837148|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837149|NCT00138606|Vildagliptin|vildagliptin|mesh-list
83837150|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83837151|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837152|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83837153|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
83837154|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837155|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837156|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
83837157|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83837158|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
83837159|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837160|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837161|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83837162|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
83837163|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83837164|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83837165|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83837166|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
83837167|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837168|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837169|NCT00443521|Triamcinolone|triamcinolone|mesh-list
83837170|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83837171|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83837172|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83837173|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837174|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
83837175|NCT00443521|Hormones|hormones|mesh-ancestor
83837176|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837177|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837178|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83837179|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
83837180|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837181|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837182|NCT03278431|Albendazole|albendazole|mesh-list
83837183|NCT03278431|Mebendazole|mebendazole|mesh-list
83837184|NCT03278431|Piperazine|piperazine|mesh-list
83837185|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
83837186|NCT03278431|Pyrantel|pyrantel|mesh-list
83837187|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
83837188|NCT03278431|Oxantel|oxantel|mesh-list
83837189|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
83837190|NCT03278431|DMP 777|dmp 777|mesh-list
83837191|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
83837192|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83837193|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837195|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83837196|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83837197|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837198|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837199|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837200|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837201|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837202|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
83837203|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837204|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83837205|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83837206|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83837207|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837208|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837209|NCT04726332|Prednisone|prednisone|mesh-list
83837210|NCT04726332|Fulvestrant|fulvestrant|mesh-list
83837211|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837212|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
83837213|NCT04726332|Hormones|hormones|mesh-ancestor
83837214|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837215|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837216|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83837217|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837218|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83837219|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83837220|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
83837221|NCT00108563|Citalopram|citalopram|mesh-list
83837222|NCT00108563|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83837223|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83837224|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837225|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837226|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837227|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
83837228|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837229|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83837230|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
83837231|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83837232|NCT00443716|Estrogens|estrogens|mesh-list
83837233|NCT00443716|Hormones|hormones|mesh-ancestor
83837234|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837235|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837236|NCT00443794|Aspirin|aspirin|mesh-list
83837237|NCT00443794|Atenolol|atenolol|mesh-list
83837238|NCT00443794|Ramipril|ramipril|mesh-list
83837239|NCT00443794|Simvastatin|simvastatin|mesh-list
83837240|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83837241|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83837242|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837243|NCT00443794|Analgesics|analgesics|mesh-ancestor
83837244|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
83837245|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837246|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837247|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837248|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837249|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83837250|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83837251|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837252|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83837253|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83837254|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837255|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
83837256|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83837257|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83837258|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
83837259|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83837260|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83837261|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83837262|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
83837263|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83837264|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83837265|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
83837266|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
83837267|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83837268|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83837269|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83837270|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
83837271|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837272|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837273|NCT00443794|Diuretics|diuretics|mesh-ancestor
83837274|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
83837275|NCT00108602|Acetazolamide|acetazolamide|mesh-list
83837276|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
83837277|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83837278|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837279|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837280|NCT00108602|Diuretics|diuretics|mesh-ancestor
83837281|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
83837282|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837283|NCT03278314|Ivacaftor|ivacaftor|mesh-list
83837284|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83837285|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837286|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837287|NCT00443950|Etanercept|etanercept|mesh-list
83837288|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83837289|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837290|NCT00443950|Analgesics|analgesics|mesh-ancestor
83837291|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
83837292|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837293|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837294|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837295|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837296|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837297|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83837298|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
83837299|NCT00444184|Timolol|timolol|mesh-list
83837300|NCT00444184|Travoprost|travoprost|mesh-list
83837301|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83837302|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83837303|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83837304|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837305|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837306|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837307|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83837308|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83837309|NCT00444223|Fluorides|fluorides|mesh-list
83837310|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
83837311|NCT00444223|Protective Agents|protective agents|mesh-ancestor
83837312|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837313|NCT03275701|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
83837314|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83837315|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83837316|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
83837317|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837318|NCT00451360|Diacerein|diacerein|mesh-list
83837319|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837320|NCT00451399|Metformin|metformin|mesh-list
83837321|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83837322|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837323|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
83837324|NCT00108797|Coagulants|coagulants|mesh-ancestor
83837325|NCT04698772|Ketamine|ketamine|mesh-list
83837326|NCT04698772|Morphine|morphine|mesh-list
83837327|NCT04698772|Analgesics|analgesics|mesh-ancestor
83837328|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
83837329|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837330|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837331|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83837332|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83837333|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
83837334|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
83837335|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83837336|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83837337|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83837338|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837339|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837340|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83837341|NCT04698772|Narcotics|narcotics|mesh-ancestor
83837342|NCT00451594|Dexamethasone|dexamethasone|mesh-list
83837343|NCT00451594|Prednisolone|prednisolone|mesh-list
83837344|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837345|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
83837346|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
83837347|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837348|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837349|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837350|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
83837352|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837353|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83837354|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837355|NCT00139035|Cyclosporine|cyclosporine|mesh-list
83837356|NCT00139035|Cyclosporins|cyclosporins|mesh-list
83837357|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837358|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837359|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83837360|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
83837361|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837362|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
83837363|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837364|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
83837365|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837366|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83837367|NCT00451672|Bromocriptine|bromocriptine|mesh-list
83837368|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83837369|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83837370|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
83837371|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837372|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837373|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
83837374|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
83837375|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837376|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837377|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
83837378|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83837379|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
83837380|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837381|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837382|NCT00451711|Amphotericin B|amphotericin b|mesh-list
83837383|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83837384|NCT00451711|Amebicides|amebicides|mesh-ancestor
83837385|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83837386|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83837387|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837388|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83837389|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
83837390|NCT00139074|Valproic Acid|valproic acid|mesh-list
83837391|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83837392|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
83837393|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83837394|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83837395|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83837396|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83837397|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837398|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
83837399|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837400|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837401|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
83837402|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837403|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
83837404|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
83837405|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837406|NCT00451828|Simvastatin|simvastatin|mesh-list
83837407|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83837408|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83837409|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
83837410|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837411|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83837412|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83837413|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837414|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
83837415|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83837416|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837417|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83837418|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
83837419|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83837420|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837421|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837422|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837423|NCT00143091|Sertraline|sertraline|mesh-list
83837424|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
83837425|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83837426|NCT00143091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83837427|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83837428|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837429|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837430|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837431|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
83837432|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837433|NCT00451984|Interleukin-2|interleukin-2|mesh-list
83837434|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837435|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837436|NCT00451984|Analgesics|analgesics|mesh-ancestor
83837437|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
83837438|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837439|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837440|NCT00452062|Dexamethasone|dexamethasone|mesh-list
83837441|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837442|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
83837443|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
83837444|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837445|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837446|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837447|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
83837448|NCT00452062|Hormones|hormones|mesh-ancestor
83837449|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837450|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83837451|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837452|NCT00108992|Diclofenac|diclofenac|mesh-list
83837453|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83837454|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837455|NCT00108992|Analgesics|analgesics|mesh-ancestor
83837456|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
83837457|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837458|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837459|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837460|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837461|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83837462|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837463|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837464|NCT00143130|Pregabalin|pregabalin|mesh-list
83837465|NCT00143130|Analgesics|analgesics|mesh-ancestor
83837466|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
83837467|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837468|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837469|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
83837470|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83837471|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837472|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837473|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83837474|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83837475|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83837476|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83837477|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83837478|NCT00109070|Bevacizumab|bevacizumab|mesh-list
83837479|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83837480|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837481|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83837482|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83837483|NCT00109070|Growth Substances|growth substances|mesh-ancestor
83837484|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837485|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
83837486|NCT00452218|Sorafenib|sorafenib|mesh-list
83837487|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837488|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83837489|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837490|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837491|NCT00143169|Parecoxib|parecoxib|mesh-list
83837492|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83837493|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83837494|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837495|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837496|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83837497|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837498|NCT00143169|Analgesics|analgesics|mesh-ancestor
83837499|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
83837500|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837501|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837502|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837503|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837504|NCT00109109|Vorinostat|vorinostat|mesh-list
83837505|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837506|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83837507|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837508|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837509|NCT03275116|Bromides|bromides|mesh-list
83837510|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
83837511|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
83837512|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83837513|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
83837514|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837515|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837516|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83837517|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
83837518|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83837519|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83837520|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83837521|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
83837522|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837523|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837524|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
83837525|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83837526|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
83837527|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
83837528|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83837529|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83837530|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83837531|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837532|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837533|NCT00109148|Hormones|hormones|mesh-ancestor
83837534|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837535|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837536|NCT00452296|Insulin|insulin|mesh-list
83837537|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83837538|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837539|NCT00452569|Thalidomide|thalidomide|mesh-list
83837540|NCT00452569|Dexamethasone|dexamethasone|mesh-list
83837541|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837542|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
83837543|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
83837544|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837545|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837546|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837547|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
83837548|NCT00452569|Hormones|hormones|mesh-ancestor
83837549|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837550|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83837551|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837552|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83837553|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
83837554|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
83837555|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83837556|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837557|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83837558|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83837559|NCT00452569|Growth Substances|growth substances|mesh-ancestor
83837560|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
83837561|NCT00143286|Varenicline|varenicline|mesh-list
83837562|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83837563|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83837564|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
83837565|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837566|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837567|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837569|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83837570|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83837571|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
83837572|NCT00452608|Atorvastatin|atorvastatin|mesh-list
83837573|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83837574|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83837575|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
83837576|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837577|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83837578|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83837579|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837580|NCT00109226|Bevacizumab|bevacizumab|mesh-list
83837581|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83837582|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837583|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83837584|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83837585|NCT00109226|Growth Substances|growth substances|mesh-ancestor
83837586|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837587|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
83837588|NCT00452725|Hormones|hormones|mesh-list
83837589|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837590|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837591|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83837592|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837593|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83837594|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837595|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837596|NCT00143364|Varenicline|varenicline|mesh-list
83837597|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83837598|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83837599|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
83837600|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837601|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837602|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837603|NCT00452881|Gemcitabine|gemcitabine|mesh-list
83837604|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
83837605|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837606|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83837607|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
83837608|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837609|NCT00452920|Docetaxel|docetaxel|mesh-list
83837610|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837611|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837612|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837613|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837614|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837615|NCT00143442|Reboxetine|reboxetine|mesh-list
83837616|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
83837617|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83837618|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83837619|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83837620|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83837621|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837622|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83837623|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837624|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837625|NCT00109382|Aspirin|aspirin|mesh-list
83837626|NCT00109382|Clopidogrel|clopidogrel|mesh-list
83837627|NCT00109382|Simvastatin|simvastatin|mesh-list
83396663|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
83837628|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83837629|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837630|NCT00109382|Analgesics|analgesics|mesh-ancestor
83837631|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
83837632|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837633|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837634|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837635|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837636|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83837637|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83837638|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837639|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83837640|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83837641|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837643|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83837644|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83837645|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83837646|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
83837647|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837648|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83837649|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83837650|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
83837651|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83837652|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83837653|NCT00453076|Paclitaxel|paclitaxel|mesh-list
83837654|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83837655|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837656|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837657|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837658|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837659|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837660|NCT00453115|Gemcitabine|gemcitabine|mesh-list
83837661|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
83837662|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83837663|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
83837664|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837665|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837666|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83837667|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83837668|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83837669|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
83837670|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837671|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837672|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837673|NCT00143481|Urological Agents|urological agents|mesh-ancestor
83837674|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83837675|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83837676|NCT00453232|Etoposide|etoposide|mesh-list
83837677|NCT00453232|Bleomycin|bleomycin|mesh-list
83837678|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837679|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83837680|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83837681|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83837682|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837683|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837684|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83837685|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
83837686|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83837687|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837688|NCT00143520|Pioglitazone|pioglitazone|mesh-list
83837689|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83837690|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837691|NCT00143559|Antibodies|antibodies|mesh-list
83837692|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
83837693|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837694|NCT00453778|Fluticasone|fluticasone|mesh-list
83837695|NCT00453778|Xhance|xhance|mesh-list
83837696|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837697|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83837698|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
83837699|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837700|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837701|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83837702|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
83837703|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
83837704|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83837705|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
83837706|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83837707|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82993212|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
83837708|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83837709|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837710|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
83837711|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
83837712|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
83837713|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
83837714|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83837715|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
83837716|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83837717|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83837718|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837719|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83837720|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837721|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837722|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83837723|NCT00454168|Sargramostim|sargramostim|mesh-list
83837724|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
83837725|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837726|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
83837727|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83837728|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
83837729|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837730|NCT03274765|Estradiol|estradiol|mesh-list
83837731|NCT03274765|Estrogens|estrogens|mesh-ancestor
83837732|NCT03274765|Hormones|hormones|mesh-ancestor
83837733|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837734|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837735|NCT00454402|Alfuzosin|alfuzosin|mesh-list
83837736|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83837737|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83837738|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83837739|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
83837740|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837741|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837742|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837743|NCT00454402|Urological Agents|urological agents|mesh-ancestor
83837744|NCT00143676|Atorvastatin|atorvastatin|mesh-list
83837745|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83837746|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83837747|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
83837748|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837749|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83837750|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83837751|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837752|NCT00454480|Cytarabine|cytarabine|mesh-list
83837753|NCT00454480|Fludarabine|fludarabine|mesh-list
83837754|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
83837755|NCT00454480|Azacitidine|azacitidine|mesh-list
83837756|NCT00454480|Melphalan|melphalan|mesh-list
83837757|NCT00454480|Busulfan|busulfan|mesh-list
83837758|NCT00454480|Daunorubicin|daunorubicin|mesh-list
83837759|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
83837760|NCT00454480|Clofarabine|clofarabine|mesh-list
83837761|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
83837762|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
83837763|NCT00454480|Tipifarnib|tipifarnib|mesh-list
83837764|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837765|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83837766|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
83837767|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837768|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83837769|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
83837770|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837771|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
83837772|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837773|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837774|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83837775|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
83837776|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83837777|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83837778|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83837779|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83837780|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83837781|NCT00454480|Immunotoxins|immunotoxins|mesh-ancestor
83837782|NCT00454480|Immunoconjugates|immunoconjugates|mesh-ancestor
83837783|NCT00110006|Prednisone|prednisone|mesh-list
83837784|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
83837785|NCT00110006|Rituximab|rituximab|mesh-list
83837786|NCT00110006|Doxorubicin|doxorubicin|mesh-list
83837787|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83837788|NCT00110006|Vincristine|vincristine|mesh-list
83837789|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83837790|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83837791|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
83837792|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837793|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837794|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83837795|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
83837796|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837797|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837798|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83837799|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83837800|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83837801|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83837802|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83837803|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837804|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837805|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
83837806|NCT00110006|Hormones|hormones|mesh-ancestor
83837807|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837808|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83837809|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83837810|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837811|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837812|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837813|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83837814|NCT00454519|Mitomycins|mitomycins|mesh-list
83837815|NCT00454519|Mitomycin|mitomycin|mesh-list
83837816|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837817|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83837818|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
83837819|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837820|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83837821|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837822|NCT00112749|Infliximab|infliximab|mesh-list
83837823|NCT00112749|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83837824|NCT00112749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83837825|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83837826|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837827|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837828|NCT00110045|Caspofungin|caspofungin|mesh-list
83837829|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
83837830|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837831|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837832|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837833|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
83837834|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
83837835|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83837836|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83837837|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837838|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837839|NCT00454714|Urological Agents|urological agents|mesh-ancestor
83837840|NCT00143715|Vitamin K|vitamin k|mesh-list
83837841|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
83837842|NCT00143715|Vitamins|vitamins|mesh-ancestor
83837843|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
83837844|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837845|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83837846|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83837847|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837848|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
83837849|NCT00143715|Coagulants|coagulants|mesh-ancestor
83837850|NCT00454831|Chitosan|chitosan|mesh-list
83837851|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83837852|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83837853|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
83837854|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837855|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83837856|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
83837857|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
83837858|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
83837859|NCT00454831|Coagulants|coagulants|mesh-ancestor
83837860|NCT00110123|Fotemustine|fotemustine|mesh-list
83837861|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837862|NCT00455026|Remifentanil|remifentanil|mesh-list
83837863|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83837864|NCT00455026|Narcotics|narcotics|mesh-ancestor
83837865|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83837866|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837867|NCT00455026|Analgesics|analgesics|mesh-ancestor
83837868|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
83837869|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837870|NCT00143325|Varenicline|varenicline|mesh-list
83837871|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83837872|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83837873|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
83837874|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83837875|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837876|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837877|NCT00112983|Eculizumab|eculizumab|mesh-list
83837878|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83837879|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83837880|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
83837881|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837882|NCT00110162|Hormones|hormones|mesh-list
83837883|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
83837884|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837885|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837886|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
83837887|NCT02273713|Paclitaxel|paclitaxel|mesh-list
83837888|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83837889|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837890|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837891|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837892|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837893|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837894|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83837895|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
83837896|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837897|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83837898|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83837899|NCT02273791|Clomiphene|clomiphene|mesh-list
83837900|NCT02273791|Enclomiphene|enclomiphene|mesh-list
83837901|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
83837902|NCT02273791|Estradiol|estradiol|mesh-list
83837903|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83837904|NCT02273791|Estrogens|estrogens|mesh-ancestor
83837905|NCT02273791|Hormones|hormones|mesh-ancestor
83837906|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83837907|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837908|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83837909|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
83837910|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83837911|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83837912|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83837913|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
83837914|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83837915|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
83837916|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83837917|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83837918|NCT00110240|Vildagliptin|vildagliptin|mesh-list
83837919|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83837920|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837921|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83837922|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83837923|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837924|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837925|NCT00455416|Selenium|selenium|mesh-list
83837926|NCT00455416|Allicin|allicin|mesh-list
83837927|NCT00455416|Resveratrol|resveratrol|mesh-list
83837928|NCT00455416|Quercetin|quercetin|mesh-list
83837929|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
83837930|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837931|NCT00455416|Protective Agents|protective agents|mesh-ancestor
83837932|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837933|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837934|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83837935|NCT00455416|Trace Elements|trace elements|mesh-ancestor
83837936|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
83837937|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837938|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83837939|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
83837940|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83837942|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83837943|NCT00143871|Rituximab|rituximab|mesh-list
83837944|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83837945|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837946|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
83837947|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837948|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83837949|NCT00455572|Vinorelbine|vinorelbine|mesh-list
83837950|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837951|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83837952|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837953|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837954|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837955|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837956|NCT00401492|Gemcitabine|gemcitabine|mesh-list
83837957|NCT00401492|Vinorelbine|vinorelbine|mesh-list
83837958|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837959|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83837960|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
83837961|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837962|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83837963|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
83837964|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
83837965|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
83837966|NCT00455806|Amoxicillin|amoxicillin|mesh-list
83837967|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
83837968|NCT00455806|Esomeprazole|esomeprazole|mesh-list
83837969|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83837970|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83837971|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83837972|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83837973|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83837974|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83837975|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83837976|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83837977|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83837978|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83837979|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
83837980|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83837981|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
83837982|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83837983|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837984|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83837985|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83837986|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83837987|NCT00110474|Acetaminophen|acetaminophen|mesh-list
83837988|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83837989|NCT00110474|Analgesics|analgesics|mesh-ancestor
83837990|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
83837991|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83837992|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83837993|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
83837994|NCT00113100|Ethanol|ethanol|mesh-list
83837995|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83837996|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83837997|NCT00113100|Estradiol|estradiol|mesh-list
83837998|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83837999|NCT00113100|Estrogens|estrogens|mesh-ancestor
83838000|NCT00113100|Hormones|hormones|mesh-ancestor
83838001|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838002|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838003|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83838004|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
83838005|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83838006|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83838007|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83838008|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838009|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838010|NCT00143949|Losartan|losartan|mesh-list
83838011|NCT00143949|Enalapril|enalapril|mesh-list
83838012|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83838013|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83838014|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83838015|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83838016|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838017|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83838018|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
83838019|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838020|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
83838021|NCT00456235|Cyclosporine|cyclosporine|mesh-list
83838022|NCT00456235|Tacrolimus|tacrolimus|mesh-list
83838023|NCT00456235|Cyclosporins|cyclosporins|mesh-list
83838024|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838025|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
83838026|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838027|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83838028|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838029|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838030|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83838031|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838032|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83838033|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
83838034|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83838035|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838036|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
83838037|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83838038|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838039|NCT00456313|Fluticasone|fluticasone|mesh-list
83838040|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83838041|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83838042|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
83838043|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838044|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838045|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83838046|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
83838047|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
83838048|NCT00456313|Hormones|hormones|mesh-ancestor
83838049|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838050|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
83838051|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838052|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
83838053|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83838054|NCT00110630|Nicotine|nicotine|mesh-list
83838055|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83838056|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
83838057|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838058|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838059|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83838060|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83838061|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
83838062|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838063|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838064|NCT00456430|Escitalopram|escitalopram|mesh-list
83838065|NCT00456430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83838066|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83838067|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838068|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838069|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838070|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
83838071|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838072|NCT00456586|Istradefylline|istradefylline|mesh-list
83838073|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83838074|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83838075|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83838076|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
83838077|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838078|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838079|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838080|NCT00110669|Prednisone|prednisone|mesh-list
83838081|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838082|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
83838083|NCT00110669|Hormones|hormones|mesh-ancestor
83838084|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838085|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838086|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83838087|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993577|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
83838089|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
83838090|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838091|NCT00113256|Rubitecan|rubitecan|mesh-list
83838092|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838093|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83838094|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83838095|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838096|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838097|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
83838098|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83838099|NCT00110708|Antibodies|antibodies|mesh-list
83838100|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
83838101|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838102|NCT00456820|Bupropion|bupropion|mesh-list
83838103|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83838104|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
83838105|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838106|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83838107|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83838108|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838109|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838110|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
83838111|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838112|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838113|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83838114|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83838115|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838116|NCT00456898|Codeine|codeine|mesh-list
83838117|NCT00456898|Paroxetine|paroxetine|mesh-list
83838118|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83838119|NCT00456898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83838120|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83838121|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838122|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838123|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838124|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
83838125|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838126|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83838127|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
83838128|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838129|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83838130|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83838131|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838132|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83838133|NCT00456898|Narcotics|narcotics|mesh-ancestor
83838134|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838135|NCT00456898|Analgesics|analgesics|mesh-ancestor
83838136|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
83838137|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838138|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
83838139|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83838140|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83838141|NCT03274102|Vaccines|vaccines|mesh-list
83838142|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
83838143|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838144|NCT00110747|Lidocaine|lidocaine|mesh-list
83838145|NCT00110747|Tetracaine|tetracaine|mesh-list
83838146|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
83838147|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
83838148|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838149|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838150|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
83838151|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838152|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83838153|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82993648|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82993649|NCT03668054|Growth Substances|growth substances|mesh-ancestor
82993650|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993651|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
82993652|NCT04698187|Nivolumab|nivolumab|mesh-list
82993653|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83838154|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83838155|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838156|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838157|NCT00456937|Escitalopram|escitalopram|mesh-list
83838158|NCT00456937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83838159|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83838160|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838161|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838162|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838163|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
83838164|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838165|NCT00456976|Selegiline|selegiline|mesh-list
83838166|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
83838167|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838168|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83838169|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83838170|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83838171|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838172|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838173|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83838174|NCT00456976|Protective Agents|protective agents|mesh-ancestor
83838175|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838176|NCT00144066|Gefitinib|gefitinib|mesh-list
83838177|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838178|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83838179|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838180|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838181|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
83838182|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
83838183|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838184|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838185|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838186|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
83838187|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83838188|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838189|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838190|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
83838191|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83838192|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838193|NCT00457405|Dipyridamole|dipyridamole|mesh-list
83838194|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83838195|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838196|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838197|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83838198|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
83838199|NCT00457483|Valsartan|valsartan|mesh-list
83838200|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83838201|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83838202|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83838203|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83838204|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838205|NCT00457483|Diuretics|diuretics|mesh-ancestor
83838206|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
83838207|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838208|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83838209|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838210|NCT00110864|Insulin|insulin|mesh-list
83838211|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83838212|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838213|NCT00457678|Dexamethasone|dexamethasone|mesh-list
83838214|NCT00457678|Ranibizumab|ranibizumab|mesh-list
83838215|NCT00457678|Verteporfin|verteporfin|mesh-list
83838216|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838217|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
83838218|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
83838219|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838220|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838221|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838222|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
83838223|NCT00457678|Hormones|hormones|mesh-ancestor
83838224|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838225|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83838226|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838227|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83838228|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83838229|NCT00457678|Growth Substances|growth substances|mesh-ancestor
83838230|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
83838231|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83838232|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
83838234|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83838235|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83838236|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83838237|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
83838238|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838239|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838240|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83838241|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
83838242|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
83838243|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
83838244|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83838245|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83838246|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
83838247|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838248|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838249|NCT00110903|Etanercept|etanercept|mesh-list
83838250|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83838251|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838252|NCT00110903|Analgesics|analgesics|mesh-ancestor
83838253|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
83838254|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838255|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838256|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838257|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838258|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838259|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838260|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
83838261|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
83838262|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
83838263|NCT00144144|Giapreza|giapreza|mesh-list
83838264|NCT00144144|Calcium|calcium|mesh-list
83838265|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
83838266|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83838267|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83838268|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838269|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83838270|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83838271|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
83838272|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838273|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838274|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838275|NCT00465673|Doxorubicin|doxorubicin|mesh-list
83838276|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83838277|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83838278|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838279|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83838280|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83838281|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838282|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838283|NCT00144183|Zidovudine|zidovudine|mesh-list
83838284|NCT00144183|Nevirapine|nevirapine|mesh-list
83838285|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
83838286|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838287|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83838288|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83838289|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838290|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
83838291|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838292|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83838293|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83838294|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83838295|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83838296|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83838297|NCT00465751|Cathartics|cathartics|mesh-ancestor
83838298|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838299|NCT00110981|Etanercept|etanercept|mesh-list
83838300|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82993808|NCT03867487|Empagliflozin|empagliflozin|mesh-list
83838301|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838302|NCT00110981|Analgesics|analgesics|mesh-ancestor
83838303|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
83838304|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838305|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838306|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838307|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838308|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838309|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838310|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
83838311|NCT00465907|Paclitaxel|paclitaxel|mesh-list
83838312|NCT00465907|Carboplatin|carboplatin|mesh-list
83838313|NCT00465907|Irinotecan|irinotecan|mesh-list
83838314|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83838315|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838316|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83838317|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83838318|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83838319|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838320|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83838321|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83838322|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838323|NCT00113685|Dextrans|dextrans|mesh-list
83838324|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83838325|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
83838326|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
83838327|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
83838328|NCT00111020|Sorafenib|sorafenib|mesh-list
83838329|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838330|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83838331|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838332|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838333|NCT00466063|Deferasirox|deferasirox|mesh-list
83838334|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83838335|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
83838336|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
83838337|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838338|NCT00466102|Everolimus|everolimus|mesh-list
83838339|NCT00466102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83838340|NCT00466102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83838341|NCT00466102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838342|NCT00466102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838343|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838344|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
83838345|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838346|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838347|NCT00144222|Telmisartan|telmisartan|mesh-list
83838348|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83838349|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83838350|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83838351|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838352|NCT00466180|Nevirapine|nevirapine|mesh-list
83838353|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83838354|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83838355|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838356|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838357|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
83838358|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838359|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83838360|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83838361|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83838362|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83838363|NCT00466219|Interferons|interferons|mesh-list
83838364|NCT00466219|Ribavirin|ribavirin|mesh-list
83838365|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
83838366|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
83838367|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83838368|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838369|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
83838370|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838371|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
83838372|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838373|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
83838374|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838375|NCT00144261|Nevirapine|nevirapine|mesh-list
83838376|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83838377|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83838378|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838379|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838380|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
83838381|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838382|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83838383|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83838384|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83838385|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83838386|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83838387|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
83838388|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838389|NCT00144378|Irinotecan|irinotecan|mesh-list
83838390|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83838391|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83838392|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838393|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838394|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838395|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
83838396|NCT00111098|Hematinics|hematinics|mesh-ancestor
83838397|NCT00347698|Bevacizumab|bevacizumab|mesh-list
83838398|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83838399|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838400|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83838401|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83838402|NCT00347698|Growth Substances|growth substances|mesh-ancestor
83838403|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838404|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
83838405|NCT00347737|Teriparatide|teriparatide|mesh-list
83838406|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83838407|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838408|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83838409|NCT00347815|Buprenorphine|buprenorphine|mesh-list
83838410|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83838411|NCT00347815|Narcotics|narcotics|mesh-ancestor
83838412|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838413|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838414|NCT00347815|Analgesics|analgesics|mesh-ancestor
83838415|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
83838416|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838417|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83838418|NCT00113802|Epratuzumab|epratuzumab|mesh-list
83838419|NCT00113802|Antibodies|antibodies|mesh-list
83838420|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
83838421|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838422|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83838423|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838424|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
83838425|NCT00111137|Hematinics|hematinics|mesh-ancestor
83838426|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83838427|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83838428|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
83838429|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83838430|NCT00347854|Laxatives|laxatives|mesh-ancestor
83838431|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838432|NCT00347971|Rituximab|rituximab|mesh-list
83838433|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83838434|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838435|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
83838436|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838437|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838438|NCT00113958|Cinacalcet|cinacalcet|mesh-list
83838439|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83838440|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838441|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83838442|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
83838443|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838444|NCT00348010|Tramadol|tramadol|mesh-list
83838445|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83838446|NCT00348010|Narcotics|narcotics|mesh-ancestor
83838447|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838448|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838449|NCT00348010|Analgesics|analgesics|mesh-ancestor
83838450|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
83838451|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838452|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
83838454|NCT00144417|Isoniazid|isoniazid|mesh-list
83838455|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
83838456|NCT00144417|Ethambutol|ethambutol|mesh-list
83838457|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83838458|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838459|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83838460|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83838461|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838462|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838463|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838464|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83838465|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
83838466|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
83838467|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83838468|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83838469|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83838470|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83838471|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83838472|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83838473|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83838474|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83838475|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83838476|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
83838477|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83838478|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83838479|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
83838480|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83838481|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83838482|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838483|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
83838484|NCT00111215|Coagulants|coagulants|mesh-ancestor
83838485|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83838486|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
83838487|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838488|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
83838489|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
83838490|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
83838491|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838492|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838493|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
83838494|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83838495|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83838496|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
83838497|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838498|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838499|NCT00348244|Prednisolone|prednisolone|mesh-list
83838500|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83838501|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
83838502|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83838503|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
83838504|NCT00348244|Ketorolac|ketorolac|mesh-list
83838505|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83838506|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
83838507|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838508|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
83838509|NCT00348244|Hormones|hormones|mesh-ancestor
83838510|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838511|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838512|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83838513|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838514|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
83838515|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
83838516|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838517|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838518|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83838519|NCT00348244|Protective Agents|protective agents|mesh-ancestor
83838520|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83838521|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838522|NCT00348244|Analgesics|analgesics|mesh-ancestor
83838523|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
83838524|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838525|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83838526|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994024|NCT04702789|Timolol|timolol|mesh-list
83838527|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838528|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83838529|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
83838530|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83838531|NCT00348361|Fluticasone|fluticasone|mesh-list
83838532|NCT00348361|Xhance|xhance|mesh-list
83838533|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838534|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83838535|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
83838536|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838537|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838538|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83838539|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
83838540|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83838541|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83838542|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83838543|NCT00348400|Dorzolamide|dorzolamide|mesh-list
83838544|NCT00348400|Latanoprost|latanoprost|mesh-list
83838545|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83838546|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83838547|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83838548|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83838549|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83838550|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83838551|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
83838552|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838553|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838554|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838555|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83838556|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838557|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
83838558|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83838559|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
83838560|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83838561|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838562|NCT00144456|Vitamins|vitamins|mesh-ancestor
83838563|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
83838564|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
83838565|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83838566|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83838567|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838568|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83838569|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83838570|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
83838571|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83838572|NCT00348517|Laxatives|laxatives|mesh-ancestor
83838573|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838574|NCT00348634|Tegaserod|tegaserod|mesh-list
83838575|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83838576|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
83838577|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838578|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838579|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838580|NCT00348712|Insulin|insulin|mesh-list
83838581|NCT00348712|Metformin|metformin|mesh-list
83838582|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
83838583|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83838584|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83838585|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838586|NCT02964689|Pemetrexed|pemetrexed|mesh-list
83838587|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838588|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838589|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838590|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83838591|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83838592|NCT00348985|Bortezomib|bortezomib|mesh-list
83838593|NCT00348985|Belinostat|belinostat|mesh-list
83838594|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838595|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83838596|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838597|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838598|NCT00349024|Povidone|povidone|mesh-list
83838599|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
83838600|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83838601|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
83838602|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838603|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
83838604|NCT00349024|Protective Agents|protective agents|mesh-ancestor
83838605|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
83838606|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
83838607|NCT00111371|Levodopa|levodopa|mesh-list
83838608|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83838609|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83838610|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
83838611|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838612|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838613|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838614|NCT00349180|Enoxaparin|enoxaparin|mesh-list
83838615|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
83838616|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
83838617|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83838618|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83838619|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838620|NCT00421369|Sertraline|sertraline|mesh-list
83838621|NCT00421369|Reboxetine|reboxetine|mesh-list
83838622|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
83838623|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838624|NCT00421369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83838625|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83838626|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838627|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838628|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838629|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
83838630|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838631|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83838632|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
83838633|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83838634|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838635|NCT00421447|Anastrozole|anastrozole|mesh-list
83838636|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83838637|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838638|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83838639|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83838640|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838641|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838642|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83838643|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
83838644|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838645|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838646|NCT04729140|Doxycycline|doxycycline|mesh-list
83838647|NCT04729140|Ivermectin|ivermectin|mesh-list
83838648|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83838649|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838650|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
83838651|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83838652|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83838653|NCT00349219|Cisplatin|cisplatin|mesh-list
83838654|NCT00349219|Gemcitabine|gemcitabine|mesh-list
83838655|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83838656|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838657|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83838658|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
83838659|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838660|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83838661|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838662|NCT00111449|Etanercept|etanercept|mesh-list
83838663|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83838664|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838665|NCT00111449|Analgesics|analgesics|mesh-ancestor
83838666|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
83838667|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838668|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838669|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838670|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838671|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838672|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838673|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
83838674|NCT00349258|Leuprolide|leuprolide|mesh-list
83838675|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83838676|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
83838677|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83838678|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838679|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83838680|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838681|NCT00349375|Simvastatin|simvastatin|mesh-list
83838682|NCT00349375|Fenofibrate|fenofibrate|mesh-list
83838683|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83838684|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83838685|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
83838686|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838687|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83838688|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83838689|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838690|NCT00349453|Deferiprone|deferiprone|mesh-list
83838691|NCT00349453|Deferoxamine|deferoxamine|mesh-list
83838692|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83838693|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
83838694|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
83838695|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838696|NCT00349453|Siderophores|siderophores|mesh-ancestor
83838698|NCT00349492|Irinotecan|irinotecan|mesh-list
83838699|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838700|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83838701|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83838702|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838703|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838704|NCT00349531|Pramipexole|pramipexole|mesh-list
83838705|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
83838706|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838707|NCT00349531|Protective Agents|protective agents|mesh-ancestor
83838708|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838709|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83838710|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83838711|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
83838712|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
83838713|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838714|NCT00111566|Eptifibatide|eptifibatide|mesh-list
83838715|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83838716|NCT00404703|Bevacizumab|bevacizumab|mesh-list
83838717|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83838718|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838719|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83838720|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83838721|NCT00404703|Growth Substances|growth substances|mesh-ancestor
83838722|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838723|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
83838724|NCT00349726|Inositol|inositol|mesh-list
83838725|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
83838726|NCT00349726|Vitamins|vitamins|mesh-ancestor
83838727|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
83838728|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838729|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
83838730|NCT00111644|Lactams|lactams|mesh-list
83838731|NCT00111644|beta-Lactams|beta-lactams|mesh-list
83838732|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83838733|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838734|NCT00350038|Irbesartan|irbesartan|mesh-list
83838735|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
83838736|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83838737|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83838738|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83838739|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838740|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83838741|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
83838742|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83838743|NCT00350077|Vitamins|vitamins|mesh-list
83838744|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
83838745|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
83838746|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838747|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
83838748|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838749|NCT00350077|Protective Agents|protective agents|mesh-ancestor
83838750|NCT00114153|Carboplatin|carboplatin|mesh-list
83838751|NCT00114153|Capecitabine|capecitabine|mesh-list
83838752|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838753|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83838754|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
83838755|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838756|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
83838757|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
83838758|NCT00350116|Vitamins|vitamins|mesh-ancestor
83838759|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
83838760|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838761|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
83838762|NCT00350116|Hematinics|hematinics|mesh-ancestor
83838763|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
83838764|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83838765|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83838766|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838767|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838768|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83838769|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838770|NCT00350155|Analgesics|analgesics|mesh-ancestor
83838771|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
83838772|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838773|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838774|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838775|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838776|NCT00404781|Aspirin|aspirin|mesh-list
83838777|NCT00404781|Cilostazol|cilostazol|mesh-list
83838778|NCT00404781|Clopidogrel|clopidogrel|mesh-list
83838779|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83838780|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838781|NCT00404781|Analgesics|analgesics|mesh-ancestor
83838782|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
83838783|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838784|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838785|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838786|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838787|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83838788|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83838789|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838790|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83838791|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83838792|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838793|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
83838794|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83838795|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83838796|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83838797|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
83838798|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838799|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83838800|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
83838801|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83838802|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
83838803|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
83838804|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83838805|NCT00404781|Protective Agents|protective agents|mesh-ancestor
83838806|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83838807|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83838808|NCT00350311|Nicotine|nicotine|mesh-list
83838809|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83838810|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
83838811|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838812|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838813|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83838814|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83838815|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
83838816|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838817|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838818|NCT00114192|Thalidomide|thalidomide|mesh-list
83838819|NCT00114192|Docetaxel|docetaxel|mesh-list
83838820|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838821|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
83838822|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
83838823|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
83838824|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838825|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838826|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
83838827|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838828|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
83838829|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83838830|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83838831|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83838832|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83838833|NCT00114192|Growth Substances|growth substances|mesh-ancestor
83838834|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
83838835|NCT00350467|Olanzapine|olanzapine|mesh-list
83838836|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83838837|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
83838838|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
83838839|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838840|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838841|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838842|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83838843|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83838844|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838845|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838846|NCT00350467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83838847|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83838848|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838849|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838850|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838851|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
83838852|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83838853|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83838854|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83838855|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83838856|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
83838857|NCT00350662|Deferiprone|deferiprone|mesh-list
83838858|NCT00350662|Deferoxamine|deferoxamine|mesh-list
83838859|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83838860|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
83838861|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
83838862|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838863|NCT00350662|Siderophores|siderophores|mesh-ancestor
83838864|NCT00350818|Azacitidine|azacitidine|mesh-list
83838865|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83838866|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
83838867|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838868|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838869|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838870|NCT00350857|Carbamazepine|carbamazepine|mesh-list
83838871|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
83838872|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
83838873|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83838874|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838875|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838876|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838877|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838878|NCT00350857|Analgesics|analgesics|mesh-ancestor
83838879|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
83838880|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838881|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83838882|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838883|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838884|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83838885|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83838886|NCT00111956|Etanercept|etanercept|mesh-list
83838887|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83838888|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838889|NCT00111956|Analgesics|analgesics|mesh-ancestor
83838890|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
83838891|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838892|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838893|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838894|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838895|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83838896|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838897|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
83838898|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
83838899|NCT00114270|Letrozole|letrozole|mesh-list
83838900|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838901|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83838902|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83838903|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838904|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838905|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83838906|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
83838907|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83838908|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838909|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83838910|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
83838911|NCT00111995|Hematinics|hematinics|mesh-ancestor
83838912|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
83838913|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83838914|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83838915|NCT00351052|Analgesics|analgesics|mesh-ancestor
83838916|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
83838917|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83838918|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838919|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83838920|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83838921|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
83838922|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83838923|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
83838924|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83838925|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838926|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838927|NCT00401609|Carboplatin|carboplatin|mesh-list
83838928|NCT00401609|Gemcitabine|gemcitabine|mesh-list
83838929|NCT00401609|Etoposide|etoposide|mesh-list
83838930|NCT00401609|Vinorelbine|vinorelbine|mesh-list
83838931|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83838932|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83838933|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
83838934|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838935|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83838936|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83838937|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83838938|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838939|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
83838940|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
83838941|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
83838942|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
83838943|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83838944|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838945|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838946|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83838947|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838948|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83838949|NCT00351130|Amlodipine|amlodipine|mesh-list
83838950|NCT00351130|Valsartan|valsartan|mesh-list
83838951|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83838952|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83838953|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838954|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838955|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83838956|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838957|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
83838958|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83838959|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83838960|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83838961|NCT00351169|Escitalopram|escitalopram|mesh-list
83838962|NCT00351169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83838963|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83838964|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83838965|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838966|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83838967|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
83838968|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838969|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
83838970|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83838971|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83838972|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83838973|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83838974|NCT00401648|Brivaracetam|brivaracetam|mesh-list
83838975|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
83838976|NCT00351286|Simvastatin|simvastatin|mesh-list
83838977|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83838978|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83838979|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
83838980|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838981|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83838982|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83838983|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83838984|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
83838985|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83838986|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83838987|NCT00112034|Prednisolone|prednisolone|mesh-list
83838988|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
83838989|NCT00112034|Methotrexate|methotrexate|mesh-list
83838990|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83838991|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
83838992|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83838993|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
83838994|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83838995|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83838996|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83838997|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
83838998|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83838999|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839000|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
83839001|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839002|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83839003|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839004|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
83839005|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839006|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83839007|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839008|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
83839009|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
83839010|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839011|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83839012|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
83839013|NCT00112034|Hormones|hormones|mesh-ancestor
83839014|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839015|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83839016|NCT00112034|Protective Agents|protective agents|mesh-ancestor
83839017|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83839018|NCT00114387|Tocopherols|tocopherols|mesh-list
83839019|NCT00114387|Vitamin E|vitamin e|mesh-list
83839020|NCT00114387|Tocotrienols|tocotrienols|mesh-list
83839021|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
83839022|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
83839023|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839024|NCT00114387|Protective Agents|protective agents|mesh-ancestor
83839025|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839026|NCT00114387|Vitamins|vitamins|mesh-ancestor
83839027|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
83839028|NCT00351364|Montelukast|montelukast|mesh-list
83839029|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83839030|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
83839031|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83839032|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83839033|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839034|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839035|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83839036|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83839037|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839038|NCT00351403|Ribavirin|ribavirin|mesh-list
83839039|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83839040|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
83839041|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839042|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
83839043|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839044|NCT05595096|Anesthetics|anesthetics|mesh-list
83839045|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839046|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994543|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
82994544|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
82994545|NCT01068860|Insulin|insulin|mesh-list
82994546|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82994547|NCT01068860|Metformin|metformin|mesh-list
82994548|NCT01068860|Glimepiride|glimepiride|mesh-list
82994549|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
82994550|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
83839047|NCT00351637|Methadone|methadone|mesh-list
83839048|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83839049|NCT00351637|Narcotics|narcotics|mesh-ancestor
83839050|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839051|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839052|NCT00351637|Analgesics|analgesics|mesh-ancestor
83839053|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
83839054|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839055|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
83839056|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83839057|NCT00351715|Methadone|methadone|mesh-list
83839058|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83839059|NCT00351715|Narcotics|narcotics|mesh-ancestor
83839060|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839061|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839062|NCT00351715|Analgesics|analgesics|mesh-ancestor
83839063|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
83839064|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839065|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
83839066|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83839067|NCT00351832|Vildagliptin|vildagliptin|mesh-list
83839068|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83839069|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839070|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83839071|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
83839072|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839073|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839074|NCT00351871|Ribavirin|ribavirin|mesh-list
83839075|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83839076|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
83839077|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839078|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
83839079|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839080|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83839081|NCT00351910|Amitriptyline|amitriptyline|mesh-list
83839082|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83839083|NCT00351910|Citalopram|citalopram|mesh-list
83839084|NCT00351910|Bupropion|bupropion|mesh-list
83839085|NCT00351910|Fluoxetine|fluoxetine|mesh-list
83839086|NCT00351910|Paroxetine|paroxetine|mesh-list
83839087|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83839088|NCT00351910|Sertraline|sertraline|mesh-list
83839089|NCT00351910|Escitalopram|escitalopram|mesh-list
83839090|NCT00351910|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83839091|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839092|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839093|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839094|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839095|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
83839096|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839097|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839098|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83839099|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
83839100|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839101|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83839102|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
83839103|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83839104|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83839105|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839106|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83839107|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83839108|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839109|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83839110|NCT00351910|Analgesics|analgesics|mesh-ancestor
83839111|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
83839112|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83839113|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83839114|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83839115|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
83839116|NCT00112346|Gemcitabine|gemcitabine|mesh-list
83839117|NCT00112346|Cetuximab|cetuximab|mesh-list
83839118|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82994621|NCT02391142|Lidocaine|lidocaine|mesh-list
83839119|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
83839120|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839121|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839122|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83839124|NCT00352144|Zopiclone|zopiclone|mesh-list
83839125|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83839126|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839127|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839128|NCT00352183|Simvastatin|simvastatin|mesh-list
83839129|NCT00352183|Fenofibrate|fenofibrate|mesh-list
83839130|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83839131|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83839132|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
83839133|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839134|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83839135|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83839136|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839137|NCT00112619|Topotecan|topotecan|mesh-list
83839138|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83839139|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83839140|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839141|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839142|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839143|NCT00352261|Esomeprazole|esomeprazole|mesh-list
83839144|NCT00352261|Lansoprazole|lansoprazole|mesh-list
83839145|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
83839146|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83839147|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83839148|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83839149|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839150|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839151|NCT00352300|Paclitaxel|paclitaxel|mesh-list
83839152|NCT00352300|Carboplatin|carboplatin|mesh-list
83839153|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83839154|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839155|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839156|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839157|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839158|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839159|NCT00112658|Leucovorin|leucovorin|mesh-list
83839160|NCT00112658|Gemcitabine|gemcitabine|mesh-list
83839161|NCT00112658|Fluorouracil|fluorouracil|mesh-list
83839162|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
83839163|NCT00112658|Irinotecan|irinotecan|mesh-list
83839164|NCT00112658|Calcium|calcium|mesh-list
83839165|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
83839166|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839167|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
83839168|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839169|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839170|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839171|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839172|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839173|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
83839174|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83839175|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83839176|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839177|NCT00112658|Antidotes|antidotes|mesh-ancestor
83839178|NCT00112658|Protective Agents|protective agents|mesh-ancestor
83839179|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
83839180|NCT00112658|Vitamins|vitamins|mesh-ancestor
83839181|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
83839182|NCT00352339|Aripiprazole|aripiprazole|mesh-list
83839183|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83839184|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839185|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83839186|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83839187|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839188|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839189|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
83839190|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
83839191|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839192|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839193|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83839194|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83839195|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
83839196|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83839197|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83839198|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83839199|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83839200|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
83839202|NCT00352378|Doxorubicin|doxorubicin|mesh-list
83839203|NCT00352378|Capecitabine|capecitabine|mesh-list
83839204|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839205|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
83839206|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839207|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839208|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83839209|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
83839210|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839211|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839212|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83839213|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839214|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839215|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839216|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83839217|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83839218|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83839219|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839220|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839221|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
83839222|NCT00352495|Carboplatin|carboplatin|mesh-list
83839223|NCT00352495|Vinblastine|vinblastine|mesh-list
83839224|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839225|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83839226|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839227|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839228|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839229|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839230|NCT00112697|Docetaxel|docetaxel|mesh-list
83839231|NCT00112697|Fluorouracil|fluorouracil|mesh-list
83839232|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839233|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839234|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839235|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839236|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839237|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
83839238|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839239|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839240|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
83839241|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839242|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
83839243|NCT02959606|Clopidogrel|clopidogrel|mesh-list
83839244|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83839245|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83839246|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83839247|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83839248|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
83839249|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839250|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839251|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839252|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83839253|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83839254|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83839255|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
83839256|NCT00352651|Pregabalin|pregabalin|mesh-list
83839257|NCT00352651|Analgesics|analgesics|mesh-ancestor
83839258|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
83839259|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839260|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839261|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
83839262|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83839263|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839264|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839265|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839266|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83839267|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83839268|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839269|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839270|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
83839271|NCT00112775|Dasatinib|dasatinib|mesh-list
83839272|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839273|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83839274|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839275|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839276|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
83839277|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839278|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839279|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83839280|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83839281|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839282|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839283|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839284|NCT00352768|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83398253|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
83839285|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839286|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839287|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839288|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
83839289|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83839290|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
83839291|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83839292|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83839293|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83839294|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83839295|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83839296|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83839297|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83839298|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83839299|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
83839300|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839301|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839302|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839303|NCT00112853|Etoposide|etoposide|mesh-list
83839304|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
83839305|NCT00112853|Tipifarnib|tipifarnib|mesh-list
83839306|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83839307|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839308|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83839309|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83839310|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839311|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839312|NCT00353002|Lidocaine|lidocaine|mesh-list
83839313|NCT00353002|Tetracaine|tetracaine|mesh-list
83839314|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
83839315|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
83839316|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839317|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839318|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
83839319|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839320|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83839321|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83839322|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83839323|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839324|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839325|NCT00353041|Lidocaine|lidocaine|mesh-list
83839326|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
83839327|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
83839328|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839329|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839330|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
83839331|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839332|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83839333|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83839334|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83839335|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839336|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839337|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
83839338|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83839339|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839340|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839341|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839342|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839343|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83839344|NCT00112892|Selenium|selenium|mesh-list
83839345|NCT00112892|Irinotecan|irinotecan|mesh-list
83839346|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83839347|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83839348|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839349|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839350|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839351|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
83839352|NCT00112892|Protective Agents|protective agents|mesh-ancestor
83839353|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839354|NCT00112892|Trace Elements|trace elements|mesh-ancestor
83839355|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
83839356|NCT00353665|Riluzole|riluzole|mesh-list
83839357|NCT00353665|Memantine|memantine|mesh-list
83839358|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83839359|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83839360|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
83839361|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839362|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839363|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839364|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83839365|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83839366|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
83839367|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83839368|NCT00353665|Protective Agents|protective agents|mesh-ancestor
83839369|NCT05594784|Prednisone|prednisone|mesh-list
83839370|NCT05594784|Vincristine|vincristine|mesh-list
83839371|NCT05594784|Venetoclax|venetoclax|mesh-list
83839372|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839373|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
83839374|NCT05594784|Hormones|hormones|mesh-ancestor
83839375|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839376|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839377|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83839378|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839379|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83839380|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839381|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839382|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839383|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839384|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
83839385|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83839386|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839387|NCT00353743|Metronidazole|metronidazole|mesh-list
83839388|NCT00353743|Doxycycline|doxycycline|mesh-list
83839389|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839390|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83839391|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83839392|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83839393|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
83839394|NCT00113165|Lamotrigine|lamotrigine|mesh-list
83839395|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
83839396|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83839397|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839398|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839399|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839400|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839401|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83839402|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83839403|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839404|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839405|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83839406|NCT00354094|Reboxetine|reboxetine|mesh-list
83839407|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
83839408|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839409|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83839410|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839411|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839412|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839413|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83839414|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839415|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839416|NCT00114816|Docetaxel|docetaxel|mesh-list
83839417|NCT00114816|Capecitabine|capecitabine|mesh-list
82994920|NCT03495232|Cimetidine|cimetidine|mesh-list
83839418|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839419|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839420|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839421|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839422|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839423|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839424|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
83839425|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
83839426|NCT00354367|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83839427|NCT00354367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839428|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839429|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
83839430|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839431|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839432|NCT00354406|Abciximab|abciximab|mesh-list
83839433|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
83839434|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83839435|NCT00354523|Capecitabine|capecitabine|mesh-list
83839436|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
83839437|NCT00354523|Dacarbazine|dacarbazine|mesh-list
83839438|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839439|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
83839440|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839441|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839442|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83839443|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839444|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83839445|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
83839446|NCT00114933|Ritonavir|ritonavir|mesh-list
83839447|NCT00114933|Lopinavir|lopinavir|mesh-list
83839448|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83839449|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83839450|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
83839451|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839452|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839453|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83839454|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83839455|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
83839456|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839457|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83839458|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83839459|NCT00113282|Interleukin-2|interleukin-2|mesh-list
83839460|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839461|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83839462|NCT00113282|Analgesics|analgesics|mesh-ancestor
83839463|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
83839464|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839465|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839466|NCT00425932|Rituximab|rituximab|mesh-list
83839467|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83839468|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839469|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
83839470|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839471|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839472|NCT00426010|Caffeine|caffeine|mesh-list
83839473|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83839474|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839475|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83839476|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839477|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839478|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83839479|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83839480|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
83839481|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839482|NCT00115011|Escitalopram|escitalopram|mesh-list
83839483|NCT00115011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83839484|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839485|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839486|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839487|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839488|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
83839489|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839490|NCT00113594|Olanzapine|olanzapine|mesh-list
83839491|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
83839492|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
83839493|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839494|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839495|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83839496|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83839497|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83839498|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839499|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839500|NCT00113594|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83839501|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839502|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839503|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839504|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839505|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
83839506|NCT00426049|Everolimus|everolimus|mesh-list
83839507|NCT00426049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83839508|NCT00426049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83839509|NCT00426049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839510|NCT00426049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839511|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839512|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
83839513|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839514|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839515|NCT05594433|Lenograstim|lenograstim|mesh-list
83839516|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83839517|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
83839518|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839519|NCT00115089|Beclomethasone|beclomethasone|mesh-list
83839520|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839521|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
83839522|NCT00115089|Hormones|hormones|mesh-ancestor
83839523|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839524|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839525|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83839526|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
83839527|NCT00115128|Lenograstim|lenograstim|mesh-list
83839528|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83839529|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
83839530|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839531|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
83839532|NCT00115167|Hematinics|hematinics|mesh-ancestor
83839533|NCT00115245|Adefovir|adefovir|mesh-list
83839534|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83839535|NCT00115245|Telbivudine|telbivudine|mesh-list
83839536|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
83839537|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839538|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83839539|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83839540|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839541|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839542|NCT01059526|Ecallantide|ecallantide|mesh-list
83839543|NCT01059526|Analgesics|analgesics|mesh-ancestor
83839544|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
83839545|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839546|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839547|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83839548|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83839549|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839550|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839551|NCT00444340|Etanercept|etanercept|mesh-list
83839552|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83839553|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83839554|NCT00444340|Analgesics|analgesics|mesh-ancestor
83839555|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
83839556|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839557|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839558|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839559|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839560|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83839561|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839562|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
83839563|NCT00444379|Ritonavir|ritonavir|mesh-list
83839564|NCT00444379|Lopinavir|lopinavir|mesh-list
83839565|NCT00444379|Tenofovir|tenofovir|mesh-list
83839566|NCT00444379|Emtricitabine|emtricitabine|mesh-list
83839567|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83839569|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83839570|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83839571|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
83839572|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839573|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839574|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83839575|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83839576|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
83839577|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839578|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83839579|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83839580|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83839581|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83839582|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83839583|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83839584|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83839585|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83839586|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83839587|NCT00444418|Naltrexone|naltrexone|mesh-list
83839588|NCT00444418|Naloxone|naloxone|mesh-list
83839589|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83839590|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83839591|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839592|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
83839593|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839594|NCT00444574|Methylphenidate|methylphenidate|mesh-list
83839595|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83839596|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839597|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83839598|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839599|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839600|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839601|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
83839602|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839603|NCT00444652|Enoxaparin|enoxaparin|mesh-list
83839604|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
83839605|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83839606|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83839607|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839608|NCT04699903|Antibodies|antibodies|mesh-list
83839609|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
83839610|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
83839611|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839612|NCT00444808|Calcitonin|calcitonin|mesh-list
83839613|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
83839614|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83839615|NCT00444808|Katacalcin|katacalcin|mesh-list
83839616|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839617|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839618|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83839619|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
83839620|NCT00113828|Cyclosporine|cyclosporine|mesh-list
83839621|NCT00113828|Cyclosporins|cyclosporins|mesh-list
83839622|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839623|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839624|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839625|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
83839626|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839627|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
83173350|NCT00647231|Analgesics|analgesics|mesh-ancestor
83839628|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839629|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83839630|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839631|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83839632|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
83839633|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83839634|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83839635|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83839636|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839637|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839638|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
83839639|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839640|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839641|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83839642|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839643|NCT05594121|Buprenorphine|buprenorphine|mesh-list
83839644|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83839645|NCT05594121|Narcotics|narcotics|mesh-ancestor
83839646|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839647|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839648|NCT05594121|Analgesics|analgesics|mesh-ancestor
83839649|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
83839650|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839651|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83839652|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83839653|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83839654|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839655|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839656|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839657|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839658|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839659|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83839660|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
83839661|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83839662|NCT00445042|Sorafenib|sorafenib|mesh-list
83839663|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839664|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83839665|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839666|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839667|NCT00445081|Cyclosporine|cyclosporine|mesh-list
83839668|NCT00445081|Prednisolone|prednisolone|mesh-list
83839669|NCT00445081|Cyclosporins|cyclosporins|mesh-list
83839670|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839671|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
83839672|NCT00445081|Hormones|hormones|mesh-ancestor
83839673|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839674|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839675|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83839676|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839677|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839678|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839679|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839680|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
83839681|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
83839682|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839683|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
83839684|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839685|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83839686|NCT00113906|Melatonin|melatonin|mesh-list
83839687|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
83839688|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839689|NCT00113906|Protective Agents|protective agents|mesh-ancestor
83839690|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839691|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839692|NCT00113945|Cinacalcet|cinacalcet|mesh-list
83839693|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839694|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839695|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83839696|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
83839697|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839698|NCT00445159|Treprostinil|treprostinil|mesh-list
83839699|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83839700|NCT00445276|Diacerein|diacerein|mesh-list
83839701|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839702|NCT00113984|Metronidazole|metronidazole|mesh-list
83839703|NCT00113984|Ipilimumab|ipilimumab|mesh-list
83839704|NCT00113984|Sargramostim|sargramostim|mesh-list
83839705|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
83839706|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839707|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839708|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83839709|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83839710|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839711|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839712|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83839713|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83839714|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83839715|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
83839716|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83839717|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83839718|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839719|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839721|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83839722|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
83839723|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839724|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839725|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
83839726|NCT00445861|Docetaxel|docetaxel|mesh-list
83839727|NCT00445861|Cetuximab|cetuximab|mesh-list
83839728|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839729|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839730|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839731|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839732|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839733|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83839734|NCT00445900|Thalidomide|thalidomide|mesh-list
83839735|NCT00445900|Prednisone|prednisone|mesh-list
83839736|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
83839737|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839738|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
83839739|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839740|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839741|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83839742|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
83839743|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839744|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839745|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83839746|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839747|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
83839748|NCT00445900|Hormones|hormones|mesh-ancestor
83839749|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839750|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83839751|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
83173366|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
83839752|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83839753|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839754|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83839755|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83839756|NCT00445900|Growth Substances|growth substances|mesh-ancestor
83839757|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
83839758|NCT00115479|Insulin|insulin|mesh-list
83839759|NCT00115479|Benzocaine|benzocaine|mesh-list
83839760|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83839761|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839762|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
83839763|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
83839764|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839765|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
83839766|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839767|NCT00446017|Milrinone|milrinone|mesh-list
83839768|NCT00446017|Epinephrine|epinephrine|mesh-list
83839769|NCT00446017|Racepinephrine|racepinephrine|mesh-list
83839770|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
83839771|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83839772|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83839773|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
83839774|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839775|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839776|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839777|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83839778|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83839779|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
83839780|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839781|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83839782|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
83839783|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
83839784|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
83839785|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83839786|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83839787|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83839788|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
83839789|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83839790|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83839791|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839792|NCT00446017|Protective Agents|protective agents|mesh-ancestor
83839793|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
83839794|NCT00446173|Busulfan|busulfan|mesh-list
83839795|NCT00446173|Sargramostim|sargramostim|mesh-list
83839796|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839797|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
83839798|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839799|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83839800|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83839801|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
83839802|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839803|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839804|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83839805|NCT00446212|Propofol|propofol|mesh-list
83839806|NCT00446212|Desflurane|desflurane|mesh-list
83839807|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83839808|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83839809|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839810|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83839811|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
83839812|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
83839813|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83839814|NCT00446329|Cinacalcet|cinacalcet|mesh-list
83839815|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839816|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839817|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83839818|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
83839819|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839820|NCT00446368|Everolimus|everolimus|mesh-list
83839821|NCT00446368|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83839822|NCT00446368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83839823|NCT00446368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839824|NCT00446368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839825|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839826|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
83839827|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839828|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839829|NCT00401765|Docetaxel|docetaxel|mesh-list
83839830|NCT00401765|Siltuximab|siltuximab|mesh-list
83839831|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839832|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839833|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839834|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839835|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839836|NCT00115518|Cetuximab|cetuximab|mesh-list
83839837|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83839838|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839839|NCT00446524|Amlodipine|amlodipine|mesh-list
83839840|NCT00446524|Valsartan|valsartan|mesh-list
83839841|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83839842|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83839843|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839844|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839845|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83839846|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839847|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
83839848|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83839849|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83839850|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
83839851|NCT00446602|Hematinics|hematinics|mesh-ancestor
83839852|NCT05589753|Acetazolamide|acetazolamide|mesh-list
83839853|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
83839854|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83839855|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839856|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839857|NCT05589753|Diuretics|diuretics|mesh-ancestor
83839858|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
83839859|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839860|NCT00114179|Bevacizumab|bevacizumab|mesh-list
83839861|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83839862|NCT00114179|Gemcitabine|gemcitabine|mesh-list
83839863|NCT00114179|Capecitabine|capecitabine|mesh-list
83839864|NCT00114179|Antibodies|antibodies|mesh-list
83839865|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
83839866|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83839867|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839868|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83839869|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83839870|NCT00114179|Growth Substances|growth substances|mesh-ancestor
83839871|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839872|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
83839873|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
83839874|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839875|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
83839876|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839877|NCT00446680|Mannitol|mannitol|mesh-list
83839878|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83839879|NCT00446680|Diuretics|diuretics|mesh-ancestor
83839880|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
83839881|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839882|NCT00114257|Decitabine|decitabine|mesh-list
83839883|NCT00114257|Romidepsin|romidepsin|mesh-list
83839884|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839885|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
83839886|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839887|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839888|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839889|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83839890|NCT00114257|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83839891|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83839892|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
83839893|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839894|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839895|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
83839896|NCT00404937|Hormones|hormones|mesh-ancestor
83839897|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839898|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839899|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83839900|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83839901|NCT00446836|Paclitaxel|paclitaxel|mesh-list
83839902|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83839903|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83839904|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839905|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839906|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839907|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839908|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839909|NCT00114374|Escitalopram|escitalopram|mesh-list
83839910|NCT00114374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83839911|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83839912|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83839913|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839914|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83839915|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
83839916|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839917|NCT00446953|Betamethasone|betamethasone|mesh-list
83839918|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839919|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
83839920|NCT00446953|Hormones|hormones|mesh-ancestor
83839921|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839922|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839923|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83839924|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
83839925|NCT00447031|Triamcinolone|triamcinolone|mesh-list
83839926|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83839927|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83839928|NCT00447031|Bevacizumab|bevacizumab|mesh-list
83839929|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83839930|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83839931|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839932|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83839933|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83839934|NCT00447031|Growth Substances|growth substances|mesh-ancestor
83839935|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839936|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
83839937|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995441|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83839938|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
83839940|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839941|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83839942|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
83839943|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839944|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839945|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83839946|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83839947|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83839948|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83839949|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839950|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839951|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83839952|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83839953|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
83839954|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839955|NCT00115635|Gemcitabine|gemcitabine|mesh-list
83839956|NCT00115635|Docetaxel|docetaxel|mesh-list
83839957|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83839958|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
83839959|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839960|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839961|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83839962|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83839963|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83839964|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
83839965|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83839966|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839967|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83839968|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83839969|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839970|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839971|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839972|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83839973|NCT00447577|Tobramycin|tobramycin|mesh-list
83839974|NCT00447577|Dexamethasone|dexamethasone|mesh-list
83839975|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83839976|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
83839977|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
83839978|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83839979|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83839980|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83839981|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
83839982|NCT00447577|Hormones|hormones|mesh-ancestor
83839983|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83839984|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83839985|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83839986|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83839987|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83839988|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83839989|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83839990|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83839991|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83839992|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
83839993|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83839994|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83839995|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83839996|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83839997|NCT00114569|Lorazepam|lorazepam|mesh-list
83839998|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
83839999|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
83840000|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
83840001|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840002|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840003|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840004|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83840005|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840006|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83840007|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83840008|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83840009|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
83840010|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
83840011|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840012|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840013|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
83840014|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
83840015|NCT00447967|Leucovorin|leucovorin|mesh-list
83840016|NCT00447967|Fluorouracil|fluorouracil|mesh-list
83840017|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
83840018|NCT00447967|Irinotecan|irinotecan|mesh-list
83840019|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
83840020|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840021|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83840022|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840023|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83840024|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
83840025|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840026|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83840027|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840028|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840029|NCT00447967|Antidotes|antidotes|mesh-ancestor
83840030|NCT00447967|Protective Agents|protective agents|mesh-ancestor
83840031|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
83840032|NCT00447967|Vitamins|vitamins|mesh-ancestor
83840033|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
83840034|NCT00401856|Eplerenone|eplerenone|mesh-list
83840035|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83840036|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
83840037|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840038|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840039|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83840040|NCT00401856|Diuretics|diuretics|mesh-ancestor
83840041|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
83840042|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83840043|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83840044|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840045|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840046|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840047|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840048|NCT00448396|Epothilone B|epothilone b|mesh-list
83840049|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840050|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840051|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840052|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840053|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840054|NCT00114686|Valproic Acid|valproic acid|mesh-list
83840055|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83840056|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
83840057|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83840058|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83840059|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83840060|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840061|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840062|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840063|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840064|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
83840065|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
83840066|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
83840067|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840068|NCT05553678|Midazolam|midazolam|mesh-list
83840069|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83840070|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83840071|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840072|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840073|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83840074|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83840075|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83840076|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83840077|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
83840078|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
83840079|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
83840080|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
83840081|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840082|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840083|NCT00448552|Capecitabine|capecitabine|mesh-list
83840084|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
83840085|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83840086|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
83840087|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840088|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840089|NCT03276520|Ethanol|ethanol|mesh-list
83840090|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83840091|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840092|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840093|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840094|NCT00114764|Lenograstim|lenograstim|mesh-list
83840095|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83840096|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
83840097|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840098|NCT00448786|Niacinamide|niacinamide|mesh-list
83840099|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
83840100|NCT00448786|Imetelstat|imetelstat|mesh-list
83840101|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840102|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840103|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840104|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
83840105|NCT00448786|Vitamins|vitamins|mesh-ancestor
83840106|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
83840107|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840108|NCT00114803|Calcitonin|calcitonin|mesh-list
83840109|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
83840110|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83840111|NCT00114803|Katacalcin|katacalcin|mesh-list
83840112|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83840113|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840114|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83840115|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
83840116|NCT00448825|Topiramate|topiramate|mesh-list
83840117|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
83840118|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840119|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840120|NCT00448903|Bemiparin|bemiparin|mesh-list
83840121|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
83840122|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
83840123|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83840124|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840125|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
83840126|NCT00402012|Pioglitazone|pioglitazone|mesh-list
83840127|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840128|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840129|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
83840130|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83840131|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840132|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
83840133|NCT03276325|Dexamethasone|dexamethasone|mesh-list
83840134|NCT03276325|Nalbuphine|nalbuphine|mesh-list
83840135|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840136|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
83840137|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
83840138|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840139|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840140|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840141|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
83840142|NCT03276325|Hormones|hormones|mesh-ancestor
83840143|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840144|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83840145|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840146|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83840147|NCT03276325|Narcotics|narcotics|mesh-ancestor
83840148|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840149|NCT03276325|Analgesics|analgesics|mesh-ancestor
83840150|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
83840151|NCT00449020|Carboplatin|carboplatin|mesh-list
83840152|NCT00449020|Docetaxel|docetaxel|mesh-list
83840153|NCT00449020|Irinotecan|irinotecan|mesh-list
83840154|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840155|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840156|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840157|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840158|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840159|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83840160|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840161|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840162|NCT00115752|Valdecoxib|valdecoxib|mesh-list
83840163|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
83840164|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83840165|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840166|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840167|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83840168|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83840169|NCT00115752|Analgesics|analgesics|mesh-ancestor
83840170|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
83840171|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840172|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840173|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840174|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83840175|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
83840176|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
83840177|NCT00449137|Leucovorin|leucovorin|mesh-list
83840178|NCT00449137|Fluorouracil|fluorouracil|mesh-list
83840179|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
83840180|NCT00449137|Calcium|calcium|mesh-list
83840181|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
83840182|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83840183|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840184|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
83840185|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840186|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83840187|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840188|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83840189|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
83840190|NCT00449137|Antidotes|antidotes|mesh-ancestor
83840191|NCT00449137|Protective Agents|protective agents|mesh-ancestor
83840192|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
83840193|NCT00449137|Vitamins|vitamins|mesh-ancestor
83840194|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
83840195|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
83840196|NCT00449254|Estrone|estrone|mesh-list
83840197|NCT00449254|Estrogens|estrogens|mesh-ancestor
83840198|NCT00449254|Hormones|hormones|mesh-ancestor
83840199|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840200|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840201|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83840202|NCT00449410|Atorvastatin|atorvastatin|mesh-list
83840203|NCT00449410|Ezetimibe|ezetimibe|mesh-list
83840204|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83840205|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83840206|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
83840207|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840208|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83840209|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83840210|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840211|NCT00449449|Lidocaine|lidocaine|mesh-list
83840212|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
83840213|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
83840214|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840215|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840216|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
83840217|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840218|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83840219|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83840220|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83840221|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83840222|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840223|NCT00115115|Dopamine|dopamine|mesh-list
83840224|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83840225|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
83840226|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
83840227|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840228|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840229|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
83840230|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840231|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840232|NCT00115115|Protective Agents|protective agents|mesh-ancestor
83840233|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
83840234|NCT00449488|Hematinics|hematinics|mesh-ancestor
83840235|NCT00115830|Atorvastatin|atorvastatin|mesh-list
83840236|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83840237|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83840238|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83840239|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
83840240|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840241|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83840242|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82995741|NCT04381936|Lopinavir|lopinavir|mesh-list
83840243|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840245|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83840246|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
83840247|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840248|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840249|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
83840250|NCT00449527|Budesonide|budesonide|mesh-list
83840251|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
83840252|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840253|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83840254|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
83840255|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840256|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840257|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83840258|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
83840259|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
83840260|NCT00449527|Hormones|hormones|mesh-ancestor
83840261|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840262|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83840263|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83840264|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83840265|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
83840266|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840267|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840268|NCT00449683|Terazosin|terazosin|mesh-list
83840269|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83840270|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83840271|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83840272|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
83840273|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840274|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840275|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840276|NCT00449683|Urological Agents|urological agents|mesh-ancestor
83840277|NCT00449722|Mesalamine|mesalamine|mesh-list
83840278|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83840279|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83840280|NCT00449722|Analgesics|analgesics|mesh-ancestor
83840281|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
83840282|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840283|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840284|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840285|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83840286|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
83840287|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83840288|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840289|NCT00449839|Insulin|insulin|mesh-list
83840290|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83840291|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
83840292|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
83840293|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83840294|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840295|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840296|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83840297|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83840298|NCT00450229|Protective Agents|protective agents|mesh-ancestor
83840299|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840300|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840301|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83840302|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83840303|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83840304|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
83840305|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840306|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83840307|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83840308|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840309|NCT00450307|Antibodies|antibodies|mesh-list
83840310|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83840311|NCT00450307|Sargramostim|sargramostim|mesh-list
83840312|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
83840313|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840314|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
83840315|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83840316|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840317|NCT03276013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83840318|NCT03276013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840320|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83840321|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83840322|NCT00450736|Analgesics|analgesics|mesh-ancestor
83840323|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
83840324|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840325|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840326|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840327|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83840328|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83840329|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83840330|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840331|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840332|NCT05536362|Clonidine|clonidine|mesh-list
83840333|NCT05536362|Ketamine|ketamine|mesh-list
83840334|NCT05536362|Propofol|propofol|mesh-list
83840335|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83840336|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840337|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840338|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83840339|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
83840340|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
83840341|NCT05536362|Analgesics|analgesics|mesh-ancestor
83840342|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
83840343|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840344|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83840345|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83840346|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83840347|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840348|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840349|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83840350|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
83840351|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
83840352|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83840353|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83840354|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83840355|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
83840356|NCT00450853|Granisetron|granisetron|mesh-list
83840357|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
83840358|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
83840359|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840360|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840361|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840362|NCT00450853|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83840363|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83840364|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
83840365|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840366|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840367|NCT00450892|Docetaxel|docetaxel|mesh-list
83840368|NCT00450892|Trastuzumab|trastuzumab|mesh-list
83840369|NCT00450892|Lapatinib|lapatinib|mesh-list
83840370|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840371|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840372|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840373|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840374|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840375|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83840376|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840377|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840378|NCT00115310|Capsaicin|capsaicin|mesh-list
83840379|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
83840380|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
83840381|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
83840382|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840383|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840384|NCT00115908|Ribavirin|ribavirin|mesh-list
83840385|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83840386|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
83840387|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840388|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
83840389|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840390|NCT00458185|Etanercept|etanercept|mesh-list
83840391|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995905|NCT01368627|Sirolimus|sirolimus|mesh-list
83840392|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83840393|NCT00458185|Analgesics|analgesics|mesh-ancestor
83840394|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
83840395|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840396|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840397|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840398|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83840399|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840400|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83840401|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
83840402|NCT00458263|Hormones|hormones|mesh-list
83840403|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840404|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840405|NCT00458419|Naloxone|naloxone|mesh-list
83840406|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83840407|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840408|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
83840409|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840410|NCT00458458|Leuprolide|leuprolide|mesh-list
83840411|NCT00458458|Norethindrone|norethindrone|mesh-list
83840412|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
83840413|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83840414|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
83840415|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83840416|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840417|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83840418|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840419|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83840420|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83840421|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83840422|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
83840423|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83840424|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83840425|NCT00458614|Lansoprazole|lansoprazole|mesh-list
83840426|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
83840427|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83840428|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840429|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83840430|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840431|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840432|NCT00458731|Bevacizumab|bevacizumab|mesh-list
83840433|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83840434|NCT00458731|Cediranib|cediranib|mesh-list
83840435|NCT00458731|Antibodies|antibodies|mesh-list
83840436|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
83840437|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83840438|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840439|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83840440|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83840441|NCT00458731|Growth Substances|growth substances|mesh-ancestor
83840442|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840443|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
83840444|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
83840445|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840446|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840447|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840448|NCT03274024|Mitomycins|mitomycins|mesh-list
83840449|NCT03274024|Mitomycin|mitomycin|mesh-list
83840450|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83840451|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840452|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
83840453|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840454|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83840455|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840456|NCT00115947|Terlipressin|terlipressin|mesh-list
83840457|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83840458|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83840459|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
83840460|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840461|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83840462|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840463|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840464|NCT00459004|Rimonabant|rimonabant|mesh-list
83840465|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83840466|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83840467|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83840468|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840469|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840470|NCT00459004|Hormones|hormones|mesh-ancestor
83840471|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840472|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840473|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
83840474|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83840475|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83840476|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83840477|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840478|NCT00115622|Fluticasone|fluticasone|mesh-list
83840479|NCT00115622|Xhance|xhance|mesh-list
83840480|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840481|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83840482|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
83840483|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840484|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840485|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83840486|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
83840487|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
83840488|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83840489|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
83840490|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840491|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
83840492|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840493|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840494|NCT04728321|Lenvatinib|lenvatinib|mesh-list
83840495|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840496|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840497|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840498|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840499|NCT00459901|Capecitabine|capecitabine|mesh-list
83840500|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83840501|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83840502|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
83840503|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840504|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840505|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840506|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840507|NCT00401804|Dexamethasone|dexamethasone|mesh-list
83840508|NCT00401804|Doxorubicin|doxorubicin|mesh-list
83840509|NCT00401804|Bortezomib|bortezomib|mesh-list
83840510|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840511|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
83840512|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
83840513|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840514|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840515|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840516|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
83840517|NCT00401804|Hormones|hormones|mesh-ancestor
83840518|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840519|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83840520|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840521|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83840522|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83840523|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840524|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840525|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840526|NCT00459940|Pioglitazone|pioglitazone|mesh-list
83840527|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840528|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840529|NCT00460057|Alendronate|alendronate|mesh-list
83840530|NCT00460057|Diphosphonates|diphosphonates|mesh-list
83840531|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83840532|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840533|NCT00401921|Minocycline|minocycline|mesh-list
83840534|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83840535|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840536|NCT00460174|Bevacizumab|bevacizumab|mesh-list
83840537|NCT00460174|Gemcitabine|gemcitabine|mesh-list
83840538|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83840539|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840540|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83840541|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82996039|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840542|NCT00460174|Growth Substances|growth substances|mesh-ancestor
83840543|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840544|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
83840545|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83840546|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
83840547|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840548|NCT00460213|Valsartan|valsartan|mesh-list
83840549|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83840550|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83840551|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83840552|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840553|NCT00460252|Insulin|insulin|mesh-list
83840554|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840555|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840556|NCT00115817|Atorvastatin|atorvastatin|mesh-list
83840557|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83840558|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83840559|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
83840560|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840561|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83840562|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83840563|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840564|NCT00460369|Artesunate|artesunate|mesh-list
83840565|NCT00460369|Lumefantrine|lumefantrine|mesh-list
83840566|NCT00460369|Artemether|artemether|mesh-list
83840567|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
83840568|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
83840569|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83840570|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83840571|NCT00460369|Amodiaquine|amodiaquine|mesh-list
83840572|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
83840573|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83840574|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83840575|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840576|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840577|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
83840578|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
83840579|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83840580|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
83840581|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83840582|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840583|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840584|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83840585|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
83840586|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83840587|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840588|NCT00460447|Immunotoxins|immunotoxins|mesh-ancestor
83840589|NCT00460447|Immunoconjugates|immunoconjugates|mesh-ancestor
83840590|NCT00460447|Immunologic Factors|immunologic factors|mesh-ancestor
83840591|NCT00460447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840592|NCT00460642|Cetrorelix|cetrorelix|mesh-list
83840593|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83840594|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
83840595|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83840596|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840597|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
83840598|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840599|NCT00460681|Thymopentin|thymopentin|mesh-list
83840600|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83840601|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
83840602|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840603|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
83840604|NCT00460759|Rifapentine|rifapentine|mesh-list
83840605|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83840606|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840607|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83840608|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840609|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840610|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840611|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840612|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83840613|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
83840614|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
83840615|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
83840616|NCT00460837|Cathartics|cathartics|mesh-ancestor
82996131|NCT02359162|Hormones|hormones|mesh-ancestor
83840617|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840618|NCT00460876|Topotecan|topotecan|mesh-list
83840619|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83840620|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840621|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840622|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840623|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840624|NCT00460915|Amlodipine|amlodipine|mesh-list
83840625|NCT00460915|Lacidipine|lacidipine|mesh-list
83840626|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83840627|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83840628|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83840629|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840630|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83840631|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840632|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
83840633|NCT00460954|Levodopa|levodopa|mesh-list
83840634|NCT00460954|Carbidopa|carbidopa|mesh-list
83840635|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83840636|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83840637|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83840638|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
83840639|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840640|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840641|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840642|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83840643|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840644|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83840645|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
83840646|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
83840647|NCT00461149|Octreotide|octreotide|mesh-list
83840648|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840649|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83840650|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840651|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
83840652|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840653|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840654|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83840655|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
83840656|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
83840657|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840658|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83840659|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83840660|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840661|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83840662|NCT00461344|Docetaxel|docetaxel|mesh-list
83840663|NCT00461344|Doxorubicin|doxorubicin|mesh-list
83840664|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840665|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840666|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840667|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840668|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840669|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83840670|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83840671|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840672|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840673|NCT03273634|Lansoprazole|lansoprazole|mesh-list
83840674|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
83840675|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83840676|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840677|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83840678|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840679|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840680|NCT03273595|Paclitaxel|paclitaxel|mesh-list
83840681|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
83840682|NCT03273595|Trastuzumab|trastuzumab|mesh-list
83840683|NCT03273595|Epirubicin|epirubicin|mesh-list
83840684|NCT03273595|Lapatinib|lapatinib|mesh-list
83840685|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83840686|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840687|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840688|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840689|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840690|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840691|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83840692|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
83840693|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840694|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83840695|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83840696|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
83840697|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83840698|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83840699|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83840700|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83840701|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840702|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840703|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840705|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
83840706|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
83840707|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840708|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840709|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
83840710|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137777|NCT03547375|Apatinib|apatinib|mesh-list
83840711|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83840712|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83840713|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83840714|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83840715|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840716|NCT04728308|Bupivacaine|bupivacaine|mesh-list
83840717|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
83840718|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
83840719|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840720|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840721|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
83840722|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840723|NCT00461422|Ganirelix|ganirelix|mesh-list
83840724|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
83840725|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840726|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840727|NCT04697992|Vitamins|vitamins|mesh-list
83840728|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
83840729|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
83840730|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
83840731|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840732|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83840733|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83840734|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840735|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
83840736|NCT04697992|Coagulants|coagulants|mesh-ancestor
83840737|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
83840738|NCT04697992|Protective Agents|protective agents|mesh-ancestor
83840739|NCT05483634|Estrogens|estrogens|mesh-list
83840740|NCT05483634|Hormones|hormones|mesh-ancestor
83840741|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840742|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840743|NCT00461578|Artesunate|artesunate|mesh-list
83840744|NCT00461578|Dapsone|dapsone|mesh-list
83840745|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
83840746|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
83840747|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83840748|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83840749|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840750|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840751|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
83840752|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
83840753|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83840754|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
83840755|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83840756|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840757|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840758|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
83840759|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83840760|NCT00461617|Mitiglinide|mitiglinide|mesh-list
83840761|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840762|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840763|NCT00116064|Lorazepam|lorazepam|mesh-list
83840764|NCT00116064|Paraldehyde|paraldehyde|mesh-list
83840765|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
83840766|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
83840767|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
83840768|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840769|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840770|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840771|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83840772|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840773|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83840774|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83840775|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83840776|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
83840777|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
83840778|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840779|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840780|NCT04728035|Irinotecan|irinotecan|mesh-list
83840781|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83840782|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840783|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840784|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840785|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840786|NCT00461890|Naltrexone|naltrexone|mesh-list
83840787|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83840788|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83840789|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840790|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
83840791|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840792|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83840793|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83840794|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840795|NCT00461968|Simvastatin|simvastatin|mesh-list
83840796|NCT00461968|Ezetimibe|ezetimibe|mesh-list
83840797|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83840798|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83840799|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
83840800|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840801|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83840802|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83840803|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840804|NCT00116103|Tacrolimus|tacrolimus|mesh-list
83840805|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83840806|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
83840807|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840808|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83840809|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840810|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840811|NCT02956252|Anesthetics|anesthetics|mesh-list
83840812|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840813|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840814|NCT00462358|Filanesib|filanesib|mesh-list
83840815|NCT00462358|Lenograstim|lenograstim|mesh-list
83840816|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83840817|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
83840818|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840819|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840820|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840821|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840822|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840823|NCT00116181|Etanercept|etanercept|mesh-list
83840824|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83840825|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83840826|NCT00116181|Analgesics|analgesics|mesh-ancestor
83840827|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
83840828|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840829|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840830|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840831|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83840832|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840833|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83840834|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
83840835|NCT00462397|Paclitaxel|paclitaxel|mesh-list
83840836|NCT00462397|Carboplatin|carboplatin|mesh-list
83840837|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83840838|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840839|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840840|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840841|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840842|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840843|NCT00462475|Hormones|hormones|mesh-list
83840844|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840845|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840847|NCT00462553|Sunitinib|sunitinib|mesh-list
83840848|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83840849|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
83840850|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840851|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840852|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83840853|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83840854|NCT00462553|Growth Substances|growth substances|mesh-ancestor
83840855|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840856|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
83840857|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83840858|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840859|NCT00462592|Budesonide|budesonide|mesh-list
83840860|NCT00462592|Montelukast|montelukast|mesh-list
83840861|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840862|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83840863|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
83840864|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840865|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840866|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83840867|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
83840868|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
83840869|NCT00462592|Hormones|hormones|mesh-ancestor
83840870|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840871|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83840872|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
83840873|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83840874|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83840875|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840876|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
83840877|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83840878|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840879|NCT00462631|Paclitaxel|paclitaxel|mesh-list
83840880|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83840881|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83840882|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840883|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840884|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840885|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840886|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840887|NCT00462787|Dexamethasone|dexamethasone|mesh-list
83840888|NCT00462787|Topotecan|topotecan|mesh-list
83840889|NCT00462787|Vinorelbine|vinorelbine|mesh-list
83840890|NCT00462787|Thiotepa|thiotepa|mesh-list
83840891|NCT00462787|Clofarabine|clofarabine|mesh-list
83840892|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840893|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
83840894|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
83840895|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840896|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840897|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840898|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
83840899|NCT00462787|Hormones|hormones|mesh-ancestor
83840900|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840901|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83840902|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83840903|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
83840904|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83840905|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83840906|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840907|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840908|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83840909|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
83840910|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
83840911|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
83840912|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83840913|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
83840914|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83840915|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83840916|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83840917|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
83840918|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83840920|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
83840921|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840922|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83840923|NCT00116259|Aripiprazole|aripiprazole|mesh-list
83840924|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
83840925|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83840926|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83840927|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83840928|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83840929|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840930|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
83840931|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
83840932|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840933|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840934|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83840935|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83840936|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
83840937|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83840938|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83840939|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83840940|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83840941|NCT00116324|Montelukast|montelukast|mesh-list
83840942|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83840943|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
83840944|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83840945|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
83840946|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83840947|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840948|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83840949|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83840950|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840951|NCT00116402|Fluticasone|fluticasone|mesh-list
83840952|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83840953|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83840954|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83840955|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
83840956|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840957|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840958|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83840959|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
83840960|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
83840961|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83840962|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83840963|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83840964|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83840965|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
83840966|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840967|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840968|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83840969|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83840970|NCT00463762|Sulbactam|sulbactam|mesh-list
83840971|NCT00463762|Cefoperazone|cefoperazone|mesh-list
83840972|NCT00463762|Sulperazone|sulperazone|mesh-list
83840973|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83840974|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83840975|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83840976|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840977|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840978|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83840979|NCT00116480|Misoprostol|misoprostol|mesh-list
83840980|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83840981|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
83840982|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83840983|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840984|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83840985|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83840986|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
83840987|NCT00463879|Galantamine|galantamine|mesh-list
83840988|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83840989|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83840990|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83840991|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
83840992|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83840993|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83840994|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83840995|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
83840996|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83840997|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
83840998|NCT00463918|Varenicline|varenicline|mesh-list
83840999|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83841000|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83841001|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
83841002|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841003|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841004|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841005|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
83841007|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
83841008|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83841009|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83841010|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841011|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841012|NCT00463957|Urological Agents|urological agents|mesh-ancestor
83841013|NCT00464035|Calcium|calcium|mesh-list
83841014|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83841015|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841016|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
83841017|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841018|NCT00464191|Escitalopram|escitalopram|mesh-list
83841019|NCT00464191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83841020|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83841021|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841022|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841023|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841024|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
83841025|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841026|NCT00464347|Triamcinolone|triamcinolone|mesh-list
83841027|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83841028|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83841029|NCT00464347|Bevacizumab|bevacizumab|mesh-list
83841030|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83841031|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83841032|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841033|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83841034|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83841035|NCT00464347|Growth Substances|growth substances|mesh-ancestor
83841036|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841037|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
83841038|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841039|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
83841040|NCT00464347|Hormones|hormones|mesh-ancestor
83841041|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841042|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841043|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
83841044|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841045|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841046|NCT00116493|Folic Acid|folic acid|mesh-list
83841047|NCT00116493|Mebendazole|mebendazole|mesh-list
83841048|NCT00116493|Piperazine|piperazine|mesh-list
83841049|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
83841050|NCT00116493|DMP 777|dmp 777|mesh-list
83841051|NCT00116493|Hematinics|hematinics|mesh-ancestor
83841052|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
83841053|NCT00116493|Vitamins|vitamins|mesh-ancestor
83841054|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
83841055|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841056|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
83841057|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
83841058|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83841059|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841060|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
83841061|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
83841062|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
83841063|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841064|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841065|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996583|NCT02639026|Durvalumab|durvalumab|mesh-list
83841066|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83841067|NCT00464503|Pravastatin|pravastatin|mesh-list
83841068|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83841069|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83841070|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
83841071|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841072|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83841073|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83841074|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841075|NCT00116532|Escitalopram|escitalopram|mesh-list
83841076|NCT00116532|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83841077|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83841078|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841079|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841080|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841081|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
83841082|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841083|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
83841084|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83841085|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841086|NCT00464893|Catumaxomab|catumaxomab|mesh-list
83841087|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83841088|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841089|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
83841090|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841091|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
83841092|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841093|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
83841094|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83841095|NCT00464932|Protective Agents|protective agents|mesh-ancestor
83841096|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841097|NCT00464971|Estradiol|estradiol|mesh-list
83841098|NCT00464971|Estrogens|estrogens|mesh-ancestor
83841099|NCT00464971|Hormones|hormones|mesh-ancestor
83841100|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841101|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841102|NCT00116870|Lovastatin|lovastatin|mesh-list
83841103|NCT00116870|L 647318|l 647318|mesh-list
83841104|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
83841105|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83841106|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83841107|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
83841108|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841109|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83841110|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83841111|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841112|NCT00465205|Valacyclovir|valacyclovir|mesh-list
83841113|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
83841114|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841115|NCT00465244|Levetiracetam|levetiracetam|mesh-list
83841116|NCT00465244|Lorazepam|lorazepam|mesh-list
83841117|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
83841118|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
83841119|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
83841120|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
83841121|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841122|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841123|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841124|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83841125|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83841126|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83841127|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83841128|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83841129|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
83841130|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
83841131|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841132|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841133|NCT00465283|Donepezil|donepezil|mesh-list
83841134|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83841135|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841136|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841137|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
83841138|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841139|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841140|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
82996649|NCT02360254|Insulin|insulin|mesh-list
83841141|NCT03272425|Allopurinol|allopurinol|mesh-list
83841142|NCT03272425|Lesinurad|lesinurad|mesh-list
83841143|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
83841144|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841145|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841146|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
83841147|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841148|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83841149|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
83841150|NCT03272425|Protective Agents|protective agents|mesh-ancestor
83841151|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841152|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
83841153|NCT00116948|Cimetidine|cimetidine|mesh-list
83841154|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83841155|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841156|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83841157|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
83841158|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
83841159|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841160|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841161|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841162|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83841163|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83841164|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841165|NCT03272503|Pimozide|pimozide|mesh-list
83841166|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83841167|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83841168|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83841169|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841170|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83841171|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83841172|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
83841173|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841174|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841175|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83841176|NCT00465439|Lidocaine|lidocaine|mesh-list
83841177|NCT00465439|Epinephrine|epinephrine|mesh-list
83841178|NCT00465439|Racepinephrine|racepinephrine|mesh-list
83841179|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
83841180|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
83841181|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
83841182|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83841183|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841184|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
83841185|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841186|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83841187|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83841188|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83841189|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841190|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841191|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83841192|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83841193|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
83841194|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841195|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83841196|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83841197|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
83841198|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83841199|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
83841200|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
83841201|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
83841202|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83841203|NCT00116727|Etanercept|etanercept|mesh-list
83841204|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841205|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841206|NCT00116727|Analgesics|analgesics|mesh-ancestor
83841207|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
83841208|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841209|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841210|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841211|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841212|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841213|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841214|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
83841215|NCT00473551|Sirolimus|sirolimus|mesh-list
83841216|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
83841217|NCT00473551|Rituximab|rituximab|mesh-list
83841218|NCT00473551|Fludarabine|fludarabine|mesh-list
83841219|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
83841220|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841221|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
83841222|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841223|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841224|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83841225|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
83841226|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841227|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841228|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83841229|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83841230|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83841231|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
83841232|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841233|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83841234|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83841235|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
83841236|NCT00117026|Benphothiamine|benphothiamine|mesh-list
83841237|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83841238|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
83841239|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841240|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
83841241|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
83841242|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841243|NCT00473980|Celecoxib|celecoxib|mesh-list
83841244|NCT00473980|Indomethacin|indomethacin|mesh-list
83841245|NCT00473980|Esomeprazole|esomeprazole|mesh-list
83841246|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841247|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841248|NCT00473980|Analgesics|analgesics|mesh-ancestor
83841249|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
83841250|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841251|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841252|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841253|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841254|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83841255|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83841256|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841257|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841258|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83841259|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841260|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83841261|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
83841262|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
83841263|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83841264|NCT00474019|Esomeprazole|esomeprazole|mesh-list
83841265|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83841266|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841267|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83841268|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841269|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841270|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
83841271|NCT00117065|Hematinics|hematinics|mesh-ancestor
83841272|NCT00474136|Diclofenac|diclofenac|mesh-list
83841273|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841274|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841275|NCT00474136|Analgesics|analgesics|mesh-ancestor
83841276|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
83841277|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841278|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841279|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841280|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841281|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83841282|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841283|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841284|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
83841285|NCT00117104|Hematinics|hematinics|mesh-ancestor
83841286|NCT03270709|Vitamin D|vitamin d|mesh-list
83841287|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
83841288|NCT03270709|Vitamins|vitamins|mesh-ancestor
83841289|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
83841290|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841291|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83841292|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83841293|NCT03270553|Metformin|metformin|mesh-list
83841294|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83841295|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841296|NCT00117182|Budesonide|budesonide|mesh-list
83841297|NCT00117182|Mannitol|mannitol|mesh-list
83841298|NCT00117182|Bromides|bromides|mesh-list
83841299|NCT00117182|Albuterol|albuterol|mesh-list
83841300|NCT00117182|Ipratropium|ipratropium|mesh-list
83841301|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841302|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83841303|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
83841304|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841305|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841306|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83841307|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83841308|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
83841309|NCT00117182|Hormones|hormones|mesh-ancestor
83841310|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841311|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
83841312|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
83841313|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83841314|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83841315|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83841316|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83841317|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
83841318|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841319|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841320|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83841321|NCT00117182|Diuretics|diuretics|mesh-ancestor
83841322|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
83841323|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83841324|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
83841325|NCT00116922|Metformin|metformin|mesh-list
83841326|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
83841327|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83841328|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841329|NCT00116961|Dexamethasone|dexamethasone|mesh-list
83841330|NCT00116961|Bortezomib|bortezomib|mesh-list
83841331|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841332|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
83841333|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
83841334|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841335|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841336|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841337|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
83841338|NCT00116961|Hormones|hormones|mesh-ancestor
83841339|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841340|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83841341|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841342|NCT00474721|Acetaminophen|acetaminophen|mesh-list
83841343|NCT00474721|Ibuprofen|ibuprofen|mesh-list
83841344|NCT00474721|Codeine|codeine|mesh-list
83841345|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841346|NCT00474721|Analgesics|analgesics|mesh-ancestor
83841347|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
83841348|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841349|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841350|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
83841351|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841352|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841353|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841354|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83841355|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841356|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841357|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83841358|NCT00474721|Narcotics|narcotics|mesh-ancestor
83841359|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83841360|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
83841361|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
83841362|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
83841363|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83841364|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83841365|NCT00117260|Estradiol|estradiol|mesh-list
83841366|NCT00117260|Estrogens|estrogens|mesh-ancestor
83841367|NCT00117260|Hormones|hormones|mesh-ancestor
83137797|NCT05575297|Febuxostat|febuxostat|mesh-list
83841368|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841369|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841370|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83841371|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
83841372|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83841373|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83841374|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83841375|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83841376|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83841377|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83841379|NCT00474838|Glimepiride|glimepiride|mesh-list
83841380|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83841381|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841382|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83841383|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841384|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
83841385|NCT00474916|KRN 5500|krn 5500|mesh-list
83841386|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841387|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83841388|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841389|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841390|NCT00475072|Ribavirin|ribavirin|mesh-list
83841391|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83841392|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
83841393|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841394|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
83841395|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841396|NCT00117299|Vatalanib|vatalanib|mesh-list
83841397|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83841398|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841399|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841400|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
83841401|NCT00117000|Testosterone|testosterone|mesh-list
83841402|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
83841403|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
83841404|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83841405|NCT00117000|Androgens|androgens|mesh-ancestor
83841406|NCT00117000|Hormones|hormones|mesh-ancestor
83841407|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841408|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841409|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83841410|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841411|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
83841412|NCT02956408|Vitamin D|vitamin d|mesh-list
83841413|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
83841414|NCT02956408|Vitamins|vitamins|mesh-ancestor
83841415|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
83841416|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841417|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83841418|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83841419|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83841420|NCT00475189|Norinyl|norinyl|mesh-list
83841421|NCT00475189|Mestranol|mestranol|mesh-list
83841422|NCT00475189|Norethindrone|norethindrone|mesh-list
83841423|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83841424|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83841425|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83841426|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
83841427|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137806|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
83841428|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841429|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83841430|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83841431|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83841432|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83841433|NCT00475189|Estrogens|estrogens|mesh-ancestor
83841434|NCT00475189|Hormones|hormones|mesh-ancestor
83841435|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841436|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
83841437|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841438|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841439|NCT00117377|Analgesics|analgesics|mesh-ancestor
83841440|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
83841441|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841442|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841443|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82996942|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841444|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841445|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
83841446|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841447|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
83841448|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83841449|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841450|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841451|NCT02964195|Rifaximin|rifaximin|mesh-list
83841452|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83841453|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841454|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83841455|NCT00475462|Metoprolol|metoprolol|mesh-list
83841456|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83841457|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83841458|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
83841459|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
83841460|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841461|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841462|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83841463|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83841464|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83841465|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
83841466|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841467|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841468|NCT00475618|Fluorides|fluorides|mesh-list
83841469|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
83841470|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
83841471|NCT00475618|Protective Agents|protective agents|mesh-ancestor
83841472|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841473|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
83841474|NCT00117039|Hematinics|hematinics|mesh-ancestor
83841475|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83841476|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83841477|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83841478|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841479|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841480|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841481|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841482|NCT00475696|Analgesics|analgesics|mesh-ancestor
83841483|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
83841484|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841485|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
83841486|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83841487|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
83841488|NCT00117455|Lenograstim|lenograstim|mesh-list
83841489|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83841490|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
83841491|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841492|NCT03270007|Vinorelbine|vinorelbine|mesh-list
83841493|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83841494|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841495|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83841496|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83841497|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83841498|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841499|NCT00475813|Fluticasone|fluticasone|mesh-list
83841500|NCT00475813|Xhance|xhance|mesh-list
83841501|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
83841502|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841503|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83841504|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
83841505|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841506|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841507|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83841508|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
83841509|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83841510|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83841511|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83841512|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83841513|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83841514|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
83841515|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841516|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841517|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
83841518|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83841519|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841520|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
83841521|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841522|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
83841523|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83841524|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83841525|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841526|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
83841527|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
83841528|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83841529|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83841530|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83841531|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841532|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841533|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841534|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841535|NCT00475969|Analgesics|analgesics|mesh-ancestor
83841536|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
83841537|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841538|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
83841539|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83841540|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
83841542|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83841543|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841544|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
83841545|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841546|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841547|NCT00402077|Pramlintide|pramlintide|mesh-list
83841548|NCT00402077|Phentermine|phentermine|mesh-list
83841549|NCT00402077|Sibutramine|sibutramine|mesh-list
83841550|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83841551|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841552|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83841553|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
83841554|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83841555|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
83841556|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
83841557|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841558|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
83841559|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841560|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841561|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
83841562|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83841563|NCT00476359|Lopinavir|lopinavir|mesh-list
83841564|NCT00476359|Saquinavir|saquinavir|mesh-list
83841565|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83841566|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83841567|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
83841568|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841569|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841570|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83841571|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83841572|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
83841573|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841574|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83841575|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83841576|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
83841577|NCT00117117|Hematinics|hematinics|mesh-ancestor
83841578|NCT00476437|Insulin|insulin|mesh-list
83841579|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83841580|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
83841581|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
83841582|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83841583|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841584|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83841585|NCT00117494|Pravastatin|pravastatin|mesh-list
83841586|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83841587|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83841588|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
83841589|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841590|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83841591|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83841592|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841593|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83841594|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841595|NCT00117533|Ribavirin|ribavirin|mesh-list
83841596|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
83841597|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
83841598|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841599|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
83841600|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841601|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841602|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
83841603|NCT00117234|Hematinics|hematinics|mesh-ancestor
83841604|NCT00117611|Omalizumab|omalizumab|mesh-list
83841605|NCT00117611|Antibodies|antibodies|mesh-list
83841606|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
83841607|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841608|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83841609|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83841610|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
83841611|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83841612|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83841613|NCT04727684|Cetrorelix|cetrorelix|mesh-list
83841614|NCT04727684|Menotropins|menotropins|mesh-list
83841615|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
83841616|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83841617|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
83841618|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83841619|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841620|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83841621|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83841622|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841623|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83841624|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
83841625|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
83841626|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841627|NCT03277261|Teriflunomide|teriflunomide|mesh-list
83841628|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841629|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841630|NCT03277261|Analgesics|analgesics|mesh-ancestor
83841631|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
83841632|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841633|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841634|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841635|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841636|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841637|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
83841638|NCT02273947|BMS-955176|bms-955176|mesh-list
83841639|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83841640|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83841641|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
83841642|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841643|NCT05367336|Fentanyl|fentanyl|mesh-list
83841644|NCT05367336|Morphine|morphine|mesh-list
83841645|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83841646|NCT05367336|Narcotics|narcotics|mesh-ancestor
83841647|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83841648|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841649|NCT05367336|Analgesics|analgesics|mesh-ancestor
83841650|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
83841651|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841652|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83841653|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83841654|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
83841655|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
83841656|NCT00476515|Rituximab|rituximab|mesh-list
83841657|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83841658|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841659|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
83841660|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841661|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841662|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
83841663|NCT00117689|Tacrolimus|tacrolimus|mesh-list
83841664|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
83841665|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83841666|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841667|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
83841668|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841669|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83841670|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841671|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841672|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83841673|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841674|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83841675|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
83841676|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83841677|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841678|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
83841679|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83841680|NCT00117273|Estradiol|estradiol|mesh-list
83841681|NCT00117273|Estrogens|estrogens|mesh-ancestor
83841682|NCT00117273|Hormones|hormones|mesh-ancestor
83841683|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841684|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841685|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83841686|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
83841687|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83841688|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83841689|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83841690|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83841691|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83841692|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83841693|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83841694|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83841695|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
83841696|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841697|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83841698|NCT00117728|Nevirapine|nevirapine|mesh-list
83841699|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83841700|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83841701|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841702|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841703|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
83841704|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137838|NCT05395117|Digoxin|digoxin|mesh-list
83841705|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83841706|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83841707|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83841708|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83841709|NCT00117767|Terbinafine|terbinafine|mesh-list
83841710|NCT00117767|Griseofulvin|griseofulvin|mesh-list
83841711|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
83841712|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841713|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841714|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841715|NCT03277066|Diclofenac|diclofenac|mesh-list
83841716|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841717|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841718|NCT03277066|Analgesics|analgesics|mesh-ancestor
83841719|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
83841720|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841721|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841722|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841723|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841724|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83841725|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841726|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841727|NCT00117351|Bortezomib|bortezomib|mesh-list
83841728|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841729|NCT00118196|Azacitidine|azacitidine|mesh-list
83841730|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
83841731|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83841732|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
83841733|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841734|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841735|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841736|NCT00118235|Bevacizumab|bevacizumab|mesh-list
83841737|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83841738|NCT00118235|Irinotecan|irinotecan|mesh-list
83841739|NCT00118235|Antibodies|antibodies|mesh-list
83841740|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
83841741|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83841742|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841743|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83841744|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83841745|NCT00118235|Growth Substances|growth substances|mesh-ancestor
82997238|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
83841746|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841747|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
83841748|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
83841749|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83841750|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83841751|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841752|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841753|NCT00118313|Imiquimod|imiquimod|mesh-list
83841754|NCT00118313|Sargramostim|sargramostim|mesh-list
83841755|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
83841756|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83841757|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
83841758|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841759|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841760|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83841761|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
83841762|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83841763|NCT00118313|Protective Agents|protective agents|mesh-ancestor
83841764|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83841765|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
83841766|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841767|NCT03271021|Minocycline|minocycline|mesh-list
83841768|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83841769|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841770|NCT02273986|Digoxin|digoxin|mesh-list
83841771|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83841772|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83841773|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841774|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841775|NCT02273986|Protective Agents|protective agents|mesh-ancestor
83841776|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841777|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
83841778|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83841779|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841780|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841781|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83841782|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841783|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83841784|NCT00476983|Ritonavir|ritonavir|mesh-list
83841785|NCT00476983|Saquinavir|saquinavir|mesh-list
83841786|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83841787|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83841788|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83841789|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
83841790|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841791|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841792|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83841793|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83841794|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
83841795|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841796|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83841797|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83841798|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83841799|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83841800|NCT00477061|Morphine|morphine|mesh-list
83841801|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83841802|NCT00477061|Narcotics|narcotics|mesh-ancestor
83841803|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83841804|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841805|NCT00477061|Analgesics|analgesics|mesh-ancestor
83841806|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
83841807|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841808|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
83841809|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83841810|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841811|NCT00477373|Valproic Acid|valproic acid|mesh-list
83841812|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
83841813|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841814|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841815|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
83841816|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841817|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841818|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
83841819|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83841820|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83841821|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83841822|NCT00477763|Cyclosporine|cyclosporine|mesh-list
83841823|NCT00477763|Cyclosporins|cyclosporins|mesh-list
83841824|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841825|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841826|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83841827|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
83841828|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841829|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
83841830|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841831|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
83841832|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841833|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83841834|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
83841835|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83841836|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83841837|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83841838|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841839|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841840|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
83841841|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841842|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841843|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83841844|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841845|NCT00477880|Cetuximab|cetuximab|mesh-list
83841846|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83841847|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841848|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83841849|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841850|NCT00477997|Hormones|hormones|mesh-list
83841851|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841852|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841853|NCT00478075|Bortezomib|bortezomib|mesh-list
83841854|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83841855|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841856|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841857|NCT00478075|Analgesics|analgesics|mesh-ancestor
83841858|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
83841859|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841860|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841861|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
83841862|NCT00117078|Hematinics|hematinics|mesh-ancestor
83841863|NCT00478114|Sorafenib|sorafenib|mesh-list
83841864|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841865|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83841866|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841867|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841868|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
83841869|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83841870|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841871|NCT00478504|Letrozole|letrozole|mesh-list
83841872|NCT00478504|Clomiphene|clomiphene|mesh-list
83841873|NCT00478504|Enclomiphene|enclomiphene|mesh-list
83841874|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
83841875|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841876|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841877|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83841878|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83841879|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841880|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83841881|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
83841882|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841883|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841884|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83841885|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
83841886|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83841887|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83841888|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83841889|NCT00117468|Progesterone|progesterone|mesh-list
83841890|NCT00117468|Progestins|progestins|mesh-ancestor
83841891|NCT00117468|Hormones|hormones|mesh-ancestor
83841892|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83841893|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841894|NCT03271879|Empagliflozin|empagliflozin|mesh-list
83841895|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83841896|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841897|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83841898|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841899|NCT00478543|Furosemide|furosemide|mesh-list
83841900|NCT00478543|Diuretics|diuretics|mesh-ancestor
83841901|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
83841902|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841903|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83841904|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83841905|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841906|NCT00118937|Metformin|metformin|mesh-list
83841907|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83841908|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841909|NCT00478621|Vaccines|vaccines|mesh-list
83841910|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
83841911|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841912|NCT00478660|Adalimumab|adalimumab|mesh-list
83841913|NCT00478660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83841914|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83841915|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83841916|NCT00478699|Cisplatin|cisplatin|mesh-list
83841917|NCT00478699|Gemcitabine|gemcitabine|mesh-list
83841918|NCT00478699|Docetaxel|docetaxel|mesh-list
83841919|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841920|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83841921|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
83841922|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841923|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
83841924|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
83841925|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
83841926|NCT00118976|Lisinopril|lisinopril|mesh-list
83841927|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83841928|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
83841929|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841930|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841931|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83841932|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83841933|NCT00118976|Protective Agents|protective agents|mesh-ancestor
83841934|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841935|NCT05288361|Acetylcholine|acetylcholine|mesh-list
83841936|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
83841937|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83841938|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
83841939|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841940|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841941|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841942|NCT00478816|Vaccines|vaccines|mesh-list
83841943|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
83841944|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841945|NCT00478855|Piperacillin|piperacillin|mesh-list
83841946|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83841947|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83841948|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841949|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83841950|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841951|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841952|NCT00117546|Methyldopa|methyldopa|mesh-list
83841953|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83841954|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
83841955|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
83841956|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83841957|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841958|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83841959|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83841960|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83841961|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83841962|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83841963|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841964|NCT00479206|Artesunate|artesunate|mesh-list
83841965|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
83841966|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83841967|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83841968|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841969|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841970|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
83841971|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
83841972|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83841973|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
83841974|NCT00119132|Artesunate|artesunate|mesh-list
83841975|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
83841976|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
83841977|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83841978|NCT00119132|Amodiaquine|amodiaquine|mesh-list
83841979|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
83841980|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83841981|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83841982|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83841983|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83841984|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
83841985|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
83841986|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83841987|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
83841988|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83841989|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83841990|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83841991|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83841992|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83841993|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
83841994|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83841995|NCT00479362|Aspirin|aspirin|mesh-list
83841996|NCT00479362|Warfarin|warfarin|mesh-list
83841997|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83841998|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83841999|NCT00479362|Analgesics|analgesics|mesh-ancestor
83842000|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
83842001|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842002|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842003|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842004|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842005|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83842006|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83842007|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842008|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83842009|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83842010|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842011|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
83842012|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
83842013|NCT00119171|Capecitabine|capecitabine|mesh-list
83842014|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83842015|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
83842016|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842017|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842018|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
83842019|NCT00117624|Hematinics|hematinics|mesh-ancestor
83842020|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
83842021|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
83842022|NCT00479479|Vitamins|vitamins|mesh-ancestor
83842023|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
83842024|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842025|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
83842026|NCT00479479|Hematinics|hematinics|mesh-ancestor
83842027|NCT00119210|Bupropion|bupropion|mesh-list
83842028|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83842029|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
83842030|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842031|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83842032|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842033|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842034|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842035|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
83842036|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842037|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842038|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83842039|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83842040|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842041|NCT00117663|Hormones|hormones|mesh-list
83842042|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842043|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842044|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
83842045|NCT00479752|Cetuximab|cetuximab|mesh-list
83842046|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842047|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83842048|NCT00119249|Sorafenib|sorafenib|mesh-list
83842049|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842050|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842051|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842052|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842053|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
83842054|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
83842055|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842056|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
83842057|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83842058|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83842059|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842060|NCT00479908|Urological Agents|urological agents|mesh-ancestor
83842061|NCT00479986|Pioglitazone|pioglitazone|mesh-list
83842062|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842063|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842064|NCT00480064|Cytarabine|cytarabine|mesh-list
83842065|NCT00480064|Lomustine|lomustine|mesh-list
83842066|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83842067|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
83842068|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842069|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842070|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
83842071|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842072|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842073|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
83842074|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842075|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83842076|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
83842077|NCT00480103|Mineral Oil|mineral oil|mesh-list
83842078|NCT00480103|Emollients|emollients|mesh-ancestor
83842079|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
83842080|NCT00480142|Oxycodone|oxycodone|mesh-list
83842081|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83842082|NCT00480142|Narcotics|narcotics|mesh-ancestor
83842083|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842084|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842085|NCT00480142|Analgesics|analgesics|mesh-ancestor
83842086|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
83842087|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842088|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
83842089|NCT00119483|Testosterone|testosterone|mesh-list
83842090|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
83842091|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
83842092|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83842093|NCT00119483|Androgens|androgens|mesh-ancestor
83842094|NCT00119483|Hormones|hormones|mesh-ancestor
83842095|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842096|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842097|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83842098|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842099|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
83842100|NCT00480181|Nabilone|nabilone|mesh-list
83842101|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
83842102|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
83842103|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842104|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842105|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842106|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83842107|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842108|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842109|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842110|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
83842111|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83842112|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83842113|NCT00480298|Prednisolone|prednisolone|mesh-list
83842114|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
83842115|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83842116|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
83842117|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842118|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
83842119|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
83842120|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842121|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842122|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842123|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
83842124|NCT00480298|Hormones|hormones|mesh-ancestor
83842125|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842126|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83842127|NCT00480298|Protective Agents|protective agents|mesh-ancestor
83842128|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83842129|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842130|NCT00480376|Gentamicins|gentamicins|mesh-list
83842131|NCT00480376|Ofloxacin|ofloxacin|mesh-list
83842132|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83842133|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842134|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83842135|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842136|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842137|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83842138|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83842139|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83842140|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842141|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83842142|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83842143|NCT00117702|Everolimus|everolimus|mesh-list
83842144|NCT00117702|Tacrolimus|tacrolimus|mesh-list
83842145|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842146|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
83842147|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842148|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83842149|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842150|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842151|NCT00117702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83842152|NCT00117702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842153|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842154|NCT00480454|Vaccines|vaccines|mesh-list
83842155|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
83842156|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842157|NCT00480571|Perphenazine|perphenazine|mesh-list
83842158|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
83842159|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
83842160|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842161|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842162|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842163|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83842164|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842165|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842166|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842167|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83842168|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
83842169|NCT00480610|Tacrolimus|tacrolimus|mesh-list
83842170|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842171|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
83842172|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842173|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83842174|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842175|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842176|NCT00480649|Fluticasone|fluticasone|mesh-list
83842177|NCT00480649|Xhance|xhance|mesh-list
83842178|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83842179|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842180|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83842181|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
83842182|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842183|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842184|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83842185|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
83842186|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
83842187|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83842188|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83842189|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83842190|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83842191|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83842192|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842193|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842194|NCT00119639|Sorafenib|sorafenib|mesh-list
83842195|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842196|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842197|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842198|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842199|NCT00480844|Risperidone|risperidone|mesh-list
83842200|NCT00480844|Sertindole|sertindole|mesh-list
83842201|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83842202|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
83842203|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842204|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842205|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842206|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83842207|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842208|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842209|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842210|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83842211|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
83842212|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83842213|NCT00480883|Allopurinol|allopurinol|mesh-list
83842214|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
83842215|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842216|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842217|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
83842218|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842219|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83842220|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
83842221|NCT00480883|Protective Agents|protective agents|mesh-ancestor
83842222|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842223|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83842224|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83842225|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842226|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83842227|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
83842228|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842229|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842230|NCT05236998|Incretins|incretins|mesh-ancestor
83842231|NCT05236998|Hormones|hormones|mesh-ancestor
83842232|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842233|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83842234|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83842235|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842236|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842237|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83842238|NCT01240096|Mirtazapine|mirtazapine|mesh-list
83842239|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
83842240|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842241|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83842242|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
83842243|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
83842244|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842245|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842246|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842247|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83842248|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842249|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842250|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83842251|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83842252|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83842253|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
83842254|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83842255|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83842256|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
83842257|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83842258|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83842259|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83842260|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842261|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842262|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842263|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842264|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83842265|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83842266|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
83842267|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842268|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842269|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83842270|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83842271|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
83842272|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83842273|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842274|NCT01240252|Insulin|insulin|mesh-list
83842275|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83842276|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842277|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842278|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
83842279|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83842280|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842281|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842282|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842283|NCT05233605|Analgesics|analgesics|mesh-ancestor
83842284|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
83842285|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842286|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83842287|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83842288|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83842289|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
83842290|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842291|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842292|NCT00117780|Insulin|insulin|mesh-list
83842293|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83842294|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
83842295|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
83842296|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842297|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842298|NCT01240408|Lenvatinib|lenvatinib|mesh-list
83842299|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842300|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842301|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842302|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842303|NCT00481273|Azacitidine|azacitidine|mesh-list
83842304|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83842305|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
83842306|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842307|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842308|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842309|NCT00481312|Midazolam|midazolam|mesh-list
83842310|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
83842311|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83842312|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842313|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842314|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842315|NCT00481312|Analgesics|analgesics|mesh-ancestor
83842316|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
83842317|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842318|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83842319|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83842320|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83842321|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83842322|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842323|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842324|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83842325|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83842326|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842327|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842328|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83842329|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
83842330|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
83842331|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
83842332|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
83842333|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
83842334|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842335|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842336|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
83842337|NCT00119990|Icodextrin|icodextrin|mesh-list
83842338|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83842339|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
83842340|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
83842341|NCT00481624|Hematinics|hematinics|mesh-ancestor
83842342|NCT00117897|Lenograstim|lenograstim|mesh-list
83842343|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83842344|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
83842345|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842346|NCT00481663|Metformin|metformin|mesh-list
83842347|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82997850|NCT02348788|Artemether|artemether|mesh-list
83842348|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842349|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842350|NCT00481663|Incretins|incretins|mesh-ancestor
83842351|NCT00481663|Hormones|hormones|mesh-ancestor
83842352|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842353|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83842354|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83842355|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842356|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842357|NCT00481702|Metronidazole|metronidazole|mesh-list
83842358|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
83842359|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842360|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83842361|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83842362|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83842363|NCT00481741|Hemostatics|hemostatics|mesh-list
83842364|NCT00481741|Coagulants|coagulants|mesh-ancestor
83842365|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
83842366|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
83842367|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83842368|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83842369|NCT00481819|Prednisolone|prednisolone|mesh-list
83842370|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
83842371|NCT00481819|Tacrolimus|tacrolimus|mesh-list
83842372|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83842373|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
83842374|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842375|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
83842376|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842377|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83842378|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842379|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842380|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83842381|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842382|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83842383|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
83842384|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83842385|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842386|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842387|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
83842388|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
83842389|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842390|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842391|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
83842392|NCT00481819|Hormones|hormones|mesh-ancestor
83842393|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842394|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83842395|NCT00481819|Protective Agents|protective agents|mesh-ancestor
83842396|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83842397|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83842398|NCT02958059|Cefoxitin|cefoxitin|mesh-list
83842399|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842400|NCT00481975|Rimonabant|rimonabant|mesh-list
83842401|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83842402|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83842403|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83842404|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842405|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842406|NCT00481975|Hormones|hormones|mesh-ancestor
83842407|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842408|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842409|NCT00482209|Misoprostol|misoprostol|mesh-list
83137865|NCT05325229|Docetaxel|docetaxel|mesh-list
83842410|NCT00482209|Mifepristone|mifepristone|mesh-list
83842411|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83842412|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
83842413|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83842414|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842415|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83842416|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842417|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
83842418|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83842419|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83842420|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83842421|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83842422|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
83842423|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83842424|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83842425|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
83842426|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842427|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
83842428|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83842429|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83842430|NCT00117936|Mitogens|mitogens|mesh-list
83842431|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
83842432|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842433|NCT00482248|Omalizumab|omalizumab|mesh-list
83842434|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83842435|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83842436|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
83842437|NCT00120185|Interleukin-2|interleukin-2|mesh-list
83842438|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842439|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842440|NCT00120185|Analgesics|analgesics|mesh-ancestor
83842441|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
83842442|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842443|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842444|NCT01240642|Vadimezan|vadimezan|mesh-list
83842445|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842446|NCT00117975|Galiximab|galiximab|mesh-list
83842447|NCT00117975|Rituximab|rituximab|mesh-list
83842448|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83842449|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842450|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
83842451|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842452|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842453|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842454|NCT00482521|Pomalidomide|pomalidomide|mesh-list
83842455|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
83842456|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842457|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83842458|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83842459|NCT00482521|Growth Substances|growth substances|mesh-ancestor
83842460|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
83842461|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842462|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
83842463|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83842464|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842465|NCT00120302|Analgesics|analgesics|mesh-ancestor
83842466|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
83842467|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842468|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842469|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842470|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842471|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
83842472|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842473|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
83842474|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83842475|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842476|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842477|NCT00482716|Iron|iron|mesh-list
83842478|NCT00482716|Dextrans|dextrans|mesh-list
83842479|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
83842480|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83842481|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
83842482|NCT00482716|Trace Elements|trace elements|mesh-ancestor
83842483|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
83842484|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842485|NCT00482716|Hematinics|hematinics|mesh-ancestor
83842486|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
83842487|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
83842488|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
83842489|NCT00482755|Sunitinib|sunitinib|mesh-list
83842490|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842491|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83842492|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83842493|NCT00482755|Growth Substances|growth substances|mesh-ancestor
83842494|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842495|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
83842496|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842497|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842498|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842499|NCT00120341|Analgesics|analgesics|mesh-list
83842500|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
83842501|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842502|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842503|NCT00482989|Sifalimumab|sifalimumab|mesh-list
83842504|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
83842505|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842507|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83842508|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
83842509|NCT00483028|Donepezil|donepezil|mesh-list
83842510|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83842511|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842512|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842513|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
83842514|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842515|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842516|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
83842517|NCT00118014|Sertraline|sertraline|mesh-list
83842518|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
83842519|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842520|NCT00118014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83842521|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842522|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842523|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842524|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842525|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
83842526|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842527|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
83842528|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83842529|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842530|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83842531|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
83842532|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83842533|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842534|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842535|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842536|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
83842537|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
83842538|NCT05176470|Fludarabine|fludarabine|mesh-list
83842539|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842540|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
83842541|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842542|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842543|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83842544|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
83842545|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842546|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842547|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83842548|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83842549|NCT05176470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83842550|NCT01241032|Udenafil|udenafil|mesh-list
83842551|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83842552|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83842553|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842554|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842555|NCT00483067|Cytarabine|cytarabine|mesh-list
83842556|NCT00483067|Cladribine|cladribine|mesh-list
83842557|NCT00483067|Lenograstim|lenograstim|mesh-list
83842558|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83842559|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
83842560|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842561|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842562|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
83842563|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842564|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842565|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
83842566|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842567|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83842568|NCT00483106|Methylphenidate|methylphenidate|mesh-list
83842569|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83842570|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842571|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83842572|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842573|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842574|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842575|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
83842576|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842577|NCT00118170|Sorafenib|sorafenib|mesh-list
83842578|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842579|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842580|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842581|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842582|NCT00120497|Hormones|hormones|mesh-list
83842583|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842584|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842585|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83842586|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83842587|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83842588|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83842589|NCT00483301|Sorafenib|sorafenib|mesh-list
83842590|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83842591|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842592|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842593|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842594|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842595|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83842596|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842597|NCT00120536|Vildagliptin|vildagliptin|mesh-list
83842598|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842599|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842600|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83842601|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
83842602|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842603|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842604|NCT00483730|Actovegin|actovegin|mesh-list
83842605|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83842606|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842607|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83842608|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842609|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
83842610|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842611|NCT00483730|Protective Agents|protective agents|mesh-ancestor
83842612|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83842613|NCT00118326|Lenograstim|lenograstim|mesh-list
83842614|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83842615|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
83842616|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842617|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
83842618|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842619|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842620|NCT00405171|Nevirapine|nevirapine|mesh-list
83842621|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83842622|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83842623|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842624|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842625|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
83842626|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842627|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83842628|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83842629|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83842630|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83842631|NCT00483886|Prucalopride|prucalopride|mesh-list
83842632|NCT00483886|Laxatives|laxatives|mesh-ancestor
83842633|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842634|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83842635|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83842636|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
83842637|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842638|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842639|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842640|NCT00483964|Olanzapine|olanzapine|mesh-list
83842641|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
83842642|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
83842643|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842644|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842645|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998137|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842646|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83842647|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842648|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842649|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842650|NCT00483964|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83842651|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842652|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842653|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842654|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842655|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
83842656|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
83842657|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83842658|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842659|NCT00484003|Analgesics|analgesics|mesh-ancestor
83842660|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
83842661|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842662|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842663|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842664|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842665|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
83842666|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842667|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
83842668|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83842669|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842670|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842671|NCT01241110|Ofloxacin|ofloxacin|mesh-list
83842672|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83842673|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842674|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83842675|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83842676|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83842677|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842678|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842679|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842680|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83842681|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83842682|NCT00120653|Metoclopramide|metoclopramide|mesh-list
83842683|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
83842684|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
83842685|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842686|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842687|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842688|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83842689|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83842690|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
83842691|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842692|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842693|NCT00484120|Diclofenac|diclofenac|mesh-list
83842694|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83842695|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842696|NCT00484120|Analgesics|analgesics|mesh-ancestor
83842697|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
83842698|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842699|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842700|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842701|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842702|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83842703|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842704|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842705|NCT00484237|Etanercept|etanercept|mesh-list
83842706|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83842707|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842708|NCT00484237|Analgesics|analgesics|mesh-ancestor
83842709|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
83842710|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842711|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842712|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842713|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842714|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842715|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842716|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
83842717|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
83842718|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
83842719|NCT00120692|Hematinics|hematinics|mesh-ancestor
83842720|NCT00484432|Doxorubicin|doxorubicin|mesh-list
83842721|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83842722|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842723|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83842724|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83842725|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842726|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842727|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
83842728|NCT00484510|Vitamins|vitamins|mesh-ancestor
83842729|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
83842730|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842731|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
83842732|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842733|NCT00484510|Protective Agents|protective agents|mesh-ancestor
83842734|NCT00120731|Acetazolamide|acetazolamide|mesh-list
83842735|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
83842736|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842737|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
83842738|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83842739|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842740|NCT00120731|Diuretics|diuretics|mesh-ancestor
83842741|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
83842742|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842743|NCT00120731|Expectorants|expectorants|mesh-ancestor
83842744|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
83842745|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
83842746|NCT00484744|Acetaminophen|acetaminophen|mesh-list
83842747|NCT00484744|Ibuprofen|ibuprofen|mesh-list
83842748|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842749|NCT00484744|Analgesics|analgesics|mesh-ancestor
83842750|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
83842751|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842752|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842753|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
83842754|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83842755|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842756|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842757|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83842758|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842759|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842760|NCT00484822|Heparin|heparin|mesh-list
83842761|NCT00484822|Calcium heparin|calcium heparin|mesh-list
83842762|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
83842763|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83842764|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83842765|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842766|NCT00405210|Docetaxel|docetaxel|mesh-list
83842767|NCT00405210|Sorafenib|sorafenib|mesh-list
83842768|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842769|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
83842770|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
83842771|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
83842772|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842773|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842774|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842775|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
83842776|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
83842777|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83842778|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
83842779|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83842780|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83842781|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842782|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83842783|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842784|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842785|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83842786|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83842787|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
83842788|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83842789|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82998272|NCT02334670|Fluconazole|fluconazole|mesh-list
83842790|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842791|NCT05062356|Ketorolac|ketorolac|mesh-list
83842792|NCT05062356|Epinephrine|epinephrine|mesh-list
83842793|NCT05062356|Bupivacaine|bupivacaine|mesh-list
83842794|NCT05062356|Prilocaine|prilocaine|mesh-list
83842795|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83842796|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
83842798|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842799|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842800|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
83842801|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842802|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83842803|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83842804|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
83842805|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842806|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842807|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83842808|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83842809|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
83842810|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83842811|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
83842812|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
83842813|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
83842814|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83842815|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83842816|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842817|NCT05062356|Analgesics|analgesics|mesh-ancestor
83842818|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842819|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842820|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83842821|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842822|NCT01241383|Bosentan|bosentan|mesh-list
83842823|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83842824|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83842825|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842826|NCT00485056|Pioglitazone|pioglitazone|mesh-list
83842827|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842828|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842829|NCT00120887|Atorvastatin|atorvastatin|mesh-list
83842830|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83842831|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83842832|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
83842833|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842834|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83842835|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83842836|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842837|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
83842838|NCT00118638|Hematinics|hematinics|mesh-ancestor
83842839|NCT00485368|Perindopril|perindopril|mesh-list
83842840|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83842841|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
83842842|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842843|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842844|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83842845|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83842846|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83842847|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842848|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842849|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842850|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83842851|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842852|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842853|NCT01241500|ON 01910|on 01910|mesh-list
83842854|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842855|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842856|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842857|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842858|NCT05058612|Midodrine|midodrine|mesh-list
83842859|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
83842860|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
83842861|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842862|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842863|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83842864|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83842865|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83842866|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83842867|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
82998354|NCT04278404|Metformin|metformin|mesh-list
83842868|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842869|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842871|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83842872|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
83842873|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842874|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842875|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83842876|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
83842877|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83842878|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83842879|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83842880|NCT01241422|Montelukast|montelukast|mesh-list
83842881|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83842882|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
83842883|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83842884|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
83842885|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83842886|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842887|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83842888|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83842889|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842890|NCT05058417|Empagliflozin|empagliflozin|mesh-list
83842891|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83842892|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842893|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842894|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842895|NCT02274337|Abivertinib|abivertinib|mesh-list
83842896|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83842897|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842898|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842899|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83842900|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842901|NCT00485680|Olanzapine|olanzapine|mesh-list
83842902|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
83842903|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
83842904|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
83842905|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842906|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842907|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83842908|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83842909|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83842910|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83842911|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83842912|NCT00485680|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83842913|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842914|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842915|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842916|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842917|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
83842918|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
83842919|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842920|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
83842921|NCT00118794|Lumefantrine|lumefantrine|mesh-list
83842922|NCT00118794|Artemether|artemether|mesh-list
83842923|NCT00118794|Dapsone|dapsone|mesh-list
83842924|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
83842925|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83842926|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
83842927|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83842928|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83842929|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842930|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83842931|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842932|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842933|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
83842934|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83842935|NCT01241773|Efavirenz|efavirenz|mesh-list
83842936|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
83842937|NCT01241773|Simeprevir|simeprevir|mesh-list
83842938|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82998431|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83842939|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83842940|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842941|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842942|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
83842943|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83842944|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83842945|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83842946|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83842947|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83842948|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83842949|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83842950|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83842951|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83842952|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83842953|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83842954|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
83842955|NCT00121277|Capecitabine|capecitabine|mesh-list
83842956|NCT00121277|Vorinostat|vorinostat|mesh-list
83842957|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83842958|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
83842959|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842960|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83842961|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83842962|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842963|NCT00485797|Methylphenidate|methylphenidate|mesh-list
83842964|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83842965|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842966|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83842967|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842968|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842969|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842970|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
83842971|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842972|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83842973|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83842974|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83842975|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83842976|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842977|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
83842978|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83842979|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842980|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
83842981|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83842982|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83842983|NCT00121316|Analgesics|analgesics|mesh-ancestor
83842984|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
83842985|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83842986|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842987|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83842988|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83842989|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
83842990|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83842991|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
83842992|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83842993|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83842994|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83842995|NCT00118950|Metformin|metformin|mesh-list
83842996|NCT00118950|Repaglinide|repaglinide|mesh-list
83842997|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83842998|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83842999|NCT00486187|Metformin|metformin|mesh-list
83843000|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
83843001|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843002|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843003|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
83843004|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83843005|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843006|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
83843007|NCT00486343|Zileuton|zileuton|mesh-list
83843008|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83843009|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83843010|NCT00486343|Analgesics|analgesics|mesh-ancestor
82998505|NCT02333890|Chloroquine|chloroquine|mesh-list
83843011|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
83843012|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843013|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843014|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843015|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843016|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83843017|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843018|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843019|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83843020|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
83843021|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843023|NCT00486421|Rituximab|rituximab|mesh-list
83843024|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83843025|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843026|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
83843027|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843028|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843029|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843030|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
83843031|NCT00486421|Hormones|hormones|mesh-ancestor
83843032|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843033|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83843034|NCT00486460|Curcumin|curcumin|mesh-list
83843035|NCT00486460|Celecoxib|celecoxib|mesh-list
83843036|NCT00486460|Gemcitabine|gemcitabine|mesh-list
83843037|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843038|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
83843039|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843040|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843041|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83843042|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83843043|NCT00486460|Analgesics|analgesics|mesh-ancestor
83843044|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
83843045|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843046|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843047|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843048|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843049|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843050|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83843051|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83843052|NCT00121511|Fluorouracil|fluorouracil|mesh-list
83843053|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
83843054|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843055|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843056|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843057|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843058|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
83843059|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843060|NCT00486694|Artesunate|artesunate|mesh-list
83843061|NCT00486694|Chloroquine|chloroquine|mesh-list
83843062|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
83843063|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
83843064|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83843065|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
83843066|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83843067|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83843068|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843069|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843070|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
83843071|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
83843072|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83843073|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
83843074|NCT00486694|Amebicides|amebicides|mesh-ancestor
83843075|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843076|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83843077|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843078|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843079|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83843080|NCT00486772|Calcium|calcium|mesh-list
83843081|NCT00486772|Sevelamer|sevelamer|mesh-list
83843082|NCT00486772|Calcium acetate|calcium acetate|mesh-list
83843083|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83843084|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843085|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
83843086|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
83843087|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843088|NCT00121550|Clarithromycin|clarithromycin|mesh-list
83843089|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83843090|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843091|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83843092|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843093|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843094|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83843095|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83843096|NCT01242046|Caffeine|caffeine|mesh-list
83843097|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83843098|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843099|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83843100|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843101|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843102|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83843103|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83843104|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
83843105|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843106|NCT01242202|Acarbose|acarbose|mesh-list
83843107|NCT01242202|Voglibose|voglibose|mesh-list
83843108|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83843109|NCT01242202|Miglitol|miglitol|mesh-list
83843110|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
83843111|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843112|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843113|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843114|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843115|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83843116|NCT00119145|Artesunate|artesunate|mesh-list
83843117|NCT00119145|Amodiaquine|amodiaquine|mesh-list
83843118|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83843119|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
83843120|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83843121|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83843122|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843123|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843124|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
83843125|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
83843126|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83843127|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
83843128|NCT00119184|Anesthetics|anesthetics|mesh-list
83843129|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843130|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843131|NCT00487123|Valsartan|valsartan|mesh-list
83843132|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83843133|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83843134|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83843135|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83843136|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843137|NCT00487123|Diuretics|diuretics|mesh-ancestor
83843138|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
83843139|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843140|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83843141|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83843142|NCT00487591|Simvastatin|simvastatin|mesh-list
83843143|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83843144|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83843145|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
83843146|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843147|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83843148|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83843149|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843150|NCT00487786|Docetaxel|docetaxel|mesh-list
83843151|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843152|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
83843153|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
83843154|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
83843155|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843156|NCT00488137|Prucalopride|prucalopride|mesh-list
83843157|NCT00488137|Laxatives|laxatives|mesh-ancestor
83843158|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998658|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
83843159|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83843160|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83843162|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843163|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843164|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843165|NCT00488176|Cetirizine|cetirizine|mesh-list
83843166|NCT00488176|Montelukast|montelukast|mesh-list
83843167|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83843168|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83843169|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83843170|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
83843171|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843172|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843173|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83843174|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83843175|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843176|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83843177|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83843178|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83843179|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
83843180|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
83843181|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843182|NCT00488215|Prucalopride|prucalopride|mesh-list
83843183|NCT00488215|Laxatives|laxatives|mesh-ancestor
83843184|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83843185|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83843186|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83843187|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
83843188|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843189|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843190|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843191|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
83843192|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83843193|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843194|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843195|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83843196|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
83843197|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843198|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
83843199|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843200|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843201|NCT00488566|Lamotrigine|lamotrigine|mesh-list
83843202|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
83843203|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83843204|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83843205|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843206|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83843207|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843208|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83843209|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83843210|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843211|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83843212|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83843213|NCT00488605|Leucovorin|leucovorin|mesh-list
83843214|NCT00488605|Prednisone|prednisone|mesh-list
83843215|NCT00488605|Methotrexate|methotrexate|mesh-list
83843216|NCT00488605|Vinblastine|vinblastine|mesh-list
83843217|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
83843218|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843219|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
83843220|NCT00488605|Hormones|hormones|mesh-ancestor
83843221|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843222|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843223|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83843224|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843225|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83843226|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
83843227|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83843228|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843229|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
82998731|NCT01372761|CKD732|ckd732|mesh-list
83843230|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843232|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843233|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83843234|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843235|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
83843236|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843237|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83843238|NCT00488605|Antidotes|antidotes|mesh-ancestor
83843239|NCT00488605|Protective Agents|protective agents|mesh-ancestor
83843240|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
83843241|NCT00488605|Vitamins|vitamins|mesh-ancestor
83843242|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
83843243|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83843244|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
83843245|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
83843246|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
83843247|NCT00488722|Goserelin|goserelin|mesh-list
83843248|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83843249|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843250|NCT00488761|Tigecycline|tigecycline|mesh-list
83843251|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83843252|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843253|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83843254|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843255|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843256|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
83843257|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83843258|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843259|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83843260|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
83843261|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83843262|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843263|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843264|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843265|NCT00145236|Nebivolol|nebivolol|mesh-list
83843266|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83843267|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
83843268|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83843269|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83843270|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83843271|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
83843272|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843273|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843274|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843275|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
83843276|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83843277|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843278|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83843279|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
83843280|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843281|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
83843282|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83843283|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843284|NCT00488995|Tremelimumab|tremelimumab|mesh-list
83843285|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843286|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
83843287|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
83843288|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83843289|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83843290|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843291|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843292|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843293|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843294|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83843295|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83843296|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83843297|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83843298|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843299|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843300|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843301|NCT00489073|Analgesics|analgesics|mesh-ancestor
83843302|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
83843303|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843304|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
83843305|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83843306|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
83843307|NCT00489151|Lamivudine|lamivudine|mesh-list
83843308|NCT00489151|Adefovir|adefovir|mesh-list
83843309|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83843310|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83843311|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83843312|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843313|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843314|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
83843315|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843316|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83843317|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83843318|NCT00145314|Leucovorin|leucovorin|mesh-list
83843319|NCT00145314|Folic Acid|folic acid|mesh-list
83843320|NCT00145314|Fluorouracil|fluorouracil|mesh-list
83843321|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
83843322|NCT00145314|Cetuximab|cetuximab|mesh-list
83843323|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
83843324|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
83843325|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843326|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843327|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843328|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843329|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
83843330|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843331|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83843332|NCT00145314|Antidotes|antidotes|mesh-ancestor
83843333|NCT00145314|Protective Agents|protective agents|mesh-ancestor
83843334|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
83843335|NCT00145314|Vitamins|vitamins|mesh-ancestor
83843336|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
83843337|NCT00145314|Hematinics|hematinics|mesh-ancestor
83843338|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
83843339|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843340|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843341|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
83843342|NCT00489229|Ramipril|ramipril|mesh-list
83843343|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843344|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843345|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83843346|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
83843347|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843348|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843349|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83843350|NCT00489385|Ribavirin|ribavirin|mesh-list
83843351|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
83843352|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843353|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
83843354|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843355|NCT01242631|Everolimus|everolimus|mesh-list
83843356|NCT01242631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83843357|NCT01242631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83843358|NCT01242631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843359|NCT01242631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843360|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843361|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
83843362|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843363|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843364|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
83843365|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
83843366|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843367|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843368|NCT01242904|Icodextrin|icodextrin|mesh-list
83843369|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
83843370|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83843371|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
83843372|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843373|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843374|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83843375|NCT00121979|Racivir|racivir|mesh-list
83843376|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83843377|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843378|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843379|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
83843380|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843381|NCT00489658|Eflornithine|eflornithine|mesh-list
83843382|NCT00489658|Nifurtimox|nifurtimox|mesh-list
83843383|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843384|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83843385|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83843386|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83843387|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843388|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83843389|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843390|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843391|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
83843392|NCT00122018|Fenoldopam|fenoldopam|mesh-list
83843393|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83843394|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
83843395|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843396|NCT00122018|Expectorants|expectorants|mesh-ancestor
83843397|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
83843398|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83843399|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
83843400|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843401|NCT00122018|Protective Agents|protective agents|mesh-ancestor
83843402|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843403|NCT00122018|Antidotes|antidotes|mesh-ancestor
83843404|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83843405|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
83843406|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
83843407|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
83843408|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843409|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83843410|NCT00489775|Paroxetine|paroxetine|mesh-list
83843411|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83843412|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83843413|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83843414|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843415|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843416|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843417|NCT00489775|Analgesics|analgesics|mesh-ancestor
83843418|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
83843419|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843420|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
83843421|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83843422|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
83843423|NCT00489775|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83843424|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
83843425|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83843426|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83843427|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83843428|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843429|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83843430|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843431|NCT00489892|Modafinil|modafinil|mesh-list
83843432|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83843433|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843434|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83843435|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83843436|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83843437|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843438|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
83843439|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83843440|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
83843441|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83843442|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843443|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83843444|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83843445|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83843446|NCT01243060|Zolpidem|zolpidem|mesh-list
83843447|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83843448|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83843449|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843450|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843451|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83843452|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
83843453|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
83843454|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843455|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843457|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83843458|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83843459|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83843460|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
83843461|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
83843462|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843463|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843464|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843465|NCT00122096|Valdecoxib|valdecoxib|mesh-list
83843466|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83843467|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83843468|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843469|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843470|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83843471|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83843472|NCT00122096|Analgesics|analgesics|mesh-ancestor
83843473|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
83843474|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843475|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843476|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843477|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843478|NCT00490243|Budesonide|budesonide|mesh-list
83843479|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
83843480|NCT00490243|Montelukast|montelukast|mesh-list
83843481|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843482|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83843483|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
83843484|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843485|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843486|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83843487|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
83843488|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
83843489|NCT00490243|Hormones|hormones|mesh-ancestor
83843490|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843491|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83843492|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83843493|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83843494|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83843495|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843496|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843497|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83843498|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
83843499|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83843500|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83843501|NCT00490360|Gemcitabine|gemcitabine|mesh-list
83843502|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843503|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843504|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
83843505|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843506|NCT00490399|Gemcitabine|gemcitabine|mesh-list
83843507|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843508|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843509|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
83843510|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843511|NCT04844385|Paclitaxel|paclitaxel|mesh-list
83843512|NCT04844385|Capecitabine|capecitabine|mesh-list
83843513|NCT04844385|Nedaplatin|nedaplatin|mesh-list
83843514|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83843515|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843516|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
83843517|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
83843518|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
83843519|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843520|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843521|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
83843522|NCT00490633|Ethanol|ethanol|mesh-list
83843523|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
83843524|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83843525|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843526|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843527|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843528|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
83843529|NCT00490711|Paclitaxel|paclitaxel|mesh-list
83843530|NCT00490711|Carboplatin|carboplatin|mesh-list
83843531|NCT00490711|Gemcitabine|gemcitabine|mesh-list
83843532|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83843533|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843534|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
83843535|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
83843536|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
83843537|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843538|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843539|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
83843540|NCT00122291|Capecitabine|capecitabine|mesh-list
83843541|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83843542|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
83843543|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843544|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843545|NCT00490789|Sirolimus|sirolimus|mesh-list
83843546|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83843547|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843548|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83843549|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843550|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
83843551|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843552|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
83843553|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843554|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
83843555|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83843556|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83843557|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83843558|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843559|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
83843560|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
83843561|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843562|NCT00490867|Protective Agents|protective agents|mesh-ancestor
83843563|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843564|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
83843565|NCT00490867|Vitamins|vitamins|mesh-ancestor
83843566|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
83843567|NCT00122330|Eculizumab|eculizumab|mesh-list
83843568|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83843569|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843570|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
83843571|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843572|NCT00490906|Interferons|interferons|mesh-list
83843573|NCT00490906|Interferon-beta|interferon-beta|mesh-list
83843574|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
83843575|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
83843576|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
83843577|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
83843578|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843579|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
83843580|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843581|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
83843582|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843583|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83843584|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843585|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843586|NCT00122486|Tenofovir|tenofovir|mesh-list
83843587|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
83843588|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843589|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83843590|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83843591|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843592|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843593|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83843594|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83843595|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
83843596|NCT00491413|Hematinics|hematinics|mesh-ancestor
83843597|NCT00145665|Telbivudine|telbivudine|mesh-list
83843598|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
83843599|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843600|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83843601|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843602|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843603|NCT00491725|Metformin|metformin|mesh-list
83843604|NCT00491725|Repaglinide|repaglinide|mesh-list
83843605|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843606|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843607|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
83843608|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
83843609|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83843610|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83843611|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843612|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843613|NCT00491803|Urological Agents|urological agents|mesh-ancestor
83843615|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
83843616|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83843617|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83843618|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
83843619|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843620|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843621|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83843622|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83843623|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
83843624|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843625|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83843626|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83843627|NCT00491920|Vitamin D|vitamin d|mesh-list
83843628|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
83843629|NCT00491920|Vitamins|vitamins|mesh-ancestor
83843630|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
83843631|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137933|NCT04940546|Bevacizumab|bevacizumab|mesh-list
83843632|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83843633|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83843634|NCT00491998|Entacapone|entacapone|mesh-list
83843635|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83843636|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83843637|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83843638|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843639|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843640|NCT00492037|Conivaptan|conivaptan|mesh-list
83843641|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83843642|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843643|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
83843644|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843645|NCT00402272|Everolimus|everolimus|mesh-list
83843646|NCT00402272|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83843647|NCT00402272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83843648|NCT00402272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843649|NCT00402272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843650|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843651|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
83843652|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843653|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843654|NCT00492388|Ketamine|ketamine|mesh-list
83843655|NCT00492388|Analgesics|analgesics|mesh-ancestor
83843656|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
83843657|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843658|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843659|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83843660|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83843661|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
83843662|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
83843663|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843664|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83843665|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83843666|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843667|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843668|NCT01243528|Vitamin D|vitamin d|mesh-list
83843669|NCT01243528|Vitamins|vitamins|mesh-ancestor
83843670|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
83843671|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843672|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83843673|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
83843674|NCT00492427|Hematinics|hematinics|mesh-ancestor
83843675|NCT00492466|Interferons|interferons|mesh-list
83843676|NCT00492466|Interferon-beta|interferon-beta|mesh-list
83843677|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
83843678|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
83843679|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843680|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
83843681|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843682|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843683|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
83843684|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
83843685|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843686|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843687|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83843688|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
83843689|NCT00492466|Hormones|hormones|mesh-ancestor
83843690|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843691|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83843692|NCT00492466|Protective Agents|protective agents|mesh-ancestor
83843693|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
83843694|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83843695|NCT00492505|Tamoxifen|tamoxifen|mesh-list
83843696|NCT00492505|Sorafenib|sorafenib|mesh-list
83843697|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843698|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843699|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83843700|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843701|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83843702|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
83843703|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843704|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843705|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83843706|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83843707|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83843708|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83843709|NCT00492661|Tacrolimus|tacrolimus|mesh-list
83843710|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83843711|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
83843712|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843713|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83843714|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843715|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843716|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
83843717|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83843718|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843719|NCT00402350|Fentanyl|fentanyl|mesh-list
83843720|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83843721|NCT00402350|Narcotics|narcotics|mesh-ancestor
83843722|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843723|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843724|NCT00402350|Analgesics|analgesics|mesh-ancestor
83843725|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
83843726|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843727|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83843728|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83843729|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
83843730|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
83843731|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
83843732|NCT00122720|Hematinics|hematinics|mesh-ancestor
83843733|NCT00492934|Menotropins|menotropins|mesh-list
83843734|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83843735|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
83843736|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83843737|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843738|NCT02274454|Oxytocin|oxytocin|mesh-list
83843739|NCT02274454|Calcium|calcium|mesh-list
83843740|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83843741|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843742|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
83843743|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83843744|NCT04760730|Vaccines|vaccines|mesh-list
83843745|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
83843746|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843747|NCT00122759|Ketamine|ketamine|mesh-list
83843748|NCT00122759|Analgesics|analgesics|mesh-ancestor
83843749|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
83843750|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843751|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843752|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83843753|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83843754|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
83843755|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
83843756|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843757|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83843758|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83843759|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843760|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843761|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
83843762|NCT00493129|Interleukin-2|interleukin-2|mesh-list
83843763|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843764|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83843765|NCT00493129|Analgesics|analgesics|mesh-ancestor
83843766|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
83843767|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843768|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843769|NCT00126542|Bevacizumab|bevacizumab|mesh-list
83843770|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83843771|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83843772|NCT00126542|Antibodies|antibodies|mesh-list
83843773|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
83843774|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83843775|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843776|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83843777|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83843778|NCT00126542|Growth Substances|growth substances|mesh-ancestor
83843779|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843780|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
83843781|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
83843782|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83843783|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843784|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843785|NCT00493324|Alefacept|alefacept|mesh-list
83843786|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83843787|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
83843788|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843789|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
83843790|NCT01243801|Ketamine|ketamine|mesh-list
83843791|NCT01243801|Analgesics|analgesics|mesh-ancestor
83843792|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
83843793|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843794|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843795|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83843796|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83843797|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
83843798|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
83843799|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843800|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83843801|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83843802|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843803|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843804|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83843805|NCT00126620|Sorafenib|sorafenib|mesh-list
83843806|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843807|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83843808|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843809|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843810|NCT00493363|Artesunate|artesunate|mesh-list
83843811|NCT00493363|Mefloquine|mefloquine|mesh-list
83843812|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
83843813|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83843814|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83843815|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843816|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843817|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
83843818|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
83843819|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83843820|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
83843821|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
83843822|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83843823|NCT00126698|Trimethoprim|trimethoprim|mesh-list
83843824|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
83843825|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83843826|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843827|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83843828|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83843829|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843830|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843831|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843832|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83843833|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83843834|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83843835|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
83843836|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83843837|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83843838|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83843839|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83843840|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83843841|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
83843842|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83843843|NCT00493402|Estrogens|estrogens|mesh-ancestor
83843844|NCT00493402|Hormones|hormones|mesh-ancestor
83843845|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843846|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843847|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83843848|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843849|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
83843850|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
83843851|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83843852|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83843853|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843854|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843855|NCT00145938|Urological Agents|urological agents|mesh-ancestor
83843856|NCT00493480|Propranolol|propranolol|mesh-list
83843857|NCT00493480|Carvedilol|carvedilol|mesh-list
83843858|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83843859|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83843860|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
83843861|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843862|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843863|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843864|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83843865|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83843866|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
83843867|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
83843868|NCT00493480|Protective Agents|protective agents|mesh-ancestor
83843869|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83843870|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83843871|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83843872|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83843873|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83843874|NCT01243996|Ibuprofen|ibuprofen|mesh-list
83843875|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83843876|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83843877|NCT01243996|Analgesics|analgesics|mesh-ancestor
83843878|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
83843879|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843880|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843881|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83843882|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83843883|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83843884|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843885|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843886|NCT01244113|Propofol|propofol|mesh-list
83843887|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83843888|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83843889|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843890|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83843891|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
83843892|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
83843893|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
83843894|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83843895|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83843896|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843897|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843898|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
83843899|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843900|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83843901|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83843902|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
83843903|NCT00493987|Testosterone|testosterone|mesh-list
83843904|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
83843905|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
83843906|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83843907|NCT00493987|Dutasteride|dutasteride|mesh-list
83843908|NCT00493987|Androgens|androgens|mesh-ancestor
83843909|NCT00493987|Hormones|hormones|mesh-ancestor
83843910|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83843911|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843912|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83843913|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843914|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
83843915|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83843916|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83843917|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843918|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843919|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
83843920|NCT00494104|Vitamin D|vitamin d|mesh-list
83843921|NCT00494104|Vitamins|vitamins|mesh-ancestor
83843922|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
83843923|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843924|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83843925|NCT00405366|Sorafenib|sorafenib|mesh-list
83843926|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843927|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83843928|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843929|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843930|NCT00494338|Docetaxel|docetaxel|mesh-list
83843931|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83843932|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
83843933|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
83843934|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
83843935|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843936|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83843937|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83843938|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83843939|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83843940|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843941|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843942|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843943|NCT00494377|Analgesics|analgesics|mesh-ancestor
83843944|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
83843945|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843946|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
83843947|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83843948|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
83843949|NCT00146016|Amantadine|amantadine|mesh-list
83843950|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83843951|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83843952|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
83843953|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843954|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
83843955|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843956|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843957|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843958|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83843959|NCT00146016|Analgesics|analgesics|mesh-ancestor
83843960|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
83843961|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83843962|NCT00126971|Dapsone|dapsone|mesh-list
83843963|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
83843964|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83843965|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
83843966|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83843967|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83843968|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83843969|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83843970|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843971|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
83843972|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83843973|NCT01244230|Fexofenadine|fexofenadine|mesh-list
83843974|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83843975|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83843976|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83843977|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
83843978|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
83843979|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999481|NCT05204628|Crizotinib|crizotinib|mesh-list
83843980|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843981|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843982|NCT01244269|Methylphenidate|methylphenidate|mesh-list
83843983|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83843984|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843985|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83843986|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83843987|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83843988|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83843989|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
83843990|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83843991|NCT00127010|Vaccines|vaccines|mesh-list
83843992|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
83843993|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83843994|NCT00494533|Treprostinil|treprostinil|mesh-list
83843995|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83843996|NCT00494572|Montelukast|montelukast|mesh-list
83843997|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83843998|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
83843999|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83844000|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
83844001|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844002|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844003|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83844004|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83844005|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844006|NCT00494611|Cetuximab|cetuximab|mesh-list
83844007|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844008|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844009|NCT00127049|Gemcitabine|gemcitabine|mesh-list
83844010|NCT00127049|Ifosfamide|ifosfamide|mesh-list
83844011|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844012|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844013|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
83844014|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844015|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83844016|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
83844017|NCT00494884|Vildagliptin|vildagliptin|mesh-list
83844018|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844019|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844020|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83844021|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
83844022|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844023|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844024|NCT00127088|Docetaxel|docetaxel|mesh-list
83844025|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844026|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844027|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844028|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844029|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844030|NCT02957877|Heparin|heparin|mesh-list
83844031|NCT02957877|Calcium heparin|calcium heparin|mesh-list
83844032|NCT02957877|Nadroparin|nadroparin|mesh-list
83844033|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
83844034|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83844035|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83844036|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844037|NCT01244581|Amoxicillin|amoxicillin|mesh-list
83844038|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
83844039|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
83844040|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83844041|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844042|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844043|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83844044|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844045|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844046|NCT01244659|Tacrolimus|tacrolimus|mesh-list
83844047|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844048|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
83844049|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844050|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83844051|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844052|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844054|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
83844055|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
83844056|NCT01244698|Cefazolin|cefazolin|mesh-list
83844057|NCT01244698|Cefadroxil|cefadroxil|mesh-list
83844058|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844059|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844060|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83844061|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844062|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844063|NCT00495118|Risperidone|risperidone|mesh-list
83844064|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83844065|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
83844066|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844067|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844068|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844069|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83844070|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83844071|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844072|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83844073|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83844074|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
83844075|NCT00495313|Metronidazole|metronidazole|mesh-list
83844076|NCT00495313|Doxycycline|doxycycline|mesh-list
83844077|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844078|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844079|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83844080|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83844081|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
83844082|NCT00495352|Bupropion|bupropion|mesh-list
83844083|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83844084|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
83844085|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83844086|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83844087|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83844088|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83844089|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844090|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
83844091|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844092|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844093|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83844094|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83844095|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844096|NCT00495547|Azacitidine|azacitidine|mesh-list
83844097|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
83844098|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844099|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
83844100|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844101|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844102|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844103|NCT00495547|Hematinics|hematinics|mesh-ancestor
83844104|NCT00495781|Iron|iron|mesh-list
83844105|NCT00495781|Trace Elements|trace elements|mesh-ancestor
83844106|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
83844107|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844108|NCT00405405|Bevacizumab|bevacizumab|mesh-list
83844109|NCT00405405|Cisplatin|cisplatin|mesh-list
83844110|NCT00405405|Docetaxel|docetaxel|mesh-list
83844111|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83844112|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844113|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844114|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83844115|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83844116|NCT00405405|Growth Substances|growth substances|mesh-ancestor
83844117|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844118|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83844119|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844120|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844121|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844122|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844123|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844124|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844125|NCT00495898|Sirolimus|sirolimus|mesh-list
83844126|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844127|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844128|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83844129|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844130|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
83844131|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844132|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
83844133|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844134|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83844135|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
83844136|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844137|NCT00127478|Atrasentan|atrasentan|mesh-list
83844138|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844139|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83844140|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83844141|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844142|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83844143|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83844144|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83844145|NCT00496405|Bevacizumab|bevacizumab|mesh-list
83844146|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844147|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844148|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83844149|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83844150|NCT00496405|Growth Substances|growth substances|mesh-ancestor
83844151|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844152|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83844153|NCT00496444|Azacitidine|azacitidine|mesh-list
83844154|NCT00496444|Valproic Acid|valproic acid|mesh-list
83844155|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844156|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
83844157|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844158|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844159|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844160|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
83844161|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
83844162|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844163|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844164|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
83844165|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83844166|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844167|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83844168|NCT00496561|Immunomodulating Agents|immunomodulating agents|mesh-list
83844169|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
83844170|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844171|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
83844172|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83844173|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
83844174|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
83844175|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844176|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844177|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83844178|NCT00146250|Analgesics|analgesics|mesh-ancestor
83844179|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
83844180|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844181|NCT00496600|Everolimus|everolimus|mesh-list
83844182|NCT00496600|Epothilone B|epothilone b|mesh-list
83844183|NCT00496600|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83844184|NCT00496600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844185|NCT00496600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844186|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844187|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844188|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
83844189|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844190|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844191|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844192|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844193|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844194|NCT00127595|Gemcitabine|gemcitabine|mesh-list
83844195|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
83844196|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844197|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
83844198|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844199|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844200|NCT04665765|Rituximab|rituximab|mesh-list
82999706|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844201|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83844202|NCT04665765|Carboplatin|carboplatin|mesh-list
83844203|NCT04665765|Etoposide|etoposide|mesh-list
83844204|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
83844205|NCT04665765|Ifosfamide|ifosfamide|mesh-list
83844206|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
83844207|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
83844208|NCT04665765|Antibodies|antibodies|mesh-list
83844209|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
83844210|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83844211|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
83844212|NCT04665765|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83844213|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
83844214|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844215|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844216|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844217|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83844218|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83844219|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844220|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844221|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844222|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83844223|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
83844224|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
83844225|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
83844226|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844227|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844228|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844229|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
83844230|NCT00497107|Leucovorin|leucovorin|mesh-list
83844231|NCT00497107|Calcium|calcium|mesh-list
83844232|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
83844233|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83844234|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844235|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83844236|NCT00497107|Antidotes|antidotes|mesh-ancestor
83844237|NCT00497107|Protective Agents|protective agents|mesh-ancestor
83844238|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
83844239|NCT00497107|Vitamins|vitamins|mesh-ancestor
83844240|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
83844241|NCT00146289|Telmisartan|telmisartan|mesh-list
83844242|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83844243|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83844244|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83844245|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844246|NCT01244932|Bupivacaine|bupivacaine|mesh-list
83844247|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
83844248|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
83844249|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844250|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844251|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
83844252|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844253|NCT01244971|Acarbose|acarbose|mesh-list
83844254|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83844255|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844256|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844257|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844258|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844259|NCT04599894|Pregabalin|pregabalin|mesh-list
83844260|NCT04599894|Analgesics|analgesics|mesh-ancestor
83844261|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
83844262|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844263|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844264|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
83844265|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83844266|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83844267|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844268|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83844269|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83844270|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83844271|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844272|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83844273|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83844274|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844275|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844276|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844277|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844278|NCT04726982|Acetazolamide|acetazolamide|mesh-list
83844279|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
83844280|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83844281|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844282|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844283|NCT04726982|Diuretics|diuretics|mesh-ancestor
83844284|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
83844285|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844286|NCT00497341|Cefuroxime|cefuroxime|mesh-list
83844287|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
83844288|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844289|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844290|NCT00127829|Gefitinib|gefitinib|mesh-list
83844291|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844292|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844293|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844294|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844295|NCT00497458|Testosterone|testosterone|mesh-list
83844296|NCT00497458|Androgens|androgens|mesh-ancestor
83844297|NCT00497458|Hormones|hormones|mesh-ancestor
83844298|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844299|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844300|NCT00497497|Bevacizumab|bevacizumab|mesh-list
83844301|NCT00497497|Cetuximab|cetuximab|mesh-list
83844302|NCT00497497|Irinotecan|irinotecan|mesh-list
83844303|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844304|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844305|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83844306|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83844307|NCT00497497|Growth Substances|growth substances|mesh-ancestor
83844308|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844309|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
83844310|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83844311|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844312|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844313|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844314|NCT00127868|Selenium|selenium|mesh-list
83844315|NCT00127868|Ketoconazole|ketoconazole|mesh-list
83844316|NCT00127868|Ciclopirox|ciclopirox|mesh-list
83844317|NCT00127868|Griseofulvin|griseofulvin|mesh-list
83844318|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
83844319|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
83844320|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844321|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83844322|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83844323|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844324|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844325|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83844326|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
83844327|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844328|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844329|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83844330|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
83844331|NCT00127868|Protective Agents|protective agents|mesh-ancestor
83844332|NCT00127868|Trace Elements|trace elements|mesh-ancestor
83844333|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
83844334|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83844335|NCT00497536|Insulin|insulin|mesh-list
83844336|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83844337|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
83844338|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
83844339|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83844340|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844341|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844342|NCT00497614|Adalimumab|adalimumab|mesh-list
83844343|NCT00497614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83844344|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83844345|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844346|NCT00127907|Vasopressins|vasopressins|mesh-list
83844347|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
83844348|NCT00127907|Epinephrine|epinephrine|mesh-list
83844349|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83844350|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83844351|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
83844352|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844353|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844354|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844355|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83844356|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83844357|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
83844358|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844359|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83844360|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
83844361|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
83844362|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
83844363|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83844364|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
83844365|NCT00127907|Coagulants|coagulants|mesh-ancestor
83844366|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83844367|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
83844368|NCT00497809|Lenograstim|lenograstim|mesh-list
83844369|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83844370|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
83844371|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844372|NCT00146484|Insulin|insulin|mesh-list
83844373|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844374|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844375|NCT00402584|Sibutramine|sibutramine|mesh-list
83844376|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
83844377|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83844378|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
83844379|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83844380|NCT00498004|Risperidone|risperidone|mesh-list
83844381|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83844382|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83844383|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
83844384|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844385|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844386|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844387|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83844388|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83844389|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844390|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83844391|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83844392|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
83844393|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
83844394|NCT00146523|Mifepristone|mifepristone|mesh-list
83844395|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83844396|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
83844397|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83844398|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844399|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83844400|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83844401|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83844402|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
83844403|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83844404|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83844405|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
83844406|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844407|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
83844408|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83844409|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83844410|NCT00402623|Quercetin|quercetin|mesh-list
83844411|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
83844412|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844413|NCT00402623|Protective Agents|protective agents|mesh-ancestor
83844414|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999925|NCT05207514|Doxorubicin|doxorubicin|mesh-list
82999926|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82999927|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
82999928|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999929|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999930|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82999931|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
82999932|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999933|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999934|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82999935|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
82999936|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
82999937|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
82999938|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82999960|NCT05207436|Oxytocin|oxytocin|mesh-list
83844415|NCT04520490|Exenatide|exenatide|mesh-list
83844416|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844417|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844418|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83844419|NCT04520490|Incretins|incretins|mesh-ancestor
83844420|NCT04520490|Hormones|hormones|mesh-ancestor
83844421|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844422|NCT00402662|Everolimus|everolimus|mesh-list
83844423|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
83844424|NCT00402662|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83844425|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844426|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844427|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844428|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844429|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
83844430|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844431|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844432|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
83844433|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
83844434|NCT00498316|Melphalan|melphalan|mesh-list
83844435|NCT00498316|Busulfan|busulfan|mesh-list
83844436|NCT00498316|Rituximab|rituximab|mesh-list
83844437|NCT00498316|Fludarabine|fludarabine|mesh-list
83844438|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
83844439|NCT00498316|Clofarabine|clofarabine|mesh-list
83844440|NCT00498316|Tacrolimus|tacrolimus|mesh-list
83844441|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
83844442|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83844443|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844444|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
83844445|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844446|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844447|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83844448|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
83844449|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844450|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844451|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83844452|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844453|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844454|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
83844455|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844456|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83844457|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844458|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83844459|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83844460|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
83844461|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844462|NCT01245166|Metformin|metformin|mesh-list
83844463|NCT01245166|Acarbose|acarbose|mesh-list
83844464|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844465|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844466|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83844467|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844468|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844469|NCT00146601|Fulvestrant|fulvestrant|mesh-list
83844470|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83844471|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844472|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83844473|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83844474|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
83844475|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844476|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844477|NCT00498589|Methotrexate|methotrexate|mesh-list
83844478|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83844479|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
83844480|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83844481|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844482|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844483|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
83844484|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844485|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844486|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
83844487|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844488|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83844489|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844490|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
83844491|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844492|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83844493|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
83844494|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83844495|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
83844496|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83844497|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844498|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83844499|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83844500|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83844501|NCT00498901|Letrozole|letrozole|mesh-list
83844502|NCT00498901|Leuprolide|leuprolide|mesh-list
83844503|NCT00498901|Goserelin|goserelin|mesh-list
83844504|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844505|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83844506|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83844507|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844508|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844509|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83844510|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
83844511|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844512|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844513|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83844514|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
83844515|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83844516|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83844517|NCT00498979|Interferons|interferons|mesh-list
83844518|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
83844519|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
83844520|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83844521|NCT00498979|Dacarbazine|dacarbazine|mesh-list
83844522|NCT00498979|Vinblastine|vinblastine|mesh-list
83844523|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844524|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
83844525|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844526|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
83844527|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844528|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83844529|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
83844530|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844531|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83844532|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844533|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844534|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844535|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83844536|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83844537|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
83844538|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83844539|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
83844540|NCT01245205|Lapatinib|lapatinib|mesh-list
83844541|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844542|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844543|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844544|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844545|NCT01245244|Morphine|morphine|mesh-list
83844546|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83844547|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83844548|NCT01245244|Narcotics|narcotics|mesh-ancestor
83844549|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844550|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844551|NCT01245244|Analgesics|analgesics|mesh-ancestor
83844552|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
83844553|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844554|NCT00405717|Atorvastatin|atorvastatin|mesh-list
83844555|NCT00405717|Pravastatin|pravastatin|mesh-list
83844556|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83844557|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83844558|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
83844559|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844560|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83844561|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83844562|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844563|NCT00499018|Cytarabine|cytarabine|mesh-list
83844564|NCT00499018|Prednisone|prednisone|mesh-list
83844565|NCT00499018|Rituximab|rituximab|mesh-list
83844566|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
83844567|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
83844568|NCT00499018|Vincristine|vincristine|mesh-list
83844569|NCT00499018|Doxorubicin|doxorubicin|mesh-list
83844570|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83844571|NCT00499018|Lenograstim|lenograstim|mesh-list
83844572|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844573|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844574|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
83844575|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844576|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844577|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83844578|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
83844580|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844581|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83844582|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844583|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
83844584|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844585|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
83844586|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844587|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844588|NCT00499018|Analgesics|analgesics|mesh-ancestor
83844589|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
83844590|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844591|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83844592|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844593|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844594|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83844595|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
83844596|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83844597|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83844598|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83844599|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844600|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844601|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844602|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83844603|NCT00127985|Prednisolone|prednisolone|mesh-list
83844604|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83844605|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
83844606|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83844607|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
83844608|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83844609|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
83844610|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83844611|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
83844612|NCT00127985|Hormones|hormones|mesh-ancestor
83844613|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844614|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844615|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83844616|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844617|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
83844618|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
83844619|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844620|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83844621|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83844622|NCT00127985|Protective Agents|protective agents|mesh-ancestor
83844623|NCT00424164|Tamoxifen|tamoxifen|mesh-list
83844624|NCT00424164|Lapatinib|lapatinib|mesh-list
83844625|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844626|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83844627|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
83844628|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844629|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844630|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83844631|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844632|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83844633|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83844634|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83844635|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844636|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844637|NCT00499135|Alovudine|alovudine|mesh-list
83844638|NCT00499135|Sunitinib|sunitinib|mesh-list
83844639|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844640|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83844641|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83000153|NCT02891811|Growth Substances|growth substances|mesh-ancestor
83844642|NCT00499135|Growth Substances|growth substances|mesh-ancestor
83844643|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844644|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
83844645|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844646|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844647|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844648|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
83844649|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844651|NCT01245361|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83844652|NCT01245361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83844653|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83844654|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83844655|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844656|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
83844657|NCT00424203|Doxorubicin|doxorubicin|mesh-list
83844658|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83844659|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844660|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
83844661|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844662|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844663|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83844664|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
83844665|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844666|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844667|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83844668|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83844669|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83844670|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844671|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844672|NCT01245556|Ipilimumab|ipilimumab|mesh-list
83844673|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844674|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844675|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83844676|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844677|NCT00499525|Paclitaxel|paclitaxel|mesh-list
83844678|NCT00499525|Sorafenib|sorafenib|mesh-list
83844679|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83844680|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844681|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844682|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844683|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844684|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844685|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844686|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844687|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
83844688|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844689|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844690|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83844691|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844692|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844693|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844694|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844695|NCT00499720|Aztreonam|aztreonam|mesh-list
83844696|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844697|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844698|NCT05562518|Estrogens|estrogens|mesh-list
83844699|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83844700|NCT05562518|Hormones|hormones|mesh-ancestor
83844701|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844702|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844703|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83844704|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
83844705|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83844706|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
83844707|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83844708|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83844709|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
83844710|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844711|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844712|NCT00499876|Mefloquine|mefloquine|mesh-list
83844713|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
83844714|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83000228|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
83844715|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83844716|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844717|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
83844718|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
83844719|NCT00146718|Amodiaquine|amodiaquine|mesh-list
83844720|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
83844721|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83844722|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83844723|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844724|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83844725|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844726|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844727|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83844728|NCT00499993|Lanreotide|lanreotide|mesh-list
83844729|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844730|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
83844731|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844732|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844733|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844734|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844735|NCT04710914|Midazolam|midazolam|mesh-list
83844736|NCT04710914|Isoflurane|isoflurane|mesh-list
83844737|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83844738|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83844739|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844740|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844741|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83844742|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83844743|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83844744|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83844745|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
83844746|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
83844747|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
83844748|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
83844749|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844750|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844751|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83844752|NCT00500344|Ranibizumab|ranibizumab|mesh-list
83844753|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83844754|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83844755|NCT00500344|Growth Substances|growth substances|mesh-ancestor
83844756|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844757|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83844758|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844759|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83844760|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
83844761|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844762|NCT01245868|Lidocaine|lidocaine|mesh-list
83844763|NCT01245868|Bupivacaine|bupivacaine|mesh-list
83844764|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
83844765|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
83844766|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83844767|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844768|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
83844769|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844770|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83844771|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83844772|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83844773|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83844774|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844775|NCT00500422|Gemcitabine|gemcitabine|mesh-list
83844776|NCT00500422|Doxorubicin|doxorubicin|mesh-list
83844777|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83844778|NCT00500422|Bortezomib|bortezomib|mesh-list
83844779|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844780|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
83844781|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844782|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844783|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83844784|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83844785|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844786|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844787|NCT01245946|Doxycycline|doxycycline|mesh-list
83844788|NCT01245946|Adapalene|adapalene|mesh-list
83844789|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83844790|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000304|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
83844791|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
83844792|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83844793|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83844794|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83844795|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83844796|NCT01245946|Analgesics|analgesics|mesh-ancestor
83844797|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
83844798|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844799|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844800|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83844801|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844802|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83844803|NCT00146913|Interferons|interferons|mesh-list
83844804|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
83844805|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844806|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
83844807|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844808|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844809|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844810|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844811|NCT00501124|Clevudine|clevudine|mesh-list
83844812|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
83844813|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844814|NCT00501241|ATI 7505|ati 7505|mesh-list
83844815|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83844816|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83844817|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
83844818|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844819|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844820|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844821|NCT01246180|Diclofenac|diclofenac|mesh-list
83844822|NCT01246180|Amiloride|amiloride|mesh-list
83844823|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83844824|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83844825|NCT01246180|Analgesics|analgesics|mesh-ancestor
83844826|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
83844827|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83844828|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844829|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83844830|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844831|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83844832|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844833|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844834|NCT01246180|Diuretics|diuretics|mesh-ancestor
83844835|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
83844836|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83844837|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83844838|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83844839|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83844840|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83844841|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
83844842|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83844843|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
83844844|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844845|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
83844846|NCT05561972|Protective Agents|protective agents|mesh-ancestor
83844847|NCT02274610|Docetaxel|docetaxel|mesh-list
83844848|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844849|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844850|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844851|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844852|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844853|NCT00501397|Ketoconazole|ketoconazole|mesh-list
83844854|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
83844855|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844856|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83844857|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83844858|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844859|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844860|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83844861|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
83844862|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844863|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844864|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83844865|NCT00501514|Hormones|hormones|mesh-list
83844866|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83844867|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844868|NCT00147186|Hylan|hylan|mesh-list
83844869|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
83844870|NCT00147186|Protective Agents|protective agents|mesh-ancestor
83844871|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844872|NCT00501748|Rituximab|rituximab|mesh-list
83844873|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844874|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844875|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
83844876|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844877|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83844878|NCT00501787|Metformin|metformin|mesh-list
83844879|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844880|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844881|NCT00147264|Telmisartan|telmisartan|mesh-list
83844882|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83844883|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83844884|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83844885|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844886|NCT00501904|Metformin|metformin|mesh-list
83844887|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844888|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844889|NCT00501982|Poractant alfa|poractant alfa|mesh-list
83844890|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83844891|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
83844892|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
83844893|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83844894|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83844895|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844896|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83844897|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83844898|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
83844899|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844900|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844901|NCT00502060|Cediranib|cediranib|mesh-list
83844902|NCT00502060|Gefitinib|gefitinib|mesh-list
83844903|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844904|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844905|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844906|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844907|NCT00502099|Interferons|interferons|mesh-list
83844908|NCT00502099|Ribavirin|ribavirin|mesh-list
83844909|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
83844910|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
83844911|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83844912|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83844913|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844914|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
83844915|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83844916|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
83844917|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844918|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
83844919|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844920|NCT00502138|Pramlintide|pramlintide|mesh-list
83844921|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83844922|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83844923|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844924|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
83844925|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83844926|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83844927|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844928|NCT00502294|Visilizumab|visilizumab|mesh-list
83844929|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
83844930|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844931|NCT00502411|Doxorubicin|doxorubicin|mesh-list
83844932|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83844933|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83844934|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844935|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83844936|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844937|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844938|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844939|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83000461|NCT02113878|Cisplatin|cisplatin|mesh-list
83844940|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83844941|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83844942|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844943|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
83844944|NCT00147381|Tacrolimus|tacrolimus|mesh-list
83844945|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844946|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
83844947|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844948|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83844949|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844950|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844951|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844952|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844953|NCT00502567|Leucovorin|leucovorin|mesh-list
83844954|NCT00502567|Docetaxel|docetaxel|mesh-list
83844955|NCT00502567|Fluorouracil|fluorouracil|mesh-list
83844956|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
83844957|NCT00502567|Irinotecan|irinotecan|mesh-list
83844958|NCT00502567|Pemetrexed|pemetrexed|mesh-list
83844959|NCT00502567|Cetuximab|cetuximab|mesh-list
83844960|NCT00502567|Cediranib|cediranib|mesh-list
83844961|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83844962|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83844963|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83844964|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83844965|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844966|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
83844967|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83844968|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83844969|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
83844970|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844971|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83844972|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83844973|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83844974|NCT00502567|Antidotes|antidotes|mesh-ancestor
83844975|NCT00502567|Protective Agents|protective agents|mesh-ancestor
83844976|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
83844977|NCT00502567|Vitamins|vitamins|mesh-ancestor
83844978|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
83844979|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83844980|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83844981|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83844982|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83844983|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
83844984|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
83844985|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
83844986|NCT00502684|Etodolac|etodolac|mesh-list
83844987|NCT00502684|Propranolol|propranolol|mesh-list
83844988|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83844989|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83844990|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
83844991|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83844992|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83844993|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83844994|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83844995|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83844996|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
83844997|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83844998|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83844999|NCT00502684|Analgesics|analgesics|mesh-ancestor
83845000|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
83845001|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845002|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845003|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845004|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83845005|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83845006|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845007|NCT00502762|Topotecan|topotecan|mesh-list
83845008|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83845009|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83845010|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845011|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845012|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845013|NCT00502879|Etanercept|etanercept|mesh-list
83845014|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845015|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845016|NCT00502879|Analgesics|analgesics|mesh-ancestor
83845017|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
83845018|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845019|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845020|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845021|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845022|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845023|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845024|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
83845025|NCT00503152|Valsartan|valsartan|mesh-list
83845026|NCT00503152|Benazepril|benazepril|mesh-list
83845027|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83845028|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83845029|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83845030|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845031|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83845032|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
83845033|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845034|NCT00503347|Bavituximab|bavituximab|mesh-list
83845035|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845036|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845037|NCT00503386|Palonosetron|palonosetron|mesh-list
83845038|NCT00503386|Granisetron|granisetron|mesh-list
83845039|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
83845040|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
83845041|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845042|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845043|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845044|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83845045|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83845046|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
83845047|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845048|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845049|NCT00503503|Etanercept|etanercept|mesh-list
83845050|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845051|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845052|NCT00503503|Analgesics|analgesics|mesh-ancestor
83845053|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
83845054|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845055|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845056|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845057|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845058|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845059|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845060|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
83845061|NCT00503542|Metronidazole|metronidazole|mesh-list
83845062|NCT00503542|Clindamycin|clindamycin|mesh-list
83845063|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
83845064|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
83845065|NCT00503542|Fluconazole|fluconazole|mesh-list
83845066|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845067|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83845068|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83845069|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83845070|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83845071|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845072|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845073|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
83845074|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83845075|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83845076|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83845077|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
83845078|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845079|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845080|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83845081|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83845082|NCT00147615|Eplerenone|eplerenone|mesh-list
83845083|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83845084|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
83845085|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845086|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845087|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83845088|NCT00147615|Diuretics|diuretics|mesh-ancestor
83000598|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
83542437|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83542438|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83542439|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542440|NCT02259348|Aldesleukin|aldesleukin|mesh-list
83542441|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
83542442|NCT02259348|Melphalan|melphalan|mesh-list
83542443|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
83542444|NCT02259348|Thiotepa|thiotepa|mesh-list
83542445|NCT02259348|Rituximab|rituximab|mesh-list
83542446|NCT02259348|Fludarabine|fludarabine|mesh-list
83542447|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
83542448|NCT02259348|Interleukin-2|interleukin-2|mesh-list
83542449|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542450|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
83542451|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542452|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542453|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542454|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
83542455|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542456|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542457|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542458|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542459|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542460|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
83542461|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
83542462|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542463|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83542464|NCT02259348|Analgesics|analgesics|mesh-ancestor
83542465|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
83542466|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542467|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83542468|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83542469|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
83542470|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83542471|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
83542472|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542473|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542474|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83542475|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
83542476|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83542477|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
83542478|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
83542479|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542480|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542481|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83542482|NCT00357019|Protective Agents|protective agents|mesh-ancestor
83542483|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83542484|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
83542485|NCT03994705|Fludarabine|fludarabine|mesh-list
83542486|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542487|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
83542488|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542489|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542490|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542491|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
83542492|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542493|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542494|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542495|NCT03587207|Vaccines|vaccines|mesh-list
83542496|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
83542497|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542498|NCT03592121|Phenylephrine|phenylephrine|mesh-list
83542499|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83542500|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
83542501|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
83542502|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542503|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542504|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
83542505|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83542506|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
83542507|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83542508|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83542509|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83542510|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83542511|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83542512|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845089|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
83542513|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542514|NCT03592121|Protective Agents|protective agents|mesh-ancestor
83542515|NCT04332809|Gentamicins|gentamicins|mesh-list
83542516|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542517|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542518|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83542519|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542520|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542521|NCT03596723|Prednisolone|prednisolone|mesh-list
83542522|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83542523|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
83542524|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83542525|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
83542526|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83542527|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
83542528|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542529|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
83542531|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542532|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542533|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83542534|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542535|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
83542536|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
83542537|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542538|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83542539|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83542540|NCT03596723|Protective Agents|protective agents|mesh-ancestor
83542541|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83542542|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83542543|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542544|NCT03472469|Acetaminophen|acetaminophen|mesh-list
83542545|NCT03472469|Ketorolac|ketorolac|mesh-list
83542546|NCT03472469|Naproxen|naproxen|mesh-list
83542547|NCT03472469|Celecoxib|celecoxib|mesh-list
83542548|NCT03472469|Lidocaine|lidocaine|mesh-list
83542549|NCT03472469|Pregabalin|pregabalin|mesh-list
83542550|NCT03472469|Gabapentin|gabapentin|mesh-list
83542551|NCT03472469|Tramadol|tramadol|mesh-list
83542552|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
83542553|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
83542554|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83542555|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542556|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
83542557|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542558|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83542559|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83542560|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83542561|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83542562|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542563|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83542564|NCT03472469|Analgesics|analgesics|mesh-ancestor
83542565|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
83542566|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
83542567|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83542568|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83542569|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83542570|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83542571|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83542572|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83542573|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83542574|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542575|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
83542576|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83542577|NCT03472469|Narcotics|narcotics|mesh-ancestor
83542578|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83542579|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542580|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542581|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83542582|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542583|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
83542584|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83542585|NCT04926233|Bromides|bromides|mesh-list
83542586|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
83542587|NCT04926233|Olodaterol|olodaterol|mesh-list
83542588|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83000755|NCT03404843|Fasudil|fasudil|mesh-list
83542589|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
83542590|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542591|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542592|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83542593|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
83542594|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
83542595|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83542596|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
83542597|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542598|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542599|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
83542600|NCT04943159|Afamelanotide|afamelanotide|mesh-list
83542601|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542602|NCT04525157|Afamelanotide|afamelanotide|mesh-list
83542603|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542604|NCT04734665|Bevacizumab|bevacizumab|mesh-list
83542606|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542607|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542608|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83542609|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83542610|NCT04734665|Growth Substances|growth substances|mesh-ancestor
83542611|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542612|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
83542613|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83542614|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542615|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542616|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
83542617|NCT03112603|Sirolimus|sirolimus|mesh-list
83542618|NCT03112603|Infliximab|infliximab|mesh-list
83542619|NCT03112603|Rituximab|rituximab|mesh-list
83542620|NCT03112603|Methotrexate|methotrexate|mesh-list
83542621|NCT03112603|Everolimus|everolimus|mesh-list
83542622|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
83542623|NCT03112603|Pentostatin|pentostatin|mesh-list
83542624|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542625|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542626|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
83542627|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542628|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542629|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83542630|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
83542631|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83542632|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542633|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
83542634|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542635|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83542636|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542637|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83542638|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542639|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83542640|NCT03112603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83542641|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83542642|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83542643|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83542644|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
83542645|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542646|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542647|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
83542648|NCT03112603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83542649|NCT03112603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542650|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83542651|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83542652|NCT02258334|Vaccines|vaccines|mesh-list
83542653|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
83542654|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542655|NCT03478163|Clindamycin|clindamycin|mesh-list
83542656|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
83542657|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
83542658|NCT03478163|Cefazolin|cefazolin|mesh-list
83542659|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542660|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542661|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83542662|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542663|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542664|NCT05646810|Lidocaine|lidocaine|mesh-list
83542665|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
83542666|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
83542667|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83542668|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542669|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
83542670|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542671|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83542672|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83542673|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83542674|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83542675|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542676|NCT04960202|Ritonavir|ritonavir|mesh-list
83542677|NCT04960202|Nirmatrelvir|nirmatrelvir|mesh-list
83542678|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83542679|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83542680|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
83542681|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542682|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542683|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83542684|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83542685|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
83542686|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542687|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83542688|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83542689|NCT02959112|Indomethacin|indomethacin|mesh-list
83542690|NCT02959112|Epinephrine|epinephrine|mesh-list
83542691|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83542692|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83542693|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
83542694|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542695|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542696|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542697|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83542698|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83542699|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
83542700|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542701|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83542702|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
83542703|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
83542704|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
83542705|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83542706|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83542707|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83542708|NCT02959112|Analgesics|analgesics|mesh-ancestor
83542709|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
83542710|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542711|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542712|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
83542713|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
83542714|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83542715|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83542716|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542717|NCT05377034|Bevacizumab|bevacizumab|mesh-list
83542718|NCT05377034|Atezolizumab|atezolizumab|mesh-list
83542719|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542720|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542721|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83542722|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83542723|NCT05377034|Growth Substances|growth substances|mesh-ancestor
83542724|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542725|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
83542726|NCT05377034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83542727|NCT05377034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542728|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83542729|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83542730|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
83542731|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83542732|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542733|NCT04428359|Vitamin D|vitamin d|mesh-list
83542734|NCT04428359|Vitamins|vitamins|mesh-ancestor
83542735|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
83542736|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542737|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83542738|NCT02257632|Ranibizumab|ranibizumab|mesh-list
83000903|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
83542739|NCT02257632|Aflibercept|aflibercept|mesh-list
83542740|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83542741|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83542742|NCT02257632|Growth Substances|growth substances|mesh-ancestor
83542743|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542744|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
83542745|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542746|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
83542747|NCT05436054|Cathartics|cathartics|mesh-ancestor
83542748|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83542749|NCT04932434|Psilocybin|psilocybin|mesh-list
83542750|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83542751|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
83542752|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542753|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83542754|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83542755|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
83542756|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542757|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542758|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83542759|NCT01642914|Linaclotide|linaclotide|mesh-list
83542760|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83542761|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
83542762|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542763|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83542764|NCT04497116|Gemcitabine|gemcitabine|mesh-list
83542765|NCT04497116|Talazoparib|talazoparib|mesh-list
83542766|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542767|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
83542768|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542769|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542770|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83542771|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542772|NCT04486352|Bevacizumab|bevacizumab|mesh-list
83542773|NCT04486352|Trastuzumab|trastuzumab|mesh-list
83542774|NCT04486352|Atezolizumab|atezolizumab|mesh-list
83542775|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83542776|NCT04486352|Letrozole|letrozole|mesh-list
83542777|NCT04486352|Maytansine|maytansine|mesh-list
83542778|NCT04486352|Talazoparib|talazoparib|mesh-list
83542779|NCT04486352|Ipatasertib|ipatasertib|mesh-list
83542780|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83542781|NCT04486352|Inavolisib|inavolisib|mesh-list
83542782|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542783|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542784|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83542785|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83542786|NCT04486352|Growth Substances|growth substances|mesh-ancestor
83542787|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542788|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
83542789|NCT04486352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83542790|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542791|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
83542792|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83542793|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83542794|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542795|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83542796|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
83542797|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542798|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83542799|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83542800|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83542801|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83542802|NCT04486352|Immunotoxins|immunotoxins|mesh-ancestor
83542803|NCT04486352|Immunoconjugates|immunoconjugates|mesh-ancestor
83542804|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83542805|NCT04486352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83542806|NCT04486352|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83542807|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
83542808|NCT01642602|Lansoprazole|lansoprazole|mesh-list
83542809|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83542810|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83542811|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83542812|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542813|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542814|NCT02256540|Resveratrol|resveratrol|mesh-list
83542815|NCT02256540|Estradiol|estradiol|mesh-list
83542816|NCT02256540|Estrogens|estrogens|mesh-ancestor
83542817|NCT02256540|Hormones|hormones|mesh-ancestor
83542818|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542819|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542820|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
83542821|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542822|NCT02256540|Protective Agents|protective agents|mesh-ancestor
83542823|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542824|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83542825|NCT05646264|Agomelatine|agomelatine|mesh-list
83542826|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83542827|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83542828|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542829|NCT01640184|Vitamin D|vitamin d|mesh-list
83542830|NCT01640184|Vitamins|vitamins|mesh-ancestor
83542831|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
83542832|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138001|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83542833|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83542834|NCT04904978|Listerine|listerine|mesh-list
83542835|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
83542836|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
83542837|NCT04904978|Protective Agents|protective agents|mesh-ancestor
83542838|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542839|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83542840|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542841|NCT03631433|Acetaminophen|acetaminophen|mesh-list
83542842|NCT03631433|Ibuprofen|ibuprofen|mesh-list
83542843|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83542844|NCT03631433|Analgesics|analgesics|mesh-ancestor
83542845|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
83542846|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542847|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542848|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
83542849|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83542850|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542851|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542852|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83542853|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542854|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542855|NCT02973659|Oxybutynin|oxybutynin|mesh-list
83542856|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
83542857|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
83542858|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542859|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542860|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83542861|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83542862|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
83542863|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542864|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542865|NCT02973659|Urological Agents|urological agents|mesh-ancestor
83542866|NCT04439396|Ketorolac|ketorolac|mesh-list
83542867|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83542868|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83542869|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83542870|NCT04439396|Analgesics|analgesics|mesh-ancestor
83542871|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
83542872|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542873|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542874|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542875|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542876|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83542877|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542878|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542879|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83542880|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
83542881|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542882|NCT00360464|Azithromycin|azithromycin|mesh-list
83542883|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542884|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542885|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
83542886|NCT04825496|Fludarabine|fludarabine|mesh-list
83542887|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542888|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
83542889|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542890|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542891|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542892|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
83542893|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542894|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542895|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542896|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
83542897|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83542898|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83542899|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83542900|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83542901|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542902|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
83542903|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83542904|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542905|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83542906|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542907|NCT04297631|Tobramycin|tobramycin|mesh-list
83542908|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542909|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542910|NCT04812470|Melphalan|melphalan|mesh-list
83542911|NCT04812470|Interleukin-2|interleukin-2|mesh-list
83542912|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542913|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
83542914|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542915|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542916|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542917|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542918|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
83542919|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542920|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83542921|NCT04812470|Analgesics|analgesics|mesh-ancestor
83542922|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
83542923|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83542924|NCT02976194|Ranibizumab|ranibizumab|mesh-list
83542925|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83542926|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83542927|NCT02976194|Growth Substances|growth substances|mesh-ancestor
83542928|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542929|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
83542930|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542931|NCT00360776|Tipifarnib|tipifarnib|mesh-list
83542932|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542933|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
83542934|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542935|NCT04342910|Paclitaxel|paclitaxel|mesh-list
83542936|NCT04342910|Irinotecan|irinotecan|mesh-list
83542937|NCT04342910|Apatinib|apatinib|mesh-list
83542938|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83542939|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542940|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83542941|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83542942|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83542943|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542944|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83542945|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83542946|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542947|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83542948|NCT04714073|Itraconazole|itraconazole|mesh-list
83542949|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
83542950|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542951|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83542952|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83542953|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542954|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542955|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83542956|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
83542957|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83542958|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542959|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83542960|NCT04342676|Panitumumab|panitumumab|mesh-list
83542961|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542962|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542963|NCT01641822|Tobramycin|tobramycin|mesh-list
83542964|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83542965|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83542966|NCT04398368|Gemcitabine|gemcitabine|mesh-list
83542967|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83542968|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
83542969|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542970|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542971|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
83542972|NCT05364762|Tacrolimus|tacrolimus|mesh-list
83542973|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83542974|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
83542975|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542976|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542977|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542978|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
83542979|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542980|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542981|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83542982|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83542983|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542984|NCT04871958|Insulin|insulin|mesh-list
83542985|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83542986|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542987|NCT04342598|Vitamin D|vitamin d|mesh-list
83542988|NCT04342598|Vitamins|vitamins|mesh-ancestor
83542989|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
83542990|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542991|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83542992|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83542993|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542994|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83542995|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83542996|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542997|NCT05641818|Vitamin D|vitamin d|mesh-list
83542998|NCT05641818|Vitamins|vitamins|mesh-ancestor
83542999|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
83543000|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543001|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83543002|NCT04762082|Tadalafil|tadalafil|mesh-list
83543003|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
83543004|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83543005|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83543006|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543007|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543008|NCT04762082|Urological Agents|urological agents|mesh-ancestor
83543009|NCT03514277|Bupivacaine|bupivacaine|mesh-list
83543010|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
83543011|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
83543012|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543013|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543014|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
83543015|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543016|NCT05334108|Ecopipam|ecopipam|mesh-list
83543017|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83543018|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83543019|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543020|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543021|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83543022|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83543023|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
83543024|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138020|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543025|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543026|NCT03984656|Lidocaine|lidocaine|mesh-list
83543027|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
83543028|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
83543029|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543030|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543031|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
83543032|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543033|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83543034|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83543035|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83543036|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543037|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543038|NCT05299944|Cannabidiol|cannabidiol|mesh-list
83543039|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
83543041|NCT04329494|Cisplatin|cisplatin|mesh-list
83543042|NCT04329494|Doxorubicin|doxorubicin|mesh-list
83543043|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83543044|NCT04329494|Fluorouracil|fluorouracil|mesh-list
83543045|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
83543046|NCT04329494|Irinotecan|irinotecan|mesh-list
83543047|NCT04329494|Daunorubicin|daunorubicin|mesh-list
83543048|NCT04329494|Mitomycins|mitomycins|mesh-list
83543049|NCT04329494|Mitomycin|mitomycin|mesh-list
83543050|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543051|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83543052|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83543053|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83543054|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543055|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543056|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
83543057|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83543058|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83543059|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
83543060|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543061|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83543062|NCT04329494|Antidotes|antidotes|mesh-ancestor
83543063|NCT04329494|Protective Agents|protective agents|mesh-ancestor
83543064|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
83543065|NCT04329494|Vitamins|vitamins|mesh-ancestor
83543066|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
83543067|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
83543068|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83543069|NCT03655301|Metformin|metformin|mesh-list
83543070|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543071|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543072|NCT04870866|Niacinamide|niacinamide|mesh-list
83543073|NCT04870866|Niacin|niacin|mesh-list
83543074|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
83543075|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
83543076|NCT04870866|Vitamins|vitamins|mesh-ancestor
83543077|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
83543078|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543079|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83543080|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
83543081|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543082|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83543083|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
83543084|NCT03657407|Glycerol|glycerol|mesh-list
83543085|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83543086|NCT03657407|Protective Agents|protective agents|mesh-ancestor
83543087|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543088|NCT01639560|Varenicline|varenicline|mesh-list
83543089|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83543090|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83543091|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543092|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543093|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138030|NCT00109837|Prednisone|prednisone|mesh-list
83543094|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543095|NCT04243616|Paclitaxel|paclitaxel|mesh-list
83543096|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
83543097|NCT04243616|Carboplatin|carboplatin|mesh-list
83543098|NCT04243616|Doxorubicin|doxorubicin|mesh-list
83543099|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83543100|NCT04243616|Cemiplimab|cemiplimab|mesh-list
83543101|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83543102|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543103|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
83543104|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
83543105|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
83543106|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543107|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83543108|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
83543109|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543110|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543111|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83543112|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
83543113|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83543114|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83543115|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83543116|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83543117|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543118|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543119|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
83543120|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83543121|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83543122|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543123|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
83543124|NCT03954314|Coagulants|coagulants|mesh-ancestor
83543125|NCT03952130|Insulin|insulin|mesh-list
83543126|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83543127|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
83543128|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
83543129|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543130|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543131|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
83543132|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83543133|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
83543134|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543135|NCT03925532|Denosumab|denosumab|mesh-list
83543136|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83543137|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543138|NCT05430828|Evolocumab|evolocumab|mesh-list
83543139|NCT05430828|Alirocumab|alirocumab|mesh-list
83543140|NCT05430828|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83543141|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83543142|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83543143|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
83543144|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543145|NCT05430828|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83543146|NCT05430828|Protease Inhibitors|protease inhibitors|mesh-ancestor
83543147|NCT05430828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543148|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83543149|NCT01640964|Terlipressin|terlipressin|mesh-list
83543150|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83543151|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83543152|NCT03663101|Lidocaine|lidocaine|mesh-list
83543153|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
83543154|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83543155|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83543156|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
83543157|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
83543158|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543159|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543160|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
83543161|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543162|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83543163|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83543164|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83543165|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543166|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543167|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83543168|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543169|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543170|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83543171|NCT05430048|Bisoprolol|bisoprolol|mesh-list
83543172|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83543173|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83543174|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
83543175|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
83543176|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543177|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543178|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83543179|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83543180|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83543181|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83543182|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543183|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543184|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
83543185|NCT05430048|Coagulants|coagulants|mesh-ancestor
83543186|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83543187|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
83543188|NCT02975570|Levofloxacin|levofloxacin|mesh-list
83543189|NCT02975570|Linezolid|linezolid|mesh-list
83543190|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
83543191|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83543192|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543193|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83543194|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83543195|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83543196|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543197|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543198|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543199|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83543200|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83543201|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83543202|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
83543203|NCT04184999|Dexamethasone|dexamethasone|mesh-list
83543204|NCT04184999|Prednisolone|prednisolone|mesh-list
83543205|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83543206|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
83543207|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83543208|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
83543209|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83543210|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
83543211|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83543212|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
83543213|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
83543214|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543215|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543216|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83543217|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
83543218|NCT04184999|Hormones|hormones|mesh-ancestor
83543219|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83543220|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83543221|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543222|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83543223|NCT04184999|Protective Agents|protective agents|mesh-ancestor
83543224|NCT03524339|Tamsulosin|tamsulosin|mesh-list
83543225|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83543226|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83543227|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83543228|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
83543229|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543230|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543231|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543232|NCT03524339|Urological Agents|urological agents|mesh-ancestor
83543233|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
83543234|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83543235|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83543236|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
83543237|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543238|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83543239|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83543240|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543241|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543242|NCT00361010|Levetiracetam|levetiracetam|mesh-list
83543243|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
83543244|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
83543245|NCT00361088|Bortezomib|bortezomib|mesh-list
83543246|NCT00361088|Tipifarnib|tipifarnib|mesh-list
83543247|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543248|NCT04172402|Gemcitabine|gemcitabine|mesh-list
83543249|NCT04172402|Nivolumab|nivolumab|mesh-list
83543250|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83543251|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
83543252|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543253|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543254|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543255|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83543256|NCT04662242|Selenium|selenium|mesh-list
83543257|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
83543258|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543259|NCT04662242|Protective Agents|protective agents|mesh-ancestor
83543260|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543261|NCT04662242|Trace Elements|trace elements|mesh-ancestor
83543262|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
83543263|NCT04160546|Aspirin|aspirin|mesh-list
83543264|NCT04160546|Ponatinib|ponatinib|mesh-list
83543265|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83543266|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83543267|NCT04160546|Analgesics|analgesics|mesh-ancestor
83543268|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
83543269|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001425|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
83543270|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543271|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83543273|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83543274|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83543275|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543276|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83543277|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83543278|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543279|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
83543280|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543281|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83543282|NCT03675581|Nintedanib|nintedanib|mesh-list
83543283|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83543284|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83543285|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543286|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83543287|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543288|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543289|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83543290|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
83543291|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83543292|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543293|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83543294|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83543295|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83543296|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83543297|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83543298|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83543299|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83543300|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83543301|NCT05142228|Erenumab|erenumab|mesh-list
83543302|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83543303|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543304|NCT05142228|Analgesics|analgesics|mesh-ancestor
83543305|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
83543306|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543307|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543308|NCT00362102|Cetuximab|cetuximab|mesh-list
83543309|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543310|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543311|NCT05122026|Isoniazid|isoniazid|mesh-list
83543312|NCT05122026|Rifapentine|rifapentine|mesh-list
83543313|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
83543314|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83543315|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543316|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83543317|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83543318|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
83543319|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543320|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83543321|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83543322|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
83543323|NCT02958878|Tamsulosin|tamsulosin|mesh-list
83543324|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83543325|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83543326|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83543327|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
83543328|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543329|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543330|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543331|NCT02958878|Urological Agents|urological agents|mesh-ancestor
83543332|NCT02976116|Gefitinib|gefitinib|mesh-list
83543333|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543334|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83543335|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543336|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543337|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
83543338|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83543339|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83543340|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83543341|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543342|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543343|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543344|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543345|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543346|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83543347|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543348|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
83543349|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
83543350|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83543351|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
83543352|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543353|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543354|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83543355|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
83543356|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83543357|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
83543358|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543359|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543360|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83543361|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
83543362|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
83543363|NCT02975258|Protective Agents|protective agents|mesh-ancestor
83543364|NCT02975258|Miotics|miotics|mesh-ancestor
83543365|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83543366|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83543367|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83543368|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83543369|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543370|NCT05114460|Naloxone|naloxone|mesh-list
83543371|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83543372|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543373|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
83543374|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543375|NCT04844814|Prednisone|prednisone|mesh-list
83543376|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83543377|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83543378|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
83543379|NCT04844814|Hormones|hormones|mesh-ancestor
83543380|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83543381|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543382|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83543383|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543384|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543385|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83543386|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83543387|NCT04833114|Carboplatin|carboplatin|mesh-list
83543388|NCT04833114|Etoposide|etoposide|mesh-list
83543389|NCT04833114|Rituximab|rituximab|mesh-list
83543390|NCT04833114|Ifosfamide|ifosfamide|mesh-list
83543391|NCT04833114|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83543392|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543393|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83543394|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83543395|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83543396|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543397|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543398|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543399|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
83543400|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543401|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543402|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83543403|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
83543404|NCT04833114|Immunoconjugates|immunoconjugates|mesh-ancestor
83543405|NCT00376883|Pamidronate|pamidronate|mesh-list
83543406|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83543407|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543408|NCT05314673|Bevacizumab|bevacizumab|mesh-list
83543409|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543410|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543411|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83543412|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83543413|NCT05314673|Growth Substances|growth substances|mesh-ancestor
83543414|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543415|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
83543416|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
83543417|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
83543418|NCT04112069|Pancrelipase|pancrelipase|mesh-list
83543419|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543420|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543421|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83543422|NCT03785210|Vancomycin|vancomycin|mesh-list
83543423|NCT03785210|Nivolumab|nivolumab|mesh-list
83543424|NCT03785210|Tadalafil|tadalafil|mesh-list
83543425|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543426|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543427|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83543428|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543429|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83543430|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543431|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
83543432|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83543433|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83543434|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543435|NCT03785210|Urological Agents|urological agents|mesh-ancestor
83543436|NCT04098575|Empagliflozin|empagliflozin|mesh-list
83543437|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83543438|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543439|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543440|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543441|NCT03776240|Trastuzumab|trastuzumab|mesh-list
83543442|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543443|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543444|NCT04832100|Pregabalin|pregabalin|mesh-list
83543445|NCT04832100|Imipramine|imipramine|mesh-list
83543446|NCT04832100|Analgesics|analgesics|mesh-ancestor
83543447|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
83543448|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543449|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543450|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
83543451|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83543452|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543453|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543454|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83543455|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83543456|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83543457|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543458|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83543459|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83543460|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
83543461|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83543462|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83543463|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
83543464|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543465|NCT02976272|Bortezomib|bortezomib|mesh-list
83543466|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543467|NCT00361790|Aripiprazole|aripiprazole|mesh-list
83543468|NCT00361790|Escitalopram|escitalopram|mesh-list
83543469|NCT00361790|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83543470|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83543471|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543472|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543473|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543474|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
83543475|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543476|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
83543477|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83543478|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83543479|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83543480|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543481|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
83543482|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
83543483|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83543484|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83543485|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83543486|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83543487|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83543488|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83543489|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
83543490|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543491|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543492|NCT04570332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83543493|NCT04570332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543495|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
83543496|NCT00361868|Fenofibrate|fenofibrate|mesh-list
83543497|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543498|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543499|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83543500|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
83543501|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543502|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83543503|NCT04564872|Linagliptin|linagliptin|mesh-list
83543504|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543505|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543506|NCT04564872|Incretins|incretins|mesh-ancestor
83543507|NCT04564872|Hormones|hormones|mesh-ancestor
83543508|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83543509|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83543510|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
83543511|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543512|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543513|NCT04343144|Nivolumab|nivolumab|mesh-list
83543514|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543515|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543516|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83543517|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543518|NCT04075409|Padsevonil|padsevonil|mesh-list
83543519|NCT04075409|Anticonvulsants|anticonvulsants|mesh-ancestor
83543520|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
83543521|NCT03743246|Fludarabine|fludarabine|mesh-list
83543522|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83543523|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
83543524|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543525|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543526|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83543527|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
83543528|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543529|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543530|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83543531|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
83543532|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
83543533|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83543534|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83543535|NCT03703778|Androgens|androgens|mesh-list
83543536|NCT03703778|Hormones|hormones|mesh-ancestor
83543537|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83543538|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543539|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
83543540|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543541|NCT03703778|Protective Agents|protective agents|mesh-ancestor
83543542|NCT03703778|Vitamins|vitamins|mesh-ancestor
83543543|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
83543544|NCT03703778|Estrogens|estrogens|mesh-ancestor
83543545|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83543546|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543547|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
83543548|NCT05346666|Midazolam|midazolam|mesh-list
83543549|NCT05346666|Phenobarbital|phenobarbital|mesh-list
83543550|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83543551|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83543552|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543553|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543554|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83543555|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83543556|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83543557|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83543558|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
83543559|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
83543560|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
83543561|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
83543562|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543563|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543564|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
83543565|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83543566|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83543567|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83543568|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83543569|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83543571|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83543572|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83543573|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83543574|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83543575|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543576|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543577|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83543578|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83543579|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83543580|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
83543581|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543582|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543583|NCT03674294|Dexamethasone|dexamethasone|mesh-list
83543584|NCT03674294|Aprepitant|aprepitant|mesh-list
83543585|NCT03674294|Palonosetron|palonosetron|mesh-list
83543586|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83543587|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
83543588|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
83543589|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543590|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543591|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83543592|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
83543593|NCT03674294|Hormones|hormones|mesh-ancestor
83543594|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83543595|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83543596|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543597|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83543598|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543599|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543600|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83543601|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83543602|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
83543603|NCT00377273|Fluorouracil|fluorouracil|mesh-list
83543604|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
83543605|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543606|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83543607|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543608|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83543609|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
83543610|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543611|NCT03706313|Bupivacaine|bupivacaine|mesh-list
83543612|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
83543613|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
83543614|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543615|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543616|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
83543617|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543618|NCT05369364|Dexamethasone|dexamethasone|mesh-list
83543619|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
83543620|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83543621|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
83543622|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
83543623|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543624|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543625|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83543626|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
83543627|NCT05369364|Hormones|hormones|mesh-ancestor
83543628|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83543629|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83543630|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543631|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83543632|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543633|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543634|NCT00361244|Irinotecan|irinotecan|mesh-list
83543635|NCT00361244|Cetuximab|cetuximab|mesh-list
83543636|NCT00361244|Sunitinib|sunitinib|mesh-list
83543637|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83543638|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83543639|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543640|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543641|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543642|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543643|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83543644|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83543645|NCT00361244|Growth Substances|growth substances|mesh-ancestor
83543646|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543647|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
83543648|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83543649|NCT03381482|Anesthetics|anesthetics|mesh-list
83543650|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543651|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543652|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83543653|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
83543654|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83543655|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543656|NCT04968522|Methylphenidate|methylphenidate|mesh-list
83543657|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
83543658|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83543659|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543660|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83543661|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83543662|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543663|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543664|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
83543665|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543666|NCT00361322|Clindamycin|clindamycin|mesh-list
83543667|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
83543668|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
83543669|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
83543670|NCT00361322|Salicylates|salicylates|mesh-list
83543671|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83543672|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543673|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83543674|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543675|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543676|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
83543677|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
83543678|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
83543679|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83543680|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83543681|NCT00361322|Analgesics|analgesics|mesh-ancestor
83543682|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
83543683|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543684|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543685|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83543686|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543687|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83543688|NCT02974712|Fentanyl|fentanyl|mesh-list
83543689|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83543690|NCT02974712|Narcotics|narcotics|mesh-ancestor
83543691|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543692|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543693|NCT02974712|Analgesics|analgesics|mesh-ancestor
83543694|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
83543695|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543696|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83543697|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83543698|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
83543699|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
83543700|NCT02974556|Capecitabine|capecitabine|mesh-list
83543701|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
83543702|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83543703|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
83543704|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543705|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543706|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83543707|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83543708|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
83543709|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83543710|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
83543711|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
83543712|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543713|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543714|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543715|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83543716|NCT03557333|Analgesics|analgesics|mesh-ancestor
83543717|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
83543718|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543719|NCT04527380|Adalimumab|adalimumab|mesh-list
83543720|NCT04527380|Ixekizumab|ixekizumab|mesh-list
83543721|NCT04527380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83543722|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83543723|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543724|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
83543725|NCT04957368|Midazolam|midazolam|mesh-list
83543726|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
83543727|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83543728|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83543729|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543730|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543731|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83543732|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83543733|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83543734|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83543735|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
83543736|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
83543737|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
83543738|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
83543739|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543740|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543741|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83543742|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83543743|NCT04957368|Analgesics|analgesics|mesh-ancestor
83543744|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
83543745|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543746|NCT04818450|Gabapentin|gabapentin|mesh-list
83543747|NCT04818450|Analgesics|analgesics|mesh-ancestor
83543748|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
83543749|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543750|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543751|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
83543752|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83543753|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83543754|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543755|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83543756|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83543757|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83543758|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543759|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543760|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
83543761|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
83543762|NCT04841148|Palbociclib|palbociclib|mesh-list
83543763|NCT04841148|Avelumab|avelumab|mesh-list
83543764|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
83543765|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83543766|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83543767|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543768|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543769|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543770|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543771|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543772|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83543773|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543774|NCT04829760|Psyllium|psyllium|mesh-list
83543775|NCT04829760|Cathartics|cathartics|mesh-ancestor
83543776|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83543777|NCT05289804|Lidocaine|lidocaine|mesh-list
83543778|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
83543779|NCT05289804|Prilocaine|prilocaine|mesh-list
83543780|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83543781|NCT05289804|Anesthetics|anesthetics|mesh-list
83543782|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543783|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543784|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
83543785|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543786|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83543787|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83543788|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83543789|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83845090|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83543790|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543791|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83543792|NCT05448872|Valsartan|valsartan|mesh-list
83543793|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83543794|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83543795|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83543796|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83543797|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543798|NCT04817826|Durvalumab|durvalumab|mesh-list
83543799|NCT04817826|Tremelimumab|tremelimumab|mesh-list
83543800|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543801|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543802|NCT00362258|Irbesartan|irbesartan|mesh-list
83543803|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83543804|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83543805|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83543806|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543807|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
83543808|NCT00362726|Ritonavir|ritonavir|mesh-list
83543809|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83543810|NCT00362726|Maleic acid|maleic acid|mesh-list
83543811|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83543812|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83543813|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
83543814|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543815|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543816|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83543817|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83543818|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
83543819|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543820|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83543821|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83543822|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543823|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543824|NCT04474470|Cetuximab|cetuximab|mesh-list
83543825|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543826|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543827|NCT05330754|Caffeine|caffeine|mesh-list
83543828|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83543829|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543830|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83543831|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543832|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543833|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83543834|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83543835|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
83543836|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543837|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83543838|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543839|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
83543840|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83543841|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83543842|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543843|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
83543844|NCT04448184|Coagulants|coagulants|mesh-ancestor
83543845|NCT04426968|Interferons|interferons|mesh-list
83543846|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543847|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
83543848|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543849|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83543850|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
83543851|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543852|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
83543853|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83543854|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83543855|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
83543856|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543857|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543858|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83543859|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83543860|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
83543861|NCT04184297|Olodaterol|olodaterol|mesh-list
83002023|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83543862|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83543864|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543865|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543866|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83543867|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
83543868|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
83543869|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83543870|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543871|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543872|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543873|NCT04031885|Paclitaxel|paclitaxel|mesh-list
83543874|NCT04031885|Docetaxel|docetaxel|mesh-list
83543875|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83543876|NCT04031885|Capecitabine|capecitabine|mesh-list
83543877|NCT04031885|Fulvestrant|fulvestrant|mesh-list
83543878|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83543879|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543880|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83543881|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83543882|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
83543883|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543884|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83543885|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
83543886|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83543887|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83543888|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83543889|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
83543890|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83543891|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543892|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
83543893|NCT01638000|Mirabegron|mirabegron|mesh-list
83543894|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83543895|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83543896|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543897|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543898|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543899|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543900|NCT01638000|Urological Agents|urological agents|mesh-ancestor
83543901|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83543902|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83543903|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83543904|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
83543905|NCT04023695|Lidocaine|lidocaine|mesh-list
83543906|NCT04023695|Epinephrine|epinephrine|mesh-list
83543907|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
83543908|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
83543909|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543910|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543911|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
83543912|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543913|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83543914|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83543915|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83543916|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543917|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543918|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83543919|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83543920|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
83543921|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543922|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83543923|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83543924|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
83543925|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83543926|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
83543927|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
83543928|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
83543929|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83543930|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
83543931|NCT04211909|Velpatasvir|velpatasvir|mesh-list
83543932|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
83543933|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83543934|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
83543935|NCT04223843|Olodaterol|olodaterol|mesh-list
83543936|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83543937|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
83543938|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543939|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543940|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83543941|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83543942|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
83543943|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83543944|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
83543945|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543946|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543947|NCT05722951|Metformin|metformin|mesh-list
83543948|NCT05722951|Levetiracetam|levetiracetam|mesh-list
83543949|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83543950|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543951|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
83543952|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
83543953|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
83543954|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83543955|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543956|NCT04838652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83543957|NCT04838652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543958|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
83543959|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83543960|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83543961|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83543962|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543963|NCT03778554|Metoprolol|metoprolol|mesh-list
83543964|NCT03778554|Carvedilol|carvedilol|mesh-list
83543965|NCT03778554|Nebivolol|nebivolol|mesh-list
83543966|NCT03778554|Bisoprolol|bisoprolol|mesh-list
83543967|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83543968|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83543969|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
83543970|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
83543971|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543972|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543973|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83543974|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83543975|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83543976|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
83543977|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83543978|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83543979|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
83543980|NCT03778554|Protective Agents|protective agents|mesh-ancestor
83543981|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83543982|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83543983|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83543984|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83543985|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83543986|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83543987|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83543988|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83543989|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83543990|NCT04810494|Lidocaine|lidocaine|mesh-list
83543991|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
83543992|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
83543993|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83543994|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83543995|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
83543996|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83543997|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83543998|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83543999|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83544000|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83544001|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544002|NCT05722405|Lenalidomide|lenalidomide|mesh-list
83544003|NCT05722405|Ixazomib|ixazomib|mesh-list
83544004|NCT05722405|Glycine|glycine|mesh-list
83544005|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
83544006|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544007|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83544008|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83544009|NCT05722405|Growth Substances|growth substances|mesh-ancestor
83544010|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83544011|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544012|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
83544013|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544014|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544015|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
83544016|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544017|NCT04259658|Calcium|calcium|mesh-list
83544018|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83544019|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544020|NCT02767531|Orlistat|orlistat|mesh-list
83544021|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544022|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544023|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83544024|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83544025|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
83544026|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83544027|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83544028|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544029|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
83544030|NCT04419246|Coagulants|coagulants|mesh-ancestor
83544031|NCT02521753|Metformin|metformin|mesh-list
83544032|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83544033|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544034|NCT04229303|Voriconazole|voriconazole|mesh-list
83544035|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
83544036|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544037|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83544038|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83544039|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544040|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544041|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83544042|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
83544043|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544044|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544045|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83544046|NCT05263986|Adagrasib|adagrasib|mesh-list
83544047|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544048|NCT00357643|Vitamin D|vitamin d|mesh-list
83544049|NCT00357643|Calcium|calcium|mesh-list
83544050|NCT00357643|Vitamins|vitamins|mesh-ancestor
83544051|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
83544052|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544053|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83544054|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83544055|NCT04812912|Hormones|hormones|mesh-list
83544056|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544057|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544058|NCT04232358|Anesthetics|anesthetics|mesh-list
83544059|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544060|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544061|NCT05395494|Cycloserine|cycloserine|mesh-list
83544062|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83544063|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544064|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83544065|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
83544066|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544067|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
83544068|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544069|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83544070|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83544071|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83544072|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
83544073|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544074|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544075|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83544076|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83544077|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
83544078|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544079|NCT03504410|Cytarabine|cytarabine|mesh-list
83544080|NCT03504410|Fludarabine|fludarabine|mesh-list
83544081|NCT03504410|Etoposide|etoposide|mesh-list
83544082|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
83544083|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002247|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
83002248|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83002250|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83544084|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83544085|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
83544086|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544087|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83544088|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
83544089|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544090|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83544091|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83544092|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83544093|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544094|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
83544095|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544096|NCT03504410|Analgesics|analgesics|mesh-ancestor
83544097|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
83544098|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544099|NCT02464969|Apixaban|apixaban|mesh-list
83544100|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83544101|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
83544102|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83544103|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
83544104|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544105|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544106|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
83544107|NCT05392530|Macitentan|macitentan|mesh-list
83544108|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83544109|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83544110|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544111|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83544112|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
83544113|NCT03498014|Narcotics|narcotics|mesh-ancestor
83544114|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544115|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544116|NCT03498014|Analgesics|analgesics|mesh-ancestor
83544117|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
83544118|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544119|NCT02460133|Ritonavir|ritonavir|mesh-list
83544120|NCT02460133|Ribavirin|ribavirin|mesh-list
83544121|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83544122|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83544123|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83544124|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544125|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544126|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83544127|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83544128|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
83544129|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544130|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83544131|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83544132|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
83544133|NCT02220452|Anesthetics|anesthetics|mesh-list
83544134|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544135|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544136|NCT04256603|Gabapentin|gabapentin|mesh-list
83544137|NCT04256603|Analgesics|analgesics|mesh-ancestor
83544138|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
83544139|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544140|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544141|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
83544142|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83544143|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83544144|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544145|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83544146|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83544147|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83544148|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544149|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544150|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
83544151|NCT05721079|Methoxsalen|methoxsalen|mesh-list
83544152|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83544153|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544154|NCT00362570|Temozolomide|temozolomide|mesh-list
83544155|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83544156|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
83544157|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544158|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544159|NCT00357253|Capecitabine|capecitabine|mesh-list
83544160|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83544161|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
83544162|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544163|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544164|NCT02386735|Prednisone|prednisone|mesh-list
83544165|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544166|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
83544167|NCT02386735|Hormones|hormones|mesh-ancestor
83544168|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544169|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544170|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83544171|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544172|NCT02068430|Riboflavin|riboflavin|mesh-list
83544173|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
83544174|NCT02068430|Vitamins|vitamins|mesh-ancestor
83544175|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
83544176|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544177|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83544178|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544179|NCT03138512|Nivolumab|nivolumab|mesh-list
83544180|NCT03138512|Ipilimumab|ipilimumab|mesh-list
83544181|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544182|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544183|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83544184|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544185|NCT03127592|Etodolac|etodolac|mesh-list
83544186|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
83544187|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83544188|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
83544189|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83544190|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83544191|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544192|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83544193|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544194|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83544195|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544196|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83544197|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83544198|NCT03127592|Analgesics|analgesics|mesh-ancestor
83544199|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
83544200|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544201|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544202|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83544203|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83544204|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544205|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544206|NCT02444234|Tedizolid|tedizolid|mesh-list
83544207|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
83544208|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544209|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544210|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83544211|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544212|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544213|NCT02444936|Vaccines|vaccines|mesh-list
83544214|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
83544215|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544216|NCT02445326|Dexamethasone|dexamethasone|mesh-list
83544217|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544218|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
83544219|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
83544220|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544221|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544222|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544223|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
83544224|NCT02445326|Hormones|hormones|mesh-ancestor
83544225|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544226|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83544227|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544228|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
83544229|NCT04344457|Azithromycin|azithromycin|mesh-list
83544230|NCT04344457|Indomethacin|indomethacin|mesh-list
83544231|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
83544232|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83544233|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83002478|NCT05178745|Fluorouracil|fluorouracil|mesh-list
83544234|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544235|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544236|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544237|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544238|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83544239|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83544240|NCT04344457|Analgesics|analgesics|mesh-ancestor
83544241|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
83544242|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544243|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544244|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544245|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
83544246|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
83544247|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83544248|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83544249|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544250|NCT01920932|Prednisone|prednisone|mesh-list
83544251|NCT01920932|Prednisolone|prednisolone|mesh-list
83544252|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
83544253|NCT01920932|Dacarbazine|dacarbazine|mesh-list
83544254|NCT01920932|Doxorubicin|doxorubicin|mesh-list
83544255|NCT01920932|Etoposide|etoposide|mesh-list
83544256|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83544257|NCT01920932|Imidazole|imidazole|mesh-list
83544258|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83544259|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
83544260|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544261|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544262|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83544263|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
83544264|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544265|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544266|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83544267|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83544268|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83544269|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83544270|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544271|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544272|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
83544273|NCT01920932|Hormones|hormones|mesh-ancestor
83544274|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544275|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83544276|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83544277|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544278|NCT01920932|Immunotoxins|immunotoxins|mesh-ancestor
83544279|NCT01920932|Immunoconjugates|immunoconjugates|mesh-ancestor
83544280|NCT05720533|Disitamab vedotin|disitamab vedotin|mesh-list
83544281|NCT05720533|Immunoconjugates|immunoconjugates|mesh-ancestor
83544282|NCT05720533|Immunologic Factors|immunologic factors|mesh-ancestor
83544283|NCT05720533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544284|NCT02446496|Cefadroxil|cefadroxil|mesh-list
83544285|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544286|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544287|NCT00355693|Propofol|propofol|mesh-list
83544288|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83544289|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544290|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544291|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83544292|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
83544293|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
83544294|NCT02448368|Verinurad|verinurad|mesh-list
83544295|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
83544296|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544297|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83544298|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83544299|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
83544300|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544301|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83544302|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83544303|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
83544304|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
83544305|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544306|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544307|NCT03496662|Paclitaxel|paclitaxel|mesh-list
83544308|NCT03496662|Gemcitabine|gemcitabine|mesh-list
83544309|NCT03496662|Nivolumab|nivolumab|mesh-list
83544310|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83544311|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544312|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
83544313|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
83544314|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
83544315|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544316|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83544317|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
83544318|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544319|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83544320|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
83544321|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83544322|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
83544323|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83544324|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83544325|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83544326|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83544327|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544328|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
83544329|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544330|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544331|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83544332|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544333|NCT05719831|Amoxicillin|amoxicillin|mesh-list
83544334|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544335|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544336|NCT01152541|Riboflavin|riboflavin|mesh-list
83544337|NCT01152541|Dextrans|dextrans|mesh-list
83544338|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83544339|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
83544340|NCT01152541|Vitamins|vitamins|mesh-ancestor
83544341|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
83544342|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544343|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83544344|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544345|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
83544346|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
83544347|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
83544348|NCT01638546|Temozolomide|temozolomide|mesh-list
83544349|NCT01638546|Veliparib|veliparib|mesh-list
83544350|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83544351|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
83544352|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544353|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544354|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83544355|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544356|NCT04948489|Norethindrone|norethindrone|mesh-list
83544357|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
83544358|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83544359|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83544360|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83544361|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
83544362|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83544363|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544364|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83544365|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83544366|NCT05723341|Morphine|morphine|mesh-list
83544367|NCT05723341|Bupivacaine|bupivacaine|mesh-list
83544368|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
83544369|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
83544370|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544371|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544372|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
83544373|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544374|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83544375|NCT05723341|Narcotics|narcotics|mesh-ancestor
83544376|NCT05723341|Analgesics|analgesics|mesh-ancestor
83544377|NCT05718583|Butyric Acid|butyric acid|mesh-list
83544378|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
83544379|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
83544380|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544381|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544382|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544383|NCT00363350|Rituximab|rituximab|mesh-list
83544384|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544385|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544386|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
83544387|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544388|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544390|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
83544391|NCT05717335|Coagulants|coagulants|mesh-ancestor
83544392|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
83544393|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83544394|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544395|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83544396|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544397|NCT04341818|Vitamin D|vitamin d|mesh-list
83544398|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
83544399|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
83544400|NCT04341818|Vitamins|vitamins|mesh-list
83544401|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
83544402|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544403|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83544404|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83544405|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
83544406|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83544407|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83544408|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83544409|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544410|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
83544411|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544412|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544413|NCT02451488|Sargramostim|sargramostim|mesh-list
83544414|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
83544415|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544416|NCT03172494|Insulin|insulin|mesh-list
83544417|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83544418|NCT03172494|Liraglutide|liraglutide|mesh-list
83544419|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
83544420|NCT03172494|Xultophy|xultophy|mesh-list
83544421|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83544422|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544423|NCT03172494|Incretins|incretins|mesh-ancestor
83544424|NCT03172494|Hormones|hormones|mesh-ancestor
83544425|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544426|NCT02452346|Tosedostat|tosedostat|mesh-list
83544427|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544428|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544429|NCT02959255|Esomeprazole|esomeprazole|mesh-list
83544430|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83544431|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544432|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83544433|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544434|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544435|NCT05716945|Fluorometholone|fluorometholone|mesh-list
83544436|NCT05716945|Dexamethasone|dexamethasone|mesh-list
83544437|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544438|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
83544439|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
83544440|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544441|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544442|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544443|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
83544444|NCT05716945|Hormones|hormones|mesh-ancestor
83544445|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544446|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83544447|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544448|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83544449|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
83544450|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544451|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544452|NCT03012620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83544453|NCT03012620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544454|NCT05716867|Cystatins|cystatins|mesh-list
83544455|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
83544456|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83544457|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
83544458|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544459|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544460|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83544461|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544462|NCT01345136|Everolimus|everolimus|mesh-list
83544463|NCT01345136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83544464|NCT01345136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83544465|NCT01345136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544466|NCT01345136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544467|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83544468|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
83544469|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544470|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544471|NCT04341428|Lansoprazole|lansoprazole|mesh-list
83544472|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
83544473|NCT04341428|Fexuprazan|fexuprazan|mesh-list
83544474|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83544475|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544476|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83544477|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544478|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544479|NCT02453360|Bupivacaine|bupivacaine|mesh-list
83544480|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
83544481|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
83544482|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544483|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544484|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
83544485|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544486|NCT03140670|Rucaparib|rucaparib|mesh-list
83544487|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83544488|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544489|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544490|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544491|NCT02453672|Bevacizumab|bevacizumab|mesh-list
83544492|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544493|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544494|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83544495|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83544496|NCT02453672|Growth Substances|growth substances|mesh-ancestor
83544497|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544498|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
83544499|NCT03119064|Irinotecan|irinotecan|mesh-list
83544500|NCT03119064|Temozolomide|temozolomide|mesh-list
83544501|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83544502|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83544503|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544504|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544505|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544506|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83544507|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
83544508|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
83544509|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
83544510|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544511|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544512|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83544513|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
83544514|NCT03831295|Antibodies|antibodies|mesh-list
83544515|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
83544516|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544517|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
83544518|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83544519|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544520|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544521|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83544522|NCT05215158|Analgesics|analgesics|mesh-ancestor
83544523|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
83544524|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544525|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83544526|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83544527|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83544528|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83544529|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544530|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544531|NCT02454296|Lidocaine|lidocaine|mesh-list
83544532|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83544533|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
83544534|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002697|NCT04999020|Ravulizumab|ravulizumab|mesh-list
83544535|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544536|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
83544537|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544538|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83544539|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83544540|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83544541|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83544542|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544543|NCT03836833|Lamivudine|lamivudine|mesh-list
83544544|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83544545|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83544546|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544547|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544548|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
83544549|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544550|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83544551|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83544552|NCT05710471|Aflibercept|aflibercept|mesh-list
83544553|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83544554|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83544555|NCT05710471|Growth Substances|growth substances|mesh-ancestor
83544556|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544557|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
83544558|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544559|NCT00358969|Guanfacine|guanfacine|mesh-list
83544560|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83544561|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83544562|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83544563|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83544564|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
83544565|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544566|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544567|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544568|NCT02896712|Modafinil|modafinil|mesh-list
83544569|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83544570|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544571|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83544572|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83544573|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83544574|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544575|NCT05346601|Chiauranib|chiauranib|mesh-list
83544576|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544577|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83544578|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544579|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544580|NCT04344379|Azithromycin|azithromycin|mesh-list
83544581|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
83544582|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544583|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544584|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
83544585|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83544586|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83544587|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544588|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544589|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544590|NCT00359125|Mifepristone|mifepristone|mesh-list
83544591|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83544592|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
83544593|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83544594|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544595|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83544596|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83544597|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83544598|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
83544599|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83544600|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83544601|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
83544602|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544603|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
83544604|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83544605|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83544606|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83544607|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
83544608|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83544609|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544610|NCT04450836|Trifluridine|trifluridine|mesh-list
83544611|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
83544612|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544613|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
83544614|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544615|NCT05679193|Propranolol|propranolol|mesh-list
83544616|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83544617|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83544618|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
83544619|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544620|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544621|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544622|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83544623|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83544624|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
83544625|NCT04795752|Cyclosporine|cyclosporine|mesh-list
83544626|NCT04795752|Cyclosporins|cyclosporins|mesh-list
83544627|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544628|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544629|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83544630|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
83544631|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544632|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
83544633|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544634|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544635|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544636|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83544637|NCT02977741|Olanzapine|olanzapine|mesh-list
83544638|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
83544639|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
83544640|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544641|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544642|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544643|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83544644|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83544645|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544646|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83544647|NCT02977741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83544648|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83544649|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83544650|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544651|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544652|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
83544653|NCT04334070|Clofazimine|clofazimine|mesh-list
83544654|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544655|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
83544656|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544657|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544658|NCT05292001|Dextrans|dextrans|mesh-list
83544659|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
83544660|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
83544661|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
83544662|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
83544663|NCT05292001|Hematinics|hematinics|mesh-ancestor
83544664|NCT01634178|Apremilast|apremilast|mesh-list
83544665|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83544666|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83544667|NCT01634178|Analgesics|analgesics|mesh-ancestor
83544668|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
83544669|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544670|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544671|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544672|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544673|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83544674|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83544675|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544676|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544677|NCT00359359|Sagopilone|sagopilone|mesh-list
83544678|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544679|NCT04782804|Capecitabine|capecitabine|mesh-list
83544680|NCT04782804|Tislelizumab|tislelizumab|mesh-list
83544681|NCT04782804|Antibodies|antibodies|mesh-list
83544682|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
83544683|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544684|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83544685|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
83544686|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544687|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544688|NCT04782804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544689|NCT04227288|Betamethasone|betamethasone|mesh-list
83544690|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
83544691|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83544692|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
83544693|NCT04227288|Calcipotriene|calcipotriene|mesh-list
83544694|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83544695|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544696|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
83544697|NCT04227288|Hormones|hormones|mesh-ancestor
83544698|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544699|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544700|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83544701|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83544702|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544703|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
83544704|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
83544705|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544706|NCT02978443|Nivolumab|nivolumab|mesh-list
83544707|NCT02978443|Ipilimumab|ipilimumab|mesh-list
83544708|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544709|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544710|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83544711|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544712|NCT02465450|Lenabasum|lenabasum|mesh-list
83544713|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83544714|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83544715|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544716|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544717|NCT02465450|Hormones|hormones|mesh-ancestor
83544718|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544719|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544720|NCT00608972|Bevacizumab|bevacizumab|mesh-list
83544721|NCT00608972|Carboplatin|carboplatin|mesh-list
83544722|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544723|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544724|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83544725|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83544726|NCT00608972|Growth Substances|growth substances|mesh-ancestor
83544727|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544728|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
83544729|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83544730|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83544731|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544732|NCT02729714|Suvorexant|suvorexant|mesh-list
83544733|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83544734|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83544735|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544736|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544737|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83544738|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544739|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544740|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
83544741|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83544742|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83544743|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544744|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
83544745|NCT04802382|Coagulants|coagulants|mesh-ancestor
83544746|NCT05648916|Celecoxib|celecoxib|mesh-list
83544747|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83544748|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83544749|NCT05648916|Analgesics|analgesics|mesh-ancestor
83544750|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
83544751|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544752|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544753|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544754|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002937|NCT05432141|Vaccines|vaccines|mesh-list
83544755|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83544756|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83544757|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544758|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544759|NCT05458609|Naltrexone|naltrexone|mesh-list
83544760|NCT05458609|Lemborexant|lemborexant|mesh-list
83544761|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83544762|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83544763|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544764|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
83544765|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544766|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83544767|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544768|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544769|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83544770|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83544771|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544772|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
83544773|NCT05648058|Promethazine|promethazine|mesh-list
83544774|NCT05648058|Nefopam|nefopam|mesh-list
83544775|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83544776|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83544777|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544778|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544779|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
83544780|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
83544781|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
83544782|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544783|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
83544784|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
83544785|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544786|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83544787|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
83544788|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
83544789|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544790|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544791|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83544792|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
83544793|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544794|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83544795|NCT05648058|Analgesics|analgesics|mesh-ancestor
83544796|NCT05649085|Cobalt|cobalt|mesh-list
83544797|NCT05649085|Chromium|chromium|mesh-list
83544798|NCT05649085|Trace Elements|trace elements|mesh-ancestor
83544799|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
83544800|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544801|NCT05639712|Fentanyl|fentanyl|mesh-list
83544802|NCT05639712|Morphine|morphine|mesh-list
83544803|NCT05639712|Oxycodone|oxycodone|mesh-list
83544804|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83544805|NCT05639712|Narcotics|narcotics|mesh-ancestor
83544806|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544807|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544808|NCT05639712|Analgesics|analgesics|mesh-ancestor
83544809|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
83544810|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544811|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83544812|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83544813|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
83544814|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
83544815|NCT05210101|Sotrovimab|sotrovimab|mesh-list
83544816|NCT05210101|Antiviral Agents|antiviral agents|mesh-ancestor
83544817|NCT05210101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544818|NCT02959411|Tolvaptan|tolvaptan|mesh-list
83544819|NCT02959411|Diuretics|diuretics|mesh-list
83544820|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
83544821|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544822|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83544823|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544824|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
83544825|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83544826|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83544827|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83544828|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83544829|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544830|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83544831|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544832|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544833|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83544834|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544835|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
83544836|NCT05630833|Gepotidacin|gepotidacin|mesh-list
83544837|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83544838|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544839|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544840|NCT05630833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83544841|NCT05630833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544842|NCT05630833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544843|NCT05630833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544844|NCT00359671|Docetaxel|docetaxel|mesh-list
83544845|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544846|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83544847|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83544848|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83544849|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544850|NCT02977897|Octreotide|octreotide|mesh-list
83544851|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544852|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83544853|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544854|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
83544855|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83544856|NCT05114941|Antibodies|antibodies|mesh-list
83544857|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
83544858|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83544859|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
83544860|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544861|NCT00359905|Tamsulosin|tamsulosin|mesh-list
83544862|NCT00359905|Silodosin|silodosin|mesh-list
83544863|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83544864|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83544865|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83544866|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
83544867|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544868|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544869|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544870|NCT00359905|Urological Agents|urological agents|mesh-ancestor
83544871|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
83544872|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83544873|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
83544874|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544875|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
83544876|NCT05086939|Protective Agents|protective agents|mesh-ancestor
83544877|NCT00358813|Casopitant|casopitant|mesh-list
83544878|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
83544879|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
83544880|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544881|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544882|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544883|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83544884|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83544885|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544886|NCT04871191|Rituximab|rituximab|mesh-list
83544887|NCT04871191|Abatacept|abatacept|mesh-list
83544888|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544889|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544890|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
83544891|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544892|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544893|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83544894|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544895|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83544896|NCT02976805|Bisacodyl|bisacodyl|mesh-list
83544897|NCT02976805|Cathartics|cathartics|mesh-ancestor
83544898|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544899|NCT02976805|Laxatives|laxatives|mesh-ancestor
83544900|NCT04835623|Cyclosporine|cyclosporine|mesh-list
83544901|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83544902|NCT04835623|Cyclosporins|cyclosporins|mesh-list
83544903|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544904|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544905|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83544906|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
83544907|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544908|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
83544909|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544910|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544911|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83544912|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83544913|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83544914|NCT04500613|Dexamethasone|dexamethasone|mesh-list
83544915|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
83544916|NCT04500613|Bupivacaine|bupivacaine|mesh-list
83544917|NCT04500613|BB 1101|bb 1101|mesh-list
83544918|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544919|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
83544920|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
83544921|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544922|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544923|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83544924|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
83544925|NCT04500613|Hormones|hormones|mesh-ancestor
83544926|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544927|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83544928|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544929|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
83544930|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544931|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544932|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
83544933|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
83544934|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544935|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
83544936|NCT04833907|Prednisone|prednisone|mesh-list
83544937|NCT04833907|Levetiracetam|levetiracetam|mesh-list
83544938|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83544939|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
83544940|NCT04833907|Hormones|hormones|mesh-ancestor
83544941|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83544942|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544943|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83544944|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544945|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
83544946|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
83544947|NCT02976259|Dolutegravir|dolutegravir|mesh-list
83544948|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83544949|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83544950|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83544951|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544952|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83544953|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83544954|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
83544955|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544956|NCT00360295|Azithromycin|azithromycin|mesh-list
83544957|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544958|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544959|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
83544960|NCT04485013|Cetuximab|cetuximab|mesh-list
83544961|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83544962|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83544963|NCT04485013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83544964|NCT04485013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83544965|NCT02976727|Vitamin D|vitamin d|mesh-list
83544966|NCT02976727|Lidocaine|lidocaine|mesh-list
83544967|NCT02976727|Prilocaine|prilocaine|mesh-list
83544968|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83544969|NCT02976727|Calcipotriene|calcipotriene|mesh-list
83544970|NCT02976727|Vitamins|vitamins|mesh-ancestor
83544971|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
83544972|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83544973|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
83544974|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
83544975|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83544976|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
83544977|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83544978|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83544979|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83544980|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83544981|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83544982|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003144|NCT03638063|Adenosine|adenosine|mesh-list
83544983|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83544984|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
83544985|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83544986|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
83544987|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83544988|NCT00360607|Metronidazole|metronidazole|mesh-list
83544989|NCT00360607|Amikacin|amikacin|mesh-list
83544990|NCT00360607|Ceftazidime|ceftazidime|mesh-list
83544991|NCT00360607|Sulbactam|sulbactam|mesh-list
83544992|NCT00360607|Cefoperazone|cefoperazone|mesh-list
83544993|NCT00360607|Sulperazone|sulperazone|mesh-list
83544994|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83544995|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83544996|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83544997|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83544998|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83544999|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545000|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545001|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83545002|NCT00360763|Candesartan|candesartan|mesh-list
83545003|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
83545004|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83545005|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83545006|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83545007|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545008|NCT04032301|Ketamine|ketamine|mesh-list
83545009|NCT04032301|Analgesics|analgesics|mesh-ancestor
83545010|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
83545011|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545012|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545013|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83545014|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83545015|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
83545016|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
83545017|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83545018|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83545019|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83545020|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545021|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545022|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
83545023|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83545024|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83545025|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545026|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83545027|NCT04010305|Analgesics|analgesics|mesh-ancestor
83545028|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
83545029|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545030|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83545031|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83545032|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83545033|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
83545034|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545035|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545036|NCT00361933|Valganciclovir|valganciclovir|mesh-list
83545037|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
83545038|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545039|NCT04786093|Durvalumab|durvalumab|mesh-list
83545040|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545041|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545042|NCT02976571|Bupivacaine|bupivacaine|mesh-list
83545043|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
83545044|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
83545045|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83545046|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545047|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
83545048|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545049|NCT04731025|Vancomycin|vancomycin|mesh-list
83545050|NCT04731025|Gentamicins|gentamicins|mesh-list
83545051|NCT04731025|Cefazolin|cefazolin|mesh-list
83545052|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83545053|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545054|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83545055|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545056|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545057|NCT04730635|Donepezil|donepezil|mesh-list
83545058|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83545059|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545060|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545061|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
83545062|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545063|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545064|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
83545065|NCT04686799|Doxycycline|doxycycline|mesh-list
83545066|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83545067|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545068|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
83545069|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83545070|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83545071|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
83545072|NCT04676035|Vitamin K|vitamin k|mesh-list
83545073|NCT04676035|Midazolam|midazolam|mesh-list
83545074|NCT04676035|Omeprazole|omeprazole|mesh-list
83545075|NCT04676035|Warfarin|warfarin|mesh-list
83545076|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83545077|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83545078|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83545079|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545080|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83545081|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83545082|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83545083|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83545084|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
83545085|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
83545086|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
83545087|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
83545088|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545089|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545090|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
83545091|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83545092|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83545093|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83545094|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545095|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83545096|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83545097|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
83545098|NCT04676035|Coagulants|coagulants|mesh-ancestor
83545099|NCT04676035|Vitamins|vitamins|mesh-ancestor
83545100|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
83545101|NCT03926299|Clobetasol|clobetasol|mesh-list
83545102|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545103|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
83545104|NCT03926299|Hormones|hormones|mesh-ancestor
83545105|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545106|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545107|NCT04359199|Cisplatin|cisplatin|mesh-list
83545108|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
83545109|NCT04359199|Nivolumab|nivolumab|mesh-list
83545110|NCT04359199|Cetuximab|cetuximab|mesh-list
83545111|NCT04359199|Durvalumab|durvalumab|mesh-list
83545112|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545113|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545114|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83545115|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545116|NCT03875911|Mitomycins|mitomycins|mesh-list
83545117|NCT03875911|Mitomycin|mitomycin|mesh-list
83545118|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83545119|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545120|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
83545121|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545122|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83545123|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545124|NCT00361075|Estradiol|estradiol|mesh-list
83545125|NCT00361075|Estrogens|estrogens|mesh-list
83545126|NCT00361075|Progesterone|progesterone|mesh-list
83545127|NCT00361075|Hormones|hormones|mesh-ancestor
83545128|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545129|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545130|NCT00361075|Progestins|progestins|mesh-ancestor
83545131|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83545132|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
83545133|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83545134|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
83545135|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83545136|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003298|NCT04853147|Aprepitant|aprepitant|mesh-list
83545137|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83545138|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83545139|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83545140|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545141|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83545142|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83545143|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83545144|NCT00362089|Dronabinol|dronabinol|mesh-list
83545145|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
83545146|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545147|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83545148|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83545149|NCT00362089|Analgesics|analgesics|mesh-ancestor
83545150|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
83545151|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545152|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83545153|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83545154|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545155|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545156|NCT00362089|Hormones|hormones|mesh-ancestor
83545157|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545158|NCT04666987|Liraglutide|liraglutide|mesh-list
83545159|NCT04666987|Xultophy|xultophy|mesh-list
83545160|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83545161|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545162|NCT04666987|Incretins|incretins|mesh-ancestor
83545163|NCT04666987|Hormones|hormones|mesh-ancestor
83545164|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545165|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
83545166|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545167|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545168|NCT04318717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83545169|NCT04318717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545170|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
83545171|NCT03822637|Albuterol|albuterol|mesh-list
83545172|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83545173|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83545174|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
83545175|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545176|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545177|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83545178|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83545179|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
83545180|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83545181|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83545182|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83545183|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83545184|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
83545185|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545186|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545187|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
83545188|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545189|NCT03822637|Expectorants|expectorants|mesh-ancestor
83545190|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83545191|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
83545192|NCT03822637|Protective Agents|protective agents|mesh-ancestor
83545193|NCT03822637|Antidotes|antidotes|mesh-ancestor
83545194|NCT05444101|Nicotine|nicotine|mesh-list
83545195|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83545196|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
83545197|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545198|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545199|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83545200|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83545201|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
83545202|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545203|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545204|NCT04342819|Empagliflozin|empagliflozin|mesh-list
83545205|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83545206|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545207|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83545208|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545209|NCT02412306|Blinatumomab|blinatumomab|mesh-list
83545210|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545211|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
83545212|NCT05616468|Fludarabine|fludarabine|mesh-list
83545213|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545214|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
83545215|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545216|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545217|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545218|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
83545219|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545220|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545221|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545222|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
83545223|NCT03654768|Dasatinib|dasatinib|mesh-list
83545224|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83545225|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545226|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83545227|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545228|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545229|NCT01352221|Ferric maltol|ferric maltol|mesh-list
83545230|NCT01352221|Hematinics|hematinics|mesh-ancestor
83545231|NCT03583710|Cisplatin|cisplatin|mesh-list
83545232|NCT03583710|Etoposide|etoposide|mesh-list
83545233|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
83545234|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
83545235|NCT03583710|Mitotane|mitotane|mesh-list
83545236|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545237|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545238|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545239|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545240|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545241|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545242|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
83545243|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
83545244|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545245|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545246|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545247|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83545248|NCT04418154|Paclitaxel|paclitaxel|mesh-list
83545249|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
83545250|NCT04418154|Epirubicin|epirubicin|mesh-list
83545251|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83545252|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545253|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545254|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545255|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545256|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545257|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545258|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545259|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
83545260|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545261|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545262|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545263|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
83545264|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545265|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83545266|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545267|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545268|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545269|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
83545270|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83545271|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83545272|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545273|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83545274|NCT05195034|Analgesics|analgesics|mesh-ancestor
83545275|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
83545276|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545277|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83545278|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83545279|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83545280|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
83545281|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545282|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545283|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
83545284|NCT05496894|Analgesics|analgesics|mesh-ancestor
83545285|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
83545286|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545287|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545288|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545289|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545290|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545291|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545292|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545293|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
83545294|NCT02065362|Fludarabine|fludarabine|mesh-list
83545295|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545296|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
83545297|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545298|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545299|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545300|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
83545301|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545302|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545303|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545304|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83545305|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
83545306|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545307|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545308|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545309|NCT03518034|Testosterone|testosterone|mesh-list
83545310|NCT03518034|Androgens|androgens|mesh-ancestor
83545311|NCT03518034|Hormones|hormones|mesh-ancestor
83545312|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545313|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545314|NCT04789668|Atezolizumab|atezolizumab|mesh-list
83545315|NCT04789668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83545316|NCT04789668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545317|NCT04789668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545318|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545319|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
83545320|NCT04448886|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83545321|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545322|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545323|NCT04448886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83545324|NCT04448886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545325|NCT04448886|Immunoconjugates|immunoconjugates|mesh-ancestor
83545326|NCT04448886|Immunologic Factors|immunologic factors|mesh-ancestor
83545327|NCT04448886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545328|NCT02389218|Sotalol|sotalol|mesh-list
83545329|NCT02389218|Flecainide|flecainide|mesh-list
83545330|NCT02389218|Propafenone|propafenone|mesh-list
83545331|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83545332|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83545333|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
83545334|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545335|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545336|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545337|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83545338|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
83545339|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
83545340|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545341|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83545342|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83545343|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83545344|NCT01953120|Abatacept|abatacept|mesh-list
83545345|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83545346|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545347|NCT01953120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545348|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545349|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545350|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
83545351|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545352|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545353|NCT01634100|Empagliflozin|empagliflozin|mesh-list
83545354|NCT01634100|Rifampin|rifampin|mesh-list
83545355|NCT01634100|Probenecid|probenecid|mesh-list
83545356|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83545357|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545358|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83545359|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545360|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83545361|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
83545362|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83545363|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545364|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
83398607|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
83398610|NCT03296813|Torsemide|torsemide|mesh-list
83545365|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83545366|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545367|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83545368|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83545369|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83545370|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83545371|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83545372|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83545373|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
83545374|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
83545375|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545376|NCT03662659|Nivolumab|nivolumab|mesh-list
83545377|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545378|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545379|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83545380|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545381|NCT03661645|Dexamethasone|dexamethasone|mesh-list
83545382|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
83545383|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
83545384|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83545385|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83545386|NCT03661645|BB 1101|bb 1101|mesh-list
83545387|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545388|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
83545389|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
83545390|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545391|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545392|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83545393|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
83545394|NCT03661645|Hormones|hormones|mesh-ancestor
83545395|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545396|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83545397|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545398|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
83545399|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545400|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545401|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83545402|NCT03661645|Protective Agents|protective agents|mesh-ancestor
83545403|NCT01633944|Buprenorphine|buprenorphine|mesh-list
83545404|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83545405|NCT01633944|Narcotics|narcotics|mesh-ancestor
83545406|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83545407|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545408|NCT01633944|Analgesics|analgesics|mesh-ancestor
83545409|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
83545410|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545411|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83545412|NCT04592419|Aflibercept|aflibercept|mesh-list
83545413|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83545414|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83545415|NCT04592419|Growth Substances|growth substances|mesh-ancestor
83545416|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545417|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
83545418|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545419|NCT00589316|Iodine|iodine|mesh-list
83545420|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
83545421|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
83545422|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
83545423|NCT00589316|Fludarabine|fludarabine|mesh-list
83545424|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
83545425|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83545426|NCT00589316|Tacrolimus|tacrolimus|mesh-list
83545427|NCT00589316|Antibodies|antibodies|mesh-list
83545428|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
83545429|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83545430|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545431|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
83545432|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545433|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545434|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545435|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
83545436|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545437|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545438|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545439|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83545440|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
83545441|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83545442|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545443|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83545444|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83545445|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
83545446|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83545447|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545448|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83545449|NCT00589316|Trace Elements|trace elements|mesh-ancestor
83545450|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
83545451|NCT00362245|Amikacin|amikacin|mesh-list
83545452|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83545453|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545454|NCT04786548|Celecoxib|celecoxib|mesh-list
83545455|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83545456|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83545457|NCT04786548|Analgesics|analgesics|mesh-ancestor
83545458|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
83545459|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545460|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545461|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545462|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545463|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83545464|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83545465|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545466|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545467|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83545468|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83545469|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
83545470|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545471|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545472|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83545473|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83545474|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83545475|NCT00003417|Carmustine|carmustine|mesh-list
83545476|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545477|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
83545478|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545479|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545480|NCT04329429|Trastuzumab|trastuzumab|mesh-list
83545481|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545482|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545483|NCT00003423|Cytarabine|cytarabine|mesh-list
83545484|NCT00003423|Dexamethasone|dexamethasone|mesh-list
83545485|NCT00003423|Prednisolone|prednisolone|mesh-list
83545486|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
83545487|NCT00003423|Methotrexate|methotrexate|mesh-list
83545488|NCT00003423|Etoposide|etoposide|mesh-list
83545489|NCT00003423|Vincristine|vincristine|mesh-list
83545490|NCT00003423|Daunorubicin|daunorubicin|mesh-list
83545491|NCT00003423|Asparaginase|asparaginase|mesh-list
83545492|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
83545493|NCT00003423|Thioguanine|thioguanine|mesh-list
83545494|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545495|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
83545496|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545497|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545498|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545499|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
83545500|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545501|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545502|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545503|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545504|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
83545505|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
83545506|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545507|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83545508|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
83545509|NCT00003423|Hormones|hormones|mesh-ancestor
83545510|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545511|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83845091|NCT05561036|Doxorubicin|doxorubicin|mesh-list
83545512|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83545514|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83545515|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83545516|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
83545517|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
83545518|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545519|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83545520|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83545521|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545522|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545523|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545524|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
83545525|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545526|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545527|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545528|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545529|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83545530|NCT00003273|Leucovorin|leucovorin|mesh-list
83545531|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
83545532|NCT00003273|Temozolomide|temozolomide|mesh-list
83545533|NCT00003273|Thiotepa|thiotepa|mesh-list
83545534|NCT00003273|Carboplatin|carboplatin|mesh-list
83545535|NCT00003273|Methotrexate|methotrexate|mesh-list
83545536|NCT00003273|Etoposide|etoposide|mesh-list
83545537|NCT00003273|Vincristine|vincristine|mesh-list
83545538|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
83545539|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545540|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
83545541|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545542|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545543|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545544|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
83545545|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545546|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545547|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545548|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83545549|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
83545550|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83545551|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83545552|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
83545553|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
83545554|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545555|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83545556|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83545557|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545558|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545559|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545560|NCT00003273|Antidotes|antidotes|mesh-ancestor
83545561|NCT00003273|Protective Agents|protective agents|mesh-ancestor
83545562|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
83545563|NCT00003273|Vitamins|vitamins|mesh-ancestor
83545564|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
83545565|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545566|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545567|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545568|NCT04329585|Flumazenil|flumazenil|mesh-list
83545569|NCT04329585|Antidotes|antidotes|mesh-ancestor
83545570|NCT04329585|Protective Agents|protective agents|mesh-ancestor
83545571|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545572|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
83545573|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
83545574|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545575|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545576|NCT00003279|Antibodies|antibodies|mesh-list
83545577|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83545578|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
83545579|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
83545580|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545581|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83545582|NCT00383487|Calcitriol|calcitriol|mesh-list
83545583|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83545584|NCT00383487|Naproxen|naproxen|mesh-list
83003748|NCT03271151|Analgesics|analgesics|mesh-ancestor
83545585|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
83545586|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83545587|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83545588|NCT00383487|Analgesics|analgesics|mesh-ancestor
83545589|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
83545590|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545591|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545592|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545593|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545594|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
83545595|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83545596|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545597|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545598|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83545599|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83545600|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83545601|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83545602|NCT00383487|Vitamins|vitamins|mesh-ancestor
83545603|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
83545604|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83545605|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83545606|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83545607|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83545608|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545609|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
83545610|NCT00003435|Melphalan|melphalan|mesh-list
83545611|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83545612|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545613|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
83545614|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545615|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545616|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545617|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545618|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
83545619|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545620|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545621|NCT00003441|Irofulven|irofulven|mesh-list
83545622|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545623|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
83545624|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545625|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545626|NCT00002805|Cobalt|cobalt|mesh-list
83545627|NCT00002805|Cytarabine|cytarabine|mesh-list
83545628|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
83545629|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83545630|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83545631|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83545632|NCT00002805|Methotrexate|methotrexate|mesh-list
83545633|NCT00002805|Etoposide|etoposide|mesh-list
83545634|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
83545635|NCT00002805|Cladribine|cladribine|mesh-list
83545636|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83545637|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
83545638|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83545639|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545640|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83545641|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
83545642|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545643|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545644|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
83545645|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545646|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83545647|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545648|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
83545649|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545650|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83545651|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545652|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545653|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545654|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
83545655|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545656|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545657|NCT00002805|Analgesics|analgesics|mesh-ancestor
83545658|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
83545659|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545660|NCT00002805|Trace Elements|trace elements|mesh-ancestor
83545661|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
83545662|NCT00003297|Topotecan|topotecan|mesh-list
83545663|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
83545664|NCT00003297|Thiotepa|thiotepa|mesh-list
83545665|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83545666|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545667|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545668|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545669|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545670|NCT00003297|Analgesics|analgesics|mesh-ancestor
83545671|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
83545672|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545673|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545674|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545675|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545676|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
83545677|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545678|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545679|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
83545680|NCT00003447|Gemcitabine|gemcitabine|mesh-list
83545681|NCT00003447|Vinorelbine|vinorelbine|mesh-list
83545682|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83545683|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
83545684|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545685|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545686|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545687|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545688|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545689|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545690|NCT00003315|Amphotericin B|amphotericin b|mesh-list
83545691|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83545692|NCT00003315|Sargramostim|sargramostim|mesh-list
83545693|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
83545694|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545695|NCT00003315|Amebicides|amebicides|mesh-ancestor
83545696|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83545697|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83545698|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545699|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83545700|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
83545701|NCT00002817|Sargramostim|sargramostim|mesh-list
83545702|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
83545703|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545704|NCT00003465|Temozolomide|temozolomide|mesh-list
83545705|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545706|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
83545707|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545708|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545709|NCT00002823|Etoposide|etoposide|mesh-list
83545710|NCT00002823|Vinorelbine|vinorelbine|mesh-list
83545711|NCT00002823|Vinblastine|vinblastine|mesh-list
83545712|NCT00002823|Vindesine|vindesine|mesh-list
83545713|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545714|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545715|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545716|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545717|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545718|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545719|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545720|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545721|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545722|NCT00361621|Prednisone|prednisone|mesh-list
83545723|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
83545724|NCT00361621|Rituximab|rituximab|mesh-list
83545725|NCT00361621|Doxorubicin|doxorubicin|mesh-list
83545726|NCT00361621|Vincristine|vincristine|mesh-list
83545727|NCT00361621|Bortezomib|bortezomib|mesh-list
83545728|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545729|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
83545730|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545731|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545732|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545733|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
83545734|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545735|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545736|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545737|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545738|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83545739|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545740|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545741|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545742|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545743|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
83545744|NCT00361621|Hormones|hormones|mesh-ancestor
83545745|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545746|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83545747|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545748|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545749|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545750|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545751|NCT00003327|Paclitaxel|paclitaxel|mesh-list
83545752|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545753|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545754|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545755|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545756|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545757|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545758|NCT00003339|Interleukin-12|interleukin-12|mesh-list
83545759|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
83545760|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83545761|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
83545762|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545763|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83545764|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83545765|NCT00003339|Growth Substances|growth substances|mesh-ancestor
83545766|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83545767|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545768|NCT00002829|Interferons|interferons|mesh-list
83545769|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
83545770|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
83545771|NCT00002829|Etoposide|etoposide|mesh-list
83545772|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545773|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
83545774|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545775|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545776|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545777|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
83545778|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545779|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545780|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545781|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545782|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545783|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545784|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545785|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
83545786|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545787|NCT03614221|Tacrolimus|tacrolimus|mesh-list
83545788|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545789|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
83545790|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545791|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83545792|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545793|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545794|NCT00003345|Irinotecan|irinotecan|mesh-list
83545795|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545796|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83545797|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545798|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545799|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545800|NCT03596905|Plecanatide|plecanatide|mesh-list
83545801|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83545802|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
83545803|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545804|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83545805|NCT00002835|Leucovorin|leucovorin|mesh-list
83545806|NCT00002835|Interferons|interferons|mesh-list
83545807|NCT00002835|Cytarabine|cytarabine|mesh-list
83545808|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
83545809|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
83545810|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83545811|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83545812|NCT00002835|Prednisolone|prednisolone|mesh-list
83545813|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
83545814|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
83545815|NCT00002835|Melphalan|melphalan|mesh-list
83003965|NCT01498770|Olanzapine|olanzapine|mesh-list
83545816|NCT00002835|Ifosfamide|ifosfamide|mesh-list
83545818|NCT00002835|Cisplatin|cisplatin|mesh-list
83545819|NCT00002835|Methotrexate|methotrexate|mesh-list
83545820|NCT00002835|Etoposide|etoposide|mesh-list
83545821|NCT00002835|Vincristine|vincristine|mesh-list
83545822|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
83545823|NCT00002835|Idarubicin|idarubicin|mesh-list
83545824|NCT00002835|Bleomycin|bleomycin|mesh-list
83545825|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
83545826|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83545827|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
83545828|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545829|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
83545830|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545831|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545832|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545833|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
83545834|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545835|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545836|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545837|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83545838|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
83545839|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83545840|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83545841|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
83545842|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
83545843|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545844|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83545845|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83545846|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545847|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545848|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545849|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
83545850|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545851|NCT00002835|Antidotes|antidotes|mesh-ancestor
83545852|NCT00002835|Protective Agents|protective agents|mesh-ancestor
83545853|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
83545854|NCT00002835|Vitamins|vitamins|mesh-ancestor
83545855|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
83545856|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545857|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545858|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545859|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545860|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
83545861|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
83545862|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545863|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83545864|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
83545865|NCT00002835|Hormones|hormones|mesh-ancestor
83545866|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545867|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83545868|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83545869|NCT00002835|Analgesics|analgesics|mesh-ancestor
83545870|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
83545871|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83545872|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83545873|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83545874|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83545875|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83545876|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545877|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83545878|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545879|NCT04560673|Analgesics|analgesics|mesh-ancestor
83545880|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
83545881|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545882|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
83545883|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83545884|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
83545885|NCT00003351|Irinotecan|irinotecan|mesh-list
83545886|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83545887|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545888|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545889|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545890|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545891|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83545892|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83545893|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83545894|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
83545895|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545896|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83545897|NCT00002847|Interferons|interferons|mesh-list
83545898|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
83545899|NCT00002847|Aldesleukin|aldesleukin|mesh-list
83545900|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545901|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
83545902|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545903|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
83545904|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545905|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83545906|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83545907|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
83545908|NCT03576001|Testosterone|testosterone|mesh-list
83545909|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
83545910|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
83545911|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83545912|NCT03576001|Androgens|androgens|mesh-ancestor
83545913|NCT03576001|Hormones|hormones|mesh-ancestor
83138173|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
83545914|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545915|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545916|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83545917|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545918|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
83545919|NCT04220827|Paclitaxel|paclitaxel|mesh-list
83545920|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83545921|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545922|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545923|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545924|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545925|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545926|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545927|NCT00002865|Leucovorin|leucovorin|mesh-list
83545928|NCT00002865|Cobalt|cobalt|mesh-list
83545929|NCT00002865|Cytarabine|cytarabine|mesh-list
83545930|NCT00002865|Dexamethasone|dexamethasone|mesh-list
83545931|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
83545932|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83545933|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83545934|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83545935|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
83545936|NCT00002865|Ifosfamide|ifosfamide|mesh-list
83545937|NCT00002865|Doxorubicin|doxorubicin|mesh-list
83545938|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83545939|NCT00002865|Methotrexate|methotrexate|mesh-list
83545940|NCT00002865|Etoposide|etoposide|mesh-list
83545941|NCT00002865|Vincristine|vincristine|mesh-list
83545942|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
83545943|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83545944|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
83545945|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545946|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83545947|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83545948|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
83545949|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545950|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545951|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83545952|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83545953|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
83545954|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
83545955|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83545956|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83545957|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
83545958|NCT00002865|Hormones|hormones|mesh-ancestor
83545959|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83545960|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83545961|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83545962|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83545963|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83545964|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545965|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83545966|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
83545967|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83545968|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83545969|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
83545970|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
83545971|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83545972|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83545973|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83545974|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
83545975|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83545977|NCT00002865|Protective Agents|protective agents|mesh-ancestor
83545978|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
83545979|NCT00002865|Vitamins|vitamins|mesh-ancestor
83545980|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
83545981|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
83545982|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
83545983|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
83545984|NCT00002865|Trace Elements|trace elements|mesh-ancestor
83545985|NCT00361309|Sunitinib|sunitinib|mesh-list
83545986|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545987|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83545988|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83545989|NCT00361309|Growth Substances|growth substances|mesh-ancestor
83545990|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83545991|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
83545992|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83545993|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83545994|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83545995|NCT04154943|Cemiplimab|cemiplimab|mesh-list
83545996|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83545997|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83545998|NCT00361387|Methylphenidate|methylphenidate|mesh-list
83545999|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83546000|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546001|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83546002|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83546003|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83546004|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546005|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
83546006|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83546007|NCT04530487|Cyclosporine|cyclosporine|mesh-list
83546008|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
83546009|NCT04530487|Fludarabine|fludarabine|mesh-list
83546010|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
83546011|NCT04530487|Etoposide|etoposide|mesh-list
83546012|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
83546013|NCT04530487|Melphalan|melphalan|mesh-list
83546014|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
83546015|NCT04530487|Thiotepa|thiotepa|mesh-list
83546016|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
83546017|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83546018|NCT04530487|Tacrolimus|tacrolimus|mesh-list
83546019|NCT04530487|Cyclosporins|cyclosporins|mesh-list
83546020|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
83546021|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83546022|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
83546023|NCT04530487|Antibodies|antibodies|mesh-list
83546024|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
83546025|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83546026|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83546027|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546028|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546029|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
83546030|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546031|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546032|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
83546033|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546034|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546035|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546036|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546037|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546038|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83546039|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
83004181|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83546040|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546041|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
83546042|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004182|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83004183|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004187|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
83546043|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546044|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83546045|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
83546046|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83546047|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546048|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
83546049|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546050|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
83546051|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546052|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546053|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546054|NCT00003369|Tirapazamine|tirapazamine|mesh-list
83546055|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546056|NCT04342351|Valsartan|valsartan|mesh-list
83546057|NCT04342351|Perindopril|perindopril|mesh-list
83546058|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83546059|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83546060|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83546061|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83546062|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546063|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83546064|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
83546065|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546066|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
83546067|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83546068|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546069|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546070|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546071|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546072|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546073|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546074|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
83546075|NCT03504241|Sirolimus|sirolimus|mesh-list
83546076|NCT03504241|Prednisone|prednisone|mesh-list
83546077|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
83546078|NCT03504241|Abatacept|abatacept|mesh-list
83546079|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546080|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
83546081|NCT03504241|Hormones|hormones|mesh-ancestor
83546082|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546083|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546084|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546085|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546086|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546087|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83546088|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
83546089|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83546090|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546091|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546092|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546093|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
83546094|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546095|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
83546096|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546097|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83546098|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546099|NCT00003375|Vincristine|vincristine|mesh-list
83546100|NCT00003375|Lomustine|lomustine|mesh-list
83546101|NCT00003375|Procarbazine|procarbazine|mesh-list
83546102|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546103|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546104|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546105|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546106|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546107|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546108|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546109|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
83546110|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
83546111|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83546112|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
83546113|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546114|NCT03499249|Expectorants|expectorants|mesh-ancestor
83004259|NCT03625050|Celecoxib|celecoxib|mesh-list
83004260|NCT03625050|Esomeprazole|esomeprazole|mesh-list
83004261|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004262|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83546115|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
83546116|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83546117|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
83546118|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546119|NCT03499249|Protective Agents|protective agents|mesh-ancestor
83546120|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546121|NCT03499249|Antidotes|antidotes|mesh-ancestor
83546122|NCT03498391|Ketamine|ketamine|mesh-list
83546123|NCT03498391|Propofol|propofol|mesh-list
83546124|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83546125|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83546126|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546127|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83546128|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
83546129|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
83546130|NCT03498391|Analgesics|analgesics|mesh-ancestor
83546131|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
83546132|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546133|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83546134|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83546135|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83546136|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83546137|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546138|NCT00003939|Trabectedin|trabectedin|mesh-list
83546139|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546140|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
83546141|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546142|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546143|NCT00003543|Fluorouracil|fluorouracil|mesh-list
83546144|NCT00003543|Vincristine|vincristine|mesh-list
83546145|NCT00003543|Carmustine|carmustine|mesh-list
83546146|NCT00003543|Streptozocin|streptozocin|mesh-list
83546147|NCT00003543|Antibodies|antibodies|mesh-list
83546148|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83546149|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
83546150|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546151|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
83546152|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546153|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546154|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546155|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546156|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546157|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546158|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546159|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546160|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546161|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
83546162|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546163|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
83546164|NCT00003549|Fluorouracil|fluorouracil|mesh-list
83546165|NCT00003549|Methotrexate|methotrexate|mesh-list
83546166|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546167|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
83546168|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546169|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546170|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546171|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
83546172|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546173|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546174|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546175|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
83546176|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546177|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83546178|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
83546179|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83546180|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
83546181|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546182|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83546183|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83546184|NCT00002883|Fluorouracil|fluorouracil|mesh-list
83546185|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546186|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
83546187|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546188|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83004332|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
83546189|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546190|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
83546191|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546193|NCT00002889|Goserelin|goserelin|mesh-list
83546194|NCT00002889|Flutamide|flutamide|mesh-list
83546195|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83546196|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
83546197|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83546198|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546199|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546200|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546201|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
83546202|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
83546203|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546204|NCT03492463|Nicotine|nicotine|mesh-list
83546205|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83546206|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
83546207|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546208|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546209|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83546210|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83546211|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
83546212|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83546213|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546214|NCT00003945|Topotecan|topotecan|mesh-list
83546215|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546216|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546217|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546218|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546219|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546220|NCT00003951|Exatecan|exatecan|mesh-list
83546221|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546222|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546223|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546224|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546225|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546226|NCT00003957|Cytarabine|cytarabine|mesh-list
83546227|NCT00003957|Paclitaxel|paclitaxel|mesh-list
83546228|NCT00003957|Etoposide|etoposide|mesh-list
83546229|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
83546230|NCT00003957|Melphalan|melphalan|mesh-list
83546231|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
83546232|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546233|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546234|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546235|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546236|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546237|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546238|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546239|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
83546240|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546241|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546242|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546243|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
83546244|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546245|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546246|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546247|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546248|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546249|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
83546250|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
83546251|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546252|NCT00003957|Analgesics|analgesics|mesh-ancestor
83546253|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
83546254|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546255|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
83546256|NCT00004833|Antibodies|antibodies|mesh-list
83546257|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
83546258|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83546259|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83546260|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
83546261|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004409|NCT02932579|Ibuprofen|ibuprofen|mesh-list
83546262|NCT00003555|Paclitaxel|paclitaxel|mesh-list
83546263|NCT00003555|Amifostine|amifostine|mesh-list
83546264|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546265|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546266|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546267|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546268|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546269|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546270|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83546271|NCT00003555|Protective Agents|protective agents|mesh-ancestor
83546272|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546273|NCT00003963|Rituximab|rituximab|mesh-list
83546274|NCT00003963|Vinorelbine|vinorelbine|mesh-list
83546275|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546276|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546277|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
83546278|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546279|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546280|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546281|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546282|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546283|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546284|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546285|NCT00004845|Naproxen|naproxen|mesh-list
83546286|NCT00004845|Rofecoxib|rofecoxib|mesh-list
83546287|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83546288|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83546289|NCT00004845|Analgesics|analgesics|mesh-ancestor
83546290|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
83546291|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546292|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546293|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546294|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546295|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
83546296|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83546297|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546298|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546299|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83546300|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83546301|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546302|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83546303|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546304|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546305|NCT00003993|Aldesleukin|aldesleukin|mesh-list
83546306|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
83546307|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546308|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83546309|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83546310|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
83546311|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546312|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83546313|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
83546314|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546315|NCT00004857|Fludarabine|fludarabine|mesh-list
83546316|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
83546317|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
83546318|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546319|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546320|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
83546321|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546322|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546323|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
83546324|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546325|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546326|NCT03476239|Blinatumomab|blinatumomab|mesh-list
83546327|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546328|NCT00004863|Paclitaxel|paclitaxel|mesh-list
83546329|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546330|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546331|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546332|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546333|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546334|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546335|NCT00004875|Heparin|heparin|mesh-list
83546336|NCT00004875|Enoxaparin|enoxaparin|mesh-list
83546337|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
83546338|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83546339|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83546340|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546341|NCT00003561|Interferons|interferons|mesh-list
83546342|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
83546343|NCT00003561|Sargramostim|sargramostim|mesh-list
83546344|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546345|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
83546346|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546347|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
83546348|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546349|NCT00003567|Temozolomide|temozolomide|mesh-list
83546350|NCT00003567|Carmustine|carmustine|mesh-list
83546351|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83546352|NCT00003567|Sargramostim|sargramostim|mesh-list
83546353|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
83546354|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546355|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546356|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
83546357|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546358|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546359|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546360|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
83546361|NCT00003573|Cisplatin|cisplatin|mesh-list
83546362|NCT00003573|Etoposide|etoposide|mesh-list
83546363|NCT00003573|Vincristine|vincristine|mesh-list
83546364|NCT00003573|Lenograstim|lenograstim|mesh-list
83546365|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546366|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
83546367|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546368|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546369|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546370|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
83546371|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546372|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546373|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546374|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546375|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546376|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546377|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546378|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83546379|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546380|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546381|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546382|NCT03468985|Nivolumab|nivolumab|mesh-list
83546383|NCT03468985|Ipilimumab|ipilimumab|mesh-list
83546384|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546385|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546386|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83546387|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546388|NCT00003585|Interferons|interferons|mesh-list
83546389|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
83546390|NCT00003585|Aldesleukin|aldesleukin|mesh-list
83546391|NCT00003585|Fluorouracil|fluorouracil|mesh-list
83546392|NCT00003585|Isotretinoin|isotretinoin|mesh-list
83546393|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
83546394|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546395|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546396|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546397|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546398|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
83546399|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546400|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
83546401|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546402|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83546403|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83546404|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83546405|NCT00003591|Paclitaxel|paclitaxel|mesh-list
83546406|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546407|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138205|NCT04440176|Vaccines|vaccines|mesh-list
83546408|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546409|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546410|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546411|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546412|NCT02975323|Carvedilol|carvedilol|mesh-list
83546413|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83546414|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83546415|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
83546416|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83546417|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546418|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546419|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83546420|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
83546421|NCT02975323|Protective Agents|protective agents|mesh-ancestor
83546422|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83546423|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83546424|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83546425|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
83546426|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83546427|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83546428|NCT00003597|Carboplatin|carboplatin|mesh-list
83546429|NCT00003597|Etoposide|etoposide|mesh-list
83546430|NCT00003597|Ifosfamide|ifosfamide|mesh-list
83546431|NCT00003597|Lenograstim|lenograstim|mesh-list
83546432|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546433|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546434|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546435|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546436|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546437|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546438|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546439|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
83546440|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83546441|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
83546442|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546443|NCT00004005|Leucovorin|leucovorin|mesh-list
83546444|NCT00004005|Fluorouracil|fluorouracil|mesh-list
83546445|NCT00004005|Irinotecan|irinotecan|mesh-list
83546446|NCT00004005|Calcium|calcium|mesh-list
83546447|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
83546448|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83546449|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546450|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
83546451|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546452|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546453|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546454|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546455|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
83546456|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546457|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546458|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546459|NCT00004005|Antidotes|antidotes|mesh-ancestor
83546460|NCT00004005|Protective Agents|protective agents|mesh-ancestor
83546461|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
83546462|NCT00004005|Vitamins|vitamins|mesh-ancestor
83546463|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
83546464|NCT00003603|Dexamethasone|dexamethasone|mesh-list
83546465|NCT00003603|Prednisolone|prednisolone|mesh-list
83546466|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
83546467|NCT00003603|Melphalan|melphalan|mesh-list
83546468|NCT00003603|Lomustine|lomustine|mesh-list
83546469|NCT00003603|Idarubicin|idarubicin|mesh-list
83546470|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546471|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
83546472|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546473|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546474|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546475|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
83546476|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546477|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546478|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546479|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546480|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
83546481|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
83546482|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546483|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83546484|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
83546485|NCT00003603|Hormones|hormones|mesh-ancestor
83546486|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546487|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546488|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546489|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546490|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546491|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546492|NCT00004887|Paclitaxel|paclitaxel|mesh-list
83546493|NCT00004887|Vinblastine|vinblastine|mesh-list
83546494|NCT00004887|Carboplatin|carboplatin|mesh-list
83546495|NCT00004887|Ifosfamide|ifosfamide|mesh-list
83546496|NCT00004887|Mitomycins|mitomycins|mesh-list
83546497|NCT00004887|Mitomycin|mitomycin|mesh-list
83546498|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546499|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546500|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546501|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546502|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546503|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546504|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546505|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
83546506|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546507|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83546508|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546509|NCT00004893|Interleukin-12|interleukin-12|mesh-list
83546510|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83546511|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
83546512|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546513|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83546514|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83546515|NCT00004893|Growth Substances|growth substances|mesh-ancestor
83546516|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
83546517|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546518|NCT04513951|Leucovorin|leucovorin|mesh-list
83546519|NCT04513951|Fluorouracil|fluorouracil|mesh-list
83546520|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
83546521|NCT04513951|Irinotecan|irinotecan|mesh-list
83546522|NCT04513951|Cetuximab|cetuximab|mesh-list
83546523|NCT04513951|Avelumab|avelumab|mesh-list
83546524|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
83546525|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
83546526|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546527|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546528|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546529|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546530|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
83546531|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546532|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546533|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546534|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546535|NCT04513951|Antidotes|antidotes|mesh-ancestor
83546536|NCT04513951|Protective Agents|protective agents|mesh-ancestor
83546537|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
83546538|NCT04513951|Vitamins|vitamins|mesh-ancestor
83546539|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
83546540|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546541|NCT00004011|Paclitaxel|paclitaxel|mesh-list
83546542|NCT00004011|Carboplatin|carboplatin|mesh-list
83546543|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546544|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546545|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546546|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546547|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546548|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546549|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
83546550|NCT03448393|Fludarabine|fludarabine|mesh-list
83546551|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546552|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
83546553|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546554|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546555|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546556|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
83546557|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546558|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546559|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546560|NCT00004017|Antibodies|antibodies|mesh-list
83546561|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83546562|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
83546563|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546564|NCT00004905|Interferons|interferons|mesh-list
83546565|NCT00004905|Cytarabine|cytarabine|mesh-list
83546566|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
83546567|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
83546568|NCT00004905|Etoposide|etoposide|mesh-list
83546569|NCT00004905|Idarubicin|idarubicin|mesh-list
83546570|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546571|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
83546572|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546573|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546574|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546575|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
83546576|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546577|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546578|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546579|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546580|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546581|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546582|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546583|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
83546584|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546585|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546586|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
83546587|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546588|NCT00004029|Sargramostim|sargramostim|mesh-list
83546589|NCT00004029|Vaccines|vaccines|mesh-list
83546590|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
83546591|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546592|NCT00362323|Metformin|metformin|mesh-list
83546593|NCT00362323|Fenofibrate|fenofibrate|mesh-list
83546594|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83546595|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546596|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83546597|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
83546598|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546599|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83546600|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
83546601|NCT00004917|Hematinics|hematinics|mesh-ancestor
83546602|NCT00421915|Etanercept|etanercept|mesh-list
83546603|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83546604|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83546605|NCT00421915|Analgesics|analgesics|mesh-ancestor
83546606|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
83546607|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546608|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546609|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546610|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546611|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83546612|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546613|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
83546614|NCT00362713|Ipilimumab|ipilimumab|mesh-list
83546615|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546616|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546617|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83546618|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546619|NCT00004047|Exatecan|exatecan|mesh-list
83546620|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546621|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546622|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546623|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546624|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546625|NCT00003627|Fluorouracil|fluorouracil|mesh-list
83546626|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546627|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
83546628|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546629|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546630|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546631|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
83546632|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546633|NCT00004059|Fluorouracil|fluorouracil|mesh-list
83546634|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83546635|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
83546636|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546637|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546638|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546639|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546640|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
83546641|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546642|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83546643|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546644|NCT00003633|Prednisone|prednisone|mesh-list
83546645|NCT00003633|Docetaxel|docetaxel|mesh-list
83546646|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
83546647|NCT00003633|Estramustine|estramustine|mesh-list
83546648|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546649|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546650|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546651|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546652|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546653|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546654|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
83546655|NCT00003633|Hormones|hormones|mesh-ancestor
83546656|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546657|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546658|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546659|NCT00003633|Analgesics|analgesics|mesh-ancestor
83546660|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
83546661|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546662|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546663|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546664|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546665|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546666|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
83546667|NCT00003639|Interferons|interferons|mesh-list
83546668|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
83546669|NCT00003639|Dexamethasone|dexamethasone|mesh-list
83546670|NCT00003639|Idarubicin|idarubicin|mesh-list
83546671|NCT00003639|Chlorambucil|chlorambucil|mesh-list
83546672|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546673|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
83546674|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
83546675|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546676|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546677|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83546678|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
83546679|NCT00003639|Hormones|hormones|mesh-ancestor
83546680|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546681|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546682|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546683|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
83546684|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546685|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
83546686|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546687|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546688|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546689|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546690|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546691|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546692|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
83546693|NCT00004923|Docetaxel|docetaxel|mesh-list
83546694|NCT00004923|Irinotecan|irinotecan|mesh-list
83546695|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546696|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546697|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546698|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546699|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546700|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546701|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546702|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546703|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
83546704|NCT02317783|Flutemetamol|flutemetamol|mesh-list
83546705|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
83546706|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546707|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
83546708|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546709|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83546710|NCT00004071|Prednisone|prednisone|mesh-list
83546711|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
83546712|NCT00004071|Leflunomide|leflunomide|mesh-list
83546713|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546714|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
83546715|NCT00004071|Hormones|hormones|mesh-ancestor
83546716|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546717|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546718|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546719|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546720|NCT00004071|Analgesics|analgesics|mesh-ancestor
83546721|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
83546722|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546723|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546724|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546725|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546726|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546727|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546728|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
83546729|NCT00004077|Paclitaxel|paclitaxel|mesh-list
83546730|NCT00004077|Ifosfamide|ifosfamide|mesh-list
83546731|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546732|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546733|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546734|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546735|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546736|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546737|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546738|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
83546739|NCT00004083|Cisplatin|cisplatin|mesh-list
83546740|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546741|NCT00004941|Infliximab|infliximab|mesh-list
83546742|NCT00004941|Antibodies|antibodies|mesh-list
83546743|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83546744|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
83546745|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546746|NCT00004941|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83546747|NCT00004941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546748|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
83546749|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83546750|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546751|NCT00003657|Carboplatin|carboplatin|mesh-list
83546752|NCT00003657|Etoposide|etoposide|mesh-list
83546753|NCT00003657|Ifosfamide|ifosfamide|mesh-list
83546754|NCT00003657|Amifostine|amifostine|mesh-list
83546755|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546756|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546757|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546758|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546759|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546760|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546761|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546762|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546763|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
83546764|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83546765|NCT00003657|Protective Agents|protective agents|mesh-ancestor
83546766|NCT00004089|Paclitaxel|paclitaxel|mesh-list
83546767|NCT00004089|Fluorouracil|fluorouracil|mesh-list
83546768|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
83546769|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546770|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546771|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546772|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546773|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546774|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546775|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
83546776|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546777|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546778|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
83546779|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546780|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
83546781|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546782|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83546783|NCT00004095|Gemcitabine|gemcitabine|mesh-list
83546784|NCT00004095|Irinotecan|irinotecan|mesh-list
83546785|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83546786|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
83546787|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546788|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546789|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546790|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546791|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546792|NCT00003663|Dexamethasone|dexamethasone|mesh-list
83546793|NCT00003663|Rituximab|rituximab|mesh-list
83546794|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546795|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546796|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
83546797|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546798|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546799|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546800|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
83546801|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
83546802|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546804|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
83546805|NCT00003663|Hormones|hormones|mesh-ancestor
83546806|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546807|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546808|NCT00004107|Epratuzumab|epratuzumab|mesh-list
83546809|NCT00004107|Antibodies|antibodies|mesh-list
83546810|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83546811|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
83546812|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546813|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546814|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546815|NCT00004113|Temozolomide|temozolomide|mesh-list
83546816|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546817|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
83546818|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546819|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546820|NCT00003675|Topotecan|topotecan|mesh-list
83546821|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546822|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546823|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546824|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546825|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546826|NCT00004137|Paclitaxel|paclitaxel|mesh-list
83546827|NCT00004137|Carboplatin|carboplatin|mesh-list
83546828|NCT00004137|Topotecan|topotecan|mesh-list
83546829|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546830|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546831|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546832|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546833|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546834|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546835|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83546836|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546837|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546838|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
83546839|NCT00003681|Amifostine|amifostine|mesh-list
83546840|NCT00003681|Hematinics|hematinics|mesh-ancestor
83546841|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83546842|NCT00003681|Protective Agents|protective agents|mesh-ancestor
83546843|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546844|NCT00005007|Etanercept|etanercept|mesh-list
83546845|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83546846|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83546847|NCT00005007|Analgesics|analgesics|mesh-ancestor
83546848|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
83546849|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546850|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546851|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546852|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546853|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83546854|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546855|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
83546856|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
83546857|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83546858|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83546859|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546860|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
83546861|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83546862|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546863|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
83546864|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546865|NCT00384657|Iron|iron|mesh-list
83546866|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83546867|NCT00384657|Trace Elements|trace elements|mesh-ancestor
83546868|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
83546869|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546870|NCT00384657|Hematinics|hematinics|mesh-ancestor
83546871|NCT00005013|Sertraline|sertraline|mesh-list
83546872|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
83546873|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83546874|NCT00005013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83005004|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546875|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83546876|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83546877|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546878|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83546879|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
83546880|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546881|NCT00004161|Fenretinide|fenretinide|mesh-list
83546882|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546883|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83546884|NCT00004161|Protective Agents|protective agents|mesh-ancestor
83546885|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546886|NCT00004173|Paclitaxel|paclitaxel|mesh-list
83546887|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
83546888|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546889|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546890|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546891|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546892|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546893|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546894|NCT00005025|Ganciclovir|ganciclovir|mesh-list
83546895|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83546896|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
83546897|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83546898|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83546899|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546900|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546901|NCT00004179|Prednisone|prednisone|mesh-list
83546902|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
83546903|NCT00004179|Rituximab|rituximab|mesh-list
83546904|NCT00004179|Doxorubicin|doxorubicin|mesh-list
83546905|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83546906|NCT00004179|Vincristine|vincristine|mesh-list
83546907|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546908|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
83546909|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546910|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546911|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546912|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
83546913|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546914|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546915|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546916|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83546917|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546918|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546919|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546920|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546921|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546922|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
83546923|NCT00004179|Hormones|hormones|mesh-ancestor
83546924|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546925|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546926|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546927|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546928|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546929|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546930|NCT00003687|Morphine|morphine|mesh-list
83546931|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
83546932|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83546933|NCT00003687|Narcotics|narcotics|mesh-ancestor
83546934|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83546935|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546936|NCT00003687|Analgesics|analgesics|mesh-ancestor
83546937|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
83546938|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546939|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
83546940|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
83546941|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83546942|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83546943|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83546944|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546945|NCT00004197|Prednisone|prednisone|mesh-list
83546946|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
83546947|NCT00004197|Doxorubicin|doxorubicin|mesh-list
83546948|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83546949|NCT00004197|Vincristine|vincristine|mesh-list
83546950|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
83546951|NCT00004197|Sargramostim|sargramostim|mesh-list
83546952|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83546954|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83546955|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
83546956|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83546957|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83546958|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546959|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
83546960|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546961|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546962|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83546963|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83546964|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83546965|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83546966|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83546967|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83546968|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
83546969|NCT00004197|Hormones|hormones|mesh-ancestor
83546970|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83546971|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83546972|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83546973|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546974|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546975|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546976|NCT00004197|Analgesics|analgesics|mesh-ancestor
83546977|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
83546978|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83546979|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83546980|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
83546981|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546982|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
83546983|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
83546984|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
83546985|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546986|NCT00005031|Irofulven|irofulven|mesh-list
83546987|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546988|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
83546989|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546990|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546991|NCT00005037|Temozolomide|temozolomide|mesh-list
83546992|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83546993|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
83546994|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83546995|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546996|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
83546997|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83546998|NCT00004209|Mitomycins|mitomycins|mesh-list
83546999|NCT00004209|Mitomycin|mitomycin|mesh-list
83547000|NCT00004209|Vinblastine|vinblastine|mesh-list
83547001|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547002|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547003|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
83547004|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547005|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547006|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547007|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547008|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83547009|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83547010|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83547011|NCT00005049|Carboplatin|carboplatin|mesh-list
83547012|NCT00005049|Floxuridine|floxuridine|mesh-list
83547013|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547014|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547015|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
83547016|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547017|NCT00004215|Cytarabine|cytarabine|mesh-list
83547018|NCT00004215|Daunorubicin|daunorubicin|mesh-list
83547019|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547020|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
83547021|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547022|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547023|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
83547024|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005153|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83547025|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547026|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
83547027|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547028|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547029|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547030|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547031|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547033|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
83547034|NCT00004221|Carboplatin|carboplatin|mesh-list
83547035|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83547036|NCT00004221|Topotecan|topotecan|mesh-list
83547037|NCT00004221|Lenograstim|lenograstim|mesh-list
83547038|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547039|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547040|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
83547041|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
83547042|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
83547043|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547044|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547045|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
83547046|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547047|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547048|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547049|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
83547050|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83547051|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83547052|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547053|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547054|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547055|NCT00003711|Irinotecan|irinotecan|mesh-list
83547056|NCT00003711|Pemetrexed|pemetrexed|mesh-list
83547057|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547058|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547059|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547060|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547061|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547062|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83547063|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547064|NCT00004227|Cetuximab|cetuximab|mesh-list
83547065|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547066|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547067|NCT00003621|Etoposide|etoposide|mesh-list
83547068|NCT00003621|Carmustine|carmustine|mesh-list
83547069|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547070|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547071|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547072|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547073|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547074|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547075|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547076|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
83547077|NCT00385359|Albuterol|albuterol|mesh-list
83547078|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83547079|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
83547080|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547081|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547082|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83547083|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
83547084|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
83547085|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83547086|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83547087|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83547088|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83547089|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
83547090|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83547091|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547092|NCT00004233|Leucovorin|leucovorin|mesh-list
83547093|NCT00004233|Fluorouracil|fluorouracil|mesh-list
83547094|NCT00004233|Calcium|calcium|mesh-list
83547095|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
83547096|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83547097|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547098|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
83547099|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547100|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547101|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547102|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547103|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
83547104|NCT00004233|Antidotes|antidotes|mesh-ancestor
83547105|NCT00004233|Protective Agents|protective agents|mesh-ancestor
83547106|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
83547107|NCT00004233|Vitamins|vitamins|mesh-ancestor
83547108|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
83547109|NCT00003717|Paclitaxel|paclitaxel|mesh-list
83547110|NCT00003717|Estramustine|estramustine|mesh-list
83547111|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547112|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547113|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83547114|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83547115|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83547116|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547117|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547118|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
83547119|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83547120|NCT00003723|Gemcitabine|gemcitabine|mesh-list
83547121|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547122|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
83547123|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547124|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547125|NCT00005061|Bevacizumab|bevacizumab|mesh-list
83547126|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547127|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547128|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83547129|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83547130|NCT00005061|Growth Substances|growth substances|mesh-ancestor
83547131|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547132|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
83547133|NCT00004245|Salicylates|salicylates|mesh-list
83547134|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
83547135|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83547136|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83547137|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83547138|NCT00004245|Analgesics|analgesics|mesh-ancestor
83547139|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
83547140|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547141|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547142|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83547143|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547144|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83547145|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547146|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547147|NCT00004251|Letrozole|letrozole|mesh-list
83547148|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547149|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83547150|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83547151|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547152|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547153|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83547154|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
83547155|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547156|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547157|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
83547158|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83547159|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83547160|NCT00003729|Cytarabine|cytarabine|mesh-list
83547161|NCT00003729|Fludarabine|fludarabine|mesh-list
83547162|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
83547163|NCT00003729|Idarubicin|idarubicin|mesh-list
83547164|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547165|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547166|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
83547167|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547168|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547169|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
83547170|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547171|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
83547172|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547173|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547174|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547175|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547176|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547177|NCT00004263|Cytarabine|cytarabine|mesh-list
83547178|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83547179|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547180|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
83547181|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547182|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547183|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
83547184|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547185|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547186|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
83547187|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547188|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83547189|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547190|NCT00003735|Topotecan|topotecan|mesh-list
83547191|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
83547192|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547193|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547194|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547195|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547196|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547197|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547198|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
83547199|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83547200|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547201|NCT00004275|Hormones|hormones|mesh-list
83547202|NCT00004275|Oxandrolone|oxandrolone|mesh-list
83547203|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547204|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547205|NCT00004275|Androgens|androgens|mesh-ancestor
83547206|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
83547207|NCT00003741|Antibodies|antibodies|mesh-list
83547208|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83547209|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
83547210|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547211|NCT00003747|Carboplatin|carboplatin|mesh-list
83547212|NCT00003747|Temozolomide|temozolomide|mesh-list
83547213|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547214|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547215|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
83547216|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547217|NCT00004311|Leuprolide|leuprolide|mesh-list
83547218|NCT00004311|Spironolactone|spironolactone|mesh-list
83547219|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83547220|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
83547221|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83547222|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547223|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83547224|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547225|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83547226|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
83547227|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547228|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83547229|NCT00004311|Diuretics|diuretics|mesh-ancestor
83547230|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
83547231|NCT00004317|Leucovorin|leucovorin|mesh-list
83547232|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
83547233|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
83547234|NCT00004317|Spiramycin|spiramycin|mesh-list
83547235|NCT00004317|Calcium|calcium|mesh-list
83547236|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
83547237|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83547238|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547239|NCT00004317|Antidotes|antidotes|mesh-ancestor
83547240|NCT00004317|Protective Agents|protective agents|mesh-ancestor
83547241|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
83547242|NCT00004317|Vitamins|vitamins|mesh-ancestor
83547243|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
83547244|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
83547245|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83547246|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83547247|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547248|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83547249|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547250|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547251|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83547252|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
83547253|NCT00005091|Exatecan|exatecan|mesh-list
83547254|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547255|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547256|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547257|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547258|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547259|NCT00004323|Cyclosporine|cyclosporine|mesh-list
83547260|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
83547261|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
83547262|NCT00004323|Methotrexate|methotrexate|mesh-list
83547263|NCT00004323|Cyclosporins|cyclosporins|mesh-list
83547264|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83547265|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547266|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
83547267|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547268|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547269|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547270|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
83547271|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547272|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547273|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83547274|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83547275|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
83547276|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83547277|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547278|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
83547279|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
83547280|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547281|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83547282|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547283|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
83547284|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547285|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83547286|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83547287|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
83547288|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
83547289|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547290|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83547291|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
83547292|NCT00004323|Hormones|hormones|mesh-ancestor
83547293|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547294|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83547295|NCT00004323|Protective Agents|protective agents|mesh-ancestor
83547296|NCT00003753|Dexamethasone|dexamethasone|mesh-list
83547297|NCT00003753|Irinotecan|irinotecan|mesh-list
83547298|NCT00003753|Floxuridine|floxuridine|mesh-list
83547299|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83547300|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
83547301|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
83547302|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547303|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547304|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83547305|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
83547306|NCT00003753|Hormones|hormones|mesh-ancestor
83547307|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547308|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83547309|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547310|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547311|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547312|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547313|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138216|NCT03595592|Pertuzumab|pertuzumab|mesh-list
83547314|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547315|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
83547316|NCT00003759|Valrubicin|valrubicin|mesh-list
83547317|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
83547318|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83547319|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
83547320|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547321|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547322|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547323|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547324|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547325|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547326|NCT00003765|Carmustine|carmustine|mesh-list
83547327|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83547328|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547329|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
83547330|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547331|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547332|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547333|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83547334|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83547335|NCT00003771|Norethindrone|norethindrone|mesh-list
83547336|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
83547337|NCT00003771|Estradiol|estradiol|mesh-list
83547338|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83547339|NCT00003771|Estrogens|estrogens|mesh-ancestor
83547340|NCT00003771|Hormones|hormones|mesh-ancestor
83547341|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547342|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547343|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83547344|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
83547345|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83547346|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83547347|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83547348|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83547349|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83547350|NCT00004359|Methoxsalen|methoxsalen|mesh-list
83547351|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83547352|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83547353|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
83547354|NCT00004401|Antibodies|antibodies|mesh-list
83547355|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
83547356|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83547357|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83547358|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
83547359|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547360|NCT00003783|Leucovorin|leucovorin|mesh-list
83547361|NCT00003783|Cytarabine|cytarabine|mesh-list
83547362|NCT00003783|Dexamethasone|dexamethasone|mesh-list
83547363|NCT00003783|Prednisone|prednisone|mesh-list
83547364|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
83547365|NCT00003783|Methotrexate|methotrexate|mesh-list
83547366|NCT00003783|Etoposide|etoposide|mesh-list
83547367|NCT00003783|Vincristine|vincristine|mesh-list
83547368|NCT00003783|Daunorubicin|daunorubicin|mesh-list
83547369|NCT00003783|Asparaginase|asparaginase|mesh-list
83547370|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
83547371|NCT00003783|Idarubicin|idarubicin|mesh-list
83547372|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
83547373|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547374|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
83547375|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547376|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547377|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547378|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
83547379|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547380|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547381|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83547382|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83547383|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
83547384|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
83547385|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547386|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83547387|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
83547388|NCT00003783|Hormones|hormones|mesh-ancestor
83547389|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547390|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83547391|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83547392|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
83547393|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83547394|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547395|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
83547396|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
83547397|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547398|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83547399|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547400|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547401|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547402|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547403|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
83547404|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547405|NCT00003783|Antidotes|antidotes|mesh-ancestor
83547406|NCT00003783|Protective Agents|protective agents|mesh-ancestor
83547407|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
83547408|NCT00003783|Vitamins|vitamins|mesh-ancestor
83547409|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
83547410|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
83547411|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
83547412|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
83547413|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547414|NCT00003789|Melphalan|melphalan|mesh-list
83547415|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547416|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
83547417|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547418|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547419|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83547420|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547421|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
83547422|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547423|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
83547424|NCT00004407|Antibodies|antibodies|mesh-list
83547425|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
83547426|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83547427|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83547428|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
83547429|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547430|NCT00004419|Mitogens|mitogens|mesh-list
83547431|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
83547432|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547433|NCT00004431|Baclofen|baclofen|mesh-list
83547434|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83547435|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547436|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83547437|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547438|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83547439|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
83547440|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
83547441|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83547442|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547443|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
83547444|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83547445|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
83547446|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547447|NCT00384969|Sorafenib|sorafenib|mesh-list
83547448|NCT00384969|Everolimus|everolimus|mesh-list
83547449|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547450|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83547451|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547452|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547453|NCT00384969|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83547454|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547455|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
83547456|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547457|NCT00385437|Mirtazapine|mirtazapine|mesh-list
83547458|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
83547459|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83547460|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83547461|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
83547462|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
83547463|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138218|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547464|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547465|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547466|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83547467|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83547468|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83547469|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83547470|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83547471|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83547472|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83547473|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83547474|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83547475|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
83547476|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83547477|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
83547478|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83547479|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
83547480|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547481|NCT00004467|Expectorants|expectorants|mesh-ancestor
83547482|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
83547483|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83547484|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
83547485|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547486|NCT00004467|Protective Agents|protective agents|mesh-ancestor
83547487|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547488|NCT00004467|Antidotes|antidotes|mesh-ancestor
83547489|NCT00004479|Midodrine|midodrine|mesh-list
83547490|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
83547491|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
83547492|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547493|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547494|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83547495|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83547496|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83547497|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83547498|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83547499|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83547500|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547501|NCT00004485|Cyclosporine|cyclosporine|mesh-list
83547502|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
83547503|NCT00004485|Fludarabine|fludarabine|mesh-list
83547504|NCT00004485|Cyclosporins|cyclosporins|mesh-list
83547505|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547506|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547507|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547508|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
83547509|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547510|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547511|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
83547512|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547513|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
83547514|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547515|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83547516|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547517|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83547518|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
83547519|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83547520|NCT00385125|Rituximab|rituximab|mesh-list
83547521|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83547522|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547523|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547524|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
83547525|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547526|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547527|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547528|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
83547529|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547530|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83547531|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83547532|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
83547533|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547534|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
83547535|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
83547536|NCT00004551|Nicotine|nicotine|mesh-list
83547537|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83547538|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
83547539|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547540|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547541|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83547542|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83547543|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
83547544|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83547545|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547546|NCT02678312|Enalapril|enalapril|mesh-list
83547547|NCT02678312|Enalaprilat|enalaprilat|mesh-list
83547548|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83547549|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83547550|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
83547551|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547552|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547553|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83547554|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83547555|NCT00003843|Irinotecan|irinotecan|mesh-list
83547556|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547557|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547558|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547559|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547560|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547561|NCT00003849|Rituximab|rituximab|mesh-list
83547562|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547563|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547564|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
83547565|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547566|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547567|NCT00004575|Miconazole|miconazole|mesh-list
83547568|NCT00004575|Bradykinin|bradykinin|mesh-list
83547569|NCT00004575|Kininogens|kininogens|mesh-list
83547570|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547571|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547572|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
83547573|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547574|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83547575|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83547576|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83547577|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
83547578|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547579|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547580|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83547581|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83547582|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
83547583|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83547584|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
83547585|NCT00004581|Ritonavir|ritonavir|mesh-list
83547586|NCT00004581|Lopinavir|lopinavir|mesh-list
83547587|NCT00004581|Nevirapine|nevirapine|mesh-list
83547588|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83547589|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83547590|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
83547591|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547592|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547593|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83547594|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83547595|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
83547596|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547597|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83547598|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83547599|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83547600|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547601|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83547602|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83547603|NCT00004257|Fluorouracil|fluorouracil|mesh-list
83547604|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
83547605|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
83547606|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547607|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547608|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547609|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547610|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
83547611|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547612|NCT00004647|Mexiletine|mexiletine|mesh-list
83547613|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83547614|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83547615|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83547616|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83547617|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547618|NCT02469116|Carboplatin|carboplatin|mesh-list
83547619|NCT02469116|Docetaxel|docetaxel|mesh-list
83547620|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547621|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
83547622|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
83547623|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
83547624|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547625|NCT00362960|Losartan|losartan|mesh-list
83547626|NCT00362960|Olmesartan|olmesartan|mesh-list
83547627|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83547628|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83547629|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83547630|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83547631|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83547632|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547633|NCT00003867|Capecitabine|capecitabine|mesh-list
83547634|NCT00003867|Irinotecan|irinotecan|mesh-list
83547635|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547636|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
83547637|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547638|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547639|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547640|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547641|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547642|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83547643|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83547644|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
83547645|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547646|NCT00363584|Capecitabine|capecitabine|mesh-list
83547647|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547648|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
83547649|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547650|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547651|NCT00003873|Fluorouracil|fluorouracil|mesh-list
83547652|NCT00003873|Eniluracil|eniluracil|mesh-list
83547653|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
83547654|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547655|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547656|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547657|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547658|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
83547659|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547660|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547661|NCT00363116|Daclizumab|daclizumab|mesh-list
83547662|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547663|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
83547664|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547665|NCT00004689|Clarithromycin|clarithromycin|mesh-list
83547666|NCT00004689|Rifampin|rifampin|mesh-list
83547667|NCT00004689|Ethambutol|ethambutol|mesh-list
83547668|NCT00004689|Streptomycin|streptomycin|mesh-list
83547669|NCT00004689|Thioacetazone|thioacetazone|mesh-list
83547670|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83547671|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547672|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83547673|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547674|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547675|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83547676|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83547677|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83547678|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
83547679|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
83547680|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547681|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83547682|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83547683|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83547684|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83547685|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83547686|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83547687|NCT00004695|Interleukin-2|interleukin-2|mesh-list
83547688|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547689|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83547690|NCT00004695|Analgesics|analgesics|mesh-ancestor
83547691|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
83547692|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547693|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547694|NCT02570984|Omalizumab|omalizumab|mesh-list
83547695|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83547696|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83547697|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
83547698|NCT00004731|Ubiquinone|ubiquinone|mesh-list
83547699|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
83547700|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
83547701|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547702|NCT00004731|Vitamins|vitamins|mesh-ancestor
83547703|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
83547704|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547706|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547707|NCT02472314|Bupivacaine|bupivacaine|mesh-list
83547708|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
83547709|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
83547710|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83547711|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547712|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
83547713|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547714|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83547715|NCT00004755|Allopurinol|allopurinol|mesh-list
83547716|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
83547717|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547718|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547719|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
83547720|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547721|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83547722|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
83547723|NCT00004755|Protective Agents|protective agents|mesh-ancestor
83547724|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547725|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83547726|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83547727|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547728|NCT00003897|Sargramostim|sargramostim|mesh-list
83547729|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
83547730|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547731|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
83547732|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547733|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83547734|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
83547735|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
83547736|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83547737|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
83547738|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547739|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547740|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
83547741|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547742|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
83547743|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547744|NCT00004785|Dexamethasone|dexamethasone|mesh-list
83547745|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
83547746|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83547747|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83547748|NCT00004785|Prednisolone|prednisolone|mesh-list
83547749|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
83547750|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83547751|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
83547752|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83547753|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
83547754|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
83547755|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547756|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547757|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83547758|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
83547759|NCT00004785|Hormones|hormones|mesh-ancestor
83547760|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547761|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83547762|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547763|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83547764|NCT00004785|Protective Agents|protective agents|mesh-ancestor
83547765|NCT00004815|Hormones|hormones|mesh-list
83547766|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547767|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547768|NCT02279823|Minoxidil|minoxidil|mesh-list
83547769|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83547770|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83547771|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
83547772|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
83547773|NCT04040361|Ramucirumab|ramucirumab|mesh-list
83547774|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547775|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547776|NCT04040361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83547777|NCT04040361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547778|NCT00386061|Rimonabant|rimonabant|mesh-list
83547779|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83547780|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83547781|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83547782|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83547783|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547784|NCT00386061|Hormones|hormones|mesh-ancestor
83547785|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547786|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547787|NCT00005571|Eculizumab|eculizumab|mesh-list
83547788|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83547789|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547790|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
83547791|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547792|NCT00005577|Gemcitabine|gemcitabine|mesh-list
83547793|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547794|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
83547795|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547796|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547797|NCT00005583|Doxorubicin|doxorubicin|mesh-list
83547798|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83547799|NCT00005583|Epirubicin|epirubicin|mesh-list
83547800|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547801|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547802|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547803|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547804|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547805|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547806|NCT00005589|Cytarabine|cytarabine|mesh-list
83547807|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
83547808|NCT00005589|Melphalan|melphalan|mesh-list
83547809|NCT00005589|Carmustine|carmustine|mesh-list
83547810|NCT00005589|Rituximab|rituximab|mesh-list
83547811|NCT00005589|Etoposide|etoposide|mesh-list
83547812|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547813|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
83547814|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547815|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547816|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547817|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
83547818|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547819|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547820|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83547821|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547822|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547823|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547824|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547825|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547826|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547827|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
83547828|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
83547829|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547830|NCT00005601|Cytarabine|cytarabine|mesh-list
83547831|NCT00005601|Dexamethasone|dexamethasone|mesh-list
83547832|NCT00005601|Rituximab|rituximab|mesh-list
83547833|NCT00005601|Sargramostim|sargramostim|mesh-list
83547834|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547835|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547836|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
83547837|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547838|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547839|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83547840|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
83547841|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
83547842|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83547843|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83547844|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
83547845|NCT00005601|Hormones|hormones|mesh-ancestor
83547846|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547847|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83547848|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547849|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
83547850|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547851|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
83547852|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547853|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547854|NCT00005607|Leucovorin|leucovorin|mesh-list
83547855|NCT00005607|Fluorouracil|fluorouracil|mesh-list
83547856|NCT00005607|Irinotecan|irinotecan|mesh-list
83547857|NCT00005607|Calcium|calcium|mesh-list
83547858|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
83547859|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83547860|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547861|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
83547862|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547863|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547864|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547865|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547866|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
83547867|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83547868|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547869|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547870|NCT00005607|Antidotes|antidotes|mesh-ancestor
83547871|NCT00005607|Protective Agents|protective agents|mesh-ancestor
83547872|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
83547873|NCT00005607|Vitamins|vitamins|mesh-ancestor
83547874|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
83547875|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
83547876|NCT00005613|Carmustine|carmustine|mesh-list
83547877|NCT00005613|Etoposide|etoposide|mesh-list
83547878|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547879|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
83547880|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547881|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547882|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547883|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
83547884|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547885|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547886|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83547887|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547888|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547889|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547890|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547891|NCT00005625|Trabectedin|trabectedin|mesh-list
83547892|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547893|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
83547894|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547895|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547896|NCT00005631|Rituximab|rituximab|mesh-list
83547897|NCT00005631|Carboplatin|carboplatin|mesh-list
83547898|NCT00005631|Etoposide|etoposide|mesh-list
83547899|NCT00005631|Ifosfamide|ifosfamide|mesh-list
83547900|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547901|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547902|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
83547903|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547904|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83547905|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547906|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547907|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547908|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547909|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547910|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547911|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
83547912|NCT00005637|Temozolomide|temozolomide|mesh-list
83547913|NCT00005637|Carmustine|carmustine|mesh-list
83547914|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83547915|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
83547916|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547917|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547918|NCT00005643|Doxorubicin|doxorubicin|mesh-list
83547919|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83547920|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547921|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547922|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547923|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547924|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547925|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547926|NCT00005649|Paclitaxel|paclitaxel|mesh-list
83547927|NCT00005649|Capecitabine|capecitabine|mesh-list
83547928|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547929|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547930|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
83547931|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
83547932|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
83547933|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547934|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547935|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
83547936|NCT00005673|Capravirine|capravirine|mesh-list
83547937|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83547938|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547939|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547940|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547941|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
83547942|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547943|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83547944|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83547945|NCT02247349|Nivolumab|nivolumab|mesh-list
83547946|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547947|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547948|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83547949|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547950|NCT03390673|Bevacizumab|bevacizumab|mesh-list
83547951|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83547952|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547953|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83547954|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83547955|NCT03390673|Growth Substances|growth substances|mesh-ancestor
83547956|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547957|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
83547958|NCT02974933|Pemetrexed|pemetrexed|mesh-list
83547959|NCT02974933|Apatinib|apatinib|mesh-list
83547960|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547961|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547962|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547963|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83547964|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83547965|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83547966|NCT00005769|Hormones|hormones|mesh-list
83547967|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83547968|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547969|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
83547970|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83547971|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83547972|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
83547973|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
83547974|NCT00005787|Sargramostim|sargramostim|mesh-list
83547975|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83547976|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
83547977|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547978|NCT00005787|Hematinics|hematinics|mesh-ancestor
83547979|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83547980|NCT00005787|Protective Agents|protective agents|mesh-ancestor
83547981|NCT00005793|Cytarabine|cytarabine|mesh-list
83547982|NCT00005793|Etoposide|etoposide|mesh-list
83547983|NCT00005793|Daunorubicin|daunorubicin|mesh-list
83547984|NCT00005793|Topotecan|topotecan|mesh-list
83547985|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83547986|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83547987|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83547988|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83547989|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83547990|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83547991|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83547992|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
83547993|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
83547994|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83547995|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83547996|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
83547997|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83547998|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83547999|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83548000|NCT00005799|Cyclosporine|cyclosporine|mesh-list
83548001|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
83548002|NCT00005799|Fludarabine|fludarabine|mesh-list
83548003|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
83548004|NCT00005799|Cyclosporins|cyclosporins|mesh-list
83548005|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548006|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83548007|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
83548008|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548009|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548010|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
83548011|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548012|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548013|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
83548014|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548015|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548016|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548017|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83548018|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83548019|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83548020|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
83548021|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83548023|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548024|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83548025|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548026|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548027|NCT00005811|Topotecan|topotecan|mesh-list
83548028|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83548029|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83548030|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548031|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548032|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548033|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
83548034|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83548035|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548036|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83548037|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548038|NCT01689987|Sirolimus|sirolimus|mesh-list
83548039|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
83548040|NCT01689987|Dexamethasone|dexamethasone|mesh-list
83548041|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
83548042|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
83548043|NCT01689987|Ichthammol|ichthammol|mesh-list
83548044|NCT01689987|BB 1101|bb 1101|mesh-list
83548045|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548046|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
83548047|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548048|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548049|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83548050|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
83548051|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548052|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548053|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83548054|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548055|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
83548056|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
83548057|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548058|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548059|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
83548060|NCT01689987|Hormones|hormones|mesh-ancestor
83548061|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548062|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83548063|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83548064|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548065|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83548066|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
83548067|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548068|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
83548069|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83548070|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83548071|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
83548072|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548073|NCT01680939|Ibuprofen|ibuprofen|mesh-list
83548074|NCT01680939|Morphine|morphine|mesh-list
83548075|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83548076|NCT01680939|Narcotics|narcotics|mesh-ancestor
83548077|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548078|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548079|NCT01680939|Analgesics|analgesics|mesh-ancestor
83548080|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
83548081|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548082|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83548083|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83548084|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548085|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548086|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83548087|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548088|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548089|NCT01689597|Morphine|morphine|mesh-list
83548090|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83548091|NCT01689597|Narcotics|narcotics|mesh-ancestor
83548092|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548093|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548094|NCT01689597|Analgesics|analgesics|mesh-ancestor
83548095|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
83548096|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548097|NCT02163733|Osimertinib|osimertinib|mesh-list
83548098|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548099|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83548100|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548101|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548102|NCT04823247|Interleukin-23|interleukin-23|mesh-list
83548103|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83548104|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83548105|NCT04823247|Growth Substances|growth substances|mesh-ancestor
83548106|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548107|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
83548108|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548109|NCT02483000|Biotin|biotin|mesh-list
83548110|NCT02483000|Cytarabine|cytarabine|mesh-list
83548111|NCT02483000|Etoposide|etoposide|mesh-list
83548112|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
83548113|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
83548114|NCT02483000|Melphalan|melphalan|mesh-list
83548115|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
83548116|NCT02483000|Carmustine|carmustine|mesh-list
83548117|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83548118|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83548119|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83548120|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548121|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83548122|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83548123|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548124|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548125|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83548126|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
83548127|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
83548128|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548129|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548130|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
83548131|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548132|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83548133|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
83548134|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83548135|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
83548136|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
83548137|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
83548138|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548139|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
83548140|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
83548141|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
83548142|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
83548143|NCT02483000|Vitamins|vitamins|mesh-ancestor
83548144|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
83548145|NCT02420210|Dexamethasone|dexamethasone|mesh-list
83548146|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83548147|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
83548148|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548149|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
83548150|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
83548151|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548152|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548153|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548154|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
83548155|NCT02420210|Hormones|hormones|mesh-ancestor
83548156|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548157|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83548158|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548159|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83548160|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
83548161|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548162|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83548164|NCT04829799|Lidocaine|lidocaine|mesh-list
83548165|NCT04829799|Phenylephrine|phenylephrine|mesh-list
83548166|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
83548167|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
83548168|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
83548169|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548170|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548171|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
83548172|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548173|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83548174|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83548175|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83548176|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548177|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548178|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83548179|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83548180|NCT04829799|Analgesics|analgesics|mesh-ancestor
83548181|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548182|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548183|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83548184|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548185|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83548186|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
83548187|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
83548188|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
83548189|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83548190|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
83548191|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83548192|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83548193|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83548194|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83548195|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
83548196|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548197|NCT04829799|Protective Agents|protective agents|mesh-ancestor
83548198|NCT01789333|Riboflavin|riboflavin|mesh-list
83548199|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83548200|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83548201|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
83548202|NCT01789333|Vitamins|vitamins|mesh-ancestor
83548203|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
83548204|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548205|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83548206|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548207|NCT02524106|Bococizumab|bococizumab|mesh-list
83548208|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83548209|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83548210|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
83548211|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548212|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83548213|NCT01761877|Sulindac|sulindac|mesh-list
83548214|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83548215|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83548216|NCT01761877|Analgesics|analgesics|mesh-ancestor
83548217|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
83548218|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548219|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548220|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548221|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548222|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548223|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83548224|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548225|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548226|NCT02488070|Edetic Acid|edetic acid|mesh-list
83548227|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83548228|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
83548229|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
83548230|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548231|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
83548232|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83548233|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83548234|NCT04116541|Trametinib|trametinib|mesh-list
83548235|NCT04116541|Dabrafenib|dabrafenib|mesh-list
83548237|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83548238|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548239|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548240|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
83548241|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83548242|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
83548243|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548244|NCT03306979|Expectorants|expectorants|mesh-ancestor
83548245|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
83548246|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83548247|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
83548248|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548249|NCT03306979|Protective Agents|protective agents|mesh-ancestor
83548250|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548251|NCT03306979|Antidotes|antidotes|mesh-ancestor
83548252|NCT00362869|Levofloxacin|levofloxacin|mesh-list
83548253|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83548254|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548255|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83548256|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83548257|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83548258|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548259|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548260|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548261|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83548262|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83548263|NCT03257215|Vitamin D|vitamin d|mesh-list
83548264|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
83548265|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
83548266|NCT03257215|Vitamins|vitamins|mesh-list
83548267|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
83548268|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548269|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83548270|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83548271|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
83548272|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83548273|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548274|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548275|NCT00588523|Temozolomide|temozolomide|mesh-list
83548276|NCT00588523|Busulfan|busulfan|mesh-list
83548277|NCT00588523|Thiotepa|thiotepa|mesh-list
83548278|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83548279|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
83548280|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548281|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548282|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548283|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
83548284|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548285|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83548286|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83548287|NCT02974387|Fluorometholone|fluorometholone|mesh-list
83548288|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83548289|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548290|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
83548291|NCT02974387|Hormones|hormones|mesh-ancestor
83548292|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548293|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548294|NCT00493831|Nicotine|nicotine|mesh-list
83548295|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83548296|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
83548297|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548298|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548299|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83548300|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83548301|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
83548302|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548303|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548304|NCT00430183|Docetaxel|docetaxel|mesh-list
83548305|NCT00430183|Leuprolide|leuprolide|mesh-list
83548306|NCT00430183|Goserelin|goserelin|mesh-list
83548307|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548308|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83548309|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83548310|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83548311|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548312|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83548313|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
83548314|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83548315|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548316|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83548317|NCT00362947|Parnaparin|parnaparin|mesh-list
83548318|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
83548319|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83548320|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83548321|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548322|NCT00363025|Daunorubicin|daunorubicin|mesh-list
83548323|NCT00363025|Idarubicin|idarubicin|mesh-list
83548324|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83548325|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548326|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83548327|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83548328|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548329|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548330|NCT02444143|Tacrolimus|tacrolimus|mesh-list
83548331|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548332|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
83548333|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548334|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83548335|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548336|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548337|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
83548338|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83548339|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548340|NCT03161431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83548341|NCT03161431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548342|NCT02445859|Cefuroxime|cefuroxime|mesh-list
83548343|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
83548344|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83548345|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548346|NCT02446483|Rabeprazole|rabeprazole|mesh-list
83548347|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83548348|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548349|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83548350|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548351|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548352|NCT00362635|Clevudine|clevudine|mesh-list
83548353|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
83548354|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548355|NCT04744753|Calcium|calcium|mesh-list
83548356|NCT04744753|Ionophores|ionophores|mesh-list
83548357|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
83548358|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83548359|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548360|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548361|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548362|NCT02420041|Triamcinolone|triamcinolone|mesh-list
83548363|NCT02420041|Lidocaine|lidocaine|mesh-list
83548364|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
83548365|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
83548366|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548367|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548368|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
83548369|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548370|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83548371|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83548372|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83548373|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548374|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548375|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548376|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
83548377|NCT02420041|Hormones|hormones|mesh-ancestor
83548378|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548379|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
83548380|NCT02421211|Ledipasvir|ledipasvir|mesh-list
83548381|NCT02421211|Simeprevir|simeprevir|mesh-list
83548382|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
83548383|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548384|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
83548385|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548386|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548388|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83548389|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
83548390|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548391|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
83548392|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548393|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
83548394|NCT03089905|Remifentanil|remifentanil|mesh-list
83548395|NCT03089905|Sevoflurane|sevoflurane|mesh-list
83548396|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83548397|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548398|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548399|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83548400|NCT03089905|Analgesics|analgesics|mesh-ancestor
83548401|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
83548402|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548403|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83548404|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83548405|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83548406|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
83548407|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548408|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548409|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83548410|NCT03089905|Narcotics|narcotics|mesh-ancestor
83548411|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83548412|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83548413|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
83548414|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
83548415|NCT02424968|Cyclosporine|cyclosporine|mesh-list
83548416|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
83548417|NCT02424968|Cyclosporins|cyclosporins|mesh-list
83548418|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
83548419|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83548420|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548421|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548422|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548423|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
83548424|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548425|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
83548426|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548427|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548428|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548429|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83548430|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83548431|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548432|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83548433|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
83548434|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83548435|NCT02424799|GSK2646264|gsk2646264|mesh-list
83548436|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83548437|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548438|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548439|NCT02492750|Dexamethasone|dexamethasone|mesh-list
83548440|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
83548441|NCT02492750|Lenalidomide|lenalidomide|mesh-list
83548442|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83548443|NCT02492750|Ichthammol|ichthammol|mesh-list
83548444|NCT02492750|BB 1101|bb 1101|mesh-list
83548445|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548446|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
83548447|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
83548448|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548449|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548450|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548451|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
83548452|NCT02492750|Hormones|hormones|mesh-ancestor
83548453|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548454|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83548455|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548456|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
83548457|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83548458|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83548459|NCT02492750|Growth Substances|growth substances|mesh-ancestor
83548460|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
83006574|NCT03690947|Ranibizumab|ranibizumab|mesh-list
83548461|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
83548462|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548463|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548464|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548465|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548466|NCT00363337|Aripiprazole|aripiprazole|mesh-list
83548467|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
83548468|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83548469|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83548470|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83548471|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548472|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548473|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
83548474|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
83548475|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548476|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548477|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83548478|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83548479|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
83548480|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83548481|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83548482|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83548483|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83548484|NCT02493452|Plecanatide|plecanatide|mesh-list
83548485|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83548486|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
83548487|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548488|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548489|NCT02429869|Everolimus|everolimus|mesh-list
83548490|NCT02429869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83548491|NCT02429869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83548492|NCT02429869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548493|NCT02429869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548494|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548495|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
83548496|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548497|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548498|NCT02428478|Desipramine|desipramine|mesh-list
83548499|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83548500|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
83548501|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83548502|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548503|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548504|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83548505|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83548506|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548507|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
83548508|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548509|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548510|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
83548511|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
83548512|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
83548513|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83548514|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83548515|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548516|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548517|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548518|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548519|NCT02432287|Metformin|metformin|mesh-list
83548520|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83548521|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548522|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
83548523|NCT02532998|Eplerenone|eplerenone|mesh-list
83548524|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83548525|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
83548526|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548527|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548528|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83548529|NCT02532998|Diuretics|diuretics|mesh-ancestor
83548530|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
83548531|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83548532|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548533|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
83548534|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
83548535|NCT02453581|Artefenomel|artefenomel|mesh-list
83548536|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
83548537|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83548538|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83548539|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548541|NCT02533466|Fluorides|fluorides|mesh-list
83548542|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
83548543|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
83548544|NCT02533466|Protective Agents|protective agents|mesh-ancestor
83548545|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548546|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83548547|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548548|NCT02974244|Exenatide|exenatide|mesh-list
83548549|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83548550|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548551|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83548552|NCT02974244|Incretins|incretins|mesh-ancestor
83548553|NCT02974244|Hormones|hormones|mesh-ancestor
83548554|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548555|NCT02436031|Desipramine|desipramine|mesh-list
83548556|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83548557|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
83548558|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83548559|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548560|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548561|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83548562|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83548563|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548564|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
83548565|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548566|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548567|NCT02454283|Vanoxerine|vanoxerine|mesh-list
83548568|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83548569|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83548570|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548571|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548572|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
83548573|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548574|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548575|NCT02437669|Hydromorphone|hydromorphone|mesh-list
83548576|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83548577|NCT02437669|Narcotics|narcotics|mesh-ancestor
83548578|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548579|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548580|NCT02437669|Analgesics|analgesics|mesh-ancestor
83548581|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
83548582|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548583|NCT02430818|Ketamine|ketamine|mesh-list
83548584|NCT02430818|Morphine|morphine|mesh-list
83548585|NCT02430818|Analgesics|analgesics|mesh-ancestor
83548586|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
83548587|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548588|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548589|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83548590|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83548591|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
83548592|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
83548593|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548594|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83548595|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83548596|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548597|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548598|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83548599|NCT02430818|Narcotics|narcotics|mesh-ancestor
83548600|NCT02455453|Estradiol|estradiol|mesh-list
83548601|NCT02455453|Estrogens|estrogens|mesh-ancestor
83548602|NCT02455453|Hormones|hormones|mesh-ancestor
83548603|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548604|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548605|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83548606|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
83548607|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548608|NCT02519023|Acetaminophen|acetaminophen|mesh-list
83548609|NCT02519023|Ibuprofen|ibuprofen|mesh-list
83006738|NCT03214367|Insulin|insulin|mesh-list
83548610|NCT02519023|Epinephrine|epinephrine|mesh-list
83548611|NCT02519023|Oxycodone|oxycodone|mesh-list
83548612|NCT02519023|Bupivacaine|bupivacaine|mesh-list
83548613|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
83548614|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
83548615|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548616|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548617|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
83548618|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548619|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83548620|NCT02519023|Analgesics|analgesics|mesh-ancestor
83548621|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
83548622|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83548623|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548624|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548625|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83548626|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548627|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548628|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83548629|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83548630|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83548631|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548632|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83548633|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83548634|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
83548635|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83548636|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
83548637|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
83548638|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
83548639|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83548640|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83548641|NCT02519023|Narcotics|narcotics|mesh-ancestor
83548642|NCT02497040|Bupivacaine|bupivacaine|mesh-list
83548643|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
83548644|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
83548645|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
83548646|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548647|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548648|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
83548649|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548650|NCT02523235|Ropivacaine|ropivacaine|mesh-list
83548651|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
83548652|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
83548653|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548654|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548655|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
83548656|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548657|NCT02498522|Metformin|metformin|mesh-list
83548658|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83548659|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548660|NCT02919787|Irinotecan|irinotecan|mesh-list
83548661|NCT02919787|Fluorouracil|fluorouracil|mesh-list
83548662|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
83548663|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83548664|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83548665|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548666|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548667|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548668|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
83548669|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83548670|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548671|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
83548672|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548673|NCT02459275|Metoclopramide|metoclopramide|mesh-list
83548674|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
83548675|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
83548676|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548677|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548678|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548679|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83548680|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83548681|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
83548682|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548683|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548684|NCT02524561|Estradiol|estradiol|mesh-list
83548685|NCT02524561|Progesterone|progesterone|mesh-list
83548686|NCT02524561|Estrogens|estrogens|mesh-ancestor
83548687|NCT02524561|Hormones|hormones|mesh-ancestor
83548688|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548689|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548690|NCT02524561|Progestins|progestins|mesh-ancestor
83548691|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83548692|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
83548693|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
83548694|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548695|NCT04743739|Cyclosporine|cyclosporine|mesh-list
83548696|NCT04743739|Rituximab|rituximab|mesh-list
83548697|NCT04743739|Cyclosporins|cyclosporins|mesh-list
83548698|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83548699|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548700|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
83548701|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548702|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548703|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548704|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548705|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548706|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
83548707|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548708|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548709|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83548710|NCT02461693|Caffeine|caffeine|mesh-list
83548711|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83548712|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548713|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83548714|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548715|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548716|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83548717|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83548718|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
83548719|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548720|NCT02525653|Paclitaxel|paclitaxel|mesh-list
83548721|NCT02525653|Gemcitabine|gemcitabine|mesh-list
83548722|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83548723|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83548724|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548725|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
83548726|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
83548727|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
83548728|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548729|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83548730|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
83548731|NCT02431754|Tadalafil|tadalafil|mesh-list
83548732|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
83548733|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83548734|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83548735|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548736|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548737|NCT02431754|Urological Agents|urological agents|mesh-ancestor
83548738|NCT02500628|Metformin|metformin|mesh-list
83548739|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83548740|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548741|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
83548742|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83548743|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83548744|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548745|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
83548746|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548747|NCT02535806|Cytarabine|cytarabine|mesh-list
83548748|NCT02535806|Dexamethasone|dexamethasone|mesh-list
83548749|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
83548750|NCT02535806|Methotrexate|methotrexate|mesh-list
83548751|NCT02535806|Vincristine|vincristine|mesh-list
83548752|NCT02535806|Bortezomib|bortezomib|mesh-list
83548753|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
83548754|NCT02535806|Pegaspargase|pegaspargase|mesh-list
83548755|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548756|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
83548757|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
83548758|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548759|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548760|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548761|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
83548762|NCT02535806|Hormones|hormones|mesh-ancestor
83548763|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548764|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83548765|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548766|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83548767|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
83548768|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83548769|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83548770|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
83548771|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548772|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548773|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548774|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83548775|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548776|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
83548777|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548778|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83548779|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
83548780|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548781|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83548782|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
83548783|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
83548784|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
83548785|NCT02535806|Analgesics|analgesics|mesh-ancestor
83548786|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
83548787|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83548788|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83548789|NCT02536040|Fluorides|fluorides|mesh-list
83548790|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
83548791|NCT02536040|Protective Agents|protective agents|mesh-ancestor
83548792|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548793|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
83548794|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
83548795|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83548796|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548797|NCT02537444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83548798|NCT02537444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548799|NCT02464033|Vitamin D|vitamin d|mesh-list
83548800|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
83548801|NCT02464033|Etanercept|etanercept|mesh-list
83548802|NCT02464033|Vitamins|vitamins|mesh-ancestor
83548803|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
83548804|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548805|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83548806|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83548807|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83548808|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83548809|NCT02464033|Analgesics|analgesics|mesh-ancestor
83548810|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
83548811|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548812|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548813|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548814|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548815|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548816|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
83548817|NCT02432456|Acetaminophen|acetaminophen|mesh-list
83548818|NCT02432456|Ibuprofen|ibuprofen|mesh-list
83548819|NCT02432456|Ketamine|ketamine|mesh-list
83548820|NCT02432456|Narcotics|narcotics|mesh-list
83548821|NCT02432456|Methocarbamol|methocarbamol|mesh-list
83548822|NCT02432456|Pantoprazole|pantoprazole|mesh-list
83548823|NCT02432456|Analgesics|analgesics|mesh-ancestor
83548824|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
83548825|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548826|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548827|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83548828|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83548829|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
83548830|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
83548831|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548832|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83548833|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83548834|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548835|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548836|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83548837|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
83548838|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83006956|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83548839|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548840|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83548841|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83548842|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548843|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83548844|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548845|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83548846|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83548847|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83548848|NCT02531971|Fentanyl|fentanyl|mesh-list
83548849|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83548850|NCT02531971|Narcotics|narcotics|mesh-ancestor
83548851|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548852|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548853|NCT02531971|Analgesics|analgesics|mesh-ancestor
83548854|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
83548855|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548856|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83548857|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83548858|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
83548859|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
83548860|NCT02464657|Cytarabine|cytarabine|mesh-list
83548861|NCT02464657|Dexamethasone|dexamethasone|mesh-list
83548862|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
83548863|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83548864|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83548865|NCT02464657|Prednisolone|prednisolone|mesh-list
83548866|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
83548867|NCT02464657|Nivolumab|nivolumab|mesh-list
83548868|NCT02464657|Idarubicin|idarubicin|mesh-list
83548869|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83548870|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
83548871|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83548872|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
83548873|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
83548874|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83548875|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548876|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548877|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
83548878|NCT02464657|Hormones|hormones|mesh-ancestor
83548879|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83548880|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83548881|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548882|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83548883|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83548884|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548885|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83548886|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
83548887|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
83548888|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548889|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83548890|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
83548891|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83548892|NCT02464657|Protective Agents|protective agents|mesh-ancestor
83548893|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83548894|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83548895|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83548896|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548897|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
83548898|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83548899|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83548900|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548901|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
83548902|NCT02535949|Coagulants|coagulants|mesh-ancestor
83548903|NCT02536105|Methylphenidate|methylphenidate|mesh-list
83548904|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83548905|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548906|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83548907|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83548908|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83548909|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548910|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
83548911|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548912|NCT02758951|Bevacizumab|bevacizumab|mesh-list
83548913|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83548914|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548915|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83548916|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83548917|NCT02758951|Growth Substances|growth substances|mesh-ancestor
83548918|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548919|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
83548920|NCT02436668|Paclitaxel|paclitaxel|mesh-list
83548921|NCT02436668|Gemcitabine|gemcitabine|mesh-list
83548922|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83548923|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83548924|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83548925|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83548926|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83548927|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548928|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83548929|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
83548930|NCT02503982|Valganciclovir|valganciclovir|mesh-list
83548931|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
83548932|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548933|NCT02438540|Metformin|metformin|mesh-list
83548934|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83548935|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548936|NCT02506634|Esomeprazole|esomeprazole|mesh-list
83548937|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83548938|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83548939|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83548940|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83548941|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548942|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
83548943|NCT02506868|Hematinics|hematinics|mesh-ancestor
83548944|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
83548945|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83548946|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
83548947|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548948|NCT02541422|Expectorants|expectorants|mesh-ancestor
83548949|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
83548950|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83548951|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
83548952|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548953|NCT02541422|Protective Agents|protective agents|mesh-ancestor
83548954|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548955|NCT02541422|Antidotes|antidotes|mesh-ancestor
83548956|NCT02439164|Midazolam|midazolam|mesh-list
83548957|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83548958|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83548959|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548960|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548961|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83548962|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83548963|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83548964|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83548965|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
83548966|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
83548967|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
83548968|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
83548969|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83548970|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548971|NCT02440178|Micafungin|micafungin|mesh-list
83548972|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
83548973|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548974|NCT05078606|Anesthetics|anesthetics|mesh-list
83548975|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83548976|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548977|NCT02546570|Oxytocin|oxytocin|mesh-list
83548978|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
83548979|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83548980|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83548981|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
83548982|NCT02548910|Citric Acid|citric acid|mesh-list
83548983|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
83548984|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83548985|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
83548986|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
83548987|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83548988|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
83548989|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83548990|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83548991|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83548992|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
83548993|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
83548994|NCT02538679|Epinephrine|epinephrine|mesh-list
83548995|NCT02538679|Racepinephrine|racepinephrine|mesh-list
83548996|NCT02538679|Bupivacaine|bupivacaine|mesh-list
83548997|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
83548998|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
83548999|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
83549000|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549001|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549002|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
83549003|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549004|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83549005|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83549006|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
83549007|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549008|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549009|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83549010|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83549011|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
83549012|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83549013|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
83549014|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
83549015|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
83549016|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83549017|NCT02511236|Nicotine|nicotine|mesh-list
83549018|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83549019|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
83549020|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549021|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549022|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83549023|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83549024|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
83549025|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549026|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549027|NCT02551094|Colchicine|colchicine|mesh-list
83549028|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
83549029|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549030|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549031|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549032|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549033|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549034|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549035|NCT02513498|Ixazomib|ixazomib|mesh-list
83549036|NCT02513498|Glycine|glycine|mesh-list
83549037|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549038|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549039|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
83549040|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549041|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
83549042|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549043|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549044|NCT04787354|Capecitabine|capecitabine|mesh-list
83549045|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
83549046|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83549047|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
83549048|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549049|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549050|NCT02514044|Adderall|adderall|mesh-list
83549051|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
83549052|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83549053|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549054|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83549055|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83549056|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83549057|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549058|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
83549059|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549060|NCT02555228|Simethicone|simethicone|mesh-list
83549061|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
83549062|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549063|NCT02555228|Emollients|emollients|mesh-ancestor
83549064|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
83549065|NCT02556788|Trifarotene|trifarotene|mesh-list
83549066|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
83549067|NCT02516150|Ethanol|ethanol|mesh-list
83549068|NCT02516150|Glucagon|glucagon|mesh-list
83549069|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83549070|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549071|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549072|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549073|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83549075|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549076|NCT04025060|Caffeine|caffeine|mesh-list
83549077|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83549078|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549079|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83549080|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549081|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549082|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83549083|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83549084|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
83549085|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549086|NCT04631510|Gabapentin|gabapentin|mesh-list
83549087|NCT04631510|Analgesics|analgesics|mesh-ancestor
83549088|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
83549089|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549090|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549091|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
83549092|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83549093|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83549094|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549095|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83549096|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83549097|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83549098|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549099|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549100|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
83549101|NCT04542434|Niclosamide|niclosamide|mesh-list
83549102|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
83549103|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83549104|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
83549105|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83549106|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549107|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
83549108|NCT04186286|Propranolol|propranolol|mesh-list
83549109|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83549110|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83549111|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
83549112|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549113|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549114|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549115|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83549116|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83549117|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
83549118|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
83549119|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83549120|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83549121|NCT04341038|Prednisolone|prednisolone|mesh-list
83549122|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
83549123|NCT04341038|Tacrolimus|tacrolimus|mesh-list
83549124|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83549125|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
83549126|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83549127|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
83549128|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549129|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83549130|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549131|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549132|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549133|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
83549134|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
83549135|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549136|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83549137|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
83549138|NCT04341038|Hormones|hormones|mesh-ancestor
83549139|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549140|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83549141|NCT04341038|Protective Agents|protective agents|mesh-ancestor
83007262|NCT04485325|Etanercept|etanercept|mesh-list
83549142|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549143|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549144|NCT02561702|Mexiletine|mexiletine|mesh-list
83549145|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83549146|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83549147|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83549148|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83549149|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549150|NCT02563496|Chloroquine|chloroquine|mesh-list
83549151|NCT02563496|Tafenoquine|tafenoquine|mesh-list
83549152|NCT02563496|Amebicides|amebicides|mesh-ancestor
83549153|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83549154|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83549155|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549156|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
83549157|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549158|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83549159|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
83549160|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549161|NCT02568644|Ketoprofen|ketoprofen|mesh-list
83549162|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83549163|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83549164|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83549165|NCT02568644|Analgesics|analgesics|mesh-ancestor
83549166|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
83549167|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549168|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549169|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549170|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83549171|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549172|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549173|NCT02541409|Interferons|interferons|mesh-list
83549174|NCT02541409|Ribavirin|ribavirin|mesh-list
83549175|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
83549176|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
83549177|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83549178|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
83549179|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549180|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
83549181|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549182|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
83549183|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549184|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
83549185|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549186|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
83549187|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83549188|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83549189|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549190|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
83549191|NCT02569658|Coagulants|coagulants|mesh-ancestor
83549192|NCT02541565|Prednisone|prednisone|mesh-list
83549193|NCT02541565|Cortisone|cortisone|mesh-list
83549194|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
83549195|NCT02541565|Rituximab|rituximab|mesh-list
83549196|NCT02541565|Doxorubicin|doxorubicin|mesh-list
83549197|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83549198|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
83549199|NCT02541565|Vincristine|vincristine|mesh-list
83549200|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83549201|NCT02541565|Antibodies|antibodies|mesh-list
83549202|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
83549203|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83549204|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83549205|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
83549206|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549207|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549208|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83549209|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
83549210|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549211|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549212|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83549213|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83549214|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83549215|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83549216|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549217|NCT02541565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83549218|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549219|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
83007338|NCT03203447|Hormones|hormones|mesh-ancestor
83549220|NCT02541565|Hormones|hormones|mesh-ancestor
83549221|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549222|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549223|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83549224|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
83549225|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
83549226|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
83549227|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
83549228|NCT04707950|Oxytocin|oxytocin|mesh-list
83549229|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
83549230|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83549231|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549232|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83549233|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83549234|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549235|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
83549236|NCT04707950|Coagulants|coagulants|mesh-ancestor
83549237|NCT04044560|Blinatumomab|blinatumomab|mesh-list
83549238|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549239|NCT03807440|Empagliflozin|empagliflozin|mesh-list
83549240|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83549241|NCT03807440|Linagliptin|linagliptin|mesh-list
83549242|NCT03807440|Metformin|metformin|mesh-list
83549243|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83549244|NCT03807440|Glucagon|glucagon|mesh-list
83549245|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83549246|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549247|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83549248|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549249|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83549250|NCT03807440|Hormones|hormones|mesh-ancestor
83549251|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549252|NCT03807440|Incretins|incretins|mesh-ancestor
83549253|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
83549254|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549255|NCT03256916|Nelfinavir|nelfinavir|mesh-list
83549256|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83549257|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83549258|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
83549259|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549260|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549261|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83549262|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83549263|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
83549264|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549265|NCT02579876|Immunomodulating Agents|immunomodulating agents|mesh-list
83549266|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
83549267|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549268|NCT00364052|Valganciclovir|valganciclovir|mesh-list
83549269|NCT00364052|Ganciclovir|ganciclovir|mesh-list
83549270|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83549271|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
83549272|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549273|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83549274|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549275|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549276|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83549277|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
83549278|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83549279|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
83549280|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83549281|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549282|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83549283|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549284|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549285|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
83549286|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83549287|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549288|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83549289|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549290|NCT00364988|Pioglitazone|pioglitazone|mesh-list
83549291|NCT00364988|Losartan|losartan|mesh-list
83549292|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83549293|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549294|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83549295|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83549296|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83549297|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83549298|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549299|NCT00365222|Temozolomide|temozolomide|mesh-list
83549300|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83549301|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
83549302|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549303|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549304|NCT03119012|Aspirin|aspirin|mesh-list
83549305|NCT03119012|Clopidogrel|clopidogrel|mesh-list
83549306|NCT03119012|Ticagrelor|ticagrelor|mesh-list
83549307|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83549308|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83549309|NCT03119012|Analgesics|analgesics|mesh-ancestor
83549310|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
83549311|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549312|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549313|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549314|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549315|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83549316|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83549317|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549318|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83549319|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83549320|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549321|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
83549322|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83549323|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83549324|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83549325|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
83549326|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549327|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83549328|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
83549329|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
83549330|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83549331|NCT02791568|Hematinics|hematinics|mesh-ancestor
83549332|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83549333|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83549334|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83549335|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549336|NCT05248022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83549337|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549338|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
83549339|NCT05247554|Prednisone|prednisone|mesh-list
83549340|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549341|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
83549342|NCT05247554|Hormones|hormones|mesh-ancestor
83549343|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549344|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549345|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83549346|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549347|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
83549348|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83549349|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83549350|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549351|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549352|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549353|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549354|NCT02596022|Ketamine|ketamine|mesh-list
83549355|NCT02596022|Analgesics|analgesics|mesh-ancestor
83549356|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
83549357|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549358|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549359|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83549360|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83549361|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
83549362|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
83549363|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549364|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83549365|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83549366|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549367|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549368|NCT00364442|Fluticasone|fluticasone|mesh-list
83549369|NCT00364442|Xhance|xhance|mesh-list
83549370|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83549371|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549372|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83549373|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
83549374|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549375|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549376|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83549377|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
83549378|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
83549379|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83549380|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83549381|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83549382|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83549383|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83549384|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549385|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549386|NCT05371574|Clonidine|clonidine|mesh-list
83549387|NCT05371574|Analgesics|analgesics|mesh-ancestor
83549388|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
83549389|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549390|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549391|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83549392|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
83549393|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
83549394|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83549395|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83549396|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83549397|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
83549398|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549399|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549400|NCT05371340|Quercetin|quercetin|mesh-list
83549401|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
83549402|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549403|NCT05371340|Protective Agents|protective agents|mesh-ancestor
83549404|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549405|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
83549406|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83549407|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
83549408|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549409|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
83549410|NCT02601170|Protective Agents|protective agents|mesh-ancestor
83549411|NCT00366002|Darifenacin|darifenacin|mesh-list
83549412|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83549413|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83549414|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
83549415|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83549416|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549417|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549418|NCT00366002|Urological Agents|urological agents|mesh-ancestor
83549419|NCT00422240|Adapalene|adapalene|mesh-list
83549420|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83549421|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83549422|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
83549423|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83549424|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83549425|NCT00422240|Analgesics|analgesics|mesh-ancestor
83549426|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
83549427|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549428|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549429|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83549430|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549431|NCT02605304|Ribavirin|ribavirin|mesh-list
83549432|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
83549433|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83549434|NCT02605304|Ledipasvir|ledipasvir|mesh-list
83549435|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
83549436|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549437|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
83549438|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549439|NCT05365880|Lidocaine|lidocaine|mesh-list
83549440|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
83549441|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
83549442|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549443|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549444|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
83549445|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549446|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83549447|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83549448|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83549449|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83549450|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549451|NCT05362994|Sirolimus|sirolimus|mesh-list
83549452|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83549453|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549454|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83549455|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83549456|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
83549457|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83549458|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
83549459|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549460|NCT02607254|Pregabalin|pregabalin|mesh-list
83549461|NCT02607254|Analgesics|analgesics|mesh-ancestor
83549462|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
83549463|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549464|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549465|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
83549466|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83549467|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83549468|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549469|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83549470|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83549471|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83549472|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83549473|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83549474|NCT02611154|Testosterone|testosterone|mesh-list
83549475|NCT02611154|Androgens|androgens|mesh-ancestor
83549476|NCT02611154|Hormones|hormones|mesh-ancestor
83549477|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83549478|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549479|NCT02617784|Oseltamivir|oseltamivir|mesh-list
83549480|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
83549481|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549482|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549483|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549484|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83549485|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83549486|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549487|NCT00365612|Tenofovir|tenofovir|mesh-list
83549488|NCT00365612|Emtricitabine|emtricitabine|mesh-list
83549489|NCT00365612|Efavirenz|efavirenz|mesh-list
83549490|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
83549491|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83549492|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83549493|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83549494|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549495|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83549496|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83549497|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83549498|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83549499|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83549500|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83549501|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83549502|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83549503|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83549504|NCT02974166|Ibuprofen|ibuprofen|mesh-list
83549505|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83549506|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
83549507|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83549508|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83549509|NCT02974166|Analgesics|analgesics|mesh-ancestor
83549510|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
83549511|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83549512|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83549513|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83549514|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83549515|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83549516|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845106|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845107|NCT00147654|Tamsulosin|tamsulosin|mesh-list
83845108|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83845109|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83845110|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83845111|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83845112|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
83845113|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845114|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845115|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845116|NCT00147654|Urological Agents|urological agents|mesh-ancestor
83845117|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83845118|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83845119|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
83845120|NCT01246921|Fluticasone|fluticasone|mesh-list
83845121|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845122|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83845123|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
83845124|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845125|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845126|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83845127|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
83845128|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
83845129|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83845130|NCT04696939|Carboplatin|carboplatin|mesh-list
83845131|NCT04696939|Etoposide|etoposide|mesh-list
83845132|NCT04696939|Atezolizumab|atezolizumab|mesh-list
83845133|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845134|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83845135|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83845136|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83845137|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845138|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845139|NCT04696939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83845140|NCT04696939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845141|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83845142|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83845143|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83845144|NCT05560919|Protective Agents|protective agents|mesh-ancestor
83845145|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845146|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83845147|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
83845148|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845149|NCT05560919|Vitamins|vitamins|mesh-ancestor
83845150|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
83845151|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83845152|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
83845153|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83845154|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83845155|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83845156|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83845157|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845158|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
83845159|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845160|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845161|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83845162|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845163|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
83845164|NCT00503659|Miotics|miotics|mesh-ancestor
83845165|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
83845166|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845167|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845168|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83845169|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83845170|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
83845171|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83845172|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83845173|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
83845174|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845175|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845176|NCT04063163|Carboplatin|carboplatin|mesh-list
83845177|NCT04063163|Etoposide|etoposide|mesh-list
83845178|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845179|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83845180|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83845181|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83845182|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845183|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845184|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83845185|NCT00503815|Laxatives|laxatives|mesh-ancestor
83845186|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845187|NCT01247077|Selenium|selenium|mesh-list
83845188|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
83845189|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845190|NCT01247077|Protective Agents|protective agents|mesh-ancestor
83845191|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845192|NCT01247077|Trace Elements|trace elements|mesh-ancestor
83845193|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
83845194|NCT03990467|Tazobactam|tazobactam|mesh-list
83845195|NCT03990467|Piperacillin|piperacillin|mesh-list
83845196|NCT03990467|Amikacin|amikacin|mesh-list
83845197|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83845198|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845199|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83845200|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845201|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845202|NCT01247311|Vitamin D|vitamin d|mesh-list
83845203|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
83845204|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
83845205|NCT01247311|Vitamins|vitamins|mesh-list
83845206|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
83845207|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845208|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83845209|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83845210|NCT00147771|Imiquimod|imiquimod|mesh-list
83845211|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83845212|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
83845213|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845214|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845215|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
83845216|NCT00503932|Capecitabine|capecitabine|mesh-list
83845217|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83845218|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
83845219|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845220|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845221|NCT03981146|Nivolumab|nivolumab|mesh-list
83845222|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845223|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845224|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83845225|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845226|NCT01247857|Ropivacaine|ropivacaine|mesh-list
83845227|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
83845228|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
83845229|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83845230|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845231|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
83845232|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845233|NCT04331730|Aflibercept|aflibercept|mesh-list
83845234|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83845235|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83845236|NCT04331730|Growth Substances|growth substances|mesh-ancestor
83845237|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845238|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
83845239|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845240|NCT01248091|Nitroprusside|nitroprusside|mesh-list
83845241|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83845242|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
83845243|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83845244|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845245|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83845246|NCT00503971|Vorinostat|vorinostat|mesh-list
83845247|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845248|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83845249|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845250|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845251|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83845252|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83845253|NCT02274961|Pantoprazole|pantoprazole|mesh-list
83845254|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83845255|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845256|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83845257|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845258|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845259|NCT02275039|Gemcitabine|gemcitabine|mesh-list
83845260|NCT02275039|Vaccines|vaccines|mesh-list
83845261|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
83845262|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845263|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83845264|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
83845265|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845266|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845267|NCT04263051|Nivolumab|nivolumab|mesh-list
83845268|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845269|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845270|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83845271|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845272|NCT01248403|Paclitaxel|paclitaxel|mesh-list
83845273|NCT01248403|Everolimus|everolimus|mesh-list
83845274|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83845275|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845276|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
83845277|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
83845278|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83845279|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845280|NCT01248403|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83845281|NCT01248403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83845282|NCT01248403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845283|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845284|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
83845285|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845286|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
83845287|NCT01248442|Vitamin D|vitamin d|mesh-list
83845288|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83845289|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845290|NCT01248442|Vitamins|vitamins|mesh-ancestor
83845291|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
83845292|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83845293|NCT01248481|Acarbose|acarbose|mesh-list
83845294|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83845295|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845296|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845297|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83845298|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845299|NCT01249339|Lobeline|lobeline|mesh-list
83845300|NCT01249339|Nicotine|nicotine|mesh-list
83845301|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83845302|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
83845303|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845304|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845305|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83845306|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83845307|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
83845308|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845309|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845310|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
83845311|NCT03809429|Cetrorelix|cetrorelix|mesh-list
83845312|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83845313|NCT03809429|Hormones|hormones|mesh-ancestor
83845314|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845315|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845316|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83845317|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
83845318|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83845319|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
83845320|NCT00504127|Naproxen|naproxen|mesh-list
83845321|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
83845322|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845323|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845324|NCT00504127|Analgesics|analgesics|mesh-ancestor
83845325|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
83845326|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845327|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845328|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845329|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084212|NCT03492138|Dexamethasone|dexamethasone|mesh-list
83845330|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
83845331|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83845332|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845333|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845334|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83845335|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83845336|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83845337|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83845338|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845339|NCT00504205|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83845340|NCT00504205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83845341|NCT00504205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845342|NCT00504205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845343|NCT04085250|Nivolumab|nivolumab|mesh-list
83845344|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845345|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845346|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83845347|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845348|NCT01249690|Thalidomide|thalidomide|mesh-list
83845349|NCT01249690|Dexamethasone|dexamethasone|mesh-list
83845350|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
83845351|NCT01249690|Bortezomib|bortezomib|mesh-list
83845352|NCT01249690|Pirarubicin|pirarubicin|mesh-list
83845353|NCT01249690|Doxorubicin|doxorubicin|mesh-list
83845354|NCT01249690|BB 1101|bb 1101|mesh-list
83845355|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845356|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
83845357|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
83845358|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845359|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845360|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845361|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
83845362|NCT01249690|Hormones|hormones|mesh-ancestor
83845363|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845364|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83845365|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845366|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
83845367|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845368|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845369|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845370|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
83845371|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
83845372|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83845373|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845374|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83845375|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83845376|NCT01249690|Growth Substances|growth substances|mesh-ancestor
83845377|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
83845378|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83845379|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83845380|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83845381|NCT03712826|Ustekinumab|ustekinumab|mesh-list
83845382|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
83845383|NCT04071366|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83845384|NCT04071366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845385|NCT04071366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845386|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
83845387|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83845388|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83845389|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845390|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
83845391|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
83845392|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
83845393|NCT00504244|Azathioprine|azathioprine|mesh-list
83845394|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
83845395|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845396|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83845397|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845398|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845399|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
83845400|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845401|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845402|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83845403|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83845404|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
83845405|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83845406|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845407|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845408|NCT00405444|Fentanyl|fentanyl|mesh-list
83845409|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83845410|NCT00405444|Narcotics|narcotics|mesh-ancestor
83845411|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83845412|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845413|NCT00405444|Analgesics|analgesics|mesh-ancestor
83845414|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
83845415|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845416|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83845417|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83845418|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
83845419|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
83845420|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83845421|NCT00504283|Morphine|morphine|mesh-list
83845422|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83845423|NCT00504283|Narcotics|narcotics|mesh-ancestor
83845424|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83845425|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845426|NCT00504283|Analgesics|analgesics|mesh-ancestor
83845427|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
83845428|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845429|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845430|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845431|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845432|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845433|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83845434|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845435|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845436|NCT00504400|Ranibizumab|ranibizumab|mesh-list
83845437|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83845438|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83845439|NCT00504400|Growth Substances|growth substances|mesh-ancestor
83845440|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845441|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
83845442|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845443|NCT00504439|Simvastatin|simvastatin|mesh-list
83845444|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83845445|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83845446|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
83845447|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845448|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83845449|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83845450|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845451|NCT04054830|Diclofenac|diclofenac|mesh-list
83845452|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845453|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845454|NCT04054830|Analgesics|analgesics|mesh-ancestor
83845455|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
83845456|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845457|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845458|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845459|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845460|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83845461|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845462|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845463|NCT03622775|Daratumumab|daratumumab|mesh-list
83845464|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845465|NCT01249651|Esomeprazole|esomeprazole|mesh-list
83845466|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83845467|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845468|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83845469|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845470|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845471|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
83845472|NCT03999723|Vitamins|vitamins|mesh-ancestor
83845473|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
83845474|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845475|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
83845476|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845477|NCT03999723|Protective Agents|protective agents|mesh-ancestor
83845478|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
83845479|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83845480|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83845481|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83845482|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83845483|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845484|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
83845485|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845486|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845487|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83845488|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845489|NCT00403325|Ranibizumab|ranibizumab|mesh-list
83845490|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83845491|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83845492|NCT00403325|Growth Substances|growth substances|mesh-ancestor
83845493|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845494|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
83845495|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845496|NCT04725747|Midazolam|midazolam|mesh-list
83845497|NCT04725747|Ketamine|ketamine|mesh-list
83845498|NCT04725747|Analgesics|analgesics|mesh-ancestor
83845499|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
83845500|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845501|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845502|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83845503|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83845504|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
83845505|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
83845506|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83845507|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83845508|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83845509|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845510|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845511|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83845512|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83845513|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83845514|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83845515|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83845516|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
83845517|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
83845518|NCT03546686|Nivolumab|nivolumab|mesh-list
83845519|NCT03546686|Ipilimumab|ipilimumab|mesh-list
83845520|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845521|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845522|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83845523|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845524|NCT04725942|Posaconazole|posaconazole|mesh-list
83845525|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
83845526|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845527|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83845528|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83845529|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83845530|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83845531|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83845532|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845533|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845534|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83845535|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
83845536|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845537|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845538|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
83845539|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
83845540|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83845541|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83845542|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845543|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83845544|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845545|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83845546|NCT03890952|Bevacizumab|bevacizumab|mesh-list
83845547|NCT03890952|Nivolumab|nivolumab|mesh-list
83845548|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83845549|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845550|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845551|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83845552|NCT03890952|Growth Substances|growth substances|mesh-ancestor
83845553|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845554|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
83845555|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83845556|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845558|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
83845559|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845560|NCT03761511|Niacinamide|niacinamide|mesh-list
83845561|NCT03761511|Niacin|niacin|mesh-list
83845562|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
83845563|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
83845564|NCT03761511|Vitamins|vitamins|mesh-ancestor
83845565|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
83845566|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845567|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83845568|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
83845569|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845570|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83845571|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
83845572|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
83845573|NCT02952092|Hematinics|hematinics|mesh-ancestor
83845574|NCT00139152|Omalizumab|omalizumab|mesh-list
83845575|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83845576|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83845577|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
83845578|NCT02824523|Aspirin|aspirin|mesh-list
83845579|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845580|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845581|NCT02824523|Analgesics|analgesics|mesh-ancestor
83845582|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
83845583|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845584|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845585|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845586|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845587|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83845588|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83845589|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845590|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83845591|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83845592|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845593|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
83845594|NCT02736422|Xenon|xenon|mesh-list
83845595|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83845596|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
83845597|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
83845598|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83845599|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845600|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
83845601|NCT03721497|Testosterone|testosterone|mesh-list
83845602|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
83845603|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
83845604|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83845605|NCT03721497|Androgens|androgens|mesh-ancestor
83845606|NCT03721497|Hormones|hormones|mesh-ancestor
83845607|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845608|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845609|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83845610|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845611|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
83845612|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
83845613|NCT03682029|Vitamins|vitamins|mesh-ancestor
83845614|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
83845615|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845616|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
83845617|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845618|NCT03682029|Protective Agents|protective agents|mesh-ancestor
83845619|NCT00139230|Leucovorin|leucovorin|mesh-list
83845620|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
83845621|NCT00139230|Fluorouracil|fluorouracil|mesh-list
83845622|NCT00139230|Docetaxel|docetaxel|mesh-list
83845623|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845624|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
83845625|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845626|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83845627|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084512|NCT02199951|Artenimol|artenimol|mesh-list
83845628|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
83845629|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845630|NCT00139230|Antidotes|antidotes|mesh-ancestor
83845631|NCT00139230|Protective Agents|protective agents|mesh-ancestor
83845632|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
83845633|NCT00139230|Vitamins|vitamins|mesh-ancestor
83845634|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
83845635|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83845636|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83845637|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83845638|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83845639|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845640|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83845641|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83845642|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845643|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83845644|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83845645|NCT03648996|Allopurinol|allopurinol|mesh-list
83845646|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
83845647|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845648|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845649|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
83845650|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845651|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83845652|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
83845653|NCT03648996|Protective Agents|protective agents|mesh-ancestor
83845654|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845655|NCT02086175|Rituximab|rituximab|mesh-list
83845656|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845657|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845658|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
83845659|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845660|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845661|NCT00139269|Docetaxel|docetaxel|mesh-list
83845662|NCT00139269|Fluorouracil|fluorouracil|mesh-list
83845663|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845664|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
83845665|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
83845666|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
83845667|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845668|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
83845669|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83845670|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845671|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
83845672|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845673|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
83845674|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845675|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
83845676|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845677|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845678|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83845679|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
83845680|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845681|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845682|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83845683|NCT00403364|Amoxicillin|amoxicillin|mesh-list
83845684|NCT00403364|Clarithromycin|clarithromycin|mesh-list
83845685|NCT00403364|Tinidazole|tinidazole|mesh-list
83845686|NCT00403364|Pantoprazole|pantoprazole|mesh-list
83845687|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83845688|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845689|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83845690|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845691|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845692|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83845693|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83845694|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83845695|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845696|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83845697|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
83845698|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83845699|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83845700|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83845701|NCT00403442|Bevacizumab|bevacizumab|mesh-list
83845702|NCT00403442|Verteporfin|verteporfin|mesh-list
83845703|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83845704|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845705|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83845706|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83845707|NCT00403442|Growth Substances|growth substances|mesh-ancestor
83845708|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845709|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
83845710|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83845711|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
83845712|NCT00139386|Candesartan|candesartan|mesh-list
83845713|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83845714|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83845715|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83845716|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845717|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
83845719|NCT00402974|Menaquinone 7|menaquinone 7|mesh-list
83845720|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83845721|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83845722|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845723|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
83845724|NCT00402974|Coagulants|coagulants|mesh-ancestor
83845725|NCT00402974|Vitamins|vitamins|mesh-ancestor
83845726|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
83845727|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845728|NCT01731236|Aspirin|aspirin|mesh-list
83845729|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83845730|NCT01731236|Vancomycin|vancomycin|mesh-list
83845731|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
83845732|NCT01731236|Neomycin|neomycin|mesh-list
83845733|NCT01731236|Choline|choline|mesh-list
83845734|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845735|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845736|NCT01731236|Analgesics|analgesics|mesh-ancestor
83845737|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
83845738|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845739|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845740|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845741|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845742|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83845743|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83845744|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845745|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83845746|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83845747|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845748|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
83845749|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845750|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83845751|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83845752|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845753|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83845754|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83845755|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
83845756|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83845757|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
83845758|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845759|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83845760|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
83845761|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83845762|NCT03510078|Insulin|insulin|mesh-list
83845763|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83845764|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845765|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
83845766|NCT00139581|Tacrolimus|tacrolimus|mesh-list
83845767|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83845768|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83845769|NCT00139581|Analgesics|analgesics|mesh-ancestor
83845770|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
83845771|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845772|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845773|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845774|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845775|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
83845776|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845777|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
83845778|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83845779|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845780|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845781|NCT03500913|Hormones|hormones|mesh-list
83845782|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845783|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845784|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83845785|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845786|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83845787|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845788|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845789|NCT00130481|Atorvastatin|atorvastatin|mesh-list
83845790|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83845791|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83845792|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
83845793|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845794|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83845795|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83845796|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845797|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83845798|NCT00139698|Olmesartan|olmesartan|mesh-list
83845799|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83845800|NCT00139698|Diuretics|diuretics|mesh-ancestor
83845801|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
83845802|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845803|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83845804|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83845805|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845806|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83845807|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83845808|NCT00130676|Mifepristone|mifepristone|mesh-list
83845809|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83845810|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
83845811|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83845812|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845813|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83845814|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83845815|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83845816|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
83845817|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83845818|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83845819|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
83845820|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845821|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
83845822|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83845823|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83845824|NCT00404274|Casopitant|casopitant|mesh-list
83845825|NCT00404274|Warfarin|warfarin|mesh-list
83845826|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
83845827|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
83845828|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
83845829|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845830|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845831|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845832|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83845833|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845834|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845835|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
83845836|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
83845837|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845838|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845839|NCT00130871|Simendan|simendan|mesh-list
83845840|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83845841|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83845842|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83845843|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83845844|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845845|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845846|NCT00130871|Protective Agents|protective agents|mesh-ancestor
83845847|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845848|NCT00130910|Albendazole|albendazole|mesh-list
83845849|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
83845850|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83845851|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845852|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
83845853|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83845854|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83845855|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83845856|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83845857|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83845858|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845859|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845860|NCT03226821|Tesamorelin|tesamorelin|mesh-list
83845861|NCT03226821|Growth Substances|growth substances|mesh-ancestor
83845862|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845863|NCT00139815|Enoxaparin|enoxaparin|mesh-list
83845864|NCT00139815|PENTA|penta|mesh-list
83845865|NCT00139815|Fondaparinux|fondaparinux|mesh-list
83845866|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
83845867|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83845868|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83845869|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845870|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83845871|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
83845872|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83845873|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
83845874|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845875|NCT00131027|Cytarabine|cytarabine|mesh-list
83845876|NCT00131027|Dexamethasone|dexamethasone|mesh-list
83845877|NCT00131027|Prednisolone|prednisolone|mesh-list
83845878|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
83845879|NCT00131027|Doxorubicin|doxorubicin|mesh-list
83845880|NCT00131027|Methotrexate|methotrexate|mesh-list
83845881|NCT00131027|Etoposide|etoposide|mesh-list
83845882|NCT00131027|Vincristine|vincristine|mesh-list
83845883|NCT00131027|Daunorubicin|daunorubicin|mesh-list
83845884|NCT00131027|Asparaginase|asparaginase|mesh-list
83845885|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
83845886|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83845887|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
83845888|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845889|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83845890|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83845891|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
83845892|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845893|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845894|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83845895|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845896|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
83845897|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
83845898|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845899|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845900|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
83845901|NCT00131027|Hormones|hormones|mesh-ancestor
83845902|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845903|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83845904|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83845905|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83845906|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83845907|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845908|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83845909|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
83845910|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83845911|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83845912|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
83845913|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
83845914|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83845915|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83845916|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83845917|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
83845918|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845919|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
83845920|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
83845921|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
83845922|NCT00139854|Alprazolam|alprazolam|mesh-list
83845923|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83845924|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83845925|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845926|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83845927|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83845928|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83845929|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
83084812|NCT02203461|Ritonavir|ritonavir|mesh-list
83845930|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
83845931|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845932|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845933|NCT00131144|Octreotide|octreotide|mesh-list
83845934|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845935|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83845936|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845937|NCT00139893|Metoclopramide|metoclopramide|mesh-list
83845938|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
83845939|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
83845940|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845941|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845942|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845943|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83845944|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83845945|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
83845946|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845947|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845948|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
83845949|NCT00131183|Androgens|androgens|mesh-ancestor
83845950|NCT00131183|Hormones|hormones|mesh-ancestor
83845951|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845952|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845953|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
83845954|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83845955|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
83845956|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845957|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845958|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83845959|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
83845960|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83845961|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83845962|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83845963|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
83845964|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83845965|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845966|NCT00131261|Dexamethasone|dexamethasone|mesh-list
83845967|NCT00131261|Belinostat|belinostat|mesh-list
83845968|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83845969|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
83845970|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
83845971|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83845972|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845973|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83845974|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
83845975|NCT00131261|Hormones|hormones|mesh-ancestor
83845976|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83845977|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83845978|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845979|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83845980|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83845981|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845982|NCT00131300|Hylan|hylan|mesh-list
83845983|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
83845984|NCT00131300|Protective Agents|protective agents|mesh-ancestor
83845985|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83845986|NCT00131339|Cycloserine|cycloserine|mesh-list
83845987|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83845988|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83845989|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83845990|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
83845991|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83845992|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
83845993|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845994|NCT00139971|Gemcitabine|gemcitabine|mesh-list
83845995|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83845996|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
83845997|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83845998|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83845999|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
83846000|NCT00140010|Hematinics|hematinics|mesh-ancestor
83846001|NCT00131495|Testosterone|testosterone|mesh-list
83846002|NCT00131495|Androgens|androgens|mesh-ancestor
83846003|NCT00131495|Hormones|hormones|mesh-ancestor
83846004|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846005|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846006|NCT04726631|Insulin|insulin|mesh-list
83846007|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83846008|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
83846009|NCT04726631|Protamines|protamines|mesh-list
83846010|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83846011|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846012|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
83846013|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846014|NCT04726631|Coagulants|coagulants|mesh-ancestor
83846015|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
83846016|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846017|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
83846018|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846019|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846020|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83846021|NCT03117309|Nivolumab|nivolumab|mesh-list
83846022|NCT03117309|Ipilimumab|ipilimumab|mesh-list
83846023|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846024|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846025|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83846026|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846027|NCT00140166|Pyridoxine|pyridoxine|mesh-list
83846028|NCT00140166|Niacinamide|niacinamide|mesh-list
83846029|NCT00140166|Niacin|niacin|mesh-list
83846030|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
83846031|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
83846032|NCT00140166|Vitamins|vitamins|mesh-ancestor
83846033|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
83846034|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846035|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83846036|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
83846037|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846038|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83846039|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
83846040|NCT03095274|Durvalumab|durvalumab|mesh-list
83846041|NCT03095274|Tremelimumab|tremelimumab|mesh-list
83846042|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846043|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846044|NCT00131768|Hylan|hylan|mesh-list
83846045|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
83846046|NCT00131768|Protective Agents|protective agents|mesh-ancestor
83846047|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846048|NCT01248949|Paclitaxel|paclitaxel|mesh-list
83846049|NCT01248949|Bevacizumab|bevacizumab|mesh-list
83846050|NCT01248949|Carboplatin|carboplatin|mesh-list
83846051|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83846052|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846053|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
83846054|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
83846055|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
83846056|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846057|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846058|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83846059|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83846060|NCT01248949|Growth Substances|growth substances|mesh-ancestor
83846061|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846062|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
83846063|NCT00403637|Maleic acid|maleic acid|mesh-list
83846064|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846065|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846066|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
83846067|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83846068|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
83846069|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846070|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
83846071|NCT04696666|Protective Agents|protective agents|mesh-ancestor
83846072|NCT01248793|Golimumab|golimumab|mesh-list
83846073|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83846074|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83846075|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846076|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846077|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
83846078|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846079|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83846080|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83846081|NCT01248364|Empagliflozin|empagliflozin|mesh-list
83846082|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83846083|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084961|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83846084|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83846085|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846086|NCT00140361|Artesunate|artesunate|mesh-list
83846087|NCT00140361|Lumefantrine|lumefantrine|mesh-list
83846088|NCT00140361|Artemether|artemether|mesh-list
83846089|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
83846090|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
83846091|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83846092|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
83846093|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83846094|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83846095|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846096|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846097|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
83846098|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
83846099|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83846100|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
83846101|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83846102|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846103|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846104|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83846105|NCT00131846|Diuretics|diuretics|mesh-list
83846106|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83846107|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
83846108|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846109|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846110|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846111|NCT00131963|Paclitaxel|paclitaxel|mesh-list
83846112|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
83846113|NCT00131963|Doxorubicin|doxorubicin|mesh-list
83846114|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83846115|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846116|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83846117|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83846118|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83846119|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846120|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846121|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
83846122|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846123|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846124|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83846125|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
83846126|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83846127|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846128|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83846129|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846130|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846131|NCT00140400|Immunomodulating Agents|immunomodulating agents|mesh-list
83846132|NCT00140400|Immunologic Factors|immunologic factors|mesh-ancestor
83846133|NCT00140400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846134|NCT00132119|Nalmefene|nalmefene|mesh-list
83846135|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83846136|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846137|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
83846138|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846139|NCT00132158|Irinotecan|irinotecan|mesh-list
83846140|NCT00132158|Gefitinib|gefitinib|mesh-list
83846141|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83846142|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846143|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846144|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846145|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846146|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83846147|NCT00140478|Mifepristone|mifepristone|mesh-list
83846148|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83846149|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
83846150|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83846151|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846152|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83846153|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83846154|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83846155|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
83846156|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83085038|NCT05151510|Lidocaine|lidocaine|mesh-list
83846157|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83846158|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
83846159|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846160|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
83846161|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83846162|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83846163|NCT00140517|Chloroquine|chloroquine|mesh-list
83846164|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
83846165|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
83846166|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83846167|NCT00140517|Amebicides|amebicides|mesh-ancestor
83846168|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83846169|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83846170|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846171|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
83846172|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846173|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83846174|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846175|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846176|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83846177|NCT00132236|Nicotine|nicotine|mesh-list
83846178|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83846179|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
83846180|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846181|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846182|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83846183|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83846184|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
83846185|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846186|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846187|NCT00132275|Amoxicillin|amoxicillin|mesh-list
83846188|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
83846189|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
83846190|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83846191|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846192|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83846193|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846194|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846195|NCT01246999|Vaccines|vaccines|mesh-list
83846196|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
83846197|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846198|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
83846199|NCT00140595|Rituximab|rituximab|mesh-list
83846200|NCT00140595|Doxorubicin|doxorubicin|mesh-list
83846201|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846202|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
83846203|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846204|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846205|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83846206|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
83846207|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846208|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846209|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83846210|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846211|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846212|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83846213|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846214|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846215|NCT04696783|Esomeprazole|esomeprazole|mesh-list
83846216|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83846217|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83846218|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83846219|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846220|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846221|NCT00132431|Cinacalcet|cinacalcet|mesh-list
83846222|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83846223|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846224|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83846225|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
83846226|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846227|NCT00140712|Ropinirole|ropinirole|mesh-list
83846228|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83846229|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83846230|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
83846231|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
83846232|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148824|NCT04135781|Paclitaxel|paclitaxel|mesh-list
83846233|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846234|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846235|NCT00132548|Artesunate|artesunate|mesh-list
83846236|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
83846237|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
83846238|NCT00132548|Amodiaquine|amodiaquine|mesh-list
83846239|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83846240|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
83846241|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83846242|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83846243|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846244|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846245|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
83846246|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
83846247|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83846248|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
83846249|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83846250|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846251|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846252|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83846253|NCT00140751|Ritonavir|ritonavir|mesh-list
83846254|NCT00140751|Lopinavir|lopinavir|mesh-list
83846255|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83846256|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83846257|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
83846258|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846259|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846260|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83846261|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83846262|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
83846263|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846264|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83846265|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83846266|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83846267|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
83846268|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83846269|NCT00132587|Protective Agents|protective agents|mesh-ancestor
83846270|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846271|NCT00140790|Valsartan|valsartan|mesh-list
83846272|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83846273|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83846274|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83846275|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846276|NCT01245673|Lenalidomide|lenalidomide|mesh-list
83846277|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83846278|NCT01245673|Poly ICLC|poly iclc|mesh-list
83846279|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
83846280|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846281|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83846282|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83846283|NCT01245673|Growth Substances|growth substances|mesh-ancestor
83846284|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
83846285|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846286|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
83846287|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
83846288|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83846289|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83846290|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846291|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
83846292|NCT02261415|Coagulants|coagulants|mesh-ancestor
83846293|NCT00132743|Cilostazol|cilostazol|mesh-list
83846294|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83846295|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
83846296|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846297|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846298|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83846299|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
83846300|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83846301|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83846302|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846303|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83846304|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
83846305|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83846306|NCT00132743|Protective Agents|protective agents|mesh-ancestor
83085187|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83846307|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83846308|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83846309|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846310|NCT00132821|Bupropion|bupropion|mesh-list
83846311|NCT00132821|Nicotine|nicotine|mesh-list
83846312|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83846313|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
83846314|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846315|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846316|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83846317|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83846318|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
83846319|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846320|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846321|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83846322|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
83846323|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846324|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83846325|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83846326|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846327|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
83846328|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83846329|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83846330|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846331|NCT00132860|Azithromycin|azithromycin|mesh-list
83846332|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83846333|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846334|NCT01244815|Asenapine|asenapine|mesh-list
83846335|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83846336|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83846337|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846338|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846339|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846340|NCT00132899|Methotrexate|methotrexate|mesh-list
83846341|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83846342|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
83846343|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83846344|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846345|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83846346|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
83846347|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846348|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846349|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
83846350|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846351|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83846352|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846353|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
83846354|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846355|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83846356|NCT00140868|Phenobarbital|phenobarbital|mesh-list
83846357|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
83846358|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83846359|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846360|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846361|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83846362|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83846363|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846364|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846365|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
83846366|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
83846367|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83846368|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83846369|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83846370|NCT00132938|Telithromycin|telithromycin|mesh-list
83846371|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83846372|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846373|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
83846374|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
83846375|NCT02955706|Vitamins|vitamins|mesh-ancestor
83846376|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
83846377|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846378|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
83846379|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83846380|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
83846381|NCT01244425|Coagulants|coagulants|mesh-ancestor
83846382|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83846383|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83846384|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846385|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83846386|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83846387|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846388|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846389|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
83846390|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846391|NCT01154439|Cytarabine|cytarabine|mesh-list
83846392|NCT01154439|Etoposide|etoposide|mesh-list
83846393|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
83846394|NCT01154439|Idarubicin|idarubicin|mesh-list
83846395|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
83846396|NCT01154439|Everolimus|everolimus|mesh-list
83846397|NCT01154439|Ifosfamide|ifosfamide|mesh-list
83846398|NCT01154439|Carboplatin|carboplatin|mesh-list
83846399|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83846400|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846401|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83846402|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846403|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846404|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846405|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83846406|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
83846407|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
83846408|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846409|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846410|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
83846411|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846412|NCT01154439|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83846413|NCT01154439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83846414|NCT01154439|Analgesics|analgesics|mesh-ancestor
83846415|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
83846416|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846417|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846418|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83846419|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
83846420|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
83846421|NCT00133172|Prednisone|prednisone|mesh-list
83846422|NCT00133172|Tacrolimus|tacrolimus|mesh-list
83846423|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846424|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
83846425|NCT00133172|Hormones|hormones|mesh-ancestor
83846426|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846427|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846428|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83846429|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846430|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846431|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
83846432|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83846433|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846434|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846435|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846436|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83846437|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
83846438|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83846439|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846440|NCT00141141|Atorvastatin|atorvastatin|mesh-list
83846441|NCT00141141|Simvastatin|simvastatin|mesh-list
83846442|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83846443|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83846444|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
83846445|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846446|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83846447|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83846448|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846449|NCT00133250|Heparin|heparin|mesh-list
83846450|NCT00133250|Calcium heparin|calcium heparin|mesh-list
83846451|NCT00133250|Abciximab|abciximab|mesh-list
83846452|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
83846453|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83846454|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83846455|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846456|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83846457|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
83846458|NCT00144495|Hematinics|hematinics|mesh-ancestor
83846459|NCT00133328|Valsartan|valsartan|mesh-list
83846460|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83846461|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83846462|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83846463|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846464|NCT00133367|Sirolimus|sirolimus|mesh-list
83846465|NCT00133367|Fludarabine|fludarabine|mesh-list
83846466|NCT00133367|Melphalan|melphalan|mesh-list
83846467|NCT00133367|Tacrolimus|tacrolimus|mesh-list
83846468|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
83846469|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83846470|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846471|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846472|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846473|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
83846474|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846475|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83846476|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846477|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83846478|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846479|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846480|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
83846481|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83846482|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
83846483|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83846484|NCT00141258|Pregabalin|pregabalin|mesh-list
83846485|NCT00141258|Analgesics|analgesics|mesh-ancestor
83846486|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
83846487|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846488|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846489|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
83846490|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83846491|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846492|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846493|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83846494|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83846495|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83846496|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846497|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846498|NCT00403910|Canrenone|canrenone|mesh-list
83846499|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83846500|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
83846501|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846502|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846503|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83846504|NCT00403910|Diuretics|diuretics|mesh-ancestor
83846505|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
83846506|NCT00141336|Pregabalin|pregabalin|mesh-list
83846507|NCT00141336|Analgesics|analgesics|mesh-ancestor
83846508|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
83846509|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846510|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846511|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
83846512|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83846513|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846514|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846515|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83846516|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83846517|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83846518|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846519|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846520|NCT00133406|Vitamin A|vitamin a|mesh-list
83846521|NCT00133406|Glycine|glycine|mesh-list
83846522|NCT00133406|Vitamins|vitamins|mesh-ancestor
83846523|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
83846524|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846525|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846526|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
83846527|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846528|NCT00133445|Vaccines|vaccines|mesh-list
83085417|NCT03475524|Metformin|metformin|mesh-list
83846529|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
83846530|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846531|NCT00141375|Pregabalin|pregabalin|mesh-list
83846532|NCT00141375|Analgesics|analgesics|mesh-ancestor
83846534|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846535|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846536|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
83846537|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83846538|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846539|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846540|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83846541|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83846542|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83846543|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846544|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846545|NCT00133523|Vaccines|vaccines|mesh-list
83846546|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
83846547|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846548|NCT00133562|Glycine|glycine|mesh-list
83846549|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
83846550|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846551|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846552|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846553|NCT00404391|Acetaminophen|acetaminophen|mesh-list
83846554|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83846555|NCT00404391|Hydrocodone|hydrocodone|mesh-list
83846556|NCT00404391|Oxycodone|oxycodone|mesh-list
83846557|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83846558|NCT00404391|Analgesics|analgesics|mesh-ancestor
83846559|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
83846560|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846561|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846562|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
83846563|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83846564|NCT00404391|Narcotics|narcotics|mesh-ancestor
83846565|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846566|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
83846567|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
83846568|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83846569|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846570|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846571|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
83846572|NCT00144807|Rituximab|rituximab|mesh-list
83846573|NCT00144807|Doxorubicin|doxorubicin|mesh-list
83846574|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846575|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
83846576|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846577|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846578|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83846579|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
83846580|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846581|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846582|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83846583|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846584|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846585|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83846586|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846587|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846588|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
83846589|NCT00133640|Vitamin D|vitamin d|mesh-list
83846590|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83846591|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846592|NCT00133640|Vitamins|vitamins|mesh-ancestor
83846593|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
83846594|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83846595|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83846596|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846597|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83846598|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846599|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846600|NCT00404508|Hydralazine|hydralazine|mesh-list
83846601|NCT00404508|Valproic Acid|valproic acid|mesh-list
83846602|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
83846603|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846604|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846605|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
83846606|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846607|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846608|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
83846609|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83846610|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846611|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846612|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83846613|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
83846614|NCT00133757|Bupropion|bupropion|mesh-list
83846615|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83846616|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
83846617|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846618|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83846619|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83846620|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846621|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846622|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
83846623|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846624|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846625|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83846626|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83846627|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846628|NCT00144846|Albuterol|albuterol|mesh-list
83846629|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83846630|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
83846631|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846632|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846633|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83846634|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
83846635|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
83846636|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83846637|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83846638|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83846639|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83846640|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
83846641|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846642|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846643|NCT00133796|Trastuzumab|trastuzumab|mesh-list
83846644|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846645|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846646|NCT00133874|Retapamulin|retapamulin|mesh-list
83846647|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83846648|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846649|NCT00141414|Pregabalin|pregabalin|mesh-list
83846650|NCT00141414|Analgesics|analgesics|mesh-ancestor
83846651|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
83846652|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846653|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846654|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
83846655|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83846656|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846657|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846658|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83846659|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83846660|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83846661|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846662|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83846663|NCT00145002|Lenograstim|lenograstim|mesh-list
83846664|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83846665|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
83846666|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846667|NCT00141492|Testosterone|testosterone|mesh-list
83846668|NCT00141492|Androgens|androgens|mesh-ancestor
83846669|NCT00141492|Hormones|hormones|mesh-ancestor
83846670|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846671|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846672|NCT00141531|Apaziquone|apaziquone|mesh-list
83846673|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846674|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83846675|NCT00134069|Cetuximab|cetuximab|mesh-list
83846676|NCT00134069|Irinotecan|irinotecan|mesh-list
83846677|NCT00134069|Sorafenib|sorafenib|mesh-list
83846678|NCT00134069|Antibodies|antibodies|mesh-list
83846679|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
83846680|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83846681|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
83846682|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846683|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846684|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83846685|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846686|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846687|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846688|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83846689|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
83846691|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
83846692|NCT00141570|Testosterone|testosterone|mesh-list
83846693|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
83846694|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
83846695|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83846696|NCT00141570|Hormones|hormones|mesh-ancestor
83846697|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846698|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846699|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83846700|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846701|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
83846702|NCT00141570|Androgens|androgens|mesh-ancestor
83846703|NCT00134147|Insulin|insulin|mesh-list
83846704|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83846705|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846706|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
83846707|NCT00403988|Vinorelbine|vinorelbine|mesh-list
83846708|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846709|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83846710|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
83846711|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
83846712|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
83846713|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846714|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
83846715|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846716|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83846717|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
83846718|NCT00141648|Prednisolone|prednisolone|mesh-list
83846719|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
83846720|NCT00141648|Doxorubicin|doxorubicin|mesh-list
83846721|NCT00141648|Vincristine|vincristine|mesh-list
83846722|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846723|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
83846724|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846725|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846726|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83846727|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
83846728|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846729|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846730|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83846731|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846732|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83846733|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846734|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846735|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83846736|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
83846737|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
83846738|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
83846739|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846740|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
83846741|NCT00141648|Hormones|hormones|mesh-ancestor
83846742|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846743|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83846744|NCT00134420|Clonidine|clonidine|mesh-list
83846745|NCT00134420|Mitogens|mitogens|mesh-list
83846746|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846747|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83846748|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846749|NCT00134420|Analgesics|analgesics|mesh-ancestor
83846750|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
83846751|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846752|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83846753|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
83846754|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
83846755|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83846756|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83846757|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83846758|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
83846759|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846760|NCT00141804|Sirolimus|sirolimus|mesh-list
83846761|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83846762|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846763|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83846764|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846765|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
83846766|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846767|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
83846768|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846769|NCT00134498|Atorvastatin|atorvastatin|mesh-list
83846770|NCT00134498|Torcetrapib|torcetrapib|mesh-list
83846771|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83846772|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83846773|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
83846774|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846775|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83846776|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83846777|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846778|NCT00141843|Factor VIII|factor viii|mesh-list
83846779|NCT00141843|Coagulants|coagulants|mesh-ancestor
83846780|NCT00141882|Memantine|memantine|mesh-list
83846781|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83846782|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83846783|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
83846784|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846785|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846786|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846787|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83846788|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83846789|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83846790|NCT00152295|Estrogens|estrogens|mesh-ancestor
83846791|NCT00152295|Hormones|hormones|mesh-ancestor
83846792|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846793|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846794|NCT00152373|Levetiracetam|levetiracetam|mesh-list
83846795|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
83846796|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
83846797|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83846798|NCT00134654|Estrogens|estrogens|mesh-ancestor
83846799|NCT00134654|Hormones|hormones|mesh-ancestor
83846800|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846801|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846802|NCT00141960|Famotidine|famotidine|mesh-list
83846803|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83846804|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83846805|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83846806|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
83846807|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
83846808|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846809|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846810|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846811|NCT00134693|Prednisolone|prednisolone|mesh-list
83846812|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83846813|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
83846814|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83846815|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
83846816|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83846817|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
83846818|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846819|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
83846820|NCT00134693|Hormones|hormones|mesh-ancestor
83846821|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846822|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846823|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83846824|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846825|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
83846826|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
83846827|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846828|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83846829|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83846830|NCT00134693|Protective Agents|protective agents|mesh-ancestor
83846831|NCT00152412|Levocetirizine|levocetirizine|mesh-list
84148825|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83846832|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83846833|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83846834|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
83846835|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
83846836|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846837|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846838|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846840|NCT00142038|Capecitabine|capecitabine|mesh-list
83846841|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846842|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83846843|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83846844|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83846845|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846846|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83846847|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
83846848|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
83846849|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83846850|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83846851|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83846852|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83846853|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846854|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
83846855|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846856|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846857|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83846858|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846859|NCT02964455|Docetaxel|docetaxel|mesh-list
83846860|NCT02964455|Nedaplatin|nedaplatin|mesh-list
83846861|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846862|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
83846863|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
83846864|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
83846865|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846866|NCT00142155|Rituximab|rituximab|mesh-list
83846867|NCT00142155|Antibodies|antibodies|mesh-list
83846868|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83846869|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
83846870|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846871|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846872|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846873|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846874|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
83846875|NCT00152490|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83846876|NCT00152490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846877|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846878|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
83846879|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846880|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846881|NCT00134888|Buprenorphine|buprenorphine|mesh-list
83846882|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83846883|NCT00134888|Naloxone|naloxone|mesh-list
83846884|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83846885|NCT00134888|Narcotics|narcotics|mesh-ancestor
83846886|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83846887|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846888|NCT00134888|Analgesics|analgesics|mesh-ancestor
83846889|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
83846890|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846891|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83846892|NCT00134966|Levodopa|levodopa|mesh-list
83846893|NCT00134966|Carbidopa|carbidopa|mesh-list
83846894|NCT00134966|Entacapone|entacapone|mesh-list
83846895|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83846896|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83846897|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
83846898|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846899|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846900|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846901|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83846902|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846903|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83846904|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
83846905|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846906|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83846907|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846908|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846909|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
83846910|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83846911|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83846912|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846913|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846914|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846915|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
83846916|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83846917|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846918|NCT04725357|Meloxicam|meloxicam|mesh-list
83846919|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83846920|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83846921|NCT04725357|Analgesics|analgesics|mesh-ancestor
83846922|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
83846923|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846924|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846925|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846926|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83846927|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83846928|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83846929|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846930|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846931|NCT00135122|Prednisolone|prednisolone|mesh-list
83846932|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83846933|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
83846934|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83846935|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
83846936|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83846937|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
83846938|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83846939|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
83846940|NCT00135122|Hormones|hormones|mesh-ancestor
83846941|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83846942|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846943|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83846944|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846945|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
83846946|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
83846947|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83846948|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83846949|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83846950|NCT00135122|Protective Agents|protective agents|mesh-ancestor
83846951|NCT00142350|Fluorouracil|fluorouracil|mesh-list
83846952|NCT00142350|Irinotecan|irinotecan|mesh-list
83846953|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846954|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
83846955|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846956|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83846957|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83846958|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
83846959|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846960|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83846961|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83846962|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846963|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
83846964|NCT00135317|Hematinics|hematinics|mesh-ancestor
83846965|NCT00152646|Clopidogrel|clopidogrel|mesh-list
83846966|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83846967|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83846968|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83846969|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83846970|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
83846971|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83846972|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846973|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846974|NCT00135434|Ritonavir|ritonavir|mesh-list
83846975|NCT00135434|Lopinavir|lopinavir|mesh-list
83846976|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83846977|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83846978|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83846979|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
83846980|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83846981|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83846982|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83846983|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83846984|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
83846985|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83846986|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83846987|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83846988|NCT00135473|Insulin|insulin|mesh-list
83846989|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83846990|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83846991|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83846992|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83846993|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
83846994|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
83846995|NCT00142428|Cetuximab|cetuximab|mesh-list
83846996|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83846997|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83846998|NCT00135551|Benidipine|benidipine|mesh-list
83846999|NCT00135551|Diuretics|diuretics|mesh-list
83847000|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83847001|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83847002|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83847003|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
83847004|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847005|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847006|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847007|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83847008|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
83847009|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847010|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83847011|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83847012|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847013|NCT00152724|Aspirin|aspirin|mesh-list
83847014|NCT00152724|Celecoxib|celecoxib|mesh-list
83847015|NCT00152724|Indomethacin|indomethacin|mesh-list
83847016|NCT00152724|Nitroprusside|nitroprusside|mesh-list
83847017|NCT00152724|Acetylcholine|acetylcholine|mesh-list
83847018|NCT00152724|Capsaicin|capsaicin|mesh-list
83847019|NCT00152724|Clopidogrel|clopidogrel|mesh-list
83847020|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847021|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847022|NCT00152724|Analgesics|analgesics|mesh-ancestor
83847023|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
83847024|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847025|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847026|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847027|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847028|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83847029|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83847030|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847031|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83847032|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847033|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847034|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
83847035|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83847036|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83847037|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83847038|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
83847039|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847040|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83847041|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
83847042|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
83847043|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
83847044|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
83847045|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83847046|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83847047|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847048|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83847049|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83847050|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
83847051|NCT00135668|Nitroprusside|nitroprusside|mesh-list
83847052|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83847053|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847054|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83847055|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847056|NCT00152802|Vaccines|vaccines|mesh-list
83847057|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
83847058|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847059|NCT00135746|Nicotine|nicotine|mesh-list
83847060|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83847061|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
83847062|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847063|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847064|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83847065|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83847066|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
83847067|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847068|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847069|NCT00135785|Bupropion|bupropion|mesh-list
83847070|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83847071|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
83847072|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847073|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83847074|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83847075|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847076|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847077|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
83847078|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847079|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847080|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83847081|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83847082|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847083|NCT00159081|Haloperidol|haloperidol|mesh-list
83847084|NCT00159081|Risperidone|risperidone|mesh-list
83847085|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
83847086|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83847087|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
83847088|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847089|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847090|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847091|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83847092|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847093|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847094|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847095|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83847096|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
83847097|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
83847098|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
83847099|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847100|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83847101|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83847102|NCT00152841|Vitamin E|vitamin e|mesh-list
83847103|NCT00152841|Vitamins|vitamins|mesh-ancestor
83847104|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
83847105|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847106|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
83847107|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847108|NCT00152841|Protective Agents|protective agents|mesh-ancestor
83847109|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
83847110|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847111|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847112|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847113|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847114|NCT00159159|Cyclosporine|cyclosporine|mesh-list
83847115|NCT00159159|Cyclosporins|cyclosporins|mesh-list
83847116|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847117|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847118|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83847119|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
83847120|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847121|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
83847122|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847123|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83847124|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847125|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83847126|NCT00135824|Povidone|povidone|mesh-list
83847127|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83847128|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83847129|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
83847130|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
83847131|NCT00135863|Tinzaparin|tinzaparin|mesh-list
83847132|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83847133|NCT00135863|Dalteparin|dalteparin|mesh-list
83847134|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
83847135|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83847136|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83847137|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847138|NCT00135902|Progesterone|progesterone|mesh-list
83847139|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83847140|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83847141|NCT00135902|Progestins|progestins|mesh-ancestor
83847142|NCT00135902|Hormones|hormones|mesh-ancestor
83847143|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847144|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847145|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83847146|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
83847147|NCT00135941|Insulin|insulin|mesh-list
83847148|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83847149|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
83847150|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
83847151|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847152|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847153|NCT00152919|Meloxicam|meloxicam|mesh-list
83847154|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847155|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847156|NCT00152919|Analgesics|analgesics|mesh-ancestor
83847157|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
83847158|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847159|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847160|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847161|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847162|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83847163|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847164|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847165|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847166|NCT00406146|Artesunate|artesunate|mesh-list
83847167|NCT00406146|Lumefantrine|lumefantrine|mesh-list
83847168|NCT00406146|Artemether|artemether|mesh-list
83847169|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83847170|NCT00406146|Amodiaquine|amodiaquine|mesh-list
83847171|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
83847172|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83847173|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83847174|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847175|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847176|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
83847177|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
83847178|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83847179|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
83847180|NCT00136058|Alendronate|alendronate|mesh-list
83847181|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
83847182|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83847183|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847184|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83847185|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847186|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847187|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83847188|NCT00152958|Pramipexole|pramipexole|mesh-list
83847189|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
83847190|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847191|NCT00152958|Protective Agents|protective agents|mesh-ancestor
83847192|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847193|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83847194|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83847195|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
83847196|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
83847197|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847198|NCT00136175|Paclitaxel|paclitaxel|mesh-list
83847199|NCT00136175|Carboplatin|carboplatin|mesh-list
83847200|NCT00136175|Gemcitabine|gemcitabine|mesh-list
83847201|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83847202|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847203|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83847204|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83847205|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83847206|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847207|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83847208|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
83847209|NCT00152997|Pramipexole|pramipexole|mesh-list
83847210|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
83847211|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847212|NCT00152997|Protective Agents|protective agents|mesh-ancestor
83847213|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847214|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83847215|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83847216|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
83847217|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
83847218|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847219|NCT00136292|Daptomycin|daptomycin|mesh-list
83847220|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83847221|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847222|NCT00153075|Fenoterol|fenoterol|mesh-list
83847223|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83847224|NCT00153075|Ipratropium|ipratropium|mesh-list
83847225|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83847226|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
83847227|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847228|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847229|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83847230|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
83847231|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
83847232|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
83847233|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83847234|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83847235|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83847236|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83847237|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
83847238|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847239|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847240|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83847241|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
83847242|NCT00159471|Gemcitabine|gemcitabine|mesh-list
83847243|NCT00159471|Capecitabine|capecitabine|mesh-list
83847244|NCT00159471|Docetaxel|docetaxel|mesh-list
83847245|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83847246|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
83847247|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847248|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847249|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
83847250|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
83847251|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
83847252|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
83847253|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83847254|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847255|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
83847256|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
83847257|NCT00159510|Methylene Blue|methylene blue|mesh-list
83847258|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83847259|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
83847260|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847261|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847262|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83847263|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
83847264|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83847265|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
83847266|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847267|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847268|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83847269|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847270|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
83847271|NCT00159510|Protective Agents|protective agents|mesh-ancestor
83847272|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847273|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
83847274|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847275|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83847276|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847277|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847278|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83847279|NCT00153114|Laxatives|laxatives|mesh-ancestor
83847280|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83847281|NCT00136448|Cytarabine|cytarabine|mesh-list
83847282|NCT00136448|Interleukin-2|interleukin-2|mesh-list
83847283|NCT00136448|Daunorubicin|daunorubicin|mesh-list
83847284|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83847285|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
84148826|NCT04135781|Capecitabine|capecitabine|mesh-list
83847286|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847287|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847288|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
83847289|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847290|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83847291|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
83847292|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847293|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847294|NCT00136448|Analgesics|analgesics|mesh-ancestor
83847295|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
83847296|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847297|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83847298|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83847299|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83847300|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847301|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83847302|NCT00153153|Laxatives|laxatives|mesh-ancestor
83847303|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83847304|NCT00136487|Celecoxib|celecoxib|mesh-list
83847305|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847306|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847307|NCT00136487|Analgesics|analgesics|mesh-ancestor
83847308|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
83847309|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847310|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847311|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847312|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847313|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83847314|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847315|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847316|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847317|NCT00153192|Dronabinol|dronabinol|mesh-list
83847318|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
83847319|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847320|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847321|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847322|NCT00153192|Analgesics|analgesics|mesh-ancestor
83847323|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
83847324|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847325|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83847326|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83847327|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847328|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847329|NCT00153192|Hormones|hormones|mesh-ancestor
83847330|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847331|NCT00136526|Docetaxel|docetaxel|mesh-list
83847332|NCT00136526|Fosfestrol|fosfestrol|mesh-list
83847333|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
83847334|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847335|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
83847336|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
83847337|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
83847338|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847339|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83847340|NCT00136526|Estrogens|estrogens|mesh-ancestor
83847341|NCT00136526|Hormones|hormones|mesh-ancestor
83847342|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847343|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847344|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83847345|NCT00136565|Prednisone|prednisone|mesh-list
83847346|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
83847347|NCT00136565|Doxorubicin|doxorubicin|mesh-list
83847348|NCT00136565|Bortezomib|bortezomib|mesh-list
83847349|NCT00136565|Bleomycin|bleomycin|mesh-list
83847350|NCT00136565|Vindesine|vindesine|mesh-list
83847351|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83847352|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
83847353|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847354|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847355|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83847356|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
83847357|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847358|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847359|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83847360|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83847361|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83847362|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83847363|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847364|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847365|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
83847366|NCT00136565|Hormones|hormones|mesh-ancestor
83847367|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847368|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83847369|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83847370|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
83847371|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
83847372|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
83847373|NCT00159627|Rolofylline|rolofylline|mesh-list
83847374|NCT00159627|Diuretics|diuretics|mesh-ancestor
83847375|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
83847376|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847377|NCT00159666|Pregabalin|pregabalin|mesh-list
83847378|NCT00159666|Analgesics|analgesics|mesh-ancestor
83847379|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
83847380|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847381|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847382|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
83847383|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83847384|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847385|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847386|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83847387|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83847388|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847389|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847390|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847391|NCT00153270|Valproic Acid|valproic acid|mesh-list
83847392|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
83847393|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847394|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847395|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
83847396|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847397|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847398|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
83847399|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847400|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847401|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847402|NCT00159705|Pregabalin|pregabalin|mesh-list
83847403|NCT00159705|Analgesics|analgesics|mesh-ancestor
83847404|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
83847405|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847406|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847407|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
83847408|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83847409|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847410|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847411|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83847412|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83847413|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847414|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847415|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847416|NCT00136994|Ziprasidone|ziprasidone|mesh-list
83847417|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83847418|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
83847419|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847420|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847421|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847422|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83847423|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847424|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847425|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847426|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83847427|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
83847428|NCT00137033|Celecoxib|celecoxib|mesh-list
83847429|NCT00137033|Naproxen|naproxen|mesh-list
83847430|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847431|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847432|NCT00137033|Analgesics|analgesics|mesh-ancestor
83847433|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
83847434|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086315|NCT04990167|Bromides|bromides|mesh-list
83847435|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847436|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847437|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847438|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83847439|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847440|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847441|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847442|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
83847443|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
83847444|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847445|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847446|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83847447|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83847448|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847449|NCT00137072|Urological Agents|urological agents|mesh-ancestor
83847450|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
83847451|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83847452|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847453|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
83847454|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847455|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847456|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83847457|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83847458|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847459|NCT00159900|Urological Agents|urological agents|mesh-ancestor
83847460|NCT00159978|Alovudine|alovudine|mesh-list
83847461|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
83847462|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847463|NCT00137345|Sirolimus|sirolimus|mesh-list
83847464|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83847465|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847466|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83847467|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847468|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
83847469|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83847470|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
83847471|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847472|NCT00137462|Atorvastatin|atorvastatin|mesh-list
83847473|NCT00137462|Torcetrapib|torcetrapib|mesh-list
83847474|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83847475|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83847476|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
83847477|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847478|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83847479|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83847480|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847481|NCT00153543|Vaccines|vaccines|mesh-list
83847482|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83847483|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
83847484|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847485|NCT00137501|Nifedipine|nifedipine|mesh-list
83847486|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83847487|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847488|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847489|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83847490|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847491|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847492|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
83847493|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83847494|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83847495|NCT00153660|Celecoxib|celecoxib|mesh-list
83847496|NCT00153660|Naproxen|naproxen|mesh-list
83847497|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847498|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847499|NCT00153660|Analgesics|analgesics|mesh-ancestor
83847500|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
83847501|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847502|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847503|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847504|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847505|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83086386|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086387|NCT04601857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086389|NCT04590508|Xanthohumol|xanthohumol|mesh-list
83847506|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847507|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847508|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847509|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
83847511|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83847512|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
83847513|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83847514|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847515|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
83847516|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83847517|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83847518|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83847519|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847520|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847521|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83847522|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83847523|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83847524|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83847525|NCT00153699|Topiramate|topiramate|mesh-list
83847526|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
83847527|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847528|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847529|NCT00160290|Lactulose|lactulose|mesh-list
83847530|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83847531|NCT00137735|Gabapentin|gabapentin|mesh-list
83847532|NCT00137735|Analgesics|analgesics|mesh-ancestor
83847533|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
83847534|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847535|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847536|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
83847537|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83847538|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847539|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847540|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847541|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83847542|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83847543|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847544|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847545|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
83847546|NCT00137774|Bevacizumab|bevacizumab|mesh-list
83847547|NCT00137774|Temozolomide|temozolomide|mesh-list
83847548|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83847549|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847550|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83847551|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83847552|NCT00137774|Growth Substances|growth substances|mesh-ancestor
83847553|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847554|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
83847555|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83847556|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
83847557|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847558|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83847559|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83847560|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83847561|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
83847562|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847563|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847564|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83847565|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83847566|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
83847567|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847568|NCT00137813|Bevacizumab|bevacizumab|mesh-list
83847569|NCT00137813|Docetaxel|docetaxel|mesh-list
83847570|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83847571|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847572|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83138254|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
83847573|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83138504|NCT04251715|Leucovorin|leucovorin|mesh-list
83138585|NCT03063788|Copper|copper|mesh-list
83847574|NCT00137813|Growth Substances|growth substances|mesh-ancestor
83847575|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847576|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
83847577|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
83139110|NCT02056379|Budesonide|budesonide|mesh-list
83139250|NCT02388724|Lansoprazole|lansoprazole|mesh-list
83847578|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
83139550|NCT02796677|Bromides|bromides|mesh-list
83847579|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
83139619|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139992|NCT02073773|Levodopa|levodopa|mesh-list
83847580|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140372|NCT02078609|Midostaurin|midostaurin|mesh-list
83847581|NCT00137852|Celecoxib|celecoxib|mesh-list
83140679|NCT03240939|Tadalafil|tadalafil|mesh-list
83847582|NCT00137852|Irinotecan|irinotecan|mesh-list
83140819|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83847583|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847584|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83847585|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83847586|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847587|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847588|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847589|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847590|NCT00137852|Analgesics|analgesics|mesh-ancestor
83141114|NCT02871401|Valganciclovir|valganciclovir|mesh-list
83141188|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83141260|NCT03056924|Vaccines|vaccines|mesh-list
83141337|NCT04928066|Prednisone|prednisone|mesh-list
83141482|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83847591|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
83847592|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847593|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847594|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847595|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847596|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83847597|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847598|NCT00160407|Orlistat|orlistat|mesh-list
83847599|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847600|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847601|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83847602|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83141625|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
83847603|NCT00153933|Lenalidomide|lenalidomide|mesh-list
83141851|NCT02148913|Melphalan|melphalan|mesh-list
83847604|NCT00153933|Bortezomib|bortezomib|mesh-list
83847605|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
83847606|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142309|NCT03198819|Cefotaxime|cefotaxime|mesh-list
83142463|NCT03197571|Antidotes|antidotes|mesh-ancestor
83847607|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83142532|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142761|NCT00189267|Imiquimod|imiquimod|mesh-list
83847608|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83143135|NCT03054662|Hemostatics|hemostatics|mesh-list
83143211|NCT04922450|Paclitaxel|paclitaxel|mesh-list
83847609|NCT00153933|Growth Substances|growth substances|mesh-ancestor
83143285|NCT03053414|Vitamin D|vitamin d|mesh-list
83143606|NCT04883996|Miotics|miotics|mesh-ancestor
83847610|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
83143739|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
83847611|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144052|NCT03541681|Hormones|hormones|mesh-ancestor
83847612|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
83144571|NCT03045770|Leucovorin|leucovorin|mesh-list
83847613|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145282|NCT02110355|Trametinib|trametinib|mesh-list
83847614|NCT00153972|Levodopa|levodopa|mesh-list
83847615|NCT00153972|Cabergoline|cabergoline|mesh-list
83145708|NCT04847024|Parecoxib|parecoxib|mesh-list
83847616|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83145929|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146085|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
83146160|NCT02424435|Hormones|hormones|mesh-ancestor
83847617|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83146642|NCT02302846|Ixazomib|ixazomib|mesh-list
83847618|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
83146915|NCT03036800|Incretins|incretins|mesh-ancestor
83847619|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847620|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847621|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847622|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
83847623|NCT00160485|Glyburide|glyburide|mesh-list
83847624|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847625|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847626|NCT00404183|Acetaminophen|acetaminophen|mesh-list
83847627|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83847628|NCT00404183|Hydrocodone|hydrocodone|mesh-list
83847629|NCT00404183|Oxycodone|oxycodone|mesh-list
83847630|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847631|NCT00404183|Analgesics|analgesics|mesh-ancestor
83847632|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
83847633|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847634|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847635|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
83847636|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83847637|NCT00404183|Narcotics|narcotics|mesh-ancestor
83847638|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847639|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
83847640|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
83847641|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847642|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847643|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847644|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
83847645|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847646|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847647|NCT00404222|Acetaminophen|acetaminophen|mesh-list
83847648|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83847649|NCT00404222|Hydrocodone|hydrocodone|mesh-list
83847650|NCT00404222|Oxycodone|oxycodone|mesh-list
83847651|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847652|NCT00404222|Analgesics|analgesics|mesh-ancestor
83847653|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
83847654|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847655|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847657|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83847658|NCT00404222|Narcotics|narcotics|mesh-ancestor
83847659|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847660|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
83847661|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
83847662|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847663|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847664|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847665|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
83847666|NCT00160602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83847667|NCT00160602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847668|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83847669|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
83847670|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847671|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847672|NCT00138242|Carboplatin|carboplatin|mesh-list
83847673|NCT00138242|Docetaxel|docetaxel|mesh-list
83847674|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847675|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83847676|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83847677|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83847678|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847679|NCT00154050|Candesartan|candesartan|mesh-list
83847680|NCT00154050|Quinapril|quinapril|mesh-list
83847681|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83847682|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83847683|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83847684|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847685|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83847686|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
83847687|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847688|NCT00154089|Masoprocol|masoprocol|mesh-list
83847689|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
83847690|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847691|NCT00154089|Protective Agents|protective agents|mesh-ancestor
83847692|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847693|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83847694|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847695|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847696|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847697|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847698|NCT00154089|Analgesics|analgesics|mesh-ancestor
83847699|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
83847700|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847701|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847702|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847703|NCT00138359|Niclosamide|niclosamide|mesh-list
83847704|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
83847705|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83847706|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
83847707|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83847708|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847709|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
83847710|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
83847711|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847712|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
83847713|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
83847714|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
83847715|NCT00154167|Phentolamine|phentolamine|mesh-list
83847716|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83847717|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83847718|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83847719|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847720|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847721|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847722|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83847723|NCT00138515|Vildagliptin|vildagliptin|mesh-list
83847724|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847725|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847726|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83847727|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
83847728|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847729|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086626|NCT03762109|Dantrolene|dantrolene|mesh-list
83847730|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
83847731|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83847732|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847733|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83847734|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
83847735|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83847736|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847737|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847738|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847739|NCT00138554|Pioglitazone|pioglitazone|mesh-list
83847740|NCT00138554|Vildagliptin|vildagliptin|mesh-list
83847741|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847742|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847743|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83847744|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
83847745|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847746|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847747|NCT00138593|Vildagliptin|vildagliptin|mesh-list
83847748|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847749|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847750|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83847751|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
83847752|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847753|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847754|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
83847755|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83847756|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847757|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83847758|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
83847759|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83847760|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847761|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847762|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847763|NCT00138632|Vatalanib|vatalanib|mesh-list
83847764|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83847765|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847766|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847767|NCT00160875|Irinotecan|irinotecan|mesh-list
83847768|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847769|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83847770|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83847771|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847772|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847773|NCT00138710|Letrozole|letrozole|mesh-list
83847774|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847775|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83847776|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83847777|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847778|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847779|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83847780|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
83847781|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847782|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847783|NCT01243762|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
83847784|NCT01243762|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83847785|NCT01243762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847786|NCT01243762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847787|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
83847788|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
83847789|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83847790|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83847791|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847792|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847793|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83847794|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83847795|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
83847796|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83847797|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847798|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847799|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83847800|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847801|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83847802|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
83847803|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
83847804|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83847805|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83847806|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847807|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847808|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83847809|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83847810|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83847811|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83847812|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83847813|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847814|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847815|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
83847816|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847817|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847818|NCT00154401|Liraglutide|liraglutide|mesh-list
83847819|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83847820|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847821|NCT00154401|Incretins|incretins|mesh-ancestor
83847823|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847824|NCT00138944|Eplerenone|eplerenone|mesh-list
83847825|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83847826|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
83847827|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847828|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847829|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83847830|NCT00138944|Diuretics|diuretics|mesh-ancestor
83847831|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
83847832|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83847833|NCT00161070|Aspirin|aspirin|mesh-list
83847834|NCT00161070|Dipyridamole|dipyridamole|mesh-list
83847835|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83847836|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847837|NCT00161070|Analgesics|analgesics|mesh-ancestor
83847838|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
83847839|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847840|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847841|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847842|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847843|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83847844|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83847845|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847846|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83847847|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83847848|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847849|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
83847850|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83847851|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847852|NCT00138983|Vitamin D|vitamin d|mesh-list
83847853|NCT00138983|Alendronate|alendronate|mesh-list
83847854|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
83847855|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83847856|NCT00138983|Vitamins|vitamins|mesh-ancestor
83847857|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
83847858|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847859|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83847860|NCT01243177|Lacosamide|lacosamide|mesh-list
83847861|NCT01243177|Carbamazepine|carbamazepine|mesh-list
83847862|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
83847863|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83847864|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83847865|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83847866|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847867|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
83847868|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83847869|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83847870|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847871|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83847872|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83847873|NCT01243177|Analgesics|analgesics|mesh-ancestor
83847874|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
83847875|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847876|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83847877|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83847878|NCT00154440|Amoxicillin|amoxicillin|mesh-list
83847879|NCT00154440|Metronidazole|metronidazole|mesh-list
83847880|NCT00154440|Clarithromycin|clarithromycin|mesh-list
83847881|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83847882|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83847883|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847884|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83847885|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83847886|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83847887|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847888|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847889|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83847890|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83847891|NCT00139061|Atorvastatin|atorvastatin|mesh-list
83847892|NCT00139061|Torcetrapib|torcetrapib|mesh-list
83847893|NCT00139061|Fenofibrate|fenofibrate|mesh-list
83847894|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83847895|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83847896|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
83847897|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847898|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83847899|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83847900|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847901|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
83847902|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83847903|NCT04705584|Cyclosporine|cyclosporine|mesh-list
83847904|NCT04705584|Prednisolone|prednisolone|mesh-list
83847905|NCT04705584|Cyclosporins|cyclosporins|mesh-list
83847906|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847907|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847908|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83847909|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
83847910|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847911|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
83847912|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83847913|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
83847914|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83847915|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83847916|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847917|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
83847918|NCT04705584|Hormones|hormones|mesh-ancestor
83847919|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847920|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83847921|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847922|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
83847923|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83847924|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
83847925|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83847926|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847927|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83847928|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
83847929|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83847930|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
83847931|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847932|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847933|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83847934|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
83847935|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
83847936|NCT00139217|Protective Agents|protective agents|mesh-ancestor
83847937|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
83847938|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83847939|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
83847940|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83847941|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847942|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83847943|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83847944|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83847945|NCT00139256|Betamethasone|betamethasone|mesh-list
83847946|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83847947|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
83847948|NCT00139256|Hormones|hormones|mesh-ancestor
83847949|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847950|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847951|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83847952|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83847954|NCT00161304|Testosterone|testosterone|mesh-list
83847955|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
83847956|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
83847957|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83847958|NCT00161304|Androgens|androgens|mesh-ancestor
83847959|NCT00161304|Hormones|hormones|mesh-ancestor
83847960|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847961|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847962|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83847963|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847964|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
83847965|NCT01242748|Goserelin|goserelin|mesh-list
83847966|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83847967|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847968|NCT00139373|Donepezil|donepezil|mesh-list
83847969|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83847970|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847971|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847972|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
83847973|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847974|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847975|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
83847976|NCT00161421|Leuprolide|leuprolide|mesh-list
83847977|NCT00161421|Testosterone|testosterone|mesh-list
83847978|NCT00161421|Dutasteride|dutasteride|mesh-list
83847979|NCT00161421|Androgens|androgens|mesh-ancestor
83847980|NCT00161421|Hormones|hormones|mesh-ancestor
83847981|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83847982|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847983|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83847984|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83847985|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83847986|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
83847987|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83847988|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83847989|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83847990|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83847991|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847992|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
83847993|NCT00139568|Tegaserod|tegaserod|mesh-list
83847994|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83847995|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
83847996|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83847997|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83847998|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83847999|NCT00139646|Diclofenac|diclofenac|mesh-list
83848000|NCT00139646|Parecoxib|parecoxib|mesh-list
83848001|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83848002|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848003|NCT00139646|Analgesics|analgesics|mesh-ancestor
83848004|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
83848005|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848006|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848007|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848008|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848009|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83848010|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848011|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848012|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83848013|NCT00406302|Docetaxel|docetaxel|mesh-list
83848014|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
83848015|NCT00406302|Cetuximab|cetuximab|mesh-list
83848016|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848017|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
83848018|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
83848019|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
83848020|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848021|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848022|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83848023|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
83848024|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
83848025|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848026|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848027|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83848028|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83848029|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83848030|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83848031|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848032|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83848033|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83848034|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83848035|NCT00406341|Difluprednate|difluprednate|mesh-list
83848036|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
83848037|NCT00406341|Hormones|hormones|mesh-ancestor
83848038|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848039|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848040|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83848041|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83848042|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83848043|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
83848044|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848045|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848046|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848047|NCT00139724|Urological Agents|urological agents|mesh-ancestor
83848048|NCT00161577|Ketorolac|ketorolac|mesh-list
83848049|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83848050|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848051|NCT00161577|Analgesics|analgesics|mesh-ancestor
83848052|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
83848053|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848054|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848055|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848056|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848057|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83848058|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848059|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848060|NCT00404261|Fluticasone|fluticasone|mesh-list
83848061|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83848062|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83848063|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848064|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83848065|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
83848066|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848067|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848068|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83848069|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
83848070|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
83848071|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83848072|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83848073|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83848074|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83848075|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83848076|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848077|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848078|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
83848079|NCT00404261|Hormones|hormones|mesh-ancestor
83848080|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848081|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
83848082|NCT00406380|Bevacizumab|bevacizumab|mesh-list
83848083|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848084|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848085|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83848086|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83848087|NCT00406380|Growth Substances|growth substances|mesh-ancestor
83848088|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848089|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
83848090|NCT00406497|Difluprednate|difluprednate|mesh-list
83848091|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
83848092|NCT00406497|Hormones|hormones|mesh-ancestor
83848093|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848094|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848095|NCT00161655|Etanercept|etanercept|mesh-list
83848096|NCT00161655|Methotrexate|methotrexate|mesh-list
83848097|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83848098|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
83848099|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848100|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848101|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83848102|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
83848103|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848104|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848105|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
83848106|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848107|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83848108|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848109|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
83848110|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848111|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83848112|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83848113|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848114|NCT00161655|Analgesics|analgesics|mesh-ancestor
83848115|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
83848116|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848117|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848118|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848119|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83848120|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
83848121|NCT00161733|Coagulants|coagulants|mesh-ancestor
83848122|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83848123|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83848124|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
83848125|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848126|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848127|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83848128|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83848129|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
83848130|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848131|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83848132|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83848133|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
83848134|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
83848135|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848136|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848137|NCT04724187|Misoprostol|misoprostol|mesh-list
83848138|NCT04724187|Oxytocin|oxytocin|mesh-list
83848139|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
83848140|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848141|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848142|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83848143|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
83848144|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83848145|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848146|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
83848147|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83848148|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
83848149|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83848150|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
83848151|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848152|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848153|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
83848154|NCT04724226|Apatinib|apatinib|mesh-list
83848155|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848156|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83848157|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848158|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848159|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83848160|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83848161|NCT04724343|Cetrorelix|cetrorelix|mesh-list
83848162|NCT04724343|Menotropins|menotropins|mesh-list
83848163|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
83848164|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83848165|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
83848166|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848167|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848168|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83848169|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83848170|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848171|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83848172|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
83848173|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
83848174|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848175|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
83848176|NCT00140075|Epirubicin|epirubicin|mesh-list
83848177|NCT00140075|Taxane|taxane|mesh-list
83848178|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848179|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
83848180|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848181|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848182|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83848183|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
83848184|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848185|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848186|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83848187|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83848188|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83848189|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83848190|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848191|NCT00140114|Misoprostol|misoprostol|mesh-list
83848192|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83848193|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
83848194|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848195|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848196|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83848197|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848198|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
83848199|NCT00140153|Testosterone|testosterone|mesh-list
83848200|NCT00140153|Androgens|androgens|mesh-ancestor
83848201|NCT00140153|Hormones|hormones|mesh-ancestor
83848202|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848203|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848204|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
83848205|NCT00140309|Rifampin|rifampin|mesh-list
83848206|NCT00140309|Isoniazid|isoniazid|mesh-list
83848207|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
83848208|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83848209|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848210|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83848211|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83848212|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848213|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848214|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848215|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83848216|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
83848217|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
83848218|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83848219|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83848220|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83848221|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83848222|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83848223|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83848224|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83848225|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83848226|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83848227|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
83848228|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83848229|NCT00161811|Vaccines|vaccines|mesh-list
83848230|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
83848231|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848232|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83848233|NCT00140348|Immunomodulating Agents|immunomodulating agents|mesh-list
83848234|NCT00140348|Immunologic Factors|immunologic factors|mesh-ancestor
83848235|NCT00140348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848236|NCT01240759|Metformin|metformin|mesh-list
83848237|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83848238|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848239|NCT01241734|Lenalidomide|lenalidomide|mesh-list
83848240|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
83848241|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848242|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83848243|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83087145|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83848244|NCT01241734|Growth Substances|growth substances|mesh-ancestor
83848245|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
83848246|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848247|NCT00140387|Immunomodulating Agents|immunomodulating agents|mesh-list
83848248|NCT00140387|Immunologic Factors|immunologic factors|mesh-ancestor
83848249|NCT00140387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848250|NCT00504634|Bortezomib|bortezomib|mesh-list
83848251|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848252|NCT00140465|Clopidogrel|clopidogrel|mesh-list
83848253|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83848254|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83848255|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83848256|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83848257|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
83848258|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848259|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848260|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848261|NCT00504673|Insulin|insulin|mesh-list
83848262|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83848263|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
83848264|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
83848265|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
83848266|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
83848267|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
83848268|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83848269|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848270|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
83848271|NCT01247701|Busulfan|busulfan|mesh-list
83848272|NCT01247701|Fludarabine|fludarabine|mesh-list
83848273|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848274|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
83848275|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848276|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848277|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83848278|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
83848279|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848280|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848281|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83848282|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
83848283|NCT00140543|Sirolimus|sirolimus|mesh-list
83848284|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83848285|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848286|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83848287|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
83848288|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83848289|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848290|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848291|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848292|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
83848293|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848294|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
83848295|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848296|NCT00154791|Gemcitabine|gemcitabine|mesh-list
83848297|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
83848298|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83848299|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
83848300|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848301|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848302|NCT00140582|Rituximab|rituximab|mesh-list
83848303|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848304|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848305|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
83848306|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848307|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848308|NCT00154869|Ribavirin|ribavirin|mesh-list
83848309|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83848310|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
83848311|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848312|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
83848313|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848314|NCT00140660|Rituximab|rituximab|mesh-list
83848315|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848316|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848317|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
83848318|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848319|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83087209|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
83848320|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
83848321|NCT00162006|Antibodies|antibodies|mesh-list
83848322|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
83848323|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83848324|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83848325|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
83848326|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848327|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83848328|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83848329|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848330|NCT02964572|Empagliflozin|empagliflozin|mesh-list
83848331|NCT02964572|Glimepiride|glimepiride|mesh-list
83848332|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83848333|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848334|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83848335|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848336|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83848337|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848338|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
83848339|NCT00162201|Abatacept|abatacept|mesh-list
83848340|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83848341|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848342|NCT00162201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848343|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848344|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848345|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
83848346|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848347|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848348|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83848349|NCT01248247|Sorafenib|sorafenib|mesh-list
83848350|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848351|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83848352|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848353|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848354|NCT00140894|Rofecoxib|rofecoxib|mesh-list
83848355|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848356|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848357|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848358|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83848359|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83848360|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848361|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83848362|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848363|NCT00140894|Analgesics|analgesics|mesh-ancestor
83848364|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
83848365|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848366|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848367|NCT00155064|Losartan|losartan|mesh-list
83848368|NCT00155064|Captopril|captopril|mesh-list
83848369|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83848370|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83848371|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83848372|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83848373|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848374|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83848375|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
83848376|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848377|NCT02483260|Ribavirin|ribavirin|mesh-list
83848378|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
83848379|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848380|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
83848381|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848382|NCT00140933|Diclofenac|diclofenac|mesh-list
83848383|NCT00140933|Rofecoxib|rofecoxib|mesh-list
83848384|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83848385|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848386|NCT00140933|Analgesics|analgesics|mesh-ancestor
83848387|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
83848388|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848389|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848390|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848391|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848392|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83848393|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848394|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848395|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83848396|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83848397|NCT04515628|Branebrutinib|branebrutinib|mesh-list
83848398|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83848399|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83848400|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
83848401|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848402|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83848403|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83848404|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848405|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83848406|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83848407|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83848409|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
83848410|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83848411|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83848412|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848413|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
83848414|NCT00504946|Vitamin D|vitamin d|mesh-list
83848415|NCT00504946|Prednisone|prednisone|mesh-list
83848416|NCT00504946|Budesonide|budesonide|mesh-list
83848417|NCT00504946|Montelukast|montelukast|mesh-list
83848418|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848419|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
83848420|NCT00504946|Hormones|hormones|mesh-ancestor
83848421|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848422|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848423|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83848424|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848425|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83848426|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83848427|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83848428|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
83848429|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83848430|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83848431|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848432|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83848433|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
83848434|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848435|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83848436|NCT00504946|Vitamins|vitamins|mesh-ancestor
83848437|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
83848438|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83848439|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83848440|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83848441|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848442|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83848443|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83848444|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848445|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848446|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
83848447|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848448|NCT04511416|Metformin|metformin|mesh-list
83848449|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83848450|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848451|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83848452|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848453|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
83848454|NCT00407082|Hormones|hormones|mesh-ancestor
83848455|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848456|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848457|NCT00141089|Tegaserod|tegaserod|mesh-list
83848458|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83848459|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
83848460|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848461|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848462|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848463|NCT00407121|Bevacizumab|bevacizumab|mesh-list
83848464|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848465|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848466|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83848467|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83848468|NCT00407121|Growth Substances|growth substances|mesh-ancestor
83848469|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848470|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
83848471|NCT00141167|Varenicline|varenicline|mesh-list
83848472|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83848473|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83848474|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83848475|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848476|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848477|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848478|NCT00141206|Varenicline|varenicline|mesh-list
83848479|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83848480|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83848481|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
83848482|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848483|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147909|NCT02129933|Bevacizumab|bevacizumab|mesh-list
83848484|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848485|NCT00141245|Pregabalin|pregabalin|mesh-list
83848486|NCT00141245|Analgesics|analgesics|mesh-ancestor
83848487|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
83848488|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848489|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848490|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
83848491|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83848492|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848493|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848494|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83848495|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83848496|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83848497|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848498|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83848499|NCT00141362|Pregabalin|pregabalin|mesh-list
83848500|NCT00141362|Analgesics|analgesics|mesh-ancestor
83848501|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
83848502|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848503|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848504|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
83848505|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83848506|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848507|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848508|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83848509|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83848510|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83848511|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848512|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83848513|NCT00155259|Docetaxel|docetaxel|mesh-list
83848514|NCT00155259|Capecitabine|capecitabine|mesh-list
83848515|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848516|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
83848517|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
83848518|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
83848519|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848520|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83848521|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
83848522|NCT04518124|Propranolol|propranolol|mesh-list
83848523|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83848524|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83848525|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
83848526|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848527|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848528|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848529|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83848530|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83848531|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
83848532|NCT00141401|Pregabalin|pregabalin|mesh-list
83848533|NCT00141401|Analgesics|analgesics|mesh-ancestor
83848534|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
83848535|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848536|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848537|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
83848538|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83848539|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84148827|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
83848540|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848541|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83848542|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83848543|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83848544|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848545|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83848546|NCT00505102|Everolimus|everolimus|mesh-list
83848547|NCT00505102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83848548|NCT00505102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83848549|NCT00505102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848550|NCT00505102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848551|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848552|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
83848553|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848554|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848555|NCT00404378|Ketoconazole|ketoconazole|mesh-list
83848556|NCT00404378|Casopitant|casopitant|mesh-list
83848557|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
83848558|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848559|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83848560|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83848561|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848562|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848563|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83848564|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
83848565|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848566|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848567|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83848568|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
83848569|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
83848570|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848571|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848572|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83848573|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848574|NCT04511728|Propofol|propofol|mesh-list
83848575|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83848576|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848577|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848578|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83848579|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
83848580|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
83848581|NCT00162318|Cetuximab|cetuximab|mesh-list
83848582|NCT00162318|Gefitinib|gefitinib|mesh-list
83848583|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848584|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848585|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83848586|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848587|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848588|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
83848589|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83848590|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83848591|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83848592|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848593|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848594|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
83848595|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848596|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848597|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83848598|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848599|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83848600|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848601|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83848602|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83848603|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848604|NCT00404456|Melatonin|melatonin|mesh-list
83848605|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
83848606|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848607|NCT00404456|Protective Agents|protective agents|mesh-ancestor
83848608|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848609|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848610|NCT00404534|Amoxicillin|amoxicillin|mesh-list
83848611|NCT00404534|Clarithromycin|clarithromycin|mesh-list
83848612|NCT00404534|Omeprazole|omeprazole|mesh-list
83848613|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83848614|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848615|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83848616|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848617|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83848618|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848619|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848620|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83848621|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83848622|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83848623|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
83848624|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83848625|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83848626|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848627|NCT00162396|Albuterol|albuterol|mesh-list
83848628|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83848629|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
83848630|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848631|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848632|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83848633|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
83848634|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
83848635|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848636|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83848637|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83848638|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83848639|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
83848640|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848641|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848642|NCT00162435|Warfarin|warfarin|mesh-list
83848643|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
83848644|NCT04518982|Lenalidomide|lenalidomide|mesh-list
83848645|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
83848646|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848647|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83848648|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83848649|NCT04518982|Growth Substances|growth substances|mesh-ancestor
83848650|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
83848651|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848652|NCT00155376|Morphine|morphine|mesh-list
83848653|NCT00155376|Glucagon|glucagon|mesh-list
83848654|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83848655|NCT00155376|Narcotics|narcotics|mesh-ancestor
83848656|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848657|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848658|NCT00155376|Analgesics|analgesics|mesh-ancestor
83848659|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
83848660|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848661|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848662|NCT00155376|Hormones|hormones|mesh-ancestor
83848663|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848664|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
83848665|NCT00141557|Estrogens|estrogens|mesh-list
83848666|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
83848667|NCT00141557|Estrone|estrone|mesh-list
83848668|NCT00141557|Testosterone|testosterone|mesh-list
83848669|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
83848670|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
83848671|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83848672|NCT00141557|Hormones|hormones|mesh-ancestor
83848673|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848674|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848675|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83848676|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848677|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
83848678|NCT00141557|Androgens|androgens|mesh-ancestor
83848679|NCT00162474|Phenytoin|phenytoin|mesh-list
83848680|NCT00162474|Warfarin|warfarin|mesh-list
83848681|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
83848682|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
83848683|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83848684|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83848685|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83087581|NCT02229825|Analgesics|analgesics|mesh-ancestor
83848686|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848687|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83848688|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83848689|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
83848690|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848692|NCT00505336|Atorvastatin|atorvastatin|mesh-list
83848693|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83848694|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83848695|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
83848696|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848697|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83848698|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83848699|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848700|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83848701|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
83848702|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848703|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848704|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83848705|NCT00505336|Diuretics|diuretics|mesh-ancestor
83848706|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
83848707|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83848708|NCT04518202|Lidocaine|lidocaine|mesh-list
83848709|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
83848710|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
83848711|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848712|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848713|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
83848714|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848715|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83848716|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83848717|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83848718|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848719|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848720|NCT04517890|Lidocaine|lidocaine|mesh-list
83848721|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
83848722|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
83848723|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848724|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848725|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
83848726|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848727|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83848728|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83848729|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83848730|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848731|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848732|NCT00141596|Amiloride|amiloride|mesh-list
83848733|NCT00141596|Furosemide|furosemide|mesh-list
83848734|NCT00141596|Diuretics|diuretics|mesh-ancestor
83848735|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
83848736|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848737|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83848738|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848739|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848740|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83848741|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83848742|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83848743|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83848744|NCT02275663|Cytarabine|cytarabine|mesh-list
83848745|NCT02275663|Fludarabine|fludarabine|mesh-list
83848746|NCT02275663|Azacitidine|azacitidine|mesh-list
83848747|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848748|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83848749|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
83848750|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848751|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848752|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
83848753|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848754|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
83848755|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087651|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83087652|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83087653|NCT04554693|Metronidazole|metronidazole|mesh-list
83087654|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848756|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848757|NCT02275702|Dexamethasone|dexamethasone|mesh-list
83848758|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848759|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
83848760|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
83848761|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848762|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848763|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848764|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
83848765|NCT02275702|Hormones|hormones|mesh-ancestor
83848766|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848767|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83848768|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848769|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
83848770|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83848771|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83848772|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848773|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
83848774|NCT04518163|Coagulants|coagulants|mesh-ancestor
83848775|NCT04517227|Durvalumab|durvalumab|mesh-list
83848776|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848777|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848778|NCT00141713|Etanercept|etanercept|mesh-list
83848779|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83848780|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848781|NCT00141713|Analgesics|analgesics|mesh-ancestor
83848782|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
83848783|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848784|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848785|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848786|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848787|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848788|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848789|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
83848790|NCT04517188|Iodine|iodine|mesh-list
83848791|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
83848792|NCT04517188|Povidone|povidone|mesh-list
83848793|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83848794|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83848795|NCT04517188|Trace Elements|trace elements|mesh-ancestor
83848796|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
83848797|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848798|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
83848799|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
83848800|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
83848801|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83848802|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848803|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848804|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83848805|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83848806|NCT00162552|Protective Agents|protective agents|mesh-ancestor
83848807|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848808|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
83848809|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83848810|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
83848811|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
83848812|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848813|NCT04516681|Vitamins|vitamins|mesh-ancestor
83848814|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
83848815|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
83848816|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848817|NCT04516681|Protective Agents|protective agents|mesh-ancestor
83848818|NCT00141791|Etanercept|etanercept|mesh-list
83848819|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83848820|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848821|NCT00141791|Analgesics|analgesics|mesh-ancestor
83848822|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
83848823|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848824|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848825|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83848826|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848827|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848828|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848829|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
83848830|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
83848831|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83848832|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848833|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848835|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83848836|NCT00162591|Narcotics|narcotics|mesh-ancestor
83848837|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848838|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848839|NCT00162591|Analgesics|analgesics|mesh-ancestor
83848840|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
83848841|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848842|NCT00505492|Paclitaxel|paclitaxel|mesh-list
83848843|NCT00505492|Cisplatin|cisplatin|mesh-list
83848844|NCT00505492|Carboplatin|carboplatin|mesh-list
83848845|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83848846|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848847|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
83848848|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
83848849|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
83848850|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848851|NCT00141830|Methotrexate|methotrexate|mesh-list
83848852|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83848853|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
83848854|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848855|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848856|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83848857|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
83848858|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848859|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848860|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
83848861|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848862|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83848863|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83848864|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
83848865|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83848866|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83848867|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
83848868|NCT04516174|Ropivacaine|ropivacaine|mesh-list
83848869|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83848870|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848871|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848872|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83848873|NCT04516174|Analgesics|analgesics|mesh-ancestor
83848874|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
83848875|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848876|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83848877|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83848878|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83848879|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
83848880|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848881|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848882|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
83848883|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
83848884|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
83848885|NCT04515979|Vactosertib|vactosertib|mesh-list
83848886|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848887|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848888|NCT04515979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83848889|NCT04515979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848890|NCT04515979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83848891|NCT04515979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83848892|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
83848893|NCT00505531|Tramadol|tramadol|mesh-list
83848894|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83848895|NCT00505531|Narcotics|narcotics|mesh-ancestor
83848896|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848897|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848898|NCT00505531|Analgesics|analgesics|mesh-ancestor
83848899|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
83848900|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848901|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83848902|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83848903|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
83848904|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
83848905|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
83848906|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
83848907|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848908|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83848909|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
83848910|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
83848911|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848912|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848913|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83848914|NCT00141908|Castor Oil|castor oil|mesh-list
83848915|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83848916|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83848917|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83848918|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
83848919|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83848920|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848921|NCT00141908|Progestins|progestins|mesh-ancestor
83848922|NCT00141908|Hormones|hormones|mesh-ancestor
83848923|NCT00141908|Cathartics|cathartics|mesh-ancestor
83848924|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848925|NCT00162669|Bevacizumab|bevacizumab|mesh-list
83848926|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848927|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848928|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83848929|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83848930|NCT00162669|Growth Substances|growth substances|mesh-ancestor
83848931|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848932|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83848933|NCT00141947|Bexarotene|bexarotene|mesh-list
83848934|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848935|NCT04514770|Misoprostol|misoprostol|mesh-list
83848936|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83848937|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
83848938|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848939|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848940|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83848941|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83848942|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
83848943|NCT00141986|Vitamin D|vitamin d|mesh-list
83848944|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
83848945|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
83848946|NCT00141986|Vitamins|vitamins|mesh-list
83848947|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
83848948|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848949|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83848950|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83848951|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
83848952|NCT04514731|Analgesics|analgesics|mesh-ancestor
83848953|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
83848954|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848955|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848956|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
83848957|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83848958|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83848959|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
83848960|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83848961|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848962|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848963|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83848964|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
83848965|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83848966|NCT04514419|Docetaxel|docetaxel|mesh-list
83848967|NCT04514419|Trastuzumab|trastuzumab|mesh-list
83848968|NCT04514419|Pertuzumab|pertuzumab|mesh-list
83848969|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83848970|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
83848971|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
83848972|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
83848973|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848974|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83848975|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
83848976|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
83848977|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83848978|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83848979|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848980|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848981|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83848982|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83848983|NCT02275897|Methamphetamine|methamphetamine|mesh-list
83848984|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83848985|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83848986|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
83848987|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
83848988|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83848989|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
83848990|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83848991|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83848992|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
83848993|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83848994|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83848995|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83848996|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83848997|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
83848998|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
83848999|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
83849000|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83849001|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
83849002|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
83849003|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849004|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849005|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849006|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
83849007|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83849008|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849009|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
83849010|NCT00505804|Haloperidol|haloperidol|mesh-list
83849011|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
83849012|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83849013|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849014|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849015|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83849016|NCT00505804|Analgesics|analgesics|mesh-ancestor
83849017|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
83849018|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849019|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83849020|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83849021|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83849022|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
83849023|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849024|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849025|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
83849026|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
83849027|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83849028|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83849029|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849030|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849031|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83849032|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
83849033|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83849034|NCT00505843|Levodopa|levodopa|mesh-list
83849035|NCT00505843|Carbidopa|carbidopa|mesh-list
83849036|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83849037|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83849038|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
83849039|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849040|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849041|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849042|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83849043|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849044|NCT00505882|Pramlintide|pramlintide|mesh-list
83849045|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83849046|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849047|NCT00142337|Zidovudine|zidovudine|mesh-list
83849048|NCT00142337|Didanosine|didanosine|mesh-list
83849049|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
83849050|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849051|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83849052|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83849053|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849054|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
83849055|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849056|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83849057|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83849058|NCT00162864|Montelukast|montelukast|mesh-list
83849059|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83849060|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
83849061|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83849062|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
83849063|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849064|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849065|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83849066|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83849067|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849068|NCT04512313|Rocuronium|rocuronium|mesh-list
83849069|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83849070|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83849071|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83849072|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849073|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849074|NCT00142493|Midazolam|midazolam|mesh-list
83849075|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
83849076|NCT00142493|Thiopental|thiopental|mesh-list
83849077|NCT00142493|Propofol|propofol|mesh-list
83849078|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83849079|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849080|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849081|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83849082|NCT00142493|Analgesics|analgesics|mesh-ancestor
83849083|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
83849084|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849085|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83849086|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83849087|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83849088|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
83849089|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849090|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849091|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83849092|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
83849093|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
83849094|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83849095|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83849096|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849097|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849098|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
83849099|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
83849100|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
83849101|NCT04511923|Heparin|heparin|mesh-list
83849102|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
83849103|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83849104|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83849105|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849106|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
83849107|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83849108|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
83849109|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83849110|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
83849111|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849112|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849113|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
83849114|NCT04511299|SMOFlipid|smoflipid|mesh-list
83849115|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83849116|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83849117|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83849118|NCT00142571|Gemcitabine|gemcitabine|mesh-list
83849119|NCT00142571|Docetaxel|docetaxel|mesh-list
83849120|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83088026|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088027|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
83088028|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088029|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83088030|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83088031|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088032|NCT03302390|Lidocaine|lidocaine|mesh-list
83088033|NCT03302390|Epinephrine|epinephrine|mesh-list
83088034|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
83088035|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
83088036|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088037|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849121|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
83849122|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849123|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849124|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83849125|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849126|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83849127|NCT00142610|Vitamins|vitamins|mesh-list
83849128|NCT00142610|Vitamin E|vitamin e|mesh-list
83849129|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
83849130|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849131|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
83849132|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849133|NCT00142610|Protective Agents|protective agents|mesh-ancestor
83849134|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
83849135|NCT04510870|Hematinics|hematinics|mesh-ancestor
83849136|NCT00406575|Methocarbamol|methocarbamol|mesh-list
83849137|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83849138|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849139|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83849140|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849141|NCT02275975|Fluconazole|fluconazole|mesh-list
83849142|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
83849143|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849144|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83849145|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83849146|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849147|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849148|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83849149|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
83849150|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849151|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849152|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83849153|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83849154|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
83849155|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83849156|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
83849157|NCT00142727|Methadone|methadone|mesh-list
83849158|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
83849159|NCT00142727|Narcotics|narcotics|mesh-ancestor
83849160|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849161|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849162|NCT00142727|Analgesics|analgesics|mesh-ancestor
83849163|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
83849164|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849165|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
83849166|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
83849167|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
83849168|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83849169|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849170|NCT00506194|Gliclazide|gliclazide|mesh-list
83849171|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83849172|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849173|NCT00404573|Cariprazine|cariprazine|mesh-list
83849174|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83849175|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849176|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849177|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849178|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849179|NCT00506272|Insulin|insulin|mesh-list
83849180|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83849181|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849182|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83849183|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
83849184|NCT00506311|Coagulants|coagulants|mesh-ancestor
83849185|NCT04519645|Lacosamide|lacosamide|mesh-list
83849186|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
83849187|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83849188|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83849189|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849190|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849191|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83088101|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849192|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849193|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849194|NCT00142844|Naltrexone|naltrexone|mesh-list
83849195|NCT00142844|Disulfiram|disulfiram|mesh-list
83849196|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83849197|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83849198|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849199|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
83849200|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849201|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83849202|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849203|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849204|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83849205|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83849206|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
83849207|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849208|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849209|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83849210|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83849211|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83849212|NCT00142883|Pregabalin|pregabalin|mesh-list
83849213|NCT00142883|Analgesics|analgesics|mesh-ancestor
83849214|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
83849215|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849216|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849217|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
83849218|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83849219|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849220|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849221|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83849222|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83849223|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849224|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849225|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849226|NCT04517851|Elotuzumab|elotuzumab|mesh-list
83849227|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849228|NCT04515238|Venetoclax|venetoclax|mesh-list
83849229|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83849230|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
83849231|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
83849232|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849233|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83849234|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
83849235|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849236|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83849237|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83849238|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849239|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83849240|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83849241|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83849242|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849243|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849244|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83849245|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849246|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849247|NCT00163254|Abciximab|abciximab|mesh-list
83849248|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
83849249|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83849250|NCT00143000|Ribavirin|ribavirin|mesh-list
83849251|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83849252|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
83849253|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849254|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
83849255|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849256|NCT04514029|Dexamethasone|dexamethasone|mesh-list
83849257|NCT04514029|Simvastatin|simvastatin|mesh-list
83849258|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83849259|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
83849260|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
83849261|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849262|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849263|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83849264|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
83849265|NCT04514029|Hormones|hormones|mesh-ancestor
83849266|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849267|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83849268|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849269|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83849270|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83849271|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
83849272|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849273|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83849274|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83849275|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849276|NCT02590393|Nicotine|nicotine|mesh-list
83849277|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83849278|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
83849279|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849280|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849281|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83849282|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83849283|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
83849284|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849285|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849286|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
83849287|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83849288|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
83849289|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849290|NCT00506506|Expectorants|expectorants|mesh-ancestor
83849291|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
83849292|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83849293|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
83849294|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849295|NCT00506506|Protective Agents|protective agents|mesh-ancestor
83849296|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849297|NCT00506506|Antidotes|antidotes|mesh-ancestor
83849298|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
83849299|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83849300|NCT00163332|Ciclesonide|ciclesonide|mesh-list
83849301|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
83849302|NCT00163332|Hormones|hormones|mesh-ancestor
83849303|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849304|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849305|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83849306|NCT00163371|Ciclesonide|ciclesonide|mesh-list
83849307|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
83849308|NCT00163371|Hormones|hormones|mesh-ancestor
83849309|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849310|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849311|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83849312|NCT00143156|Pregabalin|pregabalin|mesh-list
83849313|NCT00143156|Analgesics|analgesics|mesh-ancestor
83849314|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
83849315|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849316|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849317|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
83849318|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83849319|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849320|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849321|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83849322|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83849323|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849324|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849325|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849326|NCT00163410|Ciclesonide|ciclesonide|mesh-list
83849327|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
83849328|NCT00163410|Hormones|hormones|mesh-ancestor
83849329|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849330|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849331|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83849332|NCT00143195|Amlodipine|amlodipine|mesh-list
83849333|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83849334|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83849335|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849336|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849337|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83849338|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849339|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
83849340|NCT00163449|Ciclesonide|ciclesonide|mesh-list
83849341|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
83849342|NCT00163449|Hormones|hormones|mesh-ancestor
84148828|NCT04135781|Tegafur|tegafur|mesh-list
83849343|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849344|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849345|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83849346|NCT00143234|Amlodipine|amlodipine|mesh-list
83849347|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83849348|NCT00143234|Atorvastatin|atorvastatin|mesh-list
83849349|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83849350|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83849351|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
83849352|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849353|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83849354|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83849355|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849356|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83849357|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83849358|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849359|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83849360|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849361|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
83849362|NCT00163488|Ciclesonide|ciclesonide|mesh-list
83849363|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
83849364|NCT00163488|Hormones|hormones|mesh-ancestor
83849365|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849366|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849367|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83849368|NCT00143351|Ziprasidone|ziprasidone|mesh-list
83849369|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83849370|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
83849371|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849372|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849373|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849374|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83849375|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849376|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849377|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849378|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83849379|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
83849380|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83849381|NCT00163605|Thrombin|thrombin|mesh-list
83849382|NCT00163605|Calcium|calcium|mesh-list
83849383|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83849384|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849385|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
83849386|NCT00163605|Coagulants|coagulants|mesh-ancestor
83849387|NCT02598583|Ravulizumab|ravulizumab|mesh-list
83849388|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83849389|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83849390|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
83849391|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849392|NCT00143429|Latanoprost|latanoprost|mesh-list
83849393|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83849394|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83849395|NCT02598895|Carboplatin|carboplatin|mesh-list
83849396|NCT02598895|Docetaxel|docetaxel|mesh-list
83849397|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849398|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
83849399|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849400|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
83147924|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83849401|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849402|NCT05147272|Gemcitabine|gemcitabine|mesh-list
83849403|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849404|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
83849405|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849406|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849407|NCT00143546|Defibrotide|defibrotide|mesh-list
83849408|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83849409|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83849410|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849411|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83849412|NCT00155883|Leucovorin|leucovorin|mesh-list
83849413|NCT00155883|Fluorouracil|fluorouracil|mesh-list
83849414|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
83849415|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849416|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83088330|NCT02233881|Ipratropium|ipratropium|mesh-list
83849417|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849418|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83849419|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
83849420|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849421|NCT00155883|Antidotes|antidotes|mesh-ancestor
83849422|NCT00155883|Protective Agents|protective agents|mesh-ancestor
83849423|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
83849424|NCT00155883|Vitamins|vitamins|mesh-ancestor
83849425|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
83849426|NCT00506545|Rolapitant|rolapitant|mesh-list
83849427|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83849428|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849429|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849430|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849431|NCT04696393|Mitapivat|mitapivat|mesh-list
83849432|NCT04696393|Enzyme Activators|enzyme activators|mesh-ancestor
83849433|NCT04696393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849434|NCT05143723|Hormones|hormones|mesh-list
83849435|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849436|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849437|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
83849438|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83849439|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849440|NCT05142865|Carboplatin|carboplatin|mesh-list
83849441|NCT05142865|Etoposide|etoposide|mesh-list
83849442|NCT05142865|Apatinib|apatinib|mesh-list
83849443|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849444|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83849445|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83849446|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83849447|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849448|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849449|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83849450|NCT00143702|Riboflavin|riboflavin|mesh-list
83849451|NCT00143702|Thiamine|thiamine|mesh-list
83849452|NCT00143702|Abacavir|abacavir|mesh-list
83849453|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83849454|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83849455|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849456|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849457|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
83849458|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849459|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83849460|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83849461|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
83849462|NCT00143702|Vitamins|vitamins|mesh-ancestor
83849463|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
83849464|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849465|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83147960|NCT02130323|Imiquimod|imiquimod|mesh-list
83849466|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
83849467|NCT00156078|Pregabalin|pregabalin|mesh-list
83849468|NCT00156078|Analgesics|analgesics|mesh-ancestor
83849469|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
83849470|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849471|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849472|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
83849473|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83849474|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849475|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849476|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83849477|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83849478|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849479|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849480|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849481|NCT00506623|Capecitabine|capecitabine|mesh-list
83849482|NCT00506623|Irinotecan|irinotecan|mesh-list
83849483|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849484|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
83849485|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849486|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849487|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83849488|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83849489|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849490|NCT00143741|Atorvastatin|atorvastatin|mesh-list
83849491|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83088398|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849492|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83849493|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
83849494|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849495|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83849496|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83849497|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849498|NCT00143780|Vaccines|vaccines|mesh-list
83849499|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
83849500|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849501|NCT02276365|Pioglitazone|pioglitazone|mesh-list
83849502|NCT02276365|Empagliflozin|empagliflozin|mesh-list
83849503|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83849504|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849505|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83849506|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849507|NCT05145634|Anticoagulants|anticoagulants|mesh-list
83849508|NCT00143975|Cytarabine|cytarabine|mesh-list
83849509|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
83849510|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
83849511|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849512|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
83849513|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849514|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849515|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
83849516|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849517|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83849518|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
83849519|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849520|NCT00143975|Analgesics|analgesics|mesh-ancestor
83849521|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
83849522|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849523|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83849524|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83849525|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849526|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83849527|NCT00143975|Immunotoxins|immunotoxins|mesh-ancestor
83849528|NCT00143975|Immunoconjugates|immunoconjugates|mesh-ancestor
83849529|NCT00156312|Docetaxel|docetaxel|mesh-list
83849530|NCT00156312|Capecitabine|capecitabine|mesh-list
83849531|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849532|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
83849533|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849534|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
83849535|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849536|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849537|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
83849538|NCT00506701|Tadalafil|tadalafil|mesh-list
83849539|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
83849540|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83849541|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83849542|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849543|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849544|NCT00506701|Urological Agents|urological agents|mesh-ancestor
83849545|NCT05147857|Misoprostol|misoprostol|mesh-list
83849546|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83849547|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
83849548|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83849549|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849550|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83849551|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83849552|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
83849553|NCT00144053|Paclitaxel|paclitaxel|mesh-list
83849554|NCT00144053|Vindesine|vindesine|mesh-list
83849555|NCT00144053|Carboplatin|carboplatin|mesh-list
83849556|NCT00144053|Irinotecan|irinotecan|mesh-list
83849557|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83849558|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849559|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83849560|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849561|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088473|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088474|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088475|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83088476|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
83088477|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83088479|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83849562|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849563|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83849564|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83849565|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849567|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
83849568|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
83849569|NCT00144131|Hematinics|hematinics|mesh-ancestor
83849570|NCT00144209|Levodopa|levodopa|mesh-list
83849571|NCT00144209|Pramipexole|pramipexole|mesh-list
83849572|NCT00144209|Benserazide|benserazide|mesh-list
83849573|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83849574|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83849575|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
83849576|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849577|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849578|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849579|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
83849580|NCT00144209|Protective Agents|protective agents|mesh-ancestor
83849581|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
83849582|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849583|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
83849584|NCT05149339|Vitamin D|vitamin d|mesh-list
83849585|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83849586|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849587|NCT05149339|Vitamins|vitamins|mesh-ancestor
83849588|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
83849589|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83849590|NCT00144248|Nevirapine|nevirapine|mesh-list
83849591|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83849592|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83849593|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849594|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849595|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
83849596|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849597|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83849598|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83849599|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83849600|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83849601|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83849602|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
83849603|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849604|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849605|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849606|NCT00144287|Ritonavir|ritonavir|mesh-list
83849607|NCT00144287|Tipranavir|tipranavir|mesh-list
83849608|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83849609|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83849610|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
83849611|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849612|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849613|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83849614|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83849615|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
83849616|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849617|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83849618|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83849619|NCT00144326|Bromides|bromides|mesh-list
83849620|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
83849621|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83849622|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
83849623|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849624|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849625|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83849626|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
83849627|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
83849628|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83849629|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
83849630|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849631|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849632|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
83849633|NCT02954692|Metformin|metformin|mesh-list
83849634|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
83849635|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83849636|NCT02954692|Meglitinide|meglitinide|mesh-list
83849637|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83849638|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83849639|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849640|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849641|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849642|NCT00506935|Vigabatrin|vigabatrin|mesh-list
83849643|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
83849644|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849645|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849646|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
83849647|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849648|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849649|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83849650|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
83849651|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849652|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
83849653|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83849654|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83849655|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
83849656|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
83849657|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849658|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849659|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83849660|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849661|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
83849662|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83849663|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
83849664|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849665|NCT00507052|Expectorants|expectorants|mesh-ancestor
83849666|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
83849667|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83849668|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
83849669|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849670|NCT00507052|Protective Agents|protective agents|mesh-ancestor
83849671|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849672|NCT00507052|Antidotes|antidotes|mesh-ancestor
83849673|NCT00507091|Leucovorin|leucovorin|mesh-list
83849674|NCT00507091|Fluorouracil|fluorouracil|mesh-list
83849675|NCT00507091|Irinotecan|irinotecan|mesh-list
83849676|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
83849677|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849678|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849679|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849680|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83849681|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
83849682|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849683|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83849684|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83849685|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849686|NCT00507091|Antidotes|antidotes|mesh-ancestor
83849687|NCT00507091|Protective Agents|protective agents|mesh-ancestor
83849688|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
83849689|NCT00507091|Vitamins|vitamins|mesh-ancestor
83849690|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
83849692|NCT05148910|Trace Elements|trace elements|mesh-ancestor
83849693|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
83849694|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849695|NCT00148083|Risperidone|risperidone|mesh-list
83849696|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83849697|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
83849698|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849699|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849700|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849701|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83849702|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83849703|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849704|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83849705|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83849706|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
83849707|NCT05148442|Azacitidine|azacitidine|mesh-list
83849708|NCT05148442|Decitabine|decitabine|mesh-list
83849709|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849710|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
83849711|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088633|NCT03306836|Heparin|heparin|mesh-list
83849712|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849713|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849714|NCT05148403|Glyburide|glyburide|mesh-list
83849715|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83849716|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849717|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
83849718|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83849719|NCT05148169|Sulforaphane|sulforaphane|mesh-list
83849720|NCT05148169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83849721|NCT05148169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83849722|NCT05148169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849723|NCT05148169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849724|NCT05148169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849725|NCT05148169|Serotonin Agents|serotonin agents|mesh-ancestor
83849726|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849727|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83849728|NCT05148169|Protective Agents|protective agents|mesh-ancestor
83849729|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849730|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
83849731|NCT00144482|Hematinics|hematinics|mesh-ancestor
83849732|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
83849733|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83849734|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83849735|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
83849736|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849737|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83849738|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
83849739|NCT05146687|Bevacizumab|bevacizumab|mesh-list
83849740|NCT05146687|Ranibizumab|ranibizumab|mesh-list
83849741|NCT05146687|Aflibercept|aflibercept|mesh-list
83849742|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83849743|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849744|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83849745|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83849746|NCT05146687|Growth Substances|growth substances|mesh-ancestor
83849747|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849748|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
83849749|NCT05141422|Efavirenz|efavirenz|mesh-list
83849750|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83849751|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83849752|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849753|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849754|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
83849755|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849756|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83849757|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83849758|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83849759|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83849760|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83849761|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83849762|NCT05148637|Lidocaine|lidocaine|mesh-list
83849763|NCT05148637|Fentanyl|fentanyl|mesh-list
83849764|NCT05148637|Anesthetics|anesthetics|mesh-list
83849765|NCT05148637|Sevoflurane|sevoflurane|mesh-list
83849766|NCT05148637|Desflurane|desflurane|mesh-list
83849767|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
83849768|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849769|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849770|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
83849771|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849772|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83849773|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83849774|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83849775|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849776|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849777|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83849778|NCT05148637|Narcotics|narcotics|mesh-ancestor
83849779|NCT05148637|Analgesics|analgesics|mesh-ancestor
83849780|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83849781|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83849782|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
83849783|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83849784|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83849785|NCT00148278|Dobutamine|dobutamine|mesh-list
83849786|NCT00148278|Epinephrine|epinephrine|mesh-list
83849787|NCT00148278|Norepinephrine|norepinephrine|mesh-list
83849788|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83849789|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83849790|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
83849791|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849792|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849793|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849794|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83849795|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83849796|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
83849797|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849798|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83849799|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83849800|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
83849801|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
83849802|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83849803|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83849804|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83849805|NCT00148278|Protective Agents|protective agents|mesh-ancestor
83849806|NCT05594849|Budesonide|budesonide|mesh-list
83849807|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83849808|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83849809|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
83849810|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849811|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849812|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83849813|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
83849814|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
83849815|NCT05594849|Hormones|hormones|mesh-ancestor
83849816|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849817|NCT00507247|Daptomycin|daptomycin|mesh-list
83849818|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83849819|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849820|NCT00507286|Alprostadil|alprostadil|mesh-list
83849821|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83849822|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
83849823|NCT00507286|Urological Agents|urological agents|mesh-ancestor
83849824|NCT05143762|Acetaminophen|acetaminophen|mesh-list
83849825|NCT05143762|Dexamethasone|dexamethasone|mesh-list
83849826|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83849827|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
83849828|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
83849829|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849830|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849831|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83849832|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
83849833|NCT05143762|Hormones|hormones|mesh-ancestor
83849834|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83849835|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83849836|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849837|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83849838|NCT05143762|Analgesics|analgesics|mesh-ancestor
83849839|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
83849840|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
83849841|NCT00148356|Paclitaxel|paclitaxel|mesh-list
83849842|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83849843|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849844|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83849845|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849846|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83849847|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849848|NCT00424281|PENTA|penta|mesh-list
83849849|NCT00424281|Fondaparinux|fondaparinux|mesh-list
83849850|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83849851|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
83849852|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83849853|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83849854|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849855|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849856|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
83849857|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83849858|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83849859|NCT00148395|Carboplatin|carboplatin|mesh-list
83849860|NCT00148395|Gemcitabine|gemcitabine|mesh-list
83849861|NCT00148395|Ifosfamide|ifosfamide|mesh-list
83849862|NCT00148395|Mitomycins|mitomycins|mesh-list
83849863|NCT00148395|Mitomycin|mitomycin|mesh-list
83849864|NCT00148395|Vinorelbine|vinorelbine|mesh-list
83849865|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849866|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849867|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
83849868|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849869|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83849870|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
83849871|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83849872|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83849873|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849874|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83849875|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
83849876|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
83849877|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
83849878|NCT02276677|Oxytocin|oxytocin|mesh-list
83849879|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
83849880|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83849881|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849882|NCT05141344|Melatonin|melatonin|mesh-list
83849883|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
83849884|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849885|NCT05141344|Protective Agents|protective agents|mesh-ancestor
83849886|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849887|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83849888|NCT00156858|Busulfan|busulfan|mesh-list
83849889|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
83849890|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849891|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83849892|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
83849893|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849894|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83849895|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849896|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83849897|NCT03451825|Avelumab|avelumab|mesh-list
83849898|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83849899|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83849900|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849901|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
83849902|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849903|NCT00156897|Orlistat|orlistat|mesh-list
83849904|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849905|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849906|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83849907|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83849908|NCT03459859|Cytarabine|cytarabine|mesh-list
83849909|NCT03459859|Pevonedistat|pevonedistat|mesh-list
83849910|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849911|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
83849912|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849913|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849914|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
83849915|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849916|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83849917|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
83849918|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849919|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849920|NCT05594459|Analgesics|analgesics|mesh-list
83849921|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849922|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
83849923|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849924|NCT00507403|Infliximab|infliximab|mesh-list
83849925|NCT00507403|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83849926|NCT00507403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83849927|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83849928|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83849929|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83849930|NCT00156975|Capecitabine|capecitabine|mesh-list
83849931|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
83849932|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849933|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
83849934|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849935|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849936|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
83849937|NCT05594381|Tegafur|tegafur|mesh-list
83849938|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849939|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83849940|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
83849941|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849942|NCT00148473|Misoprostol|misoprostol|mesh-list
83849943|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83849944|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
83849945|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83849946|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849947|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83849948|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83849949|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
83849950|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
83849951|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83849952|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83849953|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83849954|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83849955|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83849956|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849957|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
83849958|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849959|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849960|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83849961|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849962|NCT05594342|Dobutamine|dobutamine|mesh-list
83849963|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83849964|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
83849965|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
83849966|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83849967|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849968|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83849969|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83849970|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83849971|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
83849972|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83849973|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849974|NCT05594342|Protective Agents|protective agents|mesh-ancestor
83849975|NCT00157053|Factor VIII|factor viii|mesh-list
83849976|NCT00157053|Coagulants|coagulants|mesh-ancestor
83849977|NCT00507793|Cyclosporine|cyclosporine|mesh-list
83849978|NCT00507793|Sirolimus|sirolimus|mesh-list
83849979|NCT00507793|Cyclosporins|cyclosporins|mesh-list
83849980|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83849981|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83849982|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83849983|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
83849984|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83849985|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
83849986|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83849987|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
83849988|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83849989|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83849990|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83849991|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83849992|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83849993|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
83849994|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83849995|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83849996|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83849997|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
83849998|NCT00507832|Tacrolimus|tacrolimus|mesh-list
83849999|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850000|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83850001|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83850002|NCT00507832|Analgesics|analgesics|mesh-ancestor
83850003|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
83850004|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850005|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850006|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850007|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850008|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850009|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
83850010|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83850011|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850012|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850013|NCT00507949|Megestrol|megestrol|mesh-list
83850014|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
83850015|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83850016|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83088926|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83850017|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83850018|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
83850019|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850020|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850021|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83850022|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83850023|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83850024|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850025|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
83850026|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83850027|NCT00148551|Triamcinolone|triamcinolone|mesh-list
83850028|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83850029|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83850030|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83850031|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850032|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
83850033|NCT00148551|Hormones|hormones|mesh-ancestor
83850034|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850035|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850036|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850037|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
83850038|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850039|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850040|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
83850041|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
83850042|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
83850043|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
83850044|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83850045|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83850046|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83850047|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850048|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
83850049|NCT05594186|Coagulants|coagulants|mesh-ancestor
83850050|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850051|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850052|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83850053|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83850054|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83850055|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83850056|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
83850057|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83850058|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83850059|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
83850060|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850061|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850062|NCT00148590|Memantine|memantine|mesh-list
83850063|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83850064|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83850065|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
83850066|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850067|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850068|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850069|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83850070|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83850071|NCT02954068|Oxytocin|oxytocin|mesh-list
83850072|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
83850073|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850074|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850075|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83850076|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
83850077|NCT00157131|Coagulants|coagulants|mesh-ancestor
83850078|NCT02954029|Hemostatics|hemostatics|mesh-list
83850079|NCT02954029|Coagulants|coagulants|mesh-ancestor
83850080|NCT00508456|Temozolomide|temozolomide|mesh-list
83850081|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83850082|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
83850083|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850084|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850085|NCT00508495|Acetaminophen|acetaminophen|mesh-list
83850086|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83850087|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83850088|NCT00508495|Analgesics|analgesics|mesh-ancestor
83850089|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
83850090|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850091|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850092|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
83850093|NCT00508690|Metronidazole|metronidazole|mesh-list
83850095|NCT00508690|Cefmetazole|cefmetazole|mesh-list
83850096|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850097|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850098|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83850099|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83850100|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83850101|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850102|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850103|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83850104|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850105|NCT05591144|Prednisone|prednisone|mesh-list
83850106|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850107|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
83850108|NCT05591144|Hormones|hormones|mesh-ancestor
83850109|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850110|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850111|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83850112|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850113|NCT02953522|Folic Acid|folic acid|mesh-list
83850114|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
83850115|NCT02953522|Hematinics|hematinics|mesh-ancestor
83850116|NCT02953522|Vitamins|vitamins|mesh-ancestor
83850117|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
83850118|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850119|NCT00148746|Cyclosporine|cyclosporine|mesh-list
83850120|NCT00148746|Prednisolone|prednisolone|mesh-list
83850121|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
83850122|NCT00148746|Prednicarbate|prednicarbate|mesh-list
83850123|NCT00148746|Tacrolimus|tacrolimus|mesh-list
83850124|NCT00148746|Cyclosporins|cyclosporins|mesh-list
83850125|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850126|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
83850127|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850128|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83850129|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850130|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850131|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
83850132|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850133|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850134|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850135|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850136|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
83850137|NCT00148746|Hormones|hormones|mesh-ancestor
83850138|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147969|NCT03549611|Gabapentin|gabapentin|mesh-list
83850139|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83850140|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850141|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850142|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83850143|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83850144|NCT00148746|Analgesics|analgesics|mesh-ancestor
83850145|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
83850146|NCT00148785|Ritonavir|ritonavir|mesh-list
83850147|NCT00148785|Indinavir|indinavir|mesh-list
83850148|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
83850149|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83850150|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83850151|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
83850152|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850153|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850154|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83850155|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83850156|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
83850157|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850158|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83850159|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83850160|NCT00148824|Vaccines|vaccines|mesh-list
83850161|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83850162|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
83850163|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850164|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
83850165|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
83850166|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850167|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850168|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83850169|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83850170|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850171|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850172|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850173|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83850174|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83850175|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83850176|NCT00466609|Fluoxetine|fluoxetine|mesh-list
83850177|NCT00466609|Clomipramine|clomipramine|mesh-list
83850178|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
83850179|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83850180|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83850181|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83850182|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83850183|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850184|NCT00466609|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83850185|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83850186|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83850187|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850188|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850189|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
83850190|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83850191|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83850192|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83850193|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850194|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83850195|NCT00157326|Tadalafil|tadalafil|mesh-list
83850196|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
83850197|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83850198|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83850199|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850200|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850201|NCT00157326|Urological Agents|urological agents|mesh-ancestor
83850202|NCT00466843|Prednisone|prednisone|mesh-list
83850203|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83850204|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850205|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
83850206|NCT00466843|Hormones|hormones|mesh-ancestor
83850207|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850208|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850209|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83850210|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850211|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
83850212|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850213|NCT00148863|Interferons|interferons|mesh-list
83850214|NCT00148863|Ribavirin|ribavirin|mesh-list
83850215|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
83850216|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
83850217|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
83850218|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83850219|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850220|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
83850221|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850222|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
83850223|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850224|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
83850225|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850226|NCT00466999|Misoprostol|misoprostol|mesh-list
83850227|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83850228|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
83850229|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850230|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850231|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83850232|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83850233|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
83850234|NCT00467116|Gemcitabine|gemcitabine|mesh-list
83850235|NCT00467116|Cetuximab|cetuximab|mesh-list
83850236|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83850237|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
83850238|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850239|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850240|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850241|NCT00157482|Simvastatin|simvastatin|mesh-list
83850242|NCT00157482|Ezetimibe|ezetimibe|mesh-list
83850243|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83850244|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83089151|NCT01510119|Everolimus|everolimus|mesh-list
83850246|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850247|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83850248|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83850249|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850250|NCT00467194|Sirolimus|sirolimus|mesh-list
83850251|NCT00467194|Bevacizumab|bevacizumab|mesh-list
83850252|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850253|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850254|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83850255|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83850256|NCT00467194|Growth Substances|growth substances|mesh-ancestor
83850257|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850258|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
83850259|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850260|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850261|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83850262|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
83850263|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850264|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
83850265|NCT00148902|Docetaxel|docetaxel|mesh-list
83850266|NCT00148902|Lapatinib|lapatinib|mesh-list
83850267|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850268|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
83850269|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
83850270|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
83850271|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850272|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83850273|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850274|NCT05507645|Saruplase|saruplase|mesh-list
83850275|NCT05507645|Anticoagulants|anticoagulants|mesh-list
83850276|NCT05507645|Clopidogrel|clopidogrel|mesh-list
83850277|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850278|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83850279|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83850280|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850281|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83850282|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83850283|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83850284|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83850285|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
83850286|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850287|NCT03271918|Cabergoline|cabergoline|mesh-list
83850288|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83850289|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83850290|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
83850291|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
83850292|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850293|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850294|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850295|NCT00467467|Alfuzosin|alfuzosin|mesh-list
83850296|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83850297|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83850298|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83850299|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
83850300|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850301|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850302|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850303|NCT00467467|Urological Agents|urological agents|mesh-ancestor
83850304|NCT00406887|Difluprednate|difluprednate|mesh-list
83850305|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
83850306|NCT00406887|Hormones|hormones|mesh-ancestor
83850307|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850308|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850309|NCT00467506|Antibodies|antibodies|mesh-list
83850310|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83850311|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
83850312|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850313|NCT00467545|Telbivudine|telbivudine|mesh-list
83850314|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
83850315|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850316|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83089213|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83850317|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850318|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850319|NCT00467662|Acyclovir|acyclovir|mesh-list
83850320|NCT00467662|Docosanol|docosanol|mesh-list
83850321|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
83850322|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850323|NCT05497310|Tretinoin|tretinoin|mesh-list
83850324|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
83850325|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850326|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
83850327|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850328|NCT00467935|Ranibizumab|ranibizumab|mesh-list
83850329|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83850330|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83850331|NCT00467935|Growth Substances|growth substances|mesh-ancestor
83850332|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850333|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
83850334|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850335|NCT00149019|Antibodies|antibodies|mesh-list
83850336|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83850337|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
83850338|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850339|NCT00468091|Atropine|atropine|mesh-list
83850340|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83850341|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83850342|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83850343|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
83850344|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850345|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850346|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83850347|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
83850348|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
83850349|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
83850350|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83850351|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83850352|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
83850353|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850354|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850355|NCT00468364|Insulin|insulin|mesh-list
83850356|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83850357|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
83850358|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
83850359|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
83850360|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
83850361|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83850362|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850363|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
83850364|NCT00149058|Hematinics|hematinics|mesh-ancestor
83850365|NCT00468520|Oxytocin|oxytocin|mesh-list
83850366|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
83850367|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850368|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850369|NCT03271450|Warfarin|warfarin|mesh-list
83850370|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
83850371|NCT03271450|Dabigatran|dabigatran|mesh-list
83850372|NCT03271450|Apixaban|apixaban|mesh-list
83850373|NCT03271450|Edoxaban|edoxaban|mesh-list
83850374|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
83850375|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83850376|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
83850377|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83850378|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
83850379|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850380|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850381|NCT00468754|Insulin|insulin|mesh-list
83850382|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83850383|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850384|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83850385|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83850386|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850387|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
83850388|NCT00468871|Hormones|hormones|mesh-ancestor
83850389|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850390|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850391|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
83850392|NCT00468988|Travoprost|travoprost|mesh-list
83850393|NCT00468988|Latanoprost|latanoprost|mesh-list
83850394|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83850395|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83850396|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83850397|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
83850398|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850399|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83850400|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850401|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850402|NCT00469261|Doxycycline|doxycycline|mesh-list
83850403|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850404|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850405|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
83850406|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83850407|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83850408|NCT00469300|Acyclovir|acyclovir|mesh-list
83850409|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
83850410|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850411|NCT04697641|Amoxicillin|amoxicillin|mesh-list
83850412|NCT04697641|Clarithromycin|clarithromycin|mesh-list
83850413|NCT04697641|Pantoprazole|pantoprazole|mesh-list
83850414|NCT04697641|Z 338|z 338|mesh-list
83850415|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850416|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850417|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83850418|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850419|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850420|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83850421|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83850422|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83850423|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83850424|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83850425|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83850426|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
83850427|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850428|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850429|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83850430|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83850431|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83850432|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850433|NCT00469495|Anthelmintics|anthelmintics|mesh-list
83850434|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83850435|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850436|NCT00469651|Vaccines|vaccines|mesh-list
83850437|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
83850438|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850439|NCT00149253|Etoricoxib|etoricoxib|mesh-list
83850440|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850441|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83850442|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83850443|NCT00149253|Analgesics|analgesics|mesh-ancestor
83850444|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
83850445|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850446|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850447|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850448|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83850449|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83850450|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850451|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850452|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83850453|NCT00469690|Bromfenac|bromfenac|mesh-list
83850454|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83850455|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83850456|NCT00469690|Analgesics|analgesics|mesh-ancestor
83850457|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
83850458|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850459|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850460|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850461|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850462|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83850463|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850464|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850465|NCT00469768|Dapivirine|dapivirine|mesh-list
83850466|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83850467|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83850468|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
83850469|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850470|NCT00469885|Nicotine|nicotine|mesh-list
83850471|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83850472|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
83850473|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089362|NCT05231382|Leucovorin|leucovorin|mesh-list
83850474|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850475|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83850476|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83850477|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
83850478|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850479|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850480|NCT00469924|Caffeine|caffeine|mesh-list
83850481|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83850482|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850483|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83850484|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850485|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850486|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83850487|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83850488|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
83850489|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850490|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
83850491|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83850492|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83850493|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850494|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
83850495|NCT00157677|Coagulants|coagulants|mesh-ancestor
83850496|NCT05425979|Bupivacaine|bupivacaine|mesh-list
83850497|NCT05425979|Mepivacaine|mepivacaine|mesh-list
83850498|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
83850499|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
83850500|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83850501|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850502|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
83850503|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850504|NCT00470041|Lamivudine|lamivudine|mesh-list
83850505|NCT00470041|Zidovudine|zidovudine|mesh-list
83850506|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
83850507|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83850508|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83850509|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850510|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850511|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850512|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83850513|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83850514|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
83850515|NCT00157716|Pyridoxal|pyridoxal|mesh-list
83850516|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83850517|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
83850518|NCT00157716|Vitamins|vitamins|mesh-ancestor
83850519|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
83850520|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850521|NCT00470197|Cytarabine|cytarabine|mesh-list
83850522|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
83850523|NCT00470197|Alvocidib|alvocidib|mesh-list
83850524|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83850525|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
83850526|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850527|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850528|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
83850529|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850530|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850531|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
83850532|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850533|NCT00470197|Analgesics|analgesics|mesh-ancestor
83850534|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
83850535|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850536|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83850537|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83850538|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850539|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
83850540|NCT00470197|Growth Substances|growth substances|mesh-ancestor
83850541|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83850542|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
83850543|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83850544|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83850545|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850546|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850547|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850548|NCT00149292|Olanzapine|olanzapine|mesh-list
83089439|NCT05379855|Atropine|atropine|mesh-list
83850549|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
83850550|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
83850551|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850552|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850553|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83850554|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83850555|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83850556|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83850557|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83850558|NCT00149292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83850559|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83850560|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83850561|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850562|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850563|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
83850564|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
83850565|NCT00470353|Vitamin D|vitamin d|mesh-list
83850566|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
83850567|NCT00470353|Calcium|calcium|mesh-list
83850568|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83850569|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850570|NCT00470353|Vitamins|vitamins|mesh-ancestor
83850571|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
83850572|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83850573|NCT00470353|Antacids|antacids|mesh-ancestor
83850574|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850575|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83850576|NCT05391893|Diltiazem|diltiazem|mesh-list
83850577|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83850578|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83850579|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83850580|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850581|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83850582|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850583|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
83850584|NCT00470509|Adalimumab|adalimumab|mesh-list
83850585|NCT00470509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83850586|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850587|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850588|NCT05378906|Darunavir|darunavir|mesh-list
83850589|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83850590|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83850591|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
83850592|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850593|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850594|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83850595|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83850596|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
83850597|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850598|NCT00470665|Sirolimus|sirolimus|mesh-list
83850599|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850600|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850601|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83850602|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850603|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
83850604|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850605|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
83850606|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850607|NCT00470743|Ibuprofen|ibuprofen|mesh-list
83850608|NCT00470743|Indomethacin|indomethacin|mesh-list
83850609|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83850610|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83850611|NCT00470743|Analgesics|analgesics|mesh-ancestor
83850612|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
83850613|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850614|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850615|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850616|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850617|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83850618|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850619|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850620|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
83850621|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
83850622|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850623|NCT00470821|Melatonin|melatonin|mesh-list
83850624|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
83850625|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850626|NCT00470821|Protective Agents|protective agents|mesh-ancestor
83850627|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850628|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83850629|NCT00335920|Dexamethasone|dexamethasone|mesh-list
83850630|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850631|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
83850632|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
83850633|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850634|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850635|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83850636|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
83850637|NCT00335920|Hormones|hormones|mesh-ancestor
83850638|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850639|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83850640|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850641|NCT00335998|Cisplatin|cisplatin|mesh-list
83850642|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850643|NCT00470977|Ranibizumab|ranibizumab|mesh-list
83850644|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83850645|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83850646|NCT00470977|Growth Substances|growth substances|mesh-ancestor
83850647|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850648|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
83850649|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850650|NCT05350592|Dobutamine|dobutamine|mesh-list
83850651|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83850652|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
83850653|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
83850654|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850655|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850656|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83850657|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83850658|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83850659|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
83850660|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850661|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850662|NCT05350592|Protective Agents|protective agents|mesh-ancestor
83850663|NCT00471055|Capsaicin|capsaicin|mesh-list
83850664|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
83850665|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850666|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
83850667|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850668|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850669|NCT00471094|Lansoprazole|lansoprazole|mesh-list
83850670|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
83850671|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83850672|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83850673|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83850674|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850675|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850676|NCT00157872|Naproxen|naproxen|mesh-list
83850677|NCT00157872|Rofecoxib|rofecoxib|mesh-list
83850678|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83850679|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83850680|NCT00157872|Analgesics|analgesics|mesh-ancestor
83850681|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
83850682|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850683|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850684|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850685|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850686|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
83850687|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83850688|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850689|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850690|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83850691|NCT03271255|Bevacizumab|bevacizumab|mesh-list
83850692|NCT03271255|Apatinib|apatinib|mesh-list
83850693|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850694|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850695|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83850696|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83850697|NCT03271255|Growth Substances|growth substances|mesh-ancestor
83850698|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850699|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
83850700|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83850701|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850702|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850703|NCT00471289|Paclitaxel|paclitaxel|mesh-list
83850704|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83850705|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850706|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
83850707|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
83850708|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
83850709|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850710|NCT00336154|Tetracycline|tetracycline|mesh-list
83850711|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850712|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850713|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83850714|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850715|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850716|NCT00158028|Risperidone|risperidone|mesh-list
83850717|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83850718|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
83850719|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850720|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850721|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850722|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83850723|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83850724|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83850725|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83850726|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83850727|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
83850728|NCT00471406|Verteporfin|verteporfin|mesh-list
83850729|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83850730|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850731|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
83850732|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850733|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
83850734|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850735|NCT00471484|Interferons|interferons|mesh-list
83850736|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
83850737|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
83850738|NCT00471484|Doxorubicin|doxorubicin|mesh-list
83850739|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83850740|NCT00471484|Fluorouracil|fluorouracil|mesh-list
83850741|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
83850742|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83850743|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850744|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83850745|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83850746|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850747|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850748|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
83850749|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83850750|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850751|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
83850752|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850753|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
83850754|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850755|NCT00471523|Metformin|metformin|mesh-list
83850756|NCT00471523|Clomiphene|clomiphene|mesh-list
83850757|NCT00471523|Enclomiphene|enclomiphene|mesh-list
83850758|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
83850759|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83850760|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850761|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83850762|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
83850763|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850764|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83850765|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
83850766|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850767|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83850768|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83850769|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83850770|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83850771|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
83850772|NCT00471640|Dexamethasone|dexamethasone|mesh-list
83850773|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83850774|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
83850775|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
83850776|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850777|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850778|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83850780|NCT00471640|Hormones|hormones|mesh-ancestor
83850781|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850782|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83850783|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850784|NCT00471679|Ethanol|ethanol|mesh-list
83850785|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83850786|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850787|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83850788|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850789|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83850790|NCT00149604|Estrogens|estrogens|mesh-list
83850791|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83850792|NCT00149604|Hormones|hormones|mesh-ancestor
83850793|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850794|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850795|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83850796|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
83850797|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83850798|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83850799|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83850800|NCT00471952|Caffeine|caffeine|mesh-list
83850801|NCT00471952|Rizatriptan|rizatriptan|mesh-list
83850802|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83850803|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850804|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83850805|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850806|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850807|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83850808|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83850809|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
83850810|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850811|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83850812|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
83850813|NCT00471991|Dienogest|dienogest|mesh-list
83850814|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83850815|NCT00471991|Estradiol|estradiol|mesh-list
83850816|NCT00471991|Estrogens|estrogens|mesh-ancestor
83850817|NCT00471991|Hormones|hormones|mesh-ancestor
83850818|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850819|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850820|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83850821|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
83850822|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83850823|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83850824|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83850825|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83850826|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83850827|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
83850828|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83850829|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850830|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83850831|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83850832|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850833|NCT00336310|Repaglinide|repaglinide|mesh-list
83850834|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83850835|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850836|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
83850837|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83850838|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83850839|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83850840|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83850841|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850842|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
83850843|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850844|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850845|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83850846|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850847|NCT00472225|Rituximab|rituximab|mesh-list
83089739|NCT03695250|Nivolumab|nivolumab|mesh-list
83850848|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850849|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850850|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
83850851|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850852|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850853|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
83850854|NCT00336466|Hematinics|hematinics|mesh-ancestor
83850855|NCT00472381|Insulin|insulin|mesh-list
83850856|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83850857|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850858|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83850859|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83850860|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
83850861|NCT00336739|Cinacalcet|cinacalcet|mesh-list
83850862|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83850863|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850864|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83850865|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
83850866|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850867|NCT00424151|Rituximab|rituximab|mesh-list
83850868|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850869|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850870|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
83850871|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850872|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850873|NCT00472810|Mitomycins|mitomycins|mesh-list
83850874|NCT00472810|Mitomycin|mitomycin|mesh-list
83850875|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83850876|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850877|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
83850878|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850879|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83850880|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850881|NCT00337051|Propofol|propofol|mesh-list
83850882|NCT00337051|Sevoflurane|sevoflurane|mesh-list
83850883|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83850884|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83850885|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850886|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83850887|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
83850888|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
83850889|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83850890|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83850891|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83850892|NCT00472927|Estrogens|estrogens|mesh-ancestor
83850893|NCT00472927|Hormones|hormones|mesh-ancestor
83850894|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83850895|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850896|NCT00337090|Mirabegron|mirabegron|mesh-list
83850897|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83850898|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83850899|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83850900|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
83850901|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850902|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850903|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850904|NCT00337090|Urological Agents|urological agents|mesh-ancestor
83850905|NCT05262452|Folfirinox|folfirinox|mesh-list
83850906|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850907|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
83850908|NCT00337246|Rituximab|rituximab|mesh-list
83850909|NCT00337246|Fludarabine|fludarabine|mesh-list
83850910|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
83850911|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
83850912|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850913|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
83850914|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850915|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83850916|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83850917|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
83850918|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850919|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850920|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83850921|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850922|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83850923|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
83850924|NCT00337246|Analgesics|analgesics|mesh-ancestor
83850925|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
83850926|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83850927|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83850928|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83850929|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850930|NCT00158301|Fluoxetine|fluoxetine|mesh-list
83850931|NCT00158301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83850932|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83850933|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83850934|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850935|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850936|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
83850937|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850938|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83850939|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
83850940|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83850941|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83850942|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83850943|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850944|NCT00473005|Capecitabine|capecitabine|mesh-list
83850945|NCT00473005|Everolimus|everolimus|mesh-list
83850946|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83850947|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
83850948|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850949|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850950|NCT00473005|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83850951|NCT00473005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83850952|NCT00473005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850953|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83850954|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
83850955|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850956|NCT00149877|Tegaserod|tegaserod|mesh-list
83850957|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83850958|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
83850959|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850960|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850961|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850962|NCT00473239|Vitamin D|vitamin d|mesh-list
83850963|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
83850964|NCT00473239|Vitamins|vitamins|mesh-ancestor
83850965|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
83850966|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850967|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83850968|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83850969|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
83850970|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83850971|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850972|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83850973|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
83850974|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83850975|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850976|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83850977|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850978|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
83850979|NCT00337441|Hematinics|hematinics|mesh-ancestor
83850980|NCT05183048|Panitumumab|panitumumab|mesh-list
83850981|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850982|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850983|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
83850984|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83850985|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83850986|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
83850987|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83850988|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83850989|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
83850990|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83850991|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83850992|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83850993|NCT00337558|Urological Agents|urological agents|mesh-ancestor
83850994|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83850995|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83850996|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83850997|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83850998|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
83850999|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83851000|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
83851001|NCT02964104|Insulin|insulin|mesh-list
83851002|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83851003|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83851004|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851005|NCT00158457|Tenofovir|tenofovir|mesh-list
83851006|NCT00158457|Emtricitabine|emtricitabine|mesh-list
83851007|NCT00158457|Efavirenz|efavirenz|mesh-list
83851008|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
83851009|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851010|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83851011|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83851012|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851013|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851014|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83851015|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83851016|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83851017|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83851018|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83851019|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83851020|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83851021|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83851022|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83851023|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83851024|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83851025|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
83851026|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851027|NCT00509158|Antacids|antacids|mesh-ancestor
83851028|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851029|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83851030|NCT00405080|Rifampin|rifampin|mesh-list
83851031|NCT00405080|Casopitant|casopitant|mesh-list
83851032|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83851033|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
83851034|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83851035|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851036|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
83851037|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83851038|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851039|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851040|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83851041|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83851042|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83851043|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83851044|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83851045|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83851046|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
83851047|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
83851048|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851049|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851050|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83851051|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83851052|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851053|NCT00158496|Interferons|interferons|mesh-list
83851054|NCT00158496|Ribavirin|ribavirin|mesh-list
83851055|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
83851056|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
83851057|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83851058|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851059|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
83851060|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851061|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
83851062|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851063|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
83851064|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851065|NCT00337792|Fentanyl|fentanyl|mesh-list
83851066|NCT00337792|Midazolam|midazolam|mesh-list
83851067|NCT00337792|Oxycodone|oxycodone|mesh-list
83851068|NCT00337792|Lorazepam|lorazepam|mesh-list
83851069|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83851070|NCT00337792|Narcotics|narcotics|mesh-ancestor
83851071|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851072|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851073|NCT00337792|Analgesics|analgesics|mesh-ancestor
83851074|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
83851075|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851076|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83851077|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83851078|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
83851079|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
83851080|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83851081|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83851082|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83851083|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851084|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
83851085|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
83851086|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851087|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851088|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
83851089|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
83851090|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
83851091|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83851092|NCT00509353|Irinotecan|irinotecan|mesh-list
83851093|NCT00509353|Vincristine|vincristine|mesh-list
83851094|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83851095|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83851096|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83851097|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851098|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851099|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851100|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83851101|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
83851102|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
83851103|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
83851104|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83851105|NCT00405119|Esomeprazole|esomeprazole|mesh-list
83851106|NCT00405119|Ranitidine|ranitidine|mesh-list
83851107|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83851108|NCT00405119|Loxtidine|loxtidine|mesh-list
83851109|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83851110|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83851111|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83851112|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851113|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851114|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83147975|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
83851115|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
83851116|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
83851117|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851118|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851119|NCT04715737|Vasopressins|vasopressins|mesh-list
83851120|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
83851121|NCT04715737|Oxytocin|oxytocin|mesh-list
83851122|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
83851123|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83851124|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851125|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
83851126|NCT04715737|Coagulants|coagulants|mesh-ancestor
83851127|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83851128|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83851129|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
83851130|NCT00509431|Sirolimus|sirolimus|mesh-list
83851131|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83851132|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851133|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851134|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851135|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851136|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83851137|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851138|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83851139|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
83851140|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83851141|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
83851142|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851143|NCT00509470|Amlodipine|amlodipine|mesh-list
83851144|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83851145|NCT00509470|Telmisartan|telmisartan|mesh-list
83851146|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83851147|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851148|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090043|NCT04015622|Docetaxel|docetaxel|mesh-list
83851149|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851150|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851151|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851152|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
83851153|NCT00509470|Diuretics|diuretics|mesh-ancestor
83851154|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
83851155|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83851156|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83851157|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83851158|NCT00405158|Acetaminophen|acetaminophen|mesh-list
83851159|NCT00405158|Antipyretics|antipyretics|mesh-list
83851160|NCT00405158|Penicillins|penicillins|mesh-list
83851161|NCT00405158|Floxacillin|floxacillin|mesh-list
83851162|NCT00405158|Cefadroxil|cefadroxil|mesh-list
83851163|NCT00405158|Oxytocin|oxytocin|mesh-list
83851164|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
83851165|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83851166|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851167|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83851168|NCT00405158|Analgesics|analgesics|mesh-ancestor
83851169|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
83851170|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851171|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83851172|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851173|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
83851174|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851175|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851176|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851177|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851178|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
83851179|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851180|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851181|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83851182|NCT00150111|Rituximab|rituximab|mesh-list
83851183|NCT00150111|Methimazole|methimazole|mesh-list
83851184|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83851185|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851186|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
83851187|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851188|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851189|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
83851190|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
83851191|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83851192|NCT02953210|Dexamethasone|dexamethasone|mesh-list
83851193|NCT02953210|Ketorolac|ketorolac|mesh-list
83851194|NCT02953210|Lidocaine|lidocaine|mesh-list
83851195|NCT02953210|Clonidine|clonidine|mesh-list
83851196|NCT02953210|Fentanyl|fentanyl|mesh-list
83851197|NCT02953210|Midazolam|midazolam|mesh-list
83851198|NCT02953210|Ketamine|ketamine|mesh-list
83851199|NCT02953210|Ondansetron|ondansetron|mesh-list
83851200|NCT02953210|Bupivacaine|bupivacaine|mesh-list
83851201|NCT02953210|Propofol|propofol|mesh-list
83851202|NCT02953210|Isoflurane|isoflurane|mesh-list
83851203|NCT02953210|Ranitidine|ranitidine|mesh-list
83851204|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83851205|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83851206|NCT02953210|Rocuronium|rocuronium|mesh-list
83851207|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851208|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
83851209|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
83851210|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851211|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851212|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83851213|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
83851214|NCT02953210|Hormones|hormones|mesh-ancestor
83851215|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83851216|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83851217|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851218|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
83851219|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
83851220|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851221|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
83851222|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83851223|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83851224|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83851225|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851226|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851227|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83090113|NCT03295760|Ubiquinone|ubiquinone|mesh-list
83851228|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83851229|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
83851230|NCT02953210|Analgesics|analgesics|mesh-ancestor
83851231|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83851232|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83851233|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83851234|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851235|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83851236|NCT02953210|Narcotics|narcotics|mesh-ancestor
83851237|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83851238|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83851239|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83851240|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851241|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
83851242|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
83851243|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
83851244|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851245|NCT02953210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83851246|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83851247|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
83851248|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83851249|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83851250|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851251|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83851252|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851253|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83851254|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83851255|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83851256|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83851257|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
83851258|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83851259|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83851260|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83851261|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
83851262|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83851263|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83851264|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83851265|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
83851266|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
83851267|NCT00509743|Diclofenac|diclofenac|mesh-list
83851268|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83851269|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83851270|NCT00509743|Analgesics|analgesics|mesh-ancestor
83851271|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
83851272|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851273|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851274|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851275|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851276|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83851277|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851278|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851279|NCT00509860|Irinotecan|irinotecan|mesh-list
83851280|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83851281|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83851282|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851283|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851284|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851285|NCT00509938|Lactoferrin|lactoferrin|mesh-list
83851286|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851287|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
83851288|NCT00337948|Hematinics|hematinics|mesh-ancestor
83851289|NCT02958215|Phenylephrine|phenylephrine|mesh-list
83851290|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
83851291|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83851292|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
83851293|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
83851294|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851295|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851296|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
83851297|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83851298|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
83851299|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
83851300|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83851301|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83851302|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83090189|NCT02462174|Analgesics|analgesics|mesh-ancestor
83851303|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
83851304|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851305|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851306|NCT02958215|Protective Agents|protective agents|mesh-ancestor
83851307|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
83851308|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
83851309|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83851311|NCT00158574|Mefloquine|mefloquine|mesh-list
83851312|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
83851313|NCT00158574|Proguanil|proguanil|mesh-list
83851314|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
83851315|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83851316|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83851317|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851318|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83851319|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851320|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851321|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83851322|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
83851323|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83851324|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
83851325|NCT00338221|Glycine|glycine|mesh-list
83851326|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
83851327|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851328|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851329|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851330|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
83851331|NCT00338299|Hematinics|hematinics|mesh-ancestor
83851332|NCT00510016|Clonidine|clonidine|mesh-list
83851333|NCT00510016|Analgesics|analgesics|mesh-ancestor
83851334|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
83851335|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851336|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851337|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83851338|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
83851339|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
83851340|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83402456|NCT00545077|Growth Substances|growth substances|mesh-ancestor
83851341|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83851342|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83851343|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
83851344|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851345|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851346|NCT00150228|Varenicline|varenicline|mesh-list
83851347|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83851348|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83851349|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
83851350|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851351|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851352|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851353|NCT00338338|Amlodipine|amlodipine|mesh-list
83851354|NCT00338338|Lacidipine|lacidipine|mesh-list
83851355|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83851356|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851357|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851358|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851359|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851360|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851361|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
83851362|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
83851363|NCT00338416|Hematinics|hematinics|mesh-ancestor
83851364|NCT00338494|Clofarabine|clofarabine|mesh-list
83851365|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851366|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
83851367|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851368|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851369|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83851370|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83851371|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83851372|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851373|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851374|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83851375|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851376|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851377|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
83851378|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851379|NCT00158652|Carboplatin|carboplatin|mesh-list
83851380|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851381|NCT00338650|Adalimumab|adalimumab|mesh-list
83851382|NCT00338650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83851383|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851384|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851385|NCT00158691|Amifostine|amifostine|mesh-list
83851386|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83851387|NCT00158691|Protective Agents|protective agents|mesh-ancestor
83851388|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851389|NCT00338767|Fluoxetine|fluoxetine|mesh-list
83851390|NCT00338767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83851391|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83851392|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851393|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851394|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851395|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
83851396|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851397|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83851398|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
83851399|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851400|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83851401|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83851402|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851403|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
83851404|NCT00339001|Hematinics|hematinics|mesh-ancestor
83851405|NCT00150306|Sertraline|sertraline|mesh-list
83851406|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
83851407|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851408|NCT00150306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83851409|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83851410|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851411|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851412|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851413|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
83851414|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851415|NCT00510172|Epoprostenol|epoprostenol|mesh-list
83851416|NCT00510172|Tezosentan|tezosentan|mesh-list
83851417|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83851418|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83851419|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
83851420|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
83851421|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
83851422|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83851423|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83851424|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851425|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851426|NCT00420901|Urological Agents|urological agents|mesh-ancestor
83851427|NCT00150384|Amlodipine|amlodipine|mesh-list
83851428|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83851429|NCT00150384|Atorvastatin|atorvastatin|mesh-list
83851430|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83851431|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83851432|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
83851433|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851434|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83851435|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83851436|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851437|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83851438|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851439|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851440|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851441|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851442|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
83851443|NCT00425191|Gemcitabine|gemcitabine|mesh-list
83851444|NCT00425191|Docetaxel|docetaxel|mesh-list
83851445|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851446|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851447|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
83851448|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851449|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
83851450|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
83851451|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
83090342|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
83851452|NCT00339118|Doxorubicin|doxorubicin|mesh-list
83851453|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
83851454|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83851455|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851456|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83851457|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83851458|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851459|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851460|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83851461|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
83851462|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851463|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851464|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83851465|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
83851466|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83851467|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83851468|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851469|NCT00339196|Azacitidine|azacitidine|mesh-list
83851470|NCT00339196|Tretinoin|tretinoin|mesh-list
83851471|NCT00339196|Valproic Acid|valproic acid|mesh-list
83851472|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851473|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
83851474|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851475|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851476|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851477|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
83851478|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851479|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
83851480|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
83851481|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851482|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851483|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
83851484|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83851485|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851486|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851487|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83851488|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
83851489|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851490|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83851491|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83851492|NCT00510211|Olanzapine|olanzapine|mesh-list
83851493|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
83851494|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
83851495|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851496|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851497|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83851498|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83851499|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83851500|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851501|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851502|NCT00510211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83851503|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83851504|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851505|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851506|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851507|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
83851508|NCT00150423|Pregabalin|pregabalin|mesh-list
83851509|NCT00150423|Analgesics|analgesics|mesh-ancestor
83851510|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
83851511|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851512|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851513|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
83851514|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851515|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851516|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851517|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851518|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83851519|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83851520|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851521|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851522|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
83851523|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83851524|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83851525|NCT04988282|Prednisolone|prednisolone|mesh-list
83851526|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
83851527|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83851528|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
83851529|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851531|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
83851532|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851533|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851534|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83851535|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
83851536|NCT04988282|Hormones|hormones|mesh-ancestor
83851537|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83851538|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83851539|NCT04988282|Protective Agents|protective agents|mesh-ancestor
83851540|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83851541|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851542|NCT00510250|Sorafenib|sorafenib|mesh-list
83851543|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851544|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851545|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851546|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851547|NCT04981067|Ropivacaine|ropivacaine|mesh-list
83851548|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
83851549|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
83851550|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851551|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851552|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
83851553|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851554|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
83851555|NCT00510367|Doxorubicin|doxorubicin|mesh-list
83851556|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83851557|NCT00510367|Fluorouracil|fluorouracil|mesh-list
83851558|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83851559|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
83851560|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851561|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851562|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83851563|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
83851564|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851565|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851566|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83851567|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83851568|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83851569|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83851570|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851571|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
83851572|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851573|NCT00158847|Fluticasone|fluticasone|mesh-list
83851574|NCT00158847|Xhance|xhance|mesh-list
83851575|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83851576|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851577|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83851578|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
83851579|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851580|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851581|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83851582|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
83851583|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851584|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83851585|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83851586|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83851587|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83851588|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
83851589|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851590|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851591|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83851592|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851593|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851594|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851595|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851596|NCT00158886|Topotecan|topotecan|mesh-list
83851597|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83851598|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83851599|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851600|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851601|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851602|NCT00510406|Tamsulosin|tamsulosin|mesh-list
83851603|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
83851604|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83851605|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83851606|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83851607|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
83851608|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851609|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851610|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851611|NCT00510406|Urological Agents|urological agents|mesh-ancestor
83851612|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83851613|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83851614|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
83851615|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
83851616|NCT00165555|Antidotes|antidotes|mesh-ancestor
83851617|NCT00165555|Protective Agents|protective agents|mesh-ancestor
83851618|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851619|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
83851620|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851621|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
83851622|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83851623|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851624|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
83851625|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
83851626|NCT00150579|Amphetamine|amphetamine|mesh-list
83851627|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
83851628|NCT00150579|Adderall|adderall|mesh-list
83851629|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83851630|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851631|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
83851632|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
83851633|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851634|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
83851635|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851636|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851637|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
83851638|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83851639|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83851640|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851641|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83851642|NCT00511732|Insulin|insulin|mesh-list
83851643|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83851644|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851645|NCT00510445|Imetelstat|imetelstat|mesh-list
83851646|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
83851647|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851648|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851649|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851650|NCT00150657|Bevacizumab|bevacizumab|mesh-list
83851651|NCT00150657|Carboplatin|carboplatin|mesh-list
83851652|NCT00150657|Gemcitabine|gemcitabine|mesh-list
83851653|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83851654|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851655|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83851656|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83851657|NCT00150657|Growth Substances|growth substances|mesh-ancestor
83851658|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851659|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
83851660|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851661|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
83851662|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851663|NCT00511771|Tegaserod|tegaserod|mesh-list
83851664|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83851665|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
83851666|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851667|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851668|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851669|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83851670|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851671|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83851672|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851673|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090561|NCT00835263|Lamotrigine|lamotrigine|mesh-list
83851675|NCT00511849|Carboplatin|carboplatin|mesh-list
83851676|NCT00511849|Sunitinib|sunitinib|mesh-list
83851677|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83851678|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851679|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
83851680|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
83851681|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
83851682|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851683|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83851684|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83851685|NCT00511849|Growth Substances|growth substances|mesh-ancestor
83851686|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851687|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
83851688|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851689|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851690|NCT00510640|Sunitinib|sunitinib|mesh-list
83851691|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851692|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83851693|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83851694|NCT00510640|Growth Substances|growth substances|mesh-ancestor
83851695|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851696|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
83851697|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851698|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851699|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851700|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
83851701|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851702|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851703|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851704|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851705|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851706|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83851707|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
83851708|NCT00165633|Menatetrenone|menatetrenone|mesh-list
83851709|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
83851710|NCT00165633|Coagulants|coagulants|mesh-ancestor
83851711|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83851712|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83851713|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851714|NCT00165633|Vitamins|vitamins|mesh-ancestor
83851715|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
83851716|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851717|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83851718|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851719|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83851720|NCT00510913|Tacrolimus|tacrolimus|mesh-list
83851721|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83851722|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
83851723|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851724|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83851725|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851726|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851727|NCT00150735|Levetiracetam|levetiracetam|mesh-list
83851728|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
83851729|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
83851730|NCT04695925|Carboplatin|carboplatin|mesh-list
83851731|NCT04695925|Pemetrexed|pemetrexed|mesh-list
83851732|NCT04695925|Osimertinib|osimertinib|mesh-list
83851733|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851734|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851735|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851736|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83851737|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83851738|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851739|NCT00511069|Bortezomib|bortezomib|mesh-list
83851740|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851741|NCT00165750|Donepezil|donepezil|mesh-list
83851742|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83851743|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851744|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851745|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
83851746|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851747|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090667|NCT04263909|Sufentanil|sufentanil|mesh-list
83851748|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
83851749|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
83851751|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851752|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851753|NCT00511225|Vitamins|vitamins|mesh-ancestor
83851754|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
83851755|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83851756|NCT00150774|Levetiracetam|levetiracetam|mesh-list
83851757|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
83851758|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
83851759|NCT04864067|Leucovorin|leucovorin|mesh-list
83851760|NCT04864067|Capecitabine|capecitabine|mesh-list
83851761|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
83851762|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851763|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
83851764|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851765|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851766|NCT04864067|Antidotes|antidotes|mesh-ancestor
83851767|NCT04864067|Protective Agents|protective agents|mesh-ancestor
83851768|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851769|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
83851770|NCT04864067|Vitamins|vitamins|mesh-ancestor
83851771|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
83851772|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
83851773|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851774|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851775|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851776|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851777|NCT00165828|Zonisamide|zonisamide|mesh-list
83851778|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
83851779|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851780|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851781|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851782|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851783|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851784|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
83851785|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
83851786|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83851787|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83851788|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851789|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851790|NCT00511498|Urological Agents|urological agents|mesh-ancestor
83851791|NCT00511576|Docetaxel|docetaxel|mesh-list
83851792|NCT00511576|Mocetinostat|mocetinostat|mesh-list
83851793|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851794|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83851795|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83851796|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83851797|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851798|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83851799|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851800|NCT00511654|Midazolam|midazolam|mesh-list
83851801|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83851802|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83851803|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851804|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851805|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83851806|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83851807|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83851808|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83851809|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
83851810|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
83851811|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
83851812|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
83851813|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851814|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851815|NCT00150852|Vancomycin|vancomycin|mesh-list
83851816|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83851817|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851818|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
83851819|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83851820|NCT02952235|Protective Agents|protective agents|mesh-ancestor
83851821|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851822|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851823|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83851824|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851825|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83851827|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851828|NCT02951806|Fentanyl|fentanyl|mesh-list
83851829|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83851830|NCT02951806|Narcotics|narcotics|mesh-ancestor
83851831|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851832|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851833|NCT02951806|Analgesics|analgesics|mesh-ancestor
83851834|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
83851835|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851836|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83851837|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83851838|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
83851839|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
83851840|NCT00512980|Prednisone|prednisone|mesh-list
83851841|NCT00512980|Gemcitabine|gemcitabine|mesh-list
83851842|NCT00512980|Doxorubicin|doxorubicin|mesh-list
83851843|NCT00512980|Vinblastine|vinblastine|mesh-list
83851844|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851845|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
83851846|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851847|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851848|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83851849|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83851850|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83851851|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851852|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851853|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
83851854|NCT00512980|Hormones|hormones|mesh-ancestor
83851855|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83851856|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851857|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83851858|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83851859|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
83851860|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
83851861|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
83851862|NCT00150891|Cyclosporine|cyclosporine|mesh-list
83851863|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
83851864|NCT00150891|Azathioprine|azathioprine|mesh-list
83851865|NCT00150891|Tacrolimus|tacrolimus|mesh-list
83851866|NCT00150891|Cyclosporins|cyclosporins|mesh-list
83851867|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83851868|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
83851869|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851870|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83851871|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851872|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851873|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
83851874|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83851875|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851876|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851877|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83851878|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851879|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83851880|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
83851881|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83851882|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
83851883|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851884|NCT00513058|Vinorelbine|vinorelbine|mesh-list
83851885|NCT00513058|Lapatinib|lapatinib|mesh-list
83851886|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83851887|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851888|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
83851889|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
83851890|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
83851891|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851892|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851893|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851894|NCT02951962|Amlodipine|amlodipine|mesh-list
83851895|NCT02951962|Telmisartan|telmisartan|mesh-list
83851896|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83851897|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83851898|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83851899|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851900|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851901|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851902|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851903|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851904|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
83851905|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83851906|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83851907|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
83851908|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83851909|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83851910|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851911|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83851912|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83851913|NCT00513253|Lapatinib|lapatinib|mesh-list
83851914|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851915|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83851916|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83851917|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851918|NCT00513487|Fluticasone|fluticasone|mesh-list
83851919|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
83851920|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83851921|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83851922|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
83851923|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851924|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851925|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83851926|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83851927|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851928|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83851929|NCT00513487|Miotics|miotics|mesh-ancestor
83851930|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83851931|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83851932|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83851933|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83851934|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
83851935|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147981|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851936|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851937|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
83851938|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83851939|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
83851940|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851941|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851942|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83851943|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
83851944|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
83851945|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83851946|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
83851947|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83851948|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851949|NCT00403949|Azelaic acid|azelaic acid|mesh-list
83851950|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851951|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
83851952|NCT00513643|Insulin|insulin|mesh-list
83851953|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83851954|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
83851955|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83851956|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851957|NCT00151008|Bexarotene|bexarotene|mesh-list
83851958|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851959|NCT00513877|Bortezomib|bortezomib|mesh-list
83851960|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851961|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
83851962|NCT04695613|Analgesics|analgesics|mesh-ancestor
83851963|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
83851964|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83851965|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851966|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
83851967|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83851968|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83851969|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
83851970|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83851971|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83851972|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851973|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83851974|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
83851975|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83851976|NCT00151047|Docetaxel|docetaxel|mesh-list
83851977|NCT00151047|Capecitabine|capecitabine|mesh-list
83851978|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851979|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
83851980|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
83851981|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
83851982|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851983|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83851984|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
83851985|NCT00513955|Prednisolone|prednisolone|mesh-list
83851986|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
83851987|NCT00513955|Doxorubicin|doxorubicin|mesh-list
83851988|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83851989|NCT00513955|Vincristine|vincristine|mesh-list
83851990|NCT00513955|Bortezomib|bortezomib|mesh-list
83851991|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83851992|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
83851993|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83851994|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83851995|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83851996|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
83851997|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83851998|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83851999|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83852000|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83852001|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83852002|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83852003|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852004|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852005|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83852006|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83852007|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852008|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852009|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
83852010|NCT00513955|Hormones|hormones|mesh-ancestor
83852011|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852012|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852013|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
83852014|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
83852015|NCT00514072|Vaccines|vaccines|mesh-list
83852016|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
83852017|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
83852018|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852019|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83852020|NCT00514111|Interferons|interferons|mesh-list
83852021|NCT00514111|Ribavirin|ribavirin|mesh-list
83852022|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852023|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
83852024|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852025|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
83852026|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852027|NCT00151086|Vinorelbine|vinorelbine|mesh-list
83852028|NCT00151086|Estramustine|estramustine|mesh-list
83852029|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852030|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852031|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
83852032|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
83852033|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852034|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852035|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83852036|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
83852037|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852038|NCT00514228|Sunitinib|sunitinib|mesh-list
83852039|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852040|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83852041|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83852042|NCT00514228|Growth Substances|growth substances|mesh-ancestor
83852043|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852044|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
83852045|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83852046|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852047|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090930|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
83852048|NCT00151125|Oprelvekin|oprelvekin|mesh-list
83852049|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852051|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83852052|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
83852053|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83852054|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852055|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83852056|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852057|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
83852058|NCT00514657|Mitogens|mitogens|mesh-list
83852059|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852060|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852061|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83852062|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83852063|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852064|NCT02951260|Metformin|metformin|mesh-list
83852065|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83852066|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852067|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
83852068|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83852069|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852070|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852071|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83852072|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83852073|NCT02951299|Protective Agents|protective agents|mesh-ancestor
83852074|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852075|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
83852076|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83852077|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
83852078|NCT00514891|Vitamin A|vitamin a|mesh-list
83852079|NCT00514891|Vitamins|vitamins|mesh-ancestor
83852080|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
83852081|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852082|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
83852083|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852084|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83852085|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852086|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852087|NCT02950948|Progesterone|progesterone|mesh-list
83852088|NCT02950948|Progestins|progestins|mesh-ancestor
83852089|NCT02950948|Hormones|hormones|mesh-ancestor
83852090|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852091|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852092|NCT00515320|Fluoxetine|fluoxetine|mesh-list
83852093|NCT00515320|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83852094|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83852095|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83852096|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852097|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852098|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
83852099|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852100|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83852101|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
83852102|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83852103|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83852104|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83852105|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852106|NCT00515359|Propofol|propofol|mesh-list
83852107|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83852108|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852109|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852110|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83852111|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
83852112|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
83852113|NCT00515554|Rituximab|rituximab|mesh-list
83852114|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852115|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852116|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
83852117|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852118|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83852119|NCT00151203|Clarithromycin|clarithromycin|mesh-list
83852120|NCT00151203|Dexamethasone|dexamethasone|mesh-list
83852121|NCT00151203|Lenalidomide|lenalidomide|mesh-list
83852122|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852123|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
83852124|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
83852125|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852126|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852127|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852128|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
83852130|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852131|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852132|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852133|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
83852134|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83852135|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83852136|NCT00151203|Growth Substances|growth substances|mesh-ancestor
83852137|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
83852138|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83852139|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852140|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83852141|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852142|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852143|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83852144|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83852145|NCT04620200|Nivolumab|nivolumab|mesh-list
83852146|NCT04620200|Ipilimumab|ipilimumab|mesh-list
83852147|NCT04620200|Immunomodulating Agents|immunomodulating agents|mesh-list
83852148|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
83852149|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852150|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852151|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852152|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852153|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852154|NCT00515593|Hormones|hormones|mesh-list
83852155|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
83852156|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852157|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852158|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83852159|NCT00515788|Cytarabine|cytarabine|mesh-list
83852160|NCT00515788|Temozolomide|temozolomide|mesh-list
83402532|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852161|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852162|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
83852163|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852164|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852165|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
83852166|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852167|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83852168|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
83852169|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852170|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83852171|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
83852172|NCT02950870|Ritonavir|ritonavir|mesh-list
83852173|NCT02950870|Ribavirin|ribavirin|mesh-list
83852174|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83852175|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83852176|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
83852177|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852178|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852179|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83852180|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83852181|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
83852182|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852183|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83852184|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83852185|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
83852186|NCT00515866|Gemcitabine|gemcitabine|mesh-list
83852187|NCT00515866|Olaparib|olaparib|mesh-list
83852188|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83852189|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852190|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
83852191|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852192|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852193|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852194|NCT00515905|Propofol|propofol|mesh-list
83852195|NCT00515905|Sevoflurane|sevoflurane|mesh-list
83852196|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83852197|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852198|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852199|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83852200|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
83852201|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
83852202|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83852203|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83852204|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
83852205|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83852206|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83852207|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83852208|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83852209|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852210|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83852211|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852212|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852213|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83852214|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852215|NCT00151242|Cytarabine|cytarabine|mesh-list
83852216|NCT00151242|Etoposide|etoposide|mesh-list
83852217|NCT00151242|Idarubicin|idarubicin|mesh-list
83852218|NCT00151242|Tretinoin|tretinoin|mesh-list
83852219|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852220|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852221|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83852222|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83852223|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852224|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852225|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852226|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
83852227|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
83852228|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852229|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83852230|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
83852231|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852232|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83852233|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
83852234|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83852235|NCT00516100|Pemetrexed|pemetrexed|mesh-list
83852236|NCT00516100|Bortezomib|bortezomib|mesh-list
83852237|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852238|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852239|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852240|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83852241|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83852242|NCT00166413|Thalidomide|thalidomide|mesh-list
83852243|NCT00166413|Lenalidomide|lenalidomide|mesh-list
83852244|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83852245|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
83852246|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852247|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
83852248|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83852249|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852250|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83852251|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83852252|NCT00166413|Growth Substances|growth substances|mesh-ancestor
83852253|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
83852254|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852255|NCT02950441|Niacinamide|niacinamide|mesh-list
83852256|NCT02950441|Niacin|niacin|mesh-list
83852257|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
83852258|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
83852259|NCT02950441|Vitamins|vitamins|mesh-ancestor
83852260|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
83852261|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852262|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83852263|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
83852264|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852265|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83852266|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
83852267|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
83852268|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83852269|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852270|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
83091158|NCT03298958|Sirolimus|sirolimus|mesh-list
83852271|NCT02950168|Edoxaban|edoxaban|mesh-list
83852272|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83852273|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
83852274|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83852275|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
83852276|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852277|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852278|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
83852279|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
83852280|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852281|NCT00166491|Insulin|insulin|mesh-list
83852282|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83852283|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852284|NCT00508885|Niacinamide|niacinamide|mesh-list
83852285|NCT00508885|Niacin|niacin|mesh-list
83852286|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
83852287|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
83852288|NCT00508885|Vitamins|vitamins|mesh-ancestor
83852289|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
83852290|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852291|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83852292|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
83852293|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852294|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83852295|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
83852296|NCT02953405|Clopidogrel|clopidogrel|mesh-list
83852297|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83852298|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83852299|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83852300|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83852301|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
83852302|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852303|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852304|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852305|NCT00516802|Olaparib|olaparib|mesh-list
83852306|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83852307|NCT00516802|Dacarbazine|dacarbazine|mesh-list
83852308|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852309|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852310|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852311|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83852312|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
83852313|NCT05861466|Ranibizumab|ranibizumab|mesh-list
83852314|NCT05861466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83852315|NCT05861466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83852316|NCT05861466|Growth Substances|growth substances|mesh-ancestor
83852317|NCT05861466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852318|NCT05861466|Growth Inhibitors|growth inhibitors|mesh-ancestor
83852319|NCT05861466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852320|NCT05861336|Paclitaxel|paclitaxel|mesh-list
83852321|NCT05861336|Gemcitabine|gemcitabine|mesh-list
83852322|NCT05861336|Losartan|losartan|mesh-list
83852323|NCT05861336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852324|NCT05861336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852325|NCT05861336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83852326|NCT05861336|Antimitotic Agents|antimitotic agents|mesh-ancestor
83852327|NCT05861336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852328|NCT05861336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852329|NCT05861336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852330|NCT05861336|Antimetabolites|antimetabolites|mesh-ancestor
83852331|NCT05861336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83852332|NCT05861336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83852333|NCT05861336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83852334|NCT05861336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83852335|NCT05861310|Metronidazole|metronidazole|mesh-list
83852336|NCT05861310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852337|NCT05861310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83852338|NCT05861310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83852339|NCT05861310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83852340|NCT05861297|Dexamethasone|dexamethasone|mesh-list
83852341|NCT05861297|Prednisolone|prednisolone|mesh-list
83852342|NCT05861297|Rituximab|rituximab|mesh-list
83852343|NCT05861297|Azathioprine|azathioprine|mesh-list
83852344|NCT05861297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852345|NCT05861297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852346|NCT05861297|Immunologic Factors|immunologic factors|mesh-ancestor
83852347|NCT05861297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852348|NCT05861297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83852349|NCT05861297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852350|NCT05861297|Antiemetics|antiemetics|mesh-ancestor
83852351|NCT05861297|Autonomic Agents|autonomic agents|mesh-ancestor
83852352|NCT05861297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852353|NCT05861297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852354|NCT05861297|Glucocorticoids|glucocorticoids|mesh-ancestor
83852355|NCT05861297|Hormones|hormones|mesh-ancestor
83852356|NCT05861297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852357|NCT05861297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852358|NCT05861297|Antimetabolites|antimetabolites|mesh-ancestor
83852359|NCT05861297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852360|NCT05861297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852361|NCT05861297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83852362|NCT05861271|Capecitabine|capecitabine|mesh-list
83852363|NCT05861271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852364|NCT05861271|Antimetabolites|antimetabolites|mesh-ancestor
83852365|NCT05861271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852366|NCT05861271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852367|NCT05861206|Listerine|listerine|mesh-list
83852368|NCT05861206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83852369|NCT05861206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852370|NCT05861167|Ustekinumab|ustekinumab|mesh-list
83852371|NCT05861167|Dermatologic Agents|dermatologic agents|mesh-ancestor
83852372|NCT05861154|Benzocaine|benzocaine|mesh-list
83852373|NCT05861154|Anesthetics, Local|anesthetics, local|mesh-ancestor
83852374|NCT05861154|Anesthetics|anesthetics|mesh-ancestor
83852375|NCT05861154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852376|NCT05861154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852377|NCT05861154|Sensory System Agents|sensory system agents|mesh-ancestor
83852378|NCT05861154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852379|NCT05861063|Lidocaine|lidocaine|mesh-list
83852380|NCT05861063|Dezocine|dezocine|mesh-list
83852381|NCT05861063|Anesthetics, Local|anesthetics, local|mesh-ancestor
83852382|NCT05861063|Anesthetics|anesthetics|mesh-ancestor
83852383|NCT05861063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852384|NCT05861063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852385|NCT05861063|Sensory System Agents|sensory system agents|mesh-ancestor
83852386|NCT05861063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852387|NCT05861063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83852388|NCT05861063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83852389|NCT05861063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83852390|NCT05861063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83852391|NCT05861063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852392|NCT05861063|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83852393|NCT05861063|Narcotics|narcotics|mesh-ancestor
83852394|NCT05861063|Analgesics|analgesics|mesh-ancestor
83852395|NCT05861050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83852396|NCT05861050|Obinutuzumab|obinutuzumab|mesh-list
83852397|NCT05861050|Lenalidomide|lenalidomide|mesh-list
83852398|NCT05861050|Venetoclax|venetoclax|mesh-list
83852399|NCT05861050|Antibodies|antibodies|mesh-list
83852400|NCT05861050|Immunoglobulins|immunoglobulins|mesh-list
83852401|NCT05861050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83852402|NCT05861050|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83852403|NCT05861050|Immunologic Factors|immunologic factors|mesh-ancestor
83852404|NCT05861050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852405|NCT05861050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852406|NCT05861050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83852407|NCT05861050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83852408|NCT05861050|Growth Substances|growth substances|mesh-ancestor
83852409|NCT05861050|Growth Inhibitors|growth inhibitors|mesh-ancestor
83852410|NCT05860699|Ethanol|ethanol|mesh-list
83852411|NCT05860699|Cannabidiol|cannabidiol|mesh-list
83852412|NCT05860699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83852413|NCT05860699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852414|NCT05860699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852415|NCT05860699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852416|NCT05860699|Anticonvulsants|anticonvulsants|mesh-ancestor
83852417|NCT05860335|Paclitaxel|paclitaxel|mesh-list
83852418|NCT05860335|Nedaplatin|nedaplatin|mesh-list
83852419|NCT05860335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852420|NCT05860335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852421|NCT05860335|Tubulin Modulators|tubulin modulators|mesh-ancestor
83852422|NCT05860335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83852423|NCT05860335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852424|NCT05860335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852425|NCT05860244|Albuterol|albuterol|mesh-list
83852426|NCT05860244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83852427|NCT05860244|Autonomic Agents|autonomic agents|mesh-ancestor
83091302|NCT03288428|Morphine|morphine|mesh-list
83852428|NCT05860244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852429|NCT05860244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852430|NCT05860244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83852431|NCT05860244|Respiratory System Agents|respiratory system agents|mesh-ancestor
83852432|NCT05860244|Tocolytic Agents|tocolytic agents|mesh-ancestor
83852433|NCT05860244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83852434|NCT05860244|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83852435|NCT05860244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83852436|NCT05860244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83852437|NCT05860244|Adrenergic Agents|adrenergic agents|mesh-ancestor
83852438|NCT05860244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852439|NCT05860244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852440|NCT05860153|Diazepam|diazepam|mesh-list
83852441|NCT05860153|Levetiracetam|levetiracetam|mesh-list
83852442|NCT05860153|Anticonvulsants|anticonvulsants|mesh-ancestor
83852443|NCT05860153|Nootropic Agents|nootropic agents|mesh-ancestor
83852444|NCT05860153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83852445|NCT05860153|Antiemetics|antiemetics|mesh-ancestor
83852446|NCT05860153|Autonomic Agents|autonomic agents|mesh-ancestor
83852447|NCT05860153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852448|NCT05860153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852449|NCT05860153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852450|NCT05860153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83852451|NCT05860153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852452|NCT05860153|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83852453|NCT05860153|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83852454|NCT05860153|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83852455|NCT05860153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83852456|NCT05860153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83852457|NCT05860153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83852458|NCT05860153|Anesthetics, General|anesthetics, general|mesh-ancestor
83852459|NCT05860153|Anesthetics|anesthetics|mesh-ancestor
83852460|NCT05860153|GABA Modulators|gaba modulators|mesh-ancestor
83852461|NCT05860153|GABA Agents|gaba agents|mesh-ancestor
83852462|NCT05860153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852463|NCT05860153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852464|NCT05860114|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83852465|NCT05860114|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83852466|NCT05860114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852467|NCT05860114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852468|NCT05860062|Vitamin D|vitamin d|mesh-list
83852469|NCT05860062|Calcium|calcium|mesh-list
83852470|NCT05860062|Vitamins|vitamins|mesh-ancestor
83852471|NCT05860062|Micronutrients|micronutrients|mesh-ancestor
83852472|NCT05860062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852473|NCT05860062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83852474|NCT05860062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83852475|NCT05860010|Epinephrine|epinephrine|mesh-list
83852476|NCT05860010|Dexmedetomidine|dexmedetomidine|mesh-list
83852477|NCT05860010|Bupivacaine|bupivacaine|mesh-list
83852478|NCT05860010|Anesthetics, Local|anesthetics, local|mesh-ancestor
83852479|NCT05860010|Anesthetics|anesthetics|mesh-ancestor
83852480|NCT05860010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852481|NCT05860010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852482|NCT05860010|Sensory System Agents|sensory system agents|mesh-ancestor
83852483|NCT05860010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852484|NCT05860010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83852485|NCT05860010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83852486|NCT05860010|Analgesics|analgesics|mesh-ancestor
83852487|NCT05860010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83852488|NCT05860010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83852489|NCT05860010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83852490|NCT05860010|Adrenergic Agents|adrenergic agents|mesh-ancestor
83852491|NCT05860010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852492|NCT05860010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852493|NCT05860010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83852494|NCT05860010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83852495|NCT05860010|Autonomic Agents|autonomic agents|mesh-ancestor
83852496|NCT05860010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83852497|NCT05860010|Respiratory System Agents|respiratory system agents|mesh-ancestor
83852498|NCT05860010|Mydriatics|mydriatics|mesh-ancestor
83852499|NCT05860010|Sympathomimetics|sympathomimetics|mesh-ancestor
83852500|NCT05860010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83852501|NCT05859984|Interferons|interferons|mesh-list
83852502|NCT05859984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852503|NCT05859984|Antiviral Agents|antiviral agents|mesh-ancestor
83852504|NCT05859984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852505|NCT05859802|4-Aminopyridine|4-aminopyridine|mesh-list
83852506|NCT05859802|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83852507|NCT05859802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83852508|NCT05859802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852509|NCT05859750|Paclitaxel|paclitaxel|mesh-list
83852510|NCT05859750|Gemcitabine|gemcitabine|mesh-list
83852511|NCT05859750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852512|NCT05859750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852513|NCT05859750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83852514|NCT05859750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83852515|NCT05859750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852516|NCT05859750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852517|NCT05859750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852518|NCT05859750|Antimetabolites|antimetabolites|mesh-ancestor
83852519|NCT05859477|Capecitabine|capecitabine|mesh-list
83852520|NCT05859477|Oxaliplatin|oxaliplatin|mesh-list
83852521|NCT05859477|Nivolumab|nivolumab|mesh-list
83852522|NCT05859477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852523|NCT05859477|Antimetabolites|antimetabolites|mesh-ancestor
83852524|NCT05859477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852525|NCT05859477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852526|NCT05859477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852527|NCT05859477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852528|NCT05859412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83852529|NCT05859412|Methylprednisolone|methylprednisolone|mesh-list
83852530|NCT05859412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83852531|NCT05859412|Prednisolone|prednisolone|mesh-list
83852532|NCT05859412|Prednisolone acetate|prednisolone acetate|mesh-list
83852533|NCT05859412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83852534|NCT05859412|Prednisolone phosphate|prednisolone phosphate|mesh-list
83852535|NCT05859412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852536|NCT05859412|Antiemetics|antiemetics|mesh-ancestor
83852537|NCT05859412|Autonomic Agents|autonomic agents|mesh-ancestor
83852538|NCT05859412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852539|NCT05859412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852540|NCT05859412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852541|NCT05859412|Glucocorticoids|glucocorticoids|mesh-ancestor
83852542|NCT05859412|Hormones|hormones|mesh-ancestor
83852543|NCT05859412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852544|NCT05859412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83852545|NCT05859412|Protective Agents|protective agents|mesh-ancestor
83852546|NCT05859412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852547|NCT05859412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852548|NCT05858918|Clopidogrel|clopidogrel|mesh-list
83852549|NCT05858918|Ticagrelor|ticagrelor|mesh-list
83852550|NCT05858918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83852551|NCT05858918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83852552|NCT05858918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83852553|NCT05858918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83852554|NCT05858918|Purinergic Agents|purinergic agents|mesh-ancestor
83852555|NCT05858918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852556|NCT05858918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852557|NCT05858918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852558|NCT05856877|Insulin|insulin|mesh-list
83852559|NCT05856877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83852560|NCT05856877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852561|NCT05856864|Ramucirumab|ramucirumab|mesh-list
83852562|NCT05856864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852563|NCT05852158|Cefazolin|cefazolin|mesh-list
83852564|NCT05852158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83852565|NCT05852158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852566|NCT05851924|Capecitabine|capecitabine|mesh-list
83852567|NCT05851924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852568|NCT05851924|Antimetabolites|antimetabolites|mesh-ancestor
83852569|NCT05851924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852570|NCT05851924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852571|NCT05829187|Piperaquine|piperaquine|mesh-list
83852572|NCT05829187|Primaquine|primaquine|mesh-list
83852573|NCT05829187|Artenimol|artenimol|mesh-list
83852574|NCT05829187|Antimalarials|antimalarials|mesh-ancestor
83852575|NCT05829187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83852576|NCT05829187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83852577|NCT05829187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852578|NCT05822765|Epinephrine|epinephrine|mesh-list
83852579|NCT05822765|Racepinephrine|racepinephrine|mesh-list
83852580|NCT05822765|Epinephryl borate|epinephryl borate|mesh-list
83852581|NCT05822765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83852582|NCT05822765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83852583|NCT05822765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83852584|NCT05822765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852585|NCT05822765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852586|NCT05822765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852587|NCT05822765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83852588|NCT05822765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83852589|NCT05822765|Autonomic Agents|autonomic agents|mesh-ancestor
83852590|NCT05822765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852591|NCT05822765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83852592|NCT05822765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83852594|NCT05822765|Sympathomimetics|sympathomimetics|mesh-ancestor
83852595|NCT05822765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83852596|NCT05816252|Carboplatin|carboplatin|mesh-list
83852597|NCT05816252|Pembrolizumab|pembrolizumab|mesh-list
83852598|NCT05816252|Osimertinib|osimertinib|mesh-list
83852599|NCT05816252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852600|NCT05816252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852601|NCT05816252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852602|NCT05816252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852603|NCT05816252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83852604|NCT05816252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852605|NCT05779644|Metformin|metformin|mesh-list
83852606|NCT05779644|Liraglutide|liraglutide|mesh-list
83852607|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83852608|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852609|NCT05779644|Incretins|incretins|mesh-ancestor
83852610|NCT05779644|Hormones|hormones|mesh-ancestor
83852611|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852612|NCT05749211|Niraparib|niraparib|mesh-list
83852613|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83852614|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852615|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852616|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852617|NCT05748093|Cobicistat|cobicistat|mesh-list
83852618|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83852619|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83852620|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
83852621|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852622|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83852623|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83852624|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852625|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852626|NCT05731596|Ubiquinone|ubiquinone|mesh-list
83852627|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
83852628|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83852629|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83852630|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83852631|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
83852632|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852633|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83852634|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83852635|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852636|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
83852637|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852638|NCT05731596|Vitamins|vitamins|mesh-ancestor
83852639|NCT05722782|Acetaminophen|acetaminophen|mesh-list
83852640|NCT05722782|Piroxicam|piroxicam|mesh-list
83852641|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83852642|NCT05722782|Analgesics|analgesics|mesh-ancestor
83852643|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
83852644|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852645|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852646|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
83852647|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83852648|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852649|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83852650|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83852651|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852652|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852653|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
83852654|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83091527|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
83852655|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83852656|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852657|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
83852658|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
83852659|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852660|NCT05709990|Vitamin D|vitamin d|mesh-list
83852661|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
83852662|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
83852663|NCT05709990|Vitamins|vitamins|mesh-ancestor
83852664|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
83852665|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852666|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83852667|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83852668|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83852669|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83852670|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
83852671|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852672|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852673|NCT05709990|Urological Agents|urological agents|mesh-ancestor
83852674|NCT05684744|Methotrexate|methotrexate|mesh-list
83852675|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83852676|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
83852677|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83852678|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852679|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852680|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
83852681|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852682|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852683|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83852684|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852685|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83852686|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83852687|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
83852688|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83852689|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83852690|NCT05678114|Inositol|inositol|mesh-list
83852691|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
83852692|NCT05678114|Vitamins|vitamins|mesh-ancestor
83852693|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
83852694|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852695|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83852696|NCT05675787|Atorvastatin|atorvastatin|mesh-list
83852697|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
83852698|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83852699|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83852700|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
83852701|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852702|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83852703|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83852704|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852705|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83852706|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83852707|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83852708|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
83852709|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83852710|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852711|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83852712|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83852713|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83852714|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852715|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852716|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
83852717|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852718|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852719|NCT05662527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852720|NCT05662527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852721|NCT05656664|Folic Acid|folic acid|mesh-list
83852722|NCT05656664|Hematinics|hematinics|mesh-ancestor
83852723|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
83852724|NCT05656664|Vitamins|vitamins|mesh-ancestor
83852725|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
83852726|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852727|NCT05576792|Ranibizumab|ranibizumab|mesh-list
83852728|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83852729|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83852730|NCT05576792|Growth Substances|growth substances|mesh-ancestor
83852731|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852732|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
83852733|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852734|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
83852735|NCT05501665|Paclitaxel|paclitaxel|mesh-list
83852736|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83852737|NCT05501665|Carboplatin|carboplatin|mesh-list
83852738|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
83852739|NCT05501665|Pemetrexed|pemetrexed|mesh-list
83852740|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83852741|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852742|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852743|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
83852744|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
83852745|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852746|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852747|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852748|NCT05501665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852749|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852750|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83852751|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83852752|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83852753|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
83852754|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
83852755|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852756|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
83852757|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83852758|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
83852759|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852760|NCT05494398|Expectorants|expectorants|mesh-ancestor
83852761|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
83852762|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83852763|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
83852764|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852765|NCT05494398|Protective Agents|protective agents|mesh-ancestor
83852766|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852767|NCT05494398|Antidotes|antidotes|mesh-ancestor
83852768|NCT05491278|Remifentanil|remifentanil|mesh-list
83852769|NCT05491278|Propofol|propofol|mesh-list
83852770|NCT05491278|Fospropofol|fospropofol|mesh-list
83852771|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83852772|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852773|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852774|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83852775|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
83852776|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
83852777|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83852778|NCT05491278|Narcotics|narcotics|mesh-ancestor
83852779|NCT05491278|Analgesics|analgesics|mesh-ancestor
83852780|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
83852781|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852782|NCT05463783|Tenofovir|tenofovir|mesh-list
83852783|NCT05463783|Emtricitabine|emtricitabine|mesh-list
83852784|NCT05463783|Darunavir|darunavir|mesh-list
83852785|NCT05463783|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83852786|NCT05463783|Cobicistat|cobicistat|mesh-list
83852787|NCT05463783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83852788|NCT05463783|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83852789|NCT05463783|Antiviral Agents|antiviral agents|mesh-ancestor
83852790|NCT05463783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852791|NCT05463783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83852792|NCT05463783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83852793|NCT05463783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852794|NCT05463783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852795|NCT05463783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83852796|NCT05463783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83852797|NCT05463783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83852798|NCT05463783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83852799|NCT05463783|Protease Inhibitors|protease inhibitors|mesh-ancestor
83852800|NCT05463783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83852801|NCT05463783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83852802|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83852803|NCT05457582|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83852804|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83852805|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83852806|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
83852807|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852808|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852809|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83852810|NCT05457582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83852811|NCT05457582|Protease Inhibitors|protease inhibitors|mesh-ancestor
83852812|NCT05405257|Oxytocin|oxytocin|mesh-list
83852813|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
83852814|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83852815|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852816|NCT05375916|Hydromorphone|hydromorphone|mesh-list
83852817|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83852818|NCT05375916|Narcotics|narcotics|mesh-ancestor
83852819|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83852820|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852821|NCT05375916|Analgesics|analgesics|mesh-ancestor
83852822|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
83852823|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852824|NCT05359354|Vaccines|vaccines|mesh-list
83852825|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
83852826|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852827|NCT05346562|Cannabidiol|cannabidiol|mesh-list
83852828|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
83852829|NCT05344469|Interferons|interferons|mesh-list
83852830|NCT05344469|Interferon-beta|interferon-beta|mesh-list
83852831|NCT05344469|Ofatumumab|ofatumumab|mesh-list
83852832|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
83852833|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
83852834|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852835|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
83852836|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852837|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83852838|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
83852839|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852840|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83852841|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83852842|NCT05313529|Metformin|metformin|mesh-list
83852843|NCT05313529|Liraglutide|liraglutide|mesh-list
83852844|NCT05313529|Empagliflozin|empagliflozin|mesh-list
83852845|NCT05313529|Linagliptin|linagliptin|mesh-list
83852846|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83852847|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852848|NCT05313529|Incretins|incretins|mesh-ancestor
83852849|NCT05313529|Hormones|hormones|mesh-ancestor
83852850|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852851|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83852852|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852853|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83852854|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
83852855|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852856|NCT05287633|Esomeprazole|esomeprazole|mesh-list
83852857|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83852858|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852859|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83852860|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852861|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852862|NCT05285449|Cannabidiol|cannabidiol|mesh-list
83852863|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
83852864|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
83852865|NCT05256901|Neostigmine|neostigmine|mesh-list
83852866|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83852867|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852868|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852869|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
83852870|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83852871|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852872|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83852873|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
83852874|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852875|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83852876|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83852877|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83852878|NCT05251090|Factor VIII|factor viii|mesh-list
83852879|NCT05251090|Coagulants|coagulants|mesh-ancestor
83852880|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83852881|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83852882|NCT05226598|Paclitaxel|paclitaxel|mesh-list
83852883|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83852884|NCT05226598|Carboplatin|carboplatin|mesh-list
83852885|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
83852887|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83852888|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852889|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
83852890|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
83852891|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
83852892|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852893|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852894|NCT05226598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852895|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852896|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83852897|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83852898|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
83852899|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
83852900|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83852901|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83852902|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83852903|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852904|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852905|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83852906|NCT05211323|Bevacizumab|bevacizumab|mesh-list
83852907|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83852908|NCT05211323|Atezolizumab|atezolizumab|mesh-list
83852909|NCT05211323|Cisplatin|cisplatin|mesh-list
83852910|NCT05211323|Gemcitabine|gemcitabine|mesh-list
83852911|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
83852912|NCT05211323|Antibodies|antibodies|mesh-list
83852913|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
83852914|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83852915|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
83852916|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852917|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83852918|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83852919|NCT05211323|Growth Substances|growth substances|mesh-ancestor
83852920|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852921|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
83852922|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
83852923|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83852924|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
83852925|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852926|NCT05211323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852927|NCT05190705|Dexamethasone|dexamethasone|mesh-list
83852928|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
83852929|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83852930|NCT05190705|BB 1101|bb 1101|mesh-list
83852931|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852932|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
83852933|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
83852934|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852935|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852936|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852937|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
83852938|NCT05190705|Hormones|hormones|mesh-ancestor
83852939|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852940|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852941|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852942|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
83852943|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852944|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852945|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852946|NCT05188118|Nivolumab|nivolumab|mesh-list
83852947|NCT05188118|Ipilimumab|ipilimumab|mesh-list
83852948|NCT05188118|Everolimus|everolimus|mesh-list
83852949|NCT05188118|Lenvatinib|lenvatinib|mesh-list
83852950|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852951|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852952|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852953|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852954|NCT05188118|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83852955|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83852956|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852957|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83852958|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
83852959|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852960|NCT05172908|Dexamethasone|dexamethasone|mesh-list
83091824|NCT03263624|Tazarotene|tazarotene|mesh-list
83852961|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852962|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
83852963|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
83852964|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83852965|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83852966|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852967|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
83852968|NCT05172908|Hormones|hormones|mesh-ancestor
83852969|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83852970|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852971|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852972|NCT05140512|Goserelin|goserelin|mesh-list
83852973|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852974|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852975|NCT05110170|Goserelin|goserelin|mesh-list
83852976|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83852977|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852978|NCT04971499|Dapansutrile|dapansutrile|mesh-list
83852979|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
83852980|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83852981|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83852982|NCT04971499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83852983|NCT04971499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852984|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83852985|NCT04918017|Esomeprazole|esomeprazole|mesh-list
83852986|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83852987|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83852988|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83852989|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83852990|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83852991|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
83852992|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83852993|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83852994|NCT04898231|Prednisolone|prednisolone|mesh-list
83852995|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
83852996|NCT04898231|Infliximab|infliximab|mesh-list
83852997|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83852998|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83852999|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
83853000|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83853001|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
83853002|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
83853003|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853004|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853005|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83853006|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
83853007|NCT04898231|Hormones|hormones|mesh-ancestor
83853008|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853009|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83853010|NCT04898231|Protective Agents|protective agents|mesh-ancestor
83853011|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83853012|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853013|NCT04898231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83853014|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
83853015|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83853016|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
83853017|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
83853018|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853019|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
83853020|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83853021|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83853022|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853023|NCT04898114|Urological Agents|urological agents|mesh-ancestor
83853024|NCT04898114|Analgesics|analgesics|mesh-ancestor
83853025|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
83853026|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853027|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853028|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
83853029|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853030|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83853031|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
83853032|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83853033|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83853034|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83853035|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
83853036|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83853038|NCT04892017|Sotorasib|sotorasib|mesh-list
83853039|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853040|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853041|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853042|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853043|NCT04892017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853044|NCT04892017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853045|NCT04856215|Antibodies|antibodies|mesh-list
83853046|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83853047|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
83853048|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853049|NCT04849026|Clozapine|clozapine|mesh-list
83853050|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83853051|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
83853052|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853053|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853054|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853055|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83853056|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83853057|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853058|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83853059|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
83853060|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
83853061|NCT04841980|Rifaximin|rifaximin|mesh-list
83853062|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853063|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853064|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83853065|NCT04831736|Ketamine|ketamine|mesh-list
83853066|NCT04831736|Analgesics|analgesics|mesh-ancestor
83853067|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
83853068|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853069|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853070|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83853071|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83853072|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
83853073|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
83853074|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853075|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83853076|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83853077|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853078|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853079|NCT04830462|Rifampin|rifampin|mesh-list
83853080|NCT04830462|Isoniazid|isoniazid|mesh-list
83853081|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83853082|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
83853083|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853084|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853085|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
83853086|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83853087|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853088|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853089|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83853090|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83853091|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83853092|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83853093|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83853094|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83853095|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83853096|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83853097|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
83853098|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83853099|NCT04797767|Cytarabine|cytarabine|mesh-list
83853100|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83853101|NCT04797767|Venetoclax|venetoclax|mesh-list
83853102|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
83853103|NCT04797767|Cladribine|cladribine|mesh-list
83853104|NCT04797767|Lenograstim|lenograstim|mesh-list
83853105|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853106|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
83853107|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853108|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853109|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
83853110|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853111|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853112|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
83853113|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853114|NCT04797767|Analgesics|analgesics|mesh-ancestor
83853115|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
83853116|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853117|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83853118|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83853119|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853120|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83853121|NCT04787341|Panitumumab|panitumumab|mesh-list
83853122|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853123|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853124|NCT04781972|Methylphenidate|methylphenidate|mesh-list
83853125|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83853126|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853127|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83853128|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83853129|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83853130|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853131|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
83853132|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853133|NCT04775381|Vitamin D|vitamin d|mesh-list
83853134|NCT04775381|Vitamins|vitamins|mesh-ancestor
83853135|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
83853136|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853137|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83853138|NCT04760275|Fluoxetine|fluoxetine|mesh-list
83853139|NCT04760275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83853140|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83853141|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83853142|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853143|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853144|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
83853145|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853146|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83853147|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
83853148|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83853149|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83853150|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83853151|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853152|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83853153|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83853154|NCT04742491|Emtricitabine|emtricitabine|mesh-list
83853155|NCT04742491|Tenofovir|tenofovir|mesh-list
83853156|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83853157|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83853158|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853159|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853160|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
83853161|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853162|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83853163|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83853164|NCT04721873|Topiramate|topiramate|mesh-list
83853165|NCT04721873|Phentermine|phentermine|mesh-list
83853166|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
83853167|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83853168|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853169|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83853170|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
83853171|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83853172|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
83853173|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
83853174|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853175|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
83853176|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853177|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853178|NCT04721015|Docetaxel|docetaxel|mesh-list
83853179|NCT04721015|Osimertinib|osimertinib|mesh-list
83853180|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853181|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83853182|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83853183|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83092057|NCT03797924|Ropivacaine|ropivacaine|mesh-list
83853184|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853185|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853186|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853187|NCT04679389|Acetazolamide|acetazolamide|mesh-list
83853188|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
83853189|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83853190|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853191|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853192|NCT04679389|Diuretics|diuretics|mesh-ancestor
83853193|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
83853194|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853195|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
83853196|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83853197|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853198|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83853199|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
83853200|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853201|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853202|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853203|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853204|NCT04644016|Cyclosporine|cyclosporine|mesh-list
83853205|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
83853206|NCT04644016|Fludarabine|fludarabine|mesh-list
83853207|NCT04644016|Busulfan|busulfan|mesh-list
83853208|NCT04644016|Clofarabine|clofarabine|mesh-list
83853209|NCT04644016|Cyclosporins|cyclosporins|mesh-list
83853210|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853211|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853212|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
83853213|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853214|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853215|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
83853216|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853217|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853218|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
83853219|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853220|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
83853221|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83853222|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83853223|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83853224|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83853225|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
83853226|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853227|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
83853228|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83853229|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83853230|NCT04634162|Cangrelor|cangrelor|mesh-list
83853231|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83853232|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83853233|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83853234|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83853235|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
83853236|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853237|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853238|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853239|NCT04617522|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83853240|NCT04617522|Immunoconjugates|immunoconjugates|mesh-ancestor
83853241|NCT04617522|Immunologic Factors|immunologic factors|mesh-ancestor
83853242|NCT04617522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853243|NCT04616196|Cetuximab|cetuximab|mesh-list
83853244|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853245|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853246|NCT04613518|Deucravacitinib|deucravacitinib|mesh-list
83853247|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
83853248|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853249|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853250|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853251|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83853252|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83853253|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
83853254|NCT04583956|Remdesivir|remdesivir|mesh-list
83853255|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
83853256|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092126|NCT03262376|Vitamins|vitamins|mesh-list
83853257|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
83853258|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853259|NCT04541407|Temozolomide|temozolomide|mesh-list
83853260|NCT04541407|Osimertinib|osimertinib|mesh-list
83853261|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83853262|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
83853263|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853264|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853265|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853266|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853267|NCT04552795|Lamivudine|lamivudine|mesh-list
83853268|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83853269|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83853270|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853271|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853272|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
83853273|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853274|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83853275|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83853276|NCT04522336|Docetaxel|docetaxel|mesh-list
83853277|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
83853278|NCT04522336|Fluorouracil|fluorouracil|mesh-list
83853279|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
83853280|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853281|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83853282|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
83853283|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83853284|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853285|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853286|NCT04522336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853287|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
83853288|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853289|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853290|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
83853291|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853292|NCT04463680|Rifampin|rifampin|mesh-list
83853293|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83853294|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
83853295|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853296|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853297|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
83853298|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83853299|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853300|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853301|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83853302|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83853303|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83853304|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83853305|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83853306|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83853307|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83853308|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853309|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
83853310|NCT04428333|Fluorouracil|fluorouracil|mesh-list
83853311|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853312|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853313|NCT04428333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853314|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853315|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
83853316|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853317|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853318|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
83853319|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853320|NCT04415944|Carboplatin|carboplatin|mesh-list
83853321|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853322|NCT04395989|Paclitaxel|paclitaxel|mesh-list
83853323|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83853324|NCT04395989|Capecitabine|capecitabine|mesh-list
83853325|NCT04395989|Everolimus|everolimus|mesh-list
83853326|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83853327|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853328|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
83853329|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
83853330|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
83092203|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
83853331|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853332|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853333|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
83853334|NCT04395989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83853335|NCT04395989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853336|NCT04395989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853337|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853338|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
83853339|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853340|NCT04393454|Sirolimus|sirolimus|mesh-list
83853341|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853342|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853343|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83853344|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853345|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
83853346|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853347|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
83853348|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853349|NCT04389632|Pembrolizumab|pembrolizumab|mesh-list
83853350|NCT04389632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853351|NCT04389632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853352|NCT04389632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853353|NCT04389632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853354|NCT04341311|Panobinostat|panobinostat|mesh-list
83853355|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853356|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83853357|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853358|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853359|NCT04304014|Sulfalene|sulfalene|mesh-list
83853360|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853361|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83853362|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
83853363|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83853364|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83853365|NCT04300231|Hydromorphone|hydromorphone|mesh-list
83853366|NCT04300231|Bupivacaine|bupivacaine|mesh-list
83853367|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
83853368|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
83853369|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853370|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853371|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
83853372|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853373|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83853374|NCT04300231|Narcotics|narcotics|mesh-ancestor
83853375|NCT04300231|Analgesics|analgesics|mesh-ancestor
83853376|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
83853377|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83853378|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
83853379|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853380|NCT04278898|Expectorants|expectorants|mesh-ancestor
83853381|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83853382|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83853383|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
83853384|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853385|NCT04278898|Protective Agents|protective agents|mesh-ancestor
83853386|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853387|NCT04278898|Antidotes|antidotes|mesh-ancestor
83853388|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83853389|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853390|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853391|NCT04254107|Immunotoxins|immunotoxins|mesh-ancestor
83853392|NCT04254107|Immunoconjugates|immunoconjugates|mesh-ancestor
83853393|NCT04254107|Immunologic Factors|immunologic factors|mesh-ancestor
83853394|NCT04254107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853395|NCT04249362|Durvalumab|durvalumab|mesh-list
83853396|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853397|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853398|NCT04235101|Trastuzumab|trastuzumab|mesh-list
83853399|NCT04235101|Niraparib|niraparib|mesh-list
83853400|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853401|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853402|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83853403|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853404|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853405|NCT04230148|Triclabendazole|triclabendazole|mesh-list
83853406|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83853407|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
83853408|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83853409|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853410|NCT04227847|Azacitidine|azacitidine|mesh-list
83853411|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853412|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
83853413|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853414|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853415|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853416|NCT04205630|Trastuzumab|trastuzumab|mesh-list
83853417|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853418|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853419|NCT04195633|Cyclosporine|cyclosporine|mesh-list
83853420|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
83853421|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
83853422|NCT04195633|Treosulfan|treosulfan|mesh-list
83853423|NCT04195633|Busulfan|busulfan|mesh-list
83853424|NCT04195633|Fludarabine|fludarabine|mesh-list
83853425|NCT04195633|Cyclosporins|cyclosporins|mesh-list
83853426|NCT04195633|Lenograstim|lenograstim|mesh-list
83853427|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853428|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
83853429|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853430|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83853431|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83853432|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
83853433|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853434|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853435|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83853436|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83853437|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853438|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
83853439|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853440|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
83853441|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83853442|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83853443|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83853444|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
83853445|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853446|NCT04171050|Anesthetics|anesthetics|mesh-list
83853447|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
83853448|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853449|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853450|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
83853451|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853452|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
83853453|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853454|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853455|NCT04128696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853456|NCT04128696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853457|NCT04098081|Gemcitabine|gemcitabine|mesh-list
83853458|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
83853459|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853460|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
83853461|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853462|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853463|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853464|NCT04039607|Nivolumab|nivolumab|mesh-list
83853465|NCT04039607|Ipilimumab|ipilimumab|mesh-list
83853466|NCT04039607|Sorafenib|sorafenib|mesh-list
83853467|NCT04039607|Lenvatinib|lenvatinib|mesh-list
83853468|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853469|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853470|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853471|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853472|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853473|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853474|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
83853475|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83853476|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
83853477|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83853478|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853479|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83092360|NCT03251768|Lenograstim|lenograstim|mesh-list
83853480|NCT03914612|Paclitaxel|paclitaxel|mesh-list
83853481|NCT03914612|Carboplatin|carboplatin|mesh-list
83853482|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
83853483|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83853484|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83853485|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853486|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83853487|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83853488|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83853489|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853490|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853491|NCT03914612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853492|NCT03900793|Sunitinib|sunitinib|mesh-list
83853493|NCT03900793|Losartan|losartan|mesh-list
83853494|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853495|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83853496|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83853497|NCT03900793|Growth Substances|growth substances|mesh-ancestor
83853498|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853499|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
83853500|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853501|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853502|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853503|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83853504|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83853505|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83853506|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83853507|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
83853508|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853509|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853510|NCT03897881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853511|NCT03897881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853512|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83853513|NCT03896880|Clotrimazole|clotrimazole|mesh-list
83853514|NCT03896880|Miconazole|miconazole|mesh-list
83853515|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
83853516|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853517|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83853518|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83853519|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83853520|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853521|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853522|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83853523|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
83853524|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853525|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853526|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83853527|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83853528|NCT03854019|Quinidine|quinidine|mesh-list
83853529|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
83853530|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
83853531|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
83853532|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83853533|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83853534|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853535|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853536|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853537|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83853538|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83853539|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83853540|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83853541|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
83853542|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83853543|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83853544|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853545|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853546|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83853547|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83853548|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
83853549|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83853550|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83853551|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83853552|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83853553|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83853554|NCT03815019|Megestrol|megestrol|mesh-list
83853555|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
83853556|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83853557|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83853558|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83853559|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
83853560|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83853561|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853562|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83853563|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83853564|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83853565|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853566|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
83853567|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83853568|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83853569|NCT03767218|Hormones|hormones|mesh-ancestor
83853570|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853571|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853572|NCT03739645|Metronidazole|metronidazole|mesh-list
83853573|NCT03739645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853574|NCT03739645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83853575|NCT03739645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83853576|NCT03739645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83853577|NCT03735979|Argatroban|argatroban|mesh-list
83853578|NCT03735979|Eptifibatide|eptifibatide|mesh-list
83853579|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
83853580|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83853581|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
83853582|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853583|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853584|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
83853585|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83853586|NCT03714308|Aflibercept|aflibercept|mesh-list
83853587|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83853588|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83853589|NCT03714308|Growth Substances|growth substances|mesh-ancestor
83853590|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853591|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
83853592|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853593|NCT03705585|Vaccines|vaccines|mesh-list
83853594|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
83853595|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853596|NCT03701282|Venetoclax|venetoclax|mesh-list
83853597|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
83853598|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853599|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853600|NCT03695237|Leuprolide|leuprolide|mesh-list
83853601|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83853602|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
83853603|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83853604|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853605|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83853606|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853607|NCT03603509|Vaccines|vaccines|mesh-list
83853608|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
83853609|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853610|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
83853611|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
83853612|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83853613|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853614|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853615|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83853616|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
83853617|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83853618|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853619|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
83853620|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
83853621|NCT03517969|Carboplatin|carboplatin|mesh-list
83853622|NCT03517969|Docetaxel|docetaxel|mesh-list
83853623|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853624|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
83853625|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
83853626|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
83853627|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853628|NCT03439293|Dexamethasone|dexamethasone|mesh-list
83853629|NCT03439293|Daratumumab|daratumumab|mesh-list
83853630|NCT03439293|Ixazomib|ixazomib|mesh-list
83853631|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83853632|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
83853633|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
83853634|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853635|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853636|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83853637|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
83853638|NCT03439293|Hormones|hormones|mesh-ancestor
83853639|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853640|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83853641|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853642|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
83853643|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853644|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853645|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
83853646|NCT03405792|Temozolomide|temozolomide|mesh-list
83853647|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853648|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853649|NCT03405792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853650|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853651|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83853652|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
83853653|NCT03400332|Nivolumab|nivolumab|mesh-list
83853654|NCT03400332|Ipilimumab|ipilimumab|mesh-list
83853655|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853656|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853657|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853658|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853659|NCT03369223|Nivolumab|nivolumab|mesh-list
83853660|NCT03369223|Ipilimumab|ipilimumab|mesh-list
83853661|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853662|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853663|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853664|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853665|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
83853666|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83853667|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83853668|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853669|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
83853670|NCT03361345|Coagulants|coagulants|mesh-ancestor
83853671|NCT03275285|Dexamethasone|dexamethasone|mesh-list
83853672|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83853673|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
83853674|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
83853675|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853676|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853677|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83853678|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
83853679|NCT03275285|Hormones|hormones|mesh-ancestor
83853680|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853681|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83853682|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853683|NCT03216187|Pregabalin|pregabalin|mesh-list
83853684|NCT03216187|Analgesics|analgesics|mesh-ancestor
83853685|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
83853686|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853687|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853688|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
83853689|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83853690|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83853691|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853692|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83853693|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83853694|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83853695|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853696|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83853697|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83853698|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83853699|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853700|NCT03172754|Nivolumab|nivolumab|mesh-list
83853701|NCT03172754|Axitinib|axitinib|mesh-list
83853702|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853703|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092576|NCT05478772|Fluconazole|fluconazole|mesh-list
83853704|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853705|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853706|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83853707|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853708|NCT03137888|Temozolomide|temozolomide|mesh-list
83853709|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83853710|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
83853711|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853712|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853713|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
83853714|NCT03123913|Testosterone|testosterone|mesh-list
83853715|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
83853716|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
83853717|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83853718|NCT03123913|Androgens|androgens|mesh-ancestor
83853719|NCT03123913|Hormones|hormones|mesh-ancestor
83853720|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853721|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853722|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83853723|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853724|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
83853725|NCT03110107|Nivolumab|nivolumab|mesh-list
83853726|NCT03110107|Ipilimumab|ipilimumab|mesh-list
83853727|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853728|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853729|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853730|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853731|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
83853732|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853733|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853734|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
83853735|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
83853736|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83853737|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853738|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853739|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
83853740|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83853741|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83853742|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853743|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83853744|NCT03008278|Olaparib|olaparib|mesh-list
83853745|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83853746|NCT03008278|Ramucirumab|ramucirumab|mesh-list
83853747|NCT03008278|Antibodies|antibodies|mesh-list
83853748|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
83853749|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83853750|NCT03008278|Lexatumumab|lexatumumab|mesh-list
83853751|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
83853752|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853753|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853754|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853755|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853756|NCT03007238|Aldesleukin|aldesleukin|mesh-list
83853757|NCT03007238|Interleukin-2|interleukin-2|mesh-list
83853758|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853759|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83853760|NCT03007238|Analgesics|analgesics|mesh-ancestor
83853761|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
83853762|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853763|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853764|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83853765|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83853766|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
83853767|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853768|NCT02902198|Quinine|quinine|mesh-list
83853769|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
83853770|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83853771|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83853772|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853773|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83853774|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853775|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83853776|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853777|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83092673|NCT03253250|Tenofovir|tenofovir|mesh-list
83853778|NCT02902198|Analgesics|analgesics|mesh-ancestor
83853779|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
83853780|NCT02888743|Durvalumab|durvalumab|mesh-list
83853781|NCT02888743|Ipilimumab|ipilimumab|mesh-list
83853782|NCT02888743|Tremelimumab|tremelimumab|mesh-list
83853783|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
83853784|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83853785|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
83853786|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853787|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853788|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
83853789|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853790|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853791|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853792|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
83853793|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853794|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853795|NCT02858869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853796|NCT02858869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853797|NCT02811523|Doxorubicin|doxorubicin|mesh-list
83853798|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83853799|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853800|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83853801|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83853802|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853803|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853804|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
83853805|NCT02750319|Amiodarone|amiodarone|mesh-list
83853806|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83853807|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
83853808|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853809|NCT02750319|Expectorants|expectorants|mesh-ancestor
83853810|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
83853811|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83853812|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
83853813|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853814|NCT02750319|Protective Agents|protective agents|mesh-ancestor
83853815|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853816|NCT02750319|Antidotes|antidotes|mesh-ancestor
83853817|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83853818|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
83853819|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83853820|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83853821|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83853822|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83853823|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83853824|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853825|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83853826|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83853827|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83853828|NCT02743494|Nivolumab|nivolumab|mesh-list
83853829|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853830|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853831|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853832|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853833|NCT02636582|Molgramostim|molgramostim|mesh-list
83853834|NCT02636582|Vaccines|vaccines|mesh-list
83853835|NCT02636582|Sargramostim|sargramostim|mesh-list
83853836|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
83853837|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853838|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853839|NCT02611258|Tadalafil|tadalafil|mesh-list
83853840|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
83853841|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83853842|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83853843|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853844|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853845|NCT02611258|Urological Agents|urological agents|mesh-ancestor
83853846|NCT02532231|Nivolumab|nivolumab|mesh-list
83853847|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853848|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853849|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853850|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853851|NCT02500407|Atezolizumab|atezolizumab|mesh-list
83853852|NCT02500407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83853853|NCT02500407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853854|NCT02500407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853855|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853856|NCT02367040|Rituximab|rituximab|mesh-list
83853857|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853858|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853859|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
83853860|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853861|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83853862|NCT02172651|Vitamin D|vitamin d|mesh-list
83853863|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
83853864|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
83853865|NCT02172651|Vitamins|vitamins|mesh-list
83853866|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
83853867|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853868|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83853869|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83853870|NCT02144857|Cyclosporine|cyclosporine|mesh-list
83853871|NCT02144857|Etanercept|etanercept|mesh-list
83853872|NCT02144857|Apremilast|apremilast|mesh-list
83853873|NCT02144857|Ustekinumab|ustekinumab|mesh-list
83853874|NCT02144857|Cyclosporins|cyclosporins|mesh-list
83853875|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853876|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853877|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83853878|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
83853879|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853880|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
83853881|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853882|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
83853883|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83853884|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83853885|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83853886|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83853887|NCT02144857|Analgesics|analgesics|mesh-ancestor
83853888|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
83853889|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853890|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83853891|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83853892|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83853893|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83853894|NCT02131597|Guadecitabine|guadecitabine|mesh-list
83853895|NCT02131597|Azacitidine|azacitidine|mesh-list
83853896|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853897|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83853898|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
83853899|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853900|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853901|NCT02095184|Letrozole|letrozole|mesh-list
83853902|NCT02095184|Anastrozole|anastrozole|mesh-list
83853903|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853904|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83853905|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83853906|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853907|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853908|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83853909|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
83853910|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853911|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853912|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83853913|NCT01886872|Rituximab|rituximab|mesh-list
83853914|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83853915|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83853916|NCT01886872|Antibodies|antibodies|mesh-list
83853917|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
83853918|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83853919|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
83853920|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853921|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853922|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83853923|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83853924|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
83853925|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853926|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
83853927|NCT01252953|Anacetrapib|anacetrapib|mesh-list
83853928|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83853929|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83853930|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
83853931|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853932|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83853933|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853934|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83853935|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853936|NCT01038778|Aldesleukin|aldesleukin|mesh-list
83853937|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
83853938|NCT01038778|Interleukin-2|interleukin-2|mesh-list
83853939|NCT01038778|Entinostat|entinostat|mesh-list
83853940|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83853941|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83853942|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853943|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83853944|NCT01038778|Analgesics|analgesics|mesh-ancestor
83853945|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
83853946|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83853947|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853948|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83853949|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83853950|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
83853951|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83853952|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83853953|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853954|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853955|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
83853956|NCT00937131|Rituximab|rituximab|mesh-list
83853957|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83853958|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853959|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
83853960|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853961|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83853962|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83853963|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83853964|NCT00837616|Estradiol|estradiol|mesh-list
83853965|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83853966|NCT00837616|Estrogens|estrogens|mesh-ancestor
83853967|NCT00837616|Hormones|hormones|mesh-ancestor
83853968|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83853969|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853970|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83853971|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
83853972|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83853973|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83853974|NCT00697073|Idebenone|idebenone|mesh-list
83853975|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
83853976|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853977|NCT00697073|Protective Agents|protective agents|mesh-ancestor
83853978|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83853979|NCT00610051|Alprostadil|alprostadil|mesh-list
83853980|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83853981|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
83853982|NCT00610051|Urological Agents|urological agents|mesh-ancestor
83853983|NCT00176254|Paclitaxel|paclitaxel|mesh-list
83853984|NCT00176254|Carboplatin|carboplatin|mesh-list
83853985|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83853986|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853987|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
83853988|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
83853989|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
83853990|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853991|NCT02949895|Etoposide|etoposide|mesh-list
83853992|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83853993|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83853994|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83853995|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83853996|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83853997|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83853998|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
83853999|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83854000|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854001|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
83854002|NCT00516841|Volociximab|volociximab|mesh-list
83854003|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83854004|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83854005|NCT00516841|Growth Substances|growth substances|mesh-ancestor
83854006|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854007|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
83854008|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854009|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
83854010|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83854011|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854012|NCT04694677|Misoprostol|misoprostol|mesh-list
83854013|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
83854014|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83854015|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83854016|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854017|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
83854018|NCT04694677|Coagulants|coagulants|mesh-ancestor
83854019|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83854020|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
83854021|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83854022|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854023|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83854024|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854025|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
83854026|NCT00516958|Levofloxacin|levofloxacin|mesh-list
83854027|NCT00516958|Ofloxacin|ofloxacin|mesh-list
83854028|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83854029|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83854030|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854031|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854032|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83854033|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83854034|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854035|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854036|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854037|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83854038|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83854039|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
83854040|NCT00517114|Rabeprazole|rabeprazole|mesh-list
83854041|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83854042|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854043|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83854044|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854045|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854046|NCT00517270|Rabeprazole|rabeprazole|mesh-list
83854047|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83854048|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854049|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83854050|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854051|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854052|NCT00517309|Vaccines|vaccines|mesh-list
83854053|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
83854054|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854055|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83854056|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
83854057|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83854058|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83854059|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83854060|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854061|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854062|NCT00517426|Acetazolamide|acetazolamide|mesh-list
83854063|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
83854064|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83854065|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854066|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854067|NCT00517426|Diuretics|diuretics|mesh-ancestor
83854068|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
83854069|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854070|NCT00517504|Methylphenidate|methylphenidate|mesh-list
83854071|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83854072|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854073|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83854074|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83854075|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854076|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854077|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
83854078|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854079|NCT00517582|Icatibant|icatibant|mesh-list
83854080|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83854081|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83854082|NCT00517582|Analgesics|analgesics|mesh-ancestor
83854083|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
83854084|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854085|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854086|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854087|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854088|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83854089|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83854090|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854091|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83854092|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854093|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
83854095|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83854096|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854097|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
83854098|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
83854099|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
83854100|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854101|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83854102|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83854103|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854104|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854105|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
83854106|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854107|NCT00151515|Minoxidil|minoxidil|mesh-list
83854108|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83854109|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
83854110|NCT00166686|Clonidine|clonidine|mesh-list
83854111|NCT00166686|Analgesics|analgesics|mesh-ancestor
83854112|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
83854113|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854114|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854115|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83854116|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
83854117|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
83854118|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83854119|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83854120|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83854121|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
83854122|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854123|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854124|NCT02949778|Ropivacaine|ropivacaine|mesh-list
83854125|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
83854126|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
83854127|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854128|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854129|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
83854130|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854131|NCT00518245|Enoxaparin|enoxaparin|mesh-list
83854132|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
83854133|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83854134|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83854135|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854136|NCT02957903|Ropivacaine|ropivacaine|mesh-list
83854137|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
83854138|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
83854139|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854140|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854141|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
83854142|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854143|NCT00518479|Amlodipine|amlodipine|mesh-list
83854144|NCT00518479|Valsartan|valsartan|mesh-list
83854145|NCT00518479|Moxonidine|moxonidine|mesh-list
83854146|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
83854147|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83854148|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83854149|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854150|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854151|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83854152|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854153|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
83854154|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83854155|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83854156|NCT00518479|Diuretics|diuretics|mesh-ancestor
83854157|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
83854158|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83854159|NCT00166725|Octreotide|octreotide|mesh-list
83854160|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854161|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83854162|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854163|NCT00518635|Insulin|insulin|mesh-list
83854164|NCT00518635|Hormones|hormones|mesh-list
83854165|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83854166|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854167|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854168|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
83854169|NCT00151632|Tacrolimus|tacrolimus|mesh-list
83854170|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854171|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
83148000|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
83854172|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854173|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83854174|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854175|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854176|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854177|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854178|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83854179|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
83854180|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854181|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854182|NCT02949232|Prednisolone|prednisolone|mesh-list
83854183|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854184|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
83854185|NCT02949232|Hormones|hormones|mesh-ancestor
83854186|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854187|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854188|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83854189|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854190|NCT00518908|Sevoflurane|sevoflurane|mesh-list
83854191|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83854192|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83854193|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
83854194|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
83854195|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854196|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854197|NCT00518947|Verapamil|verapamil|mesh-list
83854198|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
83854199|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
83854200|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83854201|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854202|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854203|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
83854204|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83854205|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854206|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854207|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83854208|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83854209|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854210|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83854211|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
83854212|NCT02949466|Triamcinolone|triamcinolone|mesh-list
83854213|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
83854214|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854215|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
83854216|NCT02949466|Hormones|hormones|mesh-ancestor
83854217|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854218|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854219|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
83854220|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83854221|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
83854222|NCT02949466|Protective Agents|protective agents|mesh-ancestor
83854223|NCT00151710|Pioglitazone|pioglitazone|mesh-list
83854224|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83854225|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854226|NCT00519181|Valproic Acid|valproic acid|mesh-list
83854227|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
83854228|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854229|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854230|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
83854231|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854232|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854233|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
83854234|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83854235|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854236|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83854237|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
83854238|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83854239|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854240|NCT02949310|Nefopam|nefopam|mesh-list
83854241|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83854242|NCT02949310|Analgesics|analgesics|mesh-ancestor
83854243|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
83854244|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854245|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854246|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
83854247|NCT02949349|Prednisolone|prednisolone|mesh-list
83854248|NCT02949349|Azathioprine|azathioprine|mesh-list
83854249|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854250|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854251|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83854252|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
83854253|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854254|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854255|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854256|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854257|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854258|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
83854259|NCT02949349|Hormones|hormones|mesh-ancestor
83854260|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854261|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854262|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83854263|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
83854264|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83854265|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854266|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
83854267|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854268|NCT00166842|Cyclosporine|cyclosporine|mesh-list
83854269|NCT00166842|Sirolimus|sirolimus|mesh-list
83854270|NCT00166842|Tacrolimus|tacrolimus|mesh-list
83854271|NCT00166842|Cyclosporins|cyclosporins|mesh-list
83854272|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854273|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
83854274|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854275|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83854276|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854277|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854278|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
83854279|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854280|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
83854281|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854282|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854283|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854284|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854285|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83854286|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83854287|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854288|NCT02949193|Incretins|incretins|mesh-ancestor
83854289|NCT02949193|Hormones|hormones|mesh-ancestor
83854290|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854291|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83854292|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
83854293|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854294|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854295|NCT00519259|Lobeline|lobeline|mesh-list
83854296|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83854297|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
83854298|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854299|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854300|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83854301|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83854302|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
83854303|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854304|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854305|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
83854306|NCT00519298|Donepezil|donepezil|mesh-list
83854307|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83854308|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854309|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854310|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
83854311|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854312|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854313|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
83854314|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
83854315|NCT00519337|Vitamins|vitamins|mesh-ancestor
83854316|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
83854317|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854318|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
83854319|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854320|NCT00519337|Protective Agents|protective agents|mesh-ancestor
83854321|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83854322|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83854323|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83854324|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
83854325|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854326|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83854327|NCT00166881|Docetaxel|docetaxel|mesh-list
83854328|NCT00166881|Irinotecan|irinotecan|mesh-list
83854329|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854330|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83854331|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83854332|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83854333|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854334|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83854335|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83854336|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854337|NCT02948998|Spironolactone|spironolactone|mesh-list
83854338|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83854339|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
83854340|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854341|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854342|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83854343|NCT02948998|Diuretics|diuretics|mesh-ancestor
83854344|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
83854345|NCT00519688|Thalidomide|thalidomide|mesh-list
83854346|NCT00519688|Tegafur|tegafur|mesh-list
83854347|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854348|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
83854349|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854350|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
83854351|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854352|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854353|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83854354|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83854355|NCT00519688|Growth Substances|growth substances|mesh-ancestor
83854356|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
83854357|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854358|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83854359|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
83854360|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854361|NCT02948920|Ephedrine|ephedrine|mesh-list
83854362|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83854363|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854364|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
83854365|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
83854366|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854367|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83854368|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
83854369|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854370|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854371|NCT00151827|Losartan|losartan|mesh-list
83854372|NCT00151827|Olmesartan|olmesartan|mesh-list
83854373|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83854374|NCT00151827|Furosemide|furosemide|mesh-list
83854375|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83854376|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83854377|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83854378|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83854379|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854380|NCT00151827|Diuretics|diuretics|mesh-ancestor
83854381|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
83854382|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854383|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83854384|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854385|NCT00519805|Dalteparin|dalteparin|mesh-list
83854386|NCT00519805|Tinzaparin|tinzaparin|mesh-list
83854387|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83854388|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
83854389|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83854390|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83854391|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854392|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
83854393|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83854394|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854395|NCT04457180|Repaglinide|repaglinide|mesh-list
83854396|NCT04457180|Apatinib|apatinib|mesh-list
83854397|NCT04457180|Bupropion|bupropion|mesh-list
83854398|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854399|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83854400|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854401|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854402|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83854403|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
83854404|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83854405|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83854406|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83854407|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854408|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
83854409|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854410|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854411|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83854412|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83854413|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83854414|NCT00520000|Carboplatin|carboplatin|mesh-list
83854415|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83854416|NCT00520000|Paclitaxel|paclitaxel|mesh-list
83854417|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854418|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83854419|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
83854420|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
83854421|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
83854422|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854423|NCT00151944|Mesalamine|mesalamine|mesh-list
83854424|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83854425|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83854426|NCT00151944|Analgesics|analgesics|mesh-ancestor
83854427|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
83854428|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854429|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854430|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854431|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854432|NCT00520507|Olanzapine|olanzapine|mesh-list
83854433|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
83854434|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
83854435|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854436|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854437|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854438|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83854439|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83854440|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854441|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83854442|NCT00520507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83854443|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83854444|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854445|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854446|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854447|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
83854448|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
83854449|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854450|NCT04694365|Fluzoparib|fluzoparib|mesh-list
83854451|NCT04694365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83854452|NCT04694365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854453|NCT04694365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854454|NCT04694365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854455|NCT00151983|Methylphenidate|methylphenidate|mesh-list
83854456|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83854457|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854458|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83854459|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83854460|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854461|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854462|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
83854463|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854464|NCT00520585|Atorvastatin|atorvastatin|mesh-list
83854465|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83854466|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83854467|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
83854468|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854469|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83854470|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83854471|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854472|NCT00152022|Amphetamine|amphetamine|mesh-list
83854473|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
83854474|NCT00152022|Adderall|adderall|mesh-list
83854475|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83854476|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854477|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
83854478|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
83854479|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854480|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
83854481|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854482|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854483|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
83854484|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83854485|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83854486|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854487|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83854488|NCT00520819|Antioxidants|antioxidants|mesh-list
83854489|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854490|NCT00520819|Protective Agents|protective agents|mesh-ancestor
83854491|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854492|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
83854493|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83854494|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83854495|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
83854496|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854497|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83854498|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83854499|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854500|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854501|NCT00521092|Sunitinib|sunitinib|mesh-list
83854502|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854503|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83854504|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83854505|NCT00521092|Growth Substances|growth substances|mesh-ancestor
83854506|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854507|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
83854508|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83854509|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854510|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854511|NCT00521131|Levocetirizine|levocetirizine|mesh-list
83854512|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83854513|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83854514|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
83854515|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
83854516|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854517|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854518|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854519|NCT04694092|Landiolol|landiolol|mesh-list
83854520|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83854521|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83854522|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
83854523|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854524|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854525|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854526|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83854528|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83854529|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83854530|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
83854531|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
83854532|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854533|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854534|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854535|NCT00521248|Morphine|morphine|mesh-list
83854536|NCT00521248|Buprenorphine|buprenorphine|mesh-list
83854537|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83854538|NCT00521248|Narcotics|narcotics|mesh-ancestor
83854539|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854540|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854541|NCT00521248|Analgesics|analgesics|mesh-ancestor
83854542|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
83854543|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854544|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83854545|NCT00167154|Risperidone|risperidone|mesh-list
83854546|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83854547|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
83854548|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854549|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854550|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854551|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83854552|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83854553|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854554|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83854555|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83854556|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
83854557|NCT00521482|Thalidomide|thalidomide|mesh-list
83854558|NCT00521482|Temozolomide|temozolomide|mesh-list
83854559|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83854560|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
83854561|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854562|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854563|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854564|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
83854565|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854566|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
83854567|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854568|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854569|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83854570|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83854571|NCT00521482|Growth Substances|growth substances|mesh-ancestor
83854572|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
83854573|NCT00521521|Docetaxel|docetaxel|mesh-list
83854574|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854575|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
83854576|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
83854577|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
83854578|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854579|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
83854580|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83854581|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854582|NCT00522184|Etanercept|etanercept|mesh-list
83854583|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83854584|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83854585|NCT00522184|Analgesics|analgesics|mesh-ancestor
83854586|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
83854587|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854588|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854589|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854590|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854591|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854592|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854593|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
83854594|NCT03458923|Diclofenac|diclofenac|mesh-list
83854595|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83854596|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83854597|NCT03458923|Ranibizumab|ranibizumab|mesh-list
83854598|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
83854599|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83854600|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83854601|NCT03458923|Growth Substances|growth substances|mesh-ancestor
83854602|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854603|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
83854604|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854605|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854606|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83854607|NCT03458923|Analgesics|analgesics|mesh-ancestor
83854608|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
83854609|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854610|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854611|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83854612|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854613|NCT04186013|Atezolizumab|atezolizumab|mesh-list
83854614|NCT04186013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83854615|NCT04186013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854616|NCT04186013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83854617|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854618|NCT00152139|Antibodies|antibodies|mesh-list
83854619|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
83854620|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854621|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83854622|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83854623|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854624|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
83854625|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83854626|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83854627|NCT00167232|Naltrexone|naltrexone|mesh-list
83854628|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83854629|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83854630|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854631|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
83854632|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854633|NCT00522886|Cetuximab|cetuximab|mesh-list
83854634|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83854635|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854636|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
83854637|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
83854638|NCT04083560|Hematinics|hematinics|mesh-ancestor
83854639|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
83854640|NCT04083560|Vitamins|vitamins|mesh-ancestor
83854641|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
83854642|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854643|NCT00511966|Rabeprazole|rabeprazole|mesh-list
83854644|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83854645|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854646|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83854647|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854648|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854649|NCT00152178|Tamoxifen|tamoxifen|mesh-list
83854650|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
83854651|NCT00152178|Fluorouracil|fluorouracil|mesh-list
83854652|NCT00152178|Methotrexate|methotrexate|mesh-list
83854653|NCT00152178|Tegafur|tegafur|mesh-list
83854654|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854655|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
83854656|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854657|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854658|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83854659|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
83854660|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854661|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854662|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83854663|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
83854664|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83854665|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83854666|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
83854667|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83854668|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
83854669|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854670|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83854671|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83854672|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83854673|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
83093540|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148829|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83854674|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854675|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83854676|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83854677|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83854678|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83854679|NCT00523120|Diclofenac|diclofenac|mesh-list
83854680|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83854681|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83854682|NCT00523120|Analgesics|analgesics|mesh-ancestor
83854683|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
83854684|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854685|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854686|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854687|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854688|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83854689|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854690|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854691|NCT00523159|Sargramostim|sargramostim|mesh-list
83854692|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
83854693|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854694|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
83854695|NCT04693897|Mirabegron|mirabegron|mesh-list
83854696|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83854697|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83854698|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
83854699|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854700|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854701|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854702|NCT04693897|Urological Agents|urological agents|mesh-ancestor
83854703|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83854704|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83854705|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83854706|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
83854707|NCT00424242|Pemetrexed|pemetrexed|mesh-list
83854708|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854709|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854710|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854711|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83854712|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83854713|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
83854714|NCT04726553|Antimalarials|antimalarials|mesh-list
83854715|NCT04726553|Methotrexate|methotrexate|mesh-list
83854716|NCT04726553|Azathioprine|azathioprine|mesh-list
83854717|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83854718|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
83854719|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83854720|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854721|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83854722|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
83854723|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854724|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854725|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
83854726|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854727|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83854728|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854729|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
83854730|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854731|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83854732|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854733|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83854734|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
83854735|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854736|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854737|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83854738|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83854739|NCT02947945|Reslizumab|reslizumab|mesh-list
83854740|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83854741|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
83854742|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
83854743|NCT02948101|Antibodies|antibodies|mesh-list
83854744|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83854745|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854746|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
83854747|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854749|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83854750|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
83854751|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854752|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854753|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83854754|NCT02952157|Lidocaine|lidocaine|mesh-list
83854755|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
83854756|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
83854757|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854758|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854759|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
83854760|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854761|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83854762|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83854763|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83854764|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83854765|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854766|NCT02951728|Prednisone|prednisone|mesh-list
83854767|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
83854768|NCT02951728|Rituximab|rituximab|mesh-list
83854769|NCT02951728|Doxorubicin|doxorubicin|mesh-list
83854770|NCT02951728|Vincristine|vincristine|mesh-list
83854771|NCT02951728|Decitabine|decitabine|mesh-list
83854772|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854773|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
83854774|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854775|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854776|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83854777|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
83854778|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854779|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854780|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83854781|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83854782|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854783|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83854784|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83854785|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854786|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854787|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
83854788|NCT02951728|Hormones|hormones|mesh-ancestor
83854789|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854790|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83854791|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83854792|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
83854793|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
83854794|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
83854795|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83854796|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
83854797|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83854798|NCT04726046|Cefotetan|cefotetan|mesh-list
83854799|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854800|NCT00523354|Infliximab|infliximab|mesh-list
83854801|NCT00523354|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83854802|NCT00523354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854803|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
83854804|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854805|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854806|NCT00523393|Insulin|insulin|mesh-list
83854807|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83854808|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83854809|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854810|NCT00523432|Sirolimus|sirolimus|mesh-list
83854811|NCT00523432|Topotecan|topotecan|mesh-list
83854812|NCT00523432|Temsirolimus|temsirolimus|mesh-list
83854813|NCT00523432|MTOR Inhibitors|mtor inhibitors|mesh-list
83854814|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83854815|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83854816|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854817|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854818|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854819|NCT00523432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83854820|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854821|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
83854822|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854823|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854824|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854825|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854826|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
83854827|NCT00512044|Anesthetics|anesthetics|mesh-list
83854828|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854829|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854830|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83854831|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83854832|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854833|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
83854834|NCT00521950|Azathioprine|azathioprine|mesh-list
83854835|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
83854836|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854837|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83854838|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854839|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854840|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
83854841|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854842|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83854843|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854844|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854845|NCT00523666|Galantamine|galantamine|mesh-list
83854846|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83854847|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854848|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854849|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
83854850|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83854851|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854852|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83854853|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
83854854|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854855|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
83854856|NCT00167583|Interferons|interferons|mesh-list
83854857|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
83854858|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
83854859|NCT00167583|Cyclosporine|cyclosporine|mesh-list
83854860|NCT00167583|Cyclosporins|cyclosporins|mesh-list
83854861|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854862|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
83854863|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854864|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854865|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854866|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854867|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
83854868|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854869|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
83854870|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83854871|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854872|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83854873|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83854874|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854875|NCT00172809|Interferons|interferons|mesh-list
83854876|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
83854877|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
83854878|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83854879|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854880|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
83854881|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854882|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
83854883|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854884|NCT04696120|Apixaban|apixaban|mesh-list
83854885|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83854886|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
83854887|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83854888|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83854889|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854890|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854891|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
83854892|NCT00512395|Fentanyl|fentanyl|mesh-list
83854893|NCT00512395|Ropivacaine|ropivacaine|mesh-list
83854894|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83854895|NCT00512395|Narcotics|narcotics|mesh-ancestor
83854896|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83854897|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854898|NCT00512395|Analgesics|analgesics|mesh-ancestor
83854899|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
83854900|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854901|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83854902|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83854903|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
83854904|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
83854905|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
83854906|NCT00512473|Hormones|hormones|mesh-list
83854907|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854908|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854909|NCT00524095|Fluticasone|fluticasone|mesh-list
83854910|NCT00524095|Xhance|xhance|mesh-list
83854911|NCT00524095|Azithromycin|azithromycin|mesh-list
83854912|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83854913|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83854914|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
83854915|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854916|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854917|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83854918|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
83854919|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
83854920|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83854921|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854922|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854923|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83854924|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83854925|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83854926|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83854927|NCT00512668|Sirolimus|sirolimus|mesh-list
83854928|NCT00512668|Leuprolide|leuprolide|mesh-list
83854929|NCT00512668|Goserelin|goserelin|mesh-list
83854930|NCT00512668|Flutamide|flutamide|mesh-list
83854931|NCT00512668|Temsirolimus|temsirolimus|mesh-list
83854932|NCT00512668|Bicalutamide|bicalutamide|mesh-list
83854933|NCT00512668|Nilutamide|nilutamide|mesh-list
83854934|NCT00512668|MTOR Inhibitors|mtor inhibitors|mesh-list
83854935|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83854936|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
83854937|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83854938|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854939|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83854940|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854941|NCT00512668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83854942|NCT00512668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854943|NCT00512668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854944|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854945|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
83854946|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854947|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854948|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854949|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
83854950|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
83854951|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
83854952|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83854953|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
83854954|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
83854955|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83854956|NCT00167739|Quinine|quinine|mesh-list
83854957|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
83854958|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83854959|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83854960|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854961|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83854962|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854963|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854964|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83854965|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83854966|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854967|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83854968|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83854969|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83854970|NCT00167739|Analgesics|analgesics|mesh-ancestor
83854971|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
83854972|NCT00524251|Esomeprazole|esomeprazole|mesh-list
83854973|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83854974|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854975|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83854976|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83854977|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854978|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
83854980|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83854981|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83854982|NCT00512824|Antacids|antacids|mesh-ancestor
83854983|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83854984|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83854985|NCT00512863|Adalimumab|adalimumab|mesh-list
83854986|NCT00512863|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83854987|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148004|NCT02137265|Clomiphene|clomiphene|mesh-list
83854988|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83854989|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
83854990|NCT00524407|Hematinics|hematinics|mesh-ancestor
83854991|NCT00525889|Sirolimus|sirolimus|mesh-list
83854992|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83854993|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83854994|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83854995|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83854996|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
83854997|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83854998|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
83854999|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855000|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
83855001|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855002|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83855003|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83855004|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855005|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855006|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
83855007|NCT03879122|Docetaxel|docetaxel|mesh-list
83855008|NCT03879122|Nivolumab|nivolumab|mesh-list
83855009|NCT03879122|Ipilimumab|ipilimumab|mesh-list
83855010|NCT03879122|Androgens|androgens|mesh-list
83855011|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855012|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
83855013|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
83855014|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
83855015|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855016|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83855017|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83855018|NCT03879122|Hormones|hormones|mesh-ancestor
83855019|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855020|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855021|NCT00525928|Varenicline|varenicline|mesh-list
83855022|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83855023|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83855024|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
83855025|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855026|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855027|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855028|NCT00167817|Aripiprazole|aripiprazole|mesh-list
83855029|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
83855030|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83855031|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83855032|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83855033|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855034|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855035|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
83855036|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
83855037|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855038|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855039|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83855040|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83855041|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
83855042|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83855043|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83855044|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83855045|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83855046|NCT02947711|Diltiazem|diltiazem|mesh-list
83855047|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83855048|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83855049|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855050|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855051|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83855052|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855053|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
83855054|NCT03845348|Ketoconazole|ketoconazole|mesh-list
83855055|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
83855056|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855057|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83855058|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83855059|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855060|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855061|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83855062|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
83855063|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855064|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855065|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83855066|NCT04723563|Heparin|heparin|mesh-list
83855067|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
83855068|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83855069|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83855070|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855071|NCT00525967|Acetaminophen|acetaminophen|mesh-list
83855072|NCT00525967|Methadone|methadone|mesh-list
83855073|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83855074|NCT00525967|Analgesics|analgesics|mesh-ancestor
83855075|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
83855076|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855077|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855078|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
83855079|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83855080|NCT00525967|Narcotics|narcotics|mesh-ancestor
83855081|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855082|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
83855083|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
83855084|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83855085|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83855086|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83855087|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855088|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855089|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855090|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855091|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83855092|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
83855093|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83855094|NCT00526006|Esomeprazole|esomeprazole|mesh-list
83855095|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83855096|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83855097|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83855098|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855099|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855100|NCT03681275|Tofacitinib|tofacitinib|mesh-list
83855101|NCT03681275|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83855102|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83855103|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855104|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855105|NCT02946814|Listerine|listerine|mesh-list
83855106|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
83855107|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83855108|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855109|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
83855110|NCT02946814|Protective Agents|protective agents|mesh-ancestor
83855111|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855112|NCT00524836|Levocetirizine|levocetirizine|mesh-list
83855113|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83855114|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83855115|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
83855116|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
83855117|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855118|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855119|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855120|NCT00524875|Bevacizumab|bevacizumab|mesh-list
83855121|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83855122|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855123|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83855124|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83855125|NCT00524875|Growth Substances|growth substances|mesh-ancestor
83855126|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855127|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
83855128|NCT00524914|Apomorphine|apomorphine|mesh-list
83855129|NCT00524914|Emetics|emetics|mesh-ancestor
83855130|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855131|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
83855132|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855133|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83855134|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
83855135|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
83855136|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855137|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855138|NCT02957864|Tenofovir|tenofovir|mesh-list
83855139|NCT02957864|Abacavir|abacavir|mesh-list
83855140|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
83855141|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855142|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83855143|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83855144|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855145|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855146|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83855147|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83855148|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
83855149|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83855150|NCT00168012|Antibodies|antibodies|mesh-list
83855151|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
83855152|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855153|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
83855154|NCT03585452|Propofol|propofol|mesh-list
83855155|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
83855156|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855157|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855158|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83855159|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83855160|NCT03585452|Analgesics|analgesics|mesh-ancestor
83855161|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
83855162|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855163|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83855164|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83855165|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83855166|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
83855167|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855168|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855169|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83855170|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
83855171|NCT02947672|Dexamethasone|dexamethasone|mesh-list
83855172|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855173|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
83855174|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
83855175|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855176|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855177|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83855178|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
83855179|NCT02947672|Hormones|hormones|mesh-ancestor
83855180|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855181|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83855182|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855183|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83855184|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83855185|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83855186|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855187|NCT02946268|Ropivacaine|ropivacaine|mesh-list
83855188|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
83855189|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
83855190|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855191|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855192|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
83855193|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855194|NCT00168051|Factor VIII|factor viii|mesh-list
83855195|NCT00168051|Coagulants|coagulants|mesh-ancestor
83855196|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
83855197|NCT00526318|Melphalan|melphalan|mesh-list
83855198|NCT00526318|Ifosfamide|ifosfamide|mesh-list
83855199|NCT00526318|Dacarbazine|dacarbazine|mesh-list
83855200|NCT00526318|Carboplatin|carboplatin|mesh-list
83855201|NCT00526318|Doxorubicin|doxorubicin|mesh-list
83855202|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83855203|NCT00526318|Etoposide|etoposide|mesh-list
83855204|NCT00526318|Vincristine|vincristine|mesh-list
83855205|NCT00526318|Topotecan|topotecan|mesh-list
83855206|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
83855207|NCT00526318|Vindesine|vindesine|mesh-list
83855208|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83855209|NCT00526318|Isotretinoin|isotretinoin|mesh-list
83855210|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83855211|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
83855212|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855213|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855214|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83855215|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
83855216|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855217|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855218|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83855219|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83855220|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83855221|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83855222|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855223|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83855224|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83855225|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83855226|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83855227|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83855228|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83855229|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83855230|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
83855231|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83855232|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83855233|NCT04693312|Prednisolone|prednisolone|mesh-list
83855234|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
83855235|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83855236|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
83855237|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855238|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
83855239|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
83855240|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855241|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855242|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83855243|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
83855244|NCT04693312|Hormones|hormones|mesh-ancestor
83855245|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855246|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83855247|NCT04693312|Protective Agents|protective agents|mesh-ancestor
83855248|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83855249|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855250|NCT00168090|Factor VIII|factor viii|mesh-list
83855251|NCT00168090|Coagulants|coagulants|mesh-ancestor
83855252|NCT00525382|Levocetirizine|levocetirizine|mesh-list
83855253|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83855254|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83855255|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
83855256|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
83855257|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855258|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855259|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855260|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
83855261|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83855262|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855263|NCT00168168|Lenograstim|lenograstim|mesh-list
83855264|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83855265|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
83855266|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855267|NCT03225755|Hormones|hormones|mesh-list
83855268|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855269|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855270|NCT00525577|Probucol|probucol|mesh-list
83855271|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83855272|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83855273|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
83855274|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855275|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83855277|NCT00525577|Protective Agents|protective agents|mesh-ancestor
83855278|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855279|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83855280|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83855281|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
83855282|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83855283|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83855284|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
83855285|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855286|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
83855287|NCT03186755|Protective Agents|protective agents|mesh-ancestor
83855288|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83855289|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83855290|NCT03186755|Analgesics|analgesics|mesh-ancestor
83855291|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
83855292|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855293|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855294|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855295|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83855296|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83855297|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83855298|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
83855299|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
83855300|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855301|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855302|NCT00525616|Rituximab|rituximab|mesh-list
83855303|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83855304|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855305|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
83855306|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855307|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855308|NCT00525694|Cocaine|cocaine|mesh-list
83855309|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
83855310|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
83855311|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855312|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855313|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
83855314|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855315|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83855316|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83855317|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83855318|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855319|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855320|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
83855321|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855322|NCT02947243|Morphine|morphine|mesh-list
83855323|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83855324|NCT02947243|Narcotics|narcotics|mesh-ancestor
83855325|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855326|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855327|NCT02947243|Analgesics|analgesics|mesh-ancestor
83855328|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
83855329|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855330|NCT02946970|Quinine|quinine|mesh-list
83855331|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
83855332|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83855333|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83855334|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855335|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83855336|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855337|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83855338|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855339|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83855340|NCT02946970|Analgesics|analgesics|mesh-ancestor
83855341|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
83855342|NCT00527020|Nicotine|nicotine|mesh-list
83855343|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83855344|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
83855345|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855346|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855347|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83855348|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83855349|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
83855350|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855351|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855352|NCT00407277|Nicotine|nicotine|mesh-list
83855353|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83855354|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
83855355|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855356|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855357|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83855358|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83855359|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
83855360|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855361|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855362|NCT00527059|Simendan|simendan|mesh-list
83855363|NCT00527059|Spironolactone|spironolactone|mesh-list
83855364|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83855365|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83855366|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
83855367|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855368|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855369|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83855370|NCT00527059|Diuretics|diuretics|mesh-ancestor
83855371|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
83855372|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83855373|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
83855374|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855375|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855376|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83855377|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
83855378|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83855379|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83855380|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855381|NCT00527059|Protective Agents|protective agents|mesh-ancestor
83855382|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
83855383|NCT03156452|Prednisolone|prednisolone|mesh-list
83855384|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83855385|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855386|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83855387|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
83855388|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83855389|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855390|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855391|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855392|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855393|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
83855394|NCT03156452|Hormones|hormones|mesh-ancestor
83855395|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855396|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855397|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83855398|NCT00525772|Ciclesonide|ciclesonide|mesh-list
83855399|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
83855400|NCT00525772|Hormones|hormones|mesh-ancestor
83855401|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855402|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855403|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83855404|NCT02945956|Entecavir|entecavir|mesh-list
83855405|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
83855406|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855407|NCT03122639|Atorvastatin|atorvastatin|mesh-list
83855408|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83855409|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83855410|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
83855411|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855412|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83855413|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83855414|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855415|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
83855416|NCT00527137|Hematinics|hematinics|mesh-ancestor
83855417|NCT02945839|Topiramate|topiramate|mesh-list
83855418|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
83855419|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83855420|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855421|NCT02957786|Varenicline|varenicline|mesh-list
83855422|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83855423|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83855424|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
83094293|NCT02450786|Donepezil|donepezil|mesh-list
83855425|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855426|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855427|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855428|NCT00407394|Amoxicillin|amoxicillin|mesh-list
83148014|NCT02592434|Tofacitinib|tofacitinib|mesh-list
83855429|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83855430|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855431|NCT03109964|Hemostatics|hemostatics|mesh-list
83855432|NCT03109964|Surgiflo|surgiflo|mesh-list
83855433|NCT03109964|Coagulants|coagulants|mesh-ancestor
83855434|NCT00407433|Gemcitabine|gemcitabine|mesh-list
83855435|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
83855436|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83855437|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
83855438|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855439|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855440|NCT00516412|Everolimus|everolimus|mesh-list
83855441|NCT00516412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83855442|NCT00516412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83855443|NCT00516412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855444|NCT00516412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855445|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83855446|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
83855447|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855448|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855449|NCT03058835|Tenofovir|tenofovir|mesh-list
83855450|NCT03058835|Emtricitabine|emtricitabine|mesh-list
83855451|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
83855452|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855453|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83855454|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83855455|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855456|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855457|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83855458|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83855459|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83855460|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
83855461|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83855462|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
83855463|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83855464|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855465|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83855466|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83855467|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855468|NCT00516607|Temozolomide|temozolomide|mesh-list
83855469|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83855470|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
83855471|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855472|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855473|NCT00173667|Nifedipine|nifedipine|mesh-list
83855474|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83855475|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855476|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855477|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83855478|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855479|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
83855480|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
83855481|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83855482|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83855483|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83855484|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
83855485|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855486|NCT03016871|Carboplatin|carboplatin|mesh-list
83855487|NCT03016871|Nivolumab|nivolumab|mesh-list
83855488|NCT03016871|Etoposide|etoposide|mesh-list
83855489|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
83855490|NCT03016871|Ifosfamide|ifosfamide|mesh-list
83855491|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
83855492|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
83855493|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855494|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83855495|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83855496|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855497|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83855498|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83855499|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83855500|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855501|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83855502|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
83855503|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
83855504|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
83855505|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
83855506|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
83855507|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
83855508|NCT03458689|Analgesics|analgesics|mesh-list
83855509|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
83855510|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855511|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855512|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
83855513|NCT00527215|Hematinics|hematinics|mesh-ancestor
83855514|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
83855515|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83855516|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83855517|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83855518|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855519|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855520|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
83855521|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855522|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855523|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83855524|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855525|NCT02945644|Trazodone|trazodone|mesh-list
83855526|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83855527|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83855528|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855529|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855530|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83855531|NCT02945644|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83855532|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83855533|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855534|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855535|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855536|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
83855537|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83855538|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
83855539|NCT02460887|Cisplatin|cisplatin|mesh-list
83855540|NCT02460887|Gemcitabine|gemcitabine|mesh-list
83855541|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855542|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83855543|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
83855544|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855545|NCT02945527|Dexamethasone|dexamethasone|mesh-list
83855546|NCT02945527|Acetazolamide|acetazolamide|mesh-list
83855547|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855548|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
83855549|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
83855550|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855551|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855552|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83855553|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
83855554|NCT02945527|Hormones|hormones|mesh-ancestor
83855555|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855556|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83855557|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855558|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
83855559|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83855560|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855561|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855562|NCT02945527|Diuretics|diuretics|mesh-ancestor
83855563|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
83855564|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83855565|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83855566|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83855567|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83855568|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83855569|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
83855570|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855571|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855572|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094436|NCT02282709|Asunaprevir|asunaprevir|mesh-list
83855574|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855575|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83855576|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855577|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855578|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
83855579|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83855580|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83855581|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83855582|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855583|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855584|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
83855585|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855586|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855587|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83855588|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855589|NCT00529594|Etoricoxib|etoricoxib|mesh-list
83855590|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83855591|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83855592|NCT00529594|Analgesics|analgesics|mesh-ancestor
83855593|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
83855594|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855595|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855596|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855597|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855598|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83855599|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83855600|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855601|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855602|NCT00173862|Gemcitabine|gemcitabine|mesh-list
83855603|NCT00173862|Ifosfamide|ifosfamide|mesh-list
83855604|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83855605|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
83855606|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855607|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855608|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83855609|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
83855610|NCT00529750|Atenolol|atenolol|mesh-list
83855611|NCT00529750|Irbesartan|irbesartan|mesh-list
83855612|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83855613|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83855614|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83855615|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855616|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83855617|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
83855618|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
83855619|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855620|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855621|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83855622|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83855623|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83855624|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
83855625|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855626|NCT00529867|Lumefantrine|lumefantrine|mesh-list
83855627|NCT00529867|Artemether|artemether|mesh-list
83855628|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83855629|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
83855630|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83855631|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83855632|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855633|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
83855634|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83855635|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83855636|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83855637|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855638|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855639|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
83855640|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855641|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855642|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83855643|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855644|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
83855645|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83855647|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83855648|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83402986|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
83855649|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855650|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
83855651|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855652|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855653|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83855654|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855655|NCT00527449|Carboplatin|carboplatin|mesh-list
83855656|NCT00527449|Docetaxel|docetaxel|mesh-list
83855657|NCT00527449|Epirubicin|epirubicin|mesh-list
83855658|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855659|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83855660|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83855661|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83855662|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855663|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83855664|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83855665|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83855666|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855667|NCT00168519|Nitroprusside|nitroprusside|mesh-list
83855668|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83855669|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
83855670|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83855671|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855672|NCT04692376|Cyclosporine|cyclosporine|mesh-list
83855673|NCT04692376|Cyclosporins|cyclosporins|mesh-list
83855674|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
83855675|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855676|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855677|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83855678|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
83855679|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855680|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
83855681|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855682|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
83855683|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855684|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83855685|NCT04692376|Hormones|hormones|mesh-ancestor
83855686|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855687|NCT00527683|Vigabatrin|vigabatrin|mesh-list
83855688|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
83855689|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855690|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855691|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
83855692|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855693|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855694|NCT00173901|Ceftazidime|ceftazidime|mesh-list
83855695|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83855696|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855697|NCT00527761|Cisplatin|cisplatin|mesh-list
83855698|NCT00527761|Docetaxel|docetaxel|mesh-list
83855699|NCT00527761|Temozolomide|temozolomide|mesh-list
83855700|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855701|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83855702|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83855703|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83855704|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855705|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83855706|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
83855707|NCT00527800|Lumefantrine|lumefantrine|mesh-list
83855708|NCT00527800|Artemether|artemether|mesh-list
83855709|NCT00527800|Piperaquine|piperaquine|mesh-list
83855710|NCT00527800|Trimethoprim|trimethoprim|mesh-list
83855711|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83855712|NCT00527800|Artenimol|artenimol|mesh-list
83855713|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83855714|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
83855715|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
83855716|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83855717|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83855718|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855719|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83855720|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83855721|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855722|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855723|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83855724|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83855725|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83855726|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83855727|NCT02945293|Oxycodone|oxycodone|mesh-list
83855728|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83855729|NCT02945293|Narcotics|narcotics|mesh-ancestor
83855730|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855731|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855732|NCT02945293|Analgesics|analgesics|mesh-ancestor
83855733|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
83855734|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855735|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
83855736|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83855737|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855738|NCT02945215|Rituximab|rituximab|mesh-list
83855739|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83855740|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855741|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
83855742|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855743|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855744|NCT00144677|Sirolimus|sirolimus|mesh-list
83855745|NCT00144677|Tacrolimus|tacrolimus|mesh-list
83855746|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83855747|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
83855748|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855749|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83855750|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855751|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855752|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83855753|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855754|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83855755|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855756|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
83855757|NCT00531076|Bevacizumab|bevacizumab|mesh-list
83855758|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83855759|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855760|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83855761|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83855762|NCT00531076|Growth Substances|growth substances|mesh-ancestor
83855763|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855764|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
83855765|NCT00531115|Cetuximab|cetuximab|mesh-list
83855766|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83855767|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855768|NCT00144716|Insect Repellents|insect repellents|mesh-list
83855769|NCT00144716|Protective Agents|protective agents|mesh-ancestor
83855770|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855771|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
83855772|NCT00531193|SCH 442416|sch 442416|mesh-list
83855773|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83855774|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83855775|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83855776|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
83855777|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855778|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855779|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855780|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
83855781|NCT00144755|Hematinics|hematinics|mesh-ancestor
83855782|NCT00531271|Docetaxel|docetaxel|mesh-list
83855783|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855784|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83855785|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83855786|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83855787|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855788|NCT00531310|Fludarabine|fludarabine|mesh-list
83855789|NCT00531310|Busulfan|busulfan|mesh-list
83855790|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855791|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855792|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83855793|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
83855794|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855795|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
83855796|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83855797|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83855799|NCT00407862|Telmisartan|telmisartan|mesh-list
83855800|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83855801|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83855802|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83855803|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83855804|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855805|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
83855806|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
83855807|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83855808|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83855809|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855810|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855811|NCT00527995|Urological Agents|urological agents|mesh-ancestor
83855812|NCT00144833|Ritonavir|ritonavir|mesh-list
83855813|NCT00144833|Lopinavir|lopinavir|mesh-list
83855814|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
83855815|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83855816|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83855817|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
83855818|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855819|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855820|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83855821|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83855822|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
83855823|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855824|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83855825|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83855826|NCT02944942|Anesthetics|anesthetics|mesh-list
83855827|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855828|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855829|NCT00144872|Lamotrigine|lamotrigine|mesh-list
83855830|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
83855831|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83855832|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855833|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855834|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83855835|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855836|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83855837|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83855838|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855839|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83855840|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83855841|NCT02945020|Simeprevir|simeprevir|mesh-list
83855842|NCT02945020|Odalasvir|odalasvir|mesh-list
83855843|NCT02945020|Dabigatran|dabigatran|mesh-list
83855844|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
83855845|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83855846|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
83855847|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855848|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855849|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
83855850|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
83855851|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855852|NCT00528073|Rifaximin|rifaximin|mesh-list
83855853|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83855854|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855855|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83855856|NCT00528151|Curcumin|curcumin|mesh-list
83855857|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83855858|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83855859|NCT00528151|Analgesics|analgesics|mesh-ancestor
83855860|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
83855861|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855862|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855863|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855864|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855865|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855866|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855867|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855868|NCT00144911|Fluticasone|fluticasone|mesh-list
83855869|NCT00144911|Xhance|xhance|mesh-list
83855870|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83855871|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855872|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83855873|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
83855874|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855875|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855876|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83855877|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
83855878|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
83855879|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83855880|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83855881|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83855882|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83855883|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
83855884|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855885|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855886|NCT00168597|Vitamin A|vitamin a|mesh-list
83855887|NCT00168597|Vitamins|vitamins|mesh-ancestor
83855888|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
83855889|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855890|NCT00528385|Spironolactone|spironolactone|mesh-list
83855891|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83855892|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
83855893|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83855894|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855895|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83855896|NCT00528385|Diuretics|diuretics|mesh-ancestor
83855897|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
83855898|NCT02944981|Gabapentin|gabapentin|mesh-list
83855899|NCT02944981|Analgesics|analgesics|mesh-ancestor
83855900|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
83855901|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855902|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855903|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
83855904|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83855905|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83855906|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855907|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83855908|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83855909|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83855910|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83855911|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855912|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
83855913|NCT00168636|Vitamin A|vitamin a|mesh-list
83855914|NCT00168636|Vitamins|vitamins|mesh-ancestor
83855915|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
83855916|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855917|NCT00144989|Cisplatin|cisplatin|mesh-list
83855918|NCT00144989|Irinotecan|irinotecan|mesh-list
83855919|NCT00144989|Etoposide|etoposide|mesh-list
83855920|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855921|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83855922|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83855923|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855924|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855925|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83855926|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83855927|NCT00528502|Lidocaine|lidocaine|mesh-list
83855928|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
83855929|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
83855930|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855931|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855932|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
83855933|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855934|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83855935|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83855936|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83855937|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83855938|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855939|NCT00528619|Carboplatin|carboplatin|mesh-list
83855940|NCT00528619|Pemetrexed|pemetrexed|mesh-list
83855941|NCT00528619|Sunitinib|sunitinib|mesh-list
83855942|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855943|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855944|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855945|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83855946|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83855947|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83855948|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83855949|NCT00528619|Growth Substances|growth substances|mesh-ancestor
83855950|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855951|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
83855952|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83855953|NCT00168714|Interferons|interferons|mesh-list
83855954|NCT00168714|Interferon-beta|interferon-beta|mesh-list
83855955|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
83855956|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855957|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
83855958|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855959|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
83855960|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855961|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83855962|NCT00528658|Acetaminophen|acetaminophen|mesh-list
83855964|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83855965|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83855966|NCT00528658|Analgesics|analgesics|mesh-ancestor
83855967|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
83855968|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83855969|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855970|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83855971|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83855972|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83855973|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855974|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855975|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
83855976|NCT00145028|Carboplatin|carboplatin|mesh-list
83855977|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83855978|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
83855979|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83855980|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855981|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
83855982|NCT00168753|Alefacept|alefacept|mesh-list
83855983|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
83855984|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
83855985|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83855986|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
83855987|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83855988|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83855989|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
83855990|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83855991|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83855992|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83855993|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83855994|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83855995|NCT00531349|Propofol|propofol|mesh-list
83855996|NCT00531349|Sevoflurane|sevoflurane|mesh-list
83855997|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
83855998|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83855999|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856000|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83856001|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83856002|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
83856003|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83856004|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83856005|NCT00531466|Tolperisone|tolperisone|mesh-list
83856006|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83856007|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856008|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83856009|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856010|NCT00168792|Tenecteplase|tenecteplase|mesh-list
83856011|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83856012|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83856013|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856014|NCT00531544|Sunitinib|sunitinib|mesh-list
83856015|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856016|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83856017|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83856018|NCT00531544|Growth Substances|growth substances|mesh-ancestor
83856019|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856020|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
83856021|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83856022|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856023|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856024|NCT00145106|Minocycline|minocycline|mesh-list
83856025|NCT00145106|Tazarotene|tazarotene|mesh-list
83856026|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83856027|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856028|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83856029|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
83856030|NCT00145184|Vitamins|vitamins|mesh-list
83856031|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
83856032|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
83856033|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856034|NCT02944357|Cisplatin|cisplatin|mesh-list
83856035|NCT02944357|Gemcitabine|gemcitabine|mesh-list
83856036|NCT02944357|Vaccines|vaccines|mesh-list
83856037|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856038|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83856039|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
83856040|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856041|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
83856042|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856043|NCT02944396|Paclitaxel|paclitaxel|mesh-list
83856044|NCT02944396|Carboplatin|carboplatin|mesh-list
83856045|NCT02944396|Nivolumab|nivolumab|mesh-list
83856046|NCT02944396|Pemetrexed|pemetrexed|mesh-list
83856047|NCT02944396|Veliparib|veliparib|mesh-list
83856048|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83856049|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856050|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
83856051|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
83856052|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
83856053|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856054|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83856055|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83856056|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856057|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83856058|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83856059|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83856060|NCT00174174|Modafinil|modafinil|mesh-list
83856061|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83856062|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856063|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83856064|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83856065|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83856066|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856067|NCT00530101|Doxorubicin|doxorubicin|mesh-list
83856068|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83856069|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856070|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856071|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856072|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856073|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856074|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83856075|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
83856076|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856077|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
83856078|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83856079|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
83856080|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856081|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83856082|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
83856083|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83856084|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83856085|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856086|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856087|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83856088|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83856089|NCT00145301|Analgesics|analgesics|mesh-ancestor
83856090|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
83856091|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856092|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856093|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856094|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856095|NCT00168870|Gemcitabine|gemcitabine|mesh-list
83856096|NCT00168870|Treosulfan|treosulfan|mesh-list
83856097|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83856098|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
83856099|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856100|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856101|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83856102|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
83856103|NCT02944201|Carvedilol|carvedilol|mesh-list
83856104|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83856105|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83856106|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
83856107|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856108|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856109|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856110|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83856111|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
83856112|NCT02944201|Protective Agents|protective agents|mesh-ancestor
83856113|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83856114|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856115|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83856116|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
83856117|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83856118|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83856119|NCT00145340|Pioglitazone|pioglitazone|mesh-list
83856120|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856121|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856122|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
83856123|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83856124|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83856125|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856126|NCT00168909|Vitamins|vitamins|mesh-ancestor
83856127|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
83856128|NCT00145379|Metformin|metformin|mesh-list
83856129|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856130|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856131|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
83856132|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
83856133|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83856134|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83856135|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856136|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83856137|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856138|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856139|NCT00530413|Phenobarbital|phenobarbital|mesh-list
83856140|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
83856141|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83856142|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856143|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856144|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83856145|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83856146|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856147|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856148|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
83856149|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
83856150|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83856151|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83856152|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83856153|NCT00174330|Amlodipine|amlodipine|mesh-list
83856154|NCT00174330|Atorvastatin|atorvastatin|mesh-list
83856155|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83856156|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83856157|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
83856158|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856159|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83856160|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83856161|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856162|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83856163|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83856164|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856165|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83856166|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856167|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
83856168|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
83856169|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
83095037|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
83856170|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856171|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
83856172|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856173|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856174|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83856175|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83856176|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83856177|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856178|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856179|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856180|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856181|NCT00531895|Analgesics|analgesics|mesh-ancestor
83856182|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
83856183|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856184|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
83856185|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83856186|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
83856187|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
83856188|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856189|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856190|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
83856191|NCT00169026|Clozapine|clozapine|mesh-list
83856192|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83856193|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856194|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856195|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83856196|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83856197|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
83856198|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856199|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856200|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
83856201|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
83856202|NCT00145613|Antibodies|antibodies|mesh-list
83856203|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
83856204|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856205|NCT00531973|Doxorubicin|doxorubicin|mesh-list
83856206|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83856207|NCT00531973|Epirubicin|epirubicin|mesh-list
83856208|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83856209|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856210|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856211|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856212|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856213|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856214|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83856215|NCT00145652|Hematinics|hematinics|mesh-ancestor
83856216|NCT00174486|Tadalafil|tadalafil|mesh-list
83856217|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
83856218|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83856219|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83856220|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856221|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856222|NCT00174486|Urological Agents|urological agents|mesh-ancestor
83856223|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
83856224|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
83856225|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83856226|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83856227|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856228|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856229|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83856230|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83856231|NCT05319340|Anticoagulants|anticoagulants|mesh-list
83856232|NCT05319301|Melatonin|melatonin|mesh-list
83856233|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
83856234|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856235|NCT05319301|Protective Agents|protective agents|mesh-ancestor
83856236|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856237|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856238|NCT00169065|Olanzapine|olanzapine|mesh-list
83856239|NCT00169065|Clozapine|clozapine|mesh-list
83856240|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
83856241|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
83856242|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856243|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856244|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856245|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83856246|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83856247|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856248|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83856249|NCT00169065|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83856250|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83856251|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856252|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856253|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856254|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
83856255|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83856256|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
83856257|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
83856258|NCT00145730|Ibuprofen|ibuprofen|mesh-list
83856259|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83856260|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83856261|NCT00145730|Analgesics|analgesics|mesh-ancestor
83856262|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
83856263|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856264|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856265|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856266|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856267|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83856268|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856269|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856270|NCT00169143|Rituximab|rituximab|mesh-list
83856271|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83856272|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856273|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
83856274|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856275|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856276|NCT02942680|Aspirin|aspirin|mesh-list
83856277|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83856278|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83856279|NCT02942680|Analgesics|analgesics|mesh-ancestor
83856280|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
83856281|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856282|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856283|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856284|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856285|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83856286|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83856287|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856288|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83856289|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83856290|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856291|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
83856292|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
83856293|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856294|NCT02276911|Ibuprofen|ibuprofen|mesh-list
83856295|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83856296|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83856297|NCT02276911|Analgesics|analgesics|mesh-ancestor
83856298|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
83856299|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856300|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856301|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856302|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856303|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83856304|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856305|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856306|NCT00145847|Naltrexone|naltrexone|mesh-list
83856307|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83856308|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83856309|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856310|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
83856311|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856312|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
83856313|NCT00169182|Niacin|niacin|mesh-list
83856314|NCT00169182|Docetaxel|docetaxel|mesh-list
83856315|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856316|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
83856317|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
83856318|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
83856319|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856321|NCT00169182|Vitamins|vitamins|mesh-ancestor
83856322|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
83856323|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856324|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83856325|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
83856326|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83856327|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
83856328|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
83856329|NCT02944825|Trimethoprim|trimethoprim|mesh-list
83856330|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
83856331|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83856332|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856333|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856334|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856335|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856336|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856337|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856338|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83856339|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83856340|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83856341|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
83856342|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83856343|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83856344|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83856345|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83856346|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83856347|NCT02942758|Pioglitazone|pioglitazone|mesh-list
83856348|NCT02942758|Azacitidine|azacitidine|mesh-list
83856349|NCT02942758|Tretinoin|tretinoin|mesh-list
83856350|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83856351|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
83856352|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856353|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856354|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856355|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856356|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856357|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
83856358|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
83856359|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
83856360|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856361|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83856362|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83856363|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
83856364|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83856365|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83856366|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83856367|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856368|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856369|NCT02942563|Capecitabine|capecitabine|mesh-list
83856370|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
83856371|NCT02942563|Irinotecan|irinotecan|mesh-list
83856372|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83856373|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
83856374|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856375|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856376|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83856377|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856378|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856379|NCT00145925|Gliclazide|gliclazide|mesh-list
83856380|NCT00145925|Perindopril|perindopril|mesh-list
83856381|NCT00145925|Indapamide|indapamide|mesh-list
83856382|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
83856383|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83856384|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
83856385|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856386|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856387|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83856388|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856389|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856390|NCT00145925|Diuretics|diuretics|mesh-ancestor
83856391|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
83856392|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83095273|NCT00405951|Docetaxel|docetaxel|mesh-list
83856393|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856394|NCT00529321|Immunomodulating Agents|immunomodulating agents|mesh-list
83856395|NCT00529321|Immunologic Factors|immunologic factors|mesh-ancestor
83856396|NCT00529321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856398|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856399|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83856400|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856401|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856402|NCT00529360|Clofarabine|clofarabine|mesh-list
83856403|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83856404|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
83856405|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856406|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856407|NCT00174642|Insulin|insulin|mesh-list
83856408|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83856409|NCT00174642|Metformin|metformin|mesh-list
83856410|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
83856411|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
83856412|NCT00174642|Secretagogues|secretagogues|mesh-list
83856413|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856414|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856415|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
83856416|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856417|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856418|NCT00146042|Erythromycin|erythromycin|mesh-list
83856419|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
83856420|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83856421|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
83856422|NCT00146042|Docetaxel|docetaxel|mesh-list
83856423|NCT00146042|Trastuzumab|trastuzumab|mesh-list
83856424|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856425|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83856426|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83856427|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83856428|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856429|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83856430|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83856431|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856432|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856433|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83856434|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856435|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83856436|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
83856437|NCT00169299|Estrogens|estrogens|mesh-list
83856438|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83856439|NCT00169299|Hormones|hormones|mesh-ancestor
83856440|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856441|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856442|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83856443|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83856444|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83856445|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
83856446|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83856447|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83856448|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83856449|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83856450|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856451|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856452|NCT02942602|Atorvastatin|atorvastatin|mesh-list
83856453|NCT02942602|Ezetimibe|ezetimibe|mesh-list
83856454|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
83856455|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83856456|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83856457|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
83856458|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856459|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83856460|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83856461|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856462|NCT02942329|Apatinib|apatinib|mesh-list
83856463|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856464|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83856465|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856466|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856467|NCT00174720|Ciclesonide|ciclesonide|mesh-list
83856468|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
83856469|NCT00174720|Hormones|hormones|mesh-ancestor
83856470|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856471|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856472|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83856473|NCT05318794|Doxorubicin|doxorubicin|mesh-list
83856474|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856475|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83856476|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856477|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856478|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856479|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856480|NCT02942212|Nicotine|nicotine|mesh-list
83856481|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83856482|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
83856483|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856484|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856485|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83856486|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83856487|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
83856488|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856489|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856490|NCT00146120|Etoposide|etoposide|mesh-list
83856491|NCT00146120|Idarubicin|idarubicin|mesh-list
83856492|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83856493|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856494|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856495|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856496|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856497|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856498|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83856499|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
83856500|NCT00146159|Analgesics|analgesics|mesh-ancestor
83856501|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
83856502|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856503|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856504|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856505|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856506|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856507|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856508|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856509|NCT02276989|Riboflavin|riboflavin|mesh-list
83856510|NCT02276989|Quinine|quinine|mesh-list
83856511|NCT02276989|Acetazolamide|acetazolamide|mesh-list
83856512|NCT02276989|Vitamins|vitamins|mesh-ancestor
83856513|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
83856514|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856515|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
83856516|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83856517|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83856518|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
83856519|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83856520|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856521|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856522|NCT02276989|Diuretics|diuretics|mesh-ancestor
83856523|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
83856524|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
83856525|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83856526|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83856527|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856528|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83856529|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83856530|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856531|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83856532|NCT02276989|Analgesics|analgesics|mesh-ancestor
83856533|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
83856534|NCT00174759|Clopidogrel|clopidogrel|mesh-list
83856535|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83856536|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83856537|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83856538|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83856539|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
83856540|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856541|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095427|NCT02287857|Tenofovir|tenofovir|mesh-list
83856542|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856543|NCT00146237|Phenytoin|phenytoin|mesh-list
83856544|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
83856545|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83856546|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83856547|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856548|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856549|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83856550|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83856551|NCT02277067|Misoprostol|misoprostol|mesh-list
83856552|NCT02277067|Carbetocin|carbetocin|mesh-list
83856553|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83856554|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
83856555|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83856556|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856557|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83856558|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856559|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
83856560|NCT00146276|Gemcitabine|gemcitabine|mesh-list
83856561|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83856562|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
83856563|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856564|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856565|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83856566|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83856567|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83856568|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
83856569|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856570|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856571|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856572|NCT00174798|Urological Agents|urological agents|mesh-ancestor
83856573|NCT02940808|Caffeine|caffeine|mesh-list
83856574|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83856575|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856576|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83856577|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856578|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856579|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83856580|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83856581|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
83856582|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856583|NCT00169416|Valacyclovir|valacyclovir|mesh-list
83856584|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
83856585|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856586|NCT00174876|Aripiprazole|aripiprazole|mesh-list
83856587|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
83856588|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83856589|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83856590|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83856591|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856592|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856593|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
83856594|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
83856595|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856596|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856597|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83856598|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83856599|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
83856600|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83856601|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83856602|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83856603|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83856604|NCT00146471|Levetiracetam|levetiracetam|mesh-list
83856605|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
83856606|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
83856607|NCT00174993|Pioglitazone|pioglitazone|mesh-list
83856608|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856609|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048310|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856610|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83856611|NCT02940379|Metoprolol|metoprolol|mesh-list
83856612|NCT02940379|Midazolam|midazolam|mesh-list
83856613|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83856614|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83856615|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856616|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856617|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83856618|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83856619|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83856620|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83856621|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
83856622|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
83856623|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
83856624|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
83856625|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856626|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856627|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83856628|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83856629|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
83856630|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
83856631|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856632|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83856633|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83856634|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83856635|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
83856636|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83856637|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856638|NCT00146549|Paclitaxel|paclitaxel|mesh-list
83856639|NCT00146549|Vinorelbine|vinorelbine|mesh-list
83856640|NCT00146549|Docetaxel|docetaxel|mesh-list
83856641|NCT00146549|Trastuzumab|trastuzumab|mesh-list
83856642|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83856643|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856644|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
83856645|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
83856646|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83856647|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856648|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83856649|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83856650|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83856651|NCT02940535|Menotropins|menotropins|mesh-list
83856652|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
83856653|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83856654|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
83856655|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83856656|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856657|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83856658|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856659|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856660|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83856661|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
83856662|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
83856663|NCT00146588|Capecitabine|capecitabine|mesh-list
83856664|NCT00146588|Epirubicin|epirubicin|mesh-list
83856665|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83856666|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
83856667|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856668|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856669|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83856670|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
83856671|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856672|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856673|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83856674|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83856675|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
83856676|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83856677|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856678|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856679|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856680|NCT00175032|Aspirin|aspirin|mesh-list
83856681|NCT00175032|Celecoxib|celecoxib|mesh-list
83856682|NCT00175032|Naproxen|naproxen|mesh-list
83856683|NCT00175032|Lansoprazole|lansoprazole|mesh-list
83856684|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
84048311|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856685|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83856686|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83856687|NCT00175032|Analgesics|analgesics|mesh-ancestor
83856688|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
83856689|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856690|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856691|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856692|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856693|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83856694|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83856695|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856696|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83856697|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83856698|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856699|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
83856700|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83856701|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
83856702|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83856703|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856704|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83856705|NCT00146627|Eflornithine|eflornithine|mesh-list
83856706|NCT00146627|Nifurtimox|nifurtimox|mesh-list
83856707|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856708|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83856709|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83856710|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83856711|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856712|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83856713|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856714|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856715|NCT00169533|Lapatinib|lapatinib|mesh-list
83856716|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856717|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83856718|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856719|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856720|NCT00424229|Lenalidomide|lenalidomide|mesh-list
83856721|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
83856722|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856723|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83856724|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83856725|NCT00424229|Growth Substances|growth substances|mesh-ancestor
83856726|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
83856727|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856728|NCT02944123|Clopidogrel|clopidogrel|mesh-list
83856729|NCT02944123|Ticagrelor|ticagrelor|mesh-list
83856730|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83856731|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83856732|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83856733|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83856734|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83856735|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
83856736|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856737|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856738|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856739|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
83856740|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83856741|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83856742|NCT02944045|Prednisolone|prednisolone|mesh-list
83856743|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
83856744|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83856745|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
83856746|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856747|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
83856748|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
83856749|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856750|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856751|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856752|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
83856753|NCT02944045|Hormones|hormones|mesh-ancestor
83856754|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856755|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83856756|NCT02944045|Protective Agents|protective agents|mesh-ancestor
83856757|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856758|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856759|NCT00169572|Dexamethasone|dexamethasone|mesh-list
83856760|NCT00169572|Ondansetron|ondansetron|mesh-list
83856761|NCT00169572|Aprepitant|aprepitant|mesh-list
83856762|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
83856763|NCT00169572|Casopitant|casopitant|mesh-list
83856764|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856765|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
83095670|NCT03203408|Hylan|hylan|mesh-list
83856766|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
83856767|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856768|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856769|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856770|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
83856771|NCT00169572|Hormones|hormones|mesh-ancestor
83856772|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856773|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856774|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856775|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
83856776|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83856777|NCT00169572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83856778|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83856779|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
83856780|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856781|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856782|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83856783|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
83856784|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
83856785|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83856786|NCT00146783|Amodiaquine|amodiaquine|mesh-list
83856787|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
83856788|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83856789|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83856790|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856791|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83856792|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856793|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856794|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83856795|NCT00169611|Methylphenidate|methylphenidate|mesh-list
83856796|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83856797|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856798|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83856799|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83856800|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856801|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856802|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
83856803|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856804|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
83856805|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83856806|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
83856807|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
83856808|NCT02943655|Progesterone|progesterone|mesh-list
83856809|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83856810|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856811|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83856812|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83856813|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83856814|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83856815|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83856816|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83856817|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856818|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856819|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83856820|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83856821|NCT02943655|Analgesics|analgesics|mesh-ancestor
83856822|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
83856823|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856824|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856825|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856826|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83856827|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856828|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856829|NCT02943655|Progestins|progestins|mesh-ancestor
83856830|NCT02943655|Hormones|hormones|mesh-ancestor
83856831|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856832|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
83856833|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83856834|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
83856835|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856836|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
83856837|NCT05085067|Protective Agents|protective agents|mesh-ancestor
83856838|NCT00175227|Furosemide|furosemide|mesh-list
83095712|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83856839|NCT00175227|Mannitol|mannitol|mesh-list
83856840|NCT00175227|Diuretics|diuretics|mesh-ancestor
83856841|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
83856842|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856843|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83856844|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856845|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856846|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83856847|NCT02940262|Edetic Acid|edetic acid|mesh-list
83856848|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83856849|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
83856850|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
83856851|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856852|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
83856853|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83856854|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83856855|NCT00146900|Escitalopram|escitalopram|mesh-list
83856856|NCT00146900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83856857|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83856858|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83856859|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856860|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856861|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
83856862|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856863|NCT02939482|Triamcinolone|triamcinolone|mesh-list
83856864|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83856865|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83856866|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83856867|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856868|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
83856869|NCT02939482|Hormones|hormones|mesh-ancestor
83856870|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856871|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856872|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83856873|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
83856874|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856875|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856876|NCT00175266|Infliximab|infliximab|mesh-list
83856877|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
83856878|NCT00175266|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83856879|NCT00175266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856880|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
83856881|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856882|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83856883|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83856884|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856885|NCT05013892|Memantine|memantine|mesh-list
83856886|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83856887|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83856888|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
83856889|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856890|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856891|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856892|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83856893|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83856894|NCT02939248|Morphine|morphine|mesh-list
83856895|NCT02939248|Naloxone|naloxone|mesh-list
83856896|NCT02939248|Ticagrelor|ticagrelor|mesh-list
83856897|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83856898|NCT02939248|Narcotics|narcotics|mesh-ancestor
83856899|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83856900|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856901|NCT02939248|Analgesics|analgesics|mesh-ancestor
83856902|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
83856903|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856904|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83856905|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83856906|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83856907|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83856908|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
83856909|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856910|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856911|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83856912|NCT02938975|Permethrin|permethrin|mesh-list
83856913|NCT02938975|Insect Repellents|insect repellents|mesh-list
83856914|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856915|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856916|NCT02938975|Protective Agents|protective agents|mesh-ancestor
83856917|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856918|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
83856919|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83856920|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856921|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
83856922|NCT00175305|Octreotide|octreotide|mesh-list
83856923|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856924|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856925|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856926|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
83856927|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
83856928|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856929|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83856930|NCT00407589|Besifloxacin|besifloxacin|mesh-list
83856931|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83856932|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83856933|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83856934|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83856935|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856936|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856937|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856938|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83856939|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83856940|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856941|NCT00175383|Hormones|hormones|mesh-list
83856942|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83856943|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856944|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856945|NCT02938468|Dexamethasone|dexamethasone|mesh-list
83856946|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83856947|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
83856948|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
83856949|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83856950|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856951|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83856952|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
83856953|NCT02938468|Hormones|hormones|mesh-ancestor
83856954|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856955|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83856956|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856957|NCT02938507|Solabegron|solabegron|mesh-list
83856958|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83856959|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83856960|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83856961|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
83856962|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83856963|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856964|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856965|NCT04836910|Metformin|metformin|mesh-list
83856966|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
83856967|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
83856968|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83856969|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83856970|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856971|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83856972|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83856973|NCT00169728|Vaccines|vaccines|mesh-list
83856974|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83856975|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
83856976|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856977|NCT00147524|Quinapril|quinapril|mesh-list
83856978|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83856979|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
83856980|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83856981|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83856982|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83856983|NCT00147563|Eplerenone|eplerenone|mesh-list
83856984|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83856985|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
83095863|NCT03202862|Fulvestrant|fulvestrant|mesh-list
83856986|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83856987|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83856988|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83856989|NCT00147563|Diuretics|diuretics|mesh-ancestor
83856990|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
83856991|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83856992|NCT02938273|Cetuximab|cetuximab|mesh-list
83856993|NCT02938273|Avelumab|avelumab|mesh-list
83856994|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83856995|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83856996|NCT00147602|Atorvastatin|atorvastatin|mesh-list
83856997|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83856998|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83856999|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
83857000|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857001|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83857002|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83857003|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857004|NCT02941744|Nivolumab|nivolumab|mesh-list
83857005|NCT02941744|Ipilimumab|ipilimumab|mesh-list
83857006|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83857007|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857008|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83857009|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857010|NCT02941822|Ambroxol|ambroxol|mesh-list
83857011|NCT02941822|Expectorants|expectorants|mesh-ancestor
83857012|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
83857013|NCT02941510|Budesonide|budesonide|mesh-list
83857014|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857015|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83857016|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
83857017|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857018|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857019|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83857020|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
83857021|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
83857022|NCT02941510|Hormones|hormones|mesh-ancestor
83857023|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857024|NCT00147680|Paclitaxel|paclitaxel|mesh-list
83857025|NCT00147680|Carboplatin|carboplatin|mesh-list
83857026|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857027|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857028|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857029|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857030|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857031|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857032|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83857033|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857034|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857035|NCT02940184|Incretins|incretins|mesh-ancestor
83857036|NCT02940184|Hormones|hormones|mesh-ancestor
83857037|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857038|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83857039|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
83857040|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857041|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857042|NCT03458143|Ketamine|ketamine|mesh-list
83857043|NCT03458143|Remifentanil|remifentanil|mesh-list
83857044|NCT03458143|Analgesics|analgesics|mesh-ancestor
83857045|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
83857046|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857047|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857048|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83857049|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83857050|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
83857051|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
83857052|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857053|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83857054|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83857055|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857056|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857057|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83857058|NCT03458143|Narcotics|narcotics|mesh-ancestor
83857059|NCT02941198|Copper|copper|mesh-list
83857060|NCT02941198|Trace Elements|trace elements|mesh-ancestor
83857061|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
83857062|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857063|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83857064|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83857065|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83857066|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
83857067|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857068|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83857069|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
83857070|NCT05273671|Nalbuphine|nalbuphine|mesh-list
83857071|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83857072|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857073|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857074|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857075|NCT05273671|Analgesics|analgesics|mesh-ancestor
83857076|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
83857077|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857078|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83857079|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83857080|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83857081|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
83857082|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857083|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857084|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83857085|NCT05273671|Narcotics|narcotics|mesh-ancestor
83857086|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83857087|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83857088|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83857089|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
83857090|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857091|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83857092|NCT02931526|Tigecycline|tigecycline|mesh-list
83857093|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857094|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857095|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83857096|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857097|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857098|NCT00169845|Tocopherols|tocopherols|mesh-list
83857099|NCT00169845|Vitamin E|vitamin e|mesh-list
83857100|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
83857101|NCT00169845|Beta Carotene|beta carotene|mesh-list
83857102|NCT00169845|Carotenoids|carotenoids|mesh-list
83857103|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
83857104|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857105|NCT00169845|Protective Agents|protective agents|mesh-ancestor
83857106|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857107|NCT00169845|Vitamins|vitamins|mesh-ancestor
83857108|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
83857109|NCT00169845|Provitamins|provitamins|mesh-ancestor
83857110|NCT00147836|Insulin|insulin|mesh-list
83857111|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83857112|NCT00147836|Metformin|metformin|mesh-list
83857113|NCT00147836|Gliclazide|gliclazide|mesh-list
83857114|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
83857115|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
83857116|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
83857117|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857118|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857119|NCT02931136|Huperzine A|huperzine a|mesh-list
83857120|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83857121|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857122|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857123|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
83857124|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857125|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857126|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83857127|NCT02931136|Protective Agents|protective agents|mesh-ancestor
83857128|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83857129|NCT02931175|Hormones|hormones|mesh-ancestor
83857130|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857131|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857132|NCT00147875|Prednisone|prednisone|mesh-list
83857133|NCT00147875|Gemcitabine|gemcitabine|mesh-list
83857134|NCT00147875|Doxorubicin|doxorubicin|mesh-list
83857135|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83857136|NCT00147875|Vinblastine|vinblastine|mesh-list
83857137|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83857139|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857140|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857141|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83857142|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83857143|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83857144|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857145|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857146|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
83857147|NCT00147875|Hormones|hormones|mesh-ancestor
83857148|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857149|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857150|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83857151|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857152|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857153|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857154|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857155|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
83857156|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857157|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857158|NCT00147914|Amoxicillin|amoxicillin|mesh-list
83857159|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
83857160|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
83857161|NCT00147914|Cefdinir|cefdinir|mesh-list
83857162|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83857163|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857164|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857165|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83857166|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857167|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857168|NCT00147953|Rituximab|rituximab|mesh-list
83857169|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83857170|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857171|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
83857172|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857173|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857174|NCT02930551|Lidocaine|lidocaine|mesh-list
83857175|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
83857176|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
83857177|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857178|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857179|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
83857180|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857181|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83857182|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83857183|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83857184|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857185|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857186|NCT00175617|Minoxidil|minoxidil|mesh-list
83857187|NCT00175617|Spironolactone|spironolactone|mesh-list
83857188|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83857189|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
83857190|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857191|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857192|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83857193|NCT00175617|Diuretics|diuretics|mesh-ancestor
83857194|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
83857195|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83857196|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
83857197|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
83857198|NCT02930707|Bupivacaine|bupivacaine|mesh-list
83857199|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
83857200|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
83857201|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857202|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857203|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
83857204|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857205|NCT02930707|Analgesics|analgesics|mesh-ancestor
83857206|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83857207|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
83857208|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83857209|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857210|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857211|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83857212|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
83857213|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83857214|NCT00148031|Interferons|interferons|mesh-list
83857215|NCT00148031|Ribavirin|ribavirin|mesh-list
83857216|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857217|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
83857218|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857219|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
83857220|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857221|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
83857222|NCT02930434|Vitamin D|vitamin d|mesh-list
83857223|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
83857224|NCT02930434|Vitamins|vitamins|mesh-ancestor
83857225|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
83857226|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857227|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83857228|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83857229|NCT00148070|Erythromycin|erythromycin|mesh-list
83857230|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
83857231|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83857232|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
83857233|NCT00148070|Docetaxel|docetaxel|mesh-list
83857234|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857235|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857236|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857237|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857238|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857239|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857240|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857241|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857242|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83857243|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857244|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83857245|NCT00175695|Protein C|protein c|mesh-list
83857246|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
83857247|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83857248|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83857249|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857250|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857251|NCT02930317|Factor VIII|factor viii|mesh-list
83857252|NCT02930317|Coagulants|coagulants|mesh-ancestor
83857253|NCT00148148|Amphotericin B|amphotericin b|mesh-list
83857254|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83857255|NCT00148148|Caspofungin|caspofungin|mesh-list
83857256|NCT00148148|Amebicides|amebicides|mesh-ancestor
83857257|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83857258|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83857259|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857260|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857261|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
83857262|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857263|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857264|NCT00170001|Esomeprazole|esomeprazole|mesh-list
83857265|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83857266|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857267|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83857268|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857269|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857270|NCT00148265|Triamcinolone|triamcinolone|mesh-list
83857271|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857272|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
83857273|NCT00148265|Hormones|hormones|mesh-ancestor
83857274|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857275|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857276|NCT02929693|Gefitinib|gefitinib|mesh-list
83857277|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857278|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83857279|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048312|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857280|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857281|NCT00175734|Chrysarobin|chrysarobin|mesh-list
83857282|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83857283|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857284|NCT00175734|Analgesics|analgesics|mesh-ancestor
83857285|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
83857286|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096164|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83857287|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857288|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857289|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857291|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857292|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857293|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83857294|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83857295|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
83857296|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
83857297|NCT00148421|Hematinics|hematinics|mesh-ancestor
83857298|NCT02929888|Aspirin|aspirin|mesh-list
83857299|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83857300|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857301|NCT02929888|Analgesics|analgesics|mesh-ancestor
83857302|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
83857303|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857304|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857305|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857306|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857307|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83857308|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83857309|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857310|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83857311|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83857312|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857313|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
83857314|NCT04689412|Resveratrol|resveratrol|mesh-list
83857315|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
83857316|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857317|NCT04689412|Protective Agents|protective agents|mesh-ancestor
83857318|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857319|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857320|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83857321|NCT00148460|Tenecteplase|tenecteplase|mesh-list
83857322|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83857323|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83857324|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857325|NCT00170196|Prednisone|prednisone|mesh-list
83857326|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857327|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
83857328|NCT00170196|Hormones|hormones|mesh-ancestor
83857329|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857330|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857331|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83857332|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857333|NCT02929459|Vitamins|vitamins|mesh-list
83857334|NCT02929459|Riboflavin|riboflavin|mesh-list
83857335|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
83857336|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
83857337|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857338|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83857339|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
83857340|NCT02929576|Paclitaxel|paclitaxel|mesh-list
83857341|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857342|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857343|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857344|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857345|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857346|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857347|NCT00175812|Tretinoin|tretinoin|mesh-list
83857348|NCT00175812|Theophylline|theophylline|mesh-list
83857349|NCT00175812|Valproic Acid|valproic acid|mesh-list
83857350|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857351|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
83857352|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
83857353|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
83857354|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857355|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857356|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
83857357|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857358|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857359|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
83857360|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83857361|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857362|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83857363|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83857364|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
83857365|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857366|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83857367|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
83857368|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83857369|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
83857370|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83857371|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83857372|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
83857373|NCT00148499|Benzocaine|benzocaine|mesh-list
83857374|NCT00148499|Ambroxol|ambroxol|mesh-list
83857375|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
83857376|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
83857377|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857378|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857379|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
83857380|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857381|NCT00148499|Expectorants|expectorants|mesh-ancestor
83857382|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83857383|NCT03457597|Pioglitazone|pioglitazone|mesh-list
83857384|NCT03457597|Tolbutamide|tolbutamide|mesh-list
83857385|NCT03457597|Metoprolol|metoprolol|mesh-list
83857386|NCT03457597|Midazolam|midazolam|mesh-list
83857387|NCT03457597|Omeprazole|omeprazole|mesh-list
83857388|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83857389|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83857390|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857391|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857392|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83857393|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83857394|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83857395|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83857396|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
83857397|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
83857398|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
83857399|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
83857400|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857401|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857402|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857403|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83857404|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857405|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83857406|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857407|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83857408|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83857409|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
83857410|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
83857411|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857412|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83857413|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83857414|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83857415|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
83857416|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83857417|NCT02929147|Morphine|morphine|mesh-list
83857418|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83857419|NCT02929147|Narcotics|narcotics|mesh-ancestor
83857420|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857421|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857422|NCT02929147|Analgesics|analgesics|mesh-ancestor
83857423|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
83857424|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857425|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83857426|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857427|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857428|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857429|NCT00175890|Levetiracetam|levetiracetam|mesh-list
83857430|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
83857431|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
83857432|NCT00148616|Memantine|memantine|mesh-list
83857433|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83857434|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83857435|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
83096360|NCT03196154|Insulin|insulin|mesh-list
83857436|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857437|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857438|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857439|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83857440|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83857441|NCT00175929|Brivaracetam|brivaracetam|mesh-list
83857442|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
83857443|NCT02928679|Liraglutide|liraglutide|mesh-list
83857444|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857445|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857446|NCT02928679|Incretins|incretins|mesh-ancestor
83857447|NCT02928679|Hormones|hormones|mesh-ancestor
83857448|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857449|NCT02928601|Ondansetron|ondansetron|mesh-list
83857450|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
83857451|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
83857452|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857453|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857454|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857455|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
83857456|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
83857457|NCT02928601|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83857458|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83857459|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
83857460|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857461|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857462|NCT02928328|Lidocaine|lidocaine|mesh-list
83857463|NCT02928328|Lorazepam|lorazepam|mesh-list
83857464|NCT02928328|Capsaicin|capsaicin|mesh-list
83857465|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
83857466|NCT02928328|Butyric Acid|butyric acid|mesh-list
83857467|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
83857468|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
83857469|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857470|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857471|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
83857472|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857473|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83857474|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83857475|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83857476|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857477|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857478|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
83857479|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83857480|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
83857481|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
83857482|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
83857483|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857484|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83857485|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83857486|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83857487|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83857488|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
83857489|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
83857490|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857491|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
83857492|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
83857493|NCT00148694|Cisplatin|cisplatin|mesh-list
83857494|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857495|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83857496|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857497|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83857498|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857499|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857500|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
83857501|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857502|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83857503|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83857504|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
83857505|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857506|NCT02927587|Propofol|propofol|mesh-list
83857507|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83857508|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857509|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857510|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83857511|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
83857512|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
83857513|NCT00148850|Pioglitazone|pioglitazone|mesh-list
83857514|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857515|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857516|NCT02927353|Adalimumab|adalimumab|mesh-list
83857517|NCT02927353|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83857518|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857519|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857520|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83857521|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83857522|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83857523|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857524|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857525|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857526|NCT02926885|Liver Extracts|liver extracts|mesh-list
83857527|NCT02926885|Hematinics|hematinics|mesh-ancestor
83857528|NCT02926846|Vancomycin|vancomycin|mesh-list
83857529|NCT02926846|Gentamicins|gentamicins|mesh-list
83857530|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857531|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857532|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83857533|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857534|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857535|NCT02926183|Paclitaxel|paclitaxel|mesh-list
83857536|NCT02926183|Gemcitabine|gemcitabine|mesh-list
83857537|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857538|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857539|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857540|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857541|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857542|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857543|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83857544|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
83857545|NCT02925832|Bupivacaine|bupivacaine|mesh-list
83857546|NCT02925832|Ropivacaine|ropivacaine|mesh-list
83857547|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
83857548|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
83857549|NCT02925832|Anesthetics|anesthetics|mesh-list
83857550|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857551|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857552|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
83857553|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857554|NCT00170430|Fluconazole|fluconazole|mesh-list
83857555|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
83857556|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857557|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83857558|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83857559|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857560|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857561|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83857562|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
83857563|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857564|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857565|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83857566|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83857567|NCT00149084|Amoxicillin|amoxicillin|mesh-list
83857568|NCT00149084|Clarithromycin|clarithromycin|mesh-list
83857569|NCT00149084|Lansoprazole|lansoprazole|mesh-list
83857570|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
83857571|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857572|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857573|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83857574|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857575|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857576|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83857577|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83857578|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83857579|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857580|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83857581|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83857582|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83857583|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
83857584|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857585|NCT00170469|Antacids|antacids|mesh-ancestor
83857586|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857587|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857588|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
83857589|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857590|NCT00149162|Aldesleukin|aldesleukin|mesh-list
83857591|NCT00149162|Interleukin-2|interleukin-2|mesh-list
83857592|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857594|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83857595|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
83857596|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857597|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857598|NCT00149162|Analgesics|analgesics|mesh-ancestor
83857599|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
83857600|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857601|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857602|NCT00170547|Vaccines|vaccines|mesh-list
83857603|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
83857604|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857605|NCT00149201|Fluorouracil|fluorouracil|mesh-list
83857606|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
83857607|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857608|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83857609|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857610|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83857611|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
83857612|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857613|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
83857614|NCT02925559|Gliclazide|gliclazide|mesh-list
83857615|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83857616|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857617|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857618|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857619|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
83857620|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83857621|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83857622|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83857623|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857624|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857625|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
83857626|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857627|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857628|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83857629|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857630|NCT02925247|Anticoagulants|anticoagulants|mesh-list
83857631|NCT00170664|Paclitaxel|paclitaxel|mesh-list
83857632|NCT00170664|Carboplatin|carboplatin|mesh-list
83857633|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857634|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857635|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857636|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857637|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857638|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857639|NCT00170742|Octreotide|octreotide|mesh-list
83857640|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857641|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83857642|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857643|NCT02917525|Vitamin K|vitamin k|mesh-list
83857644|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
83857645|NCT02917525|Vitamins|vitamins|mesh-ancestor
83857646|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
83857647|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857648|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83857649|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83857650|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857651|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
83857652|NCT02917525|Coagulants|coagulants|mesh-ancestor
83857653|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
83857654|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83857655|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83857656|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857657|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857658|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83857659|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857660|NCT00170781|Analgesics|analgesics|mesh-ancestor
83857661|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
83857662|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857663|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857664|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857665|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857666|NCT00170820|Everolimus|everolimus|mesh-list
83857667|NCT00170820|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83857668|NCT00170820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83857669|NCT00170820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857670|NCT00170820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857671|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83857672|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
83857673|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857674|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857675|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
83857676|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83857677|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857678|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857679|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857680|NCT02917018|Analgesics|analgesics|mesh-ancestor
83857681|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
83857682|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857683|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83857684|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83857685|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83857686|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
83857687|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857688|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857689|NCT00170859|Everolimus|everolimus|mesh-list
83857690|NCT00170859|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83857691|NCT00170859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83857692|NCT00170859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857693|NCT00170859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857694|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83857695|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
83857696|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857697|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857698|NCT02917057|Exenatide|exenatide|mesh-list
83857699|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857700|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857701|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83857702|NCT02917057|Incretins|incretins|mesh-ancestor
83857703|NCT02917057|Hormones|hormones|mesh-ancestor
83857704|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857705|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
83857706|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857707|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
83857708|NCT02916940|Hormones|hormones|mesh-ancestor
83857709|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857710|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857711|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
83857712|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83857713|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83857714|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857715|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857716|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83857717|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83857718|NCT00170898|Analgesics|analgesics|mesh-ancestor
83857719|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
83857720|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857721|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857722|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83857723|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857724|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83857725|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857726|NCT02916511|Paclitaxel|paclitaxel|mesh-list
83857727|NCT02916511|Carboplatin|carboplatin|mesh-list
83857728|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857729|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857730|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857731|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857732|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857733|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857734|NCT00170937|Valsartan|valsartan|mesh-list
83857735|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83857736|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83857737|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83857738|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83857739|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857740|NCT00170937|Diuretics|diuretics|mesh-ancestor
83857741|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
83857742|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857743|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83857744|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857745|NCT02916238|Fluoxetine|fluoxetine|mesh-list
83857746|NCT02916238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83857747|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83857748|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857749|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857750|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857751|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
83857752|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857753|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83857754|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
83857755|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83857756|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83857757|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83857758|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857759|NCT00149708|Hormones|hormones|mesh-list
83857760|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83857761|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857762|NCT00163761|Gemcitabine|gemcitabine|mesh-list
83857763|NCT00163761|Vinorelbine|vinorelbine|mesh-list
83857764|NCT00163761|Ifosfamide|ifosfamide|mesh-list
83857765|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83857766|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
83857767|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857768|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857769|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857770|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857771|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857772|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857773|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83857774|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
83857775|NCT02916160|Valsartan|valsartan|mesh-list
83857776|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83857777|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83857778|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83857779|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83857780|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857781|NCT02916121|Folic Acid|folic acid|mesh-list
83857782|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
83857783|NCT02916121|Vitamins|vitamins|mesh-ancestor
83857784|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
83857785|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857786|NCT02916121|Hematinics|hematinics|mesh-ancestor
83857787|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
83857788|NCT00170976|Amlodipine|amlodipine|mesh-list
83857789|NCT00170976|Valsartan|valsartan|mesh-list
83857790|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83857791|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83857792|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857793|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857794|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83857795|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857796|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
83857797|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83857798|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83857799|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
83857800|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83857801|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857802|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83857803|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
83857804|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857805|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857806|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857807|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857808|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
83857809|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83857810|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857811|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83857812|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
83857813|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857814|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857815|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857816|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857817|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
83857818|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83857819|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857820|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857821|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83857822|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83857823|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857824|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857825|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857826|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83857827|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
83857828|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83857829|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857830|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83857831|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83857832|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83857833|NCT00171015|Valsartan|valsartan|mesh-list
83857834|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83857835|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83857836|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83857837|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83857838|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857839|NCT00171015|Diuretics|diuretics|mesh-ancestor
83857840|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
83857841|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857842|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83857843|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857844|NCT05786677|Serotonin|serotonin|mesh-list
83857845|NCT05786677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83857846|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83857847|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
83857848|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857849|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857850|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857851|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83857852|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83857853|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83857854|NCT05786612|Laxatives|laxatives|mesh-ancestor
83857855|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83857856|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83857857|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857858|NCT05786443|Empagliflozin|empagliflozin|mesh-list
83857859|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83857860|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857861|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83857862|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857863|NCT05786430|Carboplatin|carboplatin|mesh-list
83857864|NCT05786430|Pemetrexed|pemetrexed|mesh-list
83857865|NCT05786430|Lazertinib|lazertinib|mesh-list
83857866|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857867|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857868|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857869|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83857870|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83857871|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83857872|NCT05786365|Ketamine|ketamine|mesh-list
83857873|NCT05786365|Analgesics|analgesics|mesh-ancestor
83857874|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
83857875|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857876|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857877|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83857878|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83857879|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
83857880|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
83857881|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857882|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83096771|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
83857883|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83857884|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857885|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857886|NCT05786339|Irbesartan|irbesartan|mesh-list
83857887|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83857888|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83857889|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83857890|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857891|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
83857892|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
83857893|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
83857894|NCT05785585|Vitamins|vitamins|mesh-ancestor
83857895|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
83857896|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857897|NCT05785585|Hematinics|hematinics|mesh-ancestor
83857898|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83857899|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857900|NCT05785429|Colchicine|colchicine|mesh-list
83857901|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
83857902|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857903|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83857904|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83857905|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83857906|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857907|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857908|NCT05785377|Bupivacaine|bupivacaine|mesh-list
83857909|NCT05785377|Neostigmine|neostigmine|mesh-list
83857910|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
83857911|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
83857912|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857913|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857914|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
83857915|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857916|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83857917|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857918|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857919|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
83857920|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857921|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83857922|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
83857923|NCT05785325|Bevacizumab|bevacizumab|mesh-list
83857924|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83857925|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857926|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83857927|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83857928|NCT05785325|Growth Substances|growth substances|mesh-ancestor
83857929|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857930|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
83857931|NCT05785234|Sufentanil|sufentanil|mesh-list
83857932|NCT05785234|Remifentanil|remifentanil|mesh-list
83857933|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83857934|NCT05785234|Narcotics|narcotics|mesh-ancestor
83857935|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83857936|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857937|NCT05785234|Analgesics|analgesics|mesh-ancestor
83857938|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
83857939|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857940|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83857941|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83857942|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
83857943|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
83857944|NCT05785208|Osimertinib|osimertinib|mesh-list
83857945|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857946|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83857947|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857948|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857949|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
83857950|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83857951|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857952|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83857953|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
83857954|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83857955|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83857956|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857957|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857959|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
83857960|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83857961|NCT05784987|Rituximab|rituximab|mesh-list
83857962|NCT05784987|Etoposide|etoposide|mesh-list
83857963|NCT05784987|Lenalidomide|lenalidomide|mesh-list
83857964|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
83857965|NCT05784987|Ifosfamide|ifosfamide|mesh-list
83857966|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
83857967|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83857968|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83857969|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
83857970|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857971|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83857972|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83857973|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83857974|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83857975|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83857976|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857977|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83857978|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83857979|NCT05784987|Growth Substances|growth substances|mesh-ancestor
83857980|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
83857981|NCT05784987|Analgesics|analgesics|mesh-ancestor
83857982|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
83857983|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857984|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83857985|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
83857986|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
83857987|NCT05784870|Hematinics|hematinics|mesh-ancestor
83857988|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83857989|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83857990|NCT05784467|Methamphetamine|methamphetamine|mesh-list
83857991|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83857992|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83857993|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
83857994|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
83857995|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83857996|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
83857997|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83857998|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83857999|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858000|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83858001|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83858002|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858003|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83858004|NCT05782894|Remifentanil|remifentanil|mesh-list
83858005|NCT05782894|Propofol|propofol|mesh-list
83858006|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83858007|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858008|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858009|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83858010|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
83858011|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
83858012|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83858013|NCT05782894|Narcotics|narcotics|mesh-ancestor
83858014|NCT05782894|Analgesics|analgesics|mesh-ancestor
83858015|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
83858016|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858017|NCT05782712|Adenosine|adenosine|mesh-list
83858018|NCT05782712|Analgesics|analgesics|mesh-ancestor
83858019|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
83858020|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858021|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858022|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83858023|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
83858024|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83858025|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
83858026|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
83858027|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858028|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858029|NCT05781516|Prednisolone|prednisolone|mesh-list
83858030|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858031|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
83858032|NCT05781516|Hormones|hormones|mesh-ancestor
83858033|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858034|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858035|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83858036|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858037|NCT05781321|Temozolomide|temozolomide|mesh-list
83858038|NCT05781321|Levodopa|levodopa|mesh-list
83858039|NCT05781321|Fluorides|fluorides|mesh-list
83858040|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83858041|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
83858042|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858043|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858044|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
83858045|NCT05781321|Protective Agents|protective agents|mesh-ancestor
83858046|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858047|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
83858048|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858049|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83858050|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83858051|NCT05780437|Remdesivir|remdesivir|mesh-list
83858052|NCT05780437|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83858053|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
83858054|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858055|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
83858056|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858057|NCT05780424|Remdesivir|remdesivir|mesh-list
83858058|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
83858059|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858060|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
83858061|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858062|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83858063|NCT05778266|Laxatives|laxatives|mesh-ancestor
83858064|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83858065|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83858066|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83858067|NCT05774405|Estradiol|estradiol|mesh-list
83858068|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83858069|NCT05774405|Estrogens|estrogens|mesh-ancestor
83858070|NCT05774405|Hormones|hormones|mesh-ancestor
83858071|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858072|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858073|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83858074|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
83858075|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83858076|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83858077|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83858078|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83858079|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83858080|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858081|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858082|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83858083|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858084|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858085|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
83858086|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858087|NCT05764941|Vinorelbine|vinorelbine|mesh-list
83858088|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83858089|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858090|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
83858091|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
83858092|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83858093|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858094|NCT05750017|Vaccines|vaccines|mesh-list
83858095|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
83858096|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858097|NCT05734105|Sunitinib|sunitinib|mesh-list
83858098|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858099|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83858100|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83858101|NCT05734105|Growth Substances|growth substances|mesh-ancestor
83858102|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858103|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
83858104|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83858105|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858106|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858107|NCT05724316|Vitamin D|vitamin d|mesh-list
83858108|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
83858110|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
83858111|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858112|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83858113|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83858114|NCT05723705|Liver Extracts|liver extracts|mesh-list
83858115|NCT05723705|Hematinics|hematinics|mesh-ancestor
83858116|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
83858117|NCT05634577|Mitotane|mitotane|mesh-list
83858118|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858119|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858120|NCT05634577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858121|NCT05634577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858122|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83858123|NCT05616260|Acetazolamide|acetazolamide|mesh-list
83858124|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
83858125|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83858126|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858127|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858128|NCT05616260|Diuretics|diuretics|mesh-ancestor
83858129|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
83858130|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858131|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
83858132|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858133|NCT05592509|Vitamins|vitamins|mesh-list
83858134|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
83858135|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858136|NCT05582213|Anesthetics|anesthetics|mesh-list
83858137|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858138|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858139|NCT05550597|Fentanyl|fentanyl|mesh-list
83858140|NCT05550597|Bupivacaine|bupivacaine|mesh-list
83858141|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
83858142|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
83858143|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858144|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858145|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
83858146|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858147|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83858148|NCT05550597|Narcotics|narcotics|mesh-ancestor
83858149|NCT05550597|Analgesics|analgesics|mesh-ancestor
83858150|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83858151|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83858152|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
83858153|NCT05541276|Melatonin|melatonin|mesh-list
83858154|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
83858155|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858156|NCT05541276|Protective Agents|protective agents|mesh-ancestor
83858157|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858158|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858159|NCT05535764|Interferons|interferons|mesh-list
83858160|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
83858161|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
83858162|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83858163|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858164|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
83858165|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858166|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
83858167|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858168|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83858169|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83858170|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
83858171|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83858172|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858173|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83858174|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83858175|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858176|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858177|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858178|NCT05334017|Cocaine|cocaine|mesh-list
83858179|NCT05334017|Xylometazoline|xylometazoline|mesh-list
83858180|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
83858181|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
83858182|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858183|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097074|NCT02436980|Midazolam|midazolam|mesh-list
83858184|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
83858185|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858186|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83858187|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83858188|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83858189|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858190|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858191|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
83858192|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858193|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
83858194|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
83858195|NCT05319639|Leucovorin|leucovorin|mesh-list
83858196|NCT05319639|Paclitaxel|paclitaxel|mesh-list
83858197|NCT05319639|Fluorouracil|fluorouracil|mesh-list
83858198|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
83858199|NCT05319639|Irinotecan|irinotecan|mesh-list
83858200|NCT05319639|Tislelizumab|tislelizumab|mesh-list
83858201|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
83858202|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83858203|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858204|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
83858205|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
83858206|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
83858207|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858208|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
83858209|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858210|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858211|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
83858212|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858213|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83858214|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83858215|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858216|NCT05319639|Antidotes|antidotes|mesh-ancestor
83858217|NCT05319639|Protective Agents|protective agents|mesh-ancestor
83858218|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
83858219|NCT05319639|Vitamins|vitamins|mesh-ancestor
83858220|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
83858221|NCT05319639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858222|NCT05292339|Triamcinolone|triamcinolone|mesh-list
83858223|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83858224|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83858225|NCT05292339|Ketorolac|ketorolac|mesh-list
83858226|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83858227|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83858228|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858229|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
83858230|NCT05292339|Hormones|hormones|mesh-ancestor
83858231|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858232|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858233|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858234|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
83858235|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858236|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858237|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83858238|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83858239|NCT05292339|Analgesics|analgesics|mesh-ancestor
83858240|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
83858241|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858242|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83858243|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83858244|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
83858245|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
83858246|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83858247|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
83858248|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858249|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
83858250|NCT05291650|Protective Agents|protective agents|mesh-ancestor
83858251|NCT05291650|Hormones|hormones|mesh-ancestor
83858252|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858253|NCT05266027|Nalbuphine|nalbuphine|mesh-list
83097145|NCT02440880|Dexamethasone|dexamethasone|mesh-list
83097146|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
83097147|NCT02440880|BB 1101|bb 1101|mesh-list
83097148|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858254|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83858255|NCT05266027|Narcotics|narcotics|mesh-ancestor
83858256|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858257|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858258|NCT05266027|Analgesics|analgesics|mesh-ancestor
83858259|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
83858260|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858261|NCT05159427|Glipizide|glipizide|mesh-list
83858262|NCT05159427|Rifaximin|rifaximin|mesh-list
83858263|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83858264|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858265|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83858266|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83858267|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858268|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
83858269|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83858270|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
83858271|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858272|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858273|NCT05131386|Trabectedin|trabectedin|mesh-list
83858274|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83858275|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
83858276|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858277|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858278|NCT05129332|Vitamin E|vitamin e|mesh-list
83858279|NCT05129332|Vitamins|vitamins|mesh-ancestor
83858280|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
83858281|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858282|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
83858283|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858284|NCT05129332|Protective Agents|protective agents|mesh-ancestor
83858285|NCT05111262|Budesonide|budesonide|mesh-list
83858286|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
83858287|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858288|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83858289|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
83858290|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858291|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858292|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83858293|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
83858294|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
83858295|NCT05111262|Hormones|hormones|mesh-ancestor
83858296|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858297|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83858298|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83858299|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83858300|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858301|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858302|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858303|NCT05091242|Clonidine|clonidine|mesh-list
83858304|NCT05091242|Analgesics|analgesics|mesh-ancestor
83858305|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
83858306|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858307|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858308|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83858309|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
83858310|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
83858311|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83858312|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83858313|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83858314|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858315|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858316|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858317|NCT05028140|Pioglitazone|pioglitazone|mesh-list
83858318|NCT05028140|Empagliflozin|empagliflozin|mesh-list
83858319|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83858320|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858321|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83858322|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858323|NCT05027516|Azithromycin|azithromycin|mesh-list
83858324|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
83858325|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83858326|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858327|NCT04992013|Niraparib|niraparib|mesh-list
83858328|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83858329|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858330|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858331|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858332|NCT04969263|Vaccines|vaccines|mesh-list
83858333|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
83858334|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858335|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83858336|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83858337|NCT04933630|Norepinephrine|norepinephrine|mesh-list
83858338|NCT04933630|Serotonin|serotonin|mesh-list
83858339|NCT04933630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83858340|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83858341|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83858342|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858343|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858344|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858345|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858346|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
83858347|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
83858348|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858349|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83858350|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83858351|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
83858352|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83858353|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858354|NCT04923841|Atropine|atropine|mesh-list
83858355|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83858356|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83858357|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83858358|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83858359|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83858360|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
83858361|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858362|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858363|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83858364|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
83858365|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
83858366|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
83858367|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83858368|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83858369|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
83858370|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858371|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858372|NCT04880863|Docetaxel|docetaxel|mesh-list
83858373|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
83858374|NCT04880863|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
83858375|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858376|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
83858377|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
83858378|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
83858379|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858380|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858381|NCT04880863|Immunoconjugates|immunoconjugates|mesh-ancestor
83858382|NCT04880863|Immunologic Factors|immunologic factors|mesh-ancestor
83858383|NCT04880863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858384|NCT04861987|Capecitabine|capecitabine|mesh-list
83858385|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858386|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
83858387|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858388|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858389|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
83858390|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83858391|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
83858392|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83858393|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
83858394|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858395|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858396|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
83858397|NCT04803877|Nivolumab|nivolumab|mesh-list
83858398|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858399|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858400|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858401|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858402|NCT04792502|Lenalidomide|lenalidomide|mesh-list
83858403|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
83858404|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858405|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83097294|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83858406|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83858407|NCT04792502|Growth Substances|growth substances|mesh-ancestor
83858408|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
83858409|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858411|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83858412|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83858413|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858414|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83858415|NCT04766021|Mirabegron|mirabegron|mesh-list
83858416|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83858417|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83858418|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83858419|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858420|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858421|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858422|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858423|NCT04766021|Urological Agents|urological agents|mesh-ancestor
83858424|NCT04761198|Nivolumab|nivolumab|mesh-list
83858425|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858426|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858427|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858428|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858429|NCT04748276|Norepinephrine|norepinephrine|mesh-list
83858430|NCT04748276|Serotonin|serotonin|mesh-list
83858431|NCT04748276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83858432|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83858433|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83858434|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858435|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858436|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858437|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858438|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
83858439|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
83858440|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858441|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83858442|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83858443|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
83858444|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83858445|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858446|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
83858447|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858448|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858449|NCT04659811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858450|NCT04659811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858451|NCT04610658|Nivolumab|nivolumab|mesh-list
83858452|NCT04610658|Ipilimumab|ipilimumab|mesh-list
83858453|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858454|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858455|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858456|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858457|NCT04595994|Gemcitabine|gemcitabine|mesh-list
83858458|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858459|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
83858460|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858461|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858462|NCT04587791|Cannabidiol|cannabidiol|mesh-list
83858463|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
83858464|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
83858465|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83858466|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
83858467|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858468|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858469|NCT04532918|Cyclosporine|cyclosporine|mesh-list
83858470|NCT04532918|Rifampin|rifampin|mesh-list
83858471|NCT04532918|Allopurinol|allopurinol|mesh-list
83858472|NCT04532918|Verinurad|verinurad|mesh-list
83858473|NCT04532918|Cyclosporins|cyclosporins|mesh-list
83858474|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858475|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858476|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858477|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
83858478|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858479|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
83858480|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858481|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
83858482|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83858483|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83858484|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83858485|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
83858486|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83858487|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
83858488|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83858489|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83858490|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83858491|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83858492|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83858493|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83858494|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83858495|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
83858496|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
83858497|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83858498|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
83858499|NCT04532918|Protective Agents|protective agents|mesh-ancestor
83858500|NCT04511247|Sirolimus|sirolimus|mesh-list
83858501|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83858502|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858503|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83858504|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858505|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
83858506|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858507|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
83858508|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858509|NCT04483466|Methotrexate|methotrexate|mesh-list
83858510|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83858511|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
83858512|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83858513|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858514|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858515|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
83858516|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858517|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858518|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
83858519|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858520|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83858521|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858522|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
83858523|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83858524|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83858525|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
83858526|NCT04387084|Nivolumab|nivolumab|mesh-list
83858527|NCT04387084|Atezolizumab|atezolizumab|mesh-list
83858528|NCT04387084|Durvalumab|durvalumab|mesh-list
83858529|NCT04387084|Avelumab|avelumab|mesh-list
83858530|NCT04387084|Cemiplimab|cemiplimab|mesh-list
83858531|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
83858532|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83858533|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
83858534|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858535|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858536|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858537|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858538|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
83858539|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858540|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
83858541|NCT04347798|Chloroquine|chloroquine|mesh-list
83858542|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
83858543|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83858544|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83858545|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858546|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858547|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858548|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83858549|NCT04347798|Amebicides|amebicides|mesh-ancestor
83858550|NCT04335669|Paclitaxel|paclitaxel|mesh-list
83858551|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83858552|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
83858553|NCT04335669|Carboplatin|carboplatin|mesh-list
83858554|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
83097445|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
83858555|NCT04335669|Capecitabine|capecitabine|mesh-list
83858556|NCT04335669|Epirubicin|epirubicin|mesh-list
83858557|NCT04335669|Taxane|taxane|mesh-list
83858558|NCT04335669|Antimetabolites|antimetabolites|mesh-list
83858559|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83858560|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858561|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83858562|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83858563|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83858564|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858565|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858566|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
83858567|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858568|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83858569|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83858570|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
83858571|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83858572|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858573|NCT04335669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858574|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858575|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83858576|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83858577|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83858578|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858579|NCT04332367|Paclitaxel|paclitaxel|mesh-list
83858580|NCT04332367|Carboplatin|carboplatin|mesh-list
83858581|NCT04332367|Ramucirumab|ramucirumab|mesh-list
83858582|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83858583|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858584|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
83858585|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
83858586|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
83858587|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858588|NCT04310176|Bevacizumab|bevacizumab|mesh-list
83858589|NCT04310176|Fluorouracil|fluorouracil|mesh-list
83858590|NCT04310176|Capecitabine|capecitabine|mesh-list
83858591|NCT04310176|Valproic Acid|valproic acid|mesh-list
83858592|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858593|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858594|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83858595|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83858596|NCT04310176|Growth Substances|growth substances|mesh-ancestor
83858597|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858598|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
83858599|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
83858600|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858601|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858602|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858603|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
83858604|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
83858605|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858606|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
83858607|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858608|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
83858609|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83858610|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858611|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83858612|NCT04298983|Androgens|androgens|mesh-list
83858613|NCT04298983|Hormones|hormones|mesh-ancestor
83858614|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858615|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858616|NCT04251416|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83858617|NCT04251416|Immunoconjugates|immunoconjugates|mesh-ancestor
83858618|NCT04251416|Immunologic Factors|immunologic factors|mesh-ancestor
83858619|NCT04251416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858620|NCT04236609|Sirolimus|sirolimus|mesh-list
83858621|NCT04236609|Everolimus|everolimus|mesh-list
83858622|NCT04236609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83858623|NCT04236609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83858624|NCT04236609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858625|NCT04236609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858626|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858627|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
83858628|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858629|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858630|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83858631|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858632|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83097520|NCT02431208|Hormones|hormones|mesh-ancestor
83858633|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
83858634|NCT04232657|Denosumab|denosumab|mesh-list
83858635|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83858636|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858637|NCT04187833|Nivolumab|nivolumab|mesh-list
83858638|NCT04187833|Talazoparib|talazoparib|mesh-list
83858639|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858640|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858641|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858642|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858643|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83858644|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858645|NCT04173585|Bortezomib|bortezomib|mesh-list
83858646|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
83858647|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858648|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858649|NCT04173585|Immunotoxins|immunotoxins|mesh-ancestor
83858650|NCT04173585|Immunoconjugates|immunoconjugates|mesh-ancestor
83858651|NCT04173585|Immunologic Factors|immunologic factors|mesh-ancestor
83858652|NCT04173585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858653|NCT04172987|Tirzepatide|tirzepatide|mesh-list
83858654|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83858655|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858656|NCT04172987|Incretins|incretins|mesh-ancestor
83858657|NCT04172987|Hormones|hormones|mesh-ancestor
83858658|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858659|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
83858660|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858661|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83858662|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858663|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858664|NCT04128501|Azacitidine|azacitidine|mesh-list
83858665|NCT04128501|Venetoclax|venetoclax|mesh-list
83858666|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858667|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
83858668|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858669|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858670|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858671|NCT04127786|Vaccines|vaccines|mesh-list
83858672|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
83858673|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858674|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
83858675|NCT04049331|Testosterone|testosterone|mesh-list
83858676|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
83858677|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
83858678|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83858679|NCT04049331|Androgens|androgens|mesh-ancestor
83858680|NCT04049331|Hormones|hormones|mesh-ancestor
83858681|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858682|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858683|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83858684|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858685|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
83858686|NCT04033055|Ropivacaine|ropivacaine|mesh-list
83858687|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
83858688|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
83858689|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858690|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858691|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
83858692|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858693|NCT04015596|Naproxen|naproxen|mesh-list
83858694|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83858695|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83858696|NCT04015596|Analgesics|analgesics|mesh-ancestor
83858697|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
83858698|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858699|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858700|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858701|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83858702|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
83858703|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83858704|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858705|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858706|NCT03985722|Trabectedin|trabectedin|mesh-list
83858707|NCT03985722|Olaratumab|olaratumab|mesh-list
83858708|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83858709|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
83858710|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858711|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858712|NCT03954327|Tenofovir|tenofovir|mesh-list
83858713|NCT03954327|Emtricitabine|emtricitabine|mesh-list
83858714|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
83858715|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
83858716|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83858717|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83858718|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83858719|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858720|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858721|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83858722|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83858723|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83858724|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83858725|NCT03762096|Resveratrol|resveratrol|mesh-list
83858726|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
83858727|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858728|NCT03762096|Protective Agents|protective agents|mesh-ancestor
83858729|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858730|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858731|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83858732|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
83858733|NCT03737955|Calicheamicins|calicheamicins|mesh-list
83858734|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858735|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858736|NCT03737955|Immunotoxins|immunotoxins|mesh-ancestor
83858737|NCT03737955|Immunoconjugates|immunoconjugates|mesh-ancestor
83858738|NCT03737955|Immunologic Factors|immunologic factors|mesh-ancestor
83858739|NCT03737955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858740|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83858741|NCT03736720|Leucovorin|leucovorin|mesh-list
83858742|NCT03736720|Fluorouracil|fluorouracil|mesh-list
83858743|NCT03736720|Irinotecan|irinotecan|mesh-list
83858744|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
83858745|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858746|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858747|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858748|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858749|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
83858750|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858751|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83858752|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83858753|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858754|NCT03736720|Antidotes|antidotes|mesh-ancestor
83858755|NCT03736720|Protective Agents|protective agents|mesh-ancestor
83858756|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
83858757|NCT03736720|Vitamins|vitamins|mesh-ancestor
83858758|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
83858759|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
83858760|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83858761|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83858762|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83858763|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
83858764|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858765|NCT03718234|Hormones|hormones|mesh-ancestor
83858766|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858767|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858768|NCT03490344|Lenalidomide|lenalidomide|mesh-list
83858769|NCT03490344|Daratumumab|daratumumab|mesh-list
83858770|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
83858771|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858772|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83858773|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83858774|NCT03490344|Growth Substances|growth substances|mesh-ancestor
83858775|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83858776|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858777|NCT03460379|Citalopram|citalopram|mesh-list
83858778|NCT03460379|Escitalopram|escitalopram|mesh-list
83858779|NCT03460379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83858780|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83858781|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858782|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858783|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097670|NCT03182114|Bupivacaine|bupivacaine|mesh-list
83858784|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
83858785|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858786|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83858787|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
83858788|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83858789|NCT03460366|Enalapril|enalapril|mesh-list
83858790|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83858791|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
83858792|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858793|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858794|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83858795|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
83858796|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83858797|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858798|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83858799|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83858800|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858801|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858802|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
83858803|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858804|NCT03460327|Candesartan|candesartan|mesh-list
83858805|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83858806|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83858807|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83858808|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858809|NCT03460314|Buprenorphine|buprenorphine|mesh-list
83858810|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83858811|NCT03460314|Narcotics|narcotics|mesh-ancestor
83858812|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858813|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858814|NCT03460314|Analgesics|analgesics|mesh-ancestor
83858815|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
83858816|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858817|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83858818|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83858819|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83858820|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83858821|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83858822|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858823|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858824|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858825|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858826|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83858827|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
83858828|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83858829|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83858830|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83858831|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858832|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858833|NCT03440879|Goserelin|goserelin|mesh-list
83858834|NCT03440879|Androgens|androgens|mesh-list
83858835|NCT03440879|Hormones|hormones|mesh-ancestor
83858836|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858837|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858838|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83858839|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858840|NCT03433755|Evolocumab|evolocumab|mesh-list
83858841|NCT03433755|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83858842|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83858843|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83858844|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
83858845|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858846|NCT03433755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83858847|NCT03433755|Protease Inhibitors|protease inhibitors|mesh-ancestor
83858848|NCT03433755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858849|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83858850|NCT03406507|Ravulizumab|ravulizumab|mesh-list
83858851|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83858852|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858853|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
83858854|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858855|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
83858856|NCT03283150|Remifentanil|remifentanil|mesh-list
83858858|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83858859|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83858860|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858861|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83858862|NCT03283150|Analgesics|analgesics|mesh-ancestor
83858863|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
83858864|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858865|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83858866|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83858867|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83858868|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
83858869|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83858870|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858871|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83858872|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
83858873|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
83858874|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83858875|NCT03283150|Narcotics|narcotics|mesh-ancestor
83858876|NCT03277924|Doxorubicin|doxorubicin|mesh-list
83858877|NCT03277924|Nivolumab|nivolumab|mesh-list
83858878|NCT03277924|Methotrexate|methotrexate|mesh-list
83858879|NCT03277924|Sunitinib|sunitinib|mesh-list
83858880|NCT03277924|Epirubicin|epirubicin|mesh-list
83858881|NCT03277924|Ifosfamide|ifosfamide|mesh-list
83858882|NCT03277924|Dacarbazine|dacarbazine|mesh-list
83858883|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858884|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83858885|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83858886|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83858887|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858888|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858889|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858890|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858891|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83858892|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
83858893|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83858894|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858895|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858896|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
83858897|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83858898|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83858899|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858900|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
83858901|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83858902|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83858903|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83858904|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83858905|NCT03277924|Growth Substances|growth substances|mesh-ancestor
83858906|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
83858907|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83858908|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83858909|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
83858910|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
83858911|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858912|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858913|NCT03249792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858914|NCT03249792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858915|NCT03149770|Naloxone|naloxone|mesh-list
83858916|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83858917|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858918|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
83858919|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858920|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
83858921|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858922|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858923|NCT03132675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858924|NCT03132675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858925|NCT03127215|Olaparib|olaparib|mesh-list
83858926|NCT03127215|Trabectedin|trabectedin|mesh-list
83858927|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83858928|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858929|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858930|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858931|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83858932|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
83858933|NCT03110744|Palbociclib|palbociclib|mesh-list
83858934|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858935|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83858936|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83858937|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858939|NCT03056040|Ravulizumab|ravulizumab|mesh-list
83858940|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83858941|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83858942|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
83858943|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858944|NCT02924038|Poly ICLC|poly iclc|mesh-list
83858945|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
83858946|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
83858947|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858948|NCT02726581|Dexamethasone|dexamethasone|mesh-list
83858949|NCT02726581|Nivolumab|nivolumab|mesh-list
83858950|NCT02726581|Pomalidomide|pomalidomide|mesh-list
83858951|NCT02726581|Elotuzumab|elotuzumab|mesh-list
83858952|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858953|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
83858954|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
83858955|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858956|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858957|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83858958|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
83858959|NCT02726581|Hormones|hormones|mesh-ancestor
83858960|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858961|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83858962|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858963|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83858964|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83858965|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858966|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
83858967|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83858968|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83858969|NCT02726581|Growth Substances|growth substances|mesh-ancestor
83858970|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
83858971|NCT02700048|Naloxone|naloxone|mesh-list
83858972|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83858973|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858974|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
83858975|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83858976|NCT02535832|Pioglitazone|pioglitazone|mesh-list
83858977|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83858978|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858979|NCT02425904|Clofarabine|clofarabine|mesh-list
83858980|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83858981|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
83858982|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83858983|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858984|NCT02406209|Prednisolone|prednisolone|mesh-list
83858985|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83858986|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
83858987|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83858988|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
83858989|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83858990|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
83858991|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83858992|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
83858993|NCT02406209|Hormones|hormones|mesh-ancestor
83858994|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83858995|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83858996|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83858997|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83858998|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
83858999|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
83859000|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859001|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859002|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83859003|NCT02406209|Protective Agents|protective agents|mesh-ancestor
83859004|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83859005|NCT02296125|Gefitinib|gefitinib|mesh-list
83097897|NCT02426840|Calcium|calcium|mesh-list
83859007|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859008|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859009|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859010|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859011|NCT02295722|Gemcitabine|gemcitabine|mesh-list
83859012|NCT02295722|Melphalan|melphalan|mesh-list
83859013|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83859014|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
83859015|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859016|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859017|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83859018|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
83859019|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83859020|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83859021|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
83859022|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859023|NCT02282059|Sunitinib|sunitinib|mesh-list
83859024|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859025|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83859026|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83859027|NCT02282059|Growth Substances|growth substances|mesh-ancestor
83859028|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859029|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
83859030|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859031|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859032|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859033|NCT01964989|Vaccines|vaccines|mesh-list
83859034|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
83859035|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859036|NCT01711554|Vitamin A|vitamin a|mesh-list
83859037|NCT01711554|Lenalidomide|lenalidomide|mesh-list
83859038|NCT01711554|Tretinoin|tretinoin|mesh-list
83859039|NCT01711554|Dinutuximab|dinutuximab|mesh-list
83859040|NCT01711554|Isotretinoin|isotretinoin|mesh-list
83859041|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83859042|NCT01711554|Vitamins|vitamins|mesh-ancestor
83859043|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
83859044|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859045|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
83859046|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83859047|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83859048|NCT01711554|Growth Substances|growth substances|mesh-ancestor
83859049|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
83859050|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859051|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
83859052|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
83859053|NCT01575860|Lenalidomide|lenalidomide|mesh-list
83859054|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
83859055|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859056|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83859057|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83859058|NCT01575860|Growth Substances|growth substances|mesh-ancestor
83859059|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
83859060|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859061|NCT01416831|Interleukin-2|interleukin-2|mesh-list
83859062|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859063|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83859064|NCT01416831|Analgesics|analgesics|mesh-ancestor
83859065|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
83859066|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859067|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859068|NCT01364051|Cediranib|cediranib|mesh-list
83859069|NCT01364051|Maleic acid|maleic acid|mesh-list
83859070|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859071|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859072|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859073|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859074|NCT01303341|Sorafenib|sorafenib|mesh-list
83859075|NCT01303341|Riluzole|riluzole|mesh-list
83859076|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859077|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859078|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859079|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859080|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
83859081|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83098012|NCT02419352|Atropine|atropine|mesh-list
83859082|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83859083|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859084|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859085|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83859086|NCT01303341|Protective Agents|protective agents|mesh-ancestor
83859087|NCT01064648|Cisplatin|cisplatin|mesh-list
83859088|NCT01064648|Pemetrexed|pemetrexed|mesh-list
83859089|NCT01064648|Cediranib|cediranib|mesh-list
83859090|NCT01064648|Maleic acid|maleic acid|mesh-list
83859091|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859092|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859093|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859094|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83859095|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83859096|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859097|NCT00878163|Gemcitabine|gemcitabine|mesh-list
83859098|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83859099|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83859100|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
83859101|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859102|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859103|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859104|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859105|NCT00635700|Ziprasidone|ziprasidone|mesh-list
83859106|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83859107|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
83859108|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859109|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859110|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859111|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83859112|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83859113|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859114|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859115|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83859116|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
83859117|NCT00582075|Temozolomide|temozolomide|mesh-list
83859118|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83859119|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
83859120|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859121|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859122|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
83859123|NCT00558961|Chlorambucil|chlorambucil|mesh-list
83859124|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859125|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859126|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859127|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859128|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83859129|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
83859130|NCT00542451|Paclitaxel|paclitaxel|mesh-list
83859131|NCT00542451|Trastuzumab|trastuzumab|mesh-list
83859132|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83859133|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859134|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859135|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859136|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859137|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859138|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83859139|NCT00392353|Azacitidine|azacitidine|mesh-list
83859140|NCT00392353|Vorinostat|vorinostat|mesh-list
83859141|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83859142|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
83859143|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859144|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859145|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859146|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83859147|NCT00382070|Letrozole|letrozole|mesh-list
83859148|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859149|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83859150|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83859151|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859152|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859153|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83859154|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
83859155|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859156|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859158|NCT00326456|Carboplatin|carboplatin|mesh-list
83859159|NCT00326456|Doxorubicin|doxorubicin|mesh-list
83859160|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83859161|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83859162|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859163|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859164|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859165|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859166|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859167|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83859168|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83859169|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83859170|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859171|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
83859172|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83859173|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859174|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83859175|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
83859176|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859177|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859178|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859179|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859180|NCT00149981|Everolimus|everolimus|mesh-list
83859181|NCT00149981|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83859182|NCT00149981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859183|NCT00149981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859184|NCT00149981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859185|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83859186|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
83859187|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859188|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859189|NCT02915731|Vitamin A|vitamin a|mesh-list
83859190|NCT02915731|Vitamins|vitamins|mesh-ancestor
83859191|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
83859192|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859193|NCT02915809|Vaccines|vaccines|mesh-list
83859194|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
83859195|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859196|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
83859197|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83859198|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859199|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83859200|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
83859201|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859202|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859203|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859204|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859205|NCT02914678|Fentanyl|fentanyl|mesh-list
83859206|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83859207|NCT02914678|Narcotics|narcotics|mesh-ancestor
83859208|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859209|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859210|NCT02914678|Analgesics|analgesics|mesh-ancestor
83859211|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
83859212|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859213|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83859214|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83859215|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
83859216|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
83859217|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
83859218|NCT00405977|Analgesics|analgesics|mesh-ancestor
83859219|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
83859220|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859221|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859222|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
83859223|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859224|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83859225|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
83859226|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83859227|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859228|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859229|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83859230|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
83859231|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83859232|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
83859233|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83859234|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859235|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83859236|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
83859237|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859238|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859239|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859240|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859241|NCT02914015|Morphine|morphine|mesh-list
83859242|NCT02914015|Ropivacaine|ropivacaine|mesh-list
83859243|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
83859244|NCT02914015|Anesthetics|anesthetics|mesh-list
83859245|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83859246|NCT02914015|Narcotics|narcotics|mesh-ancestor
83859247|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859248|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859249|NCT02914015|Analgesics|analgesics|mesh-ancestor
83859250|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
83859251|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859252|NCT00171093|Valsartan|valsartan|mesh-list
83859253|NCT00171093|Simvastatin|simvastatin|mesh-list
83859254|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83859255|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83859256|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
83859257|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859258|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83859259|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83859260|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859261|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859262|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83859263|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83859264|NCT02914054|Dexamethasone|dexamethasone|mesh-list
83859265|NCT02914054|Prednisone|prednisone|mesh-list
83859266|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83859267|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
83859268|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
83859269|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859270|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859271|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859272|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
83859273|NCT02914054|Hormones|hormones|mesh-ancestor
83859274|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859275|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83859276|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859277|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
83859278|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83859279|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83859280|NCT00150059|Analgesics|analgesics|mesh-ancestor
83859281|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
83859282|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859283|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859284|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83859285|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83859286|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
83859287|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83859288|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
83859289|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83859290|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859291|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859292|NCT00171132|Atenolol|atenolol|mesh-list
83859293|NCT00171132|Valsartan|valsartan|mesh-list
83859294|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83859295|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859296|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83859297|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83859298|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859299|NCT00171132|Diuretics|diuretics|mesh-ancestor
83859300|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
83859301|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859302|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83859303|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859304|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83098204|NCT03138889|Paclitaxel|paclitaxel|mesh-list
83859305|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
83859306|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
83859307|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859308|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83859309|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83859310|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83859311|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
83859312|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859313|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
83859314|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
83859315|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859316|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859317|NCT00150137|Methimazole|methimazole|mesh-list
83859318|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
83859319|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
83859320|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859321|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859323|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
83859324|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
83859325|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859326|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859327|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859328|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83859329|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83859330|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859331|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859332|NCT00150215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83859333|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83859334|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859335|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859336|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859337|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
83859338|NCT00171171|Deferasirox|deferasirox|mesh-list
83859339|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83859340|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
83859341|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
83859342|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859343|NCT02913430|Tamoxifen|tamoxifen|mesh-list
83859344|NCT02913430|Fulvestrant|fulvestrant|mesh-list
83859345|NCT02913430|Palbociclib|palbociclib|mesh-list
83859346|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83859347|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
83859348|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859349|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859350|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83859351|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859352|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83859353|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83859354|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83859355|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83859356|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859357|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479597|NCT05415215|Pertuzumab|pertuzumab|mesh-list
83859358|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859359|NCT02913469|Morphine|morphine|mesh-list
83859360|NCT02913469|Metoclopramide|metoclopramide|mesh-list
83859361|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83859362|NCT02913469|Narcotics|narcotics|mesh-ancestor
83859363|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859364|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859365|NCT02913469|Analgesics|analgesics|mesh-ancestor
83859366|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
83859367|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859368|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
83859369|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
83859370|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859371|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83859372|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83859373|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
83859374|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859375|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859376|NCT00150254|Varenicline|varenicline|mesh-list
83098290|NCT02886065|Poly ICLC|poly iclc|mesh-list
83859377|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83859378|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83859379|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
83859380|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859381|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859382|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859383|NCT02913508|Vedolizumab|vedolizumab|mesh-list
83859384|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859385|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
83859386|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
83859387|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83859388|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83859389|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859390|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859391|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859392|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83859393|NCT00150293|Pregabalin|pregabalin|mesh-list
83859394|NCT00150293|Analgesics|analgesics|mesh-ancestor
83859395|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
83859396|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859397|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859398|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
83859399|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83859400|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859401|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859402|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83859403|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83859404|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83859405|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859406|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859407|NCT02913118|Amoxicillin|amoxicillin|mesh-list
83859408|NCT02913118|Azithromycin|azithromycin|mesh-list
83859409|NCT02913118|Doxycycline|doxycycline|mesh-list
83859410|NCT02913118|Minocycline|minocycline|mesh-list
83859411|NCT02913118|Cephalosporins|cephalosporins|mesh-list
83859412|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
83859413|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859414|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859415|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
83859416|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83859417|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83859418|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83859419|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859420|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859421|NCT00150332|Linezolid|linezolid|mesh-list
83859422|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859423|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859424|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83859425|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859426|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859427|NCT00150371|Atorvastatin|atorvastatin|mesh-list
83859428|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83859429|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83859430|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
83859431|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859432|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83859433|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83859434|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859435|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
83859436|NCT02912494|Hematinics|hematinics|mesh-ancestor
83859437|NCT00150410|Insulin|insulin|mesh-list
83859438|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83859439|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859440|NCT00171288|Ezetimibe|ezetimibe|mesh-list
83859441|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83859442|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83859443|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
83859444|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859445|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83859446|NCT00150449|Pregabalin|pregabalin|mesh-list
83859447|NCT00150449|Analgesics|analgesics|mesh-ancestor
83859448|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
83859449|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859450|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859451|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
83859452|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83859453|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859454|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859455|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83859456|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83859457|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83859458|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859459|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859461|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83859462|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
83859463|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83859464|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
83859465|NCT02912182|Betamethasone|betamethasone|mesh-list
83859466|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83859467|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
83859468|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83859469|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
83859470|NCT02912182|Hormones|hormones|mesh-ancestor
83859471|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859472|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859473|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83859474|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859475|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
83859476|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
83859477|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859478|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859479|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83859480|NCT02912182|Protective Agents|protective agents|mesh-ancestor
83859481|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83859482|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83859483|NCT02912026|Olorofim|olorofim|mesh-list
83859484|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
83859485|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859486|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
83859487|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859488|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859489|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83859490|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83859491|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859492|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859493|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859494|NCT02843230|Bevacizumab|bevacizumab|mesh-list
83859495|NCT02843230|Temozolomide|temozolomide|mesh-list
83859496|NCT02843230|Lomustine|lomustine|mesh-list
83859497|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83859498|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859499|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83859500|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83859501|NCT02843230|Growth Substances|growth substances|mesh-ancestor
83859502|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859503|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
83859504|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83859505|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
83859506|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859507|NCT02712814|Estrogens|estrogens|mesh-list
83859508|NCT02712814|Hormones|hormones|mesh-ancestor
83859509|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859510|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859511|NCT00150527|Dexamethasone|dexamethasone|mesh-list
83859512|NCT00150527|Citalopram|citalopram|mesh-list
83859513|NCT00150527|Escitalopram|escitalopram|mesh-list
83859514|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83859515|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
83859516|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
83859517|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859518|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859519|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859520|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
83859521|NCT00150527|Hormones|hormones|mesh-ancestor
83859522|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859523|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83859524|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859525|NCT00150527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83859526|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83859527|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859528|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859529|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859530|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
83859531|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83859532|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
83859533|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859535|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859536|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83859537|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83859538|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859539|NCT02911597|Naltrexone|naltrexone|mesh-list
83859540|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83859541|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83859542|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859543|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
83859544|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859545|NCT02911480|Oxytocin|oxytocin|mesh-list
83859546|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
83859547|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83859548|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859549|NCT00171366|Amlodipine|amlodipine|mesh-list
83859550|NCT00171366|Benazepril|benazepril|mesh-list
83859551|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859552|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83859553|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859554|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859555|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83859556|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859557|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
83859558|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83859559|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
83859560|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859561|NCT00150605|Carbamazepine|carbamazepine|mesh-list
83859562|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
83859563|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
83859564|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83859565|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859566|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859567|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859568|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83859569|NCT00150605|Analgesics|analgesics|mesh-ancestor
83859570|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
83859571|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859572|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83859573|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859574|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859575|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83859576|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83859577|NCT02910778|Ticagrelor|ticagrelor|mesh-list
83859578|NCT02910778|Atorvastatin|atorvastatin|mesh-list
83859579|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83859580|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83859581|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
83859582|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859583|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83859584|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83859585|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859586|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83859587|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83859588|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83859589|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83859590|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
83859591|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859592|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859593|NCT00164112|Azithromycin|azithromycin|mesh-list
83859594|NCT00164112|Levofloxacin|levofloxacin|mesh-list
83859595|NCT00164112|Telithromycin|telithromycin|mesh-list
83859596|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859597|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859598|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83098506|NCT03177434|Lactulose|lactulose|mesh-list
83859600|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83859601|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859602|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859603|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859604|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83859605|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83859606|NCT02910817|Metformin|metformin|mesh-list
83859607|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83859608|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859609|NCT00150722|Atorvastatin|atorvastatin|mesh-list
83859610|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83859611|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83859612|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
83859613|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859614|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83859615|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83859616|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859617|NCT00150761|Levocetirizine|levocetirizine|mesh-list
83859618|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83859619|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83859620|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
83859621|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
83859622|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859623|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859624|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859625|NCT00171483|Tegaserod|tegaserod|mesh-list
83859626|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83859627|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
83859628|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859629|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859630|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859631|NCT03777904|Iron|iron|mesh-list
83859632|NCT03777904|Trace Elements|trace elements|mesh-ancestor
83859633|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
83859634|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859635|NCT00150839|Mirtazapine|mirtazapine|mesh-list
83859636|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83859637|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83859638|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83859639|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859640|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859641|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859642|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859643|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83859644|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
83859645|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859646|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83859647|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
83859648|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
83859649|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83859650|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83859651|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859652|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83859653|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83859654|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83859655|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
83859656|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83859657|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83859658|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
83859659|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83859660|NCT03782740|Melatonin|melatonin|mesh-list
83859661|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
83859662|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859663|NCT03782740|Protective Agents|protective agents|mesh-ancestor
83859664|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859665|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859666|NCT03669367|Abatacept|abatacept|mesh-list
83859667|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83859668|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098632|NCT03172052|Mesna|mesna|mesh-list
83859669|NCT03669367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83859670|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859671|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83859672|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
83859673|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859674|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83859675|NCT00532168|Ritonavir|ritonavir|mesh-list
83859676|NCT00532168|Lopinavir|lopinavir|mesh-list
83859677|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83859678|NCT00532168|Tenofovir|tenofovir|mesh-list
83859679|NCT00532168|Emtricitabine|emtricitabine|mesh-list
83859680|NCT00532168|Efavirenz|efavirenz|mesh-list
83859681|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83859682|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83859683|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
83859684|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859685|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859686|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83859687|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83859688|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
83859689|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859690|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83859691|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83859692|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83859693|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83859694|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83859695|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83859696|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83859697|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83859698|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83859699|NCT00532207|Teriparatide|teriparatide|mesh-list
83859700|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83859701|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859702|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83859703|NCT04723836|Riboflavin|riboflavin|mesh-list
83859704|NCT04723836|Vitamins|vitamins|mesh-ancestor
83859705|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
83859706|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859707|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
83859708|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83859709|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
83859710|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83859711|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
83859712|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
83859713|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859714|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859715|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83859716|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83859717|NCT00150995|Growth Substances|growth substances|mesh-ancestor
83859718|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859719|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
83859720|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859721|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83859722|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83859723|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
83859724|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859725|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859726|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83859727|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83859728|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83859729|NCT00532285|Paclitaxel|paclitaxel|mesh-list
83859730|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83859731|NCT00532285|Gemcitabine|gemcitabine|mesh-list
83859732|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83859733|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859734|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859735|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859736|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859737|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859738|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83859739|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
83859740|NCT00151034|Paclitaxel|paclitaxel|mesh-list
83859741|NCT00151034|Carboplatin|carboplatin|mesh-list
83859742|NCT00151034|Gemcitabine|gemcitabine|mesh-list
83859743|NCT00151034|Trastuzumab|trastuzumab|mesh-list
83859744|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83859745|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859746|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859747|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859748|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859749|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859750|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83859752|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83859753|NCT02817451|Vaccines|vaccines|mesh-list
83859754|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
83859755|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859756|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83859757|NCT00171522|Tegaserod|tegaserod|mesh-list
83859758|NCT00171522|Laxatives|laxatives|mesh-ancestor
83859759|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859760|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83859761|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
83859762|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859763|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859764|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859765|NCT02716012|Sorafenib|sorafenib|mesh-list
83859766|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859767|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859768|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859769|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859770|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
83859771|NCT00151073|Docetaxel|docetaxel|mesh-list
83859772|NCT00151073|Estramustine|estramustine|mesh-list
83859773|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859774|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859775|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859776|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859777|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859778|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83859779|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859780|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83859781|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
83859782|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83859783|NCT00171561|Valsartan|valsartan|mesh-list
83859784|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83859785|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859786|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83859787|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83859788|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859789|NCT00171561|Diuretics|diuretics|mesh-ancestor
83859790|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
83859791|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859792|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83859793|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859794|NCT00151112|Anesthetics|anesthetics|mesh-list
83859795|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859796|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859797|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
83859798|NCT00532324|Mupirocin|mupirocin|mesh-list
83859799|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83859800|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859801|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
83859802|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859803|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83859804|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859805|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859806|NCT00171600|Valsartan|valsartan|mesh-list
83859807|NCT00171600|Lisinopril|lisinopril|mesh-list
83859808|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859809|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83859810|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83859811|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859812|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83859813|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
83859814|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859815|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83859816|NCT00171600|Protective Agents|protective agents|mesh-ancestor
83859817|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859818|NCT05467384|Amlodipine|amlodipine|mesh-list
83859819|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859820|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83859821|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859822|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859823|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83859824|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859825|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
83859826|NCT05467189|Paclitaxel|paclitaxel|mesh-list
83859827|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83859828|NCT05467189|Busulfan|busulfan|mesh-list
83859829|NCT05467189|Lapatinib|lapatinib|mesh-list
83859830|NCT05467189|Afatinib|afatinib|mesh-list
83859831|NCT05467189|Crizotinib|crizotinib|mesh-list
83859832|NCT05467189|Ceritinib|ceritinib|mesh-list
83859833|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
83859834|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83859835|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859836|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859837|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859838|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859839|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
83859840|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83859841|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
83859842|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859843|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83859844|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83859845|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83859846|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859847|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
83859848|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83859849|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859850|NCT05466604|Dexamethasone|dexamethasone|mesh-list
83859851|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83859852|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
83859853|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
83859854|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859855|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859856|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83859857|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
83859858|NCT05466604|Hormones|hormones|mesh-ancestor
83859859|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83859860|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83859861|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859862|NCT04723875|Paclitaxel|paclitaxel|mesh-list
83859863|NCT04723875|Docetaxel|docetaxel|mesh-list
83859864|NCT04723875|Carboplatin|carboplatin|mesh-list
83859865|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83859866|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859867|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859868|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859869|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859870|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859871|NCT05466019|Leucovorin|leucovorin|mesh-list
83859872|NCT05466019|Docetaxel|docetaxel|mesh-list
83859873|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
83859874|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859875|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
83859876|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
83859877|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
83859878|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859879|NCT05466019|Antidotes|antidotes|mesh-ancestor
83859880|NCT05466019|Protective Agents|protective agents|mesh-ancestor
83859881|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859882|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
83859883|NCT05466019|Vitamins|vitamins|mesh-ancestor
83859884|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
83859885|NCT05465902|Vaccines|vaccines|mesh-list
83859886|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
83859887|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859888|NCT00151346|Fentanyl|fentanyl|mesh-list
83859889|NCT00151346|Bupivacaine|bupivacaine|mesh-list
83859890|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
83859891|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
83859892|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83859893|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859894|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
83859895|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859896|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83859898|NCT00151346|Analgesics|analgesics|mesh-ancestor
83859899|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83859900|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83859901|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
83859902|NCT00164424|Acyclovir|acyclovir|mesh-list
83859903|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
83859904|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859905|NCT00532519|Citalopram|citalopram|mesh-list
83859906|NCT00532519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83859907|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83859908|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83859909|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859910|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859911|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
83859912|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859913|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83859914|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
83859915|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83859916|NCT00171678|Diclofenac|diclofenac|mesh-list
83859917|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83859918|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83859919|NCT00171678|Analgesics|analgesics|mesh-ancestor
83859920|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
83859921|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859922|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859923|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83859924|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83859925|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83859926|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859927|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859928|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
83859929|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859930|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
83859931|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83859932|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83859933|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859934|NCT00151463|Urological Agents|urological agents|mesh-ancestor
83859935|NCT00171717|Cyclosporine|cyclosporine|mesh-list
83859936|NCT00171717|Cyclosporins|cyclosporins|mesh-list
83859937|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859938|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859939|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83859940|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
83859941|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859942|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
83859943|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859944|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83859945|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83859946|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83859947|NCT00151502|Atorvastatin|atorvastatin|mesh-list
83859948|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83859949|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83859950|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
83859951|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859952|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83859953|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83859954|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859955|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
83859956|NCT00164463|Isoniazid|isoniazid|mesh-list
83859957|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83859958|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83859959|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83859960|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83859961|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859962|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859963|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83859964|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
83859965|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83859966|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83859967|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
83098878|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
83859968|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83859969|NCT00171756|Atenolol|atenolol|mesh-list
83859970|NCT00171756|Valsartan|valsartan|mesh-list
83859971|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83859972|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83859973|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83859974|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859975|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83859976|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
83859977|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
83859978|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83859979|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859980|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83859981|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83859982|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83859983|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
83859984|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859985|NCT00171795|Rivastigmine|rivastigmine|mesh-list
83859986|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83859987|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83859988|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83859989|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
83859990|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83859991|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83859992|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83859993|NCT00171795|Protective Agents|protective agents|mesh-ancestor
83859994|NCT00151541|Dapsone|dapsone|mesh-list
83859995|NCT00151541|Adapalene|adapalene|mesh-list
83859996|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83859997|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
83859998|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83859999|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860000|NCT00151541|Analgesics|analgesics|mesh-ancestor
83860001|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
83860002|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860003|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860004|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860005|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860006|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860007|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
83860008|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83860009|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83860010|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83860011|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860012|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860013|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
83860014|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83860015|NCT00151580|Ribavirin|ribavirin|mesh-list
83860016|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
83860017|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860018|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
83860019|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860020|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
83860021|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860022|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83860023|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860024|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860025|NCT00151619|Amlodipine|amlodipine|mesh-list
83860026|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860027|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83860028|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860029|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860030|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83860031|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860032|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
83860033|NCT00532675|Lenalidomide|lenalidomide|mesh-list
83860034|NCT00532675|Panobinostat|panobinostat|mesh-list
83860035|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
83860036|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860037|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83860038|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83860039|NCT00532675|Growth Substances|growth substances|mesh-ancestor
83860040|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
83860041|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098955|NCT03116282|Ethanol|ethanol|mesh-list
83860042|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83860043|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860044|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860046|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
83860047|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860048|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860049|NCT05308030|Analgesics|analgesics|mesh-ancestor
83860050|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
83860051|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860052|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860053|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860054|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860055|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83860056|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83860057|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860058|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83860059|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83860060|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860061|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
83860062|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83860063|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
83860064|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83860065|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
83860066|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
83860067|NCT05293600|Acetazolamide|acetazolamide|mesh-list
83860068|NCT05293600|Eszopiclone|eszopiclone|mesh-list
83860069|NCT05293600|Trazodone|trazodone|mesh-list
83860070|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83860071|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83860072|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83860073|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860074|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860075|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860076|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860077|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860078|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
83860079|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83860080|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860081|NCT05293600|Diuretics|diuretics|mesh-ancestor
83860082|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
83860083|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83860084|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83860085|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83860086|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83860087|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83860088|NCT05293600|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83860089|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
83860090|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83860091|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
83860092|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
83860093|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83860094|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83860095|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860096|NCT00532714|Capecitabine|capecitabine|mesh-list
83860097|NCT00532714|Irinotecan|irinotecan|mesh-list
83860098|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83860099|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
83860100|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860101|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860102|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83860103|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83860104|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860105|NCT00151736|Etodolac|etodolac|mesh-list
83860106|NCT00151736|Chlorambucil|chlorambucil|mesh-list
83860107|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83860108|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
83860109|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860110|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860111|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860112|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860113|NCT00151736|Analgesics|analgesics|mesh-ancestor
83860114|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
83099035|NCT03115736|Tenofovir|tenofovir|mesh-list
83860115|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860116|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860117|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860118|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860119|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83860120|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83860121|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860122|NCT00171990|Famciclovir|famciclovir|mesh-list
83860123|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
83860124|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860125|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83860126|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860127|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860128|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
83860129|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83860130|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860131|NCT00406094|Montelukast|montelukast|mesh-list
83860132|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83860133|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
83860134|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83860135|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
83860136|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860137|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860138|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83860139|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83860140|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860141|NCT00164736|Ritonavir|ritonavir|mesh-list
83860142|NCT00164736|Lopinavir|lopinavir|mesh-list
83860143|NCT00164736|Lamivudine|lamivudine|mesh-list
83860144|NCT00164736|Zidovudine|zidovudine|mesh-list
83860145|NCT00164736|Nevirapine|nevirapine|mesh-list
83860146|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83860147|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83860148|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
83860149|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860150|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860151|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83860152|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83860153|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
83860154|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860155|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83860156|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83860157|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83860158|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83860159|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
83860160|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83860161|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83860162|NCT05177146|Ketamine|ketamine|mesh-list
83860163|NCT05177146|Analgesics|analgesics|mesh-ancestor
83860164|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
83860165|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860166|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860167|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83860168|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83860169|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
83860170|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
83860171|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83860172|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83860173|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83860174|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860175|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860176|NCT00532909|Bevacizumab|bevacizumab|mesh-list
83860177|NCT00532909|Capecitabine|capecitabine|mesh-list
83860178|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
83860179|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83860180|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860181|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83860182|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83860183|NCT00532909|Growth Substances|growth substances|mesh-ancestor
83860184|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860185|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
83860186|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83860187|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
83099105|NCT02404064|Cefotaxime|cefotaxime|mesh-list
83860188|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860189|NCT00172068|Vitamin D|vitamin d|mesh-list
83860190|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
83860191|NCT00172068|Calcium|calcium|mesh-list
83860192|NCT00172068|Vitamins|vitamins|mesh-ancestor
83860193|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
83860194|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860195|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83860196|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83860197|NCT00151970|Methylphenidate|methylphenidate|mesh-list
83860198|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83860199|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860200|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83860201|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83860202|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860203|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860204|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
83860205|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860206|NCT00152048|Eflornithine|eflornithine|mesh-list
83860207|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860208|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83860209|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83860210|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83860211|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860212|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83860213|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860214|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860215|NCT05060068|Ketamine|ketamine|mesh-list
83860216|NCT05060068|Esketamine|esketamine|mesh-list
83860217|NCT05060068|Analgesics|analgesics|mesh-ancestor
83860218|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
83860219|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860220|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860221|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83860222|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83860223|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
83860224|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
83860225|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83860226|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83860227|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83860228|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860229|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860230|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
83860231|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83860232|NCT04687111|Valsartan|valsartan|mesh-list
83860233|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83860234|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860235|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83860236|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83860237|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860238|NCT00164775|Imipramine|imipramine|mesh-list
83403676|NCT04844905|Piperaquine|piperaquine|mesh-list
83860239|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83860240|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
83860241|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83860242|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83860243|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83860244|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860245|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860246|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860247|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860248|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860249|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83860250|NCT00533026|Warfarin|warfarin|mesh-list
83860251|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
83860252|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83860253|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83860254|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860255|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860256|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860257|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860258|NCT00533026|Analgesics|analgesics|mesh-ancestor
83099180|NCT03170726|Ibuprofen|ibuprofen|mesh-list
83860260|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860261|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
83860262|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83860263|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
83860264|NCT00152126|Melphalan|melphalan|mesh-list
83860265|NCT00152126|Busulfan|busulfan|mesh-list
83860266|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83860267|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
83860268|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860269|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860270|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83860271|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83860272|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
83860273|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860274|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
83860275|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83860276|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860277|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
83860278|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
83860279|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83860280|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
83860281|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83860282|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860283|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
83860284|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
83860285|NCT00425451|Analgesics|analgesics|mesh-ancestor
83860286|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
83860287|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860288|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860289|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860290|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860291|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860292|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860293|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83860294|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860295|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860296|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
83860297|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
83860298|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83860299|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
83860300|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83860301|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83860302|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860303|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83860304|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860305|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860306|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83860307|NCT00533065|Donepezil|donepezil|mesh-list
83860308|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83860309|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860310|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860311|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
83860312|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860313|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860314|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
83860315|NCT00152243|Tegafur|tegafur|mesh-list
83860316|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83860317|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
83860318|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860319|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860320|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
83860321|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83860322|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860323|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83860324|NCT00152282|Estrogens|estrogens|mesh-ancestor
83860325|NCT00152282|Hormones|hormones|mesh-ancestor
83860326|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860327|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860328|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
83860329|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83860330|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83860331|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83099262|NCT00801489|Cytarabine|cytarabine|mesh-list
83860332|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860333|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860334|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
83860335|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860336|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860337|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83860338|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860339|NCT04914247|Selexipag|selexipag|mesh-list
83860340|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860341|NCT00152360|Orlistat|orlistat|mesh-list
83860342|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860343|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860344|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83860345|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83860346|NCT00164892|Rofecoxib|rofecoxib|mesh-list
83860347|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83860348|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83860349|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860350|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860351|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860352|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860353|NCT00164892|Analgesics|analgesics|mesh-ancestor
83860354|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
83860355|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860356|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860357|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860358|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860359|NCT00152399|Somatostatin|somatostatin|mesh-list
83860360|NCT00152399|Hormones|hormones|mesh-ancestor
83860361|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860362|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860363|NCT00164931|Omeprazole|omeprazole|mesh-list
83860364|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83860365|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83860366|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83860367|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860368|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860369|NCT00152438|Progesterone|progesterone|mesh-list
83860370|NCT00152438|Progestins|progestins|mesh-ancestor
83860371|NCT00152438|Hormones|hormones|mesh-ancestor
83860372|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860373|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860374|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
83860375|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
83860376|NCT00164970|Vitamins|vitamins|mesh-ancestor
83860377|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
83860378|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860379|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
83860380|NCT00164970|Hematinics|hematinics|mesh-ancestor
83860381|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
83860382|NCT02937844|Fludarabine|fludarabine|mesh-list
83860383|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83860384|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
83860385|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860386|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860387|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83860388|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
83860389|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860390|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860391|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83860392|NCT02937415|Antioxidants|antioxidants|mesh-list
83860393|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
83860394|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860395|NCT02937415|Protective Agents|protective agents|mesh-ancestor
83860396|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860397|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
83860398|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
83860399|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860400|NCT00152594|Voriconazole|voriconazole|mesh-list
83860401|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
83860402|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860403|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83860404|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83860405|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099331|NCT02295189|Analgesics|analgesics|mesh-ancestor
83860406|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860407|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83860408|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
83860409|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860410|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860411|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83860412|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83860413|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
83860414|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83860415|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83860416|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83860417|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83860418|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860419|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
83860420|NCT04725422|Pamidronate|pamidronate|mesh-list
83860421|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
83860422|NCT04725422|Adalimumab|adalimumab|mesh-list
83860423|NCT04725422|Infliximab|infliximab|mesh-list
83860424|NCT04725422|Golimumab|golimumab|mesh-list
83860425|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
83860426|NCT04725422|Etanercept|etanercept|mesh-list
83860427|NCT04725422|Methotrexate|methotrexate|mesh-list
83860428|NCT04725422|Leflunomide|leflunomide|mesh-list
83860429|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83860430|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
83860431|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83860432|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860433|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83860434|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
83860435|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860436|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860437|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
83860438|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860439|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83860440|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83860441|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
83860442|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860443|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83860444|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83860445|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860446|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83860447|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860448|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860449|NCT04725422|Analgesics|analgesics|mesh-ancestor
83860450|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
83860451|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860452|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83860453|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860454|NCT00152633|Losartan|losartan|mesh-list
83860455|NCT00152633|Metoprolol|metoprolol|mesh-list
83860456|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83860457|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860458|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83860459|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83860460|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860461|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
83860462|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
83860463|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860464|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860465|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83860466|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83860467|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83860468|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860469|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860470|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83860471|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83860472|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860473|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83860474|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83860475|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860476|NCT00425490|Incretins|incretins|mesh-ancestor
83860477|NCT00425490|Hormones|hormones|mesh-ancestor
83860478|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860479|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83860480|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
83860481|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860482|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860483|NCT03457753|Riluzole|riluzole|mesh-list
83860484|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
83860485|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83860486|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83860487|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860488|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860489|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860490|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83860491|NCT03457753|Protective Agents|protective agents|mesh-ancestor
83860492|NCT02936830|Listerine|listerine|mesh-list
83860493|NCT02936830|Fluorides|fluorides|mesh-list
83860494|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
83860495|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
83860496|NCT02936830|Glycerol|glycerol|mesh-list
83860497|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
83860498|NCT02936830|Protective Agents|protective agents|mesh-ancestor
83860499|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860500|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83860501|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860502|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83860503|NCT00165048|Rofecoxib|rofecoxib|mesh-list
83860504|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83860505|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83860506|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860507|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860508|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860509|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860510|NCT00165048|Analgesics|analgesics|mesh-ancestor
83860511|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
83860512|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860513|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860514|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860515|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860516|NCT04690270|Sumatriptan|sumatriptan|mesh-list
83860517|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83860518|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83860519|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83860520|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
83860521|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860522|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860523|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860524|NCT00165087|Doxorubicin|doxorubicin|mesh-list
83860525|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
83860526|NCT00165087|Asparaginase|asparaginase|mesh-list
83860527|NCT00165087|Razoxane|razoxane|mesh-list
83860528|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83860529|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860530|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83860531|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83860532|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860533|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860534|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83860535|NCT00165087|Protective Agents|protective agents|mesh-ancestor
83860536|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860537|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83860538|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83860539|NCT00152750|Clonidine|clonidine|mesh-list
83860540|NCT00152750|Analgesics|analgesics|mesh-ancestor
83860541|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
83860542|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860543|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860544|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860545|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
83860546|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
83860547|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83860548|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83860549|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83860550|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860551|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860552|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860553|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
83099472|NCT02296047|Bromides|bromides|mesh-list
83860554|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83860555|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83860556|NCT00152828|Celecoxib|celecoxib|mesh-list
83860557|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860558|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860559|NCT00152828|Analgesics|analgesics|mesh-ancestor
83860560|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
83860561|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860562|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860563|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860564|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860565|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83860566|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83860567|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860568|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860569|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
83860570|NCT02935933|Morphine|morphine|mesh-list
83860571|NCT02935933|Bupivacaine|bupivacaine|mesh-list
83860572|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
83860573|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
83860574|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83860575|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860576|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
83860577|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860578|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83860579|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860580|NCT02935933|Analgesics|analgesics|mesh-ancestor
83860581|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83860582|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83860583|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83860584|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860585|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860586|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860587|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83860588|NCT02935933|Narcotics|narcotics|mesh-ancestor
83860589|NCT00152867|Dexamethasone|dexamethasone|mesh-list
83860590|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860591|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
83860592|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
83860593|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860594|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860595|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83860596|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
83860597|NCT00152867|Hormones|hormones|mesh-ancestor
83860598|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860599|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83860600|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860601|NCT02935972|Lidocaine|lidocaine|mesh-list
83860602|NCT02935972|Diazepam|diazepam|mesh-list
83860603|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
83860604|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
83860605|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83860606|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860607|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
83860608|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860609|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83860610|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83860611|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83860612|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860613|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860614|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83860615|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
83860616|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
83860617|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
83860618|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83860619|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83860620|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83860621|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83860622|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83860623|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83860624|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83860625|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83860626|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
83860627|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
83860628|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
83860629|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860630|NCT02935855|Warfarin|warfarin|mesh-list
83860631|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
83860632|NCT02935855|Dabigatran|dabigatran|mesh-list
83860633|NCT02935855|Apixaban|apixaban|mesh-list
83860634|NCT02935855|Edoxaban|edoxaban|mesh-list
83860635|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
83860636|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83860637|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
83860638|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83860639|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83860640|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860641|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860642|NCT02935582|Betamethasone|betamethasone|mesh-list
83860643|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
83860644|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83860645|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
83860646|NCT02935582|Calcipotriene|calcipotriene|mesh-list
83860647|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83860648|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860649|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
83860650|NCT02935582|Hormones|hormones|mesh-ancestor
83860651|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860652|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860653|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83860654|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
83860655|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83860656|NCT00406172|Bevacizumab|bevacizumab|mesh-list
83860657|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83860658|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860659|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83860660|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83860661|NCT00406172|Growth Substances|growth substances|mesh-ancestor
83860662|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860663|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
83860664|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83860665|NCT00152945|Glycerol|glycerol|mesh-list
83860666|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83860667|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83860668|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83860669|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83860670|NCT00152945|Protective Agents|protective agents|mesh-ancestor
83860671|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860672|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83860673|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
83860674|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83860675|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860676|NCT02935231|Nicotine|nicotine|mesh-list
83860677|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83860678|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
83860679|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860680|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860681|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83860682|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83860683|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
83860684|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860685|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860686|NCT00172380|Docetaxel|docetaxel|mesh-list
83860687|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860688|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
83860689|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
83860690|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
83860691|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860692|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
83860693|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83860694|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
83860695|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860696|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860697|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83860698|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
83860699|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
83860700|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83860701|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
83860702|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860703|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860704|NCT02935075|Tenofovir|tenofovir|mesh-list
83860705|NCT02935075|Lamivudine|lamivudine|mesh-list
83860706|NCT02935075|Efavirenz|efavirenz|mesh-list
83860707|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
83860708|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860709|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83860710|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83860711|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860712|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860714|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83860715|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83860716|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83860717|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83860718|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83860719|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83860720|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83860721|NCT02934919|Nalmefene|nalmefene|mesh-list
83860722|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83860723|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860724|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
83860725|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860726|NCT00172419|Atorvastatin|atorvastatin|mesh-list
83860727|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83860728|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83860729|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
83860730|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860731|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83860732|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83860733|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860734|NCT00153023|Valsartan|valsartan|mesh-list
83860735|NCT00153023|Telmisartan|telmisartan|mesh-list
83860736|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860737|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83860738|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83860739|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860740|NCT00165204|Tibolone|tibolone|mesh-list
83860741|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
83860742|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
83860743|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860744|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860745|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860746|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83860747|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860748|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83860749|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
83860750|NCT00165204|Hormones|hormones|mesh-ancestor
83860751|NCT02934763|Propranolol|propranolol|mesh-list
83860752|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83860753|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83860754|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860755|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860756|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860757|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860758|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83860759|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860760|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
83860761|NCT04689958|Vitamin D|vitamin d|mesh-list
83860762|NCT04689958|Vitamins|vitamins|mesh-ancestor
83860763|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
83860764|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860765|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83860766|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83860767|NCT00153140|Laxatives|laxatives|mesh-ancestor
83860768|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83860769|NCT04684420|Metformin|metformin|mesh-list
83860770|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83860771|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860772|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83860773|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83860774|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
83860775|NCT00153296|Carbamazepine|carbamazepine|mesh-list
83860776|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
83860777|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
83860778|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83860779|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099739|NCT02303769|Tamsulosin|tamsulosin|mesh-list
83860780|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860781|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83860782|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860783|NCT00153296|Analgesics|analgesics|mesh-ancestor
83860784|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
83860785|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860786|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83860787|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860788|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860789|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83860790|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83860791|NCT02934295|Antibodies|antibodies|mesh-list
83860792|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
83860793|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860794|NCT02934022|Maraviroc|maraviroc|mesh-list
83860795|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83860796|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83860797|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860798|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83860799|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83860800|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
83860801|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860802|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83860803|NCT02934061|Tizanidine|tizanidine|mesh-list
83860804|NCT02934061|Analgesics|analgesics|mesh-ancestor
83860805|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
83860806|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860807|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860808|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
83860809|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83860810|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83860811|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
83860812|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
83860813|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83860814|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83860815|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83860816|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860817|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860818|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860819|NCT02934217|Cyclosporine|cyclosporine|mesh-list
83860820|NCT02934217|Cyclosporins|cyclosporins|mesh-list
83860821|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860822|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860823|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83860824|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
83860825|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860826|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
83860827|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860828|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
83403827|NCT04932564|Leflunomide|leflunomide|mesh-list
83860829|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860830|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83860831|NCT00165360|Temozolomide|temozolomide|mesh-list
83860832|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83860833|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
83860834|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860835|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860836|NCT02933905|Ranibizumab|ranibizumab|mesh-list
83860837|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83860838|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83860839|NCT02933905|Growth Substances|growth substances|mesh-ancestor
83860840|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860841|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
83860842|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860843|NCT02933788|Aspirin|aspirin|mesh-list
83860844|NCT02933788|Cilostazol|cilostazol|mesh-list
83860845|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860846|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860847|NCT02933788|Analgesics|analgesics|mesh-ancestor
83860848|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
83860849|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860850|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860851|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860852|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860853|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83860854|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83860855|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860856|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83860857|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83860858|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860859|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
83860860|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83860861|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
83860862|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83860863|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
83860864|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
83860865|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83860866|NCT02933788|Protective Agents|protective agents|mesh-ancestor
83860867|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83860868|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83860869|NCT00165399|Docetaxel|docetaxel|mesh-list
83860870|NCT00165399|Goserelin|goserelin|mesh-list
83860871|NCT00165399|Bicalutamide|bicalutamide|mesh-list
83860872|NCT00165399|Estramustine|estramustine|mesh-list
83860873|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860874|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
83860875|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
83860876|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83860877|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860878|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83860879|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
83860880|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
83860881|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860882|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860883|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83860884|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
83860885|NCT02933593|Labetalol|labetalol|mesh-list
83860886|NCT02933593|Hydralazine|hydralazine|mesh-list
83860887|NCT02933593|Nifedipine|nifedipine|mesh-list
83860888|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83860889|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860890|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860891|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83860892|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860893|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
83860894|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
83860895|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83860896|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83860897|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83860898|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
83860899|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860900|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860901|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
83860902|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
83860903|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860904|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83860905|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83860906|NCT00153491|Lumefantrine|lumefantrine|mesh-list
83860907|NCT00153491|Artemether|artemether|mesh-list
83860908|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83860909|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
83860910|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83860911|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83860912|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860913|NCT02933437|Ajmaline|ajmaline|mesh-list
83860914|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83860915|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83860916|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83860917|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83860918|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860919|NCT00153530|Methotrexate|methotrexate|mesh-list
83860920|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83860921|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
83860922|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83860923|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860924|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83860925|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
83860926|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860927|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099851|NCT03169790|Avelumab|avelumab|mesh-list
83860928|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
83860929|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860930|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83860931|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83860932|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
83860933|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860934|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83860935|NCT00165477|Lenalidomide|lenalidomide|mesh-list
83860936|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
83860937|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860938|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83860939|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83860940|NCT00165477|Growth Substances|growth substances|mesh-ancestor
83860941|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
83860942|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83860943|NCT02932930|Ropivacaine|ropivacaine|mesh-list
83860944|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
83860945|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
83860946|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83860947|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860948|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
83860949|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860950|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
83860951|NCT00165516|Antidotes|antidotes|mesh-ancestor
83860952|NCT00165516|Protective Agents|protective agents|mesh-ancestor
83860953|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860954|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
83860955|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860956|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
83860957|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83860958|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83860959|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
83860960|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
83860961|NCT04642378|Insulin|insulin|mesh-list
83860962|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83860963|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83860964|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860965|NCT00407784|Eplerenone|eplerenone|mesh-list
83860966|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83860967|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
83860968|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83860969|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860970|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83860971|NCT00407784|Diuretics|diuretics|mesh-ancestor
83860972|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
83860973|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83860974|NCT02932774|Cetirizine|cetirizine|mesh-list
83860975|NCT02932774|Loratadine|loratadine|mesh-list
83860976|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83860977|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83860978|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83860979|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
83860980|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
83860981|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83860982|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860983|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860984|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
83860985|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
83860986|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83860987|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83860988|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83860989|NCT00153725|Aspirin|aspirin|mesh-list
83860990|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83860991|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83860992|NCT00153725|Analgesics|analgesics|mesh-ancestor
83860993|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
83860994|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83860995|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83860996|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83860997|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83860998|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83860999|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83099931|NCT04481282|Terbutaline|terbutaline|mesh-list
83861000|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861001|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83861002|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83861003|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861004|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
83861005|NCT00153764|Vitamins|vitamins|mesh-list
83861006|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
83861007|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861008|NCT00180102|Cytarabine|cytarabine|mesh-list
83861009|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
83861010|NCT00180102|Amsacrine|amsacrine|mesh-list
83861011|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83861012|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
83861013|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861014|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861015|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
83861016|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861017|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861018|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
83861019|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861020|NCT00180102|Analgesics|analgesics|mesh-ancestor
83861021|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
83861022|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861023|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83861024|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83861025|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861026|NCT04690309|Insulin|insulin|mesh-list
83861027|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83861028|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861029|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861030|NCT00153881|Carboplatin|carboplatin|mesh-list
83861031|NCT00153881|Docetaxel|docetaxel|mesh-list
83861032|NCT00153881|Capecitabine|capecitabine|mesh-list
83861033|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861034|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83861035|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83861036|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83861037|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861038|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83861039|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
83861040|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
83861041|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861042|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861043|NCT00180141|Analgesics|analgesics|mesh-ancestor
83861044|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
83861045|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861046|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861047|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861048|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861049|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
83861050|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861051|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
83861052|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83861053|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861054|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861055|NCT02931877|Propofol|propofol|mesh-list
83861056|NCT02931877|Sevoflurane|sevoflurane|mesh-list
83861057|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83861058|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861059|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861060|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83861061|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
83861062|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
83861063|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83861064|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83861065|NCT00153998|Leucovorin|leucovorin|mesh-list
83861066|NCT00153998|Folic Acid|folic acid|mesh-list
83861067|NCT00153998|Fluorouracil|fluorouracil|mesh-list
83861068|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
83861069|NCT00153998|Irinotecan|irinotecan|mesh-list
83861070|NCT00153998|Cetuximab|cetuximab|mesh-list
83861071|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
83861072|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
83861073|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861074|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83861075|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861076|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861077|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
83100007|NCT03505047|Copper|copper|mesh-list
83861078|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861079|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83861080|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83861081|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861082|NCT00153998|Antidotes|antidotes|mesh-ancestor
83861083|NCT00153998|Protective Agents|protective agents|mesh-ancestor
83861084|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
83861085|NCT00153998|Vitamins|vitamins|mesh-ancestor
83861086|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
83861087|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83861088|NCT00153998|Hematinics|hematinics|mesh-ancestor
83861089|NCT02925130|Albuterol|albuterol|mesh-list
83861090|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83861091|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
83861092|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861093|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861094|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83861095|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
83861096|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
83861097|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83861098|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83861099|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83861100|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83861101|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
83861102|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861103|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861104|NCT02924974|Lidocaine|lidocaine|mesh-list
83861105|NCT02924974|Morphine|morphine|mesh-list
83861106|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
83861107|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
83861108|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861109|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861110|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
83861111|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861112|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83861113|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83861114|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83861115|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861116|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861117|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83861118|NCT02924974|Narcotics|narcotics|mesh-ancestor
83861119|NCT02924974|Analgesics|analgesics|mesh-ancestor
83861120|NCT00154037|Pioglitazone|pioglitazone|mesh-list
83861121|NCT00154037|Candesartan|candesartan|mesh-list
83861122|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861123|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861124|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83861125|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83861126|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83861127|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861128|NCT02924857|Paclitaxel|paclitaxel|mesh-list
83861129|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83861130|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861131|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
83861132|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
83861133|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
83861134|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861135|NCT00154076|Topiramate|topiramate|mesh-list
83861136|NCT00154076|Zonisamide|zonisamide|mesh-list
83861137|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
83861138|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861139|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861140|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83861141|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861142|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861143|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83861144|NCT00154115|Simendan|simendan|mesh-list
83861145|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83861146|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
83861147|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83861148|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83861149|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861150|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861151|NCT00154115|Protective Agents|protective agents|mesh-ancestor
83861152|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861153|NCT02924506|Meloxicam|meloxicam|mesh-list
83100089|NCT05454358|Letrozole|letrozole|mesh-list
83861154|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861155|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861156|NCT02924506|Analgesics|analgesics|mesh-ancestor
83861157|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
83861158|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861159|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861160|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861161|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861162|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83861163|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83861164|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861165|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861166|NCT02924311|Aflibercept|aflibercept|mesh-list
83861167|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83861168|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83861169|NCT02924311|Growth Substances|growth substances|mesh-ancestor
83861170|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861171|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
83861172|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861173|NCT02924233|Nivolumab|nivolumab|mesh-list
83861174|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83861175|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861176|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83861177|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861178|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83861179|NCT02923999|Antibodies|antibodies|mesh-list
83861180|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
83861181|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83861182|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
83861183|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861184|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861185|NCT00154193|Cyclosporine|cyclosporine|mesh-list
83861186|NCT00154193|Cyclosporins|cyclosporins|mesh-list
83861187|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861188|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861189|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861190|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
83861191|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861192|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
83861193|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861194|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83861195|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861196|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83861197|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
83861198|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83861199|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861200|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83861201|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
83861202|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83861203|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861204|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861205|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861206|NCT00154271|Valsartan|valsartan|mesh-list
83861207|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83861208|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83861209|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83861210|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861211|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
83861212|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861213|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83861214|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861215|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861216|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
83861217|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83861218|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861219|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83861220|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
83861221|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83861222|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861223|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861224|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861225|NCT02923687|Ketorolac|ketorolac|mesh-list
83861226|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83861227|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861228|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861229|NCT02923687|Analgesics|analgesics|mesh-ancestor
83861230|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
83861231|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861232|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861233|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861234|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861235|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83861236|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861237|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861238|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
83861239|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861240|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83861241|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861242|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861243|NCT02923258|Docetaxel|docetaxel|mesh-list
83861244|NCT02923258|Cisplatin|cisplatin|mesh-list
83861245|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861246|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
83861247|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
83861248|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
83861249|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861250|NCT02923336|Propranolol|propranolol|mesh-list
83861251|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83861252|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83861253|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
83861254|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861255|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861256|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861257|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83861258|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83861259|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
83861260|NCT02922946|Entinostat|entinostat|mesh-list
83861261|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861262|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83861263|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861264|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861265|NCT02922712|Nimesulide|nimesulide|mesh-list
83861266|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861267|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861268|NCT02922712|Analgesics|analgesics|mesh-ancestor
83861269|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
83861270|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861271|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861272|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861273|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861274|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83861275|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861276|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861277|NCT02922673|Aspirin|aspirin|mesh-list
83861278|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861279|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861280|NCT02922673|Analgesics|analgesics|mesh-ancestor
83861281|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
83861282|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861283|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861284|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861285|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861286|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83861287|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83861288|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861289|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83861290|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83861291|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861292|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
83861293|NCT02922283|Interleukin-2|interleukin-2|mesh-list
83861294|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861295|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861296|NCT02922283|Analgesics|analgesics|mesh-ancestor
83861297|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
83861298|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861299|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100226|NCT02306031|Diclofenac|diclofenac|mesh-list
83861300|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83861301|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83861302|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861303|NCT02922166|SRX246|srx246|mesh-list
83861304|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83861305|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861306|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
83861307|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861308|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
83861309|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
83861310|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
83861311|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83861312|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83861313|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861314|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83861315|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83861316|NCT02921659|Niacinamide|niacinamide|mesh-list
83861317|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
83861318|NCT02921659|Vitamins|vitamins|mesh-ancestor
83861319|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
83861320|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861321|NCT04689100|Leucovorin|leucovorin|mesh-list
83861322|NCT04689100|Fluorouracil|fluorouracil|mesh-list
83861323|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
83861324|NCT04689100|Irinotecan|irinotecan|mesh-list
83861325|NCT04689100|Calcium|calcium|mesh-list
83861326|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
83861327|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83861328|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861329|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
83861330|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861331|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83861332|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861333|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861334|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
83861335|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83861336|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83861337|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861338|NCT04689100|Antidotes|antidotes|mesh-ancestor
83861339|NCT04689100|Protective Agents|protective agents|mesh-ancestor
83861340|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
83861341|NCT04689100|Vitamins|vitamins|mesh-ancestor
83861342|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
83861343|NCT00188136|Fludarabine|fludarabine|mesh-list
83861344|NCT00188136|Melphalan|melphalan|mesh-list
83861345|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861346|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861347|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861348|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
83861349|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861350|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83861351|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
83861352|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83861353|NCT00406250|Bevacizumab|bevacizumab|mesh-list
83861354|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83861355|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861356|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83861357|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83861358|NCT00406250|Growth Substances|growth substances|mesh-ancestor
83861359|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861360|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
83861361|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83861362|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83861363|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861364|NCT02921269|Bevacizumab|bevacizumab|mesh-list
83861365|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83861366|NCT02921269|Atezolizumab|atezolizumab|mesh-list
83861367|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
83861368|NCT02921269|Antibodies|antibodies|mesh-list
83861369|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
83861370|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83861371|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
83861372|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100299|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83861373|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83861374|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83861375|NCT02921269|Growth Substances|growth substances|mesh-ancestor
83861376|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861377|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
83861378|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
83861379|NCT02921269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83861380|NCT02921269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861381|NCT02921191|Lenograstim|lenograstim|mesh-list
83861382|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83861383|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
83861384|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861385|NCT02920801|Metformin|metformin|mesh-list
83861386|NCT02920801|Saxagliptin|saxagliptin|mesh-list
83861387|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861388|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861389|NCT02920801|Incretins|incretins|mesh-ancestor
83861390|NCT02920801|Hormones|hormones|mesh-ancestor
83861391|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83861392|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83861393|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
83861394|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861395|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861396|NCT00180843|Bromides|bromides|mesh-list
83861397|NCT00180843|Albuterol|albuterol|mesh-list
83861398|NCT00180843|Ipratropium|ipratropium|mesh-list
83861399|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
83861400|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83861401|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
83861402|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861403|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861404|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83861405|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83861406|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
83861407|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83861408|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83861409|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83861410|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83861411|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
83861412|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861413|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861414|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83861415|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
83861416|NCT02920567|Octreotide|octreotide|mesh-list
83861417|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83861418|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83861419|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861420|NCT00180882|Rituximab|rituximab|mesh-list
83861421|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83861422|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861423|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
83861424|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861425|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861426|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
83861427|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861428|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83861429|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861430|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861431|NCT02920489|Sufentanil|sufentanil|mesh-list
83861432|NCT02920489|Dsuvia|dsuvia|mesh-list
83861433|NCT02920489|Ropivacaine|ropivacaine|mesh-list
83861434|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
83861435|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
83861436|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861437|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861438|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
83861439|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861440|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83861441|NCT02920489|Narcotics|narcotics|mesh-ancestor
83861442|NCT02920489|Analgesics|analgesics|mesh-ancestor
83861443|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83861444|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83861445|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
83861446|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
83861447|NCT02920372|Hematinics|hematinics|mesh-ancestor
83861448|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
83100377|NCT02316249|Estradiol|estradiol|mesh-list
83861449|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83861450|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861451|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861452|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83861453|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83861454|NCT00154661|Protective Agents|protective agents|mesh-ancestor
83861455|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861456|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
83861457|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83861458|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
83861459|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
83861460|NCT00180960|Irinotecan|irinotecan|mesh-list
83861461|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861462|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83861463|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83861464|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861465|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861466|NCT00154700|Folic Acid|folic acid|mesh-list
83861467|NCT00154700|Paclitaxel|paclitaxel|mesh-list
83861468|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83861469|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861470|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83861471|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83861472|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83861473|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861474|NCT00154700|Hematinics|hematinics|mesh-ancestor
83861475|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
83861476|NCT00154700|Vitamins|vitamins|mesh-ancestor
83861477|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
83861478|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861479|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
83861480|NCT04688983|Blinatumomab|blinatumomab|mesh-list
83861481|NCT04688983|Ponatinib|ponatinib|mesh-list
83861482|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861483|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83861484|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861485|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861486|NCT02920060|Levetiracetam|levetiracetam|mesh-list
83861487|NCT02920060|Valproic Acid|valproic acid|mesh-list
83861488|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
83861489|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
83861490|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861491|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861492|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
83861493|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861494|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861495|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
83861496|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83403977|NCT02594371|Paclitaxel|paclitaxel|mesh-list
83861497|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861498|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861499|NCT00154739|Gemcitabine|gemcitabine|mesh-list
83861500|NCT00154739|Epirubicin|epirubicin|mesh-list
83861501|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861502|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83861503|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
83861504|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861505|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83861506|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83861507|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83861508|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861509|NCT00154778|Leucovorin|leucovorin|mesh-list
83861510|NCT00154778|Antidotes|antidotes|mesh-ancestor
83861511|NCT00154778|Protective Agents|protective agents|mesh-ancestor
83861512|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861513|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
83861514|NCT00154778|Vitamins|vitamins|mesh-ancestor
83861515|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
83861516|NCT02919202|Listerine|listerine|mesh-list
83861517|NCT02919202|Fluorides|fluorides|mesh-list
83861518|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
83861519|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
83861520|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
83861521|NCT02919202|Protective Agents|protective agents|mesh-ancestor
83861522|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861523|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83861524|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861525|NCT00154895|Minocycline|minocycline|mesh-list
83861526|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83861527|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861528|NCT00181116|Levetiracetam|levetiracetam|mesh-list
83861529|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
83861530|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
83861531|NCT02918812|Diclofenac|diclofenac|mesh-list
83861532|NCT02918812|Lidocaine|lidocaine|mesh-list
83861533|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
83861534|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
83861535|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861536|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861537|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
83861538|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861539|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83861540|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83861541|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83861542|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861543|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861544|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861545|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861546|NCT02918812|Analgesics|analgesics|mesh-ancestor
83861547|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861548|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861549|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83861550|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861551|NCT02918110|Misoprostol|misoprostol|mesh-list
83861552|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83861553|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
83861554|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83861555|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861556|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83861557|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83861558|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
83861559|NCT00181272|Azithromycin|azithromycin|mesh-list
83861560|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83861561|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861562|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
83861563|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
83861564|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83861565|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83861566|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861567|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861568|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861569|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861570|NCT02910115|Oxytocin|oxytocin|mesh-list
83861571|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
83861572|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83861573|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861574|NCT00188565|Celecoxib|celecoxib|mesh-list
83861575|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861576|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861577|NCT00188565|Analgesics|analgesics|mesh-ancestor
83861578|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
83861579|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861580|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861581|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861582|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861583|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83861584|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83861585|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861586|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861587|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
83861588|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83861589|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861590|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861591|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83861592|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83861593|NCT00155246|Protective Agents|protective agents|mesh-ancestor
83861594|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861595|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
83861596|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83861597|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
83861598|NCT02909413|Sevoflurane|sevoflurane|mesh-list
83861599|NCT02909413|Desflurane|desflurane|mesh-list
83861600|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83861601|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83861602|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
83861603|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
83861604|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861605|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100532|NCT02545504|Vitamins|vitamins|mesh-ancestor
83861606|NCT02909257|Bupivacaine|bupivacaine|mesh-list
83861607|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
83861608|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
83861609|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861610|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861611|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
83861612|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861613|NCT02908945|Ketamine|ketamine|mesh-list
83861614|NCT02908945|Analgesics|analgesics|mesh-ancestor
83861615|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
83861616|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861617|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861618|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83861619|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83861620|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
83861621|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
83861622|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861623|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83861624|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83861625|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861626|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861627|NCT02939833|Ropivacaine|ropivacaine|mesh-list
83861628|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
83861629|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
83861630|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861631|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861632|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
83861633|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861634|NCT00188604|Selenious Acid|selenious acid|mesh-list
83861635|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
83861636|NCT00188604|Trace Elements|trace elements|mesh-ancestor
83861637|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
83861638|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861639|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83861640|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
83861641|NCT00155402|Coagulants|coagulants|mesh-ancestor
83861642|NCT04808323|Capecitabine|capecitabine|mesh-list
83861643|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
83861644|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83861645|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
83861646|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861647|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861648|NCT00188643|Lamotrigine|lamotrigine|mesh-list
83861649|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83861650|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83861651|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83861652|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861653|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861654|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861655|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861656|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83861657|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
83861658|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861659|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
83861660|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83861661|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83861662|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83861663|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83861664|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861665|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83861666|NCT00533299|Hydralazine|hydralazine|mesh-list
83861667|NCT00533299|Valproic Acid|valproic acid|mesh-list
83861668|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
83861669|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861670|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861671|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
83861672|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861673|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861674|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
83861675|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83861676|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861677|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861678|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83861679|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
83100597|NCT02441439|Iron|iron|mesh-list
83861680|NCT04788823|Prednisone|prednisone|mesh-list
83861681|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861682|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
83861683|NCT04788823|Hormones|hormones|mesh-ancestor
83861684|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83861685|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861686|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83861687|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861688|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
83861689|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83861690|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861691|NCT04696042|Lanreotide|lanreotide|mesh-list
83861692|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861693|NCT00181662|Curcumin|curcumin|mesh-list
83861694|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83861695|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861696|NCT00181662|Analgesics|analgesics|mesh-ancestor
83861697|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
83861698|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861699|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861700|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83861701|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861702|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861703|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861704|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861705|NCT00533416|ON 01910|on 01910|mesh-list
83861706|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861707|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83861708|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861709|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861710|NCT00155558|Leucovorin|leucovorin|mesh-list
83861711|NCT00155558|Fluorouracil|fluorouracil|mesh-list
83861712|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
83861713|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861714|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83861715|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861716|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861717|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
83861718|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861719|NCT00155558|Antidotes|antidotes|mesh-ancestor
83861720|NCT00155558|Protective Agents|protective agents|mesh-ancestor
83861721|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
83861722|NCT00155558|Vitamins|vitamins|mesh-ancestor
83861723|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
83861724|NCT00533455|Gabapentin|gabapentin|mesh-list
83861725|NCT00533455|Analgesics|analgesics|mesh-ancestor
83861726|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
83861727|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861728|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861729|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
83861730|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83861731|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83861732|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861733|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861734|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83861735|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83861736|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861737|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861738|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
83861739|NCT00533533|Docetaxel|docetaxel|mesh-list
83861740|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
83861741|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861742|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
83861743|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
83861744|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
83861745|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861746|NCT00533611|Niacin|niacin|mesh-list
83861747|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861748|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861749|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83861750|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
83861751|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83861752|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
83861753|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
83861754|NCT00533611|Vitamins|vitamins|mesh-ancestor
83100674|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
83861755|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
83861756|NCT04575844|Liraglutide|liraglutide|mesh-list
83861757|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861758|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861759|NCT04575844|Incretins|incretins|mesh-ancestor
83861760|NCT04575844|Hormones|hormones|mesh-ancestor
83861761|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83861762|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
83861763|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
83861764|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
83861765|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83861766|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861767|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861768|NCT00155714|Urological Agents|urological agents|mesh-ancestor
83861769|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83861770|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83861771|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83861772|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861773|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861774|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
83861775|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861776|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861777|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
83861778|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83861779|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
83861780|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83861781|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
83861782|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861783|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861784|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
83861785|NCT00181779|Aripiprazole|aripiprazole|mesh-list
83861786|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
83861787|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861788|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83861789|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83861790|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861791|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861792|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
83861793|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
83861794|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861795|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861796|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83861797|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83861798|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
83861799|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83861800|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83861801|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83861802|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83861803|NCT00533923|Cyclosporine|cyclosporine|mesh-list
83861804|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
83861805|NCT00533923|Fludarabine|fludarabine|mesh-list
83861806|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
83861807|NCT00533923|Cyclosporins|cyclosporins|mesh-list
83861808|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83861809|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
83861810|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861811|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83861812|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83861813|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
83861814|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861815|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861816|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83861817|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861818|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
83861819|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83861820|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
83861821|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83861822|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83861823|NCT00409227|Alfuzosin|alfuzosin|mesh-list
83861824|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83861825|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83861826|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83861827|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
83861828|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861829|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861830|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861831|NCT00409227|Urological Agents|urological agents|mesh-ancestor
83861832|NCT00533962|Anecortave|anecortave|mesh-list
83861833|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83861834|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83861835|NCT00533962|Growth Substances|growth substances|mesh-ancestor
83861836|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861837|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83861838|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861839|NCT00181818|Bupropion|bupropion|mesh-list
83861840|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83861841|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
83861842|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861843|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83861844|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83861845|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861846|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861847|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
83861848|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861849|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861850|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83861851|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83861852|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861853|NCT04462627|Antibodies|antibodies|mesh-list
83861854|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
83861855|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861856|NCT00406601|Sorafenib|sorafenib|mesh-list
83861857|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861858|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83861859|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861860|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861861|NCT00409305|Betahistine|betahistine|mesh-list
83861862|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
83861863|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
83861864|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
83861865|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861866|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861867|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861868|NCT00406679|Acetaminophen|acetaminophen|mesh-list
83861869|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83861870|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83861871|NCT00406679|Analgesics|analgesics|mesh-ancestor
83861872|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
83861873|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861874|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861875|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
83861876|NCT00181896|Bupropion|bupropion|mesh-list
83861877|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83861878|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
83861879|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861880|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83861881|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83861882|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861883|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861884|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
83861885|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861886|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861887|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83861888|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83861889|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861890|NCT04686448|Fentanyl|fentanyl|mesh-list
83861891|NCT04686448|Ketamine|ketamine|mesh-list
83861892|NCT04686448|Propofol|propofol|mesh-list
83861893|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83861894|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861895|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861896|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83861897|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
83861898|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
83861899|NCT04686448|Analgesics|analgesics|mesh-ancestor
83861900|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
83861901|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861902|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83861903|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83861904|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83861905|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861906|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861907|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83861908|NCT04686448|Narcotics|narcotics|mesh-ancestor
83861909|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83861911|NCT00181935|Risperidone|risperidone|mesh-list
83861912|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83861913|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
83861914|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861915|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861916|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861917|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83861918|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83861919|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861920|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861921|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83861922|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
83861923|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
83861924|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
83861925|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861926|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83861927|NCT00181935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83861928|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83861929|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861930|NCT00409383|Paclitaxel|paclitaxel|mesh-list
83861931|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83861932|NCT00409383|Temozolomide|temozolomide|mesh-list
83861933|NCT00409383|Oblimersen|oblimersen|mesh-list
83861934|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83861935|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83861936|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
83861937|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
83861938|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
83861939|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861940|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83861941|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
83861942|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
83861943|NCT04893148|Dulaglutide|dulaglutide|mesh-list
83861944|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861945|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861946|NCT04883632|Lidocaine|lidocaine|mesh-list
83861947|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
83861948|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
83861949|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861950|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861951|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
83861952|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861953|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83861954|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83861955|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83861956|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861957|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861958|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83861959|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
83861960|NCT00181974|Coagulants|coagulants|mesh-ancestor
83861961|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83861962|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83861963|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83861964|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
83861965|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861966|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83861967|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83861968|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83861969|NCT02500147|Metformin|metformin|mesh-list
83861970|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861971|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861972|NCT00182013|Olanzapine|olanzapine|mesh-list
83861973|NCT00182013|Risperidone|risperidone|mesh-list
83861974|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83861975|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83861976|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
83861977|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83861978|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83861979|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861980|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83861981|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83861982|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83861983|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83861984|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83861985|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
83861986|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
83861987|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
83861988|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83861989|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83861990|NCT00182013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83861991|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83861992|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83861993|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
83861994|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
83861995|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83861996|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83861997|NCT02115724|Vitamins|vitamins|mesh-list
83861998|NCT02115724|Vitamin E|vitamin e|mesh-list
83861999|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
83862000|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
83862001|NCT02115724|Antioxidants|antioxidants|mesh-list
83862002|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
83862003|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862004|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862005|NCT02115724|Protective Agents|protective agents|mesh-ancestor
83862006|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
83862007|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
83862008|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
83862009|NCT02081755|Everolimus|everolimus|mesh-list
83862010|NCT02081755|Azathioprine|azathioprine|mesh-list
83862011|NCT02081755|Tacrolimus|tacrolimus|mesh-list
83862012|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862013|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
83862014|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862015|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83862016|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862017|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862018|NCT02081755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83862019|NCT02081755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83862020|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862021|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83862022|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83862023|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
83862024|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862025|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862026|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
83862027|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83862028|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862029|NCT01715974|Molgramostim|molgramostim|mesh-list
83862030|NCT01715974|Sargramostim|sargramostim|mesh-list
83862031|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
83862032|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862033|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862034|NCT05471479|Charcoal|charcoal|mesh-list
83862035|NCT05471479|Antidotes|antidotes|mesh-ancestor
83862036|NCT05471479|Protective Agents|protective agents|mesh-ancestor
83862037|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862038|NCT00188877|Fluorouracil|fluorouracil|mesh-list
83862039|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
83862040|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862041|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83862042|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862043|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862044|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
83862045|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862046|NCT00182169|Hormones|hormones|mesh-list
83862047|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862048|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862049|NCT05471050|Danazol|danazol|mesh-list
83862050|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83862051|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83862052|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862053|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862055|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83862056|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862057|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862058|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862059|NCT04686058|Midazolam|midazolam|mesh-list
83862060|NCT04686058|Meperidine|meperidine|mesh-list
83862061|NCT04686058|Propofol|propofol|mesh-list
83862062|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83862063|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862064|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862065|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83862066|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
83862067|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
83862068|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83862069|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83862070|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83862071|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83862072|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
83862073|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
83862074|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862075|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862076|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83862077|NCT04686058|Narcotics|narcotics|mesh-ancestor
83862078|NCT04686058|Analgesics|analgesics|mesh-ancestor
83862079|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
83862080|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862081|NCT00156299|Dexamethasone|dexamethasone|mesh-list
83862082|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
83862083|NCT00156299|Choline|choline|mesh-list
83862084|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83862085|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
83862086|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
83862087|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862088|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862089|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83862090|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
83862091|NCT00156299|Hormones|hormones|mesh-ancestor
83862092|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862093|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83862094|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862095|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
83862096|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83862097|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
83862098|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862099|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83862100|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
83862101|NCT00156299|Analgesics|analgesics|mesh-ancestor
83862102|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
83862103|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83862104|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83862105|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862106|NCT00535951|Panobinostat|panobinostat|mesh-list
83862107|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862108|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83862109|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862110|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862111|NCT00188955|Sirolimus|sirolimus|mesh-list
83862112|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862113|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862114|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83862115|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862116|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
83862117|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862118|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
83862119|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862120|NCT00536068|Acetaminophen|acetaminophen|mesh-list
83862121|NCT00536068|Aspirin|aspirin|mesh-list
83862122|NCT00536068|Diclofenac|diclofenac|mesh-list
83862123|NCT00536068|Naproxen|naproxen|mesh-list
83862124|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83862125|NCT00536068|Analgesics|analgesics|mesh-ancestor
83862126|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
83862127|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862128|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862129|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
83862130|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83862131|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83862132|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862133|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83862134|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862135|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862136|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
83862137|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83862138|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83862139|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83862140|NCT05470582|Vaccines|vaccines|mesh-list
83862141|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
83862142|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862143|NCT00156377|Mupirocin|mupirocin|mesh-list
83862144|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862145|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862146|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83862147|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862148|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862149|NCT00188994|Insulin|insulin|mesh-list
83862150|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83862151|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862152|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83862153|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
83862154|NCT00408525|Donepezil|donepezil|mesh-list
83862155|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83862156|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862157|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862158|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
83862159|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862160|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862161|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
83862162|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
83862163|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83862164|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862165|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862166|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83862167|NCT05469529|Analgesics|analgesics|mesh-ancestor
83862168|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
83862169|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862170|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83862171|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83862172|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83862173|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
83404284|NCT03054168|Hormones|hormones|mesh-ancestor
83862174|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862175|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862176|NCT00189033|Psyllium|psyllium|mesh-list
83862177|NCT00189033|Cathartics|cathartics|mesh-ancestor
83862178|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83862179|NCT05469061|Cisplatin|cisplatin|mesh-list
83862180|NCT05469061|Tislelizumab|tislelizumab|mesh-list
83862181|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862182|NCT05469061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83862183|NCT05469022|Lazertinib|lazertinib|mesh-list
83862184|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83862185|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862186|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862187|NCT00189072|Gabapentin|gabapentin|mesh-list
83862188|NCT00189072|Analgesics|analgesics|mesh-ancestor
83862189|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
83862190|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862191|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862192|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
83862193|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83862194|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83862195|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862196|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83862197|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83862198|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83862199|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862200|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862201|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
83862202|NCT00156611|Abciximab|abciximab|mesh-list
83862203|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
83862204|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83862205|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83862206|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
83862208|NCT00156650|Acyline|acyline|mesh-list
83862209|NCT00156650|Androgens|androgens|mesh-ancestor
83862210|NCT00156650|Hormones|hormones|mesh-ancestor
83862211|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862212|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862213|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83862214|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862215|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83862216|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83862217|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83862218|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
83862219|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83862220|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83862221|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83862222|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83862223|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
83862224|NCT00536419|Methylphenidate|methylphenidate|mesh-list
83862225|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83862226|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862227|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83862228|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83862229|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83862230|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862231|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
83862232|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862233|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
83862234|NCT00189150|Valganciclovir|valganciclovir|mesh-list
83862235|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83862236|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862237|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83862238|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
83862239|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862240|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862241|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862242|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862243|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
83862244|NCT00156689|Levetiracetam|levetiracetam|mesh-list
83862245|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
83862246|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
83862247|NCT00536614|Cetuximab|cetuximab|mesh-list
83862248|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83862249|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862250|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83862251|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862252|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83862253|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862254|NCT05468164|Omeprazole|omeprazole|mesh-list
83862255|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83862256|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83862257|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83862258|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862259|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862260|NCT05468047|Ketamine|ketamine|mesh-list
83862261|NCT05468047|Analgesics|analgesics|mesh-ancestor
83862262|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
83862263|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862264|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862265|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83862266|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83862267|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
83862268|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
83862269|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862270|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83862271|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83862272|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862273|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862274|NCT00182364|Heparin|heparin|mesh-list
83862275|NCT00182364|Calcium heparin|calcium heparin|mesh-list
83862276|NCT00182364|Dalteparin|dalteparin|mesh-list
83862277|NCT00182364|Tinzaparin|tinzaparin|mesh-list
83862278|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83862279|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
83862280|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83862281|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83862282|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862283|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
83862284|NCT00536653|Vitamin D|vitamin d|mesh-list
83862285|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
83862286|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
83862287|NCT00536653|Vitamins|vitamins|mesh-list
83862288|NCT00536653|Goserelin|goserelin|mesh-list
83862289|NCT00536653|Bicalutamide|bicalutamide|mesh-list
83862290|NCT00536653|Calcium|calcium|mesh-list
83862291|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83862292|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
83862293|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862294|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83862295|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83862296|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83862297|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862298|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
83862299|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
83862300|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862301|NCT00536653|Hormones|hormones|mesh-ancestor
83862302|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
83862303|NCT05467852|Progestins|progestins|mesh-ancestor
83862304|NCT05467852|Hormones|hormones|mesh-ancestor
83862305|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862306|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862307|NCT00536692|Mecamylamine|mecamylamine|mesh-list
83862308|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83862309|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83862310|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
83862311|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862312|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862313|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83862314|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83862315|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
83862316|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862317|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862318|NCT00189345|Catumaxomab|catumaxomab|mesh-list
83862319|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
83862320|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
83862321|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862322|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862323|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83862324|NCT00156884|Cisplatin|cisplatin|mesh-list
83862325|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862326|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83862327|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862328|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
83862329|NCT00156962|Hematinics|hematinics|mesh-ancestor
83862330|NCT00182442|Olanzapine|olanzapine|mesh-list
83862331|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83862332|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
83862333|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
83862334|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862335|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862336|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83862337|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83862338|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83862339|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862340|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83862341|NCT00182442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83862342|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83862343|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83862344|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862345|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862346|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
83862347|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
83862348|NCT00536770|Calcitriol|calcitriol|mesh-list
83862349|NCT00536770|Gemcitabine|gemcitabine|mesh-list
83862350|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83862351|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83862352|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
83862353|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862354|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862355|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83862356|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862357|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83862358|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862359|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83862360|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83862361|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83862363|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
83862364|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83862365|NCT04685512|Tenofovir|tenofovir|mesh-list
83862366|NCT04685512|Emtricitabine|emtricitabine|mesh-list
83862367|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
83862368|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862369|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83862370|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83862371|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862372|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862373|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83862374|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83862375|NCT00157040|Factor VIII|factor viii|mesh-list
83862376|NCT00157040|Coagulants|coagulants|mesh-ancestor
83862377|NCT00189384|Gentamicins|gentamicins|mesh-list
83862378|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
83862379|NCT00189384|Penicillins|penicillins|mesh-list
83862380|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83862381|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
83862382|NCT00189384|Penicillin G|penicillin g|mesh-list
83862383|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83862384|NCT00189384|Procaine|procaine|mesh-list
83862385|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862386|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862387|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83862388|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862389|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862390|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83862391|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
83862392|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83862393|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83862394|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
83862395|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
83862396|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862397|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862398|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
83862399|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862400|NCT00536848|Metronidazole|metronidazole|mesh-list
83862401|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862402|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862403|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83862404|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83862405|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
83862406|NCT00157079|Antibodies|antibodies|mesh-list
83862407|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
83862408|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83862409|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83862410|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
83862411|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862412|NCT00189501|Cinacalcet|cinacalcet|mesh-list
83862413|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83862414|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862415|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83862416|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
83862417|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862418|NCT00157118|Protein C|protein c|mesh-list
83862419|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
83862420|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83862421|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83862422|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862423|NCT00189579|Trastuzumab|trastuzumab|mesh-list
83862424|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83862425|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862426|NCT00157235|Bromides|bromides|mesh-list
83862427|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
83862428|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83862429|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
83862430|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862431|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862432|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83862433|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
83862434|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
83862435|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83862436|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
83862437|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862438|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862439|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
83862440|NCT00182520|Topiramate|topiramate|mesh-list
83862441|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
83862442|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83862443|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862444|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
83862445|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83862446|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862447|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83862448|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
83862449|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83862450|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
83862451|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862452|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83862453|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83862454|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83862455|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83862456|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862457|NCT00182559|Cyclosporine|cyclosporine|mesh-list
83862458|NCT00182559|Tacrolimus|tacrolimus|mesh-list
83862459|NCT00182559|Cyclosporins|cyclosporins|mesh-list
83862460|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862461|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
83862462|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862463|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83862464|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862465|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862466|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
83862467|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862468|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
83862469|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862470|NCT00425568|Testosterone|testosterone|mesh-list
83862471|NCT00425568|Androgens|androgens|mesh-ancestor
83862472|NCT00425568|Hormones|hormones|mesh-ancestor
83862473|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862474|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862475|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
83862476|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83862477|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83862478|NCT00157508|Analgesics|analgesics|mesh-ancestor
83862479|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
83862480|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862481|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862482|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83862483|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862484|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83862485|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83862486|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862487|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83862488|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83862489|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
83862490|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862491|NCT00189618|Aspirin|aspirin|mesh-list
83862492|NCT00189618|Clopidogrel|clopidogrel|mesh-list
83862493|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83862494|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83862495|NCT00189618|Analgesics|analgesics|mesh-ancestor
83862496|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
83862497|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862498|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862499|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83862500|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862501|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83862502|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83862503|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862504|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83862505|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83101420|NCT03502005|Tenofovir|tenofovir|mesh-list
83862506|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862507|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
83862508|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83862509|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83862510|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83862511|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
83862512|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862513|NCT00406796|Ranibizumab|ranibizumab|mesh-list
83862514|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83862515|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83862516|NCT00406796|Growth Substances|growth substances|mesh-ancestor
83862517|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862518|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
83862519|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862521|NCT00534391|Neomycin|neomycin|mesh-list
83862522|NCT00534391|Polymyxin B|polymyxin b|mesh-list
83862523|NCT00534391|Gramicidin|gramicidin|mesh-list
83862524|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
83862525|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83862526|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83862527|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862528|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862529|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83862530|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862531|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862532|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83862533|NCT00534508|Tacrolimus|tacrolimus|mesh-list
83862534|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862535|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
83862536|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862537|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83862538|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862539|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862540|NCT00182715|Leucovorin|leucovorin|mesh-list
83862541|NCT00182715|Fluorouracil|fluorouracil|mesh-list
83862542|NCT00182715|Capecitabine|capecitabine|mesh-list
83862543|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
83862544|NCT00182715|Cetuximab|cetuximab|mesh-list
83862545|NCT00182715|Calcium|calcium|mesh-list
83862546|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
83862547|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83862548|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862549|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
83862550|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862551|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83862552|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862553|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862554|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
83862555|NCT00182715|Antidotes|antidotes|mesh-ancestor
83862556|NCT00182715|Protective Agents|protective agents|mesh-ancestor
83862557|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
83862558|NCT00182715|Vitamins|vitamins|mesh-ancestor
83862559|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
83862560|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83862561|NCT00534586|Ketamine|ketamine|mesh-list
83862562|NCT00534586|Remifentanil|remifentanil|mesh-list
83862563|NCT00534586|Propofol|propofol|mesh-list
83862564|NCT00534586|Sevoflurane|sevoflurane|mesh-list
83862565|NCT00534586|Esketamine|esketamine|mesh-list
83862566|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83862567|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862568|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862569|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83862570|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
83862571|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
83862572|NCT00534586|Analgesics|analgesics|mesh-ancestor
83862573|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
83862574|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862575|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83862576|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83862577|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83862578|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862579|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862580|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83862581|NCT00534586|Narcotics|narcotics|mesh-ancestor
83862582|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83101497|NCT03377699|Insulin|insulin|mesh-list
83862583|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83862584|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
83862585|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83862586|NCT00534625|Zileuton|zileuton|mesh-list
83862587|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
83862588|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83862589|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83862590|NCT00534625|Analgesics|analgesics|mesh-ancestor
83862591|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
83862592|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862593|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862594|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83862595|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862596|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83862597|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862598|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862599|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83862600|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
83862601|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862602|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862603|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
83862604|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83862605|NCT00406874|Folic Acid|folic acid|mesh-list
83862606|NCT00406874|Hematinics|hematinics|mesh-ancestor
83862607|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
83862608|NCT00406874|Vitamins|vitamins|mesh-ancestor
83862609|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
83862610|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862611|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
83862612|NCT04106830|Azathioprine|azathioprine|mesh-list
83862613|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862614|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
83862615|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862616|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862617|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83862618|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83862619|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
83862620|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862621|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862622|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862623|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862624|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
83862625|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83862626|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862627|NCT00189657|Irinotecan|irinotecan|mesh-list
83862628|NCT00189657|Fluorouracil|fluorouracil|mesh-list
83862629|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83862630|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83862631|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862632|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862633|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862634|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
83862635|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83862636|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862637|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
83862638|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862639|NCT00406913|Mupirocin|mupirocin|mesh-list
83862640|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862641|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862642|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83862643|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862644|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862645|NCT00406952|Sertraline|sertraline|mesh-list
83862646|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
83862647|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83862648|NCT00406952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83862649|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83862650|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83862651|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862652|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862653|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
83862654|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862655|NCT04090879|Nicotine|nicotine|mesh-list
83862656|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83862657|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
83862658|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862659|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862660|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83862661|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83862662|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
83862663|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862664|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862665|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
83862666|NCT00157547|Citalopram|citalopram|mesh-list
83862667|NCT00157547|Fluoxetine|fluoxetine|mesh-list
83862668|NCT00157547|Paroxetine|paroxetine|mesh-list
83862669|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83862670|NCT00157547|Sertraline|sertraline|mesh-list
83862671|NCT00157547|Escitalopram|escitalopram|mesh-list
83862672|NCT00157547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83862673|NCT00157547|Serotonin|serotonin|mesh-list
83862674|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83862675|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83862676|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862677|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862678|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
83862679|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862680|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83862681|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
83862682|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83862683|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83862684|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83862685|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862686|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83862687|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83862688|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83862689|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862690|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83862691|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83862692|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83862693|NCT04061161|Bromides|bromides|mesh-list
83862694|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
83862695|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83862696|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
83862697|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862698|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862699|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83862700|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
83862701|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
83862702|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83862703|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83862704|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862705|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862706|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
83862707|NCT00157586|Manidipine|manidipine|mesh-list
83862708|NCT00157586|Delapril|delapril|mesh-list
83862709|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83862710|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83862711|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83862712|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862713|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83862714|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862715|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83862716|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
83862717|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862718|NCT00182871|Testosterone|testosterone|mesh-list
83862719|NCT00182871|Androgens|androgens|mesh-ancestor
83862720|NCT00182871|Hormones|hormones|mesh-ancestor
83862721|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862722|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862723|NCT00189774|Nateglinide|nateglinide|mesh-list
83862724|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83862725|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862726|NCT04686643|Niacin|niacin|mesh-list
83862727|NCT04686643|Amlodipine|amlodipine|mesh-list
83862728|NCT04686643|Valsartan|valsartan|mesh-list
83862729|NCT04686643|Indapamide|indapamide|mesh-list
83862730|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83862731|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83862732|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83862733|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862734|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83862735|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862736|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
83862737|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83862738|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83862740|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
83862741|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83862742|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83862743|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
83862744|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83862745|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
83862746|NCT04686643|Vitamins|vitamins|mesh-ancestor
83862747|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
83862748|NCT00534898|Fenretinide|fenretinide|mesh-list
83862749|NCT00534898|Bexarotene|bexarotene|mesh-list
83862750|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862751|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83862752|NCT00534898|Protective Agents|protective agents|mesh-ancestor
83862753|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862754|NCT03748810|Metformin|metformin|mesh-list
83862755|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
83862756|NCT03748810|Empagliflozin|empagliflozin|mesh-list
83862757|NCT03748810|Glimepiride|glimepiride|mesh-list
83862758|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83862759|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83862760|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862761|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83862762|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862763|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83862764|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83862765|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
83862766|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
83862767|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862768|NCT00157859|Chloroquine|chloroquine|mesh-list
83862769|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
83862770|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
83862771|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83862772|NCT00157859|Amebicides|amebicides|mesh-ancestor
83862773|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83862774|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83862775|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862776|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
83862777|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862778|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83862779|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862780|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862781|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83862782|NCT00157898|Metronidazole|metronidazole|mesh-list
83862783|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
83862784|NCT00157898|Ertapenem|ertapenem|mesh-list
83862785|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862786|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862787|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83862788|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83862789|NCT03669523|Denosumab|denosumab|mesh-list
83862790|NCT03669523|Nivolumab|nivolumab|mesh-list
83862791|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83862792|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862793|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83862794|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862795|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83862796|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862797|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
83862798|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83862799|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
83862800|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
83862801|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83862802|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862803|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862804|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
83862805|NCT00158093|Atenolol|atenolol|mesh-list
83862806|NCT00158093|Nebivolol|nebivolol|mesh-list
83862807|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862808|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862809|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83862810|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83862811|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862812|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862813|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862814|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862815|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83862816|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83862817|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
83862818|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
83862819|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862820|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83862821|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83862822|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83862823|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83862824|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862825|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
83862826|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83862827|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83862828|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83862829|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83862830|NCT03429946|Spironolactone|spironolactone|mesh-list
83862831|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83862832|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
83862833|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83862834|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862835|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83862836|NCT03429946|Diuretics|diuretics|mesh-ancestor
83862837|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
83862838|NCT00189930|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83862839|NCT00189930|Antiviral Agents|antiviral agents|mesh-ancestor
83862840|NCT00189930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862841|NCT00158132|Amantadine|amantadine|mesh-list
83862842|NCT00158132|Propranolol|propranolol|mesh-list
83862843|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83862844|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83862845|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
83862846|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862847|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862848|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862849|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83862850|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83862851|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
83862852|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83862853|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83862854|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
83862855|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862856|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
83862857|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83862858|NCT00158132|Analgesics|analgesics|mesh-ancestor
83862859|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
83862860|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862861|NCT00158171|Folic Acid|folic acid|mesh-list
83862862|NCT00158171|Nicotine|nicotine|mesh-list
83862863|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83862864|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
83862865|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862866|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862867|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83862868|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83862869|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
83862870|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862871|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862872|NCT00158171|Hematinics|hematinics|mesh-ancestor
83862873|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
83862874|NCT00158171|Vitamins|vitamins|mesh-ancestor
83862875|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
83862876|NCT03370783|Ethanol|ethanol|mesh-list
83862877|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83862878|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862879|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83862880|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862881|NCT00158210|Rivastigmine|rivastigmine|mesh-list
83862882|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83101800|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83862883|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862884|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862885|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
83862886|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862887|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862888|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83862889|NCT00158210|Protective Agents|protective agents|mesh-ancestor
83862890|NCT03358693|Infliximab|infliximab|mesh-list
83862891|NCT03358693|Upadacitinib|upadacitinib|mesh-list
83862892|NCT03358693|Ustekinumab|ustekinumab|mesh-list
83862893|NCT03358693|Ixekizumab|ixekizumab|mesh-list
83862894|NCT03358693|Brodalumab|brodalumab|mesh-list
83862895|NCT03358693|Abrocitinib|abrocitinib|mesh-list
83862896|NCT03358693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83862897|NCT03358693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83862898|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
83862899|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83862900|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83862901|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83862902|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83862903|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862904|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862905|NCT00190008|Piracetam|piracetam|mesh-list
83862906|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83862907|NCT00190008|Protective Agents|protective agents|mesh-ancestor
83862908|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862909|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
83862910|NCT00183222|Naltrexone|naltrexone|mesh-list
83862911|NCT00183222|Ondansetron|ondansetron|mesh-list
83862912|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83862913|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83862914|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862915|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
83862916|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83862917|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
83862918|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
83862919|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83862920|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
83862921|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83862922|NCT00183222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83862923|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83862924|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
83862925|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83862926|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862927|NCT00158405|Ritonavir|ritonavir|mesh-list
83862928|NCT00158405|Indinavir|indinavir|mesh-list
83862929|NCT00158405|Lamivudine|lamivudine|mesh-list
83862930|NCT00158405|Zidovudine|zidovudine|mesh-list
83862931|NCT00158405|Efavirenz|efavirenz|mesh-list
83862932|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83862933|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83862934|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
83862935|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862936|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862937|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83862938|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83862939|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
83862940|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862941|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83862942|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83862943|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83862944|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83862945|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
83862946|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83862947|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83862948|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83862949|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83862950|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83862951|NCT05275738|Niacinamide|niacinamide|mesh-list
83862952|NCT05275738|Niacin|niacin|mesh-list
83862953|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
83862954|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
83862955|NCT05275738|Vitamins|vitamins|mesh-ancestor
83101892|NCT02323971|Ticagrelor|ticagrelor|mesh-list
83862956|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
83862957|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862958|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83862959|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
83862960|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862961|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83862962|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
83862964|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
83862965|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862966|NCT00158522|Interferons|interferons|mesh-list
83862967|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
83862968|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
83862969|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83862970|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862971|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
83862972|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862973|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
83862974|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83862975|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
83862976|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
83862977|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83862978|NCT00158561|Dapsone|dapsone|mesh-list
83862979|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
83862980|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
83862981|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83862982|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83862983|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862984|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83862985|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83862986|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83862987|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83862988|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
83862989|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862990|NCT05169229|Vancomycin|vancomycin|mesh-list
83862991|NCT05169229|Tobramycin|tobramycin|mesh-list
83862992|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862993|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862994|NCT00538018|Telithromycin|telithromycin|mesh-list
83862995|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83862996|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83862997|NCT00538096|Blinatumomab|blinatumomab|mesh-list
83862998|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83862999|NCT00158678|Cisplatin|cisplatin|mesh-list
83863000|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863001|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
83863002|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83863003|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863004|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863005|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863006|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83863007|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83863008|NCT04724486|Cetrorelix|cetrorelix|mesh-list
83863009|NCT04724486|Menotropins|menotropins|mesh-list
83863010|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
83863011|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83863012|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
83863013|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83863014|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863015|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83863016|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83863017|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863018|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83863019|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
83863020|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
83863021|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863022|NCT00538330|Tamoxifen|tamoxifen|mesh-list
83863023|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83863024|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
83863025|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863026|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863027|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83863028|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863029|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83863030|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83863031|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83863032|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83863033|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
83863034|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863035|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83863036|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83863037|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863038|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863039|NCT00538486|Metformin|metformin|mesh-list
83863040|NCT00538486|Amlodipine|amlodipine|mesh-list
83863041|NCT00538486|Telmisartan|telmisartan|mesh-list
83863042|NCT00538486|Candesartan|candesartan|mesh-list
83863043|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
83863044|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863045|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863046|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83863047|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83863048|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863049|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863050|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83863051|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863052|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83863053|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83863054|NCT00538525|Docetaxel|docetaxel|mesh-list
83863055|NCT00538525|Doxorubicin|doxorubicin|mesh-list
83863056|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863057|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863058|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863059|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863060|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863061|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863062|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83863063|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863064|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863065|NCT00538564|Tadalafil|tadalafil|mesh-list
83863066|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863067|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83863068|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83863069|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863070|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863071|NCT00538564|Urological Agents|urological agents|mesh-ancestor
83863072|NCT00538603|Paclitaxel|paclitaxel|mesh-list
83863073|NCT00538603|Carboplatin|carboplatin|mesh-list
83863074|NCT00538603|Doxorubicin|doxorubicin|mesh-list
83863075|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83863076|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83863077|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863078|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863079|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863080|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863081|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863082|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863083|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83863084|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863085|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863086|NCT00158834|Fluticasone|fluticasone|mesh-list
83863087|NCT00158834|Xhance|xhance|mesh-list
83863088|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83863089|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83863090|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83863091|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
83863092|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863093|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863094|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83863095|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
83863096|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83863097|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83863098|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83863099|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83863100|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83863101|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
83863102|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863103|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863104|NCT00538720|Vitamin D|vitamin d|mesh-list
83863105|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
83863106|NCT00538720|Vitamins|vitamins|mesh-ancestor
83863107|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
83863108|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863109|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83863110|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83863111|NCT00536887|Atorvastatin|atorvastatin|mesh-list
83863112|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83863113|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83863114|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
83863115|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863116|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83863117|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83863118|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863119|NCT00158873|Fentanyl|fentanyl|mesh-list
83863120|NCT00158873|Midazolam|midazolam|mesh-list
83863121|NCT00158873|Morphine|morphine|mesh-list
83863122|NCT00158873|Remifentanil|remifentanil|mesh-list
83863123|NCT00158873|Lorazepam|lorazepam|mesh-list
83863124|NCT00158873|Propofol|propofol|mesh-list
83863125|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83863126|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863127|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863128|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83863129|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
83863130|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
83863131|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83863132|NCT00158873|Narcotics|narcotics|mesh-ancestor
83863133|NCT00158873|Analgesics|analgesics|mesh-ancestor
83863134|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
83863135|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863136|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83863137|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83863138|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83863139|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863140|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
83863141|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
83863142|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863143|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863144|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
83863145|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
83863146|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
83863147|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83863148|NCT00537121|Leucovorin|leucovorin|mesh-list
83863149|NCT00537121|Fluorouracil|fluorouracil|mesh-list
83863150|NCT00537121|Irinotecan|irinotecan|mesh-list
83863151|NCT00537121|Vorinostat|vorinostat|mesh-list
83863152|NCT00537121|Calcium|calcium|mesh-list
83863153|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
83863154|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83863155|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863156|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
83863157|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863158|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863159|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863160|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83863161|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
83863162|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83863163|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863164|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863165|NCT00537121|Antidotes|antidotes|mesh-ancestor
83863166|NCT00537121|Protective Agents|protective agents|mesh-ancestor
83863167|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
83863168|NCT00537121|Vitamins|vitamins|mesh-ancestor
83863169|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
83863170|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83863171|NCT00406991|Aspirin|aspirin|mesh-list
83863172|NCT00406991|Clopidogrel|clopidogrel|mesh-list
83863173|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83863174|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83863175|NCT00406991|Analgesics|analgesics|mesh-ancestor
83863176|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
83863177|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863178|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863179|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83863180|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863181|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83863182|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83863183|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102099|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83863184|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83863185|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83863186|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863187|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
83863188|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83863189|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83863190|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83863191|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
83863192|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863193|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83863194|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83863195|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863197|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
83863198|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863199|NCT00158990|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83863200|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83863201|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863202|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863203|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863204|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
83863205|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863206|NCT00537355|Histamine|histamine|mesh-list
83863207|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
83863208|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
83863209|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863210|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863211|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863212|NCT00183612|Olanzapine|olanzapine|mesh-list
83863213|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
83863214|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
83863215|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863216|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863217|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83863218|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83863219|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83863220|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863221|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863222|NCT00183612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83863223|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83863224|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863225|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863226|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863227|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
83863228|NCT05381623|Hemostatics|hemostatics|mesh-list
83863229|NCT05381623|Coagulants|coagulants|mesh-ancestor
83863230|NCT00537472|Bupivacaine|bupivacaine|mesh-list
83863231|NCT00537472|Anesthetics|anesthetics|mesh-list
83863232|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
83863233|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863234|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863235|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
83863236|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863237|NCT00159107|Acamprosate|acamprosate|mesh-list
83863238|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83863239|NCT00537550|Methotrexate|methotrexate|mesh-list
83863240|NCT00537550|Vincristine|vincristine|mesh-list
83863241|NCT00537550|Asparaginase|asparaginase|mesh-list
83863242|NCT00537550|Daunorubicin|daunorubicin|mesh-list
83863243|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83863244|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
83863245|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83863246|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863247|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863248|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
83863249|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863250|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863251|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
83863252|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863253|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83863254|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83863255|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
83863256|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863257|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83863258|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83863259|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863260|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863261|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863262|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863263|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83863264|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863265|NCT00159146|Pindolol|pindolol|mesh-list
83863266|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83863267|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83863268|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83863269|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863270|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863271|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863272|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83863273|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83863274|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
83863275|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863276|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83863277|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863278|NCT00538876|Decitabine|decitabine|mesh-list
83863279|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863280|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
83863281|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863282|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863283|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863284|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
83863285|NCT00538954|Antacids|antacids|mesh-ancestor
83863286|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863287|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83863288|NCT00539071|Risperidone|risperidone|mesh-list
83863289|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83863290|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
83863291|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863292|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863293|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863294|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83863295|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83863296|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863297|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863298|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83863299|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
83863300|NCT00539149|Amoxicillin|amoxicillin|mesh-list
83863301|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83863302|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863303|NCT00183807|Celecoxib|celecoxib|mesh-list
83863304|NCT00183807|Irinotecan|irinotecan|mesh-list
83863305|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863306|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83863307|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863308|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863309|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863310|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83863311|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83863312|NCT00183807|Analgesics|analgesics|mesh-ancestor
83863313|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
83863314|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863315|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863316|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83863317|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863318|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83863319|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83863320|NCT00539773|Interferons|interferons|mesh-list
83863321|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863322|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
83863323|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863324|NCT00409461|Sirolimus|sirolimus|mesh-list
83863325|NCT00409461|Tacrolimus|tacrolimus|mesh-list
83863326|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83863327|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
83863328|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863329|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83863330|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863331|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863332|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83863333|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863334|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863335|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863336|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
83863337|NCT00539890|Insulin|insulin|mesh-list
83102247|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
83863338|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863339|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863340|NCT00539968|Docetaxel|docetaxel|mesh-list
83863341|NCT00539968|Lonafarnib|lonafarnib|mesh-list
83863342|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863343|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863344|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863345|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863346|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863347|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863348|NCT00183846|Irinotecan|irinotecan|mesh-list
83863349|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83863350|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863351|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863352|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863353|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863354|NCT00540085|Rocuronium|rocuronium|mesh-list
83863355|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83863356|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83863357|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83863358|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863359|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863360|NCT00540202|Lumefantrine|lumefantrine|mesh-list
83863361|NCT00540202|Artemether|artemether|mesh-list
83863362|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83863363|NCT00540202|Quinine|quinine|mesh-list
83863364|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
83863365|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83863366|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83863367|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863368|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83863369|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863370|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83863371|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863372|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83863373|NCT00540202|Analgesics|analgesics|mesh-ancestor
83863374|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
83863375|NCT00540241|Pemetrexed|pemetrexed|mesh-list
83863376|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863377|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863378|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863379|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83863380|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83863381|NCT00159224|Ritonavir|ritonavir|mesh-list
83863382|NCT00159224|Lopinavir|lopinavir|mesh-list
83863383|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83863384|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83863385|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
83863386|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863387|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863388|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83863389|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83863390|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
83863391|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863392|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83863393|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83863394|NCT00540280|Gemcitabine|gemcitabine|mesh-list
83863395|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863396|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863397|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
83863398|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863399|NCT00183924|Carboplatin|carboplatin|mesh-list
83863400|NCT00183924|Docetaxel|docetaxel|mesh-list
83863401|NCT00183924|Estramustine|estramustine|mesh-list
83863402|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863403|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863404|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863405|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863406|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863407|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83863408|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
83863409|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83863410|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
83863411|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83863412|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
83863413|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863414|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863415|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83863416|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
83863417|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83863419|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863420|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863421|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83863422|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863423|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
83863424|NCT00159302|Protective Agents|protective agents|mesh-ancestor
83863425|NCT00540631|Immunomodulating Agents|immunomodulating agents|mesh-list
83863426|NCT00540631|Immunologic Factors|immunologic factors|mesh-ancestor
83863427|NCT00540631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863428|NCT00183885|Mitomycins|mitomycins|mesh-list
83863429|NCT00183885|Mitomycin|mitomycin|mesh-list
83863430|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863431|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863432|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
83863433|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863434|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83863435|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863436|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
83863437|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863438|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863439|NCT00540748|Oxytocin|oxytocin|mesh-list
83863440|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
83863441|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83863442|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863443|NCT00540787|Quinidine|quinidine|mesh-list
83863444|NCT00540787|Amiodarone|amiodarone|mesh-list
83863445|NCT00540787|Sotalol|sotalol|mesh-list
83863446|NCT00540787|Flecainide|flecainide|mesh-list
83863447|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83863448|NCT00540787|Propafenone|propafenone|mesh-list
83863449|NCT00540787|Dofetilide|dofetilide|mesh-list
83863450|NCT00540787|Cifenline|cifenline|mesh-list
83863451|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
83863452|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83863453|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863454|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863455|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83863456|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863457|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863458|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83863459|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83863460|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83863461|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863462|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83863463|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83863464|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83863465|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83863466|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83863467|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83863468|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863469|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
83863470|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
83863471|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863472|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83863473|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83863474|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
83863475|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83863476|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83863477|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863478|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83863479|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83863480|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
83863481|NCT00159380|Pimagedine|pimagedine|mesh-list
83863482|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863483|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863484|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83863485|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83863486|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83863487|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863488|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863489|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
83863490|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863491|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863492|NCT00540943|Irinotecan|irinotecan|mesh-list
83863493|NCT00540943|Cetuximab|cetuximab|mesh-list
83863494|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83863495|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863496|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863497|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863498|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863499|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83863500|NCT00159458|Gemcitabine|gemcitabine|mesh-list
83863501|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
83863502|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863503|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
83863504|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863505|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863506|NCT00541021|Gemcitabine|gemcitabine|mesh-list
83863507|NCT00541021|Sorafenib|sorafenib|mesh-list
83863508|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863509|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
83863510|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863511|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863512|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83863513|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863514|NCT00541138|Tamoxifen|tamoxifen|mesh-list
83863515|NCT00541138|Carboplatin|carboplatin|mesh-list
83863516|NCT00541138|Topotecan|topotecan|mesh-list
83863517|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863518|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863519|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83863520|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863521|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863522|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83863523|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
83863524|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863525|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863526|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83863527|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83863528|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83863529|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83863530|NCT00541177|Atropine|atropine|mesh-list
83863531|NCT00541177|Tropicamide|tropicamide|mesh-list
83863532|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83863533|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83863534|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83863535|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
83863536|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863537|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863538|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83863539|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
83863540|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
83863541|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
83863542|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83863543|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83863544|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
83863545|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863546|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863547|NCT00541216|Ephedrine|ephedrine|mesh-list
83863548|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83863549|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863550|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
83863551|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
83863552|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863553|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83863554|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
83863555|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863556|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863557|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
83863558|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83863559|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
83863560|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863561|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83863562|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863563|NCT00541372|Insulin|insulin|mesh-list
83863564|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863565|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863567|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863568|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863569|NCT00541411|Dactinomycin|dactinomycin|mesh-list
83863570|NCT00541411|Vincristine|vincristine|mesh-list
83863571|NCT00541411|Ifosfamide|ifosfamide|mesh-list
83863572|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83863573|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863574|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863575|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863576|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863577|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863578|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83863579|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
83863580|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83863581|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863582|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863583|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83863584|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863585|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83863586|NCT00541489|Naproxen|naproxen|mesh-list
83863587|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
83863588|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83863589|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83863590|NCT00541489|Analgesics|analgesics|mesh-ancestor
83863591|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
83863592|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863593|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863594|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83863595|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863596|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
83863597|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83863598|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863599|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863600|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83863601|NCT00190437|Amoxicillin|amoxicillin|mesh-list
83863602|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83863603|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863604|NCT00159575|Metformin|metformin|mesh-list
83863605|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863606|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863607|NCT00541567|Ibipinabant|ibipinabant|mesh-list
83863608|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83863609|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83863610|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863611|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863612|NCT00541567|Hormones|hormones|mesh-ancestor
83863613|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863614|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863615|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
83863616|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83863617|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83863618|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83863619|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863620|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863621|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
83863622|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863623|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863624|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83863625|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863626|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83863627|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83863628|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863629|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863630|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83863631|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863632|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863633|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
83863634|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863635|NCT00159614|Rolofylline|rolofylline|mesh-list
83863636|NCT00159614|Diuretics|diuretics|mesh-ancestor
83863637|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
83863638|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863639|NCT00541840|Sorafenib|sorafenib|mesh-list
83863640|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863641|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83863642|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863643|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863644|NCT00190476|Docetaxel|docetaxel|mesh-list
83863645|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863646|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863647|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863648|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863649|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863650|NCT00159653|Timolol|timolol|mesh-list
83863651|NCT00159653|Latanoprost|latanoprost|mesh-list
83863652|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83863653|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83863654|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
83863655|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863656|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863657|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863658|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83863659|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83863660|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83863661|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83863662|NCT00541918|Propofol|propofol|mesh-list
83863663|NCT00541918|Sevoflurane|sevoflurane|mesh-list
83863664|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83863665|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863666|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863667|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83863668|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
83863669|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
83863670|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83863671|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83863672|NCT00190515|Leucovorin|leucovorin|mesh-list
83863673|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
83863674|NCT00190515|Antidotes|antidotes|mesh-ancestor
83863675|NCT00190515|Protective Agents|protective agents|mesh-ancestor
83863676|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863677|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
83863678|NCT00190515|Vitamins|vitamins|mesh-ancestor
83863679|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
83863680|NCT00159692|Amlodipine|amlodipine|mesh-list
83863681|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83863682|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83863683|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863684|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863685|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83863686|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863687|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863688|NCT00542074|Ethanol|ethanol|mesh-list
83863689|NCT00542074|Emollients|emollients|mesh-list
83863690|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
83863691|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83863692|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863693|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863694|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863695|NCT00542152|Cyclosporine|cyclosporine|mesh-list
83863696|NCT00542152|Infliximab|infliximab|mesh-list
83863697|NCT00542152|Cyclosporins|cyclosporins|mesh-list
83863698|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863699|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863700|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83863701|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
83863702|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863703|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
83863704|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863705|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83863706|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863707|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83863708|NCT00542152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83863709|NCT00542152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83863710|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83863711|NCT00159731|Pregabalin|pregabalin|mesh-list
83863712|NCT00159731|Analgesics|analgesics|mesh-ancestor
83863713|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
83863714|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863715|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863717|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83863718|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863719|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863720|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83863721|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83863722|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83863723|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863724|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863725|NCT00408915|Lisuride|lisuride|mesh-list
83863726|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83863727|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83863728|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83863729|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
83863730|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863731|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863732|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863733|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
83863734|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
83863735|NCT00542347|Esomeprazole|esomeprazole|mesh-list
83863736|NCT00542347|Omeprazole|omeprazole|mesh-list
83863737|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83863738|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83863739|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83863740|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863741|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863742|NCT00190554|Cisplatin|cisplatin|mesh-list
83863743|NCT00190554|Fluorouracil|fluorouracil|mesh-list
83863744|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863745|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
83863746|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863747|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863748|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83863749|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
83863750|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863751|NCT00159770|Olanzapine|olanzapine|mesh-list
83863752|NCT00159770|Risperidone|risperidone|mesh-list
83863753|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83863754|NCT00159770|Ziprasidone|ziprasidone|mesh-list
83863755|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83863756|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
83863757|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863758|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863759|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863760|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83863761|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83863762|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863763|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863764|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83863765|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
83863766|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
83863767|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
83863768|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863769|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83863770|NCT00159770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83863771|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83863772|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863773|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
83863774|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83863775|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83863776|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
83863777|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863778|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863779|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83863780|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83863781|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83863782|NCT00542893|Dacarbazine|dacarbazine|mesh-list
83863783|NCT00542893|Oblimersen|oblimersen|mesh-list
83863784|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83863785|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
83863786|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863787|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863788|NCT00184041|Cytarabine|cytarabine|mesh-list
83863789|NCT00184041|Prednisone|prednisone|mesh-list
83863790|NCT00184041|Methotrexate|methotrexate|mesh-list
83863791|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
83863792|NCT00184041|Vincristine|vincristine|mesh-list
83863793|NCT00184041|Daunorubicin|daunorubicin|mesh-list
83863794|NCT00184041|Asparaginase|asparaginase|mesh-list
83863795|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
83863796|NCT00184041|Thioguanine|thioguanine|mesh-list
83863797|NCT00184041|Pegaspargase|pegaspargase|mesh-list
83863798|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83863799|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
83863800|NCT00184041|Hormones|hormones|mesh-ancestor
83863801|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863802|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863803|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83863804|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863805|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83863806|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
83863807|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83863808|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863809|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
83863810|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863811|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
83863812|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863813|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83863814|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83863815|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
83863816|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83863817|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83863818|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83863819|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
83863820|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83863821|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83863822|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863823|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863824|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863825|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
83863826|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863827|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863828|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83863829|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863830|NCT00543049|Sunitinib|sunitinib|mesh-list
83863831|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863832|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83863833|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83863834|NCT00543049|Growth Substances|growth substances|mesh-ancestor
83863835|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863836|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
83863837|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83863838|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863839|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863840|NCT04685005|Caffeine|caffeine|mesh-list
83863841|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83863842|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863843|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83863844|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863845|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863846|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83863847|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83863848|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
83863849|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863850|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83863851|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83863852|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83863853|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863854|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863855|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863856|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863857|NCT00190632|Analgesics|analgesics|mesh-ancestor
83863858|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
83863859|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863860|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
83863861|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863862|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
83863863|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83863864|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83863865|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
83863866|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863867|NCT00543205|Oblimersen|oblimersen|mesh-list
83863868|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863869|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
83863870|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863871|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863872|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83863873|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83863874|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863875|NCT00159809|Urological Agents|urological agents|mesh-ancestor
83863876|NCT00543244|Interferons|interferons|mesh-list
83863877|NCT00543244|Ribavirin|ribavirin|mesh-list
83863878|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
83863879|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83863880|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863881|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
83863882|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863883|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
83863884|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863885|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
83863886|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863887|NCT00190710|Carboplatin|carboplatin|mesh-list
83863888|NCT00190710|Gemcitabine|gemcitabine|mesh-list
83863889|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863890|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83863891|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
83863892|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863893|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
83863894|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
83863895|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83863896|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83863897|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863898|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83863899|NCT03456661|Analgesics|analgesics|mesh-ancestor
83863900|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
83863901|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863902|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83863903|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83863904|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83863905|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
83863906|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863907|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863908|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
83863909|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
83863910|NCT03456544|Vancomycin|vancomycin|mesh-list
83863911|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83863912|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863913|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
83863914|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863915|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
83863916|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83863917|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83863918|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863919|NCT00159887|Urological Agents|urological agents|mesh-ancestor
83863920|NCT00543361|Metformin|metformin|mesh-list
83863921|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83863922|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863923|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83863924|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83863925|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83863926|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83863927|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83863928|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
83863929|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83863930|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863931|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83863932|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83863933|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83863934|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863935|NCT00543634|Estrogens|estrogens|mesh-ancestor
83863936|NCT00543634|Hormones|hormones|mesh-ancestor
83863937|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863938|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
83863939|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83863940|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863941|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863942|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
83863943|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863944|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863946|NCT00543829|Docetaxel|docetaxel|mesh-list
83863947|NCT00543829|Doxorubicin|doxorubicin|mesh-list
83863948|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83863949|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863950|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83863951|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83863952|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83863953|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863954|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83863955|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83863956|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863957|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863958|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83863959|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
83863960|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83863961|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863962|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83863963|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83863964|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83863965|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83863966|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83863967|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83863968|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83863969|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863970|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863971|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83863972|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863973|NCT00190827|Analgesics|analgesics|mesh-ancestor
83863974|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
83863975|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83863976|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
83863977|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83863978|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
83863979|NCT00160043|Vatalanib|vatalanib|mesh-list
83863980|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83863981|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863982|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863983|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
83863984|NCT00544063|Irinotecan|irinotecan|mesh-list
83863985|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83863986|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83863987|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83863988|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83863989|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863990|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
83863991|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83863992|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83863993|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83863994|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83863995|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83863996|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83863997|NCT00544219|Prednisone|prednisone|mesh-list
83863998|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
83863999|NCT00544219|Rituximab|rituximab|mesh-list
83864000|NCT00544219|Doxorubicin|doxorubicin|mesh-list
83864001|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83864002|NCT00544219|Vincristine|vincristine|mesh-list
83864003|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83864004|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
83864005|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864006|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864007|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83102980|NCT01652092|Mesna|mesna|mesh-list
83864008|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
83864009|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864010|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864011|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83864012|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864013|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83864014|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83864015|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864016|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864017|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864018|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
83864019|NCT00544219|Hormones|hormones|mesh-ancestor
83864020|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864021|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83864022|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83864023|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
83864024|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
83864025|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
83864026|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83864027|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83864028|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864029|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864030|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864031|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864032|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864033|NCT00190866|Analgesics|analgesics|mesh-ancestor
83864034|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
83864035|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864036|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864037|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864038|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
83864039|NCT00160160|Eprosartan|eprosartan|mesh-list
83864040|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864041|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83864042|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83864043|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864044|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
83864045|NCT00544570|Melphalan|melphalan|mesh-list
83864046|NCT00544570|Carmustine|carmustine|mesh-list
83864047|NCT00544570|Etoposide|etoposide|mesh-list
83864048|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83864049|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
83864050|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864051|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864052|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83864053|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
83864054|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864055|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864056|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83864057|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83864058|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83864059|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864060|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864061|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83864062|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83864063|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864064|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864065|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864066|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864067|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864068|NCT00190905|Analgesics|analgesics|mesh-ancestor
83864069|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
83864070|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864071|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864072|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864073|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
83864074|NCT00544609|Sorafenib|sorafenib|mesh-list
83864075|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864076|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83864077|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148830|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103011|NCT03697889|Naproxen|naproxen|mesh-list
83864078|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864079|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
83864080|NCT00544687|Nortriptyline|nortriptyline|mesh-list
83864081|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864082|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
83864083|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83864084|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83864085|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864086|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864087|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83864088|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864089|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864090|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864091|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
83864092|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864093|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864094|NCT00160238|Betahistine|betahistine|mesh-list
83864095|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864096|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
83864097|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
83864098|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864099|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864100|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864101|NCT00544804|Lapatinib|lapatinib|mesh-list
83864102|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864103|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83864104|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864105|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864106|NCT00160277|Moxonidine|moxonidine|mesh-list
83864107|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864108|NCT02963181|Melatonin|melatonin|mesh-list
83864109|NCT02963181|Yohimbine|yohimbine|mesh-list
83864110|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
84048313|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864111|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864112|NCT02963181|Protective Agents|protective agents|mesh-ancestor
83864113|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864114|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83864115|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
83864116|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
83864117|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864118|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83864119|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83864120|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83864121|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
83864122|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864123|NCT02963181|Urological Agents|urological agents|mesh-ancestor
83864124|NCT00544999|Cytarabine|cytarabine|mesh-list
83864125|NCT00544999|Everolimus|everolimus|mesh-list
83864126|NCT00544999|Daunorubicin|daunorubicin|mesh-list
83864127|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864128|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
83864129|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864130|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864131|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
83864132|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864133|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83864134|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
83864135|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864136|NCT00544999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83864137|NCT00544999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83864138|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864139|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83864140|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83864141|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864142|NCT00160316|Estradiol|estradiol|mesh-list
83864143|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
83864144|NCT00160316|Estrogens|estrogens|mesh-ancestor
83864145|NCT00160316|Hormones|hormones|mesh-ancestor
83864146|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864147|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864148|NCT00160316|Progestins|progestins|mesh-ancestor
83864149|NCT00545194|Dinoprostone|dinoprostone|mesh-list
83864150|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
83864151|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83864152|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864153|NCT00190944|Teriparatide|teriparatide|mesh-list
83864154|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83864155|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864156|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83864157|NCT03456466|Rituximab|rituximab|mesh-list
83864158|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864159|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864160|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
83864161|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864162|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864163|NCT00160355|Fludarabine|fludarabine|mesh-list
83864164|NCT00160355|Melphalan|melphalan|mesh-list
83864165|NCT00160355|Thiotepa|thiotepa|mesh-list
83864166|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864167|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864168|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83864169|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
83864170|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864171|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83864172|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
83864173|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83864174|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
83864175|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83864176|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83864177|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83864178|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
83864179|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864180|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864181|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864182|NCT00160394|Adapalene|adapalene|mesh-list
83864183|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83864184|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83864185|NCT00160394|Analgesics|analgesics|mesh-ancestor
83864186|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
83864187|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864188|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864189|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864190|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864191|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
83864192|NCT00191022|Paroxetine|paroxetine|mesh-list
83864193|NCT00191022|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83864194|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864195|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864196|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864197|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864198|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
83864199|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864200|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83864201|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864202|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864203|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83864204|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83864205|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864206|NCT00545389|Mesalamine|mesalamine|mesh-list
83864207|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83864208|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83864209|NCT00545389|Analgesics|analgesics|mesh-ancestor
83864210|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
83864211|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864212|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864213|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864214|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864215|NCT00545467|Aripiprazole|aripiprazole|mesh-list
83864216|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864217|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864218|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83864219|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83864220|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83864221|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864222|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
83864223|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
83864224|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864225|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103178|NCT03700229|Rituximab|rituximab|mesh-list
83864226|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83864227|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83864228|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
83864229|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83864230|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83864231|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83864232|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83864233|NCT00545857|Pioglitazone|pioglitazone|mesh-list
83864234|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83864235|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864236|NCT00545935|Artesunate|artesunate|mesh-list
83864237|NCT00545935|Amodiaquine|amodiaquine|mesh-list
83864238|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
83864239|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83864240|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83864241|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864242|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864243|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
83864244|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
83864245|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83864246|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
83864247|NCT00160511|Levetiracetam|levetiracetam|mesh-list
83864248|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
83864249|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
83864250|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83864251|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83864252|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864253|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864254|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864255|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864256|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864257|NCT00191061|Analgesics|analgesics|mesh-ancestor
83864258|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
83864259|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864260|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864261|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864262|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
83864263|NCT00160550|Levetiracetam|levetiracetam|mesh-list
83864264|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
83864265|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
83864266|NCT00160589|Levocetirizine|levocetirizine|mesh-list
83864267|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83864268|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83864269|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
83864270|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
83864271|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864272|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864273|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864274|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
83864275|NCT00546130|Cisplatin|cisplatin|mesh-list
83864276|NCT00546130|Irinotecan|irinotecan|mesh-list
83864277|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864278|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83864279|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864280|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864281|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864282|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83864283|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
83864284|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864285|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83864286|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
83864287|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864288|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
83864289|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83864290|NCT00546130|Protective Agents|protective agents|mesh-ancestor
83864291|NCT00191178|Insulin|insulin|mesh-list
83864292|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83864293|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
83864294|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
83864295|NCT00191178|Protamines|protamines|mesh-list
83864296|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83864297|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864298|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
83864299|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864300|NCT00191178|Coagulants|coagulants|mesh-ancestor
83864301|NCT00546169|Thrombin|thrombin|mesh-list
83864302|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
83864303|NCT00546169|Coagulants|coagulants|mesh-ancestor
83864304|NCT00160628|Levetiracetam|levetiracetam|mesh-list
83864305|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
83864306|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
83864307|NCT00546286|Timolol|timolol|mesh-list
83864308|NCT00546286|Dorzolamide|dorzolamide|mesh-list
83864309|NCT00546286|Maleic acid|maleic acid|mesh-list
83864310|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864311|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864312|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83864313|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83864314|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
83864315|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864316|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864317|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83864318|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864319|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83864320|NCT00546325|Rimonabant|rimonabant|mesh-list
83864321|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83864322|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83864323|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83864324|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864325|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864326|NCT00546325|Hormones|hormones|mesh-ancestor
83864327|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864328|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864329|NCT00546403|Modafinil|modafinil|mesh-list
83864330|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83864331|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864332|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83864333|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83864334|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83864335|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864336|NCT00546442|Metformin|metformin|mesh-list
83864337|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83864338|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864339|NCT00191256|Paclitaxel|paclitaxel|mesh-list
83864340|NCT00191256|Carboplatin|carboplatin|mesh-list
83864341|NCT00191256|Gemcitabine|gemcitabine|mesh-list
83864342|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83864343|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864344|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
83864345|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
83864346|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
83864347|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864348|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864349|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
83864350|NCT00546520|Ciclesonide|ciclesonide|mesh-list
83864351|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
83864352|NCT00546520|Hormones|hormones|mesh-ancestor
83864353|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864354|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864355|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83864356|NCT00546559|Simvastatin|simvastatin|mesh-list
83864357|NCT00546559|Pravastatin|pravastatin|mesh-list
83864358|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83864359|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83864360|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
83864361|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864362|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83864363|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83864364|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864365|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83864366|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83864367|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83864368|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
83864369|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864370|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83864371|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83864372|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864373|NCT00546676|Telithromycin|telithromycin|mesh-list
83864374|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83864375|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864376|NCT00546832|Celecoxib|celecoxib|mesh-list
83864377|NCT00546832|Diclofenac|diclofenac|mesh-list
83864378|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83864379|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83864380|NCT00546832|Analgesics|analgesics|mesh-ancestor
83864381|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
83864382|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864383|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864384|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864385|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864386|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83864387|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83864388|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864389|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864390|NCT00184587|Candesartan|candesartan|mesh-list
83864391|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
83864392|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
83864393|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83864394|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864395|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83864396|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864397|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83864398|NCT00547144|Gemcitabine|gemcitabine|mesh-list
83864399|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864400|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
83864401|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864402|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864403|NCT00547183|Tadalafil|tadalafil|mesh-list
83864404|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864405|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83864406|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83173421|NCT04040231|Nivolumab|nivolumab|mesh-list
83864407|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864408|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864409|NCT00547183|Urological Agents|urological agents|mesh-ancestor
83864410|NCT00184626|Insulin|insulin|mesh-list
83864411|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83864412|NCT00184626|Metformin|metformin|mesh-list
83864413|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
83864414|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
83864415|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
83864416|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83864417|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864418|NCT00547417|Tadalafil|tadalafil|mesh-list
83864419|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864420|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83864421|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83864422|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864423|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864424|NCT00547417|Urological Agents|urological agents|mesh-ancestor
83864425|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83864426|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83864427|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864428|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864429|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864430|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
83864431|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864432|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864433|NCT00547495|Tadalafil|tadalafil|mesh-list
83864434|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864435|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83864436|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83864437|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864438|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864439|NCT00547495|Urological Agents|urological agents|mesh-ancestor
83864440|NCT02277223|Curcumin|curcumin|mesh-list
83864441|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83864442|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83864443|NCT02277223|Analgesics|analgesics|mesh-ancestor
83864444|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
83864445|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864446|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864447|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864448|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864449|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864450|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148831|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
83864451|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864452|NCT00547573|Tadalafil|tadalafil|mesh-list
83864453|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864454|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83864455|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83864456|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864457|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864458|NCT00547573|Urological Agents|urological agents|mesh-ancestor
83864459|NCT00191373|Gemcitabine|gemcitabine|mesh-list
83864460|NCT00191373|Trastuzumab|trastuzumab|mesh-list
83864461|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864462|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
83864463|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864464|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864465|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864466|NCT00547612|Substance P|substance p|mesh-list
83864467|NCT00547612|Neurokinin A|neurokinin a|mesh-list
83864468|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864469|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864470|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864471|NCT00547768|Fexofenadine|fexofenadine|mesh-list
83864472|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83864473|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83864474|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83864475|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
83864476|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
83864477|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864478|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864479|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864480|NCT00184665|Insulin|insulin|mesh-list
83864481|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83864482|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
83864483|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
83864484|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
83864485|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
83864486|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
83864487|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83864488|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864489|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
83864490|NCT04983238|Trastuzumab|trastuzumab|mesh-list
83864491|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864492|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864493|NCT04983238|Antidotes|antidotes|mesh-ancestor
83864494|NCT04983238|Protective Agents|protective agents|mesh-ancestor
83864495|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864496|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
83864497|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864498|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
83864499|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83864500|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864501|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
83864502|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
83864503|NCT04974385|Bupivacaine|bupivacaine|mesh-list
83864504|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
83864505|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
83864506|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83864507|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864508|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
83864509|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864510|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
83864511|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83864512|NCT00547885|Narcotics|narcotics|mesh-ancestor
83864513|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83864514|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864515|NCT00547885|Analgesics|analgesics|mesh-ancestor
83864516|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
83864517|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864518|NCT00161018|Risperidone|risperidone|mesh-list
83864519|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83864520|NCT00161018|Fluphenazine|fluphenazine|mesh-list
83864521|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
83864522|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
83864523|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83864524|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
83864525|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864526|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864527|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864528|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83864529|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83864530|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83864531|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864532|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83864533|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
83864534|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864535|NCT00191412|Pemetrexed|pemetrexed|mesh-list
83864536|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864537|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864538|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864539|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83864540|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83864541|NCT00548002|Levofloxacin|levofloxacin|mesh-list
83864542|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
83864543|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83864544|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864545|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83864546|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83864547|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864548|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864549|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864550|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864551|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83864552|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83864553|NCT00191490|Gemcitabine|gemcitabine|mesh-list
83864554|NCT00191490|Docetaxel|docetaxel|mesh-list
83864555|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864556|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864557|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
83864558|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864559|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
83864560|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
83864561|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
83864562|NCT00548080|Caspofungin|caspofungin|mesh-list
83864563|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
83864564|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864565|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864566|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864567|NCT00161096|Pantoprazole|pantoprazole|mesh-list
83864568|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83864569|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83864570|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83864571|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864572|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864573|NCT00184821|Glyburide|glyburide|mesh-list
83864574|NCT00184821|Adenosine|adenosine|mesh-list
83864575|NCT00184821|Diazoxide|diazoxide|mesh-list
83864576|NCT00184821|Annexin A5|annexin a5|mesh-list
83864577|NCT00184821|Analgesics|analgesics|mesh-ancestor
83864578|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
83864579|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864580|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864581|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83864582|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864583|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83864584|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
83864585|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
83864586|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864587|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864588|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83864589|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864590|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864591|NCT00548509|Vitamin K|vitamin k|mesh-list
83864592|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
83864593|NCT00548509|Menatetrenone|menatetrenone|mesh-list
83864594|NCT00548509|Vitamins|vitamins|mesh-ancestor
83864595|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
83864596|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864597|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83864598|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83864599|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864600|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
83864601|NCT00548509|Coagulants|coagulants|mesh-ancestor
83864602|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
83864603|NCT00548704|Razoxane|razoxane|mesh-list
83864604|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864605|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83864606|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83864607|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864608|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864609|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864610|NCT00548704|Protective Agents|protective agents|mesh-ancestor
83864611|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864612|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
83864613|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83864614|NCT00184899|Heparin|heparin|mesh-list
83864615|NCT00184899|Calcium heparin|calcium heparin|mesh-list
83864616|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83864617|NCT00184899|Glycerol|glycerol|mesh-list
83864618|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
83864619|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83864620|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83864621|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864622|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83864623|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83864624|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83864625|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83864626|NCT00184899|Protective Agents|protective agents|mesh-ancestor
83864627|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864628|NCT00548821|Cisplatin|cisplatin|mesh-list
83864629|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864630|NCT00161291|Bevacizumab|bevacizumab|mesh-list
83864631|NCT00161291|Letrozole|letrozole|mesh-list
83864632|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864633|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864634|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83864635|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83864636|NCT00161291|Growth Substances|growth substances|mesh-ancestor
83864637|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864638|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
83864639|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83864640|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83864641|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864642|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864643|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83864644|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
83864645|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864646|NCT00548899|Sorafenib|sorafenib|mesh-list
83864647|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864648|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83864649|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864650|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864651|NCT00191568|Gemcitabine|gemcitabine|mesh-list
83864652|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
83864653|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864654|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
83864655|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864656|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864657|NCT00548938|Temozolomide|temozolomide|mesh-list
83864658|NCT00548938|Carmustine|carmustine|mesh-list
83864659|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83864660|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
83864661|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864662|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864663|NCT00161330|Amoxicillin|amoxicillin|mesh-list
83864664|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
83864665|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
83864666|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
83864667|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83864668|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864669|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864670|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864671|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83864672|NCT04939480|Atezolizumab|atezolizumab|mesh-list
83864673|NCT04939480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83864674|NCT04939480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864675|NCT04939480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864676|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864677|NCT00184938|Morphine|morphine|mesh-list
83864678|NCT00184938|Naloxone|naloxone|mesh-list
83864679|NCT00184938|Annexin A5|annexin a5|mesh-list
83864680|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83864681|NCT00184938|Narcotics|narcotics|mesh-ancestor
83864682|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83864683|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864684|NCT00184938|Analgesics|analgesics|mesh-ancestor
83864685|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
83864686|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864687|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83864688|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864689|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864690|NCT00549133|Irbesartan|irbesartan|mesh-list
83864691|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864692|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83864693|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83864694|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864695|NCT00191607|Gemcitabine|gemcitabine|mesh-list
83864696|NCT00191607|Doxorubicin|doxorubicin|mesh-list
83864697|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83864698|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864699|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
83864700|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864701|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864702|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83864703|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83864704|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864705|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864706|NCT00549289|Cyclosporine|cyclosporine|mesh-list
83864707|NCT00549289|Cyclosporins|cyclosporins|mesh-list
83864708|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864709|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864710|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83864711|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
83864712|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864713|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
83864714|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864715|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
83864716|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864717|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83864718|NCT00184977|Fluticasone|fluticasone|mesh-list
83864719|NCT00184977|Xhance|xhance|mesh-list
83864720|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
83864721|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83864722|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864723|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83864724|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
83864725|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864726|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864727|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83864728|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
83864729|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
83864730|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83864731|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
83864732|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864733|NCT00184977|Expectorants|expectorants|mesh-ancestor
83864734|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83864735|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
83864736|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864737|NCT00184977|Protective Agents|protective agents|mesh-ancestor
83864738|NCT00184977|Antidotes|antidotes|mesh-ancestor
83864739|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
83864740|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864741|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
83864742|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
83864743|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
83864744|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83864745|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
83864746|NCT00161447|Testosterone|testosterone|mesh-list
83864747|NCT00161447|Acyline|acyline|mesh-list
83864748|NCT00161447|Androgens|androgens|mesh-ancestor
83864749|NCT00161447|Hormones|hormones|mesh-ancestor
83864750|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864751|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864752|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83864753|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864754|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83864755|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83864756|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83864757|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
83864758|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83864759|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83864760|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83864761|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83864762|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
83864763|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83864764|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83864765|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864766|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864767|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864768|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864769|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864770|NCT00191685|Analgesics|analgesics|mesh-ancestor
83864771|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
83864772|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864773|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
83864774|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83864775|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
83864776|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
83864777|NCT00161486|Testosterone|testosterone|mesh-list
83864778|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
83864779|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
83864780|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83864781|NCT00161486|Acyline|acyline|mesh-list
83864782|NCT00161486|Androgens|androgens|mesh-ancestor
83864783|NCT00161486|Hormones|hormones|mesh-ancestor
83864784|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864785|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864786|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83864787|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864788|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
83864789|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
83864790|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
83864791|NCT00549874|Glyburide|glyburide|mesh-list
83864792|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83864793|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864794|NCT00191763|Gemcitabine|gemcitabine|mesh-list
83864795|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864796|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864797|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
83864798|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864799|NCT00161564|Rituximab|rituximab|mesh-list
83864800|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864801|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864802|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
83864803|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864804|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864805|NCT00185055|Valsartan|valsartan|mesh-list
83864806|NCT00185055|Olmesartan|olmesartan|mesh-list
83864807|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83864808|NCT00185055|Irbesartan|irbesartan|mesh-list
83864809|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864810|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83864811|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83864812|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864813|NCT00550108|Ethanol|ethanol|mesh-list
83864814|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83864815|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864816|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83864817|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864818|NCT00185094|Losartan|losartan|mesh-list
83864819|NCT00185094|Atenolol|atenolol|mesh-list
83864820|NCT00185094|Olmesartan|olmesartan|mesh-list
83864821|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83864822|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83864823|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864824|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83864825|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83864826|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864827|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
83864828|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
83864829|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103760|NCT03680495|Prednisolone|prednisolone|mesh-list
83864830|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864831|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83864832|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83864833|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83864834|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83864835|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864837|NCT00550303|Estrogens|estrogens|mesh-list
83864838|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83864839|NCT00550303|Hormones|hormones|mesh-ancestor
83864840|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864841|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864842|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83864843|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83864844|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
83864845|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83864846|NCT00550342|Rituximab|rituximab|mesh-list
83864847|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864848|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864849|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
83864850|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864851|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864852|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
83864853|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83864854|NCT00161681|Estradiol|estradiol|mesh-list
83864855|NCT00161681|Estrogens|estrogens|mesh-ancestor
83864856|NCT00161681|Hormones|hormones|mesh-ancestor
83864857|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864858|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864859|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83864860|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
83864861|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83864862|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83864863|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83864864|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83864865|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83864866|NCT02963454|Simendan|simendan|mesh-list
83864867|NCT02963454|Dobutamine|dobutamine|mesh-list
83864868|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83864869|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864870|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83864871|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83864872|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864873|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864874|NCT02963454|Protective Agents|protective agents|mesh-ancestor
83864875|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864876|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
83864877|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
83864878|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864879|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83864880|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83864881|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83864882|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83864883|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83864884|NCT00191802|Teriparatide|teriparatide|mesh-list
83864885|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83864886|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864887|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83864888|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
83864889|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83864890|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83864891|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
83864892|NCT00550810|Sunitinib|sunitinib|mesh-list
83864893|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864894|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83864895|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83864896|NCT00550810|Growth Substances|growth substances|mesh-ancestor
83864897|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864898|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
83864899|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83864900|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864901|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864902|NCT00191841|Gemcitabine|gemcitabine|mesh-list
83864903|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864904|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864905|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
83864906|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864907|NCT00550927|Bevacizumab|bevacizumab|mesh-list
83864908|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864909|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864910|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83864911|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83864912|NCT00550927|Growth Substances|growth substances|mesh-ancestor
83864913|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864914|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
83864915|NCT00161720|Protein C|protein c|mesh-list
83864916|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
83864917|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83864918|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83864919|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864920|NCT00185133|Amlodipine|amlodipine|mesh-list
83864921|NCT00185133|Olmesartan|olmesartan|mesh-list
83864922|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83864923|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83864924|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83864925|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864926|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864927|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83864928|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864929|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
83864930|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83864931|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83864932|NCT00551005|Celecoxib|celecoxib|mesh-list
83864933|NCT00551005|Etoposide|etoposide|mesh-list
83864934|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83864935|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864936|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83864937|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864938|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864939|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864940|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83864941|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83864942|NCT00551005|Analgesics|analgesics|mesh-ancestor
83864943|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
83864944|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83864945|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864946|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83864947|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864948|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83864949|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83864950|NCT00551044|Bicalutamide|bicalutamide|mesh-list
83864951|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
83864952|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
83864953|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83864954|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864955|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864956|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83864957|NCT00161759|Thrombin|thrombin|mesh-list
83864958|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
83864959|NCT00161759|Coagulants|coagulants|mesh-ancestor
83864960|NCT00551122|Paclitaxel|paclitaxel|mesh-list
83864961|NCT00551122|Gemcitabine|gemcitabine|mesh-list
83864962|NCT00551122|Ifosfamide|ifosfamide|mesh-list
83864963|NCT00551122|Lenograstim|lenograstim|mesh-list
83864964|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83864965|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864966|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
83864967|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
83864968|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
83864969|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864970|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864971|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
83864972|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83864973|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
83864974|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864975|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83864976|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
83864977|NCT00551239|Rituximab|rituximab|mesh-list
83864978|NCT00551239|Fludarabine|fludarabine|mesh-list
83864979|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
83864981|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83864982|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83864983|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
83864984|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83864985|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83864986|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83864987|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
83864988|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864989|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83864990|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83148078|NCT02130869|Sargramostim|sargramostim|mesh-list
83864991|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83864992|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83864993|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83864994|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83864995|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83864996|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83864997|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83864998|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
83864999|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865000|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865001|NCT00551317|Darapladib|darapladib|mesh-list
83865002|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83865003|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865004|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865005|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
83865006|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83865007|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865008|NCT02963337|Remifentanil|remifentanil|mesh-list
83865009|NCT02963337|Bupivacaine|bupivacaine|mesh-list
83865010|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
83865011|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
83865012|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865013|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865014|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
83865015|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865016|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83865017|NCT02963337|Narcotics|narcotics|mesh-ancestor
83865018|NCT02963337|Analgesics|analgesics|mesh-ancestor
83865019|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83865020|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83865021|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865022|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865023|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865024|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865025|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865026|NCT00191919|Analgesics|analgesics|mesh-ancestor
83865027|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
83865028|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865029|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83865030|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83865031|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
83865032|NCT00161837|Vaccines|vaccines|mesh-list
83865033|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
83865034|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865035|NCT00551512|Cisplatin|cisplatin|mesh-list
83865036|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865037|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83865038|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83865039|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865040|NCT00551590|Incretins|incretins|mesh-ancestor
83865041|NCT00551590|Hormones|hormones|mesh-ancestor
83865042|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865043|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83865044|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
83865045|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865046|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865047|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83865048|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
83865049|NCT00161915|Coagulants|coagulants|mesh-ancestor
83865050|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83865051|NCT00185172|Olmesartan|olmesartan|mesh-list
83865052|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83865053|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83865054|NCT00185172|Diuretics|diuretics|mesh-ancestor
83865055|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
83865056|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865057|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83865058|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865059|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865060|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83865061|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83865062|NCT00191997|Olanzapine|olanzapine|mesh-list
83865063|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
83865064|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
83865065|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865066|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865067|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83865068|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83865069|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83865070|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865071|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83865072|NCT00191997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83865073|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865074|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865075|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865076|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865077|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
83865078|NCT00551824|Mitomycins|mitomycins|mesh-list
83865079|NCT00551824|Mitomycin|mitomycin|mesh-list
83865080|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83865081|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865082|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
83865083|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865084|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83865085|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865086|NCT00185250|Interferons|interferons|mesh-list
83865087|NCT00185250|Interferon-beta|interferon-beta|mesh-list
83865088|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
83865089|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865090|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
83865091|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865092|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
83865093|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865094|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83865095|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
83865096|NCT00161993|Antibodies|antibodies|mesh-list
83865097|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
83865098|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83865099|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83865100|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
83865101|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865102|NCT00185328|Estradiol|estradiol|mesh-list
83865103|NCT00185328|Estrogens|estrogens|mesh-ancestor
83865104|NCT00185328|Hormones|hormones|mesh-ancestor
83865105|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865106|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865107|NCT00162110|Cetuximab|cetuximab|mesh-list
83865108|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83865109|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865110|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
83865111|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83865112|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865113|NCT00162149|Ritonavir|ritonavir|mesh-list
83865114|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83865115|NCT00162149|Nevirapine|nevirapine|mesh-list
83865116|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83865117|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83865118|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
83865119|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865120|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865121|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83865122|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83865123|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
83865124|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865125|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83865126|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83865127|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83865128|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83865129|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83865130|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83865131|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
83865132|NCT00162188|Efavirenz|efavirenz|mesh-list
83865133|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83865134|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83865135|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865136|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865137|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
83865138|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865139|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83865140|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83865141|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83865142|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83865143|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83865144|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83865145|NCT00162227|Efavirenz|efavirenz|mesh-list
83865146|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83865147|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83865148|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865149|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865150|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
83865151|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865152|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83865153|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83865154|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83865155|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83865156|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83865157|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83865158|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83865159|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83865160|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865161|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83865162|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83865163|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865164|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865165|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865166|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865167|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865168|NCT00552682|Analgesics|analgesics|mesh-ancestor
83865169|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
83865170|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865171|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
83865172|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83865173|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
83865174|NCT04652089|Simvastatin|simvastatin|mesh-list
83865175|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83865176|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83865177|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
83865178|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865179|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83865180|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83865181|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865182|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83865183|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83865184|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865185|NCT04684498|Oseltamivir|oseltamivir|mesh-list
83865186|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
83865187|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865188|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104131|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104132|NCT05339074|Ketamine|ketamine|mesh-list
83104133|NCT05339074|Analgesics|analgesics|mesh-ancestor
83104134|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
83104135|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104136|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104137|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83104138|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83104139|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
83104140|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
83865189|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865190|NCT00552799|Penicillins|penicillins|mesh-list
83865191|NCT00552799|Penicillin V|penicillin v|mesh-list
83865192|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83865193|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865194|NCT00409071|Sinomenine|sinomenine|mesh-list
83865195|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865196|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
83865197|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83865198|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865199|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83865200|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865201|NCT04513015|Antioxidants|antioxidants|mesh-list
83865202|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865203|NCT04513015|Protective Agents|protective agents|mesh-ancestor
83865204|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865205|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83865206|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83865207|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865208|NCT04382326|Vaccines|vaccines|mesh-list
83865209|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83865210|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
83865211|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865212|NCT00162383|Dapsone|dapsone|mesh-list
83865213|NCT00162383|Debrisoquin|debrisoquin|mesh-list
83865214|NCT00162383|Mephenytoin|mephenytoin|mesh-list
83865215|NCT00162383|Caffeine|caffeine|mesh-list
83865216|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83865217|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865218|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83865219|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865220|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865221|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83865222|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83865223|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
83865224|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865225|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865226|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
83865227|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83865228|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83865229|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83865230|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
83865231|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83865232|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83865233|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
83865234|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
83865235|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865236|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
83865237|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
83865238|NCT00162422|Albuterol|albuterol|mesh-list
83865239|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83865240|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
83865241|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865242|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865243|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83865244|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
83865245|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
83865246|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83865247|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83865248|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83865249|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83865250|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
83865251|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865252|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865253|NCT04355143|Colchicine|colchicine|mesh-list
83865254|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
83865255|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865256|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
83865257|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
83865258|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865259|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865260|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865261|NCT00185445|Fludarabine|fludarabine|mesh-list
83865262|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
83865263|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865264|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83865265|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
83865266|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865267|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865268|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
83865269|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865270|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
83865271|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83865272|NCT04233034|Verapamil|verapamil|mesh-list
83865273|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83865274|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83865275|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865276|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865277|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83865278|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865279|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
83865280|NCT04187053|Methylene Blue|methylene blue|mesh-list
83865281|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865282|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865283|NCT00162461|Phenytoin|phenytoin|mesh-list
83865284|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
83865285|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83865286|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83865287|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865288|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865289|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83865290|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83865291|NCT00185562|Adalimumab|adalimumab|mesh-list
83865292|NCT00185562|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83865293|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83865294|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865295|NCT04095364|Paclitaxel|paclitaxel|mesh-list
83865296|NCT04095364|Carboplatin|carboplatin|mesh-list
83865297|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83865298|NCT04095364|Letrozole|letrozole|mesh-list
83865299|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83865300|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865301|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
83865302|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
83865303|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865304|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865305|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83865306|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83865307|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865308|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83865309|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83865310|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865311|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865312|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
83865313|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865314|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
83865315|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865316|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865317|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83865318|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
83865319|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865320|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865321|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83865322|NCT00162695|Etoposide|etoposide|mesh-list
83865323|NCT00162695|Vincristine|vincristine|mesh-list
83865324|NCT00162695|Epirubicin|epirubicin|mesh-list
83865325|NCT00162695|Ifosfamide|ifosfamide|mesh-list
83865326|NCT00162695|Carboplatin|carboplatin|mesh-list
83865327|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83865328|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865329|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83865330|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83865331|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865332|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865333|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83865334|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
83865335|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83865336|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83865337|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865338|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83865339|NCT00162734|Interferons|interferons|mesh-list
83865340|NCT00162734|Ribavirin|ribavirin|mesh-list
83865341|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
83865342|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865343|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
83865344|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865345|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
83865346|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865347|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83865348|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
83865349|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865350|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865351|NCT00162812|Epirubicin|epirubicin|mesh-list
83865352|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83865353|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865354|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83865355|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83865356|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865357|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865358|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
83865359|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83865360|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865361|NCT04015414|Varenicline|varenicline|mesh-list
83865362|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83865363|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83865364|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
83865365|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865366|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865367|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865368|NCT00185835|Gefitinib|gefitinib|mesh-list
83865369|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865370|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83865371|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865372|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865373|NCT00162968|Escitalopram|escitalopram|mesh-list
83865374|NCT00162968|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83865375|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865376|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865377|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865378|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865379|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
83865380|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865381|NCT03970330|Naltrexone|naltrexone|mesh-list
83865382|NCT03970330|Norethindrone|norethindrone|mesh-list
83865383|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
83865384|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83865385|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83865386|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865387|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
83865388|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865389|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83865390|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83865391|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83865392|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
83865393|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83865394|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83865395|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83865396|NCT00185874|Immunomodulating Agents|immunomodulating agents|mesh-list
83865397|NCT00185874|Immunologic Factors|immunologic factors|mesh-ancestor
83865398|NCT00185874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865399|NCT03757585|Inositol|inositol|mesh-list
83865400|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
83865401|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83865402|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
83865403|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865404|NCT03757585|Expectorants|expectorants|mesh-ancestor
83865405|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
83865406|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83865407|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
83865408|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865409|NCT03757585|Protective Agents|protective agents|mesh-ancestor
83865410|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865411|NCT03757585|Antidotes|antidotes|mesh-ancestor
83104355|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83865412|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
83865413|NCT03757585|Vitamins|vitamins|mesh-ancestor
83865414|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
83865415|NCT00163046|Gabapentin|gabapentin|mesh-list
83865416|NCT00163046|Analgesics|analgesics|mesh-ancestor
83865417|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
83865418|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865419|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865420|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
83865421|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83865422|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83865423|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865424|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83865425|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83865426|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83865427|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865428|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865429|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
83865430|NCT00185952|Nifedipine|nifedipine|mesh-list
83865431|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83865432|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865433|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865434|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83865435|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865436|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
83865437|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
83865438|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83865439|NCT03541447|Octreotide|octreotide|mesh-list
83865440|NCT03541447|Tolvaptan|tolvaptan|mesh-list
83865441|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83865442|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83865443|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865444|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83865445|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865446|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
83865447|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865448|NCT00192621|Lamivudine|lamivudine|mesh-list
83865449|NCT00192621|Zidovudine|zidovudine|mesh-list
83865450|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83865451|NCT00192621|Lopinavir|lopinavir|mesh-list
83865452|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83865453|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83865454|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865455|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865456|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
83865457|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865458|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83865459|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83865460|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
83865461|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83865462|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83865463|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
83865464|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83865465|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83865466|NCT03516604|Citalopram|citalopram|mesh-list
83865467|NCT03516604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83865468|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865469|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865470|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865471|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865472|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
83865473|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865474|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83865475|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
83865476|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83865477|NCT00185991|Gentamicins|gentamicins|mesh-list
83865478|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83865479|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865480|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83865481|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865482|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865483|NCT03434158|Olaparib|olaparib|mesh-list
83865484|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83865485|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865486|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865487|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865488|NCT00163202|Atorvastatin|atorvastatin|mesh-list
83865489|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83865490|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83865491|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
83865492|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865493|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83865494|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83865495|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865496|NCT03318952|Lidocaine|lidocaine|mesh-list
83865497|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
83865498|NCT03318952|Carticaine|carticaine|mesh-list
83865499|NCT03318952|Anesthetics|anesthetics|mesh-list
83865500|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865501|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865502|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
83865503|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865504|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83865505|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83865506|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83865507|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865508|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865509|NCT00192660|Ritonavir|ritonavir|mesh-list
83865510|NCT00192660|Nelfinavir|nelfinavir|mesh-list
83865511|NCT00192660|Indinavir|indinavir|mesh-list
83865512|NCT00192660|Saquinavir|saquinavir|mesh-list
83865513|NCT00192660|Amprenavir|amprenavir|mesh-list
83865514|NCT00192660|Tenofovir|tenofovir|mesh-list
83865515|NCT00192660|Lamivudine|lamivudine|mesh-list
83865516|NCT00192660|Zidovudine|zidovudine|mesh-list
83865517|NCT00192660|Nevirapine|nevirapine|mesh-list
83865518|NCT00192660|Abacavir|abacavir|mesh-list
83865519|NCT00192660|Stavudine|stavudine|mesh-list
83865520|NCT00192660|Didanosine|didanosine|mesh-list
83865521|NCT00192660|Tipranavir|tipranavir|mesh-list
83865522|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
83865523|NCT00192660|Efavirenz|efavirenz|mesh-list
83865524|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83865525|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83865526|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
83865527|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865528|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865529|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83865530|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83865531|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
83865532|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865533|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83865534|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83865535|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83865536|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83865537|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
83865538|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83865539|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83865540|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83865541|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83865542|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83865543|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83865544|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
83865545|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83865546|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83865547|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83865548|NCT00163241|Celecoxib|celecoxib|mesh-list
83865549|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83865550|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83865551|NCT00163241|Analgesics|analgesics|mesh-ancestor
83865552|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
83865553|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865554|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865555|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83865556|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865557|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83865558|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83865559|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865560|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865561|NCT03016819|Dacarbazine|dacarbazine|mesh-list
83865562|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83865563|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
83865564|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865565|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865566|NCT02916316|Doxorubicin|doxorubicin|mesh-list
83865567|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83865568|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83865569|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865570|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83865571|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83865572|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865573|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865574|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
83865575|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83865576|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83865577|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83865578|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865579|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865580|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865581|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865582|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865583|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83865584|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
83865585|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83865586|NCT00163319|Ciclesonide|ciclesonide|mesh-list
83865587|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
83865588|NCT00163319|Hormones|hormones|mesh-ancestor
83865589|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865590|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865591|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83865592|NCT02812420|Durvalumab|durvalumab|mesh-list
83865593|NCT02812420|Ipilimumab|ipilimumab|mesh-list
83865594|NCT02812420|Tremelimumab|tremelimumab|mesh-list
83865595|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
83865596|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83865597|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
83865598|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83865599|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865600|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
83865601|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865602|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83865603|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865604|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
83865605|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
83865606|NCT02556931|Fludarabine|fludarabine|mesh-list
83865607|NCT02556931|Tacrolimus|tacrolimus|mesh-list
83865608|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865609|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
83865610|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865611|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865612|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83865613|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
83865614|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865615|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865616|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83865617|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83865618|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865619|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83865620|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83865621|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
83865622|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83865623|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865624|NCT00163358|Ciclesonide|ciclesonide|mesh-list
83865625|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
83865626|NCT00163358|Hormones|hormones|mesh-ancestor
83865627|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865628|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865629|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83865630|NCT00163397|Ciclesonide|ciclesonide|mesh-list
83865631|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
83865632|NCT00163397|Hormones|hormones|mesh-ancestor
83865633|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865634|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865635|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83865636|NCT00163436|Ciclesonide|ciclesonide|mesh-list
83865637|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
83865638|NCT00163436|Hormones|hormones|mesh-ancestor
83865639|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865640|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865641|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83865642|NCT00186420|Docetaxel|docetaxel|mesh-list
83865643|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865644|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83865645|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83865646|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865647|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865648|NCT01628029|Melatonin|melatonin|mesh-list
83865649|NCT01628029|Methylphenidate|methylphenidate|mesh-list
83865650|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
83865651|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865652|NCT01628029|Protective Agents|protective agents|mesh-ancestor
83865653|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865654|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865655|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83865656|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83865657|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865658|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865659|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
83865660|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865661|NCT00163514|Ciclesonide|ciclesonide|mesh-list
83865662|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
83865663|NCT00163514|Hormones|hormones|mesh-ancestor
83865664|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865665|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865666|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83865667|NCT00717652|Triamcinolone|triamcinolone|mesh-list
83865668|NCT00717652|Tretinoin|tretinoin|mesh-list
83865669|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83865670|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
83865671|NCT00717652|Hormones|hormones|mesh-ancestor
83865672|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83865673|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865674|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865675|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
83865676|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
83865677|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
83865678|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
83865679|NCT00066040|Fluorides|fluorides|mesh-list
83865680|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
83865681|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
83865682|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
83865683|NCT00066040|Protective Agents|protective agents|mesh-ancestor
83865684|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865685|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83865686|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865687|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
83865688|NCT00163553|Meperidine|meperidine|mesh-list
83865689|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83865690|NCT00163553|Narcotics|narcotics|mesh-ancestor
83865691|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865692|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865693|NCT00163553|Analgesics|analgesics|mesh-ancestor
83865694|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
83865695|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865696|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83865697|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83865698|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
83865699|NCT00163592|Coagulants|coagulants|mesh-ancestor
83865700|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
83865701|NCT04683445|Trastuzumab|trastuzumab|mesh-list
83865702|NCT04683445|Pertuzumab|pertuzumab|mesh-list
83865703|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83865704|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865705|NCT04683445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83865706|NCT04683445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865707|NCT00192777|Capecitabine|capecitabine|mesh-list
83865708|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83865709|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
84148832|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
83104655|NCT03473691|Immunoconjugates|immunoconjugates|mesh-ancestor
83865710|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865711|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865712|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
83865713|NCT00553072|Analgesics|analgesics|mesh-ancestor
83865714|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
83148083|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865715|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865716|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865717|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
83865718|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865719|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83865720|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
83865721|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83865722|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865723|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865724|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83865725|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
83865726|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83865727|NCT05808608|Axitinib|axitinib|mesh-list
83865728|NCT05808608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865729|NCT05808608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83865730|NCT05808608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865731|NCT05808608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865732|NCT05808387|Resveratrol|resveratrol|mesh-list
83865733|NCT05808387|Antioxidants|antioxidants|mesh-ancestor
83865734|NCT05808387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865735|NCT05808387|Protective Agents|protective agents|mesh-ancestor
83865736|NCT05808387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865737|NCT05808387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865738|NCT05808387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83865739|NCT05808231|Quinine|quinine|mesh-list
83865740|NCT05808231|Antimalarials|antimalarials|mesh-ancestor
83865741|NCT05808231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83865742|NCT05808231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83865743|NCT05808231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865744|NCT05808231|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83865745|NCT05808231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865746|NCT05808231|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83865747|NCT05808231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865748|NCT05808231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83865749|NCT05808231|Analgesics|analgesics|mesh-ancestor
83865750|NCT05808231|Sensory System Agents|sensory system agents|mesh-ancestor
83865751|NCT05808192|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83865752|NCT05808192|Immunologic Factors|immunologic factors|mesh-ancestor
83865753|NCT05808192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865754|NCT05808049|Antioxidants|antioxidants|mesh-list
83865755|NCT05808049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865756|NCT05808049|Protective Agents|protective agents|mesh-ancestor
83865757|NCT05808049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865758|NCT05808010|Hydrotalcite|hydrotalcite|mesh-list
83865759|NCT05808010|Antacids|antacids|mesh-ancestor
83865760|NCT05808010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865761|NCT05808010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83865762|NCT05807945|Ropivacaine|ropivacaine|mesh-list
83865763|NCT05807945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83865764|NCT05807945|Anesthetics, Local|anesthetics, local|mesh-ancestor
83865765|NCT05807945|Anesthetics|anesthetics|mesh-ancestor
83865766|NCT05807945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865767|NCT05807945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865768|NCT05807945|Sensory System Agents|sensory system agents|mesh-ancestor
83865769|NCT05807945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865770|NCT05807932|Mycophenolic Acid|mycophenolic acid|mesh-list
83865771|NCT05807932|Venetoclax|venetoclax|mesh-list
83865772|NCT05807932|Amsacrine|amsacrine|mesh-list
83865773|NCT05807932|Tacrolimus|tacrolimus|mesh-list
83865774|NCT05807932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865775|NCT05807932|Immunologic Factors|immunologic factors|mesh-ancestor
83865776|NCT05807932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865777|NCT05807932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83865778|NCT05807932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865779|NCT05807932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865780|NCT05807932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83865781|NCT05807932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865782|NCT05807932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83865783|NCT05807932|Antitubercular Agents|antitubercular agents|mesh-ancestor
84148833|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865785|NCT05807932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865786|NCT05807893|Bevacizumab|bevacizumab|mesh-list
83865787|NCT05807893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83865788|NCT05807893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865789|NCT05807893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83865790|NCT05807893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83865791|NCT05807893|Growth Substances|growth substances|mesh-ancestor
83865792|NCT05807893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865793|NCT05807893|Growth Inhibitors|growth inhibitors|mesh-ancestor
83865794|NCT05807880|Capecitabine|capecitabine|mesh-list
83865795|NCT05807880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83865796|NCT05807880|Antimetabolites|antimetabolites|mesh-ancestor
83865797|NCT05807880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865798|NCT05807880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865799|NCT05807776|Lenvatinib|lenvatinib|mesh-list
83865800|NCT05807776|Tislelizumab|tislelizumab|mesh-list
83865801|NCT05807776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865802|NCT05807776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83865803|NCT05807776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865804|NCT05807776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865805|NCT05807776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83865806|NCT05807711|Vitamin B 12|vitamin b 12|mesh-list
83865807|NCT05807711|Vitamin B Complex|vitamin b complex|mesh-ancestor
83865808|NCT05807711|Vitamins|vitamins|mesh-ancestor
83865809|NCT05807711|Micronutrients|micronutrients|mesh-ancestor
83865810|NCT05807711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865811|NCT05807659|Busulfan|busulfan|mesh-list
83865812|NCT05807659|Alkylating Agents|alkylating agents|mesh-ancestor
83865813|NCT05807659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865814|NCT05807659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865815|NCT05807659|Immunologic Factors|immunologic factors|mesh-ancestor
83865816|NCT05807659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865817|NCT05807659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83865818|NCT05807659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865819|NCT05807659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83865820|NCT05807542|Paclitaxel|paclitaxel|mesh-list
83865821|NCT05807542|Carboplatin|carboplatin|mesh-list
83865822|NCT05807542|Tislelizumab|tislelizumab|mesh-list
83865823|NCT05807542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83865824|NCT05807542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865825|NCT05807542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83865826|NCT05807542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83865827|NCT05807542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865828|NCT05807542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865829|NCT05807542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83865830|NCT05807503|Cerebrolysin|cerebrolysin|mesh-list
83865831|NCT05807503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83865832|NCT05807503|Protective Agents|protective agents|mesh-ancestor
83865833|NCT05807503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865834|NCT05807503|Nootropic Agents|nootropic agents|mesh-ancestor
83865835|NCT05807425|Polidocanol|polidocanol|mesh-list
83865836|NCT05807425|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83865837|NCT05807425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83865838|NCT05807347|Cytarabine|cytarabine|mesh-list
83865839|NCT05807347|Azacitidine|azacitidine|mesh-list
83865840|NCT05807347|Venetoclax|venetoclax|mesh-list
83865841|NCT05807347|Aclacinomycins|aclacinomycins|mesh-list
83865842|NCT05807347|Lenograstim|lenograstim|mesh-list
83865843|NCT05807347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83865844|NCT05807347|Antimetabolites|antimetabolites|mesh-ancestor
83865845|NCT05807347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865846|NCT05807347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865847|NCT05807347|Antiviral Agents|antiviral agents|mesh-ancestor
83865848|NCT05807347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865849|NCT05807347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865850|NCT05807347|Immunologic Factors|immunologic factors|mesh-ancestor
83865851|NCT05807347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865852|NCT05807347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865853|NCT05807347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83865854|NCT05807347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83865855|NCT05807165|Memantine|memantine|mesh-list
83865856|NCT05807165|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83865857|NCT05807165|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83865858|NCT05807165|Dopamine Agents|dopamine agents|mesh-ancestor
83865859|NCT05807165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865860|NCT05807165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865861|NCT05807165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865862|NCT05807165|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83865863|NCT05807165|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83865864|NCT05807100|Salicylic Acid|salicylic acid|mesh-list
83865865|NCT05807100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865866|NCT05807100|Antifungal Agents|antifungal agents|mesh-ancestor
83865867|NCT05807100|Keratolytic Agents|keratolytic agents|mesh-ancestor
83865868|NCT05807100|Dermatologic Agents|dermatologic agents|mesh-ancestor
83865869|NCT05807035|Vaccines|vaccines|mesh-list
83865870|NCT05807035|Immunologic Factors|immunologic factors|mesh-ancestor
83865871|NCT05807035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865872|NCT05798481|Acetylcysteine|acetylcysteine|mesh-list
83865873|NCT05798481|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83865874|NCT05798481|Antiviral Agents|antiviral agents|mesh-ancestor
83865875|NCT05798481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865876|NCT05798481|Expectorants|expectorants|mesh-ancestor
83865877|NCT05798481|Respiratory System Agents|respiratory system agents|mesh-ancestor
83865878|NCT05798481|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83865879|NCT05798481|Antioxidants|antioxidants|mesh-ancestor
83865880|NCT05798481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865881|NCT05798481|Protective Agents|protective agents|mesh-ancestor
83865882|NCT05798481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865883|NCT05798481|Antidotes|antidotes|mesh-ancestor
83865884|NCT05781698|Mesalamine|mesalamine|mesh-list
83865885|NCT05781698|Fenofibrate|fenofibrate|mesh-list
83865886|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83865887|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
83865888|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865889|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83865890|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83865891|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83865892|NCT05781698|Analgesics|analgesics|mesh-ancestor
83865893|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
83865894|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865895|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865896|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83865897|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865898|NCT05709509|Aspirin|aspirin|mesh-list
83865899|NCT05709509|Colchicine|colchicine|mesh-list
83865900|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83865901|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83865902|NCT05709509|Analgesics|analgesics|mesh-ancestor
83865903|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
83865904|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865905|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865906|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83865907|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865908|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83865909|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83865910|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865911|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83865912|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83865913|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865914|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
83865915|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
83865916|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
83865917|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
83865918|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865919|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865920|NCT05693844|Paclitaxel|paclitaxel|mesh-list
83865921|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
83865922|NCT05693844|Fludarabine|fludarabine|mesh-list
83865923|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83865924|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83865925|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83865926|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
83865927|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
83865928|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
83865929|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865930|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865931|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
83865932|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865933|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865934|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83865935|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
83865936|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83865937|NCT05690698|Haloperidol|haloperidol|mesh-list
83865938|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
83865939|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
83865940|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
83865941|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865942|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865943|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83865944|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83865945|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83865946|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83865947|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83865948|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83865949|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
83865950|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865951|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865952|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83865953|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
83865954|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83865955|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
83865956|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83865957|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865958|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83865959|NCT05644340|Methamphetamine|methamphetamine|mesh-list
83865960|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83865961|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865962|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
83865963|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
83865964|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83865965|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
83865966|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83865967|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865968|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
83865969|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83865970|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83865971|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83865972|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83865973|NCT05630872|Lamivudine|lamivudine|mesh-list
83865974|NCT05630872|Dolutegravir|dolutegravir|mesh-list
83865975|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83865976|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83865977|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865978|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865979|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
83865980|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865981|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83865982|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83865983|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83865984|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83865985|NCT05627947|Cyclosporine|cyclosporine|mesh-list
83865986|NCT05627947|Mitomycins|mitomycins|mesh-list
83865987|NCT05627947|Mitomycin|mitomycin|mesh-list
83865988|NCT05627947|Cyclosporins|cyclosporins|mesh-list
83865989|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83865990|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83865991|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83865992|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
83865993|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83865994|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
83865995|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83865996|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
83865997|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83865998|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83865999|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83866000|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866001|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
83866002|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83866003|NCT05617118|Baclofen|baclofen|mesh-list
83866004|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
83866005|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83866006|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83866007|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83866008|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83866009|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866010|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
83866011|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866012|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866013|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83866014|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866015|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83866016|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83866017|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
83866018|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
83866019|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83866020|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83866021|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
83866022|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866023|NCT05591105|Acetaminophen|acetaminophen|mesh-list
83866024|NCT05591105|Dipyrone|dipyrone|mesh-list
83866025|NCT05591105|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83866026|NCT05591105|Lidocaine|lidocaine|mesh-list
83866027|NCT05591105|Ketamine|ketamine|mesh-list
83866028|NCT05591105|Morphine|morphine|mesh-list
83866029|NCT05591105|Anesthetics, Local|anesthetics, local|mesh-ancestor
83866030|NCT05591105|Anesthetics|anesthetics|mesh-ancestor
83866031|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866032|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866033|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
83866034|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866035|NCT05591105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83866036|NCT05591105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83866037|NCT05591105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83866038|NCT05591105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83866039|NCT05591105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866040|NCT05591105|Analgesics|analgesics|mesh-ancestor
83866041|NCT05591105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83866042|NCT05591105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83866043|NCT05591105|Anesthetics, General|anesthetics, general|mesh-ancestor
83866044|NCT05591105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83866045|NCT05591105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83866046|NCT05591105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866047|NCT05591105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83866048|NCT05591105|Narcotics|narcotics|mesh-ancestor
83866049|NCT05591105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83866050|NCT05591105|Antipyretics|antipyretics|mesh-ancestor
83866051|NCT05591105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83866052|NCT05591105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83866053|NCT05591105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866054|NCT05550662|Xenon|xenon|mesh-list
83866055|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83866056|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
83866057|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
83866058|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866059|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866060|NCT05546658|Psilocybin|psilocybin|mesh-list
83866061|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
83866062|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866063|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83866064|NCT05494580|Pamiparib|pamiparib|mesh-list
83866065|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83866066|NCT05494580|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83866067|NCT05494580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866068|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866069|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866070|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866071|NCT05464654|Estrogens|estrogens|mesh-list
83866072|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83866073|NCT05464654|Hormones|hormones|mesh-ancestor
83866074|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866075|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866076|NCT05352516|Denosumab|denosumab|mesh-list
83866077|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83866078|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866079|NCT05280704|Lidocaine|lidocaine|mesh-list
83866080|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
83866081|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
83866082|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866083|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866084|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
83866085|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105042|NCT03674411|Melphalan|melphalan|mesh-list
83866086|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83866087|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83866088|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83866089|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83866090|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866091|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83866092|NCT05267873|Vortioxetine|vortioxetine|mesh-list
83866093|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83866094|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83866095|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83866096|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866097|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866098|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866099|NCT05267873|Analgesics|analgesics|mesh-ancestor
83866100|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
83866101|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866102|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
83866103|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83866104|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
83866105|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83866106|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83866107|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866108|NCT05267873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83866109|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
83866110|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83866111|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83866112|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83866113|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83866114|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
83866115|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83866116|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83866117|NCT05113901|Prednisolone|prednisolone|mesh-list
83866118|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
83866119|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83866120|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
83866121|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83866122|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
83866123|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
83866124|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866125|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866126|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83866127|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
83866128|NCT05113901|Hormones|hormones|mesh-ancestor
83866129|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866130|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83866131|NCT05113901|Protective Agents|protective agents|mesh-ancestor
83866132|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83866133|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866134|NCT05075603|Tisagenlecleucel|tisagenlecleucel|mesh-list
83866135|NCT05075603|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83866136|NCT05075603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866137|NCT05075603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866138|NCT05065216|Kallikreins|kallikreins|mesh-list
83866139|NCT05065216|Coagulants|coagulants|mesh-ancestor
83866140|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83866141|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
83866142|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83866143|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866144|NCT05024214|Sunitinib|sunitinib|mesh-list
83866145|NCT05024214|Lenvatinib|lenvatinib|mesh-list
83866146|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866147|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83866148|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83866149|NCT05024214|Growth Substances|growth substances|mesh-ancestor
83866150|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866151|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
83866152|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866153|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866154|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866155|NCT05018091|Dexamethasone|dexamethasone|mesh-list
83866156|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
83866157|NCT05018091|BB 1101|bb 1101|mesh-list
83866158|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105113|NCT03473613|Calcium|calcium|mesh-list
83866159|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
83866160|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
83866161|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866162|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866163|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83866164|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
83866165|NCT05018091|Hormones|hormones|mesh-ancestor
83866166|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866167|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83866168|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866169|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
83866170|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866171|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866172|NCT04999644|Nicotine|nicotine|mesh-list
83866173|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83866174|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
83866175|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866176|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866177|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83866178|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83866179|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
83866180|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866181|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866182|NCT04962503|Afamelanotide|afamelanotide|mesh-list
83866183|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
83866184|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
83866185|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83866186|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
83866187|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866188|NCT04916080|Expectorants|expectorants|mesh-ancestor
83866189|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
83866190|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83866191|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
83866192|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866193|NCT04916080|Protective Agents|protective agents|mesh-ancestor
83866194|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866195|NCT04916080|Antidotes|antidotes|mesh-ancestor
83866196|NCT04862975|Tenofovir|tenofovir|mesh-list
83866197|NCT04862975|Emtricitabine|emtricitabine|mesh-list
83866198|NCT04862975|Efavirenz|efavirenz|mesh-list
83866199|NCT04862975|Dolutegravir|dolutegravir|mesh-list
83866200|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
83866201|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866202|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83866203|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83866204|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866205|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866206|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83866207|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83866208|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83866209|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83866210|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83866211|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83866212|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83866213|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83866214|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83866215|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83866216|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83866217|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83866218|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866219|NCT04833140|Estradiol|estradiol|mesh-list
83866220|NCT04833140|Estrogens|estrogens|mesh-ancestor
83866221|NCT04833140|Hormones|hormones|mesh-ancestor
83866222|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866223|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866224|NCT04826562|Lamivudine|lamivudine|mesh-list
83866225|NCT04826562|Dolutegravir|dolutegravir|mesh-list
83866226|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83866227|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83866228|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866229|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866230|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
83866231|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866232|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83866233|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83866234|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83866235|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83866236|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83866237|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
83866238|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866239|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866240|NCT04767841|Metformin|metformin|mesh-list
83866241|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83866242|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866243|NCT04761861|Vildagliptin|vildagliptin|mesh-list
83866244|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83866245|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866246|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83866247|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
83866248|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866249|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866250|NCT04716699|Lidocaine|lidocaine|mesh-list
83866251|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
83866252|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
83866253|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866254|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866255|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
83866256|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866257|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83866258|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83866259|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83866260|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83866261|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866262|NCT04691817|Atezolizumab|atezolizumab|mesh-list
83866263|NCT04691817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866264|NCT04691817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866265|NCT04691817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866266|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866267|NCT04685980|Morphine|morphine|mesh-list
83866268|NCT04685980|Anesthetics|anesthetics|mesh-list
83866269|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
83866270|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866271|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866272|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83866273|NCT04685980|Narcotics|narcotics|mesh-ancestor
83866274|NCT04685980|Analgesics|analgesics|mesh-ancestor
83866275|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
83866276|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866277|NCT04657692|Anesthetics|anesthetics|mesh-list
83866278|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866279|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866280|NCT04577690|Epinephrine|epinephrine|mesh-list
83866281|NCT04577690|Racepinephrine|racepinephrine|mesh-list
83866282|NCT04577690|Bupivacaine|bupivacaine|mesh-list
83866283|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
83866284|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
83866285|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
83866286|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866287|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866288|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
83866289|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866290|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83866291|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83866292|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
83866293|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866294|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866295|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83866296|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83866297|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
83866298|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83866299|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
83866300|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
83866301|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
83866302|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83866303|NCT04531176|Liraglutide|liraglutide|mesh-list
83866304|NCT04531176|Topiramate|topiramate|mesh-list
83866305|NCT04531176|Orlistat|orlistat|mesh-list
83866306|NCT04531176|Phentermine|phentermine|mesh-list
83866307|NCT04531176|Naltrexone|naltrexone|mesh-list
83866308|NCT04531176|Bupropion|bupropion|mesh-list
83866309|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83866310|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83866311|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866312|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
83866313|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866314|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83866315|NCT04531176|Incretins|incretins|mesh-ancestor
83866316|NCT04531176|Hormones|hormones|mesh-ancestor
83866317|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866318|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83866319|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
83866320|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83866321|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83866322|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83866323|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83866324|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866325|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
83866326|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866327|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83866328|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83866329|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866330|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
83866331|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83866332|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83866333|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83866334|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
83866335|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
83866336|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
83866337|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83866338|NCT04472767|Nivolumab|nivolumab|mesh-list
83866339|NCT04472767|Ipilimumab|ipilimumab|mesh-list
83866340|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866341|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866342|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866343|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866344|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
83866345|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866346|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
83866347|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
83866348|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83866349|NCT04409860|Paclitaxel|paclitaxel|mesh-list
83866350|NCT04409860|Cisplatin|cisplatin|mesh-list
83866351|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83866352|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866353|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
83866354|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
83866355|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
83866356|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866357|NCT04311099|Ropivacaine|ropivacaine|mesh-list
83866358|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
83866359|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
83866360|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866361|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866362|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
83866363|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866364|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83866365|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
83866366|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866367|NCT04303390|Cefazolin|cefazolin|mesh-list
83866368|NCT04303390|Cefuroxime|cefuroxime|mesh-list
83866369|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
83866370|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83866371|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866372|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
83866373|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866374|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866375|NCT04093167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866376|NCT04093167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866377|NCT04075110|Montelukast|montelukast|mesh-list
83866378|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83866379|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83866380|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83866381|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
83866382|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866383|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866384|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83866385|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83866386|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866387|NCT04055909|Nangibotide|nangibotide|mesh-list
83866388|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83866389|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
83866390|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866391|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866392|NCT03978689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866393|NCT03978689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866394|NCT03910387|Paclitaxel|paclitaxel|mesh-list
83866395|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83866396|NCT03910387|Gemcitabine|gemcitabine|mesh-list
83866397|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83866398|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866399|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
83866400|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
83866401|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83866402|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866403|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866404|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
83866405|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
83866406|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866407|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866408|NCT03861793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866409|NCT03861793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866410|NCT03816553|Apatinib|apatinib|mesh-list
83866411|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866412|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866413|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866414|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866415|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
83866416|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866417|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
83866418|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866419|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866420|NCT03729245|Nivolumab|nivolumab|mesh-list
83866421|NCT03729245|Sunitinib|sunitinib|mesh-list
83866422|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866423|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866424|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866425|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866426|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83866427|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83866428|NCT03729245|Growth Substances|growth substances|mesh-ancestor
83866429|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866430|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
83866431|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866432|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866433|NCT03712397|Irinotecan|irinotecan|mesh-list
83866434|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83866435|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83866436|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866437|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866438|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866439|NCT03557918|Tremelimumab|tremelimumab|mesh-list
83866440|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866441|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
83866442|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866443|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866444|NCT03544099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866445|NCT03544099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866446|NCT03528408|Nivolumab|nivolumab|mesh-list
83866447|NCT03528408|Ipilimumab|ipilimumab|mesh-list
83866448|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866449|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866450|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866451|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866452|NCT03527108|Nivolumab|nivolumab|mesh-list
83866453|NCT03527108|Ramucirumab|ramucirumab|mesh-list
83866454|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866455|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866456|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866457|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866458|NCT03501381|Aldesleukin|aldesleukin|mesh-list
83866459|NCT03501381|Interleukin-2|interleukin-2|mesh-list
83866460|NCT03501381|Entinostat|entinostat|mesh-list
83866461|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866462|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83866463|NCT03501381|Analgesics|analgesics|mesh-ancestor
83866464|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
83866465|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866466|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866467|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83866468|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83866469|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
83866470|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866471|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83866472|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866473|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866474|NCT03478488|Gemcitabine|gemcitabine|mesh-list
83866475|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
83866476|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866477|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
83866478|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866479|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866480|NCT03451331|Carboplatin|carboplatin|mesh-list
83866481|NCT03451331|Gemcitabine|gemcitabine|mesh-list
83866482|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
83866483|NCT03451331|Nivolumab|nivolumab|mesh-list
83866484|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866485|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866486|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
83866487|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866488|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866489|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866490|NCT03412877|Aldesleukin|aldesleukin|mesh-list
83866491|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
83866492|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
83866493|NCT03412877|Fludarabine|fludarabine|mesh-list
83866494|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866495|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
83866496|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866497|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866498|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866499|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
83866500|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866501|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866502|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83866503|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866504|NCT03412877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866505|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83866506|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83866507|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
83866508|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866509|NCT03406299|Leucovorin|leucovorin|mesh-list
83866510|NCT03406299|Gemcitabine|gemcitabine|mesh-list
83866511|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
83866512|NCT03406299|Tegafur|tegafur|mesh-list
83866513|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866514|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866515|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
83866516|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866517|NCT03406299|Antidotes|antidotes|mesh-ancestor
83866518|NCT03406299|Protective Agents|protective agents|mesh-ancestor
83866519|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866520|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
83866521|NCT03406299|Vitamins|vitamins|mesh-ancestor
83866522|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
83866523|NCT03404960|Nivolumab|nivolumab|mesh-list
83866524|NCT03404960|Ipilimumab|ipilimumab|mesh-list
83866525|NCT03404960|Niraparib|niraparib|mesh-list
83866526|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866527|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866528|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866529|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866530|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83866531|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866532|NCT03396445|Paclitaxel|paclitaxel|mesh-list
83866533|NCT03396445|Carboplatin|carboplatin|mesh-list
83866534|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
83866536|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83866537|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866538|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
83866539|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
83866540|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
83866541|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866542|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866543|NCT03396445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866544|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866545|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83866546|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83866547|NCT03385655|Carboplatin|carboplatin|mesh-list
83866548|NCT03385655|Durvalumab|durvalumab|mesh-list
83866549|NCT03385655|Tremelimumab|tremelimumab|mesh-list
83866550|NCT03385655|Ipatasertib|ipatasertib|mesh-list
83866551|NCT03385655|Adavosertib|adavosertib|mesh-list
83866552|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866553|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866554|NCT03385655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866555|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866556|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866557|NCT03355469|Metformin|metformin|mesh-list
83866558|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83866559|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866560|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
83866561|NCT03330028|Promethazine|promethazine|mesh-list
83866562|NCT03330028|Dexamethasone|dexamethasone|mesh-list
83866563|NCT03330028|Paclitaxel|paclitaxel|mesh-list
83866564|NCT03330028|Cisplatin|cisplatin|mesh-list
83866565|NCT03330028|Mitomycins|mitomycins|mesh-list
83866566|NCT03330028|Mitomycin|mitomycin|mesh-list
83866567|NCT03330028|Famotidine|famotidine|mesh-list
83866568|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83866569|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866570|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83866571|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83866572|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83866573|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866574|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83866575|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
83866576|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
83866577|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866578|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866579|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83866580|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
83866581|NCT03330028|Hormones|hormones|mesh-ancestor
83866582|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866583|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83866584|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83866585|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
83866586|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83866587|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866588|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83866589|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83866590|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866591|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
83866592|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
83866593|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
83866594|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83866595|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
83866596|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
83866597|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866598|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83866599|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
83866600|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83866601|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83866602|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83866603|NCT03324373|Everolimus|everolimus|mesh-list
83866604|NCT03324373|Lenvatinib|lenvatinib|mesh-list
83866605|NCT03324373|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83866606|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866607|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866608|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866609|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866610|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
83105559|NCT02665286|Analgesics|analgesics|mesh-ancestor
83866611|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866612|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866614|NCT03311555|Androgens|androgens|mesh-list
83866615|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866616|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83866617|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83866618|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83866619|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866620|NCT03311555|Hormones|hormones|mesh-ancestor
83866621|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866622|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866623|NCT03271866|Metformin|metformin|mesh-list
83866624|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83866625|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866626|NCT03259503|Rituximab|rituximab|mesh-list
83866627|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83866628|NCT03259503|Gemcitabine|gemcitabine|mesh-list
83866629|NCT03259503|Melphalan|melphalan|mesh-list
83866630|NCT03259503|Busulfan|busulfan|mesh-list
83866631|NCT03259503|Olaparib|olaparib|mesh-list
83866632|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
83866633|NCT03259503|Vorinostat|vorinostat|mesh-list
83866634|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83866635|NCT03259503|Antibodies|antibodies|mesh-list
83866636|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
83866637|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83866638|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
83866639|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866640|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866641|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866642|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866643|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
83866644|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866645|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866646|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
83866647|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83866648|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866649|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83866650|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866651|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83866652|NCT03217565|Tedizolid|tedizolid|mesh-list
83866653|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
83866654|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
83866655|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83866656|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866657|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83866658|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866659|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866660|NCT03214562|Cytarabine|cytarabine|mesh-list
83866661|NCT03214562|Fludarabine|fludarabine|mesh-list
83866662|NCT03214562|Venetoclax|venetoclax|mesh-list
83866663|NCT03214562|Idarubicin|idarubicin|mesh-list
83866664|NCT03214562|Lenograstim|lenograstim|mesh-list
83866665|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866666|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866667|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
83866668|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866669|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866670|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
83866671|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866672|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
83866673|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866674|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83866675|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83866676|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83866677|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83866678|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866679|NCT03196180|Fluorouracil|fluorouracil|mesh-list
83866680|NCT03196180|Imiquimod|imiquimod|mesh-list
83866681|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
83866682|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866683|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866684|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866685|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866686|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
83866687|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866688|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83866689|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
83866690|NCT03162627|Olaparib|olaparib|mesh-list
83866691|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83866692|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866693|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866694|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866695|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
83866696|NCT02992743|Fludarabine|fludarabine|mesh-list
83866697|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866698|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
83866699|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866700|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866701|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866702|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
83866703|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866704|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866705|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83866706|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
83866707|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866708|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866709|NCT02853344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866710|NCT02853344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866711|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83866712|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866713|NCT02821013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866714|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866715|NCT02738229|Valacyclovir|valacyclovir|mesh-list
83866716|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
83866717|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866718|NCT02675426|Upadacitinib|upadacitinib|mesh-list
83866719|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83866720|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866721|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866722|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866723|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866724|NCT02579473|Rotigotine|rotigotine|mesh-list
83866725|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
83866726|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
83866727|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866728|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866729|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866730|NCT02427620|Cytarabine|cytarabine|mesh-list
83866731|NCT02427620|Dexamethasone|dexamethasone|mesh-list
83866732|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
83866733|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
83866734|NCT02427620|Rituximab|rituximab|mesh-list
83866735|NCT02427620|Doxorubicin|doxorubicin|mesh-list
83866736|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83866737|NCT02427620|Methotrexate|methotrexate|mesh-list
83866738|NCT02427620|Vincristine|vincristine|mesh-list
83866739|NCT02427620|Daunorubicin|daunorubicin|mesh-list
83866740|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83866741|NCT02427620|Antibodies|antibodies|mesh-list
83866742|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
83866743|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83866744|NCT02427620|BB 1101|bb 1101|mesh-list
83866745|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866746|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
83866747|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866748|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866749|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866750|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
83866751|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866752|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866753|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83866754|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83866755|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
83866756|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
83866757|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866758|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83866759|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
83866760|NCT02427620|Hormones|hormones|mesh-ancestor
83866761|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866762|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83866763|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
83866765|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83866766|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83866767|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83866768|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83866769|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
83866770|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83866771|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866772|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
83866773|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
83866774|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83866775|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83866776|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
83866777|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866778|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83866779|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
83866780|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
83866781|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
83866782|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
83866783|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866784|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83866785|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866786|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866787|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
83866788|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866789|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866790|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83866791|NCT02403505|Myeloma Proteins|myeloma proteins|mesh-list
83866792|NCT02403505|Paraproteins|paraproteins|mesh-list
83866793|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
83866794|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
83866795|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866796|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83866797|NCT02401035|Pantoprazole|pantoprazole|mesh-list
83866798|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83866799|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83866800|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83866801|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866802|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866803|NCT02365766|Gemcitabine|gemcitabine|mesh-list
83866804|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
83866805|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866806|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866807|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
83866808|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866809|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866810|NCT02365766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83866811|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83866812|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83866813|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866814|NCT02153944|Propranolol|propranolol|mesh-list
83866815|NCT02153944|Methylphenidate|methylphenidate|mesh-list
83866816|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83866817|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866818|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83866819|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83866820|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83866821|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866822|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
83866823|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866824|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83866825|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83866826|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83866827|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83866828|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83866829|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
83866830|NCT02091960|Trastuzumab|trastuzumab|mesh-list
83866831|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83866832|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866833|NCT02060721|Macitentan|macitentan|mesh-list
83866834|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83866835|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83866836|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866837|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83866838|NCT01527149|Cytarabine|cytarabine|mesh-list
83866839|NCT01527149|Dexamethasone|dexamethasone|mesh-list
83866840|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
83866841|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
83866842|NCT01527149|Doxorubicin|doxorubicin|mesh-list
83866843|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83866844|NCT01527149|Methotrexate|methotrexate|mesh-list
83866845|NCT01527149|Vincristine|vincristine|mesh-list
83866846|NCT01527149|Ofatumumab|ofatumumab|mesh-list
83866847|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83866848|NCT01527149|BB 1101|bb 1101|mesh-list
83866849|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866850|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
83866851|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866852|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866853|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866854|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
83866855|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866856|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866857|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83866858|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83866859|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
83866860|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
83866861|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866862|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83866863|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
83866864|NCT01527149|Hormones|hormones|mesh-ancestor
83866865|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866866|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83866867|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83866868|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83866869|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83866870|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866871|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83866872|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
83866873|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83866874|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83866875|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
83866876|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
83866877|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83866878|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83866879|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
83866880|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866881|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83866882|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83866883|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83866884|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83866885|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
83866886|NCT01359956|Interferons|interferons|mesh-list
83866887|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
83866888|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
83866889|NCT01359956|Dacarbazine|dacarbazine|mesh-list
83866890|NCT01359956|Fotemustine|fotemustine|mesh-list
83866891|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866892|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
83866893|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866894|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
83866895|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866896|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866897|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
83866898|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866899|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83866900|NCT01306045|Sunitinib|sunitinib|mesh-list
83866901|NCT01306045|Lapatinib|lapatinib|mesh-list
83866902|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866903|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83866904|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866905|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866906|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83866907|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83866908|NCT01306045|Growth Substances|growth substances|mesh-ancestor
83866909|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105865|NCT05798195|Dexamethasone|dexamethasone|mesh-list
83866910|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
83866911|NCT01198067|Pomalidomide|pomalidomide|mesh-list
83866912|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
83866913|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866914|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83866915|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83866916|NCT01198067|Growth Substances|growth substances|mesh-ancestor
83866917|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
83866918|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866920|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83866921|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
83866922|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83866923|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866924|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83866925|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866926|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83866927|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83866928|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83866929|NCT01192568|Oxybutynin|oxybutynin|mesh-list
83866930|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
83866931|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
83866932|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866933|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866934|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83866935|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83866936|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
83866937|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866938|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866939|NCT01192568|Urological Agents|urological agents|mesh-ancestor
83866940|NCT01075971|Buprenorphine|buprenorphine|mesh-list
83866941|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83866942|NCT01075971|Narcotics|narcotics|mesh-ancestor
83866943|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83866944|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866945|NCT01075971|Analgesics|analgesics|mesh-ancestor
83866946|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
83866947|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866948|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83866949|NCT00775749|Nicotine|nicotine|mesh-list
83866950|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83866951|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
83866952|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83866953|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866954|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83866955|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83866956|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
83866957|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83866958|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866959|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
83866960|NCT00576979|Etoposide|etoposide|mesh-list
83866961|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
83866962|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83866963|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
83866964|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83866965|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83866966|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83866967|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
83866968|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866969|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83866970|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83866971|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83866972|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83866973|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83866974|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866975|NCT00324922|Vancomycin|vancomycin|mesh-list
83866976|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83866977|NCT00324922|Trimethoprim|trimethoprim|mesh-list
83866978|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
83866979|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83866980|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83866981|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83866982|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
83866983|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83866984|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83866985|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83866986|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866987|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866988|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83866989|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83866990|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83866991|NCT00192855|Entacapone|entacapone|mesh-list
83866992|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83866993|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83866994|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83866995|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83866996|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83866997|NCT00407186|Cisplatin|cisplatin|mesh-list
83866998|NCT00407186|Capecitabine|capecitabine|mesh-list
83866999|NCT00407186|Epirubicin|epirubicin|mesh-list
83867000|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867001|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867002|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
83867003|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867004|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83867005|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83867006|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867007|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867008|NCT00163748|Gemcitabine|gemcitabine|mesh-list
83867009|NCT00163748|Vinorelbine|vinorelbine|mesh-list
83867010|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867011|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
83867012|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867013|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867014|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83867015|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867016|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867017|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867018|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
83867019|NCT00193011|Docetaxel|docetaxel|mesh-list
83867020|NCT00193011|Fluorouracil|fluorouracil|mesh-list
83867021|NCT00193011|Methotrexate|methotrexate|mesh-list
83867022|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867023|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
83867024|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867025|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867026|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83867027|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
83867028|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867029|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867030|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83867031|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867032|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867033|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867034|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
83867035|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867036|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83867037|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
83867038|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83867039|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
83867040|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867041|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83867042|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83867043|NCT00193089|Docetaxel|docetaxel|mesh-list
83867044|NCT00193089|Trastuzumab|trastuzumab|mesh-list
83106011|NCT05797038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106012|NCT05797038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106027|NCT05795933|Vitamin D|vitamin d|mesh-list
83106028|NCT05795933|Cholecalciferol|cholecalciferol|mesh-list
83106029|NCT05795933|Vitamins|vitamins|mesh-ancestor
83106030|NCT05795933|Micronutrients|micronutrients|mesh-ancestor
83106031|NCT05795933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106032|NCT05795933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83106033|NCT05795933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83106034|NCT05792774|Bupivacaine|bupivacaine|mesh-list
83106035|NCT05792774|Anesthetics, Local|anesthetics, local|mesh-ancestor
83106036|NCT05792774|Anesthetics|anesthetics|mesh-ancestor
83106037|NCT05792774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106038|NCT05792774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106039|NCT05792774|Sensory System Agents|sensory system agents|mesh-ancestor
83867045|NCT00193089|Vinorelbine|vinorelbine|mesh-list
83867046|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867047|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867048|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867049|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867050|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867051|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867052|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83867053|NCT00193167|Topotecan|topotecan|mesh-list
83867054|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83867055|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867056|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867057|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867058|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867059|NCT05208307|Dexamethasone|dexamethasone|mesh-list
83867060|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
83867061|NCT05208307|Pomalidomide|pomalidomide|mesh-list
83867062|NCT05208307|Ichthammol|ichthammol|mesh-list
83867063|NCT05208307|BB 1101|bb 1101|mesh-list
83867064|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867065|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
83867066|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
83867067|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867068|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867069|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867070|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
83867071|NCT05208307|Hormones|hormones|mesh-ancestor
83867072|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867073|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867074|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867075|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
83867076|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867077|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867078|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
83867079|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83867080|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83867081|NCT05208307|Growth Substances|growth substances|mesh-ancestor
83867082|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83867083|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
83867084|NCT00193245|Docetaxel|docetaxel|mesh-list
83867085|NCT00193245|Topotecan|topotecan|mesh-list
83867086|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867087|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867088|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867089|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867090|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867091|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83867092|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867093|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867094|NCT00193284|Carboplatin|carboplatin|mesh-list
83867095|NCT00193284|Docetaxel|docetaxel|mesh-list
83867096|NCT00193284|Fluorouracil|fluorouracil|mesh-list
83867097|NCT00193284|Gefitinib|gefitinib|mesh-list
83867098|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867099|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867100|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867101|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867102|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867103|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
83867104|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867105|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867106|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
83867107|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867108|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83867109|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867110|NCT00163982|Norfloxacin|norfloxacin|mesh-list
83867111|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867112|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867113|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83867114|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867115|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867116|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867117|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867118|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83867119|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83867120|NCT00193323|Gemcitabine|gemcitabine|mesh-list
83867121|NCT00193323|Docetaxel|docetaxel|mesh-list
83867122|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867123|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
83867124|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867125|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867126|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867127|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867128|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867129|NCT00193362|Paclitaxel|paclitaxel|mesh-list
83867130|NCT00193362|Vinorelbine|vinorelbine|mesh-list
83867131|NCT00193362|Carboplatin|carboplatin|mesh-list
83867132|NCT00193362|Gemcitabine|gemcitabine|mesh-list
83867133|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83867134|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867135|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867136|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867137|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867138|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867139|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867140|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
83867141|NCT00193401|Topotecan|topotecan|mesh-list
83867142|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83867143|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867144|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867145|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867146|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867147|NCT00553189|Topotecan|topotecan|mesh-list
83867148|NCT00553189|Veliparib|veliparib|mesh-list
83867149|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83867150|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867151|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867152|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867153|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867154|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83867155|NCT00193440|Rituximab|rituximab|mesh-list
83867156|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867157|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867158|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
83867159|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867160|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867161|NCT05077969|Celecoxib|celecoxib|mesh-list
83867162|NCT05077969|Famotidine|famotidine|mesh-list
83867163|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83867164|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83867165|NCT05077969|Analgesics|analgesics|mesh-ancestor
83867166|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
83867167|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867168|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867169|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867170|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867171|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83867172|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83867173|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867174|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867175|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83867176|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867177|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83867178|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
83867179|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
83867180|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867181|NCT05063734|Aflibercept|aflibercept|mesh-list
83867182|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83867183|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83867184|NCT05063734|Growth Substances|growth substances|mesh-ancestor
83867185|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867186|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
83867187|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867188|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
83867189|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867190|NCT00164216|Artesunate|artesunate|mesh-list
83106157|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106158|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83106159|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83106160|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83106161|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83106162|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867191|NCT00164216|Mefloquine|mefloquine|mesh-list
83867192|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
83867193|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83867194|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83867195|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867196|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867197|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
83867198|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
83867199|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83867200|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
83867201|NCT00193557|Bortezomib|bortezomib|mesh-list
83867202|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867203|NCT00164255|Artesunate|artesunate|mesh-list
83867204|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
83867205|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
83867206|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
83867207|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83867208|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83867209|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867210|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867211|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
83867212|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
83867213|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83867214|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
83867215|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83867216|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867217|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867218|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83867219|NCT00409656|Basiliximab|basiliximab|mesh-list
83867220|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867221|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
83867222|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867223|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
83867224|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83867225|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
83867226|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867227|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867228|NCT04977232|Escitalopram|escitalopram|mesh-list
83867229|NCT04977232|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83867230|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83867231|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83867232|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867233|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867234|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
83867235|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867236|NCT04974814|Atorvastatin|atorvastatin|mesh-list
83867237|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83867238|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83867239|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83867240|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
83867241|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867242|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83867243|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83867244|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867245|NCT00164411|Vaccines|vaccines|mesh-list
83867246|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83867247|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
83867248|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867249|NCT04910815|Rifaximin|rifaximin|mesh-list
83867250|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867251|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867252|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867253|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
83867254|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83867255|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867256|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83867257|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
83867258|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867259|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867260|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867261|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867262|NCT04902703|Molgramostim|molgramostim|mesh-list
83867263|NCT04902703|Sargramostim|sargramostim|mesh-list
83867264|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
83867265|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867266|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867267|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
83867268|NCT00193674|Progestins|progestins|mesh-ancestor
83867270|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867271|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867272|NCT04899778|Iron|iron|mesh-list
83867273|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83867274|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83867275|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
83867276|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
83867277|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83867278|NCT04899778|Estradiol|estradiol|mesh-list
83867279|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83867280|NCT04899778|Trace Elements|trace elements|mesh-ancestor
83867281|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
83867282|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867283|NCT04899778|Estrogens|estrogens|mesh-ancestor
83867284|NCT04899778|Hormones|hormones|mesh-ancestor
83867285|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867286|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83867287|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83867288|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83867289|NCT00164450|Isoniazid|isoniazid|mesh-list
83867290|NCT00164450|Rifapentine|rifapentine|mesh-list
83867291|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
83867292|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867293|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867294|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83867295|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83867296|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
83867297|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867298|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83867299|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83867300|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
83867301|NCT00193869|Dexamethasone|dexamethasone|mesh-list
83867302|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867303|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
83867304|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
83867305|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867306|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867307|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867308|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
83867309|NCT00193869|Hormones|hormones|mesh-ancestor
83867310|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867311|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867312|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867313|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83867314|NCT00176241|Paclitaxel|paclitaxel|mesh-list
83867315|NCT00176241|Gemcitabine|gemcitabine|mesh-list
83867316|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83867317|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867318|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867319|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867320|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867321|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867322|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867323|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
83867324|NCT04742959|Paclitaxel|paclitaxel|mesh-list
83867325|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83867326|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867327|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867328|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867329|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867330|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867331|NCT00164801|Diltiazem|diltiazem|mesh-list
83867332|NCT00164801|Baclofen|baclofen|mesh-list
83867333|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83867334|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867335|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83867336|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867337|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83867338|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
83867339|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
83867340|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867341|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867342|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83867343|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83867345|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83867346|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
83867347|NCT00176280|Dexamethasone|dexamethasone|mesh-list
83867348|NCT00176280|Sargramostim|sargramostim|mesh-list
83867349|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867350|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
83867351|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
83867352|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867353|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867354|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867355|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
83867356|NCT00176280|Hormones|hormones|mesh-ancestor
83867357|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867358|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867359|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867360|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
83867361|NCT04723940|Doxycycline|doxycycline|mesh-list
83867362|NCT04723940|Clindamycin|clindamycin|mesh-list
83867363|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
83867364|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
83867365|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83867366|NCT04723940|Cefadroxil|cefadroxil|mesh-list
83867367|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867368|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867369|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
83867370|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83867371|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83867372|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83867373|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867374|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867375|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83867376|NCT00164840|Esomeprazole|esomeprazole|mesh-list
83867377|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83867378|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867379|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83867380|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867381|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867382|NCT04641247|Niraparib|niraparib|mesh-list
83867383|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83867384|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867385|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867386|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867387|NCT04635007|Misoprostol|misoprostol|mesh-list
83867388|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
83867389|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83867390|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83867391|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867392|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
83867393|NCT04635007|Coagulants|coagulants|mesh-ancestor
83867394|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83867395|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
83867396|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83867397|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867398|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83867399|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867400|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
83867401|NCT00194064|Olanzapine|olanzapine|mesh-list
83867402|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
83867403|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
83867404|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867405|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867406|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867407|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83867408|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83867409|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867410|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83867411|NCT00194064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83867412|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83867413|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83867414|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867415|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867416|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
83867417|NCT00164996|Anesthetics|anesthetics|mesh-list
83867418|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867419|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867420|NCT04418557|Antibodies|antibodies|mesh-list
83867421|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
83867422|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867423|NCT04682782|Esketamine|esketamine|mesh-list
83405122|NCT05686993|Cinnarizine|cinnarizine|mesh-list
83867424|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
83867425|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83867426|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83867427|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83867428|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83867429|NCT00165035|Paclitaxel|paclitaxel|mesh-list
83867430|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83867431|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83867432|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867433|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867434|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867435|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867436|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867437|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
83867438|NCT04326673|Testosterone|testosterone|mesh-list
83867439|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
83867440|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
83867441|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83867442|NCT04326673|Androgens|androgens|mesh-ancestor
83867443|NCT04326673|Hormones|hormones|mesh-ancestor
83867444|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867445|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867446|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867447|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867448|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
83867449|NCT00165074|Calfactant|calfactant|mesh-list
83867450|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83867451|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
83867452|NCT04307953|Saracatinib|saracatinib|mesh-list
83867453|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867454|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867455|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867456|NCT04297267|Gemcitabine|gemcitabine|mesh-list
83867457|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867458|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867459|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
83867460|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867461|NCT00176475|Rituximab|rituximab|mesh-list
83867462|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867463|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867464|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
83867465|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867466|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867467|NCT00165191|Doxorubicin|doxorubicin|mesh-list
83867468|NCT00165191|Fluorouracil|fluorouracil|mesh-list
83867469|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867470|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83867471|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83867472|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867473|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867474|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867475|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
83867476|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867477|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867478|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
83867479|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867480|NCT04224571|Rituximab|rituximab|mesh-list
83867481|NCT04224571|Bortezomib|bortezomib|mesh-list
83867482|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867483|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867484|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
83867485|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867486|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867487|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
83867488|NCT00165230|Thalidomide|thalidomide|mesh-list
83867489|NCT00165230|Temozolomide|temozolomide|mesh-list
83867490|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867491|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
83867492|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867493|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
83867494|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867495|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867496|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83867497|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83867498|NCT00165230|Growth Substances|growth substances|mesh-ancestor
83867499|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
83867500|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867501|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83867502|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
83867503|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867504|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
83867505|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
83867506|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
83867507|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83867508|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83867509|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867510|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867511|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867512|NCT00165308|Tamoxifen|tamoxifen|mesh-list
83867513|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83867514|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
83867515|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867516|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867517|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867518|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867519|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83867520|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83867521|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83867522|NCT00165347|Vatalanib|vatalanib|mesh-list
83867523|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83867524|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867525|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867526|NCT00176670|Midazolam|midazolam|mesh-list
83867527|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83867528|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83867529|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867530|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867531|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83867532|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83867533|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83867534|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83867535|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
83867536|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
83867537|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
83867538|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
83867539|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867540|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867541|NCT00165464|Irinotecan|irinotecan|mesh-list
83867542|NCT00165464|Docetaxel|docetaxel|mesh-list
83867543|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867544|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83867545|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83867546|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867547|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867548|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867549|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867550|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867551|NCT04082650|Vitamin D|vitamin d|mesh-list
83867552|NCT04082650|Vitamins|vitamins|mesh-ancestor
83867553|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
83867554|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867555|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83867556|NCT00176787|Capecitabine|capecitabine|mesh-list
83867557|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867558|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
83867559|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867560|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867561|NCT00176943|Imiquimod|imiquimod|mesh-list
83867562|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83867563|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
83867564|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867565|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867566|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
83106543|NCT05042648|Buprenorphine|buprenorphine|mesh-list
83867568|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83867569|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83867570|NCT03978208|Analgesics|analgesics|mesh-ancestor
83867571|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
83867572|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867573|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867574|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867575|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867576|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
83867577|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83867578|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867579|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867580|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
83867581|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867582|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
83867583|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867584|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867585|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83867586|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
83867587|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867588|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867589|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83867590|NCT00165659|Donepezil|donepezil|mesh-list
83867591|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83867592|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867593|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867594|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
83867595|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867596|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867597|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
83867598|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
83867599|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
83867600|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83867601|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83867602|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867603|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867604|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867605|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867606|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
83867607|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83867608|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83867609|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83867610|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867611|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
83867612|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867613|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867614|NCT00165737|Donepezil|donepezil|mesh-list
83867615|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83867616|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867617|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867618|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
83867619|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867620|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867621|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
83867622|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83867623|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83867624|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867625|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
83867626|NCT03789916|Aspirin|aspirin|mesh-list
83867627|NCT03789916|Ticagrelor|ticagrelor|mesh-list
83867628|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83867629|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83867630|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83867631|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83867632|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
83867633|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867634|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867635|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867636|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83867637|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83867638|NCT03789916|Analgesics|analgesics|mesh-ancestor
83867639|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
83867640|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867641|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867642|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867643|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83867644|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83867645|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83867646|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867647|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
83867648|NCT00165815|Donepezil|donepezil|mesh-list
83867649|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83867650|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867651|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867652|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
83867653|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867654|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867655|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
83867656|NCT00177021|Imiquimod|imiquimod|mesh-list
83867657|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83867658|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
83867659|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867660|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867661|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
83867662|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
83867663|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
83867664|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867665|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867666|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867667|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
83867668|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
83867669|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
83867670|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867671|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83867672|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867673|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867674|NCT00177060|Hydromorphone|hydromorphone|mesh-list
83867675|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83867676|NCT00177060|Narcotics|narcotics|mesh-ancestor
83867677|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867678|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867679|NCT00177060|Analgesics|analgesics|mesh-ancestor
83867680|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
83867681|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867682|NCT03421639|Leuprolide|leuprolide|mesh-list
83867683|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83867684|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83867685|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83867686|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
83867687|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83867688|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867689|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867690|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867691|NCT03421639|Hormones|hormones|mesh-ancestor
83867692|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867693|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83867694|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867695|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867696|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83867697|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
83867698|NCT00177099|Tacrolimus|tacrolimus|mesh-list
83867699|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867700|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
83867701|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867702|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83867703|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867704|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867705|NCT03413800|Dexamethasone|dexamethasone|mesh-list
83867706|NCT03413800|Lenalidomide|lenalidomide|mesh-list
83867707|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106690|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
83106691|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106692|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83106693|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106694|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
83106695|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106697|NCT04579848|Hematinics|hematinics|mesh-ancestor
83867708|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
83867709|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
83867710|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867711|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867712|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867713|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
83867714|NCT03413800|Hormones|hormones|mesh-ancestor
83867715|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867716|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867717|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867718|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
83867719|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83867720|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83867721|NCT03413800|Growth Substances|growth substances|mesh-ancestor
83867722|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83867723|NCT03335839|Plasminogen|plasminogen|mesh-list
83867724|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83867725|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83867726|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83867727|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867728|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83867729|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
83867730|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867731|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83867732|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867733|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867734|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83867735|NCT03104491|Immunotoxins|immunotoxins|mesh-ancestor
83867736|NCT03104491|Immunoconjugates|immunoconjugates|mesh-ancestor
83867737|NCT03104491|Immunologic Factors|immunologic factors|mesh-ancestor
83867738|NCT03104491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867739|NCT05336812|Venetoclax|venetoclax|mesh-list
83867740|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
83867741|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
83867742|NCT05336812|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83867743|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867744|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867745|NCT05336812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83867746|NCT05336812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867747|NCT05336812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867748|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
83867749|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83867750|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867751|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83867752|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
83867753|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867754|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867755|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867756|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867757|NCT00537901|Bevacizumab|bevacizumab|mesh-list
83867758|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867759|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867760|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83867761|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83867762|NCT00537901|Growth Substances|growth substances|mesh-ancestor
83867763|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867764|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
83867765|NCT00166127|Simendan|simendan|mesh-list
83867766|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83867767|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
83867768|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83867769|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83867770|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867771|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867772|NCT00166127|Protective Agents|protective agents|mesh-ancestor
83867773|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867774|NCT00194649|Miglustat|miglustat|mesh-list
83867775|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867776|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867777|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83867778|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83867779|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
83867780|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867781|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83867782|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83867783|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867784|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
83867785|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83867786|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867787|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83867788|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
83867789|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867790|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867791|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867792|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867793|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
83867794|NCT00177138|Tacrolimus|tacrolimus|mesh-list
83867795|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867796|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
83867797|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867798|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83867799|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867800|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867801|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867802|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867803|NCT05311774|Tramadol|tramadol|mesh-list
83867804|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83867805|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83867806|NCT05311774|Narcotics|narcotics|mesh-ancestor
83867807|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867808|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867809|NCT05311774|Analgesics|analgesics|mesh-ancestor
83867810|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
83867811|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867812|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83867813|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83867814|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83867815|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867816|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867817|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
83867818|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83867819|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
83867820|NCT00194727|Capecitabine|capecitabine|mesh-list
83867821|NCT00194727|Vinorelbine|vinorelbine|mesh-list
83867822|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83867823|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
83867824|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867825|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867826|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83867827|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
83867828|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
83867829|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
83867830|NCT00166400|Metoprolol|metoprolol|mesh-list
83867831|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83867832|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83867833|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
83867834|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
83867835|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867836|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867837|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83867838|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83867839|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83867840|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
83867841|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867842|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867843|NCT02042287|Metronidazole|metronidazole|mesh-list
83867844|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867845|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867846|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83867847|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83867848|NCT05296213|Calcium|calcium|mesh-list
83867849|NCT05296213|Fluorides|fluorides|mesh-list
83867850|NCT05296213|Caseins|caseins|mesh-list
83867851|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83867852|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867853|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
83867854|NCT05296213|Protective Agents|protective agents|mesh-ancestor
83867855|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
83867856|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
83867857|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867858|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
83867859|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867860|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83867861|NCT00166478|Protective Agents|protective agents|mesh-ancestor
83867862|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867863|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83867864|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867865|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867866|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83867867|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83867868|NCT00166478|Analgesics|analgesics|mesh-ancestor
83867869|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
83867870|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867871|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867872|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83867873|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83867874|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
83867875|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867876|NCT00194766|Temozolomide|temozolomide|mesh-list
83867877|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83867878|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
83867879|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867880|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867881|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
83867882|NCT00166556|Tacrolimus|tacrolimus|mesh-list
83867883|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867884|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
83867885|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867886|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83867887|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867888|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867889|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83867890|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867891|NCT05276206|Anesthetics|anesthetics|mesh-list
83867892|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
83867893|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867894|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867895|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
83867896|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867897|NCT00166595|Risperidone|risperidone|mesh-list
83867898|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83867899|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
83867900|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867901|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867902|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867903|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83867904|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83867905|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867906|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83867907|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83867908|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
83867909|NCT05259631|Propofol|propofol|mesh-list
83867910|NCT05259631|Sevoflurane|sevoflurane|mesh-list
83867911|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83867912|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867913|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867914|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83867915|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
83867916|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
83867917|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83867918|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83867919|NCT00408135|Telithromycin|telithromycin|mesh-list
83867920|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867921|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867922|NCT00407225|Difluprednate|difluprednate|mesh-list
83867923|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
83867924|NCT00407225|Hormones|hormones|mesh-ancestor
83867925|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867926|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867927|NCT05124067|Dexamethasone|dexamethasone|mesh-list
83867928|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
83867929|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
83867930|NCT05124067|Ondansetron|ondansetron|mesh-list
83867931|NCT05124067|BB 1101|bb 1101|mesh-list
83867932|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83867933|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
83867934|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
83867935|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867936|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867937|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83867938|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
83867939|NCT05124067|Hormones|hormones|mesh-ancestor
83867940|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867941|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83867942|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867943|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
83867944|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867945|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867946|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83867947|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83867948|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83867949|NCT05124067|Analgesics|analgesics|mesh-ancestor
83867950|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
83867951|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83867952|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83867953|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83867954|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
83867955|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867956|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
83867957|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83867958|NCT05124067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83867959|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83867960|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
83867961|NCT00194883|Hormones|hormones|mesh-list
83867962|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83867963|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867964|NCT02277184|Cisplatin|cisplatin|mesh-list
83867965|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867966|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
83867967|NCT00166829|Sirolimus|sirolimus|mesh-list
83867968|NCT00166829|Tacrolimus|tacrolimus|mesh-list
83867969|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83867970|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
83867971|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867972|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83867973|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83867974|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867975|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83867976|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83867977|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83867978|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
83867979|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867980|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867981|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
83867982|NCT00177333|Doxycycline|doxycycline|mesh-list
83867983|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83867984|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83867985|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
83867986|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83867987|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83867988|NCT05046535|Nicotine|nicotine|mesh-list
83867989|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83867990|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
83867991|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83867992|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83867993|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83867994|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83867995|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
83867996|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83867997|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83867998|NCT00166868|Neomycin|neomycin|mesh-list
83867999|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868000|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868001|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83868002|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868003|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868004|NCT00194961|Hormones|hormones|mesh-list
83868005|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868006|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868007|NCT00177372|Misoprostol|misoprostol|mesh-list
83868008|NCT00177372|Mifepristone|mifepristone|mesh-list
83868009|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83868010|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
83868011|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868012|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868013|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83868014|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83868015|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
83868016|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83868017|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83868018|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83868019|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83868020|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
83868021|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83868022|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83868023|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
83868024|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868025|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
83868026|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83868027|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83868028|NCT04819399|Catumaxomab|catumaxomab|mesh-list
83868029|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83868030|NCT00177411|Hormones|hormones|mesh-list
83868031|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
83868032|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
83868033|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868034|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868035|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83868036|NCT00195078|Gefitinib|gefitinib|mesh-list
83868037|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868038|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83868039|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868040|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868041|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
83868042|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
83868043|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868044|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868045|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
83868046|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868047|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83868048|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83868049|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83868050|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868051|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868052|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868053|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868054|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83868055|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
83868056|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868057|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83868058|NCT04566250|Analgesics|analgesics|mesh-ancestor
83868059|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
83868060|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868061|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868062|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
83868063|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868064|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
83868065|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868066|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83868067|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83868068|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83868069|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868070|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868071|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
83868072|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83107075|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107076|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
83107077|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
83107078|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107079|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868073|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868074|NCT00177567|Lamotrigine|lamotrigine|mesh-list
83868075|NCT00177567|Valproic Acid|valproic acid|mesh-list
83868076|NCT00177567|Olanzapine|olanzapine|mesh-list
83868077|NCT00177567|Risperidone|risperidone|mesh-list
83868078|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
83868079|NCT00177567|Mirtazapine|mirtazapine|mesh-list
83868080|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
83868081|NCT00177567|Bupropion|bupropion|mesh-list
83868082|NCT00177567|Paroxetine|paroxetine|mesh-list
83868083|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83868084|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83868085|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
83868086|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868087|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868088|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868089|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83868090|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83868091|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868092|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868093|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83868094|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
83868095|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
83868096|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
83868097|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868098|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83868099|NCT00177567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83868100|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83868101|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868102|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83868103|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
83868104|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83868105|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83868106|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83868107|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868108|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
83868109|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83868110|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
83868111|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83868112|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83868113|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83868114|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83868115|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
83868116|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
83868117|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83868118|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83868119|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83868120|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83868121|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83868122|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83868123|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83868124|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
83868125|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83868126|NCT00195156|Valproic Acid|valproic acid|mesh-list
83868127|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
83868128|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868129|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868130|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
83868131|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868132|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868133|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
83868134|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83868135|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868136|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868137|NCT00167375|Eszopiclone|eszopiclone|mesh-list
83868138|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83868139|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868140|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868141|NCT00195000|Cytarabine|cytarabine|mesh-list
83868142|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
83868143|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83868144|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
83868145|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868146|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868147|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
83868148|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868149|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868150|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
83868151|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868152|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868153|NCT00195000|Immunotoxins|immunotoxins|mesh-ancestor
83868154|NCT00195000|Immunoconjugates|immunoconjugates|mesh-ancestor
83868155|NCT00195195|Sirolimus|sirolimus|mesh-list
83868156|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868157|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868158|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83868159|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868160|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
83868161|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868162|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
83868163|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868164|NCT04299880|Leucovorin|leucovorin|mesh-list
83868165|NCT04299880|Paclitaxel|paclitaxel|mesh-list
83868166|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83868167|NCT04299880|Bevacizumab|bevacizumab|mesh-list
83868168|NCT04299880|Gemcitabine|gemcitabine|mesh-list
83868169|NCT04299880|Fluorouracil|fluorouracil|mesh-list
83868170|NCT04299880|Nivolumab|nivolumab|mesh-list
83868171|NCT04299880|Irinotecan|irinotecan|mesh-list
83868172|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83868173|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868174|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
83868175|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
83868176|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
83868177|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868178|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868179|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83868180|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83868181|NCT04299880|Growth Substances|growth substances|mesh-ancestor
83868182|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868183|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
83868184|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83868185|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
83868186|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868187|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
83868188|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83868189|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83868190|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83868191|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868192|NCT04299880|Antidotes|antidotes|mesh-ancestor
83868193|NCT04299880|Protective Agents|protective agents|mesh-ancestor
83868194|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
83868195|NCT04299880|Vitamins|vitamins|mesh-ancestor
83868196|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
83868197|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
83868198|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83868199|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868200|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83868201|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
83868202|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868203|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868204|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868205|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868206|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
83868207|NCT04087096|Denosumab|denosumab|mesh-list
83868208|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83868209|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868210|NCT00177684|Amphotericin B|amphotericin b|mesh-list
83868211|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83868212|NCT00177684|Amebicides|amebicides|mesh-ancestor
83868213|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83868214|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83868215|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868216|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868217|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
83868218|NCT00532090|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83868219|NCT00532090|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83868220|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868221|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868222|NCT00195312|Bupivacaine|bupivacaine|mesh-list
83868223|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
83868224|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
83868225|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868226|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868227|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
83868228|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868229|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83868230|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83868231|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
83868232|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868233|NCT03888079|Anesthetics|anesthetics|mesh-list
83868234|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
83868235|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
83868236|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868237|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868238|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
83868239|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868241|NCT00167648|Goserelin|goserelin|mesh-list
83868242|NCT00167648|Estradiol|estradiol|mesh-list
83868243|NCT00167648|Estrogens|estrogens|mesh-ancestor
83868244|NCT00167648|Hormones|hormones|mesh-ancestor
83868245|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868246|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868247|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868248|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83868249|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
83868250|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83868251|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868252|NCT02906722|Colistin|colistin|mesh-list
83868253|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868254|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868255|NCT00167687|Prazosin|prazosin|mesh-list
83868256|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83868257|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83868258|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83868259|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83868260|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
83868261|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868262|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868263|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868264|NCT02906995|Nicotine|nicotine|mesh-list
83868265|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83868266|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
83868267|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868268|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868269|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83868270|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83868271|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
83868272|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868273|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868274|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83868275|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
83868276|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868277|NCT02906800|Digoxin|digoxin|mesh-list
83868278|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83868279|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83868280|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868281|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868282|NCT02906800|Protective Agents|protective agents|mesh-ancestor
83868283|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868284|NCT00195468|Cyclosporine|cyclosporine|mesh-list
83868285|NCT00195468|Cyclosporins|cyclosporins|mesh-list
83868286|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868287|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868288|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868289|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
83868290|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868291|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
83868292|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868293|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
83868294|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868295|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83868296|NCT00167765|Abciximab|abciximab|mesh-list
83868297|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
83107306|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
83868298|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83868299|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83868300|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868301|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
83868302|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
83868303|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83868304|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
83868305|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83868306|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83868307|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868308|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83868309|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868310|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868311|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83868313|NCT02906059|Adavosertib|adavosertib|mesh-list
83868314|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83868315|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83868316|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868317|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868318|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868319|NCT02906176|Voriconazole|voriconazole|mesh-list
83868320|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
83868321|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868322|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83868323|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83868324|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868325|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868326|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83868327|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
83868328|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868329|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868330|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83868331|NCT02905864|Liraglutide|liraglutide|mesh-list
83868332|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83868333|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868334|NCT02905864|Incretins|incretins|mesh-ancestor
83868335|NCT02905864|Hormones|hormones|mesh-ancestor
83868336|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868337|NCT00167882|Mesalamine|mesalamine|mesh-list
83868338|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83868339|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83868340|NCT00167882|Analgesics|analgesics|mesh-ancestor
83868341|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
83868342|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868343|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868344|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868345|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868346|NCT02905708|Charcoal|charcoal|mesh-list
83868347|NCT02905708|Antidotes|antidotes|mesh-ancestor
83868348|NCT02905708|Protective Agents|protective agents|mesh-ancestor
83868349|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868350|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83868351|NCT00167921|Estrogens|estrogens|mesh-ancestor
83868352|NCT00167921|Hormones|hormones|mesh-ancestor
83868353|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868354|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868355|NCT00167960|Tazobactam|tazobactam|mesh-list
83868356|NCT00167960|Piperacillin|piperacillin|mesh-list
83868357|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83868358|NCT00167960|Lactams|lactams|mesh-list
83868359|NCT00167960|beta-Lactams|beta-lactams|mesh-list
83868360|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868361|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868362|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83868363|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868364|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868365|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
83868366|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868367|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868368|NCT00167999|Tazobactam|tazobactam|mesh-list
83868369|NCT00167999|Piperacillin|piperacillin|mesh-list
83868370|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83868371|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868372|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868373|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83868374|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868375|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868376|NCT00177996|Sertraline|sertraline|mesh-list
83868377|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
83868378|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868379|NCT00177996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83868380|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83868381|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868382|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868383|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868384|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
83868385|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868386|NCT00168077|Thrombin|thrombin|mesh-list
83868387|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
83868388|NCT00168077|Coagulants|coagulants|mesh-ancestor
83868389|NCT00195585|Leucovorin|leucovorin|mesh-list
83868390|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
83868391|NCT00195585|Antidotes|antidotes|mesh-ancestor
83868392|NCT00195585|Protective Agents|protective agents|mesh-ancestor
83868393|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868394|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
83868395|NCT00195585|Vitamins|vitamins|mesh-ancestor
83868396|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
83868397|NCT02905045|Ketoprofen|ketoprofen|mesh-list
83868398|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83868399|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83868400|NCT02905045|Analgesics|analgesics|mesh-ancestor
83868401|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
83868402|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868403|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868404|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868405|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868406|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83868407|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868408|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868409|NCT02904772|Cyclosporine|cyclosporine|mesh-list
83868410|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
83868411|NCT02904772|Prednisolone|prednisolone|mesh-list
83868412|NCT02904772|Cyclosporins|cyclosporins|mesh-list
83868413|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868414|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868415|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868416|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
83868417|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868418|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
83868419|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868420|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
83868421|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868422|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83868423|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83868424|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868425|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83868426|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
83868427|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868428|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868429|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
83868430|NCT02904772|Hormones|hormones|mesh-ancestor
83868431|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868432|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83868433|NCT00195741|Valproic Acid|valproic acid|mesh-list
83868434|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
83868435|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868436|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868437|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
83868438|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868439|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868440|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
83868441|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83868442|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868443|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868444|NCT00178035|Paroxetine|paroxetine|mesh-list
83868445|NCT00178035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83868446|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83107461|NCT02101853|Hormones|hormones|mesh-ancestor
83868447|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868448|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868449|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868450|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
83868451|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868452|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83868453|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
83868454|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868455|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83868456|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83868457|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868458|NCT02904538|Dexamethasone|dexamethasone|mesh-list
83868459|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868460|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
83868461|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
83868462|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868463|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868464|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83868465|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
83868466|NCT02904538|Hormones|hormones|mesh-ancestor
83868467|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868468|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83868469|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868470|NCT02963103|Tacrolimus|tacrolimus|mesh-list
83868471|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868472|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
83868473|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868474|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83868475|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868476|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868477|NCT00407264|Fluticasone|fluticasone|mesh-list
83868478|NCT00407264|Xhance|xhance|mesh-list
83868479|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868480|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83868481|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
83868482|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868483|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868484|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83868485|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
83868486|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
83868487|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83868488|NCT02904499|Dabigatran|dabigatran|mesh-list
83868489|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
83868490|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83868491|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
83868492|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868493|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868494|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
83868495|NCT00195780|Valproic Acid|valproic acid|mesh-list
83868496|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
83868497|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868498|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868499|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
83868500|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868501|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868502|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
83868503|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83868504|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868505|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868506|NCT00407342|Alefacept|alefacept|mesh-list
83868507|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
83868508|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
83868509|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868510|NCT00553423|Lactulose|lactulose|mesh-list
83868511|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83868512|NCT02904304|Ibuprofen|ibuprofen|mesh-list
83868513|NCT02904304|Phenylephrine|phenylephrine|mesh-list
83868514|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
83868515|NCT02904304|Desloratadine|desloratadine|mesh-list
83868516|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83868517|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83868518|NCT02904304|Analgesics|analgesics|mesh-ancestor
83868519|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
83868520|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868521|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868522|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868524|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83868525|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868526|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868527|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83868528|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
83868529|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
83868530|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
83868531|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83868532|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
83868533|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83868534|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83868535|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83868536|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83868537|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
83868538|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868539|NCT02904304|Protective Agents|protective agents|mesh-ancestor
83868540|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83868541|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
83868542|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83868543|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83868544|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
83868545|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
83868546|NCT00407459|Bevacizumab|bevacizumab|mesh-list
83868547|NCT00407459|Carboplatin|carboplatin|mesh-list
83868548|NCT00407459|Pemetrexed|pemetrexed|mesh-list
83868549|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868550|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868551|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83868552|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83868553|NCT00407459|Growth Substances|growth substances|mesh-ancestor
83868554|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868555|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
83868556|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868557|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868558|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83868559|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83868560|NCT02904031|Leucovorin|leucovorin|mesh-list
83868561|NCT02904031|Fluorouracil|fluorouracil|mesh-list
83868562|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
83868563|NCT02904031|Panitumumab|panitumumab|mesh-list
83868564|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
83868565|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
83868566|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868567|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83868568|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868569|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868570|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
83868571|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868572|NCT02904031|Antidotes|antidotes|mesh-ancestor
83868573|NCT02904031|Protective Agents|protective agents|mesh-ancestor
83868574|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
83868575|NCT02904031|Vitamins|vitamins|mesh-ancestor
83868576|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
83868577|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868578|NCT02904109|Mannitol|mannitol|mesh-list
83868579|NCT02904109|Triflusal|triflusal|mesh-list
83868580|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83868581|NCT02904109|Diuretics|diuretics|mesh-ancestor
83868582|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
83868583|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868584|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83868585|NCT00178113|Lycopene|lycopene|mesh-list
83868586|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868587|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
83868588|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868589|NCT00178113|Protective Agents|protective agents|mesh-ancestor
83868590|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868591|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83868592|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83868593|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868594|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
83868595|NCT02903524|Doxorubicin|doxorubicin|mesh-list
83868596|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83868597|NCT02903524|Pirarubicin|pirarubicin|mesh-list
83868598|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868599|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
83868600|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868601|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868602|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83868603|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
83868604|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868605|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868606|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83868607|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83868608|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83868609|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83868610|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868611|NCT00168350|Memantine|memantine|mesh-list
83868612|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83868613|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83868614|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
83868615|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868616|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868617|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868618|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83868619|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83868620|NCT02903485|Anesthetics|anesthetics|mesh-list
83868621|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868622|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868623|NCT02903719|Ropivacaine|ropivacaine|mesh-list
83868624|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
83868625|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
83868626|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868627|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868628|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
83868629|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868630|NCT00178269|Docetaxel|docetaxel|mesh-list
83868631|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868632|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
83868633|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
83868634|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
83868635|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868636|NCT02903251|Oxytocin|oxytocin|mesh-list
83868637|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
83868638|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868639|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868640|NCT00168467|Ramipril|ramipril|mesh-list
83868641|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83868642|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
83868643|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868644|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868645|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83868646|NCT00195936|Cinacalcet|cinacalcet|mesh-list
83868647|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83868648|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868649|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83868650|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
83868651|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868652|NCT00168506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83868653|NCT00168506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83868654|NCT00168506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868655|NCT00168506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868656|NCT00168506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868657|NCT00168506|Serotonin Agents|serotonin agents|mesh-ancestor
83868658|NCT00168506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868659|NCT02902861|Methotrexate|methotrexate|mesh-list
83868660|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83868661|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
83868662|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868663|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868664|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83868665|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
83868666|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868667|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868668|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
83868669|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868670|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83107701|NCT01081262|Antibodies|antibodies|mesh-list
83868671|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868672|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
83868673|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868674|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83868675|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
83868676|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83868677|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83868678|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868679|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
83868680|NCT02903017|Coagulants|coagulants|mesh-ancestor
83868681|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83868682|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868683|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
83868684|NCT02902744|Hormones|hormones|mesh-ancestor
83868685|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83868686|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868687|NCT00168584|Vitamin A|vitamin a|mesh-list
83868688|NCT00168584|Vitamins|vitamins|mesh-ancestor
83868689|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
83868690|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868691|NCT02902666|Acetaminophen|acetaminophen|mesh-list
83868692|NCT02902666|Codeine|codeine|mesh-list
83868693|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83868694|NCT02902666|Analgesics|analgesics|mesh-ancestor
83868695|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
83868696|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868697|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868698|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
83868699|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83868700|NCT02902666|Narcotics|narcotics|mesh-ancestor
83868701|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868702|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
83868703|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
83868704|NCT02902354|Nifedipine|nifedipine|mesh-list
83868705|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83868706|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868707|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868708|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83868709|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868710|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
83868711|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
83868712|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868713|NCT00168623|Vitamin A|vitamin a|mesh-list
83868714|NCT00168623|Vitamins|vitamins|mesh-ancestor
83868715|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
83868716|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868717|NCT02902315|Vitamins|vitamins|mesh-list
83868718|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
83868719|NCT02902315|Tocopherols|tocopherols|mesh-list
83868720|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
83868721|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
83868722|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868723|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
83868724|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868725|NCT02902315|Protective Agents|protective agents|mesh-ancestor
83868726|NCT02902432|Endostar protein|endostar protein|mesh-list
83868727|NCT02902432|Endostatins|endostatins|mesh-list
83868728|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83868729|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83868730|NCT02902432|Growth Substances|growth substances|mesh-ancestor
83868731|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868732|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
83868733|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868734|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83868735|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83868736|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868737|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
83868738|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868739|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
83868740|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868741|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868742|NCT02902042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83868743|NCT02902042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868744|NCT00168740|Rituximab|rituximab|mesh-list
83868745|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868746|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868747|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
83868748|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868750|NCT00168779|Valsartan|valsartan|mesh-list
83868751|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83868752|NCT00168779|Telmisartan|telmisartan|mesh-list
83868753|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83868754|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83868755|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83868756|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868757|NCT00168779|Diuretics|diuretics|mesh-ancestor
83868758|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
83868759|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868760|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83868761|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83868762|NCT00168857|Losartan|losartan|mesh-list
83868763|NCT00168857|Telmisartan|telmisartan|mesh-list
83868764|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83868765|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83868766|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83868767|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83868768|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868769|NCT00196131|Morphine|morphine|mesh-list
83868770|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83868771|NCT00196131|Narcotics|narcotics|mesh-ancestor
83868772|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868773|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868774|NCT00196131|Analgesics|analgesics|mesh-ancestor
83868775|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
83868776|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868777|NCT00168896|Carboplatin|carboplatin|mesh-list
83868778|NCT00168896|Irinotecan|irinotecan|mesh-list
83868779|NCT00168896|Etoposide|etoposide|mesh-list
83868780|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868781|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83868782|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83868783|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868784|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868785|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83868786|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83868787|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
83868788|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
83868789|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868790|NCT02901379|Atorvastatin|atorvastatin|mesh-list
83868791|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83868792|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83868793|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
83868794|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868795|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83868796|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83868797|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868798|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83868799|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83868800|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868801|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
83868802|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868803|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
83868804|NCT02901145|Nivolumab|nivolumab|mesh-list
83868805|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868806|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
83868807|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868808|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868809|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83868810|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
83868811|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868812|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868813|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83868814|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868815|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83868816|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
83868817|NCT02901301|Capecitabine|capecitabine|mesh-list
83868818|NCT02901301|Trastuzumab|trastuzumab|mesh-list
83868819|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868820|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107858|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
83868821|NCT02901301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83868822|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868823|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83868825|NCT00169013|Gabapentin|gabapentin|mesh-list
83868826|NCT00169013|Analgesics|analgesics|mesh-ancestor
83868827|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
83868828|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868829|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868830|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
83868831|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83868832|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83868833|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868834|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868835|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83868836|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83868837|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868838|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868839|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
83868840|NCT00169091|Haloperidol|haloperidol|mesh-list
83868841|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
83868842|NCT00169091|Clozapine|clozapine|mesh-list
83868843|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
83868844|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
83868845|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868846|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868847|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83868848|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83868849|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83868850|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868851|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868852|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83868853|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
83868854|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868855|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868856|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83868857|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83868858|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
83868859|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
83868860|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
83868861|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
83868862|NCT00169130|Doxorubicin|doxorubicin|mesh-list
83868863|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83868864|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
83868865|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868866|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868867|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83868868|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
83868869|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868870|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868871|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83868872|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83868873|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83868874|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83868875|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868876|NCT00178620|Reteplase|reteplase|mesh-list
83868877|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83868878|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83868879|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868880|NCT00169169|Rituximab|rituximab|mesh-list
83868881|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868882|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868883|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
83868884|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868885|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868886|NCT00169208|Rituximab|rituximab|mesh-list
83868887|NCT00169208|Fludarabine|fludarabine|mesh-list
83868888|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
83868889|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868890|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868891|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
83868892|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868893|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868894|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868895|NCT00169208|Analgesics|analgesics|mesh-ancestor
83868896|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
83868897|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868898|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83868899|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83868900|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868901|NCT00178698|Interferons|interferons|mesh-list
83868902|NCT00178698|Gemcitabine|gemcitabine|mesh-list
83868903|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868904|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83868905|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
83868906|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868907|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
83868908|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868909|NCT00169247|Cetuximab|cetuximab|mesh-list
83868910|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868911|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83868912|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83868913|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
83868914|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868915|NCT02899507|Amoxicillin|amoxicillin|mesh-list
83868916|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83868917|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
83868918|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
83868919|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868920|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868921|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83868922|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868923|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868924|NCT00178854|Risperidone|risperidone|mesh-list
83868925|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83868926|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
83868927|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83868928|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868929|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868930|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83868931|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83868932|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83868933|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83868934|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83868935|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
83868936|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
83868937|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83868938|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
83868939|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83868940|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868941|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83868942|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83868943|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83868944|NCT02898961|Gentamicins|gentamicins|mesh-list
83868945|NCT02898961|Amikacin|amikacin|mesh-list
83868946|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83868947|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868948|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83868949|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868950|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868951|NCT00553618|Aldesleukin|aldesleukin|mesh-list
83868952|NCT00553618|Dacarbazine|dacarbazine|mesh-list
83868953|NCT00553618|Interleukin-2|interleukin-2|mesh-list
83868954|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83868955|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
83868956|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868957|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868958|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83868959|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83868960|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
83868961|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83868962|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83868963|NCT00553618|Analgesics|analgesics|mesh-ancestor
83868964|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
83868965|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868966|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868967|NCT02898376|Tocopherols|tocopherols|mesh-list
83868968|NCT02898376|Vitamin E|vitamin e|mesh-list
83868969|NCT02898376|Tocotrienols|tocotrienols|mesh-list
83868970|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
83868971|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
83868972|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83868973|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83868974|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83868975|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83868976|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83868977|NCT02898376|Protective Agents|protective agents|mesh-ancestor
83868978|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868979|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
83868980|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83868981|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
83868982|NCT02898376|Vitamins|vitamins|mesh-ancestor
83868983|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
83868984|NCT00408174|Balsalazide|balsalazide|mesh-list
83868985|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83868986|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83868987|NCT00408174|Analgesics|analgesics|mesh-ancestor
83868988|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
83868989|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83868990|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83868991|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83868992|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83868993|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83868994|NCT00169520|Docetaxel|docetaxel|mesh-list
83868995|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83868996|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
83868997|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
83868998|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
83868999|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869000|NCT02897986|Vinorelbine|vinorelbine|mesh-list
83869001|NCT02897986|Propranolol|propranolol|mesh-list
83869002|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83869003|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869004|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
83869005|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
83869006|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
83869007|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869008|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83869009|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83869010|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
83869011|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869012|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869013|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83869014|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869015|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
83869016|NCT00169559|Fenofibrate|fenofibrate|mesh-list
83869017|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83869018|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
83869019|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869020|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83869021|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
83869022|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83869023|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869024|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83869025|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
83869026|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869027|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869028|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869029|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869030|NCT00408252|Sunitinib|sunitinib|mesh-list
83869031|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869032|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83869033|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83869034|NCT00408252|Growth Substances|growth substances|mesh-ancestor
83869035|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869036|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
83869037|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83869038|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869039|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869040|NCT02897869|Amikacin|amikacin|mesh-list
83869041|NCT02897869|Murepavadin|murepavadin|mesh-list
83869042|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869043|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869044|NCT02897830|Dexamethasone|dexamethasone|mesh-list
83869045|NCT02897830|Lenalidomide|lenalidomide|mesh-list
83869046|NCT02897830|Ixazomib|ixazomib|mesh-list
83869047|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83869048|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
83869049|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
83869050|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869051|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869052|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869053|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
83869054|NCT02897830|Hormones|hormones|mesh-ancestor
83869055|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83869056|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83869057|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869058|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
83869059|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83869060|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83869061|NCT02897830|Growth Substances|growth substances|mesh-ancestor
83869062|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
83869063|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
83869064|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869065|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869066|NCT02897557|Pancrelipase|pancrelipase|mesh-list
83869067|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869068|NCT02897596|Grazoprevir|grazoprevir|mesh-list
83869069|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
83869070|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869071|NCT04681027|Oxymorphone|oxymorphone|mesh-list
83869072|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83869073|NCT04681027|Narcotics|narcotics|mesh-ancestor
83869074|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869075|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869076|NCT04681027|Analgesics|analgesics|mesh-ancestor
83869077|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
83869078|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869079|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83869080|NCT00408330|Azelaic acid|azelaic acid|mesh-list
83869081|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869082|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
83869083|NCT00408369|Pafuramidine|pafuramidine|mesh-list
83869084|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83869085|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83869086|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83869087|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869088|NCT02897206|Imipenem|imipenem|mesh-list
83869089|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83869090|NCT02897206|Cilastatin|cilastatin|mesh-list
83869091|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869092|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869093|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
83869094|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869095|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869096|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
83869097|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
83869098|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869099|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
83869100|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869101|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869102|NCT02897011|Methotrexate|methotrexate|mesh-list
83869103|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83869104|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
83869105|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83869106|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869107|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83869108|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
83869109|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869110|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869111|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
83869112|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869113|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83869114|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869115|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
83869116|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869117|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83869118|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
83869119|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83869120|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869121|NCT00196599|Emtricitabine|emtricitabine|mesh-list
83869122|NCT00196599|Efavirenz|efavirenz|mesh-list
83869123|NCT00196599|Didanosine|didanosine|mesh-list
83869124|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
83869125|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869126|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83869127|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83869128|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869129|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869130|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83869131|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83869132|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83869133|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83869134|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83869135|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83869136|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83869137|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83869138|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
83869139|NCT00178971|Buspirone|buspirone|mesh-list
83869140|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83869141|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83869142|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869143|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869144|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869145|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83869146|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
83869147|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869148|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869149|NCT02896621|Amlodipine|amlodipine|mesh-list
83869150|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
83869151|NCT02896621|Amiloride|amiloride|mesh-list
83869152|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869153|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83869154|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869155|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869156|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83869157|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869158|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
83869159|NCT02896621|Diuretics|diuretics|mesh-ancestor
83869160|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
83869161|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83869162|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83869163|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83869164|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83869165|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83869166|NCT02896582|Cytarabine|cytarabine|mesh-list
83869167|NCT02896582|Dexamethasone|dexamethasone|mesh-list
83869168|NCT02896582|Etoposide|etoposide|mesh-list
83869169|NCT02896582|Melphalan|melphalan|mesh-list
83869170|NCT02896582|Cisplatin|cisplatin|mesh-list
83869171|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
83869172|NCT02896582|Carmustine|carmustine|mesh-list
83869173|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83869174|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
83869175|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
83869176|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869177|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869178|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869179|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
83869180|NCT02896582|Hormones|hormones|mesh-ancestor
83869181|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83869182|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83869183|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869184|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83869185|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83869186|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83869187|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869188|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869189|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83869190|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
83869191|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
83869192|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869193|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869194|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
83869195|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83869196|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
83869197|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83869198|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83869199|NCT00196638|Interferons|interferons|mesh-list
83869200|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
83869201|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83869202|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869203|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
83869204|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869205|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
83869206|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869207|NCT02896270|Valproic Acid|valproic acid|mesh-list
83869208|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
83869209|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869210|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869211|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
83869212|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869213|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869214|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
83869215|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83869216|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869217|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869218|NCT00196677|Vitamins|vitamins|mesh-list
83869219|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
83869220|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869221|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83869222|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
83869223|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869224|NCT00169949|Aripiprazole|aripiprazole|mesh-list
83869225|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
83869226|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869227|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83869228|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83869229|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869230|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869231|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
83869232|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
83869233|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869234|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869235|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83869236|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83869237|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
83869238|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83869239|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83869240|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83869241|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83869242|NCT00196755|Calcium|calcium|mesh-list
83869243|NCT00196755|Sevelamer|sevelamer|mesh-list
83869244|NCT00196755|Calcium acetate|calcium acetate|mesh-list
83869245|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83869246|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869247|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
83869248|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
83869249|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869250|NCT00169988|Risperidone|risperidone|mesh-list
83869251|NCT00169988|Sertraline|sertraline|mesh-list
83869252|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83869253|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
83869254|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869255|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869256|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869257|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83869258|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83869259|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869260|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869261|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83869262|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
83869263|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
83869264|NCT00169988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83869265|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83869266|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869267|NCT02895529|Itraconazole|itraconazole|mesh-list
83869268|NCT02895529|Caspofungin|caspofungin|mesh-list
83869269|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
83869270|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869271|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83869272|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83108305|NCT02377388|Hormones|hormones|mesh-ancestor
83869273|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869274|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869275|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83869276|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
83869277|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83869278|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869279|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83869281|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83869282|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83869283|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869284|NCT02895061|Vitamins|vitamins|mesh-ancestor
83869285|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
83869286|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83869287|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
83869288|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869289|NCT00170222|Doxycycline|doxycycline|mesh-list
83869290|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869291|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869292|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
83869293|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83869294|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83869295|NCT02894983|Calpastatin|calpastatin|mesh-list
83869296|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83869297|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
83869298|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869299|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869300|NCT02895022|Lidocaine|lidocaine|mesh-list
83869301|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
83869302|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
83869303|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869304|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869305|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
83869306|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869307|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83869308|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83869309|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83869310|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869311|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869312|NCT00409851|Amlodipine|amlodipine|mesh-list
83869313|NCT00409851|Valsartan|valsartan|mesh-list
83869314|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869315|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83869316|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869317|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869318|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83869319|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869320|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
83869321|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869322|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869323|NCT05424445|Misoprostol|misoprostol|mesh-list
83869324|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83869325|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
83869326|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83869327|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869328|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83869329|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869330|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
83869331|NCT00409890|Scopolamine|scopolamine|mesh-list
83869332|NCT00409890|Bromides|bromides|mesh-list
83869333|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83869334|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
83869335|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83869336|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
83869337|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
83869338|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869339|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869340|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869341|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
83869342|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83869343|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
83869344|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869345|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108382|NCT02662556|Analgesics|analgesics|mesh-ancestor
83869346|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83869347|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
83869348|NCT05423821|Anesthetics|anesthetics|mesh-list
83869349|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869350|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869351|NCT00170378|Enoxaparin|enoxaparin|mesh-list
83869352|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
83869353|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83869354|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83869355|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869356|NCT00179244|Bupropion|bupropion|mesh-list
83869357|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83869358|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
83869359|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869360|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83869361|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83869362|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869363|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869364|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
83869365|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869366|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869367|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83869368|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83869369|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869370|NCT05423197|Panitumumab|panitumumab|mesh-list
83869371|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83869372|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869373|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
83869374|NCT00196872|Epirubicin|epirubicin|mesh-list
83869375|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869376|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
83869377|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869378|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869379|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83869380|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
83869381|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869382|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869383|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83869384|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83869385|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83869386|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83869387|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869388|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83869389|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83869390|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
83869391|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869392|NCT00170456|Antacids|antacids|mesh-ancestor
83869393|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869394|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869395|NCT00179283|Sertraline|sertraline|mesh-list
83869396|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83869397|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
83869398|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869399|NCT00179283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83869400|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83869401|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869402|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869403|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869404|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
83869405|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869406|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83869407|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83869408|NCT05420350|Lamotrigine|lamotrigine|mesh-list
83869409|NCT05420350|Bupropion|bupropion|mesh-list
83869410|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83869411|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
83869412|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869413|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83869414|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83869415|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869416|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869417|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
83869418|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869419|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869420|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83869421|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83869422|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869423|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
83869424|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83869425|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83869426|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83869427|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83869428|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869429|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83869431|NCT03097939|Ipilimumab|ipilimumab|mesh-list
83869432|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83869433|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869434|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83869435|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869436|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
83869437|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83869438|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83869439|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83869440|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869441|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869442|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
83869443|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869444|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869445|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83869446|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869447|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83869448|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83869449|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869450|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
83869451|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83869452|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83869453|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869454|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
83869455|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
83869456|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869457|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83869458|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83869459|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
83869460|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869461|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869462|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83869463|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
83869464|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869465|NCT00170690|Treosulfan|treosulfan|mesh-list
83869466|NCT00170690|Busulfan|busulfan|mesh-list
83869467|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83869468|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
83869469|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869470|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869471|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869472|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
83869473|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869474|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83869475|NCT00196989|Pioglitazone|pioglitazone|mesh-list
83869476|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83869477|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869478|NCT00170729|Prednisolone|prednisolone|mesh-list
83869479|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83869480|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
83869481|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83869482|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
83869483|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83869484|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
83869485|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83869486|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
83869487|NCT00170729|Hormones|hormones|mesh-ancestor
83869488|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83869489|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108583|NCT02991859|Xhance|xhance|mesh-list
83869490|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83869491|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869492|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
83869493|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
83869494|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869495|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869496|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83869497|NCT00170729|Protective Agents|protective agents|mesh-ancestor
83869498|NCT00170768|Oxybutynin|oxybutynin|mesh-list
83869499|NCT00170768|Darifenacin|darifenacin|mesh-list
83869500|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
83869501|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
83869502|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869503|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869504|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83869505|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83869506|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
83869507|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869508|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869509|NCT00170768|Urological Agents|urological agents|mesh-ancestor
83869510|NCT02655562|Montelukast|montelukast|mesh-list
83869511|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83869512|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
83869513|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83869514|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
83869515|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83869516|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869517|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83869518|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83869519|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869520|NCT00170885|Everolimus|everolimus|mesh-list
83869521|NCT00170885|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83869522|NCT00170885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83869523|NCT00170885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869524|NCT00170885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869525|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869526|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
83869527|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869528|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869529|NCT02607748|Listerine|listerine|mesh-list
83869530|NCT02607748|Fluorides|fluorides|mesh-list
83869531|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
83869532|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
83869533|NCT02607748|Protective Agents|protective agents|mesh-ancestor
83869534|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869535|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83869536|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869537|NCT02502253|Resveratrol|resveratrol|mesh-list
83869538|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
83869539|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869540|NCT02502253|Protective Agents|protective agents|mesh-ancestor
83869541|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869542|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869543|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83869544|NCT00170924|Valsartan|valsartan|mesh-list
83869545|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869546|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869547|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869548|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869549|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
83869550|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83869551|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869552|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869553|NCT00170963|Amlodipine|amlodipine|mesh-list
83869554|NCT00170963|Valsartan|valsartan|mesh-list
83869555|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869556|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83869557|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869558|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869559|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83869560|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869561|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
83869562|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869563|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869565|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83869566|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869567|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83869568|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869569|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869570|NCT00171002|Amlodipine|amlodipine|mesh-list
83869571|NCT00171002|Valsartan|valsartan|mesh-list
83869572|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869573|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83869574|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869575|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869576|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83869577|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869578|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
83869579|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869580|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869581|NCT05400031|Propolis|propolis|mesh-list
83869582|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869583|NCT00171041|Valsartan|valsartan|mesh-list
83869584|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869585|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869586|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869587|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869588|NCT05393674|Nivolumab|nivolumab|mesh-list
83869589|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83869590|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869591|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83869592|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869593|NCT05392699|Interleukin-12|interleukin-12|mesh-list
83869594|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83869595|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
83869596|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869597|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83869598|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83869599|NCT05392699|Growth Substances|growth substances|mesh-ancestor
83869600|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
83869601|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869602|NCT00171080|Valsartan|valsartan|mesh-list
83869603|NCT00171080|Irbesartan|irbesartan|mesh-list
83869604|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869605|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869606|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869607|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869608|NCT02229877|Omeprazole|omeprazole|mesh-list
83869609|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83869610|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869611|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83869612|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869613|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869614|NCT00171119|Valsartan|valsartan|mesh-list
83869615|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869616|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869617|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869618|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869619|NCT02102113|Dronabinol|dronabinol|mesh-list
83869620|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
83869621|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869622|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869623|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83869624|NCT02102113|Analgesics|analgesics|mesh-ancestor
83869625|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
83869626|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869627|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83869628|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83869629|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869630|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869631|NCT02102113|Hormones|hormones|mesh-ancestor
83869632|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83869633|NCT05379790|Irinotecan|irinotecan|mesh-list
83869634|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83869635|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83869636|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869637|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869638|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869639|NCT05349448|Triamcinolone|triamcinolone|mesh-list
83869640|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83869641|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83869642|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
83869643|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83869644|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83869645|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869646|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869647|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83869648|NCT05349448|Analgesics|analgesics|mesh-ancestor
83869649|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
83869650|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869651|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83869652|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83869653|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83869654|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
83869655|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869656|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869657|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83869658|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
83869659|NCT05349448|Hormones|hormones|mesh-ancestor
83869660|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83869661|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869662|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
83869663|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869664|NCT00171353|Valsartan|valsartan|mesh-list
83869665|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869666|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869667|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869668|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869669|NCT01656343|Abatacept|abatacept|mesh-list
83869670|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83869671|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83869672|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869673|NCT01656343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83869674|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869675|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869676|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
83869677|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869678|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869679|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869680|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83869681|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83869682|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869683|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
83869684|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
83869685|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83869686|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869687|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83869688|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
83869689|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869690|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869691|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869692|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869693|NCT00171431|Tegaserod|tegaserod|mesh-list
83869694|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83869695|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
83869696|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869697|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869698|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869699|NCT01330030|Selegiline|selegiline|mesh-list
83869700|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
83869701|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83869702|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83869703|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83869704|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83869705|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869706|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869707|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83869708|NCT01330030|Protective Agents|protective agents|mesh-ancestor
83869709|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869710|NCT00171470|Tegaserod|tegaserod|mesh-list
83869711|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83869712|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
83869713|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869714|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869715|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869716|NCT00171509|Cyclosporine|cyclosporine|mesh-list
83869717|NCT00171509|Cyclosporins|cyclosporins|mesh-list
83869718|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869719|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869720|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869721|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
83869722|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869723|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
83869724|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869725|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
83869726|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869727|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83869728|NCT00179712|Topotecan|topotecan|mesh-list
83869729|NCT00179712|Lenalidomide|lenalidomide|mesh-list
83869730|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83869731|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83869732|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869733|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869734|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869735|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
83869736|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869737|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83869738|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83869739|NCT00179712|Growth Substances|growth substances|mesh-ancestor
83869740|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
83869741|NCT00611572|Flumazenil|flumazenil|mesh-list
83869742|NCT00611572|Antidotes|antidotes|mesh-ancestor
83869743|NCT00611572|Protective Agents|protective agents|mesh-ancestor
83869744|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869745|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
83869746|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
83869747|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869748|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869749|NCT00197340|Ropivacaine|ropivacaine|mesh-list
83869750|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
83869751|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
83869752|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869753|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869754|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
83869755|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869756|NCT00171587|Vatalanib|vatalanib|mesh-list
83869757|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83869758|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869759|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869760|NCT05265052|Oxycodone|oxycodone|mesh-list
83869761|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83869762|NCT05265052|Narcotics|narcotics|mesh-ancestor
83869763|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869764|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869765|NCT05265052|Analgesics|analgesics|mesh-ancestor
83869766|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
83869767|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869768|NCT00171626|Diclofenac|diclofenac|mesh-list
83869769|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83869770|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83869771|NCT00171626|Analgesics|analgesics|mesh-ancestor
83869772|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
83869773|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869774|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869775|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83869776|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869777|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83869778|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869779|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869780|NCT00171665|Diclofenac|diclofenac|mesh-list
83869781|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83869782|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83869784|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
83869785|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869786|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869787|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83869788|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869789|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83869790|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869791|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869792|NCT00179751|Gemcitabine|gemcitabine|mesh-list
83869793|NCT00179751|Lenalidomide|lenalidomide|mesh-list
83869794|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83869795|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
83869796|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869797|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869798|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
83869799|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869800|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83869801|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83869802|NCT00179751|Growth Substances|growth substances|mesh-ancestor
83869803|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
83869804|NCT05223478|Phentolamine|phentolamine|mesh-list
83869805|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83869806|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83869807|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83869808|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83869809|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
83869810|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869811|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869812|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869813|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869814|NCT00171743|Cyclosporine|cyclosporine|mesh-list
83869815|NCT00171743|Cyclosporins|cyclosporins|mesh-list
83869816|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869817|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869818|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869819|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
83869820|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869821|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
83869822|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869823|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
83869824|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869825|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83869826|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
83869827|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83869828|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869829|NCT00171782|Valsartan|valsartan|mesh-list
83869830|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83869831|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869832|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869833|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869834|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869835|NCT00171782|Diuretics|diuretics|mesh-ancestor
83869836|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
83869837|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869838|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83869839|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869840|NCT00197379|Roxithromycin|roxithromycin|mesh-list
83869841|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869842|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869843|NCT00197418|Amoxicillin|amoxicillin|mesh-list
83869844|NCT00197418|Metronidazole|metronidazole|mesh-list
83869845|NCT00197418|Clarithromycin|clarithromycin|mesh-list
83869846|NCT00197418|Rabeprazole|rabeprazole|mesh-list
83869847|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869848|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869849|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83869850|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83869851|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83869852|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869853|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869854|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83869855|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83869856|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83869857|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869858|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83869859|NCT00171821|Deferasirox|deferasirox|mesh-list
83869860|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83869861|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
83869862|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
83869863|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869864|NCT05054023|Piroxicam|piroxicam|mesh-list
83869865|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83869866|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83869867|NCT05054023|Analgesics|analgesics|mesh-ancestor
83869868|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
83869869|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869870|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869871|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83869872|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869873|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83869874|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869875|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869876|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
83869877|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869878|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83869879|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869880|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869881|NCT00553930|Interferons|interferons|mesh-list
83869882|NCT00553930|Ribavirin|ribavirin|mesh-list
83869883|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
83869884|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
83869885|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83869886|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869887|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
83869888|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869889|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
83869890|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869891|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
83869892|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869893|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
83869894|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869895|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83869896|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869897|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869898|NCT05004259|Daratumumab|daratumumab|mesh-list
83869899|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869900|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
83869901|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869902|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83869903|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869904|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869905|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
83869906|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869907|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83869908|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869909|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869910|NCT02240407|Acetaminophen|acetaminophen|mesh-list
83869911|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
83869912|NCT02240407|Promethazine|promethazine|mesh-list
83869913|NCT02240407|Sirolimus|sirolimus|mesh-list
83869914|NCT02240407|Rituximab|rituximab|mesh-list
83869915|NCT02240407|Lidocaine|lidocaine|mesh-list
83869916|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83869917|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83869918|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
83869919|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869920|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83869921|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
83869922|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
83869923|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83869924|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
83869925|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83869926|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83869927|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83869928|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83869929|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83869930|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869931|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83869933|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
83869934|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869935|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869936|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83869937|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
83869938|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83869939|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83869940|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83869941|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
83869942|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
83869943|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83869944|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83869945|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
83869946|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
83869947|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83869948|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83869949|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
83869950|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
83869951|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
83869952|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83869953|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869954|NCT04958122|Penicillins|penicillins|mesh-list
83869955|NCT04958122|Cefixime|cefixime|mesh-list
83869956|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83869957|NCT04958122|Penicillin G|penicillin g|mesh-list
83869958|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
83869959|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83869960|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869961|NCT00197613|Lamivudine|lamivudine|mesh-list
83869962|NCT00197613|Zidovudine|zidovudine|mesh-list
83869963|NCT00197613|Efavirenz|efavirenz|mesh-list
83869964|NCT00197613|Nevirapine|nevirapine|mesh-list
83869965|NCT00197613|Stavudine|stavudine|mesh-list
83869966|NCT00197613|Didanosine|didanosine|mesh-list
83869967|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83869968|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83869969|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83869970|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869971|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
83869972|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869973|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83869974|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83869975|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
83869976|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83869977|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83869978|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83869979|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83869980|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83869981|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83869982|NCT00180024|Irbesartan|irbesartan|mesh-list
83869983|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83869984|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83869985|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83869986|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83869987|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
83869988|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83869989|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869990|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
83869991|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83869992|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
83869993|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
83869994|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
83869995|NCT03455179|Methamphetamine|methamphetamine|mesh-list
83869996|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83869997|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83869998|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
83869999|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
83870000|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870001|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
83870002|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870003|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870004|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
83870005|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83109056|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
83870006|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83870007|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83870008|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83870009|NCT00202293|Olanzapine|olanzapine|mesh-list
83870010|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
83870011|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
83870012|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
83870013|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870014|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870015|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83870016|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83870017|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83870018|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870019|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83870020|NCT00202293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83870021|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83870022|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83870023|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870024|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870025|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
83870026|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83870027|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
83870028|NCT00197730|Folic Acid|folic acid|mesh-list
83870029|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
83870030|NCT00197730|Vitamins|vitamins|mesh-ancestor
83870031|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
83870032|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870033|NCT00197730|Hematinics|hematinics|mesh-ancestor
83870034|NCT00172172|Calcium|calcium|mesh-list
83870035|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
83870036|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83870037|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870038|NCT02908711|Ropivacaine|ropivacaine|mesh-list
83870039|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
83870040|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
83870041|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870042|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870043|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
83870044|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870045|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83870046|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870047|NCT02908438|Hormones|hormones|mesh-list
83870048|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870049|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870050|NCT04731844|Curcumin|curcumin|mesh-list
83870051|NCT04731844|Piperine|piperine|mesh-list
83870052|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83870053|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83870054|NCT04731844|Analgesics|analgesics|mesh-ancestor
83870055|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
83870056|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870057|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870058|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870059|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870060|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870061|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870062|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870063|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83870064|NCT00172367|Lycopene|lycopene|mesh-list
83870065|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870066|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
83870067|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870068|NCT00172367|Protective Agents|protective agents|mesh-ancestor
83870069|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870070|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83870071|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83870072|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870073|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
83870074|NCT04632316|Fludarabine|fludarabine|mesh-list
83870075|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870076|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
83870077|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870078|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109132|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83870079|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83870080|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
83870081|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870082|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870083|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83870084|NCT00197886|Norepinephrine|norepinephrine|mesh-list
83870085|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83870086|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83870087|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83870088|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870089|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870090|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870091|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
83870092|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
83870093|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870094|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83870095|NCT02908165|Sorafenib|sorafenib|mesh-list
83870096|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
83870097|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870098|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870099|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870100|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870101|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83870102|NCT02908165|Estrogens|estrogens|mesh-ancestor
83870103|NCT02908165|Hormones|hormones|mesh-ancestor
83870104|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870105|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870106|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83870107|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
83870108|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83870109|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870110|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83870111|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870112|NCT02908282|Povidone|povidone|mesh-list
83870113|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
83870114|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
83870115|NCT02908126|Oxytocin|oxytocin|mesh-list
83870116|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
83870117|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83870118|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870119|NCT00202605|Amphetamine|amphetamine|mesh-list
83870120|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
83870121|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83870122|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870123|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
83870124|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
83870125|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870126|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
83870127|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870128|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870129|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
83870130|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83870131|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83870132|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83870133|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83870134|NCT00198120|Cycloserine|cycloserine|mesh-list
83870135|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83870136|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870137|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83870138|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
83870139|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870140|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
83870141|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870142|NCT00198159|Gefitinib|gefitinib|mesh-list
83870143|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870144|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870145|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870146|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870147|NCT02907307|Clotrimazole|clotrimazole|mesh-list
83870148|NCT02907307|Miconazole|miconazole|mesh-list
83870149|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83870150|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870151|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
83870152|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83870153|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83109206|NCT03029702|Metformin|metformin|mesh-list
83870154|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870155|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870156|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83870157|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
83870158|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870159|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870160|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83870161|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83870162|NCT00553345|Vitamin E|vitamin e|mesh-list
83870163|NCT00553345|Selenium|selenium|mesh-list
83870164|NCT00553345|Vitamins|vitamins|mesh-ancestor
83870165|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
83870166|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870167|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
83870168|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870169|NCT00553345|Protective Agents|protective agents|mesh-ancestor
83870170|NCT00553345|Trace Elements|trace elements|mesh-ancestor
83870171|NCT00407771|Tirofiban|tirofiban|mesh-list
83870172|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83870173|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83870174|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870175|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83870176|NCT00198198|Aripiprazole|aripiprazole|mesh-list
83870177|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
83870178|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83870179|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83870180|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83870181|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870182|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870183|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
83870184|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
83870185|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870186|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870187|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83870188|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83870189|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
83870190|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83870191|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83870192|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83870193|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83870194|NCT02206087|Heparin|heparin|mesh-list
83870195|NCT02206087|Calcium heparin|calcium heparin|mesh-list
83870196|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
83870197|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83870198|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83870199|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870200|NCT00198237|Docetaxel|docetaxel|mesh-list
83870201|NCT00198237|Capecitabine|capecitabine|mesh-list
83870202|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870203|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870204|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870205|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870206|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870207|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870208|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
83870209|NCT00198354|Paclitaxel|paclitaxel|mesh-list
83870210|NCT00198354|Gemcitabine|gemcitabine|mesh-list
83870211|NCT00198354|Carboplatin|carboplatin|mesh-list
83870212|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83870213|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870214|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870215|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870216|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870217|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870218|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870219|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
83870220|NCT02158585|Lamotrigine|lamotrigine|mesh-list
83870221|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
83870222|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83870223|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83870224|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109278|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83870225|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83870226|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870227|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83870228|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83870229|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870230|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83870231|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83870232|NCT00202917|Fludarabine|fludarabine|mesh-list
83870233|NCT00202917|Melphalan|melphalan|mesh-list
83870234|NCT00202917|Thiotepa|thiotepa|mesh-list
83870235|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870236|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870237|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870238|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
83870239|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870240|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83870241|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
83870242|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83870243|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
83870244|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
83870245|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
83870246|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83870247|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
83870248|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870249|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870250|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870251|NCT04677868|Methotrexate|methotrexate|mesh-list
83870252|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83870253|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
83870254|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83870255|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870256|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870257|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
83870258|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870259|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870260|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83870261|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870262|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83870263|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870264|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
83870265|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870266|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83870267|NCT00198393|Gemcitabine|gemcitabine|mesh-list
83870268|NCT00198393|Docetaxel|docetaxel|mesh-list
83870269|NCT00198393|Gefitinib|gefitinib|mesh-list
83870270|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870271|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
83870272|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870273|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870274|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870275|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870276|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870277|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870278|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870279|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
83870280|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870281|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870282|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870283|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870284|NCT00554827|Vitamins|vitamins|mesh-list
83870285|NCT00554827|Folic Acid|folic acid|mesh-list
83870286|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
83870287|NCT00554827|Hydroxocobalamin|hydroxocobalamin|mesh-list
83870288|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
83870289|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
83870290|NCT00554827|Aminopterin|aminopterin|mesh-list
83870291|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
83870292|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870293|NCT00554827|Hematinics|hematinics|mesh-ancestor
83870294|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83870295|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870296|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870297|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870298|NCT00203034|Rasagiline|rasagiline|mesh-list
83870299|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83870300|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870301|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870302|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83870303|NCT00203034|Protective Agents|protective agents|mesh-ancestor
83870304|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870305|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
83870306|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
83870307|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
83870308|NCT00203073|Analgesics|analgesics|mesh-ancestor
83870309|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
83870310|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870311|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870312|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870313|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83870314|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83870315|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870316|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870317|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83870318|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
83870319|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870320|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870321|NCT00198432|Paclitaxel|paclitaxel|mesh-list
83870322|NCT00198432|Vinorelbine|vinorelbine|mesh-list
83870323|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83870324|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870325|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870326|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870327|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870328|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870329|NCT02072863|Prednisone|prednisone|mesh-list
83870330|NCT02072863|Melphalan|melphalan|mesh-list
83870331|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870332|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
83870333|NCT02072863|Hormones|hormones|mesh-ancestor
83870334|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870335|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870336|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83870337|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870338|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83870339|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
83870340|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870341|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83870342|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870343|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
83870344|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83870345|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83870346|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
83870347|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870348|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83870349|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870350|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83870351|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870352|NCT00203112|Minocycline|minocycline|mesh-list
83870353|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
83870354|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
83870355|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870356|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870357|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83870358|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
83870359|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870360|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870361|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870362|NCT02057380|Dexamethasone|dexamethasone|mesh-list
83870363|NCT02057380|Paclitaxel|paclitaxel|mesh-list
83870364|NCT02057380|Bortezomib|bortezomib|mesh-list
83870365|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83870366|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83870367|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870368|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870369|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870370|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870371|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870372|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870373|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
83870374|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
83870375|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870376|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870377|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83870378|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
83870379|NCT02057380|Hormones|hormones|mesh-ancestor
83870380|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870381|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83870382|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870383|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870384|NCT02052778|Futibatinib|futibatinib|mesh-list
83870385|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870386|NCT02050828|Ranibizumab|ranibizumab|mesh-list
83870387|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83870388|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83870389|NCT02050828|Growth Substances|growth substances|mesh-ancestor
83870390|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870391|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
83870392|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870393|NCT02046694|Allopurinol|allopurinol|mesh-list
83870394|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
83870395|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870396|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870397|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
83870398|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870399|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83870400|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
83870401|NCT02046694|Protective Agents|protective agents|mesh-ancestor
83870402|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870403|NCT00203190|Topiramate|topiramate|mesh-list
83870404|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
83870405|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83870406|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870407|NCT02019589|Progesterone|progesterone|mesh-list
83870408|NCT02019589|Progestins|progestins|mesh-ancestor
83870409|NCT02019589|Hormones|hormones|mesh-ancestor
83870410|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870411|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870412|NCT02018926|Azacitidine|azacitidine|mesh-list
83870413|NCT02018926|Mocetinostat|mocetinostat|mesh-list
83870414|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870415|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
83870416|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870417|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870418|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870419|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83870420|NCT01989325|Dexamethasone|dexamethasone|mesh-list
83870421|NCT01989325|Filanesib|filanesib|mesh-list
83870422|NCT01989325|Lenograstim|lenograstim|mesh-list
83870423|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83870424|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870425|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
83870426|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
83870427|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870428|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870429|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83870430|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
83870431|NCT01989325|Hormones|hormones|mesh-ancestor
83870432|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870433|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83870434|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870435|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83870436|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
83870437|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
83870438|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870439|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870440|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870441|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870442|NCT01978366|Halofuginone|halofuginone|mesh-list
83870443|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870444|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
83870445|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83870446|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83870447|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870448|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83870449|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870450|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870451|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83870452|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83870453|NCT01978366|Growth Substances|growth substances|mesh-ancestor
83870454|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870455|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
83870456|NCT02962986|Phenylephrine|phenylephrine|mesh-list
83870457|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
83870458|NCT02962986|Norepinephrine|norepinephrine|mesh-list
83870459|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83870460|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
83870461|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
83870462|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870463|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870464|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
83870465|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83870466|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
83870467|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
83870468|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83870469|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83870470|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83870471|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
83870472|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870473|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870474|NCT02962986|Protective Agents|protective agents|mesh-ancestor
83870475|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
83870476|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83870477|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870478|NCT04677361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83870479|NCT04677361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870480|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
83870481|NCT01968733|Solithromycin|solithromycin|mesh-list
83870482|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870483|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870484|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83870485|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83870486|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870487|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870488|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870489|NCT00410553|Gemcitabine|gemcitabine|mesh-list
83870490|NCT00410553|Halichondrin B|halichondrin b|mesh-list
83870491|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870492|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
83870493|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870494|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870495|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870496|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870497|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870498|NCT00410592|Esomeprazole|esomeprazole|mesh-list
83870499|NCT00410592|Pantoprazole|pantoprazole|mesh-list
83870500|NCT00410592|Lansoprazole|lansoprazole|mesh-list
83870501|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
83870502|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83870503|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83870504|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83870505|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870506|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870507|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
83870508|NCT00410631|Melphalan|melphalan|mesh-list
83870509|NCT00410631|Ifosfamide|ifosfamide|mesh-list
83870510|NCT00410631|Dacarbazine|dacarbazine|mesh-list
83870511|NCT00410631|Carboplatin|carboplatin|mesh-list
83870512|NCT00410631|Doxorubicin|doxorubicin|mesh-list
83870513|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83870514|NCT00410631|Etoposide|etoposide|mesh-list
83870515|NCT00410631|Vincristine|vincristine|mesh-list
83870516|NCT00410631|Topotecan|topotecan|mesh-list
83870517|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
83870518|NCT00410631|Vindesine|vindesine|mesh-list
83870519|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83870520|NCT00410631|Isotretinoin|isotretinoin|mesh-list
83870521|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870522|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
83870523|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870524|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870525|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83870526|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
83870527|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870528|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870529|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83870530|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83870531|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83870532|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83870533|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870534|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83870536|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870537|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870538|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83870539|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83870540|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83870541|NCT01930357|Vaccines|vaccines|mesh-list
83870542|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
83870543|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870544|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
83870545|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83870546|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870547|NCT01903954|Ribavirin|ribavirin|mesh-list
83870548|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83870549|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
83870550|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870551|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
83870552|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870553|NCT01893190|Nimodipine|nimodipine|mesh-list
83870554|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83870555|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83870556|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83870557|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870558|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83870559|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870560|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
83870561|NCT00198588|Argatroban|argatroban|mesh-list
83870562|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
83870563|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83870564|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
83870565|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870566|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870567|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
83870568|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83870569|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83870570|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870571|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870572|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870573|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870574|NCT01877395|Vaccines|vaccines|mesh-list
83870575|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
83870576|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870577|NCT01874626|Ibuprofen|ibuprofen|mesh-list
83870578|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83870579|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83870580|NCT01874626|Analgesics|analgesics|mesh-ancestor
83870581|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
83870582|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870583|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870584|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870585|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870586|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83870587|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870588|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870589|NCT00410748|Hydromorphone|hydromorphone|mesh-list
83870590|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83870591|NCT00410748|Narcotics|narcotics|mesh-ancestor
83870592|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870593|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870594|NCT00410748|Analgesics|analgesics|mesh-ancestor
83870595|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
83870596|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870597|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83870598|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83870599|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870600|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870601|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
83870602|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83870603|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83870604|NCT01862224|Methotrexate|methotrexate|mesh-list
83870605|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83870606|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
83870607|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83870608|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870609|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870610|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
83870611|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870612|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870613|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
83870614|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870615|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83870616|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870617|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
83870618|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870619|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83870620|NCT01859962|Ribavirin|ribavirin|mesh-list
83870621|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
83870622|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870623|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
83870624|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870625|NCT00173888|Cisplatin|cisplatin|mesh-list
83870626|NCT00173888|Gemcitabine|gemcitabine|mesh-list
83870627|NCT00173888|Docetaxel|docetaxel|mesh-list
83870628|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870629|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83870630|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
83870631|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870632|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870633|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870634|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870635|NCT00555022|Bromides|bromides|mesh-list
83870636|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
83870637|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83870638|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
83870639|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870640|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870641|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83870642|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
83870643|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
83870644|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83870645|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
83870646|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870647|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870648|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
83870649|NCT00203385|Valproic Acid|valproic acid|mesh-list
83870650|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
83870651|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870652|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870653|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
83870654|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870655|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870656|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
83870657|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83870658|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870659|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83870660|NCT00555100|Dexamethasone|dexamethasone|mesh-list
83870661|NCT00555100|Lenalidomide|lenalidomide|mesh-list
83870662|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870663|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
83870664|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
83870665|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870666|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870667|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83870668|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
83870669|NCT00555100|Hormones|hormones|mesh-ancestor
83870670|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870671|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83870672|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870673|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
83870674|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83870675|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83870676|NCT00555100|Growth Substances|growth substances|mesh-ancestor
83870677|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
83870678|NCT00555139|Alprazolam|alprazolam|mesh-list
83870679|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83870680|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870681|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870682|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83870683|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83870684|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83870685|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
83870686|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
83870687|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870688|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870689|NCT00203463|Topiramate|topiramate|mesh-list
83870690|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
83870691|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83870692|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870693|NCT00407849|Triamcinolone|triamcinolone|mesh-list
83870694|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83870695|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83870696|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83870697|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870698|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
83870699|NCT00407849|Hormones|hormones|mesh-ancestor
83870700|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870701|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870702|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870703|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
83870704|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870705|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870706|NCT00407927|Epinastine|epinastine|mesh-list
83870707|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83870708|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
83870709|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
83870710|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870711|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870712|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870713|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
83870714|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83870715|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83870716|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83870717|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83870718|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870719|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
83870720|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870721|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870722|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83870723|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870724|NCT01807546|ON 01910|on 01910|mesh-list
83870725|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870726|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870727|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870728|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870729|NCT03454984|Guadecitabine|guadecitabine|mesh-list
83870730|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870731|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
83870732|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83870733|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
83870734|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870735|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870736|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83870737|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
83870738|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
83870739|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83870740|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
83870741|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870742|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870743|NCT00203580|Tinzaparin|tinzaparin|mesh-list
83870744|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83870745|NCT00203580|Dalteparin|dalteparin|mesh-list
83870746|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
83870747|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83870748|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83870749|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870750|NCT01777555|Levodopa|levodopa|mesh-list
83870751|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83870752|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83870753|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
83870754|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870755|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870756|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870757|NCT01773928|Vaccines|vaccines|mesh-list
83870758|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
83870759|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870761|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870762|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83870763|NCT01756924|Vancomycin|vancomycin|mesh-list
83870764|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
83870765|NCT01756924|Levofloxacin|levofloxacin|mesh-list
83870766|NCT01756924|Rifampin|rifampin|mesh-list
83870767|NCT01756924|Cefazolin|cefazolin|mesh-list
83870768|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
83870769|NCT01756924|Linezolid|linezolid|mesh-list
83870770|NCT01756924|Daptomycin|daptomycin|mesh-list
83870771|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83870772|NCT01756924|Oxacillin|oxacillin|mesh-list
83870773|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
83870774|NCT01756924|Nafcillin|nafcillin|mesh-list
83870775|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870776|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83870777|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
83870778|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83870779|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83870780|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870781|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870782|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870783|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83870784|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83870785|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83870786|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
83870787|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83870788|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83870789|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83870790|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83870791|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83870792|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83870793|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83870794|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83870795|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
83870796|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83870797|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83870798|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
83870799|NCT01756339|Solithromycin|solithromycin|mesh-list
83870800|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870801|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870802|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83870803|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83870804|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870805|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870806|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870807|NCT00174200|Risperidone|risperidone|mesh-list
83870808|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83870809|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
83870810|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870811|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870812|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870813|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83870814|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83870815|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870816|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83870817|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83870818|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
83870819|NCT00203658|Tinzaparin|tinzaparin|mesh-list
83870820|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83870821|NCT00203658|Dalteparin|dalteparin|mesh-list
83870822|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
83870823|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83870824|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83870825|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870826|NCT00174239|Levodopa|levodopa|mesh-list
83870827|NCT00174239|Carbidopa|carbidopa|mesh-list
83870828|NCT00174239|Cabergoline|cabergoline|mesh-list
83870829|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83870830|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83870831|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
83870832|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870833|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870834|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870835|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83870836|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870837|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
83870838|NCT00203697|Minocycline|minocycline|mesh-list
83870839|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870840|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870841|NCT00174317|Celecoxib|celecoxib|mesh-list
83870842|NCT00174317|Diclofenac|diclofenac|mesh-list
83870843|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83870844|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83870845|NCT00174317|Analgesics|analgesics|mesh-ancestor
83870846|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
83870847|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870848|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870849|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83870850|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83870851|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83870852|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83870853|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870854|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870855|NCT01737892|Epinephrine|epinephrine|mesh-list
83870856|NCT01737892|Racepinephrine|racepinephrine|mesh-list
83870857|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
83870858|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83870859|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83870860|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
83870861|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870862|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870863|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870864|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83870865|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83870866|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
83870867|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870868|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83870869|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
83870870|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
83870871|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
83870872|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83870873|NCT00203736|Artesunate|artesunate|mesh-list
83870874|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
83870875|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
83870876|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83870877|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
83870878|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83870879|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83870880|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870881|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870882|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
83870883|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
83870884|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83870885|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
83870886|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83870887|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870888|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870889|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83870890|NCT01719016|Adenosine|adenosine|mesh-list
83870891|NCT01719016|Analgesics|analgesics|mesh-ancestor
83870892|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
83870893|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83870894|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870895|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83870896|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
83870897|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83870898|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
83870899|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
83870900|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870901|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870902|NCT00174356|Paclitaxel|paclitaxel|mesh-list
83870903|NCT00174356|Carboplatin|carboplatin|mesh-list
83870904|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83870905|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870906|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870907|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870908|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870909|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870910|NCT01718158|Ribavirin|ribavirin|mesh-list
83870911|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83870912|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
83870913|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870914|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
83870915|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870916|NCT00174395|Eletriptan|eletriptan|mesh-list
83870917|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83870918|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
83870919|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870920|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870921|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870922|NCT00203775|Risperidone|risperidone|mesh-list
83870923|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83870924|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
83870925|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83870926|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870927|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870928|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83870929|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83870930|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83870931|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83870932|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83870933|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
83870934|NCT00555256|Sirolimus|sirolimus|mesh-list
83870935|NCT00555256|Sunitinib|sunitinib|mesh-list
83870936|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870937|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83870938|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83870939|NCT00555256|Growth Substances|growth substances|mesh-ancestor
83870940|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870941|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
83870942|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870943|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870944|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870945|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870946|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870947|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83870948|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
83870949|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83870950|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
83870951|NCT00174434|Paclitaxel|paclitaxel|mesh-list
83870952|NCT00174434|Sunitinib|sunitinib|mesh-list
83870953|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83870954|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870955|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
83870956|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
83870957|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
83870958|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870959|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83870960|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83870961|NCT00174434|Growth Substances|growth substances|mesh-ancestor
83870962|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870963|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
83870964|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83870965|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870966|NCT00203814|Artesunate|artesunate|mesh-list
83870967|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
83870968|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
83870969|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83870970|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
83870971|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83870972|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83870973|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870974|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83870975|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
83870976|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
83870977|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83870978|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
83870979|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83870980|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83870981|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870982|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83870983|NCT00174473|Voriconazole|voriconazole|mesh-list
83870984|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
83870985|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870986|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83870987|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83870989|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83870990|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83870991|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
83870992|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83870993|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83870994|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83870995|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
83870996|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83870997|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83870998|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83870999|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871000|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871001|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871002|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871003|NCT00199017|Cytarabine|cytarabine|mesh-list
83871004|NCT00199017|Dexamethasone|dexamethasone|mesh-list
83871005|NCT00199017|Prednisolone|prednisolone|mesh-list
83871006|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
83871007|NCT00199017|Methotrexate|methotrexate|mesh-list
83871008|NCT00199017|Vincristine|vincristine|mesh-list
83871009|NCT00199017|Doxorubicin|doxorubicin|mesh-list
83871010|NCT00199017|Daunorubicin|daunorubicin|mesh-list
83871011|NCT00199017|Asparaginase|asparaginase|mesh-list
83871012|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
83871013|NCT00199017|Thioguanine|thioguanine|mesh-list
83871014|NCT00199017|Cladribine|cladribine|mesh-list
83871015|NCT00199017|Vindesine|vindesine|mesh-list
83871016|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871017|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
83871018|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871019|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871020|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83871021|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
83871022|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871023|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871024|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83871025|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871026|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
83871027|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
83871028|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871029|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83871030|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
83871031|NCT00199017|Hormones|hormones|mesh-ancestor
83871032|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871033|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83871034|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83871035|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
83871036|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83871037|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871038|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
83871039|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
83871040|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871041|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83871042|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83871043|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
83871044|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871045|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871046|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
83871047|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
83871048|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
83871049|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83871050|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83871051|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871052|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83871053|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
83871054|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871055|NCT01660633|Melphalan|melphalan|mesh-list
83871056|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83871057|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
83871058|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871059|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871060|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83110119|NCT02505334|Hormones|hormones|mesh-ancestor
83871061|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871062|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
83871063|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871064|NCT00174551|Prazosin|prazosin|mesh-list
83871065|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83871066|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83871067|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83871068|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83871069|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
83871070|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871071|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871072|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871073|NCT04676659|Tenecteplase|tenecteplase|mesh-list
83871074|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83871075|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83871076|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871077|NCT00174590|Risperidone|risperidone|mesh-list
83871078|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83871079|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
83871080|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871081|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871082|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871083|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83871084|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83871085|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871086|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83871087|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83871088|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
83871089|NCT01652482|Leucovorin|leucovorin|mesh-list
83871090|NCT01652482|Fluorouracil|fluorouracil|mesh-list
83871091|NCT01652482|Irinotecan|irinotecan|mesh-list
83871092|NCT01652482|Cetuximab|cetuximab|mesh-list
83871093|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
83871094|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871095|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871096|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871097|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871098|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
83871099|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871100|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83871101|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871102|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871103|NCT01652482|Antidotes|antidotes|mesh-ancestor
83871104|NCT01652482|Protective Agents|protective agents|mesh-ancestor
83871105|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
83871106|NCT01652482|Vitamins|vitamins|mesh-ancestor
83871107|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
83871108|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871109|NCT00174629|Gemcitabine|gemcitabine|mesh-list
83871110|NCT00174629|Docetaxel|docetaxel|mesh-list
83871111|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871112|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
83871113|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871114|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871115|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
83871116|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
83871117|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
83871118|NCT02962947|Propranolol|propranolol|mesh-list
83871119|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83871120|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83871121|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
83871122|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871123|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871124|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871125|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83871126|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83871127|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
83871128|NCT00555334|Lamivudine|lamivudine|mesh-list
83871129|NCT00555334|Entecavir|entecavir|mesh-list
83871130|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83871131|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83871132|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871133|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871134|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
83871135|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871136|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83871137|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83871138|NCT01640080|Esketamine|esketamine|mesh-list
83871139|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
83871140|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83871141|NCT00174668|Insulin|insulin|mesh-list
83871142|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83871143|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
83871144|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
83871145|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83871146|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871147|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
83871148|NCT00174707|Docetaxel|docetaxel|mesh-list
83871149|NCT00174707|Methotrexate|methotrexate|mesh-list
83871150|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871151|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
83871152|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871153|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871154|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83871155|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
83871156|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871157|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871158|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83871159|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83871160|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83871161|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83871162|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83871163|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
83871164|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83871165|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871166|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
83871167|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83871168|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871169|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83871170|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83871171|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
83871172|NCT01235923|Hematinics|hematinics|mesh-ancestor
83871173|NCT00199134|Letrozole|letrozole|mesh-list
83871174|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871175|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83871176|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83871177|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871178|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871179|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83871180|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
83871181|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871182|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871183|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
83871184|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83871185|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871186|NCT00174863|SR 31747|sr 31747|mesh-list
83871187|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871188|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871189|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871190|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
83871191|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871192|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
83871193|NCT00712582|Ifosfamide|ifosfamide|mesh-list
83871194|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
83871195|NCT00712582|Carmustine|carmustine|mesh-list
83871196|NCT00712582|Rituximab|rituximab|mesh-list
83871197|NCT00712582|Carboplatin|carboplatin|mesh-list
83871198|NCT00712582|Etoposide|etoposide|mesh-list
83871199|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
83871200|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
83871201|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871202|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
83871203|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871204|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871205|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83871206|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
83871207|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871208|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871209|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83871210|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871211|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871212|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83871213|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871215|NCT00712582|Analgesics|analgesics|mesh-ancestor
83871216|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
83871217|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871218|NCT00174902|Aspirin|aspirin|mesh-list
83871219|NCT00174902|Propranolol|propranolol|mesh-list
83871220|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83871221|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871222|NCT00174902|Analgesics|analgesics|mesh-ancestor
83871223|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
83871224|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871225|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871226|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871227|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871228|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83871229|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83871230|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871231|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83871232|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83871233|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871234|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
83871235|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83871236|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83871237|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83871238|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871239|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83871240|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83871241|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
83871242|NCT00373711|Iodine|iodine|mesh-list
83871243|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
83871244|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83871245|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83871246|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871247|NCT00373711|Trace Elements|trace elements|mesh-ancestor
83871248|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
83871249|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871250|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83871251|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871252|NCT00199212|Trastuzumab|trastuzumab|mesh-list
83871253|NCT00199212|Bortezomib|bortezomib|mesh-list
83871254|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871255|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871256|NCT00555373|Sirolimus|sirolimus|mesh-list
83871257|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83871258|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871259|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83871260|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871261|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
83871262|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871263|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
83871264|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871265|NCT00555412|Loxapine|loxapine|mesh-list
83871266|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83871267|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83871268|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871269|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871270|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83871271|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83871272|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
83871273|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871274|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871275|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
83871276|NCT04676776|Mifepristone|mifepristone|mesh-list
83871277|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83871278|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
83871279|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83871280|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871281|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83871282|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83871283|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83871284|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83871285|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
83871286|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83871287|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83871288|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
83871289|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871290|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
83871291|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83871292|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
83405731|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83871293|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871294|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871295|NCT00199329|Ondansetron|ondansetron|mesh-list
83871296|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
83871297|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
83871298|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871299|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871300|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83871301|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
83871302|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
83871303|NCT00199329|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83871304|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83871305|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
83871306|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871307|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871308|NCT00555607|Prednisolone|prednisolone|mesh-list
83871309|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871310|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
83871311|NCT00555607|Hormones|hormones|mesh-ancestor
83871312|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871313|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871314|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83871315|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871316|NCT00199368|Istradefylline|istradefylline|mesh-list
83871317|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83871318|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83871319|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83871320|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
83871321|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871322|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871323|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871324|NCT04675528|Paclitaxel|paclitaxel|mesh-list
83871325|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871326|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871327|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
83871328|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
83871329|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
83871330|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871331|NCT04675177|Polidocanol|polidocanol|mesh-list
83871332|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83871333|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83871334|NCT00175370|Vancomycin|vancomycin|mesh-list
83871335|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83871336|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871337|NCT00204243|Naltrexone|naltrexone|mesh-list
83871338|NCT00204243|Methadone|methadone|mesh-list
83871339|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83871340|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83871341|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871342|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
83871343|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871344|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83871345|NCT00204243|Narcotics|narcotics|mesh-ancestor
83871346|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871347|NCT00204243|Analgesics|analgesics|mesh-ancestor
83871348|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
83871349|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
83871350|NCT04675372|Midazolam|midazolam|mesh-list
83871351|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
83871352|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83871353|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871354|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871355|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871356|NCT04675372|Analgesics|analgesics|mesh-ancestor
83871357|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
83871358|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871359|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83871360|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83871361|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83871362|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
83871363|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871364|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871365|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83871366|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83871367|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83871368|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83871369|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83871370|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
83871371|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
83871372|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
83871373|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
83871374|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
83871376|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871377|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871378|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871379|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83871380|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
83871381|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871382|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871383|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871384|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
83871385|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871386|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83871387|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
83871388|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83871389|NCT00199407|Istradefylline|istradefylline|mesh-list
83871390|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83871391|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83871392|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83871393|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
83871394|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871395|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871396|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871397|NCT00199446|Istradefylline|istradefylline|mesh-list
83871398|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83871399|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83871400|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83871401|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
83871402|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871403|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871404|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871405|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
83871406|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83871407|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
83871408|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871409|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871410|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83871411|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
83871412|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83871413|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
83871414|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871415|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871416|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83871417|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
83871418|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
83871419|NCT04306393|Protective Agents|protective agents|mesh-ancestor
83871420|NCT00204321|Sirolimus|sirolimus|mesh-list
83871421|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83871422|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871423|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83871424|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871425|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
83871426|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871427|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
83871428|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871429|NCT00175565|Fluticasone|fluticasone|mesh-list
83871430|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871431|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83871432|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
83871433|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871434|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871435|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83871436|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
83110479|NCT03654729|Vitamins|vitamins|mesh-ancestor
83871437|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83871438|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83871439|NCT04230187|Leucovorin|leucovorin|mesh-list
83871440|NCT04230187|Bevacizumab|bevacizumab|mesh-list
83871441|NCT04230187|Fluorouracil|fluorouracil|mesh-list
83871442|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
83871443|NCT04230187|Irinotecan|irinotecan|mesh-list
83871444|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
83871445|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871446|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871447|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83871448|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83871449|NCT04230187|Growth Substances|growth substances|mesh-ancestor
83871450|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871451|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
83871452|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
83871453|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871454|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871455|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871456|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
83871457|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83871458|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871459|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871460|NCT04230187|Antidotes|antidotes|mesh-ancestor
83871461|NCT04230187|Protective Agents|protective agents|mesh-ancestor
83871462|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
83871463|NCT04230187|Vitamins|vitamins|mesh-ancestor
83871464|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
83871465|NCT00175643|Imiquimod|imiquimod|mesh-list
83871466|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83871467|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
83871468|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871469|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871470|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
83871471|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83871472|NCT00204438|Desogestrel|desogestrel|mesh-list
83871473|NCT00204438|Estradiol|estradiol|mesh-list
83871474|NCT00204438|Estrogens|estrogens|mesh-ancestor
83871475|NCT00204438|Hormones|hormones|mesh-ancestor
83871476|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871477|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871478|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83871479|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
83871480|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83871481|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83871482|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83871483|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83871484|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83871485|NCT00204438|Progestins|progestins|mesh-ancestor
83871486|NCT00175682|Prazosin|prazosin|mesh-list
83871487|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83871488|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83871489|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83871490|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83871491|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
83871492|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871493|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871494|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871495|NCT00554086|Bicalutamide|bicalutamide|mesh-list
83871496|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
83871497|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
83148123|NCT02138045|Incretins|incretins|mesh-ancestor
83871498|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871499|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871500|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871501|NCT04173364|Ropivacaine|ropivacaine|mesh-list
83871502|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83871503|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
83871504|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
83871505|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871506|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871507|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
83871508|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871509|NCT04171453|Pregabalin|pregabalin|mesh-list
83871510|NCT04171453|Analgesics|analgesics|mesh-ancestor
83871511|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
83110551|NCT02899195|Durvalumab|durvalumab|mesh-list
83871512|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871514|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
83871515|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83871516|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83871517|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871518|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83871519|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83871520|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83871521|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871522|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83871523|NCT04111315|Dipyrone|dipyrone|mesh-list
83871524|NCT04111315|Ibuprofen|ibuprofen|mesh-list
83871525|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83871526|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871527|NCT04111315|Analgesics|analgesics|mesh-ancestor
83871528|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
83871529|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871530|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871531|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871532|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871533|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83871534|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871535|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871536|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
83871537|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
83871538|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
83871539|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83871540|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83871541|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871542|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871543|NCT00199563|Urological Agents|urological agents|mesh-ancestor
83871544|NCT04679506|Cytarabine|cytarabine|mesh-list
83871545|NCT04679506|Etoposide|etoposide|mesh-list
83871546|NCT04679506|Cladribine|cladribine|mesh-list
83871547|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871548|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871549|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83871550|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871551|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871552|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871553|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871554|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
83871555|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
83871556|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871557|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871558|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
83871559|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871560|NCT02962830|Sufentanil|sufentanil|mesh-list
83871561|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83871562|NCT02962830|Narcotics|narcotics|mesh-ancestor
83871563|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871564|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871565|NCT02962830|Analgesics|analgesics|mesh-ancestor
83871566|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
83871567|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871568|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83871569|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83871570|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
83871571|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
83871572|NCT00199602|Heparin|heparin|mesh-list
83871573|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
83871574|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83871575|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83871576|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871577|NCT00554125|Sirolimus|sirolimus|mesh-list
83871578|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83871579|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871580|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83871581|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871582|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
83871583|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871584|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
83871585|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871586|NCT00175838|Aspirin|aspirin|mesh-list
83871587|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
83871588|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83871589|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871590|NCT00175838|Analgesics|analgesics|mesh-ancestor
83871591|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
83871592|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871593|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871594|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871595|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871596|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83871597|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83871598|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871599|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83871600|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83871601|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871602|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
83871603|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871604|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
83871605|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83871606|NCT00204555|Imiquimod|imiquimod|mesh-list
83871607|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83871608|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
83871609|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871610|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871611|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
83871612|NCT00175955|Levetiracetam|levetiracetam|mesh-list
83871613|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
83871614|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
83871615|NCT03758287|Gefitinib|gefitinib|mesh-list
83871616|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871617|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83871618|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871619|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871620|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
83871621|NCT00204633|Hematinics|hematinics|mesh-ancestor
83871622|NCT00199719|Ribavirin|ribavirin|mesh-list
83871623|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
83871624|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871625|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
83871626|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871627|NCT03430882|Paclitaxel|paclitaxel|mesh-list
83871628|NCT03430882|Carboplatin|carboplatin|mesh-list
83871629|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83871630|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871631|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871632|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
83871633|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
83871634|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
83871635|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871636|NCT03374254|Leucovorin|leucovorin|mesh-list
83871637|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
83871638|NCT03374254|Fluorouracil|fluorouracil|mesh-list
83871639|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
83871640|NCT03374254|Irinotecan|irinotecan|mesh-list
83871641|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871642|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871643|NCT03374254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83871644|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871645|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871646|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
83871647|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871648|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871649|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
83871650|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83871651|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871652|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871653|NCT03374254|Antidotes|antidotes|mesh-ancestor
83871654|NCT03374254|Protective Agents|protective agents|mesh-ancestor
83871655|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
83871656|NCT03374254|Vitamins|vitamins|mesh-ancestor
83871657|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
83871658|NCT00199758|Gemcitabine|gemcitabine|mesh-list
83871659|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871660|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871661|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
83110702|NCT04454151|Azithromycin|azithromycin|mesh-list
83871662|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871663|NCT03291886|Exemestane|exemestane|mesh-list
83871664|NCT03291886|Entinostat|entinostat|mesh-list
83871665|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871666|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83871667|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83871668|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871669|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871670|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83871671|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
83871672|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871673|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871674|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83871676|NCT03252808|Gemcitabine|gemcitabine|mesh-list
83871677|NCT03252808|Tegafur|tegafur|mesh-list
83871678|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871679|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871680|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
83871681|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
83871682|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
83871683|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871684|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871685|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
83871686|NCT03191461|Adenosine|adenosine|mesh-list
83871687|NCT03191461|Analgesics|analgesics|mesh-ancestor
83871688|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
83871689|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871690|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871691|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83871692|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
83871693|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83871694|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
83871695|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
83871696|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871697|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871698|NCT00199953|Rabeprazole|rabeprazole|mesh-list
83871699|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83871700|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83871701|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83871702|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871703|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871704|NCT03184090|Palbociclib|palbociclib|mesh-list
83871705|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871706|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83871707|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871708|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871709|NCT03160846|Milrinone|milrinone|mesh-list
83871710|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83871711|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83871712|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
83871713|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83871714|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83871715|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871716|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871717|NCT03160846|Protective Agents|protective agents|mesh-ancestor
83871718|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871719|NCT00204789|Eflornithine|eflornithine|mesh-list
83871720|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871721|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83871722|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83871723|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83871724|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871725|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83871726|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871727|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871728|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
83871729|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
83871730|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
83871731|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83871732|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83871733|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871734|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871735|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871736|NCT02830360|Amiodarone|amiodarone|mesh-list
83871737|NCT02830360|Sotalol|sotalol|mesh-list
83871738|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83871739|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
83871740|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83871741|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83871742|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871743|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83871744|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83871745|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83871746|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871747|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83871748|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83871749|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83871750|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83871751|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83871752|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
83871753|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83871754|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871755|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
83871756|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
83871757|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871758|NCT02827435|Bromides|bromides|mesh-list
83871759|NCT02827435|Rocuronium|rocuronium|mesh-list
83871760|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
83871761|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83871762|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83871763|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83871764|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871765|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871766|NCT00176618|Curcumin|curcumin|mesh-list
83871767|NCT00176618|Sulindac|sulindac|mesh-list
83871768|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83871769|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871770|NCT00176618|Analgesics|analgesics|mesh-ancestor
83871771|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
83871772|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871773|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871774|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871775|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871776|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871777|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871778|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871779|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83871780|NCT02675959|Defibrotide|defibrotide|mesh-list
83871781|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83871782|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83871783|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871784|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83871785|NCT00410787|Hydromorphone|hydromorphone|mesh-list
83871786|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83871787|NCT00410787|Narcotics|narcotics|mesh-ancestor
83871788|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871789|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871790|NCT00410787|Analgesics|analgesics|mesh-ancestor
83871791|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
83871792|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871793|NCT00554164|Prednisone|prednisone|mesh-list
83871794|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
83871795|NCT00554164|Doxorubicin|doxorubicin|mesh-list
83871796|NCT00554164|Vincristine|vincristine|mesh-list
83871797|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871798|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
83871799|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871800|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871801|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83871802|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
83871803|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871804|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871805|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83871806|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83871807|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83871808|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871809|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871810|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871811|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
83871812|NCT00554164|Hormones|hormones|mesh-ancestor
83871813|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871814|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83871815|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871816|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
83871817|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
83871818|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
83871819|NCT02572141|Leucovorin|leucovorin|mesh-list
83871820|NCT02572141|Fluorouracil|fluorouracil|mesh-list
83871821|NCT02572141|Capecitabine|capecitabine|mesh-list
83871822|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
83871823|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
83871824|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
83871825|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871826|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871827|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871828|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871829|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
83871830|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871831|NCT02572141|Antidotes|antidotes|mesh-ancestor
83871832|NCT02572141|Protective Agents|protective agents|mesh-ancestor
83871833|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
83871834|NCT02572141|Vitamins|vitamins|mesh-ancestor
83871835|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
83871836|NCT02470039|Insulin|insulin|mesh-list
83871837|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83871838|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
83871839|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83871840|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871841|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
83871842|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871843|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83871844|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871845|NCT00554203|Analgesics|analgesics|mesh-ancestor
83871846|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
83871847|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871848|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871849|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871850|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871851|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83871852|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
83871853|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
83871854|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
83871855|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871856|NCT00554242|Protective Agents|protective agents|mesh-ancestor
83871857|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871858|NCT00554242|Vitamins|vitamins|mesh-ancestor
83871859|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
83871860|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83871861|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871862|NCT00176735|Capecitabine|capecitabine|mesh-list
83871863|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871864|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
83871865|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871866|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871867|NCT00410943|Hydromorphone|hydromorphone|mesh-list
83871868|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83871869|NCT00410943|Narcotics|narcotics|mesh-ancestor
83871870|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871871|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871872|NCT00410943|Analgesics|analgesics|mesh-ancestor
83871873|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
83871874|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871875|NCT00176774|Leucovorin|leucovorin|mesh-list
83871876|NCT00176774|Fluorouracil|fluorouracil|mesh-list
83871877|NCT00176774|Irinotecan|irinotecan|mesh-list
83871878|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83871879|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
83871880|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871881|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871882|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871883|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871884|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
83871885|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871886|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83871887|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83871888|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871889|NCT00176774|Antidotes|antidotes|mesh-ancestor
83871890|NCT00176774|Protective Agents|protective agents|mesh-ancestor
83871891|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
83871892|NCT00176774|Vitamins|vitamins|mesh-ancestor
83871893|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
83871894|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
83871895|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
83871896|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83871897|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83871898|NCT00176774|Growth Substances|growth substances|mesh-ancestor
83871899|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
83871900|NCT02434744|Metformin|metformin|mesh-list
83871901|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83871902|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871903|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
83871904|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83871905|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
83871906|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83871907|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83871908|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871909|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83871910|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871911|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83871912|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871913|NCT00410982|Rituximab|rituximab|mesh-list
83871914|NCT00410982|Gemcitabine|gemcitabine|mesh-list
83871915|NCT00410982|Melphalan|melphalan|mesh-list
83871916|NCT00410982|Busulfan|busulfan|mesh-list
83871917|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871918|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871919|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
83871920|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871921|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871922|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871923|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
83871924|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871925|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83871926|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
83871927|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83871928|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871929|NCT02372578|Pregabalin|pregabalin|mesh-list
83871930|NCT02372578|Analgesics|analgesics|mesh-ancestor
83871931|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
83871932|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871933|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871934|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
83871935|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83871936|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83871937|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871938|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83871939|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83871940|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83871941|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83871942|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83871943|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
83871944|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83871945|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83871946|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
83871947|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83871948|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83871949|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83871950|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83871951|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871952|NCT00554476|Triamcinolone|triamcinolone|mesh-list
83871953|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83871954|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83871955|NCT00554476|Indomethacin|indomethacin|mesh-list
83871956|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83871957|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83871958|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
83871959|NCT00554476|Hormones|hormones|mesh-ancestor
83871960|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83871961|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871962|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83871963|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
83871964|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110998|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83871965|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871966|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83871967|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871968|NCT00554476|Analgesics|analgesics|mesh-ancestor
83871969|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
83871970|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83871971|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83871972|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
83871973|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
83871974|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83871975|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83871976|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83871977|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
83871978|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871979|NCT00204906|Vitamin D|vitamin d|mesh-list
83871980|NCT00204906|Vitamins|vitamins|mesh-ancestor
83871981|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
83871982|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83871983|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83871984|NCT02335918|Nivolumab|nivolumab|mesh-list
83871985|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83871986|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871987|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83871988|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871989|NCT00176813|Celecoxib|celecoxib|mesh-list
83871990|NCT00176813|Gemcitabine|gemcitabine|mesh-list
83871991|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83871992|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83871993|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
83871994|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83871995|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83871996|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83871997|NCT00176813|Analgesics|analgesics|mesh-ancestor
83871998|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
83871999|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872000|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872001|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83872002|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872003|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83872004|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83872005|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872006|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
83872007|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83872008|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872009|NCT02320708|Acetaminophen|acetaminophen|mesh-list
83872010|NCT02320708|Ibuprofen|ibuprofen|mesh-list
83872011|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83872012|NCT02320708|Analgesics|analgesics|mesh-ancestor
83872013|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
83872014|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872015|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872016|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
83872017|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83872018|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83872019|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872020|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83872021|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872022|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872023|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83872024|NCT02309671|Hormones|hormones|mesh-ancestor
83872025|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872026|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872027|NCT02296645|Ethanol|ethanol|mesh-list
83872028|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
83872029|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83872030|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83872031|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872032|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872033|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872034|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
83872035|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83872036|NCT02295865|Toreforant|toreforant|mesh-list
83872037|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
83872038|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
83111073|NCT05049213|Povidone|povidone|mesh-list
83872039|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872040|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872041|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872042|NCT02282215|Lenograstim|lenograstim|mesh-list
83872043|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83872044|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
83872045|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872046|NCT00176969|Capsaicin|capsaicin|mesh-list
83872047|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
83872048|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
83872049|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
83872050|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872051|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872052|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83872053|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
83872054|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872055|NCT00177008|Aripiprazole|aripiprazole|mesh-list
83872056|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
83872057|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83872058|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83872059|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83872060|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872061|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872062|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
83872063|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
83872064|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872065|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872066|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83872067|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83872068|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
83872069|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83872070|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83872071|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83872072|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83872073|NCT04677985|Analgesics|analgesics|mesh-list
83872074|NCT04677985|Menthol|menthol|mesh-list
83872075|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
83872076|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872077|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872078|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
83872079|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
83872080|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83872081|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83872082|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83872083|NCT00554632|Norgestimate|norgestimate|mesh-list
83872084|NCT00554632|Norelgestromin|norelgestromin|mesh-list
83872085|NCT00554632|Ortho Evra|ortho evra|mesh-list
83872086|NCT00554632|Estradiol|estradiol|mesh-list
83872087|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83872088|NCT00554632|Estrogens|estrogens|mesh-ancestor
83872089|NCT00554632|Hormones|hormones|mesh-ancestor
83872090|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872091|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872092|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83872093|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
83872094|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83872095|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83872096|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83872097|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83872098|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83872099|NCT00204984|Hydralazine|hydralazine|mesh-list
83872100|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83872101|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
83872102|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872103|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872104|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
83872105|NCT02236195|Mocetinostat|mocetinostat|mesh-list
83872106|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83872107|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872108|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872109|NCT02236156|Metronidazole|metronidazole|mesh-list
83872110|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872111|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83872112|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83872113|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83872114|NCT00177086|Alfuzosin|alfuzosin|mesh-list
83872115|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83872116|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83872117|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83872118|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872119|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872120|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872121|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872122|NCT00177086|Urological Agents|urological agents|mesh-ancestor
83872123|NCT02207257|Edoxaban|edoxaban|mesh-list
83872124|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83872125|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
83872126|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83872127|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
83872128|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872129|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872130|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
83872131|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
83872132|NCT00554710|Budesonide|budesonide|mesh-list
83872133|NCT00554710|Infliximab|infliximab|mesh-list
83872134|NCT00554710|Azathioprine|azathioprine|mesh-list
83872135|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83872136|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
83872137|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
83872138|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872139|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872140|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872141|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
83872142|NCT00554710|Hormones|hormones|mesh-ancestor
83148145|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
83872143|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872144|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83872145|NCT00554710|Protective Agents|protective agents|mesh-ancestor
83872146|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872147|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83872148|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83872149|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
83872150|NCT00554710|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83872151|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
83872152|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872153|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
83872154|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872155|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83872156|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872157|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
83872158|NCT00200187|Anesthetics|anesthetics|mesh-list
83872159|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872160|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872161|NCT04659109|Glenzocimab|glenzocimab|mesh-list
83872162|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
83872163|NCT00177242|Gefitinib|gefitinib|mesh-list
83872164|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872165|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83872166|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872167|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872168|NCT04659070|Telmisartan|telmisartan|mesh-list
83872169|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83872170|NCT04659070|Ezetimibe|ezetimibe|mesh-list
83872171|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83872172|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83872173|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
83872174|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872175|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83872176|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83872177|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872178|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872179|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83872180|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83872181|NCT00177281|Belotecan|belotecan|mesh-list
83872182|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83872183|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872184|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872185|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872186|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872187|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
83872188|NCT00200226|Pyridoxal|pyridoxal|mesh-list
83872189|NCT00200226|Pyridoxine|pyridoxine|mesh-list
83111245|NCT03460743|Vaccines|vaccines|mesh-list
83872191|NCT00200226|Vitamins|vitamins|mesh-ancestor
83872192|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
83872193|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872194|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83872195|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
83872196|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83872197|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83872198|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872199|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
83872200|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
83872201|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83872202|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
83872203|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872204|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
83872205|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872206|NCT04658134|Glycine|glycine|mesh-list
83872207|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
83872208|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872209|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872210|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872211|NCT00200382|Bortezomib|bortezomib|mesh-list
83872212|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872213|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83872214|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83872215|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872216|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872217|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
83872218|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872219|NCT00177398|Insulin|insulin|mesh-list
83872220|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83872221|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
83872222|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83872223|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872224|NCT00200421|Atenolol|atenolol|mesh-list
83872225|NCT00200421|Nebivolol|nebivolol|mesh-list
83872226|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83872227|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872228|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
83872229|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
83872230|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872231|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872232|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83872233|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83872234|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83872235|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872236|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872237|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872238|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
83872239|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83872240|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83872241|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83872242|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83872243|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83872244|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872245|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
83872246|NCT04656262|Doxorubicin|doxorubicin|mesh-list
83872247|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872248|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
83872249|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872250|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872251|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83872252|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
83872253|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872254|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872255|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83872256|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83872257|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872258|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872259|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872260|NCT00200460|Nebivolol|nebivolol|mesh-list
83872261|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872262|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
83872263|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83111298|NCT03468231|Vitamins|vitamins|mesh-ancestor
83872264|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83872265|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83872266|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872267|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872268|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872269|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872270|NCT00200499|Nebivolol|nebivolol|mesh-list
83872271|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872272|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
83872273|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83872274|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83872275|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83872276|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872277|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872278|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872279|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872280|NCT00200538|Memantine|memantine|mesh-list
83872281|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83872282|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83872283|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
83872284|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872285|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872286|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872287|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83872288|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83872289|NCT00177710|Amphotericin B|amphotericin b|mesh-list
83872290|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83872291|NCT00177710|Amebicides|amebicides|mesh-ancestor
83872292|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83872293|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83872294|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872295|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83872296|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
83872297|NCT00177749|Posaconazole|posaconazole|mesh-list
83872298|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
83872299|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872300|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83872301|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83872302|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83872303|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83872304|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83872305|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872306|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872307|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83872308|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
83872309|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872310|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872311|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83872312|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83872313|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83872314|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872315|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872316|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872317|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872318|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83872319|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
83872320|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83872321|NCT04654819|Anesthetics|anesthetics|mesh-list
83872322|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872323|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872324|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83872325|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
83872326|NCT04654741|Ganirelix|ganirelix|mesh-list
83872327|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83872328|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83872329|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83872330|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
83872331|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83872332|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872333|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83872334|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83111373|NCT04370145|Sulperazone|sulperazone|mesh-list
83872335|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83872336|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83872337|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872338|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
83872339|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872340|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
83872341|NCT04654195|Doxorubicin|doxorubicin|mesh-list
83872342|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872343|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
83872344|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872345|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872346|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83872347|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
83872348|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872349|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872350|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83872351|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83872352|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872353|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872354|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872355|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
83872356|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83872358|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
83872359|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
83872360|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872361|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872362|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
83872363|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872364|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83872365|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83872366|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83872367|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872368|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872369|NCT00200655|Pravastatin|pravastatin|mesh-list
83872370|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83872371|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83872372|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
83872373|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872374|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83872375|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83872376|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872377|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
83872378|NCT04653493|Fludarabine|fludarabine|mesh-list
83872379|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872380|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
83872381|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872382|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872383|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83872384|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
83872385|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872386|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872387|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83872388|NCT00200694|Valsartan|valsartan|mesh-list
83872389|NCT00200694|Ramipril|ramipril|mesh-list
83872390|NCT00200694|Furosemide|furosemide|mesh-list
83872391|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872392|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83872393|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83872394|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872395|NCT00200694|Diuretics|diuretics|mesh-ancestor
83872396|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
83872397|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872398|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83872399|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872400|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83872401|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
83872402|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872403|NCT00557713|Bevacizumab|bevacizumab|mesh-list
83872404|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83872405|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872406|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83872407|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83872408|NCT00557713|Growth Substances|growth substances|mesh-ancestor
83872409|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872410|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
83872411|NCT00178100|Paroxetine|paroxetine|mesh-list
83872412|NCT00178100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83872413|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83872414|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872415|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872416|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872417|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
83872418|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872419|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83872420|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
83872421|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83872422|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83872423|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83872424|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872425|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
83872426|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83872427|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83872428|NCT04653415|Prednisolone|prednisolone|mesh-list
83872429|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
83872430|NCT04653415|Gabapentin|gabapentin|mesh-list
83872431|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83872432|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
83872433|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83872434|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
83872435|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
83872436|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872437|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872438|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872439|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
83872440|NCT04653415|Hormones|hormones|mesh-ancestor
83872441|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872442|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83872443|NCT04653415|Protective Agents|protective agents|mesh-ancestor
83872444|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83872445|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872446|NCT04653415|Analgesics|analgesics|mesh-ancestor
83872447|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
83872448|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
83872449|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83872450|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83872451|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872452|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83872453|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83872454|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83872455|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872456|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872457|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
83872458|NCT00557791|Ranibizumab|ranibizumab|mesh-list
83872459|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83872460|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83872461|NCT00557791|Growth Substances|growth substances|mesh-ancestor
83872462|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872463|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
83872464|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872465|NCT04652284|Amoxicillin|amoxicillin|mesh-list
83872466|NCT04652284|Clarithromycin|clarithromycin|mesh-list
83872467|NCT04652284|Rifabutin|rifabutin|mesh-list
83872468|NCT04652284|Tinidazole|tinidazole|mesh-list
83872469|NCT04652284|Esomeprazole|esomeprazole|mesh-list
83872470|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83872471|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872472|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83872473|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872474|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83872475|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872476|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872477|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83872478|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83872479|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83111523|NCT03719001|Phenylephrine|phenylephrine|mesh-list
83872480|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83872481|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
83872482|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
83872483|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83872484|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83872485|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83872486|NCT04652323|Calcium|calcium|mesh-list
83872487|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83872488|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872489|NCT04652011|Analgesics|analgesics|mesh-list
83872490|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
83872491|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872492|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872493|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
83872494|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83872495|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872496|NCT00205725|Olanzapine|olanzapine|mesh-list
83872497|NCT00205725|Ziprasidone|ziprasidone|mesh-list
83872498|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
83872499|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
83872500|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872501|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872502|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872503|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83872504|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83872505|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872506|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83872507|NCT00205725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83872508|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83872509|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872510|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872511|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872512|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
83872513|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83872514|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83872515|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
83872516|NCT00178373|Modafinil|modafinil|mesh-list
83872517|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83872518|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872519|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83872520|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83872521|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83872522|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872523|NCT00205764|Melphalan|melphalan|mesh-list
83872524|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83872525|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
83872526|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872527|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872528|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83872529|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872530|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
83872531|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872532|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
83872533|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83872534|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
83872535|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872536|NCT00558142|Expectorants|expectorants|mesh-ancestor
83872537|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
83872538|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83872539|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
83872540|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872541|NCT00558142|Protective Agents|protective agents|mesh-ancestor
83872542|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872543|NCT00558142|Antidotes|antidotes|mesh-ancestor
83872544|NCT00205842|Alvimopan|alvimopan|mesh-list
83872545|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872546|NCT00178451|Abciximab|abciximab|mesh-list
83872547|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
83872548|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83872549|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83872550|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
83872551|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83872552|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83872553|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83872554|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111597|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872555|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872556|NCT00206154|Budesonide|budesonide|mesh-list
83872557|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
83872558|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83872559|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83872560|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
83872561|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872562|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872563|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83872564|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
83872565|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
83872566|NCT00206154|Hormones|hormones|mesh-ancestor
83872567|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872568|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83872569|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83872570|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83872571|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872572|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872573|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872574|NCT00559702|Natalizumab|natalizumab|mesh-list
83872575|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
83872576|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872577|NCT00559741|Leucovorin|leucovorin|mesh-list
83872578|NCT00559741|Fluorouracil|fluorouracil|mesh-list
83872579|NCT00559741|Irinotecan|irinotecan|mesh-list
83872580|NCT00559741|Cetuximab|cetuximab|mesh-list
83872581|NCT00559741|Calcium|calcium|mesh-list
83872582|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
83872583|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83872584|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872585|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
83872586|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872587|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83872588|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872589|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872590|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
83872591|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83872592|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872593|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872594|NCT00559741|Antidotes|antidotes|mesh-ancestor
83872595|NCT00559741|Protective Agents|protective agents|mesh-ancestor
83872596|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
83872597|NCT00559741|Vitamins|vitamins|mesh-ancestor
83872598|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
83872599|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83872600|NCT00178763|Interferons|interferons|mesh-list
83872601|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
83872602|NCT00178763|Cisplatin|cisplatin|mesh-list
83872603|NCT00178763|Gemcitabine|gemcitabine|mesh-list
83872604|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872605|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83872606|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
83872607|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872608|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
83872609|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872610|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
83872611|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872612|NCT00559858|Pyridoxine|pyridoxine|mesh-list
83872613|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
83872614|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
83872615|NCT00559858|Vitamins|vitamins|mesh-ancestor
83872616|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
83872617|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872618|NCT00559975|Vaccines|vaccines|mesh-list
83872619|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
83872620|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872621|NCT00206193|Misoprostol|misoprostol|mesh-list
83872622|NCT00206193|Sulprostone|sulprostone|mesh-list
83872623|NCT00206193|Mifepristone|mifepristone|mesh-list
83872624|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83872625|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
83872626|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83872627|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872628|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83872629|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872630|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
83872631|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83872632|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83872633|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83872634|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83872635|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
83872636|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83872637|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83872638|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83872639|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872640|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
83872641|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83872642|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83872643|NCT04638439|Entecavir|entecavir|mesh-list
83872644|NCT04638439|Nivolumab|nivolumab|mesh-list
83872645|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83872646|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872647|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83872648|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872649|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
83872650|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872651|NCT00178802|Interferons|interferons|mesh-list
83872652|NCT00178802|Doxorubicin|doxorubicin|mesh-list
83872653|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83872654|NCT00178802|Fluorouracil|fluorouracil|mesh-list
83872655|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83872656|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872657|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872658|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872659|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872660|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872661|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
83872662|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83872663|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872664|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
83872665|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872666|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
83872667|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872668|NCT00408239|Enoxaparin|enoxaparin|mesh-list
83872669|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
83872670|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83872671|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83872672|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872673|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83872674|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872675|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
83872676|NCT00408278|Analgesics|analgesics|mesh-ancestor
83872677|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
83872678|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872679|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872680|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872681|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872682|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872683|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872684|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872685|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
83872686|NCT00560092|Analgesics|analgesics|mesh-ancestor
83872687|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
83872688|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872689|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872690|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
83872691|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872692|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83872693|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
83872694|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83872695|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872696|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872697|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83872698|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
83872699|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83872700|NCT00560170|Simvastatin|simvastatin|mesh-list
83872701|NCT00560170|Ezetimibe|ezetimibe|mesh-list
83872702|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83872703|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83872704|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83872705|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
83872706|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872707|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83148186|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83872708|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83872709|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872710|NCT04637152|Valsartan|valsartan|mesh-list
83872711|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83872712|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872713|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83872714|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83872715|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872716|NCT04636918|Cyclosporine|cyclosporine|mesh-list
83872717|NCT04636918|Cyclosporins|cyclosporins|mesh-list
83872718|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872719|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872720|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872721|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
83872722|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872723|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
83872724|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872725|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
83872726|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872727|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83872728|NCT00560209|Landiolol|landiolol|mesh-list
83872729|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83872730|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83872731|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872732|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872733|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872734|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872735|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83872736|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
83872737|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83872738|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83872739|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83872740|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872741|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872742|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872743|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872744|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872745|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872746|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83872747|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83872748|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83872749|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
83872750|NCT04636957|Hormones|hormones|mesh-ancestor
83872751|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83872752|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872753|NCT00560326|Tacrolimus|tacrolimus|mesh-list
83872754|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872755|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
83872756|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872757|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83872758|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872759|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872760|NCT00560443|Ketorolac|ketorolac|mesh-list
83872761|NCT00560443|Tramadol|tramadol|mesh-list
83872762|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83872763|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83872764|NCT00560443|Analgesics|analgesics|mesh-ancestor
83872765|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
83872766|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872767|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872768|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83872769|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872770|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83872771|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872772|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872773|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83872774|NCT00560443|Narcotics|narcotics|mesh-ancestor
83872775|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872776|NCT00179114|Baclofen|baclofen|mesh-list
83872777|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
83872778|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83111821|NCT03446937|Hormones|hormones|mesh-ancestor
83872779|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83872780|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83872781|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872782|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872783|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
83872784|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872785|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872786|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83872787|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872788|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83872789|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83872790|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
83872791|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
83872792|NCT00201318|Lamivudine|lamivudine|mesh-list
83872793|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
83872794|NCT00201318|Doxorubicin|doxorubicin|mesh-list
83872795|NCT00201318|Vincristine|vincristine|mesh-list
83872796|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872797|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
83872798|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872799|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872800|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83872801|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
83872802|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872803|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872804|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83872805|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83872806|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872807|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872808|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872809|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83872810|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83872811|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83872812|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83872813|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83872814|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83872815|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
83872816|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872817|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83872818|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83872819|NCT00201357|Thalidomide|thalidomide|mesh-list
83872820|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872821|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
83872822|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872823|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
83872824|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83872825|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872826|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83872827|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83872828|NCT00201357|Growth Substances|growth substances|mesh-ancestor
83872829|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
83872830|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872831|NCT00201396|Leucovorin|leucovorin|mesh-list
83872832|NCT00201396|Fluorouracil|fluorouracil|mesh-list
83872833|NCT00201396|Epirubicin|epirubicin|mesh-list
83872834|NCT00201396|Mitomycins|mitomycins|mesh-list
83872835|NCT00201396|Mitomycin|mitomycin|mesh-list
83872836|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872837|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
83872838|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872839|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83872840|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872841|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
83872842|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872843|NCT00201396|Antidotes|antidotes|mesh-ancestor
83872844|NCT00201396|Protective Agents|protective agents|mesh-ancestor
83872845|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
83872846|NCT00201396|Vitamins|vitamins|mesh-ancestor
83872847|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
83872848|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83872849|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872850|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872851|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872852|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
83872853|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83872854|NCT00201435|Paclitaxel|paclitaxel|mesh-list
83872855|NCT00201435|Docetaxel|docetaxel|mesh-list
83872856|NCT00201435|Capecitabine|capecitabine|mesh-list
83872857|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83872858|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872859|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83872860|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83872861|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83872862|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872863|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83872864|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
83872865|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
83872866|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83872867|NCT00560599|Mupirocin|mupirocin|mesh-list
83872868|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83872869|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872870|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
83872871|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
83872872|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83872873|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83872874|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872875|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872876|NCT04635553|Praziquantel|praziquantel|mesh-list
83872877|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
83872878|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83872879|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83872880|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83872881|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83872882|NCT04634656|Lidocaine|lidocaine|mesh-list
83872883|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
83872884|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
83872885|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83872886|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872887|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
83872888|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872889|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83872890|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83872891|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83872892|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872893|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872894|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
83872895|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83872896|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872897|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83872898|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872899|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83872900|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872901|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83872902|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83872903|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83872904|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872905|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872906|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872907|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872908|NCT00201630|Alfuzosin|alfuzosin|mesh-list
83872909|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83872910|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83872911|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83872912|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
83872913|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872914|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872915|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872916|NCT00201630|Urological Agents|urological agents|mesh-ancestor
83872917|NCT00179231|Olanzapine|olanzapine|mesh-list
83872918|NCT00179231|Clozapine|clozapine|mesh-list
83872919|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
83872920|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
83872921|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83872922|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872923|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83872924|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83872925|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83872926|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111970|NCT01061333|Montelukast|montelukast|mesh-list
83872927|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83872928|NCT00179231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83872929|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83872930|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83872931|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872932|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83872934|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83872935|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
83872936|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
83872937|NCT00201669|Clofarabine|clofarabine|mesh-list
83872938|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83872939|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
83872940|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872941|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872942|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
83872943|NCT00201708|Docetaxel|docetaxel|mesh-list
83872944|NCT00201708|Doxorubicin|doxorubicin|mesh-list
83872945|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83872946|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
83872947|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872948|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83872949|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83872950|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
83872951|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872952|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872953|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83872954|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
83872955|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
83872956|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
83872957|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83872958|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83872959|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83872960|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872961|NCT04632121|Nicorandil|nicorandil|mesh-list
83872962|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83872963|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83872964|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
83872965|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
83872966|NCT04632121|Vitamins|vitamins|mesh-ancestor
83872967|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
83872968|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872969|NCT00179699|Pemetrexed|pemetrexed|mesh-list
83872970|NCT00179699|Lenalidomide|lenalidomide|mesh-list
83872971|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872972|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872973|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872974|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83872975|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83872976|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
83872977|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872978|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83872979|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83872980|NCT00179699|Growth Substances|growth substances|mesh-ancestor
83872981|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
83872982|NCT00201747|Mitomycins|mitomycins|mesh-list
83872983|NCT00201747|Mitomycin|mitomycin|mesh-list
83872984|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83872985|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872986|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
83872987|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83872988|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83872989|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83872990|NCT00179738|Lenalidomide|lenalidomide|mesh-list
83872991|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
83872992|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83872993|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83872994|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83872995|NCT00179738|Growth Substances|growth substances|mesh-ancestor
83872996|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
83872997|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83872998|NCT04631341|Melatonin|melatonin|mesh-list
83872999|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
83873000|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873001|NCT04631341|Protective Agents|protective agents|mesh-ancestor
83873002|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873003|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83873004|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83873005|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83873006|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83873007|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83873008|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873009|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873010|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873011|NCT04723238|Analgesics|analgesics|mesh-ancestor
83873012|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
83873013|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873014|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
83873015|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83873016|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
83873017|NCT00201786|Pentostatin|pentostatin|mesh-list
83873018|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873019|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83873020|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873021|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873023|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
83873024|NCT04630522|Calcium|calcium|mesh-list
83873025|NCT04630522|Vitamins|vitamins|mesh-ancestor
83873026|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
83873027|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873028|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83873029|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83873030|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
83873031|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873032|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
83873033|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873034|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873035|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873036|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
83873037|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873038|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873039|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873040|NCT04630444|Riluzole|riluzole|mesh-list
83873041|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
83873042|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83873043|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83873044|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873045|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873046|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873047|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83873048|NCT04630444|Protective Agents|protective agents|mesh-ancestor
83873049|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
83873050|NCT00186810|Busulfan|busulfan|mesh-list
83873051|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873052|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
83873053|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873054|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873055|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873056|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
83873057|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873058|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873059|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873060|NCT04630288|Clopidogrel|clopidogrel|mesh-list
83873061|NCT04630288|Ticagrelor|ticagrelor|mesh-list
83873062|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83873063|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83873064|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83873065|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83873066|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
83873067|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873068|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873069|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873070|NCT00561028|Antibodies|antibodies|mesh-list
83873071|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
83873072|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873073|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
83873074|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83873075|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83873076|NCT00561067|Prednisolone|prednisolone|mesh-list
83873077|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
83873078|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
83873079|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83873080|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
83873081|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873082|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
83873083|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
83873084|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873085|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873086|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873087|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
83873088|NCT00561067|Hormones|hormones|mesh-ancestor
83873089|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873090|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83873091|NCT00561067|Protective Agents|protective agents|mesh-ancestor
83873092|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83873093|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873094|NCT00561067|Hematinics|hematinics|mesh-ancestor
83873095|NCT00561106|Valacyclovir|valacyclovir|mesh-list
83873096|NCT00561106|Prednisone|prednisone|mesh-list
83873097|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873098|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
83873099|NCT00561106|Hormones|hormones|mesh-ancestor
83873100|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873101|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873102|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83873103|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873104|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
83873105|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873106|NCT00561184|Vaccines|vaccines|mesh-list
83873107|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
83873108|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873109|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
83873110|NCT00186849|Ifosfamide|ifosfamide|mesh-list
83873111|NCT00186849|Carboplatin|carboplatin|mesh-list
83873112|NCT00186849|Doxorubicin|doxorubicin|mesh-list
83873113|NCT00186849|Etoposide|etoposide|mesh-list
83873114|NCT00186849|Topotecan|topotecan|mesh-list
83873115|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873116|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
83873117|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873118|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873119|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873120|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
83873121|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873122|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873123|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873124|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873125|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873126|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873127|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873128|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873129|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83873130|NCT00201981|Rebamipide|rebamipide|mesh-list
83873131|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83873132|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873133|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
83873134|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873135|NCT00201981|Protective Agents|protective agents|mesh-ancestor
83873136|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873137|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873138|NCT00561223|Iloprost|iloprost|mesh-list
83873139|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83873140|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
83873141|NCT00180011|Omalizumab|omalizumab|mesh-list
83873142|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83873143|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83873144|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873145|NCT00186966|Cytarabine|cytarabine|mesh-list
83873146|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
83873147|NCT00186966|Melphalan|melphalan|mesh-list
83873148|NCT00186966|Busulfan|busulfan|mesh-list
83873149|NCT00186966|Fludarabine|fludarabine|mesh-list
83873150|NCT00186966|Etoposide|etoposide|mesh-list
83873151|NCT00186966|Daunorubicin|daunorubicin|mesh-list
83873152|NCT00186966|Thioguanine|thioguanine|mesh-list
83873153|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873154|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
83873155|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873156|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873157|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873158|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
83873159|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873160|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873161|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873162|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873163|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
83873164|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873165|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873166|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873167|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873168|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
83873169|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873170|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873171|NCT00180050|Budesonide|budesonide|mesh-list
83873172|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873173|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83873174|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
83873175|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873176|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873177|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83873178|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873179|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
83873180|NCT00180050|Hormones|hormones|mesh-ancestor
83873181|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873182|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83873183|NCT00575302|Hormones|hormones|mesh-ancestor
83873184|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873185|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873186|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83873187|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83873188|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
83873189|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873190|NCT00180089|Budesonide|budesonide|mesh-list
83873191|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873192|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83873193|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
83873194|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873195|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873196|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83873197|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873198|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
83873199|NCT00180089|Hormones|hormones|mesh-ancestor
83873200|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873201|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
83873202|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83873203|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
83873204|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873205|NCT00575419|Expectorants|expectorants|mesh-ancestor
83873206|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873207|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83873208|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
83873209|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873210|NCT00575419|Protective Agents|protective agents|mesh-ancestor
83873211|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873212|NCT00575419|Antidotes|antidotes|mesh-ancestor
83873213|NCT00180128|Cytarabine|cytarabine|mesh-list
83873214|NCT00180128|Daunorubicin|daunorubicin|mesh-list
83873215|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
83873216|NCT00180128|Idarubicin|idarubicin|mesh-list
83873217|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873218|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
84048314|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873219|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873220|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873221|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
83873222|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873223|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873224|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
83873225|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873226|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873227|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873228|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873229|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873230|NCT00180128|Analgesics|analgesics|mesh-ancestor
83873231|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
83873232|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873233|NCT00575614|Prucalopride|prucalopride|mesh-list
83873234|NCT00575614|Laxatives|laxatives|mesh-ancestor
83873235|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873236|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83873237|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83873238|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
83873239|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873240|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873241|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873242|NCT00575848|Glycine|glycine|mesh-list
83873243|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
83873244|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873245|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873246|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873247|NCT00576238|Betamethasone|betamethasone|mesh-list
83873248|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
83873249|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83873250|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
83873251|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83873252|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873253|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
83873254|NCT00576238|Hormones|hormones|mesh-ancestor
83873255|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873256|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873257|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83873258|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873259|NCT00576394|Insulin|insulin|mesh-list
83873260|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83873261|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83873262|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873263|NCT00576433|Rituximab|rituximab|mesh-list
83873264|NCT00576433|Methotrexate|methotrexate|mesh-list
83873265|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83873266|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873267|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
83873268|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873269|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873270|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83873271|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873272|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873273|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873274|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
83873275|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873276|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873277|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873278|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83873279|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873280|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83873281|NCT00576511|Prucalopride|prucalopride|mesh-list
83873282|NCT00576511|Laxatives|laxatives|mesh-ancestor
83873283|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873284|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83873285|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83873286|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
83873287|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873288|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873289|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873290|NCT00576550|Betamethasone|betamethasone|mesh-list
83873291|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
83873292|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83873293|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
83873294|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83873295|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873296|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
83873297|NCT00576550|Hormones|hormones|mesh-ancestor
83873298|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873299|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873300|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83873301|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873302|NCT00576706|Misoprostol|misoprostol|mesh-list
83873303|NCT00576706|Rebamipide|rebamipide|mesh-list
83873304|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83873305|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873306|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873307|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873308|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83873309|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873310|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
83873311|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
83873312|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873313|NCT00576706|Protective Agents|protective agents|mesh-ancestor
83873314|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873315|NCT00576784|Pioglitazone|pioglitazone|mesh-list
83873316|NCT00576784|Glimepiride|glimepiride|mesh-list
83873317|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83873318|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873319|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83873320|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873321|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
83873322|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
83873323|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83873324|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873325|NCT00202020|Aspirin|aspirin|mesh-list
83873326|NCT00202020|Cilostazol|cilostazol|mesh-list
83873327|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83873328|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83873329|NCT00202020|Analgesics|analgesics|mesh-ancestor
83873330|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
83873331|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873332|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873333|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873334|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873335|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83873336|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83873337|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873338|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83873339|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83873340|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873341|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
83873342|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83873343|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
83873344|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83873345|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873346|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
83873347|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83873348|NCT00202020|Protective Agents|protective agents|mesh-ancestor
83873349|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83873350|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83873351|NCT00577018|Prucalopride|prucalopride|mesh-list
83873352|NCT00577018|Laxatives|laxatives|mesh-ancestor
83873353|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873354|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83873355|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83873356|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
83873357|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873358|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873359|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873360|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
83873361|NCT04578847|Dasatinib|dasatinib|mesh-list
83873362|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873363|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83873364|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873365|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873366|NCT00577057|Fluorouracil|fluorouracil|mesh-list
83873367|NCT00577057|Capecitabine|capecitabine|mesh-list
83873368|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873369|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
83873370|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873371|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873372|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873373|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
83873374|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873375|NCT00187005|Cytarabine|cytarabine|mesh-list
83873376|NCT00187005|Dexamethasone|dexamethasone|mesh-list
83873377|NCT00187005|Prednisone|prednisone|mesh-list
83873378|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
83873379|NCT00187005|Methotrexate|methotrexate|mesh-list
83873380|NCT00187005|Etoposide|etoposide|mesh-list
83873381|NCT00187005|Vincristine|vincristine|mesh-list
83873382|NCT00187005|Daunorubicin|daunorubicin|mesh-list
83873383|NCT00187005|Asparaginase|asparaginase|mesh-list
83873384|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
83873386|NCT00187005|Pegaspargase|pegaspargase|mesh-list
83873387|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873388|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
83873389|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873390|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873391|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873392|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
83873393|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873394|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873395|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873396|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873397|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
83873398|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
83873399|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873400|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873401|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
83873402|NCT00187005|Hormones|hormones|mesh-ancestor
83873403|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873404|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83873405|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83873406|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873407|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873408|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873409|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
83873410|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873411|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873412|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83873413|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83873414|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83148230|NCT02134379|Miconazole|miconazole|mesh-list
83873415|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873416|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873417|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
83873418|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873419|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873420|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873421|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873422|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873423|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
83873424|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83873425|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873426|NCT00577369|Desflurane|desflurane|mesh-list
83873427|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83873428|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
83873429|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
83873430|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83873431|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873432|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83873433|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
83873434|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873435|NCT00577798|Doxorubicin|doxorubicin|mesh-list
83873436|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83873437|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873438|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873439|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873440|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873441|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873442|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873443|NCT00187083|Dexamethasone|dexamethasone|mesh-list
83873444|NCT00187083|Methotrexate|methotrexate|mesh-list
83873445|NCT00187083|Fludarabine|fludarabine|mesh-list
83873446|NCT00187083|Etoposide|etoposide|mesh-list
83873447|NCT00187083|Vincristine|vincristine|mesh-list
83873448|NCT00187083|Topotecan|topotecan|mesh-list
83873449|NCT00187083|Asparaginase|asparaginase|mesh-list
83873450|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
83873451|NCT00187083|Idarubicin|idarubicin|mesh-list
83873452|NCT00187083|Pegaspargase|pegaspargase|mesh-list
83873453|NCT00187083|Teniposide|teniposide|mesh-list
83873454|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873455|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
83873456|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
83873457|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873458|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873459|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873461|NCT00187083|Hormones|hormones|mesh-ancestor
83873462|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873463|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83873464|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873465|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83873466|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873467|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873468|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873469|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
83873470|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873471|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873472|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873473|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83873474|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873475|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
83873476|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873477|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83873478|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873479|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873480|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873481|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873482|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873483|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873484|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83873485|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873486|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
83873487|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
83873488|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83873489|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048315|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
83873490|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873491|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83873492|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873493|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83873494|NCT00578149|Paclitaxel|paclitaxel|mesh-list
83873495|NCT00578149|Bevacizumab|bevacizumab|mesh-list
83873496|NCT00578149|Carboplatin|carboplatin|mesh-list
83873497|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873498|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873499|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873500|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873501|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873502|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873503|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83873504|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83873505|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83873506|NCT00578149|Growth Substances|growth substances|mesh-ancestor
83873507|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873508|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
83873509|NCT00187122|Cytarabine|cytarabine|mesh-list
83873510|NCT00187122|Dexamethasone|dexamethasone|mesh-list
83873511|NCT00187122|Prednisone|prednisone|mesh-list
83873512|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
83873513|NCT00187122|Methotrexate|methotrexate|mesh-list
83873514|NCT00187122|Etoposide|etoposide|mesh-list
83873515|NCT00187122|Vincristine|vincristine|mesh-list
83873516|NCT00187122|Asparaginase|asparaginase|mesh-list
83873517|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
83873518|NCT00187122|Daunorubicin|daunorubicin|mesh-list
83873519|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873520|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
83873521|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873522|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873523|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873524|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
83873525|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873526|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873527|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873528|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873529|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
83873530|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
83873531|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873532|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873533|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
83873534|NCT00187122|Hormones|hormones|mesh-ancestor
83873535|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873536|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83873537|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83873538|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873539|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873540|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873541|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
83873542|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873543|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873544|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83873545|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83873546|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873547|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873548|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873549|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
83873550|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873551|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873552|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873553|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873554|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873556|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873557|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873558|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
83873559|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
83873560|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873561|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
83873562|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873563|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873564|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873565|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
83873566|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873567|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873568|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873569|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83873570|NCT04578496|Afamelanotide|afamelanotide|mesh-list
83873571|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873572|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
83873573|NCT00579046|Hematinics|hematinics|mesh-ancestor
83873574|NCT00579085|Ketamine|ketamine|mesh-list
83873575|NCT00579085|Analgesics|analgesics|mesh-ancestor
83873576|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
83873577|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873578|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873579|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83873580|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83873581|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
83873582|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
83873583|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83873584|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83873585|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83873586|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873587|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873588|NCT00187161|Cytarabine|cytarabine|mesh-list
83873589|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
83873590|NCT00187161|Doxorubicin|doxorubicin|mesh-list
83873591|NCT00187161|Methotrexate|methotrexate|mesh-list
83873592|NCT00187161|Etoposide|etoposide|mesh-list
83873593|NCT00187161|Vincristine|vincristine|mesh-list
83873594|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873595|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
83873596|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873597|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873598|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873599|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
83873600|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873601|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873602|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873603|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873604|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873605|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873606|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873607|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83873608|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873609|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873610|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873611|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
83873612|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873613|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83873614|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83873615|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873616|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
83873617|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873618|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873619|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873620|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873621|NCT00579475|Mifepristone|mifepristone|mesh-list
83873622|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83873623|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873624|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873625|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873626|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83873627|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83873628|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83873629|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
83873630|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83873631|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83873632|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048316|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873633|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873634|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
83873635|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83873636|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83873637|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
83873638|NCT00579592|Rituximab|rituximab|mesh-list
83873639|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
83873640|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83873641|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873642|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
83873643|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873644|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873645|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873646|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83873647|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
83873648|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83873649|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873650|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873651|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873652|NCT00180791|Carboplatin|carboplatin|mesh-list
83873653|NCT00180791|Etoposide|etoposide|mesh-list
83873654|NCT00180791|Melphalan|melphalan|mesh-list
83873655|NCT00180791|Thiotepa|thiotepa|mesh-list
83873656|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873657|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873658|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873659|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873660|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873661|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873662|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873663|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
83873664|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873665|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873666|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
83873667|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873668|NCT01054248|Artesunate|artesunate|mesh-list
83873669|NCT01054248|Piperaquine|piperaquine|mesh-list
83873670|NCT01054248|Artenimol|artenimol|mesh-list
83873671|NCT01054248|Mefloquine|mefloquine|mesh-list
83873672|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
83873673|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83873674|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83873675|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873676|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873677|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
83873678|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
83873679|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83873680|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
83873681|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
83873682|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873683|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83112725|NCT03419949|Pregabalin|pregabalin|mesh-list
83873684|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873685|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873686|NCT00202176|Bromides|bromides|mesh-list
83873687|NCT00202176|Ipratropium|ipratropium|mesh-list
83873688|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
83873689|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83873690|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
83873691|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873692|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873693|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83873694|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83873695|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83873696|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
83873697|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873698|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873699|NCT00580060|Molgramostim|molgramostim|mesh-list
83873700|NCT00580060|Sargramostim|sargramostim|mesh-list
83873701|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
83873702|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873703|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873704|NCT00180908|Doxorubicin|doxorubicin|mesh-list
83873705|NCT00180908|Etoposide|etoposide|mesh-list
83873706|NCT00180908|Methotrexate|methotrexate|mesh-list
83873707|NCT00180908|Ifosfamide|ifosfamide|mesh-list
83873708|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873709|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873710|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873711|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873712|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873713|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873714|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83873715|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
83873716|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83873717|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873718|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83873719|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
83873720|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873721|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83873722|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873723|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
83873724|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873725|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83873726|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873727|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873728|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
83873729|NCT00580450|Thymalfasin|thymalfasin|mesh-list
83873730|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83873731|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
83873732|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873733|NCT00180947|Vinorelbine|vinorelbine|mesh-list
83873734|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83873735|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873736|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873737|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873738|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873739|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873740|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83873741|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
83873742|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873743|NCT00581425|Interferons|interferons|mesh-list
83873744|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
83873745|NCT00581425|Imiquimod|imiquimod|mesh-list
83873746|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873747|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
83873748|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873749|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
83873750|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873751|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83873752|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
83873753|NCT00209079|Docetaxel|docetaxel|mesh-list
83873754|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
83873755|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873756|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873757|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873758|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873759|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873760|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83873761|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873762|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
83873763|NCT04576975|Ketamine|ketamine|mesh-list
83873764|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83873765|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83873766|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873767|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83873768|NCT04576975|Analgesics|analgesics|mesh-ancestor
83873769|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
83873770|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873771|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83873772|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83873773|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83873774|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83873775|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873776|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873777|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83873778|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83873779|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
83873780|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
83873781|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83873782|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83873783|NCT00209118|Paroxetine|paroxetine|mesh-list
83873784|NCT00209118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83873785|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83873786|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83873787|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873788|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873789|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
83873790|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873791|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83873792|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
83873793|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83873794|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83873795|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83873796|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873797|NCT00181025|Melphalan|melphalan|mesh-list
83873798|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83873799|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
83873800|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873801|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873802|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83873803|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873804|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
83873805|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873806|NCT00209313|Acyclovir|acyclovir|mesh-list
83873807|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
83873808|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873809|NCT00582634|Docetaxel|docetaxel|mesh-list
83873810|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873811|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83873812|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83873813|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83873814|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873815|NCT00209352|Acyclovir|acyclovir|mesh-list
83873816|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
83873817|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873818|NCT00181142|Daclizumab|daclizumab|mesh-list
83873819|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873820|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
83873821|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873822|NCT00582985|Antibodies|antibodies|mesh-list
83873823|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
83873824|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873825|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
83873826|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83873827|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83873828|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873829|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83873830|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83873831|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
83873832|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873833|NCT00181181|Atorvastatin|atorvastatin|mesh-list
83112875|NCT03647579|Midazolam|midazolam|mesh-list
83873834|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83873835|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83873836|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
83873837|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873838|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83873839|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83873840|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873841|NCT00181220|Valproic Acid|valproic acid|mesh-list
83873842|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
83873843|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873844|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873845|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
83873846|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873847|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873848|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
83873849|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83873850|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83873851|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83873852|NCT00583063|Sirolimus|sirolimus|mesh-list
83873853|NCT00583063|Sunitinib|sunitinib|mesh-list
83873854|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873855|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83873856|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83873857|NCT00583063|Growth Substances|growth substances|mesh-ancestor
83873858|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873859|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
83873860|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83873861|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873862|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873863|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83873864|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873865|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83873866|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
83873867|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83873868|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
83873869|NCT00181298|Memantine|memantine|mesh-list
83873870|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83873871|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83873872|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
83873873|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873874|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873875|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873876|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83873877|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83873878|NCT00583180|Capsaicin|capsaicin|mesh-list
83873879|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
83873880|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873881|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
83873882|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873883|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873884|NCT00583258|Alfuzosin|alfuzosin|mesh-list
83873885|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83873886|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83873887|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83873888|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
83873889|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873890|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873891|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873892|NCT00583258|Urological Agents|urological agents|mesh-ancestor
83873893|NCT00181532|Celecoxib|celecoxib|mesh-list
83873894|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83873895|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83873896|NCT00181532|Analgesics|analgesics|mesh-ancestor
83873897|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
83873898|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873899|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873900|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873901|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83873902|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83873903|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83873904|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873905|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873906|NCT04576390|Ondansetron|ondansetron|mesh-list
83873907|NCT04576390|Palonosetron|palonosetron|mesh-list
83873908|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
83873909|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
83873910|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873911|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873912|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83873913|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
83873914|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
83873915|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83873916|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83873917|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
83873918|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873919|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873920|NCT00181571|Methylphenidate|methylphenidate|mesh-list
83873921|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83873922|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873923|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83873924|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83873925|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83873926|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873927|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
83873928|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873929|NCT00187707|Gabapentin|gabapentin|mesh-list
83873930|NCT00187707|Analgesics|analgesics|mesh-ancestor
83873931|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
83873932|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873933|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873934|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
83873935|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83873936|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83873937|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83873938|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83873939|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83873940|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83873941|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873942|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873943|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
83873944|NCT00187746|Adefovir|adefovir|mesh-list
83873945|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83873946|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
83873947|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873948|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83873949|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83873950|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873951|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873952|NCT00181688|Anastrozole|anastrozole|mesh-list
83873953|NCT00181688|Gefitinib|gefitinib|mesh-list
83873954|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83873955|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873956|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83873957|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83873958|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873959|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873960|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83873961|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
83873962|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83873963|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873964|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83873965|NCT00209469|Alendronate|alendronate|mesh-list
83873966|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83873967|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873968|NCT00181727|Valproic Acid|valproic acid|mesh-list
83873969|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
83873970|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873971|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873972|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
83873973|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83873974|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83873975|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
83873976|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83873977|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83873978|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83873979|NCT00584155|Ofloxacin|ofloxacin|mesh-list
83873980|NCT00584155|Levofloxacin|levofloxacin|mesh-list
83113028|NCT03643757|Bupivacaine|bupivacaine|mesh-list
83873981|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83873982|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83873983|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83873984|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83873985|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83873986|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83873987|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83873988|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83873989|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83873990|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83873992|NCT00411372|Xhance|xhance|mesh-list
83873993|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83873994|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83873995|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83873996|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83873997|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
83873998|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83873999|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874000|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83874001|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874002|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
83874003|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84048317|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
83874004|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83874005|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83874006|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83874007|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874008|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874009|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874010|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
83874011|NCT00411372|Hormones|hormones|mesh-ancestor
83874012|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874013|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
83874014|NCT00181922|Ziprasidone|ziprasidone|mesh-list
83874015|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83874016|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
83874017|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874018|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874019|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874020|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83874021|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874022|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874023|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874024|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83874025|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
83874026|NCT00182039|Metoprolol|metoprolol|mesh-list
83874027|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83874028|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83874029|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
83874030|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
83874031|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874032|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874033|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83874034|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83874035|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83874036|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874037|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874038|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874039|NCT00584389|Rimonabant|rimonabant|mesh-list
83874040|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83874041|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83874042|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83874043|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874044|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874045|NCT00584389|Hormones|hormones|mesh-ancestor
83874046|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874047|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874048|NCT00216372|Lanreotide|lanreotide|mesh-list
83874049|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874050|NCT00584662|Phenylephrine|phenylephrine|mesh-list
83874051|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
83874052|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83874053|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83874054|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874055|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874056|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874057|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874058|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
83874059|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
83874060|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874061|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
83874062|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83874063|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874064|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83874065|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
83874066|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83874067|NCT00584662|Protective Agents|protective agents|mesh-ancestor
83874068|NCT00584779|Gabapentin|gabapentin|mesh-list
83874069|NCT00584779|Analgesics|analgesics|mesh-ancestor
83874070|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
83874071|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874072|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874073|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
83874074|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83874075|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874076|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874077|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874078|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83874079|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83874080|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874081|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874082|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
83874083|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
83874084|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83874085|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83874086|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83874087|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874088|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874089|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
83874090|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874091|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874092|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83874093|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874094|NCT00585091|Phenylephrine|phenylephrine|mesh-list
83874095|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
83874096|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83874097|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
83874098|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
83874099|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874100|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874101|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
83874102|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83874103|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
83874104|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874105|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83874106|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83874107|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83874108|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874109|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874110|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874111|NCT00585091|Protective Agents|protective agents|mesh-ancestor
83874112|NCT00216450|Rabeprazole|rabeprazole|mesh-list
83874113|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83874114|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83874115|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83874116|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874117|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874118|NCT00585442|Vitamin D|vitamin d|mesh-list
83874119|NCT00585442|Calcitriol|calcitriol|mesh-list
83874120|NCT00585442|Vitamins|vitamins|mesh-ancestor
83874121|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
83874122|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874123|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83874124|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83874125|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83874126|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874127|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874128|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83874129|NCT00585520|Progesterone|progesterone|mesh-list
83874130|NCT00585520|Progestins|progestins|mesh-ancestor
83874131|NCT00585520|Hormones|hormones|mesh-ancestor
83874132|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874133|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874134|NCT00216489|Rabeprazole|rabeprazole|mesh-list
83874135|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83874136|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83874137|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83874138|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874139|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874140|NCT00585754|Guanfacine|guanfacine|mesh-list
83874141|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83874142|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83874143|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83874144|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83874145|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874146|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874147|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874148|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874149|NCT00209547|Fospropofol|fospropofol|mesh-list
83874150|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83874151|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874152|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874153|NCT00585871|Metoprolol|metoprolol|mesh-list
83874154|NCT00585871|Clonidine|clonidine|mesh-list
83874155|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83874156|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83874157|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
83874158|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
83874159|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874160|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874161|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83874162|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83874163|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83874164|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874165|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874166|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874167|NCT00585871|Analgesics|analgesics|mesh-ancestor
83874168|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
83874169|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83874170|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83874171|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83874172|NCT03452722|Plasminogen|plasminogen|mesh-list
83874173|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83874174|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83874175|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83874176|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874177|NCT00408551|Leucovorin|leucovorin|mesh-list
83874178|NCT00408551|Fluorouracil|fluorouracil|mesh-list
83874179|NCT00408551|Floxuridine|floxuridine|mesh-list
83874180|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
83874181|NCT00408551|Irinotecan|irinotecan|mesh-list
83874182|NCT00408551|Calcium|calcium|mesh-list
83874183|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
83874184|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83874185|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874186|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
83874187|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874188|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874189|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874190|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874191|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
83874192|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83874193|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874194|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874195|NCT00408551|Antidotes|antidotes|mesh-ancestor
83874196|NCT00408551|Protective Agents|protective agents|mesh-ancestor
83874197|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
83874198|NCT00408551|Vitamins|vitamins|mesh-ancestor
83874199|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
83874200|NCT04575415|Bevacizumab|bevacizumab|mesh-list
83874201|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83874202|NCT04575415|Gefitinib|gefitinib|mesh-list
83874203|NCT04575415|Osimertinib|osimertinib|mesh-list
83874204|NCT04575415|Afatinib|afatinib|mesh-list
83874205|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83874206|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874207|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83874208|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83874209|NCT04575415|Growth Substances|growth substances|mesh-ancestor
83874210|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874211|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
83874212|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83874213|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874214|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874216|NCT00209625|Fluorouracil|fluorouracil|mesh-list
83874217|NCT00209625|Irinotecan|irinotecan|mesh-list
83874218|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
83874219|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874220|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874221|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874222|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874223|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
83874224|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874225|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83874226|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874227|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874228|NCT00209625|Antidotes|antidotes|mesh-ancestor
83874229|NCT00209625|Protective Agents|protective agents|mesh-ancestor
83874230|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
83874231|NCT00209625|Vitamins|vitamins|mesh-ancestor
83874232|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
83874233|NCT00216528|Risperidone|risperidone|mesh-list
83874234|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83874235|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
83874236|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874237|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874238|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874239|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83874240|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874241|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874242|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874243|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83874244|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
83874245|NCT00182312|Caffeine|caffeine|mesh-list
83874246|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
83874247|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874248|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83874249|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874250|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83874251|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874252|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83874253|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83874254|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
83874255|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874256|NCT00209664|Irinotecan|irinotecan|mesh-list
83874257|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83874258|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874259|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874260|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874261|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874262|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
83874263|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83874264|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874265|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83874266|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874267|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874268|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874269|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874270|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83874271|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83874272|NCT00587119|Budesonide|budesonide|mesh-list
83874273|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874274|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83874275|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
83874276|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874277|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874278|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83874279|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874280|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
83874281|NCT00587119|Hormones|hormones|mesh-ancestor
83874282|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874283|NCT00216567|Topiramate|topiramate|mesh-list
83874284|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
83874285|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83874286|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874287|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
83874288|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83874289|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83874290|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874291|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
83874292|NCT00182351|Coagulants|coagulants|mesh-ancestor
83874293|NCT00587470|Candesartan|candesartan|mesh-list
83874294|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
83874295|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83874296|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83148248|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
83874297|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83874298|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874299|NCT00209703|Leucovorin|leucovorin|mesh-list
83874300|NCT00209703|Fluorouracil|fluorouracil|mesh-list
83874301|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
83874302|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
83874303|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
83874304|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874305|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874306|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874307|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874308|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
83874309|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874310|NCT00209703|Antidotes|antidotes|mesh-ancestor
83874311|NCT00209703|Protective Agents|protective agents|mesh-ancestor
83874312|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
83874313|NCT00209703|Vitamins|vitamins|mesh-ancestor
83874314|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
83874315|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
83874316|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874317|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874318|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874319|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874320|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
83874321|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83874322|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874323|NCT00216606|Topiramate|topiramate|mesh-list
83874324|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
83874325|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83874326|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874327|NCT00587665|Ketamine|ketamine|mesh-list
83874328|NCT00587665|Analgesics|analgesics|mesh-ancestor
83874329|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
83874330|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874331|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874332|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83874333|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83874334|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
83874335|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
83874336|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874337|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83874338|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83874339|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874340|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874341|NCT00182429|Metronidazole|metronidazole|mesh-list
83874342|NCT00182429|Rifampin|rifampin|mesh-list
83874343|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874344|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83874345|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83874346|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83874347|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83874348|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
83874349|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
83874350|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83874351|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874352|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874353|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83113419|NCT03411369|Vitamins|vitamins|mesh-list
83874355|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83874356|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83874357|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83874358|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83874359|NCT00216645|Doxorubicin|doxorubicin|mesh-list
83874360|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83874361|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83874362|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874363|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83874364|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874365|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874366|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874367|NCT00588016|Itraconazole|itraconazole|mesh-list
83874368|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
83874369|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874370|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83874371|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83874372|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874373|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874374|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83874375|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
83874376|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874377|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874378|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83874379|NCT00216684|Fentanyl|fentanyl|mesh-list
83874380|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83874381|NCT00216684|Narcotics|narcotics|mesh-ancestor
83874382|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874383|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874384|NCT00216684|Analgesics|analgesics|mesh-ancestor
83874385|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
83874386|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874387|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83874388|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83874389|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
83874390|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
83874391|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
83874392|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83874393|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83874394|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874395|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
83874396|NCT00588133|Coagulants|coagulants|mesh-ancestor
83874397|NCT00588172|Metformin|metformin|mesh-list
83874398|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83874399|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874400|NCT00182507|Olanzapine|olanzapine|mesh-list
83874401|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
83874402|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
83874403|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874404|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874405|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83874406|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83874407|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874408|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874409|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874410|NCT00182507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83874411|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83874412|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874413|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874414|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874415|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
83874416|NCT00209742|Leucovorin|leucovorin|mesh-list
83874417|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
83874418|NCT00209742|Tegafur|tegafur|mesh-list
83874419|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
83874420|NCT00209742|Antidotes|antidotes|mesh-ancestor
83874421|NCT00209742|Protective Agents|protective agents|mesh-ancestor
83874422|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874423|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
83874424|NCT00209742|Vitamins|vitamins|mesh-ancestor
83874425|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
83874426|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874427|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
83874428|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874429|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874430|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83874431|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
83874432|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83874433|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
83874434|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874435|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
83874436|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83874437|NCT00216723|Aripiprazole|aripiprazole|mesh-list
83874438|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
83874439|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874440|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83874441|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874442|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874443|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874444|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
83874445|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
83874446|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874447|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874448|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83874449|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83874450|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
83874451|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83874452|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83874453|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83874454|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83874455|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
83874456|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
83874457|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83874458|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
83874459|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83874460|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83874461|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874462|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83874463|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874464|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874465|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83874466|NCT00182663|Clarithromycin|clarithromycin|mesh-list
83874467|NCT00182663|Thalidomide|thalidomide|mesh-list
83874468|NCT00182663|Dexamethasone|dexamethasone|mesh-list
83874469|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874470|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
83874471|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
83874472|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874473|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874474|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83874475|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
83874476|NCT00182663|Hormones|hormones|mesh-ancestor
83874477|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874478|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83874479|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874480|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83874481|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874482|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83874483|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874484|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874485|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83874486|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83874487|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874488|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
83874489|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
83874490|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83874491|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83874492|NCT00182663|Growth Substances|growth substances|mesh-ancestor
83874493|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
83874494|NCT00216762|Rituximab|rituximab|mesh-list
83874495|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83874496|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874497|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
83874498|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874499|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874500|NCT00182702|Epothilones|epothilones|mesh-list
83113559|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
83874501|NCT00182702|Epothilone B|epothilone b|mesh-list
83874502|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
83874503|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
83874504|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
83874505|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874506|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874507|NCT00588835|Dexamethasone|dexamethasone|mesh-list
83874508|NCT00588835|Ondansetron|ondansetron|mesh-list
83874509|NCT00588835|Aprepitant|aprepitant|mesh-list
83874510|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874511|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
83874512|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
83874513|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874514|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874515|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83874516|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
83874517|NCT00588835|Hormones|hormones|mesh-ancestor
83874518|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874519|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83874520|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874521|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
83874522|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
83874523|NCT00588835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83874524|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83874525|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
83874526|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874527|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874528|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83874529|NCT00209859|Cyclosporine|cyclosporine|mesh-list
83874530|NCT00209859|Betamethasone|betamethasone|mesh-list
83874531|NCT00209859|Methotrexate|methotrexate|mesh-list
83874532|NCT00209859|Cyclosporins|cyclosporins|mesh-list
83874533|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83874534|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
83874535|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83874536|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874537|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874538|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
83874539|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874540|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874541|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
83874542|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874543|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83874544|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874545|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
83874546|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874547|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83874548|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
83874549|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874550|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83874551|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874552|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
83874553|NCT00209859|Hormones|hormones|mesh-ancestor
83874554|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874555|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83874556|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874557|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
83874558|NCT00588913|Aldesleukin|aldesleukin|mesh-list
83874559|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874560|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83874561|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83874562|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
83874563|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874564|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83874565|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874566|NCT00182741|Calcitriol|calcitriol|mesh-list
83874567|NCT00182741|Prednisone|prednisone|mesh-list
83874568|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
83874569|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874570|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
83874571|NCT00182741|Hormones|hormones|mesh-ancestor
83874572|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874573|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874574|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83874575|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874576|NCT00182741|Analgesics|analgesics|mesh-ancestor
83874577|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
83874578|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874579|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83874580|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874581|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874582|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874583|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83874584|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83874585|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874586|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83874587|NCT00182741|Vitamins|vitamins|mesh-ancestor
83874588|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
83874589|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83874590|NCT00589186|Celecoxib|celecoxib|mesh-list
83874591|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83874592|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83874593|NCT00589186|Analgesics|analgesics|mesh-ancestor
83874594|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
83874595|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874596|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874597|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874598|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874599|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83874600|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83874601|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874602|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874603|NCT00589264|Copper|copper|mesh-list
83874604|NCT00589264|Trace Elements|trace elements|mesh-ancestor
83874605|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
83874606|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874607|NCT00589381|Fenretinide|fenretinide|mesh-list
83874608|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874609|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83874610|NCT00589381|Protective Agents|protective agents|mesh-ancestor
83874611|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874612|NCT00182819|Temozolomide|temozolomide|mesh-list
83874613|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83874614|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
83874615|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874616|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874617|NCT00216840|Betamethasone|betamethasone|mesh-list
83874618|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
83874619|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83874620|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
83874621|NCT00216840|Calcipotriene|calcipotriene|mesh-list
83874622|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83874623|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874624|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
83874625|NCT00216840|Hormones|hormones|mesh-ancestor
83874626|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874627|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874628|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83874629|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874630|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
83874631|NCT00589732|Valsartan|valsartan|mesh-list
83874632|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83874633|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83874634|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83874635|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874636|NCT00216879|Betamethasone|betamethasone|mesh-list
83874637|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
83874638|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83874639|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
83874640|NCT00216879|Calcipotriene|calcipotriene|mesh-list
83874641|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83874642|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874643|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
83874644|NCT00216879|Hormones|hormones|mesh-ancestor
83874645|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874646|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874647|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83874648|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874649|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
83874650|NCT00589927|Cilostazol|cilostazol|mesh-list
83874651|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83874652|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
84048318|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
83874653|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874654|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874655|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83874656|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874657|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83874658|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83874659|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874660|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83874661|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
83874662|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83874663|NCT00589927|Protective Agents|protective agents|mesh-ancestor
83874664|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83874665|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83874666|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874667|NCT00209937|Gaboxadol|gaboxadol|mesh-list
83874668|NCT00209937|Analgesics|analgesics|mesh-ancestor
83874669|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
83874670|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874671|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874672|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
83874673|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
83874674|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
83874675|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874676|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874677|NCT00590278|Raltitrexed|raltitrexed|mesh-list
83874678|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874679|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
83874680|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874681|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874682|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83874683|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874684|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83874685|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83874686|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83874687|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874688|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874689|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874690|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874691|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874692|NCT04574791|Tizanidine|tizanidine|mesh-list
83874693|NCT04574791|Analgesics|analgesics|mesh-ancestor
83874694|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
83874695|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874696|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874697|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
83874698|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83874699|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83874700|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
83874701|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
83874702|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83874703|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83874704|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83874705|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
83874706|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874707|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874709|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
83874710|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83874711|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
83874712|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874713|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83874714|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83874715|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
83874716|NCT00590629|Vitamins|vitamins|mesh-ancestor
83874717|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
83874718|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874719|NCT00590785|Tamoxifen|tamoxifen|mesh-list
83874720|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
83874721|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
83874722|NCT00590785|Doxorubicin|doxorubicin|mesh-list
83874723|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874724|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
83874725|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874726|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874727|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83874728|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
83874729|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874730|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874731|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83874732|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83874733|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83874734|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874735|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874736|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83874737|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
83874738|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874739|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83874740|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83874741|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83874742|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83874743|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83874744|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874745|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83874746|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83874747|NCT00477295|Carbamazepine|carbamazepine|mesh-list
83874749|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
83874750|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
83874751|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874752|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874753|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874754|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874755|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83874756|NCT00477295|Analgesics|analgesics|mesh-ancestor
83874757|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
83874758|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874759|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83874760|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874761|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874762|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83874763|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83874764|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83874765|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83874766|NCT00476593|Dexamethasone|dexamethasone|mesh-list
83874767|NCT00476593|Diclofenac|diclofenac|mesh-list
83874768|NCT00476593|Lactitol|lactitol|mesh-list
83874769|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83874770|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874771|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
83874772|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
83874773|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874774|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874775|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83874776|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
83874777|NCT00476593|Hormones|hormones|mesh-ancestor
83874778|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83874779|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83874780|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874781|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83874782|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83874783|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83874784|NCT00476593|Analgesics|analgesics|mesh-ancestor
83874785|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
83874786|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874787|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83874788|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874789|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874790|NCT00476593|Cathartics|cathartics|mesh-ancestor
83874791|NCT00210132|Ropivacaine|ropivacaine|mesh-list
83874792|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
83874793|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
83874794|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874795|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874796|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
83874797|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874798|NCT00183404|Olanzapine|olanzapine|mesh-list
83874800|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
83874801|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874802|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874803|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83874804|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83874805|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874806|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874807|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874808|NCT00183404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83874809|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83874810|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874811|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874812|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874813|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
83874814|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83874815|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874816|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83874817|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874818|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874819|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
83874820|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874821|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
83874822|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83874823|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874824|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83874825|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
83874826|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83874827|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83874828|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874829|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874830|NCT00210210|Ketamine|ketamine|mesh-list
83874831|NCT00210210|Analgesics|analgesics|mesh-ancestor
83874832|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
83874833|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874834|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874835|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83874836|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83874837|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
83874838|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
83874839|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874840|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83874841|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83874842|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874843|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874844|NCT00476086|Gemcitabine|gemcitabine|mesh-list
83874845|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
83874846|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874847|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
83874848|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874849|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874850|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
83874851|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874852|NCT00217191|Ibuprofen|ibuprofen|mesh-list
83874853|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83874854|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83874855|NCT00217191|Analgesics|analgesics|mesh-ancestor
83874856|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
83874857|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874858|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874859|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874860|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874861|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83874862|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874863|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874864|NCT00476008|Memantine|memantine|mesh-list
83874865|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83874866|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83874867|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
83874868|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874869|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874870|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874872|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83874873|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
83874874|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83874875|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83874876|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83874877|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874878|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874879|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
83874880|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874881|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874882|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83874883|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874884|NCT00183833|Capecitabine|capecitabine|mesh-list
83874885|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
83874886|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874887|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
83874888|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874889|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874890|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83874891|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874892|NCT00183911|Leucovorin|leucovorin|mesh-list
83874893|NCT00183911|Fluorouracil|fluorouracil|mesh-list
83874894|NCT00183911|Floxuridine|floxuridine|mesh-list
83874895|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
83874896|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874897|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874898|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874899|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874900|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
83874901|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874902|NCT00183911|Antidotes|antidotes|mesh-ancestor
83874903|NCT00183911|Protective Agents|protective agents|mesh-ancestor
83874904|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
83874905|NCT00183911|Vitamins|vitamins|mesh-ancestor
83874906|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
83874907|NCT00412152|Oxycodone|oxycodone|mesh-list
83874908|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83874909|NCT00412152|Narcotics|narcotics|mesh-ancestor
83874910|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874911|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874912|NCT00412152|Analgesics|analgesics|mesh-ancestor
83874913|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
83874914|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874915|NCT02963402|Adalimumab|adalimumab|mesh-list
83874916|NCT02963402|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83874917|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83874918|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874919|NCT00210327|Bortezomib|bortezomib|mesh-list
83874920|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874921|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
83874922|NCT00425516|Docetaxel|docetaxel|mesh-list
83874923|NCT00425516|Fluorouracil|fluorouracil|mesh-list
83874924|NCT00425516|Epirubicin|epirubicin|mesh-list
83874925|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83874926|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
83874927|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874928|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83874929|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83874930|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
83874931|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874932|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874933|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83874934|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
83874935|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
83874936|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
83874937|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
83874938|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83874939|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83874940|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83874941|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874942|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874943|NCT00412191|Lamotrigine|lamotrigine|mesh-list
83874944|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
83874945|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83874946|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874947|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874948|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83874949|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874950|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83874951|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83874952|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874953|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83874954|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83874955|NCT00183950|Noscapine|noscapine|mesh-list
83874956|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
83874957|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
83874958|NCT00210366|Idarubicin|idarubicin|mesh-list
83874959|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83874960|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874961|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83874962|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83874963|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874964|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874965|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
83874966|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83874967|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83874968|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83874969|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874970|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874971|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
83874972|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874973|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874974|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83874975|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83874976|NCT00475735|Methylphenidate|methylphenidate|mesh-list
83874977|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83874978|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874979|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83874980|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83874981|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83874982|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874983|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
83874984|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83874985|NCT00475657|Pemetrexed|pemetrexed|mesh-list
83874986|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83874987|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83874988|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83874989|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83874990|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83874991|NCT00210405|Micronutrients|micronutrients|mesh-list
83874992|NCT00210405|Trace Elements|trace elements|mesh-list
83874993|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874994|NCT00408941|Propofol|propofol|mesh-list
83874995|NCT00408941|Prilocaine|prilocaine|mesh-list
83874996|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83874997|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83874998|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83874999|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83875000|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
83875001|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
83875002|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
83875003|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
83875004|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875005|NCT00475423|Rituximab|rituximab|mesh-list
83875006|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83875007|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875008|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
83875009|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875010|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875011|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
83875012|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83875013|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83875014|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83875015|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875016|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875017|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
83875018|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114076|NCT02032927|Oxycodone|oxycodone|mesh-list
83875019|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875020|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83875021|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875022|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
83875023|NCT00475306|Promethazine|promethazine|mesh-list
83875024|NCT00475306|Metoclopramide|metoclopramide|mesh-list
83875025|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83875026|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83875027|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875028|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875029|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
83875030|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
83875031|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
83875032|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875033|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
83875034|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
83875035|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83875036|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83875037|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
83875038|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
83875039|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875040|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875041|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83875042|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
83875043|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
83875044|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83875045|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83875046|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
83875047|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
83875048|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83875049|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
83875050|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83875051|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875052|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83875053|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83875054|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83875055|NCT00183989|Rituximab|rituximab|mesh-list
83875056|NCT00183989|Fludarabine|fludarabine|mesh-list
83875057|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
83875058|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83875059|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875060|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
83875061|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875062|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875063|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875064|NCT00183989|Analgesics|analgesics|mesh-ancestor
83875065|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
83875066|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875067|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83875068|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875069|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875070|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83875071|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83875072|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
83875073|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875074|NCT00184106|Paroxetine|paroxetine|mesh-list
83875075|NCT00184106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83875076|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83875077|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875078|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875079|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875080|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
83875081|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875082|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83875083|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
83875084|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875085|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83875086|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83875087|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875088|NCT00210483|Almotriptan|almotriptan|mesh-list
83875089|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83875090|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
83875091|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875092|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875093|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875094|NCT00210561|Acetaminophen|acetaminophen|mesh-list
83875095|NCT00210561|Tramadol|tramadol|mesh-list
83875096|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83875097|NCT00210561|Analgesics|analgesics|mesh-ancestor
83875098|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
83875099|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875100|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875101|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
83875102|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83875103|NCT00210561|Narcotics|narcotics|mesh-ancestor
83875104|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875105|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
83875106|NCT00210600|Hematinics|hematinics|mesh-ancestor
83875107|NCT00217386|Etanercept|etanercept|mesh-list
83875108|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83875109|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83875110|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83875111|NCT00217386|Analgesics|analgesics|mesh-ancestor
83875112|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
83875113|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875114|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875115|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875116|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875117|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83875118|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875119|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
83875120|NCT00217503|Zidovudine|zidovudine|mesh-list
83875121|NCT00217503|Valganciclovir|valganciclovir|mesh-list
83875122|NCT00217503|Ganciclovir|ganciclovir|mesh-list
83875123|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
83875124|NCT00217503|Bevacizumab|bevacizumab|mesh-list
83875125|NCT00217503|Doxorubicin|doxorubicin|mesh-list
83875126|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83875127|NCT00217503|Etoposide|etoposide|mesh-list
83875128|NCT00217503|Bortezomib|bortezomib|mesh-list
83875129|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875130|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
83875131|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875132|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875133|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83875134|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
83875135|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875136|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875137|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83875138|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83875139|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83875140|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83875141|NCT00217503|Growth Substances|growth substances|mesh-ancestor
83875142|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
83875143|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83875144|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83875145|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875146|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875147|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83875148|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
83875149|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83875150|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83875151|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
83875152|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875153|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83875154|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83875155|NCT00217542|Interferons|interferons|mesh-list
83875156|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
83875157|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
83875158|NCT00217542|Azacitidine|azacitidine|mesh-list
83875159|NCT00217542|Amifostine|amifostine|mesh-list
83875160|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875161|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
83875162|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875163|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83875164|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
83875165|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875166|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875167|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
83875168|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875169|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83875170|NCT00217542|Protective Agents|protective agents|mesh-ancestor
83875171|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83875172|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83875173|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83875174|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875175|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875176|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875177|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83875178|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83875179|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
83875180|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875181|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875182|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83875183|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83875184|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
83875185|NCT00184496|Methadone|methadone|mesh-list
83875186|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83875187|NCT00184496|Narcotics|narcotics|mesh-ancestor
83875188|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875189|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875190|NCT00184496|Analgesics|analgesics|mesh-ancestor
83875191|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
83875192|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875193|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
83875194|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
83875195|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
83875196|NCT00210756|Hematinics|hematinics|mesh-ancestor
83875197|NCT00217659|Anastrozole|anastrozole|mesh-list
83875198|NCT00217659|Goserelin|goserelin|mesh-list
83875199|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83875200|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875201|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83875202|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83875203|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875204|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875205|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83875206|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
83875207|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875208|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875209|NCT00184574|Metformin|metformin|mesh-list
83875210|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
83875211|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
83875212|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875213|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875214|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
83875215|NCT00210795|Hematinics|hematinics|mesh-ancestor
83875216|NCT00217698|Gemcitabine|gemcitabine|mesh-list
83875217|NCT00217698|Gefitinib|gefitinib|mesh-list
83875218|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875219|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83875220|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
83875221|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875222|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83875223|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875224|NCT00184613|Insulin|insulin|mesh-list
83875225|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83875226|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
83875227|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
83875228|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875229|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875230|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
83875231|NCT00210834|Hematinics|hematinics|mesh-ancestor
83875232|NCT00217815|Efungumab|efungumab|mesh-list
83875233|NCT00217815|Docetaxel|docetaxel|mesh-list
83875234|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875235|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
83875236|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
83875237|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
83875238|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875239|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
83875240|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875241|NCT04722471|Progesterone|progesterone|mesh-list
83875242|NCT04722471|Progestins|progestins|mesh-ancestor
83875243|NCT04722471|Hormones|hormones|mesh-ancestor
83875244|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875245|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875246|NCT00210873|Topiramate|topiramate|mesh-list
83875247|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
83875248|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875249|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875251|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
83875252|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875253|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875254|NCT00184847|Adenosine|adenosine|mesh-list
83875255|NCT00184847|Acetylcholine|acetylcholine|mesh-list
83875256|NCT00184847|Caffeine|caffeine|mesh-list
83875257|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83875258|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875259|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83875260|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875261|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875262|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83875263|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83875264|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
83875265|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875266|NCT00184847|Analgesics|analgesics|mesh-ancestor
83875267|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
83875268|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875269|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83875270|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
83875271|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83875272|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
83875273|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83875274|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
83875275|NCT00184886|Methotrexate|methotrexate|mesh-list
83875276|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83875277|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
83875278|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83875279|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875280|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83875281|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
83875282|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875283|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875284|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
83875285|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875286|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83875287|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875288|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
83875289|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875290|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83875291|NCT00217932|Valproic Acid|valproic acid|mesh-list
83875292|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
83875293|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875294|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875295|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
83875296|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875297|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875298|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
83875299|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83406260|NCT05909059|Fludarabine|fludarabine|mesh-list
83875300|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875301|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875302|NCT00210990|Doripenem|doripenem|mesh-list
83875303|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83875304|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875305|NCT00185003|Tolbutamide|tolbutamide|mesh-list
83875306|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
83875307|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875308|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875309|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875310|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875311|NCT00185120|Amlodipine|amlodipine|mesh-list
83875312|NCT00185120|Olmesartan|olmesartan|mesh-list
83875313|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83875314|NCT00185120|Benazepril|benazepril|mesh-list
83875315|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83875316|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83875317|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875318|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875319|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83875320|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875321|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
83875322|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83875323|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83875324|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83875325|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83875326|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875327|NCT00218049|Vanoxerine|vanoxerine|mesh-list
83875328|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83875329|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83875330|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875331|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875332|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
83875333|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875334|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875335|NCT00185159|Olmesartan|olmesartan|mesh-list
83875336|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83875337|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83875338|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83875339|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83875340|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875341|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
83875342|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83875343|NCT00218127|Narcotics|narcotics|mesh-ancestor
83875344|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875345|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875346|NCT00218127|Analgesics|analgesics|mesh-ancestor
83875347|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
83875348|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875349|NCT00185198|Testosterone|testosterone|mesh-list
83875350|NCT00185198|Androgens|androgens|mesh-ancestor
83875351|NCT00185198|Hormones|hormones|mesh-ancestor
83875352|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875353|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875354|NCT00185237|Estradiol|estradiol|mesh-list
83875355|NCT00185237|Estrogens|estrogens|mesh-ancestor
83875356|NCT00185237|Hormones|hormones|mesh-ancestor
83875357|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875358|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875359|NCT00218166|Triazolam|triazolam|mesh-list
83875360|NCT00218166|Tiagabine|tiagabine|mesh-list
83875361|NCT00218166|Baclofen|baclofen|mesh-list
83875362|NCT00218166|GABA Agonists|gaba agonists|mesh-list
83875363|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83875364|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875365|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83875366|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875367|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83875368|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
83875369|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875370|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875371|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83875372|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83875373|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83875374|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875375|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875376|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
83875377|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
83875378|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83875379|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83875380|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875381|NCT00185315|Iloprost|iloprost|mesh-list
83875382|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83875383|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
83875384|NCT00409019|Tenofovir|tenofovir|mesh-list
83875385|NCT00409019|Adefovir|adefovir|mesh-list
83875386|NCT00409019|Telbivudine|telbivudine|mesh-list
83875387|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
83875388|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875389|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83875390|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83875391|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875392|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875393|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83875394|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83875395|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
83875396|NCT00211146|Hematinics|hematinics|mesh-ancestor
83875397|NCT00211224|Riluzole|riluzole|mesh-list
83875398|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
83875399|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83875400|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83875401|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875402|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875403|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875404|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83875405|NCT00211224|Protective Agents|protective agents|mesh-ancestor
83875406|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
83875407|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875408|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875409|NCT00218205|Celecoxib|celecoxib|mesh-list
83875410|NCT00218205|Epirubicin|epirubicin|mesh-list
83875411|NCT00218205|Estramustine|estramustine|mesh-list
83875412|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83875413|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83875414|NCT00218205|Analgesics|analgesics|mesh-ancestor
83875415|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
83875416|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875417|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875418|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875419|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875420|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83875421|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83875422|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875423|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875424|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83875425|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875426|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83875427|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875428|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83875429|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
83875430|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83875431|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
83875432|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83875433|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83875434|NCT00185510|Prednisolone|prednisolone|mesh-list
83875435|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
83875436|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
83875437|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83875438|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
83875439|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875440|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
83875441|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
83875442|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875443|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875444|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83875445|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
83875446|NCT00185510|Hormones|hormones|mesh-ancestor
83875447|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875448|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83875449|NCT00185510|Protective Agents|protective agents|mesh-ancestor
83875450|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83875451|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875452|NCT00218244|Lobeline|lobeline|mesh-list
83875453|NCT00218244|Nicotine|nicotine|mesh-list
83875454|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83875455|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
83875456|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875457|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875458|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83875459|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83875460|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
83875461|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875462|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875463|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
83875464|NCT00211302|Aripiprazole|aripiprazole|mesh-list
83875465|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
83875466|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875467|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83875468|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83875469|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875470|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875471|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
83875472|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
83114514|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83875473|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875474|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875475|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83875476|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83875477|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
83875478|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83875479|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83875480|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83875481|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83875482|NCT00218283|Nicotine|nicotine|mesh-list
83875483|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83875484|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
83875485|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875486|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875487|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83875488|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83875489|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
83875490|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875491|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875492|NCT00185705|Telmisartan|telmisartan|mesh-list
83875493|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83875494|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83875495|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83875496|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875497|NCT00211341|Vitamin A|vitamin a|mesh-list
83875498|NCT00211341|Vitamins|vitamins|mesh-ancestor
83875499|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
83875500|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875501|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
83875502|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875503|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
83875504|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875505|NCT00211380|Aripiprazole|aripiprazole|mesh-list
83875506|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
83875507|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875508|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83875509|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83875510|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875511|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875512|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
83875513|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
83875514|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875515|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875516|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83875517|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83875518|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
83875519|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83875520|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83875521|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83875522|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83875523|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83875524|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83875525|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875526|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83875527|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875528|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875529|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83875530|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83875531|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83875532|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875533|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875534|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
83875535|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875536|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875537|NCT00218361|Hydromorphone|hydromorphone|mesh-list
83875538|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83875539|NCT00218361|Narcotics|narcotics|mesh-ancestor
83875540|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875541|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875542|NCT00218361|Analgesics|analgesics|mesh-ancestor
83875543|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
83875544|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875545|NCT00218517|Selegiline|selegiline|mesh-list
83875546|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
83875547|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875548|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83875549|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83875550|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83875551|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875552|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875553|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83875554|NCT00218517|Protective Agents|protective agents|mesh-ancestor
83875555|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875556|NCT00211419|Triamcinolone|triamcinolone|mesh-list
83875557|NCT00211419|Anecortave|anecortave|mesh-list
83875558|NCT00211419|Verteporfin|verteporfin|mesh-list
83875559|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875560|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
83875561|NCT00211419|Hormones|hormones|mesh-ancestor
83875562|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875563|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875564|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83875565|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
83875566|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83875567|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83875568|NCT00211419|Growth Substances|growth substances|mesh-ancestor
83875569|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
83875570|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875571|NCT00211458|Anecortave|anecortave|mesh-list
83875572|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83875573|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83875574|NCT00211458|Growth Substances|growth substances|mesh-ancestor
83875575|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875576|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
83875577|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875578|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
83875579|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875580|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83875581|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
83875582|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875583|NCT00211614|Lansoprazole|lansoprazole|mesh-list
83875584|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
83875585|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83875586|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83875587|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83875588|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875589|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875590|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
83875591|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83875592|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
83875593|NCT00186797|Fludarabine|fludarabine|mesh-list
83875594|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875595|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
83875596|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875597|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875598|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83875599|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
83875600|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875601|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875602|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83875603|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
83875604|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83875605|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
83875606|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875607|NCT00211653|Expectorants|expectorants|mesh-ancestor
83875608|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
83875609|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83875610|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
83875611|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875612|NCT00211653|Protective Agents|protective agents|mesh-ancestor
83875613|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875614|NCT00211653|Antidotes|antidotes|mesh-ancestor
83875615|NCT00187031|Topotecan|topotecan|mesh-list
83875616|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83875617|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875618|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875619|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875620|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875621|NCT00187070|Cytarabine|cytarabine|mesh-list
83875622|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83875623|NCT00187070|Dexamethasone|dexamethasone|mesh-list
83875624|NCT00187070|Prednisone|prednisone|mesh-list
83875625|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
83875626|NCT00187070|Ifosfamide|ifosfamide|mesh-list
83875627|NCT00187070|Carboplatin|carboplatin|mesh-list
83875628|NCT00187070|Doxorubicin|doxorubicin|mesh-list
83875629|NCT00187070|Methotrexate|methotrexate|mesh-list
83875630|NCT00187070|Etoposide|etoposide|mesh-list
83875631|NCT00187070|Vincristine|vincristine|mesh-list
83875632|NCT00187070|Vinblastine|vinblastine|mesh-list
83875633|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875634|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
83875635|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875636|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83875637|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83875638|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
83875639|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875640|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875641|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83875642|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875643|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
83875644|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
83875645|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875646|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83875647|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
83875648|NCT00187070|Hormones|hormones|mesh-ancestor
83875649|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875650|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83875651|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83875652|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83875653|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875654|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875655|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83875656|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
83875657|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83875658|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83875659|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
83875660|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
83875661|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83875662|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83875663|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83875664|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
83875665|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875666|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
83875667|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
83875668|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
83875669|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83875670|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83875671|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
83875672|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83875673|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83875674|NCT00211848|Interferons|interferons|mesh-list
83875675|NCT00211848|Ribavirin|ribavirin|mesh-list
83875676|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875677|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
83875678|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875679|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
83875680|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875681|NCT00412347|Insulin|insulin|mesh-list
83875682|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875683|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875684|NCT00187499|Fluticasone|fluticasone|mesh-list
83875685|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875686|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83875687|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
83875688|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875689|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875690|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83875691|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83875692|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
83875693|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83875694|NCT00212004|Pioglitazone|pioglitazone|mesh-list
83875695|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875696|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875697|NCT00187577|Bimatoprost|bimatoprost|mesh-list
83875698|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83875699|NCT00187577|Latanoprost|latanoprost|mesh-list
83875700|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83875701|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83875702|NCT00212043|Carboplatin|carboplatin|mesh-list
83875703|NCT00212043|Gemcitabine|gemcitabine|mesh-list
83875704|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875705|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83875706|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
83875707|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875708|NCT00212082|Docetaxel|docetaxel|mesh-list
83875709|NCT00212082|Doxorubicin|doxorubicin|mesh-list
83875710|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875711|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
83875712|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
83875713|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
83875714|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875715|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83875716|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83875717|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875718|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875719|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
83875720|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83875721|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875722|NCT00187928|Topiramate|topiramate|mesh-list
83875723|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
83875724|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83875725|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875726|NCT00212199|Orlistat|orlistat|mesh-list
83875727|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875728|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875729|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83875730|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83875731|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
83875732|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83875733|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875734|NCT00188006|Heparin|heparin|mesh-list
83875735|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
83875736|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83875737|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83875738|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875739|NCT00188045|Propranolol|propranolol|mesh-list
83875740|NCT00188045|Spironolactone|spironolactone|mesh-list
83875741|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83875742|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83875743|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
83875744|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875745|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875746|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875747|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83875748|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83875749|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
83875750|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83875751|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
83875752|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875753|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83875754|NCT00188045|Diuretics|diuretics|mesh-ancestor
83875755|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
83875756|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83875757|NCT00212277|Norethindrone|norethindrone|mesh-list
83875758|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
83875759|NCT00212277|Estradiol|estradiol|mesh-list
83875760|NCT00212277|Estrogens|estrogens|mesh-ancestor
83875761|NCT00212277|Hormones|hormones|mesh-ancestor
83875762|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875763|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875764|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83875765|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
83875766|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83875767|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83875768|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83875769|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83875770|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83875771|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83875772|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875773|NCT00219375|Sivelestat|sivelestat|mesh-list
83875774|NCT00219375|Glycine|glycine|mesh-list
83875775|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83875776|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
83875777|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875778|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875779|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
83875780|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875781|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875782|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83875783|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
83875784|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875785|NCT00188396|Citalopram|citalopram|mesh-list
83875786|NCT00188396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83875787|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83875788|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875789|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875790|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875791|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
83875792|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875793|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83875794|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
83875795|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875796|NCT00219570|Clindamycin|clindamycin|mesh-list
83875797|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
83875798|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
83875799|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
83875800|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83875801|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875802|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83875803|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875804|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875805|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83875806|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875807|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875808|NCT00212472|Factor VIII|factor viii|mesh-list
83875809|NCT00212472|Coagulants|coagulants|mesh-ancestor
83875810|NCT00188552|Tocopherols|tocopherols|mesh-list
83875811|NCT00188552|Vitamin E|vitamin e|mesh-list
83875812|NCT00188552|Tocotrienols|tocotrienols|mesh-list
83875813|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
83875814|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
83875815|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83875816|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875817|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875818|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83875819|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83875820|NCT00188552|Protective Agents|protective agents|mesh-ancestor
83875821|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875822|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
83875823|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83875824|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
83875825|NCT00188552|Vitamins|vitamins|mesh-ancestor
83875826|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
83875827|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
83875828|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83875829|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
83875830|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875831|NCT00188630|Expectorants|expectorants|mesh-ancestor
83875832|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
83875833|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83875834|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
83875835|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875836|NCT00188630|Protective Agents|protective agents|mesh-ancestor
83875837|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875838|NCT00188630|Antidotes|antidotes|mesh-ancestor
83875839|NCT00188669|Tocopherols|tocopherols|mesh-list
83875840|NCT00188669|Vitamin E|vitamin e|mesh-list
83875841|NCT00188669|Tocotrienols|tocotrienols|mesh-list
83875842|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
83875843|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
83875844|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83875845|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875846|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875847|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83875848|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83875849|NCT00188669|Protective Agents|protective agents|mesh-ancestor
83875850|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875851|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
83875852|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83875853|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
83875854|NCT00188669|Vitamins|vitamins|mesh-ancestor
83875855|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
83875856|NCT00409214|Talaporfin|talaporfin|mesh-list
83875857|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875858|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83875859|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
83875860|NCT02963051|Copper|copper|mesh-list
83875861|NCT02963051|Disulfiram|disulfiram|mesh-list
83875862|NCT02963051|Trace Elements|trace elements|mesh-ancestor
83875863|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
83875864|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875865|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83875866|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83875867|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875868|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875869|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
83875870|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875871|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83875872|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875873|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875874|NCT00409253|Nicardipine|nicardipine|mesh-list
83875875|NCT00409253|Urapidil|urapidil|mesh-list
83875876|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83875877|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83875878|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875879|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875880|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83875881|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875882|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83875883|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83875884|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
83875885|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875886|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83875887|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83875888|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83875889|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83875890|NCT00219765|Cytarabine|cytarabine|mesh-list
83875891|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
83875892|NCT00219765|Daunorubicin|daunorubicin|mesh-list
83875893|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83875894|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
83875895|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875896|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875897|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
83875898|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83875899|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875900|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
83875901|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875902|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83875903|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875904|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83875905|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83875906|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83875907|NCT00212589|Leucovorin|leucovorin|mesh-list
83875908|NCT00212589|Folic Acid|folic acid|mesh-list
83875909|NCT00212589|Fluorouracil|fluorouracil|mesh-list
83875910|NCT00212589|Capecitabine|capecitabine|mesh-list
83875911|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
83875912|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
83875913|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875914|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83875915|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875916|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875917|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
83875918|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875919|NCT00212589|Antidotes|antidotes|mesh-ancestor
83875920|NCT00212589|Protective Agents|protective agents|mesh-ancestor
83875921|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
83875922|NCT00212589|Vitamins|vitamins|mesh-ancestor
83875923|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
83875924|NCT00212589|Hematinics|hematinics|mesh-ancestor
83875925|NCT00188825|Basiliximab|basiliximab|mesh-list
83875926|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83875927|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
83114969|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
83875928|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875929|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
83875930|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83875931|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83875932|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875933|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875934|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
83875935|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875936|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875937|NCT00188864|Dexamethasone|dexamethasone|mesh-list
83875938|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83875939|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
83875940|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
83875941|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875942|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875943|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83875944|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
83875945|NCT00188864|Hormones|hormones|mesh-ancestor
83875946|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83875947|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83875948|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83875949|NCT00188942|Olanzapine|olanzapine|mesh-list
83875950|NCT00188942|Fluoxetine|fluoxetine|mesh-list
83875951|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
83875952|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
83875953|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875954|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875955|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83875956|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83875957|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83875958|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875959|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875960|NCT00188942|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83875961|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83875962|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83875963|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875964|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875965|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
83875966|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83875967|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
83875968|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83875969|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83875970|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83875971|NCT00219882|Turmeric extract|turmeric extract|mesh-list
83875972|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
83875973|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875974|NCT00219882|Protective Agents|protective agents|mesh-ancestor
83875975|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875976|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83875977|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
83875978|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875979|NCT00219921|Morphine|morphine|mesh-list
83875980|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83875981|NCT00219921|Narcotics|narcotics|mesh-ancestor
83875982|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83875983|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875984|NCT00219921|Analgesics|analgesics|mesh-ancestor
83875985|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
83875986|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83875987|NCT00212823|Almotriptan|almotriptan|mesh-list
83875988|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83875989|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
83875990|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83875991|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83875992|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83875993|NCT00189059|Amitriptyline|amitriptyline|mesh-list
83875994|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83875995|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
83875996|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83875997|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83875998|NCT00189059|Analgesics|analgesics|mesh-ancestor
83875999|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
83876000|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876001|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876002|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83876003|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876004|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876005|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876006|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
83876007|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876008|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83876009|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
83876010|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
83876011|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876012|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876013|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83876014|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83876015|NCT00189176|Growth Substances|growth substances|mesh-ancestor
83876016|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876017|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
83876018|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876019|NCT00189371|Paclitaxel|paclitaxel|mesh-list
83876020|NCT00189371|Carboplatin|carboplatin|mesh-list
83876021|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
83876022|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83876023|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876024|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876025|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
83876026|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876027|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876028|NCT00189371|Hematinics|hematinics|mesh-ancestor
83876029|NCT00189410|Carboplatin|carboplatin|mesh-list
83876030|NCT00189410|Doxorubicin|doxorubicin|mesh-list
83876031|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83876032|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876033|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83876034|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83876035|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876036|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876037|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876038|NCT00189566|Paclitaxel|paclitaxel|mesh-list
83876039|NCT00189566|Carboplatin|carboplatin|mesh-list
83876040|NCT00189566|Topotecan|topotecan|mesh-list
83876041|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83876042|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876043|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876044|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
83876045|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876046|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876047|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83876048|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876049|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876050|NCT00220116|Capecitabine|capecitabine|mesh-list
83876051|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
83876052|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876053|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
83876054|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876055|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876056|NCT02963129|Mupirocin|mupirocin|mesh-list
83876057|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83876058|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876059|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83876060|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876061|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876062|NCT00220155|Gemcitabine|gemcitabine|mesh-list
83876063|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876064|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
83876065|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876066|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876067|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
83876068|NCT00189644|Fluorouracil|fluorouracil|mesh-list
83876069|NCT00189644|Epirubicin|epirubicin|mesh-list
83876070|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876071|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
83876072|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876073|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876074|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83876075|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
83876076|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115128|NCT02335190|Lidocaine|lidocaine|mesh-list
83876077|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876078|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83876079|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
83876080|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876081|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83876082|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83876083|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876084|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876085|NCT00189683|Capecitabine|capecitabine|mesh-list
83876086|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876087|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
83876088|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876089|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876090|NCT00189722|Tacrolimus|tacrolimus|mesh-list
83876091|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876092|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
83876093|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876094|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83876095|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876096|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876097|NCT00220194|Leuprolide|leuprolide|mesh-list
83876098|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83876099|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
83876100|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83876101|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876102|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83876103|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876104|NCT00189761|Tacrolimus|tacrolimus|mesh-list
83876105|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876106|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
83876107|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876108|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83876109|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876110|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876111|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83876112|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83876113|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
83876114|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83876115|NCT00213096|ST 1435|st 1435|mesh-list
83876116|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
83876117|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
83876118|NCT00213096|Estradiol|estradiol|mesh-list
83876119|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83876120|NCT00213096|Estrogens|estrogens|mesh-ancestor
83876121|NCT00213096|Hormones|hormones|mesh-ancestor
83876122|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83876123|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876124|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83876125|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83876126|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83876127|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83876128|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83876129|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
83876130|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83876131|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83876132|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
83876133|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876134|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876135|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876136|NCT00189800|Urological Agents|urological agents|mesh-ancestor
83876137|NCT00220233|Amlodipine|amlodipine|mesh-list
83876138|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83876139|NCT00220233|Olmesartan|olmesartan|mesh-list
83876140|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83876141|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83876142|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83876143|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876144|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876145|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83876146|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876147|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
83876148|NCT00220233|Diuretics|diuretics|mesh-ancestor
83876149|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
83876150|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83115194|NCT02334254|Clopidogrel|clopidogrel|mesh-list
83876151|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83876152|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83876153|NCT00189839|Tacrolimus|tacrolimus|mesh-list
83876154|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876155|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
83876156|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876157|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83876158|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876159|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876160|NCT00189878|Methotrexate|methotrexate|mesh-list
83876161|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83876162|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
83876163|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83876164|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876165|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876166|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
83876167|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876168|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876169|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
83876170|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876171|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83876172|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876173|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
83876174|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876175|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83876176|NCT00220311|Fludarabine|fludarabine|mesh-list
83876177|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
83876178|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876179|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876180|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
83876181|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876182|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876183|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
83876184|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876185|NCT00189917|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83876186|NCT00189917|Antiviral Agents|antiviral agents|mesh-ancestor
83876187|NCT00189917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876188|NCT00189956|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83876189|NCT00189956|Antiviral Agents|antiviral agents|mesh-ancestor
83876190|NCT00189956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876191|NCT00213252|Prednisolone|prednisolone|mesh-list
83876192|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83876193|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
83876194|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83876195|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
83876196|NCT00213252|Montelukast|montelukast|mesh-list
83876197|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83876198|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
83876199|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83876200|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
83876201|NCT00213252|Hormones|hormones|mesh-ancestor
83876202|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83876203|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876204|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83876205|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876206|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
83876207|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
83876208|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876209|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876210|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83876211|NCT00213252|Protective Agents|protective agents|mesh-ancestor
83876212|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83876213|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
83876214|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83876215|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83876216|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83876217|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83876218|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876219|NCT00189995|Haloperidol|haloperidol|mesh-list
83876220|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
83876221|NCT00189995|Clozapine|clozapine|mesh-list
83876222|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
83876223|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
83876224|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876225|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876226|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876227|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83876228|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876229|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876230|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876231|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83876232|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
83876233|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876234|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876235|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83876236|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83876237|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
83876238|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
83876239|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
83876240|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
83876241|NCT00213291|Hematinics|hematinics|mesh-ancestor
83876242|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
83876243|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83876244|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
83876245|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876246|NCT00190034|Expectorants|expectorants|mesh-ancestor
83876247|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
83876248|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83876249|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
83876250|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876251|NCT00190034|Protective Agents|protective agents|mesh-ancestor
83876252|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876253|NCT00190034|Antidotes|antidotes|mesh-ancestor
83876254|NCT00412503|Temozolomide|temozolomide|mesh-list
83876255|NCT00412503|Topotecan|topotecan|mesh-list
83876256|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83876257|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
83876258|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876259|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876260|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83876261|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876262|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876263|NCT00412581|Lenalidomide|lenalidomide|mesh-list
83876264|NCT00412581|Dacarbazine|dacarbazine|mesh-list
83876265|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
83876266|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876267|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83876268|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83876269|NCT00412581|Growth Substances|growth substances|mesh-ancestor
83876270|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
83876271|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876272|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83876273|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
83876274|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876275|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
83876276|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83876277|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876278|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83876279|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876280|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876281|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876282|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876283|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83876284|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83876285|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
83876286|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876287|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
83876288|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876289|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876290|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83876291|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
83876292|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876293|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876294|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83876295|NCT00190268|Amifampridine|amifampridine|mesh-list
83876296|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83876297|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115349|NCT03394287|Apatinib|apatinib|mesh-list
83876298|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876299|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83876300|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876301|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876303|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83876304|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
83876305|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83876306|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876307|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83876308|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876309|NCT00190307|Aspirin|aspirin|mesh-list
83876310|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83876311|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83876312|NCT00190307|Analgesics|analgesics|mesh-ancestor
83876313|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
83876314|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876315|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876316|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83876317|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876318|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83876319|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83876320|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876321|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83876322|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83876323|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876324|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
83876325|NCT02963168|Docetaxel|docetaxel|mesh-list
83876326|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876327|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876328|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
83876329|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876330|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876331|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
83876332|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83876333|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
83876334|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876335|NCT00190463|Amphotericin B|amphotericin b|mesh-list
83876336|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83876337|NCT00190463|Amebicides|amebicides|mesh-ancestor
83876338|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83876339|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83876340|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876341|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83876342|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
83876343|NCT00213486|Irinotecan|irinotecan|mesh-list
83876344|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83876345|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876346|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876347|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876348|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876349|NCT00190502|Antibodies|antibodies|mesh-list
83876350|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
83876351|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876352|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83876353|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83876354|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83876355|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876356|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876357|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876358|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876359|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876360|NCT00122837|Analgesics|analgesics|mesh-ancestor
83876361|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
83876362|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876363|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876364|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876365|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
83876366|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83876367|NCT00190580|Valsartan|valsartan|mesh-list
83876368|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
83876369|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83876370|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83876371|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876373|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83876374|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876375|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83876376|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83876377|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83876378|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876379|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83876380|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83876381|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876382|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876383|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876384|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876385|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876386|NCT00190619|Analgesics|analgesics|mesh-ancestor
83876387|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
83876388|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876389|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876390|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876391|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
83876392|NCT00213564|Infliximab|infliximab|mesh-list
83876393|NCT00213564|Methotrexate|methotrexate|mesh-list
83876394|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83876395|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
83876396|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83876397|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876398|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876399|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
83876400|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876401|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876402|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
83876403|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876404|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83876405|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83876406|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
83876407|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876408|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83876409|NCT00213564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83876410|NCT00213564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83876411|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876412|NCT00122876|Talaporfin|talaporfin|mesh-list
83876413|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876414|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83876415|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
83876416|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83876417|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83876418|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876419|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876420|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876421|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
83876422|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876423|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876424|NCT00220584|Donepezil|donepezil|mesh-list
83876425|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83876426|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876427|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876428|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
83876429|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876430|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876431|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
83876432|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83876433|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83876434|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876435|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876436|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876437|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876438|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876439|NCT00190814|Analgesics|analgesics|mesh-ancestor
83876440|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
83876441|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876442|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876443|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876444|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
83876445|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
83876446|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876447|NCT00220818|Lansoprazole|lansoprazole|mesh-list
83876448|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
83876449|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83876450|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876451|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83876452|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876453|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876454|NCT00213759|Lenograstim|lenograstim|mesh-list
83876455|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83876456|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
83876457|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876458|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83876459|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83876460|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876461|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876462|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876463|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876464|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876465|NCT00190853|Analgesics|analgesics|mesh-ancestor
83876466|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
83876467|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876468|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876469|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876470|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
83876471|NCT00190892|Carbamazepine|carbamazepine|mesh-list
83876472|NCT00190892|Olanzapine|olanzapine|mesh-list
83876473|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
83876474|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
83876475|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876476|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876477|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876478|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83876479|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876480|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876481|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876482|NCT00190892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83876483|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876484|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876485|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876486|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876487|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
83876488|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
83876489|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
83876490|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83876491|NCT00190892|Analgesics|analgesics|mesh-ancestor
83876492|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
83876493|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83876494|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83876495|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83876496|NCT00220857|Rabeprazole|rabeprazole|mesh-list
83876497|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83876498|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876499|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83876500|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876501|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876502|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83876503|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83876504|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876505|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876506|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876507|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
83876508|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876509|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876510|NCT00220896|Donepezil|donepezil|mesh-list
83876511|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83876512|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876513|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876514|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
83876515|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876516|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876517|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
83876518|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
83876519|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876520|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876521|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83876522|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83876523|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876524|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876525|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876526|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
83876527|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876528|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876529|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83876530|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83876531|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876532|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876533|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876534|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83876535|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876536|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876537|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
83876538|NCT00123149|Hematinics|hematinics|mesh-ancestor
83876539|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83876540|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83876541|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83148325|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83876542|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876543|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876544|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876545|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876546|NCT00191087|Analgesics|analgesics|mesh-ancestor
83876547|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
83876548|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876549|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876550|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876551|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
83876552|NCT00191126|Gemcitabine|gemcitabine|mesh-list
83876553|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876554|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876555|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
83876556|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876557|NCT00221052|Diclofenac|diclofenac|mesh-list
83876558|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83876559|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83876560|NCT00221052|Analgesics|analgesics|mesh-ancestor
83876561|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
83876562|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876563|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876564|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83876565|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876566|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83876567|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876568|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876569|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83876570|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83876571|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876572|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876573|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876574|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876575|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876576|NCT00191204|Analgesics|analgesics|mesh-ancestor
83876577|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
83876578|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876579|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876580|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876581|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
83876582|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
83876583|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83115645|NCT02033603|Ropivacaine|ropivacaine|mesh-list
83876584|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876585|NCT00191243|Gemcitabine|gemcitabine|mesh-list
83876586|NCT00191243|Docetaxel|docetaxel|mesh-list
83876587|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876588|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
83876589|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876590|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876591|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876592|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83876593|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876594|NCT00214032|Pycnogenols|pycnogenols|mesh-list
83876595|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83876596|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
83876597|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876598|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
83876599|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876600|NCT00214032|Protective Agents|protective agents|mesh-ancestor
83876601|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83876602|NCT00123266|Plasminogen|plasminogen|mesh-list
83876603|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83876604|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83876605|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876606|NCT00191321|Teriparatide|teriparatide|mesh-list
83876607|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83876608|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876609|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83876610|NCT00123305|Plasminogen|plasminogen|mesh-list
83876611|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
83876612|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83876613|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83876614|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876615|NCT00214110|Tamoxifen|tamoxifen|mesh-list
83876616|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83876617|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
83876618|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83876619|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876620|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83876621|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876622|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83876623|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83876624|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83876625|NCT00191399|Olanzapine|olanzapine|mesh-list
83876626|NCT00191399|Fluoxetine|fluoxetine|mesh-list
83876627|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
83876628|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
83876629|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876630|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876631|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876632|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83876633|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876634|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876635|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876636|NCT00191399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83876637|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876638|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876639|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876640|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876641|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
83876642|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83876643|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876644|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83876645|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83876646|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876647|NCT00191438|Gemcitabine|gemcitabine|mesh-list
83876648|NCT00191438|Capecitabine|capecitabine|mesh-list
83876649|NCT00191438|Docetaxel|docetaxel|mesh-list
83876650|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876651|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
83876652|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876653|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876654|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876655|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
83876656|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876657|NCT00221286|Interferons|interferons|mesh-list
83876659|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
83876660|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
83876661|NCT00221286|Emtricitabine|emtricitabine|mesh-list
83876662|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83876663|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876664|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
83876665|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876666|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83876667|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83876668|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876669|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876670|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83876671|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83876672|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
83876673|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876674|NCT00123383|Modafinil|modafinil|mesh-list
83876675|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83876676|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876677|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83876678|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83876679|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83876680|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876681|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
83876682|NCT00214266|Rituximab|rituximab|mesh-list
83876683|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
83876684|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83876685|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876686|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
83876687|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876688|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876689|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83876690|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83876691|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
83876692|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83876693|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876694|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876695|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876696|NCT00221325|Rituximab|rituximab|mesh-list
83876697|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83876698|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876699|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
83876700|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876701|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83876702|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83876703|NCT00123461|Vitamins|vitamins|mesh-ancestor
83876704|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
83876705|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876706|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83876707|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83876708|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83876709|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876710|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876711|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876712|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
83876713|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876714|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876715|NCT00191555|Haloperidol|haloperidol|mesh-list
83876716|NCT00191555|Olanzapine|olanzapine|mesh-list
83876717|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
83876718|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
83876719|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
83876720|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876721|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876722|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876723|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83876724|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876725|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876726|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876727|NCT00191555|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83876728|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876729|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876730|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876731|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876732|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
83876733|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83876734|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
83876735|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83876736|NCT00221364|Azithromycin|azithromycin|mesh-list
83876737|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83876738|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876739|NCT00123539|Estrogens|estrogens|mesh-list
83876740|NCT00123539|Hormones|hormones|mesh-ancestor
83876741|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83876742|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876743|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83876744|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83876745|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876746|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876747|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876748|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876749|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876750|NCT00191594|Analgesics|analgesics|mesh-ancestor
83876751|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
83876752|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876753|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876754|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876755|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
83876756|NCT00221442|Zonisamide|zonisamide|mesh-list
83876757|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
83876758|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83876759|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876760|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876761|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83876762|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876763|NCT00123578|Pentobarbital|pentobarbital|mesh-list
83876764|NCT00123578|Lorazepam|lorazepam|mesh-list
83876765|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
83876766|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
83876767|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
83876768|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876769|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876770|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876771|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83876772|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876773|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83876774|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876775|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876776|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
83876777|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
83876778|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876779|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876780|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83876781|NCT00221481|Valproic Acid|valproic acid|mesh-list
83876782|NCT00221481|Olanzapine|olanzapine|mesh-list
83876783|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
83876784|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
83876785|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876786|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876787|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876788|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83876789|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876790|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876791|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876792|NCT00221481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83876793|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876794|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876795|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876796|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876797|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
83876798|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
83876799|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876800|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
83876801|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
83876802|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83876803|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83115867|NCT03610139|Vitamin D|vitamin d|mesh-list
83876804|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876806|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876807|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
83876808|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876809|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876810|NCT00221520|Midazolam|midazolam|mesh-list
83876811|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83876812|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83876813|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876814|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876815|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83876816|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876817|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876818|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83876819|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
83876820|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
83876821|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
83876822|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
83876823|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876824|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876825|NCT00191672|Paclitaxel|paclitaxel|mesh-list
83876826|NCT00191672|Docetaxel|docetaxel|mesh-list
83876827|NCT00191672|Gemcitabine|gemcitabine|mesh-list
83876828|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83876829|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876830|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876831|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
83876832|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876833|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876834|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876835|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
83876836|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83876837|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
83876838|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876839|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83876840|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876841|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876842|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876843|NCT00191711|Gemcitabine|gemcitabine|mesh-list
83876844|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876845|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
83876846|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876847|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876848|NCT00221637|Valproic Acid|valproic acid|mesh-list
83876849|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
83876850|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876851|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876852|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
83876853|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876854|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876855|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
83876856|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876857|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876858|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876859|NCT00123656|Fluticasone|fluticasone|mesh-list
83876860|NCT00123656|Esomeprazole|esomeprazole|mesh-list
83876861|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83876862|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83876863|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
83876864|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876865|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876866|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83876867|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
83876868|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
83876869|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83876870|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83876871|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876872|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83876873|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876874|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876875|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83876876|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83876877|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83876878|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
83115939|NCT02034071|Diazoxide|diazoxide|mesh-list
83876879|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876880|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83876881|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83876882|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876883|NCT00191750|Pemetrexed|pemetrexed|mesh-list
83876884|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876885|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876886|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876887|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83876888|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83876889|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
83876890|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83876891|NCT00221754|Pravastatin|pravastatin|mesh-list
83876892|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83876893|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83876894|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
83876895|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876896|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83876897|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83876898|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876899|NCT00191828|Olanzapine|olanzapine|mesh-list
83876900|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
83876901|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
83876902|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83876903|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876904|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83876905|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83876906|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83876907|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83876908|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83876909|NCT00191828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83876910|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83876911|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83876912|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876913|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876914|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
83876915|NCT00191867|Teriparatide|teriparatide|mesh-list
83876916|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83876917|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876918|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83876919|NCT00123851|Capecitabine|capecitabine|mesh-list
83876920|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
83876921|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83876922|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876923|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
83876924|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876925|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876926|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83876927|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876928|NCT00123890|Aplaviroc|aplaviroc|mesh-list
83876929|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83876930|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83876931|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876932|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83876933|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83876934|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
83876935|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876936|NCT00412698|Rimonabant|rimonabant|mesh-list
83876937|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83876938|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83876939|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83876940|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83876941|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876942|NCT00412698|Hormones|hormones|mesh-ancestor
83876943|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83876944|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876945|NCT00123929|Docetaxel|docetaxel|mesh-list
83876946|NCT00123929|Doxorubicin|doxorubicin|mesh-list
83876947|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876948|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876949|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
83116012|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
83876950|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876951|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876952|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83876953|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83876954|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876955|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876956|NCT00475033|Vaccines|vaccines|mesh-list
83876957|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83876958|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
83876959|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876960|NCT00192062|Gemcitabine|gemcitabine|mesh-list
83876961|NCT00192062|Vinorelbine|vinorelbine|mesh-list
83876962|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876963|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
83876964|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876965|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876966|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83876967|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83876968|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83876969|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83876970|NCT00192101|Gemcitabine|gemcitabine|mesh-list
83876971|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876972|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83876973|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
83876974|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876975|NCT00215007|Levofloxacin|levofloxacin|mesh-list
83876976|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83876977|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876978|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83876979|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83876980|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83876981|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876982|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876983|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876984|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83876985|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83876986|NCT00474994|Sunitinib|sunitinib|mesh-list
83876987|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83876988|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83876989|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83876990|NCT00474994|Growth Substances|growth substances|mesh-ancestor
83876991|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83876992|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
83876993|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83876994|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83876995|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83876996|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83876997|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
83876998|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83876999|NCT00215046|Methotrexate|methotrexate|mesh-list
83877000|NCT00215046|Vinblastine|vinblastine|mesh-list
83877001|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83877002|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
83877003|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83877004|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877005|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877006|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
83877007|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877008|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877009|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
83877010|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877011|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83877012|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877013|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
83877014|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877015|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83877016|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83877017|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877018|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877019|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877020|NCT00474487|Vaccines|vaccines|mesh-list
83877021|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
83877022|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877023|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83116085|NCT03380325|Iloprost|iloprost|mesh-list
83877024|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83877025|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
83877026|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877027|NCT00474253|Rocuronium|rocuronium|mesh-list
83877028|NCT00474253|Succinylcholine|succinylcholine|mesh-list
83877029|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83877030|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83877031|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83877032|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877033|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877034|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83877035|NCT00221871|Ketamine|ketamine|mesh-list
83877036|NCT00221871|Analgesics|analgesics|mesh-ancestor
83877037|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
83877038|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877039|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877040|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83877041|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83877042|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
83877043|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
83877044|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877045|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83877046|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83877047|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877048|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877049|NCT00474058|Rotigotine|rotigotine|mesh-list
83877050|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
83877051|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
83877052|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877053|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877054|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877055|NCT02277730|Phenylephrine|phenylephrine|mesh-list
83877056|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
83877057|NCT02277730|Ephedrine|ephedrine|mesh-list
83877058|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83877059|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83877060|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
83877061|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
83877062|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877063|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877064|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
83877065|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
83877066|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
83877067|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83877068|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83877069|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83877070|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
83877071|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877072|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877073|NCT02277730|Protective Agents|protective agents|mesh-ancestor
83877074|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83877075|NCT04571437|Capecitabine|capecitabine|mesh-list
83877076|NCT04571437|Letrozole|letrozole|mesh-list
83877077|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877078|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
83877079|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877080|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877081|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83877082|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83877083|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877084|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83877085|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
83877086|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877087|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877088|NCT00215124|Lenograstim|lenograstim|mesh-list
83877089|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83877090|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
83877091|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877092|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
83877093|NCT00473824|Antibodies|antibodies|mesh-list
83877094|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
83877095|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83877096|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83877097|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
83116161|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
83877098|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877099|NCT00215163|Paroxetine|paroxetine|mesh-list
83877100|NCT00215163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83877101|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83877102|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877103|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877104|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877105|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
83877106|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877107|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83877108|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
83877109|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83877110|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83877111|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83877112|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877113|NCT00215202|Gefitinib|gefitinib|mesh-list
83877114|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877115|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83877116|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877117|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877118|NCT00215241|Risperidone|risperidone|mesh-list
83877119|NCT00215241|Sertraline|sertraline|mesh-list
83877120|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83877121|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
83877122|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877123|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877124|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877125|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83877126|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83877127|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877128|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83877129|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83877130|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
83877131|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
83877132|NCT00215241|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83877133|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83877134|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877135|NCT00124241|Lamivudine|lamivudine|mesh-list
83877136|NCT00124241|Telbivudine|telbivudine|mesh-list
83877137|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83877138|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83877139|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877140|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877141|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
83877142|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877143|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83877144|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83877145|NCT00124280|Everolimus|everolimus|mesh-list
83877146|NCT00124280|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83877147|NCT00124280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83877148|NCT00124280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877149|NCT00124280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877150|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877151|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
83877152|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877153|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877154|NCT00215280|Ivermectin|ivermectin|mesh-list
83877155|NCT00215280|Albendazole|albendazole|mesh-list
83877156|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83877157|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877158|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
83877159|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
83877160|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83877161|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83877162|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877163|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877164|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877165|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148347|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
83877166|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877167|NCT00192413|Vaccines|vaccines|mesh-list
83877168|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
83877169|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877170|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
83877171|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83877173|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877174|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877175|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83877176|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
83877177|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83877178|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83877179|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83877180|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
83877181|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877182|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877183|NCT00192569|Interferons|interferons|mesh-list
83877184|NCT00192569|Ribavirin|ribavirin|mesh-list
83877185|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
83877186|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
83877187|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83877188|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877189|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
83877190|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877191|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
83877192|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877193|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
83877194|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877195|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
83877196|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83877197|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
83877198|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877199|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877200|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83877201|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
83877202|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83877203|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83877204|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83877205|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
83877206|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877207|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877208|NCT00192608|Saquinavir|saquinavir|mesh-list
83877209|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83877210|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83877211|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
83877212|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877213|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877214|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83877215|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83877216|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
83877217|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877218|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83877219|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83877220|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
83877221|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83877222|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
83877223|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877224|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877225|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83877226|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
83877227|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83877228|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83877229|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83877230|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83877231|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877232|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877233|NCT00215514|Fluorouracil|fluorouracil|mesh-list
83877234|NCT00215514|Epirubicin|epirubicin|mesh-list
83877235|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877236|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
83877237|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877238|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877239|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877240|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
83877241|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877242|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83877243|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83877244|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877245|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877247|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83877248|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
83877249|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83877250|NCT00215592|Zonisamide|zonisamide|mesh-list
83877251|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
83877252|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83877253|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877254|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877255|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83877256|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877257|NCT00222144|Docetaxel|docetaxel|mesh-list
83877258|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
83877259|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877260|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877261|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877262|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877263|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877264|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83877265|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877266|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
83877267|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83877268|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83877269|NCT00222183|Analgesics|analgesics|mesh-ancestor
83877270|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
83877271|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877272|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877273|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83877274|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877275|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
83877276|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877277|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
83877278|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83877279|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877280|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877281|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
83877282|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877283|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
83877284|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877285|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877286|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83877287|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
83877288|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877289|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877290|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83877291|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83877292|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83877293|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83877294|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
83877295|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877296|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877297|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83877298|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83877299|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
83877300|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877301|NCT00192803|Candesartan|candesartan|mesh-list
83877302|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83877303|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83877304|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83877305|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877306|NCT00192842|Curcumin|curcumin|mesh-list
83877307|NCT00192842|Gemcitabine|gemcitabine|mesh-list
83877308|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877309|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
83877310|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877311|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877312|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83877313|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83877314|NCT00192842|Analgesics|analgesics|mesh-ancestor
83877315|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
83877316|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877317|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877318|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83877319|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877320|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877322|NCT00411996|Indinavir|indinavir|mesh-list
83877323|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83877324|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83877325|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
83877326|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877327|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877328|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83877329|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83877330|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
83877331|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877332|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83877333|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83877334|NCT00222261|Aspirin|aspirin|mesh-list
83877335|NCT00222261|Clopidogrel|clopidogrel|mesh-list
83877336|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83877337|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83877338|NCT00222261|Analgesics|analgesics|mesh-ancestor
83877339|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
83877340|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877341|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877342|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83877343|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877344|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83877345|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83877346|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877347|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83877348|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83877349|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877350|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
83877351|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83877352|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83877353|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83877354|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
83877355|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877356|NCT00192959|Propofol|propofol|mesh-list
83877357|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83877358|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877359|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877360|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83877361|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
83877362|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
83877363|NCT00215631|Tadalafil|tadalafil|mesh-list
83877364|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
83877365|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83877366|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83877367|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877368|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877369|NCT00215631|Urological Agents|urological agents|mesh-ancestor
83877370|NCT00193076|Carboplatin|carboplatin|mesh-list
83877371|NCT00193076|Gemcitabine|gemcitabine|mesh-list
83877372|NCT00193076|Trastuzumab|trastuzumab|mesh-list
83877373|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877374|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877375|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
83877376|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877377|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83877378|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
83877379|NCT00193115|Docetaxel|docetaxel|mesh-list
83877380|NCT00193115|Doxorubicin|doxorubicin|mesh-list
83877381|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877382|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
83877383|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877384|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877385|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83877386|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
83877387|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877388|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877389|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83877390|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877391|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877392|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877393|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83877394|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83877395|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877396|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877397|NCT00193154|Bevacizumab|bevacizumab|mesh-list
83877398|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83877399|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83877400|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877401|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83877402|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83877403|NCT00193154|Growth Substances|growth substances|mesh-ancestor
83877404|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877405|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
83877406|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83877407|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877408|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877409|NCT00193193|Paclitaxel|paclitaxel|mesh-list
83877410|NCT00193193|Carboplatin|carboplatin|mesh-list
83877411|NCT00193193|Estramustine|estramustine|mesh-list
83877412|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83877413|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877414|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877415|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877416|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877417|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877418|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83877419|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
83877420|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83877421|NCT00193232|Docetaxel|docetaxel|mesh-list
83877422|NCT00193232|Bortezomib|bortezomib|mesh-list
83877423|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877424|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877425|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877426|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877427|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877428|NCT00222495|Olanzapine|olanzapine|mesh-list
83877429|NCT00222495|Risperidone|risperidone|mesh-list
83877430|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83877431|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83877432|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
83877433|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877434|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877435|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877436|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83877437|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83148379|NCT04792034|Cocaine|cocaine|mesh-list
83877438|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877439|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83877440|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83877441|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
83877442|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
83877443|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
83877444|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877445|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83877446|NCT00222495|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83877447|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83877448|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877449|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
83877450|NCT00193271|Docetaxel|docetaxel|mesh-list
83877451|NCT00193271|Estramustine|estramustine|mesh-list
83877452|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877453|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877454|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877455|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877456|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877457|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83877458|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
83877459|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83877460|NCT00222534|Acetazolamide|acetazolamide|mesh-list
83877461|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
83877462|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83877463|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877464|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877465|NCT00222534|Diuretics|diuretics|mesh-ancestor
83116537|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
83877466|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
83877467|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877468|NCT00193310|Paclitaxel|paclitaxel|mesh-list
83877469|NCT00193310|Carboplatin|carboplatin|mesh-list
83877470|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83877471|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877472|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877473|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877474|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877475|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877476|NCT00193349|Carboplatin|carboplatin|mesh-list
83877477|NCT00193349|Irinotecan|irinotecan|mesh-list
83877478|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
83877479|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877480|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83877481|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877482|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877483|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877484|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83877485|NCT00193388|Topotecan|topotecan|mesh-list
83877486|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83877487|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877488|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877489|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877490|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877491|NCT00215709|Docetaxel|docetaxel|mesh-list
83877492|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877493|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877494|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877495|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877496|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877497|NCT00193466|Rituximab|rituximab|mesh-list
83877498|NCT00193466|Fludarabine|fludarabine|mesh-list
83877499|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83877500|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877501|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
83877502|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877503|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877504|NCT00215748|Dexamethasone|dexamethasone|mesh-list
83877505|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83877506|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
83877507|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
83877508|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877509|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877510|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83877511|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
83877512|NCT00215748|Hormones|hormones|mesh-ancestor
83877513|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877514|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83877515|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877516|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
83877517|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
83877518|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877519|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
83877520|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877521|NCT00193544|Thalidomide|thalidomide|mesh-list
83877522|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
83877523|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877524|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
83877525|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877526|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
83877527|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83877528|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877529|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83877530|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83877531|NCT00193544|Growth Substances|growth substances|mesh-ancestor
83877532|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
83877533|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877534|NCT00215865|Ribavirin|ribavirin|mesh-list
83877535|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83877536|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
83877537|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877538|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
83877539|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877540|NCT00124358|Buprenorphine|buprenorphine|mesh-list
83877541|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83877542|NCT00124358|Narcotics|narcotics|mesh-ancestor
83877543|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877544|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877545|NCT00124358|Analgesics|analgesics|mesh-ancestor
83877546|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
83877547|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877548|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83877549|NCT00193583|Carboplatin|carboplatin|mesh-list
83877550|NCT00193583|Topotecan|topotecan|mesh-list
83877551|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877552|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83877553|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877554|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877555|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877556|NCT00215982|Capecitabine|capecitabine|mesh-list
83877557|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
83877558|NCT00215982|Irinotecan|irinotecan|mesh-list
83877559|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877560|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
83877561|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877562|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877563|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83877564|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877565|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877566|NCT00124397|Atorvastatin|atorvastatin|mesh-list
83877567|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83877568|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83877569|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
83877570|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877571|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83877572|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83877573|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877574|NCT00216021|Capecitabine|capecitabine|mesh-list
83877575|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
83877576|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877577|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
83877578|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877579|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877580|NCT00409526|Iloprost|iloprost|mesh-list
83877581|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83877582|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
83877583|NCT00216138|Docetaxel|docetaxel|mesh-list
83877584|NCT00216138|Capecitabine|capecitabine|mesh-list
83877585|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877586|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877587|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877588|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877589|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877590|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877591|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
83877592|NCT00216177|Adalimumab|adalimumab|mesh-list
83877593|NCT00216177|Infliximab|infliximab|mesh-list
83877594|NCT00216177|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83877595|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83877596|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877597|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
83877598|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83877599|NCT00216216|Pemetrexed|pemetrexed|mesh-list
83877600|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877601|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877602|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877603|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83877604|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83877605|NCT00473746|Dexamethasone|dexamethasone|mesh-list
83877606|NCT00473746|Prednisone|prednisone|mesh-list
83877607|NCT00473746|Prednisolone|prednisolone|mesh-list
83877608|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
83877609|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83877610|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
83877611|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
83877612|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877613|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877614|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83877615|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
83877616|NCT00473746|Hormones|hormones|mesh-ancestor
83877617|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877618|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83877619|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116709|NCT05049902|Bismuth|bismuth|mesh-list
83877620|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83877621|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877622|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877623|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
83877624|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83877625|NCT00409643|Amlodipine|amlodipine|mesh-list
83877626|NCT00409643|Valsartan|valsartan|mesh-list
83877627|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83877628|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83877629|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877630|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877631|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83877632|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877633|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
83877634|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83877635|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83877636|NCT00216294|Secretin|secretin|mesh-list
83877637|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83877638|NCT00216294|Hormones|hormones|mesh-ancestor
83877639|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877640|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877641|NCT00409721|Memantine|memantine|mesh-list
83877642|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83877643|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83877644|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
83877645|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877646|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148403|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877647|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877648|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83877649|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83877650|NCT00193622|Bevacizumab|bevacizumab|mesh-list
83877651|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83877652|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83877653|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877654|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83877655|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83877656|NCT00193622|Growth Substances|growth substances|mesh-ancestor
83877657|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877658|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
83877659|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83877660|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877661|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877662|NCT00473590|Bevacizumab|bevacizumab|mesh-list
83877663|NCT00473590|Bortezomib|bortezomib|mesh-list
83877664|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83877665|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877666|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83877667|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83877668|NCT00473590|Growth Substances|growth substances|mesh-ancestor
83877669|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877670|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
83877671|NCT00223275|Naltrexone|naltrexone|mesh-list
83877672|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83877673|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83877674|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877675|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
83877676|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877677|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
83877678|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
83877679|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
83877680|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877681|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877682|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83877683|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83877684|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
83877685|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
83877686|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877687|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877688|NCT00193661|Testosterone|testosterone|mesh-list
83877689|NCT00193661|Androgens|androgens|mesh-ancestor
83877690|NCT00193661|Hormones|hormones|mesh-ancestor
83877691|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877692|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877693|NCT00206232|Spironolactone|spironolactone|mesh-list
83877694|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83877695|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
83877696|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877697|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877698|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83877699|NCT00206232|Diuretics|diuretics|mesh-ancestor
83877700|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
83877701|NCT00193700|Testosterone|testosterone|mesh-list
83877702|NCT00193700|Androgens|androgens|mesh-ancestor
83877703|NCT00193700|Hormones|hormones|mesh-ancestor
83877704|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877705|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877706|NCT00124826|Insulin|insulin|mesh-list
83877707|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83877708|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877709|NCT00193739|Paclitaxel|paclitaxel|mesh-list
83877710|NCT00193739|Carboplatin|carboplatin|mesh-list
83877711|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83877712|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877713|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877714|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877715|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877716|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877717|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83877718|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83877719|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83877720|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
83877721|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877722|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83877723|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83877724|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877725|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
83877726|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877727|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
83877728|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877729|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877730|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83877731|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
83877732|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877733|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877734|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83877735|NCT00125021|Capecitabine|capecitabine|mesh-list
83877736|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83877737|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877738|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
83877739|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877740|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877741|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83877742|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877743|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
83877744|NCT00193856|Leuprolide|leuprolide|mesh-list
83877745|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83877746|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877747|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83877748|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
83877749|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83877750|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83877751|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877752|NCT00223509|Lamotrigine|lamotrigine|mesh-list
83877753|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
83877754|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83877755|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877756|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877757|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83877758|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877759|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83877760|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83877761|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877762|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83877763|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83877764|NCT00193895|Carboplatin|carboplatin|mesh-list
83877765|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877766|NCT00223548|Mesna|mesna|mesh-list
83877767|NCT00223548|Protective Agents|protective agents|mesh-ancestor
83877768|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877769|NCT00125060|Simvastatin|simvastatin|mesh-list
83877770|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83877771|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83877772|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
83877773|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877774|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83877775|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83877776|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877777|NCT00223626|Topiramate|topiramate|mesh-list
83877778|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
83877779|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83877780|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877781|NCT00223743|Zonisamide|zonisamide|mesh-list
83877782|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
83877783|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83877784|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877785|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877786|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83877787|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877788|NCT00193973|Methotrexate|methotrexate|mesh-list
83877789|NCT00193973|Idarubicin|idarubicin|mesh-list
83877790|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83877791|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
83877792|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83877793|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877794|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83877795|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
83877796|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877797|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877798|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
83877799|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877800|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83877801|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877802|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
83877803|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877804|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83877805|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83877806|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83877807|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877808|NCT00411879|Vasopressins|vasopressins|mesh-list
83877809|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
83877810|NCT00411879|Epinephrine|epinephrine|mesh-list
83877811|NCT00411879|Racepinephrine|racepinephrine|mesh-list
83877812|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
83877813|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83877814|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83877815|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
83877816|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83877817|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877818|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877819|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83877820|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83877821|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
83877822|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406636|NCT05902780|Analgesics|analgesics|mesh-ancestor
83877823|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83877824|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
83877825|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
83877826|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
83877827|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83877828|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
83877829|NCT00411879|Coagulants|coagulants|mesh-ancestor
83877830|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83877831|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
83877832|NCT00193505|Rituximab|rituximab|mesh-list
83877833|NCT00193505|Carboplatin|carboplatin|mesh-list
83877834|NCT00193505|Etoposide|etoposide|mesh-list
83877835|NCT00193505|Ifosfamide|ifosfamide|mesh-list
83877836|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83877837|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877838|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
83877839|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877840|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877841|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83877842|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83877843|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877844|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877845|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877846|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83877847|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
83877848|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83877849|NCT00223860|Hormones|hormones|mesh-list
83877850|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83877851|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877852|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877853|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83877854|NCT00125255|Lidocaine|lidocaine|mesh-list
83877855|NCT00125255|Tetracaine|tetracaine|mesh-list
83877856|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83877857|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
83877858|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877859|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877860|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
83877861|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877862|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83877863|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83877864|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83877865|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83877866|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877867|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
83877868|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
83877869|NCT00223938|Hematinics|hematinics|mesh-ancestor
83877870|NCT00125294|Methadone|methadone|mesh-list
83877871|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83877872|NCT00125294|Narcotics|narcotics|mesh-ancestor
83877873|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83877874|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877875|NCT00125294|Analgesics|analgesics|mesh-ancestor
83877876|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
83877877|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877878|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
83877879|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
83877880|NCT00206466|Docetaxel|docetaxel|mesh-list
83877881|NCT00206466|Doxorubicin|doxorubicin|mesh-list
83877882|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
83877883|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83877884|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877885|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877886|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877887|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877888|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877889|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83877890|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83877891|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83877892|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877893|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83877894|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
83877895|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877896|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83877897|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83877898|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
83877899|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83877900|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83877901|NCT00224094|Estrogens|estrogens|mesh-ancestor
83877902|NCT00224094|Hormones|hormones|mesh-ancestor
83877903|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877904|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877905|NCT00125411|Docetaxel|docetaxel|mesh-list
83877906|NCT00125411|Satraplatin|satraplatin|mesh-list
83877907|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877908|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877909|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877910|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877911|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877912|NCT00206505|Docetaxel|docetaxel|mesh-list
83877913|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877914|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
83877915|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
83877916|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
83877917|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877918|NCT00206544|Tamoxifen|tamoxifen|mesh-list
83877919|NCT00206544|Progesterone|progesterone|mesh-list
83877920|NCT00206544|Progestins|progestins|mesh-ancestor
83877921|NCT00206544|Hormones|hormones|mesh-ancestor
83877922|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877923|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877924|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83877925|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
83877926|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83877927|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877928|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83877929|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83877930|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83877931|NCT00194324|Miconazole|miconazole|mesh-list
83877932|NCT00194324|Clotrimazole|clotrimazole|mesh-list
83877933|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
83877934|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83877935|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83877936|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83877937|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877938|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877939|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83877940|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
83877941|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877942|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877943|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83877944|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83877945|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83877946|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83877947|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83877948|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
83877949|NCT00206622|Estradiol|estradiol|mesh-list
83877950|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83877951|NCT00206622|Estrogens|estrogens|mesh-ancestor
83877952|NCT00206622|Hormones|hormones|mesh-ancestor
83877953|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877954|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877955|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83877956|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
83877957|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83877958|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83877959|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83877960|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83877961|NCT00194402|Niacin|niacin|mesh-list
83877962|NCT00194402|Niacinamide|niacinamide|mesh-list
83877963|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
83877964|NCT00194402|Atorvastatin|atorvastatin|mesh-list
83877965|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83877966|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83877967|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
83877968|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877969|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83877970|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83877971|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83877972|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
83877973|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
83877974|NCT00194402|Vitamins|vitamins|mesh-ancestor
83877975|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
83877976|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877977|NCT00473512|Dexamethasone|dexamethasone|mesh-list
83877978|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
83877979|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83877980|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
83877981|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
83877982|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83877983|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83877984|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83877985|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
83877986|NCT00473512|Hormones|hormones|mesh-ancestor
83877987|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83877988|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83877989|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83877990|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83877991|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117064|NCT02675439|Ipilimumab|ipilimumab|mesh-list
83877992|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83877993|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
83877994|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83877995|NCT00125489|Chloroquine|chloroquine|mesh-list
83877996|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83877997|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
83877998|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
83877999|NCT00125489|Amebicides|amebicides|mesh-ancestor
83878000|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83878001|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83878002|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878003|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
83878004|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878005|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83878006|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878007|NCT00125489|Analgesics|analgesics|mesh-ancestor
83878008|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
83878009|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878010|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878011|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878012|NCT00125489|Filaricides|filaricides|mesh-ancestor
83878013|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
83878014|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
83878015|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83878016|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878017|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878018|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83878019|NCT00206661|Molgramostim|molgramostim|mesh-list
83878020|NCT00206661|Sargramostim|sargramostim|mesh-list
83878021|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
83878022|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878023|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878024|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83878025|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83878026|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83878027|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878028|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878029|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83878030|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83878031|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83878032|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
83878033|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878034|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878035|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83878036|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83878037|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
83878038|NCT00125567|Levodopa|levodopa|mesh-list
83878039|NCT00125567|Carbidopa|carbidopa|mesh-list
83878040|NCT00125567|Entacapone|entacapone|mesh-list
83878041|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83878042|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83878043|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
83878044|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878045|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878046|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878047|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83878048|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878049|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83878050|NCT00473083|Minocycline|minocycline|mesh-list
83878051|NCT00473083|Clindamycin|clindamycin|mesh-list
83878052|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
83878053|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
83878054|NCT00473083|Triamcinolone|triamcinolone|mesh-list
83878055|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83878056|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83878057|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
83878058|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83878059|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878060|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878061|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878062|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
83878063|NCT00473083|Hormones|hormones|mesh-ancestor
83878064|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83878065|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878066|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878067|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
83878068|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83878069|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878070|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83878072|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878073|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
83878074|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878075|NCT00472420|Rituximab|rituximab|mesh-list
83878076|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83878077|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878078|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
83878079|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878080|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878081|NCT00194519|Acyclovir|acyclovir|mesh-list
83878082|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
83878083|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878084|NCT00206700|Sargramostim|sargramostim|mesh-list
83878085|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
83878086|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878087|NCT00125645|Irbesartan|irbesartan|mesh-list
83878088|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83878089|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83878090|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83878091|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878092|NCT00125684|Morphine|morphine|mesh-list
83878093|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83878094|NCT00125684|Narcotics|narcotics|mesh-ancestor
83878095|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878096|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878097|NCT00125684|Analgesics|analgesics|mesh-ancestor
83878098|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
83878099|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878100|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
83878101|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878102|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
83878103|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83878104|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83878105|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878106|NCT00194597|Urological Agents|urological agents|mesh-ancestor
83878107|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
83878108|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
83878109|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
83878110|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83878111|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83878112|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878113|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83878114|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878115|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878116|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83878117|NCT00206778|Lamotrigine|lamotrigine|mesh-list
83878118|NCT00206778|Valproic Acid|valproic acid|mesh-list
83878119|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
83878120|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83878121|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878122|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878123|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83878124|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878125|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83878126|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83878127|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878128|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83878129|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83878130|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878131|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
83878132|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878133|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
83878134|NCT00125801|Hydromorphone|hydromorphone|mesh-list
83878135|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83878136|NCT00125801|Narcotics|narcotics|mesh-ancestor
83878137|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878138|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878139|NCT00125801|Analgesics|analgesics|mesh-ancestor
83878140|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
83878141|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117209|NCT03602131|Gemcitabine|gemcitabine|mesh-list
83878142|NCT00125840|Clofarabine|clofarabine|mesh-list
83878143|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878144|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
83878145|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878146|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878147|NCT00224445|Ritonavir|ritonavir|mesh-list
83878148|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83878149|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83878150|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83878151|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83878152|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
83878153|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878154|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878155|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83878156|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83878157|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
83878158|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878159|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83878160|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83878161|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83878162|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83878163|NCT00194753|Paclitaxel|paclitaxel|mesh-list
83878164|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
83878165|NCT00194753|Doxorubicin|doxorubicin|mesh-list
83878166|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83878167|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878168|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
83878169|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
83878170|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
83878171|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878172|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878173|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
83878174|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878175|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878176|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83878177|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
83878178|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83878179|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83878180|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83878181|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83878182|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878183|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83878184|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
83878185|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878186|NCT00125918|Tadalafil|tadalafil|mesh-list
83878187|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
83878188|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83878189|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83878190|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878191|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878192|NCT00125918|Urological Agents|urological agents|mesh-ancestor
83878193|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
83878194|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878195|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83878196|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83878197|NCT00472303|Morphine|morphine|mesh-list
83878198|NCT00472303|Tapentadol|tapentadol|mesh-list
83878199|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83878200|NCT00472303|Narcotics|narcotics|mesh-ancestor
83878201|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878202|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878203|NCT00472303|Analgesics|analgesics|mesh-ancestor
83878204|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
83878205|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878206|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83878207|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83878208|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878209|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878210|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
83878211|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878212|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83878213|NCT00125996|Hematinics|hematinics|mesh-ancestor
83878214|NCT00206934|Dexetimide|dexetimide|mesh-list
83878215|NCT00206934|Citalopram|citalopram|mesh-list
83878216|NCT00206934|Escitalopram|escitalopram|mesh-list
83117286|NCT05850832|Esmolol|esmolol|mesh-list
83878217|NCT00206934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83878218|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83878219|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878220|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878221|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878223|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878224|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83878225|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83878226|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
83878227|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
83878228|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878229|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83878230|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83878231|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
83878232|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83878233|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
83878234|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83878235|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
83878236|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
83878237|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83878238|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83878239|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878240|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878241|NCT00194909|Urological Agents|urological agents|mesh-ancestor
83878242|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
83878243|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
83878244|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
83878245|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878246|NCT00194948|Escitalopram|escitalopram|mesh-list
83878247|NCT00194948|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83878248|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83878249|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878250|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878251|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878252|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
83878253|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878254|NCT00206973|Mannitol|mannitol|mesh-list
83878255|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83878256|NCT00206973|Diuretics|diuretics|mesh-ancestor
83878257|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
83878258|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878259|NCT00471445|Ketamine|ketamine|mesh-list
83878260|NCT00471445|Amitriptyline|amitriptyline|mesh-list
83878261|NCT00471445|Analgesics|analgesics|mesh-ancestor
83878262|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
83878263|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878264|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878265|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83878266|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83878267|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
83878268|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
83878269|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878270|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83878271|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83878272|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878273|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878274|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83878275|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
83878276|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83878277|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878278|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83878279|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83878280|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878281|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
83878282|NCT00207051|Cetuximab|cetuximab|mesh-list
83878283|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83878284|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878285|NCT00402467|Enoxaparin|enoxaparin|mesh-list
83878286|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
83878287|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
83878288|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83878289|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
83878290|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83878291|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
83878292|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878293|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878294|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
83878295|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83878296|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83878297|NCT00224679|Aspirin|aspirin|mesh-list
83878298|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83878299|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878300|NCT00224679|Analgesics|analgesics|mesh-ancestor
83878301|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
83878302|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878303|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878304|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878305|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878306|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83878307|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83878308|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878309|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83878310|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83878311|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878312|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
83878313|NCT00402506|Pyridoxal|pyridoxal|mesh-list
83878314|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83878315|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
83878316|NCT00402506|Vitamins|vitamins|mesh-ancestor
83878317|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
83878318|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878319|NCT00207129|Capecitabine|capecitabine|mesh-list
83878320|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878321|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
83878322|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878323|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878324|NCT00402545|Docetaxel|docetaxel|mesh-list
83878325|NCT00402545|Fluorouracil|fluorouracil|mesh-list
83878326|NCT00402545|Cetuximab|cetuximab|mesh-list
83878327|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878328|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
83878329|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
83878330|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
83878331|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878332|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
83878333|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878334|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878335|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
83878336|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878337|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83878338|NCT00126074|Tedisamil|tedisamil|mesh-list
83878339|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83878340|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83878341|NCT00126074|Protective Agents|protective agents|mesh-ancestor
83878342|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878343|NCT00195104|Cytarabine|cytarabine|mesh-list
83878344|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
83878345|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878346|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
83878347|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878348|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878349|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
83878350|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878351|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878352|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
83878353|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878354|NCT00413088|Bemiparin|bemiparin|mesh-list
83878355|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
83878356|NCT00409760|Amlodipine|amlodipine|mesh-list
83878357|NCT00409760|Valsartan|valsartan|mesh-list
83878358|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83878359|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83878360|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878361|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878362|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83878363|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117435|NCT05849883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878364|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
83878365|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83878366|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83878368|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
83878369|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
83878370|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878371|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878372|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
83878373|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878374|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83878375|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83878376|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83878377|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878378|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878379|NCT00126230|Docetaxel|docetaxel|mesh-list
83878380|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878381|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83878382|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83878383|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83878384|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878385|NCT00207363|Interferons|interferons|mesh-list
83878386|NCT00207363|Ribavirin|ribavirin|mesh-list
83878387|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
83878388|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
83878389|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83878390|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878391|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
83878392|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878393|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
83878394|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878395|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
83878396|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878397|NCT00126269|Gemcitabine|gemcitabine|mesh-list
83878398|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878399|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878400|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
83878401|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878402|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
83878403|NCT00207402|Interferons|interferons|mesh-list
83878404|NCT00207402|Ribavirin|ribavirin|mesh-list
83878405|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
83878406|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878407|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
83878408|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878409|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
83878410|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878411|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83878412|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878413|NCT00195299|Sirolimus|sirolimus|mesh-list
83878414|NCT00195299|Temsirolimus|temsirolimus|mesh-list
83878415|NCT00195299|MTOR Inhibitors|mtor inhibitors|mesh-list
83878416|NCT00195299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83878417|NCT00195299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878418|NCT00195299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878419|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878420|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
83878421|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878422|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878423|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83878424|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878425|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83878426|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
83878427|NCT00471328|Sunitinib|sunitinib|mesh-list
83878428|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
83878429|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878430|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83878431|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83878432|NCT00471328|Growth Substances|growth substances|mesh-ancestor
83878433|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878434|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
83878435|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83878436|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878437|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878438|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
83878439|NCT00126308|Mannitol|mannitol|mesh-list
83878440|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83878441|NCT00126308|Diuretics|diuretics|mesh-ancestor
83878442|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
83878443|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878444|NCT00195377|Etanercept|etanercept|mesh-list
83878445|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83878446|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878447|NCT00195377|Analgesics|analgesics|mesh-ancestor
83878448|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
83878449|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878450|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878451|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878452|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878453|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83878454|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878455|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
83878456|NCT00225108|Tinzaparin|tinzaparin|mesh-list
83878457|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83878458|NCT00225108|Dalteparin|dalteparin|mesh-list
83878459|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
83878460|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83878461|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83878462|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878463|NCT00195416|Etanercept|etanercept|mesh-list
83878464|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83878465|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878466|NCT00195416|Analgesics|analgesics|mesh-ancestor
83878467|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
83878468|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878469|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878470|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878471|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878472|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83878473|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878474|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
83878475|NCT00195455|Estradiol|estradiol|mesh-list
83878476|NCT00195455|Estrogens|estrogens|mesh-ancestor
83878477|NCT00195455|Hormones|hormones|mesh-ancestor
83878478|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83878479|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878480|NCT00126347|Folic Acid|folic acid|mesh-list
83878481|NCT00126347|Betaine|betaine|mesh-list
83878482|NCT00126347|Hematinics|hematinics|mesh-ancestor
83878483|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
83878484|NCT00126347|Vitamins|vitamins|mesh-ancestor
83878485|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
83878486|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878487|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83878488|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
83878489|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83878490|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
83878491|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878492|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83878493|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
83878494|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83878495|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878496|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
83878497|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83878498|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878499|NCT00225264|Pioglitazone|pioglitazone|mesh-list
83878500|NCT00225264|Glimepiride|glimepiride|mesh-list
83878501|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83878502|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878503|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83878504|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878505|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
83878506|NCT00126464|Tamoxifen|tamoxifen|mesh-list
83878507|NCT00126464|Fulvestrant|fulvestrant|mesh-list
83878508|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83878509|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
83878510|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83878511|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878512|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117581|NCT05827705|Sympathomimetics|sympathomimetics|mesh-ancestor
83878513|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878514|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83878515|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83878516|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83878517|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83878518|NCT00195533|Tazobactam|tazobactam|mesh-list
83878519|NCT00195533|Piperacillin|piperacillin|mesh-list
83878520|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83878521|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83878522|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878523|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83878524|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878525|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878526|NCT00207558|Folic Acid|folic acid|mesh-list
83878527|NCT00207558|Hematinics|hematinics|mesh-ancestor
83878528|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
83878529|NCT00207558|Vitamins|vitamins|mesh-ancestor
83878530|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
83878531|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878532|NCT00195572|Leucovorin|leucovorin|mesh-list
83878533|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
83878534|NCT00195572|Antidotes|antidotes|mesh-ancestor
83878535|NCT00195572|Protective Agents|protective agents|mesh-ancestor
83878536|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878537|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
83878538|NCT00195572|Vitamins|vitamins|mesh-ancestor
83878539|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
83878540|NCT00202280|Folic Acid|folic acid|mesh-list
83878541|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
83878542|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
83878543|NCT00202280|Vitamins|vitamins|mesh-ancestor
83878544|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
83878545|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878546|NCT00202280|Hematinics|hematinics|mesh-ancestor
83878547|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
83878548|NCT00225303|Etravirine|etravirine|mesh-list
83878549|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83878550|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83878551|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878552|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878553|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
83878554|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878555|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
83878556|NCT00225342|Gliclazide|gliclazide|mesh-list
83878557|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83878558|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878559|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83878560|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
83878561|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878562|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
83878563|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878564|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83878565|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878566|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878567|NCT00195689|Adalimumab|adalimumab|mesh-list
83878568|NCT00195689|Antibodies|antibodies|mesh-list
83878569|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83878570|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
83878571|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878572|NCT00195689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83878573|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878574|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878575|NCT00470275|Cytarabine|cytarabine|mesh-list
83878576|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878577|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
83878578|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878579|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878580|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
83878581|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878582|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878583|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
83878584|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878585|NCT00225381|Anesthetics|anesthetics|mesh-list
83878586|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878587|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878588|NCT00195728|Acetaminophen|acetaminophen|mesh-list
83878589|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83878590|NCT00195728|Hydrocodone|hydrocodone|mesh-list
83878591|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878592|NCT00195728|Analgesics|analgesics|mesh-ancestor
83878593|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
83878594|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878595|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878596|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
83878597|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83878598|NCT00195728|Narcotics|narcotics|mesh-ancestor
83878599|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878600|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
83878601|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
83878602|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83878603|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878604|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878605|NCT00470158|Iron|iron|mesh-list
83878606|NCT00470158|Zinc|zinc|mesh-list
83878607|NCT00470158|Trace Elements|trace elements|mesh-ancestor
83878608|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
83878609|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878610|NCT00472186|Lansoprazole|lansoprazole|mesh-list
83878611|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
83878612|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83878613|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83878614|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83878615|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878616|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878617|NCT00195767|Valproic Acid|valproic acid|mesh-list
83878618|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
83878619|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878620|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878621|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
83878622|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878623|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878624|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
83878625|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83878626|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878627|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83878628|NCT00207675|Infliximab|infliximab|mesh-list
83878629|NCT00207675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83878630|NCT00207675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878631|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
83878632|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83878633|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878634|NCT00202358|Atenolol|atenolol|mesh-list
83878635|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83878636|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83878637|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
83878638|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
83878639|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878640|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878641|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83878642|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83878643|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83878644|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
83878645|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878646|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878647|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83878648|NCT00479713|Simvastatin|simvastatin|mesh-list
83878649|NCT00479713|Ezetimibe|ezetimibe|mesh-list
83878650|NCT00479713|Calcium|calcium|mesh-list
83878651|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83878652|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878653|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83878654|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83878655|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
83878656|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878657|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83878658|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83878659|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878660|NCT00207753|Ivermectin|ivermectin|mesh-list
83878661|NCT00207753|Albendazole|albendazole|mesh-list
83878662|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83878663|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878664|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
83878665|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
83878666|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83878667|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83878668|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
83878669|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
83117742|NCT05702359|Vitamin D|vitamin d|mesh-list
83878670|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
83878671|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878672|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878673|NCT00202397|Riluzole|riluzole|mesh-list
83878674|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
83878675|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83878676|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83878677|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878678|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878679|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878680|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83878681|NCT00202397|Protective Agents|protective agents|mesh-ancestor
83878682|NCT00478972|Rimonabant|rimonabant|mesh-list
83878683|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83878684|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83878685|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83878686|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878687|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878688|NCT00478972|Hormones|hormones|mesh-ancestor
83878689|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83878690|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878691|NCT00207792|Lenograstim|lenograstim|mesh-list
83878692|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83878693|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
83878694|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878695|NCT00195806|Valproic Acid|valproic acid|mesh-list
83878696|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
83878697|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878698|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878699|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
83878700|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878701|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878702|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
83878703|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83878704|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878705|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83878706|NCT00477529|Docetaxel|docetaxel|mesh-list
83878707|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878708|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
83878709|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
83878710|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
83878711|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878712|NCT00472693|Bevacizumab|bevacizumab|mesh-list
83878713|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83878714|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83878715|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878716|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83878717|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83878718|NCT00472693|Growth Substances|growth substances|mesh-ancestor
83878719|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878720|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
83878721|NCT00195845|Galantamine|galantamine|mesh-list
83878722|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83878723|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878724|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878725|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
83878726|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878727|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878728|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83878729|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
83878730|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878731|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
83878732|NCT00202514|Valproic Acid|valproic acid|mesh-list
83878733|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
83878734|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878735|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878736|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
83878737|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878738|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878739|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
83878740|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83878741|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878742|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83117810|NCT05603754|Lorecivivint|lorecivivint|mesh-list
83878743|NCT00207831|Tegafur|tegafur|mesh-list
83878744|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878745|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
83878746|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878747|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878748|NCT00195923|Clindamycin|clindamycin|mesh-list
83878749|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
83878750|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
83878751|NCT00195923|Gentamicins|gentamicins|mesh-list
83878752|NCT00195923|Ceftazidime|ceftazidime|mesh-list
83878753|NCT00195923|Ampicillin|ampicillin|mesh-list
83878754|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83878755|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878756|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83878757|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878758|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878759|NCT00225615|Verapamil|verapamil|mesh-list
83878760|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83878761|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83878762|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83878763|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878764|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83878765|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878766|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
83878767|NCT00202553|Perindopril|perindopril|mesh-list
83878768|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83878769|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
83878770|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878771|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878772|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83878773|NCT00202592|Perindopril|perindopril|mesh-list
83878774|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83878775|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
83878776|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878777|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878778|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83878779|NCT00411333|Triamcinolone|triamcinolone|mesh-list
83878780|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83878781|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83878782|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83878783|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878784|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
83878785|NCT00411333|Hormones|hormones|mesh-ancestor
83878786|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83878787|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878788|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878789|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
83878790|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878791|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878792|NCT00225849|Aspirin|aspirin|mesh-list
83878793|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83878794|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878795|NCT00225849|Analgesics|analgesics|mesh-ancestor
83878796|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
83878797|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878798|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878799|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878800|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878801|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83878802|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83878803|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878804|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83878805|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83878806|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878807|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
83878808|NCT00202787|Leucovorin|leucovorin|mesh-list
83878809|NCT00202787|Cetuximab|cetuximab|mesh-list
83878810|NCT00202787|Fluorouracil|fluorouracil|mesh-list
83878811|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
83878812|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83878813|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878814|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
83878815|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878816|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83878817|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878818|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
83878819|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878820|NCT00202787|Antidotes|antidotes|mesh-ancestor
83878821|NCT00202787|Protective Agents|protective agents|mesh-ancestor
83878822|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
83878824|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
83878825|NCT00424437|Insulin|insulin|mesh-list
83878826|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83878827|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83878828|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878829|NCT00202865|Infliximab|infliximab|mesh-list
83878830|NCT00202865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83878831|NCT00202865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878832|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
83878833|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83878834|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878835|NCT00226005|Vatalanib|vatalanib|mesh-list
83878836|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83878837|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878838|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878839|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
83878840|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83878841|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
83878842|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83878843|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878844|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83878845|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83878846|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83878847|NCT00226044|Omeprazole|omeprazole|mesh-list
83878848|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83878849|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83878850|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83878851|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878852|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878853|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
83878854|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
83878855|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83878856|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
83878857|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878858|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878859|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878860|NCT00207948|Ritonavir|ritonavir|mesh-list
83878861|NCT00207948|Lopinavir|lopinavir|mesh-list
83878862|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83878863|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83878864|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
83878865|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878866|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878867|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83878868|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83878869|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
83878870|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878871|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83406713|NCT05899140|Clindamycin phosphate|clindamycin phosphate|mesh-list
83878872|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83878873|NCT00196391|Progesterone|progesterone|mesh-list
83878874|NCT00196391|Progestins|progestins|mesh-ancestor
83878875|NCT00196391|Hormones|hormones|mesh-ancestor
83878876|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83878877|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878878|NCT00203060|Rasagiline|rasagiline|mesh-list
83878879|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83878880|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878881|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878882|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83878883|NCT00203060|Protective Agents|protective agents|mesh-ancestor
83878884|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878885|NCT00226122|Indomethacin|indomethacin|mesh-list
83878886|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83878887|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878888|NCT00226122|Analgesics|analgesics|mesh-ancestor
83878889|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
83878890|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878891|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878892|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83878893|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878894|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
83878895|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
83878896|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83878897|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83878898|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878899|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878900|NCT00196469|Heparin|heparin|mesh-list
83878901|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
83878902|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83878903|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83878904|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878905|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
83878906|NCT00208065|Ephedrine|ephedrine|mesh-list
83878907|NCT00208065|Almotriptan|almotriptan|mesh-list
83878908|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83878909|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
83878910|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83878911|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878912|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83878913|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
83878914|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
83878915|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83878916|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83878917|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
83878918|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
83878919|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878920|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878921|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83878922|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
83878923|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
83878924|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
83878925|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83878926|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
83878927|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
83878928|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878929|NCT00203099|Expectorants|expectorants|mesh-ancestor
83878930|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
83878931|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83878932|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
83878933|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878934|NCT00203099|Protective Agents|protective agents|mesh-ancestor
83878935|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878936|NCT00203099|Antidotes|antidotes|mesh-ancestor
83878937|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83878938|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
83878939|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83878940|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83878941|NCT00226200|Omalizumab|omalizumab|mesh-list
83878942|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83878943|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83878944|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
83878945|NCT00203138|Rasagiline|rasagiline|mesh-list
83878946|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83878947|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878948|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878949|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83878950|NCT00203138|Protective Agents|protective agents|mesh-ancestor
83878951|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878952|NCT00196547|Montelukast|montelukast|mesh-list
83878953|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83878954|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
83878955|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83878956|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
83878957|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83878958|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878959|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83878960|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83878961|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878962|NCT00203177|Rasagiline|rasagiline|mesh-list
83878963|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83878964|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83878965|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118030|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
83878966|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83878967|NCT00203177|Protective Agents|protective agents|mesh-ancestor
83878968|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878969|NCT00208143|Risperidone|risperidone|mesh-list
83878970|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83878971|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83878972|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
83878973|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83878974|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878975|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878976|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83878977|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83878978|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83878979|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83878980|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83878981|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
83878982|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
83878983|NCT00196586|Interferons|interferons|mesh-list
83878984|NCT00196586|Ribavirin|ribavirin|mesh-list
83878985|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
83878986|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
83878987|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83878988|NCT00196586|Interleukin-2|interleukin-2|mesh-list
83878989|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83878990|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
83878991|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83878992|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
83878993|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83878994|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
83878995|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83878996|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83878997|NCT00196586|Analgesics|analgesics|mesh-ancestor
83878998|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
83878999|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879000|NCT00226317|Aripiprazole|aripiprazole|mesh-list
83879001|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
83879002|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879003|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83879004|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879005|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879006|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879007|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
83879008|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
83879009|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879010|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879011|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83879012|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83879013|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
83879014|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83879015|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83879016|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83879017|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83879018|NCT00226356|Betaine|betaine|mesh-list
83879019|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83879020|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
83879021|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83879022|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
83879023|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879024|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83879025|NCT00208182|Risperidone|risperidone|mesh-list
83879026|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83879027|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
83879028|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879029|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879030|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879031|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83879032|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879033|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879034|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879035|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83879036|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
83879037|NCT00226395|Oxymorphone|oxymorphone|mesh-list
83879038|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83879039|NCT00226395|Narcotics|narcotics|mesh-ancestor
83879040|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879041|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879042|NCT00226395|Analgesics|analgesics|mesh-ancestor
83879043|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
83879044|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879045|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83879046|NCT00208221|Telmisartan|telmisartan|mesh-list
83879047|NCT00208221|Ramipril|ramipril|mesh-list
83879048|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83879049|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83879050|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83879051|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879052|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83879053|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
83879054|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879055|NCT00196625|Ritonavir|ritonavir|mesh-list
83879056|NCT00196625|Amprenavir|amprenavir|mesh-list
83879057|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83879058|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83879059|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
83879060|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879061|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879062|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83879063|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83879064|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
83879065|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879066|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83879067|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83879068|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83879069|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
83879070|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83879071|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83879072|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
83879073|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879074|NCT00208260|Leucovorin|leucovorin|mesh-list
83879075|NCT00208260|Fluorouracil|fluorouracil|mesh-list
83879076|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
83879077|NCT00208260|Folfirinox|folfirinox|mesh-list
83879078|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
83879079|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879080|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83879081|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879082|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879083|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
83879084|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879085|NCT00208260|Antidotes|antidotes|mesh-ancestor
83879086|NCT00208260|Protective Agents|protective agents|mesh-ancestor
83879087|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
83879088|NCT00208260|Vitamins|vitamins|mesh-ancestor
83879089|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
83879090|NCT00226473|Dacarbazine|dacarbazine|mesh-list
83879091|NCT00226473|Vindesine|vindesine|mesh-list
83879092|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879093|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83879094|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
83879095|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879096|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83879097|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
83879098|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
83879099|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
83879100|NCT00208299|Adenosine|adenosine|mesh-list
83879101|NCT00208299|Regadenoson|regadenoson|mesh-list
83879102|NCT00208299|Analgesics|analgesics|mesh-ancestor
83879103|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
83879104|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879105|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879106|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83879107|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
83879108|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83879109|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
83879110|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
83879111|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879112|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879113|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83879114|NCT00196664|Paroxetine|paroxetine|mesh-list
83879115|NCT00196664|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83879116|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83118213|NCT05165225|Docetaxel|docetaxel|mesh-list
83879117|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879118|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879119|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879120|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
83879121|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879122|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83879123|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
83879124|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879125|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83879126|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83879127|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879128|NCT00196703|Memantine|memantine|mesh-list
83879129|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83879130|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83879131|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
83879132|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879133|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879134|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879135|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83879136|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83879137|NCT00413322|Fluorouracil|fluorouracil|mesh-list
83879138|NCT00413322|Belinostat|belinostat|mesh-list
83879139|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
83879140|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879141|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83879142|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879143|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879144|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
83879145|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879146|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83879147|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879148|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
83879149|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
83879150|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83879151|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83879152|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879153|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879154|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879155|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879156|NCT00410657|Prednisone|prednisone|mesh-list
83879157|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
83879158|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83879159|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83879160|NCT00410657|Prednisolone|prednisolone|mesh-list
83879161|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
83879162|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
83879163|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83879164|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
83879165|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879166|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
83879167|NCT00410657|Hormones|hormones|mesh-ancestor
83879168|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879169|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879170|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83879171|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879172|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
83879173|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
83879174|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879175|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83879176|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83879177|NCT00410657|Protective Agents|protective agents|mesh-ancestor
83879178|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83879179|NCT00196820|Capecitabine|capecitabine|mesh-list
83879180|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83879181|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
83879182|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879183|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879184|NCT00410696|Lenograstim|lenograstim|mesh-list
83879185|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83879186|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
83879187|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879188|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
83879189|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83879190|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879191|NCT00410735|Pranlukast|pranlukast|mesh-list
83118293|NCT05024344|Hormones|hormones|mesh-ancestor
83879192|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83879193|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83879194|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83879195|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
83879196|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879197|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879198|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
83879199|NCT00203372|Bevacizumab|bevacizumab|mesh-list
83879200|NCT00203372|Docetaxel|docetaxel|mesh-list
83879201|NCT00203372|Doxorubicin|doxorubicin|mesh-list
83879202|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879203|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
83879204|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879205|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879206|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83879207|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
83879208|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879209|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879210|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83879211|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83879212|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83879213|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83879214|NCT00203372|Growth Substances|growth substances|mesh-ancestor
83879215|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
83879216|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83879217|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83879218|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83879219|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83879220|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83879221|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83879222|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879223|NCT00226551|Isoproterenol|isoproterenol|mesh-list
83879224|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83879225|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83879226|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
83879227|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879228|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879229|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879230|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83879231|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
83879232|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879233|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83879234|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
83879235|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83879236|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
83879237|NCT00226551|Protective Agents|protective agents|mesh-ancestor
83879238|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
83879239|NCT00196859|Capecitabine|capecitabine|mesh-list
83879240|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83879241|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
83879242|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879243|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879244|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83879245|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879246|NCT00208533|Aripiprazole|aripiprazole|mesh-list
83879247|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
83879248|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879249|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83879250|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879251|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879252|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879253|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
83879254|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
83879255|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879256|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879257|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83879258|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83879259|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
83879260|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83879261|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83879262|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83879263|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83879264|NCT00203450|Zonisamide|zonisamide|mesh-list
83879265|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
83879266|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83879267|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879268|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879269|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83879270|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879271|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
83879272|NCT00226668|Hormones|hormones|mesh-ancestor
83879273|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879274|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879275|NCT00208572|Citalopram|citalopram|mesh-list
83879276|NCT00208572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83879277|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83879278|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879279|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879280|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879281|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
83879282|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879283|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83879284|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
83879285|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879286|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
83879287|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83879288|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83879289|NCT00226707|Analgesics|analgesics|mesh-ancestor
83879290|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
83879291|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879292|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879293|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879294|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879295|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83879296|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879297|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
83879298|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83879299|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879300|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879301|NCT00203528|Valproic Acid|valproic acid|mesh-list
83879302|NCT00203528|Risperidone|risperidone|mesh-list
83879303|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83879304|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
83879305|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879306|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879307|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879308|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83879309|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879310|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879311|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879312|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83879313|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
83879314|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
83879315|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879316|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
83879317|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
83879318|NCT00208611|Vitamins|vitamins|mesh-list
83879319|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
83879320|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
83879321|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
83879322|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
83879323|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879324|NCT00208611|Hematinics|hematinics|mesh-ancestor
83879325|NCT00203567|Carbamazepine|carbamazepine|mesh-list
83879326|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
83879327|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
83879328|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879329|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879330|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879331|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879332|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83879333|NCT00203567|Analgesics|analgesics|mesh-ancestor
83879334|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
83879335|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879336|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83879337|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879338|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118402|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
83879339|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83879340|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83879341|NCT00226746|Paclitaxel|paclitaxel|mesh-list
83879342|NCT00226746|Gemcitabine|gemcitabine|mesh-list
83879343|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83879344|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879345|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
83879346|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
83879347|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
83879348|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879349|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83879350|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
83879351|NCT00203606|Interferons|interferons|mesh-list
83879352|NCT00203606|Ribavirin|ribavirin|mesh-list
83879353|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
83879354|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
83879355|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83879356|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879357|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
83879358|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879359|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
83879360|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879361|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
83879362|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879363|NCT00203684|Flunisolide|flunisolide|mesh-list
83879364|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879365|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83879366|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
83879367|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
83879368|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83879369|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879370|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879371|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83879372|NCT00226785|Analgesics|analgesics|mesh-ancestor
83879373|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
83879374|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879375|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83879376|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83879377|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83879378|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83879379|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879380|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879381|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
83879382|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83879383|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879384|NCT00226824|Galantamine|galantamine|mesh-list
83879385|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83879386|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879387|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879388|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
83879389|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879390|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879391|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83879392|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
83879393|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879394|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
83879395|NCT00197249|Vaccines|vaccines|mesh-list
83879396|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
83118472|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83118473|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
83118474|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118475|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118476|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83118477|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118478|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118479|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
83118480|NCT04745832|Hormones|hormones|mesh-ancestor
83118481|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118482|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83118483|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83118484|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
83118485|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
83118486|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
83118504|NCT04724668|Melatonin|melatonin|mesh-list
83879397|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879398|NCT00203723|Risperidone|risperidone|mesh-list
83879399|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83879400|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
83879401|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879402|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879403|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879404|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83879405|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879406|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879407|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879408|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83879409|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
83879410|NCT00226902|Chrysarobin|chrysarobin|mesh-list
83879411|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83879412|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83879413|NCT00226902|Analgesics|analgesics|mesh-ancestor
83879414|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
83879415|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879416|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879417|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879418|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879419|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83879420|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
83879421|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879422|NCT00226980|Thalidomide|thalidomide|mesh-list
83879423|NCT00226980|Capecitabine|capecitabine|mesh-list
83879424|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83879425|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
83879426|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879427|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879428|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879429|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
83879430|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879431|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
83879432|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83879433|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879434|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83879435|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83879436|NCT00226980|Growth Substances|growth substances|mesh-ancestor
83879437|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
83879438|NCT00203801|Artesunate|artesunate|mesh-list
83879439|NCT00203801|Lumefantrine|lumefantrine|mesh-list
83879440|NCT00203801|Artemether|artemether|mesh-list
83879441|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
83879442|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
83879443|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83879444|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83879445|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
83879446|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83879447|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83879448|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879449|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879450|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
83879451|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
83879452|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83879453|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
83879454|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83879455|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879456|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879457|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83879458|NCT00197327|Bupivacaine|bupivacaine|mesh-list
83879459|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
83879460|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
83879461|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879462|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879463|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
83879464|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879465|NCT00227097|Anticoagulants|anticoagulants|mesh-list
83879466|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
83879467|NCT00208923|Busulfan|busulfan|mesh-list
83879468|NCT00208923|Fludarabine|fludarabine|mesh-list
83879469|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879470|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
83879471|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879472|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879473|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83879474|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
83879475|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879476|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879477|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83879478|NCT00227136|Serotonin|serotonin|mesh-list
83879479|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83879480|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
83879481|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879482|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879483|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879484|NCT00203957|Istradefylline|istradefylline|mesh-list
83879485|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83879486|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83879487|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83879488|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
83879489|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879490|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879491|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879492|NCT00197444|Nedaplatin|nedaplatin|mesh-list
83879493|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879494|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83879495|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83879496|NCT00204074|Estradiol|estradiol|mesh-list
83879497|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83879498|NCT00204074|Estrogens|estrogens|mesh-ancestor
83879499|NCT00204074|Hormones|hormones|mesh-ancestor
83879500|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879501|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879502|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83879503|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
83879504|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83879505|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83879506|NCT00227292|Escitalopram|escitalopram|mesh-list
83879507|NCT00227292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83879508|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83879509|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879510|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879511|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879512|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
83879513|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879514|NCT00197483|Pergolide|pergolide|mesh-list
83879515|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
83879516|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
83879517|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879518|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879519|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879520|NCT00230529|Infliximab|infliximab|mesh-list
83879521|NCT00230529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83879522|NCT00230529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879523|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
83879524|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83879525|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879526|NCT00230568|Donepezil|donepezil|mesh-list
83879527|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83879528|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879529|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879530|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
83879531|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879532|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879533|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
83879534|NCT00227331|Amoxicillin|amoxicillin|mesh-list
83879535|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83879536|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879537|NCT00197561|Selenium|selenium|mesh-list
83879538|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
83879539|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879540|NCT00197561|Protective Agents|protective agents|mesh-ancestor
83879541|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879542|NCT00197561|Trace Elements|trace elements|mesh-ancestor
83879543|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
83879544|NCT00227409|Edetic Acid|edetic acid|mesh-list
83879545|NCT00227409|Calcium|calcium|mesh-list
83879546|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
83879547|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83879548|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879549|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
83879550|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83879551|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
83879552|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
83879553|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879554|NCT00227409|Antidotes|antidotes|mesh-ancestor
83879555|NCT00227409|Protective Agents|protective agents|mesh-ancestor
83879556|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83879557|NCT00197639|Ritonavir|ritonavir|mesh-list
83879558|NCT00197639|Indinavir|indinavir|mesh-list
83879559|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83879560|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83879561|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83879562|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879563|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879564|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83879565|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83879566|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
83879567|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879568|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83879569|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83879570|NCT00227448|Phenylephrine|phenylephrine|mesh-list
83879571|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
83879572|NCT00227448|Midodrine|midodrine|mesh-list
83879573|NCT00227448|Norepinephrine|norepinephrine|mesh-list
83879574|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83879575|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
83879576|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
83879577|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879578|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879579|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
83879580|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83879581|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
83879582|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
83879583|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83879584|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83879585|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83879586|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
83879587|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879588|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879589|NCT00227448|Protective Agents|protective agents|mesh-ancestor
83879590|NCT00204191|Tacrolimus|tacrolimus|mesh-list
83879591|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879592|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
83879593|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879594|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83879595|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879596|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879597|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
83879598|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83879599|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879600|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83879601|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
83879602|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83879603|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879604|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879605|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879606|NCT00204269|Testosterone|testosterone|mesh-list
83879607|NCT00204269|Androgens|androgens|mesh-ancestor
83879608|NCT00204269|Hormones|hormones|mesh-ancestor
83879609|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879610|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879611|NCT00197756|Vitamins|vitamins|mesh-list
83879612|NCT00197756|Vitamin A|vitamin a|mesh-list
83879613|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
83879614|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
83879615|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879616|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
83879617|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879618|NCT00197756|Protective Agents|protective agents|mesh-ancestor
83879619|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83879620|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879621|NCT00227565|Carboplatin|carboplatin|mesh-list
83879622|NCT00227565|Pemetrexed|pemetrexed|mesh-list
83879623|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879624|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879625|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879626|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83879627|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83879628|NCT00204308|Tenofovir|tenofovir|mesh-list
83879629|NCT00204308|Emtricitabine|emtricitabine|mesh-list
83879630|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
83879631|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879632|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83879633|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83879634|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879635|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879636|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83879637|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83879638|NCT00204347|Risperidone|risperidone|mesh-list
83879639|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83879640|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
83879641|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879642|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879643|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879644|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83879645|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879646|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879647|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879648|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83879649|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
83879650|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
83879651|NCT00227682|Thalidomide|thalidomide|mesh-list
83879652|NCT00227682|Dexamethasone|dexamethasone|mesh-list
83879653|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
83879654|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879655|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
83879656|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
83879657|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879658|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879659|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83879660|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
83879661|NCT00227682|Hormones|hormones|mesh-ancestor
83879662|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879663|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83879664|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879665|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879666|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
83879667|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
83879668|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83879669|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879670|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83879671|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83879672|NCT00227682|Growth Substances|growth substances|mesh-ancestor
83879673|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
83879674|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
83879675|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879676|NCT00227682|Protective Agents|protective agents|mesh-ancestor
83879677|NCT00227682|Vitamins|vitamins|mesh-ancestor
83879678|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
83879679|NCT00230763|Timolol|timolol|mesh-list
83879680|NCT00230763|Latanoprost|latanoprost|mesh-list
83879681|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83879682|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83879683|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
83879684|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879685|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879686|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879687|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83879688|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83879689|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83879690|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83879691|NCT00204386|Topiramate|topiramate|mesh-list
83879692|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
83879693|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83879694|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879695|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
83879696|NCT04721964|Trace Elements|trace elements|mesh-ancestor
83879697|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
83879698|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879699|NCT00197834|Valproic Acid|valproic acid|mesh-list
83879700|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
83879701|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879702|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879703|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
83879704|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879705|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879706|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
83879707|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879708|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879709|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879710|NCT00197912|Celecoxib|celecoxib|mesh-list
83879711|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
83879712|NCT00197912|Interleukin-2|interleukin-2|mesh-list
83879713|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
83879714|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879715|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879716|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879717|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83879718|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
83879719|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879720|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879721|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83879722|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83879723|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83879724|NCT00197912|Analgesics|analgesics|mesh-ancestor
83879725|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
83879726|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879727|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879728|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83879729|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83879730|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879731|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83879732|NCT02962323|Calcium|calcium|mesh-list
83879733|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83879734|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879735|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83879736|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83879737|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
83879738|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879739|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83879740|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83879741|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879742|NCT00204503|Valproic Acid|valproic acid|mesh-list
83879743|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
83879744|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879745|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879746|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
83879747|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879748|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879749|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
83879750|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879751|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879752|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879753|NCT00204542|Diclofenac|diclofenac|mesh-list
83879754|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83879755|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83879756|NCT00204542|Analgesics|analgesics|mesh-ancestor
83879757|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
83879758|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879759|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879760|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879761|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879762|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83879763|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879764|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879765|NCT00230958|Interferons|interferons|mesh-list
83879766|NCT00230958|Ribavirin|ribavirin|mesh-list
83879767|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
83879768|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
83879769|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83879770|NCT00230958|Taribavirin|taribavirin|mesh-list
83879771|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879772|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
83879773|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879774|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
83879775|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879776|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
83879777|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879778|NCT00227955|Imipramine|imipramine|mesh-list
83879779|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83879780|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
83879781|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879782|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83879783|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83879784|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879785|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879786|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
83879787|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879788|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879789|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
83879790|NCT00228033|Calcium|calcium|mesh-list
83879791|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83879792|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879793|NCT00228033|Antacids|antacids|mesh-ancestor
83879794|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879795|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83879796|NCT00230997|Galantamine|galantamine|mesh-list
83879797|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83879798|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879799|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879800|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
83879801|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879802|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879803|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83879804|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
83879805|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879806|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
83879807|NCT00204581|Aldesleukin|aldesleukin|mesh-list
83879808|NCT00204581|Interleukin-2|interleukin-2|mesh-list
83879809|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879810|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83879811|NCT00204581|Analgesics|analgesics|mesh-ancestor
83879812|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
83879813|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879814|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879815|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83879816|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83879817|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
83879818|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879819|NCT00231075|Paclitaxel|paclitaxel|mesh-list
83879820|NCT00231075|Carboplatin|carboplatin|mesh-list
83879821|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83879822|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879823|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
83879824|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
83879825|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
83879826|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879827|NCT00198146|Daclizumab|daclizumab|mesh-list
83879828|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879829|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
83879830|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879831|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83879832|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83879833|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
83879834|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879835|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879836|NCT02962518|Triamcinolone|triamcinolone|mesh-list
83879837|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879838|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
83879839|NCT02962518|Hormones|hormones|mesh-ancestor
83879840|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879841|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879842|NCT00204659|Rituximab|rituximab|mesh-list
83879843|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83879844|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879845|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
83879846|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879847|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83879848|NCT00231192|Repaglinide|repaglinide|mesh-list
83879849|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83879850|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879851|NCT00204698|Rabeprazole|rabeprazole|mesh-list
83879852|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83879853|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83879854|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83879855|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879856|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879857|NCT00204737|Prednisone|prednisone|mesh-list
83879858|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83879859|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
83879860|NCT00204737|Hormones|hormones|mesh-ancestor
83879861|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83879862|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879863|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83879864|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879865|NCT00198380|Gefitinib|gefitinib|mesh-list
83879866|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879867|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83879868|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879869|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879870|NCT00228267|Propofol|propofol|mesh-list
83879871|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83879872|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879873|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879874|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83879875|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
83879876|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
83879877|NCT00231348|Nefazodone|nefazodone|mesh-list
83879878|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83879879|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83879880|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879881|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879882|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879883|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879884|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83879885|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
83879886|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879887|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83879888|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83879889|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
83879890|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
83879891|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83879892|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879893|NCT00198536|Ecabet|ecabet|mesh-list
83879894|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879895|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83879896|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83879897|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
83879898|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879899|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879900|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83879901|NCT00198536|Protective Agents|protective agents|mesh-ancestor
83879902|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879903|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879904|NCT00409994|Sirolimus|sirolimus|mesh-list
83879905|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83879906|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879907|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83879908|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879909|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
83879910|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83879911|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
83879912|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879913|NCT00410033|Insulin|insulin|mesh-list
83879914|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83879915|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
83879916|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
83879917|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
83879918|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
83879919|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83879920|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879921|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83879922|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
83879923|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83879924|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83879925|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83879926|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83879927|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879928|NCT00198614|Metoprolol|metoprolol|mesh-list
83879929|NCT00198614|Carvedilol|carvedilol|mesh-list
83879930|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83879931|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83879932|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
83879933|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
83879934|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83879935|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879936|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83879937|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83879938|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83879939|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83879940|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83879941|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879942|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
83879943|NCT00198614|Protective Agents|protective agents|mesh-ancestor
83879944|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83879945|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83879946|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83879947|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
83879948|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83879949|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83879950|NCT00231582|Paclitaxel|paclitaxel|mesh-list
83879951|NCT00231582|Etoposide|etoposide|mesh-list
83879952|NCT00231582|Carboplatin|carboplatin|mesh-list
83879953|NCT00231582|Epirubicin|epirubicin|mesh-list
83879954|NCT00231582|Ifosfamide|ifosfamide|mesh-list
83879955|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83879956|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83879957|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83879958|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83879959|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83879960|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879961|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83879962|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83879963|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83879964|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83879965|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83879966|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
83879967|NCT02963324|Ivermectin|ivermectin|mesh-list
83879968|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83879969|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83879970|NCT00228540|Modafinil|modafinil|mesh-list
83879971|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83879972|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879973|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83879974|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83879975|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83879976|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83879977|NCT00231621|Topiramate|topiramate|mesh-list
83879978|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
83879979|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83879980|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879981|NCT00474526|Vaccines|vaccines|mesh-list
83879982|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83879983|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
83879984|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879985|NCT00231660|Topiramate|topiramate|mesh-list
83879986|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
83879987|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83879988|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879989|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83879990|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83879991|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83879992|NCT00198848|Folic Acid|folic acid|mesh-list
83879993|NCT00198848|Hematinics|hematinics|mesh-ancestor
83879994|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
83879995|NCT00198848|Vitamins|vitamins|mesh-ancestor
83879996|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
83879997|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83879998|NCT00478426|Sunitinib|sunitinib|mesh-list
83119069|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
83879999|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880000|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83880001|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83880002|NCT00478426|Growth Substances|growth substances|mesh-ancestor
83880003|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880004|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
83880005|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83880006|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880007|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880008|NCT00231855|Docetaxel|docetaxel|mesh-list
83880009|NCT00231855|Topotecan|topotecan|mesh-list
83880010|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880011|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
83880012|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
83880013|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
83880014|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880015|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83880016|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83880017|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880018|NCT00199004|Cytarabine|cytarabine|mesh-list
83880019|NCT00199004|Dexamethasone|dexamethasone|mesh-list
83880020|NCT00199004|Prednisolone|prednisolone|mesh-list
83880021|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
83880022|NCT00199004|Rituximab|rituximab|mesh-list
83880023|NCT00199004|Methotrexate|methotrexate|mesh-list
83880024|NCT00199004|Vincristine|vincristine|mesh-list
83880025|NCT00199004|Doxorubicin|doxorubicin|mesh-list
83880026|NCT00199004|Daunorubicin|daunorubicin|mesh-list
83880027|NCT00199004|Asparaginase|asparaginase|mesh-list
83880028|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
83880029|NCT00199004|Thioguanine|thioguanine|mesh-list
83880030|NCT00199004|Vindesine|vindesine|mesh-list
83880031|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880032|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
83880033|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880034|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880035|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83880036|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
83880037|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880038|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880039|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83880040|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83880041|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880042|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
83880043|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
83880044|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880045|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880046|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
83880047|NCT00199004|Hormones|hormones|mesh-ancestor
83880048|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880049|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880050|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83880051|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
83880052|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83880053|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880054|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
83880055|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
83880056|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880057|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83880058|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83880059|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
83880060|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880061|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83880062|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83880063|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83880064|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83880065|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83880066|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83880067|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83880068|NCT00228852|Fludarabine|fludarabine|mesh-list
83880069|NCT00228852|Busulfan|busulfan|mesh-list
83880070|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880071|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880072|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119142|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
83880073|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
83880074|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880075|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
83880076|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83880077|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83880078|NCT00204776|Capecitabine|capecitabine|mesh-list
83880079|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
83880080|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880081|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
83880082|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880083|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880084|NCT00228891|Insulin|insulin|mesh-list
83880085|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83880086|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83880087|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880088|NCT00477412|Cytarabine|cytarabine|mesh-list
83880089|NCT00477412|Dexamethasone|dexamethasone|mesh-list
83880090|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
83880091|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
83880092|NCT00477412|Rituximab|rituximab|mesh-list
83880093|NCT00477412|Doxorubicin|doxorubicin|mesh-list
83880094|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83880095|NCT00477412|Methotrexate|methotrexate|mesh-list
83880096|NCT00477412|Vincristine|vincristine|mesh-list
83880097|NCT00477412|Bortezomib|bortezomib|mesh-list
83880098|NCT00477412|Daunorubicin|daunorubicin|mesh-list
83880099|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83880100|NCT00477412|Antibodies|antibodies|mesh-list
83880101|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
83880102|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83880103|NCT00477412|BB 1101|bb 1101|mesh-list
83880104|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880105|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
83880106|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880107|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880108|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83880109|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
83880110|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880111|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880112|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83880113|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880114|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
83880115|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
83880116|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880117|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880118|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
83880119|NCT00477412|Hormones|hormones|mesh-ancestor
83880120|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880121|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880122|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83880123|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83880124|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83880125|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880126|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83880127|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
83880128|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83880129|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880130|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
83880131|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
83880132|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83880133|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83880134|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
83880135|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880136|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83880137|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
83880138|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
83880139|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
83880140|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
83880141|NCT00410774|Bevacizumab|bevacizumab|mesh-list
83880142|NCT00410774|Gemcitabine|gemcitabine|mesh-list
83880143|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83880144|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880145|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83880146|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83880147|NCT00410774|Growth Substances|growth substances|mesh-ancestor
83880148|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880149|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
83880150|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880151|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
83880152|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119218|NCT03193853|Paclitaxel|paclitaxel|mesh-list
83880153|NCT00228930|Tamoxifen|tamoxifen|mesh-list
83880154|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83880155|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
83880156|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880157|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880158|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880159|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880160|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83880161|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83880162|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83880164|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83880165|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83880166|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880167|NCT01086982|Octreotide|octreotide|mesh-list
83880168|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880169|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880170|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880171|NCT00410930|Immunomodulating Agents|immunomodulating agents|mesh-list
83880172|NCT00410930|Immunologic Factors|immunologic factors|mesh-ancestor
83880173|NCT00410930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880174|NCT00204893|Calcium|calcium|mesh-list
83880175|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83880176|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880177|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
83880178|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83880179|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83880180|NCT00232011|Analgesics|analgesics|mesh-ancestor
83880181|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
83880182|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880183|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880184|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880185|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880186|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
83880187|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880188|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
83880189|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83880190|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880191|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880192|NCT00232050|Omalizumab|omalizumab|mesh-list
83880193|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83880194|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83880195|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
83880196|NCT00232089|Tegaserod|tegaserod|mesh-list
83880197|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83880198|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
83880199|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880200|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880201|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880202|NCT00205166|Caffeine|caffeine|mesh-list
83880203|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83880204|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880205|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83880206|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880207|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880208|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83880209|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83880210|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
83880211|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880212|NCT00229125|Gabapentin|gabapentin|mesh-list
83880213|NCT00229125|Lorazepam|lorazepam|mesh-list
83880214|NCT00229125|Analgesics|analgesics|mesh-ancestor
83880215|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
83880216|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880217|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880218|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
83880219|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83880220|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880221|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880222|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880223|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83880224|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83880225|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880226|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880227|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
83880228|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
83880229|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
83880230|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880231|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83880232|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
83880233|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
83880234|NCT00205283|Nelfinavir|nelfinavir|mesh-list
83880235|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83880236|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83880237|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
83880238|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880239|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880240|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83880241|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83880242|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
83880243|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880244|NCT00232167|Indiplon|indiplon|mesh-list
83880245|NCT00232167|Sertraline|sertraline|mesh-list
83880246|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880247|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880248|NCT00232167|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83880249|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880250|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880251|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880252|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880253|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
83880254|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880255|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83880256|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880257|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
83880258|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
83880259|NCT00205322|Leucovorin|leucovorin|mesh-list
83880260|NCT00205322|Capecitabine|capecitabine|mesh-list
83880261|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
83880262|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880263|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
83880264|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880265|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880266|NCT00205322|Antidotes|antidotes|mesh-ancestor
83880267|NCT00205322|Protective Agents|protective agents|mesh-ancestor
83880268|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880269|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
83880270|NCT00205322|Vitamins|vitamins|mesh-ancestor
83880271|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
83880272|NCT00232206|Docetaxel|docetaxel|mesh-list
83880273|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880274|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83880275|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83880276|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83880277|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880278|NCT00229242|Diuretics|diuretics|mesh-list
83880279|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
83880280|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880281|NCT00232284|Sertraline|sertraline|mesh-list
83880282|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880283|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880284|NCT00232284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83880285|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880286|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880287|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880288|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880289|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
83880290|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880291|NCT00205634|Clarithromycin|clarithromycin|mesh-list
83880292|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83880293|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880294|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83880295|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880296|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880297|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83880298|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83880299|NCT00232362|Pioglitazone|pioglitazone|mesh-list
83880300|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
83880301|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83119371|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
83880302|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880303|NCT00205751|Thalidomide|thalidomide|mesh-list
83880304|NCT00205751|Dexamethasone|dexamethasone|mesh-list
83880305|NCT00205751|Prednisone|prednisone|mesh-list
83880306|NCT00205751|Melphalan|melphalan|mesh-list
83880307|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880308|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
83880309|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
83880310|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880311|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880312|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880313|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
83880314|NCT00205751|Hormones|hormones|mesh-ancestor
83880315|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880316|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880317|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880318|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83880319|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
83880320|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880321|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83880322|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880323|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
83880324|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
83880325|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83880326|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880327|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83880328|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83880329|NCT00205751|Growth Substances|growth substances|mesh-ancestor
83880330|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
83880331|NCT00229476|Sertraline|sertraline|mesh-list
83880332|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880333|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880334|NCT00229476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83880335|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880336|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880337|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880338|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880339|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
83880340|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880341|NCT00205946|Bupropion|bupropion|mesh-list
83880342|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83880343|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880344|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880345|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83880346|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880347|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880348|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880349|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
83880350|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880351|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880352|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83880353|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83880354|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880355|NCT00229515|Sirolimus|sirolimus|mesh-list
83880356|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
83880357|NCT00229515|Temsirolimus|temsirolimus|mesh-list
83880358|NCT00229515|MTOR Inhibitors|mtor inhibitors|mesh-list
83880359|NCT00229515|Tirofiban|tirofiban|mesh-list
83880360|NCT00229515|Abciximab|abciximab|mesh-list
83880361|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83880362|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880363|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83880364|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880365|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
83880366|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880367|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
83880368|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880369|NCT00229515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83880370|NCT00229515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880371|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880372|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
83880373|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83880374|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83880375|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83880376|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83880377|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
83880378|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
83880379|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83880380|NCT00229515|Protective Agents|protective agents|mesh-ancestor
83880381|NCT00206024|Esomeprazole|esomeprazole|mesh-list
83880382|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83880383|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880384|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83880385|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880386|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880387|NCT00206063|Ximelagatran|ximelagatran|mesh-list
83880388|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
83880389|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83880390|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
83880391|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880392|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880393|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
83880394|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83880395|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880396|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880397|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83880398|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880399|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880400|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880401|NCT00229593|ST 1435|st 1435|mesh-list
83880402|NCT00229593|Testosterone|testosterone|mesh-list
83880403|NCT00229593|Androgens|androgens|mesh-ancestor
83880404|NCT00229593|Hormones|hormones|mesh-ancestor
83880405|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880406|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880407|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83880408|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
83880409|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83880410|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83880411|NCT00229632|Idebenone|idebenone|mesh-list
83880412|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
83880413|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880414|NCT00229632|Protective Agents|protective agents|mesh-ancestor
83880415|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880416|NCT00206180|Esomeprazole|esomeprazole|mesh-list
83880417|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83880418|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880419|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83880420|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880421|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880422|NCT00206219|Methotrexate|methotrexate|mesh-list
83880423|NCT00206219|Gefitinib|gefitinib|mesh-list
83880424|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83880425|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
83880426|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83880427|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880428|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880429|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
83880430|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880431|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880432|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83880433|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880434|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83880435|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880436|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
83880437|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880438|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83880439|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83880440|NCT00206258|Pramlintide|pramlintide|mesh-list
83880441|NCT00206258|Glucagon|glucagon|mesh-list
83880442|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880443|NCT00206258|Hormones|hormones|mesh-ancestor
83880444|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880445|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880446|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83880447|NCT00206297|Pramlintide|pramlintide|mesh-list
83880448|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83880449|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880450|NCT00411047|Gefitinib|gefitinib|mesh-list
83880451|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880452|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83880453|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880454|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880456|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
83880457|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83880458|NCT00411125|Katacalcin|katacalcin|mesh-list
83880459|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83880460|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880461|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83880462|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
83880463|NCT00411164|Hydromorphone|hydromorphone|mesh-list
83880464|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83880465|NCT00411164|Narcotics|narcotics|mesh-ancestor
83880466|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880467|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880468|NCT00411164|Analgesics|analgesics|mesh-ancestor
83880469|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
83880470|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880471|NCT00411203|Tamoxifen|tamoxifen|mesh-list
83880472|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83880473|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
83880474|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880475|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880476|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880477|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880478|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83880479|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83880480|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83880481|NCT00411281|Cytarabine|cytarabine|mesh-list
83880482|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880483|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
83880484|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880485|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880486|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
83880487|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880488|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880489|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
83880490|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880491|NCT00206414|Gefitinib|gefitinib|mesh-list
83880492|NCT00206414|Fulvestrant|fulvestrant|mesh-list
83880493|NCT00206414|Anastrozole|anastrozole|mesh-list
83880494|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880495|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83880496|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880497|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880498|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880499|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83880500|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83880501|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
83880502|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880503|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880504|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83880505|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83880506|NCT00232674|Budesonide|budesonide|mesh-list
83880507|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880508|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83880509|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
83880510|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880511|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880512|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83880513|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
83880514|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
83880515|NCT00232674|Hormones|hormones|mesh-ancestor
83880516|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880517|NCT00206453|Docetaxel|docetaxel|mesh-list
83880518|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880519|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
83880520|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
83880521|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
83880522|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880523|NCT00206492|Tamoxifen|tamoxifen|mesh-list
83880524|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83880525|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
83880526|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880527|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880528|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880529|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880530|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83880531|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83880532|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83880533|NCT00206570|Estradiol|estradiol|mesh-list
83880534|NCT00206570|Estrogens|estrogens|mesh-ancestor
83880535|NCT00206570|Hormones|hormones|mesh-ancestor
83880536|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880537|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880538|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
83880539|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83880540|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
83880541|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880542|NCT01056159|Albuterol|albuterol|mesh-list
83880543|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83880544|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
83880545|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880546|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880547|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83880548|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
83880549|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
83880550|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83880551|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83880552|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83880553|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83880554|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
83880555|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880556|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880557|NCT00206765|Risperidone|risperidone|mesh-list
83880558|NCT00206765|Paroxetine|paroxetine|mesh-list
83880559|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83880560|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
83880561|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880562|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880563|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880564|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83880565|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880566|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880567|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880568|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83880569|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
83880570|NCT00206765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83880571|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880572|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880573|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83880574|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880575|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83880576|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83880577|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880578|NCT00424710|Ranibizumab|ranibizumab|mesh-list
83880579|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83880580|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83880581|NCT00424710|Growth Substances|growth substances|mesh-ancestor
83880582|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880583|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
83880584|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880585|NCT00206960|Risperidone|risperidone|mesh-list
83880586|NCT00206960|Clopenthixol|clopenthixol|mesh-list
83880587|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83880588|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
83880589|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880590|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880591|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880592|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83880593|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880594|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880595|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880596|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83880597|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
83880598|NCT00206999|Imipramine|imipramine|mesh-list
83880599|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83880600|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880601|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880602|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83880603|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880604|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880605|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880606|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
83880607|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880608|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880609|NCT00229944|Azithromycin|azithromycin|mesh-list
83880610|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83880611|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880612|NCT00207077|Cetuximab|cetuximab|mesh-list
83880613|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83880614|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83880615|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880616|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83880617|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880618|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880619|NCT00207116|Cetuximab|cetuximab|mesh-list
83880620|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83880621|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880622|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
83880623|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83880624|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83880625|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880626|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83880627|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83880628|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
83880629|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880630|NCT00207155|Cetuximab|cetuximab|mesh-list
83880631|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83880632|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880633|NCT00232947|Vaccines|vaccines|mesh-list
83880634|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
83880635|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880636|NCT00413712|Adenosine|adenosine|mesh-list
83880637|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
83880638|NCT00413712|Calcium|calcium|mesh-list
83880639|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83880640|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880641|NCT00413712|Analgesics|analgesics|mesh-ancestor
83880642|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
83880643|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880644|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83880645|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
83880646|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83880647|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
83880648|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
83880649|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880650|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880651|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880652|NCT00230217|Rasburicase|rasburicase|mesh-list
83880653|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
83880654|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880655|NCT00207311|Interferons|interferons|mesh-list
83880656|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
83880657|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
83880658|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83880659|NCT00207311|Orlistat|orlistat|mesh-list
83880660|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880661|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
83880662|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880663|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
83880664|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880665|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880666|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880667|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83880668|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83880669|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83880670|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83880671|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880672|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880673|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880674|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880675|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880676|NCT00233025|Analgesics|analgesics|mesh-ancestor
83880677|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
83880678|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880679|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880680|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880681|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
83880682|NCT00207428|Carbamazepine|carbamazepine|mesh-list
83880683|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
83880684|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
83880685|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880686|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880687|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880688|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880689|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83880690|NCT00207428|Analgesics|analgesics|mesh-ancestor
83880691|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
83880692|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880693|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83880694|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880695|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880696|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83880697|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83880698|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
83880699|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880700|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83880701|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880702|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880703|NCT00207584|Doxycycline|doxycycline|mesh-list
83880704|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83880705|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880706|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
83880707|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83880708|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83880709|NCT00207662|Infliximab|infliximab|mesh-list
83880710|NCT00207662|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83880711|NCT00207662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880712|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83880713|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880714|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880715|NCT00207701|Infliximab|infliximab|mesh-list
83880716|NCT00207701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83880717|NCT00207701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880718|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83880719|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880720|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880721|NCT00207779|Heparin|heparin|mesh-list
83880722|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
83880723|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83880724|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83880725|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880726|NCT00230373|Imiquimod|imiquimod|mesh-list
83880727|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83880728|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
83880729|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880730|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880731|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
83880732|NCT00230451|Paclitaxel|paclitaxel|mesh-list
83880733|NCT00230451|Fluorouracil|fluorouracil|mesh-list
83880734|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83880735|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880736|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
83880737|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
83880738|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
83880739|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880740|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
83880741|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83880742|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880743|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
83880744|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880745|NCT00411320|Dexamethasone|dexamethasone|mesh-list
83880746|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880747|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
83880748|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
83880749|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119821|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880750|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880751|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83880752|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
83880753|NCT00411320|Hormones|hormones|mesh-ancestor
83880754|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880755|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880756|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880757|NCT00233337|Artemether|artemether|mesh-list
83880758|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83880759|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
83880760|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83880761|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83880762|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880763|NCT00230490|Adefovir|adefovir|mesh-list
83880764|NCT00230490|Pradefovir|pradefovir|mesh-list
83880765|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
83880766|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880767|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83880768|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83880769|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880770|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880771|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83880772|NCT01089556|Pregabalin|pregabalin|mesh-list
83880773|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83880774|NCT01089556|Analgesics|analgesics|mesh-ancestor
83880775|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
83880776|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880777|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880778|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
83880779|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83880780|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880781|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880782|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83880783|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83880784|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880785|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880786|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880787|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83880788|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880789|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880790|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880791|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
83880792|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83880793|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83880794|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880795|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
83880796|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
83880797|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83880798|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880799|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83880800|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83880801|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
83880802|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880803|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880804|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83880805|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
83880806|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83880807|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83880808|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83880809|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
83880810|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880811|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880812|NCT00424580|Montelukast|montelukast|mesh-list
83880813|NCT00424580|Desloratadine|desloratadine|mesh-list
83880814|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83880815|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
83880816|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83880817|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
83880818|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880819|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880820|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83880821|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83119904|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
83880822|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880824|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
83880825|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880826|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83880827|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83880828|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
83880829|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
83880830|NCT00233532|Verapamil|verapamil|mesh-list
83880831|NCT00233532|Trandolapril|trandolapril|mesh-list
83880832|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83880833|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83880834|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880835|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880836|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83880837|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880838|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
83880839|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83880840|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
83880841|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880842|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83880843|NCT00233571|Adalimumab|adalimumab|mesh-list
83880844|NCT00233571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83880845|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83880846|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83880847|NCT00237198|Letrozole|letrozole|mesh-list
83880848|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880849|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83880850|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83880851|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880852|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880853|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83880854|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
83880855|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880856|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880857|NCT00233610|Tamoxifen|tamoxifen|mesh-list
83880858|NCT00233610|Bicalutamide|bicalutamide|mesh-list
83880859|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83880860|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
83880861|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83880862|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880863|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83880864|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880865|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83880866|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83880867|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83880868|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
83880869|NCT00208130|Topiramate|topiramate|mesh-list
83880870|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
83880871|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83880872|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880873|NCT00237237|Vildagliptin|vildagliptin|mesh-list
83880874|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83880875|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880876|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83880877|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
83880878|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880879|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880880|NCT00208169|Aripiprazole|aripiprazole|mesh-list
83880881|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880882|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880883|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83880884|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880885|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880886|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880887|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
83880888|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
83880889|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880890|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880891|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83880892|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83880893|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
83880894|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83880895|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83880896|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83880897|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83880898|NCT01087723|Heparin|heparin|mesh-list
83880899|NCT01087723|Bivalirudin|bivalirudin|mesh-list
83880900|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
83880901|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83880902|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83880903|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880904|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
83880905|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83880906|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
83880907|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83880908|NCT00208208|Ziprasidone|ziprasidone|mesh-list
83880909|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83880910|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
83880911|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880912|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880913|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880914|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83880915|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880916|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880917|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880918|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83880919|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
83880920|NCT01085812|Milnacipran|milnacipran|mesh-list
83880921|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
83880922|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83880923|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83880924|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880925|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880926|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880927|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880928|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880929|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880930|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83880931|NCT01085812|Analgesics|analgesics|mesh-ancestor
83880932|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
83880933|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880934|NCT01085734|Bevacizumab|bevacizumab|mesh-list
83880935|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83880936|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880937|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83880938|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83880939|NCT01085734|Growth Substances|growth substances|mesh-ancestor
83880940|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880941|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
83880942|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83880943|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
83880944|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83880945|NCT00208403|Protective Agents|protective agents|mesh-ancestor
83880946|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880947|NCT01084603|Nicotine|nicotine|mesh-list
83880948|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83880949|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
83880950|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880951|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880952|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83880953|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83880954|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
83880955|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83880956|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880957|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
83880958|NCT00208442|Diuretics|diuretics|mesh-ancestor
83880959|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
83880960|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880961|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83880962|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880963|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880964|NCT00233766|Sirolimus|sirolimus|mesh-list
83880965|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83880966|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83880967|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83880968|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83880970|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83880971|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
83880972|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880973|NCT00208520|Lamotrigine|lamotrigine|mesh-list
83880974|NCT00208520|Carbamazepine|carbamazepine|mesh-list
83880975|NCT00208520|Levetiracetam|levetiracetam|mesh-list
83880976|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
83880977|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
83880978|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83880979|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83880980|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83880981|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83880982|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83880983|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83880984|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83880985|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83880986|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880987|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83880988|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
83880989|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83880990|NCT00208520|Analgesics|analgesics|mesh-ancestor
83880991|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
83880992|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83880993|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83880994|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83880995|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83880996|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
83880997|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83880998|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83880999|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881000|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881001|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881002|NCT00208559|Ziprasidone|ziprasidone|mesh-list
83881003|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83881004|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
83881005|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881006|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881007|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881008|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83881009|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881010|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881011|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881012|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881013|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
83881014|NCT00233805|Sirolimus|sirolimus|mesh-list
83881015|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83881016|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881017|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83881018|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881019|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
83881020|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881021|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
83881022|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881023|NCT01084135|Rivastigmine|rivastigmine|mesh-list
83881024|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83881025|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881026|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881027|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
83881028|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881029|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881030|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83881031|NCT01084135|Protective Agents|protective agents|mesh-ancestor
83881032|NCT01083316|Dexamethasone|dexamethasone|mesh-list
83881033|NCT01083316|Bortezomib|bortezomib|mesh-list
83881034|NCT01083316|Melphalan|melphalan|mesh-list
83881035|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83881036|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
83881037|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
83881038|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881039|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881040|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881041|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
83881042|NCT01083316|Hormones|hormones|mesh-ancestor
83120123|NCT03584893|Provitamins|provitamins|mesh-ancestor
83881043|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881044|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83881046|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83881047|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
83881048|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881049|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83881050|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881051|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
83881052|NCT00208715|Modafinil|modafinil|mesh-list
83881053|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83881054|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881055|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83881056|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83881057|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83881058|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881059|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
83881060|NCT00208793|Vitamin D|vitamin d|mesh-list
83881061|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
83881062|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
83881063|NCT00208793|Vitamins|vitamins|mesh-list
83881064|NCT00208793|Calcium|calcium|mesh-list
83881065|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
83881066|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881067|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83881068|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83881069|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
83881070|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83881071|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83881072|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881073|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83881074|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83881075|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
83881076|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881077|NCT01081873|Leuprolide|leuprolide|mesh-list
83881078|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83881079|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
83881080|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83881081|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881082|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83881083|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881084|NCT00237471|Insulin|insulin|mesh-list
83881085|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881086|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881087|NCT00237510|Terazosin|terazosin|mesh-list
83881088|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83881089|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83881090|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83881091|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83881092|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881093|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881094|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881095|NCT00237510|Urological Agents|urological agents|mesh-ancestor
83881096|NCT01081795|Topiramate|topiramate|mesh-list
83881097|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
83881098|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881099|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881100|NCT00233961|Lenograstim|lenograstim|mesh-list
83881101|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83881102|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
83881103|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881104|NCT00234000|Azacitidine|azacitidine|mesh-list
83881105|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
83881106|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83881107|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
83881108|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881109|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881110|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881111|NCT00234117|Rabeprazole|rabeprazole|mesh-list
83881112|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83881113|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881114|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83881115|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120208|NCT02518503|Atorvastatin|atorvastatin|mesh-list
83881116|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881117|NCT00209144|Insulin|insulin|mesh-list
83881118|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881119|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881120|NCT00209222|Cytarabine|cytarabine|mesh-list
83881121|NCT00209222|Dexamethasone|dexamethasone|mesh-list
83881122|NCT00209222|Prednisone|prednisone|mesh-list
83881123|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
83881124|NCT00209222|Melphalan|melphalan|mesh-list
83881125|NCT00209222|Rituximab|rituximab|mesh-list
83881126|NCT00209222|Doxorubicin|doxorubicin|mesh-list
83881127|NCT00209222|Etoposide|etoposide|mesh-list
83881128|NCT00209222|Vincristine|vincristine|mesh-list
83881129|NCT00209222|Cisplatin|cisplatin|mesh-list
83881130|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881131|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
83881132|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881133|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881134|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83881135|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
83881136|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881137|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881138|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83881139|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83881140|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83881141|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
83881142|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
83881143|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881144|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881145|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
83881146|NCT00209222|Hormones|hormones|mesh-ancestor
83881147|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881148|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83881149|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83881150|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83881151|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881152|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881153|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83881154|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
83881155|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
83881156|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
83881157|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83881158|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
83881159|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
83881160|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881161|NCT00234195|Bupropion|bupropion|mesh-list
83881162|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83881163|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
83881164|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881165|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83881166|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83881167|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881168|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881169|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
83881170|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881171|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881172|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83881173|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83881174|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881175|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83881176|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
83881177|NCT00209261|Coagulants|coagulants|mesh-ancestor
83881178|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83881179|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
83881180|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881181|NCT00209300|Mesalamine|mesalamine|mesh-list
83881182|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83881183|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83881184|NCT00209300|Analgesics|analgesics|mesh-ancestor
83881185|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
83881186|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881187|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881188|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83881189|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881190|NCT00234234|Adalimumab|adalimumab|mesh-list
83881191|NCT00234234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83881192|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83881193|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881194|NCT00237588|Losartan|losartan|mesh-list
83881195|NCT00237588|Amlodipine|amlodipine|mesh-list
83881196|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83881197|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83881198|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881199|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881200|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83881201|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881202|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
83881203|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83881204|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83881205|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83881206|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83881207|NCT00411437|Oxybutynin|oxybutynin|mesh-list
83881208|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83881209|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83881210|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
83881211|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881212|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881213|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881214|NCT00411437|Urological Agents|urological agents|mesh-ancestor
83881215|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
83881216|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
83881217|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881218|NCT00234312|Sertraline|sertraline|mesh-list
83881219|NCT00234312|Escitalopram|escitalopram|mesh-list
83881220|NCT00234312|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83881221|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83881222|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881223|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881224|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881225|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
83881226|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881227|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
83881228|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881229|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
83881230|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83881231|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881232|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83881233|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
83881234|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83881235|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881236|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881237|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881238|NCT00237627|Doxorubicin|doxorubicin|mesh-list
83881239|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83881240|NCT00237627|Bortezomib|bortezomib|mesh-list
83881241|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83881242|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881243|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83881244|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881245|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881246|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881247|NCT00209495|Dexamethasone|dexamethasone|mesh-list
83881248|NCT00209495|Pregabalin|pregabalin|mesh-list
83881249|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83881250|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
83881251|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
83881252|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881253|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881254|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881255|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
83881256|NCT00209495|Hormones|hormones|mesh-ancestor
83881257|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881258|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83881259|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881260|NCT00209495|Analgesics|analgesics|mesh-ancestor
83881261|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
83881262|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
83881263|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83881264|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881265|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881266|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83881267|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83881268|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881269|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881270|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881271|NCT00234390|Budesonide|budesonide|mesh-list
83881272|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83881273|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83881274|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
83881275|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881276|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881277|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83881278|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
83881279|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
83881280|NCT00234390|Hormones|hormones|mesh-ancestor
83881281|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881282|NCT00209534|Fospropofol|fospropofol|mesh-list
83881283|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83881284|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881285|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881286|NCT00209573|Fospropofol|fospropofol|mesh-list
83881287|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83881288|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881289|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881290|NCT00209612|Paclitaxel|paclitaxel|mesh-list
83881291|NCT00209612|Irinotecan|irinotecan|mesh-list
83881292|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83881293|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881294|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83881295|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83881296|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83881297|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881298|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83881299|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881300|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881301|NCT01081249|Oxytocin|oxytocin|mesh-list
83881302|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
83881303|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83881304|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881305|NCT00234429|Gefitinib|gefitinib|mesh-list
83881306|NCT00234429|Raltitrexed|raltitrexed|mesh-list
83881307|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881308|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83881309|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881310|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881311|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83881312|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
83881313|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83881314|NCT00209651|Irinotecan|irinotecan|mesh-list
83881315|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83881316|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881317|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881318|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881319|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881320|NCT02961855|Diclofenac|diclofenac|mesh-list
83881321|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83881322|NCT02961855|Lidocaine|lidocaine|mesh-list
83881323|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
83881324|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
83881325|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881326|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881327|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
83881328|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881329|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83881330|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83881331|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83881332|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881333|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881334|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83881335|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83881336|NCT02961855|Analgesics|analgesics|mesh-ancestor
83881337|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881338|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83881339|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881340|NCT00209690|Cisplatin|cisplatin|mesh-list
83881341|NCT00209690|Docetaxel|docetaxel|mesh-list
83881342|NCT00209690|Fluorouracil|fluorouracil|mesh-list
83881343|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881344|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83881345|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83881346|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83881347|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881348|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
83881349|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83881350|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881351|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
83881352|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881353|NCT01081132|Guanfacine|guanfacine|mesh-list
83881354|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83881355|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83881356|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83881357|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83881358|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
83881359|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881360|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881361|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881362|NCT00234468|Gefitinib|gefitinib|mesh-list
83881363|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881364|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83881365|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881366|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881367|NCT01080625|Phenylephrine|phenylephrine|mesh-list
83881368|NCT01080625|Epinephrine|epinephrine|mesh-list
83881369|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
83881370|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83881371|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83881372|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
83881373|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881374|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881375|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881376|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83881377|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83881378|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
83881379|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881380|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83881381|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
83881382|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
83881383|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
83881384|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83881385|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83881386|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
83881387|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83881388|NCT01080625|Protective Agents|protective agents|mesh-ancestor
83881389|NCT00209729|Docetaxel|docetaxel|mesh-list
83881390|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881391|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
83881392|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
83881393|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
83881394|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881395|NCT00414180|Bupropion|bupropion|mesh-list
83881396|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83881397|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
83881398|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881399|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83881400|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83881401|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881402|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881403|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
83881404|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881405|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881406|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83881407|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83881408|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881409|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83881410|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881411|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881412|NCT01089790|Incretins|incretins|mesh-ancestor
83881413|NCT01089790|Hormones|hormones|mesh-ancestor
83881414|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881415|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83881416|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
83881417|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881418|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881419|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
83881420|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83881421|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83881422|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83881423|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881424|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881425|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
83881426|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881427|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881428|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83881429|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881430|NCT01084330|Docetaxel|docetaxel|mesh-list
83881431|NCT01084330|Irinotecan|irinotecan|mesh-list
83881432|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881433|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
83881434|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
83881435|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
83881436|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881437|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83881438|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881439|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881440|NCT00209807|Reboxetine|reboxetine|mesh-list
83881441|NCT00209807|Escitalopram|escitalopram|mesh-list
83881442|NCT00209807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83881443|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83881444|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881445|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881446|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881447|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
83881448|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881449|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
83881450|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881451|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83881452|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
83881453|NCT00209846|Gaboxadol|gaboxadol|mesh-list
83881454|NCT00209846|Analgesics|analgesics|mesh-ancestor
83881455|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
83881456|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881457|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881458|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
83881459|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
83881460|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
83881461|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881462|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881463|NCT01082068|Letrozole|letrozole|mesh-list
83881464|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881465|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83881466|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83881467|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881468|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881469|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83881470|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
83881471|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881472|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881473|NCT01086748|Risperidone|risperidone|mesh-list
83881474|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83881475|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
83881476|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881477|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881478|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881479|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83881480|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881481|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881482|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881483|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881484|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
83881485|NCT00237705|Metoclopramide|metoclopramide|mesh-list
83881486|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
83881487|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
83881488|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881489|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881490|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881491|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83881492|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881493|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
83881494|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881495|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881496|NCT00209885|Lidocaine|lidocaine|mesh-list
83881497|NCT00209885|Droperidol|droperidol|mesh-list
83881498|NCT00209885|Ketamine|ketamine|mesh-list
83881499|NCT00209885|Gabapentin|gabapentin|mesh-list
83881500|NCT00209885|Esketamine|esketamine|mesh-list
83881501|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
83881502|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
83881503|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881504|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881505|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
83881506|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881507|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83881508|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83881509|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83881510|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881511|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881512|NCT00209885|Analgesics|analgesics|mesh-ancestor
83881513|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83881514|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83881515|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
83881516|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83881517|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83881518|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881519|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
83881520|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83881521|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881522|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881523|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
83881524|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
83881525|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83881526|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
83881527|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
83881528|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881529|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83881530|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83881531|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881532|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
83881533|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
83881534|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83881535|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83881536|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83881537|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881538|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881539|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
83881540|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881541|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881542|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83881543|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881544|NCT00209924|Gaboxadol|gaboxadol|mesh-list
83881545|NCT00209924|Analgesics|analgesics|mesh-ancestor
83881546|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
83881547|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881548|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881549|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
83881550|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
83881551|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
83881552|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881553|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881554|NCT00209963|Gaboxadol|gaboxadol|mesh-list
83881555|NCT00209963|Analgesics|analgesics|mesh-ancestor
83881556|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
83881557|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881558|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881559|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
83881560|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
83881561|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
83881562|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881563|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881564|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
83881565|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83881566|NCT00210002|Hematinics|hematinics|mesh-ancestor
83881567|NCT02277886|Esomeprazole|esomeprazole|mesh-list
83881568|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83881569|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881570|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83881571|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881572|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881573|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83881574|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83881575|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83881576|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83881577|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83881578|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83881579|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83881580|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
83881581|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881582|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881583|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881584|NCT00210041|Gemcitabine|gemcitabine|mesh-list
83881585|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881586|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83881587|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
83881588|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881589|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
83881590|NCT04990804|Analgesics|analgesics|mesh-list
83881591|NCT04990804|Narcotics|narcotics|mesh-ancestor
83881592|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881593|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881594|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
83881595|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881596|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
83881597|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83881598|NCT04991662|Phenylephrine|phenylephrine|mesh-list
83881599|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
83881600|NCT04991662|Norepinephrine|norepinephrine|mesh-list
83881601|NCT04991662|Metaraminol|metaraminol|mesh-list
83881602|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83881603|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
83881604|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
83881605|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881606|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881607|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
83881608|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83881609|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
83881610|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
83881611|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83881612|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83881613|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83881614|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83881615|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881616|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881617|NCT04991662|Protective Agents|protective agents|mesh-ancestor
83881618|NCT04997941|Tamoxifen|tamoxifen|mesh-list
83881619|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83881620|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
83881621|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881622|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881623|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83881624|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881625|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83881626|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83881627|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83881628|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
83881629|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83881630|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
83881631|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
83881632|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881633|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881634|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83881635|NCT00210158|Analgesics|analgesics|mesh-ancestor
83881636|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
83881637|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881638|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83881639|NCT00413790|Darifenacin|darifenacin|mesh-list
83881640|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83881641|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83881642|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
83881643|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881644|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881645|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881646|NCT00413790|Urological Agents|urological agents|mesh-ancestor
83881647|NCT01059903|Rotigotine|rotigotine|mesh-list
83881648|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
83881649|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
83881650|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881651|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881652|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881653|NCT04996771|Cisplatin|cisplatin|mesh-list
83881654|NCT04996771|Etoposide|etoposide|mesh-list
83881655|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
83881656|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881657|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83881658|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83881659|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881660|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881661|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881662|NCT00210314|Cytarabine|cytarabine|mesh-list
83881663|NCT00210314|Methotrexate|methotrexate|mesh-list
83881664|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83881665|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
83881666|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83881667|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881668|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83881669|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
83881670|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881671|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881672|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
83881673|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881674|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83881675|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881676|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
83881677|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881678|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83881679|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
83881680|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881681|NCT00210392|Bortezomib|bortezomib|mesh-list
83881682|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881683|NCT00413829|Ranibizumab|ranibizumab|mesh-list
83881684|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83881685|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83881686|NCT00413829|Growth Substances|growth substances|mesh-ancestor
83881687|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881688|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
83881689|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881690|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
83881691|NCT02210104|Ipilimumab|ipilimumab|mesh-list
83881692|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881693|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
83881694|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881695|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881696|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83881697|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
83881698|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881699|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881700|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83881701|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83881702|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83881703|NCT02210182|Pentamidine|pentamidine|mesh-list
83881704|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
83881705|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881706|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83881707|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83881708|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83881709|NCT00210509|Almotriptan|almotriptan|mesh-list
83881710|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83881711|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
83881712|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881713|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881714|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881715|NCT02210260|Heroin|heroin|mesh-list
83881716|NCT02210260|Bupivacaine|bupivacaine|mesh-list
83881717|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
83881718|NCT02210260|Anesthetics|anesthetics|mesh-list
83881719|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881720|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881721|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
83881722|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881723|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83881724|NCT02210260|Narcotics|narcotics|mesh-ancestor
83881725|NCT02210260|Analgesics|analgesics|mesh-ancestor
83881726|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83881727|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83881728|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881729|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881730|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881731|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881732|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83881733|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83881734|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
83881735|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881736|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881737|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83881738|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881739|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
83881740|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
83881741|NCT00210587|Hematinics|hematinics|mesh-ancestor
83881742|NCT00210665|Trabectedin|trabectedin|mesh-list
83881743|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83881744|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
83881745|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881746|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881747|NCT04570345|Aspirin|aspirin|mesh-list
83881748|NCT04570345|Ticagrelor|ticagrelor|mesh-list
83881749|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83881750|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83881751|NCT04570345|Analgesics|analgesics|mesh-ancestor
83881752|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
83881753|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881754|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881755|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83881756|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881757|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83881758|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83881759|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881760|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83881761|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83881762|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881763|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
83881764|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83881765|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83881766|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83881767|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
83881768|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881769|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
83881770|NCT00234819|Estrogens|estrogens|mesh-list
83881771|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83881772|NCT00234819|Hormones|hormones|mesh-ancestor
83881773|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83881774|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881775|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83881776|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83881777|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
83881778|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83881779|NCT04570306|Belimumab|belimumab|mesh-list
83881780|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881781|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
83881782|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881783|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
83881784|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83881785|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881786|NCT00234858|Losartan|losartan|mesh-list
83881787|NCT00234858|Verapamil|verapamil|mesh-list
83881788|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83120881|NCT04504851|Isoniazid|isoniazid|mesh-list
83881789|NCT00234858|Trandolapril|trandolapril|mesh-list
83881790|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83881791|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83881792|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83881793|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83881794|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881795|NCT00234858|Diuretics|diuretics|mesh-ancestor
83881796|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
83881797|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881798|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83881799|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881800|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83881801|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83881802|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
83881803|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83881804|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
83881805|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881806|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83881807|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83881808|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
83881809|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881810|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881811|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
83881812|NCT00210743|Hematinics|hematinics|mesh-ancestor
83881813|NCT04569916|Irinotecan|irinotecan|mesh-list
83881814|NCT04569916|Apatinib|apatinib|mesh-list
83881815|NCT04569916|Antibodies|antibodies|mesh-list
83881816|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
83881817|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881818|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83881819|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881820|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881821|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881822|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881823|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83881824|NCT00210782|Topiramate|topiramate|mesh-list
83881825|NCT00210782|Phenytoin|phenytoin|mesh-list
83881826|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
83881827|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881828|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881829|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83881830|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83881831|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881832|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881833|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83881834|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83881835|NCT00237861|Olanzapine|olanzapine|mesh-list
83881836|NCT00237861|Risperidone|risperidone|mesh-list
83881837|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83881838|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83881839|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
83881840|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881841|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881842|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881843|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83881844|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881845|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881846|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881847|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881848|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
83881849|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
83881850|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
83881851|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881852|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881853|NCT00237861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83881854|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83881855|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83881856|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
83881857|NCT00237900|Leucovorin|leucovorin|mesh-list
83881858|NCT00237900|Fluorouracil|fluorouracil|mesh-list
83881859|NCT00237900|Gefitinib|gefitinib|mesh-list
83881860|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
83881861|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881862|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83881863|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881864|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881866|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881867|NCT00237900|Antidotes|antidotes|mesh-ancestor
83881868|NCT00237900|Protective Agents|protective agents|mesh-ancestor
83881869|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
83881870|NCT00237900|Vitamins|vitamins|mesh-ancestor
83881871|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
83881872|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83881873|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881874|NCT00210821|Topiramate|topiramate|mesh-list
83881875|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
83881876|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881877|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881878|NCT00237939|Aripiprazole|aripiprazole|mesh-list
83881879|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
83881880|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83881881|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83881882|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83881883|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881884|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881885|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
83881886|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
83881887|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881888|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881889|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83881890|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83881891|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
83881892|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83881893|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83881894|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83881895|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881896|NCT04569214|PAZ320|paz320|mesh-list
83881897|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881898|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881899|NCT00210860|Topiramate|topiramate|mesh-list
83881900|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
83881901|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83881902|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881903|NCT00210899|Vancomycin|vancomycin|mesh-list
83881904|NCT00210899|Ceftazidime|ceftazidime|mesh-list
83881905|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
83881906|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83881907|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83881908|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881909|NCT04568863|Melatonin|melatonin|mesh-list
83881910|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
83881911|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881912|NCT04568863|Protective Agents|protective agents|mesh-ancestor
83881913|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881914|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83881915|NCT00210938|Doripenem|doripenem|mesh-list
83881916|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83881917|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881918|NCT02278081|Lansoprazole|lansoprazole|mesh-list
83881919|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
83881920|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83881921|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881922|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83881923|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881924|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881925|NCT00211016|Doripenem|doripenem|mesh-list
83881926|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83881927|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881928|NCT00238017|Artesunate|artesunate|mesh-list
83881929|NCT00238017|Amodiaquine|amodiaquine|mesh-list
83881930|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
83881931|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83881932|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83881933|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881934|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881935|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
83881936|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
83881937|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83881938|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
83881939|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
83881940|NCT00238056|Domperidone|domperidone|mesh-list
83881941|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
83881942|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
83881943|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881944|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881945|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83881946|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83881947|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
83881948|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881949|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881950|NCT04566952|Olaparib|olaparib|mesh-list
83881951|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83881952|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881953|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881954|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881955|NCT04567069|Vaccines|vaccines|mesh-list
83881956|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
83881957|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881958|NCT04566796|Neostigmine|neostigmine|mesh-list
83881959|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83881960|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881961|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881962|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
83881963|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83881964|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881965|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83881966|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
83881967|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83881968|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
83881969|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
83881970|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
83881971|NCT00238173|Carboplatin|carboplatin|mesh-list
83881972|NCT00238173|Etoposide|etoposide|mesh-list
83881973|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
83881974|NCT00238173|Mannitol|mannitol|mesh-list
83881975|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83881976|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83881977|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
83881978|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83881979|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83881980|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83881981|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
83881982|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83881983|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83881984|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83881985|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83881986|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83881987|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83881988|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83881989|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
83881990|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83881991|NCT00238173|Expectorants|expectorants|mesh-ancestor
83881992|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
83881993|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83881994|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
83881995|NCT00238173|Protective Agents|protective agents|mesh-ancestor
83881996|NCT00238173|Antidotes|antidotes|mesh-ancestor
83881997|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83881998|NCT00238173|Diuretics|diuretics|mesh-ancestor
83881999|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
83882000|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
83882001|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882002|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
83882003|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
83882004|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
83882005|NCT00211133|Hematinics|hematinics|mesh-ancestor
83882006|NCT00238212|Sorafenib|sorafenib|mesh-list
83882007|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882008|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83882009|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882010|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882011|NCT00211250|Valproic Acid|valproic acid|mesh-list
83882012|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
83882013|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882014|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882015|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
83882016|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882017|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882018|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
83882019|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83882020|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882021|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83882022|NCT00238251|Temozolomide|temozolomide|mesh-list
83882023|NCT00238251|Gefitinib|gefitinib|mesh-list
83882024|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83882025|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
83882026|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882027|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882028|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83882029|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882030|NCT04566718|Metformin|metformin|mesh-list
83882031|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83882032|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882033|NCT02210884|Vitamin D|vitamin d|mesh-list
83882034|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
83882035|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
83882036|NCT02210884|Vitamins|vitamins|mesh-list
83882037|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
83882038|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882039|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83882040|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83882041|NCT00238290|Trastuzumab|trastuzumab|mesh-list
83882042|NCT00238290|Letrozole|letrozole|mesh-list
83882043|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882044|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882045|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83882046|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83882047|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882048|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882049|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83882050|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
83882051|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83882052|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882053|NCT00211328|Anecortave|anecortave|mesh-list
83882054|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882055|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882056|NCT00211328|Growth Substances|growth substances|mesh-ancestor
83882057|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882058|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882059|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882060|NCT00238329|Interferons|interferons|mesh-list
83882061|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
83882062|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
83882063|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83882064|NCT00238329|Thalidomide|thalidomide|mesh-list
83882065|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882066|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
83882067|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882068|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
83882069|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882070|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882071|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
83882072|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882073|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882074|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882075|NCT00238329|Growth Substances|growth substances|mesh-ancestor
83882076|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882077|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
83882078|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
83882079|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882080|NCT00211367|Anecortave|anecortave|mesh-list
83882081|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882082|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882083|NCT00211367|Growth Substances|growth substances|mesh-ancestor
83882084|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882085|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882086|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882087|NCT00238368|Cytarabine|cytarabine|mesh-list
83882088|NCT00238368|Prednisone|prednisone|mesh-list
83882089|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
83882090|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
83882091|NCT00238368|Busulfan|busulfan|mesh-list
83882092|NCT00238368|Rituximab|rituximab|mesh-list
83882093|NCT00238368|Doxorubicin|doxorubicin|mesh-list
83882094|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83882095|NCT00238368|Etoposide|etoposide|mesh-list
83882096|NCT00238368|Vincristine|vincristine|mesh-list
83882097|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83882098|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882099|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
83882100|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882101|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882102|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83882103|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
83882104|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882105|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882106|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83882107|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882108|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83882109|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83882110|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83882111|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882112|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882114|NCT00238368|Hormones|hormones|mesh-ancestor
83882115|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83882116|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83882117|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83882118|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83882119|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
83882120|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
83882121|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882122|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83882123|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83882124|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83882125|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
83882126|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
83882127|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882128|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83882129|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83882130|NCT00238368|Protective Agents|protective agents|mesh-ancestor
83882131|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83882132|NCT02894593|Ethanol|ethanol|mesh-list
83882133|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
83882134|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83882135|NCT02894593|Listerine|listerine|mesh-list
83882136|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
83882137|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83882138|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882139|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882140|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882141|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
83882142|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882143|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
83882144|NCT02894593|Protective Agents|protective agents|mesh-ancestor
83882145|NCT00211406|Anecortave|anecortave|mesh-list
83882146|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882147|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882148|NCT00211406|Growth Substances|growth substances|mesh-ancestor
83882149|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882150|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882151|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882152|NCT02894554|Lamivudine|lamivudine|mesh-list
83882153|NCT02894554|Telbivudine|telbivudine|mesh-list
83882154|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83882155|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83882156|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882157|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882158|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
83882159|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882160|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83882161|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83882162|NCT00238407|Docetaxel|docetaxel|mesh-list
83882163|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882164|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
83882165|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
83882166|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
83882167|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882168|NCT02894515|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83882169|NCT02894515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83882170|NCT02894515|Serotonin Agents|serotonin agents|mesh-ancestor
83882171|NCT02894515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882172|NCT02894515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882173|NCT02894515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882174|NCT00211445|Verteporfin|verteporfin|mesh-list
83882175|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83882176|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882177|NCT02894710|Lidocaine|lidocaine|mesh-list
83882178|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
83882179|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
83882180|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882181|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882182|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
83882183|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882184|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83882185|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83882186|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83882187|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882188|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882189|NCT00211484|Anecortave|anecortave|mesh-list
83882190|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882191|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882192|NCT00211484|Growth Substances|growth substances|mesh-ancestor
83882193|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882194|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882195|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882196|NCT05428072|Aspirin|aspirin|mesh-list
83882197|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83882198|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83882199|NCT05428072|Analgesics|analgesics|mesh-ancestor
83882200|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
83882201|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882202|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882203|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882204|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882205|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83882206|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83882207|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882208|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83882209|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83882210|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882211|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
83882212|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
83882213|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882214|NCT00211562|Vitamin E|vitamin e|mesh-list
83882215|NCT00211562|Olanzapine|olanzapine|mesh-list
83882216|NCT00211562|Vitamins|vitamins|mesh-ancestor
83882217|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
83882218|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882219|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
83882220|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
83882221|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882222|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83882223|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83882224|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83882225|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882226|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83882227|NCT00211562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83882228|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83882229|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882230|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882231|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882232|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
83882233|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
83882234|NCT00211562|Protective Agents|protective agents|mesh-ancestor
83882235|NCT05427721|Thymol|thymol|mesh-list
83882236|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882237|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83882238|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
83882239|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83882240|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
83882241|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83882242|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83882243|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83882244|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882245|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882246|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
83882247|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882248|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882249|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83882250|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882251|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83882252|NCT05427175|Methotrexate|methotrexate|mesh-list
83882253|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83882254|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
83882255|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83882256|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882257|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83882258|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
83882259|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882260|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882261|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882262|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882263|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83882264|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882265|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
83882266|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148490|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
83882267|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83882268|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
83882269|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83882270|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83882271|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83882272|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882273|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882274|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
83882275|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882276|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882277|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83882278|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882280|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882281|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882282|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83882283|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83882284|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
83882285|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882286|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83882287|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83882288|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83882289|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83882290|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83882291|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83882292|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
83882293|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83882294|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83882295|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83882296|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882297|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882298|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
83882299|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882300|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882301|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83882302|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882303|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83882304|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83882305|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83882306|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882307|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882308|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882309|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882310|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83882311|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
83882312|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83882313|NCT04680208|Anesthetics|anesthetics|mesh-list
83882314|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882315|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882316|NCT00211796|Valproic Acid|valproic acid|mesh-list
83121399|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
83882317|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
83882318|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882319|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882321|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882322|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882323|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
83882324|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83882325|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882326|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83882327|NCT05426824|Pegaspargase|pegaspargase|mesh-list
83882328|NCT05426824|Asparaginase|asparaginase|mesh-list
83882329|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882330|NCT00238797|Gefitinib|gefitinib|mesh-list
83882331|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882332|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83882333|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882334|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882335|NCT05426044|Metformin|metformin|mesh-list
83882336|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83882337|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882338|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
83882339|NCT05425654|Busulfan|busulfan|mesh-list
83882340|NCT05425654|Carmustine|carmustine|mesh-list
83882341|NCT05425654|Rituximab|rituximab|mesh-list
83882342|NCT05425654|Methotrexate|methotrexate|mesh-list
83882343|NCT05425654|Vincristine|vincristine|mesh-list
83882344|NCT05425654|Lenalidomide|lenalidomide|mesh-list
83882345|NCT05425654|Procarbazine|procarbazine|mesh-list
83882346|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882347|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
83882348|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882349|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882350|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83882351|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
83882352|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882353|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882354|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83882355|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882356|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83882357|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
83882358|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83882359|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83882360|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
83882361|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882362|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882363|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83882364|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83882365|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83882366|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
83882367|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
83882368|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
83882369|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882370|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882371|NCT05425654|Growth Substances|growth substances|mesh-ancestor
83882372|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882373|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
83882374|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882375|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882376|NCT05425576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83882377|NCT05425576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882378|NCT00238914|Naltrexone|naltrexone|mesh-list
83882379|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83882380|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83882381|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882382|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
83882383|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882384|NCT04668976|Gemcitabine|gemcitabine|mesh-list
83882385|NCT04668976|Fluorouracil|fluorouracil|mesh-list
83882386|NCT04668976|Floxuridine|floxuridine|mesh-list
83882387|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
83882388|NCT04668976|Irinotecan|irinotecan|mesh-list
83882389|NCT04668976|Cetuximab|cetuximab|mesh-list
83882390|NCT04668976|Panitumumab|panitumumab|mesh-list
83882391|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83882392|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
83882393|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882394|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882395|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882396|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
83882397|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882398|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83882399|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83882400|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882401|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882402|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
83882403|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83882404|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882405|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83882406|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
83882407|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882408|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882409|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882410|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882412|NCT04669366|Axitinib|axitinib|mesh-list
83882413|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882414|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882415|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882416|NCT04669366|Growth Substances|growth substances|mesh-ancestor
83882417|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882418|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882419|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83882420|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882421|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882422|NCT04721301|Maraviroc|maraviroc|mesh-list
83882423|NCT04721301|Nivolumab|nivolumab|mesh-list
83882424|NCT04721301|Ipilimumab|ipilimumab|mesh-list
83882425|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882426|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882427|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83882428|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882429|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83882430|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83882431|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83882432|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83882433|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
83882434|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882435|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83882436|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
83882437|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83882438|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882439|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83882440|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
83882441|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882442|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882443|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882444|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882445|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
83882446|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83882447|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
83882448|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882449|NCT00556465|Expectorants|expectorants|mesh-ancestor
83882450|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
83882451|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83882452|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
83882453|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882454|NCT00556465|Protective Agents|protective agents|mesh-ancestor
83882455|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882456|NCT00556465|Antidotes|antidotes|mesh-ancestor
83882457|NCT04668469|Acetaminophen|acetaminophen|mesh-list
83882458|NCT04668469|Vitamins|vitamins|mesh-list
83882459|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
83882460|NCT04668469|Zinc|zinc|mesh-list
83882461|NCT04668469|Azithromycin|azithromycin|mesh-list
83882462|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
83882463|NCT04668469|Ivermectin|ivermectin|mesh-list
83882464|NCT04668469|Lactoferrin|lactoferrin|mesh-list
83882465|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
83882466|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
83882467|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882468|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83882469|NCT04668469|Analgesics|analgesics|mesh-ancestor
83882470|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
83882471|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882473|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882474|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882475|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
83882476|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83882477|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83882478|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882479|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882480|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882481|NCT04668469|Trace Elements|trace elements|mesh-ancestor
83882482|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
83882483|NCT04668469|Protective Agents|protective agents|mesh-ancestor
83882484|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83882485|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83882486|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
83882487|NCT04668469|Coagulants|coagulants|mesh-ancestor
83882488|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
83882489|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83882490|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882491|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83882492|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
83882493|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882494|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882495|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882496|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882497|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
83882498|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83882499|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882500|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83882501|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
83882502|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882503|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882504|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882505|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882506|NCT00211952|Celecoxib|celecoxib|mesh-list
83882507|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83882508|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83882509|NCT00211952|Analgesics|analgesics|mesh-ancestor
83882510|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
83882511|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882512|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882513|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882514|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882515|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83882516|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83882517|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882518|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882519|NCT00239109|Olanzapine|olanzapine|mesh-list
83882520|NCT00239109|Ziprasidone|ziprasidone|mesh-list
83882521|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
83882522|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
83882523|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882524|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882525|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83882526|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83882527|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83882528|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882529|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83882530|NCT00239109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83882531|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83882532|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882533|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882534|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882535|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
83882536|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83882537|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83882538|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
83882539|NCT00212030|Nicorandil|nicorandil|mesh-list
83882540|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83882541|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83882542|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
83882543|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
83882544|NCT00212030|Vitamins|vitamins|mesh-ancestor
83882545|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
83882546|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882548|NCT00212069|Gemcitabine|gemcitabine|mesh-list
83882549|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882550|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83882551|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
83882552|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882553|NCT00212108|Celecoxib|celecoxib|mesh-list
83882554|NCT00212108|Gefitinib|gefitinib|mesh-list
83882555|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83882556|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83882557|NCT00212108|Analgesics|analgesics|mesh-ancestor
83882558|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
83882559|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882560|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882561|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882562|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882563|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83882564|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83882565|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882566|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882567|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882568|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83882569|NCT00212186|Selenium|selenium|mesh-list
83882570|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
83882571|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882572|NCT00212186|Protective Agents|protective agents|mesh-ancestor
83882573|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882574|NCT00212186|Trace Elements|trace elements|mesh-ancestor
83882575|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
83882576|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83882577|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83882578|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
83882579|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882580|NCT00414336|Antacids|antacids|mesh-ancestor
83882581|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882582|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83882583|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83882584|NCT00212342|Norethindrone|norethindrone|mesh-list
83882585|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
83882586|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83882587|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83882588|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83882589|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
83882590|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83882591|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882592|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83882593|NCT00212342|Estrogens|estrogens|mesh-ancestor
83882594|NCT00212342|Hormones|hormones|mesh-ancestor
83882595|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83882596|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83882597|NCT00414414|Prednisone|prednisone|mesh-list
83882598|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882599|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
83882600|NCT00414414|Hormones|hormones|mesh-ancestor
83882601|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83882602|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882603|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83882604|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882605|NCT00239304|Gefitinib|gefitinib|mesh-list
83882606|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882607|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83882608|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882609|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882610|NCT00239343|Gefitinib|gefitinib|mesh-list
83882611|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882612|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83882613|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882614|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882615|NCT00411593|Bevacizumab|bevacizumab|mesh-list
83882616|NCT00411593|Bortezomib|bortezomib|mesh-list
83882617|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882618|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882619|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83882620|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83882621|NCT00411593|Growth Substances|growth substances|mesh-ancestor
83882622|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882623|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
83882624|NCT00239382|Meloxicam|meloxicam|mesh-list
83882625|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83882626|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83882627|NCT00239382|Analgesics|analgesics|mesh-ancestor
83882628|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
83882629|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882630|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882631|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882632|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882633|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83882634|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83882635|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882636|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882637|NCT00239421|Fluticasone|fluticasone|mesh-list
83882638|NCT00239421|Xhance|xhance|mesh-list
83882639|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
83882640|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
83882641|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83882642|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882643|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83882644|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
83882645|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882646|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882647|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83882648|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
83882649|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882650|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83882651|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83882652|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83882653|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83882654|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
83882655|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882656|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882657|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
83882658|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83882659|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
83882660|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
83882661|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83882662|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
83882663|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882664|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882665|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83882666|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
83882667|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
83882668|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83882669|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
83882670|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882671|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882672|NCT00239499|Fluticasone|fluticasone|mesh-list
83882673|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
83882674|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83882675|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83882676|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83882677|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
83882678|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882679|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882680|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83882681|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83882682|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882683|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83882684|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
83882685|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83882686|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83882687|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882688|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882689|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83882690|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83882691|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83121758|NCT02918084|Letrozole|letrozole|mesh-list
83882692|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
83882693|NCT00212615|Capecitabine|capecitabine|mesh-list
83882694|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
83882695|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83882696|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
83882697|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882698|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882699|NCT00222573|Metoprolol|metoprolol|mesh-list
83882700|NCT00222573|Clopidogrel|clopidogrel|mesh-list
83882701|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83882702|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83882703|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83882704|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83882705|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
83882706|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882707|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882708|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882709|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83882710|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83882711|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
83882712|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
83882713|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882714|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83882715|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83882716|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83882717|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
83882718|NCT00212654|Landiolol|landiolol|mesh-list
83882719|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83882720|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83882721|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
83882722|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882723|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882724|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882725|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83882726|NCT00239538|Valsartan|valsartan|mesh-list
83882727|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83882728|NCT00239538|Telmisartan|telmisartan|mesh-list
83882729|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83882730|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83882731|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83882732|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882733|NCT00239538|Diuretics|diuretics|mesh-ancestor
83882734|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
83882735|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882736|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83882737|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83882738|NCT00212810|Topiramate|topiramate|mesh-list
83882739|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
83882740|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83882741|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882742|NCT00222651|Tenecteplase|tenecteplase|mesh-list
83882743|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83882744|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83882745|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882746|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83882747|NCT00239616|Hematinics|hematinics|mesh-ancestor
83882748|NCT00213122|Miglitol|miglitol|mesh-list
83882749|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882750|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882751|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83882752|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882753|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83882754|NCT00213200|Morphine|morphine|mesh-list
83882755|NCT00213200|Tetracaine|tetracaine|mesh-list
83882756|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83882757|NCT00213200|Narcotics|narcotics|mesh-ancestor
83882758|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882759|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882760|NCT00213200|Analgesics|analgesics|mesh-ancestor
83882761|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
83882762|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882763|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
83882764|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
83882765|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83882766|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83882767|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882768|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882769|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
83882770|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882771|NCT00213278|Vinblastine|vinblastine|mesh-list
83882772|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83882773|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882774|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83882775|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83882776|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83882777|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882778|NCT00239889|Calcitonin|calcitonin|mesh-list
83882779|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
83882780|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83882781|NCT00239889|Katacalcin|katacalcin|mesh-list
83882782|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83882783|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882784|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83882785|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
83882786|NCT00239967|Rimonabant|rimonabant|mesh-list
83882787|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83882788|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83882789|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83882790|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882791|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882792|NCT00239967|Hormones|hormones|mesh-ancestor
83882793|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83882794|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882795|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
83882796|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83882797|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882798|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
83882799|NCT00213512|Rituximab|rituximab|mesh-list
83882800|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882801|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882802|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
83882803|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882804|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882805|NCT00213551|Antioxidants|antioxidants|mesh-list
83882806|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882807|NCT00213551|Protective Agents|protective agents|mesh-ancestor
83882808|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882809|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83882810|NCT00213590|Cyclosporine|cyclosporine|mesh-list
83882811|NCT00213590|Cyclosporins|cyclosporins|mesh-list
83882812|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882813|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882814|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882815|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
83882816|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882817|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
83882818|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882819|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882820|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882821|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83882822|NCT00240045|Octreotide|octreotide|mesh-list
83882823|NCT00240045|Midodrine|midodrine|mesh-list
83882824|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83882825|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83882826|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882827|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
83882828|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
83882829|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882830|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882831|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83882832|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83882833|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83882834|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83882835|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
83882836|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882837|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882838|NCT00243672|Atorvastatin|atorvastatin|mesh-list
83882839|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
83882840|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83882841|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83882842|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
83882843|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882844|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83882845|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83882846|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882847|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83882848|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83882849|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83882850|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
83882851|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882852|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83882853|NCT00243711|Glycerol|glycerol|mesh-list
83882854|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83882855|NCT00243711|Protective Agents|protective agents|mesh-ancestor
83882856|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882857|NCT00243711|Laxatives|laxatives|mesh-ancestor
83882858|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83882859|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
83882860|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83882861|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83882862|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882863|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882864|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
83882865|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
83882866|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
83882867|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882868|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
83882869|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
83882870|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83882871|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83882872|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
83882873|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
83882874|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882875|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882876|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83882877|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83882878|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83882879|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83882880|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
83882881|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882882|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83882883|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83882884|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882885|NCT00243750|Methotrexate|methotrexate|mesh-list
83882886|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83882887|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
83882888|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83882889|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882890|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83882891|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
83882892|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882893|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882894|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83882895|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882896|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83882897|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83882898|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
83882899|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83882900|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83882901|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
83882902|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83882903|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882904|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882905|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83882906|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83882907|NCT00243789|Protective Agents|protective agents|mesh-ancestor
83882908|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882909|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
83882910|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83882911|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
83882912|NCT00214058|Carboplatin|carboplatin|mesh-list
83882913|NCT00214058|Docetaxel|docetaxel|mesh-list
83882914|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882915|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
83121972|NCT02513355|Cisplatin|cisplatin|mesh-list
83882916|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
83882917|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
83882918|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882919|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83882920|NCT00240318|Calcium|calcium|mesh-list
83882921|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83882922|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882923|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83882924|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83882925|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
83882926|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882927|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83882928|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83882929|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882930|NCT00243945|Rotigotine|rotigotine|mesh-list
83882931|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
83882932|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
83882933|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882934|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882935|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882936|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
83882937|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83882938|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882939|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83882940|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83882941|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882942|NCT00240396|Narcotics|narcotics|mesh-list
83882943|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882944|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882945|NCT00240396|Analgesics|analgesics|mesh-ancestor
83882946|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
83882947|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882948|NCT00214331|Azithromycin|azithromycin|mesh-list
83882949|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
83882950|NCT00214331|Gentamicins|gentamicins|mesh-list
83882951|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83882952|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83882953|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83882954|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83882955|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83882956|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882957|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83882958|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83882959|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83882960|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83882961|NCT00243984|Topiramate|topiramate|mesh-list
83882962|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
83882963|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83882964|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882965|NCT00214370|Fentanyl|fentanyl|mesh-list
83882966|NCT00214370|Propofol|propofol|mesh-list
83882967|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83882968|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83882969|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882970|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83882971|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
83882972|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
83882973|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83882974|NCT00214370|Narcotics|narcotics|mesh-ancestor
83882975|NCT00214370|Analgesics|analgesics|mesh-ancestor
83882976|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
83882977|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882978|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83882979|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83882980|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
83882981|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83882982|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
83882983|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83882984|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83882985|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83882986|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83882987|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
83882988|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83882989|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
83882990|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83882991|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83882992|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
83882993|NCT00244023|Testosterone|testosterone|mesh-list
83882994|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
83882995|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
83882996|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83882997|NCT00244023|Androgens|androgens|mesh-ancestor
83882998|NCT00244023|Hormones|hormones|mesh-ancestor
83882999|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883000|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883001|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883002|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883003|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
83883004|NCT00240474|Amlodipine|amlodipine|mesh-list
83883005|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83883006|NCT00240474|Telmisartan|telmisartan|mesh-list
83883007|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83883008|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83883009|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883010|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883011|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83883012|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883013|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
83883014|NCT00240474|Diuretics|diuretics|mesh-ancestor
83883015|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
83883016|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83883017|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83883018|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83883019|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83883020|NCT00214604|Pravastatin|pravastatin|mesh-list
83883021|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83883022|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83883023|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
83883024|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883025|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83883026|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83883027|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883028|NCT00214643|Clindamycin|clindamycin|mesh-list
83883029|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
83883030|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
83883031|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
83883032|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883033|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883034|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83883035|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883036|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883037|NCT00414531|Atorvastatin|atorvastatin|mesh-list
83883038|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83883039|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83883040|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
83883041|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883042|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83883043|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83883044|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883045|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
83883046|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
83883047|NCT00214682|Vitamins|vitamins|mesh-ancestor
83883048|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
83883049|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883050|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
83883051|NCT00214682|Hematinics|hematinics|mesh-ancestor
83883052|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
83883053|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83883054|NCT00240513|Minocycline|minocycline|mesh-list
83883055|NCT00240513|Tretinoin|tretinoin|mesh-list
83883056|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883057|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883058|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883059|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
83883060|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
83883061|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
83883062|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83883063|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83883064|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
83883065|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122125|NCT04501107|Insulin|insulin|mesh-list
83883066|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883067|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83883068|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83883069|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
83883070|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883071|NCT00214877|Methylene Blue|methylene blue|mesh-list
83883072|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883073|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883074|NCT00214955|Fentanyl|fentanyl|mesh-list
83883075|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83883076|NCT00214955|Narcotics|narcotics|mesh-ancestor
83883077|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883078|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883079|NCT00214955|Analgesics|analgesics|mesh-ancestor
83883080|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
83883081|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883082|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83883083|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83883084|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
83883085|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
83883086|NCT00244179|Interferons|interferons|mesh-list
83406866|NCT05857163|Diuretics|diuretics|mesh-ancestor
83883087|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
83883088|NCT00244179|Infliximab|infliximab|mesh-list
83883089|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883090|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
83883091|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883092|NCT00244179|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83883093|NCT00244179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883094|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
83883095|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883096|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883097|NCT00214994|Tiagabine|tiagabine|mesh-list
83883098|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
83883099|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83883100|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83883101|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883102|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883103|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
83883104|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883105|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883106|NCT00240630|Naproxen|naproxen|mesh-list
83883107|NCT00240630|Sumatriptan|sumatriptan|mesh-list
83883108|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83883109|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83883110|NCT00240630|Analgesics|analgesics|mesh-ancestor
83883111|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
83883112|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883113|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883114|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883115|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883116|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
83883117|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83883118|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883119|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883120|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83883121|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83883122|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83883123|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
83883124|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883125|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83883126|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83883127|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83883128|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883129|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883130|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883131|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883132|NCT00244296|Analgesics|analgesics|mesh-ancestor
83883133|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
83883134|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883135|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
83883136|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883137|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
83883138|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83122192|NCT04531592|Valproic Acid|valproic acid|mesh-list
83883140|NCT00215228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83883141|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83883142|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883143|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883144|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883145|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
83883146|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883147|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883148|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
83883149|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883150|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83883151|NCT00215228|Analgesics|analgesics|mesh-ancestor
83883152|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
83883153|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
83883154|NCT00215267|Praziquantel|praziquantel|mesh-list
83883155|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
83883156|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83883157|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883158|NCT00240708|Risperidone|risperidone|mesh-list
83883159|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83883160|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
83883161|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883162|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883163|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883164|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83883165|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83883166|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883167|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883168|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83883169|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
83883170|NCT00215345|Celecoxib|celecoxib|mesh-list
83883171|NCT00215345|Docetaxel|docetaxel|mesh-list
83883172|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883173|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
83883174|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
83883175|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
83883176|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883177|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83883178|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83883179|NCT00215345|Analgesics|analgesics|mesh-ancestor
83883180|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
83883181|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883182|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883183|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883184|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883185|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83883186|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83883187|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883188|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
83883189|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883190|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883191|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83883192|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883193|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883194|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
83883195|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83883196|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
83883197|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883198|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883199|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83883200|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
83883201|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83883202|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83883203|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83883204|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
83883205|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883206|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883207|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
83883208|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83883209|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
83883210|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883211|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883212|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83883213|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
83883214|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83883215|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83883216|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83883217|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
83883218|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883219|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883221|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883222|NCT00215462|Vinorelbine|vinorelbine|mesh-list
83883223|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83883224|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883225|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83883226|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83883227|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83883228|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883229|NCT00215501|Fluorouracil|fluorouracil|mesh-list
83883230|NCT00215501|Capecitabine|capecitabine|mesh-list
83883231|NCT00215501|Irinotecan|irinotecan|mesh-list
83883232|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883233|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
83883234|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883235|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83883236|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883237|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
83883238|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883239|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83883240|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83883241|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883242|NCT00240786|Acetaminophen|acetaminophen|mesh-list
83883243|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83883244|NCT00240786|Analgesics|analgesics|mesh-ancestor
83883245|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
83883246|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883247|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883248|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
83883249|NCT00215579|Risperidone|risperidone|mesh-list
83883250|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83883251|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
83883252|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883253|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883254|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883255|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83883256|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83883257|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883258|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883259|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83883260|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
83883261|NCT00556621|Gemcitabine|gemcitabine|mesh-list
83883262|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883263|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83883264|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
83883265|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883266|NCT00244452|Cetrorelix|cetrorelix|mesh-list
83883267|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83883268|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
83883269|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83883270|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883271|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
83883272|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883273|NCT00556699|Rituximab|rituximab|mesh-list
83883274|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83883275|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883276|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
83883277|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883278|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883279|NCT00411866|Ketoconazole|ketoconazole|mesh-list
83883280|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
83883281|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883282|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83883283|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83883284|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883285|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883286|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83883287|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
83883288|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883289|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883290|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83883291|NCT04667299|Amoxicillin|amoxicillin|mesh-list
83883292|NCT04667299|Metronidazole|metronidazole|mesh-list
83883293|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
83883294|NCT04667299|Rabeprazole|rabeprazole|mesh-list
83883295|NCT04667299|Bismuth|bismuth|mesh-list
83883296|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883297|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883298|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883299|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83883300|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83883301|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83883302|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883303|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83883304|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883305|NCT04667299|Antacids|antacids|mesh-ancestor
83883306|NCT04667299|Diuretics|diuretics|mesh-ancestor
83883307|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
83883308|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883309|NCT04667299|Expectorants|expectorants|mesh-ancestor
83883310|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
83883311|NCT04667143|Metformin|metformin|mesh-list
83883312|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83883313|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883314|NCT00240825|Acetaminophen|acetaminophen|mesh-list
83883315|NCT00240825|Ibuprofen|ibuprofen|mesh-list
83883316|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83883317|NCT00240825|Analgesics|analgesics|mesh-ancestor
83883318|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
83883319|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883320|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883321|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
83883322|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83883323|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883324|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883325|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83883326|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883327|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883328|NCT04666675|Upadacitinib|upadacitinib|mesh-list
83883329|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83883330|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83883331|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883332|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883333|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883334|NCT00244530|Nifedipine|nifedipine|mesh-list
83883335|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83883336|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883337|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883338|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83883339|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883340|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
83883341|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
83883342|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83883343|NCT00411905|Bortezomib|bortezomib|mesh-list
83883344|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883345|NCT00240864|Acetaminophen|acetaminophen|mesh-list
83883346|NCT00240864|Ibuprofen|ibuprofen|mesh-list
83883347|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83883348|NCT00240864|Analgesics|analgesics|mesh-ancestor
83883349|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
83883350|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883351|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883352|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
83883353|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83883354|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883355|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883356|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83883357|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883358|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883359|NCT00557011|Amphetamine|amphetamine|mesh-list
83883360|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83883361|NCT00557011|Adderall|adderall|mesh-list
83883362|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83883363|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883365|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
83883366|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883367|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
83883368|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883369|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883370|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
83883371|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83883372|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83883373|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883374|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83883375|NCT04666324|Simethicone|simethicone|mesh-list
83883376|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
83883377|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883378|NCT04666324|Emollients|emollients|mesh-ancestor
83883379|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
83883380|NCT04720833|Vitamin D|vitamin d|mesh-list
83883381|NCT04720833|Calcium|calcium|mesh-list
83883382|NCT04720833|Vitamins|vitamins|mesh-ancestor
83883383|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
83883384|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883385|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83883386|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83883387|NCT00244608|Budesonide|budesonide|mesh-list
83883388|NCT00244608|Terbutaline|terbutaline|mesh-list
83883389|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
83883390|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883391|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83883392|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
83883393|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883394|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883395|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83883396|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
83883397|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
83883398|NCT00244608|Hormones|hormones|mesh-ancestor
83883399|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883400|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83883401|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83883402|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83883403|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
83883404|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883405|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883406|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
83883407|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
83883408|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83883409|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
83883410|NCT04666168|Fludarabine|fludarabine|mesh-list
83883411|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883412|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
83883413|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883414|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883415|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83883416|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
83883417|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883418|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883419|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83883420|NCT00215774|Flecainide|flecainide|mesh-list
83883421|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83883422|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83883423|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83883424|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883425|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883426|NCT00240942|Letrozole|letrozole|mesh-list
83883427|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883428|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83883429|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83883430|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883431|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883432|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83883433|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
83883434|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883435|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883436|NCT00215891|Interferons|interferons|mesh-list
83883437|NCT00215891|Ribavirin|ribavirin|mesh-list
83883438|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883439|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
83883440|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883441|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
83883442|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883443|NCT02961816|Pyridoxine|pyridoxine|mesh-list
83883444|NCT02961816|Dexamethasone|dexamethasone|mesh-list
83883445|NCT02961816|Rituximab|rituximab|mesh-list
83883446|NCT02961816|Gemcitabine|gemcitabine|mesh-list
83883447|NCT02961816|Melphalan|melphalan|mesh-list
83883448|NCT02961816|Busulfan|busulfan|mesh-list
83883449|NCT02961816|Panobinostat|panobinostat|mesh-list
83883450|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83883451|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883452|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
83883453|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883454|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883455|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883456|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
83883457|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
83883458|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883459|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883460|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
83883461|NCT02961816|Hormones|hormones|mesh-ancestor
83883462|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883463|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883464|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83883465|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
83883466|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883467|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83883468|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
83883469|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83883470|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883471|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83883472|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883473|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
83883474|NCT02961816|Vitamins|vitamins|mesh-ancestor
83883475|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
83883476|NCT04665232|Progesterone|progesterone|mesh-list
83883477|NCT04665232|Progestins|progestins|mesh-ancestor
83883478|NCT04665232|Hormones|hormones|mesh-ancestor
83883479|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883480|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883481|NCT00216008|Docetaxel|docetaxel|mesh-list
83883482|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883483|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
83883484|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
83883485|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
83883486|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883487|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
83883488|NCT04665076|Fludarabine|fludarabine|mesh-list
83883489|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883490|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
83883491|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883492|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883493|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83883494|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
83883495|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883496|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883497|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83883498|NCT00241020|Octreotide|octreotide|mesh-list
83883499|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883500|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883501|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883502|NCT00216047|Trastuzumab|trastuzumab|mesh-list
83883503|NCT00216047|Vatalanib|vatalanib|mesh-list
83883504|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83883505|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883506|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83883507|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883508|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883509|NCT04665310|Tacrolimus|tacrolimus|mesh-list
83883510|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883511|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
83883512|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883513|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83883514|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883515|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883516|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
83883517|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83883518|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883519|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83883520|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
83883521|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883522|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883523|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883524|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883526|NCT00216164|Gemcitabine|gemcitabine|mesh-list
83883527|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83883528|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883529|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
83883530|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883531|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883532|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83883533|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
83883534|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883535|NCT04664803|Cefdinir|cefdinir|mesh-list
83883536|NCT04664803|Cefetamet|cefetamet|mesh-list
83883537|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883538|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883539|NCT04664725|Repaglinide|repaglinide|mesh-list
83883540|NCT04664725|Bupropion|bupropion|mesh-list
83883541|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83883542|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
83883543|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883544|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83883545|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83883546|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883547|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883548|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
83883549|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883550|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883551|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83883552|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83883553|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883554|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83883555|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
83883556|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
83883557|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
83883558|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83883559|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883560|NCT00241098|Valsartan|valsartan|mesh-list
83883561|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83883562|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83883563|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83883564|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883565|NCT00216281|Clozapine|clozapine|mesh-list
83883566|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83883567|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83883568|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83883569|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883570|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883571|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
83883572|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883573|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883574|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83883575|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
83883576|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83883577|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83883578|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883579|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883580|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
83883581|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
83883582|NCT00241137|Valsartan|valsartan|mesh-list
83883583|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83883584|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83883585|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83883586|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883587|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83883588|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
83883589|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
83883590|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883591|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83883592|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83883593|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883594|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83883595|NCT04664530|Esketamine|esketamine|mesh-list
83883596|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
83883597|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883598|NCT00216398|Lanreotide|lanreotide|mesh-list
83883599|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883600|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
83883601|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83883602|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83883603|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883604|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
83883605|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883606|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883607|NCT00216437|Capecitabine|capecitabine|mesh-list
83883608|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83883609|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
83883610|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883611|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883612|NCT00244920|Squalamine|squalamine|mesh-list
83883613|NCT00244920|Leuprolide|leuprolide|mesh-list
83883614|NCT00244920|Bicalutamide|bicalutamide|mesh-list
83883615|NCT00244920|Hormones|hormones|mesh-list
83883616|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
83883617|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883618|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883619|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83883620|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
83883621|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83883622|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883623|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883624|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
83883625|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883626|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883627|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83883628|NCT00244920|Protective Agents|protective agents|mesh-ancestor
83883629|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83883630|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83883631|NCT00244920|Growth Substances|growth substances|mesh-ancestor
83883632|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
83883633|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
83883634|NCT00216515|Galantamine|galantamine|mesh-list
83883635|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83883636|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883637|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883638|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
83883639|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883640|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883641|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83883642|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
83883643|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883644|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
83883645|NCT00244959|Anastrozole|anastrozole|mesh-list
83883646|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883647|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883648|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83883649|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83883650|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883651|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883652|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83883653|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
83883654|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883655|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883656|NCT00244998|Fulvestrant|fulvestrant|mesh-list
83883657|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883658|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883659|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83883660|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83883661|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
83883662|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883663|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883665|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83883666|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
83883667|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883668|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883669|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883670|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83883671|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83883672|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883673|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883674|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83883675|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
83883676|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
83883677|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83883678|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83883679|NCT00241254|Prednisolone|prednisolone|mesh-list
83883680|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
83883681|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
83883682|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83883683|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
83883684|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883685|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
83883686|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883687|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883688|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83883689|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
83883690|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883691|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883692|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83883693|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883694|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
83883695|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
83883696|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883697|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883698|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
83883699|NCT00241254|Hormones|hormones|mesh-ancestor
83883700|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883701|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83883702|NCT00241254|Protective Agents|protective agents|mesh-ancestor
83883703|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883704|NCT00216632|Risperidone|risperidone|mesh-list
83883705|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83883706|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
83883707|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883708|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883709|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883710|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83883711|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83883712|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883713|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883714|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83883715|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
83883716|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83883717|NCT04662736|Tedizolid|tedizolid|mesh-list
83883718|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883719|NCT04662658|Xenon|xenon|mesh-list
83883720|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83883721|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
83883722|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
83883723|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883724|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883725|NCT00216788|Esomeprazole|esomeprazole|mesh-list
83883726|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83883727|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883728|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83883729|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883730|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883731|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
83883732|NCT00245115|Busulfan|busulfan|mesh-list
83883733|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883734|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
83883735|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883736|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883737|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83883738|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
83883739|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883740|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883741|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83883742|NCT04662385|Listerine|listerine|mesh-list
83883743|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
83883744|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
83883745|NCT04662385|Protective Agents|protective agents|mesh-ancestor
83883746|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883747|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83883748|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883749|NCT00216827|Betamethasone|betamethasone|mesh-list
83883750|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
83883751|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83883752|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
83883753|NCT00216827|Calcipotriene|calcipotriene|mesh-list
83883754|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83883755|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883756|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
83883757|NCT00216827|Hormones|hormones|mesh-ancestor
83883758|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883759|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883760|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83883761|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
83883762|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83883763|NCT00241332|Fentanyl|fentanyl|mesh-list
83883764|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83883765|NCT00241332|Narcotics|narcotics|mesh-ancestor
83883766|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883767|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883768|NCT00241332|Analgesics|analgesics|mesh-ancestor
83883769|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
83883770|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883771|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83883772|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83883773|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
83883774|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
83883775|NCT00216866|Dalteparin|dalteparin|mesh-list
83883776|NCT00216866|Tinzaparin|tinzaparin|mesh-list
83883777|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83883778|NCT00216866|Warfarin|warfarin|mesh-list
83883779|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
83883780|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83883781|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83883782|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883783|NCT00557206|Docetaxel|docetaxel|mesh-list
83883784|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
83883785|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883786|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83883787|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83883788|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83883789|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883790|NCT00245154|Paclitaxel|paclitaxel|mesh-list
83883791|NCT00245154|Carboplatin|carboplatin|mesh-list
83883792|NCT00245154|Cediranib|cediranib|mesh-list
83883793|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83883794|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883795|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83883796|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83883797|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83883798|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883799|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883800|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83883801|NCT00241371|Clofarabine|clofarabine|mesh-list
83883802|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83883803|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
83883804|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883805|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883806|NCT04660786|Vitamin D|vitamin d|mesh-list
83883807|NCT04660786|Triamcinolone|triamcinolone|mesh-list
83883808|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83883809|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83883810|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83883811|NCT04660786|Vitamins|vitamins|mesh-ancestor
83883812|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
83883813|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883814|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83883815|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883816|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
83883817|NCT04660786|Hormones|hormones|mesh-ancestor
83883818|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883819|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83883820|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
83883821|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883822|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883823|NCT00217178|Folic Acid|folic acid|mesh-list
83883824|NCT00217178|Vitamins|vitamins|mesh-ancestor
83883825|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
83883826|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883827|NCT00217178|Hematinics|hematinics|mesh-ancestor
83883828|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
83883829|NCT00241449|Tamoxifen|tamoxifen|mesh-list
83883830|NCT00241449|Fulvestrant|fulvestrant|mesh-list
83883831|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83883832|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83883833|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883834|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883835|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883836|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883837|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83883838|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83883839|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83883840|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83883841|NCT00412100|Oxycodone|oxycodone|mesh-list
83883842|NCT00412100|Naloxone|naloxone|mesh-list
83883843|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83883844|NCT00412100|Narcotics|narcotics|mesh-ancestor
83883845|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883846|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883847|NCT00412100|Analgesics|analgesics|mesh-ancestor
83883848|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
83883849|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883850|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83883851|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83883852|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83883853|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83883854|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
83883855|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883856|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83883857|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83883858|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883859|NCT04659499|Paclitaxel|paclitaxel|mesh-list
83883860|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83883861|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883862|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83883863|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83883864|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83883865|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883866|NCT00241527|Esomeprazole|esomeprazole|mesh-list
83883867|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83883868|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883869|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83883870|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883871|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883872|NCT04648813|Bromides|bromides|mesh-list
83883873|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
83883874|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83883875|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
83883876|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883877|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883878|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83883879|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
83883880|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
83883881|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83883882|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
83883883|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883884|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883885|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
83883886|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
83883887|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83883888|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83883889|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
83883890|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
83883891|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883892|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883893|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
83883894|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83883895|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83883896|NCT00558181|Prednisolone|prednisolone|mesh-list
83883897|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
83883898|NCT00558181|Rituximab|rituximab|mesh-list
83883899|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83883900|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
83416192|NCT01517243|Sirolimus|sirolimus|mesh-list
83883901|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83883902|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883903|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
83883904|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883905|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883906|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883907|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
83883908|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
83883909|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883910|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83883911|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
83883912|NCT00558181|Hormones|hormones|mesh-ancestor
83883913|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83883914|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83883915|NCT00558181|Protective Agents|protective agents|mesh-ancestor
83883916|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83883917|NCT00558220|Immunomodulating Agents|immunomodulating agents|mesh-list
83883918|NCT00558220|Immunologic Factors|immunologic factors|mesh-ancestor
83883919|NCT00558220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883920|NCT00217295|Topiramate|topiramate|mesh-list
83883921|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
83883922|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83883923|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883924|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83883925|NCT00245427|Lactams|lactams|mesh-list
83883926|NCT00245427|beta-Lactams|beta-lactams|mesh-list
83883927|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83883928|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883929|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
83883930|NCT00558298|Risperidone|risperidone|mesh-list
83883931|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83883932|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
83883933|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83883934|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883935|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883936|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83883937|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83883938|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883939|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83883940|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83883941|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
83883942|NCT00245505|Mesalamine|mesalamine|mesh-list
83883943|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83883944|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83883945|NCT00245505|Analgesics|analgesics|mesh-ancestor
83883946|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
83883947|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83883948|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883949|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83883950|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83883951|NCT04647838|Tepotinib|tepotinib|mesh-list
83883952|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883953|NCT00217373|Interferons|interferons|mesh-list
83883954|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
83883955|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
83883956|NCT00217373|Metronidazole|metronidazole|mesh-list
83883957|NCT00217373|Vaccines|vaccines|mesh-list
83883958|NCT00217373|Sargramostim|sargramostim|mesh-list
83883959|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
83883960|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883961|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883962|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
83883963|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883964|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883965|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83883966|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83883967|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
83883968|NCT00241605|Metformin|metformin|mesh-list
83883969|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
83883970|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83883971|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83883972|NCT00217412|Vorinostat|vorinostat|mesh-list
83883973|NCT00217412|Isotretinoin|isotretinoin|mesh-list
83883974|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883975|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83883976|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883977|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883978|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
83883979|NCT04646824|Pemetrexed|pemetrexed|mesh-list
83883980|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83883981|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883982|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883983|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83883984|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83883985|NCT00217451|Clindamycin|clindamycin|mesh-list
83883986|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
83883987|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
83883988|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
83883989|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83883990|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83883991|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83883992|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83883993|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83883994|NCT04646707|Lidocaine|lidocaine|mesh-list
83883995|NCT04646707|Bupivacaine|bupivacaine|mesh-list
83883996|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
83883997|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
83883998|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83883999|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884000|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
83884001|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884002|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83884003|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83884004|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83884005|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884006|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884007|NCT00217529|Carboplatin|carboplatin|mesh-list
83884008|NCT00217529|Docetaxel|docetaxel|mesh-list
83884009|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83884010|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884011|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
83884012|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
83884013|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
83884014|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884015|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83884016|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884017|NCT00245661|Temazepam|temazepam|mesh-list
83884018|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83884019|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884020|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884021|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83884022|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83884023|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83884024|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
83884025|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
83884026|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884027|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884028|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
83884029|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83884030|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884031|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884032|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884033|NCT04646317|Analgesics|analgesics|mesh-ancestor
83884034|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
83884035|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884036|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83884037|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83884038|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83884039|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
83884040|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884041|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884042|NCT00217568|Carboplatin|carboplatin|mesh-list
83884043|NCT00217568|Docetaxel|docetaxel|mesh-list
83884044|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884045|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
83884046|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
83884047|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
83884048|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884049|NCT04646161|Misoprostol|misoprostol|mesh-list
83884050|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83884051|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
83884052|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83884053|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884054|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83884055|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884056|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
83884057|NCT00241722|Alvimopan|alvimopan|mesh-list
83884058|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884059|NCT00558337|Levodopa|levodopa|mesh-list
83884060|NCT00558337|Carbidopa|carbidopa|mesh-list
83884061|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83884062|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83884063|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83884064|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
83884065|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884066|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884067|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884068|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83884069|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884070|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83884071|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
83884072|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
83884073|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83884074|NCT00558376|Laxatives|laxatives|mesh-ancestor
83884075|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884076|NCT00217646|Sorafenib|sorafenib|mesh-list
83884077|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884078|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83884079|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884080|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884081|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
83884082|NCT00558454|Hematinics|hematinics|mesh-ancestor
83884083|NCT00558493|Clevudine|clevudine|mesh-list
83884084|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
83884085|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884086|NCT04645303|Triamcinolone|triamcinolone|mesh-list
83884087|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83884088|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83884089|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
83884090|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83884091|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884092|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
83884093|NCT04645303|Hormones|hormones|mesh-ancestor
83884094|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884095|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884096|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884097|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
83884098|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884099|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884100|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83884101|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
83884102|NCT04645303|Protective Agents|protective agents|mesh-ancestor
83884103|NCT00217607|Paclitaxel|paclitaxel|mesh-list
83884104|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83884105|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884106|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
83884107|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
83884108|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
83884109|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884110|NCT04644484|Vaccines|vaccines|mesh-list
83884111|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
83884112|NCT04644484|Antibodies|antibodies|mesh-list
83884113|NCT04644484|gamma-Globulins|gamma-globulins|mesh-list
83884114|NCT04644484|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83884115|NCT04644484|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83884116|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
83884117|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884118|NCT04644250|Paclitaxel|paclitaxel|mesh-list
83884119|NCT04644250|Carboplatin|carboplatin|mesh-list
83884120|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83884121|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884122|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
83884123|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
83884124|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
83884125|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884126|NCT00245739|Darunavir|darunavir|mesh-list
83884127|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83884128|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83884129|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
83884130|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884131|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884132|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83884133|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83884134|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
83884135|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884136|NCT00558883|Acarbose|acarbose|mesh-list
83884137|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83884138|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884139|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884140|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83884141|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884142|NCT04644094|Dexamethasone|dexamethasone|mesh-list
83884143|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884144|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
83884145|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
83884146|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884147|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884148|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884149|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
83884150|NCT04644094|Hormones|hormones|mesh-ancestor
83884151|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884152|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83884153|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884154|NCT04644406|Trastuzumab|trastuzumab|mesh-list
83884155|NCT04644406|Pertuzumab|pertuzumab|mesh-list
83884156|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83884157|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884158|NCT04643821|Calcitriol|calcitriol|mesh-list
83884159|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
83884160|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83884161|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
83884162|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884163|NCT04643821|Expectorants|expectorants|mesh-ancestor
83884164|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884165|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83884166|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
83884167|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884168|NCT04643821|Protective Agents|protective agents|mesh-ancestor
83884169|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884170|NCT04643821|Antidotes|antidotes|mesh-ancestor
83884171|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83884172|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83884173|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884174|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83884175|NCT04643821|Vitamins|vitamins|mesh-ancestor
83884176|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
83884177|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83884178|NCT00218075|Levodopa|levodopa|mesh-list
83884179|NCT00218075|Carbidopa|carbidopa|mesh-list
83884180|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83884181|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83884182|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
83884183|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884184|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884185|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884186|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83884187|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884188|NCT00218114|Valproic Acid|valproic acid|mesh-list
83884189|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
83884190|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884191|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884192|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
83884193|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884194|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884195|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
83884196|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83884197|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884198|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83884199|NCT00424788|Natalizumab|natalizumab|mesh-list
83884200|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
83884201|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884202|NCT00218153|Naltrexone|naltrexone|mesh-list
83884203|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83884204|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83884205|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884206|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
83884207|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884208|NCT04642846|Fluorides|fluorides|mesh-list
83884209|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
83884210|NCT04642846|Protective Agents|protective agents|mesh-ancestor
83884211|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884212|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
83884213|NCT00245895|Hematinics|hematinics|mesh-ancestor
83884214|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
83884215|NCT00559195|Hematinics|hematinics|mesh-ancestor
83884216|NCT00245934|Etanercept|etanercept|mesh-list
83884217|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83884218|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884219|NCT00245934|Analgesics|analgesics|mesh-ancestor
83884220|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
83884221|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884222|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884223|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884224|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884225|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884226|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884227|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
83884228|NCT00218231|Bupropion|bupropion|mesh-list
83884229|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83884230|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
83884231|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83884232|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83884233|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83884234|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884235|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884236|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
83884237|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884238|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884239|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83884240|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83884241|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884242|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
83884243|NCT00218309|Hydromorphone|hydromorphone|mesh-list
83884244|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83884245|NCT00218309|Narcotics|narcotics|mesh-ancestor
83884246|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884247|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884248|NCT00218309|Analgesics|analgesics|mesh-ancestor
83884249|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
83884250|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884251|NCT00218348|Amphetamine|amphetamine|mesh-list
83884252|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
83884253|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83884254|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884255|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
83884256|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
83884257|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884258|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
83884259|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884260|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884261|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
83884262|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83884263|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83884264|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884265|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83884266|NCT00559312|Fluticasone|fluticasone|mesh-list
83884267|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83884268|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83884269|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884270|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83884271|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
83884272|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884273|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884274|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83884275|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884276|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
83884277|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83884278|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83884279|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83884280|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83884281|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83884282|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884283|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884284|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
83884285|NCT00559312|Hormones|hormones|mesh-ancestor
83884286|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884287|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
83884288|NCT00559351|Fluorouracil|fluorouracil|mesh-list
83884289|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884290|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
83884291|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884292|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83884293|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884294|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
83884295|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884296|NCT00218504|Dronabinol|dronabinol|mesh-list
83884297|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
83884298|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884299|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83884300|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884301|NCT00218504|Analgesics|analgesics|mesh-ancestor
83884302|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
83884303|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884304|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83884305|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83884306|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884307|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884308|NCT00218504|Hormones|hormones|mesh-ancestor
83884309|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884310|NCT00559429|Docetaxel|docetaxel|mesh-list
83884311|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83884312|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884313|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83884314|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83884315|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83884316|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884317|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884318|NCT00559429|Analgesics|analgesics|mesh-ancestor
83884319|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
83884320|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884321|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884322|NCT00218621|Buprenorphine|buprenorphine|mesh-list
83884323|NCT00218621|Methadone|methadone|mesh-list
83884324|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83884325|NCT00218621|Narcotics|narcotics|mesh-ancestor
83884326|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884327|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884328|NCT00218621|Analgesics|analgesics|mesh-ancestor
83884329|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
83884330|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884331|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83884332|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
83884333|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884334|NCT00246168|Acetaminophen|acetaminophen|mesh-list
83884335|NCT00246168|Tramadol|tramadol|mesh-list
83884336|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884337|NCT00246168|Analgesics|analgesics|mesh-ancestor
83884338|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
83884339|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884340|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884341|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
83884342|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83884344|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884345|NCT00218660|Naltrexone|naltrexone|mesh-list
83884346|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83884347|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83884348|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884349|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
83884350|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884351|NCT00559546|Montelukast|montelukast|mesh-list
83884352|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83884353|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884354|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83884355|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
83884356|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884357|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884358|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83884359|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83884360|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884361|NCT00246207|Methylphenidate|methylphenidate|mesh-list
83884362|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83884363|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884364|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83884365|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83884366|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884367|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884368|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
83884369|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884370|NCT04639804|Celecoxib|celecoxib|mesh-list
83884371|NCT04639804|Naproxen|naproxen|mesh-list
83884372|NCT04639804|Aceclofenac|aceclofenac|mesh-list
83884373|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83884374|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884375|NCT04639804|Analgesics|analgesics|mesh-ancestor
83884376|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
83884377|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884378|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884379|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884380|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884381|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83884382|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83884383|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884384|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884385|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
83884386|NCT00218855|Thalidomide|thalidomide|mesh-list
83884387|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884388|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
83884389|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884390|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
83884391|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83884392|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884393|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83884394|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83884395|NCT00218855|Growth Substances|growth substances|mesh-ancestor
83884396|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
83884397|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884398|NCT00246246|Risperidone|risperidone|mesh-list
83884399|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83884400|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
83884401|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884402|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884403|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884404|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83884405|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83884406|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884407|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83884408|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83884409|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
83884410|NCT00242190|Gemcitabine|gemcitabine|mesh-list
83884411|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
83884412|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83884413|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
83884414|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123447|NCT03337191|Analgesics|analgesics|mesh-ancestor
83884415|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884417|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
83884418|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83884419|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83884420|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884421|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83884422|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
83884423|NCT00412334|Ribavirin|ribavirin|mesh-list
83884424|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
83884425|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884426|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
83884427|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884428|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
83884429|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884430|NCT00561379|Rituximab|rituximab|mesh-list
83884431|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83884432|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884433|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
83884434|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884435|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884436|NCT04629118|Sirolimus|sirolimus|mesh-list
83884437|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83884438|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884439|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83884440|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884441|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
83884442|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884443|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
83884444|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884445|NCT00561496|Tenofovir|tenofovir|mesh-list
83884446|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
83884447|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884448|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83884449|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83884450|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884451|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884452|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83884453|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83884454|NCT00246285|Risperidone|risperidone|mesh-list
83884455|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83884456|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
83884457|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884458|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884459|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884460|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83884461|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83884462|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884463|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83884464|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83884465|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
83884466|NCT00242268|Simvastatin|simvastatin|mesh-list
83884467|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83884468|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83884469|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
83884470|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884471|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83884472|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83884473|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884474|NCT00246363|Silymarin|silymarin|mesh-list
83884475|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
83884476|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884477|NCT00246363|Protective Agents|protective agents|mesh-ancestor
83884478|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884479|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
83884480|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83884481|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83884482|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83884483|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884484|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884485|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884486|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
83884487|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
83884488|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884489|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
83884490|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83884491|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884493|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83884494|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
83884495|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884496|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83884497|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
83884498|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83884499|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884500|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83884501|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
83884502|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83884503|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
83884504|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83884505|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884506|NCT04628143|Nafamostat|nafamostat|mesh-list
83884507|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83884508|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884509|NCT04628143|Analgesics|analgesics|mesh-ancestor
83884510|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
83884511|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884512|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884513|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884514|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884515|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
83884516|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
83884517|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884518|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884519|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83884520|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83884521|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83884522|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884523|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
83884524|NCT00242346|Candesartan|candesartan|mesh-list
83884525|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
83884526|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83884527|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83884528|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83884529|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884530|NCT00219245|Rivastigmine|rivastigmine|mesh-list
83884531|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83884532|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884533|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884534|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
83884535|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884536|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884537|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83884538|NCT00219245|Protective Agents|protective agents|mesh-ancestor
83884539|NCT04627363|Bevacizumab|bevacizumab|mesh-list
83884540|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83884541|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884542|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83884543|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83884544|NCT04627363|Growth Substances|growth substances|mesh-ancestor
83884545|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884546|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
83884547|NCT00219323|Omalizumab|omalizumab|mesh-list
83884548|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83884549|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83884550|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884551|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
83884552|NCT00246597|Hematinics|hematinics|mesh-ancestor
83884553|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
83884554|NCT04626739|Fludarabine|fludarabine|mesh-list
83884555|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884556|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
83884557|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884558|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884559|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83884560|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
83884561|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884562|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884563|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83884564|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83884565|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
83884566|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884567|NCT04627129|Itraconazole|itraconazole|mesh-list
83884568|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
83884569|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884570|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83884571|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83884572|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884573|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884574|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83884575|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
83884576|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884577|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884578|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83884579|NCT00246636|Fenofibrate|fenofibrate|mesh-list
83884580|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83884581|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
83884582|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884583|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83884584|NCT00219440|Metformin|metformin|mesh-list
83884585|NCT00219440|Pioglitazone|pioglitazone|mesh-list
83884586|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83884587|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884588|NCT00246675|Furosemide|furosemide|mesh-list
83884589|NCT00246675|Diuretics|diuretics|mesh-ancestor
83884590|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
83884591|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884592|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83884593|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884594|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884595|NCT00219479|Phenytoin|phenytoin|mesh-list
83884596|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
83884597|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83884598|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83884599|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884600|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884601|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83884602|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83884603|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83884604|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83884605|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884606|NCT04626973|Ezetimibe|ezetimibe|mesh-list
83884607|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83884608|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83884609|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83884610|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
83884611|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884612|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83884613|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884614|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83884615|NCT00242463|Nandrolone|nandrolone|mesh-list
83884616|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83884617|NCT00242463|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
83884618|NCT00242463|Androgens|androgens|mesh-ancestor
83884619|NCT00242463|Hormones|hormones|mesh-ancestor
83884620|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884621|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884622|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
83884623|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83884624|NCT00242463|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
83884625|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
83884626|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83884627|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
83884628|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884629|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884630|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83884631|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884632|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83884633|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83884634|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83884635|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83884636|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884637|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884638|NCT00561964|Irbesartan|irbesartan|mesh-list
83884639|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83884640|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83884641|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83884642|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884643|NCT00219596|Timolol|timolol|mesh-list
83884644|NCT00219596|Latanoprost|latanoprost|mesh-list
83884645|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83884646|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83884647|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83884648|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884649|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884650|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884651|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83884652|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83884653|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83884654|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83884655|NCT04626193|Amoxicillin|amoxicillin|mesh-list
83884656|NCT04626193|Doxycycline|doxycycline|mesh-list
83884657|NCT04626193|Levofloxacin|levofloxacin|mesh-list
83884658|NCT04626193|Esomeprazole|esomeprazole|mesh-list
83884659|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83884660|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884661|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83884662|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884663|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83884664|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884665|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884666|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
83884667|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83884668|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83884669|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83884670|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83884671|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83884672|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884673|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83884674|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83884675|NCT00242541|Octreotide|octreotide|mesh-list
83884676|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884677|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83884678|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884679|NCT04625608|Acetaminophen|acetaminophen|mesh-list
83884680|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884681|NCT04625608|Analgesics|analgesics|mesh-ancestor
83884682|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
83884683|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884684|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884685|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
83884686|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
83884687|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83884688|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
83884689|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
83884690|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884691|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884692|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884693|NCT00219713|Analgesics|analgesics|mesh-ancestor
83884694|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
83884695|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884696|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
83884697|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884698|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83884699|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884700|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884701|NCT00242697|Anesthetics|anesthetics|mesh-list
83884702|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884703|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884704|NCT04625179|Melatonin|melatonin|mesh-list
83884705|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
83884706|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
83884707|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884708|NCT04625179|Protective Agents|protective agents|mesh-ancestor
83884709|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123758|NCT03327987|Vaccines|vaccines|mesh-list
83884710|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83884711|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83884712|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
83884713|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
83884714|NCT02962232|Paclitaxel|paclitaxel|mesh-list
83884715|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83884716|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884717|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
83884718|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
83884719|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
83884720|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884721|NCT00246909|Pantoprazole|pantoprazole|mesh-list
83884722|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83884723|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884724|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83884725|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884726|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884727|NCT00219869|Galantamine|galantamine|mesh-list
83884728|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83884729|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884730|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884731|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
83884732|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884733|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884734|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83884735|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
83884736|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884737|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
83884738|NCT04624360|Dexamethasone|dexamethasone|mesh-list
83884739|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884740|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
83884741|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
83884742|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884743|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884744|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884745|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
83884746|NCT04624360|Hormones|hormones|mesh-ancestor
83884747|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884748|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83884749|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884750|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
83884751|NCT00219908|Analgesics|analgesics|mesh-ancestor
83884752|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
83884753|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884754|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884755|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884756|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83884757|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83884758|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884759|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884760|NCT00242736|Esomeprazole|esomeprazole|mesh-list
83884761|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83884762|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83884763|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83884764|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884765|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884766|NCT00242775|Fluticasone|fluticasone|mesh-list
83884767|NCT00242775|Budesonide|budesonide|mesh-list
83884768|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
83884769|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83884770|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884771|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83884772|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
83884773|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884774|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884775|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83884776|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884777|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
83884778|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83884779|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
83884780|NCT00242775|Hormones|hormones|mesh-ancestor
83884781|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884782|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83884783|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83884784|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83884785|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83884786|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884787|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884788|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
83884789|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
83884790|NCT04623619|Vitamins|vitamins|mesh-ancestor
83884791|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
83884792|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884793|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
83884794|NCT00562198|Carbidopa|carbidopa|mesh-list
83884795|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83884796|NCT00562198|Entacapone|entacapone|mesh-list
83884797|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83884798|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83884799|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
83884800|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884801|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884802|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884803|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83884804|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884805|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83884806|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
83884807|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
83884808|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83884809|NCT00220064|Leucovorin|leucovorin|mesh-list
83884810|NCT00220064|Fluorouracil|fluorouracil|mesh-list
83884811|NCT00220064|Irinotecan|irinotecan|mesh-list
83884812|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
83884813|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884814|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83884815|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884816|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884817|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
83884818|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884819|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83884820|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83884821|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884822|NCT00220064|Antidotes|antidotes|mesh-ancestor
83884823|NCT00220064|Protective Agents|protective agents|mesh-ancestor
83884824|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
83884825|NCT00220064|Vitamins|vitamins|mesh-ancestor
83884826|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
83884827|NCT00220103|Capecitabine|capecitabine|mesh-list
83884828|NCT00220103|Epirubicin|epirubicin|mesh-list
83884829|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884830|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83884831|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
83884832|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884833|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83884834|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83884835|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83884836|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884837|NCT00247026|Ubiquinone|ubiquinone|mesh-list
83884838|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
83884839|NCT00247026|Curcumin|curcumin|mesh-list
83884840|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83884841|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884842|NCT00247026|Analgesics|analgesics|mesh-ancestor
83884843|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
83884844|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884845|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884846|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884847|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884848|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884849|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884850|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884851|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
83884852|NCT00247026|Vitamins|vitamins|mesh-ancestor
83884853|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
83884854|NCT01580683|Vitamins|vitamins|mesh-ancestor
83884855|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
83884856|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884857|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
83884858|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884859|NCT01580683|Protective Agents|protective agents|mesh-ancestor
83884860|NCT00242814|Amlodipine|amlodipine|mesh-list
83884861|NCT00242814|Telmisartan|telmisartan|mesh-list
83884862|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83884864|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884865|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884866|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83884867|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884868|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
83884869|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83884870|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83884871|NCT04623385|Tretinoin|tretinoin|mesh-list
83884872|NCT04623385|Isotretinoin|isotretinoin|mesh-list
83884873|NCT04623385|Testosterone|testosterone|mesh-list
83884874|NCT04623385|Androgens|androgens|mesh-ancestor
83884875|NCT04623385|Hormones|hormones|mesh-ancestor
83884876|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884877|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884878|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884879|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
83884880|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
83884881|NCT00220220|Amlodipine|amlodipine|mesh-list
83884882|NCT00220220|Olmesartan|olmesartan|mesh-list
83884883|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83884884|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83884885|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83884886|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884887|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884888|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83884889|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884890|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
83884891|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83884892|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83884893|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
83884894|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83884895|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
83884896|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884897|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884898|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83884899|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884900|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83884901|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
83884902|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884903|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83884904|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83884905|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
83884906|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
83884907|NCT00242853|Protective Agents|protective agents|mesh-ancestor
83884908|NCT00220259|Fluticasone|fluticasone|mesh-list
83884909|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884910|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83884911|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
83884912|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884913|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884914|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83884915|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
83884916|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
83884917|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83884918|NCT04622956|Methotrexate|methotrexate|mesh-list
83884919|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83884920|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
83884921|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83884922|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884923|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83884924|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
83884925|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884926|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884927|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
83884928|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884929|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83884930|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83884931|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
83884932|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884933|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83884934|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
83884935|NCT04622566|Lenvatinib|lenvatinib|mesh-list
83884936|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83884937|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884938|NCT04622566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83884939|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884940|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83884941|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884942|NCT04622488|Diclofenac|diclofenac|mesh-list
83884943|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83884944|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83884945|NCT04622488|Analgesics|analgesics|mesh-ancestor
83884946|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
83884947|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83884948|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884949|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83884950|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83884951|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83884952|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884953|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884954|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
83884955|NCT00220298|Testosterone|testosterone|mesh-list
83884956|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
83884957|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
83884958|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83884959|NCT00220298|Androgens|androgens|mesh-ancestor
83884960|NCT00220298|Hormones|hormones|mesh-ancestor
83884961|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83884962|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884963|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83884964|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884965|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
83884966|NCT00220337|Lacosamide|lacosamide|mesh-list
83884967|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
83884968|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83884969|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83884970|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83884971|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884972|NCT00412412|Trastuzumab|trastuzumab|mesh-list
83884973|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83884974|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83884975|NCT04621669|Metformin|metformin|mesh-list
83884976|NCT04621669|Digoxin|digoxin|mesh-list
83884977|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83884978|NCT04621669|Calcium|calcium|mesh-list
83884979|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83884980|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83884981|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83884982|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83884983|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83884984|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
83884985|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884986|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83884987|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83884988|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884989|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83884990|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83884991|NCT04621669|Protective Agents|protective agents|mesh-ancestor
83884992|NCT00412646|Etravirine|etravirine|mesh-list
83884993|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83884994|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83884995|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83884996|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83884997|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
83884998|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83884999|NCT00243009|Cyclosporine|cyclosporine|mesh-list
83885000|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
83885001|NCT00243009|Fludarabine|fludarabine|mesh-list
83885002|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
83885003|NCT00243009|Cyclosporins|cyclosporins|mesh-list
83885004|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885005|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83885006|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
83885007|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885008|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885009|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
83885010|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885011|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885012|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
83885013|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885014|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885015|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885016|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83885017|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83885018|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83885019|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
83885020|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885021|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
83885022|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83885023|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83885024|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
83885025|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885026|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83885027|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83885028|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885029|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885030|NCT04621513|Montelukast|montelukast|mesh-list
83885031|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83885032|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
83885033|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83885034|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
83885035|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885036|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885037|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83885038|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83885039|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885040|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
83885041|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83885042|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83885043|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83885044|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885045|NCT00562705|Hormones|hormones|mesh-list
83885046|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885047|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885048|NCT04620967|Insulin|insulin|mesh-list
83885049|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83885050|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
83885051|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
83885052|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83885053|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83885054|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885055|NCT00220493|Methylphenidate|methylphenidate|mesh-list
83885056|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83885057|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885058|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83885059|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83885060|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885061|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885062|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
83885063|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885064|NCT04620616|Menthol|menthol|mesh-list
83885065|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
83885066|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885067|NCT00220532|Folic Acid|folic acid|mesh-list
83885068|NCT00220532|Riboflavin|riboflavin|mesh-list
83885069|NCT00220532|Hematinics|hematinics|mesh-ancestor
83885070|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
83885071|NCT00220532|Vitamins|vitamins|mesh-ancestor
83885072|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
83885073|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885074|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83885075|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885076|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
83885077|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885078|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
83885079|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885080|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885081|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83885082|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
83885083|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885084|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885085|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83885087|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885088|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83885089|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83885090|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83885091|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885092|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83885093|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885094|NCT04620031|Propofol|propofol|mesh-list
83885095|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83885096|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885097|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885098|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83885099|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
83885100|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
83885101|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83885102|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83885103|NCT00220649|Leucovorin|leucovorin|mesh-list
83885104|NCT00220649|Gemcitabine|gemcitabine|mesh-list
83885105|NCT00220649|Fluorouracil|fluorouracil|mesh-list
83885106|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
83885107|NCT00220649|Irinotecan|irinotecan|mesh-list
83885108|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83885109|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
83885110|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885111|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885112|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885113|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
83885114|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885115|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83885116|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83885117|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885118|NCT00220649|Antidotes|antidotes|mesh-ancestor
83885119|NCT00220649|Protective Agents|protective agents|mesh-ancestor
83885120|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
83885121|NCT00220649|Vitamins|vitamins|mesh-ancestor
83885122|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
83885123|NCT04619758|Emollients|emollients|mesh-list
83885124|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885125|NCT04619914|Letrozole|letrozole|mesh-list
83885126|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885127|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83885128|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83885129|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885130|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885131|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83885132|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
83885133|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885134|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885135|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
83885136|NCT00220766|Antibodies|antibodies|mesh-list
83885137|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
83885138|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83885139|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83885140|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
83885141|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
83885142|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885143|NCT04619875|Lactulose|lactulose|mesh-list
83885144|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885145|NCT04619290|Methylene Blue|methylene blue|mesh-list
83885146|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885147|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885148|NCT04619563|Docetaxel|docetaxel|mesh-list
83885149|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885150|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
83885151|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
83885152|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
83885153|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885154|NCT00220844|Amitriptyline|amitriptyline|mesh-list
83885155|NCT00220844|Desipramine|desipramine|mesh-list
83885156|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83885157|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
83885158|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885159|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83885160|NCT00220844|Analgesics|analgesics|mesh-ancestor
83885161|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
83885162|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885163|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885164|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83885165|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83885166|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885167|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885168|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
83885169|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885170|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885171|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
83885172|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83885173|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885174|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83885175|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
83885176|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885177|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885178|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885179|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885180|NCT04619251|Itraconazole|itraconazole|mesh-list
83885181|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
83885182|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885183|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83885184|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83885185|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885186|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885187|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83885188|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
83885189|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885190|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885191|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83885192|NCT00243399|Oxandrolone|oxandrolone|mesh-list
83885193|NCT00243399|Androgens|androgens|mesh-ancestor
83885194|NCT00243399|Hormones|hormones|mesh-ancestor
83885195|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885196|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885197|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
83885198|NCT00220922|Ethanol|ethanol|mesh-list
83885199|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83885200|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885201|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885202|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885203|NCT00221000|Methoxsalen|methoxsalen|mesh-list
83885204|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83885205|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885206|NCT00243477|Escitalopram|escitalopram|mesh-list
83885207|NCT00243477|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83885208|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83885209|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885210|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885211|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885212|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
83885213|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885214|NCT00221039|Methoxsalen|methoxsalen|mesh-list
83885215|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83885216|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885217|NCT00562939|Vaccines|vaccines|mesh-list
83885218|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83885219|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
83885220|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885221|NCT00221156|Acarbose|acarbose|mesh-list
83885222|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83885223|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885224|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885225|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83885226|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885227|NCT04617613|Amoxicillin|amoxicillin|mesh-list
83885228|NCT04617613|Metronidazole|metronidazole|mesh-list
83885229|NCT04617613|Clarithromycin|clarithromycin|mesh-list
83885230|NCT04617613|Omeprazole|omeprazole|mesh-list
83885231|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885232|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885233|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83124277|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
83885235|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83885236|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885237|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83885238|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885239|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885240|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83885241|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83885242|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83885243|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
83885244|NCT04617652|Analgesics|analgesics|mesh-ancestor
83885245|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
83885246|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885247|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885248|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
83885249|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885250|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83885251|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
83885252|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83885253|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885254|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885255|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83885256|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
83885257|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83885258|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83885259|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83885260|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885261|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83885262|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83885263|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885264|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885265|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
83885266|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885267|NCT00221312|Alendronate|alendronate|mesh-list
83885268|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83885269|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885270|NCT04616872|Methotrexate|methotrexate|mesh-list
83885271|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83885272|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
83885273|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83885274|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885275|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83885276|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
83885277|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885278|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885279|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885280|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885281|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83885282|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885283|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
83885284|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885285|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83885286|NCT00221390|Ropinirole|ropinirole|mesh-list
83885287|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83885288|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83885289|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
83885290|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
83885291|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885292|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885293|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885294|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
83885295|NCT00247650|Letrozole|letrozole|mesh-list
83885296|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885297|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83885298|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83885299|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885300|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885301|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83885302|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
83885303|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885304|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885305|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83885306|NCT00221429|Valproic Acid|valproic acid|mesh-list
83885307|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885308|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885309|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885310|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
83885311|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83885312|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885313|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885314|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
83885315|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
83885316|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885317|NCT00563017|Risperidone|risperidone|mesh-list
83885318|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83885319|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
83885320|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885321|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885322|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885323|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83885324|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83885325|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885326|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885327|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83885328|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
83885329|NCT00563056|Fluticasone|fluticasone|mesh-list
83885330|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
83885331|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83885332|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
83885333|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885334|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885335|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83885336|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
83885337|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83885338|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83885339|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83885340|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
83885341|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885342|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885343|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885344|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885345|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83885346|NCT00563095|Interferons|interferons|mesh-list
83885347|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885348|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
83885349|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885350|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83885351|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
83885352|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885353|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83885354|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83885355|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885356|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885357|NCT00563212|Interferons|interferons|mesh-list
83885358|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
83885359|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885360|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
83885361|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885362|NCT00563251|Azithromycin|azithromycin|mesh-list
83885363|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885364|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885365|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83885366|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83885367|NCT00251082|Estradiol|estradiol|mesh-list
83885368|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83885369|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
83885370|NCT00251082|Estrogens|estrogens|mesh-ancestor
83885371|NCT00251082|Hormones|hormones|mesh-ancestor
83885372|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885373|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885374|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83885375|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
83885376|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83885377|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83885378|NCT00251082|Progestins|progestins|mesh-ancestor
83885379|NCT00221624|Ribavirin|ribavirin|mesh-list
83885380|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83885381|NCT00221624|Amantadine|amantadine|mesh-list
83885382|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
83885383|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885384|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
83885385|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885386|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83885387|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83885388|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
83885389|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885390|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885391|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83885392|NCT00221624|Analgesics|analgesics|mesh-ancestor
83885393|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
83885394|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885395|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
83885396|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83885397|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
83885398|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83885399|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
83885400|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885401|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885402|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
83885403|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83885404|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
83885405|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885406|NCT04615702|Acetaminophen|acetaminophen|mesh-list
83885407|NCT04615702|Metronidazole|metronidazole|mesh-list
83885408|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
83885409|NCT04615702|Imipenem|imipenem|mesh-list
83885410|NCT04615702|Diclofenac|diclofenac|mesh-list
83885411|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83885412|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
83885413|NCT04615702|Secretin|secretin|mesh-list
83885414|NCT04615702|Bilirubin|bilirubin|mesh-list
83885415|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885416|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83885417|NCT04615702|Analgesics|analgesics|mesh-ancestor
83885418|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
83885419|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885420|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
83885421|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885422|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885423|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83885424|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83885425|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885426|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885427|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83885428|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885429|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885430|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83885431|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83885432|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885433|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83885434|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83885435|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83885436|NCT04615702|Narcotics|narcotics|mesh-ancestor
83885437|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885438|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885439|NCT04615702|Hormones|hormones|mesh-ancestor
83885440|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885441|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
83885442|NCT04615702|Protective Agents|protective agents|mesh-ancestor
83885443|NCT04615351|Metformin|metformin|mesh-list
83885444|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83885445|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885446|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
83885447|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83885448|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
83885449|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885450|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
83885451|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885452|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83885453|NCT04614727|Calcium|calcium|mesh-list
83885454|NCT04614727|Fluorides|fluorides|mesh-list
83885455|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83885456|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885457|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
83885458|NCT04614727|Protective Agents|protective agents|mesh-ancestor
83885459|NCT04614298|Brodalumab|brodalumab|mesh-list
83885460|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885461|NCT04614259|Bupivacaine|bupivacaine|mesh-list
83885462|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
83885463|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
83885464|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885465|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885466|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
83885467|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885468|NCT00412763|Silymarin|silymarin|mesh-list
83885469|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
83885470|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885471|NCT00412763|Protective Agents|protective agents|mesh-ancestor
83885472|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885473|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
83885474|NCT00563446|Hematinics|hematinics|mesh-ancestor
83885475|NCT00563485|Doxazosin|doxazosin|mesh-list
83885476|NCT00563485|Terazosin|terazosin|mesh-list
83885477|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83885478|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83885479|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83885480|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83885481|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83885482|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885483|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885484|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885485|NCT00563485|Urological Agents|urological agents|mesh-ancestor
83885486|NCT00251277|Rituximab|rituximab|mesh-list
83885487|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83885488|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885489|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
83885490|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885491|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885492|NCT00412802|Enoxaparin|enoxaparin|mesh-list
83885493|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
83885494|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
83885495|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83885496|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83885497|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885498|NCT00563524|Fezakinumab|fezakinumab|mesh-list
83885499|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885500|NCT04613869|Hydromorphone|hydromorphone|mesh-list
83885501|NCT04613869|Esketamine|esketamine|mesh-list
83885502|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83885503|NCT04613869|Narcotics|narcotics|mesh-ancestor
83885504|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885505|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885506|NCT04613869|Analgesics|analgesics|mesh-ancestor
83885507|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
83885508|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885509|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
83885510|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885511|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
83885512|NCT04613557|Fludarabine|fludarabine|mesh-list
83885513|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
83885514|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885515|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
83885516|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885517|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885518|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83885519|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
83885520|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885521|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885522|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83885523|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83885524|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
83885525|NCT00251355|Gemcitabine|gemcitabine|mesh-list
83885526|NCT00251355|Fluorouracil|fluorouracil|mesh-list
83885527|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83885528|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
83885529|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885530|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885531|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885532|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
83885533|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885534|NCT02962388|Anagrelide|anagrelide|mesh-list
83885535|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83885536|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83885537|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885538|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83885539|NCT04613167|Evolocumab|evolocumab|mesh-list
83885540|NCT04613167|Alirocumab|alirocumab|mesh-list
83885541|NCT04613167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83885542|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83885543|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83885544|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
83885545|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885546|NCT04613167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83885547|NCT04613167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83885548|NCT04613167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885549|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83885550|NCT04613284|Durvalumab|durvalumab|mesh-list
83885551|NCT04613284|Endostar protein|endostar protein|mesh-list
83885552|NCT04613284|Endostatins|endostatins|mesh-list
83885553|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83885554|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885555|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83885556|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83885557|NCT04613284|Growth Substances|growth substances|mesh-ancestor
83885558|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885559|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
83885560|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83885561|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
83885562|NCT00248118|Bupropion|bupropion|mesh-list
83885563|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83885564|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
83885565|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885566|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83885567|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83885568|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885569|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885570|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
83885571|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885572|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885573|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83885574|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83885575|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885576|NCT04612894|Apatinib|apatinib|mesh-list
83885577|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885578|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83885579|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885580|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885581|NCT00251394|Rituximab|rituximab|mesh-list
83885582|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83885583|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885584|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
83885585|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885586|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885587|NCT00221975|Lamotrigine|lamotrigine|mesh-list
83885588|NCT00221975|Valproic Acid|valproic acid|mesh-list
83885589|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885590|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885591|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885592|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
83885593|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83885594|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885595|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885596|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
83885597|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83885598|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885599|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83885600|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83885601|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83885602|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
83885603|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885604|NCT04612582|Thalidomide|thalidomide|mesh-list
83885605|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
83885606|NCT04612582|Bortezomib|bortezomib|mesh-list
83885607|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885608|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
83885609|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885610|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885611|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83885612|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
83885613|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885614|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885615|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83885616|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
83885617|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885618|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885619|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83885620|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83885621|NCT04612582|Growth Substances|growth substances|mesh-ancestor
83885622|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
83885624|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885625|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83885626|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885627|NCT00251472|Paclitaxel|paclitaxel|mesh-list
83885628|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83885629|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885630|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83885631|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83885632|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83885633|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885634|NCT00222053|Diphosphonates|diphosphonates|mesh-list
83885635|NCT00222053|Thalidomide|thalidomide|mesh-list
83885636|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885637|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
83885638|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885639|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
83885640|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885641|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885642|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83885643|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83885644|NCT00222053|Growth Substances|growth substances|mesh-ancestor
83885645|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
83885646|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885647|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83885648|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
83885649|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885650|NCT04611958|Bupivacaine|bupivacaine|mesh-list
83885651|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
83885652|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
83885653|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885654|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885655|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
83885656|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885657|NCT00412919|Azacitidine|azacitidine|mesh-list
83885658|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83885659|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
83885660|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885661|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885662|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885663|NCT00222170|Rabeprazole|rabeprazole|mesh-list
83885664|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83885665|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885666|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83885667|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885668|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885669|NCT04611724|Folfirinox|folfirinox|mesh-list
83885670|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885671|NCT00563758|Tegaserod|tegaserod|mesh-list
83885672|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83885673|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
83885674|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885675|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885676|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885677|NCT00563836|Catumaxomab|catumaxomab|mesh-list
83885678|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885679|NCT00563875|Aspirin|aspirin|mesh-list
83885680|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83885681|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83885682|NCT00563875|Analgesics|analgesics|mesh-ancestor
83885683|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
83885684|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885685|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885686|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885687|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885688|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83885689|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83885690|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885691|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83885692|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83885693|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885695|NCT04611685|Parecoxib|parecoxib|mesh-list
83885696|NCT04611685|Loxoprofen|loxoprofen|mesh-list
83885697|NCT04611685|Tramadol|tramadol|mesh-list
83885698|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83885699|NCT04611685|Narcotics|narcotics|mesh-ancestor
83885700|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885701|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885702|NCT04611685|Analgesics|analgesics|mesh-ancestor
83885703|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
83885704|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885705|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83885706|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83885707|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885708|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885709|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83885710|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83885711|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885712|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885713|NCT00563914|Amodiaquine|amodiaquine|mesh-list
83885714|NCT00563914|Ferroquine|ferroquine|mesh-list
83885715|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
83885716|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83885717|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83885718|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885719|NCT00563953|Doxorubicin|doxorubicin|mesh-list
83885720|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83885721|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885722|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83885723|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83885724|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885725|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885726|NCT00563992|Valproic Acid|valproic acid|mesh-list
83885727|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885728|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885729|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885730|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
83885731|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83885732|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885733|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885734|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
83885735|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
83885736|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885737|NCT00251550|Pemetrexed|pemetrexed|mesh-list
83885738|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885739|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885740|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885741|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83885742|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83885743|NCT04611373|Levamisole|levamisole|mesh-list
83885744|NCT04611373|Acetazolamide|acetazolamide|mesh-list
83885745|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
83885746|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83885747|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885748|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885749|NCT04611373|Diuretics|diuretics|mesh-ancestor
83885750|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
83885751|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885752|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83885753|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
83885754|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
83885755|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
83885756|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83885757|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885758|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885759|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83885760|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
83885761|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83124812|NCT02483169|Aspirin|aspirin|mesh-list
83885762|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
83885763|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83885764|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885765|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83885766|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83885767|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83885768|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885769|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83885770|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83885771|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83885772|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
83885773|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
83885774|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885775|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
83885776|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83885777|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83885778|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885779|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
83885780|NCT04610164|Coagulants|coagulants|mesh-ancestor
83885781|NCT00222443|Irinotecan|irinotecan|mesh-list
83885782|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83885783|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83885784|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885785|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885786|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885787|NCT04610398|Dexamethasone|dexamethasone|mesh-list
83885788|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
83885789|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885790|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
83885791|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
83885792|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885793|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885794|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885795|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
83885796|NCT04610398|Hormones|hormones|mesh-ancestor
83885797|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885798|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83885799|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885800|NCT00222482|Valproic Acid|valproic acid|mesh-list
83885801|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
83885802|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885803|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885804|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
83885805|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885806|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885807|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
83885808|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83885809|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885810|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885811|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
83885812|NCT04610125|Fludarabine|fludarabine|mesh-list
83885813|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885814|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
83885815|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885816|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885817|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83885818|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
84048319|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885819|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885820|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885821|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83885822|NCT00564148|Bevacizumab|bevacizumab|mesh-list
83885823|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83885824|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885825|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83885826|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83885827|NCT00564148|Growth Substances|growth substances|mesh-ancestor
83885828|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885829|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
83885830|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
83885831|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83885832|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885833|NCT04609540|Trastuzumab|trastuzumab|mesh-list
83885834|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83885835|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885836|NCT00564187|Irbesartan|irbesartan|mesh-list
83885837|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83885838|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83885839|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83885840|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885841|NCT00222677|Aspirin|aspirin|mesh-list
83885842|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83885843|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83885844|NCT00222677|Analgesics|analgesics|mesh-ancestor
83885845|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
83885846|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885847|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885848|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885849|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83885850|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83885851|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83885852|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885853|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83885854|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83885855|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885856|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
83885857|NCT00564460|Finasteride|finasteride|mesh-list
83885858|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83885859|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83885860|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885861|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885862|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
83885863|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885864|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885865|NCT00564460|Urological Agents|urological agents|mesh-ancestor
83885866|NCT04609033|Ketamine|ketamine|mesh-list
83885867|NCT04609033|Morphine|morphine|mesh-list
83885868|NCT04609033|Bupivacaine|bupivacaine|mesh-list
83885869|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
83885870|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
83885871|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885872|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885873|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
83885874|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885875|NCT04609033|Analgesics|analgesics|mesh-ancestor
83885876|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83885877|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83885878|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
83885879|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83885880|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83885881|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885882|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885883|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83885884|NCT04609033|Narcotics|narcotics|mesh-ancestor
83885885|NCT00248313|Sirolimus|sirolimus|mesh-list
83885886|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83885887|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885888|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83885889|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885890|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
83885891|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885892|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
83885893|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885894|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83885895|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83885896|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83885897|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885898|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885899|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
83885900|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885901|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885902|NCT04608253|Choline|choline|mesh-list
83885903|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
83885904|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83885905|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
83885906|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885907|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83885908|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83885909|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
83885910|NCT00222833|Aripiprazole|aripiprazole|mesh-list
83885911|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
83885912|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83885913|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83885914|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83885915|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83885916|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885917|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
83885918|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
83885919|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885920|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885921|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83885922|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83885923|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
83885924|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83885925|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83885926|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83885927|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83885928|NCT00564538|Tacrolimus|tacrolimus|mesh-list
83885929|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
83885930|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83885931|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83885932|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
83885933|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885934|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83885935|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885936|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885937|NCT00251706|Amiodarone|amiodarone|mesh-list
83885938|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83885939|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
83885940|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83885941|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83885942|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885943|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83885944|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83885945|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83885946|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885947|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83885948|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83885949|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83885950|NCT00199121|Zidovudine|zidovudine|mesh-list
83885951|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
83885952|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885953|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83885954|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83885955|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885956|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
83885957|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885958|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83885959|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83885960|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
83885961|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83885962|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83885963|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83885964|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
83885965|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83885966|NCT00199160|Sorafenib|sorafenib|mesh-list
83885967|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83885968|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83885969|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885970|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885971|NCT04607629|Omalizumab|omalizumab|mesh-list
83885972|NCT04607629|Budesonide|budesonide|mesh-list
83885973|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
83885974|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83885975|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83885976|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83885977|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83885978|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
83885979|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83885980|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83885981|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83885982|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
83125026|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
83885984|NCT04607629|Hormones|hormones|mesh-ancestor
83885985|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83885986|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83885987|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83885988|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83885989|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
83885990|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83885991|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83885992|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83885993|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
83885994|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
83885995|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
83885996|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83885997|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83885998|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83885999|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886000|NCT00251784|Urological Agents|urological agents|mesh-ancestor
83886001|NCT00248430|Aldesleukin|aldesleukin|mesh-list
83886002|NCT00248430|Melphalan|melphalan|mesh-list
83886003|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83886004|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
83886005|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886006|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886007|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83886008|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886009|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
83886010|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886011|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83886012|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83886013|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
83886014|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886015|NCT05556356|Acetaminophen|acetaminophen|mesh-list
83886016|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83886017|NCT05556356|Analgesics|analgesics|mesh-ancestor
83886018|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
83886019|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886020|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886021|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
83886022|NCT00564655|Epinephrine|epinephrine|mesh-list
83886023|NCT00564655|Racepinephrine|racepinephrine|mesh-list
83886024|NCT00564655|Bupivacaine|bupivacaine|mesh-list
83886025|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
83886026|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
83886027|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
83886028|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886029|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886030|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
83886031|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886032|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83886033|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83886034|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83886035|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886036|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886037|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83886038|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83886039|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
83886040|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83886041|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83886042|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
83886043|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
83886044|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83886045|NCT04606537|Itraconazole|itraconazole|mesh-list
83886046|NCT04606537|Rifampin|rifampin|mesh-list
83886047|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
83886048|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886049|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83886050|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83886051|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886052|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886053|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83886054|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
83886055|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886056|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886057|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83886058|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83886059|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
83886060|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83886061|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
83886062|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83886063|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83886064|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83886065|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83886066|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83886067|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83886068|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83886069|NCT00251823|Eptifibatide|eptifibatide|mesh-list
83886070|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83886071|NCT04606225|Losartan|losartan|mesh-list
83886072|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83886073|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83886074|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83886075|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83886076|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886077|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83886078|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886079|NCT04606108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83886080|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886081|NCT04719507|Meperidine|meperidine|mesh-list
83886082|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83886083|NCT04719507|Narcotics|narcotics|mesh-ancestor
83886084|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886085|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886086|NCT04719507|Analgesics|analgesics|mesh-ancestor
83886087|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
83886088|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886089|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83886090|NCT04605952|Antibodies|antibodies|mesh-list
83886091|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
83886092|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
83886093|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886094|NCT04605562|Palbociclib|palbociclib|mesh-list
83886095|NCT04605562|Antibodies|antibodies|mesh-list
83886096|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
83886097|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
83886098|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886099|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886100|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83886101|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886102|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886103|NCT00251901|Esomeprazole|esomeprazole|mesh-list
83886104|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83886105|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886106|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83886107|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886108|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886109|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
83886110|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83886111|NCT00564772|Ritonavir|ritonavir|mesh-list
83886112|NCT00564772|Lopinavir|lopinavir|mesh-list
83886113|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
83886114|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83886115|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83886116|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
83886117|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886118|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886119|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83886120|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83886121|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
83886122|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886123|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83886124|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83886125|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83886126|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83886127|NCT00251940|Glyburide|glyburide|mesh-list
83886128|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83886129|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886130|NCT04604938|Losartan|losartan|mesh-list
83886131|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83886132|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83886133|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83886134|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83886135|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886136|NCT00565006|Anacetrapib|anacetrapib|mesh-list
83886137|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83886138|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83886139|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
83886140|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886141|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83886142|NCT00565123|Levofloxacin|levofloxacin|mesh-list
83886143|NCT00565123|Ofloxacin|ofloxacin|mesh-list
83886144|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83886145|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83886146|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83886147|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886148|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83886149|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83886150|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83886151|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886152|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886153|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886154|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83886155|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83886156|NCT04604509|Bupropion|bupropion|mesh-list
83886157|NCT04604509|Nicotine|nicotine|mesh-list
83886158|NCT04604509|Varenicline|varenicline|mesh-list
83886159|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83886160|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
83886161|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886162|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886163|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83886164|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83886165|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
83886166|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886167|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886168|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83886169|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
83886170|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886171|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83886172|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83886173|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83886174|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
83886175|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83886176|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83886177|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886178|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
83886179|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83886180|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886181|NCT04603729|Dexamethasone|dexamethasone|mesh-list
83886182|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
83886183|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83886184|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83886185|NCT04603729|Prednisolone|prednisolone|mesh-list
83886186|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
83886187|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83886188|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
83886189|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886190|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
83886191|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
83886192|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886193|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886194|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886195|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
83886196|NCT04603729|Hormones|hormones|mesh-ancestor
83886197|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886198|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83886199|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886200|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83886201|NCT04603729|Protective Agents|protective agents|mesh-ancestor
83886202|NCT04603924|Niclosamide|niclosamide|mesh-list
83886203|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
83886204|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83886205|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
83886206|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83886207|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886208|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
83886209|NCT04603573|Listerine|listerine|mesh-list
83886210|NCT04603573|Fluorides|fluorides|mesh-list
83886211|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
83886212|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
83886213|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
83886214|NCT04603573|Protective Agents|protective agents|mesh-ancestor
83886215|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886216|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83886217|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886218|NCT05361824|Acetaminophen|acetaminophen|mesh-list
83886219|NCT05361824|Ketorolac|ketorolac|mesh-list
83886220|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83886221|NCT05361824|Analgesics|analgesics|mesh-ancestor
83886222|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
83886223|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886224|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886225|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
83886226|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83886227|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886228|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83886229|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83886230|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886231|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886232|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
83886233|NCT04603456|Antacids|antacids|mesh-ancestor
83886234|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886235|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886236|NCT05285813|Acetaminophen|acetaminophen|mesh-list
83886237|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
83886238|NCT05285813|Promethazine|promethazine|mesh-list
83886239|NCT05285813|Dexamethasone|dexamethasone|mesh-list
83886240|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886241|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
83886242|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
83886243|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886244|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886245|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886246|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
83886247|NCT05285813|Hormones|hormones|mesh-ancestor
83886248|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886249|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83886250|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886251|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83886252|NCT05285813|Analgesics|analgesics|mesh-ancestor
83886253|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
83886254|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
83886255|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83886256|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83886257|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886258|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
83886259|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
83886260|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83886261|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
83886262|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
83886263|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886264|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886265|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83886266|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
83886267|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83886268|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
83886269|NCT00252291|Miotics|miotics|mesh-ancestor
83886270|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
83886271|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886272|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886273|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83886274|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83886275|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
83886276|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83886277|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83886278|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
83886279|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886280|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886281|NCT00565240|Letrozole|letrozole|mesh-list
83886282|NCT00565240|NuvaRing|nuvaring|mesh-list
83886283|NCT00565240|Desogestrel|desogestrel|mesh-list
83886284|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886285|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83886286|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83886287|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886288|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886289|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83886290|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
83886291|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886292|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886293|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83886294|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
83886295|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83886296|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83886297|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83886298|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83886299|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83886300|NCT00565240|Progestins|progestins|mesh-ancestor
83886301|NCT00565240|Hormones|hormones|mesh-ancestor
83886302|NCT04602247|Fesoterodine|fesoterodine|mesh-list
83886303|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83886304|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83886305|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
83886306|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886307|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886308|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886309|NCT04602247|Urological Agents|urological agents|mesh-ancestor
83886310|NCT00252330|Amibegron|amibegron|mesh-list
83886311|NCT00252330|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83886312|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83886313|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83886314|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
83886315|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886316|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886317|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886318|NCT00252330|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83886319|NCT04602013|Paclitaxel|paclitaxel|mesh-list
83886320|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83886321|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83886322|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886323|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83886324|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83886325|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83886326|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886327|NCT04601701|Dexamethasone|dexamethasone|mesh-list
83886328|NCT04601701|Bevacizumab|bevacizumab|mesh-list
83886329|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83886330|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886331|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83886332|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83886333|NCT04601701|Growth Substances|growth substances|mesh-ancestor
83886334|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886335|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
83886336|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886337|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
83886338|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
83886339|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886340|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886341|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
83886342|NCT04601701|Hormones|hormones|mesh-ancestor
83886343|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886344|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83886345|NCT00252369|Infliximab|infliximab|mesh-list
83886346|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83125402|NCT05871957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83125403|NCT05871957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83125404|NCT05871684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83125405|NCT05871684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125406|NCT05871684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83125407|NCT05871684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125418|NCT05871424|Buprenorphine|buprenorphine|mesh-list
83125419|NCT05871424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83125420|NCT05871424|Narcotics|narcotics|mesh-ancestor
83886347|NCT00252369|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83886348|NCT00252369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886349|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
83886350|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886351|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83886352|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
83886353|NCT00252369|Coagulants|coagulants|mesh-ancestor
83886354|NCT00565318|Benphothiamine|benphothiamine|mesh-list
83886355|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83886356|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
83886357|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886358|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
83886359|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
83886360|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886361|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
83886362|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
83886363|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83886364|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83886365|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886366|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886367|NCT05201144|Urological Agents|urological agents|mesh-ancestor
83886368|NCT00252408|Hormones|hormones|mesh-list
83886369|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886370|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886371|NCT04601389|Omalizumab|omalizumab|mesh-list
83886372|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83886373|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83886374|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83886375|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
83886376|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
83886377|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886378|NCT00565396|Losartan|losartan|mesh-list
83886379|NCT00565396|Fosinopril|fosinopril|mesh-list
83886380|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83886381|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83886382|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83886383|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83886384|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886385|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83886386|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
83886387|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886388|NCT04601116|Atorvastatin|atorvastatin|mesh-list
83886389|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83886390|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83886391|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
83886392|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886393|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83886394|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83886395|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886396|NCT00249132|Risperidone|risperidone|mesh-list
83886397|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83886398|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
83886399|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886400|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886401|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886402|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83886403|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83886404|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886405|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886406|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83886407|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
83886408|NCT04600492|Riociguat|riociguat|mesh-list
83886409|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
83886410|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886411|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83886412|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83886413|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886414|NCT00414648|Sirolimus|sirolimus|mesh-list
83886415|NCT00414648|Temsirolimus|temsirolimus|mesh-list
83886416|NCT00414648|MTOR Inhibitors|mtor inhibitors|mesh-list
83886417|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83886418|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886419|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83886420|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886421|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
83886422|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886423|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
83886424|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886425|NCT00414648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83886426|NCT00414648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886427|NCT00414648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886428|NCT00414687|Iloprost|iloprost|mesh-list
83886429|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83886430|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
83886431|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
83886432|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83886433|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83886434|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886435|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
83886436|NCT04599205|Coagulants|coagulants|mesh-ancestor
83886437|NCT05070260|Glenzocimab|glenzocimab|mesh-list
83886438|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
83886439|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
83886440|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
83886441|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886442|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886443|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886444|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
83886445|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83886446|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886447|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886448|NCT05055128|Lansoprazole|lansoprazole|mesh-list
83886449|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
83886450|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83886451|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886452|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83886453|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886454|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886455|NCT00565591|Albuterol|albuterol|mesh-list
83886456|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83886457|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
83886458|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886459|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886460|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83886461|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
83886462|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
83886463|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83886464|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83886465|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83886466|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83886467|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
83886468|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886469|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886470|NCT00252603|Galantamine|galantamine|mesh-list
83886471|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83886472|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886473|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886474|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
83886475|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886476|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886477|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83886478|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
83886479|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886480|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
83886481|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
83886482|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83886483|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83886484|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886485|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83886486|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83886487|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886488|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886489|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886490|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83886491|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
83886492|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83886493|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886494|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83886495|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83886496|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83886498|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83886499|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83886500|NCT00565708|Analgesics|analgesics|mesh-ancestor
83886501|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
83886502|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886503|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886504|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886505|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83886506|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83886507|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83886508|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886509|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83886510|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83886511|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886512|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
83886513|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83886514|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
83886515|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886516|NCT04598542|Triamcinolone|triamcinolone|mesh-list
83886517|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83886518|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83886519|NCT04598542|Lorecivivint|lorecivivint|mesh-list
83886520|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83886521|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886522|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
83886523|NCT04598542|Hormones|hormones|mesh-ancestor
83886524|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886525|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886526|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886527|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
83886528|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886529|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886530|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83886531|NCT04995263|Caffeine|caffeine|mesh-list
83886532|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83886533|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886534|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83886535|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886536|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886537|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83886538|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83886539|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
83886540|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886541|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886542|NCT04598191|Iloprost|iloprost|mesh-list
83886543|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83886544|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83886545|NCT04955366|Abatacept|abatacept|mesh-list
83886546|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83886547|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886548|NCT04955366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83886549|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886550|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886551|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
83886552|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886553|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83886554|NCT00249171|Risperidone|risperidone|mesh-list
83886555|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83886556|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
83886557|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886558|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886559|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886560|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83886561|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83886562|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886563|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886564|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83886565|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
83886566|NCT00565981|Fludarabine|fludarabine|mesh-list
83886567|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
83886568|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
83125626|NCT05855395|Dexamethasone|dexamethasone|mesh-list
83886569|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886570|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83886571|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
83886572|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886573|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886574|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
83886575|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886576|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83886577|NCT04952519|Amantadine|amantadine|mesh-list
83886578|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83886579|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83886580|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
83886581|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886582|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
83886583|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886584|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886585|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886586|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83886587|NCT04952519|Analgesics|analgesics|mesh-ancestor
83886588|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
83886589|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886590|NCT00414921|Clonidine|clonidine|mesh-list
83886591|NCT00414921|Methylphenidate|methylphenidate|mesh-list
83886592|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83886593|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886594|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83886595|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83886596|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83886597|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886598|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
83886599|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886600|NCT00414921|Analgesics|analgesics|mesh-ancestor
83886601|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
83886602|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886603|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83886604|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
83886605|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
83886606|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83886607|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83886608|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83886609|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
83886610|NCT04597762|Cyclosporine|cyclosporine|mesh-list
83886611|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
83886612|NCT04597762|Cyclosporins|cyclosporins|mesh-list
83886613|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886614|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886615|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886616|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
83886617|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886618|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
83886619|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886620|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
83886621|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83886622|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83886623|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886624|NCT00249210|Levofloxacin|levofloxacin|mesh-list
83886625|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83886626|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886627|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83886628|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83886629|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83886630|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886631|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886632|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886633|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83886634|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83886635|NCT00252798|Paclitaxel|paclitaxel|mesh-list
83886636|NCT00252798|Carboplatin|carboplatin|mesh-list
83886637|NCT00252798|Gefitinib|gefitinib|mesh-list
83125703|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125704|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125705|NCT05691712|Tirzepatide|tirzepatide|mesh-list
83125706|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83125707|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886638|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83886639|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886640|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
83886641|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83886642|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
83886643|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886644|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83886645|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886646|NCT02961660|Odalasvir|odalasvir|mesh-list
83886647|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
83886648|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886649|NCT00403013|Anesthetics|anesthetics|mesh-list
83886650|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886651|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886652|NCT00566332|Fludarabine|fludarabine|mesh-list
83886653|NCT00566332|Chlorambucil|chlorambucil|mesh-list
83886654|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886655|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886656|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83886657|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
83886658|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83886659|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83886660|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
83886661|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886662|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83886663|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83886664|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83886665|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83886666|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886667|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83886668|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886669|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886670|NCT04595929|Leucovorin|leucovorin|mesh-list
83886671|NCT04595929|Docetaxel|docetaxel|mesh-list
83886672|NCT04595929|Fluorouracil|fluorouracil|mesh-list
83886673|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
83886674|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886675|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
83886676|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
83886677|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
83886678|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886679|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
83886680|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83886681|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886682|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
83886683|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886684|NCT04595929|Antidotes|antidotes|mesh-ancestor
83886685|NCT04595929|Protective Agents|protective agents|mesh-ancestor
83886686|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
83886687|NCT04595929|Vitamins|vitamins|mesh-ancestor
83886688|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
83886689|NCT00252954|Levetiracetam|levetiracetam|mesh-list
83886690|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
83886691|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
83886692|NCT04595812|Misoprostol|misoprostol|mesh-list
83886693|NCT04595812|Hemostatics|hemostatics|mesh-list
83886694|NCT04595812|Oxytocin|oxytocin|mesh-list
83886695|NCT04595812|Carbetocin|carbetocin|mesh-list
83886696|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
83886697|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83886698|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886699|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83886700|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
83886701|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83886702|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886703|NCT04595812|Coagulants|coagulants|mesh-ancestor
83886704|NCT00249366|Lorazepam|lorazepam|mesh-list
83886705|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
83886706|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
83886707|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
83886708|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886709|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886710|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886711|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83886712|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886713|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83886714|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83886715|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886716|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
83886717|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
83886718|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886719|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886720|NCT04635683|Lenalidomide|lenalidomide|mesh-list
83886721|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
83886722|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886723|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83886724|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83886725|NCT04635683|Growth Substances|growth substances|mesh-ancestor
83886726|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
83886727|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886728|NCT00249405|Citalopram|citalopram|mesh-list
83886729|NCT00249405|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83886730|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83886731|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83886732|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886733|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886734|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
83886735|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886736|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83886737|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
83886738|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886739|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
83886740|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83886741|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
83886742|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83886743|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886744|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83886745|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83886746|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83886747|NCT00253110|Haloperidol|haloperidol|mesh-list
83886748|NCT00253110|Risperidone|risperidone|mesh-list
83886749|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
83886750|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83886751|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
83886752|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886753|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886754|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886755|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83886756|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83886757|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886758|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886759|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83886760|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
83886761|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
83886762|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
83886763|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886764|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886765|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83886766|NCT00566683|Meperidine|meperidine|mesh-list
83886767|NCT00566683|Diazepam|diazepam|mesh-list
83886768|NCT00566683|Alfentanil|alfentanil|mesh-list
83886769|NCT00566683|Propofol|propofol|mesh-list
83886770|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83886771|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886772|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886773|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83886774|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
83886775|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
83886776|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83886777|NCT00566683|Narcotics|narcotics|mesh-ancestor
83886778|NCT00566683|Analgesics|analgesics|mesh-ancestor
83886779|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
83886780|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886781|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83886782|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
83886783|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
83886784|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
83886785|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886786|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83886787|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83886788|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83886789|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83886790|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886791|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
83125856|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
83886792|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
83886793|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886794|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886795|NCT00566761|Triamcinolone|triamcinolone|mesh-list
83886796|NCT00566761|Bevacizumab|bevacizumab|mesh-list
83886797|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83886798|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886799|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83886800|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83886801|NCT00566761|Growth Substances|growth substances|mesh-ancestor
83886802|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886803|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
83886804|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886805|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
83886806|NCT00566761|Hormones|hormones|mesh-ancestor
83886807|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886808|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83886809|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886810|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83886811|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886812|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886813|NCT04593706|Dexamethasone|dexamethasone|mesh-list
83886814|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
83886815|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83886816|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83886817|NCT04593706|Prednisolone|prednisolone|mesh-list
83886818|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
83886819|NCT04593706|Triamcinolone|triamcinolone|mesh-list
83886820|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83886821|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83886822|NCT04593706|Betamethasone|betamethasone|mesh-list
83886823|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
83886824|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83886825|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
83886826|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
83886827|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
83886828|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83886829|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
83886830|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83886831|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83886832|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83886833|NCT04593706|BB 1101|bb 1101|mesh-list
83886834|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886835|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
83886836|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
83886837|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886838|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886839|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83886840|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
83886841|NCT04593706|Hormones|hormones|mesh-ancestor
83886842|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83886843|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83886844|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886845|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83886846|NCT04593706|Protective Agents|protective agents|mesh-ancestor
83886847|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83886848|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
83886849|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886850|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886851|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83886852|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
83886853|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
83886854|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83886855|NCT04593238|Calcium|calcium|mesh-list
83886856|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83886857|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886858|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83886859|NCT04593160|Acetaminophen|acetaminophen|mesh-list
83886860|NCT04593160|Diclofenac|diclofenac|mesh-list
83886861|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83886862|NCT04593160|Analgesics|analgesics|mesh-ancestor
83886863|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
83886864|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886865|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886866|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
83886867|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83886868|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886869|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83886870|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83886871|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886872|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886873|NCT00253149|Risperidone|risperidone|mesh-list
83886874|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83886875|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
83886876|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886877|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886878|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886879|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83886880|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83886881|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886882|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886883|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83886884|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
83886885|NCT04539236|Lenalidomide|lenalidomide|mesh-list
83886886|NCT04539236|Luspatercept|luspatercept|mesh-list
83886887|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
83886888|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886889|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83886890|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83886891|NCT04539236|Growth Substances|growth substances|mesh-ancestor
83886892|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
83886893|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886894|NCT04539236|Hematinics|hematinics|mesh-ancestor
83886895|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83886896|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83886897|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83886898|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83886899|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886900|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886901|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886902|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83886903|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
83886904|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886905|NCT00567034|Naltrexone|naltrexone|mesh-list
83886906|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83886907|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83886908|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886909|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
83886910|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886911|NCT04593043|Warfarin|warfarin|mesh-list
83886912|NCT04593043|Dabigatran|dabigatran|mesh-list
83886913|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
83886914|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
83886915|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83886916|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
83886917|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886918|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886919|NCT04484363|Azacitidine|azacitidine|mesh-list
83886920|NCT04484363|Pevonedistat|pevonedistat|mesh-list
83886921|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83886922|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
83886923|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886924|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886925|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886926|NCT04592380|Clevidipine|clevidipine|mesh-list
83886927|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83886928|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83886929|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83886930|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83886931|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83886932|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83886933|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886934|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83886935|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886936|NCT00253188|Galantamine|galantamine|mesh-list
83886937|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83886938|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886939|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886940|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
83886942|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886943|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83886944|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
83886945|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886946|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
83886947|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
83886948|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83886949|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83886950|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83886951|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886952|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
83886953|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
83886954|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
83886955|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83886956|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886957|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
83886958|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886959|NCT04591795|Diclofenac|diclofenac|mesh-list
83886960|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83886961|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83886962|NCT04591795|Analgesics|analgesics|mesh-ancestor
83886963|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
83886964|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886965|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886966|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83886967|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83886968|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83886969|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83886970|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886971|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
83886972|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83886973|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886974|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83886975|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886976|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83886977|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886978|NCT04719585|Analgesics|analgesics|mesh-ancestor
83886979|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
83886980|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83886981|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83886982|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83886983|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83886984|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83886985|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83886986|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
83886987|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83886988|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
83886989|NCT04592029|Bevacizumab|bevacizumab|mesh-list
83886990|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83886991|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83886992|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83886993|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83886994|NCT04592029|Growth Substances|growth substances|mesh-ancestor
83886995|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83886996|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
83886997|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83886998|NCT04409873|Listerine|listerine|mesh-list
83886999|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
83887000|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
83887001|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83887002|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887003|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
83887004|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
83887005|NCT00253227|Galantamine|galantamine|mesh-list
83887006|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83887007|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887008|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887009|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
83887010|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887011|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887012|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83887013|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
83887014|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887015|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
83887016|NCT04591444|Fluorides|fluorides|mesh-list
83887017|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
83887018|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
83887019|NCT04591444|Protective Agents|protective agents|mesh-ancestor
83887020|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887021|NCT04591327|Anesthetics|anesthetics|mesh-list
83887022|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887023|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887024|NCT04396730|Cannabidiol|cannabidiol|mesh-list
83887025|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
83887026|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
83887027|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83887028|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
83887029|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83887030|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887031|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83887032|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83887033|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83887034|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887035|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887036|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83887037|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887038|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887039|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887040|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83887041|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83887042|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83887043|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887044|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887045|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83887046|NCT00253305|Terbinafine|terbinafine|mesh-list
83887047|NCT00253305|Naftifine|naftifine|mesh-list
83887048|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
83887049|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887050|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887051|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887052|NCT04591600|Ivermectin|ivermectin|mesh-list
83887053|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83887054|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887055|NCT04591405|Vaccines|vaccines|mesh-list
83887056|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
83887057|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887058|NCT04590742|Melatonin|melatonin|mesh-list
83887059|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
83887060|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887061|NCT04590742|Protective Agents|protective agents|mesh-ancestor
83887062|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887063|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887064|NCT00253344|Docetaxel|docetaxel|mesh-list
83887065|NCT00253344|Lenalidomide|lenalidomide|mesh-list
83887066|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887067|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
83887068|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
83887069|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
83887070|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887071|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
83887072|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887073|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887074|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887075|NCT00253344|Growth Substances|growth substances|mesh-ancestor
83887076|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887077|NCT00567463|Fluticasone|fluticasone|mesh-list
83887078|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83887079|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83887080|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
83887081|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887082|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887083|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83887084|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83887085|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
83887086|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83887087|NCT00253422|Fulvestrant|fulvestrant|mesh-list
83887088|NCT00253422|Anastrozole|anastrozole|mesh-list
83126155|NCT05076110|Ibuprofen|ibuprofen|mesh-list
83887089|NCT00253422|Exemestane|exemestane|mesh-list
83887090|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83887091|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887092|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83887093|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83887094|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
83887095|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83887096|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887097|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83887098|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83887099|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887100|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887101|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83887102|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83887103|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83887104|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
83887105|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887106|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83887107|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83887108|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887109|NCT04590625|Carboplatin|carboplatin|mesh-list
83887110|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83887111|NCT04590625|Apatinib|apatinib|mesh-list
83887112|NCT04590625|Cisplatin|cisplatin|mesh-list
83887113|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887114|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887115|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83887116|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887117|NCT00253461|Topotecan|topotecan|mesh-list
83887118|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83887119|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83887120|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83887121|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887122|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887123|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887124|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83887125|NCT04272242|Pyridoxine|pyridoxine|mesh-list
83887126|NCT04272242|Pyridoxal|pyridoxal|mesh-list
83887127|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
83887128|NCT04272242|Isoniazid|isoniazid|mesh-list
83887129|NCT04272242|Rifapentine|rifapentine|mesh-list
83887130|NCT04272242|Dolutegravir|dolutegravir|mesh-list
83887131|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83887132|NCT04272242|Vitamins|vitamins|mesh-ancestor
83887133|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
83887134|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887135|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
83887136|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
83887137|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83887138|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887139|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83887140|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83887141|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
83887142|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887143|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83887144|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83887145|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83887146|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887147|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83887148|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
83887149|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83887150|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
83887151|NCT04244552|Doxorubicin|doxorubicin|mesh-list
83887152|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83887153|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
83887154|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83887155|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887156|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83887157|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83887158|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887159|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887160|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83887161|NCT04244552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83887162|NCT00567658|Esomeprazole|esomeprazole|mesh-list
83887163|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83887164|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83887165|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83887166|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887167|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887168|NCT00567697|Ranibizumab|ranibizumab|mesh-list
83887169|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887170|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887171|NCT00567697|Growth Substances|growth substances|mesh-ancestor
83887172|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887173|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887174|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887175|NCT04589494|Morphine|morphine|mesh-list
83887176|NCT04589494|Tramadol|tramadol|mesh-list
83887177|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83887178|NCT04589494|Narcotics|narcotics|mesh-ancestor
83887179|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887180|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887181|NCT04589494|Analgesics|analgesics|mesh-ancestor
83887182|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
83887183|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887184|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
83887185|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83887186|NCT04589299|Antibodies|antibodies|mesh-list
83887187|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
83887188|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887189|NCT00253500|Epirubicin|epirubicin|mesh-list
83887190|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83887191|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887192|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83887193|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83887194|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887195|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887196|NCT04589143|Agomelatine|agomelatine|mesh-list
83887197|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83887198|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887199|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887200|NCT04588987|Apatinib|apatinib|mesh-list
83887201|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887202|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83887203|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887204|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887205|NCT00253539|Tamoxifen|tamoxifen|mesh-list
83887206|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83887207|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
83887208|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83887209|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887210|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83887211|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887212|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83887213|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83887214|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83887215|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
83887216|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887217|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
83887218|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
83887219|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
83887220|NCT00567775|Insulin|insulin|mesh-list
83887221|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83887222|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83887223|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887224|NCT00567814|Oxazepam|oxazepam|mesh-list
83887225|NCT00567814|Metyrapone|metyrapone|mesh-list
83887226|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
83887227|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887228|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887229|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83887230|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887231|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887232|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83887233|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887234|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887235|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
83887236|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
83887237|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887238|NCT04588090|Cisplatin|cisplatin|mesh-list
83887239|NCT04588090|Paclitaxel|paclitaxel|mesh-list
83887240|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887241|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83887242|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
83887243|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
83887244|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
83887245|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887246|NCT00253578|Sorafenib|sorafenib|mesh-list
83887247|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887248|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83887249|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887250|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887251|NCT04588285|Ambroxol|ambroxol|mesh-list
83887252|NCT04588285|Expectorants|expectorants|mesh-ancestor
83887253|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
83887254|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
83887255|NCT04153565|Pemetrexed|pemetrexed|mesh-list
83887256|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887257|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83887258|NCT04153565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83887259|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887260|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887261|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83887262|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83887263|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
83887264|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83887265|NCT00253617|Trioxsalen|trioxsalen|mesh-list
83887266|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887267|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
83887268|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83887269|NCT04587778|Ketamine|ketamine|mesh-list
83887270|NCT04587778|Esketamine|esketamine|mesh-list
83887271|NCT04587778|Analgesics|analgesics|mesh-ancestor
83887272|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
83887273|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887274|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887275|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83887276|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83887277|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
83887278|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
83887279|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887280|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83887281|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83887282|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887283|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887284|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887285|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887286|NCT04587505|Morphine|morphine|mesh-list
83887287|NCT04587505|Tramadol|tramadol|mesh-list
83887288|NCT04587505|Anesthetics|anesthetics|mesh-list
83887289|NCT04587505|Ropivacaine|ropivacaine|mesh-list
83887290|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887291|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887292|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83887293|NCT04587505|Narcotics|narcotics|mesh-ancestor
83887294|NCT04587505|Analgesics|analgesics|mesh-ancestor
83887295|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
83887296|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887297|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
83887298|NCT04128683|Bromocriptine|bromocriptine|mesh-list
83887299|NCT04128683|Amisulpride|amisulpride|mesh-list
83887300|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83887301|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887302|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887303|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887304|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887305|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83887306|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
83887307|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887308|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887309|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83887310|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887311|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83887312|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83887313|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83887314|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83887315|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
83887316|NCT04587115|Oxycodone|oxycodone|mesh-list
83887318|NCT04587115|Ziprasidone|ziprasidone|mesh-list
83887319|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83887320|NCT04587115|Narcotics|narcotics|mesh-ancestor
83887321|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887322|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887323|NCT04587115|Analgesics|analgesics|mesh-ancestor
83887324|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
83887325|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887326|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83887327|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
83887328|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887329|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887330|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83887331|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887332|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887333|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83887334|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
83887335|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
83887336|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
83887337|NCT00403247|Pyridoxine|pyridoxine|mesh-list
83887338|NCT00403247|Vitamins|vitamins|mesh-ancestor
83887339|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
83887340|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887341|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
83887342|NCT00403247|Hematinics|hematinics|mesh-ancestor
83887343|NCT00253773|Acetaminophen|acetaminophen|mesh-list
83887344|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83887345|NCT00253773|Analgesics|analgesics|mesh-ancestor
83887346|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
83887347|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887348|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887349|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
83887350|NCT00403286|Fluticasone|fluticasone|mesh-list
83887351|NCT00403286|Xhance|xhance|mesh-list
83887352|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
83887353|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83887354|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83887355|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83887356|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
83887357|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887358|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887359|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83887360|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
83887361|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
83887362|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83887363|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83887364|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83887365|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83887366|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
83887367|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887368|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887369|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83887370|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83887371|NCT04585867|Bupivacaine|bupivacaine|mesh-list
83887372|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
83887373|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
83887374|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887375|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887376|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
83887377|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887378|NCT00253851|Heparin|heparin|mesh-list
83887379|NCT00253851|Calcium heparin|calcium heparin|mesh-list
83887380|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
83887381|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83887382|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83887383|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887384|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83887385|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83887386|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83887387|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
83887388|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887389|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83887390|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83887391|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887392|NCT04585438|Diclofenac|diclofenac|mesh-list
83887393|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83887394|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83887395|NCT04585438|Analgesics|analgesics|mesh-ancestor
83887396|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
83887397|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887398|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887399|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83887400|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83887401|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83887402|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887403|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887404|NCT00223223|Levetiracetam|levetiracetam|mesh-list
83887405|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
83887406|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
83887407|NCT00567931|Tryptophan|tryptophan|mesh-list
83887408|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83887409|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887410|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887411|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
83887412|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83887413|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887414|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83887415|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
83887416|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83887417|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887418|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887419|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887420|NCT04585321|Diclofenac|diclofenac|mesh-list
83887421|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83887422|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83887423|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83887424|NCT04585321|Analgesics|analgesics|mesh-ancestor
83887425|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
83887426|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887427|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887428|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83887429|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83887430|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83887431|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887432|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887433|NCT00412997|Panobinostat|panobinostat|mesh-list
83887434|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887435|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83887436|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887437|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887438|NCT00253929|Adenosine|adenosine|mesh-list
83887439|NCT00253929|Nitroprusside|nitroprusside|mesh-list
83887440|NCT00253929|Acetylcholine|acetylcholine|mesh-list
83887441|NCT00253929|Caffeine|caffeine|mesh-list
83887442|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83887443|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887444|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83887445|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887446|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887447|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83887448|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83887449|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
83887450|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887451|NCT00253929|Analgesics|analgesics|mesh-ancestor
83887452|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
83887453|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887454|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83887455|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
83887456|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83887457|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
83887458|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83887459|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83887460|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83887461|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
83887462|NCT00568048|Bevacizumab|bevacizumab|mesh-list
83887463|NCT00568048|Temozolomide|temozolomide|mesh-list
83887464|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83887465|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887466|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887467|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887468|NCT00568048|Growth Substances|growth substances|mesh-ancestor
83887469|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887470|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887471|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83887472|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
83887473|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887474|NCT04584580|Heparin|heparin|mesh-list
83887475|NCT04584580|Enoxaparin|enoxaparin|mesh-list
83887476|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83887477|NCT04584580|Tinzaparin|tinzaparin|mesh-list
83887478|NCT04584580|Dalteparin|dalteparin|mesh-list
83887479|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
83887480|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83887481|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83887482|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887483|NCT00250029|Capecitabine|capecitabine|mesh-list
83887484|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
83887485|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83887486|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
83887487|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887488|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887489|NCT00223418|Aripiprazole|aripiprazole|mesh-list
83887490|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887491|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887492|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83887493|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887494|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887495|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887496|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
83887497|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
83887498|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887499|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887500|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83887501|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83887502|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
83887503|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83887504|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83887505|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83887506|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83887507|NCT04584736|Ezetimibe|ezetimibe|mesh-list
83887508|NCT04584736|Pitavastatin|pitavastatin|mesh-list
83887509|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83887510|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83887511|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
83887512|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887513|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83887514|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83887515|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887516|NCT00250068|Rubitecan|rubitecan|mesh-list
83887517|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887518|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83887519|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83887520|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887521|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887522|NCT04584307|Pomalidomide|pomalidomide|mesh-list
83887523|NCT04584307|Elotuzumab|elotuzumab|mesh-list
83887524|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
83887525|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887526|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887527|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887528|NCT04584307|Growth Substances|growth substances|mesh-ancestor
83887529|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887530|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887531|NCT04584034|Albuterol|albuterol|mesh-list
83887532|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
83887533|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
83887534|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887535|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887536|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83887537|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
83887538|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
83887539|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83887540|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83887541|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83887542|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83887543|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
83887544|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887545|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887546|NCT04583410|Nicotine|nicotine|mesh-list
83887547|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83887548|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
83887549|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887550|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887551|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83887552|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83887553|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
83887554|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887555|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887556|NCT00254007|Citalopram|citalopram|mesh-list
83887557|NCT00254007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83887558|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83887559|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83887560|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887561|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887562|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
83887563|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887564|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83887565|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887566|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887567|NCT00223613|Insulin|insulin|mesh-list
83887568|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83887569|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887570|NCT04583137|Lidocaine|lidocaine|mesh-list
83887571|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
83887572|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
83887573|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887574|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887575|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
83887576|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887577|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83887578|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83887579|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83887580|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83887581|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887582|NCT00223691|Acarbose|acarbose|mesh-list
83887583|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
83887584|NCT00223691|Promethazine|promethazine|mesh-list
83887585|NCT00223691|Ibuprofen|ibuprofen|mesh-list
83887586|NCT00223691|Celecoxib|celecoxib|mesh-list
83887587|NCT00223691|Indomethacin|indomethacin|mesh-list
83887588|NCT00223691|Octreotide|octreotide|mesh-list
83887589|NCT00223691|Phenylephrine|phenylephrine|mesh-list
83887590|NCT00223691|Acetazolamide|acetazolamide|mesh-list
83887591|NCT00223691|Midodrine|midodrine|mesh-list
83887592|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
83887593|NCT00223691|Ephedrine|ephedrine|mesh-list
83887594|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
83887595|NCT00223691|Ergotamine|ergotamine|mesh-list
83887596|NCT00223691|Bromides|bromides|mesh-list
83887597|NCT00223691|Levodopa|levodopa|mesh-list
83887598|NCT00223691|Carbidopa|carbidopa|mesh-list
83887599|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83887600|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
83887601|NCT00223691|Caffeine|caffeine|mesh-list
83887602|NCT00223691|Methylphenidate|methylphenidate|mesh-list
83887603|NCT00223691|Modafinil|modafinil|mesh-list
83887604|NCT00223691|Rivastigmine|rivastigmine|mesh-list
83887605|NCT00223691|Ranitidine|ranitidine|mesh-list
83887606|NCT00223691|Yohimbine|yohimbine|mesh-list
83887607|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83887608|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83887609|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83887610|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83887611|NCT00223691|Analgesics|analgesics|mesh-ancestor
83887612|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
83887613|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887614|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887615|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83887616|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83887617|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83887618|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887619|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887620|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83887621|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83887622|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83887623|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83887624|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83887625|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
83887626|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887627|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83887628|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83887629|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83887630|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
83887631|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
83887632|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83887633|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83887634|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83887635|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83887636|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887637|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83887638|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83887639|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
83887640|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83887641|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83887642|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887643|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
83887644|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
83887645|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
83887646|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
83887647|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83887648|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
83887649|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
83887650|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83887651|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
83887652|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83887653|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83887654|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83887655|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83887656|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
83887657|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
83887658|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83887659|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83887660|NCT00223691|Diuretics|diuretics|mesh-ancestor
83887661|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
83887662|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83887663|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83887664|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83887665|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
83887666|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83887667|NCT00223691|Protective Agents|protective agents|mesh-ancestor
83887668|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
83887669|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83887670|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83887671|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83887672|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83887673|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83887674|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
83887675|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
83887676|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83887677|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83887678|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
83887679|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
83887680|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83887681|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
83887682|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83887683|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83887684|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83887685|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83887686|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83887687|NCT00223691|Urological Agents|urological agents|mesh-ancestor
83887688|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887689|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887690|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83887691|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83887692|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887693|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
83887694|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83887695|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
83887696|NCT04583020|Temozolomide|temozolomide|mesh-list
83887697|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83887698|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
83887699|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887700|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887701|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83887702|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887703|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887704|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887706|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83887707|NCT04582786|Narcotics|narcotics|mesh-ancestor
83887708|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887709|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887710|NCT04582786|Analgesics|analgesics|mesh-ancestor
83887711|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
83887712|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887713|NCT00223769|Oxandrolone|oxandrolone|mesh-list
83887714|NCT00223769|Androgens|androgens|mesh-ancestor
83887715|NCT00223769|Hormones|hormones|mesh-ancestor
83887716|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83887717|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887718|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
83887719|NCT04582084|Etanercept|etanercept|mesh-list
83887720|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83887721|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83887722|NCT04582084|Analgesics|analgesics|mesh-ancestor
83887723|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
83887724|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887725|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887726|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83887727|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83887728|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83887729|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83887730|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
83887731|NCT00254046|Etravirine|etravirine|mesh-list
83887732|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83887733|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83887734|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887735|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887736|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
83887737|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887738|NCT00223925|Maribavir|maribavir|mesh-list
83887739|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
83887740|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887741|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
83887742|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83887743|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887744|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
83887745|NCT04581967|Doxorubicin|doxorubicin|mesh-list
83887746|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83887747|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
83887748|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887749|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83887750|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83887751|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
83887752|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887753|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887754|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83887755|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83887756|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83887757|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83887758|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887759|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
83887760|NCT00223964|Hematinics|hematinics|mesh-ancestor
83887761|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
83887762|NCT00224081|Hematinics|hematinics|mesh-ancestor
83887763|NCT04581265|Paclitaxel|paclitaxel|mesh-list
83887764|NCT04581265|Ifosfamide|ifosfamide|mesh-list
83887765|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83887766|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83887767|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887768|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
83887769|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
83887770|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
83887771|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887772|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83887774|NCT04580797|PF-06700841|pf-06700841|mesh-list
83887775|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83887776|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887777|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887778|NCT00568477|Rituximab|rituximab|mesh-list
83887779|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83887780|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887781|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
83887782|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887783|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83887784|NCT00568711|Doxycycline|doxycycline|mesh-list
83887785|NCT00568711|Rifampin|rifampin|mesh-list
83887786|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83887787|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887788|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
83887789|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83887790|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83887791|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83887792|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
83887793|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
83887794|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83887795|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887796|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887797|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83887798|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83887799|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83887800|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83887801|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83887802|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83887803|NCT00415116|Carboplatin|carboplatin|mesh-list
83887804|NCT00415116|Docetaxel|docetaxel|mesh-list
83887805|NCT00415116|Lenalidomide|lenalidomide|mesh-list
83887806|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887807|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
83887808|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
83887809|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
83887810|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887811|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
83887812|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887813|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887814|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887815|NCT00415116|Growth Substances|growth substances|mesh-ancestor
83887816|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887817|NCT00568750|Dasatinib|dasatinib|mesh-list
83887818|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887819|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83887820|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887821|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887822|NCT00568789|Zolpidem|zolpidem|mesh-list
83887823|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83887824|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83887825|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887826|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887827|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83887828|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
83887829|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
83887830|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887831|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887832|NCT00254202|Iloperidone|iloperidone|mesh-list
83887833|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83887834|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887835|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887836|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887837|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887838|NCT00568984|Metformin|metformin|mesh-list
83887839|NCT00568984|Repaglinide|repaglinide|mesh-list
83887840|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83887841|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887842|NCT00254241|Risperidone|risperidone|mesh-list
83887843|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83887844|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83126934|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
83887845|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
83887846|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887847|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887848|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887850|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887851|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887852|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887853|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83887854|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
83887855|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
83887856|NCT00224315|Risperidone|risperidone|mesh-list
83887857|NCT00224315|Ziprasidone|ziprasidone|mesh-list
83887858|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83887859|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
83887860|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83887861|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887862|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887863|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83887864|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887865|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887866|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887867|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83887868|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
83887869|NCT00569101|Tacrolimus|tacrolimus|mesh-list
83887870|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83887871|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
83887872|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887873|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83887874|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887875|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887876|NCT00224354|Interleukin-2|interleukin-2|mesh-list
83887877|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
83887878|NCT00224354|Immunotoxins|immunotoxins|mesh-list
83887879|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887880|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83887881|NCT00224354|Analgesics|analgesics|mesh-ancestor
83887882|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
83887883|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887884|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887885|NCT00224354|Immunoconjugates|immunoconjugates|mesh-ancestor
83887886|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
83887887|NCT00569296|Aldesleukin|aldesleukin|mesh-list
83887888|NCT00569296|Sargramostim|sargramostim|mesh-list
83887889|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
83887890|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887891|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887892|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83887893|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83887894|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
83887895|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887896|NCT00569335|Bevacizumab|bevacizumab|mesh-list
83887897|NCT00569335|Irinotecan|irinotecan|mesh-list
83887898|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83887899|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887900|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887901|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887902|NCT00569335|Growth Substances|growth substances|mesh-ancestor
83887903|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887904|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887905|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83887906|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83887907|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887908|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887909|NCT00254319|Bevacizumab|bevacizumab|mesh-list
83887910|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83887911|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887912|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887913|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887914|NCT00254319|Growth Substances|growth substances|mesh-ancestor
83887915|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887916|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887917|NCT00569452|Insulin|insulin|mesh-list
83887918|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83887919|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83887920|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887921|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
83887922|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
83887923|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83887924|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83887925|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83887926|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83887927|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887928|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887929|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887930|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83887931|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83887932|NCT00224471|Vaccines|vaccines|mesh-list
83887933|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
83887934|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887935|NCT00569920|Dexamethasone|dexamethasone|mesh-list
83887936|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
83887937|NCT00569920|BB 1101|bb 1101|mesh-list
83887938|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83887939|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
83887940|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
83887941|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887942|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887943|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83887944|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
83887945|NCT00569920|Hormones|hormones|mesh-ancestor
83887946|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83887947|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83887948|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887949|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
83887950|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83887951|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887952|NCT00224510|Lamotrigine|lamotrigine|mesh-list
83887953|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
83887954|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83887955|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83887956|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887957|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83887958|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887959|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83887960|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83887961|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83887962|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83887963|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83887964|NCT00570193|Ranibizumab|ranibizumab|mesh-list
83887965|NCT00570193|Verteporfin|verteporfin|mesh-list
83887966|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83887967|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83887968|NCT00570193|Growth Substances|growth substances|mesh-ancestor
83887969|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887970|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
83887971|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83887972|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83887973|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83887974|NCT00224549|Amlodipine|amlodipine|mesh-list
83887975|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83887976|NCT00224549|Irbesartan|irbesartan|mesh-list
83887977|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83887978|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83887979|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83887980|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83887981|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83887982|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887983|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
83887984|NCT00224549|Diuretics|diuretics|mesh-ancestor
83887985|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
83887986|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83887987|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83887988|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83887989|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
83887990|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83887991|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
83887992|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83887993|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83887994|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83887995|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
83887996|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
83887997|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83887998|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
83887999|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888000|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888001|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
83888002|NCT00254436|Hematinics|hematinics|mesh-ancestor
83888003|NCT00224588|Ketamine|ketamine|mesh-list
83888004|NCT00224588|Analgesics|analgesics|mesh-ancestor
83888005|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
83888006|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888007|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888008|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83888009|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83888010|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
83888011|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
83888012|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888013|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83888014|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83888015|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888016|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888017|NCT00570622|Pioglitazone|pioglitazone|mesh-list
83888018|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83888019|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888020|NCT00254475|Valsartan|valsartan|mesh-list
83888021|NCT00254475|Simvastatin|simvastatin|mesh-list
83888022|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83888023|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83888024|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
83888025|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888026|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83888027|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83888028|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888029|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83888030|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83888031|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83888032|NCT00570856|Folic Acid|folic acid|mesh-list
83888033|NCT00570856|Hematinics|hematinics|mesh-ancestor
83888034|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
83888035|NCT00570856|Vitamins|vitamins|mesh-ancestor
83888036|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
83888037|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888038|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
83888039|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
83888040|NCT00570934|Vitamin D|vitamin d|mesh-list
83888041|NCT00570934|Calcium|calcium|mesh-list
83888042|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83888043|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888044|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83888045|NCT00570934|Vitamins|vitamins|mesh-ancestor
83888046|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
83888047|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
83888048|NCT00254553|Testosterone|testosterone|mesh-list
83888049|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
83888050|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
83888051|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83888052|NCT00254553|Androgens|androgens|mesh-ancestor
83888053|NCT00254553|Hormones|hormones|mesh-ancestor
83888054|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888055|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888056|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83888057|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888058|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
83888059|NCT00571129|Mitomycins|mitomycins|mesh-list
83888060|NCT00571129|Mitomycin|mitomycin|mesh-list
83888061|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83888062|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888063|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
83888064|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888065|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83888066|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888067|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83888068|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888069|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
83888070|NCT03453931|Hormones|hormones|mesh-ancestor
83888071|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127149|NCT03339635|Androgens|androgens|mesh-ancestor
83888072|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888073|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83888074|NCT03453931|Protective Agents|protective agents|mesh-ancestor
83888075|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83888076|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888077|NCT00571246|Topiramate|topiramate|mesh-list
83888078|NCT00571246|Lamotrigine|lamotrigine|mesh-list
83888079|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
83888080|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83888081|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888082|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83888083|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888084|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888085|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83888086|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83888087|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888088|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888089|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888090|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83888091|NCT00254631|Oxycodone|oxycodone|mesh-list
83888092|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83888093|NCT00254631|Narcotics|narcotics|mesh-ancestor
83888094|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888095|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888096|NCT00254631|Analgesics|analgesics|mesh-ancestor
83888097|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
83888098|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888099|NCT00571285|Vitamin D|vitamin d|mesh-list
83888100|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
83888101|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
83888102|NCT00571285|Vitamins|vitamins|mesh-list
83888103|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
83888104|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888105|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83888106|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83888107|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83888108|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83888109|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
83888110|NCT00571636|Fentanyl|fentanyl|mesh-list
83888111|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83888112|NCT00571636|Narcotics|narcotics|mesh-ancestor
83888113|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888114|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888115|NCT00571636|Analgesics|analgesics|mesh-ancestor
83888116|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
83888117|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888118|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83888119|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83888120|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
83888121|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
83888122|NCT00571675|Prednisone|prednisone|mesh-list
83888123|NCT00571675|Docetaxel|docetaxel|mesh-list
83888124|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888125|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
83888126|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
83888127|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
83888128|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888129|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888130|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
83888131|NCT00571675|Hormones|hormones|mesh-ancestor
83888132|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888133|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888134|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83888135|NCT00571714|Ribavirin|ribavirin|mesh-list
83888136|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83888137|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
83888138|NCT00571714|Betaine|betaine|mesh-list
83888139|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
83888140|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888141|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
83888142|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888143|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
83888144|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888145|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83888146|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
83888147|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83127230|NCT03126916|Vitamins|vitamins|mesh-ancestor
83888148|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83888149|NCT00571753|Isoniazid|isoniazid|mesh-list
83888150|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
83888151|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83888152|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888153|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83888154|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83888155|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
83888156|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888157|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83888158|NCT00254709|Sirolimus|sirolimus|mesh-list
83888159|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83888160|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888161|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83888162|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888163|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
83888164|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83888165|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
83888166|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888167|NCT00224822|Aripiprazole|aripiprazole|mesh-list
83888168|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888169|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888170|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83888171|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888172|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888173|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888174|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
83888175|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
83888176|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888177|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888178|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83888179|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83888180|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
83888181|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83888182|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83888183|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83888184|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83888185|NCT00571870|Cetrorelix|cetrorelix|mesh-list
83888186|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83888187|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
83888188|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83888189|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888190|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
83888191|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888192|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83888193|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888194|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888195|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83888196|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888197|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888198|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888199|NCT00572026|Methylphenidate|methylphenidate|mesh-list
83888200|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83888201|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888202|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83888203|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83888204|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888205|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888206|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
83888207|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888208|NCT00572065|Cytarabine|cytarabine|mesh-list
83888209|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
83888210|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83888211|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
83888212|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888213|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888214|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
83888215|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888216|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83888217|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
83888218|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888219|NCT00234897|Adalimumab|adalimumab|mesh-list
83888220|NCT00234897|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83888221|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888223|NCT00572182|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
83888224|NCT00572182|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83888225|NCT00572182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888226|NCT00572182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888227|NCT00572299|Alendronate|alendronate|mesh-list
83888228|NCT00572299|Prednisone|prednisone|mesh-list
83888229|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888230|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
83888231|NCT00572299|Hormones|hormones|mesh-ancestor
83888232|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888233|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888234|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83888235|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888236|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83888237|NCT00234936|Adalimumab|adalimumab|mesh-list
83888238|NCT00234936|Methotrexate|methotrexate|mesh-list
83888239|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83888240|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
83888241|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83888242|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888243|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83888244|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
83888245|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888246|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888247|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
83888248|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888249|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83888250|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83888251|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
83888252|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888253|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83888254|NCT00234936|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83888255|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888256|NCT00413075|Belinostat|belinostat|mesh-list
83888257|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888258|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83888259|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888260|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888261|NCT00572650|Vildagliptin|vildagliptin|mesh-list
83888262|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83888263|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888264|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83888265|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
83888266|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888267|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888268|NCT00572689|Exenatide|exenatide|mesh-list
83888269|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83888270|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888271|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83888272|NCT00572689|Incretins|incretins|mesh-ancestor
83888273|NCT00572689|Hormones|hormones|mesh-ancestor
83888274|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888275|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
83888276|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83888277|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888278|NCT00224978|Chloroquine|chloroquine|mesh-list
83888279|NCT00224978|Amebicides|amebicides|mesh-ancestor
83888280|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83888281|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83888282|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888283|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
83888284|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888285|NCT00572884|Permethrin|permethrin|mesh-list
83888286|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888287|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888288|NCT00573001|Ritonavir|ritonavir|mesh-list
83888289|NCT00573001|Lopinavir|lopinavir|mesh-list
83888290|NCT00573001|Tenofovir|tenofovir|mesh-list
83888291|NCT00573001|Emtricitabine|emtricitabine|mesh-list
83888292|NCT00573001|Zidovudine|zidovudine|mesh-list
83888293|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83888294|NCT00573001|Nevirapine|nevirapine|mesh-list
83127390|NCT03007147|Vitamins|vitamins|mesh-ancestor
83888295|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83888296|NCT00573001|Efavirenz|efavirenz|mesh-list
83888297|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83888298|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83888299|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
83888300|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888301|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888302|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83888303|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83888304|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
83888305|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888306|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83888307|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83888308|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83888309|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83888310|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
83888311|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83888312|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83888313|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83888314|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83888315|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83888316|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83888317|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888318|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888319|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83888320|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888321|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888322|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888323|NCT00225056|Docetaxel|docetaxel|mesh-list
83888324|NCT00225056|Capecitabine|capecitabine|mesh-list
83888325|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888326|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
83888327|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
83888328|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
83888329|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888330|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83888331|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
83888332|NCT00225173|Prednisone|prednisone|mesh-list
83888333|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
83888334|NCT00225173|Gemcitabine|gemcitabine|mesh-list
83888335|NCT00225173|Doxorubicin|doxorubicin|mesh-list
83888336|NCT00225173|Etoposide|etoposide|mesh-list
83888337|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
83888338|NCT00225173|Vincristine|vincristine|mesh-list
83888339|NCT00225173|Vinorelbine|vinorelbine|mesh-list
83888340|NCT00225173|Bleomycin|bleomycin|mesh-list
83888341|NCT00225173|Vinblastine|vinblastine|mesh-list
83888342|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83888343|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
83888344|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888345|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888346|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83888347|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
83888348|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888349|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888350|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83888351|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83888352|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
83888353|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83888354|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83888355|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83888356|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888357|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888358|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
83888359|NCT00225173|Hormones|hormones|mesh-ancestor
83888360|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888361|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83888362|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83888363|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83888364|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83888365|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83888366|NCT00234975|Ritonavir|ritonavir|mesh-list
83888367|NCT00234975|Lopinavir|lopinavir|mesh-list
83888368|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83888369|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83888370|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
83888371|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888372|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888373|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83888374|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83888375|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
83888376|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888377|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83888378|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83888379|NCT00235014|Verapamil|verapamil|mesh-list
83888380|NCT00235014|Trandolapril|trandolapril|mesh-list
83888381|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83888382|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83888383|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888384|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888385|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83888386|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888387|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
83888388|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83888389|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
83888390|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888391|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83888392|NCT00225290|Thalidomide|thalidomide|mesh-list
83888393|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83888394|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
83888395|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888396|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
83888397|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83888398|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888399|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83888400|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83888401|NCT00225290|Growth Substances|growth substances|mesh-ancestor
83888402|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
83888403|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888404|NCT00573547|Fluoxetine|fluoxetine|mesh-list
83888405|NCT00573547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83888406|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83888407|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888408|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888409|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888410|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
83888411|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888412|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83888413|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888414|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888415|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83888416|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83888417|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888418|NCT00573664|Gabapentin|gabapentin|mesh-list
83888419|NCT00573664|Analgesics|analgesics|mesh-ancestor
83888420|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
83888421|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888422|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888423|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
83888424|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83888425|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888426|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888427|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888428|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83888429|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83888430|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888431|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888432|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
83888433|NCT00573742|Candesartan|candesartan|mesh-list
83888434|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83888435|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83888436|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83888437|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888438|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83888439|NCT00254865|Norelgestromin|norelgestromin|mesh-list
83888440|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
83888441|NCT00254865|Estradiol|estradiol|mesh-list
83888442|NCT00254865|Estrogens|estrogens|mesh-ancestor
83888444|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888445|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888446|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83888447|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83888448|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83888449|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83888450|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83888451|NCT00235053|Fluticasone|fluticasone|mesh-list
83888452|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83888453|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83888454|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888455|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83888456|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
83888457|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888458|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888459|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83888460|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83888461|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
83888462|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83888463|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83888464|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83888465|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83888466|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
83888467|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888468|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888469|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
83888470|NCT00235053|Hormones|hormones|mesh-ancestor
83888471|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888472|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
83888473|NCT00574015|Acetaminophen|acetaminophen|mesh-list
83888474|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83888475|NCT00574015|Hydrocodone|hydrocodone|mesh-list
83888476|NCT00574015|Bupivacaine|bupivacaine|mesh-list
83888477|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
83888478|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
83888479|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888480|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888481|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
83888482|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888483|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83888484|NCT00574015|Analgesics|analgesics|mesh-ancestor
83888485|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
83888486|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83888487|NCT00574015|Narcotics|narcotics|mesh-ancestor
83888488|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
83888489|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
83888490|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83888491|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888492|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888493|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83888494|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83888495|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83888496|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888497|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888498|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888499|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888500|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83888501|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888502|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888503|NCT00574093|Ranibizumab|ranibizumab|mesh-list
83888504|NCT00574093|Verteporfin|verteporfin|mesh-list
83888505|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83888506|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83888507|NCT00574093|Growth Substances|growth substances|mesh-ancestor
83888508|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888509|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
83888510|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888511|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83888512|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
83888513|NCT00574366|Everolimus|everolimus|mesh-list
83888514|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83888515|NCT00574366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83888516|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83888517|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888518|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888519|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83888520|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
83888521|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888522|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888523|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83888524|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83888525|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83888526|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888527|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888528|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888529|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888530|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83888531|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888532|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888533|NCT00574483|Quinacrine|quinacrine|mesh-list
83888534|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
83888535|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83888536|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
83888537|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83888538|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888539|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
83888540|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83888541|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
83888542|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888543|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888544|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888545|NCT00235092|Sirolimus|sirolimus|mesh-list
83888546|NCT00235092|Paclitaxel|paclitaxel|mesh-list
83888547|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83888548|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888549|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
83888550|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
83888551|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
83888552|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888553|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83888554|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888555|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83888556|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
83888557|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83888558|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
83888559|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888560|NCT00574600|Vaccines|vaccines|mesh-list
83888561|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
83888562|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888563|NCT00574639|Alprazolam|alprazolam|mesh-list
83888564|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83888565|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888566|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888567|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83888568|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888569|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888570|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
83888571|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
83888572|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888573|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888574|NCT00255255|Budesonide|budesonide|mesh-list
83888575|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
83888576|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888577|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83888578|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
83888579|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888580|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888581|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83888582|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
83888583|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
83888584|NCT00255255|Hormones|hormones|mesh-ancestor
83888585|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888586|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83888587|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83888588|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83888589|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
83888590|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888591|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888593|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83888594|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888595|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888596|NCT03453346|Ribavirin|ribavirin|mesh-list
83888597|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
83888598|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
83888599|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888600|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
83888601|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888602|NCT00575068|Galiximab|galiximab|mesh-list
83888603|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888604|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888605|NCT00575224|Interferons|interferons|mesh-list
83888606|NCT00575224|Ribavirin|ribavirin|mesh-list
83888607|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888608|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
83888609|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888610|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
83888611|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888612|NCT00225797|Oxymorphone|oxymorphone|mesh-list
83888613|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83888614|NCT00225797|Narcotics|narcotics|mesh-ancestor
83888615|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888616|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888617|NCT00225797|Analgesics|analgesics|mesh-ancestor
83888618|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
83888619|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888620|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83888621|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
83888622|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83888623|NCT00591487|Lidocaine|lidocaine|mesh-list
83888624|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
83888625|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
83888626|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888627|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888628|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
83888629|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888630|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83888631|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83888632|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83888633|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888634|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888635|NCT00225875|Rituximab|rituximab|mesh-list
83888636|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83888637|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888638|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
83888639|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888640|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888641|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
83888642|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83888643|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888644|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
83888645|NCT00255372|Lactulose|lactulose|mesh-list
83888646|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83888647|NCT00225914|Paroxetine|paroxetine|mesh-list
83888648|NCT00225914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83888649|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83888650|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888651|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888652|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888653|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
83888654|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888655|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83888656|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888657|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888658|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83888659|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83888660|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888661|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83888662|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83888663|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83888664|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888665|NCT00235248|Aspirin|aspirin|mesh-list
83888666|NCT00235248|Warfarin|warfarin|mesh-list
83888667|NCT00235248|Clopidogrel|clopidogrel|mesh-list
83888668|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83888669|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83888670|NCT00235248|Analgesics|analgesics|mesh-ancestor
83888671|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
83888672|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888673|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888674|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888675|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888676|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83888677|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83888678|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888679|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83888680|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83888681|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888682|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
83888683|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83888684|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83888685|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83888686|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
83888687|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888688|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
83888689|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
83888690|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888691|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
83888692|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83888693|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
83888694|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888695|NCT03451435|Expectorants|expectorants|mesh-ancestor
83888696|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83888697|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83888698|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
83888699|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888700|NCT03451435|Protective Agents|protective agents|mesh-ancestor
83888701|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888702|NCT03451435|Antidotes|antidotes|mesh-ancestor
83888703|NCT04575064|Remdesivir|remdesivir|mesh-list
83888704|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
83888705|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888706|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
83888707|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888708|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
83888709|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888710|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83888711|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83888712|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83888713|NCT00255450|Hematinics|hematinics|mesh-ancestor
83888714|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83888715|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83888716|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
83888717|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83888718|NCT04573855|Antibodies|antibodies|mesh-list
83888719|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
83888720|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888721|NCT00226109|Spironolactone|spironolactone|mesh-list
83888722|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83888723|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
83888724|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888725|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888726|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83888727|NCT00226109|Diuretics|diuretics|mesh-ancestor
83888728|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
83888729|NCT04573426|Acetaminophen|acetaminophen|mesh-list
83888730|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83888731|NCT04573426|Analgesics|analgesics|mesh-ancestor
83888732|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
83888733|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888734|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888735|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
83888736|NCT00235287|Candesartan|candesartan|mesh-list
83888737|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
83888738|NCT00235287|Enalapril|enalapril|mesh-list
83888739|NCT00235287|Enalaprilat|enalaprilat|mesh-list
83888740|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83888741|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83888742|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83888743|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888744|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83888745|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
83888746|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888747|NCT00255489|Gefitinib|gefitinib|mesh-list
83888748|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888749|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83888750|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888751|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888752|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
83888753|NCT04573153|Sorbitol|sorbitol|mesh-list
83888754|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
83888755|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83888756|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83888757|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888758|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888759|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888760|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888761|NCT04573153|Cathartics|cathartics|mesh-ancestor
83888762|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83888763|NCT00255528|Metoprolol|metoprolol|mesh-list
83888764|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83888765|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83888766|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
83888767|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
83888768|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888769|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888770|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83888771|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83888772|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83888773|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
83888774|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888775|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888776|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83888777|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83888778|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888779|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888780|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888781|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888782|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83888783|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83888784|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
83888785|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888786|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888787|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83888788|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83888789|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
83888790|NCT04572724|Valsartan|valsartan|mesh-list
83888791|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83888792|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83888793|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83888794|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83888795|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888796|NCT00255567|Paromomycin|paromomycin|mesh-list
83888797|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83888798|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83888799|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888800|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83888801|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83888802|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
83888803|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83888804|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
83888805|NCT03450967|Durvalumab|durvalumab|mesh-list
83888806|NCT03450967|Tremelimumab|tremelimumab|mesh-list
83888807|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83888808|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888809|NCT00255606|Prednisone|prednisone|mesh-list
83888810|NCT00255606|Docetaxel|docetaxel|mesh-list
83888811|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888812|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
83888813|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
83888814|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
83888815|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888817|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
83888818|NCT00255606|Hormones|hormones|mesh-ancestor
83888819|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888820|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888821|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83888822|NCT00226343|Valproic Acid|valproic acid|mesh-list
83888823|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
83888824|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888825|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888826|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
83888827|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888828|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888829|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
83888830|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888831|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888832|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888833|NCT03450499|Ketamine|ketamine|mesh-list
83888834|NCT03450499|Analgesics|analgesics|mesh-ancestor
83888835|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
83888836|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888837|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888838|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83888839|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83888840|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
83888841|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
83888842|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888843|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83888844|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83888845|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888846|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888847|NCT00226382|Interferons|interferons|mesh-list
83888848|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
83888849|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
83888850|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83888851|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888852|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
83888853|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888854|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
83888855|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888856|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83888857|NCT01580839|Plasminogen|plasminogen|mesh-list
83888858|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83888859|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83888860|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888861|NCT03450226|Bupivacaine|bupivacaine|mesh-list
83888862|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
83888863|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
83888864|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888865|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888866|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
83888867|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888868|NCT00226421|Oxymorphone|oxymorphone|mesh-list
83888869|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83888870|NCT00226421|Narcotics|narcotics|mesh-ancestor
83888871|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888872|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888873|NCT00226421|Analgesics|analgesics|mesh-ancestor
83888874|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
83888875|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888876|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83888877|NCT04572373|SMOFlipid|smoflipid|mesh-list
83888878|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83888879|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83888880|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83888881|NCT03450109|Goserelin|goserelin|mesh-list
83888882|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83888883|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888884|NCT00413387|Budesonide|budesonide|mesh-list
83888885|NCT00413387|Beclomethasone|beclomethasone|mesh-list
83888886|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
83888887|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888888|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83888889|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
83888890|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888891|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888892|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83888893|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83888894|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
83888895|NCT00413387|Hormones|hormones|mesh-ancestor
83888896|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83888897|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83888898|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83888899|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83888900|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
83888901|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888902|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888903|NCT00413426|Darifenacin|darifenacin|mesh-list
83888904|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83888905|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83888906|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
83888907|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888908|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888909|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888910|NCT00413426|Urological Agents|urological agents|mesh-ancestor
83888911|NCT00255762|Paclitaxel|paclitaxel|mesh-list
83888912|NCT00255762|Bevacizumab|bevacizumab|mesh-list
83888913|NCT00255762|Carboplatin|carboplatin|mesh-list
83888914|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83888915|NCT00255762|Antibodies|antibodies|mesh-list
83888916|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
83888917|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83888918|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83888919|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888920|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83888921|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83888922|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83888923|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888924|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83888925|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83888926|NCT00255762|Growth Substances|growth substances|mesh-ancestor
83888927|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888928|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
83888929|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
83888930|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83888931|NCT02277457|Crizotinib|crizotinib|mesh-list
83888932|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888933|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83888934|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888935|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888936|NCT00255879|Olanzapine|olanzapine|mesh-list
83888937|NCT00255879|Risperidone|risperidone|mesh-list
83888938|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83888939|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83888940|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
83888941|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83888942|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888943|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888944|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83888945|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83888946|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83888947|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83888948|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83888949|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
83888950|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
83888951|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
83888952|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888953|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83888954|NCT00255879|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83888955|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83888956|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83888957|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
83888958|NCT00413504|PENTA|penta|mesh-list
83888959|NCT00413504|Fondaparinux|fondaparinux|mesh-list
83888960|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83888961|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
83888962|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83888963|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
83888964|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888965|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888967|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83888968|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83888969|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83888970|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888971|NCT04721223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83888972|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888973|NCT04710498|Atezolizumab|atezolizumab|mesh-list
83888974|NCT04710498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83888975|NCT04710498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888976|NCT04710498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83888977|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83888978|NCT00226538|Fluconazole|fluconazole|mesh-list
83888979|NCT00226538|Rifampin|rifampin|mesh-list
83888980|NCT00226538|Diclofenac|diclofenac|mesh-list
83888981|NCT00226538|Phenytoin|phenytoin|mesh-list
83888982|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83888983|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83888984|NCT00226538|Analgesics|analgesics|mesh-ancestor
83888985|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
83888986|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83888987|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83888988|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83888989|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83888990|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83888991|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83888992|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83888993|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
83888994|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83888995|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83888996|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83888997|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83888998|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
83888999|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889000|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83889001|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83889002|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83889003|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
83889004|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889005|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
83889006|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83889007|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83889008|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83889009|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83889010|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83889011|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83889012|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83889013|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
83889014|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83889015|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83889016|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889017|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83889018|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
83889019|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83889020|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83889021|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
83889022|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889023|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889024|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889025|NCT00226694|Citalopram|citalopram|mesh-list
83889026|NCT00226694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83889027|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83889028|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889029|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889030|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889031|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
83889032|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889033|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83889034|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
83889035|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889036|NCT00255996|Linezolid|linezolid|mesh-list
83889037|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889038|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889039|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83889040|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889041|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889042|NCT00226889|Bosentan|bosentan|mesh-list
83889043|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83889044|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83889045|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889046|NCT00226967|Octreotide|octreotide|mesh-list
83889047|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889048|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83889049|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889050|NCT00199381|Istradefylline|istradefylline|mesh-list
83889051|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83889052|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83889053|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83889054|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
83889055|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889056|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889057|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889058|NCT00227084|Hemostatics|hemostatics|mesh-list
83889059|NCT00227084|Coagulants|coagulants|mesh-ancestor
83889060|NCT00227123|Risperidone|risperidone|mesh-list
83889061|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83889062|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83889063|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
83889064|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889065|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889066|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889067|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83889068|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83889069|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889070|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889071|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83889072|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
83889073|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
83889074|NCT00235521|Iloprost|iloprost|mesh-list
83889075|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83889076|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
83889077|NCT00235560|Sirolimus|sirolimus|mesh-list
83889078|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889079|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889080|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83889081|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889082|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
83889083|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83889084|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
83889085|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889086|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
83889087|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83889088|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83889089|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83889090|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889091|NCT00227357|Buprenorphine|buprenorphine|mesh-list
83889092|NCT00227357|Methadone|methadone|mesh-list
83889093|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83889094|NCT00227357|Naloxone|naloxone|mesh-list
83889095|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83889096|NCT00227357|Narcotics|narcotics|mesh-ancestor
83889097|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889098|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889099|NCT00227357|Analgesics|analgesics|mesh-ancestor
83889100|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
83889101|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889102|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83889103|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
83889104|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
83889105|NCT00198133|Pemetrexed|pemetrexed|mesh-list
83889106|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889107|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889108|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889109|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83889110|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83889111|NCT00227474|Vaccines|vaccines|mesh-list
83889112|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
83889113|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889114|NCT00227513|Bortezomib|bortezomib|mesh-list
83889115|NCT00227513|Vorinostat|vorinostat|mesh-list
83889116|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889117|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83889118|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889119|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889120|NCT00227630|Pemetrexed|pemetrexed|mesh-list
83889121|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889122|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889123|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889124|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83889125|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83889126|NCT00256230|Disulfiram|disulfiram|mesh-list
83889127|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83889128|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83889129|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889130|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889131|NCT00227669|Gemcitabine|gemcitabine|mesh-list
83889132|NCT00227669|Docetaxel|docetaxel|mesh-list
83889133|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889134|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
83889135|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889136|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889137|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83889138|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83889139|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83889140|NCT00235794|Sirolimus|sirolimus|mesh-list
83889141|NCT00235794|Temsirolimus|temsirolimus|mesh-list
83889142|NCT00235794|MTOR Inhibitors|mtor inhibitors|mesh-list
83889143|NCT00235794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83889144|NCT00235794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889145|NCT00235794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889146|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83889147|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
83889148|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889149|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889150|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889151|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889152|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83889153|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
83889154|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
83889155|NCT00256269|Irinotecan|irinotecan|mesh-list
83889156|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889157|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83889158|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83889159|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889160|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889161|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83889162|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
83889163|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889164|NCT00227708|Docetaxel|docetaxel|mesh-list
83889165|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889166|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
83889167|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
83889168|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
83889169|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889170|NCT00235911|Budesonide|budesonide|mesh-list
83889171|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
83889172|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889173|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83889174|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
83889175|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889176|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889177|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83889178|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
83889179|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
83889180|NCT00235911|Hormones|hormones|mesh-ancestor
83889181|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889182|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83889183|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83889184|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83889185|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
83889186|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889187|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889188|NCT00256347|Morphine|morphine|mesh-list
83889189|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83889190|NCT00256347|Narcotics|narcotics|mesh-ancestor
83889191|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889192|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889193|NCT00256347|Analgesics|analgesics|mesh-ancestor
83889194|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
83889195|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889196|NCT00227747|Capecitabine|capecitabine|mesh-list
83889197|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
83889198|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889199|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
83889200|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889201|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889202|NCT00235950|Clopidogrel|clopidogrel|mesh-list
83889203|NCT00235950|Atorvastatin|atorvastatin|mesh-list
83889204|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83889205|NCT00235950|Simvastatin|simvastatin|mesh-list
83889206|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83889207|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83889208|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
83889209|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889210|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83889211|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83889212|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889213|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83889214|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83889215|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83889216|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83889217|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
83889218|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889219|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889220|NCT00227942|Zolpidem|zolpidem|mesh-list
83889221|NCT00227942|Estrogens|estrogens|mesh-list
83889222|NCT00227942|Hormones|hormones|mesh-ancestor
83889223|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889224|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889225|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83889226|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83889227|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889228|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83889229|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
83889230|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
83889231|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889232|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889233|NCT00227981|Fluoxetine|fluoxetine|mesh-list
83889234|NCT00227981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83889235|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83889236|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889237|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889238|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889239|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
83889240|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889241|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83889242|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
83889243|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889244|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83889245|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83889246|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889247|NCT00236028|Infliximab|infliximab|mesh-list
83889248|NCT00236028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83889249|NCT00236028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889250|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83889251|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889252|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83889253|NCT00256542|Lidocaine|lidocaine|mesh-list
83889254|NCT00256542|Heparin|heparin|mesh-list
83889255|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
83889256|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
83889257|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889258|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889259|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
83889260|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889261|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83889262|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83889263|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83889264|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889265|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889266|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
83889267|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83889268|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83889269|NCT00228020|Cyclosporine|cyclosporine|mesh-list
83889270|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
83889271|NCT00228020|Prednisone|prednisone|mesh-list
83889272|NCT00228020|Cyclosporins|cyclosporins|mesh-list
83889273|NCT00228020|Basiliximab|basiliximab|mesh-list
83889274|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889275|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
83889276|NCT00228020|Hormones|hormones|mesh-ancestor
83889277|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889278|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889279|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83889280|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889281|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889282|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889283|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83889284|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
83889285|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
83889286|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889287|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
83889288|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83889289|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83889290|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83889291|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83889292|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
83889293|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889294|NCT00236067|Tiagabine|tiagabine|mesh-list
83889295|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
83889296|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83889297|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83889298|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889299|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889300|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
83889301|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889302|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889303|NCT00195715|Adalimumab|adalimumab|mesh-list
83889304|NCT00195715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83889305|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889306|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83889307|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
83889308|NCT00236106|Tacrolimus|tacrolimus|mesh-list
83889309|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83889310|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
83889311|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889312|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83889313|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889314|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889315|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889316|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83889317|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83889318|NCT00236145|Fentanyl|fentanyl|mesh-list
83889319|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83889320|NCT00236145|Narcotics|narcotics|mesh-ancestor
83889321|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889322|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889323|NCT00236145|Analgesics|analgesics|mesh-ancestor
83889324|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
83889325|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889326|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83889327|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83889328|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
83889329|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
83889330|NCT00228254|Vitamin A|vitamin a|mesh-list
83889331|NCT00228254|Vitamins|vitamins|mesh-ancestor
83889332|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
83889333|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889334|NCT00195676|Adalimumab|adalimumab|mesh-list
83889335|NCT00195676|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83889336|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889337|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83889338|NCT00194077|Aripiprazole|aripiprazole|mesh-list
83889339|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
83889340|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889341|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83889342|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83889343|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889344|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889345|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
83889346|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
83889347|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889348|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889349|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83889350|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83889351|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
83889352|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83889353|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83889354|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83889355|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83889356|NCT00193609|Capecitabine|capecitabine|mesh-list
83889357|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
83889358|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889359|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
83889360|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889361|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889362|NCT00228410|Vancomycin|vancomycin|mesh-list
83889363|NCT00228410|Tigecycline|tigecycline|mesh-list
83889364|NCT00228410|Aztreonam|aztreonam|mesh-list
83889365|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889366|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889367|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83889368|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889369|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889370|NCT00193180|Docetaxel|docetaxel|mesh-list
83889371|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
83889372|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889373|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
83889374|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
83889375|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
83889376|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889377|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83889378|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889379|NCT00193063|Gemcitabine|gemcitabine|mesh-list
83889380|NCT00193063|Trastuzumab|trastuzumab|mesh-list
83889381|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889382|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
83889383|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889384|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889385|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83889386|NCT00228488|Gefitinib|gefitinib|mesh-list
83889387|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889388|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83889389|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889390|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889391|NCT00228527|Esomeprazole|esomeprazole|mesh-list
83889392|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83889393|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889394|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83889395|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889396|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889397|NCT00191854|Paclitaxel|paclitaxel|mesh-list
83889398|NCT00191854|Carboplatin|carboplatin|mesh-list
83889399|NCT00191854|Gemcitabine|gemcitabine|mesh-list
83889400|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83889401|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889402|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
83889403|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
83889404|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
83889405|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889406|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889407|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
83128571|NCT02313194|Buspirone|buspirone|mesh-list
83889408|NCT00228605|Fentanyl|fentanyl|mesh-list
83889409|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83889410|NCT00228605|Narcotics|narcotics|mesh-ancestor
83889411|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889412|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889413|NCT00228605|Analgesics|analgesics|mesh-ancestor
83889414|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
83889415|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889416|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83889417|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83889418|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
83889419|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
83889420|NCT00191815|Gemcitabine|gemcitabine|mesh-list
83889421|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889422|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889423|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
83889424|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889425|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83889426|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83889427|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83889428|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889429|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889430|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
83889431|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889432|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889433|NCT00191308|Pemetrexed|pemetrexed|mesh-list
83889434|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889435|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889436|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889437|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83889438|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83889439|NCT00228839|Infliximab|infliximab|mesh-list
83889440|NCT00228839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83889441|NCT00228839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889442|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
83889443|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889444|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83889445|NCT00191269|Gemcitabine|gemcitabine|mesh-list
83889446|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889447|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
83889448|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889449|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889450|NCT00228878|Insulin|insulin|mesh-list
83889451|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
83889452|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889453|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889454|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
83889455|NCT00228995|Hematinics|hematinics|mesh-ancestor
83889456|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
83889457|NCT00413946|Hematinics|hematinics|mesh-ancestor
83889458|NCT00229112|Tazobactam|tazobactam|mesh-list
83889459|NCT00229112|Piperacillin|piperacillin|mesh-list
83889460|NCT00229112|Ertapenem|ertapenem|mesh-list
83889461|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83889462|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889463|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889464|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889465|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83889466|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889467|NCT00256737|Omeprazole|omeprazole|mesh-list
83889468|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83889469|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889470|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83889471|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889472|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889473|NCT00191191|Pemetrexed|pemetrexed|mesh-list
83889474|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889475|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889476|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889477|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83889478|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83889479|NCT00414024|Tegaserod|tegaserod|mesh-list
83889480|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83889481|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
83889482|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889483|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889484|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889485|NCT00256893|Ropinirole|ropinirole|mesh-list
83889486|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83889487|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83889488|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
83889489|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
83889490|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889491|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889492|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889493|NCT00229385|Ziprasidone|ziprasidone|mesh-list
83889494|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83889495|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
83889496|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889497|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889498|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889499|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83889500|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83889501|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889502|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889503|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83889504|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
83889505|NCT00236223|Dexamethasone|dexamethasone|mesh-list
83889506|NCT00236223|Ketamine|ketamine|mesh-list
83889507|NCT00236223|Gabapentin|gabapentin|mesh-list
83889508|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889509|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
83889510|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
83889511|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889512|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889513|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889514|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
83889515|NCT00236223|Hormones|hormones|mesh-ancestor
83889516|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889517|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83889518|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889519|NCT00236223|Analgesics|analgesics|mesh-ancestor
83889520|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
83889521|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83889522|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83889523|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
83889524|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
83889525|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889526|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83889527|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83889528|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889529|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889530|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
83889531|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83889532|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83889533|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889534|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
83889535|NCT00229424|Famotidine|famotidine|mesh-list
83889536|NCT00229424|Lafutidine|lafutidine|mesh-list
83889537|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83889538|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889539|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83889540|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
83889541|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
83889542|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889543|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889544|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889545|NCT00256932|Alvimopan|alvimopan|mesh-list
83889546|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889547|NCT00191152|Gemcitabine|gemcitabine|mesh-list
83889548|NCT00191152|Capecitabine|capecitabine|mesh-list
83889549|NCT00191152|Docetaxel|docetaxel|mesh-list
83889550|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889551|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
83889552|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889553|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889554|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
83889555|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
83889556|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
83889557|NCT00257049|Levofloxacin|levofloxacin|mesh-list
83889558|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83889559|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889560|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889561|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83889562|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83889563|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889564|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889565|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889566|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83889567|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83889569|NCT01059188|Cetuximab|cetuximab|mesh-list
83889570|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889571|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
83889572|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
83889573|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
83889574|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889575|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83889576|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83889577|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83889578|NCT00236301|Estradiol|estradiol|mesh-list
83889579|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83889580|NCT00236301|Estrogens|estrogens|mesh-ancestor
83889581|NCT00236301|Hormones|hormones|mesh-ancestor
83889582|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889583|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889584|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83889585|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
83889586|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83889587|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83889588|NCT00229697|Tamoxifen|tamoxifen|mesh-list
83889589|NCT00229697|Gefitinib|gefitinib|mesh-list
83889590|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83889591|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
83889592|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889593|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889594|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83889595|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889596|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83889597|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83889598|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83889599|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83889600|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889601|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889602|NCT00236379|Olanzapine|olanzapine|mesh-list
83889603|NCT00236379|Risperidone|risperidone|mesh-list
83889604|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83889605|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
83889606|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889607|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889608|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889609|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83889610|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83889611|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889612|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889613|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83889614|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
83889615|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
83889616|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
83889617|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889618|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889619|NCT00236379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83889620|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83889621|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889622|NCT00229775|Chloroquine|chloroquine|mesh-list
83889623|NCT00229775|Artemether|artemether|mesh-list
83889624|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
83889625|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
83889626|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83889627|NCT00229775|Amebicides|amebicides|mesh-ancestor
83889628|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83889629|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83889630|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889631|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
83889632|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83889633|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83889634|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889635|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889636|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83889637|NCT00257127|Vaccines|vaccines|mesh-list
83889638|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83889639|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
83889640|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889641|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83889642|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83889643|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83889644|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83889645|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889646|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
83889647|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889648|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889649|NCT00236418|Topiramate|topiramate|mesh-list
83889650|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
83889651|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889652|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889653|NCT00236457|Risperidone|risperidone|mesh-list
83889654|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83889655|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
83889656|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889657|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889658|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889659|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83889660|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83889661|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889662|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889663|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83889664|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
83889665|NCT00236496|Topiramate|topiramate|mesh-list
83889666|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
83889667|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889668|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889669|NCT00199277|Iron|iron|mesh-list
83889670|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83889671|NCT00199277|Trace Elements|trace elements|mesh-ancestor
83889672|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
83889673|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889674|NCT00199277|Hematinics|hematinics|mesh-ancestor
83889675|NCT00236535|Acetaminophen|acetaminophen|mesh-list
83889676|NCT00236535|Tramadol|tramadol|mesh-list
83889677|NCT00236535|Hydrocodone|hydrocodone|mesh-list
83889678|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83889679|NCT00236535|Analgesics|analgesics|mesh-ancestor
83889680|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
83889681|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889682|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889683|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
83889684|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83889685|NCT00236535|Narcotics|narcotics|mesh-ancestor
83889686|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889687|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
83889688|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
83889689|NCT00193219|Leucovorin|leucovorin|mesh-list
83889690|NCT00193219|Bevacizumab|bevacizumab|mesh-list
83889691|NCT00193219|Cetuximab|cetuximab|mesh-list
83889692|NCT00193219|Fluorouracil|fluorouracil|mesh-list
83889693|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
83889694|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83889695|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889696|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83889697|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83889698|NCT00193219|Growth Substances|growth substances|mesh-ancestor
83889699|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889700|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
83889701|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
83889702|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889703|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83889704|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83889705|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
83889706|NCT00193219|Antidotes|antidotes|mesh-ancestor
83889707|NCT00193219|Protective Agents|protective agents|mesh-ancestor
83889708|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
83889709|NCT00193219|Vitamins|vitamins|mesh-ancestor
83889710|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
83889711|NCT00199316|Morphine|morphine|mesh-list
83889712|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83889714|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889715|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889716|NCT00199316|Analgesics|analgesics|mesh-ancestor
83889717|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
83889718|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889719|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
83889720|NCT00196339|Cyproterone|cyproterone|mesh-list
83889721|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
83889722|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
83889723|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889724|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889725|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889726|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83889727|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
83889728|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83889729|NCT00257361|Cycloserine|cycloserine|mesh-list
83889730|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83889731|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889732|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83889733|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
83889734|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889735|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
83889736|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889737|NCT00199355|Istradefylline|istradefylline|mesh-list
83889738|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83889739|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83889740|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83889741|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
83889742|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889743|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889744|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889745|NCT00179959|Mupirocin|mupirocin|mesh-list
83889746|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83889747|NCT00179959|Eusol|eusol|mesh-list
83889748|NCT00179959|Petrolatum|petrolatum|mesh-list
83889749|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889750|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889751|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83889752|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889753|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889754|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
83889755|NCT00179959|Emollients|emollients|mesh-ancestor
83889756|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
83889757|NCT00199394|Istradefylline|istradefylline|mesh-list
83889758|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83889759|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83889760|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83889761|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
83889762|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889763|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889764|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889765|NCT00236574|Galantamine|galantamine|mesh-list
83889766|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83889767|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889768|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889769|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
83889770|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889771|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889772|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83889773|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
83889774|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889775|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
83889776|NCT00199433|Istradefylline|istradefylline|mesh-list
83889777|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83889778|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83889779|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83889780|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
83889781|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889782|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889783|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889784|NCT00199472|Diuretics|diuretics|mesh-list
83889785|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
83889786|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889787|NCT00199511|Mannitol|mannitol|mesh-list
83889788|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83889789|NCT00199511|Diuretics|diuretics|mesh-ancestor
83889790|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
83889791|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889792|NCT00236613|Topiramate|topiramate|mesh-list
83889793|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
83889794|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889795|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889796|NCT00236652|Levofloxacin|levofloxacin|mesh-list
83889797|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83889798|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889799|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889800|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83889801|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83889802|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889803|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889804|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889805|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83889806|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83889807|NCT00257595|Cetirizine|cetirizine|mesh-list
83889808|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83889809|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83889810|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83889811|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
83889812|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
83889813|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889814|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889815|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889816|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
83889817|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83889818|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889819|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83889820|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
83889821|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889822|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889823|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889824|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889825|NCT00236691|Topiramate|topiramate|mesh-list
83889826|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
83889827|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889828|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889829|NCT00236730|Topiramate|topiramate|mesh-list
83889830|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
83889831|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889832|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889833|NCT00199745|Atorvastatin|atorvastatin|mesh-list
83889834|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83889835|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83889836|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
83889837|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889838|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83889839|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83889840|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889841|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
83889842|NCT04709172|Cefditoren|cefditoren|mesh-list
83889843|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889844|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889845|NCT00199784|Phenylephrine|phenylephrine|mesh-list
83889846|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
83889847|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83889848|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
83889849|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
83889850|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889851|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889852|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
83889853|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83889854|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
83889855|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
83889856|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83889857|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83889858|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83889859|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
83889860|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129034|NCT02477397|Xhance|xhance|mesh-list
83889861|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889862|NCT00199784|Protective Agents|protective agents|mesh-ancestor
83889863|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83889865|NCT00236769|Estradiol|estradiol|mesh-list
83889866|NCT00236769|Estrogens|estrogens|mesh-ancestor
83889867|NCT00236769|Hormones|hormones|mesh-ancestor
83889868|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889869|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889870|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83889871|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
83889872|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83889873|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83889874|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83889875|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83889876|NCT00415311|Lectins|lectins|mesh-list
83889877|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
83889878|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
83889879|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889880|NCT00415311|Coagulants|coagulants|mesh-ancestor
83889881|NCT00199940|Ziprasidone|ziprasidone|mesh-list
83889882|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83889883|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
83889884|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83889885|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889886|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889887|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83889888|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83889889|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83889890|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83889891|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83889892|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
83889893|NCT00236808|Levofloxacin|levofloxacin|mesh-list
83889894|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83889895|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889896|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889897|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83889898|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83889899|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889900|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889901|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889902|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83889903|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83889904|NCT00199979|Nevirapine|nevirapine|mesh-list
83889905|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83889906|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83889907|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889908|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889909|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
83889910|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889911|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83889912|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83889913|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83889914|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83889915|NCT00257634|Dexamethasone|dexamethasone|mesh-list
83889916|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889917|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
83889918|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
83889919|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889920|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889921|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889922|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
83889923|NCT00257634|Hormones|hormones|mesh-ancestor
83889924|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889925|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83889926|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889927|NCT00236847|Topiramate|topiramate|mesh-list
83889928|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
83889929|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889930|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889931|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
83889932|NCT00410306|Testosterone|testosterone|mesh-list
83129049|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
83889933|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
83889934|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
83889935|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83889936|NCT00410306|Androgens|androgens|mesh-ancestor
83889937|NCT00410306|Hormones|hormones|mesh-ancestor
83889938|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889939|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889940|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83889941|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889942|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
83889943|NCT00257712|Hormones|hormones|mesh-list
83889944|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
83889945|NCT00257712|Tesamorelin|tesamorelin|mesh-list
83889946|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889947|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889948|NCT00257712|Growth Substances|growth substances|mesh-ancestor
83889949|NCT00179647|Dexamethasone|dexamethasone|mesh-list
83889950|NCT00179647|Lenalidomide|lenalidomide|mesh-list
83889951|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83889952|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
83889953|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
83889954|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83889955|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889956|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83889957|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
83889958|NCT00179647|Hormones|hormones|mesh-ancestor
83889959|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83889960|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83889961|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889962|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
83889963|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83889964|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83889965|NCT00179647|Growth Substances|growth substances|mesh-ancestor
83889966|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
83889967|NCT00257751|Aprotinin|aprotinin|mesh-list
83889968|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
83889969|NCT00257751|Coagulants|coagulants|mesh-ancestor
83889970|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83889971|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83889972|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
83889973|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83889974|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889975|NCT00179413|Interferons|interferons|mesh-list
83889976|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
83889977|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
83889978|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83889979|NCT00179413|Colchicine|colchicine|mesh-list
83889980|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83889981|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
83889982|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889983|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
83889984|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889985|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
83889986|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83889987|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
83889988|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
83889989|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
83889990|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83889991|NCT00236886|Topiramate|topiramate|mesh-list
83889992|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
83889993|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83889994|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83889995|NCT00257790|Tobramycin|tobramycin|mesh-list
83889996|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83889997|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83889998|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83889999|NCT00200174|Exemestane|exemestane|mesh-list
83890000|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890001|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83890002|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83890003|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890004|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890005|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83890006|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
83890007|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890008|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129122|NCT02477007|Acetaminophen|acetaminophen|mesh-list
83890009|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83890010|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83890011|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83890012|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
83890013|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890014|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
83890015|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83890016|NCT00236964|Hematinics|hematinics|mesh-ancestor
83890017|NCT00200252|Oxytocin|oxytocin|mesh-list
83890018|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
83890019|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83890020|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890021|NCT00177307|Bevacizumab|bevacizumab|mesh-list
83890022|NCT00177307|Capecitabine|capecitabine|mesh-list
83890023|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
83890024|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83890025|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890026|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83890027|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83890028|NCT00177307|Growth Substances|growth substances|mesh-ancestor
83890029|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890030|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83890031|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83890032|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
83890033|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890034|NCT00257829|Methazolamide|methazolamide|mesh-list
83890035|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83890036|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890037|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890038|NCT00257829|Diuretics|diuretics|mesh-ancestor
83890039|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
83890040|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890041|NCT00176644|Estradiol|estradiol|mesh-list
83890042|NCT00176644|Estrogens|estrogens|mesh-ancestor
83890043|NCT00176644|Hormones|hormones|mesh-ancestor
83890044|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890045|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890046|NCT02484664|Celecoxib|celecoxib|mesh-list
83890047|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83890048|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83890049|NCT02484664|Analgesics|analgesics|mesh-ancestor
83890050|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
83890051|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890052|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890053|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890054|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890055|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83890056|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83890057|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890058|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890059|NCT00257868|Rivastigmine|rivastigmine|mesh-list
83890060|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83890061|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890062|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890063|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
83890064|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890065|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890066|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83890067|NCT00257868|Protective Agents|protective agents|mesh-ancestor
83890068|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
83890069|NCT00176605|Etoposide|etoposide|mesh-list
83890070|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890071|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
83890072|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890073|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890074|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83890075|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
83890076|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890077|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890078|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83890079|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83890080|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83890081|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83890082|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890083|NCT00176488|Vinorelbine|vinorelbine|mesh-list
83890084|NCT00176488|Epirubicin|epirubicin|mesh-list
83890085|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83890086|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890087|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890088|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890089|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890090|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890091|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83890092|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83890093|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83890094|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890095|NCT00200447|Carbidopa|carbidopa|mesh-list
83890096|NCT00200447|Levodopa|levodopa|mesh-list
83890097|NCT00200447|Entacapone|entacapone|mesh-list
83890098|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83890099|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83890100|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83890101|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
83890102|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890103|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890104|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890105|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83890106|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890107|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83890108|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
83890109|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890110|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83890111|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890112|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890113|NCT00175825|Brivaracetam|brivaracetam|mesh-list
83890114|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
83890115|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
83890116|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
83890117|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890118|NCT04710329|Protective Agents|protective agents|mesh-ancestor
83890119|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890120|NCT04710329|Vitamins|vitamins|mesh-ancestor
83890121|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
83890122|NCT00200525|Apomorphine|apomorphine|mesh-list
83890123|NCT00200525|Emetics|emetics|mesh-ancestor
83890124|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890125|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
83890126|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890127|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890128|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
83890129|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
83890130|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890131|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890132|NCT00174967|Febuxostat|febuxostat|mesh-list
83890133|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
83890134|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890135|NCT00200564|Ketamine|ketamine|mesh-list
83890136|NCT00200564|Analgesics|analgesics|mesh-ancestor
83890137|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
83890138|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890139|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890140|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83890141|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83890142|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
83890143|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
83890144|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890145|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83890146|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83890147|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890148|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890149|NCT00174265|Olanzapine|olanzapine|mesh-list
83890150|NCT00174265|Asenapine|asenapine|mesh-list
83890151|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
83890152|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
83890153|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890154|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890155|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890156|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83890157|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83890158|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890159|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83129282|NCT02414932|Midazolam|midazolam|mesh-list
83890160|NCT00174265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83890161|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83890162|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890163|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890164|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890165|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
83890166|NCT00200603|Calcium|calcium|mesh-list
83890167|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83890168|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890169|NCT00200681|Bortezomib|bortezomib|mesh-list
83890170|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890171|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83890172|NCT00258063|Norelgestromin|norelgestromin|mesh-list
83890173|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
83890174|NCT00258063|Estradiol|estradiol|mesh-list
83890175|NCT00258063|Estrogens|estrogens|mesh-ancestor
83890176|NCT00258063|Hormones|hormones|mesh-ancestor
83890177|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890178|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890179|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83890180|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83890181|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83890182|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83890183|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83890184|NCT00258102|Levofloxacin|levofloxacin|mesh-list
83890185|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83890186|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890187|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83890188|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83890189|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83890190|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890191|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890192|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890193|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83890194|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83890195|NCT00265278|Modafinil|modafinil|mesh-list
83890196|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83890197|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890198|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83890199|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83890200|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83890201|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890202|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
83890203|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83890204|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890205|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
83890206|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83890207|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890208|NCT00258297|Gefitinib|gefitinib|mesh-list
83890209|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83890210|NCT00258297|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83890211|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890212|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83890213|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890214|NCT00258336|Rituximab|rituximab|mesh-list
83890215|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
83890216|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83890217|NCT00258336|Antibodies|antibodies|mesh-list
83890218|NCT00258336|Sargramostim|sargramostim|mesh-list
83890219|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83890220|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83890221|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890222|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
83890223|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890224|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890225|NCT00171925|Vitamin D|vitamin d|mesh-list
83890226|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
83890227|NCT00171925|Calcium|calcium|mesh-list
83890228|NCT00171925|Vitamins|vitamins|mesh-ancestor
83890229|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
83890230|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890231|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83890232|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83129356|NCT05550909|Artesunate|artesunate|mesh-list
83890233|NCT00258375|Docetaxel|docetaxel|mesh-list
83890234|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890235|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890236|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890237|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890238|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890239|NCT00201305|Leucovorin|leucovorin|mesh-list
83890240|NCT00201305|Gemcitabine|gemcitabine|mesh-list
83890241|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83890242|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
83890243|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890244|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890245|NCT00201305|Antidotes|antidotes|mesh-ancestor
83890246|NCT00201305|Protective Agents|protective agents|mesh-ancestor
83890247|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890248|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
83890249|NCT00201305|Vitamins|vitamins|mesh-ancestor
83890250|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
83890251|NCT00265551|Olanzapine|olanzapine|mesh-list
83890252|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
83890253|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
83890254|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890255|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890256|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890257|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83890258|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83890259|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890260|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83890261|NCT00265551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83890262|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83890263|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890264|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890265|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890266|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
83890267|NCT00201344|Leucovorin|leucovorin|mesh-list
83890268|NCT00201344|Antidotes|antidotes|mesh-ancestor
83890269|NCT00201344|Protective Agents|protective agents|mesh-ancestor
83890270|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890271|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
83890272|NCT00201344|Vitamins|vitamins|mesh-ancestor
83890273|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
83890274|NCT00201383|Cisplatin|cisplatin|mesh-list
83890275|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890276|NCT00201422|Amoxicillin|amoxicillin|mesh-list
83890277|NCT00201422|Clarithromycin|clarithromycin|mesh-list
83890278|NCT00201422|Omeprazole|omeprazole|mesh-list
83890279|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83890280|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890281|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83890282|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890283|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83890284|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890285|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890286|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83890287|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83890288|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83890289|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
83890290|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83890291|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83890292|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83890293|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890294|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890295|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
83890296|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890297|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890298|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83890299|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890300|NCT00265746|Metformin|metformin|mesh-list
83890301|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890302|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890303|NCT00201539|Morphine|morphine|mesh-list
83890304|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83890305|NCT00201539|Narcotics|narcotics|mesh-ancestor
83890306|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890307|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890308|NCT00201539|Analgesics|analgesics|mesh-ancestor
83890309|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
83890310|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890311|NCT00265824|Bevacizumab|bevacizumab|mesh-list
83890312|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83890313|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83890314|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890315|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83890316|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83890317|NCT00265824|Growth Substances|growth substances|mesh-ancestor
83890318|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890319|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
83890320|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83890321|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890322|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890323|NCT00201695|Dexamethasone|dexamethasone|mesh-list
83890324|NCT00201695|Doxorubicin|doxorubicin|mesh-list
83890325|NCT00201695|Vincristine|vincristine|mesh-list
83890326|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
83890327|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890328|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
83890329|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
83890330|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890331|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890332|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890333|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
83890334|NCT00201695|Hormones|hormones|mesh-ancestor
83890335|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890336|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83890337|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890338|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83890339|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83890340|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83890341|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890342|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890343|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83890344|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890345|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890346|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890347|NCT00410345|Mifepristone|mifepristone|mesh-list
83890348|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83890349|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
83890350|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83890351|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890352|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83890353|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83890354|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83890355|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
83890356|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83890357|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83890358|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
83890359|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890360|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
83890361|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83890362|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83890363|NCT00265863|Mitomycins|mitomycins|mesh-list
83890364|NCT00265863|Mitomycin|mitomycin|mesh-list
83890365|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83890366|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890367|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
83890368|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890369|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83890370|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890371|NCT00410462|Doxorubicin|doxorubicin|mesh-list
83890372|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83890373|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83890374|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890375|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83890376|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83890377|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890378|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890379|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
83890380|NCT00258765|Docetaxel|docetaxel|mesh-list
83890381|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890382|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890383|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890385|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890386|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83890387|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890388|NCT00410540|Morphine|morphine|mesh-list
83890389|NCT00410540|Hydromorphone|hydromorphone|mesh-list
83890390|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83890391|NCT00410540|Narcotics|narcotics|mesh-ancestor
83890392|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890393|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890394|NCT00410540|Analgesics|analgesics|mesh-ancestor
83890395|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
83890396|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890397|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
83890398|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890399|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890400|NCT00201812|Dexamethasone|dexamethasone|mesh-list
83890401|NCT00201812|Etanercept|etanercept|mesh-list
83890402|NCT00201812|Docetaxel|docetaxel|mesh-list
83890403|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
83890404|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890405|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
83890406|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
83890407|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890408|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890409|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890410|NCT00201812|Hormones|hormones|mesh-ancestor
83890411|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890412|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83890413|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890414|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890415|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890416|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890417|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890418|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83890419|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83890420|NCT00201812|Analgesics|analgesics|mesh-ancestor
83890421|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
83890422|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890423|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890424|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
83890425|NCT00258843|Vaccines|vaccines|mesh-list
83890426|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
83890427|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890428|NCT04709094|Bupropion|bupropion|mesh-list
83890429|NCT04709094|Warfarin|warfarin|mesh-list
83890430|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83890431|NCT04709094|Norethindrone|norethindrone|mesh-list
83890432|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
83890433|NCT04709094|Norinyl|norinyl|mesh-list
83890434|NCT04709094|Estradiol|estradiol|mesh-list
83890435|NCT04709094|Estrogens|estrogens|mesh-ancestor
83890436|NCT04709094|Hormones|hormones|mesh-ancestor
83890437|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890438|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890439|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83890440|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
83890441|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83890442|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83890443|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
83890444|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83890445|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
83890446|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83890447|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83890448|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83890449|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890450|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890451|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
83890452|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890453|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83890454|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83890455|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890456|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83890457|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83890458|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83890459|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83890460|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
83890461|NCT00171340|Letrozole|letrozole|mesh-list
83890462|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890463|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83890464|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83890465|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890466|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890467|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83890468|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
83890469|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890470|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890471|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83890472|NCT00202007|Risperidone|risperidone|mesh-list
83890473|NCT00202007|Aripiprazole|aripiprazole|mesh-list
83890474|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83890475|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
83890476|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890477|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890478|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890479|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83890480|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83890481|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890482|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83890483|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83890484|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
83890485|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
83890486|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
83890487|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83890488|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83890489|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83890490|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83890491|NCT00171301|Deferasirox|deferasirox|mesh-list
83890492|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83890493|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
83890494|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
83890495|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890496|NCT00266058|Ritonavir|ritonavir|mesh-list
83890497|NCT00266058|Lopinavir|lopinavir|mesh-list
83890498|NCT00266058|Efavirenz|efavirenz|mesh-list
83890499|NCT00266058|Lumefantrine|lumefantrine|mesh-list
83890500|NCT00266058|Artemether|artemether|mesh-list
83890501|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83890502|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83890503|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83890504|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
83890505|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83408159|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
83890506|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890507|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83890508|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83890509|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
83890510|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890511|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83890512|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83890513|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83890514|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83890515|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83890516|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83890517|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83890518|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83890519|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83890520|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
83890521|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83890522|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83890523|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
83890524|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890525|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83890526|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890527|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890528|NCT00202124|Tryptophan|tryptophan|mesh-list
83890529|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83890530|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
83890531|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83890532|NCT00266097|Gemcitabine|gemcitabine|mesh-list
83890533|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
83890534|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83890535|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83890536|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
83890537|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890538|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890539|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83890540|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890541|NCT00202163|Testosterone|testosterone|mesh-list
83890542|NCT00202163|Androgens|androgens|mesh-ancestor
83890543|NCT00202163|Hormones|hormones|mesh-ancestor
83890544|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890545|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890546|NCT00476554|Sapacitabine|sapacitabine|mesh-list
83890547|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890548|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83890549|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83890550|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
83890551|NCT00202241|Testosterone|testosterone|mesh-list
83890552|NCT00202241|Androgens|androgens|mesh-ancestor
83890553|NCT00202241|Hormones|hormones|mesh-ancestor
83890554|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890555|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890556|NCT00266136|Cytarabine|cytarabine|mesh-list
83890557|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
83890558|NCT00266136|Daunorubicin|daunorubicin|mesh-list
83890559|NCT00266136|Thioguanine|thioguanine|mesh-list
83890560|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890561|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
83890562|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890563|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890564|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83890565|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
83890566|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890567|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890568|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83890569|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83890570|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
83890571|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
83890572|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890573|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83890574|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83890575|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83890576|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890577|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83890578|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
83890579|NCT00230594|Coagulants|coagulants|mesh-ancestor
83890580|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83890581|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
83890582|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890583|NCT00259077|Omeprazole|omeprazole|mesh-list
83890584|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83890585|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890586|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83890587|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890588|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890589|NCT00479674|Paclitaxel|paclitaxel|mesh-list
83890590|NCT00479674|Bevacizumab|bevacizumab|mesh-list
83890591|NCT00479674|Carboplatin|carboplatin|mesh-list
83890592|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83890593|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83890594|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890595|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890596|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890597|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890598|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890599|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83890600|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83890601|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83890602|NCT00479674|Growth Substances|growth substances|mesh-ancestor
83890603|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890604|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
83890605|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83890606|NCT02962310|Calcium|calcium|mesh-list
83890607|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83890608|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890609|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83890610|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83890611|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
83890612|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890613|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83890614|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83890615|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890616|NCT00259116|Methocarbamol|methocarbamol|mesh-list
83890617|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83890618|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890619|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83890620|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890621|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
83890622|NCT00415779|Docetaxel|docetaxel|mesh-list
83890623|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890624|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890625|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890626|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890627|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890628|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83890629|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890630|NCT00259155|Rifaximin|rifaximin|mesh-list
83890631|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83890632|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890633|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890634|NCT00479401|Pramipexole|pramipexole|mesh-list
83890635|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
83890636|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890637|NCT00479401|Protective Agents|protective agents|mesh-ancestor
83890638|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890639|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83890640|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83890641|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
83890642|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
83890643|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890644|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83890645|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83890646|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83890647|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
83890648|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890649|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890650|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890651|NCT00230789|Urological Agents|urological agents|mesh-ancestor
83890652|NCT00478777|Dexamethasone|dexamethasone|mesh-list
83890653|NCT00478777|Lenalidomide|lenalidomide|mesh-list
83890654|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890655|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
83890656|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
83890657|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890658|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890659|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890660|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
83890661|NCT00478777|Hormones|hormones|mesh-ancestor
83890662|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890663|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83890664|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890665|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
83890666|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83890667|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83890668|NCT00478777|Growth Substances|growth substances|mesh-ancestor
83890669|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
83890670|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
83890671|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
83890672|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890673|NCT00477607|Protective Agents|protective agents|mesh-ancestor
83890674|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890675|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
83890676|NCT00477607|Vitamins|vitamins|mesh-ancestor
83890677|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
83890678|NCT00230867|Acyclovir|acyclovir|mesh-list
83890679|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
83890680|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890681|NCT00266214|Lidocaine|lidocaine|mesh-list
83890682|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
83890683|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
83890684|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890685|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890686|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
83890687|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890688|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83890689|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83890690|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83890691|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890692|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890693|NCT00266253|Metformin|metformin|mesh-list
83890694|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890695|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890696|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
83890697|NCT00230984|Testosterone|testosterone|mesh-list
83890698|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
83890699|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
83890700|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83890701|NCT00230984|Androgens|androgens|mesh-ancestor
83890702|NCT00230984|Hormones|hormones|mesh-ancestor
83890703|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890704|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890705|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83890706|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890707|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
83890708|NCT00415350|Azithromycin|azithromycin|mesh-list
83890709|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83890710|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890711|NCT00231023|Triamcinolone|triamcinolone|mesh-list
83890712|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83890713|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83890714|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83890715|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890716|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
83890717|NCT00231023|Hormones|hormones|mesh-ancestor
83890718|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890719|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890720|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890721|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
83890722|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890723|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890724|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83890725|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
83890726|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83890727|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83890728|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83890729|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83890730|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890731|NCT00231140|Thalidomide|thalidomide|mesh-list
83890732|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890733|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
83890734|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890735|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
83890736|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83890737|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890738|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83890739|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83890740|NCT00231140|Growth Substances|growth substances|mesh-ancestor
83890741|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
83890742|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890743|NCT00231218|Propolis|propolis|mesh-list
83890744|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890745|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
83890746|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83890747|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890748|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
83890749|NCT00231335|Escitalopram|escitalopram|mesh-list
83890750|NCT00231335|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83890751|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83890752|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890753|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890754|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890755|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
83890756|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890757|NCT00266487|Vitamins|vitamins|mesh-list
83890758|NCT00266487|Folic Acid|folic acid|mesh-list
83890759|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
83890760|NCT00266487|Hydroxocobalamin|hydroxocobalamin|mesh-list
83890761|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
83890762|NCT00266487|Pyridoxal|pyridoxal|mesh-list
83890763|NCT00266487|Pyridoxine|pyridoxine|mesh-list
83890764|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
83890765|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
83890766|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890767|NCT00266487|Hematinics|hematinics|mesh-ancestor
83890768|NCT00231452|Artesunate|artesunate|mesh-list
83890769|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
83890770|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
83890771|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83890772|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
83890773|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83890774|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83890775|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890776|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890777|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
83890778|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
83890779|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83890780|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
83890781|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83890782|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890783|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890784|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83890785|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
83890786|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83890787|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83890788|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83890789|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890790|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890791|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
83890792|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890793|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890794|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83890795|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890796|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83890797|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
83890798|NCT00477490|Coagulants|coagulants|mesh-ancestor
83890799|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83890800|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
83890801|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890802|NCT00231530|Topiramate|topiramate|mesh-list
83890803|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
83890804|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890805|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890806|NCT00231569|Mipomersen|mipomersen|mesh-list
83890807|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83890808|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83890809|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
83890810|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890811|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83890812|NCT00477334|Famciclovir|famciclovir|mesh-list
83890813|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
83890814|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890815|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83890816|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890817|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890818|NCT00231608|Topiramate|topiramate|mesh-list
83890819|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
83890820|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890821|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890822|NCT00266604|Topiramate|topiramate|mesh-list
83890823|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
83890824|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890825|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890826|NCT04561336|Cetuximab|cetuximab|mesh-list
83890827|NCT04561336|Avelumab|avelumab|mesh-list
83890828|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83890829|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890830|NCT00259428|Dronedarone|dronedarone|mesh-list
83890831|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83890832|NCT00231647|Topiramate|topiramate|mesh-list
83129944|NCT02467023|Fentanyl|fentanyl|mesh-list
83890833|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
83890834|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890835|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890836|NCT04560322|Venetoclax|venetoclax|mesh-list
83890837|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
83890838|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
83890839|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890840|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83890842|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890843|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83890844|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890845|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890846|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83890847|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83890848|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83890849|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890850|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890851|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890852|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890853|NCT00266643|Analgesics|analgesics|mesh-ancestor
83890854|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
83890855|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890856|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
83890857|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83890858|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
83890859|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
83890860|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890861|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890862|NCT04560049|Phenol|phenol|mesh-list
83890863|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
83890864|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83890865|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83890866|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
83890867|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83890868|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83890869|NCT04559425|Dexamethasone|dexamethasone|mesh-list
83890870|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
83890871|NCT04559425|BB 1101|bb 1101|mesh-list
83890872|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890873|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
83890874|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
83890875|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890876|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890877|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890878|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
83890879|NCT04559425|Hormones|hormones|mesh-ancestor
83890880|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890881|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83890882|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890883|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
83890884|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890885|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890886|NCT00231764|Daclizumab|daclizumab|mesh-list
83890887|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890888|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
83890889|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890890|NCT04559308|Metformin|metformin|mesh-list
83890891|NCT04559308|Paclitaxel|paclitaxel|mesh-list
83890892|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
83890893|NCT04559308|Doxorubicin|doxorubicin|mesh-list
83890894|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83890895|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890896|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83890897|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83890898|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83890899|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890900|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890901|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
83890902|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890903|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890904|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83890905|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
83890906|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83890907|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83890908|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83890909|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83890910|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83890911|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890912|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
83890913|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83890914|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83890915|NCT04559113|Prednisolone|prednisolone|mesh-list
83890916|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
83890917|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83890918|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
83890919|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890920|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
83890921|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
83890922|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890923|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890924|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890925|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
83890926|NCT04559113|Hormones|hormones|mesh-ancestor
83890927|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890928|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83890929|NCT04559113|Protective Agents|protective agents|mesh-ancestor
83890930|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83890931|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890932|NCT00266721|Pancrelipase|pancrelipase|mesh-list
83890933|NCT00266721|Pancreatin|pancreatin|mesh-list
83890934|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890935|NCT04559074|Amlodipine|amlodipine|mesh-list
83890936|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83890937|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83890938|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83890939|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890940|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83890941|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890942|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
83890943|NCT02211976|Bisacodyl|bisacodyl|mesh-list
83890944|NCT02211976|Cathartics|cathartics|mesh-ancestor
83890945|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890946|NCT02211976|Laxatives|laxatives|mesh-ancestor
83890947|NCT04558684|Immunomodulating Agents|immunomodulating agents|mesh-list
83890948|NCT04558684|Immunologic Factors|immunologic factors|mesh-ancestor
83890949|NCT04558684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890950|NCT00231959|Pramipexole|pramipexole|mesh-list
83890951|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
83890952|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890953|NCT00231959|Protective Agents|protective agents|mesh-ancestor
83890954|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890955|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83890956|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83890957|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
83890958|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
83890959|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890960|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
83890961|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83890962|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83890963|NCT00231998|Analgesics|analgesics|mesh-ancestor
83890964|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
83890965|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890966|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890967|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890968|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83890969|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
83890970|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83890971|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
83890972|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83890973|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83890974|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890975|NCT00266838|Dexamethasone|dexamethasone|mesh-list
83890976|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83890977|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
83890978|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
83890979|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83890980|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890981|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83890982|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
83890983|NCT00266838|Hormones|hormones|mesh-ancestor
83890984|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83890985|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83890986|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83890987|NCT00232037|Tegaserod|tegaserod|mesh-list
83890988|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83890989|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
83890990|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83890991|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83890992|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83890993|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
83890994|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83890995|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83890996|NCT02212210|Prednisolone|prednisolone|mesh-list
83890997|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
83890998|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83890999|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
83891000|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891001|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
83891002|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
83891003|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891004|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891005|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83891006|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
83891007|NCT02212210|Hormones|hormones|mesh-ancestor
83891008|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891009|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83891010|NCT02212210|Protective Agents|protective agents|mesh-ancestor
83891011|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83891012|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891013|NCT00232076|Cyclosporine|cyclosporine|mesh-list
83891014|NCT00232076|Cyclosporins|cyclosporins|mesh-list
83891015|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891016|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891017|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891018|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
83891019|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891020|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
83891021|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891022|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891023|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891024|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83891025|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
83891026|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83891027|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83891028|NCT00232115|Analgesics|analgesics|mesh-ancestor
83891029|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
83891030|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891031|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891032|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891033|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891034|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891035|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891036|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
83891037|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83891038|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891039|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891040|NCT04558021|Niclosamide|niclosamide|mesh-list
83891041|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
83891042|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83891043|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
83891044|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83891045|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891046|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
83891047|NCT00232154|Azithromycin|azithromycin|mesh-list
83891048|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891049|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891050|NCT00259662|Atorvastatin|atorvastatin|mesh-list
83891051|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83891052|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83891053|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
83891054|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891055|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83891056|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83891057|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891058|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
83891059|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83891060|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
83891061|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130167|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891062|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
83891063|NCT04557943|Protective Agents|protective agents|mesh-ancestor
83891064|NCT04557475|Aspirin|aspirin|mesh-list
83891065|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83891066|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83891067|NCT04557475|Analgesics|analgesics|mesh-ancestor
83891068|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
83891069|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891070|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891071|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891072|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891073|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83891074|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83891075|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891076|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83891077|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83891078|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891079|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
83891080|NCT00232271|Enoxaparin|enoxaparin|mesh-list
83891081|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
83891082|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83891083|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83891084|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891085|NCT04557397|Itraconazole|itraconazole|mesh-list
83891086|NCT04557397|Rifampin|rifampin|mesh-list
83891087|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
83891088|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891089|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83891090|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83891091|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891092|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891093|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83891094|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
83891095|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891096|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891097|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83891098|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83891099|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
83891100|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891101|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
83891102|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83891103|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83891104|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83891105|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83891106|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83891107|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83891108|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83891109|NCT04557202|Tamsulosin|tamsulosin|mesh-list
83891110|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83891111|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83891112|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83891113|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891114|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891115|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891116|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891117|NCT04557202|Urological Agents|urological agents|mesh-ancestor
83891118|NCT00232349|Galantamine|galantamine|mesh-list
83891119|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83891120|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891121|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891122|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
83891123|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891124|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891125|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83891126|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
83891127|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891128|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
83891129|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
83891130|NCT00259701|Acetylcholine|acetylcholine|mesh-list
83891131|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
83891132|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83891133|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
83891134|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891135|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891136|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891137|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83891138|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83891139|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891140|NCT04566211|Amoxicillin|amoxicillin|mesh-list
83891141|NCT04566211|Metronidazole|metronidazole|mesh-list
83891142|NCT04566211|Clarithromycin|clarithromycin|mesh-list
83891143|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83891144|NCT04566211|Pantoprazole|pantoprazole|mesh-list
83891145|NCT04566211|Bismuth|bismuth|mesh-list
83891146|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891147|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891148|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83891149|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83891150|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83891151|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891152|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891153|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83891154|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83891155|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83891156|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83891157|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83891158|NCT04566211|Antacids|antacids|mesh-ancestor
83891159|NCT00259779|Prednisolone|prednisolone|mesh-list
83891160|NCT00259779|Budesonide|budesonide|mesh-list
83891161|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
83891162|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891163|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
83891164|NCT00259779|Hormones|hormones|mesh-ancestor
83891165|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891166|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891167|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83891168|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891169|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
83891170|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891171|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83891172|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83891173|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891174|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83891175|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83891176|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83891177|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891178|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891179|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891180|NCT02211079|Tolbutamide|tolbutamide|mesh-list
83891181|NCT02211079|Midazolam|midazolam|mesh-list
83891182|NCT02211079|Caffeine|caffeine|mesh-list
83891183|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83891184|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83891185|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891186|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891187|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83891188|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83891189|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83891190|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83891191|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
83891192|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
83891193|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
83891194|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
83891195|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891196|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891197|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83891198|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83891199|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891200|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83891201|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83891202|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
83891203|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83891204|NCT00232622|Streptokinase|streptokinase|mesh-list
83891205|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83891206|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83891207|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891208|NCT00232661|Tamoxifen|tamoxifen|mesh-list
83891209|NCT00232661|Anastrozole|anastrozole|mesh-list
83891210|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83891211|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
83891212|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891213|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891214|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83891215|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891216|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83891217|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83891218|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83891219|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83891220|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83891221|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891222|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891223|NCT00267267|Atorvastatin|atorvastatin|mesh-list
83891224|NCT00267267|Simvastatin|simvastatin|mesh-list
83891225|NCT00267267|Ezetimibe|ezetimibe|mesh-list
83891226|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83891227|NCT00267267|Torcetrapib|torcetrapib|mesh-list
83891228|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83891229|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83891230|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
83891231|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891232|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83891233|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83891234|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891235|NCT04564690|Vitamin E|vitamin e|mesh-list
83891236|NCT04564690|Selenium|selenium|mesh-list
83891237|NCT04564690|Vitamins|vitamins|mesh-ancestor
83891238|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
83891239|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891240|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
83891241|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891242|NCT04564690|Protective Agents|protective agents|mesh-ancestor
83891243|NCT04564690|Trace Elements|trace elements|mesh-ancestor
83891244|NCT00232700|Escitalopram|escitalopram|mesh-list
83891245|NCT00232700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83891246|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83891247|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891248|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891249|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891250|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
83891251|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891252|NCT04564456|Fluticasone|fluticasone|mesh-list
83891253|NCT04564456|Xhance|xhance|mesh-list
83891254|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83891255|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83891256|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891257|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83891258|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
83891259|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891260|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891261|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83891262|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891263|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891264|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83891265|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83891266|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83891267|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83891268|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891269|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891270|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891271|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
83891272|NCT04564456|Hormones|hormones|mesh-ancestor
83891273|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891274|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
83891275|NCT04564144|Meclizine|meclizine|mesh-list
83891276|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
83891277|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
83891278|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891279|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891280|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83891281|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83891282|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
83891283|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
83891284|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891285|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130393|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83891286|NCT04564144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83891287|NCT04564144|Cholinergic Agents|cholinergic agents|mesh-ancestor
83891288|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83891290|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
83891291|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891292|NCT00259896|Exenatide|exenatide|mesh-list
83891293|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83891294|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891295|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83891296|NCT00259896|Incretins|incretins|mesh-ancestor
83891297|NCT00259896|Hormones|hormones|mesh-ancestor
83891298|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891299|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
83891300|NCT04721795|Atorvastatin|atorvastatin|mesh-list
83891301|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83891302|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83891303|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
83891304|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891305|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83891306|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83891307|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891308|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891309|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891310|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83891311|NCT04564222|Micronutrients|micronutrients|mesh-list
83891312|NCT04564222|Trace Elements|trace elements|mesh-list
83891313|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891314|NCT00232817|Nicotine|nicotine|mesh-list
83891315|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83891316|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
83891317|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891318|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891319|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83891320|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83891321|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
83891322|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891323|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891324|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
83891325|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83891326|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
83891327|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891328|NCT00267384|Expectorants|expectorants|mesh-ancestor
83891329|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891330|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83891331|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
83891332|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891333|NCT00267384|Protective Agents|protective agents|mesh-ancestor
83891334|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891335|NCT00267384|Antidotes|antidotes|mesh-ancestor
83891336|NCT00259935|Topotecan|topotecan|mesh-list
83891337|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83891338|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83891339|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891340|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891341|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891342|NCT00232856|Sirolimus|sirolimus|mesh-list
83891343|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891344|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891345|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83891346|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891347|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
83891348|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891349|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
83891350|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891351|NCT00259974|Rituximab|rituximab|mesh-list
83891352|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891353|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891354|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
83891355|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891356|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891357|NCT00232895|Propofol|propofol|mesh-list
83891358|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83891359|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891360|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130466|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
83891361|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83891362|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
83891363|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
83891364|NCT00232934|Thalidomide|thalidomide|mesh-list
83891365|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891366|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
83891367|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891368|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
83891369|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891370|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891371|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83891372|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83891373|NCT00232934|Growth Substances|growth substances|mesh-ancestor
83891374|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
83891375|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891376|NCT04673812|Fentanyl|fentanyl|mesh-list
83891377|NCT04673812|Bupivacaine|bupivacaine|mesh-list
83891378|NCT04673812|Naloxone|naloxone|mesh-list
83891379|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
83891380|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
83891381|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891382|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891383|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
83891384|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891385|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83891386|NCT04673812|Narcotics|narcotics|mesh-ancestor
83891387|NCT04673812|Analgesics|analgesics|mesh-ancestor
83891388|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83891389|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83891390|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
83891391|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83891392|NCT04673461|Xylometazoline|xylometazoline|mesh-list
83891393|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
83891394|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83891395|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891396|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
83891397|NCT00260052|Hematinics|hematinics|mesh-ancestor
83891398|NCT04673500|Lidocaine|lidocaine|mesh-list
83891399|NCT04673500|Propofol|propofol|mesh-list
83891400|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83891401|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
83891402|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891403|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891404|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
83891405|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891406|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83891407|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83891408|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83891409|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891410|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891411|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83891412|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83891413|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
83891414|NCT00233012|Topiramate|topiramate|mesh-list
83891415|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
83891416|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83891417|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891418|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
83891419|NCT00267540|Vitamin D|vitamin d|mesh-list
83891420|NCT00267540|Vitamins|vitamins|mesh-ancestor
83891421|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
83891422|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891423|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83891424|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83891425|NCT00233051|Fluticasone|fluticasone|mesh-list
83891426|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83891427|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891428|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83891429|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
83891430|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891431|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891432|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83891433|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891434|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891435|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83891436|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83891437|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83891438|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83891439|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891440|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891441|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891442|NCT04672759|Durvalumab|durvalumab|mesh-list
83891443|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83891444|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891445|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891446|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
83891447|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891448|NCT04672330|Tislelizumab|tislelizumab|mesh-list
83891449|NCT04672330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891450|NCT04672330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891451|NCT00260247|Carbamazepine|carbamazepine|mesh-list
83891452|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
83891453|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
83891454|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
83891455|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83891456|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891457|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891458|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83891459|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83891460|NCT00260247|Analgesics|analgesics|mesh-ancestor
83891461|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
83891462|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891463|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83891464|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891465|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891466|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83891467|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83891468|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83891469|NCT04671589|Meropenem|meropenem|mesh-list
83891470|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891471|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891472|NCT00260325|Valdecoxib|valdecoxib|mesh-list
83891473|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83891474|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83891475|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891476|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891477|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83891478|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83891479|NCT00260325|Analgesics|analgesics|mesh-ancestor
83891480|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
83891481|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891482|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891483|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891484|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891485|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83891486|NCT04671160|Dalteparin|dalteparin|mesh-list
83891487|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
83891488|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83891489|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83891490|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891491|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
83891492|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891493|NCT00233558|Adalimumab|adalimumab|mesh-list
83891494|NCT00233558|Methotrexate|methotrexate|mesh-list
83891495|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83891496|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
83891497|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83891498|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891499|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83891500|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
83891501|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891502|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891503|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891504|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891505|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83891506|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891507|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
83891508|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891509|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83891510|NCT00233558|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83891511|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891512|NCT00233636|Gefitinib|gefitinib|mesh-list
83891513|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891514|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83891515|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891516|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891517|NCT00267657|Reserpine|reserpine|mesh-list
83891518|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83891519|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83891520|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83891521|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891522|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891523|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83891524|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83891525|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83891526|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891527|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891528|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891529|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891530|NCT04670809|Clevidipine|clevidipine|mesh-list
83891531|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83891532|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891533|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891534|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83891535|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891536|NCT00233714|Sirolimus|sirolimus|mesh-list
83891537|NCT00233714|Temsirolimus|temsirolimus|mesh-list
83891538|NCT00233714|MTOR Inhibitors|mtor inhibitors|mesh-list
83891539|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891540|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891541|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83891542|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891543|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
83891544|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891545|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
83891546|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891547|NCT00233714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83891548|NCT00233714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891549|NCT00233714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891550|NCT04670497|Epinephrine|epinephrine|mesh-list
83891551|NCT04670497|Racepinephrine|racepinephrine|mesh-list
83891552|NCT04670497|Bupivacaine|bupivacaine|mesh-list
83891553|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
83891554|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
83891555|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
83891556|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891557|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891558|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
83891559|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891560|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83891561|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83891562|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891563|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891564|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891565|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83891566|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83891567|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
83891568|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83891569|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891570|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
83891571|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
83891572|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83891573|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83891574|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891575|NCT04670107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891576|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891577|NCT00260364|Bevacizumab|bevacizumab|mesh-list
83891578|NCT00260364|Gemcitabine|gemcitabine|mesh-list
83891579|NCT00260364|Capecitabine|capecitabine|mesh-list
83891580|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83891581|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891582|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891583|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83891584|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83891585|NCT00260364|Growth Substances|growth substances|mesh-ancestor
83891586|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891587|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
83891588|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83891589|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
83891590|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891591|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83891592|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891593|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
83891594|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891595|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891596|NCT04557007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83891597|NCT04557007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891598|NCT00233792|Sirolimus|sirolimus|mesh-list
83891599|NCT00233792|Temsirolimus|temsirolimus|mesh-list
83891600|NCT00233792|MTOR Inhibitors|mtor inhibitors|mesh-list
83891601|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891602|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891603|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83891604|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891605|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
83891606|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891607|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
83891608|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891609|NCT00233792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83891610|NCT00233792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891611|NCT00233792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891612|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83891613|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891614|NCT00556192|Rituximab|rituximab|mesh-list
83891615|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891616|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891617|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
83891618|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891619|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891620|NCT00556270|Fentanyl|fentanyl|mesh-list
83891621|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83891622|NCT00556270|Narcotics|narcotics|mesh-ancestor
83891623|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891624|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891625|NCT00556270|Analgesics|analgesics|mesh-ancestor
83891626|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
83891627|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891628|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83891629|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83891630|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
83891631|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
83891632|NCT00260520|Dalteparin|dalteparin|mesh-list
83891633|NCT00260520|Tinzaparin|tinzaparin|mesh-list
83891634|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83891635|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
83891636|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83891637|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83891638|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891639|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
83891640|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891641|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891642|NCT00233909|Immunotoxins|immunotoxins|mesh-ancestor
83891643|NCT00233909|Immunoconjugates|immunoconjugates|mesh-ancestor
83891644|NCT00233909|Immunologic Factors|immunologic factors|mesh-ancestor
83891645|NCT00233909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891646|NCT00267813|Bupropion|bupropion|mesh-list
83891647|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83891648|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
83891649|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83891650|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83891651|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83891652|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891653|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891654|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
83891655|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891656|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891657|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83891658|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83891659|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891660|NCT00234026|Gemcitabine|gemcitabine|mesh-list
83130819|NCT02060851|Iron|iron|mesh-list
83891661|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83891662|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
83891663|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891664|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891665|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
83891666|NCT00234143|Hematinics|hematinics|mesh-ancestor
83891667|NCT00234182|Interferons|interferons|mesh-list
83891668|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
83891669|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
83891670|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891671|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
83891672|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891673|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
83891674|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891675|NCT04669990|Remdesivir|remdesivir|mesh-list
83891676|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
83891677|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891678|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
83891679|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891680|NCT00556348|Bevacizumab|bevacizumab|mesh-list
83891681|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891682|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891683|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83891684|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83891685|NCT00556348|Growth Substances|growth substances|mesh-ancestor
83891686|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891687|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
83891688|NCT00556387|Ketamine|ketamine|mesh-list
83891689|NCT00556387|Analgesics|analgesics|mesh-ancestor
83891690|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
83891691|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891692|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148824|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
83891693|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83891694|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83891695|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
83891696|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
83891697|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891698|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83891699|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83891700|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891701|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891702|NCT04552093|Floxuridine|floxuridine|mesh-list
83891703|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83891704|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
83891705|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891706|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891707|NCT04556110|Perindopril|perindopril|mesh-list
83891708|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83891709|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
83891710|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891711|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891712|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83891713|NCT00234299|Aspirin|aspirin|mesh-list
83891714|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83891715|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83891716|NCT00234299|Analgesics|analgesics|mesh-ancestor
83891717|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
83891718|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891719|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891720|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891721|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891722|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83891723|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83891724|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891725|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83891726|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83891727|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891728|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
83891729|NCT04556032|Ergothioneine|ergothioneine|mesh-list
83891730|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
83891731|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891732|NCT04556032|Protective Agents|protective agents|mesh-ancestor
83891733|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130846|NCT03299517|Lidocaine|lidocaine|mesh-list
83891734|NCT04556071|Bevacizumab|bevacizumab|mesh-list
83891735|NCT04556071|Niraparib|niraparib|mesh-list
83891736|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891737|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891738|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83148907|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891739|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83891740|NCT04556071|Growth Substances|growth substances|mesh-ancestor
83891741|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891742|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
83891743|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83891744|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891745|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891746|NCT04563871|Osimertinib|osimertinib|mesh-list
83891747|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891748|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83891749|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891750|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891751|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83891752|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
83891753|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83891754|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83891755|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83891756|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891757|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891758|NCT04563754|Proflavine|proflavine|mesh-list
83891759|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83891760|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891761|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
83891762|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83891763|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891764|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891765|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83891766|NCT02211118|Analgesics|analgesics|mesh-ancestor
83891767|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
83891768|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891769|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83891770|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83891771|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83891772|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891773|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891774|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891775|NCT00234416|Gemcitabine|gemcitabine|mesh-list
83891776|NCT00234416|Gefitinib|gefitinib|mesh-list
83891777|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83891778|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
83891779|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891780|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891781|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83891782|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891783|NCT00234455|Sirolimus|sirolimus|mesh-list
83891784|NCT00234455|Temsirolimus|temsirolimus|mesh-list
83891785|NCT00234455|MTOR Inhibitors|mtor inhibitors|mesh-list
83891786|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83891787|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891788|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83891789|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891790|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
83891791|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891792|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
83891793|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891794|NCT00234455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83891795|NCT00234455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891796|NCT00234455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891797|NCT00234572|Lanreotide|lanreotide|mesh-list
83891798|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891799|NCT00260793|Ropinirole|ropinirole|mesh-list
83891800|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83891801|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83891802|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
83891803|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
83891804|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891805|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891806|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891807|NCT00415935|Methotrexate|methotrexate|mesh-list
83891808|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83891809|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
83891810|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83891811|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891812|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83891813|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
83891814|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891815|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891816|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891817|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891818|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83891819|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891820|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
83891821|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891822|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83891823|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83891824|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891825|NCT02211391|Caseins|caseins|mesh-list
83891826|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
83891827|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
83891828|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891829|NCT04562311|Tislelizumab|tislelizumab|mesh-list
83891830|NCT04562311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83891831|NCT04562311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891832|NCT00234689|Naltrexone|naltrexone|mesh-list
83891833|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83891834|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83891835|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891836|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
83891837|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891838|NCT04561960|Fluorides|fluorides|mesh-list
83891839|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
83891840|NCT04561960|Protective Agents|protective agents|mesh-ancestor
83891841|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891842|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
83891843|NCT04561921|Nordefrin|nordefrin|mesh-list
83891844|NCT04561921|Mepivacaine|mepivacaine|mesh-list
83891845|NCT04561921|Analgesics|analgesics|mesh-ancestor
83891846|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
83891847|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891848|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891849|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
83891850|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891851|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83891852|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
83891853|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83891854|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891855|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891856|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83891857|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
83891858|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83891859|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
83891860|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83891861|NCT04561687|Azelastine|azelastine|mesh-list
83891862|NCT04561687|Budesonide|budesonide|mesh-list
83891863|NCT04561687|Montelukast|montelukast|mesh-list
83891864|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891865|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83891866|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
83891867|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891868|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891869|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83891870|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891871|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
83891872|NCT04561687|Hormones|hormones|mesh-ancestor
83891873|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891874|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83891875|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
83891876|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83891877|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83149164|NCT00103285|Vincristine|vincristine|mesh-list
83891878|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891879|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83891880|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891881|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83130987|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
83130988|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891882|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83891883|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83891884|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
83891885|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
83891886|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891887|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
83891888|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83891889|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891890|NCT00234845|Adalimumab|adalimumab|mesh-list
83891891|NCT00234845|Methotrexate|methotrexate|mesh-list
83891892|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83891893|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
83891894|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83891895|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891896|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83891897|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
83891898|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891899|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891900|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
83891901|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891902|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83891903|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83891904|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
83891905|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83891906|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83891907|NCT00234845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83891908|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891909|NCT02211625|Oxycodone|oxycodone|mesh-list
83891910|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83891911|NCT02211625|Narcotics|narcotics|mesh-ancestor
83891912|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83891913|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891914|NCT02211625|Analgesics|analgesics|mesh-ancestor
83891915|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
83891916|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891917|NCT00234923|Ritonavir|ritonavir|mesh-list
83891918|NCT00234923|Lopinavir|lopinavir|mesh-list
83891919|NCT00234923|Lamivudine|lamivudine|mesh-list
83891920|NCT00234923|Zidovudine|zidovudine|mesh-list
83891921|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83891922|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83891923|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83891924|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
83891925|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891926|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891927|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83891928|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83891929|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
83891930|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891931|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83891932|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83891933|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83891934|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83891935|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
83891936|NCT02213887|Pantoprazole|pantoprazole|mesh-list
83891937|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83891938|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83891939|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83891940|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891941|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891942|NCT00234962|Ritonavir|ritonavir|mesh-list
83891943|NCT00234962|Lopinavir|lopinavir|mesh-list
83891944|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83149313|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
83891945|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83891946|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
83891947|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891948|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891949|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83891950|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83891951|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
83891952|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83891953|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83891954|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83891955|NCT04551703|Epinephrine|epinephrine|mesh-list
83891956|NCT04551703|Racepinephrine|racepinephrine|mesh-list
83891957|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
83891958|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83891959|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83891960|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
83891961|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83891962|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891963|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891964|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83891965|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83891967|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83891968|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83891969|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
83891970|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
83891971|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
83891972|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83891973|NCT00235001|Verapamil|verapamil|mesh-list
83891974|NCT00235001|Trandolapril|trandolapril|mesh-list
83891975|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83891976|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83891977|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83891978|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83891979|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83149371|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
83891980|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891981|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
83891982|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83891983|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
83891984|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83891985|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83891986|NCT04551781|Prednisone|prednisone|mesh-list
83891987|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83891988|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
83891989|NCT04551781|Hormones|hormones|mesh-ancestor
83891990|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83891991|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891992|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83891993|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83891994|NCT00424944|Vaccines|vaccines|mesh-list
83891995|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
83891996|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83891997|NCT02214004|Trastuzumab|trastuzumab|mesh-list
83891998|NCT02214004|Letrozole|letrozole|mesh-list
83891999|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83892000|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892001|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83892002|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83892003|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892004|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892005|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83892006|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83892007|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892008|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892009|NCT00235079|Colchicine|colchicine|mesh-list
83892010|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
83892011|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892012|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892013|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
83892014|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892015|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892016|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892017|NCT00260988|Dalteparin|dalteparin|mesh-list
83892018|NCT00260988|Tinzaparin|tinzaparin|mesh-list
83892019|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83892020|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
83892021|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83892022|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83892023|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892024|NCT00235157|Sirolimus|sirolimus|mesh-list
83892025|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892026|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131138|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892027|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83892028|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892029|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
83892030|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892032|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892033|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
83892034|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83892035|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83892036|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892037|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
83892038|NCT04550338|Coagulants|coagulants|mesh-ancestor
83892039|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
83892040|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83892041|NCT04550611|Antibodies|antibodies|mesh-list
83892042|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
83892043|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83892044|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
83892045|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892046|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
83892047|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83892048|NCT00261027|Exemestane|exemestane|mesh-list
83892049|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892050|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83892051|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83892052|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892053|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892054|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83892055|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
83892056|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892057|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892058|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
83892059|NCT00235235|Gemcitabine|gemcitabine|mesh-list
83892060|NCT00235235|Doxorubicin|doxorubicin|mesh-list
83892061|NCT00235235|Capecitabine|capecitabine|mesh-list
83892062|NCT00235235|Vinorelbine|vinorelbine|mesh-list
83892063|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892064|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
83892065|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892066|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892067|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83892068|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
83892069|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892070|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892071|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83892072|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83892073|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
83892074|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83892075|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83892076|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892077|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892078|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83892079|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892080|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
83892081|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892082|NCT00268359|Bevacizumab|bevacizumab|mesh-list
83892083|NCT00268359|Irinotecan|irinotecan|mesh-list
83892084|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83892085|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892086|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83892087|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83892088|NCT00268359|Growth Substances|growth substances|mesh-ancestor
83892089|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892090|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83892091|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83892092|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892093|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892094|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892095|NCT00235274|Secretin|secretin|mesh-list
83892096|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892097|NCT00235274|Hormones|hormones|mesh-ancestor
83892098|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892099|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892100|NCT00268398|Leucovorin|leucovorin|mesh-list
83892101|NCT00268398|Folic Acid|folic acid|mesh-list
83892102|NCT00268398|Fluorouracil|fluorouracil|mesh-list
83892103|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
83892104|NCT00268398|Irinotecan|irinotecan|mesh-list
83892105|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
83892106|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
83892107|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892108|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83892109|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892110|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892111|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
83892112|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892113|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83892114|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892115|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892116|NCT00268398|Antidotes|antidotes|mesh-ancestor
83892117|NCT00268398|Protective Agents|protective agents|mesh-ancestor
83892118|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
83892119|NCT00268398|Vitamins|vitamins|mesh-ancestor
83892120|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
83892121|NCT00268398|Hematinics|hematinics|mesh-ancestor
83892122|NCT00235313|Nicotine|nicotine|mesh-list
83892123|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83892124|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
83892125|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892126|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892127|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83892128|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83892129|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
83892130|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892131|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892132|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
83892133|NCT04549012|Oxytocin|oxytocin|mesh-list
83892134|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
83892135|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83892136|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892137|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83892138|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83892139|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892140|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
83892141|NCT04549012|Coagulants|coagulants|mesh-ancestor
83892142|NCT00261105|Telithromycin|telithromycin|mesh-list
83892143|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892144|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892145|NCT00235508|Eszopiclone|eszopiclone|mesh-list
83892146|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83892147|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892148|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892149|NCT00268515|Cyclosporine|cyclosporine|mesh-list
83892150|NCT00268515|Prednisone|prednisone|mesh-list
83892151|NCT00268515|Azathioprine|azathioprine|mesh-list
83892152|NCT00268515|Tacrolimus|tacrolimus|mesh-list
83892153|NCT00268515|Cyclosporins|cyclosporins|mesh-list
83892154|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892155|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
83892156|NCT00268515|Hormones|hormones|mesh-ancestor
83892157|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892158|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892159|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83892160|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892161|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892162|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
83892163|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83892164|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892165|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892166|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
83892167|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892168|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
83892169|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892170|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
83892171|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83892172|NCT04548700|Prednisone|prednisone|mesh-list
83892173|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
83892174|NCT04548700|Vincristine|vincristine|mesh-list
83892175|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
83892176|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892177|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
83892178|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892179|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892180|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83892181|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
83149694|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892182|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892183|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892184|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83892185|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892186|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
83892187|NCT04548700|Hormones|hormones|mesh-ancestor
83892188|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892189|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83892190|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83892191|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892192|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83892193|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892194|NCT04548700|Analgesics|analgesics|mesh-ancestor
83892195|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
83892196|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892197|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83892198|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892199|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892200|NCT02214433|Pantoprazole|pantoprazole|mesh-list
83892201|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83892202|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83892203|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892204|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83892205|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892206|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892207|NCT02212561|Cytarabine|cytarabine|mesh-list
83892208|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
83892209|NCT02212561|Methotrexate|methotrexate|mesh-list
83892210|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
83892211|NCT02212561|Fludarabine|fludarabine|mesh-list
83892212|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83149741|NCT02161237|Tacrolimus|tacrolimus|mesh-list
83892213|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
83892214|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83892215|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892216|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83892217|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
83892218|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892219|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892220|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
83892221|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892222|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83892223|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892224|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
83892225|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892226|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83892227|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
83892228|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892229|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892230|NCT00268554|Dipyridamole|dipyridamole|mesh-list
83892231|NCT00268554|Caffeine|caffeine|mesh-list
83892232|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83892233|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892234|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83892235|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892236|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892237|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83892238|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83892239|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
83892240|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892241|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83892242|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83892243|NCT00268593|Prednisone|prednisone|mesh-list
83892244|NCT00268593|Docetaxel|docetaxel|mesh-list
83892245|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892246|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892247|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
83892248|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892249|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892250|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892251|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
83892252|NCT00268593|Hormones|hormones|mesh-ancestor
83892253|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892254|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892255|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83892256|NCT04555525|Sarecycline|sarecycline|mesh-list
83892257|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892258|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892259|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
83892260|NCT00261183|Melatonin|melatonin|mesh-list
83892261|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
83892262|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892263|NCT00261183|Protective Agents|protective agents|mesh-ancestor
83892264|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892265|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892266|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
83892267|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83892268|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892269|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892270|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83892271|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892272|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83892273|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83892274|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
83892275|NCT04554979|Anticoagulants|anticoagulants|mesh-list
83149826|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83892276|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892277|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
83892278|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83892279|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83892280|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892281|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892282|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892283|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
83892284|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83892285|NCT00261222|Amodiaquine|amodiaquine|mesh-list
83892286|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
83892287|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83892288|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83892289|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892290|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
83892291|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
83892292|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892293|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892294|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
83892295|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83892296|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83892297|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83892298|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
83892299|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892300|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892301|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892302|NCT00268671|Docetaxel|docetaxel|mesh-list
83892303|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892304|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892305|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83149883|NCT02416167|Dotinurad|dotinurad|mesh-list
83892306|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892307|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892308|NCT04554433|Ethanol|ethanol|mesh-list
83892309|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83892310|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892311|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892312|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892313|NCT04721054|Lidocaine|lidocaine|mesh-list
83892314|NCT04721054|Bupivacaine|bupivacaine|mesh-list
83892315|NCT04721054|Anesthetics|anesthetics|mesh-list
83892316|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
83892317|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892318|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892319|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
83892320|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892321|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83892322|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83892323|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83892324|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892325|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892326|NCT02212639|Digoxin|digoxin|mesh-list
83892327|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83892328|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83892329|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892330|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892331|NCT02212639|Protective Agents|protective agents|mesh-ancestor
83892332|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892333|NCT02212756|Metformin|metformin|mesh-list
83892334|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892335|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892336|NCT02212795|Levofloxacin|levofloxacin|mesh-list
83892337|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
83892338|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83892339|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892340|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892341|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83892342|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892343|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892344|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892345|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892346|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83892347|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892348|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83892349|NCT00261261|Midazolam|midazolam|mesh-list
83892350|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83892351|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83892352|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892353|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892354|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83892355|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83892356|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83892357|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83892358|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
83892359|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
83892360|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
83892361|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
83892362|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892363|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892364|NCT00235820|Adalimumab|adalimumab|mesh-list
83892365|NCT00235820|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83892366|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892367|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892368|NCT00268710|Docetaxel|docetaxel|mesh-list
83892369|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892370|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892371|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
83892372|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892373|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892374|NCT00261300|Pantoprazole|pantoprazole|mesh-list
83892375|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83892376|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892377|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83892378|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892379|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892380|NCT02212990|Acetaminophen|acetaminophen|mesh-list
83892381|NCT02212990|Ibuprofen|ibuprofen|mesh-list
83892382|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83892383|NCT02212990|Analgesics|analgesics|mesh-ancestor
83892384|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
83892385|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892386|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892387|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
83892388|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83892389|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892390|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892391|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83892392|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892393|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892394|NCT00235859|Adalimumab|adalimumab|mesh-list
83892395|NCT00235859|Methotrexate|methotrexate|mesh-list
83892396|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83892397|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
83892398|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83892399|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892400|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83892401|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
83892402|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892403|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892404|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
83892405|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892406|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83892407|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892408|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
83892409|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892410|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83892411|NCT00235859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83892412|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892413|NCT02213029|Oxytocin|oxytocin|mesh-list
83892414|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
83892415|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83892416|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892417|NCT02213146|Insulin|insulin|mesh-list
83892418|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
83892419|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83892420|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892421|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892422|NCT00268749|Glycine|glycine|mesh-list
83892423|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
83892424|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892425|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892426|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892427|NCT00235898|Leucovorin|leucovorin|mesh-list
83892428|NCT00235898|Fluorouracil|fluorouracil|mesh-list
83892429|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
83892430|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892431|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83892432|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892433|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892434|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
83892435|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892436|NCT00235898|Antidotes|antidotes|mesh-ancestor
83892437|NCT00235898|Protective Agents|protective agents|mesh-ancestor
83892438|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
83892439|NCT00235898|Vitamins|vitamins|mesh-ancestor
83892440|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
83892441|NCT02213224|Amlodipine|amlodipine|mesh-list
83892442|NCT02213224|Telmisartan|telmisartan|mesh-list
83892443|NCT02213224|Perindopril|perindopril|mesh-list
83892444|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83892445|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83892446|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892447|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892448|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83892449|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892450|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
83892451|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83892452|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83892453|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83892454|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
83892455|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892456|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
83892457|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83892458|NCT00268788|Antibodies|antibodies|mesh-list
83892459|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
83892460|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83892461|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
83892462|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892463|NCT00235937|Anastrozole|anastrozole|mesh-list
83892464|NCT00235937|Goserelin|goserelin|mesh-list
83892465|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83892466|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892467|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83892468|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83892469|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892470|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892471|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83892472|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
83892473|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892474|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892475|NCT00261339|Pantoprazole|pantoprazole|mesh-list
83892476|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83892477|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892478|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83892479|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892480|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892481|NCT04553380|Insulin|insulin|mesh-list
83131585|NCT02071927|Azacitidine|azacitidine|mesh-list
83892482|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
83892483|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892484|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892485|NCT00236015|Tiagabine|tiagabine|mesh-list
83892486|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
83892487|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83892488|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83892489|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892490|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892491|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
83892492|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892493|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892494|NCT00261378|Doxorubicin|doxorubicin|mesh-list
83892495|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83892496|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83892497|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892498|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83892499|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892500|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892501|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892502|NCT04553458|Ethanol|ethanol|mesh-list
83892503|NCT04553458|Sorafenib|sorafenib|mesh-list
83892504|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892505|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83892506|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892507|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892508|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83892509|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892510|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892511|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892512|NCT00236054|Tiagabine|tiagabine|mesh-list
83892513|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
83892514|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83892515|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83892516|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892517|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892518|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
83892519|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892520|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892521|NCT04552951|Vitamin D|vitamin d|mesh-list
83892522|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
83892523|NCT04552951|Vitamins|vitamins|mesh-ancestor
83892524|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
83892525|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892526|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83892527|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83892528|NCT02213419|Ethanol|ethanol|mesh-list
83892529|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83892530|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892531|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150232|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83892532|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892533|NCT00236093|Fentanyl|fentanyl|mesh-list
83892534|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83892535|NCT00236093|Narcotics|narcotics|mesh-ancestor
83892536|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892537|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892538|NCT00236093|Analgesics|analgesics|mesh-ancestor
83892539|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
83892540|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892541|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83892542|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83892543|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
83892544|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
83892545|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
83892546|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83892547|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892548|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
83892549|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
83892550|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83892551|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892552|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892553|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
83892554|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83892555|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892556|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892557|NCT02213653|Iron|iron|mesh-list
83892559|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
83892560|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892561|NCT04552444|Biapenem|biapenem|mesh-list
83892562|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892563|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
83892564|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892565|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83892566|NCT02213848|Calcium|calcium|mesh-list
83892567|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83892568|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892569|NCT00261573|Galantamine|galantamine|mesh-list
83892570|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83892571|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892572|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892573|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83892574|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892575|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892576|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83892577|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
83892578|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892579|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
83892580|NCT04548271|Apatinib|apatinib|mesh-list
83892581|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892582|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83892583|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892584|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892585|NCT04541719|Remifentanil|remifentanil|mesh-list
83892586|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83892587|NCT04541719|Narcotics|narcotics|mesh-ancestor
83892588|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892589|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892590|NCT04541719|Analgesics|analgesics|mesh-ancestor
83892591|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
83892592|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892593|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83892594|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
83892595|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892596|NCT00261612|Dexamethasone|dexamethasone|mesh-list
83892597|NCT00261612|Rituximab|rituximab|mesh-list
83892598|NCT00261612|Bortezomib|bortezomib|mesh-list
83892599|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83892600|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892601|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
83892602|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892603|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83892604|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83892605|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
83892606|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
83892607|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892608|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892609|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
83892610|NCT00261612|Hormones|hormones|mesh-ancestor
83892611|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892612|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83892613|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83892614|NCT04547764|Calcium|calcium|mesh-list
83892615|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83892616|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892617|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892618|NCT04547608|Propofol|propofol|mesh-list
83892619|NCT04547608|Rocuronium|rocuronium|mesh-list
83892620|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83892621|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892622|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892623|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83892624|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
83892625|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
83892626|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83892627|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83892628|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83892629|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892630|NCT00236249|Lidocaine|lidocaine|mesh-list
83892631|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
83892632|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
83131738|NCT02071459|Droxidopa|droxidopa|mesh-list
83892633|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892634|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892635|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
83892636|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892637|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83892638|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83892639|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83892640|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892641|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892642|NCT00269061|Pioglitazone|pioglitazone|mesh-list
83892643|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83150433|NCT02761057|Sunitinib|sunitinib|mesh-list
83892644|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892645|NCT04547452|Antibodies|antibodies|mesh-list
83892646|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
83892647|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892648|NCT04547335|Voriconazole|voriconazole|mesh-list
83892649|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
83892650|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892651|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83892652|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892653|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892654|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892655|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83892656|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
83892657|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892658|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892659|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83892660|NCT00236288|Bupropion|bupropion|mesh-list
83150482|NCT02167321|Antidotes|antidotes|mesh-ancestor
83892661|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83892662|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
83892663|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83892664|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83892665|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83892666|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892667|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892668|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
83892669|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892670|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892671|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83892672|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892673|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892674|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83892675|NCT00236327|Fentanyl|fentanyl|mesh-list
83892676|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83892677|NCT00236327|Narcotics|narcotics|mesh-ancestor
83892678|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892679|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892680|NCT00236327|Analgesics|analgesics|mesh-ancestor
83892681|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
83892682|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892683|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83892684|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83892685|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
83892686|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
83892687|NCT00236366|Fentanyl|fentanyl|mesh-list
83892688|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83892689|NCT00236366|Narcotics|narcotics|mesh-ancestor
83892690|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892691|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892692|NCT00236366|Analgesics|analgesics|mesh-ancestor
83892693|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
83892694|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892695|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83892696|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83892697|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
83892698|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
83892699|NCT04547179|Erenumab|erenumab|mesh-list
83892700|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83892701|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892702|NCT04547179|Analgesics|analgesics|mesh-ancestor
83892703|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
83892704|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892705|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892706|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
83892707|NCT00236405|Hematinics|hematinics|mesh-ancestor
83892708|NCT00236444|Risperidone|risperidone|mesh-list
83892709|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83892710|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
83892711|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892712|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892713|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892714|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83892715|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83892716|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892717|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83892718|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83892719|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
83892720|NCT00269217|Niacin|niacin|mesh-list
83892721|NCT00269217|Niacinamide|niacinamide|mesh-list
83892722|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
83892723|NCT00269217|Simvastatin|simvastatin|mesh-list
83892724|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83892725|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83892726|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
83892727|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892728|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83892729|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83892730|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892731|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
83892732|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
83892733|NCT00269217|Vitamins|vitamins|mesh-ancestor
83892734|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
83892735|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892736|NCT04546282|Osimertinib|osimertinib|mesh-list
83892737|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892738|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83892739|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892740|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892741|NCT00236483|Acetaminophen|acetaminophen|mesh-list
83892742|NCT00236483|Tramadol|tramadol|mesh-list
83892743|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83892744|NCT00236483|Analgesics|analgesics|mesh-ancestor
83892745|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
83892746|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892747|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892748|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
83892749|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83892750|NCT00236483|Narcotics|narcotics|mesh-ancestor
83892751|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892752|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
83892753|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83892754|NCT04545970|Protective Agents|protective agents|mesh-ancestor
83892755|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892756|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
83892757|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83892758|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
83892759|NCT04545931|Coagulants|coagulants|mesh-ancestor
83892760|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83892761|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
83892762|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892763|NCT00236522|Levofloxacin|levofloxacin|mesh-list
83892764|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83892765|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892766|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892767|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83892768|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892769|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892770|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892771|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892772|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83892773|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892774|NCT00261729|Prazosin|prazosin|mesh-list
83892775|NCT00261729|Paroxetine|paroxetine|mesh-list
83892776|NCT00261729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83892777|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83892778|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892779|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892780|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892781|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
83892782|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892783|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83892784|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
83892785|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83892786|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83892787|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892788|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892789|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83892790|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83892791|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83892792|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83892793|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
83892794|NCT00236561|Topiramate|topiramate|mesh-list
83892795|NCT00236561|Propranolol|propranolol|mesh-list
83892796|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83892797|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83892798|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
83892799|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892800|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892801|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892802|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83892803|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83892804|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
83892805|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
83892806|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892807|NCT02215330|Eplerenone|eplerenone|mesh-list
83892808|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83892809|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
83892810|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892811|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892812|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83892813|NCT02215330|Diuretics|diuretics|mesh-ancestor
83892814|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
83892815|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83892816|NCT02278510|Topotecan|topotecan|mesh-list
83892817|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83892818|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892819|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892820|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892821|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892822|NCT04545892|Capsaicin|capsaicin|mesh-list
83892823|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
83892824|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
83892825|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
83892826|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892827|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892828|NCT02214706|Sirolimus|sirolimus|mesh-list
83892829|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892830|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892831|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83892832|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892833|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
83892834|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83892835|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
83892836|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892837|NCT00236600|Topiramate|topiramate|mesh-list
83150920|NCT00701883|Atorvastatin|atorvastatin|mesh-list
83892838|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
83892839|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892840|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892841|NCT00236639|Topiramate|topiramate|mesh-list
83892842|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
83892843|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892844|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892845|NCT04545463|Psyllium|psyllium|mesh-list
83892846|NCT04545463|Cathartics|cathartics|mesh-ancestor
83892847|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892848|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
83892849|NCT00236678|Hematinics|hematinics|mesh-ancestor
83892850|NCT00269334|Paroxetine|paroxetine|mesh-list
83892851|NCT00269334|Citalopram|citalopram|mesh-list
83892852|NCT00269334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83892853|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83892854|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892855|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892856|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892858|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892859|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83892860|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
83892861|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83150975|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
83892862|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83892863|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892864|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892865|NCT04541251|Paclitaxel|paclitaxel|mesh-list
83892866|NCT04541251|Carboplatin|carboplatin|mesh-list
83892867|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83892868|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892869|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892870|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83892871|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892872|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892873|NCT00236717|Topiramate|topiramate|mesh-list
83892874|NCT00236717|Carbamazepine|carbamazepine|mesh-list
83892875|NCT00236717|Valproic Acid|valproic acid|mesh-list
83892876|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
83892877|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892878|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892879|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892880|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892881|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
83892882|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83892883|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
83892884|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83892885|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83892886|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83892887|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83892888|NCT00236717|Analgesics|analgesics|mesh-ancestor
83892889|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
83892890|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83892891|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83892892|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83892893|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83892894|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83892895|NCT00236756|Topiramate|topiramate|mesh-list
83892896|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
83892897|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892898|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892899|NCT00269412|Rifaximin|rifaximin|mesh-list
83892900|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892901|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892902|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892903|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83892904|NCT00236795|Norelgestromin|norelgestromin|mesh-list
83892905|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83892906|NCT00236795|Estradiol|estradiol|mesh-list
83892907|NCT00236795|Estrogens|estrogens|mesh-ancestor
83892908|NCT00236795|Hormones|hormones|mesh-ancestor
83892909|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892910|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892911|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83892912|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
83892913|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83892914|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83892915|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83892916|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83892917|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83892918|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83892919|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83892920|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83892921|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83892922|NCT04540627|Palivizumab|palivizumab|mesh-list
83892923|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
83892924|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892925|NCT00236834|Levofloxacin|levofloxacin|mesh-list
83892926|NCT00236834|Imipenem|imipenem|mesh-list
83892927|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83892928|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892929|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132011|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83892930|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83892931|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892932|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892933|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892934|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892935|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83892936|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892937|NCT00236873|Topiramate|topiramate|mesh-list
83892938|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
83892939|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83892940|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892941|NCT00236912|Metronidazole|metronidazole|mesh-list
83892942|NCT00236912|Levofloxacin|levofloxacin|mesh-list
83892943|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83892944|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83892945|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83892946|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83892947|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83892948|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83892949|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83892950|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892951|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892952|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892953|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83892954|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83892955|NCT02215447|Paclitaxel|paclitaxel|mesh-list
83892956|NCT02215447|Carboplatin|carboplatin|mesh-list
83892957|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83892958|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83892959|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
83892960|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
83892961|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
83892962|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892963|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
83892964|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
83892965|NCT00237068|Lansoprazole|lansoprazole|mesh-list
83892966|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
83892967|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83892968|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892969|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83892970|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83892971|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83892972|NCT00269568|Misoprostol|misoprostol|mesh-list
83892973|NCT00269568|Mifepristone|mifepristone|mesh-list
83892974|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83892975|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
83892976|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83892977|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892978|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83892979|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83892980|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
83892981|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83892982|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83892983|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83892984|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83892985|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
83892986|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83892987|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83892988|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
83892989|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83892990|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
83892991|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83892992|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83892993|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
83892994|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83892995|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892996|NCT04544059|Lenalidomide|lenalidomide|mesh-list
83892997|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
83892998|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83892999|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83893000|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83893001|NCT04544059|Growth Substances|growth substances|mesh-ancestor
83893002|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
83893003|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132084|NCT02082067|Ketorolac|ketorolac|mesh-list
83893004|NCT00269607|Naltrexone|naltrexone|mesh-list
83893005|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83893006|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83893007|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893008|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
83893009|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893010|NCT00237224|Letrozole|letrozole|mesh-list
83893011|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893012|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83893013|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83893014|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893015|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893016|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83893017|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
83893018|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893019|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893020|NCT00237263|Entacapone|entacapone|mesh-list
83893021|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83893022|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83893023|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83893024|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893025|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893026|NCT00237302|Topiramate|topiramate|mesh-list
83893027|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
83893028|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83893029|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893030|NCT00262275|Aspirin|aspirin|mesh-list
83893031|NCT00262275|Clopidogrel|clopidogrel|mesh-list
83893032|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83893033|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83893034|NCT00262275|Analgesics|analgesics|mesh-ancestor
83893035|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
83893036|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893037|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893038|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893039|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893040|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83893041|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83893042|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893043|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83151320|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
83893044|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83893045|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893046|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
83893047|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83893048|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83893049|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83893050|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
83893051|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893052|NCT02214979|Telmisartan|telmisartan|mesh-list
83893053|NCT02214979|Ramipril|ramipril|mesh-list
83893054|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83893055|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83893056|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83893057|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893058|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83893059|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
83893060|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893061|NCT00237341|Fentanyl|fentanyl|mesh-list
83893062|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83893063|NCT00237341|Narcotics|narcotics|mesh-ancestor
83893064|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893065|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893066|NCT00237341|Analgesics|analgesics|mesh-ancestor
83893067|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
83893068|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893069|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83893070|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83893071|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
83893072|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
83893073|NCT04539301|Anticoagulants|anticoagulants|mesh-list
83893074|NCT00237419|Infliximab|infliximab|mesh-list
83893075|NCT00237419|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83893076|NCT00237419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893077|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
83893078|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83893079|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893080|NCT04539106|Ranibizumab|ranibizumab|mesh-list
83893081|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83893082|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83893083|NCT04539106|Growth Substances|growth substances|mesh-ancestor
83893084|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893085|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83893086|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893087|NCT00237497|Zopiclone|zopiclone|mesh-list
83893088|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83893089|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893090|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893091|NCT00416130|Vorinostat|vorinostat|mesh-list
83893092|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893093|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83893094|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893095|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893096|NCT00416169|Galantamine|galantamine|mesh-list
83893097|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83893098|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893099|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893100|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
83893101|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893102|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893103|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83893104|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
83893105|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893106|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
83893107|NCT00237536|Lonidamine|lonidamine|mesh-list
83893108|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893109|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83151409|NCT05696366|Volagidemab|volagidemab|mesh-list
83893110|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893111|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83893112|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
83893113|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83893114|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83893115|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83893116|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83893117|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893118|NCT02215720|Sirolimus|sirolimus|mesh-list
83893119|NCT02215720|Cetuximab|cetuximab|mesh-list
83893120|NCT02215720|Temsirolimus|temsirolimus|mesh-list
83893121|NCT02215720|MTOR Inhibitors|mtor inhibitors|mesh-list
83893122|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83893123|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893124|NCT02215720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83893125|NCT02215720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893126|NCT02215720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893127|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83893128|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
83893129|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893130|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893131|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893132|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893133|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
83893134|NCT00416208|Bortezomib|bortezomib|mesh-list
83893135|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893136|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83893137|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83893138|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83893139|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83151464|NCT02174887|Paclitaxel|paclitaxel|mesh-list
83893140|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893141|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893142|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893143|NCT02215798|Analgesics|analgesics|mesh-ancestor
83893144|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
83893145|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893146|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
83893147|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83893148|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
83893149|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83893150|NCT02215057|Lidocaine|lidocaine|mesh-list
83893151|NCT02215057|Anesthetics|anesthetics|mesh-list
83893152|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
83893153|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893154|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893155|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
83893156|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893157|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83893158|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83893159|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83893160|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83893161|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893162|NCT00269685|Vasopressins|vasopressins|mesh-list
83893163|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
83893164|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
83893165|NCT00269685|Coagulants|coagulants|mesh-ancestor
83893166|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83893167|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83893168|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
83893169|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893170|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
83893171|NCT04543123|Escitalopram|escitalopram|mesh-list
83893172|NCT04543123|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83893173|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83893174|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83893175|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893176|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893177|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
83893178|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893179|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83893180|NCT04539418|Vitamin K|vitamin k|mesh-list
83893181|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
83893182|NCT04539418|Vitamins|vitamins|mesh-ancestor
83893183|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
83893184|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893185|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83893186|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83893187|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893188|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
83893189|NCT04539418|Coagulants|coagulants|mesh-ancestor
83893190|NCT00269724|Oxybutynin|oxybutynin|mesh-list
83893191|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
83893192|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
83893193|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893194|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893195|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83893196|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83893197|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
83893198|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893199|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893200|NCT00269724|Urological Agents|urological agents|mesh-ancestor
83893201|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83893202|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
83893203|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
83893204|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83893205|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83893206|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893207|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
83893208|NCT04710017|Coagulants|coagulants|mesh-ancestor
83893209|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83893210|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83893211|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83893212|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
83893213|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83893214|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893215|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83893216|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83893217|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83893218|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83893219|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893220|NCT04538521|Niacin|niacin|mesh-list
83893221|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
83893222|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83893223|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
83893224|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893225|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83893226|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
83893227|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
83893228|NCT04538521|Vitamins|vitamins|mesh-ancestor
83893229|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
83893230|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893231|NCT00269763|Fentanyl|fentanyl|mesh-list
83893232|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83893233|NCT00269763|Narcotics|narcotics|mesh-ancestor
83893234|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893235|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893236|NCT00269763|Analgesics|analgesics|mesh-ancestor
83893237|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
83893238|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893239|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83893240|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83893241|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
83893242|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
83893243|NCT00237575|Gemcitabine|gemcitabine|mesh-list
83893244|NCT00237575|Sargramostim|sargramostim|mesh-list
83893245|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893246|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83893247|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
83893248|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893249|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
83893250|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893251|NCT00269802|Methylphenidate|methylphenidate|mesh-list
83893252|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83893253|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151703|NCT05438186|Hormones|hormones|mesh-ancestor
83893254|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83893255|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83893256|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83893257|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893258|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
83893259|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893260|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83893261|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83893262|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83893263|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
83893264|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893265|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83893266|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83893267|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893268|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
83893269|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83893270|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
83893271|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893272|NCT00237614|Expectorants|expectorants|mesh-ancestor
83893273|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
83893274|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83893275|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
83893276|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893277|NCT00237614|Protective Agents|protective agents|mesh-ancestor
83893278|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893279|NCT00237614|Antidotes|antidotes|mesh-ancestor
83893280|NCT00269841|Infliximab|infliximab|mesh-list
83893281|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83893282|NCT00269841|Antibodies|antibodies|mesh-list
83893283|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
83893284|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83893285|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
83893286|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893287|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893288|NCT00269841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83893289|NCT00269841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893290|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
83893291|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83893292|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893293|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
83893294|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
83893295|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83893296|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
83893297|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893298|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893299|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83893300|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
83893301|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893302|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893303|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83893305|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83893306|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
83893307|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893308|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151822|NCT02176135|Auranofin|auranofin|mesh-list
83893309|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893310|NCT04538365|Triclosan|triclosan|mesh-list
83893311|NCT04538365|Propranolol|propranolol|mesh-list
83893312|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83893313|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83893314|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893315|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83893316|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83893317|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
83893318|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893319|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83893320|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83893321|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83893322|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
83893323|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893324|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893325|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83893326|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83893327|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
83893328|NCT00414245|Metformin|metformin|mesh-list
83893329|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83893330|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893331|NCT00269880|Heparin|heparin|mesh-list
83893332|NCT00269880|Abciximab|abciximab|mesh-list
83893333|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
83893334|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83893335|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83893336|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893337|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83893338|NCT00237653|Valganciclovir|valganciclovir|mesh-list
83893339|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
83893340|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893341|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
83893342|NCT00269958|Hematinics|hematinics|mesh-ancestor
83893343|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
83893344|NCT02215876|Doxorubicin|doxorubicin|mesh-list
83893345|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83893346|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
83893347|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893348|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893349|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83893350|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
83893351|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893352|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893353|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83893354|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893355|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83893356|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83893357|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893358|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
83893359|NCT00269997|Hematinics|hematinics|mesh-ancestor
83893360|NCT00237731|Morphine|morphine|mesh-list
83151908|NCT04597268|Midazolam|midazolam|mesh-list
83893361|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83893362|NCT00237731|Narcotics|narcotics|mesh-ancestor
83893363|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893364|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893365|NCT00237731|Analgesics|analgesics|mesh-ancestor
83893366|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
83893367|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893368|NCT04542226|Bromides|bromides|mesh-list
83893369|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
83893370|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
83893371|NCT00270036|Hematinics|hematinics|mesh-ancestor
83893372|NCT00262392|Pamidronate|pamidronate|mesh-list
83893373|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83893374|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893375|NCT04537780|Montelukast|montelukast|mesh-list
83132463|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
83893376|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83893377|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
83893378|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83893379|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
83893380|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893381|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893382|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83893383|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83893384|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893385|NCT00237887|Adalimumab|adalimumab|mesh-list
83893386|NCT00237887|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83893387|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893388|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893389|NCT02215993|Ticagrelor|ticagrelor|mesh-list
83893390|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83893391|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83893392|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83893393|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83893394|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83893395|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
83893396|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893397|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893398|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893399|NCT02216149|Capecitabine|capecitabine|mesh-list
83893400|NCT02216149|Tegafur|tegafur|mesh-list
83893401|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
83893402|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83893403|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
83893404|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893405|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893406|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
83893407|NCT00238004|Niacin|niacin|mesh-list
83893408|NCT00238004|Niacinamide|niacinamide|mesh-list
83893409|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
83893410|NCT00238004|Vitamins|vitamins|mesh-ancestor
83893411|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
83893412|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893413|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83893414|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
83893415|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893416|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83893417|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
83893418|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83893419|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83893420|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83893421|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
83893422|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893423|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83893424|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83893425|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893426|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
83893427|NCT00238043|Hematinics|hematinics|mesh-ancestor
83893428|NCT00415584|Cinacalcet|cinacalcet|mesh-list
83893429|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83893430|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893431|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83893432|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
83893433|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893434|NCT04536922|Aldesleukin|aldesleukin|mesh-list
83893435|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
83893436|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
83893437|NCT04536922|Fludarabine|fludarabine|mesh-list
83893438|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83893439|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
83893440|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893441|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893442|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83893443|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
83893444|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893445|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893446|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83893447|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83893448|NCT04536922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83893449|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83893450|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83893451|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
83893452|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893453|NCT04536961|Deucravacitinib|deucravacitinib|mesh-list
83893454|NCT04536961|Famotidine|famotidine|mesh-list
83893455|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83893456|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83893457|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83893458|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
83893459|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
83893460|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893461|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893462|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893463|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83893464|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83893465|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893466|NCT00238160|Fluorouracil|fluorouracil|mesh-list
83893467|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893468|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
83893469|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893470|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83893471|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83893472|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
83893473|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893474|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
83893475|NCT00415701|Propofol|propofol|mesh-list
83893476|NCT00415701|Etomidate|etomidate|mesh-list
83893477|NCT00415701|Cosyntropin|cosyntropin|mesh-list
83893478|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83893479|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893480|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893481|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83893482|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
83893483|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
83893484|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893485|NCT00415701|Hormones|hormones|mesh-ancestor
83893486|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893487|NCT02961998|Celecoxib|celecoxib|mesh-list
83893488|NCT02961998|Sorafenib|sorafenib|mesh-list
83893489|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893490|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83893491|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893492|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893493|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83893494|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83893495|NCT02961998|Analgesics|analgesics|mesh-ancestor
83893496|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
83893497|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893498|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893499|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893500|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893501|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83893502|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83893503|NCT04536415|Oseltamivir|oseltamivir|mesh-list
83893504|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
83893505|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893506|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893507|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893508|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83893509|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83893510|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
83893511|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893512|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893513|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83893514|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
83893515|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
83893516|NCT00262587|Hormones|hormones|mesh-ancestor
83893517|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893518|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
83893519|NCT00238199|Calcitriol|calcitriol|mesh-list
83893520|NCT00238199|Docetaxel|docetaxel|mesh-list
83893521|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893522|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83893523|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83893524|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83893525|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893526|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83893527|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132617|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
83893528|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83893529|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83893530|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83893531|NCT00238199|Vitamins|vitamins|mesh-ancestor
83893532|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
83893533|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83893534|NCT04536493|Lidocaine|lidocaine|mesh-list
83893535|NCT04536493|Epinephrine|epinephrine|mesh-list
83893536|NCT04536493|Racepinephrine|racepinephrine|mesh-list
83893537|NCT04536493|Tetracaine|tetracaine|mesh-list
83893538|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
83893539|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
83893540|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
83893541|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893542|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893543|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
83893544|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893545|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83893546|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83893547|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83893548|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83893549|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893550|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83893551|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83893552|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
83893553|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893554|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83893555|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83893556|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
83893557|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83893558|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
83893559|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
83893560|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
83893561|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83893562|NCT04536181|Prednisone|prednisone|mesh-list
83893563|NCT04536181|Prednisolone|prednisolone|mesh-list
83893564|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893565|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
83893566|NCT04536181|Hormones|hormones|mesh-ancestor
83893567|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893568|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893569|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83893570|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893571|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
83893572|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
83893573|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893574|NCT02216227|Iodine|iodine|mesh-list
83893575|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
83893576|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83893577|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
83893578|NCT02216227|Vancomycin|vancomycin|mesh-list
83893579|NCT02216227|Cefazolin|cefazolin|mesh-list
83893580|NCT02216227|Mupirocin|mupirocin|mesh-list
83893581|NCT02216227|Povidone|povidone|mesh-list
83893582|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83893583|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893584|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
83893585|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
83893586|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893587|NCT02216227|Trace Elements|trace elements|mesh-ancestor
83893588|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
83893589|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893590|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
83893591|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
83893592|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83893593|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893594|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893595|NCT00238277|Temozolomide|temozolomide|mesh-list
83893596|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83893597|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
83893598|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893599|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893600|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83893601|NCT02216266|Physostigmine|physostigmine|mesh-list
83893602|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83893603|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893604|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893605|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
83893606|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893607|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893608|NCT02216266|Miotics|miotics|mesh-ancestor
83893609|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
83893610|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893611|NCT00238316|Letrozole|letrozole|mesh-list
83893612|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893613|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83893614|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83893615|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893616|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893617|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83893618|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
83893619|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893620|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893621|NCT04535518|Aspirin|aspirin|mesh-list
83893622|NCT04535518|Infliximab|infliximab|mesh-list
83893623|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
83893624|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83893625|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
83893626|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83893627|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83893628|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83893629|NCT04535518|Analgesics|analgesics|mesh-ancestor
83893630|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
83893631|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893632|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893633|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893634|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893635|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83893636|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83893637|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893638|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83893639|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83893640|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893641|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
83893642|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
83893643|NCT04535518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83893644|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
83893645|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83893646|NCT02216383|Oxytocin|oxytocin|mesh-list
83893647|NCT02216383|Carbetocin|carbetocin|mesh-list
83893648|NCT02216383|Syntometrine|syntometrine|mesh-list
83893649|NCT02216383|Ergonovine|ergonovine|mesh-list
83893650|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
83893651|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83893652|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893653|NCT00262782|Fludarabine|fludarabine|mesh-list
83893654|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893655|NCT00238394|Cediranib|cediranib|mesh-list
83893656|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893657|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893658|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893659|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83893660|NCT00238472|Nateglinide|nateglinide|mesh-list
83893661|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83893662|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893663|NCT00238628|Bexarotene|bexarotene|mesh-list
83893664|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893665|NCT02216617|Docetaxel|docetaxel|mesh-list
83893666|NCT02216617|Afatinib|afatinib|mesh-list
83893667|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893668|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
83893669|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
83893670|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
83893671|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893672|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83893673|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893674|NCT00262977|Aspirin|aspirin|mesh-list
83893675|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83893676|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83893677|NCT00262977|Analgesics|analgesics|mesh-ancestor
83893678|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
83893679|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893680|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893681|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893682|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893683|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83893684|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83893685|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893686|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83893687|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83893688|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893689|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
83893690|NCT00238667|Aspirin|aspirin|mesh-list
83893691|NCT00238667|Heparin|heparin|mesh-list
83893692|NCT00238667|Calcium heparin|calcium heparin|mesh-list
83893693|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83893694|NCT00238667|Dalteparin|dalteparin|mesh-list
83893695|NCT00238667|Dipyridamole|dipyridamole|mesh-list
83893696|NCT00238667|Warfarin|warfarin|mesh-list
83893697|NCT00238667|Anticoagulants|anticoagulants|mesh-list
83893698|NCT00238667|Clopidogrel|clopidogrel|mesh-list
83893699|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83893700|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83893701|NCT00238667|Analgesics|analgesics|mesh-ancestor
83893702|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
83893703|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893704|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893705|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893706|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893707|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83893708|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83893709|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893710|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83893711|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83893712|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893713|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
83893714|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83893715|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83893716|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83893717|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
83893718|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893719|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83893720|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
83893721|NCT00263016|Docetaxel|docetaxel|mesh-list
83893722|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893723|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
83893724|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
83893725|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
83893726|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893727|NCT04534465|Mannitol|mannitol|mesh-list
83893728|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83893729|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83893730|NCT04534465|Diuretics|diuretics|mesh-ancestor
83893731|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
83893732|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893733|NCT04534465|Laxatives|laxatives|mesh-ancestor
83893734|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83893735|NCT02216656|Cinacalcet|cinacalcet|mesh-list
83893736|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83893737|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893738|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83893739|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
83893740|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893741|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
83893742|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893743|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
83893744|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83893745|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83893746|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
83893747|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893748|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893749|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83893750|NCT04534231|Nicotine|nicotine|mesh-list
83893751|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83893752|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
83893753|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893754|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893755|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83893756|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83132839|NCT05043740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893757|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
83893758|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893759|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893761|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83893762|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83893763|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893764|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893765|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83893766|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83893767|NCT00263094|Analgesics|analgesics|mesh-ancestor
83893768|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
83893769|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893770|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893771|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893772|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83893773|NCT00238784|Budesonide|budesonide|mesh-list
83893774|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
83893775|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893776|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83893777|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
83893778|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893779|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893780|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83893781|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
83893782|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
83893783|NCT00238784|Hormones|hormones|mesh-ancestor
83893784|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893785|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83893786|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83893787|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83893788|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
83893789|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893790|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893791|NCT00263133|Sertraline|sertraline|mesh-list
83893792|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
83893793|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83893794|NCT00263133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83893795|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83893796|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83893797|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893798|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893799|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
83893800|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893801|NCT04533724|Amisulpride|amisulpride|mesh-list
83893802|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83893803|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83893804|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893805|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893806|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83893807|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83893808|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
83893809|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83893810|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893811|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83893812|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
83893813|NCT00238901|Basiliximab|basiliximab|mesh-list
83893814|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83893815|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
83893816|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893817|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
83893818|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893819|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893820|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83893821|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
83893822|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893823|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893824|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893825|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893826|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
83893827|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893828|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893829|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83893830|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
83893831|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893832|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893833|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893834|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893835|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
83893836|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893837|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893838|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83893839|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
83893840|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893841|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893842|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893843|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893845|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83893846|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
83893847|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
83893848|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893849|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893850|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
83893851|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893852|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893853|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83893854|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
83893855|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893856|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893857|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893858|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893859|NCT00238082|Beclomethasone|beclomethasone|mesh-list
83893860|NCT00238082|Norflurane|norflurane|mesh-list
83893861|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893862|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
83893863|NCT00238082|Hormones|hormones|mesh-ancestor
83893864|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893865|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893866|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83893867|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
83893868|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
83893869|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893870|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
83893871|NCT02217007|Acamprosate|acamprosate|mesh-list
83893872|NCT02217007|Calcium|calcium|mesh-list
83893873|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83893874|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893875|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83893876|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83893877|NCT05897658|Levetiracetam|levetiracetam|mesh-list
83893878|NCT05897658|Anticonvulsants|anticonvulsants|mesh-ancestor
83893879|NCT05897658|Nootropic Agents|nootropic agents|mesh-ancestor
83893880|NCT05897385|Lidocaine|lidocaine|mesh-list
83893881|NCT05897385|Anesthetics, Local|anesthetics, local|mesh-ancestor
83893882|NCT05897385|Anesthetics|anesthetics|mesh-ancestor
83893883|NCT05897385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893884|NCT05897385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893885|NCT05897385|Sensory System Agents|sensory system agents|mesh-ancestor
83893886|NCT05897385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893887|NCT05897385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83893888|NCT05897385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83893889|NCT05897385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83893890|NCT05897385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83893891|NCT05897385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893892|NCT05897372|Pentoxifylline|pentoxifylline|mesh-list
83893893|NCT05897372|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83893894|NCT05897372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893895|NCT05897372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893896|NCT05897372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83893897|NCT05897372|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83893898|NCT05897372|Protective Agents|protective agents|mesh-ancestor
83893899|NCT05897372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893900|NCT05897372|Vasodilator Agents|vasodilator agents|mesh-ancestor
83893901|NCT05897372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83893902|NCT05897372|Antioxidants|antioxidants|mesh-ancestor
83893903|NCT05897307|Ropivacaine|ropivacaine|mesh-list
83893904|NCT05897307|Anesthetics, Local|anesthetics, local|mesh-ancestor
83893905|NCT05897307|Anesthetics|anesthetics|mesh-ancestor
83893906|NCT05897307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83893907|NCT05897307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893908|NCT05897307|Sensory System Agents|sensory system agents|mesh-ancestor
83893909|NCT05897307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893910|NCT05897294|Voriconazole|voriconazole|mesh-list
83893911|NCT05897294|Antifungal Agents|antifungal agents|mesh-ancestor
83893912|NCT05897294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893913|NCT05897294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83893914|NCT05897294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83893915|NCT05897294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893916|NCT05897294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893917|NCT05897294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83893918|NCT05897294|Hormone Antagonists|hormone antagonists|mesh-ancestor
83893919|NCT05897294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893920|NCT05897294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893921|NCT05897294|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83893922|NCT05897086|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83893923|NCT05897086|Laxatives|laxatives|mesh-ancestor
83893924|NCT05897086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83893925|NCT05896943|Ustekinumab|ustekinumab|mesh-list
83893926|NCT05896943|Dermatologic Agents|dermatologic agents|mesh-ancestor
83893927|NCT05896930|Amoxicillin|amoxicillin|mesh-list
83893928|NCT05896930|Rifampin|rifampin|mesh-list
83893929|NCT05896930|Meropenem|meropenem|mesh-list
83893930|NCT05896930|Ertapenem|ertapenem|mesh-list
83893931|NCT05896930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893932|NCT05896930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893933|NCT05896930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83893934|NCT05896930|Antitubercular Agents|antitubercular agents|mesh-ancestor
83893935|NCT05896930|Leprostatic Agents|leprostatic agents|mesh-ancestor
83893936|NCT05896930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83893937|NCT05896930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893938|NCT05896930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893939|NCT05896930|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83893940|NCT05896930|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83893941|NCT05896930|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83893942|NCT05896930|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83893943|NCT05896930|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83893944|NCT05896930|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83893945|NCT05896839|Sirolimus|sirolimus|mesh-list
83893946|NCT05896839|Prednisone|prednisone|mesh-list
83893947|NCT05896839|Cortisone|cortisone|mesh-list
83893948|NCT05896839|Nivolumab|nivolumab|mesh-list
83893949|NCT05896839|Ipilimumab|ipilimumab|mesh-list
83893950|NCT05896839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83893951|NCT05896839|Glucocorticoids|glucocorticoids|mesh-ancestor
83893952|NCT05896839|Hormones|hormones|mesh-ancestor
83893953|NCT05896839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83893954|NCT05896839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893955|NCT05896839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83893956|NCT05896839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893957|NCT05896839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83893958|NCT05896839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83893959|NCT05896839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893960|NCT05896839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83893961|NCT05896839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893962|NCT05896839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83893963|NCT05896839|Antifungal Agents|antifungal agents|mesh-ancestor
83893964|NCT05896839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83893965|NCT05896839|Immunologic Factors|immunologic factors|mesh-ancestor
83893966|NCT05896800|Nitric Oxide|nitric oxide|mesh-list
83893967|NCT05896800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83893968|NCT05896800|Autonomic Agents|autonomic agents|mesh-ancestor
83893969|NCT05896800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83893970|NCT05896800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83893971|NCT05896800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83893972|NCT05896800|Respiratory System Agents|respiratory system agents|mesh-ancestor
83893973|NCT05896800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83893974|NCT05896800|Antioxidants|antioxidants|mesh-ancestor
83893975|NCT05896800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893976|NCT05896800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133064|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83893977|NCT05896800|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83893978|NCT05896800|Vasodilator Agents|vasodilator agents|mesh-ancestor
83893979|NCT05896800|Gasotransmitters|gasotransmitters|mesh-ancestor
83893980|NCT05896800|Protective Agents|protective agents|mesh-ancestor
83893981|NCT05896787|Paclitaxel|paclitaxel|mesh-list
83893982|NCT05896787|Carboplatin|carboplatin|mesh-list
83893983|NCT05896787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83893984|NCT05896787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83893985|NCT05896787|Tubulin Modulators|tubulin modulators|mesh-ancestor
83893986|NCT05896787|Antimitotic Agents|antimitotic agents|mesh-ancestor
83893987|NCT05896787|Mitosis Modulators|mitosis modulators|mesh-ancestor
83893988|NCT05896787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893989|NCT05896761|Rilpivirine|rilpivirine|mesh-list
83893990|NCT05896761|Cabotegravir|cabotegravir|mesh-list
83893991|NCT05896761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83893992|NCT05896761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83893993|NCT05896761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83893994|NCT05896761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83893995|NCT05896761|Antiviral Agents|antiviral agents|mesh-ancestor
83893996|NCT05896761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83893997|NCT05896761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83893998|NCT05896761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83893999|NCT05896761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83894000|NCT05896761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83894001|NCT05896748|Rilpivirine|rilpivirine|mesh-list
83894002|NCT05896748|Cabotegravir|cabotegravir|mesh-list
83894003|NCT05896748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83894004|NCT05896748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83894005|NCT05896748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894006|NCT05896748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894007|NCT05896748|Antiviral Agents|antiviral agents|mesh-ancestor
83894008|NCT05896748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894009|NCT05896748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83894010|NCT05896748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83894011|NCT05896748|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83894012|NCT05896748|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83894013|NCT05896683|Lazertinib|lazertinib|mesh-list
83894014|NCT05896683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894015|NCT05896683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894016|NCT05896683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894017|NCT05896631|Bupivacaine|bupivacaine|mesh-list
83894018|NCT05896631|Anesthetics, Local|anesthetics, local|mesh-ancestor
83894019|NCT05896631|Anesthetics|anesthetics|mesh-ancestor
83894020|NCT05896631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894021|NCT05896631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894022|NCT05896631|Sensory System Agents|sensory system agents|mesh-ancestor
83894023|NCT05896631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894024|NCT05896605|Azathioprine|azathioprine|mesh-list
83894025|NCT05896605|Antimetabolites|antimetabolites|mesh-ancestor
83894026|NCT05896605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894027|NCT05896605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894028|NCT05896605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894029|NCT05896605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83894030|NCT05896605|Immunologic Factors|immunologic factors|mesh-ancestor
83894031|NCT05896605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894032|NCT05896605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894033|NCT05896553|Oxytocin|oxytocin|mesh-list
83894034|NCT05896553|Oxytocics|oxytocics|mesh-ancestor
83894035|NCT05896553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83894036|NCT05896553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894037|NCT05896462|Povidone-Iodine|povidone-iodine|mesh-list
83894038|NCT05896462|Povidone|povidone|mesh-list
83894039|NCT05896462|Plasma Substitutes|plasma substitutes|mesh-ancestor
83894040|NCT05896462|Blood Substitutes|blood substitutes|mesh-ancestor
83894041|NCT05896462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83894042|NCT05896462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894043|NCT05896449|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83894044|NCT05896449|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83894045|NCT05896449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894046|NCT05896319|Hyaluronic Acid|hyaluronic acid|mesh-list
83894047|NCT05896319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83894048|NCT05896319|Immunologic Factors|immunologic factors|mesh-ancestor
83894049|NCT05896319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894050|NCT05896319|Viscosupplements|viscosupplements|mesh-ancestor
83894051|NCT05896319|Protective Agents|protective agents|mesh-ancestor
83894052|NCT05896228|Acetaminophen|acetaminophen|mesh-list
83894053|NCT05896228|Diphenhydramine|diphenhydramine|mesh-list
83894054|NCT05896228|Promethazine|promethazine|mesh-list
83894055|NCT05896228|Dexamethasone|dexamethasone|mesh-list
83894056|NCT05896228|Daratumumab|daratumumab|mesh-list
83894057|NCT05896228|Montelukast|montelukast|mesh-list
83894058|NCT05896228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83894059|NCT05896228|Antiemetics|antiemetics|mesh-ancestor
83894060|NCT05896228|Autonomic Agents|autonomic agents|mesh-ancestor
83894061|NCT05896228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83409387|NCT03616886|Durvalumab|durvalumab|mesh-list
83894062|NCT05896228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894063|NCT05896228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83894064|NCT05896228|Glucocorticoids|glucocorticoids|mesh-ancestor
83894065|NCT05896228|Hormones|hormones|mesh-ancestor
83894066|NCT05896228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894067|NCT05896228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894068|NCT05896228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894069|NCT05896228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83894070|NCT05896228|Analgesics|analgesics|mesh-ancestor
83894071|NCT05896228|Sensory System Agents|sensory system agents|mesh-ancestor
83894072|NCT05896228|Antipyretics|antipyretics|mesh-ancestor
83894073|NCT05896228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83894074|NCT05896228|Respiratory System Agents|respiratory system agents|mesh-ancestor
83894075|NCT05896228|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83894076|NCT05896228|Hormone Antagonists|hormone antagonists|mesh-ancestor
83894077|NCT05896228|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83894078|NCT05896228|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83894079|NCT05896228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894080|NCT05896228|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83894081|NCT05896228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83894082|NCT05896228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894083|NCT05896228|Anesthetics, Local|anesthetics, local|mesh-ancestor
83894084|NCT05896228|Anesthetics|anesthetics|mesh-ancestor
83894085|NCT05896228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83894086|NCT05896228|Histamine Antagonists|histamine antagonists|mesh-ancestor
83894087|NCT05896228|Histamine Agents|histamine agents|mesh-ancestor
83894088|NCT05896228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894089|NCT05896228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83894090|NCT05896228|Antipruritics|antipruritics|mesh-ancestor
83894091|NCT05896228|Dermatologic Agents|dermatologic agents|mesh-ancestor
83894092|NCT05896163|Obinutuzumab|obinutuzumab|mesh-list
83894093|NCT05896163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894094|NCT05896163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894095|NCT05896059|Tislelizumab|tislelizumab|mesh-list
83894096|NCT05896059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894097|NCT05896059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894098|NCT05896033|Menthol|menthol|mesh-list
83894099|NCT05896033|Antipruritics|antipruritics|mesh-ancestor
83894100|NCT05896033|Dermatologic Agents|dermatologic agents|mesh-ancestor
83894101|NCT05896007|Rituximab|rituximab|mesh-list
83894102|NCT05896007|Methotrexate|methotrexate|mesh-list
83894103|NCT05896007|Temozolomide|temozolomide|mesh-list
83894104|NCT05896007|Zanubrutinib|zanubrutinib|mesh-list
83894105|NCT05896007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894106|NCT05896007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894107|NCT05896007|Immunologic Factors|immunologic factors|mesh-ancestor
83894108|NCT05896007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894109|NCT05896007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894110|NCT05896007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83894111|NCT05896007|Abortifacient Agents|abortifacient agents|mesh-ancestor
83894112|NCT05896007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83894113|NCT05896007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894114|NCT05896007|Antimetabolites|antimetabolites|mesh-ancestor
83894115|NCT05896007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894116|NCT05896007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83894117|NCT05896007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894118|NCT05896007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83894119|NCT05896007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83894120|NCT05896007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83894121|NCT05896007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83894122|NCT05896007|Alkylating Agents|alkylating agents|mesh-ancestor
83894123|NCT05896007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894124|NCT05895942|Imatinib Mesylate|imatinib mesylate|mesh-list
83894125|NCT05895942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894126|NCT05895942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894127|NCT05895942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894128|NCT05895942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894129|NCT05893771|Methylprednisolone|methylprednisolone|mesh-list
83894130|NCT05893771|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83894131|NCT05893771|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83894132|NCT05893771|Prednisolone|prednisolone|mesh-list
83894133|NCT05893771|Prednisolone acetate|prednisolone acetate|mesh-list
83894134|NCT05893771|Bupivacaine|bupivacaine|mesh-list
83894135|NCT05893771|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83894136|NCT05893771|Prednisolone phosphate|prednisolone phosphate|mesh-list
83894137|NCT05893771|Anesthetics, Local|anesthetics, local|mesh-ancestor
83894138|NCT05893771|Anesthetics|anesthetics|mesh-ancestor
83894139|NCT05893771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894140|NCT05893771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894141|NCT05893771|Sensory System Agents|sensory system agents|mesh-ancestor
83894142|NCT05893771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894143|NCT05893771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83894144|NCT05893771|Antiemetics|antiemetics|mesh-ancestor
83894145|NCT05893771|Autonomic Agents|autonomic agents|mesh-ancestor
83894146|NCT05893771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83894147|NCT05893771|Glucocorticoids|glucocorticoids|mesh-ancestor
83894148|NCT05893771|Hormones|hormones|mesh-ancestor
83894149|NCT05893771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894150|NCT05893771|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83894151|NCT05893771|Protective Agents|protective agents|mesh-ancestor
83894152|NCT05893771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894153|NCT05893771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894154|NCT05876715|Nivolumab|nivolumab|mesh-list
83894155|NCT05876715|Ipilimumab|ipilimumab|mesh-list
83894156|NCT05876715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894157|NCT05876715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894158|NCT05876715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894159|NCT05876715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894160|NCT05867849|Cannabidiol|cannabidiol|mesh-list
83894161|NCT05867849|Anticonvulsants|anticonvulsants|mesh-ancestor
83894162|NCT05864846|Cannabidiol|cannabidiol|mesh-list
83894163|NCT05864846|Anticonvulsants|anticonvulsants|mesh-ancestor
83894164|NCT05860296|Pembrolizumab|pembrolizumab|mesh-list
83894165|NCT05860296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894166|NCT05860296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894167|NCT05860296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894168|NCT05860296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894169|NCT05853120|Doxycycline|doxycycline|mesh-list
83894170|NCT05853120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83894171|NCT05853120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894172|NCT05853120|Antimalarials|antimalarials|mesh-ancestor
83894173|NCT05853120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83894174|NCT05853120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83894175|NCT05847686|Psilocybin|psilocybin|mesh-list
83894176|NCT05847686|Hallucinogens|hallucinogens|mesh-ancestor
83894177|NCT05847686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894178|NCT05847686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83894179|NCT05841160|Moxifloxacin|moxifloxacin|mesh-list
83894180|NCT05841160|Ecopipam|ecopipam|mesh-list
83894181|NCT05841160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83894182|NCT05841160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894183|NCT05841160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83894184|NCT05841160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83894185|NCT05841160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894186|NCT05841160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894187|NCT05841160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894188|NCT05841160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894189|NCT05841160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83894190|NCT05841160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83894191|NCT05841160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894192|NCT05841160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83894193|NCT05841160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83894194|NCT05841160|Dopamine Agents|dopamine agents|mesh-ancestor
83894195|NCT05841160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894196|NCT05815758|Ketotifen|ketotifen|mesh-list
83894197|NCT05815758|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83894198|NCT05815758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83894199|NCT05815758|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83894200|NCT05815758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83894201|NCT05815758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83894202|NCT05815758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83894203|NCT05815758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83894204|NCT05815758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83894205|NCT05815758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894206|NCT05815758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894207|NCT05815758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894208|NCT05815758|Antipruritics|antipruritics|mesh-ancestor
83894209|NCT05815758|Dermatologic Agents|dermatologic agents|mesh-ancestor
83894210|NCT05815758|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83894211|NCT05815758|Histamine Antagonists|histamine antagonists|mesh-ancestor
83894212|NCT05815758|Histamine Agents|histamine agents|mesh-ancestor
83894213|NCT05815758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83894214|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83894215|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83894216|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83894217|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83894218|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894219|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894220|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894221|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83894222|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
83894223|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83894224|NCT05705258|Aflibercept|aflibercept|mesh-list
83894225|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83894226|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83894227|NCT05705258|Growth Substances|growth substances|mesh-ancestor
83894228|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894229|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
83894230|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894231|NCT05694533|Midazolam|midazolam|mesh-list
83894232|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83894233|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83894234|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894235|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894236|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83894237|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83894238|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83894239|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83894240|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
83894241|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
83894242|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
83894243|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
83894244|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894245|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894246|NCT05681390|Tislelizumab|tislelizumab|mesh-list
83894247|NCT05681390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894248|NCT05681390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894249|NCT05669547|Hormones|hormones|mesh-list
83894250|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894251|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894252|NCT05669079|Decitabine|decitabine|mesh-list
83894253|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
83894254|NCT05669079|Lenograstim|lenograstim|mesh-list
83894255|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894256|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
83894257|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894258|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894259|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894260|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83894261|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
83894262|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894263|NCT05669079|Hematinics|hematinics|mesh-ancestor
83894264|NCT05661188|Atezolizumab|atezolizumab|mesh-list
83894265|NCT05661188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894266|NCT05661188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894267|NCT05661188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894268|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894269|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
83894270|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83894271|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894272|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894273|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83894274|NCT05658510|Analgesics|analgesics|mesh-ancestor
83894275|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
83894276|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894277|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83894278|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83894279|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83894280|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83894281|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894282|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894283|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83894284|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83894285|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
83894286|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894287|NCT05611905|Probenecid|probenecid|mesh-list
83894288|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
83894289|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
83894290|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894291|NCT05586373|Dipyrone|dipyrone|mesh-list
83894292|NCT05586373|Ibuprofen|ibuprofen|mesh-list
83894293|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83894294|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83894295|NCT05586373|Analgesics|analgesics|mesh-ancestor
83894296|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
83894297|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894298|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894299|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83894300|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894301|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83894302|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894303|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894304|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
83894305|NCT05579626|Ezetimibe|ezetimibe|mesh-list
83894306|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83894307|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83894308|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83894309|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
83894310|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894311|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83894312|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894313|NCT05538910|Nicotine|nicotine|mesh-list
83894314|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83894315|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
83894316|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894317|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894318|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83894319|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83894320|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
83894321|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894322|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894323|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
83894324|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83894325|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
83894326|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894327|NCT05537220|Expectorants|expectorants|mesh-ancestor
83894328|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
83894329|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83894330|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
83894331|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894332|NCT05537220|Protective Agents|protective agents|mesh-ancestor
83894333|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894334|NCT05537220|Antidotes|antidotes|mesh-ancestor
83894335|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
83894336|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
83894337|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894338|NCT05507658|Capecitabine|capecitabine|mesh-list
83894339|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
83894340|NCT05507658|Tislelizumab|tislelizumab|mesh-list
83894341|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894342|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
83894343|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894344|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894345|NCT05507658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894346|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83894347|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83894348|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
83894349|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894350|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83894351|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894352|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83894353|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894354|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
83894355|NCT05485012|Narcotics|narcotics|mesh-ancestor
83894356|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894357|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894358|NCT05485012|Analgesics|analgesics|mesh-ancestor
83894359|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
83894360|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894361|NCT05477953|Nifurtimox|nifurtimox|mesh-list
83894362|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83894363|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83894364|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83894365|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894366|NCT05473715|Aflibercept|aflibercept|mesh-list
83894367|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83894368|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83894369|NCT05473715|Growth Substances|growth substances|mesh-ancestor
83894370|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894371|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
83894372|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894373|NCT05467891|Letrozole|letrozole|mesh-list
83894374|NCT05467891|Fulvestrant|fulvestrant|mesh-list
83894375|NCT05467891|Anastrozole|anastrozole|mesh-list
83894376|NCT05467891|Exemestane|exemestane|mesh-list
83894377|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894378|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83894379|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83894380|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894381|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894382|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83894383|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
83894384|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894385|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894386|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894387|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83894388|NCT05455658|Vaccines|vaccines|mesh-list
83894389|NCT05455658|Sargramostim|sargramostim|mesh-list
83894390|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
83894391|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894392|NCT05442567|Vedolizumab|vedolizumab|mesh-list
83894393|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83894394|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
83894395|NCT05442515|Fludarabine|fludarabine|mesh-list
83894396|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83894397|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
83894398|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894399|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894400|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83894401|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
83894402|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894403|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894404|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83894405|NCT05434546|Pregnanolone|pregnanolone|mesh-list
83894406|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
83894407|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894408|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894409|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
83894410|NCT05400122|Fludarabine|fludarabine|mesh-list
83894411|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
83894412|NCT05400122|Vactosertib|vactosertib|mesh-list
83894413|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83894414|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
83894415|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894416|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894417|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83894418|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
83894419|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894420|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894421|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83894422|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894423|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
83894424|NCT05400122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894425|NCT05400122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894426|NCT05386472|Ritonavir|ritonavir|mesh-list
83133513|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
83894427|NCT05386472|Nirmatrelvir|nirmatrelvir|mesh-list
83894428|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83894429|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83894430|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
83894431|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894432|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894433|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83894434|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83894435|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
83894436|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894437|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83894438|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83894439|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83894440|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83894441|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83894442|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83894443|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83894444|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83894445|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83894446|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
83894447|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894448|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894449|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894450|NCT05359939|Choline|choline|mesh-list
83894451|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
83894452|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83894453|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
83894454|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894455|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83894456|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83894457|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
83894458|NCT05277051|Dostarlimab|dostarlimab|mesh-list
83894459|NCT05277051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894460|NCT05261139|Ritonavir|ritonavir|mesh-list
83894461|NCT05261139|Nirmatrelvir|nirmatrelvir|mesh-list
83894462|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83894463|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83894464|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
83894465|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894466|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894467|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83894468|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83894469|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
83894470|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894471|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83894472|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83894473|NCT05251909|Benralizumab|benralizumab|mesh-list
83894474|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83894475|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
83894476|NCT05250791|Lidocaine|lidocaine|mesh-list
83894477|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
83894478|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
83894479|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894480|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894481|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
83894482|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894483|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83894484|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83894485|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83894486|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83894487|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894488|NCT05241873|Carboplatin|carboplatin|mesh-list
83894489|NCT05241873|Pemetrexed|pemetrexed|mesh-list
83894490|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894491|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894492|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894493|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83894494|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83894495|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
83894496|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894497|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894498|NCT05197322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894499|NCT05197322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894500|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
83894501|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
83894502|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133584|NCT02113813|Naquotinib|naquotinib|mesh-list
83894503|NCT05149131|Leuprolide|leuprolide|mesh-list
83894504|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83894505|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
83894506|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83894507|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894508|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894509|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894510|NCT05145764|Suvorexant|suvorexant|mesh-list
83894511|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83894512|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83894513|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894514|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894515|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83894516|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894517|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894518|NCT05132075|Docetaxel|docetaxel|mesh-list
83894519|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894520|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
83894521|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
83894522|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
83894523|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894524|NCT05128162|Psilocybin|psilocybin|mesh-list
83894525|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
83894526|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894527|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83894528|NCT05116189|Paclitaxel|paclitaxel|mesh-list
83894529|NCT05116189|Docetaxel|docetaxel|mesh-list
83894530|NCT05116189|Bevacizumab|bevacizumab|mesh-list
83894531|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
83894532|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83894533|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894534|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
83894535|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
83894536|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
83894537|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894538|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894539|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83894540|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83894541|NCT05116189|Growth Substances|growth substances|mesh-ancestor
83894542|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894543|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
83894544|NCT05116189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894545|NCT05276973|Paclitaxel|paclitaxel|mesh-list
83894546|NCT05276973|Carboplatin|carboplatin|mesh-list
83894547|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83894548|NCT05276973|Ipatasertib|ipatasertib|mesh-list
83894549|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83894550|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894551|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
83894552|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
83894553|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
83894554|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894555|NCT05276973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894556|NCT05276973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894557|NCT05099848|Leucovorin|leucovorin|mesh-list
83894558|NCT05099848|Fluorouracil|fluorouracil|mesh-list
83894559|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
83894560|NCT05099848|Apatinib|apatinib|mesh-list
83894561|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
83894562|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894563|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894564|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894565|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83894566|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
83894567|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894568|NCT05099848|Antidotes|antidotes|mesh-ancestor
83894569|NCT05099848|Protective Agents|protective agents|mesh-ancestor
83894570|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
83894571|NCT05099848|Vitamins|vitamins|mesh-ancestor
83894572|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
83894573|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894574|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894575|NCT05085496|Atezolizumab|atezolizumab|mesh-list
83894576|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83133717|NCT03090698|Hylan|hylan|mesh-list
83894577|NCT05085496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894578|NCT05085496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894579|NCT05085496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894580|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894581|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
83894582|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894583|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
83894584|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
83894585|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894587|NCT05074810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894588|NCT05074810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894589|NCT05074810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894590|NCT05074810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894591|NCT05038735|Fulvestrant|fulvestrant|mesh-list
83894592|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894593|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894594|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83894595|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83894596|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
83894597|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894598|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894599|NCT05028062|Naltrexone|naltrexone|mesh-list
83894600|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83894601|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83894602|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894603|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
83894604|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894605|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
83894606|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894607|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894608|NCT04999202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894609|NCT04999202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894610|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83894611|NCT04997811|Valproic Acid|valproic acid|mesh-list
83894612|NCT04997811|Bezafibrate|bezafibrate|mesh-list
83894613|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
83894614|NCT04997811|Danazol|danazol|mesh-list
83894615|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
83894616|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894617|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894618|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
83894619|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894620|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894621|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
83894622|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83894623|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894624|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83894625|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83894626|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83894627|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83894628|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
83894629|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83894630|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83894631|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83894632|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83894633|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894634|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894635|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83894636|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
83894637|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894638|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83894639|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
83894640|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83894641|NCT04983836|Anesthetics|anesthetics|mesh-list
83894642|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894643|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894644|NCT04952753|Leucovorin|leucovorin|mesh-list
83894645|NCT04952753|Bevacizumab|bevacizumab|mesh-list
83894646|NCT04952753|Tislelizumab|tislelizumab|mesh-list
83894647|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
83894648|NCT04952753|Irinotecan|irinotecan|mesh-list
83894649|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
83894650|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894651|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894652|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83894653|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83894654|NCT04952753|Growth Substances|growth substances|mesh-ancestor
83894655|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894656|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
83894657|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83894658|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83894659|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894660|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894661|NCT04952753|Antidotes|antidotes|mesh-ancestor
83894662|NCT04952753|Protective Agents|protective agents|mesh-ancestor
83894663|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
83894664|NCT04952753|Vitamins|vitamins|mesh-ancestor
83894665|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
83894666|NCT04948333|Niacinamide|niacinamide|mesh-list
83894667|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
83894668|NCT04948333|Vitamins|vitamins|mesh-ancestor
83894669|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
83894670|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894671|NCT04933383|Budesonide|budesonide|mesh-list
83894672|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83894673|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83894674|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
83894675|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894676|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894677|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83894678|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
83894679|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
83894680|NCT04933383|Hormones|hormones|mesh-ancestor
83894681|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894682|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83894683|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83894684|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83894685|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894686|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894687|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
83894688|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894689|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83894690|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83894691|NCT04923776|Carboplatin|carboplatin|mesh-list
83894692|NCT04923776|Etoposide|etoposide|mesh-list
83894693|NCT04923776|Atezolizumab|atezolizumab|mesh-list
83894694|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894695|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83894696|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83894697|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83894698|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894699|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894700|NCT04923776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894701|NCT04923776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894702|NCT04899583|Sirolimus|sirolimus|mesh-list
83894703|NCT04899583|Paclitaxel|paclitaxel|mesh-list
83894704|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83894705|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894706|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83894707|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83894708|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83894709|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894710|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83894711|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894712|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83894713|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
83894714|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83894715|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
83894716|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894717|NCT04898894|Cytarabine|cytarabine|mesh-list
83894718|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
83894719|NCT04898894|Methotrexate|methotrexate|mesh-list
83894720|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
83894721|NCT04898894|Fludarabine|fludarabine|mesh-list
83894722|NCT04898894|Venetoclax|venetoclax|mesh-list
83894723|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83894724|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
83894725|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83894726|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894727|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894728|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
84048320|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83894729|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894730|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894731|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
83894732|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894733|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83894734|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83894735|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
83894736|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894737|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83894738|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
83894739|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894740|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83894741|NCT04886531|Trastuzumab|trastuzumab|mesh-list
83894743|NCT04886531|Anastrozole|anastrozole|mesh-list
83894744|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894745|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894746|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83894747|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83894748|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894749|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894750|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83894751|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
83894752|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894753|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894754|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894755|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
83894756|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83894757|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
83894758|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894759|NCT04868565|Caffeine|caffeine|mesh-list
83894760|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
83894761|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894762|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83894763|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894764|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83894765|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894766|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83894767|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83894768|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
83894769|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83894770|NCT04849364|Capecitabine|capecitabine|mesh-list
83894771|NCT04849364|Atezolizumab|atezolizumab|mesh-list
83894772|NCT04849364|Talazoparib|talazoparib|mesh-list
83894773|NCT04849364|Inavolisib|inavolisib|mesh-list
83894774|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894775|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
83894776|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894777|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894778|NCT04849364|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894779|NCT04849364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894780|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83894781|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894782|NCT04849364|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83894783|NCT04738942|Vedolizumab|vedolizumab|mesh-list
83894784|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83894785|NCT04716881|Naltrexone|naltrexone|mesh-list
83894786|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83894787|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83894788|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894789|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
83894790|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894791|NCT04711824|Paclitaxel|paclitaxel|mesh-list
83894792|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83894793|NCT04711824|Cisplatin|cisplatin|mesh-list
83894794|NCT04711824|Carboplatin|carboplatin|mesh-list
83894795|NCT04711824|Gemcitabine|gemcitabine|mesh-list
83894796|NCT04711824|Capecitabine|capecitabine|mesh-list
83894797|NCT04711824|Durvalumab|durvalumab|mesh-list
83894798|NCT04711824|Olaparib|olaparib|mesh-list
83894799|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83894800|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894801|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
83894802|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
83894803|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
83133880|NCT03286803|Vaccines|vaccines|mesh-list
83894804|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894805|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894806|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
83894807|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894808|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83894809|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894810|NCT04644237|Trastuzumab|trastuzumab|mesh-list
83894811|NCT04644237|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83894812|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894813|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894814|NCT04644237|Immunoconjugates|immunoconjugates|mesh-ancestor
83894815|NCT04644237|Immunologic Factors|immunologic factors|mesh-ancestor
83894816|NCT04644237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894817|NCT04589845|Trastuzumab|trastuzumab|mesh-list
83894818|NCT04589845|Atezolizumab|atezolizumab|mesh-list
83894819|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83894820|NCT04589845|Maytansine|maytansine|mesh-list
83894821|NCT04589845|Ipatasertib|ipatasertib|mesh-list
83894822|NCT04589845|Pralsetinib|pralsetinib|mesh-list
83894823|NCT04589845|Entrectinib|entrectinib|mesh-list
83894824|NCT04589845|Inavolisib|inavolisib|mesh-list
83894825|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894826|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894827|NCT04589845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894828|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894829|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83894830|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83894831|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83894832|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83894833|NCT04589845|Immunotoxins|immunotoxins|mesh-ancestor
83894834|NCT04589845|Immunoconjugates|immunoconjugates|mesh-ancestor
83894835|NCT04589845|Immunologic Factors|immunologic factors|mesh-ancestor
83894836|NCT04589845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894837|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894838|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894839|NCT04589845|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83894840|NCT04582266|Remdesivir|remdesivir|mesh-list
83894841|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
83894842|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894843|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
83894844|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894845|NCT04577755|Pomalidomide|pomalidomide|mesh-list
83894846|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
83894847|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894848|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83894849|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83894850|NCT04577755|Growth Substances|growth substances|mesh-ancestor
83894851|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
83894852|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894853|NCT04528134|Listerine|listerine|mesh-list
83894854|NCT04528134|Fluorides|fluorides|mesh-list
83894855|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
83894856|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
83894857|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
83894858|NCT04528134|Protective Agents|protective agents|mesh-ancestor
83894859|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894860|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83894861|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894862|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83894863|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83894864|NCT04521920|Narcotics|narcotics|mesh-ancestor
83894865|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83894866|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894867|NCT04521920|Analgesics|analgesics|mesh-ancestor
83894868|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
83894869|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894870|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83894871|NCT04491136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83894872|NCT04491136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83894873|NCT04491136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894874|NCT04482621|Decitabine|decitabine|mesh-list
83894875|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894876|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
83894877|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894878|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894879|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894881|NCT04452877|Dabrafenib|dabrafenib|mesh-list
83894882|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894883|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894884|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894885|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894886|NCT05050916|Vitamin D|vitamin d|mesh-list
83894887|NCT05050916|Vitamins|vitamins|mesh-ancestor
83894888|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
83894889|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894890|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83894891|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
83894892|NCT04613596|Pemetrexed|pemetrexed|mesh-list
83894893|NCT04613596|Adagrasib|adagrasib|mesh-list
83894894|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894895|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894896|NCT04613596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894897|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894898|NCT04613596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894899|NCT04613596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83894900|NCT04613596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83894901|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
83894902|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894903|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894904|NCT04381650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894905|NCT04381650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894906|NCT04381143|Aspirin|aspirin|mesh-list
83894907|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83894908|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83894909|NCT04381143|Analgesics|analgesics|mesh-ancestor
83894910|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
83894911|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894912|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894913|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83894914|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83894915|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83894916|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83894917|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894918|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83894919|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83894920|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894921|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
83894922|NCT04370093|Pioglitazone|pioglitazone|mesh-list
83894923|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83894924|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894925|NCT04340193|Nivolumab|nivolumab|mesh-list
83894926|NCT04340193|Ipilimumab|ipilimumab|mesh-list
83894927|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894928|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894929|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894930|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894931|NCT04313881|Azacitidine|azacitidine|mesh-list
83894932|NCT04313881|Magrolimab|magrolimab|mesh-list
83894933|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83894934|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
83894935|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894936|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894937|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894938|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894939|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
83894940|NCT04298229|Diuretics|diuretics|mesh-list
83894941|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83894942|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894943|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83894944|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894945|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
83894946|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
83894947|NCT04209660|Lenvatinib|lenvatinib|mesh-list
83894948|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894949|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894950|NCT04209660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894951|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894952|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83894953|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83894954|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
83894955|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83894956|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83894957|NCT04177433|Prednisolone|prednisolone|mesh-list
83894958|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
83894959|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83894960|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
83894961|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83894962|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
83894963|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
83894964|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83894965|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894966|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83894967|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
83894968|NCT04177433|Hormones|hormones|mesh-ancestor
83894969|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83894970|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83894971|NCT04177433|Protective Agents|protective agents|mesh-ancestor
83894972|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83894973|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894974|NCT04166383|Nivolumab|nivolumab|mesh-list
83894975|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894976|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894977|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83894978|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83894979|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
83894980|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894981|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894982|NCT04108897|Doxycycline|doxycycline|mesh-list
83894983|NCT04108897|Ivermectin|ivermectin|mesh-list
83894984|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83894985|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83894986|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
83894987|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83894988|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83894989|NCT04101877|Bevacizumab|bevacizumab|mesh-list
83894990|NCT04101877|Aflibercept|aflibercept|mesh-list
83894991|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83894992|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83894993|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83894994|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83894995|NCT04101877|Growth Substances|growth substances|mesh-ancestor
83894996|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83894997|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
83894998|NCT04101838|Vaccines|vaccines|mesh-list
83894999|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
83895000|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895001|NCT04075747|Venetoclax|venetoclax|mesh-list
83895002|NCT04075747|Midostaurin|midostaurin|mesh-list
83895003|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895004|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895005|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895006|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895007|NCT04069273|Paclitaxel|paclitaxel|mesh-list
83895008|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
83895009|NCT04069273|Ramucirumab|ramucirumab|mesh-list
83895010|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83895011|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895012|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
83895013|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
83895014|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
83895015|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895016|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895017|NCT04069273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895018|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
83895019|NCT04026958|Clarithromycin|clarithromycin|mesh-list
83895020|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83895021|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895022|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83895023|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895024|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895025|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83895026|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83895027|NCT04024254|Folic Acid|folic acid|mesh-list
83134100|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
83895028|NCT04024254|Hematinics|hematinics|mesh-ancestor
83895029|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
83895030|NCT04024254|Vitamins|vitamins|mesh-ancestor
83895031|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
83895032|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895034|NCT04023331|Trace Elements|trace elements|mesh-ancestor
83895035|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
83895036|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895037|NCT03994601|Nivolumab|nivolumab|mesh-list
83895038|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895039|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895040|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895041|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895042|NCT03975829|Trametinib|trametinib|mesh-list
83895043|NCT03975829|Dabrafenib|dabrafenib|mesh-list
83895044|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895045|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895046|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895047|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895048|NCT03939182|Abexinostat|abexinostat|mesh-list
83895049|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83895050|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895051|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895052|NCT03934372|Ponatinib|ponatinib|mesh-list
83895053|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895054|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895055|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895056|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895057|NCT03908437|Buprenorphine|buprenorphine|mesh-list
83895058|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83895059|NCT03908437|Naloxone|naloxone|mesh-list
83895060|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83895061|NCT03908437|Narcotics|narcotics|mesh-ancestor
83895062|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895063|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895064|NCT03908437|Analgesics|analgesics|mesh-ancestor
83895065|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
83895066|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895067|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83895068|NCT03887702|Tenofovir|tenofovir|mesh-list
83895069|NCT03887702|Entecavir|entecavir|mesh-list
83895070|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
83895071|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895072|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83895073|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83895074|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895075|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895076|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83895077|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83895078|NCT03878589|Oxytocin|oxytocin|mesh-list
83895079|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
83895080|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83895081|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895082|NCT03876262|Ivermectin|ivermectin|mesh-list
83895083|NCT03876262|Moxidectin|moxidectin|mesh-list
83895084|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83895085|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895086|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
83895087|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
83895088|NCT03875287|Decitabine|decitabine|mesh-list
83895089|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83895090|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
83895091|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895092|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895093|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895094|NCT03832010|Triamcinolone|triamcinolone|mesh-list
83895095|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
83895096|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895097|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
83895098|NCT03832010|Hormones|hormones|mesh-ancestor
83895099|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895100|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895101|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
83895102|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895103|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895104|NCT03813836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895105|NCT03813836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895106|NCT03730649|Sulforaphane|sulforaphane|mesh-list
83895107|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83895108|NCT03730649|Protective Agents|protective agents|mesh-ancestor
83895109|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895110|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895111|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83895112|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83895113|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895114|NCT03632720|Vaccines|vaccines|mesh-list
83895115|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
83895116|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895117|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
83895118|NCT03622788|Fludarabine|fludarabine|mesh-list
83895119|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83895120|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895121|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
83895122|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895123|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83895124|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83895125|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
83895126|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895127|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895128|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83895129|NCT03598426|Dexamethasone|dexamethasone|mesh-list
83895130|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895131|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
83895132|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
83895133|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895134|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895135|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895136|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
83895137|NCT03598426|Hormones|hormones|mesh-ancestor
83895138|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895139|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83895140|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895141|NCT03581487|Durvalumab|durvalumab|mesh-list
83895142|NCT03581487|Ipilimumab|ipilimumab|mesh-list
83895143|NCT03581487|Tremelimumab|tremelimumab|mesh-list
83895144|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
83895145|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83895146|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
83895147|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895148|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895149|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
83895150|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895151|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895152|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895153|NCT03568890|Aspirin|aspirin|mesh-list
83895154|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
83895155|NCT03568890|Apixaban|apixaban|mesh-list
83895156|NCT03568890|Edoxaban|edoxaban|mesh-list
83895157|NCT03568890|Dabigatran|dabigatran|mesh-list
83895158|NCT03568890|Clopidogrel|clopidogrel|mesh-list
83895159|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83895160|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83895161|NCT03568890|Analgesics|analgesics|mesh-ancestor
83895162|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
83895163|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895164|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895165|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895166|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83895167|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83895168|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83895169|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895170|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83895171|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83895172|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895173|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
83895174|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83895175|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83895176|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83895177|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
83895178|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895179|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83134272|NCT02120911|Pertuzumab|pertuzumab|mesh-list
83895180|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
83895181|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83895182|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
83895183|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
83895185|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895186|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895187|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895188|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895189|NCT03499444|Rucaparib|rucaparib|mesh-list
83895190|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895191|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895192|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895193|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895194|NCT03494322|Cetuximab|cetuximab|mesh-list
83895195|NCT03494322|Avelumab|avelumab|mesh-list
83895196|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895197|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895198|NCT03480191|Daptomycin|daptomycin|mesh-list
83895199|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83895200|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895201|NCT03478878|Vitamin A|vitamin a|mesh-list
83895202|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
83895203|NCT03478878|Vitamins|vitamins|mesh-ancestor
83895204|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
83895205|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895206|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
83895207|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895208|NCT03478878|Protective Agents|protective agents|mesh-ancestor
83895209|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83895210|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895211|NCT03467958|Ozanimod|ozanimod|mesh-list
83895212|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83895213|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895214|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895215|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
83895216|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895217|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
83895218|NCT03441633|Apixaban|apixaban|mesh-list
83895219|NCT03441633|Dabigatran|dabigatran|mesh-list
83895220|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83895221|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
83895222|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83895223|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
83895224|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895225|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895226|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
83895227|NCT03436862|Nivolumab|nivolumab|mesh-list
83895228|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895229|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895230|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895231|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895232|NCT03424005|Bevacizumab|bevacizumab|mesh-list
83895233|NCT03424005|Carboplatin|carboplatin|mesh-list
83895234|NCT03424005|Gemcitabine|gemcitabine|mesh-list
83895235|NCT03424005|Capecitabine|capecitabine|mesh-list
83895236|NCT03424005|Trastuzumab|trastuzumab|mesh-list
83895237|NCT03424005|Atezolizumab|atezolizumab|mesh-list
83895238|NCT03424005|Fulvestrant|fulvestrant|mesh-list
83895239|NCT03424005|Ipatasertib|ipatasertib|mesh-list
83895240|NCT03424005|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83895241|NCT03424005|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83895242|NCT03424005|SGN-LIV1A|sgn-liv1a|mesh-list
83895243|NCT03424005|Inavolisib|inavolisib|mesh-list
83895244|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895245|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895246|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895247|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83895248|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83895249|NCT03424005|Growth Substances|growth substances|mesh-ancestor
83895250|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895251|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
83895252|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83895253|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
83895254|NCT03424005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895255|NCT03424005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134329|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83895256|NCT03424005|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83895258|NCT03424005|Hormone Antagonists|hormone antagonists|mesh-ancestor
83895259|NCT03424005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895260|NCT03424005|Immunoconjugates|immunoconjugates|mesh-ancestor
83895261|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
83895262|NCT03424005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895263|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895264|NCT03424005|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83895265|NCT03418961|Carvedilol|carvedilol|mesh-list
83895266|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83895267|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83895268|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83895269|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895270|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895271|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895272|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83895273|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
83895274|NCT03418961|Protective Agents|protective agents|mesh-ancestor
83895275|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83895276|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83895277|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83895278|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
83895279|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83895280|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83895281|NCT03397394|Rucaparib|rucaparib|mesh-list
83895282|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895283|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895284|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895285|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895286|NCT03395080|Paclitaxel|paclitaxel|mesh-list
83895287|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83895288|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895289|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83895290|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83895291|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83895292|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895293|NCT03373760|Durvalumab|durvalumab|mesh-list
83895294|NCT03373760|Ipilimumab|ipilimumab|mesh-list
83895295|NCT03373760|Tremelimumab|tremelimumab|mesh-list
83895296|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
83895297|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83895298|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
83895299|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895300|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895301|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
83895302|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895303|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895304|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895305|NCT03354728|Vaccines|vaccines|mesh-list
83895306|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
83895307|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895308|NCT03290794|Aflibercept|aflibercept|mesh-list
83895309|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83895310|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83895311|NCT03290794|Growth Substances|growth substances|mesh-ancestor
83895312|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895313|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
83895314|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895315|NCT03283878|Cefazolin|cefazolin|mesh-list
83895316|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83895317|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895318|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
83895319|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
83895320|NCT03128359|Melphalan|melphalan|mesh-list
83895321|NCT03128359|Busulfan|busulfan|mesh-list
83895322|NCT03128359|Fludarabine|fludarabine|mesh-list
83895323|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
83895324|NCT03128359|Tacrolimus|tacrolimus|mesh-list
83895325|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895326|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
83895327|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895328|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83895329|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83895330|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
83895331|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895332|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895333|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83895334|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83895335|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
83895336|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83895337|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895338|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83895339|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83895340|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
83895341|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83895342|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895343|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
83895344|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895345|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895346|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895347|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895348|NCT02986100|Rucaparib|rucaparib|mesh-list
83895349|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895350|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895351|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895352|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895353|NCT02965027|Prazosin|prazosin|mesh-list
83895354|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83895355|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83895356|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83895357|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83895358|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
83895359|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895360|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895361|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895362|NCT02952534|Rucaparib|rucaparib|mesh-list
83895363|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895364|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895365|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895366|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895367|NCT02949934|Tolcapone|tolcapone|mesh-list
83895368|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83895369|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83895370|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83895371|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895372|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895373|NCT02935634|Nivolumab|nivolumab|mesh-list
83895374|NCT02935634|Ipilimumab|ipilimumab|mesh-list
83895375|NCT02935634|Relatlimab|relatlimab|mesh-list
83895376|NCT02935634|Rucaparib|rucaparib|mesh-list
83895377|NCT02935634|Linrodostat|linrodostat|mesh-list
83895378|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895379|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895380|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895381|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895382|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895383|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895384|NCT02921256|Leucovorin|leucovorin|mesh-list
83895385|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
83895386|NCT02921256|Fluorouracil|fluorouracil|mesh-list
83895387|NCT02921256|Capecitabine|capecitabine|mesh-list
83895388|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
83895389|NCT02921256|Veliparib|veliparib|mesh-list
83895390|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895391|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895392|NCT02921256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895393|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895394|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
83895395|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83895396|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895397|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
83895398|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895399|NCT02921256|Antidotes|antidotes|mesh-ancestor
83895400|NCT02921256|Protective Agents|protective agents|mesh-ancestor
83895401|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
83895402|NCT02921256|Vitamins|vitamins|mesh-ancestor
83895403|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
83895404|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83134509|NCT03286101|Ivermectin|ivermectin|mesh-list
83895405|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895406|NCT02864992|Tepotinib|tepotinib|mesh-list
83895407|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895408|NCT02825160|Iloprost|iloprost|mesh-list
83895409|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83895410|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
83895411|NCT02807636|Carboplatin|carboplatin|mesh-list
83895412|NCT02807636|Gemcitabine|gemcitabine|mesh-list
83895413|NCT02807636|Atezolizumab|atezolizumab|mesh-list
83895414|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895415|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83895416|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
83895417|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895418|NCT02807636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895419|NCT02807636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895420|NCT02740712|Vitamin K|vitamin k|mesh-list
83895421|NCT02740712|Rucaparib|rucaparib|mesh-list
83895422|NCT02740712|Digoxin|digoxin|mesh-list
83895423|NCT02740712|Midazolam|midazolam|mesh-list
83895424|NCT02740712|Caffeine|caffeine|mesh-list
83895425|NCT02740712|Omeprazole|omeprazole|mesh-list
83895426|NCT02740712|Warfarin|warfarin|mesh-list
83895427|NCT02740712|Vitamins|vitamins|mesh-ancestor
83895428|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
83895429|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895430|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83895431|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83895432|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895433|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83895434|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83895435|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83895436|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83895437|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
83895438|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
83895439|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
83895440|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
83895441|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895442|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895443|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
83895444|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83895445|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83895446|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895447|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83895448|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83895449|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
83895450|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83895451|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895452|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83895453|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83895454|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83895455|NCT02740712|Protective Agents|protective agents|mesh-ancestor
83895456|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83895457|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83895458|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
83895459|NCT02740712|Coagulants|coagulants|mesh-ancestor
83895460|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895461|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895462|NCT02684578|Metformin|metformin|mesh-list
83895463|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83895464|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895465|NCT02580305|Memantine|memantine|mesh-list
83895466|NCT02580305|Donepezil|donepezil|mesh-list
83895467|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
83895468|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83895469|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895470|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895471|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
83895472|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895473|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895474|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
83895475|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83895476|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83895477|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
83134560|NCT03091166|Analgesics|analgesics|mesh-ancestor
83895478|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83895479|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83895480|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83895481|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
83895482|NCT02379416|Paclitaxel|paclitaxel|mesh-list
83895483|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83895484|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895485|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
83895486|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
83895487|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
83895488|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895489|NCT02279394|Dexamethasone|dexamethasone|mesh-list
83895490|NCT02279394|Lenalidomide|lenalidomide|mesh-list
83895491|NCT02279394|Elotuzumab|elotuzumab|mesh-list
83895492|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895493|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
83895494|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
83895495|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895496|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895497|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895498|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
83895499|NCT02279394|Hormones|hormones|mesh-ancestor
83895500|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895501|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83895502|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895503|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
83895504|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83895505|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83895506|NCT02279394|Growth Substances|growth substances|mesh-ancestor
83895507|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
83895508|NCT02229578|Lidocaine|lidocaine|mesh-list
83895509|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
83895510|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
83895511|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895512|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895513|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
83895514|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895515|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83895516|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83895517|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83895518|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83895519|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895520|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83895521|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895522|NCT01821781|Fludarabine|fludarabine|mesh-list
83895523|NCT01821781|Melphalan|melphalan|mesh-list
83895524|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
83895525|NCT01821781|Thiotepa|thiotepa|mesh-list
83895526|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895527|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895528|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895529|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
83895530|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895531|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83895532|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
83895533|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83895534|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895535|NCT01555463|Azelaic acid|azelaic acid|mesh-list
83895536|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895537|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
83895538|NCT01482715|Rucaparib|rucaparib|mesh-list
83895539|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895540|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895541|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895542|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895543|NCT01306019|Busulfan|busulfan|mesh-list
83895544|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
83895545|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895546|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895547|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
83895548|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895549|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83895550|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895551|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83895552|NCT01257919|Azelaic acid|azelaic acid|mesh-list
83895553|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895554|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
83895555|NCT01081951|Paclitaxel|paclitaxel|mesh-list
83895556|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83895557|NCT01081951|Carboplatin|carboplatin|mesh-list
83895559|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83895560|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895561|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
83895562|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
83895563|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
83895564|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895565|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83895566|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895567|NCT00915837|Triamcinolone|triamcinolone|mesh-list
83895568|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83895569|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83895570|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83895571|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895572|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
83895573|NCT00915837|Hormones|hormones|mesh-ancestor
83895574|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895575|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895576|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895577|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
83895578|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895579|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895580|NCT00239096|Losartan|losartan|mesh-list
83895581|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83895582|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83895583|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83895584|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83895585|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895586|NCT04532554|Hormones|hormones|mesh-list
83895587|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895588|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895589|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
83895590|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83895591|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895592|NCT02217163|Dexamethasone|dexamethasone|mesh-list
83895593|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
83895594|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895595|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
83895596|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895597|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83895598|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83895599|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
83895600|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895601|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895602|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83895603|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895604|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
83895605|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
83895606|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895607|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895608|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
83895609|NCT02217163|Hormones|hormones|mesh-ancestor
83895610|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895611|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83895612|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83895613|NCT02217202|Laxatives|laxatives|mesh-ancestor
83895614|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895615|NCT00239174|Surinabant|surinabant|mesh-list
83895616|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83895617|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83895618|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895619|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895620|NCT00239174|Hormones|hormones|mesh-ancestor
83895621|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895622|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895623|NCT04531423|Golimumab|golimumab|mesh-list
83895624|NCT04531423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83895625|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83895626|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895627|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83134704|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
83895628|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
83895629|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895630|NCT04531423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83895631|NCT04531423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83895632|NCT04531423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895633|NCT04531423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895634|NCT04531423|Serotonin Agents|serotonin agents|mesh-ancestor
83895635|NCT00239252|Interferons|interferons|mesh-list
83895636|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
83895637|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895638|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
83895639|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895640|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83895641|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
83895642|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895643|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895644|NCT04531267|Calcium|calcium|mesh-list
83895645|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83895646|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895647|NCT04531228|Lenvatinib|lenvatinib|mesh-list
83895648|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895649|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895650|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895651|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895652|NCT04531072|Ritonavir|ritonavir|mesh-list
83895653|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83895654|NCT04531072|Lumefantrine|lumefantrine|mesh-list
83895655|NCT04531072|Artemether|artemether|mesh-list
83895656|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83895657|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83895658|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83895659|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
83895660|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895661|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895662|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83895663|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83895664|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
83895665|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895666|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83895667|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83895668|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
83895669|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83895670|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83895671|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83895672|NCT00414323|Escitalopram|escitalopram|mesh-list
83895673|NCT00414323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83895674|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83895675|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83895676|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895677|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895678|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
83895679|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895680|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895681|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
83895682|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83895683|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83895684|NCT00414323|Analgesics|analgesics|mesh-ancestor
83895685|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
83895686|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
83895687|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
83895688|NCT00263484|Thalidomide|thalidomide|mesh-list
83895689|NCT00263484|Dexamethasone|dexamethasone|mesh-list
83895690|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
83895691|NCT00263484|BB 1101|bb 1101|mesh-list
83895692|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895693|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
83895694|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
83895695|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895696|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895697|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895698|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
83895699|NCT00263484|Hormones|hormones|mesh-ancestor
83895700|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895701|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83895702|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895703|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
83895704|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895705|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895706|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83895707|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
83895708|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
83895709|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83895710|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895711|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83895712|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83895713|NCT00263484|Growth Substances|growth substances|mesh-ancestor
83895714|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
83895715|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83895716|NCT02217319|Sevoflurane|sevoflurane|mesh-list
83895717|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83895718|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83895719|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
83895720|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
83895721|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895722|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895723|NCT00263601|Immunomodulating Agents|immunomodulating agents|mesh-list
83895724|NCT00263601|Immunologic Factors|immunologic factors|mesh-ancestor
83895725|NCT00263601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895726|NCT02217514|Midazolam|midazolam|mesh-list
83895727|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83895728|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83895729|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895730|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895731|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83895732|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83895733|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83895734|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83895735|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
83895736|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
83895737|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
83895738|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
83895739|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895740|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895741|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
83895742|NCT02217553|Vitamin D|vitamin d|mesh-list
83895743|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83895744|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895745|NCT02217553|Vitamins|vitamins|mesh-ancestor
83895746|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
83895747|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83895748|NCT02217631|Prednisolone|prednisolone|mesh-list
83895749|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83895750|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
83895751|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83895752|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
83895753|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83895754|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
83895755|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895756|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
83895757|NCT02217631|Hormones|hormones|mesh-ancestor
83895758|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895759|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895760|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83895761|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895762|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
83895763|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
83895764|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895765|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895766|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83895767|NCT02217631|Protective Agents|protective agents|mesh-ancestor
83895768|NCT02217670|Metformin|metformin|mesh-list
83895769|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83895770|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895771|NCT00239291|Gefitinib|gefitinib|mesh-list
83895772|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895773|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895774|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134859|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
83895775|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895776|NCT00263640|Immunomodulating Agents|immunomodulating agents|mesh-list
83895777|NCT00263640|Immunologic Factors|immunologic factors|mesh-ancestor
83895778|NCT00263640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895779|NCT02217826|Octreotide|octreotide|mesh-list
83895780|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895781|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83895782|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895783|NCT00239330|Atorvastatin|atorvastatin|mesh-list
83895784|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83895785|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83895786|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83895787|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
83895788|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895789|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83895790|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83895791|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895792|NCT02218021|Oxycodone|oxycodone|mesh-list
83895793|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83895794|NCT02218021|Narcotics|narcotics|mesh-ancestor
83895795|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895796|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895797|NCT02218021|Analgesics|analgesics|mesh-ancestor
83895798|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
83895799|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895800|NCT00239369|Telmisartan|telmisartan|mesh-list
83895801|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83895802|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83895803|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83895804|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83895805|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895806|NCT00239369|Diuretics|diuretics|mesh-ancestor
83895807|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
83895808|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895809|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83895810|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83895811|NCT04529668|Vitamin D|vitamin d|mesh-list
83895812|NCT04529668|Vitamins|vitamins|mesh-ancestor
83895813|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
83895814|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895815|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83895816|NCT00239408|Bromides|bromides|mesh-list
83895817|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
83895818|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83895819|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
83895820|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895821|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895822|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83895823|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
83895824|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
83895825|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83895826|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
83895827|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895828|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895829|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
83895830|NCT02218177|Ranibizumab|ranibizumab|mesh-list
83895831|NCT02218177|Aflibercept|aflibercept|mesh-list
83895832|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83895833|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83895834|NCT02218177|Growth Substances|growth substances|mesh-ancestor
83895835|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895836|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
83895837|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895838|NCT00263718|Betamethasone|betamethasone|mesh-list
83895839|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
83895840|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83895841|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
83895842|NCT00263718|Calcipotriene|calcipotriene|mesh-list
83895843|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83895844|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83895845|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
83895846|NCT00263718|Hormones|hormones|mesh-ancestor
83895847|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895848|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895849|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83895850|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
83134944|NCT02126995|Metadoxine|metadoxine|mesh-list
83895851|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
83895852|NCT02218645|Brotizolam|brotizolam|mesh-list
83895853|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83895854|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895855|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895856|NCT02218684|Telmisartan|telmisartan|mesh-list
83895857|NCT02218684|Lacidipine|lacidipine|mesh-list
83895858|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83895859|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83895860|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83895861|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895862|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83895863|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83895864|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83895865|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895866|NCT02278861|Tretinoin|tretinoin|mesh-list
83895867|NCT02278861|Isotretinoin|isotretinoin|mesh-list
83895868|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
83895869|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
83895870|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895871|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
83895872|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83895873|NCT02278861|Protective Agents|protective agents|mesh-ancestor
83895874|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895875|NCT01642030|Buprenorphine|buprenorphine|mesh-list
83895876|NCT01642030|Hydromorphone|hydromorphone|mesh-list
83895877|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83895878|NCT01642030|Narcotics|narcotics|mesh-ancestor
83895879|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83895880|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895881|NCT01642030|Analgesics|analgesics|mesh-ancestor
83895882|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
83895883|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895884|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83895885|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
83895886|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83895887|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
83895888|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895889|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895890|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83895891|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
83895892|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
83895893|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83895894|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
83895895|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895896|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895897|NCT00263796|Oxytocin|oxytocin|mesh-list
83895898|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
83895899|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83895900|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895901|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83895902|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83895903|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895904|NCT01642108|Incretins|incretins|mesh-ancestor
83895905|NCT01642108|Hormones|hormones|mesh-ancestor
83895906|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895907|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83895908|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
83895909|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895910|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895911|NCT00250185|Acetylcholine|acetylcholine|mesh-list
83895912|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
83895913|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83895914|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
83895915|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895916|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895917|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895918|NCT00239486|Pramipexole|pramipexole|mesh-list
83895919|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
83895920|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895921|NCT00239486|Protective Agents|protective agents|mesh-ancestor
83895922|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895923|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83895924|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83895925|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
83135006|NCT04993040|Paclitaxel|paclitaxel|mesh-list
83895926|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
83895927|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895928|NCT01642966|Ticagrelor|ticagrelor|mesh-list
83895929|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83895930|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83895931|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83895932|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83895933|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83895934|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
83895935|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83895936|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895937|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895938|NCT01643083|Rifaximin|rifaximin|mesh-list
83895939|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83895940|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83895941|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895942|NCT01643278|Ipilimumab|ipilimumab|mesh-list
83895943|NCT01643278|Dasatinib|dasatinib|mesh-list
83895944|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895945|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895946|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83895947|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895948|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83895949|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895950|NCT01643629|Minoxidil|minoxidil|mesh-list
83895951|NCT01643629|Finasteride|finasteride|mesh-list
83895952|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83895953|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83895954|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83895955|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83895956|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895957|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895958|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
83895959|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83895960|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895961|NCT01643629|Urological Agents|urological agents|mesh-ancestor
83895962|NCT01644253|Rituximab|rituximab|mesh-list
83895963|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
83895964|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83895965|NCT01644253|Idelalisib|idelalisib|mesh-list
83895966|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
83895967|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83895968|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895969|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
83895970|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895971|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83895972|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83895973|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
83895974|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895975|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895976|NCT01644799|Lenalidomide|lenalidomide|mesh-list
83895977|NCT01644799|Idelalisib|idelalisib|mesh-list
83895978|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
83895979|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895980|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83895981|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83895982|NCT01644799|Growth Substances|growth substances|mesh-ancestor
83895983|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
83895984|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83895985|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83895986|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83895987|NCT01644838|Promethazine|promethazine|mesh-list
83895988|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
83895989|NCT01644838|Scopolamine|scopolamine|mesh-list
83895990|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83895991|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
83895992|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
83895993|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83895994|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83895995|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83895996|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
83895997|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83895998|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
83895999|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896000|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896001|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83896002|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
83896003|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
83896004|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83896005|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
83896006|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
83896007|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83896008|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83896009|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83896010|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896011|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
83896012|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
83896013|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
83896014|NCT01644955|Carboplatin|carboplatin|mesh-list
83896015|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896017|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896018|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
83896019|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83896020|NCT04528888|Heparin|heparin|mesh-list
83896021|NCT04528888|Enoxaparin|enoxaparin|mesh-list
83896022|NCT04528888|Calcium heparin|calcium heparin|mesh-list
83896023|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896024|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
83896025|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
83896026|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896027|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896028|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83896029|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
83896030|NCT04528888|Hormones|hormones|mesh-ancestor
83896031|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896032|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83896033|NCT04528888|Protective Agents|protective agents|mesh-ancestor
83896034|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896035|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896036|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
83896037|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83896038|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83896039|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896040|NCT01645384|Atorvastatin|atorvastatin|mesh-list
83896041|NCT01645384|Calcium|calcium|mesh-list
83896042|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83896043|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896044|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83896045|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83896046|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
83896047|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896048|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83896049|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83896050|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896051|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83896052|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83896053|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896054|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83896055|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
83896056|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896057|NCT01645423|Atorvastatin|atorvastatin|mesh-list
83896058|NCT01645423|Calcium|calcium|mesh-list
83896059|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83896060|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896061|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83896062|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83896063|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
83896064|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896065|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83896066|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83896067|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896068|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
83896069|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83896070|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83896071|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896072|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896073|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896074|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896075|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
83896076|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
83896077|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896078|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
83896079|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83896080|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
83896081|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83896082|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83896083|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896084|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83896085|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
83896086|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896087|NCT02961075|Anesthetics|anesthetics|mesh-list
83896088|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896089|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896090|NCT01646281|Flecainide|flecainide|mesh-list
83896091|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83896092|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83896093|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83896094|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896095|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896096|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
83896097|NCT01646554|Aflibercept|aflibercept|mesh-list
83896098|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896099|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83896100|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83896101|NCT01646554|Growth Substances|growth substances|mesh-ancestor
83896102|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896103|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
83896104|NCT00250263|Immunomodulating Agents|immunomodulating agents|mesh-list
83896105|NCT00250263|Immunologic Factors|immunologic factors|mesh-ancestor
83896106|NCT00250263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896107|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
83896108|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
83896109|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83896110|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83896111|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896112|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896113|NCT01646788|Paclitaxel|paclitaxel|mesh-list
83896114|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83896115|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896116|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
83896117|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
83896118|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
83896119|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896120|NCT01647256|Nikkomycin|nikkomycin|mesh-list
83896121|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
83896122|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83896123|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896124|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896125|NCT00239954|Escitalopram|escitalopram|mesh-list
83896126|NCT00239954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83896127|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83896128|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896129|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896130|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896131|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
83896132|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896133|NCT04528927|Azithromycin|azithromycin|mesh-list
83896134|NCT04528927|Doxycycline|doxycycline|mesh-list
83896135|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83896136|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83896137|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
83896138|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83896139|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83896140|NCT04720287|Bupivacaine|bupivacaine|mesh-list
83896141|NCT04720287|Neostigmine|neostigmine|mesh-list
83896142|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
83896143|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
83896144|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896145|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896146|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
83896147|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896148|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83896149|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896150|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896151|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
83896152|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896153|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83896154|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
83896155|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
83896156|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
83896157|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83896158|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
83896159|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896160|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83896161|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896162|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
83896163|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
83896164|NCT00264108|Hematinics|hematinics|mesh-ancestor
83896165|NCT01647412|Curcumin|curcumin|mesh-list
83896166|NCT01647412|Hormones|hormones|mesh-list
83896167|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896168|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896169|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83896170|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896171|NCT01647412|Analgesics|analgesics|mesh-ancestor
83896172|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
83896173|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896174|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896175|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896176|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896177|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896178|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896179|NCT01647529|Ganciclovir|ganciclovir|mesh-list
83896180|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83896181|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
83896182|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83896183|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83896184|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896185|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896186|NCT00240032|Cetirizine|cetirizine|mesh-list
83896187|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
83896188|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
83896189|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83896190|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83896191|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83896192|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
83896193|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
83896194|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896195|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896196|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896197|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83896198|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
83896199|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83896200|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896201|NCT00240149|Insulin|insulin|mesh-list
83896202|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83896203|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83896204|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896205|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83896206|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83896207|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
83896208|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83896209|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
83896210|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896211|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896212|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
83896213|NCT01647646|Hormones|hormones|mesh-ancestor
83896214|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896215|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
83896216|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
83896217|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83896218|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83896219|NCT01647685|Prednisolone|prednisolone|mesh-list
83896220|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
83896221|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83896222|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
83896223|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896224|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
83896225|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
83896226|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896227|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896228|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83896229|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
83896230|NCT01647685|Hormones|hormones|mesh-ancestor
83896231|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896232|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83896233|NCT01647685|Protective Agents|protective agents|mesh-ancestor
83896234|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896235|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896236|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83896237|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83896238|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83896239|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
83896240|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896241|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83896242|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83896243|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896244|NCT01648036|Heparin|heparin|mesh-list
83896245|NCT01648036|Calcium heparin|calcium heparin|mesh-list
83896246|NCT01648036|Dalteparin|dalteparin|mesh-list
83896247|NCT01648036|Tinzaparin|tinzaparin|mesh-list
83896248|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83896249|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
83896250|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83896251|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83896252|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896253|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83896254|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83896255|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83896256|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
83896257|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896258|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83896259|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83896260|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896261|NCT01648231|Losartan|losartan|mesh-list
83896262|NCT01648231|Amlodipine|amlodipine|mesh-list
83896263|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83896264|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83896265|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896266|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896267|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83896268|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896269|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
83896270|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83896271|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83896272|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83896273|NCT00264186|Norepinephrine|norepinephrine|mesh-list
83896274|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
83896275|NCT00264186|Acetylcholine|acetylcholine|mesh-list
83896276|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83896277|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83896278|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896279|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896280|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896281|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896282|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
83896283|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
83896284|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896285|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83896286|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
83896287|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83896288|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
83896289|NCT00240422|Telmisartan|telmisartan|mesh-list
83896290|NCT00240422|Ramipril|ramipril|mesh-list
83896291|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83896292|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83896293|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83896294|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896295|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83896296|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
83896297|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896298|NCT00264225|Codeine|codeine|mesh-list
83896299|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83896300|NCT00264225|Narcotics|narcotics|mesh-ancestor
83896301|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896302|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896303|NCT00264225|Analgesics|analgesics|mesh-ancestor
83896304|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
83896305|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896306|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
83896307|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
83896308|NCT02279563|Fluticasone|fluticasone|mesh-list
83896310|NCT02279563|Azelastine|azelastine|mesh-list
83896311|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896312|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83896313|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
83896314|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896315|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896316|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83896317|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
83896318|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
83896319|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83896320|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83896321|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896322|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896323|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83896324|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83896325|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
83896326|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
83896327|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896328|NCT02279758|Metformin|metformin|mesh-list
83896329|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83896330|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896331|NCT01649245|Interferons|interferons|mesh-list
83896332|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896333|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
83896334|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83896335|NCT01649284|Afatinib|afatinib|mesh-list
83896336|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896337|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83896338|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896339|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896340|NCT00415740|Levodopa|levodopa|mesh-list
83896341|NCT00415740|Carbidopa|carbidopa|mesh-list
83896342|NCT00415740|Entacapone|entacapone|mesh-list
83896343|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83896344|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83896345|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83896346|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
83896347|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896348|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896349|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896350|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83896351|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896352|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83896353|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83896354|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
83896355|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
83896356|NCT01649479|Antibodies|antibodies|mesh-list
83896357|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
83896358|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
83896359|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896360|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
83896361|NCT01649635|Prednisone|prednisone|mesh-list
83896362|NCT01649635|Lenograstim|lenograstim|mesh-list
83896363|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896364|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
83896365|NCT01649635|Hormones|hormones|mesh-ancestor
83896366|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896367|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896368|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896369|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896370|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83896371|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83896372|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83896373|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83896374|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896375|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896376|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83896377|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83896378|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83896379|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
83896380|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83896381|NCT00250536|Nandrolone|nandrolone|mesh-list
83896382|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83896383|NCT00250536|Androgens|androgens|mesh-ancestor
83896384|NCT00250536|Hormones|hormones|mesh-ancestor
83896385|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896386|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896387|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
83896388|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83896389|NCT00240617|Naproxen|naproxen|mesh-list
83896390|NCT00240617|Sumatriptan|sumatriptan|mesh-list
83896391|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83896392|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896393|NCT00240617|Analgesics|analgesics|mesh-ancestor
83896394|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
83896395|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896396|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896397|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896398|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896399|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
83896400|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83896401|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896402|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896403|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83896404|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83896405|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83896406|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
83896407|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896408|NCT01649830|Temozolomide|temozolomide|mesh-list
83896409|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83896410|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
83896411|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896412|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896413|NCT00240656|Carvedilol|carvedilol|mesh-list
83896414|NCT00240656|Captopril|captopril|mesh-list
83896415|NCT00240656|Spironolactone|spironolactone|mesh-list
83896416|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83896417|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
83896418|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896419|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896420|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83896421|NCT00240656|Diuretics|diuretics|mesh-ancestor
83896422|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
83896423|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83896424|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83896425|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896426|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896427|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896428|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83896429|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
83896430|NCT00240656|Protective Agents|protective agents|mesh-ancestor
83896431|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83896432|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896433|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83896434|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
83896435|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83896436|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83896437|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83896438|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
83896439|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896440|NCT00250575|Clozapine|clozapine|mesh-list
83896441|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83896442|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
83896443|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896444|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896445|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896446|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83896447|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83896448|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896449|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83896450|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
83896451|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
83896452|NCT00240695|Galantamine|galantamine|mesh-list
83896453|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83896454|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896455|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896456|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
83896457|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896458|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896459|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83896460|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
83896461|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896462|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
83896463|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
83896464|NCT00240734|Hematinics|hematinics|mesh-ancestor
83896465|NCT04720248|Dipyrone|dipyrone|mesh-list
83896466|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83896467|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896468|NCT04720248|Analgesics|analgesics|mesh-ancestor
83896469|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
83896470|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896471|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896472|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896473|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896474|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
83896475|NCT01646515|Udenafil|udenafil|mesh-list
83896476|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83896477|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83896478|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896479|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896480|NCT00240773|Acetaminophen|acetaminophen|mesh-list
83896481|NCT00240773|Naproxen|naproxen|mesh-list
83896482|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896483|NCT00240773|Analgesics|analgesics|mesh-ancestor
83896484|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
83896485|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896486|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896487|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
83896488|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83896489|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896490|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896491|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
83896492|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83896493|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896494|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896495|NCT01688401|Melphalan|melphalan|mesh-list
83896496|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83896497|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
83896498|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896499|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896500|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83896501|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83896502|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
83896503|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896504|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83896505|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83896506|NCT04708821|Dexamethasone|dexamethasone|mesh-list
83896507|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83896508|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896509|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
83896510|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
83896511|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896512|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896513|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83896514|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
83896515|NCT04708821|Hormones|hormones|mesh-ancestor
83896516|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896517|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896518|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896519|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83896520|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83896521|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83896522|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896523|NCT04708821|Analgesics|analgesics|mesh-ancestor
83896524|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
83896525|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896526|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83896527|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83896528|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
83896529|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
83896530|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896531|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896532|NCT00240812|Ibuprofen|ibuprofen|mesh-list
83896533|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
83896534|NCT00240812|Ephedrine|ephedrine|mesh-list
83896535|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83896536|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896537|NCT00240812|Analgesics|analgesics|mesh-ancestor
83896538|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
83896539|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896540|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896541|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896542|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896543|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83896544|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896545|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896546|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83896547|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
83896548|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83896549|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
83896550|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
83896551|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83896552|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83896553|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
83896554|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896555|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896556|NCT01688518|Lidocaine|lidocaine|mesh-list
83896557|NCT01688518|Tetracaine|tetracaine|mesh-list
83896558|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
83896559|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
83896560|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896561|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896562|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
83896563|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896564|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83896565|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83896566|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83896567|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896568|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896569|NCT00240851|Acetaminophen|acetaminophen|mesh-list
83896570|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896571|NCT00240851|Analgesics|analgesics|mesh-ancestor
83896572|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
83896573|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896574|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896575|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
83896576|NCT00240929|Palivizumab|palivizumab|mesh-list
83896577|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
83896578|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83896579|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
83896580|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83896581|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
83896582|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
83896583|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896584|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896585|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83896586|NCT00250692|Analgesics|analgesics|mesh-ancestor
83896587|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
83896588|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896589|NCT01688791|Paclitaxel|paclitaxel|mesh-list
83896590|NCT01688791|Carboplatin|carboplatin|mesh-list
83896591|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83896592|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896593|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
83896594|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
83896595|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
83896596|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896597|NCT01688947|Pregabalin|pregabalin|mesh-list
83896598|NCT01688947|Analgesics|analgesics|mesh-ancestor
83896599|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
83896600|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896601|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896602|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
83896603|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83896604|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896605|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896606|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83896607|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83896608|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83896609|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896610|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83896612|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83896613|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83896614|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83896615|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83896616|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896617|NCT00241007|Diuretics|diuretics|mesh-ancestor
83896618|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
83896619|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896620|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83896621|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896622|NCT01689142|Insulin|insulin|mesh-list
83896623|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83896624|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
83896625|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83896626|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896627|NCT00241046|Letrozole|letrozole|mesh-list
83896628|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896629|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83896630|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83896631|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896632|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896633|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83896634|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
83896635|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896636|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896637|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
83896638|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83896639|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
83896640|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83896641|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83896642|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896643|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83896644|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896645|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83896646|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896647|NCT01689298|Oxytocin|oxytocin|mesh-list
83896648|NCT01689298|Carbetocin|carbetocin|mesh-list
83896649|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
83896650|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83896651|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896652|NCT00241085|Valsartan|valsartan|mesh-list
83896653|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83896654|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83896655|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83896656|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896657|NCT00241124|Valsartan|valsartan|mesh-list
83896658|NCT00241124|Lisinopril|lisinopril|mesh-list
83896659|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83896660|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83896661|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83896662|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896663|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83896664|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
83896665|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896666|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83896667|NCT00241124|Protective Agents|protective agents|mesh-ancestor
83896668|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896669|NCT00241163|Thrombin|thrombin|mesh-list
83896670|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
83896671|NCT00241163|Coagulants|coagulants|mesh-ancestor
83896672|NCT02277106|Brexanolone|brexanolone|mesh-list
83896674|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896675|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896676|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896677|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
83896678|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
83896679|NCT00241241|Interferons|interferons|mesh-list
83896680|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
83896681|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
83896682|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83896683|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896684|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
83896685|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83896686|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
83896687|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896688|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
83896689|NCT02279602|Combretastatin|combretastatin|mesh-list
83896690|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83896691|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896692|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
83896693|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
83896694|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
83896695|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896696|NCT00241436|Anastrozole|anastrozole|mesh-list
83896697|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896698|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896699|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83896700|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83896701|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896702|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896703|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83896704|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
83896705|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896706|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896707|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
83896708|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83896709|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896710|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
83896711|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83896712|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896713|NCT00241475|Gefitinib|gefitinib|mesh-list
83896714|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896715|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83896716|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896717|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896718|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
83896719|NCT01685359|Hematinics|hematinics|mesh-ancestor
83896720|NCT02278978|Nintedanib|nintedanib|mesh-list
83896721|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896722|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83896723|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896724|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896725|NCT02218762|Fluticasone|fluticasone|mesh-list
83896726|NCT02218762|Xhance|xhance|mesh-list
83896727|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83896728|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83896729|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896730|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83896731|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
83896732|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896733|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896734|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83896735|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
83896736|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
83896737|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83896738|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83896739|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83896740|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83896741|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896742|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896743|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896744|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
83896745|NCT02218762|Hormones|hormones|mesh-ancestor
83135844|NCT03069950|Antidotes|antidotes|mesh-ancestor
83896746|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896748|NCT00264459|Immunomodulating Agents|immunomodulating agents|mesh-list
83896749|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
83896750|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896751|NCT00241514|Esomeprazole|esomeprazole|mesh-list
83896752|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83896753|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83896754|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83896755|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896756|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896757|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83896758|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
83896759|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83896760|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
83896761|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896762|NCT00241553|Esomeprazole|esomeprazole|mesh-list
83896763|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83896764|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83896765|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83896766|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896767|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896768|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
83896769|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83896770|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83896771|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896772|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
83896773|NCT02219152|Coagulants|coagulants|mesh-ancestor
83896774|NCT00264615|Lamotrigine|lamotrigine|mesh-list
83896775|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
83896776|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83896777|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896778|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896779|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83896780|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896781|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83896782|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83896783|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896784|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83896785|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83896786|NCT02219191|Puerarin|puerarin|mesh-list
83896787|NCT02219191|Atorvastatin|atorvastatin|mesh-list
83896788|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83896789|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83896790|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
83896791|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896792|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83896793|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83896794|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896795|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83896796|NCT04529512|Dexamethasone|dexamethasone|mesh-list
83896797|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896798|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
83896799|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
83896800|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896801|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896802|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83896803|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
83896804|NCT04529512|Hormones|hormones|mesh-ancestor
83896805|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896806|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896807|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896808|NCT04720131|Capecitabine|capecitabine|mesh-list
83896809|NCT04720131|Apatinib|apatinib|mesh-list
83896810|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83896811|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
83896812|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896813|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896814|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83896815|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896816|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83896817|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83896818|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
83896819|NCT02219737|Rituximab|rituximab|mesh-list
83896820|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83896822|NCT02219737|Etoposide|etoposide|mesh-list
83896823|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
83896824|NCT02219737|Ifosfamide|ifosfamide|mesh-list
83896825|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
83896826|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
83896827|NCT02219737|Antibodies|antibodies|mesh-list
83896828|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
83896829|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83896830|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
83896831|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896832|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896833|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83896834|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83896835|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83896836|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83896837|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896838|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896839|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83896840|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
83896841|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
83896842|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
83896843|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
83896844|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
83896845|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
83896846|NCT02219893|Immunotoxins|immunotoxins|mesh-list
83896847|NCT02219893|MOC31PE immunotoxin|moc31pe immunotoxin|mesh-list
83896848|NCT02219893|Immunoconjugates|immunoconjugates|mesh-ancestor
83896849|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
83896850|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896851|NCT02218606|Prednisone|prednisone|mesh-list
83896852|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
83896853|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896854|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
83896855|NCT02218606|Hormones|hormones|mesh-ancestor
83896856|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896857|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896858|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896859|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896860|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83896861|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896862|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896863|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
83896864|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83896865|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
83896866|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83896867|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896868|NCT02210806|Albuterol|albuterol|mesh-list
83896869|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83896870|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
83896871|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896872|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896873|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83896874|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
83896875|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
83896876|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83896877|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83896878|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83896879|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83896880|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896881|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896882|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896883|NCT00264654|Paroxetine|paroxetine|mesh-list
83896884|NCT00264654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83896885|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83896886|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896887|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896888|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896889|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
83896890|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896891|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83896892|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
83896893|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83896894|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83896895|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83896896|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83896897|NCT02219659|Fentanyl|fentanyl|mesh-list
83896898|NCT02219659|Midazolam|midazolam|mesh-list
83896899|NCT02219659|Propofol|propofol|mesh-list
83896900|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83896901|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896902|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896903|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83896904|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
83896905|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
83896906|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83896907|NCT02219659|Narcotics|narcotics|mesh-ancestor
83896908|NCT02219659|Analgesics|analgesics|mesh-ancestor
83896909|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
83896910|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896911|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83896912|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83896913|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83896914|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83896915|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
83896916|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
83896917|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896918|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896919|NCT00241982|Prednisolone|prednisolone|mesh-list
83896920|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896921|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
83896922|NCT00241982|Hormones|hormones|mesh-ancestor
83896923|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83896924|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896925|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83896926|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896927|NCT02212015|Paclitaxel|paclitaxel|mesh-list
83896928|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83896929|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83896930|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83896931|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83896932|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83896933|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896934|NCT04720859|Canagliflozin|canagliflozin|mesh-list
83896935|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83896936|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896937|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83896938|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896939|NCT02961842|Ephedrine|ephedrine|mesh-list
83896940|NCT02961842|Fentanyl|fentanyl|mesh-list
83896941|NCT02961842|Bupivacaine|bupivacaine|mesh-list
83896942|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
83896943|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
83896944|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83896945|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896946|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
83896947|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896948|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83896949|NCT02961842|Narcotics|narcotics|mesh-ancestor
83896950|NCT02961842|Analgesics|analgesics|mesh-ancestor
83896951|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83896952|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83896953|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
83896954|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83896955|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
83896956|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
83896957|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83896958|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896959|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896960|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896961|NCT00272805|Carvedilol|carvedilol|mesh-list
83896962|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83896963|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83896964|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
83896965|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83896966|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896967|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896968|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83896969|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
83896970|NCT00272805|Protective Agents|protective agents|mesh-ancestor
83896971|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83896972|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83896973|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83896974|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
83896975|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83896976|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83896977|NCT00242177|Pioglitazone|pioglitazone|mesh-list
83896978|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83896979|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896980|NCT00264927|Satavaptan|satavaptan|mesh-list
83896981|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83896982|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896983|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
83896984|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896985|NCT00242372|Insulin|insulin|mesh-list
83896986|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83896987|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896988|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83896989|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83896990|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83896991|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83896992|NCT00242411|Budesonide|budesonide|mesh-list
83896993|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
83896994|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83896995|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83896996|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
83896997|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83896998|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83896999|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83897000|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897001|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
83897002|NCT00242411|Hormones|hormones|mesh-ancestor
83897003|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897004|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83897005|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83897006|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83897007|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
83897008|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897009|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897010|NCT02962037|Melatonin|melatonin|mesh-list
83897011|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
83897012|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897013|NCT02962037|Protective Agents|protective agents|mesh-ancestor
83897014|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897015|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897016|NCT00282399|Decitabine|decitabine|mesh-list
83897017|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83897018|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
83897019|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897020|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897021|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897022|NCT00242450|Metoclopramide|metoclopramide|mesh-list
83897023|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
83897024|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
83897025|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897026|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897027|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83897028|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83897029|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83897030|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
83897031|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897032|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897033|NCT00273039|Paroxetine|paroxetine|mesh-list
83897034|NCT00273039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83897035|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83897036|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897037|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897038|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897039|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
83897040|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897041|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83897042|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
83897043|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897044|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83897045|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83897046|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897047|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
83897048|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83897049|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897050|NCT00242606|Lamotrigine|lamotrigine|mesh-list
83897051|NCT00242606|Levetiracetam|levetiracetam|mesh-list
83897052|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
83897053|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
83897054|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83897055|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897056|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897057|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83897058|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897059|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83897060|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897061|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897062|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897063|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83897064|NCT00242762|Docetaxel|docetaxel|mesh-list
83897065|NCT00242762|Gefitinib|gefitinib|mesh-list
83897066|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897067|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897068|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897069|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897070|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897071|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897072|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897073|NCT00242801|Gefitinib|gefitinib|mesh-list
83897074|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897075|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897076|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897077|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897078|NCT00242879|Ritonavir|ritonavir|mesh-list
83897079|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83897080|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83897081|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
83897082|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897083|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897084|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83897085|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83897086|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
83897087|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897088|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83897089|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83897090|NCT00282594|Insulin|insulin|mesh-list
83897091|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83897092|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897093|NCT00242918|Docetaxel|docetaxel|mesh-list
83897094|NCT00242918|Gefitinib|gefitinib|mesh-list
83897095|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897096|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897097|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897098|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897099|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897100|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897101|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897102|NCT00273312|Epothilone B|epothilone b|mesh-list
83897103|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897104|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897105|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897106|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897107|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897108|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
83897109|NCT00242996|Carmustine|carmustine|mesh-list
83897110|NCT00242996|Rituximab|rituximab|mesh-list
83897111|NCT00242996|Etoposide|etoposide|mesh-list
83897112|NCT00242996|Sargramostim|sargramostim|mesh-list
83897113|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897114|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
83897115|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897116|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897117|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897118|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
83897119|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897120|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897121|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83897122|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83897123|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897124|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83897125|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83897126|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897128|NCT00273390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83897129|NCT00273390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897130|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
83897131|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83897132|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897133|NCT00243035|Bortezomib|bortezomib|mesh-list
83897134|NCT00243035|Tipifarnib|tipifarnib|mesh-list
83897135|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897136|NCT00243113|Docetaxel|docetaxel|mesh-list
83897137|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897138|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897139|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897140|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897141|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897142|NCT00273429|Timolol|timolol|mesh-list
83897143|NCT00273429|Dorzolamide|dorzolamide|mesh-list
83897144|NCT00273429|Latanoprost|latanoprost|mesh-list
83897145|NCT00273429|Maleic acid|maleic acid|mesh-list
83897146|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897147|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897148|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83897149|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83897150|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
83897151|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897152|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897153|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83897154|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83897155|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83897156|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83897157|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83897158|NCT00273468|Granisetron|granisetron|mesh-list
83897159|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
83897160|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
83897161|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897162|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897163|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83897164|NCT00273468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83897165|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83897166|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
83897167|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897168|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897169|NCT00243464|Betamethasone|betamethasone|mesh-list
83897170|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
83897171|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83897172|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
83897173|NCT00243464|Calcipotriene|calcipotriene|mesh-list
83897174|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83897175|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897176|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
83897177|NCT00243464|Hormones|hormones|mesh-ancestor
83897178|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897179|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897180|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83897181|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897182|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83897183|NCT00273507|Paclitaxel|paclitaxel|mesh-list
83897184|NCT00273507|Carboplatin|carboplatin|mesh-list
83897185|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897186|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897187|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897188|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897189|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897190|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897191|NCT00282945|Metformin|metformin|mesh-list
83897192|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
83136301|NCT03256071|Decitabine|decitabine|mesh-list
83897193|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83897194|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897195|NCT00273546|Docetaxel|docetaxel|mesh-list
83897196|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897197|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897198|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897199|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897200|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897201|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
83897202|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83897203|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897204|NCT00243737|Artesunate|artesunate|mesh-list
83897205|NCT00243737|Mefloquine|mefloquine|mesh-list
83897206|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
83897207|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83897208|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83897209|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897210|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897211|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
83897212|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
83897213|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83897214|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
83897215|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
83897216|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83897217|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
83897218|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897219|NCT00273702|Expectorants|expectorants|mesh-ancestor
83897220|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897221|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83897222|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
83897223|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897224|NCT00273702|Protective Agents|protective agents|mesh-ancestor
83897225|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897226|NCT00273702|Antidotes|antidotes|mesh-ancestor
83897227|NCT00243815|Ibuprofen|ibuprofen|mesh-list
83897228|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83897229|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83897230|NCT00243815|Analgesics|analgesics|mesh-ancestor
83897231|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
83897232|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897233|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897234|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897235|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897236|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83897237|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897238|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897239|NCT00283179|Risperidone|risperidone|mesh-list
83897240|NCT00283179|Aripiprazole|aripiprazole|mesh-list
83897241|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83897242|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
83897243|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897244|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897245|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897246|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83897247|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897248|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897249|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897250|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83897251|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
83897252|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
83897253|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
83897254|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83897255|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83897256|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83897257|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83897258|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83897259|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897260|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897261|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897262|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897263|NCT00273741|Methylphenidate|methylphenidate|mesh-list
83897264|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83897265|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897266|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83897267|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83897268|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897269|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897270|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
83897271|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897272|NCT02279134|Paclitaxel|paclitaxel|mesh-list
83897273|NCT02279134|Nedaplatin|nedaplatin|mesh-list
83897274|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897275|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897276|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897277|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897278|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897279|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897280|NCT00243893|Doxycycline|doxycycline|mesh-list
83897281|NCT00243893|Minocycline|minocycline|mesh-list
83897282|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83897283|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897284|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
83897285|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83897286|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83897287|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
83897288|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83897289|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83897290|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897291|NCT00244127|Prednisone|prednisone|mesh-list
83897292|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
83897293|NCT00244127|Rituximab|rituximab|mesh-list
83897294|NCT00244127|Vincristine|vincristine|mesh-list
83897295|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897296|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
83897297|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897298|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897299|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897300|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
83897301|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897302|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897303|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83897304|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83897305|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897306|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
83897307|NCT00244127|Hormones|hormones|mesh-ancestor
83897308|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897309|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83897310|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897311|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897312|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897313|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897314|NCT00244166|Prednisolone|prednisolone|mesh-list
83897315|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897316|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
83897317|NCT00244166|Hormones|hormones|mesh-ancestor
83897318|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897319|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897320|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83897321|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897322|NCT00273975|Lamivudine|lamivudine|mesh-list
83897323|NCT00273975|Zidovudine|zidovudine|mesh-list
83897324|NCT00273975|Nevirapine|nevirapine|mesh-list
83897325|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83897326|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83897327|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897328|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897329|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
83897330|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897331|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83897332|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83897333|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
83897334|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83897335|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83897336|NCT00244283|Sevoflurane|sevoflurane|mesh-list
83897337|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83897338|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83897339|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
83897340|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
83897341|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897342|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897343|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
83897344|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83897345|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
83897346|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897347|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83897348|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83897349|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83897350|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897351|NCT00244322|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
83897352|NCT00244322|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83897353|NCT00244322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897354|NCT00244322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897355|NCT00244361|Rituximab|rituximab|mesh-list
83897356|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83897357|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897358|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
83897359|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897360|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897361|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
83897362|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83897363|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
83897364|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897365|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897366|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83897367|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897368|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
83897369|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83897370|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
83897371|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897372|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897373|NCT00244439|Permethrin|permethrin|mesh-list
83897374|NCT00244439|Malathion|malathion|mesh-list
83897375|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897376|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897377|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83897378|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83897379|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897380|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897381|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83897382|NCT00417144|Ganirelix|ganirelix|mesh-list
83897383|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
83897384|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83897385|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
83897386|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83897387|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897388|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83897389|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83897390|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897391|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
83897392|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897393|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
83897394|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83897395|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
83897396|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897397|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897398|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83897399|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897400|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
83897401|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83897402|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
83897403|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897404|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897405|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83897406|NCT00417183|Ganirelix|ganirelix|mesh-list
83897407|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
83897408|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83897409|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
83897410|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83897411|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897412|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83897413|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83897414|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897415|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
83897416|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897417|NCT00244517|Remifentanil|remifentanil|mesh-list
83897418|NCT00244517|Sevoflurane|sevoflurane|mesh-list
83897419|NCT00244517|Desflurane|desflurane|mesh-list
83897420|NCT00244517|Isoflurane|isoflurane|mesh-list
83897421|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
83897422|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897423|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897424|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83897425|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83897426|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
83897427|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83897428|NCT00244517|Narcotics|narcotics|mesh-ancestor
83897429|NCT00244517|Analgesics|analgesics|mesh-ancestor
83897430|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
83897431|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897432|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
83897433|NCT00274092|Ipratropium|ipratropium|mesh-list
83897434|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83897435|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
83897436|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897437|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897438|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83897439|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897440|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
83897441|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83897442|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
83897443|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897444|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897445|NCT00244556|Etanercept|etanercept|mesh-list
83897446|NCT00244556|Methotrexate|methotrexate|mesh-list
83897447|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83897448|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
83897449|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83897450|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897451|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83897452|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
83897453|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897454|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897455|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
83897456|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897457|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83897458|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897459|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
83897460|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897461|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83897462|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83897463|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83897464|NCT00244556|Analgesics|analgesics|mesh-ancestor
83897465|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
83897466|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897467|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897468|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83897469|NCT00274131|Pramipexole|pramipexole|mesh-list
83897470|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
83897471|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897472|NCT00274131|Protective Agents|protective agents|mesh-ancestor
83897473|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897474|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83897475|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83897476|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
83897477|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
83897478|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897479|NCT00274170|Octreotide|octreotide|mesh-list
83897480|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83897481|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83897482|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897483|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
83897484|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897485|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897486|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897487|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897488|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
83897489|NCT00244907|Genistein|genistein|mesh-list
83897490|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83897491|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897492|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897493|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83897494|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897495|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83897496|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83897498|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897499|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897500|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897501|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
83897502|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83897503|NCT00244907|Estrogens|estrogens|mesh-ancestor
83897504|NCT00244907|Hormones|hormones|mesh-ancestor
83897505|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897506|NCT00244946|Cytarabine|cytarabine|mesh-list
83897507|NCT00244946|Etoposide|etoposide|mesh-list
83897508|NCT00244946|Melphalan|melphalan|mesh-list
83897509|NCT00244946|Carmustine|carmustine|mesh-list
83897510|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897511|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897512|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83897513|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83897514|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897515|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897516|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83897517|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
83897518|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
83897519|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897520|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897521|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
83897522|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897523|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897524|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
83897525|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83897526|NCT00245024|Sulindac|sulindac|mesh-list
83897527|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83897528|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83897529|NCT00245024|Analgesics|analgesics|mesh-ancestor
83897530|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
83897531|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897532|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897533|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897534|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897535|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897536|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83897537|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897538|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897539|NCT00274326|Satavaptan|satavaptan|mesh-list
83897540|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83897541|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897542|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
83897543|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897544|NCT00245141|Dactinomycin|dactinomycin|mesh-list
83897545|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
83897546|NCT00245141|Vincristine|vincristine|mesh-list
83897547|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897548|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
83897549|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897550|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897551|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897552|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
83897553|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897554|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897555|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83897556|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897557|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897558|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897559|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897560|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83897561|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897562|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83897563|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83897565|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83897566|NCT00416637|Bevacizumab|bevacizumab|mesh-list
83897567|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83897568|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897569|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83897570|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83897571|NCT00416637|Growth Substances|growth substances|mesh-ancestor
83897572|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897573|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
83897574|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
83897575|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897576|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
83897577|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83897578|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83897579|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897580|NCT00245258|Urological Agents|urological agents|mesh-ancestor
83897581|NCT02961803|Biotin|biotin|mesh-list
83897582|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
83897583|NCT02961803|Vitamins|vitamins|mesh-ancestor
83897584|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
83897585|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897586|NCT00245297|Factor VIII|factor viii|mesh-list
83897587|NCT00245297|Coagulants|coagulants|mesh-ancestor
83897588|NCT00274404|Valacyclovir|valacyclovir|mesh-list
83897589|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
83897590|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897591|NCT00283764|Latanoprost|latanoprost|mesh-list
83897592|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83897593|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83897594|NCT00245336|Thrombin|thrombin|mesh-list
83897595|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
83897596|NCT00245336|Coagulants|coagulants|mesh-ancestor
83897597|NCT00274443|Carboplatin|carboplatin|mesh-list
83897598|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83897599|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897600|NCT00245375|Acetaminophen|acetaminophen|mesh-list
83897601|NCT00245375|Ibuprofen|ibuprofen|mesh-list
83897602|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83897603|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83897604|NCT00245375|Analgesics|analgesics|mesh-ancestor
83897605|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
83897606|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897607|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897608|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897609|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897610|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83897611|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897612|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897613|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
83897614|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83897615|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
83897616|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
83897617|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897618|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
83897619|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897620|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
83897621|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83897622|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
83897623|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897624|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897625|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83897626|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897627|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
83897628|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83897629|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
83897630|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897631|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897632|NCT00245453|Azithromycin|azithromycin|mesh-list
83897633|NCT00245453|Clarithromycin|clarithromycin|mesh-list
83897634|NCT00245453|Telithromycin|telithromycin|mesh-list
83897635|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83897636|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897637|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83897638|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897639|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897640|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83897641|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83897642|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
83897643|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83897644|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83897645|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
83897646|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897647|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897648|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83897649|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
83897650|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
83897651|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83897652|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
83897653|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897654|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897655|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83897656|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83897657|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83897658|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
83897659|NCT00245609|Pregabalin|pregabalin|mesh-list
83897660|NCT00245609|Alprazolam|alprazolam|mesh-list
83897661|NCT00245609|Analgesics|analgesics|mesh-ancestor
83897662|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
83897663|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897664|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897665|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
83897666|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83897667|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897668|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897669|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83897670|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83897671|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897672|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897673|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897674|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83897675|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
83897676|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
83897677|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897678|NCT00274599|Telmisartan|telmisartan|mesh-list
83897679|NCT00274599|Ramipril|ramipril|mesh-list
83897680|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83897681|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83897682|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83897683|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897684|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83897685|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
83897686|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897687|NCT00274638|Losartan|losartan|mesh-list
83897688|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83897689|NCT00274638|Telmisartan|telmisartan|mesh-list
83897690|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83897691|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83897692|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83897693|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83897694|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897695|NCT00274638|Diuretics|diuretics|mesh-ancestor
83897696|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
83897697|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897698|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83897699|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897700|NCT00274677|Lamotrigine|lamotrigine|mesh-list
83897701|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
83897702|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83897703|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897704|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897705|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83897706|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897707|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83897708|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897709|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897710|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897711|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83897712|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
83897713|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83897714|NCT00245921|Estradiol|estradiol|mesh-list
83897715|NCT00245921|Estrogens|estrogens|mesh-ancestor
83897716|NCT00245921|Hormones|hormones|mesh-ancestor
83897717|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897718|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897719|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83897720|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
83897721|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83897722|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83897723|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83897724|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83897725|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83897726|NCT00274794|Rituximab|rituximab|mesh-list
83897727|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83897728|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897729|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
83897730|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897731|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897732|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
83897733|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83897734|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83897735|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83897736|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897737|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897738|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
83897739|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152070|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897740|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897741|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83897742|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897743|NCT00284193|Thrombin|thrombin|mesh-list
83897744|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
83897745|NCT00284193|Factor VIII|factor viii|mesh-list
83897746|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
83897747|NCT00284193|Coagulants|coagulants|mesh-ancestor
83897748|NCT00246194|Risperidone|risperidone|mesh-list
83897749|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83897750|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
83897751|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897752|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897753|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897754|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83897755|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897756|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897757|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897758|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83897759|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
83897760|NCT00284232|Insulin|insulin|mesh-list
83897761|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83897762|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897763|NCT00246233|Methylphenidate|methylphenidate|mesh-list
83897764|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83897765|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897766|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83897767|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83897768|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897769|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897770|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
83897771|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897772|NCT00274833|Temozolomide|temozolomide|mesh-list
83897773|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83897774|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897775|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
83897776|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897777|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897778|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897779|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897780|NCT00274872|Leucovorin|leucovorin|mesh-list
83897781|NCT00274872|Fluorouracil|fluorouracil|mesh-list
83897782|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
83897783|NCT00274872|Calcium|calcium|mesh-list
83897784|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
83897785|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83897786|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897787|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
83897788|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897789|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83897791|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897792|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
83897793|NCT00274872|Antidotes|antidotes|mesh-ancestor
83897794|NCT00274872|Protective Agents|protective agents|mesh-ancestor
83897795|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
83897796|NCT00274872|Vitamins|vitamins|mesh-ancestor
83897797|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
83897798|NCT00246272|Risperidone|risperidone|mesh-list
83897799|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83897800|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
83897801|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897802|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897803|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897804|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83897805|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897806|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897807|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897808|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83897809|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
83897810|NCT00284271|Prednisone|prednisone|mesh-list
83897811|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
83897812|NCT00284271|Vincristine|vincristine|mesh-list
83897813|NCT00284271|Bleomycin|bleomycin|mesh-list
83897814|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
83897815|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897816|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
83897817|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897818|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897819|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897820|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
83897821|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897822|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897823|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83897824|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897825|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
83897826|NCT00284271|Hormones|hormones|mesh-ancestor
83897827|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897828|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83897829|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897830|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897831|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897832|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897833|NCT00284271|Hematinics|hematinics|mesh-ancestor
83897834|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83897835|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
83897836|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83897837|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
83897838|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897839|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83897840|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897841|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83897842|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897843|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897844|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897845|NCT00274911|Vincristine|vincristine|mesh-list
83897846|NCT00274911|Lomustine|lomustine|mesh-list
83897847|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897848|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897849|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897850|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897851|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897852|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897853|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897854|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
83897855|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83897856|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83897857|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
83897858|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897859|NCT00246467|Antacids|antacids|mesh-ancestor
83897860|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897861|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83897862|NCT00277251|Alendronate|alendronate|mesh-list
83897863|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83897864|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897865|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
83897866|NCT00416676|Carboplatin|carboplatin|mesh-list
83897867|NCT00416676|Etoposide|etoposide|mesh-list
83897868|NCT00416676|Vincristine|vincristine|mesh-list
83897869|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897870|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
83897871|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897872|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897873|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83897874|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
83897875|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897876|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897877|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83897878|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897879|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83897880|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83897881|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897882|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897883|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897884|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897885|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83897886|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897887|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
83897888|NCT00284427|Vitamins|vitamins|mesh-ancestor
83897889|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
83897890|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897891|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
83897892|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897893|NCT00284427|Protective Agents|protective agents|mesh-ancestor
83897894|NCT00246701|Simvastatin|simvastatin|mesh-list
83897895|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83897896|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83897897|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
83897898|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897899|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83897900|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83897901|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897902|NCT00284505|Thalidomide|thalidomide|mesh-list
83897903|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83897904|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
83897905|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897906|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
83897907|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83897908|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83897909|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83897910|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83897911|NCT00284505|Growth Substances|growth substances|mesh-ancestor
83897912|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
83897913|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897914|NCT00246974|Gemcitabine|gemcitabine|mesh-list
83897915|NCT00246974|Gefitinib|gefitinib|mesh-list
83897916|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897917|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83897918|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
83897919|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897920|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83897921|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897922|NCT00284583|Lidocaine|lidocaine|mesh-list
83897923|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
83897924|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
83897925|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897926|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897927|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
83897928|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897929|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83897930|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83897931|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83897932|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897933|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897934|NCT00247052|Diclofenac|diclofenac|mesh-list
83897935|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83897936|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83897937|NCT00247052|Analgesics|analgesics|mesh-ancestor
83897938|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
83897939|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83897940|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897941|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83897942|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83897943|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83897944|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897945|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897946|NCT00277602|Riluzole|riluzole|mesh-list
83897947|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
83897948|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83897949|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83897950|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897951|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897952|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897953|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83897954|NCT00277602|Protective Agents|protective agents|mesh-ancestor
83897955|NCT00277641|Lamotrigine|lamotrigine|mesh-list
83897956|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
83897957|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83897958|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83897959|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897960|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83897961|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897962|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83897963|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83897964|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83897965|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83897966|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83897967|NCT00247130|Omeprazole|omeprazole|mesh-list
83897968|NCT00247130|Ranitidine|ranitidine|mesh-list
83897969|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83897970|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83897971|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83897972|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83897973|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83897974|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897975|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83897976|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
83897977|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
83897978|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83897979|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897980|NCT00247169|Progesterone|progesterone|mesh-list
83897981|NCT00247169|Progestins|progestins|mesh-ancestor
83897982|NCT00247169|Hormones|hormones|mesh-ancestor
83897983|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83897984|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83897985|NCT00247208|Paclitaxel|paclitaxel|mesh-list
83897986|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83897987|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897988|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897989|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897990|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897991|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897992|NCT00284778|Docetaxel|docetaxel|mesh-list
83897993|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83897994|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
83897995|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83897996|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83897997|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83897998|NCT00247247|Entacapone|entacapone|mesh-list
83897999|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83898000|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83898001|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83898002|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898003|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898004|NCT00277758|Interferons|interferons|mesh-list
83898005|NCT00277758|Ribavirin|ribavirin|mesh-list
83898006|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
83898007|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83898008|NCT00277758|Interleukin-2|interleukin-2|mesh-list
83898009|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898010|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
83898011|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137139|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
83898012|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
83898013|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898014|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
83898015|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898016|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83898017|NCT00277758|Analgesics|analgesics|mesh-ancestor
83898018|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
83898019|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898020|NCT00247364|Levetiracetam|levetiracetam|mesh-list
83898021|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
83898022|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
83898023|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
83898024|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
83898025|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898026|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
83898027|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898028|NCT00424814|Ritonavir|ritonavir|mesh-list
83898029|NCT00424814|Lopinavir|lopinavir|mesh-list
83898030|NCT00424814|Lamivudine|lamivudine|mesh-list
83898031|NCT00424814|Zidovudine|zidovudine|mesh-list
83898032|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83898033|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83898034|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83898035|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
83898036|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898037|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898038|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83898039|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83898040|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
83898041|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898042|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83898043|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83898044|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83898045|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83898046|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
83898047|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83898048|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83898049|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
83898050|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898051|NCT00247481|Docetaxel|docetaxel|mesh-list
83898052|NCT00247481|Gefitinib|gefitinib|mesh-list
83898053|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898054|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898055|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898056|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898057|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898058|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83898059|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898060|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
83898061|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83898062|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83898063|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83898064|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898065|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898066|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
83898067|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898068|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898069|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83898070|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898071|NCT00285051|Ondansetron|ondansetron|mesh-list
83898072|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
83898073|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
83898074|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898075|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898076|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898077|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
83898078|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
83898079|NCT00285051|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83898080|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83898081|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
83898082|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898083|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898084|NCT00247715|Pantoprazole|pantoprazole|mesh-list
83898085|NCT00247715|Ranitidine|ranitidine|mesh-list
83898086|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83898087|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
83898088|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83898089|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83898090|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898091|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83898092|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898093|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898094|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83898095|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
83898096|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
83898097|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898098|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898099|NCT00247715|Antacids|antacids|mesh-ancestor
83898100|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83898101|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
83898102|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
83898103|NCT00285090|Vitamin D|vitamin d|mesh-list
83898104|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
83898105|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
83898106|NCT00285090|Vitamins|vitamins|mesh-list
83898107|NCT00285090|Calcium|calcium|mesh-list
83898108|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
83898109|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898110|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83898111|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83898112|NCT00417222|Olmesartan|olmesartan|mesh-list
83898113|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83898114|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83898115|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83898116|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83898117|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898118|NCT00278070|Vinorelbine|vinorelbine|mesh-list
83898119|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83898120|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898121|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898122|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898123|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898124|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898125|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
83898126|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83898127|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898128|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83898129|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83898130|NCT00247910|Diuretics|diuretics|mesh-ancestor
83898131|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
83898132|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898133|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83898134|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898135|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898136|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83898137|NCT00278187|Volociximab|volociximab|mesh-list
83898138|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898139|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83898140|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898141|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898142|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83898143|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83898144|NCT00278187|Growth Substances|growth substances|mesh-ancestor
83898145|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898146|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
83898147|NCT00247988|Carboplatin|carboplatin|mesh-list
83898148|NCT00247988|Docetaxel|docetaxel|mesh-list
83898149|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898150|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898151|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898152|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898153|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898154|NCT00248144|Famciclovir|famciclovir|mesh-list
83898155|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
83898156|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898157|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83898158|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898159|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898160|NCT00278265|Methotrexate|methotrexate|mesh-list
83898161|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
83898162|NCT00278265|Fludarabine|fludarabine|mesh-list
83898163|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83898164|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
83898165|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83898166|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898167|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898168|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
83898169|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898170|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898171|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
83898172|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898173|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83898174|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898175|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
83898176|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83898177|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83898178|NCT00248183|Naluzotan|naluzotan|mesh-list
83898179|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83898180|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83898181|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
83898182|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898183|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898184|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898185|NCT00278343|Cediranib|cediranib|mesh-list
83898186|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898187|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898188|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898189|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83898190|NCT00248261|Ziprasidone|ziprasidone|mesh-list
83898191|NCT00248261|Sertraline|sertraline|mesh-list
83898192|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
83898193|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898194|NCT00248261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83898195|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83898196|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898197|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898198|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898199|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
83898200|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898201|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83898202|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83898203|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83898204|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898205|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83898206|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
83898207|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
83898208|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83898209|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898210|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
83898211|NCT00278382|Sorafenib|sorafenib|mesh-list
83898212|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898213|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83898214|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898215|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898216|NCT00248339|Ribavirin|ribavirin|mesh-list
83898217|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83898218|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
83898219|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
83898220|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898221|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
83898222|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898223|NCT00248339|Hematinics|hematinics|mesh-ancestor
83898224|NCT00278421|Prednisone|prednisone|mesh-list
83898225|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
83898226|NCT00278421|Rituximab|rituximab|mesh-list
83898227|NCT00278421|Doxorubicin|doxorubicin|mesh-list
83898228|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83898229|NCT00278421|Vincristine|vincristine|mesh-list
83898230|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898231|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
83898232|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898233|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83898234|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83898235|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
83898236|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898237|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898238|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83898239|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83898240|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83898241|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83898242|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898243|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898244|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898245|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
83898246|NCT00278421|Hormones|hormones|mesh-ancestor
83898247|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83898248|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83898249|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83898250|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898251|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898252|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898253|NCT00248456|Betamethasone|betamethasone|mesh-list
83898254|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
83898255|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83898256|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
83898257|NCT00248456|Calcipotriene|calcipotriene|mesh-list
83898258|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83898259|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898260|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
83898261|NCT00248456|Hormones|hormones|mesh-ancestor
84048321|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83898262|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83898263|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898264|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83898265|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
83898266|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
83898267|NCT00278460|Gemcitabine|gemcitabine|mesh-list
83898268|NCT00278460|Docetaxel|docetaxel|mesh-list
83898269|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898270|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
83898271|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898272|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898273|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898274|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898275|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898276|NCT00248729|Midazolam|midazolam|mesh-list
83898277|NCT00248729|Etomidate|etomidate|mesh-list
83898278|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83898279|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83898280|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898281|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898282|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83898283|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83898284|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898285|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83898286|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
83898287|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
83898288|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
83898289|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
83898290|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898291|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898292|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
83898293|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898294|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
83898295|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83898296|NCT00248963|Estradiol|estradiol|mesh-list
83898297|NCT00248963|Estrogens|estrogens|mesh-ancestor
83898298|NCT00248963|Hormones|hormones|mesh-ancestor
83898299|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83898300|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898301|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83898302|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
83898303|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83898304|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83898305|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83898306|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83898307|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83898308|NCT00249041|Etanercept|etanercept|mesh-list
83898309|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83898310|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83898311|NCT00249041|Analgesics|analgesics|mesh-ancestor
83898312|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
83898313|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898314|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898315|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898316|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83898317|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898318|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898319|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
83898320|NCT00285519|Doxazosin|doxazosin|mesh-list
83898321|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83898322|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83898323|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83898324|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83898325|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
83898326|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898327|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898328|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898329|NCT00278772|Valproic Acid|valproic acid|mesh-list
83898330|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
83898331|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898332|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898333|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
83898334|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898335|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898336|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
83898337|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83898338|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898339|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898340|NCT00249119|Risperidone|risperidone|mesh-list
83898341|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83898342|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
83898343|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898344|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898345|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898346|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83898347|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83898348|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898349|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898350|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83898351|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
83898352|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83898353|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83898354|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898355|NCT00249158|Risperidone|risperidone|mesh-list
83898356|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83898357|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
83898358|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898359|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898360|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898361|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83898362|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83898363|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898364|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898365|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83898366|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
83898367|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83898368|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83898369|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83898370|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83898371|NCT00249197|Levofloxacin|levofloxacin|mesh-list
83898372|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83898373|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898374|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83898375|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83898376|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898377|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898378|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898379|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898380|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83898381|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83898382|NCT00278967|Bisacodyl|bisacodyl|mesh-list
83898383|NCT00278967|Cathartics|cathartics|mesh-ancestor
83898384|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898385|NCT00278967|Laxatives|laxatives|mesh-ancestor
83898386|NCT00249236|Risperidone|risperidone|mesh-list
83898387|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83898388|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
83898389|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898390|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898391|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898392|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83898393|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83898394|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898395|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898396|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83898397|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
83898398|NCT00285675|Calcitriol|calcitriol|mesh-list
83898399|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83898400|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898401|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83898402|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898403|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898404|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83898405|NCT00285675|Vitamins|vitamins|mesh-ancestor
83898406|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
83898407|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83898408|NCT02215096|GSK2636771|gsk2636771|mesh-list
83898409|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898410|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83898411|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898412|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898413|NCT00279045|Metformin|metformin|mesh-list
83898414|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
83898415|NCT00279045|Glyburide|glyburide|mesh-list
83898416|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83898417|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898418|NCT00249353|Methylphenidate|methylphenidate|mesh-list
83898419|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83898420|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898421|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83898422|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83898423|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898424|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898425|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
83898426|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898427|NCT00249431|Sertraline|sertraline|mesh-list
83898428|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
83898429|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898430|NCT00249431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83898431|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83898432|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898433|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898434|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898435|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
83898436|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898437|NCT00249509|Bupropion|bupropion|mesh-list
83898438|NCT00249509|Nefazodone|nefazodone|mesh-list
83898439|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83898440|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
83898441|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898442|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83898443|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83898444|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898445|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898446|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
83898447|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898448|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898449|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83898450|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83898451|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898452|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83898453|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83898454|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83898455|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
83898456|NCT00279084|Chrysarobin|chrysarobin|mesh-list
83898457|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
83898458|NCT00279084|Hematinics|hematinics|mesh-ancestor
83898459|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83898460|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83898462|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
83898463|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898464|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898465|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898466|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83898467|NCT00249587|Methadone|methadone|mesh-list
83898468|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83898469|NCT00249587|Narcotics|narcotics|mesh-ancestor
83898470|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898471|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898472|NCT00249587|Analgesics|analgesics|mesh-ancestor
83898473|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
83898474|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898475|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
83898476|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
83898477|NCT00279123|Pantoprazole|pantoprazole|mesh-list
83898478|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83898479|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898480|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83898481|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048322|NCT04408625|Protective Agents|protective agents|mesh-ancestor
83898482|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898483|NCT00279162|Betamethasone|betamethasone|mesh-list
83898484|NCT00279162|Calcipotriene|calcipotriene|mesh-list
83898485|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898486|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
83898487|NCT00279162|Hormones|hormones|mesh-ancestor
83898488|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83898489|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898490|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83898491|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
83898492|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
83898493|NCT00249704|Vitamin D|vitamin d|mesh-list
83898494|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
83898495|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
83898496|NCT00249704|Vitamins|vitamins|mesh-list
83898497|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
83898498|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898499|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83898500|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83898501|NCT00249782|Metronidazole|metronidazole|mesh-list
83898502|NCT00249782|Dapsone|dapsone|mesh-list
83898503|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898504|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83898505|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83898506|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83898507|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
83898508|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83898509|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898510|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898511|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
83898512|NCT00279240|Metformin|metformin|mesh-list
83898513|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83898514|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898515|NCT00249860|Interferons|interferons|mesh-list
83898516|NCT00249860|Ribavirin|ribavirin|mesh-list
83898517|NCT00249860|Interferon-beta|interferon-beta|mesh-list
83898518|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
83898519|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898520|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
83898521|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898522|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
83898523|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898524|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
83898525|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898526|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83898527|NCT00249899|Atorvastatin|atorvastatin|mesh-list
83898528|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83898529|NCT00249899|Simvastatin|simvastatin|mesh-list
83898530|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83898531|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83898532|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83898533|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
83898534|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898535|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83898536|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898537|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83898538|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83898539|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83898540|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
83898541|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898542|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83898543|NCT00249977|Capecitabine|capecitabine|mesh-list
83898544|NCT00249977|Irinotecan|irinotecan|mesh-list
83898545|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898546|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898547|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
83898548|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898549|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83898550|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898551|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898552|NCT00250094|Topotecan|topotecan|mesh-list
83898553|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83898554|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898555|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898556|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898557|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898558|NCT00279435|Visilizumab|visilizumab|mesh-list
83898559|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
83898560|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898561|NCT00286026|Azithromycin|azithromycin|mesh-list
83898562|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83898563|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898564|NCT00250172|Rolipram|rolipram|mesh-list
83898565|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
83898566|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898567|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83898568|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83898569|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898570|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898571|NCT02961608|Tacrolimus|tacrolimus|mesh-list
83898572|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898573|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
83898574|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898575|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83898576|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898577|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898578|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83898579|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898580|NCT00286143|Fentanyl|fentanyl|mesh-list
83898581|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83898582|NCT00286143|Narcotics|narcotics|mesh-ancestor
83898583|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898584|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898585|NCT00286143|Analgesics|analgesics|mesh-ancestor
83898586|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
83898587|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898588|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83898589|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83898590|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
83898591|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
83898592|NCT00286260|Levetiracetam|levetiracetam|mesh-list
83898593|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
83898594|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
83898595|NCT00250367|Risperidone|risperidone|mesh-list
83898596|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83898597|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
83898598|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898599|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898600|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898601|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83898602|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83898603|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898604|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83898605|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83898606|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
83898607|NCT00250562|Valsartan|valsartan|mesh-list
83898608|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83898609|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83898610|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83898611|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83898612|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898613|NCT00250562|Diuretics|diuretics|mesh-ancestor
83898614|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
83898615|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898616|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83898617|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898618|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
83898619|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
83898620|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83898621|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
83898622|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83898623|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
83898624|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898625|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898626|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
83898627|NCT00279747|Naproxen|naproxen|mesh-list
83898628|NCT00279747|Meloxicam|meloxicam|mesh-list
83898629|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83898630|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83898631|NCT00279747|Analgesics|analgesics|mesh-ancestor
83898632|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
83898633|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898634|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898635|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898636|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83898637|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
83898638|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83898639|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898640|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898641|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83898642|NCT00250640|Iloprost|iloprost|mesh-list
83898643|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83898644|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
83898645|NCT00250796|Interferons|interferons|mesh-list
83898646|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
83898647|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83898648|NCT00250796|Thalidomide|thalidomide|mesh-list
83898649|NCT00250796|Octreotide|octreotide|mesh-list
83898650|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898651|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
83898652|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898653|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898654|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
83898655|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898656|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
83898657|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83898658|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83898659|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83898660|NCT00250796|Growth Substances|growth substances|mesh-ancestor
83898661|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
83898662|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898663|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83898664|NCT00286416|Omalizumab|omalizumab|mesh-list
83898665|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83898666|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83898667|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
83898668|NCT00250874|Docetaxel|docetaxel|mesh-list
83898669|NCT00250874|Doxorubicin|doxorubicin|mesh-list
83898670|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83898671|NCT00250874|Trastuzumab|trastuzumab|mesh-list
83898672|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898673|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898674|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898675|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898676|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898677|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83898678|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83898679|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898680|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898681|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83898682|NCT00279825|Levodopa|levodopa|mesh-list
83898683|NCT00279825|Carbidopa|carbidopa|mesh-list
83898684|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83898685|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83898686|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83898687|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
83898688|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898689|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898690|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898691|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83898692|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898693|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83898694|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
83898695|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
83898696|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83898697|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83898698|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83898699|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898700|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898701|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83898702|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898703|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898704|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
83898705|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898706|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83898707|NCT00250991|Eptifibatide|eptifibatide|mesh-list
83898708|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83898709|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83898710|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898711|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83898712|NCT00286611|Amifostine|amifostine|mesh-list
83898713|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83898714|NCT00286611|Protective Agents|protective agents|mesh-ancestor
83898715|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898716|NCT00416832|Prednisone|prednisone|mesh-list
83898717|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
83898718|NCT00416832|Dacarbazine|dacarbazine|mesh-list
83898719|NCT00416832|Doxorubicin|doxorubicin|mesh-list
83898720|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83898721|NCT00416832|Etoposide|etoposide|mesh-list
83898722|NCT00416832|Vincristine|vincristine|mesh-list
83898723|NCT00416832|Procarbazine|procarbazine|mesh-list
83898724|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898725|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
83898726|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898727|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83898728|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83898729|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
83898730|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898731|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898732|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83898733|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83898734|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83898735|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898736|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898737|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898738|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
83898739|NCT00416832|Hormones|hormones|mesh-ancestor
83898740|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83898741|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83898742|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83898743|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898744|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898745|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898746|NCT00251030|Nelfinavir|nelfinavir|mesh-list
83898747|NCT00251030|Omeprazole|omeprazole|mesh-list
83898748|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83898749|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898750|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83898751|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898752|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898753|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83898754|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83898755|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
83898756|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83898757|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83898758|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
83898759|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898760|NCT00286689|Hormones|hormones|mesh-list
83898761|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83898762|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898763|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83898764|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898765|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898766|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898767|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83898768|NCT01640002|Bromides|bromides|mesh-list
83898769|NCT01640002|Propantheline|propantheline|mesh-list
83898770|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
83898771|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83898772|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898773|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83898774|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83898775|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
83898776|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898777|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898778|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898779|NCT00279903|Cortisone|cortisone|mesh-list
83898780|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
83898781|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83898782|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84048323|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
83898783|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83898784|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83898785|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898786|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
83898787|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898788|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898789|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83898790|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898791|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83898792|NCT01640275|Propofol|propofol|mesh-list
83898793|NCT01640275|Isoflurane|isoflurane|mesh-list
83898794|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83898795|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83898796|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898797|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83898798|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
83898799|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
83898800|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83898801|NCT04529356|Acetaminophen|acetaminophen|mesh-list
83898802|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83898803|NCT04529356|Analgesics|analgesics|mesh-ancestor
83898804|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
83898805|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898806|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898807|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
83898808|NCT01640665|Capecitabine|capecitabine|mesh-list
83898809|NCT01640665|Sorafenib|sorafenib|mesh-list
83898810|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898811|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
83898812|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898813|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898814|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83898815|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898816|NCT01640782|Leucovorin|leucovorin|mesh-list
83898817|NCT01640782|Docetaxel|docetaxel|mesh-list
83898818|NCT01640782|Fluorouracil|fluorouracil|mesh-list
83898819|NCT01640782|Irinotecan|irinotecan|mesh-list
83898820|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
83898821|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898822|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898823|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898824|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898825|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898826|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
83898827|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898828|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898829|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
83898830|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898831|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83898832|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898833|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898834|NCT01640782|Antidotes|antidotes|mesh-ancestor
83898835|NCT01640782|Protective Agents|protective agents|mesh-ancestor
83898836|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
83898837|NCT01640782|Vitamins|vitamins|mesh-ancestor
83898838|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
83898839|NCT00251186|Capecitabine|capecitabine|mesh-list
83137954|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
83898840|NCT00251186|Cetuximab|cetuximab|mesh-list
83898841|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898842|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
83898843|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898844|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898845|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83898846|NCT01641250|Cytarabine|cytarabine|mesh-list
83898847|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898848|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
83898849|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898850|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898851|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
83898852|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898853|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898854|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
83898855|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898856|NCT01641289|Acetaminophen|acetaminophen|mesh-list
83898857|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83898858|NCT01641289|Analgesics|analgesics|mesh-ancestor
83898859|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
83898860|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898861|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898862|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
83898863|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
83898864|NCT01641406|Bevacizumab|bevacizumab|mesh-list
83898865|NCT01641406|Docetaxel|docetaxel|mesh-list
83898866|NCT01641406|Capecitabine|capecitabine|mesh-list
83898867|NCT01641406|Trastuzumab|trastuzumab|mesh-list
83898868|NCT01641406|Epirubicin|epirubicin|mesh-list
83898869|NCT01641406|Vinorelbine|vinorelbine|mesh-list
83898870|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898871|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
83898872|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898873|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83898874|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83898875|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
83898876|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898877|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898878|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83898879|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83898880|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83898881|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83898882|NCT01641406|Growth Substances|growth substances|mesh-ancestor
83898883|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
83898884|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898885|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898886|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898887|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898888|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
83898889|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83898890|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83898891|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83898892|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898893|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83898894|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83898895|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
83898896|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83898897|NCT01641523|Protective Agents|protective agents|mesh-ancestor
83898898|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898899|NCT01641796|Paromomycin|paromomycin|mesh-list
83898900|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83898901|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898902|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83898903|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83898904|NCT00280098|Docetaxel|docetaxel|mesh-list
83898905|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898906|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
83898907|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
83898908|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
83898909|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898910|NCT00251381|Cetuximab|cetuximab|mesh-list
83898911|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83898912|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898913|NCT01685827|Eflornithine|eflornithine|mesh-list
83898914|NCT01685827|Nifurtimox|nifurtimox|mesh-list
83898915|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898916|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83898917|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83898918|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83898919|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898920|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83898921|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898922|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898923|NCT05140096|Fluconazole|fluconazole|mesh-list
83898924|NCT05140096|Isavuconazole|isavuconazole|mesh-list
83898925|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
83898926|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
83898927|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83898928|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83898929|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83898930|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83898931|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898932|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83898933|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
83898934|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83898935|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898936|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83898937|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83898938|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898939|NCT00251459|Ranibizumab|ranibizumab|mesh-list
83898940|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83898941|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83898942|NCT00251459|Growth Substances|growth substances|mesh-ancestor
83898943|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898944|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
83898945|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898946|NCT04823065|Scopolamine|scopolamine|mesh-list
83898947|NCT04823065|Loperamide|loperamide|mesh-list
83898948|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
83898949|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83898950|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83898951|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83898952|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
83898953|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
83898954|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898955|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898956|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
83898957|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83898958|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
83898959|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83898960|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898961|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83898962|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
83898963|NCT00280176|Fluorouracil|fluorouracil|mesh-list
83898964|NCT00280176|Bortezomib|bortezomib|mesh-list
83898965|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
83898966|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898967|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83898968|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898969|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83898970|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
83898971|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898972|NCT00280215|Losartan|losartan|mesh-list
83898973|NCT00280215|Lisinopril|lisinopril|mesh-list
83898974|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83898975|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83898976|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83898977|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83898978|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83898979|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83898980|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83898981|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
83898982|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83898983|NCT00280215|Protective Agents|protective agents|mesh-ancestor
83898984|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898985|NCT00251498|Cetuximab|cetuximab|mesh-list
83898986|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83898987|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83898988|NCT02271334|Albuterol|albuterol|mesh-list
83898989|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83898990|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
83898991|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83898992|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83898993|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83898994|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
83898996|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83898997|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83898998|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83898999|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83899000|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899001|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899002|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899003|NCT02276755|Vitamin D|vitamin d|mesh-list
83899004|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
83899005|NCT02276755|Vitamins|vitamins|mesh-ancestor
83899006|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
83899007|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899008|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83899009|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83899010|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
83899011|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83899012|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
83899013|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899014|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899015|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83899016|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
83899017|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83899018|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83899019|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83899020|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899021|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899022|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899023|NCT04455139|Melphalan|melphalan|mesh-list
83899024|NCT04455139|Topotecan|topotecan|mesh-list
83899025|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83899026|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
83899027|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899028|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899029|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83899030|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899031|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
83899032|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899033|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83899034|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83899035|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899036|NCT00251654|Anesthetics|anesthetics|mesh-list
83899037|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899038|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899039|NCT00286923|Topiramate|topiramate|mesh-list
83899040|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
83899041|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83899042|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899043|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
83899044|NCT00251732|Nortriptyline|nortriptyline|mesh-list
83899045|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
83899046|NCT00251732|Rabeprazole|rabeprazole|mesh-list
83899047|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83899048|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899049|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83899050|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899051|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899052|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899053|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83899054|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83899055|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83899056|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899057|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899058|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899059|NCT00286962|Insulin|insulin|mesh-list
83899060|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83899061|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83899062|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899063|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
83899064|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83899065|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899066|NCT00251849|KRM 1648|krm 1648|mesh-list
83899067|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83899068|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
83899069|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899070|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899071|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
83899072|NCT04822597|Lidocaine|lidocaine|mesh-list
83899073|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
83899074|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
83899075|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899076|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899077|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
83899078|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899079|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83899080|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83899081|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83899082|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83899083|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899084|NCT00251888|Irinotecan|irinotecan|mesh-list
83899085|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899086|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83899087|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83899088|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899089|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899090|NCT00251966|Esomeprazole|esomeprazole|mesh-list
83899091|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83899092|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899093|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83899094|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899095|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899096|NCT00252044|Pergolide|pergolide|mesh-list
83899097|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
83899098|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
83899099|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899100|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899101|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899102|NCT01805284|Linezolid|linezolid|mesh-list
83899103|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899104|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899105|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83899106|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899107|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899108|NCT00280605|Alfuzosin|alfuzosin|mesh-list
83899109|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83899110|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83899111|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83899112|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899113|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899114|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899115|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899116|NCT00280605|Urological Agents|urological agents|mesh-ancestor
83899117|NCT01134601|Capecitabine|capecitabine|mesh-list
83899118|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83899119|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
83899120|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899121|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899122|NCT00252122|Ketamine|ketamine|mesh-list
83899123|NCT00252122|Analgesics|analgesics|mesh-ancestor
83899124|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
83899125|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899126|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899127|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83899128|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83899129|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
83899130|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
83899131|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899132|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83899133|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83899134|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899135|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899136|NCT00287157|Tizanidine|tizanidine|mesh-list
83899137|NCT00287157|Analgesics|analgesics|mesh-ancestor
83899138|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
83899139|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138257|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
83899140|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899141|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
83899142|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83899143|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83899144|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
83899145|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
83899146|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83899147|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83899148|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83899149|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899150|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899151|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899152|NCT00280644|Leflunomide|leflunomide|mesh-list
83899153|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899154|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899155|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899156|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
83899157|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899158|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83899159|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
83899160|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899161|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83899162|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83899163|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83899164|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83899165|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899166|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899167|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899168|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899169|NCT00252317|Captopril|captopril|mesh-list
83899170|NCT00252317|Trandolapril|trandolapril|mesh-list
83899171|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83899172|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
83899173|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899174|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899175|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83899176|NCT00252356|Amibegron|amibegron|mesh-list
83899177|NCT00252356|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83899178|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83899179|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83899180|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899181|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899182|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899183|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899184|NCT00252356|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83899185|NCT02753998|Paclitaxel|paclitaxel|mesh-list
83899186|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83899187|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899188|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83899189|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83899190|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899191|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899192|NCT02754154|Warfarin|warfarin|mesh-list
83899193|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
83899194|NCT02754154|Dabigatran|dabigatran|mesh-list
83899195|NCT02754154|Apixaban|apixaban|mesh-list
83899196|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
83899197|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83899198|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
83899199|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83899200|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
83899201|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899202|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899203|NCT00252434|Methamphetamine|methamphetamine|mesh-list
83899204|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83899205|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899206|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
83899207|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
83899208|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899209|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
83899210|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899211|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899212|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899213|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83899214|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83899215|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83899216|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83899217|NCT00280839|Topiramate|topiramate|mesh-list
83899218|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
83899219|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83899220|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899221|NCT00280878|Rituximab|rituximab|mesh-list
83899222|NCT00280878|Gemcitabine|gemcitabine|mesh-list
83899223|NCT00280878|Vinorelbine|vinorelbine|mesh-list
83899224|NCT00280878|Ifosfamide|ifosfamide|mesh-list
83899225|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83899226|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899227|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
83899228|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899229|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83899230|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83899231|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
83899232|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899233|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83899234|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
83899235|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
83899236|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899237|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83899238|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
83899239|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83899240|NCT02758717|Nivolumab|nivolumab|mesh-list
83899241|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83899242|NCT02758717|Antibodies|antibodies|mesh-list
83899243|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
83899244|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83899245|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
83899246|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
83899247|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899248|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899249|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83899250|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899251|NCT02758717|Immunotoxins|immunotoxins|mesh-ancestor
83899252|NCT00287313|Vitamin K|vitamin k|mesh-list
83899253|NCT00287313|Vitamins|vitamins|mesh-ancestor
83899254|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
83899255|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899256|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83899257|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83899258|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899259|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
83899260|NCT00287313|Coagulants|coagulants|mesh-ancestor
83899261|NCT01680250|Sirolimus|sirolimus|mesh-list
83899262|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899263|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899264|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83899265|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899266|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
83899267|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899268|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
83899269|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899270|NCT00280956|Natalizumab|natalizumab|mesh-list
83899271|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
83899272|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899273|NCT02279875|Rifampin|rifampin|mesh-list
83899274|NCT02279875|Isoniazid|isoniazid|mesh-list
83899275|NCT02279875|Linezolid|linezolid|mesh-list
83899276|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
83899277|NCT02279875|Ethambutol|ethambutol|mesh-list
83899278|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83899279|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
83899280|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899281|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899282|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
83899283|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83899284|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899285|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899286|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83899287|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83899288|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83899289|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83899290|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83899291|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83899292|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83899293|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83899294|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
83899295|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83899296|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83899297|NCT00280995|Mipomersen|mipomersen|mesh-list
83899298|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83899299|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83899300|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
83899301|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899302|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83899303|NCT05139667|Tacrolimus|tacrolimus|mesh-list
83899304|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899305|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
83899306|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899307|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83899308|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899309|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899310|NCT00287352|Amantadine|amantadine|mesh-list
83899311|NCT00287352|Olanzapine|olanzapine|mesh-list
83899312|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
83899313|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
83899314|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899315|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899316|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899317|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83899318|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83899319|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899320|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899321|NCT00287352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83899322|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83899323|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83899324|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899325|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899326|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
83899327|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83899328|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83899329|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
83899330|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899331|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
83899332|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83899333|NCT00287352|Analgesics|analgesics|mesh-ancestor
83899334|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
83899335|NCT04823962|Molgramostim|molgramostim|mesh-list
83899336|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899337|NCT00252668|Etanercept|etanercept|mesh-list
83899338|NCT00252668|Methotrexate|methotrexate|mesh-list
83899339|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83899340|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
83899341|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83899342|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899343|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83899344|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
83899345|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899346|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899347|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
83899348|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899349|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83899350|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899351|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
83899352|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83899353|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83899354|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83899355|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83899356|NCT00252668|Analgesics|analgesics|mesh-ancestor
83899357|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
83899358|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899359|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83899360|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899361|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
83899362|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
83899363|NCT02271997|Trace Elements|trace elements|mesh-ancestor
83899364|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
83899365|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899366|NCT02271997|Hematinics|hematinics|mesh-ancestor
83899367|NCT00287391|Rabeprazole|rabeprazole|mesh-list
83899368|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83899369|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899370|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83899371|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899372|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899373|NCT00252707|Docetaxel|docetaxel|mesh-list
83899374|NCT00252707|Gefitinib|gefitinib|mesh-list
83899375|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899376|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83899377|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83899378|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899379|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899380|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83899381|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899382|NCT01680406|Chloroquine|chloroquine|mesh-list
83899383|NCT01680406|Lumefantrine|lumefantrine|mesh-list
83899384|NCT01680406|Artemether|artemether|mesh-list
83899385|NCT01680406|Primaquine|primaquine|mesh-list
83899386|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83899387|NCT01680406|Amebicides|amebicides|mesh-ancestor
83899388|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83899389|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83899390|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899391|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
83899392|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83899393|NCT00287430|Hormones|hormones|mesh-list
83899394|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899395|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899396|NCT01680679|Vaccines|vaccines|mesh-list
83899397|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
83899398|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899399|NCT01680718|Vasopressins|vasopressins|mesh-list
83899400|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
83899401|NCT01680718|Oxytocin|oxytocin|mesh-list
83899402|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
83899403|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83899404|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899405|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
83899406|NCT01680718|Coagulants|coagulants|mesh-ancestor
83899407|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83899408|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83899409|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
83899410|NCT01680796|Dexamethasone|dexamethasone|mesh-list
83899411|NCT01680796|Bortezomib|bortezomib|mesh-list
83899412|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83899413|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
83899414|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
83899415|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899416|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899417|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899418|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
83899419|NCT01680796|Hormones|hormones|mesh-ancestor
83899420|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899421|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83899422|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899423|NCT00252785|Budesonide|budesonide|mesh-list
83899424|NCT00252785|Theophylline|theophylline|mesh-list
83899425|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
83899426|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83899427|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83899428|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
83899429|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899430|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899431|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83899432|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
83899433|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
83899434|NCT00252785|Hormones|hormones|mesh-ancestor
83899435|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899436|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83899437|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83899438|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83899439|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899440|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899441|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899442|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83899443|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899444|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
83899445|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83899446|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83899447|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
83899448|NCT01680913|Anesthetics|anesthetics|mesh-list
83899449|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899450|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899451|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
83899452|NCT01680952|Sirolimus|sirolimus|mesh-list
83899453|NCT01680952|Tacrolimus|tacrolimus|mesh-list
83899454|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899455|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
83899456|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899457|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83899458|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899459|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899460|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83899461|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899462|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83899463|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
83899464|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899465|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899466|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
83899467|NCT00252824|Budesonide|budesonide|mesh-list
83899468|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
83899469|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83899470|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83899471|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
83899472|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899473|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899474|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83899475|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
83899476|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
83899477|NCT00252824|Hormones|hormones|mesh-ancestor
83899478|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899479|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83899480|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83899481|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83899482|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899483|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899484|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899485|NCT00281190|Dimercaprol|dimercaprol|mesh-list
83899486|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
83899487|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
83899488|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899489|NCT00252863|Fluticasone|fluticasone|mesh-list
83899491|NCT00252863|Budesonide|budesonide|mesh-list
83899492|NCT00252863|Theophylline|theophylline|mesh-list
83899493|NCT00252863|Albuterol|albuterol|mesh-list
83899494|NCT00252863|Terbutaline|terbutaline|mesh-list
83899495|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
83899496|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83899497|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83899498|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83899499|NCT00252863|Montelukast|montelukast|mesh-list
83899500|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83899501|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83899502|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
83899503|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899504|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899505|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83899506|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
83899507|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
83899508|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83899509|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
83899510|NCT00252863|Hormones|hormones|mesh-ancestor
83899511|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899512|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83899513|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83899514|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83899515|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899516|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899517|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899518|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
83899519|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83899520|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83899521|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
83899522|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83899523|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83899524|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83899525|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899526|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
83899527|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83899528|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83899529|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
83899530|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
83899532|NCT01681537|Etoposide|etoposide|mesh-list
83899533|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
83899534|NCT01681537|Lenalidomide|lenalidomide|mesh-list
83899535|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83899536|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899537|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83899538|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83899539|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899540|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899541|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83899542|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
83899543|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
83899544|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899545|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899546|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
83899547|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899548|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83899549|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83899550|NCT01681537|Growth Substances|growth substances|mesh-ancestor
83899551|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
83899552|NCT01681537|Analgesics|analgesics|mesh-ancestor
83899553|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
83899554|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899555|NCT01681693|Metformin|metformin|mesh-list
83899556|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83899557|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899558|NCT01681966|Ropivacaine|ropivacaine|mesh-list
83899559|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83899560|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
83899561|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
83899562|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899563|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899564|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
83899565|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899566|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83899567|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83899568|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83899569|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899570|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899571|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899572|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83899573|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83899574|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
83899575|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899576|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899577|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83899578|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83899579|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
83899580|NCT02279914|Misoprostol|misoprostol|mesh-list
83899581|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83899582|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
83899583|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83899584|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899585|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83899586|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899587|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
83899588|NCT00281307|Tocopherols|tocopherols|mesh-list
83899589|NCT00281307|Vitamin E|vitamin e|mesh-list
83899590|NCT00281307|Tocotrienols|tocotrienols|mesh-list
83899591|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
83899592|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
83899593|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138706|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
83899594|NCT00281307|Protective Agents|protective agents|mesh-ancestor
83899595|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899597|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
83899598|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83899599|NCT01682746|Trioxsalen|trioxsalen|mesh-list
83899600|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899601|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
83899602|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83899603|NCT00287664|Terlipressin|terlipressin|mesh-list
83899604|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83899605|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83899606|NCT01682902|Insulin|insulin|mesh-list
83899607|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83899608|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
83899609|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
83899610|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83899611|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83899612|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899613|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83899614|NCT01683175|Cisplatin|cisplatin|mesh-list
83899615|NCT01683175|Vinorelbine|vinorelbine|mesh-list
83899616|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899617|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83899618|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899619|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899620|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83899621|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83899622|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83899623|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899624|NCT01683253|Dopamine|dopamine|mesh-list
83899625|NCT01683253|Levodopa|levodopa|mesh-list
83899626|NCT01683253|Carbidopa|carbidopa|mesh-list
83899627|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
83899628|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83899629|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83899630|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
83899631|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899632|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899633|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899634|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83899635|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899636|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83899637|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
83899638|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
83899639|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899640|NCT01683253|Protective Agents|protective agents|mesh-ancestor
83899641|NCT01683292|Apomorphine|apomorphine|mesh-list
83899642|NCT01683292|Emetics|emetics|mesh-ancestor
83899643|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899644|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
83899645|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899646|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899647|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
83899648|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
83899649|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899650|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899651|NCT00253058|Cetirizine|cetirizine|mesh-list
83899652|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83899653|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83899654|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83899655|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
83899656|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
83899657|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899658|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899659|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899660|NCT01683682|Carboplatin|carboplatin|mesh-list
83899661|NCT01683682|Vinorelbine|vinorelbine|mesh-list
83899662|NCT01683682|Nintedanib|nintedanib|mesh-list
83899663|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899664|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83899665|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
83899666|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
83899667|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899668|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899669|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83899670|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899671|NCT00287742|Risperidone|risperidone|mesh-list
83899672|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83899673|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
83899674|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899675|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899676|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899677|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83899678|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83899679|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899680|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899681|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83899682|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
83899683|NCT04527562|Colchicine|colchicine|mesh-list
83899684|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
83899685|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83899686|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83899687|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83899688|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899689|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899690|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899691|NCT01684072|Vaccines|vaccines|mesh-list
83899692|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
83899693|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899694|NCT01684111|Vinorelbine|vinorelbine|mesh-list
83899695|NCT01684111|Nintedanib|nintedanib|mesh-list
83899696|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83899697|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899698|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
83899699|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
83899700|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899701|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899702|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83899703|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899704|NCT00253136|Risperidone|risperidone|mesh-list
83899705|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83899706|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
83899707|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899708|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899709|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899710|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83899711|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83899712|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899713|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899714|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83899715|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
83899716|NCT01684306|Modafinil|modafinil|mesh-list
83899717|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83899718|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899719|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83899720|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83899721|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83899722|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899723|NCT00287781|Lidocaine|lidocaine|mesh-list
83899724|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
83899725|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
83899726|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899727|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899728|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
83899729|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899730|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83899731|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83899732|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83899733|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83899734|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899735|NCT00416871|Interferons|interferons|mesh-list
83899736|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
83899737|NCT00416871|Aldesleukin|aldesleukin|mesh-list
83899738|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899739|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
83899740|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899741|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
83899742|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899743|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83899744|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83138851|NCT03562169|Dexamethasone|dexamethasone|mesh-list
83899745|NCT01684657|Asenapine|asenapine|mesh-list
83899746|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83899747|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83899748|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899749|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899750|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899751|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
83899752|NCT00416910|Fludarabine|fludarabine|mesh-list
83899753|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
83899754|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899755|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
83899756|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899757|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83899758|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83899759|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
83899760|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899761|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899762|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83899763|NCT00416910|Analgesics|analgesics|mesh-ancestor
83899764|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
83899765|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899766|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83899767|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83899768|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899769|NCT01684774|Bupivacaine|bupivacaine|mesh-list
83899770|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
83899771|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
83899772|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899773|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899774|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
83899775|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899776|NCT02279992|Carboplatin|carboplatin|mesh-list
83899777|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83899778|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899779|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
83899780|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83899781|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83899782|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899783|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899784|NCT02279992|Urological Agents|urological agents|mesh-ancestor
83899786|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
83899787|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83899788|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899789|NCT00287820|Olanzapine|olanzapine|mesh-list
83899790|NCT00287820|Risperidone|risperidone|mesh-list
83899791|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83899792|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
83899793|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899794|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899795|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899796|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83899797|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83899798|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899799|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899800|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83899801|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
83899802|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
83899803|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
83899804|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899805|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899806|NCT00287820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83899807|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83899808|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83899809|NCT02272348|Insulin|insulin|mesh-list
83899810|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83899811|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899812|NCT00253214|Galantamine|galantamine|mesh-list
83899813|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83899814|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899815|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899816|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
83899817|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899818|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899819|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83899820|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
83899821|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899823|NCT00287859|Topotecan|topotecan|mesh-list
83899824|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83899825|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83899826|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899827|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899828|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899829|NCT01684969|Haloperidol|haloperidol|mesh-list
83899830|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
83899831|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
83899832|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
83899833|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83899834|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899835|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899836|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83899837|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83899838|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83899839|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83899840|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83899841|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
83899842|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899843|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899844|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83899845|NCT01685125|Prednisone|prednisone|mesh-list
83899846|NCT01685125|Dasatinib|dasatinib|mesh-list
83899847|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
83899848|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83899849|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
83899850|NCT01685125|Hormones|hormones|mesh-ancestor
83899851|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899852|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899853|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83899854|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899855|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83899856|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899857|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899858|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83899859|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
83899860|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83899861|NCT04527679|Lenvatinib|lenvatinib|mesh-list
83899862|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899863|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83899864|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899865|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899866|NCT01685281|Metadoxine|metadoxine|mesh-list
83899867|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83899868|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83899869|NCT00417066|Ganirelix|ganirelix|mesh-list
83899870|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
83899871|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83899872|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
83899873|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83899874|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899875|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83899876|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83899877|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899878|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
83899879|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899880|NCT01685398|Timolol|timolol|mesh-list
83899881|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83899882|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83899883|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899884|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83899885|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83899886|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
83899887|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83899888|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899889|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83899890|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83899891|NCT01685515|Decitabine|decitabine|mesh-list
83899892|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
83899893|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83899894|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
83899895|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152086|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899896|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899897|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899899|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899900|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899901|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83899902|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
83899903|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
83899904|NCT00253487|Temozolomide|temozolomide|mesh-list
83899905|NCT00253487|Busulfan|busulfan|mesh-list
83899906|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83899907|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83899908|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
83899909|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899910|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899911|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899912|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
83899913|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899914|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83899915|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899916|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
83899917|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83899918|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899919|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83899920|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
83899921|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899922|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899923|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899924|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899925|NCT04527211|Ivermectin|ivermectin|mesh-list
83899926|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83899927|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899928|NCT00253526|Bevacizumab|bevacizumab|mesh-list
83899929|NCT00253526|Gemcitabine|gemcitabine|mesh-list
83899930|NCT00253526|Antibodies|antibodies|mesh-list
83899931|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
83899932|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83899933|NCT00253526|Mitogens|mitogens|mesh-list
83899934|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83899935|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899936|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83899937|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83899938|NCT00253526|Growth Substances|growth substances|mesh-ancestor
83899939|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899940|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
83899941|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
83899942|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83899943|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
83899944|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899945|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
83899946|NCT01686217|Niacinamide|niacinamide|mesh-list
83899947|NCT01686217|Peficitinib|peficitinib|mesh-list
83899948|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899949|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899950|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83899951|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
83899952|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899953|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
83899954|NCT01686217|Vitamins|vitamins|mesh-ancestor
83899955|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
83899956|NCT00253565|Capecitabine|capecitabine|mesh-list
83899957|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
83899958|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83899959|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
83899960|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899961|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899962|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83899963|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899964|NCT01686529|Bevacizumab|bevacizumab|mesh-list
83899965|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83899966|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83899967|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83899968|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83899969|NCT01686529|Growth Substances|growth substances|mesh-ancestor
83899970|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899971|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
83899972|NCT01686607|Itraconazole|itraconazole|mesh-list
83899973|NCT01686607|Fluconazole|fluconazole|mesh-list
83899974|NCT01686607|Voriconazole|voriconazole|mesh-list
83899975|NCT01686607|Amphotericin B|amphotericin b|mesh-list
83899976|NCT01686607|Caspofungin|caspofungin|mesh-list
83899977|NCT01686607|Micafungin|micafungin|mesh-list
83899978|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
83899979|NCT01686607|Clotrimazole|clotrimazole|mesh-list
83899980|NCT01686607|Miconazole|miconazole|mesh-list
83899981|NCT01686607|Anidulafungin|anidulafungin|mesh-list
83899982|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83899983|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83899984|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83899985|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83899986|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83899987|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83899988|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
83899989|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83899990|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83899991|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83899992|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83899993|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83899994|NCT01686607|Amebicides|amebicides|mesh-ancestor
83899995|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83899996|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83899997|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83899998|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83899999|NCT01686802|Ibuprofen|ibuprofen|mesh-list
83900000|NCT01686802|Morphine|morphine|mesh-list
83900001|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83900002|NCT01686802|Narcotics|narcotics|mesh-ancestor
83900003|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900004|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900005|NCT01686802|Analgesics|analgesics|mesh-ancestor
83900006|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
83900007|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900008|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83900009|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83900010|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83900011|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900012|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83900013|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900014|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900015|NCT00253721|Melphalan|melphalan|mesh-list
83900016|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83900017|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
83900018|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900019|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900020|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83900021|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900022|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
83900023|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900024|NCT00281892|Vidarabine|vidarabine|mesh-list
83900025|NCT00281892|Fludarabine|fludarabine|mesh-list
83900026|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
83900027|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900028|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83900029|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
83900030|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900031|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900032|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
83900033|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900034|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
83900035|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900036|NCT02276443|Immunomodulating Agents|immunomodulating agents|mesh-list
83900037|NCT02276443|Immunologic Factors|immunologic factors|mesh-ancestor
83900038|NCT02276443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900039|NCT02274571|Estrogens|estrogens|mesh-list
83900040|NCT02274571|Hormones|hormones|mesh-ancestor
83900041|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900042|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900043|NCT00253799|Hylan|hylan|mesh-list
83900044|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
83900045|NCT00253799|Protective Agents|protective agents|mesh-ancestor
83900046|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900048|NCT00281931|Rituximab|rituximab|mesh-list
83900049|NCT00281931|Fludarabine|fludarabine|mesh-list
83900050|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
83900051|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900052|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
83900053|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900054|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900055|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83900056|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
83900057|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900058|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900059|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83900060|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83900061|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83900062|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
83900063|NCT01687348|Lidocaine|lidocaine|mesh-list
83900064|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
83900065|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
83900066|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900067|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900068|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
83900069|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900070|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83900071|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83900072|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83900073|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900074|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900075|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83900076|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83900077|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83900078|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83900079|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83900080|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
83900081|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900082|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900083|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900084|NCT01687582|Liraglutide|liraglutide|mesh-list
83900085|NCT01687582|Exenatide|exenatide|mesh-list
83900086|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83900087|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900088|NCT01687582|Incretins|incretins|mesh-ancestor
83900089|NCT01687582|Hormones|hormones|mesh-ancestor
83900090|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900091|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83900092|NCT01687699|Spironolactone|spironolactone|mesh-list
83900093|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83900094|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
83900095|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900096|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900097|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83900098|NCT01687699|Diuretics|diuretics|mesh-ancestor
83900099|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
83900100|NCT00287937|Paclitaxel|paclitaxel|mesh-list
83900101|NCT00287937|Carboplatin|carboplatin|mesh-list
83900102|NCT00287937|Vorinostat|vorinostat|mesh-list
83900103|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83900104|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900105|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900106|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900107|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900108|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900109|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83900110|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900111|NCT01687894|Vasopressins|vasopressins|mesh-list
83900112|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
83900113|NCT01687894|Propofol|propofol|mesh-list
83900114|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83900115|NCT01687894|Anesthetics|anesthetics|mesh-list
83900116|NCT01687894|Sevoflurane|sevoflurane|mesh-list
83900117|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
83900118|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83900119|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900120|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900121|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83900122|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83900123|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
83900124|NCT01687894|Coagulants|coagulants|mesh-ancestor
83900125|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83900126|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83900127|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
83900128|NCT00287976|Irinotecan|irinotecan|mesh-list
83900129|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83900130|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83900131|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900132|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900133|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900134|NCT01688089|Levodopa|levodopa|mesh-list
83900135|NCT01688089|Carbidopa|carbidopa|mesh-list
83900136|NCT01688089|Entacapone|entacapone|mesh-list
83900137|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83900138|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83900139|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
83900140|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900141|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900142|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900143|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83900144|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900145|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83900146|NCT01688206|Atezolizumab|atezolizumab|mesh-list
83900147|NCT01688206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83900148|NCT01688206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900149|NCT01688206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83900150|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900151|NCT00288171|Allopurinol|allopurinol|mesh-list
83900152|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
83900153|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900154|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900155|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
83900156|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900157|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83900158|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
83900159|NCT00288171|Protective Agents|protective agents|mesh-ancestor
83900160|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900161|NCT00253955|Levofloxacin|levofloxacin|mesh-list
83900162|NCT00253955|Tazobactam|tazobactam|mesh-list
83900163|NCT00253955|Piperacillin|piperacillin|mesh-list
83900164|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83900165|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83900166|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900167|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83900168|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83900169|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83900170|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900171|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900172|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900173|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83900174|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83900175|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83900176|NCT00288249|Sagopilone|sagopilone|mesh-list
83900177|NCT00288249|Epothilones|epothilones|mesh-list
83900178|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900179|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900180|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900181|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900182|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900183|NCT00254033|Methylphenidate|methylphenidate|mesh-list
83900184|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
83900185|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83900186|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900187|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83900188|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83900189|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900190|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900191|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
83900192|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900193|NCT01600573|Topotecan|topotecan|mesh-list
83900194|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83900195|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83900196|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900197|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900198|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900199|NCT01600612|Oxytocin|oxytocin|mesh-list
83900200|NCT01600612|Carbetocin|carbetocin|mesh-list
83900201|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
83900202|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83900203|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900204|NCT01600768|Lactams|lactams|mesh-list
83900205|NCT01600768|beta-Lactams|beta-lactams|mesh-list
83900206|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83900207|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900208|NCT00414947|Vildagliptin|vildagliptin|mesh-list
83900209|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83900210|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900211|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83900212|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
83900213|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900214|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900215|NCT00288444|Docetaxel|docetaxel|mesh-list
83900216|NCT00288444|Lonafarnib|lonafarnib|mesh-list
83900217|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900218|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900219|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900220|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900221|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900222|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900223|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83900224|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
83900225|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900226|NCT00415064|Dexamethasone|dexamethasone|mesh-list
83900227|NCT00415064|Lenalidomide|lenalidomide|mesh-list
83900228|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83900229|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
83900230|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
83900231|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900232|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900233|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83900234|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
83900235|NCT00415064|Hormones|hormones|mesh-ancestor
83900236|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900237|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83900238|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900239|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
83900240|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83900241|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83900242|NCT00415064|Growth Substances|growth substances|mesh-ancestor
83900243|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
83900244|NCT00415103|Aprepitant|aprepitant|mesh-list
83900245|NCT00415103|Palonosetron|palonosetron|mesh-list
83900246|NCT00415103|Granisetron|granisetron|mesh-list
83900247|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
83900248|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
83900249|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900250|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900251|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83900252|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83900253|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900254|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900255|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83900256|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83900257|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
83900258|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83900259|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
83900260|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83900261|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900262|NCT00417729|Acarbose|acarbose|mesh-list
83900263|NCT00417729|Glyburide|glyburide|mesh-list
83900264|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83900265|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900266|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900267|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83900268|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900269|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
83900270|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83900271|NCT00254189|Estradiol|estradiol|mesh-list
83900272|NCT00254189|Estrogens|estrogens|mesh-ancestor
83900273|NCT00254189|Hormones|hormones|mesh-ancestor
83900274|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900275|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900276|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83900277|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
83900278|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83900279|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83900280|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83900281|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83900282|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83900283|NCT01600807|Gemcitabine|gemcitabine|mesh-list
83900284|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83900285|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83900286|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
83900287|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900288|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900289|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900290|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900291|NCT00288483|Policosanol|policosanol|mesh-list
83900292|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83900293|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83900294|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
83900295|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900296|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83900297|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83900298|NCT01600963|Bedaquiline|bedaquiline|mesh-list
83900299|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
83900300|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
83900301|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83900302|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900303|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83900304|NCT00288522|Lanreotide|lanreotide|mesh-list
83900305|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900306|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
83900307|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900308|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900309|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900310|NCT01601002|Mirtazapine|mirtazapine|mesh-list
83900311|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
83900312|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900313|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83900314|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
83900315|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
83900316|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900317|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900318|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900319|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83900320|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900321|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900322|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83900323|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83900324|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83900325|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
83900326|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83900327|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83900328|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
83900329|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83900330|NCT00288561|Ranibizumab|ranibizumab|mesh-list
83900331|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83900332|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83900333|NCT00288561|Growth Substances|growth substances|mesh-ancestor
83900334|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900335|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
83900336|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900337|NCT01607086|Lamotrigine|lamotrigine|mesh-list
83900338|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
83900339|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83900340|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900341|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900342|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83900343|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139446|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
83900344|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83900345|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900346|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900347|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900348|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83900349|NCT01607125|Vortioxetine|vortioxetine|mesh-list
83900350|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
83900351|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900352|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83900353|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900354|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900355|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900356|NCT01607125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83900357|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83900358|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900359|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900360|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900361|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
83900362|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83900363|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83900364|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83900365|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83900366|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83900367|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
83900368|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83900369|NCT00254345|Protective Agents|protective agents|mesh-ancestor
83900370|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900371|NCT00254618|Mesalamine|mesalamine|mesh-list
83900372|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83900373|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83900374|NCT00254618|Analgesics|analgesics|mesh-ancestor
83900375|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
83900376|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900377|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900378|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83900379|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900380|NCT00288717|Telmisartan|telmisartan|mesh-list
83900381|NCT00288717|Candesartan|candesartan|mesh-list
83900382|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83900383|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83900384|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83900385|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900386|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
83900387|NCT01601314|Analgesics|analgesics|mesh-ancestor
83900388|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
83900389|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900390|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900391|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
83900392|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900393|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83900394|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
83900395|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83900396|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900397|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900398|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83900399|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
83900400|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83900401|NCT00254657|Levetiracetam|levetiracetam|mesh-list
83900402|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
83900403|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
83900404|NCT02482753|Exemestane|exemestane|mesh-list
83900405|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900406|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83900407|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83900408|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900409|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900410|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83900411|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
83900412|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900413|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900414|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83900415|NCT00254735|Clomipramine|clomipramine|mesh-list
83900416|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
83900417|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900418|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83900419|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900420|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900421|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900422|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83900423|NCT00254735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83900424|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83900425|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900426|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900427|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900428|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
83900429|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
83900430|NCT00288873|Vitamin D|vitamin d|mesh-list
83900431|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
83900432|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83900433|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900434|NCT00288873|Vitamins|vitamins|mesh-ancestor
83900435|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
83900436|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83900437|NCT01608139|Curcumin|curcumin|mesh-list
83900438|NCT01608139|Sorafenib|sorafenib|mesh-list
83900439|NCT01608139|Vorinostat|vorinostat|mesh-list
83900440|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900441|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900442|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900443|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900444|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83900445|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83900446|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83900447|NCT01608139|Analgesics|analgesics|mesh-ancestor
83900448|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
83900449|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900450|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900451|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83900452|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900453|NCT01607671|Timolol|timolol|mesh-list
83900454|NCT01607671|Maleic acid|maleic acid|mesh-list
83900455|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900456|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900457|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83900458|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83900459|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
83900460|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900461|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900462|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83900463|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83900464|NCT00288951|Travoprost|travoprost|mesh-list
83900465|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83900466|NCT00254774|Valproic Acid|valproic acid|mesh-list
83900467|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83900468|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
83900469|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900470|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83900471|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900472|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900473|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900474|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
83900475|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900476|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900477|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
83900478|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900479|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
83900480|NCT01608334|Fentanyl|fentanyl|mesh-list
83900481|NCT01608334|Sufentanil|sufentanil|mesh-list
83900482|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83900483|NCT01608334|Narcotics|narcotics|mesh-ancestor
83900484|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900485|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900486|NCT01608334|Analgesics|analgesics|mesh-ancestor
83900487|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
83900488|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900489|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83900490|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83900491|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
83900492|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
83900493|NCT01608373|Lidocaine|lidocaine|mesh-list
83900494|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
83900495|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
83900496|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900497|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900498|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
83900499|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900500|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83900501|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83900502|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83900503|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900504|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900505|NCT01608412|Everolimus|everolimus|mesh-list
83900506|NCT01608412|Tacrolimus|tacrolimus|mesh-list
83900507|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900508|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
83900509|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900510|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83900511|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900512|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900513|NCT01608412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83900514|NCT01608412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900515|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900516|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83900517|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
83900518|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900519|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83900520|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900521|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900522|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900523|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
83900524|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900525|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83900526|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900527|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900528|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900529|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900530|NCT00254930|Risperidone|risperidone|mesh-list
83900531|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83900532|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
83900533|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900534|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900535|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900536|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83900537|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900538|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900539|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900540|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83900541|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
83900542|NCT02273440|Theophylline|theophylline|mesh-list
83900543|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83900544|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
83900545|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900546|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900547|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83900548|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
83900549|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83900550|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900551|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900552|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
83900553|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83900554|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83900555|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
83900556|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900557|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
83900558|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83900559|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83900560|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83900561|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
83152103|NCT02578316|Lenvatinib|lenvatinib|mesh-list
83900562|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900563|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900564|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900565|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
83900566|NCT00270075|Hematinics|hematinics|mesh-ancestor
83900567|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
83900568|NCT01588756|Goralatide|goralatide|mesh-list
83900569|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
83900570|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900571|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83900572|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900573|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
83900574|NCT01588756|Growth Substances|growth substances|mesh-ancestor
83900575|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900576|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83900577|NCT01588756|Protective Agents|protective agents|mesh-ancestor
83900578|NCT04719104|Bilirubin|bilirubin|mesh-list
83900579|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
83900580|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900581|NCT04719104|Protective Agents|protective agents|mesh-ancestor
83900582|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900583|NCT01588795|Vitamin D|vitamin d|mesh-list
83900584|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
83900585|NCT01588795|Diuretics|diuretics|mesh-list
83900586|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83900587|NCT01588795|Vitamins|vitamins|mesh-ancestor
83900588|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
83900589|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900590|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83900591|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83900592|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
83900593|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900594|NCT00107614|Rituximab|rituximab|mesh-list
83900595|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83900596|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900597|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
83900598|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900599|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900600|NCT00255242|Simvastatin|simvastatin|mesh-list
83900601|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83900602|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83900603|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
83900604|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900605|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83900606|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83900607|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900608|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
83900609|NCT00270114|Hematinics|hematinics|mesh-ancestor
83900610|NCT00107380|Prednisone|prednisone|mesh-list
83900611|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
83900612|NCT00107380|Rituximab|rituximab|mesh-list
83900613|NCT00107380|Doxorubicin|doxorubicin|mesh-list
83900614|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83900615|NCT00107380|Vincristine|vincristine|mesh-list
83900616|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
83900617|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900618|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
83900619|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900620|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900621|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83900622|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
83900623|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900624|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900625|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83900626|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83900627|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83900628|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83900629|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83900630|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900631|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83900632|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
83900633|NCT00107380|Hormones|hormones|mesh-ancestor
83900634|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900635|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83900636|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83900637|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900638|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900639|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900640|NCT00270153|Enalapril|enalapril|mesh-list
83900641|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83900642|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
83900643|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900644|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900645|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83900646|NCT04050085|Nivolumab|nivolumab|mesh-list
83900647|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83900648|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900649|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83900650|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900651|NCT04054531|Paclitaxel|paclitaxel|mesh-list
83900652|NCT04054531|Carboplatin|carboplatin|mesh-list
83900653|NCT04054531|Pemetrexed|pemetrexed|mesh-list
83900654|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83900655|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900656|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900657|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900658|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900659|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900660|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900661|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83900662|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83900663|NCT00289263|Paclitaxel|paclitaxel|mesh-list
83900664|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83900665|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900666|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900667|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900668|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900669|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900670|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83900671|NCT00255437|Hematinics|hematinics|mesh-ancestor
83900672|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83900673|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83900674|NCT00255476|Gefitinib|gefitinib|mesh-list
83900675|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900676|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900677|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900678|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900679|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
83900680|NCT00270270|Hematinics|hematinics|mesh-ancestor
83900681|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83900682|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83900683|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900684|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83900685|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
83900686|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900687|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83900688|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900689|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900690|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900691|NCT00289419|Ketorolac|ketorolac|mesh-list
83900692|NCT00289419|Epinephrine|epinephrine|mesh-list
83900693|NCT00289419|Racepinephrine|racepinephrine|mesh-list
83900694|NCT00289419|Morphine|morphine|mesh-list
83900695|NCT00289419|Ropivacaine|ropivacaine|mesh-list
83900696|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
83900697|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83900698|NCT00289419|Narcotics|narcotics|mesh-ancestor
83900699|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900700|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900701|NCT00289419|Analgesics|analgesics|mesh-ancestor
83900702|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
83900703|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900704|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
83900705|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
83900706|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83900707|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83900708|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83900709|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900710|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83900711|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900712|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900713|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83900714|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83900715|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
83900716|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900717|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83900718|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83900719|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
83900720|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83900721|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
83900722|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
83900723|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
83900724|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83900725|NCT00255554|Escitalopram|escitalopram|mesh-list
83900726|NCT00255554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83900727|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83900728|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900729|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900730|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900731|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
83900732|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900733|NCT00270348|Ciclesonide|ciclesonide|mesh-list
83900734|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
83900735|NCT00270348|Hormones|hormones|mesh-ancestor
83900736|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900737|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900738|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83900739|NCT00255593|Rituximab|rituximab|mesh-list
83900740|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83900741|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900742|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
83900743|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900744|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900745|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83900746|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
83900747|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900748|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
83900749|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
83900750|NCT00255710|Fludarabine|fludarabine|mesh-list
83900751|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
83900752|NCT00255710|Tacrolimus|tacrolimus|mesh-list
83900753|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900754|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
83900755|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900756|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83900757|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83900758|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
83900759|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900760|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900761|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83900762|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83900763|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
83900764|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83900765|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900766|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83900767|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83900768|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
83900769|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83900770|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900771|NCT00270426|Benazepril|benazepril|mesh-list
83900772|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83900773|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
83900774|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900775|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900776|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83900777|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
83900778|NCT00255749|Hematinics|hematinics|mesh-ancestor
83900779|NCT00255788|Everolimus|everolimus|mesh-list
83900780|NCT00255788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83900781|NCT00255788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900782|NCT00255788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900783|NCT00255788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900784|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900785|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
83900786|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900787|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900788|NCT04482361|Antibodies|antibodies|mesh-list
83900789|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
83900790|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900791|NCT00270543|Leucovorin|leucovorin|mesh-list
83900792|NCT00270543|Fluorouracil|fluorouracil|mesh-list
83900793|NCT00270543|Docetaxel|docetaxel|mesh-list
83900794|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
83900795|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900796|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83900797|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900798|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900799|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
83900800|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900801|NCT00270543|Antidotes|antidotes|mesh-ancestor
83900802|NCT00270543|Protective Agents|protective agents|mesh-ancestor
83900803|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
83900805|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
83900806|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900807|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900808|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900809|NCT02960919|Amoxicillin|amoxicillin|mesh-list
83900810|NCT02960919|Gentamicins|gentamicins|mesh-list
83900811|NCT02960919|Penicillins|penicillins|mesh-list
83900812|NCT02960919|Ampicillin|ampicillin|mesh-list
83900813|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83900814|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900815|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83900816|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900817|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900818|NCT00270582|Gemcitabine|gemcitabine|mesh-list
83900819|NCT00270582|Docetaxel|docetaxel|mesh-list
83900820|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900821|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83900822|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
83900823|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900824|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83900825|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83900826|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83900827|NCT01600456|Sertraline|sertraline|mesh-list
83900828|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
83900829|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900830|NCT01600456|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83900831|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83900832|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83900833|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900834|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900835|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
83900836|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900837|NCT00289809|Ifosfamide|ifosfamide|mesh-list
83900838|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83900839|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
83900840|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900841|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900842|NCT00256100|PENTA|penta|mesh-list
83900843|NCT00256100|Fondaparinux|fondaparinux|mesh-list
83900844|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83900845|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
83900846|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83900847|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
83900848|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900849|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900850|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
83900851|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83900852|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83900853|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83900854|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83900855|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
83900856|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900857|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
83900858|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900859|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
83900860|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900861|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900862|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83900863|NCT01609387|Tocopherols|tocopherols|mesh-list
83900864|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
83900865|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900866|NCT01609387|Protective Agents|protective agents|mesh-ancestor
83900867|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900868|NCT01609387|Vitamins|vitamins|mesh-ancestor
83900869|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
83900870|NCT00256178|Simvastatin|simvastatin|mesh-list
83900871|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83900872|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83900873|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
83900874|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900875|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83900876|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83900877|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900879|NCT02488408|Decitabine|decitabine|mesh-list
83900880|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83900881|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
83900882|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900883|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900884|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
83900885|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900886|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83900887|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
83900888|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900889|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900890|NCT00270777|Promethazine|promethazine|mesh-list
83900891|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
83900892|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
83900893|NCT00270777|Epinephrine|epinephrine|mesh-list
83900894|NCT00270777|Racepinephrine|racepinephrine|mesh-list
83900895|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
83900896|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83900897|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83900898|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83900899|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
83900900|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900901|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900902|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900903|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83900904|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83900905|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
83900906|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900907|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83900908|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
83900909|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
83900910|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
83900911|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83900912|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
83900913|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
83900914|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83900915|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
83900916|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
83900917|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83900918|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83900919|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83900920|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900921|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
83900922|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
83900923|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
83900924|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
83900925|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83900926|NCT00256256|Glucagon|glucagon|mesh-list
83900927|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83900928|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83900929|NCT00256256|Hormones|hormones|mesh-ancestor
83900930|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83900931|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900932|NCT00256256|Incretins|incretins|mesh-ancestor
83900933|NCT00256334|Resveratrol|resveratrol|mesh-list
83900934|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
83900935|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900936|NCT00256334|Protective Agents|protective agents|mesh-ancestor
83900937|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900938|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900939|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83900940|NCT01609855|Scopolamine|scopolamine|mesh-list
83900941|NCT01609855|Bromides|bromides|mesh-list
83900942|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83900943|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
83900944|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83900945|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
83900946|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
83900947|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83900948|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900949|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83900950|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
83900951|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83900952|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
83900953|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900954|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900955|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83900956|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
83900957|NCT00270816|Interferons|interferons|mesh-list
83900958|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900959|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
83900960|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83900961|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
83900962|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900963|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83900964|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
83900966|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83900967|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83900968|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83900969|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900970|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
83900971|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83900972|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900973|NCT00290082|Midazolam|midazolam|mesh-list
83900974|NCT00290082|Loxapine|loxapine|mesh-list
83900975|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83900976|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83900977|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83900978|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900979|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83900980|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83900981|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83900982|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83900983|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
83900984|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
83900985|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
83900986|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
83900987|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83900988|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83900989|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83900990|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83900991|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
83900992|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
83900993|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83900994|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83900995|NCT02270437|Epinephrine|epinephrine|mesh-list
83900996|NCT02270437|Racepinephrine|racepinephrine|mesh-list
83900997|NCT02270437|Fentanyl|fentanyl|mesh-list
83900998|NCT02270437|Ropivacaine|ropivacaine|mesh-list
83900999|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
83901000|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
83901001|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
83901002|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901003|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901004|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
83901005|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901006|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83901007|NCT02270437|Narcotics|narcotics|mesh-ancestor
83901008|NCT02270437|Analgesics|analgesics|mesh-ancestor
83901009|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83901010|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83901011|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
83901012|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83901013|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83901014|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83901015|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901016|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901017|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83901018|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83901019|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
83901020|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83901021|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83901022|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
83901023|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
83901024|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83901025|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
83901026|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
83901027|NCT02270749|Vitamins|vitamins|mesh-ancestor
83901028|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
83901029|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901030|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
83901031|NCT02270749|Hematinics|hematinics|mesh-ancestor
83901032|NCT02270788|Leucovorin|leucovorin|mesh-list
83901033|NCT02270788|Cytarabine|cytarabine|mesh-list
83901034|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
83901035|NCT02270788|Methotrexate|methotrexate|mesh-list
83901036|NCT02270788|Sorafenib|sorafenib|mesh-list
83901037|NCT02270788|Crenolanib|crenolanib|mesh-list
83901038|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83901039|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
83901040|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83901041|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901042|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83901043|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
83901044|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901045|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901046|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
83901047|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901048|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83901049|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901050|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
83901051|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901052|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83901053|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
83901054|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901055|NCT02270788|Antidotes|antidotes|mesh-ancestor
83901056|NCT02270788|Protective Agents|protective agents|mesh-ancestor
83901057|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
83901058|NCT02270788|Vitamins|vitamins|mesh-ancestor
83901059|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
83901060|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83901061|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901062|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
83901063|NCT02270827|Aminophylline|aminophylline|mesh-list
83901064|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901065|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83901066|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
83901067|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901068|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901069|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83901070|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
83901071|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83901072|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83901073|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901074|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901075|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83901076|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83901077|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
83901078|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901079|NCT02270827|Protective Agents|protective agents|mesh-ancestor
83901080|NCT00290121|Olanzapine|olanzapine|mesh-list
83901081|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
83901082|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
83901083|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901084|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901085|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901086|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83901087|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901088|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901089|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901090|NCT00290121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83901091|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83901092|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83901093|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901094|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901095|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
83901096|NCT04709744|Vitamin D|vitamin d|mesh-list
83901097|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
83901098|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
83901099|NCT04709744|Vitamins|vitamins|mesh-list
83901100|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
83901101|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901102|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83140187|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83901103|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83901104|NCT02271295|Enoxaparin|enoxaparin|mesh-list
83901105|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
83901106|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83901107|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83901108|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901109|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83901110|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83901111|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83901112|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83901113|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901114|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901115|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901116|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
83901117|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901118|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83901119|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
83901120|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901121|NCT02271646|Bupivacaine|bupivacaine|mesh-list
83901122|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
83901123|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
83901124|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901125|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901126|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
83901127|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901128|NCT02271802|Butyric Acid|butyric acid|mesh-list
83901129|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
83901130|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
83901131|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901132|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901133|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901134|NCT02271958|Mifepristone|mifepristone|mesh-list
83901135|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83901136|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
83901137|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83901138|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901139|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83901140|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83901141|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83901142|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
83901143|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83901144|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83901145|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
83901146|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901147|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
83901148|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83901149|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83901150|NCT00257036|Levofloxacin|levofloxacin|mesh-list
83901151|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83901152|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901153|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901154|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83901155|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83901156|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901157|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901158|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901159|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83901160|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83901161|NCT00257075|Risperidone|risperidone|mesh-list
83901162|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83901163|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
83901164|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901165|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901166|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901167|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83901168|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901169|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901170|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901171|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83901172|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
83901173|NCT02272270|Minocycline|minocycline|mesh-list
83901174|NCT02272270|Temozolomide|temozolomide|mesh-list
83901175|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83901177|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901178|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901179|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901180|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901181|NCT02272387|Vitamin D|vitamin d|mesh-list
83901182|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
83901183|NCT02272387|Vitamins|vitamins|mesh-ancestor
83901184|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
83901185|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901186|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83901187|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83901188|NCT00257114|Bortezomib|bortezomib|mesh-list
83901189|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901190|NCT00271206|Progesterone|progesterone|mesh-list
83901191|NCT00271206|Progestins|progestins|mesh-ancestor
83901192|NCT00271206|Hormones|hormones|mesh-ancestor
83901193|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901194|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901195|NCT02272582|Heparin|heparin|mesh-list
83901196|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
83901197|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83901198|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83901199|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901200|NCT02272660|Parecoxib|parecoxib|mesh-list
83901201|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83901202|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83901203|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901204|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901205|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83901206|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83901207|NCT02272660|Analgesics|analgesics|mesh-ancestor
83901208|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
83901209|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901210|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901211|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901212|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901213|NCT02272699|Paclitaxel|paclitaxel|mesh-list
83901214|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
83901215|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83901216|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901217|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901218|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901219|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901220|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901221|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83901222|NCT02272738|Paclitaxel|paclitaxel|mesh-list
83901223|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83901224|NCT02272738|Gemcitabine|gemcitabine|mesh-list
83901225|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83901226|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901227|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901228|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901229|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901230|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901231|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83901232|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
83901233|NCT00271245|Selenium|selenium|mesh-list
83901234|NCT00271245|Selenic Acid|selenic acid|mesh-list
83901235|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
83901236|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901237|NCT00271245|Protective Agents|protective agents|mesh-ancestor
83901238|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901239|NCT00271245|Trace Elements|trace elements|mesh-ancestor
83901240|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
83901241|NCT02272855|Ipilimumab|ipilimumab|mesh-list
83901242|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83901243|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901244|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83901245|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901246|NCT00257270|Gabapentin|gabapentin|mesh-list
83901247|NCT00257270|Analgesics|analgesics|mesh-ancestor
83140345|NCT02076191|Decitabine|decitabine|mesh-list
83901248|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
83901249|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901250|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901252|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83901253|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901254|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901255|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901256|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83901257|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83901258|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901259|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901260|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
83901261|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
83901262|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83901263|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901264|NCT00257348|Docetaxel|docetaxel|mesh-list
83901265|NCT00257348|Capecitabine|capecitabine|mesh-list
83901266|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901267|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901268|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901269|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901270|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901271|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83901272|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
83901273|NCT02273128|Calcitonin|calcitonin|mesh-list
83901274|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83901275|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901276|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83901277|NCT00257387|Cyclosporine|cyclosporine|mesh-list
83901278|NCT00257387|Cyclosporins|cyclosporins|mesh-list
83901279|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901280|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901281|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901282|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
83901283|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901284|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
83901285|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901286|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
83901287|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901288|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83901289|NCT00257426|Octreotide|octreotide|mesh-list
83901290|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901291|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83901292|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901293|NCT01601509|Tramazoline|tramazoline|mesh-list
83901294|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
83901295|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
83901296|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901297|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901298|NCT00416325|Lycopene|lycopene|mesh-list
83901299|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901300|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
83901301|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901302|NCT00416325|Protective Agents|protective agents|mesh-ancestor
83901303|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901304|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83901305|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83901306|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901307|NCT00257465|Vaccines|vaccines|mesh-list
83901308|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
83901309|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901310|NCT01601899|Tenofovir|tenofovir|mesh-list
83901311|NCT01601899|Lamivudine|lamivudine|mesh-list
83901312|NCT01601899|Efavirenz|efavirenz|mesh-list
83901313|NCT01601899|Stavudine|stavudine|mesh-list
83901314|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
83901315|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901316|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83901317|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83901318|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901319|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901320|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83901321|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83901322|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83901323|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83901324|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83901325|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83901326|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83901327|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83901328|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
83901330|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
83901331|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901332|NCT01601938|Protective Agents|protective agents|mesh-ancestor
83901333|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901334|NCT01601938|Trace Elements|trace elements|mesh-ancestor
83901335|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
83901336|NCT01602055|Azithromycin|azithromycin|mesh-list
83901337|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901338|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901339|NCT01602250|Ropivacaine|ropivacaine|mesh-list
83901340|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
83901341|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83901342|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
83901343|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
83901344|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901345|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901346|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
83901347|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901348|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83901349|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83901350|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83901351|NCT00257582|Cetirizine|cetirizine|mesh-list
83901352|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83901353|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83901354|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83901355|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
83901356|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
83901357|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901358|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901359|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901360|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83901361|NCT01602289|Gefitinib|gefitinib|mesh-list
83901362|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901363|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83901364|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901365|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901366|NCT00257621|Ritonavir|ritonavir|mesh-list
83901367|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83901368|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83901369|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
83901370|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901371|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901372|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83901373|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83901374|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
83901375|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901376|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83901377|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83901378|NCT01602406|Trastuzumab|trastuzumab|mesh-list
83901379|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83901380|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901381|NCT00290628|Cyclosporine|cyclosporine|mesh-list
83901382|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
83901383|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
83901384|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
83901385|NCT00290628|Melphalan|melphalan|mesh-list
83901386|NCT00290628|Busulfan|busulfan|mesh-list
83901387|NCT00290628|Cyclosporins|cyclosporins|mesh-list
83901388|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83901389|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901390|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
83901391|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901392|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901393|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83901394|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
84048324|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83901395|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901396|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901397|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83140489|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
83901398|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901399|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
83901400|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901401|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
83901402|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83901403|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83901404|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83901405|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
83901406|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901407|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901409|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
83901410|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901411|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901412|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
83901413|NCT00290628|Hormones|hormones|mesh-ancestor
83901414|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901415|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83901416|NCT00290628|Protective Agents|protective agents|mesh-ancestor
83901417|NCT01602523|Budesonide|budesonide|mesh-list
83901418|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
83901419|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901420|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83901421|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
83901422|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901423|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901424|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83901425|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
83901426|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
83901427|NCT01602523|Hormones|hormones|mesh-ancestor
83901428|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901429|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83901430|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83901431|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83901432|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83901433|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901434|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901435|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
83901436|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901437|NCT01602640|Fentanyl|fentanyl|mesh-list
83901438|NCT01602640|Midazolam|midazolam|mesh-list
83901439|NCT01602640|Morphine|morphine|mesh-list
83901440|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83901441|NCT01602640|Narcotics|narcotics|mesh-ancestor
83901442|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901443|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901444|NCT01602640|Analgesics|analgesics|mesh-ancestor
83901445|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
83901446|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901447|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83901448|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83901449|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
83901450|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
83901451|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83901452|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83901453|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901454|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901455|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
83901456|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
83901457|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901458|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901459|NCT00290667|Prednisone|prednisone|mesh-list
83901460|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
83901461|NCT00290667|Rituximab|rituximab|mesh-list
83901462|NCT00290667|Doxorubicin|doxorubicin|mesh-list
83901463|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83901464|NCT00290667|Vincristine|vincristine|mesh-list
83901465|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901466|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
83901467|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901468|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901469|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83901470|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
84048325|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
83901471|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901472|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901473|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83140563|NCT01369433|Sirolimus|sirolimus|mesh-list
83901474|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83901475|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83901476|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83901477|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83901478|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901479|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901480|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
83901481|NCT00290667|Hormones|hormones|mesh-ancestor
83901482|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901483|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83901484|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83901485|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901486|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901487|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901488|NCT01602757|Lidocaine|lidocaine|mesh-list
83901489|NCT01602757|Tetracaine|tetracaine|mesh-list
83901490|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
83901491|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
83901492|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901493|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901494|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
83901495|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901496|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83901497|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83901498|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83901499|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83901500|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901501|NCT02961101|Decitabine|decitabine|mesh-list
83901502|NCT02961101|Antibodies|antibodies|mesh-list
83901503|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
83901504|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901505|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83901506|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
83901507|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901508|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901509|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901510|NCT01602913|Paroxetine|paroxetine|mesh-list
83901511|NCT01602913|Pravastatin|pravastatin|mesh-list
83901512|NCT01602913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83901513|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83901514|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83901515|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901516|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901517|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
83901518|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901519|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83901520|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
83901521|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901522|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83901523|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83901524|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901525|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83901526|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83901527|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
83901528|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83901529|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83901530|NCT00257699|Metronidazole|metronidazole|mesh-list
83901531|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
83901532|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901533|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901534|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83901535|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83901536|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83901537|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83901538|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901539|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901540|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901541|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83901542|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83901543|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
83901544|NCT01603030|Prednisolone|prednisolone|mesh-list
83901545|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83901546|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
83901547|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83901548|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
83901549|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83901550|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83901551|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
83901552|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901553|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
83901554|NCT01603030|Hormones|hormones|mesh-ancestor
83901555|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901556|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901557|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83901558|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901559|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
83901560|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
83901561|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901562|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901563|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83901564|NCT01603030|Protective Agents|protective agents|mesh-ancestor
83901565|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901566|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901567|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83901568|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83901569|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901570|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901571|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83901572|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
83901573|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83901574|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83901575|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83901576|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83901577|NCT01603108|Rifaximin|rifaximin|mesh-list
83901578|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901579|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901580|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901581|NCT00290823|Albendazole|albendazole|mesh-list
83901582|NCT00290823|Dexamethasone|dexamethasone|mesh-list
83901583|NCT00290823|Omeprazole|omeprazole|mesh-list
83901584|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901585|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
83901586|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
83901587|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901588|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901589|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901590|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
83901591|NCT00290823|Hormones|hormones|mesh-ancestor
83901592|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901593|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83901594|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901595|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83901596|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83901597|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901598|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901599|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
83901600|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83901601|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901602|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
83901603|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83901604|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83901605|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901606|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901607|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901608|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83901609|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
83901610|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901611|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83901612|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901613|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901614|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901615|NCT00271284|Insulin|insulin|mesh-list
83901616|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83901617|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
83901618|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
83901619|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
83140719|NCT03237507|Paclitaxel|paclitaxel|mesh-list
83901620|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83901621|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901622|NCT00257816|Topotecan|topotecan|mesh-list
83901623|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901624|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83901625|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83901626|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901627|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901628|NCT00271323|Docetaxel|docetaxel|mesh-list
83901629|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901630|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901631|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901632|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901633|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901634|NCT01603342|Clopidogrel|clopidogrel|mesh-list
83901635|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83901636|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83901637|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83901638|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83901639|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
83901640|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901641|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901642|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901643|NCT00257855|Lamotrigine|lamotrigine|mesh-list
83901644|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
83901645|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83901646|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83901647|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901648|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83901649|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901650|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83901651|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901652|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901653|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901654|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83901655|NCT01603498|Dexamethasone|dexamethasone|mesh-list
83901656|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
83901657|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83901658|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83901659|NCT01603498|Prednisolone|prednisolone|mesh-list
83901660|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
83901661|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83901662|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
83901663|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901664|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
83901665|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
83901666|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901667|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901668|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901669|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
83901670|NCT01603498|Hormones|hormones|mesh-ancestor
83901671|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901672|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83901673|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901674|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83901675|NCT01603498|Protective Agents|protective agents|mesh-ancestor
83901676|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
83901677|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
83901678|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
83901679|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901680|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
83901681|NCT01603654|Protective Agents|protective agents|mesh-ancestor
83901682|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901683|NCT01603654|Vitamins|vitamins|mesh-ancestor
83901684|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
83901685|NCT01603654|Cathartics|cathartics|mesh-ancestor
83901686|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901687|NCT00257972|Aripiprazole|aripiprazole|mesh-list
83901688|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
83901689|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901690|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83901691|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901692|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901693|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901694|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
83901695|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
83901696|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901697|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901698|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83901699|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83901701|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83901702|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83901703|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83901704|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83901705|NCT01603693|Calcium|calcium|mesh-list
83901706|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83901707|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901708|NCT00258050|Lapatinib|lapatinib|mesh-list
83901709|NCT00258050|Midazolam|midazolam|mesh-list
83901710|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83901711|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83901712|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901713|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901714|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83901715|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83901716|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83901717|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83901718|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
83901719|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
83901720|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
83901721|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
83901722|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901723|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901724|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901725|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83901726|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901727|NCT00271401|Heparin|heparin|mesh-list
83901728|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
83901729|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83901730|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83901731|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901732|NCT00258089|Levofloxacin|levofloxacin|mesh-list
83901733|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83901734|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901735|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901736|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83901737|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83901738|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901739|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901740|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901741|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83901742|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83901743|NCT00290901|Celecoxib|celecoxib|mesh-list
83901744|NCT00290901|Tramadol|tramadol|mesh-list
83901745|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83901746|NCT00290901|Narcotics|narcotics|mesh-ancestor
83901747|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901748|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901749|NCT00290901|Analgesics|analgesics|mesh-ancestor
83901750|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
83901751|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901752|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83901753|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83901754|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901755|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901756|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83901757|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83901758|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901759|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901760|NCT00258245|Aspirin|aspirin|mesh-list
83901761|NCT00258245|Vitamins|vitamins|mesh-list
83901762|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
83901763|NCT00258245|Thalidomide|thalidomide|mesh-list
83901764|NCT00258245|Dexamethasone|dexamethasone|mesh-list
83901765|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
83901766|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
83901767|NCT00258245|Bortezomib|bortezomib|mesh-list
83901768|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
83901769|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83901770|NCT00258245|BB 1101|bb 1101|mesh-list
83901771|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
83901772|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901773|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901774|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
83901775|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
83901776|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901777|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901778|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
83901779|NCT00258245|Hormones|hormones|mesh-ancestor
83901780|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901781|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83901782|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901783|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
83901784|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901785|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901786|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83901787|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83901788|NCT00258245|Analgesics|analgesics|mesh-ancestor
83901789|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
83901790|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901791|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83901792|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83901793|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83901794|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83901795|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
83901796|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
83901797|NCT00258245|Protective Agents|protective agents|mesh-ancestor
83901798|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901799|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
83901800|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
83901801|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901802|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901803|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83901804|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83901805|NCT00258245|Growth Substances|growth substances|mesh-ancestor
83901806|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
83901807|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
83901808|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83901809|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901810|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
83901811|NCT01604629|Adalimumab|adalimumab|mesh-list
83901812|NCT01604629|Infliximab|infliximab|mesh-list
83901813|NCT01604629|Golimumab|golimumab|mesh-list
83901814|NCT01604629|Etanercept|etanercept|mesh-list
83901815|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83901816|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83901817|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901818|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901819|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83901820|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901821|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83901822|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83901823|NCT01604629|Analgesics|analgesics|mesh-ancestor
83901824|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
83901825|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901826|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901827|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901828|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
83901829|NCT00258284|Docetaxel|docetaxel|mesh-list
83901830|NCT00258284|Capecitabine|capecitabine|mesh-list
83901831|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901832|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901833|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901834|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901835|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901836|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83901837|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
83901838|NCT00290940|Metformin|metformin|mesh-list
83901839|NCT00290940|Pioglitazone|pioglitazone|mesh-list
83901840|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83901841|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901842|NCT00258323|Fluorouracil|fluorouracil|mesh-list
83901843|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901844|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
83901845|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901846|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83901847|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901848|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
83901849|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901850|NCT01604863|Paclitaxel|paclitaxel|mesh-list
83901851|NCT01604863|Etoposide|etoposide|mesh-list
83901852|NCT01604863|Docetaxel|docetaxel|mesh-list
83901853|NCT01604863|Carboplatin|carboplatin|mesh-list
83901854|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83901855|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901856|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
83901857|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
83901858|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
83901859|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901860|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83901861|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83901862|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901863|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
83901864|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83901865|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901866|NCT00258479|Modafinil|modafinil|mesh-list
83901867|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83901868|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901869|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83901870|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83901871|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83901872|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901873|NCT00271518|Hormones|hormones|mesh-list
83901874|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83901875|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901876|NCT01340014|Timolol|timolol|mesh-list
83901877|NCT01340014|Dorzolamide|dorzolamide|mesh-list
83901878|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83901879|NCT01340014|Brinzolamide|brinzolamide|mesh-list
83901880|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83901881|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83901882|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83901883|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
83901884|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83901885|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901886|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901887|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83901888|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83901889|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83901890|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901891|NCT00258557|Darunavir|darunavir|mesh-list
83901892|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83901893|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83901894|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
83901895|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901896|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901897|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83901898|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83901899|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
83901900|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901901|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83901902|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
83901903|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901904|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
83901905|NCT00271635|Vitamins|vitamins|mesh-ancestor
83901906|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
83901907|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901908|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
83901909|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901910|NCT00271635|Protective Agents|protective agents|mesh-ancestor
83901911|NCT00258596|Sirolimus|sirolimus|mesh-list
83901912|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83901913|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901914|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83901915|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901916|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
83901917|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83901918|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
83901919|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901920|NCT01339273|Anesthetics|anesthetics|mesh-list
83901921|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
83901922|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83901923|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141014|NCT03559751|Nicotine|nicotine|mesh-list
83901924|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
83901925|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901926|NCT04709315|Choline|choline|mesh-list
83901927|NCT04709315|Rocuronium|rocuronium|mesh-list
83901928|NCT04709315|Succinylcholine|succinylcholine|mesh-list
83901929|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83901930|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83901931|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83901932|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901933|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901934|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
83901935|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83901936|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
83901937|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901938|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83901939|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83901940|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
83901941|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83901942|NCT01334710|Sorafenib|sorafenib|mesh-list
83901943|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901944|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83901945|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901946|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901947|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
83901948|NCT00271713|Vitamin D|vitamin d|mesh-list
83901949|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
83901950|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
83901951|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
83901952|NCT00271713|Vitamins|vitamins|mesh-list
83901953|NCT00271713|Calcium|calcium|mesh-list
83901954|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
83901955|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901956|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83901957|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83901958|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
83901959|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83901960|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83901961|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83901962|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901963|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901964|NCT01334554|Urological Agents|urological agents|mesh-ancestor
83901965|NCT00291213|Levetiracetam|levetiracetam|mesh-list
83901966|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
83901967|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
83901968|NCT01332799|Allopurinol|allopurinol|mesh-list
83901969|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
83901970|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901971|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901972|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
83901973|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901974|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83901975|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
83901976|NCT01332799|Protective Agents|protective agents|mesh-ancestor
83901977|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901978|NCT00258791|Ibuprofen|ibuprofen|mesh-list
83901979|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83901980|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83901981|NCT00258791|Analgesics|analgesics|mesh-ancestor
83901982|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
83901983|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83901984|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83901985|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83901986|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83901987|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83901988|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83901989|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83901990|NCT00291369|Interferons|interferons|mesh-list
83901991|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
83901992|NCT00291369|Interleukin-2|interleukin-2|mesh-list
83901993|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83901994|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
83901995|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83901996|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
83901997|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83901998|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
83901999|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902000|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902001|NCT00291369|Analgesics|analgesics|mesh-ancestor
83902002|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
83902003|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902004|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83902005|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83902006|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83902007|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
83902008|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83902009|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83902010|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83902011|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83902012|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902013|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
83902014|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83902015|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
83902016|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902017|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902018|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83902019|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902020|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83902021|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
83902022|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902023|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902024|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83902025|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
83902026|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
83902027|NCT00291408|Protective Agents|protective agents|mesh-ancestor
83902028|NCT00271791|Prednisone|prednisone|mesh-list
83902029|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902030|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
83902031|NCT00271791|Hormones|hormones|mesh-ancestor
83902032|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902033|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902034|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902035|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902036|NCT01332331|Ambrisentan|ambrisentan|mesh-list
83902037|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83902038|NCT00259064|Gefitinib|gefitinib|mesh-list
83902039|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902040|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83902041|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902042|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902043|NCT01332292|Fluticasone|fluticasone|mesh-list
83902044|NCT01332292|Xhance|xhance|mesh-list
83902045|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902046|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83902047|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
83902048|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902049|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902050|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83902051|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902052|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
83902053|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83902054|NCT00259142|Chloroquine|chloroquine|mesh-list
83902055|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
83902056|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
83902057|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83902058|NCT00259142|Amebicides|amebicides|mesh-ancestor
83902059|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83902060|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83902061|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902062|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
83902063|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902064|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83902065|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902066|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902067|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83902068|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
83902069|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83902070|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83902071|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83902072|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902073|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
83141155|NCT03056846|Sulfalene|sulfalene|mesh-list
83902074|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
83902075|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
83902076|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83902077|NCT00259181|Protective Agents|protective agents|mesh-ancestor
83902078|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902080|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83902081|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
83902082|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902083|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902084|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83902085|NCT00291720|Diuretics|diuretics|mesh-ancestor
83902086|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
83902087|NCT00259220|Erythromycin|erythromycin|mesh-list
83902088|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
83902089|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83902090|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
83902091|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83902092|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902093|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902094|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83902095|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902096|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902097|NCT00291759|Tamoxifen|tamoxifen|mesh-list
83902098|NCT00291759|Anastrozole|anastrozole|mesh-list
83902099|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83902100|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
83902101|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902102|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902103|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902104|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902105|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83902106|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83902107|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83902108|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83902109|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83902110|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902111|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902112|NCT00272025|Escitalopram|escitalopram|mesh-list
83902113|NCT00272025|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83902114|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83902115|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902116|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902117|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902118|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
83902119|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902120|NCT04709081|Itraconazole|itraconazole|mesh-list
83902121|NCT04709081|Digoxin|digoxin|mesh-list
83902122|NCT04709081|Midazolam|midazolam|mesh-list
83902123|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83902124|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83902125|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83902126|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902127|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83902128|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83902129|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902130|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83902131|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
83902132|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
83902133|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
83902134|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
83902135|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902136|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902137|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
83902138|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902139|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83902140|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83902141|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902142|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83902143|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
83902144|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902145|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83902146|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83902147|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83902148|NCT04709081|Protective Agents|protective agents|mesh-ancestor
83902150|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83902151|NCT00272064|Metformin|metformin|mesh-list
83902152|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
83902153|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
83902154|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83902155|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902156|NCT00259376|Dronedarone|dronedarone|mesh-list
83902157|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83902158|NCT01332019|Interferons|interferons|mesh-list
83902159|NCT01332019|Interferon-beta|interferon-beta|mesh-list
83902160|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
83902161|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902162|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
83902163|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902164|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
83902165|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902166|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83902167|NCT00415376|Levetiracetam|levetiracetam|mesh-list
83902168|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
83902169|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
83902170|NCT00291915|Adalimumab|adalimumab|mesh-list
83902171|NCT00291915|Methotrexate|methotrexate|mesh-list
83902172|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83902173|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
83902174|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83902175|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902176|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83902177|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
83902178|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902179|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902180|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
83902181|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902182|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83902183|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83902184|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
83902185|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902186|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83902187|NCT00291915|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83902188|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902189|NCT00259766|Budesonide|budesonide|mesh-list
83902190|NCT00259766|Terbutaline|terbutaline|mesh-list
83902191|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
83902192|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902193|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83902194|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
83902195|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902196|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902197|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83902198|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902199|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
83902200|NCT00259766|Hormones|hormones|mesh-ancestor
83902201|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902202|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83902203|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83902204|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83902205|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
83902206|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902207|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902208|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
83902209|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
83902210|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83902211|NCT00292071|Caspofungin|caspofungin|mesh-list
83902212|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
83902213|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902214|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902215|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902216|NCT00292110|Methadone|methadone|mesh-list
83902217|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83902218|NCT00292110|Narcotics|narcotics|mesh-ancestor
83902219|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83902220|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902221|NCT00292110|Analgesics|analgesics|mesh-ancestor
83902222|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
83902223|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902224|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
83902225|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902226|NCT00259805|Rituximab|rituximab|mesh-list
83902227|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83902228|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902229|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
83902230|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902231|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902232|NCT00259883|Paroxetine|paroxetine|mesh-list
83902233|NCT00259883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83902234|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83902235|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902236|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902237|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902238|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
83902239|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902240|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83902241|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
83902242|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902243|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83902244|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83902245|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902246|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
83902247|NCT04718376|Analgesics|analgesics|mesh-ancestor
83902248|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
83902249|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902250|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902251|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902252|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83902253|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83902254|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902255|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902256|NCT00272415|Temozolomide|temozolomide|mesh-list
83902257|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83902258|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
83902259|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902260|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902261|NCT00259922|Alvimopan|alvimopan|mesh-list
83902262|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902263|NCT00272454|Aspirin|aspirin|mesh-list
83902264|NCT00272454|Cilostazol|cilostazol|mesh-list
83902265|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83902266|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902267|NCT00272454|Analgesics|analgesics|mesh-ancestor
83902268|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
83902269|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902270|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902271|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902272|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902273|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83902274|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83902275|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902276|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83902277|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83902278|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902279|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
83902280|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83902281|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
83902282|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83902283|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902284|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
83902285|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83902286|NCT00272454|Protective Agents|protective agents|mesh-ancestor
83902287|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83902288|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83902289|NCT00272493|Vaccines|vaccines|mesh-list
83902290|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
83902291|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902292|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
83902293|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83902294|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
83902295|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902296|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902297|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
83902298|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902300|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
83902301|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902302|NCT00292344|Rifaximin|rifaximin|mesh-list
83902303|NCT00292344|Loperamide|loperamide|mesh-list
83902304|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
83902305|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83902306|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902307|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902308|NCT00417768|Plasminogen|plasminogen|mesh-list
83902309|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83902310|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83902311|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83902312|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902313|NCT00272610|Vitamin A|vitamin a|mesh-list
83902314|NCT00272610|Vitamins|vitamins|mesh-ancestor
83902315|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
83902316|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902317|NCT00260351|Vaccines|vaccines|mesh-list
83902318|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
83902319|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902320|NCT00272688|Levodopa|levodopa|mesh-list
83902321|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83902322|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83902323|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
83902324|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902325|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902326|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902327|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
83902328|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902329|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902330|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
83902331|NCT00260390|Hormones|hormones|mesh-ancestor
83902332|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902333|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902334|NCT00260624|Escitalopram|escitalopram|mesh-list
83902335|NCT00260624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83902336|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83902337|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902338|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902339|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902340|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
83902341|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902342|NCT00292695|Ifosfamide|ifosfamide|mesh-list
83902343|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902344|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83902345|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
83902346|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902347|NCT00292734|Zolpidem|zolpidem|mesh-list
83902348|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83902349|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83902350|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83902351|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902352|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83902353|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
83902354|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
83902355|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902356|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902357|NCT00260702|Omalizumab|omalizumab|mesh-list
83902358|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83902359|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83902360|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902361|NCT00260819|Bosentan|bosentan|mesh-list
83902362|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83902363|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83902364|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902365|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
83902366|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
83902367|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902368|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902369|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83902370|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83902371|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
83902372|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902373|NCT00292890|Insulin|insulin|mesh-list
83902374|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83902375|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902376|NCT00292929|Artesunate|artesunate|mesh-list
83902377|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
83902378|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83902379|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83902380|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902381|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902382|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
83902383|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
83902384|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83902385|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
83902386|NCT00424853|Cisplatin|cisplatin|mesh-list
83902387|NCT00424853|Gemcitabine|gemcitabine|mesh-list
83902388|NCT00424853|Docetaxel|docetaxel|mesh-list
83902389|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902390|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83902391|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
83902392|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902393|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
83902394|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
83902395|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
83902396|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
83902397|NCT00298506|Tacrolimus|tacrolimus|mesh-list
83902398|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83902399|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
83902400|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902401|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83902402|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902403|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902404|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83902405|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902406|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83902407|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
83902408|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83902409|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902410|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83902411|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83902412|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83902413|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902414|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902415|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902416|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902417|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
83902418|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902419|NCT00424931|Modafinil|modafinil|mesh-list
83902420|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83902421|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902422|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83902423|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83902424|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83902425|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902426|NCT00298545|Calcitriol|calcitriol|mesh-list
83902427|NCT00298545|Calcium|calcium|mesh-list
83902428|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83902429|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902430|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83902431|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902432|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902433|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83902434|NCT00298545|Vitamins|vitamins|mesh-ancestor
83902435|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
83152115|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
83902436|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83902437|NCT01331161|Vaccines|vaccines|mesh-list
83902438|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
83902439|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902440|NCT00424970|Acetazolamide|acetazolamide|mesh-list
83902441|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
83902442|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83902443|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902444|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902445|NCT00424970|Diuretics|diuretics|mesh-ancestor
83902446|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
83902447|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902448|NCT01331005|Nepafenac|nepafenac|mesh-list
83902449|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83902450|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902451|NCT01331005|Analgesics|analgesics|mesh-ancestor
83902452|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
83902453|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902454|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902455|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902456|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902457|NCT01330459|Acetaminophen|acetaminophen|mesh-list
83902458|NCT01330459|Ibuprofen|ibuprofen|mesh-list
83902459|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83902460|NCT01330459|Lidocaine|lidocaine|mesh-list
83902461|NCT01330459|Hydrocodone|hydrocodone|mesh-list
83902462|NCT01330459|Lorazepam|lorazepam|mesh-list
83902463|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
83902464|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
83902465|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83902466|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902467|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
83902468|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902469|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83902470|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83902471|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83902472|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902473|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902474|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902475|NCT01330459|Analgesics|analgesics|mesh-ancestor
83902476|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
83902477|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83902478|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902479|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902480|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83902481|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902482|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83902483|NCT01330459|Narcotics|narcotics|mesh-ancestor
83902484|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
83902485|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902486|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
83902487|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
83902488|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
83902489|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902490|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83902491|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83902492|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83902493|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902494|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
83902495|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
83902496|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902497|NCT00293085|Docetaxel|docetaxel|mesh-list
83902498|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902499|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
83902500|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
83902501|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
83902502|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902503|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83902504|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83902505|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83902506|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
83902507|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902508|NCT00298662|Interferons|interferons|mesh-list
83902509|NCT00298662|Interferon-beta|interferon-beta|mesh-list
83902510|NCT00298662|Tacrolimus|tacrolimus|mesh-list
83902511|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
83902512|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902513|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
83902514|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902515|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83902516|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
83902517|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902518|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83902519|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902520|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902521|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83902522|NCT01330381|Prucalopride|prucalopride|mesh-list
83902523|NCT01330381|Laxatives|laxatives|mesh-ancestor
83902524|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902525|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83902526|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83902527|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
83902528|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902529|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902530|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902531|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
83902532|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902533|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
83902534|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902535|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83902536|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902537|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902538|NCT01330108|Ambrisentan|ambrisentan|mesh-list
83902539|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83902540|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
83902541|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83902542|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83902543|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83902544|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902545|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902546|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
83902547|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902548|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902549|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83902550|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902551|NCT00261170|Bupropion|bupropion|mesh-list
83902552|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83902553|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
83902554|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902555|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83902556|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83902557|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902558|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902559|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
83902560|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902561|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902562|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83902563|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83902564|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902565|NCT00261287|Ciclesonide|ciclesonide|mesh-list
83902566|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
83902567|NCT00261287|Hormones|hormones|mesh-ancestor
83902568|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902569|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902570|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83902571|NCT00261326|Simvastatin|simvastatin|mesh-list
83902572|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83902573|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83902574|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
83902575|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902576|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83902577|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83902578|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902579|NCT00293163|Hylan|hylan|mesh-list
83902580|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
83902581|NCT00293163|Protective Agents|protective agents|mesh-ancestor
83902582|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902583|NCT00261365|Ipilimumab|ipilimumab|mesh-list
83902584|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83902585|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902586|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83902587|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902588|NCT00293280|Lomustine|lomustine|mesh-list
83902589|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83902590|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
83902591|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902592|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902593|NCT00298779|Bortezomib|bortezomib|mesh-list
83902594|NCT00298779|Omeprazole|omeprazole|mesh-list
83902595|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902596|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83902597|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902598|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83902599|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902600|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902601|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83902602|NCT00261482|Norelgestromin|norelgestromin|mesh-list
83902603|NCT00261482|Estradiol|estradiol|mesh-list
83902604|NCT00261482|Estrogens|estrogens|mesh-ancestor
83902605|NCT00261482|Hormones|hormones|mesh-ancestor
83902606|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902607|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902608|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83902609|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
83902610|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83902611|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83902612|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83902613|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83902614|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
83902615|NCT00261521|Hematinics|hematinics|mesh-ancestor
83902616|NCT00298857|Valproic Acid|valproic acid|mesh-list
83902617|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
83902618|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902619|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902620|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
83902621|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902622|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902623|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
83902624|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83902625|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83902626|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902627|NCT00261560|Acetaminophen|acetaminophen|mesh-list
83902628|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902629|NCT00261560|Analgesics|analgesics|mesh-ancestor
83902630|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
83902631|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902632|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902633|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
83902634|NCT00261599|Midazolam|midazolam|mesh-list
83902635|NCT00261599|Fospropofol|fospropofol|mesh-list
83902636|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83902637|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83902638|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83902639|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902640|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83902641|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83902642|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902643|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83902644|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
83902645|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
83902646|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
83902647|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
83902648|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902649|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902650|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83902651|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902652|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902653|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902654|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83902655|NCT00293358|Carboplatin|carboplatin|mesh-list
83902656|NCT00293358|Etoposide|etoposide|mesh-list
83902657|NCT00293358|Ifosfamide|ifosfamide|mesh-list
83902658|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
83902659|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902660|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83902661|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83902662|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83902663|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902664|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902665|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83902666|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
83902667|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
83902668|NCT00261677|Hematinics|hematinics|mesh-ancestor
83902669|NCT00298974|Acetaminophen|acetaminophen|mesh-list
83902670|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83902671|NCT00298974|Hydrocodone|hydrocodone|mesh-list
83902672|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902673|NCT00298974|Analgesics|analgesics|mesh-ancestor
83902674|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
83902675|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902676|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902677|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
83902678|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83902679|NCT00298974|Narcotics|narcotics|mesh-ancestor
83902680|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83902681|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
83902682|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
83902683|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83902684|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902685|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902686|NCT00293436|Celecoxib|celecoxib|mesh-list
83902687|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83902688|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902689|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83902690|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902691|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902692|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83902693|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902694|NCT00293436|Analgesics|analgesics|mesh-ancestor
83902695|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
83902696|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902697|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902698|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902699|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902700|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83902701|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83902702|NCT00261872|Methylphenidate|methylphenidate|mesh-list
83902703|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83902704|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902705|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83902706|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83902707|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902708|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902709|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
83902710|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902711|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
83902712|NCT00293475|Rituximab|rituximab|mesh-list
83902713|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83902714|NCT00293475|Carboplatin|carboplatin|mesh-list
83902715|NCT00293475|Methotrexate|methotrexate|mesh-list
83902716|NCT00293475|Mannitol|mannitol|mesh-list
83902717|NCT00293475|Antibodies|antibodies|mesh-list
83902718|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
83902719|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83902720|NCT00293475|Antidotes|antidotes|mesh-list
83902721|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
83902722|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902723|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902724|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902725|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83902726|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
83902727|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83902728|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83902729|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
83902730|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902731|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83902732|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902733|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83902734|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83902735|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83902736|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83902737|NCT00293475|Diuretics|diuretics|mesh-ancestor
83902738|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
83902739|NCT00293475|Protective Agents|protective agents|mesh-ancestor
83902740|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
83902741|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
83902742|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83902743|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902744|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
83902745|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
83902746|NCT00261911|Sibutramine|sibutramine|mesh-list
83902747|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
83902748|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83902749|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
83902750|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83902751|NCT00299013|Prednisolone|prednisolone|mesh-list
83902752|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83902753|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
83902754|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83902755|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
83902756|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83902757|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
83902758|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902759|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
83902760|NCT00299013|Hormones|hormones|mesh-ancestor
83902761|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902762|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902763|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902764|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902765|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
83902766|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
83902767|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902768|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902769|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83902770|NCT00299013|Protective Agents|protective agents|mesh-ancestor
83902771|NCT00293514|Thrombin|thrombin|mesh-list
83902772|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
83902773|NCT00293514|Coagulants|coagulants|mesh-ancestor
83902774|NCT00299091|Efavirenz|efavirenz|mesh-list
83902775|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83902776|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83902777|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902778|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902779|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
83902780|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902781|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83902782|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83902783|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83902784|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83902785|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83902786|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83902787|NCT00299208|Azithromycin|azithromycin|mesh-list
83902788|NCT00299208|Artesunate|artesunate|mesh-list
83902789|NCT00299208|Quinine|quinine|mesh-list
83902790|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83902791|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902792|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
83902793|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83902794|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83902795|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902796|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
83902797|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
83902798|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83902799|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
83902800|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83902801|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902802|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83902803|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902804|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902805|NCT00299208|Analgesics|analgesics|mesh-ancestor
83902806|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
83902807|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
83902808|NCT00418119|Hematinics|hematinics|mesh-ancestor
83902809|NCT00293592|Dexamethasone|dexamethasone|mesh-list
83902810|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902811|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
83902812|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
83902813|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902814|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902815|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902816|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
83902817|NCT00293592|Hormones|hormones|mesh-ancestor
83902818|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902819|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902820|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902821|NCT00293631|Ketorolac|ketorolac|mesh-list
83902822|NCT00293631|Lornoxicam|lornoxicam|mesh-list
83902823|NCT00293631|Piroxicam|piroxicam|mesh-list
83902824|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83902825|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83902826|NCT00293631|Analgesics|analgesics|mesh-ancestor
83902827|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
83902828|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902829|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902830|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83902831|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902832|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83902833|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902834|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902835|NCT00262262|Levetiracetam|levetiracetam|mesh-list
83902836|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
83902837|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
83902838|NCT00293670|Goserelin|goserelin|mesh-list
83902839|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902840|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902841|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
83902842|NCT00262379|Hematinics|hematinics|mesh-ancestor
83902843|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
83902844|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
83902845|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
83902846|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83902847|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83902848|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902849|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83902850|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902851|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902852|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83902853|NCT00262418|Ivermectin|ivermectin|mesh-list
83902854|NCT00262418|Permethrin|permethrin|mesh-list
83902855|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83902856|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902857|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902858|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902859|NCT00299286|Lapatinib|lapatinib|mesh-list
83902860|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902861|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83902862|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902863|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902864|NCT00293787|Timolol|timolol|mesh-list
83902865|NCT00293787|Travoprost|travoprost|mesh-list
83902866|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83902867|NCT00293787|Latanoprost|latanoprost|mesh-list
83902868|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83902869|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902870|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83902871|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83902872|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83902873|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902874|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902875|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83902876|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83902877|NCT00299364|Tibolone|tibolone|mesh-list
83902878|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
83902879|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83902880|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902881|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902882|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83902883|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83902884|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902885|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83902886|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
83902887|NCT00299364|Hormones|hormones|mesh-ancestor
83902888|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83902889|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
83902890|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902891|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83902892|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
83902893|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902894|NCT00262769|Cisplatin|cisplatin|mesh-list
83902895|NCT00262769|Gemcitabine|gemcitabine|mesh-list
83902896|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902897|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83902898|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
83902899|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902900|NCT00299520|Linezolid|linezolid|mesh-list
83902901|NCT00299520|Iclaprim|iclaprim|mesh-list
83902902|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83902903|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902904|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83141981|NCT03209427|Morphine|morphine|mesh-list
83902905|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902906|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902907|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83902908|NCT00261755|Analgesics|analgesics|mesh-list
83902909|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
83902910|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83902911|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902912|NCT00262808|Leucovorin|leucovorin|mesh-list
83902913|NCT00262808|Fluorouracil|fluorouracil|mesh-list
83902914|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
83902915|NCT00262808|Calcium|calcium|mesh-list
83902916|NCT00262808|Sargramostim|sargramostim|mesh-list
83902917|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
83902918|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83902919|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902920|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
83902921|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902922|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83902923|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902924|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83902925|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
83902926|NCT00262808|Antidotes|antidotes|mesh-ancestor
83902927|NCT00262808|Protective Agents|protective agents|mesh-ancestor
83902928|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
83902929|NCT00262808|Vitamins|vitamins|mesh-ancestor
83902930|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
83902931|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
83902932|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
83902933|NCT00262886|Fludarabine|fludarabine|mesh-list
83902934|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
83902935|NCT00262886|Tacrolimus|tacrolimus|mesh-list
83902936|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83902937|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83902938|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
83902939|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902940|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83902941|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83902942|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
83902943|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902944|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902945|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83902946|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83902947|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
83902948|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83902949|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902950|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83902951|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83902952|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
83902953|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83902954|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902955|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83902956|NCT00263003|Irbesartan|irbesartan|mesh-list
83902957|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83902958|NCT00263003|Diuretics|diuretics|mesh-ancestor
83902959|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
83902960|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902961|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83902962|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83902963|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902964|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83902965|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83902966|NCT00299559|Camphor|camphor|mesh-list
83902967|NCT00299559|Menthol|menthol|mesh-list
83902968|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
83902969|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
83902970|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83902971|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902972|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83902973|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83902974|NCT00263198|Letrozole|letrozole|mesh-list
83902975|NCT00263198|Vatalanib|vatalanib|mesh-list
83902976|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83902977|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83902978|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83902979|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902980|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902981|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83902982|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
83902983|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83902984|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902985|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83902987|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83902988|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
83902989|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83902990|NCT00294099|Antacids|antacids|mesh-ancestor
83902991|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902992|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83902993|NCT00299676|Galantamine|galantamine|mesh-list
83902994|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83902995|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83902996|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83902997|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
83902998|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83902999|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903000|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83903001|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
83903002|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903003|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
83903004|NCT00263276|Metformin|metformin|mesh-list
83903005|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
83903006|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83903007|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903008|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83903009|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903010|NCT00299754|Misoprostol|misoprostol|mesh-list
83903011|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83903012|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
83903013|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83903014|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903015|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83903016|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83903017|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
83903018|NCT00263315|Amphotericin B|amphotericin b|mesh-list
83903019|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83903020|NCT00263315|Amebicides|amebicides|mesh-ancestor
83903021|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83903022|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83903023|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903024|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83903025|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
83903026|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
83903027|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903028|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83903029|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903030|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903031|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
83903032|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903033|NCT00263393|Atenolol|atenolol|mesh-list
83903034|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83903035|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83903036|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83903037|NCT00263393|Diuretics|diuretics|mesh-ancestor
83903038|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
83903039|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903040|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83903041|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903042|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903043|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83903044|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
83903045|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
83903046|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903047|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83903048|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83903049|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83903050|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
83903051|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903052|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
83903053|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903054|NCT00299871|Lixisenatide|lixisenatide|mesh-list
83903055|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83903056|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903057|NCT00299910|Montelukast|montelukast|mesh-list
83903058|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83903059|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
83903060|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83903061|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
83903062|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903063|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903064|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83903065|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83903066|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903067|NCT00263627|Immunomodulating Agents|immunomodulating agents|mesh-list
83903068|NCT00263627|Immunologic Factors|immunologic factors|mesh-ancestor
83903069|NCT00263627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903070|NCT00425594|Bisacodyl|bisacodyl|mesh-list
83903071|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83903072|NCT00425594|Cathartics|cathartics|mesh-ancestor
83903073|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83903074|NCT00425594|Laxatives|laxatives|mesh-ancestor
83903075|NCT00294255|Risperidone|risperidone|mesh-list
83903076|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83903077|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
83903078|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903079|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903080|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903081|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83903082|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83903083|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903084|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83903085|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83903086|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
83903087|NCT00263705|Capecitabine|capecitabine|mesh-list
83903088|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83903089|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
83903090|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903091|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903092|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83903093|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83903094|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
83903095|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903096|NCT00263744|Antacids|antacids|mesh-ancestor
83903097|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903098|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83903099|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83903100|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
83903101|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903102|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83903103|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903104|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83903105|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903106|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903107|NCT00300222|Capsaicin|capsaicin|mesh-list
83903108|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
83903109|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83903110|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
83903111|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903112|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903113|NCT00263978|Defibrotide|defibrotide|mesh-list
83903114|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83903115|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83903116|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903117|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83903118|NCT00264134|Carboplatin|carboplatin|mesh-list
83903119|NCT00264134|Docetaxel|docetaxel|mesh-list
83903120|NCT00264134|Irinotecan|irinotecan|mesh-list
83903121|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903122|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
83903123|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
83903124|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
83903125|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903126|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83903127|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83903128|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903129|NCT00300339|Clopidogrel|clopidogrel|mesh-list
83903130|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83903131|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83903132|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83903133|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83903134|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
83903135|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903136|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903137|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903138|NCT00264173|Valproic Acid|valproic acid|mesh-list
83903139|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
83903140|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903141|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903142|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
83903143|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903144|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903145|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
83903146|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83903147|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903148|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83903149|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83903150|NCT00264212|Irbesartan|irbesartan|mesh-list
83903151|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83903152|NCT00264212|Diuretics|diuretics|mesh-ancestor
83903153|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
83903154|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903155|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83903156|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903157|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903158|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83903159|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83903160|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83903161|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83903162|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83903163|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903164|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903165|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903166|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903167|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
83903168|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83903169|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
83903170|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83903171|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903172|NCT00294567|Amlodipine|amlodipine|mesh-list
83903173|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
83903174|NCT00294567|Calcium|calcium|mesh-list
83903175|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83903176|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903177|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83903178|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903179|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903180|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
83903181|NCT00294606|Phenylephrine|phenylephrine|mesh-list
83903182|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
83903183|NCT00294606|Norepinephrine|norepinephrine|mesh-list
83903184|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83903185|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
83903186|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
83903187|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903188|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903189|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
83903190|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83903191|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
83903192|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
83903193|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83903194|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83903195|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83903196|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
83903197|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903198|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903199|NCT00294606|Protective Agents|protective agents|mesh-ancestor
83903200|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
83903201|NCT04708964|Analgesics|analgesics|mesh-ancestor
83903202|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
83903203|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903204|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903205|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903206|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903207|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903208|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903209|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903210|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903211|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903212|NCT00264368|Ganciclovir|ganciclovir|mesh-list
83903213|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83903214|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
83903215|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903216|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83903217|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903218|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903219|NCT00264407|Hormones|hormones|mesh-list
83903220|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903221|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903222|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
83903223|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83903224|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83903225|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903226|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903227|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
83903228|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903229|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83903230|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83903231|NCT00264446|Eniluracil|eniluracil|mesh-list
83903232|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903233|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903234|NCT00264485|Fentanyl|fentanyl|mesh-list
83903235|NCT00264485|Morphine|morphine|mesh-list
83903236|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83903237|NCT00264485|Narcotics|narcotics|mesh-ancestor
83903238|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903239|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903240|NCT00264485|Analgesics|analgesics|mesh-ancestor
83903241|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
83903242|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903243|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83903244|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83903245|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
83903246|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
83903247|NCT00294918|Hormones|hormones|mesh-list
83903248|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903249|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903250|NCT00264680|Lamotrigine|lamotrigine|mesh-list
83903251|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
83903252|NCT00264680|Valproic Acid|valproic acid|mesh-list
83903253|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83903254|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903255|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903256|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83903257|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903258|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83903259|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83903260|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903261|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83903262|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83903263|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903264|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
83903265|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903266|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
83903267|NCT00300729|Celecoxib|celecoxib|mesh-list
83903268|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903269|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903270|NCT00300729|Analgesics|analgesics|mesh-ancestor
83903271|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
83903272|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903273|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903274|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903275|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903276|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83903277|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903278|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903279|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903280|NCT00264719|Metoclopramide|metoclopramide|mesh-list
83903281|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
83903282|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
83903283|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903284|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903285|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83903286|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83903287|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83903288|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
83903289|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903290|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903291|NCT00264914|Satavaptan|satavaptan|mesh-list
83903292|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83903293|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903294|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
83903295|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903296|NCT00264953|Prednisone|prednisone|mesh-list
83903297|NCT00264953|Etoposide|etoposide|mesh-list
83903298|NCT00264953|Vincristine|vincristine|mesh-list
83903299|NCT00264953|Doxorubicin|doxorubicin|mesh-list
83903300|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83903301|NCT00264953|Bleomycin|bleomycin|mesh-list
83903302|NCT00264953|Vinblastine|vinblastine|mesh-list
83903303|NCT00264953|Procarbazine|procarbazine|mesh-list
83903304|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903305|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
83903306|NCT00264953|Hormones|hormones|mesh-ancestor
83903307|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903308|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903309|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83903310|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903311|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83903312|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83903313|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83903314|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903315|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903316|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83903317|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83903318|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83903319|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83903320|NCT00300846|Aripiprazole|aripiprazole|mesh-list
83903321|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
83903322|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83903323|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83903324|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83903325|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903326|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903327|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
83903328|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
83903329|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903330|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903331|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83903332|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83903333|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
83903334|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83903335|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83903336|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83903337|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83903338|NCT00294996|Doxorubicin|doxorubicin|mesh-list
83903339|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83903340|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903341|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83903342|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83903343|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903344|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903345|NCT00265031|Prednisone|prednisone|mesh-list
83903346|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
83903347|NCT00265031|Etoposide|etoposide|mesh-list
83903348|NCT00265031|Vincristine|vincristine|mesh-list
83903349|NCT00265031|Doxorubicin|doxorubicin|mesh-list
83903350|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83903351|NCT00265031|Bleomycin|bleomycin|mesh-list
83903352|NCT00265031|Procarbazine|procarbazine|mesh-list
83903353|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903354|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
83903355|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903356|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903357|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83903358|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
83903359|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903360|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903361|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83903362|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903363|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
83903364|NCT00265031|Hormones|hormones|mesh-ancestor
83903365|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903366|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83903367|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83903368|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83903369|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83903370|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903371|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
83903372|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
83903373|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
83903374|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83903375|NCT00300924|Acetaminophen|acetaminophen|mesh-list
83903376|NCT00300924|Rizatriptan|rizatriptan|mesh-list
83903377|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903378|NCT00300924|Analgesics|analgesics|mesh-ancestor
83903379|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
83903380|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903381|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903382|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
83903383|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83903384|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
83903385|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903386|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903387|NCT00265070|Gefitinib|gefitinib|mesh-list
83903388|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903389|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83903390|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903391|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903392|NCT00295035|Celecoxib|celecoxib|mesh-list
83903393|NCT00295035|Curcumin|curcumin|mesh-list
83903394|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903395|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903396|NCT00295035|Analgesics|analgesics|mesh-ancestor
83903397|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
83903398|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903399|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903400|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903401|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903402|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83903403|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903404|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903405|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903406|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903407|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83903408|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83903409|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83903410|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903411|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903412|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
83903413|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903414|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903415|NCT00418275|Plasminogen|plasminogen|mesh-list
83903416|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83903417|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83903418|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903419|NCT00265304|Ketoprofen|ketoprofen|mesh-list
83903420|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903421|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903422|NCT00265304|Analgesics|analgesics|mesh-ancestor
83903423|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
83903424|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903425|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903427|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903428|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903429|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903430|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903431|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
83903432|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83903433|NCT00265460|Lobeline|lobeline|mesh-list
83903434|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83903435|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
83903436|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903437|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903438|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83903439|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83903440|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
83903441|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903442|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903443|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
83903444|NCT00301002|Alefacept|alefacept|mesh-list
83903445|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
83903446|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
83903447|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903448|NCT00265694|Carboplatin|carboplatin|mesh-list
83903449|NCT00265694|Gemcitabine|gemcitabine|mesh-list
83903450|NCT00265694|Vinorelbine|vinorelbine|mesh-list
83903451|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903452|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83903453|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
83903454|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903455|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83903456|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83903457|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
83903458|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83903459|NCT00265733|Paclitaxel|paclitaxel|mesh-list
83903460|NCT00265733|Capecitabine|capecitabine|mesh-list
83903461|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83903462|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83903463|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903464|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
83903465|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
83903466|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
83903467|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903468|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83903469|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
83903470|NCT00265772|Prednisolone|prednisolone|mesh-list
83903471|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903472|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
83903473|NCT00265772|Hormones|hormones|mesh-ancestor
83903474|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903475|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903476|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83903477|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903478|NCT00265811|Cetuximab|cetuximab|mesh-list
83903479|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83903480|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903481|NCT00295308|Clonidine|clonidine|mesh-list
83903482|NCT00295308|Analgesics|analgesics|mesh-ancestor
83903483|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
83903484|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903485|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903486|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83903487|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
83903488|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
83903489|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83903490|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83903491|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83903492|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
83903493|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903494|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903495|NCT00265928|Rituximab|rituximab|mesh-list
83903496|NCT00265928|Bortezomib|bortezomib|mesh-list
83903497|NCT00265928|Antibodies|antibodies|mesh-list
83903498|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
83903499|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83903500|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83903501|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
83903502|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903503|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83903504|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903505|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903506|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903507|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
83903508|NCT00295347|Spironolactone|spironolactone|mesh-list
83903509|NCT00295347|Escitalopram|escitalopram|mesh-list
83903510|NCT00295347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83903511|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83903512|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903513|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903514|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903515|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
83903516|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903517|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83903518|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
83903519|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903520|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83903521|NCT00295347|Diuretics|diuretics|mesh-ancestor
83903522|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
83903523|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903524|NCT00265967|Irbesartan|irbesartan|mesh-list
83903525|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83903526|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83903527|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83903528|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903529|NCT00295386|Zopiclone|zopiclone|mesh-list
83903530|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83903531|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903532|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903533|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83903534|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83903535|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903536|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83903537|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83903538|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903539|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903540|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
83903541|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903542|NCT00295425|Cyclosporine|cyclosporine|mesh-list
83903543|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
83903544|NCT00295425|Cyclosporins|cyclosporins|mesh-list
83903545|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903546|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903547|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903548|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
83903549|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903550|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
83903551|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903552|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
83903553|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903554|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83903555|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83903556|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903557|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83903558|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
83903559|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83903560|NCT00266123|Sirolimus|sirolimus|mesh-list
83903561|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83903562|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903563|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83903564|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903565|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
83903566|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903567|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
83903568|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903569|NCT00266162|Bosentan|bosentan|mesh-list
83903570|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83903571|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83903572|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903573|NCT00295464|Betamethasone|betamethasone|mesh-list
83903574|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903575|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
83903576|NCT00295464|Hormones|hormones|mesh-ancestor
83903577|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903578|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903579|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83903580|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
83903581|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83903582|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83903583|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903584|NCT00301392|Pitavastatin|pitavastatin|mesh-list
83903585|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83903586|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83903587|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83903588|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
83903589|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903590|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903591|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83903592|NCT00415844|Levodopa|levodopa|mesh-list
83903593|NCT00415844|Carbidopa|carbidopa|mesh-list
83903594|NCT00415844|Entacapone|entacapone|mesh-list
83903595|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83903596|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83903597|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83903598|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
83903599|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903600|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903601|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903602|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83903603|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903604|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83903605|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83903606|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
83903607|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
83903608|NCT00415883|Valsartan|valsartan|mesh-list
83903609|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83903610|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83903611|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83903612|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903613|NCT00295542|Atenolol|atenolol|mesh-list
83903614|NCT00295542|Valsartan|valsartan|mesh-list
83903615|NCT00295542|Telmisartan|telmisartan|mesh-list
83903616|NCT00295542|Carvedilol|carvedilol|mesh-list
83903617|NCT00295542|Olmesartan|olmesartan|mesh-list
83903618|NCT00295542|Enalapril|enalapril|mesh-list
83903619|NCT00295542|Lisinopril|lisinopril|mesh-list
83903620|NCT00295542|Nebivolol|nebivolol|mesh-list
83903621|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
83903622|NCT00295542|Doxazosin|doxazosin|mesh-list
83903623|NCT00295542|Indapamide|indapamide|mesh-list
83903624|NCT00295542|Quinapril|quinapril|mesh-list
83903625|NCT00295542|Torsemide|torsemide|mesh-list
83903626|NCT00295542|Spirapril|spirapril|mesh-list
83903627|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83903628|NCT00295542|Diuretics|diuretics|mesh-list
83903629|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83903630|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83903631|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903632|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83903633|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83903634|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903635|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903636|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
83903637|NCT00295542|Protective Agents|protective agents|mesh-ancestor
83903638|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83903639|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903640|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83903641|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
83903642|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83903643|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83903644|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83903645|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
83903646|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903647|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
83903648|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83903649|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83903650|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
83903651|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
83903652|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903653|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83903654|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83903655|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83903656|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83903657|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83903658|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83903659|NCT00266318|Interferons|interferons|mesh-list
83903660|NCT00266318|Ribavirin|ribavirin|mesh-list
83903661|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
83903662|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903663|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
83903664|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903665|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
83903666|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903667|NCT00266357|Gaboxadol|gaboxadol|mesh-list
83903668|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903669|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903670|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903671|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903672|NCT00266357|Analgesics|analgesics|mesh-ancestor
83903673|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
83903674|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
83903675|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
83903676|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
83903677|NCT00301509|Ribavirin|ribavirin|mesh-list
83903678|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
83903679|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903680|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
83903681|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903682|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
83903683|NCT00295698|Filaricides|filaricides|mesh-ancestor
83903684|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
83903685|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
83903686|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83903687|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903688|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83903689|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903690|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903691|NCT00266552|Risperidone|risperidone|mesh-list
83903692|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83903693|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
83903694|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903695|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903696|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903697|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83903698|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83903699|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903700|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83903701|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83903702|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
83903703|NCT00301587|Folic Acid|folic acid|mesh-list
83903704|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
83903705|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83903706|NCT00301587|Norgestimate|norgestimate|mesh-list
83903707|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83903708|NCT00301587|Estradiol|estradiol|mesh-list
83903709|NCT00301587|Estrogens|estrogens|mesh-ancestor
83903710|NCT00301587|Hormones|hormones|mesh-ancestor
83903711|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83903712|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903713|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83903714|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
83903715|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83903716|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83903717|NCT00301587|Hematinics|hematinics|mesh-ancestor
83903718|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
83903719|NCT00301587|Vitamins|vitamins|mesh-ancestor
83903720|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
83903721|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83903722|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83903723|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83903724|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83903725|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903726|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83903727|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83903728|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903729|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903730|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903731|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83903733|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
83903734|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83903735|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903736|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
83903737|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83903738|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83903739|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83903740|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903741|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903742|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
83903743|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903744|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903745|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83903746|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903747|NCT00295776|Lamotrigine|lamotrigine|mesh-list
83903748|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
83903749|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83903750|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83903751|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903752|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83903753|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903754|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83903755|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83903756|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83903757|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83903758|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83903759|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
83903760|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
83903761|NCT00266747|Amibegron|amibegron|mesh-list
83903762|NCT00266747|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83903763|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83903764|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83903765|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
83903766|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903767|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903768|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903769|NCT00266747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83903770|NCT00266786|Ketorolac|ketorolac|mesh-list
83903771|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83903772|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903773|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903774|NCT00266786|Analgesics|analgesics|mesh-ancestor
83903775|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
83903776|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903777|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903778|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903779|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903780|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903781|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903782|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903783|NCT00295815|Lomustine|lomustine|mesh-list
83903784|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83903785|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
83903786|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903787|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903788|NCT00295971|Fludarabine|fludarabine|mesh-list
83903789|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
83903790|NCT00295971|Thiotepa|thiotepa|mesh-list
83903791|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83903792|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903793|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83903794|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
83903795|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903796|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903797|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
83142877|NCT02443545|Deferiprone|deferiprone|mesh-list
83903798|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903799|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83903800|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
83903801|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83903802|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
83903803|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83903804|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903805|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903806|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903807|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903808|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903809|NCT00267176|Analgesics|analgesics|mesh-ancestor
83903810|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
83903811|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903812|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903813|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903814|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903815|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
83903816|NCT00296010|Doxorubicin|doxorubicin|mesh-list
83903817|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83903818|NCT00296010|Methotrexate|methotrexate|mesh-list
83903819|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903820|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
83903821|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903822|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903823|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83903824|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
83903825|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903826|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903827|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83903828|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83903829|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83903830|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83903831|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903832|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83903833|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
83903834|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83903835|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83903836|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
83903837|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
83903838|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83903839|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83903840|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
83903841|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83903842|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903843|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903844|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903845|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903846|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903847|NCT00267215|Analgesics|analgesics|mesh-ancestor
83903848|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
83903849|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903850|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903851|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903852|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903853|NCT00296049|Vancomycin|vancomycin|mesh-list
83903854|NCT00296049|Daptomycin|daptomycin|mesh-list
83903855|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83903856|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903857|NCT00267254|Atorvastatin|atorvastatin|mesh-list
83903858|NCT00267254|Simvastatin|simvastatin|mesh-list
83903859|NCT00267254|Torcetrapib|torcetrapib|mesh-list
83903860|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83903861|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83903862|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
83903863|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903864|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83903865|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83903866|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903867|NCT00301782|Carboplatin|carboplatin|mesh-list
83903868|NCT00301782|Etoposide|etoposide|mesh-list
83903869|NCT00301782|Vincristine|vincristine|mesh-list
83903870|NCT00301782|Bleomycin|bleomycin|mesh-list
83903871|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
83903872|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903873|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83903874|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83903875|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83903876|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903877|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903878|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
83903879|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
83903880|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
83903881|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83903883|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83903884|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903885|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83903886|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83903887|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83903888|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903889|NCT04718649|Celecoxib|celecoxib|mesh-list
83903890|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903891|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903892|NCT04718649|Analgesics|analgesics|mesh-ancestor
83903893|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
83903894|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903895|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903896|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903897|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903898|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83903899|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903900|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903901|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903902|NCT00301860|Cyclosporine|cyclosporine|mesh-list
83903903|NCT00301860|Methotrexate|methotrexate|mesh-list
83903904|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
83903905|NCT00301860|Fludarabine|fludarabine|mesh-list
83903906|NCT00301860|Melphalan|melphalan|mesh-list
83903907|NCT00301860|Cyclosporins|cyclosporins|mesh-list
83903908|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83903909|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83903910|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
83903911|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83903912|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903913|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83903914|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
83903915|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903916|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903917|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83903918|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903919|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83903920|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903921|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
83903922|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903923|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83903924|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
83903925|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83903926|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83903927|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83903928|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
83903929|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83903930|NCT00301899|Trastuzumab|trastuzumab|mesh-list
83903931|NCT00301899|Pertuzumab|pertuzumab|mesh-list
83903932|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83903933|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903934|NCT00296127|Celecoxib|celecoxib|mesh-list
83903935|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83903936|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83903937|NCT00296127|Analgesics|analgesics|mesh-ancestor
83903938|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
83903939|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903940|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903941|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83903942|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903943|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83903944|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83903945|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143025|NCT05438758|Esketamine|esketamine|mesh-list
83903946|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903947|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
83903948|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903949|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
83903950|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903951|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83903952|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83903953|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
83903954|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903955|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903956|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83903957|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
83903958|NCT00267683|Glyburide|glyburide|mesh-list
83903959|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83903960|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903961|NCT00267722|Visilizumab|visilizumab|mesh-list
83903962|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
83903963|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903964|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83903965|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83903966|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83903967|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903968|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903969|NCT00267917|Fenoterol|fenoterol|mesh-list
83903970|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83903971|NCT00267917|Ipratropium|ipratropium|mesh-list
83903972|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83903973|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
83903974|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83903975|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903976|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83903977|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
83903978|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
83903979|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
83903980|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83903981|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83903982|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83903983|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83903984|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
83903985|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83903986|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903987|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83903988|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
83903989|NCT00296361|Tacrolimus|tacrolimus|mesh-list
83903990|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83903991|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
83903992|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83903993|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83903994|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83903995|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83903996|NCT00415922|Levodopa|levodopa|mesh-list
83903997|NCT00415922|Carbidopa|carbidopa|mesh-list
83903998|NCT00415922|Entacapone|entacapone|mesh-list
83903999|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83904000|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83904001|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83904002|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
83904003|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904004|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904005|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904006|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83904007|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904008|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83904009|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83904010|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
83904011|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
83904012|NCT00415961|Paclitaxel|paclitaxel|mesh-list
83904013|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83904014|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904015|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904016|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904017|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904018|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904019|NCT00416039|Midazolam|midazolam|mesh-list
83904020|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83904021|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83904022|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904023|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904024|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83904025|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83904026|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904027|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83904028|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
83904029|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
83904030|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
83904031|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
83904032|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904033|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904034|NCT00296478|Progesterone|progesterone|mesh-list
83904035|NCT00296478|Progestins|progestins|mesh-ancestor
83904036|NCT00296478|Hormones|hormones|mesh-ancestor
83904037|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904038|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904039|NCT00268151|Capecitabine|capecitabine|mesh-list
83904040|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
83904041|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83904042|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
83904043|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904044|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904045|NCT00418080|Bicalutamide|bicalutamide|mesh-list
83904046|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
83904047|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83904048|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904049|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904050|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904051|NCT00268229|Cytarabine|cytarabine|mesh-list
83904052|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
83904053|NCT00268229|Daunorubicin|daunorubicin|mesh-list
83904054|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83904055|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
83904056|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904057|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904058|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
83904059|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904060|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83904061|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
83904062|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904063|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83904064|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904065|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83904066|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83904067|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83904068|NCT00302289|Caffeine|caffeine|mesh-list
83904069|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83904070|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904071|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83904072|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904073|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904074|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83904075|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83904076|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
83904077|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904078|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83904079|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83904080|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
83904081|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904082|NCT00296634|Antacids|antacids|mesh-ancestor
83904083|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904084|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904085|NCT00268619|Ramipril|ramipril|mesh-list
83904086|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83904087|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
83904088|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904089|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904090|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83904091|NCT00296712|Dexetimide|dexetimide|mesh-list
83904092|NCT00296712|Citalopram|citalopram|mesh-list
83904093|NCT00296712|Bupropion|bupropion|mesh-list
83904094|NCT00296712|Escitalopram|escitalopram|mesh-list
83904095|NCT00296712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83904096|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83904097|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904098|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904099|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904100|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
83904101|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904102|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83904103|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83904104|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
83904105|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
83904106|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904107|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83904108|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83904109|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
83904110|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83904111|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
83904112|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904113|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83904114|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
83904115|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83904116|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83904117|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904118|NCT00268697|Ezetimibe|ezetimibe|mesh-list
83904119|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83904120|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83904121|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
83904122|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904123|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83904124|NCT00296751|Fentanyl|fentanyl|mesh-list
83904125|NCT00296751|Meperidine|meperidine|mesh-list
83904126|NCT00296751|Bupivacaine|bupivacaine|mesh-list
83904127|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
83904128|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
83904129|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904130|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904131|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
83904132|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904133|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83904134|NCT00296751|Narcotics|narcotics|mesh-ancestor
83904135|NCT00296751|Analgesics|analgesics|mesh-ancestor
83904136|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83904137|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83904138|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
83904139|NCT00302367|Methylphenidate|methylphenidate|mesh-list
83904140|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83904141|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904142|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83904143|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83904144|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904145|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904146|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
83904147|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904148|NCT00296790|Zolpidem|zolpidem|mesh-list
83904149|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83904150|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83904151|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904152|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904153|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83904154|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
83904155|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
83904156|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904157|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904158|NCT00302406|Methylphenidate|methylphenidate|mesh-list
83904159|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83904160|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904161|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83904162|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83904163|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904164|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904165|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
83904166|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904167|NCT00268814|Methadone|methadone|mesh-list
83904168|NCT00268814|Heroin|heroin|mesh-list
83904169|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83904170|NCT00268814|Narcotics|narcotics|mesh-ancestor
83904171|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904172|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904173|NCT00268814|Analgesics|analgesics|mesh-ancestor
83904174|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
83904175|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904176|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
83904177|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
83904178|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
83904179|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83904180|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904181|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
83904182|NCT00296868|Vitamins|vitamins|mesh-ancestor
83904183|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
83904184|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904185|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
83904186|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904187|NCT00296868|Protective Agents|protective agents|mesh-ancestor
83904188|NCT00268970|Paclitaxel|paclitaxel|mesh-list
83904189|NCT00268970|Satraplatin|satraplatin|mesh-list
83904190|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83904191|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904192|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904193|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904194|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904195|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904196|NCT00296946|Bromides|bromides|mesh-list
83904197|NCT00296946|Ipratropium|ipratropium|mesh-list
83904198|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
83904199|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83904200|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
83904201|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904202|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904203|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83904204|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83904205|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83904206|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
83904207|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904208|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904209|NCT00269048|Darapladib|darapladib|mesh-list
83904210|NCT00269048|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83904211|NCT00269048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904212|NCT00269048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904213|NCT00302523|Tacrolimus|tacrolimus|mesh-list
83904214|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83904215|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
83904216|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904217|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83904218|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904219|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904220|NCT02960412|Furosemide|furosemide|mesh-list
83904221|NCT02960412|Diuretics|diuretics|mesh-ancestor
83904222|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
83904223|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904224|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83904225|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904226|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904227|NCT00269126|Fluticasone|fluticasone|mesh-list
83904228|NCT00269126|Xhance|xhance|mesh-list
83904229|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83904230|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83904231|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904232|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83904233|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
83904234|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904235|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904236|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83904237|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
83904238|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
83904239|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83904240|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83904241|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83143326|NCT04900766|Analgesics|analgesics|mesh-ancestor
83904242|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83904243|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
83904244|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904245|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904246|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
83904248|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904249|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
83904250|NCT00269204|Niacin|niacin|mesh-list
83904251|NCT00269204|Niacinamide|niacinamide|mesh-list
83904252|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
83904253|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83904254|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
83904255|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904256|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83904257|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
83904258|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
83904259|NCT00269204|Vitamins|vitamins|mesh-ancestor
83904260|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
83904261|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904262|NCT00297141|Capecitabine|capecitabine|mesh-list
83904263|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
83904264|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83904265|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
83904266|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904267|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904268|NCT00269243|Quinapril|quinapril|mesh-list
83904269|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83904270|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
83904271|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904272|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904273|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83904274|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83904275|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83904276|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904277|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83904278|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
83904279|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904280|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
83904281|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
83904282|NCT00297219|Calcium|calcium|mesh-list
83904283|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83904284|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904285|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83904286|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83904287|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
83904288|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83904289|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904290|NCT00418353|Dexamethasone|dexamethasone|mesh-list
83904291|NCT00418353|Betamethasone|betamethasone|mesh-list
83904292|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
83904293|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83904294|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
83904295|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
83904296|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83904297|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904298|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
83904299|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
83904300|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904301|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904302|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904303|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
83904304|NCT00418353|Hormones|hormones|mesh-ancestor
83904305|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904306|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83904307|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904308|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83904309|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
83904310|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83904311|NCT00418392|Minocycline|minocycline|mesh-list
83904312|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83904313|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904314|NCT00269555|Genistein|genistein|mesh-list
83904315|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83904316|NCT00269555|Protective Agents|protective agents|mesh-ancestor
83904317|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904318|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904319|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83904320|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904321|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904322|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
83904323|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83904324|NCT00269555|Estrogens|estrogens|mesh-ancestor
83904325|NCT00269555|Hormones|hormones|mesh-ancestor
83904326|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904327|NCT00418431|Bevacizumab|bevacizumab|mesh-list
83904328|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83904329|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904330|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83904331|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83904332|NCT00418431|Growth Substances|growth substances|mesh-ancestor
83904333|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904334|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
83904335|NCT00269594|Lamotrigine|lamotrigine|mesh-list
83904336|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
83904337|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83904338|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904339|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904340|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83904341|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904342|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83904343|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83904344|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904345|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904346|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83904347|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83904348|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83904349|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904350|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
83904351|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83904352|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
83904353|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904354|NCT00302835|Analgesics|analgesics|mesh-list
83904355|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
83904356|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904357|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904358|NCT00269750|Oxybutynin|oxybutynin|mesh-list
83904359|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
83904360|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
83904361|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904362|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904363|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83904364|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83904365|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
83904366|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904367|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904368|NCT00269750|Urological Agents|urological agents|mesh-ancestor
83904369|NCT00269789|Methylphenidate|methylphenidate|mesh-list
83904370|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83904371|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904372|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83904373|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83904374|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904375|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904376|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
83904377|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904378|NCT00302913|Clopidogrel|clopidogrel|mesh-list
83904379|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83904380|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83904381|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83904382|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83904383|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
83904384|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904385|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904386|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904387|NCT00269828|Paclitaxel|paclitaxel|mesh-list
83904388|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83143481|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
83904389|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83904390|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83904391|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904392|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904393|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904394|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904395|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904396|NCT00269867|Infliximab|infliximab|mesh-list
83904397|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83904398|NCT00269867|Antibodies|antibodies|mesh-list
83904399|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
83904400|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83904401|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
83904402|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904403|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904404|NCT00269867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83904405|NCT00269867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904406|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
83904407|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904408|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83904409|NCT00269906|Abciximab|abciximab|mesh-list
83904410|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
83904411|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83904412|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
83904413|NCT00269945|Hematinics|hematinics|mesh-ancestor
83904414|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
83904415|NCT00269984|Hematinics|hematinics|mesh-ancestor
83904416|NCT00297336|Topiramate|topiramate|mesh-list
83904417|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
83904418|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83904419|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904420|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
83904421|NCT00270023|Hematinics|hematinics|mesh-ancestor
83904422|NCT00297375|Acetaminophen|acetaminophen|mesh-list
83904423|NCT00297375|Tramadol|tramadol|mesh-list
83904424|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83904425|NCT00297375|Analgesics|analgesics|mesh-ancestor
83904426|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
83904427|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904428|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904429|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
83904430|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83904431|NCT00297375|Narcotics|narcotics|mesh-ancestor
83904432|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904433|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
83904434|NCT00270062|Hematinics|hematinics|mesh-ancestor
83904435|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
83904436|NCT00270101|Hematinics|hematinics|mesh-ancestor
83904437|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
83904438|NCT00270140|Hematinics|hematinics|mesh-ancestor
83904439|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
83904440|NCT00270179|Hematinics|hematinics|mesh-ancestor
83904441|NCT00297570|Interferons|interferons|mesh-list
83904442|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
83904443|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904444|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
83904445|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904446|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83904447|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904448|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904449|NCT00270335|Propofol|propofol|mesh-list
83904450|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83904451|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904452|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904453|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83904454|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
83904455|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
83904456|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83904457|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
83904458|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904459|NCT00270491|Paclitaxel|paclitaxel|mesh-list
83904460|NCT00270491|Capecitabine|capecitabine|mesh-list
83904461|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83904462|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904463|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904464|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904465|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904466|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904467|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83904468|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
83904469|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
83904470|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
83904471|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83904472|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
83904473|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83904474|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83904475|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904476|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83904477|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904478|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904479|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83904480|NCT00297765|Tacrolimus|tacrolimus|mesh-list
83904481|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83904482|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
83904483|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904484|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83904485|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904486|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904487|NCT00270569|Cisplatin|cisplatin|mesh-list
83904488|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904489|NCT00297804|Paclitaxel|paclitaxel|mesh-list
83904490|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83904491|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904492|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904493|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904494|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904495|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904496|NCT00270647|Vitamins|vitamins|mesh-list
83904497|NCT00270647|Vitamin E|vitamin e|mesh-list
83904498|NCT00270647|Beta Carotene|beta carotene|mesh-list
83904499|NCT00270647|Carotenoids|carotenoids|mesh-list
83904500|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
83904501|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904502|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
83904503|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904504|NCT00270647|Protective Agents|protective agents|mesh-ancestor
83904505|NCT00270647|Provitamins|provitamins|mesh-ancestor
83904506|NCT00297960|Olanzapine|olanzapine|mesh-list
83904507|NCT00297960|Ziprasidone|ziprasidone|mesh-list
83904508|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
83904509|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
83904510|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904511|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904512|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904513|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83904514|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83904515|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904516|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904517|NCT00297960|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83904518|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83904519|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904520|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904521|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904522|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
83904523|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83904524|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83904525|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
83904526|NCT00270881|Cytarabine|cytarabine|mesh-list
83904527|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
83904528|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83904529|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
83904530|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904531|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83904532|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83904533|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
83904534|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904535|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904536|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83904537|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83904538|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
83904539|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
83904540|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904541|NCT00298194|Z 338|z 338|mesh-list
83904542|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83904543|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904544|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904545|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
83904546|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904547|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904548|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904549|NCT00418548|Etanercept|etanercept|mesh-list
83904550|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83904551|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83904552|NCT00418548|Analgesics|analgesics|mesh-ancestor
83904553|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
83904554|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904555|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904556|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904557|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83904558|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904559|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83904560|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
83904561|NCT00418587|Vitamin D|vitamin d|mesh-list
83904562|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
83904563|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
83904564|NCT00418587|Vitamins|vitamins|mesh-list
83904565|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
83904566|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904567|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83904568|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83904569|NCT00416273|Bortezomib|bortezomib|mesh-list
83904570|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904571|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
83904572|NCT00306462|Nifedipine|nifedipine|mesh-list
83904573|NCT00306462|Analgesics|analgesics|mesh-ancestor
83904574|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
83904575|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904576|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904577|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
83904578|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904579|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83904580|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
83904581|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83904582|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904583|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904584|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83904585|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
83904586|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83904587|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
83904588|NCT00416390|Lycopene|lycopene|mesh-list
83904589|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904590|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
83904591|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904592|NCT00416390|Protective Agents|protective agents|mesh-ancestor
83904593|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904594|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83904595|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83904596|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904597|NCT00416429|Interferons|interferons|mesh-list
83904598|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
83904599|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
83904600|NCT00416429|Aldesleukin|aldesleukin|mesh-list
83904601|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83904602|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
83904603|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904604|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
83904605|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904606|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
83904607|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904608|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83904609|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83904610|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83904611|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83904612|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83904613|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
83904614|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83904615|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83904616|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83904617|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83904618|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83904619|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83904620|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
83904621|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904622|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83904623|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83904624|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904625|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904626|NCT00271271|Gemcitabine|gemcitabine|mesh-list
83904627|NCT00271271|Vinorelbine|vinorelbine|mesh-list
83904628|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
83904629|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83904630|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
83904631|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904632|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904633|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83904634|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904635|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904636|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904637|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83904638|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904639|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904640|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904641|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904642|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904643|NCT00271349|Budesonide|budesonide|mesh-list
83904644|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904645|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83904646|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
83904647|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904648|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904649|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83904650|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
83904651|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
83904652|NCT00271349|Hormones|hormones|mesh-ancestor
83904653|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904654|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
83904655|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83904656|NCT00306696|Spironolactone|spironolactone|mesh-list
83904657|NCT00306696|Furosemide|furosemide|mesh-list
83904658|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83904659|NCT00306696|Diuretics|diuretics|mesh-ancestor
83904660|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
83904661|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904662|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83904663|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904664|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904665|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83904666|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
83904667|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904668|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83904669|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83904670|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83904671|NCT00271427|Selenium|selenium|mesh-list
83904672|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
83904673|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904674|NCT00271427|Protective Agents|protective agents|mesh-ancestor
83904675|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904676|NCT00271427|Trace Elements|trace elements|mesh-ancestor
83904677|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
83904678|NCT00271466|Fentanyl|fentanyl|mesh-list
83904679|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83904680|NCT00271466|Narcotics|narcotics|mesh-ancestor
83904681|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904682|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904683|NCT00271466|Analgesics|analgesics|mesh-ancestor
83904684|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
83904685|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904686|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83904687|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83904688|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
83904689|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
83904690|NCT00306735|Palonosetron|palonosetron|mesh-list
83904691|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
83904692|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
83904693|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904694|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904695|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904696|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83904697|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83904698|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
83904699|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904700|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904702|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83904703|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
83904704|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83904705|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904706|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83904707|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83904708|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83904709|NCT00306774|Vitamin D|vitamin d|mesh-list
83904710|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
83904711|NCT00306774|Vitamins|vitamins|mesh-ancestor
83904712|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
83904713|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904714|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83904715|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83904716|NCT00306813|Lenalidomide|lenalidomide|mesh-list
83904717|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
83904718|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904719|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83904720|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83904721|NCT00306813|Growth Substances|growth substances|mesh-ancestor
83904722|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
83904723|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904724|NCT00271973|Oxycodone|oxycodone|mesh-list
83904725|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83904726|NCT00271973|Narcotics|narcotics|mesh-ancestor
83904727|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904728|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904729|NCT00271973|Analgesics|analgesics|mesh-ancestor
83904730|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
83904731|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904732|NCT00306969|Bexarotene|bexarotene|mesh-list
83904733|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904734|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
83904735|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83904736|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904737|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83904738|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
83904739|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904740|NCT00272051|Xaliproden|xaliproden|mesh-list
83904741|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83904742|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83904743|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
83904744|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904745|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904746|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904747|NCT00307203|Bupropion|bupropion|mesh-list
83904748|NCT00307203|Nicotine|nicotine|mesh-list
83904749|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83904750|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
83904751|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904752|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904753|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83904754|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83904755|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
83904756|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904757|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904758|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83904759|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
83904760|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904761|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83904762|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83904763|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904764|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
83904765|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83904766|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83904767|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904768|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
83143854|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
83904769|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83904770|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904772|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
83904773|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
83904774|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904775|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904776|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904777|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83904778|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83904779|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904780|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904781|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83904782|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
83904783|NCT00307515|Coagulants|coagulants|mesh-ancestor
83904784|NCT00272285|Granisetron|granisetron|mesh-list
83904785|NCT00272285|Ramosetron|ramosetron|mesh-list
83904786|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
83904787|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
83904788|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904789|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904790|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904791|NCT00272285|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83904792|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83904793|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
83904794|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904795|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904796|NCT00272324|Aspirin|aspirin|mesh-list
83904797|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83904798|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83904799|NCT00272324|Analgesics|analgesics|mesh-ancestor
83904800|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
83904801|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904802|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904803|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904804|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83904805|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83904806|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83904807|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904808|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83904809|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83904810|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904811|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
83904812|NCT00307593|Infliximab|infliximab|mesh-list
83904813|NCT00307593|Rituximab|rituximab|mesh-list
83904814|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83904815|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904816|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
83904817|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904818|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83904819|NCT00307593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83904820|NCT00307593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904821|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83904822|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904823|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83904824|NCT00307632|Estradiol|estradiol|mesh-list
83904825|NCT00307632|Estrogens|estrogens|mesh-ancestor
83904826|NCT00307632|Hormones|hormones|mesh-ancestor
83904827|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904828|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904829|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83904830|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
83904831|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83904832|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83904833|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83904834|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83904835|NCT00272480|Lamivudine|lamivudine|mesh-list
83904836|NCT00272480|Zidovudine|zidovudine|mesh-list
83904837|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83904838|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83904839|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904840|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904841|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
83904842|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904843|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83143930|NCT02153437|Sotalol|sotalol|mesh-list
83904844|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83904845|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
83904846|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
83904847|NCT00307671|Prednisone|prednisone|mesh-list
83904848|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
83904849|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83904850|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83904851|NCT00307671|Prednisolone|prednisolone|mesh-list
83904852|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
83904853|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
83904854|NCT00307671|Methotrexate|methotrexate|mesh-list
83904855|NCT00307671|Azathioprine|azathioprine|mesh-list
83904856|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83904857|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
83904858|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83904859|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
83904860|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904861|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83904862|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83904863|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
83904864|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904865|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904866|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83904867|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904868|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
83904869|NCT00307671|Hormones|hormones|mesh-ancestor
83904870|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904871|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83904872|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83904873|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
83904874|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83904875|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83904876|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
83904877|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83904878|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904879|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83904880|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83904881|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83904882|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83904883|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
83904884|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83904885|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904886|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
83904887|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
83904888|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904889|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904890|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83904891|NCT00307671|Protective Agents|protective agents|mesh-ancestor
83904892|NCT00272558|Carboplatin|carboplatin|mesh-list
83904893|NCT00272558|Vinorelbine|vinorelbine|mesh-list
83904894|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904895|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83904896|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904897|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904898|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904899|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904900|NCT00272597|Risperidone|risperidone|mesh-list
83904901|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83904902|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
83904903|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904904|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904905|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904906|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83904907|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83904908|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83904909|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83904910|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83904911|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
83904912|NCT00272636|Amiodarone|amiodarone|mesh-list
83904913|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83904914|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
83904915|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83904916|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83904917|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904918|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83144007|NCT02159287|Heparin|heparin|mesh-list
83904919|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83904920|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83904921|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904922|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83904923|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83904924|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83904925|NCT00281970|Docetaxel|docetaxel|mesh-list
83904926|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904927|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
83904928|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
83904929|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
83904930|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904931|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
83904932|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83904933|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83904934|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83904935|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
83904936|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
83904937|NCT00307827|Visilizumab|visilizumab|mesh-list
83904938|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
83904939|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904940|NCT00272714|Afimoxifene|afimoxifene|mesh-list
83904941|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83904942|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83904943|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
83904944|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904945|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904946|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83904947|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83904948|NCT00272753|Budesonide|budesonide|mesh-list
83904949|NCT00272753|Albuterol|albuterol|mesh-list
83904950|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
83904951|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83904952|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83904953|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
83904954|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904955|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904956|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83904957|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
83904958|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
83904959|NCT00272753|Hormones|hormones|mesh-ancestor
83904960|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83904961|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83904962|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83904963|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83904964|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
83904965|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83904966|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904967|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
83904968|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83904969|NCT00272831|Cilostazol|cilostazol|mesh-list
83904970|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83904971|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
83904972|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83904973|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83904974|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83904975|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
83904976|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83904977|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83904978|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904979|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83904980|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
83904981|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83904982|NCT00272831|Protective Agents|protective agents|mesh-ancestor
83904983|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83904984|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83904985|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904986|NCT00416468|Valsartan|valsartan|mesh-list
83904987|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83904988|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83904989|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83904990|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904991|NCT00307944|Pantoprazole|pantoprazole|mesh-list
83904992|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83904993|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83904994|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83904995|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83904996|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83904997|NCT00416507|Gemcitabine|gemcitabine|mesh-list
83904998|NCT00416507|Fluorouracil|fluorouracil|mesh-list
83904999|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905000|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83905001|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
83905002|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905003|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83905004|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
83905005|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905006|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
83905007|NCT00282126|Diuretics|diuretics|mesh-ancestor
83905008|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
83905009|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905010|NCT00282126|Expectorants|expectorants|mesh-ancestor
83905011|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905012|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83905013|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905014|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905015|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905016|NCT00272909|Piclozotan|piclozotan|mesh-list
83905017|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83905018|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83905019|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
83905020|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905021|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905022|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905023|NCT00282165|Naratriptan|naratriptan|mesh-list
83905024|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83905025|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83905026|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83905027|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
83905028|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905029|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905030|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905031|NCT00272948|Defibrotide|defibrotide|mesh-list
83905032|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83905033|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83905034|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905035|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83905036|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83905037|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
83905038|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
83905039|NCT00273026|Fluticasone|fluticasone|mesh-list
83905040|NCT00273026|Xhance|xhance|mesh-list
83905041|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83905042|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905043|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905044|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
83905045|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905046|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905047|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905048|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905049|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83905050|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83905051|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83905052|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83905053|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83905054|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
83905055|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905056|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905057|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83905058|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905059|NCT00282360|Trimetazidine|trimetazidine|mesh-list
83905060|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
83905061|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
83905062|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83905063|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83905064|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905065|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905067|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83905068|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905069|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
83905070|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
83905071|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83905072|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905073|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83905074|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905075|NCT00313950|Vaccines|vaccines|mesh-list
83905076|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
83905077|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905078|NCT00273299|Valsartan|valsartan|mesh-list
83905079|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83905080|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83905081|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83905082|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83905083|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905084|NCT00273299|Diuretics|diuretics|mesh-ancestor
83905085|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
83905086|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905087|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83905088|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83905089|NCT00418782|Naproxen|naproxen|mesh-list
83905090|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83905091|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83905092|NCT00418782|Analgesics|analgesics|mesh-ancestor
83905093|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
83905094|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905095|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905096|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905097|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83905098|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
83905099|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83905100|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905101|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905102|NCT00273338|Calcitriol|calcitriol|mesh-list
83905103|NCT00273338|Docetaxel|docetaxel|mesh-list
83905104|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905105|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
83905106|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
83905107|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
83905108|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905109|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83905110|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905111|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83905112|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83905113|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83905114|NCT00273338|Vitamins|vitamins|mesh-ancestor
83905115|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
83905116|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83905117|NCT00273377|Dexamethasone|dexamethasone|mesh-list
83905118|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905119|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
83905120|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
83905121|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905122|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905123|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83905124|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
83905125|NCT00273377|Hormones|hormones|mesh-ancestor
83905126|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905127|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83905128|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905129|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
83905130|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
83905131|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83905132|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83905133|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905134|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905135|NCT00273416|Urological Agents|urological agents|mesh-ancestor
83905136|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83905137|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
83905138|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83144232|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
83905140|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83905141|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905142|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905143|NCT00273455|Timolol|timolol|mesh-list
83905144|NCT00273455|Bimatoprost|bimatoprost|mesh-list
83905145|NCT00273455|Dorzolamide|dorzolamide|mesh-list
83905146|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905147|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905148|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83905149|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83905150|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
83905151|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905152|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905153|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83905154|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83905155|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83905156|NCT00273533|Ramipril|ramipril|mesh-list
83905157|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83905158|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
83905159|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905160|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905161|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83905162|NCT00273611|Vitamin D|vitamin d|mesh-list
83905163|NCT00273611|Vitamins|vitamins|mesh-ancestor
83905164|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
83905165|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905166|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83905167|NCT00273689|Albuterol|albuterol|mesh-list
83905168|NCT00273689|Montelukast|montelukast|mesh-list
83905169|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905170|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905171|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83905172|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
83905173|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905174|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905175|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83905176|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83905177|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905178|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905179|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
83905180|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905181|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
83905182|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83905183|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83905184|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83905185|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83905186|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83905187|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905188|NCT00308334|Domperidone|domperidone|mesh-list
83905189|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
83905190|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
83905191|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905192|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905193|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83905194|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83905195|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
83905196|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905197|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905198|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
83905199|NCT00273767|Hematinics|hematinics|mesh-ancestor
83905200|NCT00314379|Vitamin E|vitamin e|mesh-list
83905201|NCT00314379|Vitamins|vitamins|mesh-ancestor
83905202|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
83905203|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905204|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
83905205|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905206|NCT00314379|Protective Agents|protective agents|mesh-ancestor
83905207|NCT00273884|Cytarabine|cytarabine|mesh-list
83905208|NCT00273884|Amonafide|amonafide|mesh-list
83905209|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83905210|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
83905211|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905212|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905213|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
83905215|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83905216|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
83905217|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905218|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905219|NCT00308373|Metformin|metformin|mesh-list
83905220|NCT00308373|Pioglitazone|pioglitazone|mesh-list
83905221|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83905222|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83905223|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905224|NCT00273962|Albuterol|albuterol|mesh-list
83905225|NCT00273962|Ipratropium|ipratropium|mesh-list
83905226|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905227|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
83905228|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905229|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905230|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905231|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905232|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
83905233|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83905234|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83905235|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83905236|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83905237|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
83905238|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905239|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905240|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83905241|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
83905242|NCT00274001|Nevirapine|nevirapine|mesh-list
83905243|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83905244|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83905245|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905246|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905247|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
83905248|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905249|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83905250|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83905251|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83905252|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83905253|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
83905254|NCT00274040|Ipratropium|ipratropium|mesh-list
83905255|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905256|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
83905257|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905258|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905259|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905260|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905261|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
83905262|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83905263|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
83905264|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905265|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905266|NCT00314457|Bupivacaine|bupivacaine|mesh-list
83905267|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
83905268|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
83905269|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905270|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905271|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
83905272|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905273|NCT00308451|Chromium|chromium|mesh-list
83905274|NCT00308451|Biotin|biotin|mesh-list
83905275|NCT00308451|Picolinic acid|picolinic acid|mesh-list
83905276|NCT00308451|Trace Elements|trace elements|mesh-ancestor
83905277|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
83905278|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905279|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
83905280|NCT00308451|Vitamins|vitamins|mesh-ancestor
83905281|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83905282|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
83905283|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
83905284|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905285|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
83905286|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905287|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
83144384|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
83905288|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905289|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905290|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905291|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905292|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
83905293|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83905294|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
83905295|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905296|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905297|NCT00274118|Telmisartan|telmisartan|mesh-list
83905298|NCT00274118|Enalapril|enalapril|mesh-list
83905299|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83905300|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83905301|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83905302|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905303|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83905304|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
83905305|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905306|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83905307|NCT00308490|Hematinics|hematinics|mesh-ancestor
83905308|NCT00416585|Isotretinoin|isotretinoin|mesh-list
83905309|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83905310|NCT00308529|Bevacizumab|bevacizumab|mesh-list
83905311|NCT00308529|Carboplatin|carboplatin|mesh-list
83905312|NCT00308529|Irinotecan|irinotecan|mesh-list
83905313|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83905314|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905315|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83905316|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83905317|NCT00308529|Growth Substances|growth substances|mesh-ancestor
83905318|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905319|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
83905320|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83905321|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83905322|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905323|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905324|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
83905325|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
83905326|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83905327|NCT00274235|Mefloquine|mefloquine|mesh-list
83905328|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
83905329|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83905330|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83905331|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905332|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83905333|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905334|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905335|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83905336|NCT00274274|Insulin|insulin|mesh-list
83905337|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83905338|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
83905339|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
83905340|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83905341|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905342|NCT00308607|Interferons|interferons|mesh-list
83905343|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
83905344|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
83905345|NCT00308607|Bevacizumab|bevacizumab|mesh-list
83905346|NCT00308607|Dacarbazine|dacarbazine|mesh-list
83905347|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83905348|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905349|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83905350|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83905351|NCT00308607|Growth Substances|growth substances|mesh-ancestor
83905352|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905353|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
83905354|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
83905355|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905356|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
83905357|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83905358|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
83905359|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905360|NCT00314613|Risperidone|risperidone|mesh-list
83905361|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
83905362|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83905363|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
83905364|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905365|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905366|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905368|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905369|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83905370|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83905371|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
83905372|NCT00274352|Adalimumab|adalimumab|mesh-list
83905373|NCT00274352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83905374|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905375|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83905376|NCT00314652|Buprenorphine|buprenorphine|mesh-list
83905377|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83905378|NCT00314652|Narcotics|narcotics|mesh-ancestor
83905379|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905380|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905381|NCT00314652|Analgesics|analgesics|mesh-ancestor
83905382|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
83905383|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905384|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83905385|NCT00274391|Amiloride|amiloride|mesh-list
83905386|NCT00274391|Diuretics|diuretics|mesh-ancestor
83905387|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
83905388|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905389|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83905390|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83905391|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83905392|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905393|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83905394|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83905395|NCT00274430|Dexamethasone|dexamethasone|mesh-list
83905396|NCT00274430|Tadalafil|tadalafil|mesh-list
83905397|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905398|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
83905399|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
83905400|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905401|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905402|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83905403|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
83905404|NCT00274430|Hormones|hormones|mesh-ancestor
83905405|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905406|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83905407|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905408|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
83905409|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83905410|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83905411|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905412|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905413|NCT00274430|Urological Agents|urological agents|mesh-ancestor
83905414|NCT00274508|Bromides|bromides|mesh-list
83905415|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
83905416|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905417|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
83905418|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905419|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905420|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905421|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905422|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
83905423|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83905424|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
83905425|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905426|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905427|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
83905428|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
83905429|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905430|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
83905431|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905432|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905433|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905434|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905435|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
83905436|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83905437|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
83905438|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905439|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905440|NCT00308763|Bupropion|bupropion|mesh-list
83905441|NCT00308763|Nicotine|nicotine|mesh-list
83905442|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83905443|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
83905444|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905445|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905446|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83905447|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83905448|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
83905449|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905450|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905451|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83905452|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
83905453|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83905454|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83905455|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83905456|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83905457|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
83905458|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83905459|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83905460|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905461|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83905462|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83905463|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
83905464|NCT00274820|Thalidomide|thalidomide|mesh-list
83905465|NCT00274820|Dexamethasone|dexamethasone|mesh-list
83905466|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
83905467|NCT00274820|Vitamins|vitamins|mesh-ancestor
83905468|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
83905469|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905470|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905471|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
83905472|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
83905473|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905474|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83905475|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
83905476|NCT00274820|Hormones|hormones|mesh-ancestor
83905477|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905478|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83905479|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905480|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
83905481|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905482|NCT00274820|Protective Agents|protective agents|mesh-ancestor
83905483|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83905484|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
83905485|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
83905486|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83905487|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905488|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83905489|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83905490|NCT00274820|Growth Substances|growth substances|mesh-ancestor
83905491|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83905492|NCT00308841|Lidocaine|lidocaine|mesh-list
83905493|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
83905494|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
83905495|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905496|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905497|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
83905498|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905499|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83905500|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83905501|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83905502|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83905503|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905504|NCT00274859|Gemcitabine|gemcitabine|mesh-list
83905505|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
83905506|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83905507|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
83905508|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905509|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905510|NCT00274898|Celecoxib|celecoxib|mesh-list
83905511|NCT00274898|Docetaxel|docetaxel|mesh-list
83905512|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905513|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
83905514|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
83905515|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
83905516|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905517|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83905518|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83905519|NCT00274898|Analgesics|analgesics|mesh-ancestor
83905520|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
83905521|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905522|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905523|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905524|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83905525|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83905526|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83905527|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905528|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
83905529|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83905530|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83905531|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905532|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
83905533|NCT00308880|Coagulants|coagulants|mesh-ancestor
83905534|NCT00277199|Abatacept|abatacept|mesh-list
83905535|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83905536|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905537|NCT00277199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83905538|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905539|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83905540|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
83905541|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905542|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83905543|NCT00277472|Valsartan|valsartan|mesh-list
83905544|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83905545|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83905546|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83905547|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83905548|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905549|NCT00277472|Diuretics|diuretics|mesh-ancestor
83905550|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
83905551|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905552|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83905553|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83905554|NCT00277511|Levofloxacin|levofloxacin|mesh-list
83905555|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83905556|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905557|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83905558|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83905559|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83905560|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905561|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905562|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905563|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83905564|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83905565|NCT00315003|Azithromycin|azithromycin|mesh-list
83905566|NCT00315003|Telithromycin|telithromycin|mesh-list
83905567|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83905568|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905569|NCT00277550|Tegaserod|tegaserod|mesh-list
83905570|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83905571|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
83905572|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905573|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905574|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905575|NCT00277589|Iodine|iodine|mesh-list
83905576|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83905577|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905578|NCT00277589|Trace Elements|trace elements|mesh-ancestor
83905579|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
83905580|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905581|NCT00315042|Penicillins|penicillins|mesh-list
83905582|NCT00315042|Telithromycin|telithromycin|mesh-list
83905583|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83905584|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905585|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83905586|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
83905587|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83905588|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83905589|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83905590|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905591|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905592|NCT00315081|Bromocriptine|bromocriptine|mesh-list
83905593|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83905594|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83905595|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
83905596|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905597|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905598|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
83905599|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
83905600|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905601|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905602|NCT00277706|Vitamin D|vitamin d|mesh-list
83905603|NCT00277706|Calcium|calcium|mesh-list
83905604|NCT00277706|Vitamins|vitamins|mesh-ancestor
83905605|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
83905606|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905607|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83905608|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83905609|NCT00277862|Ribavirin|ribavirin|mesh-list
83905610|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
83905611|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
83905612|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83905613|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83905614|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
83905615|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905616|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
83905617|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905618|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
83905619|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905620|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905621|NCT00278018|Immunomodulating Agents|immunomodulating agents|mesh-list
83905622|NCT00278018|Immunologic Factors|immunologic factors|mesh-ancestor
83905623|NCT00278018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905624|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
83905625|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83905626|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905627|NCT00315276|Modafinil|modafinil|mesh-list
83905628|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83905629|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362171|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83905630|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83905631|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83905632|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83905633|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905634|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
83905635|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83905636|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905637|NCT00278174|Interferons|interferons|mesh-list
83905638|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
83905639|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83905640|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905641|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
83905642|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905643|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
83905644|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905645|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
83905646|NCT00278213|Fludarabine|fludarabine|mesh-list
83905647|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
83905648|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
83905649|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
83905650|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83905651|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
83905652|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905653|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83905654|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83905655|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
83905656|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905657|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905658|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83905659|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83905660|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
83905661|NCT00278213|Analgesics|analgesics|mesh-ancestor
83905662|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
83905663|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905664|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83905665|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83905666|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905667|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83905669|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83905670|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905671|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83905672|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83905673|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905674|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905675|NCT00315432|Interferons|interferons|mesh-list
83905676|NCT00315432|Ribavirin|ribavirin|mesh-list
83905677|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905678|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
83905679|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905680|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
83905681|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905682|NCT00278330|Vorinostat|vorinostat|mesh-list
83905683|NCT00278330|Alvocidib|alvocidib|mesh-list
83905684|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905685|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83905686|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905687|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905688|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83905689|NCT00278330|Growth Substances|growth substances|mesh-ancestor
83905690|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905691|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83905692|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83905693|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83905694|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83905695|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
83905696|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905697|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83905698|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83905699|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905700|NCT00278369|Aldesleukin|aldesleukin|mesh-list
83905701|NCT00278369|Interleukin-2|interleukin-2|mesh-list
83905702|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
83905703|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905704|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83905705|NCT00278369|Analgesics|analgesics|mesh-ancestor
83905706|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
83905707|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905708|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905709|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83905710|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83905711|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
83905712|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905713|NCT00315549|Penicillins|penicillins|mesh-list
83905714|NCT00315549|Telithromycin|telithromycin|mesh-list
83905715|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83905716|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905717|NCT00278408|Prednisone|prednisone|mesh-list
83905718|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
83905719|NCT00278408|Rituximab|rituximab|mesh-list
83905720|NCT00278408|Doxorubicin|doxorubicin|mesh-list
83905721|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83905722|NCT00278408|Vincristine|vincristine|mesh-list
83905723|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83905724|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
83905725|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905726|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83905727|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83905728|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
83905729|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905730|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905731|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83905732|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83905733|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83905734|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83905735|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83905736|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905737|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905738|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
83905739|NCT00278408|Hormones|hormones|mesh-ancestor
83905740|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905741|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83905742|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83905743|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
83905744|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
83905745|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
83905746|NCT00315666|Memantine|memantine|mesh-list
83905747|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83905748|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83905749|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
83905750|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905751|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905752|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905753|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83905754|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83905755|NCT00315744|Fluticasone|fluticasone|mesh-list
83905756|NCT00315744|Xhance|xhance|mesh-list
83905757|NCT00315744|Albuterol|albuterol|mesh-list
83905758|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83905759|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905760|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83905761|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
83905762|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905763|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905764|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83905765|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
83905766|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83905767|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83905768|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83905769|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83905770|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83905771|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
83905772|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905773|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905774|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
83905775|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83905776|NCT00309543|Leucovorin|leucovorin|mesh-list
83905777|NCT00309543|Fluorouracil|fluorouracil|mesh-list
83905778|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
83905779|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905780|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83905781|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905782|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83905783|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
83905784|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905785|NCT00309543|Antidotes|antidotes|mesh-ancestor
83905786|NCT00309543|Protective Agents|protective agents|mesh-ancestor
83905787|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
83905788|NCT00309543|Vitamins|vitamins|mesh-ancestor
83905789|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
83905790|NCT00315861|Pemetrexed|pemetrexed|mesh-list
83905791|NCT00315861|Topotecan|topotecan|mesh-list
83905792|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905793|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905794|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905795|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83905796|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83905797|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83905798|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83905799|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
83905800|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83905801|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905802|NCT00315900|Valproic Acid|valproic acid|mesh-list
83905803|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83905804|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
83905805|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83905806|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83905807|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83905808|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905809|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905810|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
83905811|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905812|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905813|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
83905814|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905815|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
83905816|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83905817|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
83905818|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905819|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83905820|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83905821|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
83905822|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83905823|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83905824|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83905825|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905826|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905827|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83905828|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83905829|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
83905830|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905831|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905832|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83905833|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83905834|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
83905835|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
83905836|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
83905837|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83905838|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83905839|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905840|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905841|NCT00309816|Urological Agents|urological agents|mesh-ancestor
83905842|NCT00279266|Thiamine|thiamine|mesh-list
83905843|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
83905844|NCT00279266|Vitamins|vitamins|mesh-ancestor
83905845|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
83905846|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905847|NCT00316095|Telmisartan|telmisartan|mesh-list
83905848|NCT00316095|Simvastatin|simvastatin|mesh-list
83905849|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83905850|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83905851|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
83905852|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905853|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83905854|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83905855|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905856|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83905857|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83905858|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83905859|NCT00279344|Fentanyl|fentanyl|mesh-list
83905860|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83905861|NCT00279344|Narcotics|narcotics|mesh-ancestor
83905862|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83905863|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905864|NCT00279344|Analgesics|analgesics|mesh-ancestor
83905865|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
83905866|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905867|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83905868|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83905869|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
83905870|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
83905871|NCT00418860|Aspirin|aspirin|mesh-list
83905872|NCT00418860|Clopidogrel|clopidogrel|mesh-list
83905873|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83905874|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83905875|NCT00418860|Analgesics|analgesics|mesh-ancestor
83905876|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
83905877|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83905878|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905879|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905880|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83905881|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83905882|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83905883|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905884|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83905885|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83905886|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905887|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
83905888|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83905889|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83905890|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83905891|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
83905892|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905893|NCT00316212|INS 50589|ins 50589|mesh-list
83905894|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83905895|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83905896|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
83905897|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83905898|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905899|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905900|NCT00309855|Anastrozole|anastrozole|mesh-list
83905901|NCT00309855|Testosterone|testosterone|mesh-list
83905902|NCT00309855|Dutasteride|dutasteride|mesh-list
83905903|NCT00309855|Androgens|androgens|mesh-ancestor
83905904|NCT00309855|Hormones|hormones|mesh-ancestor
83905905|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905906|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905907|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83905908|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905909|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83905910|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83905911|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905912|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905913|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
83905914|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83905915|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83905916|NCT00279383|Thrombin|thrombin|mesh-list
83905917|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
83905918|NCT00279383|Coagulants|coagulants|mesh-ancestor
83905919|NCT00279422|Visilizumab|visilizumab|mesh-list
83905920|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
83905921|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905922|NCT00309894|Ketoconazole|ketoconazole|mesh-list
83905923|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
83905924|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83905925|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83905926|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83905927|NCT00309894|Sargramostim|sargramostim|mesh-list
83905928|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83905929|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
83905930|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905931|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
83905932|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905933|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83905934|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83905935|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905936|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905937|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83905938|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
83905939|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83905940|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83905941|NCT00279461|Vitamin D|vitamin d|mesh-list
83905942|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
83905943|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
83905944|NCT00279461|Vitamins|vitamins|mesh-list
83905945|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
83905946|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905947|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83905948|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83905949|NCT00316329|Artesunate|artesunate|mesh-list
83905950|NCT00316329|Amodiaquine|amodiaquine|mesh-list
83905951|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
83905952|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83905953|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83905954|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83905955|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905956|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
83905957|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
83905958|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83905959|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
83905960|NCT00279539|Mitogens|mitogens|mesh-list
83905961|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
83905962|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
83905963|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905964|NCT00279539|Growth Substances|growth substances|mesh-ancestor
83905965|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83905966|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
83905967|NCT00279578|Factor VIII|factor viii|mesh-list
83905968|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83905969|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83905970|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905971|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
83905972|NCT00279578|Coagulants|coagulants|mesh-ancestor
83905973|NCT00279617|Levetiracetam|levetiracetam|mesh-list
83905974|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
83905975|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
83905976|NCT00310011|Paclitaxel|paclitaxel|mesh-list
83905977|NCT00310011|Gemcitabine|gemcitabine|mesh-list
83905978|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83905979|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905980|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
83905981|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
83905982|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
83905983|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905984|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83905985|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
83905986|NCT00316407|Paclitaxel|paclitaxel|mesh-list
83905987|NCT00316407|Carboplatin|carboplatin|mesh-list
83905988|NCT00316407|Lapatinib|lapatinib|mesh-list
83905989|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83905990|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83905991|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
83905992|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
83905993|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
83905994|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83905995|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83905996|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83905997|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
83905998|NCT00310089|Docetaxel|docetaxel|mesh-list
83905999|NCT00310089|Doxorubicin|doxorubicin|mesh-list
83906000|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83906001|NCT00310089|Cediranib|cediranib|mesh-list
83906002|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906003|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
83906004|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906005|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906006|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83906007|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
83906008|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906009|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906010|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83906011|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83906012|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83906013|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83906014|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83906015|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906016|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906017|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906018|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83906019|NCT00279734|Abatacept|abatacept|mesh-list
83906020|NCT00279734|Vaccines|vaccines|mesh-list
83906021|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
83906022|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906023|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83906024|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906025|NCT00279734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83906026|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906027|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906028|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906029|NCT00310128|Cytarabine|cytarabine|mesh-list
83906030|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
83906031|NCT00310128|Rituximab|rituximab|mesh-list
83906032|NCT00310128|Etoposide|etoposide|mesh-list
83906033|NCT00310128|Antibodies|antibodies|mesh-list
83906034|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
83906035|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83906036|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
83906037|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906038|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83906039|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906040|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906041|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83145140|NCT02610140|Vinorelbine|vinorelbine|mesh-list
83906042|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906043|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906044|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906045|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906046|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83906047|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
83906048|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
83906049|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906050|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906051|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906052|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
83906053|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
83906054|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906055|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906056|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
83906057|NCT00310128|Hormones|hormones|mesh-ancestor
83906058|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906059|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83906060|NCT00310128|Protective Agents|protective agents|mesh-ancestor
83906061|NCT00316563|Dronabinol|dronabinol|mesh-list
83906062|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
83906063|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906064|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83906065|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906066|NCT00316563|Analgesics|analgesics|mesh-ancestor
83906067|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
83906068|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906069|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83906070|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83906071|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906072|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906073|NCT00316563|Hormones|hormones|mesh-ancestor
83906074|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906075|NCT00416819|Leucovorin|leucovorin|mesh-list
83906076|NCT00416819|Cytarabine|cytarabine|mesh-list
83906077|NCT00416819|Rituximab|rituximab|mesh-list
83906078|NCT00416819|Methotrexate|methotrexate|mesh-list
83906079|NCT00416819|Etoposide|etoposide|mesh-list
83906080|NCT00416819|Temozolomide|temozolomide|mesh-list
83906081|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
83906082|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
83906083|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83906084|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906085|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
83906086|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906087|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906088|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83906089|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
83906090|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83906091|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83906092|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
83906093|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906094|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
83906095|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906096|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83906097|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906098|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83906099|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83906100|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906101|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906102|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
83906103|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906104|NCT00416819|Antidotes|antidotes|mesh-ancestor
83906105|NCT00416819|Protective Agents|protective agents|mesh-ancestor
83906106|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
83906107|NCT00416819|Vitamins|vitamins|mesh-ancestor
83906108|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
83906109|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83906110|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
83906111|NCT00310206|Vaccines|vaccines|mesh-list
83906112|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
83906113|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906114|NCT00280007|Bevacizumab|bevacizumab|mesh-list
83906115|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83906116|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906117|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83906118|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83906119|NCT00280007|Growth Substances|growth substances|mesh-ancestor
83906120|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906121|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
83906122|NCT00316680|Vaccines|vaccines|mesh-list
83906123|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
83906124|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906125|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
83906126|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
83906127|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906128|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906129|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
83906130|NCT00310323|Caffeine|caffeine|mesh-list
83906131|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83906132|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906133|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83906134|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906135|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906136|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83906137|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83906138|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
83906139|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906140|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
83906141|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83906142|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83906143|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83906144|NCT00280280|Baclofen|baclofen|mesh-list
83906145|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83906146|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906147|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83906148|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906149|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83906150|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
83906151|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
83906152|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906153|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906154|NCT00316758|Metformin|metformin|mesh-list
83906155|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906156|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906157|NCT00280358|Fluticasone|fluticasone|mesh-list
83906158|NCT00280358|Xhance|xhance|mesh-list
83906159|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
83906160|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906161|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83906162|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
83906163|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906164|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906165|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83906166|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
83906167|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83906168|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83906169|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83906170|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83906171|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83906172|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
83906173|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906174|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906175|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
83906176|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906177|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83906178|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83906179|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906180|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906181|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
83906182|NCT00280436|Casopitant|casopitant|mesh-list
83906183|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
83906184|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
83906185|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906186|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906187|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906188|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83906189|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906190|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906191|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
83906192|NCT00280514|Cefpirome|cefpirome|mesh-list
83906193|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83145283|NCT02110355|Dabrafenib|dabrafenib|mesh-list
83906194|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906195|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906196|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906197|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906198|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906199|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906200|NCT00280553|Bupivacaine|bupivacaine|mesh-list
83906201|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
83906202|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
83906203|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906204|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906205|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
83906206|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906207|NCT00316875|Doxorubicin|doxorubicin|mesh-list
83906208|NCT00316875|Lapatinib|lapatinib|mesh-list
83906209|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83906210|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906211|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906212|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906213|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906214|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906215|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83906216|NCT00316953|Dasatinib|dasatinib|mesh-list
83906217|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906218|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83906219|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906220|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906221|NCT00419172|Rifampin|rifampin|mesh-list
83906222|NCT00419172|Deferasirox|deferasirox|mesh-list
83906223|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83906224|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
83906225|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83906226|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906227|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
83906228|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83906229|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906230|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906231|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83906232|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83906233|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83906234|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83906235|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83906236|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83906237|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83906238|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
83906239|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
83906240|NCT00280787|Paclitaxel|paclitaxel|mesh-list
83906241|NCT00280787|Carboplatin|carboplatin|mesh-list
83906242|NCT00280787|Irinotecan|irinotecan|mesh-list
83906243|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83906244|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906245|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
83906246|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
83906247|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
83906248|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906249|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83906250|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906251|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906252|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
83906253|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83906254|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83906255|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906256|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906257|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906258|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906259|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906260|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906261|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83906262|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
83906263|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83906264|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906265|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83906266|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83906267|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83906268|NCT00280865|Pioglitazone|pioglitazone|mesh-list
83906269|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906270|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906271|NCT00317031|Naltrexone|naltrexone|mesh-list
83906272|NCT00317031|Acamprosate|acamprosate|mesh-list
83906273|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83906274|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83906275|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906276|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
83906277|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906278|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83906279|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83906280|NCT00317070|Protective Agents|protective agents|mesh-ancestor
83906281|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906282|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83906283|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
83906284|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906285|NCT00281255|Allopurinol|allopurinol|mesh-list
83906286|NCT00281255|Dobutamine|dobutamine|mesh-list
83906287|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
83906288|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906289|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906290|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
83906291|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906292|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83906293|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
83906294|NCT00281255|Protective Agents|protective agents|mesh-ancestor
83906295|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906296|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83906297|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
83906298|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
83906299|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906300|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83906301|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83906302|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83906303|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
83906304|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906305|NCT00317187|Vaccines|vaccines|mesh-list
83906306|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
83906307|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906308|NCT00310908|Tramadol|tramadol|mesh-list
83906309|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83906310|NCT00310908|Narcotics|narcotics|mesh-ancestor
83906311|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906312|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906313|NCT00310908|Analgesics|analgesics|mesh-ancestor
83906314|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
83906315|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906316|NCT00281489|Anesthetics|anesthetics|mesh-list
83906317|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906318|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906319|NCT00317343|Anticoagulants|anticoagulants|mesh-list
83906320|NCT00317343|Bivalirudin|bivalirudin|mesh-list
83906321|NCT00317343|Thrombin|thrombin|mesh-list
83906322|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
83906323|NCT00317343|Coagulants|coagulants|mesh-ancestor
83906324|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
83906325|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83906326|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
83906327|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906328|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906329|NCT00416858|Fluorouracil|fluorouracil|mesh-list
83906330|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906331|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
83906332|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906333|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83906334|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906335|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
83906336|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906337|NCT00416897|Dexamethasone|dexamethasone|mesh-list
83906338|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906339|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
83906340|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
83906341|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906342|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906343|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906344|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
83906345|NCT00416897|Hormones|hormones|mesh-ancestor
83906346|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906347|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83906348|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906349|NCT00417014|Prednisolone|prednisolone|mesh-list
83906350|NCT00417014|Vinblastine|vinblastine|mesh-list
83906351|NCT00417014|Procarbazine|procarbazine|mesh-list
83906352|NCT00417014|Chlorambucil|chlorambucil|mesh-list
83906353|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906354|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
83906355|NCT00417014|Hormones|hormones|mesh-ancestor
83906356|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906357|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906358|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83906359|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906360|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83906361|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
83906362|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
83906363|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
83906364|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906365|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83906366|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
83906367|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
83906368|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906369|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
83906370|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83906371|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83906372|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906373|NCT00317421|Urological Agents|urological agents|mesh-ancestor
83906374|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
83906375|NCT00417053|Melphalan|melphalan|mesh-list
83906376|NCT00417053|Busulfan|busulfan|mesh-list
83906377|NCT00417053|Carboplatin|carboplatin|mesh-list
83906378|NCT00417053|Doxorubicin|doxorubicin|mesh-list
83906379|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83906380|NCT00417053|Etoposide|etoposide|mesh-list
83906381|NCT00417053|Vincristine|vincristine|mesh-list
83906382|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
83906383|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906384|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
83906385|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906386|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906387|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83906388|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
83906389|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906390|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906391|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83906392|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83906393|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906394|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906395|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906396|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83906397|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83906398|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83906399|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83906400|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
83906401|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83906402|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
83906403|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906404|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906405|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83906406|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
83906407|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
83906408|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83906409|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
83906410|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906411|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906412|NCT00317499|Etanercept|etanercept|mesh-list
83906413|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83906414|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906415|NCT00317499|Analgesics|analgesics|mesh-ancestor
83906416|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
83906417|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906418|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906419|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906421|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906422|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906423|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
83906424|NCT00281606|Ritonavir|ritonavir|mesh-list
83906425|NCT00281606|Lopinavir|lopinavir|mesh-list
83906426|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83906427|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83906428|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
83906429|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906430|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906431|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83906432|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83906433|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
83906434|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906435|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83906436|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83906437|NCT00317538|Infliximab|infliximab|mesh-list
83906438|NCT00317538|Etanercept|etanercept|mesh-list
83906439|NCT00317538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83906440|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906441|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
83906442|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906443|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906444|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83906445|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906446|NCT00317538|Analgesics|analgesics|mesh-ancestor
83906447|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
83906448|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906449|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906450|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906451|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
83906452|NCT00281645|Analgesics|analgesics|mesh-list
83906453|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
83906454|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906455|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906456|NCT00317577|Timolol|timolol|mesh-list
83906457|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83906458|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83906459|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83906460|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
83906461|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906462|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906463|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906464|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83906465|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83906466|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83906467|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83906468|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83906469|NCT00317655|Ibuprofen|ibuprofen|mesh-list
83906470|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83906471|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906472|NCT00317655|Analgesics|analgesics|mesh-ancestor
83906473|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
83906474|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906475|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906476|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906477|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906478|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83906479|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906480|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906481|NCT00281996|Gemcitabine|gemcitabine|mesh-list
83906482|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
83906483|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83906484|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
83906485|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906486|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906487|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83906488|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906489|NCT00311259|Melatonin|melatonin|mesh-list
83906490|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
83906491|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906492|NCT00311259|Protective Agents|protective agents|mesh-ancestor
83906493|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906494|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906496|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83906497|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906498|NCT00317733|Analgesics|analgesics|mesh-ancestor
83906499|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
83906500|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906501|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906502|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906503|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906504|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83906505|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906506|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906507|NCT00311337|Bortezomib|bortezomib|mesh-list
83906508|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906509|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
83906510|NCT00317811|Bortezomib|bortezomib|mesh-list
83906511|NCT00317811|Melphalan|melphalan|mesh-list
83906512|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906513|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83906514|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
83906515|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906516|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83906517|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906518|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
83906519|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906520|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
83906521|NCT00317811|Protective Agents|protective agents|mesh-ancestor
83906522|NCT00317811|Vitamins|vitamins|mesh-ancestor
83906523|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
83906524|NCT00282386|Rofecoxib|rofecoxib|mesh-list
83906525|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906526|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906527|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906528|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83906529|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83906530|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906531|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83906532|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906533|NCT00282386|Analgesics|analgesics|mesh-ancestor
83906534|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
83906535|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906536|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906537|NCT00317850|Gabapentin|gabapentin|mesh-list
83906538|NCT00317850|Analgesics|analgesics|mesh-ancestor
83906539|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
83906540|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906541|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906542|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
83906543|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83906544|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83906545|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906546|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83906547|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83906548|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83906549|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906550|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906551|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
83906552|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
83906553|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83906554|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83906555|NCT00282503|Prednisolone|prednisolone|mesh-list
83906556|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
83906557|NCT00282503|Methoxsalen|methoxsalen|mesh-list
83906558|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83906559|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
83906560|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906561|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
83906562|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
83906563|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906564|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906565|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906566|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
83906567|NCT00282503|Hormones|hormones|mesh-ancestor
83906568|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906569|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83906570|NCT00282503|Protective Agents|protective agents|mesh-ancestor
83906571|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83906572|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906573|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83906574|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
83906576|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906577|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124608|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124609|NCT04374773|Hormones|hormones|mesh-ancestor
84124610|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124611|NCT00720538|Thalidomide|thalidomide|mesh-list
84124612|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84124613|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
84124614|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124615|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
84124616|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84124617|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124618|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84124619|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84124620|NCT00720538|Growth Substances|growth substances|mesh-ancestor
84124621|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
84124622|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124623|NCT00678990|Heparin|heparin|mesh-list
84124624|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
84124625|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84124626|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84124627|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124628|NCT00679068|Bosentan|bosentan|mesh-list
84124629|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124630|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84124631|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124632|NCT00679146|Ketoprofen|ketoprofen|mesh-list
84124633|NCT00679146|Colchicine|colchicine|mesh-list
84124634|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84124635|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124636|NCT00679146|Analgesics|analgesics|mesh-ancestor
84124637|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
84124638|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124639|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124640|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124641|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124642|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84124643|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124644|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124645|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
84124646|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
84124647|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
84124648|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
84124649|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124650|NCT00679224|Ambrisentan|ambrisentan|mesh-list
84124651|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124652|NCT02748005|Fenugreek seed meal|fenugreek seed meal|mesh-list
84124653|NCT02748005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84124654|NCT02748005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124655|NCT00990847|Procaterol|procaterol|mesh-list
84124656|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84124657|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
84124658|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124659|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124660|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84124661|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
84124662|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
84124663|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84124664|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84124665|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84124666|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124667|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124668|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124669|NCT00594516|Tapentadol|tapentadol|mesh-list
84124670|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124671|NCT00594516|Narcotics|narcotics|mesh-ancestor
84124672|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145738|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
83906578|NCT00282698|Insulin|insulin|mesh-list
83906579|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906580|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906581|NCT00317967|Atorvastatin|atorvastatin|mesh-list
83906582|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83906583|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83906584|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
83906585|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906586|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83906587|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83906588|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906589|NCT00318084|Esomeprazole|esomeprazole|mesh-list
83906590|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83906591|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906592|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83906593|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906594|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906595|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83906596|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83906597|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83906598|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
83906599|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906600|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906601|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906602|NCT00282932|Urological Agents|urological agents|mesh-ancestor
83906603|NCT00318162|Naltrexone|naltrexone|mesh-list
83906604|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83906605|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83906606|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906607|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
83906608|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906609|NCT00283088|Plasminogen|plasminogen|mesh-list
83906610|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83906611|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83906612|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83906613|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906614|NCT00318201|Erythromycin|erythromycin|mesh-list
83906615|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
83906616|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83906617|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
83906618|NCT00318201|Diltiazem|diltiazem|mesh-list
83906619|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83906620|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83906621|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83906622|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906623|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83906624|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906625|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
83906626|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83906627|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906628|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906629|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83906630|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906631|NCT00311688|Interleukin-2|interleukin-2|mesh-list
83906632|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906633|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906634|NCT00311688|Analgesics|analgesics|mesh-ancestor
83906635|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
83906636|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906637|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906638|NCT00283478|Gemcitabine|gemcitabine|mesh-list
83906639|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83906640|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
83906641|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906642|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906643|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83906644|NCT00318318|Estrogens|estrogens|mesh-ancestor
83906645|NCT00318318|Hormones|hormones|mesh-ancestor
83906646|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906647|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906648|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
83906649|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83906650|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906651|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906652|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83906653|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
83906654|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
83906655|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83906656|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83906657|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906658|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906659|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906660|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906661|NCT00283556|Irinotecan|irinotecan|mesh-list
83906662|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83906663|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906664|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906665|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906666|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906667|NCT00283634|Bortezomib|bortezomib|mesh-list
83906668|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83906669|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906670|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83906671|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906672|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906673|NCT00318513|Bevacizumab|bevacizumab|mesh-list
83906674|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83906675|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906676|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83906677|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83906678|NCT00318513|Growth Substances|growth substances|mesh-ancestor
83906679|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906680|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
83906681|NCT00318552|Meropenem|meropenem|mesh-list
83906682|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83906683|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906684|NCT00283751|Insulin|insulin|mesh-list
83906685|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83906686|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
83906687|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
83906688|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152135|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
83906689|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906690|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
83906691|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906692|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906693|NCT00283790|Zolpidem|zolpidem|mesh-list
83906694|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83906695|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83906696|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906697|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906698|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83906699|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
83906700|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
83906701|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906702|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906703|NCT00318669|Paroxetine|paroxetine|mesh-list
83906704|NCT00318669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83906705|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83906706|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83906707|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906708|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906709|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
83906710|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906711|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83906712|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
83906713|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83906714|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83906715|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83906716|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906717|NCT00283829|Docetaxel|docetaxel|mesh-list
83906718|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906719|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83906720|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83906721|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83906722|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906723|NCT00311961|Prednisolone|prednisolone|mesh-list
83906724|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83145885|NCT02429271|Ticagrelor|ticagrelor|mesh-list
83906725|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
83906726|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83906727|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
83906728|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83906729|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
83906730|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906731|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
83906733|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906734|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906735|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83906736|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906737|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
83906738|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
83906739|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906740|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906741|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83906742|NCT00311961|Protective Agents|protective agents|mesh-ancestor
83906743|NCT00283946|Zolpidem|zolpidem|mesh-list
83906744|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83906745|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83906746|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906747|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906748|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83906749|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
83906750|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
83906751|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906752|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906753|NCT00312000|Capecitabine|capecitabine|mesh-list
83906754|NCT00312000|Irinotecan|irinotecan|mesh-list
83906755|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83906756|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
83906757|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906758|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906759|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83906760|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906761|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906762|NCT00283985|Dexamethasone|dexamethasone|mesh-list
83906763|NCT00283985|Methotrexate|methotrexate|mesh-list
83906764|NCT00283985|Asparaginase|asparaginase|mesh-list
83906765|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906766|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
83906767|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
83906768|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906769|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906770|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906771|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
83906772|NCT00283985|Hormones|hormones|mesh-ancestor
83906773|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83906774|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83906775|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906776|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83906777|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
83906778|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83906779|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83906780|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
83906781|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906782|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
83906783|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906784|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83906785|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906786|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
83906787|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906788|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83906789|NCT00419250|Lenalidomide|lenalidomide|mesh-list
83906790|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
83906791|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906792|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83906793|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83906794|NCT00419250|Growth Substances|growth substances|mesh-ancestor
83906795|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
83906796|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906797|NCT00284024|Domperidone|domperidone|mesh-list
83906798|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
83906799|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
83906800|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906801|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906802|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83906803|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83906804|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
83906805|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906806|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906807|NCT00312039|Lamivudine|lamivudine|mesh-list
83906808|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
83906809|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83906810|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83906811|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906812|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906813|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
83906814|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906815|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83906816|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83906817|NCT00284258|Irinotecan|irinotecan|mesh-list
83906818|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83906819|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906820|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906821|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906822|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906823|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
83906824|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
83906825|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906826|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906827|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
83906828|NCT00284336|Doxorubicin|doxorubicin|mesh-list
83906829|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83906830|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906831|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
83906832|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906833|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906834|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83906835|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
83906836|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906837|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906838|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83906839|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83906840|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906841|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906842|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906843|NCT00312156|Insulin|insulin|mesh-list
83906844|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83906845|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
83906846|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
83906847|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
83906848|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
83906849|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
83906850|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906851|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906852|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
83906853|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83906854|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
83906855|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
83906856|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906857|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906858|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906859|NCT00318825|Analgesics|analgesics|mesh-ancestor
83906860|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
83906861|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906862|NCT00284531|Daclizumab|daclizumab|mesh-list
83906863|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906864|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
83906865|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906866|NCT00312273|Aminophylline|aminophylline|mesh-list
83906867|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83906868|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
83906869|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906870|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906871|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83906872|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83906873|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83906874|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83906875|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906876|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906877|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83906878|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83906880|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906881|NCT00312273|Protective Agents|protective agents|mesh-ancestor
83906882|NCT00312312|Immunomodulating Agents|immunomodulating agents|mesh-list
83906883|NCT00312312|Immunologic Factors|immunologic factors|mesh-ancestor
83906884|NCT00312312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906885|NCT00284687|Artesunate|artesunate|mesh-list
83906886|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
83906887|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83906888|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83906889|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906890|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906891|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
83906892|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
83906893|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83906894|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
83906895|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83906896|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83906897|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83906898|NCT00284765|Analgesics|analgesics|mesh-ancestor
83906899|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
83906900|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906901|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906902|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83906903|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83906904|NCT00318981|Methylphenidate|methylphenidate|mesh-list
83906905|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83906906|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906907|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83906908|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83906909|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83906910|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906911|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
83906912|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906913|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
83906914|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83906915|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906916|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83906917|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
83906918|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83906919|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906920|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906921|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906922|NCT00319059|Annexin A5|annexin a5|mesh-list
83906923|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906924|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906925|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83906926|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
83906927|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
83906928|NCT00312546|Valproic Acid|valproic acid|mesh-list
83906929|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
83906930|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906931|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906932|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
83906933|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906934|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906935|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
83906936|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83906937|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906938|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83906939|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83906940|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83906941|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83906942|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83906943|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
83906944|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906945|NCT00425009|Metformin|metformin|mesh-list
83906946|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906947|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906948|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
83906949|NCT04718402|Analgesics|analgesics|mesh-ancestor
83906950|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
83146121|NCT00702273|Progesterone|progesterone|mesh-list
83906951|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83906952|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906953|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906954|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83906955|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83906956|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906957|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906958|NCT00319215|Zopiclone|zopiclone|mesh-list
83906959|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83906960|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83906961|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906962|NCT00285155|Bupropion|bupropion|mesh-list
83906963|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83906964|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
83906965|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83906966|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83906967|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83906968|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83906969|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906970|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
83906971|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83906972|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906973|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83906974|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83906975|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906976|NCT00319293|Metformin|metformin|mesh-list
83906977|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83906978|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83906979|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
83906980|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906981|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
83906982|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83906983|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83906984|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83906985|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
83906986|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83906987|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83906988|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83906989|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83906990|NCT00285389|Dexamethasone|dexamethasone|mesh-list
83906991|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
83906992|NCT00285389|Melphalan|melphalan|mesh-list
83906993|NCT00285389|Chlorambucil|chlorambucil|mesh-list
83906994|NCT00285389|Rituximab|rituximab|mesh-list
83906995|NCT00285389|Vincristine|vincristine|mesh-list
83906996|NCT00285389|Doxorubicin|doxorubicin|mesh-list
83906997|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83906998|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
83906999|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907000|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83907001|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83907002|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
83907003|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907004|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907005|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83907006|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83907007|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83907008|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
83907009|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
83907010|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907011|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83907012|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
83907013|NCT00285389|Hormones|hormones|mesh-ancestor
83907014|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907015|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83907016|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83907017|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907018|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907019|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907020|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83907021|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83907022|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83907023|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907024|NCT00285428|Veltuzumab|veltuzumab|mesh-list
83907025|NCT00285428|Antibodies|antibodies|mesh-list
83907026|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
83907027|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907028|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907029|NCT00312819|Disulfiram|disulfiram|mesh-list
83907030|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83907031|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83907032|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907033|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907034|NCT00319488|Budesonide|budesonide|mesh-list
83907035|NCT00319488|Albuterol|albuterol|mesh-list
83907036|NCT00319488|Montelukast|montelukast|mesh-list
83907037|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
83907038|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83907039|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83907040|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
83907041|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907042|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907043|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83907044|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
83907045|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
83907046|NCT00319488|Hormones|hormones|mesh-ancestor
83907047|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907048|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
83907049|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83907050|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83907051|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907052|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
83907053|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83907054|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83907055|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83907056|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83907057|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
83907058|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907059|NCT00285623|Thrombin|thrombin|mesh-list
83907060|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
83907061|NCT00285623|Coagulants|coagulants|mesh-ancestor
83907062|NCT00285662|Artesunate|artesunate|mesh-list
83907063|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
83907064|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
83907065|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83907066|NCT00285662|Amodiaquine|amodiaquine|mesh-list
83907067|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
83907068|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83907069|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83907070|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907071|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907072|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
83907073|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
83907074|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83907075|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
83907076|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83907077|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907078|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907079|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83907080|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83907081|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
83907082|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83907083|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83907084|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83907085|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83907086|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
83907087|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83907088|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907089|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83907090|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83907091|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83907092|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83907093|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907094|NCT00319566|Estrogens|estrogens|mesh-ancestor
83907095|NCT00319566|Hormones|hormones|mesh-ancestor
83907096|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907097|NCT00319605|Levetiracetam|levetiracetam|mesh-list
83907098|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
83907099|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
83907100|NCT00313053|Vincristine|vincristine|mesh-list
83907101|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83907102|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907103|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907104|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907105|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907106|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907107|NCT00285896|Glucagon|glucagon|mesh-list
83907108|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83907109|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83907110|NCT00285896|Hormones|hormones|mesh-ancestor
83907111|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907112|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907113|NCT00285896|Incretins|incretins|mesh-ancestor
83907114|NCT00319683|Eniluracil|eniluracil|mesh-list
83907115|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907116|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907117|NCT00286052|Naloxone|naloxone|mesh-list
83907118|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83907119|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907120|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
83907121|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907122|NCT00319761|Calcitriol|calcitriol|mesh-list
83907123|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83907124|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907125|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83907126|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83907127|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907128|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83907129|NCT00319761|Vitamins|vitamins|mesh-ancestor
83907130|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
83907131|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83907132|NCT00286130|Leucovorin|leucovorin|mesh-list
83907133|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
83907134|NCT00286130|Irinotecan|irinotecan|mesh-list
83907135|NCT00286130|Cetuximab|cetuximab|mesh-list
83907136|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907137|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83907138|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83907139|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907140|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907141|NCT00286130|Antidotes|antidotes|mesh-ancestor
83907142|NCT00286130|Protective Agents|protective agents|mesh-ancestor
83907143|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907144|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
83907145|NCT00286130|Vitamins|vitamins|mesh-ancestor
83907146|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
83907147|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83907148|NCT00286208|Misoprostol|misoprostol|mesh-list
83907149|NCT00286208|Mifepristone|mifepristone|mesh-list
83907150|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83907151|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
83907152|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83907153|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907154|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83907155|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83907156|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
83907157|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83907158|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83907159|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83907160|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83907161|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
83907162|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83907163|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83907164|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
83907165|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907166|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
83907167|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83907168|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83907169|NCT00319800|Irinotecan|irinotecan|mesh-list
83907170|NCT00319800|Gefitinib|gefitinib|mesh-list
83907171|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83907172|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83907173|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907174|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907175|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907176|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83907177|NCT00313131|Metronidazole|metronidazole|mesh-list
83907178|NCT00313131|Fluconazole|fluconazole|mesh-list
83907179|NCT00313131|Clotrimazole|clotrimazole|mesh-list
83907180|NCT00313131|Miconazole|miconazole|mesh-list
83907181|NCT00313131|Tinidazole|tinidazole|mesh-list
83907182|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907183|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83907184|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83907185|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83907186|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
83907187|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83907188|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83907189|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907190|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907191|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83907192|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
83907193|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907194|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907195|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83907196|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83907197|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83907198|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83907199|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
83907200|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83907201|NCT00319878|Cyclosporine|cyclosporine|mesh-list
83907202|NCT00319878|Sirolimus|sirolimus|mesh-list
83907203|NCT00319878|Cyclosporins|cyclosporins|mesh-list
83907204|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907205|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907206|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907207|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
83907208|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907209|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
83907210|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907211|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
83907212|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83907213|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83907214|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83907215|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83907216|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907217|NCT00286364|Androgens|androgens|mesh-list
83907218|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83907219|NCT00286364|Hormones|hormones|mesh-ancestor
83907220|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907221|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907222|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83907223|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907224|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907225|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83907226|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83907227|NCT00319917|Tacrolimus|tacrolimus|mesh-list
83907228|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907229|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
83907230|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907231|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83907232|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907233|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907234|NCT00286403|Fenoldopam|fenoldopam|mesh-list
83907235|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907236|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83907237|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
83907238|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
83907239|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
83907240|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907241|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907242|NCT00313287|Clevudine|clevudine|mesh-list
83907243|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
83907244|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907245|NCT00286481|Simvastatin|simvastatin|mesh-list
83907246|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83907247|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83907248|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
83907249|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907250|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83907251|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83907252|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907253|NCT00320034|Albuterol|albuterol|mesh-list
83907254|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83907255|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
83907256|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907257|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907258|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83907259|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
83907260|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
83907261|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83907262|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83907263|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83907264|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83907265|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
83907266|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907267|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907268|NCT00320073|Pemetrexed|pemetrexed|mesh-list
83907269|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83907270|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907271|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907272|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907273|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83907274|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83907275|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83907276|NCT00286871|Tacrolimus|tacrolimus|mesh-list
83907277|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907278|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
83907279|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907280|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83907281|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907282|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907283|NCT00417326|Sivelestat|sivelestat|mesh-list
83907284|NCT00417326|Glycine|glycine|mesh-list
83907285|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83907286|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
83907287|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907288|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907289|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
83907290|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907291|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907292|NCT00320229|Abciximab|abciximab|mesh-list
83907293|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
83907294|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83907295|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83907296|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
83907297|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83907298|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83907299|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83907300|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907301|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907302|NCT00417404|Vitamins|vitamins|mesh-list
83907303|NCT00417404|Vitamin A|vitamin a|mesh-list
83907304|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
83907305|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
83907306|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907307|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
83907308|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907309|NCT00417404|Protective Agents|protective agents|mesh-ancestor
83907310|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83907311|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907312|NCT00417443|Clonidine|clonidine|mesh-list
83907313|NCT00417443|Analgesics|analgesics|mesh-ancestor
83907314|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
83907315|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907316|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907317|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83907318|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
83907319|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
83907320|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83907321|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83907322|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83907323|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
83907324|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907325|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907326|NCT00313482|Prednisone|prednisone|mesh-list
83907327|NCT00313482|Docetaxel|docetaxel|mesh-list
83907328|NCT00313482|Sargramostim|sargramostim|mesh-list
83907329|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907330|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907331|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907332|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907333|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907334|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83907335|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
83907336|NCT00313482|Hormones|hormones|mesh-ancestor
83907337|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907338|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907339|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83907340|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
83907341|NCT00286988|Topiramate|topiramate|mesh-list
83907342|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
83907343|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83907344|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907345|NCT00320307|Abacavir|abacavir|mesh-list
83907346|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83907347|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83907348|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907349|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907350|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
83907351|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907352|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83907353|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83907354|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
83907355|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907356|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83907357|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907358|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83907359|NCT02960906|Nivolumab|nivolumab|mesh-list
83907360|NCT02960906|Ipilimumab|ipilimumab|mesh-list
83907361|NCT02960906|Sunitinib|sunitinib|mesh-list
83907362|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83907363|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907364|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83907365|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907366|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83907367|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83907368|NCT02960906|Growth Substances|growth substances|mesh-ancestor
83907369|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907370|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
83907371|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83907372|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907373|NCT00287066|Insulin|insulin|mesh-list
83907374|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83907375|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83907376|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907377|NCT00313521|Thiotepa|thiotepa|mesh-list
83907378|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83907379|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
83907380|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907381|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907382|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83907383|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907384|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
83907385|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907386|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
83907387|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83907388|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907389|NCT00313599|Paclitaxel|paclitaxel|mesh-list
83907390|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83907391|NCT00313599|Lapatinib|lapatinib|mesh-list
83907392|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83907393|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907394|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907395|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907396|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907397|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907398|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83907399|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907400|NCT00287300|Azithromycin|azithromycin|mesh-list
83907401|NCT00287300|Artesunate|artesunate|mesh-list
83907402|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
83907403|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
83907404|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83907405|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83907406|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907407|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
83907408|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83907409|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83907410|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907411|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
83907412|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
83907413|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83907414|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
83907415|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83907416|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907417|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907418|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83907419|NCT00287378|Omalizumab|omalizumab|mesh-list
83907420|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83907421|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83907422|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
83907423|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83907424|NCT00320580|Norelgestromin|norelgestromin|mesh-list
83907425|NCT00320580|Estradiol|estradiol|mesh-list
83907426|NCT00320580|Estrogens|estrogens|mesh-ancestor
83907427|NCT00320580|Hormones|hormones|mesh-ancestor
83907428|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907429|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907430|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83907431|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
83907432|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83907433|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83907434|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83907435|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83907436|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
83907437|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83907438|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83907439|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907440|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
83907441|NCT00320619|Coagulants|coagulants|mesh-ancestor
83907442|NCT00287456|Insulin|insulin|mesh-list
83907443|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83907444|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83907445|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907446|NCT00313833|Buprenorphine|buprenorphine|mesh-list
83907447|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83907448|NCT00313833|Narcotics|narcotics|mesh-ancestor
83907449|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907450|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907451|NCT00313833|Analgesics|analgesics|mesh-ancestor
83907452|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
83907453|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907454|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83907455|NCT00287495|Sorafenib|sorafenib|mesh-list
83907456|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907457|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83907458|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907459|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907460|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83907461|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83907462|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
83907463|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907464|NCT00320658|Antacids|antacids|mesh-ancestor
83907465|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907466|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83907467|NCT00287534|Tamoxifen|tamoxifen|mesh-list
83907468|NCT00287534|Anastrozole|anastrozole|mesh-list
83907469|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83907470|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
83907471|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907472|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907473|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83907474|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907475|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83907476|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83907477|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83907478|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83907479|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83907480|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907481|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907482|NCT00320697|Bupropion|bupropion|mesh-list
83907483|NCT00320697|Nicotine|nicotine|mesh-list
83907484|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83907485|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
83907486|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907487|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907488|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83907489|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83907490|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
83907491|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907492|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907493|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83907494|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
83907495|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83907496|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83907497|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83907498|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83907499|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
83907500|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83907501|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83907502|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907503|NCT00287651|Insulin|insulin|mesh-list
83907504|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83907505|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83907506|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907507|NCT00322296|Bexarotene|bexarotene|mesh-list
83907508|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907509|NCT00320736|Galantamine|galantamine|mesh-list
83907510|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83907511|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907512|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907513|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
83907514|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907515|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907516|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83907517|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
83907518|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907519|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
83907520|NCT00287768|Docetaxel|docetaxel|mesh-list
83907521|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907522|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907523|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907524|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907525|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907526|NCT00320775|Aflibercept|aflibercept|mesh-list
83907527|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83907528|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83907529|NCT00320775|Growth Substances|growth substances|mesh-ancestor
83907530|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907531|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
83907532|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907533|NCT00320814|Aflibercept|aflibercept|mesh-list
83907534|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83907535|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83907536|NCT00320814|Growth Substances|growth substances|mesh-ancestor
83907537|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907538|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
83907539|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907540|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
83907541|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907542|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83907543|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907544|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907545|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
83907546|NCT00322413|Hematinics|hematinics|mesh-ancestor
83907547|NCT00320853|Vitamin D|vitamin d|mesh-list
83907548|NCT00320853|Vitamins|vitamins|mesh-ancestor
83907549|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
83907550|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907551|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83907552|NCT00287885|Docetaxel|docetaxel|mesh-list
83907553|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907554|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907555|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907556|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907557|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907558|NCT00287924|Methotrexate|methotrexate|mesh-list
83907559|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83907560|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
83907561|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83907562|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907563|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83907564|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
83907565|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907566|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907567|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83907568|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907569|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83907570|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907571|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
83907572|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83907573|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83907574|NCT00287963|Topotecan|topotecan|mesh-list
83907575|NCT00287963|Vinorelbine|vinorelbine|mesh-list
83907576|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83907577|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83907578|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907579|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907580|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907581|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83907582|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907583|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907584|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907585|NCT00320892|Atropine|atropine|mesh-list
83907586|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83907587|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83907588|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83907589|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83907590|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
83907591|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907592|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907593|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83907594|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
83907595|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
83907596|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
83907597|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83907598|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83907599|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
83907600|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907601|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907602|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83907603|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
83907604|NCT00288002|Docetaxel|docetaxel|mesh-list
83907605|NCT00288002|Capecitabine|capecitabine|mesh-list
83907606|NCT00288002|Trastuzumab|trastuzumab|mesh-list
83907607|NCT00288002|Epirubicin|epirubicin|mesh-list
83907608|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907609|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
83907610|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907611|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83907612|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83907613|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
83907614|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907615|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907616|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83907617|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907618|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907619|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907620|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83907621|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
83907622|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83907623|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83907624|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83907625|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83907626|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146819|NCT02251223|Ritonavir|ritonavir|mesh-list
83907627|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
83907628|NCT00322569|Paclitaxel|paclitaxel|mesh-list
83907629|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83907630|NCT00322569|Tacrolimus|tacrolimus|mesh-list
83907631|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83907632|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907633|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907634|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907635|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907636|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907637|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83907638|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83907639|NCT00322569|Analgesics|analgesics|mesh-ancestor
83907640|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
83907641|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907642|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907643|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83907644|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83907645|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
83907646|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907647|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
83907648|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83907649|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907650|NCT00288041|Paclitaxel|paclitaxel|mesh-list
83907651|NCT00288041|Carboplatin|carboplatin|mesh-list
83907652|NCT00288041|Bortezomib|bortezomib|mesh-list
83907653|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83907654|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907655|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907656|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907657|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907658|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907659|NCT00320970|Candesartan|candesartan|mesh-list
83907660|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83907661|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83907662|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83907663|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907664|NCT00288158|Allopurinol|allopurinol|mesh-list
83907665|NCT00288158|Probenecid|probenecid|mesh-list
83907666|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
83907667|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907668|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907669|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
83907670|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83907671|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83907672|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
83907673|NCT00288158|Protective Agents|protective agents|mesh-ancestor
83907674|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907675|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
83907676|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83907677|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83907678|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907679|NCT00288197|Voriconazole|voriconazole|mesh-list
83907680|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
83907681|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907682|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83907683|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83907684|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907685|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907686|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83907687|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
83907688|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907689|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907690|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83907691|NCT00288236|Rimonabant|rimonabant|mesh-list
83907692|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83907693|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83907694|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83907695|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907696|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907697|NCT00288236|Hormones|hormones|mesh-ancestor
83907698|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907699|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907700|NCT00321126|Zinc|zinc|mesh-list
83907701|NCT00321126|Trace Elements|trace elements|mesh-ancestor
83907702|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
83907703|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907704|NCT00288353|Aripiprazole|aripiprazole|mesh-list
83907705|NCT00288353|Ziprasidone|ziprasidone|mesh-list
83907706|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
83907707|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83907708|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83907709|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83907710|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907711|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907712|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
83907713|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
83907714|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907715|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907716|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83907717|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83907718|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
83907719|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83907720|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83907721|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83907722|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83907723|NCT00288431|Sirolimus|sirolimus|mesh-list
83907724|NCT00288431|Doxorubicin|doxorubicin|mesh-list
83907725|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83907726|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907727|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83907728|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83907729|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907730|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907731|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83907732|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907733|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
83907734|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907735|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
83907736|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907737|NCT00321165|Taurolidine|taurolidine|mesh-list
83907738|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907739|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83907740|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907741|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
83907742|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
83907743|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83907744|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83907745|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907746|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907747|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83907748|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83907749|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
83907750|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
83907751|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907752|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907753|NCT00322920|Topotecan|topotecan|mesh-list
83907754|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907755|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83907756|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83907757|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907758|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907759|NCT00321009|Enoxaparin|enoxaparin|mesh-list
83907760|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
83907761|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83907762|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83907763|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907764|NCT00417677|Sirolimus|sirolimus|mesh-list
83907765|NCT00417677|Sunitinib|sunitinib|mesh-list
83907766|NCT00417677|Temsirolimus|temsirolimus|mesh-list
83907767|NCT00417677|MTOR Inhibitors|mtor inhibitors|mesh-list
83907768|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907769|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83907770|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83907771|NCT00417677|Growth Substances|growth substances|mesh-ancestor
83907772|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907773|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
83907774|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83907775|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907776|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146945|NCT02115035|Vemurafenib|vemurafenib|mesh-list
83907777|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907778|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
83907779|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83907780|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907781|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83907782|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
83907783|NCT00417716|Bevacizumab|bevacizumab|mesh-list
83907784|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83907785|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907786|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83907787|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83907788|NCT00417716|Growth Substances|growth substances|mesh-ancestor
83907789|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907790|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
83907791|NCT00288470|Hylan|hylan|mesh-list
83907792|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
83907793|NCT00288470|Protective Agents|protective agents|mesh-ancestor
83907794|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907795|NCT00321360|Propofol|propofol|mesh-list
83907796|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83907797|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907798|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907799|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83907800|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
83907801|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
83907802|NCT00288548|Metoprolol|metoprolol|mesh-list
83907803|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83907804|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83907805|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
83907806|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
83907807|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907808|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907809|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83907810|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83907811|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83907812|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
83907813|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907814|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907815|NCT00321477|Casopitant|casopitant|mesh-list
83907816|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
83907817|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
83907818|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907819|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907820|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83907821|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83907822|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907823|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907824|NCT00321516|Aripiprazole|aripiprazole|mesh-list
83907825|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
83907826|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83907827|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83907828|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83907829|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907830|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907831|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
83907832|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
83907833|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907834|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907835|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83907836|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83907837|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
83907838|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83907839|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83907840|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83907841|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83907842|NCT00288743|Insulin|insulin|mesh-list
83907843|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83907844|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907845|NCT00321633|Carboplatin|carboplatin|mesh-list
83907846|NCT00321633|Docetaxel|docetaxel|mesh-list
83907847|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907848|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907849|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907850|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907851|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907852|NCT00288782|Mirtazapine|mirtazapine|mesh-list
83907853|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
83907854|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83907855|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83907856|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
83907857|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
83907858|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83907859|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907860|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907861|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83907862|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83907863|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907864|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83907865|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83907866|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83907867|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
83907868|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83907869|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83907870|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
83907871|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83907873|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83907874|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
83907875|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83907876|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907877|NCT01059825|Incretins|incretins|mesh-ancestor
83907878|NCT01059825|Hormones|hormones|mesh-ancestor
83907879|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83907880|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83907881|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
83907882|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907883|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907884|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83907885|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
83907886|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83907887|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83907888|NCT00321750|Analgesics|analgesics|mesh-ancestor
83907889|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
83907890|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907891|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907892|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83907893|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83907894|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83907895|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907896|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
83907897|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83907898|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907899|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907900|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83907901|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83907902|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
83907903|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907904|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907905|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83907906|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83907907|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907908|NCT00323154|Nalbuphine|nalbuphine|mesh-list
83907909|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83907910|NCT00323154|Narcotics|narcotics|mesh-ancestor
83907911|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83907912|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907913|NCT00323154|Analgesics|analgesics|mesh-ancestor
83907914|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
83907915|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83907916|NCT00289250|Artesunate|artesunate|mesh-list
83907917|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
83907918|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
83907919|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83907920|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
83907921|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83907922|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83907923|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147095|NCT03552653|Vitamins|vitamins|mesh-list
83147152|NCT04815200|Copper|copper|mesh-list
83907924|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907925|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
83907926|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
83907927|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83907928|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
83907929|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83907930|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907931|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907932|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83907934|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
83907935|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
83907936|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907937|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
83907938|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907939|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
83907940|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907941|NCT00289406|Amlodipine|amlodipine|mesh-list
83907942|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83907943|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83907944|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83907945|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907946|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83907947|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907948|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
83907949|NCT00323544|Tenofovir|tenofovir|mesh-list
83907950|NCT00323544|Lamivudine|lamivudine|mesh-list
83907951|NCT00323544|Emtricitabine|emtricitabine|mesh-list
83907952|NCT00323544|Zidovudine|zidovudine|mesh-list
83907953|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83907954|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
83907955|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83907956|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83907957|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83907958|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907959|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907960|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83907961|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83907962|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
83907963|NCT00289445|Leucovorin|leucovorin|mesh-list
83907964|NCT00289445|Folic Acid|folic acid|mesh-list
83907965|NCT00289445|Mitomycins|mitomycins|mesh-list
83907966|NCT00289445|Mitomycin|mitomycin|mesh-list
83907967|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
83907968|NCT00289445|Antidotes|antidotes|mesh-ancestor
83907969|NCT00289445|Protective Agents|protective agents|mesh-ancestor
83907970|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907971|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
83907972|NCT00289445|Vitamins|vitamins|mesh-ancestor
83907973|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
83907974|NCT00289445|Hematinics|hematinics|mesh-ancestor
83907975|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83907976|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907977|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
83907978|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907979|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83907980|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83907981|NCT00323583|Leucovorin|leucovorin|mesh-list
83907982|NCT00323583|Paclitaxel|paclitaxel|mesh-list
83907983|NCT00323583|Fluorouracil|fluorouracil|mesh-list
83907984|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
83907985|NCT00323583|Calcium|calcium|mesh-list
83907986|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83907987|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83907988|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83907989|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83907990|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83907991|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83907992|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83907993|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83907994|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
83907995|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83907996|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83907997|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
83907998|NCT00323583|Antidotes|antidotes|mesh-ancestor
83907999|NCT00323583|Protective Agents|protective agents|mesh-ancestor
83908000|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
83908001|NCT00323583|Vitamins|vitamins|mesh-ancestor
83908002|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
83908003|NCT00289601|Eptifibatide|eptifibatide|mesh-list
83908004|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83908005|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
83908006|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83908007|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
83908008|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908009|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
83908010|NCT00323778|Protective Agents|protective agents|mesh-ancestor
83908011|NCT00323817|Z 338|z 338|mesh-list
83908012|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83908013|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908014|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908015|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
83908016|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908017|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908018|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83908019|NCT00289835|Paclitaxel|paclitaxel|mesh-list
83908020|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83908021|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83908022|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908023|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83908024|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83908025|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83908026|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908027|NCT00303225|Tecovirimat|tecovirimat|mesh-list
83908028|NCT00303225|Antiviral Agents|antiviral agents|mesh-ancestor
83908029|NCT00303225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908030|NCT00323934|Mocetinostat|mocetinostat|mesh-list
83908031|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83908032|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908033|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908034|NCT00290030|Alfuzosin|alfuzosin|mesh-list
83908035|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83908036|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83908037|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83908038|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908039|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908040|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908041|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908042|NCT00290030|Urological Agents|urological agents|mesh-ancestor
83908043|NCT00303264|Esomeprazole|esomeprazole|mesh-list
83908044|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83908045|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83908046|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83908047|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908048|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908049|NCT00290069|Sirolimus|sirolimus|mesh-list
83908050|NCT00290069|Tacrolimus|tacrolimus|mesh-list
83908051|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908052|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
83908053|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908054|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83908055|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908056|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908057|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83908058|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908059|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83908060|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908061|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
83908062|NCT04718259|Midazolam|midazolam|mesh-list
83908063|NCT04718259|Bupivacaine|bupivacaine|mesh-list
83908064|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
83908065|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
83908066|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908067|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908068|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
83908069|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908070|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83908071|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83908072|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83908073|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908074|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83908075|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83908076|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
83147261|NCT02121119|Lidocaine|lidocaine|mesh-list
83908077|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
83908078|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
83908079|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908080|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908081|NCT00290108|Propofol|propofol|mesh-list
83908082|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83908083|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908084|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908085|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83908086|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
83908087|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
83908088|NCT00323973|Bisoprolol|bisoprolol|mesh-list
83908089|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83908090|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
83908091|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
83908092|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908093|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908094|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83908095|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83908096|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83908097|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908098|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908099|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908100|NCT00324012|Docetaxel|docetaxel|mesh-list
83908101|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908102|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
83908103|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83908104|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83908105|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908106|NCT00290264|Budesonide|budesonide|mesh-list
83908107|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
83908108|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908109|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83908110|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
83908111|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908112|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908113|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83908114|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
83908115|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
83908116|NCT00290264|Hormones|hormones|mesh-ancestor
83908117|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908118|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83908119|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83908120|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83908121|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908122|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908123|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908124|NCT00324051|Olanzapine|olanzapine|mesh-list
83908125|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
83908126|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
83908127|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908128|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908129|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83908130|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83908131|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908132|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908133|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83908134|NCT00324051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83908135|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83908136|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83908137|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908138|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908139|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
83908140|NCT00303381|Interferons|interferons|mesh-list
83908141|NCT00303381|Interferon-beta|interferon-beta|mesh-list
83908142|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
83908143|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908144|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
83908145|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908146|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
83908147|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908148|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83908149|NCT00290420|Chloroquine|chloroquine|mesh-list
83908150|NCT00290420|Amebicides|amebicides|mesh-ancestor
83908151|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83908152|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83908153|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908154|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
83908155|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908156|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83908157|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83908158|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83908159|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908161|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83908162|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908163|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908164|NCT00303537|Metformin|metformin|mesh-list
83908165|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83908166|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908167|NCT00290849|Bivalirudin|bivalirudin|mesh-list
83908168|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
83908169|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83908170|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
83908171|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908172|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908173|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
83908174|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
83908175|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83908176|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908177|NCT00303576|Dapivirine|dapivirine|mesh-list
83908178|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83908179|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83908180|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
83908181|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908182|NCT00291005|Docetaxel|docetaxel|mesh-list
83908183|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908184|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83908185|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83908186|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83908187|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908188|NCT00303615|Anastrozole|anastrozole|mesh-list
83908189|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
83908190|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83908191|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908192|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83908193|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83908194|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908195|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908196|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83908197|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
83908198|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908199|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908200|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
83908201|NCT00303615|Hormones|hormones|mesh-ancestor
83908202|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
83908203|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83908204|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83908205|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908206|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83908207|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83908208|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908209|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908210|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908211|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83908212|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
83908213|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83908214|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908215|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83908216|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83908217|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83908218|NCT00291122|Celecoxib|celecoxib|mesh-list
83908219|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83908220|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83908221|NCT00291122|Analgesics|analgesics|mesh-ancestor
83908222|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
83908223|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908224|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908225|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908226|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908227|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83908228|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83908229|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908230|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908231|NCT00324363|Exenatide|exenatide|mesh-list
83908232|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83908233|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908234|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83908235|NCT00324363|Incretins|incretins|mesh-ancestor
83908236|NCT00324363|Hormones|hormones|mesh-ancestor
83908237|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908238|NCT00303732|Everolimus|everolimus|mesh-list
83908239|NCT00303732|Vatalanib|vatalanib|mesh-list
83908240|NCT00303732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83908241|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83908242|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908243|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908244|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908245|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
83908246|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908247|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908248|NCT00303771|Leucovorin|leucovorin|mesh-list
83908249|NCT00303771|Fluorouracil|fluorouracil|mesh-list
83908250|NCT00303771|Irinotecan|irinotecan|mesh-list
83908251|NCT00303771|Calcium|calcium|mesh-list
83908252|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
83908253|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83908254|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908255|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
83908256|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908257|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83908258|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908259|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908260|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
83908261|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83908262|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83908263|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908264|NCT00303771|Antidotes|antidotes|mesh-ancestor
83908265|NCT00303771|Protective Agents|protective agents|mesh-ancestor
83908266|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
83908267|NCT00303771|Vitamins|vitamins|mesh-ancestor
83908268|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
83908269|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
83908270|NCT00303810|Thiotepa|thiotepa|mesh-list
83908271|NCT00303810|Lomustine|lomustine|mesh-list
83908272|NCT00303810|Carboplatin|carboplatin|mesh-list
83908273|NCT00303810|Methotrexate|methotrexate|mesh-list
83908274|NCT00303810|Etoposide|etoposide|mesh-list
83908275|NCT00303810|Vincristine|vincristine|mesh-list
83908276|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
83908277|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908278|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
83908279|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908280|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908281|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83908282|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
83908283|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908284|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908285|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83908286|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83908287|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
83908288|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83908289|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83908290|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
83908291|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83908292|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908293|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83908294|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83908295|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83908296|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83908297|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83908298|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83908299|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83147469|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
83908300|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83908301|NCT00324480|Vorinostat|vorinostat|mesh-list
83908302|NCT00324480|Alvocidib|alvocidib|mesh-list
83908303|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908304|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83908305|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908306|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908307|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
83908308|NCT00324480|Growth Substances|growth substances|mesh-ancestor
83908309|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908310|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83908311|NCT00303888|Docetaxel|docetaxel|mesh-list
83908312|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908313|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
83908314|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
83908315|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
83908316|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908317|NCT00291707|Pemetrexed|pemetrexed|mesh-list
83908318|NCT00291707|Cetuximab|cetuximab|mesh-list
83908319|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908320|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908321|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908322|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83908323|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83908324|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83908325|NCT00324519|Misoprostol|misoprostol|mesh-list
83908326|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83908327|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
83908328|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83908329|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908330|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83908331|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83908332|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
83908333|NCT00291746|Esomeprazole|esomeprazole|mesh-list
83908334|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83908335|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83908336|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83908337|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908338|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908339|NCT00303927|Capecitabine|capecitabine|mesh-list
83908340|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83908341|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
83908342|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908343|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908344|NCT00419484|Pioglitazone|pioglitazone|mesh-list
83908345|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83908346|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908347|NCT00291785|Leucovorin|leucovorin|mesh-list
83908348|NCT00291785|Folic Acid|folic acid|mesh-list
83908349|NCT00291785|Fluorouracil|fluorouracil|mesh-list
83908350|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
83908351|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
83908352|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908353|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83908354|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908355|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908356|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
83908357|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908358|NCT00291785|Antidotes|antidotes|mesh-ancestor
83908359|NCT00291785|Protective Agents|protective agents|mesh-ancestor
83908360|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
83908361|NCT00291785|Vitamins|vitamins|mesh-ancestor
83908362|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
83908363|NCT00291785|Hematinics|hematinics|mesh-ancestor
83908364|NCT00324558|Bemiparin|bemiparin|mesh-list
83908365|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
83908366|NCT00291863|Simvastatin|simvastatin|mesh-list
83908367|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83908368|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83908369|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
83908370|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908371|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83908372|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83908373|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908374|NCT00304200|Temozolomide|temozolomide|mesh-list
83908375|NCT00304200|Sunitinib|sunitinib|mesh-list
83908376|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83908377|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
83908378|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908379|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908380|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83908381|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83908382|NCT00304200|Growth Substances|growth substances|mesh-ancestor
83908383|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908384|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
83908385|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83908386|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908387|NCT00304239|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83908388|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83908389|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83908390|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
83908392|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
83908393|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908394|NCT00324597|Gemcitabine|gemcitabine|mesh-list
83908395|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
83908396|NCT00324597|Imetelstat|imetelstat|mesh-list
83908397|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83908398|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
83908399|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908400|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908401|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83908402|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908403|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
83908404|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83908405|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83908406|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908407|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83908408|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908409|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83908410|NCT00304317|Celecoxib|celecoxib|mesh-list
83908411|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83908412|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83908413|NCT00304317|Analgesics|analgesics|mesh-ancestor
83908414|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
83908415|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908416|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908417|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908418|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908419|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83908420|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83908421|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908422|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908423|NCT00324792|Insulin|insulin|mesh-list
83908424|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83908425|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908426|NCT00292214|Acetaminophen|acetaminophen|mesh-list
83908427|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83908428|NCT00292214|Analgesics|analgesics|mesh-ancestor
83908429|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
83908430|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908431|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908432|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
83908433|NCT00324831|Prednisone|prednisone|mesh-list
83908434|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
83908435|NCT00324831|Rituximab|rituximab|mesh-list
83908436|NCT00324831|Doxorubicin|doxorubicin|mesh-list
83908437|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83908438|NCT00324831|Vincristine|vincristine|mesh-list
83908439|NCT00324831|Vaccines|vaccines|mesh-list
83908440|NCT00324831|Antibodies|antibodies|mesh-list
83908441|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
83908442|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83908443|NCT00324831|Sargramostim|sargramostim|mesh-list
83908444|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83908445|NCT00324831|Immunomodulating Agents|immunomodulating agents|mesh-list
83908446|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
83908447|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908448|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908449|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908450|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83908451|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
83908452|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908453|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908454|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83908455|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83908456|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83908457|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83908458|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83908459|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908460|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908461|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
83908462|NCT00324831|Hormones|hormones|mesh-ancestor
83908463|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908464|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83908465|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83908466|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
83908467|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
83908468|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
83908469|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
83908470|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83908471|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
83908472|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908473|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908474|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
83908475|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908476|NCT00304434|Oseltamivir|oseltamivir|mesh-list
83908477|NCT00304434|Probenecid|probenecid|mesh-list
83908478|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
83908479|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908480|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908481|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908482|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
83908483|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
83908484|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908485|NCT00292409|Aripiprazole|aripiprazole|mesh-list
83908486|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
83908487|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83908488|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83908489|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908490|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908491|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908492|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
83908493|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
83908494|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908495|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908496|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83908497|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83908498|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
83908499|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83908500|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83908501|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83908502|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83908503|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83908504|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
83908505|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83908506|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83908507|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908508|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908509|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908510|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
83908511|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83908512|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
83908513|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908514|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908515|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83908516|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
83908517|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
83908518|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83908519|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
83908520|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908521|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908522|NCT00324948|Alprostadil|alprostadil|mesh-list
83908523|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83908524|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
83908525|NCT00324948|Urological Agents|urological agents|mesh-ancestor
83908526|NCT00304551|Ribavirin|ribavirin|mesh-list
83908527|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83908528|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
83908529|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
83908530|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908531|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
83908532|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908533|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
83908534|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908535|NCT00325026|Misoprostol|misoprostol|mesh-list
83908536|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83908537|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
83908538|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83908539|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908540|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83908541|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83908542|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
83908543|NCT00325104|Calcium|calcium|mesh-list
83908544|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
83908545|NCT00325104|Hormones|hormones|mesh-list
83908546|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83908547|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908548|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908549|NCT00292526|Enalapril|enalapril|mesh-list
83908550|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83908551|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
83908552|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908553|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908554|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83908555|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
83908556|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
83908557|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83908558|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
83908559|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908560|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908561|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83908562|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
83908563|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83908564|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83908565|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83908566|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908567|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908568|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908569|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908570|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
83908571|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83908572|NCT00292721|Celecoxib|celecoxib|mesh-list
83908573|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83908574|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83908575|NCT00292721|Analgesics|analgesics|mesh-ancestor
83908576|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
83908577|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908578|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908579|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908580|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908581|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83908582|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83908583|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908584|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908585|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
83908586|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83908587|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908588|NCT00325182|Levetiracetam|levetiracetam|mesh-list
83908589|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
83908590|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
83908591|NCT00292799|Metformin|metformin|mesh-list
83908592|NCT00292799|Orlistat|orlistat|mesh-list
83908593|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83908594|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908595|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908596|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908597|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83908598|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83908599|NCT00304629|Galantamine|galantamine|mesh-list
83908600|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83908601|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908602|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908603|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
83908604|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908605|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908606|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83908607|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
83908608|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908609|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
83908610|NCT00292838|Fluticasone|fluticasone|mesh-list
83908611|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908612|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83908613|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
83908614|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908615|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908616|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83908617|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
83908618|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
83908619|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83908620|NCT00304668|Dapivirine|dapivirine|mesh-list
83908621|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83908622|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83908623|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
83908624|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908625|NCT00292955|Cetuximab|cetuximab|mesh-list
83908626|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83908627|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908628|NCT00293072|Rituximab|rituximab|mesh-list
83908629|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83908630|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908631|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
83908632|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908633|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908634|NCT00293111|Etodolac|etodolac|mesh-list
83908635|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83908636|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83908637|NCT00293111|Analgesics|analgesics|mesh-ancestor
83908638|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
83908639|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908640|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908641|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908642|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908643|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83908644|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83908645|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908646|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908647|NCT00304785|Latanoprost|latanoprost|mesh-list
83908648|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83908649|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83908650|NCT00293150|Eplerenone|eplerenone|mesh-list
83908651|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83908652|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
83908653|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908654|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908655|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83908656|NCT00293150|Diuretics|diuretics|mesh-ancestor
83908657|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
83908658|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83908659|NCT00293228|Isoniazid|isoniazid|mesh-list
83908660|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
83908661|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83908662|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908663|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83908664|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83908665|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
83908666|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908667|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83908668|NCT00293345|Gemcitabine|gemcitabine|mesh-list
83908669|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83908670|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
83908671|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908672|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908673|NCT00293501|Tinzaparin|tinzaparin|mesh-list
83908674|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83908675|NCT00293501|Dalteparin|dalteparin|mesh-list
83908676|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
83908677|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83908678|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84124673|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908679|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908680|NCT00325455|Anacetrapib|anacetrapib|mesh-list
83908681|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83908682|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83908683|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
83908684|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908685|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83908686|NCT00293657|Lornoxicam|lornoxicam|mesh-list
83908687|NCT00293657|Piroxicam|piroxicam|mesh-list
83908688|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83908689|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83908690|NCT00293657|Analgesics|analgesics|mesh-ancestor
83908691|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
83908692|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908693|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908694|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83908695|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83908696|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83908697|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908698|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908699|NCT00293696|Goserelin|goserelin|mesh-list
83908700|NCT00293696|Bicalutamide|bicalutamide|mesh-list
83908701|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83908702|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908703|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
83908704|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
83908705|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908706|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908707|NCT00293735|Labetalol|labetalol|mesh-list
83908708|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83908709|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83908710|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908711|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908712|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908713|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908714|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83908715|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
83908716|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
83908717|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908718|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83908719|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83908720|NCT00304980|Lumefantrine|lumefantrine|mesh-list
83908721|NCT00304980|Artemether|artemether|mesh-list
83908722|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
83908723|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
83908724|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83908725|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83908726|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
83908727|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83908728|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83908729|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908730|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83908731|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908732|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908733|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83908734|NCT00293891|Tacrolimus|tacrolimus|mesh-list
83908735|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908736|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
83908737|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908738|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83908739|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908740|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908741|NCT00293930|Tacrolimus|tacrolimus|mesh-list
83908742|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83908743|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
83908744|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908745|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83908746|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908747|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908748|NCT00305019|Clevudine|clevudine|mesh-list
83908749|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
83908750|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908751|NCT00293969|Morphine|morphine|mesh-list
83908752|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83908753|NCT00293969|Narcotics|narcotics|mesh-ancestor
83908754|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908755|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908757|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
83908758|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908759|NCT00294008|Risperidone|risperidone|mesh-list
83908760|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83908761|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
83908762|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908763|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908764|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908765|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83908766|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908767|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908768|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83908769|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83908770|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
83908771|NCT00294086|Valsartan|valsartan|mesh-list
83908772|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83908773|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83908774|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83908775|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908776|NCT00325689|Risperidone|risperidone|mesh-list
83908777|NCT00325689|Aripiprazole|aripiprazole|mesh-list
83908778|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83908779|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83908780|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
83908781|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908782|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908783|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908784|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83908785|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908786|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908787|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83908788|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83908789|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
83908790|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
83908791|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
83908792|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83908793|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83908794|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83908795|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83908796|NCT00294164|Hormones|hormones|mesh-list
83908797|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908798|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908799|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83908800|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83908801|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83908802|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83908803|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908804|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908805|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908806|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908807|NCT00417833|Bevacizumab|bevacizumab|mesh-list
83908808|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83908809|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908810|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83908811|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83908812|NCT00417833|Growth Substances|growth substances|mesh-ancestor
83908813|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908814|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
83908815|NCT00417872|Metronidazole|metronidazole|mesh-list
83908816|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
83908817|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908818|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83908819|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83908820|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83908821|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
83908822|NCT00294203|Hematinics|hematinics|mesh-ancestor
83908823|NCT00305292|Modafinil|modafinil|mesh-list
83908824|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83908825|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908826|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83908827|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83908828|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83908829|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908830|NCT00305331|Domperidone|domperidone|mesh-list
83908831|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
83908832|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
83908833|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908834|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908835|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83908836|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83908837|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
83908838|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908839|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908840|NCT00325767|Albuterol|albuterol|mesh-list
83908841|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83908842|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
83908843|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908844|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908845|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83908846|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
83908847|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
83908848|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83908849|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83908850|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83908851|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83908852|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908853|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908854|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908855|NCT00294359|Bevacizumab|bevacizumab|mesh-list
83908856|NCT00294359|Capecitabine|capecitabine|mesh-list
83908857|NCT00294359|Mitomycins|mitomycins|mesh-list
83908858|NCT00294359|Mitomycin|mitomycin|mesh-list
83908859|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83908860|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908861|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83908862|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83908863|NCT00294359|Growth Substances|growth substances|mesh-ancestor
83908864|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908865|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83908866|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83908867|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
83908868|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908869|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83908870|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
83908871|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83908872|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908873|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
83908874|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83908875|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908876|NCT00305370|Aripiprazole|aripiprazole|mesh-list
83908877|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
83908878|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83908879|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83908880|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908881|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908882|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908883|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
83908884|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
83908885|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908886|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908887|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83908888|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83908889|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
83908890|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83908891|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83908892|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83908893|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83908894|NCT00325806|Ramipril|ramipril|mesh-list
83908895|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83908896|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
83908897|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908898|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148066|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908899|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83908900|NCT00305409|Sulfalene|sulfalene|mesh-list
83908901|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908902|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83908903|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
83908904|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83908905|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83908906|NCT00294593|Leucovorin|leucovorin|mesh-list
83908907|NCT00294593|Folic Acid|folic acid|mesh-list
83908908|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
83908909|NCT00294593|Antidotes|antidotes|mesh-ancestor
83908910|NCT00294593|Protective Agents|protective agents|mesh-ancestor
83908911|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908912|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
83908913|NCT00294593|Vitamins|vitamins|mesh-ancestor
83908914|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
83908915|NCT00294593|Hematinics|hematinics|mesh-ancestor
83908916|NCT00325845|Hylan|hylan|mesh-list
83908917|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
83908918|NCT00325845|Protective Agents|protective agents|mesh-ancestor
83908919|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908920|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
83908921|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83908922|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908923|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83908924|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83908925|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908926|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908927|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908928|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83908929|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83908930|NCT00325962|Verapamil|verapamil|mesh-list
83908931|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83908932|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83908933|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83908934|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908935|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83908936|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908937|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
83908938|NCT00305487|Ciclesonide|ciclesonide|mesh-list
83908939|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
83908940|NCT00305487|Hormones|hormones|mesh-ancestor
83908941|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908942|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908943|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83908944|NCT00294944|Idazoxan|idazoxan|mesh-list
83908945|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83908946|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83908947|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83908948|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83908949|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908950|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908951|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908952|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83908953|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
83908954|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908955|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83908956|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83908957|NCT00295100|Tamoxifen|tamoxifen|mesh-list
83908958|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83908959|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
83908960|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908961|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908962|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83908963|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908964|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83908965|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83908966|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83908967|NCT00326235|Buspirone|buspirone|mesh-list
83908968|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83908969|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83908970|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83908971|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908972|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83148142|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83908973|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83908974|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
83908975|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83908976|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908977|NCT00295178|Vancomycin|vancomycin|mesh-list
83908978|NCT00295178|Daptomycin|daptomycin|mesh-list
83908979|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83908980|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83908981|NCT00305838|Tamoxifen|tamoxifen|mesh-list
83908982|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83908983|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
83908984|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83908985|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83908986|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83908987|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83908988|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83908989|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83908990|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83908991|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83908992|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83908993|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83908994|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
83908995|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83908996|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83908997|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83908998|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83908999|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83909000|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
83909001|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909002|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83909003|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83909004|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909005|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909006|NCT00326352|Remifentanil|remifentanil|mesh-list
83909007|NCT00326352|Propofol|propofol|mesh-list
83909008|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83909009|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909010|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909011|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83909012|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
83909013|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
83909014|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83909015|NCT00326352|Narcotics|narcotics|mesh-ancestor
83909016|NCT00326352|Analgesics|analgesics|mesh-ancestor
83909017|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
83909018|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909019|NCT00419601|Fentanyl|fentanyl|mesh-list
83909020|NCT00419601|Remifentanil|remifentanil|mesh-list
83909021|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83909022|NCT00419601|Narcotics|narcotics|mesh-ancestor
83909023|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909024|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909025|NCT00419601|Analgesics|analgesics|mesh-ancestor
83909026|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
83909027|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909028|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83909029|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83909030|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
83909031|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
83909032|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83909033|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
83909034|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83909035|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
83909036|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
83909037|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909038|NCT00295607|Antibodies|antibodies|mesh-list
83909039|NCT00295607|Tacrolimus|tacrolimus|mesh-list
83909040|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
83909041|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909042|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909043|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83909044|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909045|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909046|NCT00326391|Methylphenidate|methylphenidate|mesh-list
83909047|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83909048|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909049|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83909050|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83909051|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909052|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909053|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
83909054|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909055|NCT00295685|Antacids|antacids|mesh-list
83909056|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909057|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83909058|NCT00306150|Aprotinin|aprotinin|mesh-list
83909059|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
83909060|NCT00306150|Coagulants|coagulants|mesh-ancestor
83909061|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83909062|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83909063|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
83909064|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909065|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909066|NCT00417911|Bortezomib|bortezomib|mesh-list
83909067|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909068|NCT00326469|Lanreotide|lanreotide|mesh-list
83909069|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909070|NCT00417950|Acarbose|acarbose|mesh-list
83909071|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83909072|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909073|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909074|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83909075|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909076|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
83909077|NCT00306267|Hematinics|hematinics|mesh-ancestor
83909078|NCT00326508|Daclizumab|daclizumab|mesh-list
83909079|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909080|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
83909081|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909082|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
83909083|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
83909084|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
83909085|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909086|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909087|NCT00295841|Cytarabine|cytarabine|mesh-list
83909088|NCT00295841|Clofarabine|clofarabine|mesh-list
83909089|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909090|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
83909091|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909092|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909093|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
83909094|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909095|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909096|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
83909097|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909098|NCT00326664|Cediranib|cediranib|mesh-list
83909099|NCT00326664|Maleic acid|maleic acid|mesh-list
83909100|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909101|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909102|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909103|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83909104|NCT00295919|Ketoconazole|ketoconazole|mesh-list
83909105|NCT00295919|Fenretinide|fenretinide|mesh-list
83909106|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
83909107|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909108|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83909109|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83909110|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909111|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909112|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83909113|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
83909114|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909115|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909116|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83909117|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909118|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83909119|NCT00295919|Protective Agents|protective agents|mesh-ancestor
83909120|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
83909121|NCT00295958|Immunotoxins|immunotoxins|mesh-list
83148368|NCT04090190|Oxybutynin|oxybutynin|mesh-list
83909122|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83909123|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
83909124|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909125|NCT00295958|Immunoconjugates|immunoconjugates|mesh-ancestor
83909126|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
83909127|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
83909128|NCT00295997|Busulfan|busulfan|mesh-list
83909129|NCT00295997|Methotrexate|methotrexate|mesh-list
83909130|NCT00295997|Fludarabine|fludarabine|mesh-list
83909131|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
83909132|NCT00295997|Tacrolimus|tacrolimus|mesh-list
83909133|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83909134|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909135|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
83909136|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909137|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909138|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83909139|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
83909140|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909141|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909142|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83909143|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83909144|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
83909145|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83909146|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909147|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
83909148|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
83909149|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909150|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83909151|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83909152|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83909153|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909154|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83909155|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
83909156|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909157|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909158|NCT00418067|Sirolimus|sirolimus|mesh-list
83909159|NCT00418067|Paclitaxel|paclitaxel|mesh-list
83909160|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83909161|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909162|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
83909163|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
83909164|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
83909165|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909166|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909167|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909168|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909169|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
83909170|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909171|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
83909172|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909173|NCT00296309|Tacrolimus|tacrolimus|mesh-list
83909174|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909175|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
83909176|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909177|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83909178|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909179|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909180|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
83909181|NCT00296348|Tacrolimus|tacrolimus|mesh-list
83909182|NCT00296348|Daclizumab|daclizumab|mesh-list
83909183|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909184|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
83909185|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909186|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83909187|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909188|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909189|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909190|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909191|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83909192|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
83909193|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909194|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909195|NCT00296387|Atorvastatin|atorvastatin|mesh-list
83909196|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83909197|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83909198|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83909199|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
83909200|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909201|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83909202|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83909203|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909204|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
83909205|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
83909206|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83909207|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909208|NCT00296465|Citric Acid|citric acid|mesh-list
83909209|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
83909211|NCT00296465|Enclomiphene|enclomiphene|mesh-list
83909212|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
83909213|NCT00296465|Hormones|hormones|mesh-list
83909214|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83909215|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
83909216|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83909217|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
83909218|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
83909219|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909220|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909221|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909222|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83909223|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
83909224|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83909225|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
83909226|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83909227|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83909228|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83909229|NCT00326859|Remifentanil|remifentanil|mesh-list
83909230|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83909231|NCT00326859|Narcotics|narcotics|mesh-ancestor
83909232|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909233|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909234|NCT00326859|Analgesics|analgesics|mesh-ancestor
83909235|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
83909236|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909237|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83909238|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83909239|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83909240|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909241|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909242|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909243|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909244|NCT00296699|Analgesics|analgesics|mesh-ancestor
83909245|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
83909246|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909247|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
83909248|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909249|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
83909250|NCT00296777|Bupropion|bupropion|mesh-list
83909251|NCT00296777|Imipramine|imipramine|mesh-list
83909252|NCT00296777|Escitalopram|escitalopram|mesh-list
83909253|NCT00296777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83909254|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83909255|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909256|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909257|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909258|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
83909259|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909260|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83909261|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
83909262|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909263|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83909264|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
83909265|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83909266|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83909267|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909268|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83909269|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83909270|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
83909271|NCT00296894|Adalimumab|adalimumab|mesh-list
83909272|NCT00296894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83909273|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83909274|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909275|NCT00296933|Bupropion|bupropion|mesh-list
83909276|NCT00296933|Escitalopram|escitalopram|mesh-list
83909277|NCT00296933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83909278|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83909279|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909280|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909281|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909282|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
83909283|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909284|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83909285|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
83909286|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909287|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83909288|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
83909289|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83909290|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83909291|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909292|NCT00296972|Interferons|interferons|mesh-list
83909293|NCT00296972|Ribavirin|ribavirin|mesh-list
83909294|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909295|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
83909296|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909297|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
83909298|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909299|NCT00297011|Valacyclovir|valacyclovir|mesh-list
83909300|NCT00297011|Clobetasol|clobetasol|mesh-list
83909301|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
83909302|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909303|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83909304|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
83909305|NCT00297011|Hormones|hormones|mesh-ancestor
83909306|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909307|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909308|NCT00327093|Bevacizumab|bevacizumab|mesh-list
83909309|NCT00327093|Cetuximab|cetuximab|mesh-list
83909310|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83909311|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909312|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83909313|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83909314|NCT00327093|Growth Substances|growth substances|mesh-ancestor
83909315|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909316|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
83909317|NCT00297050|Peramivir|peramivir|mesh-list
83909318|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
83909319|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909320|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909321|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909322|NCT00297128|Capecitabine|capecitabine|mesh-list
83909323|NCT00297128|Cetuximab|cetuximab|mesh-list
83909324|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909325|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
83909326|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909327|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909328|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83909329|NCT00327132|Amoxicillin|amoxicillin|mesh-list
83909330|NCT00327132|Clarithromycin|clarithromycin|mesh-list
83909331|NCT00327132|Omeprazole|omeprazole|mesh-list
83909332|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909333|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909334|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83909335|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83909336|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83909337|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909338|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909339|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83909340|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83909341|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83909342|NCT00297206|Valacyclovir|valacyclovir|mesh-list
83148525|NCT00988364|Simvastatin|simvastatin|mesh-list
83909343|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
83909344|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909345|NCT04485195|Procainamide|procainamide|mesh-list
84124674|NCT00594516|Analgesics|analgesics|mesh-ancestor
83909346|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83909347|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83909348|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83909349|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909350|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909352|NCT04478019|Povidone|povidone|mesh-list
83909353|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
83909354|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
83909355|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83909356|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909357|NCT00297284|Modafinil|modafinil|mesh-list
83909358|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83909359|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909360|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83909361|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83909362|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83909363|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909364|NCT04392531|Cyclosporine|cyclosporine|mesh-list
83909365|NCT04392531|Cyclosporins|cyclosporins|mesh-list
83909366|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909367|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909368|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909369|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
83909370|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909371|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
83909372|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909373|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
83909374|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909375|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83909376|NCT00297323|Topiramate|topiramate|mesh-list
83909377|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
83909378|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83909379|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909380|NCT00327288|Docetaxel|docetaxel|mesh-list
83909381|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909382|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
83909383|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
83909384|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
83909385|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909386|NCT04333134|Fluzoparib|fluzoparib|mesh-list
83909387|NCT04333134|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83909388|NCT04333134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909389|NCT04333134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909390|NCT04333134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909391|NCT00327327|Gemcitabine|gemcitabine|mesh-list
83909392|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909393|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
83909394|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909395|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909396|NCT00297362|Galantamine|galantamine|mesh-list
83909397|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83909398|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909399|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909400|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
83909401|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909402|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909403|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83909404|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
83909405|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909406|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
83909407|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
83909408|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83909409|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
83909410|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909411|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909412|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83909413|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
83909414|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83909415|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
83909416|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909417|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909418|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83909419|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
83909420|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
83909421|NCT04231773|Protective Agents|protective agents|mesh-ancestor
83909422|NCT00297674|Clarithromycin|clarithromycin|mesh-list
83909423|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909424|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909425|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83909426|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909427|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909428|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83909429|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83909430|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83909431|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83909432|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909433|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83909434|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
83909435|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909436|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83909437|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83909438|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909439|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909440|NCT04718714|Midazolam|midazolam|mesh-list
83909441|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
83909442|NCT04718714|Propofol|propofol|mesh-list
83909443|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83909444|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909445|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909446|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83909447|NCT04718714|Analgesics|analgesics|mesh-ancestor
83909448|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
83909449|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909450|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83909451|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83909452|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83909453|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
83909454|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909455|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909456|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83909457|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
83909458|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
83909459|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83909460|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83909461|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83909462|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909463|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
83909464|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
83909465|NCT00298025|Cetrorelix|cetrorelix|mesh-list
83909466|NCT00298025|Menotropins|menotropins|mesh-list
83909467|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83909468|NCT00298025|Hormones|hormones|mesh-list
83909469|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83909470|NCT00298025|Ganirelix|ganirelix|mesh-list
83909471|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909472|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909473|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
83909474|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83909475|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
83909476|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83909477|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
83909478|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83909479|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
83909480|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909481|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909482|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909483|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
83909484|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909485|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
83909486|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83909487|NCT00298181|Protective Agents|protective agents|mesh-ancestor
83909488|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83909489|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83909490|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909491|NCT03754140|Polidocanol|polidocanol|mesh-list
83909492|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83909493|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83909494|NCT00298415|Paclitaxel|paclitaxel|mesh-list
83148682|NCT05474690|Docetaxel|docetaxel|mesh-list
83909495|NCT00298415|Vinorelbine|vinorelbine|mesh-list
83909496|NCT00298415|Carboplatin|carboplatin|mesh-list
83909497|NCT00298415|Gemcitabine|gemcitabine|mesh-list
83909498|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83909499|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83909500|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909501|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
83909502|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
83909503|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
83909504|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909505|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909506|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
83909507|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83909508|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909509|NCT00298454|Furosemide|furosemide|mesh-list
83909510|NCT00298454|Diuretics|diuretics|mesh-ancestor
83909511|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
83909512|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909513|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83909514|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909515|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909516|NCT00298571|Epinephrine|epinephrine|mesh-list
83909517|NCT00298571|Bupivacaine|bupivacaine|mesh-list
83909518|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
83909519|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
83909520|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909521|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909522|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
83909523|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909524|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83909525|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83909526|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
83909527|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909528|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909529|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83909530|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83909531|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
83909532|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83909533|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
83909534|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
83909535|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
83909536|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83909537|NCT00298688|Gefitinib|gefitinib|mesh-list
83909538|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909539|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83909540|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909541|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909542|NCT05457894|Vaccines|vaccines|mesh-list
83909543|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
83909544|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909545|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
83909546|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909547|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909548|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83909549|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
83909550|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909551|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909552|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909553|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909554|NCT00298922|Azithromycin|azithromycin|mesh-list
83909555|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909556|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909557|NCT00299039|Acetaminophen|acetaminophen|mesh-list
83909558|NCT00299039|Ibuprofen|ibuprofen|mesh-list
83909559|NCT00299039|Codeine|codeine|mesh-list
83909560|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83909561|NCT00299039|Analgesics|analgesics|mesh-ancestor
83909562|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
83909563|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909564|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909565|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
83909566|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83909567|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83909568|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909569|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83909570|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909571|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909573|NCT00299039|Narcotics|narcotics|mesh-ancestor
83909574|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909575|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
83909576|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83909577|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83909578|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83909579|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83909580|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909581|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909582|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
83909583|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909584|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909585|NCT00299351|Romidepsin|romidepsin|mesh-list
83909586|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909587|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909588|NCT00299351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83909589|NCT00299351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909590|NCT00299351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909591|NCT00299390|Sagopilone|sagopilone|mesh-list
83909592|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909593|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
83909594|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
83909595|NCT00299819|Sifalimumab|sifalimumab|mesh-list
83909596|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83909597|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
83909598|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909599|NCT00299858|Theophylline|theophylline|mesh-list
83909600|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83909601|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
83909602|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909603|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909604|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83909605|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
83909606|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83909607|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909608|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909609|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
83909610|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83909611|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83909612|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
83909613|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909614|NCT05455944|Pregabalin|pregabalin|mesh-list
83909615|NCT05455944|Analgesics|analgesics|mesh-ancestor
83909616|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
83909617|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909618|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909619|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
83909620|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83909621|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909622|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909623|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83909624|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83909625|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83909626|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909627|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909628|NCT00299936|Ribavirin|ribavirin|mesh-list
83909629|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83909630|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
83909631|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909632|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
83909633|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909634|NCT00300014|Triamcinolone|triamcinolone|mesh-list
83909635|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83909636|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
83909637|NCT00300014|Hormones|hormones|mesh-ancestor
83909638|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909639|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909640|NCT00300131|Everolimus|everolimus|mesh-list
83909641|NCT00300131|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83909642|NCT00300131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83909643|NCT00300131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909644|NCT00300131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909645|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909646|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
83909647|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909648|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909649|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
83909650|NCT01785459|Bupivacaine|bupivacaine|mesh-list
83909651|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
83909652|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
83909653|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909654|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909655|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
83909656|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909657|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
83909658|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
83909659|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83909660|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83909661|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83909662|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909663|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83909664|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
83909665|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909666|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909667|NCT04716894|Itraconazole|itraconazole|mesh-list
83909668|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
83909669|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909670|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83909671|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83909672|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909673|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909674|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83909675|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
83909676|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909677|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909678|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83909679|NCT00300287|Vildagliptin|vildagliptin|mesh-list
83909680|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83909681|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909682|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83909683|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
83909684|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909685|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909686|NCT00300404|Leucovorin|leucovorin|mesh-list
83909687|NCT00300404|Folic Acid|folic acid|mesh-list
83909688|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
83909689|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
83909690|NCT00300404|Antidotes|antidotes|mesh-ancestor
83909691|NCT00300404|Protective Agents|protective agents|mesh-ancestor
83909692|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909693|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
83909694|NCT00300404|Vitamins|vitamins|mesh-ancestor
83909695|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
83909696|NCT00300404|Hematinics|hematinics|mesh-ancestor
83909697|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
83909698|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83909699|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83909700|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909701|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83909702|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909703|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909704|NCT01539447|Naproxen|naproxen|mesh-list
83909705|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83909706|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83909707|NCT01539447|Analgesics|analgesics|mesh-ancestor
83909708|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
83909709|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909710|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909711|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83909712|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909713|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
83909714|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83909715|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909716|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909717|NCT00300443|Bimatoprost|bimatoprost|mesh-list
83909718|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83909720|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909721|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909722|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83909723|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
83909724|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909725|NCT00300716|Memantine|memantine|mesh-list
83909726|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83909727|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83909728|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
83909729|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909730|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909731|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909732|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83909733|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83909734|NCT00300794|Ketamine|ketamine|mesh-list
83909735|NCT00300794|Analgesics|analgesics|mesh-ancestor
83909736|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
83909737|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909738|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909739|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83909740|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83909741|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
83909742|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
83909743|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909744|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83909745|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83909746|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909747|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909748|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
83909749|NCT05373303|Hematinics|hematinics|mesh-ancestor
83909750|NCT00300833|Tirofiban|tirofiban|mesh-list
83909751|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83909752|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83909753|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909754|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83909755|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
83909756|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83909757|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909758|NCT00327678|Rituximab|rituximab|mesh-list
83909759|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
83909760|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83909761|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909762|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
83909763|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909764|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909765|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83909766|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909767|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909768|NCT00300950|Gemcitabine|gemcitabine|mesh-list
83909769|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909770|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
83909771|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909772|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909773|NCT00327756|Ubiquinone|ubiquinone|mesh-list
83909774|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
83909775|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
83909776|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909777|NCT00327756|Vitamins|vitamins|mesh-ancestor
83909778|NCT00301106|Interleukin-12|interleukin-12|mesh-list
83909779|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83909780|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
83909781|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909782|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83909783|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83909784|NCT00301106|Growth Substances|growth substances|mesh-ancestor
83909785|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83909786|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909787|NCT00301145|Varenicline|varenicline|mesh-list
83909788|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83909789|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83909790|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83909791|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909792|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148984|NCT05279183|Erythritol|erythritol|mesh-list
83909793|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909795|NCT00301223|Analgesics|analgesics|mesh-ancestor
83909796|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
83909797|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909798|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909799|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
83909800|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83909801|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909802|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909803|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83909804|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83909805|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83909806|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83909807|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83909808|NCT00301301|Rituximab|rituximab|mesh-list
83909809|NCT00301301|Gemcitabine|gemcitabine|mesh-list
83909810|NCT00301301|Cisplatin|cisplatin|mesh-list
83909811|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83909812|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909813|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
83909814|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909815|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909816|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909817|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
83909818|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909819|NCT00301535|Chrysarobin|chrysarobin|mesh-list
83909820|NCT00301535|HBOC 201|hboc 201|mesh-list
83909821|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83909822|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83909823|NCT00301535|Analgesics|analgesics|mesh-ancestor
83909824|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
83909825|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909826|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909827|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83909828|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909829|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
83909830|NCT00301574|Galantamine|galantamine|mesh-list
83909831|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83909832|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909833|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909834|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
83909835|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909836|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909837|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83909838|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
83909839|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83909840|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
83909841|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83909842|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83909843|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83909844|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909845|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909846|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
83909847|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909848|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909849|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
83909850|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909851|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909852|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83909853|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
83909854|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909855|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909856|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909857|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909858|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
83909859|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909860|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909861|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83909862|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
83909863|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83909864|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909865|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909866|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909867|NCT00301730|Aldesleukin|aldesleukin|mesh-list
83909868|NCT00301730|Paclitaxel|paclitaxel|mesh-list
83909869|NCT00301730|Trastuzumab|trastuzumab|mesh-list
83909870|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83909871|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909872|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
83909873|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
83909874|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
83909875|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909876|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83909877|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83909878|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83909879|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
83909880|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83909881|NCT00301847|Sorafenib|sorafenib|mesh-list
83909882|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909883|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83909884|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909885|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909886|NCT00327990|Alendronate|alendronate|mesh-list
83909887|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
83909888|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83909889|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909890|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
83909891|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
83909892|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83909893|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909894|NCT05238831|Paclitaxel|paclitaxel|mesh-list
83909895|NCT05238831|Vinorelbine|vinorelbine|mesh-list
83909896|NCT05238831|Maytansine|maytansine|mesh-list
83909897|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83909898|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83909899|NCT05238831|Bevacizumab|bevacizumab|mesh-list
83909900|NCT05238831|Carboplatin|carboplatin|mesh-list
83909901|NCT05238831|Capecitabine|capecitabine|mesh-list
83909902|NCT05238831|Trastuzumab|trastuzumab|mesh-list
83909903|NCT05238831|Irinotecan|irinotecan|mesh-list
83909904|NCT05238831|Atezolizumab|atezolizumab|mesh-list
83909905|NCT05238831|Letrozole|letrozole|mesh-list
83909906|NCT05238831|Fulvestrant|fulvestrant|mesh-list
83909907|NCT05238831|Olaparib|olaparib|mesh-list
83909908|NCT05238831|Palbociclib|palbociclib|mesh-list
83909909|NCT05238831|Pertuzumab|pertuzumab|mesh-list
83909910|NCT05238831|Anastrozole|anastrozole|mesh-list
83909911|NCT05238831|Niraparib|niraparib|mesh-list
83909912|NCT05238831|Vemurafenib|vemurafenib|mesh-list
83909913|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83909914|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
83909915|NCT05238831|Antibodies|antibodies|mesh-list
83909916|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
83909917|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83909918|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83909919|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
83909920|NCT05238831|Entrectinib|entrectinib|mesh-list
83909921|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
83909922|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
83909923|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83909924|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909925|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
83909926|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
83909927|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
83909928|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909929|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83909930|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83909931|NCT05238831|Growth Substances|growth substances|mesh-ancestor
83909932|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909933|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83909934|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
83909935|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909936|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
83909937|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83909938|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83909939|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909940|NCT05238831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83909941|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83909942|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83909943|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83149137|NCT01666730|Vitamins|vitamins|mesh-ancestor
83909944|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
83909945|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83909946|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83909947|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83909948|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83909949|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83909951|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
83909952|NCT00301925|Fluorouracil|fluorouracil|mesh-list
83909953|NCT00301925|Capecitabine|capecitabine|mesh-list
83909954|NCT00301925|Methotrexate|methotrexate|mesh-list
83909955|NCT00301925|Epirubicin|epirubicin|mesh-list
83909956|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909957|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
83909958|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909959|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83909960|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83909961|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
83909962|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909963|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909964|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83909965|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
83909966|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83909967|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83909968|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
83909969|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83909970|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
83909971|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83909972|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83909973|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83909974|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83909975|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83909976|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83909977|NCT00328029|Busulfan|busulfan|mesh-list
83909978|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
83909979|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909980|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83909981|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
83909982|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909983|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83909984|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83909985|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83909986|NCT00302354|Methylphenidate|methylphenidate|mesh-list
83909987|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83909988|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909989|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83909990|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83909991|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83909992|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83909993|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
83909994|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83909995|NCT00302393|Methylphenidate|methylphenidate|mesh-list
83909996|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83909997|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83909998|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83909999|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83910000|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83910001|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910002|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
83910003|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910004|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
83910005|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
83910006|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
83910007|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910008|NCT00328107|Coagulants|coagulants|mesh-ancestor
83910009|NCT00302432|Menthol|menthol|mesh-list
83910010|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
83910011|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
83910012|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83910013|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83910014|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
83910015|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910016|NCT00302549|Tacrolimus|tacrolimus|mesh-list
83910017|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910018|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
83910019|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910020|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83910021|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910022|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910023|NCT00419991|Tigecycline|tigecycline|mesh-list
83910024|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910025|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910026|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83910027|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910028|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910029|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
83910030|NCT00302627|Vitamin D|vitamin d|mesh-list
83910031|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
83910032|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
83910033|NCT00302627|Pamidronate|pamidronate|mesh-list
83910034|NCT00302627|Vitamins|vitamins|mesh-list
83910035|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
83910036|NCT00302627|Calcium|calcium|mesh-list
83910037|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
83910038|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910039|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83910040|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83910041|NCT00302627|Antacids|antacids|mesh-ancestor
83910042|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910043|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910044|NCT00302666|Dienogest|dienogest|mesh-list
83910045|NCT00302666|Nandrolone|nandrolone|mesh-list
83910046|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83910047|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
83910048|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83910049|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910050|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83910051|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83910052|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83910053|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83910054|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
83910055|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910056|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83910057|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910058|NCT00302666|Androgens|androgens|mesh-ancestor
83910059|NCT00302666|Hormones|hormones|mesh-ancestor
83910060|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
83910061|NCT00328302|Candesartan|candesartan|mesh-list
83910062|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910063|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83910064|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83910065|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910066|NCT00328380|Rifaximin|rifaximin|mesh-list
83910067|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910068|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910069|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910070|NCT00418496|Aldesleukin|aldesleukin|mesh-list
83910071|NCT00418496|Sorafenib|sorafenib|mesh-list
83910072|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910073|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83910074|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910075|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910076|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83910077|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83910078|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
83910079|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910080|NCT00302705|Valsartan|valsartan|mesh-list
83910081|NCT00302705|Enalapril|enalapril|mesh-list
83910082|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910083|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83910084|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83910085|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910086|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83910087|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
83910088|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910089|NCT00302822|Tenofovir|tenofovir|mesh-list
83910090|NCT00302822|Emtricitabine|emtricitabine|mesh-list
83910091|NCT00302822|Efavirenz|efavirenz|mesh-list
83149283|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
83910092|NCT00302822|Lopinavir|lopinavir|mesh-list
83910093|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
83910094|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
83910095|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910096|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83910097|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83910098|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910099|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910100|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83910101|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83910102|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83910103|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83910104|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83910105|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83910106|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83910107|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83910108|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83910109|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83910110|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
83910111|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83910112|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83910113|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83910114|NCT00328458|Epothilones|epothilones|mesh-list
83910115|NCT00328458|Epothilone B|epothilone b|mesh-list
83910116|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
83910117|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
83910118|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
83910119|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910120|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910121|NCT05008224|Prednisone|prednisone|mesh-list
83910122|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
83910123|NCT05008224|Dacarbazine|dacarbazine|mesh-list
83910124|NCT05008224|Doxorubicin|doxorubicin|mesh-list
83910125|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
83910126|NCT05008224|Etoposide|etoposide|mesh-list
83910127|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
83910128|NCT05008224|Vincristine|vincristine|mesh-list
83910129|NCT05008224|Bleomycin|bleomycin|mesh-list
83910130|NCT05008224|Vinblastine|vinblastine|mesh-list
83910131|NCT05008224|Procarbazine|procarbazine|mesh-list
83910132|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910133|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
83910134|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910135|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910136|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83910137|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
83910138|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910139|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910140|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83910141|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83910142|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83910143|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83910144|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910145|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83910146|NCT05008224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83910147|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910148|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
83910149|NCT05008224|Hormones|hormones|mesh-ancestor
83910150|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910151|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83910152|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83910153|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
83910154|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
83910155|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
83910156|NCT00303017|Naproxen|naproxen|mesh-list
83910157|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83910158|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910159|NCT00303017|Analgesics|analgesics|mesh-ancestor
83910160|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
83910161|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910162|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910163|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910164|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910165|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
83910166|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83910167|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149359|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910168|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910169|NCT00303056|Icatibant|icatibant|mesh-list
83910170|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83910171|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910172|NCT00303056|Analgesics|analgesics|mesh-ancestor
83910173|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
83910174|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910175|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910176|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910177|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910178|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83910179|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83910180|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910181|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83910182|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910183|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
83910184|NCT00328497|Bevacizumab|bevacizumab|mesh-list
83910185|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83910186|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83910187|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910188|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83910189|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83910190|NCT00328497|Growth Substances|growth substances|mesh-ancestor
83910191|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910192|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
83910193|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
83910194|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
83910195|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
83910196|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910197|NCT00303290|Interferons|interferons|mesh-list
83910198|NCT00303290|Cytarabine|cytarabine|mesh-list
83910199|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
83910200|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
83910201|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83910202|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910203|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
83910204|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910205|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83910206|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
83910207|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910208|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910209|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
83910210|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910211|NCT00328692|Rolofylline|rolofylline|mesh-list
83910212|NCT00328692|Diuretics|diuretics|mesh-ancestor
83910213|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
83910214|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910215|NCT00419718|Insulin|insulin|mesh-list
83910216|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83910217|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83910218|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910219|NCT00303407|Nadroparin|nadroparin|mesh-list
83910220|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
83910221|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83910222|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83910223|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910224|NCT00303524|Goserelin|goserelin|mesh-list
83910225|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83910226|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910227|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
83910228|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83910229|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83910230|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910231|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910232|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83910233|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910234|NCT00419796|Analgesics|analgesics|mesh-ancestor
83910235|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
83910236|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910237|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910238|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910239|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910240|NCT00419835|Losartan|losartan|mesh-list
83149433|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
83910241|NCT00419835|Enalapril|enalapril|mesh-list
83910242|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83910243|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910244|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83910245|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83910246|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910247|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83910248|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
83910249|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910250|NCT00328809|Spironolactone|spironolactone|mesh-list
83910251|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83910252|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
83910253|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910254|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910255|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83910256|NCT00328809|Diuretics|diuretics|mesh-ancestor
83910257|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
83910258|NCT00420030|Abciximab|abciximab|mesh-list
83910259|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
83910260|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83910261|NCT00303758|Leucovorin|leucovorin|mesh-list
83910262|NCT00303758|Gemcitabine|gemcitabine|mesh-list
83910263|NCT00303758|Fluorouracil|fluorouracil|mesh-list
83910264|NCT00303758|Calcium|calcium|mesh-list
83910265|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
83910266|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910267|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83910268|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
83910269|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910270|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83910271|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910272|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910273|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
83910274|NCT00303758|Antidotes|antidotes|mesh-ancestor
83910275|NCT00303758|Protective Agents|protective agents|mesh-ancestor
83910276|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
83910277|NCT00303758|Vitamins|vitamins|mesh-ancestor
83910278|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
83910279|NCT00303797|Bortezomib|bortezomib|mesh-list
83910280|NCT00303797|Sorafenib|sorafenib|mesh-list
83910281|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910282|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83910283|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910284|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910285|NCT00303836|Aldesleukin|aldesleukin|mesh-list
83910286|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
83910287|NCT00303836|Fludarabine|fludarabine|mesh-list
83910288|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
83910289|NCT00303836|Interleukin-2|interleukin-2|mesh-list
83910290|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
83910291|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910292|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
83910293|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910294|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910295|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83910296|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
83910297|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910298|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910299|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83910300|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83910301|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
83910302|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83910303|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910304|NCT00303836|Analgesics|analgesics|mesh-ancestor
83910305|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
83910306|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910307|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83910308|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83910309|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
83910310|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910311|NCT00303992|Trastuzumab|trastuzumab|mesh-list
83910312|NCT00303992|Irinotecan|irinotecan|mesh-list
83910313|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83910314|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910315|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83910316|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83910317|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149514|NCT02422953|Micronutrients|micronutrients|mesh-list
83910318|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910320|NCT00304226|Valsartan|valsartan|mesh-list
83910321|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910322|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83910323|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83910324|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910325|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83910326|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910327|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
83910328|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83910329|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83910330|NCT00332319|Casopitant|casopitant|mesh-list
83910331|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
83910332|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
83910333|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910334|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910335|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910336|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83910337|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910338|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910339|NCT00304382|Vaccines|vaccines|mesh-list
83910340|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83910341|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
83910342|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910343|NCT00304421|Rabeprazole|rabeprazole|mesh-list
83910344|NCT00304421|Pantoprazole|pantoprazole|mesh-list
83910345|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83910346|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910347|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83910348|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910349|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910350|NCT00332397|Sirolimus|sirolimus|mesh-list
83910351|NCT00332397|Temsirolimus|temsirolimus|mesh-list
83910352|NCT00332397|MTOR Inhibitors|mtor inhibitors|mesh-list
83910353|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910354|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910355|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83910356|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910357|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
83910358|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910359|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
83910360|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910361|NCT00332397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83910362|NCT00332397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910363|NCT00332397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910364|NCT00304460|Aldesleukin|aldesleukin|mesh-list
83910365|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910366|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83910367|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83910368|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
83910369|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910370|NCT00304499|Oxybutynin|oxybutynin|mesh-list
83910371|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
83910372|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
83910373|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910374|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910375|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83910376|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83910377|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83910378|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910379|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910380|NCT00304499|Urological Agents|urological agents|mesh-ancestor
83910381|NCT00304538|Glucagon|glucagon|mesh-list
83910382|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910383|NCT00304538|Hormones|hormones|mesh-ancestor
83910384|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910385|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910386|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83910387|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83910388|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83910389|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149586|NCT03635021|Bevacizumab|bevacizumab|mesh-list
83910390|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910392|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910393|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910394|NCT00328965|Lacidipine|lacidipine|mesh-list
83910395|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910396|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83910397|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83910398|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910399|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83910400|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910401|NCT00304616|Olanzapine|olanzapine|mesh-list
83910402|NCT00304616|Risperidone|risperidone|mesh-list
83910403|NCT00304616|Aripiprazole|aripiprazole|mesh-list
83910404|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83910405|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83910406|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
83910407|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910408|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910409|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910410|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83910411|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83910412|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83910413|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83910414|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83910415|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
83910416|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
83910417|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
83910418|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910419|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910420|NCT00304616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83910421|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83910422|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83910423|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
83910424|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
83910425|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83910426|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83910427|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83910428|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83910429|NCT00332436|Timolol|timolol|mesh-list
83910430|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83910431|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83910432|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83910433|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83910434|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910435|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910436|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910437|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83910438|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910439|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83910440|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83910441|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83910442|NCT00304655|Aripiprazole|aripiprazole|mesh-list
83910443|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
83910444|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83910445|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83910446|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83910447|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83910448|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910449|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
83910450|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
83910451|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910452|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910453|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83910454|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83910455|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
83910456|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83910457|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83910458|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83910459|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83910460|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83149657|NCT03810794|Donepezil|donepezil|mesh-list
83910461|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83910462|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83910463|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83910464|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
83910466|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83910467|NCT00332553|Estrogens|estrogens|mesh-list
83910468|NCT00332553|Hormones|hormones|mesh-ancestor
83910469|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910470|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910471|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83910472|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
83910473|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83910474|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83910475|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83910476|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83910477|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83910478|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83910479|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83910480|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910481|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83910482|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
83910483|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83910484|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83910485|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83910486|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
83910487|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83910488|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
83910489|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910490|NCT00332631|Expectorants|expectorants|mesh-ancestor
83910491|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
83910492|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83910493|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
83910494|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910495|NCT00332631|Protective Agents|protective agents|mesh-ancestor
83910496|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910497|NCT00332631|Antidotes|antidotes|mesh-ancestor
83910498|NCT00304772|Fluconazole|fluconazole|mesh-list
83910499|NCT00304772|Micafungin|micafungin|mesh-list
83910500|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
83910501|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910502|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83910503|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83910504|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910505|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910506|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83910507|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83910508|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910509|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910510|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83910511|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83910512|NCT00304811|Vancomycin|vancomycin|mesh-list
83910513|NCT00304811|Rifampin|rifampin|mesh-list
83910514|NCT00304811|Gentamicins|gentamicins|mesh-list
83910515|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910516|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910517|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83910518|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
83910519|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
83910520|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83910521|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910522|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910523|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83910524|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83910525|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83910526|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83910527|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83910528|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83910529|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83910530|NCT00332787|Fluoxetine|fluoxetine|mesh-list
83910531|NCT00332787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83910532|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83910533|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83910534|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910535|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910536|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
83910537|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910538|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83910539|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
83910540|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83910541|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83910542|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83910543|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910544|NCT00304850|Ketamine|ketamine|mesh-list
83910545|NCT00304850|Analgesics|analgesics|mesh-ancestor
83910546|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
83910547|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910548|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910549|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83910550|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83910551|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
83910552|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
83910553|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83910554|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83910555|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83910556|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910557|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910558|NCT00329316|Progesterone|progesterone|mesh-list
83910559|NCT00329316|Progestins|progestins|mesh-ancestor
83910560|NCT00329316|Hormones|hormones|mesh-ancestor
83910561|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910562|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910563|NCT00332826|Insulin|insulin|mesh-list
83910564|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83910565|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910566|NCT00305201|Pravastatin|pravastatin|mesh-list
83910567|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83910568|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83910569|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
83910570|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910571|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83910572|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83910573|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910574|NCT00329355|Naproxen|naproxen|mesh-list
83910575|NCT00329355|Sumatriptan|sumatriptan|mesh-list
83910576|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83910577|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910578|NCT00329355|Analgesics|analgesics|mesh-ancestor
83910579|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
83910580|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910581|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910582|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910583|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910584|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
83910585|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83910586|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910587|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910588|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83910589|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83910590|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83910591|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
83910592|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910593|NCT00332904|Propranolol|propranolol|mesh-list
83910594|NCT00332904|Spironolactone|spironolactone|mesh-list
83910595|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83910596|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83910597|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83910598|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910599|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910600|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910601|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83910602|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910603|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
83910604|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83910605|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
83910606|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910607|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83910608|NCT00332904|Diuretics|diuretics|mesh-ancestor
83910609|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
83910610|NCT00329394|Ketamine|ketamine|mesh-list
83910611|NCT00329394|Analgesics|analgesics|mesh-ancestor
83910612|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
83910613|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910614|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910615|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83910616|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83910617|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
83910618|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
83910619|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83910620|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83910621|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83910622|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910623|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910624|NCT00305396|Sirolimus|sirolimus|mesh-list
83910625|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910626|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910627|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83910628|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910629|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
83910630|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910631|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
83910632|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910633|NCT00329472|Gemcitabine|gemcitabine|mesh-list
83910634|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910635|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83910636|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
83910637|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910638|NCT00305474|Risperidone|risperidone|mesh-list
83910639|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83910640|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
83910641|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910642|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910643|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910644|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83910645|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83910646|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83910647|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83910648|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83910649|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
83910650|NCT00329511|Clonidine|clonidine|mesh-list
83910651|NCT00329511|Methyldopa|methyldopa|mesh-list
83910652|NCT00329511|Analgesics|analgesics|mesh-ancestor
83910653|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
83910654|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910655|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910656|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910657|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
83910658|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
83910659|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83910660|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83910661|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83910662|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83910663|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910664|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910665|NCT00305513|Caffeine|caffeine|mesh-list
83910666|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83910667|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910668|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83910669|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910670|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910671|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83910672|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83910673|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
83910674|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910675|NCT00333021|PENTA|penta|mesh-list
83910676|NCT00333021|Fondaparinux|fondaparinux|mesh-list
83910677|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83910678|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
83910679|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83149880|NCT02416245|Micronutrients|micronutrients|mesh-list
83910681|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910682|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910683|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
83910684|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83910685|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83910686|NCT00305552|Thalidomide|thalidomide|mesh-list
83910687|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910688|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
83910689|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910690|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
83910691|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910692|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910693|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83910694|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83910695|NCT00305552|Growth Substances|growth substances|mesh-ancestor
83910696|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
83910697|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910698|NCT00329589|Bortezomib|bortezomib|mesh-list
83910699|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910700|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
83910701|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83910702|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83910703|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910704|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910705|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910706|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83910707|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83910708|NCT00305630|Triamcinolone|triamcinolone|mesh-list
83910709|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83910710|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83910711|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83910712|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910713|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
83910714|NCT00305630|Hormones|hormones|mesh-ancestor
83910715|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910716|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910717|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910718|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
83910719|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910720|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910721|NCT00329628|Enoxaparin|enoxaparin|mesh-list
83910722|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
83910723|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83910724|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
83910725|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83910726|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
83910727|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910728|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910729|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
83910730|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83910731|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83910732|NCT00305669|Sargramostim|sargramostim|mesh-list
83910733|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
83910734|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910735|NCT00305708|Fludarabine|fludarabine|mesh-list
83910736|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
83910737|NCT00305708|Busulfan|busulfan|mesh-list
83910738|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83910739|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910740|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83910741|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
83910742|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910743|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910744|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
83910745|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910746|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
83910747|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83910748|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83910749|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83910750|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83910751|NCT00305747|Protective Agents|protective agents|mesh-ancestor
83910752|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910753|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910754|NCT00333255|Nepafenac|nepafenac|mesh-list
83910755|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83910756|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910757|NCT00333255|Analgesics|analgesics|mesh-ancestor
83910758|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
83910759|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910760|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910761|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910762|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910763|NCT00305786|Gemcitabine|gemcitabine|mesh-list
83910764|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
83910765|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83910766|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
83910767|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910768|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910769|NCT00305825|Bevacizumab|bevacizumab|mesh-list
83910770|NCT00305825|Letrozole|letrozole|mesh-list
83910771|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83910772|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910773|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83910774|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83910775|NCT00305825|Growth Substances|growth substances|mesh-ancestor
83910776|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910777|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
83910778|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83910779|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83910780|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910781|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910782|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83910783|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
83910784|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910785|NCT00333294|Vinorelbine|vinorelbine|mesh-list
83910786|NCT00333294|Gefitinib|gefitinib|mesh-list
83910787|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910788|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83910789|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
83910790|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
83910791|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
83910792|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910793|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83910794|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910795|NCT00305903|Memantine|memantine|mesh-list
83910796|NCT00305903|Rivastigmine|rivastigmine|mesh-list
83910797|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83910798|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83910799|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
83910800|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910801|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910802|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910803|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83910804|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83910805|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83910806|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910807|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
83910808|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83910809|NCT00305903|Protective Agents|protective agents|mesh-ancestor
83910810|NCT00329823|Etanercept|etanercept|mesh-list
83910811|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83910812|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910813|NCT00329823|Analgesics|analgesics|mesh-ancestor
83910814|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
83910815|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910816|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910817|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910818|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910819|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910820|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910821|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
83910822|NCT00306020|Morphine|morphine|mesh-list
83910823|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83910824|NCT00306020|Narcotics|narcotics|mesh-ancestor
83910825|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83910826|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910827|NCT00306020|Analgesics|analgesics|mesh-ancestor
83910828|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
83910829|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910830|NCT00306137|Aprotinin|aprotinin|mesh-list
83910831|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
83910832|NCT00306137|Coagulants|coagulants|mesh-ancestor
83910833|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83910834|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83910835|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152178|NCT05532020|Diazoxide|diazoxide|mesh-list
83910836|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910837|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910838|NCT00329940|Letrozole|letrozole|mesh-list
83910839|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910840|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83910841|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83910842|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910843|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910844|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83910845|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
83910846|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83910847|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910848|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
83910849|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83910850|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910851|NCT00333372|Z 338|z 338|mesh-list
83910852|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83910853|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910854|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910855|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
83910856|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910857|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910858|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83910859|NCT00330018|Acyclovir|acyclovir|mesh-list
83910860|NCT00330018|Valganciclovir|valganciclovir|mesh-list
83910861|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
83910862|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910863|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83910864|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
83910865|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910866|NCT00306254|Enoxaparin|enoxaparin|mesh-list
83910867|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
83910868|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
83910869|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83910870|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83910871|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910872|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83910873|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
83910874|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83910875|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
83910876|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910877|NCT00333489|Valsartan|valsartan|mesh-list
83910878|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83910879|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83910880|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83910881|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910882|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
83910883|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83910884|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
83910885|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910886|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
83910887|NCT00330135|Protective Agents|protective agents|mesh-ancestor
83910888|NCT03275558|Sunitinib|sunitinib|mesh-list
83910889|NCT03275558|Axitinib|axitinib|mesh-list
83910890|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910891|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83910892|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83910893|NCT03275558|Growth Substances|growth substances|mesh-ancestor
83910894|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910895|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
83910896|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83910897|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910898|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910899|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83910900|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83910901|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910902|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
83910903|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
83910904|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83910905|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83910906|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910907|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910908|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83910909|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910910|NCT00333567|Analgesics|analgesics|mesh-ancestor
83910911|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
83910912|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910913|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910914|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83910915|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910917|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
83910918|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83910919|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910920|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
83910921|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910922|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910923|NCT00333645|Caspofungin|caspofungin|mesh-list
83910924|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
83910925|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910926|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910927|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910928|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
83910929|NCT00451100|Neostigmine|neostigmine|mesh-list
83910930|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83910931|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910932|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910933|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
83910934|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83910935|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910936|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83910937|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
83910938|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910939|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83910940|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83910941|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83910942|NCT00420537|Cyclosporine|cyclosporine|mesh-list
83910943|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
83910944|NCT00420537|Everolimus|everolimus|mesh-list
83910945|NCT00420537|Cyclosporins|cyclosporins|mesh-list
83910946|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910947|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910948|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83910949|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
83910950|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910951|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
83910952|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910953|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
83910954|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83910955|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83910956|NCT00420537|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83910957|NCT00420537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83910958|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83910959|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83910960|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83910961|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
83910962|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910963|NCT00451139|Lumefantrine|lumefantrine|mesh-list
83910964|NCT00451139|Artemether|artemether|mesh-list
83910965|NCT00451139|Quinine|quinine|mesh-list
83910966|NCT00451139|Atovaquone|atovaquone|mesh-list
83910967|NCT00451139|Proguanil|proguanil|mesh-list
83910968|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83910969|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83910970|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
83910971|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83910972|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83910973|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910974|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83910975|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910976|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83910977|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83910978|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83910979|NCT00451139|Analgesics|analgesics|mesh-ancestor
83910980|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
83910981|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83910982|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83910983|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
83910984|NCT00330486|Acamprosate|acamprosate|mesh-list
83910985|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83910986|NCT00451373|Vancomycin|vancomycin|mesh-list
83910987|NCT00451373|Daptomycin|daptomycin|mesh-list
83910988|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83910989|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83910990|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
83910991|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83910992|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83910993|NCT00451412|Heparin|heparin|mesh-list
83910994|NCT00451412|Calcium heparin|calcium heparin|mesh-list
83910995|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83910996|NCT00451412|Tinzaparin|tinzaparin|mesh-list
83910997|NCT00451412|Dalteparin|dalteparin|mesh-list
83910998|NCT00451412|Certoparin|certoparin|mesh-list
83910999|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
83911000|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83911001|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83911002|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911003|NCT00451490|Agomelatine|agomelatine|mesh-list
83911004|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83911005|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911006|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911007|NCT00330525|Sibutramine|sibutramine|mesh-list
83911008|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
83911009|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83911010|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
83911011|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83911012|NCT00333918|Bromfenac|bromfenac|mesh-list
83911013|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83911014|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83911015|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83911016|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83911017|NCT00333918|Analgesics|analgesics|mesh-ancestor
83911018|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
83911019|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911020|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911021|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911022|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83911023|NCT00451568|Metformin|metformin|mesh-list
83911024|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83911025|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911026|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83911027|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83911028|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83911029|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83911030|NCT00451724|Ketamine|ketamine|mesh-list
83911031|NCT00451724|Analgesics|analgesics|mesh-ancestor
83911032|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
83911033|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911034|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911035|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83911036|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83911037|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
83911038|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
83911039|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911040|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83911041|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83911042|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911043|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911044|NCT00451763|Bevacizumab|bevacizumab|mesh-list
83911045|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83911046|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911047|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83911048|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83911049|NCT00451763|Growth Substances|growth substances|mesh-ancestor
83911050|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911051|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
83911052|NCT00330798|Ketorolac|ketorolac|mesh-list
83911053|NCT00330798|Nepafenac|nepafenac|mesh-list
83911054|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83911055|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83911056|NCT00330798|Analgesics|analgesics|mesh-ancestor
83911057|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
83911058|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911059|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911060|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911061|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83911062|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83911063|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911064|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911066|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83911067|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911068|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83911069|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
83911070|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
83911071|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911072|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911073|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911074|NCT00451997|Cytarabine|cytarabine|mesh-list
83911075|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
83911076|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911077|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
83911078|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911079|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911080|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
83911081|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911082|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911083|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
83911084|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911085|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83911086|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911087|NCT00330993|Misoprostol|misoprostol|mesh-list
83911088|NCT00330993|Mifepristone|mifepristone|mesh-list
83911089|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83911090|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
83911091|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83911092|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911093|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83911094|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911095|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
83911096|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83911097|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83911098|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83911099|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83911100|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
83911101|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83911102|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83911103|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
83911104|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911105|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
83911106|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83911107|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83911108|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83911109|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911110|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83911111|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911112|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911113|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
83911114|NCT00331071|Ortho Evra|ortho evra|mesh-list
83911115|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
83911116|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83911117|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911118|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83911119|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83911120|NCT00333996|Dexamethasone|dexamethasone|mesh-list
83911121|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911122|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
83911123|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
83911124|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911125|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911126|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911127|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
83911128|NCT00333996|Hormones|hormones|mesh-ancestor
83911129|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911130|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83911131|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911132|NCT00452192|Telmisartan|telmisartan|mesh-list
83911133|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911134|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83911135|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83911136|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911137|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83911138|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
83911139|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83911140|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83911141|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83911142|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911143|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911144|NCT00334152|Casopitant|casopitant|mesh-list
83911145|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
83911146|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
83911147|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911148|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911149|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911150|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83911151|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911152|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911153|NCT04698512|Sirolimus|sirolimus|mesh-list
83911154|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83911155|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911156|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83911157|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911158|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
83911159|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911160|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
83911161|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911162|NCT00334308|Caseins|caseins|mesh-list
83911163|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
83911164|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
83911165|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911166|NCT00334347|Valproic Acid|valproic acid|mesh-list
83911167|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
83911168|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911169|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911170|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
83911171|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911172|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911173|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
83911174|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83911175|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911176|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83911177|NCT00334386|Torsemide|torsemide|mesh-list
83911178|NCT00334386|Diuretics|diuretics|mesh-list
83911179|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83911180|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
83911181|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911182|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83911183|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911184|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911185|NCT00452231|Cycloserine|cycloserine|mesh-list
83911186|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83911187|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911188|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83911189|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
83911190|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83911191|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
83911192|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911193|NCT00334425|Menotropins|menotropins|mesh-list
83911194|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83911195|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
83911196|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83911197|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911198|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
83911199|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83911200|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911201|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911202|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83911203|NCT03275207|Analgesics|analgesics|mesh-ancestor
83911204|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
83911205|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911206|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83911207|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83911208|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83911209|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
83911210|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911211|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911212|NCT00334464|Warfarin|warfarin|mesh-list
83911213|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
83911214|NCT03275012|Morphine|morphine|mesh-list
83911215|NCT03275012|Gabapentin|gabapentin|mesh-list
83911216|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83911217|NCT03275012|Narcotics|narcotics|mesh-ancestor
83911218|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911219|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911220|NCT03275012|Analgesics|analgesics|mesh-ancestor
83911221|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
83911222|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911223|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
83911224|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83911225|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83911226|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83911227|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83911228|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83911229|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911230|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911231|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
83911232|NCT00334503|Miglitol|miglitol|mesh-list
83911233|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911234|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911235|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83911236|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911237|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83911238|NCT00334581|Irbesartan|irbesartan|mesh-list
83911239|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911240|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83911241|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83911242|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911243|NCT00452270|Xylometazoline|xylometazoline|mesh-list
83911244|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
83911245|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83911246|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
83911247|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
83911248|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
83911249|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83911250|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83911251|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911252|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911253|NCT00452582|Urological Agents|urological agents|mesh-ancestor
83911254|NCT00334698|Cetirizine|cetirizine|mesh-list
83911255|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
83911256|NCT00334698|Ephedrine|ephedrine|mesh-list
83911257|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83911258|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83911259|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83911260|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
83911261|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
83911262|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911263|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911264|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911265|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83911266|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
83911267|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911268|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83911269|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
83911270|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
83911271|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83911272|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83911273|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
83911274|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
83911275|NCT00452660|Deferasirox|deferasirox|mesh-list
83911276|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83911277|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
83911278|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
83911279|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911280|NCT00334854|Doxorubicin|doxorubicin|mesh-list
83911281|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83911282|NCT00334854|Ifosfamide|ifosfamide|mesh-list
83911283|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83911284|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911285|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83911286|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83911287|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911288|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911289|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83911290|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
83911291|NCT00334932|Doxorubicin|doxorubicin|mesh-list
83911292|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83911293|NCT00334932|Bortezomib|bortezomib|mesh-list
83911294|NCT00334932|Melphalan|melphalan|mesh-list
83911295|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83911296|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911297|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83911298|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83911299|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911300|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911301|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83911302|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
83911303|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83911304|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911305|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
83911306|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911307|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
83911308|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
83911309|NCT00452855|Remifentanil|remifentanil|mesh-list
83911310|NCT00452855|Sevoflurane|sevoflurane|mesh-list
83911311|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
83911312|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911313|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911314|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83911315|NCT00452855|Narcotics|narcotics|mesh-ancestor
83911316|NCT00452855|Analgesics|analgesics|mesh-ancestor
83911317|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
83911318|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911319|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83911320|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83911321|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
83911322|NCT00335088|Iodine|iodine|mesh-list
83911323|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
83911324|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
83911325|NCT00335088|Povidone|povidone|mesh-list
83911326|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83911327|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911328|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83911329|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83911330|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911331|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911332|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911333|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911334|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83911335|NCT00335088|Trace Elements|trace elements|mesh-ancestor
83911336|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
83911337|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
83911338|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
83911339|NCT00452894|Varenicline|varenicline|mesh-list
83911340|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83911341|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83911342|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
83911343|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911344|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911345|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911346|NCT00335166|Pramipexole|pramipexole|mesh-list
83911347|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
83911348|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911349|NCT00335166|Protective Agents|protective agents|mesh-ancestor
83911350|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911351|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83150565|NCT03176199|Analgesics|analgesics|mesh-ancestor
83911352|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83911353|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
83911354|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
83911355|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911356|NCT00452972|Anesthetics|anesthetics|mesh-list
83911357|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911358|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911359|NCT00335205|Ropinirole|ropinirole|mesh-list
83911360|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83911361|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83911362|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
83911363|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
83911364|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911365|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911366|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911367|NCT00453050|Imiquimod|imiquimod|mesh-list
83911368|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83911369|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
83911370|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911371|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911372|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
83911373|NCT00335400|Anesthetics|anesthetics|mesh-list
83911374|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911375|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911376|NCT00420615|Epothilone B|epothilone b|mesh-list
83911377|NCT00420615|Epothilones|epothilones|mesh-list
83911378|NCT00420615|Omeprazole|omeprazole|mesh-list
83911379|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83911380|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911381|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83911382|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911383|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911384|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911385|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83911386|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83911387|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83911388|NCT00453167|Paclitaxel|paclitaxel|mesh-list
83911389|NCT00453167|Gemcitabine|gemcitabine|mesh-list
83911390|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83911391|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911392|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
83911393|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
83911394|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
83911395|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911396|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911397|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
83911398|NCT00420654|Hormones|hormones|mesh-list
83911399|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911400|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911401|NCT00420693|Sevoflurane|sevoflurane|mesh-list
83911402|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83911403|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83911404|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
83911405|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
83911406|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911407|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911408|NCT03274895|Biguanides|biguanides|mesh-list
83911409|NCT03274895|Polihexanide|polihexanide|mesh-list
83911410|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
83911411|NCT03274895|Propamidine|propamidine|mesh-list
83911412|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83911413|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911414|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
83911415|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911416|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83911417|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83911418|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83911419|NCT00453323|Paclitaxel|paclitaxel|mesh-list
83911420|NCT00453323|Capecitabine|capecitabine|mesh-list
83911421|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83911422|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911423|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
83911424|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
83911425|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
83911426|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911427|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911428|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
83911429|NCT00335439|Ketorolac|ketorolac|mesh-list
83911430|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83911431|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83911432|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83911433|NCT00335439|Analgesics|analgesics|mesh-ancestor
83911434|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
83911435|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911436|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911437|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911438|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83911439|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83911440|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911441|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911442|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
83911443|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
83911444|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911445|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911446|NCT00335673|Irbesartan|irbesartan|mesh-list
83911447|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911448|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83911449|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83911450|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911451|NCT00453635|Carboplatin|carboplatin|mesh-list
83911452|NCT00453635|Docetaxel|docetaxel|mesh-list
83911453|NCT00453635|Trastuzumab|trastuzumab|mesh-list
83911454|NCT00453635|Vinorelbine|vinorelbine|mesh-list
83911455|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911456|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83911457|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83911458|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83911459|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911460|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83911461|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83911462|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83911463|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
83911464|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83911465|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
83911466|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83911467|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
83911468|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911469|NCT00336141|Vorinostat|vorinostat|mesh-list
83911470|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911471|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83911472|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911473|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911474|NCT00336219|Pantoprazole|pantoprazole|mesh-list
83911475|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83911476|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911477|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83911478|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911479|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911480|NCT00453908|Alfuzosin|alfuzosin|mesh-list
83911481|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83911482|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83911483|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83911484|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
83911485|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911486|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911487|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911488|NCT00453908|Urological Agents|urological agents|mesh-ancestor
83911489|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83911490|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83911491|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83911492|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
83911493|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911494|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83911495|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83911496|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911497|NCT00336375|Lumefantrine|lumefantrine|mesh-list
83911498|NCT00336375|Artemether|artemether|mesh-list
83911499|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83911500|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
83911501|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83911502|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83911503|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150713|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911504|NCT00336414|Prednisone|prednisone|mesh-list
83911505|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
83911506|NCT00336414|Azathioprine|azathioprine|mesh-list
83911507|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911508|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
83911509|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911510|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83911511|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83911512|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
83911513|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911514|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911515|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83911516|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911517|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
83911518|NCT00336414|Hormones|hormones|mesh-ancestor
83911519|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911520|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83911521|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
83911522|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911523|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
83911524|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
83911525|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
83911526|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911527|NCT00336453|Coagulants|coagulants|mesh-ancestor
83911528|NCT00336531|Itraconazole|itraconazole|mesh-list
83911529|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
83911530|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911531|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83911532|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83911533|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911534|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911535|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83911536|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
83911537|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911538|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911539|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83911540|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
83911541|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83911542|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
83911543|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911544|NCT00322062|Protective Agents|protective agents|mesh-ancestor
83911545|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911546|NCT00322062|Vitamins|vitamins|mesh-ancestor
83911547|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
83911548|NCT00322062|Laxatives|laxatives|mesh-ancestor
83911549|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911550|NCT00336648|Bevacizumab|bevacizumab|mesh-list
83911551|NCT00336648|Gemcitabine|gemcitabine|mesh-list
83911552|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83911553|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911554|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83911555|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83911556|NCT00336648|Growth Substances|growth substances|mesh-ancestor
83911557|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911558|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
83911559|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911560|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
83911561|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911562|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83911563|NCT03274817|Escitalopram|escitalopram|mesh-list
83911564|NCT03274817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83911565|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83911566|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83911567|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911568|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911569|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
83911570|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911571|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83911572|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
83911573|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83911574|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83911575|NCT00230204|Antibodies|antibodies|mesh-list
83911576|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
83911577|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911578|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
83911579|NCT00230321|Hematinics|hematinics|mesh-ancestor
83911580|NCT00230399|Celecoxib|celecoxib|mesh-list
83911581|NCT00230399|Capecitabine|capecitabine|mesh-list
83911582|NCT00230399|Irinotecan|irinotecan|mesh-list
83911583|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911584|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
83911585|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911586|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911587|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83911588|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83911589|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911590|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83911591|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83911592|NCT00230399|Analgesics|analgesics|mesh-ancestor
83911593|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
83911594|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911595|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911596|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911597|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83911598|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83911599|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83911600|NCT00336765|XL647|xl647|mesh-list
83911601|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911602|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83911603|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911604|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911605|NCT00230477|Lamivudine|lamivudine|mesh-list
83911606|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83911607|NCT00230477|Adefovir|adefovir|mesh-list
83911608|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83911609|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83911610|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911611|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911612|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
83911613|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911614|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83911615|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83911616|NCT00230516|Lansoprazole|lansoprazole|mesh-list
83911617|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83911618|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911619|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83911620|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911621|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911622|NCT00336882|Midazolam|midazolam|mesh-list
83911623|NCT00336882|Propofol|propofol|mesh-list
83911624|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83911625|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911626|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911627|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83911628|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
83911629|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
83911630|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83911631|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83911632|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83911633|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83911634|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
83911635|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
83911636|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911637|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911638|NCT00336921|Alfuzosin|alfuzosin|mesh-list
83911639|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83911640|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83911641|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83911642|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
83911643|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911644|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911645|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911646|NCT00336921|Urological Agents|urological agents|mesh-ancestor
83911647|NCT00336960|Celecoxib|celecoxib|mesh-list
83911648|NCT00336960|Fluorouracil|fluorouracil|mesh-list
83911649|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
83911650|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911651|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911652|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911653|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911655|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911656|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83911657|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83911658|NCT00336960|Analgesics|analgesics|mesh-ancestor
83911659|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
83911660|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911661|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911662|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83911663|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83911664|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83911665|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911666|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
83911667|NCT00306410|Vitamin D|vitamin d|mesh-list
83911668|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83911669|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911670|NCT00306410|Vitamins|vitamins|mesh-ancestor
83911671|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
83911672|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83911673|NCT00340080|Abacavir|abacavir|mesh-list
83911674|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83911675|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83911676|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911677|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911678|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
83911679|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911680|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83911681|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83911682|NCT00418535|Cisplatin|cisplatin|mesh-list
83911683|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911684|NCT02960711|Metformin|metformin|mesh-list
83911685|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83911686|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911687|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83911688|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911689|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83911690|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
83911691|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83911692|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911693|NCT00306683|Diazoxide|diazoxide|mesh-list
83911694|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911695|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
83911696|NCT00306722|Fospropofol|fospropofol|mesh-list
83911697|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83911698|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911699|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911700|NCT00337389|Leucovorin|leucovorin|mesh-list
83911701|NCT00337389|Bevacizumab|bevacizumab|mesh-list
83911702|NCT00337389|Fluorouracil|fluorouracil|mesh-list
83911703|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83911704|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911705|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83911706|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83911707|NCT00337389|Growth Substances|growth substances|mesh-ancestor
83911708|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911709|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
83911710|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
83911711|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911712|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911713|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911714|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
83911715|NCT00337389|Antidotes|antidotes|mesh-ancestor
83911716|NCT00337389|Protective Agents|protective agents|mesh-ancestor
83911717|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
83911718|NCT00337389|Vitamins|vitamins|mesh-ancestor
83911719|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
83911720|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83911721|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83911722|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83911723|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
83911724|NCT00306878|Abatacept|abatacept|mesh-list
83911725|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83911726|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911727|NCT00306878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83911728|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911729|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911730|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
83911731|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911732|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83911733|NCT00337506|Dexamethasone|dexamethasone|mesh-list
83911734|NCT00337506|Bortezomib|bortezomib|mesh-list
83911735|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911736|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
83911737|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
83911738|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911739|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911740|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911741|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
83911742|NCT00337506|Hormones|hormones|mesh-ancestor
83911743|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911744|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83911745|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911746|NCT00307307|Niacin|niacin|mesh-list
83911747|NCT00307307|Simvastatin|simvastatin|mesh-list
83911748|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83911749|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83911750|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
83911751|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911752|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83911753|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83911754|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911755|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
83911756|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
83911757|NCT00307307|Vitamins|vitamins|mesh-ancestor
83911758|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
83911759|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911760|NCT00337623|Prednisolone|prednisolone|mesh-list
83911761|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911762|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
83911763|NCT00337623|Hormones|hormones|mesh-ancestor
83911764|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911765|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911766|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83911767|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911768|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
83911769|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83911770|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83911771|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911772|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83911773|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83911774|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
83911775|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911776|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
83911777|NCT00337740|Propranolol|propranolol|mesh-list
83911778|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83911779|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83911780|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
83911781|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911782|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911783|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911784|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83911785|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911786|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
83911787|NCT00307502|Ritonavir|ritonavir|mesh-list
83911788|NCT00307502|Lopinavir|lopinavir|mesh-list
83911789|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83911790|NCT00307502|Darunavir|darunavir|mesh-list
83911791|NCT00307502|Nelfinavir|nelfinavir|mesh-list
83911792|NCT00307502|Indinavir|indinavir|mesh-list
83911793|NCT00307502|Saquinavir|saquinavir|mesh-list
83911794|NCT00307502|Amprenavir|amprenavir|mesh-list
83911795|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
83911796|NCT00307502|Nevirapine|nevirapine|mesh-list
83911797|NCT00307502|Tipranavir|tipranavir|mesh-list
83911798|NCT00307502|Efavirenz|efavirenz|mesh-list
83911799|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83911800|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83911801|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
83911802|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911803|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151015|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83911804|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83911805|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83911806|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
83911807|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911808|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83411088|NCT00209599|Fospropofol|fospropofol|mesh-list
83911809|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83911810|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83911811|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83911812|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83911813|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83911814|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83911815|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83911816|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83911817|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83911818|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
83911819|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83911820|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83911821|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83911822|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83911823|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911824|NCT00307619|Topiramate|topiramate|mesh-list
83911825|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
83911826|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83911827|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911828|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
83911829|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83911830|NCT00307658|Antibodies|antibodies|mesh-list
83911831|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
83911832|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
83911833|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83911834|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
83911835|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911836|NCT00337545|Everolimus|everolimus|mesh-list
83911837|NCT00337545|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83911838|NCT00337545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83911839|NCT00337545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911840|NCT00337545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911841|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83911842|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
83911843|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911844|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911845|NCT00307775|Estradiol|estradiol|mesh-list
83911846|NCT00307775|Estrogens|estrogens|mesh-ancestor
83911847|NCT00307775|Hormones|hormones|mesh-ancestor
83911848|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911849|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911850|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
83911851|NCT00307814|Hematinics|hematinics|mesh-ancestor
83911852|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
83911853|NCT00341055|Hematinics|hematinics|mesh-ancestor
83911854|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83911855|NCT00338052|Norethindrone|norethindrone|mesh-list
83911856|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
83911857|NCT00338052|Estradiol|estradiol|mesh-list
83911858|NCT00338052|Estrogens|estrogens|mesh-ancestor
83911859|NCT00338052|Hormones|hormones|mesh-ancestor
83911860|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911861|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911862|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83911863|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
83911864|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83911865|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83911866|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83911867|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83911868|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83911869|NCT00338091|Losartan|losartan|mesh-list
83911870|NCT00338091|Benazepril|benazepril|mesh-list
83911871|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83911872|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911873|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83911874|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83911875|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911876|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83911877|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
83911878|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911879|NCT00308048|Interferons|interferons|mesh-list
83911880|NCT00308048|Ribavirin|ribavirin|mesh-list
83911881|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
83911882|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
83911883|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83911884|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911885|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
83911886|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83911887|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
83911888|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911889|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
83911890|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911891|NCT00338130|Temozolomide|temozolomide|mesh-list
83911892|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83911893|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
83911894|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911895|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911896|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83911897|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
83911898|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
83911899|NCT00308165|Topotecan|topotecan|mesh-list
83911900|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83911901|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83911902|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911903|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911904|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911905|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83911906|NCT00338247|Capecitabine|capecitabine|mesh-list
83911907|NCT00338247|Lapatinib|lapatinib|mesh-list
83911908|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83911909|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
83911910|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911911|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911912|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83911913|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911914|NCT00308321|Prednisolone|prednisolone|mesh-list
83911915|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83911916|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
83911917|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83911918|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
83911919|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83911920|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
83911921|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911922|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
83911923|NCT00308321|Hormones|hormones|mesh-ancestor
83911924|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911925|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911926|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83911927|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911928|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
83911929|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
83911930|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911931|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911932|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83911933|NCT00308321|Protective Agents|protective agents|mesh-ancestor
83911934|NCT00308360|Valproic Acid|valproic acid|mesh-list
83911935|NCT00308360|Risperidone|risperidone|mesh-list
83911936|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83911937|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
83911938|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83911939|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911940|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911941|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83911942|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83911943|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911944|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83911945|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83911946|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
83911947|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
83911948|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83911949|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
83911950|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
83911951|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83911952|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83911953|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
83911954|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911955|NCT00341250|Antacids|antacids|mesh-ancestor
83911956|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83911957|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911958|NCT00308438|Teduglutide|teduglutide|mesh-list
83911959|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911960|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83911961|NCT00308438|Protective Agents|protective agents|mesh-ancestor
83911962|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911963|NCT00308477|Dexamethasone|dexamethasone|mesh-list
83911964|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911965|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
83911966|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
83911967|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911968|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911969|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911970|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
83911971|NCT00308477|Hormones|hormones|mesh-ancestor
83911972|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911973|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83911974|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911975|NCT00308594|Dexamethasone|dexamethasone|mesh-list
83911976|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83911977|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
83911978|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
83911979|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83911980|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911981|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83911982|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
83911983|NCT00308594|Hormones|hormones|mesh-ancestor
83911984|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83911985|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83911986|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83911987|NCT00308945|Travoprost|travoprost|mesh-list
83911988|NCT00308945|Latanoprost|latanoprost|mesh-list
83911989|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83911990|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83911991|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83911992|NCT00338481|Morphine|morphine|mesh-list
83911993|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83911994|NCT00338481|Narcotics|narcotics|mesh-ancestor
83911995|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83911996|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83911997|NCT00338481|Analgesics|analgesics|mesh-ancestor
83911998|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
83911999|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912000|NCT00309101|Tacrolimus|tacrolimus|mesh-list
83912001|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912002|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
83912003|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912004|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83912005|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912006|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912007|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
83912008|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83912009|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83912010|NCT00309218|Prednisolone|prednisolone|mesh-list
83912011|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
83912012|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83912013|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
83912014|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912015|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
83912016|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
83912017|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912018|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912019|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83912020|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
83912021|NCT00309218|Hormones|hormones|mesh-ancestor
83912022|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912023|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83912024|NCT00309218|Protective Agents|protective agents|mesh-ancestor
83912025|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83912026|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912027|NCT00309335|Phentolamine|phentolamine|mesh-list
83912028|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83912029|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83912030|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
83912031|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912032|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912033|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912034|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912035|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83912036|NCT00309374|Simvastatin|simvastatin|mesh-list
83912037|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83912038|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83912039|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
83912040|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912041|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83912042|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83912043|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912044|NCT00309413|Cannabidiol|cannabidiol|mesh-list
83912045|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
83912046|NCT00309491|Tamoxifen|tamoxifen|mesh-list
83912047|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
83912048|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83912049|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
83912050|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912051|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912052|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83912053|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912054|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83912055|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83912056|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83912057|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83912058|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83912059|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912060|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912061|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
83912062|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912063|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
83912064|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
83912065|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
83912066|NCT00309530|Interferons|interferons|mesh-list
83912067|NCT00309530|Fluorouracil|fluorouracil|mesh-list
83912068|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
83912069|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912070|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912071|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912072|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912073|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
83912074|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912075|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
83912076|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912077|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
83912078|NCT00309569|Fluorouracil|fluorouracil|mesh-list
83912079|NCT00309569|Methotrexate|methotrexate|mesh-list
83912080|NCT00309569|Epirubicin|epirubicin|mesh-list
83912081|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912082|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
83912083|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912084|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912085|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83912086|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
83912087|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912088|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912089|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83912090|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
83912091|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912092|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83912093|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
83912094|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83912095|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
83912096|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912097|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83912098|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83912099|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83912100|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83912101|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83912102|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83912103|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83912104|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83912105|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912106|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912107|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83151328|NCT05696678|Morphine|morphine|mesh-list
83912108|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83912109|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83912110|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
83912111|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912112|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912113|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83912114|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83912115|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
83912116|NCT00309725|Galantamine|galantamine|mesh-list
83912117|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83912118|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912119|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912120|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
83912121|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912122|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912123|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83912124|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
83912125|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912126|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
83912127|NCT00338754|Adalimumab|adalimumab|mesh-list
83912128|NCT00338754|Antibodies|antibodies|mesh-list
83912129|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83912130|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
83912131|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912132|NCT00338754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83912133|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912134|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912135|NCT00338793|Prednisolone|prednisolone|mesh-list
83912136|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912137|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
83912138|NCT00338793|Hormones|hormones|mesh-ancestor
83912139|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912140|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912141|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83912142|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912143|NCT00418847|Miglustat|miglustat|mesh-list
83912144|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912145|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912146|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83912147|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83912148|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
83912149|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912150|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83912151|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83912152|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912153|NCT00309881|Prednisone|prednisone|mesh-list
83912154|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
83912155|NCT00309881|Rituximab|rituximab|mesh-list
83912156|NCT00309881|Doxorubicin|doxorubicin|mesh-list
83912157|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83912158|NCT00309881|Vincristine|vincristine|mesh-list
83912159|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912160|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
83912161|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912162|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912163|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83912164|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
83912165|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912166|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912167|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83912168|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83912169|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83912170|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83912171|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83912172|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912173|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912174|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
83912175|NCT00309881|Hormones|hormones|mesh-ancestor
83912176|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912177|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83912178|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83912179|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912180|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912181|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912182|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
83912183|NCT00309920|Docetaxel|docetaxel|mesh-list
83912184|NCT00309920|Doxorubicin|doxorubicin|mesh-list
83912185|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83912186|NCT00309920|Fluorouracil|fluorouracil|mesh-list
83912187|NCT00309920|Epirubicin|epirubicin|mesh-list
83912188|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
83912189|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912190|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
83912191|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912192|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912193|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83912194|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
83912195|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912196|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912197|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83912198|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912199|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912200|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912201|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83912202|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83912203|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83912204|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912205|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
83912206|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912207|NCT00309920|Hematinics|hematinics|mesh-ancestor
83912208|NCT00309998|Bevacizumab|bevacizumab|mesh-list
83912209|NCT00309998|Vinorelbine|vinorelbine|mesh-list
83912210|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83912211|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912212|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83912213|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83912214|NCT00309998|Growth Substances|growth substances|mesh-ancestor
83912215|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912216|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
83912217|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83912218|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912219|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912220|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912221|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912222|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
83912223|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912224|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
83912225|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912226|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912227|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83912228|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
83912229|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912230|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912231|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83912232|NCT00310154|Docetaxel|docetaxel|mesh-list
83912233|NCT00310154|Gefitinib|gefitinib|mesh-list
83912234|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912235|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912236|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912237|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912238|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912239|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83912240|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912241|NCT00338910|Metronidazole|metronidazole|mesh-list
83912242|NCT00338910|Budesonide|budesonide|mesh-list
83912243|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912244|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83912245|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
83912246|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912247|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912248|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83912249|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
83912250|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
83912251|NCT00338910|Hormones|hormones|mesh-ancestor
83912252|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912253|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912254|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83912255|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83912256|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83151478|NCT05142319|Vaccines|vaccines|mesh-list
83912257|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
83912258|NCT00310232|Hematinics|hematinics|mesh-ancestor
83912260|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
83912261|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912262|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912263|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83912264|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
83912265|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912266|NCT00310505|Amphotericin B|amphotericin b|mesh-list
83912267|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83912268|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
83912269|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
83912270|NCT00310505|Amebicides|amebicides|mesh-ancestor
83912271|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83912272|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83912273|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912274|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83912275|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
83912276|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83912277|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83912278|NCT00339066|Sertraline|sertraline|mesh-list
83912279|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
83912280|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83912281|NCT00339066|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83912282|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83912283|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912284|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912285|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912286|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
83912287|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912288|NCT00310583|Pregabalin|pregabalin|mesh-list
83912289|NCT00310583|Analgesics|analgesics|mesh-ancestor
83912290|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
83912291|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912292|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912293|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
83912294|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83912295|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912296|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912297|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83912298|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83912299|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83912300|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912301|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83912302|NCT00421044|Epothilone B|epothilone b|mesh-list
83912303|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912304|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912305|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912306|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912307|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912308|NCT00425217|Rituximab|rituximab|mesh-list
83912309|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83912310|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912311|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
83912312|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912313|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912314|NCT00310778|Atenolol|atenolol|mesh-list
83912315|NCT00310778|Valsartan|valsartan|mesh-list
83912316|NCT00310778|Candesartan|candesartan|mesh-list
83912317|NCT00310778|Ramipril|ramipril|mesh-list
83912318|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912319|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83912320|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83912321|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912322|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83912323|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
83912324|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912325|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83912326|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
83912327|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
83912328|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912329|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912330|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83912331|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83912332|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83912333|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
83912334|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912335|NCT00421083|Tadalafil|tadalafil|mesh-list
83912336|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912337|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83912338|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83912339|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912340|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912341|NCT00421083|Urological Agents|urological agents|mesh-ancestor
83912342|NCT00310895|Imetelstat|imetelstat|mesh-list
83912343|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
83912344|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912345|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912346|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83912347|NCT00310934|Buprenorphine|buprenorphine|mesh-list
83912348|NCT00310934|Methadone|methadone|mesh-list
83912349|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83912350|NCT00310934|Narcotics|narcotics|mesh-ancestor
83912351|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912352|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912353|NCT00310934|Analgesics|analgesics|mesh-ancestor
83912354|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
83912355|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912356|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83912357|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
83912358|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
83912359|NCT00421122|Budesonide|budesonide|mesh-list
83912360|NCT00421122|Terbutaline|terbutaline|mesh-list
83912361|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
83912362|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83912363|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912364|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83912365|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
83912366|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912367|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912368|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83912369|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
83912370|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
83912371|NCT00421122|Hormones|hormones|mesh-ancestor
83912372|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912373|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83912374|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83912375|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83912376|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
83912377|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912378|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912379|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
83912380|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
83912381|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83912382|NCT00311051|Ramatroban|ramatroban|mesh-list
83912383|NCT00311051|Montelukast|montelukast|mesh-list
83912384|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83912385|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
83912386|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83912387|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
83912388|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912389|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912390|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83912391|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83912392|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912393|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83912394|NCT00311129|Rituximab|rituximab|mesh-list
83912395|NCT00311129|Fludarabine|fludarabine|mesh-list
83912396|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
83912397|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83912398|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912399|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
83912400|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912401|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912402|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912403|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
83912404|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151617|NCT02175355|Diuretics|diuretics|mesh-ancestor
83912405|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912406|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
83912407|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912408|NCT00342381|Amifampridine|amifampridine|mesh-list
83912409|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83912410|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912411|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912412|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83912413|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912414|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912415|NCT00311558|Interferons|interferons|mesh-list
83912416|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
83912417|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
83912418|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83912419|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912420|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
83912421|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912422|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
83912423|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912424|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83912425|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83912426|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
83912427|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83912428|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
83912429|NCT00418925|Dronabinol|dronabinol|mesh-list
83912430|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
83912431|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912432|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83912433|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83912434|NCT00418925|Analgesics|analgesics|mesh-ancestor
83912435|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
83912436|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912437|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83912438|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83912439|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912440|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912441|NCT00418925|Hormones|hormones|mesh-ancestor
83912442|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912443|NCT00339417|Ivermectin|ivermectin|mesh-list
83912444|NCT00339417|Albendazole|albendazole|mesh-list
83912445|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83912446|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912447|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
83912448|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
83912449|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83912450|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83912451|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912452|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912453|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912454|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912455|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912456|NCT00311636|Paclitaxel|paclitaxel|mesh-list
83912457|NCT00311636|Docetaxel|docetaxel|mesh-list
83912458|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
83912459|NCT00311636|Doxorubicin|doxorubicin|mesh-list
83912460|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83912461|NCT00311636|Fluorouracil|fluorouracil|mesh-list
83912462|NCT00311636|Methotrexate|methotrexate|mesh-list
83912463|NCT00311636|Epirubicin|epirubicin|mesh-list
83912464|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83912465|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83912466|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912467|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912468|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912469|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912470|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912471|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912472|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
83912473|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912474|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912475|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83912476|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
83912477|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83912478|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83912479|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83912480|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83912481|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912482|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
83912483|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912484|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83912485|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
83912486|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83912487|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
83912488|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83912489|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83912490|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
83912491|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83912492|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
83912493|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83912494|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83912495|NCT00311753|Heparin|heparin|mesh-list
83912496|NCT00311753|Certoparin|certoparin|mesh-list
83912497|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
83912498|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83912499|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83912500|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912501|NCT00311870|Lisinopril|lisinopril|mesh-list
83912502|NCT00311870|Nisoldipine|nisoldipine|mesh-list
83912503|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83912504|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
83912505|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912506|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912507|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912508|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83912509|NCT00311870|Protective Agents|protective agents|mesh-ancestor
83912510|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912511|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83912512|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912513|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83912514|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912515|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
83912516|NCT00311987|Hormones|hormones|mesh-ancestor
83912517|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912518|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912519|NCT00342849|Succimer|succimer|mesh-list
83912520|NCT00342849|Antidotes|antidotes|mesh-ancestor
83912521|NCT00342849|Protective Agents|protective agents|mesh-ancestor
83912522|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912523|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
83912524|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
83912525|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912526|NCT00312104|Insulin|insulin|mesh-list
83912527|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83912528|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
83912529|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
83912530|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
83912531|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83912532|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912533|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
83912534|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83912535|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912536|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83912537|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
83912538|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83912539|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912540|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912541|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912542|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83912543|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83912544|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
83912545|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912546|NCT00343005|Antacids|antacids|mesh-ancestor
83912547|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912548|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83912549|NCT00312182|Nelfinavir|nelfinavir|mesh-list
83912550|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83912551|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83912552|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
83912553|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912554|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912555|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83912556|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83912557|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
83912558|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912560|NCT00312260|Amitriptyline|amitriptyline|mesh-list
83912561|NCT00312260|Analgesics|analgesics|mesh-ancestor
83912562|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
83912563|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912564|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912565|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
83912566|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83912567|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83912568|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912569|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83912570|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83912571|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83912572|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912573|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912574|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
83912575|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83912576|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
83912577|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83912578|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83912579|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83912580|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912581|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
83912582|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83912583|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912584|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83912585|NCT00312299|Protective Agents|protective agents|mesh-ancestor
83912586|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912587|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83912588|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912589|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83912590|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83912591|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83912592|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
83912593|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912594|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912595|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912596|NCT00339768|Amoxicillin|amoxicillin|mesh-list
83912597|NCT00339768|Omeprazole|omeprazole|mesh-list
83912598|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83912599|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912600|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83912601|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83912602|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83912603|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912604|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912605|NCT00343161|Esomeprazole|esomeprazole|mesh-list
83912606|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83912607|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
83912608|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83912609|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83912610|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83912611|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912612|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912613|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83912614|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
83912615|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912616|NCT00343161|Antacids|antacids|mesh-ancestor
83912617|NCT00312533|Hylan|hylan|mesh-list
83912618|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
83912619|NCT00312533|Protective Agents|protective agents|mesh-ancestor
83912620|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912621|NCT00312650|Gemcitabine|gemcitabine|mesh-list
83912622|NCT00312650|Doxorubicin|doxorubicin|mesh-list
83912623|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83912624|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912625|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
83912626|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912627|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912628|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83912629|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83912630|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83912631|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912632|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
83912633|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912634|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912635|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83912636|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83912637|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912638|NCT00343200|Urological Agents|urological agents|mesh-ancestor
83912639|NCT00312806|Pantoprazole|pantoprazole|mesh-list
83912640|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83912641|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83912642|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83912643|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912644|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912645|NCT00347685|Tramadol|tramadol|mesh-list
83912646|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83912647|NCT00347685|Narcotics|narcotics|mesh-ancestor
83912648|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912649|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912650|NCT00347685|Analgesics|analgesics|mesh-ancestor
83912651|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
83912652|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912653|NCT00343239|Docetaxel|docetaxel|mesh-list
83912654|NCT00343239|Fluorouracil|fluorouracil|mesh-list
83912655|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912656|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912657|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912658|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912659|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912660|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
83912661|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912662|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912663|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
83912664|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912665|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
83912666|NCT00313001|Exenatide|exenatide|mesh-list
83912667|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
83912668|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83912669|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912670|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83912671|NCT00313001|Incretins|incretins|mesh-ancestor
83912672|NCT00313001|Hormones|hormones|mesh-ancestor
83912673|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83912674|NCT00343278|Valacyclovir|valacyclovir|mesh-list
83912675|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
83912676|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912677|NCT00343317|Cefoxitin|cefoxitin|mesh-list
83912678|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83912679|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912680|NCT00313079|Vincristine|vincristine|mesh-list
83912681|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83912682|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912683|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
83912684|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
83912685|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
83912686|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912687|NCT00347724|Tramadol|tramadol|mesh-list
83912688|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83912689|NCT00347724|Narcotics|narcotics|mesh-ancestor
83912690|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912691|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912692|NCT00347724|Analgesics|analgesics|mesh-ancestor
83912693|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
83912694|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912695|NCT00313157|Metoprolol|metoprolol|mesh-list
83912696|NCT00313157|Verapamil|verapamil|mesh-list
83912697|NCT00313157|Carvedilol|carvedilol|mesh-list
83912698|NCT00313157|Diltiazem|diltiazem|mesh-list
83912699|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83912700|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912701|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
83912702|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
83912703|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912704|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912705|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83912706|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83912707|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83912708|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
83151927|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
83912709|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912710|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912712|NCT00313157|Protective Agents|protective agents|mesh-ancestor
83912713|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83912714|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912715|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83912716|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912717|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83912718|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83912719|NCT00347763|Permethrin|permethrin|mesh-list
83912720|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912721|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912722|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
83912723|NCT00313235|Vaccines|vaccines|mesh-list
83912724|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
83912725|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912726|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912727|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912728|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83912729|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
83912730|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912731|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912732|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83912733|NCT00347802|Bimatoprost|bimatoprost|mesh-list
83912734|NCT00347802|Travoprost|travoprost|mesh-list
83912735|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912736|NCT00313274|Clevudine|clevudine|mesh-list
83912737|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
83912738|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912739|NCT00419042|Gemcitabine|gemcitabine|mesh-list
83912740|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83912741|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912742|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
83912743|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912744|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912745|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83912746|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912747|NCT00347841|Bimatoprost|bimatoprost|mesh-list
83912748|NCT00347841|Latanoprost|latanoprost|mesh-list
83912749|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83912750|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83912751|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912752|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
83912753|NCT00425126|Hematinics|hematinics|mesh-ancestor
83912754|NCT00343629|Sulindac|sulindac|mesh-list
83912755|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83912756|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83912757|NCT00343629|Analgesics|analgesics|mesh-ancestor
83912758|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
83912759|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912760|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912761|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912762|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912763|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912764|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83912765|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912766|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912767|NCT00343668|Irinotecan|irinotecan|mesh-list
83912768|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83912769|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83912770|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912771|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912772|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912773|NCT00343707|Paroxetine|paroxetine|mesh-list
83912774|NCT00343707|Vestipitant|vestipitant|mesh-list
83912775|NCT00343707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83912776|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83912777|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912778|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912779|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912780|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
83912781|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151996|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83912782|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83912783|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
83912784|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83912785|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83912786|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83912787|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912788|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83912789|NCT00313391|Risperidone|risperidone|mesh-list
83912790|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83912791|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
83912792|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912793|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912794|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912795|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83912796|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83912797|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912798|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83912799|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83912800|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
83912801|NCT00348153|Adalimumab|adalimumab|mesh-list
83912802|NCT00348153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83912803|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83912804|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912805|NCT00313508|Vidarabine|vidarabine|mesh-list
83912806|NCT00313508|Fludarabine|fludarabine|mesh-list
83912807|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
83912808|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912809|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912810|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
83912811|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912812|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912813|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
83912814|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912815|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
83912816|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912817|NCT00313547|Amlodipine|amlodipine|mesh-list
83912818|NCT00313547|Quinapril|quinapril|mesh-list
83912819|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912820|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83912821|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912822|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912823|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83912824|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912825|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912826|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83912827|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
83912828|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912829|NCT00348192|Donepezil|donepezil|mesh-list
83912830|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83912831|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912832|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912833|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
83912834|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912835|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912836|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
83912837|NCT00313625|Methotrexate|methotrexate|mesh-list
83912838|NCT00313625|Melphalan|melphalan|mesh-list
83912839|NCT00313625|Busulfan|busulfan|mesh-list
83912840|NCT00313625|Tacrolimus|tacrolimus|mesh-list
83912841|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83912842|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
83912843|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83912844|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912845|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912846|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
83912847|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912848|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912849|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
83912850|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912851|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83912852|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912853|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
83912854|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912855|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83912856|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83912857|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83912858|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
83912859|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83912860|NCT00343980|Insulin|insulin|mesh-list
83912861|NCT00343980|Glimepiride|glimepiride|mesh-list
83912862|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
83912863|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83912864|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83912865|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912866|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83912867|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912868|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
83912869|NCT00313742|Insulin|insulin|mesh-list
83912870|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83912871|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
83912872|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
83912873|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
83912874|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
83912875|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
83912876|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83912877|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912878|NCT00313859|Simvastatin|simvastatin|mesh-list
83912879|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83912880|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83912881|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
83912882|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912883|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83912884|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83912885|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912886|NCT00348231|Insulin|insulin|mesh-list
83912887|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83912888|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912889|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
83912890|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912891|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83912892|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83912893|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912894|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912895|NCT00313898|Urological Agents|urological agents|mesh-ancestor
83912896|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
83912897|NCT00344058|Analgesics|analgesics|mesh-ancestor
83912898|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
83912899|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83912900|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912901|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
83912902|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912903|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83912904|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
83912905|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83912906|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83912907|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912908|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83912909|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
83912910|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83912911|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
83912912|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83912913|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912914|NCT00313976|Interferons|interferons|mesh-list
83912915|NCT00313976|Interferon-beta|interferon-beta|mesh-list
83912916|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
83912917|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912918|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
83912919|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912920|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
83912921|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912922|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83912923|NCT00348387|Vaccines|vaccines|mesh-list
83912924|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
83912925|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152129|NCT05532332|Fluoxetine|fluoxetine|mesh-list
83152130|NCT05532332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83912926|NCT00314171|Timolol|timolol|mesh-list
83152131|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83152132|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83152134|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912927|NCT00314171|Dorzolamide|dorzolamide|mesh-list
83912928|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83912930|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83912931|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83912932|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83912933|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83912934|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83912935|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912936|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912937|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83912938|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83912939|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83912940|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912941|NCT00348426|Antitoxins|antitoxins|mesh-list
83912942|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
83912943|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
83912944|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912945|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83912946|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
83912947|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83912948|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83912949|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83912950|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83912951|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912952|NCT00344253|Interferons|interferons|mesh-list
83912953|NCT00344253|Interferon-beta|interferon-beta|mesh-list
83912954|NCT00344253|Methotrexate|methotrexate|mesh-list
83912955|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83912956|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
83912957|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83912958|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83912959|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83912960|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
83912961|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912962|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83912963|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
83912964|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912965|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83912966|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83912967|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
83912968|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912969|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83912970|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
83912971|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912972|NCT00314405|Methylene Blue|methylene blue|mesh-list
83912973|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912974|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912975|NCT04715295|Azithromycin|azithromycin|mesh-list
83912976|NCT04715295|Doxycycline|doxycycline|mesh-list
83912977|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
83912978|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
83912979|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83912980|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83912981|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83912982|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
83912983|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83912984|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
83912985|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912986|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83912987|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
83912988|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
83912989|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83912990|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83912991|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83912992|NCT00348504|Simendan|simendan|mesh-list
83912993|NCT00348504|Dobutamine|dobutamine|mesh-list
83912994|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83912995|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
83912996|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83912997|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83912998|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83912999|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913000|NCT00348504|Protective Agents|protective agents|mesh-ancestor
83152202|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83913001|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913002|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
83913003|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
83913004|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913005|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83913006|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83913007|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83913008|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
83913009|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913011|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
83913012|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83913013|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913014|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
83913015|NCT00344409|Hematinics|hematinics|mesh-ancestor
83913016|NCT00348582|Ketorolac|ketorolac|mesh-list
83913017|NCT00348582|Nepafenac|nepafenac|mesh-list
83913018|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83913019|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83913020|NCT00348582|Analgesics|analgesics|mesh-ancestor
83913021|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
83913022|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913023|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913024|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913025|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913026|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83913027|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913028|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913029|NCT00314639|Modafinil|modafinil|mesh-list
83913030|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83913031|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913032|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83913033|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83913034|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83913035|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913036|NCT00314678|Paclitaxel|paclitaxel|mesh-list
83913037|NCT00314678|Topotecan|topotecan|mesh-list
83913038|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83913039|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913040|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
83913041|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
83913042|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
83913043|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913044|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83913045|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83913046|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913047|NCT00344526|Dexamethasone|dexamethasone|mesh-list
83913048|NCT00344526|Melphalan|melphalan|mesh-list
83913049|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913050|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
83913051|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
83913052|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913053|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913054|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83913055|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
83913056|NCT00344526|Hormones|hormones|mesh-ancestor
83913057|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913058|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83913059|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913060|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83913061|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
83913062|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913063|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83913064|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913065|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
83913066|NCT00314756|Imiquimod|imiquimod|mesh-list
83913067|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83913068|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
83913069|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913070|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913071|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
83913072|NCT00344565|Modafinil|modafinil|mesh-list
83913073|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83913074|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913075|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83913076|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83913077|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83913078|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913080|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913081|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913082|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913083|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913084|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
83913085|NCT00348738|Hematinics|hematinics|mesh-ancestor
83913086|NCT00314912|Tramiprosate|tramiprosate|mesh-list
83913087|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
83913088|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
83913089|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
83913090|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913091|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913092|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913093|NCT00314990|Folic Acid|folic acid|mesh-list
83913094|NCT00314990|Pyridoxine|pyridoxine|mesh-list
83913095|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
83913096|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
83913097|NCT00314990|Hematinics|hematinics|mesh-ancestor
83913098|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
83913099|NCT00314990|Vitamins|vitamins|mesh-ancestor
83913100|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
83913101|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913102|NCT02960126|Aspirin|aspirin|mesh-list
83913103|NCT02960126|Clopidogrel|clopidogrel|mesh-list
83913104|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83913105|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83913106|NCT02960126|Analgesics|analgesics|mesh-ancestor
83913107|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
83913108|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913109|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913110|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913111|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913112|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83913113|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83913114|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913115|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83913116|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83913117|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913118|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
83913119|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83913120|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83913121|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83913122|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
83913123|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913124|NCT00315185|Cetuximab|cetuximab|mesh-list
83913125|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913126|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913127|NCT00344760|Tenofovir|tenofovir|mesh-list
83913128|NCT00344760|Lamivudine|lamivudine|mesh-list
83913129|NCT00344760|Efavirenz|efavirenz|mesh-list
83913130|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
83913131|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
83913132|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913133|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83913134|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83913135|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913136|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913137|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83913138|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83913139|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83913140|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83913141|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83913142|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83913143|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83913144|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83913145|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83913146|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83913147|NCT00348894|Reboxetine|reboxetine|mesh-list
83913148|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
83913149|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83913150|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83913151|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83913152|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83913153|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913154|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
83913155|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913156|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913157|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
83913158|NCT00315536|Remifentanil|remifentanil|mesh-list
83913159|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83913160|NCT00315536|Narcotics|narcotics|mesh-ancestor
83913161|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913162|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913163|NCT00315536|Analgesics|analgesics|mesh-ancestor
83913164|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
83913165|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913166|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83913167|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83913168|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83913169|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
83913170|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913171|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913172|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
83913173|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83913174|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913175|NCT00349089|Pemetrexed|pemetrexed|mesh-list
83913176|NCT00349089|Vinorelbine|vinorelbine|mesh-list
83913177|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913178|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913179|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913180|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83913181|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83913182|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83913183|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83913184|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83913185|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83913186|NCT00349128|Metformin|metformin|mesh-list
83913187|NCT00349128|Fenofibrate|fenofibrate|mesh-list
83913188|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83913189|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913190|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913191|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
83913192|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913193|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913194|NCT00315848|Buprenorphine|buprenorphine|mesh-list
83913195|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83913196|NCT00315848|Narcotics|narcotics|mesh-ancestor
83913197|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913198|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913199|NCT00315848|Analgesics|analgesics|mesh-ancestor
83913200|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
83913201|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913202|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83913203|NCT00349206|Sirolimus|sirolimus|mesh-list
83913204|NCT00349206|Sorafenib|sorafenib|mesh-list
83913205|NCT00349206|Temsirolimus|temsirolimus|mesh-list
83913206|NCT00349206|MTOR Inhibitors|mtor inhibitors|mesh-list
83913207|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913208|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913209|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913210|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913211|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913212|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
83913213|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913214|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83913215|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913216|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83913217|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
83913218|NCT00315887|Buprenorphine|buprenorphine|mesh-list
83913219|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83913220|NCT00315887|Narcotics|narcotics|mesh-ancestor
83913221|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913222|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913223|NCT00315887|Analgesics|analgesics|mesh-ancestor
83913224|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
83913225|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913226|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83913227|NCT00421395|Epratuzumab|epratuzumab|mesh-list
83913228|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913229|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913231|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
83913232|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913233|NCT00315926|Protective Agents|protective agents|mesh-ancestor
83913234|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913235|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913236|NCT00421434|Ribavirin|ribavirin|mesh-list
83913237|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83913238|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
83913239|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
83913240|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
83913241|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913242|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
83913243|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913244|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
83913245|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913246|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83913247|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
83913248|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
83913249|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83913250|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
83913251|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913252|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913253|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83913254|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
83913255|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83913256|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
83913257|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913258|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913259|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83913260|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
83913261|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
83913262|NCT00315965|Protective Agents|protective agents|mesh-ancestor
83913263|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
83913264|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
83913265|NCT00349245|Remifentanil|remifentanil|mesh-list
83913266|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83913267|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913268|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913269|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83913270|NCT00349245|Analgesics|analgesics|mesh-ancestor
83913271|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
83913272|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913273|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83913274|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83913275|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83913276|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
83913277|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913278|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913279|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83913280|NCT00349245|Narcotics|narcotics|mesh-ancestor
83913281|NCT00349284|Ezetimibe|ezetimibe|mesh-list
83913282|NCT00349284|Fenofibrate|fenofibrate|mesh-list
83913283|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83913284|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913285|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
83913286|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913287|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913288|NCT00316160|Bupropion|bupropion|mesh-list
83913289|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83913290|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83913291|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
83913292|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83913293|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83913294|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83913295|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83913296|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913297|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
83913298|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913299|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913300|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83913301|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83913302|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913303|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83913304|NCT00349362|Testosterone|testosterone|mesh-list
83913305|NCT00349362|Androgens|androgens|mesh-ancestor
83913306|NCT00349362|Hormones|hormones|mesh-ancestor
83913307|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913308|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913309|NCT00316238|Olanzapine|olanzapine|mesh-list
83913310|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
83913311|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
83913312|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913313|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913314|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83913315|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83913316|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83913317|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913318|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83913319|NCT00316238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83913320|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83913321|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83913322|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913323|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913324|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
83913325|NCT00349401|Ketorolac|ketorolac|mesh-list
83913326|NCT00349401|Morphine|morphine|mesh-list
83913327|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83913328|NCT00349401|Narcotics|narcotics|mesh-ancestor
83913329|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913330|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913331|NCT00349401|Analgesics|analgesics|mesh-ancestor
83913332|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
83913333|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913334|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83913335|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83913336|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913337|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913338|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83913339|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913340|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913341|NCT00349440|Cyclosporine|cyclosporine|mesh-list
83913342|NCT00349440|Cyclosporins|cyclosporins|mesh-list
83913343|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913344|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913345|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913346|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
83913347|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913348|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
83913349|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913350|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
83913351|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913352|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83913353|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
83913354|NCT00316433|Irinotecan|irinotecan|mesh-list
83913355|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913356|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83913357|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83913358|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913359|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913360|NCT00349518|Dasatinib|dasatinib|mesh-list
83913361|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913362|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913363|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913364|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913365|NCT00316472|Niacinamide|niacinamide|mesh-list
83913366|NCT00316472|Niacin|niacin|mesh-list
83913367|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
83913368|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
83913369|NCT00316472|Vitamins|vitamins|mesh-ancestor
83913370|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
83913371|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913372|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913373|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
83913374|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913375|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913376|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
83913377|NCT00349557|Bevacizumab|bevacizumab|mesh-list
83913378|NCT00349557|Goserelin|goserelin|mesh-list
83913379|NCT00349557|Bicalutamide|bicalutamide|mesh-list
83913380|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913381|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913382|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83913383|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83913384|NCT00349557|Growth Substances|growth substances|mesh-ancestor
83913385|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913386|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
83913387|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83913388|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
83913389|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
83913390|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913391|NCT00349596|Decitabine|decitabine|mesh-list
83913392|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913393|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
83913394|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913395|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913396|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913397|NCT00349635|Metformin|metformin|mesh-list
83913398|NCT00349635|Fenofibrate|fenofibrate|mesh-list
83913399|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83913400|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913401|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913402|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
83913403|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913404|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913405|NCT00316745|Leucovorin|leucovorin|mesh-list
83913406|NCT00316745|Fluorouracil|fluorouracil|mesh-list
83913407|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
83913408|NCT00316745|Irinotecan|irinotecan|mesh-list
83913409|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
83913410|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913411|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913412|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913413|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913414|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
83913415|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913416|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83913417|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83913418|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913419|NCT00316745|Antidotes|antidotes|mesh-ancestor
83913420|NCT00316745|Protective Agents|protective agents|mesh-ancestor
83913421|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
83913422|NCT00316745|Vitamins|vitamins|mesh-ancestor
83913423|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
83913424|NCT00349674|Methotrexate|methotrexate|mesh-list
83913425|NCT00349674|Azathioprine|azathioprine|mesh-list
83913426|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83913427|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
83913428|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83913429|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913430|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913431|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
83913432|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913433|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913434|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
83913435|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913436|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83913437|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913438|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
83913439|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913440|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83913441|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83913442|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913443|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913444|NCT00344955|Atorvastatin|atorvastatin|mesh-list
83913445|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83913446|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913447|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
84048326|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913448|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913449|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913450|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83913451|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913452|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83913453|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83913454|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913455|NCT00316940|Bortezomib|bortezomib|mesh-list
83913456|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83913457|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913458|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83913459|NCT00316940|Analgesics|analgesics|mesh-ancestor
83913460|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
83913461|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913462|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913463|NCT00344994|Pramipexole|pramipexole|mesh-list
83913464|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
83913465|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913466|NCT00344994|Protective Agents|protective agents|mesh-ancestor
83913467|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913468|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83913469|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83913470|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
83913471|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
83913472|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913473|NCT00349791|Testosterone|testosterone|mesh-list
83913474|NCT00349791|Androgens|androgens|mesh-ancestor
83913475|NCT00349791|Hormones|hormones|mesh-ancestor
83913476|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913477|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913478|NCT00317096|Rituximab|rituximab|mesh-list
83913479|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913480|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913481|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
83913482|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913483|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913484|NCT00317135|Vaccines|vaccines|mesh-list
83913485|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
83913486|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913487|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
83913488|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83913489|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913490|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83913491|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913492|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913493|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83913494|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
83913495|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913496|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913497|NCT00317330|Rifampin|rifampin|mesh-list
83913498|NCT00317330|Isoniazid|isoniazid|mesh-list
83913499|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
83913500|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83913501|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
83913502|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83913503|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913504|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
83913505|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83913506|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913507|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913508|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83913509|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83913510|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83913511|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83913512|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83913513|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83913514|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83913515|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913516|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
83913517|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913518|NCT00317408|Leucovorin|leucovorin|mesh-list
83913519|NCT00317408|Cytarabine|cytarabine|mesh-list
83913520|NCT00317408|Cyclosporine|cyclosporine|mesh-list
83913521|NCT00317408|Dexamethasone|dexamethasone|mesh-list
83913522|NCT00317408|Prednisolone|prednisolone|mesh-list
83913523|NCT00317408|Carboplatin|carboplatin|mesh-list
83913524|NCT00317408|Methotrexate|methotrexate|mesh-list
83913525|NCT00317408|Etoposide|etoposide|mesh-list
83913526|NCT00317408|Melphalan|melphalan|mesh-list
83913527|NCT00317408|Busulfan|busulfan|mesh-list
83913528|NCT00317408|Ifosfamide|ifosfamide|mesh-list
83913529|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
83913530|NCT00317408|Idarubicin|idarubicin|mesh-list
83913531|NCT00317408|Thiotepa|thiotepa|mesh-list
83913532|NCT00317408|Carmustine|carmustine|mesh-list
83913533|NCT00317408|Vinblastine|vinblastine|mesh-list
83913534|NCT00317408|Lomustine|lomustine|mesh-list
83913535|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
83913536|NCT00317408|Vindesine|vindesine|mesh-list
83913537|NCT00317408|Cyclosporins|cyclosporins|mesh-list
83913538|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83913539|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
83913540|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913541|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
83913542|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
83913543|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913544|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913545|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83913546|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
83913547|NCT00317408|Hormones|hormones|mesh-ancestor
83913548|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913549|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83913550|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913551|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83913552|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
83913553|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83913554|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913555|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
83913556|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913557|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
83913558|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913559|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83913560|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913561|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
83913562|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913563|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83913564|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83913565|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83913566|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83913567|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
83913568|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913569|NCT00317408|Antidotes|antidotes|mesh-ancestor
83913570|NCT00317408|Protective Agents|protective agents|mesh-ancestor
83913571|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
83913572|NCT00317408|Vitamins|vitamins|mesh-ancestor
83913573|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
83913574|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
83913575|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83913576|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83913577|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
83913578|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83913579|NCT00317408|Analgesics|analgesics|mesh-ancestor
83913580|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
83913581|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83913582|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
83913583|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
83913584|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
83913585|NCT00317447|Prednisone|prednisone|mesh-list
83913586|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913587|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
83913588|NCT00317447|Hormones|hormones|mesh-ancestor
83913589|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913590|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913591|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83913592|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913593|NCT02959554|Nivolumab|nivolumab|mesh-list
83913594|NCT02959554|Sunitinib|sunitinib|mesh-list
83913595|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913596|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913597|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83913598|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913599|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83913600|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83913601|NCT02959554|Growth Substances|growth substances|mesh-ancestor
83913602|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913603|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
83913604|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913605|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152798|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913606|NCT00345306|Progesterone|progesterone|mesh-list
83913607|NCT00345306|Progestins|progestins|mesh-ancestor
83913609|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913610|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913611|NCT00317681|Tacrolimus|tacrolimus|mesh-list
83913612|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913613|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
83913614|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913615|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83913616|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913617|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913618|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
83913619|NCT00350181|Sirolimus|sirolimus|mesh-list
83913620|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
83913621|NCT00350181|Busulfan|busulfan|mesh-list
83913622|NCT00350181|Carmustine|carmustine|mesh-list
83913623|NCT00350181|Etoposide|etoposide|mesh-list
83913624|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913625|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
83913626|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913627|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913628|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83913629|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
83913630|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913631|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913632|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83913633|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83913634|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83913635|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83913636|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913637|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83913638|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83913639|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
83913640|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83913641|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913642|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
83913643|NCT00317759|Fludarabine|fludarabine|mesh-list
83913644|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
83913645|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913646|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913647|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
83913648|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913649|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913650|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
83913651|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913652|NCT00317798|Sirolimus|sirolimus|mesh-list
83913653|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83913654|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83913655|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913656|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83913657|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913658|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
83913659|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913660|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
83913661|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913662|NCT00345501|Iloprost|iloprost|mesh-list
83913663|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83913664|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
83913665|NCT00345657|Niacin|niacin|mesh-list
83913666|NCT00345657|Lovastatin|lovastatin|mesh-list
83913667|NCT00345657|L 647318|l 647318|mesh-list
83913668|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
83913669|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913670|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
83913671|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913672|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913673|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83913674|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
83913675|NCT00345657|Vitamins|vitamins|mesh-ancestor
83913676|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
83913677|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913678|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83913679|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83913680|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913681|NCT00317876|Cyclosporine|cyclosporine|mesh-list
83913682|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
83913683|NCT00317876|Methotrexate|methotrexate|mesh-list
83913684|NCT00317876|Cyclosporins|cyclosporins|mesh-list
83913685|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913686|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
83913687|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913688|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913689|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83913690|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
83913691|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913692|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913693|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83913694|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83913695|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
83913696|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83913697|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913698|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
83913699|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
83913700|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913701|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83913702|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83913703|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
83913704|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913705|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83913706|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
83913707|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913708|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
83913709|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913710|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913711|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83913712|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
83913713|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913714|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913715|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83913716|NCT00317915|Irbesartan|irbesartan|mesh-list
83913717|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83913718|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83913719|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83913720|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913721|NCT00317954|Spironolactone|spironolactone|mesh-list
83913722|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83913723|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
83913724|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913725|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913726|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83913727|NCT00317954|Diuretics|diuretics|mesh-ancestor
83913728|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
83913729|NCT00317993|Simvastatin|simvastatin|mesh-list
83913730|NCT00317993|Ezetimibe|ezetimibe|mesh-list
83913731|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83913732|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83913733|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
83913734|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913735|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83913736|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83913737|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913738|NCT00350415|Mesalamine|mesalamine|mesh-list
83913739|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83913740|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83913741|NCT00350415|Analgesics|analgesics|mesh-ancestor
83913742|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
83913743|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913744|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913745|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913746|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913747|NCT00345696|Bevacizumab|bevacizumab|mesh-list
83913748|NCT00345696|Capecitabine|capecitabine|mesh-list
83913749|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
83913750|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913751|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913752|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83913753|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83913754|NCT00345696|Growth Substances|growth substances|mesh-ancestor
83913755|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913756|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
83913757|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913758|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
83913759|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913760|NCT00350454|Sirolimus|sirolimus|mesh-list
83913761|NCT00350454|Temsirolimus|temsirolimus|mesh-list
83913762|NCT00350454|MTOR Inhibitors|mtor inhibitors|mesh-list
83913763|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83913764|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913765|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83913766|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913767|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
83913768|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913769|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
83913770|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913771|NCT00350454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913772|NCT00350454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913773|NCT00350454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913774|NCT00345735|Fentanyl|fentanyl|mesh-list
83913775|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83913776|NCT00345735|Narcotics|narcotics|mesh-ancestor
83913777|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913778|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913779|NCT00345735|Analgesics|analgesics|mesh-ancestor
83913780|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
83913781|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913782|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83913783|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83913784|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
83913785|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
83913786|NCT02959749|Bevacizumab|bevacizumab|mesh-list
83913787|NCT02959749|Docetaxel|docetaxel|mesh-list
83913788|NCT02959749|Osimertinib|osimertinib|mesh-list
83913789|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913790|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913791|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83913792|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83913793|NCT02959749|Growth Substances|growth substances|mesh-ancestor
83913794|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913795|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
83913796|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83913797|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83913798|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83913799|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913800|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913801|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913802|NCT00318383|Vaccines|vaccines|mesh-list
83913803|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
83913804|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913805|NCT00318422|Liraglutide|liraglutide|mesh-list
83913806|NCT00318422|Glimepiride|glimepiride|mesh-list
83913807|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
83913808|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83913809|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913810|NCT00318422|Incretins|incretins|mesh-ancestor
83913811|NCT00318422|Hormones|hormones|mesh-ancestor
83913812|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913813|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83913814|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913815|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
83913816|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83913817|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
83913818|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83913819|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83913820|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83913821|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913822|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913823|NCT00346047|Buprenorphine|buprenorphine|mesh-list
83913824|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83913825|NCT00346047|Narcotics|narcotics|mesh-ancestor
83913826|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83913827|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913828|NCT00346047|Analgesics|analgesics|mesh-ancestor
83913829|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
83913830|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913831|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83913832|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83913833|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83913834|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
83913835|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
83913836|NCT00318773|Sertraline|sertraline|mesh-list
83913837|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
83913838|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83913839|NCT00318773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83913840|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83913841|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83913842|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913843|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913844|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
83913845|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913846|NCT00318890|Docetaxel|docetaxel|mesh-list
83913847|NCT00318890|Amifostine|amifostine|mesh-list
83913848|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913849|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83913850|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83913851|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83913852|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913853|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83913854|NCT00318890|Protective Agents|protective agents|mesh-ancestor
83913855|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913856|NCT00318968|Esomeprazole|esomeprazole|mesh-list
83913857|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83913858|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83913859|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83913860|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913861|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913862|NCT00319007|Sulindac|sulindac|mesh-list
83913863|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83913864|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83913865|NCT00319007|Analgesics|analgesics|mesh-ancestor
83913866|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
83913867|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913868|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913869|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83913870|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913871|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913872|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83913873|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913874|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913875|NCT00350961|Gemcitabine|gemcitabine|mesh-list
83913876|NCT00350961|Capecitabine|capecitabine|mesh-list
83913877|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
83913878|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913879|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
83913880|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913881|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913882|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
83913883|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83913884|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913885|NCT00421473|Atovaquone|atovaquone|mesh-list
83913886|NCT00421473|Proguanil|proguanil|mesh-list
83913887|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83913888|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83913889|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
83913890|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83913891|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83913892|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913893|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913894|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
83913895|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
83913896|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83913897|NCT00319163|Estradiol|estradiol|mesh-list
83913898|NCT00319163|Estrogens|estrogens|mesh-ancestor
83913899|NCT00319163|Hormones|hormones|mesh-ancestor
83913900|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83913901|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913902|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83913903|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
83913904|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83913905|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83913906|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83913907|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83913908|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83913909|NCT00319202|Candesartan|candesartan|mesh-list
83913910|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83913911|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83913912|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83913913|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913914|NCT00421512|Bevacizumab|bevacizumab|mesh-list
83913915|NCT00421512|Sunitinib|sunitinib|mesh-list
83913916|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83913917|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913918|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83913919|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83913920|NCT00421512|Growth Substances|growth substances|mesh-ancestor
83913921|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913922|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
83913923|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913924|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913925|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913926|NCT00319319|Mecamylamine|mecamylamine|mesh-list
83913927|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83913928|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83913929|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
83913930|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83913931|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913932|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83913933|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83913934|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
83913935|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913936|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913937|NCT00346359|Methotrexate|methotrexate|mesh-list
83913938|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
83913939|NCT00346359|Fludarabine|fludarabine|mesh-list
83913940|NCT00346359|Busulfan|busulfan|mesh-list
83913941|NCT00346359|Tacrolimus|tacrolimus|mesh-list
83913942|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83913943|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83913944|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
83913945|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83913946|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913947|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913948|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
83913949|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913950|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913951|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83913952|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913953|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83913954|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83913955|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
83913956|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83913957|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83913958|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83913959|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
83913960|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83913961|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83913962|NCT00319358|Antioxidants|antioxidants|mesh-list
83913963|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913964|NCT00319358|Protective Agents|protective agents|mesh-ancestor
83913965|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913966|NCT00319514|Docetaxel|docetaxel|mesh-list
83913967|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913968|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
83913969|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
83913970|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
83913971|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913972|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83913973|NCT00319670|Laxatives|laxatives|mesh-ancestor
83913974|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83913975|NCT00351195|Capecitabine|capecitabine|mesh-list
83913976|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
83913977|NCT00351195|Etoposide|etoposide|mesh-list
83913978|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83913979|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
83913980|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913981|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913982|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83913983|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83913984|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83913985|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913987|NCT00319709|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83913988|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83913989|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83913990|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
83913991|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83913992|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83913993|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83913994|NCT00319709|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83913995|NCT00319787|Gefitinib|gefitinib|mesh-list
83913996|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83913997|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83913998|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83913999|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914000|NCT00319865|Thalidomide|thalidomide|mesh-list
83914001|NCT00319865|Dexamethasone|dexamethasone|mesh-list
83914002|NCT00319865|Doxorubicin|doxorubicin|mesh-list
83914003|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83914004|NCT00319865|Bortezomib|bortezomib|mesh-list
83914005|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914006|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
83914007|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
83914008|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914009|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914010|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914011|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
83914012|NCT00319865|Hormones|hormones|mesh-ancestor
83914013|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914014|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83914015|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914016|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83914017|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83914018|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83914019|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914020|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914021|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914022|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
83914023|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
83914024|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914025|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914026|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83914027|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83914028|NCT00319865|Growth Substances|growth substances|mesh-ancestor
83914029|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
83914030|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
83914031|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
83914032|NCT00320021|Vitamins|vitamins|mesh-ancestor
83914033|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
83914034|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914035|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
83914036|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
83914037|NCT00320060|Vitamins|vitamins|mesh-ancestor
83914038|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
83914039|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914040|NCT00320099|Insulin|insulin|mesh-list
83914041|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83914042|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
83914043|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83914044|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83914045|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83914046|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
83914047|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914048|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914049|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914050|NCT00320294|Irinotecan|irinotecan|mesh-list
83914051|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914052|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83914053|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83914054|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914055|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914056|NCT00346749|Fluticasone|fluticasone|mesh-list
83914057|NCT00346749|Xhance|xhance|mesh-list
83914058|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83914059|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914060|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83914061|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
83914062|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914063|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914064|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83914065|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
83914066|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83914067|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83914068|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83914069|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83914070|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83914071|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
83914072|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914073|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914075|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914076|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914077|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83914078|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
83914079|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914080|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914081|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83914082|NCT00320567|Norgestimate|norgestimate|mesh-list
83914083|NCT00320567|Estradiol|estradiol|mesh-list
83914084|NCT00320567|Estrogens|estrogens|mesh-ancestor
83914085|NCT00320567|Hormones|hormones|mesh-ancestor
83914086|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914087|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914088|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83914089|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
83914090|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83914091|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83914092|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83914093|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83914094|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83914095|NCT00346827|Apomorphine|apomorphine|mesh-list
83914096|NCT00346827|Emetics|emetics|mesh-ancestor
83914097|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914098|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
83914099|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914100|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914101|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
83914102|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
83914103|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914104|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914105|NCT00346866|Anecortave|anecortave|mesh-list
83914106|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83914107|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83914108|NCT00346866|Growth Substances|growth substances|mesh-ancestor
83914109|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914110|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
83914111|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914112|NCT00320723|Bupropion|bupropion|mesh-list
83914113|NCT00320723|Nicotine|nicotine|mesh-list
83914114|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83914115|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
83914116|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914117|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914118|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83914119|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83914120|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
83914121|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914122|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914123|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83914124|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
83914125|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83914126|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83914127|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83914128|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914129|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
83914130|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83914131|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83914132|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914133|NCT00351546|Vildagliptin|vildagliptin|mesh-list
83153329|NCT02191423|Oxytocin|oxytocin|mesh-list
83914134|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914135|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914136|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83914137|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
83914138|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914139|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914140|NCT00351585|Vildagliptin|vildagliptin|mesh-list
83914141|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914142|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914143|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83914144|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
83914145|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914146|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914147|NCT00320879|Irbesartan|irbesartan|mesh-list
83914148|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83914149|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83914150|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83914151|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914152|NCT00347100|Metformin|metformin|mesh-list
83914153|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
83914154|NCT00347100|Glyburide|glyburide|mesh-list
83914155|NCT00347100|Glipizide|glipizide|mesh-list
83914156|NCT00347100|Gliclazide|gliclazide|mesh-list
83914157|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914158|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914159|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83914160|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83914161|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
83914162|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914163|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914164|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83914165|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
83914166|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83914167|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83914168|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83914169|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
83914170|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914171|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914172|NCT00321074|Tacrolimus|tacrolimus|mesh-list
83914173|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914174|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
83914175|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914176|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83914177|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914178|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914179|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
83914180|NCT00321113|Tacrolimus|tacrolimus|mesh-list
83914181|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914182|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
83914183|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914184|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83914185|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914186|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914187|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83914188|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914189|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83914190|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
83914191|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914192|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914193|NCT00347256|Cisplatin|cisplatin|mesh-list
83914194|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914195|NCT00347295|Estazolam|estazolam|mesh-list
83914196|NCT00347295|Brotizolam|brotizolam|mesh-list
83914197|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
83914198|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83914199|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83914200|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914201|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914202|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83914203|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
83914204|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
83914205|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914206|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914207|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83914208|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
83914209|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83914210|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
83914211|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
83914212|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914213|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914214|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914215|NCT00321191|Analgesics|analgesics|mesh-ancestor
83914216|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
83914217|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914218|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
83914219|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83914220|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
83914221|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914222|NCT00321230|Protective Agents|protective agents|mesh-ancestor
83914223|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914224|NCT00321230|Vitamins|vitamins|mesh-ancestor
83914225|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
83914226|NCT00321230|Laxatives|laxatives|mesh-ancestor
83914227|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914228|NCT00351663|Enoxaparin|enoxaparin|mesh-list
83914229|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
83914230|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83914231|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83914232|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914233|NCT00321347|Lidocaine|lidocaine|mesh-list
83914234|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
83914235|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
83914236|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914237|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914238|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
83914239|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914240|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83914241|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83914242|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83914243|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914244|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914245|NCT00351702|Isoniazid|isoniazid|mesh-list
83914246|NCT00351702|Ethambutol|ethambutol|mesh-list
83914247|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
83914248|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914249|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914250|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83914251|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83914252|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
83914253|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914254|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83914255|NCT00351975|Azacitidine|azacitidine|mesh-list
83914256|NCT00351975|Belinostat|belinostat|mesh-list
83914257|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83914258|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
83914259|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914260|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914261|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914262|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83914263|NCT00321581|Cediranib|cediranib|mesh-list
83914264|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914265|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83914266|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914267|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914268|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
83914269|NCT00352092|Sirolimus|sirolimus|mesh-list
83914270|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83914271|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83914272|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914273|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83914274|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
83914275|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914276|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914277|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914278|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914279|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
83914280|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914281|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
83914282|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914283|NCT00322127|Plerixafor|plerixafor|mesh-list
83914284|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83914285|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83914286|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
83914287|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914288|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
83914289|NCT00352170|Vitamin D|vitamin d|mesh-list
83914290|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
83914291|NCT00352170|Calcium|calcium|mesh-list
83914292|NCT00352170|Vitamins|vitamins|mesh-ancestor
83914293|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
83914294|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914295|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83914296|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83914297|NCT00322166|Calcium|calcium|mesh-list
83914298|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83914299|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914300|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
83914301|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
83914302|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914303|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
83914304|NCT00352287|Pioglitazone|pioglitazone|mesh-list
83914305|NCT00352287|Hormones|hormones|mesh-list
83914306|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914307|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914308|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914309|NCT00352443|Everolimus|everolimus|mesh-list
83914310|NCT00352443|Lapatinib|lapatinib|mesh-list
83914311|NCT00352443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83914312|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83914313|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914314|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914315|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914316|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
83914317|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914318|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914319|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
83914320|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
83914321|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83914322|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83914323|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914324|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914325|NCT00352482|Urological Agents|urological agents|mesh-ancestor
83914326|NCT00322400|Paclitaxel|paclitaxel|mesh-list
83914327|NCT00322400|Docetaxel|docetaxel|mesh-list
83914328|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
83914329|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83914330|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914331|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
83914332|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
83914333|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
83914334|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914335|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83914336|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914337|NCT00352521|Bevacizumab|bevacizumab|mesh-list
83914338|NCT00352521|Irinotecan|irinotecan|mesh-list
83914339|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83914340|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914341|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83914342|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83914343|NCT00352521|Growth Substances|growth substances|mesh-ancestor
83914344|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914345|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
83914346|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83914347|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83914348|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914349|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914350|NCT00352599|Lovastatin|lovastatin|mesh-list
83914351|NCT00352599|L 647318|l 647318|mesh-list
83914352|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
83914353|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83914354|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83914355|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
83914356|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914357|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83914358|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83914359|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914360|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83914361|NCT00322595|Paroxetine|paroxetine|mesh-list
83914362|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
83914363|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83914364|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83914365|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83914366|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914367|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914368|NCT00322595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83914369|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83914370|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914371|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914372|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914373|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
83914374|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83914375|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83914376|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83914377|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914378|NCT00352677|Bafetinib|bafetinib|mesh-list
83914379|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83914380|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914381|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914382|NCT00331149|Ropinirole|ropinirole|mesh-list
83914383|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83914384|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83914385|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
83914386|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
83914387|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914388|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914389|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914390|NCT00331188|Vapreotide|vapreotide|mesh-list
83914391|NCT00331188|Analgesics|analgesics|mesh-ancestor
83914392|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
83914393|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914394|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914395|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914396|NCT00352833|Catumaxomab|catumaxomab|mesh-list
83914397|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914398|NCT00331305|Sertraline|sertraline|mesh-list
83914399|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
83914400|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83914401|NCT00331305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83914402|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83914403|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914404|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914405|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914406|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
83914407|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914408|NCT00322751|Topotecan|topotecan|mesh-list
83914409|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83914410|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83914411|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914412|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914413|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914414|NCT00352950|Panitumumab|panitumumab|mesh-list
83914415|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83914416|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914417|NCT00322907|Mefloquine|mefloquine|mesh-list
83914418|NCT00322907|Quinine|quinine|mesh-list
83914419|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
83914420|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83914421|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83914422|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914423|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83914424|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914425|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83914426|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914427|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914428|NCT00322907|Analgesics|analgesics|mesh-ancestor
83914429|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
83914430|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83914431|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83914432|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83914433|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83914434|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914436|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
83914437|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914438|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914439|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914440|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914441|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83914442|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83914443|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83914444|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
83914445|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
83914446|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914447|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914448|NCT00322985|Lenalidomide|lenalidomide|mesh-list
83914449|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
83914450|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914451|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83914452|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83914453|NCT00322985|Growth Substances|growth substances|mesh-ancestor
83914454|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
83914455|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914456|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
83914457|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914458|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914459|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83914460|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83914461|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914462|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914463|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83914464|NCT00353028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83914465|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83914466|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914467|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914468|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
83914469|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83914470|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
83914471|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83914472|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83914473|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83914474|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
83914475|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83914476|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914477|NCT00353067|Analgesics|analgesics|mesh-ancestor
83914478|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
83914479|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914480|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914481|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914482|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914483|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83914484|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914485|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914486|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
83914487|NCT00323219|Cefazolin|cefazolin|mesh-list
83914488|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914489|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914490|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83914491|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83914492|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914493|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914494|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914495|NCT00323375|Chloroquine|chloroquine|mesh-list
83914496|NCT00323375|Amebicides|amebicides|mesh-ancestor
83914497|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83914498|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83914499|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914500|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
83914501|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914502|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83914503|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83914504|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83914505|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
83153699|NCT04392505|Durvalumab|durvalumab|mesh-list
83914506|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914508|NCT00331695|Progestins|progestins|mesh-ancestor
83914509|NCT00331695|Hormones|hormones|mesh-ancestor
83914510|NCT00353145|Gemcitabine|gemcitabine|mesh-list
83914511|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
83914512|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83914513|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
83914514|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914515|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914516|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83914517|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914518|NCT00353184|Montelukast|montelukast|mesh-list
83914519|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83914520|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
83914521|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83914522|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
83914523|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914524|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914525|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83914526|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83914527|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914528|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83914529|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83914530|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83914531|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914532|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914533|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
83914534|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914535|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83914536|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83914537|NCT00323804|Ribavirin|ribavirin|mesh-list
83914538|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83914539|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
83914540|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914541|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
83914542|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914543|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
83914544|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83914545|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
83914546|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914547|NCT00353340|Expectorants|expectorants|mesh-ancestor
83914548|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
83914549|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83914550|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
83914551|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914552|NCT00353340|Protective Agents|protective agents|mesh-ancestor
83914553|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914554|NCT00353340|Antidotes|antidotes|mesh-ancestor
83914555|NCT00323843|Isoproterenol|isoproterenol|mesh-list
83914556|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83914557|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83914558|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
83914559|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914560|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914561|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914562|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83914563|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
83914564|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914565|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83914566|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83914567|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83914568|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
83914569|NCT00323843|Protective Agents|protective agents|mesh-ancestor
83914570|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
83914571|NCT00331851|Metformin|metformin|mesh-list
83914572|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
83914573|NCT00331851|Liraglutide|liraglutide|mesh-list
83914574|NCT00331851|Glimepiride|glimepiride|mesh-list
83914575|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914576|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914577|NCT00331851|Incretins|incretins|mesh-ancestor
83914578|NCT00331851|Hormones|hormones|mesh-ancestor
83153769|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83914579|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914580|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83914581|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914582|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
83914583|NCT00331890|Choline|choline|mesh-list
83914584|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83914585|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
83914586|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83914587|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
83914588|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914589|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914590|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83914591|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
83914592|NCT01059773|Methotrexate|methotrexate|mesh-list
83914593|NCT01059773|Ustekinumab|ustekinumab|mesh-list
83914594|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83914595|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
83914596|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83914597|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914598|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83914599|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
83914600|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914601|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914602|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
83914603|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914604|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83914605|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914606|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
83914607|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914608|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83914609|NCT00353379|Guanfacine|guanfacine|mesh-list
83914610|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83914611|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83914612|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83914613|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83914614|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
83914615|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914616|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914617|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914618|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
83914619|NCT00324077|Dasatinib|dasatinib|mesh-list
83914620|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914621|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83914622|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914623|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914624|NCT00324194|Mocetinostat|mocetinostat|mesh-list
83914625|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83914626|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914627|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914628|NCT00324389|Interferons|interferons|mesh-list
83914629|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
83914630|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914631|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
83914632|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914633|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
83914634|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914635|NCT00353691|Metformin|metformin|mesh-list
83914636|NCT00353691|Glimepiride|glimepiride|mesh-list
83914637|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914638|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914639|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83914640|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914641|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
83914642|NCT00332046|Casopitant|casopitant|mesh-list
83914643|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
83914644|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
83914645|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914646|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914647|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914648|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83914649|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914650|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914651|NCT00324467|Acetaminophen|acetaminophen|mesh-list
83914652|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
83914653|NCT00324467|Promethazine|promethazine|mesh-list
83914654|NCT00324467|Dexamethasone|dexamethasone|mesh-list
83914655|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
83914656|NCT00324467|Prednisone|prednisone|mesh-list
83914657|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
83914658|NCT00324467|Ifosfamide|ifosfamide|mesh-list
83914659|NCT00324467|Rituximab|rituximab|mesh-list
83914660|NCT00324467|Carboplatin|carboplatin|mesh-list
83914661|NCT00324467|Doxorubicin|doxorubicin|mesh-list
83914662|NCT00324467|Etoposide|etoposide|mesh-list
83914663|NCT00324467|Vincristine|vincristine|mesh-list
83914664|NCT00324467|Ondansetron|ondansetron|mesh-list
83914665|NCT00324467|BB 1101|bb 1101|mesh-list
83914666|NCT00324467|Mesna|mesna|mesh-list
83914667|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914668|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
83914669|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914670|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914671|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83914672|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
83914673|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914674|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914675|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83914676|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83914677|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914678|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
83914679|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
83914680|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914681|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914682|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
83914683|NCT00324467|Hormones|hormones|mesh-ancestor
83914684|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914685|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83914686|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
83914687|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914688|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83914689|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83914690|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83914691|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83914692|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
83914693|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
83914694|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
83914695|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914696|NCT00324467|Analgesics|analgesics|mesh-ancestor
83914697|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
83914698|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
83914699|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
83914700|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
83914701|NCT00324467|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83914702|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83914703|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
83914704|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914705|NCT00324467|Protective Agents|protective agents|mesh-ancestor
83914706|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83914707|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83914708|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914709|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
83914710|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
83914711|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83914712|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
83914713|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
83914714|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83914715|NCT00332085|Chromium|chromium|mesh-list
83914716|NCT00332085|Picolinic acid|picolinic acid|mesh-list
83914717|NCT00332085|Trace Elements|trace elements|mesh-ancestor
83914718|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
83914719|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914720|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83914721|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
83914722|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
83914723|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914724|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
83914725|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83914726|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914727|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83914728|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
83914729|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914730|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914731|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124675|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
83914732|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914733|NCT00332124|Choline|choline|mesh-list
83914734|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
83914735|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83914736|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
83914737|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914738|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914739|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83914740|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
83914741|NCT04714554|Erythromycin|erythromycin|mesh-list
83914742|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
83914743|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83914744|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
83914745|NCT04714554|Relugolix|relugolix|mesh-list
83914746|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914747|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914748|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914749|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83914750|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914751|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914752|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
83914753|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
83914754|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914755|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914756|NCT00419471|Escitalopram|escitalopram|mesh-list
83914757|NCT00419471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83914758|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83914759|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914760|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914761|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914762|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
83914763|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914764|NCT00426348|Valsartan|valsartan|mesh-list
83914765|NCT00426348|Probucol|probucol|mesh-list
83914766|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83914767|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83914768|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83914769|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914770|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83914771|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83914772|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
83914773|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83914774|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
83914775|NCT00426348|Protective Agents|protective agents|mesh-ancestor
83914776|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914777|NCT00353808|Reboxetine|reboxetine|mesh-list
83914778|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
83914779|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83914780|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83914781|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83914782|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914783|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914784|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
83914785|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914786|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914787|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
83914788|NCT00324623|Fludarabine|fludarabine|mesh-list
83914789|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
83914790|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914791|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
83914792|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914793|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914794|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83914795|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
83914796|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914797|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914798|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83914799|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83914800|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
83914801|NCT00324779|Rituximab|rituximab|mesh-list
83914802|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83914803|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914804|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
83914805|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914806|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914807|NCT00324818|Azithromycin|azithromycin|mesh-list
83914808|NCT00324818|Metronidazole|metronidazole|mesh-list
83914809|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83914810|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914811|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83914812|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83914813|NCT00324974|Lansoprazole|lansoprazole|mesh-list
83914814|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
83914815|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83914816|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914817|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83914818|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914819|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914820|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
83914821|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83914822|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83914823|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
83914824|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914825|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914826|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83914827|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
83914828|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
83914829|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83914830|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
83914831|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83914832|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914833|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
83914834|NCT00325169|Hormones|hormones|mesh-ancestor
83914835|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914836|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
83914837|NCT00426543|Rituximab|rituximab|mesh-list
83914838|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83914839|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914840|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
83914841|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914842|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914843|NCT00325286|Carbamazepine|carbamazepine|mesh-list
83914844|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83914845|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914846|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
83914847|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83914848|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914849|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914850|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
83914851|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914852|NCT00325286|Analgesics|analgesics|mesh-ancestor
83914853|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
83914854|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914855|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83914856|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914857|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83914858|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83914859|NCT00325325|Everolimus|everolimus|mesh-list
83914860|NCT00325325|Tacrolimus|tacrolimus|mesh-list
83914861|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914862|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
83914863|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914864|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83914865|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914866|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914867|NCT00325325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83914868|NCT00325325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83914869|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914870|NCT00354081|Vitamins|vitamins|mesh-list
83914871|NCT00354081|Folic Acid|folic acid|mesh-list
83914872|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
83914873|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
83914874|NCT00354081|Pyridoxine|pyridoxine|mesh-list
83914875|NCT00354081|Pyridoxal|pyridoxal|mesh-list
83914876|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
83914877|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
83914878|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
83914879|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914880|NCT00354081|Hematinics|hematinics|mesh-ancestor
83154072|NCT02207959|Proflavine|proflavine|mesh-list
83914881|NCT00325637|Losartan|losartan|mesh-list
83914882|NCT00325637|Cilnidipine|cilnidipine|mesh-list
83914883|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83914884|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83914885|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83914886|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83914887|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914888|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83914889|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914890|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83914891|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914892|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
83914893|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914894|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
83914895|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914896|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914897|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83914898|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
83914899|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914900|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914901|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83914902|NCT00426582|Epothilone B|epothilone b|mesh-list
83914903|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914904|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83914905|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83914906|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83914907|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914908|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83914909|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
83914910|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83914911|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914912|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914913|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83914914|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83914915|NCT00354198|Protective Agents|protective agents|mesh-ancestor
83914916|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914917|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
83914918|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83914919|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
83914920|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914921|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
83914922|NCT00354198|Hormones|hormones|mesh-ancestor
83914923|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83914924|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83914925|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83914926|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914927|NCT00325676|Pantoprazole|pantoprazole|mesh-list
83914928|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83914929|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914930|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83914931|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914932|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914933|NCT00325715|Esomeprazole|esomeprazole|mesh-list
83914934|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83914935|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83914936|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83914937|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914938|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914939|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83914940|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914941|NCT00325793|Nicardipine|nicardipine|mesh-list
83914942|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83914943|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83914944|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83914945|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914946|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83914947|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914948|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
83914949|NCT00426621|Diclofenac|diclofenac|mesh-list
83914950|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83914951|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914952|NCT00426621|Analgesics|analgesics|mesh-ancestor
83914953|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
83914954|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914955|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914956|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914957|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914958|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83914959|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83914960|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914961|NCT04714242|Ranibizumab|ranibizumab|mesh-list
83914962|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83914963|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83914964|NCT04714242|Growth Substances|growth substances|mesh-ancestor
83914965|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914966|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83914967|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914968|NCT00354276|Cytarabine|cytarabine|mesh-list
83914969|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83914970|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
83914971|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83914972|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83914973|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
83914974|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83914975|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83914976|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
83914977|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914978|NCT00325910|Metformin|metformin|mesh-list
83914979|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83914980|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914981|NCT00325949|Acetaminophen|acetaminophen|mesh-list
83914982|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83914983|NCT00325949|Hydrocodone|hydrocodone|mesh-list
83914984|NCT00325949|Oxycodone|oxycodone|mesh-list
83914985|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83914986|NCT00325949|Analgesics|analgesics|mesh-ancestor
83914987|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
83914988|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83914989|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83914990|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
83914991|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83914992|NCT00325949|Narcotics|narcotics|mesh-ancestor
83914993|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83914994|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
83914995|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
83914996|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83914997|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83914998|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83914999|NCT00326027|Pantoprazole|pantoprazole|mesh-list
83915000|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83915001|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915002|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83915003|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915004|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915005|NCT01059318|Everolimus|everolimus|mesh-list
83915006|NCT01059318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83915007|NCT01059318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83915008|NCT01059318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915009|NCT01059318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915010|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915011|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
83915012|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915013|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915014|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
83915015|NCT04714515|Ivermectin|ivermectin|mesh-list
83915016|NCT04714515|Montelukast|montelukast|mesh-list
83915017|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
83915018|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83915019|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83915020|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915021|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915022|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915023|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915024|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83915025|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
83915026|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83915027|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
83915028|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915029|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915030|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83915031|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83915032|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83915033|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
83915034|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915035|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83915036|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83915037|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915038|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915039|NCT00354354|Ipratropium|ipratropium|mesh-list
83915040|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83915041|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
83915042|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915043|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915044|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83915045|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
83915046|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915047|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915048|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83915049|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
83915050|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83915051|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
83915052|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915053|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83915054|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83915055|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915056|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915057|NCT01058655|Everolimus|everolimus|mesh-list
83915058|NCT01058655|Tivozanib|tivozanib|mesh-list
83915059|NCT01058655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83915060|NCT01058655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83915061|NCT01058655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915062|NCT01058655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915063|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915064|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
83915065|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915066|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915067|NCT00326300|Methylphenidate|methylphenidate|mesh-list
83915068|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83915069|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915070|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83915071|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83915072|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915073|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915074|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
83915075|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915076|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
83915077|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
83915078|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83915079|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915080|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915081|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83915082|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915083|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83915084|NCT00419549|Valdecoxib|valdecoxib|mesh-list
83915085|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83915086|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83915087|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915088|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915089|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83915090|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83915091|NCT00419549|Analgesics|analgesics|mesh-ancestor
83915092|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
83915093|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915094|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915095|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915096|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915097|NCT00326378|Docetaxel|docetaxel|mesh-list
83915098|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915099|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
83915100|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
83154298|NCT02209831|Pantoprazole|pantoprazole|mesh-list
83915101|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
83915102|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915103|NCT00326768|Telmisartan|telmisartan|mesh-list
83915104|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83915105|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83915106|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83915107|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83915108|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915109|NCT00326768|Diuretics|diuretics|mesh-ancestor
83915110|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
83915111|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915112|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83915113|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915114|NCT00326807|Naltrexone|naltrexone|mesh-list
83915115|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83915116|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83915117|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915118|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
83915119|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915120|NCT00354549|Bevacizumab|bevacizumab|mesh-list
83915121|NCT00354549|Carboplatin|carboplatin|mesh-list
83915122|NCT00354549|Gemcitabine|gemcitabine|mesh-list
83915123|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83915124|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915125|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915126|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83915127|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83915128|NCT00354549|Growth Substances|growth substances|mesh-ancestor
83915129|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915130|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
83915131|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83915132|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
83915133|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915134|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83915135|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915136|NCT01057251|Nebivolol|nebivolol|mesh-list
83915137|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83915138|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915139|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83915140|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83915141|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83915142|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
83915143|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915144|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915145|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915146|NCT04708353|Pregabalin|pregabalin|mesh-list
83915147|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915148|NCT04708353|Analgesics|analgesics|mesh-ancestor
83915149|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
83915150|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915151|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
83915152|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83915153|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915154|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915155|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83915156|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83915157|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83915158|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915159|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915160|NCT00425646|Bevacizumab|bevacizumab|mesh-list
83915161|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
83915162|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915163|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915164|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83915165|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83915166|NCT00425646|Growth Substances|growth substances|mesh-ancestor
83915167|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915168|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
83915169|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83915170|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915171|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915172|NCT00327080|Acetylcholine|acetylcholine|mesh-list
83915173|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915174|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83915175|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
83915176|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915177|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915178|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915179|NCT00327119|Panitumumab|panitumumab|mesh-list
83915180|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915181|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915183|NCT00426933|Daptomycin|daptomycin|mesh-list
83915184|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83915185|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915186|NCT00327197|Prednisolone|prednisolone|mesh-list
83915187|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915188|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
83915189|NCT00327197|Hormones|hormones|mesh-ancestor
83915190|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915191|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915192|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915193|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915194|NCT00425724|Cyclosporine|cyclosporine|mesh-list
83915195|NCT00425724|Prednisone|prednisone|mesh-list
83915196|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
83915197|NCT00425724|Cyclosporins|cyclosporins|mesh-list
83915198|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915199|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
83915200|NCT00425724|Hormones|hormones|mesh-ancestor
83915201|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915202|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915203|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915204|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915205|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915206|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915207|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915208|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
83915209|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
83915210|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915211|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
83915212|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915213|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83915214|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
83915215|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
83915216|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915217|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915218|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83915219|NCT00425724|Protective Agents|protective agents|mesh-ancestor
83915220|NCT00426972|Estradiol|estradiol|mesh-list
83915221|NCT00426972|Estrogens|estrogens|mesh-ancestor
83915222|NCT00426972|Hormones|hormones|mesh-ancestor
83915223|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915224|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915225|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
83915226|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83915227|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83915228|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
83915229|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915230|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915231|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83915232|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
83915233|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83915234|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83915235|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83915236|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
83915237|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915238|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915239|NCT00425841|Gemcitabine|gemcitabine|mesh-list
83915240|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
83915241|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83915242|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
83915243|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915244|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915245|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
83915246|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83915247|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
83915248|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915249|NCT00427089|Protective Agents|protective agents|mesh-ancestor
83915250|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915251|NCT00427089|Vitamins|vitamins|mesh-ancestor
83915252|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
83915253|NCT00427089|Laxatives|laxatives|mesh-ancestor
83915254|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915255|NCT00427128|Fluoxetine|fluoxetine|mesh-list
83915256|NCT00427128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83915257|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83915258|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915259|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915260|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915261|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
83915262|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915263|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83915264|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
83915265|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915266|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83915267|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83915268|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915269|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83915270|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83915271|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
83915272|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915273|NCT00427167|Antacids|antacids|mesh-ancestor
83915274|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915275|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915276|NCT00427206|Acetaminophen|acetaminophen|mesh-list
83915277|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83915278|NCT00427206|Analgesics|analgesics|mesh-ancestor
83915279|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
83915280|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915281|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915282|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
83915283|NCT00425997|Amlodipine|amlodipine|mesh-list
83915284|NCT00425997|Valsartan|valsartan|mesh-list
83915285|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83915286|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83915287|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83915288|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915289|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915290|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83915291|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915292|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915293|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83915294|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83915295|NCT00425997|Diuretics|diuretics|mesh-ancestor
83915296|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
83915297|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83915298|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
83915299|NCT00427245|Goserelin|goserelin|mesh-list
83915300|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915301|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
83915302|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915303|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915304|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83915305|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
83915306|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915307|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915308|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83915309|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915310|NCT05458076|Ritonavir|ritonavir|mesh-list
83915311|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83915312|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83915313|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83915314|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915315|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915316|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83915317|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83915318|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
83915319|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915320|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83915321|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83915322|NCT00427362|Adalimumab|adalimumab|mesh-list
83915323|NCT00427362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83915324|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915325|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915326|NCT00426192|Mannitol|mannitol|mesh-list
83915327|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83915328|NCT00426192|Diuretics|diuretics|mesh-ancestor
83915329|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
83915330|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915331|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83915332|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
83915333|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915334|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83915335|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83915336|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915337|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915338|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83915339|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83915340|NCT00432393|Levodopa|levodopa|mesh-list
83915341|NCT00432393|Carbidopa|carbidopa|mesh-list
83915342|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83915343|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83915344|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83915345|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
83915346|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915347|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915348|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915349|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83915350|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915351|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83915352|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
83915353|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
83915354|NCT05453045|Albendazole|albendazole|mesh-list
83915355|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
83915356|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83915357|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915358|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
83915359|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83915360|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83915361|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
83915362|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
83915363|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
83915364|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915365|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915366|NCT00432432|Infliximab|infliximab|mesh-list
83915367|NCT00432432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83915368|NCT00432432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915369|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
83915370|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915371|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915372|NCT02957448|Rifampin|rifampin|mesh-list
83915373|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83915374|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
83915375|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83915376|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915377|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
83915378|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83915379|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915380|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915381|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83915382|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83915383|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83915384|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83915385|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83915386|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83915387|NCT00427596|Solabegron|solabegron|mesh-list
83915388|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83915389|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83915390|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83915391|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83915392|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915393|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915394|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915395|NCT00432510|Complement C1s|complement c1s|mesh-list
83915396|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83915397|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83915398|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
83915399|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915400|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83915401|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915402|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
83915403|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
83915404|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83915405|NCT05354258|Amodiaquine|amodiaquine|mesh-list
83915406|NCT05354258|Albendazole|albendazole|mesh-list
83915407|NCT05354258|Praziquantel|praziquantel|mesh-list
83915408|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
83915409|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83915410|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83915411|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915412|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83915413|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915414|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915415|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83915416|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
83915417|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
83915418|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83915419|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
83915420|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
83915421|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
83915422|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915423|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
83915424|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915425|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915426|NCT05338580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83915427|NCT05338580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915428|NCT02273466|Desipramine|desipramine|mesh-list
83915429|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83915430|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
83915431|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915432|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915433|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915434|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83915435|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83915436|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915437|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
83915438|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915439|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915440|NCT00427713|Capecitabine|capecitabine|mesh-list
83915441|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
83915442|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83915443|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
83915444|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915445|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915446|NCT02273505|Aspirin|aspirin|mesh-list
83915447|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
83915448|NCT02273505|Salicylates|salicylates|mesh-list
83915449|NCT02273505|Dipyridamole|dipyridamole|mesh-list
83915450|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83915451|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915452|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
83915453|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
83915454|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
83915455|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83411168|NCT03449108|Interleukin-2|interleukin-2|mesh-list
83915456|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83915457|NCT02273505|Analgesics|analgesics|mesh-ancestor
83915458|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
83915459|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915460|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915461|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915462|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915463|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83915464|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915465|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915466|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83915467|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83915468|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83915469|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
83915470|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83915471|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915472|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
83915473|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
83915474|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915475|NCT05198960|Aspirin|aspirin|mesh-list
83915476|NCT05198960|Anticoagulants|anticoagulants|mesh-list
83915477|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83915478|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83915479|NCT05198960|Analgesics|analgesics|mesh-ancestor
83915480|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
83915481|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915482|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915483|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915484|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915485|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83915486|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83915487|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915488|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83915489|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83915490|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915491|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
83915492|NCT00432549|Topiramate|topiramate|mesh-list
83915493|NCT00432549|Almotriptan|almotriptan|mesh-list
83915494|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
83915495|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83915496|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915497|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83915498|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
83915499|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915500|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915501|NCT00427947|Ropivacaine|ropivacaine|mesh-list
83915502|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
83915503|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
83915504|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915505|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915506|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
83915507|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915508|NCT00432588|Misoprostol|misoprostol|mesh-list
83915509|NCT00432588|Dinoprostone|dinoprostone|mesh-list
83915510|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83915511|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
83915512|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83915513|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915514|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83915515|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915516|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
83915517|NCT00428025|Diclofenac|diclofenac|mesh-list
83915518|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83915519|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83915520|NCT00428025|Analgesics|analgesics|mesh-ancestor
83915521|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
83915522|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915523|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915524|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915525|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915526|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83915527|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915528|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915529|NCT00428064|Cyclosporine|cyclosporine|mesh-list
83915530|NCT00428064|Sirolimus|sirolimus|mesh-list
83915531|NCT00428064|Cyclosporins|cyclosporins|mesh-list
83915532|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915533|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915534|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915535|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
83915536|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915537|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
83915538|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915539|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
83915540|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915541|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83915542|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83915543|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83154756|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83915544|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915545|NCT00432627|Deferasirox|deferasirox|mesh-list
83915546|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83915547|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
83915548|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
83915549|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915550|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
83915551|NCT00419783|Ketoconazole|ketoconazole|mesh-list
83915552|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83915553|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915554|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83915555|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83915556|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915557|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915558|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915559|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915560|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
83915561|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83915562|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83915563|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83915564|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
83915565|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915566|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83915567|NCT00428142|Prednisone|prednisone|mesh-list
83915568|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
83915569|NCT00428142|Rituximab|rituximab|mesh-list
83915570|NCT00428142|Vincristine|vincristine|mesh-list
83915571|NCT00428142|Bortezomib|bortezomib|mesh-list
83915572|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915573|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
83915574|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915575|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915576|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83915577|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
83915578|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915579|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915580|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83915581|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915582|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915583|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
83915584|NCT00428142|Hormones|hormones|mesh-ancestor
83915585|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915586|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915587|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83915588|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
83915589|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
83915590|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
83915591|NCT00428181|Ethanol|ethanol|mesh-list
83915592|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83915593|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915594|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915595|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915596|NCT00432861|Pancrelipase|pancrelipase|mesh-list
83915597|NCT00432861|Pancreatin|pancreatin|mesh-list
83915598|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915599|NCT04575233|Ropivacaine|ropivacaine|mesh-list
83915600|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
83915601|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
83915602|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915603|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915604|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
83915605|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915606|NCT04507412|Dexamethasone|dexamethasone|mesh-list
83915607|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915608|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
83915609|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
83915610|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915611|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915612|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915613|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
83915614|NCT04507412|Hormones|hormones|mesh-ancestor
83915615|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915616|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915617|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915618|NCT00428454|Sirolimus|sirolimus|mesh-list
83915619|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83915620|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154846|NCT02221999|Paclitaxel|paclitaxel|mesh-list
83915621|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83915622|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915623|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
83915624|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915625|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
83915626|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915627|NCT00432978|Bosentan|bosentan|mesh-list
83915628|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83915629|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83915630|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915631|NCT01051791|Everolimus|everolimus|mesh-list
83915632|NCT01051791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83915633|NCT01051791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83915634|NCT01051791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915635|NCT01051791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915636|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915637|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
83915638|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915639|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915640|NCT01056510|Rituximab|rituximab|mesh-list
83915641|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83915642|NCT01056510|Chlorambucil|chlorambucil|mesh-list
83915643|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915644|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915645|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
83915646|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915647|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915648|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83915649|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
83915650|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915651|NCT04326257|Nivolumab|nivolumab|mesh-list
83915652|NCT04326257|Ipilimumab|ipilimumab|mesh-list
83915653|NCT04326257|Relatlimab|relatlimab|mesh-list
83915654|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915655|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915656|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83915657|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915658|NCT01056276|Dexamethasone|dexamethasone|mesh-list
83915659|NCT01056276|Bortezomib|bortezomib|mesh-list
83915660|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83915661|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915662|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
83915663|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
83915664|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915665|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915666|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915667|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
83915668|NCT01056276|Hormones|hormones|mesh-ancestor
83915669|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915670|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915671|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915672|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83915673|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
83915674|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915675|NCT01055886|Nicotine|nicotine|mesh-list
83915676|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83915677|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
83915678|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915679|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915680|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83915681|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83915682|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
83915683|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915684|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915685|NCT00433095|Trastuzumab|trastuzumab|mesh-list
83915686|NCT00433095|Vinorelbine|vinorelbine|mesh-list
83915687|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915688|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915689|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83915690|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83915691|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83915692|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83915693|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915694|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83915695|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83915696|NCT00428649|Selenium|selenium|mesh-list
83915697|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
83915698|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915699|NCT00428649|Protective Agents|protective agents|mesh-ancestor
83915700|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915701|NCT00428649|Trace Elements|trace elements|mesh-ancestor
83915702|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
83915703|NCT03852992|Minoxidil|minoxidil|mesh-list
83915704|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83915705|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915706|NCT00433173|Anastrozole|anastrozole|mesh-list
83915707|NCT00433173|Goserelin|goserelin|mesh-list
83915708|NCT00433173|Testosterone|testosterone|mesh-list
83915709|NCT00433173|Androgens|androgens|mesh-ancestor
83915710|NCT00433173|Hormones|hormones|mesh-ancestor
83915711|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915712|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915713|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915714|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915715|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83915716|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83915717|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915718|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915719|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83915720|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
83915721|NCT01055028|Paclitaxel|paclitaxel|mesh-list
83915722|NCT01055028|Bevacizumab|bevacizumab|mesh-list
83915723|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83915724|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915725|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83915726|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83915727|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83915728|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915729|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915730|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83915731|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83915732|NCT01055028|Growth Substances|growth substances|mesh-ancestor
83915733|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915734|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83915735|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
83915736|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83915737|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
83915738|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915739|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915740|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83915741|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
83915742|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83915743|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
83915744|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915745|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915746|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83915747|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915748|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
83915749|NCT00428727|Protective Agents|protective agents|mesh-ancestor
83915750|NCT03474029|Rifampin|rifampin|mesh-list
83915751|NCT03474029|Rifapentine|rifapentine|mesh-list
83915752|NCT03474029|Isoniazid|isoniazid|mesh-list
83915753|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83915754|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
83915755|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83915756|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915757|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
83915758|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83915759|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915760|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915761|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83915762|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83915763|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83915764|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83915765|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83915766|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83915767|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83915768|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83915769|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
83915770|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83915771|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
83915772|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83915773|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83915774|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915775|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915776|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915777|NCT00428766|Farletuzumab|farletuzumab|mesh-list
83915778|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915779|NCT04716569|Ivermectin|ivermectin|mesh-list
83915780|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83915781|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915782|NCT04703127|Lidocaine|lidocaine|mesh-list
83915783|NCT04703127|Tadalafil|tadalafil|mesh-list
83915784|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
83915785|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
83915786|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915787|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915788|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
83915789|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915790|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83915791|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83915792|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83915793|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915794|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915795|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915796|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83915797|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83915798|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915799|NCT04703127|Urological Agents|urological agents|mesh-ancestor
83915800|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
83915801|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83915802|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
83915803|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915804|NCT00428883|Expectorants|expectorants|mesh-ancestor
83915805|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
83915806|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83915807|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
83915808|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915809|NCT00428883|Protective Agents|protective agents|mesh-ancestor
83915810|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915811|NCT00428883|Antidotes|antidotes|mesh-ancestor
83915812|NCT04702971|Flunarizine|flunarizine|mesh-list
83915813|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
83915814|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83915815|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915816|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915817|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83915818|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915819|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83915820|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
83915821|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
83915822|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915823|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915824|NCT00433407|Trastuzumab|trastuzumab|mesh-list
83915825|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83915826|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915827|NCT00433485|Sirolimus|sirolimus|mesh-list
83915828|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83915829|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915830|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83915831|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915832|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
83915833|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83915834|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
83915835|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915836|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
83915837|NCT02676791|Povidone|povidone|mesh-list
83915838|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
83915839|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
83915840|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83915841|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915842|NCT02244125|Dexamethasone|dexamethasone|mesh-list
83155048|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
83915843|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
83915844|NCT02244125|Pomalidomide|pomalidomide|mesh-list
83915846|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
83915847|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915848|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915849|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83915850|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
83915851|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915852|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915853|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83915854|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915855|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
83915856|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
83915857|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915858|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915859|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
83915860|NCT02244125|Hormones|hormones|mesh-ancestor
83915861|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83915862|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83915863|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83915864|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83915865|NCT02244125|Growth Substances|growth substances|mesh-ancestor
83915866|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
83915867|NCT01600079|Vaccines|vaccines|mesh-list
83915868|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
83915869|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915870|NCT01370486|Melatonin|melatonin|mesh-list
83915871|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
83915872|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915873|NCT01370486|Protective Agents|protective agents|mesh-ancestor
83915874|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915875|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915876|NCT00327587|Amlodipine|amlodipine|mesh-list
83915877|NCT00327587|Valsartan|valsartan|mesh-list
83915878|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83915879|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83915880|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83915881|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915882|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915883|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83915884|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915885|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
83915886|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83915887|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83915888|NCT00327587|Diuretics|diuretics|mesh-ancestor
83915889|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
83915890|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83915891|NCT00327665|Vaccines|vaccines|mesh-list
83915892|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83915893|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
83915894|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915895|NCT00433641|Sibutramine|sibutramine|mesh-list
83915896|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
83915897|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915898|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
83915899|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83915900|NCT00429234|Gemcitabine|gemcitabine|mesh-list
83915901|NCT00429234|Dasatinib|dasatinib|mesh-list
83915902|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83915903|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
83915904|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915905|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83915906|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83915907|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915908|NCT00433719|Efavirenz|efavirenz|mesh-list
83915909|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83915910|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83915911|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83915912|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915913|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915914|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
83915915|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83915916|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83155144|NCT02396979|Methadone|methadone|mesh-list
83915917|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83915918|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83915919|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83915920|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83915921|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83915922|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83915923|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83915924|NCT04704297|Acetaminophen|acetaminophen|mesh-list
83915925|NCT04704297|Ibuprofen|ibuprofen|mesh-list
83915926|NCT04704297|Ketorolac|ketorolac|mesh-list
83915927|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83915928|NCT04704297|Amitriptyline|amitriptyline|mesh-list
83915929|NCT04704297|Bupivacaine|bupivacaine|mesh-list
83915930|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
83915931|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
83915932|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
83915933|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915934|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915935|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
83915936|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915937|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83915938|NCT04704297|Analgesics|analgesics|mesh-ancestor
83915939|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
83915940|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83915941|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915942|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83915943|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83915944|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83915945|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915946|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83915947|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
83915948|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915949|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83915950|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83915951|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83915952|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83915953|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83915954|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83915955|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
83915956|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915957|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
83915958|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915959|NCT00328367|Aripiprazole|aripiprazole|mesh-list
83915960|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
83915961|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83915962|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83915963|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83915964|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83915965|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915966|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
83915967|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
83915968|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915969|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83915970|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83915971|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83915972|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
83915973|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83915974|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83915975|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83915976|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83915977|NCT04703088|Ondansetron|ondansetron|mesh-list
83915978|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
83915979|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
83915980|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915981|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915982|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83915983|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
83915984|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
83915985|NCT04703088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83915986|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83915987|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
83915988|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83915989|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155195|NCT02149433|Hormones|hormones|mesh-ancestor
83915990|NCT00328718|Fluticasone|fluticasone|mesh-list
83915992|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83915993|NCT00328718|Montelukast|montelukast|mesh-list
83915994|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83915995|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83915996|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
83915997|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83915998|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83915999|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83916000|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
83916001|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
83916002|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83916003|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83916004|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83916005|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83916006|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916007|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916008|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916009|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83916010|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
83916011|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916012|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83916013|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83916014|NCT00328796|Lidocaine|lidocaine|mesh-list
83916015|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
83916016|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
83916017|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916018|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916019|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
83916020|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916021|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83916022|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83916023|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83916024|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83916025|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916026|NCT00429468|Acetaminophen|acetaminophen|mesh-list
83916027|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83916028|NCT00429468|Hydrocodone|hydrocodone|mesh-list
83916029|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916030|NCT00429468|Analgesics|analgesics|mesh-ancestor
83916031|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
83916032|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916033|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916034|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
83916035|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83916036|NCT00429468|Narcotics|narcotics|mesh-ancestor
83916037|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916038|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
83916039|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
83916040|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83916041|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916042|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916043|NCT04702698|Peposertib|peposertib|mesh-list
83916044|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83916045|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048327|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916046|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916047|NCT00328874|Ubiquinone|ubiquinone|mesh-list
83916048|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
83916049|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
83916050|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916051|NCT00328874|Vitamins|vitamins|mesh-ancestor
83916052|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83916053|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83916054|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
83916055|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916056|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
83916057|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83916058|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916059|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83916060|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
83916061|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916062|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916063|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155266|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916064|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916065|NCT02957643|Iron|iron|mesh-list
83916066|NCT02957643|Trace Elements|trace elements|mesh-ancestor
83916067|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
83916068|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916069|NCT02957604|Evolocumab|evolocumab|mesh-list
83916070|NCT02957604|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83916071|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83916072|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83916073|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
83916074|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916075|NCT02957604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83916076|NCT02957604|Protease Inhibitors|protease inhibitors|mesh-ancestor
83916077|NCT02957604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916078|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83916079|NCT00329069|Atorvastatin|atorvastatin|mesh-list
83916080|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83916081|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83916082|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
83916083|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916084|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83916085|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83916086|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916087|NCT00429624|Acetaminophen|acetaminophen|mesh-list
83916088|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916089|NCT00429624|Analgesics|analgesics|mesh-ancestor
83916090|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
83916091|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916092|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916093|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
83916094|NCT00329147|Paroxetine|paroxetine|mesh-list
83916095|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83916096|NCT00329147|Desipramine|desipramine|mesh-list
83916097|NCT00329147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83916098|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83916099|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83916100|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916101|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916102|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
83916103|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916104|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83916105|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
83916106|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916107|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83916108|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83916109|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916110|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83916111|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83916112|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83916113|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916114|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83916115|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83916116|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83916117|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83916118|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83916119|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916120|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916121|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916122|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83916123|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
83916124|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916125|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
83916126|NCT00434031|Docetaxel|docetaxel|mesh-list
83916127|NCT00434031|Doxorubicin|doxorubicin|mesh-list
83916128|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83916129|NCT00434031|Trastuzumab|trastuzumab|mesh-list
83916130|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83916131|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
83916132|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916133|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916134|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83916135|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
84124676|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916136|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916137|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916138|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83916139|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
83916140|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
83916141|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
83916142|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83916143|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83916144|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83916145|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916146|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83916147|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
83916148|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83916149|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916150|NCT01050543|Neostigmine|neostigmine|mesh-list
83916151|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83916152|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916153|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916154|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
83916155|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916156|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916157|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83916158|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
83916159|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916160|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83916161|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
83916162|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916163|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83916164|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83916165|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916166|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916168|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83916169|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83916170|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83916171|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
83916172|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
83916173|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916174|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
83916175|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83916176|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
83916177|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916178|NCT00329459|Naproxen|naproxen|mesh-list
83916179|NCT00329459|Sumatriptan|sumatriptan|mesh-list
83916180|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83916181|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916182|NCT00329459|Analgesics|analgesics|mesh-ancestor
83916183|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
83916184|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916185|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916186|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916187|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916188|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
83916189|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83916190|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916191|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916192|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83916193|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83916194|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83916195|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
83916196|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916197|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
83916198|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
83916199|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916200|NCT00329498|Protective Agents|protective agents|mesh-ancestor
83916201|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916202|NCT00329498|Vitamins|vitamins|mesh-ancestor
83916203|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
83916204|NCT00329537|Sargramostim|sargramostim|mesh-list
83916205|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
83916206|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916207|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
83916208|NCT00429897|Amiloride|amiloride|mesh-list
83916209|NCT00429897|Spironolactone|spironolactone|mesh-list
83916210|NCT00429897|Furosemide|furosemide|mesh-list
83155419|NCT02149901|Ephedrine|ephedrine|mesh-list
83916211|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83916213|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916214|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916215|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83916216|NCT00429897|Diuretics|diuretics|mesh-ancestor
83916217|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
83916218|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83916219|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83916220|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83916221|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916222|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83916223|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83916224|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916225|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83916226|NCT00429936|Fenretinide|fenretinide|mesh-list
83916227|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916228|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83916229|NCT00429936|Protective Agents|protective agents|mesh-ancestor
83916230|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916231|NCT00429975|Levofloxacin|levofloxacin|mesh-list
83916232|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
83916233|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83916234|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916235|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916236|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83916237|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83916238|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916239|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916240|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916241|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83916242|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83916243|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
83916244|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
83916245|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
83916246|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83916247|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916248|NCT04716686|Niraparib|niraparib|mesh-list
83916249|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83916250|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916251|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916252|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916253|NCT01056393|Ibalizumab|ibalizumab|mesh-list
83916254|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83916255|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83916256|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83916257|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
83916258|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916259|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
83916260|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916261|NCT01055106|Metronidazole|metronidazole|mesh-list
83916262|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916263|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916264|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83916265|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83916266|NCT00329693|Quinagolide|quinagolide|mesh-list
83916267|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
83916268|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
83916269|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916270|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916271|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916272|NCT00329810|Aripiprazole|aripiprazole|mesh-list
83916273|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
83916274|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916275|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83916276|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83916277|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916278|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916279|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
83916280|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
83916281|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916282|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916283|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83916284|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83916285|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
83916286|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83916287|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83916288|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83916289|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83916290|NCT00430170|Dipyridamole|dipyridamole|mesh-list
83916292|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83916293|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916294|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83916295|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916296|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916297|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83916298|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83916299|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
83916300|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916301|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83916302|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
83916303|NCT00330044|Carboplatin|carboplatin|mesh-list
83916304|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916305|NCT00430365|Lenalidomide|lenalidomide|mesh-list
83916306|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
83916307|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916308|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83916309|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83916310|NCT00430365|Growth Substances|growth substances|mesh-ancestor
83916311|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
83916312|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916313|NCT00330239|Paroxetine|paroxetine|mesh-list
83916314|NCT00330239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83916315|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83916316|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83916317|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916318|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916319|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
83916320|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916321|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83916322|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
83916323|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916324|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83916325|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83916326|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916327|NCT01051557|Sirolimus|sirolimus|mesh-list
83916328|NCT01051557|Temsirolimus|temsirolimus|mesh-list
83916329|NCT01051557|MTOR Inhibitors|mtor inhibitors|mesh-list
83916330|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916331|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916332|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83916333|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916334|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
83916335|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83916336|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
83916337|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152206|NCT02716805|Durvalumab|durvalumab|mesh-list
83916338|NCT01051557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83916339|NCT01051557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916340|NCT01051557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916341|NCT00330278|Cefazolin|cefazolin|mesh-list
83916342|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916343|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916344|NCT00330317|Letrozole|letrozole|mesh-list
83916345|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916346|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83916347|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83916348|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916349|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916350|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83916351|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
83916352|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916353|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916354|NCT00430443|Annamycin|annamycin|mesh-list
83155567|NCT04093765|Antimalarials|antimalarials|mesh-list
83916355|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83916356|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916357|NCT00330395|Caspofungin|caspofungin|mesh-list
83916358|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
83916359|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916360|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916361|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916362|NCT00434382|Fentanyl|fentanyl|mesh-list
83916363|NCT00434382|Sufentanil|sufentanil|mesh-list
83916364|NCT00434382|Remifentanil|remifentanil|mesh-list
83916365|NCT00434382|Alfentanil|alfentanil|mesh-list
83916366|NCT00434382|Propofol|propofol|mesh-list
83916367|NCT00434382|Sevoflurane|sevoflurane|mesh-list
83916368|NCT00434382|Desflurane|desflurane|mesh-list
83916369|NCT00434382|Isoflurane|isoflurane|mesh-list
83916370|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83916371|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916372|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916373|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83916374|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
83916375|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
83916376|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83916377|NCT00434382|Narcotics|narcotics|mesh-ancestor
83916378|NCT00434382|Analgesics|analgesics|mesh-ancestor
83916379|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
83916380|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916381|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83916382|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83916383|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83916384|NCT00330707|Interferons|interferons|mesh-list
83916385|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
83916386|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
83916387|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916388|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
83916389|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916390|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
83916391|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916392|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83916393|NCT00330746|Gemcitabine|gemcitabine|mesh-list
83916394|NCT00330746|Cetuximab|cetuximab|mesh-list
83916395|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83916396|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
83916397|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916398|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916399|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83916400|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
83916401|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83916402|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83916403|NCT00330785|Amlodipine|amlodipine|mesh-list
83916404|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83916405|NCT00330785|Atorvastatin|atorvastatin|mesh-list
83916406|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83916407|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83916408|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
83916409|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916410|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83916411|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83916412|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916413|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916414|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83916415|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83916416|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83916417|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916418|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
83916419|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83916420|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
83916421|NCT00330824|Dexamethasone|dexamethasone|mesh-list
83916422|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
83916423|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83916424|NCT00330824|BB 1101|bb 1101|mesh-list
83916425|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916426|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
83916427|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
83916428|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916429|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916430|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83916431|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
83916432|NCT00330824|Hormones|hormones|mesh-ancestor
83916433|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916434|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83916435|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916436|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
83916437|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916438|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916439|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916440|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83916441|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83916442|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83916443|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
83916444|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83916445|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83916446|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83916447|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83916448|NCT00330902|Artesunate|artesunate|mesh-list
83916449|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
83916450|NCT00330902|Primaquine|primaquine|mesh-list
83916451|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
83916452|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83916453|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
83916454|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83916455|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83916456|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916457|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916458|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
83916459|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
83916460|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83916461|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
83916462|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83916463|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916464|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916465|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83916466|NCT04703868|Rabeprazole|rabeprazole|mesh-list
83916467|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83916468|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83916469|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83916470|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916471|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916472|NCT00430794|Spironolactone|spironolactone|mesh-list
83916473|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83916474|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
83916475|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916476|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916477|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83916478|NCT00430794|Diuretics|diuretics|mesh-ancestor
83916479|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
83916480|NCT00330980|Simvastatin|simvastatin|mesh-list
83916481|NCT00330980|Pravastatin|pravastatin|mesh-list
83916482|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83916483|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83916484|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
84048328|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83916485|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916486|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83916487|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83916488|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916489|NCT00430833|Candesartan|candesartan|mesh-list
83916490|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916491|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83916492|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83916493|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916494|NCT00331058|Prednisolone|prednisolone|mesh-list
83916495|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916496|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
83916497|NCT00331058|Hormones|hormones|mesh-ancestor
83916498|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916499|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916500|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83916501|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916502|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
83916503|NCT00331097|Docetaxel|docetaxel|mesh-list
83916504|NCT00331097|Fluorouracil|fluorouracil|mesh-list
83916505|NCT00331097|Methotrexate|methotrexate|mesh-list
83155715|NCT02691507|Decanoic acid|decanoic acid|mesh-list
83916506|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83916507|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
83916508|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916509|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916510|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83916511|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
83916512|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916513|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916514|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83916515|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
83916516|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
83916517|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
83916519|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83916520|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83916521|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
83916522|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83916523|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
83916524|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916525|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83916526|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83916527|NCT00331214|Testosterone|testosterone|mesh-list
83916528|NCT00331214|Androgens|androgens|mesh-ancestor
83916529|NCT00331214|Hormones|hormones|mesh-ancestor
83916530|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916531|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916532|NCT00434772|Glucagon|glucagon|mesh-list
83916533|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83916534|NCT00434772|Hormones|hormones|mesh-ancestor
83916535|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916536|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916537|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
83916538|NCT00431028|Triamcinolone|triamcinolone|mesh-list
83916539|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916540|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
83916541|NCT00431028|Hormones|hormones|mesh-ancestor
83916542|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916543|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916544|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916545|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916546|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916547|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916548|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83916549|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83916550|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916551|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83916552|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83916553|NCT00431106|Gemcitabine|gemcitabine|mesh-list
83916554|NCT00431106|Capecitabine|capecitabine|mesh-list
83916555|NCT00431106|Vinorelbine|vinorelbine|mesh-list
83916556|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83916557|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
83916558|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916559|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916560|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83916561|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
83916562|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
83916563|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
83916564|NCT00431145|Niacin|niacin|mesh-list
83916565|NCT00431145|Niacinamide|niacinamide|mesh-list
83916566|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
83916567|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83916568|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
83916569|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916570|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83916571|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
83916572|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
83916573|NCT00431145|Vitamins|vitamins|mesh-ancestor
83916574|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
83916575|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916576|NCT00331487|Pioglitazone|pioglitazone|mesh-list
83916577|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
83916578|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83916579|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916580|NCT00331526|Aldesleukin|aldesleukin|mesh-list
83916581|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916582|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83916583|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83916584|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
83916585|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916586|NCT00431262|Disulfiram|disulfiram|mesh-list
83916587|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83916588|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83916589|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916590|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916591|NCT00331604|Insulin|insulin|mesh-list
83916592|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83916593|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
83916594|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
83916595|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83916596|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
83916597|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83916598|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916599|NCT00331643|Epothilones|epothilones|mesh-list
83916600|NCT00331643|Epothilone B|epothilone b|mesh-list
83916601|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83916602|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83916603|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83916604|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916605|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916606|NCT00431340|Belinostat|belinostat|mesh-list
83916607|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916608|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83916609|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916610|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916611|NCT00431379|Tenecteplase|tenecteplase|mesh-list
83916612|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83916613|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83916614|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916615|NCT00331838|Enoxaparin|enoxaparin|mesh-list
83916616|NCT00331838|Semuloparin|semuloparin|mesh-list
83916617|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83916618|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
83916619|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
83916620|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83916621|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83916622|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916623|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
83916624|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
83916625|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83916626|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83916627|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916628|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916629|NCT00431418|Urological Agents|urological agents|mesh-ancestor
83916630|NCT00331955|Doxorubicin|doxorubicin|mesh-list
83916631|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83916632|NCT00331955|Vorinostat|vorinostat|mesh-list
83916633|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83916634|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916635|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83916636|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83916637|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916638|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916639|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83916640|NCT03277482|Durvalumab|durvalumab|mesh-list
83916641|NCT03277482|Tremelimumab|tremelimumab|mesh-list
83916642|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83916643|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916644|NCT00331994|Metronidazole|metronidazole|mesh-list
83916645|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916646|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916647|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83916648|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83916649|NCT00332033|Pirfenidone|pirfenidone|mesh-list
83916650|NCT00332033|Analgesics|analgesics|mesh-ancestor
83916651|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
83916652|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916653|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916654|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83916655|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916656|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916657|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916658|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916659|NCT00435279|Eszopiclone|eszopiclone|mesh-list
83916660|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83916661|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83916662|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83916663|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83916664|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916665|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916666|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916667|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83916668|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
83916669|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916670|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83916671|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916672|NCT00332072|Timolol|timolol|mesh-list
83916673|NCT00332072|Bimatoprost|bimatoprost|mesh-list
83916674|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83916675|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83916676|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916677|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916678|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916679|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916680|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83916681|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916682|NCT00431613|Carboplatin|carboplatin|mesh-list
83916683|NCT00431613|Gemcitabine|gemcitabine|mesh-list
83916684|NCT00431613|Docetaxel|docetaxel|mesh-list
83916685|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916686|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83916687|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
83916688|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916689|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
83916690|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
83916691|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
83916692|NCT00332228|Naltrexone|naltrexone|mesh-list
83916693|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83916694|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83916695|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916696|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
83916697|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916698|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
83916699|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
83916700|NCT00332306|Lamivudine|lamivudine|mesh-list
83916701|NCT00332306|Efavirenz|efavirenz|mesh-list
83916702|NCT00332306|Nevirapine|nevirapine|mesh-list
83916703|NCT00332306|Didanosine|didanosine|mesh-list
83916704|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83916705|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83916706|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916707|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916708|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
83916709|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916710|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83916711|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83916712|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83916713|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83916714|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83916715|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83916716|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83916717|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83916718|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
83916719|NCT00332345|Timolol|timolol|mesh-list
83916720|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83916721|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83916722|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83916723|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916724|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916725|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916726|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916727|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83916728|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916729|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83155937|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
83916730|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83916731|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83916732|NCT00332384|Timolol|timolol|mesh-list
83916733|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83916734|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83916735|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83916736|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916737|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916738|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916739|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916740|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83916741|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916742|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83916743|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83916744|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83916745|NCT00435435|Disulfiram|disulfiram|mesh-list
83916746|NCT00435435|Acamprosate|acamprosate|mesh-list
83916747|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83916748|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83916749|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916750|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916751|NCT00332540|Timolol|timolol|mesh-list
83916752|NCT00332540|Bimatoprost|bimatoprost|mesh-list
83916753|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83916754|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83916755|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916756|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916757|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916758|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916759|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83916760|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916761|NCT00332618|Glycerol|glycerol|mesh-list
83916762|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83916763|NCT00332618|Protective Agents|protective agents|mesh-ancestor
83916764|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916765|NCT00332735|Bupivacaine|bupivacaine|mesh-list
83916766|NCT00332735|Carticaine|carticaine|mesh-list
83916767|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
83916768|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
83916769|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916770|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916771|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
83916772|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916773|NCT00332774|Ketorolac|ketorolac|mesh-list
83916774|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83916775|NCT00332774|Nepafenac|nepafenac|mesh-list
83916776|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83916777|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83916778|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83916779|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916780|NCT00332774|Analgesics|analgesics|mesh-ancestor
83916781|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
83916782|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916783|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916784|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916785|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916786|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83916787|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916788|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916789|NCT00431769|Bortezomib|bortezomib|mesh-list
83916790|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916791|NCT00332852|Letrozole|letrozole|mesh-list
83916792|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916793|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83916794|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83916795|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916796|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916797|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83916798|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
83916799|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916800|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916801|NCT00332891|Amibegron|amibegron|mesh-list
83916802|NCT00332891|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83916803|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83916804|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83916805|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916806|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916807|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916808|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916809|NCT00332891|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83916810|NCT00332930|Interferons|interferons|mesh-list
83916811|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
83916812|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916813|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
83916814|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916815|NCT00332969|Octreotide|octreotide|mesh-list
83916816|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83916817|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83916818|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916819|NCT00333008|Prednisone|prednisone|mesh-list
83916820|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
83916821|NCT00333008|Rituximab|rituximab|mesh-list
83916822|NCT00333008|Vincristine|vincristine|mesh-list
83916823|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83916824|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
83916825|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916826|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916827|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83916828|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
83916829|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916830|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916831|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83916832|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83916833|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916834|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
83916835|NCT00333008|Hormones|hormones|mesh-ancestor
83916836|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916837|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83916838|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83916839|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
83916840|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
83916841|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
83916842|NCT00435747|Parecoxib|parecoxib|mesh-list
83916843|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83916844|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83916845|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916846|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916847|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83916848|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916849|NCT00435747|Analgesics|analgesics|mesh-ancestor
83916850|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
83916851|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916852|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916853|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916854|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916855|NCT00333047|Letrozole|letrozole|mesh-list
83916856|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916857|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83916858|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83916859|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916860|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916861|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83916862|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
83916863|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916864|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916865|NCT00333086|Letrozole|letrozole|mesh-list
83916866|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916867|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83916868|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83916869|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916870|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916871|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83916872|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
83916873|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916874|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916875|NCT00333125|Timolol|timolol|mesh-list
83916876|NCT00333125|Travoprost|travoprost|mesh-list
83916877|NCT00333125|Dorzolamide|dorzolamide|mesh-list
83916878|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83916879|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83916880|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83916881|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83916882|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916883|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916884|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916885|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916886|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83916887|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83916888|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83916889|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916891|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83916892|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
83916893|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916894|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916895|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83916896|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
83916897|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83916898|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83916899|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916900|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83916901|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
83916902|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83916903|NCT00333164|Protective Agents|protective agents|mesh-ancestor
83916904|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83916905|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83916906|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916907|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
83916908|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83916909|NCT01052493|Hormones|hormones|mesh-ancestor
83916910|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83916911|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916912|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
83916913|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
83916914|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
83916915|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83916916|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83916917|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916918|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916919|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916920|NCT00333281|Tadalafil|tadalafil|mesh-list
83916921|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
83916922|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83916923|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83916924|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916925|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916926|NCT00333281|Urological Agents|urological agents|mesh-ancestor
83916927|NCT00333398|Vaccines|vaccines|mesh-list
83916928|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
83916929|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916930|NCT00333476|Squalamine|squalamine|mesh-list
83916931|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83916932|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83916933|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83916934|NCT00333476|Protective Agents|protective agents|mesh-ancestor
83916935|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916936|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916937|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83916938|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83916939|NCT00333476|Growth Substances|growth substances|mesh-ancestor
83916940|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
83916941|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83916942|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83916943|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
83916944|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916945|NCT00435981|Antacids|antacids|mesh-ancestor
83916946|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916947|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83916948|NCT00432081|Indomethacin|indomethacin|mesh-list
83916949|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83916950|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916951|NCT00432081|Analgesics|analgesics|mesh-ancestor
83916952|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
83916953|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916954|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916955|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83916956|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83916957|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
83916958|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
83916959|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83916960|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83916961|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83916962|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916963|NCT00333632|Fentanyl|fentanyl|mesh-list
83916964|NCT00333632|Midazolam|midazolam|mesh-list
83916965|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
83916966|NCT00333632|Propofol|propofol|mesh-list
83916967|NCT00333632|Isoflurane|isoflurane|mesh-list
83916968|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83916969|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83916970|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83916971|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83916972|NCT00333632|Analgesics|analgesics|mesh-ancestor
83916973|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
83916974|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83916975|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83916976|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83916977|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83916978|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
83916979|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83916980|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83916981|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83916982|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
83916983|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
83916984|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83916985|NCT00333632|Narcotics|narcotics|mesh-ancestor
83916986|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83916987|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83916988|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83916989|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83916990|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
83916991|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
83916992|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83916993|NCT00436059|Bortezomib|bortezomib|mesh-list
83916994|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916995|NCT00420524|Epothilone B|epothilone b|mesh-list
83916996|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83916997|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
83916998|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
83916999|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
83917000|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917001|NCT00432120|Clopidogrel|clopidogrel|mesh-list
83917002|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83917003|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83917004|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83917005|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83917006|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
83917007|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917008|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917009|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917010|NCT00432198|Zolpidem|zolpidem|mesh-list
83917011|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83917012|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83917013|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917014|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917015|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83917016|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
83917017|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
83917018|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917019|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917020|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
83917021|NCT00420563|Megestrol|megestrol|mesh-list
83917022|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917023|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
83917024|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917025|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83917026|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83917027|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
83917028|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917029|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917030|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83917031|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83917032|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83917033|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83917034|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
83917035|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83917036|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83917037|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83917038|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83917039|NCT00432315|Docetaxel|docetaxel|mesh-list
83917040|NCT00432315|Cisplatin|cisplatin|mesh-list
83917041|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917042|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
83917043|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83917044|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83917045|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917046|NCT00333671|Glycerol|glycerol|mesh-list
83917047|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83917048|NCT00333671|Protective Agents|protective agents|mesh-ancestor
83917049|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917050|NCT00432354|Atorvastatin|atorvastatin|mesh-list
83917051|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83917052|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83917053|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
83917054|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917055|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83917056|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83917057|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917058|NCT00333944|Pralidoxime|pralidoxime|mesh-list
83917059|NCT00333944|Antidotes|antidotes|mesh-ancestor
83917060|NCT00333944|Protective Agents|protective agents|mesh-ancestor
83917061|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917062|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
83917063|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
83917064|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917065|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83917066|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917067|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
83917068|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83917069|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83917070|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917071|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83917072|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83917073|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
83917074|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917075|NCT04701528|Tacrolimus|tacrolimus|mesh-list
83917076|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917077|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
83917078|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917079|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83917080|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917081|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917082|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
83917083|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83917084|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917085|NCT03279978|Midazolam|midazolam|mesh-list
83917086|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83917087|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83917088|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917089|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917090|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83917091|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83917092|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83917093|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83917094|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
83917095|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
83917096|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
83917097|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
83917098|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917099|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917100|NCT00438048|Pilocarpine|pilocarpine|mesh-list
83917101|NCT00438048|Miotics|miotics|mesh-ancestor
83917102|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
83917103|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917104|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917105|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83917106|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83917107|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
83917108|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917109|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917111|NCT00334256|Emtricitabine|emtricitabine|mesh-list
83917112|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
83917113|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917114|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83917115|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83917116|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917117|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917118|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83917119|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83917120|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
83917121|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83917122|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83917123|NCT00438087|Prednisolone|prednisolone|mesh-list
83917124|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
83917125|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83917126|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
83917127|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83917128|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
83917129|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
83917130|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917131|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917132|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83917133|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
83917134|NCT00438087|Hormones|hormones|mesh-ancestor
83917135|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917136|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83917137|NCT00438087|Protective Agents|protective agents|mesh-ancestor
83917138|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83917139|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917140|NCT00334412|Caspofungin|caspofungin|mesh-list
83917141|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83917142|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
83917143|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917144|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917145|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917146|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83917147|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83917148|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
83917149|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
83917150|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83917151|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83917152|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917153|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917154|NCT00334490|Urological Agents|urological agents|mesh-ancestor
83917155|NCT00334529|Oseltamivir|oseltamivir|mesh-list
83917156|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
83917157|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917158|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917159|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917160|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
83917161|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83917162|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917163|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83917164|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83917165|NCT00436293|Docetaxel|docetaxel|mesh-list
83917166|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917167|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
83917168|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
83917169|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
83917170|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917171|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
83917172|NCT00334646|Casopitant|casopitant|mesh-list
83917173|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917174|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
83917175|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917176|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156408|NCT02233075|REP 2139|rep 2139|mesh-list
83917177|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83917179|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917180|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917181|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83917182|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
83917183|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
83917184|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917185|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83917186|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83917187|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917188|NCT04701606|Artesunate|artesunate|mesh-list
83917189|NCT04701606|Pyronaridine|pyronaridine|mesh-list
83917190|NCT04701606|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83917191|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
83917192|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83917193|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83917194|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917195|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917196|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
83917197|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
83917198|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83917199|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
83917200|NCT00334685|Pregabalin|pregabalin|mesh-list
83917201|NCT00334685|Reboxetine|reboxetine|mesh-list
83917202|NCT00334685|Analgesics|analgesics|mesh-ancestor
83917203|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
83917204|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917205|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917206|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
83917207|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83917208|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917209|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917210|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83917211|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83917212|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83917213|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917214|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83917215|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
83917216|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83917217|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83917218|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
83917219|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917220|NCT00436371|Amisulpride|amisulpride|mesh-list
83917221|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83917222|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83917223|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917224|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917225|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83917226|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83917227|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
83917228|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917229|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83411843|NCT01891747|Growth Substances|growth substances|mesh-ancestor
83917230|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83917231|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
83917232|NCT00334763|Paclitaxel|paclitaxel|mesh-list
83917233|NCT00334763|Bevacizumab|bevacizumab|mesh-list
83917234|NCT00334763|Carboplatin|carboplatin|mesh-list
83917235|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83917236|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917237|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
83917238|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
83917239|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
83917240|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917241|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83917242|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83917243|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83917244|NCT00334763|Growth Substances|growth substances|mesh-ancestor
83917245|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917246|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
83917247|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
83917248|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83917249|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
83156462|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
83917250|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917251|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917252|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83917253|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83917254|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917255|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83917256|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83917257|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917258|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917259|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
83917260|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917261|NCT00436761|Cyclosporine|cyclosporine|mesh-list
83917262|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
83917263|NCT00436761|Melphalan|melphalan|mesh-list
83917264|NCT00436761|Busulfan|busulfan|mesh-list
83917265|NCT00436761|Cyclosporins|cyclosporins|mesh-list
83917266|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83917267|NCT00436761|Sargramostim|sargramostim|mesh-list
83917268|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917269|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917270|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917271|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
83917272|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917273|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
83917274|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917275|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83917276|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83917277|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83917278|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83917279|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
83917280|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
83917281|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917282|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83917283|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
83917284|NCT00436761|Hormones|hormones|mesh-ancestor
83917285|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917286|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83917287|NCT00436761|Protective Agents|protective agents|mesh-ancestor
83917288|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917289|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83917290|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
83917291|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83917292|NCT00436800|Gemcitabine|gemcitabine|mesh-list
83917293|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
83917294|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83917295|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
83917296|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917297|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917298|NCT00436839|Prednisone|prednisone|mesh-list
83917299|NCT00436839|Docetaxel|docetaxel|mesh-list
83917300|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
83917301|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917302|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
83917303|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
83917304|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
83917305|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917306|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83917307|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
83917308|NCT00436839|Hormones|hormones|mesh-ancestor
83917309|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917310|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917311|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83917312|NCT00436839|Analgesics|analgesics|mesh-ancestor
83917313|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
83917314|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917315|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83917316|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83917317|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917318|NCT00335075|Temozolomide|temozolomide|mesh-list
83917319|NCT00335075|Semustine|semustine|mesh-list
83917320|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83917321|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
83917322|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917323|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917324|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
83156541|NCT02558894|Durvalumab|durvalumab|mesh-list
83917325|NCT00436995|Hematinics|hematinics|mesh-ancestor
83917326|NCT04716179|Hormones|hormones|mesh-list
83917327|NCT04716179|Testosterone|testosterone|mesh-list
83917328|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917329|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917330|NCT04716179|Androgens|androgens|mesh-ancestor
83917331|NCT00437229|Dexamethasone|dexamethasone|mesh-list
83917332|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
83917333|NCT00437229|Ondansetron|ondansetron|mesh-list
83917334|NCT00437229|Casopitant|casopitant|mesh-list
83917335|NCT00437229|BB 1101|bb 1101|mesh-list
83917336|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83917337|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
83917338|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
83917339|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917340|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917341|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83917342|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
83917343|NCT00437229|Hormones|hormones|mesh-ancestor
83917344|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917345|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83917346|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917347|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
83917348|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917349|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917350|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
83917351|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
83917352|NCT00437229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83917353|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83917354|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
83917355|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917356|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83917357|NCT00335192|Tenofovir|tenofovir|mesh-list
83917358|NCT00335192|Lamivudine|lamivudine|mesh-list
83917359|NCT00335192|Abacavir|abacavir|mesh-list
83917360|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
83917361|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917362|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83917363|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83917364|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917365|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917366|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83917367|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83917368|NCT00437307|Topotecan|topotecan|mesh-list
83917369|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83917370|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83917371|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917372|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917373|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917374|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
83917375|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917376|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917377|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83917378|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83917379|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83917380|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83917381|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917382|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917383|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917384|NCT00335270|Ritonavir|ritonavir|mesh-list
83917385|NCT00335270|Amprenavir|amprenavir|mesh-list
83917386|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
83917387|NCT00335270|Lamivudine|lamivudine|mesh-list
83917388|NCT00335270|Abacavir|abacavir|mesh-list
83917389|NCT00335270|Calcium|calcium|mesh-list
83917390|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83917391|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917392|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83917393|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83917394|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
83917395|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917396|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917397|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83917398|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83917399|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
83917400|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917401|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83917402|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83917403|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83917404|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83917405|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83917406|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
83917407|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917408|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
83917409|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
83917410|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83917411|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917412|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917413|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
83917414|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83917415|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917416|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917417|NCT00335309|Amoxicillin|amoxicillin|mesh-list
83917418|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
83917419|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
83917420|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917421|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917422|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83917423|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917424|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917425|NCT00335348|Dexamethasone|dexamethasone|mesh-list
83917426|NCT00335348|Bortezomib|bortezomib|mesh-list
83917427|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83917428|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
83917429|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
83917430|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917431|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917432|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83917433|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
83917434|NCT00335348|Hormones|hormones|mesh-ancestor
83917435|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917436|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83917437|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917438|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83917439|NCT00437463|Ramipril|ramipril|mesh-list
83917440|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83917441|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
83917442|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917443|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917444|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83917445|NCT00437502|Vaccines|vaccines|mesh-list
83917446|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
83917447|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917448|NCT00420797|Phenylephrine|phenylephrine|mesh-list
83917449|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
83917450|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83917451|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
83917452|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
83917453|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917454|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917455|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
83917456|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83917457|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
83917458|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
83917459|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83917460|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83917461|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83917462|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
83917463|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917464|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917465|NCT00420797|Protective Agents|protective agents|mesh-ancestor
83917466|NCT00437619|Calcipotriene|calcipotriene|mesh-list
83917467|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
83917468|NCT00420836|Tobramycin|tobramycin|mesh-list
83917469|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917470|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917471|NCT00437697|Dalteparin|dalteparin|mesh-list
83917472|NCT00437697|Tinzaparin|tinzaparin|mesh-list
83917473|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83917474|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
83917475|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83917476|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83156684|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
83917477|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917478|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
83917479|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83917480|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917481|NCT00335543|Gemcitabine|gemcitabine|mesh-list
83917482|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917483|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83917484|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
83917485|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917486|NCT00437814|Ketamine|ketamine|mesh-list
83917487|NCT00437814|Analgesics|analgesics|mesh-ancestor
83917488|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
83917489|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917490|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917491|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83917492|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83917493|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
83917494|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
83917495|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917496|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83917497|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83917498|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917499|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917500|NCT00335582|Clonidine|clonidine|mesh-list
83917501|NCT00335582|Analgesics|analgesics|mesh-ancestor
83917502|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
83917503|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917504|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917505|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83917506|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
83917507|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
83917508|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83917509|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83917510|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83917511|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
83917512|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917513|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917514|NCT00437853|Anastrozole|anastrozole|mesh-list
83917515|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83917516|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917517|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83917518|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83917519|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917520|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917521|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83917522|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
83917523|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917524|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917525|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
83917526|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83917527|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
83917528|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917529|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917530|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83917531|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
83917532|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
83917533|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83917534|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
83917535|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917536|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917537|NCT00437892|Atorvastatin|atorvastatin|mesh-list
83917538|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83917539|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83917540|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
83917541|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917542|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83917543|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83917544|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917545|NCT00437970|Metformin|metformin|mesh-list
83917546|NCT00437970|Pioglitazone|pioglitazone|mesh-list
83917547|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83917548|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917549|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83917550|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83917551|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83917552|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
83917553|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917554|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83917555|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83917556|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917557|NCT03277170|Montelukast|montelukast|mesh-list
83917558|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83917559|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
83917560|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83917561|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
83917562|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917563|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917564|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83917565|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83917566|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917567|NCT00335933|Gabapentin|gabapentin|mesh-list
83917568|NCT00335933|Analgesics|analgesics|mesh-ancestor
83917569|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
83917570|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917571|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917572|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
83917573|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83917574|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83917575|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917576|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83917577|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83917578|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83917579|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917580|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917581|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
83917582|NCT00336167|Bezafibrate|bezafibrate|mesh-list
83917583|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83917584|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
83917585|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917586|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83917587|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
83917588|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83917589|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917590|NCT00336245|Copper|copper|mesh-list
83917591|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
83917592|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83917593|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917594|NCT00336245|Trace Elements|trace elements|mesh-ancestor
83917595|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
83917596|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
83917597|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917598|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
83917599|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917600|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917601|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83917602|NCT00336401|Propofol|propofol|mesh-list
83917603|NCT00336401|Sevoflurane|sevoflurane|mesh-list
83917604|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83917605|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917606|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917607|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83917608|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
83917609|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
83917610|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83917611|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83917612|NCT00336518|Ribavirin|ribavirin|mesh-list
83917613|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83917614|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
83917615|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917616|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
83917617|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917618|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
83917619|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
83917620|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
83917621|NCT00347490|Enoxaparin|enoxaparin|mesh-list
83917622|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
83917623|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83917624|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83917625|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917626|NCT00336674|Insulin|insulin|mesh-list
83917627|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83917628|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917629|NCT00444522|Alprazolam|alprazolam|mesh-list
83917630|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83917631|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917632|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917633|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83917634|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83917635|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83917636|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
83917637|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
83917638|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917639|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917640|NCT00336791|Paclitaxel|paclitaxel|mesh-list
83917641|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
83917642|NCT00336791|Doxorubicin|doxorubicin|mesh-list
83917643|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83917644|NCT00336791|Fluorouracil|fluorouracil|mesh-list
83917645|NCT00336791|Epirubicin|epirubicin|mesh-list
83917646|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83917647|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917648|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
83917649|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
83917650|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
83917651|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917652|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917653|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
83917654|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917655|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83917656|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83917657|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
83917658|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83917659|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83917660|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83917661|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83917662|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917663|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
83917664|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83917665|NCT00444561|Pramlintide|pramlintide|mesh-list
83917666|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83917667|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917668|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83917669|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
83917670|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83917671|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
83917672|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83917673|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917674|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83917675|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83917676|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917677|NCT00336947|Tegafur|tegafur|mesh-list
83917678|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83917679|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
83917680|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917681|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917682|NCT00444717|Pitavastatin|pitavastatin|mesh-list
83917683|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83917684|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83917685|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83917686|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
83917687|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917688|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917689|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83917690|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
83917691|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83917692|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83917693|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917694|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
83917695|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917696|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83917697|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124677|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83156917|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917698|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917699|NCT00337259|Gemcitabine|gemcitabine|mesh-list
83917700|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83917701|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
83917702|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917703|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917704|NCT04699734|Lidocaine|lidocaine|mesh-list
83917705|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
83917706|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
83917707|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917708|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917709|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
83917710|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917711|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83917712|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83917713|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83917714|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917715|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917716|NCT00337298|Amlodipine|amlodipine|mesh-list
83917717|NCT00337298|Lisinopril|lisinopril|mesh-list
83917718|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83917719|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83917720|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917721|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917722|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83917723|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917724|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
83917725|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83917726|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
83917727|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917728|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83917729|NCT00337298|Protective Agents|protective agents|mesh-ancestor
83917730|NCT00337376|Sirolimus|sirolimus|mesh-list
83917731|NCT00337376|Paclitaxel|paclitaxel|mesh-list
83917732|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83917733|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83917734|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917735|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
83917736|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
83917737|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
83917738|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917739|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917740|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917741|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83917742|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
83917743|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917744|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
83917745|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917746|NCT00337493|Cyclosporine|cyclosporine|mesh-list
83917747|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
83917748|NCT00337493|Tacrolimus|tacrolimus|mesh-list
83917749|NCT00337493|Cyclosporins|cyclosporins|mesh-list
83917750|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83917751|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
83917752|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917753|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83917754|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917755|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917756|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
83917757|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917758|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
83917759|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83917760|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83917761|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917762|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83917763|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
83917764|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917765|NCT00444756|Lidocaine|lidocaine|mesh-list
83917766|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
83917767|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
83917768|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917769|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917770|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
83917771|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917772|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83917773|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83917774|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83917775|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917776|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917777|NCT00444834|Carvedilol|carvedilol|mesh-list
83917778|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83917779|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83917780|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
83917781|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917782|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917783|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917784|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83917785|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
83917786|NCT00444834|Protective Agents|protective agents|mesh-ancestor
83917787|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83917788|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917789|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83917790|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
83917791|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83917792|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83917793|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83917794|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
83917795|NCT00337766|Coagulants|coagulants|mesh-ancestor
83917796|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83917797|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
83917798|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917799|NCT00444873|Lanreotide|lanreotide|mesh-list
83917800|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917801|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83917802|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
83917803|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
83917804|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83917805|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917806|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83917807|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917808|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917809|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83917810|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83917811|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83917812|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917813|NCT00451113|Incretins|incretins|mesh-ancestor
83917814|NCT00451113|Hormones|hormones|mesh-ancestor
83917815|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917816|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
83917817|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917818|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917819|NCT00337922|Lamivudine|lamivudine|mesh-list
83917820|NCT00337922|Abacavir|abacavir|mesh-list
83917821|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83917822|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83411919|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
83917823|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917824|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917825|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
83917826|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917827|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83917828|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83917829|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
83917830|NCT00451230|Cocaine|cocaine|mesh-list
83917831|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83917832|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
83917833|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
83917834|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917835|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917836|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
83917837|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917838|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83917839|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83917840|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83917841|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917842|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917843|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
83157067|NCT02262481|Hormones|hormones|mesh-ancestor
83917844|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917845|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
83917846|NCT00338000|Hematinics|hematinics|mesh-ancestor
83917847|NCT00338117|Galantamine|galantamine|mesh-list
83917848|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83917849|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917850|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917851|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
83917852|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917853|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917854|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83917855|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
83917856|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917857|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
83917858|NCT00338195|Caffeine|caffeine|mesh-list
83917859|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83917860|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917861|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83917862|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917863|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917864|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83917865|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83917866|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
83917867|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917868|NCT00338273|Aripiprazole|aripiprazole|mesh-list
83917869|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
83917870|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83917871|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83917872|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83917873|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917874|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917875|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
83917876|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
83917877|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917878|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917879|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83917880|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83917881|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
83917882|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83917883|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83917884|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83917885|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83917886|NCT00338312|Testosterone|testosterone|mesh-list
83917887|NCT00338312|Androgens|androgens|mesh-ancestor
83917888|NCT00338312|Hormones|hormones|mesh-ancestor
83917889|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83917890|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917891|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
83917892|NCT00451386|Ertapenem|ertapenem|mesh-list
83917893|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917894|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917895|NCT00338390|Lamivudine|lamivudine|mesh-list
83917896|NCT00338390|Abacavir|abacavir|mesh-list
83917897|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
83917898|NCT00338390|Didanosine|didanosine|mesh-list
83917899|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83917900|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83917901|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917902|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917903|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
83917904|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917905|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83917906|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83917907|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
83917908|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
83917909|NCT00338468|Hematinics|hematinics|mesh-ancestor
83917910|NCT00338507|Erdosteine|erdosteine|mesh-list
83917911|NCT00338507|Expectorants|expectorants|mesh-ancestor
83917912|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
83917913|NCT00445185|Vaccines|vaccines|mesh-list
83917914|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
83917915|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917916|NCT00338546|Cocaine|cocaine|mesh-list
83917917|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
83917918|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83917919|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917920|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917921|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83917922|NCT00338546|Analgesics|analgesics|mesh-ancestor
83917923|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
83917924|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917925|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83917926|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83917927|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83917928|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83917929|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917930|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917931|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
83917932|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
83917933|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83917934|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83917935|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83917936|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917937|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
83917938|NCT00338624|Oxybutynin|oxybutynin|mesh-list
83917939|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
83917940|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
83917941|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83917942|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917943|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83917944|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83917945|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
83917946|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83917947|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917948|NCT00338624|Urological Agents|urological agents|mesh-ancestor
83917949|NCT00338780|Lamivudine|lamivudine|mesh-list
83917950|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83917951|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83917952|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917953|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917954|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
83917955|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917956|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83917957|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83917958|NCT00451620|Glyburide|glyburide|mesh-list
83917959|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83917960|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917961|NCT00445497|Amoxicillin|amoxicillin|mesh-list
83917962|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
83917963|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
83917964|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
83917965|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83917966|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83917967|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83917968|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83917969|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83917970|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83917971|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917972|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83917973|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83917974|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83917975|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83917976|NCT00451776|Propofol|propofol|mesh-list
83917977|NCT00451776|Etomidate|etomidate|mesh-list
83917978|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83917979|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83917980|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917981|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83917982|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
83917983|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
83917984|NCT00338936|Valsartan|valsartan|mesh-list
83917985|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83917986|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83917987|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83917988|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83917989|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83917990|NCT00338936|Diuretics|diuretics|mesh-ancestor
83917991|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
83917992|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83917993|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83157209|NCT02264665|Sunitinib|sunitinib|mesh-list
83917994|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917995|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
83917996|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
83917997|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83917998|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83917999|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918000|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918001|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918002|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83918003|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
83918004|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83918005|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83918006|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83918007|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
83918008|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918009|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918010|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918012|NCT00339014|Bupropion|bupropion|mesh-list
83918013|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83918014|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
83918015|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83918016|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83918017|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83918018|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918019|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918020|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
83918021|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918022|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918023|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83918024|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83918025|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918026|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
83918027|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83918028|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918029|NCT00420953|Amiodarone|amiodarone|mesh-list
83918030|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83918031|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
83918032|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83918033|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918034|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918035|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83918036|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83918037|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83918038|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918039|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83918040|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83918041|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83918042|NCT00425204|Panitumumab|panitumumab|mesh-list
83918043|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83918044|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918045|NCT00425243|Zolpidem|zolpidem|mesh-list
83918046|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83918047|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83918048|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918049|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918050|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83918051|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
83918052|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
83918053|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918054|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918055|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83918056|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918057|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918058|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918059|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83918060|NCT00451971|Leflunomide|leflunomide|mesh-list
83918061|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918062|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918063|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918064|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
83918065|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918066|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
83918067|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83918068|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918069|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
83918070|NCT00446004|Omeprazole|omeprazole|mesh-list
83918071|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83918072|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918073|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83918074|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918075|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918076|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83918077|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83918078|NCT00446043|Adapalene|adapalene|mesh-list
83918079|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83918080|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83918081|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83918082|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83918083|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83918084|NCT00446043|Analgesics|analgesics|mesh-ancestor
83918085|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
83918086|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918087|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918088|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83918089|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918090|NCT00446082|Pasireotide|pasireotide|mesh-list
83918091|NCT00446082|Hormones|hormones|mesh-ancestor
83918092|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918093|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918094|NCT03275376|Atorvastatin|atorvastatin|mesh-list
83918095|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83918096|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918097|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
83918098|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918099|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918100|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83918101|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918102|NCT00340184|Paclitaxel|paclitaxel|mesh-list
83918103|NCT00340184|Carboplatin|carboplatin|mesh-list
83918104|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83918105|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918106|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918107|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918108|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918109|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918110|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
83918111|NCT00446316|Antacids|antacids|mesh-list
83918112|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918113|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83918114|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918115|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918116|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83918117|NCT00446433|Lenalidomide|lenalidomide|mesh-list
83918118|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
83918119|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918120|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83918121|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83918122|NCT00446433|Growth Substances|growth substances|mesh-ancestor
83918123|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
83918124|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918125|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83918126|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83918127|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
83918128|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918129|NCT00340574|Antacids|antacids|mesh-ancestor
83918130|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918131|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83918132|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
83918133|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83918134|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918135|NCT00340691|Doxycycline|doxycycline|mesh-list
83918136|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83918137|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918138|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
83918139|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83918140|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83918142|NCT00452244|Simvastatin|simvastatin|mesh-list
83918143|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83918144|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918145|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
83918146|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918147|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918148|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83918149|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918150|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918151|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83918152|NCT00446472|Becaplermin|becaplermin|mesh-list
83918153|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
83918154|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83918155|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83918156|NCT00446472|Growth Substances|growth substances|mesh-ancestor
83918157|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918158|NCT00446589|Teriparatide|teriparatide|mesh-list
83918159|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
83918160|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918161|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918162|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83918163|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
83918164|NCT00452322|Testosterone|testosterone|mesh-list
83918165|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
83918166|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
83918167|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83918168|NCT00452322|Androgens|androgens|mesh-ancestor
83918169|NCT00452322|Hormones|hormones|mesh-ancestor
83918170|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918171|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918172|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83918173|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918174|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
83918175|NCT00452556|Docetaxel|docetaxel|mesh-list
83918176|NCT00452556|Leuprolide|leuprolide|mesh-list
83918177|NCT00452556|Androgens|androgens|mesh-list
83918178|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918179|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918180|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918181|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918182|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918183|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83918184|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
83918185|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83918186|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918187|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83918188|NCT00452556|Hormones|hormones|mesh-ancestor
83918189|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918190|NCT00446667|Mannitol|mannitol|mesh-list
83918191|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83918192|NCT00446667|Diuretics|diuretics|mesh-ancestor
83918193|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
83918194|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918195|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
83918196|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
83918197|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918198|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83918199|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83918200|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83918201|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918202|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918203|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918204|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918205|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
83918206|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83918207|NCT00341432|Nicotine|nicotine|mesh-list
83918208|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83918209|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
83918210|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918211|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918212|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83918213|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83918214|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
83918215|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918216|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918217|NCT00452634|Irinotecan|irinotecan|mesh-list
83918218|NCT00452634|Simvastatin|simvastatin|mesh-list
83918219|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918220|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83918221|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83918222|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918223|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918224|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83918225|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918226|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
83918227|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918228|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83918229|NCT03277599|Tramadol|tramadol|mesh-list
83918230|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83918231|NCT03277599|Narcotics|narcotics|mesh-ancestor
83918232|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918233|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918234|NCT03277599|Analgesics|analgesics|mesh-ancestor
83918235|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
83918236|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918237|NCT00452829|Folic Acid|folic acid|mesh-list
83918238|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
83918239|NCT00452829|Inositol|inositol|mesh-list
83918240|NCT00452829|Hematinics|hematinics|mesh-ancestor
83918241|NCT00452829|Vitamins|vitamins|mesh-ancestor
83918242|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
83918243|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918244|NCT00452907|Artesunate|artesunate|mesh-list
83918245|NCT00452907|Lumefantrine|lumefantrine|mesh-list
83918246|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
83918247|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
83918248|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83918249|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
83918250|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83918251|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83918252|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918253|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918254|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
83918255|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
83918256|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83918257|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
83918258|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83918259|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918260|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918261|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83918262|NCT00446784|Methotrexate|methotrexate|mesh-list
83918263|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83918264|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
83918265|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83918266|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918267|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83918268|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
83918269|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918270|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918271|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83918272|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918273|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83918274|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918275|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
83918276|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918277|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83918278|NCT00452985|Carboplatin|carboplatin|mesh-list
83918279|NCT00452985|Docetaxel|docetaxel|mesh-list
83918280|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918281|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918282|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918283|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918284|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918285|NCT03277209|Plerixafor|plerixafor|mesh-list
83918286|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83918287|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83918288|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
83918289|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918290|NCT00453141|Betamethasone|betamethasone|mesh-list
83918291|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83918292|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
83918293|NCT00453141|Hormones|hormones|mesh-ancestor
83918294|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918295|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918296|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83918297|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
83918298|NCT00421109|Levocetirizine|levocetirizine|mesh-list
83918299|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83918300|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83918301|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
83918302|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
83918303|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918304|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918305|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918306|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
83918307|NCT02273583|Methotrexate|methotrexate|mesh-list
83918308|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918309|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
83918310|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918311|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918312|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83918313|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
83918314|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918315|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918316|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83918317|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83918318|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
83918319|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83918320|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83918321|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
83918322|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83918323|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918324|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83918325|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83918326|NCT00446862|Losartan|losartan|mesh-list
83918327|NCT00446862|Enalapril|enalapril|mesh-list
83918328|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83918329|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83918330|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83918331|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83918332|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83918333|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83918334|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918335|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
83918336|NCT00446901|Selenium|selenium|mesh-list
83918337|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
83918338|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918339|NCT00446901|Protective Agents|protective agents|mesh-ancestor
83918340|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918341|NCT00446901|Trace Elements|trace elements|mesh-ancestor
83918342|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
83918343|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
83918344|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
83918345|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918346|NCT00453375|Protective Agents|protective agents|mesh-ancestor
83918347|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918348|NCT00446940|Atorvastatin|atorvastatin|mesh-list
83918349|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83918350|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83918351|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918352|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
83918353|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918354|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918355|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83918356|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918357|NCT00453414|Iloprost|iloprost|mesh-list
83918358|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83918359|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
83918360|NCT00446979|UC-781|uc-781|mesh-list
83918361|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83918362|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
83918363|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918364|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83918365|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
83918366|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918367|NCT00447018|Mannitol|mannitol|mesh-list
83918368|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83918369|NCT00447018|Diuretics|diuretics|mesh-ancestor
83918370|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
83918371|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918372|NCT00343070|Escitalopram|escitalopram|mesh-list
83918373|NCT00343070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83918374|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83918375|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918376|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918377|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918378|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
83918379|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918380|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
83918381|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83918382|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918383|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918384|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918385|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918386|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83918387|NCT00343187|Dapsone|dapsone|mesh-list
83918388|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918389|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
83918390|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83918391|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83918392|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83918393|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918394|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918395|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
83918396|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83918397|NCT00343226|Basiliximab|basiliximab|mesh-list
83918398|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918399|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
83918400|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918401|NCT00343265|Progesterone|progesterone|mesh-list
83918402|NCT00343265|Progestins|progestins|mesh-ancestor
83918403|NCT00343265|Hormones|hormones|mesh-ancestor
83918404|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918405|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918406|NCT00453609|Naltrexone|naltrexone|mesh-list
83918407|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83918408|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83918409|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918410|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
83918411|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918412|NCT00447213|Insulin|insulin|mesh-list
83918413|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83918414|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
83918415|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83918416|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918417|NCT00453648|Vitamin A|vitamin a|mesh-list
83918418|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
83918419|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
83918420|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918421|NCT00453648|Protective Agents|protective agents|mesh-ancestor
83918422|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918423|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83918424|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918425|NCT00453648|Vitamins|vitamins|mesh-ancestor
83918426|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
83918427|NCT00343421|Vaccines|vaccines|mesh-list
83918428|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83918429|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
83918430|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918431|NCT00343499|Valsartan|valsartan|mesh-list
83918432|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83918433|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83918434|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83918435|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918436|NCT04715360|Favipiravir|favipiravir|mesh-list
83918437|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
83918438|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918439|NCT00447369|Pregabalin|pregabalin|mesh-list
83157661|NCT02628704|Hormones|hormones|mesh-ancestor
83918440|NCT00447369|Valproic Acid|valproic acid|mesh-list
83918441|NCT00447369|Analgesics|analgesics|mesh-ancestor
83918442|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
83918443|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918444|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918445|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
83918446|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83918447|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918448|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918449|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918450|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83918451|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83918452|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918453|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83918454|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918455|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
83918456|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918457|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
83918458|NCT00343655|Atorvastatin|atorvastatin|mesh-list
83918459|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83918460|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918461|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
83918462|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918463|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918464|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83918465|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918466|NCT00453765|Montelukast|montelukast|mesh-list
83918467|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83918468|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83918469|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83918470|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
83918471|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918472|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918473|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83918474|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83918475|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918476|NCT00343733|Fentanyl|fentanyl|mesh-list
83918477|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83918478|NCT00343733|Narcotics|narcotics|mesh-ancestor
83918479|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918480|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918481|NCT00343733|Analgesics|analgesics|mesh-ancestor
83918482|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
83918483|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918484|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83918485|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83918486|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
83918487|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
83918488|NCT00343811|Modafinil|modafinil|mesh-list
83918489|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83918490|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918491|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83918492|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83918493|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83918494|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918495|NCT00453804|Naltrexone|naltrexone|mesh-list
83918496|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83918497|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83918498|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918499|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
83918500|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918501|NCT00343850|Mesalamine|mesalamine|mesh-list
83918502|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83918503|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83918504|NCT00343850|Analgesics|analgesics|mesh-ancestor
83918505|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
83918506|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918507|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918508|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83918509|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918510|NCT00344006|Artesunate|artesunate|mesh-list
83918511|NCT00344006|Lumefantrine|lumefantrine|mesh-list
83918512|NCT00344006|Artemether|artemether|mesh-list
83918513|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83918514|NCT00344006|Dapsone|dapsone|mesh-list
83918515|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
83918516|NCT00344006|Proguanil|proguanil|mesh-list
83918517|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
83918518|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83918519|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83918520|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918521|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918522|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
83918523|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
83918524|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83918525|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
83918526|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83918527|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918528|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918529|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
83918530|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83918531|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
83918532|NCT02273661|Amphotericin B|amphotericin b|mesh-list
83918533|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83918534|NCT02273661|Amebicides|amebicides|mesh-ancestor
83918535|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83918536|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83918537|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918538|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83918539|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
83918540|NCT00344123|Ritonavir|ritonavir|mesh-list
83918541|NCT00344123|Tipranavir|tipranavir|mesh-list
83918542|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83918543|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83918544|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83918545|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
83918546|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918547|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918548|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83918549|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83918550|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
83918551|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918552|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83918553|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83918554|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83918555|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918556|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
83918557|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918558|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83918559|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83918560|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
83918561|NCT00344201|Coagulants|coagulants|mesh-ancestor
83918562|NCT00453960|Norethindrone|norethindrone|mesh-list
83918563|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
83918564|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83918565|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83918566|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83918567|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
83918568|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83918569|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918570|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83918571|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83918572|NCT00447681|Fezakinumab|fezakinumab|mesh-list
83918573|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
83918574|NCT00447759|Ibuprofen|ibuprofen|mesh-list
83918575|NCT00447759|Celecoxib|celecoxib|mesh-list
83918576|NCT00447759|Diclofenac|diclofenac|mesh-list
83918577|NCT00447759|Naproxen|naproxen|mesh-list
83918578|NCT00447759|Meloxicam|meloxicam|mesh-list
83918579|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83918580|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83918581|NCT00447759|Analgesics|analgesics|mesh-ancestor
83918582|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
83918583|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918584|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918585|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83918586|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918587|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83918588|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918589|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918590|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83918591|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
83918592|NCT00344513|Carvedilol|carvedilol|mesh-list
83918593|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83918594|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83918595|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83918596|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
83918597|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918598|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918599|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918600|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83918601|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
83918602|NCT00344513|Protective Agents|protective agents|mesh-ancestor
83918603|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83918604|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918605|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918606|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
83918607|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83918608|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83918609|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
83918610|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918611|NCT00344552|Paclitaxel|paclitaxel|mesh-list
83918612|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83918613|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918614|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918615|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918616|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918617|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918618|NCT00447915|Vitamin D|vitamin d|mesh-list
83918619|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
83918620|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
83918621|NCT00447915|Calcium|calcium|mesh-list
83918622|NCT00447915|Vitamins|vitamins|mesh-ancestor
83918623|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
83918624|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918625|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918626|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83918627|NCT00344669|Albendazole|albendazole|mesh-list
83918628|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
83918629|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83918630|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918631|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
83918632|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83918633|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83918634|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918635|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918636|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918637|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918638|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918639|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
83918640|NCT04715165|Bupivacaine|bupivacaine|mesh-list
83918641|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
83918642|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
83918643|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918644|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918645|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
83918646|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918647|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83918648|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83918649|NCT04715165|Analgesics|analgesics|mesh-ancestor
83918650|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83918651|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83918652|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83918653|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
83918654|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918655|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918656|NCT00454233|Metformin|metformin|mesh-list
83918657|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83918658|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918659|NCT00454272|Vancomycin|vancomycin|mesh-list
83918660|NCT00454272|Teicoplanin|teicoplanin|mesh-list
83918661|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83918662|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918663|NCT00344825|Fludarabine|fludarabine|mesh-list
83918664|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
83918665|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
83918666|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918667|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83918668|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
83918669|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918670|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918671|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
83918672|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918673|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83918674|NCT00448110|Diclofenac|diclofenac|mesh-list
83918675|NCT00448110|Ketorolac|ketorolac|mesh-list
83918676|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83918677|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83918678|NCT00448110|Analgesics|analgesics|mesh-ancestor
83918679|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
83918680|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83918681|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918682|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83918683|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918684|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83918685|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918686|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918687|NCT00448149|Everolimus|everolimus|mesh-list
83918688|NCT00448149|Sorafenib|sorafenib|mesh-list
83918689|NCT00448149|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83918690|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83918691|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918692|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918693|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918694|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
83918695|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918696|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918697|NCT00344942|Triamcinolone|triamcinolone|mesh-list
83918698|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83918699|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83918700|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83918701|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83918702|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
83918703|NCT00344942|Hormones|hormones|mesh-ancestor
83918704|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918705|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918706|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918707|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
83918708|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918709|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918710|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83918711|NCT00454350|Vitamins|vitamins|mesh-ancestor
83918712|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
83918713|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918714|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83918715|NCT00454389|Ranibizumab|ranibizumab|mesh-list
83918716|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83918717|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83918718|NCT00454389|Growth Substances|growth substances|mesh-ancestor
83918719|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918720|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
83918721|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918722|NCT00344981|Tenofovir|tenofovir|mesh-list
83918723|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
83918724|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
83918725|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918726|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83918727|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83918728|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918729|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918730|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83918731|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83918732|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918733|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
83918734|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
83918735|NCT00448266|Thiotepa|thiotepa|mesh-list
83918736|NCT00448266|Carboplatin|carboplatin|mesh-list
83918737|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918738|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
83918739|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918740|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918741|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83918742|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
84124678|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83918743|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918744|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918745|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83918747|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83918748|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918749|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
83918750|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918751|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918752|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83918753|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918754|NCT00345059|Gemcitabine|gemcitabine|mesh-list
83918755|NCT00345059|Capecitabine|capecitabine|mesh-list
83918756|NCT00345059|Docetaxel|docetaxel|mesh-list
83918757|NCT00345059|Vinorelbine|vinorelbine|mesh-list
83918758|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83918759|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
83918760|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918761|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918762|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918763|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918764|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918765|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83918766|NCT00345098|Amibegron|amibegron|mesh-list
83918767|NCT00345098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83918768|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83918769|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83918770|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83918771|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918772|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918773|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918774|NCT00345098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83918775|NCT00448305|Paclitaxel|paclitaxel|mesh-list
83918776|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83918777|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83918778|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918779|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918780|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918781|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918782|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918783|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83918784|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918785|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918786|NCT00448383|Adalimumab|adalimumab|mesh-list
83918787|NCT00448383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83918788|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83918789|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918790|NCT00448461|Heparin|heparin|mesh-list
83918791|NCT00448461|Bivalirudin|bivalirudin|mesh-list
83918792|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
83918793|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83918794|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83918795|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918796|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
83918797|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83918798|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
83918799|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918800|NCT00454662|Amlodipine|amlodipine|mesh-list
83918801|NCT00454662|Olmesartan|olmesartan|mesh-list
83918802|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83918803|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83918804|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83918805|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83918806|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918807|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918808|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918809|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
83918810|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83918811|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83918812|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
83918813|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
83918814|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83918815|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158030|NCT02538614|BI 836826|bi 836826|mesh-list
83918816|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918817|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83918818|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918819|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83918820|NCT00454701|Alefacept|alefacept|mesh-list
83918821|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83918822|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
83918823|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918824|NCT00345761|Bevacizumab|bevacizumab|mesh-list
83918825|NCT00345761|Capecitabine|capecitabine|mesh-list
83918826|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
83918827|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83918828|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918829|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83918830|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83918831|NCT00345761|Growth Substances|growth substances|mesh-ancestor
83918832|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918833|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
83918834|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83918835|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
83918836|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918837|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
83918838|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83918839|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83918840|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
83918841|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
83918842|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918843|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918844|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
83918845|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83918846|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83918847|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
83918848|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918849|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918850|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918851|NCT00454740|Urological Agents|urological agents|mesh-ancestor
83918852|NCT03276858|Midazolam|midazolam|mesh-list
83918853|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83918854|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83918855|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83918856|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918857|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918858|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83918859|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83918860|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83918861|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83918862|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
83918863|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
83918864|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
83918865|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
83918866|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918867|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918868|NCT00421187|Amphotericin B|amphotericin b|mesh-list
83918869|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83918870|NCT00421187|Amebicides|amebicides|mesh-ancestor
83918871|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83918872|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83918873|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918874|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83918875|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
83918876|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
83918877|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83918878|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83918879|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
83918880|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83918881|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918882|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918883|NCT00454896|Urological Agents|urological agents|mesh-ancestor
83918884|NCT00346190|Alendronate|alendronate|mesh-list
83918885|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83918886|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918887|NCT00346229|Doxorubicin|doxorubicin|mesh-list
83918888|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83918889|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83918890|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918891|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83918892|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83918893|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918894|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918895|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
83918896|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83918897|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918898|NCT00346385|Immunotoxins|immunotoxins|mesh-ancestor
83918899|NCT00346385|Immunoconjugates|immunoconjugates|mesh-ancestor
83918900|NCT00346385|Immunologic Factors|immunologic factors|mesh-ancestor
83918901|NCT00346385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918902|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83918903|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83918904|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
83918905|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83918906|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83918907|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83918908|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83918909|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918910|NCT00346463|Allopurinol|allopurinol|mesh-list
83918911|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
83918912|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918913|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918914|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
83918915|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83918916|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83918917|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
83918918|NCT00346463|Protective Agents|protective agents|mesh-ancestor
83918919|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918921|NCT00455091|Adefovir|adefovir|mesh-list
83918922|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83918923|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83918924|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83918925|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918926|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918927|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
83918928|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918929|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83918930|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83918931|NCT00346580|Nelfinavir|nelfinavir|mesh-list
83918932|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83918933|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83918934|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
83918935|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918936|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918937|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83918938|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83918939|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
83918940|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918941|NCT00346619|Nelfinavir|nelfinavir|mesh-list
83918942|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83918943|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83918944|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
83918945|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918946|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918947|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83918948|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83918949|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
83918950|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83918951|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
83918952|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83918953|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
83918954|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83918955|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
83918956|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918957|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918958|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
83918959|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83918960|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
83918961|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83918962|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
83918963|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918964|NCT04698213|Avelumab|avelumab|mesh-list
83918965|NCT04698213|Axitinib|axitinib|mesh-list
83918966|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83918967|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918968|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83918969|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918970|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918971|NCT02273817|Ciclesonide|ciclesonide|mesh-list
83918972|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
83918974|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83918975|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918976|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83918977|NCT00346853|Fomepizole|fomepizole|mesh-list
83918978|NCT00346853|Antidotes|antidotes|mesh-ancestor
83918979|NCT00346853|Protective Agents|protective agents|mesh-ancestor
83918980|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918981|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83918982|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918983|NCT00448734|Docetaxel|docetaxel|mesh-list
83918984|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83918985|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83918986|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83918987|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83918988|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918989|NCT00346970|Niacin|niacin|mesh-list
83918990|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83918991|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
83918992|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83918993|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83918994|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
83918995|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
83918996|NCT00346970|Vitamins|vitamins|mesh-ancestor
83918997|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
83918998|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83918999|NCT00455130|Mannitol|mannitol|mesh-list
83919000|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83919001|NCT00455130|Diuretics|diuretics|mesh-ancestor
83919002|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
83919003|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919004|NCT00347048|Tacrolimus|tacrolimus|mesh-list
83919005|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919006|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
83919007|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919008|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83919009|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919010|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919011|NCT00347087|Irbesartan|irbesartan|mesh-list
83919012|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83919013|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83919014|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83919015|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919016|NCT00347165|Bevacizumab|bevacizumab|mesh-list
83919017|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83919018|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919019|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919020|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919021|NCT00347165|Growth Substances|growth substances|mesh-ancestor
83919022|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919023|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919024|NCT00347204|Ketorolac|ketorolac|mesh-list
83919025|NCT00347204|Nepafenac|nepafenac|mesh-list
83919026|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83919027|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83919028|NCT00347204|Analgesics|analgesics|mesh-ancestor
83919029|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
83919030|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919031|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919032|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919033|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919034|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83919035|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919036|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919037|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
83919038|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83919039|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83919040|NCT00455286|Prednisolone|prednisolone|mesh-list
83919041|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
83919043|NCT00455286|Temozolomide|temozolomide|mesh-list
83919044|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83919045|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
83919046|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83919047|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
83919048|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83919049|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919050|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83919051|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
83919052|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919053|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919054|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
83919055|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919056|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83919057|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919058|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
83919059|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919060|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83919061|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83919062|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
83919063|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919064|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
83919065|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
83919066|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919067|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83919068|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
83919069|NCT00455286|Hormones|hormones|mesh-ancestor
83919070|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919071|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83919072|NCT00455286|Protective Agents|protective agents|mesh-ancestor
83919073|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919074|NCT00455364|Voriconazole|voriconazole|mesh-list
83919075|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
83919076|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919077|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83919078|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83919079|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919080|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919081|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83919082|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83919083|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919084|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919085|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83919086|NCT00347399|Bevacizumab|bevacizumab|mesh-list
83919087|NCT00347399|Verteporfin|verteporfin|mesh-list
83919088|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83919089|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919090|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919091|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919092|NCT00347399|Growth Substances|growth substances|mesh-ancestor
83919093|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919094|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919095|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83919096|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
83919097|NCT00455442|Mifepristone|mifepristone|mesh-list
83919098|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83919099|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
83919100|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83919101|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919102|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83919103|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83919104|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83919105|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
83919106|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83919107|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83919108|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
83919109|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919110|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
83919111|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83919112|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83919113|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
83919114|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83919115|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
83919116|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919117|NCT00347555|Antacids|antacids|mesh-ancestor
83919118|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919119|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83919120|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
83919121|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83919122|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83919123|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83919124|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83919125|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919126|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
83919127|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919128|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919129|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83919130|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919131|NCT00347750|Lopinavir|lopinavir|mesh-list
83919132|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83919133|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83919134|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
83919135|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919136|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919137|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83919138|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83919139|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
83919140|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919141|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83919142|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83919143|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
83919144|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
83919145|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83919146|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83919147|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919148|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919149|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83919150|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83919151|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919152|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919153|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919154|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
83919155|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919156|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83919157|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83919158|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919159|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919160|NCT00347867|Urological Agents|urological agents|mesh-ancestor
83919161|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
83919162|NCT00449202|Estrone|estrone|mesh-list
83919163|NCT00449202|Estrogens|estrogens|mesh-ancestor
83919164|NCT00449202|Hormones|hormones|mesh-ancestor
83919165|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919166|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919167|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83919168|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
83919169|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919170|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83919171|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83919172|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919173|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919174|NCT00455715|Urological Agents|urological agents|mesh-ancestor
83919175|NCT00455754|Esomeprazole|esomeprazole|mesh-list
83919176|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83919177|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83919178|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83919179|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919180|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919181|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83919182|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
83919183|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83919184|NCT00348023|Timolol|timolol|mesh-list
83919185|NCT00348023|Bimatoprost|bimatoprost|mesh-list
83919186|NCT00348023|Travoprost|travoprost|mesh-list
83919187|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83158437|NCT03542825|Iron|iron|mesh-list
83919188|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83919190|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919191|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919192|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919193|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83919194|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83919195|NCT00348062|Bimatoprost|bimatoprost|mesh-list
83919196|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83919197|NCT00348101|Enoximone|enoximone|mesh-list
83919198|NCT00348101|Esmolol|esmolol|mesh-list
83919199|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83919200|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83919201|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83919202|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
83919203|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919204|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919205|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919206|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83919207|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919208|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83919209|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83919210|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919211|NCT00348101|Protective Agents|protective agents|mesh-ancestor
83919212|NCT00455832|Ribavirin|ribavirin|mesh-list
83919213|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
83919214|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919215|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
83919216|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919217|NCT00455871|Ranibizumab|ranibizumab|mesh-list
83919218|NCT00455871|Verteporfin|verteporfin|mesh-list
83919219|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919220|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919221|NCT00455871|Growth Substances|growth substances|mesh-ancestor
83919222|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919223|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919224|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919225|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83919226|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
83919227|NCT00449280|Sirolimus|sirolimus|mesh-list
83919228|NCT00449280|Sorafenib|sorafenib|mesh-list
83919229|NCT00449280|Temsirolimus|temsirolimus|mesh-list
83919230|NCT00449280|MTOR Inhibitors|mtor inhibitors|mesh-list
83919231|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919232|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919233|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919234|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919235|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919236|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919237|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83919238|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
83919239|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919240|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
83919241|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919242|NCT00455910|Thalidomide|thalidomide|mesh-list
83919243|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919244|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
83919245|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919246|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
83919247|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919248|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919249|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919250|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919251|NCT00455910|Growth Substances|growth substances|mesh-ancestor
83919252|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919253|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919254|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
83919255|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83919256|NCT00348296|Antibodies|antibodies|mesh-list
83919257|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
83919258|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83919259|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
83919260|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919261|NCT00449319|Daunorubicin|daunorubicin|mesh-list
83919262|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83919263|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919264|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83919265|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83919266|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919267|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919268|NCT00348335|Cyclosporine|cyclosporine|mesh-list
83919269|NCT00348335|Cyclosporins|cyclosporins|mesh-list
83919270|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919271|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919272|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919273|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
83919274|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919275|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
83919276|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919277|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
83919278|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919279|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83919280|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
83919281|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83919282|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83919283|NCT00348413|Prednisolone|prednisolone|mesh-list
83919284|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
83919285|NCT00348413|Methotrexate|methotrexate|mesh-list
83919286|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83919287|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
83919288|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83919289|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
83919290|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83919291|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919292|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83919293|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
83919294|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919295|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919296|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
83919297|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919298|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83919299|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919300|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
83919301|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919302|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83919303|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919304|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
83919305|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
83919306|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919307|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83919308|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
83919309|NCT00348413|Hormones|hormones|mesh-ancestor
83919310|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919311|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83919312|NCT00348413|Protective Agents|protective agents|mesh-ancestor
83919313|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919314|NCT00348452|Celecoxib|celecoxib|mesh-list
83919315|NCT00348452|Tramadol|tramadol|mesh-list
83919316|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83919317|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83919318|NCT00348452|Analgesics|analgesics|mesh-ancestor
83919319|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
83919320|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919321|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919322|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919323|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919324|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83919325|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83919326|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919327|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919328|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83919329|NCT00348452|Narcotics|narcotics|mesh-ancestor
83919330|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919331|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83919332|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
83919333|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83919334|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83919335|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83919336|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919337|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919338|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
83919339|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83919340|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83919341|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919342|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919343|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83919344|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83919345|NCT00348491|Analgesics|analgesics|mesh-ancestor
83919346|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
83919347|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919348|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919349|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919350|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919351|NCT03274323|Travoprost|travoprost|mesh-list
83919352|NCT03274323|Latanoprost|latanoprost|mesh-list
83919353|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83919354|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83919355|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83919356|NCT00348530|Verapamil|verapamil|mesh-list
83919357|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83919358|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83919359|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83919360|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919361|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83919362|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919363|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919364|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83919365|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83919366|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
83919367|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83919368|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919369|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919370|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
83919371|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919372|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83919373|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83919374|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83919375|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83919376|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83919377|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
83919378|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919379|NCT00456027|Antacids|antacids|mesh-ancestor
83919380|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919381|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83919382|NCT00348725|Metformin|metformin|mesh-list
83919383|NCT00348725|Fenofibrate|fenofibrate|mesh-list
83919384|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83919385|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919386|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83919387|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
83919388|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919389|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83919390|NCT00348764|Polidocanol|polidocanol|mesh-list
83919391|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83919392|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83919393|NCT03276156|Apatinib|apatinib|mesh-list
83919394|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919395|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919396|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919397|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919398|NCT00456144|Hormones|hormones|mesh-list
83919399|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919400|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919401|NCT00348920|Bupivacaine|bupivacaine|mesh-list
83919402|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
83919403|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
83919404|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919405|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919406|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
83919407|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919408|NCT00449514|Tamoxifen|tamoxifen|mesh-list
83919409|NCT00449514|Clomiphene|clomiphene|mesh-list
83919410|NCT00449514|Enclomiphene|enclomiphene|mesh-list
83919411|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
83919412|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83158638|NCT04787965|Opicapone|opicapone|mesh-list
83919414|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919415|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919416|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919417|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919418|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83919419|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83919420|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83919421|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83919422|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
83919423|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83919424|NCT00348998|Bevacizumab|bevacizumab|mesh-list
83919425|NCT00348998|Goserelin|goserelin|mesh-list
83919426|NCT00348998|Bicalutamide|bicalutamide|mesh-list
83919427|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83919428|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919429|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919430|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919431|NCT00348998|Growth Substances|growth substances|mesh-ancestor
83919432|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919433|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919434|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919435|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
83919436|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
83919437|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919438|NCT00449553|Metformin|metformin|mesh-list
83919439|NCT00449553|Pioglitazone|pioglitazone|mesh-list
83919440|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83919441|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919442|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
83919443|NCT00349076|Fluorouracil|fluorouracil|mesh-list
83919444|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919445|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
83919446|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919447|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83919448|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919449|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
83919450|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919451|NCT00349115|Thalidomide|thalidomide|mesh-list
83919452|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919453|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
83919454|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919455|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
83919456|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919457|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919458|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919459|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919460|NCT00349115|Growth Substances|growth substances|mesh-ancestor
83919461|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919462|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919463|NCT00456339|Amoxicillin|amoxicillin|mesh-list
83919464|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
83919465|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
83919466|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83919467|NCT00456339|Prednisolone|prednisolone|mesh-list
83919468|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919469|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919470|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919471|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
83919472|NCT00456339|Hormones|hormones|mesh-ancestor
83919473|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919474|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919475|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919476|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919477|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83919478|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919479|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919480|NCT00421421|Dutasteride|dutasteride|mesh-list
83919481|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83919482|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83919483|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919484|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919485|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
83919486|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919487|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919488|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
83919489|NCT00421460|Testosterone|testosterone|mesh-list
83919490|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
83919491|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
83919492|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83919493|NCT00421460|Androgens|androgens|mesh-ancestor
83919494|NCT00421460|Hormones|hormones|mesh-ancestor
83919495|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919496|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919497|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919498|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919499|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
83919500|NCT00349310|Pramipexole|pramipexole|mesh-list
83919501|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
83919502|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919503|NCT00349310|Protective Agents|protective agents|mesh-ancestor
83919504|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919505|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83919506|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83919507|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
83919508|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
83919509|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919510|NCT03274167|Gabapentin|gabapentin|mesh-list
83919511|NCT03274167|Analgesics|analgesics|mesh-ancestor
83919512|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
83919513|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919514|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919515|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
83919516|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83919517|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83919518|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919519|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83919520|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83919521|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83919522|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919523|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919524|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
83919525|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
83919526|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83919527|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919528|NCT00349583|Cyclosporine|cyclosporine|mesh-list
83919529|NCT00349583|Cyclosporins|cyclosporins|mesh-list
83919530|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919531|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919532|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919533|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
83919534|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919535|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
83919536|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919537|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83919538|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919539|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83919540|NCT00349739|Anecortave|anecortave|mesh-list
83919541|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919542|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919543|NCT00349739|Growth Substances|growth substances|mesh-ancestor
83919544|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919545|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919546|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919547|NCT00456729|Metronidazole|metronidazole|mesh-list
83919548|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919549|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919550|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83919551|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83919552|NCT00450099|Bupivacaine|bupivacaine|mesh-list
83919553|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
83919554|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
83919555|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919556|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919557|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
83919558|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919559|NCT00450138|Cisplatin|cisplatin|mesh-list
83158787|NCT00813163|Irinotecan|irinotecan|mesh-list
83919560|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919562|NCT00350051|Sagopilone|sagopilone|mesh-list
83919563|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919564|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
83919565|NCT00350051|Hormones|hormones|mesh-ancestor
83919566|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919567|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919568|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919569|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919570|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
83919571|NCT00350090|Hematinics|hematinics|mesh-ancestor
83919572|NCT04699110|Adenosine|adenosine|mesh-list
83919573|NCT04699110|Epinephrine|epinephrine|mesh-list
83919574|NCT04699110|Racepinephrine|racepinephrine|mesh-list
83919575|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
83919576|NCT04699110|Analgesics|analgesics|mesh-ancestor
83919577|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
83919578|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919579|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919580|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83919581|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919582|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83919583|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
83919584|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
83919585|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919586|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919587|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83919588|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83919589|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83919590|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83919591|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83919592|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
83919593|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83919594|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83919595|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
83919596|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
83919597|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83919598|NCT00350168|Amlodipine|amlodipine|mesh-list
83919599|NCT00350168|Valsartan|valsartan|mesh-list
83919600|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83919601|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83919602|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83919603|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919604|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83919605|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919606|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919607|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83919608|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83919609|NCT00105534|Azithromycin|azithromycin|mesh-list
83919610|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919611|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919612|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
83919613|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919614|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919615|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83919616|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83919617|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919618|NCT00350441|Urological Agents|urological agents|mesh-ancestor
83919619|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83919620|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
83919621|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83919622|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83919623|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
83919624|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83919625|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919626|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83919627|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83919628|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83919629|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919630|NCT00456963|Losartan|losartan|mesh-list
83919631|NCT00456963|Enalapril|enalapril|mesh-list
83919632|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83919633|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83919634|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83919635|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83919636|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919637|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83919638|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
83919639|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919640|NCT00350597|Molgramostim|molgramostim|mesh-list
83919641|NCT00350597|Sargramostim|sargramostim|mesh-list
83919642|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
83919643|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919644|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919645|NCT00350753|Bevacizumab|bevacizumab|mesh-list
83919646|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83919647|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83919648|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919649|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919650|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919651|NCT00350753|Growth Substances|growth substances|mesh-ancestor
83919652|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919653|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919654|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919655|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919656|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919657|NCT00457119|Everolimus|everolimus|mesh-list
83919658|NCT00457119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83919659|NCT00457119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919660|NCT00457119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919661|NCT00457119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919662|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919663|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
83919664|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919665|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919666|NCT00350948|Doxorubicin|doxorubicin|mesh-list
83919667|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83919668|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83919669|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919670|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83919671|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83919672|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919673|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919674|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83919675|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83919676|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919677|NCT00421538|Nadroparin|nadroparin|mesh-list
83919678|NCT00421538|Calcium|calcium|mesh-list
83919679|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83919680|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919681|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
83919682|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83919683|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83919684|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919685|NCT00351026|Methadone|methadone|mesh-list
83919686|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83919687|NCT00351026|Narcotics|narcotics|mesh-ancestor
83919688|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919689|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919690|NCT00351026|Analgesics|analgesics|mesh-ancestor
83919691|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
83919692|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919693|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
83919694|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
83919695|NCT00351104|Ketoprofen|ketoprofen|mesh-list
83919696|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83919697|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83919698|NCT00351104|Analgesics|analgesics|mesh-ancestor
83919699|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
83919700|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919701|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919702|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919703|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919704|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83919705|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919706|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919707|NCT00351143|Fluticasone|fluticasone|mesh-list
83919709|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83919710|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919711|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83919712|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
83919713|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919714|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919715|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83919716|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
83919717|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83919718|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83919719|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83919720|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83919721|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83919722|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
83919723|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919724|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919725|NCT00457470|Rucaparib|rucaparib|mesh-list
83919726|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83919727|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919728|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919729|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919730|NCT00457509|Vaccines|vaccines|mesh-list
83919731|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
83919732|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919733|NCT00450645|Heparin|heparin|mesh-list
83919734|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83919735|NCT00450645|Tinzaparin|tinzaparin|mesh-list
83919736|NCT00450645|Dalteparin|dalteparin|mesh-list
83919737|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
83919738|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83919739|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83919740|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919741|NCT00351182|Doxycycline|doxycycline|mesh-list
83919742|NCT00351182|Telithromycin|telithromycin|mesh-list
83919743|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919744|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919745|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
83919746|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83919747|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83919748|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
83919749|NCT00457860|Immunotoxins|immunotoxins|mesh-list
83919750|NCT00457860|Immunoconjugates|immunoconjugates|mesh-ancestor
83919751|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
83919752|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919753|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919754|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83919755|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
83919756|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83919757|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83919758|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83919759|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919760|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919761|NCT00351884|Vildagliptin|vildagliptin|mesh-list
83919762|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83919763|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919764|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83919765|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
83919766|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919767|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919768|NCT00458055|Niacin|niacin|mesh-list
83919769|NCT00458055|Atorvastatin|atorvastatin|mesh-list
83919770|NCT00458055|Fenofibrate|fenofibrate|mesh-list
83919771|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83919772|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83919773|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
83919774|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919775|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83919776|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83919777|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919778|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919779|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
83919780|NCT00458055|Vitamins|vitamins|mesh-ancestor
83919781|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
83919782|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919783|NCT00450762|Carboplatin|carboplatin|mesh-list
83919784|NCT00450762|Gemcitabine|gemcitabine|mesh-list
83919785|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919786|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83919787|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
83919788|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919789|NCT00352079|Gefitinib|gefitinib|mesh-list
83919790|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
83919791|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919792|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919793|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919794|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919795|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83919796|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
83919797|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919798|NCT00450840|Simvastatin|simvastatin|mesh-list
83919799|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83919800|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83919801|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
83919802|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919803|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83919804|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83919805|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919806|NCT00352196|Risperidone|risperidone|mesh-list
83919807|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83919808|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
83919809|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919810|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919811|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919812|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83919813|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83919814|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919815|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83919816|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83919817|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
83919818|NCT00352235|KRN 7000|krn 7000|mesh-list
83919819|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83919820|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
83919821|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919822|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919823|NCT00352313|Carboplatin|carboplatin|mesh-list
83919824|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919825|NCT00450957|Lycopene|lycopene|mesh-list
83919826|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919827|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
83919828|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919829|NCT00450957|Protective Agents|protective agents|mesh-ancestor
83919830|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919831|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83919832|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83919833|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919834|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
83919835|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83919836|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
83919837|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919838|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919839|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83919840|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
83919841|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83919842|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
83919843|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919844|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919845|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83919846|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
83919847|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
83919848|NCT00352430|Protective Agents|protective agents|mesh-ancestor
83919849|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83919850|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
83919851|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83919852|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83919853|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83919854|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83919855|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919856|NCT00451074|Gentamicins|gentamicins|mesh-list
83919857|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83919858|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919859|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83919860|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124679|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83919861|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919863|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83919864|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83919865|NCT00352625|Ketoprofen|ketoprofen|mesh-list
83919866|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83919867|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83919868|NCT00352625|Analgesics|analgesics|mesh-ancestor
83919869|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
83919870|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919871|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919872|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919873|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919874|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83919875|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919876|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919877|NCT00352742|Bortezomib|bortezomib|mesh-list
83919878|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83919879|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919880|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
83919881|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
83919882|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919883|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919884|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83919885|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83919886|NCT00352742|Growth Substances|growth substances|mesh-ancestor
83919887|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919888|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
83919889|NCT00352859|Interferons|interferons|mesh-list
83919890|NCT00352859|Gemcitabine|gemcitabine|mesh-list
83919891|NCT00352859|Sorafenib|sorafenib|mesh-list
83919892|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83919893|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
83919894|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919895|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919896|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
83919897|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919898|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919899|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919900|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
83919901|NCT00105183|Antibodies|antibodies|mesh-list
83919902|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
83919903|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83919904|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83919905|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
83919906|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83919907|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
83919908|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919909|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83919910|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83919911|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919912|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919913|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919914|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919915|NCT00466128|Indomethacin|indomethacin|mesh-list
83919916|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83919917|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83919918|NCT00466128|Analgesics|analgesics|mesh-ancestor
83919919|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
83919920|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83919921|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919922|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83919923|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83919924|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
83919925|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
83919926|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83919927|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83919928|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919929|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919930|NCT00353015|Cisplatin|cisplatin|mesh-list
83919931|NCT00353015|Irinotecan|irinotecan|mesh-list
83919932|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919933|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83919934|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83919935|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919936|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919937|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83919938|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83919939|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83919940|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919941|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919942|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
83919943|NCT00353054|Antacids|antacids|mesh-ancestor
83919944|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919945|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83919946|NCT00466401|Simvastatin|simvastatin|mesh-list
83919947|NCT00466401|Ezetimibe|ezetimibe|mesh-list
83919948|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83919949|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83919950|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
83919951|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919952|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83919953|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83919954|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919955|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83919956|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83919957|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83919958|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83919959|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83919960|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83919961|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83919962|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919963|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919964|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83919965|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83919966|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919967|NCT00466518|Incretins|incretins|mesh-ancestor
83919968|NCT00466518|Hormones|hormones|mesh-ancestor
83919969|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919970|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83919971|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
83919972|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919973|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919974|NCT00353561|Fluconazole|fluconazole|mesh-list
83919975|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
83919976|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83919977|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83919978|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83919979|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83919980|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919981|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83919982|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
83919983|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83919984|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919985|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83919986|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83919987|NCT00466596|Vitamins|vitamins|mesh-list
83919988|NCT00466596|Vitamin E|vitamin e|mesh-list
83919989|NCT00466596|Tocopherols|tocopherols|mesh-list
83919990|NCT00466596|Tocotrienols|tocotrienols|mesh-list
83919991|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
83919992|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
83919993|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
83919994|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83919995|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
83919996|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83919997|NCT00466596|Protective Agents|protective agents|mesh-ancestor
83919998|NCT00353678|Darexaban|darexaban|mesh-list
83919999|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83920000|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
83920001|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83920002|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
83920003|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920004|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920005|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
83920006|NCT00458250|Cyclosporine|cyclosporine|mesh-list
83920007|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
83920008|NCT00458250|Busulfan|busulfan|mesh-list
83920009|NCT00458250|Methotrexate|methotrexate|mesh-list
83920010|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
83920011|NCT00458250|Cyclosporins|cyclosporins|mesh-list
83920012|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920013|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
83920014|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920015|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920016|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83920017|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
83920018|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920019|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920020|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83920021|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83920022|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
83920023|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83920024|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83920025|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
83920026|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920027|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920028|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83920029|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83920030|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
83920031|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920032|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83920033|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920034|NCT00353717|Paclitaxel|paclitaxel|mesh-list
83920035|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83920036|NCT00353717|Cetuximab|cetuximab|mesh-list
83920037|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83920038|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920039|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83920040|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83920041|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83920042|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920043|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920044|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
83920045|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83920046|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920047|NCT00466791|Methylphenidate|methylphenidate|mesh-list
83920048|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83920049|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920050|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83920051|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83920052|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83920053|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920054|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
83920055|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920056|NCT00353912|Amlodipine|amlodipine|mesh-list
83920057|NCT00353912|Valsartan|valsartan|mesh-list
83920058|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83920059|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83920060|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83920061|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920062|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83920063|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920064|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
83920065|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83920066|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83920067|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
83920068|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83920069|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920070|NCT00458328|Z 338|z 338|mesh-list
83920071|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83920072|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920073|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920074|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
83920075|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920076|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920077|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920078|NCT00354068|Temozolomide|temozolomide|mesh-list
83920079|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
83920080|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83920081|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
83920082|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920083|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920084|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83920085|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920087|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
83920088|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
83920089|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
83920090|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920091|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920092|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920093|NCT00354146|Tipifarnib|tipifarnib|mesh-list
83920094|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920095|NCT00458367|Risperidone|risperidone|mesh-list
83920096|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83920097|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
83920098|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920099|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920100|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920101|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83920102|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83920103|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920104|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83920105|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83920106|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
83920107|NCT00354185|Belinostat|belinostat|mesh-list
83920108|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920109|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83920110|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920111|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920112|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83920113|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920114|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
83920115|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
83920116|NCT00354302|Alendronate|alendronate|mesh-list
83920117|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
83920118|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
83920119|NCT00354302|Calcium|calcium|mesh-list
83920120|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83920121|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920122|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83920123|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920124|NCT00354302|Vitamins|vitamins|mesh-ancestor
83920125|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
83920126|NCT00354302|Antacids|antacids|mesh-ancestor
83920127|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920128|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83920129|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83920130|NCT04714229|Vaccines|vaccines|mesh-list
83920131|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
83920132|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920133|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
83920134|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920135|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920136|NCT00354380|Artesunate|artesunate|mesh-list
83920137|NCT00354380|Amodiaquine|amodiaquine|mesh-list
83920138|NCT00354380|Methylene Blue|methylene blue|mesh-list
83920139|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
83920140|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83920141|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920142|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920143|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920144|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
83920145|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
83920146|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83920147|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
83920148|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920149|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920150|NCT00354419|Cyclosporine|cyclosporine|mesh-list
83920151|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
83920152|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
83920153|NCT00354419|Cyclosporins|cyclosporins|mesh-list
83920154|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
83920155|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83920156|NCT00354419|Lenograstim|lenograstim|mesh-list
83920157|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
83920158|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920159|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
83920160|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920161|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920162|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83920163|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
83920164|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920165|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920166|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83920167|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83920168|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920169|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
83920170|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920171|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920172|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83920173|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83920174|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83920175|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
83920176|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83920177|NCT00354458|Rolofylline|rolofylline|mesh-list
83920178|NCT00354458|Diuretics|diuretics|mesh-ancestor
83920179|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
83920180|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920181|NCT00458718|Rimonabant|rimonabant|mesh-list
83920182|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83920183|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83920184|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83920185|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920186|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920187|NCT00458718|Hormones|hormones|mesh-ancestor
83920188|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83920189|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920190|NCT00467181|Fenoldopam|fenoldopam|mesh-list
83920191|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83920192|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
83920193|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
83920194|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
83920195|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920196|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920197|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920198|NCT00425711|Acamprosate|acamprosate|mesh-list
83920199|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83920200|NCT03274011|Apatinib|apatinib|mesh-list
83920201|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920202|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83920203|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920204|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920205|NCT00425906|Nicotine|nicotine|mesh-list
83920206|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83920207|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
83920208|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920209|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920210|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83920211|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83920212|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
83920213|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920214|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920215|NCT00467376|Insulin|insulin|mesh-list
83920216|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83920217|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
83920218|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
83920219|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83920220|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920221|NCT00426023|Ketotifen|ketotifen|mesh-list
83920222|NCT00426023|Cyclosporine|cyclosporine|mesh-list
83920223|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83920224|NCT00426023|Cyclosporins|cyclosporins|mesh-list
83920225|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920226|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920227|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920228|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
83920229|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920230|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
83920231|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920232|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920233|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920234|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83920235|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83920236|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
83920238|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
83920239|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
83920240|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920241|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83920242|NCT00467454|Naltrexone|naltrexone|mesh-list
83920243|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83920244|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83920245|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920246|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
83920247|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920248|NCT00426101|Cyclosporine|cyclosporine|mesh-list
83920249|NCT00426101|Dexamethasone|dexamethasone|mesh-list
83920250|NCT00426101|Etoposide|etoposide|mesh-list
83920251|NCT00426101|Cyclosporins|cyclosporins|mesh-list
83920252|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83920253|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
83920254|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
83920255|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920256|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920257|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920258|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
83920259|NCT00426101|Hormones|hormones|mesh-ancestor
83920260|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83920261|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83920262|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920263|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83920264|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83920265|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83920266|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920267|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920268|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920269|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
83920270|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
83920271|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920272|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920273|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920274|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83920275|NCT00426140|Epothilone B|epothilone b|mesh-list
83920276|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920277|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83920278|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83920279|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83920280|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920281|NCT00467493|Anastrozole|anastrozole|mesh-list
83920282|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83920283|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920284|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83920285|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83920286|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920287|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920288|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83920289|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
83920290|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83920291|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920292|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
83920293|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920294|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83920295|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920296|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920297|NCT00458913|Bortezomib|bortezomib|mesh-list
83920298|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920299|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
83920300|NCT00458991|Caffeine|caffeine|mesh-list
83920301|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83920302|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920303|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83920304|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920305|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920306|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83920307|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83920308|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
83920309|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920310|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
83920311|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
83920312|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83920313|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83920314|NCT01059617|Vaccines|vaccines|mesh-list
83920315|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
83920316|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920317|NCT04705337|Simendan|simendan|mesh-list
83920318|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83920319|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
83920320|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83920321|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83920322|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920323|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920324|NCT04705337|Protective Agents|protective agents|mesh-ancestor
83920325|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920326|NCT00467571|Amoxicillin|amoxicillin|mesh-list
83920327|NCT00467571|Clarithromycin|clarithromycin|mesh-list
83920328|NCT00467571|Lansoprazole|lansoprazole|mesh-list
83920329|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
83920330|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83920331|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920332|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83920333|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920334|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920335|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83920336|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83920337|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83920338|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920339|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83920340|NCT00426296|Ritonavir|ritonavir|mesh-list
83920341|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83920342|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83920343|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83920344|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
83920345|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920346|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920347|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83920348|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83920349|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
83920350|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920351|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83920352|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83920353|NCT03271905|Bromides|bromides|mesh-list
83920354|NCT03271905|Albuterol|albuterol|mesh-list
83920355|NCT03271905|Ipratropium|ipratropium|mesh-list
83920356|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
83920357|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83920358|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
83920359|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920360|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920361|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83920362|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
83920363|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
83920364|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83920365|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83920366|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83920367|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83920368|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
83920369|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920370|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920371|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83920372|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
83920373|NCT00426413|Pioglitazone|pioglitazone|mesh-list
83920374|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83920375|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920376|NCT00459264|Folic Acid|folic acid|mesh-list
83920377|NCT00459264|Hematinics|hematinics|mesh-ancestor
83920378|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
83920379|NCT00459264|Vitamins|vitamins|mesh-ancestor
83920380|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
83920381|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920382|NCT00426452|Vatalanib|vatalanib|mesh-list
83920383|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83920384|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920385|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920386|NCT00426491|Misoprostol|misoprostol|mesh-list
83920387|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83920388|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
83920389|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83920390|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920391|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83920392|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920393|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
83920394|NCT00426530|Everolimus|everolimus|mesh-list
83920395|NCT00426530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83920396|NCT00426530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83920397|NCT00426530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920398|NCT00426530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920399|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920400|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
83920401|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920402|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920403|NCT00459420|Caffeine|caffeine|mesh-list
83920404|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83920405|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920406|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83920407|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920408|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920409|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83920410|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83920411|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
83920412|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920413|NCT00467766|Donepezil|donepezil|mesh-list
83920414|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83920415|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920416|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920417|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
83920418|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920419|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920420|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
83920421|NCT04705415|Niclosamide|niclosamide|mesh-list
83920422|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
83920423|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83920424|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
83920425|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920426|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920427|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
83920428|NCT00467883|Amphotericin B|amphotericin b|mesh-list
83920429|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83920430|NCT00467883|Amebicides|amebicides|mesh-ancestor
83920431|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83920432|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920433|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920434|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83920435|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
83920436|NCT00426608|Alprazolam|alprazolam|mesh-list
83920437|NCT00426608|Metyrapone|metyrapone|mesh-list
83920438|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83920439|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920440|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920441|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83920442|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83920443|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83920444|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
83920445|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
83920446|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920447|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920448|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
83920449|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920450|NCT00426647|Buprenorphine|buprenorphine|mesh-list
83920451|NCT00426647|Tramadol|tramadol|mesh-list
83920452|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83920453|NCT00426647|Narcotics|narcotics|mesh-ancestor
83920454|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920455|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920456|NCT00426647|Analgesics|analgesics|mesh-ancestor
83920457|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
83920458|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920459|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83920460|NCT01059071|Eflornithine|eflornithine|mesh-list
83159694|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
83920461|NCT01059071|Etoposide|etoposide|mesh-list
83920462|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83920463|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920464|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83920465|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83920466|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920467|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920468|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83920469|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83920470|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920471|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920472|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83920473|NCT00468234|Nicotine|nicotine|mesh-list
83920474|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83920475|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
83920476|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920477|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920478|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83920479|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83920480|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
83920481|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920482|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920483|NCT00459615|Artesunate|artesunate|mesh-list
83920484|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
83920485|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83920486|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920487|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920488|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920489|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
83920490|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
83920491|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83920492|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
83920493|NCT00468351|Triamcinolone|triamcinolone|mesh-list
83920494|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83920495|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83920496|NCT00468351|Bevacizumab|bevacizumab|mesh-list
83920497|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83920498|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920499|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920500|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83920501|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83920502|NCT00468351|Growth Substances|growth substances|mesh-ancestor
83920503|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920504|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
83920505|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83920506|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
83920507|NCT00468351|Hormones|hormones|mesh-ancestor
83920508|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83920509|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920510|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
83920511|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920512|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920513|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83920514|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920515|NCT00468429|Bevacizumab|bevacizumab|mesh-list
83920516|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920517|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920518|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83920519|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83920520|NCT00468429|Growth Substances|growth substances|mesh-ancestor
83920521|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920522|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
83920523|NCT00459771|Candesartan|candesartan|mesh-list
83920524|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83920525|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83920526|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83920527|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920528|NCT01058369|Deferasirox|deferasirox|mesh-list
83920529|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83920530|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
83920531|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
83920532|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920533|NCT01057433|Ritonavir|ritonavir|mesh-list
83920534|NCT01057433|Lopinavir|lopinavir|mesh-list
83920535|NCT01057433|Pitavastatin|pitavastatin|mesh-list
83920536|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83920537|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83920538|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
83920539|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920540|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920541|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83920542|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83920543|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
83920544|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920545|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83920546|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83920547|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83920548|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83920549|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83920550|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
83920551|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83920552|NCT01058642|Pregabalin|pregabalin|mesh-list
83920553|NCT01058642|Analgesics|analgesics|mesh-ancestor
83920554|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
83920555|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920556|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920557|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
83920558|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83920559|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83920560|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920561|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83920562|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83920563|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83920564|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920565|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83920566|NCT00426920|Insulin|insulin|mesh-list
83920567|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83920568|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920569|NCT00426998|Bevacizumab|bevacizumab|mesh-list
83920570|NCT00426998|Verteporfin|verteporfin|mesh-list
83920571|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920572|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920573|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83920574|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83920575|NCT00426998|Growth Substances|growth substances|mesh-ancestor
83920576|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920577|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
83920578|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83920579|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920580|NCT00427076|Vancomycin|vancomycin|mesh-list
83920581|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83920582|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83920583|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920584|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83920585|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
83920586|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83920587|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920588|NCT00427232|BQ 788|bq 788|mesh-list
83920589|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83920590|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83920591|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920592|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83920593|NCT00427271|Aspirin|aspirin|mesh-list
83920594|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83920595|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83920596|NCT00427271|Analgesics|analgesics|mesh-ancestor
83920597|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
83920598|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920599|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920600|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83920601|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920602|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83920603|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83920604|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920605|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83920606|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83920607|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920608|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
83920609|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
83920610|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83920611|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83920613|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
83920614|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920615|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920616|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83920617|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920618|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920619|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920620|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
83920621|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83920622|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920623|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920624|NCT00427310|Fluorouracil|fluorouracil|mesh-list
83920625|NCT00427310|Heparin|heparin|mesh-list
83920626|NCT00427310|Calcium heparin|calcium heparin|mesh-list
83920627|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
83920628|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920629|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83920630|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920631|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920632|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
83920633|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920634|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
83920635|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83920636|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83920637|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
83920638|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83920639|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83920640|NCT00427388|Prednisolone|prednisolone|mesh-list
83920641|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
83920642|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83920643|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
83920644|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83920645|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
83920646|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
83920647|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920648|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920649|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920650|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
83920651|NCT00427388|Hormones|hormones|mesh-ancestor
83920652|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83920653|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83920654|NCT00427388|Protective Agents|protective agents|mesh-ancestor
83920655|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83920656|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920657|NCT00427427|Trastuzumab|trastuzumab|mesh-list
83920658|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920659|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920660|NCT04704947|Alendronate|alendronate|mesh-list
83920661|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83920662|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
83920663|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83920664|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920665|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83920666|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
83920667|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920668|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920669|NCT00427466|Pemetrexed|pemetrexed|mesh-list
83920670|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920671|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920672|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920673|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83920674|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83920675|NCT00427505|Deferasirox|deferasirox|mesh-list
83920676|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83920677|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
83920678|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
83920679|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920680|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
83920681|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920682|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83920683|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920684|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159913|NCT02669043|Analgesics|analgesics|mesh-ancestor
83920685|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
83920686|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83920687|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920688|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83920689|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
83920690|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83920691|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920692|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920693|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920694|NCT00469053|Buprenorphine|buprenorphine|mesh-list
83920695|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83920696|NCT00469053|Narcotics|narcotics|mesh-ancestor
83920697|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920698|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920699|NCT00469053|Analgesics|analgesics|mesh-ancestor
83920700|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
83920701|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920702|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83920703|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
83920704|NCT00469131|Tacrolimus|tacrolimus|mesh-list
83920705|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920706|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
83920707|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920708|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83920709|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920710|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920711|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83920712|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920713|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83920714|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
83920715|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83920716|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920717|NCT00428129|Plasminogen|plasminogen|mesh-list
83920718|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83920719|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83920720|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920721|NCT00428168|Betahistine|betahistine|mesh-list
83920722|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
83920723|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
83920724|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
83920725|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920726|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920727|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920728|NCT00428480|Methamphetamine|methamphetamine|mesh-list
83920729|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83920730|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920731|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
83920732|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
83920733|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920734|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
83920735|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920736|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920737|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
83920738|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83920739|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83920740|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83920741|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83920742|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
83920743|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83920744|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920745|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920746|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83920747|NCT00460473|Analgesics|analgesics|mesh-ancestor
83920748|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
83920749|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920750|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83920751|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83920752|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83920753|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
83920754|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920755|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920756|NCT00428519|Aprepitant|aprepitant|mesh-list
83920757|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
83920758|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
83920759|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
83920760|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920761|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920762|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920763|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83920764|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920765|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920766|NCT00428558|Cytarabine|cytarabine|mesh-list
83920767|NCT00428558|Daunorubicin|daunorubicin|mesh-list
83920768|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83920769|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
83920770|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920771|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920772|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
83920773|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920774|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920775|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
83920776|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920777|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83920778|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83920779|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83920780|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920781|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83920782|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83920783|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83920784|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920785|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920786|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83920787|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83920788|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83920789|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
83920790|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920791|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920792|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83920793|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83920794|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
83920795|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
83920796|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920797|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920798|NCT01055834|Eszopiclone|eszopiclone|mesh-list
83920799|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83920800|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920801|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920802|NCT00469326|Atorvastatin|atorvastatin|mesh-list
83920803|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83920804|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83920805|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
83920806|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920807|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83920808|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83920809|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920810|NCT04704713|Afamelanotide|afamelanotide|mesh-list
83920811|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920812|NCT00460707|Ketoconazole|ketoconazole|mesh-list
83920813|NCT00460707|Casopitant|casopitant|mesh-list
83920814|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
83920815|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920816|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83920817|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83920818|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920819|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920820|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83920821|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
83920822|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83920823|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920824|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83920825|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
83920826|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
83920827|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920828|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920829|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83920830|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920831|NCT00469404|Buprenorphine|buprenorphine|mesh-list
83920832|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83920833|NCT00469404|Narcotics|narcotics|mesh-ancestor
83920834|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920835|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920836|NCT00469404|Analgesics|analgesics|mesh-ancestor
83920837|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
83920838|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920839|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83920840|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
83920841|NCT00460785|Narcotics|narcotics|mesh-ancestor
83920842|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83920843|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920844|NCT00460785|Analgesics|analgesics|mesh-ancestor
83920845|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
83920846|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920847|NCT01054976|Galantamine|galantamine|mesh-list
83920848|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83920849|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920850|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920851|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
83920852|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83920853|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920854|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83920855|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
83920856|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920857|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
83920858|NCT00469443|Leucovorin|leucovorin|mesh-list
83920859|NCT00469443|Bevacizumab|bevacizumab|mesh-list
83920860|NCT00469443|Fluorouracil|fluorouracil|mesh-list
83920861|NCT00469443|Capecitabine|capecitabine|mesh-list
83920862|NCT00469443|Irinotecan|irinotecan|mesh-list
83920863|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920864|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920865|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83920866|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83920867|NCT00469443|Growth Substances|growth substances|mesh-ancestor
83920868|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920869|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
83920870|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
83920871|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920872|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83920873|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920874|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
83920875|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83920876|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83920877|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920878|NCT00469443|Antidotes|antidotes|mesh-ancestor
83920879|NCT00469443|Protective Agents|protective agents|mesh-ancestor
83920880|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
83920881|NCT00469443|Vitamins|vitamins|mesh-ancestor
83920882|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
83920883|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
83920884|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83920885|NCT00428909|Acetaminophen|acetaminophen|mesh-list
83920886|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
83920887|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83920888|NCT00428909|Analgesics|analgesics|mesh-ancestor
83920889|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
83920890|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920891|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920892|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
83920893|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920894|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83920895|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920896|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920897|NCT00429065|Rituximab|rituximab|mesh-list
83920898|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920899|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920900|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
83920901|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920902|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920903|NCT00469560|Deferasirox|deferasirox|mesh-list
83920904|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83920905|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
83920906|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
83920907|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920908|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
83920909|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83920910|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83920911|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920912|NCT00469599|Vitamins|vitamins|mesh-ancestor
83920913|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
83920914|NCT00429377|Tacrolimus|tacrolimus|mesh-list
83920915|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920916|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
83920917|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920918|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83920919|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920920|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920921|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83920922|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
83920923|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
83920924|NCT00429533|Dapsone|dapsone|mesh-list
83920925|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83920926|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
83920927|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83920928|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83920929|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83920930|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920931|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920932|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
83920933|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83920934|NCT04704245|Petrolatum|petrolatum|mesh-list
83920935|NCT04704245|Mitogens|mitogens|mesh-list
83920936|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
83920937|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920938|NCT04704245|Emollients|emollients|mesh-ancestor
83920939|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
83920940|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83920941|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83920942|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
83920943|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920944|NCT00429962|Ranibizumab|ranibizumab|mesh-list
83920945|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83920946|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83920947|NCT00429962|Growth Substances|growth substances|mesh-ancestor
83920948|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920949|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83920950|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920951|NCT00430001|Docetaxel|docetaxel|mesh-list
83920952|NCT00430001|Trastuzumab|trastuzumab|mesh-list
83920953|NCT00430001|Vinorelbine|vinorelbine|mesh-list
83920954|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920955|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
83920956|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
83920957|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
83920958|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920959|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83920960|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83920961|NCT00430079|Etanidazole|etanidazole|mesh-list
83920962|NCT00430079|Imidazole|imidazole|mesh-list
83920963|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83920964|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920965|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920966|NCT00430118|Cytarabine|cytarabine|mesh-list
83920967|NCT00430118|Dexamethasone|dexamethasone|mesh-list
83920968|NCT00430118|Prednisone|prednisone|mesh-list
83920969|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
83920970|NCT00430118|Ifosfamide|ifosfamide|mesh-list
83920971|NCT00430118|Doxorubicin|doxorubicin|mesh-list
83920972|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83920973|NCT00430118|Methotrexate|methotrexate|mesh-list
83920974|NCT00430118|Etoposide|etoposide|mesh-list
83920975|NCT00430118|Vincristine|vincristine|mesh-list
83920976|NCT00430118|Daunorubicin|daunorubicin|mesh-list
83920977|NCT00430118|Asparaginase|asparaginase|mesh-list
83920978|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
83920979|NCT00430118|Thioguanine|thioguanine|mesh-list
83920980|NCT00430118|Vindesine|vindesine|mesh-list
83920981|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83920982|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
83920983|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83920984|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83920985|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83920986|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
83920987|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83920988|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83920989|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83920990|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83920991|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
83920992|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
83920993|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83920994|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83920995|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
83920996|NCT00430118|Hormones|hormones|mesh-ancestor
83920997|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83920998|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83920999|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83921000|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83921001|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83921002|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921003|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83921004|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
83921005|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83921006|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921007|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
83921008|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83921009|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83921010|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83921011|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83921012|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
83921013|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921014|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83921015|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83921016|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83921017|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
83921018|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83921019|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83921020|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921021|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921022|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
83921023|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83921024|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
83921025|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83921026|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83921027|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921028|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921029|NCT00461565|Urological Agents|urological agents|mesh-ancestor
83921030|NCT00430196|Tizanidine|tizanidine|mesh-list
83921031|NCT00430196|Analgesics|analgesics|mesh-ancestor
83921032|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
83921033|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921034|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921035|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
83921036|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83921037|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83921038|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
83921039|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
83921040|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83921041|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83921042|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83921043|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
83921044|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921045|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921046|NCT00430235|Sorafenib|sorafenib|mesh-list
83921047|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921048|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83921049|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921050|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921051|NCT00470340|Gemcitabine|gemcitabine|mesh-list
83921052|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
83921053|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
83921054|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921055|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921056|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
83921057|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921058|NCT00430469|Lactoferrin|lactoferrin|mesh-list
83921059|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921060|NCT00461643|Metformin|metformin|mesh-list
83921061|NCT00461643|Citric Acid|citric acid|mesh-list
83921062|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
83921063|NCT00461643|Clomiphene|clomiphene|mesh-list
83921064|NCT00461643|Enclomiphene|enclomiphene|mesh-list
83921065|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
83921066|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83921067|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921068|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
83921069|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83921070|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
83921071|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
83921072|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921073|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83921074|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
83921075|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921076|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83921077|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
83921078|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83921079|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83921080|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83921081|NCT00430547|Carbimazole|carbimazole|mesh-list
83921082|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
83921083|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
83921084|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921085|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921086|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83921087|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83921088|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
83921089|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83921090|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83921091|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921092|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921093|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83921094|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921095|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921096|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
83921097|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921098|NCT01053962|Plecanatide|plecanatide|mesh-list
83921099|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83921100|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
83921101|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921102|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83921103|NCT00461799|Orlistat|orlistat|mesh-list
83921104|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921105|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921106|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83921107|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83921108|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
83921109|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83921110|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921111|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
83921112|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83921113|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83921114|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152214|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
83921115|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921116|NCT00430742|Hormones|hormones|mesh-ancestor
83921117|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921118|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921119|NCT00470457|Immunomodulating Agents|immunomodulating agents|mesh-list
83921120|NCT00470457|Immunologic Factors|immunologic factors|mesh-ancestor
83921121|NCT00470457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921122|NCT03271164|Vitamin E|vitamin e|mesh-list
83921123|NCT03271164|Vitamins|vitamins|mesh-ancestor
83921124|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
83921125|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921126|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
83921127|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921128|NCT03271164|Protective Agents|protective agents|mesh-ancestor
83921129|NCT00430898|Basiliximab|basiliximab|mesh-list
83921130|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83921131|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
83921132|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921133|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83921134|NCT00461916|Buserelin|buserelin|mesh-list
83921135|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
83921136|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83921137|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
83921138|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83921139|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921140|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83921141|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83921142|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921143|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83921144|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
83921145|NCT02957409|Valsartan|valsartan|mesh-list
83921146|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83921147|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83921148|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83921149|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83921150|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921151|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
83921152|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83921153|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921154|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83921155|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
83921156|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83921157|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921158|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921159|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921160|NCT00431054|Docetaxel|docetaxel|mesh-list
83921161|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921162|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
83921163|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
83921164|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
83921165|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921166|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
83921167|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
83921168|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83921169|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921170|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921171|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
83921172|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83921173|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921174|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921175|NCT00431210|Immunomodulating Agents|immunomodulating agents|mesh-list
83921176|NCT00431210|Immunologic Factors|immunologic factors|mesh-ancestor
83921177|NCT00431210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921178|NCT00431249|Cilostazol|cilostazol|mesh-list
83921179|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83921180|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
83921181|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921182|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921183|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83921184|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
83921185|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83921186|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83921187|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921188|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83921189|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
83921190|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83921191|NCT00431249|Protective Agents|protective agents|mesh-ancestor
83921192|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83921193|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83921194|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921195|NCT00470886|Telmisartan|telmisartan|mesh-list
83921196|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83921197|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83921198|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83921199|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921200|NCT00431522|Valproic Acid|valproic acid|mesh-list
83921201|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
83921202|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921203|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160441|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921204|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
83921205|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921206|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921207|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
83921208|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83921209|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921210|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83921211|NCT00462111|Indomethacin|indomethacin|mesh-list
83921212|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83921213|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83921214|NCT00462111|Analgesics|analgesics|mesh-ancestor
83921215|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
83921216|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921217|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921218|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83921219|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83921220|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
83921221|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
83921222|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83921223|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83921224|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921225|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921226|NCT00431561|Temozolomide|temozolomide|mesh-list
83921227|NCT00431561|Lomustine|lomustine|mesh-list
83921228|NCT00431561|Trabedersen|trabedersen|mesh-list
83921229|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83921230|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
83921231|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921232|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921233|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
83921234|NCT00462189|Immunotoxins|immunotoxins|mesh-list
83921235|NCT00462189|Immunoconjugates|immunoconjugates|mesh-ancestor
83921236|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
83921237|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921238|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921239|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
83921240|NCT00431678|Levofloxacin|levofloxacin|mesh-list
83921241|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
83921242|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83921243|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83921244|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921245|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83921246|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83921247|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921248|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921249|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921250|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83921251|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
83921252|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83921253|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921254|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83921255|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83921256|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83921257|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83921258|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83921259|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83921260|NCT00471003|Telmisartan|telmisartan|mesh-list
83921261|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83921262|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83921263|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83921264|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921265|NCT00471042|Buprenorphine|buprenorphine|mesh-list
83921266|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83921267|NCT00471042|Narcotics|narcotics|mesh-ancestor
83921268|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921269|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921270|NCT00471042|Analgesics|analgesics|mesh-ancestor
83921271|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
83921272|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921273|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83921274|NCT00462540|Bromides|bromides|mesh-list
83921275|NCT00462540|Albuterol|albuterol|mesh-list
83921276|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
83921277|NCT00462540|Ipratropium|ipratropium|mesh-list
83921278|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83921280|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921281|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921282|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83921283|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
83921284|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83921285|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83921286|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83921287|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
83921288|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921289|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921290|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
83921291|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
83921292|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83921293|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83921294|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
83921295|NCT04703465|Tenofovir|tenofovir|mesh-list
83921296|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
83921297|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921298|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83921299|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83921300|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921301|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921302|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83921303|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83921304|NCT00471159|Docetaxel|docetaxel|mesh-list
83921305|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921306|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83921307|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83921308|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83921309|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921310|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83921311|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
83921312|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83921313|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83921314|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83921315|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921316|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921317|NCT00431795|Doxorubicin|doxorubicin|mesh-list
83921318|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83921319|NCT00431795|Epirubicin|epirubicin|mesh-list
83921320|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83921321|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921322|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83921323|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83921324|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921325|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921326|NCT00462657|Dimercaprol|dimercaprol|mesh-list
83921327|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
83921328|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
83921329|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921330|NCT00431990|Dexamethasone|dexamethasone|mesh-list
83921331|NCT00431990|Bortezomib|bortezomib|mesh-list
83921332|NCT00431990|Romidepsin|romidepsin|mesh-list
83921333|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83921334|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
83921335|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
83921336|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921337|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921338|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83921339|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
83921340|NCT00431990|Hormones|hormones|mesh-ancestor
83921341|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921342|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83921343|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921344|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83921345|NCT00431990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83921346|NCT00431990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921347|NCT00431990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921348|NCT00462696|Docetaxel|docetaxel|mesh-list
83921349|NCT00462696|Epirubicin|epirubicin|mesh-list
83921350|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921351|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
83921352|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
83921353|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
83921354|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921355|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83921356|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83921358|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921359|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83921360|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83921361|NCT00462813|Protective Agents|protective agents|mesh-ancestor
83921362|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921363|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921364|NCT01052012|Bupivacaine|bupivacaine|mesh-list
83921365|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
83921366|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
83921367|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921368|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921369|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
83921370|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921371|NCT00462852|Gemcitabine|gemcitabine|mesh-list
83921372|NCT00462852|Dalteparin|dalteparin|mesh-list
83921373|NCT00462852|Tinzaparin|tinzaparin|mesh-list
83921374|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83921375|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921376|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
83921377|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921378|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921379|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
83921380|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83921381|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83921382|NCT00471393|Diclofenac|diclofenac|mesh-list
83921383|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83921384|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83921385|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83921386|NCT00471393|Analgesics|analgesics|mesh-ancestor
83921387|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
83921388|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921389|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921390|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83921391|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83921392|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83921393|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921394|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921395|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83921396|NCT00471393|Protective Agents|protective agents|mesh-ancestor
83921397|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83921398|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
83921399|NCT00432068|Octreotide|octreotide|mesh-list
83921400|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83921401|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83921402|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921403|NCT03273231|Ketamine|ketamine|mesh-list
83921404|NCT03273231|Analgesics|analgesics|mesh-ancestor
83921405|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
83921406|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921407|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921408|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83921409|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83921410|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
83921411|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
83921412|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921413|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83921414|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83921415|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921416|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921417|NCT00432146|Lugol's solution|lugol's solution|mesh-list
83921418|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
83921419|NCT00432146|Coagulants|coagulants|mesh-ancestor
83921420|NCT00432302|Sagopilone|sagopilone|mesh-list
83921421|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921422|NCT00463008|Methotrexate|methotrexate|mesh-list
83921423|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83921424|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
83921425|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83921426|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921427|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921428|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
83921429|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921431|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
83921432|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921433|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83921434|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83921435|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
83921436|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83921437|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83921438|NCT00471432|Docetaxel|docetaxel|mesh-list
83921439|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921440|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83921441|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83921442|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83921443|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921444|NCT00463086|Isoniazid|isoniazid|mesh-list
83921445|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
83921446|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83921447|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921448|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83921449|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83921450|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
83921451|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921452|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83921453|NCT02957435|Eplerenone|eplerenone|mesh-list
83921454|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83921455|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
83921456|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921457|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921458|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83921459|NCT02957435|Diuretics|diuretics|mesh-ancestor
83921460|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
83921461|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83921462|NCT00471471|Sargramostim|sargramostim|mesh-list
83921463|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
83921464|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921465|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83921466|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83921467|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83921468|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
83921469|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921470|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921471|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83921472|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83921473|NCT00463203|Bevacizumab|bevacizumab|mesh-list
83921474|NCT00463203|Irinotecan|irinotecan|mesh-list
83921475|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83921476|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921477|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83921478|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83921479|NCT00463203|Growth Substances|growth substances|mesh-ancestor
83921480|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921481|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
83921482|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83921483|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83921484|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921485|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921486|NCT00471549|Simvastatin|simvastatin|mesh-list
83921487|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83921488|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83921489|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
83921490|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921491|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83921492|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83921493|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921494|NCT00432575|Surinabant|surinabant|mesh-list
83921495|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83921496|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83921497|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921498|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921499|NCT00432575|Hormones|hormones|mesh-ancestor
83160790|NCT02742649|Timolol|timolol|mesh-list
83921500|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921501|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921502|NCT00432614|Escitalopram|escitalopram|mesh-list
83921503|NCT00432614|Amibegron|amibegron|mesh-list
83921504|NCT00432614|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83921505|NCT00432614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83921506|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83921507|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921508|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921509|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921510|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
83921511|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921512|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83921513|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83921514|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83921515|NCT00432614|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83921516|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83921517|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83921518|NCT00432653|Rituximab|rituximab|mesh-list
83921519|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83921520|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921521|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
83921522|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921523|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83921524|NCT00471588|Pramipexole|pramipexole|mesh-list
83921525|NCT00471588|Amisulpride|amisulpride|mesh-list
83921526|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
83921527|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921528|NCT00471588|Protective Agents|protective agents|mesh-ancestor
83921529|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921530|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83921531|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83921532|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
83921533|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
83921534|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921535|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83921536|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83921537|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921538|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83921539|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83921540|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83921541|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
83921542|NCT00463359|Imiquimod|imiquimod|mesh-list
83921543|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83921544|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
83921545|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921546|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921547|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
83921548|NCT00471627|Pancrelipase|pancrelipase|mesh-list
83921549|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83921550|NCT00432887|Caffeine|caffeine|mesh-list
83921551|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83921552|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921553|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83921554|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921555|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921556|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83921557|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83921558|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
83921559|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921560|NCT00471744|Levetiracetam|levetiracetam|mesh-list
83921561|NCT00471744|Sulthiame|sulthiame|mesh-list
83921562|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
83921563|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
83921564|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
83921565|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83921566|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921567|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
83921568|NCT00463515|Carboplatin|carboplatin|mesh-list
83921569|NCT00463515|Gemcitabine|gemcitabine|mesh-list
83921570|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921571|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921572|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
83921573|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921574|NCT00433043|Metoprolol|metoprolol|mesh-list
83921575|NCT00433043|Carvedilol|carvedilol|mesh-list
83921576|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83921577|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83921578|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83921579|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
83921580|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
83921581|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921582|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921583|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83921584|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83921585|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83921586|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921587|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921588|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
83921589|NCT00433043|Protective Agents|protective agents|mesh-ancestor
83921590|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83921591|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921592|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83921593|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
83921594|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83921595|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83921596|NCT03273075|Ticagrelor|ticagrelor|mesh-list
83921597|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83921598|NCT03273075|Cangrelor|cangrelor|mesh-list
83921599|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83921600|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83921601|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83921602|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83921603|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
83921604|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921605|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921606|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921607|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83921608|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83921609|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
83921610|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921611|NCT01051661|Vaccines|vaccines|mesh-list
83921612|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
83921613|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921614|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83921615|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83921616|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83921617|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921618|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921619|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921620|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921621|NCT01051466|Analgesics|analgesics|mesh-ancestor
83921622|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
83921623|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921624|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
83921625|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83921626|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
83921627|NCT04446793|Bevacizumab|bevacizumab|mesh-list
83921628|NCT04446793|Onvansertib|onvansertib|mesh-list
83921629|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83921630|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921631|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83921632|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83921633|NCT04446793|Growth Substances|growth substances|mesh-ancestor
83921634|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921635|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
83921636|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83921637|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921638|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921639|NCT01051349|Daclizumab|daclizumab|mesh-list
83921640|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83921641|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
83921642|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921643|NCT00433121|Olanzapine|olanzapine|mesh-list
83921644|NCT00433121|Risperidone|risperidone|mesh-list
83921645|NCT00433121|Citalopram|citalopram|mesh-list
83921646|NCT00433121|Escitalopram|escitalopram|mesh-list
83921647|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83921648|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
83921649|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921650|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921651|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921652|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83921653|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83921654|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921655|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83921656|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83921657|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
83921658|NCT00433121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83921659|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83921660|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921661|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
83921662|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921663|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83921664|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
83921665|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
83921666|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83921667|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
83921668|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83921669|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
83921670|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921671|NCT00463671|Expectorants|expectorants|mesh-ancestor
83921672|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
83921673|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83921674|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
83921675|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921676|NCT00463671|Protective Agents|protective agents|mesh-ancestor
83921677|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921678|NCT00463671|Antidotes|antidotes|mesh-ancestor
83921679|NCT00591526|Cytarabine|cytarabine|mesh-list
83921680|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921681|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
83921682|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921683|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921684|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
83921685|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921686|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83921687|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
83921688|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921689|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
83921690|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83921691|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
83921692|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921693|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921694|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
83921695|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921696|NCT00433277|Cyclosporine|cyclosporine|mesh-list
83921697|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83921698|NCT00433277|Cyclosporins|cyclosporins|mesh-list
83921699|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921700|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921701|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83921702|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
83921703|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921704|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
83921705|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921706|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
83921707|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83921708|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83921709|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83921710|NCT00463827|Atorvastatin|atorvastatin|mesh-list
83921711|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83921712|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83921713|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
83921714|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921715|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83921716|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83921717|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921718|NCT00433316|Ropivacaine|ropivacaine|mesh-list
83921719|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
83921720|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
83921721|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921722|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921723|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
83921724|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921726|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
83921727|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
83921728|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921729|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921730|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
83921731|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921732|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83921733|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83921734|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921735|NCT03270969|Tenofovir|tenofovir|mesh-list
83921736|NCT03270969|Emtricitabine|emtricitabine|mesh-list
83921737|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
83921738|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921739|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83921740|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83921741|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921742|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921743|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83921744|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83921745|NCT00463983|Octreotide|octreotide|mesh-list
83921746|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83921747|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83921748|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921749|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
83921750|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83921751|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83921752|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
83921753|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921754|NCT00472173|Calcium|calcium|mesh-list
83921755|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83921756|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921757|NCT00472329|Fludarabine|fludarabine|mesh-list
83921758|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921759|NCT00464217|Idarubicin|idarubicin|mesh-list
83921760|NCT00464217|Molgramostim|molgramostim|mesh-list
83921761|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83921762|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921763|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83921764|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83921765|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921766|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921767|NCT00433784|Clopidogrel|clopidogrel|mesh-list
83921768|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83921769|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83921770|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83921771|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83921772|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
83921773|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921774|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921775|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921776|NCT00464256|Rimonabant|rimonabant|mesh-list
83921777|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83921778|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83921779|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83921780|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921781|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921782|NCT00464256|Hormones|hormones|mesh-ancestor
83921783|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921784|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921785|NCT00433823|Atorvastatin|atorvastatin|mesh-list
83921786|NCT00433823|Ezetimibe|ezetimibe|mesh-list
83921787|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83921788|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83921789|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
83921790|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921791|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83921792|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83921793|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921794|NCT00464295|Capecitabine|capecitabine|mesh-list
83921795|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921796|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
83921797|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921798|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921799|NCT03273036|Triamcinolone|triamcinolone|mesh-list
83921800|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83921801|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
83921802|NCT03273036|Hormones|hormones|mesh-ancestor
83921803|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921804|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921805|NCT03270735|Thrombin|thrombin|mesh-list
83921806|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
83921807|NCT03270735|Coagulants|coagulants|mesh-ancestor
83921808|NCT04702685|Ropivacaine|ropivacaine|mesh-list
83921809|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
83921810|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
83921811|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921812|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921813|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
83921814|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921815|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
83921816|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83921817|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83921818|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83921819|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921820|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921821|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
83921822|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921823|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921824|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83921825|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921826|NCT00472368|Panobinostat|panobinostat|mesh-list
83921827|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921828|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83921829|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921830|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921831|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
83921832|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83921833|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921834|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921835|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83921836|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921837|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83921838|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
83921839|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
83921840|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83921841|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921842|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921843|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83921844|NCT00464451|Analgesics|analgesics|mesh-ancestor
83921845|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
83921846|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921847|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83921848|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83921849|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83921850|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
83921851|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921852|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921853|NCT00433940|Prednisolone|prednisolone|mesh-list
83921854|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83921855|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
83921856|NCT00433940|Hormones|hormones|mesh-ancestor
83921857|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921858|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921859|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83921860|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921861|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83921862|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
83921863|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921864|NCT01050764|Vidarabine|vidarabine|mesh-list
83921865|NCT01050764|Fludarabine|fludarabine|mesh-list
83921866|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
83921867|NCT01050764|Melphalan|melphalan|mesh-list
83921868|NCT01050764|Thiotepa|thiotepa|mesh-list
83921869|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
83921870|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83921871|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921872|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921873|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
83921874|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921875|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83921876|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
83921877|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921878|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
83921879|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921880|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83921881|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
83921882|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83921883|NCT00434096|Rimonabant|rimonabant|mesh-list
83921884|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83921885|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83921886|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83921887|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921888|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921889|NCT00434096|Hormones|hormones|mesh-ancestor
83921890|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83921891|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921892|NCT01050569|Nicotine|nicotine|mesh-list
83921893|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83921894|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
83921895|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921896|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921897|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83921898|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83921899|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
83921900|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921901|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921902|NCT04702490|Empagliflozin|empagliflozin|mesh-list
83921903|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83921904|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921905|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83921906|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921907|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
83921908|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83921909|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83921910|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921911|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83921912|NCT00464763|Analgesics|analgesics|mesh-ancestor
83921913|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
83921914|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83921915|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83921916|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83921917|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83921918|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
83921919|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921920|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921921|NCT00434135|Paclitaxel|paclitaxel|mesh-list
83921922|NCT00434135|Gemcitabine|gemcitabine|mesh-list
83921923|NCT00434135|Pemetrexed|pemetrexed|mesh-list
83921924|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83921925|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921926|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
83921927|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
83921928|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
83921929|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921930|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921931|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
83921932|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921933|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83921934|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83921935|NCT01050530|Tolvaptan|tolvaptan|mesh-list
83921936|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83921937|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921938|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
83921939|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921940|NCT01050257|Oseltamivir|oseltamivir|mesh-list
83921941|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
83921942|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83921943|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921944|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921945|NCT03272802|Riluzole|riluzole|mesh-list
83921946|NCT03272802|Edaravone|edaravone|mesh-list
83921947|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83921948|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
83921949|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921950|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83921951|NCT03272802|Protective Agents|protective agents|mesh-ancestor
83921952|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921953|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
83921954|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83921955|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83921956|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921957|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83921958|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83921959|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83921960|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921961|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921962|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83921963|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921964|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
83921965|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83921966|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83921967|NCT01050062|Telmisartan|telmisartan|mesh-list
83921968|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83921969|NCT01050062|Diuretics|diuretics|mesh-ancestor
83921970|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
83921971|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921972|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83921973|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83921974|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921975|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83921976|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83921977|NCT00464919|Sorafenib|sorafenib|mesh-list
83921978|NCT00464919|Tegafur|tegafur|mesh-list
83921979|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921980|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83921981|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921982|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921983|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83921984|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
83921985|NCT00434174|Pemetrexed|pemetrexed|mesh-list
83921986|NCT00434174|Everolimus|everolimus|mesh-list
83921987|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83921988|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83921989|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83921990|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83921991|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83921992|NCT00434174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83921993|NCT00434174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83921994|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83921995|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
83921996|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83921997|NCT00464958|Tizanidine|tizanidine|mesh-list
83921998|NCT00464958|Analgesics|analgesics|mesh-ancestor
83921999|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
83922000|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922001|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922002|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
83922003|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83922004|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83922005|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
83922006|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
83922007|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83922008|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83922009|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83922010|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922011|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922012|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922013|NCT00472758|Sifalimumab|sifalimumab|mesh-list
83922014|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
83922015|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922016|NCT01055444|Lidocaine|lidocaine|mesh-list
83922017|NCT01055444|Tetracaine|tetracaine|mesh-list
83922018|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
83922019|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
83922020|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922021|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922022|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
83922023|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922024|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83922025|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83922026|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83922027|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922028|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922029|NCT01055015|Morphine|morphine|mesh-list
83922030|NCT01055015|Oxycodone|oxycodone|mesh-list
83922031|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83922032|NCT01055015|Narcotics|narcotics|mesh-ancestor
83922033|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922034|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922035|NCT01055015|Analgesics|analgesics|mesh-ancestor
83922036|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
83922037|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922038|NCT00472875|Glyburide|glyburide|mesh-list
83922039|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83922040|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922041|NCT00434291|Nemonoxacin|nemonoxacin|mesh-list
83922042|NCT00434291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922043|NCT00434291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922044|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
83922045|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83922046|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922047|NCT00472953|Insulin|insulin|mesh-list
83922048|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83922049|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
83922050|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83922051|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922052|NCT02957630|Drospirenone|drospirenone|mesh-list
83922053|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
83922054|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83922055|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83922056|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
83922057|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83922058|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922059|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83922060|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83922061|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83922062|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83922063|NCT02957630|Estrogens|estrogens|mesh-ancestor
83922064|NCT02957630|Hormones|hormones|mesh-ancestor
83922065|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922066|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83922067|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
83922068|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83922069|NCT02957630|Diuretics|diuretics|mesh-ancestor
83922070|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
83922071|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83922072|NCT00465036|Cathartics|cathartics|mesh-ancestor
83922073|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922074|NCT04702061|Anesthetics|anesthetics|mesh-list
83922075|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922076|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922077|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
83922078|NCT00465075|Estrogens|estrogens|mesh-list
83922079|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83922080|NCT00465075|Hormones|hormones|mesh-ancestor
83922081|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922082|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922083|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83922084|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83922085|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
83922086|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83922087|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83922088|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83922089|NCT00465192|Estradiol|estradiol|mesh-list
83922090|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83922091|NCT00465192|Estrogens|estrogens|mesh-ancestor
83922092|NCT00465192|Hormones|hormones|mesh-ancestor
83922093|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922094|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922095|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83922096|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
83922097|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83922098|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83922099|NCT00434681|Acetaminophen|acetaminophen|mesh-list
83922100|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83922101|NCT00434681|Analgesics|analgesics|mesh-ancestor
83922102|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
83922103|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922104|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922105|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
83922106|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
83922107|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922108|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922109|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922110|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
83922111|NCT00473070|Hormones|hormones|mesh-ancestor
83922112|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922113|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922114|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83922115|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83922116|NCT00465231|Fentanyl|fentanyl|mesh-list
83922117|NCT00465231|Bupivacaine|bupivacaine|mesh-list
83922118|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
83922119|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
83922120|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922121|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922122|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
83922123|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922124|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83922125|NCT00465231|Narcotics|narcotics|mesh-ancestor
83922126|NCT00465231|Analgesics|analgesics|mesh-ancestor
83922127|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83922128|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83922129|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
83922130|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83922131|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
83922132|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922133|NCT04702334|Lidocaine|lidocaine|mesh-list
83922134|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
83922135|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
83922136|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
83922137|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922138|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922139|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
83922140|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922141|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83922142|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83922143|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83922144|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922145|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922146|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83922147|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
83922148|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
83922149|NCT04702334|Protective Agents|protective agents|mesh-ancestor
83922150|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
83922151|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83922152|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922153|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922154|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83922155|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83922156|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922157|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922158|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922159|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83922160|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
83922161|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83922162|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922163|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83922164|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83922165|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83922166|NCT00435305|Vancomycin|vancomycin|mesh-list
83922167|NCT00435305|Meropenem|meropenem|mesh-list
83922168|NCT00435305|Linezolid|linezolid|mesh-list
83922170|NCT00435305|Piperacillin|piperacillin|mesh-list
83922171|NCT00435305|Ceftazidime|ceftazidime|mesh-list
83922172|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83922173|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922174|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922175|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83922176|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922177|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922178|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83922179|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
83922180|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83922181|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83922182|NCT00465543|Analgesics|analgesics|mesh-ancestor
83922183|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
83922184|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922185|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922186|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922187|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83922188|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
83922189|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922190|NCT00465543|Protective Agents|protective agents|mesh-ancestor
83922191|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83922192|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83922193|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
83922194|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922195|NCT00435500|Fluorides|fluorides|mesh-list
83922196|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
83922197|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
83922198|NCT00435500|Protective Agents|protective agents|mesh-ancestor
83922199|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922200|NCT03272412|Progesterone|progesterone|mesh-list
83922201|NCT03272412|Progestins|progestins|mesh-ancestor
83922202|NCT03272412|Hormones|hormones|mesh-ancestor
83922203|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922204|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922205|NCT00473616|Irinotecan|irinotecan|mesh-list
83922206|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83922207|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83922208|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922209|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922210|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922211|NCT00435851|Hormones|hormones|mesh-list
83922212|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922213|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922214|NCT00436124|Oseltamivir|oseltamivir|mesh-list
83922215|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
83922216|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922217|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922218|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922219|NCT02957474|Omeprazole|omeprazole|mesh-list
83922220|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83922221|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922222|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83922223|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922224|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922225|NCT00436241|Capecitabine|capecitabine|mesh-list
83922226|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
83922227|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83922228|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
83922229|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922230|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922231|NCT00481455|Temozolomide|temozolomide|mesh-list
83922232|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83922233|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83922234|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
83922235|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922236|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922237|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
83922238|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
83922239|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
83922240|NCT00481533|Oxytocin|oxytocin|mesh-list
83922241|NCT00481533|Ergonovine|ergonovine|mesh-list
83922242|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
83922243|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83922244|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922245|NCT00481572|Terlipressin|terlipressin|mesh-list
83922246|NCT00481572|Vasopressins|vasopressins|mesh-list
83922247|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
83922248|NCT00481572|Norepinephrine|norepinephrine|mesh-list
83922249|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83922250|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83922251|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922252|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922253|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922254|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922255|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
83922256|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
83922257|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922258|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83922259|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
83922260|NCT00481572|Coagulants|coagulants|mesh-ancestor
83922261|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83922262|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
83922263|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83922264|NCT00474006|Daunorubicin|daunorubicin|mesh-list
83922265|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83922266|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922267|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83922268|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83922269|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922270|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922271|NCT04697745|Dexamethasone|dexamethasone|mesh-list
83922272|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
83922273|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922274|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
83922275|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
83922276|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922277|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922278|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922279|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
83922280|NCT04697745|Hormones|hormones|mesh-ancestor
83922281|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922282|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83922283|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922284|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83922285|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922286|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83922287|NCT04697745|Analgesics|analgesics|mesh-ancestor
83922288|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
83922289|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83922290|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83922291|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83922292|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922293|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922294|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922295|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
83922296|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922297|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922298|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83922299|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83922300|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922301|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922302|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922303|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83922304|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922305|NCT00436709|Paclitaxel|paclitaxel|mesh-list
83922306|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
83922307|NCT00436709|Bevacizumab|bevacizumab|mesh-list
83922308|NCT00436709|Doxorubicin|doxorubicin|mesh-list
83922309|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83922310|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83922311|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83922312|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922313|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83922314|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83922315|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83922316|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922317|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83922318|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
83922319|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922320|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83922321|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83922322|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
83922323|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83922324|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83922325|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83922326|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83922327|NCT00436709|Growth Substances|growth substances|mesh-ancestor
83922328|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
83922329|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83922330|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83922331|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83922332|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922334|NCT00436787|Fondaparinux|fondaparinux|mesh-list
83922335|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83922336|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
83922337|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83922338|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
83922339|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922340|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922341|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
83922342|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83922343|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83922344|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83922345|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83922346|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83922347|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
83922348|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922349|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922350|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922351|NCT00481728|Urological Agents|urological agents|mesh-ancestor
83922352|NCT00436943|Bupropion|bupropion|mesh-list
83922353|NCT00436943|Nicotine|nicotine|mesh-list
83922354|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83922355|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
83922356|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922357|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922358|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83922359|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83922360|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
83922361|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922362|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922363|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83922364|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
83922365|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83922366|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83922367|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83922368|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922369|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
83922370|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83922371|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922372|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922373|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83922374|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
83922375|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
83922376|NCT00481884|Petrolatum|petrolatum|mesh-list
83922377|NCT00481884|Emollients|emollients|mesh-ancestor
83922378|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
83922379|NCT00481923|Rimonabant|rimonabant|mesh-list
83922380|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83922381|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83922382|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83922383|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922384|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922385|NCT00481923|Hormones|hormones|mesh-ancestor
83922386|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922387|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922388|NCT00481962|Tigecycline|tigecycline|mesh-list
83922389|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922390|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922391|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83161633|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
83922392|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922393|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922394|NCT00437177|Apomorphine|apomorphine|mesh-list
83922395|NCT00437177|Emetics|emetics|mesh-ancestor
83922396|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922397|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
83922398|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922399|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922400|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
83922401|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
83922402|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922403|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922404|NCT00437333|Metformin|metformin|mesh-list
83922405|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83922406|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922407|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83922408|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83922409|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922410|NCT00482079|Incretins|incretins|mesh-ancestor
83922411|NCT00482079|Hormones|hormones|mesh-ancestor
83922412|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922413|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83922414|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
83922415|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922416|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922417|NCT00437372|Sunitinib|sunitinib|mesh-list
83922418|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922419|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83922420|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83922421|NCT00437372|Growth Substances|growth substances|mesh-ancestor
83922422|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922423|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
83922424|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83922425|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922426|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922427|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
83922428|NCT00437450|Hematinics|hematinics|mesh-ancestor
83922429|NCT04701710|Ivermectin|ivermectin|mesh-list
83922430|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83922431|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922432|NCT00437606|Ethanol|ethanol|mesh-list
83922433|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83922434|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922435|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922436|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922437|NCT00482313|Methylphenidate|methylphenidate|mesh-list
83922438|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83922439|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922440|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83922441|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83922442|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922443|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922444|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
83922445|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922446|NCT00437684|Ribavirin|ribavirin|mesh-list
83922447|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83922448|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
83922449|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922450|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
83922451|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922452|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
83922453|NCT00437723|Hematinics|hematinics|mesh-ancestor
83922454|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
83922455|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83922456|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83922457|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83922458|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922459|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922460|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
83922461|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922462|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922463|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83922464|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922465|NCT00482508|Omalizumab|omalizumab|mesh-list
83161739|NCT00393991|Xhance|xhance|mesh-list
83922466|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83922467|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83922468|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
83922469|NCT00437918|Acarbose|acarbose|mesh-list
83922470|NCT00437918|Nateglinide|nateglinide|mesh-list
83922471|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83922472|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922473|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922474|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83922475|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922476|NCT00437957|Temozolomide|temozolomide|mesh-list
83922477|NCT00437957|Valproic Acid|valproic acid|mesh-list
83922478|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83922479|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
83922480|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922481|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922482|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
83922483|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922484|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
83922485|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922486|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922487|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
83922488|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83922489|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922490|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83922491|NCT03270176|Avelumab|avelumab|mesh-list
83922492|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83922493|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922494|NCT00474279|Hormones|hormones|mesh-list
83922495|NCT00474279|Secretagogues|secretagogues|mesh-list
83922496|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922497|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922498|NCT03270696|Propofol|propofol|mesh-list
83922499|NCT03270696|Rocuronium|rocuronium|mesh-list
83922500|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83922501|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922502|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922503|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83922504|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
83922505|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
83922506|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83922507|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83922508|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83922509|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922510|NCT00437996|Clonidine|clonidine|mesh-list
83922511|NCT00437996|Sufentanil|sufentanil|mesh-list
83922512|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
83922513|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83922514|NCT00437996|Narcotics|narcotics|mesh-ancestor
83922515|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922516|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922517|NCT00437996|Analgesics|analgesics|mesh-ancestor
83922518|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
83922519|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922520|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83922521|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83922522|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
83922523|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
83922524|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83922525|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
83922526|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
83922527|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83922528|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83922529|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83922530|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922531|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922532|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922533|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
83922534|NCT04701242|Ezetimibe|ezetimibe|mesh-list
83922535|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83922536|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83922537|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
83922538|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922539|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83922540|NCT00474435|Tenofovir|tenofovir|mesh-list
83161783|NCT02191007|Vitamins|vitamins|mesh-ancestor
83922541|NCT00474435|Emtricitabine|emtricitabine|mesh-list
83922542|NCT00474435|Efavirenz|efavirenz|mesh-list
83922543|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
83922544|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922545|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83922546|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83922547|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922548|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922549|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83922550|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83922551|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83922552|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922553|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83922554|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83922555|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83922556|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83922557|NCT04701320|Methamphetamine|methamphetamine|mesh-list
83922558|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83922559|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922560|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
83922561|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
83922562|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922563|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
83922564|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922565|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922566|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922567|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83922568|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83922569|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922570|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83922571|NCT00438113|Atenolol|atenolol|mesh-list
83922572|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83922573|NCT00438113|Terazosin|terazosin|mesh-list
83922574|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83922575|NCT00438113|Diuretics|diuretics|mesh-ancestor
83922576|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
83922577|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922578|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83922579|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922580|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922581|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83922582|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
83922583|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
83922584|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922585|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83922586|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83922587|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83922588|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922589|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922590|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83922591|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83922592|NCT00438113|Urological Agents|urological agents|mesh-ancestor
83922593|NCT00438152|Ritonavir|ritonavir|mesh-list
83922594|NCT00438152|Lopinavir|lopinavir|mesh-list
83922595|NCT00438152|Saquinavir|saquinavir|mesh-list
83922596|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83922597|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83922598|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
83922599|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922600|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922601|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83922602|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83922603|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
83922604|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922605|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83922606|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922607|NCT00438230|Warfarin|warfarin|mesh-list
83922608|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
83922609|NCT00438269|Metronidazole|metronidazole|mesh-list
83922610|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
83922611|NCT00438269|Meropenem|meropenem|mesh-list
83922612|NCT00438269|Cefazolin|cefazolin|mesh-list
83922613|NCT00438269|Tazobactam|tazobactam|mesh-list
83922614|NCT00438269|Piperacillin|piperacillin|mesh-list
83922615|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83922616|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922617|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922618|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83922619|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83922620|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83922621|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83922622|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922623|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922624|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922625|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83922626|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922627|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83922628|NCT00474591|PENTA|penta|mesh-list
83922629|NCT00474591|Fondaparinux|fondaparinux|mesh-list
83922630|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83922631|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
83922632|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83922633|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
83922634|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922635|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922636|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
83922637|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83922638|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83922639|NCT03279809|Aspirin|aspirin|mesh-list
83922640|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83922641|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83922642|NCT03279809|Analgesics|analgesics|mesh-ancestor
83922643|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
83922644|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922645|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922646|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922647|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83922648|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83922649|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83922650|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922651|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83922652|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83922653|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922654|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
83922655|NCT00438386|Aripiprazole|aripiprazole|mesh-list
83922656|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
83922657|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83922658|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83922659|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83922660|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922661|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922662|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
83922663|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
83922664|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922665|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922666|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83922667|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83922668|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
83922669|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83922670|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83922671|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83922672|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83922673|NCT00475059|Cimetidine|cimetidine|mesh-list
83922674|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83922675|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922676|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83922677|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
83922678|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
83922679|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922680|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922681|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922682|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83922683|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922684|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922685|NCT00475098|Tinzaparin|tinzaparin|mesh-list
83922686|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83922687|NCT00475098|Dalteparin|dalteparin|mesh-list
83922688|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
83922689|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83922690|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83161934|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
83922691|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922693|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
83922694|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83922695|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922696|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922697|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83922698|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922699|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83922700|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83922701|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922702|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83922703|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83922704|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83922705|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
83922706|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922707|NCT00475293|Panitumumab|panitumumab|mesh-list
83922708|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922709|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83922710|NCT00438737|Leucovorin|leucovorin|mesh-list
83922711|NCT00438737|Bevacizumab|bevacizumab|mesh-list
83922712|NCT00438737|Cetuximab|cetuximab|mesh-list
83922713|NCT00438737|Fluorouracil|fluorouracil|mesh-list
83922714|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
83922715|NCT00438737|Calcium|calcium|mesh-list
83922716|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
83922717|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83922718|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922719|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83922720|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83922721|NCT00438737|Growth Substances|growth substances|mesh-ancestor
83922722|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922723|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
83922724|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83922725|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
83922726|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922727|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83922728|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83922729|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
83922730|NCT00438737|Antidotes|antidotes|mesh-ancestor
83922731|NCT00438737|Protective Agents|protective agents|mesh-ancestor
83922732|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
83922733|NCT00438737|Vitamins|vitamins|mesh-ancestor
83922734|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
83922735|NCT00438776|Olanzapine|olanzapine|mesh-list
83922736|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
83922737|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
83922738|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922739|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922740|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922741|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83922742|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83922743|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83922744|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83922745|NCT00438776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83922746|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83922747|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922748|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922749|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922750|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
83922751|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83922752|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
83922753|NCT00475410|Coagulants|coagulants|mesh-ancestor
83922754|NCT00475527|Amoxicillin|amoxicillin|mesh-list
83922755|NCT00475527|Metronidazole|metronidazole|mesh-list
83922756|NCT00475527|Clarithromycin|clarithromycin|mesh-list
83922757|NCT00475527|Omeprazole|omeprazole|mesh-list
83922758|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922759|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922760|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83922761|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83922762|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83922763|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922764|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83922765|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922766|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922767|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83922768|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83922769|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922771|NCT00439049|Modafinil|modafinil|mesh-list
83922772|NCT00439049|Amphetamine|amphetamine|mesh-list
83922773|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
83922774|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83922775|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83922776|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922777|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
83922778|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922779|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83922780|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83922781|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83922782|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83922783|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922784|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
83922785|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
83922786|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
83922787|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922788|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922789|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83922790|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83922791|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922792|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83922793|NCT00475566|Everolimus|everolimus|mesh-list
83922794|NCT00475566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83922795|NCT00475566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83922796|NCT00475566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922797|NCT00475566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922798|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83922799|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
83922800|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922801|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922802|NCT00439166|Doxycycline|doxycycline|mesh-list
83922803|NCT00439166|Rifampin|rifampin|mesh-list
83922804|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922805|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922806|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
83922807|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83922808|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83922809|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83922810|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
83922811|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
83922812|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83922813|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922814|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922815|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83922816|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83922817|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83922818|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83922819|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83922820|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83922821|NCT00439283|Infliximab|infliximab|mesh-list
83922822|NCT00439283|Methotrexate|methotrexate|mesh-list
83922823|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83922824|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
83922825|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83922826|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922827|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83922828|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
83922829|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922830|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922831|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83922832|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922833|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83922834|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83922835|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
83922836|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83922837|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83922838|NCT00439283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83922839|NCT00439283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922840|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83922841|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
83922842|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83922843|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83922844|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922845|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922846|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83922847|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83922848|NCT00475800|Analgesics|analgesics|mesh-ancestor
83922849|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
83922850|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922851|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922852|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922853|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83922854|NCT00439361|Carboplatin|carboplatin|mesh-list
83922855|NCT00439361|Etoposide|etoposide|mesh-list
83922856|NCT00439361|Bortezomib|bortezomib|mesh-list
83922857|NCT00439361|Ifosfamide|ifosfamide|mesh-list
83922858|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922859|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83922860|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83922861|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83922862|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922863|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922864|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83922865|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
83922866|NCT00475917|Gemcitabine|gemcitabine|mesh-list
83922867|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83922868|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
83922869|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922870|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922871|NCT00474669|Docetaxel|docetaxel|mesh-list
83922872|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922873|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83922874|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83922875|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83922876|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922877|NCT00439400|Doxycycline|doxycycline|mesh-list
83922878|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83922879|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922880|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
83922881|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83922882|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83922883|NCT00475956|Cediranib|cediranib|mesh-list
83922884|NCT00475956|Saracatinib|saracatinib|mesh-list
83922885|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922886|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83922887|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922888|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922889|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
83922890|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83922891|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83922892|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922893|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922894|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83922895|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83922896|NCT00476034|Analgesics|analgesics|mesh-ancestor
83922897|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
83922898|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922899|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922900|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922901|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83922902|NCT00476073|Fluticasone|fluticasone|mesh-list
83922903|NCT00476073|Xhance|xhance|mesh-list
83922904|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
83922905|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922906|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83922907|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
83922908|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922909|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922910|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83922911|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
83922912|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
83922913|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83922914|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83922915|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83922916|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83922917|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922918|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922919|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922921|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
83922922|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83922923|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
83922924|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922925|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922926|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83922927|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
83922928|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83922929|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83922930|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83922931|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
83922932|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922933|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922934|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922935|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
83922936|NCT00476268|Hormones|hormones|mesh-ancestor
83922937|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83922938|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83922939|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83922940|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83922941|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83922942|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922943|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922944|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922945|NCT00105989|Analgesics|analgesics|mesh-ancestor
83922946|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
83922947|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922948|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
83922949|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83922950|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
83922951|NCT00476346|Vitamin D|vitamin d|mesh-list
83922952|NCT00476346|Calcium|calcium|mesh-list
83922953|NCT00476346|Vitamins|vitamins|mesh-ancestor
83922954|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
83922955|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922956|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83922957|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83922958|NCT00476424|Efavirenz|efavirenz|mesh-list
83922959|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83922960|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83922961|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922962|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922963|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
83922964|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922965|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83922966|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83922967|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83922968|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83922969|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83922970|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83922971|NCT00439712|Levocetirizine|levocetirizine|mesh-list
83922972|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83922973|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83922974|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
83922975|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
83922976|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83922977|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922978|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922979|NCT00476463|Emtricitabine|emtricitabine|mesh-list
83922980|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
83922981|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83922982|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83922983|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83922984|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83922985|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83922986|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83922987|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83922988|NCT00439751|Goserelin|goserelin|mesh-list
83922989|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83922990|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83922991|NCT00438243|Bromfenac|bromfenac|mesh-list
83922992|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83922993|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83922994|NCT00438243|Analgesics|analgesics|mesh-ancestor
83922995|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
83922996|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83922997|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83922998|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83922999|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923000|NCT00439829|Cetrorelix|cetrorelix|mesh-list
83923001|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83923002|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
83923003|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83923004|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923005|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
83923006|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923007|NCT03277248|Teriflunomide|teriflunomide|mesh-list
83923008|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923009|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923010|NCT03277248|Analgesics|analgesics|mesh-ancestor
83923011|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
83923012|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923013|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923014|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923015|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923016|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83923017|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
83923018|NCT00440024|Tazarotene|tazarotene|mesh-list
83923019|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
83923020|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
83923021|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
83923022|NCT00440063|Hematinics|hematinics|mesh-ancestor
83923023|NCT00440102|Ketamine|ketamine|mesh-list
83923024|NCT00440102|Etomidate|etomidate|mesh-list
83923025|NCT00440102|Analgesics|analgesics|mesh-ancestor
83923026|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
83923027|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923028|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923029|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83923030|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83923031|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
83923032|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
83923033|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923034|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83923035|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83923036|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923037|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923038|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83923039|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
83923040|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923041|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923042|NCT00476541|Immunotoxins|immunotoxins|mesh-ancestor
83923043|NCT00476541|Immunoconjugates|immunoconjugates|mesh-ancestor
83923044|NCT00476541|Immunologic Factors|immunologic factors|mesh-ancestor
83923045|NCT00476541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923046|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83923047|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83923048|NCT00440141|Latanoprost|latanoprost|mesh-list
83923049|NCT00440141|Brinzolamide|brinzolamide|mesh-list
83923050|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83923051|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83923052|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83923053|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83923054|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83923055|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
83923056|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923057|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923058|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923059|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83923060|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162288|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
83923061|NCT00438321|Anastrozole|anastrozole|mesh-list
83923062|NCT00438321|Goserelin|goserelin|mesh-list
83923063|NCT00438321|Testosterone|testosterone|mesh-list
83923064|NCT00438321|Androgens|androgens|mesh-ancestor
83923065|NCT00438321|Hormones|hormones|mesh-ancestor
83923066|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923067|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923068|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83923069|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923070|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83923071|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83923072|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923073|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923074|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83923075|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83923076|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
83923077|NCT00476619|Hematinics|hematinics|mesh-ancestor
83923078|NCT03279536|Lactoferrin|lactoferrin|mesh-list
83923079|NCT03279536|Dextrans|dextrans|mesh-list
83923080|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
83923081|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923082|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
83923083|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
83923084|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
83923085|NCT03279536|Hematinics|hematinics|mesh-ancestor
83923086|NCT00440219|Prednisone|prednisone|mesh-list
83923087|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923088|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
83923089|NCT00440219|Hormones|hormones|mesh-ancestor
83923090|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923091|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923092|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83923093|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923094|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83923095|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83923096|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923097|NCT00440258|Cabergoline|cabergoline|mesh-list
83923098|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83923099|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83923100|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
83923101|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
83923102|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923103|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923104|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923105|NCT00440336|Latanoprost|latanoprost|mesh-list
83923106|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83923107|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83923108|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
83923109|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83923110|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923111|NCT00440414|Pemetrexed|pemetrexed|mesh-list
83923112|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83923113|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923114|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923115|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923116|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83923117|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83923118|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83923119|NCT03270462|Tacrolimus|tacrolimus|mesh-list
83923120|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83923121|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
83923122|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923123|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83923124|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923125|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923126|NCT00440609|Ranibizumab|ranibizumab|mesh-list
83923127|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83923128|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83923129|NCT00440609|Growth Substances|growth substances|mesh-ancestor
83923130|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923131|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
83923132|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923133|NCT00440648|Sevelamer|sevelamer|mesh-list
83923134|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
83923135|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
83923136|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923138|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923139|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83923140|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
83923141|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923142|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923143|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83923144|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
83923145|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
83923146|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83923147|NCT03271047|Nivolumab|nivolumab|mesh-list
83923148|NCT03271047|Ipilimumab|ipilimumab|mesh-list
83923149|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923150|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923151|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83923152|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923153|NCT00440765|Bortezomib|bortezomib|mesh-list
83923154|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923155|NCT00440804|Ibuprofen|ibuprofen|mesh-list
83923156|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923157|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923158|NCT00440804|Analgesics|analgesics|mesh-ancestor
83923159|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
83923160|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923161|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923162|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923163|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923164|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83923165|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923166|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923167|NCT00440843|Olanzapine|olanzapine|mesh-list
83923168|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
83923169|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
83923170|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923171|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923172|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923173|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83923174|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83923175|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923176|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83923177|NCT00440843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83923178|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83923179|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83923180|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923181|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923182|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
83923183|NCT00438789|Eculizumab|eculizumab|mesh-list
83923184|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83923185|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83923186|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
83923187|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923188|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83923189|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
83923190|NCT00440921|Coagulants|coagulants|mesh-ancestor
83923191|NCT00440960|Lidocaine|lidocaine|mesh-list
83923192|NCT00440960|Midazolam|midazolam|mesh-list
83923193|NCT00440960|Alfentanil|alfentanil|mesh-list
83923194|NCT00440960|Propofol|propofol|mesh-list
83923195|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
83923196|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
83923197|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923198|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923199|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
83923200|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923201|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83923202|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83923203|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83923204|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83923205|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923206|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83923207|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83923208|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
83923209|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83923210|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83923211|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83923213|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
83923214|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
83923215|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923216|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83923217|NCT00440960|Narcotics|narcotics|mesh-ancestor
83923218|NCT00440960|Analgesics|analgesics|mesh-ancestor
83923219|NCT00438828|Dexamethasone|dexamethasone|mesh-list
83923220|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923221|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
83923222|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
83923223|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923224|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923225|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923226|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
83923227|NCT00438828|Hormones|hormones|mesh-ancestor
83923228|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923229|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83923230|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923231|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
83923232|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923233|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83923234|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923235|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923236|NCT00106002|Pemetrexed|pemetrexed|mesh-list
83923237|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923238|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923239|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923240|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83923241|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83923242|NCT00476853|Nevirapine|nevirapine|mesh-list
83923243|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83923244|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83923245|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923246|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923247|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
83923248|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923249|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83923250|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83923251|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83923252|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83923253|NCT00438906|Secretin|secretin|mesh-list
83923254|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923255|NCT00438906|Hormones|hormones|mesh-ancestor
83923256|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923257|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923258|NCT00438945|Eprosartan|eprosartan|mesh-list
83923259|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83923260|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83923261|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83923262|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923263|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
83923264|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83923265|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83923266|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
83923267|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923268|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923269|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923270|NCT00441428|Urological Agents|urological agents|mesh-ancestor
83923271|NCT00438984|Aldesleukin|aldesleukin|mesh-list
83923272|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
83923273|NCT00438984|Interleukin-2|interleukin-2|mesh-list
83923274|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83923275|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
83923276|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923277|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923278|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83923279|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
83923280|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923281|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923282|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83923283|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923284|NCT00438984|Analgesics|analgesics|mesh-ancestor
83162534|NCT02376309|Nandrolone|nandrolone|mesh-list
83923285|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
83923286|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923288|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83923289|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
83923290|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923291|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83923292|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923293|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923294|NCT00441662|Triamcinolone|triamcinolone|mesh-list
83923295|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923296|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
83923297|NCT00441662|Hormones|hormones|mesh-ancestor
83923298|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923299|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923300|NCT00439062|Roxithromycin|roxithromycin|mesh-list
83923301|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83923302|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923303|NCT02957162|Atorvastatin|atorvastatin|mesh-list
83923304|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83923305|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83923306|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
83923307|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923308|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83923309|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83923310|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923311|NCT00441740|Gemcitabine|gemcitabine|mesh-list
83923312|NCT00441740|Docetaxel|docetaxel|mesh-list
83923313|NCT00441740|Vinorelbine|vinorelbine|mesh-list
83923314|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83923315|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
83923316|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923317|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923318|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
83923319|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
83923320|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
83923321|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83923322|NCT02274012|Paclitaxel|paclitaxel|mesh-list
83923323|NCT02274012|Afatinib|afatinib|mesh-list
83923324|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83923325|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923326|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
83923327|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83923328|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83152238|NCT02581982|Paclitaxel|paclitaxel|mesh-list
83923329|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923330|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83923331|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923332|NCT00477048|Saquinavir|saquinavir|mesh-list
83923333|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83923334|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83923335|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
83923336|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923337|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923338|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83923339|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83923340|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
83923341|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923342|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83923343|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83923344|NCT00477126|Ritonavir|ritonavir|mesh-list
83923345|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83923346|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83923347|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
83923348|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923349|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923350|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83923351|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83923352|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
83923353|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923354|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83923355|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83923356|NCT03279341|Prucalopride|prucalopride|mesh-list
83923357|NCT03279341|Bisacodyl|bisacodyl|mesh-list
83923358|NCT03279341|Laxatives|laxatives|mesh-ancestor
83923359|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923360|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83923361|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83923362|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
83923363|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923364|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923365|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923366|NCT03279341|Cathartics|cathartics|mesh-ancestor
83923367|NCT03279146|Tenofovir|tenofovir|mesh-list
83923368|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
83923369|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923370|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83923371|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83923372|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923373|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923374|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83923375|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83923376|NCT00442052|Aspirin|aspirin|mesh-list
83923377|NCT00442052|Omeprazole|omeprazole|mesh-list
83923378|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923379|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923380|NCT00442052|Analgesics|analgesics|mesh-ancestor
83923381|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
83923382|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923383|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923384|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923385|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923386|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83923387|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83923388|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923389|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83923390|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83923391|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923392|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
83923393|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83923394|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923395|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83923396|NCT00477282|Topotecan|topotecan|mesh-list
83923397|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83923398|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83923399|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923400|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923401|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923402|NCT00439530|Oseltamivir|oseltamivir|mesh-list
83923403|NCT00439530|Probenecid|probenecid|mesh-list
83923404|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
83923405|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923406|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923407|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923408|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
83923409|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
83923410|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923411|NCT00442325|Atorvastatin|atorvastatin|mesh-list
83923412|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83923413|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83923414|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
83923415|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923416|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83923417|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83923418|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923419|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
83923420|NCT00477516|Calcium|calcium|mesh-list
83923421|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83923422|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923423|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83923424|NCT00477711|Capecitabine|capecitabine|mesh-list
83923425|NCT00477711|Cetuximab|cetuximab|mesh-list
83923426|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923427|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83923428|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
83923429|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923430|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923431|NCT00442403|Chloroquine|chloroquine|mesh-list
83923432|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83923433|NCT00442403|Amebicides|amebicides|mesh-ancestor
83923434|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83923435|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83923436|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923437|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
83923438|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923439|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923440|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83923441|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
83923442|NCT00477789|Allopurinol|allopurinol|mesh-list
83923443|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
83923444|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923445|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923446|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
83923447|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923448|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83923449|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
83923450|NCT00477789|Protective Agents|protective agents|mesh-ancestor
83923451|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923452|NCT00442481|Escitalopram|escitalopram|mesh-list
83923453|NCT00442481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83923454|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83923455|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83923456|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923457|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923458|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
83923459|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923460|NCT00442637|Bevacizumab|bevacizumab|mesh-list
83923461|NCT00442637|Capecitabine|capecitabine|mesh-list
83923462|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923463|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923464|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83923465|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83923466|NCT00442637|Growth Substances|growth substances|mesh-ancestor
83923467|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923468|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
83923469|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83923470|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
83923471|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923472|NCT00442676|Celecoxib|celecoxib|mesh-list
83923473|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923474|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923475|NCT00442676|Analgesics|analgesics|mesh-ancestor
83923476|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
83923477|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923478|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923479|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923480|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923481|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83923482|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83923483|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923484|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923485|NCT00477945|Clofarabine|clofarabine|mesh-list
83923486|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83923487|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
83923488|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923489|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923490|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
83923491|NCT00442793|Hematinics|hematinics|mesh-ancestor
83923492|NCT00442832|Vancomycin|vancomycin|mesh-list
83923493|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83923494|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923495|NCT00477984|Ethanol|ethanol|mesh-list
83923496|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83923497|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923498|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923499|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923500|NCT00478101|Fentanyl|fentanyl|mesh-list
83923501|NCT00478101|Oxycodone|oxycodone|mesh-list
83923502|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83923503|NCT00478101|Narcotics|narcotics|mesh-ancestor
83923504|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923505|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923506|NCT00478101|Analgesics|analgesics|mesh-ancestor
83923507|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
83923508|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923509|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83923510|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83923511|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
83923512|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
83923513|NCT00440076|Bortezomib|bortezomib|mesh-list
83923514|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923515|NCT00443105|Tacrolimus|tacrolimus|mesh-list
83923516|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83923517|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
83923518|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923519|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83923520|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923521|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923522|NCT00443144|Hormones|hormones|mesh-list
83923523|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923524|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923525|NCT00440154|Ezetimibe|ezetimibe|mesh-list
83923526|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83923527|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83923528|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
83923529|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923530|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83923531|NCT00478374|Doxorubicin|doxorubicin|mesh-list
83923532|NCT00478374|Sorafenib|sorafenib|mesh-list
83923533|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83923534|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923535|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83923536|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83923537|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923538|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923539|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83923540|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
83923541|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83923542|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
83923543|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923544|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923545|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83923546|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
83923547|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923548|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923549|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83923550|NCT03279549|Mitogens|mitogens|mesh-list
83923551|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83923552|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923553|NCT03271983|Metronidazole|metronidazole|mesh-list
83923554|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923555|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83923556|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83923557|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83923558|NCT00443222|Infliximab|infliximab|mesh-list
83923559|NCT00443222|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83923560|NCT00443222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923561|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83923562|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923563|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923564|NCT00440349|Tamoxifen|tamoxifen|mesh-list
83923565|NCT00440349|Prednisone|prednisone|mesh-list
83923566|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923567|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
83923568|NCT00440349|Hormones|hormones|mesh-ancestor
83923569|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923570|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923571|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83923572|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923573|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83923574|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
83923575|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83923576|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83923577|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83923578|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
83923579|NCT00443339|Hematinics|hematinics|mesh-ancestor
83923580|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
83923581|NCT04700228|Bupivacaine|bupivacaine|mesh-list
83923582|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
83923583|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
83923584|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923585|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923587|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923588|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83923589|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923590|NCT04700228|Analgesics|analgesics|mesh-ancestor
83923591|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83923592|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83923593|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83923594|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
83923595|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923596|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923597|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83923598|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83923599|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83923600|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83923601|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923602|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923603|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923604|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
83923605|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83923606|NCT03278522|Ramosetron|ramosetron|mesh-list
83923607|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
83923608|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
83923609|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923610|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923611|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923612|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83923613|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
83923614|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923615|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923616|NCT00440622|Gemcitabine|gemcitabine|mesh-list
83923617|NCT00440622|Capecitabine|capecitabine|mesh-list
83923618|NCT00440622|Trastuzumab|trastuzumab|mesh-list
83923619|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83923620|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
83923621|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923622|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923623|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923624|NCT00440661|Diacerein|diacerein|mesh-list
83923625|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923626|NCT03278444|Trimetazidine|trimetazidine|mesh-list
83923627|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
83923628|NCT00440739|Etoricoxib|etoricoxib|mesh-list
83923629|NCT00440739|Flavoxate|flavoxate|mesh-list
83923630|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923631|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923632|NCT00440739|Analgesics|analgesics|mesh-ancestor
83923633|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
83923634|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923635|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923636|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923637|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923638|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83923639|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83923640|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923641|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923642|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
83923643|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
83923644|NCT00440739|Urological Agents|urological agents|mesh-ancestor
83923645|NCT00443573|Protein C|protein c|mesh-list
83923646|NCT00443573|Anticoagulants|anticoagulants|mesh-list
83923647|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83923648|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83923649|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923650|NCT00478764|Triamcinolone|triamcinolone|mesh-list
83923651|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923652|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
83923653|NCT00478764|Hormones|hormones|mesh-ancestor
83923654|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923655|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923656|NCT00440778|Abciximab|abciximab|mesh-list
83923657|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
83923658|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83923659|NCT03278405|Avelumab|avelumab|mesh-list
83923660|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923661|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923662|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83923663|NCT00443612|Irbesartan|irbesartan|mesh-list
83923664|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83923665|NCT00443612|Diuretics|diuretics|mesh-ancestor
83923666|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
83923667|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923668|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83923669|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83923670|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923671|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83923672|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83923673|NCT00443690|Rolofylline|rolofylline|mesh-list
83923674|NCT00443690|Diuretics|diuretics|mesh-ancestor
83923675|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
83923676|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923677|NCT00440895|Abciximab|abciximab|mesh-list
83923678|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
83923679|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83923680|NCT00440973|Bevacizumab|bevacizumab|mesh-list
83923681|NCT00440973|Interleukin-2|interleukin-2|mesh-list
83923682|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923683|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923684|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83923685|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83923686|NCT00440973|Growth Substances|growth substances|mesh-ancestor
83923687|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923688|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
83923689|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923690|NCT00440973|Analgesics|analgesics|mesh-ancestor
83923691|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
83923692|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923693|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83923694|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83923695|NCT00441051|Diclofenac|diclofenac|mesh-list
83923696|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923697|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923698|NCT00441051|Analgesics|analgesics|mesh-ancestor
83923699|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
83923700|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923701|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923702|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923703|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923704|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83923705|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923706|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923707|NCT00443963|Esomeprazole|esomeprazole|mesh-list
83923708|NCT00443963|Ranitidine|ranitidine|mesh-list
83923709|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83923710|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923711|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83923712|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923713|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923714|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83923715|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
83923716|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
83923717|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923718|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923719|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
83923720|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
83923721|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923722|NCT00441207|Protective Agents|protective agents|mesh-ancestor
83923723|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923724|NCT00441207|Vitamins|vitamins|mesh-ancestor
83923725|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
83923726|NCT00444041|Bevacizumab|bevacizumab|mesh-list
83923727|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923728|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923729|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83923730|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83923731|NCT00444041|Growth Substances|growth substances|mesh-ancestor
83923732|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923733|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
83923734|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
83923735|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
83923736|NCT00441246|Ephedrine|ephedrine|mesh-list
83923737|NCT00441246|Guaifenesin|guaifenesin|mesh-list
83923738|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83923739|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83923740|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
83923741|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923742|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923743|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83923744|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
83923745|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
83923746|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83923747|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83923748|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
83923749|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
83923750|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923751|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923752|NCT00441246|Expectorants|expectorants|mesh-ancestor
83923753|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83923754|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83923755|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
83923756|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83923757|NCT00478959|Lenalidomide|lenalidomide|mesh-list
83923758|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
83923759|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923760|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83923761|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83923762|NCT00478959|Growth Substances|growth substances|mesh-ancestor
83923763|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
83923764|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923765|NCT00444236|Esomeprazole|esomeprazole|mesh-list
83923766|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83923767|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923768|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83923769|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923770|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923771|NCT00478998|Tamsulosin|tamsulosin|mesh-list
83923772|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83923773|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83923774|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83923775|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
83923776|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923777|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923778|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923779|NCT00478998|Urological Agents|urological agents|mesh-ancestor
83923780|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83923781|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923782|NCT00479076|Aflibercept|aflibercept|mesh-list
83923783|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83923784|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83923785|NCT00479076|Growth Substances|growth substances|mesh-ancestor
83923786|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923787|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
83923788|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923789|NCT00441519|Aspirin|aspirin|mesh-list
83923790|NCT00441519|Omeprazole|omeprazole|mesh-list
83923791|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923792|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923793|NCT00441519|Analgesics|analgesics|mesh-ancestor
83923794|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
83923795|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923796|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923797|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923798|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83923799|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83923800|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83923801|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923802|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83923803|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83923804|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923805|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
83923806|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83923807|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923808|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83163045|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923810|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83923811|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83923812|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
83923813|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923814|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83923815|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83923816|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923817|NCT00479193|Bacitracin|bacitracin|mesh-list
83923818|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83923819|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923820|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83923821|NCT03278015|Paclitaxel|paclitaxel|mesh-list
83923822|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83923823|NCT03278015|Gemcitabine|gemcitabine|mesh-list
83923824|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83923825|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923826|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83923827|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83923828|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83923829|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923830|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83923831|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
83923832|NCT00444314|Sunitinib|sunitinib|mesh-list
83923833|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923834|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83923835|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83923836|NCT00444314|Growth Substances|growth substances|mesh-ancestor
83923837|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923838|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
83923839|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83923840|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923841|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923842|NCT02274051|Kinetin|kinetin|mesh-list
83923843|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83923844|NCT02274051|Growth Substances|growth substances|mesh-ancestor
83923845|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923846|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
83923847|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83923848|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83923849|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923850|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
83923851|NCT00444470|Coagulants|coagulants|mesh-ancestor
83923852|NCT00444548|Reboxetine|reboxetine|mesh-list
83923853|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
83923854|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83923855|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83923856|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83923857|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83923858|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923859|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
83923860|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923861|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923862|NCT00444665|Travoprost|travoprost|mesh-list
83923863|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83923864|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
83923865|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83923866|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923867|NCT04699643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83923868|NCT04699643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923869|NCT02274090|Metformin|metformin|mesh-list
83923870|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83923871|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923872|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
83923873|NCT00479661|Propofol|propofol|mesh-list
83923874|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83923875|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923876|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923877|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923878|NCT00479661|Analgesics|analgesics|mesh-ancestor
83923879|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
83923880|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923881|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83923882|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83923883|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83923884|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
83923885|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923886|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923887|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83923888|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
83923889|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
83923890|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
83923891|NCT04700670|Coagulants|coagulants|mesh-ancestor
83923892|NCT00441870|Folic Acid|folic acid|mesh-list
83923893|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
83923894|NCT00441870|Hematinics|hematinics|mesh-ancestor
83923895|NCT00441870|Vitamins|vitamins|mesh-ancestor
83923896|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
83923897|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923898|NCT04700592|Ketamine|ketamine|mesh-list
83923899|NCT04700592|Gabapentin|gabapentin|mesh-list
83923900|NCT04700592|Analgesics|analgesics|mesh-ancestor
83923901|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
83923902|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923903|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923904|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83923905|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83923906|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
83923907|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
83923908|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923909|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83923910|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83923911|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923912|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923913|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
83923914|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83923915|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83923916|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83923917|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
83923918|NCT00441909|UC-781|uc-781|mesh-list
83923919|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83923920|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
83923921|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923922|NCT00445016|Anesthetics|anesthetics|mesh-list
83923923|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923924|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923925|NCT00445055|Droperidol|droperidol|mesh-list
83923926|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83923927|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
83923928|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
83923929|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923930|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923931|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83923932|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83923933|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83923934|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83923935|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83923936|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83923937|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83923938|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
83923939|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923940|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923941|NCT00479739|Fluticasone|fluticasone|mesh-list
83923942|NCT00479739|Xhance|xhance|mesh-list
83923943|NCT00479739|Budesonide|budesonide|mesh-list
83923944|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
83923945|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83923946|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83923947|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83923948|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
83923949|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83923950|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923951|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83923952|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
83923953|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
83923954|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83923955|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
83923956|NCT00479739|Hormones|hormones|mesh-ancestor
83923957|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923958|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83923959|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83923960|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83923962|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83923963|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923964|NCT00445094|Vancomycin|vancomycin|mesh-list
83923965|NCT00445094|Imipenem|imipenem|mesh-list
83923966|NCT00445094|Amikacin|amikacin|mesh-list
83923967|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83923968|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83923969|NCT00445094|Cilastatin|cilastatin|mesh-list
83923970|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83923971|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83923972|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923973|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83923974|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83923975|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83923976|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
83923977|NCT00479778|Estrogens|estrogens|mesh-list
83923978|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83923979|NCT00479778|Hormones|hormones|mesh-ancestor
83923980|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83923981|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83923982|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83923983|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83923984|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
83923985|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83923986|NCT00442026|Gemcitabine|gemcitabine|mesh-list
83923987|NCT00442026|Docetaxel|docetaxel|mesh-list
83923988|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83923989|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
83923990|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83923991|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83923992|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
83923993|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
83923994|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
83923995|NCT00479895|Chrysarobin|chrysarobin|mesh-list
83923996|NCT00479895|HBOC 201|hboc 201|mesh-list
83923997|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83923998|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83923999|NCT00479895|Analgesics|analgesics|mesh-ancestor
83924000|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
83924001|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924002|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924003|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924004|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83924005|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
83924006|NCT00445250|Calcipotriene|calcipotriene|mesh-list
83924007|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
83924008|NCT03279120|Tenofovir|tenofovir|mesh-list
83924009|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
83924010|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
83924011|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924012|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83924013|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83924014|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924015|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924016|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83924017|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83924018|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83924019|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
83924020|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83924021|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924022|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83924023|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83924024|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83924025|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
83924026|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924027|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924028|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924029|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924030|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83924031|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83924032|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924033|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924034|NCT03274700|Tamsulosin|tamsulosin|mesh-list
83924035|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83924036|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83924037|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83924038|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
83924039|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924040|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924041|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924042|NCT03274700|Urological Agents|urological agents|mesh-ancestor
83924043|NCT00442221|Naproxen|naproxen|mesh-list
83924044|NCT00442221|Sumatriptan|sumatriptan|mesh-list
83924045|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83924046|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83924047|NCT00442221|Analgesics|analgesics|mesh-ancestor
83924048|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
83924049|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924050|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924051|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924052|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83924053|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
83924054|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83924055|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924056|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924057|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83924058|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83924059|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83924060|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
83924061|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924062|NCT00454259|Fentanyl|fentanyl|mesh-list
83924063|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83924064|NCT00454259|Narcotics|narcotics|mesh-ancestor
83924065|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924066|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924067|NCT00454259|Analgesics|analgesics|mesh-ancestor
83924068|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
83924069|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924070|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83924071|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83924072|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
83924073|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
83924074|NCT03278808|Azithromycin|azithromycin|mesh-list
83924075|NCT03278808|Chloroquine|chloroquine|mesh-list
83924076|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83924077|NCT03278808|Atovaquone|atovaquone|mesh-list
83924078|NCT03278808|Proguanil|proguanil|mesh-list
83924079|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83924080|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924081|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924082|NCT03278808|Amebicides|amebicides|mesh-ancestor
83924083|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83924084|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83924085|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
83924086|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83924087|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83924088|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83924089|NCT03278808|Analgesics|analgesics|mesh-ancestor
83924090|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
83924091|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924092|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924093|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924094|NCT03278808|Filaricides|filaricides|mesh-ancestor
83924095|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
83924096|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
83924097|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924098|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924099|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
83924100|NCT00480090|Cytarabine|cytarabine|mesh-list
83924101|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83924102|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
83924103|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924104|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924105|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
83924106|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924107|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924108|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
83924109|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924110|NCT00454883|Ziprasidone|ziprasidone|mesh-list
83924111|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83924112|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
83924113|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924114|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924115|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924116|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83924117|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83924118|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924119|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83924120|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83924121|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
83924122|NCT03278652|Analgesics|analgesics|mesh-list
83924123|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
83924124|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924125|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924126|NCT00454961|Lumefantrine|lumefantrine|mesh-list
83924127|NCT00454961|Artemether|artemether|mesh-list
83924128|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83924129|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
83924130|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83924131|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83924132|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924133|NCT00455039|Lapatinib|lapatinib|mesh-list
83924134|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924135|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924136|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924137|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924138|NCT00480207|Folic Acid|folic acid|mesh-list
83924139|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
83924140|NCT00480207|Hematinics|hematinics|mesh-ancestor
83924141|NCT00480207|Vitamins|vitamins|mesh-ancestor
83924142|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
83924143|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924144|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83924145|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924146|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924147|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924148|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924149|NCT02956655|Insulin|insulin|mesh-list
83924150|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83924151|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83924152|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924153|NCT00480246|Perphenazine|perphenazine|mesh-list
83924154|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83924155|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83924156|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924157|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924158|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83924159|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83924160|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
83924161|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924162|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924163|NCT00455117|Parecoxib|parecoxib|mesh-list
83924164|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83924165|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83924166|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924167|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924168|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83924169|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83924170|NCT00455117|Analgesics|analgesics|mesh-ancestor
83924171|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
83924172|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924173|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924174|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924175|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83924176|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
83924177|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924178|NCT03274427|Trimetazidine|trimetazidine|mesh-list
83924179|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
83924180|NCT00455234|Promethazine|promethazine|mesh-list
83924181|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
83924182|NCT00455234|Haloperidol|haloperidol|mesh-list
83924183|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
83924184|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
83924185|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
83924186|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924187|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924188|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83924189|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83924190|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83924191|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924192|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83924193|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83924194|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
83924195|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924196|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924197|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83924198|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
83924199|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
83924200|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83924201|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
83924202|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
83924203|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83924204|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83924205|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83924206|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
83924207|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
83924208|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
83924209|NCT00480363|Dexamethasone|dexamethasone|mesh-list
83924210|NCT00480363|Lenalidomide|lenalidomide|mesh-list
83924211|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924212|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
83924213|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
83924214|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924215|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924216|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83924217|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
83924218|NCT00480363|Hormones|hormones|mesh-ancestor
83924219|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924220|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83924221|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924222|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
83924223|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83924224|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83924225|NCT00480363|Growth Substances|growth substances|mesh-ancestor
83924226|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
83924227|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
83924228|NCT00442845|Atorvastatin|atorvastatin|mesh-list
83924229|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83924230|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83924231|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
83924232|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924233|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83924234|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83924235|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924236|NCT00455507|Istradefylline|istradefylline|mesh-list
83924237|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83924238|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83924239|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83924240|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
83924241|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924242|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924243|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924244|NCT00480402|Progesterone|progesterone|mesh-list
83924245|NCT00480402|Progestins|progestins|mesh-ancestor
83924246|NCT00480402|Hormones|hormones|mesh-ancestor
83924247|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924248|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924249|NCT00455585|Lamivudine|lamivudine|mesh-list
83924250|NCT00455585|Nevirapine|nevirapine|mesh-list
83924251|NCT00455585|Stavudine|stavudine|mesh-list
83924252|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83924253|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83924254|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924255|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924256|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
83924257|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924258|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83924259|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83924260|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83924261|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83163506|NCT05518734|Midazolam|midazolam|mesh-list
83924262|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
83924263|NCT00455624|Androgens|androgens|mesh-list
83924264|NCT00455624|Hormones|hormones|mesh-ancestor
83924265|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924266|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924267|NCT00455897|Rituximab|rituximab|mesh-list
83924268|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83924269|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924270|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
83924271|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924272|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83924273|NCT00455936|Gefitinib|gefitinib|mesh-list
83924274|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924275|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924276|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924277|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924278|NCT00443235|Thalidomide|thalidomide|mesh-list
83924279|NCT00443235|Prednisone|prednisone|mesh-list
83924280|NCT00443235|Melphalan|melphalan|mesh-list
83924281|NCT00443235|Bortezomib|bortezomib|mesh-list
83924282|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924283|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
83924284|NCT00443235|Hormones|hormones|mesh-ancestor
83924285|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924286|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924287|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83924288|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924289|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83924290|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
83924291|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924292|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83924293|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924294|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
83924295|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
83924296|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924297|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924298|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83924299|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83924300|NCT00443235|Growth Substances|growth substances|mesh-ancestor
83924301|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
83924302|NCT04700943|Anesthetics|anesthetics|mesh-list
83924303|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924304|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924305|NCT00456248|Ribavirin|ribavirin|mesh-list
83924306|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
83924307|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
83924308|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924309|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
83924310|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924311|NCT00480558|Vaccines|vaccines|mesh-list
83924312|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
83924313|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924314|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
83924315|NCT04700709|Sirolimus|sirolimus|mesh-list
83924316|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83924317|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924318|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83924319|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
83924320|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924321|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924322|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924323|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924324|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
83924325|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924326|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
83924327|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924328|NCT04698317|Mitogens|mitogens|mesh-list
83924329|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
83924330|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924331|NCT04700475|Citric Acid|citric acid|mesh-list
83924332|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
83924333|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
83924334|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83924335|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
83924336|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
83924337|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924338|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83924339|NCT04700436|Ezetimibe|ezetimibe|mesh-list
83924340|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83924341|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83924342|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
83924343|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924344|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83924345|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83924346|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924347|NCT00480597|Gemcitabine|gemcitabine|mesh-list
83924348|NCT00480597|Capecitabine|capecitabine|mesh-list
83924349|NCT00480597|Vinorelbine|vinorelbine|mesh-list
83924350|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924351|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83924352|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
83924353|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924354|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83924355|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
83924356|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
83924357|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
83924358|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83924359|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924360|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
83924361|NCT00456482|Hormones|hormones|mesh-ancestor
83924362|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924363|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924364|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83924365|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
83924366|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83924367|NCT00480675|Prednisolone|prednisolone|mesh-list
83924368|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
83924369|NCT00480675|Bupivacaine|bupivacaine|mesh-list
83924370|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83924371|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
83924372|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
83924373|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
83924374|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924375|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924376|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
83924377|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924378|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83924379|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
83924380|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
83924381|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83924382|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
83924383|NCT00480675|Hormones|hormones|mesh-ancestor
83924384|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924385|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83924386|NCT00480675|Protective Agents|protective agents|mesh-ancestor
83924387|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83924388|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924389|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
83924390|NCT00456560|Paroxetine|paroxetine|mesh-list
83924391|NCT00456560|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83924392|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83924393|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924394|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924395|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924396|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
83924397|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924398|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83924399|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
83924400|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83924401|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83924402|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83924403|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924404|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83924405|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83924406|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924407|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83924408|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83924409|NCT00456677|Minocycline|minocycline|mesh-list
83924410|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924411|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924412|NCT00456716|Sorafenib|sorafenib|mesh-list
83924413|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924414|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924415|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924416|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924417|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
83924418|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
83924419|NCT00456794|Istradefylline|istradefylline|mesh-list
83924420|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83924421|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83924422|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83924423|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
83924424|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924425|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924426|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924427|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83924428|NCT00456833|Everolimus|everolimus|mesh-list
83924429|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924430|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924431|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924432|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924433|NCT00456833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83924434|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924435|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
83924436|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924437|NCT00456872|Lidocaine|lidocaine|mesh-list
83924438|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
83924439|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
83924440|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924441|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924442|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
83924443|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924444|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83924445|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83924446|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83924447|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924448|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924449|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
83924450|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
83924451|NCT04700046|Mexiletine|mexiletine|mesh-list
83924452|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83924453|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83924454|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83924455|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924456|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924457|NCT00457067|Ranibizumab|ranibizumab|mesh-list
83924458|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83924459|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83924460|NCT00457067|Growth Substances|growth substances|mesh-ancestor
83924461|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924462|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
83924463|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924464|NCT00480870|Donepezil|donepezil|mesh-list
83924465|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83924466|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924467|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924468|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
83924469|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924470|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924471|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
83924472|NCT00457106|Risperidone|risperidone|mesh-list
83924473|NCT00457106|Paroxetine|paroxetine|mesh-list
83924474|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83924475|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
83924476|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924477|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924478|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924479|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83924480|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83924481|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924482|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83924483|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83924484|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
83924485|NCT00457106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83924486|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83924487|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924488|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83924489|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
83924490|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83924491|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83924492|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924493|NCT00457145|Ranibizumab|ranibizumab|mesh-list
83924494|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83924495|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83924496|NCT00457145|Growth Substances|growth substances|mesh-ancestor
83924497|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924498|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
83924499|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924500|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83924501|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
83924502|NCT00457223|Coagulants|coagulants|mesh-ancestor
83924503|NCT00443508|Everolimus|everolimus|mesh-list
83924504|NCT00443508|Tacrolimus|tacrolimus|mesh-list
83924505|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924506|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
83924507|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924508|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83924509|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924510|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924511|NCT00443508|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83924512|NCT00443508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924513|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924514|NCT00457340|Atorvastatin|atorvastatin|mesh-list
83924515|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83924516|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83924517|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
83924518|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924519|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83924520|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83924521|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924522|NCT03278379|Avelumab|avelumab|mesh-list
83924523|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83924524|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924525|NCT02956538|Thalidomide|thalidomide|mesh-list
83924526|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924527|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
83924528|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924529|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
83924530|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924531|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924532|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83924533|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83924534|NCT02956538|Growth Substances|growth substances|mesh-ancestor
83924535|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
83924536|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924537|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83924538|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83924539|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83924540|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
83924541|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924542|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83924543|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83924544|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924545|NCT00457769|Donepezil|donepezil|mesh-list
83924546|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83924547|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924548|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924549|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
83924550|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924551|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924552|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
83924553|NCT00457808|Sirolimus|sirolimus|mesh-list
83924554|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924555|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924556|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83924557|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924558|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
83924559|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924560|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
83924561|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924562|NCT00481143|Deferasirox|deferasirox|mesh-list
83924563|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83924564|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
83924565|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
83924566|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924567|NCT00457964|Everolimus|everolimus|mesh-list
83924568|NCT00457964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83924569|NCT00457964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924570|NCT00457964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924571|NCT00457964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924572|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924573|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
83924574|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924575|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924576|NCT00458042|Treprostinil|treprostinil|mesh-list
83924577|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83924578|NCT00458081|Rimonabant|rimonabant|mesh-list
83924579|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83924580|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83924581|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83924582|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924583|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924584|NCT00458081|Hormones|hormones|mesh-ancestor
83924585|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924586|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924587|NCT00481182|Ritonavir|ritonavir|mesh-list
83924588|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
83924589|NCT00481182|Methadone|methadone|mesh-list
83924590|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83924591|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83924592|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
83924593|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924594|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924595|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83924596|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83924597|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
83924598|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924599|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83924600|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83924601|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83924602|NCT00481182|Narcotics|narcotics|mesh-ancestor
83924603|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924604|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924605|NCT00481182|Analgesics|analgesics|mesh-ancestor
83924606|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
83924607|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924608|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
83924609|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83924610|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
83924611|NCT00443937|Everolimus|everolimus|mesh-list
83924612|NCT00443937|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83924613|NCT00443937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924614|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924615|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924616|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924617|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
83924618|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924619|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924620|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83924621|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83924622|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
83924623|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924624|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924625|NCT00458315|Paclitaxel|paclitaxel|mesh-list
83924626|NCT00458315|Bevacizumab|bevacizumab|mesh-list
83924627|NCT00458315|Gemcitabine|gemcitabine|mesh-list
83924628|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83924629|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924630|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
83924631|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83924632|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83924633|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924634|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83924635|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83924636|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83924638|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924639|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
83924640|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83924641|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
83924642|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83924643|NCT00444015|Dasatinib|dasatinib|mesh-list
83924644|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924645|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83924646|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924647|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924648|NCT00458510|Fentanyl|fentanyl|mesh-list
83924649|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83924650|NCT00458510|Narcotics|narcotics|mesh-ancestor
83924651|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924652|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924653|NCT00458510|Analgesics|analgesics|mesh-ancestor
83924654|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
83924655|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924656|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83924657|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83924658|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
83924659|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
83924660|NCT00444132|Clopidogrel|clopidogrel|mesh-list
83924661|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83924662|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83924663|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83924664|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83924665|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
83924666|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924667|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924668|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924669|NCT00444171|Insulin|insulin|mesh-list
83924670|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83924671|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83924672|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924673|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
83924674|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924675|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924676|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83924677|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83924678|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048329|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
83924679|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924680|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924681|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83924682|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83924683|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83924684|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924685|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924686|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
83924687|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924688|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924689|NCT00459173|Rimonabant|rimonabant|mesh-list
83924690|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83924691|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83924692|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83924693|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924694|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924695|NCT00459173|Hormones|hormones|mesh-ancestor
83924696|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83924697|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924698|NCT00444249|Dipivefrin|dipivefrin|mesh-list
83924699|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83924700|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83924701|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924702|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924703|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924704|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83924705|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
83924706|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924707|NCT00459407|Protective Agents|protective agents|mesh-ancestor
83924708|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924710|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83924711|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924712|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83924713|NCT03278262|Aflibercept|aflibercept|mesh-list
83924714|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83924715|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83924716|NCT03278262|Growth Substances|growth substances|mesh-ancestor
83924717|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924718|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
83924719|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924720|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
83924721|NCT00459485|Astringents|astringents|mesh-ancestor
83924722|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924723|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
83924724|NCT00459563|Vitamin D|vitamin d|mesh-list
83924725|NCT00459563|Calcitriol|calcitriol|mesh-list
83924726|NCT00459563|Vitamins|vitamins|mesh-ancestor
83924727|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
83924728|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924729|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83924730|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83924731|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83924732|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924733|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924734|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83924735|NCT01242384|Silicon|silicon|mesh-list
83924736|NCT01242384|Trace Elements|trace elements|mesh-ancestor
83924737|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
83924738|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924739|NCT00488436|Cyclosporine|cyclosporine|mesh-list
83924740|NCT00488436|Cyclosporins|cyclosporins|mesh-list
83924741|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83924742|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924743|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924744|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924745|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
83924746|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924747|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
83924748|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924749|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
83924750|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83924751|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83924752|NCT00459719|Tacrolimus|tacrolimus|mesh-list
83924753|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924754|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
83924755|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924756|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83924757|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924758|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924759|NCT00495183|Biperiden|biperiden|mesh-list
83924760|NCT00495183|Caffeine|caffeine|mesh-list
83924761|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83924762|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924763|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83924764|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924765|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924766|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83924767|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83924768|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
83924769|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924770|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83924771|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83924772|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
83924773|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
83924774|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924775|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83924776|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83924777|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
83924778|NCT00488670|Escitalopram|escitalopram|mesh-list
83924779|NCT00488670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83924780|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83924781|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83164025|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
83924782|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924783|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924784|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
83924785|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924786|NCT00459836|Gemcitabine|gemcitabine|mesh-list
83924787|NCT00459836|Docetaxel|docetaxel|mesh-list
83924788|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83924789|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
83924790|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924791|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924792|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
83924793|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
83924794|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
83924795|NCT00488709|Cytarabine|cytarabine|mesh-list
83924796|NCT00488709|Fludarabine|fludarabine|mesh-list
83924797|NCT00488709|Topotecan|topotecan|mesh-list
83924798|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924799|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83924800|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
83924801|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924802|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83924803|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
83924804|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924805|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
83924806|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924807|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83924808|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83924809|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924810|NCT00459992|Betahistine|betahistine|mesh-list
83924811|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
83924812|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
83924813|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
83924814|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924815|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924816|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924817|NCT00495339|Levofloxacin|levofloxacin|mesh-list
83924818|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83924819|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924820|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924821|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83924822|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83924823|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924824|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924825|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924826|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83924827|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83924828|NCT00460148|Ropinirole|ropinirole|mesh-list
83924829|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83924830|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83924831|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
83924832|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
83924833|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924834|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924835|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924836|NCT00460226|Lamotrigine|lamotrigine|mesh-list
83924837|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
83924838|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83924839|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924840|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924841|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83924842|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924843|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83924844|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83924845|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924846|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83924847|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83924848|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
83924849|NCT00495378|Hematinics|hematinics|mesh-ancestor
83924850|NCT00460304|Pramlintide|pramlintide|mesh-list
83924851|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83924852|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924853|NCT00460382|Ritonavir|ritonavir|mesh-list
83924854|NCT00460382|Darunavir|darunavir|mesh-list
83924855|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
83924856|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
83924857|NCT00460382|Etravirine|etravirine|mesh-list
83924858|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83924859|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83924860|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
83924861|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924862|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924864|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83924865|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
83924866|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924867|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83924868|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83924869|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83924870|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83924871|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83924872|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83924873|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83924874|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83924875|NCT01242579|Maraviroc|maraviroc|mesh-list
83924876|NCT01242579|Dapivirine|dapivirine|mesh-list
83924877|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83924878|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83924879|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924880|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83924881|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83924882|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
83924883|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924884|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83924885|NCT00460499|Insulin|insulin|mesh-list
83924886|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83924887|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924888|NCT00495573|Acyclovir|acyclovir|mesh-list
83924889|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
83924890|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924891|NCT00488787|Ketamine|ketamine|mesh-list
83924892|NCT00488787|Analgesics|analgesics|mesh-ancestor
83924893|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
83924894|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924895|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924896|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83924897|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83924898|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
83924899|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
83924900|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83924901|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83924902|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83924903|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924904|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924905|NCT00460616|Cabergoline|cabergoline|mesh-list
83924906|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83924907|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83924908|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
83924909|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
83924910|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924911|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924912|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924913|NCT00495651|Isoniazid|isoniazid|mesh-list
83924914|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83924915|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
83924916|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924917|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924918|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83924919|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83924920|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
83924921|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924922|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83924923|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
83924924|NCT00460733|Vitamin D|vitamin d|mesh-list
83924925|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
83924926|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
83924927|NCT00460733|Calcium|calcium|mesh-list
83924928|NCT00460733|Vitamins|vitamins|mesh-ancestor
83924929|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
83924930|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924931|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83924932|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83924933|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83924934|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83924935|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924936|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83924937|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
83924938|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924940|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83924941|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83924942|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
83924943|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924944|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83924945|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83924946|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924947|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
83924948|NCT00460928|Antibodies|antibodies|mesh-list
83924949|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
83924950|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83924951|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83924952|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
83924953|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924954|NCT00461084|Clarithromycin|clarithromycin|mesh-list
83924955|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83924956|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924957|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83924958|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924959|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924960|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83924961|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83924962|NCT00495846|Octreotide|octreotide|mesh-list
83924963|NCT00495846|Lanreotide|lanreotide|mesh-list
83924964|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83924965|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83924966|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83924967|NCT00105482|Naltrexone|naltrexone|mesh-list
83924968|NCT00105482|Nicotine|nicotine|mesh-list
83924969|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83924970|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
83924971|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83924972|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924973|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83924974|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83924975|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
83924976|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83924977|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924978|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83924979|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83924980|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
83924981|NCT00496002|Adefovir|adefovir|mesh-list
83924982|NCT00496002|Clevudine|clevudine|mesh-list
83924983|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
83924984|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924985|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83924986|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83924987|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924988|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83924989|NCT00489099|Vaccines|vaccines|mesh-list
83924990|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
83924991|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83924992|NCT00496158|Adefovir|adefovir|mesh-list
83924993|NCT00496158|Clevudine|clevudine|mesh-list
83924994|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
83924995|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83924996|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83924997|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83924998|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83924999|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925000|NCT00489138|Ertapenem|ertapenem|mesh-list
83925001|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925002|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925003|NCT00461396|Interferons|interferons|mesh-list
83925004|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
83925005|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925006|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
83925007|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164253|NCT01565499|Paclitaxel|paclitaxel|mesh-list
83925008|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83925009|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
83925010|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925011|NCT01327651|Tenofovir|tenofovir|mesh-list
83925012|NCT01327651|Emtricitabine|emtricitabine|mesh-list
83925013|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
83925014|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925015|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83925016|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83925017|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925018|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925019|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83925020|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83925021|NCT00496275|Cisplatin|cisplatin|mesh-list
83925022|NCT00496275|Gemcitabine|gemcitabine|mesh-list
83925023|NCT00496275|Vinorelbine|vinorelbine|mesh-list
83925024|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925025|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925026|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
83925027|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925028|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83925029|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
83925030|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
83925031|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
83925032|NCT00591604|Vitamin D|vitamin d|mesh-list
83925033|NCT00591604|Vitamins|vitamins|mesh-ancestor
83925034|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
83925035|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925036|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83925037|NCT00591643|Epinephrine|epinephrine|mesh-list
83925038|NCT00591643|Racepinephrine|racepinephrine|mesh-list
83925039|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
83925040|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83925041|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83925042|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
83925043|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925044|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925045|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925046|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83925047|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83925048|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
83925049|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925050|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83925051|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
83925052|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
83925053|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
83925054|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83925055|NCT00461747|Thalidomide|thalidomide|mesh-list
83925056|NCT00461747|Dexamethasone|dexamethasone|mesh-list
83925057|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
83925058|NCT00461747|Bortezomib|bortezomib|mesh-list
83925059|NCT00461747|BB 1101|bb 1101|mesh-list
83925060|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925061|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
83925062|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
83925063|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925064|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925065|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83925066|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
83925067|NCT00461747|Hormones|hormones|mesh-ancestor
83925068|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925069|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83925070|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925071|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
83925072|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925073|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925074|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925075|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
83925076|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
83925077|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925078|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925079|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925080|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925081|NCT00461747|Growth Substances|growth substances|mesh-ancestor
83925082|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925083|NCT00461825|Cyclosporine|cyclosporine|mesh-list
83925084|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
83925085|NCT00461825|Azathioprine|azathioprine|mesh-list
83925086|NCT00461825|Cyclosporins|cyclosporins|mesh-list
83925087|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925088|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925089|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925090|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
83925091|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925092|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
83925093|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925094|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
83925095|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925096|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83925097|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83925098|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925099|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83925100|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
83925101|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925102|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
83925103|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925104|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83925105|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
83925106|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925107|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
83925108|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83925109|NCT00489372|Protective Agents|protective agents|mesh-ancestor
83925110|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925111|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925112|NCT00461903|Perindopril|perindopril|mesh-list
83925113|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83925114|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
83925115|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925116|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925117|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83925119|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83925120|NCT00496392|Narcotics|narcotics|mesh-ancestor
83925121|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83925122|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925123|NCT00496392|Analgesics|analgesics|mesh-ancestor
83925124|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
83925125|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925126|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83925127|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83925128|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
83925129|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
83925130|NCT02893618|Diazoxide|diazoxide|mesh-list
83925131|NCT02893618|Choline|choline|mesh-list
83925132|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
83925133|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83925134|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
83925135|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925136|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83925137|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83925138|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
83925139|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83925140|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
83925141|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
83925142|NCT00496665|Methotrexate|methotrexate|mesh-list
83925143|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925144|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
83925145|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925146|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925147|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83925148|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
83925149|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925150|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925151|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83925152|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83925153|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
83925154|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83925155|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925156|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
83925157|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
83925158|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925159|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83925160|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83925161|NCT00496704|Gemcitabine|gemcitabine|mesh-list
83925162|NCT00496704|Capecitabine|capecitabine|mesh-list
83925163|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
83925164|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925165|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
83925166|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925167|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925168|NCT00591916|Thrombin|thrombin|mesh-list
83925169|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
83925170|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
83925171|NCT00591916|Coagulants|coagulants|mesh-ancestor
83925172|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83925173|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
83925174|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925175|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
83925176|NCT00591916|Protective Agents|protective agents|mesh-ancestor
83925177|NCT00462215|Vaccines|vaccines|mesh-list
83925178|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
83925179|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925180|NCT00462371|Insulin|insulin|mesh-list
83925181|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925182|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925183|NCT00497016|Atorvastatin|atorvastatin|mesh-list
83925184|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83925185|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83925186|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
83925187|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925188|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83925189|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83925190|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925191|NCT00222872|Hormones|hormones|mesh-list
83925192|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
83925193|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
83925194|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925195|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925196|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83925197|NCT00497172|Sirolimus|sirolimus|mesh-list
83925198|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925199|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925200|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83925201|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925202|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
83925203|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925204|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
83925205|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925206|NCT03273296|Amoxicillin|amoxicillin|mesh-list
83925207|NCT03273296|Azithromycin|azithromycin|mesh-list
83925208|NCT03273296|Vancomycin|vancomycin|mesh-list
83925209|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925210|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925211|NCT00497250|Gefitinib|gefitinib|mesh-list
83925212|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925213|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925214|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925215|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925216|NCT00462878|Vancomycin|vancomycin|mesh-list
83925217|NCT00462878|Meropenem|meropenem|mesh-list
83925218|NCT00462878|Teicoplanin|teicoplanin|mesh-list
83925219|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925220|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925221|NCT00462956|Lapatinib|lapatinib|mesh-list
83925222|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925223|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925224|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925225|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925226|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83925227|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925228|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925229|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925230|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925231|NCT00489528|Hormones|hormones|mesh-list
83925232|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925233|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925234|NCT00463073|Bevacizumab|bevacizumab|mesh-list
83925235|NCT00463073|Cetuximab|cetuximab|mesh-list
83925236|NCT00463073|Irinotecan|irinotecan|mesh-list
83925237|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83925238|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925239|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925240|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925241|NCT00463073|Growth Substances|growth substances|mesh-ancestor
83925242|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925243|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925244|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83925245|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83925246|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925247|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925248|NCT00463112|Sibutramine|sibutramine|mesh-list
83925249|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
83925250|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83925251|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
83925252|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83925253|NCT00223028|Sirolimus|sirolimus|mesh-list
83925254|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925255|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925256|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83925257|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925258|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
83925259|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925260|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
83925261|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925262|NCT00489645|Pramlintide|pramlintide|mesh-list
83925263|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83925264|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925265|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925266|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
83925267|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83925268|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83925269|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925270|NCT00463268|Vitamin D|vitamin d|mesh-list
83925271|NCT00463268|Alendronate|alendronate|mesh-list
83925272|NCT00463268|Calcium|calcium|mesh-list
83925273|NCT00463268|Vitamins|vitamins|mesh-ancestor
83925274|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
83925275|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925276|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83925277|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83925278|NCT00489723|Tamsulosin|tamsulosin|mesh-list
83925279|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83925280|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83925281|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83925282|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83925283|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925284|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925285|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925286|NCT00489723|Urological Agents|urological agents|mesh-ancestor
83925287|NCT00105443|Sorafenib|sorafenib|mesh-list
83925288|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925289|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925290|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925291|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925292|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
83925293|NCT00489840|Anecortave|anecortave|mesh-list
83925294|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925295|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925296|NCT00489840|Growth Substances|growth substances|mesh-ancestor
83925297|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925298|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925299|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925300|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925301|NCT00463502|Metformin|metformin|mesh-list
83925302|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925303|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925304|NCT00489996|Gemcitabine|gemcitabine|mesh-list
83925305|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925306|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925307|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
83925308|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925309|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
83925310|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83925311|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83925312|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
83925313|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925314|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925315|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925316|NCT00463541|Urological Agents|urological agents|mesh-ancestor
83925317|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
83925318|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
83925319|NCT00490113|Vitamins|vitamins|mesh-ancestor
83925320|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
83925321|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925322|NCT01243203|Varenicline|varenicline|mesh-list
83925323|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83925324|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83925325|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
83925326|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925327|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925328|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925329|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
83925330|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83925331|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
83925332|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925333|NCT00497328|Expectorants|expectorants|mesh-ancestor
83925334|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
83925335|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83925336|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
83925337|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925338|NCT00497328|Protective Agents|protective agents|mesh-ancestor
83925339|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925340|NCT00497328|Antidotes|antidotes|mesh-ancestor
83925341|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
83925342|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
83925343|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83925344|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
83925345|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925346|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925347|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925348|NCT00466154|Aspirin|aspirin|mesh-list
83925349|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83925350|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83925351|NCT00466154|Analgesics|analgesics|mesh-ancestor
83925352|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
83925353|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925354|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925355|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925356|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925357|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83925358|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83925359|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925360|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83925361|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83925362|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925363|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
83925364|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83925365|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83925366|NCT00490308|Estradiol|estradiol|mesh-list
83925367|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83925368|NCT00490308|Estrogens|estrogens|mesh-ancestor
83925369|NCT00490308|Hormones|hormones|mesh-ancestor
83925370|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925371|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925372|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83925373|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
83925374|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83925375|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83925376|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
83925377|NCT00463736|Analgesics|analgesics|mesh-ancestor
83925378|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
83925379|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925380|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925381|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
83925382|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83925383|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83925384|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
83925385|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83925386|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83925387|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925388|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83925390|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83925391|NCT00490464|Nicardipine|nicardipine|mesh-list
83925392|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83925393|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83925394|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83925395|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925396|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83925397|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925398|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
83925399|NCT00497523|Beclomethasone|beclomethasone|mesh-list
83925400|NCT00497523|Albuterol|albuterol|mesh-list
83925401|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83925402|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
83925403|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925404|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925405|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83925406|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
83925407|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
83925408|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83925409|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83925410|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83925411|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83925412|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83925413|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925414|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925415|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925416|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
83925417|NCT00497523|Hormones|hormones|mesh-ancestor
83925418|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925419|NCT00463775|Topiramate|topiramate|mesh-list
83925420|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
83925421|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925422|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925423|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
83925424|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925425|NCT00466232|Sorafenib|sorafenib|mesh-list
83925426|NCT00466232|Topotecan|topotecan|mesh-list
83925427|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925428|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925429|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925430|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925431|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83925432|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83925433|NCT00490659|Gemcitabine|gemcitabine|mesh-list
83925434|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925435|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925436|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
83925437|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925438|NCT00490737|Daptomycin|daptomycin|mesh-list
83925439|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925440|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925441|NCT00497562|Tramadol|tramadol|mesh-list
83925442|NCT00497562|Amitriptyline|amitriptyline|mesh-list
83925443|NCT00497562|Fluoxetine|fluoxetine|mesh-list
83925444|NCT00497562|Hormones|hormones|mesh-list
83925445|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925446|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925447|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83925448|NCT00497562|Narcotics|narcotics|mesh-ancestor
83925449|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83925450|NCT00497562|Analgesics|analgesics|mesh-ancestor
83925451|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
83925452|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925453|NCT00497562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83925454|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83925455|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83925456|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925457|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925458|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
83925459|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83925460|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
83925461|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83164707|NCT02208791|Sirolimus|sirolimus|mesh-list
83925462|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83925463|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83925464|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925465|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83925466|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83925467|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83925468|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
83925470|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83925471|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83925472|NCT00497601|Amebicides|amebicides|mesh-ancestor
83925473|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83925474|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83925475|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925476|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925477|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
83925478|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83925479|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83925480|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83925481|NCT00466388|Cevimeline|cevimeline|mesh-list
83925482|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83925483|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
83925484|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925485|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925486|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83925487|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83925488|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
83925489|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925490|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925491|NCT00466466|Everolimus|everolimus|mesh-list
83925492|NCT00466466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83925493|NCT00466466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925494|NCT00466466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925495|NCT00466466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925496|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925497|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
83925498|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925499|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925500|NCT00490854|Insulin|insulin|mesh-list
83925501|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83925502|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
83925503|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
83925504|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
83925505|NCT00490854|Protamines|protamines|mesh-list
83925506|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925507|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925508|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
83925509|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925510|NCT00490854|Coagulants|coagulants|mesh-ancestor
83925511|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
83925512|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925513|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925514|NCT03272126|Vitamin D|vitamin d|mesh-list
83925515|NCT03272126|Vitamins|vitamins|mesh-ancestor
83925516|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
83925517|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925518|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83925519|NCT00491049|Levofloxacin|levofloxacin|mesh-list
83925520|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83925521|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83925522|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83925523|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925524|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925525|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83925526|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83925527|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925528|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925529|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925530|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83925531|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83925532|NCT00464165|Rimonabant|rimonabant|mesh-list
83925533|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83925534|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83925535|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83925536|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925537|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925539|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925540|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925541|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
83925542|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83925543|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83925544|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83925545|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83925546|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925547|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
83925548|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925549|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925550|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83925551|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925552|NCT03272321|Oxytocin|oxytocin|mesh-list
83925553|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
83925554|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83925555|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925556|NCT00491127|Dexamethasone|dexamethasone|mesh-list
83925557|NCT00491127|Gemcitabine|gemcitabine|mesh-list
83925558|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925559|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
83925560|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
83925561|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925562|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925563|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83925564|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
83925565|NCT00491127|Hormones|hormones|mesh-ancestor
83925566|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925567|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83925568|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925569|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925570|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
83925571|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925572|NCT00491166|Bromfenac|bromfenac|mesh-list
83925573|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83925574|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83925575|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83925576|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83925577|NCT00491166|Analgesics|analgesics|mesh-ancestor
83925578|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
83925579|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925580|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925581|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925582|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925583|NCT03273062|Tolcapone|tolcapone|mesh-list
83925584|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83925585|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83925586|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83925587|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925588|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925589|NCT00498108|Rotigotine|rotigotine|mesh-list
83925590|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
83925591|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
83925592|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925593|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925594|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925595|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83925596|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
83925597|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925598|NCT00498225|Gemcitabine|gemcitabine|mesh-list
83925599|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925600|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
83925601|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925602|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925603|NCT00466622|Metformin|metformin|mesh-list
83925604|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925605|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925606|NCT01327612|Leucovorin|leucovorin|mesh-list
83925607|NCT01327612|Bevacizumab|bevacizumab|mesh-list
83925608|NCT01327612|Conatumumab|conatumumab|mesh-list
83925609|NCT01327612|Fluorouracil|fluorouracil|mesh-list
83925610|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
83925611|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83925612|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925613|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925614|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925615|NCT01327612|Growth Substances|growth substances|mesh-ancestor
83925616|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925617|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925618|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
83925619|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925620|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925621|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925622|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
83925624|NCT01327612|Protective Agents|protective agents|mesh-ancestor
83925625|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
83925626|NCT01327612|Vitamins|vitamins|mesh-ancestor
83925627|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
83925628|NCT01243281|Entecavir|entecavir|mesh-list
83925629|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
83925630|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925631|NCT00464399|Everolimus|everolimus|mesh-list
83925632|NCT00464399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83925633|NCT00464399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925634|NCT00464399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925635|NCT00464399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925636|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925637|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
83925638|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925639|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925640|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
83925641|NCT04132882|Antidotes|antidotes|mesh-ancestor
83925642|NCT04132882|Protective Agents|protective agents|mesh-ancestor
83925643|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925644|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
83925645|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925646|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
83925647|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925648|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925649|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
83925650|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
83925651|NCT01243359|Bevacizumab|bevacizumab|mesh-list
83925652|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83925653|NCT01243359|Sunitinib|sunitinib|mesh-list
83925654|NCT01243359|Antibodies|antibodies|mesh-list
83925655|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
83925656|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83925657|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925658|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925659|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925660|NCT01243359|Growth Substances|growth substances|mesh-ancestor
83925661|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925662|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925663|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
83925664|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83925665|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925666|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925667|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
83925668|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83925669|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
83925670|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925671|NCT00498342|Expectorants|expectorants|mesh-ancestor
83925672|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
83925673|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83925674|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
83925675|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925676|NCT00498342|Protective Agents|protective agents|mesh-ancestor
83925677|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925678|NCT00498342|Antidotes|antidotes|mesh-ancestor
83925679|NCT00466856|Octreotide|octreotide|mesh-list
83925680|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83925681|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83925682|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925683|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
83925684|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925685|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925686|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83164980|NCT03522649|Leucovorin|leucovorin|mesh-list
83925688|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925689|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925690|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925691|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83925692|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83925693|NCT00591994|Piribedil|piribedil|mesh-list
83925694|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83925695|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83925696|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
83925697|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
83925698|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925699|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925700|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925701|NCT00464594|Metformin|metformin|mesh-list
83925702|NCT00464594|Acarbose|acarbose|mesh-list
83925703|NCT00464594|Gliclazide|gliclazide|mesh-list
83925704|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925705|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925706|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83925707|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925708|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925709|NCT04397302|Valsartan|valsartan|mesh-list
83925710|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83925711|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83925712|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83925713|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83925714|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925715|NCT00466895|Lenalidomide|lenalidomide|mesh-list
83925716|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
83925717|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925718|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925719|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925720|NCT00466895|Growth Substances|growth substances|mesh-ancestor
83925721|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925722|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925723|NCT02893540|Capecitabine|capecitabine|mesh-list
83925724|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83925725|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
83925726|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925727|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925728|NCT01327573|Eculizumab|eculizumab|mesh-list
83925729|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83925730|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925731|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
83925732|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925733|NCT02893384|Anesthetics|anesthetics|mesh-list
83925734|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
83925735|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83925736|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925737|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
83925738|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925739|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
83925740|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
83925741|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
83925742|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83925743|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925744|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
83925745|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925746|NCT00498537|Spironolactone|spironolactone|mesh-list
83925747|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83925748|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
83925749|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925750|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925751|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83925752|NCT00498537|Diuretics|diuretics|mesh-ancestor
83925753|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
83925754|NCT00491478|Sertraline|sertraline|mesh-list
83925755|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
83925756|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83925757|NCT00491478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83925758|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83925759|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83925760|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925761|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925763|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925764|NCT00491517|Sirolimus|sirolimus|mesh-list
83925765|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925766|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925767|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83925768|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925769|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
83925770|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925771|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
83925772|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925773|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
83925774|NCT00464789|Estrogens|estrogens|mesh-list
83925775|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83925776|NCT00464789|Hormones|hormones|mesh-ancestor
83925777|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925778|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925779|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83925780|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83925781|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
83925782|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83925783|NCT00467012|Paclitaxel|paclitaxel|mesh-list
83925784|NCT00467012|Bevacizumab|bevacizumab|mesh-list
83925785|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83925786|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925787|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
83925788|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83925789|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83925790|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925791|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83925792|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925793|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925794|NCT00467012|Growth Substances|growth substances|mesh-ancestor
83925795|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925796|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925797|NCT03272867|Mannitol|mannitol|mesh-list
83925798|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83925799|NCT03272867|Diuretics|diuretics|mesh-ancestor
83925800|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
83925801|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925802|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
83925803|NCT01327495|Testosterone|testosterone|mesh-list
83925804|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
83925805|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
83925806|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83925807|NCT01327495|Acyline|acyline|mesh-list
83925808|NCT01327495|Androgens|androgens|mesh-ancestor
83925809|NCT01327495|Hormones|hormones|mesh-ancestor
83925810|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925811|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925812|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83925813|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925814|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
83925815|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
83925816|NCT00491634|Treosulfan|treosulfan|mesh-list
83925817|NCT00491634|Busulfan|busulfan|mesh-list
83925818|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83925819|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
83925820|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925821|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925822|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925823|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
83925824|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925825|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83925826|NCT01327339|Ropinirole|ropinirole|mesh-list
83925827|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83925828|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83925829|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
83925830|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
83925831|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925832|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165134|NCT02365935|Paclitaxel|paclitaxel|mesh-list
83925833|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925834|NCT01327300|Mesalamine|mesalamine|mesh-list
83925835|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83925836|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83925837|NCT01327300|Analgesics|analgesics|mesh-ancestor
83925838|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
83925839|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925840|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925841|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925842|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925843|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
83925844|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83925845|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83925846|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83925847|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83925848|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925849|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
83925850|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925851|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925852|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83925853|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925854|NCT00592111|Prednisone|prednisone|mesh-list
83925855|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
83925856|NCT00592111|Etoposide|etoposide|mesh-list
83925857|NCT00592111|Vincristine|vincristine|mesh-list
83925858|NCT00592111|Doxorubicin|doxorubicin|mesh-list
83925859|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83925860|NCT00592111|Bleomycin|bleomycin|mesh-list
83925861|NCT00592111|Vinblastine|vinblastine|mesh-list
83925862|NCT00592111|Procarbazine|procarbazine|mesh-list
83925863|NCT00592111|Mitogens|mitogens|mesh-list
83925864|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925865|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
83925866|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925867|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925868|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83925869|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
83925870|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925871|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925872|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83925873|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925874|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
83925875|NCT00592111|Hormones|hormones|mesh-ancestor
83925876|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925877|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83925878|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83925879|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83925880|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83925881|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925882|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
83925883|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
83925884|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
83925885|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83925886|NCT00592150|Fenoldopam|fenoldopam|mesh-list
83925887|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83925888|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
83925889|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
83925890|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
83925891|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925892|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925893|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925894|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
83925895|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83925896|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
83925897|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925898|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83925899|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
83925900|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83925901|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925902|NCT04377295|Ranibizumab|ranibizumab|mesh-list
83925903|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83925904|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83925905|NCT04377295|Growth Substances|growth substances|mesh-ancestor
83925906|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925907|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
83925908|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925909|NCT00491712|Triamcinolone|triamcinolone|mesh-list
83925910|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83925911|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
83925912|NCT00491712|Hormones|hormones|mesh-ancestor
83925913|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925914|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925915|NCT02893111|Bortezomib|bortezomib|mesh-list
83925916|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925917|NCT04328272|Azithromycin|azithromycin|mesh-list
83925918|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
83925919|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925920|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925921|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
83925922|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83925923|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83925924|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925925|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925926|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83925927|NCT04328194|Thrombin|thrombin|mesh-list
83925928|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
83925929|NCT04328194|Coagulants|coagulants|mesh-ancestor
83925930|NCT00491790|Montelukast|montelukast|mesh-list
83925931|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83925932|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
83925933|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83925934|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
83925935|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83925936|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925937|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83925938|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83925939|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925940|NCT03272009|Interferons|interferons|mesh-list
83925941|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
83925942|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
83925943|NCT03272009|Entecavir|entecavir|mesh-list
83925944|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83925945|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925946|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
83925947|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925948|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
83925949|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925950|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83925951|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83925952|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83925953|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
83925954|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83925955|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925956|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925957|NCT00498888|Urological Agents|urological agents|mesh-ancestor
83925958|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
83925959|NCT00491868|Hematinics|hematinics|mesh-ancestor
83925960|NCT00491907|Folic Acid|folic acid|mesh-list
83925961|NCT00491907|Hematinics|hematinics|mesh-ancestor
83925962|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
83925963|NCT00491907|Vitamins|vitamins|mesh-ancestor
83925964|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
83925965|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925966|NCT00499005|Carbetocin|carbetocin|mesh-list
83925967|NCT00499005|Oxytocin|oxytocin|mesh-list
83925968|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
83925969|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83925970|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925971|NCT00491946|Dactinomycin|dactinomycin|mesh-list
83925972|NCT00491946|Vincristine|vincristine|mesh-list
83925973|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83925974|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83925975|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
83925976|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
83925977|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
83925978|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83925979|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83925980|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83925981|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83925982|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83925983|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83925984|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83925985|NCT00491985|Vaccines|vaccines|mesh-list
83925986|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
83925987|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925988|NCT02892916|Ketamine|ketamine|mesh-list
83925989|NCT02892916|Analgesics|analgesics|mesh-ancestor
83925990|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
83925991|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83925992|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83925993|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83925994|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83925995|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
83925996|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
83925997|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83925998|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83925999|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83926000|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926001|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926002|NCT00492102|Montelukast|montelukast|mesh-list
83926003|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83926004|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
83926005|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83926006|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
83926007|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83926008|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926009|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83926010|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83926011|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926012|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
83926013|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83926014|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926015|NCT00492141|Temozolomide|temozolomide|mesh-list
83926016|NCT00492141|Camptothecin|camptothecin|mesh-list
83926017|NCT00492141|Rubitecan|rubitecan|mesh-list
83926018|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83926019|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
83926020|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926021|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926022|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83926023|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83926024|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83926025|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926026|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
83926027|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83926028|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926029|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926030|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83926031|NCT04327726|Analgesics|analgesics|mesh-ancestor
83926032|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
83926033|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926034|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83926035|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83926036|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83926037|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
83926038|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926039|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926040|NCT00492219|Cimetidine|cimetidine|mesh-list
83926041|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83926042|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926043|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83926044|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
83926045|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
83926046|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926047|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926048|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926049|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83926050|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83926051|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926052|NCT00465257|Artesunate|artesunate|mesh-list
83926053|NCT00465257|Amodiaquine|amodiaquine|mesh-list
83926054|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
83926055|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83926056|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83926057|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926058|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926059|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
83926060|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
83926061|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83926062|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
83926063|NCT04130776|Kallikreins|kallikreins|mesh-list
83926064|NCT04130776|Coagulants|coagulants|mesh-ancestor
83926065|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83926066|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
83926067|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83926068|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926069|NCT00492258|Sorafenib|sorafenib|mesh-list
83926070|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926071|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83926072|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926073|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926074|NCT02955810|Dexamethasone|dexamethasone|mesh-list
83926075|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
83926076|NCT02955810|Bortezomib|bortezomib|mesh-list
83926077|NCT02955810|Daratumumab|daratumumab|mesh-list
83926078|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926079|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
83926080|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926081|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83926082|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83926083|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
83926084|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926085|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926086|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83926087|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926088|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
83926089|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
83926090|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926091|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926092|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
83926093|NCT02955810|Hormones|hormones|mesh-ancestor
83926094|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83926095|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83926096|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
83926097|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83926098|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926099|NCT00492414|Paroxetine|paroxetine|mesh-list
83926100|NCT00492414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83926101|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83926102|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926103|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926104|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926105|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
83926106|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926107|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83926108|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
83926109|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83926110|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83926111|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83926112|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926113|NCT01243632|Gemcitabine|gemcitabine|mesh-list
83926114|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83926115|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
83926116|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926117|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926118|NCT00467909|Micronutrients|micronutrients|mesh-list
83926119|NCT00467909|Trace Elements|trace elements|mesh-list
83926120|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926121|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83926122|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83926123|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926124|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
83926125|NCT00467948|Cefazolin|cefazolin|mesh-list
83926126|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926127|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926128|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
83926129|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926130|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
83926131|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
83926132|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
83926133|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926134|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
83926136|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
83926137|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926138|NCT00592618|Expectorants|expectorants|mesh-ancestor
83926139|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
83926140|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83926141|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
83926142|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926143|NCT00592618|Protective Agents|protective agents|mesh-ancestor
83926144|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926145|NCT00592618|Antidotes|antidotes|mesh-ancestor
83926146|NCT01243710|Taurolidine|taurolidine|mesh-list
83926147|NCT01243710|Heparin|heparin|mesh-list
83926148|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
83926149|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83926150|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83926151|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926152|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926153|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83926154|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926155|NCT00622843|Vaccines|vaccines|mesh-list
83926156|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83926157|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
83926158|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926159|NCT01245543|Docetaxel|docetaxel|mesh-list
83926160|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926161|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83926162|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83926163|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83926164|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926165|NCT00592930|Olanzapine|olanzapine|mesh-list
83926166|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
83926167|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
83926168|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926169|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926170|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926171|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83926172|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83926173|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926174|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83926175|NCT00592930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83926176|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83926177|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926178|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926179|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926180|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
83926181|NCT00592969|Metformin|metformin|mesh-list
83926182|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
83926183|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
83926184|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83926185|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926186|NCT01245582|Capecitabine|capecitabine|mesh-list
83926187|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
83926188|NCT01245582|Sorafenib|sorafenib|mesh-list
83926189|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83926190|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
83926191|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926192|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926193|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83926194|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926195|NCT00593008|Sirolimus|sirolimus|mesh-list
83926196|NCT00593008|Gemcitabine|gemcitabine|mesh-list
83926197|NCT00593008|Temsirolimus|temsirolimus|mesh-list
83926198|NCT00593008|MTOR Inhibitors|mtor inhibitors|mesh-list
83926199|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83926200|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
83926201|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926202|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926203|NCT00593008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83926204|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926205|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926206|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
83165474|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
83926207|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926208|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926209|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926210|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83926211|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
83926212|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83926213|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83926214|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926215|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926216|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
83926217|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926218|NCT00593125|Levetiracetam|levetiracetam|mesh-list
83926219|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
83926220|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
83926221|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
83926222|NCT00593164|Analgesics|analgesics|mesh-ancestor
83926223|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
83926224|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926225|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926226|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
83926227|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926228|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83926229|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
83926230|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83926231|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926232|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926233|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83926234|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
83926235|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83926236|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
83926237|NCT01316107|Nateglinide|nateglinide|mesh-list
83926238|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83926239|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926240|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83926241|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926242|NCT05654194|Azacitidine|azacitidine|mesh-list
83926243|NCT05654194|Venetoclax|venetoclax|mesh-list
83926244|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83926245|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
83926246|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926247|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926248|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926249|NCT05653453|Paclitaxel|paclitaxel|mesh-list
83926250|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83926251|NCT05653453|Gemcitabine|gemcitabine|mesh-list
83926252|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83926253|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926254|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
83926255|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
83926256|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
83926257|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926258|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83926259|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
83926260|NCT00468182|Interferons|interferons|mesh-list
83926261|NCT00468182|Interferon-beta|interferon-beta|mesh-list
83926262|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
83926263|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926264|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
83926265|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926266|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
83926267|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926268|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83926269|NCT05649163|Disitamab vedotin|disitamab vedotin|mesh-list
83926270|NCT05649163|Immunoconjugates|immunoconjugates|mesh-ancestor
83926271|NCT05649163|Immunologic Factors|immunologic factors|mesh-ancestor
83926272|NCT05649163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926273|NCT00465452|Dopamine|dopamine|mesh-list
83926274|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
83926275|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83926276|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
83926277|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
83926278|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926279|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926280|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
83926281|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926282|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926283|NCT00465452|Protective Agents|protective agents|mesh-ancestor
83926284|NCT01379521|Everolimus|everolimus|mesh-list
83926285|NCT01379521|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83926286|NCT01379521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83926287|NCT01379521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926288|NCT01379521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926289|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926290|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
83926291|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926292|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926293|NCT00468260|Epothilone B|epothilone b|mesh-list
83926294|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926295|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
83926296|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
83926297|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
83926298|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926299|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
83926300|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83926301|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83926302|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
83926303|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926304|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926305|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926306|NCT01371994|Urological Agents|urological agents|mesh-ancestor
83926307|NCT00465608|Propranolol|propranolol|mesh-list
83926308|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83926309|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83926310|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
83926311|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926312|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926313|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926314|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83926315|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83926316|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
83926318|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
83926319|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
83926320|NCT01371877|Vitamins|vitamins|mesh-list
83926321|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
83926322|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926323|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83926324|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83926325|NCT01245816|Eflornithine|eflornithine|mesh-list
83926326|NCT01245816|Sulindac|sulindac|mesh-list
83926327|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926328|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83926329|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83926330|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83926331|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926332|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83926333|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926334|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926335|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83926336|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83926337|NCT01245816|Analgesics|analgesics|mesh-ancestor
83926338|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
83926339|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926340|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926341|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926342|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83926343|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83926344|NCT00492687|Tamoxifen|tamoxifen|mesh-list
83926345|NCT00492687|Carboplatin|carboplatin|mesh-list
83926346|NCT00492687|Temozolomide|temozolomide|mesh-list
83926347|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926348|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926349|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83926350|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
83926351|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83926352|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
83926353|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83926354|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926355|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83165615|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83926356|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83926357|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83926358|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83926359|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
83926360|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83926361|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926362|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926363|NCT01245855|Alprostadil|alprostadil|mesh-list
83926364|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83926365|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
83926366|NCT01245855|Urological Agents|urological agents|mesh-ancestor
83926367|NCT00473603|Heparin|heparin|mesh-list
83926368|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
83926369|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83926370|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83926371|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926372|NCT00492765|Interferons|interferons|mesh-list
83926373|NCT00492765|Interferon-beta|interferon-beta|mesh-list
83926374|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
83926375|NCT00492765|Simvastatin|simvastatin|mesh-list
83926376|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926377|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
83926378|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926379|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83926380|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83926381|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
83926382|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926383|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83926384|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83926385|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926386|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
83926387|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926388|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83926389|NCT00468533|Aripiprazole|aripiprazole|mesh-list
83926390|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
83926391|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83926392|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83926393|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83926394|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926395|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926396|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
83926397|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
83926398|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926399|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926400|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83926401|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83926402|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
83926403|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83926404|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83926405|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83926406|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83926407|NCT00473720|Paclitaxel|paclitaxel|mesh-list
83926408|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83926409|NCT00473720|Satraplatin|satraplatin|mesh-list
83926410|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83926411|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926412|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
83926413|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
83926414|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
83926415|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926416|NCT00499668|Ondansetron|ondansetron|mesh-list
83926417|NCT00499668|Aprepitant|aprepitant|mesh-list
83926418|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
83926419|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
83926420|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926421|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926422|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926423|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
83926424|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
83926425|NCT00499668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83926426|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83926427|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
83926428|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926429|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926430|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83926431|NCT00499707|Metformin|metformin|mesh-list
83926432|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
83165687|NCT03521245|Trastuzumab|trastuzumab|mesh-list
83926433|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83926434|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926435|NCT01366534|Vaccines|vaccines|mesh-list
83926436|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
83926437|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926438|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
83926439|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83926440|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926441|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
83926442|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
83926443|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
83926444|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926445|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83926446|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
83926447|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
83926448|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926449|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926450|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926451|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83926452|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
83926453|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83926454|NCT01365910|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83926455|NCT01365910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83926456|NCT01365910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926457|NCT01365910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926458|NCT01605526|Doxorubicin|doxorubicin|mesh-list
83926459|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83926460|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926461|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83926462|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83926463|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926464|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926465|NCT00468689|Ketoconazole|ketoconazole|mesh-list
83926466|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
83926467|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926468|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83926469|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83926470|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926471|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926472|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83926473|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
83926474|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83926475|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926476|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83926477|NCT00473915|Fluticasone|fluticasone|mesh-list
83926479|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926480|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83926481|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
83926482|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926483|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926484|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83926485|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
83926486|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
83926487|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83926488|NCT00493077|Interferons|interferons|mesh-list
83926489|NCT00493077|Interferon-beta|interferon-beta|mesh-list
83926490|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
83926491|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926492|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
83926493|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926494|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
83926495|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926496|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83926497|NCT00474071|Remifentanil|remifentanil|mesh-list
83926498|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83926499|NCT00474071|Narcotics|narcotics|mesh-ancestor
83926500|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926501|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926502|NCT00474071|Analgesics|analgesics|mesh-ancestor
83926503|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
83926504|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926505|NCT00474110|Ketamine|ketamine|mesh-list
83926506|NCT00474110|Hydromorphone|hydromorphone|mesh-list
83926507|NCT00474110|Analgesics|analgesics|mesh-ancestor
83926508|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
83926509|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926510|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926511|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83926512|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83926513|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
83926514|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
83926515|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926516|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83926517|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83926518|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926519|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926520|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83926521|NCT00474110|Narcotics|narcotics|mesh-ancestor
83926522|NCT00500058|Rituximab|rituximab|mesh-list
83926523|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83926524|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926525|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
83926526|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926527|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83926528|NCT00468923|Candesartan|candesartan|mesh-list
83926529|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83926530|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83926531|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83926532|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
83926533|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926534|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83926535|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83926536|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926537|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83926538|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83926539|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83926540|NCT01365481|Amlodipine|amlodipine|mesh-list
83926541|NCT01365481|Valsartan|valsartan|mesh-list
83926542|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83926543|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83926544|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83926545|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926546|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926547|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83926548|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926549|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
83926550|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83926551|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83926552|NCT01365481|Diuretics|diuretics|mesh-ancestor
83926553|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
83926554|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83926555|NCT00493116|Interferons|interferons|mesh-list
83926556|NCT00493116|Interferon-beta|interferon-beta|mesh-list
83926557|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
83926558|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
83926559|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926560|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
83926561|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926562|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926563|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
83926564|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
83926565|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926566|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926567|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926568|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
83926569|NCT00493116|Hormones|hormones|mesh-ancestor
83926570|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83926571|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83926572|NCT00493116|Protective Agents|protective agents|mesh-ancestor
83926573|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
83926574|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83926575|NCT00493194|Cyclosporine|cyclosporine|mesh-list
83926576|NCT00493194|Sirolimus|sirolimus|mesh-list
83926577|NCT00493194|Cyclosporins|cyclosporins|mesh-list
83926578|NCT00493194|Daclizumab|daclizumab|mesh-list
83926579|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926580|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926581|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926582|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
83926583|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926584|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
83926585|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926586|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
83926587|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83926588|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83926589|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926590|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83926591|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926592|NCT01605721|Everolimus|everolimus|mesh-list
83926593|NCT01605721|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83926594|NCT01605721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83926595|NCT01605721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926596|NCT01605721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926597|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926598|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
83926599|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926600|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926601|NCT01605760|Immunomodulating Agents|immunomodulating agents|mesh-list
83926602|NCT01605760|Immunologic Factors|immunologic factors|mesh-ancestor
83926603|NCT01605760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926604|NCT01350271|Mebendazole|mebendazole|mesh-list
83926605|NCT01350271|Piperazine|piperazine|mesh-list
83926606|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
83926607|NCT01350271|DMP 777|dmp 777|mesh-list
83926608|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
83926609|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
83926610|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83926611|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926612|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83926613|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83926614|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83926615|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926616|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926617|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926618|NCT00493233|Olanzapine|olanzapine|mesh-list
83926619|NCT00493233|Risperidone|risperidone|mesh-list
83926620|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83926621|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
83926622|NCT00493233|Clozapine|clozapine|mesh-list
83926623|NCT00493233|Perphenazine|perphenazine|mesh-list
83926624|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83926625|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
83926626|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926627|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926628|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926629|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83926630|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926631|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83926632|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83926633|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
83926634|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
83926635|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
83926636|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926637|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926638|NCT00493233|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83926639|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83926640|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926641|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
83926642|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
83926643|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
83926644|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
83926645|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
83926646|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83926647|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
83926648|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926649|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926650|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83926651|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
83926652|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83926653|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
83926654|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926655|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926656|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83926657|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83165920|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
83926658|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
83926660|NCT00500253|Miotics|miotics|mesh-ancestor
83926661|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83926662|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83926663|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83926664|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83926665|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
83926666|NCT01243788|Fluticasone|fluticasone|mesh-list
83926667|NCT01243788|Xhance|xhance|mesh-list
83926668|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83926669|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926670|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83926671|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
83926672|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926673|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926674|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83926675|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
83926676|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
83926677|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83926678|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83926679|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83926680|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83926681|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
83926682|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926683|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926684|NCT01243827|Carvedilol|carvedilol|mesh-list
83926685|NCT01243827|Bisoprolol|bisoprolol|mesh-list
83926686|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83926687|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83926688|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
83926689|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926690|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926691|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926692|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83926693|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
83926694|NCT01243827|Protective Agents|protective agents|mesh-ancestor
83926695|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83926696|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926697|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83926698|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
83926699|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83926700|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83926701|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
83926702|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
83926703|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926704|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83926705|NCT00500409|Vitamin D|vitamin d|mesh-list
83926706|NCT00500409|Vitamins|vitamins|mesh-ancestor
83926707|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
83926708|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926709|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83926710|NCT00469352|Ranibizumab|ranibizumab|mesh-list
83926711|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83926712|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83926713|NCT00469352|Growth Substances|growth substances|mesh-ancestor
83926714|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926715|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
83926716|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926717|NCT00469430|Metronidazole|metronidazole|mesh-list
83926718|NCT00469430|Cefotaxime|cefotaxime|mesh-list
83926719|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926720|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926721|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83926722|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83926723|NCT00469469|Bevacizumab|bevacizumab|mesh-list
83926724|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83926725|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926726|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83926727|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83926728|NCT00469469|Growth Substances|growth substances|mesh-ancestor
83926729|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926730|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
83926731|NCT00500565|Bupivacaine|bupivacaine|mesh-list
83926732|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
83926733|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
83926734|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926735|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926737|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926738|NCT00469547|Ethanol|ethanol|mesh-list
83926739|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
83926740|NCT00469547|Emollients|emollients|mesh-list
83926741|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83926742|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926743|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926744|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
83926745|NCT00500604|Valsartan|valsartan|mesh-list
83926746|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83926747|NCT00500604|Irbesartan|irbesartan|mesh-list
83926748|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83926749|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83926750|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83926751|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926752|NCT00500604|Diuretics|diuretics|mesh-ancestor
83926753|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
83926754|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926755|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83926756|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926757|NCT00493389|Hormones|hormones|mesh-list
83926758|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83926759|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83926760|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926761|NCT01605994|Antacids|antacids|mesh-list
83926762|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926763|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926764|NCT00500721|Desipramine|desipramine|mesh-list
83926765|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83926766|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
83926767|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83926768|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926769|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926770|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83926771|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83926772|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926773|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
83926774|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926775|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926776|NCT00469586|Insulin|insulin|mesh-list
83926777|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83926778|NCT00469586|Metformin|metformin|mesh-list
83926779|NCT00469586|Glimepiride|glimepiride|mesh-list
83926780|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83926781|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926782|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83926783|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926784|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
83926785|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
83926786|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83926787|NCT01606111|Protective Agents|protective agents|mesh-ancestor
83926788|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926789|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
83926790|NCT00493428|Baclofen|baclofen|mesh-list
83926791|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83926792|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926793|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83926794|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926795|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83926796|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
83926797|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
83926798|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926799|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926800|NCT01342510|Lidocaine|lidocaine|mesh-list
83926801|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
83926802|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
83926803|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
83926804|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926805|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926806|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
83926807|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926808|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83926809|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83926810|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83926811|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83926812|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926813|NCT01342510|Analgesics|analgesics|mesh-ancestor
83926814|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
83926815|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83926816|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83926817|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
83926818|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83926820|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926821|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83926822|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83926823|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926824|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926825|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83926826|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83926827|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83926828|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
83926829|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926830|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83926831|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83926832|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926833|NCT00469664|Guanfacine|guanfacine|mesh-list
83926834|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83926835|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83926836|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83926837|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83926838|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
83926839|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926840|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926841|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926842|NCT00469703|Thalidomide|thalidomide|mesh-list
83926843|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83926844|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
83926845|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926846|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
83926847|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926848|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926849|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83926850|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83926851|NCT00469703|Growth Substances|growth substances|mesh-ancestor
83926852|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
83926853|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926854|NCT01244100|Aspirin|aspirin|mesh-list
83926855|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83926856|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83926857|NCT01244100|Analgesics|analgesics|mesh-ancestor
83926858|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
83926859|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926860|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926861|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926862|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83926863|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83926864|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83926865|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926866|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83926867|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83926868|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926869|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
83926870|NCT01340872|Ferric maltol|ferric maltol|mesh-list
83926871|NCT01340872|Hematinics|hematinics|mesh-ancestor
83926872|NCT00469781|Bromfenac|bromfenac|mesh-list
83926873|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
83926874|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83926875|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
83926876|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83926877|NCT00469781|Prednisolone|prednisolone|mesh-list
83926878|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83926879|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
83926880|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83926881|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83926882|NCT00469781|Analgesics|analgesics|mesh-ancestor
83926883|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
83926884|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926885|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926886|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926887|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83926888|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
83926889|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
83926890|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83926891|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
83926892|NCT00469781|Hormones|hormones|mesh-ancestor
83926893|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83926894|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83926895|NCT00469781|Protective Agents|protective agents|mesh-ancestor
83926896|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83926897|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926898|NCT00474695|Ranibizumab|ranibizumab|mesh-list
83926899|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83926900|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83926901|NCT00474695|Growth Substances|growth substances|mesh-ancestor
83926902|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926903|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
83926904|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926905|NCT03271502|Anesthetics|anesthetics|mesh-list
83926906|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926907|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926908|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
83926909|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83926910|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926911|NCT00474773|Celecoxib|celecoxib|mesh-list
83926912|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83926913|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83926914|NCT00474773|Analgesics|analgesics|mesh-ancestor
83926915|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
83926916|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926917|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926918|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83926919|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83926920|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83926921|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83926922|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926923|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926924|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
83926925|NCT00474890|Ephedrine|ephedrine|mesh-list
83926926|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83926927|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
83926928|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926929|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926930|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83926931|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
83926932|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
83926933|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83926934|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83926935|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
83926936|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
83926937|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926938|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926939|NCT00501111|Donepezil|donepezil|mesh-list
83926940|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83926941|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926942|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926943|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
83926944|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926945|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926946|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
83926947|NCT00501150|Linezolid|linezolid|mesh-list
83926948|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926949|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926950|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83926951|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926952|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926953|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
83926954|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83926955|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
83166212|NCT02296021|Bismuth|bismuth|mesh-list
83926956|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926957|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926958|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83926959|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
83926960|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
83926961|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83926962|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
83926963|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926964|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926965|NCT01246089|Ranibizumab|ranibizumab|mesh-list
83926966|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83926967|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83926968|NCT01246089|Growth Substances|growth substances|mesh-ancestor
83926969|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926970|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83926971|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83926972|NCT00598897|Clarithromycin|clarithromycin|mesh-list
83926973|NCT00598897|Rifabutin|rifabutin|mesh-list
83926974|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83926975|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83926976|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83926977|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83926978|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926979|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83926980|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83926981|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83926982|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
83926983|NCT04697732|Anesthetics|anesthetics|mesh-list
83926984|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83926985|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926986|NCT00501267|Oxybutynin|oxybutynin|mesh-list
83926987|NCT00501267|Solabegron|solabegron|mesh-list
83926988|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
83926989|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
83926990|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83926991|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83926992|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83926993|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83926994|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
83926995|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83926996|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83926997|NCT00501267|Urological Agents|urological agents|mesh-ancestor
83926998|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83926999|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83927000|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83927001|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
83927002|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
83927003|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
83927004|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927005|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927006|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927007|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
83927008|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83927009|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83927010|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927011|NCT00599287|Haloperidol|haloperidol|mesh-list
83927012|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
83927013|NCT00599287|Methylphenidate|methylphenidate|mesh-list
83927014|NCT00599287|Rivastigmine|rivastigmine|mesh-list
83927015|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83927016|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927017|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83927018|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83927019|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927020|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927021|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
83927022|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927023|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
83927024|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
83927025|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927026|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83927027|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83927028|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83927029|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83927030|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927031|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83927032|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83927033|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83927034|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927035|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
83927036|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83927037|NCT00599287|Protective Agents|protective agents|mesh-ancestor
83927038|NCT04326166|Metformin|metformin|mesh-list
83927039|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83927040|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927041|NCT00501384|Satavaptan|satavaptan|mesh-list
83927042|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83927043|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927044|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
83927045|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927046|NCT00599560|Vasopressins|vasopressins|mesh-list
83927047|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
83927048|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
83927049|NCT00599560|Coagulants|coagulants|mesh-ancestor
83927050|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83927051|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83927052|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
83927053|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927054|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
83927055|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83927056|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
83927057|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927058|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
83927059|NCT00599716|Protective Agents|protective agents|mesh-ancestor
83927060|NCT01246284|Triamcinolone|triamcinolone|mesh-list
83927061|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83927062|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83927063|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83927064|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927065|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
83927066|NCT01246284|Hormones|hormones|mesh-ancestor
83927067|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927068|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927069|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927070|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
83927071|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927072|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927073|NCT00599833|Cetuximab|cetuximab|mesh-list
83927074|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83927075|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927076|NCT00469976|Bevacizumab|bevacizumab|mesh-list
83927077|NCT00469976|Carboplatin|carboplatin|mesh-list
83927078|NCT00469976|Gemcitabine|gemcitabine|mesh-list
83927079|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83927080|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927081|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83927082|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83927083|NCT00469976|Growth Substances|growth substances|mesh-ancestor
83927084|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927085|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
83927086|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927087|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
83927088|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927089|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83927090|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83927091|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83927092|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927093|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927094|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927095|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927096|NCT00599911|Analgesics|analgesics|mesh-ancestor
83927097|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
83927098|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927099|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
83927100|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927101|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
83927102|NCT00599950|Mitomycins|mitomycins|mesh-list
83927103|NCT00599950|Mitomycin|mitomycin|mesh-list
83927104|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83927105|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927106|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
83927107|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927108|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83927109|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927110|NCT00600145|Mirtazapine|mirtazapine|mesh-list
83927111|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
83927112|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927113|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83927114|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
83927115|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
83927116|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927117|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927118|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927119|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83927120|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83927121|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83927122|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83927123|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83927124|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83927125|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83927126|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83927127|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83927128|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
83927129|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83927130|NCT00470015|Aldesleukin|aldesleukin|mesh-list
83927131|NCT00470015|Interleukin-2|interleukin-2|mesh-list
83927132|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927133|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83927134|NCT00470015|Analgesics|analgesics|mesh-ancestor
83927135|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
83927136|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927137|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927138|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83927139|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83927140|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
83927141|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927142|NCT00600262|Bevacizumab|bevacizumab|mesh-list
83927143|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83927144|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927145|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83927146|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83927147|NCT00600262|Growth Substances|growth substances|mesh-ancestor
83927148|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927149|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
83927150|NCT00600301|Triamcinolone|triamcinolone|mesh-list
83927151|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83927152|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83927153|NCT00600301|Bevacizumab|bevacizumab|mesh-list
83927154|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83927155|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83927156|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927157|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83927158|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83927159|NCT00600301|Growth Substances|growth substances|mesh-ancestor
83927160|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927161|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
83927162|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927163|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
83927164|NCT00600301|Hormones|hormones|mesh-ancestor
83927165|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927166|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927167|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
83927168|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927169|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927170|NCT00501579|Prednisolone|prednisolone|mesh-list
83927171|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83927172|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
83927173|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83927174|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
83927175|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83927176|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
83927177|NCT00501579|Difluprednate|difluprednate|mesh-list
83927178|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927179|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
83927180|NCT00501579|Hormones|hormones|mesh-ancestor
83927181|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927182|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927183|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83927184|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927185|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
83927186|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
83927187|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927188|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83927189|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83927190|NCT00501579|Protective Agents|protective agents|mesh-ancestor
83927191|NCT00501618|Clozapine|clozapine|mesh-list
83927192|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83927193|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
83927194|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927195|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927196|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927197|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83927198|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83927199|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83927200|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927201|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
83927202|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
83927203|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
83927204|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
83927205|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927206|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83927207|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927208|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927209|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
83927210|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927211|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927212|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83927213|NCT00600535|Hormones|hormones|mesh-ancestor
83927214|NCT00600691|Finasteride|finasteride|mesh-list
83927215|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83927216|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83927217|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927218|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927219|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
83927220|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927221|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927222|NCT00600691|Urological Agents|urological agents|mesh-ancestor
83927223|NCT00623077|Etoposide|etoposide|mesh-list
83927224|NCT00623077|Melphalan|melphalan|mesh-list
83927225|NCT00623077|Busulfan|busulfan|mesh-list
83927226|NCT00623077|Ifosfamide|ifosfamide|mesh-list
83927227|NCT00623077|Thiotepa|thiotepa|mesh-list
83927228|NCT00623077|Sargramostim|sargramostim|mesh-list
83927229|NCT00623077|Mesna|mesna|mesh-list
83927230|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83927231|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927232|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83927233|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83927234|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927235|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927236|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
83927237|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927238|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83927239|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
83927240|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83927241|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927242|NCT00623077|Protective Agents|protective agents|mesh-ancestor
83927243|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83927244|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83927245|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83927246|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927247|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927248|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927249|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927250|NCT00475358|Analgesics|analgesics|mesh-ancestor
83927251|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
83927252|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927253|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
83927254|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927255|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
83927256|NCT00623116|Testosterone|testosterone|mesh-list
83927257|NCT00623116|Estrogens|estrogens|mesh-list
83927258|NCT00623116|Androgens|androgens|mesh-ancestor
83927259|NCT00623116|Hormones|hormones|mesh-ancestor
83927260|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927261|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927262|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
83927263|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
83927264|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83927265|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
83927266|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83927267|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83927268|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927269|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83927270|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927271|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927272|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83927273|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83927274|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927275|NCT00600769|Clarithromycin|clarithromycin|mesh-list
83927276|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83927277|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927278|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83927279|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927280|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927281|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83927282|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83927283|NCT00470210|Ribavirin|ribavirin|mesh-list
83927284|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83927285|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
83927286|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927287|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
83927288|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927289|NCT00600847|Loratadine|loratadine|mesh-list
83927290|NCT00600847|Desloratadine|desloratadine|mesh-list
83927291|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83927292|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
83927293|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927294|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927295|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927296|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83927297|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83927298|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
83927299|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
83927300|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
83927301|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83927302|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83927303|NCT04325932|Kallikreins|kallikreins|mesh-list
83927304|NCT04325932|Coagulants|coagulants|mesh-ancestor
83927305|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83927306|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
83927307|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83927308|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927309|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83927310|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83927311|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927312|NCT00501657|Incretins|incretins|mesh-ancestor
83927313|NCT00501657|Hormones|hormones|mesh-ancestor
83927314|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927315|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83927316|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
83927317|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927318|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927319|NCT00600964|Obatoclax|obatoclax|mesh-list
83927320|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927321|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927322|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83927323|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83927324|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83927325|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927326|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927327|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927328|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927329|NCT00475397|Analgesics|analgesics|mesh-ancestor
83927330|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
83927331|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927332|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
83927333|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927334|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
83927335|NCT00601042|Lobeline|lobeline|mesh-list
83927336|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83927337|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
83927338|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927339|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927340|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83927341|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83927342|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
83927343|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927344|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927345|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
83927346|NCT00501696|Naltrexone|naltrexone|mesh-list
83927347|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83927348|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83927349|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927350|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
83927351|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927352|NCT00601198|Leucovorin|leucovorin|mesh-list
83927353|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
83927354|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
83927355|NCT00601198|Amifostine|amifostine|mesh-list
83927356|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927357|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927358|NCT00601198|Antidotes|antidotes|mesh-ancestor
83927359|NCT00601198|Protective Agents|protective agents|mesh-ancestor
83927360|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
83927361|NCT00601198|Vitamins|vitamins|mesh-ancestor
83927362|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
83927363|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83927364|NCT00601276|Leuprolide|leuprolide|mesh-list
83927365|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
83927366|NCT00601276|Cyproterone|cyproterone|mesh-list
83927367|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83927368|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
83927369|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83927370|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927371|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83927372|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927373|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
83927374|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
83927375|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927376|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83927377|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
83927378|NCT00601315|Clarithromycin|clarithromycin|mesh-list
83927379|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83927380|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927381|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83927382|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927383|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927384|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83927385|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83927386|NCT00470249|Carboplatin|carboplatin|mesh-list
83927387|NCT00470249|Gemcitabine|gemcitabine|mesh-list
83927388|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927389|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927390|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
83927391|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927392|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
83927393|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
83927394|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83927395|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83927396|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927397|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927398|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927399|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83927400|NCT00601432|Levofloxacin|levofloxacin|mesh-list
83166674|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
83927401|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83927402|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927403|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83927404|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83927405|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83927406|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927407|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927408|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927409|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83927410|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83927411|NCT00475514|Frovatriptan|frovatriptan|mesh-list
83927412|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83927413|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
83927414|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927415|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927416|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927417|NCT00601510|Capecitabine|capecitabine|mesh-list
83927418|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
83927419|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927420|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927421|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
83927422|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927423|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83927424|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927426|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
83927427|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927428|NCT00601588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83927429|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83927430|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927431|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927432|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927433|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
83927434|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927435|NCT00601666|Zolpidem|zolpidem|mesh-list
83927436|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83927437|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83927438|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83927439|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927440|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83927441|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
83927442|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
83927443|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927444|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927445|NCT01246362|Etoricoxib|etoricoxib|mesh-list
83927446|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83927447|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83927448|NCT01246362|Analgesics|analgesics|mesh-ancestor
83927449|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
83927450|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927451|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927452|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927453|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83927454|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83927455|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83927456|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927457|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927458|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
83927459|NCT00470405|Pemetrexed|pemetrexed|mesh-list
83927460|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927461|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927462|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927463|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83927464|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83927465|NCT00601978|Levodopa|levodopa|mesh-list
83927466|NCT00601978|Carbidopa|carbidopa|mesh-list
83927467|NCT00601978|Entacapone|entacapone|mesh-list
83927468|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83927469|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83927470|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83927471|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
83927472|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927473|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927474|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927475|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83927476|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927477|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83927478|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83927479|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
83927480|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
83927481|NCT00601159|Gemcitabine|gemcitabine|mesh-list
83927482|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927483|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927484|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
83927485|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927486|NCT00602017|Amlodipine|amlodipine|mesh-list
83927487|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83927488|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83927489|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927490|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927491|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83927492|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927493|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
83927494|NCT00470483|Paroxetine|paroxetine|mesh-list
83927495|NCT00470483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83927496|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83927497|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927498|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927499|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927500|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
83927501|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927502|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83927503|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
83927504|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83927505|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83927506|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83927507|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927508|NCT00602095|Misoprostol|misoprostol|mesh-list
83927509|NCT00602095|Dinoprostone|dinoprostone|mesh-list
83927510|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83927511|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
83927512|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83927513|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927514|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83927515|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83927516|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
83927517|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83927518|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83927519|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83927520|NCT00475553|Etonogestrel|etonogestrel|mesh-list
83927521|NCT00475553|Desogestrel|desogestrel|mesh-list
83927522|NCT00475553|NuvaRing|nuvaring|mesh-list
83927523|NCT00475553|Estradiol|estradiol|mesh-list
83927524|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83927525|NCT00475553|Estrogens|estrogens|mesh-ancestor
83927526|NCT00475553|Hormones|hormones|mesh-ancestor
83927527|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927528|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927529|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83927530|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
83927531|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83927532|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83927533|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83927534|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83927535|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83927536|NCT00475553|Progestins|progestins|mesh-ancestor
83927537|NCT01326481|Capecitabine|capecitabine|mesh-list
83927538|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927539|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
83927540|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927541|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927542|NCT00502164|Cediranib|cediranib|mesh-list
83927543|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927544|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83927545|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927546|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927547|NCT00470522|Folic Acid|folic acid|mesh-list
83927548|NCT00470522|Methotrexate|methotrexate|mesh-list
83927549|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83927551|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83927552|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927553|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927554|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
83927555|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927556|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927557|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
83927558|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927559|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83927560|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927561|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
83927562|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83927563|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83927564|NCT00470522|Hematinics|hematinics|mesh-ancestor
83927565|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
83927566|NCT00470522|Vitamins|vitamins|mesh-ancestor
83927567|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
83927568|NCT01244178|Insulin|insulin|mesh-list
83927569|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83927570|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83927571|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927572|NCT00470561|Aspirin|aspirin|mesh-list
83927573|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83927574|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83927575|NCT00470561|Analgesics|analgesics|mesh-ancestor
83927576|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
83927577|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927578|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927579|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927580|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83927581|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83927582|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83927583|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927584|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83927585|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83927586|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927587|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
83927588|NCT00475826|Ezetimibe|ezetimibe|mesh-list
83927589|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83927590|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83927591|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
83927592|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927593|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83927594|NCT00502437|Granisetron|granisetron|mesh-list
83927595|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
83927596|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
83927597|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927598|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927599|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83927600|NCT00502437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83927601|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83927602|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
83927603|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927604|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927605|NCT00470678|Ranibizumab|ranibizumab|mesh-list
83927606|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83927607|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83927608|NCT00470678|Growth Substances|growth substances|mesh-ancestor
83927609|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927610|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
83927611|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927612|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
83927613|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83927614|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927615|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
83927616|NCT00493545|Poly ICLC|poly iclc|mesh-list
83927617|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
83927618|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
83927619|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927620|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83927621|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
83927622|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83927623|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83927624|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927625|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927626|NCT00470873|Urological Agents|urological agents|mesh-ancestor
83927627|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
83927628|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83927629|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927630|NCT00476099|Budesonide|budesonide|mesh-list
83927631|NCT00476099|Beclomethasone|beclomethasone|mesh-list
83927632|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
83927633|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927634|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83927635|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
83927636|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927637|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927638|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83927639|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
83927640|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
83927641|NCT00476099|Hormones|hormones|mesh-ancestor
83927642|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927643|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83927644|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83927645|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83927646|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
83927647|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927648|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927649|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
83927650|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83927651|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
83927652|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927653|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
83927654|NCT00493662|Protective Agents|protective agents|mesh-ancestor
83927655|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
83927656|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83927657|NCT00470912|Protective Agents|protective agents|mesh-ancestor
83927658|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927659|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
83927660|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83927661|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
83927662|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927663|NCT00476138|Protective Agents|protective agents|mesh-ancestor
83927664|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927665|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83927666|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83927667|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927668|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83927669|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83927670|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83927671|NCT00470990|Acyline|acyline|mesh-list
83927672|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
83927673|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927674|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927675|NCT01246440|Catumaxomab|catumaxomab|mesh-list
83927676|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83927677|NCT00471029|Esomeprazole|esomeprazole|mesh-list
83927678|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83927679|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83927680|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83927681|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927682|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927683|NCT00476216|Fondaparinux|fondaparinux|mesh-list
83927684|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83927685|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
83927686|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83927687|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
83927688|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927689|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927690|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
83927691|NCT00471185|Acyline|acyline|mesh-list
83927692|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
83927693|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927694|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927695|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
83927696|NCT00493857|Antibodies|antibodies|mesh-list
83927697|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83927698|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
83927699|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927700|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83927701|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927702|NCT00502788|Ribavirin|ribavirin|mesh-list
83927703|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83927704|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
83927705|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927706|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
83927707|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927708|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
83927709|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
83927710|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927711|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927712|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927713|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927714|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
83927715|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927716|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83927717|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927718|NCT00494208|Testosterone|testosterone|mesh-list
83927719|NCT00494208|Androgens|androgens|mesh-ancestor
83927720|NCT00494208|Hormones|hormones|mesh-ancestor
83927721|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927722|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927723|NCT00471341|Celecoxib|celecoxib|mesh-list
83927724|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83927725|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83927726|NCT00471341|Analgesics|analgesics|mesh-ancestor
83927727|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
83927728|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927729|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927730|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927731|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83927732|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83927733|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83927734|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927735|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927736|NCT01325428|Vinorelbine|vinorelbine|mesh-list
83927737|NCT01325428|Afatinib|afatinib|mesh-list
83927738|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83927739|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927740|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83927741|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83927742|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83927743|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927744|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83927745|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927746|NCT00494247|Antibodies|antibodies|mesh-list
83927747|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
83927748|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927749|NCT00471419|Rimexolone|rimexolone|mesh-list
83927750|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
83927751|NCT00471419|Hormones|hormones|mesh-ancestor
83927752|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927753|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927754|NCT01325350|Bimatoprost|bimatoprost|mesh-list
83927755|NCT01325350|Minoxidil|minoxidil|mesh-list
83927756|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83927757|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83927758|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
83927759|NCT01324999|Tadalafil|tadalafil|mesh-list
83927760|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
83927761|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83927762|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83927763|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927764|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927765|NCT01324999|Urological Agents|urological agents|mesh-ancestor
83927766|NCT01324570|Buprenorphine|buprenorphine|mesh-list
83927767|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83927768|NCT01324570|Narcotics|narcotics|mesh-ancestor
83927769|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83927770|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927771|NCT01324570|Analgesics|analgesics|mesh-ancestor
83927772|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
83927773|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927774|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83927775|NCT04325698|Paclitaxel|paclitaxel|mesh-list
83927777|NCT04325698|Carboplatin|carboplatin|mesh-list
83927778|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83927779|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927780|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
83927781|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
83927782|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
83927783|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927784|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83927785|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83927786|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83927787|NCT04325698|Growth Substances|growth substances|mesh-ancestor
83927788|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927789|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
83927790|NCT01324141|Fluorouracil|fluorouracil|mesh-list
83927791|NCT01324141|Mitomycins|mitomycins|mesh-list
83927792|NCT01324141|Mitomycin|mitomycin|mesh-list
83927793|NCT01324141|Tempol|tempol|mesh-list
83927794|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
83927795|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927796|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927797|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927798|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927799|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
83927800|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927801|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83927802|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
83927803|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83927804|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927805|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
83927806|NCT01324141|Protective Agents|protective agents|mesh-ancestor
83927807|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83927808|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83927809|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83927810|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83927811|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83927812|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927813|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83927814|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83927815|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83927816|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927817|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
83927818|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927819|NCT01244217|Fexofenadine|fexofenadine|mesh-list
83927820|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83927821|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83927822|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83927823|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
83927824|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
83927825|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927826|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927827|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927828|NCT00471653|Temozolomide|temozolomide|mesh-list
83927829|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83927830|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
83927831|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927832|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927833|NCT00494559|Pioglitazone|pioglitazone|mesh-list
83927834|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83927835|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927836|NCT00494598|Sufentanil|sufentanil|mesh-list
83927837|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83927838|NCT00494598|Narcotics|narcotics|mesh-ancestor
83927839|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83927840|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927841|NCT00494598|Analgesics|analgesics|mesh-ancestor
83927842|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
83927843|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927844|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83927845|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83927846|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
83927847|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
83927848|NCT00503412|Cediranib|cediranib|mesh-list
83927849|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927850|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83927851|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927852|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927853|NCT00503451|Panobinostat|panobinostat|mesh-list
83927854|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927855|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83927856|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927857|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927858|NCT00471809|Azithromycin|azithromycin|mesh-list
83927859|NCT00471809|Budesonide|budesonide|mesh-list
83927860|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83927861|NCT00471809|Montelukast|montelukast|mesh-list
83927862|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927863|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83927864|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
83927865|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927866|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927867|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83927868|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
83927869|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
83927870|NCT00471809|Hormones|hormones|mesh-ancestor
83927871|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927872|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83927873|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927874|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83927875|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83927876|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83927877|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
83927878|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83927879|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927880|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83927881|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
83927882|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83927883|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83927884|NCT00503490|Levofloxacin|levofloxacin|mesh-list
83927885|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83927886|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83927887|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83927888|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83927889|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83927890|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927891|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927892|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927893|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83927894|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83927895|NCT00471965|Leucovorin|leucovorin|mesh-list
83927896|NCT00471965|Doxorubicin|doxorubicin|mesh-list
83927897|NCT00471965|Fluorouracil|fluorouracil|mesh-list
83927898|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
83927899|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83927900|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927901|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83927902|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83927903|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927904|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927905|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
83927906|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927907|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927908|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
83927909|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927910|NCT00471965|Antidotes|antidotes|mesh-ancestor
83927911|NCT00471965|Protective Agents|protective agents|mesh-ancestor
83927912|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
83927913|NCT00471965|Vitamins|vitamins|mesh-ancestor
83927914|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
83927915|NCT00472004|Tibolone|tibolone|mesh-list
83927916|NCT00472004|Estradiol|estradiol|mesh-list
83927917|NCT00472004|Estrogens|estrogens|mesh-ancestor
83927918|NCT00472004|Hormones|hormones|mesh-ancestor
83927919|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927920|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927921|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
83927922|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83927923|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83927924|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83927925|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927926|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83927927|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
83927929|NCT00494715|Benazepril|benazepril|mesh-list
83927930|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83927931|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83927932|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83927933|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927934|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83927935|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
83927936|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927937|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83927938|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83927939|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83927940|NCT03271073|Apatinib|apatinib|mesh-list
83927941|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927942|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83927943|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927944|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927945|NCT01246557|Dexamethasone|dexamethasone|mesh-list
83927946|NCT01246557|Lenalidomide|lenalidomide|mesh-list
83927947|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927948|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
83927949|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
83927950|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927951|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927952|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83927953|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
83927954|NCT01246557|Hormones|hormones|mesh-ancestor
83927955|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927956|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83927957|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927958|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
83927959|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83927960|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83927961|NCT01246557|Growth Substances|growth substances|mesh-ancestor
83927962|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
83927963|NCT00476918|Triamcinolone|triamcinolone|mesh-list
83927964|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83927965|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83927966|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83927967|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83927968|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
83927969|NCT00476918|Hormones|hormones|mesh-ancestor
83927970|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83927971|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927972|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927973|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
83927974|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83927975|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927976|NCT01323790|Naloxegol|naloxegol|mesh-list
83927977|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83927978|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927979|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
83927980|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83927981|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
83927982|NCT00477035|Melphalan|melphalan|mesh-list
83927983|NCT00477035|Carmustine|carmustine|mesh-list
83927984|NCT00477035|Gemcitabine|gemcitabine|mesh-list
83927985|NCT00477035|Etoposide|etoposide|mesh-list
83927986|NCT00477035|Vinorelbine|vinorelbine|mesh-list
83927987|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83927988|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
83927989|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83927990|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83927991|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83927992|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
83927993|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83927994|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83927995|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83927996|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83927997|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
83927998|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83927999|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83928000|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83928001|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928002|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83928003|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83928004|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83928005|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
83928006|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83928007|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928008|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928009|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83928010|NCT00494832|Analgesics|analgesics|mesh-ancestor
83928011|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
83928012|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928013|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83928014|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83928015|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83928016|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
83928017|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928018|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928019|NCT00477074|Dimercaprol|dimercaprol|mesh-list
83928020|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
83928021|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
83928022|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928023|NCT01323673|Clobetasol|clobetasol|mesh-list
83928024|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928025|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
83928026|NCT01323673|Hormones|hormones|mesh-ancestor
83928027|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928028|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928029|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83928030|NCT01246752|Cytarabine|cytarabine|mesh-list
83928031|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83928032|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
83928033|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928034|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928035|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
83928036|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928037|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928038|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
83928039|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928040|NCT01323634|Fluticasone|fluticasone|mesh-list
83928041|NCT01323634|Xhance|xhance|mesh-list
83928042|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83928043|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928044|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83928045|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
83928046|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928047|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928048|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83928049|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
83928050|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
83928051|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83928052|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83928053|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83928054|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83928055|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83928056|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928057|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928058|NCT05645302|Lidocaine|lidocaine|mesh-list
83928059|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
83928060|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
83928061|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928062|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928063|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
83928064|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928065|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83928066|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83928067|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83928068|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83928069|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928070|NCT00494988|Insulin|insulin|mesh-list
83928071|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83928072|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
83928073|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
83928074|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
83928076|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83928077|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928078|NCT01323478|Vortioxetine|vortioxetine|mesh-list
83928079|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
83928080|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83928081|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83928082|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83928083|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928084|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928085|NCT01323478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83928086|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83928087|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83928088|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928089|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928090|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
83928091|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83928092|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83928093|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83928094|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83928095|NCT00472355|Apomorphine|apomorphine|mesh-list
83928096|NCT00472355|Emetics|emetics|mesh-ancestor
83928097|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928098|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
83928099|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928100|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928101|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
83928102|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
83928103|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928104|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928105|NCT04325581|Liraglutide|liraglutide|mesh-list
83928106|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83928107|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928108|NCT04325581|Incretins|incretins|mesh-ancestor
83928109|NCT04325581|Hormones|hormones|mesh-ancestor
83928110|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928111|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
83928112|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83928113|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928114|NCT01322386|Vancomycin|vancomycin|mesh-list
83928115|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83928116|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928117|NCT00495066|Ipilimumab|ipilimumab|mesh-list
83928118|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928119|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928120|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83928121|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928122|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
83928123|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928124|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928125|NCT00472472|Paclitaxel|paclitaxel|mesh-list
83928126|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83928127|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928128|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83928129|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83928130|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83928131|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928132|NCT00503568|Vaccines|vaccines|mesh-list
83928133|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
83928134|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928135|NCT00472550|Esomeprazole|esomeprazole|mesh-list
83928136|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83928137|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928138|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83928139|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928140|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928141|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83928142|NCT00503607|Laxatives|laxatives|mesh-ancestor
83928143|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928144|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
83928145|NCT00477503|Gallium citrate|gallium citrate|mesh-list
83928146|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
83928147|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
83167424|NCT02340117|Gemcitabine|gemcitabine|mesh-list
83928148|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928149|NCT00477503|Antidotes|antidotes|mesh-ancestor
83928150|NCT00477503|Protective Agents|protective agents|mesh-ancestor
83928151|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928152|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83928153|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83928154|NCT01244334|Prednisolone|prednisolone|mesh-list
83928155|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83928156|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
83928157|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83928158|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
83928159|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83928160|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
83928161|NCT01244334|Difluprednate|difluprednate|mesh-list
83928162|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928163|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
83928164|NCT01244334|Hormones|hormones|mesh-ancestor
83928165|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928166|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928167|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83928168|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928169|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
83928170|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
83928171|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928172|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928173|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83928174|NCT01244334|Protective Agents|protective agents|mesh-ancestor
83928175|NCT00477542|Clofarabine|clofarabine|mesh-list
83928176|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83928177|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
83928178|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928179|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928180|NCT00503763|Simvastatin|simvastatin|mesh-list
83928181|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83928182|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83928183|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
83928184|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928185|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83928186|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83928187|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928188|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83928189|NCT00477581|Exenatide|exenatide|mesh-list
83928190|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83928191|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928192|NCT00477581|Incretins|incretins|mesh-ancestor
83928193|NCT00477581|Hormones|hormones|mesh-ancestor
83928194|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928195|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83928196|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
83928197|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928198|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928199|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83928200|NCT00477737|Propofol|propofol|mesh-list
83928201|NCT00477737|Sevoflurane|sevoflurane|mesh-list
83928202|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83928203|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928204|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928205|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83928206|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
83928207|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
83928208|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83928209|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83928210|NCT00477776|Metoclopramide|metoclopramide|mesh-list
83928211|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
83928212|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
83928213|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928214|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928215|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928216|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83928217|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83928218|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
83928219|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928220|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928221|NCT00477815|Rituximab|rituximab|mesh-list
83928222|NCT00477815|Melphalan|melphalan|mesh-list
83928223|NCT00477815|Sargramostim|sargramostim|mesh-list
83928224|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83928225|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928226|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928227|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
83928228|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928229|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928230|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83928231|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
83928232|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928233|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83928234|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928235|NCT00477854|Chromium|chromium|mesh-list
83928236|NCT00477854|Picolinic acid|picolinic acid|mesh-list
83928237|NCT00477854|Trace Elements|trace elements|mesh-ancestor
83928238|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
83928239|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928240|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83928241|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
83928242|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
83928243|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928244|NCT00477893|Adalimumab|adalimumab|mesh-list
83928245|NCT00477893|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83928246|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928247|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928248|NCT01247337|Gemcitabine|gemcitabine|mesh-list
83928249|NCT01247337|Capecitabine|capecitabine|mesh-list
83928250|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
83928251|NCT01247337|Cetuximab|cetuximab|mesh-list
83928252|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83928253|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
83928254|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928255|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928256|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928257|NCT00478049|Docetaxel|docetaxel|mesh-list
83928258|NCT00478049|Gefitinib|gefitinib|mesh-list
83928259|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928260|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83928261|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83928262|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83928263|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928264|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928265|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928266|NCT01248975|Montelukast|montelukast|mesh-list
83928267|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83928268|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83928269|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83928270|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
83928271|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928272|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928273|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83928274|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83928275|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928276|NCT02955927|Atropine|atropine|mesh-list
83928277|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83928278|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83928279|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83928280|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83928281|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83928282|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
83928283|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928284|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928285|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83928286|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83928287|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
83928288|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
83928289|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83928290|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83928291|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928292|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928293|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928294|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
83928295|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83928296|NCT01247493|Cytarabine|cytarabine|mesh-list
83928297|NCT01247493|Fludarabine|fludarabine|mesh-list
83928298|NCT01247493|Idarubicin|idarubicin|mesh-list
83928299|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928300|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83928302|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928303|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928304|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
83928305|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928306|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
83928307|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928308|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83928309|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83928310|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83928311|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928312|NCT04325425|Carboplatin|carboplatin|mesh-list
83928313|NCT04325425|Etoposide|etoposide|mesh-list
83928314|NCT04325425|Folfirinox|folfirinox|mesh-list
83928315|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928316|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83928317|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83928318|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83928319|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928320|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928321|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
83928322|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928323|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928324|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928325|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928326|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
83928327|NCT00478517|Hematinics|hematinics|mesh-ancestor
83928328|NCT01321879|Telavancin|telavancin|mesh-list
83928329|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83928330|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928331|NCT01321723|Teriparatide|teriparatide|mesh-list
83928332|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83928333|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928334|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83928335|NCT00478634|Irinotecan|irinotecan|mesh-list
83928336|NCT00478634|Cetuximab|cetuximab|mesh-list
83928337|NCT00478634|Everolimus|everolimus|mesh-list
83928338|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83928339|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83928340|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928341|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928342|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928343|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928344|NCT00478634|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83928345|NCT00478634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928346|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928347|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
83928348|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928349|NCT01247688|Fludarabine|fludarabine|mesh-list
83928350|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
83928351|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928352|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928353|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928354|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
83928355|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928356|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928357|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83928358|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
83928359|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83928360|NCT00478907|Ketamine|ketamine|mesh-list
83928361|NCT00478907|Thiopental|thiopental|mesh-list
83928362|NCT00478907|Propofol|propofol|mesh-list
83928363|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83928364|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928365|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928366|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83928367|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
83928368|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
83928369|NCT00478907|Analgesics|analgesics|mesh-ancestor
83928370|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
83928371|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928372|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83928373|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83928374|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83928375|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928376|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928377|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
83928378|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
83928380|NCT00478946|Leucovorin|leucovorin|mesh-list
83928381|NCT00478946|Antidotes|antidotes|mesh-ancestor
83928382|NCT00478946|Protective Agents|protective agents|mesh-ancestor
83928383|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928384|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
83928385|NCT00478946|Vitamins|vitamins|mesh-ancestor
83928386|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
83928387|NCT01247961|Dexamethasone|dexamethasone|mesh-list
83928388|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
83928389|NCT01247961|BB 1101|bb 1101|mesh-list
83928390|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928391|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
83928392|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
83928393|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928394|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928395|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928396|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
83928397|NCT01247961|Hormones|hormones|mesh-ancestor
83928398|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928399|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83928400|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928401|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
83928402|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928403|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928404|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
83928405|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928406|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928407|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928408|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928409|NCT01248078|Cephalexin|cephalexin|mesh-list
83928410|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83928411|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928412|NCT00472823|Vitamin D|vitamin d|mesh-list
83928413|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
83928414|NCT00472823|Calcium|calcium|mesh-list
83928415|NCT00472823|Vitamins|vitamins|mesh-ancestor
83928416|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
83928417|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928418|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83928419|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83928420|NCT02275416|Ipilimumab|ipilimumab|mesh-list
83928421|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928422|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928423|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83928424|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928425|NCT00472901|Afamelanotide|afamelanotide|mesh-list
83928426|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
83928427|NCT02483247|Paclitaxel|paclitaxel|mesh-list
83928428|NCT02483247|Doxorubicin|doxorubicin|mesh-list
83928429|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
83928430|NCT02483247|Capecitabine|capecitabine|mesh-list
83928431|NCT02483247|Nivolumab|nivolumab|mesh-list
83928432|NCT02483247|Sunitinib|sunitinib|mesh-list
83928433|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83928434|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928435|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
83928436|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
83928437|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
83928438|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928439|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83928440|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83928441|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83928442|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928443|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928444|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83928445|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83928446|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
83928447|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83928448|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83928449|NCT02483247|Growth Substances|growth substances|mesh-ancestor
83928450|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928451|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
83928452|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928453|NCT02482233|Nicotine|nicotine|mesh-list
83928454|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83928455|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
83928456|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928457|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928458|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83928459|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83928460|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928461|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928462|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928463|NCT01248117|Ranibizumab|ranibizumab|mesh-list
83928464|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83928465|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83928466|NCT01248117|Growth Substances|growth substances|mesh-ancestor
83928467|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928468|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
83928469|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928470|NCT01248234|Propofol|propofol|mesh-list
83928471|NCT01248234|Etomidate|etomidate|mesh-list
83928472|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83928473|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928474|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928475|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83928476|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
83928477|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
83928478|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83928479|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
83928480|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928481|NCT00473174|Ramipril|ramipril|mesh-list
83928482|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83928483|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
83928484|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928485|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928486|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83928487|NCT00473213|Interferons|interferons|mesh-list
83928488|NCT00473213|Interferon-beta|interferon-beta|mesh-list
83928489|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928490|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
83928491|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928492|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
83928493|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928494|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
83928495|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83928496|NCT01319383|Vorinostat|vorinostat|mesh-list
83928497|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928498|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83928499|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928500|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928501|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
83928502|NCT05645029|Methamphetamine|methamphetamine|mesh-list
83928503|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
83928504|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83928505|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928506|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
83928507|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
83928508|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83928509|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928510|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
83928511|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
83928512|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928513|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
83928514|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928515|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928516|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
83928517|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83928518|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83928519|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83928520|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83928521|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
83928522|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83928523|NCT05645029|Protective Agents|protective agents|mesh-ancestor
83928524|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83167802|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
83928525|NCT00479609|Testosterone|testosterone|mesh-list
83928526|NCT00479609|Androgens|androgens|mesh-ancestor
83928528|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928529|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928530|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
83928531|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
83928532|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
83928533|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928534|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928535|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
83928536|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928537|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
83928538|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83928539|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928540|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83928541|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928542|NCT02891161|Durvalumab|durvalumab|mesh-list
83928543|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928544|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928545|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
83928546|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83928547|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928548|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928549|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83928550|NCT02955732|Analgesics|analgesics|mesh-ancestor
83928551|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
83928552|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928553|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83928554|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83928555|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83928556|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
83928557|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928558|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928559|NCT01315678|Tobramycin|tobramycin|mesh-list
83928560|NCT01315678|Amikacin|amikacin|mesh-list
83928561|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83928562|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928563|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83928564|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
83928565|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928566|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
83928567|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928568|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83928569|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83928570|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83928571|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83928572|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928573|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928574|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928575|NCT00479726|Analgesics|analgesics|mesh-ancestor
83928576|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
83928577|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928578|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
83928579|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83928580|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
83928581|NCT01315249|Fluticasone|fluticasone|mesh-list
83928582|NCT01315249|Xhance|xhance|mesh-list
83928583|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
83928584|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83928585|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83928586|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928587|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83928588|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
83928589|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928590|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928591|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83928592|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
83928593|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
83928594|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83928595|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83928596|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83928597|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83928598|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83928599|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928600|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928601|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83928602|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83928603|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83928604|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928605|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
83928606|NCT01315249|Hormones|hormones|mesh-ancestor
83928607|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928608|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
83928609|NCT04207411|Lidocaine|lidocaine|mesh-list
83928610|NCT04207411|Bupivacaine|bupivacaine|mesh-list
83928611|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
83928612|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
83928613|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928614|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928615|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
83928616|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928617|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83928618|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83928619|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83928620|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83928621|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928622|NCT00473486|Carboplatin|carboplatin|mesh-list
83928623|NCT00473486|Pemetrexed|pemetrexed|mesh-list
83928624|NCT00473486|Sorafenib|sorafenib|mesh-list
83928625|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928626|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928627|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928628|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83928629|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83928630|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928631|NCT05644483|Propofol|propofol|mesh-list
83928632|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83928633|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928634|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928635|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83928636|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
83928637|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
83928638|NCT01248819|Ropivacaine|ropivacaine|mesh-list
83928639|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
83928640|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
83928641|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928642|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928643|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
83928644|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928645|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
83928646|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83928647|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83928648|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83928649|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83928650|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928651|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928652|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928653|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928654|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83928655|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928656|NCT01248858|Trametinib|trametinib|mesh-list
83928657|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928658|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928659|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928660|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928661|NCT01313728|Dapsone|dapsone|mesh-list
83928662|NCT01313728|Tretinoin|tretinoin|mesh-list
83928663|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928664|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
83928665|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
83928666|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928667|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
83928668|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83928669|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83928670|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83928671|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928672|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928673|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
83167950|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
83928674|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83928676|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83928677|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83928678|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
83928679|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928680|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83928681|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83928682|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928683|NCT00481442|Phenylephrine|phenylephrine|mesh-list
83928684|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
83928685|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83928686|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
83928687|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
83928688|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928689|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928690|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
83928691|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83928692|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
83928693|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
83928694|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83928695|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83928696|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83928697|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83928698|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928699|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928700|NCT00481442|Protective Agents|protective agents|mesh-ancestor
83928701|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
83928702|NCT04697537|Ropivacaine|ropivacaine|mesh-list
83928703|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
83928704|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928705|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928706|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83928707|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83928708|NCT04697537|Analgesics|analgesics|mesh-ancestor
83928709|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
83928710|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928711|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83928712|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83928713|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83928714|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
83928715|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928716|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928717|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
83928718|NCT00481481|Tacrolimus|tacrolimus|mesh-list
83928719|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928720|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
83928721|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928722|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83928723|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928724|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928725|NCT04516317|Artesunate|artesunate|mesh-list
83928726|NCT04516317|Quinine|quinine|mesh-list
83928727|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
83928728|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83928729|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83928730|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928731|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928732|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
83928733|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
83928734|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83928735|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
83928736|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83928737|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928738|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83928739|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928740|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83928741|NCT04516317|Analgesics|analgesics|mesh-ancestor
83928742|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
83928743|NCT02891083|Paclitaxel|paclitaxel|mesh-list
83928744|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83928745|NCT02891083|Cisplatin|cisplatin|mesh-list
83928746|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83928747|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928748|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83928749|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83928750|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83928751|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928752|NCT04515147|Vaccines|vaccines|mesh-list
83928753|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83928754|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
83928755|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928756|NCT05661253|Bupivacaine|bupivacaine|mesh-list
83928757|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
83928758|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
83928759|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928760|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928761|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
83928762|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928763|NCT02891005|Paclitaxel|paclitaxel|mesh-list
83928764|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83928765|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928766|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83928767|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83928768|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83928769|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928770|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83928771|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83928772|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83928773|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83928774|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
83928775|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83928776|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928777|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83928778|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83928779|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83928780|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83928781|NCT00480116|Vaccines|vaccines|mesh-list
83928782|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
83928783|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928784|NCT00504855|Calpastatin|calpastatin|mesh-list
83928785|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83928786|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83928787|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928788|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928789|NCT00504933|Cetirizine|cetirizine|mesh-list
83928790|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83928791|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83928792|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83928793|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
83928794|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
83928795|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928796|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928797|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928798|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
83928799|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83928800|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83928801|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83928802|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83928803|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928804|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928805|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928806|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928807|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83928808|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928809|NCT01313221|Etanercept|etanercept|mesh-list
83928810|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83928811|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83928812|NCT01313221|Analgesics|analgesics|mesh-ancestor
83928813|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
83928814|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928815|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928816|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928817|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928818|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928819|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928820|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
83168099|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83928821|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
83928822|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83928823|NCT01313182|Mupirocin|mupirocin|mesh-list
83928824|NCT01313182|Povidone|povidone|mesh-list
83928825|NCT01313182|Calcium|calcium|mesh-list
83928826|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83928827|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928828|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
83928829|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
83928830|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928831|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83928832|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83928833|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928834|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928835|NCT00480194|Xylometazoline|xylometazoline|mesh-list
83928836|NCT00480194|Bromides|bromides|mesh-list
83928837|NCT00480194|Ipratropium|ipratropium|mesh-list
83928838|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
83928839|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83928840|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
83928841|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928842|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928843|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83928844|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
83928845|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83928846|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928847|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928848|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928849|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
83928850|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83928851|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83928852|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
83928853|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928854|NCT00505167|Memantine|memantine|mesh-list
83928855|NCT00505167|Donepezil|donepezil|mesh-list
83928856|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83928857|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928858|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928859|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928860|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928861|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928862|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
83928863|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83928864|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83928865|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
83928866|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83928867|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83928868|NCT00480272|Prednisone|prednisone|mesh-list
83928869|NCT00480272|Adalimumab|adalimumab|mesh-list
83928870|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928871|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
83928872|NCT00480272|Hormones|hormones|mesh-ancestor
83928873|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928874|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928875|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83928876|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928877|NCT00480272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83928878|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928879|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
83928880|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83928881|NCT00480389|Sorafenib|sorafenib|mesh-list
83928882|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928883|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928884|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928885|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928886|NCT04519710|Rituximab|rituximab|mesh-list
83928887|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
83928888|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928889|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928890|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
83928891|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928892|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928893|NCT00482027|Vaccines|vaccines|mesh-list
83928894|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
83928895|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928896|NCT00482066|Abatacept|abatacept|mesh-list
83928897|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83928898|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928899|NCT00482066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928901|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928902|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
83928903|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928904|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928905|NCT00482183|Pioglitazone|pioglitazone|mesh-list
83928906|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83928907|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928908|NCT01312909|Varenicline|varenicline|mesh-list
83928909|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83928910|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83928911|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
83928912|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83928913|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928914|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928915|NCT00482222|Leucovorin|leucovorin|mesh-list
83928916|NCT00482222|Fluorouracil|fluorouracil|mesh-list
83928917|NCT00482222|Capecitabine|capecitabine|mesh-list
83928918|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
83928919|NCT00482222|Cetuximab|cetuximab|mesh-list
83928920|NCT00482222|Calcium|calcium|mesh-list
83928921|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
83928922|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83928923|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928924|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
83928925|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928926|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83928927|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928928|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83928929|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
83928930|NCT00482222|Antidotes|antidotes|mesh-ancestor
83928931|NCT00482222|Protective Agents|protective agents|mesh-ancestor
83928932|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
83928933|NCT00482222|Vitamins|vitamins|mesh-ancestor
83928934|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
83928935|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83928936|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
83928937|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83928938|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83928939|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83928940|NCT01312129|Analgesics|analgesics|mesh-ancestor
83928941|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
83928942|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928943|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928944|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928945|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928946|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928947|NCT04518852|Sorafenib|sorafenib|mesh-list
83928948|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928949|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83928950|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928951|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928952|NCT01311661|Olodaterol|olodaterol|mesh-list
83928953|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83928954|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
83928955|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928956|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928957|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83928958|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
83928959|NCT04518735|Anticoagulants|anticoagulants|mesh-list
83928960|NCT00482261|Aspirin|aspirin|mesh-list
83928961|NCT00482261|Dexamethasone|dexamethasone|mesh-list
83928962|NCT00482261|Lenalidomide|lenalidomide|mesh-list
83928963|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83928964|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
83928965|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
83928966|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83928967|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928968|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83928969|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
83928970|NCT00482261|Hormones|hormones|mesh-ancestor
83928971|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83928972|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83928973|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83928974|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83928975|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83928976|NCT00482261|Analgesics|analgesics|mesh-ancestor
83928977|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
83928978|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83928979|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83928980|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83928981|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83928982|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83928983|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83928984|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83928985|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
83928986|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
83928987|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83928988|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83928989|NCT00482261|Growth Substances|growth substances|mesh-ancestor
83928990|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
83928991|NCT04518618|Fentanyl|fentanyl|mesh-list
83928992|NCT04518618|Naloxone|naloxone|mesh-list
83928993|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83928994|NCT04518618|Narcotics|narcotics|mesh-ancestor
83928995|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83928996|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83928997|NCT04518618|Analgesics|analgesics|mesh-ancestor
83928998|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
83928999|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929000|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83929001|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83929002|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
83929003|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
83929004|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83929005|NCT00480584|Gemcitabine|gemcitabine|mesh-list
83929006|NCT00480584|Capecitabine|capecitabine|mesh-list
83929007|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83929008|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83929009|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
83929010|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929011|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929012|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83929013|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929014|NCT01311505|Rifampin|rifampin|mesh-list
83929015|NCT01311505|Isoniazid|isoniazid|mesh-list
83929016|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83929017|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
83929018|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929019|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929020|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
83929021|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83929022|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929023|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929024|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83929025|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83929026|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83929027|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83929028|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83929029|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83929030|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83929031|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83929032|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
83929033|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83929034|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
83929035|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83929036|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
83929037|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929038|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83929039|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83929040|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
83929041|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929042|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929043|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83929044|NCT01310803|Valrubicin|valrubicin|mesh-list
83929045|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929046|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83929047|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83929048|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929049|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929051|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
83929052|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929053|NCT04518540|Protective Agents|protective agents|mesh-ancestor
83929054|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929055|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
83929056|NCT04518540|Vitamins|vitamins|mesh-ancestor
83929057|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
83929058|NCT00480623|Satraplatin|satraplatin|mesh-list
83929059|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929060|NCT01240655|Paclitaxel|paclitaxel|mesh-list
83929061|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83929062|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929063|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83929064|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83929065|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83929066|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929067|NCT04518189|Lidocaine|lidocaine|mesh-list
83929068|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
83929069|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
83929070|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929071|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929072|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
83929073|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929074|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83929075|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83929076|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83929077|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83929078|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929079|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
83929080|NCT00482378|Pamidronate|pamidronate|mesh-list
83929081|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83929082|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929083|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
83929084|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83929085|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
83929086|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
83929087|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929088|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929089|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83929090|NCT00482456|Analgesics|analgesics|mesh-ancestor
83929091|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
83929092|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929093|NCT00480896|Tacrolimus|tacrolimus|mesh-list
83929094|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83929095|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
83929096|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929097|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83929098|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929099|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929100|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83929101|NCT01309828|Olmesartan|olmesartan|mesh-list
83929102|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83929103|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
83929104|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83929105|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83929106|NCT01309828|Diuretics|diuretics|mesh-ancestor
83929107|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
83929108|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929109|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83929110|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83929111|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929112|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83929113|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83929114|NCT00482495|Bevacizumab|bevacizumab|mesh-list
83929115|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83929116|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929117|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83929118|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83929119|NCT00482495|Growth Substances|growth substances|mesh-ancestor
83929120|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929121|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
83929122|NCT00480935|Sunitinib|sunitinib|mesh-list
83929123|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929124|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83929125|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83929126|NCT00480935|Growth Substances|growth substances|mesh-ancestor
83929127|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929128|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
83929129|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83929130|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929131|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929133|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83929134|NCT00482573|Anesthetics|anesthetics|mesh-list
83929135|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929136|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929137|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83929138|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83929139|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
83929140|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929141|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929142|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83929143|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83929144|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
83929145|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929146|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83929147|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
83929148|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
83929149|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
83929150|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
83929151|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929152|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929153|NCT00481013|Valproic Acid|valproic acid|mesh-list
83929154|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
83929155|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929156|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929157|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
83929158|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929159|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929160|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
83929161|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83929162|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929163|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83929164|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83929165|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
83929166|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83929167|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83929168|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929169|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929170|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
83929171|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929172|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83929173|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83929174|NCT01240109|Remifentanil|remifentanil|mesh-list
83929175|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83929176|NCT01240109|Narcotics|narcotics|mesh-ancestor
83929177|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929178|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929179|NCT01240109|Analgesics|analgesics|mesh-ancestor
83929180|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
83929181|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929182|NCT04517526|Bevacizumab|bevacizumab|mesh-list
83929183|NCT04517526|Durvalumab|durvalumab|mesh-list
83929184|NCT04517526|Carboplatin|carboplatin|mesh-list
83929185|NCT04517526|Pemetrexed|pemetrexed|mesh-list
83929186|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83929187|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929188|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83929189|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83929190|NCT04517526|Growth Substances|growth substances|mesh-ancestor
83929191|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929192|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
83929193|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929194|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929195|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83929196|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83929197|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83929198|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83929200|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83929201|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83929202|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83929203|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83929204|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83929205|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
83929206|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929207|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929208|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929209|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83929210|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929211|NCT00482807|Docetaxel|docetaxel|mesh-list
83929212|NCT00482807|Goserelin|goserelin|mesh-list
83929213|NCT00482807|Bicalutamide|bicalutamide|mesh-list
83929214|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929215|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83929216|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83929217|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83929218|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929219|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83929220|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
83929221|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
83929222|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929223|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929224|NCT01240148|Lidocaine|lidocaine|mesh-list
83929225|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
83929226|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
83929227|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929228|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929229|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
83929230|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929231|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83929232|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83929233|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83929234|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83929235|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929236|NCT04325191|Melatonin|melatonin|mesh-list
83929237|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
83929238|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929239|NCT04325191|Protective Agents|protective agents|mesh-ancestor
83929240|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929241|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929242|NCT04517292|Cisplatin|cisplatin|mesh-list
83929243|NCT04517292|Gemcitabine|gemcitabine|mesh-list
83929244|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929245|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83929246|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
83929247|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929248|NCT00482846|Melphalan|melphalan|mesh-list
83929249|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83929250|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
83929251|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929252|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929253|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83929254|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83929255|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
83929256|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929257|NCT01308736|Varenicline|varenicline|mesh-list
83929258|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83929259|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83929260|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
83929261|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929262|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929263|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929264|NCT04517214|Gemcitabine|gemcitabine|mesh-list
83929265|NCT04517214|Capecitabine|capecitabine|mesh-list
83929266|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929267|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83929268|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
83929269|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929271|NCT00483054|Nevirapine|nevirapine|mesh-list
83929272|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83929273|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83929274|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929275|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929276|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
83929277|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929278|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83929279|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83929280|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83929281|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83929282|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83929283|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83929284|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83929285|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83929286|NCT01240226|Ketoconazole|ketoconazole|mesh-list
83929287|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
83929288|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929289|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83929290|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83929291|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929292|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929293|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83929294|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
83929295|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929296|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929297|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83929298|NCT01240824|Aminophylline|aminophylline|mesh-list
83929299|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83929300|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
83929301|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929302|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929303|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83929304|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
83929305|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83929306|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83929307|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929308|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929309|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83929310|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83929311|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
83929312|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929313|NCT01240824|Protective Agents|protective agents|mesh-ancestor
83929314|NCT01240941|Exemestane|exemestane|mesh-list
83929315|NCT01240941|Goserelin|goserelin|mesh-list
83929316|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929317|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83929318|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83929319|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929320|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929321|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83929322|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
83929323|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929324|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929325|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83929326|NCT00482963|Efavirenz|efavirenz|mesh-list
83929327|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
83929328|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83929329|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83929330|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929331|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929332|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
83929333|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929334|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83929335|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83929336|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83929337|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83929338|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83929339|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83929340|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83929341|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
83929342|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83929343|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929344|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83929345|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83929346|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83929348|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
83929349|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83929350|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929351|NCT01240928|Exemestane|exemestane|mesh-list
83929352|NCT01240928|Goserelin|goserelin|mesh-list
83929353|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929354|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83929355|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83929356|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929357|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929358|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83929359|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
83929360|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929361|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929362|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83929363|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
83929364|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83929365|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83929366|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
83929367|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929368|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929369|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83929370|NCT00483093|Cisplatin|cisplatin|mesh-list
83929371|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929372|NCT00483132|Interferons|interferons|mesh-list
83929373|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
83929374|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
83929375|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929376|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
83929377|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929378|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
83929379|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929380|NCT00483210|Fenofibrate|fenofibrate|mesh-list
83929381|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83929382|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
83929383|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929384|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83929385|NCT00487994|Atorvastatin|atorvastatin|mesh-list
83929386|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83929387|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83929388|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
83929389|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929390|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83929391|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83929392|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929393|NCT00483158|Finafloxacin|finafloxacin|mesh-list
83929394|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83929395|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929396|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929397|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83929398|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83929399|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929400|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929401|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929402|NCT00483366|Gemcitabine|gemcitabine|mesh-list
83929403|NCT00483366|Capecitabine|capecitabine|mesh-list
83929404|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
83929405|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83929406|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
83929407|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929408|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929409|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83929410|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929411|NCT01308580|Prednisone|prednisone|mesh-list
83168714|NCT04881955|Ecopipam|ecopipam|mesh-list
83929412|NCT01308580|Prednisolone|prednisolone|mesh-list
83929413|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929414|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
83929415|NCT01308580|Hormones|hormones|mesh-ancestor
83929416|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929417|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929418|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83929419|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929420|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
83929421|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83929422|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83929423|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929424|NCT00483275|Vitamins|vitamins|mesh-ancestor
83929425|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
83929426|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
83929427|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83929428|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
83929429|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929430|NCT00483314|Expectorants|expectorants|mesh-ancestor
83929431|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
83929432|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83929433|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
83929434|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929435|NCT00483314|Protective Agents|protective agents|mesh-ancestor
83929436|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929437|NCT00483314|Antidotes|antidotes|mesh-ancestor
83929438|NCT00483392|Metformin|metformin|mesh-list
83929439|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
83929440|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83929441|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929442|NCT00483431|Menaquinone 7|menaquinone 7|mesh-list
83929443|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
83929444|NCT00483431|Coagulants|coagulants|mesh-ancestor
83929445|NCT00483600|PENTA|penta|mesh-list
83929446|NCT00483600|Fondaparinux|fondaparinux|mesh-list
83929447|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83929448|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
83929449|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83929450|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
83929451|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929452|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929453|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
83929454|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83929455|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83929456|NCT00488189|Tazobactam|tazobactam|mesh-list
83929457|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83929458|NCT00488189|Piperacillin|piperacillin|mesh-list
83929459|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929460|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929461|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83929462|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929463|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929464|NCT02956421|Vaccines|vaccines|mesh-list
83929465|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
83929466|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929467|NCT00483470|Vaccines|vaccines|mesh-list
83929468|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
83929469|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929470|NCT00488306|Tigecycline|tigecycline|mesh-list
83929471|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929472|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929473|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83929474|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929475|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929476|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
83929477|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
83929478|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83929479|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83929480|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929481|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929482|NCT00483626|Urological Agents|urological agents|mesh-ancestor
83929483|NCT00483795|Citric Acid|citric acid|mesh-list
83929484|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
83929485|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
83929486|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83929487|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
83929488|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
83929489|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929490|NCT05644210|Aspirin|aspirin|mesh-list
83929491|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
83929492|NCT05644210|Prednisone|prednisone|mesh-list
83929493|NCT05644210|Rituximab|rituximab|mesh-list
83929494|NCT05644210|Warfarin|warfarin|mesh-list
83929495|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83929496|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929497|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
83929498|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929499|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83929500|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929501|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
83929502|NCT05644210|Hormones|hormones|mesh-ancestor
83929503|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929504|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83929505|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83929506|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83929507|NCT05644210|Analgesics|analgesics|mesh-ancestor
83929508|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
83929509|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929510|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83929511|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83929512|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929513|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83929514|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83929515|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929516|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
83929517|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
83929518|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
83929519|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83929520|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83929521|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929522|NCT00488384|Acitretin|acitretin|mesh-list
83929523|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
83929524|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
83929525|NCT00483834|Bevacizumab|bevacizumab|mesh-list
83929526|NCT00483834|Capecitabine|capecitabine|mesh-list
83929527|NCT00483834|Irinotecan|irinotecan|mesh-list
83929528|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83929529|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929530|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83929531|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83929532|NCT00483834|Growth Substances|growth substances|mesh-ancestor
83929533|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929534|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
83929535|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83929536|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
83929537|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929538|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83929539|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83929540|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929541|NCT01307449|Vaccines|vaccines|mesh-list
83929542|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83929543|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
83929544|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929545|NCT01307020|Ibuprofen|ibuprofen|mesh-list
83929546|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83929547|NCT01307020|Ketoprofen|ketoprofen|mesh-list
83929548|NCT01307020|Tramadol|tramadol|mesh-list
83929549|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83929550|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83929551|NCT01307020|Analgesics|analgesics|mesh-ancestor
83929552|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
83929553|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929554|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929555|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929556|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83929557|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83929558|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929559|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929560|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83929561|NCT01307020|Narcotics|narcotics|mesh-ancestor
83929562|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929563|NCT00483743|Budesonide|budesonide|mesh-list
83929564|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929565|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83929566|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
83929567|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929568|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929569|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83929570|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
83929571|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
83929572|NCT00483743|Hormones|hormones|mesh-ancestor
83929573|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929574|NCT00483782|Paclitaxel|paclitaxel|mesh-list
83929575|NCT00483782|Bevacizumab|bevacizumab|mesh-list
83929576|NCT00483782|Carboplatin|carboplatin|mesh-list
83929577|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83929578|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929579|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
83929580|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
83929581|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
83929582|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929583|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83929584|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83929585|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83929586|NCT00483782|Growth Substances|growth substances|mesh-ancestor
83929587|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929588|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
83929589|NCT02890771|Turmeric extract|turmeric extract|mesh-list
83929590|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
83929591|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929592|NCT02890771|Protective Agents|protective agents|mesh-ancestor
83929593|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929594|NCT01306162|Dronedarone|dronedarone|mesh-list
83929595|NCT01306162|Dabigatran|dabigatran|mesh-list
83929596|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
83929597|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83929598|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
83929599|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929600|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929601|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
83929602|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83929603|NCT04515732|Apremilast|apremilast|mesh-list
83929604|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83929605|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83929606|NCT04515732|Analgesics|analgesics|mesh-ancestor
83929607|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
83929608|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929609|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929610|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929611|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83929612|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83929613|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83929614|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929615|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929616|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
83929617|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83929618|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83929619|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83929620|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
83929621|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
83929622|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929623|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929624|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
83929625|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929626|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83929627|NCT01304329|Empagliflozin|empagliflozin|mesh-list
83929628|NCT01304329|Simvastatin|simvastatin|mesh-list
83929629|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83929630|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83929631|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
83929632|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929633|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83929634|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83929635|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929636|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83929637|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83929638|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929639|NCT04515420|Norepinephrine|norepinephrine|mesh-list
83929640|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83929641|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83929642|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
83929643|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929644|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929645|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929646|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
83929647|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
83929648|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929649|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83929650|NCT00488540|Acetaminophen|acetaminophen|mesh-list
83929651|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83929652|NCT00488540|Analgesics|analgesics|mesh-ancestor
83929653|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
83929654|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929655|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929656|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
83929657|NCT00484068|Enalapril|enalapril|mesh-list
83929658|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83929659|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
83929660|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929661|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929662|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83929663|NCT00483860|Topotecan|topotecan|mesh-list
83929664|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83929665|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83929666|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929667|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929668|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929669|NCT01241097|Simvastatin|simvastatin|mesh-list
83929670|NCT01241097|Ezetimibe|ezetimibe|mesh-list
83929671|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83929672|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83929673|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
83929674|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929675|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83929676|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83929677|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929678|NCT01303861|Bupropion|bupropion|mesh-list
83929679|NCT01303861|Nicotine|nicotine|mesh-list
83929680|NCT01303861|Varenicline|varenicline|mesh-list
83929681|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83929682|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
83929683|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929684|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929685|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83929686|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83929687|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
83929688|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929689|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929690|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83929691|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
83929692|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83929693|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83929694|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83929695|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83929696|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
83929697|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83929698|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83929699|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929700|NCT01303627|Remifentanil|remifentanil|mesh-list
83929701|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83929702|NCT01303627|Narcotics|narcotics|mesh-ancestor
83929703|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929704|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929705|NCT01303627|Analgesics|analgesics|mesh-ancestor
83929706|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
83929707|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929708|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
83929709|NCT01241175|Analgesics|analgesics|mesh-ancestor
83929710|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
83929711|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929712|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929713|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
83929714|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929715|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83929716|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
83929717|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83929718|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83929719|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929720|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83929721|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
83929722|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83929723|NCT00484107|Estrogens|estrogens|mesh-list
83929724|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83929725|NCT00484107|Hormones|hormones|mesh-ancestor
83929726|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929727|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929728|NCT01302964|Mirtazapine|mirtazapine|mesh-list
83929729|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
83929730|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83929731|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83929732|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
83929733|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
83929734|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929735|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929736|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929737|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83929738|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83929739|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929740|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83929741|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83929742|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83929743|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
83929744|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83929745|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83929746|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
83929747|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83929748|NCT00484055|Gentamicins|gentamicins|mesh-list
83929749|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929750|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929751|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83929752|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929753|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929754|NCT01302691|Losartan|losartan|mesh-list
83929755|NCT01302691|Amlodipine|amlodipine|mesh-list
83929756|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83929757|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83929758|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83929759|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83929760|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929761|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83929762|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929763|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
83929764|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83929765|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83929766|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83929767|NCT01302691|Diuretics|diuretics|mesh-ancestor
83929768|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
83929769|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83929770|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
83929771|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
83929772|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83929773|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929774|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83929775|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
83929776|NCT05643820|Ivermectin|ivermectin|mesh-list
83929777|NCT05643820|Permethrin|permethrin|mesh-list
83929778|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83929779|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929780|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929781|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929782|NCT01242449|Trastuzumab|trastuzumab|mesh-list
83929783|NCT01242449|Vinorelbine|vinorelbine|mesh-list
83929784|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83929785|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929786|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83929787|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83929788|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83929789|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83929790|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929791|NCT01241162|Decitabine|decitabine|mesh-list
83929792|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83929793|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
83929794|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929795|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929796|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929797|NCT00484133|Dobutamine|dobutamine|mesh-list
83929798|NCT00484133|Dopamine|dopamine|mesh-list
83929799|NCT00484133|Enoximone|enoximone|mesh-list
83929800|NCT00484133|Norepinephrine|norepinephrine|mesh-list
83929801|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
83929802|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
83929803|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83929804|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
83929805|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
83929806|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929807|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929808|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83929809|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83929810|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83929811|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
83929812|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929813|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929814|NCT00484133|Protective Agents|protective agents|mesh-ancestor
83929815|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
83929816|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83929817|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83929818|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83929819|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83929820|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929821|NCT00484341|Doxorubicin|doxorubicin|mesh-list
83929822|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83929823|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929824|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83929825|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83929826|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929827|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929828|NCT01242566|Temozolomide|temozolomide|mesh-list
83929829|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83929830|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
83929831|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929832|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929833|NCT04514835|Capecitabine|capecitabine|mesh-list
83929834|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929835|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83929836|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
83929837|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929838|NCT00488813|Cephalosporins|cephalosporins|mesh-list
83929839|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929840|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929841|NCT00484250|Metronidazole|metronidazole|mesh-list
83929842|NCT00484250|Doxycycline|doxycycline|mesh-list
83929843|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929844|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929845|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83929846|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83929847|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
83929848|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83929849|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
83929850|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83929851|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929852|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929853|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83929854|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83929855|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83929856|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
83929857|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929858|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929859|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83929860|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83929861|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
83929862|NCT00484328|Ribavirin|ribavirin|mesh-list
83929863|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
83929864|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929865|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
83929866|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929867|NCT00484575|Propofol|propofol|mesh-list
83929868|NCT00484575|Sevoflurane|sevoflurane|mesh-list
83929869|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83929870|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929871|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929872|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83929873|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
83929874|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
83929875|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83929876|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83929877|NCT04514796|Adalimumab|adalimumab|mesh-list
83929878|NCT04514796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83929879|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929880|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83929881|NCT00488969|Morphine|morphine|mesh-list
83929882|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83929883|NCT00488969|Narcotics|narcotics|mesh-ancestor
83929884|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929885|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929886|NCT00488969|Analgesics|analgesics|mesh-ancestor
83929887|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
83929888|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929889|NCT00484692|Bupropion|bupropion|mesh-list
83929890|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83929891|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
83929892|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83929893|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83929894|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83929895|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83929896|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929897|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
83929898|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929899|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929900|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83929901|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83929902|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929903|NCT00484731|Bupivacaine|bupivacaine|mesh-list
83929904|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
83929905|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
83929906|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929907|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929908|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
83929909|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929910|NCT00484484|Ketamine|ketamine|mesh-list
83929911|NCT00484484|Analgesics|analgesics|mesh-ancestor
83929912|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
83929913|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929914|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929915|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83929916|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83929917|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
83929918|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
83929919|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83929920|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83929921|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83929922|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929923|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929924|NCT00484601|Doxorubicin|doxorubicin|mesh-list
83929925|NCT00484601|Ifosfamide|ifosfamide|mesh-list
83929926|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83929927|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929928|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83929929|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83929930|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929931|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929932|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83929933|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
83929934|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83929935|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
83929936|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169224|NCT02264171|Tamsulosin|tamsulosin|mesh-list
83929937|NCT00484640|Warfarin|warfarin|mesh-list
83929938|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
83929939|NCT00489164|Sirolimus|sirolimus|mesh-list
83929940|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83929941|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83929942|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83929943|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929944|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
83929945|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83929946|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
83929947|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929948|NCT00484809|Etanercept|etanercept|mesh-list
83929949|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83929950|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83929951|NCT00484809|Analgesics|analgesics|mesh-ancestor
83929952|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
83929953|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929954|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929955|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929956|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83929957|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83929958|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83929959|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
83929960|NCT04514094|Fluorides|fluorides|mesh-list
83929961|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
83929962|NCT04514094|Protective Agents|protective agents|mesh-ancestor
83929963|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929964|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83929965|NCT00484926|Aspirin|aspirin|mesh-list
83929966|NCT00484926|Clopidogrel|clopidogrel|mesh-list
83929967|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83929968|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83929969|NCT00484926|Analgesics|analgesics|mesh-ancestor
83929970|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
83929971|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83929972|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83929973|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83929974|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83929975|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83929976|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83929977|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929978|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83929979|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83929980|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929981|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
83929982|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83929983|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83929984|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83929985|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
83929986|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83929987|NCT02275806|Irinotecan|irinotecan|mesh-list
83929988|NCT02275806|Camptothecin|camptothecin|mesh-list
83929989|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83929990|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83929991|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83929992|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83929993|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83929994|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83929995|NCT01241409|Rabeprazole|rabeprazole|mesh-list
83929996|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83929997|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83929998|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83929999|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930000|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930001|NCT02275845|Metformin|metformin|mesh-list
83930002|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83930003|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930004|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83930005|NCT00489398|Epinastine|epinastine|mesh-list
83930006|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83930007|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83930008|NCT00489398|Analgesics|analgesics|mesh-ancestor
83930009|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
83930010|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930011|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930012|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930013|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930014|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83930015|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83930016|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83930017|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
83930018|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
83930019|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930020|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930021|NCT00485004|Sirolimus|sirolimus|mesh-list
83930022|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83930023|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930024|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83930025|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930026|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
83930027|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83930028|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
83930029|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930030|NCT00484991|Verapamil|verapamil|mesh-list
83930031|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83930032|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83930033|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930034|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930035|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930036|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930037|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
83930038|NCT00485121|Ezetimibe|ezetimibe|mesh-list
83930039|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83930040|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83930041|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
83930042|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930043|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83930044|NCT00489437|Heparin|heparin|mesh-list
83930045|NCT00489437|Antibodies|antibodies|mesh-list
83930046|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
83930047|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930048|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
83930049|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83930050|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83930051|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930052|NCT00485160|Ibuprofen|ibuprofen|mesh-list
83930053|NCT00485160|Indomethacin|indomethacin|mesh-list
83930054|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83930055|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83930056|NCT00485160|Analgesics|analgesics|mesh-ancestor
83930057|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
83930058|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930059|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930060|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930061|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930062|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83930063|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930064|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930065|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
83930066|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
83930067|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83930068|NCT00485030|Sirolimus|sirolimus|mesh-list
83930069|NCT00485030|Everolimus|everolimus|mesh-list
83930070|NCT00485030|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83930071|NCT00485030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83930072|NCT00485030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930073|NCT00485030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930074|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83930075|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
83930076|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930077|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930078|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83930079|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930080|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83930081|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
83930082|NCT04513821|Minocycline|minocycline|mesh-list
83930083|NCT04513821|Ethanol|ethanol|mesh-list
83930084|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83930085|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930086|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83930087|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930088|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930089|NCT00485108|Prednisolone|prednisolone|mesh-list
83930090|NCT00485108|Ketorolac|ketorolac|mesh-list
83930091|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
83930092|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930093|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
83930094|NCT00485108|Hormones|hormones|mesh-ancestor
83930095|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83930096|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930097|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83930098|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930099|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930100|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83930101|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83930102|NCT00485108|Analgesics|analgesics|mesh-ancestor
83930103|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
83930104|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930105|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83930106|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930107|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930108|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83930109|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83930110|NCT00485238|Acetazolamide|acetazolamide|mesh-list
83930111|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
83930112|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83930113|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930114|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930115|NCT00485238|Diuretics|diuretics|mesh-ancestor
83930116|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
83930117|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930118|NCT00485277|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83930119|NCT00485277|Antiviral Agents|antiviral agents|mesh-ancestor
83930120|NCT00485277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930121|NCT04513509|Propranolol|propranolol|mesh-list
83930122|NCT04513509|Metoprolol|metoprolol|mesh-list
83930123|NCT04513509|Digoxin|digoxin|mesh-list
83930124|NCT04513509|Atenolol|atenolol|mesh-list
83930125|NCT04513509|Verapamil|verapamil|mesh-list
83930126|NCT04513509|Nebivolol|nebivolol|mesh-list
83930127|NCT04513509|Bisoprolol|bisoprolol|mesh-list
83930128|NCT04513509|Diltiazem|diltiazem|mesh-list
83930129|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83930130|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83930131|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930132|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930133|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930134|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930135|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83930136|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83930137|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
83930138|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
83930139|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
83930140|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930141|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83930142|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83930143|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930144|NCT04513509|Protective Agents|protective agents|mesh-ancestor
83930145|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83930146|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83930147|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83930148|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83930149|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930150|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930151|NCT00485342|Interferons|interferons|mesh-list
83930152|NCT00485342|Ribavirin|ribavirin|mesh-list
83930153|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
83930154|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
83930155|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83930156|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930157|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
83930158|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930159|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
83930160|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930161|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
83930162|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930163|NCT00489593|Olanzapine|olanzapine|mesh-list
83930165|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
83930166|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
83930167|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930168|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930169|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930170|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930171|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930172|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930173|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930174|NCT00489593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930175|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930176|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930177|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930178|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930179|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
83930180|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83930181|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
83930182|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83930183|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83930184|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930185|NCT01241487|Amlodipine|amlodipine|mesh-list
83930186|NCT01241487|Valsartan|valsartan|mesh-list
83930187|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83930188|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83930189|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930190|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930191|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930192|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930193|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83930194|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83930195|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83930196|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83930197|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
83930198|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930199|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
83930200|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83930201|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83930202|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
83930203|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930204|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83930205|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83930206|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930207|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930208|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83930209|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83930210|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930211|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930212|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930213|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930214|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930215|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930216|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83930217|NCT00489710|Immunomodulating Agents|immunomodulating agents|mesh-list
83930218|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930219|NCT00489710|Immunologic Factors|immunologic factors|mesh-ancestor
83930220|NCT00489710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930221|NCT04697511|Midazolam|midazolam|mesh-list
83930222|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83930223|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83930224|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930225|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930226|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83930227|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930228|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930229|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83930230|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
83930231|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
83930232|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
83930233|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
83930234|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169519|NCT02267915|Rituximab|rituximab|mesh-list
83930235|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930236|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
83930237|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930238|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
83930239|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930240|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930241|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83930242|NCT00485498|Olanzapine|olanzapine|mesh-list
83930243|NCT00485498|Risperidone|risperidone|mesh-list
83930244|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83930245|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
83930246|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930247|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930248|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930249|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930250|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930251|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930252|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930253|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83930254|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
83930255|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
83930256|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
83930257|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930258|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930259|NCT00485498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930260|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930261|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930262|NCT01302067|Fesoterodine|fesoterodine|mesh-list
83930263|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83930264|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83930265|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
83930266|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930267|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930268|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930269|NCT01302067|Urological Agents|urological agents|mesh-ancestor
83930270|NCT00485550|Methylphenidate|methylphenidate|mesh-list
83930271|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83930272|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83930273|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930274|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83930275|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930276|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930277|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930278|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
83930279|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930280|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83930281|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930282|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83930283|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83930284|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930285|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930286|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930287|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930288|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930289|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930290|NCT00485576|Eculizumab|eculizumab|mesh-list
83930291|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83930292|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83930293|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
83930294|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930295|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
83930296|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83930297|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930298|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83930299|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83930300|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930301|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930302|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930303|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
83930304|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83930305|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169600|NCT01234025|Hormones|hormones|mesh-ancestor
83930306|NCT00489944|Tamoxifen|tamoxifen|mesh-list
83930307|NCT00489944|Sunitinib|sunitinib|mesh-list
83930308|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930309|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930310|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83930311|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83930312|NCT00489944|Growth Substances|growth substances|mesh-ancestor
83930313|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930314|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
83930315|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83930316|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930317|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83930318|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
83930319|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83930320|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83930321|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83930322|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83930323|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83930324|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
83930325|NCT00485706|Calcium|calcium|mesh-list
83930326|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930327|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930328|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83930329|NCT00505947|Infliximab|infliximab|mesh-list
83930330|NCT00505947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83930331|NCT00505947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930332|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
83930333|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930334|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930335|NCT00489983|Gemcitabine|gemcitabine|mesh-list
83930336|NCT00489983|Pemetrexed|pemetrexed|mesh-list
83930337|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83930338|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
83930339|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930340|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930341|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930342|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83930343|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83930344|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
83930345|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83930346|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
83930347|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930348|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930349|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83930350|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
83930351|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930352|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930353|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83930354|NCT00490178|Metformin|metformin|mesh-list
83930355|NCT00490178|Fenofibrate|fenofibrate|mesh-list
83930356|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83930357|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930358|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83930359|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
83930360|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930361|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83930362|NCT00485771|Lamotrigine|lamotrigine|mesh-list
83930363|NCT00485771|Olanzapine|olanzapine|mesh-list
83930364|NCT00485771|Fluoxetine|fluoxetine|mesh-list
83930365|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
83930366|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
83930367|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930368|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930369|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930370|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930371|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930372|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930373|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930374|NCT00485771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930375|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930376|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930377|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930378|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169686|NCT01173497|Irinotecan|irinotecan|mesh-list
83930379|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
83930380|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83930381|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
83930382|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83930383|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83930384|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930385|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
83930386|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83930387|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930388|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83930389|NCT00485810|Olanzapine|olanzapine|mesh-list
83930390|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
83930391|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
83930392|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930393|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930394|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930395|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930396|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930397|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930398|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930399|NCT00485810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930400|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930401|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930402|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930403|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930404|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
83930405|NCT00490373|Pemetrexed|pemetrexed|mesh-list
83930406|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930407|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930408|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930409|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83930410|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83930411|NCT00485823|Olanzapine|olanzapine|mesh-list
83930412|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
83930413|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
83930414|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930415|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930416|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930417|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930418|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930419|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930420|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930421|NCT00485823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930422|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930423|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930424|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930425|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930426|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
83930427|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83930428|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83930429|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930430|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930431|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930432|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930433|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930434|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930435|NCT00485888|Escitalopram|escitalopram|mesh-list
83930436|NCT00485888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930437|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930438|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930439|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930440|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930441|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
83930442|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930443|NCT00485862|Sertraline|sertraline|mesh-list
83930444|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83930445|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
83930446|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930447|NCT00485862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930448|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930449|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930450|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930452|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
83930453|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930454|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83930455|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930456|NCT00485901|Haloperidol|haloperidol|mesh-list
83930457|NCT00485901|Olanzapine|olanzapine|mesh-list
83930458|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
83930459|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
83930460|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
83930461|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930462|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930463|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930464|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930465|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930466|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930467|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930468|NCT00485901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930469|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930470|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930471|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930472|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930473|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
83930474|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83930475|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
83930476|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83930477|NCT00490412|Vitamin D|vitamin d|mesh-list
83930478|NCT00490412|Vitamins|vitamins|mesh-ancestor
83930479|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
83930480|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930481|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83930482|NCT00485940|Prucalopride|prucalopride|mesh-list
83930483|NCT00485940|Laxatives|laxatives|mesh-ancestor
83930484|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930485|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83930486|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83930487|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
83930488|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930489|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930490|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930491|NCT00486005|Olanzapine|olanzapine|mesh-list
83930492|NCT00486005|Nizatidine|nizatidine|mesh-list
83930493|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
83930494|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
83930495|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930496|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930497|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930498|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930499|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930500|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930501|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930502|NCT00486005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83930503|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930504|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930505|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930506|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930507|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
83930508|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83930509|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83930510|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
83930511|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
83930512|NCT00485979|Docetaxel|docetaxel|mesh-list
83930513|NCT00485979|Trastuzumab|trastuzumab|mesh-list
83930514|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930515|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
83930516|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
83930517|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
83930518|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930519|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83930520|NCT00486083|Methylphenidate|methylphenidate|mesh-list
83930521|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83930522|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83930523|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930524|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83930525|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930526|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930527|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930529|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930530|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83930531|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930532|NCT00490685|Sorafenib|sorafenib|mesh-list
83930533|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930534|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83930535|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930536|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930537|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83930538|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83930539|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930540|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930541|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930542|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930543|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930544|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930545|NCT04511715|Bevacizumab|bevacizumab|mesh-list
83930546|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83930547|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930548|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83930549|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83930550|NCT04511715|Growth Substances|growth substances|mesh-ancestor
83930551|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930552|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
83930553|NCT00486317|Calcitonin|calcitonin|mesh-list
83930554|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
83930555|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83930556|NCT00486317|Katacalcin|katacalcin|mesh-list
83930557|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930558|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930559|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83930560|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
83930561|NCT00490880|Gemcitabine|gemcitabine|mesh-list
83930562|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930563|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83930564|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
83930565|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930566|NCT00486174|Methylene Blue|methylene blue|mesh-list
83930567|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930568|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930569|NCT00486356|Carboplatin|carboplatin|mesh-list
83930570|NCT00486356|Capecitabine|capecitabine|mesh-list
83930571|NCT00486356|Epirubicin|epirubicin|mesh-list
83930572|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930573|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83930574|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
83930575|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930576|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83930577|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83930578|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83930579|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930580|NCT00490958|Telmisartan|telmisartan|mesh-list
83930581|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83930582|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83930583|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83930584|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930585|NCT00486213|Pyridoxine|pyridoxine|mesh-list
83930586|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
83930587|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
83930588|NCT00486213|Vitamins|vitamins|mesh-ancestor
83930589|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
83930590|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930591|NCT00486369|Calcitonin|calcitonin|mesh-list
83930592|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
83930593|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83930594|NCT00486369|Katacalcin|katacalcin|mesh-list
83930595|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930596|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930597|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83930598|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
83930600|NCT00490997|Propofol|propofol|mesh-list
83930601|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83930602|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930603|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930604|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83930605|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
83930606|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
83930607|NCT00490997|Analgesics|analgesics|mesh-ancestor
83930608|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
83930609|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930610|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83930611|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83930612|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83930613|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930614|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930615|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
83930616|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83930617|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
83930618|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83930619|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
83930620|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930621|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930622|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
83930623|NCT00486486|Timolol|timolol|mesh-list
83930624|NCT00486486|Bimatoprost|bimatoprost|mesh-list
83930625|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83930626|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83930627|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930628|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930629|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930630|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930631|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83930632|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83930633|NCT00491114|Gemcitabine|gemcitabine|mesh-list
83930634|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83930635|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
83930636|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930637|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930638|NCT00486564|Nifurtimox|nifurtimox|mesh-list
83930639|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83930640|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83930641|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83930642|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930643|NCT00486668|Paclitaxel|paclitaxel|mesh-list
83930644|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
83930645|NCT00486668|Doxorubicin|doxorubicin|mesh-list
83930646|NCT00486668|Trastuzumab|trastuzumab|mesh-list
83930647|NCT00486668|Lapatinib|lapatinib|mesh-list
83930648|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83930649|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930650|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83930651|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83930652|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83930653|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930654|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83930655|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
83930656|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930657|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930658|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83930659|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
83930660|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83930661|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83930662|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83930663|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83930664|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930665|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83930666|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83930667|NCT04510935|Anesthetics|anesthetics|mesh-list
83930668|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930669|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930670|NCT00491192|Diclofenac|diclofenac|mesh-list
83930671|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83930672|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83930673|NCT00491192|Analgesics|analgesics|mesh-ancestor
83930674|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
83930675|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930676|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930677|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930678|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930679|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83930680|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930681|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930682|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83930683|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
83930684|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930685|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83930686|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83930687|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930688|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930689|NCT01301833|Biguanides|biguanides|mesh-list
83930690|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83930691|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83930692|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930693|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930694|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930695|NCT00486785|Alfuzosin|alfuzosin|mesh-list
83930696|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83930697|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83930698|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83930699|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930700|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930701|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930702|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930703|NCT00486785|Urological Agents|urological agents|mesh-ancestor
83930704|NCT04324411|Sirolimus|sirolimus|mesh-list
83930705|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83930706|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930707|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83930708|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930709|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
83930710|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83930711|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
83930712|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930713|NCT00486876|Tofisopam|tofisopam|mesh-list
83930714|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
83930715|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930716|NCT05643586|Ticagrelor|ticagrelor|mesh-list
83930717|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83930718|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83930719|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83930720|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83930721|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83930722|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
83930723|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930724|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930725|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930726|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
83930727|NCT01242072|Ifosfamide|ifosfamide|mesh-list
83930728|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83930729|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
83930730|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930731|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930732|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83930733|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83930734|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83930735|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83930736|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930737|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930738|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930739|NCT00491348|Analgesics|analgesics|mesh-ancestor
83930740|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
83930741|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930742|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
83930743|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83930744|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
83930746|NCT01242098|Beclomethasone|beclomethasone|mesh-list
83930747|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
83930748|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83930749|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930750|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83930751|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
83930752|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930753|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930754|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83930755|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
83930756|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
83930757|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83930758|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83930759|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83930760|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83930761|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930762|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930763|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930764|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
83930765|NCT01242098|Hormones|hormones|mesh-ancestor
83930766|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83930767|NCT01301092|Dulaglutide|dulaglutide|mesh-list
83930768|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83930769|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930770|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83930771|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
83930772|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930773|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930774|NCT04510818|Capecitabine|capecitabine|mesh-list
83930775|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83930776|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
83930777|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930778|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930779|NCT05642845|Atorvastatin|atorvastatin|mesh-list
83930780|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83930781|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83930782|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
83930783|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930784|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83930785|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83930786|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930787|NCT04510662|Telmisartan|telmisartan|mesh-list
83930788|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83930789|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83930790|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83930791|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930792|NCT05642689|Iron|iron|mesh-list
83930793|NCT05642689|Trace Elements|trace elements|mesh-ancestor
83930794|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
83930795|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930796|NCT01300819|Rotigotine|rotigotine|mesh-list
83930797|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
83930798|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
83930799|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930800|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930801|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930802|NCT00486980|Peramivir|peramivir|mesh-list
83930803|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
83930804|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930805|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930806|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930807|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
83930808|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
83930809|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930810|NCT02275962|Rifampin|rifampin|mesh-list
83930811|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83930812|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
83930813|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83930814|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930815|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
83930816|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83930817|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930818|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930819|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83930820|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83930821|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83930822|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83930823|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83930824|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83930826|NCT00487032|Xhance|xhance|mesh-list
83930827|NCT00487032|Prazosin|prazosin|mesh-list
83930828|NCT00487032|Phenylephrine|phenylephrine|mesh-list
83930829|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
83930830|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930831|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83930832|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
83930833|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930834|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930835|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83930836|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
83930837|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
83930838|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83930839|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83930840|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83930841|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
83930842|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930843|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930844|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
83930845|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
83930846|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83930847|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83930848|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
83930849|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83930850|NCT00487032|Protective Agents|protective agents|mesh-ancestor
83930851|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83930852|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83930853|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83930854|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83930855|NCT00491426|Metronidazole|metronidazole|mesh-list
83930856|NCT00491426|Tazobactam|tazobactam|mesh-list
83930857|NCT00491426|Amphotericin B|amphotericin b|mesh-list
83930858|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83930859|NCT00491426|Piperacillin|piperacillin|mesh-list
83930860|NCT00491426|Acyclovir|acyclovir|mesh-list
83930861|NCT00491426|Ampicillin|ampicillin|mesh-list
83930862|NCT00491426|Caspofungin|caspofungin|mesh-list
83930863|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83930864|NCT00491426|Anidulafungin|anidulafungin|mesh-list
83930865|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930866|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83930867|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83930868|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83930869|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83930870|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930871|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930872|NCT00491426|Amebicides|amebicides|mesh-ancestor
83930873|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
83930874|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
83930875|NCT01300546|Naproxen|naproxen|mesh-list
83930876|NCT01300546|Sumatriptan|sumatriptan|mesh-list
83930877|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83930878|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83930879|NCT01300546|Analgesics|analgesics|mesh-ancestor
83930880|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
83930881|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930882|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930883|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83930884|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930885|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
83930886|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83930887|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930888|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930889|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83930890|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83930891|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83930892|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
83170205|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
83930893|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930894|NCT00487110|Acetaminophen|acetaminophen|mesh-list
83930895|NCT00487110|Tropisetron|tropisetron|mesh-list
83930896|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83930897|NCT00487110|Analgesics|analgesics|mesh-ancestor
83930898|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
83930899|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930900|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930901|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
83930902|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
83930903|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
83930904|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83930905|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83930906|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83930907|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
83930908|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930909|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930911|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83930912|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
83930913|NCT00487136|Fenofibrate|fenofibrate|mesh-list
83930914|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83930915|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83930916|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
83930917|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930918|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83930919|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83930920|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930921|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
83930922|NCT02276001|Cyclosporine|cyclosporine|mesh-list
83930923|NCT02276001|Cyclosporins|cyclosporins|mesh-list
83930924|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930925|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930926|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83930927|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
83930928|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930929|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
83930930|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930931|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
83930932|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83930933|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83930934|NCT00491582|Hormones|hormones|mesh-list
83930935|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83930936|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930937|NCT00487175|Tramadol|tramadol|mesh-list
83930938|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83930939|NCT00487175|Narcotics|narcotics|mesh-ancestor
83930940|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930941|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930942|NCT00487175|Analgesics|analgesics|mesh-ancestor
83930943|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
83930944|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930945|NCT00487227|Caffeine|caffeine|mesh-list
83930946|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83930947|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930948|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83930949|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930950|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930951|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83930952|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83930953|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
83930954|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83930955|NCT01300351|Fulvestrant|fulvestrant|mesh-list
83930956|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83930957|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83930958|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83930959|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83930960|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
83930961|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83930962|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930963|NCT00487253|Miltefosine|miltefosine|mesh-list
83930964|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83930965|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
83170268|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
83930966|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930968|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83930969|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83930970|NCT04510233|Ivermectin|ivermectin|mesh-list
83930971|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83930972|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83930973|NCT05641909|Fentanyl|fentanyl|mesh-list
83930974|NCT05641909|Remifentanil|remifentanil|mesh-list
83930975|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83930976|NCT05641909|Narcotics|narcotics|mesh-ancestor
83930977|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83930978|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930979|NCT05641909|Analgesics|analgesics|mesh-ancestor
83930980|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
83930981|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83930982|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83930983|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83930984|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
83930985|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
83930986|NCT05641753|Atorvastatin|atorvastatin|mesh-list
83930987|NCT05641753|Ezetimibe|ezetimibe|mesh-list
83930988|NCT05641753|Evolocumab|evolocumab|mesh-list
83930989|NCT05641753|Calcium|calcium|mesh-list
83930990|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83930991|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83930992|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83930993|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83930994|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
83930995|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83930996|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83930997|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83930998|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83930999|NCT05641753|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83931000|NCT05641753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83931001|NCT05641753|Protease Inhibitors|protease inhibitors|mesh-ancestor
83931002|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
83931003|NCT02276196|Lixisenatide|lixisenatide|mesh-list
83931004|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931005|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931006|NCT00487422|Prucalopride|prucalopride|mesh-list
83931007|NCT00487422|Laxatives|laxatives|mesh-ancestor
83931008|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83931009|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83931010|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83931011|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
83931012|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931013|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931014|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931015|NCT04697355|Beta Carotene|beta carotene|mesh-list
83931016|NCT04697355|Naringenin|naringenin|mesh-list
83931017|NCT04697355|Carotenoids|carotenoids|mesh-list
83931018|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
83931019|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931020|NCT04697355|Protective Agents|protective agents|mesh-ancestor
83931021|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931022|NCT04697355|Provitamins|provitamins|mesh-ancestor
83931023|NCT04697355|Vitamins|vitamins|mesh-ancestor
83931024|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
83931025|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83931026|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83931027|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83931028|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
83931029|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931030|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83931031|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931032|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83931033|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931034|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931035|NCT00491855|Paclitaxel|paclitaxel|mesh-list
83931036|NCT00491855|Bevacizumab|bevacizumab|mesh-list
83931037|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
83931038|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83931039|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170338|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83931040|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
83931041|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
83931042|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
83931043|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931044|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931045|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83931046|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83931047|NCT00491855|Growth Substances|growth substances|mesh-ancestor
83931048|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931049|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
83931050|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83931051|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931053|NCT00487448|Fludarabine|fludarabine|mesh-list
83931054|NCT00487448|Idarubicin|idarubicin|mesh-list
83931055|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931056|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931057|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
83931058|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931059|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931060|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
83931061|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931062|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
83931063|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931064|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83931065|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83931066|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83931067|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931068|NCT00506259|Melatonin|melatonin|mesh-list
83931069|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
83931070|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931071|NCT00506259|Protective Agents|protective agents|mesh-ancestor
83931072|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931073|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931074|NCT00506298|Diflunisal|diflunisal|mesh-list
83931075|NCT00506298|Bezafibrate|bezafibrate|mesh-list
83931076|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83931077|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
83931078|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931079|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83931080|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83931081|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83931082|NCT00506298|Analgesics|analgesics|mesh-ancestor
83931083|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
83931084|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931085|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931086|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931087|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931088|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83931089|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931090|NCT01242215|Glimepiride|glimepiride|mesh-list
83931091|NCT01242215|Gliclazide|gliclazide|mesh-list
83931092|NCT01242215|Glyburide|glyburide|mesh-list
83931093|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
83931094|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83931095|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931096|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931097|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931098|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
83931099|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83931100|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931101|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83931102|NCT01242228|Vildagliptin|vildagliptin|mesh-list
83931103|NCT01242228|Saxagliptin|saxagliptin|mesh-list
83931104|NCT01242228|Alogliptin|alogliptin|mesh-list
83931105|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
83931106|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83931107|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931108|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931109|NCT01242228|Incretins|incretins|mesh-ancestor
83931110|NCT01242228|Hormones|hormones|mesh-ancestor
83931111|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931112|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83931113|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931114|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931115|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83931116|NCT01242306|Acetylcholine|acetylcholine|mesh-list
83931117|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931118|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83931119|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
83931120|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931121|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931122|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931123|NCT00492128|Losartan|losartan|mesh-list
83931124|NCT00492128|Amlodipine|amlodipine|mesh-list
83931125|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83931126|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83931127|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83931128|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83931129|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931130|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931131|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931132|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931133|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83931134|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83931135|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83931136|NCT00492128|Diuretics|diuretics|mesh-ancestor
83931137|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
83931138|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83931139|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
83931140|NCT00487734|Testosterone|testosterone|mesh-list
83931141|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
83931142|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
83931143|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83931144|NCT00487734|Androgens|androgens|mesh-ancestor
83931145|NCT00487734|Hormones|hormones|mesh-ancestor
83931146|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931147|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931148|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83931149|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931150|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
83931151|NCT01300234|Tenofovir|tenofovir|mesh-list
83931152|NCT01300234|Adefovir|adefovir|mesh-list
83931153|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83931154|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
83931155|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931156|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83931157|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83931158|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931159|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931160|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83931161|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83931162|NCT01242332|Pregabalin|pregabalin|mesh-list
83931163|NCT01242332|Analgesics|analgesics|mesh-ancestor
83931164|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
83931165|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931166|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931167|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
83931168|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83931169|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83931170|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931171|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931172|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83931173|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83931174|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931175|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83931176|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
83931177|NCT00487773|Budesonide|budesonide|mesh-list
83931178|NCT00487773|Albuterol|albuterol|mesh-list
83931179|NCT00487773|Montelukast|montelukast|mesh-list
83931180|NCT00487773|Vitamins|vitamins|mesh-ancestor
83931181|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
83931182|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931183|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931184|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83931185|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
83931186|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931187|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83931188|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931189|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
83931190|NCT00487773|Hormones|hormones|mesh-ancestor
83931191|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170488|NCT05302856|Androgens|androgens|mesh-ancestor
83931192|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83931193|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
83931194|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83931195|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83931196|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931198|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83931199|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83931200|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83931201|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83931202|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
83931203|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931204|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931205|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83931206|NCT01299961|Abatacept|abatacept|mesh-list
83931207|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83931208|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931209|NCT01299961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931210|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931211|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931212|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
83931213|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931214|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931215|NCT00492245|Mitomycins|mitomycins|mesh-list
83931216|NCT00492245|Mitomycin|mitomycin|mesh-list
83931217|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83931218|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931219|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
83931220|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931221|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83931222|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931223|NCT00487812|Dobutamine|dobutamine|mesh-list
83931224|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83931225|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
83931226|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
83931227|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931228|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931229|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83931230|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83931231|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83931232|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
83931233|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931234|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931235|NCT00487812|Protective Agents|protective agents|mesh-ancestor
83931236|NCT01299805|Vortioxetine|vortioxetine|mesh-list
83931237|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
83931238|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83931239|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83931240|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83931241|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931242|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931243|NCT01299805|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83931244|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83931245|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83931246|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931247|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931248|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
83931249|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83931250|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83931251|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83931252|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83931253|NCT00487682|Valacyclovir|valacyclovir|mesh-list
83931254|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
83931255|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931256|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
83931257|NCT04512261|Trastuzumab|trastuzumab|mesh-list
83931258|NCT04512261|Tucatinib|tucatinib|mesh-list
83931259|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931260|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931261|NCT04512261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83931262|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931263|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83931264|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931266|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83931267|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
83931268|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931269|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931270|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83931271|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931272|NCT00487799|Diuretics|diuretics|mesh-ancestor
83931273|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
83931274|NCT05149170|Antibodies|antibodies|mesh-list
83931275|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83931276|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
83931277|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931278|NCT05149092|Caseins|caseins|mesh-list
83931279|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
83931280|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
83931281|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931282|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
83931283|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931284|NCT00495287|Cytarabine|cytarabine|mesh-list
83931285|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931286|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
83931287|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931288|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931289|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
83931290|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931291|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931292|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
83931293|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931294|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
83931295|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83931296|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931297|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931298|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931299|NCT00495326|Efavirenz|efavirenz|mesh-list
83931300|NCT00495326|Nevirapine|nevirapine|mesh-list
83931301|NCT00495326|Rifampin|rifampin|mesh-list
83931302|NCT00495326|Isoniazid|isoniazid|mesh-list
83931303|NCT00495326|Ethambutol|ethambutol|mesh-list
83931304|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83931305|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83931306|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931307|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931308|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
83931309|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931310|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83931311|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83931312|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83931313|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83931314|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83931315|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83931316|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83931317|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
83931318|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83931319|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
83931320|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83931321|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83931322|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83931323|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83931324|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83931325|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83931326|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83931327|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
83931328|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83931329|NCT00492479|Kinetin|kinetin|mesh-list
83931330|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83931331|NCT00492479|Growth Substances|growth substances|mesh-ancestor
83931332|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931333|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
83931334|NCT00495365|Hematinics|hematinics|mesh-ancestor
83931335|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
83931336|NCT00492518|Theophylline|theophylline|mesh-list
83931337|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83931338|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
83931339|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931340|NCT00492518|Expectorants|expectorants|mesh-ancestor
83931341|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931342|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83931343|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
83931344|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931345|NCT00492518|Protective Agents|protective agents|mesh-ancestor
83931346|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931347|NCT00492518|Antidotes|antidotes|mesh-ancestor
83931348|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83931349|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
83931350|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931351|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83931352|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83931353|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931354|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931355|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83931356|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83931357|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
83931358|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931359|NCT04513860|Cenobamate|cenobamate|mesh-list
83931360|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
83931361|NCT00495560|Misoprostol|misoprostol|mesh-list
83931362|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83931363|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
83931364|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83931365|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931366|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83931367|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83931368|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
83931369|NCT00506844|Capecitabine|capecitabine|mesh-list
83931370|NCT00506844|Irinotecan|irinotecan|mesh-list
83931371|NCT00506844|Cetuximab|cetuximab|mesh-list
83931372|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931373|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
83931374|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931375|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931376|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83931377|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83931378|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931379|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931380|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83931381|NCT00506961|Simvastatin|simvastatin|mesh-list
83931382|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83931383|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83931384|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
83931385|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931386|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83931387|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83931388|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931389|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83931390|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931391|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83931392|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83931393|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931394|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931395|NCT00492635|Urological Agents|urological agents|mesh-ancestor
83931396|NCT00507000|Vitamin D|vitamin d|mesh-list
83931397|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
83931398|NCT00507000|Vitamins|vitamins|mesh-ancestor
83931399|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
83931400|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931401|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83931402|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931403|NCT00495872|Lenalidomide|lenalidomide|mesh-list
83931404|NCT00495872|Sunitinib|sunitinib|mesh-list
83931405|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83931406|NCT00495872|Sorafenib|sorafenib|mesh-list
83931407|NCT00495872|Dasatinib|dasatinib|mesh-list
83931408|NCT00495872|Lapatinib|lapatinib|mesh-list
83931409|NCT00495872|Valproic Acid|valproic acid|mesh-list
83931410|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
83931411|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931412|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83931413|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83931414|NCT00495872|Growth Substances|growth substances|mesh-ancestor
83170710|NCT05259800|Emollients|emollients|mesh-ancestor
83931415|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
83931416|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931417|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83931418|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931419|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931420|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
83931421|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
83931422|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931423|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
83931424|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83931425|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931426|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83931427|NCT00507117|Eszopiclone|eszopiclone|mesh-list
83931428|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83931429|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931430|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931431|NCT00492830|Antibodies|antibodies|mesh-list
83931432|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83931433|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
83931434|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931435|NCT01299571|Dutasteride|dutasteride|mesh-list
83931436|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83931437|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83931438|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931439|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931440|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
83931441|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931442|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931443|NCT01243736|Metoclopramide|metoclopramide|mesh-list
83931444|NCT01243736|Simethicone|simethicone|mesh-list
83931445|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
83931446|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
83931447|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931448|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931449|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83931450|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83931451|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83931452|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
83931453|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931454|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931455|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
83931456|NCT01243736|Emollients|emollients|mesh-ancestor
83931457|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83931458|NCT00492986|Sorafenib|sorafenib|mesh-list
83931459|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931460|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83931461|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931462|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931463|NCT01243970|Phenylephrine|phenylephrine|mesh-list
83931464|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
83931465|NCT01243970|Ephedrine|ephedrine|mesh-list
83931466|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83931467|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
83931468|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
83931469|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931470|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931471|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
83931472|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83931473|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
83931474|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931475|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83931476|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83931477|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83931478|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
83931479|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931480|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931481|NCT01243970|Protective Agents|protective agents|mesh-ancestor
83931482|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83931483|NCT04515576|Dulaglutide|dulaglutide|mesh-list
83931484|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931485|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931486|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83931487|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83931488|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931489|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931490|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83931491|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
83931492|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931493|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931494|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
83931495|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931496|NCT01244009|Niraparib|niraparib|mesh-list
83931497|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83931498|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931499|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931500|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931501|NCT04511832|Diclofenac|diclofenac|mesh-list
83931502|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83931503|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83931504|NCT04511832|Analgesics|analgesics|mesh-ancestor
83931505|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
83931506|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931507|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931508|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931509|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931510|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83931511|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931512|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931513|NCT01244204|Vitamin D|vitamin d|mesh-list
83931514|NCT01244204|Vitamins|vitamins|mesh-ancestor
83931515|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
83931516|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931517|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83931518|NCT00496028|Paclitaxel|paclitaxel|mesh-list
83931519|NCT00496028|Carboplatin|carboplatin|mesh-list
83931520|NCT00496028|Saracatinib|saracatinib|mesh-list
83931521|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83931522|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931523|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83931524|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83931525|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83931526|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931527|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931528|NCT04516278|Bevacizumab|bevacizumab|mesh-list
83931529|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931530|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931531|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83931532|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83931533|NCT04516278|Growth Substances|growth substances|mesh-ancestor
83931534|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931535|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
83931536|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
83931537|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83931538|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931539|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83931540|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83931541|NCT01297465|Hormones|hormones|mesh-ancestor
83931542|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931543|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931544|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83931545|NCT04518462|Bupivacaine|bupivacaine|mesh-list
83931546|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
83931547|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
83931548|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931549|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931550|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
83931551|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931552|NCT00496184|Nifedipine|nifedipine|mesh-list
83931553|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83931554|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83931555|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931556|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931557|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931558|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931559|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
83931560|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83931561|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
83931562|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83931563|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
83931564|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931565|NCT00493610|Expectorants|expectorants|mesh-ancestor
83931566|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931567|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83931568|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
83931569|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931570|NCT00493610|Protective Agents|protective agents|mesh-ancestor
83931571|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931572|NCT00493610|Antidotes|antidotes|mesh-ancestor
83931573|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
83931574|NCT02274506|Fludarabine|fludarabine|mesh-list
83931575|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
83931576|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931577|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
83931578|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931579|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931580|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83931581|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
83931582|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931583|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931584|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83931585|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931586|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
83931587|NCT00496223|Sunitinib|sunitinib|mesh-list
83931588|NCT00496223|Dacarbazine|dacarbazine|mesh-list
83931589|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931590|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83931591|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83931592|NCT00496223|Growth Substances|growth substances|mesh-ancestor
83931593|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931594|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
83931595|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83931596|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931597|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931598|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83931599|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
83931600|NCT00496301|Gemcitabine|gemcitabine|mesh-list
83931601|NCT00496301|Capecitabine|capecitabine|mesh-list
83931602|NCT00496301|Sorafenib|sorafenib|mesh-list
83931603|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931604|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
83931605|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931606|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931607|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83931608|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931609|NCT05141838|Vitamin D|vitamin d|mesh-list
83931610|NCT05141838|Vitamins|vitamins|mesh-ancestor
83931611|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
83931612|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931613|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83931614|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
83931615|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83931616|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
83931617|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931618|NCT00493727|Expectorants|expectorants|mesh-ancestor
83931619|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
83412611|NCT02143219|Vitamins|vitamins|mesh-ancestor
83931620|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83931621|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
83931622|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931623|NCT00493727|Protective Agents|protective agents|mesh-ancestor
83931624|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931625|NCT00493727|Antidotes|antidotes|mesh-ancestor
83931626|NCT00493766|Panobinostat|panobinostat|mesh-list
83931627|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931628|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83931629|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931630|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931631|NCT05146479|Fluorides|fluorides|mesh-list
83931632|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
83931633|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
83931634|NCT05146479|Protective Agents|protective agents|mesh-ancestor
83931635|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931636|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83931637|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83931638|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931639|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931640|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
83931641|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931642|NCT01296568|Gemcitabine|gemcitabine|mesh-list
83931643|NCT01296568|Pemetrexed|pemetrexed|mesh-list
83931644|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931645|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
83931646|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931647|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931648|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931649|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83931650|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83931651|NCT02598999|Lactoferrin|lactoferrin|mesh-list
83931652|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
83931653|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931654|NCT01296412|Metformin|metformin|mesh-list
83931655|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83931656|NCT01296412|Liraglutide|liraglutide|mesh-list
83931657|NCT01296412|Glimepiride|glimepiride|mesh-list
83931658|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931659|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931660|NCT01296412|Incretins|incretins|mesh-ancestor
83931661|NCT01296412|Hormones|hormones|mesh-ancestor
83931662|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931663|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83931664|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
83931665|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931666|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931667|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83931668|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931669|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
83931670|NCT00496652|Zalutumumab|zalutumumab|mesh-list
83931671|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931672|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931673|NCT02597634|Ibuprofen|ibuprofen|mesh-list
83931674|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83931675|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83931676|NCT02597634|Analgesics|analgesics|mesh-ancestor
83931677|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
83931678|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931679|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931680|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931681|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931682|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83931683|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931684|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931685|NCT02591199|Lidocaine|lidocaine|mesh-list
83931686|NCT02591199|Heparin|heparin|mesh-list
83931687|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
83931688|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
83931689|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931690|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931691|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
83931692|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931693|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83931694|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83931695|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83931696|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83931697|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931698|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
83931699|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83931700|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83931701|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
83931702|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
83931703|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83931704|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931705|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931706|NCT02596035|Nivolumab|nivolumab|mesh-list
83931707|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931708|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931709|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83931710|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931711|NCT00494156|Aspirin|aspirin|mesh-list
83931712|NCT00494156|Heparin|heparin|mesh-list
83931713|NCT00494156|Clopidogrel|clopidogrel|mesh-list
83931714|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83931715|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83931716|NCT00494156|Analgesics|analgesics|mesh-ancestor
83931717|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
83931718|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931719|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931720|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931721|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931722|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83931723|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83931724|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931725|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83931726|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83931727|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931728|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
83931729|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83931730|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83931731|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83931732|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
83931733|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931734|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
83931735|NCT02595489|Vitamin D|vitamin d|mesh-list
83931736|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
83931737|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
83931738|NCT02595489|Vitamins|vitamins|mesh-list
83931739|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
83931740|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931741|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83931742|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931743|NCT00497003|Metoprolol|metoprolol|mesh-list
83931744|NCT00497003|Carvedilol|carvedilol|mesh-list
83931745|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83931746|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83931747|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
83931748|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
83931749|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931750|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931751|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83931752|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83931753|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83931754|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
83931755|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931756|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931757|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
83931758|NCT00497003|Protective Agents|protective agents|mesh-ancestor
83931759|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83931760|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83931761|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931762|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931763|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83931764|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83931765|NCT00494312|Pioglitazone|pioglitazone|mesh-list
83931766|NCT00494312|Glyburide|glyburide|mesh-list
83931767|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83931768|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931769|NCT02595372|Omeprazole|omeprazole|mesh-list
83931770|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83931771|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83931772|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83931773|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931774|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931775|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
83931776|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83931777|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931778|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
83931779|NCT02596503|Cefixime|cefixime|mesh-list
83931780|NCT02596503|Irinotecan|irinotecan|mesh-list
83931781|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83931782|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83931783|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931784|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931785|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931786|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83931787|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931788|NCT00494429|Morphine|morphine|mesh-list
83931789|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83931790|NCT00494429|Narcotics|narcotics|mesh-ancestor
83931791|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931792|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931793|NCT00494429|Analgesics|analgesics|mesh-ancestor
83931794|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
83931795|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931796|NCT00497120|Acetazolamide|acetazolamide|mesh-list
83931797|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
83931798|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83931799|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931800|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931801|NCT00497120|Diuretics|diuretics|mesh-ancestor
83931802|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
83931803|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931804|NCT00494468|Zolpidem|zolpidem|mesh-list
83931805|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83931806|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83931807|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931808|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931809|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83931810|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
83931811|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
83931812|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931813|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931814|NCT00497237|Fluticasone|fluticasone|mesh-list
83931815|NCT00497237|Beclomethasone|beclomethasone|mesh-list
83931816|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
83931817|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83931818|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931819|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83931820|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
83931821|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931822|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931823|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83931824|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931825|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
83931826|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83931827|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83931828|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83931829|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83931830|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
83931831|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931832|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931833|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
83931834|NCT00497237|Hormones|hormones|mesh-ancestor
83931835|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931836|NCT00497315|Pemetrexed|pemetrexed|mesh-list
83931837|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931838|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931839|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931840|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83931841|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83931842|NCT05142072|Vitamin D|vitamin d|mesh-list
83931843|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
83931844|NCT05142072|Vitamins|vitamins|mesh-ancestor
83931845|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
83931846|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931847|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83931848|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83931849|NCT00497354|Anesthetics|anesthetics|mesh-list
83931850|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
83931851|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931852|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931853|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
83931854|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931855|NCT00494624|Prednisolone|prednisolone|mesh-list
83931856|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931857|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
83931858|NCT00494624|Hormones|hormones|mesh-ancestor
83931859|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931860|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931861|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83931862|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171163|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931863|NCT00494663|Ketoconazole|ketoconazole|mesh-list
83931864|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
83931865|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931866|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83931867|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83931869|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931870|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83931871|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
83931872|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931873|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931874|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83931875|NCT05146674|Tadalafil|tadalafil|mesh-list
83931876|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
83931877|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83931878|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83931879|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931880|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931881|NCT05146674|Urological Agents|urological agents|mesh-ancestor
83931882|NCT00507195|Midazolam|midazolam|mesh-list
83931883|NCT00507195|Propofol|propofol|mesh-list
83931884|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83931885|NCT00507195|Sevoflurane|sevoflurane|mesh-list
83931886|NCT00507195|Desflurane|desflurane|mesh-list
83931887|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83931888|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931889|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83931890|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
83931891|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
83931892|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83931893|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83931894|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83931895|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83931896|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
83931897|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
83931898|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931899|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931900|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83931901|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83931902|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
83931903|NCT00497471|Dapsone|dapsone|mesh-list
83931904|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
83931905|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83931906|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83931907|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931908|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83931909|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931910|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931911|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
83931912|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83931913|NCT05146635|Epirubicin|epirubicin|mesh-list
83931914|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83931915|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931916|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83931917|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83931918|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931919|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931920|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
83931921|NCT00494741|Azathioprine|azathioprine|mesh-list
83931922|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83931923|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931924|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83931925|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
83931926|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83931927|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83931928|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931929|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931930|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
83931931|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931932|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931933|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
83931934|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931935|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931936|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
83931937|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83931938|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
83931939|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83931940|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931941|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83931942|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931943|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83931944|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83931945|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83931946|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
83931947|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931948|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931950|NCT05148546|Ipilimumab|ipilimumab|mesh-list
83931951|NCT05148546|Relatlimab|relatlimab|mesh-list
83931952|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83931953|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931954|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83931955|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931956|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83931957|NCT00506532|Calfactant|calfactant|mesh-list
83931958|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
83931959|NCT05149560|Ticagrelor|ticagrelor|mesh-list
83931960|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83931961|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83931962|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83931963|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83931964|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
83931965|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83931966|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931967|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931968|NCT00494897|Cytarabine|cytarabine|mesh-list
83931969|NCT00494897|Prednisone|prednisone|mesh-list
83931970|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
83931971|NCT00494897|Methotrexate|methotrexate|mesh-list
83931972|NCT00494897|Vincristine|vincristine|mesh-list
83931973|NCT00494897|Daunorubicin|daunorubicin|mesh-list
83931974|NCT00494897|Asparaginase|asparaginase|mesh-list
83931975|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
83931976|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83931977|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
83931978|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83931979|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83931980|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83931981|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
83931982|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83931983|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83931984|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83931985|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83931986|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
83931987|NCT00494897|Hormones|hormones|mesh-ancestor
83931988|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83931989|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83931990|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83931991|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
83931992|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83931993|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83931994|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
83931995|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
83931996|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83931997|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83931998|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83931999|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
83932000|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932001|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83932002|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
83932003|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
83932004|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
83932005|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83932006|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83932007|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83932008|NCT00497744|Cefepime|cefepime|mesh-list
83932009|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83932010|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932011|NCT00495092|Biperiden|biperiden|mesh-list
83932012|NCT00495092|Caffeine|caffeine|mesh-list
83932013|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83932014|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932015|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83932016|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932017|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932018|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83932019|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83932020|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
83932021|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932022|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83932023|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83932024|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
83932025|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
83932026|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932027|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83932028|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83932029|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
83932030|NCT01244360|Resveratrol|resveratrol|mesh-list
83932031|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
83932032|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932033|NCT01244360|Protective Agents|protective agents|mesh-ancestor
83932034|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932035|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932036|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83932037|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
83932038|NCT00506571|Irinotecan|irinotecan|mesh-list
83932039|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932040|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83932041|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83932042|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932043|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932044|NCT00497900|Vitamin D|vitamin d|mesh-list
83932045|NCT00497900|Vitamins|vitamins|mesh-ancestor
83932046|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
83932047|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932048|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83932049|NCT05143125|Decitabine|decitabine|mesh-list
83932050|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932051|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
83932052|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932053|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932054|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932055|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
83932056|NCT00497939|Urological Agents|urological agents|mesh-ancestor
83932057|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83932058|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83932059|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932060|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932061|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83932062|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83932063|NCT00498134|Analgesics|analgesics|mesh-ancestor
83932064|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
83932065|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932066|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932067|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932068|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932069|NCT00498251|Albuterol|albuterol|mesh-list
83932070|NCT00498251|Ipratropium|ipratropium|mesh-list
83932071|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83932072|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
83932073|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932074|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932075|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83932076|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
83932077|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
83932078|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83932079|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83932080|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83932081|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83932082|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932083|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932084|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932085|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83932086|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
83932087|NCT00502658|Vitamins|vitamins|mesh-list
83932088|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
83932089|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932090|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
83932091|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83932092|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932093|NCT05146245|Risperidone|risperidone|mesh-list
83932094|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83932095|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
83932096|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932097|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932098|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932099|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83932100|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83932101|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932102|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83932103|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83932104|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
83932105|NCT05146089|Bosentan|bosentan|mesh-list
83932106|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83932107|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83932108|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932109|NCT02954913|Liver Extracts|liver extracts|mesh-list
83932110|NCT02954913|Hematinics|hematinics|mesh-ancestor
83932111|NCT00502892|Carboplatin|carboplatin|mesh-list
83932112|NCT00502892|Topotecan|topotecan|mesh-list
83932113|NCT00502892|Ifosfamide|ifosfamide|mesh-list
83932114|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932115|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83932116|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83932117|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932118|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932119|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83932120|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
83932121|NCT00502970|Interferons|interferons|mesh-list
83932122|NCT00502970|Ribavirin|ribavirin|mesh-list
83932123|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
83932124|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932125|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
83932126|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932127|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
83932128|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932129|NCT00502970|Hematinics|hematinics|mesh-ancestor
83932130|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
83932131|NCT05149287|Lidocaine|lidocaine|mesh-list
83932132|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
83932133|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
83932134|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932135|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932136|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
83932137|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932138|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83932139|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83932140|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83932141|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932142|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932143|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83932144|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932145|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
83932146|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83932147|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
83932148|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83932149|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83932150|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932151|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932152|NCT00498680|Urological Agents|urological agents|mesh-ancestor
83932153|NCT00498953|Carboplatin|carboplatin|mesh-list
83932154|NCT00498953|Docetaxel|docetaxel|mesh-list
83932155|NCT00498953|Fluorouracil|fluorouracil|mesh-list
83932156|NCT00498953|Lapatinib|lapatinib|mesh-list
83932157|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83932158|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932159|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83932160|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83932161|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83932162|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932163|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
83932164|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932165|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932166|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
83932167|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932168|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932169|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932170|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83932171|NCT00503126|Bivalirudin|bivalirudin|mesh-list
83932172|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
83932173|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83932174|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
83932175|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932176|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932177|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
83932178|NCT05145543|Dexamethasone|dexamethasone|mesh-list
83932179|NCT05145543|Fentanyl|fentanyl|mesh-list
83932180|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
83932181|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932182|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
83932183|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
83932184|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932185|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932186|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83932187|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
83932188|NCT05145543|Hormones|hormones|mesh-ancestor
83932189|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83932190|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83932191|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932192|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83932193|NCT05145543|Narcotics|narcotics|mesh-ancestor
83932194|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932195|NCT05145543|Analgesics|analgesics|mesh-ancestor
83932196|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
83932197|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83932198|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83932199|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
83932200|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
83932201|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
83932202|NCT00503204|Cediranib|cediranib|mesh-list
83932203|NCT00503204|Lomustine|lomustine|mesh-list
83932204|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932205|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932206|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932207|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932208|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83932209|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
83932210|NCT00503243|Mesalamine|mesalamine|mesh-list
83932211|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83932212|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83932213|NCT00503243|Analgesics|analgesics|mesh-ancestor
83932214|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
83932215|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932216|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932217|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932218|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932219|NCT00498992|Vitamin E|vitamin e|mesh-list
83932220|NCT00498992|Lidocaine|lidocaine|mesh-list
83932221|NCT00498992|Vitamins|vitamins|mesh-ancestor
83932222|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
83932223|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932224|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
83932225|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
83932226|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932227|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
83932228|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932229|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83932230|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83932231|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83932232|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932233|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932234|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
83932235|NCT00498992|Protective Agents|protective agents|mesh-ancestor
83932236|NCT02276391|Telmisartan|telmisartan|mesh-list
83932237|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83932238|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83932239|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83932240|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171538|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83932242|NCT05145270|Dexetimide|dexetimide|mesh-list
83932243|NCT05145270|Citalopram|citalopram|mesh-list
83932244|NCT05145270|Escitalopram|escitalopram|mesh-list
83932245|NCT05145270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83932246|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83932247|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932248|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932249|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932250|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
83932251|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932252|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83932253|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83932254|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
83932255|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
83932256|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932257|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83932258|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83932259|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
83932260|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83932261|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
83932262|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83932263|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83932264|NCT05145270|Protective Agents|protective agents|mesh-ancestor
83932265|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932266|NCT01245179|Panobinostat|panobinostat|mesh-list
83932267|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932268|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83932269|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932270|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932271|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
83932272|NCT00503321|Tegafur|tegafur|mesh-list
83932273|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932274|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
83932275|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932276|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932277|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83932278|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
83932279|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932280|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83932281|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
83932282|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932283|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
83932284|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83932285|NCT00503321|Protective Agents|protective agents|mesh-ancestor
83932286|NCT00503477|Cediranib|cediranib|mesh-list
83932287|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932288|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932289|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932290|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932291|NCT05144295|Lactulose|lactulose|mesh-list
83932292|NCT05144295|Bisacodyl|bisacodyl|mesh-list
83932293|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
83932294|NCT05144295|Lubiprostone|lubiprostone|mesh-list
83932295|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83932296|NCT05144295|Cathartics|cathartics|mesh-ancestor
83932297|NCT05144295|Laxatives|laxatives|mesh-ancestor
83932298|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83932299|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932300|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932301|NCT01245452|Methotrexate|methotrexate|mesh-list
83932302|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83932303|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
83932304|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83932305|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932306|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932307|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
83932308|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932309|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932310|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
83932311|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932312|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83932313|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932314|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
83171619|NCT05082441|Bupivacaine|bupivacaine|mesh-list
83932315|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932316|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83932317|NCT00503516|Megestrol|megestrol|mesh-list
83932318|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
83932319|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83932320|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83932321|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83932322|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
83932323|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83932324|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932325|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83932326|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83932327|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83932328|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932329|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
83932330|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83932331|NCT05148195|Leucovorin|leucovorin|mesh-list
83932332|NCT05148195|Docetaxel|docetaxel|mesh-list
83932333|NCT05148195|Irinotecan|irinotecan|mesh-list
83932334|NCT05148195|Calcium|calcium|mesh-list
83932335|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
83932336|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932337|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
83932338|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
83932339|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
83932340|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932341|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83932342|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932343|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83932344|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83932345|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932346|NCT05148195|Antidotes|antidotes|mesh-ancestor
83932347|NCT05148195|Protective Agents|protective agents|mesh-ancestor
83932348|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
83932349|NCT05148195|Vitamins|vitamins|mesh-ancestor
83932350|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
83932351|NCT00499265|Gemcitabine|gemcitabine|mesh-list
83932352|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
83932353|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
83932354|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932355|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
83932356|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932357|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932358|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932359|NCT01246622|Cytarabine|cytarabine|mesh-list
83932360|NCT01246622|Lenalidomide|lenalidomide|mesh-list
83932361|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932362|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
83932363|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932364|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932365|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
83932366|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932367|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932368|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
83932369|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932370|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83932371|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83932372|NCT01246622|Growth Substances|growth substances|mesh-ancestor
83932373|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
83932374|NCT01245530|Donepezil|donepezil|mesh-list
83932375|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83932376|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932377|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932378|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
83932379|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932380|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932381|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
83932382|NCT05148312|Budesonide|budesonide|mesh-list
83932383|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932384|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83932385|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
83171692|NCT00836069|Paroxetine|paroxetine|mesh-list
83932386|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932387|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932388|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83932389|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83932390|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
83932391|NCT05148312|Hormones|hormones|mesh-ancestor
83932392|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83932393|NCT01246817|Sirolimus|sirolimus|mesh-list
83932394|NCT01246817|Temsirolimus|temsirolimus|mesh-list
83932395|NCT01246817|MTOR Inhibitors|mtor inhibitors|mesh-list
83932396|NCT01246817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932397|NCT01246817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932398|NCT01246817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932399|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932400|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
83932401|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932402|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932403|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83932404|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932405|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83932406|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
83932407|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83932408|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83932409|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83932410|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
83932411|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932412|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83932413|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83932414|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932415|NCT05148975|Dimercaprol|dimercaprol|mesh-list
83932416|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
83932417|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
83932418|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932419|NCT00499577|Vaccines|vaccines|mesh-list
83932420|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83932421|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
83932422|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932423|NCT02274740|Metformin|metformin|mesh-list
83932424|NCT02274740|Lixisenatide|lixisenatide|mesh-list
83932425|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83932426|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932427|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
83932428|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932429|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
83932430|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932431|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932432|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83932433|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
83932434|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932435|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932436|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83932437|NCT00503594|Cytarabine|cytarabine|mesh-list
83932438|NCT00503594|Methotrexate|methotrexate|mesh-list
83932439|NCT00503594|Vincristine|vincristine|mesh-list
83932440|NCT00503594|Temozolomide|temozolomide|mesh-list
83932441|NCT00503594|Procarbazine|procarbazine|mesh-list
83932442|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83932443|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
83932444|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83932445|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932446|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932447|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
83932448|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932449|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932450|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
83932451|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932452|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83932453|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932454|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
83932455|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932456|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83932457|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
83932458|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932459|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83932460|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
83932461|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
83932462|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
83932463|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83932464|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
83932465|NCT00499811|Vorinostat|vorinostat|mesh-list
83932466|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932467|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83932468|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932469|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932471|NCT00499850|Fluorouracil|fluorouracil|mesh-list
83932472|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
83932473|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
83932474|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932475|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932476|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932477|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932478|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
83932479|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932480|NCT00499850|Antidotes|antidotes|mesh-ancestor
83932481|NCT00499850|Protective Agents|protective agents|mesh-ancestor
83932482|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
83932483|NCT00499850|Vitamins|vitamins|mesh-ancestor
83932484|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
83932485|NCT05146713|Propolis|propolis|mesh-list
83932486|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83932487|NCT05146713|Eusol|eusol|mesh-list
83932488|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932489|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
83932490|NCT00503828|Naproxen|naproxen|mesh-list
83932491|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83932492|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83932493|NCT00503828|Analgesics|analgesics|mesh-ancestor
83932494|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
83932495|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932496|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932497|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932498|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932499|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
83932500|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83932501|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932502|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932503|NCT00500006|Dasatinib|dasatinib|mesh-list
83932504|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932505|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932506|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932507|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932508|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83932509|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
83932510|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83932511|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83932512|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
83932513|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932514|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932515|NCT00506727|Amphetamine|amphetamine|mesh-list
83932516|NCT00506727|Adderall|adderall|mesh-list
83932517|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83932518|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83932519|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83932520|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932521|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932522|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932523|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932524|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932525|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83932526|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
83932527|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
83932528|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932529|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
83932530|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83932531|NCT03455517|Rituximab|rituximab|mesh-list
83932532|NCT03455517|Venetoclax|venetoclax|mesh-list
83932533|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83932534|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932535|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
83932536|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932537|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932538|NCT04696536|Listerine|listerine|mesh-list
83932539|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83932540|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932541|NCT00500279|Celecoxib|celecoxib|mesh-list
83932542|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83932544|NCT00500279|Analgesics|analgesics|mesh-ancestor
83932545|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
83932546|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932547|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932548|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932549|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932550|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83932551|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83932552|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932553|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932554|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
83932555|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83932556|NCT01245881|Protective Agents|protective agents|mesh-ancestor
83932557|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932558|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
83932559|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
83932560|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932561|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83932562|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932563|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932564|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
83932565|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83932566|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932567|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83932568|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
83932569|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
83932570|NCT01247558|Vitamins|vitamins|mesh-ancestor
83932571|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
83932572|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932573|NCT00500552|Perhexiline|perhexiline|mesh-list
83932574|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83932575|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932576|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932577|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83932578|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932579|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
83932580|NCT00508209|Bortezomib|bortezomib|mesh-list
83932581|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932582|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
83932583|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83932584|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932585|NCT00507585|Leucovorin|leucovorin|mesh-list
83932586|NCT00507585|Bevacizumab|bevacizumab|mesh-list
83932587|NCT00507585|Fluorouracil|fluorouracil|mesh-list
83932588|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
83932589|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83932590|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932591|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83932592|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83932593|NCT00507585|Growth Substances|growth substances|mesh-ancestor
83932594|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932595|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
83932596|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
83932597|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932598|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932599|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932600|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
83932601|NCT00507585|Antidotes|antidotes|mesh-ancestor
83932602|NCT00507585|Protective Agents|protective agents|mesh-ancestor
83932603|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
83932604|NCT00507585|Vitamins|vitamins|mesh-ancestor
83932605|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
83932606|NCT01247714|Phentermine|phentermine|mesh-list
83932607|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83932608|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932609|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
83932610|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83932611|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
83932612|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
83932613|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932614|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932615|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932616|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932617|NCT00507663|Atenolol|atenolol|mesh-list
83932618|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83932619|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83932620|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
83932621|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
83932622|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932623|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932624|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83932625|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83932626|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83932627|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932628|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932629|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932630|NCT00508287|Exenatide|exenatide|mesh-list
83932631|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83932632|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932633|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83932634|NCT00508287|Incretins|incretins|mesh-ancestor
83932635|NCT00508287|Hormones|hormones|mesh-ancestor
83932636|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83932637|NCT00508326|Paclitaxel|paclitaxel|mesh-list
83932638|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83932639|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932640|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83932641|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83932642|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83932643|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932644|NCT00507858|Dexamethasone|dexamethasone|mesh-list
83932645|NCT00507858|Pemetrexed|pemetrexed|mesh-list
83932646|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932647|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
83932648|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
83932649|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932650|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932651|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83932652|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
83932653|NCT00507858|Hormones|hormones|mesh-ancestor
83932654|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83932655|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83932656|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932657|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932658|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932659|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83932660|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83932661|NCT00508365|Carvedilol|carvedilol|mesh-list
83932662|NCT00508365|Lisinopril|lisinopril|mesh-list
83932663|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83932664|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83932665|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932666|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932667|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932668|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932669|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83932670|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
83932671|NCT00508365|Protective Agents|protective agents|mesh-ancestor
83932672|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83932673|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932674|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83932675|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
83932676|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83932677|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83932678|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83932679|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
83932680|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932681|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83932682|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
83932683|NCT00500864|Analgesics|analgesics|mesh-ancestor
83932684|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
83932685|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932686|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932687|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
83932688|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932689|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83932690|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
83932691|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83932692|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932693|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932694|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83932695|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
83932696|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83932697|NCT00507975|Nicotine|nicotine|mesh-list
83932698|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83932699|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
83932700|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932701|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932702|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83932703|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83932704|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
83932705|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932706|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932707|NCT01247909|Gentamicins|gentamicins|mesh-list
83932708|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
83932709|NCT01247909|Penicillins|penicillins|mesh-list
83932710|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83932711|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932712|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83932713|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932714|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932715|NCT01245998|Dalteparin|dalteparin|mesh-list
83932716|NCT01245998|Tinzaparin|tinzaparin|mesh-list
83932717|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83932718|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
83932719|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83932720|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83932721|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932722|NCT02954484|Acetaminophen|acetaminophen|mesh-list
83932723|NCT02954484|Etoricoxib|etoricoxib|mesh-list
83932724|NCT02954484|Pregabalin|pregabalin|mesh-list
83932725|NCT02954484|Morphine|morphine|mesh-list
83932726|NCT02954484|Ropivacaine|ropivacaine|mesh-list
83932727|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83932728|NCT02954484|Narcotics|narcotics|mesh-ancestor
83932729|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932730|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932731|NCT02954484|Analgesics|analgesics|mesh-ancestor
83932732|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
83932733|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932734|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
83932735|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
83932736|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83932737|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
83932738|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
83932739|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83932740|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932741|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932742|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83932743|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83932744|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83932745|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83932746|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83932747|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932748|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932749|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83932750|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83932751|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932752|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
83932753|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83932754|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932755|NCT00501098|Caspofungin|caspofungin|mesh-list
83932756|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
83932757|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932758|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932759|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932760|NCT00501137|Vaccines|vaccines|mesh-list
83932761|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
83932762|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932763|NCT01248260|Folic Acid|folic acid|mesh-list
83932764|NCT01248260|Hematinics|hematinics|mesh-ancestor
83172068|NCT05096390|Axitinib|axitinib|mesh-list
83932765|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
83932766|NCT01248260|Vitamins|vitamins|mesh-ancestor
83932767|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
83932768|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932769|NCT01246037|Bisoprolol|bisoprolol|mesh-list
83932770|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83932771|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
83932772|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
83932773|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932774|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932775|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83932776|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83932777|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83932778|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932779|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932780|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932781|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
83932782|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83932783|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932784|NCT00509184|Rituximab|rituximab|mesh-list
83932785|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83932786|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932787|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
83932788|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932789|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932790|NCT00501254|Aspirin|aspirin|mesh-list
83932791|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
83932792|NCT00501254|Salicylates|salicylates|mesh-list
83932793|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932794|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
83932795|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
83932796|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
83932797|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83932798|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83932799|NCT00501254|Analgesics|analgesics|mesh-ancestor
83932800|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
83932801|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932802|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932803|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83932804|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932805|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83932806|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932807|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932808|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83932809|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83932810|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83932811|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
83932812|NCT01248338|Metoprolol|metoprolol|mesh-list
83932813|NCT01248338|Nebivolol|nebivolol|mesh-list
83932814|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83932815|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83932816|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
83932817|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
83932818|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932819|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932820|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83932821|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83932822|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83932823|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932824|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932825|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932826|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
83932827|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83932828|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83932829|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83932830|NCT02953743|Lenvatinib|lenvatinib|mesh-list
83932831|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932832|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932833|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932834|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932835|NCT00509379|Rituximab|rituximab|mesh-list
83932836|NCT00509379|Bortezomib|bortezomib|mesh-list
83932837|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83932838|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932839|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
83932840|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932841|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83932842|NCT02274974|Lidocaine|lidocaine|mesh-list
83932843|NCT02274974|Epinephrine|epinephrine|mesh-list
83932844|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
83932845|NCT02274974|Anesthetics|anesthetics|mesh-list
83932846|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932847|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932848|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
83932849|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932850|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83932851|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83932852|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83932853|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932854|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932855|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83932856|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83932857|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
83932858|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932859|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83932860|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83932861|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
83932862|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83932863|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
83932864|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
83932865|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
83932866|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83932867|NCT02274545|Vaccines|vaccines|mesh-list
83932868|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
83932869|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932870|NCT02275013|Simendan|simendan|mesh-list
83932871|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83932872|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
83932873|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83932874|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83932875|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932876|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932877|NCT02275013|Protective Agents|protective agents|mesh-ancestor
83932878|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932879|NCT02274623|Calcifediol|calcifediol|mesh-list
83932880|NCT02274623|Vitamins|vitamins|mesh-ancestor
83932881|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
83932882|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932883|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83932884|NCT00509613|Sirolimus|sirolimus|mesh-list
83932885|NCT00509613|Sorafenib|sorafenib|mesh-list
83932886|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932887|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932888|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932889|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932890|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83932891|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932892|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83932893|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
83932894|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932895|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
83932896|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932897|NCT00501410|Leucovorin|leucovorin|mesh-list
83932898|NCT00501410|Fluorouracil|fluorouracil|mesh-list
83932899|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
83932900|NCT00501410|Cetuximab|cetuximab|mesh-list
83932901|NCT00501410|Dasatinib|dasatinib|mesh-list
83932902|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
83932903|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932904|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83932905|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932906|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83932907|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
83932908|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932909|NCT00501410|Antidotes|antidotes|mesh-ancestor
83932910|NCT00501410|Protective Agents|protective agents|mesh-ancestor
83932911|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
83932912|NCT00501410|Vitamins|vitamins|mesh-ancestor
83932913|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
83932914|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83932915|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932916|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932917|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
83932918|NCT02953275|Vedolizumab|vedolizumab|mesh-list
83932919|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83932920|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932921|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932922|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83932923|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83932924|NCT02953275|Protective Agents|protective agents|mesh-ancestor
83932925|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932926|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
83932927|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83932928|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
83932929|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83932930|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
83932931|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83932932|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932933|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
83932934|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
83932935|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83932936|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932937|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83932938|NCT02955719|Sertraline|sertraline|mesh-list
83932939|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83932940|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
83932941|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83932942|NCT02955719|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83932943|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83932944|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932945|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932946|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932947|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
83932948|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932949|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83932950|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83932951|NCT00501527|Immunomodulating Agents|immunomodulating agents|mesh-list
83932952|NCT00501527|Immunologic Factors|immunologic factors|mesh-ancestor
83932953|NCT00501527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932954|NCT02955524|Lidocaine|lidocaine|mesh-list
83932955|NCT02955524|Tetracaine|tetracaine|mesh-list
83932956|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
83932957|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
83932958|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83932959|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932960|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
83932961|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83932962|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83932963|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83932964|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83932965|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83932966|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932967|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
83932968|NCT02953041|Bromides|bromides|mesh-list
83932969|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
83932970|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83932971|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83932972|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83932973|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
83932974|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83932975|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932976|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932977|NCT00501566|Satavaptan|satavaptan|mesh-list
83932978|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83932979|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932980|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
83932981|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83932982|NCT00501605|Cediranib|cediranib|mesh-list
83932983|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932984|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83932985|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932986|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932987|NCT00509847|Lactoferrin|lactoferrin|mesh-list
83932988|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83932989|NCT01248494|Letrozole|letrozole|mesh-list
83932990|NCT01248494|Dactolisib|dactolisib|mesh-list
83932991|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83932992|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83932993|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83932994|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83932995|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83932996|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83932997|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
83932998|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83932999|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933000|NCT02952573|Dexamethasone|dexamethasone|mesh-list
83933001|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
83933002|NCT02952573|BB 1101|bb 1101|mesh-list
83933003|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933004|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
83933005|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
83933006|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933007|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933008|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933009|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
83933010|NCT02952573|Hormones|hormones|mesh-ancestor
83933011|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933012|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83933013|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933014|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
83933015|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933016|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933017|NCT00501722|Satavaptan|satavaptan|mesh-list
83933018|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83933019|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933020|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
83933021|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933022|NCT01248611|Fentanyl|fentanyl|mesh-list
83933023|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83933024|NCT01248611|Narcotics|narcotics|mesh-ancestor
83933025|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933026|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933027|NCT01248611|Analgesics|analgesics|mesh-ancestor
83933028|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
83933029|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933030|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83933031|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83933032|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
83933033|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
83933034|NCT00509964|Irinotecan|irinotecan|mesh-list
83933035|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83933036|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83933037|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933038|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933039|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933040|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
83933041|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83933042|NCT00510471|Antibodies|antibodies|mesh-list
83933043|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
83933044|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
83933045|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933046|NCT00501839|Clomiphene|clomiphene|mesh-list
83933047|NCT00501839|Enclomiphene|enclomiphene|mesh-list
83933048|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
83933049|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83933050|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
83933051|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933052|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933053|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83933054|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
83933055|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83933056|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83933057|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83933058|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
83933059|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83933060|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83933061|NCT00510003|Analgesics|analgesics|mesh-ancestor
83933062|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
83933063|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933064|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933065|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933067|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933068|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83933069|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
83933070|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83933071|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933072|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933073|NCT00501878|Phenylephrine|phenylephrine|mesh-list
83933074|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
83933075|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83933076|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
83933077|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
83933078|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933079|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933080|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
83933081|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83933082|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
83933083|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
83933084|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83933085|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83933086|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83933087|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
83933088|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933089|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933090|NCT00501878|Protective Agents|protective agents|mesh-ancestor
83933091|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
83933092|NCT00501917|Hematinics|hematinics|mesh-ancestor
83933093|NCT00510588|Metformin|metformin|mesh-list
83933094|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933095|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933096|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
83933097|NCT00510627|Irinotecan|irinotecan|mesh-list
83933098|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933099|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83933100|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83933101|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933102|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933103|NCT00502034|Interferons|interferons|mesh-list
83933104|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
83933105|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
83933106|NCT00502034|Interleukin-2|interleukin-2|mesh-list
83933107|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933108|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
83933109|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933110|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
83933111|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933112|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83933113|NCT00502034|Analgesics|analgesics|mesh-ancestor
83933114|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
83933115|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933116|NCT00510666|Tramadol|tramadol|mesh-list
83933117|NCT00510666|Butorphanol|butorphanol|mesh-list
83933118|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83933119|NCT00510666|Narcotics|narcotics|mesh-ancestor
83933120|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933121|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933122|NCT00510666|Analgesics|analgesics|mesh-ancestor
83933123|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
83933124|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933125|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
83933126|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
83933127|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83933128|NCT00508092|Anesthetics|anesthetics|mesh-list
83933129|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
83933130|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933131|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933132|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
83933133|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933134|NCT00510705|Metformin|metformin|mesh-list
83933135|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933136|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933137|NCT00502073|Cyclosporine|cyclosporine|mesh-list
83933138|NCT00502073|Cyclosporins|cyclosporins|mesh-list
83933139|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933140|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933141|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83933142|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
83933143|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933144|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
83933145|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933146|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933147|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83933148|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83933149|NCT01248923|Dexamethasone|dexamethasone|mesh-list
83933150|NCT01248923|Bortezomib|bortezomib|mesh-list
83933151|NCT01248923|Filanesib|filanesib|mesh-list
83933152|NCT01248923|Lenograstim|lenograstim|mesh-list
83933153|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83933154|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933155|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
83933156|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
83933157|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933158|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933159|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933160|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
83933161|NCT01248923|Hormones|hormones|mesh-ancestor
83933162|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933163|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83933164|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933165|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83933166|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
83933167|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
83933168|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933169|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933170|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
83933171|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
83933172|NCT01249001|Aprepitant|aprepitant|mesh-list
83933173|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
83933174|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
83933175|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
83933176|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933177|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933178|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933179|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83933180|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933181|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933182|NCT00502112|Lenalidomide|lenalidomide|mesh-list
83933183|NCT00502112|Lintuzumab|lintuzumab|mesh-list
83933184|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
83933185|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933186|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83933187|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83933188|NCT00502112|Growth Substances|growth substances|mesh-ancestor
83933189|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
83933190|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933191|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83933192|NCT00502190|Silicon|silicon|mesh-list
83933193|NCT00502190|Trace Elements|trace elements|mesh-ancestor
83933194|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
83933195|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933196|NCT00502229|Metformin|metformin|mesh-list
83933197|NCT00502229|Clomiphene|clomiphene|mesh-list
83933198|NCT00502229|Enclomiphene|enclomiphene|mesh-list
83933199|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
83933200|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933201|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933202|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83933203|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
83933204|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933205|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83933206|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
83933207|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83933208|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83933209|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83933210|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83933211|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
83933212|NCT00502268|Vitamins|vitamins|mesh-ancestor
83933213|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
83933214|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933215|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83933216|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83933217|NCT00510081|Calcium|calcium|mesh-list
83172506|NCT00730639|Nivolumab|nivolumab|mesh-list
83933218|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83933219|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933220|NCT00502385|Cediranib|cediranib|mesh-list
83933221|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933222|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83933223|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933224|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933225|NCT00510159|Artesunate|artesunate|mesh-list
83933226|NCT00510159|Sulfalene|sulfalene|mesh-list
83933227|NCT00510159|Praziquantel|praziquantel|mesh-list
83933228|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
83933229|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83933230|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83933231|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933232|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933233|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
83933234|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
83933235|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83933236|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
83933237|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83933238|NCT00502463|Immunomodulating Agents|immunomodulating agents|mesh-list
83933239|NCT00502463|Immunologic Factors|immunologic factors|mesh-ancestor
83933240|NCT00502463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933241|NCT02952807|Misoprostol|misoprostol|mesh-list
83933242|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83933243|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
83933244|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83933245|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933246|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83933247|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933248|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
83933249|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
83933250|NCT02275130|Calcium|calcium|mesh-list
83933251|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83933252|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933253|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83933254|NCT03459417|Morphine|morphine|mesh-list
83933255|NCT03459417|Sulpiride|sulpiride|mesh-list
83933256|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83933257|NCT03459417|Narcotics|narcotics|mesh-ancestor
83933258|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933259|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933260|NCT03459417|Analgesics|analgesics|mesh-ancestor
83933261|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
83933262|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933263|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83933264|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83933265|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83933266|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83933267|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
83933268|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933269|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933270|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83933271|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
83933272|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83933273|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933274|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
83933275|NCT00502541|Hormones|hormones|mesh-ancestor
83933276|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933277|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933278|NCT01249430|Cytarabine|cytarabine|mesh-list
83933279|NCT01249430|Etoposide|etoposide|mesh-list
83933280|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
83933281|NCT01249430|Azacitidine|azacitidine|mesh-list
83933282|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
83933283|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83933284|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933285|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83933286|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83933287|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933288|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933289|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83933290|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
83933291|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
83933292|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933293|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83933294|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
83933295|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933297|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
83933298|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933299|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83933300|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83933301|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83933302|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83933303|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
83933304|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933305|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83933306|NCT02952963|Cathartics|cathartics|mesh-ancestor
83933307|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933308|NCT00510939|Bortezomib|bortezomib|mesh-list
83933309|NCT00510939|Tipifarnib|tipifarnib|mesh-list
83933310|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933311|NCT00504062|Fluticasone|fluticasone|mesh-list
83933312|NCT00504062|Budesonide|budesonide|mesh-list
83933313|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933314|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83933315|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
83933316|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933317|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933318|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83933319|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
83933320|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933321|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83933322|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
83933323|NCT00504062|Hormones|hormones|mesh-ancestor
83933324|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933325|NCT00504101|Bortezomib|bortezomib|mesh-list
83933326|NCT00504101|Melphalan|melphalan|mesh-list
83933327|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
83933328|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933329|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83933330|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
83933331|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933332|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83933333|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83933334|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
83933335|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933336|NCT00504140|Interferons|interferons|mesh-list
83933337|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
83933338|NCT00504140|Etoposide|etoposide|mesh-list
83933339|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83933340|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933341|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83933342|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83933343|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933344|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933345|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
83933346|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933347|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
83933348|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933349|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83933350|NCT00511017|Vitamins|vitamins|mesh-ancestor
83933351|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
83933352|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933353|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83933354|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
83933355|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83933356|NCT00511212|Antibodies|antibodies|mesh-list
83933357|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
83933358|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83933359|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
83933360|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933361|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
83933362|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933363|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83933364|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933365|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933366|NCT01241006|Dexamethasone|dexamethasone|mesh-list
83933367|NCT01241006|Prednisone|prednisone|mesh-list
83933368|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
83933369|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933370|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
83933371|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
83933372|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933373|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933374|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933375|NCT01241006|Hormones|hormones|mesh-ancestor
83933376|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933377|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83933378|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933379|NCT00510393|Everolimus|everolimus|mesh-list
83933380|NCT00510393|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83933381|NCT00510393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83933382|NCT00510393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933383|NCT00510393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933384|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83933385|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
83933386|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933387|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933388|NCT01249547|Axitinib|axitinib|mesh-list
83933389|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933390|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83933391|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933392|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933393|NCT00511719|Insulin|insulin|mesh-list
83933394|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83933395|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933396|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933397|NCT01246232|Amisulpride|amisulpride|mesh-list
83933398|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83933399|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83933400|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933401|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933402|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83933403|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83933404|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
83933405|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933406|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933407|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83933408|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
83933409|NCT01248962|Carboplatin|carboplatin|mesh-list
83933410|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933411|NCT00511446|Docetaxel|docetaxel|mesh-list
83933412|NCT00511446|Capecitabine|capecitabine|mesh-list
83933413|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
83933414|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933415|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
83933416|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
83933417|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
83933418|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933419|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83933420|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
83933421|NCT02955446|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83933422|NCT02955446|Nirogacestat|nirogacestat|mesh-list
83933423|NCT02955446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933424|NCT02955446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933425|NCT00511602|Insulin|insulin|mesh-list
83933426|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933427|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933428|NCT00511953|Gabapentin|gabapentin|mesh-list
83933429|NCT00511953|Analgesics|analgesics|mesh-ancestor
83933430|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
83933431|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933432|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933433|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
83933434|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83933435|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83933436|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933437|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83933438|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83933439|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83933440|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933441|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933442|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
83933443|NCT01249820|Anidulafungin|anidulafungin|mesh-list
83933444|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
83933445|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933446|NCT01247090|Vasopressins|vasopressins|mesh-list
83933447|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
83933448|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
83933449|NCT01247090|Coagulants|coagulants|mesh-ancestor
83933450|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83933451|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83933452|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
83933453|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933454|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
83933455|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933456|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83933457|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933458|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933459|NCT02951754|Methylphenidate|methylphenidate|mesh-list
83933460|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83933461|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933462|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83933463|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83933464|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83933465|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933466|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
83933467|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933468|NCT00504413|Digoxin|digoxin|mesh-list
83933469|NCT00504413|Midazolam|midazolam|mesh-list
83933470|NCT00504413|Methadone|methadone|mesh-list
83933471|NCT00504413|Bupropion|bupropion|mesh-list
83933472|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83933473|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83933474|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933475|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933476|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83933477|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83933478|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83933479|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83933480|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
83933481|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
83933482|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
83933483|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
83933484|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933485|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933486|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83933487|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
83933488|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83933489|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83933490|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83933491|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
83933492|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83933493|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83933494|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933495|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83933496|NCT00504413|Narcotics|narcotics|mesh-ancestor
83933497|NCT00504413|Analgesics|analgesics|mesh-ancestor
83933498|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
83933499|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933500|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
83933501|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
83933502|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83933503|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83933504|NCT00504413|Protective Agents|protective agents|mesh-ancestor
83933505|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
83933506|NCT01243658|Oxytocin|oxytocin|mesh-list
83933507|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
83933508|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83933509|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933510|NCT01249664|Aflibercept|aflibercept|mesh-list
83933511|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83933512|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83933513|NCT01249664|Growth Substances|growth substances|mesh-ancestor
83933514|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933515|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
83933516|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933517|NCT00513162|Etoposide|etoposide|mesh-list
83933518|NCT00513162|Valproic Acid|valproic acid|mesh-list
83933519|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83933520|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933521|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83933522|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83933523|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933524|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933525|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
83933526|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
83933527|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933528|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933529|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
83933530|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83933531|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933532|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83933533|NCT00513201|Insulin|insulin|mesh-list
83933534|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83933535|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933536|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933537|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
83933538|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83933539|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
83933540|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933541|NCT00512265|Expectorants|expectorants|mesh-ancestor
83933542|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
83933543|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83933544|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
83933545|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933546|NCT00512265|Protective Agents|protective agents|mesh-ancestor
83933547|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933548|NCT00512265|Antidotes|antidotes|mesh-ancestor
83933549|NCT00513396|Isoniazid|isoniazid|mesh-list
83933550|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
83933551|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83933552|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933553|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83933554|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83933555|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
83933556|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933557|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83933558|NCT01249274|Progesterone|progesterone|mesh-list
83933559|NCT01249274|Progestins|progestins|mesh-ancestor
83933560|NCT01249274|Hormones|hormones|mesh-ancestor
83933561|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933562|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933563|NCT00513513|Ritonavir|ritonavir|mesh-list
83933564|NCT00513513|Darunavir|darunavir|mesh-list
83933565|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83933566|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83933567|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
83933568|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933569|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933570|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83933571|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83933572|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
83933573|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933574|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83933575|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83933576|NCT00504959|Ranibizumab|ranibizumab|mesh-list
83933577|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83933578|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83933579|NCT00504959|Growth Substances|growth substances|mesh-ancestor
83933580|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933581|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
83933582|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933583|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
83933584|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83933585|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933586|NCT00505037|Sevelamer|sevelamer|mesh-list
83933587|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
83933588|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
83933589|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933590|NCT00513552|Clarithromycin|clarithromycin|mesh-list
83933591|NCT00513552|Rifabutin|rifabutin|mesh-list
83933592|NCT00513552|Clofazimine|clofazimine|mesh-list
83933593|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83933594|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933595|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83933596|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933597|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933598|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83933599|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83933600|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83933601|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
83933602|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933603|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
83933604|NCT00513630|Metformin|metformin|mesh-list
83933605|NCT00513630|Glipizide|glipizide|mesh-list
83933606|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933607|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933608|NCT02275247|Ropivacaine|ropivacaine|mesh-list
83933609|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
83933610|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
83933611|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933612|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933613|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
83933614|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933615|NCT04515719|Belimumab|belimumab|mesh-list
83933616|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83933617|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
83933618|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933619|NCT00513786|Paclitaxel|paclitaxel|mesh-list
83933620|NCT00513786|Bevacizumab|bevacizumab|mesh-list
83933621|NCT00513786|Carboplatin|carboplatin|mesh-list
83933622|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83933623|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933624|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
83933625|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
83933626|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
83933627|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933628|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83933629|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83933630|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83933631|NCT00513786|Growth Substances|growth substances|mesh-ancestor
83933632|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933633|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
83933634|NCT00504491|Rituximab|rituximab|mesh-list
83933635|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
83933636|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83933637|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933638|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
83933639|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933640|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83933641|NCT00512811|Furosemide|furosemide|mesh-list
83933642|NCT00512811|Diuretics|diuretics|mesh-ancestor
83933643|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
83933644|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933645|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83933646|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83933647|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933648|NCT00513864|Morphine|morphine|mesh-list
83933649|NCT00513864|Codeine|codeine|mesh-list
83933650|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
83933651|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83933652|NCT00513864|Narcotics|narcotics|mesh-ancestor
83933653|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933654|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933655|NCT00513864|Analgesics|analgesics|mesh-ancestor
83933656|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
83933657|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933658|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
83933659|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
83933660|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83933661|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83933662|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933663|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933664|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83933665|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
83933666|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933667|NCT00512850|Folic Acid|folic acid|mesh-list
83933668|NCT00512850|Hematinics|hematinics|mesh-ancestor
83933669|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
83933670|NCT00512850|Vitamins|vitamins|mesh-ancestor
83933671|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
83933672|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933673|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
83933674|NCT00512928|Vitamin K|vitamin k|mesh-list
83933675|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
83933676|NCT00512928|Menaquinone 7|menaquinone 7|mesh-list
83933677|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83933678|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83933679|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933680|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
83933681|NCT00512928|Coagulants|coagulants|mesh-ancestor
83933682|NCT00512928|Vitamins|vitamins|mesh-ancestor
83933683|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
83933684|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933685|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
83933686|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83933687|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83933688|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83933689|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
83933690|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933691|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83933692|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83933693|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933694|NCT01246973|Curcumin|curcumin|mesh-list
83933695|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83933696|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83933697|NCT01246973|Analgesics|analgesics|mesh-ancestor
83933698|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
83933699|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933700|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933701|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933702|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83933703|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933704|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933705|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933706|NCT00514605|Antibodies|antibodies|mesh-list
83933707|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
83933708|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
83933709|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933710|NCT00513981|Leucovorin|leucovorin|mesh-list
83933711|NCT00513981|Methotrexate|methotrexate|mesh-list
83933712|NCT00513981|Calcium|calcium|mesh-list
83933713|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
83933714|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83933715|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933716|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83933717|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
83933718|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83933719|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83933720|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
83933721|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933722|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933723|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933724|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933725|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83933726|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83933727|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
83933728|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83933729|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83933730|NCT00513981|Antidotes|antidotes|mesh-ancestor
83933731|NCT00513981|Protective Agents|protective agents|mesh-ancestor
83933732|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
83933733|NCT00513981|Vitamins|vitamins|mesh-ancestor
83933734|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
83933735|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83933736|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
83933737|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933738|NCT00514761|Capecitabine|capecitabine|mesh-list
83933739|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83933740|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
83933741|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933742|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933743|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
83933744|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83933745|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83933746|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83933747|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83933748|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933749|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
83933750|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933751|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933752|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83933753|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933754|NCT01245140|Alitretinoin|alitretinoin|mesh-list
83933755|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933756|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933757|NCT02951637|Carboplatin|carboplatin|mesh-list
83933758|NCT02951637|Pemetrexed|pemetrexed|mesh-list
83933759|NCT02951637|Gefitinib|gefitinib|mesh-list
83933760|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933761|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933762|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933763|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83933764|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83933765|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83933766|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
83933767|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83933768|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83933769|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
83933770|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933771|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83933772|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83933773|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933774|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933775|NCT01245062|Trametinib|trametinib|mesh-list
83933776|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933777|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83933778|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933779|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933780|NCT01244984|Fluticasone|fluticasone|mesh-list
83933782|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933783|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83933784|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
83933785|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933786|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933787|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83933788|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
83933789|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933790|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83933791|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83933792|NCT04695483|Hormones|hormones|mesh-ancestor
83933793|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933794|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933795|NCT01244126|Fentanyl|fentanyl|mesh-list
83933796|NCT01244126|Morphine|morphine|mesh-list
83933797|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83933798|NCT01244126|Narcotics|narcotics|mesh-ancestor
83933799|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933800|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933801|NCT01244126|Analgesics|analgesics|mesh-ancestor
83933802|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
83933803|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933804|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83933805|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83933806|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
83933807|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
83933808|NCT01243775|Docetaxel|docetaxel|mesh-list
83933809|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
83933810|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933811|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
83933812|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
83933813|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
83933814|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933815|NCT00514293|Carboplatin|carboplatin|mesh-list
83933816|NCT00514293|Docetaxel|docetaxel|mesh-list
83933817|NCT00514293|Capecitabine|capecitabine|mesh-list
83933818|NCT00514293|Tretinoin|tretinoin|mesh-list
83933819|NCT00514293|Bexarotene|bexarotene|mesh-list
83933820|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933821|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
83933822|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
83933823|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
83933824|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933825|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83933826|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
83173110|NCT05647954|Hormones|hormones|mesh-ancestor
83933827|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
83933828|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933830|NCT02955641|Nepafenac|nepafenac|mesh-list
83933831|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83933832|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933833|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
83933834|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
83933835|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933836|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933837|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933838|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
83933839|NCT02955641|Hormones|hormones|mesh-ancestor
83933840|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933841|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83933842|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933843|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83933844|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83933845|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83933846|NCT02955641|Analgesics|analgesics|mesh-ancestor
83933847|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
83933848|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83933849|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83933850|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83933851|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83933852|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83933853|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933854|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
83933855|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83933856|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83933857|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
83933858|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
83933859|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933860|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933861|NCT01242176|Empagliflozin|empagliflozin|mesh-list
83933862|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83933863|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933864|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83933865|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933866|NCT00515151|Ethanol|ethanol|mesh-list
83933867|NCT00515151|Octenidine|octenidine|mesh-list
83933868|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83933869|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933870|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933871|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933872|NCT01241786|Lenalidomide|lenalidomide|mesh-list
83933873|NCT01241786|Azacitidine|azacitidine|mesh-list
83933874|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
83933875|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933876|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83933877|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83933878|NCT01241786|Growth Substances|growth substances|mesh-ancestor
83933879|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
83933880|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933881|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83933882|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
83933883|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933884|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933885|NCT00514410|Folic Acid|folic acid|mesh-list
83933886|NCT00514410|Hematinics|hematinics|mesh-ancestor
83933887|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
83933888|NCT00514410|Vitamins|vitamins|mesh-ancestor
83933889|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
83933890|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933891|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
83933892|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83933893|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83933894|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933895|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
83933896|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933897|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
83933898|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933899|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83933900|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83933901|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933902|NCT00514527|Oritavancin|oritavancin|mesh-list
83933903|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83933904|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83933906|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83933907|NCT01241240|Bimatoprost|bimatoprost|mesh-list
83933908|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83933909|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83933910|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83933911|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83933912|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83933913|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83933914|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933915|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933916|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83933917|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83933918|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83933919|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83933920|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83933921|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
83933922|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
83933923|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83933924|NCT02950623|Protective Agents|protective agents|mesh-ancestor
83933925|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933926|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933927|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83933928|NCT00516009|Dexamethasone|dexamethasone|mesh-list
83933929|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83933930|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
83933931|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
83933932|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933933|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933934|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83933935|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
83933936|NCT00516009|Hormones|hormones|mesh-ancestor
83933937|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83933938|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83933939|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933940|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
83933941|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
83933942|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83933943|NCT02950584|Protective Agents|protective agents|mesh-ancestor
83933944|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933945|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933946|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83933947|NCT01240811|Copper|copper|mesh-list
83933948|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
83933949|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83933950|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
83933951|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83933952|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933953|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83933954|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83933955|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83933956|NCT01240811|Trace Elements|trace elements|mesh-ancestor
83933957|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
83933958|NCT03459144|Ranibizumab|ranibizumab|mesh-list
83933959|NCT03459144|Verteporfin|verteporfin|mesh-list
83933960|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83933961|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83933962|NCT03459144|Growth Substances|growth substances|mesh-ancestor
83933963|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933964|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83933965|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933966|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83933967|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
83933968|NCT03459105|Bupivacaine|bupivacaine|mesh-list
83933969|NCT03459105|Anesthetics|anesthetics|mesh-list
83933970|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
83933971|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933972|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933973|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
83933974|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83933975|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83933976|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83933977|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
83933978|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83933979|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
83933980|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933981|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
83933982|NCT01240382|Protective Agents|protective agents|mesh-ancestor
83933983|NCT01244828|Asenapine|asenapine|mesh-list
83933984|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83933985|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83933986|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83933987|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83933988|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83933989|NCT00504192|Gemcitabine|gemcitabine|mesh-list
83933990|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
83933991|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83933992|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
83933993|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83933994|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933995|NCT01243346|Crenolanib|crenolanib|mesh-list
83933996|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83933997|NCT01249443|Paclitaxel|paclitaxel|mesh-list
83933998|NCT01249443|Carboplatin|carboplatin|mesh-list
83933999|NCT01249443|Vorinostat|vorinostat|mesh-list
83934000|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83934001|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934002|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
83934003|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
83934004|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83934005|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934006|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83934007|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934008|NCT01243073|Imetelstat|imetelstat|mesh-list
83934009|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
83934010|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934011|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934012|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83934013|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83934014|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
83934015|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934016|NCT00516243|Protective Agents|protective agents|mesh-ancestor
83934017|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934018|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83934019|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83934020|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934021|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83934022|NCT01240889|Fluticasone|fluticasone|mesh-list
83934023|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934024|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83934025|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
83934026|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934027|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934028|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83934029|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
83934030|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
83934031|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83934032|NCT00516282|Temozolomide|temozolomide|mesh-list
83934033|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83934034|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
83934035|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934036|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934037|NCT01249521|Bevacizumab|bevacizumab|mesh-list
83934038|NCT01249521|Trebananib|trebananib|mesh-list
83934039|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934040|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934041|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83934042|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83934043|NCT01249521|Growth Substances|growth substances|mesh-ancestor
83934044|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934045|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
83934046|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
83934047|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83934048|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934049|NCT04511975|Azacitidine|azacitidine|mesh-list
83934050|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934051|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
83934052|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934053|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934054|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934055|NCT04511897|Expectorants|expectorants|mesh-list
83934056|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
83934058|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
83934059|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
83934060|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934061|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934062|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
83934063|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934064|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83934065|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83934066|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83934067|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934068|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934069|NCT04696848|Durvalumab|durvalumab|mesh-list
83934070|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934071|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934072|NCT01244256|Gentamicins|gentamicins|mesh-list
83934073|NCT01244256|Clotrimazole|clotrimazole|mesh-list
83934074|NCT01244256|Miconazole|miconazole|mesh-list
83934075|NCT01244256|Beclomethasone|beclomethasone|mesh-list
83934076|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83934077|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934078|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83934079|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934080|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934081|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934082|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
83934083|NCT01244256|Hormones|hormones|mesh-ancestor
83934084|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83934085|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934086|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83934087|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83934088|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83934089|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
83934090|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83934091|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83934092|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83934093|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
83934094|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83934095|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83934096|NCT01249833|Oseltamivir|oseltamivir|mesh-list
83934097|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
83934098|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934099|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934100|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934101|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
83934102|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83934103|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83934104|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934105|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934106|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934107|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
83934108|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83934109|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83934110|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83934111|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934112|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934113|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
83934114|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934115|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934116|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83934117|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934118|NCT04511000|Atorvastatin|atorvastatin|mesh-list
83934119|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83934120|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83934121|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
83934122|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934123|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83934124|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83934125|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934126|NCT04519385|Dexamethasone|dexamethasone|mesh-list
83934127|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934129|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
83934130|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934131|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934132|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83934133|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
83934134|NCT04519385|Hormones|hormones|mesh-ancestor
83934135|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83934136|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83934137|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934138|NCT00506051|Pemetrexed|pemetrexed|mesh-list
83934139|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934140|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934141|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934142|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83934143|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934144|NCT00504465|Dinoprostone|dinoprostone|mesh-list
83934145|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
83934146|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934147|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934148|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
83934149|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83934150|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934151|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
83934152|NCT04510649|Rifampin|rifampin|mesh-list
83934153|NCT04510649|Rabeprazole|rabeprazole|mesh-list
83934154|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83934155|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83934156|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83934157|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934158|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934159|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83934160|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
83934161|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83934162|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934163|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
83934164|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934165|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83934166|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83934167|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83934168|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83934169|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83934170|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83934171|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
83934172|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83934173|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934174|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934175|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83934176|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83934177|NCT01249092|Protective Agents|protective agents|mesh-ancestor
83934178|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934179|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
83934180|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83934181|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
83934182|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
83934183|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83934184|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934185|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934186|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83934187|NCT02275182|Analgesics|analgesics|mesh-ancestor
83934188|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
83934189|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934190|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83934191|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83934192|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83934193|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
83934194|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934195|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934196|NCT01248780|Golimumab|golimumab|mesh-list
83934197|NCT01248780|Methotrexate|methotrexate|mesh-list
83934198|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83934199|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
83173477|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
83934200|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934201|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934202|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934203|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
83934204|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934205|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934206|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
83934207|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934208|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83934209|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934210|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
83934211|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934212|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934213|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83934214|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934215|NCT01248468|Aspirin|aspirin|mesh-list
83934216|NCT01248468|Acetaminophen|acetaminophen|mesh-list
83934217|NCT01248468|Sumatriptan|sumatriptan|mesh-list
83934218|NCT01248468|Caffeine|caffeine|mesh-list
83934219|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83934220|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83934221|NCT01248468|Analgesics|analgesics|mesh-ancestor
83934222|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
83934223|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934224|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934225|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934226|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934227|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83934228|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83934229|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934230|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83934231|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83934232|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934233|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
83934234|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83934235|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83934236|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83934237|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83934238|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
83934239|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934240|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83934241|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83934242|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83934243|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
83934244|NCT02275299|Methotrexate|methotrexate|mesh-list
83934245|NCT02275299|Leflunomide|leflunomide|mesh-list
83934246|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83934247|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
83934248|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934249|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934250|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934251|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
83934252|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934253|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934254|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
83934255|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934256|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83934257|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934258|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
83934259|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934260|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934261|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83934262|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934263|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83934264|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934265|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934266|NCT01246206|Tacrolimus|tacrolimus|mesh-list
83934267|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
83934268|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934269|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
83934270|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934271|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83934272|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934273|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934274|NCT04510610|Decitabine|decitabine|mesh-list
83934275|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934276|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
83934277|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934278|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934279|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934280|NCT01246011|Warfarin|warfarin|mesh-list
83934281|NCT01246011|Argatroban|argatroban|mesh-list
83934282|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
83934283|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
83934284|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83934285|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
83934286|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934287|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934288|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83934289|NCT01244490|Guanfacine|guanfacine|mesh-list
83934290|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83934291|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83934292|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83934293|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934294|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934295|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
83934296|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934297|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934298|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83934299|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83934300|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83934301|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83934302|NCT01243944|Lenalidomide|lenalidomide|mesh-list
83934303|NCT01243944|Pomalidomide|pomalidomide|mesh-list
83934304|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
83934305|NCT01243944|Pipobroman|pipobroman|mesh-list
83934306|NCT01243944|Anagrelide|anagrelide|mesh-list
83934307|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
83934308|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934309|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83934310|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83934311|NCT01243944|Growth Substances|growth substances|mesh-ancestor
83934312|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
83934313|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934314|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
83934315|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934316|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934317|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934318|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83934319|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83934320|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83934321|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83934322|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
83934323|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
83934324|NCT00516399|Natamycin|natamycin|mesh-list
83934325|NCT00516399|Povidone|povidone|mesh-list
83934326|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83934327|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83934328|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
83934329|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
83934330|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83934331|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934332|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83934333|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
83934334|NCT00516438|Topotecan|topotecan|mesh-list
83934335|NCT00516438|Olaparib|olaparib|mesh-list
83934336|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83934337|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83934338|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83934339|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934340|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934341|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934342|NCT02275988|Clarithromycin|clarithromycin|mesh-list
83934343|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83934344|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934345|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83934346|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173639|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
83934347|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934348|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83934349|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83934350|NCT02950155|Rituximab|rituximab|mesh-list
83934351|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934352|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934353|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
83934354|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934355|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934356|NCT00516672|Lapatinib|lapatinib|mesh-list
83934357|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934358|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83934359|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934360|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934361|NCT00516711|Sevoflurane|sevoflurane|mesh-list
83934362|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83934363|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83934364|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
83934365|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
83934366|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934367|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934368|NCT00516750|Doxorubicin|doxorubicin|mesh-list
83934369|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83934370|NCT00516750|Methotrexate|methotrexate|mesh-list
83934371|NCT00516750|Vinblastine|vinblastine|mesh-list
83934372|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934373|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83934374|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83934375|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83934376|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934377|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934378|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83934379|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
83934380|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934381|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934382|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934383|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
83934384|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83934385|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83934386|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934387|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
83934388|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934389|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934390|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83934391|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83934392|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83934393|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83934394|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
83934395|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
83934396|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934397|NCT00505427|Protective Agents|protective agents|mesh-ancestor
83934398|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934399|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
83934400|NCT00505427|Vitamins|vitamins|mesh-ancestor
83934401|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
83934402|NCT00506168|Capecitabine|capecitabine|mesh-list
83934403|NCT00506168|Irinotecan|irinotecan|mesh-list
83934404|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934405|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
83934406|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934407|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934408|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83934409|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83934410|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934411|NCT02950038|Nivolumab|nivolumab|mesh-list
83934412|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934413|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934414|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83934415|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934416|NCT04510220|Ofatumumab|ofatumumab|mesh-list
83934417|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934418|NCT02949648|Nicotine|nicotine|mesh-list
83934419|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83934420|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
83934421|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934422|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934423|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83173704|NCT02260258|Rocuronium|rocuronium|mesh-list
83934424|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83934425|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
83934426|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934427|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934428|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
83934429|NCT04510337|Rocuronium|rocuronium|mesh-list
83934430|NCT04510337|Analgesics|analgesics|mesh-ancestor
83934431|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
83934432|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934433|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934434|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
83934435|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934436|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83934437|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
83934438|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83934439|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934440|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934441|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83934442|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
83934443|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934444|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83934445|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83934446|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83934447|NCT00516828|Cytarabine|cytarabine|mesh-list
83934448|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934449|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
83934450|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934451|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934452|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
83934453|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934454|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934455|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
83934456|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934457|NCT02949765|Iron|iron|mesh-list
83934458|NCT02949765|Trace Elements|trace elements|mesh-ancestor
83934459|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
83934460|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934461|NCT04518176|Oxytocin|oxytocin|mesh-list
83934462|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
83934463|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934464|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934465|NCT00516945|Lamivudine|lamivudine|mesh-list
83934466|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83934467|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934468|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934469|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934470|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
83934471|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934472|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83934473|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83934474|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83934475|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934476|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934477|NCT02275598|Immunotoxins|immunotoxins|mesh-ancestor
83934478|NCT02275598|Immunoconjugates|immunoconjugates|mesh-ancestor
83934479|NCT02275598|Immunologic Factors|immunologic factors|mesh-ancestor
83934480|NCT02275598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934481|NCT00517062|Hormones|hormones|mesh-list
83934482|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83934483|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934484|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83934485|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
83934486|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83934487|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83934488|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934489|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934490|NCT00517179|Urological Agents|urological agents|mesh-ancestor
83934491|NCT00517218|Oblimersen|oblimersen|mesh-list
83934492|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934493|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
83934494|NCT00506207|Irinotecan|irinotecan|mesh-list
83934495|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934496|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83934497|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83934498|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934499|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934501|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83934502|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83934503|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
83934504|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934505|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83934506|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83934507|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934508|NCT00506246|Propofol|propofol|mesh-list
83934509|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83934510|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934511|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934512|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83934513|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
83934514|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
83934515|NCT01243242|Metadoxine|metadoxine|mesh-list
83934516|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83934517|NCT00517491|Lanreotide|lanreotide|mesh-list
83934518|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934519|NCT04517201|Insulin|insulin|mesh-list
83934520|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83934521|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83934522|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934523|NCT01241292|Elotuzumab|elotuzumab|mesh-list
83934524|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934525|NCT00517725|Carvedilol|carvedilol|mesh-list
83934526|NCT00517725|Nebivolol|nebivolol|mesh-list
83934527|NCT00517725|Bisoprolol|bisoprolol|mesh-list
83934528|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83934529|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83934530|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
83934531|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934532|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934533|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934534|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83934535|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
83934536|NCT00517725|Protective Agents|protective agents|mesh-ancestor
83934537|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83934538|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934539|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83934540|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
83934541|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83934542|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83934543|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83934544|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83934545|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83934546|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
83934547|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
83934548|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934549|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83934550|NCT01240863|Hydrocodone|hydrocodone|mesh-list
83934551|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83934552|NCT01240863|Narcotics|narcotics|mesh-ancestor
83934553|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934554|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934555|NCT01240863|Analgesics|analgesics|mesh-ancestor
83934556|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
83934557|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934558|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
83934559|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
83934560|NCT01240746|Vaccines|vaccines|mesh-list
83934561|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
83934562|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934563|NCT01240590|Cisplatin|cisplatin|mesh-list
83934564|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934565|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
83934566|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83934567|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934568|NCT00504543|Everolimus|everolimus|mesh-list
83934569|NCT00504543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934570|NCT00504543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934571|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934572|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
83934573|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173854|NCT02258074|Niacin|niacin|mesh-list
83934574|NCT00504543|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83934575|NCT00504543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83934576|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934577|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
83934578|NCT02949843|Nivolumab|nivolumab|mesh-list
83934579|NCT02949843|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83934580|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934581|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934582|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83934583|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934584|NCT02949843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83934585|NCT02949843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934586|NCT00517764|Citalopram|citalopram|mesh-list
83934587|NCT00517764|Escitalopram|escitalopram|mesh-list
83934588|NCT00517764|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83934589|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83934590|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934591|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934592|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934593|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
83934594|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934595|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83934596|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
83934597|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83934598|NCT00517803|Micronutrients|micronutrients|mesh-list
83934599|NCT00517803|Trace Elements|trace elements|mesh-list
83934600|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934602|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
83934603|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83934604|NCT04516304|Estrogens|estrogens|mesh-ancestor
83934605|NCT04516304|Hormones|hormones|mesh-ancestor
83934606|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83934607|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934608|NCT01242930|Niacinamide|niacinamide|mesh-list
83934609|NCT01242930|Lenalidomide|lenalidomide|mesh-list
83934610|NCT01242930|Imetelstat|imetelstat|mesh-list
83934611|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
83934612|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
83934613|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934614|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83934615|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83934616|NCT01242930|Growth Substances|growth substances|mesh-ancestor
83934617|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
83934618|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934619|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934620|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934621|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83934622|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
83934623|NCT01242930|Vitamins|vitamins|mesh-ancestor
83934624|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
83934625|NCT01241214|Cetirizine|cetirizine|mesh-list
83934626|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83934627|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83934628|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83934629|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
83934630|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
83934631|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934632|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934633|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934634|NCT01240512|Vitamin D|vitamin d|mesh-list
83934635|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
83934636|NCT01240512|Vitamins|vitamins|mesh-ancestor
83934637|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
83934638|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934639|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83934640|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83934641|NCT01240629|Doxorubicin|doxorubicin|mesh-list
83934642|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83934643|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83934644|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934645|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83934646|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83934647|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934648|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934649|NCT04515641|Islatravir|islatravir|mesh-list
83934650|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
83934651|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934652|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934653|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934654|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83934655|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83934656|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83934657|NCT00518232|Methylphenidate|methylphenidate|mesh-list
83934658|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83934659|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934660|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83934661|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83934662|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934663|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934664|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
83934665|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934666|NCT00505505|Insulin|insulin|mesh-list
83934667|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83934668|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83934669|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934670|NCT00518271|Sirolimus|sirolimus|mesh-list
83934671|NCT00518271|Tacrolimus|tacrolimus|mesh-list
83934672|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934673|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
83934674|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934675|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83934676|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934677|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934678|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83934679|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934680|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83934681|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934682|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
83934683|NCT00518193|Cetuximab|cetuximab|mesh-list
83934684|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934685|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934686|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
83934687|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83934688|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934689|NCT00518466|Topiramate|topiramate|mesh-list
83934690|NCT00518466|Phentermine|phentermine|mesh-list
83934691|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
83934692|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83934693|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934694|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83934695|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
83934696|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83934697|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
83934698|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
83934699|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934700|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
83934701|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934702|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934703|NCT00518583|Paclitaxel|paclitaxel|mesh-list
83934704|NCT00518583|Doxorubicin|doxorubicin|mesh-list
83934705|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83934706|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83934707|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934708|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83934709|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83934710|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83934711|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934712|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83934713|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83934714|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83934715|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934716|NCT00519753|Timolol|timolol|mesh-list
83934717|NCT00519753|Travoprost|travoprost|mesh-list
83934718|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83934719|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83934720|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934721|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83934722|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83934723|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
83934724|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934725|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934726|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83934727|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83934728|NCT00519870|Losartan|losartan|mesh-list
83934729|NCT00519870|Nifedipine|nifedipine|mesh-list
83934730|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83934731|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83934732|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83934733|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83934734|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934735|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83934736|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934737|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83934738|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934739|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
83934740|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
83934741|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934742|NCT00519909|Calcium|calcium|mesh-list
83934743|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83934744|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934745|NCT02949492|Interleukin-2|interleukin-2|mesh-list
83934746|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934747|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83934748|NCT02949492|Analgesics|analgesics|mesh-ancestor
83934749|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
83934750|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934751|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934752|NCT04511234|Sirolimus|sirolimus|mesh-list
83934753|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83934754|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83934755|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83934756|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934757|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
83934758|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934759|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
83934760|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934761|NCT04514588|Caffeine|caffeine|mesh-list
83934762|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83934763|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934764|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83934765|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934766|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934767|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83934768|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83934769|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
83934770|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934771|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
83934772|NCT02276300|Imiquimod|imiquimod|mesh-list
83934773|NCT02276300|Sargramostim|sargramostim|mesh-list
83934774|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934775|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
83934776|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934777|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934778|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83934779|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
83934780|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934781|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934782|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83934783|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83934784|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
83934785|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
83934786|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
83934787|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83934788|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934789|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934790|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
83934791|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83934792|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934793|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934794|NCT02955251|Nivolumab|nivolumab|mesh-list
83934795|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934796|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934797|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83934798|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934799|NCT00518895|Dacarbazine|dacarbazine|mesh-list
83934800|NCT00518895|Oblimersen|oblimersen|mesh-list
83934801|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83934802|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
83934803|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934804|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934805|NCT00520104|Ketamine|ketamine|mesh-list
83934806|NCT00520104|Analgesics|analgesics|mesh-ancestor
83934807|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
83934808|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934809|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934810|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83934811|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83934812|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
83934813|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
83934814|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934815|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83934816|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83934817|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934818|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934819|NCT00519012|Sertraline|sertraline|mesh-list
83934820|NCT00519012|Paroxetine|paroxetine|mesh-list
83934821|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
83934822|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83934823|NCT00519012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83934824|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83934825|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934826|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934827|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934828|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
83934829|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934830|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83934831|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83934832|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83934833|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934834|NCT00520260|Ketorolac|ketorolac|mesh-list
83934835|NCT00520260|Bromfenac|bromfenac|mesh-list
83934836|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83934837|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83934838|NCT00520260|Analgesics|analgesics|mesh-ancestor
83934839|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
83934840|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934841|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934842|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934843|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934844|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83934845|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934846|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934847|NCT00520338|Celecoxib|celecoxib|mesh-list
83934848|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83934849|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83934850|NCT00520338|Analgesics|analgesics|mesh-ancestor
83934851|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
83934852|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934853|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934854|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934855|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934856|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83934857|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83934858|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934859|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934860|NCT02594072|Goserelin|goserelin|mesh-list
83934861|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83934862|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934863|NCT00519051|Fluoxetine|fluoxetine|mesh-list
83934864|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
83934865|NCT00519051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83934866|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83934867|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934868|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934869|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934870|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
83934871|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934872|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83934873|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83934874|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83934875|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83934876|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934877|NCT02275832|Minoxidil|minoxidil|mesh-list
83934878|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83934879|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
83934880|NCT00519207|Lidocaine|lidocaine|mesh-list
83934881|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
83934882|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
83934883|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934884|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934885|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
83934886|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934887|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83934888|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83934889|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83934890|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83934891|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934892|NCT02590094|Bevacizumab|bevacizumab|mesh-list
83934893|NCT02590094|Aflibercept|aflibercept|mesh-list
83934894|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83934895|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934896|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83934897|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83934898|NCT02590094|Growth Substances|growth substances|mesh-ancestor
83934899|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934900|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
83934901|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
83934902|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83934903|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
83934904|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83934905|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934906|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83934907|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83934908|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83934909|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
83934910|NCT02949258|Etoposide|etoposide|mesh-list
83934911|NCT02949258|Epirubicin|epirubicin|mesh-list
83934912|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934913|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83934914|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83934915|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83934916|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934917|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934918|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83934919|NCT04514081|Decitabine|decitabine|mesh-list
83934920|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83934921|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
83934922|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934923|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934924|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934925|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83934926|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
83934927|NCT00519246|Narcotics|narcotics|mesh-ancestor
83934928|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934929|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934930|NCT00519246|Analgesics|analgesics|mesh-ancestor
83934931|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
83934932|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934933|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83934934|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934935|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83934936|NCT00519987|Ketamine|ketamine|mesh-list
83934937|NCT00519987|Analgesics|analgesics|mesh-ancestor
83934938|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
83934939|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83934940|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934941|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83934942|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83934943|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
83934944|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
83934945|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934946|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83934947|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83934948|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934949|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934950|NCT00519324|Everolimus|everolimus|mesh-list
83934951|NCT00519324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83934952|NCT00519324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83934953|NCT00519324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934954|NCT00519324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934955|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83934956|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
83934957|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934958|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83934959|NCT00520650|Aripiprazole|aripiprazole|mesh-list
83934960|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
83934961|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83934962|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83934963|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83934964|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83934965|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934966|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
83934967|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
83934968|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83934969|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934970|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83934971|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83934972|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
83934973|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83934974|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83934975|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83934976|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83934977|NCT00519363|Atorvastatin|atorvastatin|mesh-list
83934978|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83934979|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83934980|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
83934981|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83934982|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83934983|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83934984|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83934985|NCT00519480|Metformin|metformin|mesh-list
83934986|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83934987|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934988|NCT02955056|Teriparatide|teriparatide|mesh-list
83934989|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934990|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83934991|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83934992|NCT02954939|Prednisone|prednisone|mesh-list
83934993|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83934994|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
83934995|NCT02954939|Hormones|hormones|mesh-ancestor
83934996|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83934997|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83934998|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83934999|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935000|NCT00519519|Omeprazole|omeprazole|mesh-list
83935001|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83935002|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935003|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83935004|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935005|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935006|NCT02598557|Exemestane|exemestane|mesh-list
83935007|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935008|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83935009|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83935010|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935011|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935012|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83935013|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
83935014|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935015|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935016|NCT00520806|Methocarbamol|methocarbamol|mesh-list
83935017|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83935018|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935019|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83935020|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935021|NCT00505739|Mifepristone|mifepristone|mesh-list
83935022|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83935023|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
83935024|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935025|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935026|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83935027|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83935028|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83935029|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
83935030|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83935031|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83935032|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
83935033|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935034|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
83935035|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83935036|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83935037|NCT02948985|Cetuximab|cetuximab|mesh-list
83935038|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83935039|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935040|NCT04513457|Liver Extracts|liver extracts|mesh-list
83935041|NCT04513457|Hematinics|hematinics|mesh-ancestor
83935042|NCT00521040|Levocetirizine|levocetirizine|mesh-list
83935043|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83935044|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83935045|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
83935046|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
83935047|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935048|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935049|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935050|NCT04513340|Levodopa|levodopa|mesh-list
83935051|NCT04513340|Carbidopa|carbidopa|mesh-list
83935052|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83935053|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83935054|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
83935055|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935056|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935057|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935058|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83935059|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935060|NCT05144945|Vaccines|vaccines|mesh-list
83935061|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
83935062|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935063|NCT04513379|Efavirenz|efavirenz|mesh-list
83935064|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83935065|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83935066|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935067|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935068|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
83935069|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935070|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83935071|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83935072|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83935073|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83935074|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83935075|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83935076|NCT00521157|Naltrexone|naltrexone|mesh-list
83935077|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83935078|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83935079|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935080|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
83935081|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935082|NCT00505817|Leuprolide|leuprolide|mesh-list
83935083|NCT00505817|Cetrorelix|cetrorelix|mesh-list
83935084|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83935085|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
83935086|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935087|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935088|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83935089|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935090|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
83935091|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935092|NCT00521430|Cyclosporine|cyclosporine|mesh-list
83935093|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
83935094|NCT00521430|Methotrexate|methotrexate|mesh-list
83935095|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
83935096|NCT00521430|Fludarabine|fludarabine|mesh-list
83935097|NCT00521430|Busulfan|busulfan|mesh-list
83935098|NCT00521430|Cyclosporins|cyclosporins|mesh-list
83935099|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83935100|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83935101|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
83935102|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935103|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935104|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83935105|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
83935106|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935107|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935108|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
83935109|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935110|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83935111|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935112|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
83935113|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935114|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83935115|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
83935116|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935117|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83935118|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935119|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
83935120|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
83935121|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935122|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935123|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
83935124|NCT00521430|Hormones|hormones|mesh-ancestor
83935125|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935126|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83935127|NCT00521430|Protective Agents|protective agents|mesh-ancestor
83935128|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
83935129|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83935130|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83935131|NCT00521274|Docetaxel|docetaxel|mesh-list
83935132|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935133|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
83935134|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
83935135|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
83935136|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935137|NCT05146778|Lidocaine|lidocaine|mesh-list
83935138|NCT05146778|Fentanyl|fentanyl|mesh-list
83935139|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
83935140|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
83935141|NCT05146778|Anesthetics|anesthetics|mesh-list
83935142|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
83935143|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935144|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935145|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
83935146|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935147|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83935148|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83935149|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83935150|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935151|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935152|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83935153|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83935154|NCT05146778|Analgesics|analgesics|mesh-ancestor
83935155|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83935156|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83935157|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83935158|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
83935159|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935160|NCT05146778|Narcotics|narcotics|mesh-ancestor
83935161|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83935162|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83935163|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
83935164|NCT00505700|Cytarabine|cytarabine|mesh-list
83935165|NCT00505700|Bortezomib|bortezomib|mesh-list
83935166|NCT00505700|Idarubicin|idarubicin|mesh-list
83935167|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83935168|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
83935169|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935170|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935171|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
83935172|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935173|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935174|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
83935175|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935176|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83935177|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83935178|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83935179|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935180|NCT02948283|Metformin|metformin|mesh-list
83935181|NCT02948283|Ritonavir|ritonavir|mesh-list
83935182|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83935183|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935184|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83935185|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83935186|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
83935187|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935188|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935189|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83935190|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83935191|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
83935192|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935193|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83935194|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83935195|NCT04512872|Denosumab|denosumab|mesh-list
83935196|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83935197|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935198|NCT00523185|Diazepam|diazepam|mesh-list
83935199|NCT00523185|Lorazepam|lorazepam|mesh-list
83935200|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
83935201|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
83935202|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
83935203|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935204|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935205|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935206|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83935207|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935208|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83935209|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83935210|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83935211|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
83935212|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
83935213|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935214|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935215|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83935216|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83935217|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83935218|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83935219|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
83935220|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
83935221|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83935222|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83935223|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83935224|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
83935225|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935226|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935227|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83935228|NCT04693962|Mitogens|mitogens|mesh-list
83935229|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
83935230|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935231|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83935232|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935233|NCT00521703|Lidocaine|lidocaine|mesh-list
83935234|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
83935235|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
83935236|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935237|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935238|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
83935239|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935240|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83935241|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83935242|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83935243|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935244|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935245|NCT00521742|Pioglitazone|pioglitazone|mesh-list
83935246|NCT00521742|Glyburide|glyburide|mesh-list
83935247|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83935248|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935249|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83935250|NCT00521781|Leuprolide|leuprolide|mesh-list
83935251|NCT00521781|Bicalutamide|bicalutamide|mesh-list
83935252|NCT00521781|Androgens|androgens|mesh-list
83935253|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
83935254|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935255|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83935256|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
83935257|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935258|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935259|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83935260|NCT00521781|Hormones|hormones|mesh-ancestor
83935261|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935262|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
83935263|NCT00521820|Pioglitazone|pioglitazone|mesh-list
83935264|NCT00521820|Glyburide|glyburide|mesh-list
83935265|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83935266|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935267|NCT00523263|Heparin|heparin|mesh-list
83935268|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
83935269|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83935270|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83935271|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935272|NCT00521859|Fludarabine|fludarabine|mesh-list
83935273|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
83935274|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935275|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83935276|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
83935277|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935278|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935279|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
83935280|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935281|NCT02954822|Glimepiride|glimepiride|mesh-list
83935282|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83935283|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83935284|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935285|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935286|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
83935287|NCT00522015|Rivastigmine|rivastigmine|mesh-list
83935288|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83935289|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935290|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935291|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
83935292|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935293|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935294|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83935295|NCT00522015|Protective Agents|protective agents|mesh-ancestor
83935296|NCT00523380|Doxorubicin|doxorubicin|mesh-list
83935297|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83935298|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83935299|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935300|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83935301|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83935302|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935303|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935304|NCT00523458|Efavirenz|efavirenz|mesh-list
83935305|NCT00523458|Nevirapine|nevirapine|mesh-list
83935306|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83935307|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83935308|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935309|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935310|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
83935311|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935312|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83935313|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83935314|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83935315|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83935316|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83935317|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83935319|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83935320|NCT00507065|Amphetamine|amphetamine|mesh-list
83935321|NCT00507065|Adderall|adderall|mesh-list
83935322|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83935323|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935324|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
83935325|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
83935326|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935327|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
83935328|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935329|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935330|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
83935331|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83935332|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83935333|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935334|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83935335|NCT00522132|Artesunate|artesunate|mesh-list
83935336|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
83935337|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83935338|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83935339|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935340|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935341|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
83935342|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
83935343|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83935344|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
83935345|NCT00522210|Insulin|insulin|mesh-list
83935346|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
83935347|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83935348|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935349|NCT00522249|Interferons|interferons|mesh-list
83935350|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83935351|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
83935352|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83935353|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83935354|NCT00522249|Sunitinib|sunitinib|mesh-list
83935355|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935356|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
83935357|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935358|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83935359|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935360|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935361|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83935362|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83935363|NCT00522249|Growth Substances|growth substances|mesh-ancestor
83935364|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935365|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
83935366|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
83935367|NCT05148767|Irinotecan|irinotecan|mesh-list
83935368|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83935369|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83935370|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935371|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935372|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935373|NCT00523692|Etanercept|etanercept|mesh-list
83935374|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83935375|NCT00523692|Methylprednisolone|methylprednisolone|mesh-list
83935376|NCT00523692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83935377|NCT00523692|Prednisolone|prednisolone|mesh-list
83935378|NCT00523692|Prednisolone acetate|prednisolone acetate|mesh-list
83935379|NCT00523692|Methotrexate|methotrexate|mesh-list
83935380|NCT00523692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83935381|NCT00523692|Prednisolone phosphate|prednisolone phosphate|mesh-list
83935382|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83935383|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
83935384|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935385|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935386|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83935387|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
83935388|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935389|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935390|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
83935391|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935392|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83935393|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935394|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
83935395|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935396|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83935397|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83935398|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83935400|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
83935401|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935402|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935403|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935404|NCT00523692|Antiemetics|antiemetics|mesh-ancestor
83935405|NCT00523692|Autonomic Agents|autonomic agents|mesh-ancestor
83935406|NCT00523692|Glucocorticoids|glucocorticoids|mesh-ancestor
83935407|NCT00523692|Hormones|hormones|mesh-ancestor
83935408|NCT00523692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935409|NCT00523692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83935410|NCT00523692|Protective Agents|protective agents|mesh-ancestor
83935411|NCT00523692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83935412|NCT05148689|Phenylephrine|phenylephrine|mesh-list
83935413|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
83935414|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83935415|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83935416|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83935417|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935418|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935419|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935420|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
83935421|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
83935422|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935423|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
83935424|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83935425|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
83935426|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83935427|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
83935428|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83935429|NCT05148689|Protective Agents|protective agents|mesh-ancestor
83935430|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
83935431|NCT00522444|Analgesics|analgesics|mesh-ancestor
83935432|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
83935433|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935434|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935435|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
83935436|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935437|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83935438|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
83935439|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83935440|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935441|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935442|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83935443|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
83935444|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935445|NCT05148143|Raltitrexed|raltitrexed|mesh-list
83935446|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83935447|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
83935448|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935449|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935450|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83935451|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935452|NCT00523887|Fentanyl|fentanyl|mesh-list
83935453|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83935454|NCT00523887|Narcotics|narcotics|mesh-ancestor
83935455|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935456|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935457|NCT00523887|Analgesics|analgesics|mesh-ancestor
83935458|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
83935459|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935460|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83935461|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83935462|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
83935463|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
83935464|NCT05145218|Paclitaxel|paclitaxel|mesh-list
83935465|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83935466|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174754|NCT00330473|Insulin|insulin|mesh-list
83935467|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
83935468|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
83935469|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
83935470|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935472|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
83935473|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83935474|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935475|NCT05146271|Anesthetics|anesthetics|mesh-list
83935476|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935477|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935478|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
83935479|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
83935480|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935481|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
83935482|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935483|NCT05142098|Dexamethasone|dexamethasone|mesh-list
83935484|NCT05142098|Etoricoxib|etoricoxib|mesh-list
83935485|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83935486|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
83935487|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935488|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
83935489|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
83935490|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935491|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935492|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935493|NCT05142098|Hormones|hormones|mesh-ancestor
83935494|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935495|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83935496|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935497|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83935498|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83935499|NCT05142098|Analgesics|analgesics|mesh-ancestor
83935500|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
83935501|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935502|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83935503|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935504|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935505|NCT00523965|Amphotericin B|amphotericin b|mesh-list
83935506|NCT00523965|Paromomycin|paromomycin|mesh-list
83935507|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83935508|NCT00523965|Miltefosine|miltefosine|mesh-list
83935509|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
83935510|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
83935511|NCT00523965|Amebicides|amebicides|mesh-ancestor
83935512|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83935513|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83935514|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935515|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83935516|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
83935517|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935518|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83935519|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935520|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83935521|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83935522|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935523|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935524|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
83935525|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935526|NCT05141240|Palbociclib|palbociclib|mesh-list
83935527|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935528|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83935529|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935530|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935531|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
83935532|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
83935533|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935534|NCT05148377|Heparin|heparin|mesh-list
83935535|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
83935536|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83935537|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83935538|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935539|NCT00524160|Fentanyl|fentanyl|mesh-list
83935540|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83935541|NCT00524160|Narcotics|narcotics|mesh-ancestor
83935542|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935543|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935544|NCT00524160|Analgesics|analgesics|mesh-ancestor
83935545|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
83935546|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935547|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83935548|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83935549|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
83935550|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
83935551|NCT00524199|Mesna|mesna|mesh-list
83935552|NCT00524199|Protective Agents|protective agents|mesh-ancestor
83935553|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935554|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83935555|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83935556|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83935557|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
83935558|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935559|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935560|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935561|NCT00523068|Urological Agents|urological agents|mesh-ancestor
83935562|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83935563|NCT02276378|Telmisartan|telmisartan|mesh-list
83935564|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83935565|NCT02276378|Diuretics|diuretics|mesh-ancestor
83935566|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
83935567|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935568|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83935569|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935570|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935571|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83935572|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83935573|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
83935574|NCT04696250|Immunomodulating Agents|immunomodulating agents|mesh-list
83935575|NCT04696250|Immunologic Factors|immunologic factors|mesh-ancestor
83935576|NCT04696250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935577|NCT00524433|Tezosentan|tezosentan|mesh-list
83935578|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
83935579|NCT02947932|Indomethacin|indomethacin|mesh-list
83935580|NCT02947932|Resveratrol|resveratrol|mesh-list
83935581|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
83935582|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935583|NCT02947932|Protective Agents|protective agents|mesh-ancestor
83935584|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935585|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935586|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83935587|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83935588|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83935589|NCT02947932|Analgesics|analgesics|mesh-ancestor
83935590|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
83935591|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935592|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935593|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935594|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
83935595|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
83935596|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935597|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83935598|NCT05146154|Imipenem|imipenem|mesh-list
83935599|NCT05146154|Relebactam|relebactam|mesh-list
83935600|NCT05146154|Cilastatin|cilastatin|mesh-list
83935601|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83935602|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935603|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
83935604|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935605|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935606|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83935607|NCT00524667|Fludarabine|fludarabine|mesh-list
83935608|NCT00524667|Valproic Acid|valproic acid|mesh-list
83935609|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935610|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935611|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935612|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
83935613|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935614|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
83935615|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935616|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
83935617|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83935618|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935619|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83935620|NCT00524706|Leucovorin|leucovorin|mesh-list
83935621|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
83935622|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935623|NCT00524706|Antidotes|antidotes|mesh-ancestor
83935624|NCT00524706|Protective Agents|protective agents|mesh-ancestor
83935625|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935626|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
83935627|NCT00524706|Vitamins|vitamins|mesh-ancestor
83935628|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
83935629|NCT00507143|Irinotecan|irinotecan|mesh-list
83935630|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83935631|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83935632|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935633|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935634|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935635|NCT00525993|Etoricoxib|etoricoxib|mesh-list
83935636|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83935637|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83935638|NCT00525993|Analgesics|analgesics|mesh-ancestor
83935639|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
83935640|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935641|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935642|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935643|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935644|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83935645|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83935646|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935647|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935648|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
83935649|NCT02947854|Poly ICLC|poly iclc|mesh-list
83935650|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83935651|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
83935652|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
83935653|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935654|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83935655|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
83935656|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
83935657|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83935658|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83935659|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83935660|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935661|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935662|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
83935663|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935664|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935665|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83935666|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935667|NCT00507221|Albendazole|albendazole|mesh-list
83935668|NCT00507221|Praziquantel|praziquantel|mesh-list
83935669|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
83935670|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83935671|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935672|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
83935673|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83935674|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83935675|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
83935676|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
83935677|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
83935678|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935679|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935680|NCT02947737|Gentamicins|gentamicins|mesh-list
83935681|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83935682|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935683|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83935684|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935685|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935686|NCT05146895|Imiquimod|imiquimod|mesh-list
83935687|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83935688|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
83935689|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935690|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935691|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
83935692|NCT05143073|Ethanol|ethanol|mesh-list
83935693|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83935694|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935695|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935696|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935697|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
83935698|NCT00524901|Hematinics|hematinics|mesh-ancestor
83935699|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
83935700|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
83935701|NCT02954588|Vitamins|vitamins|mesh-ancestor
83935702|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
83935703|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935704|NCT02954549|Vitamin D|vitamin d|mesh-list
83935705|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
83935706|NCT02954549|Vitamins|vitamins|mesh-ancestor
83935707|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
83935708|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935709|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83935710|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83935711|NCT05145608|Lamotrigine|lamotrigine|mesh-list
83935712|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
83935713|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83935714|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935715|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935716|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83935717|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935718|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83935719|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83935720|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935721|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83935722|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83935723|NCT02946294|Epinephrine|epinephrine|mesh-list
83935724|NCT02946294|Racepinephrine|racepinephrine|mesh-list
83935725|NCT02946294|Bupivacaine|bupivacaine|mesh-list
83935726|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
83935727|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
83935728|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
83935729|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935730|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935731|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
83935732|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935733|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83935734|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83935735|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
83935736|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935737|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935738|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83935739|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83935740|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
83935741|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83935742|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
83935743|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
83935744|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
83935745|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83935746|NCT05146232|Anesthetics|anesthetics|mesh-list
83935747|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83935748|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935749|NCT00525096|Celecoxib|celecoxib|mesh-list
83935750|NCT00525096|Exemestane|exemestane|mesh-list
83935751|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83935752|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83935753|NCT00525096|Analgesics|analgesics|mesh-ancestor
83935754|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
83935755|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935756|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935757|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935758|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935759|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83935760|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83935761|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935762|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935763|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935764|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83935765|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83935766|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83935767|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
83935768|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935769|NCT04693026|Remdesivir|remdesivir|mesh-list
83935770|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
83935771|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935772|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
83935773|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935774|NCT02276859|Insulin|insulin|mesh-list
83935775|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83935776|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
83935777|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
83935778|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
83935779|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83935780|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935781|NCT05143970|Trastuzumab|trastuzumab|mesh-list
83935782|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83935783|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935784|NCT05147090|Empagliflozin|empagliflozin|mesh-list
83935785|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83935786|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935787|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83935788|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935789|NCT00525252|Baclofen|baclofen|mesh-list
83935790|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83935791|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935792|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83935793|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935794|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83935795|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
83935796|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
83935797|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935798|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935799|NCT02947113|Etoposide|etoposide|mesh-list
83935800|NCT02947113|Pemetrexed|pemetrexed|mesh-list
83935801|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935802|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83935803|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83935804|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83935805|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935806|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935807|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83935808|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83935809|NCT05149274|Fexuprazan|fexuprazan|mesh-list
83935810|NCT05149274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935811|NCT02276690|Hepcidins|hepcidins|mesh-list
83935812|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935813|NCT02947269|Prucalopride|prucalopride|mesh-list
83935814|NCT02947269|Laxatives|laxatives|mesh-ancestor
83935815|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935816|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83935817|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83935818|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
83935819|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935820|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935821|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935822|NCT00526305|Cytarabine|cytarabine|mesh-list
83935823|NCT00526305|Dexamethasone|dexamethasone|mesh-list
83935824|NCT00526305|Prednisone|prednisone|mesh-list
83935825|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
83935826|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
83935827|NCT00526305|Vincristine|vincristine|mesh-list
83935828|NCT00526305|Daunorubicin|daunorubicin|mesh-list
83935829|NCT00526305|Asparaginase|asparaginase|mesh-list
83935830|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
83935831|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
83935832|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935833|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
83935834|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935835|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935836|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83935837|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
83935838|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935839|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935840|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83935841|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935842|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
83935843|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
83935844|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935845|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935846|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
83935847|NCT00526305|Hormones|hormones|mesh-ancestor
83935848|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935849|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83935850|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83935851|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
83935852|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
83935853|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
83935854|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83935855|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
83935856|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
83935857|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935858|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83935859|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83935860|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83935861|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935862|NCT00526305|Analgesics|analgesics|mesh-ancestor
83935863|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
83935864|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83935865|NCT02276768|Trimebutine|trimebutine|mesh-list
83935866|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935867|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
83935868|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
83935869|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935870|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935871|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
83935872|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
83935873|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83935874|NCT05147753|Moxonidine|moxonidine|mesh-list
83935875|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83935876|NCT00525408|Docetaxel|docetaxel|mesh-list
83935877|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935878|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
83935879|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
83935880|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
83935881|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935882|NCT00525447|Dexamethasone|dexamethasone|mesh-list
83935883|NCT00525447|Lenalidomide|lenalidomide|mesh-list
83935884|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
83935885|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83935886|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
83935887|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
83935888|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935889|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935890|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83935891|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
83935892|NCT00525447|Hormones|hormones|mesh-ancestor
83935893|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83935894|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83935895|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935896|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
83935897|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83935898|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83935899|NCT00525447|Growth Substances|growth substances|mesh-ancestor
83935900|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
83935901|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83935902|NCT00525486|Nifedipine|nifedipine|mesh-list
83935903|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83935904|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935905|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935906|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83935907|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935908|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
83935909|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
83935910|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83935911|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83935912|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
83935913|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935914|NCT02946060|TEMPO|tempo|mesh-list
83935915|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
83935916|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935917|NCT02946060|Protective Agents|protective agents|mesh-ancestor
83935918|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935919|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83935920|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83175197|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
83935921|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
83935922|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83935923|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935924|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83935925|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
83935926|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83935927|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83935928|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83935929|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
83935930|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935931|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935932|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
83935933|NCT00525642|Docetaxel|docetaxel|mesh-list
83935934|NCT00525642|Doxorubicin|doxorubicin|mesh-list
83935935|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83935936|NCT00525642|Epirubicin|epirubicin|mesh-list
83935937|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935938|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
83935939|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935940|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935941|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83935942|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
83935943|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935944|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83935945|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83935946|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
83935947|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
83935948|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
83935949|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83935950|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83935951|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83935952|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935953|NCT00525681|Cyclosporine|cyclosporine|mesh-list
83935954|NCT00525681|Tacrolimus|tacrolimus|mesh-list
83935955|NCT00525681|Cyclosporins|cyclosporins|mesh-list
83935956|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83935957|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
83935958|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935959|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83935960|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83935961|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935962|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
83935963|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935964|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
83935965|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83935966|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
83935967|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83935968|NCT02945982|Entecavir|entecavir|mesh-list
83935969|NCT02945982|Carvedilol|carvedilol|mesh-list
83935970|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
83935971|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935972|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83935973|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83935974|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
83935975|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935976|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83935977|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83935978|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83935979|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
83935980|NCT02945982|Protective Agents|protective agents|mesh-ancestor
83935981|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83935982|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83935983|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83935984|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
83935985|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83935986|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83935987|NCT02954393|Amoxicillin|amoxicillin|mesh-list
83935988|NCT02954393|Metronidazole|metronidazole|mesh-list
83935989|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83935990|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83935991|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83935992|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83935993|NCT02954276|Sumatriptan|sumatriptan|mesh-list
83935994|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83935995|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83935996|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83935997|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
83935998|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83935999|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936000|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936001|NCT00507494|Pioglitazone|pioglitazone|mesh-list
83936002|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83936003|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936004|NCT00526617|Temozolomide|temozolomide|mesh-list
83936005|NCT00526617|Veliparib|veliparib|mesh-list
83936006|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83936007|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
83936008|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936009|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936010|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83936011|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936012|NCT00507845|Felodipine|felodipine|mesh-list
83936013|NCT00507845|Ramipril|ramipril|mesh-list
83936014|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83936015|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
83936016|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936017|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936018|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83936019|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83936020|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83936021|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936022|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83936023|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936024|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
83936025|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
83936026|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
83936027|NCT00525759|Docetaxel|docetaxel|mesh-list
83936028|NCT00525759|Fluorouracil|fluorouracil|mesh-list
83936029|NCT00525759|Epirubicin|epirubicin|mesh-list
83936030|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83936031|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
83936032|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936033|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83936034|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83936035|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
83936036|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936037|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936038|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83936039|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
83936040|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
83936041|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
83936042|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
83936043|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936044|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83936045|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83936046|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83936047|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936048|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83936049|NCT00507962|Cisplatin|cisplatin|mesh-list
83936050|NCT00507962|Doxorubicin|doxorubicin|mesh-list
83936051|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83936052|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936053|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83936054|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83936055|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83936056|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936057|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936058|NCT00508040|Interferons|interferons|mesh-list
83936059|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
83936060|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
83936061|NCT00508040|Prednisone|prednisone|mesh-list
83936062|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83936063|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
83936064|NCT00508040|Hormones|hormones|mesh-ancestor
83936065|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936066|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936067|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83936068|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936069|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
83936070|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936071|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
83936072|NCT00508664|Docetaxel|docetaxel|mesh-list
83936073|NCT00508664|Fluorouracil|fluorouracil|mesh-list
83936074|NCT00508664|Cetuximab|cetuximab|mesh-list
83936075|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936076|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
83936077|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
83936078|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
83936079|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936080|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
83936081|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936082|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83936083|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
83936084|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936085|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936086|NCT02946684|Letrozole|letrozole|mesh-list
83936087|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83936088|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936089|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83936090|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936091|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936092|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83936093|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
83936094|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936095|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936096|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
83936097|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83936098|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936099|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83936100|NCT02946801|Listerine|listerine|mesh-list
83936101|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
83936102|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83936103|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936104|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
83936105|NCT02946801|Protective Agents|protective agents|mesh-ancestor
83936106|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936107|NCT02953847|Rifampin|rifampin|mesh-list
83936108|NCT02953847|Isoniazid|isoniazid|mesh-list
83936109|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83936110|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
83936111|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83936112|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936113|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
83936114|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83936115|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936116|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936117|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83936118|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83936119|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83936120|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83936121|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83936122|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83936123|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83936124|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83936125|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
83936126|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83936127|NCT00526695|Sevoflurane|sevoflurane|mesh-list
83936128|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83936129|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83936130|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
83936131|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
83936132|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936133|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936134|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
83936135|NCT00526929|Hematinics|hematinics|mesh-ancestor
83936136|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
83936137|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
83936138|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936139|NCT00526734|Melphalan|melphalan|mesh-list
83936140|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
83936141|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936142|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83936143|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
83936144|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936145|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936146|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83936147|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175432|NCT05069740|Analgesics|analgesics|mesh-ancestor
83936149|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
83936150|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83936151|NCT00508859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83936152|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83936153|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936154|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936155|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936156|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
83936157|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936158|NCT00508898|Calcitriol|calcitriol|mesh-list
83936159|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83936160|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936161|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83936162|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936163|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936164|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83936165|NCT00508898|Vitamins|vitamins|mesh-ancestor
83936166|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
83936167|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83936168|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
83936169|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83936170|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
83936171|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936172|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
83936173|NCT04692558|Protective Agents|protective agents|mesh-ancestor
83936174|NCT02952599|Edoxaban|edoxaban|mesh-list
83936175|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83936176|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
83936177|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83936178|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
83936179|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936180|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936181|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
83936182|NCT00510419|Sumatriptan|sumatriptan|mesh-list
83936183|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83936184|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83936185|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83936186|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
83936187|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936188|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936189|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936190|NCT00510536|Acetaminophen|acetaminophen|mesh-list
83936191|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83936192|NCT00510536|Analgesics|analgesics|mesh-ancestor
83936193|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
83936194|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936195|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936196|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
83936197|NCT03458715|Empagliflozin|empagliflozin|mesh-list
83936198|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83936199|NCT03458715|Linagliptin|linagliptin|mesh-list
83936200|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83936201|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936202|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83936203|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936204|NCT03458715|Incretins|incretins|mesh-ancestor
83936205|NCT03458715|Hormones|hormones|mesh-ancestor
83936206|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936207|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
83936208|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936209|NCT00510614|Tinidazole|tinidazole|mesh-list
83936210|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
83936211|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936212|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83936213|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936214|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83936215|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83936216|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83936217|NCT00508976|Lidocaine|lidocaine|mesh-list
83936218|NCT00508976|Bupivacaine|bupivacaine|mesh-list
83936219|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
83936220|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
83936221|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936222|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936223|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
83936224|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936225|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83936226|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83936227|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83936228|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936229|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936231|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83936232|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83936233|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936234|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936235|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83936236|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
83936237|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
83936238|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936239|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936240|NCT00509015|Artesunate|artesunate|mesh-list
83936241|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
83936242|NCT00509015|Primaquine|primaquine|mesh-list
83936243|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
83936244|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83936245|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
83936246|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83936247|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83936248|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936249|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936250|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
83936251|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
83936252|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83936253|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
83936254|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83936255|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936256|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936257|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83936258|NCT00528060|Ritonavir|ritonavir|mesh-list
83936259|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83936260|NCT00528060|Tenofovir|tenofovir|mesh-list
83936261|NCT00528060|Emtricitabine|emtricitabine|mesh-list
83936262|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83936263|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83936264|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
83936265|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936266|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936267|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83936268|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83936269|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
83936270|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936271|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83936272|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83936273|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83936274|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83936275|NCT00527085|Cinacalcet|cinacalcet|mesh-list
83936276|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83936277|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936278|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83936279|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
83936280|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936281|NCT00509327|Bisacodyl|bisacodyl|mesh-list
83936282|NCT00509327|Cathartics|cathartics|mesh-ancestor
83936283|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83936284|NCT00509327|Laxatives|laxatives|mesh-ancestor
83936285|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
83936286|NCT00509405|Diuretics|diuretics|mesh-ancestor
83936287|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
83936288|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936289|NCT00509405|Expectorants|expectorants|mesh-ancestor
83936290|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
83936291|NCT00509561|Capecitabine|capecitabine|mesh-list
83936292|NCT00509561|Cetuximab|cetuximab|mesh-list
83936293|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936294|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936295|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
83175572|NCT02230163|Antibodies|antibodies|mesh-list
83175575|NCT02230319|Paclitaxel|paclitaxel|mesh-list
83936296|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936297|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936298|NCT00509639|Metronidazole|metronidazole|mesh-list
83936299|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936300|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83936301|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83936302|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83936303|NCT00528177|Morphine|morphine|mesh-list
83936304|NCT00528177|Oxycodone|oxycodone|mesh-list
83936305|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83936306|NCT00528177|Narcotics|narcotics|mesh-ancestor
83936307|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936308|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936309|NCT00528177|Analgesics|analgesics|mesh-ancestor
83936310|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
83936311|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936312|NCT00509678|Rituximab|rituximab|mesh-list
83936313|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936314|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936315|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
83936316|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936317|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83936318|NCT00528216|Capsaicin|capsaicin|mesh-list
83936319|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
83936320|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936321|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
83936322|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936323|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936324|NCT00528255|Misoprostol|misoprostol|mesh-list
83936325|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83936326|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
83936327|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83936328|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936329|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83936330|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83936331|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
83936332|NCT02953106|Fluticasone|fluticasone|mesh-list
83936333|NCT02953106|Azelastine|azelastine|mesh-list
83936334|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83936335|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83936336|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
83936337|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936338|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936339|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83936340|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
83936341|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936342|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83936343|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83936344|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936345|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936346|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83936347|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83936348|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
83936349|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
83936350|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936351|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
83936352|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936353|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936354|NCT02952989|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83936355|NCT02952989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936356|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
83936357|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936358|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83936359|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936360|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936361|NCT00509834|Lactoferrin|lactoferrin|mesh-list
83936362|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936363|NCT03459404|Sufentanil|sufentanil|mesh-list
83936364|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83936365|NCT03459404|Narcotics|narcotics|mesh-ancestor
83936366|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936367|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936368|NCT03459404|Analgesics|analgesics|mesh-ancestor
83936369|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
83936370|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175656|NCT00004907|Busulfan|busulfan|mesh-list
83936371|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83936372|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83936373|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
83936374|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
83936375|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
83936376|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83936377|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83936378|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83936379|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936380|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936381|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
83936382|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936383|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936384|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83936385|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936386|NCT00510965|Ranibizumab|ranibizumab|mesh-list
83936387|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83936388|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83936389|NCT00510965|Growth Substances|growth substances|mesh-ancestor
83936390|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936391|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
83936392|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936393|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
83936394|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83936395|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83936396|NCT00509990|Analgesics|analgesics|mesh-ancestor
83936397|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
83936398|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936399|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936400|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83936401|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83936402|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936403|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83936404|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
83936405|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83936406|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936407|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936408|NCT03459911|Losartan|losartan|mesh-list
83936409|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83936410|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83936411|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83936412|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83936413|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936414|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
83936415|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83936416|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
83936417|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936418|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
83936419|NCT03459833|Protective Agents|protective agents|mesh-ancestor
83936420|NCT05648487|Antibodies|antibodies|mesh-list
83936421|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
83936422|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936423|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83936424|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
83936425|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936426|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83936427|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936428|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936429|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
83936430|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936431|NCT04692051|Paclitaxel|paclitaxel|mesh-list
83936432|NCT04692051|Cisplatin|cisplatin|mesh-list
83936433|NCT04692051|Gemcitabine|gemcitabine|mesh-list
83936434|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83936435|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936436|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
83936437|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
83936438|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
83936439|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936440|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936441|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
83936442|NCT00528723|Albuterol|albuterol|mesh-list
83936443|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83936444|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
83936445|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936446|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936447|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83936448|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
83936449|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
83936450|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83936451|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83936452|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83936453|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83936454|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83936455|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936456|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936457|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
83936458|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936459|NCT01580514|Exenatide|exenatide|mesh-list
83936460|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83936461|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936462|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83936463|NCT01580514|Incretins|incretins|mesh-ancestor
83936464|NCT01580514|Hormones|hormones|mesh-ancestor
83936465|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936466|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
83936467|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83936468|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936469|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
83936470|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936471|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83936472|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
83936473|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83936474|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83936475|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83936476|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936477|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936478|NCT02953184|Vitamins|vitamins|mesh-list
83936479|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
83936480|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
83936481|NCT02953184|Docetaxel|docetaxel|mesh-list
83936482|NCT02953184|Doxorubicin|doxorubicin|mesh-list
83936483|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83936484|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
83936485|NCT02953184|Razoxane|razoxane|mesh-list
83936486|NCT02953184|Pirarubicin|pirarubicin|mesh-list
83936487|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83936488|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
83936489|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936490|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83936491|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83936492|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
83936493|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936494|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936495|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83936496|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
83936497|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
83936498|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
83936499|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
83936500|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83936501|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83936502|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83936503|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936504|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83936505|NCT02953184|Protective Agents|protective agents|mesh-ancestor
83936506|NCT00515229|Amitriptyline|amitriptyline|mesh-list
83936507|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83936508|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
83936509|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83936510|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83936511|NCT00515229|Analgesics|analgesics|mesh-ancestor
83936512|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
83936513|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936514|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936515|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83936516|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83936517|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936518|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936519|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
83175799|NCT03529331|Narcotics|narcotics|mesh-ancestor
83936520|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936521|NCT00511316|Montelukast|montelukast|mesh-list
83936522|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83936523|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
83936524|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83936525|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
83936526|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936527|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936528|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83936529|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83936530|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936531|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
83936532|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83936533|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936534|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83936535|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
83936536|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83936537|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936538|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936539|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936540|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
83936541|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83936542|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83936543|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936544|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936545|NCT01356966|Folic Acid|folic acid|mesh-list
83936546|NCT01356966|Hematinics|hematinics|mesh-ancestor
83936547|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
83936548|NCT01356966|Vitamins|vitamins|mesh-ancestor
83936549|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
83936550|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936551|NCT02944734|Amlodipine|amlodipine|mesh-list
83936552|NCT02944734|Candesartan|candesartan|mesh-list
83936553|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
83936554|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83936555|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83936556|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936557|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936558|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83936559|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936560|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
83936561|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83936562|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83936563|NCT00510263|Valacyclovir|valacyclovir|mesh-list
83936564|NCT00510263|Prednisolone|prednisolone|mesh-list
83936565|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83936566|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
83936567|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83936568|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
83936569|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83936570|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
83936571|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83936572|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
83936573|NCT00510263|Hormones|hormones|mesh-ancestor
83936574|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936575|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936576|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83936577|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936578|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
83936579|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
83936580|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936581|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83936582|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83936583|NCT00510263|Protective Agents|protective agents|mesh-ancestor
83936584|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
83936585|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936586|NCT00511628|Risperidone|risperidone|mesh-list
83936587|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83936588|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
83936589|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936590|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936591|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936592|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83936593|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83936594|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936595|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83936596|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83936597|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
83936598|NCT00529425|Ropivacaine|ropivacaine|mesh-list
83936599|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
83936600|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
83936601|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936602|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936603|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
83936604|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936605|NCT02950935|Progesterone|progesterone|mesh-list
83936606|NCT02950935|Progestins|progestins|mesh-ancestor
83936607|NCT02950935|Hormones|hormones|mesh-ancestor
83936608|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936609|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936610|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
83936611|NCT00529620|Piperaquine|piperaquine|mesh-list
83936612|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
83936613|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83936614|NCT00529620|Amodiaquine|amodiaquine|mesh-list
83936615|NCT00529620|Artenimol|artenimol|mesh-list
83936616|NCT00529620|Sulfalene|sulfalene|mesh-list
83936617|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
83936618|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83936619|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83936620|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936621|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83936622|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936623|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936624|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83936625|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
83936626|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83936627|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936628|NCT00513032|Methylene Blue|methylene blue|mesh-list
83936629|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936630|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936631|NCT00513110|Caffeine|caffeine|mesh-list
83936632|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83936633|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936634|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83936635|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936636|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936637|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83936638|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83936639|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
83936640|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936641|NCT02951897|Pemetrexed|pemetrexed|mesh-list
83936642|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936643|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936644|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936645|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83936646|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83936647|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
83936648|NCT00511823|Granisetron|granisetron|mesh-list
83936649|NCT00511823|Casopitant|casopitant|mesh-list
83936650|NCT00511823|Dolasetron|dolasetron|mesh-list
83936651|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83936652|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936653|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
83936654|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
83936655|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936656|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83936657|NCT00511823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83936658|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83936659|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
83936660|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936661|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936662|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83936663|NCT00515736|Vitamins|vitamins|mesh-list
83936664|NCT00515736|Vitamin E|vitamin e|mesh-list
83936665|NCT00515736|Thiamine|thiamine|mesh-list
83936666|NCT00515736|Zinc|zinc|mesh-list
83936667|NCT00515736|Selenium|selenium|mesh-list
83936668|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
83936669|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936670|NCT00515736|Trace Elements|trace elements|mesh-ancestor
83936671|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
83936672|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936673|NCT00515736|Protective Agents|protective agents|mesh-ancestor
83936674|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
83936675|NCT00511940|Acamprosate|acamprosate|mesh-list
83936676|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83936677|NCT00513149|Clopidogrel|clopidogrel|mesh-list
83936678|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83936679|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83936680|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83936681|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83936682|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
83936683|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936684|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936685|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936686|NCT02944227|Ranibizumab|ranibizumab|mesh-list
83936687|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83936688|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83936689|NCT02944227|Growth Substances|growth substances|mesh-ancestor
83936690|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936691|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
83936692|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936693|NCT00513188|Leucovorin|leucovorin|mesh-list
83936694|NCT00513188|Cytarabine|cytarabine|mesh-list
83936695|NCT00513188|Prednisone|prednisone|mesh-list
83936696|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
83936697|NCT00513188|Doxorubicin|doxorubicin|mesh-list
83936698|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83936699|NCT00513188|Methotrexate|methotrexate|mesh-list
83936700|NCT00513188|Vincristine|vincristine|mesh-list
83936701|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
83936702|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
83936703|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83936704|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
83936705|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936706|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83936707|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83936708|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
83936709|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936710|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936711|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83936712|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83936713|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83936714|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83936715|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936716|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83936717|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
83936718|NCT00513188|Hormones|hormones|mesh-ancestor
83936719|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936720|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83936721|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83936722|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
83936723|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83936724|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936725|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
83936726|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936727|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83936728|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83936729|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
83936730|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936731|NCT00513188|Antidotes|antidotes|mesh-ancestor
83936732|NCT00513188|Protective Agents|protective agents|mesh-ancestor
83936733|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
83936734|NCT00513188|Vitamins|vitamins|mesh-ancestor
83936735|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
83936736|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83936737|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
83936738|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
83936739|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
83936740|NCT00513266|Leucovorin|leucovorin|mesh-list
83936741|NCT00513266|Bevacizumab|bevacizumab|mesh-list
83936742|NCT00513266|Cetuximab|cetuximab|mesh-list
83936743|NCT00513266|Fluorouracil|fluorouracil|mesh-list
83936744|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
83936745|NCT00513266|Irinotecan|irinotecan|mesh-list
83936746|NCT00513266|Calcium|calcium|mesh-list
83936747|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
83936748|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936749|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936750|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83936751|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83936752|NCT00513266|Growth Substances|growth substances|mesh-ancestor
83936753|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936754|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
83936755|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83936756|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
83936757|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936758|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936759|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83936760|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
83936761|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83936762|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83936763|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936764|NCT00513266|Antidotes|antidotes|mesh-ancestor
83936765|NCT00513266|Protective Agents|protective agents|mesh-ancestor
83936766|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
83936767|NCT00513266|Vitamins|vitamins|mesh-ancestor
83936768|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
83936769|NCT00513383|Paclitaxel|paclitaxel|mesh-list
83936770|NCT00513383|Docetaxel|docetaxel|mesh-list
83936771|NCT00513383|Carboplatin|carboplatin|mesh-list
83936772|NCT00513383|Fluorouracil|fluorouracil|mesh-list
83936773|NCT00513383|Panitumumab|panitumumab|mesh-list
83936774|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83936775|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936776|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
83936777|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
83936778|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
83936779|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936780|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
83936781|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936782|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83936783|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
83936784|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936785|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936786|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
83936787|NCT00515892|Antibodies|antibodies|mesh-list
83936788|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
83936789|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83936790|NCT00515892|Immunotoxins|immunotoxins|mesh-list
83936791|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
83936792|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936793|NCT00515892|Immunoconjugates|immunoconjugates|mesh-ancestor
83936794|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936795|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83936796|NCT00513539|Trioxsalen|trioxsalen|mesh-list
83936797|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936798|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936799|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83936800|NCT00511979|Insulin|insulin|mesh-list
83936801|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83936802|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83936803|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936804|NCT00513578|Sargramostim|sargramostim|mesh-list
83936805|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
83936806|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
83936807|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936808|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83936809|NCT00513656|Oxycodone|oxycodone|mesh-list
83936810|NCT00513656|Naloxone|naloxone|mesh-list
83936811|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83936812|NCT00513656|Narcotics|narcotics|mesh-ancestor
83936813|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936814|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936815|NCT00513656|Analgesics|analgesics|mesh-ancestor
83936816|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
83936817|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936818|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83936819|NCT00530127|Deferiprone|deferiprone|mesh-list
83936820|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83936821|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
83936822|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
83936823|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936824|NCT04691934|Anesthetics|anesthetics|mesh-list
83936825|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936826|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936827|NCT00512057|Allopurinol|allopurinol|mesh-list
83936828|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
83936829|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936830|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936831|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
83936832|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83936833|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83936834|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
83936835|NCT00512057|Protective Agents|protective agents|mesh-ancestor
83936836|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936837|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
83936838|NCT00513929|Astringents|astringents|mesh-ancestor
83936839|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936840|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936841|NCT00513968|Adefovir|adefovir|mesh-list
83936842|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
83936843|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936844|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83936845|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83936846|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936847|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936848|NCT02944500|Liraglutide|liraglutide|mesh-list
83936849|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83936850|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936851|NCT02944500|Incretins|incretins|mesh-ancestor
83936852|NCT02944500|Hormones|hormones|mesh-ancestor
83936853|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936854|NCT03459248|Anesthetics|anesthetics|mesh-list
83936855|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936856|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936857|NCT00512291|Olanzapine|olanzapine|mesh-list
83936858|NCT00512291|Fluoxetine|fluoxetine|mesh-list
83936859|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
83936860|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
83936861|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936862|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936863|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83936864|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83936865|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83936866|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936867|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83936868|NCT00512291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83936869|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83936870|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936871|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936872|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936873|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
83936874|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83936875|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
83936876|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83936877|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83936878|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936879|NCT00514163|Gemcitabine|gemcitabine|mesh-list
83936880|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936881|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
83936882|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936883|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936884|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
83936885|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83936886|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936887|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83936888|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83936889|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83936890|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936891|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
83936892|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936893|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83936894|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
83936895|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936896|NCT00512408|Testosterone|testosterone|mesh-list
83936897|NCT00512408|Androgens|androgens|mesh-ancestor
83936898|NCT00512408|Hormones|hormones|mesh-ancestor
84124680|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176176|NCT04221035|Ifosfamide|ifosfamide|mesh-list
83936899|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936900|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936901|NCT00530400|Cefuroxime|cefuroxime|mesh-list
83936902|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
83936903|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83936904|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936905|NCT00531336|Bevacizumab|bevacizumab|mesh-list
83936906|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936907|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936908|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83936909|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83936910|NCT00531336|Growth Substances|growth substances|mesh-ancestor
83936911|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936912|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
83936913|NCT00530478|Donepezil|donepezil|mesh-list
83936914|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83936915|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936916|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936917|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
83936918|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936919|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936920|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
83936921|NCT00530556|Zolpidem|zolpidem|mesh-list
83936922|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83936923|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83936924|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83936925|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936926|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83936927|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
83936928|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
83936929|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83936930|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936931|NCT00512486|Benralizumab|benralizumab|mesh-list
83936932|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83936933|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
83936934|NCT00530595|Losartan|losartan|mesh-list
83936935|NCT00530595|Valsartan|valsartan|mesh-list
83936936|NCT00530595|Candesartan|candesartan|mesh-list
83936937|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83936938|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83936939|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83936940|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936941|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83936942|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
83936943|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83936944|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83936945|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83936946|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
83936947|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
83936948|NCT02944110|Glucagon|glucagon|mesh-list
83936949|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83936950|NCT02944110|Hormones|hormones|mesh-ancestor
83936951|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936952|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936953|NCT02951975|Dexamethasone|dexamethasone|mesh-list
83936954|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83936955|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
83936956|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
83936957|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83936958|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936959|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83936960|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
83936961|NCT02951975|Hormones|hormones|mesh-ancestor
83936962|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83936963|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83936964|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936965|NCT00514397|Temozolomide|temozolomide|mesh-list
83936966|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
83936967|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83936968|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
83936969|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936970|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936971|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83936972|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176258|NCT05214664|Anesthetics|anesthetics|mesh-list
83936973|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
83936974|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83936975|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936976|NCT02943603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83936977|NCT02943603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936978|NCT00531687|Paclitaxel|paclitaxel|mesh-list
83936979|NCT00531687|Gemcitabine|gemcitabine|mesh-list
83936980|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83936981|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936982|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
83936983|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
83936984|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
83936985|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936986|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83936987|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
83936988|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83936989|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
83936990|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83936991|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
83936992|NCT00512681|Irinotecan|irinotecan|mesh-list
83936993|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83936994|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83936995|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83936996|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83936997|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83936998|NCT00530868|Bevacizumab|bevacizumab|mesh-list
83936999|NCT00530868|Letrozole|letrozole|mesh-list
83937000|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937001|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937002|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83937003|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937004|NCT00530868|Growth Substances|growth substances|mesh-ancestor
83937005|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937006|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
83937007|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83937008|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83937009|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937010|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937011|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83937012|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
83937013|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83937014|NCT00530907|Bevacizumab|bevacizumab|mesh-list
83937015|NCT00530907|Valproic Acid|valproic acid|mesh-list
83937016|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937017|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937018|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83937019|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937020|NCT00530907|Growth Substances|growth substances|mesh-ancestor
83937021|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937022|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
83937023|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
83937024|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937025|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937026|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
83937027|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937028|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
83937029|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83937030|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937031|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937032|NCT00531024|Bevacizumab|bevacizumab|mesh-list
83937033|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937034|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937035|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83937036|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937037|NCT00531024|Growth Substances|growth substances|mesh-ancestor
83937038|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937039|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
83937040|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
83937041|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
83937042|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
83937043|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83937044|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937045|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
83937046|NCT00531063|Everolimus|everolimus|mesh-list
83937047|NCT00531063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83937048|NCT00531063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83937049|NCT00531063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937050|NCT00531063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937051|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937052|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
83937053|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937054|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937055|NCT02943798|Paclitaxel|paclitaxel|mesh-list
83937056|NCT02943798|Etoposide|etoposide|mesh-list
83937057|NCT02943798|Carboplatin|carboplatin|mesh-list
83937058|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83937059|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937060|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
83937061|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83937062|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
83937063|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937064|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83937065|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83937066|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937067|NCT02943369|Ticagrelor|ticagrelor|mesh-list
83937068|NCT02943369|Cangrelor|cangrelor|mesh-list
83937069|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83937070|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83937071|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83937072|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83937073|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
83937074|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937075|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937076|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937077|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83937078|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937079|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937080|NCT00514748|Analgesics|analgesics|mesh-ancestor
83937081|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
83937082|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937083|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937084|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937085|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937086|NCT00515957|Antibodies|antibodies|mesh-list
83937087|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
83937088|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937089|NCT02943642|Vorinostat|vorinostat|mesh-list
83937090|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937091|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83937092|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937093|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937094|NCT04695509|Propofol|propofol|mesh-list
83937095|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83937096|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937097|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937098|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83937099|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
83937100|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
83937101|NCT02943135|Lidocaine|lidocaine|mesh-list
83937102|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
83937103|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
83937104|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937105|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937106|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
83937107|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937108|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83937109|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83937110|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83937111|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83937112|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937113|NCT02951234|Aspirin|aspirin|mesh-list
83937114|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83937115|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
83937116|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83937117|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937118|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937119|NCT02951234|Analgesics|analgesics|mesh-ancestor
83937120|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
83176405|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
83937121|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937122|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937123|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937124|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937125|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83937126|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83937127|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937128|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83937129|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83937130|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937131|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
83937132|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
83937133|NCT02943252|Apatinib|apatinib|mesh-list
83937134|NCT02943252|Tegafur|tegafur|mesh-list
83937135|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937136|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83937137|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937138|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937139|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83937140|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
83937141|NCT00514982|Adalimumab|adalimumab|mesh-list
83937142|NCT00514982|Infliximab|infliximab|mesh-list
83937143|NCT00514982|Mesalamine|mesalamine|mesh-list
83937144|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
83937145|NCT00514982|Tacrolimus|tacrolimus|mesh-list
83937146|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937147|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
83937148|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937149|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83937150|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937151|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937152|NCT00514982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83937153|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937154|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937155|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
83937156|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937157|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
83937158|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83937159|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937160|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83937161|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937162|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937163|NCT00514982|Analgesics|analgesics|mesh-ancestor
83937164|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
83937165|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937166|NCT00531999|Ritonavir|ritonavir|mesh-list
83937167|NCT00531999|Lopinavir|lopinavir|mesh-list
83937168|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
83937169|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83937170|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83937171|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
83937172|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937173|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937174|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83937175|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83937176|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
83937177|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937178|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83937179|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83937180|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83937181|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83937182|NCT05319912|Molybdenum|molybdenum|mesh-list
83937183|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83937184|NCT05319912|Choline|choline|mesh-list
83937185|NCT05319912|Omeprazole|omeprazole|mesh-list
83937186|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83937187|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937188|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83937189|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937190|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937191|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
83937192|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83937193|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
83937194|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83937195|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
83937196|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
83937197|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
83937198|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83937199|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937200|NCT05319912|Growth Substances|growth substances|mesh-ancestor
83937201|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937202|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
83937203|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937204|NCT05319912|Trace Elements|trace elements|mesh-ancestor
83937205|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
83937206|NCT00515138|Rituximab|rituximab|mesh-list
83937207|NCT00515138|Carboplatin|carboplatin|mesh-list
83937208|NCT00515138|Etoposide|etoposide|mesh-list
83937209|NCT00515138|Bortezomib|bortezomib|mesh-list
83937210|NCT00515138|Ifosfamide|ifosfamide|mesh-list
83937211|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937212|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937213|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
83937214|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937215|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937216|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83937217|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83937218|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83937219|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937220|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937221|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83937222|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
83937223|NCT05319834|Aspirin|aspirin|mesh-list
83937224|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937225|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937226|NCT05319834|Analgesics|analgesics|mesh-ancestor
83937227|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
83937228|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937229|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937230|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937231|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937232|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83937233|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83937234|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937235|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83937236|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83937237|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937238|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
83937239|NCT00515255|Minocycline|minocycline|mesh-list
83937240|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83937241|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937242|NCT00516113|Paroxetine|paroxetine|mesh-list
83937243|NCT00516113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83937244|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83937245|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83937246|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937247|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937248|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
83937249|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937250|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83937251|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
83937252|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937253|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83937254|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83937255|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937256|NCT04695197|Artesunate|artesunate|mesh-list
83937257|NCT04695197|Lumefantrine|lumefantrine|mesh-list
83937258|NCT04695197|Artemether|artemether|mesh-list
83937259|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83937260|NCT04695197|Pyronaridine|pyronaridine|mesh-list
83937261|NCT04695197|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83937262|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
83937263|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83937264|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83937265|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937266|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937267|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
83937268|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
83937269|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83937270|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
83937271|NCT00516152|Methotrexate|methotrexate|mesh-list
83937272|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
83937273|NCT00516152|Fludarabine|fludarabine|mesh-list
83937275|NCT00516152|Tacrolimus|tacrolimus|mesh-list
83937276|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83937277|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
83937278|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83937279|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937280|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83937281|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
83937282|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937283|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937284|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83937285|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937286|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83937287|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937288|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
83937289|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937290|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83937291|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83937292|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
83937293|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83937294|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83937295|NCT00516191|Doxorubicin|doxorubicin|mesh-list
83937296|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83937297|NCT00516191|Bortezomib|bortezomib|mesh-list
83937298|NCT00516191|Melphalan|melphalan|mesh-list
83937299|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83937300|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937301|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83937302|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83937303|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937304|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937305|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83937306|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
83937307|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83937308|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937309|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
83937310|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937311|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
83937312|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83937313|NCT00515450|Antibodies|antibodies|mesh-list
83937314|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
83937315|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83937316|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
83937317|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937318|NCT00515489|Risperidone|risperidone|mesh-list
83937319|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83937320|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
83937321|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937322|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937323|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937324|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83937325|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83937326|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937327|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937328|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83937329|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
83937330|NCT02941575|Methamphetamine|methamphetamine|mesh-list
83937331|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83937332|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937333|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
83937334|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
83937335|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937336|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
83937337|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937338|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937339|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
83937340|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83937341|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83937342|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83937343|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83937344|NCT02941731|Oseltamivir|oseltamivir|mesh-list
83937345|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
83937346|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937347|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176634|NCT03840148|Meropenem|meropenem|mesh-list
83937348|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937349|NCT02951039|Edoxaban|edoxaban|mesh-list
83937350|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83937351|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
83937352|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83937353|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
83937354|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937355|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937356|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
83937357|NCT02951117|Dexamethasone|dexamethasone|mesh-list
83937358|NCT02951117|Venetoclax|venetoclax|mesh-list
83937359|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937360|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
83937361|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
83937362|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937363|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937364|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937365|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
83937366|NCT02951117|Hormones|hormones|mesh-ancestor
83937367|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83937368|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83937369|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937370|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
83937371|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937372|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937373|NCT02950220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83937374|NCT02950220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937375|NCT00515684|Bevacizumab|bevacizumab|mesh-list
83937376|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937377|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937378|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83937379|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937380|NCT00515684|Growth Substances|growth substances|mesh-ancestor
83937381|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937382|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83937383|NCT05317767|Vaccines|vaccines|mesh-list
83937384|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
83937385|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937386|NCT00515801|Glyburide|glyburide|mesh-list
83937387|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83937388|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937389|NCT05317611|Ondansetron|ondansetron|mesh-list
83937390|NCT05317611|Bupivacaine|bupivacaine|mesh-list
83937391|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
83937392|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
83937393|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937394|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937395|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
83937396|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937397|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
83937398|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
83937399|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937400|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
83937401|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83937402|NCT05317611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83937403|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83937404|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
83937405|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937406|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937407|NCT05317572|Morphine|morphine|mesh-list
83937408|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83937409|NCT05317572|Narcotics|narcotics|mesh-ancestor
83937410|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937411|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937412|NCT05317572|Analgesics|analgesics|mesh-ancestor
83937413|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
83937414|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937415|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
83937416|NCT00516425|Doxorubicin|doxorubicin|mesh-list
83937417|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83937418|NCT00516425|Epirubicin|epirubicin|mesh-list
83937419|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937420|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
83937421|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937422|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937423|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83937424|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
83937425|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937426|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937427|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83937428|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83937429|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83937430|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83937431|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937432|NCT02942706|Cetuximab|cetuximab|mesh-list
83937433|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937434|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937435|NCT00516464|Ranibizumab|ranibizumab|mesh-list
83937436|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83937437|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937438|NCT00516464|Growth Substances|growth substances|mesh-ancestor
83937439|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937440|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
83937441|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937442|NCT00516542|Letrozole|letrozole|mesh-list
83937443|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937444|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83937445|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83937446|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937447|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937448|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83937449|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
83937450|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83937451|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937452|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
83937453|NCT03458481|Yimitasvir|yimitasvir|mesh-list
83937454|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
83937455|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937456|NCT02949752|Aripiprazole|aripiprazole|mesh-list
83937457|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
83937458|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937459|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83937460|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83937461|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937462|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937463|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
83937464|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
83937465|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937466|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937467|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83937468|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83937469|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
83937470|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83937471|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83937472|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83937473|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83937474|NCT02942550|Bromides|bromides|mesh-list
83937475|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
83937476|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
83937477|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83937478|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937479|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
83937480|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937481|NCT04694612|Remdesivir|remdesivir|mesh-list
83937482|NCT04694612|Favipiravir|favipiravir|mesh-list
83937483|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
83937484|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937485|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
83937486|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937487|NCT02941224|Sirolimus|sirolimus|mesh-list
83937488|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83937489|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937490|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83937491|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937492|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
83937493|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937494|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
83937495|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937496|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
83937497|NCT00516854|Clidinium|clidinium|mesh-list
83937498|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83937499|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83937500|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937501|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937502|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83937503|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83937504|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937505|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
83937506|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
83937507|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937508|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937509|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
83937510|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
83937511|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937512|NCT02940990|Paclitaxel|paclitaxel|mesh-list
83937513|NCT02940990|Etoposide|etoposide|mesh-list
83937514|NCT02940990|Vinorelbine|vinorelbine|mesh-list
83937515|NCT02940990|Docetaxel|docetaxel|mesh-list
83937516|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83937517|NCT02940990|Carboplatin|carboplatin|mesh-list
83937518|NCT02940990|Gemcitabine|gemcitabine|mesh-list
83937519|NCT02940990|Pemetrexed|pemetrexed|mesh-list
83937520|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83937521|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937522|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
83937523|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
83937524|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
83937525|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937526|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83937527|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
83937528|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83937529|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83937530|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937531|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83937532|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83937533|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
83937534|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83937535|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83937536|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83937537|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
83937538|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937539|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83937540|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83937541|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937542|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937543|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83937544|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83937545|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
83937546|NCT00518375|Cyclosporine|cyclosporine|mesh-list
83937547|NCT00518375|Sirolimus|sirolimus|mesh-list
83937548|NCT00518375|Cyclosporins|cyclosporins|mesh-list
83937549|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937550|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937551|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937552|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
83937553|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937554|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
83937555|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937556|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
83937557|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937558|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83937559|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83937560|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83937561|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937562|NCT02942043|Bevacizumab|bevacizumab|mesh-list
83937563|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83937564|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937565|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83937566|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937567|NCT02942043|Growth Substances|growth substances|mesh-ancestor
83937568|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937569|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
83937570|NCT00516971|Esomeprazole|esomeprazole|mesh-list
83937571|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83937572|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937573|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83937574|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937575|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937576|NCT00518570|Levetiracetam|levetiracetam|mesh-list
83937577|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
83937578|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
83937579|NCT03458208|Metformin|metformin|mesh-list
83937580|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83937581|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937582|NCT00517283|Exenatide|exenatide|mesh-list
83937583|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83937584|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937585|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83937586|NCT00517283|Incretins|incretins|mesh-ancestor
83937587|NCT00517283|Hormones|hormones|mesh-ancestor
83937588|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83937589|NCT02940912|Apomorphine|apomorphine|mesh-list
83937590|NCT02940912|Emetics|emetics|mesh-ancestor
83937591|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937592|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
83937593|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937594|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937595|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
83937596|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
83937597|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937598|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937599|NCT00517322|Ramipril|ramipril|mesh-list
83937600|NCT00517322|Irbesartan|irbesartan|mesh-list
83937601|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83937602|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
83937603|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937604|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937605|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83937606|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83937607|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83937608|NCT02939430|Atropine|atropine|mesh-list
83937609|NCT02939430|Neostigmine|neostigmine|mesh-list
83937610|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83937611|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83937612|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83937613|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
83937614|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937615|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937616|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83937617|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
83937618|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
83937619|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
83937620|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83937621|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83937622|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
83937623|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937624|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937625|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83937626|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937627|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83937628|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
83937629|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
83937630|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937631|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937632|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937633|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
83937634|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83937635|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937636|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937637|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
83937638|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
83937639|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
83937640|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937641|NCT00517517|Coagulants|coagulants|mesh-ancestor
83937642|NCT02940756|Artesunate|artesunate|mesh-list
83937643|NCT02940756|Lumefantrine|lumefantrine|mesh-list
83937644|NCT02940756|Artemether|artemether|mesh-list
83937645|NCT02940756|Piperaquine|piperaquine|mesh-list
83937646|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83937647|NCT02940756|Amodiaquine|amodiaquine|mesh-list
83937648|NCT02940756|Artenimol|artenimol|mesh-list
83937649|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
83937650|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83937651|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83937652|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937653|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937654|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
83937655|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
83937656|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83937657|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
83937659|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
83937660|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937661|NCT02941068|Fluconazole|fluconazole|mesh-list
83937662|NCT02941068|Caspofungin|caspofungin|mesh-list
83937663|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
83937664|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937665|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83937666|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83937667|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937668|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937669|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83937670|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
83937671|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83937672|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937673|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83937674|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83937675|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
83937676|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937677|NCT02939274|Verteporfin|verteporfin|mesh-list
83937678|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83937679|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
83937680|NCT04694183|Paclitaxel|paclitaxel|mesh-list
83937681|NCT04694183|Antibodies|antibodies|mesh-list
83937682|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
83937683|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83937684|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937685|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83937686|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83937687|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83937688|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937689|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
83937690|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937691|NCT00517946|Cetirizine|cetirizine|mesh-list
83937692|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
83937693|NCT00517946|Ephedrine|ephedrine|mesh-list
83937694|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83937695|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83937696|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83937697|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
83937698|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
83937699|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937700|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937701|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937702|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83937703|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
83937704|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937705|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83937706|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83937707|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
83937708|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83937709|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83937710|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
83937711|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
83937712|NCT04988685|Sirolimus|sirolimus|mesh-list
83937713|NCT04988685|Paclitaxel|paclitaxel|mesh-list
83937714|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83937715|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937716|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
83937717|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
83937718|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
83937719|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937720|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83937721|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937722|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83937723|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
83937724|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937725|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
83937726|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937727|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83937728|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83937729|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83937730|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83937731|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937732|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937733|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937734|NCT00517985|Analgesics|analgesics|mesh-ancestor
83937735|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
83937736|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937737|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
83937738|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937739|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
83937740|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83937741|NCT04690920|Remdesivir|remdesivir|mesh-list
83937742|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937743|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937744|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
83937745|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
83937746|NCT00518102|Becaplermin|becaplermin|mesh-list
83937747|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
83937748|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83937749|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83937750|NCT00518102|Growth Substances|growth substances|mesh-ancestor
83937751|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937752|NCT02939235|Morphine|morphine|mesh-list
83937753|NCT02939235|Metoclopramide|metoclopramide|mesh-list
83937754|NCT02939235|Ticagrelor|ticagrelor|mesh-list
83937755|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83937756|NCT02939235|Narcotics|narcotics|mesh-ancestor
83937757|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937758|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937759|NCT02939235|Analgesics|analgesics|mesh-ancestor
83937760|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
83937761|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937762|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83937763|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83937764|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83937765|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83937766|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
83937767|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937768|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937769|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
83937770|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
83937771|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937772|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83937773|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83937774|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
83937775|NCT00518141|Aspirin|aspirin|mesh-list
83937776|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
83937777|NCT00518141|Salicylates|salicylates|mesh-list
83937778|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937779|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
83937780|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
83937781|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
83937782|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937783|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937784|NCT00518141|Analgesics|analgesics|mesh-ancestor
83937785|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
83937786|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937787|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937788|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937789|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937790|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83937791|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937792|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937793|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83937794|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83937795|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83937796|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
83937797|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
83937798|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83937799|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83937800|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937801|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
83937802|NCT02938962|Coagulants|coagulants|mesh-ancestor
83937803|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
83937804|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937805|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
83937806|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937807|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937808|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83937810|NCT00519116|Tacrolimus|tacrolimus|mesh-list
83937811|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937812|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
83937813|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937814|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83937815|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937816|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937817|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83937818|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937819|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83937820|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937821|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
83937822|NCT04691076|Fentanyl|fentanyl|mesh-list
83937823|NCT04691076|Propofol|propofol|mesh-list
83937824|NCT04691076|Esketamine|esketamine|mesh-list
83937825|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83937826|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937827|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937828|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83937829|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
83937830|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
83937831|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83937832|NCT04691076|Narcotics|narcotics|mesh-ancestor
83937833|NCT04691076|Analgesics|analgesics|mesh-ancestor
83937834|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
83937835|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937836|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83937837|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
83937838|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83937839|NCT02949206|Thrombin|thrombin|mesh-list
83937840|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
83937841|NCT02949206|Coagulants|coagulants|mesh-ancestor
83937842|NCT05108454|Micronutrients|micronutrients|mesh-list
83937843|NCT05108454|Trace Elements|trace elements|mesh-list
83937844|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937845|NCT02940561|Methotrexate|methotrexate|mesh-list
83937846|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83937847|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
83937848|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83937849|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937850|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83937851|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
83937852|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937853|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937854|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
83937855|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937856|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83937857|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83937858|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
83937859|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937860|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83937861|NCT02940366|Atorvastatin|atorvastatin|mesh-list
83937862|NCT02940366|Pitavastatin|pitavastatin|mesh-list
83937863|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83937864|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83937865|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
83937866|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937867|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83937868|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83937869|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937870|NCT02940405|Ketorolac|ketorolac|mesh-list
83937871|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83937872|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937873|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937874|NCT02940405|Analgesics|analgesics|mesh-ancestor
83937875|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
83937876|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937877|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937878|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937879|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937880|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83937881|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937882|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937883|NCT02940444|Heparin|heparin|mesh-list
83937884|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
83937885|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83937886|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83937887|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937888|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
83937889|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83937890|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937891|NCT04690647|Dexamethasone|dexamethasone|mesh-list
83937892|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83937893|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937894|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
83937895|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
83937896|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937897|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937898|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83937899|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
83937900|NCT04690647|Hormones|hormones|mesh-ancestor
83937901|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83937902|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83937903|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937904|NCT04690647|Analgesics|analgesics|mesh-ancestor
83937905|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
83937906|NCT00519467|Artesunate|artesunate|mesh-list
83937907|NCT00519467|Dapsone|dapsone|mesh-list
83937908|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
83937909|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
83937910|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83937911|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83937912|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83937913|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937914|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
83937915|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
83937916|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83937917|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
83937918|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83937919|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937920|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937921|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
83937922|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83937923|NCT02940483|Azacitidine|azacitidine|mesh-list
83937924|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83937925|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
83937926|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937927|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937928|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937929|NCT04974684|Apixaban|apixaban|mesh-list
83937930|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83937931|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
83937932|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83937933|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
83937934|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937935|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937936|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
83937937|NCT00520091|Celecoxib|celecoxib|mesh-list
83937938|NCT00520091|Irinotecan|irinotecan|mesh-list
83937939|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83937940|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83937941|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83937942|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937943|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937944|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937945|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937946|NCT00520091|Analgesics|analgesics|mesh-ancestor
83937947|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
83937948|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937949|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937950|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937951|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937952|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83937953|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83937954|NCT00520169|Ketamine|ketamine|mesh-list
83937955|NCT00520169|Analgesics|analgesics|mesh-ancestor
83177238|NCT02240680|Hormones|hormones|mesh-ancestor
83937956|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
83937957|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937958|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937959|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83937960|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83937961|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
83937962|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
83937963|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83937964|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83937965|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83937966|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83937967|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937968|NCT00520247|Folic Acid|folic acid|mesh-list
83937969|NCT00520247|Enalapril|enalapril|mesh-list
83937970|NCT00520247|Hematinics|hematinics|mesh-ancestor
83937971|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
83937972|NCT00520247|Vitamins|vitamins|mesh-ancestor
83937973|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
83937974|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937975|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83937976|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
83937977|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83937978|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83937979|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83937980|NCT02949050|Immunomodulating Agents|immunomodulating agents|mesh-list
83937981|NCT02949050|Immunologic Factors|immunologic factors|mesh-ancestor
83937982|NCT02949050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937983|NCT00520325|Lectins|lectins|mesh-list
83937984|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
83937985|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
83937986|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937987|NCT00520325|Coagulants|coagulants|mesh-ancestor
83937988|NCT00520442|Ibuprofen|ibuprofen|mesh-list
83937989|NCT00520442|Codeine|codeine|mesh-list
83937990|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83937991|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83937992|NCT00520442|Analgesics|analgesics|mesh-ancestor
83937993|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
83937994|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83937995|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83937996|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83937997|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83937998|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83937999|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938000|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938001|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83938002|NCT00520442|Narcotics|narcotics|mesh-ancestor
83938003|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938004|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
83938005|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
83938006|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
83938007|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83938008|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938009|NCT02939898|Letrozole|letrozole|mesh-list
83938010|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83938011|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938012|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83938013|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938014|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938015|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83938016|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
83938017|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938018|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938019|NCT00520754|Levocetirizine|levocetirizine|mesh-list
83938020|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83938021|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83938022|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
83938023|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
83938024|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938025|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938026|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938027|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
83938028|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
83938029|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84124681|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
83177316|NCT02291471|T0001|t0001|mesh-list
83938030|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83938032|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938033|NCT02277132|Urological Agents|urological agents|mesh-ancestor
83938034|NCT00520949|Amoxicillin|amoxicillin|mesh-list
83938035|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83938036|NCT00520949|Furazolidone|furazolidone|mesh-list
83938037|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83938038|NCT00520949|Esomeprazole|esomeprazole|mesh-list
83938039|NCT00520949|Bismuth|bismuth|mesh-list
83938040|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83938041|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938042|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83938043|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938044|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83938045|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938046|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938047|NCT00520949|Antacids|antacids|mesh-ancestor
83938048|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83938049|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83938050|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83938051|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83938052|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83938053|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83938054|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83938055|NCT02938260|Metoprolol|metoprolol|mesh-list
83938056|NCT02938260|Diltiazem|diltiazem|mesh-list
83938057|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83938058|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83938059|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
83938060|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
83938061|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938062|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938063|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83938064|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83938065|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83938066|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
83938067|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938068|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938069|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83938070|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83938071|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83938072|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
83938073|NCT02938182|Clopidogrel|clopidogrel|mesh-list
83938074|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83938075|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83938076|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83938077|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83938078|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
83938079|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938080|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938081|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938082|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
83938083|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
83938084|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938085|NCT00521612|Sevoflurane|sevoflurane|mesh-list
83938086|NCT00521612|Isoflurane|isoflurane|mesh-list
83938087|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83938088|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83938089|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
83938090|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
83938091|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938092|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938093|NCT00521261|Antibodies|antibodies|mesh-list
83938094|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83938095|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
83938096|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938097|NCT02931591|Metformin|metformin|mesh-list
83938098|NCT02931591|Hormones|hormones|mesh-list
83938099|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83938100|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938101|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938102|NCT00521300|Octreotide|octreotide|mesh-list
83177380|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
83938103|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938104|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83938105|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938106|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
83938107|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83938108|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938110|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83938111|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83938112|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938113|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
83938114|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938115|NCT02937792|Bupivacaine|bupivacaine|mesh-list
83938116|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
83938117|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
83938118|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938119|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938120|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
83938121|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938122|NCT02931474|Tesamorelin|tesamorelin|mesh-list
83938123|NCT02931474|Growth Substances|growth substances|mesh-ancestor
83938124|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938125|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
83938126|NCT02931357|Lidocaine|lidocaine|mesh-list
83938127|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
83938128|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
83938129|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
83938130|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938131|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938132|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
83938133|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938134|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83938135|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83938136|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83938137|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83938138|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938139|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83938140|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
83938141|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
83938142|NCT02931357|Protective Agents|protective agents|mesh-ancestor
83938143|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83938144|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938145|NCT02937519|Cisplatin|cisplatin|mesh-list
83938146|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938147|NCT00521963|Infliximab|infliximab|mesh-list
83938148|NCT00521963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83938149|NCT00521963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938150|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
83938151|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938152|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83938153|NCT02937402|Dimercaprol|dimercaprol|mesh-list
83938154|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
83938155|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
83152269|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83938156|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938157|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
83938158|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
83938159|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938160|NCT02937363|Protective Agents|protective agents|mesh-ancestor
83938161|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938162|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
83938163|NCT02937363|Vitamins|vitamins|mesh-ancestor
83938164|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
83938165|NCT02948348|Capecitabine|capecitabine|mesh-list
83938166|NCT02948348|Nivolumab|nivolumab|mesh-list
83938167|NCT02948348|Ipilimumab|ipilimumab|mesh-list
83938168|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938169|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
83938170|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938171|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938172|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83938173|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83938174|NCT04693910|Hormones|hormones|mesh-list
83938175|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938176|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177455|NCT03517943|Loratadine|loratadine|mesh-list
83938177|NCT00522158|Atorvastatin|atorvastatin|mesh-list
83938178|NCT00522158|Simvastatin|simvastatin|mesh-list
83938179|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83938180|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83938181|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
83938182|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938183|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83938184|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83938185|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938186|NCT02931123|Rifaximin|rifaximin|mesh-list
83938187|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83938188|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938189|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938190|NCT02936934|Morphine|morphine|mesh-list
83938191|NCT02936934|Oxycodone|oxycodone|mesh-list
83938192|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83938193|NCT02936934|Narcotics|narcotics|mesh-ancestor
83938194|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938195|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938196|NCT02936934|Analgesics|analgesics|mesh-ancestor
83938197|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
83938198|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938199|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
83938200|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83938201|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938202|NCT00522509|Floxuridine|floxuridine|mesh-list
83938203|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938204|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
83938205|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938206|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938207|NCT00522587|Remifentanil|remifentanil|mesh-list
83938208|NCT00522587|Sevoflurane|sevoflurane|mesh-list
83938209|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83938210|NCT00522587|Narcotics|narcotics|mesh-ancestor
83938211|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938212|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938213|NCT00522587|Analgesics|analgesics|mesh-ancestor
83938214|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
83938215|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938216|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83938217|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83938218|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
83938219|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
83938220|NCT00522665|Irinotecan|irinotecan|mesh-list
83938221|NCT00522665|Cetuximab|cetuximab|mesh-list
83938222|NCT00522665|Everolimus|everolimus|mesh-list
83938223|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83938224|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83938225|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938226|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938227|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938228|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83938229|NCT00522665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83938230|NCT00522665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83938231|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938232|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
83938233|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938234|NCT00522743|Hormones|hormones|mesh-list
83938235|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938236|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938237|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83938238|NCT02937012|Bezafibrate|bezafibrate|mesh-list
83938239|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83938240|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938241|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83938242|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
83938243|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938244|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83938245|NCT00522782|Budesonide|budesonide|mesh-list
83938246|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
83938247|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938248|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83938249|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
83938250|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177549|NCT04542993|Zinc|zinc|mesh-list
83938251|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938252|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83938253|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
83938254|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
83938255|NCT00522782|Hormones|hormones|mesh-ancestor
83938256|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938257|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83938258|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
83938259|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938260|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938261|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83938262|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
83938263|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
83938264|NCT00522782|Protective Agents|protective agents|mesh-ancestor
83938265|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83938266|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
83938267|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83938268|NCT00522821|Antibodies|antibodies|mesh-list
83938269|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
83938270|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83938271|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938272|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
83938273|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938274|NCT02936895|Vitamin D|vitamin d|mesh-list
83938275|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
83938276|NCT02936895|Vitamins|vitamins|mesh-ancestor
83938277|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
83938278|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938279|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83938280|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83938281|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83938282|NCT00522938|Tosedostat|tosedostat|mesh-list
83938283|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938284|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83938285|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938286|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938287|NCT04694105|Dexamethasone|dexamethasone|mesh-list
83938288|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
83938289|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938290|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
83938291|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
83938292|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938293|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938294|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938295|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
83938296|NCT04694105|Hormones|hormones|mesh-ancestor
83938297|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938298|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83938299|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938300|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83938301|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938302|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83938303|NCT04694105|Analgesics|analgesics|mesh-ancestor
83938304|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
83938305|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83938306|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83938307|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83938308|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
83938309|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938310|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938311|NCT02930733|Bupivacaine|bupivacaine|mesh-list
83938312|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
83938313|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
83938314|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938315|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938316|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
83938317|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938318|NCT00523055|Lidocaine|lidocaine|mesh-list
83938319|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
83938320|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
83938321|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938322|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938323|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
83938324|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938325|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83938326|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83938327|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83938328|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83938329|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938331|NCT00523289|Ropivacaine|ropivacaine|mesh-list
83938332|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
83938333|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
83938334|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938335|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938336|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
83938337|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938338|NCT00524381|Etanercept|etanercept|mesh-list
83938339|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83938340|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83938341|NCT00524381|Analgesics|analgesics|mesh-ancestor
83938342|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
83938343|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938344|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938345|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938346|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83938347|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938348|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938349|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
83938350|NCT04502667|Vitamin D|vitamin d|mesh-list
83938351|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
83938352|NCT04502667|Vitamins|vitamins|mesh-ancestor
83938353|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
83938354|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938355|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83938356|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83938357|NCT00524498|Cisplatin|cisplatin|mesh-list
83938358|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938359|NCT00523406|Triamcinolone|triamcinolone|mesh-list
83938360|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938361|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
83938362|NCT00523406|Hormones|hormones|mesh-ancestor
83938363|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938364|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938365|NCT00524615|Spironolactone|spironolactone|mesh-list
83938366|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83938367|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
83938368|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938369|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938370|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83938371|NCT00524615|Diuretics|diuretics|mesh-ancestor
83938372|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
83938373|NCT00523445|Varenicline|varenicline|mesh-list
83938374|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83938375|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83938376|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83938377|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938378|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938379|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938380|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
83938381|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83938382|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83938383|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938384|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
83938385|NCT02936661|Coagulants|coagulants|mesh-ancestor
83938386|NCT02948075|Paclitaxel|paclitaxel|mesh-list
83938387|NCT02948075|Carboplatin|carboplatin|mesh-list
83938388|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83938389|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938390|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938391|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
83938392|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938393|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938394|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
83938395|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
83938396|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83938397|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83938398|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938399|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938400|NCT02930811|Urological Agents|urological agents|mesh-ancestor
83938401|NCT02947880|Bumetanide|bumetanide|mesh-list
83938402|NCT02947880|Diuretics|diuretics|mesh-ancestor
83938403|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
83938404|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938405|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83938406|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83938407|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938409|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83938410|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
83938411|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938412|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938413|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83938414|NCT00523757|Diuretics|diuretics|mesh-ancestor
83938415|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
83938416|NCT00524693|Montelukast|montelukast|mesh-list
83938417|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83938418|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
83938419|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83938420|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
83938421|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938422|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938423|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83938424|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83938425|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938426|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83938427|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83938428|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938429|NCT02936427|Dexamethasone|dexamethasone|mesh-list
83938430|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
83938431|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83938432|NCT02936427|BB 1101|bb 1101|mesh-list
83938433|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938434|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
83938435|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
83938436|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938437|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938438|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938439|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
83938440|NCT02936427|Hormones|hormones|mesh-ancestor
83938441|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938442|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83938443|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938444|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
83938445|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938446|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938447|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
83938448|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83938449|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938450|NCT02947763|Metronidazole|metronidazole|mesh-list
83938451|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
83938452|NCT02947763|Minocycline|minocycline|mesh-list
83938453|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938454|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83938455|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83938456|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83938457|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83938458|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83938459|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938460|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938461|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938462|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83938463|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83938464|NCT00523952|Tacrolimus|tacrolimus|mesh-list
83938465|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938466|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
83938467|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938468|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83938469|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938470|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938471|NCT00524069|Bevacizumab|bevacizumab|mesh-list
83938472|NCT00524069|Gemcitabine|gemcitabine|mesh-list
83938473|NCT00524069|Capecitabine|capecitabine|mesh-list
83938474|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83938475|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938476|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83938477|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83938478|NCT00524069|Growth Substances|growth substances|mesh-ancestor
83938479|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938480|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
83938481|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938482|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
83938483|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938484|NCT00524810|Docetaxel|docetaxel|mesh-list
83938485|NCT00524810|Doxorubicin|doxorubicin|mesh-list
83938486|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83938487|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938488|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938489|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83938490|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938491|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938492|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83938493|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83938494|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83938495|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938496|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
83938497|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83938498|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938499|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
83938500|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83938501|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
83938502|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
83938503|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938504|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938505|NCT00524966|Hemostatics|hemostatics|mesh-list
83938506|NCT00524966|Coagulants|coagulants|mesh-ancestor
83938507|NCT02276846|Paclitaxel|paclitaxel|mesh-list
83938508|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83938509|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938510|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938511|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83938512|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938513|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938514|NCT02935725|Ketamine|ketamine|mesh-list
83938515|NCT02935725|Analgesics|analgesics|mesh-ancestor
83938516|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
83938517|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938518|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938519|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83938520|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83938521|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
83938522|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
83938523|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938524|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83938525|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83938526|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938527|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938528|NCT02935764|Leucovorin|leucovorin|mesh-list
83938529|NCT02935764|Fluorouracil|fluorouracil|mesh-list
83938530|NCT02935764|Irinotecan|irinotecan|mesh-list
83938531|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
83938532|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938533|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938534|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938535|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938536|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
83938537|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938538|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83938539|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83938540|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938541|NCT02935764|Antidotes|antidotes|mesh-ancestor
83938542|NCT02935764|Protective Agents|protective agents|mesh-ancestor
83938543|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
83938544|NCT02935764|Vitamins|vitamins|mesh-ancestor
83938545|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
83938546|NCT02935998|Ziprasidone|ziprasidone|mesh-list
83938547|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83938548|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
83938549|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938550|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938551|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938552|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83938553|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83938554|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938555|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83938556|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83938557|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
83938558|NCT02930109|Cytarabine|cytarabine|mesh-list
83938559|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938560|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
83938561|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938562|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938563|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
83938564|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938565|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938566|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
83938567|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938568|NCT00524186|Leucovorin|leucovorin|mesh-list
83938569|NCT00524186|Fluorouracil|fluorouracil|mesh-list
83938570|NCT00524186|Irinotecan|irinotecan|mesh-list
83938571|NCT00524186|Sunitinib|sunitinib|mesh-list
83938572|NCT00524186|Calcium|calcium|mesh-list
83938573|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
83938574|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83938575|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938576|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
83938577|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938578|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938579|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938580|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938581|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
83938582|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83938583|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83938584|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938585|NCT00524186|Antidotes|antidotes|mesh-ancestor
83938586|NCT00524186|Protective Agents|protective agents|mesh-ancestor
83938587|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
83938588|NCT00524186|Vitamins|vitamins|mesh-ancestor
83938589|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
83938590|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83938591|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83938592|NCT00524186|Growth Substances|growth substances|mesh-ancestor
83938593|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
83938594|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83938595|NCT00525005|Docetaxel|docetaxel|mesh-list
83938596|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
83938597|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938598|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938599|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83938600|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938601|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938602|NCT00525200|Docetaxel|docetaxel|mesh-list
83938603|NCT00525200|Cisplatin|cisplatin|mesh-list
83938604|NCT00525200|Fluorouracil|fluorouracil|mesh-list
83938605|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152271|NCT02254577|Progesterone|progesterone|mesh-list
83938606|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938607|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83938608|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938609|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938610|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
83938611|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938612|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938613|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
83938614|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938615|NCT02930265|Liraglutide|liraglutide|mesh-list
83938616|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83938617|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938618|NCT02930265|Incretins|incretins|mesh-ancestor
83938619|NCT02930265|Hormones|hormones|mesh-ancestor
83938620|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938621|NCT02947178|Bupivacaine|bupivacaine|mesh-list
83938622|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
83938623|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
83938624|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938625|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938626|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
83938627|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938628|NCT02929797|Gemcitabine|gemcitabine|mesh-list
83938629|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938630|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
83938631|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938632|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938633|NCT00525239|Ritonavir|ritonavir|mesh-list
83938634|NCT00525239|Lopinavir|lopinavir|mesh-list
83938635|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83938636|NCT00525239|Efavirenz|efavirenz|mesh-list
83938637|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83938638|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83938639|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
83938640|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938641|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938642|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83938643|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83938644|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
83938645|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938646|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83938647|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83938648|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83938649|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83938650|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83938651|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83938652|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83938653|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83938654|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83938655|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
83938656|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83938657|NCT02947334|Bococizumab|bococizumab|mesh-list
83938658|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83938659|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83938660|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
83938661|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938662|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83938663|NCT00525278|Levocetirizine|levocetirizine|mesh-list
83938664|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83938665|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83938666|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
83938667|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
83938668|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938669|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938670|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938671|NCT02929719|Dapsone|dapsone|mesh-list
83938672|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938673|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
83938674|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83938675|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83938676|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83938677|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938678|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938679|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
83938680|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83938681|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83938682|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938683|NCT02929524|Ketamine|ketamine|mesh-list
83938684|NCT02929524|Analgesics|analgesics|mesh-ancestor
83938685|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
83938686|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938687|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938688|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83938689|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83938690|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
83938691|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
83938692|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938693|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83938694|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83938695|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938696|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938697|NCT00525473|Azathioprine|azathioprine|mesh-list
83938698|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
83938699|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938700|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938701|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177996|NCT05089539|Valsartan|valsartan|mesh-list
83938702|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938703|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
83938704|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938705|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83938706|NCT00526175|Cytarabine|cytarabine|mesh-list
83938707|NCT00526175|Prednisone|prednisone|mesh-list
83938708|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
83938709|NCT00526175|Methotrexate|methotrexate|mesh-list
83938710|NCT00526175|Vincristine|vincristine|mesh-list
83938711|NCT00526175|Daunorubicin|daunorubicin|mesh-list
83938712|NCT00526175|Asparaginase|asparaginase|mesh-list
83938713|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
83938714|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938715|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
83938716|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938717|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83938718|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83938719|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
83938720|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938721|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938722|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83938723|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938724|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
83938725|NCT00526175|Hormones|hormones|mesh-ancestor
83938726|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938727|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83938728|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83938729|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
83938730|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83938731|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938732|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
83938733|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
83938734|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938735|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83938736|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83938737|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83938738|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938739|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83938740|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938741|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
83938742|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938743|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83938744|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83938745|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83938746|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
83938747|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83938748|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
83938749|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938750|NCT02930031|Expectorants|expectorants|mesh-ancestor
83938751|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
83938752|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83938753|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
83938754|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938755|NCT02930031|Protective Agents|protective agents|mesh-ancestor
83938756|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938757|NCT02930031|Antidotes|antidotes|mesh-ancestor
83938758|NCT02929563|Pantoprazole|pantoprazole|mesh-list
83938759|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83938760|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83938761|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83938762|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938763|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938764|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
83938765|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83938766|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
83938767|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938768|NCT00525551|Expectorants|expectorants|mesh-ancestor
83938769|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
83938770|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83938771|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
83938772|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938773|NCT00525551|Protective Agents|protective agents|mesh-ancestor
83938774|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938775|NCT00525551|Antidotes|antidotes|mesh-ancestor
83938776|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
83938777|NCT04288323|Edetic Acid|edetic acid|mesh-list
83938778|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
83938779|NCT04288323|Antidotes|antidotes|mesh-ancestor
83938780|NCT04288323|Protective Agents|protective agents|mesh-ancestor
83938781|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938782|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
83938783|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
83938784|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938785|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83938786|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
83938787|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83938788|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83938789|NCT02946359|Bevacizumab|bevacizumab|mesh-list
83938790|NCT02946359|Crizotinib|crizotinib|mesh-list
83938791|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83938792|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938793|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83938794|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83938795|NCT02946359|Growth Substances|growth substances|mesh-ancestor
83938796|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938797|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83938798|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83938799|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938800|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938801|NCT02946437|Midazolam|midazolam|mesh-list
83938802|NCT02946437|Propofol|propofol|mesh-list
83938803|NCT02946437|Sevoflurane|sevoflurane|mesh-list
83938804|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83938805|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938806|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938807|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83938808|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
83938809|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
83938810|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83938811|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83938812|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83938813|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83938814|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
83938815|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
83938816|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938817|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938818|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83938819|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83938820|NCT02946632|Metformin|metformin|mesh-list
83938821|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83938822|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
83938823|NCT02946632|Glimepiride|glimepiride|mesh-list
83938824|NCT02946632|Saxagliptin|saxagliptin|mesh-list
83938825|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83938826|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938827|NCT02946632|Incretins|incretins|mesh-ancestor
83938828|NCT02946632|Hormones|hormones|mesh-ancestor
83938829|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938830|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83938831|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
83938832|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938833|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938834|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83938835|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83938836|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938837|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
83938838|NCT02929134|Doxycycline|doxycycline|mesh-list
83938839|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83938840|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938841|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
83938842|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83938843|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83938844|NCT02929212|Acetaminophen|acetaminophen|mesh-list
83938845|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83938846|NCT02929212|Analgesics|analgesics|mesh-ancestor
83938847|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
83938848|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938849|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938850|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
83938851|NCT02929251|Adalimumab|adalimumab|mesh-list
83938852|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83938853|NCT02929251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83938854|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938855|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83938856|NCT02929095|Midazolam|midazolam|mesh-list
83938857|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
83938859|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83938860|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938861|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938862|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83938863|NCT02929095|Analgesics|analgesics|mesh-ancestor
83938864|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
83938865|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938866|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83938867|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83938868|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83938869|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
83938870|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83938871|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938872|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83938873|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83938874|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83938875|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83938876|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83938877|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
83938878|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
83938879|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
83938880|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
83938881|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83938882|NCT02929095|Narcotics|narcotics|mesh-ancestor
83938883|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83938884|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83938885|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938886|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83938887|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
83938888|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938889|NCT00525668|Protective Agents|protective agents|mesh-ancestor
83938890|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938891|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83938892|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83938893|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938894|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83938895|NCT00525707|Tezosentan|tezosentan|mesh-list
83938896|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
83938897|NCT00526214|Celecoxib|celecoxib|mesh-list
83938898|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83938899|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83938900|NCT00526214|Analgesics|analgesics|mesh-ancestor
83938901|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
83938902|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938903|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938904|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938905|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83938906|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83938907|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83938908|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048330|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83938909|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938910|NCT02928510|Idelalisib|idelalisib|mesh-list
83938911|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938912|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938913|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938914|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
83938915|NCT02946944|Apixaban|apixaban|mesh-list
83938916|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
83938917|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83938918|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83938919|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938920|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938921|NCT02946944|Urological Agents|urological agents|mesh-ancestor
83938922|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83938923|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
83938924|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83938925|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
83938926|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
83938927|NCT02947061|Docetaxel|docetaxel|mesh-list
83938928|NCT02947061|Capecitabine|capecitabine|mesh-list
83938929|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938930|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938931|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
83178253|NCT03135795|Dsuvia|dsuvia|mesh-list
83938932|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938933|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938934|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938935|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
83938936|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
83938937|NCT02928315|Analgesics|analgesics|mesh-ancestor
83938938|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
83938939|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83938940|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938941|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
83938942|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83938943|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83938944|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
83938945|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83938946|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83938947|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938948|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83938949|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
83938950|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83938951|NCT00526409|Cytarabine|cytarabine|mesh-list
83938952|NCT00526409|Prednisolone|prednisolone|mesh-list
83938953|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
83938954|NCT00526409|Methotrexate|methotrexate|mesh-list
83938955|NCT00526409|Vincristine|vincristine|mesh-list
83938956|NCT00526409|Daunorubicin|daunorubicin|mesh-list
83938957|NCT00526409|Asparaginase|asparaginase|mesh-list
83938958|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83938959|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
83938960|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83938961|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83938962|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83938963|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
83938964|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938965|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83938966|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83938967|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83938968|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
83938969|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83938970|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83938971|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
83938972|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
83938973|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83938974|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83938975|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83938976|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83938977|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
83938978|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
83938979|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
83938980|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83938981|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
83938982|NCT00526409|Hormones|hormones|mesh-ancestor
83938983|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83938984|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83938985|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
83938986|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938987|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83938988|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83938989|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83938990|NCT00526448|Ribavirin|ribavirin|mesh-list
83938991|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83938992|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
83938993|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83938994|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
83938995|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83938996|NCT02946671|Nivolumab|nivolumab|mesh-list
83938997|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
83938998|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83938999|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939000|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83939001|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939002|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
83939003|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83939004|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939005|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939006|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
83939007|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939008|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939009|NCT02945280|Apixaban|apixaban|mesh-list
83939010|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83939011|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
83939012|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83939013|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
83939014|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939015|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939016|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
83939017|NCT02945241|Vancomycin|vancomycin|mesh-list
83939018|NCT02945241|Cystatins|cystatins|mesh-list
83939019|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939020|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939021|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83939022|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
83939023|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939024|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939025|NCT00526643|Gemcitabine|gemcitabine|mesh-list
83939026|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939027|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83939028|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
83939029|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939030|NCT02945163|Tenofovir|tenofovir|mesh-list
83939031|NCT02945163|Lamivudine|lamivudine|mesh-list
83939032|NCT02945163|Efavirenz|efavirenz|mesh-list
83939033|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
83939034|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939035|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83939036|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83939037|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939038|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939039|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83939040|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83939041|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83939042|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83939043|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83939044|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83939045|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83939046|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83939047|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
83939048|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83939049|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939050|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939051|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83939052|NCT00526760|Analgesics|analgesics|mesh-ancestor
83939053|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
83939054|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939055|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83939056|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83939057|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83939058|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
83939059|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939060|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939061|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
83939062|NCT02927379|Ketamine|ketamine|mesh-list
83939063|NCT02927379|Bupivacaine|bupivacaine|mesh-list
83939064|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
83939065|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
83939066|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939067|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939068|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
83939069|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939070|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83939071|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83939072|NCT02927379|Analgesics|analgesics|mesh-ancestor
83939073|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83939074|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83939075|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83939076|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
83939077|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939078|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939079|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83939080|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83939081|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
83939082|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83939083|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83939085|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83939086|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
83939087|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939088|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939089|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939090|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83939091|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83939092|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939093|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83939094|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83939095|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
83939096|NCT02927496|Doxycycline|doxycycline|mesh-list
83939097|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939098|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939099|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
83939100|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83939101|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83939102|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83939103|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939104|NCT00527033|Mirabegron|mirabegron|mesh-list
83939105|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83939106|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83939107|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83939108|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83939109|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939110|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939111|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939112|NCT00527033|Urological Agents|urological agents|mesh-ancestor
83939113|NCT02945072|Sevoflurane|sevoflurane|mesh-list
83939114|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83939115|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83939116|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
83939117|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
83939118|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939119|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939120|NCT02924922|Mannitol|mannitol|mesh-list
83939121|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83939122|NCT02924922|Diuretics|diuretics|mesh-ancestor
83939123|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
83939124|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939125|NCT04692896|Lidocaine|lidocaine|mesh-list
83939126|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
83939127|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
83939128|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939129|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939130|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
83939131|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939132|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83939133|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83939134|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83939135|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939136|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939137|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
83939138|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83939139|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
83939140|NCT00528008|Povidone|povidone|mesh-list
83939141|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83939142|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939143|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
83939144|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
83939145|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
83939146|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
83939147|NCT04692740|Chlorambucil|chlorambucil|mesh-list
83939148|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83939149|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
83939150|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939151|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939152|NCT02925000|Vinorelbine|vinorelbine|mesh-list
83939153|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83939154|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939155|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
83939156|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
83939157|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
83939158|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939159|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
83939160|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83939161|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83939162|NCT02945696|Ropivacaine|ropivacaine|mesh-list
83939163|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
83939164|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
83939165|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939166|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939167|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
83939168|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939169|NCT02924766|Prednisone|prednisone|mesh-list
83939170|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
83939171|NCT02924766|Niraparib|niraparib|mesh-list
83939172|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939173|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
83939174|NCT02924766|Hormones|hormones|mesh-ancestor
83939175|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939176|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939177|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83939178|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939179|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83939180|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939181|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939182|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
83939183|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83939184|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83939185|NCT00528281|Pemetrexed|pemetrexed|mesh-list
83939186|NCT00528281|Lapatinib|lapatinib|mesh-list
83939187|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939188|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939189|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939190|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83939191|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83939192|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83939193|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
83939194|NCT01580501|Tadalafil|tadalafil|mesh-list
83939195|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
83939196|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83939197|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83939198|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939199|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939200|NCT01580501|Urological Agents|urological agents|mesh-ancestor
83939201|NCT02924532|Hormones|hormones|mesh-list
83939202|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
83939203|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939204|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048331|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
83939205|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83939206|NCT00528359|Olanzapine|olanzapine|mesh-list
83939207|NCT00528359|Risperidone|risperidone|mesh-list
83939208|NCT00528359|Aripiprazole|aripiprazole|mesh-list
83939209|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83939210|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83939211|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
83939212|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939213|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939214|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939215|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83939216|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83939217|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939218|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83939219|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83939220|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
83939221|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
83939222|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
83939223|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939224|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939225|NCT00528359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83939226|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83939227|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939228|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
83939229|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
83939230|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83939231|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83939232|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83939233|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83939234|NCT00527150|Varenicline|varenicline|mesh-list
83939235|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83939236|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83939237|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
83939238|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939239|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939240|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939241|NCT00527228|Deflazacort|deflazacort|mesh-list
83939242|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939243|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939244|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
83939245|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939246|NCT00527267|Cinacalcet|cinacalcet|mesh-list
83939247|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83939248|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939249|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83939250|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
83939251|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939252|NCT02924454|Metoprolol|metoprolol|mesh-list
83939253|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83939254|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83939255|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83939256|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83939257|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83939258|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
83939259|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
83939260|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939261|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939262|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83939263|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83939264|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83939265|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
83939266|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939267|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939268|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83939269|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
83939270|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939271|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939272|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83939273|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83939274|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939275|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939276|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939277|NCT00528515|Propofol|propofol|mesh-list
83939278|NCT00528515|Desflurane|desflurane|mesh-list
83939279|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83939280|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939281|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939282|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83939283|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
83939284|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
83939285|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83939286|NCT02923986|Dasatinib|dasatinib|mesh-list
83939287|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939288|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83939289|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939290|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939291|NCT02926248|Colchicine|colchicine|mesh-list
83939292|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
83939293|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939294|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
83939295|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
83939296|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
83939297|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939298|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939299|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
83939300|NCT00528593|Hematinics|hematinics|mesh-ancestor
83178580|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939301|NCT02926326|Azithromycin|azithromycin|mesh-list
83939302|NCT02926326|Acumapimod|acumapimod|mesh-list
83939303|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939304|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939305|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83939306|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939307|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939308|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
83939309|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
83939310|NCT00528827|Nicardipine|nicardipine|mesh-list
83939311|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83939312|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83939313|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939314|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939315|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83939316|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939317|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
83939318|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
83939319|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83939320|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
83939321|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83939322|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
83939323|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939324|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939325|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
83939326|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83939327|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939328|NCT04691687|Furosemide|furosemide|mesh-list
83939329|NCT04691687|Diuretics|diuretics|mesh-ancestor
83939330|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
83939331|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939332|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83939333|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939334|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939335|NCT04107675|Cyclosporine|cyclosporine|mesh-list
83939336|NCT04107675|Cyclosporins|cyclosporins|mesh-list
83939337|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939338|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939339|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939340|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
83939341|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939342|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
83939343|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939344|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
83939345|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939346|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83939347|NCT02923869|Bupivacaine|bupivacaine|mesh-list
83939348|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
83939349|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
83939350|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
83939351|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939352|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939353|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
83939354|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939355|NCT02923791|Lenograstim|lenograstim|mesh-list
83939356|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83939357|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
83939358|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939359|NCT00527540|Interferons|interferons|mesh-list
83939360|NCT00527540|Ribavirin|ribavirin|mesh-list
83939361|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
83939362|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
83939363|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83939364|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939365|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
83939366|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939367|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
83939368|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939369|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
83939370|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939371|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
83939372|NCT02926053|Fludarabine|fludarabine|mesh-list
83939373|NCT02926053|Interleukin-2|interleukin-2|mesh-list
83939374|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939375|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
83939376|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178655|NCT02234362|Vortioxetine|vortioxetine|mesh-list
83939377|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939378|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83939379|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
83939380|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939381|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939382|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83939383|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83939385|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
83939386|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939387|NCT00527657|Thalidomide|thalidomide|mesh-list
83939388|NCT00527657|Temozolomide|temozolomide|mesh-list
83939389|NCT00527657|Lomustine|lomustine|mesh-list
83939390|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83939391|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
83939392|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939393|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939394|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939395|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
83939396|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939397|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
83939398|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939399|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939400|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83939401|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83939402|NCT00527657|Growth Substances|growth substances|mesh-ancestor
83939403|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
83939404|NCT00528983|Azacitidine|azacitidine|mesh-list
83939405|NCT00528983|Cc-486|cc-486|mesh-list
83939406|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83939407|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
83939408|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939409|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939410|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939411|NCT00529022|Carboplatin|carboplatin|mesh-list
83939412|NCT00529022|Azacitidine|azacitidine|mesh-list
83939413|NCT00529022|Valproic Acid|valproic acid|mesh-list
83939414|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939415|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83939416|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
83939417|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939418|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939419|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
83939420|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
83939421|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939422|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939423|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
83939424|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83939425|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939426|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83939427|NCT02923557|Pirarubicin|pirarubicin|mesh-list
83939428|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939429|NCT02925975|Carvedilol|carvedilol|mesh-list
83939430|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83939431|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83939432|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83939433|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939434|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939435|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939436|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83939437|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
83939438|NCT02925975|Protective Agents|protective agents|mesh-ancestor
83939439|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83939440|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939441|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83939442|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
83939443|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83939444|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83939445|NCT02945033|Aspirin|aspirin|mesh-list
83939446|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83939447|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83939448|NCT02945033|Analgesics|analgesics|mesh-ancestor
83939449|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
83939450|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939451|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939452|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939453|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939454|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83939455|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83939456|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939457|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83939458|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83939459|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939460|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
83939461|NCT04231968|Ziresovir|ziresovir|mesh-list
83939462|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
83939463|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939464|NCT00529295|Misoprostol|misoprostol|mesh-list
83939465|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83939466|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
83939467|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83939468|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939469|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83939470|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939471|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
83939472|NCT02922933|Entinostat|entinostat|mesh-list
83939473|NCT02922933|Omeprazole|omeprazole|mesh-list
83939474|NCT02922933|Famotidine|famotidine|mesh-list
83939475|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83939476|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939477|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83939478|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939479|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939480|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83939481|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
83939482|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
83939483|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939484|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939485|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939486|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83939487|NCT02945267|Tegafur|tegafur|mesh-list
83939488|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
83939489|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83939490|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
83939491|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939492|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939493|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83939494|NCT00529646|APD791|apd791|mesh-list
83939495|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83939496|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83939497|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
83939498|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939499|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939500|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939501|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
83939502|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939503|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
83939504|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83939505|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939506|NCT00529880|Cytarabine|cytarabine|mesh-list
83939507|NCT00529880|Fludarabine|fludarabine|mesh-list
83939508|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939509|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83939510|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
83939511|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939512|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939513|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
83939514|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939515|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
83939516|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939517|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83939518|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939519|NCT00531089|Rituximab|rituximab|mesh-list
83939520|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83939521|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939522|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
83939523|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939524|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939525|NCT02922699|Omeprazole|omeprazole|mesh-list
83939526|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83939527|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939528|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83178801|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83939529|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939530|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939531|NCT02922660|Remifentanil|remifentanil|mesh-list
83939532|NCT02922660|Anesthetics|anesthetics|mesh-list
83939533|NCT02922660|Propofol|propofol|mesh-list
83939534|NCT02922660|Desflurane|desflurane|mesh-list
83939535|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939536|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939537|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83939538|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83939539|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
83939540|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83939541|NCT02922660|Narcotics|narcotics|mesh-ancestor
83939542|NCT02922660|Analgesics|analgesics|mesh-ancestor
83939543|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
83939544|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939545|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83939546|NCT02922465|Clopidogrel|clopidogrel|mesh-list
83939547|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83939548|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83939549|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83939550|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83939551|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
83939552|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939553|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939554|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939555|NCT02944292|Propofol|propofol|mesh-list
83939556|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83939557|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939558|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939559|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83939560|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
83939561|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
83939562|NCT02922426|Olanzapine|olanzapine|mesh-list
83939563|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
83939564|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
83939565|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939566|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939567|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939568|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83939569|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83939570|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939571|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83939572|NCT02922426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83939573|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83939574|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939575|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939576|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939577|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
83939578|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
83939579|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83939580|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
83939581|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939582|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83939583|NCT02925351|Clofarabine|clofarabine|mesh-list
83939584|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83939585|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
83939586|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939587|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939588|NCT00531167|Lamivudine|lamivudine|mesh-list
83939589|NCT00531167|Adefovir|adefovir|mesh-list
83939590|NCT00531167|Entecavir|entecavir|mesh-list
83939591|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83939592|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83939593|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939594|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939595|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
83939596|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939597|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83939598|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83939599|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
83939600|NCT02944214|Febuxostat|febuxostat|mesh-list
83939601|NCT02944214|Benzbromarone|benzbromarone|mesh-list
83939602|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
83939603|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939604|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
83939605|NCT02922075|Amoxicillin|amoxicillin|mesh-list
83939606|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
83939607|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939608|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939609|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83939610|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
83939611|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
83939612|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939613|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83939614|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83939615|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83939616|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
83939617|NCT02922348|Norgestimate|norgestimate|mesh-list
83939618|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
83939619|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
83939620|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83939621|NCT02922348|Hormones|hormones|mesh-list
83939622|NCT02922348|Estradiol|estradiol|mesh-list
83939623|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83939624|NCT02922348|Progestins|progestins|mesh-list
83939625|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939626|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939627|NCT02922348|Estrogens|estrogens|mesh-ancestor
83939628|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83939629|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83939630|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83939631|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83939632|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83939633|NCT00527501|Travoprost|travoprost|mesh-list
83939634|NCT00527501|Brinzolamide|brinzolamide|mesh-list
83939635|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83939636|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83939637|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939638|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939639|NCT02922387|Varenicline|varenicline|mesh-list
83939640|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83939641|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83939642|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
83939643|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939644|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939645|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939646|NCT00531323|Etravirine|etravirine|mesh-list
83939647|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83939648|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83939649|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939650|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939651|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
83939652|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939653|NCT00531362|Aspirin|aspirin|mesh-list
83939654|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83939655|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83939656|NCT00531362|Analgesics|analgesics|mesh-ancestor
83939657|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
83939658|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939659|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939660|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939661|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939662|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83939663|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83939664|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939665|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83939666|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83939667|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939668|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
83939669|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
83939670|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939671|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939672|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939673|NCT00531440|Everolimus|everolimus|mesh-list
83939674|NCT00531440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83939675|NCT00531440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83939676|NCT00531440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939677|NCT00531440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939678|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939679|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
83939680|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939681|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939682|NCT02944526|Ropivacaine|ropivacaine|mesh-list
83939683|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
83939684|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
83939685|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939686|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939687|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
83939688|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939689|NCT04000854|Calcium|calcium|mesh-list
83939690|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83939691|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939692|NCT00530387|Ibuprofen|ibuprofen|mesh-list
83939693|NCT00530387|Diclofenac|diclofenac|mesh-list
83939694|NCT00530387|Ketoprofen|ketoprofen|mesh-list
83939695|NCT00530387|Piroxicam|piroxicam|mesh-list
83939696|NCT00530387|Salicylates|salicylates|mesh-list
83939697|NCT00530387|Etofenamate|etofenamate|mesh-list
83939698|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
83939699|NCT00530387|Homosalate|homosalate|mesh-list
83939700|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
83939701|NCT00530387|Benzophenone|benzophenone|mesh-list
83939702|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83939703|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83939704|NCT00530387|Analgesics|analgesics|mesh-ancestor
83939705|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
83939706|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939707|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939708|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939709|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939710|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83939711|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939712|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939713|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83939714|NCT00530387|Protective Agents|protective agents|mesh-ancestor
83939715|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
83939716|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83939717|NCT04689165|Vaccines|vaccines|mesh-list
83939718|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
83939719|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939720|NCT00530582|Progesterone|progesterone|mesh-list
83939721|NCT00530582|Progestins|progestins|mesh-ancestor
83939722|NCT00530582|Hormones|hormones|mesh-ancestor
83939723|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939724|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939725|NCT02944175|Neostigmine|neostigmine|mesh-list
83939726|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83152276|NCT02176759|Citric Acid|citric acid|mesh-list
83939727|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939728|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939729|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
83939730|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939731|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939732|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83939733|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
83939734|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939735|NCT02917746|Imiquimod|imiquimod|mesh-list
83939736|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83939737|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
83939738|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939739|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939740|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
83939741|NCT00531557|Ritonavir|ritonavir|mesh-list
83939742|NCT00531557|Darunavir|darunavir|mesh-list
83939743|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83939744|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83939745|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
83939746|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939747|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939748|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83939749|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83939750|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
83939751|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939752|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83939753|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83939754|NCT00531596|Selegiline|selegiline|mesh-list
83179030|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
83939755|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
83939756|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83939757|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83939758|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83939759|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83939761|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939762|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83939763|NCT00531596|Protective Agents|protective agents|mesh-ancestor
83939764|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939765|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83939766|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83939767|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939768|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
83939769|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83939770|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939771|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83939772|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
83939773|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939774|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939775|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939776|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939777|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83939778|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83939779|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939780|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
83939781|NCT00531674|Tocopherols|tocopherols|mesh-list
83939782|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
83939783|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939784|NCT00531674|Protective Agents|protective agents|mesh-ancestor
83939785|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939786|NCT00531674|Vitamins|vitamins|mesh-ancestor
83939787|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
83939788|NCT00530972|Ribavirin|ribavirin|mesh-list
83939789|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83939790|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
83939791|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939792|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
83939793|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939794|NCT02943317|Avelumab|avelumab|mesh-list
83939795|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83939796|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939797|NCT02943356|Tadalafil|tadalafil|mesh-list
83939798|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
83939799|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83939800|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83939801|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939802|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939803|NCT02943356|Urological Agents|urological agents|mesh-ancestor
83939804|NCT02917512|Cyclosporine|cyclosporine|mesh-list
83939805|NCT02917512|Cyclosporins|cyclosporins|mesh-list
83939806|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939807|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939808|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939809|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
83939810|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939811|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
83939812|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939813|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
83939814|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939815|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83939816|NCT02943902|Vaccines|vaccines|mesh-list
83939817|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83939818|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
83939819|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939820|NCT00531908|Furosemide|furosemide|mesh-list
83939821|NCT00531908|Diuretics|diuretics|mesh-ancestor
83939822|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
83939823|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939824|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83939825|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939826|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939827|NCT03403569|Triptolide|triptolide|mesh-list
83939828|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83939829|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939830|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83939831|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
83939832|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83939833|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83939834|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
83939835|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83939836|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
83939837|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939838|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939840|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939841|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
83939842|NCT00531791|Hormones|hormones|mesh-ancestor
83939843|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939844|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939845|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83939846|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939847|NCT02921178|Omalizumab|omalizumab|mesh-list
83939848|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83939849|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83939850|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
83939851|NCT00531986|Lopinavir|lopinavir|mesh-list
83939852|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83939853|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83939854|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
83939855|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939856|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939857|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83939858|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83939859|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
83939860|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939861|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83939862|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83939863|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83939864|NCT05319899|Choline|choline|mesh-list
83939865|NCT05319899|Omeprazole|omeprazole|mesh-list
83939866|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83939867|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939868|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83939869|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939870|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939871|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
83939872|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83939873|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
83939874|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83939875|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
83939876|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
83939877|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
83939878|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83939879|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83939880|NCT05319899|Growth Substances|growth substances|mesh-ancestor
83939881|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939882|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
83939883|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939884|NCT02920827|Dapivirine|dapivirine|mesh-list
83939885|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83939886|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83939887|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
83939888|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939889|NCT02920905|Lidocaine|lidocaine|mesh-list
83939890|NCT02920905|Atracurium|atracurium|mesh-list
83939891|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
83939892|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
83939893|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83939894|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939895|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
83939896|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939897|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83939898|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83939899|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83939900|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83939901|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939902|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83939903|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83939904|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83939905|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83939906|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83939907|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
83939908|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939909|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
83939910|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939911|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939912|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83939913|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83939914|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939915|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939916|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939917|NCT02920515|Leuprolide|leuprolide|mesh-list
83939918|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83939919|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
83939920|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83939921|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939922|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83939923|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939924|NCT02917005|Palbociclib|palbociclib|mesh-list
83939925|NCT02917005|Exemestane|exemestane|mesh-list
83939926|NCT02917005|Goserelin|goserelin|mesh-list
83939927|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939928|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83939929|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939930|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939931|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83939932|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83939933|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83939934|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
83939935|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939936|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939937|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83939938|NCT02942810|Cefepime|cefepime|mesh-list
83939939|NCT02942810|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
83939940|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83939941|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83939942|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83939943|NCT02920710|Hormones|hormones|mesh-ancestor
83939944|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83939945|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939946|NCT02941913|Palonosetron|palonosetron|mesh-list
83939947|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
83939948|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
83939949|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939950|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939951|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83939952|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83939953|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83939954|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
83939955|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83939956|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939957|NCT02942693|Apatinib|apatinib|mesh-list
83939958|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939959|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83939960|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83939961|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939962|NCT02920593|Vitamin D|vitamin d|mesh-list
83939963|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
83939964|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
83939965|NCT02920593|Vitamins|vitamins|mesh-list
83939966|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
83939967|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939968|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83939969|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83939970|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
83939971|NCT02942732|Vitamin D|vitamin d|mesh-list
83939972|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83939973|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939974|NCT02942732|Vitamins|vitamins|mesh-ancestor
83939975|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
83939976|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83939977|NCT02942420|Bucillamine|bucillamine|mesh-list
83939978|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83939979|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83939980|NCT02942420|Analgesics|analgesics|mesh-ancestor
83939981|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
83939982|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83939983|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939984|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83939985|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83939986|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
83939987|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83939988|NCT02942420|Protective Agents|protective agents|mesh-ancestor
83939989|NCT02920359|Leuprolide|leuprolide|mesh-list
83939990|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83939991|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
83939992|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83939993|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83939994|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83939995|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83939996|NCT02916654|Iron|iron|mesh-list
83939997|NCT02916654|Trace Elements|trace elements|mesh-ancestor
83939998|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
83939999|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940000|NCT02941562|Leucovorin|leucovorin|mesh-list
83940001|NCT02941562|Fluorouracil|fluorouracil|mesh-list
83940002|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
83940003|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
83940004|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940005|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83940006|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940007|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83940008|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
83940009|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940010|NCT02941562|Antidotes|antidotes|mesh-ancestor
83940011|NCT02941562|Protective Agents|protective agents|mesh-ancestor
83940012|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
83940013|NCT02941562|Vitamins|vitamins|mesh-ancestor
83940014|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
83940015|NCT02942888|Niacinamide|niacinamide|mesh-list
83940016|NCT02942888|Niacin|niacin|mesh-list
83940017|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
83940018|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
83940019|NCT02942888|Vitamins|vitamins|mesh-ancestor
83940020|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
83940021|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940022|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83940023|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
83940024|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940025|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83940026|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
83940027|NCT02916420|Dexamethasone|dexamethasone|mesh-list
83940028|NCT02916420|Pomalidomide|pomalidomide|mesh-list
83940029|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940030|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
83940031|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
83940032|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940033|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940034|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940035|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
83940036|NCT02916420|Hormones|hormones|mesh-ancestor
83940037|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940038|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83940039|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940040|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
83940041|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83940042|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83940043|NCT02916420|Growth Substances|growth substances|mesh-ancestor
83940044|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
83940045|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
83940046|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
83940047|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83940048|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83940049|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940050|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940051|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940052|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940053|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
83940054|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83940055|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83940056|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940057|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
83940058|NCT03458468|Coagulants|coagulants|mesh-ancestor
83940059|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83940060|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83940061|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83940062|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940063|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
83940064|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940065|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940067|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940068|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940069|NCT02920047|Amlodipine|amlodipine|mesh-list
83940070|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83940071|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83940072|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83940073|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940074|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83940075|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940076|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
83940077|NCT02941016|Evolocumab|evolocumab|mesh-list
83940078|NCT02941016|Alirocumab|alirocumab|mesh-list
83940079|NCT02941016|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83940080|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83940081|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83940082|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
83940083|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940084|NCT02941016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83940085|NCT02941016|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940086|NCT02941016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940087|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83940088|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
83940089|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940090|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83940091|NCT02941445|Metformin|metformin|mesh-list
83940092|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83940093|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83940094|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940095|NCT02941445|Incretins|incretins|mesh-ancestor
83940096|NCT02941445|Hormones|hormones|mesh-ancestor
83940097|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940098|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83940099|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940100|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940101|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940102|NCT02919501|Vortioxetine|vortioxetine|mesh-list
83940103|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
83940104|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83940105|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83940106|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83940107|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940108|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940109|NCT02919501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83940110|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83940111|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83940112|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940113|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940114|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
83940115|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83940116|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83940117|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83940118|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83940119|NCT02919579|Esketamine|esketamine|mesh-list
83940120|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
83940121|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83940122|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83940123|NCT02940821|Fluorides|fluorides|mesh-list
83940124|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
83940125|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
83940126|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
83940127|NCT02940821|Protective Agents|protective agents|mesh-ancestor
83940128|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940129|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83940130|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940131|NCT02941601|Carboplatin|carboplatin|mesh-list
83940132|NCT02941601|Gemcitabine|gemcitabine|mesh-list
83940133|NCT02941601|Necitumumab|necitumumab|mesh-list
83940134|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940135|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83940136|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
83940137|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940138|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940140|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83940141|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940142|NCT02919462|Cisplatin|cisplatin|mesh-list
83940143|NCT02919462|Pemetrexed|pemetrexed|mesh-list
83940144|NCT02919462|Vinorelbine|vinorelbine|mesh-list
83940145|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940146|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940147|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940148|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83940149|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83940150|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83940151|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83940152|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83940153|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83940154|NCT02941367|Metformin|metformin|mesh-list
83940155|NCT02941367|Lixisenatide|lixisenatide|mesh-list
83940156|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83940157|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940158|NCT03153150|Warfarin|warfarin|mesh-list
83940159|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
83940160|NCT03153150|Dabigatran|dabigatran|mesh-list
83940161|NCT03153150|Apixaban|apixaban|mesh-list
83940162|NCT03153150|Edoxaban|edoxaban|mesh-list
83940163|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
83940164|NCT03153150|Phenindione|phenindione|mesh-list
83940165|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
83940166|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83940167|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
83940168|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83940169|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940170|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940171|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940172|NCT02916147|Propofol|propofol|mesh-list
83940173|NCT02916147|Sevoflurane|sevoflurane|mesh-list
83940174|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83940175|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940176|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940177|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83940178|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
83940179|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
83940180|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83940181|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83940182|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
83940183|NCT05302388|Promethazine|promethazine|mesh-list
83940184|NCT05302388|Dexamethasone|dexamethasone|mesh-list
83940185|NCT05302388|Prednisolone|prednisolone|mesh-list
83940186|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83940187|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
83940188|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83940189|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
83940190|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83940191|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
83940192|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940193|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
83940194|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
83940195|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940196|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940197|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940198|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
83940199|NCT05302388|Hormones|hormones|mesh-ancestor
83940200|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940201|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83940202|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940203|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83940204|NCT05302388|Protective Agents|protective agents|mesh-ancestor
83940205|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83940206|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83940207|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940208|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
83940209|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
83940210|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
83940211|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83940212|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
83940213|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
83940214|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940215|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940216|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83940217|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
83940218|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
83940219|NCT02919072|Ropivacaine|ropivacaine|mesh-list
83940220|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
83940221|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
83940222|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
83940223|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940224|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940225|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
83940226|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940227|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83940228|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83940229|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940230|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940231|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
83940232|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940233|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940234|NCT02915796|Lenograstim|lenograstim|mesh-list
83940235|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83940236|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
83940237|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940238|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
83940239|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83940240|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940241|NCT02277041|Misoprostol|misoprostol|mesh-list
83940242|NCT02277041|Carbetocin|carbetocin|mesh-list
83940243|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83940244|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
83940245|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83940246|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940247|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83940248|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940249|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
83940250|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
83940251|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83940252|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
83940253|NCT02915289|Povidone|povidone|mesh-list
83940254|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83940255|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940256|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
83940257|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
83940258|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
83940259|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
83940260|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
83940261|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83940262|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940263|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
83940264|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940265|NCT02939417|Protective Agents|protective agents|mesh-ancestor
83940266|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940267|NCT05034536|Infliximab|infliximab|mesh-list
83940268|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
83940269|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940270|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940271|NCT05034536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83940272|NCT05034536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940273|NCT05034536|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83940274|NCT05034536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940275|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
83940276|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940277|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940278|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83940279|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940280|NCT02915172|Capecitabine|capecitabine|mesh-list
83940281|NCT02915172|Lenvatinib|lenvatinib|mesh-list
83940282|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83940283|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
83940284|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940285|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940286|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83940287|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940288|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
83940289|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83940290|NCT02938988|Methylene Blue|methylene blue|mesh-list
83940291|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940292|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940293|NCT02915055|Acetaminophen|acetaminophen|mesh-list
83940294|NCT02915055|Ibuprofen|ibuprofen|mesh-list
83940295|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83940296|NCT02915055|Oxycodone|oxycodone|mesh-list
83940297|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83940298|NCT02915055|Analgesics|analgesics|mesh-ancestor
83940299|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
83940300|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940301|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940302|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
83940303|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83940304|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940305|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940306|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83940307|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940308|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940309|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83940310|NCT02915055|Narcotics|narcotics|mesh-ancestor
83940311|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940312|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
83940313|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940314|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940315|NCT01295827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83940316|NCT01295827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940317|NCT02918760|Gabapentin|gabapentin|mesh-list
83940318|NCT02918760|Analgesics|analgesics|mesh-ancestor
83940319|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
83940320|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940321|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940322|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
83940323|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83940324|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83940325|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940326|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83940327|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83940328|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83940329|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940330|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940331|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
83940332|NCT04690751|Cenobamate|cenobamate|mesh-list
83940333|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
83940334|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
83940335|NCT03458078|Midazolam|midazolam|mesh-list
83940336|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83940337|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83940338|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940339|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940340|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83940341|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83940342|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83940343|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83940344|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
83940345|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
83940346|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
83940347|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
83940348|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940349|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940350|NCT03458078|Analgesics|analgesics|mesh-ancestor
83940351|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
83940352|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940353|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83940354|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
83940355|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83940356|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83940357|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83940358|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
83940359|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83940360|NCT04690556|Ranibizumab|ranibizumab|mesh-list
83940361|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83940362|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83179635|NCT02813655|Hormones|hormones|mesh-ancestor
83940363|NCT04690556|Growth Substances|growth substances|mesh-ancestor
83940364|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940365|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
83940366|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940367|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83940368|NCT01294579|Ofatumumab|ofatumumab|mesh-list
83940369|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83940370|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
83940371|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940372|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940373|NCT02914626|Ranibizumab|ranibizumab|mesh-list
83940374|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83940375|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83940376|NCT02914626|Growth Substances|growth substances|mesh-ancestor
83940377|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940378|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
83940379|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940380|NCT02918331|Dexamethasone|dexamethasone|mesh-list
83940381|NCT02918331|Lenalidomide|lenalidomide|mesh-list
83940382|NCT02918331|Daratumumab|daratumumab|mesh-list
83940383|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940384|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
83940385|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
83940386|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940387|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940388|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940389|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
83940390|NCT02918331|Hormones|hormones|mesh-ancestor
83940391|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940392|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83940393|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940394|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
83940395|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83940396|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83940397|NCT02918331|Growth Substances|growth substances|mesh-ancestor
83940398|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
83940399|NCT02918136|Cortisone|cortisone|mesh-list
83940400|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940401|NCT01294462|Aspirin|aspirin|mesh-list
83940402|NCT01294462|Clopidogrel|clopidogrel|mesh-list
83940403|NCT01294462|Ticagrelor|ticagrelor|mesh-list
83940404|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83940405|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83940406|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83940407|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83940408|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
83940409|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940410|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940411|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940412|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83940413|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83940414|NCT01294462|Analgesics|analgesics|mesh-ancestor
83940415|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
83940416|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940417|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940418|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940419|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83940420|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83940421|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83940422|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940423|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
83940424|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
83940425|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83940426|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940427|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83940428|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940429|NCT02910570|Liraglutide|liraglutide|mesh-list
83940430|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83940431|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940432|NCT02910570|Incretins|incretins|mesh-ancestor
83940433|NCT02910570|Hormones|hormones|mesh-ancestor
83940434|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940435|NCT03077685|Paclitaxel|paclitaxel|mesh-list
83940436|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83940437|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940438|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
83940439|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
83940440|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
83940441|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940442|NCT02910141|Insulin|insulin|mesh-list
83940443|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83940444|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83940445|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940446|NCT04817033|Midazolam|midazolam|mesh-list
83940447|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
83940448|NCT04817033|Anesthetics|anesthetics|mesh-list
83940449|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940450|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940451|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83940452|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83940453|NCT04817033|Analgesics|analgesics|mesh-ancestor
83940454|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
83940455|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940456|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83940457|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83940458|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83940459|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83940460|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940461|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940462|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83940463|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83940464|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83940465|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83940466|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83940467|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
83940468|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
83940469|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
83940470|NCT01292473|Omalizumab|omalizumab|mesh-list
83940471|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83940472|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83940473|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
83940474|NCT02938286|Epinephrine|epinephrine|mesh-list
83940475|NCT02938286|Carticaine|carticaine|mesh-list
83940476|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83940477|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83940478|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
83940479|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940480|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940481|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940482|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83940483|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83940484|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
83940485|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940486|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83940487|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
83940488|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
83940489|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
83940490|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83940491|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
83940492|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
83940493|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940494|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
83940495|NCT01292239|Ribavirin|ribavirin|mesh-list
83940496|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83940497|NCT01292239|Simeprevir|simeprevir|mesh-list
83940498|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
83940499|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940500|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
83940501|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940502|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940503|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940504|NCT05600179|Dexamethasone|dexamethasone|mesh-list
83940505|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940506|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
83940507|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
83940508|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940509|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940510|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940511|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
83940512|NCT05600179|Hormones|hormones|mesh-ancestor
83940513|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940514|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83940515|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940516|NCT02937662|Cytarabine|cytarabine|mesh-list
83940517|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
83940518|NCT02937662|Idarubicin|idarubicin|mesh-list
83940519|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83940520|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
83940521|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940522|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940523|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83940524|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
83940525|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940526|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940527|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83940528|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83940529|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
83940530|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
83940531|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940532|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83940533|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83940534|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83940535|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940536|NCT01290757|Dabigatran|dabigatran|mesh-list
83940537|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
83940538|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83940539|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940540|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940541|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940542|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
83940543|NCT02937857|Antipyretics|antipyretics|mesh-list
83940544|NCT02937857|Expectorants|expectorants|mesh-list
83940545|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
83940546|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940547|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
83940548|NCT04324060|Danazol|danazol|mesh-list
83940549|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83940550|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
83940551|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940552|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940553|NCT01290718|Capecitabine|capecitabine|mesh-list
83940554|NCT01290718|Trastuzumab|trastuzumab|mesh-list
83940555|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83940556|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
83940557|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940558|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940559|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940560|NCT04324294|Pancrelipase|pancrelipase|mesh-list
83940561|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940562|NCT02937896|Ketorolac|ketorolac|mesh-list
83940563|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83940564|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83940565|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83940566|NCT02937896|Analgesics|analgesics|mesh-ancestor
83940567|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
83940568|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940569|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940570|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940571|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940572|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83940573|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940574|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940575|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
83940576|NCT02937896|Coagulants|coagulants|mesh-ancestor
83940577|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83940578|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
83940579|NCT04688151|Rituximab|rituximab|mesh-list
83940580|NCT04688151|Durvalumab|durvalumab|mesh-list
83940581|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
83940582|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940583|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940584|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
83940585|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940586|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940587|NCT02937779|Tenofovir|tenofovir|mesh-list
83940588|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
83940589|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179853|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
83940590|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83940591|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83940592|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940593|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940594|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83940595|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83940596|NCT01290679|Ribavirin|ribavirin|mesh-list
83940597|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83940598|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83940599|NCT01290679|Simeprevir|simeprevir|mesh-list
83940600|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
83940601|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940602|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
83940603|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940604|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940605|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940606|NCT03457389|Cabergoline|cabergoline|mesh-list
83940607|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83940608|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83940609|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
83940610|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
83940611|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940612|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940613|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940614|NCT02890186|Remifentanil|remifentanil|mesh-list
83940615|NCT02890186|Propofol|propofol|mesh-list
83940616|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83940617|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940618|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940619|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83940620|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
83940621|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
83940622|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83940623|NCT02890186|Narcotics|narcotics|mesh-ancestor
83940624|NCT02890186|Analgesics|analgesics|mesh-ancestor
83940625|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
83940626|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940627|NCT02909751|Tocotrienols|tocotrienols|mesh-list
83940628|NCT02909751|Vitamin E|vitamin e|mesh-list
83940629|NCT02909751|Tocopherols|tocopherols|mesh-list
83940630|NCT02909751|Docetaxel|docetaxel|mesh-list
83940631|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
83940632|NCT02909751|Trastuzumab|trastuzumab|mesh-list
83940633|NCT02909751|Epirubicin|epirubicin|mesh-list
83940634|NCT02909751|Pertuzumab|pertuzumab|mesh-list
83940635|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940636|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83940637|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83940638|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83940639|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940640|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83940641|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
83940642|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940643|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940644|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83940645|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
83940646|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83940647|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940648|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83940649|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83940650|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83940651|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940652|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
83940653|NCT02909751|Protective Agents|protective agents|mesh-ancestor
83940654|NCT02909751|Vitamins|vitamins|mesh-ancestor
83940655|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
83940656|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
83940657|NCT02909712|Piperaquine|piperaquine|mesh-list
83940658|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
83940659|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83940660|NCT02909712|Artenimol|artenimol|mesh-list
83940661|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
83940662|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83940663|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83179929|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940664|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940665|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83940666|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940667|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940668|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83940669|NCT02913885|Fluorides|fluorides|mesh-list
83940670|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
83940671|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
83940672|NCT02913885|Protective Agents|protective agents|mesh-ancestor
83940673|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940674|NCT01290601|Chloroquine|chloroquine|mesh-list
83940675|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83940676|NCT01290601|Primaquine|primaquine|mesh-list
83940677|NCT01290601|Tafenoquine|tafenoquine|mesh-list
83940678|NCT01290601|Amebicides|amebicides|mesh-ancestor
83940679|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83940680|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83940681|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940682|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
83940683|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940684|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83940685|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83940686|NCT01290601|Analgesics|analgesics|mesh-ancestor
83940687|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
83940688|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940689|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940690|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940691|NCT01290601|Filaricides|filaricides|mesh-ancestor
83940692|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
83940693|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
83940694|NCT02978391|Epinephrine|epinephrine|mesh-list
83940695|NCT02978391|Hemostatics|hemostatics|mesh-list
83940696|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83940697|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83940698|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83940699|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940700|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940701|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940702|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83940703|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83940704|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
83940705|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940706|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83940707|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
83940708|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
83940709|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
83940710|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83940711|NCT02978391|Coagulants|coagulants|mesh-ancestor
83940712|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
83940713|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83940714|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940715|NCT04688346|Epinephrine|epinephrine|mesh-list
83940716|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83940717|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83940718|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
83940719|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940720|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940721|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940722|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83940723|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83940724|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
83940725|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940726|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83940727|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
83940728|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
83940729|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
83940730|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83940731|NCT01289821|Leucovorin|leucovorin|mesh-list
83940732|NCT01289821|Folic Acid|folic acid|mesh-list
83940733|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
83940734|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
83940735|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940736|NCT01289821|Antidotes|antidotes|mesh-ancestor
83940737|NCT01289821|Protective Agents|protective agents|mesh-ancestor
83940738|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940739|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
83940740|NCT01289821|Vitamins|vitamins|mesh-ancestor
83940741|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
83940742|NCT01289821|Hematinics|hematinics|mesh-ancestor
83940743|NCT02913768|Ondansetron|ondansetron|mesh-list
83940744|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
83180029|NCT04936399|Nivolumab|nivolumab|mesh-list
83940745|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
83940746|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940747|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940748|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940749|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
83940750|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
83940751|NCT02913768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83940752|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83940753|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
83940754|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940755|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940756|NCT01289782|Ribavirin|ribavirin|mesh-list
83940757|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83940758|NCT01289782|Simeprevir|simeprevir|mesh-list
83940759|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
83940760|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940761|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
83940762|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940763|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940764|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940765|NCT02913417|Nivolumab|nivolumab|mesh-list
83940766|NCT02913417|Ipilimumab|ipilimumab|mesh-list
83940767|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940768|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940769|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83940770|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940771|NCT02936492|Clobetasol|clobetasol|mesh-list
83940772|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940773|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
83940774|NCT02936492|Hormones|hormones|mesh-ancestor
83940775|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940776|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940777|NCT02913573|Bupivacaine|bupivacaine|mesh-list
83940778|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
83940779|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
83940780|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940781|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940782|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
83940783|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940784|NCT01289353|Carboplatin|carboplatin|mesh-list
83940785|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940786|NCT02913300|Lidocaine|lidocaine|mesh-list
83940787|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83940788|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
83940789|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
83940790|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940791|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940792|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
83940793|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940794|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83940795|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83940796|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83940797|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83940798|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940799|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
83940800|NCT02936375|Azathioprine|azathioprine|mesh-list
83940801|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83940802|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
83940803|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940804|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940805|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83940806|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
83940807|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940808|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940809|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83940810|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
83940811|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83940812|NCT02913690|Vitamin E|vitamin e|mesh-list
83940813|NCT02913690|Vitamins|vitamins|mesh-ancestor
83940814|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
83940815|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940816|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
83940817|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940818|NCT02913690|Protective Agents|protective agents|mesh-ancestor
83940819|NCT01289119|Metformin|metformin|mesh-list
83940820|NCT01289119|Pioglitazone|pioglitazone|mesh-list
83940821|NCT01289119|Alogliptin|alogliptin|mesh-list
83940822|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83940823|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940824|NCT01289119|Incretins|incretins|mesh-ancestor
83940825|NCT01289119|Hormones|hormones|mesh-ancestor
83940826|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83940827|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83940828|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940829|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940830|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940831|NCT01287832|Vancomycin|vancomycin|mesh-list
83940832|NCT01287832|Daptomycin|daptomycin|mesh-list
83940833|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83940834|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940835|NCT02913066|Cisplatin|cisplatin|mesh-list
83940836|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940837|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83940838|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940839|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83940840|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940841|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940842|NCT02912793|Betadex|betadex|mesh-list
83940843|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
83940844|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940845|NCT02935751|Apixaban|apixaban|mesh-list
83940846|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83940847|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
83940848|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83940849|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
83940850|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940851|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940852|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
83940853|NCT02935790|Nivolumab|nivolumab|mesh-list
83940854|NCT02935790|Ipilimumab|ipilimumab|mesh-list
83940855|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83940856|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940857|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83940858|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940859|NCT02912637|Xenon|xenon|mesh-list
83940860|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83940861|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
83940862|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
83940863|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940864|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940865|NCT02912910|Labetalol|labetalol|mesh-list
83940866|NCT02912910|Nifedipine|nifedipine|mesh-list
83940867|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83940868|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83940869|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940870|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83940871|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940872|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
83940873|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
83940874|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83940875|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83940876|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83940877|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
83940878|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940879|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83940880|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
83940881|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
83940882|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940883|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83940884|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83940885|NCT02935829|Locust bean gum|locust bean gum|mesh-list
83940886|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
83940887|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940888|NCT02912676|Methotrexate|methotrexate|mesh-list
83940889|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
83940890|NCT02912676|Thioguanine|thioguanine|mesh-list
83940891|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83940892|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
83940893|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83940894|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940895|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83940896|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
83940897|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940898|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940899|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
83940900|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940901|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83940902|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83940903|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
83940904|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940905|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83940906|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
83940907|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83940908|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83940909|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940910|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
83940911|NCT02935985|Coagulants|coagulants|mesh-ancestor
83940912|NCT02912169|Anesthetics|anesthetics|mesh-list
83940913|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940914|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940915|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83940916|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940917|NCT02935959|Midazolam|midazolam|mesh-list
83940918|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
83940919|NCT02935959|Ketamine|ketamine|mesh-list
83940920|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83940921|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940922|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940923|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83940924|NCT02935959|Analgesics|analgesics|mesh-ancestor
83940925|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
83940926|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83940927|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83940928|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83940929|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83940930|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83940931|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83940932|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940933|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83940934|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83940935|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
83940936|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
83940937|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83940938|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83940939|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83940940|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83940941|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83940942|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83940943|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
83940944|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
83940945|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
83940946|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83940947|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83940948|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940949|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
83940950|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
83940951|NCT02935647|Propofol|propofol|mesh-list
83940952|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83940953|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83940954|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940955|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83940956|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
83940957|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
83940958|NCT02912247|Adalimumab|adalimumab|mesh-list
83940959|NCT02912247|Antibodies|antibodies|mesh-list
83940960|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83940961|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
83940962|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940963|NCT02912247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83940964|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83940965|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83940966|NCT02935010|Amoxicillin|amoxicillin|mesh-list
83940967|NCT02935010|Metronidazole|metronidazole|mesh-list
83940968|NCT02935010|Clarithromycin|clarithromycin|mesh-list
83940969|NCT02935010|Levofloxacin|levofloxacin|mesh-list
83940970|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
83940971|NCT02935010|Esomeprazole|esomeprazole|mesh-list
83940972|NCT02935010|Bismuth|bismuth|mesh-list
83940973|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83940974|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83940975|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83940976|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83940977|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83940978|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83940979|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83940980|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83940981|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83940982|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83940983|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83940984|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83940985|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83940986|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83940987|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83940988|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83940989|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83940990|NCT02935010|Antacids|antacids|mesh-ancestor
83940991|NCT02935010|Diuretics|diuretics|mesh-ancestor
83940992|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
83940993|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83940994|NCT02935010|Expectorants|expectorants|mesh-ancestor
83940995|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
83940996|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83940997|NCT02935530|Tinzaparin|tinzaparin|mesh-list
83940998|NCT02935530|Dalteparin|dalteparin|mesh-list
83940999|NCT02935530|Argatroban|argatroban|mesh-list
83941000|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
83941001|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83941002|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83941003|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941004|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
83941005|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83941006|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
83941007|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941008|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83941009|NCT02934464|Leucovorin|leucovorin|mesh-list
83941010|NCT02934464|Paclitaxel|paclitaxel|mesh-list
83941011|NCT02934464|Ramucirumab|ramucirumab|mesh-list
83941012|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
83941013|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
83941014|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83941015|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941016|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
83941017|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
83941018|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
83941019|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941020|NCT02934464|Antidotes|antidotes|mesh-ancestor
83941021|NCT02934464|Protective Agents|protective agents|mesh-ancestor
83941022|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941023|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
83941024|NCT02934464|Vitamins|vitamins|mesh-ancestor
83941025|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
83941026|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83941027|NCT02934035|Fluoxetine|fluoxetine|mesh-list
83941028|NCT02934035|Paroxetine|paroxetine|mesh-list
83941029|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83941030|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
83941031|NCT02934035|Escitalopram|escitalopram|mesh-list
83941032|NCT02934035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83941033|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83941034|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941035|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941036|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941037|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
83941038|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941039|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941040|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83941041|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83941042|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83941043|NCT02934035|Analgesics|analgesics|mesh-ancestor
83941044|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
83941045|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
83941046|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83941047|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83941048|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941049|NCT02934152|Amoxicillin|amoxicillin|mesh-list
83941050|NCT02934152|Clarithromycin|clarithromycin|mesh-list
83941051|NCT02934152|Rabeprazole|rabeprazole|mesh-list
83941052|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83941053|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941054|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83941055|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941056|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941057|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83941058|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83941059|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83941060|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941061|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83941062|NCT02935335|Menotropins|menotropins|mesh-list
83941063|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83941064|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
83941065|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83941066|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941067|NCT02911662|Cephalexin|cephalexin|mesh-list
83941068|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
83941069|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83941070|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941071|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83941072|NCT02935101|Prednisolone|prednisolone|mesh-list
83941073|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83941074|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
83941075|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83941076|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
83941077|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83941078|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
83941079|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941080|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
83941081|NCT02935101|Hormones|hormones|mesh-ancestor
83941082|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941083|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941084|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83941085|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941086|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
83941087|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
83941088|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941089|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941090|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83941091|NCT02935101|Protective Agents|protective agents|mesh-ancestor
83941092|NCT04689971|Vitamins|vitamins|mesh-list
83941093|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
83941094|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
83941095|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941096|NCT02934945|Budesonide|budesonide|mesh-list
83941097|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
83941098|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941099|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83941100|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
83941101|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941102|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941103|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83941104|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
83941105|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
83941106|NCT02934945|Hormones|hormones|mesh-ancestor
83941107|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941108|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83941109|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83941110|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83941111|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
83941112|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941113|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941114|NCT02933645|Insulin|insulin|mesh-list
83941115|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83941116|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83941117|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941118|NCT02911701|Acetaminophen|acetaminophen|mesh-list
83941119|NCT02911701|Ibuprofen|ibuprofen|mesh-list
83941120|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941121|NCT02911701|Analgesics|analgesics|mesh-ancestor
83941122|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
83941123|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941124|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941125|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
83941126|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83941127|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941128|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83180372|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
83941129|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83941130|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941131|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941132|NCT02933684|Cycloserine|cycloserine|mesh-list
83941133|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83941134|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941135|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83941136|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
83941137|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83941138|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
83941139|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941140|NCT02933333|Molgramostim|molgramostim|mesh-list
83941141|NCT02933333|Lenograstim|lenograstim|mesh-list
83941142|NCT02933333|Sargramostim|sargramostim|mesh-list
83941143|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83941144|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
83941145|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941146|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941147|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
83941148|NCT02670252|Busulfan|busulfan|mesh-list
83941149|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941150|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
83941151|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941152|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941153|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83941154|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
83941155|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941156|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941157|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83941158|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
83941159|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
83941160|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83941161|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83941162|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941163|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83941164|NCT02933099|Dexamethasone|dexamethasone|mesh-list
83941165|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
83941166|NCT02933099|Aprepitant|aprepitant|mesh-list
83941167|NCT02933099|Palonosetron|palonosetron|mesh-list
83941168|NCT02933099|BB 1101|bb 1101|mesh-list
83941169|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941170|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
83941171|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
83941172|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941173|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941174|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941175|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
83941176|NCT02933099|Hormones|hormones|mesh-ancestor
83941177|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941178|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83941179|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941180|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
83941181|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941182|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941183|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83941184|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941185|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83941186|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83941187|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
83941188|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
83941189|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83941190|NCT02934906|Antibodies|antibodies|mesh-list
83941191|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
83941192|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83941193|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
83941194|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941195|NCT02911350|Paclitaxel|paclitaxel|mesh-list
83941196|NCT02911350|Hormones|hormones|mesh-list
83941197|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83941198|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941199|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
83941200|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
83941201|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
83941202|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941203|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941204|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941205|NCT02932397|Propofol|propofol|mesh-list
83941206|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83941207|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941208|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941209|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83941210|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
83941211|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
83941212|NCT02911272|Oxytocin|oxytocin|mesh-list
83941213|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
83941214|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83941215|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941216|NCT02932436|Empagliflozin|empagliflozin|mesh-list
83941217|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83941218|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941219|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83941220|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941221|NCT02932007|Chloroquine|chloroquine|mesh-list
83941222|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83941223|NCT02932007|Amebicides|amebicides|mesh-ancestor
83941224|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83941225|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83941226|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941227|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
83941228|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941229|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83941230|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941231|NCT02932007|Analgesics|analgesics|mesh-ancestor
83941232|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
83941233|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941234|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941235|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941236|NCT02932007|Filaricides|filaricides|mesh-ancestor
83941237|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
83941238|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
83941239|NCT02910882|Gemcitabine|gemcitabine|mesh-list
83941240|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83941241|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
83941242|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941243|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941244|NCT02910765|Methylene Blue|methylene blue|mesh-list
83941245|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941246|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941247|NCT02925026|Lactoferrin|lactoferrin|mesh-list
83941248|NCT02925026|Muramidase|muramidase|mesh-list
83941249|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941250|NCT02924987|Aflibercept|aflibercept|mesh-list
83941251|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83941252|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83941253|NCT02924987|Growth Substances|growth substances|mesh-ancestor
83941254|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941255|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
83941256|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941257|NCT02924909|Paclitaxel|paclitaxel|mesh-list
83941258|NCT02924909|Carboplatin|carboplatin|mesh-list
83941259|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83941260|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941261|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
83941262|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
83941263|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
83941264|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941265|NCT02934321|Erythritol|erythritol|mesh-list
83941266|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
83941267|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
83941268|NCT02924753|Fludarabine|fludarabine|mesh-list
83941269|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941270|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
83941271|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941272|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941273|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83941274|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
83941275|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941276|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941277|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83941278|NCT02924675|Pregabalin|pregabalin|mesh-list
83941279|NCT02924675|Analgesics|analgesics|mesh-ancestor
83941280|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
83941281|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941282|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941283|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
83941284|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83941285|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941286|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941287|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83941288|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83941289|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83941290|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941291|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83941292|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
83941293|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83941294|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941295|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941296|NCT02924285|Amiodarone|amiodarone|mesh-list
83941297|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83941298|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
83941299|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83941300|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941301|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941302|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83941303|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83941304|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83941305|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941306|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83941307|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83941308|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83941309|NCT01287520|Carboplatin|carboplatin|mesh-list
83941310|NCT01287520|Pemetrexed|pemetrexed|mesh-list
83941311|NCT01287520|Ranitidine|ranitidine|mesh-list
83941312|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83941313|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941314|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941315|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941316|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83941317|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83941318|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83941319|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941320|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83941321|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
83941322|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
83941323|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941324|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941325|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
83941326|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83941327|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83941328|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83941329|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941330|NCT02923934|Nivolumab|nivolumab|mesh-list
83941331|NCT02923934|Ipilimumab|ipilimumab|mesh-list
83941332|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83941333|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941334|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83941335|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941336|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
83941337|NCT01287364|Ciclesonide|ciclesonide|mesh-list
83941338|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941339|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
83941340|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83941341|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
83941342|NCT01287364|Hormones|hormones|mesh-ancestor
83941343|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941344|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941345|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
83941346|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83941347|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941348|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
83941349|NCT02924090|Ketamine|ketamine|mesh-list
83941350|NCT02924090|Etomidate|etomidate|mesh-list
83941351|NCT02924090|Analgesics|analgesics|mesh-ancestor
83941352|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
83941353|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180608|NCT00846430|Interferons|interferons|mesh-list
83941354|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941355|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83941356|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83941357|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
83941358|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
83941359|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941360|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83941361|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83941362|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941363|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941364|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83941365|NCT04137770|Ketorolac|ketorolac|mesh-list
83941366|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83941367|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941368|NCT04137770|Analgesics|analgesics|mesh-ancestor
83941369|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
83941370|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941371|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941372|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941373|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941374|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83941375|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941376|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941377|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
83941378|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
83941379|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941380|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83941381|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83941382|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941383|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941384|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83941385|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83941386|NCT02923856|Clarithromycin|clarithromycin|mesh-list
83941387|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83941388|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941389|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83941390|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941391|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941392|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83941393|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83941394|NCT02934204|Methotrexate|methotrexate|mesh-list
83941395|NCT02934204|Temozolomide|temozolomide|mesh-list
83941396|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83941397|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
83941398|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83941399|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941400|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83941401|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
83941402|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941403|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941404|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
83941405|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941406|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83941407|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941408|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
83941409|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941410|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83941411|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83941412|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
83941413|NCT01286077|Bortezomib|bortezomib|mesh-list
83941414|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941415|NCT05590936|Ondansetron|ondansetron|mesh-list
83941416|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
83941417|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
83941418|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
83941419|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941420|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941421|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941422|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
83941423|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
83941424|NCT05590936|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83941425|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83941426|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
83941427|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941428|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941429|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83941430|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
83941431|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
83941432|NCT02933814|Bupivacaine|bupivacaine|mesh-list
83941433|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
83941434|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
83941435|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941436|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941437|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
83941438|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941439|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
83941440|NCT02933775|Fludarabine|fludarabine|mesh-list
83941441|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941442|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
83941443|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941444|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941445|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83941446|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
83941447|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941448|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941449|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83941450|NCT02923583|Abatacept|abatacept|mesh-list
83941451|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83941452|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941453|NCT02923583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83941454|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941455|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941456|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
83941457|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941458|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941459|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
83941460|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
83941461|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941462|NCT02923388|Vitamins|vitamins|mesh-list
83941463|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
83941464|NCT02923388|Pyridoxine|pyridoxine|mesh-list
83941465|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
83941466|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
83941467|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
83941468|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941469|NCT02933658|Amlodipine|amlodipine|mesh-list
83941470|NCT02933658|Telmisartan|telmisartan|mesh-list
83941471|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83941472|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83941473|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83941474|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941475|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941476|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83941477|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941478|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
83941479|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83941480|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83941481|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
83941482|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83941483|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83941484|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941485|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83941486|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83941487|NCT02933853|Insulin|insulin|mesh-list
83941488|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83941489|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
83941490|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
83941491|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83941492|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83941493|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941494|NCT00532194|Cediranib|cediranib|mesh-list
83941495|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941496|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83941497|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941498|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941499|NCT02665143|Nintedanib|nintedanib|mesh-list
83941500|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941501|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83941502|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941503|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941505|NCT00532272|Goserelin|goserelin|mesh-list
83941506|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941507|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83941508|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83941509|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941510|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941511|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83941512|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
83941513|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941514|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941515|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83941516|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
83941517|NCT02922803|Vitamin D|vitamin d|mesh-list
83941518|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
83941519|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
83941520|NCT02922803|Vitamins|vitamins|mesh-list
83941521|NCT02922803|Calcium|calcium|mesh-list
83941522|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
83941523|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941524|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83941525|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83941526|NCT02834559|Fluorouracil|fluorouracil|mesh-list
83941527|NCT02834559|Heparin|heparin|mesh-list
83941528|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83941529|NCT02834559|Tinzaparin|tinzaparin|mesh-list
83941530|NCT02834559|Dalteparin|dalteparin|mesh-list
83941531|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
83941532|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941533|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83941534|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941535|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941536|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
83941537|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941538|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
83941539|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83941540|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83941541|NCT02922686|Floxacillin|floxacillin|mesh-list
83941542|NCT02922686|Penicillin V|penicillin v|mesh-list
83941543|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83941544|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941545|NCT02922491|Vitamin E|vitamin e|mesh-list
83941546|NCT02922491|Vitamins|vitamins|mesh-ancestor
83941547|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
83941548|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941549|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
83941550|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941551|NCT02922491|Protective Agents|protective agents|mesh-ancestor
83941552|NCT02922179|Insulin|insulin|mesh-list
83941553|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
83941554|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83941555|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941556|NCT02921984|Docetaxel|docetaxel|mesh-list
83941557|NCT02921984|Pemetrexed|pemetrexed|mesh-list
83941558|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941559|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
83941560|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
83941561|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
83941562|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941563|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941564|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83941565|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83941566|NCT01285609|Paclitaxel|paclitaxel|mesh-list
83941567|NCT01285609|Carboplatin|carboplatin|mesh-list
83941568|NCT01285609|Ipilimumab|ipilimumab|mesh-list
83941569|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83941570|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941571|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
83941572|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
83941573|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
83941574|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941575|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83941576|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83941577|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
83941578|NCT03981341|Estrogens|estrogens|mesh-list
83941579|NCT03981341|Hormones|hormones|mesh-ancestor
83941580|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941581|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941582|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83941583|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83941585|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83941586|NCT03924440|Nonoxynol|nonoxynol|mesh-list
83941587|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83941588|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83941589|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941590|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83941591|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
83941592|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83941593|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83941594|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
83941595|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83941596|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
83941597|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941598|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941599|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83941600|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
83941601|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
83941602|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83941603|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
83941604|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941605|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941606|NCT04615143|Tislelizumab|tislelizumab|mesh-list
83941607|NCT04615143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83941608|NCT04615143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941609|NCT01284634|Cannabidiol|cannabidiol|mesh-list
83941610|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
83941611|NCT02932722|Anesthetics|anesthetics|mesh-list
83941612|NCT02932722|Propofol|propofol|mesh-list
83941613|NCT02932722|Sevoflurane|sevoflurane|mesh-list
83941614|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941615|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941616|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83941617|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83941618|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
83941619|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83941620|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83941621|NCT02932761|Goserelin|goserelin|mesh-list
83941622|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83941623|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941624|NCT01283971|Adalimumab|adalimumab|mesh-list
83941625|NCT01283971|Methotrexate|methotrexate|mesh-list
83941626|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83941627|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
83941628|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83941629|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941630|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83941631|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
83941632|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941633|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941634|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
83941635|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941636|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83941637|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941638|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
83941639|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941640|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83941641|NCT01283971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83941642|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941643|NCT02921282|Dopamine|dopamine|mesh-list
83941644|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83941645|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
83941646|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
83941647|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941648|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941649|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
83941650|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941651|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941652|NCT02921282|Protective Agents|protective agents|mesh-ancestor
83941653|NCT02921360|Aspirin|aspirin|mesh-list
83941654|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83941655|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941657|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
83941658|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941659|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941660|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941661|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941662|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83941663|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83941664|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941665|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83941666|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83941667|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941668|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
83941669|NCT02932605|Cannabidiol|cannabidiol|mesh-list
83941670|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
83941671|NCT02921204|Vitamin D|vitamin d|mesh-list
83941672|NCT02921204|Vitamins|vitamins|mesh-ancestor
83941673|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
83941674|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941675|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83941676|NCT01283581|Vancomycin|vancomycin|mesh-list
83941677|NCT01283581|Linezolid|linezolid|mesh-list
83941678|NCT01283581|Delafloxacin|delafloxacin|mesh-list
83941679|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83941680|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941681|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83941682|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941683|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941684|NCT01283542|Pasireotide|pasireotide|mesh-list
83941685|NCT01283542|Hormones|hormones|mesh-ancestor
83941686|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941687|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941688|NCT02932488|Sumatriptan|sumatriptan|mesh-list
83941689|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83941690|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83941691|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83941692|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
83941693|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941694|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941695|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941696|NCT02921165|Aspirin|aspirin|mesh-list
83941697|NCT02921165|Analgesics|analgesics|mesh-list
83941698|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83941699|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941700|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
83941701|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941702|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941703|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941704|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941705|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83941706|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83941707|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941708|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83941709|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83941710|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941711|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
83941712|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
83941713|NCT01283386|Chlorambucil|chlorambucil|mesh-list
83941714|NCT01283386|Rituximab|rituximab|mesh-list
83941715|NCT01283386|Fludarabine|fludarabine|mesh-list
83941716|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941717|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
83941718|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941719|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941720|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83941721|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
83941722|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941723|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941724|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83941725|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83941726|NCT02920931|Tenofovir|tenofovir|mesh-list
83941727|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
83941728|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941729|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83941730|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83941731|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941732|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941734|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83941735|NCT01283152|Lactulose|lactulose|mesh-list
83941736|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83941737|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941738|NCT01283152|Laxatives|laxatives|mesh-ancestor
83941739|NCT01283464|Vitamin A|vitamin a|mesh-list
83941740|NCT01283464|Tretinoin|tretinoin|mesh-list
83941741|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941742|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
83941743|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83941744|NCT01283464|Vitamins|vitamins|mesh-ancestor
83941745|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
83941746|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941747|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83941748|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83941749|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83941750|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941751|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941752|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941753|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941754|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83941755|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
83941756|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83941757|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
83941758|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83941759|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
83941760|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941761|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941762|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83941763|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
83941764|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
83941765|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83941766|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
83941767|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941768|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941769|NCT02932566|Pirfenidone|pirfenidone|mesh-list
83941770|NCT02932566|Analgesics|analgesics|mesh-ancestor
83941771|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
83941772|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941773|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941774|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83941775|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941776|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941777|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83941778|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941779|NCT00532389|Panobinostat|panobinostat|mesh-list
83941780|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941781|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83941782|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941783|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941784|NCT02932644|Vitamin D|vitamin d|mesh-list
83941785|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
83941786|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
83941787|NCT02932644|Vitamins|vitamins|mesh-list
83941788|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
83941789|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941790|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83941791|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83941792|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
83941793|NCT05466708|Ketamine|ketamine|mesh-list
83941794|NCT05466708|Esketamine|esketamine|mesh-list
83941795|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83941796|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941797|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941798|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941799|NCT05466708|Analgesics|analgesics|mesh-ancestor
83941800|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
83941801|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941802|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83941803|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83941805|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
83941806|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941807|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941808|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83941809|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83941810|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
83941811|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
83941812|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83941813|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83941814|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
83941815|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83941816|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
83941817|NCT02920502|Vitamin D|vitamin d|mesh-list
83941818|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83941819|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941820|NCT02920502|Vitamins|vitamins|mesh-ancestor
83941821|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
83941822|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83941823|NCT01282216|Vaccines|vaccines|mesh-list
83941824|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83941825|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
83941826|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941827|NCT01281865|Everolimus|everolimus|mesh-list
83941828|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
83941829|NCT01281865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83941830|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83941831|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941832|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941833|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941834|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
83941835|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941836|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941837|NCT02920658|Betamethasone|betamethasone|mesh-list
83941838|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
83941839|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83941840|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
83941841|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83941842|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941843|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
83941844|NCT02920658|Hormones|hormones|mesh-ancestor
83941845|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941846|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941847|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83941848|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
83941849|NCT01281202|Vigabatrin|vigabatrin|mesh-list
83941850|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
83941851|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941852|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941853|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
83941854|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941855|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941856|NCT01281124|Azacitidine|azacitidine|mesh-list
83941857|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83941858|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
83941859|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941860|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941861|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941862|NCT00623857|Vitamins|vitamins|mesh-list
83941863|NCT00623857|Zinc|zinc|mesh-list
83941864|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
83941865|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941866|NCT00623857|Trace Elements|trace elements|mesh-ancestor
83941867|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83941868|NCT01280968|Vaccines|vaccines|mesh-list
83941869|NCT01280968|Nicotine|nicotine|mesh-list
83941870|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
83941871|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941872|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83941873|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
83941874|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941875|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83941876|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83941877|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
83941878|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941879|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941880|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83941881|NCT01280968|Antacids|antacids|mesh-ancestor
83941882|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941883|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83941884|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
83941885|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83941886|NCT02932020|Prednisolone|prednisolone|mesh-list
83941887|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
83941888|NCT02932020|Bupivacaine|bupivacaine|mesh-list
83941889|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83941890|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
83941891|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
83941892|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
83941893|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941894|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941895|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
83941896|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941897|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83941898|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
83941899|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
83941900|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83941901|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
83941902|NCT02932020|Hormones|hormones|mesh-ancestor
83941903|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941904|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83941905|NCT02932020|Protective Agents|protective agents|mesh-ancestor
83941906|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83941907|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941908|NCT05466279|Midazolam|midazolam|mesh-list
83941909|NCT05466279|Propofol|propofol|mesh-list
83941910|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83941911|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941912|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941913|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83941914|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
83941915|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
83941916|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83941917|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83941918|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83941919|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83941920|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
83941921|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
83941922|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83941923|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941924|NCT01280656|Interferons|interferons|mesh-list
83941925|NCT01280656|Ribavirin|ribavirin|mesh-list
83941926|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83941927|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83941928|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941929|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
83941930|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83941931|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
83941932|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941933|NCT03741530|Glyburide|glyburide|mesh-list
83941934|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83941935|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941936|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
83941937|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83941938|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
83941939|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941940|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83941941|NCT02932137|Interleukin-2|interleukin-2|mesh-list
83941942|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941943|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83941944|NCT02932137|Analgesics|analgesics|mesh-ancestor
83941945|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
83941946|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941947|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941948|NCT01280266|Amlodipine|amlodipine|mesh-list
83941949|NCT01280266|Udenafil|udenafil|mesh-list
83941950|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83941951|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83941952|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941953|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941954|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83941955|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941957|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83941958|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83941959|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83941960|NCT01279447|Bupivacaine|bupivacaine|mesh-list
83941961|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
83941962|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
83941963|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941964|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941965|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
83941966|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941967|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
83941968|NCT02932254|Analgesics|analgesics|mesh-ancestor
83941969|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
83941970|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83941971|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941972|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
83941973|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941974|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83941975|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
83941976|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83941977|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83941978|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941979|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83941980|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
83941981|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83941982|NCT02920190|Liraglutide|liraglutide|mesh-list
83941983|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83941984|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941985|NCT02920190|Incretins|incretins|mesh-ancestor
83941986|NCT02920190|Hormones|hormones|mesh-ancestor
83941987|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83941988|NCT02919878|Gemcitabine|gemcitabine|mesh-list
83941989|NCT02919878|Capecitabine|capecitabine|mesh-list
83941990|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83941991|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
83941992|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83941993|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83941994|NCT02931786|Ketamine|ketamine|mesh-list
83941995|NCT02931786|Propofol|propofol|mesh-list
83941996|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83941997|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83941998|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83941999|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83942000|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
83942001|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
83942002|NCT02931786|Analgesics|analgesics|mesh-ancestor
83942003|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
83942004|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942005|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83942006|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83942007|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83942008|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942009|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942010|NCT02919605|Pentamidine|pentamidine|mesh-list
83942011|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
83942012|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942013|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83942014|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83942015|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83942016|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83942017|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83942018|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
83942019|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942020|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942021|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83942022|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83942023|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83942024|NCT05465733|Pemetrexed|pemetrexed|mesh-list
83942025|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942026|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942027|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942028|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83942029|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83942030|NCT03673787|Atezolizumab|atezolizumab|mesh-list
83942031|NCT03673787|Ipatasertib|ipatasertib|mesh-list
83942032|NCT03673787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83942033|NCT03673787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942034|NCT03673787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942035|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942036|NCT03673787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83942037|NCT03673787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942038|NCT03571802|Simvastatin|simvastatin|mesh-list
83942039|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83942040|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83942041|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
83942042|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942043|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83942044|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83942045|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942046|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
83942047|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83942048|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83942049|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942050|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
83942051|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
83942052|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942053|NCT02919293|Vaccines|vaccines|mesh-list
83942054|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
83942055|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942056|NCT02919371|Bevacizumab|bevacizumab|mesh-list
83942057|NCT02919371|Sunitinib|sunitinib|mesh-list
83942058|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942059|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942060|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83942061|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83942062|NCT02919371|Growth Substances|growth substances|mesh-ancestor
83942063|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942064|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
83942065|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83942066|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942067|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942068|NCT02919449|Atezolizumab|atezolizumab|mesh-list
83942069|NCT02919449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83942070|NCT02919449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942071|NCT02919449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942072|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942073|NCT04736901|Enoxaparin|enoxaparin|mesh-list
83942074|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
83942075|NCT04736901|Apixaban|apixaban|mesh-list
83942076|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
83942077|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83942078|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
83942079|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83942080|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
83942081|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942082|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942083|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
83942084|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83942085|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83942086|NCT02919176|Pioglitazone|pioglitazone|mesh-list
83942087|NCT02919176|Mirabegron|mirabegron|mesh-list
83942088|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83942089|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942090|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83942091|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83942092|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83942093|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83942094|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942095|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942096|NCT02919176|Urological Agents|urological agents|mesh-ancestor
83942097|NCT04734678|Infliximab|infliximab|mesh-list
83942098|NCT04734678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83942099|NCT04734678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942100|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
83942101|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83942102|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942103|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
83942104|NCT02919059|Glimepiride|glimepiride|mesh-list
83942105|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83942106|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942107|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83942108|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942109|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83942110|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83942111|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
83942112|NCT04727775|Remdesivir|remdesivir|mesh-list
83942113|NCT04727775|Favipiravir|favipiravir|mesh-list
83942114|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
83942115|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942116|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
83942117|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942118|NCT02918825|Olanzapine|olanzapine|mesh-list
83942119|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83942120|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
83942121|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
83942122|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942123|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942124|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83942125|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83942126|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942127|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942128|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942129|NCT02918825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83942130|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83942131|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83942132|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942133|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942134|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
83942135|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83942136|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83942137|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83942138|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83942139|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
83942140|NCT02918747|Dexamethasone|dexamethasone|mesh-list
83942141|NCT02918747|Prednisone|prednisone|mesh-list
83942142|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
83942143|NCT02918747|Gemcitabine|gemcitabine|mesh-list
83942144|NCT02918747|Doxorubicin|doxorubicin|mesh-list
83942145|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
83942146|NCT02918747|Vincristine|vincristine|mesh-list
83942147|NCT02918747|Pegaspargase|pegaspargase|mesh-list
83942148|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83942149|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
83942150|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942151|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942152|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83942153|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
83942154|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942155|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942156|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83942157|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942158|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
83942159|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
83942160|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942161|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83942162|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
83942163|NCT02918747|Hormones|hormones|mesh-ancestor
83942164|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942165|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83942166|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83942167|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
83942168|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83942169|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83942170|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83942171|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942172|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83942173|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942174|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942175|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942176|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83942177|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
83942178|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942179|NCT02918591|Empagliflozin|empagliflozin|mesh-list
83942180|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83942181|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942182|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83942183|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942184|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
83942185|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
83942186|NCT02918045|Coagulants|coagulants|mesh-ancestor
83942187|NCT00532545|Teriparatide|teriparatide|mesh-list
83942188|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83942189|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942190|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83942191|NCT00533520|Ranibizumab|ranibizumab|mesh-list
83942192|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83942193|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83942194|NCT00533520|Growth Substances|growth substances|mesh-ancestor
83942195|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942196|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
83942197|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942198|NCT03694262|Bevacizumab|bevacizumab|mesh-list
83942199|NCT03694262|Atezolizumab|atezolizumab|mesh-list
83942200|NCT03694262|Rucaparib|rucaparib|mesh-list
83942201|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942202|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942203|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83942204|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83942205|NCT03694262|Growth Substances|growth substances|mesh-ancestor
83942206|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942207|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
83942208|NCT03694262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83942209|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942210|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83942211|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942212|NCT05356104|Exenatide|exenatide|mesh-list
83942213|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83942214|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942215|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83942216|NCT05356104|Incretins|incretins|mesh-ancestor
83942217|NCT05356104|Hormones|hormones|mesh-ancestor
83942218|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942219|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83942220|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942221|NCT03685253|Niacinamide|niacinamide|mesh-list
83942222|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
83942223|NCT03685253|Vitamins|vitamins|mesh-ancestor
83942224|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
83942225|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942226|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
83942227|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83942228|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942229|NCT00532584|Beclomethasone|beclomethasone|mesh-list
83942230|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942231|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
83942232|NCT00532584|Hormones|hormones|mesh-ancestor
83942233|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942234|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942235|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83942236|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
83942237|NCT04687332|Tryptophan|tryptophan|mesh-list
83942238|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83942239|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
83942240|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942241|NCT05467709|Midazolam|midazolam|mesh-list
83942242|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83942243|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83942244|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942245|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942246|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83942247|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942248|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942249|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83942250|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
83942251|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
83942252|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
83942253|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
83942254|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181499|NCT02137252|Naltrexone|naltrexone|mesh-list
83942255|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942257|NCT00532623|Vinorelbine|vinorelbine|mesh-list
83942258|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83942259|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
83942260|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942261|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942262|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83942263|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942264|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942265|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942266|NCT05467670|Doxorubicin|doxorubicin|mesh-list
83942267|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83942268|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
83942269|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83942270|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942271|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83942272|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83942273|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942274|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942275|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942276|NCT05467670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83942277|NCT00532662|Ketamine|ketamine|mesh-list
83942278|NCT00532662|Analgesics|analgesics|mesh-ancestor
83942279|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
83942280|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942281|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942282|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83942283|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83942284|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
83942285|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
83942286|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942287|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83942288|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83942289|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942290|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942291|NCT05341167|Phenylephrine|phenylephrine|mesh-list
83942292|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
83942293|NCT05341167|Norepinephrine|norepinephrine|mesh-list
83942294|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83942295|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
83942296|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
83942297|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942298|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942299|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
83942300|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83942301|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
83942302|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83942303|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83942304|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83942305|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83942306|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83942307|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942308|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942309|NCT05341167|Protective Agents|protective agents|mesh-ancestor
83942310|NCT05467436|Analgesics|analgesics|mesh-list
83942311|NCT05467436|Anesthetics|anesthetics|mesh-list
83942312|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
83942313|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942314|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942315|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
83942316|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942317|NCT00533637|Cetirizine|cetirizine|mesh-list
83942318|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83942319|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83942320|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83942321|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
83942322|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
83942323|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942324|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942325|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942326|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
83942327|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83942328|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83942329|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
83942330|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942331|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942332|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942333|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
83942334|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
83942335|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942336|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
83942337|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83942338|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
83942339|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83942340|NCT05467319|Hematinics|hematinics|mesh-ancestor
83942341|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
83942342|NCT05466695|Tadalafil|tadalafil|mesh-list
83942343|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942344|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83942345|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83942346|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942347|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942348|NCT05466695|Urological Agents|urological agents|mesh-ancestor
83942349|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
83942350|NCT04484610|Narcotics|narcotics|mesh-ancestor
83942351|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942352|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942353|NCT04484610|Analgesics|analgesics|mesh-ancestor
83942354|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
83942355|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942356|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83942357|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83942358|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942359|NCT05466149|Aflutinib|aflutinib|mesh-list
83942360|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83942361|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942362|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942363|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83942364|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
83942365|NCT00532701|Ribavirin|ribavirin|mesh-list
83942366|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
83942367|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942368|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
83942369|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942370|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
83942371|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942372|NCT01276639|Tofacitinib|tofacitinib|mesh-list
83942373|NCT01276639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83942374|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83942375|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942376|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942377|NCT04449198|Resveratrol|resveratrol|mesh-list
83942378|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
83942379|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942380|NCT04449198|Protective Agents|protective agents|mesh-ancestor
83942381|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942382|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942383|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83942384|NCT00532415|Triamcinolone|triamcinolone|mesh-list
83942385|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83942386|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83942387|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83942388|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942389|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
83942390|NCT00532415|Hormones|hormones|mesh-ancestor
83942391|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942392|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942393|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83942394|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
83942395|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942396|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942397|NCT00532454|Tamoxifen|tamoxifen|mesh-list
83942398|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83942399|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
83942400|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942401|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942402|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83942403|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942404|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83942405|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83942406|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83942407|NCT01275625|Maraviroc|maraviroc|mesh-list
83942408|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83942409|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83942410|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942411|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83942412|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83942413|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
83942414|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942415|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83942416|NCT05459792|Lidocaine|lidocaine|mesh-list
83942417|NCT05459792|Bupivacaine|bupivacaine|mesh-list
83942418|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
83942419|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
83942420|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942421|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942422|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
83942423|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942424|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83942425|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83942426|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83942427|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83942428|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942429|NCT04686825|DA-8010|da-8010|mesh-list
83942430|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83942431|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83942432|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
83942433|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942434|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942435|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942436|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
83942437|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83942438|NCT05281185|Factor VIII|factor viii|mesh-list
83942439|NCT05281185|Coagulants|coagulants|mesh-ancestor
83942440|NCT00532532|Tolperisone|tolperisone|mesh-list
83942441|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83942442|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942443|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83942444|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942445|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
83942446|NCT00532571|Vitamins|vitamins|mesh-ancestor
83942447|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
83942448|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942449|NCT04322565|Colchicine|colchicine|mesh-list
83942450|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
83942451|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942452|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942453|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942454|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942455|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942456|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942457|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
83942458|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83942459|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
83942460|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942461|NCT00532688|Expectorants|expectorants|mesh-ancestor
83942462|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
83942463|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83942464|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
83942465|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942466|NCT00532688|Protective Agents|protective agents|mesh-ancestor
83942467|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942468|NCT00532688|Antidotes|antidotes|mesh-ancestor
83942469|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83942470|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
83942471|NCT00534144|Hematinics|hematinics|mesh-ancestor
83942472|NCT00534183|Haloperidol|haloperidol|mesh-list
83942473|NCT00534183|Olanzapine|olanzapine|mesh-list
83942474|NCT00534183|Risperidone|risperidone|mesh-list
83942475|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
83942476|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83942477|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
83942478|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181711|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83942479|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942480|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942481|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83942482|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942483|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942484|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942485|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83942486|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
83942487|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
83942488|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
83942489|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942490|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83942491|NCT00534183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83942492|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83942493|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83942494|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83942495|NCT04269408|Nicardipine|nicardipine|mesh-list
83942496|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83942497|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83942498|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83942499|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942500|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83942501|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942502|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942503|NCT00532727|Carboplatin|carboplatin|mesh-list
83942504|NCT00532727|Docetaxel|docetaxel|mesh-list
83942505|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942506|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942507|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942508|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942509|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942510|NCT04261218|Paclitaxel|paclitaxel|mesh-list
83942511|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83942512|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942513|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942514|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942515|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942516|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942517|NCT04687449|Curcumin|curcumin|mesh-list
83942518|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83942519|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83942520|NCT04687449|Analgesics|analgesics|mesh-ancestor
83942521|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
83942522|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942523|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942524|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942525|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942526|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942527|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942528|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942529|NCT05258279|Carboplatin|carboplatin|mesh-list
83942530|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
83942531|NCT05258279|Pemetrexed|pemetrexed|mesh-list
83942532|NCT05258279|Lenvatinib|lenvatinib|mesh-list
83942533|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942534|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942535|NCT05258279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83942536|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942537|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942538|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83942539|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83942540|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83942541|NCT00532818|Hydralazine|hydralazine|mesh-list
83942542|NCT00532818|Valproic Acid|valproic acid|mesh-list
83942543|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
83942544|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942545|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942546|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
83942547|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942548|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942549|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
83942550|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942551|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942552|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942553|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83942554|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942556|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83942557|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942558|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942559|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942560|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942561|NCT05209035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83942562|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83942563|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83942564|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942565|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942566|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
83942567|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83942568|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
83942569|NCT00534261|Interferons|interferons|mesh-list
83942570|NCT00534261|Interferon-beta|interferon-beta|mesh-list
83942571|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
83942572|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942573|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
83942574|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942575|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
83942576|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942577|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83942578|NCT00532857|Paclitaxel|paclitaxel|mesh-list
83942579|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83942580|NCT00532857|Gemcitabine|gemcitabine|mesh-list
83942581|NCT00532857|Trastuzumab|trastuzumab|mesh-list
83942582|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83942583|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942584|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942585|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942586|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942587|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942588|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83942589|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
83942590|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942591|NCT05201300|Propofol|propofol|mesh-list
83942592|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83942593|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942594|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942595|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83942596|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
83942597|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
83942598|NCT05152004|Amoxicillin|amoxicillin|mesh-list
83942599|NCT05152004|Metronidazole|metronidazole|mesh-list
83942600|NCT05152004|Clarithromycin|clarithromycin|mesh-list
83942601|NCT05152004|Rabeprazole|rabeprazole|mesh-list
83942602|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83942603|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942604|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83942605|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83942606|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83942607|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942608|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942609|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83942610|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83942611|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83942612|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83942613|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83942614|NCT05132153|Milrinone|milrinone|mesh-list
83942615|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83942616|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83942617|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942618|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83942619|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83942620|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942621|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942622|NCT05132153|Protective Agents|protective agents|mesh-ancestor
83942623|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942624|NCT00534378|Midazolam|midazolam|mesh-list
83942625|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83942626|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83181864|NCT04503707|Hormones|hormones|mesh-ancestor
83942627|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942628|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942629|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83942630|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942631|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942632|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83942633|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
83942634|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
83942635|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
83942636|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
83942637|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83942638|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942639|NCT05131997|Atorvastatin|atorvastatin|mesh-list
83942640|NCT05131997|Ezetimibe|ezetimibe|mesh-list
83942641|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83942642|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83942643|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
83942644|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942645|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83942646|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83942647|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942648|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
83942649|NCT00534456|Hematinics|hematinics|mesh-ancestor
83942650|NCT05104229|Aspirin|aspirin|mesh-list
83942651|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83942652|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83942653|NCT05104229|Analgesics|analgesics|mesh-ancestor
83942654|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
83942655|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942656|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942657|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942658|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942659|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83942660|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83942661|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942662|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83942663|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83942664|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942665|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
83942666|NCT04153032|Diltiazem|diltiazem|mesh-list
83942667|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83942668|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83942669|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83942670|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942671|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83942672|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942673|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942674|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83942675|NCT00532961|Tobramycin|tobramycin|mesh-list
83942676|NCT00532961|Dexamethasone|dexamethasone|mesh-list
83942677|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942678|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
83942679|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
83942680|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942681|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942682|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83942683|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
83942684|NCT00532961|Hormones|hormones|mesh-ancestor
83942685|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942686|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83942687|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942688|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83942689|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942690|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83942691|NCT00534573|Amisulpride|amisulpride|mesh-list
83942692|NCT00534573|Moclobemide|moclobemide|mesh-list
83942693|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83942694|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942695|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942696|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942697|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942698|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83942699|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
83942700|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124682|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181941|NCT03469895|Idelalisib|idelalisib|mesh-list
83942701|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942702|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83942703|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
83942704|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83942705|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942706|NCT04686890|Acetaminophen|acetaminophen|mesh-list
83942707|NCT04686890|Tramadol|tramadol|mesh-list
83942708|NCT04686890|Analgesics|analgesics|mesh-list
83942709|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83942710|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
83942711|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942712|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942713|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
83942714|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83942715|NCT04686890|Narcotics|narcotics|mesh-ancestor
83942716|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942717|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
83942718|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83942719|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942720|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942721|NCT05103306|Empagliflozin|empagliflozin|mesh-list
83942722|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83942723|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942724|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83942725|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942726|NCT00534651|Acetaminophen|acetaminophen|mesh-list
83942727|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83942728|NCT00534651|Analgesics|analgesics|mesh-ancestor
83942729|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
83942730|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942731|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942732|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
83942733|NCT05080959|Ropivacaine|ropivacaine|mesh-list
83942734|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
83942735|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
83942736|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942737|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942738|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
83942739|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942740|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
83942741|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
83942742|NCT04942730|Busulfan|busulfan|mesh-list
83942743|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83942744|NCT04942730|Fludarabine|fludarabine|mesh-list
83942745|NCT04942730|Tacrolimus|tacrolimus|mesh-list
83942746|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83942747|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
83942748|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942749|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942750|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83942751|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
83942752|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942753|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942754|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83942755|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83942756|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942757|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83942758|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83942759|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
83942760|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83942761|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942762|NCT01272193|Insulin|insulin|mesh-list
83942763|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83942764|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
83942765|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
83942766|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83942767|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942768|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
83942769|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942770|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
83942771|NCT04687163|Fluorouracil|fluorouracil|mesh-list
83942772|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942773|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
83942774|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942775|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83942776|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83942777|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
83942778|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942779|NCT01270828|Pregabalin|pregabalin|mesh-list
83942780|NCT01270828|Analgesics|analgesics|mesh-ancestor
83942781|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
83942782|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942783|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942784|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
83942785|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83942786|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83942787|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942788|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83942789|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83942790|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83942791|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942792|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83942793|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
83942794|NCT00533195|Methoxsalen|methoxsalen|mesh-list
83942795|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83942796|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
83942797|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942798|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83942799|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83942800|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942801|NCT01269385|Rituximab|rituximab|mesh-list
83942802|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83942803|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
83942804|NCT01269385|Antibodies|antibodies|mesh-list
83942805|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
83942806|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83942807|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
83942808|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942809|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942810|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942811|NCT02071862|Paclitaxel|paclitaxel|mesh-list
83942812|NCT02071862|Docetaxel|docetaxel|mesh-list
83942813|NCT02071862|Everolimus|everolimus|mesh-list
83942814|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83942815|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942816|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942817|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942818|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942819|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942820|NCT02071862|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83942821|NCT02071862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83942822|NCT02071862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942823|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83942824|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
83942825|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942826|NCT00535691|Tacrolimus|tacrolimus|mesh-list
83942827|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83942828|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
83942829|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942830|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83942831|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942832|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942833|NCT01268683|Glyburide|glyburide|mesh-list
83942834|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83942835|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942836|NCT02021474|Phenol|phenol|mesh-list
83942837|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83942838|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942839|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
83942840|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83942841|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83942842|NCT01803152|Gemcitabine|gemcitabine|mesh-list
83942843|NCT01803152|Imiquimod|imiquimod|mesh-list
83942844|NCT01803152|Vaccines|vaccines|mesh-list
83942845|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
83942846|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942847|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83942848|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
83942849|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942850|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942851|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83942852|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
83942853|NCT04959825|Melatonin|melatonin|mesh-list
83942854|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
83942855|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942856|NCT04959825|Protective Agents|protective agents|mesh-ancestor
83942857|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942858|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942859|NCT05471453|Tocotrienols|tocotrienols|mesh-list
83942860|NCT05471453|Vitamin E|vitamin e|mesh-list
83942861|NCT05471453|Tocopherols|tocopherols|mesh-list
83942862|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83942863|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83942864|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
83942865|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942866|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
83942867|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942868|NCT05471453|Protective Agents|protective agents|mesh-ancestor
83942869|NCT05471453|Vitamins|vitamins|mesh-ancestor
83942870|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
83942871|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83942872|NCT03457233|Cetrorelix|cetrorelix|mesh-list
83942873|NCT03457233|Menotropins|menotropins|mesh-list
83942874|NCT03457233|Progesterone|progesterone|mesh-list
83942875|NCT03457233|Progestins|progestins|mesh-ancestor
83942876|NCT03457233|Hormones|hormones|mesh-ancestor
83942877|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942878|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942879|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83942880|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83942881|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
83942882|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
83942883|NCT00535808|Nitroprusside|nitroprusside|mesh-list
83942884|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
83942885|NCT00535808|Sevoflurane|sevoflurane|mesh-list
83942886|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83942887|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83942888|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
83942889|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
83942890|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942891|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942892|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942893|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83942894|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83942895|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942896|NCT05471063|Fluconazole|fluconazole|mesh-list
83942897|NCT05471063|Amphotericin B|amphotericin b|mesh-list
83942898|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83942899|NCT05471063|Flucytosine|flucytosine|mesh-list
83942900|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
83942901|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
83942902|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942903|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83942904|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83942905|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942906|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942907|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83942908|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
83942909|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942910|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942911|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83942912|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83942913|NCT05471063|Amebicides|amebicides|mesh-ancestor
83942914|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83942915|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83942916|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83942917|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
83942918|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83942919|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
83942920|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83942921|NCT05471063|Protective Agents|protective agents|mesh-ancestor
83942922|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942923|NCT04910100|Timolol|timolol|mesh-list
83942924|NCT04910100|Nebivolol|nebivolol|mesh-list
83942925|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83942926|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83942927|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83942928|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83942929|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
83942930|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182173|NCT03468595|Listerine|listerine|mesh-list
83942931|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942932|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942933|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83942934|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83942935|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
83942936|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83942937|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83942938|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83942939|NCT01268059|Paclitaxel|paclitaxel|mesh-list
83942940|NCT01268059|Carboplatin|carboplatin|mesh-list
83942941|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83942942|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942943|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83942944|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83942945|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83942946|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942947|NCT01267825|Bupivacaine|bupivacaine|mesh-list
83942948|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
83942949|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
83942950|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83942951|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942952|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
83942953|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942954|NCT00536003|Progesterone|progesterone|mesh-list
83942955|NCT00536003|Progestins|progestins|mesh-ancestor
83942956|NCT00536003|Hormones|hormones|mesh-ancestor
83942957|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83942958|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942959|NCT00533091|Sifalimumab|sifalimumab|mesh-list
83942960|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
83942961|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942962|NCT00536042|Minocycline|minocycline|mesh-list
83942963|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83942964|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83942965|NCT01606384|Vasopressins|vasopressins|mesh-list
83942966|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
83942967|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
83942968|NCT01606384|Coagulants|coagulants|mesh-ancestor
83942969|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83942970|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83942971|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
83942972|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942973|NCT01606462|Oxytocin|oxytocin|mesh-list
83942974|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
83942975|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83942976|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942977|NCT05470595|Atezolizumab|atezolizumab|mesh-list
83942978|NCT05470595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83942979|NCT05470595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942980|NCT05470595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83942981|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942982|NCT01606540|Ibuprofen|ibuprofen|mesh-list
83942983|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83942984|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83942985|NCT01606540|Analgesics|analgesics|mesh-ancestor
83942986|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
83942987|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83942988|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83942989|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83942990|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83942991|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83942992|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83942993|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83942994|NCT00533169|Tretinoin|tretinoin|mesh-list
83942995|NCT00533169|Isotretinoin|isotretinoin|mesh-list
83942996|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83942997|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
83942998|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
83942999|NCT00593710|Losartan|losartan|mesh-list
83943000|NCT00593710|Atenolol|atenolol|mesh-list
83943001|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83943002|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83943003|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83943004|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83182249|NCT05165615|Insulin|insulin|mesh-list
83943005|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943006|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
83943007|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
83943008|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943009|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943010|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83943011|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83943012|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83943013|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
83943014|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943015|NCT04885686|Formaldehyde|formaldehyde|mesh-list
83943016|NCT04885686|Thymol|thymol|mesh-list
83943017|NCT04885686|Dexamethasone|dexamethasone|mesh-list
83943018|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
83943019|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943020|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
83943021|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
83943022|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943023|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943024|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943025|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
83943026|NCT04885686|Hormones|hormones|mesh-ancestor
83943027|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943028|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83943029|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943030|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
83943031|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943032|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83943033|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
83943034|NCT00594217|Progesterone|progesterone|mesh-list
83943035|NCT00594217|Progestins|progestins|mesh-ancestor
83943036|NCT00594217|Hormones|hormones|mesh-ancestor
83943037|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943038|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943039|NCT00536237|Niacin|niacin|mesh-list
83943040|NCT00536237|Niacinamide|niacinamide|mesh-list
83943041|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
83943042|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943043|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943044|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83943045|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
83943046|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83943047|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
83943048|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
83943049|NCT00536237|Vitamins|vitamins|mesh-ancestor
83943050|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
83943051|NCT00533247|Celecoxib|celecoxib|mesh-list
83943052|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83943053|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943054|NCT00533247|Analgesics|analgesics|mesh-ancestor
83943055|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
83943056|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943057|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943058|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943059|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943060|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83943061|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83943062|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943063|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943064|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83943065|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943066|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943067|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943068|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943069|NCT00536276|Vitamin D|vitamin d|mesh-list
83943070|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
83943071|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
83943072|NCT00536276|Vitamins|vitamins|mesh-list
83943073|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
83943074|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943075|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83943076|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83943077|NCT02690064|Vitamins|vitamins|mesh-list
83943078|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
83943079|NCT02690064|Vitamin E|vitamin e|mesh-list
83182340|NCT01857115|Hormones|hormones|mesh-ancestor
83943080|NCT02690064|Tocopherols|tocopherols|mesh-list
83943081|NCT02690064|Tocotrienols|tocotrienols|mesh-list
83943082|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
83943083|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
83943084|NCT02690064|Ubiquinone|ubiquinone|mesh-list
83943085|NCT02690064|Resveratrol|resveratrol|mesh-list
83943086|NCT02690064|Antioxidants|antioxidants|mesh-list
83943087|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
83943088|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943089|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943090|NCT02690064|Protective Agents|protective agents|mesh-ancestor
83943091|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943092|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83943093|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
83943094|NCT00594373|Tenofovir|tenofovir|mesh-list
83943095|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
83943096|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943097|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83943098|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83943099|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943100|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943101|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83943102|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83943103|NCT05470166|Lidocaine|lidocaine|mesh-list
83943104|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
83943105|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
83943106|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943107|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943108|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
83943109|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943110|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83943111|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83943112|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83943113|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83943114|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943115|NCT02496585|Prednisone|prednisone|mesh-list
83943116|NCT02496585|Nintedanib|nintedanib|mesh-list
83943117|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943118|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
83943119|NCT02496585|Hormones|hormones|mesh-ancestor
83943120|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943121|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943122|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83943123|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943124|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943125|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943126|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943127|NCT01260142|Propofol|propofol|mesh-list
83943128|NCT01260142|Fospropofol|fospropofol|mesh-list
83943129|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83943130|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943131|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943132|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83943133|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
83943134|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
83943135|NCT02116335|Bosentan|bosentan|mesh-list
83943136|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83943137|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83943138|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943139|NCT05469659|Metformin|metformin|mesh-list
83943140|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
83943141|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943142|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943143|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83943144|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943145|NCT01808820|Imiquimod|imiquimod|mesh-list
83943146|NCT01808820|Vaccines|vaccines|mesh-list
83943147|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
83943148|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943149|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83943150|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943151|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
83943152|NCT05469386|Methylphenidate|methylphenidate|mesh-list
83943153|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84124683|NCT00682500|Calfactant|calfactant|mesh-list
83182392|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
83943154|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943155|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83943156|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83943157|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83943158|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943159|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
83943160|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943162|NCT05469347|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83943163|NCT05469347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83943164|NCT05469347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83943165|NCT05469347|Antimetabolites|antimetabolites|mesh-ancestor
83943166|NCT05469347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943167|NCT05469347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83943168|NCT05469347|Protease Inhibitors|protease inhibitors|mesh-ancestor
83943169|NCT05469347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943170|NCT05469347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83943171|NCT01462890|Paclitaxel|paclitaxel|mesh-list
83943172|NCT01462890|Bevacizumab|bevacizumab|mesh-list
83943173|NCT01462890|Carboplatin|carboplatin|mesh-list
83943174|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83943175|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943176|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83943177|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83943178|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83943179|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943180|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83943181|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83943182|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83943183|NCT01462890|Growth Substances|growth substances|mesh-ancestor
83943184|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943185|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
83943186|NCT05469113|Repaglinide|repaglinide|mesh-list
83943187|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943188|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943189|NCT01259713|Amphotericin B|amphotericin b|mesh-list
83943190|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83943191|NCT01259713|Amebicides|amebicides|mesh-ancestor
83943192|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83943193|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83943194|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943195|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83943196|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
83943197|NCT05469035|Heparin|heparin|mesh-list
83943198|NCT05469035|Calcium heparin|calcium heparin|mesh-list
83943199|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
83943200|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83943201|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83943202|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943203|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
83943204|NCT05582590|Fludarabine|fludarabine|mesh-list
83943205|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83943206|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
83943207|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943208|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943209|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83943210|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
83943211|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943212|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943213|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83943214|NCT05468879|Glimepiride|glimepiride|mesh-list
83943215|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83943216|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943217|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943218|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83943219|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
83943220|NCT05471427|Docetaxel|docetaxel|mesh-list
83943221|NCT05471427|Taxane|taxane|mesh-list
83943222|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943223|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83943224|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83943225|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83943226|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943227|NCT05558449|Midazolam|midazolam|mesh-list
83943228|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83943229|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83943230|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943231|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943233|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83943234|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83943235|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83943236|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
83943237|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
83943238|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
83943239|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
83943240|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943241|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943242|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
83943243|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83943244|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
83943245|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943246|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
83943247|NCT04326985|Protective Agents|protective agents|mesh-ancestor
83943248|NCT00536393|Doxorubicin|doxorubicin|mesh-list
83943249|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83943250|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83943251|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943252|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83943253|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83943254|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943255|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943256|NCT00595543|Diclofenac|diclofenac|mesh-list
83943257|NCT00595543|Ketorolac|ketorolac|mesh-list
83943258|NCT00595543|Bromfenac|bromfenac|mesh-list
83943259|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83943260|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943261|NCT00595543|Analgesics|analgesics|mesh-ancestor
83943262|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
83943263|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943264|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943265|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943266|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943267|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83943268|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943269|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943270|NCT04326868|Albendazole|albendazole|mesh-list
83943271|NCT04326868|Mebendazole|mebendazole|mesh-list
83943272|NCT04326868|Benzimidazole|benzimidazole|mesh-list
83943273|NCT04326868|Pyrantel|pyrantel|mesh-list
83943274|NCT04326868|Anthelmintics|anthelmintics|mesh-list
83943275|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83943276|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943277|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
83943278|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83943279|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83943280|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
83943281|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
83943282|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
83943283|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943284|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943285|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
83943286|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83943287|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83943288|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83943289|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943290|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943291|NCT00595972|Endostar protein|endostar protein|mesh-list
83943292|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83943293|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83943294|NCT00595972|Growth Substances|growth substances|mesh-ancestor
83943295|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943296|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
83943297|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943298|NCT00596050|Lidocaine|lidocaine|mesh-list
83943299|NCT00596050|Fentanyl|fentanyl|mesh-list
83943300|NCT00596050|Midazolam|midazolam|mesh-list
83943301|NCT00596050|Ketamine|ketamine|mesh-list
83943302|NCT00596050|Etomidate|etomidate|mesh-list
83943303|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
83943304|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
83943305|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943306|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943307|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
83943308|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943309|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83943310|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83943311|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83943312|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83943313|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943314|NCT00596050|Analgesics|analgesics|mesh-ancestor
83943315|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83943316|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83943317|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
83943318|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83943319|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83943320|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943321|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83943322|NCT00596050|Narcotics|narcotics|mesh-ancestor
83943323|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83943324|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83943325|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83943326|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83943327|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83943328|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
83943329|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
83943330|NCT02888899|Loperamide|loperamide|mesh-list
83943331|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
83943332|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
83943333|NCT02888899|Psyllium|psyllium|mesh-list
83943334|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943335|NCT02888899|Cathartics|cathartics|mesh-ancestor
83943336|NCT05468645|Hemay005|hemay005|mesh-list
83943337|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83943338|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83943339|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83943340|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943341|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943342|NCT00596128|Insulin|insulin|mesh-list
83943343|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943344|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943345|NCT00596206|Leflunomide|leflunomide|mesh-list
83943346|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943347|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943348|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83943349|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
83943350|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943351|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83943352|NCT00624130|Dacuronium|dacuronium|mesh-list
83943353|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83943354|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943355|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83943356|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83943357|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83943358|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943359|NCT05468450|Polidocanol|polidocanol|mesh-list
83943360|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
83943361|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83943362|NCT05399329|Palbociclib|palbociclib|mesh-list
83943363|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943364|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943365|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943366|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943367|NCT00535860|Teriparatide|teriparatide|mesh-list
83943368|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83943369|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943370|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83943371|NCT00596479|Lenograstim|lenograstim|mesh-list
83943372|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83943373|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
83943374|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943375|NCT05468372|Amphotericin B|amphotericin b|mesh-list
83943376|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83943377|NCT05468372|Posaconazole|posaconazole|mesh-list
83943378|NCT05468372|Amebicides|amebicides|mesh-ancestor
83943379|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83943380|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83943381|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943382|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83943383|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
83943384|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83943385|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83943386|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83943387|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943388|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943389|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83943390|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
83943391|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943392|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943393|NCT04207957|Olorofim|olorofim|mesh-list
83943394|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
83943395|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943396|NCT00596557|Everolimus|everolimus|mesh-list
83943397|NCT00596557|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83943398|NCT00596557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943399|NCT00596557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943400|NCT00596557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943401|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83943402|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
83943403|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943404|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943405|NCT00596596|Prucalopride|prucalopride|mesh-list
83943406|NCT00596596|Laxatives|laxatives|mesh-ancestor
83943407|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943408|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83943409|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83943410|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
83943411|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943412|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943413|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943414|NCT05468294|Nivolumab|nivolumab|mesh-list
83943415|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83943416|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943417|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83943418|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943419|NCT05312866|Acetaminophen|acetaminophen|mesh-list
83943420|NCT05312866|Dexamethasone|dexamethasone|mesh-list
83943421|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
83943422|NCT05312866|Fentanyl|fentanyl|mesh-list
83943423|NCT05312866|Bupivacaine|bupivacaine|mesh-list
83943424|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943425|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
83943426|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
83943427|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943428|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943429|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943430|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
83943431|NCT05312866|Hormones|hormones|mesh-ancestor
83943432|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943433|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83943434|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943435|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
83943436|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
83943437|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943438|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
83943439|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83943440|NCT05312866|Narcotics|narcotics|mesh-ancestor
83943441|NCT05312866|Analgesics|analgesics|mesh-ancestor
83943442|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83943443|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83943444|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
83943445|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943446|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
83943447|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83943448|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
83943449|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83943450|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83943451|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943452|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83943453|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
83943454|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83943455|NCT04326790|Colchicine|colchicine|mesh-list
83943456|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
83943457|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943458|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
83943459|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
83943460|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
83943461|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943462|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943463|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83943464|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83943465|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83943466|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83943467|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943468|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943469|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943470|NCT00596986|Analgesics|analgesics|mesh-ancestor
83943471|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
83943472|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943473|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
83943474|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83943475|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
83943477|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943478|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
83943479|NCT00597064|Hormones|hormones|mesh-ancestor
83943480|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943481|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943482|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83943483|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943484|NCT00597181|Mitomycins|mitomycins|mesh-list
83943485|NCT00597181|Mitomycin|mitomycin|mesh-list
83943486|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83943487|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943488|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
83943489|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943490|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83943491|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943492|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83943493|NCT00597259|Entecavir|entecavir|mesh-list
83943494|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
83943495|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943496|NCT05470764|Amlodipine|amlodipine|mesh-list
83943497|NCT05470764|Perindopril|perindopril|mesh-list
83943498|NCT05470764|Indapamide|indapamide|mesh-list
83943499|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83943500|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83943501|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83943502|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943503|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83943504|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943505|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
83943506|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83943507|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
83943508|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943509|NCT05470764|Diuretics|diuretics|mesh-ancestor
83943510|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
83943511|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83943512|NCT00597415|Celecoxib|celecoxib|mesh-list
83943513|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83943514|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943515|NCT00597415|Analgesics|analgesics|mesh-ancestor
83943516|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
83943517|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943518|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943519|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943520|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943521|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83943522|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83943523|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943524|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943525|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
83943526|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83943527|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943528|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
83943529|NCT05470530|Dexamethasone|dexamethasone|mesh-list
83943530|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182838|NCT03367741|Nivolumab|nivolumab|mesh-list
83943531|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
83943532|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
83943533|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943534|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943535|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943536|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
83943537|NCT05470530|Hormones|hormones|mesh-ancestor
83943538|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943539|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83943540|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943541|NCT02891980|Vaccines|vaccines|mesh-list
83943542|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
83943543|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943544|NCT05467826|Ribavirin|ribavirin|mesh-list
83943545|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
83943546|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83943547|NCT05467826|Velpatasvir|velpatasvir|mesh-list
83943548|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
83943549|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943550|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
83943551|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943552|NCT00598156|Bevacizumab|bevacizumab|mesh-list
83943553|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83943554|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83943555|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943556|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83943557|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83943558|NCT00598156|Growth Substances|growth substances|mesh-ancestor
83943559|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943560|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
83943561|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943562|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943563|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943564|NCT00598195|Ketamine|ketamine|mesh-list
83943565|NCT00598195|Analgesics|analgesics|mesh-ancestor
83943566|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
83943567|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943568|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943569|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83943570|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83943571|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
83943572|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
83943573|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943574|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83943575|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83943576|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943577|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943578|NCT00598234|Celecoxib|celecoxib|mesh-list
83943579|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83943580|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943581|NCT00598234|Analgesics|analgesics|mesh-ancestor
83943582|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
83943583|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943584|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943585|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943586|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943587|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83943588|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83943589|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943590|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943591|NCT00598429|Alprostadil|alprostadil|mesh-list
83943592|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83943593|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
83943594|NCT00598429|Urological Agents|urological agents|mesh-ancestor
83943595|NCT00598624|Treosulfan|treosulfan|mesh-list
83943596|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83943597|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
83943598|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943599|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943600|NCT02891785|Antipain|antipain|mesh-list
83943601|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
83943602|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943603|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943604|NCT00598858|Prednisone|prednisone|mesh-list
83943605|NCT00598858|Cortisone|cortisone|mesh-list
83943606|NCT00598858|Docetaxel|docetaxel|mesh-list
83943607|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943608|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
83943609|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
83943610|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
83943611|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943612|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943613|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
83943614|NCT00598858|Hormones|hormones|mesh-ancestor
83943615|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943616|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943617|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83943618|NCT05466305|Cobalt|cobalt|mesh-list
83943619|NCT05466305|Trace Elements|trace elements|mesh-ancestor
83943620|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
83943621|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943622|NCT04207684|Testosterone|testosterone|mesh-list
83943623|NCT04207684|Androgens|androgens|mesh-ancestor
83943624|NCT04207684|Hormones|hormones|mesh-ancestor
83943625|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943626|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943627|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
83943628|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
83943629|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943630|NCT02909400|Protective Agents|protective agents|mesh-ancestor
83943631|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943632|NCT02909478|Dexamethasone|dexamethasone|mesh-list
83943633|NCT02909478|Aprepitant|aprepitant|mesh-list
83943634|NCT02909478|Tropisetron|tropisetron|mesh-list
83943635|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943636|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
83943637|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
83943638|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943639|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943640|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943641|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
83943642|NCT02909478|Hormones|hormones|mesh-ancestor
83943643|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943644|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83943645|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943646|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83943647|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943648|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943649|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83943650|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83943651|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
83943652|NCT00536211|Metformin|metformin|mesh-list
83943653|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943654|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943655|NCT00536705|Montelukast|montelukast|mesh-list
83943656|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83943657|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
83943658|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83943659|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
83943660|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943661|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943662|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83943663|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83943664|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943665|NCT00624208|Droperidol|droperidol|mesh-list
83943666|NCT00624208|Ondansetron|ondansetron|mesh-list
83943667|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
83943668|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
83943669|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943670|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943671|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943672|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
83943673|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
83943674|NCT00624208|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83943675|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83943676|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
83943677|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943678|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943679|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83943680|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83943681|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83943682|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943683|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83943684|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83943685|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83943686|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
83943687|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83943688|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
83943689|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83943690|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83943691|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83943692|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943693|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943695|NCT04685642|Atorvastatin|atorvastatin|mesh-list
83943696|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83943697|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943698|NCT04685642|Analgesics|analgesics|mesh-ancestor
83943699|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
83943700|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943701|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943702|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943703|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943704|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83943705|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83943706|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943707|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83943708|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83943709|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943710|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
83943711|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83943712|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83943713|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
83943714|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83943715|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83943716|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
83943717|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
83943718|NCT05312346|Hematinics|hematinics|mesh-ancestor
83943719|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
83943720|NCT05312346|Vitamins|vitamins|mesh-ancestor
83943721|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
83943722|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943723|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
83943724|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
83943725|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
83943726|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943727|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943728|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
83943729|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943730|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83943731|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943732|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943733|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943734|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943735|NCT05469984|Gentamicins|gentamicins|mesh-list
83943736|NCT05469984|Ampicillin|ampicillin|mesh-list
83943737|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83943738|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943739|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83943740|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943741|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943742|NCT05312190|Progesterone|progesterone|mesh-list
83943743|NCT05312190|Progestins|progestins|mesh-ancestor
83943744|NCT05312190|Hormones|hormones|mesh-ancestor
83943745|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943746|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943747|NCT00537173|Paclitaxel|paclitaxel|mesh-list
83943748|NCT00537173|Bevacizumab|bevacizumab|mesh-list
83943749|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83943750|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182999|NCT03237611|Hormones|hormones|mesh-ancestor
83943751|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83943752|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83943753|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83943754|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943755|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83943756|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83943757|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83943758|NCT00537173|Growth Substances|growth substances|mesh-ancestor
83943759|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943760|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
83943761|NCT02503839|Etoricoxib|etoricoxib|mesh-list
83943762|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83943763|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943764|NCT02503839|Analgesics|analgesics|mesh-ancestor
83943765|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
83943766|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943767|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943768|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83943769|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943770|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83943771|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83943772|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943773|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943774|NCT05469750|Capecitabine|capecitabine|mesh-list
83943775|NCT05469750|Letrozole|letrozole|mesh-list
83943776|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83943777|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
83943778|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943779|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943780|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83943781|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83943782|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943783|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83943784|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
83943785|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943786|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943787|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
83943788|NCT02143830|Busulfan|busulfan|mesh-list
83943789|NCT02143830|Fludarabine|fludarabine|mesh-list
83943790|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
83943791|NCT02143830|Lenograstim|lenograstim|mesh-list
83943792|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83943793|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
83943794|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943795|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943796|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83943797|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
83943798|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943799|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943800|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83413749|NCT01896349|Sertraline|sertraline|mesh-list
83943801|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83943802|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
83943803|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943804|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943805|NCT03457194|Vaccines|vaccines|mesh-list
83943806|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
83943807|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943808|NCT05478707|Dulaglutide|dulaglutide|mesh-list
83943809|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943810|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943811|NCT05469204|Acetaminophen|acetaminophen|mesh-list
83943812|NCT05469204|Digoxin|digoxin|mesh-list
83943813|NCT05469204|Midazolam|midazolam|mesh-list
83943814|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83943815|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83943816|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83943817|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943818|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943819|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83943820|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83943821|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83943822|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83943823|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
83943824|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
83943825|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
83943826|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
83943827|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183080|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
84124684|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83943828|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943829|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83943830|NCT05469204|Analgesics|analgesics|mesh-ancestor
83943831|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
83943832|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943833|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
83943834|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83943835|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83943836|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943837|NCT05469204|Protective Agents|protective agents|mesh-ancestor
83943838|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
83943839|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
83943840|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
83943841|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943842|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83943843|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
83943844|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
83943845|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943846|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943847|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943848|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83943849|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
83943850|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83943851|NCT04319926|Lidocaine|lidocaine|mesh-list
83943852|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
83943853|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
83943854|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943855|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943856|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
83943857|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943858|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83943859|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83943860|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83943861|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83943862|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943863|NCT01313923|Sirolimus|sirolimus|mesh-list
83943864|NCT01313923|Temsirolimus|temsirolimus|mesh-list
83943865|NCT01313923|MTOR Inhibitors|mtor inhibitors|mesh-list
83943866|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83943867|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943868|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83943869|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943870|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
83943871|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83943872|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
83943873|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943874|NCT01313923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943875|NCT01313923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943876|NCT01313923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943877|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
83943878|NCT01313884|Temozolomide|temozolomide|mesh-list
83943879|NCT01313884|Doxorubicin|doxorubicin|mesh-list
83943880|NCT01313884|Irinotecan|irinotecan|mesh-list
83943881|NCT01313884|Vincristine|vincristine|mesh-list
83943882|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83943883|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
83943884|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943885|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83943886|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83943887|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
83943888|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943889|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943890|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83943891|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83943892|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83943893|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83943894|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943895|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83943896|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83943897|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
83943898|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
83943899|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
83943900|NCT00537524|Vaccines|vaccines|mesh-list
83943901|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
83943902|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943903|NCT00537563|Telithromycin|telithromycin|mesh-list
83943904|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83943905|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943906|NCT00537602|Miglustat|miglustat|mesh-list
83943907|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943908|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943909|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83943910|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83943911|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
83943912|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943913|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83943914|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943915|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943916|NCT01259284|Atorvastatin|atorvastatin|mesh-list
83943917|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83943918|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83943919|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
83943920|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943921|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83943922|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83943923|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943924|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
83943925|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83943926|NCT00537836|Estradiol|estradiol|mesh-list
83943927|NCT00537836|Estrogens|estrogens|mesh-ancestor
83943928|NCT00537836|Hormones|hormones|mesh-ancestor
83943929|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943930|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943931|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
83943932|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83943933|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943934|NCT05338658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83943935|NCT05338658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943936|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
83943937|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83943938|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
83943939|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943940|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943941|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83943942|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
83943943|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83943944|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
83943945|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943946|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943947|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83943948|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
83943949|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
83943950|NCT02277171|Protective Agents|protective agents|mesh-ancestor
83943951|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
83943952|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943953|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943954|NCT05105061|Ketamine|ketamine|mesh-list
83943955|NCT05105061|Analgesics|analgesics|mesh-ancestor
83943956|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
83943957|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83943958|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943959|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83943960|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83943961|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
83943962|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
83943963|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943964|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83943965|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83943966|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83943967|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943968|NCT05056584|Glucagon|glucagon|mesh-list
83943969|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83943970|NCT05056584|Hormones|hormones|mesh-ancestor
83943971|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83943972|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943973|NCT00551954|Acarbose|acarbose|mesh-list
83943974|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83943975|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83943976|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943977|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83943978|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943980|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83943981|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943982|NCT05467878|Anesthetics|anesthetics|mesh-list
83943983|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83943984|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943985|NCT00536640|Bevacizumab|bevacizumab|mesh-list
83943986|NCT00536640|Gemcitabine|gemcitabine|mesh-list
83943987|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83943988|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83943989|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83943990|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83943991|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83943992|NCT00536640|Growth Substances|growth substances|mesh-ancestor
83943993|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83943994|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
83943995|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83943996|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
83943997|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83943998|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83943999|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944000|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
83944001|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944002|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944003|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83944004|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944005|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83944006|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944007|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944008|NCT00552266|Methylphenidate|methylphenidate|mesh-list
83944009|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83944010|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944011|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83944012|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83944013|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944014|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944015|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
83944016|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944017|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
83944018|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83944019|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944020|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
83944021|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944022|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944023|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83944024|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
83944025|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944026|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944027|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83944028|NCT00552461|Rituximab|rituximab|mesh-list
83944029|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83944030|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944031|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
83944032|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944033|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944034|NCT00552500|Valproic Acid|valproic acid|mesh-list
83944035|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
83944036|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944037|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944038|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
83944039|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944040|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944041|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
83944042|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83944043|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944044|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944045|NCT01258738|Etanercept|etanercept|mesh-list
83944046|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83944047|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83944048|NCT01258738|Analgesics|analgesics|mesh-ancestor
83183296|NCT01677507|Latanoprost|latanoprost|mesh-list
83183316|NCT03522753|Hormones|hormones|mesh-ancestor
83944049|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
83944050|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944051|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944052|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944053|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944054|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83944055|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944056|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
83944057|NCT00552656|Sirolimus|sirolimus|mesh-list
83944058|NCT00552656|Temsirolimus|temsirolimus|mesh-list
83944059|NCT00552656|MTOR Inhibitors|mtor inhibitors|mesh-list
83944060|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83944061|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944062|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83944063|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944064|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
83944065|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944066|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
83944067|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944068|NCT00552656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83944069|NCT00552656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944070|NCT00552656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944071|NCT01824537|Vaccines|vaccines|mesh-list
83944072|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
83944073|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944074|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
83944075|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83944076|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83944077|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944078|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
83944079|NCT04863339|Coagulants|coagulants|mesh-ancestor
83944080|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
83944081|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944082|NCT00552734|Insulin|insulin|mesh-list
83944083|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83944084|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83944085|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944086|NCT04543682|Iloprost|iloprost|mesh-list
83944087|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83944088|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
83944089|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
83944090|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83944091|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
83944092|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944093|NCT01258660|Folic Acid|folic acid|mesh-list
83944094|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
83944095|NCT01258660|Drospirenone|drospirenone|mesh-list
83944096|NCT01258660|Hematinics|hematinics|mesh-ancestor
83944097|NCT01258660|Vitamins|vitamins|mesh-ancestor
83944098|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
83944099|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944100|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83944101|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
83944102|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944103|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83944104|NCT01258660|Diuretics|diuretics|mesh-ancestor
83944105|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
83944106|NCT04772274|Ustekinumab|ustekinumab|mesh-list
83944107|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
83944108|NCT04362527|Milrinone|milrinone|mesh-list
83944109|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83944110|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83944111|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83944112|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
83944113|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83944114|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83944115|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944116|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944117|NCT04362527|Protective Agents|protective agents|mesh-ancestor
83944118|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944119|NCT04758975|Rituximab|rituximab|mesh-list
83944120|NCT04758975|Venetoclax|venetoclax|mesh-list
83944121|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83944122|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944123|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
83944124|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944125|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944126|NCT01614171|Hormones|hormones|mesh-list
83944127|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944128|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944129|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83944130|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
83944131|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83944132|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83944133|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944134|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944135|NCT05567367|Urological Agents|urological agents|mesh-ancestor
83944136|NCT04656951|Daratumumab|daratumumab|mesh-list
83944137|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944138|NCT04173533|Azacitidine|azacitidine|mesh-list
83944139|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83944140|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
83944141|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944142|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944143|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944144|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
83944145|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83944146|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944147|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83944148|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83944149|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944150|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944151|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944152|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944153|NCT04137107|Analgesics|analgesics|mesh-ancestor
83944154|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
83944155|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944156|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
83944157|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944158|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
83944159|NCT01258348|Sunitinib|sunitinib|mesh-list
83944160|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944161|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83944162|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83944163|NCT01258348|Growth Substances|growth substances|mesh-ancestor
83944164|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944165|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
83944166|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83944167|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944168|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944169|NCT05136898|Mitomycins|mitomycins|mesh-list
83944170|NCT05136898|Mitomycin|mitomycin|mesh-list
83944171|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83944172|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944173|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
83944174|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944175|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83944176|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944177|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83944178|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83944179|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83944180|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
83944181|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944182|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83944183|NCT04687878|Insulin|insulin|mesh-list
83944184|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83944185|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83944186|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944187|NCT05116774|Eculizumab|eculizumab|mesh-list
83944188|NCT05116774|Ravulizumab|ravulizumab|mesh-list
83944189|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83944190|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944191|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
83944192|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944193|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83944194|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83944195|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
83944196|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944197|NCT04687566|Memantine|memantine|mesh-list
83944198|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
83944199|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83183449|NCT04430699|Cisplatin|cisplatin|mesh-list
83944200|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83944201|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
83944202|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944203|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944204|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944205|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83944206|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83944207|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
83944208|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
83944209|NCT01256593|Pregabalin|pregabalin|mesh-list
83944210|NCT01256593|Analgesics|analgesics|mesh-ancestor
83944211|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
83944212|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944213|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944214|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
83944215|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83944216|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944217|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944218|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83944219|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83944220|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83944221|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944222|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944223|NCT01256476|Pravastatin|pravastatin|mesh-list
83944224|NCT01256476|Pitavastatin|pitavastatin|mesh-list
83944225|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83944226|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83944227|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
83944228|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944229|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83944230|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83944231|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944232|NCT05507892|Canagliflozin|canagliflozin|mesh-list
83944233|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83944234|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944235|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83944236|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944237|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
83944238|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83944239|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944240|NCT05491083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83944241|NCT05491083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944242|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
83944243|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83944244|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944245|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944246|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83944247|NCT04106999|Analgesics|analgesics|mesh-ancestor
83944248|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
83944249|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944250|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83944251|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83944252|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83944253|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
83944254|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944255|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944256|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
83944257|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83944258|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944259|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83944260|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
83944261|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944262|NCT05003089|Prednisolone|prednisolone|mesh-list
83944263|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944264|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
83944265|NCT05003089|Hormones|hormones|mesh-ancestor
83944266|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183514|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
83183515|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83183516|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
83183517|NCT04636671|Dexamethasone|dexamethasone|mesh-list
83183518|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
83944267|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944268|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83944269|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944271|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83944272|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83944273|NCT04207021|Analgesics|analgesics|mesh-ancestor
83944274|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
83944275|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944276|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944277|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944278|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944279|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944280|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944281|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944282|NCT01255423|Diclofenac|diclofenac|mesh-list
83944283|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83944284|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83944285|NCT01255423|Analgesics|analgesics|mesh-ancestor
83944286|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
83944287|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944288|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944289|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944290|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944291|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83944292|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944293|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944294|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83944295|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83944296|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83944297|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83944298|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83944299|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83944300|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944301|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944302|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944303|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83944304|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
83944305|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944306|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83944307|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83944308|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944309|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944310|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
83944311|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83944312|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
83944313|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944314|NCT04005053|Expectorants|expectorants|mesh-ancestor
83944315|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83944316|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83944317|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
83944318|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944319|NCT04005053|Protective Agents|protective agents|mesh-ancestor
83944320|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944321|NCT04005053|Antidotes|antidotes|mesh-ancestor
83944322|NCT04003805|Nicotine|nicotine|mesh-list
83944323|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83944324|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
83944325|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944326|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944327|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83944328|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83944329|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
83944330|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944331|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944332|NCT04842604|Azacitidine|azacitidine|mesh-list
83944333|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83944334|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
83944335|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944336|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944337|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944338|NCT01254604|Timolol|timolol|mesh-list
83944339|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944340|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83944341|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83944342|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
83944343|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944344|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944345|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83944346|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83944347|NCT01220583|Cisplatin|cisplatin|mesh-list
83944348|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944349|NCT03911414|Inositol|inositol|mesh-list
83944350|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
83944351|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83944352|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
83944353|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944354|NCT03911414|Expectorants|expectorants|mesh-ancestor
83944355|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
83944356|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83944357|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
83944358|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944359|NCT03911414|Protective Agents|protective agents|mesh-ancestor
83944360|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944361|NCT03911414|Antidotes|antidotes|mesh-ancestor
83944362|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
83944363|NCT03911414|Vitamins|vitamins|mesh-ancestor
83944364|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
83944365|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
83944366|NCT04390698|Anesthetics|anesthetics|mesh-list
83944367|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944368|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944369|NCT04390698|Narcotics|narcotics|mesh-ancestor
83944370|NCT04390698|Analgesics|analgesics|mesh-ancestor
83944371|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
83944372|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944373|NCT03795701|Liraglutide|liraglutide|mesh-list
83944374|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83944375|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944376|NCT03795701|Incretins|incretins|mesh-ancestor
83944377|NCT03795701|Hormones|hormones|mesh-ancestor
83944378|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944379|NCT04673578|Celecoxib|celecoxib|mesh-list
83944380|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83944381|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83944382|NCT04673578|Analgesics|analgesics|mesh-ancestor
83944383|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
83944384|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944385|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944386|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944387|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944388|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83944389|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83944390|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944391|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944392|NCT05414058|Methylphenidate|methylphenidate|mesh-list
83944393|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83944394|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944395|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83944396|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83944397|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944398|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944399|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
83944400|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944401|NCT03757403|Mebendazole|mebendazole|mesh-list
83944402|NCT03757403|Piperazine|piperazine|mesh-list
83944403|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
83944404|NCT03757403|DMP 777|dmp 777|mesh-list
83944405|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
83944406|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
83944407|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83944408|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944409|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
83944410|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
83944411|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83944412|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944413|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944414|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944415|NCT00537342|Immunomodulating Agents|immunomodulating agents|mesh-list
83944416|NCT00537342|Immunologic Factors|immunologic factors|mesh-ancestor
83944417|NCT00537342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944418|NCT00537420|Sibutramine|sibutramine|mesh-list
83944419|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
83944420|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944421|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
83944422|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83944423|NCT03534284|Trazodone|trazodone|mesh-list
83944424|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83944425|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83944426|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944427|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944428|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944429|NCT03534284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83944430|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83944431|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944432|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944433|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944434|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
83944435|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83944436|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
83944437|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
83944438|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83944439|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
83944440|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83944441|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944442|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83944443|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83944444|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83944445|NCT04683458|Paclitaxel|paclitaxel|mesh-list
83944446|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83944447|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83944448|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944449|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
83944450|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
83944451|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
83944452|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944453|NCT01253317|Mecasermin|mecasermin|mesh-list
83944454|NCT01253317|Growth Substances|growth substances|mesh-ancestor
83944455|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944456|NCT00537537|Telbivudine|telbivudine|mesh-list
83944457|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
83944458|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944459|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83944460|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944461|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944462|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
83944463|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83944464|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
83944465|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944466|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
83944467|NCT04319770|Protective Agents|protective agents|mesh-ancestor
83944468|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83944469|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
83944470|NCT02722616|Pancrelipase|pancrelipase|mesh-list
83944471|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83944472|NCT01253200|Acifluorfen|acifluorfen|mesh-list
83944473|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944474|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944475|NCT04515901|Lidocaine|lidocaine|mesh-list
83944476|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
83944477|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
83944478|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944479|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944480|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
83944481|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944482|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83944483|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83944484|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83944485|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944486|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944487|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
83944488|NCT02605421|Melphalan|melphalan|mesh-list
83944489|NCT02605421|Thiotepa|thiotepa|mesh-list
83944490|NCT02605421|Carboplatin|carboplatin|mesh-list
83944491|NCT02605421|Etoposide|etoposide|mesh-list
83944493|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944494|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
83944495|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944496|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944497|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83944498|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
83944499|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944500|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944501|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83944502|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83944503|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83944504|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83944505|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944506|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83944507|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
83944508|NCT04320589|Anesthetics|anesthetics|mesh-list
83944509|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
83944510|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83944511|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944512|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944513|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83944514|NCT04320589|Analgesics|analgesics|mesh-ancestor
83944515|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
83944516|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944517|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83944518|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83944519|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83944520|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
83944521|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944522|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944523|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
83944524|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83944525|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
83944526|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944527|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944528|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83944529|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
83944530|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83944531|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
83944532|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944533|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944534|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83944535|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
83944536|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
83944537|NCT04397692|Protective Agents|protective agents|mesh-ancestor
83944538|NCT02203643|Dexamethasone|dexamethasone|mesh-list
83944539|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
83944540|NCT02203643|Lenalidomide|lenalidomide|mesh-list
83944541|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944542|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
83944543|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944544|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944545|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83944546|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
83944547|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944548|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944549|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83944550|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944551|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
83944552|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
83944553|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944554|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83944555|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
83944556|NCT02203643|Hormones|hormones|mesh-ancestor
83944557|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944558|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83944559|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83944560|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83944561|NCT02203643|Growth Substances|growth substances|mesh-ancestor
83944562|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83944563|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
83944564|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
83944565|NCT01252186|Desogestrel|desogestrel|mesh-list
83944566|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
83944567|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83944568|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944569|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83944570|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83944571|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83944572|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83944573|NCT01252186|Progestins|progestins|mesh-ancestor
83944574|NCT01252186|Hormones|hormones|mesh-ancestor
83944575|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944576|NCT02188745|Letrozole|letrozole|mesh-list
83944577|NCT02188745|Anastrozole|anastrozole|mesh-list
83944578|NCT02188745|Exemestane|exemestane|mesh-list
83944579|NCT02188745|Estradiol|estradiol|mesh-list
83944580|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83944581|NCT02188745|Estrogens|estrogens|mesh-ancestor
83944582|NCT02188745|Hormones|hormones|mesh-ancestor
83944583|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944584|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944585|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944586|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83944587|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944588|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944589|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83944590|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
83944591|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83944592|NCT01731782|Bupivacaine|bupivacaine|mesh-list
83944593|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
83944594|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
83944595|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944596|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944597|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
83944598|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944599|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
83944600|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944601|NCT04356430|Prednisone|prednisone|mesh-list
83944602|NCT04356430|Goserelin|goserelin|mesh-list
83944603|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
83944604|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944605|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
83944606|NCT04356430|Hormones|hormones|mesh-ancestor
83944607|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944608|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944609|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83944610|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944611|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83944612|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944613|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944614|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
83944615|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83944616|NCT03974139|Metformin|metformin|mesh-list
83944617|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83944618|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944619|NCT04320238|Interferons|interferons|mesh-list
83944620|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
83944621|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83944622|NCT04320238|Thymalfasin|thymalfasin|mesh-list
83944623|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944624|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
83944625|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944626|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
83944627|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944628|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83944629|NCT01229072|Heparin|heparin|mesh-list
83944630|NCT01229072|Calcium heparin|calcium heparin|mesh-list
83944631|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
83944632|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83944633|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83944634|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944635|NCT01199978|Losartan|losartan|mesh-list
83944636|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83944637|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83944638|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83944639|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83944640|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944641|NCT00532116|Selegiline|selegiline|mesh-list
83944642|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
83944643|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944644|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83944645|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83944646|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83944647|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944648|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944649|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83944650|NCT00532116|Protective Agents|protective agents|mesh-ancestor
83944651|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944653|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
83944654|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944655|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
83944656|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944657|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
83944658|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83944659|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83944660|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83944661|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944662|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944663|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
83944664|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944665|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944666|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83944667|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944668|NCT03910998|Rocuronium|rocuronium|mesh-list
83944669|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83944670|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83944671|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83944672|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944673|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944674|NCT04685148|Estradiol|estradiol|mesh-list
83944675|NCT04685148|Estrogens|estrogens|mesh-ancestor
83944676|NCT04685148|Hormones|hormones|mesh-ancestor
83944677|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944678|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944679|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
83944680|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83944681|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83944682|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83944683|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944684|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944685|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
83944686|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944687|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944688|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83944689|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944690|NCT04246684|Leucovorin|leucovorin|mesh-list
83944691|NCT04246684|Folic Acid|folic acid|mesh-list
83944692|NCT04246684|Capecitabine|capecitabine|mesh-list
83944693|NCT04246684|Fluorouracil|fluorouracil|mesh-list
83944694|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
83944695|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
83944696|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83944697|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
83944698|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944699|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944700|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944701|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
83944702|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944703|NCT04246684|Antidotes|antidotes|mesh-ancestor
83944704|NCT04246684|Protective Agents|protective agents|mesh-ancestor
83944705|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
83944706|NCT04246684|Vitamins|vitamins|mesh-ancestor
83944707|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
83944708|NCT04246684|Hematinics|hematinics|mesh-ancestor
83944709|NCT03883893|Acetaminophen|acetaminophen|mesh-list
83944710|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83944711|NCT03883893|Analgesics|analgesics|mesh-ancestor
83944712|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
83944713|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944714|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944715|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
83944716|NCT00537732|Omeprazole|omeprazole|mesh-list
83944717|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83944718|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83944719|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83944720|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944721|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944722|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
83944723|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83944724|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
83944725|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83944726|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
83944727|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944728|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944729|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
83944730|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83944731|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944732|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83944733|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944734|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944735|NCT04320277|Ritonavir|ritonavir|mesh-list
83944736|NCT04320277|Lopinavir|lopinavir|mesh-list
83944737|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83944738|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83944739|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
83944740|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944741|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944742|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83944743|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83944744|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
83944745|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944746|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83944747|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83944748|NCT01250002|Lidocaine|lidocaine|mesh-list
83944749|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
83944750|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
83944751|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944752|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944753|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
83944754|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944755|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83944756|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83944757|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83944758|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944759|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944760|NCT04157153|Sirolimus|sirolimus|mesh-list
83944761|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83944762|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944763|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83944764|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944765|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
83944766|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944767|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
83944768|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944769|NCT05329116|Lidocaine|lidocaine|mesh-list
83944770|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
83944771|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
83944772|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
83944773|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944774|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944775|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
83944776|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944777|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83944778|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83944779|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83944780|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944781|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944782|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83944783|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944784|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83944785|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83944786|NCT05329116|Protective Agents|protective agents|mesh-ancestor
83944787|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
83944788|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83944789|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
83944790|NCT00537888|Fluconazole|fluconazole|mesh-list
83944791|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
83944792|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944793|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83944794|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83944795|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944796|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944797|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83944798|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
83944799|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944800|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944801|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83944802|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83944803|NCT05264142|Voriconazole|voriconazole|mesh-list
83944804|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
83944805|NCT05264142|Omeprazole|omeprazole|mesh-list
83944806|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83944807|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83944808|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83944809|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944810|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944811|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
83944812|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944813|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83944814|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83944815|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83944816|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
83944817|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944818|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944819|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83944820|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83944821|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83944822|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944823|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944824|NCT05264142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83944825|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83944826|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83944827|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944828|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
83944829|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83944830|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
83944831|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83944832|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83944833|NCT01246960|Leucovorin|leucovorin|mesh-list
83944834|NCT01246960|Fluorouracil|fluorouracil|mesh-list
83944835|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
83944836|NCT01246960|Ramucirumab|ramucirumab|mesh-list
83944837|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
83944838|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944839|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83944840|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944841|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944842|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
83944843|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944844|NCT01246960|Antidotes|antidotes|mesh-ancestor
83944845|NCT01246960|Protective Agents|protective agents|mesh-ancestor
83944846|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
83944847|NCT01246960|Vitamins|vitamins|mesh-ancestor
83944848|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
83944849|NCT00544986|Anastrozole|anastrozole|mesh-list
83944850|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83944851|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944852|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83944853|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83944854|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944855|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944856|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83944857|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
83944858|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944859|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944860|NCT03851588|Dolutegravir|dolutegravir|mesh-list
83944861|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83944862|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83944863|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944864|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944865|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83944866|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83944867|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
83944868|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944869|NCT05239182|Gemcitabine|gemcitabine|mesh-list
83944870|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83944871|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83944872|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
83944873|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944874|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944875|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
83944877|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
83944878|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
83944879|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83944880|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83944881|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944882|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944883|NCT01244620|Urological Agents|urological agents|mesh-ancestor
83944884|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83944885|NCT04319692|Acetic Acid|acetic acid|mesh-list
83944886|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83944887|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944888|NCT00545142|Valproic Acid|valproic acid|mesh-list
83944889|NCT00545142|Aripiprazole|aripiprazole|mesh-list
83944890|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
83944891|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83944892|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83944893|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83944894|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83944895|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944896|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
83944897|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
83944898|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944899|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944900|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83944901|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83944902|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
83944903|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83944904|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83944905|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83944906|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83944907|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
83944908|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944909|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
83944910|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
83944911|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
83944912|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83944913|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83944914|NCT01267201|Prednisolone|prednisolone|mesh-list
83944915|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
83944916|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83944917|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
83944918|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83944919|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
83944920|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
83944921|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944922|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944923|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83944924|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
83944925|NCT01267201|Hormones|hormones|mesh-ancestor
83944926|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944927|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83944928|NCT01267201|Protective Agents|protective agents|mesh-ancestor
83944929|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83944930|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944931|NCT03778931|Fulvestrant|fulvestrant|mesh-list
83944932|NCT03778931|Anastrozole|anastrozole|mesh-list
83944933|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83944934|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944935|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83944936|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83944937|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
83944938|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83944939|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944940|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83944941|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83944942|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944943|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944945|NCT03736616|Rituximab|rituximab|mesh-list
83944946|NCT03736616|Carboplatin|carboplatin|mesh-list
83944947|NCT03736616|Etoposide|etoposide|mesh-list
83944948|NCT03736616|Melphalan|melphalan|mesh-list
83944949|NCT03736616|Ifosfamide|ifosfamide|mesh-list
83944950|NCT03736616|Carmustine|carmustine|mesh-list
83944951|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
83944952|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83944953|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83944954|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
83944955|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944956|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83944957|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83944958|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83944959|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83944960|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944961|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944962|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83944963|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
83944964|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
83944965|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83944966|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83944967|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83944968|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
83944969|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83944970|NCT03718403|Theophylline|theophylline|mesh-list
83944971|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83944972|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
83944973|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83944974|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83944975|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83944976|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
83944977|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83944978|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83944979|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83944980|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
83944981|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83944982|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83944983|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
83944984|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83944985|NCT00537966|Ritonavir|ritonavir|mesh-list
83944986|NCT00537966|Darunavir|darunavir|mesh-list
83944987|NCT00537966|Tenofovir|tenofovir|mesh-list
83944988|NCT00537966|Lamivudine|lamivudine|mesh-list
83944989|NCT00537966|Emtricitabine|emtricitabine|mesh-list
83944990|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
83944991|NCT00537966|Dolutegravir|dolutegravir|mesh-list
83944992|NCT00537966|Abacavir|abacavir|mesh-list
83944993|NCT00537966|Cobicistat|cobicistat|mesh-list
83944994|NCT00537966|Rilpivirine|rilpivirine|mesh-list
83944995|NCT00537966|Elvitegravir|elvitegravir|mesh-list
83944996|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83944997|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83944998|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
83944999|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945000|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945001|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83945002|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83945003|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
83945004|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945005|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83945006|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83945007|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83945008|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83945009|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83945010|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83945011|NCT01266967|Dabrafenib|dabrafenib|mesh-list
83945012|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945013|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945014|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945015|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945016|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
83945017|NCT03615326|Capecitabine|capecitabine|mesh-list
83945018|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
83945019|NCT03615326|Trastuzumab|trastuzumab|mesh-list
83945020|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945021|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83945022|NCT03615326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83945023|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945024|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83945025|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
83945026|NCT00538005|Bevacizumab|bevacizumab|mesh-list
83945027|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
83945028|NCT00538005|Sorafenib|sorafenib|mesh-list
83945029|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83945030|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945031|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83945032|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83945033|NCT00538005|Growth Substances|growth substances|mesh-ancestor
83945034|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945035|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
83945036|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945037|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945038|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945039|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
83945040|NCT03610412|Antacids|antacids|mesh-ancestor
83945041|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945042|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945043|NCT00538044|Simvastatin|simvastatin|mesh-list
83945044|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83945045|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83945046|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
83945047|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945048|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83945049|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83945050|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945051|NCT03504956|Metoprolol|metoprolol|mesh-list
83945052|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83945053|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83945054|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83945055|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
83945056|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
83945057|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945058|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945059|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83945060|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83945061|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
83945062|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945063|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945064|NCT00545493|Tacrolimus|tacrolimus|mesh-list
83945065|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
83945066|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83945067|NCT00545493|Antibodies|antibodies|mesh-list
83945068|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945069|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
83945070|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945071|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83945072|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945073|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945074|NCT01266460|Vaccines|vaccines|mesh-list
83945075|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
83945076|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945077|NCT05119257|Antibodies|antibodies|mesh-list
83945078|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83945079|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
83945080|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945081|NCT01266265|Treprostinil|treprostinil|mesh-list
83945082|NCT01266265|Bosentan|bosentan|mesh-list
83945083|NCT01266265|Ambrisentan|ambrisentan|mesh-list
83945084|NCT01266265|Epoprostenol|epoprostenol|mesh-list
83945085|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
83945086|NCT01266265|Tadalafil|tadalafil|mesh-list
83945087|NCT01266265|Iloprost|iloprost|mesh-list
83945088|NCT01266265|Tezosentan|tezosentan|mesh-list
83945089|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83184367|NCT03579693|Niacin|niacin|mesh-list
83945090|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945091|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83945092|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945093|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945094|NCT01266265|Urological Agents|urological agents|mesh-ancestor
83945095|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83945096|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83945097|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83945098|NCT03338387|Acipimox|acipimox|mesh-list
83945099|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83945100|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
83945101|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945102|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83945103|NCT05112549|Nivolumab|nivolumab|mesh-list
83945104|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83945105|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945106|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83945107|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945108|NCT03268382|Doxorubicin|doxorubicin|mesh-list
83945109|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83945110|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83945111|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945112|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83945113|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83945114|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945115|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945116|NCT01266148|Cyclosporine|cyclosporine|mesh-list
83945117|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
83945118|NCT01266148|Everolimus|everolimus|mesh-list
83945119|NCT01266148|Cyclosporins|cyclosporins|mesh-list
83945120|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83945121|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945122|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945123|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945124|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
83945125|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945126|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
83945127|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945128|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
83945129|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945130|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83945131|NCT01266148|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83945132|NCT01266148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945133|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945134|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83945135|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83945136|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
83945137|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945138|NCT00538239|Sirolimus|sirolimus|mesh-list
83945139|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945140|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945141|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83945142|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945143|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
83945144|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945145|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
83945146|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945147|NCT00538317|Tirofiban|tirofiban|mesh-list
83945148|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83945149|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83945150|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945151|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83945152|NCT01265953|Sulforaphane|sulforaphane|mesh-list
83945153|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83945154|NCT01265953|Protective Agents|protective agents|mesh-ancestor
83945155|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945156|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945157|NCT01265875|Secretin|secretin|mesh-list
83945158|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945159|NCT01265875|Hormones|hormones|mesh-ancestor
83945160|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945161|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945162|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
83945163|NCT00538395|Doxorubicin|doxorubicin|mesh-list
83945164|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83184415|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
83945165|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945166|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
83945167|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945168|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945169|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83945170|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
83945171|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945172|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945173|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83945174|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83945175|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83945176|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83945177|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945178|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
83945179|NCT01265563|Silybin|silybin|mesh-list
83945180|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83945181|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
83945182|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945183|NCT01265563|Expectorants|expectorants|mesh-ancestor
83945184|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
83945185|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83945186|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
83945187|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945188|NCT01265563|Protective Agents|protective agents|mesh-ancestor
83945189|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945190|NCT01265563|Antidotes|antidotes|mesh-ancestor
83945191|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83945192|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945193|NCT01265056|Gabapentin|gabapentin|mesh-list
83945194|NCT01265056|Analgesics|analgesics|mesh-ancestor
83945195|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
83945196|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945197|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945198|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
83945199|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83945200|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83945201|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83945202|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83945203|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83945204|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83945205|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945206|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945207|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
83945208|NCT02942498|Vitamins|vitamins|mesh-list
83945209|NCT02942498|Vitamin E|vitamin e|mesh-list
83945210|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
83945211|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945212|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
83945213|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945214|NCT02942498|Protective Agents|protective agents|mesh-ancestor
83945215|NCT00545961|Amoxicillin|amoxicillin|mesh-list
83945216|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
83945217|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
83945218|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83945219|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945220|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945221|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83945222|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945223|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945224|NCT01264939|Omalizumab|omalizumab|mesh-list
83945225|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
83945226|NCT01264939|Promethazine|promethazine|mesh-list
83945227|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
83945228|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83945229|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
83945230|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83945231|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83945232|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
83945233|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83945234|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83945235|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83945236|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945237|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
83945238|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
83945239|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
83945240|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184488|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83945241|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
83945242|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
83945243|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945244|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
83945245|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945246|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945247|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
83945248|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
83945249|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
83945250|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945251|NCT02889367|Odalasvir|odalasvir|mesh-list
83945252|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
83945253|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945254|NCT00546039|Genistein|genistein|mesh-list
83945255|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83945256|NCT00546039|Protective Agents|protective agents|mesh-ancestor
83945257|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945258|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945259|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945260|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945261|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945262|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
83945263|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83945264|NCT00546039|Estrogens|estrogens|mesh-ancestor
83945265|NCT00546039|Hormones|hormones|mesh-ancestor
83945266|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945267|NCT01264081|Lapatinib|lapatinib|mesh-list
83945268|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945269|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945270|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945271|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945272|NCT02711969|Apatinib|apatinib|mesh-list
83945273|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945274|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945275|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945276|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945277|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
83945278|NCT01263925|Alprostadil|alprostadil|mesh-list
83945279|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83945280|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945281|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945282|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83945283|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83945284|NCT01263925|Protective Agents|protective agents|mesh-ancestor
83945285|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945286|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945287|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83945288|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
83945289|NCT01263925|Urological Agents|urological agents|mesh-ancestor
83945290|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
83945291|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
83945292|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83945293|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83945294|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945295|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945296|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945297|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945298|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
83945299|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83945300|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
83945301|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945302|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945303|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83945304|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
83945305|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
83945306|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83945307|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
83945308|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945309|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945310|NCT01263769|Axitinib|axitinib|mesh-list
83945311|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945312|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945313|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945314|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945315|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
83945316|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945317|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
83945318|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945319|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945320|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83945321|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
83945322|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945323|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945324|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83945325|NCT00539331|Paclitaxel|paclitaxel|mesh-list
83945326|NCT00539331|Carboplatin|carboplatin|mesh-list
83945327|NCT00539331|Cediranib|cediranib|mesh-list
83945328|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83945329|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945330|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
83945331|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
83945332|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
83945333|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945334|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945335|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945336|NCT02236013|Cytarabine|cytarabine|mesh-list
83945337|NCT02236013|Daunorubicin|daunorubicin|mesh-list
83945338|NCT02236013|Idarubicin|idarubicin|mesh-list
83945339|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83945340|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
83945341|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945342|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945343|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
83945344|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945345|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945346|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
83945347|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945348|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83945349|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83945350|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83945351|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945352|NCT00539409|Insulin|insulin|mesh-list
83945353|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
83945354|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83945355|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83945356|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945357|NCT01263691|Vaccines|vaccines|mesh-list
83945358|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
83945359|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945360|NCT02178410|Vitamin D|vitamin d|mesh-list
83945361|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
83945362|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
83945363|NCT02178410|Vitamins|vitamins|mesh-list
83945364|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
83945365|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945366|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83945367|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83945368|NCT00539448|Insulin|insulin|mesh-list
83945369|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83945370|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
83945371|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
83945372|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83945373|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945374|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
83945375|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83945376|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945377|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83945378|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945379|NCT01808456|Vaccines|vaccines|mesh-list
83945380|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
83945381|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945382|NCT01715714|Atorvastatin|atorvastatin|mesh-list
83945383|NCT01715714|Simvastatin|simvastatin|mesh-list
83945384|NCT01715714|Pravastatin|pravastatin|mesh-list
83945385|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83945386|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83945387|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
83945388|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945389|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83945390|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83945391|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945392|NCT01540253|Docetaxel|docetaxel|mesh-list
83945393|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945394|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
83945395|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
83945396|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
83945397|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945398|NCT01497392|Gemcitabine|gemcitabine|mesh-list
83945399|NCT01497392|Capecitabine|capecitabine|mesh-list
83945400|NCT01497392|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83945401|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83945402|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
83945403|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945404|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945405|NCT01497392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945406|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945407|NCT01310192|Choline|choline|mesh-list
83945408|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
83945409|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83945410|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
83945411|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945412|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945413|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83945414|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
83945415|NCT00539565|Prednisolone|prednisolone|mesh-list
83945416|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83945417|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
83945418|NCT00539565|Hormones|hormones|mesh-ancestor
83945419|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945420|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945421|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83945422|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945423|NCT00539799|Prednisolone|prednisolone|mesh-list
83945424|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83945425|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
83945426|NCT00539799|Hormones|hormones|mesh-ancestor
83945427|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945428|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945429|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83945430|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945431|NCT00945152|Vancomycin|vancomycin|mesh-list
83945432|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945433|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945434|NCT00546507|Celecoxib|celecoxib|mesh-list
83945435|NCT00546507|Diclofenac|diclofenac|mesh-list
83945436|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83945437|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83945438|NCT00546507|Analgesics|analgesics|mesh-ancestor
83945439|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
83945440|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945441|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945442|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83945443|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945444|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83945445|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83945446|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945447|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945448|NCT00546546|Methotrexate|methotrexate|mesh-list
83945449|NCT00546546|Azathioprine|azathioprine|mesh-list
83945450|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83945451|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83945452|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
83945453|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83945454|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945455|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83945456|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
83945457|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945458|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945459|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
83945460|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945461|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83945462|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
83945463|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945464|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83945465|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83945466|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83945467|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945468|NCT00659711|Incretins|incretins|mesh-ancestor
83945469|NCT00659711|Hormones|hormones|mesh-ancestor
83945470|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945471|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83945472|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
83945473|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945474|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945475|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
83945476|NCT02581007|Melphalan|melphalan|mesh-list
83945477|NCT02581007|Fludarabine|fludarabine|mesh-list
83945478|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945479|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
83945480|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945481|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945482|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83945483|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
83945484|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945485|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945486|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83945487|NCT00546741|Metformin|metformin|mesh-list
83945488|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
83945489|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83945490|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945491|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83945492|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945493|NCT02540330|Fulvestrant|fulvestrant|mesh-list
83945494|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83945495|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945496|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83945497|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83945498|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
83945499|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945500|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945501|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
83945502|NCT02467361|Nivolumab|nivolumab|mesh-list
83945503|NCT02467361|Ipilimumab|ipilimumab|mesh-list
83945504|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83945505|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945506|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83945507|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945508|NCT00546936|Ranibizumab|ranibizumab|mesh-list
83945509|NCT00546936|Verteporfin|verteporfin|mesh-list
83945510|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83945511|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83945512|NCT00546936|Growth Substances|growth substances|mesh-ancestor
83945513|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945514|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
83945515|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945516|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83945517|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
83945518|NCT02231723|Leucovorin|leucovorin|mesh-list
83945519|NCT02231723|Paclitaxel|paclitaxel|mesh-list
83945520|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83945521|NCT02231723|Gemcitabine|gemcitabine|mesh-list
83945522|NCT02231723|Fluorouracil|fluorouracil|mesh-list
83945523|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
83945524|NCT02231723|Irinotecan|irinotecan|mesh-list
83945525|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83945526|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945527|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
83945528|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
83945529|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
83945530|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945531|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83945532|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
83945533|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945534|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
83945535|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945536|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83945537|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83945538|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945539|NCT02231723|Antidotes|antidotes|mesh-ancestor
83945540|NCT02231723|Protective Agents|protective agents|mesh-ancestor
83945541|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
83945542|NCT02231723|Vitamins|vitamins|mesh-ancestor
83945543|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
83184784|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
83945545|NCT01263496|Voglibose|voglibose|mesh-list
83945546|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83945547|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945548|NCT01263496|Incretins|incretins|mesh-ancestor
83945549|NCT01263496|Hormones|hormones|mesh-ancestor
83945550|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945551|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83945552|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
83945553|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945554|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945555|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83945556|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
83945557|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83945558|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83945559|NCT04681937|Prednisolone|prednisolone|mesh-list
83945560|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
83945561|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83945562|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
83945563|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
83945564|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83945565|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
83945566|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
83945567|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945568|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945569|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945570|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
83945571|NCT04681937|Hormones|hormones|mesh-ancestor
83945572|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945573|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83945574|NCT04681937|Protective Agents|protective agents|mesh-ancestor
83945575|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83945576|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945577|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83945578|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
83945579|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
83945580|NCT00547053|Amiloride|amiloride|mesh-list
83945581|NCT00547053|Diuretics|diuretics|mesh-ancestor
83945582|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
83945583|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945584|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83945585|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83945586|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83945587|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945588|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83945589|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83945590|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
83945591|NCT00547092|Tadalafil|tadalafil|mesh-list
83945592|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945593|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83945594|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83945595|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945596|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945597|NCT00547092|Urological Agents|urological agents|mesh-ancestor
83945598|NCT00547131|Temozolomide|temozolomide|mesh-list
83945599|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83945600|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
83945601|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945602|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945603|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83945604|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83945605|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945606|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
83945607|NCT00547170|Doxycycline|doxycycline|mesh-list
83945608|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945609|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945610|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
83945611|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83945612|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83945613|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
83945614|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83945615|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
83945616|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
83945617|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184858|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945618|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945619|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83945620|NCT00547209|Analgesics|analgesics|mesh-ancestor
83945621|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
83945622|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945623|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
83945624|NCT00547287|Tadalafil|tadalafil|mesh-list
83945625|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945626|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83945627|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83945628|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945629|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945630|NCT00547287|Urological Agents|urological agents|mesh-ancestor
83945631|NCT01263106|Theophylline|theophylline|mesh-list
83945632|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83945633|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
83945634|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945635|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945636|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83945637|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
83945638|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83945639|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945640|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945641|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945642|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83945643|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83945644|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
83945645|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945646|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
83945647|NCT01263028|Vitamin D|vitamin d|mesh-list
83945648|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83945649|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945650|NCT01263028|Vitamins|vitamins|mesh-ancestor
83945651|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
83945652|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83945653|NCT00547443|Paclitaxel|paclitaxel|mesh-list
83945654|NCT00547443|Carboplatin|carboplatin|mesh-list
83945655|NCT00547443|Sorafenib|sorafenib|mesh-list
83945656|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83945657|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945658|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
83945659|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
83945660|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83945661|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945662|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945663|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945664|NCT00547560|Begacestat|begacestat|mesh-list
83945665|NCT00547560|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83945666|NCT00547560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945667|NCT00547560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945668|NCT00547599|Tadalafil|tadalafil|mesh-list
83945669|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945670|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83945671|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83945672|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945673|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945674|NCT00547599|Urological Agents|urological agents|mesh-ancestor
83945675|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83945676|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83945677|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
83945678|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945679|NCT02908412|Bupivacaine|bupivacaine|mesh-list
83945680|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
83945681|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
83945682|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83945683|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945684|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
83945685|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945686|NCT02908295|Misoprostol|misoprostol|mesh-list
83945687|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83945688|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
83945689|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83945690|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184931|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945691|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83945692|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945693|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
83945694|NCT03809442|Dexamethasone|dexamethasone|mesh-list
83945695|NCT03809442|Midazolam|midazolam|mesh-list
83945696|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
83945697|NCT03809442|Ketamine|ketamine|mesh-list
83945698|NCT03809442|Tramadol|tramadol|mesh-list
83945699|NCT03809442|Ropivacaine|ropivacaine|mesh-list
83945700|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83945701|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
83945702|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
83945703|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945704|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945705|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945706|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
83945707|NCT03809442|Hormones|hormones|mesh-ancestor
83945708|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945709|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83945710|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945711|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83945712|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83945713|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83945714|NCT03809442|Analgesics|analgesics|mesh-ancestor
83945715|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
83945716|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83945717|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83945718|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83945719|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83945720|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945721|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945722|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83945723|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83945724|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
83945725|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
83945726|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83945727|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83945728|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
83945729|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83945730|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83945731|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83945732|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83945733|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
83945734|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
83945735|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83945736|NCT03809442|Narcotics|narcotics|mesh-ancestor
83945737|NCT00534729|Carboplatin|carboplatin|mesh-list
83945738|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945739|NCT00547989|Bupivacaine|bupivacaine|mesh-list
83945740|NCT00547989|Ropivacaine|ropivacaine|mesh-list
83945741|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
83945742|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
83945743|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83945744|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945745|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
83945746|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945747|NCT00534807|Rifampin|rifampin|mesh-list
83945748|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83945749|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
83945750|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945751|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945752|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
83945753|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83945754|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945755|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945756|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83945757|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83945758|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83945759|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83945760|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83945761|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83945762|NCT00534846|Toremifene|toremifene|mesh-list
83945763|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83945764|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945765|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83185006|NCT03437707|Analgesics|analgesics|mesh-ancestor
83945766|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83945767|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
83945768|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945769|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945770|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83945771|NCT00548067|Amlodipine|amlodipine|mesh-list
83945772|NCT00548067|Valsartan|valsartan|mesh-list
83945773|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83945774|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83945775|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83945776|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83945777|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945778|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83945779|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945780|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945781|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83945782|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83945783|NCT00548067|Diuretics|diuretics|mesh-ancestor
83945784|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
83945785|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83945786|NCT02907749|Carvedilol|carvedilol|mesh-list
83945787|NCT02907749|Spironolactone|spironolactone|mesh-list
83945788|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83945789|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
83945790|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945791|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945792|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83945793|NCT02907749|Diuretics|diuretics|mesh-ancestor
83945794|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
83945795|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83945796|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83945797|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
83945798|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945799|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945800|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83945801|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
83945802|NCT02907749|Protective Agents|protective agents|mesh-ancestor
83945803|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83945804|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83945805|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83945806|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
83945807|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83945808|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83945809|NCT02907593|Budesonide|budesonide|mesh-list
83945810|NCT02907593|Calfactant|calfactant|mesh-list
83945811|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83945812|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83945813|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
83945814|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945815|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945816|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83945817|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
83945818|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
83945819|NCT02907593|Hormones|hormones|mesh-ancestor
83945820|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83945821|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83945822|NCT00548301|Cyclosporine|cyclosporine|mesh-list
83945823|NCT00548301|Cyclosporins|cyclosporins|mesh-list
83945824|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945825|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945826|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945827|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
83945828|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945829|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
83945830|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945831|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
83945832|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945833|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83945834|NCT02907710|Endostar protein|endostar protein|mesh-list
83945835|NCT02907710|Endostatins|endostatins|mesh-list
83945836|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83945837|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83945838|NCT02907710|Growth Substances|growth substances|mesh-ancestor
83945839|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945840|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
83945841|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945842|NCT03781362|Capecitabine|capecitabine|mesh-list
83945843|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83945844|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
83945845|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945846|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945847|NCT04682249|Apatinib|apatinib|mesh-list
83945848|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945849|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945850|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945851|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945852|NCT00548379|Vitamin D|vitamin d|mesh-list
83945853|NCT00548379|Vitamins|vitamins|mesh-ancestor
83945854|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
83945855|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945856|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83945857|NCT04972617|Furosemide|furosemide|mesh-list
83945858|NCT04972617|Diuretics|diuretics|mesh-ancestor
83945859|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
83945860|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945861|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83945862|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83945863|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945864|NCT04682210|Bevacizumab|bevacizumab|mesh-list
83945865|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83945866|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945867|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83945868|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83945869|NCT04682210|Growth Substances|growth substances|mesh-ancestor
83945870|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945871|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
83945872|NCT04682132|Antibodies|antibodies|mesh-list
83945873|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
83945874|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945875|NCT02907554|Cyclosporine|cyclosporine|mesh-list
83945876|NCT02907554|Cyclosporins|cyclosporins|mesh-list
83945877|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945878|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945879|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83945880|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
83945881|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945882|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
83945883|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945884|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
83945885|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945886|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83945887|NCT02907632|Metoclopramide|metoclopramide|mesh-list
83945888|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
83945889|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
83945890|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945891|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945892|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83945893|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83945894|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83945895|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
83945896|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83945897|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945898|NCT02907437|Minocycline|minocycline|mesh-list
83945899|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945900|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945901|NCT01262872|Vaccines|vaccines|mesh-list
83945902|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83945903|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
83945904|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945905|NCT00548574|Mesalamine|mesalamine|mesh-list
83945906|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83945907|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83945908|NCT00548574|Analgesics|analgesics|mesh-ancestor
83945909|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
83945910|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945911|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945912|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83945913|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83945914|NCT01262677|Pregabalin|pregabalin|mesh-list
83945915|NCT01262677|Analgesics|analgesics|mesh-ancestor
83945916|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
83945917|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83945918|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945919|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
83945920|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83945921|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83945922|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945923|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83945924|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83945925|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83945926|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83945927|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83945928|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
83945929|NCT02899364|Antidotes|antidotes|mesh-ancestor
83945930|NCT02899364|Protective Agents|protective agents|mesh-ancestor
83945931|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945932|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
83945933|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945934|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
83945935|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83945936|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945937|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
83945938|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
83945939|NCT04206865|Valsartan|valsartan|mesh-list
83945940|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
83945941|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83945942|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83945943|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83945944|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83945945|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945946|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83945947|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83945948|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83945949|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
83945950|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83945951|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83945952|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
83945953|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945954|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83945955|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945956|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83945957|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945958|NCT00535119|Paclitaxel|paclitaxel|mesh-list
83945959|NCT00535119|Carboplatin|carboplatin|mesh-list
83945960|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83945961|NCT00535119|Veliparib|veliparib|mesh-list
83945962|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83945963|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945964|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
83945965|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
83945966|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
83945967|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945968|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83945969|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945970|NCT00535158|Vitamin D|vitamin d|mesh-list
83945971|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
83945972|NCT00535158|Vitamins|vitamins|mesh-ancestor
83945973|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
83945974|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945975|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83945976|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83945977|NCT03436992|Resveratrol|resveratrol|mesh-list
83945978|NCT03436992|Antioxidants|antioxidants|mesh-list
83945979|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83945980|NCT03436992|Protective Agents|protective agents|mesh-ancestor
83945981|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945982|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83945983|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83945984|NCT04083118|Listerine|listerine|mesh-list
83945985|NCT04083118|Fluorides|fluorides|mesh-list
83945986|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
83945987|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
83945988|NCT04083118|Protective Agents|protective agents|mesh-ancestor
83945989|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83945990|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83945991|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945992|NCT04207450|Glutaral|glutaral|mesh-list
83945993|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
83945994|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83945995|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
83945996|NCT04070443|Ponatinib|ponatinib|mesh-list
83945997|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83945998|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83945999|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946000|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946001|NCT04043494|Cytarabine|cytarabine|mesh-list
83946002|NCT04043494|Dexamethasone|dexamethasone|mesh-list
83946003|NCT04043494|Prednisone|prednisone|mesh-list
83946004|NCT04043494|Prednisolone|prednisolone|mesh-list
83946005|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
83946006|NCT04043494|Ifosfamide|ifosfamide|mesh-list
83946007|NCT04043494|Doxorubicin|doxorubicin|mesh-list
83946008|NCT04043494|Methotrexate|methotrexate|mesh-list
83946009|NCT04043494|Vincristine|vincristine|mesh-list
83946010|NCT04043494|Daunorubicin|daunorubicin|mesh-list
83946011|NCT04043494|Asparaginase|asparaginase|mesh-list
83946012|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
83946013|NCT04043494|Thioguanine|thioguanine|mesh-list
83946014|NCT04043494|Pegaspargase|pegaspargase|mesh-list
83946015|NCT04043494|Vindesine|vindesine|mesh-list
83946016|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946017|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
83946018|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946019|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946020|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946021|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
83946022|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946023|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946024|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83946025|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83946026|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
83946027|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
83946028|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946029|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83946030|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
83946031|NCT04043494|Hormones|hormones|mesh-ancestor
83946032|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946033|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83946034|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83946035|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83946036|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83946037|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946038|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83946039|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
83946040|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83946041|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83946042|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
83946043|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
83946044|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83946045|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83946046|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
83946047|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946048|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83946049|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
83946050|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
83946051|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
83946052|NCT02899286|BCT-100|bct-100|mesh-list
83946053|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946054|NCT04322422|Montelukast|montelukast|mesh-list
83946055|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83946056|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
83946057|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83946058|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
83946059|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946060|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946061|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83946062|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83946063|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946064|NCT02899169|Tretinoin|tretinoin|mesh-list
83946065|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
83946066|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
83946067|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946068|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
83946069|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
83946070|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
83946071|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946072|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946073|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83946075|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
83946076|NCT00548964|Analgesics|analgesics|mesh-ancestor
83946077|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
83946078|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946079|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946080|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83946081|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83946082|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
83946083|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
83946084|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946085|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83946086|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83946087|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946088|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946089|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
83946090|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83946091|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946092|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
83946093|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83946094|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
83946095|NCT03382938|Ropivacaine|ropivacaine|mesh-list
83946096|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83946097|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946098|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946099|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83946100|NCT03382938|Analgesics|analgesics|mesh-ancestor
83946101|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
83946102|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946103|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83946104|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83946105|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83946106|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
83946107|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946108|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946109|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
83946110|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
83946111|NCT00535353|Irinotecan|irinotecan|mesh-list
83946112|NCT00535353|Olaparib|olaparib|mesh-list
83946113|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83946114|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83946115|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946116|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946117|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946118|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83946119|NCT02898779|Primaquine|primaquine|mesh-list
83946120|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
83946121|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83946122|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83946123|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946124|NCT00549120|Propranolol|propranolol|mesh-list
83946125|NCT00549120|Albuterol|albuterol|mesh-list
83946126|NCT00549120|Ipratropium|ipratropium|mesh-list
83946127|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83946128|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83946129|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
83946130|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946131|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946132|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946133|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83946134|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83946135|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
83946136|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83946137|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
83946138|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946139|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83946140|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
83946141|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
83946142|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83946143|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83946144|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83946146|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83946147|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
83946148|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
83946149|NCT04680884|Clotrimazole|clotrimazole|mesh-list
83946150|NCT04680884|Miconazole|miconazole|mesh-list
83946151|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946152|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83946153|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83946154|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83946155|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946156|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946157|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83946158|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
83946159|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946160|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946161|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83946162|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83946163|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
83946164|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
83946165|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946166|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946167|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946168|NCT00535509|Cisplatin|cisplatin|mesh-list
83946169|NCT00535509|Docetaxel|docetaxel|mesh-list
83946170|NCT00535509|Trastuzumab|trastuzumab|mesh-list
83946171|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946172|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
83946173|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
83946174|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
83946175|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946176|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946177|NCT01262365|Epratuzumab|epratuzumab|mesh-list
83946178|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946179|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946180|NCT03244176|Avelumab|avelumab|mesh-list
83946181|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946182|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946183|NCT00535665|Vaccines|vaccines|mesh-list
83946184|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
83946185|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946186|NCT03971110|Goserelin|goserelin|mesh-list
83946187|NCT03971110|Bicalutamide|bicalutamide|mesh-list
83946188|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83946189|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946190|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
83946191|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
83946192|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946193|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946194|NCT01262287|Dutasteride|dutasteride|mesh-list
83946195|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83946196|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83946197|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946198|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946199|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
83946200|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946201|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946202|NCT01262092|Buprenorphine|buprenorphine|mesh-list
83946203|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83946204|NCT01262092|Narcotics|narcotics|mesh-ancestor
83946205|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946206|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946207|NCT01262092|Analgesics|analgesics|mesh-ancestor
83946208|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
83946209|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946210|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83946211|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
83946212|NCT03898180|Lenvatinib|lenvatinib|mesh-list
83946213|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946214|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185452|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
83946215|NCT03898180|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83946216|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946217|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83946218|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946219|NCT04680962|Rituximab|rituximab|mesh-list
83946220|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946221|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946222|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
83946223|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946224|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946225|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
83946226|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83946227|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83946228|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83946229|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83946230|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946231|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
83946232|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946233|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946234|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83946235|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946236|NCT03088410|Zidovudine|zidovudine|mesh-list
83946237|NCT03088410|Nevirapine|nevirapine|mesh-list
83946238|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
83946239|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946240|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83946241|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83946242|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946243|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
83946244|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946245|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83946246|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83946247|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83946248|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83946249|NCT02897765|Nivolumab|nivolumab|mesh-list
83946250|NCT02897765|Poly ICLC|poly iclc|mesh-list
83946251|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
83946252|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946253|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946254|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946255|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83946256|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946257|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
83946258|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
83946259|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83946260|NCT00549588|Protective Agents|protective agents|mesh-ancestor
83946261|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946262|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
83946263|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
83946264|NCT04321642|Entonox|entonox|mesh-list
83946265|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83946266|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
83946267|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946268|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946269|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83946270|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
83946271|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83946272|NCT04321642|Analgesics|analgesics|mesh-ancestor
83946273|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
83946274|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946275|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
83946276|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83946277|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946278|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83946279|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946280|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
83946281|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
83946282|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946283|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946284|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946285|NCT04321837|Vitamin D|vitamin d|mesh-list
83946286|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
83946287|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
83946288|NCT04321837|Vitamins|vitamins|mesh-ancestor
83185531|NCT03463993|Oxytocin|oxytocin|mesh-list
83946289|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
83946290|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946291|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83946292|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83946293|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
83946294|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946295|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83946296|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946297|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946298|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
83946299|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83946300|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83946301|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83946302|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83946303|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946304|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946305|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83946306|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83946307|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83946308|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83946309|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
83946310|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946311|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946312|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83946313|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83946314|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
83946315|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83946316|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83946317|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
83946318|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83946319|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
83946320|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83946321|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83946322|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83946323|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83946324|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83946325|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946326|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83946327|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83946328|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946329|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946330|NCT04680923|Bupivacaine|bupivacaine|mesh-list
83946331|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
83946332|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
83946333|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946334|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946335|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
83946336|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946337|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
83946338|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83946339|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946340|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
83946341|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946342|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946343|NCT04891419|Lidocaine|lidocaine|mesh-list
83946344|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
83946345|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
83946346|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946347|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946348|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
83946349|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946350|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83946351|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83946352|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83946353|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83946354|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946355|NCT00551577|Carboplatin|carboplatin|mesh-list
83946356|NCT00551577|Docetaxel|docetaxel|mesh-list
83946357|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946358|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83946359|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83946360|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83185604|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
83946361|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946362|NCT04207723|Paroxetine|paroxetine|mesh-list
83946363|NCT04207723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83946364|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83946365|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83946366|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946367|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946368|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
83946369|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946370|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83946371|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
83946372|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83946373|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83946374|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83946375|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946376|NCT04321096|Camostat|camostat|mesh-list
83946377|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
83946378|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946379|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946380|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83946381|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83946382|NCT03556696|Remifentanil|remifentanil|mesh-list
83946383|NCT03556696|Propofol|propofol|mesh-list
83946384|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83946385|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946386|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946387|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83946388|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
83946389|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
83946390|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83946391|NCT03556696|Narcotics|narcotics|mesh-ancestor
83946392|NCT03556696|Analgesics|analgesics|mesh-ancestor
83946393|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
83946394|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946395|NCT04320706|Oxytocin|oxytocin|mesh-list
83946396|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
83946397|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83946398|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946399|NCT03482479|Naltrexone|naltrexone|mesh-list
83946400|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83946401|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83946402|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946403|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
83946404|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946405|NCT00553709|Nicotine|nicotine|mesh-list
83946406|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83946407|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
83946408|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946409|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946410|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83946411|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83946412|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
83946413|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946414|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946415|NCT00551733|Paclitaxel|paclitaxel|mesh-list
83946416|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83946417|NCT00551733|Carboplatin|carboplatin|mesh-list
83946418|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83946419|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83946420|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946421|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
83946422|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
83946423|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
83946424|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946425|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
83946426|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83946427|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946428|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83946429|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
83946430|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83946431|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946432|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946433|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185673|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83946434|NCT04922424|Atorvastatin|atorvastatin|mesh-list
83946435|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83946436|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83946437|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
83946438|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946439|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83946440|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83946441|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946442|NCT00553748|Alovudine|alovudine|mesh-list
83946443|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
83946444|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946445|NCT00551850|MP 412|mp 412|mesh-list
83946446|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946447|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83946448|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946449|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946450|NCT00550095|Valsartan|valsartan|mesh-list
83946451|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83946452|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83946453|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83946454|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946455|NCT00551889|Celecoxib|celecoxib|mesh-list
83946456|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
83946457|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946458|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
83946459|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946460|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946461|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946462|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
83946463|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946464|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946465|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83946466|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83946467|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83946468|NCT00551889|Analgesics|analgesics|mesh-ancestor
83946469|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
83946470|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946471|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83946472|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83946473|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83946474|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946475|NCT03455764|Trametinib|trametinib|mesh-list
83946476|NCT03455764|Dabrafenib|dabrafenib|mesh-list
83946477|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946478|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83946479|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946480|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946481|NCT04902495|Pemetrexed|pemetrexed|mesh-list
83946482|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946483|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946484|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946485|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83946486|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83946487|NCT03433183|Sirolimus|sirolimus|mesh-list
83946488|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83946489|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946490|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83946491|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946492|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
83946493|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946494|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
83946495|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946496|NCT02895659|Norepinephrine|norepinephrine|mesh-list
83946497|NCT02895659|Epinephrine|epinephrine|mesh-list
83946498|NCT02895659|Racepinephrine|racepinephrine|mesh-list
83946499|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
83946500|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83946501|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83946502|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
83946503|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946504|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946505|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946506|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
83946507|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
83946508|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946509|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83946510|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83946511|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83946512|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83946513|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
83946515|NCT00552201|Tacrolimus|tacrolimus|mesh-list
83946516|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946517|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
83946518|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946519|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83946520|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946521|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946522|NCT03391882|Apomorphine|apomorphine|mesh-list
83946523|NCT03391882|Emetics|emetics|mesh-ancestor
83946524|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946525|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
83946526|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946527|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83946528|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
83946529|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
83946530|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946531|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946532|NCT00550329|Glipizide|glipizide|mesh-list
83946533|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83946534|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946535|NCT00550485|Escitalopram|escitalopram|mesh-list
83946536|NCT00550485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83946537|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83946538|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83946539|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946540|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946541|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
83946542|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946543|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
83946544|NCT00550563|Vitamin D|vitamin d|mesh-list
83946545|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83946546|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946547|NCT00550563|Vitamins|vitamins|mesh-ancestor
83946548|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
83946549|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83946550|NCT02895191|Urinastatin|urinastatin|mesh-list
83946551|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
83946552|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83946553|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
83946554|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946555|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946556|NCT04680650|Anesthetics|anesthetics|mesh-list
83946557|NCT04680650|Propofol|propofol|mesh-list
83946558|NCT04680650|Sevoflurane|sevoflurane|mesh-list
83946559|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946560|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946561|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83946562|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83946563|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
83946564|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83946565|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83946566|NCT02895113|Aspirin|aspirin|mesh-list
83946567|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83946568|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83946569|NCT02895113|Analgesics|analgesics|mesh-ancestor
83946570|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
83946571|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946572|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946573|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83946574|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946575|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83946576|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83946577|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946578|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83946579|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83946580|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946581|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
83946582|NCT00552630|Penicillamine|penicillamine|mesh-list
83946583|NCT00552630|Antidotes|antidotes|mesh-ancestor
83946584|NCT00552630|Protective Agents|protective agents|mesh-ancestor
83946585|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946586|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
83946587|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
83946588|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946589|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946590|NCT02894957|Varenicline|varenicline|mesh-list
83946591|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83946592|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83946593|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
83946594|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946595|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946596|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946597|NCT00550992|Leucovorin|leucovorin|mesh-list
83946598|NCT00550992|Cytarabine|cytarabine|mesh-list
83946599|NCT00550992|Cyclosporine|cyclosporine|mesh-list
83946600|NCT00550992|Prednisone|prednisone|mesh-list
83946601|NCT00550992|Prednisolone|prednisolone|mesh-list
83946602|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
83946603|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83946604|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83946605|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83946606|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
83946607|NCT00550992|Melphalan|melphalan|mesh-list
83946608|NCT00550992|Busulfan|busulfan|mesh-list
83946609|NCT00550992|Methotrexate|methotrexate|mesh-list
83946610|NCT00550992|Etoposide|etoposide|mesh-list
83946611|NCT00550992|Vincristine|vincristine|mesh-list
83946612|NCT00550992|Daunorubicin|daunorubicin|mesh-list
83946613|NCT00550992|Asparaginase|asparaginase|mesh-list
83946614|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
83946615|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
83946616|NCT00550992|Pegaspargase|pegaspargase|mesh-list
83946617|NCT00550992|Thioguanine|thioguanine|mesh-list
83946618|NCT00550992|Cyclosporins|cyclosporins|mesh-list
83946619|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83946620|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
83946621|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946622|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
83946623|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946624|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946625|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946626|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
83946627|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946628|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946629|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83946630|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83946631|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
83946632|NCT00550992|Hormones|hormones|mesh-ancestor
83946633|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946634|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83946635|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83946636|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
83946637|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83946638|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83946639|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
83946640|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
83946641|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946642|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83946643|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83946644|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83946645|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83946646|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83946647|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
83946648|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946649|NCT00550992|Antidotes|antidotes|mesh-ancestor
83946650|NCT00550992|Protective Agents|protective agents|mesh-ancestor
83946651|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
83946652|NCT00550992|Vitamins|vitamins|mesh-ancestor
83946653|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
83946654|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83946655|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83946656|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83946657|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
83946658|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83946659|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946660|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83946661|NCT00550992|Analgesics|analgesics|mesh-ancestor
83946662|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
83946664|NCT02895074|Tropicamide|tropicamide|mesh-list
83946665|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
83946666|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
83946667|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946668|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946669|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83946670|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83946671|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83946672|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946673|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946674|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
83946675|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
83946676|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946677|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
83946678|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83946679|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
83946680|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946681|NCT00551109|SA 4503|sa 4503|mesh-list
83946682|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
83946683|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
83946684|NCT00551265|Oregovomab|oregovomab|mesh-list
83946685|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83946686|NCT00551265|Antibodies|antibodies|mesh-list
83946687|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
83946688|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83946689|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946690|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
83946691|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946692|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946693|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946694|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
83946695|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946696|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946697|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83946698|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
83946699|NCT02894606|Basiliximab|basiliximab|mesh-list
83946700|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
83946701|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946702|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946703|NCT00551343|Exenatide|exenatide|mesh-list
83946704|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83946705|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946706|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83946707|NCT00551343|Incretins|incretins|mesh-ancestor
83946708|NCT00551343|Hormones|hormones|mesh-ancestor
83946709|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946710|NCT00551382|Montelukast|montelukast|mesh-list
83946711|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83946712|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
83946713|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83946714|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
83946715|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946716|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946717|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83946718|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83946719|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946720|NCT02894684|Aztreonam|aztreonam|mesh-list
83946721|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83946722|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946723|NCT02894645|Cytarabine|cytarabine|mesh-list
83946724|NCT02894645|Dexamethasone|dexamethasone|mesh-list
83946725|NCT02894645|Prednisolone|prednisolone|mesh-list
83946726|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
83946727|NCT02894645|Doxorubicin|doxorubicin|mesh-list
83946728|NCT02894645|Methotrexate|methotrexate|mesh-list
83946729|NCT02894645|Fludarabine|fludarabine|mesh-list
83946730|NCT02894645|Vincristine|vincristine|mesh-list
83946731|NCT02894645|Daunorubicin|daunorubicin|mesh-list
83946732|NCT02894645|Asparaginase|asparaginase|mesh-list
83946733|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
83946734|NCT02894645|Thioguanine|thioguanine|mesh-list
83946735|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946736|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
83946737|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946738|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946739|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946740|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
83946741|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946742|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946743|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83946744|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83946745|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
83946746|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
83946747|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946748|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83946749|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
83946750|NCT02894645|Hormones|hormones|mesh-ancestor
83946751|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946752|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83946753|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83946754|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83946755|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83946756|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946757|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83946758|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
83946759|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83946760|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83946761|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
83946762|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83946763|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83946764|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83946765|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
83946766|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946767|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83946768|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
83946769|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
83946770|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
83946771|NCT00552747|Fenofibrate|fenofibrate|mesh-list
83946772|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83946773|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
83946774|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946775|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83946776|NCT05427617|Fulvestrant|fulvestrant|mesh-list
83946777|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83946778|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83946779|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946780|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83946781|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83946782|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
83946783|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946784|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946785|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946786|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946787|NCT05427500|Bupivacaine|bupivacaine|mesh-list
83946788|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83946789|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
83946790|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946791|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946792|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
83946793|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946794|NCT05427383|Paclitaxel|paclitaxel|mesh-list
83946795|NCT05427383|Docetaxel|docetaxel|mesh-list
83946796|NCT05427383|Irinotecan|irinotecan|mesh-list
83946797|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83946798|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946799|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
83946800|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
83946801|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
83946802|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946803|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83946804|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83946805|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946806|NCT05427305|Bevacizumab|bevacizumab|mesh-list
83946807|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946808|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946809|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83946810|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83946811|NCT05427305|Growth Substances|growth substances|mesh-ancestor
83946812|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946813|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
83946814|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
83946816|NCT01099449|Calcium|calcium|mesh-list
83946817|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83946818|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946819|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946820|NCT01099449|Analgesics|analgesics|mesh-ancestor
83946821|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
83946822|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946823|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
83946824|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946825|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83946826|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
83946827|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83946828|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83946829|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946830|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
83946831|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83946832|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
83946833|NCT04680143|Hematinics|hematinics|mesh-ancestor
83946834|NCT05426798|Azacitidine|azacitidine|mesh-list
83946835|NCT05426798|Decitabine|decitabine|mesh-list
83946836|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83946837|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
83946838|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946839|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946840|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946841|NCT01234402|Capecitabine|capecitabine|mesh-list
83946842|NCT01234402|Ramucirumab|ramucirumab|mesh-list
83946843|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83946844|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
83946845|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946846|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946847|NCT01260922|Donepezil|donepezil|mesh-list
83946848|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83946849|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946850|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946851|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
83946852|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946853|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946854|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
83946855|NCT01212094|Rituximab|rituximab|mesh-list
83946856|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946857|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946858|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
83946859|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946860|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946861|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
83946862|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83946863|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
83946864|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946865|NCT05409885|Anesthetics|anesthetics|mesh-list
83946866|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946867|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946868|NCT00552864|Ropivacaine|ropivacaine|mesh-list
83946869|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
83946870|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
83946871|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
83946872|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946873|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946874|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
83946875|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946876|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
83946877|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83946878|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83946879|NCT01211665|Prednisolone|prednisolone|mesh-list
83946880|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
83946881|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83946882|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
83946883|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83946884|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
83946885|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
83946886|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946887|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946888|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83946889|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
83946890|NCT01211665|Hormones|hormones|mesh-ancestor
83946891|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946892|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83946893|NCT01211665|Protective Agents|protective agents|mesh-ancestor
83946894|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83946895|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946896|NCT04401176|Lidocaine|lidocaine|mesh-list
83946897|NCT04401176|Heparin|heparin|mesh-list
83946898|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
83946899|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
83946900|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83946901|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946902|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
83946903|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946904|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83946905|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83946906|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83946907|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83946908|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946909|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
83946910|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83946911|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83946912|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
83946913|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83946914|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946915|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
83946916|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83946917|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946918|NCT04335305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83946919|NCT04335305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946920|NCT04288089|Palbociclib|palbociclib|mesh-list
83946921|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946922|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83946923|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946924|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946925|NCT05371899|Chiauranib|chiauranib|mesh-list
83946926|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946927|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83946928|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946929|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946930|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
83946931|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83946932|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946933|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946934|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83946935|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83946936|NCT04152980|Protective Agents|protective agents|mesh-ancestor
83946937|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946938|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
83946939|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83946940|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
83946941|NCT01232452|Pemetrexed|pemetrexed|mesh-list
83946942|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946943|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946944|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946945|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83946946|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83946947|NCT05345613|Epinephrine|epinephrine|mesh-list
83946948|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
83946949|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83946950|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83946951|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946952|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
83946953|NCT05345613|Coagulants|coagulants|mesh-ancestor
83946954|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83946955|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83946956|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
83946957|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83946958|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946959|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83946960|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83946961|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
83946962|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83946963|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83946964|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
83946965|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
83946966|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
83946967|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83946968|NCT01211197|Metformin|metformin|mesh-list
83946969|NCT01211197|Empagliflozin|empagliflozin|mesh-list
83946970|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83946971|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946972|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83946973|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946974|NCT00553137|Fluconazole|fluconazole|mesh-list
83946975|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
83946976|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83946977|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83946978|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83946979|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83946980|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946981|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83946982|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
83946983|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83946984|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946985|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83946986|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83946987|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
83946988|NCT04090775|Nivolumab|nivolumab|mesh-list
83946989|NCT04090775|Ipilimumab|ipilimumab|mesh-list
83946990|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83946991|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
83946992|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83946993|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83946994|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83946995|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
83946996|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83946997|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83946998|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83946999|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947000|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83947001|NCT01232296|Sorafenib|sorafenib|mesh-list
83947002|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947003|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83947004|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947005|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947006|NCT04041011|Fluzoparib|fluzoparib|mesh-list
83947007|NCT04041011|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83947008|NCT04041011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947009|NCT04041011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947010|NCT04041011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947011|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83947012|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83947013|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83947014|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
83947015|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947016|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83947017|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83947018|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947019|NCT01231555|Efavirenz|efavirenz|mesh-list
83947020|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83947021|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83947022|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947023|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947024|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
83947025|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947026|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83947027|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83947028|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83947029|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83947030|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83947031|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83947032|NCT04116528|Ketamine|ketamine|mesh-list
83947033|NCT04116528|Buprenorphine|buprenorphine|mesh-list
83947034|NCT04116528|Analgesics|analgesics|mesh-ancestor
83186276|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
83947035|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
83947036|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947037|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947038|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83947039|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83947040|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
83947041|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
83947042|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947043|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83947044|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83947045|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83947046|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947047|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83947048|NCT04116528|Narcotics|narcotics|mesh-ancestor
83947049|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83947050|NCT05288907|Lidocaine|lidocaine|mesh-list
83947051|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
83947052|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
83947053|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947054|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947055|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
83947056|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947057|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83947058|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83947059|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83947060|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83947061|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947062|NCT03911336|Acetaminophen|acetaminophen|mesh-list
83947063|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83947064|NCT03911336|Ketoprofen|ketoprofen|mesh-list
83947065|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83947066|NCT03911336|Analgesics|analgesics|mesh-ancestor
83947067|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
83947068|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947069|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947070|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
83947071|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947072|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947073|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83947074|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947075|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947076|NCT03850535|Cytarabine|cytarabine|mesh-list
83947077|NCT03850535|Daunorubicin|daunorubicin|mesh-list
83947078|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947079|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
83947080|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947081|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947082|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
83947083|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947084|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947085|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
83947086|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947087|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83947088|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83947089|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83947090|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947091|NCT03850301|Etifoxine|etifoxine|mesh-list
83947092|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83947093|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83947094|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947095|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947096|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83947098|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83947099|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947100|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
83947101|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83947102|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83947103|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83947104|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947105|NCT03653000|Anesthetics|anesthetics|mesh-list
83947106|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
83947107|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947108|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947109|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
83947110|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947112|NCT03639389|Analgesics|analgesics|mesh-list
83947113|NCT03639389|Bupivacaine|bupivacaine|mesh-list
83947114|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
83947115|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
83947116|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947117|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947118|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
83947119|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947120|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83947121|NCT03639389|Narcotics|narcotics|mesh-ancestor
83947122|NCT05172531|Cisatracurium|cisatracurium|mesh-list
83947123|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83947124|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83947125|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947126|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947127|NCT03570983|Cytarabine|cytarabine|mesh-list
83947128|NCT03570983|Etoposide|etoposide|mesh-list
83947129|NCT03570983|Melphalan|melphalan|mesh-list
83947130|NCT03570983|Carmustine|carmustine|mesh-list
83947131|NCT03570983|Allopurinol|allopurinol|mesh-list
83947132|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947133|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947134|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83947135|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83947136|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947137|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947138|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947139|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
83947140|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
83947141|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947142|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947143|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
83947144|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947145|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83947146|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
83947147|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83947148|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
83947149|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947150|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83947151|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
83947152|NCT03570983|Protective Agents|protective agents|mesh-ancestor
83947153|NCT03540758|Niacin|niacin|mesh-list
83947154|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
83947155|NCT03540758|Niacinamide|niacinamide|mesh-list
83947156|NCT03540758|Diazoxide|diazoxide|mesh-list
83947157|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83947158|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
83947159|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947160|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83947161|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
83947162|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
83947163|NCT03540758|Vitamins|vitamins|mesh-ancestor
83947164|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
83947165|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947166|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83947167|NCT03187379|Bupivacaine|bupivacaine|mesh-list
83947168|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
83947169|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
83947170|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947171|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947172|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
83947173|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947174|NCT03182231|Exenatide|exenatide|mesh-list
83947175|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947176|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947177|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83947178|NCT03182231|Incretins|incretins|mesh-ancestor
83947179|NCT03182231|Hormones|hormones|mesh-ancestor
83947180|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947181|NCT03182192|Exenatide|exenatide|mesh-list
83947182|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947183|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947184|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83947185|NCT03182192|Incretins|incretins|mesh-ancestor
83186424|NCT04448015|Narcotics|narcotics|mesh-ancestor
83947186|NCT03182192|Hormones|hormones|mesh-ancestor
83947187|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947188|NCT02964884|Lovastatin|lovastatin|mesh-list
83947189|NCT02964884|L 647318|l 647318|mesh-list
83947190|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
83947191|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83947192|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83947193|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
83947194|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947195|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83947196|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83947197|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947198|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
83947199|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947200|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947201|NCT02837042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83947202|NCT02837042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947203|NCT05098470|Metformin|metformin|mesh-list
83947204|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
83947205|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947206|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947207|NCT02710643|Ofatumumab|ofatumumab|mesh-list
83947208|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947209|NCT05093205|Midazolam|midazolam|mesh-list
83947210|NCT05093205|Atorvastatin|atorvastatin|mesh-list
83947211|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
83947212|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83947213|NCT05093205|Estradiol|estradiol|mesh-list
83947214|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83947215|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83947216|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947217|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947218|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83947219|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83947220|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83947221|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83947222|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
83947223|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
83947224|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
83947225|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
83947226|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83947227|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947228|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83947229|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83947230|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
83947231|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83947232|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83947233|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947234|NCT05093205|Estrogens|estrogens|mesh-ancestor
83947235|NCT05093205|Hormones|hormones|mesh-ancestor
83947236|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947237|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83947238|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
83947239|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83947240|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83947241|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83947242|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83947243|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83947244|NCT02623751|Exemestane|exemestane|mesh-list
83947245|NCT02623751|Entinostat|entinostat|mesh-list
83947246|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947247|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83947248|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83947249|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947250|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947251|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83947252|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
83947253|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947254|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947255|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83947256|NCT02469155|Risperidone|risperidone|mesh-list
83947257|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83947258|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
83947259|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83947260|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186499|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83947261|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947262|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83947263|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83947264|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947265|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83947266|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83947267|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
83947268|NCT02465606|Triamcinolone|triamcinolone|mesh-list
83947269|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83947270|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83947271|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
83947272|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83947273|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947274|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
83947275|NCT02465606|Hormones|hormones|mesh-ancestor
83947276|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947277|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947278|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947279|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
83947280|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947281|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947282|NCT05080530|Vitamin D|vitamin d|mesh-list
83947283|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
83947284|NCT05080530|Vitamins|vitamins|mesh-ancestor
83947285|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
83947286|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947287|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83947288|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83947289|NCT00554177|Mifepristone|mifepristone|mesh-list
83947290|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83947291|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
83947292|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83947293|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947294|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83947295|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83947296|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83947297|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
83947298|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83947299|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83947300|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
83947301|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947302|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
83947303|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83947304|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83947305|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
83947306|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947307|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947308|NCT03425565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83947309|NCT03425565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947310|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
83947311|NCT05073627|Dabigatran|dabigatran|mesh-list
83947312|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
83947313|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83947314|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
83947315|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947316|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947317|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
83947318|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83947319|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947320|NCT04678739|Remdesivir|remdesivir|mesh-list
83947321|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
83947322|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947323|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
83947324|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947325|NCT03368196|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83947326|NCT03368196|Immunoconjugates|immunoconjugates|mesh-ancestor
83947327|NCT03368196|Immunologic Factors|immunologic factors|mesh-ancestor
83947328|NCT03368196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947329|NCT03230565|Ropivacaine|ropivacaine|mesh-list
83947330|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
83947331|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
83947332|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947333|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947334|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
83186575|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
83947335|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947337|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947338|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947339|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83947340|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83947341|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83947342|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947343|NCT03147612|Cytarabine|cytarabine|mesh-list
83947344|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
83947345|NCT03147612|Rituximab|rituximab|mesh-list
83947346|NCT03147612|Methotrexate|methotrexate|mesh-list
83947347|NCT03147612|Vincristine|vincristine|mesh-list
83947348|NCT03147612|Blinatumomab|blinatumomab|mesh-list
83947349|NCT03147612|Ponatinib|ponatinib|mesh-list
83947350|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83947351|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
83947352|NCT03147612|Antibodies|antibodies|mesh-list
83947353|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
83947354|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83947355|NCT03147612|Lenograstim|lenograstim|mesh-list
83947356|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83947357|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947358|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
83947359|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947360|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947361|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83947362|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
83947363|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947364|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947365|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83947366|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83947367|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
83947368|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83947369|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947370|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
83947371|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
83947372|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947373|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83947374|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83947375|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
83947376|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947377|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83947378|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947379|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83947380|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83947381|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83947382|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83947383|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83947384|NCT02365649|Upadacitinib|upadacitinib|mesh-list
83947385|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83947386|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83947387|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947388|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947389|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947390|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
83947391|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83947392|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
83947393|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83947394|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947395|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83947396|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83947397|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83947398|NCT05007132|Trifluridine|trifluridine|mesh-list
83947399|NCT05007132|Bevacizumab|bevacizumab|mesh-list
83947400|NCT05007132|Panitumumab|panitumumab|mesh-list
83947401|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947402|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947403|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83947404|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83947405|NCT05007132|Growth Substances|growth substances|mesh-ancestor
83947406|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947407|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
83947408|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
83947409|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947410|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
83947411|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947412|NCT04684017|Carboplatin|carboplatin|mesh-list
83947413|NCT04684017|Etoposide|etoposide|mesh-list
83947414|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947415|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947416|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83947417|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83947418|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947419|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947420|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
83947421|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83947422|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947423|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947424|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947425|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
83947426|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947427|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947428|NCT00554528|Meloxicam|meloxicam|mesh-list
83947429|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83947430|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83947431|NCT00554528|Analgesics|analgesics|mesh-ancestor
83947432|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
83947433|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947434|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947435|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947436|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947437|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83947438|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83947439|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947440|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947441|NCT04683198|Carboplatin|carboplatin|mesh-list
83947442|NCT04683198|Etoposide|etoposide|mesh-list
83947443|NCT04683198|Apatinib|apatinib|mesh-list
83947444|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947445|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947446|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83947447|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83947448|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947449|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947450|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83947451|NCT03075423|Nivolumab|nivolumab|mesh-list
83947452|NCT03075423|Ipilimumab|ipilimumab|mesh-list
83947453|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947454|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947455|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83947456|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947457|NCT02342249|Oseltamivir|oseltamivir|mesh-list
83947458|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
83947459|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947460|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947461|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947462|NCT02339129|Ibuprofen|ibuprofen|mesh-list
83947463|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83947464|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83947465|NCT02339129|Analgesics|analgesics|mesh-ancestor
83947466|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
83947467|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947468|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947469|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947470|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947471|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83947472|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947473|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947474|NCT02884206|Valsartan|valsartan|mesh-list
83947475|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83947476|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83947477|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83947478|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83947479|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947480|NCT04961541|Vaccines|vaccines|mesh-list
83947481|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
83947482|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947483|NCT02326454|Talaporfin|talaporfin|mesh-list
83947484|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947485|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83947486|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
83947487|NCT02871219|Lenalidomide|lenalidomide|mesh-list
83947488|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
83947489|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
83947490|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947491|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83947492|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83947493|NCT02871219|Growth Substances|growth substances|mesh-ancestor
83947494|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
83947495|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947496|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947497|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
83947498|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947499|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947500|NCT02306291|Cytarabine|cytarabine|mesh-list
83947501|NCT02306291|Etoposide|etoposide|mesh-list
83947502|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
83947503|NCT02306291|Idarubicin|idarubicin|mesh-list
83947504|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947505|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947506|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83947507|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83947508|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947509|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947510|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947511|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
83947512|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
83947513|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947514|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947515|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
83947516|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947517|NCT02306291|Analgesics|analgesics|mesh-ancestor
83947518|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
83947519|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947520|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83947521|NCT02302079|Ranibizumab|ranibizumab|mesh-list
83947522|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83947523|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83947524|NCT02302079|Growth Substances|growth substances|mesh-ancestor
83947525|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947526|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
83947527|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947528|NCT01210495|Axitinib|axitinib|mesh-list
83947529|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947530|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83947531|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947532|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947533|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83947534|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
83947535|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947536|NCT04678076|Ketoprofen|ketoprofen|mesh-list
83947537|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
83947538|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83947539|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83947540|NCT04678076|Analgesics|analgesics|mesh-ancestor
83947541|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
83947542|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947543|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947544|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947545|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947546|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83947547|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947548|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947549|NCT02257619|Docetaxel|docetaxel|mesh-list
83947550|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947551|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
83947552|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
83947553|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
83947554|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947555|NCT04891302|Clevudine|clevudine|mesh-list
83947556|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
83947557|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947558|NCT04857645|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83947559|NCT04857645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947560|NCT04857645|Antimetabolites|antimetabolites|mesh-ancestor
83947561|NCT04857645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947562|NCT04857645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947563|NCT02224235|Aspirin|aspirin|mesh-list
83947564|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83947565|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83947566|NCT02224235|Analgesics|analgesics|mesh-ancestor
83947567|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
83947568|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947569|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947570|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947571|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947572|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83947573|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83947574|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947575|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83947576|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83947577|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947578|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
83947579|NCT02529852|Prednisone|prednisone|mesh-list
83947580|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
83947581|NCT02529852|Doxorubicin|doxorubicin|mesh-list
83947582|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83947583|NCT02529852|Vincristine|vincristine|mesh-list
83947584|NCT02529852|Lenalidomide|lenalidomide|mesh-list
83947585|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
83947586|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947587|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
83947588|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947589|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947590|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83947591|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
83947592|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947593|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947594|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83947595|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83947596|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83947597|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83947598|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947599|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947600|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
83947601|NCT02529852|Hormones|hormones|mesh-ancestor
83947602|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947603|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83947604|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947605|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
83947606|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
83947607|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
83947608|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83947609|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83947610|NCT02529852|Growth Substances|growth substances|mesh-ancestor
83947611|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
83947612|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947613|NCT02221232|Ethanol|ethanol|mesh-list
83947614|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
83947615|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83947616|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83947617|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947618|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947619|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947620|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
83947621|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
83947622|NCT02206100|Enoxaparin|enoxaparin|mesh-list
83947623|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
83947624|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83947625|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83947626|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947627|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
83947628|NCT01231516|Dolutegravir|dolutegravir|mesh-list
83947629|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83947630|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83947631|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
83947632|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947633|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83947634|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83947635|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947636|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947638|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
83947639|NCT01962636|Fludarabine|fludarabine|mesh-list
83947640|NCT01962636|Cyclosporins|cyclosporins|mesh-list
83947641|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947642|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
83947643|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947644|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947645|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83947646|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
83947647|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947648|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947649|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83947650|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947651|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
83947652|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947653|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
83947654|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83947655|NCT01231321|Adalimumab|adalimumab|mesh-list
83947656|NCT01231321|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83947657|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947658|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947659|NCT01722240|Liraglutide|liraglutide|mesh-list
83947660|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947661|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947662|NCT01722240|Incretins|incretins|mesh-ancestor
83947663|NCT01722240|Hormones|hormones|mesh-ancestor
83947664|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947665|NCT01666080|Fludarabine|fludarabine|mesh-list
83947666|NCT01666080|Busulfan|busulfan|mesh-list
83947667|NCT01666080|Levetiracetam|levetiracetam|mesh-list
83947668|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947669|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947670|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947671|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
83947672|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947673|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
83947674|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83947675|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83947676|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
83947677|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
83947678|NCT01210222|Trebananib|trebananib|mesh-list
83947679|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83947680|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83947681|NCT01210222|Growth Substances|growth substances|mesh-ancestor
83947682|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947683|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
83947684|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947685|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83947686|NCT01210144|Hormones|hormones|mesh-list
83947687|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83947688|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947689|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947690|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83947691|NCT01209949|Adapalene|adapalene|mesh-list
83947692|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83947693|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
83947694|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83947695|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83947696|NCT01209949|Analgesics|analgesics|mesh-ancestor
83947697|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
83947698|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947699|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947700|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947701|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83947702|NCT04831593|Anesthetics|anesthetics|mesh-list
83947703|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947704|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947705|NCT04667897|Ranibizumab|ranibizumab|mesh-list
83947706|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83947707|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83947708|NCT04667897|Growth Substances|growth substances|mesh-ancestor
83947709|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947710|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
83947711|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947713|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83947714|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83947715|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947716|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947717|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83947718|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83947719|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83947720|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83947721|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
83947722|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
83947723|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
83947724|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
83947725|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83947726|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947727|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
83947728|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83947729|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
83947730|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947731|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
83947732|NCT04667819|Protective Agents|protective agents|mesh-ancestor
83947733|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83947734|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83947735|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83947736|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83947737|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83947738|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
83947739|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83947740|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947741|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947742|NCT01230892|Atenolol|atenolol|mesh-list
83947743|NCT01230892|Nebivolol|nebivolol|mesh-list
83947744|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83947745|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83947746|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
83947747|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
83947748|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947749|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947750|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83947751|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83947752|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83947753|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
83947754|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83947755|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947756|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
83947757|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83947758|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83947759|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83947760|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83947761|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83947762|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83947763|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83947764|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947765|NCT04667351|Fluorouracil|fluorouracil|mesh-list
83947766|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
83947767|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947768|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947769|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947770|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947771|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
83947772|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947773|NCT01230814|Metronidazole|metronidazole|mesh-list
83947774|NCT01230814|Miconazole|miconazole|mesh-list
83947775|NCT01230814|Clotrimazole|clotrimazole|mesh-list
83947776|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947777|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83947778|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83947779|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83947780|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
83947781|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83947782|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83947783|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187021|NCT04452383|Ketamine|ketamine|mesh-list
83947784|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947785|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83947786|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
83947787|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947788|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947789|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83947790|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83947791|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83947792|NCT01230307|Vitamin D|vitamin d|mesh-list
83947793|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
83947794|NCT01230307|Vitamins|vitamins|mesh-ancestor
83947795|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
83947796|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947797|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83947798|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83947799|NCT01209598|Palbociclib|palbociclib|mesh-list
83947800|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947801|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83947802|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947803|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947804|NCT00556634|Efavirenz|efavirenz|mesh-list
83947805|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83947806|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83947807|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947808|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947809|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
83947810|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947811|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83947812|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83947813|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83947814|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83947815|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83947816|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83947817|NCT01209520|Paclitaxel|paclitaxel|mesh-list
83947818|NCT01209520|Vinorelbine|vinorelbine|mesh-list
83947819|NCT01209520|Docetaxel|docetaxel|mesh-list
83947820|NCT01209520|Cisplatin|cisplatin|mesh-list
83947821|NCT01209520|Carboplatin|carboplatin|mesh-list
83947822|NCT01209520|Pemetrexed|pemetrexed|mesh-list
83947823|NCT01209520|Azacitidine|azacitidine|mesh-list
83947824|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947825|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947826|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
83947827|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
83947828|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
83413831|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
83947829|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947830|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947831|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83947832|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83947833|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947834|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
83947835|NCT04805541|Tropicamide|tropicamide|mesh-list
83947836|NCT04805541|Mydriatics|mydriatics|mesh-list
83947837|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
83947838|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947839|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947840|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83947841|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83947842|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
83947843|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83947844|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947845|NCT04784754|Melatonin|melatonin|mesh-list
83947846|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
83947847|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947848|NCT04784754|Protective Agents|protective agents|mesh-ancestor
83947849|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947850|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947851|NCT04666805|Tamoxifen|tamoxifen|mesh-list
83947852|NCT04666805|Toremifene|toremifene|mesh-list
83947853|NCT04666805|Letrozole|letrozole|mesh-list
83947854|NCT04666805|Anastrozole|anastrozole|mesh-list
83947855|NCT04666805|Exemestane|exemestane|mesh-list
83947856|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947857|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83947858|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83947860|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947861|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83947862|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
83947863|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947864|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947865|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83947866|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83947867|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83947868|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83947869|NCT04766853|Dexamethasone|dexamethasone|mesh-list
83947870|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
83947871|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83947872|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
83947873|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
83947874|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83947875|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947876|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83947877|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
83947878|NCT04766853|Hormones|hormones|mesh-ancestor
83947879|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947880|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83947881|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947882|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83947883|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
83947884|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
83947885|NCT04766853|Protective Agents|protective agents|mesh-ancestor
83947886|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
83947887|NCT04721457|Listerine|listerine|mesh-list
83947888|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83947889|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
83947890|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83947891|NCT04721457|Eusol|eusol|mesh-list
83947892|NCT04721457|Povidone|povidone|mesh-list
83947893|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83947894|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
83947895|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
83947896|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
83947897|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83947898|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947899|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
83947900|NCT04721457|Protective Agents|protective agents|mesh-ancestor
83947901|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947902|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
83947903|NCT04665986|Docetaxel|docetaxel|mesh-list
83947904|NCT04665986|Vinorelbine|vinorelbine|mesh-list
83947905|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947906|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
83947907|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
83947908|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
83947909|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947910|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83947911|NCT04638309|Azacitidine|azacitidine|mesh-list
83947912|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947913|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
83947914|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947915|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947916|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947917|NCT04632927|Ustekinumab|ustekinumab|mesh-list
83947918|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
83947919|NCT04665830|Evolocumab|evolocumab|mesh-list
83947920|NCT04665830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83947921|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83947922|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83947923|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
83947924|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947925|NCT04665830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83947926|NCT04665830|Protease Inhibitors|protease inhibitors|mesh-ancestor
83947927|NCT04665830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947928|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83947929|NCT04683237|Liraglutide|liraglutide|mesh-list
83947930|NCT04683237|Megestrol|megestrol|mesh-list
83947931|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
83947932|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947933|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947934|NCT04683237|Incretins|incretins|mesh-ancestor
83947935|NCT04683237|Hormones|hormones|mesh-ancestor
83947936|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83947937|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83947938|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83947939|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83947940|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
83947941|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83947942|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83947943|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83947944|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83947945|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947946|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
83947947|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83947948|NCT04665362|Apatinib|apatinib|mesh-list
83947949|NCT04665362|Antibodies|antibodies|mesh-list
83947950|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
83947951|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947952|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947953|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83947954|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947955|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947956|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83947957|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
83947958|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947959|NCT04665284|Empagliflozin|empagliflozin|mesh-list
83947960|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83947961|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947962|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83947963|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947964|NCT04432974|Anesthetics|anesthetics|mesh-list
83947965|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83947966|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947967|NCT04664894|Ribavirin|ribavirin|mesh-list
83947968|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
83947969|NCT04664894|Velpatasvir|velpatasvir|mesh-list
83947970|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
83947971|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947972|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
83947973|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83947974|NCT00557102|Leucovorin|leucovorin|mesh-list
83947975|NCT00557102|Fluorouracil|fluorouracil|mesh-list
83947976|NCT00557102|Irinotecan|irinotecan|mesh-list
83947977|NCT00557102|Cetuximab|cetuximab|mesh-list
83947978|NCT00557102|Calcium|calcium|mesh-list
83947979|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
83947980|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83947981|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83947982|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
83947983|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83947984|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83947985|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83947986|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83947987|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
83947988|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83947989|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83947990|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83947991|NCT00557102|Antidotes|antidotes|mesh-ancestor
83947992|NCT00557102|Protective Agents|protective agents|mesh-ancestor
83947993|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
83947994|NCT00557102|Vitamins|vitamins|mesh-ancestor
83947995|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
83947996|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83947997|NCT04682691|Erythromycin|erythromycin|mesh-list
83947998|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
83947999|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83948000|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
83948001|NCT04682691|Metoclopramide|metoclopramide|mesh-list
83948002|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
83948003|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
83948004|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948005|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948006|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83948007|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83948008|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83948009|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
83948010|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187249|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
83948011|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948012|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83948013|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948014|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83948015|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948016|NCT01209286|Blinatumomab|blinatumomab|mesh-list
83948017|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948018|NCT04663763|Capecitabine|capecitabine|mesh-list
83948019|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
83948021|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
83948022|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948023|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83948024|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
83948025|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948026|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948027|NCT04351737|Dexamethasone|dexamethasone|mesh-list
83948028|NCT04351737|Prednisolone|prednisolone|mesh-list
83948029|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83948030|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
83948031|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83948032|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
83948033|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83948034|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
83948035|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948036|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
83948037|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
83948038|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948039|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948040|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83948041|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
83948042|NCT04351737|Hormones|hormones|mesh-ancestor
83948043|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948044|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948045|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948046|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83948047|NCT04351737|Protective Agents|protective agents|mesh-ancestor
83948048|NCT04347915|Clevudine|clevudine|mesh-list
83948049|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
83948050|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948051|NCT04185051|Aticaprant|aticaprant|mesh-list
83948052|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83948053|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948054|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
83948055|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948056|NCT04662788|Antibodies|antibodies|mesh-list
83948057|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83948058|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
83948059|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948060|NCT04662866|Metformin|metformin|mesh-list
83948061|NCT04662866|Pioglitazone|pioglitazone|mesh-list
83948062|NCT04662866|Empagliflozin|empagliflozin|mesh-list
83948063|NCT04662866|Linagliptin|linagliptin|mesh-list
83948064|NCT04662866|Biguanides|biguanides|mesh-list
83948065|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
83948066|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83948067|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948068|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83948069|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948070|NCT04662866|Incretins|incretins|mesh-ancestor
83948071|NCT04662866|Hormones|hormones|mesh-ancestor
83948072|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948073|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83948074|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948075|NCT04662476|Vitamin D|vitamin d|mesh-list
83948076|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
83948077|NCT04662476|Vitamins|vitamins|mesh-ancestor
83948078|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
83948079|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948080|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83948081|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83948082|NCT03986424|Memantine|memantine|mesh-list
83948083|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83187326|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948084|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83948085|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
83948086|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948087|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948088|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948089|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83948090|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83948091|NCT03918252|Nivolumab|nivolumab|mesh-list
83948092|NCT03918252|Ipilimumab|ipilimumab|mesh-list
83948093|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948094|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948095|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83948096|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948097|NCT04662125|Acetaminophen|acetaminophen|mesh-list
83948098|NCT04662125|Prednisolone|prednisolone|mesh-list
83948099|NCT04662125|Pregabalin|pregabalin|mesh-list
83948100|NCT04662125|Caffeine|caffeine|mesh-list
83948101|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948102|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
83948103|NCT04662125|Hormones|hormones|mesh-ancestor
83948104|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948105|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948106|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948107|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948108|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948109|NCT04662125|Analgesics|analgesics|mesh-ancestor
83948110|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
83948111|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
83948112|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83948113|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83948114|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948115|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83948116|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83948117|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83948118|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948119|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83948120|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83948121|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
83948122|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83948123|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83948124|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948125|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83948126|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83948127|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
83948128|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948129|NCT00557180|Beclomethasone|beclomethasone|mesh-list
83948130|NCT00557180|Bromides|bromides|mesh-list
83948131|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
83948132|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83948133|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83948134|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
83948135|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948136|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948137|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83948138|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
83948139|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
83948140|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83948141|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
83948142|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948143|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948144|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83948145|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83948146|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83948147|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
83948148|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
83948149|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948150|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
83948151|NCT00557180|Hormones|hormones|mesh-ancestor
83948152|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948153|NCT00557219|Fenoldopam|fenoldopam|mesh-list
83948154|NCT00557219|Ketanserin|ketanserin|mesh-list
83948155|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83948156|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
83948157|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
83948158|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
83948159|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948160|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187405|NCT03398837|Analgesics|analgesics|mesh-ancestor
83948161|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948162|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83948163|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83948164|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
83948165|NCT00539877|Irinotecan|irinotecan|mesh-list
83948166|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83948167|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83948168|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948169|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948170|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948171|NCT03798405|Analgesics|analgesics|mesh-list
83948172|NCT03798405|Narcotics|narcotics|mesh-list
83948173|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
83948174|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948175|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948176|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948177|NCT04661696|Paclitaxel|paclitaxel|mesh-list
83948178|NCT04661696|Carboplatin|carboplatin|mesh-list
83948179|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83948180|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948181|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
83948182|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
83948183|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
83948184|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948185|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
83948186|NCT03776136|Lenvatinib|lenvatinib|mesh-list
83948187|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948188|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948189|NCT03776136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83948190|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948191|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83948192|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948193|NCT04661345|Coagulase|coagulase|mesh-list
83948194|NCT04661345|Coagulants|coagulants|mesh-ancestor
83948195|NCT00540072|Daptomycin|daptomycin|mesh-list
83948196|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83948197|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948198|NCT03689946|Listerine|listerine|mesh-list
83948199|NCT03689946|Evolocumab|evolocumab|mesh-list
83948200|NCT03689946|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83948201|NCT03689946|Fluorides|fluorides|mesh-list
83948202|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
83948203|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
83948204|NCT03689946|Protective Agents|protective agents|mesh-ancestor
83948205|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948206|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83948207|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948208|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83948209|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83948210|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
83948211|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948212|NCT03689946|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83948213|NCT03689946|Protease Inhibitors|protease inhibitors|mesh-ancestor
83948214|NCT03689946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948215|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83948216|NCT04660916|Isotretinoin|isotretinoin|mesh-list
83948217|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
83948218|NCT00540150|Immunomodulating Agents|immunomodulating agents|mesh-list
83948219|NCT00540150|Immunologic Factors|immunologic factors|mesh-ancestor
83948220|NCT00540150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948221|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
83948222|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83948223|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83948224|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948225|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948226|NCT04660565|Prednisone|prednisone|mesh-list
83948227|NCT04660565|Belimumab|belimumab|mesh-list
83948228|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948229|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
83948230|NCT04660565|Hormones|hormones|mesh-ancestor
83948231|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948232|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187485|NCT03394001|Analgesics|analgesics|mesh-ancestor
83948233|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948234|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948235|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83948236|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
83948237|NCT04319341|Autoantibodies|autoantibodies|mesh-list
83948238|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
83948239|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948240|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
83948241|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
83948242|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
83948243|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948244|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
83948245|NCT01208038|Testosterone|testosterone|mesh-list
83948246|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
83948247|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
83948248|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83948249|NCT01208038|Androgens|androgens|mesh-ancestor
83948250|NCT01208038|Hormones|hormones|mesh-ancestor
83948251|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948252|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948253|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948254|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948255|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
83948256|NCT04659785|Apatinib|apatinib|mesh-list
83948257|NCT04659785|Fluzoparib|fluzoparib|mesh-list
83948258|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948259|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83948260|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948261|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948262|NCT04659785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83948263|NCT01207687|Bevacizumab|bevacizumab|mesh-list
83948264|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83948265|NCT01207687|Antibodies|antibodies|mesh-list
83948266|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
83948267|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83948268|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948269|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83948270|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83948271|NCT01207687|Growth Substances|growth substances|mesh-ancestor
83948272|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948273|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
83948274|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
83948275|NCT01207453|Milnacipran|milnacipran|mesh-list
83948276|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
83948277|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83948278|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83948279|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83948280|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948281|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948282|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948283|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83948284|NCT01207453|Analgesics|analgesics|mesh-ancestor
83948285|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
83948286|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948287|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
83948288|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83948289|NCT00540345|Interferons|interferons|mesh-list
83948290|NCT00540345|Ribavirin|ribavirin|mesh-list
83948291|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
83948292|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
83948293|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83948294|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948295|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
83948296|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948297|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
83948298|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948299|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
83948300|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948301|NCT01207414|Iloperidone|iloperidone|mesh-list
83948302|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83948303|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83948304|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948305|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948306|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83948307|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
83187552|NCT00540839|Fluticasone|fluticasone|mesh-list
83948308|NCT00540384|Hematinics|hematinics|mesh-ancestor
83948309|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
83948310|NCT04659551|Nivolumab|nivolumab|mesh-list
83948311|NCT04659551|Epirubicin|epirubicin|mesh-list
83948312|NCT04659551|Exemestane|exemestane|mesh-list
83948313|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83948314|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83948315|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
83948316|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948317|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948318|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83948319|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
83948320|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948321|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948322|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83948323|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948324|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83948325|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83948326|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83948327|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83948328|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948329|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83948330|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83948331|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83948332|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
83948333|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948334|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
83948335|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83948336|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
83948337|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83948338|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83948339|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948340|NCT01206517|Asenapine|asenapine|mesh-list
83948341|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83948342|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83948343|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948344|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948345|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83948346|NCT01206439|Nebivolol|nebivolol|mesh-list
83948347|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83948348|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
83948349|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83948350|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83948351|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83948352|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
83948353|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948354|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948355|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948356|NCT01206322|Insulin|insulin|mesh-list
83948357|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83948358|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948359|NCT00540501|Oseltamivir|oseltamivir|mesh-list
83948360|NCT00540501|Zanamivir|zanamivir|mesh-list
83948361|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
83948362|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948363|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948364|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948365|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83948366|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83948367|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948368|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
83948369|NCT01207102|Paclitaxel|paclitaxel|mesh-list
83948370|NCT01207102|Carboplatin|carboplatin|mesh-list
83948371|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83948372|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83948373|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948374|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
83948375|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
83948376|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
83948377|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948378|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
83948379|NCT04658732|Gabapentin|gabapentin|mesh-list
83948380|NCT04658732|Alprazolam|alprazolam|mesh-list
83948381|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83948382|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948383|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948384|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187620|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83948386|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
83948387|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948388|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83948389|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83948390|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83948391|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
83948392|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948393|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948394|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
83948395|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83948396|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83948397|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83948398|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83948399|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83948400|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
83948401|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
83948402|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
83948403|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
83948404|NCT00540696|Hematinics|hematinics|mesh-ancestor
83948405|NCT04658420|Ketamine|ketamine|mesh-list
83948406|NCT04658420|Analgesics|analgesics|mesh-ancestor
83948407|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
83948408|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948409|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948410|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83948411|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83948412|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
83948413|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
83948414|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948415|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83948416|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83948417|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948418|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948419|NCT00540891|Alfuzosin|alfuzosin|mesh-list
83948420|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83948421|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83948422|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83948423|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83948424|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948425|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948426|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948427|NCT00540891|Urological Agents|urological agents|mesh-ancestor
83948428|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
83948429|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83948430|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948431|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
83948432|NCT00540930|Ranibizumab|ranibizumab|mesh-list
83948433|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83948434|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83948435|NCT00540930|Growth Substances|growth substances|mesh-ancestor
83948436|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948437|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
83948438|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948439|NCT00541008|Sunitinib|sunitinib|mesh-list
83948440|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948441|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83948442|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83948443|NCT00541008|Growth Substances|growth substances|mesh-ancestor
83948444|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948445|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
83948446|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83948447|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948448|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948449|NCT00541047|Leuprolide|leuprolide|mesh-list
83948450|NCT00541047|Goserelin|goserelin|mesh-list
83948451|NCT00541047|Bicalutamide|bicalutamide|mesh-list
83948452|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83948453|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
83948454|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83948455|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948456|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948457|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948458|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
83948459|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
83948460|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948462|NCT00541086|Letrozole|letrozole|mesh-list
83948463|NCT00541086|Anastrozole|anastrozole|mesh-list
83948464|NCT00541086|Exemestane|exemestane|mesh-list
83948465|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948466|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948467|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83948468|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83948469|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948470|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83948471|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
83948472|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948473|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948474|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948475|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83948476|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83948477|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83948478|NCT04657484|Prednisolone|prednisolone|mesh-list
83948479|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83948480|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
83948481|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83948482|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
83948483|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83948484|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
83948485|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948486|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
83948487|NCT04657484|Hormones|hormones|mesh-ancestor
83948488|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948489|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948490|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948491|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948492|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
83948493|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
83948494|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948495|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83948496|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83948497|NCT04657484|Protective Agents|protective agents|mesh-ancestor
83948498|NCT00541125|Leucovorin|leucovorin|mesh-list
83948499|NCT00541125|Bevacizumab|bevacizumab|mesh-list
83948500|NCT00541125|Fluorouracil|fluorouracil|mesh-list
83948501|NCT00541125|Irinotecan|irinotecan|mesh-list
83948502|NCT00541125|Calcium|calcium|mesh-list
83948503|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
83948504|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948505|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948506|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83948507|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83948508|NCT00541125|Growth Substances|growth substances|mesh-ancestor
83948509|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948510|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
83948511|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83948512|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
83948513|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948514|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83948515|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83948516|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
83948517|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83948518|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83948519|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948520|NCT00541125|Antidotes|antidotes|mesh-ancestor
83948521|NCT00541125|Protective Agents|protective agents|mesh-ancestor
83948522|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
83948523|NCT00541125|Vitamins|vitamins|mesh-ancestor
83948524|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
83948525|NCT00541164|Ubiquinone|ubiquinone|mesh-list
83948526|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
83948527|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
83948528|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948529|NCT00541164|Vitamins|vitamins|mesh-ancestor
83948530|NCT00541281|Prednisone|prednisone|mesh-list
83948531|NCT00541281|Docetaxel|docetaxel|mesh-list
83948532|NCT00541281|Estramustine|estramustine|mesh-list
83948533|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948534|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83948535|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83948536|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83948537|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948538|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948539|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
83948540|NCT00541281|Hormones|hormones|mesh-ancestor
83948541|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948542|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948543|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948544|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83948545|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
83948546|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
83948547|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83948548|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
83948549|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83948550|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
83948551|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948552|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948553|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
83948554|NCT04657172|Pilocarpine|pilocarpine|mesh-list
83948555|NCT04657172|Miotics|miotics|mesh-ancestor
83948556|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
83948557|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948558|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948559|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83948560|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83948561|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
83948562|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948563|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948564|NCT03199794|Factor VIII|factor viii|mesh-list
83948565|NCT03199794|Coagulants|coagulants|mesh-ancestor
83948566|NCT00541359|Bortezomib|bortezomib|mesh-list
83948567|NCT00541359|Topotecan|topotecan|mesh-list
83948568|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948569|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83948570|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83948571|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948572|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948573|NCT03096249|Oxytocin|oxytocin|mesh-list
83948574|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
83948575|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83948576|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948577|NCT04656665|Aspirin|aspirin|mesh-list
83948578|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83948579|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83948580|NCT04656665|Analgesics|analgesics|mesh-ancestor
83948581|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
83948582|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948583|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948584|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948585|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948586|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83948587|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83948588|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948589|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83948590|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83948591|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948592|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
83948593|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
83948594|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83948595|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83948596|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83948597|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83948598|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948599|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
83948600|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948601|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948602|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83948603|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948604|NCT03013218|Paclitaxel|paclitaxel|mesh-list
83948605|NCT03013218|Rituximab|rituximab|mesh-list
83948606|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
83948607|NCT03013218|Trastuzumab|trastuzumab|mesh-list
83948608|NCT03013218|Ramucirumab|ramucirumab|mesh-list
83948609|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83948610|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948611|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
83948612|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
83948613|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
83948614|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948615|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948616|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
83948617|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948618|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948619|NCT03013218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83948621|NCT04655807|Ustekinumab|ustekinumab|mesh-list
83948622|NCT04655807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83948623|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948624|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948625|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
83948626|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
83948627|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83948628|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83948629|NCT00541515|Insulin|insulin|mesh-list
83948630|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83948631|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948632|NCT04655729|Infliximab|infliximab|mesh-list
83948633|NCT04655729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83948634|NCT04655729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948635|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
83948636|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83948637|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948638|NCT00541554|Aripiprazole|aripiprazole|mesh-list
83948639|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
83948640|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83948641|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83948642|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83948643|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948644|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948645|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
83948646|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
83948647|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948648|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948649|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83948650|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83948651|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
83948652|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83948653|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83948654|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83948655|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83948656|NCT04655183|Niraparib|niraparib|mesh-list
83948657|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83948658|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948659|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948660|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948661|NCT00541710|Genistein|genistein|mesh-list
83948662|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83948663|NCT00541710|Protective Agents|protective agents|mesh-ancestor
83948664|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948665|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948666|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83948667|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948668|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948669|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
83948670|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83948671|NCT00541710|Estrogens|estrogens|mesh-ancestor
83948672|NCT00541710|Hormones|hormones|mesh-ancestor
83948673|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948674|NCT04654676|Vildagliptin|vildagliptin|mesh-list
83948675|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83948676|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948677|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83948678|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
83948679|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948680|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948681|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83948682|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83948683|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187930|NCT01164995|Carboplatin|carboplatin|mesh-list
83948684|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948685|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83948686|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83948687|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948688|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
83948689|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948691|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83948692|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83948693|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
83948694|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948695|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948696|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948697|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
83948698|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
83948699|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948700|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
83948701|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83948702|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
83948703|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
83948704|NCT02546583|Furosemide|furosemide|mesh-list
83948705|NCT02546583|Bumetanide|bumetanide|mesh-list
83948706|NCT02546583|Diuretics|diuretics|mesh-list
83948707|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83948708|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
83948709|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948710|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83948711|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948712|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83948713|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83948714|NCT01205581|Vaccines|vaccines|mesh-list
83948715|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
83948716|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948717|NCT00542139|Betamethasone|betamethasone|mesh-list
83948718|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948719|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
83948720|NCT00542139|Hormones|hormones|mesh-ancestor
83948721|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948722|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948723|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83948724|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
83948725|NCT02499354|Iron|iron|mesh-list
83948726|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83948727|NCT02499354|Trace Elements|trace elements|mesh-ancestor
83948728|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
83948729|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948730|NCT02499354|Hematinics|hematinics|mesh-ancestor
83948731|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83948732|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83948733|NCT00542295|Mebeverine|mebeverine|mesh-list
83948734|NCT00542295|Alverine|alverine|mesh-list
83948735|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
83948736|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
83948737|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948738|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948739|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
83948740|NCT03454841|Ticagrelor|ticagrelor|mesh-list
83948741|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83948742|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83948743|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83948744|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83948745|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83948746|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
83948747|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948748|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948749|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948750|NCT02293980|Nivolumab|nivolumab|mesh-list
83948751|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948752|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948753|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83948754|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948755|NCT04653506|Acetaminophen|acetaminophen|mesh-list
83948756|NCT04653506|Ibuprofen|ibuprofen|mesh-list
83948757|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83948758|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83948759|NCT04653506|Analgesics|analgesics|mesh-ancestor
83948760|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
83948761|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948762|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948763|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948764|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948765|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83948766|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948767|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948768|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
83948769|NCT00542412|Riluzole|riluzole|mesh-list
83948770|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
83948771|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83948772|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83948773|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948774|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948775|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948776|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83948777|NCT00542412|Protective Agents|protective agents|mesh-ancestor
83948778|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
83948779|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83948780|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83948781|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948782|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
83948783|NCT04653623|Coagulants|coagulants|mesh-ancestor
83948784|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
83948785|NCT00542568|Hematinics|hematinics|mesh-ancestor
83948786|NCT04653779|Metformin|metformin|mesh-list
83948787|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83948788|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948789|NCT00542607|Levocetirizine|levocetirizine|mesh-list
83948790|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83948791|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83948792|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
83948793|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
83948794|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948795|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948796|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948797|NCT04685031|Clobetasol|clobetasol|mesh-list
83948798|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
83948799|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
83948800|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948801|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
83948802|NCT04685031|Hormones|hormones|mesh-ancestor
83948803|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948804|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948805|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
83948806|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83948807|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948808|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83948809|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
83948810|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83948811|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948812|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948813|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948814|NCT01854684|Temoporfin|temoporfin|mesh-list
83948815|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948816|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83948817|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
83948818|NCT00542802|Carbamazepine|carbamazepine|mesh-list
83948819|NCT00542802|Levetiracetam|levetiracetam|mesh-list
83948820|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
83948821|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
83948822|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
83948823|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83948824|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948825|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948826|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83948827|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83948828|NCT00542802|Analgesics|analgesics|mesh-ancestor
83948829|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
83948830|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948831|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83948832|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124685|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
83948833|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948834|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83948835|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83948836|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
83948837|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
83948838|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83948839|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83948840|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948841|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948842|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948843|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948844|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
83948845|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948846|NCT04652765|Bicalutamide|bicalutamide|mesh-list
83948847|NCT04652765|Camostat|camostat|mesh-list
83948848|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
83948849|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
83948850|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948851|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948852|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948853|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
83948854|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948855|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948856|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83948857|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83948858|NCT04652492|Tislelizumab|tislelizumab|mesh-list
83948859|NCT04652492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948860|NCT04652492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948861|NCT00543075|Oblimersen|oblimersen|mesh-list
83948862|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948863|NCT00543114|Rituximab|rituximab|mesh-list
83948864|NCT00543114|Fludarabine|fludarabine|mesh-list
83948865|NCT00543114|Lenalidomide|lenalidomide|mesh-list
83948866|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83948867|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948868|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
83948869|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948870|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948871|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83948872|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83948873|NCT00543114|Growth Substances|growth substances|mesh-ancestor
83948874|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
83948875|NCT03454724|Sirolimus|sirolimus|mesh-list
83948876|NCT03454724|Everolimus|everolimus|mesh-list
83948877|NCT03454724|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83948878|NCT03454724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83948879|NCT03454724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948880|NCT03454724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948881|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83948882|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
83948883|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948884|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948885|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83948886|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83948887|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83948888|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
83948889|NCT01014546|Vitamins|vitamins|mesh-list
83948890|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
83948891|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
83948892|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
83948893|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948894|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
83948895|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948896|NCT01014546|Protective Agents|protective agents|mesh-ancestor
83948897|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948898|NCT00543231|Oblimersen|oblimersen|mesh-list
83948899|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948900|NCT00557843|Bupivacaine|bupivacaine|mesh-list
83948901|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
83948902|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
83948903|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948904|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948905|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
83948906|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948907|NCT04651556|Acetaminophen|acetaminophen|mesh-list
83948908|NCT04651556|Ketorolac|ketorolac|mesh-list
83948909|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
83948910|NCT04651556|Bupivacaine|bupivacaine|mesh-list
83948911|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
83948912|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
83948913|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83948914|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948915|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
83948916|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948917|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83948918|NCT04651556|Analgesics|analgesics|mesh-ancestor
83948919|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
83948920|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83948921|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948922|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948923|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83948924|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948925|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948926|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83948927|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
83948928|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83948929|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83948930|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83948931|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
83948932|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83948933|NCT04651049|Propranolol|propranolol|mesh-list
83948934|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83948935|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83948936|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
83948937|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948938|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948939|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948940|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83948941|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83948942|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
83948943|NCT04651205|Thiamine|thiamine|mesh-list
83948944|NCT04651205|Vitamins|vitamins|mesh-ancestor
83948945|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
83948946|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948947|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
83948948|NCT03456648|Apixaban|apixaban|mesh-list
83948949|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83948950|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
83948951|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83948952|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
83948953|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948954|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948955|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
83948956|NCT00557921|Aspirin|aspirin|mesh-list
83948957|NCT00557921|Omeprazole|omeprazole|mesh-list
83948958|NCT00557921|Clopidogrel|clopidogrel|mesh-list
83948959|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83948960|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83948961|NCT00557921|Analgesics|analgesics|mesh-ancestor
83948962|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
83948963|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948964|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948965|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948966|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83948967|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83948968|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83948969|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948970|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83948971|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83948972|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948973|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
83948974|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83948975|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83948976|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83948977|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
83948978|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83948979|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83948980|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83948981|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83948982|NCT02352558|Dexamethasone|dexamethasone|mesh-list
83948983|NCT02352558|Bortezomib|bortezomib|mesh-list
83948984|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
83948985|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83948986|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
83948987|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
83948988|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83948989|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83948990|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83948991|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
83948992|NCT02352558|Hormones|hormones|mesh-ancestor
83948993|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83948994|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83948995|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83948996|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83948997|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83948998|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83948999|NCT02324283|Propofol|propofol|mesh-list
83949000|NCT02324283|Desflurane|desflurane|mesh-list
83949001|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83949002|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949003|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949004|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83949005|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
83949006|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
83949007|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83949008|NCT00557960|Amphetamine|amphetamine|mesh-list
83949009|NCT00557960|Adderall|adderall|mesh-list
83949010|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83949011|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83949012|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83949013|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83949014|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949015|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
83949016|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949017|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949018|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83949019|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
83949020|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
83949021|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949022|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
83949023|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83949024|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83949025|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83949026|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949027|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83949028|NCT02311998|Immunotoxins|immunotoxins|mesh-ancestor
83949029|NCT02311998|Immunoconjugates|immunoconjugates|mesh-ancestor
83949030|NCT02311998|Immunologic Factors|immunologic factors|mesh-ancestor
83949031|NCT02311998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949032|NCT00558077|Metformin|metformin|mesh-list
83949033|NCT00558077|Clomiphene|clomiphene|mesh-list
83949034|NCT00558077|Enclomiphene|enclomiphene|mesh-list
83949035|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
83949036|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83949037|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949038|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83949039|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
83949040|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949041|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83949042|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
83949043|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83949044|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83949045|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83949046|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
83949047|NCT05077254|Vaccines|vaccines|mesh-list
83949048|NCT05077254|Tacrolimus|tacrolimus|mesh-list
83949049|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
83949050|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949051|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949052|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83949053|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949054|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949055|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83949056|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949057|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83949058|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
83949059|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188294|NCT03375515|Hydromorphone|hydromorphone|mesh-list
83949060|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949062|NCT00543504|Trastuzumab|trastuzumab|mesh-list
83949063|NCT00543504|Cetuximab|cetuximab|mesh-list
83949064|NCT00543504|Sunitinib|sunitinib|mesh-list
83949065|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83949066|NCT00543504|Sorafenib|sorafenib|mesh-list
83949067|NCT00543504|Lapatinib|lapatinib|mesh-list
83949068|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83949069|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949070|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83949071|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83949072|NCT00543504|Growth Substances|growth substances|mesh-ancestor
83949073|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949074|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
83949075|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83949076|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949077|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949078|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
83949079|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83949080|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
83949081|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949082|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949083|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83949084|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
83949085|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83949086|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
83949087|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949088|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949089|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83949090|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
83949091|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
83949092|NCT00543933|Protective Agents|protective agents|mesh-ancestor
83949093|NCT00544011|Bevacizumab|bevacizumab|mesh-list
83949094|NCT00544011|Fluorouracil|fluorouracil|mesh-list
83949095|NCT00544011|Capecitabine|capecitabine|mesh-list
83949096|NCT00544011|Irinotecan|irinotecan|mesh-list
83949097|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83949098|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949099|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83949100|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83949101|NCT00544011|Growth Substances|growth substances|mesh-ancestor
83949102|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949103|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
83949104|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
83949105|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949106|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83949107|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949108|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
83949109|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83949110|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83949111|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949112|NCT00544050|Levetiracetam|levetiracetam|mesh-list
83949113|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
83949114|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
83949115|NCT04649723|Rifampin|rifampin|mesh-list
83949116|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83949117|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
83949118|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83949119|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949120|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
83949121|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83949122|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949123|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949124|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83949125|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83949126|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83949127|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83949128|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83949129|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83949130|NCT02909088|Ecopipam|ecopipam|mesh-list
83949131|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83949132|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83949133|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188369|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83949134|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949135|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949136|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83949137|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
83949138|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949139|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949140|NCT04649645|Nicotine|nicotine|mesh-list
83949141|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83949142|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
83949143|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949144|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949145|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83949146|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83949147|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
83949148|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949149|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949150|NCT00544128|Ritonavir|ritonavir|mesh-list
83949151|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83949152|NCT00544128|Tenofovir|tenofovir|mesh-list
83949153|NCT00544128|Lamivudine|lamivudine|mesh-list
83949154|NCT00544128|Emtricitabine|emtricitabine|mesh-list
83949155|NCT00544128|Abacavir|abacavir|mesh-list
83949156|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83949157|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83949158|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
83949159|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949160|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949161|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83949162|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83949163|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
83949164|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949165|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83949166|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83949167|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83949168|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83949169|NCT05476432|Leucovorin|leucovorin|mesh-list
83949170|NCT05476432|Fluorouracil|fluorouracil|mesh-list
83949171|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
83949172|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
83949173|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949174|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83949175|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949176|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949177|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
83949178|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949179|NCT05476432|Antidotes|antidotes|mesh-ancestor
83949180|NCT05476432|Protective Agents|protective agents|mesh-ancestor
83949181|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
83949182|NCT05476432|Vitamins|vitamins|mesh-ancestor
83949183|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
83949184|NCT01239745|Exemestane|exemestane|mesh-list
83949185|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949186|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83949187|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83949188|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949189|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949190|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83949191|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
83949192|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949193|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949194|NCT01239472|Everolimus|everolimus|mesh-list
83949195|NCT01239472|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83949196|NCT01239472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83949197|NCT01239472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949198|NCT01239472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949199|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949200|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
83949201|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949202|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949203|NCT00544284|Temozolomide|temozolomide|mesh-list
83949204|NCT00544284|Bortezomib|bortezomib|mesh-list
83949205|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83949206|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
83949207|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188445|NCT03090997|Protective Agents|protective agents|mesh-ancestor
83949208|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949209|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
83949210|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83949211|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949212|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949213|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83949214|NCT02888275|Analgesics|analgesics|mesh-ancestor
83949215|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
83949216|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949217|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83949218|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83949219|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83949220|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
83949221|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949222|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949223|NCT03456531|Aspirin|aspirin|mesh-list
83949224|NCT03456531|Analgesics|analgesics|mesh-list
83949225|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83949226|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83949227|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
83949228|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949229|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949230|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949231|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83949232|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83949233|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83949234|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949235|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83949236|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83949237|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949238|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
83949239|NCT02909049|Midazolam|midazolam|mesh-list
83949240|NCT02909049|Ketamine|ketamine|mesh-list
83949241|NCT02909049|Mepivacaine|mepivacaine|mesh-list
83949242|NCT02909049|Analgesics|analgesics|mesh-ancestor
83949243|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
83949244|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949245|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949246|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83949247|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83949248|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
83949249|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
83949250|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949251|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83949252|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83949253|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949254|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949255|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83949256|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83949257|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83949258|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83949259|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949260|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
83949261|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
83949262|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
83949263|NCT01229449|Acetaminophen|acetaminophen|mesh-list
83949264|NCT01229449|Ibuprofen|ibuprofen|mesh-list
83949265|NCT01229449|Codeine|codeine|mesh-list
83949266|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83949267|NCT01229449|Analgesics|analgesics|mesh-ancestor
83949268|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
83949269|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949270|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949271|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
83949272|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83949273|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949274|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83949275|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83949276|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949277|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949278|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83949279|NCT01229449|Narcotics|narcotics|mesh-ancestor
83949280|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949281|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
83949282|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188519|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
83949283|NCT01238575|Guanfacine|guanfacine|mesh-list
83949284|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83949285|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83949286|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83949287|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83949288|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
83949289|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949290|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949291|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949292|NCT01237951|Dexamethasone|dexamethasone|mesh-list
83949293|NCT01237951|Gemcitabine|gemcitabine|mesh-list
83949294|NCT01237951|Melphalan|melphalan|mesh-list
83949295|NCT01237951|Busulfan|busulfan|mesh-list
83949296|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949297|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
83949298|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
83949299|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949300|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949301|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949302|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
83949303|NCT01237951|Hormones|hormones|mesh-ancestor
83949304|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949305|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949306|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949307|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83949308|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
83949309|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949310|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83949311|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
83949312|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83949313|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949314|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
83949315|NCT02908581|Folic Acid|folic acid|mesh-list
83949316|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
83949317|NCT02908581|Hematinics|hematinics|mesh-ancestor
83949318|NCT02908581|Vitamins|vitamins|mesh-ancestor
83949319|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
83949320|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949321|NCT00544362|Fluorouracil|fluorouracil|mesh-list
83949322|NCT00544362|Cetuximab|cetuximab|mesh-list
83949323|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949324|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
83949325|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949326|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83949327|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949328|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
83949329|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949330|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83949331|NCT01239394|Ofatumumab|ofatumumab|mesh-list
83949332|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949333|NCT00553293|Hormones|hormones|mesh-list
83949334|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83949335|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949336|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949337|NCT04648358|Dexamethasone|dexamethasone|mesh-list
83949338|NCT04648358|Bupivacaine|bupivacaine|mesh-list
83949339|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949340|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
83949341|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
83949342|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949343|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949344|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949345|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
83949346|NCT04648358|Hormones|hormones|mesh-ancestor
83949347|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949348|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949349|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949350|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
83949351|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
83949352|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949353|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
83949354|NCT00544518|Metformin|metformin|mesh-list
83949355|NCT00544518|Benfluorex|benfluorex|mesh-list
83949356|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83949357|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949358|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83949359|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
83949360|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949361|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83949362|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
83949363|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83949364|NCT02908698|Prednisone|prednisone|mesh-list
83949365|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949366|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
83949367|NCT02908698|Hormones|hormones|mesh-ancestor
83949368|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949369|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949370|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949371|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949372|NCT00544596|Acetic Acid|acetic acid|mesh-list
83949373|NCT00544596|Etoposide|etoposide|mesh-list
83949374|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
83949375|NCT00544596|Retinol acetate|retinol acetate|mesh-list
83949376|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
83949377|NCT00544596|Gossypol|gossypol|mesh-list
83949378|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949379|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83949380|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83949381|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83949382|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949383|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949384|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83949385|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949386|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83949387|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
83949388|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949389|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83949390|NCT00544596|Protective Agents|protective agents|mesh-ancestor
83949391|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83949392|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
83949393|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83949394|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83949395|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83949396|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83949397|NCT02908191|Tenofovir|tenofovir|mesh-list
83949398|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83949399|NCT02908191|Entecavir|entecavir|mesh-list
83949400|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
83949401|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949402|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83949403|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83949404|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949405|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949406|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83949407|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83949408|NCT00544791|Melatonin|melatonin|mesh-list
83949409|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
83949410|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949411|NCT00544791|Protective Agents|protective agents|mesh-ancestor
83949412|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949413|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949414|NCT04647773|Pregabalin|pregabalin|mesh-list
83949415|NCT04647773|Analgesics|analgesics|mesh-ancestor
83949416|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
83949417|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949418|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949419|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
83949420|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83949421|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83949422|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949423|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83949424|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83949425|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83949426|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949427|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949428|NCT01237678|Carboplatin|carboplatin|mesh-list
83949429|NCT01237678|Etoposide|etoposide|mesh-list
83949430|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
83949431|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949432|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83949433|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83949434|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83949435|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949436|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949437|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83949438|NCT01237678|Immunotoxins|immunotoxins|mesh-ancestor
83949439|NCT01237678|Immunoconjugates|immunoconjugates|mesh-ancestor
83949440|NCT01237678|Immunologic Factors|immunologic factors|mesh-ancestor
83949441|NCT01237678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949442|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83949443|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83949444|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83949445|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83949446|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83949447|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83949448|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83949449|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
83949450|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949451|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949452|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949453|NCT01229371|Vaccines|vaccines|mesh-list
83949454|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
83949455|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949456|NCT02908152|Curcumin|curcumin|mesh-list
83949457|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83949458|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83949459|NCT02908152|Analgesics|analgesics|mesh-ancestor
83949460|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
83949461|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949462|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949463|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949464|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83949465|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949466|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949467|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949468|NCT01237327|Exemestane|exemestane|mesh-list
83949469|NCT01237327|Megestrol|megestrol|mesh-list
83949470|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
83949471|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949472|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83949473|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83949474|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949475|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949476|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83949477|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
83949478|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949479|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949480|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83949481|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83949482|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83949483|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
83949484|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83949485|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83949486|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83949487|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949488|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
83949489|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83949490|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83949491|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83949492|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
83949493|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949494|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949495|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949496|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83949497|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83949498|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949499|NCT04647695|Interferons|interferons|mesh-list
83949500|NCT04647695|Interferon-beta|interferon-beta|mesh-list
83949501|NCT04647695|Remdesivir|remdesivir|mesh-list
83949502|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
83949503|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949504|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
83949505|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949506|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
83949507|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949508|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
83949509|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949510|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83949511|NCT04647344|Paclitaxel|paclitaxel|mesh-list
83949512|NCT04647344|Carboplatin|carboplatin|mesh-list
83949513|NCT04647344|Pemetrexed|pemetrexed|mesh-list
83949514|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83949515|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949516|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
83949517|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
83949518|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
83949519|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949520|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949521|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83949522|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83949523|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
83949524|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83949525|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949526|NCT02907957|Anesthetics|anesthetics|mesh-list
83949527|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949528|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949529|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
83949530|NCT04646876|Analgesics|analgesics|mesh-ancestor
83949531|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
83949532|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949533|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949534|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
83949535|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949536|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83949537|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
83949538|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83949539|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83949540|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949541|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83949542|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
83949543|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83949544|NCT02908035|Sirolimus|sirolimus|mesh-list
83949545|NCT02908035|Temsirolimus|temsirolimus|mesh-list
83949546|NCT02908035|MTOR Inhibitors|mtor inhibitors|mesh-list
83949547|NCT02908035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83949548|NCT02908035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949549|NCT02908035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949550|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949551|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
83949552|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949553|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949554|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83949555|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949556|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83949557|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
83949558|NCT04646759|Capecitabine|capecitabine|mesh-list
83949559|NCT04646759|Fulvestrant|fulvestrant|mesh-list
83949560|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83949561|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
83949562|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949563|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949564|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949565|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83949566|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83949567|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
83949568|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949569|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949570|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83949571|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
83949572|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
83949573|NCT04646135|Lorazepam|lorazepam|mesh-list
83949574|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
83949575|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
83949576|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
83949577|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949578|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949579|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949580|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83949581|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949582|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83949583|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83949584|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949585|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
83949586|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
83949587|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949588|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949589|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
83949590|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
83949591|NCT04682184|Propranolol|propranolol|mesh-list
83949592|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
83949593|NCT04682184|Ephedrine|ephedrine|mesh-list
83949594|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83949595|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83949596|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83949597|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949598|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949599|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949600|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83949601|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83949602|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
83949603|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83949604|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
83949605|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949606|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83949607|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
83949608|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
83949609|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83949610|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83949611|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
83949612|NCT04645940|Rabeprazole|rabeprazole|mesh-list
83949613|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83949614|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949615|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83949616|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949617|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949618|NCT00558506|Abatacept|abatacept|mesh-list
83949619|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83949620|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949621|NCT00558506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83949622|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949623|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949624|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
83949625|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949626|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83949627|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
83949628|NCT00558623|Calcium|calcium|mesh-list
83949629|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83949630|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949631|NCT00558623|Antacids|antacids|mesh-ancestor
83949632|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949633|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949634|NCT00558662|Monensin|monensin|mesh-list
83949635|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
83949636|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949637|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83949638|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83949639|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
83949640|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
83949641|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
83949642|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949643|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949644|NCT00558662|Ionophores|ionophores|mesh-ancestor
83949645|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83949646|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
83949647|NCT02905890|Norethindrone|norethindrone|mesh-list
83949648|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
83949649|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
83949650|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83949651|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83949652|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83949653|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
83949654|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83949655|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949656|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84124686|NCT00538291|Capecitabine|capecitabine|mesh-list
83949657|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83949659|NCT02906163|Afatinib|afatinib|mesh-list
83949660|NCT02906163|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83949661|NCT02906163|Thymalfasin|thymalfasin|mesh-list
83949662|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949663|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83949664|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949665|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949666|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83949667|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
83949668|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949669|NCT04645745|Folic Acid|folic acid|mesh-list
83949670|NCT04645745|Inositol|inositol|mesh-list
83949671|NCT04645745|Hematinics|hematinics|mesh-ancestor
83949672|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
83949673|NCT04645745|Vitamins|vitamins|mesh-ancestor
83949674|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
83949675|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949676|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
83949677|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
83949678|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
83949679|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949680|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949681|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
83949682|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949683|NCT00558818|Clevudine|clevudine|mesh-list
83949684|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
83949685|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949686|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
83949687|NCT04681911|Paclitaxel|paclitaxel|mesh-list
83949688|NCT04681911|Vinorelbine|vinorelbine|mesh-list
83949689|NCT04681911|Carboplatin|carboplatin|mesh-list
83949690|NCT04681911|Gemcitabine|gemcitabine|mesh-list
83949691|NCT04681911|Capecitabine|capecitabine|mesh-list
83949692|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83949693|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949694|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
83949695|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
83949696|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
83949697|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949698|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83949699|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
83949700|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83949701|NCT02905539|Hematinics|hematinics|mesh-ancestor
83949702|NCT02905734|Nicotine|nicotine|mesh-list
83949703|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83949704|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
83949705|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949706|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949707|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83414515|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
83949708|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83949709|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
83949710|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949711|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949712|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
83949713|NCT04644185|Paraproteins|paraproteins|mesh-list
83949714|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
83949715|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949716|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
83949717|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83949718|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949719|NCT02905305|Dexamethasone|dexamethasone|mesh-list
83949720|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949721|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
83949722|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
83949723|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949724|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949725|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949726|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
83949727|NCT02905305|Hormones|hormones|mesh-ancestor
83949728|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949729|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949730|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949731|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
83949732|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83949733|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
83949734|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
83949735|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949736|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949737|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83949738|NCT02899182|Analgesics|analgesics|mesh-ancestor
83949739|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
83949740|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949741|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
83949742|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83949743|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83949744|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
83949745|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949746|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949747|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949748|NCT04643483|Adalimumab|adalimumab|mesh-list
83949749|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
83949750|NCT04643483|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83949751|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949752|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83949753|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949754|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
83949755|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949756|NCT00559052|Pancrelipase|pancrelipase|mesh-list
83949757|NCT00559052|Pancreatin|pancreatin|mesh-list
83949758|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949759|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83949760|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949761|NCT04643132|Ketamine|ketamine|mesh-list
83949762|NCT04643132|Esketamine|esketamine|mesh-list
83949763|NCT04643132|Analgesics|analgesics|mesh-ancestor
83949764|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
83949765|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949766|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949767|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83949768|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83949769|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
83949770|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
83949771|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949772|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83949773|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83949774|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949775|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949776|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
83949777|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949778|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83949779|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949780|NCT02899026|Prednisone|prednisone|mesh-list
83949781|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83949782|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949783|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
83949784|NCT02899026|Hormones|hormones|mesh-ancestor
83949785|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949786|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949787|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949788|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949789|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
83949790|NCT00559169|Verapamil|verapamil|mesh-list
83949791|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83949792|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83949793|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83949794|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949795|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83949796|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949797|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
83949798|NCT04642664|Apatinib|apatinib|mesh-list
83949799|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949800|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83949801|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949802|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949803|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83949804|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
83949805|NCT02904759|Coagulants|coagulants|mesh-ancestor
83949806|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83949807|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
83949808|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949809|NCT04642547|Lenvatinib|lenvatinib|mesh-list
83949810|NCT04642547|Gefitinib|gefitinib|mesh-list
83949811|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949812|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83949813|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949814|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949815|NCT02898792|Remifentanil|remifentanil|mesh-list
83949816|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83949817|NCT02898792|Narcotics|narcotics|mesh-ancestor
83949818|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949819|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949820|NCT02898792|Analgesics|analgesics|mesh-ancestor
83949821|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
83949822|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949823|NCT04642391|Cosyntropin|cosyntropin|mesh-list
83949824|NCT04642391|Hormones|hormones|mesh-ancestor
83949825|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949826|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949827|NCT02904564|Fluorouracil|fluorouracil|mesh-list
83949828|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
83949829|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949830|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83949831|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949832|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83949833|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
83949834|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949835|NCT04642001|Listerine|listerine|mesh-list
83949836|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
83949837|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
83949838|NCT04642001|Protective Agents|protective agents|mesh-ancestor
83949839|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949840|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83949841|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949842|NCT00559286|Telmisartan|telmisartan|mesh-list
83949843|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83949844|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83949845|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83949846|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949847|NCT04640870|Afatinib|afatinib|mesh-list
83949848|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949849|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83949850|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949851|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949852|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83949853|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
83949854|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949855|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949856|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83949857|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
83949858|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949859|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949860|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83949861|NCT02897934|Bupivacaine|bupivacaine|mesh-list
83949862|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
83949863|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
83949864|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949865|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949866|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
83949867|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949868|NCT04640129|Interferons|interferons|mesh-list
83949869|NCT04640129|Tenofovir|tenofovir|mesh-list
83949870|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
83949871|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949872|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
83949873|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949874|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83949875|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83949876|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949877|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949878|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83949879|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83949880|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
83949881|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949882|NCT02898012|Bevacizumab|bevacizumab|mesh-list
83949883|NCT02898012|Temozolomide|temozolomide|mesh-list
83189125|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949884|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83949885|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949886|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83949887|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83949888|NCT02898012|Growth Substances|growth substances|mesh-ancestor
83949889|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949890|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
83949891|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83949892|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
83949893|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949895|NCT04640324|Vitamins|vitamins|mesh-list
83949896|NCT04640324|Vitamin E|vitamin e|mesh-list
83949897|NCT04640324|Silybin|silybin|mesh-list
83949898|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
83949899|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949900|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83949901|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
83949902|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949903|NCT04640324|Protective Agents|protective agents|mesh-ancestor
83949904|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83949905|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949906|NCT04640285|Menthol|menthol|mesh-list
83949907|NCT04640285|Nicotine|nicotine|mesh-list
83949908|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83949909|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
83949910|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949911|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949912|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83949913|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83949914|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
83949915|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949916|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949917|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
83949918|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
83949919|NCT00559481|Ketoconazole|ketoconazole|mesh-list
83949920|NCT00559481|Dexamethasone|dexamethasone|mesh-list
83949921|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
83949922|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83949923|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83949924|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83949925|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83949926|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
83949927|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
83949928|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83949929|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949930|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83949931|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
83949932|NCT00559481|Hormones|hormones|mesh-ancestor
84048332|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949933|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83949934|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83949935|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949936|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
83949937|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949938|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83949939|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83949940|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949941|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949942|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83949943|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
83949944|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83949945|NCT02897856|Midazolam|midazolam|mesh-list
83949946|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83949947|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83949948|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83949949|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83949950|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83949951|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83949952|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83949953|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83949954|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
83949955|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
83949956|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
83949957|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
83949958|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83949959|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949960|NCT01236118|Ixekizumab|ixekizumab|mesh-list
83949961|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83949962|NCT04206631|Doxycycline|doxycycline|mesh-list
83949963|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83949964|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949965|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
83949966|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83949967|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83949968|NCT04639817|Levofloxacin|levofloxacin|mesh-list
83949969|NCT04639817|Trimethoprim|trimethoprim|mesh-list
83949970|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83949971|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
83949972|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83949973|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83949974|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83949975|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83949976|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83949977|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83949978|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949979|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83949980|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83949981|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83949982|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
83949983|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83949984|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83949985|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83949986|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83949987|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83949988|NCT01236001|Lacosamide|lacosamide|mesh-list
83949989|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
83949990|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83949991|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83949992|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83949993|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83949994|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
83949995|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83949996|NCT01229254|Amiodarone|amiodarone|mesh-list
83949997|NCT01229254|Betrixaban|betrixaban|mesh-list
83949998|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83949999|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
83950000|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83950001|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950002|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950003|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83950004|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83950005|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83950006|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950007|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83950008|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83950009|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83950010|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83950011|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
83950012|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83950013|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
83950014|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
83950015|NCT04639232|Probenecid|probenecid|mesh-list
83950016|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
83950017|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
83950018|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950019|NCT01235728|Calcitriol|calcitriol|mesh-list
83950020|NCT01235728|MK 0873|mk 0873|mesh-list
83950021|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83950022|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950023|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83950024|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950025|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950026|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83950027|NCT01235728|Vitamins|vitamins|mesh-ancestor
83950028|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
83950029|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83950030|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83950031|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83189272|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950032|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950034|NCT00559676|Fluorouracil|fluorouracil|mesh-list
83950035|NCT00559676|Capecitabine|capecitabine|mesh-list
83950036|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
83950037|NCT00559676|Irinotecan|irinotecan|mesh-list
83950038|NCT00559676|Calcium|calcium|mesh-list
83950039|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
83950040|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83950041|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950042|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
83950043|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950044|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83950045|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950046|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950047|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
83950048|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83950049|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83950050|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950051|NCT00559676|Antidotes|antidotes|mesh-ancestor
83950052|NCT00559676|Protective Agents|protective agents|mesh-ancestor
83950053|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
83950054|NCT00559676|Vitamins|vitamins|mesh-ancestor
83950055|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
83950056|NCT04639271|Trastuzumab|trastuzumab|mesh-list
83950057|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83950058|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83950059|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950060|NCT04681053|Ivermectin|ivermectin|mesh-list
83950061|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83950062|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950063|NCT04639193|Acetazolamide|acetazolamide|mesh-list
83950064|NCT04639193|Eszopiclone|eszopiclone|mesh-list
83950065|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83950066|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83950067|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83950068|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950069|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950070|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950071|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950072|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83950073|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
83950074|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83950075|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
83950076|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83950077|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950078|NCT04639193|Diuretics|diuretics|mesh-ancestor
83950079|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
83950080|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83950081|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950082|NCT01235689|Prednisone|prednisone|mesh-list
83950083|NCT01235689|Adalimumab|adalimumab|mesh-list
83950084|NCT01235689|Azathioprine|azathioprine|mesh-list
83950085|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950086|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
83950087|NCT01235689|Hormones|hormones|mesh-ancestor
83950088|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950089|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950090|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83950091|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950092|NCT01235689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83950093|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950094|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
83950095|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950096|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83950097|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950098|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
83950099|NCT04638686|Lamivudine|lamivudine|mesh-list
83950100|NCT04638686|Dolutegravir|dolutegravir|mesh-list
83950101|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83950102|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83950103|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950104|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950105|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
83950106|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950107|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83950108|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83950109|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83950110|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83950112|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950113|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
83950114|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950115|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83950116|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950117|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950118|NCT00559715|Bevacizumab|bevacizumab|mesh-list
83950119|NCT00559715|Ranibizumab|ranibizumab|mesh-list
83950120|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83950121|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950122|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83950123|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83950124|NCT00559715|Growth Substances|growth substances|mesh-ancestor
83950125|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950126|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
83950127|NCT02896803|Fluorouracil|fluorouracil|mesh-list
83950128|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
83950129|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
83950130|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950131|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83950132|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950133|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950134|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
83950135|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950136|NCT02897037|Heparin|heparin|mesh-list
83950137|NCT02897037|Bivalirudin|bivalirudin|mesh-list
83950138|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
83950139|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83950140|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83950141|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950142|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
83950143|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83950144|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
83950145|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950146|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
83950147|NCT00553683|Poly ICLC|poly iclc|mesh-list
83950148|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950149|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
83950150|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950151|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950152|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83950153|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
83950154|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950155|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950156|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83950157|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
83950158|NCT01229176|Vaccines|vaccines|mesh-list
83950159|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83950160|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
83950161|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950162|NCT01228747|Levetiracetam|levetiracetam|mesh-list
83950163|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
83950164|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
83950165|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
83950166|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83950167|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950168|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950169|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950170|NCT02896413|Analgesics|analgesics|mesh-ancestor
83950171|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
83950172|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950173|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83950174|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83950175|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83950176|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
83950177|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950178|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950179|NCT00553722|Eplerenone|eplerenone|mesh-list
83950180|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83950181|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
83189419|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83950182|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950183|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950184|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83950186|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
83950187|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83950188|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83950189|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83950190|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83950191|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83950192|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950193|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950194|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950195|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950196|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83950197|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
83950198|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83950199|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83950200|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83950201|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
83950202|NCT01234675|Milnacipran|milnacipran|mesh-list
83950203|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
83950204|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83950205|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83950206|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950207|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950208|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950209|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950210|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950211|NCT01234675|Analgesics|analgesics|mesh-ancestor
83950212|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
83950213|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950214|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
83950215|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83950216|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
83950217|NCT02896101|Tacrolimus|tacrolimus|mesh-list
83950218|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83950219|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950220|NCT02896101|Analgesics|analgesics|mesh-ancestor
83950221|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
83950222|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950223|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950224|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950225|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950226|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83950227|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950228|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
83950229|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83950230|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950231|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950232|NCT02896023|Menotropins|menotropins|mesh-list
83950233|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83950234|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
83950235|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83950236|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950237|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
83950238|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83950239|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83950240|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
83950241|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83950242|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950243|NCT02895672|Exenatide|exenatide|mesh-list
83950244|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950245|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950246|NCT02895672|Incretins|incretins|mesh-ancestor
83950247|NCT02895672|Hormones|hormones|mesh-ancestor
83950248|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950249|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83950250|NCT01227967|Ribavirin|ribavirin|mesh-list
83950251|NCT01227967|Oseltamivir|oseltamivir|mesh-list
83950252|NCT01227967|Amantadine|amantadine|mesh-list
83950253|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
83189503|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
83950254|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950255|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
83950256|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950257|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950258|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83950259|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83950260|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
83950261|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950262|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950263|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950265|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
83950266|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950267|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83950268|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
83950269|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950270|NCT04637204|Axitinib|axitinib|mesh-list
83950271|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950272|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83950273|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950274|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950275|NCT04637360|Calcitriol|calcitriol|mesh-list
83950276|NCT04637360|Cinacalcet|cinacalcet|mesh-list
83950277|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83950278|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950279|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83950280|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950281|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950282|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83950283|NCT04637360|Vitamins|vitamins|mesh-ancestor
83950284|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
83950285|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83950286|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83950287|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
83950288|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950289|NCT04317703|Metformin|metformin|mesh-list
83950290|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950291|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950292|NCT05656534|Suvorexant|suvorexant|mesh-list
83950293|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83950294|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83950295|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950296|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950297|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83950298|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950299|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950300|NCT00560222|Lactoferrin|lactoferrin|mesh-list
83950301|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950302|NCT04317508|Benzocaine|benzocaine|mesh-list
83950303|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
83950304|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
83950305|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950306|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950307|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
83950308|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950309|NCT00560300|Vitamin D|vitamin d|mesh-list
83950310|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
83950311|NCT00560300|Calcitriol|calcitriol|mesh-list
83950312|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83950313|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83950314|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
83950315|NCT00560300|Calcium|calcium|mesh-list
83950316|NCT00560300|Sevelamer|sevelamer|mesh-list
83950317|NCT00560300|Vitamins|vitamins|mesh-ancestor
83950318|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
83950319|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950320|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83950321|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83950322|NCT00560300|Antacids|antacids|mesh-ancestor
83950323|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950324|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950325|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83950326|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950327|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83950328|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
83950329|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
83950330|NCT02904369|Tenofovir|tenofovir|mesh-list
83950331|NCT02904369|Emtricitabine|emtricitabine|mesh-list
83950332|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
83950333|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950334|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83950335|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83950336|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950337|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950338|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83950339|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83950340|NCT00560378|Tacrolimus|tacrolimus|mesh-list
83950341|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950342|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
83950343|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950344|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83950345|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950346|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950347|NCT02895321|Listerine|listerine|mesh-list
83950348|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
83950349|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
83950350|NCT02895321|Protective Agents|protective agents|mesh-ancestor
83950351|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950352|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83950353|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950354|NCT02894892|Esomeprazole|esomeprazole|mesh-list
83950355|NCT02894892|Bismuth|bismuth|mesh-list
83950356|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83950357|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950358|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83950359|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950360|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950361|NCT02894892|Antacids|antacids|mesh-ancestor
83950362|NCT04635566|Mebeverine|mebeverine|mesh-list
83950363|NCT04635566|Alverine|alverine|mesh-list
83950364|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
83950365|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
83950366|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
83950367|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950368|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950369|NCT04635293|Simendan|simendan|mesh-list
83950370|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83950371|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
83950372|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83950373|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83950374|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950375|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950376|NCT04635293|Protective Agents|protective agents|mesh-ancestor
83950377|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950378|NCT01227889|Dacarbazine|dacarbazine|mesh-list
83950379|NCT01227889|Dabrafenib|dabrafenib|mesh-list
83950380|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83950381|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
83950382|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950383|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950384|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83950385|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950386|NCT02888392|Psyllium|psyllium|mesh-list
83950387|NCT02888392|Cathartics|cathartics|mesh-ancestor
83950388|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950389|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
83950390|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
83950391|NCT00624676|Salicylates|salicylates|mesh-list
83950392|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83950393|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
83950394|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950395|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
83950396|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
83950397|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83950398|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950399|NCT00624676|Analgesics|analgesics|mesh-ancestor
83950400|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
83950401|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950402|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189646|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950403|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950404|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124687|NCT00538291|Cetuximab|cetuximab|mesh-list
83950405|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83950406|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950407|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950408|NCT05655754|Methohexital|methohexital|mesh-list
83950409|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83950410|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
83950411|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
83950412|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950413|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950414|NCT05655715|Nivolumab|nivolumab|mesh-list
83950415|NCT05655715|Ipilimumab|ipilimumab|mesh-list
83950416|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83950417|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950418|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83950419|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950420|NCT04317235|Ropivacaine|ropivacaine|mesh-list
83950421|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
83950422|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
83950423|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950424|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950425|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
83950426|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950427|NCT00560690|Metformin|metformin|mesh-list
83950428|NCT00560690|Interferons|interferons|mesh-list
83950429|NCT00560690|Ribavirin|ribavirin|mesh-list
83950430|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950431|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950432|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950433|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
83950434|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950435|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
83950436|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950437|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
83950438|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83950439|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950440|NCT02903901|Melatonin|melatonin|mesh-list
83950441|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
83950442|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950443|NCT02903901|Protective Agents|protective agents|mesh-ancestor
83950444|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950445|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950446|NCT04634981|Anesthetics|anesthetics|mesh-list
83950447|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950448|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950449|NCT00553449|Rabeprazole|rabeprazole|mesh-list
83950450|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83950451|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950452|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83950453|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950454|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950455|NCT05655130|Dexamethasone|dexamethasone|mesh-list
83950456|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
83950457|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83950458|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83950459|NCT05655130|Prednisolone|prednisolone|mesh-list
83950460|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
83950461|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83950462|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
83950463|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950464|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
83950465|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
83950466|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950467|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950468|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950469|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
83950470|NCT05655130|Hormones|hormones|mesh-ancestor
83950471|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950472|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83950473|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950474|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83950475|NCT05655130|Protective Agents|protective agents|mesh-ancestor
83950476|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
83950477|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83950478|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950479|NCT04633850|Dexamethasone|dexamethasone|mesh-list
83950480|NCT04633850|Bupivacaine|bupivacaine|mesh-list
83950481|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950483|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
83950484|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950485|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950486|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950487|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
83950488|NCT04633850|Hormones|hormones|mesh-ancestor
83950489|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950490|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83950491|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950492|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
83950493|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
83950494|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950495|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
83950496|NCT04633733|Tacrolimus|tacrolimus|mesh-list
83950497|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950498|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
83950499|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950500|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83950501|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950502|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950503|NCT05427942|Adalimumab|adalimumab|mesh-list
83950504|NCT05427942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83950505|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950506|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950507|NCT05427903|Epinephrine|epinephrine|mesh-list
83950508|NCT05427903|Anesthetics|anesthetics|mesh-list
83950509|NCT05427903|Carticaine|carticaine|mesh-list
83950510|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
83950511|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950512|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950513|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83950514|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83950515|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
83950516|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950517|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950518|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83950519|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83950520|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
83950521|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950522|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83950523|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
83950524|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
83950525|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
83950526|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83950527|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
83950528|NCT05427747|Meropenem|meropenem|mesh-list
83950529|NCT05427747|Cefotaxime|cefotaxime|mesh-list
83950530|NCT05427747|Cefoxitin|cefoxitin|mesh-list
83950531|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83950532|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950533|NCT00445406|Bevacizumab|bevacizumab|mesh-list
83950534|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83950535|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950536|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83950537|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83950538|NCT00445406|Growth Substances|growth substances|mesh-ancestor
83950539|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950540|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
83950541|NCT00445523|Interferons|interferons|mesh-list
83950542|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
83950543|NCT00445523|Vaccines|vaccines|mesh-list
83950544|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950545|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
83950546|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950547|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
83950548|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950549|NCT02903004|Paclitaxel|paclitaxel|mesh-list
83950550|NCT02903004|Carboplatin|carboplatin|mesh-list
83950551|NCT02903004|Gemcitabine|gemcitabine|mesh-list
83950552|NCT02903004|Doxorubicin|doxorubicin|mesh-list
83950553|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83950554|NCT02903004|Topotecan|topotecan|mesh-list
83950555|NCT02903004|Trabectedin|trabectedin|mesh-list
83950556|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83950557|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950558|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83950560|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83950561|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950562|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83950563|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
83950564|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83950565|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83950566|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83950567|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950568|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83950569|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83950570|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
83950571|NCT05427084|Canagliflozin|canagliflozin|mesh-list
83950572|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83950573|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950574|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950575|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950576|NCT00445796|Artesunate|artesunate|mesh-list
83950577|NCT00445796|Amodiaquine|amodiaquine|mesh-list
83950578|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
83950579|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83950580|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83950581|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950582|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950583|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
83950584|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
83950585|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83950586|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
83950587|NCT01225822|Enoxaparin|enoxaparin|mesh-list
83950588|NCT01225822|Dabigatran|dabigatran|mesh-list
83950589|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
83950590|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83950591|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83950592|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950593|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
83950594|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83950595|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
83950596|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950597|NCT00445874|Ketotifen|ketotifen|mesh-list
83950598|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
83950599|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
83950600|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83950601|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
83950602|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
83950603|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950604|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950605|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950606|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83950607|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83950608|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950609|NCT01225549|Budesonide|budesonide|mesh-list
83950610|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950611|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83950612|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
83950613|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950614|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950615|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83950616|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
83950617|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
83950618|NCT01225549|Hormones|hormones|mesh-ancestor
83950619|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950620|NCT05469685|Amoxicillin|amoxicillin|mesh-list
83950621|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83950622|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950623|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
83950624|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950625|NCT00446069|Morphine|morphine|mesh-list
83950626|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83950627|NCT00446069|Narcotics|narcotics|mesh-ancestor
83950628|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950629|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950630|NCT00446069|Analgesics|analgesics|mesh-ancestor
83950631|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
83950632|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950633|NCT02902653|Misoprostol|misoprostol|mesh-list
83950634|NCT02902653|Dinoprostone|dinoprostone|mesh-list
83950635|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83950636|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
83950637|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83950638|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950639|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83950640|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950641|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
83950642|NCT00446303|Azacitidine|azacitidine|mesh-list
83950643|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83950644|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
83950645|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950646|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950647|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950648|NCT01223404|Mecamylamine|mecamylamine|mesh-list
83950649|NCT01223404|Nicotine|nicotine|mesh-list
83950650|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83950651|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
83950652|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950653|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950654|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83950655|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83950656|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
83950657|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950658|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950659|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83950660|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83950661|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83950662|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83950663|NCT00446420|Fentanyl|fentanyl|mesh-list
83950664|NCT00446420|Midazolam|midazolam|mesh-list
83950665|NCT00446420|Propofol|propofol|mesh-list
83950666|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83950667|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950668|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950669|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83950670|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
83950671|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
83950672|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83950673|NCT00446420|Narcotics|narcotics|mesh-ancestor
83950674|NCT00446420|Analgesics|analgesics|mesh-ancestor
83950675|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
83950676|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950677|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83950678|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83950679|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83950680|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83950681|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
83950682|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
83950683|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950684|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950685|NCT00446537|Methylphenidate|methylphenidate|mesh-list
83950686|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83950687|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950688|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83950689|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83950690|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950691|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950692|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
83950693|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950694|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
83950695|NCT00446576|Hematinics|hematinics|mesh-ancestor
83950696|NCT02902302|Ibuprofen|ibuprofen|mesh-list
83950697|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83950698|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950699|NCT02902302|Analgesics|analgesics|mesh-ancestor
83950700|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
83950701|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950702|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950703|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950704|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950705|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83950706|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950707|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950708|NCT01223365|Hydrocodone|hydrocodone|mesh-list
83950709|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83950710|NCT01223365|Narcotics|narcotics|mesh-ancestor
83950711|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950712|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950713|NCT01223365|Analgesics|analgesics|mesh-ancestor
83950714|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
83950715|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950716|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
83950717|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
83950718|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
83950719|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83950720|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950721|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950722|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950723|NCT04319419|Micronutrients|micronutrients|mesh-list
83950724|NCT04319419|Trace Elements|trace elements|mesh-list
83950725|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950726|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83950728|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83950729|NCT05657704|Narcotics|narcotics|mesh-ancestor
83950730|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950731|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950732|NCT05657704|Analgesics|analgesics|mesh-ancestor
83950733|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
83950734|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950735|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83950736|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950737|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83950738|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950739|NCT00446771|Mannitol|mannitol|mesh-list
83950740|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83950741|NCT00446771|Diuretics|diuretics|mesh-ancestor
83950742|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
83950743|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950744|NCT04317157|Caffeine|caffeine|mesh-list
83950745|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83950746|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950747|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83950748|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950749|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950750|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83950751|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83950752|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
83950753|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950754|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83950755|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950756|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
83950757|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950758|NCT04317079|Protective Agents|protective agents|mesh-ancestor
83950759|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950760|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83950761|NCT03277430|Tacrolimus|tacrolimus|mesh-list
83950762|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950763|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
83950764|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950765|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83950766|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950767|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950768|NCT04699214|Endostar protein|endostar protein|mesh-list
83950769|NCT04699214|Endostatins|endostatins|mesh-list
83950770|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83950771|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83950772|NCT04699214|Growth Substances|growth substances|mesh-ancestor
83950773|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950774|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
83950775|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950776|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
83950777|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83950778|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950779|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950780|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83950781|NCT02902380|Analgesics|analgesics|mesh-ancestor
83950782|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
83950783|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190026|NCT05131893|Goserelin|goserelin|mesh-list
83950784|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83950785|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83950786|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83950787|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
83950788|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950789|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950791|NCT01221727|Midazolam|midazolam|mesh-list
83950792|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83950793|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83950794|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950795|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950796|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83950797|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83950798|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83950799|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83950800|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
83950801|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
83950802|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
83950803|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
83950804|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950805|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950806|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83950807|NCT01221181|Eculizumab|eculizumab|mesh-list
83950808|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83950809|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83950810|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
83950811|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950812|NCT03277079|Ezetimibe|ezetimibe|mesh-list
83950813|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83950814|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83950815|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83950816|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
83950817|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950818|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83950819|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950820|NCT01220557|Insulin|insulin|mesh-list
83950821|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950822|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950823|NCT04317001|Modafinil|modafinil|mesh-list
83950824|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83950825|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950826|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83950827|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83950828|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83950829|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950830|NCT05426499|Fluconazole|fluconazole|mesh-list
83950831|NCT05426499|Isavuconazole|isavuconazole|mesh-list
83950832|NCT05426499|Anidulafungin|anidulafungin|mesh-list
83950833|NCT05426499|Meropenem|meropenem|mesh-list
83950834|NCT05426499|Cefotaxime|cefotaxime|mesh-list
83950835|NCT05426499|Cefoxitin|cefoxitin|mesh-list
83950836|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
83950837|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950838|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83950839|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83950840|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950841|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950842|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83950843|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83950844|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950845|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950846|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83950847|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83950848|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83950849|NCT00446810|Benphothiamine|benphothiamine|mesh-list
83950850|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83950851|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
83950852|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950853|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
83950854|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
83950855|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950856|NCT01220167|Ondansetron|ondansetron|mesh-list
83950857|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
83950858|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
83950859|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950860|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950861|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950862|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
83950863|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
83950864|NCT01220167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83950865|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83950866|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
83950867|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950868|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950869|NCT00447239|Insulin|insulin|mesh-list
83950870|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950871|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950872|NCT05425914|Vitamin D|vitamin d|mesh-list
83950873|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
83950874|NCT05425914|Vitamins|vitamins|mesh-ancestor
83950875|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
83950876|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950877|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83950878|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83950879|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83950880|NCT00447356|Interferons|interferons|mesh-list
83950881|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
83950882|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950883|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
83950884|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950885|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
83950886|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950887|NCT05425875|Dimercaprol|dimercaprol|mesh-list
83950888|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
83950889|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
83950890|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950891|NCT00447473|Ketoconazole|ketoconazole|mesh-list
83950892|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
83950893|NCT00447473|Analgesics|analgesics|mesh-ancestor
83950894|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
83950895|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950896|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950897|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950898|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83950899|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83950900|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83950901|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950902|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
83950903|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83950904|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83950905|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83950906|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83950907|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
83950908|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950909|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83950910|NCT00553488|Insulin|insulin|mesh-list
83950911|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83950912|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
83950913|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83950914|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950915|NCT03455322|Octreotide|octreotide|mesh-list
83950916|NCT03455322|Norepinephrine|norepinephrine|mesh-list
83950917|NCT03455322|Midodrine|midodrine|mesh-list
83950918|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950919|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83950920|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950921|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83950922|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83950923|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
83950924|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950925|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950926|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950927|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
83950928|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
83950929|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950930|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83950931|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83950932|NCT05425368|Fluorides|fluorides|mesh-list
83950933|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
83950934|NCT05425368|Protective Agents|protective agents|mesh-ancestor
83950935|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950936|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
83950937|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83950939|NCT00447863|Estrogens|estrogens|mesh-ancestor
83950940|NCT00447863|Hormones|hormones|mesh-ancestor
83950941|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83950942|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950943|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83950944|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
83950945|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83950946|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83950947|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83950948|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83950949|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83950950|NCT00448097|Docetaxel|docetaxel|mesh-list
83950951|NCT00448097|Cetuximab|cetuximab|mesh-list
83950952|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83950953|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
83950954|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
83950955|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
83950956|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950957|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83950958|NCT00448214|Warfarin|warfarin|mesh-list
83950959|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
83950960|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
83950961|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
83950962|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950963|NCT00448292|Naluzotan|naluzotan|mesh-list
83950964|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83950965|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83950966|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
83950967|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83950968|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950969|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950970|NCT02901561|Misoprostol|misoprostol|mesh-list
83950971|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83950972|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
83950973|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83950974|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950975|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83950976|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83950977|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
83950978|NCT00448409|Sargramostim|sargramostim|mesh-list
83950979|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
83950980|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950981|NCT02901366|Dotinurad|dotinurad|mesh-list
83950982|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
83950983|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
83950984|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83950985|NCT03276689|Pregabalin|pregabalin|mesh-list
83950986|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83950987|NCT03276689|Analgesics|analgesics|mesh-ancestor
83950988|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
83950989|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83950990|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83950991|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
83950992|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83950993|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83950994|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83950995|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83950996|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83950997|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83950998|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83950999|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83951000|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83951001|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83951002|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951003|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
83951004|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
83951005|NCT01220128|Paclitaxel|paclitaxel|mesh-list
83951006|NCT01220128|Docetaxel|docetaxel|mesh-list
83951007|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
83951008|NCT01220128|Carboplatin|carboplatin|mesh-list
83951009|NCT01220128|Doxorubicin|doxorubicin|mesh-list
83951010|NCT01220128|Fluorouracil|fluorouracil|mesh-list
83951011|NCT01220128|Trastuzumab|trastuzumab|mesh-list
83951013|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83951014|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83951015|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951016|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
83951017|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
83951018|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
83951019|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951020|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951021|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
83951022|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951023|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951024|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83951025|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
83951026|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83951027|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83951028|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83951029|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83951030|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951031|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
83951032|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951033|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951034|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83951035|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83951036|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
83951037|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951038|NCT04698941|Paclitaxel|paclitaxel|mesh-list
83951039|NCT04698941|Simvastatin|simvastatin|mesh-list
83951040|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83951041|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951042|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
83951043|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
83951044|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83951045|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951046|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83951047|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83951048|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
83951049|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83951050|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83951051|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951052|NCT02901288|Levofloxacin|levofloxacin|mesh-list
83951053|NCT02901288|Rifampin|rifampin|mesh-list
83951054|NCT02901288|Isoniazid|isoniazid|mesh-list
83951055|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
83951056|NCT02901288|Ethambutol|ethambutol|mesh-list
83951057|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83951058|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951059|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951060|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83951061|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83951062|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951063|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951064|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951065|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83951066|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83951067|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83951068|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
83951069|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
83951070|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83951071|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83951072|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83951073|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83951074|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83951075|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83951076|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83951077|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83951078|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83951079|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
83951080|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83951081|NCT00448643|Cisplatin|cisplatin|mesh-list
83951082|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951083|NCT05424393|Etanercept|etanercept|mesh-list
83951084|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951085|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951087|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
83951088|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951089|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951090|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951091|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951092|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951093|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951094|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
83951095|NCT00448838|Gemcitabine|gemcitabine|mesh-list
83951096|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
83951097|NCT00448838|Cetuximab|cetuximab|mesh-list
83951098|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951099|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
83951100|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951101|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951102|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951103|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
83951104|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83951105|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83951106|NCT01219933|Prednisolone|prednisolone|mesh-list
83951107|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
83951108|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83951109|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
83951110|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951111|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
83951112|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
83951113|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951114|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951115|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951116|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
83951117|NCT01219933|Hormones|hormones|mesh-ancestor
83951118|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951119|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83951120|NCT01219933|Protective Agents|protective agents|mesh-ancestor
83951121|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83951122|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951123|NCT05373901|Tretinoin|tretinoin|mesh-list
83951124|NCT05373901|Dinutuximab|dinutuximab|mesh-list
83951125|NCT05373901|Isotretinoin|isotretinoin|mesh-list
83951126|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951127|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
83951128|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
83951129|NCT05368441|Midazolam|midazolam|mesh-list
83951130|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83951131|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83951132|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951133|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951134|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83951135|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83951136|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83951137|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83951138|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
83951139|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
83951140|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
83951141|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
83951142|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951143|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951144|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
83951145|NCT05468359|Bevacizumab|bevacizumab|mesh-list
83951146|NCT05468359|Sorafenib|sorafenib|mesh-list
83951147|NCT05468359|Atezolizumab|atezolizumab|mesh-list
83951148|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951149|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
83951150|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951151|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951152|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83951153|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
83951154|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951155|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951156|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83951157|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951158|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951159|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951161|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951162|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83951163|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951164|NCT05468359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83951165|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83951166|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83951167|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951168|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83951169|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83951170|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83951171|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
83951172|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951173|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83951174|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83951175|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951176|NCT02887222|Bupivacaine|bupivacaine|mesh-list
83951177|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
83951178|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
83951179|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951180|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951181|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
83951182|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951183|NCT01218646|Vaccines|vaccines|mesh-list
83951184|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
83951185|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951186|NCT00449423|Acipimox|acipimox|mesh-list
83951187|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83951188|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
83951189|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951190|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83951191|NCT00449501|Budesonide|budesonide|mesh-list
83951192|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
83951193|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951194|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83951195|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
83951196|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951197|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951198|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83951199|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
83951200|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
83951201|NCT00449501|Hormones|hormones|mesh-ancestor
83951202|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951203|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83951204|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83951205|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83951206|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
83951207|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951208|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951209|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83951210|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83951211|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951212|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
83951213|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
83951214|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
83951215|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951216|NCT01188655|Etanercept|etanercept|mesh-list
83951217|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951218|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951219|NCT01188655|Analgesics|analgesics|mesh-ancestor
83951220|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
83951221|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951222|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951223|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951224|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951225|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951226|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951227|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
83951228|NCT00449618|Aspirin|aspirin|mesh-list
83951229|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951230|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951231|NCT00449618|Analgesics|analgesics|mesh-ancestor
83951232|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
83951233|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951234|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951235|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951236|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951237|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83951238|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83951239|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951240|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83951241|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83951242|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951243|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
83951244|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83951245|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951246|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951247|NCT01188538|Analgesics|analgesics|mesh-ancestor
83951248|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
83951249|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951250|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951251|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951252|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951253|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
83951254|NCT00449657|Paclitaxel|paclitaxel|mesh-list
83951255|NCT00449657|Carboplatin|carboplatin|mesh-list
83951256|NCT00449657|Gemcitabine|gemcitabine|mesh-list
83951257|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83951258|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951259|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
83951260|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
83951261|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83951262|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951263|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951264|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
83951265|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
83951266|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
83951267|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83951268|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83951269|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951270|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951271|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951272|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951273|NCT03276143|Enoxaparin|enoxaparin|mesh-list
83951274|NCT03276143|Apixaban|apixaban|mesh-list
83951275|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
83951276|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83951277|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83951278|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951279|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83951280|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
83951281|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83951282|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
83951283|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951284|NCT00449774|Lamotrigine|lamotrigine|mesh-list
83951285|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
83951286|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83951287|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83951288|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951289|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83951290|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951291|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83951292|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83951293|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951294|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83951295|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83951296|NCT02900742|Gemcitabine|gemcitabine|mesh-list
83951297|NCT02900742|Docetaxel|docetaxel|mesh-list
83951298|NCT02900742|Pemetrexed|pemetrexed|mesh-list
83951299|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951300|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
83951301|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951302|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951303|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
83951304|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
83951305|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
83951306|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951307|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83951308|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83951309|NCT00449813|Pantoprazole|pantoprazole|mesh-list
83951310|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83951311|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951312|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83951313|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951314|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951315|NCT01218100|Lisinopril|lisinopril|mesh-list
83951316|NCT01218100|Nebivolol|nebivolol|mesh-list
83951317|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83951318|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
83951319|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951320|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951321|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83951322|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83951323|NCT01218100|Protective Agents|protective agents|mesh-ancestor
83951324|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951325|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
83951326|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83951327|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83951328|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83951329|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
83951330|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951331|NCT00450008|Thalidomide|thalidomide|mesh-list
83951332|NCT00450008|Docetaxel|docetaxel|mesh-list
83951333|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951334|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
83951335|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
83951336|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
83951337|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951338|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951339|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
83951340|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951341|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
83951342|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951343|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951344|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951345|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951346|NCT00450008|Growth Substances|growth substances|mesh-ancestor
83951347|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951348|NCT02900469|Denosumab|denosumab|mesh-list
83951349|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83951350|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951351|NCT00450086|Budesonide|budesonide|mesh-list
83951352|NCT00450086|Mesalamine|mesalamine|mesh-list
83951353|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951354|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83951355|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
83951356|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951357|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951358|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83951359|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83951360|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
83951361|NCT00450086|Hormones|hormones|mesh-ancestor
83951362|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951363|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951364|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951365|NCT00450086|Analgesics|analgesics|mesh-ancestor
83951366|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
83951367|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951368|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
83951369|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951370|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83951371|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951372|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951373|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
83951374|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951375|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951376|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83951377|NCT00450164|Nadolol|nadolol|mesh-list
83951378|NCT00450164|Prazosin|prazosin|mesh-list
83951379|NCT00450164|Isosorbide|isosorbide|mesh-list
83951380|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83951381|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83951382|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83951383|NCT00450164|Diuretics|diuretics|mesh-ancestor
83951384|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
83951385|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951386|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
83951387|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83951388|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951389|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83951390|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83951391|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83951392|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83951393|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
83951394|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951395|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83951396|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83951397|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
83951398|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
83951399|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951400|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
83951401|NCT02900430|Clotrimazole|clotrimazole|mesh-list
83951402|NCT02900430|Miconazole|miconazole|mesh-list
83951403|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951404|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83951405|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83951406|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83951407|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951408|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951409|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83951410|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
83951411|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951412|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951413|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83951414|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83951415|NCT00450203|Bevacizumab|bevacizumab|mesh-list
83951416|NCT00450203|Capecitabine|capecitabine|mesh-list
83951417|NCT00450203|Epirubicin|epirubicin|mesh-list
83951418|NCT00450203|Lapatinib|lapatinib|mesh-list
83951419|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951420|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951421|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951422|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951423|NCT00450203|Growth Substances|growth substances|mesh-ancestor
83951424|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951425|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951426|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951427|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
83951428|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951429|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83951430|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83951431|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83951432|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951433|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83951434|NCT00450281|Antibodies|antibodies|mesh-list
83951435|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
83951436|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951437|NCT04699097|Azithromycin|azithromycin|mesh-list
83951438|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951439|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951440|NCT04698746|Anesthetics|anesthetics|mesh-list
83951441|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
83951442|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951443|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951444|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
83951445|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951446|NCT00450320|Sirolimus|sirolimus|mesh-list
83951447|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951448|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951449|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83951450|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951451|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
83951452|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951453|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
83951454|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951455|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
83951456|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83951457|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
83951458|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951459|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83951460|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951461|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
83951462|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951463|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
83951464|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83951465|NCT00450398|Protective Agents|protective agents|mesh-ancestor
83951466|NCT00450515|Capecitabine|capecitabine|mesh-list
83951467|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951468|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
83951469|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951470|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951471|NCT00450827|Bevacizumab|bevacizumab|mesh-list
83951472|NCT00450827|Antibodies|antibodies|mesh-list
83951473|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83951474|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951475|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951476|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951477|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951478|NCT00450827|Growth Substances|growth substances|mesh-ancestor
83951479|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951480|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951481|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
83951482|NCT00450944|Immunotoxins|immunotoxins|mesh-list
83951483|NCT00450944|Immunoconjugates|immunoconjugates|mesh-ancestor
83951484|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
83951485|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951486|NCT00451061|Tamsulosin|tamsulosin|mesh-list
83951487|NCT00451061|Alfuzosin|alfuzosin|mesh-list
83951488|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83951489|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83951490|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83951491|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83951492|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951493|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951494|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951495|NCT00451061|Urological Agents|urological agents|mesh-ancestor
83951496|NCT02931383|Liraglutide|liraglutide|mesh-list
83951497|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83951498|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951499|NCT02931383|Incretins|incretins|mesh-ancestor
83951500|NCT02931383|Hormones|hormones|mesh-ancestor
83951501|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951502|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
83951503|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
83951504|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83951505|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83951506|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951507|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951508|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951509|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951510|NCT01187953|Tacrolimus|tacrolimus|mesh-list
83951511|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951512|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
83951513|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951514|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83951515|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048333|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951516|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951517|NCT02900157|Durvalumab|durvalumab|mesh-list
83951518|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951519|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951520|NCT04262817|Nicotine|nicotine|mesh-list
83951521|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83951522|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
83951523|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951524|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951525|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83951526|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83951527|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
83951528|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951529|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951530|NCT02931188|Anacetrapib|anacetrapib|mesh-list
83951531|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83951532|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83951533|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
83951534|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951535|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83951537|NCT01217944|Verteporfin|verteporfin|mesh-list
83951538|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951539|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951540|NCT01217944|Growth Substances|growth substances|mesh-ancestor
83951541|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951542|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951543|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951544|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83951545|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
83951546|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
83951547|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951548|NCT01187446|Vorinostat|vorinostat|mesh-list
83951549|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951550|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83951551|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951552|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951553|NCT02931071|Plerixafor|plerixafor|mesh-list
83951554|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83951555|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83951556|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
83951557|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951558|NCT01187407|Serotonin|serotonin|mesh-list
83951559|NCT01187407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83951560|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83951561|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
83951562|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951563|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951564|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951565|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83951566|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83951567|NCT01186939|Azacitidine|azacitidine|mesh-list
83951568|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951569|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
83951570|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951571|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951572|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951573|NCT04447040|Acetaminophen|acetaminophen|mesh-list
83951574|NCT04447040|Naproxen|naproxen|mesh-list
83951575|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951576|NCT04447040|Analgesics|analgesics|mesh-ancestor
83951577|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
83951578|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951579|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951580|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
83951581|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951582|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951583|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951584|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
83951585|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83951586|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951587|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951588|NCT05321043|Riboflavin|riboflavin|mesh-list
83951589|NCT05321043|Vitamins|vitamins|mesh-ancestor
83951590|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
83951591|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951592|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
83951593|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83951594|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83951595|NCT02930954|Bevacizumab|bevacizumab|mesh-list
83951596|NCT02930954|Carboplatin|carboplatin|mesh-list
83951597|NCT02930954|Gemcitabine|gemcitabine|mesh-list
83951598|NCT02930954|Pemetrexed|pemetrexed|mesh-list
83951599|NCT02930954|Gefitinib|gefitinib|mesh-list
83951600|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951601|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951602|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951603|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951604|NCT02930954|Growth Substances|growth substances|mesh-ancestor
83951605|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951606|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951607|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951608|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
83951609|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951610|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951611|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83951612|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83951613|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83951614|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83951615|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83951616|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951617|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951618|NCT05289492|Dexamethasone|dexamethasone|mesh-list
83951619|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951620|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
83951621|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
83951622|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951623|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951624|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951625|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
83951626|NCT05289492|Hormones|hormones|mesh-ancestor
83951627|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951628|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83951629|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951630|NCT02930057|Betamethasone|betamethasone|mesh-list
83951631|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951632|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
83951633|NCT02930057|Hormones|hormones|mesh-ancestor
83951634|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951635|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951636|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83951637|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
83951638|NCT02929901|Caffeine|caffeine|mesh-list
83951639|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83951640|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951641|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83951642|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951643|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951644|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83951645|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83951646|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
83951647|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951648|NCT02929706|Azathioprine|azathioprine|mesh-list
83951649|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
83951650|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951651|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83951652|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951653|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951654|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
83951655|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951656|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951657|NCT03993132|Empagliflozin|empagliflozin|mesh-list
83951658|NCT03993132|Glucagon|glucagon|mesh-list
83951659|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83951660|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83951661|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951662|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83951663|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951664|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951665|NCT03993132|Hormones|hormones|mesh-ancestor
83951666|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951667|NCT03993132|Incretins|incretins|mesh-ancestor
83951668|NCT00553878|Dutasteride|dutasteride|mesh-list
83951669|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83951670|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83951671|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951672|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951673|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
83951674|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951675|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951676|NCT00624325|Interferons|interferons|mesh-list
83951677|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
83951678|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
83951679|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951680|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
83951681|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951682|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
83951683|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951684|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83951685|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
83951686|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
83951687|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951688|NCT05184192|Gabapentin|gabapentin|mesh-list
83951689|NCT05184192|Analgesics|analgesics|mesh-ancestor
83951690|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
83951691|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951692|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951693|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
83951694|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83951695|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83951696|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951697|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83951698|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83951699|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83951700|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951701|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951702|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
83951703|NCT02929121|Doxycycline|doxycycline|mesh-list
83951704|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951705|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951706|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
83951707|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83951708|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83951709|NCT02929394|Trabectedin|trabectedin|mesh-list
83951710|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83951711|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
83951712|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951713|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951714|NCT02929316|Vedolizumab|vedolizumab|mesh-list
83951715|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951716|NCT05134974|Phentolamine|phentolamine|mesh-list
83951717|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83951718|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83951719|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83951720|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83951721|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
83951722|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951723|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951724|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951725|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83951726|NCT02928965|Minocycline|minocycline|mesh-list
83951727|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951728|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951729|NCT02928692|Minocycline|minocycline|mesh-list
83951730|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951731|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951732|NCT04679142|Baclofen|baclofen|mesh-list
83951733|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83951734|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951735|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83951736|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951737|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83951738|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
83951739|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
83951740|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951741|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951742|NCT02928419|Lenalidomide|lenalidomide|mesh-list
83951743|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
83951744|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951745|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951746|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951747|NCT02928419|Growth Substances|growth substances|mesh-ancestor
83951748|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951749|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951750|NCT02928614|Liraglutide|liraglutide|mesh-list
83951751|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83951752|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951753|NCT02928614|Incretins|incretins|mesh-ancestor
83951754|NCT02928614|Hormones|hormones|mesh-ancestor
83951755|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951756|NCT03685500|Emtricitabine|emtricitabine|mesh-list
83951757|NCT03685500|Darunavir|darunavir|mesh-list
83951758|NCT03685500|Cobicistat|cobicistat|mesh-list
83951759|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
83951760|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951761|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83951762|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83951763|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951764|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951765|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83951766|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83951767|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83951768|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83951769|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
83951770|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83951771|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83951772|NCT02928575|Temozolomide|temozolomide|mesh-list
83951774|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83951775|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
83951776|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951777|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951778|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951779|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951780|NCT02928575|Growth Substances|growth substances|mesh-ancestor
83951781|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951782|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951783|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83951784|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951785|NCT02927951|Pregabalin|pregabalin|mesh-list
83951786|NCT02927951|Analgesics|analgesics|mesh-ancestor
83951787|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
83951788|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951789|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951790|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
83951791|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83951792|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83951793|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951794|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83951795|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83951796|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83951797|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951798|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83951799|NCT02927405|Gabapentin|gabapentin|mesh-list
83951800|NCT02927405|Analgesics|analgesics|mesh-ancestor
83951801|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
83951802|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951803|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951804|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
83951805|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83951806|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83951807|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951808|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83951809|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83951810|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83951811|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951812|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951813|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
83951814|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
83951815|NCT05005299|Fludarabine|fludarabine|mesh-list
83951816|NCT05005299|Venetoclax|venetoclax|mesh-list
83951817|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951818|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
83951819|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951820|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951821|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83951822|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
83951823|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951824|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951825|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83951826|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83951827|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
83951828|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951829|NCT02927522|Donepezil|donepezil|mesh-list
83951830|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83951831|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191089|NCT02505295|Selenium|selenium|mesh-list
83951832|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951834|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951835|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951836|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
83951837|NCT02926976|Valproic Acid|valproic acid|mesh-list
83951838|NCT02926976|Risperidone|risperidone|mesh-list
83951839|NCT02926976|Aripiprazole|aripiprazole|mesh-list
83951840|NCT02926976|Clozapine|clozapine|mesh-list
83951841|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83951842|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
83951843|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951844|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951845|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951846|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83951847|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83951848|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951849|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83951850|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83951851|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
83951852|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
83951853|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
83951854|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83951855|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83951856|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83951857|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83951858|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
83951859|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951860|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
83951861|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
83951862|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
83951863|NCT02927015|Iproplatin|iproplatin|mesh-list
83951864|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951865|NCT04680195|Thalidomide|thalidomide|mesh-list
83951866|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951867|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
83951868|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951869|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
83951870|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951871|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951872|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83951873|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83951874|NCT04680195|Growth Substances|growth substances|mesh-ancestor
83951875|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
83951876|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951877|NCT04864431|Vitamin D|vitamin d|mesh-list
83951878|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
83951879|NCT04864431|Vitamins|vitamins|mesh-ancestor
83951880|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
83951881|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951882|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83951883|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83951884|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83951885|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951886|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951887|NCT00553995|Analgesics|analgesics|mesh-ancestor
83951888|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
83951889|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951890|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951891|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951892|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951893|NCT04798287|Adalimumab|adalimumab|mesh-list
83951894|NCT04798287|Infliximab|infliximab|mesh-list
83951895|NCT04798287|Golimumab|golimumab|mesh-list
83951896|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
83951897|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83951898|NCT04798287|Etanercept|etanercept|mesh-list
83951899|NCT04798287|Tofacitinib|tofacitinib|mesh-list
83951900|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951901|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83951902|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
83951903|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951904|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83951905|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83951906|NCT04798287|Analgesics|analgesics|mesh-ancestor
83951907|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
83951908|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951909|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951910|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83951912|NCT04798287|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83951913|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83951914|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951915|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951916|NCT04689191|Vaccines|vaccines|mesh-list
83951917|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
83951918|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951919|NCT02925299|Insulin|insulin|mesh-list
83951920|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83951921|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951922|NCT02925416|Oritavancin|oritavancin|mesh-list
83951923|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83951924|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951925|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
83951926|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83951927|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83951928|NCT02925533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83951929|NCT02925533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951930|NCT02917889|Caffeine|caffeine|mesh-list
83951931|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83951932|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951933|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83951934|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951935|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951936|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83951937|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83951938|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
83951939|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951940|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
83951941|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83951942|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83951943|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951944|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
83951945|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83951946|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951947|NCT04485273|Anesthetics|anesthetics|mesh-list
83951948|NCT04485273|Sevoflurane|sevoflurane|mesh-list
83951949|NCT04485273|Bupivacaine|bupivacaine|mesh-list
83951950|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
83951951|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83951952|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83951953|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951954|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83951955|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83951956|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
83951957|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
83951958|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951959|NCT02205528|Metformin|metformin|mesh-list
83951960|NCT02205528|Liraglutide|liraglutide|mesh-list
83951961|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83951962|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951963|NCT02205528|Incretins|incretins|mesh-ancestor
83951964|NCT02205528|Hormones|hormones|mesh-ancestor
83951965|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951966|NCT03532022|Dexamethasone|dexamethasone|mesh-list
83951967|NCT03532022|Prednisone|prednisone|mesh-list
83951968|NCT03532022|Prednisolone|prednisolone|mesh-list
83951969|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
83951970|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83951971|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83951972|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83951973|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83951974|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
83951975|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
83951976|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83951977|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83951978|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83951979|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
83951980|NCT03532022|Hormones|hormones|mesh-ancestor
83951981|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83951982|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83951984|NCT02200380|Plerixafor|plerixafor|mesh-list
83951985|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83951986|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83951987|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
83951988|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83951989|NCT02191878|TKM-080301|tkm-080301|mesh-list
83951990|NCT02191878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83951991|NCT02191878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83951992|NCT02191878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83951993|NCT02160678|Tazarotene|tazarotene|mesh-list
83951994|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
83951995|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
83951996|NCT02153502|Quinidine|quinidine|mesh-list
83951997|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
83951998|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
83951999|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
83952000|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
83952001|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83952002|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83952003|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952004|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952005|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952006|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83952007|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83952008|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
83952009|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83952010|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
83952011|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83952012|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83952013|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952014|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952015|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83952016|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83952017|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
83952018|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83952019|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83952020|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952021|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83952022|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83952023|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83952024|NCT02130687|Aprepitant|aprepitant|mesh-list
83952025|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952026|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952027|NCT02130687|Incretins|incretins|mesh-ancestor
83952028|NCT02130687|Hormones|hormones|mesh-ancestor
83952029|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952030|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83952031|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
83952032|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952033|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952034|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
83952035|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
83952036|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952037|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83952038|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83952039|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952040|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
83952041|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
83952042|NCT01228656|Salicylates|salicylates|mesh-list
83952043|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952044|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
83952045|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83952046|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952047|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
83952048|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
83952049|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83952050|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83952051|NCT01228656|Analgesics|analgesics|mesh-ancestor
83952052|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
83952053|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952054|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952055|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952056|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83952057|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952058|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952059|NCT02128113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83952060|NCT02128113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83952061|NCT02125266|Methotrexate|methotrexate|mesh-list
83952062|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83952063|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
83952064|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83952065|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952066|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83952067|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
83952068|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952069|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952070|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
83952071|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952072|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83952073|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952074|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
83952075|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952076|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83952077|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83952078|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83952079|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
83952080|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952081|NCT02116998|Antacids|antacids|mesh-ancestor
83952082|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952083|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83952084|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
83952085|NCT02110368|Testosterone|testosterone|mesh-list
83952086|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
83952087|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
83952088|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83952089|NCT02110368|Androgens|androgens|mesh-ancestor
83952090|NCT02110368|Hormones|hormones|mesh-ancestor
83952091|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952092|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952093|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83952094|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952095|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
83952096|NCT02916485|Sirolimus|sirolimus|mesh-list
83952097|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83952098|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952099|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83952100|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952101|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
83952102|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952103|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
83952104|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952105|NCT01709214|Oxycodone|oxycodone|mesh-list
83952106|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83952107|NCT01709214|Narcotics|narcotics|mesh-ancestor
83952108|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952109|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952110|NCT01709214|Analgesics|analgesics|mesh-ancestor
83952111|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
83952112|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952113|NCT02916602|Losartan|losartan|mesh-list
83952114|NCT02916602|Amlodipine|amlodipine|mesh-list
83952115|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
83952116|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83952117|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83952118|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952119|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952120|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83952121|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952122|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
83952123|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83952124|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83952125|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83952126|NCT02916602|Diuretics|diuretics|mesh-ancestor
83952127|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
83952128|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83952129|NCT02916251|Glucagon|glucagon|mesh-list
83952130|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83952131|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83952132|NCT02916251|Hormones|hormones|mesh-ancestor
83952133|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952134|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952135|NCT02916251|Incretins|incretins|mesh-ancestor
83952136|NCT02106546|Paclitaxel|paclitaxel|mesh-list
83952137|NCT02106546|Carboplatin|carboplatin|mesh-list
83952138|NCT02106546|Veliparib|veliparib|mesh-list
83952139|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83952140|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952141|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
83952142|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
83952143|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
83952144|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952145|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83952146|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952147|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83952148|NCT02916173|Hormones|hormones|mesh-list
83952149|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952150|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952151|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83952152|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83952153|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952154|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
83952155|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83952156|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952157|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83952158|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83952159|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952160|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952161|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952162|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83952163|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83952164|NCT01699737|Glimepiride|glimepiride|mesh-list
83952165|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83952166|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952167|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952168|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952169|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
83952170|NCT04688723|Dabigatran|dabigatran|mesh-list
83952171|NCT04688723|Clopidogrel|clopidogrel|mesh-list
83952172|NCT04688723|Ticagrelor|ticagrelor|mesh-list
83952173|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83952174|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83952175|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83952176|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83952177|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
83952178|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952179|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952180|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952181|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
83952182|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83952183|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
83952184|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952185|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
83952186|NCT01699464|Timolol|timolol|mesh-list
83952187|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83952188|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83952189|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952190|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83952191|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83952192|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
83952193|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952194|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952195|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83952196|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83952197|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83952198|NCT02104050|Dapansutrile|dapansutrile|mesh-list
83952199|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952200|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83952201|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
83952202|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952203|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83952204|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
83952205|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952206|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952207|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83952208|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83952209|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952210|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
83952211|NCT01694277|Sunitinib|sunitinib|mesh-list
83952212|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952213|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83952214|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83952215|NCT01694277|Growth Substances|growth substances|mesh-ancestor
83952216|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952217|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
83952218|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83952219|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952220|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952221|NCT01669980|Vancomycin|vancomycin|mesh-list
83952222|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
83952223|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83952224|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83952225|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952226|NCT02915666|Trametinib|trametinib|mesh-list
83952227|NCT02915666|Dabrafenib|dabrafenib|mesh-list
83952228|NCT02915666|Digoxin|digoxin|mesh-list
83952229|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952230|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83952231|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952232|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952233|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83952234|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83952235|NCT02915666|Protective Agents|protective agents|mesh-ancestor
83952236|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952237|NCT02092935|Vancomycin|vancomycin|mesh-list
83952238|NCT02092935|Ridinilazole|ridinilazole|mesh-list
83952239|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83952240|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952241|NCT01666977|Carboplatin|carboplatin|mesh-list
83952242|NCT01666977|Pemetrexed|pemetrexed|mesh-list
83952243|NCT01666977|Trebananib|trebananib|mesh-list
83952244|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952245|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952246|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952247|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83952248|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83952249|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83952250|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83952251|NCT01666977|Growth Substances|growth substances|mesh-ancestor
83952252|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952253|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
83952254|NCT02915354|Etanercept|etanercept|mesh-list
83952255|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83952256|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83952257|NCT02915354|Analgesics|analgesics|mesh-ancestor
83952258|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
83952259|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952260|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952261|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952262|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952263|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83952264|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952265|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
83952266|NCT01661634|Ularitide|ularitide|mesh-list
83952267|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83952268|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
83952269|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952270|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952271|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83952272|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
83952273|NCT01661634|Diuretics|diuretics|mesh-ancestor
83952274|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
83952275|NCT01661166|Fesoterodine|fesoterodine|mesh-list
83952276|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83952277|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83952278|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
83952279|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952280|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952281|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952282|NCT01661166|Urological Agents|urological agents|mesh-ancestor
83191535|NCT02500069|Caseins|caseins|mesh-list
83952283|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
83952284|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83952285|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952286|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952287|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83952289|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
83952290|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952291|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83952292|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83952293|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83952294|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
83952295|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952296|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952297|NCT01658826|Valacyclovir|valacyclovir|mesh-list
83952298|NCT01658826|Pritelivir|pritelivir|mesh-list
83952299|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
83952300|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952301|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952302|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952303|NCT02092077|Hormones|hormones|mesh-list
83952304|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952305|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952306|NCT02914886|Insulin|insulin|mesh-list
83952307|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83952308|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952309|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952310|NCT01643226|Riboflavin|riboflavin|mesh-list
83952311|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83952312|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
83952313|NCT01643226|Vitamins|vitamins|mesh-ancestor
83952314|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
83952315|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952316|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83952317|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
83952318|NCT02914652|Albuterol|albuterol|mesh-list
83952319|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83952320|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
83952321|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952322|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952323|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83952324|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
83952325|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
83952326|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83952327|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83952328|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83952329|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83952330|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
83952331|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952332|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952333|NCT02081118|Exenatide|exenatide|mesh-list
83952334|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952335|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952336|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83952337|NCT02081118|Incretins|incretins|mesh-ancestor
83952338|NCT02081118|Hormones|hormones|mesh-ancestor
83952339|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952340|NCT02077881|Paclitaxel|paclitaxel|mesh-list
83952341|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83952342|NCT02077881|Gemcitabine|gemcitabine|mesh-list
83952343|NCT02077881|Tryptophan|tryptophan|mesh-list
83952344|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83952345|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952346|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83952347|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83952348|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83952349|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952350|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83952351|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
83952352|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83952353|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
83952354|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83952355|NCT01632228|Bevacizumab|bevacizumab|mesh-list
83952356|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83952357|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952358|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83952359|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83952360|NCT01632228|Growth Substances|growth substances|mesh-ancestor
83952361|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952362|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
83952363|NCT01628094|Ritonavir|ritonavir|mesh-list
83952364|NCT01628094|Ribavirin|ribavirin|mesh-list
83952365|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83952366|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83952367|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83952368|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952369|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952370|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83952371|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83952372|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
83952373|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952374|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83952375|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83952376|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
83952377|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
83952378|NCT02073123|Nivolumab|nivolumab|mesh-list
83952379|NCT02073123|Ipilimumab|ipilimumab|mesh-list
83952380|NCT02073123|Tryptophan|tryptophan|mesh-list
83952381|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83952382|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952383|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83952384|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952385|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83952386|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
83952387|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83952388|NCT02914145|Piperaquine|piperaquine|mesh-list
83952389|NCT02914145|Artenimol|artenimol|mesh-list
83952390|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
83952391|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83952392|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83952393|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952394|NCT02914028|Acetaminophen|acetaminophen|mesh-list
83952395|NCT02914028|Tramadol|tramadol|mesh-list
83952396|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83952397|NCT02914028|Analgesics|analgesics|mesh-ancestor
83952398|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
83952399|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952400|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952401|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
83952402|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83952403|NCT02914028|Narcotics|narcotics|mesh-ancestor
83952404|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952405|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
83952406|NCT02064426|Hematinics|hematinics|mesh-ancestor
83952407|NCT02063997|Colchicine|colchicine|mesh-list
83952408|NCT02063997|Allopurinol|allopurinol|mesh-list
83952409|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
83952410|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952411|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
83952412|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
83952413|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
83952414|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952415|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952416|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
83952417|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952418|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83952419|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
83952420|NCT02063997|Protective Agents|protective agents|mesh-ancestor
83952421|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952422|NCT00585507|Fulvestrant|fulvestrant|mesh-list
83952423|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83952424|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952425|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83952426|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83952427|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83952428|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952429|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952430|NCT02063685|Prednisone|prednisone|mesh-list
83952431|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
83952432|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83191684|NCT03335527|Analgesics|analgesics|mesh-ancestor
83952433|NCT02063685|Rituximab|rituximab|mesh-list
83952434|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83952435|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952436|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
83952437|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952438|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952439|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83952440|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
83952441|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952442|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952443|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83952444|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83952445|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952446|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
83952447|NCT02063685|Hormones|hormones|mesh-ancestor
83952448|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952449|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83952450|NCT02063295|CKD732|ckd732|mesh-list
83952451|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83952452|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83952453|NCT02063295|Growth Substances|growth substances|mesh-ancestor
83952454|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952455|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
83952456|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952457|NCT02057172|Liraglutide|liraglutide|mesh-list
83952458|NCT02057172|Exenatide|exenatide|mesh-list
83952459|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952460|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952461|NCT02057172|Incretins|incretins|mesh-ancestor
83952462|NCT02057172|Hormones|hormones|mesh-ancestor
83952463|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952464|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83952465|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
83952466|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83952467|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
83952468|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83952469|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
83952470|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952471|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952472|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
83952473|NCT02052648|Bevacizumab|bevacizumab|mesh-list
83952474|NCT02052648|Temozolomide|temozolomide|mesh-list
83952475|NCT02052648|Tryptophan|tryptophan|mesh-list
83952476|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83952477|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952478|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83952479|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83952480|NCT02052648|Growth Substances|growth substances|mesh-ancestor
83952481|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952482|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
83952483|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83952484|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
83952485|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952486|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83952487|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
83952488|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83952489|NCT01186744|Tofacitinib|tofacitinib|mesh-list
83952490|NCT01186744|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83952491|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83952492|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952493|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952494|NCT02044341|Benzocaine|benzocaine|mesh-list
83952495|NCT02044341|Glycerol|glycerol|mesh-list
83952496|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83952497|NCT02044341|Protective Agents|protective agents|mesh-ancestor
83952498|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952499|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
83952500|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
83952501|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952502|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
83952503|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952504|NCT00555399|Temozolomide|temozolomide|mesh-list
83952505|NCT00555399|Vorinostat|vorinostat|mesh-list
83952506|NCT00555399|Isotretinoin|isotretinoin|mesh-list
83952507|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83952508|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
83952509|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952510|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952511|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83952512|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952513|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
83952514|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
83952515|NCT02912663|Verapamil|verapamil|mesh-list
83952516|NCT02912663|Analgesics|analgesics|mesh-ancestor
83952517|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
83952518|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952519|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952520|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
83952521|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952522|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83952523|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
83952524|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83952525|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952526|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952527|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83952528|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
83952529|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83952530|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
83952531|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83952532|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
83952533|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83952534|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83952535|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83952536|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
83952537|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83952538|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952539|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83952540|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83952541|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83952542|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83952543|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952544|NCT02912702|Dexamethasone|dexamethasone|mesh-list
83952545|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
83952546|NCT02912702|Doxorubicin|doxorubicin|mesh-list
83952547|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83952548|NCT02912702|Etoposide|etoposide|mesh-list
83952549|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
83952550|NCT02912702|Pegaspargase|pegaspargase|mesh-list
83952551|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952552|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
83952553|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
83952554|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952555|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952556|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83952557|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
83952558|NCT02912702|Hormones|hormones|mesh-ancestor
83952559|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952560|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83952561|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952562|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83952563|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83952564|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83952565|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952566|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952567|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83952568|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83952569|NCT02912702|Protective Agents|protective agents|mesh-ancestor
83952570|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
83952571|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
83952572|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
83952573|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952574|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952575|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
83952576|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952577|NCT02008344|Favipiravir|favipiravir|mesh-list
83952578|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
83952579|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952580|NCT02912156|Voriconazole|voriconazole|mesh-list
83952581|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
83952582|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952583|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83952584|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83191834|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
83952585|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952586|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952587|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83952588|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
83952589|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952590|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952591|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83952592|NCT03455049|Andrographolide|andrographolide|mesh-list
83952593|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952594|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83952595|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83952596|NCT03455049|Analgesics|analgesics|mesh-ancestor
83952597|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
83952598|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952599|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952600|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952601|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83952602|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83952603|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952604|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
83952605|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83952606|NCT02912234|Clarithromycin|clarithromycin|mesh-list
83952607|NCT02912234|Apixaban|apixaban|mesh-list
83952608|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83952609|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952610|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83952611|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952612|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952613|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83952614|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83952615|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83952616|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
83952617|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83952618|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
83952619|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
83952620|NCT04676139|Fluoxetine|fluoxetine|mesh-list
83952621|NCT04676139|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83952622|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83952623|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952624|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952625|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952626|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
83952627|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952628|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83952629|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
83952630|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83952631|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83952632|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83952633|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952634|NCT01999764|Retinol acetate|retinol acetate|mesh-list
83952635|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83952636|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
83952637|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952638|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83952639|NCT01999764|Protective Agents|protective agents|mesh-ancestor
83952640|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952641|NCT02911961|Acetaminophen|acetaminophen|mesh-list
83952642|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83952643|NCT02911961|Analgesics|analgesics|mesh-ancestor
83952644|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
83952645|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952646|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952647|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
83952648|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83952649|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83952650|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952651|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952652|NCT04676061|Norethindrone|norethindrone|mesh-list
83952653|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
83952654|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83952655|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83191911|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952656|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83952657|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
83952658|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83952659|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952660|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83952661|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83952662|NCT04675944|Treprostinil|treprostinil|mesh-list
83952663|NCT04675944|Zamicastat|zamicastat|mesh-list
83952664|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83952665|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952666|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952667|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
83952668|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83952669|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83952670|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952671|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
83952672|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
83952673|NCT01993641|Azacitidine|azacitidine|mesh-list
83952674|NCT01993641|Decitabine|decitabine|mesh-list
83952675|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83952676|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
83952677|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952678|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952679|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952680|NCT01989429|Vitamin D|vitamin d|mesh-list
83952681|NCT01989429|Vitamins|vitamins|mesh-ancestor
83952682|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
83952683|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952684|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83952685|NCT02911298|Metronidazole|metronidazole|mesh-list
83952686|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952687|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83952688|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83952689|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83952690|NCT01983306|Dolcanatide|dolcanatide|mesh-list
83952691|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83952692|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
83952693|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952694|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83952695|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
83952696|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83952697|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952698|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
83952699|NCT01975818|Hematinics|hematinics|mesh-ancestor
83952700|NCT01973049|Ribavirin|ribavirin|mesh-list
83952701|NCT01973049|Asunaprevir|asunaprevir|mesh-list
83952702|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
83952703|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952704|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
83952705|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952706|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83952707|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952708|NCT01185964|Doxorubicin|doxorubicin|mesh-list
83952709|NCT01185964|Olaratumab|olaratumab|mesh-list
83952710|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83952711|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952712|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83952713|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83952714|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952715|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952716|NCT01972854|Riboflavin|riboflavin|mesh-list
83952717|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83952718|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
83952719|NCT01972854|Vitamins|vitamins|mesh-ancestor
83952720|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
83952721|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952722|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83952723|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
83952724|NCT02550470|Sevoflurane|sevoflurane|mesh-list
83952725|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83191983|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191984|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83191985|NCT03329443|Diuretics|diuretics|mesh-ancestor
83191986|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
83191987|NCT03328975|Dexamethasone|dexamethasone|mesh-list
83191989|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
83952726|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83952727|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
83952728|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
83952729|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952730|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952731|NCT02910518|Insulin|insulin|mesh-list
83952732|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83952733|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
83952734|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
83952735|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
83952736|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
83952737|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
83952738|NCT02910518|Heparin|heparin|mesh-list
83952739|NCT02910518|Calcium heparin|calcium heparin|mesh-list
83952740|NCT02910518|Glucagon|glucagon|mesh-list
83952741|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952742|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952743|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
83952744|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83952745|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83952746|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952747|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83952748|NCT02910518|Hormones|hormones|mesh-ancestor
83952749|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952750|NCT01217437|Bevacizumab|bevacizumab|mesh-list
83952751|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83952752|NCT01217437|Irinotecan|irinotecan|mesh-list
83952753|NCT01217437|Temozolomide|temozolomide|mesh-list
83952754|NCT01217437|Camptothecin|camptothecin|mesh-list
83952755|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
83952756|NCT01217437|Antibodies|antibodies|mesh-list
83952757|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
83952758|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83952759|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
83952760|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952761|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83952762|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83952763|NCT01217437|Growth Substances|growth substances|mesh-ancestor
83952764|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952765|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
83952766|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
83952767|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83952768|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83952769|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952770|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952771|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83952772|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
83952773|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83952774|NCT00624364|Metformin|metformin|mesh-list
83952775|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
83952776|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
83952777|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952778|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952779|NCT02910596|Bethanechol|bethanechol|mesh-list
83952780|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83952781|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
83952782|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952783|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952784|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83952785|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83952786|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
83952787|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952788|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952789|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
83952790|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
83952791|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83952792|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83952793|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952794|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952795|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952796|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952797|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
83952798|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83952799|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83192057|NCT05430087|Piperine|piperine|mesh-list
83952800|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83952801|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952802|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952803|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
83952804|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952805|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952806|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83952807|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952808|NCT04676997|Paclitaxel|paclitaxel|mesh-list
83952809|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
83952810|NCT04676997|Epirubicin|epirubicin|mesh-list
83952811|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83952812|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952813|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
83952814|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
83952815|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
83952816|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952817|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952818|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
83952819|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952820|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952821|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83952822|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
83952823|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83952824|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83952825|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83952826|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83952827|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952828|NCT02910206|Sufentanil|sufentanil|mesh-list
83952829|NCT02910206|Propofol|propofol|mesh-list
83952830|NCT02910206|Etomidate|etomidate|mesh-list
83952831|NCT02910206|Cisatracurium|cisatracurium|mesh-list
83952832|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83952833|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952834|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952835|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83952836|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
83952837|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
83952838|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83952839|NCT02910206|Narcotics|narcotics|mesh-ancestor
83952840|NCT02910206|Analgesics|analgesics|mesh-ancestor
83952841|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
83952842|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952843|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83952844|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83952845|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83952846|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
83952847|NCT04675086|Remdesivir|remdesivir|mesh-list
83952848|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
83952849|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83952850|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952851|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
83952852|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952853|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952854|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83952855|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83952856|NCT02909972|Cytarabine|cytarabine|mesh-list
83952857|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83952858|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
83952859|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952860|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952861|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
83952862|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83952863|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952864|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
83952865|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952866|NCT00555594|Bevacizumab|bevacizumab|mesh-list
83952867|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83952868|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952869|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83952870|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83952871|NCT00555594|Growth Substances|growth substances|mesh-ancestor
83952872|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952873|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
83952874|NCT02910050|Letrozole|letrozole|mesh-list
83952875|NCT02910050|Anastrozole|anastrozole|mesh-list
83952876|NCT02910050|Exemestane|exemestane|mesh-list
83952877|NCT02910050|Bicalutamide|bicalutamide|mesh-list
83952878|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83952879|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952880|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83952881|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952882|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952884|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83952885|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952886|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952887|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83952888|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
83952889|NCT02909933|Metformin|metformin|mesh-list
83952890|NCT02909933|Liraglutide|liraglutide|mesh-list
83952891|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83952892|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952893|NCT02909933|Incretins|incretins|mesh-ancestor
83952894|NCT02909933|Hormones|hormones|mesh-ancestor
83952895|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952896|NCT02910245|Prednisone|prednisone|mesh-list
83952897|NCT02910245|Mesalamine|mesalamine|mesh-list
83952898|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
83952899|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952900|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
83952901|NCT02910245|Hormones|hormones|mesh-ancestor
83952902|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83952903|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952904|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83952905|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952906|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
83952907|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952908|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83952909|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952910|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
83952911|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83952912|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952913|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83952914|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83952915|NCT02910245|Analgesics|analgesics|mesh-ancestor
83952916|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
83952917|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952918|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952919|NCT01185340|Serotonin|serotonin|mesh-list
83952920|NCT01185340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83952921|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83952922|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
83952923|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952924|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952925|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952926|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83952927|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952928|NCT01959282|Niacinamide|niacinamide|mesh-list
83952929|NCT01959282|Peficitinib|peficitinib|mesh-list
83952930|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952931|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952932|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952933|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
83952934|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952935|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
83952936|NCT01959282|Vitamins|vitamins|mesh-ancestor
83952937|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
83952938|NCT01185301|Adalimumab|adalimumab|mesh-list
83952939|NCT01185301|Methotrexate|methotrexate|mesh-list
83952940|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83952941|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
83952942|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83952943|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952944|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83952945|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
83952946|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952947|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83952948|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
83952949|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83952950|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83952951|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952952|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
83952953|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83952954|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83952955|NCT01185301|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83952956|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83952957|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83952958|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
83952959|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83952960|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952961|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83952962|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
83952963|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952964|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83952965|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
83952966|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83952967|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83952968|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83952969|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83952970|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952971|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
83952972|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952973|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952974|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83952975|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952976|NCT02909465|Midazolam|midazolam|mesh-list
83952977|NCT02909465|Ketamine|ketamine|mesh-list
83952978|NCT02909465|Haloperidol|haloperidol|mesh-list
83952979|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
83952980|NCT02909465|Analgesics|analgesics|mesh-ancestor
83952981|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
83952982|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83952983|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83952984|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83952985|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83952986|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
83952987|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
83952988|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83952989|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83952990|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83952991|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83952992|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83952993|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83952994|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83952995|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83952996|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83952997|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83952998|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
83952999|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
83953000|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
83953001|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
83953002|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953003|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83953004|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83953005|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
83953006|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83953007|NCT04312555|Alprostadil|alprostadil|mesh-list
83953008|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953009|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
83953010|NCT04312555|Urological Agents|urological agents|mesh-ancestor
83953011|NCT01184989|Dabigatran|dabigatran|mesh-list
83953012|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
83953013|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83953014|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
83953015|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953016|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953017|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
83953018|NCT04674423|Tenofovir|tenofovir|mesh-list
83953019|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
83953020|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953021|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83953022|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83953023|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953024|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953025|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83953026|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83192284|NCT03318835|Hormones|hormones|mesh-ancestor
83953027|NCT00555867|Anastrozole|anastrozole|mesh-list
83953028|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953029|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953030|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83953031|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83953032|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953033|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953034|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83953035|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
83953036|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953037|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953038|NCT00555984|Remifentanil|remifentanil|mesh-list
83953039|NCT00555984|Propofol|propofol|mesh-list
83953040|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83953041|NCT00555984|Anesthetics|anesthetics|mesh-list
83953042|NCT00555984|Sevoflurane|sevoflurane|mesh-list
83953043|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953044|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953045|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953046|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
83953047|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83953048|NCT00555984|Narcotics|narcotics|mesh-ancestor
83953049|NCT00555984|Analgesics|analgesics|mesh-ancestor
83953050|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
83953051|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953052|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953053|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83953054|NCT03457337|Gefitinib|gefitinib|mesh-list
83953055|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953056|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953057|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953058|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953059|NCT02274779|Leuprolide|leuprolide|mesh-list
83953060|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83953061|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
83953062|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83953063|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953064|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953065|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953066|NCT01908738|Lidocaine|lidocaine|mesh-list
83953067|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
83953068|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
83953069|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953070|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953071|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
83953072|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953073|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83953074|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83953075|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83953076|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83953077|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953078|NCT04673955|Cetuximab|cetuximab|mesh-list
83953079|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953080|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953081|NCT01904409|Rifaximin|rifaximin|mesh-list
83953082|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83953083|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953084|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953085|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
83953086|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
83953087|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953088|NCT01902381|Protective Agents|protective agents|mesh-ancestor
83953089|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953090|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
83953091|NCT01902381|Vitamins|vitamins|mesh-ancestor
83953092|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
83953093|NCT04673799|Denosumab|denosumab|mesh-list
83953094|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83953095|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953096|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
83953097|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
83953098|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
83953099|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953100|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
83953101|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83953102|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953103|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
84124688|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83192359|NCT03321955|Analgesics|analgesics|mesh-ancestor
83953104|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83953105|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953106|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83953107|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953109|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83953110|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953111|NCT05189717|Everolimus|everolimus|mesh-list
83953112|NCT05189717|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83953113|NCT05189717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953114|NCT05189717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953115|NCT05189717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953116|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953117|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
83953118|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953119|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953120|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83953121|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
83953122|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953123|NCT02277197|Cetuximab|cetuximab|mesh-list
83953124|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953125|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953126|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
83953127|NCT00555087|Testosterone|testosterone|mesh-list
83953128|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
83953129|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
83953130|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83953131|NCT00555087|Androgens|androgens|mesh-ancestor
83953132|NCT00555087|Hormones|hormones|mesh-ancestor
83953133|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953134|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953135|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953136|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953137|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
83953138|NCT04673214|Acetaminophen|acetaminophen|mesh-list
83953139|NCT04673214|Azithromycin|azithromycin|mesh-list
83953140|NCT04673214|Ivermectin|ivermectin|mesh-list
83953141|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83953142|NCT04673214|Analgesics|analgesics|mesh-ancestor
83953143|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
83953144|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953145|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953146|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
83953147|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83953148|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953149|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83953150|NCT00556023|Gemcitabine|gemcitabine|mesh-list
83953151|NCT00556023|Tremelimumab|tremelimumab|mesh-list
83953152|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83953153|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
83953154|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953155|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953156|NCT05011214|Ketamine|ketamine|mesh-list
83953157|NCT05011214|Sevoflurane|sevoflurane|mesh-list
83953158|NCT05011214|Esketamine|esketamine|mesh-list
83953159|NCT05011214|Analgesics|analgesics|mesh-ancestor
83953160|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
83953161|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953162|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953163|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83953164|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83953165|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
83953166|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
83953167|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953168|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83953169|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83953170|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953171|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953172|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953173|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83953174|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
83953175|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83953176|NCT00556062|Vaccines|vaccines|mesh-list
83953177|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
83953178|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953179|NCT04965155|Dexamethasone|dexamethasone|mesh-list
83953180|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953181|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
83953182|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
83953183|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953184|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953185|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953186|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
83953187|NCT04965155|Hormones|hormones|mesh-ancestor
83953188|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953189|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953190|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953191|NCT04676763|Histamine|histamine|mesh-list
83953192|NCT04676763|Substance P|substance p|mesh-list
83953193|NCT04676763|Neurokinin A|neurokinin a|mesh-list
83953194|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
83953195|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
83953196|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953197|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953198|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953199|NCT04672707|Bromhexine|bromhexine|mesh-list
83953200|NCT04672707|Expectorants|expectorants|mesh-ancestor
83953201|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
83953202|NCT04932083|Fentanyl|fentanyl|mesh-list
83953203|NCT04932083|Midazolam|midazolam|mesh-list
83953204|NCT04932083|Nalbuphine|nalbuphine|mesh-list
83953205|NCT04932083|Bupivacaine|bupivacaine|mesh-list
83953206|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
83953207|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
83953208|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953209|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953210|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
83953211|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953212|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83953213|NCT04932083|Narcotics|narcotics|mesh-ancestor
83953214|NCT04932083|Analgesics|analgesics|mesh-ancestor
83953215|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83953216|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83953217|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
83953218|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953219|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83953220|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83953221|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83953222|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
83953223|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
83953224|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953225|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953226|NCT01825980|Ritonavir|ritonavir|mesh-list
83953227|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83953228|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83953229|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
83953230|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953231|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953232|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83953233|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83953234|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
83953235|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953236|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83953237|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83953238|NCT04672317|Immunomodulating Agents|immunomodulating agents|mesh-list
83953239|NCT04672317|Immunologic Factors|immunologic factors|mesh-ancestor
83953240|NCT04672317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953241|NCT04790045|Venetoclax|venetoclax|mesh-list
83953242|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953243|NCT01655225|Pemetrexed|pemetrexed|mesh-list
83953244|NCT01655225|Letrozole|letrozole|mesh-list
83953245|NCT01655225|Fulvestrant|fulvestrant|mesh-list
83953246|NCT01655225|Midazolam|midazolam|mesh-list
83953247|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953248|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83953249|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953250|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953251|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953252|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83953253|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83953254|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83953255|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83953256|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
83953257|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
83953258|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
83953259|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
83953260|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953261|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953262|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953263|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83953264|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83953265|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83953266|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83953267|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83953268|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
83953269|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953270|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953271|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83953273|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83953274|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83953275|NCT01818921|Growth Substances|growth substances|mesh-ancestor
83953276|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953277|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
83953278|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953279|NCT01810575|Alprostadil|alprostadil|mesh-list
83953280|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953281|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
83953282|NCT01810575|Urological Agents|urological agents|mesh-ancestor
83953283|NCT01785771|Exenatide|exenatide|mesh-list
83953284|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83953285|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953286|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83953287|NCT01785771|Incretins|incretins|mesh-ancestor
83953288|NCT01785771|Hormones|hormones|mesh-ancestor
83953289|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953290|NCT01784874|Vaccines|vaccines|mesh-list
83953291|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
83953292|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953293|NCT04607252|Metformin|metformin|mesh-list
83953294|NCT04607252|Megestrol|megestrol|mesh-list
83953295|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
83953296|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83953297|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953298|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83953299|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83953300|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83953301|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
83953302|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83953303|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83953304|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83953305|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953306|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953307|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
83953308|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83953309|NCT01782729|Tacrolimus|tacrolimus|mesh-list
83953310|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953311|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
83953312|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953313|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83953314|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953315|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953316|NCT01780428|Acetaminophen|acetaminophen|mesh-list
83953317|NCT01780428|Promethazine|promethazine|mesh-list
83953318|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
83953319|NCT01780428|Hydrocodone|hydrocodone|mesh-list
83953320|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83953321|NCT01780428|Analgesics|analgesics|mesh-ancestor
83953322|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
83953323|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953324|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953325|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
83953326|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83953327|NCT01780428|Narcotics|narcotics|mesh-ancestor
83953328|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953329|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
83953330|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
83953331|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
83953332|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
83953333|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83192590|NCT05129475|Ritonavir|ritonavir|mesh-list
83953334|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
83953335|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
83953336|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953337|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953338|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83953339|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83953340|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953341|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
83953342|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
83953343|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
83953344|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
83953345|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953346|NCT04671420|Rituximab|rituximab|mesh-list
83953347|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953348|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953349|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
83953350|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953351|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83953352|NCT04573556|Lemborexant|lemborexant|mesh-list
83953353|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83953354|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953355|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953356|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83953357|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953358|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953359|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953360|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
83953361|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83953362|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
83953363|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953364|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
83953365|NCT04671108|Protective Agents|protective agents|mesh-ancestor
83953366|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83953367|NCT01779453|Atorvastatin|atorvastatin|mesh-list
83953368|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83953369|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83953370|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
83953371|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953372|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83953373|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83953374|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953375|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83953376|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953377|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
83953378|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83953379|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83953380|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83953381|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83953382|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953383|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
83953384|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953385|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953386|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83953387|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953388|NCT04567160|Propofol|propofol|mesh-list
83953389|NCT04567160|Sevoflurane|sevoflurane|mesh-list
83953390|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953391|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953392|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953393|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83953394|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
83953395|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
83953396|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953397|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83953398|NCT01774578|Gemcitabine|gemcitabine|mesh-list
83953399|NCT01774578|Docetaxel|docetaxel|mesh-list
83953400|NCT01774578|Pemetrexed|pemetrexed|mesh-list
83953401|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83953402|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
83953403|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953404|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953405|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83953406|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83953407|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83192664|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
83953408|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953409|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83953410|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83953411|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
83953412|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953413|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
83953414|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953415|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
83953416|NCT04670601|Analgesics|analgesics|mesh-ancestor
83953417|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
83953418|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953419|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953420|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83953421|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83953422|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953423|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83953424|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83953425|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953426|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953427|NCT04670913|Apatinib|apatinib|mesh-list
83953428|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953429|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953430|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953431|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953432|NCT04671069|Clopidogrel|clopidogrel|mesh-list
83953433|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953434|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83953435|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83953436|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83953437|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
83953438|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953439|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953440|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953441|NCT04322123|Azithromycin|azithromycin|mesh-list
83953442|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
83953443|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83953444|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953445|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
83953446|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83953447|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83953448|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953449|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953450|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83953451|NCT04259138|Vedolizumab|vedolizumab|mesh-list
83953452|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953453|NCT01741155|Docetaxel|docetaxel|mesh-list
83953454|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953455|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
83953456|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
83953457|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
83953458|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953459|NCT04244630|Antioxidants|antioxidants|mesh-list
83953460|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953461|NCT04244630|Protective Agents|protective agents|mesh-ancestor
83953462|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953463|NCT04239053|Bupivacaine|bupivacaine|mesh-list
83953464|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
83953465|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
83953466|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953467|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953468|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
83953469|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953470|NCT01718145|Ribavirin|ribavirin|mesh-list
83953471|NCT01718145|Asunaprevir|asunaprevir|mesh-list
83953472|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
83953473|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953474|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
83953475|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953476|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
83953477|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953478|NCT00556257|Cyclosporine|cyclosporine|mesh-list
83953479|NCT00556257|Cyclosporins|cyclosporins|mesh-list
83953480|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953481|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953482|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953483|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
83953484|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953485|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
83953486|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953487|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
83953488|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83953489|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83953490|NCT01712451|Fluticasone|fluticasone|mesh-list
83953492|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83953493|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953494|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83953495|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
83953496|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953497|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953498|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83953499|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
83953500|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
83953501|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83953502|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83953503|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83953504|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83953505|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
83953506|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953507|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953508|NCT01712217|Crizotinib|crizotinib|mesh-list
83953509|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953510|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953511|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953512|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953513|NCT04669158|Idebenone|idebenone|mesh-list
83953514|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
83953515|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953516|NCT04669158|Protective Agents|protective agents|mesh-ancestor
83953517|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953518|NCT04669821|Propofol|propofol|mesh-list
83953519|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953520|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953521|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953522|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83953523|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
83953524|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
83953525|NCT00532025|Sorafenib|sorafenib|mesh-list
83953526|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953527|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953528|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953529|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953530|NCT04669392|Ethanol|ethanol|mesh-list
83953531|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83953532|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953533|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953534|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953535|NCT00532142|Triamcinolone|triamcinolone|mesh-list
83953536|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953537|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
83953538|NCT00532142|Hormones|hormones|mesh-ancestor
83953539|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953540|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953541|NCT04749641|Vaccines|vaccines|mesh-list
83953542|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
83953543|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953544|NCT00533312|Niacin|niacin|mesh-list
83953545|NCT00533312|Niacinamide|niacinamide|mesh-list
83953546|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
83953547|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83953548|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
83953549|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953550|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83953551|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
83953552|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
83953553|NCT00533312|Vitamins|vitamins|mesh-ancestor
83953554|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
83953555|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953556|NCT00533390|Efavirenz|efavirenz|mesh-list
83953557|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83953558|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83953559|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953560|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953562|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953563|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83953564|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83953565|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83953566|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83953567|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83953568|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83953569|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83953570|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83953571|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953572|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83953573|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83953574|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83953575|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953576|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
83953577|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953578|NCT04668456|Lidocaine|lidocaine|mesh-list
83953579|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
83953580|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
83953581|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
83953582|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953583|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953584|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
83953585|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953586|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83953587|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83953588|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83953589|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83953590|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953591|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953592|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83953593|NCT04668456|Analgesics|analgesics|mesh-ancestor
83953594|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83953595|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83953596|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83953597|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
83953598|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953599|NCT04693169|Choline|choline|mesh-list
83953600|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
83953601|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83953602|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
83953603|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953604|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953605|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83953606|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
83953607|NCT04668417|Vaccines|vaccines|mesh-list
83953608|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
83953609|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953610|NCT00556413|Leucovorin|leucovorin|mesh-list
83953611|NCT00556413|Fluorouracil|fluorouracil|mesh-list
83953612|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
83953613|NCT00556413|Irinotecan|irinotecan|mesh-list
83953614|NCT00556413|Cetuximab|cetuximab|mesh-list
83953615|NCT00556413|Calcium|calcium|mesh-list
83953616|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
83953617|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83953618|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953619|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
83953620|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953621|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83953622|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953623|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953624|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
83953625|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83953626|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83953627|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953628|NCT00556413|Antidotes|antidotes|mesh-ancestor
83953629|NCT00556413|Protective Agents|protective agents|mesh-ancestor
83953630|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
83953631|NCT00556413|Vitamins|vitamins|mesh-ancestor
83953632|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
83953633|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953634|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
83953635|NCT04668690|Analgesics|analgesics|mesh-ancestor
83953636|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
83953637|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953638|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953639|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953640|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83953641|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83953642|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953643|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953645|NCT00533585|Bevacizumab|bevacizumab|mesh-list
83953646|NCT00533585|Carboplatin|carboplatin|mesh-list
83953647|NCT00533585|Sorafenib|sorafenib|mesh-list
83953648|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83953649|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953650|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83953651|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83953652|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83953653|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953654|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953655|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83953656|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83953657|NCT00533585|Growth Substances|growth substances|mesh-ancestor
83953658|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953659|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
83953660|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953661|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953662|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
83953663|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83953664|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953665|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83953666|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
83953667|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83953668|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953669|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953670|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953671|NCT04562441|Avelumab|avelumab|mesh-list
83953672|NCT04562441|Axitinib|axitinib|mesh-list
83953673|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953674|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953675|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953676|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953677|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953678|NCT04659057|Lidocaine|lidocaine|mesh-list
83953679|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
83953680|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
83953681|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
83953682|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953683|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953684|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
83953685|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953686|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83953687|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83953688|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83953689|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83953690|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953691|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953692|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83953693|NCT04659057|Analgesics|analgesics|mesh-ancestor
83953694|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83953695|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83953696|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83953697|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83953698|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953699|NCT04547153|Docetaxel|docetaxel|mesh-list
83953700|NCT04547153|Fluorouracil|fluorouracil|mesh-list
83953701|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953702|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
83953703|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
83953704|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
83953705|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953706|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
83953707|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83953708|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953709|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
83953710|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953712|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83953713|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
83953714|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953715|NCT00533741|Antacids|antacids|mesh-ancestor
83953716|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953717|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953718|NCT00533858|Losartan|losartan|mesh-list
83953719|NCT00533858|Lacidipine|lacidipine|mesh-list
83953720|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83953721|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83953722|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83953723|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83953724|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953725|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83953726|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83953727|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83953728|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953729|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
83953730|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83953731|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
83953732|NCT04658355|Povidone|povidone|mesh-list
83953733|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83953734|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953735|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
83953736|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83953737|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
83953738|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
83953739|NCT00533936|Paclitaxel|paclitaxel|mesh-list
83953740|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
83953741|NCT00533936|Doxorubicin|doxorubicin|mesh-list
83953742|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83953743|NCT00533936|Fluorouracil|fluorouracil|mesh-list
83953744|NCT00533936|Trastuzumab|trastuzumab|mesh-list
83953745|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83953746|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953747|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
83953748|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
83953749|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
83953750|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953751|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953752|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
83953753|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953754|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83953755|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83953756|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
83953757|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83953758|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83953759|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83953760|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83953761|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953762|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
83953763|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83953764|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953765|NCT00557544|Ketoprofen|ketoprofen|mesh-list
83953766|NCT00557544|Metoclopramide|metoclopramide|mesh-list
83953767|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
83953768|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
83953769|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953770|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953771|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953772|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83953773|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83953774|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
83953775|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953776|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953777|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83953778|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83953779|NCT00557544|Analgesics|analgesics|mesh-ancestor
83953780|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
83953781|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953782|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83953783|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83953784|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953785|NCT04667910|Ranibizumab|ranibizumab|mesh-list
83953786|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83953787|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83953788|NCT04667910|Growth Substances|growth substances|mesh-ancestor
83953789|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953790|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
83953791|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953792|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83953793|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
83953795|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83953796|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
83953797|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953798|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
83953799|NCT00556608|Protective Agents|protective agents|mesh-ancestor
83953800|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
83953801|NCT00534287|Meropenem|meropenem|mesh-list
83953802|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83953803|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83953804|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953805|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83953806|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83953807|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953808|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953809|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953810|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83953811|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
83953812|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83953813|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953814|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83953815|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83953816|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83953817|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
83953818|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953819|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953820|NCT04168502|Immunotoxins|immunotoxins|mesh-ancestor
83953821|NCT04168502|Immunoconjugates|immunoconjugates|mesh-ancestor
83953822|NCT04168502|Immunologic Factors|immunologic factors|mesh-ancestor
83953823|NCT04168502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953824|NCT04166396|Resveratrol|resveratrol|mesh-list
83953825|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
83953826|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953827|NCT04166396|Protective Agents|protective agents|mesh-ancestor
83953828|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953829|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953830|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953831|NCT01215916|Pemetrexed|pemetrexed|mesh-list
83953832|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953833|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953834|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953835|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83953836|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83953837|NCT01184872|Vancomycin|vancomycin|mesh-list
83953838|NCT01184872|Daptomycin|daptomycin|mesh-list
83953839|NCT01184872|Penicillins|penicillins|mesh-list
83953840|NCT01184872|Floxacillin|floxacillin|mesh-list
83953841|NCT01184872|Cloxacillin|cloxacillin|mesh-list
83953842|NCT01184872|Oxacillin|oxacillin|mesh-list
83953843|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83953844|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83953845|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
83953846|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83953847|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83953848|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
83953849|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953850|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953851|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953852|NCT01215721|Urological Agents|urological agents|mesh-ancestor
83953853|NCT04666623|Esketamine|esketamine|mesh-list
83953854|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
83953855|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83953856|NCT00534677|Octreotide|octreotide|mesh-list
83953857|NCT00534677|Terlipressin|terlipressin|mesh-list
83953858|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953859|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953860|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953861|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83953862|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83953863|NCT00556959|Clonidine|clonidine|mesh-list
83953864|NCT00556959|Analgesics|analgesics|mesh-ancestor
83953865|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
83953866|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953867|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953868|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83953869|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
83953870|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
83953871|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83953872|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83953873|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83953874|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83953875|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953876|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953877|NCT01184326|Everolimus|everolimus|mesh-list
83953878|NCT01184326|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83953879|NCT01184326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953880|NCT01184326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953881|NCT01184326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953882|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953883|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
83953884|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953885|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953886|NCT01215253|Ranolazine|ranolazine|mesh-list
83953887|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83953888|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83953889|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953890|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
83953891|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953892|NCT03813875|Fentanyl|fentanyl|mesh-list
83953893|NCT03813875|Midazolam|midazolam|mesh-list
83953894|NCT03813875|Alfentanil|alfentanil|mesh-list
83953895|NCT03813875|Propofol|propofol|mesh-list
83953896|NCT03813875|Sevoflurane|sevoflurane|mesh-list
83953897|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953898|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953899|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953900|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83953901|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
83953902|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
83953903|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83953904|NCT03813875|Narcotics|narcotics|mesh-ancestor
83953905|NCT03813875|Analgesics|analgesics|mesh-ancestor
83953906|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
83953907|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953908|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83953909|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83953910|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83953911|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83953912|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
83953913|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
83953914|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953915|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953916|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83953917|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83953918|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83953919|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953920|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83953921|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953922|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953923|NCT05449522|Vitamin D|vitamin d|mesh-list
83953924|NCT05449522|Vitamins|vitamins|mesh-ancestor
83953925|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
83953926|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953927|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83953928|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83953929|NCT03737981|Venetoclax|venetoclax|mesh-list
83953930|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
83953931|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953932|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83953933|NCT04665141|Omalizumab|omalizumab|mesh-list
83953934|NCT04665141|Benralizumab|benralizumab|mesh-list
83953935|NCT04665141|Reslizumab|reslizumab|mesh-list
83953936|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83953937|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83953938|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
83953939|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
83953940|NCT04665063|Fludarabine|fludarabine|mesh-list
83953941|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83953942|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
83953943|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953944|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83953945|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83953946|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
83953947|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953948|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953949|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83953950|NCT04664595|Propofol|propofol|mesh-list
83953951|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83953952|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953953|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953954|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83953955|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
83953956|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
83953957|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83953958|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
83953959|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953960|NCT03580148|Cortisone|cortisone|mesh-list
83953961|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83953962|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953963|NCT04664517|Anesthetics|anesthetics|mesh-list
83953964|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83953965|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953966|NCT05335915|Nicotine|nicotine|mesh-list
83953967|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83953968|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
83953969|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953970|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953971|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83953972|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83953973|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
83953974|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83953975|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953976|NCT01215097|Linagliptin|linagliptin|mesh-list
83953977|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83953978|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953979|NCT01215097|Incretins|incretins|mesh-ancestor
83953980|NCT01215097|Hormones|hormones|mesh-ancestor
83953981|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953982|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83953983|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
83953984|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83953985|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83953986|NCT03527576|Dexamethasone|dexamethasone|mesh-list
83953987|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83953988|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
83953989|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
83953990|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83953991|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83953992|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83953993|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
83953994|NCT03527576|Hormones|hormones|mesh-ancestor
83953995|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83953996|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83953997|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83953998|NCT04664010|Vitamins|vitamins|mesh-list
83953999|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
83954000|NCT04664010|Interferons|interferons|mesh-list
83954001|NCT04664010|Ribavirin|ribavirin|mesh-list
83954002|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
83954003|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83954004|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
83954005|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954006|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954007|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
83954008|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954009|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
83954010|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954011|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
83954012|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
83954013|NCT04664010|Protective Agents|protective agents|mesh-ancestor
83954014|NCT04664127|Valacyclovir|valacyclovir|mesh-list
83954015|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
83954016|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954017|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83954018|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83954019|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83954020|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954021|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954022|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954023|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954024|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83954025|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
83954026|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83954027|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
83954028|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954029|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954030|NCT04663386|Budesonide|budesonide|mesh-list
83954031|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
83954032|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83954033|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83954034|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
83954035|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954036|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954037|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83954038|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
83954039|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
83954040|NCT04663386|Hormones|hormones|mesh-ancestor
83954041|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954042|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83954043|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83954044|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83954045|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
83954046|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954047|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954048|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83954049|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954050|NCT03504488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954051|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954052|NCT04663269|Dexamethasone|dexamethasone|mesh-list
83954053|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83954054|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
83954055|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
83954056|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954057|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954058|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83954059|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
83954060|NCT04663269|Hormones|hormones|mesh-ancestor
83954061|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954062|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83954063|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954064|NCT03312738|Everolimus|everolimus|mesh-list
83954065|NCT03312738|Exemestane|exemestane|mesh-list
83954066|NCT03312738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83954067|NCT03312738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83954068|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954069|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954070|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954071|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
83954072|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954073|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954074|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83954075|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83954076|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83954077|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
83954078|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954079|NCT03303339|Cytarabine|cytarabine|mesh-list
83954080|NCT03303339|Decitabine|decitabine|mesh-list
83954081|NCT03303339|Onvansertib|onvansertib|mesh-list
83954082|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83954083|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
83954084|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954085|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954086|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
83954087|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954088|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954089|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
83954090|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954091|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954092|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83954093|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83954094|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954095|NCT03299946|Nivolumab|nivolumab|mesh-list
83954096|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954097|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954098|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83954099|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954100|NCT00535340|Amibegron|amibegron|mesh-list
83954101|NCT00535340|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
83954102|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83954103|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83954104|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
83954105|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954106|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954107|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954108|NCT00535340|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83954109|NCT00535379|Sunitinib|sunitinib|mesh-list
83954110|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954111|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83954112|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83954113|NCT00535379|Growth Substances|growth substances|mesh-ancestor
83954114|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954115|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
83954116|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83954117|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954118|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954119|NCT00535418|Letrozole|letrozole|mesh-list
83954120|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954121|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83954122|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83954123|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954124|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954125|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83954126|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
83954127|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954128|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954129|NCT04679064|Paclitaxel|paclitaxel|mesh-list
83954130|NCT04679064|Bevacizumab|bevacizumab|mesh-list
83954131|NCT04679064|Gemcitabine|gemcitabine|mesh-list
83954132|NCT04679064|Doxorubicin|doxorubicin|mesh-list
83954133|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83954134|NCT04679064|Topotecan|topotecan|mesh-list
83954135|NCT04679064|Niraparib|niraparib|mesh-list
83954136|NCT04679064|Dostarlimab|dostarlimab|mesh-list
83954137|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83954138|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954139|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
83954140|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
83954141|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
83954142|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954143|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954144|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83954145|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83954146|NCT04679064|Growth Substances|growth substances|mesh-ancestor
83954147|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954148|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
83954149|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83954150|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
83954151|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83954152|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83954153|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83954154|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954155|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83954156|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83954157|NCT01183780|Leucovorin|leucovorin|mesh-list
83954158|NCT01183780|Folic Acid|folic acid|mesh-list
83954159|NCT01183780|Fluorouracil|fluorouracil|mesh-list
83954160|NCT01183780|Irinotecan|irinotecan|mesh-list
83954161|NCT01183780|Ramucirumab|ramucirumab|mesh-list
83954162|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
83954163|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
83954164|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954165|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83954166|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954167|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954168|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
83954169|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954170|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83954171|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83954172|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954173|NCT01183780|Antidotes|antidotes|mesh-ancestor
83954174|NCT01183780|Protective Agents|protective agents|mesh-ancestor
83954175|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
83954176|NCT01183780|Vitamins|vitamins|mesh-ancestor
83954177|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
83954178|NCT01183780|Hematinics|hematinics|mesh-ancestor
83954179|NCT04679103|Eculizumab|eculizumab|mesh-list
83954180|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83954181|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954182|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
83954183|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954184|NCT00535574|Bexarotene|bexarotene|mesh-list
83954185|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954186|NCT04678830|Leronlimab|leronlimab|mesh-list
83954187|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83954188|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83954189|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954190|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83954191|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83954192|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
83954193|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954194|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83954195|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
83954196|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83954197|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83954198|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
83954199|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954200|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954201|NCT03245021|Rituximab|rituximab|mesh-list
83954202|NCT03245021|Nivolumab|nivolumab|mesh-list
83954203|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954204|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954205|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
83954206|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954207|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83954208|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83954209|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954210|NCT04678791|Cisplatin|cisplatin|mesh-list
83954211|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
83954212|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954213|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954214|NCT01183390|Anastrozole|anastrozole|mesh-list
83954215|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83954216|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954217|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83954218|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83954219|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954220|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954221|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83954222|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
83954223|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954224|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954225|NCT02887807|Cyclosporine|cyclosporine|mesh-list
83954226|NCT02887807|Cyclosporins|cyclosporins|mesh-list
83954227|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954228|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954229|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954230|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
83954231|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954232|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
83954233|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954234|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
83954235|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193496|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83954236|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83954237|NCT04663035|Tislelizumab|tislelizumab|mesh-list
83954238|NCT04663035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954239|NCT04663035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954240|NCT03098589|Lenalidomide|lenalidomide|mesh-list
83954241|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
83954242|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954243|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83954244|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83954245|NCT03098589|Growth Substances|growth substances|mesh-ancestor
83954246|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
83954247|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954248|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
83954249|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83954250|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954251|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954252|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954253|NCT04662177|Analgesics|analgesics|mesh-ancestor
83954254|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
83954255|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954256|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83954257|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83954258|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83954259|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
83954260|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954261|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954262|NCT03026517|Phenformin|phenformin|mesh-list
83954263|NCT03026517|Trametinib|trametinib|mesh-list
83954264|NCT03026517|Dabrafenib|dabrafenib|mesh-list
83954265|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954266|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83954267|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954268|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954269|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83954270|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954271|NCT00537953|Miltefosine|miltefosine|mesh-list
83954272|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83954273|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
83954274|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954275|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954276|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83954277|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83954278|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
83954279|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954280|NCT05226299|Capsaicin|capsaicin|mesh-list
83954281|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
83954282|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
83954283|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
83954284|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954285|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954286|NCT00557232|Bevacizumab|bevacizumab|mesh-list
83954287|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954288|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954289|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83954290|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83954291|NCT00557232|Growth Substances|growth substances|mesh-ancestor
83954292|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954293|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
83954294|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
83954295|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83954296|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83954297|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954298|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
83954299|NCT02797119|Coagulants|coagulants|mesh-ancestor
83954300|NCT05161208|Varenicline|varenicline|mesh-list
83954301|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83954302|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83954303|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
83954304|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954305|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954306|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954307|NCT00538070|Glycine|glycine|mesh-list
83954308|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
83954309|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954310|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954311|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954313|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954314|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83954315|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954316|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954317|NCT00538148|Telithromycin|telithromycin|mesh-list
83954318|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83954319|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954320|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
83954321|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954322|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
83954323|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
83954324|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
83954325|NCT05119439|Misoprostol|misoprostol|mesh-list
83954326|NCT05119439|Mifepristone|mifepristone|mesh-list
83954327|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83954328|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
83954329|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83954330|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954331|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83954332|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83954333|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
83954334|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83954335|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83954336|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83954337|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83954338|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
83954339|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83954340|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83954341|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
83954342|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954343|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
83954344|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83954345|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83954346|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83954347|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83954348|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954349|NCT00538187|Bortezomib|bortezomib|mesh-list
83954350|NCT00538187|Obatoclax|obatoclax|mesh-list
83954351|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954352|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954353|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954354|NCT04661709|Aspirin|aspirin|mesh-list
83954355|NCT04661709|Metoprolol|metoprolol|mesh-list
83954356|NCT04661709|Isosorbide|isosorbide|mesh-list
83954357|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83954358|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83954359|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
83954360|NCT04661709|Trimetazidine|trimetazidine|mesh-list
83954361|NCT04661709|Clopidogrel|clopidogrel|mesh-list
83954362|NCT04661709|Atorvastatin|atorvastatin|mesh-list
83954363|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954364|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83954365|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954366|NCT04661709|Analgesics|analgesics|mesh-ancestor
83954367|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
83954368|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954369|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83954370|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83954371|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83954372|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83954373|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954374|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83954375|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83954376|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954377|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
83954378|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83954379|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83954380|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
83954381|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83954382|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83954383|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83954384|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83954385|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83193649|NCT02299999|Bevacizumab|bevacizumab|mesh-list
83954386|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
83954387|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954388|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83954389|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83954390|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
83954391|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
83954392|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83954393|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83954394|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83954395|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
83954396|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83954397|NCT04661709|Diuretics|diuretics|mesh-ancestor
83954398|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
83954399|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
83954400|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83954402|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
83954403|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954404|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
83954405|NCT00538265|Tacrolimus|tacrolimus|mesh-list
83954406|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
83954407|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954408|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
83954409|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954410|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83954411|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954412|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954413|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83954414|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954415|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83954416|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
83954417|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83954418|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954419|NCT02462811|Acetaminophen|acetaminophen|mesh-list
83954420|NCT02462811|Promethazine|promethazine|mesh-list
83954421|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
83954422|NCT02462811|Hydrocodone|hydrocodone|mesh-list
83954423|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954424|NCT02462811|Analgesics|analgesics|mesh-ancestor
83954425|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
83954426|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954427|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954428|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
83954429|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83954430|NCT02462811|Narcotics|narcotics|mesh-ancestor
83954431|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954432|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
83954433|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
83954434|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
83954435|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83954436|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83954437|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
83954438|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
83954439|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954440|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954441|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83954442|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83954443|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83954444|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
83954445|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
83954446|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
83954447|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
83954448|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83954449|NCT00538382|Artesunate|artesunate|mesh-list
83954450|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
83954451|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83954452|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83954453|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954454|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954455|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
83954456|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
83954457|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83954458|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
83954459|NCT00538421|Propofol|propofol|mesh-list
83954460|NCT00538421|Sevoflurane|sevoflurane|mesh-list
83193731|NCT03744793|Pemetrexed|pemetrexed|mesh-list
83954461|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83954462|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954463|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954464|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83954465|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
83954466|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
83954467|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83954468|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83954469|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
83954470|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83954471|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954472|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954473|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954474|NCT04661475|Analgesics|analgesics|mesh-ancestor
83954475|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
83954476|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954477|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83954478|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83954479|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83954480|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
83954481|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954482|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954483|NCT00538499|Fentanyl|fentanyl|mesh-list
83954484|NCT00538499|Bupivacaine|bupivacaine|mesh-list
83954485|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
83954486|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
83954487|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954488|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954489|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
83954490|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954491|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83954492|NCT00538499|Narcotics|narcotics|mesh-ancestor
83954493|NCT00538499|Analgesics|analgesics|mesh-ancestor
83954494|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83954495|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83954496|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
83954497|NCT00538538|Ranibizumab|ranibizumab|mesh-list
83954498|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83954499|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83954500|NCT00538538|Growth Substances|growth substances|mesh-ancestor
83954501|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954502|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
83954503|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954504|NCT00554346|Etoricoxib|etoricoxib|mesh-list
83954505|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83954506|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954507|NCT00554346|Analgesics|analgesics|mesh-ancestor
83954508|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
83954509|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954510|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954511|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83954512|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83954513|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83954514|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83954515|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954516|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954517|NCT00538655|Modafinil|modafinil|mesh-list
83954518|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83954519|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954520|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83954521|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83954522|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83954523|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954524|NCT00538694|Daptomycin|daptomycin|mesh-list
83954525|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83954526|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954527|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
83954528|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83954529|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
83954530|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83954531|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83954532|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954533|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83954534|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954535|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83954536|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954537|NCT00538811|Interferons|interferons|mesh-list
83954538|NCT00538811|Ribavirin|ribavirin|mesh-list
83954539|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
83954540|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
83954541|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
83954543|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954544|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
83954545|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954546|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
83954547|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954548|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
83954549|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954550|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83954551|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83954552|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
83954553|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954554|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954555|NCT00538811|Analgesics|analgesics|mesh-ancestor
83954556|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
83954557|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954558|NCT04660773|Pregabalin|pregabalin|mesh-list
83954559|NCT04660773|Analgesics|analgesics|mesh-ancestor
83954560|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
83954561|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954562|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954563|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
83954564|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83954565|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954566|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954567|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83954568|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83954569|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83954570|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954571|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83954572|NCT00538889|Citalopram|citalopram|mesh-list
83954573|NCT00538889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83954574|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83954575|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954576|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954577|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954578|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
83954579|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954580|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83954581|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
83954582|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83954583|NCT02413827|Ipilimumab|ipilimumab|mesh-list
83954584|NCT02413827|Poly ICLC|poly iclc|mesh-list
83954585|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83954586|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954587|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954588|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83954589|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954590|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
83954591|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
83954592|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954593|NCT00538967|Doxycycline|doxycycline|mesh-list
83954594|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83954595|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954596|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
83954597|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83954598|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83954599|NCT00539123|Buprenorphine|buprenorphine|mesh-list
83954600|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83954601|NCT00539123|Narcotics|narcotics|mesh-ancestor
83954602|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954603|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954604|NCT00539123|Analgesics|analgesics|mesh-ancestor
83954605|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
83954606|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954607|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83954608|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
83954609|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83954610|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
83954611|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954612|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193886|NCT03302299|Pyridoxine|pyridoxine|mesh-list
83954613|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83954614|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
83954615|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
83954616|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83954617|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
83954618|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954619|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954620|NCT00539396|Insulin|insulin|mesh-list
83954621|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83954622|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954623|NCT00539435|Insulin|insulin|mesh-list
83954624|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
83954625|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83954626|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954627|NCT00539630|Docetaxel|docetaxel|mesh-list
83954628|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954629|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
83954630|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
83954631|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
83954632|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954633|NCT04660461|Lansoprazole|lansoprazole|mesh-list
83954634|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
83954635|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83954636|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83954637|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83954638|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954639|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954640|NCT00539669|Docetaxel|docetaxel|mesh-list
83954641|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954642|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83954643|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83954644|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83954645|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954646|NCT00554424|Lidocaine|lidocaine|mesh-list
83954647|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
83954648|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
83954649|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954650|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954651|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
83954652|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954653|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83954654|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83954655|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83954656|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954657|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954658|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
83954659|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83954660|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954661|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83954662|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83954663|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
83954664|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954665|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
83954666|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954667|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954668|NCT00539786|Rabeprazole|rabeprazole|mesh-list
83954669|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83954670|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83954671|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83954672|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954673|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954674|NCT02341989|Carboplatin|carboplatin|mesh-list
83954675|NCT02341989|Etoposide|etoposide|mesh-list
83954676|NCT02341989|Bleomycin|bleomycin|mesh-list
83954677|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954678|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83954679|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83954680|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83954681|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954682|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954683|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83954684|NCT00540098|Paroxetine|paroxetine|mesh-list
83954685|NCT00540098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83954686|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83954687|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954688|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954689|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954690|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
83954691|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954692|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83954693|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
83954694|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83954695|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83954696|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83954697|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954699|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83954700|NCT00540137|Nevirapine|nevirapine|mesh-list
83954701|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83954702|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83954703|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
83954704|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954705|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954706|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83954707|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83954708|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
83954709|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954710|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83954711|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83954712|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83954713|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83954714|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83954715|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83954716|NCT04660110|Piperaquine|piperaquine|mesh-list
83954717|NCT04660110|Artenimol|artenimol|mesh-list
83954718|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
83954719|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83954720|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83954721|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954722|NCT02339064|Apomorphine|apomorphine|mesh-list
83954723|NCT02339064|Emetics|emetics|mesh-ancestor
83954724|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954725|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
83954726|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954727|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83954728|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
83954729|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
83954730|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954731|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954732|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83954733|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954734|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
83954735|NCT00540410|Artesunate|artesunate|mesh-list
83954736|NCT00540410|Lumefantrine|lumefantrine|mesh-list
83954737|NCT00540410|Amodiaquine|amodiaquine|mesh-list
83954738|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83954739|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
83954740|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83954741|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83954742|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954743|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954744|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
83954745|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
83954746|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83954747|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
83954748|NCT00540527|Plasminogen|plasminogen|mesh-list
83954749|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83954750|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83954751|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83954752|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954753|NCT00540605|Tenofovir|tenofovir|mesh-list
83954754|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
83954755|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954756|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83954757|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83954758|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954759|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954760|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83194029|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954761|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83954762|NCT04659915|Metformin|metformin|mesh-list
83954763|NCT04659915|Prednisone|prednisone|mesh-list
83954764|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83954765|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954766|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83954767|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
83954768|NCT04659915|Hormones|hormones|mesh-ancestor
83954769|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954770|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83954771|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954772|NCT00557427|Fluoxetine|fluoxetine|mesh-list
83954773|NCT00557427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83954774|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83954775|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954776|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954777|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954778|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
83954779|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954780|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83954781|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
83954782|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83954783|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83954784|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83954785|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954786|NCT00540800|Docetaxel|docetaxel|mesh-list
83954787|NCT00540800|Capecitabine|capecitabine|mesh-list
83954788|NCT00540800|Epirubicin|epirubicin|mesh-list
83954789|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954790|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
83954791|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
83954792|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
83954793|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954794|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83954795|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
83954796|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83954797|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83954798|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83954799|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954800|NCT00540956|Cytarabine|cytarabine|mesh-list
83954801|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83954802|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
83954803|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954804|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954805|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
83954806|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954807|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954808|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
83954809|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954810|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
83954811|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
83954812|NCT00541073|Pemetrexed|pemetrexed|mesh-list
83954813|NCT00541073|Vitamins|vitamins|mesh-ancestor
83954814|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
83954815|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954816|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954817|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954818|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954819|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83954820|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83954821|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
83954822|NCT00541073|Hematinics|hematinics|mesh-ancestor
83954823|NCT00541112|Leucovorin|leucovorin|mesh-list
83954824|NCT00541112|Fluorouracil|fluorouracil|mesh-list
83954825|NCT00541112|Capecitabine|capecitabine|mesh-list
83954826|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
83954827|NCT00541112|Cetuximab|cetuximab|mesh-list
83954828|NCT00541112|Calcium|calcium|mesh-list
83954829|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
83954830|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83954831|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954832|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
83954833|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954834|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83954835|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954836|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954837|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
83954838|NCT00541112|Antidotes|antidotes|mesh-ancestor
83954839|NCT00541112|Protective Agents|protective agents|mesh-ancestor
83954840|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
83954841|NCT00541112|Vitamins|vitamins|mesh-ancestor
83954842|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
83954843|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83954844|NCT04659525|Ezetimibe|ezetimibe|mesh-list
83954845|NCT04659525|Evolocumab|evolocumab|mesh-list
83954846|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83954847|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83954848|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
83954849|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954850|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83954851|NCT04659525|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83954852|NCT04659525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83954853|NCT04659525|Protease Inhibitors|protease inhibitors|mesh-ancestor
83954854|NCT04659525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954855|NCT02333643|Digoxin|digoxin|mesh-list
83954856|NCT02333643|Furosemide|furosemide|mesh-list
83954857|NCT02333643|Diuretics|diuretics|mesh-ancestor
83954858|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
83954859|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954860|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83954861|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954862|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954863|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83954864|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83954865|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954866|NCT02333643|Protective Agents|protective agents|mesh-ancestor
83954867|NCT00541463|Nelfinavir|nelfinavir|mesh-list
83954868|NCT00541463|Indinavir|indinavir|mesh-list
83954869|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954870|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83954871|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83954872|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
83954873|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954874|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83954875|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83954876|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
83954877|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954878|NCT02324985|Ibuprofen|ibuprofen|mesh-list
83954879|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83954880|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954881|NCT02324985|Analgesics|analgesics|mesh-ancestor
83954882|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
83954883|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954884|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954885|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83954886|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83954887|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83954888|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954889|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954890|NCT04659642|Fentanyl|fentanyl|mesh-list
83954891|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
83954892|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83954893|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83954894|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954895|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954896|NCT04659642|Analgesics|analgesics|mesh-ancestor
83954897|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
83954898|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954899|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83954900|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83954901|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83954902|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83954903|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954904|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954905|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83954906|NCT04659642|Narcotics|narcotics|mesh-ancestor
83954907|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83954908|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83954909|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
83954910|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
83954911|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
83954912|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
83194190|NCT05727163|Leucovorin|leucovorin|mesh-list
83954913|NCT00541814|Cyclosporine|cyclosporine|mesh-list
83954914|NCT00541814|Cyclosporins|cyclosporins|mesh-list
83954915|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954916|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954917|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83954918|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
83954919|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954920|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
83954921|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83954922|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83954923|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83954924|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83954925|NCT00541853|Candesartan|candesartan|mesh-list
83954926|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
83954927|NCT00541853|Cilnidipine|cilnidipine|mesh-list
83954928|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83954929|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83954930|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83954931|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954932|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83954933|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83954934|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83954935|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954936|NCT02301234|Celecoxib|celecoxib|mesh-list
83954937|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83954938|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83954939|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954940|NCT02301234|Analgesics|analgesics|mesh-ancestor
83954941|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
83954942|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954943|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954944|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83954945|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83954946|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83954947|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83954948|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954949|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954950|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
83954951|NCT02300142|Vaccines|vaccines|mesh-list
83954952|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
83954953|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954954|NCT01214668|Doxorubicin|doxorubicin|mesh-list
83954955|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83954956|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83954957|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954958|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83954959|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83954960|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954961|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954962|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83954963|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
83954964|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83954965|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
83954966|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83954967|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954968|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83954969|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83954970|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83954971|NCT00542165|Alfuzosin|alfuzosin|mesh-list
83954972|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83954973|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83954974|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83954975|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
83954976|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83954977|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954978|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954979|NCT00542165|Urological Agents|urological agents|mesh-ancestor
83954980|NCT00542243|Finasteride|finasteride|mesh-list
83954981|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83954982|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83954983|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83954984|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83954985|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
83954986|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83954987|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954988|NCT00542243|Urological Agents|urological agents|mesh-ancestor
83954989|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
83954990|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83954991|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83954992|NCT00542555|Naproxen|naproxen|mesh-list
83954993|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
83954994|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83954995|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83954996|NCT00542555|Analgesics|analgesics|mesh-ancestor
83954997|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
83954998|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83954999|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955000|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955001|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955002|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
83955003|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83955004|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955005|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955006|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83955007|NCT00542711|Curcumin|curcumin|mesh-list
83955008|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83955009|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83955010|NCT00542711|Analgesics|analgesics|mesh-ancestor
83955011|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
83955012|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955013|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955014|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955015|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955016|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955017|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955018|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955019|NCT00542984|Teriparatide|teriparatide|mesh-list
83955020|NCT00542984|Calcitonin|calcitonin|mesh-list
83955021|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
83955022|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83955023|NCT00542984|Katacalcin|katacalcin|mesh-list
83955024|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83955025|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955026|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83955027|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
83955028|NCT02257983|Ubiquinone|ubiquinone|mesh-list
83955029|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
83955030|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955031|NCT00543023|Teriparatide|teriparatide|mesh-list
83955032|NCT00543023|Calcitonin|calcitonin|mesh-list
83955033|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
83955034|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83955035|NCT00543023|Katacalcin|katacalcin|mesh-list
83955036|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83955037|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955038|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83955039|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
83955040|NCT04648917|Caffeic acid|caffeic acid|mesh-list
83955041|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
83955042|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955043|NCT04648917|Protective Agents|protective agents|mesh-ancestor
83955044|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955045|NCT00543179|Lanreotide|lanreotide|mesh-list
83955046|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955047|NCT00543218|Teriparatide|teriparatide|mesh-list
83955048|NCT00543218|Calcitonin|calcitonin|mesh-list
83955049|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
83955050|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83955051|NCT00543218|Katacalcin|katacalcin|mesh-list
83955052|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83955053|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955054|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83955055|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83955056|NCT02252835|Colchicine|colchicine|mesh-list
83955057|NCT02252835|Febuxostat|febuxostat|mesh-list
83955058|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
83955059|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955060|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83194328|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83955061|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83955062|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83955063|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955064|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955065|NCT03456752|Dexamethasone|dexamethasone|mesh-list
83955066|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955067|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
83955068|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
83955069|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955070|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955071|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955072|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
83955073|NCT03456752|Hormones|hormones|mesh-ancestor
83955074|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955075|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955076|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955077|NCT03456713|Mirikizumab|mirikizumab|mesh-list
83955078|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83955079|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83955080|NCT03456713|Analgesics|analgesics|mesh-ancestor
83955081|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
83955082|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955083|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955084|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955085|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955086|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83955087|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955088|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83955089|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
83955090|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955091|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83955092|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
83955093|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955094|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955095|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83955096|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83955097|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83955098|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
83955099|NCT04648332|Bupivacaine|bupivacaine|mesh-list
83955100|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
83955101|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
83955102|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955103|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955104|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
83955105|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955106|NCT00543335|Sorafenib|sorafenib|mesh-list
83955107|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955108|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955109|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955110|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955111|NCT00543413|Enalapril|enalapril|mesh-list
83955112|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83955113|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
83955114|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955115|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955116|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83955117|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83955118|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
83955119|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83955120|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83955121|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83955122|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955123|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955124|NCT00543608|Vancomycin|vancomycin|mesh-list
83955125|NCT00543608|Iclaprim|iclaprim|mesh-list
83955126|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83955127|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955128|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83955129|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955130|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955131|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83955132|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955133|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83194420|NCT04150861|Hormones|hormones|mesh-ancestor
83955134|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955135|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955136|NCT00543647|Fenofibrate|fenofibrate|mesh-list
83955137|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83955138|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
83955139|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955140|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83955141|NCT04647669|Interferons|interferons|mesh-list
83955142|NCT04647669|Interferon-beta|interferon-beta|mesh-list
83955143|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
83955144|NCT04647669|Remdesivir|remdesivir|mesh-list
83955145|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
83955146|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955147|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
83955148|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955149|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
83955150|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955151|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83955152|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
83955153|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955154|NCT00543686|Fluticasone|fluticasone|mesh-list
83955155|NCT00543686|Montelukast|montelukast|mesh-list
83955156|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955157|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83955158|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
83955159|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955160|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955161|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83955162|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
83955163|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
83955164|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83955165|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83955166|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
83955167|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955168|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83955169|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83955170|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955171|NCT00543842|Bevacizumab|bevacizumab|mesh-list
83955172|NCT00543842|Capecitabine|capecitabine|mesh-list
83955173|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83955174|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955175|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955176|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83955177|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83955178|NCT00543842|Growth Substances|growth substances|mesh-ancestor
83955179|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955180|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
83955181|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955182|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
83955183|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955184|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955185|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955186|NCT04638816|Lidocaine|lidocaine|mesh-list
83955187|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
83955188|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
83955189|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
83955190|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955191|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955192|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
83955193|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955194|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83955195|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83955196|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83955197|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83955198|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955199|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83955200|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
83955201|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
83955202|NCT04638816|Protective Agents|protective agents|mesh-ancestor
83955203|NCT00543959|Pioglitazone|pioglitazone|mesh-list
83955204|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83955205|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955206|NCT00544037|Interferons|interferons|mesh-list
83955207|NCT00544037|Interferon-beta|interferon-beta|mesh-list
83955208|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
83955209|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955210|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
83955211|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955212|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
83955213|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955214|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83955215|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
83955216|NCT00544154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83955217|NCT00544154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955218|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955219|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
83955220|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955221|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955222|NCT04638582|Paclitaxel|paclitaxel|mesh-list
83955223|NCT04638582|Carboplatin|carboplatin|mesh-list
83955224|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
83955225|NCT04638582|Pemetrexed|pemetrexed|mesh-list
83955226|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83955227|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955228|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83955229|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83955230|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83955231|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955232|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955233|NCT04638582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83955234|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955235|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83955236|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83955237|NCT00544193|Gemcitabine|gemcitabine|mesh-list
83955238|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955239|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
83955240|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955241|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955242|NCT00544232|Paclitaxel|paclitaxel|mesh-list
83955243|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83955244|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
83955245|NCT00544232|Methotrexate|methotrexate|mesh-list
83955246|NCT00544232|Epirubicin|epirubicin|mesh-list
83955247|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
83955248|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83955249|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955250|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
83955251|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
83955252|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
83955253|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955254|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955255|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
83955256|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955257|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955258|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83955259|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
83955260|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83955261|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83955262|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
83955263|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83955264|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955265|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
83955266|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
83955267|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955268|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83955269|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83955270|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83955271|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83955272|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83955273|NCT00544232|Hematinics|hematinics|mesh-ancestor
83955274|NCT01191268|Insulin|insulin|mesh-list
83955275|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83955276|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
83955277|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
83955278|NCT01191268|Dulaglutide|dulaglutide|mesh-list
83955279|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83955280|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955281|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
83955282|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955283|NCT00544349|Leucovorin|leucovorin|mesh-list
83955284|NCT00544349|Fluorouracil|fluorouracil|mesh-list
83955285|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
83955286|NCT00544349|Cetuximab|cetuximab|mesh-list
83955287|NCT00544349|Calcium|calcium|mesh-list
83955288|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
83955289|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83955290|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955291|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
83955292|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955293|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955294|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955295|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955296|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
83955297|NCT00544349|Antidotes|antidotes|mesh-ancestor
83955298|NCT00544349|Protective Agents|protective agents|mesh-ancestor
83955299|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
83955300|NCT00544349|Vitamins|vitamins|mesh-ancestor
83955301|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
83955302|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955303|NCT01191190|Ofatumumab|ofatumumab|mesh-list
83955304|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955305|NCT00544388|Levocetirizine|levocetirizine|mesh-list
83955306|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83955307|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83955308|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
83955309|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
83955310|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955311|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955312|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955313|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
83955314|NCT00544505|Fluorouracil|fluorouracil|mesh-list
83955315|NCT00544505|Epirubicin|epirubicin|mesh-list
83955316|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955317|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
83955318|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955319|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955320|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83955321|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
83955322|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955323|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955324|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83955325|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
83955326|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955327|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83955328|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83955329|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83955330|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955331|NCT00544700|Bevacizumab|bevacizumab|mesh-list
83955332|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955333|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955334|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83955335|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83955336|NCT00544700|Growth Substances|growth substances|mesh-ancestor
83955337|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955338|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
83955339|NCT05824481|Lenvatinib|lenvatinib|mesh-list
83955340|NCT05824481|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83955341|NCT05824481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955342|NCT05824481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955343|NCT05824481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955344|NCT05824481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955345|NCT05824468|Lenvatinib|lenvatinib|mesh-list
83955346|NCT05824468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83955347|NCT05824468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955348|NCT05824468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955349|NCT05824468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955350|NCT05824468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955351|NCT05824455|Irinotecan|irinotecan|mesh-list
83955352|NCT05824455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83955353|NCT05824455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83955354|NCT05824455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955355|NCT05824455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955356|NCT05824455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955357|NCT05824390|Rituximab|rituximab|mesh-list
83955358|NCT05824390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955359|NCT05824390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955360|NCT05824390|Immunologic Factors|immunologic factors|mesh-ancestor
84124689|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
83955361|NCT05824390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955362|NCT05824390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955363|NCT05824312|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83955364|NCT05824312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955365|NCT05824312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955366|NCT05824312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955367|NCT05824156|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
83955368|NCT05824156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955370|NCT05823883|Empagliflozin|empagliflozin|mesh-list
83955371|NCT05823883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83955372|NCT05823883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955373|NCT05823883|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83955374|NCT05823883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955375|NCT05823870|Metformin|metformin|mesh-list
83955376|NCT05823870|Empagliflozin|empagliflozin|mesh-list
83955377|NCT05823870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83955378|NCT05823870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955379|NCT05823870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83955380|NCT05823870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955381|NCT05823701|Azacitidine|azacitidine|mesh-list
83955382|NCT05823701|Mitoxantrone|mitoxantrone|mesh-list
83955383|NCT05823701|Obinutuzumab|obinutuzumab|mesh-list
83955384|NCT05823701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955385|NCT05823701|Antimetabolites|antimetabolites|mesh-ancestor
83955386|NCT05823701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955387|NCT05823701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955388|NCT05823701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955389|NCT05823701|Analgesics|analgesics|mesh-ancestor
83955390|NCT05823701|Sensory System Agents|sensory system agents|mesh-ancestor
83955391|NCT05823701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955392|NCT05823701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955393|NCT05823701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83955394|NCT05823701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83955395|NCT05823701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955396|NCT05823623|Vinorelbine|vinorelbine|mesh-list
83955397|NCT05823623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83955398|NCT05823623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955399|NCT05823623|Tubulin Modulators|tubulin modulators|mesh-ancestor
83955400|NCT05823623|Antimitotic Agents|antimitotic agents|mesh-ancestor
83955401|NCT05823623|Mitosis Modulators|mitosis modulators|mesh-ancestor
83955402|NCT05823623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955403|NCT05823480|Azacitidine|azacitidine|mesh-list
83955404|NCT05823480|Magrolimab|magrolimab|mesh-list
83955405|NCT05823480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955406|NCT05823480|Antimetabolites|antimetabolites|mesh-ancestor
83955407|NCT05823480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955408|NCT05823480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955409|NCT05823480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955410|NCT05823480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955411|NCT05823441|Oxytocin|oxytocin|mesh-list
83955412|NCT05823441|Oxytocics|oxytocics|mesh-ancestor
83955413|NCT05823441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83955414|NCT05823441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955415|NCT05823168|Anticonvulsants|anticonvulsants|mesh-list
83955416|NCT05823155|Penicillins|penicillins|mesh-list
83955417|NCT05823155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83955418|NCT05823155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955419|NCT05822882|Anesthetics|anesthetics|mesh-list
83955420|NCT05822882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955421|NCT05822882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955422|NCT05822713|Amisulpride|amisulpride|mesh-list
83955423|NCT05822713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83955424|NCT05822713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83955425|NCT05822713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955426|NCT05822713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955427|NCT05822713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83955428|NCT05822713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83955429|NCT05822713|Dopamine Agents|dopamine agents|mesh-ancestor
83955430|NCT05822713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955431|NCT05822713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955432|NCT05822713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83194700|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
83955433|NCT05822713|Antidepressive Agents|antidepressive agents|mesh-ancestor
83955434|NCT05822674|Metformin|metformin|mesh-list
83955435|NCT05822674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83955436|NCT05822674|Empagliflozin|empagliflozin|mesh-list
83955437|NCT05822674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83955438|NCT05822674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955439|NCT05822674|Incretins|incretins|mesh-ancestor
83955440|NCT05822674|Hormones|hormones|mesh-ancestor
83955441|NCT05822674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955442|NCT05822674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83955443|NCT05822674|Protease Inhibitors|protease inhibitors|mesh-ancestor
83955444|NCT05822674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955445|NCT05822674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955446|NCT05822674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83955447|NCT05820451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83955448|NCT05817474|Lidocaine|lidocaine|mesh-list
83955449|NCT05817474|Tranexamic Acid|tranexamic acid|mesh-list
83955450|NCT05817474|Anesthetics, Local|anesthetics, local|mesh-ancestor
83955451|NCT05817474|Anesthetics|anesthetics|mesh-ancestor
83955452|NCT05817474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955453|NCT05817474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955454|NCT05817474|Sensory System Agents|sensory system agents|mesh-ancestor
83955455|NCT05817474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955456|NCT05817474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83955457|NCT05817474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83955458|NCT05817474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83955459|NCT05817474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83955460|NCT05817474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955461|NCT05817474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83955462|NCT05817474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83955463|NCT05817474|Hemostatics|hemostatics|mesh-ancestor
83955464|NCT05817474|Coagulants|coagulants|mesh-ancestor
83955465|NCT05824338|Bupivacaine|bupivacaine|mesh-list
83955466|NCT05824338|Ropivacaine|ropivacaine|mesh-list
83955467|NCT05824338|Anesthetics|anesthetics|mesh-list
83955468|NCT05824338|Anesthetics, Local|anesthetics, local|mesh-ancestor
83955469|NCT05824338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955470|NCT05824338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955471|NCT05824338|Sensory System Agents|sensory system agents|mesh-ancestor
83955472|NCT05824338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955473|NCT05794503|Neostigmine|neostigmine|mesh-list
83955474|NCT05794503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83955475|NCT05794503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955476|NCT05794503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955477|NCT05794503|Cholinergic Agents|cholinergic agents|mesh-ancestor
83955478|NCT05794503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955479|NCT05794503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955480|NCT05794503|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83955481|NCT05794503|Autonomic Agents|autonomic agents|mesh-ancestor
83955482|NCT05794503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955483|NCT05780567|Tamoxifen|tamoxifen|mesh-list
83955484|NCT05780567|Letrozole|letrozole|mesh-list
83955485|NCT05780567|Anastrozole|anastrozole|mesh-list
83955486|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955487|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83955488|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83955489|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955490|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955491|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83955492|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
83955493|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955494|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955495|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955496|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83955497|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83955498|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83955499|NCT05756972|Carboplatin|carboplatin|mesh-list
83955500|NCT05756972|Pemetrexed|pemetrexed|mesh-list
83955501|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955502|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955503|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955504|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83955505|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83955506|NCT05751629|Bevacizumab|bevacizumab|mesh-list
83955508|NCT05751629|Dostarlimab|dostarlimab|mesh-list
83955509|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955510|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955511|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83955512|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83955513|NCT05751629|Growth Substances|growth substances|mesh-ancestor
83955514|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955515|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
83955516|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83955517|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955518|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955519|NCT05746273|Nicotine|nicotine|mesh-list
83955520|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83955521|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
83955522|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955523|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955524|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83955525|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83955526|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
83955527|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955528|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955529|NCT05736640|Denosumab|denosumab|mesh-list
83955530|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83955531|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955532|NCT05728294|Ropivacaine|ropivacaine|mesh-list
83955533|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
83955534|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
83955535|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955536|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955537|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
83955538|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955539|NCT05726916|Eculizumab|eculizumab|mesh-list
83955540|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83955541|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955542|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
83955543|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955544|NCT05712278|Cytarabine|cytarabine|mesh-list
83955545|NCT05712278|Fludarabine|fludarabine|mesh-list
83955546|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955547|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955548|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
83955549|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955550|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955551|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
83955552|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955553|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
83955554|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955555|NCT05704829|Trastuzumab|trastuzumab|mesh-list
83955556|NCT05704829|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83955557|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955558|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955559|NCT05704829|Immunoconjugates|immunoconjugates|mesh-ancestor
83955560|NCT05704829|Immunologic Factors|immunologic factors|mesh-ancestor
83955561|NCT05704829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955562|NCT05685004|Temozolomide|temozolomide|mesh-list
83955563|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83955564|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
83955565|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955566|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955567|NCT05681572|Midazolam|midazolam|mesh-list
83955568|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
83955569|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83955570|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955571|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955572|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83955573|NCT05681572|Analgesics|analgesics|mesh-ancestor
83955574|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
83955575|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955576|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83955577|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83955578|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83955579|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
83955580|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955581|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955582|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83955583|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83955584|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83955585|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83955586|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83955587|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
83955588|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
83955589|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
83955590|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
83955591|NCT05671757|Daratumumab|daratumumab|mesh-list
83955592|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83955593|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955594|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
83955595|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955596|NCT05608252|Fulvestrant|fulvestrant|mesh-list
83955597|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955598|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955599|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83955600|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83955601|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83955602|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955603|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955604|NCT05564221|Omalizumab|omalizumab|mesh-list
83955605|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83955606|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83955607|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
83955608|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83955609|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83955610|NCT05490888|Terlipressin|terlipressin|mesh-list
83955611|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83955612|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83955613|NCT05410301|Bevacizumab|bevacizumab|mesh-list
83955614|NCT05410301|Lomustine|lomustine|mesh-list
83955615|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955616|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955617|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83955618|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83955619|NCT05410301|Growth Substances|growth substances|mesh-ancestor
83955620|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955621|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
83955622|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83955623|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
83955624|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955625|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83955626|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
83955627|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955628|NCT05388487|Complement Factor H|complement factor h|mesh-list
83955629|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83955630|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955631|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
83955632|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955633|NCT05297578|Vaccines|vaccines|mesh-list
83955634|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83955635|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
83955636|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955637|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
83955638|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83955639|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83955640|NCT05293249|Prednisolone|prednisolone|mesh-list
83955641|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
83955642|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83955643|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
83955644|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955645|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
83955646|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
83955647|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955648|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955649|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955650|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
83955651|NCT05293249|Hormones|hormones|mesh-ancestor
83955652|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955653|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83955654|NCT05293249|Protective Agents|protective agents|mesh-ancestor
83955655|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955656|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955657|NCT05180474|Antibodies|antibodies|mesh-list
83955658|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83955659|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
83955660|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955661|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83955662|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
83955663|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955664|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83955665|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
83955666|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955667|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955668|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83955669|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83955670|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83955671|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
83955672|NCT05172934|Tenecteplase|tenecteplase|mesh-list
83955673|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83955674|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83955675|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955676|NCT05171816|Olaparib|olaparib|mesh-list
83955677|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
83955678|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83955679|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955680|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955681|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955682|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83955683|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
83955684|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955685|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955686|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83955687|NCT05126966|Ranibizumab|ranibizumab|mesh-list
83955688|NCT05126966|Aflibercept|aflibercept|mesh-list
83955689|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83955690|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83955691|NCT05126966|Growth Substances|growth substances|mesh-ancestor
83955692|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955693|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
83955694|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955695|NCT05126784|Denosumab|denosumab|mesh-list
83955696|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83955697|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955698|NCT05065294|Psilocybin|psilocybin|mesh-list
83955699|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83955700|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
83955701|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955702|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83955703|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83955704|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
83955705|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955706|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955707|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83955708|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
83955709|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83955710|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83955711|NCT05058287|Prednisolone|prednisolone|mesh-list
83955712|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
83955713|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83955714|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
83955715|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955716|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
83955717|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
83955718|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955719|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955720|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955721|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
83955722|NCT05058287|Hormones|hormones|mesh-ancestor
83955723|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955724|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83955725|NCT05058287|Protective Agents|protective agents|mesh-ancestor
83955726|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955727|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955728|NCT04968899|Dexamethasone|dexamethasone|mesh-list
83955729|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
83955730|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83955731|NCT04968899|Antibodies|antibodies|mesh-list
83955732|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
83955733|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83955734|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955735|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
83955736|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
83955737|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955738|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955739|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955740|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
83955741|NCT04968899|Hormones|hormones|mesh-ancestor
83955742|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955743|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955744|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955745|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
83955746|NCT04965818|Futibatinib|futibatinib|mesh-list
83955747|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955748|NCT04952597|Tislelizumab|tislelizumab|mesh-list
83955749|NCT04952597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955750|NCT04952597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955751|NCT04943224|Trametinib|trametinib|mesh-list
83955752|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955753|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955754|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955755|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955756|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83955757|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83955758|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955759|NCT04943198|Vemurafenib|vemurafenib|mesh-list
83955760|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955761|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955762|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955763|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955764|NCT04941105|Evolocumab|evolocumab|mesh-list
83955765|NCT04941105|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83955766|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83955767|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83955768|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
83955769|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955770|NCT04941105|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83955771|NCT04941105|Protease Inhibitors|protease inhibitors|mesh-ancestor
83955772|NCT04941105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955773|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83955774|NCT04933695|Sotorasib|sotorasib|mesh-list
83955775|NCT04933695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83955776|NCT04933695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955777|NCT04933695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955778|NCT04933695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955779|NCT04873102|Danazol|danazol|mesh-list
83955780|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83955781|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
83955782|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955783|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955784|NCT04860141|Gabapentin|gabapentin|mesh-list
83955785|NCT04860141|Analgesics|analgesics|mesh-ancestor
83955786|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
83955787|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955788|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955789|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
83955790|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83955791|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83955792|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955793|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83955794|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83955795|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83955796|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955797|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955798|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
83955799|NCT04823156|Calcium|calcium|mesh-list
83955800|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83955801|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955802|NCT04813653|Cyclosporine|cyclosporine|mesh-list
83955803|NCT04813653|Dexamethasone|dexamethasone|mesh-list
83955804|NCT04813653|Cyclosporins|cyclosporins|mesh-list
83955805|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955806|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
83955807|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
83955808|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955809|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955810|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955811|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
83955812|NCT04813653|Hormones|hormones|mesh-ancestor
83955813|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955814|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955815|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955816|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955817|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955818|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955819|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
83955820|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
83955821|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955822|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
83955823|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955824|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83955825|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
83955826|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83955827|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83955828|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955829|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
83955830|NCT04803747|Coagulants|coagulants|mesh-ancestor
83955831|NCT04790474|Dexamethasone|dexamethasone|mesh-list
83955832|NCT04790474|Pomalidomide|pomalidomide|mesh-list
83955833|NCT04790474|Ixazomib|ixazomib|mesh-list
83955834|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955835|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
83955836|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
83955837|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955838|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955839|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955840|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
83955841|NCT04790474|Hormones|hormones|mesh-ancestor
83955842|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83955843|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83955844|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955845|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
83955846|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83955847|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83955848|NCT04790474|Growth Substances|growth substances|mesh-ancestor
83955849|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
83955850|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
83955851|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955852|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955853|NCT04778410|Cytarabine|cytarabine|mesh-list
83955854|NCT04778410|Etoposide|etoposide|mesh-list
83955855|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
83955856|NCT04778410|Azacitidine|azacitidine|mesh-list
83955857|NCT04778410|Venetoclax|venetoclax|mesh-list
83955859|NCT04778410|Magrolimab|magrolimab|mesh-list
83955860|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83955861|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955862|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83955863|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83955864|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955865|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955866|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955867|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
83955868|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
83955869|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955870|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955871|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
83955872|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955873|NCT04778410|Analgesics|analgesics|mesh-ancestor
83955874|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
83955875|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955876|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955877|NCT04767594|Palbociclib|palbociclib|mesh-list
83955878|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955879|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83195156|NCT03363191|Xhance|xhance|mesh-list
83955880|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955881|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955882|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
83955883|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83955884|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955885|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
83955886|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955887|NCT04718025|Aspirin|aspirin|mesh-list
83955888|NCT04718025|Ticagrelor|ticagrelor|mesh-list
83955889|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83955890|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83955891|NCT04718025|Analgesics|analgesics|mesh-ancestor
83955892|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
83955893|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955894|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955895|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955896|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955897|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83955898|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83955899|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955900|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83955901|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83955902|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955903|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
83955904|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83955905|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83955906|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83955907|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
83955908|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955909|NCT04666948|Vancomycin|vancomycin|mesh-list
83955910|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83955911|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955912|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
83955913|NCT04660539|Azathioprine|azathioprine|mesh-list
83955914|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83955915|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955916|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83955917|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
83955918|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83955919|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955920|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955921|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955922|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
83955923|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83955924|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955925|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
83955926|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955927|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955928|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
83955929|NCT04642430|Apixaban|apixaban|mesh-list
83955930|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83955931|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
83955932|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83955933|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
83955934|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955935|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955936|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
83955937|NCT04609176|Apatinib|apatinib|mesh-list
83955938|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955939|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83955940|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83955941|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955942|NCT04593940|Remdesivir|remdesivir|mesh-list
83955943|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
83955944|NCT04593940|Infliximab|infliximab|mesh-list
83955945|NCT04593940|Abatacept|abatacept|mesh-list
83955946|NCT04593940|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83955947|NCT04593940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83955948|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
83955949|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955950|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83955951|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83955952|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955953|NCT04593940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83955954|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83955955|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83955956|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
83955957|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955958|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
83955959|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
83955960|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83955961|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83955962|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83955963|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83955964|NCT04562090|Mirabegron|mirabegron|mesh-list
83955965|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83955966|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83955967|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83955968|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
83955969|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955970|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955971|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955972|NCT04562090|Urological Agents|urological agents|mesh-ancestor
83955973|NCT04557189|Ondansetron|ondansetron|mesh-list
83955974|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
83955975|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
83955976|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83955977|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955978|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83955979|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
83955980|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83955981|NCT04557189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83955982|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83955983|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
83955984|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83955985|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83955986|NCT04530838|Vaccines|vaccines|mesh-list
83955987|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83955988|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
83955989|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955990|NCT04442919|Morphine|morphine|mesh-list
83955991|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
83955992|NCT04442919|Ticagrelor|ticagrelor|mesh-list
83955993|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83955994|NCT04442919|Narcotics|narcotics|mesh-ancestor
83955995|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83955996|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83955997|NCT04442919|Analgesics|analgesics|mesh-ancestor
83955998|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
83955999|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956000|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83956001|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83956002|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83956003|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83956004|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
83956005|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956006|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956007|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83956008|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
83956009|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
83956010|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
83956011|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956012|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956013|NCT04435197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956014|NCT04435197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956015|NCT04424901|Dipyridamole|dipyridamole|mesh-list
83956016|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83956017|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956018|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956019|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83956020|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956021|NCT04415060|Sevoflurane|sevoflurane|mesh-list
83956022|NCT04415060|Isoflurane|isoflurane|mesh-list
83956023|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83956024|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83956025|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
83956026|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
83956027|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956028|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956029|NCT04410445|Nivolumab|nivolumab|mesh-list
83956030|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956031|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956032|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956033|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956034|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
83956035|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83956036|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
83956037|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956038|NCT04408664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83956039|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956040|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83956041|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
83956043|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956044|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956045|NCT04381091|Idebenone|idebenone|mesh-list
83956046|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
83956047|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956048|NCT04381091|Protective Agents|protective agents|mesh-ancestor
83956049|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956050|NCT04293562|Cytarabine|cytarabine|mesh-list
83956051|NCT04293562|Deoxyglucose|deoxyglucose|mesh-list
83956052|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
83956053|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83956054|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83956055|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83956056|NCT04293562|Methotrexate|methotrexate|mesh-list
83956057|NCT04293562|Etoposide|etoposide|mesh-list
83956058|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
83956059|NCT04293562|Daunorubicin|daunorubicin|mesh-list
83956060|NCT04293562|Asparaginase|asparaginase|mesh-list
83956061|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
83956062|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
83956063|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
83956064|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
83956065|NCT04293562|Razoxane|razoxane|mesh-list
83956066|NCT04293562|Calicheamicins|calicheamicins|mesh-list
83956067|NCT04293562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83956068|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83956069|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
83956070|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83956071|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956072|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83956073|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
83956074|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956075|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956076|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
83956077|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956078|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83956079|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83956080|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
83956081|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956082|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83956083|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83956084|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83956085|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956086|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
83956087|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956088|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956089|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83956090|NCT04293562|Analgesics|analgesics|mesh-ancestor
83956091|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
83956092|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956093|NCT04293562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83956094|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
83956095|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83956096|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956097|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83956098|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956099|NCT04293562|Immunotoxins|immunotoxins|mesh-ancestor
83956100|NCT04293562|Immunoconjugates|immunoconjugates|mesh-ancestor
83956101|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83956102|NCT04293562|Protective Agents|protective agents|mesh-ancestor
83956103|NCT04225312|Natalizumab|natalizumab|mesh-list
83956104|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
83956105|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956106|NCT04221542|Docetaxel|docetaxel|mesh-list
83195393|NCT03365765|Apatinib|apatinib|mesh-list
83956107|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956108|NCT04221542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83956109|NCT04221542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956110|NCT04221542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83956111|NCT04221542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956112|NCT04209205|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83956113|NCT04209205|Immunologic Factors|immunologic factors|mesh-ancestor
83956114|NCT04209205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956115|NCT04156347|Topotecan|topotecan|mesh-list
83956116|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83956117|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956118|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956119|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956120|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956121|NCT04129086|Ketamine|ketamine|mesh-list
83956122|NCT04129086|Analgesics|analgesics|mesh-ancestor
83956123|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
83956124|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956125|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956126|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83956127|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83956128|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
83956129|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
83956130|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956131|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83956132|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83956133|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956134|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956135|NCT04108156|Ranibizumab|ranibizumab|mesh-list
83956136|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956137|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956138|NCT04108156|Growth Substances|growth substances|mesh-ancestor
83956139|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956140|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956141|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956142|NCT04062448|Rituximab|rituximab|mesh-list
83956143|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956144|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956145|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
83956146|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956147|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956148|NCT04003285|Pregnanolone|pregnanolone|mesh-list
83956149|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
83956150|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956151|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956152|NCT04000555|Vancomycin|vancomycin|mesh-list
83956153|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83956154|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956155|NCT03994393|Durvalumab|durvalumab|mesh-list
83956156|NCT03994393|Tremelimumab|tremelimumab|mesh-list
83956157|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956158|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956159|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
83956160|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83956161|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
83956162|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956163|NCT03933163|Resveratrol|resveratrol|mesh-list
83956164|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
83956165|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956166|NCT03933163|Protective Agents|protective agents|mesh-ancestor
83956167|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956168|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956169|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83195452|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
83195453|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195454|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83195455|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83195456|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195457|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195458|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83195459|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
83195460|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195461|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195462|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83956171|NCT03873818|Ipilimumab|ipilimumab|mesh-list
83956172|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956173|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956174|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956175|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956176|NCT03829501|Atezolizumab|atezolizumab|mesh-list
83956177|NCT03829501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956178|NCT03829501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956179|NCT03829501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956180|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956181|NCT03798639|Nivolumab|nivolumab|mesh-list
83956182|NCT03798639|Ipilimumab|ipilimumab|mesh-list
83956183|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956184|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956185|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956186|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956187|NCT03774901|Avelumab|avelumab|mesh-list
83956188|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956189|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956190|NCT03762018|Bevacizumab|bevacizumab|mesh-list
83956191|NCT03762018|Atezolizumab|atezolizumab|mesh-list
83956192|NCT03762018|Carboplatin|carboplatin|mesh-list
83956193|NCT03762018|Pemetrexed|pemetrexed|mesh-list
83956194|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956195|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956196|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956197|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956198|NCT03762018|Growth Substances|growth substances|mesh-ancestor
83956199|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956200|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956201|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956202|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956203|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83956204|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83956205|NCT03762018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956206|NCT03737643|Paclitaxel|paclitaxel|mesh-list
83956207|NCT03737643|Bevacizumab|bevacizumab|mesh-list
83956208|NCT03737643|Carboplatin|carboplatin|mesh-list
83956209|NCT03737643|Durvalumab|durvalumab|mesh-list
83956210|NCT03737643|Olaparib|olaparib|mesh-list
83956211|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83956212|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83956213|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956214|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83956215|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956216|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83956217|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956218|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956219|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956220|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956221|NCT03737643|Growth Substances|growth substances|mesh-ancestor
83956222|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956223|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956224|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
83956225|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83956226|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956227|NCT03644186|Paclitaxel|paclitaxel|mesh-list
83956228|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83956229|NCT03644186|Trastuzumab|trastuzumab|mesh-list
83956230|NCT03644186|Letrozole|letrozole|mesh-list
83956231|NCT03644186|Palbociclib|palbociclib|mesh-list
83956232|NCT03644186|Pertuzumab|pertuzumab|mesh-list
83956233|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83956234|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956235|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
83956236|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956237|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
83956238|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956239|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956240|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83956241|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83956242|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956243|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83956244|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
83956245|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83956246|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956247|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83956248|NCT03471143|Betadex|betadex|mesh-list
83956249|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
83956250|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956251|NCT03456882|RNS60|rns60|mesh-list
83956252|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83956253|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83956254|NCT03456882|Analgesics|analgesics|mesh-ancestor
83956255|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
83956256|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956257|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956258|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956259|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956260|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83956261|NCT03433807|Idebenone|idebenone|mesh-list
83956262|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
83956263|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956264|NCT03433807|Protective Agents|protective agents|mesh-ancestor
83956265|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956266|NCT03416179|Cytarabine|cytarabine|mesh-list
83956267|NCT03416179|Azacitidine|azacitidine|mesh-list
83956268|NCT03416179|Daunorubicin|daunorubicin|mesh-list
83956269|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83956270|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
83956271|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956272|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956273|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
83956274|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956275|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83956276|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
83956277|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956278|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956279|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83956280|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83956281|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956282|NCT03313544|Nivolumab|nivolumab|mesh-list
83956283|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956284|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956285|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956286|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956287|NCT03309150|Paclitaxel|paclitaxel|mesh-list
83956288|NCT03309150|Carboplatin|carboplatin|mesh-list
83956289|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83956290|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956291|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
83956292|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956293|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
83956294|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956295|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
83956296|NCT03266783|Apixaban|apixaban|mesh-list
83956297|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83956298|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
83956299|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83956300|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
83956301|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956302|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956303|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
83956304|NCT03251859|Ticagrelor|ticagrelor|mesh-list
83956305|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83956306|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83956307|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83956308|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83956309|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
83956310|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956311|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956312|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956313|NCT03186638|Ibuprofen|ibuprofen|mesh-list
83956314|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83956315|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83956316|NCT03186638|Analgesics|analgesics|mesh-ancestor
83956317|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
83956318|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956319|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956320|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956321|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956322|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83956323|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956324|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956326|NCT03043872|Etoposide|etoposide|mesh-list
83956327|NCT03043872|Durvalumab|durvalumab|mesh-list
83956328|NCT03043872|Tremelimumab|tremelimumab|mesh-list
83956329|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956330|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83956331|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83956332|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956333|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956334|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956335|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956336|NCT02923128|Sufentanil|sufentanil|mesh-list
83956337|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
83956338|NCT02923128|Dsuvia|dsuvia|mesh-list
83956339|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83956340|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956341|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956342|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83956343|NCT02923128|Analgesics|analgesics|mesh-ancestor
83956344|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
83956345|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956346|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83956347|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83956348|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83956349|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
83956350|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956351|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956352|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83956353|NCT02923128|Narcotics|narcotics|mesh-ancestor
83956354|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83956355|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83956356|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
83956357|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
83956358|NCT02918409|Tobramycin|tobramycin|mesh-list
83956359|NCT02918409|Colistin|colistin|mesh-list
83956360|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83956361|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956362|NCT02859792|Riluzole|riluzole|mesh-list
83956363|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
83956364|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83956365|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83956366|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956367|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956368|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956369|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83956370|NCT02859792|Protective Agents|protective agents|mesh-ancestor
83956371|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
83956372|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83956373|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83956374|NCT02793466|Durvalumab|durvalumab|mesh-list
83956375|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83956376|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956377|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956378|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
83956379|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956380|NCT02774005|Idebenone|idebenone|mesh-list
83956381|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
83956382|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956383|NCT02774005|Protective Agents|protective agents|mesh-ancestor
83956384|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956385|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
83956386|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83956387|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956388|NCT02695771|Gemcitabine|gemcitabine|mesh-list
83956389|NCT02695771|Mitomycins|mitomycins|mesh-list
83956390|NCT02695771|Mitomycin|mitomycin|mesh-list
83956391|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83956392|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
83956393|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956394|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956395|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83956396|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
83956397|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83956398|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956399|NCT02568267|Entrectinib|entrectinib|mesh-list
83956400|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83956401|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956402|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956404|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83956405|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
83956406|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956407|NCT02259621|Paclitaxel|paclitaxel|mesh-list
83956408|NCT02259621|Carboplatin|carboplatin|mesh-list
83956409|NCT02259621|Nivolumab|nivolumab|mesh-list
83956410|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83956411|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956412|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
83956413|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956414|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
83956415|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956416|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956417|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83956418|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
83956419|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
83956420|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956421|NCT01941641|Capecitabine|capecitabine|mesh-list
83956422|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83956423|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
83956424|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956425|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956426|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
83956427|NCT01804634|Melphalan|melphalan|mesh-list
83956428|NCT01804634|Fludarabine|fludarabine|mesh-list
83956429|NCT01804634|Tacrolimus|tacrolimus|mesh-list
83956430|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83956431|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
83956432|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956433|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956434|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83956435|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
83956436|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956437|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956438|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83956439|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83956440|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956441|NCT01792934|Bevacizumab|bevacizumab|mesh-list
83956442|NCT01792934|Irinotecan|irinotecan|mesh-list
83956443|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956444|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956445|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956446|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956447|NCT01792934|Growth Substances|growth substances|mesh-ancestor
83956448|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956449|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956450|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83956451|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956452|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956453|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956454|NCT01749969|Dexamethasone|dexamethasone|mesh-list
83956455|NCT01749969|Lenalidomide|lenalidomide|mesh-list
83956456|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956457|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
83956458|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
83956459|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956460|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956461|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83956462|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
83956463|NCT01749969|Hormones|hormones|mesh-ancestor
83956464|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83956465|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83956466|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956467|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
83956468|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956469|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956470|NCT01749969|Growth Substances|growth substances|mesh-ancestor
83956471|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956472|NCT01669915|Vitamin D|vitamin d|mesh-list
83956473|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
83956474|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
83956475|NCT01669915|Vitamins|vitamins|mesh-list
83956476|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
83956477|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956478|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83956479|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83956480|NCT01653223|Simvastatin|simvastatin|mesh-list
83956481|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83956482|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83956483|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
83956484|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956485|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83956486|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83956487|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956488|NCT01549587|Listerine|listerine|mesh-list
83956489|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
83956490|NCT01549587|Fluorides|fluorides|mesh-list
83956491|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
83956492|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
83956493|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
83956494|NCT01549587|Protective Agents|protective agents|mesh-ancestor
83956495|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956496|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83956497|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956498|NCT01356290|Cytarabine|cytarabine|mesh-list
83956499|NCT01356290|Thalidomide|thalidomide|mesh-list
83956500|NCT01356290|Celecoxib|celecoxib|mesh-list
83956501|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
83956502|NCT01356290|Bevacizumab|bevacizumab|mesh-list
83956503|NCT01356290|Etoposide|etoposide|mesh-list
83956504|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
83956505|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
83956506|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83956507|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
83956508|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956509|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956510|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83956511|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
83956512|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956513|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956514|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83956515|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956516|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956517|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956518|NCT01356290|Growth Substances|growth substances|mesh-ancestor
83956519|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956520|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83956521|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83956522|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956523|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956524|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83956525|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
83956526|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
83956527|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956528|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83956529|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83956530|NCT01356290|Analgesics|analgesics|mesh-ancestor
83956531|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
83956532|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956533|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956534|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83956535|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83956536|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
83956537|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83956538|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83956539|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83956540|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83956541|NCT01047540|Pritelivir|pritelivir|mesh-list
83956542|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
83956543|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956544|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956545|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956546|NCT00521222|Fluticasone|fluticasone|mesh-list
83956547|NCT00521222|Xhance|xhance|mesh-list
83956548|NCT00521222|Albuterol|albuterol|mesh-list
83956549|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83956550|NCT00521222|Ipratropium|ipratropium|mesh-list
83956551|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83956552|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956553|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83956554|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
83956555|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956556|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956557|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83956558|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
83956559|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83956560|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83956561|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83956562|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83956563|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83956564|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83956565|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956566|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956567|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
83956568|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83956569|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83956570|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
83956571|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
83956572|NCT00521222|Hormones|hormones|mesh-ancestor
83956573|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83956574|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
83956575|NCT00378482|Tremelimumab|tremelimumab|mesh-list
83956576|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956577|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83956578|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
83956579|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
83956580|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956581|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956582|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956583|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956584|NCT00195091|Growth Substances|growth substances|mesh-ancestor
83956585|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956586|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956587|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956588|NCT00545012|Levetiracetam|levetiracetam|mesh-list
83956589|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
83956590|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
83956591|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
83956592|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83956593|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956594|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
83956595|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83956596|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956597|NCT00545246|Docetaxel|docetaxel|mesh-list
83956598|NCT00545246|Aflibercept|aflibercept|mesh-list
83956599|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956600|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
83956601|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956602|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
83956603|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956604|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956605|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956606|NCT00545246|Growth Substances|growth substances|mesh-ancestor
83956607|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956608|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956609|NCT03456401|Sorafenib|sorafenib|mesh-list
83956610|NCT03456401|Sunitinib|sunitinib|mesh-list
83956611|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956612|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83956613|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956614|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956615|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956616|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956617|NCT03456401|Growth Substances|growth substances|mesh-ancestor
83956618|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956619|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956620|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
83956621|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83956622|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956623|NCT04646694|Ketamine|ketamine|mesh-list
83956624|NCT04646694|Analgesics|analgesics|mesh-ancestor
83956625|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
83956626|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956627|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956628|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83956629|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83956630|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
83956631|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
83956632|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956633|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83956634|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83956635|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956636|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956637|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
83956638|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
83956639|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956640|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83956641|NCT00545558|Tenofovir|tenofovir|mesh-list
83956642|NCT00545558|Emtricitabine|emtricitabine|mesh-list
83956643|NCT00545558|Efavirenz|efavirenz|mesh-list
83956644|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83956645|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
83956646|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956647|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83956648|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83956649|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956650|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956651|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83956652|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83956653|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83956654|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83956655|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83956656|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83956657|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83956658|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83956659|NCT04684667|Propranolol|propranolol|mesh-list
83956660|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83956661|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83956662|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
83956663|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956664|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956665|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956666|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83956667|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83956668|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956669|NCT00545675|Valproic Acid|valproic acid|mesh-list
83956670|NCT00545675|Aripiprazole|aripiprazole|mesh-list
83956671|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
83956672|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83956673|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83956674|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83956675|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956676|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956677|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
83956678|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
83956679|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956680|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956681|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83956682|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83956683|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
83956684|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83956685|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83956686|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83956687|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83956688|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
83956689|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956690|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
83956691|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
83956692|NCT00545831|Taurolidine|taurolidine|mesh-list
83956693|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956694|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83956695|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956696|NCT00545870|Bevacizumab|bevacizumab|mesh-list
83956697|NCT00545870|Ranibizumab|ranibizumab|mesh-list
83956698|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83956699|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956700|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83956701|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83956702|NCT00545870|Growth Substances|growth substances|mesh-ancestor
83956703|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956704|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
83956705|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
83956706|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83956707|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956708|NCT04645914|Nicotine|nicotine|mesh-list
83956709|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83956710|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
83956711|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956712|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956713|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83956714|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83956715|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
83956716|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956717|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956718|NCT00546065|Esomeprazole|esomeprazole|mesh-list
83956719|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83956720|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83956721|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83956722|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956723|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956724|NCT00546143|Omalizumab|omalizumab|mesh-list
83956725|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83956726|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83956727|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83956728|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
83956729|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
83956730|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956731|NCT00560079|Allopurinol|allopurinol|mesh-list
83956732|NCT00560079|Dipyridamole|dipyridamole|mesh-list
83956733|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
83956734|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956735|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956736|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
83956737|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956738|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83956739|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
83956740|NCT00560079|Protective Agents|protective agents|mesh-ancestor
83956741|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956742|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83956743|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83956744|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956745|NCT00560118|Fotemustine|fotemustine|mesh-list
83956746|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956747|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83956748|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83956749|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83956750|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83956751|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956752|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956753|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956754|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83956755|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
83956756|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83956757|NCT00546533|Etanercept|etanercept|mesh-list
83956758|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83956759|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83956760|NCT00546533|Analgesics|analgesics|mesh-ancestor
83956761|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
83956762|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956763|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956764|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956765|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956766|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83956767|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83956768|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
83956769|NCT00558480|Vitamins|vitamins|mesh-list
83956770|NCT00558480|Vitamin A|vitamin a|mesh-list
83956771|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
83956772|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
83956773|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956774|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
83956775|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956776|NCT00558480|Protective Agents|protective agents|mesh-ancestor
83956777|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83956778|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956779|NCT00546650|Sumatriptan|sumatriptan|mesh-list
83956780|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83956781|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83956782|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83956783|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
83956784|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956785|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956786|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956787|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83956788|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83956789|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83956790|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83956791|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956792|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83956793|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956794|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83956795|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
83956796|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83956797|NCT00547001|Estradiol|estradiol|mesh-list
83956798|NCT00547001|Estrogens|estrogens|mesh-ancestor
83956799|NCT00547001|Hormones|hormones|mesh-ancestor
83956800|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83956801|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956802|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
83956803|NCT00547352|Tadalafil|tadalafil|mesh-list
83956804|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956805|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83956806|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83956807|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956808|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956809|NCT00547352|Urological Agents|urological agents|mesh-ancestor
83956810|NCT00547508|Tadalafil|tadalafil|mesh-list
83956811|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956812|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83956813|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83956814|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956815|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956816|NCT00547508|Urological Agents|urological agents|mesh-ancestor
83956817|NCT00560274|Ribavirin|ribavirin|mesh-list
83956818|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83956819|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
83956820|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956821|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
83956822|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956823|NCT00547547|Selenium|selenium|mesh-list
83956824|NCT00547547|Capecitabine|capecitabine|mesh-list
83956825|NCT00547547|Irinotecan|irinotecan|mesh-list
83956826|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83956827|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
83956828|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956829|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956830|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83956831|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956832|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956833|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
83956834|NCT00547547|Protective Agents|protective agents|mesh-ancestor
83956835|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956836|NCT00547547|Trace Elements|trace elements|mesh-ancestor
83956837|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
83956838|NCT00547625|Tadalafil|tadalafil|mesh-list
83956839|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956840|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83956841|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83956842|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956843|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956844|NCT00547625|Urological Agents|urological agents|mesh-ancestor
83956845|NCT00547664|Morphine|morphine|mesh-list
83196122|NCT03258931|Crenolanib|crenolanib|mesh-list
83956846|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83956847|NCT00547664|Narcotics|narcotics|mesh-ancestor
83956848|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956849|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956850|NCT00547664|Analgesics|analgesics|mesh-ancestor
83956851|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
83956852|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956853|NCT00560430|Telmisartan|telmisartan|mesh-list
83956854|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83956855|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83956856|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83956857|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956858|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
83956859|NCT00560547|Hematinics|hematinics|mesh-ancestor
83956860|NCT04636125|Doxycycline|doxycycline|mesh-list
83956861|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83956862|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83956863|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
83956864|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83956865|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83956866|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83956867|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83956868|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956869|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83956870|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83956871|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83956872|NCT00548288|Pamidronate|pamidronate|mesh-list
83956873|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83956874|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956875|NCT04644354|Nifedipine|nifedipine|mesh-list
83956876|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83956877|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83956878|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956879|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83956880|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956881|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956882|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
83956883|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83956884|NCT00548483|Dexamethasone|dexamethasone|mesh-list
83956885|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956886|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
83956887|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
83956888|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956889|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956890|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83956891|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
83956892|NCT00548483|Hormones|hormones|mesh-ancestor
83956893|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83956894|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83956895|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956896|NCT04635852|Fentanyl|fentanyl|mesh-list
83956897|NCT04635852|Morphine|morphine|mesh-list
83956898|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83956899|NCT04635852|Narcotics|narcotics|mesh-ancestor
83956900|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956901|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956902|NCT04635852|Analgesics|analgesics|mesh-ancestor
83956903|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
83956904|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956905|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83956906|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83956907|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
83956908|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
83956909|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
83956910|NCT00548561|Razoxane|razoxane|mesh-list
83956911|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83956912|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83956913|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83956914|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83956915|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956916|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956917|NCT00548561|Protective Agents|protective agents|mesh-ancestor
83956918|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956919|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
83956920|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
83196200|NCT04505657|Analgesics|analgesics|mesh-ancestor
83956921|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
83956922|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
83956923|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
83956924|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956925|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956926|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
83956927|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956928|NCT00548678|Aspirin|aspirin|mesh-list
83956929|NCT00548678|Diclofenac|diclofenac|mesh-list
83956930|NCT00548678|Ketorolac|ketorolac|mesh-list
83956931|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83956932|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83956933|NCT00548678|Analgesics|analgesics|mesh-ancestor
83956934|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
83956935|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956936|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956937|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956938|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956939|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83956940|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83956941|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956942|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83956943|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83956944|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956945|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
83956946|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
83956947|NCT00548834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83956948|NCT00548834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956949|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83956950|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
83956951|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956952|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83956953|NCT04684199|Melatonin|melatonin|mesh-list
83956954|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
83956955|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956956|NCT04684199|Protective Agents|protective agents|mesh-ancestor
83956957|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956958|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83956959|NCT00560586|Budesonide|budesonide|mesh-list
83956960|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956961|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83956962|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
83956963|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956964|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956965|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83956966|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
83956967|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
83956968|NCT00560586|Hormones|hormones|mesh-ancestor
83956969|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83956970|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
83956971|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83956972|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83956973|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956974|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83956975|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956976|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83956977|NCT00549107|Simendan|simendan|mesh-list
83956978|NCT00549107|Milrinone|milrinone|mesh-list
83956979|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83956980|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
83956981|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83956982|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83956983|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83956984|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83956985|NCT00549107|Protective Agents|protective agents|mesh-ancestor
83956986|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956987|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83956988|NCT00549146|Fluticasone|fluticasone|mesh-list
83956989|NCT00549146|Xhance|xhance|mesh-list
83956990|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83956991|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83956992|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83956993|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83956994|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
83196272|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
83956995|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83956996|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83956997|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83956998|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
83956999|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
83957000|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83957001|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83957002|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83957003|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83957004|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957005|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957006|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957007|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
83957008|NCT00549146|Hormones|hormones|mesh-ancestor
83957009|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957010|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
83957011|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
83957012|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83957013|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957014|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957015|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
83957016|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957017|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957018|NCT00549419|Dobutamine|dobutamine|mesh-list
83957019|NCT00549419|Norepinephrine|norepinephrine|mesh-list
83957020|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83957021|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83957022|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957023|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957024|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957025|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957026|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
83957027|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
83957028|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957029|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83957030|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83957031|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83957032|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83957033|NCT00549419|Protective Agents|protective agents|mesh-ancestor
83957034|NCT04643691|Losartan|losartan|mesh-list
83957035|NCT04643691|Spironolactone|spironolactone|mesh-list
83957036|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83957037|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83957038|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83957039|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83957040|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957041|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83957042|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
83957043|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957044|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957045|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83957046|NCT04643691|Diuretics|diuretics|mesh-ancestor
83957047|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
83957048|NCT03455972|Immunomodulating Agents|immunomodulating agents|mesh-list
83957049|NCT03455972|Immunologic Factors|immunologic factors|mesh-ancestor
83957050|NCT03455972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957051|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
83957052|NCT00549536|Calcium|calcium|mesh-list
83957053|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83957054|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957055|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83957056|NCT00549614|Acipimox|acipimox|mesh-list
83957057|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83957058|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
83957059|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957060|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83957061|NCT04923542|Hormones|hormones|mesh-list
83957062|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957063|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957064|NCT00559026|Dacarbazine|dacarbazine|mesh-list
83957065|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83957066|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
83957067|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957068|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957069|NCT00549887|Insulin|insulin|mesh-list
83957070|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83957071|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83957072|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957073|NCT00549926|Atorvastatin|atorvastatin|mesh-list
83957074|NCT00549926|Pravastatin|pravastatin|mesh-list
83957075|NCT00549926|Pitavastatin|pitavastatin|mesh-list
83957076|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83957077|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83957078|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
83957079|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957080|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83957081|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83957082|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957083|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
83957084|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83957085|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957086|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957087|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83957088|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957089|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83957090|NCT00550004|Gemcitabine|gemcitabine|mesh-list
83957091|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957092|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
83957093|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957094|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957095|NCT04634721|Bupivacaine|bupivacaine|mesh-list
83957096|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
83957097|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
83957098|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957099|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957100|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
83957101|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957102|NCT00550160|Artesunate|artesunate|mesh-list
83957103|NCT00550160|Amodiaquine|amodiaquine|mesh-list
83957104|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
83957105|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83957106|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83957107|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957108|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957109|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
83957110|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
83957111|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83957112|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
83957113|NCT00550199|Gemcitabine|gemcitabine|mesh-list
83957114|NCT00550199|Panobinostat|panobinostat|mesh-list
83957115|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957116|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
83957117|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957118|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957119|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83957120|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957121|NCT04643301|Liraglutide|liraglutide|mesh-list
83957122|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83957123|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957124|NCT04643301|Incretins|incretins|mesh-ancestor
83957125|NCT04643301|Hormones|hormones|mesh-ancestor
83957126|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957127|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
83957128|NCT00550433|Estrogens|estrogens|mesh-list
83957129|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83957130|NCT00550433|Hormones|hormones|mesh-ancestor
83957131|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957132|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957133|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83957134|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83957135|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
83957136|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83957137|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83957138|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957139|NCT04634058|Antibodies|antibodies|mesh-list
83957140|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
83957141|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
83957142|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957143|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83957144|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83957145|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957146|NCT00560820|Deferasirox|deferasirox|mesh-list
83957147|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83957148|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
83957149|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
83957150|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957151|NCT00550784|Paclitaxel|paclitaxel|mesh-list
83957152|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
83957153|NCT00550784|Melphalan|melphalan|mesh-list
83957154|NCT00550784|Topotecan|topotecan|mesh-list
83957155|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83957156|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957157|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
83957158|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
83957159|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
83957160|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957161|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83957162|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
83957163|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957164|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957165|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83957166|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
83957167|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83957168|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83957169|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83957170|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957171|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
83957172|NCT00550901|Razoxane|razoxane|mesh-list
83957173|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957174|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83957175|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83957176|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83957177|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957178|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957179|NCT00550901|Protective Agents|protective agents|mesh-ancestor
83957180|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957181|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83957182|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83957183|NCT04633746|Endostatins|endostatins|mesh-list
83957184|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957185|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83957186|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83957187|NCT04633746|Growth Substances|growth substances|mesh-ancestor
83957188|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957189|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
83957190|NCT00551018|Tenofovir|tenofovir|mesh-list
83957191|NCT00551018|Emtricitabine|emtricitabine|mesh-list
83957192|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
83957193|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957194|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83957195|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83957196|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957197|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957198|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83957199|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83957200|NCT00551096|Gemcitabine|gemcitabine|mesh-list
83957201|NCT00551096|Capecitabine|capecitabine|mesh-list
83957202|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957203|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
83957204|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957205|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957206|NCT00551252|Gemcitabine|gemcitabine|mesh-list
83957207|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
83957208|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957209|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
83957210|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957211|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957212|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83957213|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957214|NCT01125761|Clemastine|clemastine|mesh-list
83957215|NCT01125761|Dexamethasone|dexamethasone|mesh-list
83957216|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
83957217|NCT01125761|BB 1101|bb 1101|mesh-list
83196501|NCT03249259|Choline|choline|mesh-list
83957218|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957219|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
83957220|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
83957221|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957222|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957223|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83957224|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
83957225|NCT01125761|Hormones|hormones|mesh-ancestor
83957226|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957227|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83957228|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957229|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
83957230|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957231|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957232|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
83957233|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83957234|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83957235|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
83957236|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
83957237|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957238|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83957239|NCT00871013|Thalidomide|thalidomide|mesh-list
83957240|NCT00871013|Dexamethasone|dexamethasone|mesh-list
83957241|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
83957242|NCT00871013|Melphalan|melphalan|mesh-list
83957243|NCT00871013|Doxorubicin|doxorubicin|mesh-list
83957244|NCT00871013|Etoposide|etoposide|mesh-list
83957245|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83957246|NCT00871013|Bortezomib|bortezomib|mesh-list
83957247|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83957248|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
83957249|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957250|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957251|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83957252|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
83957253|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957254|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957255|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83957256|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957257|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
83957258|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
83957259|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957260|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83957261|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
83957262|NCT00871013|Hormones|hormones|mesh-ancestor
83957263|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957264|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83957265|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83957266|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83957267|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83957268|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957269|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83957270|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
83957271|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83957272|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957273|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83957274|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83957275|NCT00871013|Growth Substances|growth substances|mesh-ancestor
83957276|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
83957277|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
83957278|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
83957279|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957280|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957281|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957282|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
83957283|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
83957284|NCT05408312|Vaccines|vaccines|mesh-list
83957285|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
83957286|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957287|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83957288|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
83957289|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196582|NCT04502771|Clotrimazole|clotrimazole|mesh-list
83957290|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
83957291|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83957292|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957293|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
83957294|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957295|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
83957296|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957297|NCT00553124|Vitamin E|vitamin e|mesh-list
83957298|NCT00553124|Selenium|selenium|mesh-list
83957299|NCT00553124|Vitamins|vitamins|mesh-ancestor
83957300|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
83957301|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957302|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
83957303|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957304|NCT00553124|Protective Agents|protective agents|mesh-ancestor
83957305|NCT00553124|Trace Elements|trace elements|mesh-ancestor
83957306|NCT04640181|Enoxaparin|enoxaparin|mesh-list
83957307|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
83957308|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83957309|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
83957310|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83957311|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
83957312|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957313|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957314|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
83957315|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83957316|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83957317|NCT05317364|Estradiol|estradiol|mesh-list
83957318|NCT05317364|Estrogens|estrogens|mesh-ancestor
83957319|NCT05317364|Hormones|hormones|mesh-ancestor
83957320|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957321|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957322|NCT00559455|Leucovorin|leucovorin|mesh-list
83957323|NCT00559455|Fluorouracil|fluorouracil|mesh-list
83957324|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
83957325|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
83957326|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957327|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957328|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957329|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83957330|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
83957331|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957332|NCT00559455|Antidotes|antidotes|mesh-ancestor
83957333|NCT00559455|Protective Agents|protective agents|mesh-ancestor
83957334|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
83957335|NCT00559455|Vitamins|vitamins|mesh-ancestor
83957336|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
83957337|NCT00559494|Minocycline|minocycline|mesh-list
83957338|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83957339|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957340|NCT05209412|Aspirin|aspirin|mesh-list
83957341|NCT05209412|Paclitaxel|paclitaxel|mesh-list
83957342|NCT05209412|Clopidogrel|clopidogrel|mesh-list
83957343|NCT05209412|Ticagrelor|ticagrelor|mesh-list
83957344|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83957345|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957346|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
83957347|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
83957348|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
83957349|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957350|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83957351|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957352|NCT05209412|Analgesics|analgesics|mesh-ancestor
83957353|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
83957354|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957355|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957356|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957357|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957358|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83957359|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83957360|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83957361|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83957362|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957363|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
83957364|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83957365|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83957366|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83957367|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
83957368|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957369|NCT05186675|Epinephrine|epinephrine|mesh-list
83957370|NCT05186675|Racepinephrine|racepinephrine|mesh-list
83957371|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
83957372|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83957373|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83957374|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957375|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957376|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957377|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957378|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83957379|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83957380|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
83957381|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957382|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83957383|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
83957384|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
83957385|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
83957386|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83957387|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83957388|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957389|NCT04639362|Venetoclax|venetoclax|mesh-list
83957390|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
83957391|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957392|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83957393|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83957394|NCT04639284|Antibodies|antibodies|mesh-list
83957395|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
83957396|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957397|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83957398|NCT04639284|Growth Substances|growth substances|mesh-ancestor
83957399|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
83957400|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957401|NCT00559689|Budesonide|budesonide|mesh-list
83957402|NCT00559689|Beclomethasone|beclomethasone|mesh-list
83957403|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957404|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83957405|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
83957406|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957407|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957408|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83957409|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
83957410|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
83957411|NCT00559689|Hormones|hormones|mesh-ancestor
83957412|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957413|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83957414|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957415|NCT04629027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83957416|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957417|NCT00561288|Acetaminophen|acetaminophen|mesh-list
83957418|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957419|NCT00561288|Analgesics|analgesics|mesh-ancestor
83957420|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
83957421|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957422|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957423|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
83957424|NCT00561327|Losartan|losartan|mesh-list
83957425|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83957426|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83957427|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83957428|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83957429|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957430|NCT00561522|Capecitabine|capecitabine|mesh-list
83957431|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957432|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
83957433|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957434|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957435|NCT03454620|Irinotecan|irinotecan|mesh-list
83957436|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83957437|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83957438|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957439|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957440|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957441|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
83957442|NCT04628559|Ketamine|ketamine|mesh-list
83957443|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83957444|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957445|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957446|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957447|NCT04628559|Analgesics|analgesics|mesh-ancestor
83957448|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
83957449|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957450|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83957451|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83957452|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83957453|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957454|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957455|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957456|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83957457|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83957458|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
83957459|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
83957460|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83957461|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83957462|NCT04683341|Tenofovir|tenofovir|mesh-list
83957463|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
83957464|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957465|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83957466|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83957467|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957468|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957469|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83957470|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83957471|NCT04628676|Epinephrine|epinephrine|mesh-list
83957472|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
83957473|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
83957474|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83957475|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83957476|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957477|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
83957478|NCT04628676|Coagulants|coagulants|mesh-ancestor
83957479|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83957480|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83957481|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957482|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957483|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957484|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83957485|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83957486|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
83957487|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957488|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83957489|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
83957490|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
83957491|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
83957492|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83957493|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
83957494|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83957495|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83957496|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957497|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83957498|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83957499|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957500|NCT04628325|Furosemide|furosemide|mesh-list
83957501|NCT04628325|Diuretics|diuretics|mesh-ancestor
83957502|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
83957503|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957504|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83957505|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957506|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957507|NCT04657497|Camostat|camostat|mesh-list
83957508|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
83957509|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957510|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957511|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83957512|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83957513|NCT01214434|Emollients|emollients|mesh-list
83957514|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
83957515|NCT04971356|Aspirin|aspirin|mesh-list
83957516|NCT04971356|Ticagrelor|ticagrelor|mesh-list
83957517|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83957518|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957519|NCT04971356|Analgesics|analgesics|mesh-ancestor
83957520|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
83196813|NCT03345797|Hormones|hormones|mesh-ancestor
83957521|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957522|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957523|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957524|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957525|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83957526|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83957527|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957528|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83957529|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83957530|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957531|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
83957532|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83957533|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83957534|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83957535|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
83957536|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957537|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
83957538|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83957539|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957540|NCT01214239|Linagliptin|linagliptin|mesh-list
83957541|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83957542|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957543|NCT01214239|Incretins|incretins|mesh-ancestor
83957544|NCT01214239|Hormones|hormones|mesh-ancestor
83957545|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957546|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83957547|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
83957548|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957549|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957550|NCT01214044|Dexetimide|dexetimide|mesh-list
83957551|NCT01214044|Citalopram|citalopram|mesh-list
83957552|NCT01214044|Escitalopram|escitalopram|mesh-list
83957553|NCT01214044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83957554|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83957555|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957556|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957557|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957558|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
83957559|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957560|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83957561|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83957562|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
83957563|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
83957564|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957565|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83957566|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83957567|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
83957568|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83957569|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
83957570|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83957571|NCT01213966|Artefenomel|artefenomel|mesh-list
83957572|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
83957573|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83957574|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83957575|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957576|NCT01213264|Anesthetics|anesthetics|mesh-list
83957577|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196871|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196872|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196873|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
83196874|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196875|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83196876|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
83196877|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83196878|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196879|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196880|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83196881|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
83196882|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83196883|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
83196884|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83196885|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83196887|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
83957578|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957579|NCT04657107|Ketamine|ketamine|mesh-list
83957580|NCT04657107|Esketamine|esketamine|mesh-list
83957581|NCT04657107|Analgesics|analgesics|mesh-ancestor
83957582|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
83957583|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957584|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957585|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83957586|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83957587|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
83957588|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
83957589|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957590|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83957591|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83957592|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957593|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957594|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
83957595|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83957596|NCT00561717|Cetirizine|cetirizine|mesh-list
83957597|NCT00561717|Loratadine|loratadine|mesh-list
83957598|NCT00561717|Azelastine|azelastine|mesh-list
83957599|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83957600|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83957601|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83957602|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
83957603|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
83957604|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957605|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957606|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957607|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
83957608|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83957609|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83957610|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
83957611|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957612|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83957613|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
83957614|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83957615|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957616|NCT00561756|Vaccines|vaccines|mesh-list
83957617|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
83957618|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957619|NCT04863950|Lomustine|lomustine|mesh-list
83957620|NCT04863950|Imipramine|imipramine|mesh-list
83957621|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83957622|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
83957623|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957624|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957625|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83957626|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
83957627|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83957628|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83957629|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83957630|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957631|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957632|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957633|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957634|NCT04824911|Aspirin|aspirin|mesh-list
83957635|NCT04824911|Clopidogrel|clopidogrel|mesh-list
83957636|NCT04824911|Atorvastatin|atorvastatin|mesh-list
83957637|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83957638|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83957639|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957640|NCT04824911|Analgesics|analgesics|mesh-ancestor
83957641|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
83957642|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957643|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957644|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957645|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957646|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83957647|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83957648|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957649|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83957650|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83957651|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957652|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
83957653|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83957654|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83957656|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83957657|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83957658|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83957659|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83957660|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83957661|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
83957662|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957663|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
83957664|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83957665|NCT04683146|Propranolol|propranolol|mesh-list
83957666|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83957667|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957668|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
83957669|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
83957670|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83957671|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83957672|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957673|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957674|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957675|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957676|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83957677|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83957678|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
83957679|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
83957680|NCT04816877|Narcotics|narcotics|mesh-ancestor
83957681|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957682|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957683|NCT04816877|Analgesics|analgesics|mesh-ancestor
83957684|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
83957685|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957686|NCT04800302|Morphine|morphine|mesh-list
83957687|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83957688|NCT04800302|Narcotics|narcotics|mesh-ancestor
83957689|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957690|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957691|NCT04800302|Analgesics|analgesics|mesh-ancestor
83957692|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
83957693|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957694|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
83957695|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83957696|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
83957697|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957698|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
83957699|NCT04711304|Protective Agents|protective agents|mesh-ancestor
83957700|NCT04710719|Triamcinolone|triamcinolone|mesh-list
83957701|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83957702|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83957703|NCT04710719|Fluorouracil|fluorouracil|mesh-list
83957704|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83957705|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
83957706|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957707|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957708|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957709|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83957710|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
83957711|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957712|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957713|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
83957714|NCT04710719|Hormones|hormones|mesh-ancestor
83957715|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957716|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957717|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
83957718|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83957719|NCT04627779|Analgesics|analgesics|mesh-ancestor
83957720|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
83957721|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957722|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957723|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83957724|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957725|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957726|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197040|NCT03235141|Azithromycin|azithromycin|mesh-list
83957727|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83957728|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957729|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957730|NCT04537598|Morphine|morphine|mesh-list
83957731|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83957732|NCT04537598|Narcotics|narcotics|mesh-ancestor
83957733|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957734|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957735|NCT04537598|Analgesics|analgesics|mesh-ancestor
83957736|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
83957737|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957738|NCT04627467|Chloroquine|chloroquine|mesh-list
83957739|NCT04627467|Amebicides|amebicides|mesh-ancestor
83957740|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83957741|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83957742|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957743|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
83957744|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957745|NCT04627623|Antibodies|antibodies|mesh-list
83957746|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
83957747|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
83957748|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957749|NCT04656249|Lenvatinib|lenvatinib|mesh-list
83957750|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957751|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83957752|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957753|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957754|NCT04481555|Azithromycin|azithromycin|mesh-list
83957755|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83957756|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957757|NCT04682795|Insulin|insulin|mesh-list
83957758|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83957759|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957760|NCT04655664|Vitamin D|vitamin d|mesh-list
83957761|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
83957762|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
83957763|NCT04655664|Vitamins|vitamins|mesh-list
83957764|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
83957765|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957766|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83957767|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83957768|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83957769|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83957770|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
83957771|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957772|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957773|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83957774|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
83957775|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
83957776|NCT04655508|Hormones|hormones|mesh-ancestor
83957777|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957778|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
83957779|NCT04655040|Caffeine|caffeine|mesh-list
83957780|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83957781|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957782|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83957783|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957784|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957785|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83957786|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83957787|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
83957788|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957789|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
83957790|NCT04626765|Fludarabine|fludarabine|mesh-list
83957791|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83957792|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
83957793|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957794|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957795|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83957796|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
83957797|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957798|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957799|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83957800|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
83197100|NCT03237637|Propranolol|propranolol|mesh-list
83957801|NCT04626726|Fludarabine|fludarabine|mesh-list
83957802|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83957803|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
83957804|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957805|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957806|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83957807|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
83957808|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957809|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957810|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83957811|NCT04654962|Anesthetics|anesthetics|mesh-list
83957812|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957813|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957814|NCT04626414|Ferric maltol|ferric maltol|mesh-list
83957815|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
83957816|NCT04626414|Hematinics|hematinics|mesh-ancestor
83957817|NCT04654416|Colchicine|colchicine|mesh-list
83957818|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
83957819|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957820|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
83957821|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
83957822|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
83957823|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957824|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957825|NCT02906150|Cisplatin|cisplatin|mesh-list
83957826|NCT02906150|Carboplatin|carboplatin|mesh-list
83957827|NCT02906150|Pemetrexed|pemetrexed|mesh-list
83957828|NCT02906150|Thymalfasin|thymalfasin|mesh-list
83957829|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957830|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957831|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957832|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83957833|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83957834|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83957835|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
83957836|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957837|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
83957838|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83957839|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957840|NCT02905994|Cytarabine|cytarabine|mesh-list
83957841|NCT02905994|Idarubicin|idarubicin|mesh-list
83957842|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83957843|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
83957844|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957845|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83957846|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
83957847|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957848|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83957849|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
83957850|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957851|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83957852|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83957853|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83957854|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957855|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83957856|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
83957857|NCT02905682|Coagulants|coagulants|mesh-ancestor
83957858|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83957859|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
83957860|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957861|NCT04626258|Fluconazole|fluconazole|mesh-list
83957862|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
83957863|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957864|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83957865|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83957866|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957867|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957868|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83957869|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
83957870|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83957871|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957872|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83957873|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83957874|NCT04681820|Flumatinib|flumatinib|mesh-list
83957875|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83957876|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957877|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957879|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83957880|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83957881|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957882|NCT04626063|Analgesics|analgesics|mesh-ancestor
83957883|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
83957884|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957885|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957886|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
83957887|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957888|NCT04625985|Metformin|metformin|mesh-list
83957889|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83957890|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957891|NCT02905760|Furosemide|furosemide|mesh-list
83957892|NCT02905760|Diuretics|diuretics|mesh-list
83957893|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
83957894|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957895|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83957896|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957897|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957898|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
83957899|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83957900|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957901|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
83957902|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83957903|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83957904|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83957905|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
83957906|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
83957907|NCT04654026|Aspirin|aspirin|mesh-list
83957908|NCT04654026|Clopidogrel|clopidogrel|mesh-list
83957909|NCT04654026|Ticagrelor|ticagrelor|mesh-list
83957910|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83957911|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957912|NCT04654026|Analgesics|analgesics|mesh-ancestor
83957913|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
83957914|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957915|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957916|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957917|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957918|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83957919|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83957920|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957921|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83957922|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83957923|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957924|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
83957925|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83957926|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83957927|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83957928|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
83957929|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957930|NCT04625595|Methyldopa|methyldopa|mesh-list
83957931|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83957932|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
83957933|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
83957934|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957935|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957936|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83957937|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83957938|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83957939|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957940|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957941|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957942|NCT02905058|Ketoprofen|ketoprofen|mesh-list
83957943|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83957944|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83957945|NCT02905058|Analgesics|analgesics|mesh-ancestor
83957946|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
83957947|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957948|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957949|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957950|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83957951|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83957952|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83957953|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957954|NCT04653792|Pregabalin|pregabalin|mesh-list
83957955|NCT04653792|Analgesics|analgesics|mesh-ancestor
83957956|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
83957957|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957958|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957959|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
83957960|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83957961|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957962|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957963|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83957964|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83957965|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83957966|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83957967|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83957968|NCT00557700|Bromides|bromides|mesh-list
83957969|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
83957970|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83957971|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
83957972|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83957973|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957974|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83957975|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
83957976|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
83957977|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83957978|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
83957979|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957980|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957981|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
83957982|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
83957983|NCT00557739|Nortriptyline|nortriptyline|mesh-list
83957984|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83957985|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
83957986|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83957987|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83957988|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
83957989|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83957990|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83957991|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83957992|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83957993|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83957994|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
83957995|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83957996|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83957997|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
83957998|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83957999|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
83958000|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83958001|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958002|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83958003|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83958004|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83958005|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
83958006|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
83958007|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83958008|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83958009|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958010|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958011|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958012|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958013|NCT04652739|Prednisolone|prednisolone|mesh-list
83958014|NCT04652739|Lycopene|lycopene|mesh-list
83958015|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958016|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
83958017|NCT04652739|Hormones|hormones|mesh-ancestor
83958018|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958019|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958020|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83958021|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958022|NCT04652739|Protective Agents|protective agents|mesh-ancestor
83958023|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
83958024|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958025|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83958026|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83958027|NCT02903498|Tegafur|tegafur|mesh-list
83958028|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83958029|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
83958030|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958031|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958032|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
83958033|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83958034|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958035|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958036|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958037|NCT04652427|Analgesics|analgesics|mesh-ancestor
83958038|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
83958039|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958040|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83958041|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83958042|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83958043|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958044|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958045|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958046|NCT04623879|Ivacaftor|ivacaftor|mesh-list
83958047|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83958048|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83958049|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958050|NCT02903537|Vitamin D|vitamin d|mesh-list
83958051|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
83958052|NCT02903537|Interferons|interferons|mesh-list
83958053|NCT02903537|Interferon-beta|interferon-beta|mesh-list
83958054|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958055|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
83958056|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958057|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
83958058|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958059|NCT02903537|Vitamins|vitamins|mesh-ancestor
83958060|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
83958061|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83958062|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83958063|NCT00562068|Prednisolone|prednisolone|mesh-list
83958064|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
83958065|NCT00562068|Doxorubicin|doxorubicin|mesh-list
83958066|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83958067|NCT00562068|Vincristine|vincristine|mesh-list
83958068|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
83958069|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83958070|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
83958071|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958072|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958073|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83958074|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
83958075|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958076|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958077|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83958078|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83958079|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83958080|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83958081|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958082|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83958083|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
83958084|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
83958085|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
83958086|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958087|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
83958088|NCT00562068|Hormones|hormones|mesh-ancestor
83958089|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958090|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83958091|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83958092|NCT00562185|Carboplatin|carboplatin|mesh-list
83958093|NCT00562185|Doxorubicin|doxorubicin|mesh-list
83958094|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83958095|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958096|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83958097|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83958098|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83958099|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958100|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958101|NCT00562224|Abexinostat|abexinostat|mesh-list
83958102|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83958103|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958104|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958105|NCT02903069|Temozolomide|temozolomide|mesh-list
83958106|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83958107|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
83958108|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958109|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958110|NCT04623840|Tadalafil|tadalafil|mesh-list
83958111|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
83958112|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83958113|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83958114|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958115|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958116|NCT04623840|Urological Agents|urological agents|mesh-ancestor
83958117|NCT02902640|Trimethoprim|trimethoprim|mesh-list
83958118|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
83958119|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
83958120|NCT02902640|Guaifenesin|guaifenesin|mesh-list
83958121|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83958122|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83958123|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958124|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
83958125|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83958126|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83958127|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83958128|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958129|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958130|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83958131|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83958132|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83958133|NCT02902640|Expectorants|expectorants|mesh-ancestor
83958134|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
83958135|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83958136|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83958137|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958138|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958139|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958140|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
83958141|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83958142|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
83958143|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
83958144|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958145|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
83958146|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83958147|NCT04624893|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83958148|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
83958149|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83958150|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
83958151|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958152|NCT02902523|Tenofovir|tenofovir|mesh-list
83958153|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
83958154|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958155|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83958156|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83958157|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958158|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958159|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83958160|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83958161|NCT02902289|Ibuprofen|ibuprofen|mesh-list
83958162|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83958163|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958164|NCT02902289|Analgesics|analgesics|mesh-ancestor
83958165|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
83958166|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958167|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958168|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958169|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958170|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83958171|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958172|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958173|NCT02902133|Acetazolamide|acetazolamide|mesh-list
83958174|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
83958175|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83958176|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958177|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958178|NCT02902133|Diuretics|diuretics|mesh-ancestor
83958179|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
83958180|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958181|NCT04623021|Nafamostat|nafamostat|mesh-list
83958182|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83958183|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958184|NCT04623021|Analgesics|analgesics|mesh-ancestor
83958185|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
83958186|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958187|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958188|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958189|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958190|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
83958191|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
83958192|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958193|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958194|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83958195|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83958196|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83958197|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83958198|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
83958199|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83958200|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83958201|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958202|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958203|NCT02901977|Ramipril|ramipril|mesh-list
83958204|NCT02901977|Doxazosin|doxazosin|mesh-list
83958205|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83958206|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
83958207|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958208|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958209|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83958210|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83958211|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83958212|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83958213|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958214|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958215|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958216|NCT00553553|Morphine|morphine|mesh-list
83958217|NCT00553553|Remifentanil|remifentanil|mesh-list
83958218|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83958219|NCT00553553|Narcotics|narcotics|mesh-ancestor
83958220|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958221|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958222|NCT00553553|Analgesics|analgesics|mesh-ancestor
83958223|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
83958224|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958225|NCT04622982|Vitamin D|vitamin d|mesh-list
83958226|NCT04622982|Vitamins|vitamins|mesh-ancestor
83958227|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
83958228|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958229|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83958230|NCT04622202|Pregabalin|pregabalin|mesh-list
83958231|NCT04622202|Analgesics|analgesics|mesh-ancestor
83958232|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
83958233|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958234|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958235|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
83958236|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83958237|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83958238|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958239|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83958240|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83958241|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958242|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958243|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958244|NCT04622358|Rabeprazole|rabeprazole|mesh-list
83958245|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83958246|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83958247|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83958248|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958249|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958250|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83958251|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
83958252|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958253|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83958254|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958255|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958256|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958257|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
83958258|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83958259|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83958260|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958261|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
83958262|NCT04622397|Coagulants|coagulants|mesh-ancestor
83958263|NCT02901353|Sirolimus|sirolimus|mesh-list
83958264|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83958265|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958266|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83958267|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958268|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
83958269|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83958270|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
83958271|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958272|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
83958273|NCT04621461|Astringents|astringents|mesh-ancestor
83958274|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958275|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
83958276|NCT02901236|Antifibrotic Agents|antifibrotic agents|mesh-list
83958277|NCT02901236|Bevacizumab|bevacizumab|mesh-list
83958278|NCT02901236|Mitomycins|mitomycins|mesh-list
83958279|NCT02901236|Mitomycin|mitomycin|mesh-list
83958280|NCT02901236|Antimetabolites|antimetabolites|mesh-list
83958281|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83958282|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958283|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83958284|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83958285|NCT02901236|Growth Substances|growth substances|mesh-ancestor
83958286|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958287|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
83958288|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83958289|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
83958290|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958291|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83958292|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958293|NCT02901236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958294|NCT04621617|Midodrine|midodrine|mesh-list
83958295|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
83958296|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
83958297|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958298|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958299|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83958300|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83958301|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83958302|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83958303|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958304|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958305|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958306|NCT01212757|Thalidomide|thalidomide|mesh-list
83958307|NCT01212757|Apremilast|apremilast|mesh-list
83958308|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83958309|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958310|NCT01212757|Analgesics|analgesics|mesh-ancestor
83958311|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
83958312|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958313|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958314|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958315|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958316|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83958317|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83958318|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958319|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958320|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83958321|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
83958322|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
83958323|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83958324|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958325|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83958326|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83958327|NCT01212757|Growth Substances|growth substances|mesh-ancestor
83958328|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83958329|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958330|NCT00562419|Irinotecan|irinotecan|mesh-list
83958331|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83958332|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83958333|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958334|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958335|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958336|NCT00562458|Anastrozole|anastrozole|mesh-list
83958337|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83958338|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958339|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83958340|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83958341|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958342|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958343|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83958344|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
83958345|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958346|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958347|NCT02900729|Losartan|losartan|mesh-list
83958348|NCT02900729|Amlodipine|amlodipine|mesh-list
83958349|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83958350|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83958351|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83958352|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83958353|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958354|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83958355|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958356|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
83958357|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83958358|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83958359|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83958360|NCT02900729|Diuretics|diuretics|mesh-ancestor
83958361|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
83958362|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83958363|NCT04621227|Midazolam|midazolam|mesh-list
83958364|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83958365|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83958366|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83958367|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958368|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958369|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83958370|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958371|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958372|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83958373|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
83958374|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
83958375|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
83958376|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
83958377|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958378|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958379|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83958380|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83958381|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
83958382|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83958383|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83958384|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958385|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
83958386|NCT01190410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83958387|NCT01190410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958388|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83958389|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
83958390|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958391|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958392|NCT01190254|Asenapine|asenapine|mesh-list
83958393|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83958394|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958395|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958396|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958397|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958398|NCT04620954|Nivolumab|nivolumab|mesh-list
83958399|NCT04620954|Oregovomab|oregovomab|mesh-list
83958400|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83958401|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958402|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83958403|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958404|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83958405|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
83958406|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958407|NCT04621110|Fentanyl|fentanyl|mesh-list
83958408|NCT04621110|Midazolam|midazolam|mesh-list
83958409|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
83958410|NCT04621110|Ketamine|ketamine|mesh-list
83958411|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83958412|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958413|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958414|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958415|NCT04621110|Analgesics|analgesics|mesh-ancestor
83958416|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
83958417|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958418|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83958419|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83958420|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83958421|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958422|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958423|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958424|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83958425|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83958426|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
83958427|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
83958428|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83958429|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83958430|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83958431|NCT04621110|Narcotics|narcotics|mesh-ancestor
83958432|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83958433|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83958434|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958435|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958436|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
83958437|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
83958438|NCT04620720|Gabapentin|gabapentin|mesh-list
83958439|NCT04620720|Analgesics|analgesics|mesh-ancestor
83958440|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
83958441|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958442|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958443|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
83958444|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83958445|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958446|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958447|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958448|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83958449|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83958450|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958451|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958452|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
83958453|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83958454|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83958455|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958456|NCT02900417|Incretins|incretins|mesh-ancestor
83958457|NCT02900417|Hormones|hormones|mesh-ancestor
83958458|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958459|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83958460|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
83958461|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958462|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958463|NCT04620837|Tislelizumab|tislelizumab|mesh-list
83958464|NCT04620837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83958465|NCT04620837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958466|NCT04620018|Amoxicillin|amoxicillin|mesh-list
83958467|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83958468|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958469|NCT02900105|Letrozole|letrozole|mesh-list
83958470|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958471|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83958472|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83958473|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958474|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958475|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83958476|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
83958477|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958478|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958479|NCT04620213|Phentolamine|phentolamine|mesh-list
83958480|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83958481|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83958482|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83958483|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83958484|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958485|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958486|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958487|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958488|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83958489|NCT04619862|Gabapentin|gabapentin|mesh-list
83958490|NCT04619862|Analgesics|analgesics|mesh-ancestor
83958491|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
83958492|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958493|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958494|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
83958495|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83958496|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958497|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958498|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958499|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83958500|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83958501|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958502|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958503|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
83958504|NCT01190839|Infliximab|infliximab|mesh-list
83958505|NCT01190839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83958506|NCT01190839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958507|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
83958508|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83958509|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958510|NCT00562770|Valacyclovir|valacyclovir|mesh-list
83958511|NCT00562770|Valganciclovir|valganciclovir|mesh-list
83958512|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
83958513|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958514|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83958515|NCT05424692|Fluorouracil|fluorouracil|mesh-list
83958516|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
83958517|NCT05424692|Irinotecan|irinotecan|mesh-list
83958518|NCT05424692|Cetuximab|cetuximab|mesh-list
83958519|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
83958520|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958521|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83958522|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958523|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83958524|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
83958525|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958526|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83958527|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83958528|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958529|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83958530|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
83958531|NCT05424692|Vitamins|vitamins|mesh-ancestor
83958532|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
83958533|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
83958534|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83958535|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958536|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958537|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958538|NCT04618965|Analgesics|analgesics|mesh-ancestor
83958539|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
83958540|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958541|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83958542|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83958543|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83958544|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958545|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958546|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958547|NCT01190449|Ofatumumab|ofatumumab|mesh-list
83958548|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958549|NCT00562809|Irbesartan|irbesartan|mesh-list
83958550|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83958551|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83958552|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83958553|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958554|NCT01190098|Lacosamide|lacosamide|mesh-list
83958555|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
83958556|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83958557|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83958558|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83958559|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958560|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
83958561|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83958562|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958563|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
83958564|NCT04314739|Resveratrol|resveratrol|mesh-list
83958565|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
83958566|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958567|NCT04314739|Protective Agents|protective agents|mesh-ancestor
83958568|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958569|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958570|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83958571|NCT02885740|Adenosine|adenosine|mesh-list
83958572|NCT02885740|Analgesics|analgesics|mesh-ancestor
83958573|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
83958574|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958575|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958576|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83958577|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
83958578|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83958579|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
83958580|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
83958581|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958582|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958583|NCT05309785|Canagliflozin|canagliflozin|mesh-list
83958584|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83958585|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958586|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83958587|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958588|NCT01190020|Lubiprostone|lubiprostone|mesh-list
83958589|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83958590|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83958591|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958592|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83958593|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958594|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83958595|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958596|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958597|NCT01165996|Decitabine|decitabine|mesh-list
83958598|NCT01165996|Azacitidine|azacitidine|mesh-list
83958599|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83958600|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
83958601|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958602|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958603|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958604|NCT04619433|Carboplatin|carboplatin|mesh-list
83958605|NCT04619433|Pemetrexed|pemetrexed|mesh-list
83958606|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958607|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958608|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958609|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83958610|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83958611|NCT04619160|Propofol|propofol|mesh-list
83958612|NCT04619160|Sevoflurane|sevoflurane|mesh-list
83958613|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83958614|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958615|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958616|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83958617|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
83958618|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
83958619|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83958620|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83197927|NCT00707057|Ibuprofen|ibuprofen|mesh-list
83958621|NCT01165684|Insulin|insulin|mesh-list
83958622|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83958623|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
83958624|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
83958625|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83958626|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
83958627|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83958628|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958629|NCT01189201|Linagliptin|linagliptin|mesh-list
83958630|NCT01189201|Empagliflozin|empagliflozin|mesh-list
83958631|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83958632|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958633|NCT01189201|Incretins|incretins|mesh-ancestor
83958634|NCT01189201|Hormones|hormones|mesh-ancestor
83958635|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958636|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83958637|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
83958638|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958639|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958640|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83958641|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
83958642|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
83958643|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958644|NCT01188811|Protective Agents|protective agents|mesh-ancestor
83958645|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958646|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
83958647|NCT01188811|Vitamins|vitamins|mesh-ancestor
83958648|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
83958649|NCT01183234|Methylphenidate|methylphenidate|mesh-list
83958650|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83958651|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958652|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83958653|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83958654|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83958655|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958656|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
83958657|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958658|NCT04618497|Ketorolac|ketorolac|mesh-list
83958659|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
83958660|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83958661|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958662|NCT04618497|Analgesics|analgesics|mesh-ancestor
83958663|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
83958664|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958665|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958666|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958667|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958668|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83958669|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958670|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958671|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83958672|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
83958673|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
83958674|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958675|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83958676|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83958677|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83958678|NCT04679948|Midazolam|midazolam|mesh-list
83958679|NCT04679948|Caffeine|caffeine|mesh-list
83958680|NCT04679948|Omeprazole|omeprazole|mesh-list
83958681|NCT04679948|Warfarin|warfarin|mesh-list
83958682|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83958683|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83958684|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958685|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958686|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83958687|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83958688|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83958689|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83958690|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
83958691|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
83958692|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
83958693|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
83958694|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958695|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958696|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
83958697|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83958698|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83958699|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958700|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83958701|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83958702|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
83958703|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83958704|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83958705|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83958706|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
83958707|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83958708|NCT04618536|Protective Agents|protective agents|mesh-ancestor
83958709|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958710|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
83958711|NCT04651959|Favipiravir|favipiravir|mesh-list
83958712|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
83958713|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958714|NCT01165216|Paclitaxel|paclitaxel|mesh-list
83958715|NCT01165216|Carboplatin|carboplatin|mesh-list
83958716|NCT01165216|Ipilimumab|ipilimumab|mesh-list
83958717|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83958718|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958719|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
83958720|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
83958721|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
83958722|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958723|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83958724|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83958725|NCT04652115|Defibrotide|defibrotide|mesh-list
83958726|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83958727|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83958728|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958729|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83958730|NCT04618107|Anesthetics|anesthetics|mesh-list
83958731|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958732|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958733|NCT05423015|Levan|levan|mesh-list
83958734|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958735|NCT04618146|Morphine|morphine|mesh-list
83958736|NCT04618146|Bupivacaine|bupivacaine|mesh-list
83958737|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
83958738|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
83958739|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958740|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958741|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
83958742|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958743|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83958744|NCT04618146|Narcotics|narcotics|mesh-ancestor
83958745|NCT04618146|Analgesics|analgesics|mesh-ancestor
83958746|NCT04651842|Insulin|insulin|mesh-list
83958747|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83958748|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958749|NCT05421962|Fentanyl|fentanyl|mesh-list
83958750|NCT05421962|Ketamine|ketamine|mesh-list
83958751|NCT05421962|Analgesics|analgesics|mesh-ancestor
83958752|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
83958753|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958754|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958755|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83958756|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83958757|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
83958758|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
83958759|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958760|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83958761|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83958762|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958763|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958764|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83958765|NCT05421962|Narcotics|narcotics|mesh-ancestor
83958766|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83958767|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
83958768|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83958769|NCT00557817|Hematinics|hematinics|mesh-ancestor
83958770|NCT05419583|Aspirin|aspirin|mesh-list
83958771|NCT05419583|Warfarin|warfarin|mesh-list
83958772|NCT05419583|Apixaban|apixaban|mesh-list
83958773|NCT05419583|Anticoagulants|anticoagulants|mesh-list
83958774|NCT05419583|Edoxaban|edoxaban|mesh-list
83958775|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83958776|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83958777|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83958778|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958779|NCT05419583|Analgesics|analgesics|mesh-ancestor
83958780|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
83958781|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958782|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958783|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958784|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958785|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83958786|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83958787|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958788|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83958789|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958790|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
83958791|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83958792|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
83958793|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83958794|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83958795|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83958796|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83958797|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
83958798|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83958799|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
83958800|NCT05387408|Narcotics|narcotics|mesh-ancestor
83958801|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958802|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958803|NCT05387408|Analgesics|analgesics|mesh-ancestor
83958804|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
83958805|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958806|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
83958807|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83958808|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958809|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958810|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958811|NCT05376761|Analgesics|analgesics|mesh-ancestor
83958812|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
83958813|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958814|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83958815|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83958816|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83958817|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958818|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958819|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958820|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
83958821|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83958822|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83958823|NCT04617561|Prednisolone|prednisolone|mesh-list
83958824|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
83958825|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83958826|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83958827|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
83958828|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
83958829|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958830|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
83958831|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
83958832|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958833|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958834|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83958835|NCT04617561|Hormones|hormones|mesh-ancestor
83958836|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958837|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83958838|NCT04617561|Protective Agents|protective agents|mesh-ancestor
83958839|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83958840|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958841|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83958842|NCT04617483|Vaccines|vaccines|mesh-list
83958843|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
83958844|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958845|NCT04617249|Anesthetics|anesthetics|mesh-list
83958846|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958847|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958848|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
83958849|NCT05349383|Antibodies|antibodies|mesh-list
83958850|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
83958851|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
83958852|NCT05349383|Immunomodulating Agents|immunomodulating agents|mesh-list
83958853|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
83958854|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958855|NCT04617171|Benralizumab|benralizumab|mesh-list
83958856|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83958857|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
83958858|NCT00557934|Dobutamine|dobutamine|mesh-list
83958859|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83958860|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
83958861|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
83958862|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958863|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958864|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83958865|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83958866|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83958867|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
83958868|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958869|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958870|NCT00557934|Protective Agents|protective agents|mesh-ancestor
83958871|NCT00558051|Vaccines|vaccines|mesh-list
83958872|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
83958873|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958874|NCT00558090|Morphine|morphine|mesh-list
83958875|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83958876|NCT00558090|Narcotics|narcotics|mesh-ancestor
83958877|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958878|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958879|NCT00558090|Analgesics|analgesics|mesh-ancestor
83958880|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
83958881|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958882|NCT04617015|Bromides|bromides|mesh-list
83958883|NCT04617015|Ipratropium|ipratropium|mesh-list
83958884|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
83958885|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83958886|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
83958887|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958888|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958889|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83958890|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
83958891|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83958892|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
83958893|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958894|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958895|NCT04650828|Tenofovir|tenofovir|mesh-list
83958896|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
83958897|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958898|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83958899|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83958900|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958901|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958902|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83958903|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83958904|NCT04650555|Genistein|genistein|mesh-list
83958905|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83958906|NCT04650555|Protective Agents|protective agents|mesh-ancestor
83958907|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958908|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958909|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83958910|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958911|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958912|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
83479773|NCT05017454|Valproic Acid|valproic acid|mesh-list
83958913|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83958914|NCT04650555|Estrogens|estrogens|mesh-ancestor
83958915|NCT04650555|Hormones|hormones|mesh-ancestor
83958916|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83958917|NCT05181683|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83958918|NCT05181683|Antiviral Agents|antiviral agents|mesh-ancestor
83958919|NCT05181683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958920|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
83958921|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
83958922|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958923|NCT05153525|Cisatracurium|cisatracurium|mesh-list
83958924|NCT05153525|Atracurium|atracurium|mesh-list
83958925|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83958926|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83958927|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958928|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958929|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83958930|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83958931|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83958932|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
83958933|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83958934|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958935|NCT04649892|Naltrexone|naltrexone|mesh-list
83958936|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83958937|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83958938|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958939|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
83958940|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958941|NCT05125796|Acetaminophen|acetaminophen|mesh-list
83958942|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83958943|NCT05125796|Ketoprofen|ketoprofen|mesh-list
83958944|NCT05125796|Lidocaine|lidocaine|mesh-list
83958945|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
83958946|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
83958947|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958948|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958949|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
83958950|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83958951|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83958952|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83958953|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83958954|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83958955|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958956|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83958957|NCT05125796|Analgesics|analgesics|mesh-ancestor
83958958|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
83958959|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83958960|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83958961|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958962|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83958963|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83958964|NCT04616859|Ethanol|ethanol|mesh-list
83958965|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83958966|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958967|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83958968|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958969|NCT04616586|Siltuximab|siltuximab|mesh-list
83958970|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958971|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83958972|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958973|NCT04616352|Cefuroxime|cefuroxime|mesh-list
83958974|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
83958975|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83958976|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958977|NCT00553943|Cytarabine|cytarabine|mesh-list
83958978|NCT00553943|Rituximab|rituximab|mesh-list
83958979|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83958980|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958981|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
83958982|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83958983|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83958984|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83958985|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
83958986|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958987|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
83958988|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83958989|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83958990|NCT00563160|Carboplatin|carboplatin|mesh-list
83958991|NCT00563160|Gemcitabine|gemcitabine|mesh-list
83958992|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83958993|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83958994|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
83958995|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83958996|NCT00563238|Metoprolol|metoprolol|mesh-list
83958997|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83958998|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83958999|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
83959000|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
83959001|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959002|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959003|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83959004|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83959005|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83959006|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959007|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959008|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959009|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
83959010|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83959011|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959012|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
83959013|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83959014|NCT04934228|Clonidine|clonidine|mesh-list
83959015|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83959016|NCT04934228|Diuretics|diuretics|mesh-ancestor
83959017|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
83959018|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959019|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83959020|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83959021|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959022|NCT04934228|Analgesics|analgesics|mesh-ancestor
83959023|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
83959024|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959025|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
83959026|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
83959027|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83959028|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83959029|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83959030|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959031|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959032|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
83959033|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959034|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83959035|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959036|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959037|NCT04616391|Insulin|insulin|mesh-list
83959038|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83959039|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959040|NCT04890236|Tisagenlecleucel|tisagenlecleucel|mesh-list
83959041|NCT04890236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959042|NCT04890236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959043|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
83959044|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
83959045|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83959046|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83959047|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83959048|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959049|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959050|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83959051|NCT04881929|Docetaxel|docetaxel|mesh-list
83959052|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959053|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
83959054|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
83959055|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
83959056|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959057|NCT04615767|Inositol|inositol|mesh-list
83959058|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
83959059|NCT04615767|Vitamins|vitamins|mesh-ancestor
83959060|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
83959061|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959062|NCT04615611|Albuterol|albuterol|mesh-list
83959063|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83959064|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
83959065|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959066|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959067|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83959068|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
83959069|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
83959070|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83959071|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83959072|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83959073|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83959074|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959075|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959076|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959077|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83959078|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959079|NCT04833959|Panitumumab|panitumumab|mesh-list
83959080|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959081|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959082|NCT04725812|Eculizumab|eculizumab|mesh-list
83959083|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83959084|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959085|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
83959086|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959087|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
83959088|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
83959089|NCT04713371|Ipilimumab|ipilimumab|mesh-list
83959090|NCT04713371|Sargramostim|sargramostim|mesh-list
83959091|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959092|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
83959093|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959094|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959095|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83959096|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
83959097|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959098|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959099|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83959100|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959101|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83959102|NCT04683614|Norepinephrine|norepinephrine|mesh-list
83959103|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83959104|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83959105|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959106|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959107|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959108|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959109|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
83959110|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
83959111|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959112|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83959113|NCT04613895|Fexuprazan|fexuprazan|mesh-list
83959114|NCT04613895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959115|NCT04613700|Secretin|secretin|mesh-list
83959116|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959117|NCT04613700|Hormones|hormones|mesh-ancestor
83959118|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959119|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959120|NCT04675151|Phentolamine|phentolamine|mesh-list
83959121|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83959122|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83959123|NCT04675151|Pilocarpine|pilocarpine|mesh-list
83959124|NCT04675151|Miotics|miotics|mesh-ancestor
83959125|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
83959126|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959127|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959128|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83959129|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83959130|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
83959131|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959132|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959133|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83959134|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83959135|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959136|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83959137|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
83959138|NCT00563355|Hematinics|hematinics|mesh-ancestor
83959139|NCT00563394|Ofloxacin|ofloxacin|mesh-list
83959140|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83959141|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959142|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83959143|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83959144|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83959145|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959146|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959147|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959148|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83959149|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83959150|NCT00563433|Ofloxacin|ofloxacin|mesh-list
83959151|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83959152|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959153|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83959154|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83959155|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83959156|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959157|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959158|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959159|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83959160|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83959161|NCT00563472|Desogestrel|desogestrel|mesh-list
83959162|NCT00563472|Progesterone|progesterone|mesh-list
83959163|NCT00563472|Progestins|progestins|mesh-ancestor
83959164|NCT00563472|Hormones|hormones|mesh-ancestor
83959165|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959166|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959167|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83959168|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83959169|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83959170|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
83959171|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83959172|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83959173|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83959174|NCT04679597|Capecitabine|capecitabine|mesh-list
83959175|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
83959176|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959177|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
83959178|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959179|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959180|NCT04615910|Exenatide|exenatide|mesh-list
83959181|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83959182|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959183|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83959184|NCT04615910|Incretins|incretins|mesh-ancestor
83959185|NCT04615910|Hormones|hormones|mesh-ancestor
83959186|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959187|NCT04609397|Hemay005|hemay005|mesh-list
83959188|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959189|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83959190|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83959191|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959192|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959193|NCT04587947|Valsartan|valsartan|mesh-list
83959194|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83959195|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83959196|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83959197|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83959198|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959199|NCT04612998|Atropine|atropine|mesh-list
83959200|NCT04612998|Ephedrine|ephedrine|mesh-list
83959201|NCT04612998|Metoclopramide|metoclopramide|mesh-list
83959202|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83959203|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83959204|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83959205|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
83959206|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959207|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959208|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83959209|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
83959210|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
83959211|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
83959212|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83959213|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83959214|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
83959215|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959216|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959217|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
83959218|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959219|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83959220|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83959221|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
83959222|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83959223|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
83959224|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83959225|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959226|NCT00563589|Cyclosporine|cyclosporine|mesh-list
83959227|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
83959229|NCT00563589|Cyclosporins|cyclosporins|mesh-list
83959230|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83959231|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
83959232|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83959233|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959234|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959235|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
83959236|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959237|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959238|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959239|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959240|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83959241|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959242|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
83959243|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959244|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83959245|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
83959246|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959247|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83959248|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83959249|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83959250|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
83959251|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83959252|NCT04465643|Nivolumab|nivolumab|mesh-list
83959253|NCT04465643|Ipilimumab|ipilimumab|mesh-list
83959254|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959255|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959256|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83959257|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959258|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
83959259|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83959260|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
83959261|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959262|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959263|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959264|NCT02204345|Paclitaxel|paclitaxel|mesh-list
83959265|NCT02204345|Carboplatin|carboplatin|mesh-list
83959266|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83959267|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959268|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
83959269|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
83959270|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
83959271|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959272|NCT02187302|Bevacizumab|bevacizumab|mesh-list
83959273|NCT02187302|Sunitinib|sunitinib|mesh-list
83959274|NCT02187302|Everolimus|everolimus|mesh-list
83959275|NCT02187302|Sorafenib|sorafenib|mesh-list
83959276|NCT02187302|Axitinib|axitinib|mesh-list
83959277|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959278|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959279|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83959280|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83959281|NCT02187302|Growth Substances|growth substances|mesh-ancestor
83959282|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959283|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
83959284|NCT02187302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83959285|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83959286|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959287|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959288|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959289|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
83959290|NCT02179151|CKD732|ckd732|mesh-list
83959291|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83959292|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83959293|NCT02179151|Growth Substances|growth substances|mesh-ancestor
83959294|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959295|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
83959296|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959297|NCT04612257|Insulin|insulin|mesh-list
83959298|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83959299|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959300|NCT02160665|Tazarotene|tazarotene|mesh-list
83198604|NCT03093597|Emollients|emollients|mesh-ancestor
83959301|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959302|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
83959303|NCT02138630|Capsaicin|capsaicin|mesh-list
83959304|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
83959305|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959306|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
83959307|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959308|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959309|NCT02137343|Capecitabine|capecitabine|mesh-list
83959310|NCT02137343|Rilotumumab|rilotumumab|mesh-list
83959311|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959312|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959313|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
83959314|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959315|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959316|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
83959317|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959318|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959319|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83959320|NCT02114060|Vaccines|vaccines|mesh-list
83959321|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
83959322|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959323|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83959324|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83959325|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83959326|NCT04633044|Betaine|betaine|mesh-list
83959327|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959328|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
83959329|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83959330|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
83959331|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959332|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83959333|NCT04611438|Cannabidiol|cannabidiol|mesh-list
83959334|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
83959335|NCT00563823|Vatalanib|vatalanib|mesh-list
83959336|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83959337|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959338|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959339|NCT00563862|Fluorouracil|fluorouracil|mesh-list
83959340|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959341|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
83959342|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959343|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959344|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959345|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
83959346|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959347|NCT04611711|Decitabine|decitabine|mesh-list
83959348|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959349|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
83959350|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959351|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959352|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959353|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
83959354|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83959355|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
83959356|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959357|NCT02092922|Filanesib|filanesib|mesh-list
83959358|NCT02092922|Lenograstim|lenograstim|mesh-list
83959359|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83959360|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
83959361|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959362|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
83959363|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
83959364|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959365|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959366|NCT02092454|Benzocaine|benzocaine|mesh-list
83959367|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
83959368|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
83959369|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959370|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959371|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
83959372|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959373|NCT02083289|Latanoprost|latanoprost|mesh-list
83959374|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83959375|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83959376|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
83959377|NCT02081300|Testosterone|testosterone|mesh-list
83959378|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
83959379|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
83959380|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83959381|NCT02081300|Androgens|androgens|mesh-ancestor
83959382|NCT02081300|Hormones|hormones|mesh-ancestor
83959383|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959384|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959385|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83959386|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959387|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
83959388|NCT02074007|Benzocaine|benzocaine|mesh-list
83959389|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959390|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83959391|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
83959392|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959393|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
83959394|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959395|NCT02072954|Asenapine|asenapine|mesh-list
83959396|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83959397|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83959398|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959399|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959400|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83959401|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
83959402|NCT00554918|Prednisolone|prednisolone|mesh-list
83959403|NCT00554918|Docetaxel|docetaxel|mesh-list
83959404|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959405|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83959406|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83959407|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83959408|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959409|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959410|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
83959411|NCT00554918|Hormones|hormones|mesh-ancestor
83959412|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959413|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959414|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83959415|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83959416|NCT04631874|Varenicline|varenicline|mesh-list
83959417|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83959418|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83959419|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
83959420|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959421|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959422|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959423|NCT02057315|Ketoprofen|ketoprofen|mesh-list
83959424|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83959425|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83959426|NCT02057315|Analgesics|analgesics|mesh-ancestor
83959427|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
83959428|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959429|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959430|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959431|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959432|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83959433|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959434|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959435|NCT02047214|Bevacizumab|bevacizumab|mesh-list
83959436|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959437|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959438|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83959439|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83959440|NCT02047214|Growth Substances|growth substances|mesh-ancestor
83959441|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959442|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
83959443|NCT02046395|Amlodipine|amlodipine|mesh-list
83959444|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83959445|NCT02046395|Hydralazine|hydralazine|mesh-list
83959446|NCT02046395|Terazosin|terazosin|mesh-list
83959447|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83959448|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83959449|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83959450|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959451|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83959452|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959453|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
83959454|NCT02046395|Diuretics|diuretics|mesh-ancestor
83959455|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
83959456|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83959457|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83959458|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83959459|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83959460|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959461|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959462|NCT02046395|Urological Agents|urological agents|mesh-ancestor
83959463|NCT02032277|Paclitaxel|paclitaxel|mesh-list
83959464|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
83959465|NCT02032277|Carboplatin|carboplatin|mesh-list
83959466|NCT02032277|Doxorubicin|doxorubicin|mesh-list
83959467|NCT02032277|Veliparib|veliparib|mesh-list
83959468|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83959469|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959470|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
83959471|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
83959472|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
83959473|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959474|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959475|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
83959476|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959477|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959478|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83959479|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
83959480|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83959481|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83959482|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83959483|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83959484|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959485|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83959486|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83959487|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
83959488|NCT00560976|Hematinics|hematinics|mesh-ancestor
83959489|NCT02026349|Favipiravir|favipiravir|mesh-list
83959490|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
83959491|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959492|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
83959493|NCT04611126|Nivolumab|nivolumab|mesh-list
83959494|NCT04611126|Fludarabine|fludarabine|mesh-list
83959495|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
83959496|NCT04611126|Ipilimumab|ipilimumab|mesh-list
83959497|NCT04611126|Relatlimab|relatlimab|mesh-list
83959498|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959499|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
83959500|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959501|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959502|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83959503|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
83959504|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959505|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959506|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83959507|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959508|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83959509|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959510|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
83959511|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
83959512|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
83959513|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83959514|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83959515|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959516|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959517|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959518|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959519|NCT04611165|Nivolumab|nivolumab|mesh-list
83959520|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959521|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959522|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83959523|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959524|NCT02014649|Laninamivir|laninamivir|mesh-list
83959525|NCT02014649|Zanamivir|zanamivir|mesh-list
83198829|NCT05016063|Fludarabine|fludarabine|mesh-list
83959526|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
83959527|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959528|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959529|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959530|NCT02014142|Latanoprost|latanoprost|mesh-list
83959531|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83959532|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83959533|NCT04610580|Choline|choline|mesh-list
83959534|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
83959535|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83959536|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
83959537|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959538|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959539|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83959540|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
83959541|NCT02009579|Nintedanib|nintedanib|mesh-list
83959542|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959543|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83959544|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959545|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959546|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83959547|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83959548|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959549|NCT01998035|Azacitidine|azacitidine|mesh-list
83959550|NCT01998035|Romidepsin|romidepsin|mesh-list
83959551|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959552|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
83959553|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959554|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959555|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959556|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83959557|NCT01998035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83959558|NCT04611243|Vaccines|vaccines|mesh-list
83959559|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
83959560|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959561|NCT00564057|Candesartan|candesartan|mesh-list
83959562|NCT00564057|Lercanidipine|lercanidipine|mesh-list
83959563|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83959564|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83959565|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83959566|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959567|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83959568|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83959569|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83959570|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959571|NCT04610541|Remdesivir|remdesivir|mesh-list
83959572|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
83959573|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959574|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
83959575|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959576|NCT04677335|Lovastatin|lovastatin|mesh-list
83959577|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83959578|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83959579|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
83959580|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959581|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83959582|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83959583|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959584|NCT04630548|Copper|copper|mesh-list
83959585|NCT04630548|Trace Elements|trace elements|mesh-ancestor
83959586|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
83959587|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959588|NCT01975610|Spebrutinib|spebrutinib|mesh-list
83959589|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83959590|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959591|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959592|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83959593|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83959594|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959595|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959596|NCT01967810|Bevacizumab|bevacizumab|mesh-list
83959597|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959598|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959599|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83959600|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83959601|NCT01967810|Growth Substances|growth substances|mesh-ancestor
83959602|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959603|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
83959604|NCT01165138|Fluticasone|fluticasone|mesh-list
83959606|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959607|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83959608|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
83959609|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959610|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959611|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83959612|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
83959613|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959614|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83959615|NCT00561054|Cetuximab|cetuximab|mesh-list
83959616|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959617|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959618|NCT04206358|Molgramostim|molgramostim|mesh-list
83959619|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959620|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83959621|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
83959622|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83959623|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959624|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959625|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83959626|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83959627|NCT00561093|Protective Agents|protective agents|mesh-ancestor
83959628|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959629|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
83959630|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83959631|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
83959632|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83959633|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83959634|NCT01165021|Folic Acid|folic acid|mesh-list
83959635|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
83959636|NCT01165021|Hydroxocobalamin|hydroxocobalamin|mesh-list
83959637|NCT01165021|Dexamethasone|dexamethasone|mesh-list
83959638|NCT01165021|Pemetrexed|pemetrexed|mesh-list
83959639|NCT01165021|Vitamins|vitamins|mesh-ancestor
83959640|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
83959641|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959642|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959643|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
83959644|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
83959645|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959646|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959647|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
83959648|NCT01165021|Hormones|hormones|mesh-ancestor
83959649|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959650|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83959651|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959652|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959653|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959654|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83959655|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83959656|NCT01165021|Hematinics|hematinics|mesh-ancestor
83959657|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
83959658|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
83959659|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
83959660|NCT00561132|Antacids|antacids|mesh-ancestor
83959661|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959662|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959663|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83959664|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959665|NCT01956812|Gemcitabine|gemcitabine|mesh-list
83959666|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959667|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
83959668|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959669|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959670|NCT01952990|Phenylephrine|phenylephrine|mesh-list
83959671|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
83959672|NCT01952990|Tetracaine|tetracaine|mesh-list
83959673|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
83959674|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
83959675|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959676|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959677|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
83959678|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959679|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83959680|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83959681|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959682|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959683|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959684|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
83959685|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
83959686|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
83959687|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83959688|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
83959689|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83959690|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
83959691|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83959692|NCT01952990|Protective Agents|protective agents|mesh-ancestor
83959693|NCT04314310|Tenoxicam|tenoxicam|mesh-list
83959694|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83959695|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83959696|NCT04314310|Analgesics|analgesics|mesh-ancestor
83959697|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
83959698|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959699|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959700|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959701|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959702|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83959703|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959704|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959705|NCT04610307|Anesthetics|anesthetics|mesh-list
83959706|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959707|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959708|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
83959709|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83959710|NCT04610502|Antibodies|antibodies|mesh-list
83959711|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
83959712|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959713|NCT01164475|Plerixafor|plerixafor|mesh-list
83959714|NCT01164475|Lenograstim|lenograstim|mesh-list
83959715|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83959716|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
83959717|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959718|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83959719|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83959720|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
83959721|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959722|NCT01164007|Bevacizumab|bevacizumab|mesh-list
83959723|NCT01164007|Dacarbazine|dacarbazine|mesh-list
83959724|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959725|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959726|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83959727|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83959728|NCT01164007|Growth Substances|growth substances|mesh-ancestor
83959729|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959730|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
83959731|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83959732|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
83959733|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959734|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83959735|NCT01941836|Ezetimibe|ezetimibe|mesh-list
83959736|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83959737|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83959738|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
83959739|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959740|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83959741|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959742|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83959743|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959744|NCT04629885|Oxytocin|oxytocin|mesh-list
83959745|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
83959746|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83959747|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959748|NCT01163851|Bococizumab|bococizumab|mesh-list
83959749|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83959750|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83959751|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
83959752|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959753|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83959754|NCT01917383|Timolol|timolol|mesh-list
83959755|NCT01917383|Latanoprost|latanoprost|mesh-list
83959756|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83959757|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83959758|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959759|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959760|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959761|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959762|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83959763|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83959764|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83959765|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83959766|NCT01163617|Adalimumab|adalimumab|mesh-list
83959767|NCT01163617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83959768|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959769|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959770|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83959771|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959772|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959773|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
83959774|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959775|NCT04629846|Docetaxel|docetaxel|mesh-list
83959776|NCT04629846|Trastuzumab|trastuzumab|mesh-list
83959777|NCT04629846|Pertuzumab|pertuzumab|mesh-list
83959778|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959779|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83959780|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83959781|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83959782|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959783|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959784|NCT01909427|Methotrexate|methotrexate|mesh-list
83959785|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83959786|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
83959787|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83959788|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959789|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959790|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
83959791|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959792|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959793|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
83959794|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959795|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83959796|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959797|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
83959798|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959799|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83959800|NCT04629573|Anesthetics|anesthetics|mesh-list
83959801|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959802|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959803|NCT00564174|Aspirin|aspirin|mesh-list
83959804|NCT00564174|Heparin|heparin|mesh-list
83959805|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83959806|NCT00564174|Tinzaparin|tinzaparin|mesh-list
83959807|NCT00564174|Dalteparin|dalteparin|mesh-list
83959808|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83959809|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83959810|NCT00564174|Analgesics|analgesics|mesh-ancestor
83959811|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
83959812|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959813|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959814|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959815|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959816|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83959817|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83959818|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959819|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83959820|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83959821|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959822|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
83959823|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
83959824|NCT01163266|Vortioxetine|vortioxetine|mesh-list
83959825|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
83959826|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83959827|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83959828|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83959829|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959830|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959831|NCT01163266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83959832|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83959833|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83959834|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959835|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959836|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
83959837|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83959838|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83959839|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83959840|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83959841|NCT01873703|Azacitidine|azacitidine|mesh-list
83959842|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83959843|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
83959844|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959845|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959846|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959847|NCT01870505|Letrozole|letrozole|mesh-list
83959848|NCT01870505|Exemestane|exemestane|mesh-list
83959849|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959850|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83959851|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83959852|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959853|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959854|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83959855|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
83959856|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959857|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959858|NCT04629612|Anesthetics|anesthetics|mesh-list
83959859|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959860|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959861|NCT00564213|Mitomycins|mitomycins|mesh-list
83959862|NCT00564213|Mitomycin|mitomycin|mesh-list
83959863|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83959864|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959865|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
83959866|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959867|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83959868|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959869|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83959870|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83959871|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
83959872|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959873|NCT00564252|Finasteride|finasteride|mesh-list
83959874|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83959875|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83959876|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959877|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959878|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
83959879|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959880|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959881|NCT00564252|Urological Agents|urological agents|mesh-ancestor
83959882|NCT04629144|Belimumab|belimumab|mesh-list
83959883|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83959884|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
83959885|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959886|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83959887|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
83959888|NCT01847573|Halofuginone|halofuginone|mesh-list
83959889|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959890|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
83959891|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83959892|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83959893|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83959894|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83959895|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959896|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959897|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83959898|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83959899|NCT01847573|Growth Substances|growth substances|mesh-ancestor
83959900|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959901|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
83959902|NCT04609254|Acetaminophen|acetaminophen|mesh-list
83959903|NCT04609254|Ibuprofen|ibuprofen|mesh-list
83959904|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83959905|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83959906|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83959907|NCT04609254|Analgesics|analgesics|mesh-ancestor
83959908|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
83959909|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959910|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959911|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959912|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83959913|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83959914|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959915|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959916|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
83959917|NCT01846481|Cocaine|cocaine|mesh-list
83959918|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
83959919|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
83959920|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83959921|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959922|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
83959923|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959924|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83959925|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83959926|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83959927|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83959928|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959929|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
83959930|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959931|NCT04609293|Apatinib|apatinib|mesh-list
83959932|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959933|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83959934|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959935|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959936|NCT04676789|Pegaspargase|pegaspargase|mesh-list
83959937|NCT04676789|Antibodies|antibodies|mesh-list
83959938|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83959939|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
83959940|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959941|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959942|NCT01811576|Hormones|hormones|mesh-list
83959943|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83959944|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959945|NCT01811498|Bevacizumab|bevacizumab|mesh-list
83959946|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83959947|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83959948|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83959949|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83959950|NCT01811498|Growth Substances|growth substances|mesh-ancestor
83959951|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959952|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
83959953|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
83959954|NCT01804829|Antibodies|antibodies|mesh-list
83959955|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
83959956|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83959957|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83959958|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
83959959|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
83959960|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959961|NCT00565422|Escitalopram|escitalopram|mesh-list
83959962|NCT00565422|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83959963|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83959964|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83959965|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959966|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959967|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
83959968|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959969|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83959970|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83959971|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
83959972|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83959973|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83959974|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83199282|NCT03091257|Trametinib|trametinib|mesh-list
83959975|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
83959976|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83959977|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83959978|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83959979|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83959980|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83959981|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959982|NCT01789736|Travoprost|travoprost|mesh-list
83959983|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83959984|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83959985|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83959986|NCT00564330|Esomeprazole|esomeprazole|mesh-list
83959987|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83959988|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83959989|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83959990|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83959991|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83959992|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
83959993|NCT01780844|Prednisone|prednisone|mesh-list
83959994|NCT01780844|Tacrolimus|tacrolimus|mesh-list
83959995|NCT01780844|Basiliximab|basiliximab|mesh-list
83959996|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83959997|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
83959998|NCT01780844|Hormones|hormones|mesh-ancestor
83959999|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960000|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960001|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83960002|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960003|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83960004|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
83960005|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83960006|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960007|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960008|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83960009|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83960010|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
83960011|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83960012|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960013|NCT01779947|Estradiol|estradiol|mesh-list
83960014|NCT01779947|Estrogens|estrogens|mesh-ancestor
83960015|NCT01779947|Hormones|hormones|mesh-ancestor
83960016|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960017|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960018|NCT00564408|Carbachol|carbachol|mesh-list
83960019|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83960020|NCT00564408|Miotics|miotics|mesh-ancestor
83960021|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
83960022|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960023|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960024|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83960025|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
83960026|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960027|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960028|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960029|NCT00564408|Analgesics|analgesics|mesh-ancestor
83960030|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
83960031|NCT00564408|Protective Agents|protective agents|mesh-ancestor
83960032|NCT01773785|Docetaxel|docetaxel|mesh-list
83960033|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960034|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
83960035|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
83960036|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
83960037|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960038|NCT01758458|Interferons|interferons|mesh-list
83960039|NCT01758458|Aldesleukin|aldesleukin|mesh-list
83960040|NCT01758458|Interferon-beta|interferon-beta|mesh-list
83960041|NCT01758458|Interleukin-2|interleukin-2|mesh-list
83960042|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960043|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
83960044|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960045|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960046|NCT01758458|Analgesics|analgesics|mesh-ancestor
83199361|NCT02487407|Simendan|simendan|mesh-list
83960047|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
83960048|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960049|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960050|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83960051|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83960052|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
83960053|NCT04608981|Prednisolone|prednisolone|mesh-list
83960055|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960056|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
83960057|NCT04608981|Hormones|hormones|mesh-ancestor
83960058|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960059|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960060|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83960061|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960062|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960063|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83960064|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960065|NCT04608981|Analgesics|analgesics|mesh-ancestor
83960066|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
83960067|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960068|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83960069|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960070|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960071|NCT01737905|Epinephrine|epinephrine|mesh-list
83960072|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83960073|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83960074|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
83960075|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960076|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960077|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960078|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83960079|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83960080|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
83960081|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960082|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83960083|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
83960084|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
83960085|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
83960086|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83960087|NCT01730027|Montelukast|montelukast|mesh-list
83960088|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83960089|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
83960090|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83960091|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
83960092|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960093|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960094|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83960095|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83960096|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960097|NCT04608669|Acetaminophen|acetaminophen|mesh-list
83960098|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960099|NCT04608669|Analgesics|analgesics|mesh-ancestor
83960100|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
83960101|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960102|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960103|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
83960104|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83960105|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83960106|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83960107|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
83960108|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960109|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83960110|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83960111|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960112|NCT04600089|Ketamine|ketamine|mesh-list
83960113|NCT04600089|Analgesics|analgesics|mesh-ancestor
83960114|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
83960115|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960116|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960117|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83960118|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83960119|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
83960120|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
83960121|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960122|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83960123|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83960124|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960125|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960126|NCT01704365|Vaccines|vaccines|mesh-list
83960127|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
83960128|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960129|NCT01698281|Dexamethasone|dexamethasone|mesh-list
83960130|NCT01698281|Doxorubicin|doxorubicin|mesh-list
83960131|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960132|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
83960133|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
83960134|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960135|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960136|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960137|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
83960138|NCT01698281|Hormones|hormones|mesh-ancestor
83960139|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960140|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83960141|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960142|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83960143|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83960144|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83960145|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960146|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960147|NCT00565461|Vaccines|vaccines|mesh-list
83960148|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
83960149|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960150|NCT01858883|Paclitaxel|paclitaxel|mesh-list
83960151|NCT01858883|Gemcitabine|gemcitabine|mesh-list
83960152|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83960153|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960154|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83960155|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83960156|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83960157|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960158|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960159|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
83960160|NCT01697072|Cisplatin|cisplatin|mesh-list
83960161|NCT01697072|Capecitabine|capecitabine|mesh-list
83960162|NCT01697072|Epirubicin|epirubicin|mesh-list
83960163|NCT01697072|Rilotumumab|rilotumumab|mesh-list
83960164|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960165|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960166|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
83960167|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960168|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83960169|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83960170|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83960171|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960172|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83960173|NCT00565500|Ibuprofen|ibuprofen|mesh-list
83960174|NCT00565500|Celecoxib|celecoxib|mesh-list
83960175|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83960176|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960177|NCT00565500|Analgesics|analgesics|mesh-ancestor
83960178|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
83960179|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960180|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960181|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960182|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960183|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83960184|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960185|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960186|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83960187|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83960188|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83960189|NCT01691846|Metformin|metformin|mesh-list
83960190|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83960191|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960192|NCT01658501|Metformin|metformin|mesh-list
83960193|NCT01658501|Liraglutide|liraglutide|mesh-list
83960194|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83960195|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960196|NCT01658501|Incretins|incretins|mesh-ancestor
83960197|NCT01658501|Hormones|hormones|mesh-ancestor
83960198|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960199|NCT01651871|Cetirizine|cetirizine|mesh-list
83960200|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83960201|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83960202|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83960203|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
83960204|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
83960205|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960206|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960207|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960208|NCT04608006|Fentanyl|fentanyl|mesh-list
83960209|NCT04608006|Bupivacaine|bupivacaine|mesh-list
83960210|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
83960211|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
83960212|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960213|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960214|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
83960215|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960216|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83960217|NCT04608006|Narcotics|narcotics|mesh-ancestor
83960218|NCT04608006|Analgesics|analgesics|mesh-ancestor
83960219|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83960220|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83960221|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
83960222|NCT04599621|Uric Acid|uric acid|mesh-list
83960223|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
83960224|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960225|NCT04599621|Protective Agents|protective agents|mesh-ancestor
83960226|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960227|NCT00564525|Amitriptyline|amitriptyline|mesh-list
83960228|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83960229|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
83960230|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960231|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960232|NCT00564525|Analgesics|analgesics|mesh-ancestor
83960233|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
83960234|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960235|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960236|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83960237|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83960238|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83960239|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960240|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
83960241|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960242|NCT04607733|Mirikizumab|mirikizumab|mesh-list
83960243|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83960244|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960245|NCT04607733|Analgesics|analgesics|mesh-ancestor
83960246|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
83960247|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960248|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960249|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960250|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960251|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83960252|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960253|NCT01632137|Rebamipide|rebamipide|mesh-list
83960254|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83960255|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960256|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
83960257|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960258|NCT01632137|Protective Agents|protective agents|mesh-ancestor
83960259|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960260|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960261|NCT00565539|Interferons|interferons|mesh-list
83960262|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960263|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
83960264|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960265|NCT04599699|Androgens|androgens|mesh-list
83960266|NCT04599699|Hormones|hormones|mesh-ancestor
83960267|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960268|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960269|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
83960270|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
83960271|NCT01563731|Atorvastatin|atorvastatin|mesh-list
83960272|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83960273|NCT01563731|Simvastatin|simvastatin|mesh-list
83960274|NCT01563731|Pravastatin|pravastatin|mesh-list
83960275|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83960276|NCT01563731|Diuretics|diuretics|mesh-list
83960277|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83960278|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83960279|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83960280|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83960281|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83960282|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960283|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83960284|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83960285|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
83960286|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960287|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83960288|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83960289|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
83960290|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
83960291|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83960292|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
83960293|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960294|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83960295|NCT01516346|Hydralazine|hydralazine|mesh-list
83960296|NCT01516346|Isosorbide|isosorbide|mesh-list
83960297|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83960298|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83960299|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83960300|NCT01516346|Diuretics|diuretics|mesh-ancestor
83960301|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
83960302|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960303|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
83960304|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83960305|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960306|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83960307|NCT01303796|Decitabine|decitabine|mesh-list
83960308|NCT01303796|Sapacitabine|sapacitabine|mesh-list
83960309|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960310|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
83960311|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960312|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960313|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960314|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
83960315|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
83960316|NCT04598880|Cathartics|cathartics|mesh-ancestor
83960317|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960318|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83960319|NCT00564564|Clomipramine|clomipramine|mesh-list
83960320|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
83960321|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960322|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83960323|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83960324|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960325|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960326|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83960327|NCT00564564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83960328|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83960329|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83960330|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960331|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960332|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
83960333|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83960334|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83960335|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83960336|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960337|NCT00565656|Bevacizumab|bevacizumab|mesh-list
83960338|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83960339|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960340|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83960341|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83960342|NCT00565656|Growth Substances|growth substances|mesh-ancestor
83960343|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960344|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
83960345|NCT00564603|Dexamethasone|dexamethasone|mesh-list
83960346|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
83960347|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83960348|NCT00564603|BB 1101|bb 1101|mesh-list
83960349|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960350|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
83960351|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
83960352|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960353|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960354|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960355|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
83960357|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960358|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83960359|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960360|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
83960361|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960362|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960363|NCT00555347|Modafinil|modafinil|mesh-list
83960364|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83960365|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960366|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83960367|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83960368|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83960369|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960370|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
83960371|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83960372|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
83960373|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960374|NCT00564642|Expectorants|expectorants|mesh-ancestor
83960375|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
83960376|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83960377|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
83960378|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960379|NCT00564642|Protective Agents|protective agents|mesh-ancestor
83960380|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960381|NCT00564642|Antidotes|antidotes|mesh-ancestor
83960382|NCT00555386|Selenium|selenium|mesh-list
83960383|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
83960384|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960385|NCT00555386|Protective Agents|protective agents|mesh-ancestor
83960386|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960387|NCT00555386|Trace Elements|trace elements|mesh-ancestor
83960388|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
83960389|NCT00565929|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83960390|NCT00565929|Antiviral Agents|antiviral agents|mesh-ancestor
83960391|NCT00565929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960392|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
83960393|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960394|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960395|NCT04675697|Etoposide|etoposide|mesh-list
83960396|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83960397|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960398|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83960399|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83960400|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960401|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960402|NCT04606836|Bupivacaine|bupivacaine|mesh-list
83960403|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
83960404|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
83960405|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960406|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960407|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
83960408|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960409|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
83960410|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
83960411|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960412|NCT04676126|Dorzolamide|dorzolamide|mesh-list
83960413|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83960414|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83960415|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960416|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960417|NCT04675619|Pirfenidone|pirfenidone|mesh-list
83960418|NCT04675619|Analgesics|analgesics|mesh-ancestor
83960419|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
83960420|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960421|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960422|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83960423|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960424|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960425|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960426|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960427|NCT05305300|Vaccines|vaccines|mesh-list
83960428|NCT05305300|Somatomedin B|somatomedin b|mesh-list
83960429|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
83960430|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960431|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83960432|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83960433|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
83960434|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960435|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960436|NCT04187755|Ceftazidime|ceftazidime|mesh-list
83960437|NCT04187755|Cefepime|cefepime|mesh-list
83960438|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83960439|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960440|NCT00555542|Rituximab|rituximab|mesh-list
83960441|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83960442|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960443|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
83960444|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960445|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960446|NCT04606563|Losartan|losartan|mesh-list
83960447|NCT04606563|Valsartan|valsartan|mesh-list
83960448|NCT04606563|Telmisartan|telmisartan|mesh-list
83960449|NCT04606563|Candesartan|candesartan|mesh-list
83960450|NCT04606563|Olmesartan|olmesartan|mesh-list
83960451|NCT04606563|Irbesartan|irbesartan|mesh-list
83960452|NCT04606563|Eprosartan|eprosartan|mesh-list
83960453|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83960454|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83960455|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83960456|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83960457|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960458|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83960459|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83960460|NCT00565968|Sorafenib|sorafenib|mesh-list
83960461|NCT00565968|Melphalan|melphalan|mesh-list
83960462|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960463|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83960464|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960465|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960466|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83960467|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
83960468|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83960469|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83960470|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
83960471|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960472|NCT01162486|Rifampin|rifampin|mesh-list
83960473|NCT01162486|Rifapentine|rifapentine|mesh-list
83960474|NCT01162486|Midazolam|midazolam|mesh-list
83960475|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83960476|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83960477|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960478|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960479|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83960480|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83960481|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960482|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83960483|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
83960484|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
83960485|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
83960486|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
83960487|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960488|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960489|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83960490|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
83960491|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83960492|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960493|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
83960494|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83199819|NCT03204877|Melatonin|melatonin|mesh-list
83960495|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960496|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83960497|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83960498|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83960499|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83960500|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83960501|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83960502|NCT01162135|Digoxin|digoxin|mesh-list
83960503|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83960504|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83960505|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960506|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960507|NCT01162135|Protective Agents|protective agents|mesh-ancestor
83960508|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960509|NCT00555776|Gabapentin|gabapentin|mesh-list
83960510|NCT00555776|Analgesics|analgesics|mesh-ancestor
83960511|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
83960512|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960513|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960514|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
83960515|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83960516|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83960517|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960518|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960519|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83960520|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83960521|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960522|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960523|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
83960524|NCT01161628|Rituximab|rituximab|mesh-list
83960525|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83960526|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960527|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
83960528|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960529|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960530|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
83960531|NCT04314505|Narcotics|narcotics|mesh-ancestor
83960532|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960533|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960534|NCT04314505|Analgesics|analgesics|mesh-ancestor
83960535|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
83960536|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960537|NCT02885545|Anticoagulants|anticoagulants|mesh-list
83960538|NCT01161472|Alprazolam|alprazolam|mesh-list
83960539|NCT01161472|Fesoterodine|fesoterodine|mesh-list
83960540|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83960541|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960542|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960543|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83960544|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83960545|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960546|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
83960547|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
83960548|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960549|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960550|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83960551|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83960552|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
83960553|NCT01161472|Urological Agents|urological agents|mesh-ancestor
83960554|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
83960555|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83960556|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
83960557|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960558|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
83960559|NCT04675385|Protective Agents|protective agents|mesh-ancestor
83960560|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
83960561|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83960562|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960563|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960564|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960565|NCT04598061|Analgesics|analgesics|mesh-ancestor
83960566|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
83960567|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960568|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83960569|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83960570|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83960571|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83960572|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960573|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960575|NCT04674956|Gemcitabine|gemcitabine|mesh-list
83960576|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83960577|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960578|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
83960579|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
83960580|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
83960581|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960582|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960583|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
83960584|NCT00564720|Gemcitabine|gemcitabine|mesh-list
83960585|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
83960586|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83960587|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960588|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
83960589|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960590|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960591|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83960592|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960593|NCT01160770|Clobazam|clobazam|mesh-list
83960594|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
83960595|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83960596|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83960597|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960598|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960599|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960600|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83960601|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
83960602|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
83960603|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960604|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960605|NCT04632758|Crizotinib|crizotinib|mesh-list
83960606|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960607|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83960608|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960609|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960610|NCT00566046|Levetiracetam|levetiracetam|mesh-list
83960611|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
83960612|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
83960613|NCT01160614|Oxycodone|oxycodone|mesh-list
83960614|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83960615|NCT01160614|Narcotics|narcotics|mesh-ancestor
83960616|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960617|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960618|NCT01160614|Analgesics|analgesics|mesh-ancestor
83960619|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
83960620|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960621|NCT00566124|Insulin|insulin|mesh-list
83960622|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83960623|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
83960624|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
83960625|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
83960626|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
83960627|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
83960628|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83960629|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960630|NCT01159912|Fluticasone|fluticasone|mesh-list
83960632|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960633|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83960634|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
83960635|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960636|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960637|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83960638|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
83960639|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
83960640|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83960641|NCT04606212|Losartan|losartan|mesh-list
83960642|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83960643|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83960644|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83960645|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83960646|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960647|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
83960648|NCT04606017|Antacids|antacids|mesh-ancestor
83960649|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960650|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960651|NCT04631822|Dexamethasone|dexamethasone|mesh-list
83960652|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960653|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
83960654|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
83960655|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960656|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960657|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960658|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
83960659|NCT04631822|Hormones|hormones|mesh-ancestor
83960660|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960661|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83960662|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960663|NCT04605705|Chrysarobin|chrysarobin|mesh-list
83960664|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83960665|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960666|NCT04605705|Analgesics|analgesics|mesh-ancestor
83960667|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
83960668|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960669|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960670|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960671|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960672|NCT00560924|Estradiol|estradiol|mesh-list
83960673|NCT00560924|Estrogens|estrogens|mesh-ancestor
83960674|NCT00560924|Hormones|hormones|mesh-ancestor
83960675|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960676|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960677|NCT00560963|Everolimus|everolimus|mesh-list
83960678|NCT00560963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83960679|NCT00560963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83960680|NCT00560963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960681|NCT00560963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960682|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83960683|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
83960684|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960685|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960686|NCT01159600|Empagliflozin|empagliflozin|mesh-list
83960687|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83960688|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960689|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83960690|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960691|NCT04631627|Aspirin|aspirin|mesh-list
83960692|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83960693|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960694|NCT04631627|Analgesics|analgesics|mesh-ancestor
83960695|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
83960696|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960697|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960698|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960699|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960700|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83960701|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83960702|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960703|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83960704|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83960705|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960706|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
83960707|NCT04314193|Prednisolone|prednisolone|mesh-list
83960708|NCT04314193|Methotrexate|methotrexate|mesh-list
83960709|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83960710|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
83960711|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83960712|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960713|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960714|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
83960715|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960716|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960717|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83960718|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960719|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83960720|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83960721|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
83200035|NCT03204019|Growth Substances|growth substances|mesh-ancestor
83960722|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960723|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83960724|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960725|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
83960727|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960728|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83960729|NCT01159171|Bevacizumab|bevacizumab|mesh-list
83960730|NCT01159171|Capecitabine|capecitabine|mesh-list
83960731|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
83960732|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83960733|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960734|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83960735|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83960736|NCT01159171|Growth Substances|growth substances|mesh-ancestor
83960737|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960738|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
83960739|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960740|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
83960741|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960742|NCT04631315|Prednisolone|prednisolone|mesh-list
83960743|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83960744|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
83960745|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83960746|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
83960747|NCT04631315|Phenylephrine|phenylephrine|mesh-list
83960748|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
83960749|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83960750|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83960751|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
83960752|NCT04631315|Difluprednate|difluprednate|mesh-list
83960753|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83960754|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960755|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
83960756|NCT04631315|Hormones|hormones|mesh-ancestor
83960757|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960758|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960759|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83960760|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960761|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
83960762|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
83960763|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960764|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83960765|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83960766|NCT04631315|Protective Agents|protective agents|mesh-ancestor
83960767|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83960768|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
83960769|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
83960770|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83960771|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
83960772|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
83960773|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83960774|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83960775|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83960776|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
83960777|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960778|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960779|NCT04597203|Hydroquinone|hydroquinone|mesh-list
83960780|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
83960781|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960782|NCT04597203|Protective Agents|protective agents|mesh-ancestor
83960783|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960784|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83960785|NCT01158118|Plerixafor|plerixafor|mesh-list
83960786|NCT01158118|Sargramostim|sargramostim|mesh-list
83960787|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
83960788|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960789|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83960790|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83960791|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
83960792|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960793|NCT02885311|Naltrexone|naltrexone|mesh-list
83960794|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83960795|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83960796|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960797|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
83960798|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960799|NCT00566241|Mecasermin|mecasermin|mesh-list
83960800|NCT00566241|Growth Substances|growth substances|mesh-ancestor
83960801|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960802|NCT00561119|Paclitaxel|paclitaxel|mesh-list
83960803|NCT00561119|Gemcitabine|gemcitabine|mesh-list
83960804|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83960805|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960806|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
83960807|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
83960808|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
83960809|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960810|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83960811|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
83960812|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
83960813|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83960814|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960815|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83960816|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
83960817|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83960818|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960819|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83960820|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83960821|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83960822|NCT00564993|Dobutamine|dobutamine|mesh-list
83960823|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83960824|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
83960825|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
83960826|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960827|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960828|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83960829|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83960830|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83960831|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
83960832|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960833|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960834|NCT00564993|Protective Agents|protective agents|mesh-ancestor
83960835|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
83960836|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83960837|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
83960838|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960839|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83960840|NCT04604886|Dobutamine|dobutamine|mesh-list
83960841|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83960842|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
83960843|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
83960844|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960845|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960846|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83960847|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83960848|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83960849|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83960850|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960851|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960852|NCT04604886|Protective Agents|protective agents|mesh-ancestor
83960853|NCT04595877|Dipyrone|dipyrone|mesh-list
83960854|NCT04595877|Endorphins|endorphins|mesh-list
83960855|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
83960856|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83960857|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960858|NCT04595877|Analgesics|analgesics|mesh-ancestor
83960859|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
83960860|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960861|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960862|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960863|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960864|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
83960865|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960866|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960867|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
83960868|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960869|NCT03454646|Rivastigmine|rivastigmine|mesh-list
83960870|NCT03454646|Donepezil|donepezil|mesh-list
83960871|NCT03454646|Galantamine|galantamine|mesh-list
83960872|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83960873|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83960874|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960875|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
83960876|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960877|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960878|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
83960879|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83960880|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
83960881|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960882|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83960883|NCT03454646|Protective Agents|protective agents|mesh-ancestor
83960884|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
83960885|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83960886|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960887|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
83960888|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960889|NCT00566553|Protective Agents|protective agents|mesh-ancestor
83960890|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960891|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83960892|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83960893|NCT01157182|Norethindrone|norethindrone|mesh-list
83960894|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
83960895|NCT01157182|Estradiol|estradiol|mesh-list
83960896|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83960897|NCT01157182|Estrogens|estrogens|mesh-ancestor
83960898|NCT01157182|Hormones|hormones|mesh-ancestor
83960899|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960900|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960901|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83960902|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
83960903|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83960904|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83960905|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83960906|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83960907|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83960908|NCT01157065|Ranibizumab|ranibizumab|mesh-list
83960909|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83960910|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83960911|NCT01157065|Growth Substances|growth substances|mesh-ancestor
83960912|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960913|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
83960914|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960915|NCT00566592|Ethanol|ethanol|mesh-list
83960916|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83960917|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83960918|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960919|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960920|NCT01156792|Montelukast|montelukast|mesh-list
83960921|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83960922|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
83960923|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83960924|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
83960925|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83960926|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960927|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83960928|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83960929|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960930|NCT04604223|Pioglitazone|pioglitazone|mesh-list
83960931|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83960932|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960933|NCT04628624|Antioxidants|antioxidants|mesh-list
83960934|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960935|NCT04628624|Protective Agents|protective agents|mesh-ancestor
83960936|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960937|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
83960938|NCT04604028|Lenalidomide|lenalidomide|mesh-list
83960939|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83960940|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
83960941|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960942|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83960943|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83960944|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
83960945|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960946|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83960947|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83960948|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83960949|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83960950|NCT04604028|Growth Substances|growth substances|mesh-ancestor
83960951|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83960953|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83960954|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83960955|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
83960956|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83960957|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83960958|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83960959|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83960960|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960961|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
83960962|NCT01156363|Hematinics|hematinics|mesh-ancestor
83960963|NCT02884921|Acetaminophen|acetaminophen|mesh-list
83960964|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83960965|NCT02884921|Analgesics|analgesics|mesh-ancestor
83960966|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
83960967|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83960968|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960969|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
83960970|NCT00561704|Losartan|losartan|mesh-list
83960971|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83960972|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83960973|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83960974|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83960975|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960976|NCT01156051|Guanfacine|guanfacine|mesh-list
83960977|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83960978|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83960979|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83960980|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83960981|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83960982|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83960983|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83960984|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960985|NCT04595409|Ustekinumab|ustekinumab|mesh-list
83960986|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
83960987|NCT04628000|Vitamin D|vitamin d|mesh-list
83960988|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
83960989|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
83960990|NCT04628000|Vitamins|vitamins|mesh-list
83960991|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
83960992|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83960993|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83960994|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83960995|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
83960996|NCT01155661|Serotonin|serotonin|mesh-list
83960997|NCT01155661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83960998|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83960999|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
83961000|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961001|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961002|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961003|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83961004|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961005|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83961006|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961007|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
83961008|NCT00565188|Adenosine|adenosine|mesh-list
83961009|NCT00565188|Analgesics|analgesics|mesh-ancestor
83961010|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
83961011|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961012|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961013|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83961014|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
83961015|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83961016|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
83961017|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
83961018|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961019|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961020|NCT04603833|Docetaxel|docetaxel|mesh-list
83200336|NCT02450149|Sorafenib|sorafenib|mesh-list
83961021|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961022|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
83961023|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83961024|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83961025|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961026|NCT04603872|Dasatinib|dasatinib|mesh-list
83961027|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961028|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83961029|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961030|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961031|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
83961032|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83961033|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
83961034|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83961035|NCT04603794|Povidone|povidone|mesh-list
83961036|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83961037|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961038|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
83961039|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
83961040|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
83961041|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
83961042|NCT01155583|Dexamethasone|dexamethasone|mesh-list
83961043|NCT01155583|Lenalidomide|lenalidomide|mesh-list
83961044|NCT01155583|Azacitidine|azacitidine|mesh-list
83961045|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961046|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
83961047|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
83961048|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961049|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961050|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961051|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
83961052|NCT01155583|Hormones|hormones|mesh-ancestor
83961053|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961054|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961055|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961056|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
83961057|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83961058|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83961059|NCT01155583|Growth Substances|growth substances|mesh-ancestor
83961060|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
83961061|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83961062|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
83961063|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961064|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961065|NCT04603131|Vaccines|vaccines|mesh-list
83961066|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
83961067|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961068|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
83961069|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
83961070|NCT04627181|Hematinics|hematinics|mesh-ancestor
83961071|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
83961072|NCT04627181|Vitamins|vitamins|mesh-ancestor
83961073|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
83961074|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961075|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
83961076|NCT04626752|Fludarabine|fludarabine|mesh-list
83961077|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961078|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
83961079|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961080|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961081|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83961082|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
83961083|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961084|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961085|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83961086|NCT01155466|Rasagiline|rasagiline|mesh-list
83961087|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83961088|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961089|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961090|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83961091|NCT01155466|Protective Agents|protective agents|mesh-ancestor
83961092|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961093|NCT00561899|Piperaquine|piperaquine|mesh-list
83961094|NCT00561899|Amodiaquine|amodiaquine|mesh-list
83961095|NCT00561899|Artenimol|artenimol|mesh-list
83961096|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
83961097|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83961098|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83961099|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961100|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
83961101|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83961102|NCT01155388|Hematinics|hematinics|mesh-ancestor
83961103|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83961104|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83961105|NCT01155388|Trace Elements|trace elements|mesh-ancestor
83961106|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
83961107|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961108|NCT00565227|Docetaxel|docetaxel|mesh-list
83961109|NCT00565227|Vorinostat|vorinostat|mesh-list
83961110|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961111|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83961112|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83961113|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83961114|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961115|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83961116|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961117|NCT04602273|Azacitidine|azacitidine|mesh-list
83961118|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83961119|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
83961120|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961121|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961122|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961123|NCT04313764|Bupivacaine|bupivacaine|mesh-list
83961124|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
83961125|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
83961126|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961127|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961128|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
83961129|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961130|NCT04626089|Metformin|metformin|mesh-list
83961131|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961132|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961133|NCT04601688|Dexamethasone|dexamethasone|mesh-list
83961134|NCT04601688|Bevacizumab|bevacizumab|mesh-list
83961135|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83961136|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961137|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83961138|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83961139|NCT04601688|Growth Substances|growth substances|mesh-ancestor
83961140|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961141|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
83961142|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961143|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
83961144|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
83961145|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961146|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961147|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
83961148|NCT04601688|Hormones|hormones|mesh-ancestor
83961149|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961150|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961151|NCT01154452|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83961152|NCT01154452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83961153|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961154|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961155|NCT04313452|Insulin|insulin|mesh-list
83961156|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961157|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961158|NCT01154218|Crizotinib|crizotinib|mesh-list
83961159|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961160|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83961161|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961162|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961163|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
83961164|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83961165|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83961166|NCT04601142|Prednisolone|prednisolone|mesh-list
83961167|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
83961168|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83961169|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
83961170|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961171|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
83961172|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
83200483|NCT02448199|Analgesics|analgesics|mesh-ancestor
83961173|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961174|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961175|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961176|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
83961177|NCT04601142|Hormones|hormones|mesh-ancestor
83961178|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961179|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83961180|NCT04601142|Protective Agents|protective agents|mesh-ancestor
83961181|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961182|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961183|NCT04625543|Paclitaxel|paclitaxel|mesh-list
83961184|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83961185|NCT04625543|Cisplatin|cisplatin|mesh-list
83961186|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83961187|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961188|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83961189|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83961190|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83961191|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961192|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
83961193|NCT04601259|Salicylates|salicylates|mesh-list
83961194|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961195|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
83961196|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
83961197|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
83961198|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83961199|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83961200|NCT04601259|Analgesics|analgesics|mesh-ancestor
83961201|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
83961202|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961203|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961204|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961205|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961206|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83961207|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961208|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961209|NCT00565383|Fentanyl|fentanyl|mesh-list
83961210|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83961211|NCT00565383|Narcotics|narcotics|mesh-ancestor
83961212|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961213|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961214|NCT00565383|Analgesics|analgesics|mesh-ancestor
83961215|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
83961216|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961217|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83961218|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83961219|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
83961220|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
83961221|NCT04625426|Protective Agents|protective agents|mesh-list
83961222|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961223|NCT04625114|Gabexate|gabexate|mesh-list
83961224|NCT04625114|Camostat|camostat|mesh-list
83961225|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
83961226|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961227|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961228|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83961229|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83961230|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
83961231|NCT00567099|Aripiprazole|aripiprazole|mesh-list
83961232|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
83961233|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83961234|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83961235|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83961236|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961237|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961238|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
83961239|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
83961240|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961241|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961242|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83961243|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83961244|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
83961245|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83961246|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83961247|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83961248|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83961249|NCT00567177|Cyclosporine|cyclosporine|mesh-list
83961250|NCT00567177|Cyclosporins|cyclosporins|mesh-list
83961251|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961252|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961253|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961254|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
83961255|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961256|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
83961257|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961258|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
83961259|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961260|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83961261|NCT00567216|Nadolol|nadolol|mesh-list
83961262|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83961263|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83961264|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
83961265|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961266|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961267|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961268|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83961269|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83961270|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
83961271|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
83961272|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961273|NCT00562055|Reboxetine|reboxetine|mesh-list
83961274|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83961275|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83961276|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83961277|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961278|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961279|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
83961280|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961281|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961282|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
83961283|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83961284|NCT04624217|Paclitaxel|paclitaxel|mesh-list
83961285|NCT04624217|Gemcitabine|gemcitabine|mesh-list
83961286|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83961287|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961288|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83961289|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83961290|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83961291|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961292|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83961293|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
83961294|NCT04623866|Valsartan|valsartan|mesh-list
83961295|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83961296|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83961297|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83961298|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961299|NCT00567372|Bevacizumab|bevacizumab|mesh-list
83961300|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83961301|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961302|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83961303|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83961304|NCT00567372|Growth Substances|growth substances|mesh-ancestor
83961305|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961306|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
83961307|NCT00562133|Insulin|insulin|mesh-list
83961308|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83961309|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
83961310|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961311|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961312|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83961313|NCT00567411|Apraclonidine|apraclonidine|mesh-list
83961314|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83961315|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83961316|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83961317|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83961318|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
83961319|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961320|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961321|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961322|NCT00562172|Metformin|metformin|mesh-list
83961323|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
83961324|NCT00562172|Glimepiride|glimepiride|mesh-list
83961325|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961326|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961327|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83961328|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961329|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
83961330|NCT00567450|Ropivacaine|ropivacaine|mesh-list
83961331|NCT00567450|Mepivacaine|mepivacaine|mesh-list
83961332|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
83961333|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
83961334|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961335|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961336|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
83961337|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961338|NCT00567528|Ibuprofen|ibuprofen|mesh-list
83961339|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83961340|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83961341|NCT00567528|Analgesics|analgesics|mesh-ancestor
83961342|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
83961343|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961344|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961345|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961346|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961347|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83961348|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961349|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961350|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
83961351|NCT00567606|Calcium|calcium|mesh-list
83961352|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83961353|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961354|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83961355|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961356|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961357|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83961358|NCT04590612|Levodopa|levodopa|mesh-list
83961359|NCT04590612|Carbidopa|carbidopa|mesh-list
83961360|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83961361|NCT04590612|Citalopram|citalopram|mesh-list
83961362|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83961363|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83961364|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83961365|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
83961366|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961367|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961368|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961369|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83961370|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961371|NCT04590612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83961372|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83961373|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961374|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
83961375|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83961376|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
83961377|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83961378|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83961379|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
83961380|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
83961381|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
83961382|NCT00562250|Glimepiride|glimepiride|mesh-list
83961383|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83961384|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961385|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961386|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961387|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83961388|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961389|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
83961390|NCT00562289|Aspirin|aspirin|mesh-list
83961391|NCT00562289|Dipyridamole|dipyridamole|mesh-list
83961392|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
83961393|NCT00562289|Apixaban|apixaban|mesh-list
83961394|NCT00562289|Dabigatran|dabigatran|mesh-list
83961395|NCT00562289|Antivitamins K|antivitamins k|mesh-list
83961396|NCT00562289|Clopidogrel|clopidogrel|mesh-list
83961397|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83961398|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83961399|NCT00562289|Analgesics|analgesics|mesh-ancestor
83961400|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
83961401|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961402|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961403|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961404|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961405|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83961406|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83961407|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961408|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83961409|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83961410|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961411|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
83961412|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83961413|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83961414|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83961415|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
83961416|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961417|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83961418|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
83961419|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83961420|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
83961421|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
83961422|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83961423|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
83961424|NCT04313218|Misoprostol|misoprostol|mesh-list
83961425|NCT04313218|Carbetocin|carbetocin|mesh-list
83961426|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83961427|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
83961428|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83961429|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961430|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83961431|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961432|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
83961433|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
83961434|NCT00624871|Ibuprofen|ibuprofen|mesh-list
83961435|NCT00624871|Vitamins|vitamins|mesh-ancestor
83961436|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
83961437|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961438|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83961439|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83961440|NCT00624871|Analgesics|analgesics|mesh-ancestor
83961441|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
83961442|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961443|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961444|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961445|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83961446|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961447|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961448|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
83961449|NCT00624871|Protective Agents|protective agents|mesh-ancestor
83961450|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83961451|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961452|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83961453|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961454|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961455|NCT04590183|Prednisolone|prednisolone|mesh-list
83961456|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83961457|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
83961458|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83961459|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
83961460|NCT04590183|Tacrolimus|tacrolimus|mesh-list
83961461|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83961462|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
83961463|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961464|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
83961465|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961466|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83961467|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961468|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961469|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961470|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
83961471|NCT04590183|Hormones|hormones|mesh-ancestor
83200781|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
84124690|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961472|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961473|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961474|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961475|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
83961476|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
83961477|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961478|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961479|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83961480|NCT04590183|Protective Agents|protective agents|mesh-ancestor
83961481|NCT04622618|Gabapentin|gabapentin|mesh-list
83961482|NCT04622618|Analgesics|analgesics|mesh-ancestor
83961483|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
83961484|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961485|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961486|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
83961487|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83961488|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83961489|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961490|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83961491|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83961492|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83961493|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961494|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961495|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
83961496|NCT04622891|Azithromycin|azithromycin|mesh-list
83961497|NCT04622891|Clarithromycin|clarithromycin|mesh-list
83961498|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83961499|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961500|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83961501|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961502|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961503|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83961504|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83961505|NCT04622579|Rituximab|rituximab|mesh-list
83961506|NCT04622579|Lenalidomide|lenalidomide|mesh-list
83961507|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83961508|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961509|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
83961510|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961511|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961512|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83961513|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83961514|NCT04622579|Growth Substances|growth substances|mesh-ancestor
83961515|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
83961516|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83961517|NCT01153009|Vortioxetine|vortioxetine|mesh-list
83961518|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83961519|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83961520|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961521|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961522|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961523|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961524|NCT01153009|Analgesics|analgesics|mesh-ancestor
83961525|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
83961526|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961527|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
83961528|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83961529|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
83961530|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83961531|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83961532|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961533|NCT01153009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83961534|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
83961535|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83961536|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83961537|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83961538|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83961539|NCT04622111|Metformin|metformin|mesh-list
83961540|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961541|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961542|NCT04622033|Brodalumab|brodalumab|mesh-list
83961543|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
83961544|NCT01152580|Melatonin|melatonin|mesh-list
83961545|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
83961546|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961547|NCT01152580|Protective Agents|protective agents|mesh-ancestor
83961548|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961549|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961550|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83961551|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
83961552|NCT04621799|Coagulants|coagulants|mesh-ancestor
83961553|NCT04621370|Capecitabine|capecitabine|mesh-list
83961554|NCT04621370|Durvalumab|durvalumab|mesh-list
83961555|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83961556|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
83961557|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961558|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961559|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83961560|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
83961561|NCT04589130|Naltrexone|naltrexone|mesh-list
83961562|NCT04589130|Bupropion|bupropion|mesh-list
83961563|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83961564|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83961565|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961566|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
83961567|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961568|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83961569|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
83961570|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83961571|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83961572|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83961573|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961574|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961575|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
83961576|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961577|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83961578|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83961579|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961580|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83961581|NCT04621487|Amoxicillin|amoxicillin|mesh-list
83961582|NCT04621487|Metronidazole|metronidazole|mesh-list
83961583|NCT04621487|Clarithromycin|clarithromycin|mesh-list
83961584|NCT04621487|Pantoprazole|pantoprazole|mesh-list
83961585|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83961586|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961587|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83961588|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83961589|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83961590|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961591|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961592|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83961593|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83961594|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83961595|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961596|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83961597|NCT01152190|Tadalafil|tadalafil|mesh-list
83961598|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
83961599|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83961600|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83961601|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961602|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961603|NCT01152190|Urological Agents|urological agents|mesh-ancestor
83961604|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
83961605|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83961606|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83961607|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83961608|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961609|NCT01151410|Enalapril|enalapril|mesh-list
83961610|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83961611|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
83961612|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961613|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961614|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83961615|NCT00562406|Ranibizumab|ranibizumab|mesh-list
83961616|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83961617|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83961618|NCT00562406|Growth Substances|growth substances|mesh-ancestor
83961619|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961620|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
83961621|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961622|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
83961623|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83961624|NCT04588935|Bisoprolol|bisoprolol|mesh-list
83961625|NCT04588935|Perindopril|perindopril|mesh-list
83961626|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83961627|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
83961628|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
83961629|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961630|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961631|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83961632|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83961633|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83961634|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
83961635|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961636|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961637|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83961638|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83961639|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961640|NCT00562523|Sorafenib|sorafenib|mesh-list
83961641|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961642|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83961643|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961644|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961645|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
83961646|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961647|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
83961648|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961649|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961650|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83961651|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
83961652|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961653|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961654|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83961655|NCT04649697|Clobetasol|clobetasol|mesh-list
83961656|NCT04649697|Rebamipide|rebamipide|mesh-list
83961657|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961658|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
83961659|NCT04649697|Hormones|hormones|mesh-ancestor
83961660|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961661|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961662|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83961663|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961664|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
83961665|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961666|NCT04649697|Protective Agents|protective agents|mesh-ancestor
83961667|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961668|NCT04649502|Metformin|metformin|mesh-list
83961669|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961670|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961671|NCT04621253|Dipyrone|dipyrone|mesh-list
83961672|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83961673|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83961674|NCT04621253|Analgesics|analgesics|mesh-ancestor
83961675|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
83961676|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961677|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961678|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961679|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961680|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
83961681|NCT00567762|Tacrolimus|tacrolimus|mesh-list
83961682|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961683|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
83961684|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961685|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83961686|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961687|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961688|NCT04620785|Methylene Blue|methylene blue|mesh-list
83961689|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961690|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961691|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
83961692|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83201007|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
83961693|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961694|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961695|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961696|NCT04691063|Carboplatin|carboplatin|mesh-list
83961697|NCT04691063|Etoposide|etoposide|mesh-list
83961698|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
83961699|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961700|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83961701|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83961702|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83961703|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961704|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961705|NCT01151215|Anastrozole|anastrozole|mesh-list
83961706|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961707|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961708|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83961709|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83961710|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961711|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961712|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83961713|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
83961714|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961715|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961716|NCT04588389|Lidocaine|lidocaine|mesh-list
83961717|NCT04588389|Ropivacaine|ropivacaine|mesh-list
83961718|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
83961719|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
83961720|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961721|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961722|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
83961723|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961724|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83961725|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83961726|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83961727|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961728|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961729|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
83961730|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
83961731|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83961732|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83961733|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961734|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961735|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83961736|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83961737|NCT04588194|Dexamethasone|dexamethasone|mesh-list
83961738|NCT04588194|Rituximab|rituximab|mesh-list
83961739|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83961740|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961741|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
83961742|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961743|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961744|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961745|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
83961746|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
83961747|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961748|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961749|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
83961750|NCT04588194|Hormones|hormones|mesh-ancestor
83961751|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961752|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961753|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
83961754|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83961755|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83961756|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
83961757|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961758|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961759|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961760|NCT02940314|Urological Agents|urological agents|mesh-ancestor
83961761|NCT04581213|Anesthetics|anesthetics|mesh-list
83961762|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961763|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201086|NCT04433481|Dabigatran|dabigatran|mesh-list
83961764|NCT01151137|Dronedarone|dronedarone|mesh-list
83961765|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83961766|NCT01151098|Buprenorphine|buprenorphine|mesh-list
83961767|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83961768|NCT01151098|Narcotics|narcotics|mesh-ancestor
83961769|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83961770|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961771|NCT01151098|Analgesics|analgesics|mesh-ancestor
83961772|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
83961773|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961774|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83961775|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
83961776|NCT04587843|Naltrexone|naltrexone|mesh-list
83961777|NCT04587843|Bupropion|bupropion|mesh-list
83961778|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83961779|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83961780|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961781|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
83961782|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961783|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83961784|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
83961785|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83961786|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83961787|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83961788|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83961789|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961790|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
83961791|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961792|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83961793|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83961794|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961795|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83961796|NCT04619303|Dexamethasone|dexamethasone|mesh-list
83961797|NCT04619303|Bevacizumab|bevacizumab|mesh-list
83961798|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83961799|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961800|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83961801|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83961802|NCT04619303|Growth Substances|growth substances|mesh-ancestor
83961803|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961804|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
83961805|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961806|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
83961807|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
83961808|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961809|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961810|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
83961811|NCT04619303|Hormones|hormones|mesh-ancestor
83961812|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961813|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961814|NCT04619537|Docetaxel|docetaxel|mesh-list
83961815|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961816|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
83961817|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
83961818|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
83961819|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961820|NCT04619381|Clopidogrel|clopidogrel|mesh-list
83961821|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83961822|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83961823|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83961824|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83961825|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
83961826|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961827|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961828|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961829|NCT00568503|Bromides|bromides|mesh-list
83961830|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
83961831|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83961832|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
83961833|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201155|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
83961834|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961835|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83961836|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83961838|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83961839|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
83961840|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961841|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961842|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
83961843|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
83961844|NCT00568542|Hematinics|hematinics|mesh-ancestor
83961845|NCT00562835|Thiamine|thiamine|mesh-list
83961846|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
83961847|NCT00562835|Vitamins|vitamins|mesh-ancestor
83961848|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
83961849|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961850|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961851|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
83961852|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
83961853|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961854|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83961855|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
83961856|NCT00562835|Hormones|hormones|mesh-ancestor
83961857|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961858|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83961859|NCT00562835|Protective Agents|protective agents|mesh-ancestor
83961860|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
83961861|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83961862|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961863|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
83961864|NCT04587141|Hematinics|hematinics|mesh-ancestor
83961865|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83961866|NCT04586790|Epinephrine|epinephrine|mesh-list
83961867|NCT04586790|Racepinephrine|racepinephrine|mesh-list
83961868|NCT04586790|Midodrine|midodrine|mesh-list
83961869|NCT04586790|Norepinephrine|norepinephrine|mesh-list
83961870|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
83961871|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83961872|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83961873|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
83961874|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961875|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961876|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961877|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83961878|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83961879|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
83961880|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961881|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83961882|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
83961883|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
83961884|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
83961885|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83961886|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83961887|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
83961888|NCT04586790|Coagulants|coagulants|mesh-ancestor
83961889|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83961890|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
83961891|NCT00568815|Rituximab|rituximab|mesh-list
83961892|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83961893|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961894|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
83961895|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961896|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961897|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83961898|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83961899|NCT00568971|Docetaxel|docetaxel|mesh-list
83961900|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961901|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83961902|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83961903|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83961904|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961905|NCT00562913|Sorafenib|sorafenib|mesh-list
83961906|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961907|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83961908|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961909|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961910|NCT00569088|Mannitol|mannitol|mesh-list
83961911|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83961912|NCT00569088|Diuretics|diuretics|mesh-ancestor
83961913|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
83961914|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961915|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83961916|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83961917|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961918|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
83961919|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83961920|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
83961921|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961922|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
83961923|NCT04586361|Protective Agents|protective agents|mesh-ancestor
83961925|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83961926|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961927|NCT04619069|Hormones|hormones|mesh-list
83961928|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961929|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961930|NCT04585932|Leuprolide|leuprolide|mesh-list
83961931|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83961932|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
83961933|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83961934|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961935|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83961936|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961937|NCT00569400|Insulin|insulin|mesh-list
83961938|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83961939|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83961940|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961941|NCT04618367|Lenvatinib|lenvatinib|mesh-list
83961942|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83961943|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83961944|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961945|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961946|NCT00562952|Telmisartan|telmisartan|mesh-list
83961947|NCT00562952|Bisoprolol|bisoprolol|mesh-list
83961948|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83961949|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83961950|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83961951|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961952|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
83961953|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
83961954|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961955|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961956|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83961957|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83961958|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83961959|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
83961960|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83961961|NCT05035316|Aspirin|aspirin|mesh-list
83961962|NCT05035316|Calcium|calcium|mesh-list
83961963|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83961964|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961965|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83961966|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83961967|NCT05035316|Analgesics|analgesics|mesh-ancestor
83961968|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
83961969|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83961970|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961971|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83961972|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83961973|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83961974|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961975|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83961976|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83961977|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961978|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
83961979|NCT04618601|Spironolactone|spironolactone|mesh-list
83961980|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83961981|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
83961982|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83961983|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961984|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83961985|NCT04618601|Diuretics|diuretics|mesh-ancestor
83961986|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
83961987|NCT00567918|Tacrolimus|tacrolimus|mesh-list
83961988|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83961989|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
83961990|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83961991|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83961992|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83961993|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83961995|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
83961996|NCT00569712|Dimercaprol|dimercaprol|mesh-list
83961997|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83961998|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83961999|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
83962000|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962001|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962002|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962003|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962004|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
83962005|NCT00569712|Hormones|hormones|mesh-ancestor
83962006|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962007|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83962008|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83962009|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83962010|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962011|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962012|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962013|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
83962014|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
83962015|NCT00569751|Paclitaxel|paclitaxel|mesh-list
83962016|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962017|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962018|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83962019|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83962020|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962021|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962022|NCT00569790|Bevacizumab|bevacizumab|mesh-list
83962023|NCT00569790|Irinotecan|irinotecan|mesh-list
83962024|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83962025|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962026|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83962027|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83962028|NCT00569790|Growth Substances|growth substances|mesh-ancestor
83962029|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962030|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83962031|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83962032|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83962033|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962034|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962035|NCT00567957|Remifentanil|remifentanil|mesh-list
83962036|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83962037|NCT00567957|Narcotics|narcotics|mesh-ancestor
83962038|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962039|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962040|NCT00567957|Analgesics|analgesics|mesh-ancestor
83962041|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
83962042|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962043|NCT02940002|Betamethasone|betamethasone|mesh-list
83962044|NCT02940002|Clobetasol|clobetasol|mesh-list
83962045|NCT02940002|Calcipotriene|calcipotriene|mesh-list
83962046|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962047|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
83962048|NCT02940002|Hormones|hormones|mesh-ancestor
83962049|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962050|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962051|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962052|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962053|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
83962054|NCT04618328|Tretinoin|tretinoin|mesh-list
83962055|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962056|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
83962057|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83962058|NCT04617782|Donepezil|donepezil|mesh-list
83962059|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83962060|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962061|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201382|NCT00705263|Ribavirin|ribavirin|mesh-list
83962062|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
83962063|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962064|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962065|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
83962066|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
83962067|NCT00569985|Carmustine|carmustine|mesh-list
83962068|NCT00569985|Etoposide|etoposide|mesh-list
83962069|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
83962070|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962071|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
83962072|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962073|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962074|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83962075|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
83962076|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962077|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962078|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83962079|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962080|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83962081|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83962082|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962083|NCT04617626|Azithromycin|azithromycin|mesh-list
83962084|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83962085|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962086|NCT04585230|Mineral Oil|mineral oil|mesh-list
83962087|NCT04585230|Emollients|emollients|mesh-ancestor
83962088|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
83962089|NCT00570180|Bortezomib|bortezomib|mesh-list
83962090|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962091|NCT02939846|Trametinib|trametinib|mesh-list
83962092|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962093|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83962094|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962095|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962096|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
83962097|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
83962098|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83962099|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83962100|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962101|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962102|NCT02939495|Urological Agents|urological agents|mesh-ancestor
83962103|NCT00570219|Valproic Acid|valproic acid|mesh-list
83962104|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
83962105|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962106|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962107|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
83962108|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962109|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962110|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
83962111|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83962112|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962113|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83962114|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83962115|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962116|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83962117|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962118|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962119|NCT00568074|Repaglinide|repaglinide|mesh-list
83962120|NCT00568074|Acarbose|acarbose|mesh-list
83962121|NCT00568074|Gliquidone|gliquidone|mesh-list
83962122|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83962123|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962124|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83962125|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962126|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962127|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
83962128|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83962129|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
83962130|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962131|NCT00568113|Expectorants|expectorants|mesh-ancestor
83962132|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962133|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83962134|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
83962135|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962136|NCT00568113|Protective Agents|protective agents|mesh-ancestor
83962137|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962138|NCT00568113|Antidotes|antidotes|mesh-ancestor
83962139|NCT00568152|Aspirin|aspirin|mesh-list
83962140|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83962141|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83962142|NCT00568152|Analgesics|analgesics|mesh-ancestor
83962143|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
83962144|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962145|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962146|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962147|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962148|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83962149|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83962150|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962151|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83962152|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83962153|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962154|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
83962155|NCT04610879|Carbamazepine|carbamazepine|mesh-list
83962156|NCT04610879|Levetiracetam|levetiracetam|mesh-list
83962157|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
83962158|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
83962159|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
83962160|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83962161|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962162|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962163|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83962164|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83962165|NCT04610879|Analgesics|analgesics|mesh-ancestor
83962166|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
83962167|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962168|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83962169|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83962170|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962171|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83962172|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83962173|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
83962174|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83962175|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
83962176|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962177|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
83962178|NCT00570648|Protective Agents|protective agents|mesh-ancestor
83962179|NCT00570726|Ranibizumab|ranibizumab|mesh-list
83962180|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83962181|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83962182|NCT00570726|Growth Substances|growth substances|mesh-ancestor
83962183|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962184|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
83962185|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962186|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
83962187|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83962188|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83962189|NCT00563069|Midazolam|midazolam|mesh-list
83962190|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83962191|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83962192|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962193|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962194|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83962195|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83962196|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83962197|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83962198|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
83962199|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
83962200|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
83962201|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
83962202|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962203|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962204|NCT04580355|Amoxicillin|amoxicillin|mesh-list
83962205|NCT04580355|Metronidazole|metronidazole|mesh-list
83962206|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83962207|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962208|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83962209|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83962210|NCT00563108|Basiliximab|basiliximab|mesh-list
83962211|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962212|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
83962213|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962214|NCT00570882|Sunitinib|sunitinib|mesh-list
83962215|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962216|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83962217|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83962218|NCT00570882|Growth Substances|growth substances|mesh-ancestor
83962219|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962220|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
83962221|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83962222|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962223|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962224|NCT00563147|Sirolimus|sirolimus|mesh-list
83962225|NCT00563147|Temsirolimus|temsirolimus|mesh-list
83962226|NCT00563147|MTOR Inhibitors|mtor inhibitors|mesh-list
83962227|NCT00563147|Tivozanib|tivozanib|mesh-list
83962228|NCT00563147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83962229|NCT00563147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962230|NCT00563147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962231|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962232|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
83962233|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962234|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962235|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83962236|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962237|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83962238|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
83962239|NCT00570999|Mitogens|mitogens|mesh-list
83962240|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962241|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962242|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
83962243|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83962244|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
83962245|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962246|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962247|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962248|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962249|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83962250|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83962251|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83962252|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962253|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962254|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962255|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
83962256|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83962257|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962258|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
83962259|NCT00571116|Disulfiram|disulfiram|mesh-list
83962260|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962261|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83962262|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83962263|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962264|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962265|NCT00571155|Levetiracetam|levetiracetam|mesh-list
83962266|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
83962267|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
83962268|NCT04615481|Metronidazole|metronidazole|mesh-list
83962269|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962270|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83962271|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83962272|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83962273|NCT04614584|Mirtazapine|mirtazapine|mesh-list
83962274|NCT04614584|Methamphetamine|methamphetamine|mesh-list
83962275|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
83962276|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83962277|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83962278|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
83962279|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
83962280|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962281|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962282|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962283|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83962284|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83962285|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962286|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83962287|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83962288|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83201600|NCT03311321|Vitamin K|vitamin k|mesh-list
83962290|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83962291|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83962292|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
83962293|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83962294|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83962295|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
83962296|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
83962297|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962298|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
83962299|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83962300|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83962301|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83962302|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83962303|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
83962304|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962305|NCT00571506|Pioglitazone|pioglitazone|mesh-list
83962306|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
83962307|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83962308|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962309|NCT04613609|Nicotine|nicotine|mesh-list
83962310|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83962311|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
83962312|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962313|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962314|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83962315|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83962316|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
83962317|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962318|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962319|NCT00571740|Leucovorin|leucovorin|mesh-list
83962320|NCT00571740|Bevacizumab|bevacizumab|mesh-list
83962321|NCT00571740|Cetuximab|cetuximab|mesh-list
83962322|NCT00571740|Fluorouracil|fluorouracil|mesh-list
83962323|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
83962324|NCT00571740|Calcium|calcium|mesh-list
83962325|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
83962326|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83962327|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962328|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83962329|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83962330|NCT00571740|Growth Substances|growth substances|mesh-ancestor
83962331|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962332|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
83962333|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83962334|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
83962335|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962336|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83962337|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962338|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
83962339|NCT00571740|Antidotes|antidotes|mesh-ancestor
83962340|NCT00571740|Protective Agents|protective agents|mesh-ancestor
83962341|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
83962342|NCT00571740|Vitamins|vitamins|mesh-ancestor
83962343|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
83962344|NCT00563342|Ethanol|ethanol|mesh-list
83962345|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83962346|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962347|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962348|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962349|NCT04583046|Iloprost|iloprost|mesh-list
83962350|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83962351|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
83962352|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83962353|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83962354|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962355|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962356|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83962357|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83962358|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962359|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
83962360|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962361|NCT04613726|Ondansetron|ondansetron|mesh-list
83962362|NCT04613726|Granisetron|granisetron|mesh-list
83962363|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
83962364|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
83962365|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962366|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962367|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83962368|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
83962369|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
83962370|NCT04613726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83962371|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83962372|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
83962373|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962374|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962375|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83962376|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962377|NCT04613804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83962378|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962379|NCT04613102|Cannabidiol|cannabidiol|mesh-list
83962380|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
83962381|NCT04613219|Tofacitinib|tofacitinib|mesh-list
83962382|NCT04613219|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83962383|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83962384|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962385|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962387|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83962388|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
83962389|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962390|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962391|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962392|NCT00563654|Alfuzosin|alfuzosin|mesh-list
83962393|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83962394|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83962395|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83962396|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962397|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962398|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962399|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962400|NCT00563654|Urological Agents|urological agents|mesh-ancestor
83962401|NCT04613180|Montelukast|montelukast|mesh-list
83962402|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962403|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962404|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83962405|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
83962406|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962407|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962408|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83962409|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83962410|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962411|NCT00571935|Insulin|insulin|mesh-list
83962412|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83962413|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
83962414|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83962415|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962416|NCT00572013|Rituximab|rituximab|mesh-list
83962417|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83962418|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962419|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
83962420|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962421|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962422|NCT04612634|Vaccines|vaccines|mesh-list
83962423|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
83962424|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962425|NCT04612556|Vaccines|vaccines|mesh-list
83962426|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
83962427|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962428|NCT04580199|Ethanol|ethanol|mesh-list
83962429|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83962430|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962431|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962432|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962433|NCT00568347|Fluticasone|fluticasone|mesh-list
83962434|NCT00568347|Xhance|xhance|mesh-list
83962435|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83962436|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83962437|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962438|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83962439|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
83962440|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962441|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962442|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962443|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962444|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
83962445|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83962446|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83962447|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83962448|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83962449|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962450|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962451|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962452|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
83962453|NCT00568347|Hormones|hormones|mesh-ancestor
83962454|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962455|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
83962456|NCT04611971|Belimumab|belimumab|mesh-list
83962457|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962458|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
83962459|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962460|NCT00572208|Gabapentin|gabapentin|mesh-list
83962461|NCT00572208|Analgesics|analgesics|mesh-ancestor
83962462|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
83962463|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962464|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962465|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
83962466|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83962467|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83962468|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962469|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83962470|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83962471|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83962472|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962473|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962474|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
83962475|NCT00572364|Olaparib|olaparib|mesh-list
83962476|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83962477|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962478|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962479|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962480|NCT00563771|Rasburicase|rasburicase|mesh-list
83962481|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
83962482|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962483|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83962484|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83962485|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83962486|NCT04582032|Analgesics|analgesics|mesh-ancestor
83962487|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
83962488|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962489|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962490|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962491|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962492|NCT00563849|Leflunomide|leflunomide|mesh-list
83962493|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962494|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962495|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962496|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
83962497|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962498|NCT04581876|Paclitaxel|paclitaxel|mesh-list
83962499|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83962500|NCT04581876|Raltitrexed|raltitrexed|mesh-list
83962501|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962502|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962503|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
83962504|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
83962505|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962506|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962507|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83962508|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
83962509|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83201828|NCT02721875|Azacitidine|azacitidine|mesh-list
83962510|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962511|NCT00563927|Fluorouracil|fluorouracil|mesh-list
83962512|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962513|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
83962514|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962515|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83962516|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962517|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
83962518|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962519|NCT01150123|Vaccines|vaccines|mesh-list
83962520|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
83962521|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962522|NCT00572559|Vancomycin|vancomycin|mesh-list
83962523|NCT00572559|Linezolid|linezolid|mesh-list
83962524|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83962525|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962526|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83962527|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962528|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962529|NCT04611464|Misoprostol|misoprostol|mesh-list
83962530|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83962531|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
83962532|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83962533|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962534|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83962535|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83962536|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
83962537|NCT04611776|Paclitaxel|paclitaxel|mesh-list
83962538|NCT04611776|Carboplatin|carboplatin|mesh-list
83962539|NCT04611776|Gemcitabine|gemcitabine|mesh-list
83962540|NCT04611776|Pemetrexed|pemetrexed|mesh-list
83962541|NCT04611776|Atezolizumab|atezolizumab|mesh-list
83962542|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962543|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962544|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
83962545|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
83962546|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962547|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962548|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83962549|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
83962550|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962551|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83962552|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83962553|NCT04611776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83962554|NCT04611776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83962555|NCT00572637|Delanzomib|delanzomib|mesh-list
83962556|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
83962557|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
83962558|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962559|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962560|NCT01149655|Aripiprazole|aripiprazole|mesh-list
83962561|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
83962562|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83962563|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83962564|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83962565|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962566|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962567|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
83962568|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
83962569|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962570|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962571|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83962572|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83962573|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
83962574|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83962575|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83962576|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83962577|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83962578|NCT00575406|Prednisolone|prednisolone|mesh-list
83962579|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
83962580|NCT00575406|Rituximab|rituximab|mesh-list
83962581|NCT00575406|Doxorubicin|doxorubicin|mesh-list
83962582|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83962583|NCT00575406|Vincristine|vincristine|mesh-list
83962584|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962585|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
83962586|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962587|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962588|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83962589|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
83962590|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962591|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962592|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83962593|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83962594|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83962595|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83962596|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83962597|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962598|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962599|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
83962600|NCT00575406|Hormones|hormones|mesh-ancestor
83962601|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962602|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83962603|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962604|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83962605|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83962606|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962607|NCT01149538|Choline|choline|mesh-list
83962608|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
83962609|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83962610|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
83962611|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962612|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83962613|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83962614|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
83962615|NCT01149460|Valacyclovir|valacyclovir|mesh-list
83962616|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
83962617|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962618|NCT00575523|Atropine|atropine|mesh-list
83962619|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83962620|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83962621|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83962622|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
83962623|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962624|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962625|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962626|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962627|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
83962628|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
83962629|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83962630|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83962631|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
83962632|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962633|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962634|NCT01149421|Dulaglutide|dulaglutide|mesh-list
83962635|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83962636|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962637|NCT00575601|Simvastatin|simvastatin|mesh-list
83962638|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83962639|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83962640|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
83962641|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962642|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83962643|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83962644|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962645|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83962646|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83962647|NCT04600271|Norepinephrine|norepinephrine|mesh-list
83962648|NCT04600271|Analgesics|analgesics|mesh-list
83962649|NCT04600271|Diuretics|diuretics|mesh-list
83962650|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
83962651|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962652|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962653|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
83962654|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83962655|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83962656|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962657|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962658|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962659|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
83962660|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
83962661|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83962662|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83962663|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962664|NCT00575640|Hydralazine|hydralazine|mesh-list
83962665|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83962666|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
83962667|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
83962668|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962669|NCT04579731|Lactitol|lactitol|mesh-list
83962670|NCT04579731|Cathartics|cathartics|mesh-ancestor
83962671|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83962672|NCT00565487|Capecitabine|capecitabine|mesh-list
83962673|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83962674|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83962675|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
83962676|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962677|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962678|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83962679|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962680|NCT04600115|Adenosine|adenosine|mesh-list
83962681|NCT04600115|Regadenoson|regadenoson|mesh-list
83962682|NCT04600115|Analgesics|analgesics|mesh-ancestor
83962683|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
83962684|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962685|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962686|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83962687|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
83962688|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83962689|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
83962690|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
83962691|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962692|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962693|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83962694|NCT04600037|Pregabalin|pregabalin|mesh-list
83962695|NCT04600037|Analgesics|analgesics|mesh-ancestor
83962696|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
83962697|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962698|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962699|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
83962700|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83962701|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83962702|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962703|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83962704|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83962705|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83962706|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962707|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83962708|NCT00575796|Vinblastine|vinblastine|mesh-list
83962709|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962710|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962711|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83962712|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83962713|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962714|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962715|NCT00575835|Vitamin D|vitamin d|mesh-list
83962716|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
83962717|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
83962718|NCT00575835|Vitamins|vitamins|mesh-list
83962719|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
83962720|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962721|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83962722|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83962723|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83962724|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962725|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962726|NCT00575874|Pioglitazone|pioglitazone|mesh-list
83962727|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83962728|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962729|NCT03454217|Oxycodone|oxycodone|mesh-list
83962730|NCT03454217|Tramadol|tramadol|mesh-list
83962731|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83962732|NCT03454217|Narcotics|narcotics|mesh-ancestor
83962733|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962734|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962735|NCT03454217|Analgesics|analgesics|mesh-ancestor
83962736|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
83962737|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962738|NCT00575913|Alfuzosin|alfuzosin|mesh-list
83962739|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83962740|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83962741|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83962742|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962743|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962744|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962745|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962746|NCT00575913|Urological Agents|urological agents|mesh-ancestor
83962747|NCT04579302|Bupivacaine|bupivacaine|mesh-list
83962748|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
83962749|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
83962750|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962751|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962752|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
83962753|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962754|NCT00565682|Etoricoxib|etoricoxib|mesh-list
83962755|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83962756|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83962757|NCT00565682|Analgesics|analgesics|mesh-ancestor
83962758|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
83962759|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962760|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962761|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962762|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962763|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83962764|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83962765|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962766|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962767|NCT00575952|Paclitaxel|paclitaxel|mesh-list
83962768|NCT00575952|Doxorubicin|doxorubicin|mesh-list
83962769|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83962770|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962771|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962772|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
83962773|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
83962774|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962775|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962776|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83962777|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83962778|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83962779|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962780|NCT00573417|Modafinil|modafinil|mesh-list
83962781|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83962782|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962783|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83962784|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83962785|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83962786|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962787|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
83962788|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83962789|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
83962790|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962791|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962792|NCT00565955|Montelukast|montelukast|mesh-list
83962793|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962794|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962795|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83962796|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
83962797|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962798|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962799|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83962800|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83962801|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962802|NCT04598594|Nicotine|nicotine|mesh-list
83962803|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83962804|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
83962805|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962806|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962807|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83962808|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83962809|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
83962810|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962811|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962812|NCT00576069|Fluticasone|fluticasone|mesh-list
83962813|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
83962814|NCT00576069|Prednisone|prednisone|mesh-list
83962815|NCT00576069|Budesonide|budesonide|mesh-list
83962816|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
83962817|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83962818|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83962819|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83962820|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962821|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
83962822|NCT00576069|Hormones|hormones|mesh-ancestor
83962823|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962824|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962825|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83962826|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962827|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83962828|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
83962829|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962830|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83962831|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
83962832|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83962833|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83962834|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83962835|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83962836|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83962837|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962838|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83962839|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962840|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
83962841|NCT00573690|Carboplatin|carboplatin|mesh-list
83962842|NCT00573690|Etoposide|etoposide|mesh-list
83962843|NCT00573690|Pemetrexed|pemetrexed|mesh-list
83962844|NCT00573690|Sorafenib|sorafenib|mesh-list
83962845|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962846|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962847|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83962848|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83962849|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962850|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962851|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83962852|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83962853|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83962854|NCT00576225|Paclitaxel|paclitaxel|mesh-list
83962855|NCT00576225|Carboplatin|carboplatin|mesh-list
83962856|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83962857|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83962858|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962859|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83962860|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83962861|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83962862|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962863|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
83962864|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83962865|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962866|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83962867|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962868|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
83962869|NCT00576459|Hormones|hormones|mesh-ancestor
83962870|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83962871|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962872|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
83962873|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
83962874|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83962875|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83962876|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962877|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962878|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962879|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962880|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83962881|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
83962882|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962883|NCT00573885|Protective Agents|protective agents|mesh-ancestor
83962884|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962885|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83962886|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83962887|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962888|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83962889|NCT04597424|Doxycycline|doxycycline|mesh-list
83962890|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83962891|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962892|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
83962893|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83962894|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83962895|NCT00573924|Lansoprazole|lansoprazole|mesh-list
83962896|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
83962897|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83962898|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83962899|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83962900|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962901|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962902|NCT00573963|Ropivacaine|ropivacaine|mesh-list
83962903|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
83962904|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
83962905|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962906|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962907|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
83962908|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962909|NCT00576615|Propofol|propofol|mesh-list
83962910|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83962911|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83962912|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962913|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83962914|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
83962915|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
83962916|NCT00574041|Interferons|interferons|mesh-list
83962917|NCT00574041|Interferon-beta|interferon-beta|mesh-list
83962918|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
83962919|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962920|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
83962921|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962922|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
83962923|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962924|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83962925|NCT00566267|Simvastatin|simvastatin|mesh-list
83962926|NCT00566267|Ezetimibe|ezetimibe|mesh-list
83962927|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83962928|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83962929|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
83962930|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962931|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83962932|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83962933|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962934|NCT00574353|Misonidazole|misonidazole|mesh-list
83962935|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962936|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83962937|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83962938|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962939|NCT04596839|Remdesivir|remdesivir|mesh-list
83962940|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
83962941|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962942|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
83962943|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962944|NCT00574470|Infliximab|infliximab|mesh-list
83962945|NCT00574470|Daclizumab|daclizumab|mesh-list
83962946|NCT00574470|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83962947|NCT00574470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83962948|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
83962949|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83962950|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962951|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962952|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
83962953|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962954|NCT00577161|Vidarabine|vidarabine|mesh-list
83962955|NCT00577161|Rituximab|rituximab|mesh-list
83962956|NCT00577161|Fludarabine|fludarabine|mesh-list
83962957|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
83962958|NCT00577161|Pixantrone|pixantrone|mesh-list
83962959|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83962960|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962961|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
83202272|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
83962962|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962963|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83962964|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83962965|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
83962966|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962967|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83962968|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
83962969|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962970|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83962971|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83962972|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962973|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
83962974|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83962975|NCT04596488|Efavirenz|efavirenz|mesh-list
83962976|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83962977|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83962978|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83962979|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83962980|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
83962981|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83962982|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83962983|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83962984|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83962985|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83962986|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83962987|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83962988|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
83962989|NCT04595942|Midodrine|midodrine|mesh-list
83962990|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
83962991|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
83962992|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83962993|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83962994|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83962995|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83962996|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83962997|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83962998|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
83962999|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963000|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963001|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963002|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83963003|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83963004|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
83963005|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963006|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
83963007|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83963008|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963009|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83963010|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
83963011|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83963012|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963013|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963014|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963015|NCT04595825|Antibodies|antibodies|mesh-list
83963016|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83963017|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
83963018|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963019|NCT04595318|Varenicline|varenicline|mesh-list
83963020|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83963021|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83963022|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
83963023|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963024|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963025|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963026|NCT00577668|Thalidomide|thalidomide|mesh-list
83963027|NCT00577668|Dexamethasone|dexamethasone|mesh-list
83963028|NCT00577668|Melphalan|melphalan|mesh-list
83963029|NCT00577668|Bortezomib|bortezomib|mesh-list
83963030|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963031|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
83963032|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
83963033|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963034|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963035|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963036|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
83963037|NCT00577668|Hormones|hormones|mesh-ancestor
83963038|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963039|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83963040|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963041|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83963042|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
83963043|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963044|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83963045|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83963046|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
83963047|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
83963048|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83963049|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963050|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83963051|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83963052|NCT00577668|Growth Substances|growth substances|mesh-ancestor
83963053|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
83963054|NCT01147744|Fluticasone|fluticasone|mesh-list
83963055|NCT01147744|Xhance|xhance|mesh-list
83963056|NCT01147744|Montelukast|montelukast|mesh-list
83963057|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963058|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83963059|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
83963060|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963061|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963062|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83963063|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
83963064|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83963065|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83963066|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83963067|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
83963068|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963069|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83963070|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83963071|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963072|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83963073|NCT04313374|Morphine|morphine|mesh-list
83963074|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83963075|NCT04313374|Narcotics|narcotics|mesh-ancestor
83963076|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963077|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963078|NCT04313374|Analgesics|analgesics|mesh-ancestor
83963079|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
83963080|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963081|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963082|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963083|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963084|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963085|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83963086|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83963087|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83963088|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83963089|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963090|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963091|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963092|NCT04313335|Analgesics|analgesics|mesh-ancestor
83963093|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
83963094|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963095|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
83963096|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963097|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
83963098|NCT00577980|Testosterone|testosterone|mesh-list
83963099|NCT00577980|Androgens|androgens|mesh-ancestor
83963100|NCT00577980|Hormones|hormones|mesh-ancestor
83963101|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963102|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963103|NCT04594343|Disulfiram|disulfiram|mesh-list
83963104|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83963105|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83963106|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963107|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963108|NCT01147393|Epratuzumab|epratuzumab|mesh-list
83963109|NCT01147393|Veltuzumab|veltuzumab|mesh-list
83202433|NCT05582811|Riociguat|riociguat|mesh-list
83963110|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83963111|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83963112|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963113|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
83963114|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
83963115|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963116|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
83963117|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83963118|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83963119|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83963120|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83963121|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963122|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
83963123|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963124|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963125|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83963126|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963127|NCT00578370|Cyclosporine|cyclosporine|mesh-list
83963128|NCT00578370|Betamethasone|betamethasone|mesh-list
83963129|NCT00578370|Calcipotriene|calcipotriene|mesh-list
83963130|NCT00578370|Cyclosporins|cyclosporins|mesh-list
83963131|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963132|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963133|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83963134|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
83963135|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963136|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
83963137|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963138|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
83963139|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963140|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83963141|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963142|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
83963143|NCT00578370|Hormones|hormones|mesh-ancestor
83963144|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963145|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83963146|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
83963147|NCT04593836|Peppermint oil|peppermint oil|mesh-list
83963148|NCT04593836|Menthol|menthol|mesh-list
83963149|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
83963150|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
83963151|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
83963152|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
83963153|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963154|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963155|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963156|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
83963157|NCT04593524|Vitamin D|vitamin d|mesh-list
83963158|NCT04593524|Vitamins|vitamins|mesh-ancestor
83963159|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
83963160|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963161|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83963162|NCT00578526|Sunitinib|sunitinib|mesh-list
83963163|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963164|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83963165|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83963166|NCT00578526|Growth Substances|growth substances|mesh-ancestor
83963167|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963168|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
83963169|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83963170|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963171|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963172|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
83963173|NCT04593446|Cathartics|cathartics|mesh-ancestor
83963174|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963175|NCT00566891|Tirofiban|tirofiban|mesh-list
83963176|NCT00566891|Clopidogrel|clopidogrel|mesh-list
83963177|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83963178|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83963179|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83963180|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83963181|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
83963182|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963183|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963184|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963186|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83963187|NCT00578760|Aspirin|aspirin|mesh-list
83963188|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963189|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963190|NCT00578760|Analgesics|analgesics|mesh-ancestor
83963191|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
83963192|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963193|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963194|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963195|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963196|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83963197|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83963198|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963199|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83963200|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83963201|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963202|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
83963203|NCT04592822|Dabigatran|dabigatran|mesh-list
83963204|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
83963205|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83963206|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
83963207|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963208|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963209|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
83963210|NCT00567047|Vildagliptin|vildagliptin|mesh-list
83963211|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83963212|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963213|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83963214|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83963215|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963216|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963217|NCT04592666|Carboplatin|carboplatin|mesh-list
83963218|NCT04592666|Pemetrexed|pemetrexed|mesh-list
83963219|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963220|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963221|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963222|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83963223|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83963224|NCT04593056|Warfarin|warfarin|mesh-list
83963225|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
83963226|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
83963227|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83963228|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
83963229|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83963230|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
83963231|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963232|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963233|NCT04592198|Palonosetron|palonosetron|mesh-list
83963234|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
83963235|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
83963236|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963237|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963238|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963239|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83963240|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83963241|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
83963242|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963243|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963244|NCT04592081|Dexamethasone|dexamethasone|mesh-list
83963245|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
83963246|NCT04592081|BB 1101|bb 1101|mesh-list
83963247|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963248|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
83963249|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
83963250|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963251|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963252|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963253|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
83963254|NCT04592081|Hormones|hormones|mesh-ancestor
83963255|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963256|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83963257|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963258|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
83963259|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963260|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963261|NCT00579969|Timolol|timolol|mesh-list
83963262|NCT00579969|Latanoprost|latanoprost|mesh-list
83963263|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83963264|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83963265|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
83963266|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963267|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963268|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963269|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83963270|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83963271|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83963272|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83963273|NCT04591847|Vitamin D|vitamin d|mesh-list
83963274|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
83963275|NCT04591847|Vitamins|vitamins|mesh-ancestor
83963276|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
83963277|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963278|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83963279|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83963280|NCT04591535|Levodopa|levodopa|mesh-list
83963281|NCT04591535|Carbidopa|carbidopa|mesh-list
83963282|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83963283|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83963284|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83963285|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
83963286|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963287|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963288|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963289|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83963290|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963291|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83963292|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
83963293|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
83963294|NCT00580242|Lenalidomide|lenalidomide|mesh-list
83963295|NCT00580242|Bortezomib|bortezomib|mesh-list
83963296|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
83963297|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963298|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83963299|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83963300|NCT00580242|Growth Substances|growth substances|mesh-ancestor
83963301|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
83963302|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963303|NCT04591457|Insulin|insulin|mesh-list
83963304|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83963305|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
83963306|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83963307|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963308|NCT00580320|Bortezomib|bortezomib|mesh-list
83963309|NCT00580320|Dacarbazine|dacarbazine|mesh-list
83963310|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963311|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83963312|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
83963313|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963314|NCT00580359|Capecitabine|capecitabine|mesh-list
83963315|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83963316|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
83963317|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963318|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963319|NCT00580437|Dobutamine|dobutamine|mesh-list
83963320|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83963321|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
83963322|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
83963323|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963324|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963325|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83963326|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83963327|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83963328|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83963329|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963330|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963331|NCT00580437|Protective Agents|protective agents|mesh-ancestor
83963332|NCT00580827|Disulfiram|disulfiram|mesh-list
83963333|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83202650|NCT02462447|Choline|choline|mesh-list
83963334|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83963335|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963336|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963337|NCT00580905|Adenosine|adenosine|mesh-list
83963338|NCT00580905|Nitroprusside|nitroprusside|mesh-list
83963339|NCT00580905|Analgesics|analgesics|mesh-ancestor
83963340|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
83963341|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963342|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963343|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83963344|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
83963345|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83963346|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
83963347|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
83963348|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963349|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963350|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83963351|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83963352|NCT04590638|Epinephrine|epinephrine|mesh-list
83963353|NCT04590638|Racepinephrine|racepinephrine|mesh-list
83963354|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
83963355|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83963356|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83963357|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
83963358|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963359|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963360|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963361|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83963362|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83963363|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
83963364|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963365|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83963366|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
83963367|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
83963368|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
83963369|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83963370|NCT00567554|Paclitaxel|paclitaxel|mesh-list
83963371|NCT00567554|Docetaxel|docetaxel|mesh-list
83963372|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83963373|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
83963374|NCT00567554|Bevacizumab|bevacizumab|mesh-list
83963375|NCT00567554|Trastuzumab|trastuzumab|mesh-list
83963376|NCT00567554|Everolimus|everolimus|mesh-list
83963377|NCT00567554|Epirubicin|epirubicin|mesh-list
83963378|NCT00567554|Lapatinib|lapatinib|mesh-list
83963379|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83963380|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963381|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
83963382|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
83963383|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
83963384|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963385|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83963386|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
83963387|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963388|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963389|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83963390|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
83963391|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83963392|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83963393|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83963394|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83963395|NCT00567554|Growth Substances|growth substances|mesh-ancestor
83963396|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
83963397|NCT00567554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83963398|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83963399|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963400|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83963401|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83963402|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83963403|NCT00581139|Midazolam|midazolam|mesh-list
83963404|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
83963405|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963406|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963407|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83963408|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83963409|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83202730|NCT03433469|Osimertinib|osimertinib|mesh-list
83963410|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83963411|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963412|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83963413|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
83963414|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
83963415|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
83963416|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963417|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963418|NCT04590482|Letrozole|letrozole|mesh-list
83963419|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963420|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83963421|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83963422|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963423|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963424|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83963425|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
83963426|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963427|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963428|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83963429|NCT00581217|Laxatives|laxatives|mesh-ancestor
83963430|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963431|NCT00567710|Risperidone|risperidone|mesh-list
83963432|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83963433|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
83963434|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963435|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963436|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963437|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83963438|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83963439|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963440|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963441|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83963442|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
83963443|NCT04589429|Morphine|morphine|mesh-list
83963444|NCT04589429|Nalbuphine|nalbuphine|mesh-list
83963445|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83963446|NCT04589429|Narcotics|narcotics|mesh-ancestor
83963447|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963448|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963449|NCT04589429|Analgesics|analgesics|mesh-ancestor
83963450|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
83963451|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963452|NCT04589390|Selexipag|selexipag|mesh-list
83963453|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83963454|NCT04577040|Tadalafil|tadalafil|mesh-list
83963455|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
83963456|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83963457|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83963458|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963459|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963460|NCT04577040|Urological Agents|urological agents|mesh-ancestor
83963461|NCT04589234|Gemcitabine|gemcitabine|mesh-list
83963462|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83963463|NCT04589234|Folfirinox|folfirinox|mesh-list
83963464|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83963465|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
83963466|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963467|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963468|NCT03453177|Fosfomycin|fosfomycin|mesh-list
83963469|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83963470|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963471|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
83963472|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83963473|NCT04588532|Doxepin|doxepin|mesh-list
83963474|NCT04588532|Histamine|histamine|mesh-list
83963475|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
83963476|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
83963477|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963478|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963479|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963480|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83963481|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83963482|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963483|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83963484|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
83963485|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963486|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
83963488|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83963489|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963490|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963491|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963492|NCT04577430|Analgesics|analgesics|mesh-ancestor
83963493|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
83963494|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963495|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83963496|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83963497|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83963498|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
83963499|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963500|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963501|NCT00567788|Bimatoprost|bimatoprost|mesh-list
83963502|NCT00567788|Latanoprost|latanoprost|mesh-list
83963503|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83963504|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83963505|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83963506|NCT00581607|Bosentan|bosentan|mesh-list
83963507|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83963508|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83963509|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963510|NCT00581685|Celecoxib|celecoxib|mesh-list
83963511|NCT00581685|Pregabalin|pregabalin|mesh-list
83963512|NCT00581685|Analgesics|analgesics|mesh-ancestor
83963513|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
83963514|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963515|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963516|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
83963517|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83963518|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83963519|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963520|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83963521|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83963522|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83963523|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963524|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963525|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963526|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963527|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963528|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963529|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83963530|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83963531|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963532|NCT04588220|Plasminogen|plasminogen|mesh-list
83963533|NCT04588220|Melatonin|melatonin|mesh-list
83963534|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
83963535|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963536|NCT04588220|Protective Agents|protective agents|mesh-ancestor
83963537|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963538|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963539|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83963540|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83963541|NCT04586543|Docetaxel|docetaxel|mesh-list
83963542|NCT04586543|Selegiline|selegiline|mesh-list
83963543|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963544|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83963545|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83963546|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83963547|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963548|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
83963549|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963550|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83963551|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83963552|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83963553|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963554|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83963555|NCT04586543|Protective Agents|protective agents|mesh-ancestor
83963556|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963557|NCT04586465|Carboplatin|carboplatin|mesh-list
83963558|NCT04586465|Gemcitabine|gemcitabine|mesh-list
83963559|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
83963560|NCT04586465|Pemetrexed|pemetrexed|mesh-list
83963561|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963562|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83963563|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
83963564|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963565|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83963566|NCT04586465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83963567|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963568|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83963569|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83963570|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
83963571|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83963572|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
83963573|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963574|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83963575|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83963576|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83963577|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963578|NCT04585997|Omalizumab|omalizumab|mesh-list
83963579|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83963580|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83963581|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
83963582|NCT04593108|Letrozole|letrozole|mesh-list
83963583|NCT04593108|Misoprostol|misoprostol|mesh-list
83963584|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963585|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83963586|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83963587|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963588|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963589|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83963590|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
83963591|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963592|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963593|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83963594|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
83963595|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83963596|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83963597|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963598|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
83963599|NCT04585334|Diclofenac|diclofenac|mesh-list
83963600|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963601|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963602|NCT04585334|Analgesics|analgesics|mesh-ancestor
83963603|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
83963604|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963605|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963606|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963607|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963608|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83963609|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963610|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963611|NCT04585412|Palonosetron|palonosetron|mesh-list
83963612|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
83963613|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
83963614|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963615|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963616|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963617|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83963618|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83963619|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
83963620|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963621|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963622|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83963623|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
83963624|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963625|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83963626|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83963627|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963628|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963629|NCT04593030|Warfarin|warfarin|mesh-list
83963630|NCT04593030|Apixaban|apixaban|mesh-list
83963631|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
83963632|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83963633|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
83963634|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83202964|NCT00701363|Lanreotide|lanreotide|mesh-list
83963635|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
83963636|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963637|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963638|NCT00567983|Cyclosporine|cyclosporine|mesh-list
83963639|NCT00567983|Cyclosporins|cyclosporins|mesh-list
83963640|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963641|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963642|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83963643|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
83963644|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963645|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
83963646|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963647|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
83963648|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963649|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83963650|NCT00582582|Vitamin D|vitamin d|mesh-list
83963651|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83963652|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83963653|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83963654|NCT00582582|Docetaxel|docetaxel|mesh-list
83963655|NCT00582582|Vitamins|vitamins|mesh-ancestor
83963656|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
83963657|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963658|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963659|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83963660|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83963661|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83963662|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963663|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83963664|NCT00566904|Aspirin|aspirin|mesh-list
83963665|NCT00566904|Lidocaine|lidocaine|mesh-list
83963666|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
83963667|NCT00566904|Anesthetics|anesthetics|mesh-list
83963668|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963669|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963670|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
83963671|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963672|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83963673|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83963674|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83963675|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83963676|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963677|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963678|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963679|NCT00566904|Analgesics|analgesics|mesh-ancestor
83963680|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963681|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963682|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83963683|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83963684|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83963685|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83963686|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963687|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
83963688|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83963689|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83963690|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83963691|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83963692|NCT04584515|Itraconazole|itraconazole|mesh-list
83963693|NCT04584515|Rifampin|rifampin|mesh-list
83963694|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
83963695|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963696|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83963697|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83963698|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963699|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963700|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83963701|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
83963702|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963703|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963704|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83963705|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83963706|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
83963707|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83963708|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
83963709|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83963710|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83963711|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83963712|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83963713|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83963714|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83963715|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83963717|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963718|NCT04584671|Xenon|xenon|mesh-list
83963719|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83963720|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
83963721|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
83963722|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963723|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963724|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83963725|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963726|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963727|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963728|NCT04592211|Paclitaxel|paclitaxel|mesh-list
83963729|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
83963730|NCT04592211|Olaparib|olaparib|mesh-list
83963731|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83963732|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963733|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
83963734|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
83963735|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
83963736|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963737|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83963738|NCT04592211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83963739|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83963740|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963741|NCT04583813|Empagliflozin|empagliflozin|mesh-list
83963742|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83963743|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963744|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83963745|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963746|NCT04576143|Paclitaxel|paclitaxel|mesh-list
83963747|NCT04576143|Docetaxel|docetaxel|mesh-list
83963748|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
83963749|NCT04576143|Epirubicin|epirubicin|mesh-list
83963750|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83963751|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963752|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
83963753|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
83963754|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83963755|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963756|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83963757|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
83963758|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963759|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963760|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83963761|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
83963762|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83963763|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83963764|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83963765|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83963766|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963767|NCT04583267|Tenofovir|tenofovir|mesh-list
83963768|NCT04583267|Emtricitabine|emtricitabine|mesh-list
83963769|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
83963770|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963771|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83963772|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83963773|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963774|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963775|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83963776|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83963777|NCT04583111|Domperidone|domperidone|mesh-list
83963778|NCT04583111|Sulpiride|sulpiride|mesh-list
83963779|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
83963780|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
83963781|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963782|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963783|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963784|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83963785|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
83963786|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963787|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963788|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83963789|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83963790|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83963791|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963792|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83963793|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
83963794|NCT01146613|Varenicline|varenicline|mesh-list
83963795|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83963796|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83963797|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
83963798|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963799|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963800|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963801|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83963802|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83963803|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83963804|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83963805|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963806|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963807|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963808|NCT01145755|Analgesics|analgesics|mesh-ancestor
83963809|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
83963810|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963811|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
83963812|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83963813|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
83963814|NCT04591743|Nicotine|nicotine|mesh-list
83963815|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83963816|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
83963817|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963818|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963819|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83963820|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83963821|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
83963822|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963823|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963824|NCT00567060|Piracetam|piracetam|mesh-list
83963825|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83963826|NCT00567060|Protective Agents|protective agents|mesh-ancestor
83963827|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963828|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
83963829|NCT00568217|Acetaminophen|acetaminophen|mesh-list
83963830|NCT00568217|Ibuprofen|ibuprofen|mesh-list
83963831|NCT00568217|Diclofenac|diclofenac|mesh-list
83963832|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963833|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963834|NCT00568217|Analgesics|analgesics|mesh-ancestor
83963835|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
83963836|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963837|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963838|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963839|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963840|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83963841|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963842|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963843|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
83963844|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
83963845|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963846|NCT04582604|Decitabine|decitabine|mesh-list
83963847|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83963848|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
83963849|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963850|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963851|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963852|NCT00590928|Esomeprazole|esomeprazole|mesh-list
83963853|NCT00590928|Ranitidine|ranitidine|mesh-list
83963854|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83963855|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83963856|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963857|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83963858|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963859|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963860|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83963861|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
83963862|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
83963863|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963864|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963866|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
83963867|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83963868|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963869|NCT00568295|Acetaminophen|acetaminophen|mesh-list
83963870|NCT00568295|Rofecoxib|rofecoxib|mesh-list
83963871|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963872|NCT00568295|Analgesics|analgesics|mesh-ancestor
83963873|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
83963874|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963875|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963876|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
83963877|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83963878|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83963879|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963880|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963881|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963882|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963883|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963884|NCT00591162|Tetracycline|tetracycline|mesh-list
83963885|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83963886|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963887|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83963888|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963889|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963890|NCT00583518|Hormones|hormones|mesh-list
83963891|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
83963892|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963893|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963894|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83963895|NCT04582136|Sirolimus|sirolimus|mesh-list
83963896|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83963897|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963898|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83963899|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963900|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
83963901|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83963902|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
83963903|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963904|NCT00591201|Infliximab|infliximab|mesh-list
83963905|NCT00591201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83963906|NCT00591201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963907|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
83963908|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963909|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963910|NCT04582097|Ramipril|ramipril|mesh-list
83963911|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83963912|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
83963913|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963914|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963915|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83963916|NCT00591357|Loperamide|loperamide|mesh-list
83963917|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
83963918|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83963919|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
83963920|NCT04575675|Valsartan|valsartan|mesh-list
83963921|NCT04575675|Carvedilol|carvedilol|mesh-list
83963922|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83963923|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83963924|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83963925|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
83963926|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83963927|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963928|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83963929|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963930|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83963931|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83963932|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83963933|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83963934|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
83963935|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83963937|NCT04575675|Protective Agents|protective agents|mesh-ancestor
83963938|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83963939|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83963940|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83963941|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
83963942|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83963943|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83963944|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
83963945|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963946|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83963947|NCT04575675|Diuretics|diuretics|mesh-ancestor
83963948|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
83963949|NCT04575675|Hormones|hormones|mesh-ancestor
83963950|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
83963951|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83963952|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83963953|NCT00568412|Analgesics|analgesics|mesh-ancestor
83963954|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
83963955|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963956|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963957|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83963958|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963959|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
83963960|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83963961|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
83963962|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83963963|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963964|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963965|NCT00568529|Capecitabine|capecitabine|mesh-list
83963966|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
83963967|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83963968|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
83963969|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963970|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963971|NCT00568568|Hormones|hormones|mesh-list
83963972|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83963973|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963974|NCT04575558|Azithromycin|azithromycin|mesh-list
83963975|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
83963976|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83963977|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83963978|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
83963979|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83963980|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83963981|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963982|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963983|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83963984|NCT00568763|Sargramostim|sargramostim|mesh-list
83963985|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
83963986|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963987|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83963988|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83963989|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83963990|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83963991|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83963992|NCT00583869|Pregabalin|pregabalin|mesh-list
83963993|NCT00583869|Analgesics|analgesics|mesh-ancestor
83963994|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
83963995|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83963996|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83963997|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
83963998|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83963999|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83964000|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964001|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83964002|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83964003|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83964004|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964005|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83964006|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
83964007|NCT00568880|Bortezomib|bortezomib|mesh-list
83964008|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964009|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
83964010|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83964011|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83964012|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964013|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964014|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964015|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964016|NCT03451695|Morphine|morphine|mesh-list
83964017|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83964018|NCT03451695|Narcotics|narcotics|mesh-ancestor
83964019|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964020|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964021|NCT03451695|Analgesics|analgesics|mesh-ancestor
83964022|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
83964023|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964024|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
83964025|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83964026|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
83964027|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964028|NCT00569465|Expectorants|expectorants|mesh-ancestor
83964029|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
83964030|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83964031|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
83964032|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964033|NCT00569465|Protective Agents|protective agents|mesh-ancestor
83964034|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964035|NCT00569465|Antidotes|antidotes|mesh-ancestor
83964036|NCT00583986|Albuterol|albuterol|mesh-list
83964037|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83964038|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
83964039|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964040|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964041|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83964042|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
83964043|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
83964044|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964045|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83964046|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83964047|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83964048|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
83964049|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964050|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964051|NCT00569621|Moxaverine|moxaverine|mesh-list
83964052|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
83964053|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
83964054|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964055|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964056|NCT00569699|Bevacizumab|bevacizumab|mesh-list
83964057|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964058|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964059|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964060|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964061|NCT00569699|Growth Substances|growth substances|mesh-ancestor
83964062|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964063|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964064|NCT00569816|Sevoflurane|sevoflurane|mesh-list
83964065|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83964066|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83964067|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
83964068|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
83964069|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964070|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964071|NCT00570050|Insulin|insulin|mesh-list
83964072|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83964073|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83964074|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964075|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
83964076|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83964077|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
83203405|NCT04971291|Bupropion|bupropion|mesh-list
83964078|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964079|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964081|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
83964082|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83964083|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
83964084|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964085|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964086|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83964087|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
83964088|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
83964089|NCT00570245|Protective Agents|protective agents|mesh-ancestor
83964090|NCT00570284|Panobinostat|panobinostat|mesh-list
83964091|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964092|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83964093|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964094|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964095|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
83964096|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83964097|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
83964098|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
83964099|NCT00570440|Estradiol|estradiol|mesh-list
83964100|NCT00570440|Estrogens|estrogens|mesh-ancestor
83964101|NCT00570440|Hormones|hormones|mesh-ancestor
83964102|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964103|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964104|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83964105|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964106|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83964107|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83964108|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83964109|NCT00570479|Anecortave|anecortave|mesh-list
83964110|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964111|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964112|NCT00570479|Growth Substances|growth substances|mesh-ancestor
83964113|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964114|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964115|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964116|NCT00584298|Octreotide|octreotide|mesh-list
83964117|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964118|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83964119|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964120|NCT00584376|Pregabalin|pregabalin|mesh-list
83964121|NCT00584376|Analgesics|analgesics|mesh-ancestor
83964122|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
83964123|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964124|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964125|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
83964126|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83964127|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83964128|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964129|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83964130|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83964131|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83964132|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964133|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83964134|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83964135|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964136|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
83964137|NCT00570830|Hormones|hormones|mesh-ancestor
83964138|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964139|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964140|NCT00584493|Tremelimumab|tremelimumab|mesh-list
83964141|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964142|NCT04580342|Propranolol|propranolol|mesh-list
83964143|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83964144|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83964145|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
83964146|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964147|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964148|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964149|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83964150|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83964151|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
83964152|NCT00571142|Bevacizumab|bevacizumab|mesh-list
83964153|NCT00571142|Temazepam|temazepam|mesh-list
83964154|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964155|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964156|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964157|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964158|NCT00571142|Growth Substances|growth substances|mesh-ancestor
83964159|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964160|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964161|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83964162|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964163|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83964164|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83964165|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83964166|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
83964167|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
83964168|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964169|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964171|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83964172|NCT00584532|Protective Agents|protective agents|mesh-ancestor
83964173|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964174|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964175|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964176|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964177|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964178|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
83964179|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83964180|NCT00584532|Estrogens|estrogens|mesh-ancestor
83964181|NCT00584532|Hormones|hormones|mesh-ancestor
83964182|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964183|NCT00584571|Dexetimide|dexetimide|mesh-list
83964184|NCT00584571|Citalopram|citalopram|mesh-list
83964185|NCT00584571|Escitalopram|escitalopram|mesh-list
83964186|NCT00584571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83964187|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83964188|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83964189|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964190|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964191|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
83964192|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964193|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83964194|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83964195|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
83964196|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
83964197|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964198|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83964199|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83964200|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
83964201|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83964202|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83964203|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83964204|NCT03451500|Levodopa|levodopa|mesh-list
83964205|NCT03451500|Carbidopa|carbidopa|mesh-list
83964206|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83964207|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83964208|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83964209|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
83964210|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964211|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964212|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964213|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83964214|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964215|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83964216|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
83964217|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
83964218|NCT00584610|Copper|copper|mesh-list
83964219|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
83964220|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83964221|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
83964222|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964223|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964224|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83964225|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83964226|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83203556|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964227|NCT00584610|Trace Elements|trace elements|mesh-ancestor
83964228|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
83964229|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
83964230|NCT00571298|Gemcitabine|gemcitabine|mesh-list
83964232|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964233|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83964234|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
83964235|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964236|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83964237|NCT00571298|Protective Agents|protective agents|mesh-ancestor
83964238|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964239|NCT00571298|Antidotes|antidotes|mesh-ancestor
83964240|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
83964241|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
83964242|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964243|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964244|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
83964245|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
83964246|NCT00571337|Infliximab|infliximab|mesh-list
83964247|NCT00571337|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83964248|NCT00571337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964249|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
83964250|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964251|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964252|NCT04575519|Aspirin|aspirin|mesh-list
83964253|NCT04575519|Ibuprofen|ibuprofen|mesh-list
83964254|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83964255|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83964256|NCT04575519|Analgesics|analgesics|mesh-ancestor
83964257|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
83964258|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964259|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964260|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964261|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964262|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83964263|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964264|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964265|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83964266|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83964267|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83964268|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
83964269|NCT04573803|Phenytoin|phenytoin|mesh-list
83964270|NCT04573803|Levetiracetam|levetiracetam|mesh-list
83964271|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
83964272|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
83964273|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83964274|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83964275|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83964276|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964277|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83964278|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83964279|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83964280|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
83964281|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83964282|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83964283|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83964284|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964285|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964286|NCT00571727|Mecasermin|mecasermin|mesh-list
83964287|NCT00571727|Growth Substances|growth substances|mesh-ancestor
83964288|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964289|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
83964290|NCT04573686|Hematinics|hematinics|mesh-ancestor
83964291|NCT01143337|Methotrexate|methotrexate|mesh-list
83964292|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83964293|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
83964294|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964295|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964296|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83964297|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
83964298|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964299|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964300|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
83964301|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964302|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83964303|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83964304|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
83964305|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964306|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83964307|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
83964308|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
83964309|NCT02883595|Thymalfasin|thymalfasin|mesh-list
83964310|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83964311|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
83964312|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964313|NCT01143259|Alvimopan|alvimopan|mesh-list
83964314|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964315|NCT00571805|Varenicline|varenicline|mesh-list
83964316|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83964317|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83964318|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
83964319|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964320|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964321|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964322|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
83964323|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964324|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964325|NCT02883556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83964326|NCT02883556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964327|NCT00585000|Tremelimumab|tremelimumab|mesh-list
83964328|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964329|NCT00572078|Sorafenib|sorafenib|mesh-list
83964330|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964331|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964332|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964333|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964334|NCT00572312|Atorvastatin|atorvastatin|mesh-list
83964335|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83964336|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83964337|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
83964338|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964339|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83964340|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83964341|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964342|NCT00585156|Celecoxib|celecoxib|mesh-list
83964343|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83964344|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83964345|NCT00585156|Analgesics|analgesics|mesh-ancestor
83964346|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
83964347|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964348|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964349|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964350|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964351|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83964352|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83964353|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964354|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964355|NCT01142596|Asenapine|asenapine|mesh-list
83964356|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83964357|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83964358|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964359|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964360|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83964361|NCT00572390|Estrogens|estrogens|mesh-list
83964362|NCT00572390|Hormones|hormones|mesh-ancestor
83964363|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964364|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964365|NCT01142128|Esomeprazole|esomeprazole|mesh-list
83964366|NCT01142128|Pancrelipase|pancrelipase|mesh-list
83964367|NCT01142128|Pancreatin|pancreatin|mesh-list
83964368|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83964369|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964370|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83964371|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964372|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964373|NCT04572867|Diuretics|diuretics|mesh-list
83964374|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
83964375|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964376|NCT01142089|Rifamycins|rifamycins|mesh-list
83203702|NCT02710045|Vaccines|vaccines|mesh-list
83964378|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964379|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964380|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964381|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
83964382|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83964383|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
83964384|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964385|NCT00572663|Expectorants|expectorants|mesh-ancestor
83964386|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
83964387|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83964388|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
83964389|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964390|NCT00572663|Protective Agents|protective agents|mesh-ancestor
83964391|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964392|NCT00572663|Antidotes|antidotes|mesh-ancestor
83964393|NCT01140880|Tenofovir|tenofovir|mesh-list
83964394|NCT01140880|Emtricitabine|emtricitabine|mesh-list
83964395|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83964396|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
83964397|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964398|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83964399|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83964400|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964401|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964402|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83964403|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83964404|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
83964405|NCT00572741|Vitamins|vitamins|mesh-ancestor
83964406|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
83964407|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964408|NCT00572819|Misoprostol|misoprostol|mesh-list
83964409|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83964410|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
83964411|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964412|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964413|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83964414|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964415|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
83964416|NCT03451110|Fluconazole|fluconazole|mesh-list
83964417|NCT03451110|Lemborexant|lemborexant|mesh-list
83964418|NCT03451110|Famotidine|famotidine|mesh-list
83964419|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83964420|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
83964421|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964422|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83964423|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83964424|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964425|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964426|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83964427|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
83964428|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964429|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964430|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83964431|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83964432|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83964433|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964434|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83964435|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
83964436|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
83964437|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964438|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83964439|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83964440|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83964441|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964442|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83964443|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83964444|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83964445|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
83964446|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964447|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83964448|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83203781|NCT02458625|Iron|iron|mesh-list
83964449|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83964450|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83964452|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
83964453|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964454|NCT03450798|Anesthetics|anesthetics|mesh-list
83964455|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964456|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964457|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
83964458|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964459|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964460|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964461|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964462|NCT01140061|MK 0873|mk 0873|mesh-list
83964463|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83964464|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83964465|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964466|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964467|NCT04312750|Lidocaine|lidocaine|mesh-list
83964468|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
83964469|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
83964470|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964471|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964472|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
83964473|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964474|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83964475|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83964476|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83964477|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83964478|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964479|NCT00573404|Sunitinib|sunitinib|mesh-list
83964480|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
83964481|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964482|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964483|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964484|NCT00573404|Growth Substances|growth substances|mesh-ancestor
83964485|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964486|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964487|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964488|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964489|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964490|NCT01139125|Cysteamine|cysteamine|mesh-list
83964491|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83964492|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964493|NCT01139047|Metronidazole|metronidazole|mesh-list
83964494|NCT01139047|Azelaic acid|azelaic acid|mesh-list
83964495|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964496|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964497|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83964498|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83964499|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964500|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
83964501|NCT01139008|Metronidazole|metronidazole|mesh-list
83964502|NCT01139008|Azelaic acid|azelaic acid|mesh-list
83964503|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964504|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964505|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83964506|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83964507|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964508|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
83964509|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
83964510|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
83964511|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83964512|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83964513|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964514|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964515|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
83964516|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
83964517|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
83964518|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964519|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
83964520|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
83964521|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203868|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
83964522|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83964523|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
83964525|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964526|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964527|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83964528|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83964529|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83964530|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83964531|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83964532|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
83964533|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83964534|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83964535|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83964536|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964537|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964538|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83964539|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83964540|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964541|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83964542|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964543|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83964544|NCT00573638|Latanoprost|latanoprost|mesh-list
83964545|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83964546|NCT01138657|Prednisone|prednisone|mesh-list
83964547|NCT01138657|Adalimumab|adalimumab|mesh-list
83964548|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964549|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
83964550|NCT01138657|Hormones|hormones|mesh-ancestor
83964551|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964552|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964553|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83964554|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964555|NCT01138657|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83964556|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964557|NCT01138501|Factor VIII|factor viii|mesh-list
83964558|NCT01138501|Coagulants|coagulants|mesh-ancestor
83964559|NCT01138150|Naproxen|naproxen|mesh-list
83964560|NCT01138150|Sumatriptan|sumatriptan|mesh-list
83964561|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83964562|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83964563|NCT01138150|Analgesics|analgesics|mesh-ancestor
83964564|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
83964565|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964566|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964567|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964568|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964569|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
83964570|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83964571|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964572|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964573|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83964574|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83964575|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83964576|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
83964577|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964578|NCT00586092|Bevacizumab|bevacizumab|mesh-list
83964579|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964580|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964581|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964582|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964583|NCT00586092|Growth Substances|growth substances|mesh-ancestor
83964584|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964585|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964586|NCT01137955|Rifaximin|rifaximin|mesh-list
83964587|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964588|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964589|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964590|NCT00573950|Cilostazol|cilostazol|mesh-list
83964591|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83964592|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
83964593|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964594|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964595|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83964596|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
83964597|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83964598|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83964599|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964600|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83964601|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
83964602|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83964603|NCT00573950|Protective Agents|protective agents|mesh-ancestor
83964604|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83964605|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83964606|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964607|NCT00586131|Citric Acid|citric acid|mesh-list
83964608|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
83964609|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
83964610|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83964611|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
83964612|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
83964613|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964614|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
83964615|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
83964616|NCT00586365|Naproxen|naproxen|mesh-list
83964617|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83964618|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83964619|NCT00586365|Analgesics|analgesics|mesh-ancestor
83964620|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
83964621|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964622|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964623|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964624|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964625|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
83964626|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83964627|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964628|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964629|NCT00574652|Aldesleukin|aldesleukin|mesh-list
83964630|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964631|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83964632|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83964633|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
83964634|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964635|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83964636|NCT00574730|Rituximab|rituximab|mesh-list
83964637|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964638|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964639|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
83964640|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964641|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964642|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
83964643|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964644|NCT00574769|Bevacizumab|bevacizumab|mesh-list
83964645|NCT00574769|Docetaxel|docetaxel|mesh-list
83964646|NCT00574769|Everolimus|everolimus|mesh-list
83964647|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964648|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964649|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964650|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964651|NCT00574769|Growth Substances|growth substances|mesh-ancestor
83964652|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964653|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964654|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
83964655|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
83964656|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
83964657|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964658|NCT00574769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83964659|NCT00574769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964660|NCT00574769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964661|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83964662|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
83964663|NCT00586443|Bevacizumab|bevacizumab|mesh-list
83964664|NCT00586443|Panitumumab|panitumumab|mesh-list
83964665|NCT00586443|Everolimus|everolimus|mesh-list
83964666|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964667|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964668|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964669|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964670|NCT00586443|Growth Substances|growth substances|mesh-ancestor
83964671|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964672|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964673|NCT00586443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83964674|NCT00586443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964675|NCT00586443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964676|NCT00586443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964677|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83964678|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
83964679|NCT00574925|Esomeprazole|esomeprazole|mesh-list
83964680|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83964681|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964682|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83964683|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964684|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964685|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
83964686|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83964687|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
83964688|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964689|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964690|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83964691|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
83964692|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964693|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964694|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83964695|NCT00574964|Temozolomide|temozolomide|mesh-list
83964696|NCT00574964|Carmustine|carmustine|mesh-list
83964697|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83964698|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
83964699|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964700|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964701|NCT03450057|Daratumumab|daratumumab|mesh-list
83964702|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964703|NCT01137682|Octreotide|octreotide|mesh-list
83964704|NCT01137682|Lanreotide|lanreotide|mesh-list
83964705|NCT01137682|Pasireotide|pasireotide|mesh-list
83964706|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964707|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83964708|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964709|NCT01137682|Hormones|hormones|mesh-ancestor
83964710|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964711|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964712|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
83964713|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
83964714|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83964715|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83964716|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964717|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964718|NCT00586794|Urological Agents|urological agents|mesh-ancestor
83964719|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83964720|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964721|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964722|NCT00575354|Sevoflurane|sevoflurane|mesh-list
83964723|NCT00575354|Isoflurane|isoflurane|mesh-list
83964724|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83964725|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83964726|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
83964727|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
83964728|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964729|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964730|NCT00586911|Betaine|betaine|mesh-list
83964731|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964732|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
83964733|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83964734|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
83964735|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964736|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83964737|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
83964738|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964739|NCT00575549|Dobutamine|dobutamine|mesh-list
83964740|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83964741|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
83964742|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
83964743|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964744|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964745|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83964746|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83204076|NCT04647383|Lemborexant|lemborexant|mesh-list
83964747|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83964748|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
83964749|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964750|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964751|NCT00575549|Protective Agents|protective agents|mesh-ancestor
83964752|NCT03453684|Vancomycin|vancomycin|mesh-list
83964753|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964754|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964755|NCT00575627|Interferons|interferons|mesh-list
83964756|NCT00575627|Ribavirin|ribavirin|mesh-list
83964757|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
83964758|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
83964759|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83964760|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964761|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
83964762|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964763|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
83964764|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964765|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
83964766|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964767|NCT00555854|Benzocaine|benzocaine|mesh-list
83964768|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
83964769|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
83964770|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964771|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964772|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
83964773|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964774|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
83964775|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83964776|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964777|NCT00587145|Docetaxel|docetaxel|mesh-list
83964778|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964779|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
83964780|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
83964781|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
83964782|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964783|NCT04674176|Rifaximin|rifaximin|mesh-list
83964784|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964785|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964786|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83964787|NCT04674527|Temozolomide|temozolomide|mesh-list
83964788|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83964789|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
83964790|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964791|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964792|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83964793|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83964794|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
83964795|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964796|NCT00199797|Leucovorin|leucovorin|mesh-list
83964797|NCT00199797|Fluorouracil|fluorouracil|mesh-list
83964798|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
83964799|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
83964800|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964801|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83964802|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964803|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83964804|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
83964805|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964806|NCT00199797|Antidotes|antidotes|mesh-ancestor
83964807|NCT00199797|Protective Agents|protective agents|mesh-ancestor
83964808|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
83964809|NCT00199797|Vitamins|vitamins|mesh-ancestor
83964810|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
83964811|NCT01137604|Bevacizumab|bevacizumab|mesh-list
83964812|NCT01137604|Lenvatinib|lenvatinib|mesh-list
83964813|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964814|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964815|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83964816|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83964817|NCT01137604|Growth Substances|growth substances|mesh-ancestor
83964818|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964819|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83964820|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964821|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964822|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964823|NCT03454919|Palbociclib|palbociclib|mesh-list
83964824|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964825|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83964826|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964827|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964828|NCT00198822|Vitamin A|vitamin a|mesh-list
83964829|NCT00198822|Beta Carotene|beta carotene|mesh-list
83964830|NCT00198822|Carotenoids|carotenoids|mesh-list
83964831|NCT00198822|Vitamins|vitamins|mesh-ancestor
83964832|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
83964833|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964834|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
83964835|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964836|NCT00198822|Protective Agents|protective agents|mesh-ancestor
83964837|NCT00198822|Provitamins|provitamins|mesh-ancestor
83964838|NCT05214976|Paclitaxel|paclitaxel|mesh-list
83964839|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83964840|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964841|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
83964842|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
83964843|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
83964844|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964845|NCT05204134|Insulin|insulin|mesh-list
83964846|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83964847|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964848|NCT05181436|Chrysarobin|chrysarobin|mesh-list
83964849|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83964850|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83964851|NCT05181436|Analgesics|analgesics|mesh-ancestor
83964852|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
83964853|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964854|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964855|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964856|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964857|NCT01137292|Voriconazole|voriconazole|mesh-list
83964858|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
83964859|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964860|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83964861|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83964862|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964863|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964864|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83964865|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
83964866|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964867|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964868|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83964869|NCT02883478|Riboflavin|riboflavin|mesh-list
83964870|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
83964871|NCT02883478|Vitamins|vitamins|mesh-ancestor
83964872|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
83964873|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964874|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83964875|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83964876|NCT00197145|Aplaviroc|aplaviroc|mesh-list
83964877|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83964878|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83964879|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964880|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83964881|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83964882|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
83964883|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964884|NCT04674137|Histamine|histamine|mesh-list
83964885|NCT04674137|Glutarimide|glutarimide|mesh-list
83964886|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
83964887|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
83964888|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964889|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964890|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964891|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83964892|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964893|NCT04312438|Caseins|caseins|mesh-list
83964894|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
83964895|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
83964896|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964897|NCT04312360|Metronidazole|metronidazole|mesh-list
83964898|NCT04312360|Fosfomycin|fosfomycin|mesh-list
83964899|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964900|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83964901|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83964902|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83964903|NCT00197106|Fluticasone|fluticasone|mesh-list
83964904|NCT00197106|Xhance|xhance|mesh-list
83964905|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83964906|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964907|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83964908|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
83964909|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964910|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964911|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83964912|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
83964913|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83964914|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83964915|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83964916|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83964917|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83964918|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
83964919|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83964920|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964921|NCT01136746|Insulin|insulin|mesh-list
83964922|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83964923|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
83964924|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
83964925|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83964926|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964927|NCT01136356|Morphine|morphine|mesh-list
83964928|NCT01136356|Buprenorphine|buprenorphine|mesh-list
83964929|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83964930|NCT01136356|Narcotics|narcotics|mesh-ancestor
83964931|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83964932|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964933|NCT01136356|Analgesics|analgesics|mesh-ancestor
83964934|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
83964935|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964936|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83964937|NCT00587379|Atorvastatin|atorvastatin|mesh-list
83964938|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83964939|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83964940|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
83964941|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964942|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83964943|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83964944|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964945|NCT04673396|Norcantharidin|norcantharidin|mesh-list
83964946|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964947|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964948|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964949|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
83964950|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83964951|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964952|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
83964953|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83964954|NCT00196326|Estradiol|estradiol|mesh-list
83964955|NCT00196326|Estrogens|estrogens|mesh-ancestor
83964956|NCT00196326|Hormones|hormones|mesh-ancestor
83964957|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83964958|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964959|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83964960|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
83964961|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964962|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83964963|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83964964|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83964965|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83964966|NCT00587496|Aspirin|aspirin|mesh-list
83964967|NCT00587496|Valacyclovir|valacyclovir|mesh-list
83964968|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83964969|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83964970|NCT00587496|Analgesics|analgesics|mesh-ancestor
83964971|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
83964972|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83964973|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964974|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83964975|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83964976|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83204303|NCT03062163|Vitamins|vitamins|mesh-ancestor
83964977|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83964978|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964979|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83964980|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83964981|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964982|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
83964983|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
83964984|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83964985|NCT00195663|Adalimumab|adalimumab|mesh-list
83964986|NCT00195663|Methotrexate|methotrexate|mesh-list
83964987|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83964988|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
83964989|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83964990|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83964991|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83964992|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
83964993|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83964994|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83964995|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
83964996|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83964997|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83964998|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83964999|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
83965000|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965001|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83965002|NCT00195663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83965003|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965004|NCT01135498|Bevacizumab|bevacizumab|mesh-list
83965005|NCT01135498|Capecitabine|capecitabine|mesh-list
83965006|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83965007|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
83965008|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965009|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965010|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83965011|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83965012|NCT01135498|Growth Substances|growth substances|mesh-ancestor
83965013|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965014|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
83965015|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965016|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
83965017|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965018|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83965019|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965020|NCT04610567|Methotrexate|methotrexate|mesh-list
83965021|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83965022|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
83965023|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83965024|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965025|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965026|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
83965027|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965028|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965029|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
83965030|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965031|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83965032|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965033|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
83965034|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965035|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83965036|NCT02883439|Fluticasone|fluticasone|mesh-list
83965037|NCT02883439|Xhance|xhance|mesh-list
83965038|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965039|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83965040|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
83965041|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965042|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965043|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83965044|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
83965045|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
83965046|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83965047|NCT00195507|Etanercept|etanercept|mesh-list
83965048|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83965049|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83965050|NCT00195507|Analgesics|analgesics|mesh-ancestor
83965051|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
83204376|NCT03256487|Morphine|morphine|mesh-list
83965052|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965053|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965054|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965055|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965056|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965057|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965058|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
83965059|NCT00195429|Sirolimus|sirolimus|mesh-list
83965060|NCT00195429|Prednisone|prednisone|mesh-list
83965061|NCT00195429|Tacrolimus|tacrolimus|mesh-list
83965062|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965063|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
83965064|NCT00195429|Hormones|hormones|mesh-ancestor
83965065|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965066|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965067|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83965068|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965069|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965070|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
83965071|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83965072|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965073|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965074|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83965075|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965076|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83965077|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
83965078|NCT00195351|Metronidazole|metronidazole|mesh-list
83965079|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
83965080|NCT00195351|Tigecycline|tigecycline|mesh-list
83965081|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965082|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83965083|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83965084|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83965085|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83965086|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965087|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965088|NCT04609748|Nimesulide|nimesulide|mesh-list
83965089|NCT04609748|Cannabidiol|cannabidiol|mesh-list
83965090|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
83965091|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83965092|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83965093|NCT04609748|Analgesics|analgesics|mesh-ancestor
83965094|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
83965095|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965096|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965097|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965098|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965099|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83965100|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965101|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965102|NCT00195273|Cyclosporine|cyclosporine|mesh-list
83965103|NCT00195273|Sirolimus|sirolimus|mesh-list
83965104|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
83965105|NCT00195273|Cyclosporins|cyclosporins|mesh-list
83965106|NCT00195273|Daclizumab|daclizumab|mesh-list
83965107|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965108|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965109|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965110|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
83965111|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965112|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
83965113|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965114|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
83965115|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965116|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83965117|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83965118|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965119|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83965120|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
83965121|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83965122|NCT00564200|Dexamethasone|dexamethasone|mesh-list
83965123|NCT00564200|Fludarabine|fludarabine|mesh-list
83965124|NCT00564200|Bortezomib|bortezomib|mesh-list
83965125|NCT00564200|Melphalan|melphalan|mesh-list
83965126|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965127|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
83965128|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
83965129|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965130|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965131|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965132|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
83965133|NCT00564200|Hormones|hormones|mesh-ancestor
83965134|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965135|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83965136|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965137|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965138|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965139|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
83965140|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83965141|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
83965142|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83965143|NCT00193479|Prednisone|prednisone|mesh-list
83965144|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
83965145|NCT00193479|Rituximab|rituximab|mesh-list
83965146|NCT00193479|Vincristine|vincristine|mesh-list
83965147|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
83965148|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965149|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
83965150|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965151|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965152|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83965153|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
83965154|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965155|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965156|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83965157|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965158|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965159|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
83965160|NCT00193479|Hormones|hormones|mesh-ancestor
83965161|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965162|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83965163|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83965164|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965165|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965166|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965167|NCT00193479|Analgesics|analgesics|mesh-ancestor
83965168|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
83965169|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965170|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83965171|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83965172|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965173|NCT00193206|Paclitaxel|paclitaxel|mesh-list
83965174|NCT00193206|Gemcitabine|gemcitabine|mesh-list
83965175|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83965176|NCT00193206|Epirubicin|epirubicin|mesh-list
83965177|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83965178|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965179|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965180|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965181|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965182|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965183|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965184|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
83965185|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83965186|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83965187|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83965188|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965189|NCT00193050|Gemcitabine|gemcitabine|mesh-list
83965190|NCT00193050|Docetaxel|docetaxel|mesh-list
83965191|NCT00193050|Epirubicin|epirubicin|mesh-list
83965192|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965193|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
83965194|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965195|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965196|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965197|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965198|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965199|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83965200|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83965201|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83965202|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965203|NCT04608734|Midazolam|midazolam|mesh-list
83965204|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83204520|NCT04953117|Paclitaxel|paclitaxel|mesh-list
83965205|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83965206|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965207|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965208|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83965209|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83965210|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965211|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83965212|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
83965213|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
83965214|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
83965215|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
83965216|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965217|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965218|NCT00192075|Leucovorin|leucovorin|mesh-list
83965219|NCT00192075|Folic Acid|folic acid|mesh-list
83965220|NCT00192075|Gemcitabine|gemcitabine|mesh-list
83965221|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
83965222|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
83965223|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965224|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
83965225|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965226|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965227|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965228|NCT00192075|Antidotes|antidotes|mesh-ancestor
83965229|NCT00192075|Protective Agents|protective agents|mesh-ancestor
83965230|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
83965231|NCT00192075|Vitamins|vitamins|mesh-ancestor
83965232|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
83965233|NCT00192075|Hematinics|hematinics|mesh-ancestor
83965234|NCT00192036|Gemcitabine|gemcitabine|mesh-list
83965235|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965236|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965237|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
83965238|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965239|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83965240|NCT00191724|Enoxaparin|enoxaparin|mesh-list
83965241|NCT00191724|Protein C|protein c|mesh-list
83965242|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
83965243|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83965244|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83965245|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965246|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965247|NCT00191646|Paclitaxel|paclitaxel|mesh-list
83965248|NCT00191646|Carboplatin|carboplatin|mesh-list
83965249|NCT00191646|Gemcitabine|gemcitabine|mesh-list
83965250|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83965251|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965252|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965253|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965254|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965255|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965256|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965257|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
83965258|NCT00191451|Carboplatin|carboplatin|mesh-list
83965259|NCT00191451|Gemcitabine|gemcitabine|mesh-list
83965260|NCT00191451|Trastuzumab|trastuzumab|mesh-list
83965261|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965262|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965263|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
83965264|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965265|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965266|NCT00191334|Gemcitabine|gemcitabine|mesh-list
83965267|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965268|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965269|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
83965270|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965271|NCT00191139|Cisplatin|cisplatin|mesh-list
83965272|NCT00191139|Gemcitabine|gemcitabine|mesh-list
83965273|NCT00191139|Docetaxel|docetaxel|mesh-list
83965274|NCT00191139|Etoposide|etoposide|mesh-list
83965275|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
83965276|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965277|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965278|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
83965279|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965280|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965281|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965282|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965283|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83965284|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83965285|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83965286|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965287|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
83965288|NCT00564512|Rituximab|rituximab|mesh-list
83965289|NCT00564512|Fludarabine|fludarabine|mesh-list
83965290|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
83965291|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965292|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
83965293|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965294|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965295|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83965296|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
83965297|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965298|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965299|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83965300|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965301|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
83965302|NCT00564551|Calcium|calcium|mesh-list
83965303|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83965304|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965305|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83965306|NCT00190983|Pemetrexed|pemetrexed|mesh-list
83965307|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965308|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965309|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965310|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83965311|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83965312|NCT00190749|Olanzapine|olanzapine|mesh-list
83965313|NCT00190749|Risperidone|risperidone|mesh-list
83965314|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83965315|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
83965316|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965317|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965318|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965319|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83965320|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83965321|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965322|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965323|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83965324|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
83965325|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
83965326|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
83965327|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965328|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965329|NCT00190749|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83965330|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83965331|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965332|NCT04607447|Dexamethasone|dexamethasone|mesh-list
83965333|NCT04607447|Atorvastatin|atorvastatin|mesh-list
83965334|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965335|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
83965336|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
83965337|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965338|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965339|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965340|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
83965341|NCT04607447|Hormones|hormones|mesh-ancestor
83965342|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965343|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83965344|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965345|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83965346|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83965347|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
83965348|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965349|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83965350|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83965351|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965352|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
83965353|NCT00190671|Pemetrexed|pemetrexed|mesh-list
83965354|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965355|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
83204673|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
83965356|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965357|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965358|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83965359|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
83965360|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965361|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965362|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83965363|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965364|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83965365|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83965366|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
83965367|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83965368|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965369|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965370|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83965371|NCT04607525|Analgesics|analgesics|mesh-ancestor
83965372|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
83965373|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965374|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83965375|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83965376|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83965377|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
83965378|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965379|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965380|NCT00198276|Bleomycin|bleomycin|mesh-list
83965381|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83965382|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965383|NCT04607642|Manganese|manganese|mesh-list
83965384|NCT04607642|Trace Elements|trace elements|mesh-ancestor
83965385|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
83965386|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965387|NCT00588003|Anastrozole|anastrozole|mesh-list
83965388|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83965389|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965390|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83965391|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83965392|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965393|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965394|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83965395|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
83965396|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965397|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965398|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
83965399|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83965400|NCT00564590|Melatonin|melatonin|mesh-list
83965401|NCT00564590|Omeprazole|omeprazole|mesh-list
83965402|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
83965403|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965404|NCT00564590|Protective Agents|protective agents|mesh-ancestor
83965405|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965406|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965407|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83965408|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965409|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83965410|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965411|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
83965412|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
83965413|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83965414|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965415|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
83965416|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83965417|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83965418|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83965419|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965420|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965421|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
83965422|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965423|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965424|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83965425|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965426|NCT04574778|Acetaminophen|acetaminophen|mesh-list
83965427|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83965428|NCT04574778|Analgesics|analgesics|mesh-ancestor
83965429|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
83204748|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
83965430|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965431|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965432|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
83965433|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83965434|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83965435|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965436|NCT04605770|Pemetrexed|pemetrexed|mesh-list
83965437|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965438|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965439|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965440|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83965441|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83965442|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83965443|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83965444|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
83965445|NCT04605419|Calcium|calcium|mesh-list
83965446|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83965447|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965448|NCT04605575|Vinorelbine|vinorelbine|mesh-list
83965449|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83965450|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965451|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965452|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965453|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965454|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965455|NCT00589134|Ganirelix|ganirelix|mesh-list
83965456|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
83965457|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965458|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965459|NCT00589251|Penicillins|penicillins|mesh-list
83965460|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83965461|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965462|NCT00564824|Caffeine|caffeine|mesh-list
83965463|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83965464|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965465|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83965466|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965467|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965468|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83965469|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83965470|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
83965471|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965472|NCT00589485|Cobalt|cobalt|mesh-list
83965473|NCT00589485|Trace Elements|trace elements|mesh-ancestor
83965474|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
83965475|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965476|NCT00564941|Deferasirox|deferasirox|mesh-list
83965477|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83965478|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
83965479|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
83965480|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965481|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83965482|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83965483|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965484|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
83965485|NCT00589953|Hematinics|hematinics|mesh-ancestor
83965486|NCT00589992|Ibutilide|ibutilide|mesh-list
83965487|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83965488|NCT00590070|Adenosine|adenosine|mesh-list
83965489|NCT00590070|Nitroprusside|nitroprusside|mesh-list
83965490|NCT00590070|Analgesics|analgesics|mesh-ancestor
83965491|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
83965492|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965493|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965494|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83965495|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
83965496|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83965497|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
83965498|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
83965499|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965500|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965501|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83965502|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83965503|NCT00565019|Triamcinolone|triamcinolone|mesh-list
83965504|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83965505|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83965506|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83965507|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965508|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
83965509|NCT00565019|Hormones|hormones|mesh-ancestor
83965510|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965511|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965512|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965513|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
83965514|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965515|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965516|NCT00565097|Lanreotide|lanreotide|mesh-list
83965517|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965518|NCT04604756|Losartan|losartan|mesh-list
83965519|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83965520|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83965521|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83965522|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83965523|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965524|NCT00590343|Vatalanib|vatalanib|mesh-list
83965525|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83965526|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965527|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965528|NCT04604678|Metformin|metformin|mesh-list
83965529|NCT04604678|Naltrexone|naltrexone|mesh-list
83965530|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83965531|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965532|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83965533|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83965534|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
83965535|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965536|NCT04604327|Bemiparin|bemiparin|mesh-list
83965537|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
83965538|NCT00590694|Ranibizumab|ranibizumab|mesh-list
83965539|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83965540|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83965541|NCT00590694|Growth Substances|growth substances|mesh-ancestor
83965542|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965543|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
83965544|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965545|NCT00565175|Famotidine|famotidine|mesh-list
83965546|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83965547|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965548|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83965549|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
83965550|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
83965551|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965552|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965553|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965554|NCT00477165|Citalopram|citalopram|mesh-list
83965555|NCT00477165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83965556|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83965557|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965558|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965559|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965560|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
83965561|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965562|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83965563|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
83965564|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965565|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83965566|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83965567|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965568|NCT00476229|Rituximab|rituximab|mesh-list
83965569|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
83965570|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83965571|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965572|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965573|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
83965574|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965575|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965576|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965577|NCT04603976|Erenumab|erenumab|mesh-list
83965578|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83965579|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965580|NCT04603976|Analgesics|analgesics|mesh-ancestor
83965581|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
83965582|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965583|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965585|NCT00476151|Amitriptyline|amitriptyline|mesh-list
83965586|NCT00476151|Analgesics|analgesics|mesh-ancestor
83965587|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
83965588|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965589|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965590|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83965591|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83965592|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
83965593|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
83965594|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965595|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83965596|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83965597|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965598|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965599|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83965600|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
83965601|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965602|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83965603|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83965604|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83965605|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965606|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
83965607|NCT04603664|Cystatins|cystatins|mesh-list
83965608|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83965609|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
83965610|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965611|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965612|NCT00474903|Aspirin|aspirin|mesh-list
83965613|NCT00474903|Esomeprazole|esomeprazole|mesh-list
83965614|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83965615|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965616|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83965617|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965618|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965619|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83965620|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83965621|NCT00474903|Analgesics|analgesics|mesh-ancestor
83965622|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
83965623|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965624|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965625|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965626|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965627|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83965628|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83965629|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83965630|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83965631|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
83965632|NCT01134055|Ranibizumab|ranibizumab|mesh-list
83965633|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83965634|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83965635|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83965636|NCT01134055|Growth Substances|growth substances|mesh-ancestor
83965637|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965638|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
83965639|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965640|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83965641|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83965642|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83965643|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83965644|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965645|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965646|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965647|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965648|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83965649|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
83965650|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965651|NCT00474240|Atorvastatin|atorvastatin|mesh-list
83965652|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83965653|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83965654|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
83965655|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965656|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83965657|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83965658|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965659|NCT00473889|Paclitaxel|paclitaxel|mesh-list
83965660|NCT00473889|Carboplatin|carboplatin|mesh-list
83965661|NCT00473889|Vorinostat|vorinostat|mesh-list
83965662|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83965663|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965664|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965665|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965666|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965667|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965668|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83965669|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965670|NCT00565214|Vitamins|vitamins|mesh-list
83965671|NCT00565214|Vitamin E|vitamin e|mesh-list
83965672|NCT00565214|Selenium|selenium|mesh-list
83965673|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
83965674|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965675|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
83965676|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965677|NCT00565214|Protective Agents|protective agents|mesh-ancestor
83965678|NCT00565214|Trace Elements|trace elements|mesh-ancestor
83965679|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
83965680|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83965681|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
83965682|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965683|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965684|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83965685|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
83965686|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83965687|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
83965688|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965689|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965690|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83965691|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83965692|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
83965693|NCT00565253|Protective Agents|protective agents|mesh-ancestor
83965694|NCT02277600|Darunavir|darunavir|mesh-list
83965695|NCT02277600|Cobicistat|cobicistat|mesh-list
83965696|NCT02277600|Fostemsavir|fostemsavir|mesh-list
83965697|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83965698|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83965699|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
83965700|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965701|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965702|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83965703|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83965704|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
83965705|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965706|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83965707|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83965708|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83965709|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83965710|NCT04602143|Testosterone|testosterone|mesh-list
83965711|NCT04602143|Androgens|androgens|mesh-ancestor
83965712|NCT04602143|Hormones|hormones|mesh-ancestor
83965713|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965714|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965715|NCT02277678|Morphine|morphine|mesh-list
83965716|NCT02277678|Oxycodone|oxycodone|mesh-list
83965717|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
83965718|NCT02277678|Narcotics|narcotics|mesh-ancestor
83965719|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965720|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965721|NCT02277678|Analgesics|analgesics|mesh-ancestor
83965722|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
83965723|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965724|NCT02277717|Trastuzumab|trastuzumab|mesh-list
83965725|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965726|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205049|NCT04944381|Vaccines|vaccines|mesh-list
83965727|NCT04601675|Dexamethasone|dexamethasone|mesh-list
83965728|NCT04601675|Ranibizumab|ranibizumab|mesh-list
83965729|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965730|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
83965731|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
83965732|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965733|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965734|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965735|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
83965736|NCT04601675|Hormones|hormones|mesh-ancestor
83965737|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965738|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83965739|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965740|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83965741|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83965742|NCT04601675|Growth Substances|growth substances|mesh-ancestor
83965743|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
83965744|NCT00565292|Anacetrapib|anacetrapib|mesh-list
83965745|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83965746|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83965747|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
83965748|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965749|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83965750|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
83965751|NCT01580865|Tacrolimus|tacrolimus|mesh-list
83965752|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83965753|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
83965754|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965755|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83965756|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965757|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965758|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83965759|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965760|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83965761|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
83965762|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83965763|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965764|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
83965765|NCT00473694|Rocuronium|rocuronium|mesh-list
83965766|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
83965767|NCT00473694|Neostigmine|neostigmine|mesh-list
83965768|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83965769|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83965770|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83965771|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965772|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965773|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83965774|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965775|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965776|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83965777|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965778|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83965779|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
83965780|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83965781|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83965782|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83965783|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83965784|NCT04601324|Fluticasone|fluticasone|mesh-list
83965785|NCT04601324|Xhance|xhance|mesh-list
83965786|NCT04601324|Azelastine|azelastine|mesh-list
83965787|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965788|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83965789|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
83965790|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965791|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965792|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83965793|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
83965794|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
83965795|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83965796|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83965797|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965798|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965799|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83965800|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83965801|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
83965802|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
83965803|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965804|NCT00565331|Rituximab|rituximab|mesh-list
83965805|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965806|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965807|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
83965808|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965809|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83965810|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83965811|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83965812|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83965813|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
83965814|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965815|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83965816|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83965817|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965818|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
83965819|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83965820|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965821|NCT00473382|Ranibizumab|ranibizumab|mesh-list
83965822|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83965823|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83965824|NCT00473382|Growth Substances|growth substances|mesh-ancestor
83965825|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965826|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
83965827|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965828|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
83965829|NCT04576364|Analgesics|analgesics|mesh-ancestor
83965830|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
83965831|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965832|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965833|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
83965834|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965835|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83965836|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
83965837|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83965838|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965839|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965840|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83965841|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
83965842|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83965843|NCT02210325|Azithromycin|azithromycin|mesh-list
83965844|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
83965845|NCT02210325|Solithromycin|solithromycin|mesh-list
83965846|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83965847|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965848|NCT00473265|Teriparatide|teriparatide|mesh-list
83965849|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83965850|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965851|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83965852|NCT00472641|Ziprasidone|ziprasidone|mesh-list
83965853|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83965854|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
83965855|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965856|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965857|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965858|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83965859|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83965860|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965861|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965862|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83965863|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
83965864|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
83965865|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83965866|NCT04571151|Halobetasol|halobetasol|mesh-list
83965867|NCT04571151|Calcipotriene|calcipotriene|mesh-list
83965868|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
83965869|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83965870|NCT01133977|Lenvatinib|lenvatinib|mesh-list
83965871|NCT01133977|Dacarbazine|dacarbazine|mesh-list
83965872|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965873|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83965874|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83965875|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965876|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83965877|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
83965878|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83965879|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83965880|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83965881|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965882|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965883|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965884|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965885|NCT00583193|Analgesics|analgesics|mesh-ancestor
83965886|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
83965887|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965888|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
83965889|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965890|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
83965891|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83965892|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
83965893|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965894|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83965895|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83965896|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965897|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965899|NCT00583271|Triamcinolone|triamcinolone|mesh-list
83965900|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965901|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
83965902|NCT00583271|Hormones|hormones|mesh-ancestor
83965903|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965904|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965905|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83965906|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83965907|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83965908|NCT00583349|Paclitaxel|paclitaxel|mesh-list
83965909|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83965910|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965911|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
83965912|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
83965913|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
83965914|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965915|NCT01133665|Lenalidomide|lenalidomide|mesh-list
83965916|NCT01133665|Cetuximab|cetuximab|mesh-list
83965917|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
83965918|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965919|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83965920|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83965921|NCT01133665|Growth Substances|growth substances|mesh-ancestor
83965922|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
83965923|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965924|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965925|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83965926|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
83965927|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83965928|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
83965929|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965930|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83965931|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83965932|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83965933|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83965934|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965935|NCT01133626|Prednisone|prednisone|mesh-list
83965936|NCT01133626|Beclomethasone|beclomethasone|mesh-list
83965937|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83965938|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
83965939|NCT01133626|Hormones|hormones|mesh-ancestor
83965940|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83965941|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965942|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83965943|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965944|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83965945|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
83965946|NCT01133392|Insulin|insulin|mesh-list
83965947|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83965948|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
83965949|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83965950|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205280|NCT03237533|Promethazine|promethazine|mesh-list
83965951|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83965952|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83965953|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83965954|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965955|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965956|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
83965957|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965958|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965959|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83965960|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83965961|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83965962|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965963|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965964|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83965965|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965966|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965967|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
83965968|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965969|NCT02210364|Capecitabine|capecitabine|mesh-list
83965970|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83965971|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
83965972|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965973|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965974|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83965975|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83965976|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83965977|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83965978|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965979|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83965980|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965981|NCT00471315|Analgesics|analgesics|mesh-ancestor
83965982|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
83965983|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83965984|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
83965985|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83965986|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
83965987|NCT00471237|Alendronate|alendronate|mesh-list
83965988|NCT00471237|Teriparatide|teriparatide|mesh-list
83965989|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83965990|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83965991|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83965992|NCT04570683|Nivolumab|nivolumab|mesh-list
83965993|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83965994|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83965995|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83965996|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83965997|NCT04570449|Fluoxetine|fluoxetine|mesh-list
83965998|NCT04570449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83965999|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83966000|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83966001|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966002|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966003|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
83966004|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966005|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83966006|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
83966007|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83966008|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83966009|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83966010|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966011|NCT00470847|Trastuzumab|trastuzumab|mesh-list
83966012|NCT00470847|Lapatinib|lapatinib|mesh-list
83966013|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966014|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966015|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83966016|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966017|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966018|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
83966019|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83205354|NCT05269030|Hormones|hormones|mesh-ancestor
83966020|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83966021|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
83966022|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966023|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966024|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966025|NCT00584090|Urological Agents|urological agents|mesh-ancestor
83966026|NCT00584168|Dexamethasone|dexamethasone|mesh-list
83966027|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966028|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
83966029|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
83966030|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966031|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966032|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966033|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
83966034|NCT00584168|Hormones|hormones|mesh-ancestor
83966035|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966036|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83966037|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966038|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83966039|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966040|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83966041|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966042|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966043|NCT01133275|Prednisone|prednisone|mesh-list
83966044|NCT01133275|Lenalidomide|lenalidomide|mesh-list
83966045|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966046|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
83966047|NCT01133275|Hormones|hormones|mesh-ancestor
83966048|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966049|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966050|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83966051|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966052|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
83966053|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83966054|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83966055|NCT01133275|Growth Substances|growth substances|mesh-ancestor
83966056|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
83966057|NCT00470184|Capecitabine|capecitabine|mesh-list
83966058|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
83966059|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83966060|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
83966061|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966062|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966063|NCT04570254|Vitamins|vitamins|mesh-list
83966064|NCT04570254|Vitamin E|vitamin e|mesh-list
83966065|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
83966066|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
83966067|NCT04570254|Melatonin|melatonin|mesh-list
83966068|NCT04570254|Antioxidants|antioxidants|mesh-list
83966069|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83966070|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
83966071|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966072|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966073|NCT04570254|Protective Agents|protective agents|mesh-ancestor
83966074|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966075|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83966076|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966077|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966078|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83966079|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
83966080|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83966081|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
83966082|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966083|NCT04570254|Expectorants|expectorants|mesh-ancestor
83966084|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
83966085|NCT04570254|Antidotes|antidotes|mesh-ancestor
83966086|NCT00470067|Carboplatin|carboplatin|mesh-list
83966087|NCT00470067|Doxorubicin|doxorubicin|mesh-list
83966088|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83966089|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966090|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83966091|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83966092|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83966093|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966094|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966095|NCT00584636|Budesonide|budesonide|mesh-list
83966096|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966097|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83966098|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
83966099|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966100|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966101|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83966102|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
83966103|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
83966104|NCT00584636|Hormones|hormones|mesh-ancestor
83966105|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966106|NCT00479817|Paclitaxel|paclitaxel|mesh-list
83966107|NCT00479817|Trebananib|trebananib|mesh-list
83966108|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83966109|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966110|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
83966111|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
83966112|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
83966113|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966114|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83966115|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83966116|NCT00479817|Growth Substances|growth substances|mesh-ancestor
83966117|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966118|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
83966119|NCT04575194|Liraglutide|liraglutide|mesh-list
83966120|NCT04575194|Naltrexone|naltrexone|mesh-list
83966121|NCT04575194|Bupropion|bupropion|mesh-list
83966122|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83966123|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83966124|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966125|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
83966126|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966127|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83966128|NCT04575194|Incretins|incretins|mesh-ancestor
83966129|NCT04575194|Hormones|hormones|mesh-ancestor
83966130|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966131|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83966132|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
83966133|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83966134|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83966135|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83966136|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83966137|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966138|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
83966139|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966140|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83966141|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83966142|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966143|NCT00478179|Bupivacaine|bupivacaine|mesh-list
83966144|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
83966145|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
83966146|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966147|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966148|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
83966149|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966150|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83966151|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83966152|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83966153|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
83966154|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966155|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83966156|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83966157|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966158|NCT00585260|Mannitol|mannitol|mesh-list
83966159|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83966160|NCT00585260|Diuretics|diuretics|mesh-ancestor
83966161|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
83966162|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966163|NCT00475020|Fludarabine|fludarabine|mesh-list
83966164|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
83966165|NCT00475020|Busulfan|busulfan|mesh-list
83966166|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
83966167|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83966168|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966169|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83966170|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
83966171|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966172|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966173|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
83966174|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966175|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
83966176|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83966177|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83966178|NCT00585455|Sertraline|sertraline|mesh-list
83966179|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
83966180|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83966181|NCT00585455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83966182|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83966183|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83966184|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966185|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966186|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
83966187|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966188|NCT01083966|Bevacizumab|bevacizumab|mesh-list
83966189|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966190|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966191|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83966192|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83966193|NCT01083966|Growth Substances|growth substances|mesh-ancestor
83966194|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966195|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
83966196|NCT01132807|Prednisone|prednisone|mesh-list
83966197|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
83966198|NCT01132807|Dacarbazine|dacarbazine|mesh-list
83966199|NCT01132807|Doxorubicin|doxorubicin|mesh-list
83966200|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83966201|NCT01132807|Etoposide|etoposide|mesh-list
83966202|NCT01132807|Bleomycin|bleomycin|mesh-list
83966203|NCT01132807|Vinblastine|vinblastine|mesh-list
83966204|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
83966205|NCT01132807|Procarbazine|procarbazine|mesh-list
83966206|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83966207|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966208|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
83966209|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966210|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966211|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83966212|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
83966213|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966214|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966215|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83966216|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83966217|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83966218|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83966219|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966220|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966221|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
83966222|NCT01132807|Hormones|hormones|mesh-ancestor
83966223|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966224|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83966225|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83966226|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83966227|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83966228|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83966229|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83966230|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
83966231|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83966232|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966233|NCT01089543|Rabeprazole|rabeprazole|mesh-list
83966234|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83966235|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966236|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83966237|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966238|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966239|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83966240|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966241|NCT01089504|Phenobarbital|phenobarbital|mesh-list
83966242|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
83966243|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83966244|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966245|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966246|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83966247|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83966248|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966249|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966250|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
83966252|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83966253|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83966254|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83966255|NCT03452696|Calcium|calcium|mesh-list
83966256|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83966257|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966258|NCT01088997|Milrinone|milrinone|mesh-list
83966259|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83966260|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966261|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
83966262|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83966263|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83966264|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966265|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966266|NCT01088997|Protective Agents|protective agents|mesh-ancestor
83966267|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966268|NCT00586118|Propofol|propofol|mesh-list
83966269|NCT00586118|Sevoflurane|sevoflurane|mesh-list
83966270|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83966271|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966272|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966273|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83966274|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
83966275|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
83966276|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966277|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83966278|NCT01088529|Prednisone|prednisone|mesh-list
83966279|NCT01088529|Leuprolide|leuprolide|mesh-list
83966280|NCT01088529|Goserelin|goserelin|mesh-list
83966281|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
83966282|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966283|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
83966284|NCT01088529|Hormones|hormones|mesh-ancestor
83966285|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966286|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966287|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83966288|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966289|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83966290|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
83966291|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83966292|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83966293|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966294|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966295|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
83966296|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83966297|NCT00586274|Fludarabine|fludarabine|mesh-list
83966298|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
83966299|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966300|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966301|NCT00586430|Lorazepam|lorazepam|mesh-list
83966302|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
83966303|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
83966304|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
83966305|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531097|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
83966306|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966307|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966308|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83966309|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966310|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83966311|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83966312|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83966313|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
83966314|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
83966315|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966316|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966317|NCT04569279|Warfarin|warfarin|mesh-list
83966318|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
83966319|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
83966320|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83966321|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
83966322|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83966323|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
83966324|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966325|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966326|NCT04312204|Carboplatin|carboplatin|mesh-list
83966327|NCT04312204|Gemcitabine|gemcitabine|mesh-list
83966328|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966329|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83966330|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
83966331|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966332|NCT04312282|Itraconazole|itraconazole|mesh-list
83966333|NCT04312282|Rifampin|rifampin|mesh-list
83966334|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
83966335|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966336|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83966337|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83966338|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966339|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966340|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83966341|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
83966342|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966343|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966344|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83966345|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83966346|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
83966347|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83966348|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
83966349|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83966350|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83966351|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83966352|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83966353|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83966354|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83966355|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83966356|NCT01087905|Nicotine|nicotine|mesh-list
83966357|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83966358|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
83966359|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966360|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966361|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83966362|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83966363|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
83966364|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966365|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966366|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
83966367|NCT01087788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83966368|NCT01087788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966369|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966370|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
83966371|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966372|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966373|NCT00586976|Ropivacaine|ropivacaine|mesh-list
83966374|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
83966375|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
83966376|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966377|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966378|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
83966379|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966380|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
83966381|NCT00587015|Immunotoxins|immunotoxins|mesh-ancestor
83966382|NCT00587015|Immunoconjugates|immunoconjugates|mesh-ancestor
83966383|NCT00587015|Immunologic Factors|immunologic factors|mesh-ancestor
83966384|NCT00587015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966385|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966386|NCT04568772|Atovaquone|atovaquone|mesh-list
83966387|NCT04568772|Proguanil|proguanil|mesh-list
83966388|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83966389|NCT04568772|Esomeprazole|esomeprazole|mesh-list
83966390|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83966391|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966392|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83966393|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966394|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966395|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966396|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
83966397|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83966398|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83966399|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
83966400|NCT04575389|Uric Acid|uric acid|mesh-list
83966401|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
83966402|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966403|NCT04575389|Protective Agents|protective agents|mesh-ancestor
83966404|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966405|NCT01086150|Lidocaine|lidocaine|mesh-list
83966406|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
83966407|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
83966408|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966409|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966410|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
83966411|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966412|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83966413|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83966414|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83966415|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83966416|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966417|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83966418|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83966419|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
83966420|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966421|NCT00587249|Antacids|antacids|mesh-ancestor
83966422|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966423|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966424|NCT00587327|Atosiban|atosiban|mesh-list
83966425|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
83966426|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966427|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966428|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
83966429|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83966430|NCT00587444|Heparin|heparin|mesh-list
83966431|NCT00587444|Calcium heparin|calcium heparin|mesh-list
83966432|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
83966433|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83966434|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83966435|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966436|NCT02278302|Ethanol|ethanol|mesh-list
83966437|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83966438|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83966439|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966440|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966441|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966442|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966443|NCT00587717|Simvastatin|simvastatin|mesh-list
83966444|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83966445|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83966446|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
83966447|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966448|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83966449|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83966450|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966451|NCT01085136|Afatinib|afatinib|mesh-list
83966452|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966453|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83966454|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966455|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966456|NCT00587873|Leucovorin|leucovorin|mesh-list
83966457|NCT00587873|Methotrexate|methotrexate|mesh-list
83966458|NCT00587873|Thioguanine|thioguanine|mesh-list
83966459|NCT00587873|Calcium|calcium|mesh-list
83966460|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
83966461|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83966462|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966463|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83966464|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
83966465|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83966466|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83205790|NCT02120794|Insulin|insulin|mesh-list
83966467|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
83966468|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966469|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966470|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
83966471|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966472|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83966473|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966474|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
83966475|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966476|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83966477|NCT00587873|Antidotes|antidotes|mesh-ancestor
83966478|NCT00587873|Protective Agents|protective agents|mesh-ancestor
83966479|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
83966480|NCT00587873|Vitamins|vitamins|mesh-ancestor
83966481|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
83966482|NCT01084707|Nicotine|nicotine|mesh-list
83966483|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83966484|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
83966485|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966486|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966487|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83966488|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83966489|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
83966490|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966491|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966492|NCT02210598|Oxytocin|oxytocin|mesh-list
83966493|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
83966494|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83966495|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966496|NCT04574960|Carboplatin|carboplatin|mesh-list
83966497|NCT04574960|Gemcitabine|gemcitabine|mesh-list
83966498|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966499|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83966500|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
83966501|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966502|NCT03452657|Ranibizumab|ranibizumab|mesh-list
83966503|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83966504|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83966505|NCT03452657|Growth Substances|growth substances|mesh-ancestor
83966506|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966507|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
83966508|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966509|NCT03452501|Infliximab|infliximab|mesh-list
83966510|NCT03452501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83966511|NCT03452501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966512|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
83966513|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966514|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966515|NCT00588302|Moexipril|moexipril|mesh-list
83966516|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83966517|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
83966518|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966519|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966520|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83966521|NCT01084005|Linagliptin|linagliptin|mesh-list
83966522|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83966523|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966524|NCT01084005|Incretins|incretins|mesh-ancestor
83966525|NCT01084005|Hormones|hormones|mesh-ancestor
83966526|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966527|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83966528|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
83966529|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966530|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966531|NCT01083810|Ritonavir|ritonavir|mesh-list
83966532|NCT01083810|Lopinavir|lopinavir|mesh-list
83966533|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83966534|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83966535|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
83966536|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966537|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966538|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83966539|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83966540|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
83966541|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966542|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83966543|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83966545|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83966546|NCT00588926|Narcotics|narcotics|mesh-ancestor
83966547|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966548|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966549|NCT00588926|Analgesics|analgesics|mesh-ancestor
83966550|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
83966551|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966552|NCT00589082|Daunorubicin|daunorubicin|mesh-list
83966553|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83966554|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966555|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83966556|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83966557|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966558|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966559|NCT00589238|Paclitaxel|paclitaxel|mesh-list
83966560|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
83966561|NCT00589238|Carboplatin|carboplatin|mesh-list
83966562|NCT00589238|Doxorubicin|doxorubicin|mesh-list
83966563|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83966564|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83966565|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966566|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
83966567|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
83966568|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
83966569|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966570|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966571|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
83966572|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966573|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966574|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83966575|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
83966576|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83966577|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83966578|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83966579|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83966580|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966581|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83966582|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
83966583|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966584|NCT01083576|Gentamicins|gentamicins|mesh-list
83966585|NCT01083576|Paromomycin|paromomycin|mesh-list
83966586|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83966587|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966588|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83966589|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966590|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966591|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83966592|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83966593|NCT04568265|Entecavir|entecavir|mesh-list
83966594|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
83966595|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966596|NCT04568304|Carboplatin|carboplatin|mesh-list
83966597|NCT04568304|Gemcitabine|gemcitabine|mesh-list
83966598|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966599|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83966600|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
83966601|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966602|NCT01082640|Febuxostat|febuxostat|mesh-list
83966603|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
83966604|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966605|NCT00589862|Clopidogrel|clopidogrel|mesh-list
83966606|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966607|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83966608|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83966609|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83966610|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
83966611|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966612|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966613|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966614|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
83966615|NCT00589901|Capecitabine|capecitabine|mesh-list
83966616|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966617|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
83966618|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966619|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966620|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83966621|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
83966622|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966623|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966624|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83966625|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83966626|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
83966627|NCT00590174|Aspirin|aspirin|mesh-list
83966628|NCT00590174|Clopidogrel|clopidogrel|mesh-list
83966629|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83966630|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83966631|NCT00590174|Analgesics|analgesics|mesh-ancestor
83966632|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
83966633|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966634|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966635|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966636|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966637|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83966638|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83966639|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966640|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966641|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83966642|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966643|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
83966644|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83966645|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83966646|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83966647|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
83966648|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966649|NCT00590213|Bicalutamide|bicalutamide|mesh-list
83966650|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
83966651|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
83966652|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966653|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966654|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966655|NCT00590408|Ubiquinone|ubiquinone|mesh-list
83966656|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
83966657|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
83966658|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966659|NCT00590408|Vitamins|vitamins|mesh-ancestor
83966660|NCT00590447|Rituximab|rituximab|mesh-list
83966661|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966662|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966663|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
83966664|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966665|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966666|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83966667|NCT01081626|Hormones|hormones|mesh-ancestor
83966668|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966669|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966670|NCT01080768|Amlodipine|amlodipine|mesh-list
83966671|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83966672|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83966673|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83966674|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966675|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83966676|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966677|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
83966678|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83966679|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83966680|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966681|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966682|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83966683|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83966684|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966685|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
83966686|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966687|NCT03452306|Metformin|metformin|mesh-list
83966688|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83966689|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206016|NCT04430361|Megestrol|megestrol|mesh-list
83966690|NCT01080300|Gabapentin|gabapentin|mesh-list
83966691|NCT01080300|Analgesics|analgesics|mesh-ancestor
83966692|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
83966693|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966694|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966695|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
83966696|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83966697|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83966698|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966699|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83966700|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83966701|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83966702|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966703|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966704|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
83966705|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
83966706|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83966707|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83966708|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
83966709|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966710|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83966711|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83966712|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966713|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966714|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
83966715|NCT00590603|Bortezomib|bortezomib|mesh-list
83966716|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
83966717|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966718|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
83966719|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966720|NCT00590603|Protective Agents|protective agents|mesh-ancestor
83966721|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966722|NCT00590603|Vitamins|vitamins|mesh-ancestor
83966723|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
83966724|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
83966725|NCT01085097|Prednisone|prednisone|mesh-list
83966726|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
83966727|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83966728|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83966729|NCT01085097|Prednisolone|prednisolone|mesh-list
83966730|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
83966731|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83966732|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
83966733|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966734|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
83966735|NCT01085097|Hormones|hormones|mesh-ancestor
83966736|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966737|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966738|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83966739|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966740|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83966741|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83966742|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
83966743|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83966744|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966745|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966746|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966747|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
83966748|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
83966749|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966750|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966751|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83966752|NCT01085097|Protective Agents|protective agents|mesh-ancestor
83966753|NCT00590837|Lomustine|lomustine|mesh-list
83966754|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83966755|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
83966756|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966757|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966758|NCT01086267|Cetuximab|cetuximab|mesh-list
83966759|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966760|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966761|NCT00590915|Asparaginase|asparaginase|mesh-list
83966762|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966763|NCT04567290|Ticagrelor|ticagrelor|mesh-list
83966764|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966765|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83966766|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83966767|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83966768|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
83966769|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966770|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966771|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966772|NCT01084161|Morphine|morphine|mesh-list
83966773|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83966774|NCT01084161|Narcotics|narcotics|mesh-ancestor
83966775|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966776|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966777|NCT01084161|Analgesics|analgesics|mesh-ancestor
83966778|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
83966779|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966780|NCT01083615|Prednisone|prednisone|mesh-list
83966781|NCT01083615|Docetaxel|docetaxel|mesh-list
83966782|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966783|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83966784|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83966785|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83966786|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966787|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966788|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
83966789|NCT01083615|Hormones|hormones|mesh-ancestor
83966790|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966791|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966792|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83966793|NCT00591188|Interferons|interferons|mesh-list
83966794|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
83966795|NCT00591188|Capecitabine|capecitabine|mesh-list
83966796|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83966797|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
83966798|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966799|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966800|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
83966801|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966802|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
83966803|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966804|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83966805|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966806|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83966807|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966808|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966809|NCT01081782|Ceralifimod|ceralifimod|mesh-list
83966810|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83966811|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966812|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966813|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
83966814|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966815|NCT01080222|Ribavirin|ribavirin|mesh-list
83966816|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83966817|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
83966818|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966819|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
83966820|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966821|NCT03452267|Metformin|metformin|mesh-list
83966822|NCT03452267|Pioglitazone|pioglitazone|mesh-list
83966823|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83966824|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966825|NCT01088802|Carboplatin|carboplatin|mesh-list
83966826|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966827|NCT03451682|Procyanidin|procyanidin|mesh-list
83966828|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
83966829|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966830|NCT03451682|Protective Agents|protective agents|mesh-ancestor
83966831|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966832|NCT02210754|Menthol|menthol|mesh-list
83966833|NCT02210754|Nicotine|nicotine|mesh-list
83966834|NCT02210754|Glycerol|glycerol|mesh-list
83966835|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83966836|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
83966837|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966838|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966839|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83966840|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83966841|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
83966842|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966843|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966844|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
83966845|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
83966846|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83966847|NCT02210754|Protective Agents|protective agents|mesh-ancestor
83966848|NCT04998279|Lenograstim|lenograstim|mesh-list
83966849|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83966850|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
83966851|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966852|NCT04574141|Melatonin|melatonin|mesh-list
83966853|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
83966854|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966855|NCT04574141|Protective Agents|protective agents|mesh-ancestor
83966856|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966857|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966858|NCT04998981|Fenofibrate|fenofibrate|mesh-list
83966859|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83966860|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
83966861|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966862|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83966863|NCT04573049|Simendan|simendan|mesh-list
83966864|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83966865|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
83966866|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83966867|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83966868|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966869|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966870|NCT04573049|Protective Agents|protective agents|mesh-ancestor
83966871|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966872|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
83966873|NCT04572698|Growth Substances|growth substances|mesh-ancestor
83966874|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966875|NCT04572542|Paclitaxel|paclitaxel|mesh-list
83966876|NCT04572542|Apatinib|apatinib|mesh-list
83966877|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83966878|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966879|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83966880|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83966881|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83966882|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966883|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83966884|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966885|NCT04991103|Dexamethasone|dexamethasone|mesh-list
83966886|NCT04991103|Lenalidomide|lenalidomide|mesh-list
83966887|NCT04991103|Bortezomib|bortezomib|mesh-list
83966888|NCT04991103|Daratumumab|daratumumab|mesh-list
83966889|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966890|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
83966891|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
83966892|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966893|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966894|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83966895|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
83966896|NCT04991103|Hormones|hormones|mesh-ancestor
83966897|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83966898|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83966899|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966900|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
83966901|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83966902|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83966903|NCT04991103|Growth Substances|growth substances|mesh-ancestor
83966904|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
83966905|NCT04572620|Rituximab|rituximab|mesh-list
83966906|NCT04572620|Abatacept|abatacept|mesh-list
83966907|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966908|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966909|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
83966910|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966911|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966912|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83966913|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966914|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83966915|NCT03451019|Sevelamer|sevelamer|mesh-list
83966916|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
83966917|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
83966918|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966919|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
83966920|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83966921|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966922|NCT02211066|Clopidogrel|clopidogrel|mesh-list
83966923|NCT02211066|Ticagrelor|ticagrelor|mesh-list
83966924|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966925|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83966926|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83966927|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83966928|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
83966929|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83966930|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966931|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966932|NCT03450317|Aspirin|aspirin|mesh-list
83966933|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83966934|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83966935|NCT03450317|Analgesics|analgesics|mesh-ancestor
83966936|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
83966937|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966938|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966939|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83966940|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83966941|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83966942|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83966943|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966944|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83966945|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83966946|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966947|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
83966948|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
83966949|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966950|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966951|NCT04565496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83966952|NCT04565496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966953|NCT03450161|Fentanyl|fentanyl|mesh-list
83966954|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83966955|NCT03450161|Narcotics|narcotics|mesh-ancestor
83966956|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83966957|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966958|NCT03450161|Analgesics|analgesics|mesh-ancestor
83966959|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
83966960|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83966961|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83966962|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83966963|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
83966964|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
83966965|NCT04565184|Artesunate|artesunate|mesh-list
83966966|NCT04565184|Lumefantrine|lumefantrine|mesh-list
83966967|NCT04565184|Artemether|artemether|mesh-list
83966968|NCT04565184|Amodiaquine|amodiaquine|mesh-list
83966969|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83966970|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
83966971|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
83966972|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83966973|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83966974|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83966975|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966976|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
83966977|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
83966978|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83966979|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
83966980|NCT03452579|Bevacizumab|bevacizumab|mesh-list
83966981|NCT03452579|Nivolumab|nivolumab|mesh-list
83966982|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83966983|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966984|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83966985|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83966986|NCT03452579|Growth Substances|growth substances|mesh-ancestor
83966987|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83966988|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
83966989|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83966990|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966991|NCT04997850|Lenvatinib|lenvatinib|mesh-list
83966992|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83966993|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83966994|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83966995|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83966996|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83966997|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83966998|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83966999|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83967000|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83967001|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83967002|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83967003|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
83967004|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967005|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967006|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967007|NCT03456947|Pregabalin|pregabalin|mesh-list
83967008|NCT03456947|Analgesics|analgesics|mesh-ancestor
83967009|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
83967010|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967011|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967012|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
83967013|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83967014|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83967015|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967016|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83967017|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83967018|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83967019|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967020|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83967021|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
83967022|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967023|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967024|NCT04564638|Cyclosporine|cyclosporine|mesh-list
83967025|NCT04564638|Cyclosporins|cyclosporins|mesh-list
83967026|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967027|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967028|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967029|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
83967030|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967031|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
83967032|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967033|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
83967034|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967035|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83967036|NCT04564326|Fentanyl|fentanyl|mesh-list
83967037|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83967038|NCT04564326|Narcotics|narcotics|mesh-ancestor
83967039|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967040|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967041|NCT04564326|Analgesics|analgesics|mesh-ancestor
83967042|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
83967043|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967044|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83967045|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83967046|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
83967047|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
83967048|NCT03453164|Nivolumab|nivolumab|mesh-list
83967049|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83967050|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967051|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83152300|NCT05312216|Durvalumab|durvalumab|mesh-list
83967052|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967053|NCT03450434|Histamine|histamine|mesh-list
83967054|NCT03450434|Glutarimide|glutarimide|mesh-list
83967055|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
83967056|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
83967057|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967058|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967059|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967060|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83967061|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967062|NCT00198029|Hylan|hylan|mesh-list
83967063|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
83967064|NCT00198029|Protective Agents|protective agents|mesh-ancestor
83967065|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967066|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83967067|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83967068|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
83967069|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967070|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967071|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83967072|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
83967073|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
83967074|NCT02215122|Hormones|hormones|mesh-ancestor
83967075|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967076|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
83967077|NCT00196976|Edetic Acid|edetic acid|mesh-list
83967078|NCT00196976|Vaccines|vaccines|mesh-list
83967079|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
83967080|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
83967081|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967082|NCT00196976|Antidotes|antidotes|mesh-ancestor
83967083|NCT00196976|Protective Agents|protective agents|mesh-ancestor
83967084|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
83967085|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
83967086|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967087|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83967088|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
83967089|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83967090|NCT04563936|Goserelin|goserelin|mesh-list
83967091|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967092|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967093|NCT04563975|Paclitaxel|paclitaxel|mesh-list
83967094|NCT04563975|Docetaxel|docetaxel|mesh-list
83967095|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83967096|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967097|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
83967098|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
83967099|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
83967100|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967101|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
83967102|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83967103|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
83967104|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83967105|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967106|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83967107|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83967108|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83967109|NCT00195650|Adalimumab|adalimumab|mesh-list
83967110|NCT00195650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83967111|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967112|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967113|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
83967114|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83967115|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967116|NCT04560894|Sorafenib|sorafenib|mesh-list
83967117|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967118|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967119|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967120|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967121|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
83967122|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83967123|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83967124|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967125|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
83967126|NCT04560465|Coagulants|coagulants|mesh-ancestor
83967127|NCT00195494|Etanercept|etanercept|mesh-list
83967128|NCT00195494|Methotrexate|methotrexate|mesh-list
83967129|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83967130|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
83967131|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83967132|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967133|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967134|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
83967135|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967136|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967137|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
83967138|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967139|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83967140|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967141|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
83206464|NCT04865445|Midazolam|midazolam|mesh-list
83967142|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967143|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83967144|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83967145|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83967146|NCT00195494|Analgesics|analgesics|mesh-ancestor
83967147|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
83967148|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967149|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967150|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83967151|NCT00194987|Prednisone|prednisone|mesh-list
83967152|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
83967153|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83967154|NCT00194987|Antibodies|antibodies|mesh-list
83967155|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
83967156|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83967157|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967158|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
83967159|NCT00194987|Hormones|hormones|mesh-ancestor
83967160|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967161|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967162|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967163|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967164|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
83967165|NCT00194792|Paclitaxel|paclitaxel|mesh-list
83967166|NCT00194792|Vinorelbine|vinorelbine|mesh-list
83967167|NCT00194792|Capecitabine|capecitabine|mesh-list
83967168|NCT00194792|Methotrexate|methotrexate|mesh-list
83967169|NCT00194792|Exemestane|exemestane|mesh-list
83967170|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83967171|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83967172|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967173|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
83967174|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
83967175|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
83967176|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967177|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967178|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
83967179|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83967180|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
83967181|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83967182|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967183|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83967184|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967185|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83967186|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967187|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
83967188|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967189|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83967190|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83967191|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83967192|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83967193|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
83967194|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967195|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
83967196|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83967197|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
83967198|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83967199|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967200|NCT02486367|Clopidogrel|clopidogrel|mesh-list
83967201|NCT02486367|Ticagrelor|ticagrelor|mesh-list
83967202|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83967203|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83967204|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83967205|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83967206|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
83967207|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967208|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967209|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967210|NCT00194675|Testosterone|testosterone|mesh-list
83967211|NCT00194675|Dutasteride|dutasteride|mesh-list
83967212|NCT00194675|Androgens|androgens|mesh-ancestor
83967213|NCT00194675|Hormones|hormones|mesh-ancestor
83967214|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967215|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967216|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83967217|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83967218|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967219|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967220|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
83967222|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
83967223|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83967224|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83967225|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83967226|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967227|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967228|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
83967229|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
83967230|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967231|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967232|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83967233|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83967234|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
83967235|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83967236|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83967237|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83967238|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83967239|NCT04563351|Anesthetics|anesthetics|mesh-list
83967240|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
83967241|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967242|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967243|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
83967244|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967245|NCT00192647|Ribavirin|ribavirin|mesh-list
83967246|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83967247|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
83967248|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
83967249|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967250|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
83967251|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967252|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967253|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
83967254|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83967255|NCT04560816|Choline|choline|mesh-list
83967256|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83967257|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967258|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83967259|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83967260|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967261|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967262|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967263|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967264|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
83967265|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83967266|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
83967267|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83967268|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83967269|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
83967270|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
83967271|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
83967272|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83967273|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83967274|NCT04560816|Growth Substances|growth substances|mesh-ancestor
83967275|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
83967276|NCT04563429|Vitamin A|vitamin a|mesh-list
83967277|NCT04563429|Vitamins|vitamins|mesh-ancestor
83967278|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
83967279|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967280|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83967281|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83967282|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83967283|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83967284|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967285|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83967286|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967287|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967288|NCT00191984|Irinotecan|irinotecan|mesh-list
83967289|NCT00191984|Pemetrexed|pemetrexed|mesh-list
83967290|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83967291|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83967292|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967293|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967294|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967295|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83967296|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83967297|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
83967298|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83967299|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967300|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83967301|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83967302|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83967303|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83967304|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967305|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
83967306|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967307|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967308|NCT00191789|Gemcitabine|gemcitabine|mesh-list
83967309|NCT00191789|Doxorubicin|doxorubicin|mesh-list
83967310|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967311|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967312|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
83967313|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967314|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83967315|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83967316|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83967317|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967318|NCT00191282|Insulin|insulin|mesh-list
83967319|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83967320|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
83967321|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
83967322|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
83967323|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
83967324|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
83967325|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83967326|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967327|NCT04560231|Remdesivir|remdesivir|mesh-list
83967328|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
83967329|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967330|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
83967331|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967332|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83967333|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83967334|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83967335|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83967336|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967337|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83967338|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967339|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967340|NCT00198263|Bleomycin|bleomycin|mesh-list
83967341|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83967342|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967343|NCT00198107|Cycloserine|cycloserine|mesh-list
83967344|NCT00198107|Aripiprazole|aripiprazole|mesh-list
83967345|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
83967346|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83967347|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83967348|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83967349|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967350|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967351|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
83967352|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
83967353|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967354|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967355|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83967356|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83967357|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
83967358|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83967359|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83967360|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83967361|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83967362|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83967363|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206693|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
83967364|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83967365|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
83967366|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83967367|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
83967368|NCT00179660|Lenalidomide|lenalidomide|mesh-list
83967369|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
83967370|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967371|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83967372|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83967373|NCT00179660|Growth Substances|growth substances|mesh-ancestor
83967374|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
83967375|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967376|NCT00178256|Paclitaxel|paclitaxel|mesh-list
83967377|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83967378|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967379|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
83967380|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
83967381|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
83967382|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967383|NCT02211222|Lenvatinib|lenvatinib|mesh-list
83967384|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967385|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967386|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967387|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967388|NCT00177164|Olanzapine|olanzapine|mesh-list
83967389|NCT00177164|Risperidone|risperidone|mesh-list
83967390|NCT00177164|Aripiprazole|aripiprazole|mesh-list
83967391|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83967392|NCT00177164|Ziprasidone|ziprasidone|mesh-list
83967393|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
83967394|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83967395|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
83967396|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967397|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967398|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967399|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83967400|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967401|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83967402|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83967403|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
83967404|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
83967405|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
83967406|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967407|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83967408|NCT00177164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83967409|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83967410|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83967411|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
83967412|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
83967413|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83967414|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83967415|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83967416|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83967417|NCT04559841|Simvastatin|simvastatin|mesh-list
83967418|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83967419|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83967420|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
83967421|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967422|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83967423|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83967424|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967425|NCT02489942|Empagliflozin|empagliflozin|mesh-list
83967426|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83967427|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967428|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83967429|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967430|NCT04559568|Midazolam|midazolam|mesh-list
83967431|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83967432|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83967433|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967434|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967435|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83967436|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83967437|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83967438|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83967439|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
83967440|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
83967441|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
83967442|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
83967443|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967444|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967445|NCT00176462|Leucovorin|leucovorin|mesh-list
83967446|NCT00176462|Cytarabine|cytarabine|mesh-list
83967447|NCT00176462|Dexamethasone|dexamethasone|mesh-list
83967448|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
83967449|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
83967450|NCT00176462|Methotrexate|methotrexate|mesh-list
83967451|NCT00176462|Vincristine|vincristine|mesh-list
83967452|NCT00176462|Asparaginase|asparaginase|mesh-list
83967453|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
83967454|NCT00176462|Daunorubicin|daunorubicin|mesh-list
83967455|NCT00176462|Thioguanine|thioguanine|mesh-list
83967456|NCT00176462|Aminopterin|aminopterin|mesh-list
83967457|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967458|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
83967459|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967460|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967461|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83967462|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
83967463|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967464|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967465|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83967466|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967467|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
83967468|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
83967469|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967470|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83967471|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
83967472|NCT00176462|Hormones|hormones|mesh-ancestor
83967473|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967474|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967475|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83967476|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
83967477|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83967478|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967479|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
83967480|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
83967481|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967482|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83967483|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83967484|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
83967485|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967486|NCT00176462|Antidotes|antidotes|mesh-ancestor
83967487|NCT00176462|Protective Agents|protective agents|mesh-ancestor
83967488|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
83967489|NCT00176462|Vitamins|vitamins|mesh-ancestor
83967490|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
83967491|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83967492|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83967493|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83967494|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83967495|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83967496|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83967497|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83967498|NCT00175019|Allopurinol|allopurinol|mesh-list
83967499|NCT00175019|Febuxostat|febuxostat|mesh-list
83967500|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
83967501|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967502|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967503|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
83967504|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967505|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83967506|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
83967507|NCT00175019|Protective Agents|protective agents|mesh-ancestor
83967508|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967509|NCT00174941|Febuxostat|febuxostat|mesh-list
83967510|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
83967511|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967512|NCT00171704|Tamoxifen|tamoxifen|mesh-list
83206843|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
83967513|NCT00171704|Letrozole|letrozole|mesh-list
83967514|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967515|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83967516|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83967517|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967518|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967519|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83967520|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
83967521|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967522|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967523|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967524|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83967525|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83967526|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83967527|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
83967528|NCT00171314|Letrozole|letrozole|mesh-list
83967529|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967530|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83967531|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83967532|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967533|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967534|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83967535|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
83967536|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967537|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967538|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83967539|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
83967540|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967541|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967542|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967543|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967544|NCT00170846|Everolimus|everolimus|mesh-list
83967545|NCT00170846|Azathioprine|azathioprine|mesh-list
83967546|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83967547|NCT00170846|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83967548|NCT00170846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967549|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967550|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967551|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967552|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
83967553|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967554|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967555|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
83967556|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967557|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967558|NCT00476606|Ritonavir|ritonavir|mesh-list
83967559|NCT00476606|Nelfinavir|nelfinavir|mesh-list
83967560|NCT00476606|Indinavir|indinavir|mesh-list
83967561|NCT00476606|Saquinavir|saquinavir|mesh-list
83967562|NCT00476606|Lamivudine|lamivudine|mesh-list
83967563|NCT00476606|Zidovudine|zidovudine|mesh-list
83967564|NCT00476606|Nevirapine|nevirapine|mesh-list
83967565|NCT00476606|Stavudine|stavudine|mesh-list
83967566|NCT00476606|Didanosine|didanosine|mesh-list
83967567|NCT00476606|Efavirenz|efavirenz|mesh-list
83967568|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83967569|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83967570|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
83967571|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967572|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967573|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83967574|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83967575|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
83967576|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967577|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83967578|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83967579|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83967580|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83967581|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
83967582|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83967583|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83967584|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83967585|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83967586|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83967587|NCT04562103|Epinephrine|epinephrine|mesh-list
83967588|NCT04562103|Ropivacaine|ropivacaine|mesh-list
83967589|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
83967590|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
83967591|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83967592|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967593|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
83967594|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967595|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83967596|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83967597|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
83967598|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967599|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967600|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83967601|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83967602|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
83967603|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83967604|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
83967605|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
83967606|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
83967607|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83967608|NCT04561635|Micronutrients|micronutrients|mesh-list
83967609|NCT04561635|Trace Elements|trace elements|mesh-list
83967610|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967611|NCT00479882|Simvastatin|simvastatin|mesh-list
83967612|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83967613|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83967614|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
83967615|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967616|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83967617|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83967618|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967619|NCT00479765|Paclitaxel|paclitaxel|mesh-list
83967620|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83967621|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967622|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
83967623|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
83967624|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
83967625|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967626|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
83967627|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83967628|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
83967629|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967630|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
83967631|NCT00479687|Protective Agents|protective agents|mesh-ancestor
83967632|NCT00479336|Tolvaptan|tolvaptan|mesh-list
83967633|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83967634|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967635|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
83967636|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967637|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
83967638|NCT00478244|Busulfan|busulfan|mesh-list
83967639|NCT00478244|Fludarabine|fludarabine|mesh-list
83967640|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
83967641|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967642|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
83967643|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967644|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967645|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83967646|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
83967647|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967648|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967649|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83967650|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967651|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
83967652|NCT00478205|Donepezil|donepezil|mesh-list
83967653|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83967654|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967655|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967656|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
83967657|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967658|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967659|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
83967660|NCT00477971|Dexamethasone|dexamethasone|mesh-list
83967661|NCT00477971|Melphalan|melphalan|mesh-list
83967662|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967663|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
83967664|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
83967665|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967666|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967667|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83967668|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
83967670|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967671|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967672|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967673|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
83967674|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83967675|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
83967676|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967677|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83967678|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967679|NCT00477464|Capecitabine|capecitabine|mesh-list
83967680|NCT00477464|Lapatinib|lapatinib|mesh-list
83967681|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967682|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
83967683|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967684|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967685|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967686|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967687|NCT00477386|Decitabine|decitabine|mesh-list
83967688|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967689|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
83967690|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967691|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967692|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967693|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
83967694|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967695|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967696|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967697|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967698|NCT00476996|Methotrexate|methotrexate|mesh-list
83967699|NCT00476996|Leflunomide|leflunomide|mesh-list
83967700|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
83967701|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83967702|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
83967703|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83967704|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967705|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83967706|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
83967707|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967708|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967709|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
83967710|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967711|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83967712|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967713|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
83967714|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967715|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83967716|NCT00476957|Sirolimus|sirolimus|mesh-list
83967717|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83967718|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967719|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83967720|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967721|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
83967722|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967723|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
83967724|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967725|NCT00475865|Teriflunomide|teriflunomide|mesh-list
83967726|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
83967727|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
83967728|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83967729|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
83967730|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967731|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967732|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967733|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83967734|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83967735|NCT00475865|Analgesics|analgesics|mesh-ancestor
83967736|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
83967737|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967738|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967739|NCT00475670|Paclitaxel|paclitaxel|mesh-list
83967740|NCT00475670|Docetaxel|docetaxel|mesh-list
83967741|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83967743|NCT00475670|Taxane|taxane|mesh-list
83967744|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83967745|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967746|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
83967747|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
83967748|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
83967749|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967750|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83967751|NCT04556760|Prednisolone|prednisolone|mesh-list
83967752|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967753|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
83967754|NCT04556760|Hormones|hormones|mesh-ancestor
83967755|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967756|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967757|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967758|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967759|NCT00474929|Everolimus|everolimus|mesh-list
83967760|NCT00474929|Sorafenib|sorafenib|mesh-list
83967761|NCT00474929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83967762|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967763|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967764|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967765|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83967766|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
83967767|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967768|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967769|NCT00474812|Dasatinib|dasatinib|mesh-list
83967770|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967771|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967772|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967773|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967774|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
83967775|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
83967776|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967777|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83967778|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967779|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967780|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
83967781|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967782|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967783|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83967784|NCT00474383|Hormones|hormones|mesh-ancestor
83967785|NCT00472199|Pramipexole|pramipexole|mesh-list
83967786|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
83967787|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967788|NCT00472199|Protective Agents|protective agents|mesh-ancestor
83967789|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967790|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83967791|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83967792|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
83967793|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
83967794|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967795|NCT04556136|Vitamin D|vitamin d|mesh-list
83967796|NCT04556136|Vitamins|vitamins|mesh-ancestor
83967797|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
83967798|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967799|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83967800|NCT00471887|Tremelimumab|tremelimumab|mesh-list
83967801|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967802|NCT04556058|Perindopril|perindopril|mesh-list
83967803|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83967804|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
83967805|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967806|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967807|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83967808|NCT00470834|Bicalutamide|bicalutamide|mesh-list
83967809|NCT00470834|Dutasteride|dutasteride|mesh-list
83967810|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
83967811|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
83967812|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967813|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967814|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967815|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83967816|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83967817|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967818|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967819|NCT00470366|Paclitaxel|paclitaxel|mesh-list
83967820|NCT00470366|Ifosfamide|ifosfamide|mesh-list
83967821|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83967822|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967823|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
83967824|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
83967825|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
83967826|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967827|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83967828|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
83967829|NCT02212431|Cysteamine|cysteamine|mesh-list
83967830|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83967831|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967832|NCT00470093|Interferons|interferons|mesh-list
83967833|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967834|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
83967835|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967836|NCT00470054|Dasatinib|dasatinib|mesh-list
83967837|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967838|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83967839|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967840|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967841|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83967842|NCT00478595|Rimonabant|rimonabant|mesh-list
83967843|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83967844|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83967845|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83967846|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967847|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967848|NCT00478595|Hormones|hormones|mesh-ancestor
83967849|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967850|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967851|NCT04555707|Betamethasone|betamethasone|mesh-list
83967852|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
83967853|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83967854|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
83967855|NCT04555707|Apremilast|apremilast|mesh-list
83967856|NCT04555707|Calcipotriene|calcipotriene|mesh-list
83967857|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83967858|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967859|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
83967860|NCT04555707|Hormones|hormones|mesh-ancestor
83967861|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967862|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967863|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83967864|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
83967865|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83967866|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83967867|NCT04555707|Analgesics|analgesics|mesh-ancestor
83967868|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
83967869|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967870|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967871|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83967872|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83967873|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967874|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967875|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83967876|NCT00474188|Dexamethasone|dexamethasone|mesh-list
83967877|NCT00474188|Lenalidomide|lenalidomide|mesh-list
83967878|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967879|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
83967880|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
83967881|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967882|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967883|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83967884|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
83967885|NCT00474188|Hormones|hormones|mesh-ancestor
83967886|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967887|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83967888|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207219|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
83967889|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
83967890|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83967891|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83967892|NCT00474188|Growth Substances|growth substances|mesh-ancestor
83967893|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
83967894|NCT01089647|Budesonide|budesonide|mesh-list
83967895|NCT01089647|Montelukast|montelukast|mesh-list
83967896|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967897|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83967898|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
83967899|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967900|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967901|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83967902|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
83967903|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
83967904|NCT01089647|Hormones|hormones|mesh-ancestor
83967905|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967906|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83967907|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
83967908|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83967909|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83967910|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967911|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
83967912|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83967913|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83967914|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83967915|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83967916|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967917|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
83967918|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83967919|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967920|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83967921|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967922|NCT01089608|Azithromycin|azithromycin|mesh-list
83967923|NCT01089608|Povidone|povidone|mesh-list
83967924|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83967925|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967926|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
83967927|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
83967928|NCT04554654|Progesterone|progesterone|mesh-list
83967929|NCT04554654|Progestins|progestins|mesh-ancestor
83967930|NCT04554654|Hormones|hormones|mesh-ancestor
83967931|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967932|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967933|NCT04554615|Insulin|insulin|mesh-list
83967934|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83967935|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967936|NCT01089413|Bevacizumab|bevacizumab|mesh-list
83967937|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83967938|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967939|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83967940|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83967941|NCT01089413|Growth Substances|growth substances|mesh-ancestor
83967942|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967943|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
83967944|NCT02212782|Linagliptin|linagliptin|mesh-list
83967945|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83967946|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967947|NCT02212782|Incretins|incretins|mesh-ancestor
83967948|NCT02212782|Hormones|hormones|mesh-ancestor
83967949|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83967950|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83967951|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
83967952|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83967953|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967954|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83967955|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83967956|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
83967957|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967958|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967959|NCT02212821|Erythromycin|erythromycin|mesh-list
83967960|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
83967961|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83967962|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
83967963|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83967964|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83967965|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83967966|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83967968|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967969|NCT01088243|Mesalamine|mesalamine|mesh-list
83967970|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83967971|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83967972|NCT01088243|Analgesics|analgesics|mesh-ancestor
83967973|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
83967974|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83967975|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967976|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967977|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83967978|NCT04672499|Cortisone|cortisone|mesh-list
83967979|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83967980|NCT04554303|Amlodipine|amlodipine|mesh-list
83967981|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83967982|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83967983|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83967984|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83967985|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83967986|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83967987|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
83967988|NCT01088048|Rituximab|rituximab|mesh-list
83967989|NCT01088048|Fludarabine|fludarabine|mesh-list
83967990|NCT01088048|Lenalidomide|lenalidomide|mesh-list
83967991|NCT01088048|Everolimus|everolimus|mesh-list
83967992|NCT01088048|Bortezomib|bortezomib|mesh-list
83967993|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83967994|NCT01088048|Ofatumumab|ofatumumab|mesh-list
83967995|NCT01088048|Idelalisib|idelalisib|mesh-list
83967996|NCT01088048|Chlorambucil|chlorambucil|mesh-list
83967997|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83967998|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83967999|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
83968000|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968001|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83968002|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968003|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968004|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83968005|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83968006|NCT01088048|Growth Substances|growth substances|mesh-ancestor
83968007|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
83968008|NCT01088048|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83968009|NCT01088048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83968010|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968011|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83968012|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
83968013|NCT01087970|Carboplatin|carboplatin|mesh-list
83968014|NCT01087970|Pemetrexed|pemetrexed|mesh-list
83968015|NCT01087970|Cetuximab|cetuximab|mesh-list
83968016|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968017|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968018|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968019|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83968020|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83968021|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968022|NCT01087814|Efavirenz|efavirenz|mesh-list
83968023|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83968024|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83968025|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968026|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968027|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
83968028|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968029|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83968030|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83968031|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83968032|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83968033|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83968034|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83968035|NCT04554030|Immunomodulating Agents|immunomodulating agents|mesh-list
83968036|NCT04554030|Immunologic Factors|immunologic factors|mesh-ancestor
83968037|NCT04554030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968038|NCT01087502|Glimepiride|glimepiride|mesh-list
83968039|NCT01087502|Linagliptin|linagliptin|mesh-list
83968040|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83968041|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83968042|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968043|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968044|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
83968045|NCT01087502|Incretins|incretins|mesh-ancestor
83968046|NCT01087502|Hormones|hormones|mesh-ancestor
83968047|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968048|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83968049|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
83968050|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968051|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968052|NCT02213211|Lumefantrine|lumefantrine|mesh-list
83968053|NCT02213211|Artemether|artemether|mesh-list
83968054|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83968055|NCT02213211|Artemisinins|artemisinins|mesh-list
83968056|NCT02213211|Artemisinin|artemisinin|mesh-list
83968057|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
83968058|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83968059|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83968060|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968061|NCT01086410|Fluticasone|fluticasone|mesh-list
83968062|NCT01086410|Xhance|xhance|mesh-list
83968063|NCT01086410|Prednisolone|prednisolone|mesh-list
83968064|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968065|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83968066|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
83968067|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968068|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968069|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83968070|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
83968071|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
83968072|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83968073|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
83968074|NCT01086410|Hormones|hormones|mesh-ancestor
83968075|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968076|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968077|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968078|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83968079|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83968080|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968081|NCT04553328|Bupivacaine|bupivacaine|mesh-list
83968082|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
83968083|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
83968084|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968085|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968086|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
83968087|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968088|NCT01085591|Vancomycin|vancomycin|mesh-list
83968089|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83968090|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968091|NCT04552977|Temozolomide|temozolomide|mesh-list
83968092|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83968093|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
83968094|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968095|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968096|NCT01085201|Regadenoson|regadenoson|mesh-list
83968097|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83968098|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83968099|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
83968100|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
83968101|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968102|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968103|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968104|NCT02213718|Sufentanil|sufentanil|mesh-list
83968105|NCT02213718|Propofol|propofol|mesh-list
83968106|NCT02213718|Desflurane|desflurane|mesh-list
83968107|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83968108|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968109|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968110|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83207447|NCT04847895|Growth Substances|growth substances|mesh-ancestor
83968111|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
83968112|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
83968113|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83968114|NCT02213718|Narcotics|narcotics|mesh-ancestor
83968115|NCT02213718|Analgesics|analgesics|mesh-ancestor
83968116|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
83968117|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968118|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83968119|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83968120|NCT01085045|Bromides|bromides|mesh-list
83968121|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
83968122|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
83968123|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83968124|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
83968125|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968126|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968127|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83968128|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
83968129|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83968130|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83968131|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83968132|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
83968133|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968134|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968135|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
83968136|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83968137|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
83968138|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
83968139|NCT02213796|Meropenem|meropenem|mesh-list
83968140|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83968141|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968142|NCT00179673|Lenalidomide|lenalidomide|mesh-list
83968143|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
83968144|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968145|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83968146|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83968147|NCT00179673|Growth Substances|growth substances|mesh-ancestor
83968148|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
83968149|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968150|NCT01084655|Prednisone|prednisone|mesh-list
83968151|NCT01084655|Docetaxel|docetaxel|mesh-list
83968152|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968153|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83968154|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83968155|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83968156|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152320|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
83968157|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968158|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
83968159|NCT01084655|Hormones|hormones|mesh-ancestor
83968160|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968161|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968162|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968163|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
83968164|NCT04552431|Tamsulosin|tamsulosin|mesh-list
83968165|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83968166|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968167|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83968168|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83968169|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968170|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968171|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968172|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83968173|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83968174|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83968175|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83968176|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83968177|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
83968178|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968179|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968180|NCT04552431|Urological Agents|urological agents|mesh-ancestor
83968181|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
83968182|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83968183|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968184|NCT01084538|Vitamins|vitamins|mesh-ancestor
83968185|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
83968186|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83968187|NCT00179517|Anastrozole|anastrozole|mesh-list
83968188|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968189|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968190|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83968191|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83968192|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968193|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968194|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83968195|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
83968196|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968197|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968198|NCT01083641|Estradiol|estradiol|mesh-list
83968199|NCT01083641|Estrogens|estrogens|mesh-ancestor
83968200|NCT01083641|Hormones|hormones|mesh-ancestor
83968201|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968202|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968203|NCT00179010|Adenosine|adenosine|mesh-list
83968204|NCT00179010|Analgesics|analgesics|mesh-ancestor
83968205|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
83968206|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968207|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968208|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83968209|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
83968210|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83968211|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
83968212|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
83968213|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968214|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968215|NCT01083602|Dexamethasone|dexamethasone|mesh-list
83968216|NCT01083602|Bortezomib|bortezomib|mesh-list
83968217|NCT01083602|Panobinostat|panobinostat|mesh-list
83968218|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968219|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
83968220|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
83968221|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968222|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968223|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968224|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
83968225|NCT01083602|Hormones|hormones|mesh-ancestor
83968226|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968227|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968228|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968229|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83968230|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968231|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968232|NCT00178464|Aspirin|aspirin|mesh-list
83968233|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83968234|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83968235|NCT00178464|Analgesics|analgesics|mesh-ancestor
83968236|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
83968237|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968238|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968239|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968240|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83968241|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83968242|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83968243|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968244|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83968245|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83968246|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968247|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
83968248|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
83968249|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83968250|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
83968251|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968252|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
83968253|NCT04671914|Protective Agents|protective agents|mesh-ancestor
83968254|NCT01083485|Oxycodone|oxycodone|mesh-list
83968255|NCT01083485|Naloxone|naloxone|mesh-list
83968256|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83968257|NCT01083485|Narcotics|narcotics|mesh-ancestor
83968258|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968259|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968260|NCT01083485|Analgesics|analgesics|mesh-ancestor
83968261|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
83968262|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968263|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83968264|NCT04551924|Ropivacaine|ropivacaine|mesh-list
83968265|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
83968266|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
83968267|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968268|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968269|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
83968270|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968271|NCT04671836|Lorazepam|lorazepam|mesh-list
83968272|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
83968273|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
83968274|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
83968275|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968276|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968277|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968278|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83968279|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968280|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83968281|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83968282|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83968283|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
83968284|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
83968285|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968286|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968287|NCT00556088|Paclitaxel|paclitaxel|mesh-list
83968288|NCT00556088|Bevacizumab|bevacizumab|mesh-list
83968289|NCT00556088|Carboplatin|carboplatin|mesh-list
83968290|NCT00556088|Panobinostat|panobinostat|mesh-list
83968291|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83968292|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968293|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83968294|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83968295|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83968296|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968297|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968298|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83968299|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83968300|NCT00556088|Growth Substances|growth substances|mesh-ancestor
83968301|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968302|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
83968303|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83968304|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968305|NCT00177294|Escitalopram|escitalopram|mesh-list
83968306|NCT00177294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83968307|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83968308|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968309|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968310|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968311|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
83968312|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968313|NCT01082081|Acetaminophen|acetaminophen|mesh-list
83968314|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83968315|NCT01082081|Analgesics|analgesics|mesh-ancestor
83968316|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
83968317|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968318|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968319|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
83968320|NCT00177216|Zolpidem|zolpidem|mesh-list
83968321|NCT00177216|Escitalopram|escitalopram|mesh-list
83968322|NCT00177216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83968323|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83968324|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968325|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968326|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968327|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
83968328|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968329|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83968330|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83968331|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968332|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83968333|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
83968334|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
83968335|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83968336|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
83968337|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83968338|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968339|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968340|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83968341|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83968342|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83968343|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
83968344|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968345|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968346|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83968347|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83968348|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
83968350|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
83968351|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968352|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
83968353|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968354|NCT04671563|Tenofovir|tenofovir|mesh-list
83968355|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
83968356|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968357|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83968358|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83968359|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968360|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968361|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83968362|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83968363|NCT04551573|Rifapentine|rifapentine|mesh-list
83968364|NCT04551573|Rifampin|rifampin|mesh-list
83968365|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83968366|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
83968367|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83968368|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968369|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
83968370|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83968371|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968372|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968373|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83968374|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83968375|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83968376|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83968377|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83968378|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83968379|NCT01081145|Guanfacine|guanfacine|mesh-list
83968380|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83968381|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83968382|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83968383|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83968384|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83968385|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968386|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968387|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968388|NCT00174915|Allopurinol|allopurinol|mesh-list
83968389|NCT00174915|Febuxostat|febuxostat|mesh-list
83968390|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
83968391|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968392|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968393|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
83968394|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83968395|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83968396|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
83968397|NCT00174915|Protective Agents|protective agents|mesh-ancestor
83968398|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968399|NCT01080716|Vaccines|vaccines|mesh-list
83968400|NCT01080716|Complement Factor H|complement factor h|mesh-list
83968401|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
83968402|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968403|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83968404|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968405|NCT04671446|Autoantibodies|autoantibodies|mesh-list
83968406|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
83968407|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968408|NCT04571489|Gemcitabine|gemcitabine|mesh-list
83968409|NCT04571489|Tegafur|tegafur|mesh-list
83968410|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83207735|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
83968412|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968413|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968414|NCT00172185|Teduglutide|teduglutide|mesh-list
83968415|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968416|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83968417|NCT00172185|Protective Agents|protective agents|mesh-ancestor
83968418|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968419|NCT00171951|Pasireotide|pasireotide|mesh-list
83968420|NCT00171951|Hormones|hormones|mesh-ancestor
83968421|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968422|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968423|NCT01080131|Triamcinolone|triamcinolone|mesh-list
83968424|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83968425|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83968426|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83968427|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83968428|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968429|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
83968430|NCT01080131|Hormones|hormones|mesh-ancestor
83968431|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968432|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968433|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968434|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
83968435|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968436|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968437|NCT00171873|Octreotide|octreotide|mesh-list
83968438|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968439|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968440|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968441|NCT01087151|Rituximab|rituximab|mesh-list
83968442|NCT01087151|Navitoclax|navitoclax|mesh-list
83968443|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968444|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968445|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
83968446|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968447|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83968448|NCT00171834|Epothilones|epothilones|mesh-list
83968449|NCT00171834|Epothilone B|epothilone b|mesh-list
83968450|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
83968451|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
83968452|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
83968453|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968454|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968455|NCT04571996|Acetaminophen|acetaminophen|mesh-list
83968456|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83968457|NCT04571996|Analgesics|analgesics|mesh-ancestor
83968458|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
83968459|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968460|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968461|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
83968462|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
83968463|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968464|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83968465|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968466|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968467|NCT04671056|Pioglitazone|pioglitazone|mesh-list
83968468|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83968469|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968470|NCT01082549|Carboplatin|carboplatin|mesh-list
83968471|NCT01082549|Gemcitabine|gemcitabine|mesh-list
83968472|NCT01082549|Iniparib|iniparib|mesh-list
83968473|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968474|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83968475|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
83968476|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968477|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83968478|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968479|NCT04550949|Denosumab|denosumab|mesh-list
83968480|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83968481|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207809|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83968482|NCT01085630|Pemetrexed|pemetrexed|mesh-list
83968483|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968484|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968485|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968486|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83968487|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83968488|NCT00171210|Deferasirox|deferasirox|mesh-list
83968489|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83968490|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
83968491|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
83968492|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968493|NCT00171054|Amlodipine|amlodipine|mesh-list
83968494|NCT00171054|Valsartan|valsartan|mesh-list
83968495|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83968496|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83968497|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83968498|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968499|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968500|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83968501|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968502|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
83968503|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83968504|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83968505|NCT00171054|Diuretics|diuretics|mesh-ancestor
83968506|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
83968507|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83968508|NCT00174837|Tirapazamine|tirapazamine|mesh-list
83968509|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968510|NCT00179400|Pioglitazone|pioglitazone|mesh-list
83968511|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83968512|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968513|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
83968514|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83968515|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968516|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968517|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
83968518|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968519|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968520|NCT00479856|Paclitaxel|paclitaxel|mesh-list
83968521|NCT00479856|Docetaxel|docetaxel|mesh-list
83968522|NCT00479856|Capecitabine|capecitabine|mesh-list
83968523|NCT00479856|Lapatinib|lapatinib|mesh-list
83968524|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83968525|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968526|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
83968527|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
83968528|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
83968529|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968530|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83968531|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
83968532|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83968533|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968534|NCT04997759|Neostigmine|neostigmine|mesh-list
83968535|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83968536|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968537|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968538|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
83968539|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968540|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968541|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83968542|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
83968543|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968544|NCT00479466|Metformin|metformin|mesh-list
83968545|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83968546|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968547|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
83968548|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968549|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968550|NCT04991948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83968551|NCT04991948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968552|NCT04990778|Venetoclax|venetoclax|mesh-list
83968553|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968554|NCT00479388|Niacin|niacin|mesh-list
83968555|NCT00479388|Atorvastatin|atorvastatin|mesh-list
83968556|NCT00479388|Simvastatin|simvastatin|mesh-list
83968557|NCT00479388|Calcium|calcium|mesh-list
83968558|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83968559|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968560|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83968561|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83968562|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
83968563|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968564|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83968565|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83968566|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968567|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
83968568|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
83968569|NCT00479388|Vitamins|vitamins|mesh-ancestor
83968570|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
83968571|NCT00479232|Decitabine|decitabine|mesh-list
83968572|NCT00479232|Vorinostat|vorinostat|mesh-list
83968573|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83968574|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
83968575|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968576|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968577|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968578|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83968579|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83968580|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
83968581|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83968582|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83968583|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968584|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968585|NCT00478881|Urological Agents|urological agents|mesh-ancestor
83968586|NCT00556127|Cytarabine|cytarabine|mesh-list
83968587|NCT00556127|Dexamethasone|dexamethasone|mesh-list
83968588|NCT00556127|Prednisone|prednisone|mesh-list
83968589|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
83968590|NCT00556127|Melphalan|melphalan|mesh-list
83968591|NCT00556127|Carmustine|carmustine|mesh-list
83968592|NCT00556127|Rituximab|rituximab|mesh-list
83968593|NCT00556127|Etoposide|etoposide|mesh-list
83968594|NCT00556127|Vincristine|vincristine|mesh-list
83968595|NCT00556127|Epirubicin|epirubicin|mesh-list
83968596|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
83968597|NCT00556127|Lenograstim|lenograstim|mesh-list
83968598|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968599|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
83968600|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968601|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83968602|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83968603|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
83968604|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968605|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968606|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83968607|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968608|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968609|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
83968610|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
83968611|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968612|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968613|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
83968614|NCT00556127|Hormones|hormones|mesh-ancestor
83968615|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968616|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968617|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83968618|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83968619|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83968620|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968621|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83968622|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
83968623|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
83968624|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968625|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
83968626|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
83968627|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
83968628|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83968629|NCT00556127|Analgesics|analgesics|mesh-ancestor
83968630|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
83968631|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83968632|NCT00556205|Bevacizumab|bevacizumab|mesh-list
83968633|NCT00556205|Sunitinib|sunitinib|mesh-list
83207953|NCT04365933|Interferons|interferons|mesh-list
83968634|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968635|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968636|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83968637|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83968638|NCT00556205|Growth Substances|growth substances|mesh-ancestor
83968639|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968640|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
83968641|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83968642|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968643|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968644|NCT00478608|Sirolimus|sirolimus|mesh-list
83968645|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83968646|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968647|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83968648|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968649|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
83968650|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968651|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
83968652|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968653|NCT00478140|Trastuzumab|trastuzumab|mesh-list
83968654|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968655|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968656|NCT00478023|Morphine|morphine|mesh-list
83968657|NCT00478023|Tapentadol|tapentadol|mesh-list
83968658|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83968659|NCT00478023|Narcotics|narcotics|mesh-ancestor
83968660|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968661|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968662|NCT00478023|Analgesics|analgesics|mesh-ancestor
83968663|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
83968664|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968665|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83968666|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83968667|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968668|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968669|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83968670|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968671|NCT00477750|Prednisone|prednisone|mesh-list
83968672|NCT00477750|Lenalidomide|lenalidomide|mesh-list
83968673|NCT00477750|Melphalan|melphalan|mesh-list
83968674|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968675|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
83968676|NCT00477750|Hormones|hormones|mesh-ancestor
83968677|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968678|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968679|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968680|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968681|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
83968682|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83968683|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83968684|NCT00477750|Growth Substances|growth substances|mesh-ancestor
83968685|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
83968686|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83968687|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
83968688|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968689|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83968690|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968691|NCT00477672|Pimavanserin|pimavanserin|mesh-list
83968692|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83968693|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83968694|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83968695|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83968696|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968697|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968698|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83968699|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83968700|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83968701|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
83968702|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968703|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968704|NCT04549935|Prednisolone|prednisolone|mesh-list
83968705|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968706|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
83968707|NCT04549935|Hormones|hormones|mesh-ancestor
83968708|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968709|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968710|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968711|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968713|NCT00477633|Norethindrone|norethindrone|mesh-list
83968714|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
83968715|NCT00477633|Estradiol|estradiol|mesh-list
83968716|NCT00477633|Estrogens|estrogens|mesh-ancestor
83968717|NCT00477633|Hormones|hormones|mesh-ancestor
83968718|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968719|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968720|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83968721|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
83968722|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83968723|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83968724|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83968725|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83968726|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83968727|NCT04541823|Propofol|propofol|mesh-list
83968728|NCT04541823|Desflurane|desflurane|mesh-list
83968729|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83968730|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968731|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968732|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83968733|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
83968734|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
83968735|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83968736|NCT00556361|Ketamine|ketamine|mesh-list
83968737|NCT00556361|Analgesics|analgesics|mesh-ancestor
83968738|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
83968739|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968740|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968741|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83968742|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83968743|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
83968744|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
83968745|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968746|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83968747|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83968748|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968749|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968750|NCT04571606|Bupivacaine|bupivacaine|mesh-list
83968751|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
83968752|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
83968753|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83968754|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968755|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
83968756|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968757|NCT02210117|Bevacizumab|bevacizumab|mesh-list
83968758|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83968759|NCT02210117|Nivolumab|nivolumab|mesh-list
83968760|NCT02210117|Ipilimumab|ipilimumab|mesh-list
83968761|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
83968762|NCT02210117|Antibodies|antibodies|mesh-list
83968763|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
83968764|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83968765|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
83968766|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968767|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83968768|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83968769|NCT02210117|Growth Substances|growth substances|mesh-ancestor
83968770|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968771|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
83968772|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
83968773|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83968774|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968775|NCT04541277|Cytarabine|cytarabine|mesh-list
83968776|NCT04541277|Azacitidine|azacitidine|mesh-list
83968777|NCT04541277|Decitabine|decitabine|mesh-list
83968778|NCT04541277|Tislelizumab|tislelizumab|mesh-list
83968779|NCT04541277|Idarubicin|idarubicin|mesh-list
83968780|NCT04541277|Lenograstim|lenograstim|mesh-list
83968781|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83968782|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
83968783|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968784|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968785|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
83208099|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
83968786|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968787|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968788|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
83968789|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968790|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968791|NCT04541277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83968792|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83968793|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83968794|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83968795|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83968796|NCT04995653|Vancomycin|vancomycin|mesh-list
83968797|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83968798|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968799|NCT04540926|Cyclosporine|cyclosporine|mesh-list
83968800|NCT04540926|Cyclosporins|cyclosporins|mesh-list
83968801|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968802|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968803|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83968804|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
83968805|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968806|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
83968807|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968808|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
83968809|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83968810|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83968811|NCT04540965|Famotidine|famotidine|mesh-list
83968812|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83968813|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968814|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83968815|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
83968816|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
83968817|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968818|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968819|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968820|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
83968821|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83968822|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968823|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83968824|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968825|NCT04570592|Dexamethasone|dexamethasone|mesh-list
83968826|NCT04570592|Granisetron|granisetron|mesh-list
83968827|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83968828|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968829|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
83968830|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
83968831|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968832|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968833|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968834|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
83968835|NCT04570592|Hormones|hormones|mesh-ancestor
83968836|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968837|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968838|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968839|NCT04570592|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83968840|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83968841|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
83968842|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968843|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968844|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83968845|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
83968846|NCT02215395|Estradiol|estradiol|mesh-list
83968847|NCT02215395|Estrogens|estrogens|mesh-ancestor
83968848|NCT02215395|Hormones|hormones|mesh-ancestor
83968849|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968850|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968851|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83968852|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83968853|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83968854|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83968855|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83968856|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
83968857|NCT02215434|Testosterone|testosterone|mesh-list
83968858|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
83968859|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
83968860|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83968861|NCT02215434|Androgens|androgens|mesh-ancestor
83968862|NCT02215434|Hormones|hormones|mesh-ancestor
83968863|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83968864|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968865|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83968866|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968867|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
83968868|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
83968869|NCT04561076|Paraproteins|paraproteins|mesh-list
83968870|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
83968871|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968872|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
83968873|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83968874|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83968875|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968876|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
83968877|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
83968878|NCT04548219|Mirikizumab|mirikizumab|mesh-list
83968879|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83968880|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83968881|NCT04548219|Analgesics|analgesics|mesh-ancestor
83968882|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
83968883|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968884|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968885|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968886|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83968887|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83968888|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968889|NCT04547829|Lenograstim|lenograstim|mesh-list
83968890|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83968891|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
83968892|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968893|NCT02211911|Bisacodyl|bisacodyl|mesh-list
83968894|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
83968895|NCT02211911|Cathartics|cathartics|mesh-ancestor
83968896|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968897|NCT02211911|Laxatives|laxatives|mesh-ancestor
83968898|NCT01131676|Empagliflozin|empagliflozin|mesh-list
83968899|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83968900|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968901|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83968902|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968903|NCT04560569|Antibodies|antibodies|mesh-list
83968904|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
83968905|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968906|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
83968907|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83968908|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83968909|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83968910|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968911|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968912|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
83968913|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968914|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968915|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83968916|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968917|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83968918|NCT02214498|Enalapril|enalapril|mesh-list
83968919|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83968920|NCT02214498|Diuretics|diuretics|mesh-ancestor
83968921|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
83968922|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968923|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83968924|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968925|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968926|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83968927|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
83968928|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968929|NCT04560218|Misoprostol|misoprostol|mesh-list
83968930|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83968931|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
83968932|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83968933|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968934|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83968935|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968936|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
83968937|NCT05135104|Palbociclib|palbociclib|mesh-list
83968938|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83968939|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83968940|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83968941|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968942|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
83968943|NCT04540185|Vaccines|vaccines|mesh-list
83968944|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
83968945|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968946|NCT04540185|Protective Agents|protective agents|mesh-ancestor
83968947|NCT01130272|Eluxadoline|eluxadoline|mesh-list
83968948|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968949|NCT04546815|Daptomycin|daptomycin|mesh-list
83968950|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83968951|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83968952|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83968953|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
83968954|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83968955|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83968956|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83968957|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968958|NCT04559165|Chitosan|chitosan|mesh-list
83968959|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83968960|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83968961|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
83968962|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968963|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83968964|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
83968965|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
83968966|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
83968967|NCT04559165|Coagulants|coagulants|mesh-ancestor
83968968|NCT04312048|Isosorbide|isosorbide|mesh-list
83968969|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83968970|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83968971|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83968972|NCT04312048|Diuretics|diuretics|mesh-ancestor
83968973|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
83968974|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968975|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
83968976|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83968977|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968978|NCT04311697|Phentolamine|phentolamine|mesh-list
83968979|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
83968980|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83968981|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83968982|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
83968983|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83968984|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83968985|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968986|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83968987|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83968988|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
83968989|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83968990|NCT04311697|Protective Agents|protective agents|mesh-ancestor
83968991|NCT00575861|Zileuton|zileuton|mesh-list
83968992|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83968993|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83968994|NCT00575861|Analgesics|analgesics|mesh-ancestor
83968995|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
83968996|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83968997|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83968998|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83968999|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969000|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83969001|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969002|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969003|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83969004|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
83969005|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969006|NCT04547088|Apatinib|apatinib|mesh-list
83969007|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969008|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83969009|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969010|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969011|NCT01129882|Aripiprazole|aripiprazole|mesh-list
83969012|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
83969013|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83969014|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83969015|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83969016|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969017|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969018|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
83969019|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
83969020|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969021|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969022|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83969023|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83969024|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
83969025|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83969026|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83969027|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83969028|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83969029|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
83969030|NCT02278419|Simeprevir|simeprevir|mesh-list
83969031|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
83969032|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969033|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969034|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969035|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969036|NCT02882737|Glucagon|glucagon|mesh-list
83969037|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83969038|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83969039|NCT02882737|Hormones|hormones|mesh-ancestor
83969040|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969041|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969042|NCT02882737|Incretins|incretins|mesh-ancestor
83969043|NCT02211950|Acarbose|acarbose|mesh-list
83969044|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83969045|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969046|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969047|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83969048|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969049|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
83969050|NCT04539249|Pentazocine|pentazocine|mesh-list
83969051|NCT04539249|Analgesics|analgesics|mesh-ancestor
83969052|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
83969053|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969054|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969055|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
83969056|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969057|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83969058|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
83969059|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83969060|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969061|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969062|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83969063|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
83969064|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83969065|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83969066|NCT04539249|Narcotics|narcotics|mesh-ancestor
83969067|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83969068|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83969069|NCT04559048|Tacrolimus|tacrolimus|mesh-list
83969070|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83969071|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
83969072|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969073|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83969074|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969075|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969076|NCT04538820|Dexamethasone|dexamethasone|mesh-list
83969077|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
83969078|NCT04538820|BB 1101|bb 1101|mesh-list
83969079|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969080|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
83969081|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
83969082|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969083|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969084|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208398|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
83969085|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
83969086|NCT04538820|Hormones|hormones|mesh-ancestor
83969087|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969088|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83969089|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969090|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969091|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969092|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969094|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83969095|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
83969096|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83969097|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83969098|NCT04539054|Caffeine|caffeine|mesh-list
83969099|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83969100|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969101|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83969102|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969103|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969104|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83969105|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83969106|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
83969107|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969108|NCT00576017|Fentanyl|fentanyl|mesh-list
83969109|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83969110|NCT00576017|Narcotics|narcotics|mesh-ancestor
83969111|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969112|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969113|NCT00576017|Analgesics|analgesics|mesh-ancestor
83969114|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
83969115|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969116|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83969117|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83969118|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
83969119|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
83969120|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
83969121|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83969122|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969123|NCT04558580|Rufinamide|rufinamide|mesh-list
83969124|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
83969125|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83969126|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83969127|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969128|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969129|NCT02278458|Gemcitabine|gemcitabine|mesh-list
83969130|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83969131|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
83969132|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969133|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969134|NCT01128595|Fluticasone|fluticasone|mesh-list
83969135|NCT01128595|Xhance|xhance|mesh-list
83969136|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969137|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83969138|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
83969139|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969140|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969141|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83969142|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
83969143|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
83969144|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83969145|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
83969146|NCT01129336|Diphosphonates|diphosphonates|mesh-list
83969147|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83969148|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969149|NCT01128244|Pyridoxine|pyridoxine|mesh-list
83969150|NCT01128244|Pyridoxal|pyridoxal|mesh-list
83969151|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
83969152|NCT01128244|Vitamins|vitamins|mesh-ancestor
83969153|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
83969154|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969155|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
83969156|NCT01127893|Tanezumab|tanezumab|mesh-list
83969157|NCT01127893|Analgesics|analgesics|mesh-ancestor
83969158|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
83969159|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969160|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969161|NCT00576173|Acetaminophen|acetaminophen|mesh-list
83969162|NCT00576173|Tramadol|tramadol|mesh-list
83969163|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83969165|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
83969166|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969167|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969168|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
83969169|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83969170|NCT00576173|Narcotics|narcotics|mesh-ancestor
83969171|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969172|NCT00625339|Lamivudine|lamivudine|mesh-list
83969173|NCT00625339|Entecavir|entecavir|mesh-list
83969174|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83969175|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83969176|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969177|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969178|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
83969179|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969180|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83969181|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83969182|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83969183|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
83969184|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969185|NCT04558463|Oseltamivir|oseltamivir|mesh-list
83969186|NCT04558463|Favipiravir|favipiravir|mesh-list
83969187|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
83969188|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969189|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969190|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969191|NCT01126879|Genistein|genistein|mesh-list
83969192|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83969193|NCT01126879|Protective Agents|protective agents|mesh-ancestor
83969194|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969195|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969196|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83969197|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969198|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969199|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
83969200|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83969201|NCT01126879|Estrogens|estrogens|mesh-ancestor
83969202|NCT01126879|Hormones|hormones|mesh-ancestor
83969203|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969204|NCT04311658|Isosorbide|isosorbide|mesh-list
83969205|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83969206|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83969207|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83969208|NCT04311658|Diuretics|diuretics|mesh-ancestor
83969209|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
83969210|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969211|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
83969212|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83969213|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969214|NCT02882308|Durvalumab|durvalumab|mesh-list
83969215|NCT02882308|Olaparib|olaparib|mesh-list
83969216|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969217|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83969218|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83969219|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969220|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969221|NCT00625456|Molgramostim|molgramostim|mesh-list
83969222|NCT00625456|Sargramostim|sargramostim|mesh-list
83969223|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
83969224|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969225|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969226|NCT04539444|Tislelizumab|tislelizumab|mesh-list
83969227|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83969228|NCT04539444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83969229|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969230|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969231|NCT00576329|Ketorolac|ketorolac|mesh-list
83969232|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83969233|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83969234|NCT00576329|Analgesics|analgesics|mesh-ancestor
83969235|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
83969236|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208554|NCT03204929|Copper|copper|mesh-list
83969237|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969238|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969239|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969240|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83969241|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969242|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969243|NCT02882581|Metformin|metformin|mesh-list
83969244|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83969245|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969246|NCT02882347|Somatostatin|somatostatin|mesh-list
83969247|NCT02882347|Hormones|hormones|mesh-ancestor
83969248|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969249|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969250|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
83969251|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83969252|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969253|NCT00637468|Aspirin|aspirin|mesh-list
83969254|NCT00637468|Heparin|heparin|mesh-list
83969255|NCT00637468|Acetazolamide|acetazolamide|mesh-list
83969256|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83969257|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
83969258|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83969259|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83969260|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969261|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83969262|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83969263|NCT00637468|Analgesics|analgesics|mesh-ancestor
83969264|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
83969265|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969266|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969267|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969268|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969269|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83969270|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83969271|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969272|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
83969273|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
83969274|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83969275|NCT00637468|Diuretics|diuretics|mesh-ancestor
83969276|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
83969277|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83969278|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
83969279|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969280|NCT02278575|Antithrombins|antithrombins|mesh-list
83969281|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
83969282|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83969283|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969284|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969285|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969286|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
83969287|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83969288|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
83969289|NCT01126060|Coagulants|coagulants|mesh-ancestor
83969290|NCT01125748|Omalizumab|omalizumab|mesh-list
83969291|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83969292|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83969293|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
83969294|NCT04558268|Folic Acid|folic acid|mesh-list
83969295|NCT04558268|Prednisone|prednisone|mesh-list
83969296|NCT04558268|Progesterone|progesterone|mesh-list
83969297|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969298|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
83969299|NCT04558268|Hormones|hormones|mesh-ancestor
83969300|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969301|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969302|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83969303|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969304|NCT04558268|Progestins|progestins|mesh-ancestor
83969305|NCT04558268|Hematinics|hematinics|mesh-ancestor
83969306|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
83969307|NCT04558268|Vitamins|vitamins|mesh-ancestor
83969308|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
83969309|NCT01125514|Furosemide|furosemide|mesh-list
83969310|NCT01125514|Diuretics|diuretics|mesh-ancestor
83969311|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
83969312|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969313|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83969314|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969315|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969316|NCT04545879|Allicin|allicin|mesh-list
83969317|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969318|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83969319|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
83969320|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969321|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83969322|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
83969323|NCT04545879|Protective Agents|protective agents|mesh-ancestor
83969324|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969325|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83969326|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83969327|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83969328|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83969329|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83969330|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969331|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969332|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83969333|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969334|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969335|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
83969336|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969337|NCT04538391|Bupivacaine|bupivacaine|mesh-list
83969338|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
83969339|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
83969340|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969341|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969342|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
83969343|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969344|NCT04545801|Ketamine|ketamine|mesh-list
83969345|NCT04545801|Analgesics|analgesics|mesh-ancestor
83969346|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
83969347|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969348|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969349|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83969350|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83969351|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
83969352|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
83969353|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969354|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83969355|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83969356|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969357|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969358|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
83969359|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
83969360|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969361|NCT04558424|Protective Agents|protective agents|mesh-ancestor
83969362|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969363|NCT04558424|Vitamins|vitamins|mesh-ancestor
83969364|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
83969365|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
83969366|NCT00576602|Hematinics|hematinics|mesh-ancestor
83969367|NCT02212223|Vitamin D|vitamin d|mesh-list
83969368|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
83969369|NCT02212223|Vitamins|vitamins|mesh-ancestor
83969370|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
83969371|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969372|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83969373|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83969374|NCT00637585|Fexofenadine|fexofenadine|mesh-list
83969375|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83969376|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83969377|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83969378|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
83969379|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
83969380|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969381|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969382|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969383|NCT02214810|Bupivacaine|bupivacaine|mesh-list
83969384|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
83969385|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
83969386|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969387|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969388|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
83208701|NCT05615727|Zolpidem|zolpidem|mesh-list
83969389|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969390|NCT01125046|Bevacizumab|bevacizumab|mesh-list
83969391|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83969392|NCT01125046|Antibodies|antibodies|mesh-list
83969393|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
83969394|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83969395|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969396|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83969397|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83969398|NCT01125046|Growth Substances|growth substances|mesh-ancestor
83969399|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969400|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
83969401|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
83969402|NCT04557878|Mitogens|mitogens|mesh-list
83969403|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
83969404|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969405|NCT01124734|Temozolomide|temozolomide|mesh-list
83969406|NCT01124734|Interleukin-2|interleukin-2|mesh-list
83969407|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83969408|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
83969409|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969410|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969411|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83969412|NCT01124734|Analgesics|analgesics|mesh-ancestor
83969413|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
83969414|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969415|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969416|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
83969417|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
83969418|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83969419|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83969420|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969421|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969422|NCT04538976|Urological Agents|urological agents|mesh-ancestor
83969423|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
83969424|NCT04545450|Testosterone|testosterone|mesh-list
83969425|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
83969426|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
83969427|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83969428|NCT04545450|Dutasteride|dutasteride|mesh-list
83969429|NCT04545450|Androgens|androgens|mesh-ancestor
83969430|NCT04545450|Hormones|hormones|mesh-ancestor
83969431|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969432|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969433|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83969434|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969435|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
83969436|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83969437|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83969438|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969439|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969440|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
83969441|NCT04579133|Durvalumab|durvalumab|mesh-list
83969442|NCT04579133|Olaparib|olaparib|mesh-list
83969443|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83969444|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969445|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83969446|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969447|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969448|NCT00576914|Endostatins|endostatins|mesh-list
83969449|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83969450|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83969451|NCT00576914|Growth Substances|growth substances|mesh-ancestor
83969452|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969453|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
83969454|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969455|NCT02212340|Remifentanil|remifentanil|mesh-list
83969456|NCT02212340|Desflurane|desflurane|mesh-list
83969457|NCT02212340|Propofol|propofol|mesh-list
83969458|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83969459|NCT02212340|Narcotics|narcotics|mesh-ancestor
83969460|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208803|NCT03195569|Paclitaxel|paclitaxel|mesh-list
83969461|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969462|NCT02212340|Analgesics|analgesics|mesh-ancestor
83969463|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
83969464|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969465|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83969466|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
83969467|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
83969468|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83969469|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83969470|NCT01124617|Tapentadol|tapentadol|mesh-list
83969471|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83969472|NCT01124617|Narcotics|narcotics|mesh-ancestor
83969473|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969474|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969475|NCT01124617|Analgesics|analgesics|mesh-ancestor
83969476|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
83969477|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969478|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83969479|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83969480|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969481|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969482|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
83969483|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969484|NCT04205890|Ketamine|ketamine|mesh-list
83969485|NCT04205890|Analgesics|analgesics|mesh-ancestor
83969486|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
83969487|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969488|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969489|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83969490|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83969491|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
83969492|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
83969493|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969494|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83969495|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83969496|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969497|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969498|NCT00577109|Leucovorin|leucovorin|mesh-list
83969499|NCT00577109|Bevacizumab|bevacizumab|mesh-list
83969500|NCT00577109|Cetuximab|cetuximab|mesh-list
83969501|NCT00577109|Irinotecan|irinotecan|mesh-list
83969502|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83969503|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969504|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83969505|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83969506|NCT00577109|Growth Substances|growth substances|mesh-ancestor
83969507|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969508|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
83969509|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83969510|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83969511|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969512|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969513|NCT00577109|Antidotes|antidotes|mesh-ancestor
83969514|NCT00577109|Protective Agents|protective agents|mesh-ancestor
83969515|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
83969516|NCT00577109|Vitamins|vitamins|mesh-ancestor
83969517|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
83969518|NCT01124422|Fluticasone|fluticasone|mesh-list
83969519|NCT01124422|Xhance|xhance|mesh-list
83969520|NCT01124422|Bromides|bromides|mesh-list
83969521|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
83969522|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83969523|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969524|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83969525|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
83969526|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969527|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969528|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83969529|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
83969530|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
83969531|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83969532|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
83969533|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83969534|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
83969535|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969536|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969537|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83969538|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83969539|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83969540|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
83969541|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
83969542|NCT00625495|Esomeprazole|esomeprazole|mesh-list
83969543|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83969544|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83969545|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83969546|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969547|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969548|NCT02882425|Selexipag|selexipag|mesh-list
83969549|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83969550|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
83969551|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
83969552|NCT01124149|Mesalamine|mesalamine|mesh-list
83969553|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83969554|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83969555|NCT01124149|Analgesics|analgesics|mesh-ancestor
83969556|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
83969557|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969558|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969559|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969560|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969561|NCT04545099|Neostigmine|neostigmine|mesh-list
83969562|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83969563|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969564|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969565|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
83969566|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969567|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969568|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83969569|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
83969570|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969571|NCT02882269|Capecitabine|capecitabine|mesh-list
83969572|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83969573|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
83969574|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969575|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969576|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
83969577|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83969578|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969579|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
83969580|NCT04537767|Esmolol|esmolol|mesh-list
83969581|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83969582|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83969583|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83969584|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
83969585|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969586|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969587|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969588|NCT01121926|Trazodone|trazodone|mesh-list
83969589|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83969590|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83969591|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969592|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969593|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83969594|NCT01121926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83969595|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83969596|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969597|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969598|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969599|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
83969600|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83969601|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
83969602|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
83969603|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83969604|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969605|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969606|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83969607|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969608|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83969609|NCT00577694|Clofarabine|clofarabine|mesh-list
83969610|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
83969611|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83969612|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
83208925|NCT03195023|Diuretics|diuretics|mesh-ancestor
83969613|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969614|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969615|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83969617|NCT00577694|Immunoconjugates|immunoconjugates|mesh-ancestor
83969618|NCT00577694|Immunologic Factors|immunologic factors|mesh-ancestor
83969619|NCT00577694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969620|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
83969621|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83969622|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83969623|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969624|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
83969625|NCT04537533|Coagulants|coagulants|mesh-ancestor
83969626|NCT02216058|Sirolimus|sirolimus|mesh-list
83969627|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83969628|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969629|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83969630|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969631|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
83969632|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83969633|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
83969634|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969635|NCT00577850|Alendronate|alendronate|mesh-list
83969636|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
83969637|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83969638|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969639|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83969640|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969641|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969642|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83969643|NCT00577967|Gabapentin|gabapentin|mesh-list
83969644|NCT00577967|Analgesics|analgesics|mesh-ancestor
83969645|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
83969646|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969647|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969648|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
83969649|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83969650|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83969651|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969652|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83969653|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83969654|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83969655|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969656|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969657|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
83969658|NCT00578201|Cetuximab|cetuximab|mesh-list
83969659|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83969660|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969661|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
83969662|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83969663|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969664|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83969665|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969666|NCT04578470|Vitamin D|vitamin d|mesh-list
83969667|NCT04578470|Vitamins|vitamins|mesh-ancestor
83969668|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
83969669|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969670|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83969671|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
83969672|NCT00578435|Busulfan|busulfan|mesh-list
83969673|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83969674|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
83969675|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969676|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969677|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83969678|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
83969679|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969680|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969681|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83969682|NCT04537065|Mydriatics|mydriatics|mesh-list
83969683|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
83969684|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969685|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969686|NCT04544163|Lidocaine|lidocaine|mesh-list
83969687|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
83969688|NCT04544163|Fentanyl|fentanyl|mesh-list
83969689|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
83969690|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
83969691|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969692|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969693|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
83969694|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969695|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83969696|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83969697|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83969698|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969699|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969700|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83969701|NCT04544163|Narcotics|narcotics|mesh-ancestor
83969702|NCT04544163|Analgesics|analgesics|mesh-ancestor
83969703|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83969704|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83969705|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
83969706|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
83969707|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83969708|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83969709|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
83969710|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83969711|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
83969712|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83969713|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969714|NCT00578591|Rituximab|rituximab|mesh-list
83969715|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83969716|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969717|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
83969718|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969719|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969720|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
83969721|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969722|NCT04543890|Etoposide|etoposide|mesh-list
83969723|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969724|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83969725|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83969726|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83969727|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969728|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969729|NCT04536831|Vitamin D|vitamin d|mesh-list
83969730|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
83969731|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
83969732|NCT04536831|Vitamins|vitamins|mesh-list
83969733|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
83969734|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969735|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83969736|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83969737|NCT02214966|Telmisartan|telmisartan|mesh-list
83969738|NCT02214966|Ramipril|ramipril|mesh-list
83969739|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83969740|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83969741|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83969742|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969743|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83969744|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969745|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969746|NCT04536558|Olanzapine|olanzapine|mesh-list
83969747|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
83969748|NCT04536558|Aprepitant|aprepitant|mesh-list
83969749|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
83969750|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
83969751|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969752|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969753|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83969754|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83969755|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83969756|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969757|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83969758|NCT04536558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83969759|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83969760|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969761|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969762|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83969763|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
83969764|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83969765|NCT04557137|Somatostatin|somatostatin|mesh-list
83969766|NCT04557137|Hormones|hormones|mesh-ancestor
83969767|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969768|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969769|NCT04536675|Bromides|bromides|mesh-list
83969770|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
83969771|NCT04536363|Alprostadil|alprostadil|mesh-list
83969772|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83969773|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
83969774|NCT04536363|Urological Agents|urological agents|mesh-ancestor
83969775|NCT00578825|Ritonavir|ritonavir|mesh-list
83969776|NCT00578825|Lopinavir|lopinavir|mesh-list
83969777|NCT00578825|Ribavirin|ribavirin|mesh-list
83969778|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83969779|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83969780|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969781|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969782|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969783|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83969784|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83969785|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
83969786|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969787|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83969788|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83969789|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
83969790|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
83969791|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969792|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
83969793|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83969794|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969795|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
83969796|NCT04535973|Hormones|hormones|mesh-list
83969797|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969798|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969799|NCT04536051|Acetaminophen|acetaminophen|mesh-list
83969800|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83969801|NCT04536051|Analgesics|analgesics|mesh-ancestor
83969802|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
83969803|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969804|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969805|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
83969806|NCT02215005|Telmisartan|telmisartan|mesh-list
83969807|NCT02215005|Ramipril|ramipril|mesh-list
83969808|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83969809|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83969810|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83969811|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969812|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83969813|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969814|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969815|NCT02215044|Gemcitabine|gemcitabine|mesh-list
83969816|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83969817|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
83969818|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969819|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969820|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83969821|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
83969822|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969823|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969824|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83969825|NCT04556279|Diuretics|diuretics|mesh-ancestor
83969826|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
83969827|NCT02216331|Rifampin|rifampin|mesh-list
83969828|NCT02216331|Rifapentine|rifapentine|mesh-list
83969829|NCT02216331|Bedaquiline|bedaquiline|mesh-list
83969830|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83969831|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
83969832|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83969833|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969834|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
83969835|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83969836|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209157|NCT02444585|Denosumab|denosumab|mesh-list
83969837|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969838|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83969839|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83969840|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83969841|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83969842|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83969843|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83969844|NCT04535817|Omalizumab|omalizumab|mesh-list
83969845|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83969846|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83969847|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
83969848|NCT04578236|Tretinoin|tretinoin|mesh-list
83969849|NCT04578236|Captopril|captopril|mesh-list
83969850|NCT04578236|Isotretinoin|isotretinoin|mesh-list
83969851|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969852|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
83969853|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
83969854|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83969855|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969856|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969857|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969858|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83969859|NCT04542759|Besifloxacin|besifloxacin|mesh-list
83969860|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83969861|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83969862|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83969863|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969864|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83969865|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83969866|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969867|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969868|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969869|NCT04542213|Insulin|insulin|mesh-list
83969870|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83969871|NCT04542213|Linagliptin|linagliptin|mesh-list
83969872|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83969873|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969874|NCT04542213|Incretins|incretins|mesh-ancestor
83969875|NCT04542213|Hormones|hormones|mesh-ancestor
83969876|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969877|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83969878|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
83969879|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969880|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969881|NCT04542252|Cyclosporine|cyclosporine|mesh-list
83969882|NCT04542252|Cyclosporins|cyclosporins|mesh-list
83969883|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969884|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969885|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83969886|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
83969887|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969888|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
83969889|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969890|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
83969891|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969892|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83969893|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83969894|NCT04555694|Cyclosporine|cyclosporine|mesh-list
83969895|NCT04555694|Dexamethasone|dexamethasone|mesh-list
83969896|NCT04555694|Cyclosporins|cyclosporins|mesh-list
83969897|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969898|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
83969899|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
83969900|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969901|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969902|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83969903|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
83969904|NCT04555694|Hormones|hormones|mesh-ancestor
83969905|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969906|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83969907|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969908|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969909|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969910|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83969911|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
83969912|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
83969913|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969914|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
83969915|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969916|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83969917|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83969918|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
83969919|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83969920|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83969921|NCT04532775|Prednisolone|prednisolone|mesh-list
83969922|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
83969923|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
83969924|NCT04532775|Bupivacaine|bupivacaine|mesh-list
83969925|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83969926|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
83969927|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
83969928|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
83969929|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83969930|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969931|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
83969932|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969933|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969934|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
83969935|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
83969936|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83969937|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
83969938|NCT04532775|Hormones|hormones|mesh-ancestor
83969939|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83969940|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83969941|NCT04532775|Protective Agents|protective agents|mesh-ancestor
83969942|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83969943|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969944|NCT04532775|Analgesics|analgesics|mesh-ancestor
83969945|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83969946|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
83969947|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83969948|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83969949|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969950|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83969951|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
83969952|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83969953|NCT00579644|Minocycline|minocycline|mesh-list
83969954|NCT00579644|Methotrexate|methotrexate|mesh-list
83969955|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83969956|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
83969957|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83969958|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969959|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83969960|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
83969961|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969962|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969963|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
83969964|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969965|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83969966|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83969967|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
83969968|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969969|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83969970|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83969971|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83969972|NCT04578158|Quercetin|quercetin|mesh-list
83969973|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
83969974|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969975|NCT04578158|Protective Agents|protective agents|mesh-ancestor
83969976|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969977|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
83969978|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
83969979|NCT04532736|Methotrexate|methotrexate|mesh-list
83969980|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83969981|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
83969982|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83969983|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83969984|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83969985|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
84124691|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209310|NCT02116972|FX006|fx006|mesh-list
83969986|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83969987|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83969988|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83969989|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83969990|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83969991|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83969992|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
83969993|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83969994|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83969995|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83969997|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
83969998|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83969999|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970000|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
83970001|NCT04532736|Hormones|hormones|mesh-ancestor
83970002|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970003|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83970004|NCT04532736|Protective Agents|protective agents|mesh-ancestor
83970005|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83970006|NCT04555733|Lemborexant|lemborexant|mesh-list
83970007|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83970008|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970009|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970010|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83970011|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83970012|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970013|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970014|NCT02216994|Mineral Oil|mineral oil|mesh-list
83970015|NCT02216994|Lactulose|lactulose|mesh-list
83970016|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970017|NCT02216994|Emollients|emollients|mesh-ancestor
83970018|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
83970019|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
83970020|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
83970021|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970022|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970023|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970024|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
83970025|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
83970026|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
83970027|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83970028|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970029|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
83970030|NCT02217189|Astringents|astringents|mesh-ancestor
83970031|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970032|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83970033|NCT00579956|Meropenem|meropenem|mesh-list
83970034|NCT00579956|Ceftazidime|ceftazidime|mesh-list
83970035|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970036|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970037|NCT04555304|Paclitaxel|paclitaxel|mesh-list
83970038|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83970039|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83970040|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970041|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
83970042|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
83970043|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
83970044|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970045|NCT04531800|Mitogens|mitogens|mesh-list
83970046|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
83970047|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970048|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
83970049|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83970050|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
83970051|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970052|NCT00579995|Expectorants|expectorants|mesh-ancestor
83970053|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
83970054|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83970055|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
83970056|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970057|NCT00579995|Protective Agents|protective agents|mesh-ancestor
83970058|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970059|NCT00579995|Antidotes|antidotes|mesh-ancestor
83970060|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
83970061|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83970062|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970063|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970064|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970066|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
83970067|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970068|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83970069|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83970070|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970071|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970072|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970073|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970074|NCT00580112|Dexamethasone|dexamethasone|mesh-list
83970075|NCT00580112|Trabectedin|trabectedin|mesh-list
83970076|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970077|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
83970078|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
83970079|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970080|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970081|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970082|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
83970083|NCT00580112|Hormones|hormones|mesh-ancestor
83970084|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970085|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83970086|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970087|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83970088|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
83970089|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970090|NCT04531332|Linezolid|linezolid|mesh-list
83970091|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970092|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970093|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83970094|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970095|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970096|NCT04530864|Dexamethasone|dexamethasone|mesh-list
83970097|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
83970098|NCT04530864|BB 1101|bb 1101|mesh-list
83970099|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970100|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
83970101|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
83970102|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970103|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970104|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970105|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
83970106|NCT04530864|Hormones|hormones|mesh-ancestor
83970107|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970108|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83970109|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970110|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
83970111|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970112|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970113|NCT00580190|Alprazolam|alprazolam|mesh-list
83970114|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83970115|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970116|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970117|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83970118|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83970119|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83970120|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
83970121|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
83970122|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970123|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970124|NCT04530903|Clonidine|clonidine|mesh-list
83970125|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
83970126|NCT04530903|Analgesics|analgesics|mesh-ancestor
83970127|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
83970128|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970129|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970130|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83970131|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
83970132|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
83970133|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83970134|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83970135|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970136|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970137|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970138|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970139|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
83970141|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970142|NCT04530474|Ivermectin|ivermectin|mesh-list
83970143|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83970144|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970145|NCT04554680|Trametinib|trametinib|mesh-list
83970146|NCT04554680|Dabrafenib|dabrafenib|mesh-list
83970147|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970148|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83970149|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970150|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970151|NCT00580424|Norethindrone|norethindrone|mesh-list
83970152|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
83970153|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83970154|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83970155|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83970156|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
83970157|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83970158|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970159|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83970160|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83970161|NCT01121575|Crizotinib|crizotinib|mesh-list
83970162|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970163|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83970164|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970165|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970166|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83970167|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970168|NCT04205851|Gimsilumab|gimsilumab|mesh-list
83970169|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970170|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
83970171|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970172|NCT02882113|Tacrolimus|tacrolimus|mesh-list
83970173|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83970174|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
83970175|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970176|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83970177|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970178|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970179|NCT04530045|Piperacillin|piperacillin|mesh-list
83970180|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970181|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970182|NCT01121536|Modafinil|modafinil|mesh-list
83970183|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83970184|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970185|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83970186|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83970187|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83970188|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970189|NCT00580619|Methyldopa|methyldopa|mesh-list
83970190|NCT00580619|Trimethaphan|trimethaphan|mesh-list
83970191|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
83970192|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970193|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83970194|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
83970195|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
83970196|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970197|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970198|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83970199|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83970200|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970201|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970202|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970203|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83970204|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83970205|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83970206|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83970207|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
83970208|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
83970209|NCT04554524|Paclitaxel|paclitaxel|mesh-list
83970210|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
83970211|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83970212|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970213|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
83970214|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
83970215|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
83970216|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970217|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83970218|NCT04554524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83970219|NCT02212652|Vitamin D|vitamin d|mesh-list
83970220|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
83970221|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
83970222|NCT02212652|Vitamins|vitamins|mesh-list
83970223|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
83970224|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970225|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83970226|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83970227|NCT02212769|Losartan|losartan|mesh-list
83970228|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83970229|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83970230|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83970231|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83970232|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970233|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
83970234|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83970235|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83970236|NCT02217852|Captopril|captopril|mesh-list
83970237|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
83970238|NCT02217852|Nitrendipine|nitrendipine|mesh-list
83970239|NCT02217852|Diuretics|diuretics|mesh-ancestor
83970240|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
83970241|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970242|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83970243|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83970244|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970245|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83970246|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
83970247|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970248|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83970249|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83970250|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
83970251|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
83970252|NCT02217930|Levonadifloxacin|levonadifloxacin|mesh-list
83970253|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970254|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970255|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83970256|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83970257|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970258|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970259|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970260|NCT02217930|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83970261|NCT04577846|Cephalexin|cephalexin|mesh-list
83970262|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970263|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970264|NCT04529811|Rifaximin|rifaximin|mesh-list
83970265|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970266|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970267|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970268|NCT02218047|Interferons|interferons|mesh-list
83970269|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
83970270|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
83970271|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970272|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
83970273|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970274|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
83970275|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970276|NCT00580814|Methylphenidate|methylphenidate|mesh-list
83970277|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83970278|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970279|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83970280|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83970281|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83970282|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970283|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
83209595|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970284|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970285|NCT01120600|Vitamin D|vitamin d|mesh-list
83970286|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
83970287|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
83970288|NCT01120600|Calcium|calcium|mesh-list
83970289|NCT01120600|Vitamins|vitamins|mesh-ancestor
83970290|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
83970291|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970292|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83970293|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83970294|NCT01120600|Antacids|antacids|mesh-ancestor
83970295|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970296|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970297|NCT04577885|Rifampin|rifampin|mesh-list
83970298|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83970299|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
83970300|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970301|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970302|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
83970303|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83970304|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970305|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970306|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83970307|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83970308|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83970309|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83970310|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83970311|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83970312|NCT00580931|Niacinamide|niacinamide|mesh-list
83970313|NCT00580931|Niacin|niacin|mesh-list
83970314|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
83970315|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
83970316|NCT00580931|Vitamins|vitamins|mesh-ancestor
83970317|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
83970318|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970319|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83970320|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
83970321|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970322|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83970323|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83970324|NCT01120093|Bromides|bromides|mesh-list
83970325|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
83970326|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83970327|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
83970328|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970329|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970330|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83970331|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
83970332|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83970333|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83970334|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970335|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970336|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970337|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970338|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
83970339|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
83970340|NCT00581009|Sertraline|sertraline|mesh-list
83970341|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
83970342|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83970343|NCT00581009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83970344|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83970345|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83970346|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970347|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970348|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
83970349|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970350|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970351|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
83970352|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83970353|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970354|NCT02218359|Amikacin|amikacin|mesh-list
83970355|NCT02218359|Fosfomycin|fosfomycin|mesh-list
83970356|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83970357|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970358|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970359|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
83970360|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83970361|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
83970362|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83970363|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970364|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83970365|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83970366|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83970367|NCT02218398|Albuterol|albuterol|mesh-list
83970368|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83970369|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
83970370|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970371|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970372|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83970373|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
83970374|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
83970375|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83970376|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83970377|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83970378|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970379|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970380|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970381|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970382|NCT02218671|Brotizolam|brotizolam|mesh-list
83970383|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83970384|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970385|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970386|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
83970387|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
83970388|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83970389|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
83970390|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970391|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970392|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83970393|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83970394|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
83970395|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83970396|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
83970397|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970398|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970399|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83970400|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83970401|NCT01119898|Diclofenac|diclofenac|mesh-list
83970402|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83970403|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970404|NCT01119898|Analgesics|analgesics|mesh-ancestor
83970405|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
83970406|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970407|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970408|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970409|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970410|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83970411|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970412|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970413|NCT01119859|Adalimumab|adalimumab|mesh-list
83970414|NCT01119859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83970415|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970416|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970417|NCT02278926|Insulin|insulin|mesh-list
83970418|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83970419|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970420|NCT01119703|Vaccines|vaccines|mesh-list
83970421|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
83970422|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970423|NCT02882230|Dolutegravir|dolutegravir|mesh-list
83970424|NCT02882230|Rilpivirine|rilpivirine|mesh-list
83970425|NCT02882230|Elvitegravir|elvitegravir|mesh-list
83970426|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83970427|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83970428|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970429|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970430|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83970431|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83970432|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
83970433|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970434|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83970435|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83970436|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83970437|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
83970438|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970439|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83970440|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83970441|NCT02881762|Maraviroc|maraviroc|mesh-list
83970442|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83970443|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83970444|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970445|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83970446|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83970447|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
83970448|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970449|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83970450|NCT04561947|Mitogens|mitogens|mesh-list
83970451|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
83970452|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970453|NCT01118962|Lacosamide|lacosamide|mesh-list
83970454|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
83970455|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83970456|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83970457|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83970458|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970459|NCT00581165|Etanercept|etanercept|mesh-list
83970460|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83970461|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970462|NCT00581165|Analgesics|analgesics|mesh-ancestor
83970463|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
83970464|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970465|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970466|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970467|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970468|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970469|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83970470|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
83970471|NCT05092984|Spironolactone|spironolactone|mesh-list
83970472|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83970473|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
83970474|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970475|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970476|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83970477|NCT05092984|Diuretics|diuretics|mesh-ancestor
83970478|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
83970479|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
83970480|NCT02213159|Morphine|morphine|mesh-list
83970481|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83970482|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970483|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970484|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970485|NCT02213159|Analgesics|analgesics|mesh-ancestor
83970486|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
83970487|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970488|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83970489|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83970490|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970491|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970492|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970493|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970494|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83970495|NCT02213159|Narcotics|narcotics|mesh-ancestor
83970496|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
83970497|NCT02219100|Mifepristone|mifepristone|mesh-list
83970498|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83970499|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
83970500|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83970501|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970502|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83970503|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83970504|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83970505|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
83970506|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83209818|NCT04757740|Protective Agents|protective agents|mesh-ancestor
83970507|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83970508|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
83970509|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970510|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
83970511|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83970512|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83970513|NCT01118377|Capecitabine|capecitabine|mesh-list
83970514|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83970515|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
83970516|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970517|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970518|NCT02219178|Dexamethasone|dexamethasone|mesh-list
83970519|NCT02219178|Lenalidomide|lenalidomide|mesh-list
83970520|NCT02219178|Bortezomib|bortezomib|mesh-list
83970521|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970522|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
83970523|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
83970524|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970525|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970526|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970527|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
83970528|NCT02219178|Hormones|hormones|mesh-ancestor
83970529|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970530|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83970531|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970532|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
83970533|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83970534|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83970535|NCT02219178|Growth Substances|growth substances|mesh-ancestor
83970536|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
83970537|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
83970538|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83970539|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970540|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
83970541|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970542|NCT02219217|Dolutegravir|dolutegravir|mesh-list
83970543|NCT02219217|Cobicistat|cobicistat|mesh-list
83970544|NCT02219217|Elvitegravir|elvitegravir|mesh-list
83970545|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83970546|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83970547|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970548|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970549|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83970550|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83970551|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
83970552|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970553|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83970554|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83970555|NCT04577378|Itraconazole|itraconazole|mesh-list
83970556|NCT04577378|Tretinoin|tretinoin|mesh-list
83970557|NCT04577378|Isotretinoin|isotretinoin|mesh-list
83970558|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
83970559|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970560|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83970561|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83970562|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970563|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970564|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83970565|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
83970566|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970567|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970568|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83970569|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970570|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
83970571|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
83970572|NCT02219412|Aspirin|aspirin|mesh-list
83970573|NCT02219412|Ticagrelor|ticagrelor|mesh-list
83970574|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83970575|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970576|NCT02219412|Analgesics|analgesics|mesh-ancestor
83970577|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
83970578|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970579|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970580|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970581|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970582|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83970583|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83970584|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970585|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83970586|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83970587|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970588|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
83970589|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83970590|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83970591|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83970592|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
83970593|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970594|NCT04577027|Travoprost|travoprost|mesh-list
83970595|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83970596|NCT02211690|Tenofovir|tenofovir|mesh-list
83970597|NCT02211690|Emtricitabine|emtricitabine|mesh-list
83970598|NCT02211690|Dolutegravir|dolutegravir|mesh-list
83970599|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
83970600|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970601|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83970602|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83970603|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970604|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970605|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83970606|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83970607|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83970608|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83970609|NCT04553393|Decitabine|decitabine|mesh-list
83970610|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83970611|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
83970612|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970613|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970614|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970615|NCT02211846|Mirabegron|mirabegron|mesh-list
83970616|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83970617|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83970618|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970619|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970620|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970621|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970622|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970623|NCT02211846|Urological Agents|urological agents|mesh-ancestor
83970624|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83970625|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
83970626|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83970627|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83970628|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970629|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970630|NCT02219646|Urological Agents|urological agents|mesh-ancestor
83970631|NCT04553510|Bevacizumab|bevacizumab|mesh-list
83970632|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83970633|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970634|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83970635|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83970636|NCT04553510|Growth Substances|growth substances|mesh-ancestor
83970637|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970638|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
83970639|NCT03453281|Aflibercept|aflibercept|mesh-list
83970640|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83970641|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83970642|NCT03453281|Growth Substances|growth substances|mesh-ancestor
83970643|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970644|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83970645|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970646|NCT01642134|Aspirin|aspirin|mesh-list
83970647|NCT01642134|Clopidogrel|clopidogrel|mesh-list
83970648|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83970649|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970650|NCT01642134|Analgesics|analgesics|mesh-ancestor
83970651|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
83970652|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970653|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970654|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970655|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970656|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83970658|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970659|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83970660|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83970661|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970662|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
83970663|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83970664|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83970665|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83970666|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
83970667|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970668|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83970669|NCT00581789|Sunitinib|sunitinib|mesh-list
83970670|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970671|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83970672|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970673|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970674|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83970675|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83970676|NCT00581789|Growth Substances|growth substances|mesh-ancestor
83970677|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970678|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
83970679|NCT02213588|Antioxidants|antioxidants|mesh-list
83970680|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970681|NCT02213588|Protective Agents|protective agents|mesh-ancestor
83970682|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970683|NCT01642524|Dextrans|dextrans|mesh-list
83970684|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
83970685|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
83970686|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
83970687|NCT02213783|Imipenem|imipenem|mesh-list
83970688|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970689|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970690|NCT04552613|Carboplatin|carboplatin|mesh-list
83970691|NCT04552613|Pemetrexed|pemetrexed|mesh-list
83970692|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970693|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970694|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970695|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83970696|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83970697|NCT02213328|Tenofovir|tenofovir|mesh-list
83970698|NCT02213328|Emtricitabine|emtricitabine|mesh-list
83970699|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83970700|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
83970701|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970702|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83970703|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83970704|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970705|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970706|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83970707|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83970708|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
83970709|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970710|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83970711|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970712|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970713|NCT02219490|Ritonavir|ritonavir|mesh-list
83970714|NCT02219490|Ribavirin|ribavirin|mesh-list
83970715|NCT02219490|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83970716|NCT02219490|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83970717|NCT02219490|Protease Inhibitors|protease inhibitors|mesh-ancestor
83970718|NCT02219490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970719|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970720|NCT02219490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83970721|NCT02219490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83970722|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
83970723|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970724|NCT02219490|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83970725|NCT02219490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83970726|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
83970727|NCT01117051|Prucalopride|prucalopride|mesh-list
83970728|NCT01117051|Laxatives|laxatives|mesh-ancestor
83970729|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83210056|NCT02105116|Cytarabine|cytarabine|mesh-list
83970730|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83970731|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83970732|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
83970733|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970734|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970735|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970736|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
83970737|NCT02211417|Mineral Oil|mineral oil|mesh-list
83970738|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83970739|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970740|NCT02211417|Analgesics|analgesics|mesh-ancestor
83970741|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
83970742|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970743|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970744|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970745|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970746|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83970747|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
83970748|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970749|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83970750|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
83970751|NCT02211417|Emollients|emollients|mesh-ancestor
83970752|NCT02279121|Taurolidine|taurolidine|mesh-list
83970753|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83970754|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970755|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83970756|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970757|NCT02218164|Interferons|interferons|mesh-list
83970758|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
83970759|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
83970760|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83970761|NCT02218164|Fluorouracil|fluorouracil|mesh-list
83970762|NCT02218164|Capecitabine|capecitabine|mesh-list
83970763|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
83970764|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970765|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83970766|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970767|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83970768|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
83970769|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970770|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
83970771|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970772|NCT04552067|Enoxaparin|enoxaparin|mesh-list
83970773|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
83970774|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83970775|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83970776|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970777|NCT01643187|Vitamins|vitamins|mesh-list
83970778|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
83970779|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970780|NCT01643265|Caseins|caseins|mesh-list
83970781|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
83970782|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
83970783|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970784|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
83970785|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
83970786|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
83970787|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970788|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970789|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
83970790|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970791|NCT04551755|Doxycycline|doxycycline|mesh-list
83970792|NCT04551755|Ivermectin|ivermectin|mesh-list
83970793|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970794|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970795|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
83970796|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83970797|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83970798|NCT01643499|Leucovorin|leucovorin|mesh-list
83970799|NCT01643499|Fluorouracil|fluorouracil|mesh-list
83970800|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
83970801|NCT01643499|Irinotecan|irinotecan|mesh-list
83970802|NCT01643499|Calcium|calcium|mesh-list
83970803|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
83970804|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83210128|NCT05550207|Meloxicam|meloxicam|mesh-list
83970805|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970806|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
83970807|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970808|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83970809|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970810|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83970811|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
83970812|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83970813|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83970814|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970815|NCT01643499|Antidotes|antidotes|mesh-ancestor
83970816|NCT01643499|Protective Agents|protective agents|mesh-ancestor
83970817|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
83970818|NCT01643499|Vitamins|vitamins|mesh-ancestor
83970819|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
83970820|NCT01117012|Ivacaftor|ivacaftor|mesh-list
83970821|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83970822|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83970823|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970824|NCT01116739|Fluorides|fluorides|mesh-list
83970825|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
83970826|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
83970827|NCT01116739|Protective Agents|protective agents|mesh-ancestor
83970828|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970829|NCT01640496|Vitamin D|vitamin d|mesh-list
83970830|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
83970831|NCT01640496|Vitamins|vitamins|mesh-ancestor
83970832|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
83970833|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970834|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83970835|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83970836|NCT04551248|Vaccines|vaccines|mesh-list
83970837|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83970838|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
83970839|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970840|NCT01640535|Cetirizine|cetirizine|mesh-list
83970841|NCT01640535|Montelukast|montelukast|mesh-list
83970842|NCT01640535|Levocetirizine|levocetirizine|mesh-list
83970843|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83970844|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
83970845|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83970846|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
83970847|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970848|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970849|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83970850|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83970851|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970852|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83970853|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83970854|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
83970855|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
83970856|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970857|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83970858|NCT04550936|Isavuconazole|isavuconazole|mesh-list
83970859|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
83970860|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970861|NCT04550858|Rebamipide|rebamipide|mesh-list
83970862|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83970863|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970864|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
83970865|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970866|NCT04550858|Protective Agents|protective agents|mesh-ancestor
83970867|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970868|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970869|NCT01640574|Chloroquine|chloroquine|mesh-list
83970870|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83970871|NCT01640574|Piperaquine|piperaquine|mesh-list
83970872|NCT01640574|Artenimol|artenimol|mesh-list
83970873|NCT01640574|Artemisinins|artemisinins|mesh-list
83970874|NCT01640574|Amebicides|amebicides|mesh-ancestor
83970875|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83970876|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83970877|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970878|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
83970879|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970880|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83970881|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83970882|NCT01640574|Analgesics|analgesics|mesh-ancestor
83970883|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
83970884|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970885|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970886|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83970887|NCT01640574|Filaricides|filaricides|mesh-ancestor
83970888|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
83970889|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
83970890|NCT01116427|Abatacept|abatacept|mesh-list
83970891|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83970892|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970893|NCT01116427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83970894|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970895|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83970896|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
83970897|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970898|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970899|NCT04529226|Haloperidol|haloperidol|mesh-list
83970900|NCT04529226|Pimozide|pimozide|mesh-list
83970901|NCT04529226|Olanzapine|olanzapine|mesh-list
83970902|NCT04529226|Risperidone|risperidone|mesh-list
83970903|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
83970904|NCT04529226|Clozapine|clozapine|mesh-list
83970905|NCT04529226|Amisulpride|amisulpride|mesh-list
83970906|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83970907|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
83970908|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970909|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970910|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970911|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83970912|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83970913|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83970914|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83970915|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83970916|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
83970917|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
83970918|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
83970919|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970920|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970921|NCT04529226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83970922|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83970923|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83970924|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83970925|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
83970926|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
83970927|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83970928|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
83970929|NCT04310683|Hormones|hormones|mesh-list
83970930|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83970931|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970932|NCT04550702|Mirabegron|mirabegron|mesh-list
83970933|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83970934|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83970935|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83970936|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
83970937|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970938|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970939|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970940|NCT04550702|Urological Agents|urological agents|mesh-ancestor
83970941|NCT01116232|Sirolimus|sirolimus|mesh-list
83970942|NCT01116232|Rituximab|rituximab|mesh-list
83970943|NCT01116232|Tacrolimus|tacrolimus|mesh-list
83970944|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83970945|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83970946|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970947|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
83970948|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970949|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83970950|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83970951|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83970952|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970953|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970954|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970955|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970956|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83970957|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
83970958|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83970959|NCT04550351|Vaccines|vaccines|mesh-list
83970960|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
83970961|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970962|NCT01640691|Vaccines|vaccines|mesh-list
83970963|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
83970964|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970965|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
83970966|NCT01643889|Domperidone|domperidone|mesh-list
83970967|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83970968|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83970969|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83970970|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83970971|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83970972|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970973|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970974|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970975|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
83970976|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
83970977|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83970978|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970979|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83970980|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
83970981|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83970982|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
83970983|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
83970984|NCT04550078|Calcium|calcium|mesh-list
83970985|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83970986|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970987|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83970988|NCT04550078|Antacids|antacids|mesh-ancestor
83970989|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83970990|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83970991|NCT01205035|Ranibizumab|ranibizumab|mesh-list
83970992|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83970993|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83970994|NCT01205035|Growth Substances|growth substances|mesh-ancestor
83970995|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83970996|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
83970997|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83970998|NCT04549844|Bupivacaine|bupivacaine|mesh-list
83970999|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
83971000|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
83971001|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971002|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971003|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
83152325|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
83971004|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971005|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83971006|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
83971007|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
83971008|NCT01204918|Riluzole|riluzole|mesh-list
83971009|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
83971010|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83971011|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83971012|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971013|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971014|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971015|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83971016|NCT01204918|Protective Agents|protective agents|mesh-ancestor
83971017|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
83971018|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83971019|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83971020|NCT04528797|Prednisolone|prednisolone|mesh-list
83971021|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
83971022|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83971023|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
83971024|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971025|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
83971026|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
83971027|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971028|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971029|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83971030|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
83971031|NCT04528797|Hormones|hormones|mesh-ancestor
83971032|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971033|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83971034|NCT04528797|Protective Agents|protective agents|mesh-ancestor
83210342|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
83971035|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83971037|NCT00624481|Teriparatide|teriparatide|mesh-list
83971038|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971039|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971040|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83971041|NCT04529187|Midazolam|midazolam|mesh-list
83971042|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
83971043|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83971044|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971045|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971046|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83971047|NCT04529187|Analgesics|analgesics|mesh-ancestor
83971048|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
83971049|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971050|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83971051|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83971052|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83971053|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
83971054|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971055|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971056|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83971057|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83971058|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83971059|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83971060|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971061|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
83971062|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
83971063|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
83971064|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
83971065|NCT04549415|Metformin|metformin|mesh-list
83971066|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83971067|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971068|NCT02214368|Propofol|propofol|mesh-list
83971069|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83971070|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971071|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971072|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971073|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
83971074|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
83971075|NCT01204294|Metformin|metformin|mesh-list
83971076|NCT01204294|Linagliptin|linagliptin|mesh-list
83971077|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83971078|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971079|NCT01204294|Incretins|incretins|mesh-ancestor
83971080|NCT01204294|Hormones|hormones|mesh-ancestor
83971081|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971082|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83971083|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
83971084|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971085|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971086|NCT01182181|Anastrozole|anastrozole|mesh-list
83971087|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83971088|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971089|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83971090|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83971091|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971092|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971093|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83971094|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
83971095|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971096|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971097|NCT01181986|Exenatide|exenatide|mesh-list
83971098|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83971099|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971100|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83971101|NCT01181986|Incretins|incretins|mesh-ancestor
83971102|NCT01181986|Hormones|hormones|mesh-ancestor
83971103|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971104|NCT04315909|Vitamin E|vitamin e|mesh-list
83971105|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83971106|NCT04315909|Vitamins|vitamins|mesh-ancestor
83971107|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
83971108|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971109|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
83971110|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971111|NCT04315909|Protective Agents|protective agents|mesh-ancestor
83971112|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
83971113|NCT04315909|Coagulants|coagulants|mesh-ancestor
83971114|NCT01181167|Enoxaparin|enoxaparin|mesh-list
83971115|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
83971116|NCT01181167|Edoxaban|edoxaban|mesh-list
83971117|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
83971118|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83971119|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83971120|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971121|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83971122|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
83971123|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83971124|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83971125|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971126|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
83971127|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83971128|NCT04548557|Antibodies|antibodies|mesh-list
83971129|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
83971130|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83971131|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
83971132|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971133|NCT01181128|Factor VIII|factor viii|mesh-list
83971134|NCT01181128|Coagulants|coagulants|mesh-ancestor
83971135|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83971136|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
83971137|NCT04548284|Hormones|hormones|mesh-ancestor
83971138|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971139|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971140|NCT04547894|TMC-310911|tmc-310911|mesh-list
83971141|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
83971142|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971143|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971144|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
83971145|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
83971146|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971147|NCT01644825|Paclitaxel|paclitaxel|mesh-list
83971148|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83971149|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971150|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83971151|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83971152|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83971153|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971154|NCT01644864|Ropivacaine|ropivacaine|mesh-list
83971155|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
83971156|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
83971157|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971158|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971159|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
83971160|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971161|NCT04547855|Temozolomide|temozolomide|mesh-list
83971162|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83971163|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
83971164|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971165|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971166|NCT01641510|Clopidogrel|clopidogrel|mesh-list
83971167|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83971168|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83971169|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83971170|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83971171|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83971172|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
83971173|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971174|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971175|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971176|NCT04547621|Temozolomide|temozolomide|mesh-list
83971177|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83971178|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
83971179|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971180|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971181|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83971182|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83971183|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971184|NCT04547348|Denosumab|denosumab|mesh-list
83971185|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83971186|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971188|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83971189|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
83971190|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971191|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971192|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83971193|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83971194|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
83971195|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971196|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971197|NCT01641666|Ribavirin|ribavirin|mesh-list
83971198|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83971199|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
83971200|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
83971201|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971202|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
83971203|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971204|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
83971205|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971206|NCT01203787|Sorafenib|sorafenib|mesh-list
83971207|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971208|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83971209|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971210|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971211|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
83971212|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83971213|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971214|NCT04547504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83971215|NCT04547504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971216|NCT01645254|Antimalarials|antimalarials|mesh-list
83971217|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83971218|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83971219|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971220|NCT01181011|Amlodipine|amlodipine|mesh-list
83971221|NCT01181011|Telmisartan|telmisartan|mesh-list
83971222|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83971223|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83971224|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83971225|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971226|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971227|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971228|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971229|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
83971230|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83971231|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83971232|NCT01641783|Paclitaxel|paclitaxel|mesh-list
83971233|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83971234|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83971235|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971236|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
83971237|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
83971238|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
83971239|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971240|NCT02214602|Doxorubicin|doxorubicin|mesh-list
83971241|NCT02214602|Epirubicin|epirubicin|mesh-list
83971242|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83971243|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971244|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83971245|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83971246|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971247|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971248|NCT01646580|Ciclopirox|ciclopirox|mesh-list
83971249|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
83971250|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971251|NCT04546802|Grazoprevir|grazoprevir|mesh-list
83971252|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83971253|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
83971254|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971255|NCT01580033|Vaccines|vaccines|mesh-list
83971256|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
83971257|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971258|NCT04546373|Niraparib|niraparib|mesh-list
83971259|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83971260|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971261|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971262|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971263|NCT01645410|Atorvastatin|atorvastatin|mesh-list
83971264|NCT01645410|Calcium|calcium|mesh-list
83971265|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971266|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971267|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83971268|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83971269|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
83971270|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971271|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83971272|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83971273|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971274|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
83971275|NCT04546334|Analgesics|analgesics|mesh-ancestor
83971276|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
83971277|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971278|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971279|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
83971280|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971281|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83971282|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
83971283|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83971284|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971285|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971286|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971287|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
83971288|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83971289|NCT04546256|Fluticasone|fluticasone|mesh-list
83971290|NCT04546256|Xhance|xhance|mesh-list
83971291|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83971292|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83971293|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971294|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83971295|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
83971296|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971297|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971298|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83971299|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83971300|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
83971301|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83971302|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83971303|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83971304|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83971305|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83971306|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971307|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971308|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
83971309|NCT04546256|Hormones|hormones|mesh-ancestor
83971310|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971311|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
83971312|NCT01645449|Atorvastatin|atorvastatin|mesh-list
83971313|NCT01645449|Calcium|calcium|mesh-list
83971314|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971315|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971316|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83971317|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83971318|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
83971319|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971320|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83971321|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83971322|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971323|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83971324|NCT01645800|Muramidase|muramidase|mesh-list
83971325|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971326|NCT02214680|Timolol|timolol|mesh-list
83971327|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83971328|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
83971329|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83971330|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83210637|NCT02600897|Rituximab|rituximab|mesh-list
83971331|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
83971332|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971333|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971334|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971335|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83971336|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83971337|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83971338|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83971339|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83971340|NCT02756208|Vaccines|vaccines|mesh-list
83971341|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
83971342|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971343|NCT04545788|Linezolid|linezolid|mesh-list
83971344|NCT04545788|Cycloserine|cycloserine|mesh-list
83971345|NCT04545788|Bedaquiline|bedaquiline|mesh-list
83971346|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83971347|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971348|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83971349|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971350|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971351|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83971352|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83971353|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
83971354|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
83971355|NCT02756013|Paclitaxel|paclitaxel|mesh-list
83971356|NCT02756013|Carboplatin|carboplatin|mesh-list
83971357|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83971358|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971359|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83971360|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83971361|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83971362|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971363|NCT01680042|Phenytoin|phenytoin|mesh-list
83971364|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
83971365|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83971366|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83971367|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971368|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971369|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83971370|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83971371|NCT04545710|Osimertinib|osimertinib|mesh-list
83971372|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971373|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83971374|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971375|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971376|NCT01646229|Polymyxins|polymyxins|mesh-list
83971377|NCT01646229|Polymyxin B|polymyxin b|mesh-list
83971378|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83971379|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971380|NCT01680081|Adenosine|adenosine|mesh-list
83971381|NCT01680081|Analgesics|analgesics|mesh-ancestor
83971382|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
83971383|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971384|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971385|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83971386|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
83971387|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83971388|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
83971389|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
83971390|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971391|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971392|NCT01646307|Atorvastatin|atorvastatin|mesh-list
83971393|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83971394|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83971395|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83971396|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
83971397|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971398|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83971399|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83971400|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971401|NCT04544969|Cisplatin|cisplatin|mesh-list
83971402|NCT04544969|Gemcitabine|gemcitabine|mesh-list
83971403|NCT04544969|Docetaxel|docetaxel|mesh-list
83971404|NCT04544969|Fluorouracil|fluorouracil|mesh-list
83971405|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971406|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83971407|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
83971408|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971409|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
83971410|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
83971411|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
83971412|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83971413|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
83971414|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971415|NCT04541732|Anesthetics|anesthetics|mesh-list
83971416|NCT04541732|Propofol|propofol|mesh-list
83971417|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971418|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971419|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83971420|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971421|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
83971422|NCT01680471|Midazolam|midazolam|mesh-list
83971423|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83971424|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83971425|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971426|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971427|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83971428|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83971429|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83971430|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971431|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
83971432|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
83971433|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
83971434|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
83971435|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971436|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971437|NCT02279316|Vitamin D|vitamin d|mesh-list
83971438|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
83971439|NCT02279316|Vitamins|vitamins|mesh-ancestor
83971440|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
83971441|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971442|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83971443|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971444|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
83971445|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83971446|NCT04544228|Ketamine|ketamine|mesh-list
83971447|NCT04544228|Bupivacaine|bupivacaine|mesh-list
83971448|NCT04544228|Neostigmine|neostigmine|mesh-list
83971449|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
83971450|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
83971451|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971452|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971453|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
83971454|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971455|NCT04544228|Analgesics|analgesics|mesh-ancestor
83971456|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83971457|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971458|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
83971459|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83971460|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83971461|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971462|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971463|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83971464|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971465|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
83971466|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83971467|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
83971468|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
83971469|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83971470|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
83971471|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971472|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83971473|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83971474|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
83971475|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971476|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971477|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83971478|NCT04542005|Albuterol|albuterol|mesh-list
83971479|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83971480|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
83971481|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971482|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971483|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83971484|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
83971485|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
83971486|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83971487|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83971488|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83971489|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83971490|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
83971491|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971492|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971493|NCT01646775|Fentanyl|fentanyl|mesh-list
83971494|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83971495|NCT01646775|Narcotics|narcotics|mesh-ancestor
83971496|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971497|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971498|NCT01646775|Analgesics|analgesics|mesh-ancestor
83971499|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
83971500|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971501|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83971502|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971503|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
83971504|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
83971505|NCT01646853|Fluorouracil|fluorouracil|mesh-list
83971506|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971507|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
83971508|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971509|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83971510|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83971511|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
83971512|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971513|NCT01647165|Dexamethasone|dexamethasone|mesh-list
83971514|NCT01647165|Lenalidomide|lenalidomide|mesh-list
83971515|NCT01647165|Bortezomib|bortezomib|mesh-list
83971516|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971517|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
83971518|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
83971519|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971520|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971521|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83971522|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
83971523|NCT01647165|Hormones|hormones|mesh-ancestor
83971524|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971525|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83971526|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971527|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
83971528|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83971529|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83971530|NCT01647165|Growth Substances|growth substances|mesh-ancestor
83971531|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
83971532|NCT01681134|Tacrolimus|tacrolimus|mesh-list
83971533|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83971534|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
83971535|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971536|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83971537|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971538|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971539|NCT04543916|Irinotecan|irinotecan|mesh-list
83971540|NCT04543916|Venetoclax|venetoclax|mesh-list
83971541|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83971542|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83971543|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971544|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971545|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971546|NCT04541147|Dexamethasone|dexamethasone|mesh-list
83971547|NCT04541147|Analgesics|analgesics|mesh-list
83971548|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971549|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
83971550|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
83971551|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971552|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971553|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83971554|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
83971555|NCT04541147|Hormones|hormones|mesh-ancestor
83971556|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210860|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
83971557|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83971558|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971559|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
83971561|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83971562|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83971563|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971564|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
83971565|NCT04541303|Coagulants|coagulants|mesh-ancestor
83971566|NCT02214992|Telmisartan|telmisartan|mesh-list
83971567|NCT02214992|Ramipril|ramipril|mesh-list
83971568|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83971569|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83971570|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83971571|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971572|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83971573|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
83971574|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971575|NCT04528095|Clozapine|clozapine|mesh-list
83971576|NCT04528095|Amisulpride|amisulpride|mesh-list
83971577|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83971578|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
83971579|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971580|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971581|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971582|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83971583|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83971584|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971585|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83971586|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
83971587|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
83971588|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83971589|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
83971590|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83971591|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
83971592|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
83971593|NCT04528056|Ambrisentan|ambrisentan|mesh-list
83971594|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971595|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83971596|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83971597|NCT04528056|Analgesics|analgesics|mesh-ancestor
83971598|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
83971599|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971600|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971601|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971602|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83971603|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83971604|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83971605|NCT04543565|Tenofovir|tenofovir|mesh-list
83971606|NCT04543565|Pradefovir|pradefovir|mesh-list
83971607|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
83971608|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971609|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83971610|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83971611|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971612|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971613|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83971614|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83971615|NCT01647555|Cetuximab|cetuximab|mesh-list
83971616|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83971617|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971618|NCT04543370|Deflazacort|deflazacort|mesh-list
83971619|NCT04543370|Midazolam|midazolam|mesh-list
83971620|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83971621|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83971622|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971623|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971624|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83971625|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83971626|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83971627|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971628|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
83971629|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
83971630|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
83971631|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
83971632|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971633|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971634|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971635|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83971636|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
83971637|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
83971638|NCT01681563|Ofatumumab|ofatumumab|mesh-list
83971639|NCT01681563|Pentostatin|pentostatin|mesh-list
83971640|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83971641|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
83971642|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971643|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83971644|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83971645|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
83971646|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971647|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971648|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83971649|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83971650|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971651|NCT01681680|Metformin|metformin|mesh-list
83971652|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83971653|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971654|NCT01647633|Calcium|calcium|mesh-list
83971655|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971656|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971657|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83971658|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971659|NCT01647984|Vitamins|vitamins|mesh-list
83971660|NCT01647984|Vitamin E|vitamin e|mesh-list
83971661|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
83971662|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
83971663|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971664|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
83971665|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971666|NCT01647984|Protective Agents|protective agents|mesh-ancestor
83971667|NCT02215382|Atropine|atropine|mesh-list
83971668|NCT02215382|Neostigmine|neostigmine|mesh-list
83971669|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83971670|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83971671|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83971672|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
83971673|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971674|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971675|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83971676|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
83971677|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
83971678|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
83971679|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83971680|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83971681|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
83971682|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971683|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971684|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83971685|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971686|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83971687|NCT01682109|Valacyclovir|valacyclovir|mesh-list
83971688|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
83971689|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971690|NCT02215148|Tolvaptan|tolvaptan|mesh-list
83971691|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83971692|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971693|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
83971694|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971695|NCT01682343|Calcium|calcium|mesh-list
83971696|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971697|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971698|NCT01648257|Cabotegravir|cabotegravir|mesh-list
83971699|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83971700|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83971701|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971702|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971703|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83971704|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83971705|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
83971706|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971707|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
83971708|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83971710|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83971711|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971712|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
83971713|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83971714|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83971715|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
83971716|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83971717|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83971718|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
83971719|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
83971720|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971721|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971722|NCT01648608|Exemestane|exemestane|mesh-list
83971723|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971724|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83971725|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83971726|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971727|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971728|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83971729|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
83971730|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971731|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971732|NCT02215538|Methylphenidate|methylphenidate|mesh-list
83971733|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83971734|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971735|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83971736|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83971737|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971738|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971739|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
83971740|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971741|NCT01682421|Dexamethasone|dexamethasone|mesh-list
83971742|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
83971743|NCT01682421|BB 1101|bb 1101|mesh-list
83971744|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971745|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971746|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971747|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
83971748|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
83971749|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971750|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83971751|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
83971752|NCT01682421|Hormones|hormones|mesh-ancestor
83971753|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971754|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83971755|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971756|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
83971757|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971758|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
83971759|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
83971760|NCT01682499|Calcium|calcium|mesh-list
83971761|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971762|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971763|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83971764|NCT01682499|Analgesics|analgesics|mesh-ancestor
83971765|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
83971766|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971767|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
83971768|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971769|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83971770|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
83971771|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83971772|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971773|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971774|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
83971775|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83971776|NCT04540055|Anesthetics|anesthetics|mesh-list
83971777|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971778|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971779|NCT01180660|Lidocaine|lidocaine|mesh-list
83211111|NCT02576145|Daclizumab|daclizumab|mesh-list
83971780|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
83971781|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
83971782|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971783|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971784|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
83971785|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971786|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83971787|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83971788|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83971789|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971790|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971791|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83971792|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83971793|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971794|NCT01202227|Pregabalin|pregabalin|mesh-list
83971795|NCT01202227|Analgesics|analgesics|mesh-ancestor
83971796|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
83971797|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971798|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971799|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
83971800|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83971801|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971802|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971803|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971804|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83971805|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83971806|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971807|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83971808|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
83971809|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83971810|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971811|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971812|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
83971813|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971814|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971815|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
83971816|NCT04539314|Bupivacaine|bupivacaine|mesh-list
83971817|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
83971818|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
83971819|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971820|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971821|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
83971822|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971823|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83971824|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83971825|NCT04539314|Analgesics|analgesics|mesh-ancestor
83971826|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83971827|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83971828|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83971829|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
83971830|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971831|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971832|NCT01682772|Olaparib|olaparib|mesh-list
83971833|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83971834|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971835|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971836|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971837|NCT01649037|Terlipressin|terlipressin|mesh-list
83971838|NCT01649037|Epinephrine|epinephrine|mesh-list
83971839|NCT01649037|Racepinephrine|racepinephrine|mesh-list
83971840|NCT01649037|Norepinephrine|norepinephrine|mesh-list
83971841|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
83971842|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83971843|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83971844|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
83971845|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971846|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971847|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971848|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83971849|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83971850|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
83971851|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971852|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83971853|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
83971854|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
83971855|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
83971856|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83971857|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83971858|NCT04539119|Tenofovir|tenofovir|mesh-list
83971859|NCT04539119|Entecavir|entecavir|mesh-list
83971860|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
83971861|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971862|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83971863|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83971864|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971865|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971866|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83971867|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83971868|NCT02279511|Adenosine|adenosine|mesh-list
83971869|NCT02279511|Analgesics|analgesics|mesh-ancestor
83971870|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
83971871|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971872|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971873|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83971874|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
83971875|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83971876|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
83971877|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
83971878|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971879|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971880|NCT02279628|Morphine|morphine|mesh-list
83971881|NCT02279628|Ropivacaine|ropivacaine|mesh-list
83971882|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83971883|NCT02279628|Narcotics|narcotics|mesh-ancestor
83971884|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971885|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971886|NCT02279628|Analgesics|analgesics|mesh-ancestor
83971887|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
83971888|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971889|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
83971890|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
83971891|NCT04542629|Trace Elements|trace elements|mesh-list
83971892|NCT04542629|Rituximab|rituximab|mesh-list
83971893|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83971894|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971895|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
83971896|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971897|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83971898|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
83971899|NCT01683006|Rocuronium|rocuronium|mesh-list
83971900|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83152327|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
83971901|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83971902|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83971903|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971904|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971905|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83971906|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83971907|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83971908|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83971909|NCT02215733|Telmisartan|telmisartan|mesh-list
83971910|NCT02215733|Diuretics|diuretics|mesh-list
83971911|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83971912|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83971913|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83971914|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83971915|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971916|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
83971917|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971918|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83971919|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
83971920|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971921|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
83971922|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
83971923|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83971924|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
83971925|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971926|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971927|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83971928|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
83211233|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
83971929|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
83971930|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83971931|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
83971932|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971933|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971934|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83971935|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83971936|NCT01179919|Oseltamivir|oseltamivir|mesh-list
83971937|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
83971938|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83971939|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971940|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971941|NCT01201798|Prednisolone|prednisolone|mesh-list
83971942|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83971943|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
83971944|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83971945|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
83971946|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83971947|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
83971948|NCT01201798|Difluprednate|difluprednate|mesh-list
83971949|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971950|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
83971951|NCT01201798|Hormones|hormones|mesh-ancestor
83971952|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83971953|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971954|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83971955|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83971956|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
83971957|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
83971958|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971959|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83971960|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83971961|NCT01201798|Protective Agents|protective agents|mesh-ancestor
83971962|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83971963|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
83971964|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83971965|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83971966|NCT01201759|Analgesics|analgesics|mesh-ancestor
83971967|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
83971968|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971969|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971970|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83971971|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83971972|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83971973|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83971974|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971975|NCT04532684|Pregabalin|pregabalin|mesh-list
83971976|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83971977|NCT04532684|Analgesics|analgesics|mesh-ancestor
83971978|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
83971979|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83971980|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971981|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
83971982|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83971983|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83971984|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83971985|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83971986|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83971987|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83971988|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83971989|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83971990|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83971991|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83971992|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83971993|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
83971994|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
83971995|NCT01649466|Insulin|insulin|mesh-list
83971996|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83971997|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83971998|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83971999|NCT01200589|Rituximab|rituximab|mesh-list
83972000|NCT01200589|Ofatumumab|ofatumumab|mesh-list
83972001|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83972002|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83211316|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
83972003|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972004|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
83972005|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972006|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972007|NCT01683552|Fexofenadine|fexofenadine|mesh-list
83972008|NCT01683552|Prednisone|prednisone|mesh-list
83972009|NCT01683552|Aprepitant|aprepitant|mesh-list
83972010|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83972011|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
83972012|NCT01683552|Hormones|hormones|mesh-ancestor
83972013|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972014|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972015|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83972016|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972017|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
83972018|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
83972019|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972020|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972021|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83972022|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972023|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972024|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83972025|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83972026|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83972027|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
83972028|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
83972029|NCT04532606|Anesthetics|anesthetics|mesh-list
83972030|NCT04532606|Propofol|propofol|mesh-list
83972031|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972032|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972033|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83972034|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83972035|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
83972036|NCT01649544|Amiodarone|amiodarone|mesh-list
83972037|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83972038|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
83972039|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83972040|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83972041|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972042|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83972043|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83972044|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83972045|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972046|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83972047|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83972048|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83972049|NCT04528290|Ozanimod|ozanimod|mesh-list
83972050|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83972051|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972052|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83972053|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
83972054|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972055|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
83972056|NCT01179334|Riociguat|riociguat|mesh-list
83972057|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
83972058|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83972059|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83972060|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972061|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972062|NCT01179334|Urological Agents|urological agents|mesh-ancestor
83972063|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
83972064|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83972065|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83972066|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
83972067|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972068|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972069|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
83972070|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83972071|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83972072|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972073|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
83972074|NCT01683747|Coagulants|coagulants|mesh-ancestor
83972075|NCT01178671|Mirtazapine|mirtazapine|mesh-list
83972077|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
83972078|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83972079|NCT01178671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83972080|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83972081|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83972082|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972083|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972084|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
83972085|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972086|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83972087|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
83972088|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
83972089|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83972090|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83972091|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972092|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83972093|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83972094|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83972095|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
83972096|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83972097|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83972098|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83972099|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
83972100|NCT04532060|Nystatin|nystatin|mesh-list
83972101|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83972102|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
83972103|NCT04532060|Ionophores|ionophores|mesh-ancestor
83972104|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83972105|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972106|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83972107|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
83972108|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83972109|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83972110|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972111|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972112|NCT01649739|Urological Agents|urological agents|mesh-ancestor
83972113|NCT04532333|Heparin|heparin|mesh-list
83972114|NCT04532333|Bivalirudin|bivalirudin|mesh-list
83972115|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
83972116|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83972117|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83972118|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972119|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
83972120|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83972121|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
83972122|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972123|NCT01649895|Cycloserine|cycloserine|mesh-list
83972124|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83972125|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972126|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83972127|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
83972128|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83972129|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
83972130|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972131|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83972132|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
83972133|NCT01649505|Coagulants|coagulants|mesh-ancestor
83972134|NCT01178086|Rituximab|rituximab|mesh-list
83972135|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83972136|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972137|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
83972138|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972139|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972140|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
83972141|NCT04531865|Rituximab|rituximab|mesh-list
83972142|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83972143|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972144|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
83972145|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972146|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972147|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83972148|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83972149|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
83972150|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83972151|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972152|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972153|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972154|NCT01643070|Capecitabine|capecitabine|mesh-list
83972155|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
83972156|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83972157|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
83972158|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972159|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972160|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
83972161|NCT01684059|Astringents|astringents|mesh-ancestor
83972162|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972163|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
83972164|NCT04531748|Toremifene|toremifene|mesh-list
83972165|NCT04531748|Melatonin|melatonin|mesh-list
83972166|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
83972167|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972168|NCT04531748|Protective Agents|protective agents|mesh-ancestor
83972169|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972170|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972171|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83972172|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972173|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83972174|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83972175|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
83972176|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972177|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83972178|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83972179|NCT01177813|Empagliflozin|empagliflozin|mesh-list
83972180|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972181|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972182|NCT01177813|Incretins|incretins|mesh-ancestor
83972183|NCT01177813|Hormones|hormones|mesh-ancestor
83972184|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972185|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83972186|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
83972187|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972188|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972189|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83972190|NCT04315831|Buprenorphine|buprenorphine|mesh-list
83972191|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83972192|NCT04315831|Narcotics|narcotics|mesh-ancestor
83972193|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972194|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972195|NCT04315831|Analgesics|analgesics|mesh-ancestor
83972196|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
83972197|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972198|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83972199|NCT02216045|Ribavirin|ribavirin|mesh-list
83972200|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83972201|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
83972202|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
83972203|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972204|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
83972205|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972206|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
83972207|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972208|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
83972209|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83972210|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83972211|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972212|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
83972213|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83972214|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83972215|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972216|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972217|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972218|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
83972219|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972220|NCT04531475|Lansoprazole|lansoprazole|mesh-list
83972221|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
83972222|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83972223|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972224|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83972225|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972226|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972227|NCT01684449|Sirolimus|sirolimus|mesh-list
83972228|NCT01684449|Gemcitabine|gemcitabine|mesh-list
83972229|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83972230|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
83972231|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972232|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972233|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83972234|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972235|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83972236|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
83972237|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83972238|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
83972239|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972240|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83972241|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
83972242|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
83972243|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972244|NCT01684683|Theophylline|theophylline|mesh-list
83972245|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83972246|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
83972247|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972248|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972249|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83972250|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
83972251|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83972252|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972253|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972254|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
83972255|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83972256|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83972257|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
83972258|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972259|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83972260|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
83972261|NCT01684800|Coagulants|coagulants|mesh-ancestor
83972262|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83972263|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
83972264|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972265|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
83972266|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83972267|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
83972268|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972269|NCT04531163|Expectorants|expectorants|mesh-ancestor
83972270|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
83972271|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83972272|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
83972273|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972274|NCT04531163|Protective Agents|protective agents|mesh-ancestor
83972275|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972276|NCT04531163|Antidotes|antidotes|mesh-ancestor
83972277|NCT01684995|Nicotine|nicotine|mesh-list
83972278|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83972279|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
83972280|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972281|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972282|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83972283|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83972284|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
83972285|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972286|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972287|NCT01685502|Acarbose|acarbose|mesh-list
83972288|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83972289|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972290|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972291|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972292|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972293|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
83972294|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83972295|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972296|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
83972297|NCT01200355|Posaconazole|posaconazole|mesh-list
83972298|NCT01200355|Micafungin|micafungin|mesh-list
83972299|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
83972300|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972301|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83972302|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83972303|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83972304|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83972305|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83972306|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972307|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972308|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83972309|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
83972310|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972311|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972312|NCT04527666|Anticoagulants|anticoagulants|mesh-list
83972313|NCT04530500|Androgens|androgens|mesh-list
83972314|NCT04530500|Hormones|hormones|mesh-ancestor
83972315|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972316|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972317|NCT01685658|Acetaminophen|acetaminophen|mesh-list
83972318|NCT01685658|Ketoprofen|ketoprofen|mesh-list
83972319|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83972320|NCT01685658|Analgesics|analgesics|mesh-ancestor
83972321|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
83972322|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972323|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972324|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
83972325|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83972326|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83972327|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972328|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83972329|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972330|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972331|NCT04530578|Heparin|heparin|mesh-list
83972332|NCT04530578|Calcium heparin|calcium heparin|mesh-list
83972333|NCT04530578|Enoxaparin|enoxaparin|mesh-list
83972334|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83972335|NCT04530578|Tinzaparin|tinzaparin|mesh-list
83972336|NCT04530578|Dalteparin|dalteparin|mesh-list
83972337|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
83972338|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83972339|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83972340|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972341|NCT01685853|Bisacodyl|bisacodyl|mesh-list
83972342|NCT01685853|Cathartics|cathartics|mesh-ancestor
83972343|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972344|NCT01685853|Laxatives|laxatives|mesh-ancestor
83972345|NCT04530422|Azithromycin|azithromycin|mesh-list
83972346|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
83972347|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
83972348|NCT04530422|Oseltamivir|oseltamivir|mesh-list
83972349|NCT04530422|Ledipasvir|ledipasvir|mesh-list
83972350|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83972351|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972352|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
83972353|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83972354|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83972355|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972356|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972357|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972358|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
83972359|NCT02887573|Mosapride|mosapride|mesh-list
83972360|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972361|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972362|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83972363|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
83972364|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972365|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972366|NCT01685892|Venetoclax|venetoclax|mesh-list
83972367|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
83972368|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972369|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83972370|NCT02887534|Tizanidine|tizanidine|mesh-list
83972371|NCT02887534|Analgesics|analgesics|mesh-ancestor
83972372|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
83972373|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972374|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972375|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
83972376|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83972377|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83972378|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
83972379|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
83972380|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83972381|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83972382|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83972383|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
83972384|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972385|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972386|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83972387|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83972388|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83972389|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972390|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972391|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83972392|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83972393|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83972394|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
83972395|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972396|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972397|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83972398|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83972399|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
83972400|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
83972401|NCT01685970|Cathartics|cathartics|mesh-ancestor
83972402|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972403|NCT04530617|Camostat|camostat|mesh-list
83972404|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
83972405|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972406|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972407|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83972408|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83972409|NCT01686009|Ketamine|ketamine|mesh-list
83972410|NCT01686009|Analgesics|analgesics|mesh-ancestor
83972411|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
83972412|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972413|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972414|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83972415|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83972416|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
83972417|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
83972418|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972419|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83972420|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83972421|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972422|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972423|NCT04536662|Dexamethasone|dexamethasone|mesh-list
83972424|NCT04536662|Prednisone|prednisone|mesh-list
83972425|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
83972426|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83972427|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
83972428|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
83972429|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972430|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972431|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972432|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
83972433|NCT04536662|Hormones|hormones|mesh-ancestor
83972434|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972435|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83972436|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972437|NCT01686321|Rituximab|rituximab|mesh-list
83972438|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83972439|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83972440|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972441|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
83972442|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972443|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972444|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83972445|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
83972446|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972447|NCT01199731|Etravirine|etravirine|mesh-list
83972448|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83972449|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83972450|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972451|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972452|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
83972453|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972454|NCT01686555|Venetoclax|venetoclax|mesh-list
83972455|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972456|NCT01686711|Pioglitazone|pioglitazone|mesh-list
83972457|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972458|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972459|NCT01686789|Interferons|interferons|mesh-list
83972460|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
83972461|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
83972462|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83972463|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972464|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
83972465|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972466|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
83972467|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972468|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
83972469|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83972470|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
83972471|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972472|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972473|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83972474|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
83972475|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83972476|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
83972477|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972478|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972479|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83972480|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
83972481|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
83972482|NCT02217683|Protective Agents|protective agents|mesh-ancestor
83972483|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83972484|NCT02217722|Amoxicillin|amoxicillin|mesh-list
83972485|NCT02217722|Metronidazole|metronidazole|mesh-list
83972486|NCT02217722|Doxycycline|doxycycline|mesh-list
83972487|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972488|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83972489|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83972490|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
83972491|NCT02217839|Octreotide|octreotide|mesh-list
83972492|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972493|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83972494|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972495|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
83972496|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83972497|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
83972498|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
83972499|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972500|NCT02217956|Bevacizumab|bevacizumab|mesh-list
83972501|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83972502|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972503|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83972504|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83972505|NCT02217956|Growth Substances|growth substances|mesh-ancestor
83972506|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972507|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
83972508|NCT01687140|Cycloserine|cycloserine|mesh-list
83972509|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83972510|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972511|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83972512|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
83972513|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83972514|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
83972515|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972516|NCT04535960|Liraglutide|liraglutide|mesh-list
83972517|NCT04535960|Empagliflozin|empagliflozin|mesh-list
83972518|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972519|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972520|NCT04535960|Incretins|incretins|mesh-ancestor
83972521|NCT04535960|Hormones|hormones|mesh-ancestor
83972522|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972523|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83972524|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972525|NCT04536428|Hemostatics|hemostatics|mesh-list
83972526|NCT04536428|Coagulants|coagulants|mesh-ancestor
83972527|NCT01687374|Hormones|hormones|mesh-list
83972528|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
83972529|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972530|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972531|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83972532|NCT04530188|Propofol|propofol|mesh-list
83972533|NCT04530188|Sevoflurane|sevoflurane|mesh-list
83972534|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83972535|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972536|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972537|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83972538|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
83972539|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
83972540|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83972541|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83972542|NCT01687491|Enoxaparin|enoxaparin|mesh-list
83972543|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
83972544|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83972545|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83972546|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972547|NCT04530227|Paclitaxel|paclitaxel|mesh-list
83972548|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83972549|NCT04530227|Pemetrexed|pemetrexed|mesh-list
83972550|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83972551|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972552|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83972553|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83972554|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83972555|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972556|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972557|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83972558|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83972559|NCT01199263|Paclitaxel|paclitaxel|mesh-list
83972560|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83972561|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83972562|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972563|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
83972564|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
83972565|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
83972566|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972567|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
83972568|NCT02218034|Tazarotene|tazarotene|mesh-list
83972569|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
83972570|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
83972571|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
83972572|NCT02218034|Vitamins|vitamins|mesh-ancestor
83972573|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
83972574|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972575|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
83972576|NCT01688154|Procyanidin|procyanidin|mesh-list
83972577|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
83972578|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972579|NCT01688154|Protective Agents|protective agents|mesh-ancestor
83972580|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972581|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83972582|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83972583|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972584|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
83972585|NCT01688349|Hormones|hormones|mesh-ancestor
83972586|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972587|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972588|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
83972589|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83972590|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83972591|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972592|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
83972593|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83972594|NCT04535804|Aspirin|aspirin|mesh-list
83972595|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83972596|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83972597|NCT04535804|Analgesics|analgesics|mesh-ancestor
83972598|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
83972599|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972600|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972601|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83972602|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972603|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83972604|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83972605|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972606|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83972607|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83972608|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972609|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
83972610|NCT04529525|Ivermectin|ivermectin|mesh-list
83972611|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83972612|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972613|NCT02216409|Magrolimab|magrolimab|mesh-list
83972614|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83972615|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972616|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83972617|NCT05126121|Amoxicillin|amoxicillin|mesh-list
83972618|NCT05126121|Clarithromycin|clarithromycin|mesh-list
83972619|NCT05126121|Levofloxacin|levofloxacin|mesh-list
83972620|NCT05126121|Ofloxacin|ofloxacin|mesh-list
83972621|NCT05126121|Tetracycline|tetracycline|mesh-list
83972622|NCT05126121|Tinidazole|tinidazole|mesh-list
83972623|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83972624|NCT05126121|Furazolidone|furazolidone|mesh-list
83972625|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972626|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
83972627|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83972628|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972629|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972630|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83972631|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83972632|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83972633|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83972634|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83972635|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972636|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83972637|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83972638|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83972639|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83972640|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83972641|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83972642|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
83972643|NCT02218658|Brotizolam|brotizolam|mesh-list
83972644|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83972645|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972646|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972647|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83972648|NCT01199068|Efatutazone|efatutazone|mesh-list
83972649|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972650|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83972651|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972652|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972653|NCT01198873|Dronedarone|dronedarone|mesh-list
83972654|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83972655|NCT01198795|Escitalopram|escitalopram|mesh-list
83972656|NCT01198795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83972657|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83972658|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83972659|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972660|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972661|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
83972662|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972663|NCT02278913|Insulin|insulin|mesh-list
83972664|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
83972665|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83972666|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972667|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972668|NCT02216513|Deferoxamine|deferoxamine|mesh-list
83972669|NCT02216513|Siderophores|siderophores|mesh-ancestor
83972670|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83972671|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
83972672|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
83972673|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972674|NCT02218775|Aticaprant|aticaprant|mesh-list
83972675|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83972676|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972677|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
83972678|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972679|NCT02216552|Resveratrol|resveratrol|mesh-list
83972680|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
83972681|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972682|NCT02216552|Protective Agents|protective agents|mesh-ancestor
83972683|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972684|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972685|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83972686|NCT01198756|Vaccines|vaccines|mesh-list
83972687|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
83972688|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972689|NCT02216487|Irinotecan|irinotecan|mesh-list
83972690|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83972691|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83972692|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972693|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972694|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972695|NCT02218814|Bupivacaine|bupivacaine|mesh-list
83972696|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
83972697|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
83972698|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972699|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972700|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
83972701|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972702|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83972703|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83972704|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83972705|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972706|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
83972707|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83972708|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
83972709|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972710|NCT01198132|Vitamin D|vitamin d|mesh-list
83972711|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
83972712|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
83972713|NCT01198132|Vitamins|vitamins|mesh-list
83972714|NCT01198132|Interferons|interferons|mesh-list
83972715|NCT01198132|Interferon-beta|interferon-beta|mesh-list
83972716|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
83972717|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
83972718|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972719|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83972720|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83972721|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972722|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
83972723|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972724|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
83972725|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83972726|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
83972727|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83972728|NCT02219165|Antibodies|antibodies|mesh-list
83972729|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
83972730|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972731|NCT04534725|Interferons|interferons|mesh-list
83972732|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
83972733|NCT04534725|Lenzilumab|lenzilumab|mesh-list
83972734|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972735|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
83972736|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972737|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
83972738|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972739|NCT04534725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83972740|NCT04534478|Prednisone|prednisone|mesh-list
83972741|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83972742|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
83972743|NCT04534478|Hormones|hormones|mesh-ancestor
83972744|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972745|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972746|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83972747|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972748|NCT02216669|Imidazole|imidazole|mesh-list
83972749|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972750|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972751|NCT03772158|Cetirizine|cetirizine|mesh-list
83972752|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83972753|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83972754|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83212059|NCT02422121|RNS60|rns60|mesh-list
83972755|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
83972756|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
83972757|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972758|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972759|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972760|NCT01196416|Cisplatin|cisplatin|mesh-list
83972761|NCT01196416|Temozolomide|temozolomide|mesh-list
83972762|NCT01196416|Vinblastine|vinblastine|mesh-list
83972763|NCT01196416|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83972764|NCT01196416|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83972765|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972766|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83972767|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
83972768|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972769|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83972770|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
83972771|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
83972772|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
83972773|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972774|NCT01196104|Insulin|insulin|mesh-list
83972775|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83972776|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
83972777|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
83972778|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972779|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972780|NCT04534322|Dexamethasone|dexamethasone|mesh-list
83972781|NCT04534322|Melphalan|melphalan|mesh-list
83972782|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83972783|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
83972784|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
83972785|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972786|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972787|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972788|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
83972789|NCT04534322|Hormones|hormones|mesh-ancestor
83972790|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972791|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83972792|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972793|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83972794|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
83972795|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972796|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83972797|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83972798|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
83972799|NCT02219672|Ritonavir|ritonavir|mesh-list
83972800|NCT02219672|Lopinavir|lopinavir|mesh-list
83972801|NCT02219672|Tenofovir|tenofovir|mesh-list
83972802|NCT02219672|Lamivudine|lamivudine|mesh-list
83972803|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
83972804|NCT02219672|Triptolide|triptolide|mesh-list
83972805|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83972806|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83972807|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
83972808|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972809|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972810|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83972811|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83972812|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
83972813|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972814|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83972815|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83972816|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83972817|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83972818|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83972819|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83972820|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83972821|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972822|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83972823|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
83972824|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83972825|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83972826|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
83972827|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83972828|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
83972829|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972830|NCT03113955|Epirubicin|epirubicin|mesh-list
83972831|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83972832|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972833|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83972834|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83972835|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972836|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972837|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83972838|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972839|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972840|NCT04534452|Phenylephrine|phenylephrine|mesh-list
83972841|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
83972842|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83972843|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
83972844|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
83972845|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972846|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972847|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
83972848|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83972849|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
83972850|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
83972851|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83972852|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83972853|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83972854|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
83972855|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972856|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972857|NCT04534452|Protective Agents|protective agents|mesh-ancestor
83972858|NCT03016338|Niraparib|niraparib|mesh-list
83972859|NCT03016338|Dostarlimab|dostarlimab|mesh-list
83972860|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83972861|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972862|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972863|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972864|NCT02219789|Fulvestrant|fulvestrant|mesh-list
83972865|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83972866|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972867|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83972868|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83972869|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
83972870|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972871|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972872|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83972873|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83972874|NCT04533867|Ondansetron|ondansetron|mesh-list
83972875|NCT04533867|Palonosetron|palonosetron|mesh-list
83972876|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
83972877|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
83972878|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972879|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972880|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83972881|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
83972882|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
83972883|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83972884|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83972885|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
83972886|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972887|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972888|NCT02219867|Ketamine|ketamine|mesh-list
83972889|NCT02219867|Analgesics|analgesics|mesh-ancestor
83972890|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
83972891|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972892|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972893|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83972894|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83972895|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
83972896|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
83972897|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972898|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83972899|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83972900|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83972901|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972902|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
83972903|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83972904|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972905|NCT02219906|Resveratrol|resveratrol|mesh-list
83972906|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
83972907|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972908|NCT02219906|Protective Agents|protective agents|mesh-ancestor
83972909|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972910|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972911|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83972912|NCT04533243|Fentanyl|fentanyl|mesh-list
83972913|NCT04533243|Morphine|morphine|mesh-list
83972914|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83972915|NCT04533243|Narcotics|narcotics|mesh-ancestor
83972916|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972917|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972918|NCT04533243|Analgesics|analgesics|mesh-ancestor
83972919|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
83972920|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972921|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83972922|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83972923|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
83972924|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
83972925|NCT04533321|Afatinib|afatinib|mesh-list
83972926|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972927|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83972928|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972929|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972930|NCT01195831|Calcipotriene|calcipotriene|mesh-list
83972931|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83972932|NCT01195675|Empagliflozin|empagliflozin|mesh-list
83972933|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
83972934|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83972935|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972936|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83972937|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83972938|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972939|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972940|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972941|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972942|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83972943|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972944|NCT04532931|Acetaminophen|acetaminophen|mesh-list
83972945|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
83972946|NCT04532931|Artesunate|artesunate|mesh-list
83972947|NCT04532931|Favipiravir|favipiravir|mesh-list
83972948|NCT04532931|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83972949|NCT04532931|Amodiaquine|amodiaquine|mesh-list
83972950|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
83972951|NCT04532931|Pyronaridine|pyronaridine|mesh-list
83972952|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83972953|NCT04532931|Analgesics|analgesics|mesh-ancestor
83972954|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
83972955|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83972956|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972957|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
83972958|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
83972959|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83972960|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
83972961|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83972962|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83972963|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83972964|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
83972965|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83972966|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
83972967|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83972968|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
83972969|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83972970|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83972971|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83972972|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83972973|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972974|NCT01195090|Pioglitazone|pioglitazone|mesh-list
83972975|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83972976|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83972977|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972978|NCT01195090|Incretins|incretins|mesh-ancestor
83972979|NCT01195090|Hormones|hormones|mesh-ancestor
83972980|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83972981|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83972982|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
83972983|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83972984|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83972985|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
83972986|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83972987|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
83972988|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83972989|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972990|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83972991|NCT02213627|Menotropins|menotropins|mesh-list
83972992|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83972993|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
83972994|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83972995|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83972996|NCT02216799|Insulin|insulin|mesh-list
83972997|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83972998|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
83972999|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83973000|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973001|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83973002|NCT02216877|Antacids|antacids|mesh-ancestor
83973003|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973004|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83973005|NCT02214563|Vitamin D|vitamin d|mesh-list
83973006|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
83973007|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
83973008|NCT02214563|Vitamins|vitamins|mesh-list
83973009|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
83973010|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973011|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83973012|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83973013|NCT01194973|Eculizumab|eculizumab|mesh-list
83973014|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83973015|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83973016|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
83973017|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973018|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83973019|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
83973020|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973021|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83973022|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83973023|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83973024|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
83973025|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973026|NCT02216747|Prednisone|prednisone|mesh-list
83973027|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973028|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
83973029|NCT02216747|Hormones|hormones|mesh-ancestor
83973030|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973031|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973032|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83973033|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973034|NCT02216786|Everolimus|everolimus|mesh-list
83973035|NCT02216786|Fulvestrant|fulvestrant|mesh-list
83973036|NCT02216786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83973037|NCT02216786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83973038|NCT02216786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973039|NCT02216786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973040|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83973041|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
83973042|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973043|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973044|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83973045|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83973046|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83973047|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
83973048|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973049|NCT02279147|Neostigmine|neostigmine|mesh-list
83973050|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83973051|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973052|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973053|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
83973054|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212345|NCT05525481|Tamoxifen|tamoxifen|mesh-list
83973055|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973056|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83973057|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
83973058|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973059|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
83973060|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83973061|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83973062|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973063|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
83973064|NCT02279186|Coagulants|coagulants|mesh-ancestor
83973066|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83973067|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
83973068|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973069|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973070|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973071|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83973072|NCT01177384|Glimepiride|glimepiride|mesh-list
83973073|NCT01177384|Acarbose|acarbose|mesh-list
83973074|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83973075|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973076|NCT01177384|Incretins|incretins|mesh-ancestor
83973077|NCT01177384|Hormones|hormones|mesh-ancestor
83973078|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973079|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83973080|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
83973081|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973082|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973083|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83973084|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83973085|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
83973086|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83973087|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
83973088|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973089|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83973090|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973091|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973092|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83973093|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973094|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973095|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83973096|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
83973097|NCT01194154|Hematinics|hematinics|mesh-ancestor
83973098|NCT01640210|Insulin|insulin|mesh-list
83973099|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83973100|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973101|NCT01640405|Bevacizumab|bevacizumab|mesh-list
83973102|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83973103|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973104|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83973105|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83973106|NCT01640405|Growth Substances|growth substances|mesh-ancestor
83973107|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973108|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83973109|NCT01640444|Bevacizumab|bevacizumab|mesh-list
83973110|NCT01640444|Cetuximab|cetuximab|mesh-list
83973111|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83973112|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973113|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83973114|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83973115|NCT01640444|Growth Substances|growth substances|mesh-ancestor
83973116|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973117|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
83973118|NCT01642433|Prazosin|prazosin|mesh-list
83973119|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83973120|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83973121|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83973122|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83973123|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83973124|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973125|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973126|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973127|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
83212419|NCT02098876|Everolimus|everolimus|mesh-list
83973128|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83973129|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
83973130|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83973131|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973132|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83973134|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83973135|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
83973136|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973137|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
83973138|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83973139|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973140|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83973141|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83973142|NCT01640639|Growth Substances|growth substances|mesh-ancestor
83973143|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
83973144|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973145|NCT01642667|Saruplase|saruplase|mesh-list
83973146|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83973147|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83973148|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973149|NCT01642745|Mannitol|mannitol|mesh-list
83973150|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
83973151|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83973152|NCT01642745|Diuretics|diuretics|mesh-ancestor
83973153|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
83973154|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973155|NCT01642745|Miotics|miotics|mesh-ancestor
83973156|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
83973157|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973158|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83973159|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83973160|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
83973161|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83973162|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83973163|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
83973164|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973165|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973166|NCT01640990|GW 328267|gw 328267|mesh-list
83973167|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83973168|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83973169|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
83973170|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
83973171|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973172|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973173|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973174|NCT01642862|Simvastatin|simvastatin|mesh-list
83973175|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83973176|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83973177|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
83973178|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973179|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83973180|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83973181|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973182|NCT01642940|Ticagrelor|ticagrelor|mesh-list
83973183|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83973184|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83973185|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83973186|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83973187|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83973188|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
83973189|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973190|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973191|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973192|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
83973193|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
83973194|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83973195|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83973196|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973197|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973198|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973199|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83973200|NCT01641224|Pinaverium|pinaverium|mesh-list
83973201|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83973202|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83973203|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973204|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83973205|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973206|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
83973207|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
83973208|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973209|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
83973210|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
83973211|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83973212|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83973213|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973214|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
83973215|NCT01643135|Coagulants|coagulants|mesh-ancestor
83973216|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
83973217|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83973218|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83973219|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973220|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83973221|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83973222|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973223|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973224|NCT01641419|Dexamethasone|dexamethasone|mesh-list
83973225|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
83973226|NCT01641419|BB 1101|bb 1101|mesh-list
83973227|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973228|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
83973229|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
83973230|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973231|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973232|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83973233|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
83973234|NCT01641419|Hormones|hormones|mesh-ancestor
83973235|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973236|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83973237|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973238|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
83973239|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973240|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973241|NCT01643252|Riboflavin|riboflavin|mesh-list
83973242|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83973243|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83973244|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
83973245|NCT01643252|Vitamins|vitamins|mesh-ancestor
83973246|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
83973247|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973248|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83973249|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
83973250|NCT01641458|Capecitabine|capecitabine|mesh-list
83973251|NCT01641458|Fluorouracil|fluorouracil|mesh-list
83973252|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83973253|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
83973254|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973255|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973256|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83973257|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
83973258|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973259|NCT01641536|Entecavir|entecavir|mesh-list
83973260|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
83973261|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973262|NCT01641575|Gemcitabine|gemcitabine|mesh-list
83973263|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973264|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83973265|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
83973266|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973267|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
83973268|NCT01643447|Urinastatin|urinastatin|mesh-list
83973269|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83973270|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83973271|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
83973272|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973273|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973274|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973275|NCT01643603|Dasatinib|dasatinib|mesh-list
83973276|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973277|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83973278|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973279|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973280|NCT02754011|Capecitabine|capecitabine|mesh-list
83973281|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83973282|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
83973283|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973284|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973286|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
83973287|NCT02755844|Olaparib|olaparib|mesh-list
83973288|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83973289|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
83973290|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973291|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83973292|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83973293|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
83973294|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973295|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973296|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83973297|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83973298|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83973299|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973300|NCT02756897|Venetoclax|venetoclax|mesh-list
83973301|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973302|NCT01601106|Prednisolone|prednisolone|mesh-list
83973303|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973304|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
83973305|NCT01601106|Hormones|hormones|mesh-ancestor
83973306|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973307|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973308|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83973309|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973310|NCT02750540|Tenofovir|tenofovir|mesh-list
83973311|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
83973312|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973313|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83973314|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83973315|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973316|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973317|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83973318|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83973319|NCT01601184|Temozolomide|temozolomide|mesh-list
83973320|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83973321|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
83973322|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973323|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973324|NCT01643759|Buprenorphine|buprenorphine|mesh-list
83973325|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83973326|NCT01643759|Narcotics|narcotics|mesh-ancestor
83973327|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973328|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973329|NCT01643759|Analgesics|analgesics|mesh-ancestor
83973330|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
83973331|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973332|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83973333|NCT04488237|Vitamin D|vitamin d|mesh-list
83973334|NCT04488237|Vitamins|vitamins|mesh-ancestor
83973335|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
83973336|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973337|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83973338|NCT04528628|Norepinephrine|norepinephrine|mesh-list
83973339|NCT04528628|Serotonin|serotonin|mesh-list
83973340|NCT04528628|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83973341|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
83973342|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83973343|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83973344|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
83973345|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973346|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973347|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973348|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
83973349|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
83973350|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212643|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
83973351|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83973352|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83973353|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83973354|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
83973355|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83973356|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
83973357|NCT01641341|Pancrelipase|pancrelipase|mesh-list
83973359|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83973360|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973361|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83973362|NCT01680107|Cycloserine|cycloserine|mesh-list
83973363|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83973364|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973365|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83973366|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
83973367|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83973368|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
83973369|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973370|NCT01680146|Caseins|caseins|mesh-list
83973371|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
83973372|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
83973373|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973374|NCT01680185|Insulin|insulin|mesh-list
83973375|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83973376|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
83973377|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
83973378|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
83973379|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
83973380|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
83973381|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83973382|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973383|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83973384|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83973385|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83973386|NCT01680263|Analgesics|analgesics|mesh-ancestor
83973387|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
83973388|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973389|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973390|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83973391|NCT01601730|Dexetimide|dexetimide|mesh-list
83973392|NCT01601730|Modafinil|modafinil|mesh-list
83973393|NCT01601730|Citalopram|citalopram|mesh-list
83973394|NCT01601730|Escitalopram|escitalopram|mesh-list
83973395|NCT01601730|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83973396|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83973397|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83973398|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973399|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973400|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
83973401|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973402|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83973403|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83973404|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
83973405|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
83973406|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973407|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83973408|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83973409|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
83973410|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83973411|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
83973412|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83973413|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83973414|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83973415|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83973416|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83973417|NCT01644071|Dexetimide|dexetimide|mesh-list
83973418|NCT01644071|Citalopram|citalopram|mesh-list
83973419|NCT01644071|Escitalopram|escitalopram|mesh-list
83973420|NCT01644071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83973421|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83973422|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83973423|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973424|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973425|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
83973426|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973427|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83973428|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83973429|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
83973431|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973432|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83973433|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83973434|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
83973435|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83973436|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
83973437|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83973438|NCT01680536|Maraviroc|maraviroc|mesh-list
83973439|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83973440|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83973441|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973442|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83973443|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83973444|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
83973445|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973446|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83973447|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83973448|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83973449|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973450|NCT01602003|Incretins|incretins|mesh-ancestor
83973451|NCT01602003|Hormones|hormones|mesh-ancestor
83973452|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973453|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83973454|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
83973455|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973456|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973457|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83973458|NCT01193920|Vaccines|vaccines|mesh-list
83973459|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
83973460|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973461|NCT01644773|Dasatinib|dasatinib|mesh-list
83973462|NCT01644773|Crizotinib|crizotinib|mesh-list
83973463|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973464|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83973465|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973466|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973467|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
83973468|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
83973469|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83973470|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83973471|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973472|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973473|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973474|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83973475|NCT01681550|Incretins|incretins|mesh-list
83973476|NCT01681550|Hormones|hormones|mesh-ancestor
83973477|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973478|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973479|NCT01645085|Mannitol|mannitol|mesh-list
83973480|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83973481|NCT01645085|Diuretics|diuretics|mesh-ancestor
83973482|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
83973483|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973484|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
83973485|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973486|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
83973487|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973488|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973489|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83973490|NCT01602861|Spironolactone|spironolactone|mesh-list
83973491|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83973492|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
83973493|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973494|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973495|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83973496|NCT01602861|Diuretics|diuretics|mesh-ancestor
83973497|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
83973498|NCT01681667|Ibuprofen|ibuprofen|mesh-list
83973499|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83973500|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83973501|NCT01681667|Analgesics|analgesics|mesh-ancestor
83973502|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
83973503|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973504|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973505|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973506|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83973507|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83973508|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973509|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973510|NCT01600365|Ganciclovir|ganciclovir|mesh-list
83973511|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83973512|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
83973513|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83973514|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83973515|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
83973516|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973517|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83973518|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973519|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973520|NCT01602900|Rolipram|rolipram|mesh-list
83973521|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
83973522|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83973523|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83973524|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83973525|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973526|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973527|NCT01645241|Ganirelix|ganirelix|mesh-list
83973528|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
83973529|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973530|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973531|NCT01602939|Cladribine|cladribine|mesh-list
83973532|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973533|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83973534|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
83973535|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973536|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83973537|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83973538|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
83973539|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973540|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973541|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973542|NCT01603134|Allopurinol|allopurinol|mesh-list
83973543|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
83973544|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973545|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973546|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
83973547|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83973548|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83973549|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
83973550|NCT01603134|Protective Agents|protective agents|mesh-ancestor
83973551|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973552|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83973553|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
83973554|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83973555|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83973556|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83973557|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973558|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973559|NCT01603212|Interferons|interferons|mesh-list
83973560|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
83973561|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
83973562|NCT01603212|Aldesleukin|aldesleukin|mesh-list
83973563|NCT01603212|Interleukin-2|interleukin-2|mesh-list
83973564|NCT01603212|Vemurafenib|vemurafenib|mesh-list
83973565|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973566|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
83973567|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973568|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
83973569|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973570|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83973571|NCT01603212|Analgesics|analgesics|mesh-ancestor
83973572|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
83973573|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973574|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83973575|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83973576|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83973577|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973578|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973579|NCT01645748|Cisplatin|cisplatin|mesh-list
83973580|NCT01645748|Docetaxel|docetaxel|mesh-list
83973581|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973582|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
83973583|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
83973584|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
83973585|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973586|NCT02484924|Clopidogrel|clopidogrel|mesh-list
83973587|NCT02484924|Ticagrelor|ticagrelor|mesh-list
83973588|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83973589|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83973590|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83973591|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83973592|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
83973593|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973594|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973595|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973596|NCT01645826|Diltiazem|diltiazem|mesh-list
83973597|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83973598|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83973599|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83973600|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973601|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83973602|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973603|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
83973604|NCT01607034|Pramipexole|pramipexole|mesh-list
83973605|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
83973606|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973607|NCT01607034|Protective Agents|protective agents|mesh-ancestor
83973608|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973609|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83973610|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83973611|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
83973612|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
83973613|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973614|NCT01603251|Ivermectin|ivermectin|mesh-list
83973615|NCT01603251|Lumefantrine|lumefantrine|mesh-list
83973616|NCT01603251|Artemether|artemether|mesh-list
83973617|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83973618|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83973619|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973620|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
83973621|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83973622|NCT01646294|Mirabegron|mirabegron|mesh-list
83973623|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83973624|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83973625|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83973626|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
83973627|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973628|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973629|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973630|NCT01646294|Urological Agents|urological agents|mesh-ancestor
83973631|NCT01603758|Ezetimibe|ezetimibe|mesh-list
83973632|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83973633|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83973634|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
83973635|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973636|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83973637|NCT01177228|Vedolizumab|vedolizumab|mesh-list
83973638|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83973639|NCT02279342|Febuxostat|febuxostat|mesh-list
83973640|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
83973641|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83973642|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83973643|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
83973644|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83973645|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973646|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
83973647|NCT01646567|Betamethasone|betamethasone|mesh-list
83973648|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
83973649|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83973650|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
83973651|NCT01646567|Calcipotriene|calcipotriene|mesh-list
83973652|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83973653|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973654|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
83973656|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973657|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973658|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83973659|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
83973660|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
83973661|NCT01681979|Fluticasone|fluticasone|mesh-list
83973662|NCT01681979|Xhance|xhance|mesh-list
83973663|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83973664|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973665|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83973666|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
83973667|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973668|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973669|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83973670|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
83973671|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
83973672|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83973673|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83973674|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83973675|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83973676|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
83973677|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973678|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973679|NCT01646684|Pasireotide|pasireotide|mesh-list
83973680|NCT01646684|Hormones|hormones|mesh-ancestor
83973681|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973682|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973683|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
83973684|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83973685|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83973686|NCT01607580|Prednisolone|prednisolone|mesh-list
83973687|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
83973688|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83973689|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
83973690|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
83973691|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973692|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
83973693|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
83973694|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973695|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973696|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83973697|NCT01607580|Hormones|hormones|mesh-ancestor
83973698|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973699|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83973700|NCT01607580|Protective Agents|protective agents|mesh-ancestor
83973701|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83973702|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973703|NCT01647152|Ustekinumab|ustekinumab|mesh-list
83973704|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83973705|NCT01604187|Fentanyl|fentanyl|mesh-list
83973706|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83973707|NCT01604187|Narcotics|narcotics|mesh-ancestor
83973708|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973709|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973710|NCT01604187|Analgesics|analgesics|mesh-ancestor
83973711|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
83973712|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973713|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83973714|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83973715|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
83973716|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
83973717|NCT01604382|Remifentanil|remifentanil|mesh-list
83973718|NCT01604382|Bupivacaine|bupivacaine|mesh-list
83973719|NCT01604382|Anesthetics|anesthetics|mesh-list
83973720|NCT01604382|Propofol|propofol|mesh-list
83973721|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
83973722|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973723|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973724|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
83973725|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973726|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83973727|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83973728|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
83973729|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83973731|NCT01604382|Analgesics|analgesics|mesh-ancestor
83973732|NCT01682408|Mannitol|mannitol|mesh-list
83973733|NCT01682408|Ranitidine|ranitidine|mesh-list
83973734|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83973735|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83973736|NCT01682408|Diuretics|diuretics|mesh-ancestor
83973737|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
83973738|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973739|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83973740|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83973741|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83973742|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
83973743|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
83973744|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973745|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973746|NCT01607970|Oxytocin|oxytocin|mesh-list
83973747|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
83973748|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83973749|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973750|NCT01608009|Paclitaxel|paclitaxel|mesh-list
83973751|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83973752|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973753|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83973754|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83973755|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83973756|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973757|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
83973758|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83973759|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973760|NCT01604031|Lenalidomide|lenalidomide|mesh-list
83973761|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
83973762|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973763|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83973764|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83973765|NCT01604031|Growth Substances|growth substances|mesh-ancestor
83973766|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
83973767|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973768|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
83973769|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83973770|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83973771|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83973772|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973773|NCT01608360|Lidocaine|lidocaine|mesh-list
83973774|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
83973775|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
83973776|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973777|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973778|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
83973779|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973780|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83973781|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83973782|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83973783|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83973784|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973785|NCT01647659|Trametinib|trametinib|mesh-list
83973786|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973787|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83973788|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973789|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973790|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
83973791|NCT01604811|Tamsulosin|tamsulosin|mesh-list
83973792|NCT01604811|Urological Agents|urological agents|mesh-ancestor
83973793|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83973794|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83973795|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83973796|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
83973797|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973798|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973799|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973800|NCT01683032|Methylphenidate|methylphenidate|mesh-list
83973801|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83973802|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973803|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83973804|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83973805|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83973806|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973807|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
83973808|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973810|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83973811|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83973812|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83973813|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83973814|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
83973815|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973816|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973817|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973818|NCT01604928|Urological Agents|urological agents|mesh-ancestor
83973819|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83973820|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83973821|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
83973822|NCT01683149|Sorafenib|sorafenib|mesh-list
83973823|NCT01683149|Topotecan|topotecan|mesh-list
83973824|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
83973825|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973826|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83973827|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973828|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973829|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83973830|NCT01608555|Tobramycin|tobramycin|mesh-list
83973831|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83973832|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973833|NCT01605084|Ritonavir|ritonavir|mesh-list
83973834|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83973835|NCT01605084|Darunavir|darunavir|mesh-list
83973836|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83973837|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83973838|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
83973839|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973840|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973841|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83973842|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83973843|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
83973844|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973845|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83973846|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83973847|NCT01647893|Bivalirudin|bivalirudin|mesh-list
83973848|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
83973849|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83973850|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
83973851|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973852|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973853|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
83973854|NCT01648010|Mitomycins|mitomycins|mesh-list
83973855|NCT01648010|Mitomycin|mitomycin|mesh-list
83973856|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83973857|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973858|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
83973859|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973860|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83973861|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973862|NCT01605318|Irinotecan|irinotecan|mesh-list
83973863|NCT01605318|Labetuzumab|labetuzumab|mesh-list
83973864|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
83973865|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
83973866|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973867|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83973868|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83973869|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83973870|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973871|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973872|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83973873|NCT01608711|Gemcitabine|gemcitabine|mesh-list
83973874|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83973875|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
83213177|NCT02410655|Oxytocin|oxytocin|mesh-list
83973876|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973877|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973879|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83973880|NCT01605357|Diuretics|diuretics|mesh-ancestor
83973881|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
83973882|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973883|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83973884|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83973885|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973886|NCT01608750|Folic Acid|folic acid|mesh-list
83973887|NCT01608750|Hematinics|hematinics|mesh-ancestor
83973888|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
83973889|NCT01608750|Vitamins|vitamins|mesh-ancestor
83973890|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
83973891|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973892|NCT01605513|Interferons|interferons|mesh-list
83973893|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973894|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
83973895|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973896|NCT04528277|Isoniazid|isoniazid|mesh-list
83973897|NCT04528277|Rifapentine|rifapentine|mesh-list
83973898|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
83973899|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83973900|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973901|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83973902|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83973903|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
83973904|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973905|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83973906|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83973907|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
83973908|NCT01683656|Niacin|niacin|mesh-list
83973909|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83973910|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
83973911|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973912|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83973913|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
83973914|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
83973915|NCT01683656|Vitamins|vitamins|mesh-ancestor
83973916|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
83973917|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973918|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83973919|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83973920|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83973921|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
83973922|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83973923|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83973924|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83973925|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973926|NCT01608984|Sufentanil|sufentanil|mesh-list
83973927|NCT01608984|Isoflurane|isoflurane|mesh-list
83973928|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83973929|NCT01608984|Narcotics|narcotics|mesh-ancestor
83973930|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973931|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973932|NCT01608984|Analgesics|analgesics|mesh-ancestor
83973933|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
83973934|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973935|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83973936|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83973937|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
83973938|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
83973939|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83973940|NCT01648517|Carboplatin|carboplatin|mesh-list
83973941|NCT01648517|Gemcitabine|gemcitabine|mesh-list
83973942|NCT01648517|Docetaxel|docetaxel|mesh-list
83973943|NCT01648517|Vinorelbine|vinorelbine|mesh-list
83973944|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973945|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83973946|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
83973947|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973948|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
83973949|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
83973950|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
83973951|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83973952|NCT01609101|Cobalt|cobalt|mesh-list
83973953|NCT01609101|Trace Elements|trace elements|mesh-ancestor
83973954|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
83973955|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973957|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83973958|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
83973959|NCT01648556|Hormones|hormones|mesh-ancestor
83973960|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83973961|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973962|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83973963|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83973964|NCT01648595|Fentanyl|fentanyl|mesh-list
83973965|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83973966|NCT01648595|Narcotics|narcotics|mesh-ancestor
83973967|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973968|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973969|NCT01648595|Analgesics|analgesics|mesh-ancestor
83973970|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
83973971|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973972|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83973973|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83973974|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
83973975|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
83973976|NCT01648634|Nebivolol|nebivolol|mesh-list
83973977|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83973978|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
83973979|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83973980|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83973981|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83973982|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83973983|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83973984|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83973985|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973986|NCT01606059|Acetaminophen|acetaminophen|mesh-list
83973987|NCT01606059|Tramadol|tramadol|mesh-list
83973988|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83973989|NCT01606059|Analgesics|analgesics|mesh-ancestor
83973990|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
83973991|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83973992|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83973993|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
83973994|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83973995|NCT01606059|Narcotics|narcotics|mesh-ancestor
83973996|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83973997|NCT01648712|Heparin|heparin|mesh-list
83973998|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
83973999|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83974000|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83974001|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974002|NCT01688544|Benzimidazole|benzimidazole|mesh-list
83974003|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
83974004|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83974005|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974006|NCT01688583|Fentanyl|fentanyl|mesh-list
83974007|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83974008|NCT01688583|Narcotics|narcotics|mesh-ancestor
83974009|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974010|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974011|NCT01688583|Analgesics|analgesics|mesh-ancestor
83974012|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
83974013|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974014|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83974015|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83974016|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
83974017|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
83974018|NCT01648829|Atorvastatin|atorvastatin|mesh-list
83974019|NCT01648829|Pitavastatin|pitavastatin|mesh-list
83974020|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83974021|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83974022|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
83974023|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974024|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83974025|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83974026|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974027|NCT01688700|Paclitaxel|paclitaxel|mesh-list
83213323|NCT05509569|Analgesics|analgesics|mesh-ancestor
83974028|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
83974029|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83974030|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974031|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83974032|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83974033|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83974034|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974035|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83974037|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
83974038|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
83974039|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
83974040|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974041|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974042|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974043|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83974044|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974045|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83974046|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83974047|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83974048|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
83974049|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
83974050|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974051|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974052|NCT01684241|Vaccines|vaccines|mesh-list
83974053|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
83974054|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974055|NCT01688934|Naproxen|naproxen|mesh-list
83974056|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974057|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974058|NCT01688934|Analgesics|analgesics|mesh-ancestor
83974059|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
83974060|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974061|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974062|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974063|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974064|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
83974065|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83974066|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974067|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974068|NCT01684319|Caseins|caseins|mesh-list
83974069|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
83974070|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
83974071|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974072|NCT02279576|Paclitaxel|paclitaxel|mesh-list
83974073|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83974074|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83974075|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974076|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83974077|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83974078|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83974079|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974080|NCT02279615|Tamsulosin|tamsulosin|mesh-list
83974081|NCT02279615|Mirabegron|mirabegron|mesh-list
83974082|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83974083|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83974084|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83974085|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
83974086|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974087|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974088|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974089|NCT02279615|Urological Agents|urological agents|mesh-ancestor
83974090|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83974091|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83974092|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83974093|NCT01689051|Glucagon|glucagon|mesh-list
83974094|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83974095|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974096|NCT01689051|Hormones|hormones|mesh-ancestor
83974097|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974098|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974099|NCT01689051|Incretins|incretins|mesh-ancestor
83974100|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
83974101|NCT01689090|Citric Acid|citric acid|mesh-list
83974102|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
83974103|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83974104|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
83974105|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83974106|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
83974107|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
83974108|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974109|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974110|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974111|NCT01689090|Analgesics|analgesics|mesh-ancestor
83974112|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
83974113|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974114|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974115|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974116|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974117|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974119|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83974120|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
83974121|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83974122|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974123|NCT01689285|Valacyclovir|valacyclovir|mesh-list
83974124|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
83974125|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974126|NCT01606527|Ibuprofen|ibuprofen|mesh-list
83974127|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974128|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974129|NCT01606527|Analgesics|analgesics|mesh-ancestor
83974130|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
83974131|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974132|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974133|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974134|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974135|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83974136|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974137|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974138|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83974139|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83974140|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974141|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
83974142|NCT01609413|Antacids|antacids|mesh-ancestor
83974143|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974144|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974145|NCT02279966|Vortioxetine|vortioxetine|mesh-list
83974146|NCT02279966|Paroxetine|paroxetine|mesh-list
83974147|NCT02279966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83974148|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83974149|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83974150|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974151|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974152|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
83974153|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974154|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83974155|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
83974156|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83974157|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83974158|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83974159|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974160|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83974161|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83974162|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974163|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83974164|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83974165|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83974166|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83974167|NCT01684787|Ribavirin|ribavirin|mesh-list
83974168|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83974169|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
83974170|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
83974171|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974172|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
83974173|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974174|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
83974175|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974176|NCT01649258|Granisetron|granisetron|mesh-list
83974177|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
83974178|NCT01649258|Aprepitant|aprepitant|mesh-list
83974179|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
83974181|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974182|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974183|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974184|NCT01649258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83974185|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83974186|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
83974187|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974188|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974189|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83974190|NCT01649336|Paclitaxel|paclitaxel|mesh-list
83974191|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
83974192|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83974193|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974194|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83974195|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83974196|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974197|NCT01609491|Phenylephrine|phenylephrine|mesh-list
83974198|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
83974199|NCT01609491|Norepinephrine|norepinephrine|mesh-list
83974200|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83974201|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
83974202|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
83974203|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974204|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974205|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
83974206|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83974207|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
83974208|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
83974209|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83974210|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83974211|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83974212|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
83974213|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974214|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974215|NCT01609491|Protective Agents|protective agents|mesh-ancestor
83974216|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
83974217|NCT01606878|Doxorubicin|doxorubicin|mesh-list
83974218|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83974219|NCT01606878|Vincristine|vincristine|mesh-list
83974220|NCT01606878|Topotecan|topotecan|mesh-list
83974221|NCT01606878|Crizotinib|crizotinib|mesh-list
83974222|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
83974223|NCT01606878|Razoxane|razoxane|mesh-list
83974224|NCT01606878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83974225|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83974226|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
83974227|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974228|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974229|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83974230|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
83974231|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974232|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974233|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83974234|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83974235|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83974236|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83974237|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974238|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83974239|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
83974240|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
83974241|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
83974242|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83974243|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83974244|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83974245|NCT01606878|Protective Agents|protective agents|mesh-ancestor
83974246|NCT01684865|Rituximab|rituximab|mesh-list
83974247|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83974248|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974249|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
83974250|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974251|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974252|NCT01580163|Methadone|methadone|mesh-list
83213544|NCT03171389|Ponatinib|ponatinib|mesh-list
83974253|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83974254|NCT01580163|Narcotics|narcotics|mesh-ancestor
83974255|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974256|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974257|NCT01580163|Analgesics|analgesics|mesh-ancestor
83974258|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
83974259|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974260|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
83974261|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
83974262|NCT01609647|Clopidogrel|clopidogrel|mesh-list
83974263|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83974264|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83974265|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83974266|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83974267|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83974268|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
83974269|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974270|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974271|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974272|NCT01580202|Lamivudine|lamivudine|mesh-list
83974273|NCT01580202|Entecavir|entecavir|mesh-list
83974274|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83974275|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83974276|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974277|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974278|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
83974279|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974280|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83974281|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83974282|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
83974283|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83974284|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974285|NCT01609881|Ketorolac|ketorolac|mesh-list
83974286|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974287|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974288|NCT01609881|Analgesics|analgesics|mesh-ancestor
83974289|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
83974290|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974291|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974292|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974293|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974294|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83974295|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974296|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974297|NCT01609959|Valsartan|valsartan|mesh-list
83974298|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83974299|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83974300|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83974301|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83974302|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974303|NCT01609998|Vaccines|vaccines|mesh-list
83974304|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
83974305|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974306|NCT01606098|Bevacizumab|bevacizumab|mesh-list
83974307|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83974308|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974309|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83974310|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83974311|NCT01606098|Growth Substances|growth substances|mesh-ancestor
83974312|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974313|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
83974314|NCT01649921|Interferons|interferons|mesh-list
83974315|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
83974316|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974317|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
83974318|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974319|NCT01606566|Bleomycin|bleomycin|mesh-list
83974320|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83974321|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974322|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
83974323|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83974324|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974325|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974326|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974327|NCT01649999|Peficitinib|peficitinib|mesh-list
83974328|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974329|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974330|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83974331|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
83974332|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974333|NCT01604889|Ipilimumab|ipilimumab|mesh-list
83974334|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83974335|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974336|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83974337|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974338|NCT01685762|Metformin|metformin|mesh-list
83974339|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83974340|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974341|NCT01602822|Ritonavir|ritonavir|mesh-list
83974342|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83974343|NCT01602822|Tenofovir|tenofovir|mesh-list
83974344|NCT01602822|Emtricitabine|emtricitabine|mesh-list
83974345|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83974346|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83974347|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83974348|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
83974349|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974350|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974351|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83974352|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83974353|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
83974354|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974355|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83974356|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83974357|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83974358|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83974359|NCT02273154|Buspirone|buspirone|mesh-list
83974360|NCT02273154|Paroxetine|paroxetine|mesh-list
83974361|NCT02273154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83974362|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83974363|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83974364|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974365|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974366|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
83974367|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974368|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83974369|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
83974370|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83974371|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83974372|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83974373|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974374|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83974375|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83974376|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974377|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83974378|NCT01602393|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
83974379|NCT01602393|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83974380|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974381|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974382|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
83974383|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83974384|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83974385|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974386|NCT02270034|Crizotinib|crizotinib|mesh-list
83974387|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974388|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83974389|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974390|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974391|NCT02273271|Alovudine|alovudine|mesh-list
83974392|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
83974393|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974394|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
83974395|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83974396|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
83974397|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974398|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974399|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83974400|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
83974401|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974402|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974403|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83974404|NCT02270424|Fluticasone|fluticasone|mesh-list
83974405|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83974406|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83974407|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974408|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83974409|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
83974410|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974411|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974412|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83974413|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
83974414|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
83974415|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83974416|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83974417|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83974418|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83974419|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
83974420|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974421|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974422|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
83974423|NCT02270424|Hormones|hormones|mesh-ancestor
83974424|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974425|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
83974426|NCT01686347|Ropivacaine|ropivacaine|mesh-list
83974427|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
83974428|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
83974429|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974430|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974431|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
83974432|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974433|NCT05140655|Fulvestrant|fulvestrant|mesh-list
83974434|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83974435|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974436|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83974437|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83974438|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
83974439|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974440|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974441|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
83974442|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83974443|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83974444|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83974445|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83974446|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974447|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974448|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974449|NCT01688570|Analgesics|analgesics|mesh-ancestor
83974450|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
83974451|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974452|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
83974453|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83974454|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
83974455|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
83974456|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
83974457|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974458|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83974459|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
83974460|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
83974461|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83974462|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
83974463|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83974464|NCT01686464|Valacyclovir|valacyclovir|mesh-list
83974465|NCT01686464|Prednisone|prednisone|mesh-list
83974466|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974467|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
83974468|NCT01686464|Hormones|hormones|mesh-ancestor
83974469|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974470|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974471|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83974472|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974473|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
83974474|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974475|NCT02270970|Belimumab|belimumab|mesh-list
83974476|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83974477|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
83974478|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974479|NCT01688648|Lidocaine|lidocaine|mesh-list
83974480|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
83974481|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
83974482|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
83974483|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974484|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974485|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
83974486|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974487|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83974488|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83974489|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83974490|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83974491|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974492|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83974493|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974494|NCT01688648|Analgesics|analgesics|mesh-ancestor
83974495|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83974496|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83974497|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83974498|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
83974499|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974500|NCT01686659|Chrysarobin|chrysarobin|mesh-list
83974501|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974502|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974503|NCT01686659|Analgesics|analgesics|mesh-ancestor
83974504|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
83974505|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974506|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974507|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974508|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974509|NCT02271126|Heparin|heparin|mesh-list
83974510|NCT02271126|Thromboplastin|thromboplastin|mesh-list
83974511|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
83974512|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83974513|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83974514|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974515|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
83974516|NCT02271126|Coagulants|coagulants|mesh-ancestor
83974517|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
83974518|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83974519|NCT02271165|Antibodies|antibodies|mesh-list
83974520|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
83974521|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974522|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
83974523|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83974524|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974525|NCT02271282|Toremifene|toremifene|mesh-list
83974526|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83974527|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974528|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83974529|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83974530|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
83974531|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974532|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974533|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83974534|NCT01688960|Aflibercept|aflibercept|mesh-list
83974535|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83974536|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83974537|NCT01688960|Growth Substances|growth substances|mesh-ancestor
83974538|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974539|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
83974540|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974541|NCT02271360|Cabergoline|cabergoline|mesh-list
83974542|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
83974543|NCT02271360|Calcium|calcium|mesh-list
83974544|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83974545|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974546|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83974547|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83974548|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
83974549|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
83974550|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974551|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974552|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
83974553|NCT02271360|Coagulants|coagulants|mesh-ancestor
83974554|NCT01687049|Red yeast rice|red yeast rice|mesh-list
83974555|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83974556|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83974557|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83974558|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
83974559|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974560|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974561|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83974562|NCT02271399|Aspirin|aspirin|mesh-list
83974563|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
83974564|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974565|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974566|NCT02271399|Analgesics|analgesics|mesh-ancestor
83974567|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
83974568|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974569|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974570|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974571|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974572|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83974573|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83974574|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974575|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83974576|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83974577|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974578|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
83974579|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83974580|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
83974581|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83974582|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
83974583|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
83974584|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
83974585|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83974586|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83974587|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974588|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83974589|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83974590|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974591|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974592|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974593|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83974594|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
83974595|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83974596|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974597|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83974598|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83974599|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83974600|NCT01687127|Folic Acid|folic acid|mesh-list
83974601|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
83974602|NCT01687127|Calcium|calcium|mesh-list
83974603|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83974604|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974605|NCT01687127|Hematinics|hematinics|mesh-ancestor
83974606|NCT01687127|Vitamins|vitamins|mesh-ancestor
83974607|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
83974608|NCT02271555|Remifentanil|remifentanil|mesh-list
83974609|NCT02271555|Sevoflurane|sevoflurane|mesh-list
83974610|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83974611|NCT02271555|Narcotics|narcotics|mesh-ancestor
83974612|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974613|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974614|NCT02271555|Analgesics|analgesics|mesh-ancestor
83974615|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
83974616|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974617|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83974618|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83974619|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
83974620|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
83974621|NCT01687205|Tenofovir|tenofovir|mesh-list
83974622|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
83974623|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974624|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83974625|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83974626|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974627|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974628|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83974629|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83974630|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
83974631|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83974632|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83974633|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974634|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83974635|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83974636|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974637|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974638|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974639|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83974640|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
83974641|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83974642|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974643|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83974644|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83974645|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83974646|NCT01689194|genexol-PM|genexol-pm|mesh-list
83974647|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974648|NCT01689194|Tubulin Modulators|tubulin modulators|mesh-ancestor
83974649|NCT01689194|Antimitotic Agents|antimitotic agents|mesh-ancestor
83974650|NCT01689194|Mitosis Modulators|mitosis modulators|mesh-ancestor
83974651|NCT01689194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974652|NCT01687439|Vinorelbine|vinorelbine|mesh-list
83974653|NCT01687439|Endostar protein|endostar protein|mesh-list
83974654|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974655|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83974656|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
83974657|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
83974658|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
83974659|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974660|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83974661|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83974662|NCT01687439|Growth Substances|growth substances|mesh-ancestor
83974663|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974664|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
83974665|NCT01588704|Bevacizumab|bevacizumab|mesh-list
83974666|NCT01588704|Pemetrexed|pemetrexed|mesh-list
83974667|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83974668|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974669|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83974670|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83974671|NCT01588704|Growth Substances|growth substances|mesh-ancestor
83974672|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974673|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
83974674|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974675|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974676|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83974677|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83974678|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
83974679|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83974680|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974681|NCT01689311|Alprostadil|alprostadil|mesh-list
83974682|NCT01689311|Misoprostol|misoprostol|mesh-list
83974683|NCT01689311|Oxytocin|oxytocin|mesh-list
83974684|NCT01689311|Ergonovine|ergonovine|mesh-list
83974685|NCT01689311|Dinoprost|dinoprost|mesh-list
83974686|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
83974687|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
83974688|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83974689|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974690|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83974691|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
83974692|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83974693|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974694|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83974695|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
83974696|NCT01689311|Urological Agents|urological agents|mesh-ancestor
83974697|NCT01588782|Ketoconazole|ketoconazole|mesh-list
83974698|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
83974699|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974700|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83974701|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83974702|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974703|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974704|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83974705|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
83974706|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974707|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974708|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83974709|NCT02272101|Vitamin D|vitamin d|mesh-list
83974710|NCT02272101|Vitamins|vitamins|mesh-ancestor
83974711|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
83974712|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974713|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83974714|NCT02278133|Cetuximab|cetuximab|mesh-list
83974715|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83974716|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974717|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
83974718|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83974719|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974720|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974721|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974722|NCT01687868|Analgesics|analgesics|mesh-ancestor
83974723|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
83974724|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974725|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83974726|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83974727|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83974728|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
83974729|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974730|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974731|NCT01688024|Mitomycins|mitomycins|mesh-list
83974732|NCT01688024|Mitomycin|mitomycin|mesh-list
83974733|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83974734|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974735|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
83974736|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974737|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83974738|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974739|NCT01689623|Simeprevir|simeprevir|mesh-list
83974740|NCT01689623|Atorvastatin|atorvastatin|mesh-list
83974741|NCT01689623|Simvastatin|simvastatin|mesh-list
83974742|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83974743|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83974744|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
83974745|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974746|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83974747|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83974748|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974749|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
83974750|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974751|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
83974752|NCT04055142|Cidofovir|cidofovir|mesh-list
83974753|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
83974754|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974755|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974756|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974757|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83974758|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83974759|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83974760|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
83974761|NCT02272647|Estradiol|estradiol|mesh-list
83974762|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83974763|NCT02272647|Progesterone|progesterone|mesh-list
83974764|NCT02272647|Estrogens|estrogens|mesh-ancestor
83974765|NCT02272647|Hormones|hormones|mesh-ancestor
83974766|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974767|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974768|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83974769|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
83974770|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83974771|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83974772|NCT02272647|Progestins|progestins|mesh-ancestor
83974773|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83974774|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83974775|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83974776|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83974777|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83974778|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974779|NCT02272764|Itraconazole|itraconazole|mesh-list
83974780|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83974781|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
83974782|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83974783|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83974784|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83974785|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974786|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974787|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83974788|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
83974789|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974790|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974791|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83974792|NCT01689896|Testosterone|testosterone|mesh-list
83974793|NCT01689896|Androgens|androgens|mesh-ancestor
83974794|NCT01689896|Hormones|hormones|mesh-ancestor
83974795|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974796|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974797|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
83974798|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83974799|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974800|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83974801|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974802|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83974803|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83974804|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
83974805|NCT01316133|Tacrolimus|tacrolimus|mesh-list
83974806|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83974807|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
83974808|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974809|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83974810|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974811|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974812|NCT05654064|Fentanyl|fentanyl|mesh-list
83974813|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
83974814|NCT05654064|Remifentanil|remifentanil|mesh-list
83974815|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83974816|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974817|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974818|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974819|NCT05654064|Analgesics|analgesics|mesh-ancestor
83974820|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
83974821|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974822|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83974823|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83974824|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83974825|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
83974826|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83974827|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974828|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83974829|NCT05654064|Narcotics|narcotics|mesh-ancestor
83974830|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83974831|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83974832|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
83974833|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
83974834|NCT01687985|Laxatives|laxatives|mesh-list
83974835|NCT01687985|Cathartics|cathartics|mesh-list
83974836|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974837|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
83974838|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83974839|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974840|NCT05653401|Diclofenac|diclofenac|mesh-list
83974841|NCT05653401|Lidocaine|lidocaine|mesh-list
83974842|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
83974843|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
83974844|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
83974845|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214146|NCT02700815|Capsaicin|capsaicin|mesh-list
83974846|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974847|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
83974848|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974849|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83974850|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83974851|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83974852|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83974853|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974854|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974855|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974856|NCT05653401|Analgesics|analgesics|mesh-ancestor
83974857|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974858|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974859|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83974860|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974861|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
83974862|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83974863|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83974864|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
83974865|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83974867|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83974868|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
83974869|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974870|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974871|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83974872|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974873|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83974874|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83974875|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83974876|NCT01680965|Ofatumumab|ofatumumab|mesh-list
83974877|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974878|NCT02272998|Ponatinib|ponatinib|mesh-list
83974879|NCT02272998|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83974880|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83974881|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974882|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974883|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974884|NCT01683188|Vemurafenib|vemurafenib|mesh-list
83974885|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974886|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83974887|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974888|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974889|NCT01339923|Vaccines|vaccines|mesh-list
83974890|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
83974891|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974892|NCT04417088|Carboplatin|carboplatin|mesh-list
83974893|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974894|NCT01380093|Naltrexone|naltrexone|mesh-list
83974895|NCT01380093|Morphine|morphine|mesh-list
83974896|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83974897|NCT01380093|Narcotics|narcotics|mesh-ancestor
83974898|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83974899|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974900|NCT01380093|Analgesics|analgesics|mesh-ancestor
83974901|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
83974902|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974903|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83974904|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83974905|NCT01379937|Vaccines|vaccines|mesh-list
83974906|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
83974907|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974908|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83974909|NCT03558854|Aspirin|aspirin|mesh-list
83974910|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83974911|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83974912|NCT03558854|Analgesics|analgesics|mesh-ancestor
83974913|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
83974914|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974915|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974916|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974917|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83974918|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83214224|NCT02402231|Omalizumab|omalizumab|mesh-list
83974919|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83974920|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974921|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83974922|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83974923|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974924|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
83974925|NCT01335477|Nintedanib|nintedanib|mesh-list
83974926|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974927|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83974928|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974929|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974930|NCT03389438|Immunomodulating Agents|immunomodulating agents|mesh-list
83974931|NCT03389438|Immunologic Factors|immunologic factors|mesh-ancestor
83974932|NCT03389438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974933|NCT01371747|Losartan|losartan|mesh-list
83974934|NCT01371747|Spironolactone|spironolactone|mesh-list
83974935|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83974936|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83974937|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83974938|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83974939|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974940|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83974941|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
83974942|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974943|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974944|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83974945|NCT01371747|Diuretics|diuretics|mesh-ancestor
83974946|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
83974947|NCT01335399|Dexamethasone|dexamethasone|mesh-list
83974948|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
83974949|NCT01335399|Lenalidomide|lenalidomide|mesh-list
83974950|NCT01335399|Elotuzumab|elotuzumab|mesh-list
83974951|NCT01335399|BB 1101|bb 1101|mesh-list
83974952|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974953|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
83974954|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
83974955|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974956|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974957|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974958|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
83974959|NCT01335399|Hormones|hormones|mesh-ancestor
83974960|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974961|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83974962|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974963|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
83974964|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974965|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974966|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
83974967|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83974968|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83974969|NCT01335399|Growth Substances|growth substances|mesh-ancestor
83974970|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
83974971|NCT04825262|Tacrolimus|tacrolimus|mesh-list
83974972|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83974973|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
83974974|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974975|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83974976|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83974977|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83974978|NCT01335009|Antibodies|antibodies|mesh-list
83974979|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83974980|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
83974981|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974982|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
83974983|NCT01332630|Dexamethasone|dexamethasone|mesh-list
83974984|NCT01332630|Ranitidine|ranitidine|mesh-list
83974985|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83974986|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83974987|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
83974988|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
83974989|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83974990|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83974991|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83974992|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
83974993|NCT01332630|Hormones|hormones|mesh-ancestor
83214317|NCT02418533|Hormones|hormones|mesh-list
83974994|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83974995|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83974996|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83974997|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83974998|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83974999|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975000|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
83975002|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
83975003|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83975004|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
83975005|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
83975006|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975007|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975008|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83975009|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83975010|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83975011|NCT01366209|Pirfenidone|pirfenidone|mesh-list
83975012|NCT01366209|Analgesics|analgesics|mesh-ancestor
83975013|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
83975014|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975015|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975016|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83975017|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83975018|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975019|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975020|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975021|NCT01365507|Insulin|insulin|mesh-list
83975022|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
83975023|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83975024|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975025|NCT02995694|Estradiol|estradiol|mesh-list
83975026|NCT02995694|Estrogens|estrogens|mesh-ancestor
83975027|NCT02995694|Hormones|hormones|mesh-ancestor
83975028|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975029|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975030|NCT01365468|Everolimus|everolimus|mesh-list
83975031|NCT01365468|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83975032|NCT01365468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83975033|NCT01365468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975034|NCT01365468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975035|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83975036|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
83975037|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975038|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975039|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
83975040|NCT04827836|Povidone|povidone|mesh-list
83975041|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83975042|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83975043|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
83975044|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
83975045|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83975046|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975047|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
83975048|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83975049|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83975050|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83975051|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975052|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975053|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
83975054|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975055|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975056|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83975057|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975058|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
83975059|NCT01332318|Promethazine|promethazine|mesh-list
83975060|NCT01332318|Gabapentin|gabapentin|mesh-list
83975061|NCT01332318|Analgesics|analgesics|mesh-ancestor
83975062|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
83975063|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975064|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975065|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
83975066|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83975067|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83975068|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975069|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975070|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83975071|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83975072|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975073|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975074|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
83975075|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83975076|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83975077|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
83975078|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
83975079|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
83975080|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
83975081|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975082|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83975083|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
83975084|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
83975085|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83975086|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
83975087|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83975088|NCT04828226|Clonidine|clonidine|mesh-list
83975089|NCT04828226|Analgesics|analgesics|mesh-ancestor
83975090|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
83975091|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975092|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975093|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83975094|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
83975095|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
83975096|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83975097|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83975098|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83975099|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83975100|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975101|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975102|NCT01331109|Milnacipran|milnacipran|mesh-list
83975103|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
83975104|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83975105|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83975106|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975107|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975108|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975109|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975110|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83975111|NCT01331109|Analgesics|analgesics|mesh-ancestor
83975112|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
83975113|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975114|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
83975115|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975116|NCT01357161|Paclitaxel|paclitaxel|mesh-list
83975117|NCT01357161|Carboplatin|carboplatin|mesh-list
83975118|NCT01357161|Adavosertib|adavosertib|mesh-list
83975119|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83975120|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975121|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
83975122|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
83975123|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
83975124|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975125|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975126|NCT01351350|Paclitaxel|paclitaxel|mesh-list
83975127|NCT01351350|Trastuzumab|trastuzumab|mesh-list
83975128|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83975129|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975130|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
83975131|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
83975132|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
83975133|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975134|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83975135|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83975136|NCT02271503|Carbidopa|carbidopa|mesh-list
83975137|NCT02271503|Levodopa|levodopa|mesh-list
83975138|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83975139|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
83975140|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975141|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83975142|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83975143|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
83975144|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
83975145|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975146|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975147|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83975148|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975149|NCT01350804|Abatacept|abatacept|mesh-list
83975150|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83975151|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975152|NCT01350804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83975153|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975154|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83975155|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
83975156|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975157|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975158|NCT02270957|Abatacept|abatacept|mesh-list
83975159|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83975160|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975161|NCT02270957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83975162|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975163|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83975164|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
83975165|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975166|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975167|NCT01348542|Trazodone|trazodone|mesh-list
83975168|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83975169|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83975170|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975171|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975172|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975173|NCT01348542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83975174|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83975175|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975176|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975177|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975178|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
83975179|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83975180|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
83975181|NCT01346592|Vaccines|vaccines|mesh-list
83975182|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
83975183|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975184|NCT01193335|Vaccines|vaccines|mesh-list
83975185|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83975186|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
83975187|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975188|NCT02893995|Treprostinil|treprostinil|mesh-list
83975189|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83975190|NCT01342887|Cyclosporine|cyclosporine|mesh-list
83975191|NCT01342887|Etoposide|etoposide|mesh-list
83975192|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
83975193|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
83975194|NCT01342887|Pravastatin|pravastatin|mesh-list
83975195|NCT01342887|Cyclosporins|cyclosporins|mesh-list
83975196|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83975197|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975198|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83975199|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83975200|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975201|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975202|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83975203|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
83975204|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975205|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
83975206|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975207|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
83975208|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975209|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83975210|NCT01342887|Analgesics|analgesics|mesh-ancestor
83975211|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
83975212|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975213|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83975214|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83975215|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
83975216|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83975217|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83975218|NCT04445415|Antibodies|antibodies|mesh-list
83975219|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
83975220|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975221|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
83975222|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83975223|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975224|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83975225|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975226|NCT01340664|Metformin|metformin|mesh-list
83975227|NCT01340664|Canagliflozin|canagliflozin|mesh-list
83975228|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83975229|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975230|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83975231|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975232|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83975233|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83975234|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83975235|NCT01340625|Norethindrone|norethindrone|mesh-list
83975236|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
83975237|NCT01340625|Estradiol|estradiol|mesh-list
83975238|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83975239|NCT01340625|Estrogens|estrogens|mesh-ancestor
83975240|NCT01340625|Hormones|hormones|mesh-ancestor
83975241|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975242|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975243|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83975244|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
83975245|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83975246|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83975247|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83975248|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83975249|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83975250|NCT04823468|Cisplatin|cisplatin|mesh-list
83975251|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975252|NCT01340196|Tenofovir|tenofovir|mesh-list
83975253|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
83975254|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975255|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83975256|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83975257|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975258|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975259|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83975260|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83975261|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83975262|NCT02893332|Gefitinib|gefitinib|mesh-list
83975263|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975264|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83975265|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975266|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975267|NCT04328493|Chloroquine|chloroquine|mesh-list
83975268|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83975269|NCT04328493|Amebicides|amebicides|mesh-ancestor
83975270|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83975271|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83975272|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975273|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
83975274|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975275|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83975276|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83975277|NCT04328493|Analgesics|analgesics|mesh-ancestor
83975278|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
83975279|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975280|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975281|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975282|NCT04328493|Filaricides|filaricides|mesh-ancestor
83975283|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
83975284|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
83975285|NCT04396587|Sufentanil|sufentanil|mesh-list
83975286|NCT04396587|Oxycodone|oxycodone|mesh-list
83975287|NCT04396587|Hydromorphone|hydromorphone|mesh-list
83975288|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83975289|NCT04396587|Narcotics|narcotics|mesh-ancestor
83975290|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214605|NCT03250299|Lisavanbulin|lisavanbulin|mesh-list
83975291|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975292|NCT04396587|Analgesics|analgesics|mesh-ancestor
83975293|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
83975294|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975295|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83975296|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83975297|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
83975298|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
83975299|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
83975300|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
83975301|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975302|NCT01327599|Timolol|timolol|mesh-list
83975303|NCT01327599|Travoprost|travoprost|mesh-list
83975304|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83975305|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83975306|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83975307|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83975308|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
83975309|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975310|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975311|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975312|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83975313|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83975314|NCT01193257|Prednisone|prednisone|mesh-list
83975315|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975316|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
83975317|NCT01193257|Hormones|hormones|mesh-ancestor
83975318|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975319|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975320|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83975321|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975322|NCT02893371|Lamotrigine|lamotrigine|mesh-list
83975323|NCT02893371|Carbamazepine|carbamazepine|mesh-list
83975324|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
83975325|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83975326|NCT02893371|Valproic Acid|valproic acid|mesh-list
83975327|NCT02893371|Haloperidol|haloperidol|mesh-list
83975328|NCT02893371|Olanzapine|olanzapine|mesh-list
83975329|NCT02893371|Risperidone|risperidone|mesh-list
83975330|NCT02893371|Aripiprazole|aripiprazole|mesh-list
83975331|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83975332|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83975333|NCT02893371|Ziprasidone|ziprasidone|mesh-list
83975334|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83975335|NCT02893371|Clozapine|clozapine|mesh-list
83975336|NCT02893371|Asenapine|asenapine|mesh-list
83975337|NCT02893371|Perphenazine|perphenazine|mesh-list
83975338|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
83975339|NCT02893371|Mirtazapine|mirtazapine|mesh-list
83975340|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
83975341|NCT02893371|Doxepin|doxepin|mesh-list
83975342|NCT02893371|Citalopram|citalopram|mesh-list
83975343|NCT02893371|Bupropion|bupropion|mesh-list
83975344|NCT02893371|Sertraline|sertraline|mesh-list
83975345|NCT02893371|Fluoxetine|fluoxetine|mesh-list
83975346|NCT02893371|Paroxetine|paroxetine|mesh-list
83975347|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83975348|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83975349|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83975350|NCT02893371|Escitalopram|escitalopram|mesh-list
83975351|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83975352|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
83975353|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975354|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975355|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975356|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83975357|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83975358|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975359|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975360|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83975361|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
83975362|NCT02893371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83975363|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83975364|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975365|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83975366|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
83975367|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975368|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83975369|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
83975370|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
83975371|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975372|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83975373|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83975374|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83975375|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975376|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
83975377|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83975378|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83975379|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83975380|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83975381|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83975382|NCT02893371|Analgesics|analgesics|mesh-ancestor
83975383|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
83975384|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
83975385|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
83975386|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83975387|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83975388|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83975389|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
83975390|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83975391|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
83975392|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
83975393|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83975394|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83975395|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83975396|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83975397|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
83975398|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83975399|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83975400|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83975401|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83975402|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
83975403|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83975404|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83975405|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83975406|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83975407|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83975408|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83975409|NCT05138978|Listerine|listerine|mesh-list
83975410|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
83975411|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
83975412|NCT05138978|Protective Agents|protective agents|mesh-ancestor
83975413|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975414|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83975415|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975416|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83975417|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83975418|NCT02893176|Macitentan|macitentan|mesh-list
83975419|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83975420|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83975421|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975422|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83975423|NCT01193218|Empagliflozin|empagliflozin|mesh-list
83975424|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83975425|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975426|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83975427|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975428|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83975429|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83975430|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975431|NCT04328805|Ibuprofen|ibuprofen|mesh-list
83975432|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83975433|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83975434|NCT04328805|Analgesics|analgesics|mesh-ancestor
83975435|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
83975436|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975437|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975438|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975439|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975440|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83975441|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975442|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975443|NCT04329000|Esomeprazole|esomeprazole|mesh-list
83975444|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83975445|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975446|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83975447|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975448|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975449|NCT01192399|Eculizumab|eculizumab|mesh-list
83975450|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83975451|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83975452|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
83975453|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975454|NCT04389294|Antibodies|antibodies|mesh-list
83975455|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
83975456|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975457|NCT01176916|Exemestane|exemestane|mesh-list
83975458|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975459|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83975460|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83975461|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975462|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975463|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83975464|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
83975465|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975466|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975467|NCT05382091|Naltrexone|naltrexone|mesh-list
83975468|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83975469|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83975470|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975471|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
83975472|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975473|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83975474|NCT02894268|Doxycycline|doxycycline|mesh-list
83975475|NCT02894268|Furazolidone|furazolidone|mesh-list
83975476|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83975477|NCT02894268|Esomeprazole|esomeprazole|mesh-list
83975478|NCT02894268|Bismuth|bismuth|mesh-list
83975479|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975480|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83975481|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975482|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83975483|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975484|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975485|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
83975486|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83975487|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83975488|NCT02894268|Antacids|antacids|mesh-ancestor
83975489|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83975490|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83975491|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83975492|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83975493|NCT01600625|Minocycline|minocycline|mesh-list
83975494|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83975495|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975496|NCT01600742|Vorinostat|vorinostat|mesh-list
83975497|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975498|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83975499|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975500|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975501|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
83975502|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83975503|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83975504|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
83975505|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975506|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83975507|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83975508|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975509|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975510|NCT02893488|Lamivudine|lamivudine|mesh-list
83975511|NCT02893488|Dolutegravir|dolutegravir|mesh-list
83975512|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83975513|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83975514|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975515|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975516|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
83975517|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975518|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83975519|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83975520|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83975521|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83975522|NCT04328883|Aspirin|aspirin|mesh-list
83975523|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83975524|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83975525|NCT04328883|Analgesics|analgesics|mesh-ancestor
83975526|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
83975527|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975528|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975529|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975530|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975531|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83975532|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83975533|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975534|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83975535|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83975536|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975537|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
83975538|NCT01600235|Phenylephrine|phenylephrine|mesh-list
83975539|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
83975540|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83975541|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
83975542|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
83975543|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975544|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975545|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
83975546|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83975547|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
83975548|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
83975549|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83975550|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83975551|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83975552|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
83975553|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975554|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975555|NCT01600235|Protective Agents|protective agents|mesh-ancestor
83975556|NCT02893254|Adalimumab|adalimumab|mesh-list
83975557|NCT02893254|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83975558|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975559|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975560|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
83975561|NCT00592137|Calcium|calcium|mesh-list
83975562|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83975563|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975564|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83975565|NCT04455776|Propofol|propofol|mesh-list
83975566|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83975567|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975568|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975569|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83975570|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
83975571|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
83975572|NCT04135092|Aldesleukin|aldesleukin|mesh-list
83975573|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
83975574|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
83975575|NCT04135092|Fludarabine|fludarabine|mesh-list
83975576|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83975577|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
83975578|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975579|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975580|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83975581|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
83975582|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975583|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975584|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83975585|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83975586|NCT04135092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83975587|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83975588|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83975589|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
83975590|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975591|NCT00592215|Misoprostol|misoprostol|mesh-list
83975592|NCT00592215|Mifepristone|mifepristone|mesh-list
83975593|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83975594|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
83975595|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83975596|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975597|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83975598|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975599|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
83975600|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83975601|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83975602|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83975603|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83975604|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
83975605|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83975606|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83975607|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
83975608|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975609|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
83975610|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83975611|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83975612|NCT00592332|Alprazolam|alprazolam|mesh-list
83975613|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83975614|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975615|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975616|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83975617|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83975618|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975619|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
83975620|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
83975621|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975622|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975623|NCT04477382|Tretinoin|tretinoin|mesh-list
83975624|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975625|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
83975626|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
83975627|NCT01600274|Dienogest|dienogest|mesh-list
83975628|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83975629|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83975630|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83975631|NCT01600274|Estradiol|estradiol|mesh-list
83975632|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83975633|NCT01600274|Nandrolone|nandrolone|mesh-list
83975634|NCT01600274|Estrogens|estrogens|mesh-ancestor
83975635|NCT01600274|Hormones|hormones|mesh-ancestor
83975636|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975637|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975638|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83975639|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
83975640|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83975641|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83975642|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83975643|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83975644|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83975645|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
83975646|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83975647|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975648|NCT01600274|Androgens|androgens|mesh-ancestor
83975649|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
83975650|NCT01176565|Nicardipine|nicardipine|mesh-list
83975651|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83975652|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83975653|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975654|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975655|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83975656|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975657|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
83975658|NCT04374123|Antibodies|antibodies|mesh-list
83975659|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
83975660|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
83975661|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975662|NCT01113541|Ziprasidone|ziprasidone|mesh-list
83975663|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83975664|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
83975665|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975666|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975667|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975668|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83975669|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83215022|NCT05481645|Paclitaxel|paclitaxel|mesh-list
83975670|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975671|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975672|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83975673|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
83975674|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
83975675|NCT00591708|Citric Acid|citric acid|mesh-list
83975676|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
83975677|NCT00591708|Calcium|calcium|mesh-list
83975678|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
83975679|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83975680|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975681|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83975682|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
83975683|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83975684|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
83975685|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
83975686|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975687|NCT01176058|Fluconazole|fluconazole|mesh-list
83975688|NCT01176058|Anidulafungin|anidulafungin|mesh-list
83975689|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
83975690|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975691|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83975692|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83975693|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975694|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975695|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83975696|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
83975697|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975698|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975699|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83975700|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83975701|NCT04328766|Fexuprazan|fexuprazan|mesh-list
83975702|NCT04328766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975703|NCT02273765|Tenofovir|tenofovir|mesh-list
83975704|NCT02273765|Lamivudine|lamivudine|mesh-list
83975705|NCT02273765|Efavirenz|efavirenz|mesh-list
83975706|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
83975707|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
83975708|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975709|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83975710|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83975711|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975712|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975713|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83975714|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83975715|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83975716|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83975717|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83975718|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83975719|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83975720|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83975721|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83975722|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83975723|NCT01607333|Lamotrigine|lamotrigine|mesh-list
83975724|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
83975725|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83975726|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975727|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975728|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83975729|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975730|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83975731|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83975732|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975733|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975734|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83975735|NCT01601093|Sulbactam|sulbactam|mesh-list
83975736|NCT01601093|Cefoperazone|cefoperazone|mesh-list
83975737|NCT01601093|Sulperazone|sulperazone|mesh-list
83975738|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83975739|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975740|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83975741|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975742|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975743|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83975744|NCT04367688|Tenofovir|tenofovir|mesh-list
83215052|NCT03426891|Vorinostat|vorinostat|mesh-list
83975745|NCT04367688|Emtricitabine|emtricitabine|mesh-list
83975746|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
83975747|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975748|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83975749|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83975750|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975751|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975752|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83975753|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83975755|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83975756|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975757|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975758|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83975759|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
83975760|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
83975761|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
83975762|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975763|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
83975764|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975765|NCT01175824|Insulin|insulin|mesh-list
83975766|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83975767|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
83975768|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
83975769|NCT01175824|Protamines|protamines|mesh-list
83975770|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83975771|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975772|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
83975773|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975774|NCT01175824|Coagulants|coagulants|mesh-ancestor
83975775|NCT01175707|Vancomycin|vancomycin|mesh-list
83975776|NCT01175707|Daptomycin|daptomycin|mesh-list
83975777|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83975778|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975779|NCT01112059|Doxycycline|doxycycline|mesh-list
83975780|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83975781|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975782|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
83975783|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83975784|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83975785|NCT01175668|Clonidine|clonidine|mesh-list
83975786|NCT01175668|Phenobarbital|phenobarbital|mesh-list
83975787|NCT01175668|Analgesics|analgesics|mesh-ancestor
83975788|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
83975789|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975790|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975791|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83975792|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
83975793|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
83975794|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83975795|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83975796|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83975797|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
83975798|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975799|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975800|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
83975801|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83975802|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975803|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83975804|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83975805|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
83975806|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
83975807|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83975808|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83975809|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83975810|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
83975811|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83975812|NCT01601327|Testosterone|testosterone|mesh-list
83975813|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
83975814|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
83975815|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83975816|NCT01601327|Androgens|androgens|mesh-ancestor
83975817|NCT01601327|Hormones|hormones|mesh-ancestor
83975818|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975819|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975820|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83975821|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975822|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
83975823|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83975824|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
83975825|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
83975826|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83975827|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83975828|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975829|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83975830|NCT01607762|Olanzapine|olanzapine|mesh-list
83975831|NCT01607762|Risperidone|risperidone|mesh-list
83975832|NCT01607762|Aripiprazole|aripiprazole|mesh-list
83975833|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83975834|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83975835|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83975836|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
83975837|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975838|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975839|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975840|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83975841|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83975842|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975843|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975844|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83975845|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
83975846|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
83975847|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
83975848|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975849|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975850|NCT01607762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83975851|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83975852|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975853|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
83975854|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
83975855|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83975856|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83975857|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83975858|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83975859|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
83975860|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83975861|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
83975862|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975863|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
83975864|NCT04327947|Protective Agents|protective agents|mesh-ancestor
83975865|NCT01607879|Androgens|androgens|mesh-list
83975866|NCT01607879|Hormones|hormones|mesh-ancestor
83975867|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975868|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975869|NCT01607918|Amoxicillin|amoxicillin|mesh-list
83975870|NCT01607918|Metronidazole|metronidazole|mesh-list
83975871|NCT01607918|Clarithromycin|clarithromycin|mesh-list
83975872|NCT01607918|Lansoprazole|lansoprazole|mesh-list
83975873|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
83975874|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83975875|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975876|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83975877|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83975878|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83975879|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975880|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975881|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83975882|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83975883|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83975884|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83975885|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83975886|NCT01607996|Anesthetics|anesthetics|mesh-list
83975887|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975888|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975889|NCT01601561|Insulin|insulin|mesh-list
83975890|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83975891|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83975892|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975893|NCT01601795|Sevoflurane|sevoflurane|mesh-list
83975894|NCT01601795|Isoflurane|isoflurane|mesh-list
83975895|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83975896|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83975897|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
83975899|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975900|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975901|NCT01601912|Dexetimide|dexetimide|mesh-list
83975902|NCT01601912|Citalopram|citalopram|mesh-list
83975903|NCT01601912|Escitalopram|escitalopram|mesh-list
83975904|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83975905|NCT01601912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83975906|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83975907|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975908|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975909|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975910|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
83975911|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975912|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83975913|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
83975914|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975915|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83975916|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83975917|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
83975918|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
83975919|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83975920|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83975921|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83975922|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
83975923|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83975924|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
83975925|NCT01111825|Sirolimus|sirolimus|mesh-list
83975926|NCT01111825|Temsirolimus|temsirolimus|mesh-list
83975927|NCT01111825|MTOR Inhibitors|mtor inhibitors|mesh-list
83975928|NCT01111825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83975929|NCT01111825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975930|NCT01111825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975931|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83975932|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
83975933|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975934|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975935|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83975936|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975937|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83975938|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
83975939|NCT01175590|Besifloxacin|besifloxacin|mesh-list
83975940|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83975941|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83975942|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83975943|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83975944|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83975945|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975946|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83975947|NCT01175473|Metformin|metformin|mesh-list
83975948|NCT01175473|Liraglutide|liraglutide|mesh-list
83975949|NCT01175473|Lixisenatide|lixisenatide|mesh-list
83975950|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83975951|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975952|NCT01175473|Incretins|incretins|mesh-ancestor
83975953|NCT01175473|Hormones|hormones|mesh-ancestor
83975954|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83975955|NCT01111552|Aripiprazole|aripiprazole|mesh-list
83975956|NCT01111552|Escitalopram|escitalopram|mesh-list
83975957|NCT01111552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83975958|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83975959|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83975960|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975961|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975962|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
83975963|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975964|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
83975965|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83975966|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83975967|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83975968|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83975969|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
83975970|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
83975971|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83975972|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83975973|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83975974|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83975975|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83975976|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83975977|NCT01602185|Memantine|memantine|mesh-list
83975978|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
83975979|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
83975980|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83975981|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83975982|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
83975983|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83975984|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83975985|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83975986|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83975987|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83975988|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
83975989|NCT01602302|Adalimumab|adalimumab|mesh-list
83975990|NCT01602302|Infliximab|infliximab|mesh-list
83975991|NCT01602302|Golimumab|golimumab|mesh-list
83975992|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
83975993|NCT01602302|Etanercept|etanercept|mesh-list
83975994|NCT01602302|Abatacept|abatacept|mesh-list
83975995|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83975996|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83975997|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83975998|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
83975999|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976000|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83976001|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83976002|NCT01602302|Analgesics|analgesics|mesh-ancestor
83976003|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
83976004|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976005|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976006|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976007|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
83976008|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83976009|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976010|NCT01602302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83976011|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976012|NCT02893722|Oxytocin|oxytocin|mesh-list
83976013|NCT02893722|Atosiban|atosiban|mesh-list
83976014|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
83976015|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83976016|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976017|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
83976018|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976019|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
83976020|NCT01608269|Lamivudine|lamivudine|mesh-list
83976021|NCT01608269|Abacavir|abacavir|mesh-list
83976022|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83976023|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83976024|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976025|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976026|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
83976027|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976028|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83976029|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83976030|NCT01608347|Folic Acid|folic acid|mesh-list
83976031|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
83976032|NCT01608347|Hematinics|hematinics|mesh-ancestor
83976033|NCT01608347|Vitamins|vitamins|mesh-ancestor
83976034|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
83976035|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976036|NCT04405284|Disinfectants|disinfectants|mesh-list
83976037|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976038|NCT01608464|Cisplatin|cisplatin|mesh-list
83976039|NCT01608464|Docetaxel|docetaxel|mesh-list
83976040|NCT01608464|Fluorouracil|fluorouracil|mesh-list
83976041|NCT01608464|Irinotecan|irinotecan|mesh-list
83976042|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976043|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
83976044|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
83976045|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
83976046|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976047|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
83976048|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976049|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976050|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
83976051|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976052|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83976053|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83976054|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976055|NCT01608698|Drospirenone|drospirenone|mesh-list
83976056|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83976057|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
83976058|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83976059|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83976060|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83976061|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
83976062|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83976063|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976064|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83976065|NCT01608698|Estrogens|estrogens|mesh-ancestor
83976066|NCT01608698|Hormones|hormones|mesh-ancestor
83976067|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976068|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83976069|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
83976070|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83976071|NCT01608698|Diuretics|diuretics|mesh-ancestor
83976072|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
83976073|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
83976074|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83976075|NCT04310254|Edetic Acid|edetic acid|mesh-list
83976076|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83976077|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
83976078|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
83976079|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83976080|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
83976081|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
83976082|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976083|NCT04310254|Antidotes|antidotes|mesh-ancestor
83976084|NCT04310254|Protective Agents|protective agents|mesh-ancestor
83976085|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976086|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83976087|NCT01603511|Charcoal|charcoal|mesh-list
83976088|NCT01603511|Antidotes|antidotes|mesh-ancestor
83976089|NCT01603511|Protective Agents|protective agents|mesh-ancestor
83976090|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976091|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83976092|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83976093|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976094|NCT01174186|Adalimumab|adalimumab|mesh-list
83976095|NCT01174186|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83976096|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83976097|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976098|NCT01609049|Ribavirin|ribavirin|mesh-list
83976099|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83976100|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
83976101|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976102|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
83976103|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976104|NCT01609088|Erythritol|erythritol|mesh-list
83976105|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
83976106|NCT01609127|Capecitabine|capecitabine|mesh-list
83976107|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976108|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
83976109|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976110|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976111|NCT01609166|Allopurinol|allopurinol|mesh-list
83976112|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
83976113|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976114|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976115|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
83976116|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976117|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83976118|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
83976119|NCT01609166|Protective Agents|protective agents|mesh-ancestor
83976120|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976121|NCT01609205|Adalimumab|adalimumab|mesh-list
83976122|NCT01609205|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83215431|NCT05727527|Anesthetics|anesthetics|mesh-list
83976123|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83976124|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976125|NCT01604057|Teriparatide|teriparatide|mesh-list
83976126|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976127|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976128|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83976129|NCT00592566|Dexamethasone|dexamethasone|mesh-list
83976130|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83976131|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83976132|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
83976133|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
83976134|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976135|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976136|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976137|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
83976138|NCT00592566|Hormones|hormones|mesh-ancestor
83976139|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976140|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83976141|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976142|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
83976143|NCT00592566|Coagulants|coagulants|mesh-ancestor
83976144|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83976145|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
83976146|NCT01111123|Halobetasol|halobetasol|mesh-list
83976147|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83976148|NCT01604330|Baclofen|baclofen|mesh-list
83976149|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83976150|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976151|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83976152|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976153|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83976154|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
83976155|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
83976156|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976157|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976158|NCT00622830|Darapladib|darapladib|mesh-list
83976159|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83976160|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976161|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976162|NCT01173679|Rituximab|rituximab|mesh-list
83976163|NCT01173679|Fludarabine|fludarabine|mesh-list
83976164|NCT01173679|Dasatinib|dasatinib|mesh-list
83976165|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83976166|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976167|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
83976168|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976169|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976170|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976171|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83976172|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976173|NCT02881528|Metformin|metformin|mesh-list
83976174|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83976175|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976176|NCT01609439|Vitamin D|vitamin d|mesh-list
83976177|NCT01609439|Vitamins|vitamins|mesh-ancestor
83976178|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
83976179|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976180|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83976181|NCT01110382|Amoxicillin|amoxicillin|mesh-list
83976182|NCT01110382|Meropenem|meropenem|mesh-list
83976183|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
83976184|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
83976185|NCT01110382|Doripenem|doripenem|mesh-list
83976186|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83976187|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83976188|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976189|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83976190|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976191|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976192|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
83976193|NCT00592917|Vitamin D|vitamin d|mesh-list
83976194|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
83976195|NCT00592917|Calcium|calcium|mesh-list
83976196|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976197|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976198|NCT00592917|Vitamins|vitamins|mesh-ancestor
83976199|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
83976200|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83976201|NCT00592917|Antacids|antacids|mesh-ancestor
83976202|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976203|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976204|NCT01609517|Bupivacaine|bupivacaine|mesh-list
83976205|NCT01609517|Anesthetics|anesthetics|mesh-list
83976206|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
83976207|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976208|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976209|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
83976210|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976211|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
83976212|NCT05265325|Hematinics|hematinics|mesh-ancestor
83976213|NCT00593151|Interferons|interferons|mesh-list
83976214|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
83976215|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
83976216|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83976217|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976218|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
83976219|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976220|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
83976221|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976222|NCT02489006|Olaparib|olaparib|mesh-list
83976223|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83976224|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976225|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976226|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976227|NCT01173601|Serotonin|serotonin|mesh-list
83976228|NCT01173601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83976229|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83976230|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
83976231|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976232|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976233|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976234|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83976235|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83976236|NCT01609673|Everolimus|everolimus|mesh-list
83976237|NCT01609673|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83976238|NCT01609673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83976239|NCT01609673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976240|NCT01609673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976241|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976242|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
83976243|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976244|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976245|NCT01173055|Milnacipran|milnacipran|mesh-list
83976246|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
83976247|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83976248|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83976249|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83976250|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976251|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976252|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976253|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83976254|NCT01173055|Analgesics|analgesics|mesh-ancestor
83976255|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
83976256|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976257|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
83976258|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83976259|NCT00593502|Oseltamivir|oseltamivir|mesh-list
83976260|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
83976261|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976262|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976263|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976264|NCT01609907|Valsartan|valsartan|mesh-list
83976265|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83976266|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83976267|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83976268|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
83976269|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976270|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83976271|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83976272|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976273|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83976274|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83976275|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83976276|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
83976278|NCT00593580|Alendronate|alendronate|mesh-list
83976279|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976280|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976281|NCT00593580|Vitamins|vitamins|mesh-ancestor
83976282|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
83976283|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83976284|NCT04327011|Flucytosine|flucytosine|mesh-list
83976285|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
83976286|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976287|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
83976288|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976289|NCT00593619|Iron|iron|mesh-list
83976290|NCT00593619|Dextrans|dextrans|mesh-list
83976291|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83976292|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
83976293|NCT00593619|Trace Elements|trace elements|mesh-ancestor
83976294|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
83976295|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976296|NCT00593619|Hematinics|hematinics|mesh-ancestor
83976297|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
83976298|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
83976299|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
83976300|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
83976301|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83976302|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976303|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976304|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83976305|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83976306|NCT00593658|Protective Agents|protective agents|mesh-ancestor
83976307|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976308|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
83976309|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83976310|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
83976311|NCT00593697|Docetaxel|docetaxel|mesh-list
83976312|NCT00593697|Trastuzumab|trastuzumab|mesh-list
83976313|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976314|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
83976315|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
83976316|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
83976317|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976318|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83976319|NCT01601522|Ranitidine|ranitidine|mesh-list
83976320|NCT01601522|Desloratadine|desloratadine|mesh-list
83976321|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
83976322|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83976323|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83976324|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
83976325|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976326|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976327|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976328|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83976329|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
83976330|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83976331|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976332|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83976333|NCT00593853|Methylphenidate|methylphenidate|mesh-list
83976334|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83976335|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976336|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83976337|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83976338|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83976339|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976340|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
83976341|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976342|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83976343|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83976344|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
83976345|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976346|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83976347|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976348|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83215651|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
83976349|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976350|NCT00594087|Eszopiclone|eszopiclone|mesh-list
83976351|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83976352|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976353|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976354|NCT00594126|Imetelstat|imetelstat|mesh-list
83976355|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
83976356|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976357|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976358|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83976359|NCT01605344|Leucovorin|leucovorin|mesh-list
83976360|NCT01605344|Fluorouracil|fluorouracil|mesh-list
83976361|NCT01605344|Irinotecan|irinotecan|mesh-list
83976362|NCT01605344|Atorvastatin|atorvastatin|mesh-list
83976363|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
83976364|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976365|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976366|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976367|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976368|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
83976369|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976370|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83976371|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83976372|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976373|NCT01605344|Antidotes|antidotes|mesh-ancestor
83976374|NCT01605344|Protective Agents|protective agents|mesh-ancestor
83976375|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
83976376|NCT01605344|Vitamins|vitamins|mesh-ancestor
83976377|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
83976378|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83976379|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83976380|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83976381|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83976382|NCT00593463|Cycloserine|cycloserine|mesh-list
83976383|NCT00593463|Verapamil|verapamil|mesh-list
83976384|NCT00593463|Diltiazem|diltiazem|mesh-list
83976385|NCT00593463|Isradipine|isradipine|mesh-list
83976386|NCT00593463|Nifedipine|nifedipine|mesh-list
83976387|NCT00593463|Gabapentin|gabapentin|mesh-list
83976388|NCT00593463|Naloxone|naloxone|mesh-list
83976389|NCT00593463|Analgesics|analgesics|mesh-ancestor
83976390|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
83976391|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976392|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976393|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
83976394|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83976395|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83976396|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976397|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83976398|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83976399|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83976400|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976401|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976402|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
83976403|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83976404|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83976405|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83976406|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976407|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
83976408|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
83976409|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83976410|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83976411|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976412|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83976413|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
83976414|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83976415|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
83976416|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83976417|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83976418|NCT00592410|Insulin|insulin|mesh-list
83976419|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83976420|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83976421|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976422|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83976423|NCT04328064|Calcium|calcium|mesh-list
83976424|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976425|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976426|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83976427|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83976429|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976430|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83976431|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83976432|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976433|NCT01605734|Sorafenib|sorafenib|mesh-list
83976434|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
83976435|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976436|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83976437|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976438|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976439|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83976440|NCT01605734|Estrogens|estrogens|mesh-ancestor
83976441|NCT01605734|Hormones|hormones|mesh-ancestor
83976442|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976443|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976444|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83976445|NCT01605773|Glyburide|glyburide|mesh-list
83976446|NCT01605773|Repaglinide|repaglinide|mesh-list
83976447|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83976448|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976449|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
83976450|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83976451|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976452|NCT00594555|Cytarabine|cytarabine|mesh-list
83976453|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
83976454|NCT00594555|Cladribine|cladribine|mesh-list
83976455|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976456|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
83976457|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976458|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976459|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
83976460|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976461|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976462|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
83976463|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976464|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83976465|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976466|NCT01605929|Mepivacaine|mepivacaine|mesh-list
83976467|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
83976468|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
83976469|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976470|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976471|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
83976472|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976473|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
83976474|NCT02270606|Leucovorin|leucovorin|mesh-list
83976475|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
83976476|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83976477|NCT02270606|Fluorouracil|fluorouracil|mesh-list
83976478|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
83976479|NCT02270606|Calcium|calcium|mesh-list
83976480|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
83976481|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976482|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976483|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83976484|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
83976485|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976486|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976487|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976488|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976489|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
83976490|NCT02270606|Antidotes|antidotes|mesh-ancestor
83976491|NCT02270606|Protective Agents|protective agents|mesh-ancestor
83976492|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
83976493|NCT02270606|Vitamins|vitamins|mesh-ancestor
83976494|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
83976495|NCT00594633|Donepezil|donepezil|mesh-list
83976496|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83976497|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976498|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976499|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
83976500|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976501|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976502|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
83215800|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
83976503|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83976504|NCT01605968|Laxatives|laxatives|mesh-ancestor
83976505|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976506|NCT01606046|Anesthetics|anesthetics|mesh-list
83976507|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
83976508|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83976509|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
83976510|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976511|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976512|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
83976513|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976514|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83976515|NCT02892942|Cetrorelix|cetrorelix|mesh-list
83976516|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83976517|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
83976518|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83976519|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976520|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
83976521|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976522|NCT00594867|Aspirin|aspirin|mesh-list
83976523|NCT00594867|Acetaminophen|acetaminophen|mesh-list
83976524|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83976525|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83976526|NCT00594867|Analgesics|analgesics|mesh-ancestor
83976527|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
83976528|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976529|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976530|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83976531|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976532|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83976533|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83976534|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976535|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83976536|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83976537|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976538|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
83976539|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
83976540|NCT01606241|Vaccines|vaccines|mesh-list
83976541|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
83976542|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976543|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976544|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976545|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83976546|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
83976547|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976548|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976549|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83976550|NCT02270918|Apixaban|apixaban|mesh-list
83976551|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83976552|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
83976553|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83976554|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83976555|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976556|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976557|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
83976558|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
83976559|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83976560|NCT00595140|Octreotide|octreotide|mesh-list
83976561|NCT00595140|Dopamine|dopamine|mesh-list
83976562|NCT00595140|Cabergoline|cabergoline|mesh-list
83976563|NCT00595140|Somatostatin|somatostatin|mesh-list
83976564|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
83976565|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976566|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83976567|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976568|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83976569|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
83976570|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
83976571|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976572|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976573|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
83976574|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976575|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976576|NCT00595140|Protective Agents|protective agents|mesh-ancestor
83976577|NCT00595140|Hormones|hormones|mesh-ancestor
83976578|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976580|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83976581|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
83976582|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83976583|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
83976584|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976585|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
83976586|NCT02271035|Protective Agents|protective agents|mesh-ancestor
83976587|NCT01606358|Carboplatin|carboplatin|mesh-list
83976588|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976589|NCT02271113|Enoxaparin|enoxaparin|mesh-list
83976590|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
83976591|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
83976592|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83976593|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83976594|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976595|NCT02271191|Nicardipine|nicardipine|mesh-list
83976596|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83976597|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83976598|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83976599|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976600|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976601|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976602|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83976603|NCT00595374|Insulin|insulin|mesh-list
83976604|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83976605|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
83976606|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
83976607|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
83976608|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
83976609|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
83976610|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83976611|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976612|NCT00595569|Insulin|insulin|mesh-list
83976613|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83976614|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976615|NCT02271347|Brincidofovir|brincidofovir|mesh-list
83976616|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
83976617|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976618|NCT01172938|Thalidomide|thalidomide|mesh-list
83976619|NCT01172938|Apremilast|apremilast|mesh-list
83976620|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83976621|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83976622|NCT01172938|Analgesics|analgesics|mesh-ancestor
83976623|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
83976624|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976625|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976626|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83976627|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976628|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83976629|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83976630|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976631|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976632|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976633|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
83976634|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
83976635|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83976636|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976637|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83976638|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83976639|NCT01172938|Growth Substances|growth substances|mesh-ancestor
83976640|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
83976641|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976642|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
83976643|NCT02271464|Bevacizumab|bevacizumab|mesh-list
83976644|NCT02271464|Capecitabine|capecitabine|mesh-list
83976645|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976646|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
83976647|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976648|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976649|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83976650|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
83215951|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83976651|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976652|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976653|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83976654|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83976655|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83976656|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83976658|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
83976659|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976660|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
83976661|NCT04326894|Methotrexate|methotrexate|mesh-list
83976662|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83976663|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
83976664|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83976665|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976666|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976667|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
83976668|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976669|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976670|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
83976671|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976672|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83976673|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976674|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
83976675|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976676|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83976677|NCT02271542|Propofol|propofol|mesh-list
83976678|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83976679|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976680|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976681|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83976682|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
83976683|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
83976684|NCT01109992|Regadenoson|regadenoson|mesh-list
83976685|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83976686|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83976687|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
83976688|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
83976689|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976690|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976691|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976692|NCT02892357|Omeprazole|omeprazole|mesh-list
83976693|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83976694|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976695|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83976696|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976697|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976698|NCT01109524|Cetuximab|cetuximab|mesh-list
83976699|NCT01109524|Vinorelbine|vinorelbine|mesh-list
83976700|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976701|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83976702|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83976703|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
83976704|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
83976705|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
83976706|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976707|NCT01109173|Nepafenac|nepafenac|mesh-list
83976708|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83976709|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83976710|NCT01109173|Analgesics|analgesics|mesh-ancestor
83976711|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
83976712|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976713|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976714|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83976715|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976716|NCT02271971|Vitamin D|vitamin d|mesh-list
83976717|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
83976718|NCT02271971|Vitamins|vitamins|mesh-ancestor
83976719|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
83976720|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976721|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83976722|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83976723|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
83976724|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83976725|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83976726|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
83976727|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976728|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976730|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83976731|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
83976732|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83976733|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
83976734|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976735|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976736|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83976737|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83976738|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83976739|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
83976740|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
83976741|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83976742|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
83976743|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976744|NCT01172275|Expectorants|expectorants|mesh-ancestor
83976745|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
83976746|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83976747|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
83976748|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976749|NCT01172275|Protective Agents|protective agents|mesh-ancestor
83976750|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976751|NCT01172275|Antidotes|antidotes|mesh-ancestor
83976752|NCT05034952|Acetaminophen|acetaminophen|mesh-list
83976753|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83976754|NCT05034952|Analgesics|analgesics|mesh-ancestor
83976755|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
83976756|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976757|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976758|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
83976759|NCT00596037|Hormones|hormones|mesh-list
83976760|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976761|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976762|NCT02273102|Tretinoin|tretinoin|mesh-list
83976763|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
83976764|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976765|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
83976766|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83976767|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
83976768|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83976769|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83976770|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976771|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976772|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83976773|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83976774|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976775|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976776|NCT02272478|Decitabine|decitabine|mesh-list
83976777|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
83976778|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976779|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
83976780|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976781|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976782|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976783|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83976784|NCT02272478|Immunotoxins|immunotoxins|mesh-ancestor
83976785|NCT02272478|Immunoconjugates|immunoconjugates|mesh-ancestor
83976786|NCT02272478|Immunologic Factors|immunologic factors|mesh-ancestor
83976787|NCT02272478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976788|NCT02272517|Vortioxetine|vortioxetine|mesh-list
83976789|NCT02272517|Escitalopram|escitalopram|mesh-list
83976790|NCT02272517|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83976791|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83976792|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83976793|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976794|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976795|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
83976796|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976797|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
83976798|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83976799|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83976800|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83976801|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976802|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83976803|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83976804|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83976805|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83976806|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
83976807|NCT02272829|Narcotics|narcotics|mesh-ancestor
83976808|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976809|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976810|NCT02272829|Analgesics|analgesics|mesh-ancestor
83976811|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
83976812|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976813|NCT00596115|Pramipexole|pramipexole|mesh-list
83976814|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
83976815|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976816|NCT00596115|Protective Agents|protective agents|mesh-ancestor
83976817|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976818|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83976819|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83976820|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
83976821|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
83976822|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976823|NCT02272868|Rifaximin|rifaximin|mesh-list
83976824|NCT02272868|Omeprazole|omeprazole|mesh-list
83976825|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83976826|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83976827|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976828|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83976829|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976830|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976831|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83976832|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976833|NCT02272868|Laxatives|laxatives|mesh-ancestor
83976834|NCT02273453|Oxazepam|oxazepam|mesh-list
83976835|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83976836|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976837|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976838|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83976839|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83976840|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83976841|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
83976842|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
83976843|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976844|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976845|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83976846|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83976847|NCT01108510|Cobicistat|cobicistat|mesh-list
83976848|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83976849|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83976850|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976851|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976852|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
83976853|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976854|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83976855|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83976856|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83976857|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83976858|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
83976859|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83976860|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83976861|NCT02273258|Insulin|insulin|mesh-list
83976862|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83976863|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
83976864|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83976865|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976866|NCT05015686|Vaccines|vaccines|mesh-list
83976867|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
83976868|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976869|NCT04327245|Tagatose|tagatose|mesh-list
83976870|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83976871|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
83976872|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
83976873|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976874|NCT01588769|Immunomodulating Agents|immunomodulating agents|mesh-list
83976875|NCT01588769|Immunologic Factors|immunologic factors|mesh-ancestor
83976876|NCT01588769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976877|NCT04327401|Dexamethasone|dexamethasone|mesh-list
83976878|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83976879|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
83976880|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
83976881|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976882|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976883|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83976884|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
83976885|NCT04327401|Hormones|hormones|mesh-ancestor
83976886|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976887|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83976888|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976889|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
83976890|NCT01340027|Mirabegron|mirabegron|mesh-list
83976891|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83976892|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83976893|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
83976894|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976895|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976896|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976897|NCT01340027|Urological Agents|urological agents|mesh-ancestor
83976898|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83976899|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83976900|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83976901|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
83976902|NCT01107925|Clopidogrel|clopidogrel|mesh-list
83976903|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83976904|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83976905|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83976906|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83976907|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83976908|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
83976909|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83976910|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976911|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976912|NCT04310293|Hormones|hormones|mesh-list
83976913|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83976914|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976915|NCT01339559|Brivaracetam|brivaracetam|mesh-list
83976916|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
83976917|NCT01588847|Sufentanil|sufentanil|mesh-list
83976918|NCT01588847|Bupivacaine|bupivacaine|mesh-list
83976919|NCT01588847|Anesthetics|anesthetics|mesh-list
83976920|NCT01588847|Propofol|propofol|mesh-list
83976921|NCT01588847|Sevoflurane|sevoflurane|mesh-list
83976922|NCT01588847|Rocuronium|rocuronium|mesh-list
83976923|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
83976924|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83976925|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976926|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
83976927|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83976928|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83976929|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83976930|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
83976931|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83976932|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83976933|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83976934|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83976935|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83976936|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83976937|NCT01588847|Narcotics|narcotics|mesh-ancestor
83976938|NCT01588847|Analgesics|analgesics|mesh-ancestor
83976939|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83976940|NCT00107900|Edoxaban|edoxaban|mesh-list
83976941|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83976942|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
83976943|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83976944|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
83976945|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976946|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976947|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
83976948|NCT00107315|Bevacizumab|bevacizumab|mesh-list
83976949|NCT00107315|Capecitabine|capecitabine|mesh-list
83976950|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83976951|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216258|NCT03806309|Antidotes|antidotes|mesh-ancestor
83976952|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83976953|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83976954|NCT00107315|Growth Substances|growth substances|mesh-ancestor
83976955|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976956|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
83976957|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976958|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
83976959|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976960|NCT01335971|Sulforaphane|sulforaphane|mesh-list
83976961|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83976962|NCT01335971|Protective Agents|protective agents|mesh-ancestor
83976963|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976964|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976965|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
83976966|NCT00107276|Capecitabine|capecitabine|mesh-list
83976967|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976968|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
83976969|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83976970|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83976971|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83976972|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
83976973|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976974|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83976975|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83976976|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83976977|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
83976978|NCT01335698|Ritonavir|ritonavir|mesh-list
83976979|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83976980|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83976981|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83976982|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
83976983|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83976984|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83976985|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83976986|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83976987|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
83976988|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83976989|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83976990|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83976991|NCT00107198|Prednisone|prednisone|mesh-list
83976992|NCT00107198|Cortisone|cortisone|mesh-list
83976993|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
83976994|NCT00107198|Doxorubicin|doxorubicin|mesh-list
83976995|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83976996|NCT00107198|Vincristine|vincristine|mesh-list
83976997|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83976998|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
83976999|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977000|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977001|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83977002|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
83977003|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977004|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977005|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83977006|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83977007|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83977008|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83977009|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977010|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83977011|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
83977012|NCT00107198|Hormones|hormones|mesh-ancestor
83977013|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977014|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83977015|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83977016|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
83977017|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
83977018|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
83977019|NCT00107120|Escitalopram|escitalopram|mesh-list
83977020|NCT00107120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83977021|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83977022|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977023|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977024|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977025|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
83977026|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977028|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977029|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83977030|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977031|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977032|NCT00106184|Rituximab|rituximab|mesh-list
83977033|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977034|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977035|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
83977036|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977037|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977038|NCT00598923|Topiramate|topiramate|mesh-list
83977039|NCT00598923|Phenytoin|phenytoin|mesh-list
83977040|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
83977041|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83977042|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977043|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83977044|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83977045|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977046|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977047|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83977048|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83977049|NCT02892318|Atezolizumab|atezolizumab|mesh-list
83977050|NCT02892318|Guadecitabine|guadecitabine|mesh-list
83977051|NCT02892318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83977052|NCT02892318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977053|NCT02892318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977054|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977055|NCT01334918|Regadenoson|regadenoson|mesh-list
83977056|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83977057|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83977058|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83977059|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
83977060|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
83977061|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977062|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977063|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977064|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83977065|NCT00598962|Azithromycin|azithromycin|mesh-list
83977066|NCT00598962|Rifampin|rifampin|mesh-list
83977067|NCT00598962|Rifabutin|rifabutin|mesh-list
83977068|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83977069|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977070|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83977071|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
83977072|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
83977073|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83977074|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977075|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977076|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83977077|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83977078|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83977079|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83977080|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83977081|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83977082|NCT01332968|Prednisone|prednisone|mesh-list
83977083|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
83977084|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83977085|NCT01332968|Rituximab|rituximab|mesh-list
83977086|NCT01332968|Doxorubicin|doxorubicin|mesh-list
83977087|NCT01332968|Vincristine|vincristine|mesh-list
83977088|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
83977089|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83977090|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
83977091|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977092|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977093|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83977094|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
83977095|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977096|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977097|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83977098|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977099|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83977100|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83977101|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83977102|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977103|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83977104|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
83977105|NCT01332968|Hormones|hormones|mesh-ancestor
83977106|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977107|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83977108|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83977109|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
83977110|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
83977111|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
83977112|NCT00599079|Azithromycin|azithromycin|mesh-list
83977113|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83977114|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977115|NCT00599235|Hydralazine|hydralazine|mesh-list
83977116|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
83977117|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
83977118|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83977119|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83977120|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977121|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977122|NCT00599235|Urological Agents|urological agents|mesh-ancestor
83977123|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977124|NCT00599274|Interferons|interferons|mesh-list
83977125|NCT00599274|Interferon-beta|interferon-beta|mesh-list
83977126|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
83977127|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977128|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
83977129|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977130|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
83977131|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977132|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83977133|NCT01332227|Ritonavir|ritonavir|mesh-list
83977134|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83977135|NCT01332227|Tenofovir|tenofovir|mesh-list
83977136|NCT01332227|Emtricitabine|emtricitabine|mesh-list
83977137|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
83977138|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83977139|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83977140|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
83977141|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977142|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977143|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83977144|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83977145|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
83977146|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977147|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83977148|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83977149|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83977150|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83977151|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83977152|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83977153|NCT01332149|Pregabalin|pregabalin|mesh-list
83977154|NCT01332149|Analgesics|analgesics|mesh-ancestor
83977155|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
83977156|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977157|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977158|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
83977159|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83977160|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977161|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977162|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83977163|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83977164|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83977165|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977166|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83977167|NCT01326702|Rituximab|rituximab|mesh-list
83977168|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83977169|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83977170|NCT01326702|Veliparib|veliparib|mesh-list
83977171|NCT01326702|Antibodies|antibodies|mesh-list
83977172|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
83977173|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83977174|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
83977175|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977176|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977177|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977178|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83977179|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
83977180|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977181|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83977182|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977183|NCT00599625|Pravastatin|pravastatin|mesh-list
83977184|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83977185|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83977186|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
83977187|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977188|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83977189|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83977190|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977191|NCT05650697|Cannabidiol|cannabidiol|mesh-list
83977192|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
83977193|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
83977194|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83977195|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83977196|NCT05649878|Prednisolone|prednisolone|mesh-list
83977197|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
83977198|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83977199|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
83977200|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83977201|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
83977202|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
83977203|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977204|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977205|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83977206|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
83977207|NCT05649878|Hormones|hormones|mesh-ancestor
83977208|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977209|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83977210|NCT05649878|Protective Agents|protective agents|mesh-ancestor
83977211|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83977212|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977213|NCT01327703|Pancreatin|pancreatin|mesh-list
83977214|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83977215|NCT01380080|Efavirenz|efavirenz|mesh-list
83977216|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83977217|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83977218|NCT01380080|Rifampin|rifampin|mesh-list
83977219|NCT01380080|Isoniazid|isoniazid|mesh-list
83977220|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
83977221|NCT01380080|Ethambutol|ethambutol|mesh-list
83977222|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
83977223|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83977224|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83977225|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977226|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977227|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
83977228|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977229|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83977230|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83977231|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83977232|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83977233|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83977234|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83977235|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83977236|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83977237|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83977238|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
83977239|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83977240|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
83977241|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83977242|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83977243|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83977244|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83977245|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83977246|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
83977247|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83977248|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
83977249|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
83977250|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83977251|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83977252|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977253|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977254|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977255|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977256|NCT01371851|Doxazosin|doxazosin|mesh-list
83977257|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977258|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83977259|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83977260|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83977261|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
83977262|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977263|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977264|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977265|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83977266|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83977267|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83977268|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977269|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977270|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977271|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977272|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
83977273|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83977274|NCT04328870|Oxytocin|oxytocin|mesh-list
83977275|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977276|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
83977277|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83977278|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83977279|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83977280|NCT00591617|Narcotics|narcotics|mesh-ancestor
83977281|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977282|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977283|NCT00591617|Analgesics|analgesics|mesh-ancestor
83977284|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
83977285|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977286|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83977287|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
83977288|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83977289|NCT01357889|Incretins|incretins|mesh-ancestor
83977290|NCT01357889|Hormones|hormones|mesh-ancestor
83977291|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977292|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977293|NCT01357655|Dasatinib|dasatinib|mesh-list
83977294|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977295|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83977296|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977297|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977298|NCT01357616|Timolol|timolol|mesh-list
83977299|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83977300|NCT01357616|Brinzolamide|brinzolamide|mesh-list
83977301|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83977302|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83977303|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83977304|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
83977305|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977306|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977307|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977308|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83977309|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977310|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83977311|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977312|NCT01351025|Atorvastatin|atorvastatin|mesh-list
83977313|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83977314|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83977315|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
83977316|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977317|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83977318|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83977319|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977320|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83977322|NCT01348763|Darunavir|darunavir|mesh-list
83977323|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83977324|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83977325|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977326|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977327|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
83977328|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977329|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83977330|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83977331|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83977332|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83977333|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83977334|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83977335|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83977336|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
83977337|NCT01346540|Nintedanib|nintedanib|mesh-list
83977338|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977339|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83977340|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977341|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977342|NCT01342913|Fluticasone|fluticasone|mesh-list
83977343|NCT01342913|Xhance|xhance|mesh-list
83977344|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83977345|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83977346|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83977347|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
83977348|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977349|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977350|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83977351|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
83977352|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
83977353|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83977354|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83977355|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83977356|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83977357|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
83977358|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977359|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977360|NCT01342796|Vaccines|vaccines|mesh-list
83977361|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
83977362|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977363|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
83977364|NCT01342640|Hematinics|hematinics|mesh-ancestor
83977365|NCT01342484|Linagliptin|linagliptin|mesh-list
83977366|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83977367|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977368|NCT01342484|Incretins|incretins|mesh-ancestor
83977369|NCT01342484|Hormones|hormones|mesh-ancestor
83977370|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977371|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83977372|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
83977373|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977374|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977375|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83977376|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83977377|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977378|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83977379|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83977380|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977381|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977382|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
83977383|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977384|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83977385|NCT01342211|Bococizumab|bococizumab|mesh-list
83977386|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83977387|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83977388|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
83977389|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977390|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977391|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83977392|NCT01342094|Timolol|timolol|mesh-list
83977393|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83977394|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83977395|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83977396|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83977397|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83977398|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977399|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977400|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977401|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83977402|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977403|NCT01340768|Metformin|metformin|mesh-list
83977404|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83977405|NCT01340768|Glimepiride|glimepiride|mesh-list
83977406|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83977407|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977408|NCT01340768|Incretins|incretins|mesh-ancestor
83977409|NCT01340768|Hormones|hormones|mesh-ancestor
83977410|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977411|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83977412|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
83977413|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977414|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977415|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83977416|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83977417|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
83977418|NCT01340300|Metformin|metformin|mesh-list
83977419|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83977420|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977421|NCT01107535|Palivizumab|palivizumab|mesh-list
83977422|NCT01107535|Antibodies|antibodies|mesh-list
83977423|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83977424|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
83977425|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977426|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
83977427|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977428|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83977429|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977430|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
83977431|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83977432|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83977433|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83977434|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977435|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977436|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
83977437|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977438|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977439|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83977440|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977441|NCT00598338|Prucalopride|prucalopride|mesh-list
83977442|NCT00598338|Laxatives|laxatives|mesh-ancestor
83977443|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83977444|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83977445|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83977446|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
83977447|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977448|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977449|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977450|NCT00598572|Deferoxamine|deferoxamine|mesh-list
83977451|NCT00598572|Siderophores|siderophores|mesh-ancestor
83977452|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83977453|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
83977454|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
83977455|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977456|NCT00599820|Bevacizumab|bevacizumab|mesh-list
83977457|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977458|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977459|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83977460|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83977461|NCT00599820|Growth Substances|growth substances|mesh-ancestor
83977462|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977463|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83977464|NCT00599898|Nifedipine|nifedipine|mesh-list
83977465|NCT00599898|Atosiban|atosiban|mesh-list
83977466|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83977467|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977468|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977469|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83977470|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977471|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
83977472|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
83977473|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83977474|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
83977475|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977476|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
83977477|NCT00600054|Antibodies|antibodies|mesh-list
83977478|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83977479|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
83977480|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977481|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977482|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977483|NCT00600210|Bevacizumab|bevacizumab|mesh-list
83977484|NCT00600210|Carboplatin|carboplatin|mesh-list
83977485|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977486|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977487|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83977488|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83977489|NCT00600210|Growth Substances|growth substances|mesh-ancestor
83977490|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977491|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
83977492|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
83977493|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
83977494|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83977495|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83977496|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977497|NCT01326546|Entecavir|entecavir|mesh-list
83977498|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
83977499|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977500|NCT00600600|Tigecycline|tigecycline|mesh-list
83977501|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83977502|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977503|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83977504|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977505|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977506|NCT00623064|Gemcitabine|gemcitabine|mesh-list
83977507|NCT00623064|Lapatinib|lapatinib|mesh-list
83977508|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977509|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83977510|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
83977511|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977512|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83977513|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977514|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
83977515|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83977516|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
83977517|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
83977518|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977519|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977520|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83977521|NCT00623220|Analgesics|analgesics|mesh-ancestor
83977522|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
83977523|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977524|NCT00600912|SMOFlipid|smoflipid|mesh-list
83977525|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83977526|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83977527|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83977528|NCT00600990|Vestipitant|vestipitant|mesh-list
83977529|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83977530|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977531|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977532|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977533|NCT00601302|Amlodipine|amlodipine|mesh-list
83977534|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977535|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83977536|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977537|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977538|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83977539|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977540|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
83977541|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
83977542|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
83977543|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83977544|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977545|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977546|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
83977547|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83977548|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977549|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977550|NCT00601614|Temozolomide|temozolomide|mesh-list
83977551|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83977552|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
83977553|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977554|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977555|NCT00601692|Docetaxel|docetaxel|mesh-list
83977556|NCT00601692|Irinotecan|irinotecan|mesh-list
83977557|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977558|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
83977559|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
83977560|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
83977561|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977562|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83977563|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83977564|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977565|NCT00602004|Losartan|losartan|mesh-list
83977566|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83977567|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977568|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83977569|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83977570|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977571|NCT00602082|Capecitabine|capecitabine|mesh-list
83977572|NCT00602082|Streptozocin|streptozocin|mesh-list
83977573|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977574|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83977575|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
83977576|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977577|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83977578|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
83977579|NCT01171963|Vaccines|vaccines|mesh-list
83977580|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
83977581|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977582|NCT01171183|Carvedilol|carvedilol|mesh-list
83977583|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83977584|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83977585|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
83977586|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977587|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977588|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977589|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977590|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
83977591|NCT01171183|Protective Agents|protective agents|mesh-ancestor
83977592|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83977593|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977594|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83977595|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
83977596|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83977597|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83977598|NCT01169779|Metformin|metformin|mesh-list
83977599|NCT01169779|Lixisenatide|lixisenatide|mesh-list
83977600|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83977601|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977602|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
83977603|NCT01169701|Everolimus|everolimus|mesh-list
83977604|NCT01169701|Tacrolimus|tacrolimus|mesh-list
83977605|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83977606|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
83977607|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977608|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83977609|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977610|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977611|NCT01169701|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83977612|NCT01169701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83977613|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977614|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83216933|NCT02373449|Ketamine|ketamine|mesh-list
83977615|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83977616|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
83977617|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83977618|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977619|NCT01167907|Ropivacaine|ropivacaine|mesh-list
83977620|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
83977621|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
83977622|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977623|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977624|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
83977625|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977626|NCT01115491|Bevacizumab|bevacizumab|mesh-list
83977627|NCT01115491|Temozolomide|temozolomide|mesh-list
83977628|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977629|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977630|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83977631|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83977632|NCT01115491|Growth Substances|growth substances|mesh-ancestor
83977633|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977634|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
83977635|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83977636|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
83977637|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977638|NCT01113931|Doxycycline|doxycycline|mesh-list
83977639|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83977640|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977641|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
83977642|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83977643|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83977644|NCT02881177|Oxytocin|oxytocin|mesh-list
83977645|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
83977646|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83977647|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977648|NCT02880787|Rocuronium|rocuronium|mesh-list
83977649|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83977650|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83977651|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83977652|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977653|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977654|NCT01106677|Metformin|metformin|mesh-list
83977655|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83977656|NCT01106677|Canagliflozin|canagliflozin|mesh-list
83977657|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83977658|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977659|NCT01106677|Incretins|incretins|mesh-ancestor
83977660|NCT01106677|Hormones|hormones|mesh-ancestor
83977661|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977662|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83977663|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
83977664|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977665|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977666|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83977667|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83977668|NCT04309357|Plasminogen|plasminogen|mesh-list
83977669|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83977670|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83977671|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977672|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
83977673|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
83977674|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83977675|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83977676|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977677|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977678|NCT04985929|Urological Agents|urological agents|mesh-ancestor
83977679|NCT04308343|Methotrexate|methotrexate|mesh-list
83977680|NCT04308343|Letrozole|letrozole|mesh-list
83977681|NCT04308343|Cetrorelix|cetrorelix|mesh-list
83977682|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83977683|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
83977684|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83977685|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977686|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83977687|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
84124692|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83217002|NCT02372903|Palmidrol|palmidrol|mesh-list
83977688|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977689|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977690|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
83977691|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977692|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83977693|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83977694|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
83977695|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977696|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83977697|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83977698|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83977699|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83977700|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
83977701|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977702|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83977703|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
83977704|NCT01099579|Ritonavir|ritonavir|mesh-list
83977705|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83977706|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83977707|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83977708|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
83977709|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977710|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977711|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83977712|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83977713|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
83977714|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977715|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83977716|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83977717|NCT01103713|Azithromycin|azithromycin|mesh-list
83977718|NCT01103713|Chloroquine|chloroquine|mesh-list
83977719|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83977720|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977721|NCT01103713|Amebicides|amebicides|mesh-ancestor
83977722|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83977723|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83977724|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
83977725|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977726|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83977727|NCT01103245|Spironolactone|spironolactone|mesh-list
83977728|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977729|NCT01103245|Diuretics|diuretics|mesh-ancestor
83977730|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
83977731|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977732|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83977733|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977734|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977735|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83977736|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
83977737|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977738|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83977739|NCT02878837|Midazolam|midazolam|mesh-list
83977740|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
83977741|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83977742|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977743|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977744|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83977745|NCT02878837|Analgesics|analgesics|mesh-ancestor
83977746|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
83977747|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977748|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83977749|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83977750|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83977751|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
83977752|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977753|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977754|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83977755|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83977756|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83977757|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83977758|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83977759|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
83977760|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
83977761|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
83977762|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
83977763|NCT02880007|Cisplatin|cisplatin|mesh-list
83977764|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977765|NCT04982029|Cannabidiol|cannabidiol|mesh-list
83977766|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
83977767|NCT02880085|Lidocaine|lidocaine|mesh-list
83977768|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
83977769|NCT02880085|Anesthetics|anesthetics|mesh-list
83977770|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977771|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977772|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
83977773|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977774|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83977775|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83977776|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83977777|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977778|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977779|NCT01098097|Ribavirin|ribavirin|mesh-list
83977780|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
83977781|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977782|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
83977783|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977784|NCT04407572|Vitamin D|vitamin d|mesh-list
83977785|NCT04407572|Vitamins|vitamins|mesh-list
83977786|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
83977787|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
83977788|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
83977789|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977790|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83977791|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
83977792|NCT04407572|Hematinics|hematinics|mesh-ancestor
83977793|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
83977794|NCT04328636|Analgesics|analgesics|mesh-ancestor
83977795|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
83977796|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977797|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977798|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
83977799|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977800|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83977801|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
83977802|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83977803|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977804|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977805|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83977806|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
83977807|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83977808|NCT02893826|Nimodipine|nimodipine|mesh-list
83977809|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83977810|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83977811|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977812|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977813|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83977814|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977815|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
83977816|NCT02893280|Aspirin|aspirin|mesh-list
83977817|NCT02893280|Enoxaparin|enoxaparin|mesh-list
83977818|NCT02893280|Streptokinase|streptokinase|mesh-list
83977819|NCT02893280|Clopidogrel|clopidogrel|mesh-list
83977820|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83977821|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83977822|NCT02893280|Analgesics|analgesics|mesh-ancestor
83977823|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
83977824|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977825|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977826|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83977827|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977828|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83977829|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83977830|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977831|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83977832|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83977833|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977834|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
83977835|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83977836|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83217153|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977837|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83977838|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
83977839|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977840|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
83977841|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83977842|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83977843|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
83977844|NCT04328480|Colchicine|colchicine|mesh-list
83977845|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
83977846|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83977847|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
83977848|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
83977849|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
83977850|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977851|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977852|NCT00592280|Pancrelipase|pancrelipase|mesh-list
83977853|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83977854|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83977855|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83977856|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
83977857|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83977858|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83977859|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
83977860|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977861|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83977862|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
83977863|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977864|NCT00592670|Fluoxetine|fluoxetine|mesh-list
83977865|NCT00592670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83977866|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83977867|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977868|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977869|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977870|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
83977871|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977872|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83977873|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
83977874|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83977875|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83977876|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83977877|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977878|NCT04327232|Spironolactone|spironolactone|mesh-list
83977879|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83977880|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
83977881|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977882|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977883|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83977884|NCT04327232|Diuretics|diuretics|mesh-ancestor
83977885|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
83977886|NCT00593138|Methylphenidate|methylphenidate|mesh-list
83977887|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83977888|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83977889|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977890|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83977891|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83977892|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977893|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977894|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
83977895|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977896|NCT00593294|Drospirenone|drospirenone|mesh-list
83977897|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83977898|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977899|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83977900|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
83977901|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83977902|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83977903|NCT00593294|Diuretics|diuretics|mesh-ancestor
83977904|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
83977905|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83977906|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83977907|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83977908|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
83217232|NCT03324113|Hormones|hormones|mesh-ancestor
83977909|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83977910|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83977911|NCT00593294|Estrogens|estrogens|mesh-ancestor
83977912|NCT00593294|Hormones|hormones|mesh-ancestor
83977913|NCT00593996|Vitamin D|vitamin d|mesh-list
83977914|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
83977915|NCT00593996|Vitamins|vitamins|mesh-ancestor
83977916|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
83977917|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977918|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83977919|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83977920|NCT00594542|Lidocaine|lidocaine|mesh-list
83977921|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
83977922|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
83977923|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977924|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977925|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
83977926|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977927|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83977928|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83977929|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83977930|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977931|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977932|NCT00595322|Bevacizumab|bevacizumab|mesh-list
83977933|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83977934|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977935|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83977936|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83977937|NCT00595322|Growth Substances|growth substances|mesh-ancestor
83977938|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977939|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
83977940|NCT00596336|Imiquimod|imiquimod|mesh-list
83977941|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83977942|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
83977943|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977944|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977945|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
83977946|NCT00596414|Midazolam|midazolam|mesh-list
83977947|NCT00596414|Meperidine|meperidine|mesh-list
83977948|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83977949|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83977950|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83977951|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977952|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83977953|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83977954|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83977955|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83977956|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
83977957|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
83977958|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
83977959|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
83977960|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977961|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977962|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83977963|NCT00596414|Narcotics|narcotics|mesh-ancestor
83977964|NCT00596414|Analgesics|analgesics|mesh-ancestor
83977965|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
83977966|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83977967|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83977968|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977969|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83977970|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83977971|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977972|NCT00596804|Veltuzumab|veltuzumab|mesh-list
83977973|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977974|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
83977975|NCT00622934|Hematinics|hematinics|mesh-ancestor
83977976|NCT00597662|Icodextrin|icodextrin|mesh-list
83977977|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
83977978|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83977979|NCT00598052|Escitalopram|escitalopram|mesh-list
83977980|NCT00598052|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83977981|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83977982|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83977983|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83977984|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83977986|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977987|NCT04326296|Lenalidomide|lenalidomide|mesh-list
83977988|NCT04326296|Antibodies|antibodies|mesh-list
83977989|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83977990|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
83977991|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83977992|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83977993|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83977994|NCT04326296|Growth Substances|growth substances|mesh-ancestor
83977995|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
83977996|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83977997|NCT00598676|Sirolimus|sirolimus|mesh-list
83977998|NCT00598676|Everolimus|everolimus|mesh-list
83977999|NCT00598676|MTOR Inhibitors|mtor inhibitors|mesh-list
83978000|NCT00598676|Temsirolimus|temsirolimus|mesh-list
83978001|NCT00598676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978002|NCT00598676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978003|NCT00598676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978004|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978005|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
83978006|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978007|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978008|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83978009|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978010|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83978011|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
83978012|NCT00599222|Ranibizumab|ranibizumab|mesh-list
83978013|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83978014|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83978015|NCT00599222|Growth Substances|growth substances|mesh-ancestor
83978016|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978017|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
83978018|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978019|NCT00599534|Montelukast|montelukast|mesh-list
83978020|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83978021|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
83978022|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83978023|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
83978024|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978025|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978026|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83978027|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83978028|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978029|NCT00600158|Lidocaine|lidocaine|mesh-list
83978030|NCT00600158|Hydromorphone|hydromorphone|mesh-list
83978031|NCT00600158|Bupivacaine|bupivacaine|mesh-list
83978032|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
83978033|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
83978034|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978035|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978036|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
83978037|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978038|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83978039|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83978040|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83978041|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83978042|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978043|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83978044|NCT00600158|Narcotics|narcotics|mesh-ancestor
83978045|NCT00600158|Analgesics|analgesics|mesh-ancestor
83978046|NCT04325984|Dexamethasone|dexamethasone|mesh-list
83978047|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978048|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
83978049|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
83978050|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978051|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978052|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83978053|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
83978054|NCT04325984|Hormones|hormones|mesh-ancestor
83978055|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978056|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83978057|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978058|NCT00600548|Miltefosine|miltefosine|mesh-list
83978059|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83978060|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
83978061|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978062|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978063|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83978064|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83978065|NCT00600626|Insulin|insulin|mesh-list
83978066|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83978067|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
83978068|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
83978069|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83978070|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
83978071|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
83978072|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
83978073|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
83978074|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83978075|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978076|NCT00623168|Ribavirin|ribavirin|mesh-list
83978077|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
83978078|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978079|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
83978080|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978081|NCT00601016|Imiquimod|imiquimod|mesh-list
83978082|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83978083|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
83978084|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978085|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978086|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
83978087|NCT00601328|Calcitriol|calcitriol|mesh-list
83978088|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83978089|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978090|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83978091|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83978092|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978093|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83978094|NCT00601328|Vitamins|vitamins|mesh-ancestor
83978095|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
83978096|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83978097|NCT00601562|Zidovudine|zidovudine|mesh-list
83978098|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
83978099|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978100|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83978101|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83978102|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978103|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
83978104|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978105|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83978106|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83978107|NCT00601874|Pilocarpine|pilocarpine|mesh-list
83978108|NCT00601874|Miotics|miotics|mesh-ancestor
83978109|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
83978110|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978111|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978112|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83978113|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83978114|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
83978115|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978116|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978117|NCT01326026|Insulin|insulin|mesh-list
83978118|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83978119|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
83978120|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83978121|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978122|NCT01097629|Suvorexant|suvorexant|mesh-list
83978123|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83978124|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83978125|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978126|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978127|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83978128|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978129|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978130|NCT04308031|Digoxin|digoxin|mesh-list
83978131|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83978132|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83978133|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978134|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978135|NCT04308031|Protective Agents|protective agents|mesh-ancestor
83978136|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978137|NCT01096849|Levofloxacin|levofloxacin|mesh-list
83978138|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83978139|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978140|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83978141|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83978142|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83978143|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978144|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978145|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978146|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83978147|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83978148|NCT01324388|Dulaglutide|dulaglutide|mesh-list
83978149|NCT01324388|Metoprolol|metoprolol|mesh-list
83978150|NCT01324388|Lisinopril|lisinopril|mesh-list
83978151|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83978152|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83978153|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
83978154|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
83978155|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978156|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978157|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83978158|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83978159|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83978160|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
83978161|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978162|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978163|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83978164|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83978165|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978166|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83978167|NCT01324388|Protective Agents|protective agents|mesh-ancestor
83978168|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83978169|NCT02878681|Ranibizumab|ranibizumab|mesh-list
83978170|NCT02878681|Aflibercept|aflibercept|mesh-list
83978171|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83978172|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83978173|NCT02878681|Growth Substances|growth substances|mesh-ancestor
83978174|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978175|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83978176|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978177|NCT01324310|Ketoconazole|ketoconazole|mesh-list
83978178|NCT01324310|Romidepsin|romidepsin|mesh-list
83978179|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
83978180|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978181|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83978182|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83978183|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978184|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978185|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83978186|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
83978187|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978188|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978189|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83978190|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83978191|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978192|NCT01324310|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83978193|NCT01102231|Cetuximab|cetuximab|mesh-list
83978194|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83978195|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978196|NCT01095835|Interferons|interferons|mesh-list
83978197|NCT01095835|Lamivudine|lamivudine|mesh-list
83978198|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83978199|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
83978200|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978201|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
83978202|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978203|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83978204|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83978205|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978206|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978207|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83978208|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83978209|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
83978210|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978212|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978213|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
83978214|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978215|NCT01324232|Quinidine|quinidine|mesh-list
83978216|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
83978217|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
83978218|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
83978219|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83978220|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83978221|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978222|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978223|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978224|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83978225|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83978226|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
83978227|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83978228|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
83978229|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83978230|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83978231|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978232|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978233|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83978234|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83978235|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
83978236|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83978237|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83978238|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83978239|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83978240|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83978241|NCT02878291|Vaccines|vaccines|mesh-list
83978242|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
83978243|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978244|NCT05350891|Immunomodulating Agents|immunomodulating agents|mesh-list
83978245|NCT05350891|Immunologic Factors|immunologic factors|mesh-ancestor
83978246|NCT05350891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978247|NCT01323920|Methotrexate|methotrexate|mesh-list
83978248|NCT01323920|Bortezomib|bortezomib|mesh-list
83978249|NCT01323920|Tacrolimus|tacrolimus|mesh-list
83978250|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83978251|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
83978252|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83978253|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978254|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83978255|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
83978256|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978257|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978258|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
83978259|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978260|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83978261|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978262|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
83978263|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978264|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83978265|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83978266|NCT01093885|Ambrisentan|ambrisentan|mesh-list
83978267|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83978268|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83978269|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978270|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978271|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978272|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978273|NCT02891967|Z 350|z 350|mesh-list
83978274|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83978275|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83978276|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978277|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978278|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
83978279|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978280|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978281|NCT00598377|Cosyntropin|cosyntropin|mesh-list
83978282|NCT00598377|Hormones|hormones|mesh-ancestor
83217608|NCT02359643|Aspirin|aspirin|mesh-list
83978283|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978284|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978286|NCT00598533|Probucol|probucol|mesh-list
83978287|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83978288|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978289|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83978290|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978291|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
83978292|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978293|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
83978294|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978295|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978296|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83978297|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83978298|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
83978299|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83978300|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
83978301|NCT00598533|Protective Agents|protective agents|mesh-ancestor
83978302|NCT00599937|Tretinoin|tretinoin|mesh-list
83978303|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978304|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
83978305|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
83978306|NCT00600093|Amantadine|amantadine|mesh-list
83978307|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83978308|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83978309|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
83978310|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978311|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
83978312|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978313|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978314|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978315|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978316|NCT00600093|Analgesics|analgesics|mesh-ancestor
83978317|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
83978318|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978319|NCT00600249|Docetaxel|docetaxel|mesh-list
83978320|NCT00600249|Cetuximab|cetuximab|mesh-list
83978321|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978322|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
83978323|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
83978324|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
83978325|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978326|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83978327|NCT00600405|Ibuprofen|ibuprofen|mesh-list
83978328|NCT00600405|Oxycodone|oxycodone|mesh-list
83978329|NCT00600405|Tamsulosin|tamsulosin|mesh-list
83978330|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83978331|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978332|NCT00600405|Analgesics|analgesics|mesh-ancestor
83978333|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
83978334|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978335|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978336|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978337|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978338|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83978339|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978340|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978341|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83978342|NCT00600405|Narcotics|narcotics|mesh-ancestor
83978343|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978344|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83978345|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83978346|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83978347|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83978348|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978349|NCT00600405|Urological Agents|urological agents|mesh-ancestor
83978350|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83978351|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83978352|NCT00600639|Prednisolone|prednisolone|mesh-list
83978353|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83978354|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
83978355|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83978356|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
83978357|NCT00600639|Albuterol|albuterol|mesh-list
83978358|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83978359|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
83978360|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978361|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
83978362|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978363|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
83978364|NCT00600639|Hormones|hormones|mesh-ancestor
83978365|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978366|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978367|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83978368|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978369|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
83978370|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
83978371|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978372|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83978373|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83978374|NCT00600639|Protective Agents|protective agents|mesh-ancestor
83978375|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83978376|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83978377|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
83978378|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
83978379|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83978380|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83978381|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83978382|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83978383|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
83978384|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978385|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978386|NCT00600873|Pramipexole|pramipexole|mesh-list
83978387|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
83978388|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978389|NCT00600873|Protective Agents|protective agents|mesh-ancestor
83978390|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978391|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83978392|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83978393|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
83978394|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
83978395|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978396|NCT00598611|Loratadine|loratadine|mesh-list
83978397|NCT00598611|Desloratadine|desloratadine|mesh-list
83978398|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83978399|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
83978400|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978401|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978402|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978403|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83978404|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83978405|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
83978406|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
83978407|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
83978408|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83978409|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83978410|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
83978411|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
83978412|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978413|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
83978414|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
83978415|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83978416|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978417|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978418|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
83978419|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83978420|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978421|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978422|NCT00601887|Meloxicam|meloxicam|mesh-list
83978423|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83978424|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978425|NCT00601887|Analgesics|analgesics|mesh-ancestor
83978426|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
83978427|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978428|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978429|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978430|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978431|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83978432|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83978433|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978434|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978435|NCT01325493|Ketamine|ketamine|mesh-list
83978436|NCT01325493|Analgesics|analgesics|mesh-ancestor
83978437|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
83978438|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978439|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978440|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83978441|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83978442|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
83978443|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
83978444|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978445|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83978446|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83978447|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978448|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978449|NCT01325337|Bimatoprost|bimatoprost|mesh-list
83978450|NCT01325337|Minoxidil|minoxidil|mesh-list
83978451|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83978452|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83978453|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
83978454|NCT01324947|Pomalidomide|pomalidomide|mesh-list
83978455|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
83978456|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978457|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83978458|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83978459|NCT01324947|Growth Substances|growth substances|mesh-ancestor
83978460|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
83978461|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978462|NCT01101841|Paroxetine|paroxetine|mesh-list
83978463|NCT01101841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83978464|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83978465|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83978466|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978467|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978468|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
83978469|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978470|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83978471|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
83978472|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83978473|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83978474|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83978475|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978476|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
83978477|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83978478|NCT02877511|Protective Agents|protective agents|mesh-ancestor
83978479|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978480|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
83978481|NCT01324323|Rifampin|rifampin|mesh-list
83978482|NCT01324323|Romidepsin|romidepsin|mesh-list
83978483|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83978484|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
83978485|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83978486|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978487|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
83978488|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83978489|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978490|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978491|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83978492|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83978493|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83978494|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83978495|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83978496|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83978497|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83978498|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978499|NCT01324323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83978500|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83978501|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978502|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83978503|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978504|NCT02879227|Cisplatin|cisplatin|mesh-list
83978505|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
83978506|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978508|NCT01323582|Erythromycin|erythromycin|mesh-list
83978509|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
83978510|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83978511|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
83978512|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83978513|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978514|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83978515|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83978516|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978517|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978518|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
83978519|NCT05367765|Flumatinib|flumatinib|mesh-list
83978520|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978521|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978522|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978523|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978524|NCT01323621|Fluticasone|fluticasone|mesh-list
83978525|NCT01323621|Xhance|xhance|mesh-list
83978526|NCT01323621|Albuterol|albuterol|mesh-list
83978527|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83978528|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978529|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83978530|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
83978531|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978532|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978533|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83978534|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
83978535|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83978536|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83978537|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83978538|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83978539|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83978540|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
83978541|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978542|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978543|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
83978544|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83978545|NCT05645289|Alendronate|alendronate|mesh-list
83978546|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83978547|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978548|NCT01320033|Doxycycline|doxycycline|mesh-list
83978549|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83978550|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978551|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
83978552|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83978553|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83978554|NCT05644743|Gemcitabine|gemcitabine|mesh-list
83978555|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978556|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83978557|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
83978558|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978559|NCT01317615|Paclitaxel|paclitaxel|mesh-list
83978560|NCT01317615|Carboplatin|carboplatin|mesh-list
83978561|NCT01317615|Everolimus|everolimus|mesh-list
83978562|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83978563|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978564|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83978565|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83978566|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83978567|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978568|NCT01317615|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83978569|NCT01317615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978570|NCT01317615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978571|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978572|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
83978573|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978574|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
83978575|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83978576|NCT01078675|Calcium|calcium|mesh-list
83978577|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83978578|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978579|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83978580|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83978581|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83978582|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
83978583|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978584|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83978585|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83978586|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978587|NCT01100437|Naltrexone|naltrexone|mesh-list
83978588|NCT01100437|Morphine|morphine|mesh-list
83978589|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83978590|NCT01100437|Narcotics|narcotics|mesh-ancestor
83978591|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978592|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978593|NCT01100437|Analgesics|analgesics|mesh-ancestor
83978594|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
83978595|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978596|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83978597|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83978598|NCT01322490|Molgramostim|molgramostim|mesh-list
83978599|NCT01322490|Sargramostim|sargramostim|mesh-list
83978600|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
83978601|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978602|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978603|NCT01314261|Interferons|interferons|mesh-list
83978604|NCT01314261|Ribavirin|ribavirin|mesh-list
83978605|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978606|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
83978607|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978608|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
83978609|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978610|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83978611|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83978612|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978613|NCT05661357|Disitamab vedotin|disitamab vedotin|mesh-list
83978614|NCT05661357|Immunoconjugates|immunoconjugates|mesh-ancestor
83978615|NCT05661357|Immunologic Factors|immunologic factors|mesh-ancestor
83978616|NCT05661357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978617|NCT01321710|Acetaminophen|acetaminophen|mesh-list
83978618|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978619|NCT01321710|Analgesics|analgesics|mesh-ancestor
83978620|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
83978621|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978622|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978623|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
83978624|NCT01321008|Prednisone|prednisone|mesh-list
83978625|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
83978626|NCT01321008|Doxorubicin|doxorubicin|mesh-list
83978627|NCT01321008|Vincristine|vincristine|mesh-list
83978628|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978629|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
83978630|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978631|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978632|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83978633|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
83978634|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978635|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978636|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83978637|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83978638|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83978639|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83978640|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978641|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978642|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
83978643|NCT01321008|Hormones|hormones|mesh-ancestor
83978644|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978645|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83978646|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83978647|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
83978648|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
83978649|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
83978650|NCT01323530|Capecitabine|capecitabine|mesh-list
83978651|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83978652|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
83978653|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978654|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978655|NCT01313637|Bromides|bromides|mesh-list
83978656|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
83978657|NCT01320722|Vitamin D|vitamin d|mesh-list
83978658|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
83978659|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
83978660|NCT01320722|Vitamins|vitamins|mesh-list
83978661|NCT01320722|Allopurinol|allopurinol|mesh-list
83978662|NCT01320722|Probenecid|probenecid|mesh-list
83978663|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
83978664|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978665|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83978666|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83978667|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
83978668|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978669|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978670|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
83978671|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978672|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83978673|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
83978674|NCT01320722|Protective Agents|protective agents|mesh-ancestor
83978675|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
83978676|NCT01313559|Everolimus|everolimus|mesh-list
83978677|NCT01313559|Pasireotide|pasireotide|mesh-list
83978678|NCT01313559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83978679|NCT01313559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978680|NCT01313559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978681|NCT01313559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978682|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978683|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
83978684|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978685|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978686|NCT01313559|Hormones|hormones|mesh-ancestor
83978687|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978688|NCT05661279|Acetaminophen|acetaminophen|mesh-list
83978689|NCT05661279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978690|NCT05661279|Analgesics|analgesics|mesh-ancestor
83978691|NCT05661279|Sensory System Agents|sensory system agents|mesh-ancestor
83978692|NCT05661279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978693|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978694|NCT05661279|Antipyretics|antipyretics|mesh-ancestor
83978695|NCT02890875|Ethanol|ethanol|mesh-list
83978696|NCT02890875|Heparin|heparin|mesh-list
83978697|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
83978698|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83978699|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83978700|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978701|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83978702|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978703|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978704|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978705|NCT01312467|Metformin|metformin|mesh-list
83978706|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83978707|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978708|NCT01310127|Nepafenac|nepafenac|mesh-list
83978709|NCT01310127|Bromfenac|bromfenac|mesh-list
83978710|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83978711|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83978712|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83978713|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978714|NCT01310127|Analgesics|analgesics|mesh-ancestor
83978715|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
83978716|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978717|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978718|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978719|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978720|NCT01318902|Dexamethasone|dexamethasone|mesh-list
83978721|NCT01318902|Ixazomib|ixazomib|mesh-list
83978722|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978723|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
83978724|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
83978725|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978726|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978727|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83978728|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
83978729|NCT01318902|Hormones|hormones|mesh-ancestor
83978730|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978731|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83978732|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978733|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
83978734|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978735|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978737|NCT01313858|Methotrexate|methotrexate|mesh-list
83978738|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83978739|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
83978740|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83978741|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978742|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83978743|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
83978744|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978745|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978746|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
83978747|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978748|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83978749|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978750|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
83978751|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978752|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83978753|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83978754|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978755|NCT01313780|Oxycodone|oxycodone|mesh-list
83978756|NCT01313780|Naloxone|naloxone|mesh-list
83978757|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83978758|NCT01313780|Narcotics|narcotics|mesh-ancestor
83978759|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83978760|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978761|NCT01313780|Analgesics|analgesics|mesh-ancestor
83978762|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
83978763|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978764|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83978765|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83978766|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
83978767|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978768|NCT01170364|Sibutramine|sibutramine|mesh-list
83978769|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
83978770|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83978771|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
83978772|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83978773|NCT01170208|Insulin|insulin|mesh-list
83978774|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83978775|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978776|NCT02891018|Paclitaxel|paclitaxel|mesh-list
83978777|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83978778|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83978779|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978780|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83978781|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83978782|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83978783|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978784|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83978785|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83978786|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978787|NCT01169038|Azithromycin|azithromycin|mesh-list
83978788|NCT01169038|Rifampin|rifampin|mesh-list
83978789|NCT01169038|Ethambutol|ethambutol|mesh-list
83978790|NCT01169038|Levofloxacin|levofloxacin|mesh-list
83978791|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83978792|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978793|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83978794|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
83978795|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
83978796|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83978797|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978798|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978799|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83978800|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83978801|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83978802|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83978803|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83978804|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83978805|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83978806|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83978807|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83978808|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978809|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83978810|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83978811|NCT00624754|Budesonide|budesonide|mesh-list
83978812|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
83978813|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978814|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83978815|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
83978816|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978817|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978818|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83978819|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
83978820|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
83978821|NCT00624754|Hormones|hormones|mesh-ancestor
83978822|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978823|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83978824|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83978825|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83978826|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
83978827|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978828|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978829|NCT01114828|Tolvaptan|tolvaptan|mesh-list
83978830|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83978831|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978832|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
83978833|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978834|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
83978835|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83978836|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83978837|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83978838|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83978839|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978840|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
83978841|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83978842|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978843|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83978844|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978845|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
83978846|NCT01114672|Vitamin D|vitamin d|mesh-list
83978847|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83978848|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978849|NCT01114672|Vitamins|vitamins|mesh-ancestor
83978850|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
83978851|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83978852|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83978853|NCT01114516|Clindamycin|clindamycin|mesh-list
83978854|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
83978855|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
83978856|NCT01114516|Cefazolin|cefazolin|mesh-list
83978857|NCT01114516|Indomethacin|indomethacin|mesh-list
83978858|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978859|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83978860|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978861|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978862|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83978863|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978864|NCT01114516|Analgesics|analgesics|mesh-ancestor
83978865|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
83978866|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978867|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978868|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978869|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978870|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
83978871|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
83978872|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83978873|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83978874|NCT01313078|Asparaginase|asparaginase|mesh-list
83978875|NCT01313078|Pegaspargase|pegaspargase|mesh-list
83978876|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978877|NCT01114360|Melatonin|melatonin|mesh-list
83978878|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
83978879|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978880|NCT01114360|Protective Agents|protective agents|mesh-ancestor
83978881|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978882|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218192|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83978883|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83978884|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978885|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978886|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978887|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978888|NCT01075321|Lenalidomide|lenalidomide|mesh-list
83978889|NCT01075321|Everolimus|everolimus|mesh-list
83978890|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
83978891|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978892|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83978893|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83978894|NCT01075321|Growth Substances|growth substances|mesh-ancestor
83978895|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
83978896|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978897|NCT01075321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83978898|NCT01075321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978899|NCT01075321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978900|NCT01075321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978901|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978902|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83978903|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83978904|NCT01114204|Hematinics|hematinics|mesh-ancestor
83978905|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83978906|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83978907|NCT01075243|Acetaminophen|acetaminophen|mesh-list
83978908|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83978909|NCT01075243|Analgesics|analgesics|mesh-ancestor
83978910|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
83978911|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978912|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978913|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
83978914|NCT01078441|Dexamethasone|dexamethasone|mesh-list
83978915|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
83978916|NCT01078441|Doxorubicin|doxorubicin|mesh-list
83978917|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83978918|NCT01078441|Bortezomib|bortezomib|mesh-list
83978919|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978920|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
83978921|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978922|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83978923|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83978924|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
83978925|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978926|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978927|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83978928|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83978929|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
83978930|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
83978931|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83978932|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83978933|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
83978934|NCT01078441|Hormones|hormones|mesh-ancestor
83978935|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83978936|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83978937|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83978938|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83978939|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83978940|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978941|NCT00626665|Tadalafil|tadalafil|mesh-list
83978942|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
83978943|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83978944|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83978945|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978946|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978947|NCT00626665|Urological Agents|urological agents|mesh-ancestor
83978948|NCT01090063|Ustekinumab|ustekinumab|mesh-list
83978949|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
83978950|NCT01306214|Empagliflozin|empagliflozin|mesh-list
83978951|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83978952|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978953|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83978954|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978955|NCT00623402|Interferons|interferons|mesh-list
83978956|NCT00623402|Sorafenib|sorafenib|mesh-list
83218286|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
83978957|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978958|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
83978959|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83978960|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978961|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978962|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978963|NCT01077739|Leucovorin|leucovorin|mesh-list
83978964|NCT01077739|Bevacizumab|bevacizumab|mesh-list
83978965|NCT01077739|Fluorouracil|fluorouracil|mesh-list
83978966|NCT01077739|Capecitabine|capecitabine|mesh-list
83978967|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
83978968|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83978969|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978970|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83978971|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83978972|NCT01077739|Growth Substances|growth substances|mesh-ancestor
83978973|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978974|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
83978975|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
83978976|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978977|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83978978|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83978979|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
83978980|NCT01077739|Antidotes|antidotes|mesh-ancestor
83978981|NCT01077739|Protective Agents|protective agents|mesh-ancestor
83978982|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
83978983|NCT01077739|Vitamins|vitamins|mesh-ancestor
83978984|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
83978985|NCT01306058|Sorafenib|sorafenib|mesh-list
83978986|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978987|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978988|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978989|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83978990|NCT00626509|Sunitinib|sunitinib|mesh-list
83978991|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83978992|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83978993|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83978994|NCT00626509|Growth Substances|growth substances|mesh-ancestor
83978995|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83978996|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
83978997|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83978998|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83978999|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979000|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83979001|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83979002|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83979003|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
83979004|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979005|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979006|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979007|NCT02877901|Urological Agents|urological agents|mesh-ancestor
83979008|NCT04306159|Anesthetics|anesthetics|mesh-list
83979009|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979010|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979011|NCT01305200|Calcium|calcium|mesh-list
83979012|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83979013|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979014|NCT01304498|Vaccines|vaccines|mesh-list
83979015|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
83979016|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979017|NCT01074931|Ritonavir|ritonavir|mesh-list
83979018|NCT01074931|Lopinavir|lopinavir|mesh-list
83979019|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83979020|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83979021|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
83979022|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979023|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979024|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83979025|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83979026|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
83979027|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979028|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83979029|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83979030|NCT04774159|Colchicine|colchicine|mesh-list
83979031|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
83979032|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979033|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83979034|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83979035|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83979036|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979037|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979038|NCT01303172|Gemcitabine|gemcitabine|mesh-list
83979039|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83979040|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
83979041|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979042|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979043|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83979044|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83979045|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83979046|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
83979047|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979048|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979049|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979050|NCT01302938|Urological Agents|urological agents|mesh-ancestor
83979051|NCT01076647|Insulin|insulin|mesh-list
83979052|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83979053|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
83979054|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979055|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979056|NCT04306081|Evolocumab|evolocumab|mesh-list
83979057|NCT04306081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83979058|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83979059|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83979060|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
83979061|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979062|NCT04306081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83979063|NCT04306081|Protease Inhibitors|protease inhibitors|mesh-ancestor
83979064|NCT04306081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979065|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83979066|NCT01074307|Bisoprolol|bisoprolol|mesh-list
83979067|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83979068|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
83979069|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
83979070|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979071|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979072|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83979073|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83979074|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83979075|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
83979076|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979077|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979078|NCT01076335|Docetaxel|docetaxel|mesh-list
83979079|NCT01076335|Leuprolide|leuprolide|mesh-list
83979080|NCT01076335|Goserelin|goserelin|mesh-list
83979081|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979082|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
83979083|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83979084|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83979085|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979086|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83979087|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
83979088|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83979089|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979090|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83979091|NCT01309737|Tofacitinib|tofacitinib|mesh-list
83979092|NCT01309737|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83979093|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83979094|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979095|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979096|NCT01074229|Ropivacaine|ropivacaine|mesh-list
83979097|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
83979098|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
83979099|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979100|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979101|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
83979102|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979103|NCT01106014|Selexipag|selexipag|mesh-list
83979104|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83218410|NCT02336477|Mexiletine|mexiletine|mesh-list
83979105|NCT01105936|Acetaminophen|acetaminophen|mesh-list
83979106|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83979107|NCT01105936|Analgesics|analgesics|mesh-ancestor
83979108|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
83979109|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979110|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979111|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
83979112|NCT01309659|Iron|iron|mesh-list
83979113|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83979114|NCT01309659|Trace Elements|trace elements|mesh-ancestor
83979115|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
83979116|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979117|NCT01309659|Hematinics|hematinics|mesh-ancestor
83979118|NCT04989166|Curcumin|curcumin|mesh-list
83979119|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83979120|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83979121|NCT04989166|Analgesics|analgesics|mesh-ancestor
83979122|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
83979123|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979124|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979125|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979126|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979127|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979128|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979129|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979130|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
83979131|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83979132|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979133|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979134|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83979135|NCT05320705|Analgesics|analgesics|mesh-ancestor
83979136|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
83979137|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979138|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83979139|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83979140|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83979141|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
83979142|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979143|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979144|NCT01104766|Aripiprazole|aripiprazole|mesh-list
83979145|NCT01104766|Cariprazine|cariprazine|mesh-list
83979146|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
83979147|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83979148|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83979149|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83979150|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979151|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979152|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
83979153|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
83979154|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979155|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979156|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83979157|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83979158|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
83979159|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83979160|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83979161|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83979162|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83979163|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83979164|NCT02880280|Menotropins|menotropins|mesh-list
83979165|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83979166|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979167|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83979168|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
83979169|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
83979170|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83979171|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979172|NCT04862455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83979173|NCT04862455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979174|NCT01104376|Efavirenz|efavirenz|mesh-list
83979175|NCT01104376|Voriconazole|voriconazole|mesh-list
83979176|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83979177|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83979178|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979179|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979180|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
83979181|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979182|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83979183|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83979184|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83979185|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83979186|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83979187|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83979188|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
83979189|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83979190|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83979191|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
83979192|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979193|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979194|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83979196|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
83979197|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83979198|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979199|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
83979200|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
83979201|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979202|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
83979203|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979204|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979205|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
83979206|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83979207|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83979208|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83979209|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83979210|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83979211|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83979212|NCT01072357|Bevacizumab|bevacizumab|mesh-list
83979213|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83979214|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83979215|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979216|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83979217|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83979218|NCT01072357|Growth Substances|growth substances|mesh-ancestor
83979219|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979220|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
83979221|NCT01072357|Laxatives|laxatives|mesh-ancestor
83979222|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979223|NCT01072201|Triclosan|triclosan|mesh-list
83979224|NCT01072201|Fluorides|fluorides|mesh-list
83979225|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
83979226|NCT01072201|Protective Agents|protective agents|mesh-ancestor
83979227|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979228|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83979229|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979230|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83979231|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83979232|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
83979233|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979234|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84124693|NCT00682578|Artesunate|artesunate|mesh-list
84124694|NCT00682578|Chloroquine|chloroquine|mesh-list
84124695|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
84124696|NCT00682578|Piperaquine|piperaquine|mesh-list
84124697|NCT00682578|Artenimol|artenimol|mesh-list
84124698|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
84124699|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84124700|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84124701|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124702|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124703|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
84124704|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
84124705|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84124706|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
84124707|NCT00682578|Amebicides|amebicides|mesh-ancestor
84124708|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124709|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84124710|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124711|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124712|NCT00594906|Teriparatide|teriparatide|mesh-list
84124713|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84124714|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979235|NCT02893709|Omeprazole|omeprazole|mesh-list
83979236|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83979237|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979238|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83979239|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979240|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979241|NCT04972396|Metformin|metformin|mesh-list
83979242|NCT04972396|Digoxin|digoxin|mesh-list
83979243|NCT04972396|Warfarin|warfarin|mesh-list
83979244|NCT04972396|Atorvastatin|atorvastatin|mesh-list
83979245|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
83979246|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83979247|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979248|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979249|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83979250|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83979251|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
83979252|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979253|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83979254|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83979255|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979256|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
83979257|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83979258|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
83979259|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83979260|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83979261|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83979262|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83979263|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83979264|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83979265|NCT04972396|Protective Agents|protective agents|mesh-ancestor
83979266|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83979267|NCT04972396|Estrogens|estrogens|mesh-ancestor
83979268|NCT04972396|Hormones|hormones|mesh-ancestor
83979269|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979270|NCT01089361|Ketamine|ketamine|mesh-list
83979271|NCT01089361|Analgesics|analgesics|mesh-ancestor
83979272|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
83979273|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979274|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979275|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83979276|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83979277|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
83979278|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
83979279|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979280|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83979281|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83979282|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979283|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979284|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83979285|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83979286|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83979287|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83979288|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979289|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979290|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
83979291|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979292|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83979293|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83979294|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83979295|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83979296|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
83979297|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
83979298|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83979299|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979300|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
83979301|NCT01087489|Lidocaine|lidocaine|mesh-list
83979302|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
83979303|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
83979304|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979305|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979306|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
83979307|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979308|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83218638|NCT02335151|Desflurane|desflurane|mesh-list
83979309|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83979310|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83979311|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83979312|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979313|NCT04306627|Amlodipine|amlodipine|mesh-list
83979314|NCT04306627|Perindopril|perindopril|mesh-list
83979315|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83979316|NCT04306627|Atorvastatin|atorvastatin|mesh-list
83979317|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83979318|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83979319|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
83979320|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979321|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83979322|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83979323|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979324|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83979325|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83979326|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83979327|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83979328|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979329|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
83979330|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83979331|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
83979332|NCT04306471|Evolocumab|evolocumab|mesh-list
83979333|NCT04306471|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83979334|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83979335|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83979336|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
83979337|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979338|NCT04306471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83979339|NCT04306471|Protease Inhibitors|protease inhibitors|mesh-ancestor
83979340|NCT04306471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979341|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83979342|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83979343|NCT04296253|Mitogens|mitogens|mesh-list
83979344|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
83979345|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979346|NCT01082965|Donepezil|donepezil|mesh-list
83979347|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83979348|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979349|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979350|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
83979351|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979352|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979353|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
83979354|NCT01102426|Dexamethasone|dexamethasone|mesh-list
83979355|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979356|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
83979357|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
83979358|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979359|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979360|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979361|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
83979362|NCT01102426|Hormones|hormones|mesh-ancestor
83979363|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979364|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83979365|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979366|NCT04308850|Vitamin D|vitamin d|mesh-list
83979367|NCT04308850|Vitamins|vitamins|mesh-ancestor
83979368|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
83979369|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979370|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83979371|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83979372|NCT01101334|Efatutazone|efatutazone|mesh-list
83979373|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979374|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83979375|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979376|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979377|NCT01327547|Maraviroc|maraviroc|mesh-list
83979378|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83979379|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83979380|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979381|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83979382|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83979383|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
83979384|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979385|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83979386|NCT01308567|Prednisone|prednisone|mesh-list
83979387|NCT01308567|Docetaxel|docetaxel|mesh-list
83979388|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979389|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83979390|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83979391|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83979392|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979393|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979394|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
83979395|NCT01308567|Hormones|hormones|mesh-ancestor
83979396|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979397|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979398|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83979399|NCT00592241|Insulin|insulin|mesh-list
83979400|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83979401|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979402|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979403|NCT02890719|Ribavirin|ribavirin|mesh-list
83979404|NCT02890719|Grazoprevir|grazoprevir|mesh-list
83979405|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
83979406|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979407|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
83979408|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979409|NCT04325061|Dexamethasone|dexamethasone|mesh-list
83979410|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
83979411|NCT04325061|BB 1101|bb 1101|mesh-list
83979412|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979413|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
83979414|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
83979415|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979416|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979417|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979418|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
83979419|NCT04325061|Hormones|hormones|mesh-ancestor
83979420|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979421|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83979422|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979423|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
83979424|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979425|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979426|NCT01307319|Beclomethasone|beclomethasone|mesh-list
83979427|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979428|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
83979429|NCT01307319|Hormones|hormones|mesh-ancestor
83979430|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979431|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979432|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83979433|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
83979434|NCT04365725|Remdesivir|remdesivir|mesh-list
83979435|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
83979436|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979437|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
83979438|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979439|NCT01080391|Dexamethasone|dexamethasone|mesh-list
83979440|NCT01080391|Lenalidomide|lenalidomide|mesh-list
83979441|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979442|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
83979443|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
83979444|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979445|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979446|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979447|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
83979448|NCT01080391|Hormones|hormones|mesh-ancestor
83979449|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979450|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83979451|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979452|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
83979453|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83979454|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83979455|NCT01080391|Growth Substances|growth substances|mesh-ancestor
83979456|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
83979457|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83979458|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83979459|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83979460|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83979461|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979462|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979463|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979464|NCT01070329|Analgesics|analgesics|mesh-ancestor
83979465|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
83979466|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979467|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
83979468|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83979469|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
83979470|NCT04327427|Aspirin|aspirin|mesh-list
83979471|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83979472|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83979473|NCT04327427|Analgesics|analgesics|mesh-ancestor
83979474|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
83979475|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979476|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979477|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979478|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979479|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83979480|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83979481|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979482|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83979483|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83979484|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979485|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
83979486|NCT02875717|Aspirin|aspirin|mesh-list
83979487|NCT02875717|Heparin|heparin|mesh-list
83979488|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83979489|NCT02875717|Tinzaparin|tinzaparin|mesh-list
83979490|NCT02875717|Dalteparin|dalteparin|mesh-list
83979491|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
83979492|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83979493|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83979494|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979495|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83979496|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83979497|NCT02875717|Analgesics|analgesics|mesh-ancestor
83979498|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
83979499|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979500|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979501|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979502|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979503|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83979504|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83979505|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979506|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
83979507|NCT04334837|Copper|copper|mesh-list
83979508|NCT04334837|Trace Elements|trace elements|mesh-ancestor
83979509|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
83979510|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979511|NCT00593099|Bupropion|bupropion|mesh-list
83979512|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83979513|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
83979514|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83979515|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83979516|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83979517|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83979518|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979519|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
83979520|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979521|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979522|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83979523|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83979524|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979525|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
83979526|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83979527|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979528|NCT00593255|Insulin|insulin|mesh-list
83979529|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83979530|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
83979531|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
83979532|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
83979533|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
83979534|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979535|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979536|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
83979537|NCT00593801|Hematinics|hematinics|mesh-ancestor
83979538|NCT00593879|Mecamylamine|mecamylamine|mesh-list
83979539|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83979540|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83979541|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
83979542|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979543|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979544|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83979545|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83979546|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
83979547|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979548|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979549|NCT00594191|Simvastatin|simvastatin|mesh-list
83979550|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83979551|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83979552|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
83979553|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979554|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83979555|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83979556|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979557|NCT00594269|Risperidone|risperidone|mesh-list
83979558|NCT00594269|Citalopram|citalopram|mesh-list
83979559|NCT00594269|Sertraline|sertraline|mesh-list
83979560|NCT00594269|Paroxetine|paroxetine|mesh-list
83979561|NCT00594269|Escitalopram|escitalopram|mesh-list
83979562|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83979563|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
83979564|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979565|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979566|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979567|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83979568|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83979569|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979570|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83979571|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83979572|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
83979573|NCT00594269|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83979574|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83979575|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83979576|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83979577|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
83979578|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83979579|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83979580|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979581|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83979582|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
83979583|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979584|NCT04326959|Triamcinolone|triamcinolone|mesh-list
83979585|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83979586|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83979587|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83979588|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979589|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
83979590|NCT04326959|Hormones|hormones|mesh-ancestor
83979591|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979592|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979593|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83979594|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
83979595|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979596|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979597|NCT00594737|Memantine|memantine|mesh-list
83979598|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83979599|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83979600|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
83979601|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979602|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979603|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979604|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83979605|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83979606|NCT00595049|Bosentan|bosentan|mesh-list
83979607|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83979608|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83979609|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979610|NCT00595985|Sorafenib|sorafenib|mesh-list
83979611|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979612|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83979613|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979614|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979615|NCT00596063|Insulin|insulin|mesh-list
83979616|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979617|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979618|NCT00596219|Celecoxib|celecoxib|mesh-list
83979619|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83979620|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83979621|NCT00596219|Analgesics|analgesics|mesh-ancestor
83979622|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
83979623|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979624|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979625|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979626|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979627|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83979628|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83979629|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979630|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979631|NCT00596297|Bevacizumab|bevacizumab|mesh-list
83979632|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83979633|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979634|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83979635|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83979636|NCT00596297|Growth Substances|growth substances|mesh-ancestor
83979637|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979638|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
83979639|NCT00596375|Lidocaine|lidocaine|mesh-list
83979640|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
83979641|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
83979642|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979643|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979644|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
83979645|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979646|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83979647|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83979648|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83979649|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83979650|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979651|NCT00596531|Acamprosate|acamprosate|mesh-list
83979652|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83979653|NCT00596609|Morphine|morphine|mesh-list
83979654|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83979655|NCT00596609|Narcotics|narcotics|mesh-ancestor
83979656|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83979657|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979658|NCT00596609|Analgesics|analgesics|mesh-ancestor
83979659|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
83979660|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979661|NCT04326803|Vaccines|vaccines|mesh-list
83979662|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
83979663|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979664|NCT00597233|Insulin|insulin|mesh-list
83979665|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83979666|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
83979667|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
83979668|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
83979669|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
83979670|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979671|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979672|NCT01064401|Interferons|interferons|mesh-list
83979673|NCT01064401|Interferon-beta|interferon-beta|mesh-list
83979674|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
83979675|NCT01064401|Daclizumab|daclizumab|mesh-list
83979676|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979677|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
83979678|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979679|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
83979680|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979681|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83979682|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83979683|NCT00597389|Propranolol|propranolol|mesh-list
83979684|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83979685|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83979686|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
83979687|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979688|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979689|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979690|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83979691|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83979692|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
83979693|NCT01306617|Ritonavir|ritonavir|mesh-list
83979694|NCT01306617|Ribavirin|ribavirin|mesh-list
83979695|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83979696|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83979697|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
83979698|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979699|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979700|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83979701|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83979702|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
83979703|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979704|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83979705|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83979706|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
83979707|NCT00597623|Adalimumab|adalimumab|mesh-list
83979708|NCT00597623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83979709|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979710|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979711|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
83979712|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979713|NCT00627133|Levetiracetam|levetiracetam|mesh-list
83979714|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
83979715|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
83979716|NCT00598013|Pioglitazone|pioglitazone|mesh-list
83979717|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979718|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979719|NCT04303429|Capecitabine|capecitabine|mesh-list
83979720|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83979721|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
83979722|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979723|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979724|NCT00598091|Gemcitabine|gemcitabine|mesh-list
83979725|NCT00598091|Dasatinib|dasatinib|mesh-list
83979726|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83979727|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
83979728|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979729|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979730|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83979731|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979732|NCT00623415|Flupirtine|flupirtine|mesh-list
83979733|NCT00623415|Analgesics|analgesics|mesh-ancestor
83979734|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
83979735|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979736|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979737|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
83979738|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
83979739|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83979740|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83979741|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979742|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979743|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979744|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979745|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
83979746|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979747|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
83979748|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83979749|NCT00598169|Dexamethasone|dexamethasone|mesh-list
83979750|NCT00598169|Rituximab|rituximab|mesh-list
83979751|NCT00598169|Carboplatin|carboplatin|mesh-list
83979752|NCT00598169|Etoposide|etoposide|mesh-list
83979753|NCT00598169|Bortezomib|bortezomib|mesh-list
83979754|NCT00598169|Ifosfamide|ifosfamide|mesh-list
83979755|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83979756|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979757|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
83979758|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979759|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979760|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83979761|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
83979762|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
83979763|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979764|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979765|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
83979766|NCT00598169|Hormones|hormones|mesh-ancestor
83979767|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979768|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83979769|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83979770|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83979771|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83979772|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979773|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979774|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83979775|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
83979776|NCT00598247|Paclitaxel|paclitaxel|mesh-list
83979777|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83979778|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83979779|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979780|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
83979781|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
83979782|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
83979783|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979784|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
83979785|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
83979786|NCT00598403|Cefditoren|cefditoren|mesh-list
83979787|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83979788|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979789|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83979790|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83979791|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979792|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979793|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979794|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83979795|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83979796|NCT00598637|Everolimus|everolimus|mesh-list
83979797|NCT00598637|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83979798|NCT00598637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83979799|NCT00598637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979800|NCT00598637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979801|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83979802|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
83979803|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979804|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979805|NCT00598715|Sirolimus|sirolimus|mesh-list
83979806|NCT00598715|Paclitaxel|paclitaxel|mesh-list
83979807|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83979808|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979809|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
83979810|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
83979811|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
83979812|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979813|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83979814|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979815|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83979816|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
83979817|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83979818|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
83979819|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979820|NCT00598793|Insulin|insulin|mesh-list
83979821|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83979822|NCT00598793|Metformin|metformin|mesh-list
83979823|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
83979824|NCT00598793|Pioglitazone|pioglitazone|mesh-list
83979825|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
83979826|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
83979827|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979828|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979829|NCT01326845|Deferasirox|deferasirox|mesh-list
83979830|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83979831|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
83979832|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
83979833|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979834|NCT01062763|Spironolactone|spironolactone|mesh-list
83979835|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83979836|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
83979837|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83979838|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979839|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83979840|NCT01062763|Diuretics|diuretics|mesh-ancestor
83979841|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
83979842|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
83979843|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83979844|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
83979845|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979846|NCT00599573|Ondansetron|ondansetron|mesh-list
83979847|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
83979848|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
83979849|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979850|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979851|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979852|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
83979853|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
83979854|NCT00599573|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83979855|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83979856|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
83979857|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979858|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979859|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83979860|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
83979861|NCT01048099|Trastuzumab|trastuzumab|mesh-list
83979863|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83979864|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979865|NCT00599807|Vitamin D|vitamin d|mesh-list
83979866|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
83979867|NCT00599807|Vitamins|vitamins|mesh-ancestor
83979868|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
83979869|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979870|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83979871|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83979872|NCT00599885|Valsartan|valsartan|mesh-list
83979873|NCT00599885|Telmisartan|telmisartan|mesh-list
83979874|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83979875|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83979876|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83979877|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979878|NCT01303965|Sirolimus|sirolimus|mesh-list
83979879|NCT01303965|Lenalidomide|lenalidomide|mesh-list
83979880|NCT01303965|Tacrolimus|tacrolimus|mesh-list
83979881|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83979882|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
83979883|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979884|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83979885|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979886|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979887|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83979888|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83979889|NCT01303965|Growth Substances|growth substances|mesh-ancestor
83979890|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
83979891|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979892|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83979893|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979894|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83979895|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
83979896|NCT00600041|Pantoprazole|pantoprazole|mesh-list
83979897|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83979898|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83979899|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83979900|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979901|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979902|NCT01045993|Analgesics|analgesics|mesh-list
83979903|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
83979904|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979905|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979906|NCT00600509|Levetiracetam|levetiracetam|mesh-list
83979907|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
83979908|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
83979909|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
83979910|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
83979911|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83979912|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83979913|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83979914|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979915|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979916|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83979917|NCT00600587|Carboplatin|carboplatin|mesh-list
83979918|NCT00600587|Gemcitabine|gemcitabine|mesh-list
83979919|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83979920|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979921|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83979922|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
83979923|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979924|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83979925|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979927|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83979928|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
83979929|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
83979930|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83979931|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979932|NCT00623207|Atropine|atropine|mesh-list
83979933|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83979934|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83979935|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83979936|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
83979937|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979938|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979939|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83979940|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
83979941|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
83979942|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
83979943|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83979944|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83979945|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
83979946|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979947|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979948|NCT00600977|Doxorubicin|doxorubicin|mesh-list
83979949|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83979950|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83979951|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979952|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83979953|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83979954|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979955|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979956|NCT04695847|Antibodies|antibodies|mesh-list
83979957|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
83979958|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83979959|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
83979960|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
83979961|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979962|NCT00601211|Pilocarpine|pilocarpine|mesh-list
83979963|NCT00601211|Miotics|miotics|mesh-ancestor
83979964|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
83979965|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979966|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979967|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83979968|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83979969|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
83979970|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83979971|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979972|NCT00601289|Temozolomide|temozolomide|mesh-list
83979973|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83979974|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
83979975|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979976|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979977|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83979978|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979979|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83979980|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979981|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979982|NCT00601991|Aflibercept|aflibercept|mesh-list
83979983|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
83979984|NCT00601991|Growth Substances|growth substances|mesh-ancestor
83979985|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83979986|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83979987|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83979988|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
83979989|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83979990|NCT01301391|Maleic acid|maleic acid|mesh-list
83979991|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83979992|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83979993|NCT04325633|Naproxen|naproxen|mesh-list
83979994|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83979995|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83979996|NCT04325633|Analgesics|analgesics|mesh-ancestor
83979997|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
83979998|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83979999|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980000|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980001|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980002|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
83980003|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83980004|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980005|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980006|NCT05643651|Aspirin|aspirin|mesh-list
83980007|NCT05643651|Vitamin K|vitamin k|mesh-list
83980008|NCT05643651|Warfarin|warfarin|mesh-list
83980009|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
83980010|NCT05643651|Clopidogrel|clopidogrel|mesh-list
83980011|NCT05643651|Vitamins|vitamins|mesh-ancestor
83980012|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
83980013|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980014|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83980015|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83980016|NCT05643651|Analgesics|analgesics|mesh-ancestor
83980017|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
83980018|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980019|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980020|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980021|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83980022|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83980023|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980024|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83980025|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83980026|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980027|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
83980028|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83980029|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83980030|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83980031|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
83980032|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980033|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
83980034|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83980035|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
83980036|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83980037|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
83980038|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83980039|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
83980040|NCT05643651|Coagulants|coagulants|mesh-ancestor
83980041|NCT01061359|Epirubicin|epirubicin|mesh-list
83980042|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83980043|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980044|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83980045|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83980046|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980047|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980048|NCT05643417|Bevacizumab|bevacizumab|mesh-list
83980049|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83980050|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980051|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83980052|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83980053|NCT05643417|Growth Substances|growth substances|mesh-ancestor
83980054|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980055|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
83980056|NCT04303741|Apatinib|apatinib|mesh-list
83980057|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980058|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83980059|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980060|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980061|NCT00626977|Clonidine|clonidine|mesh-list
83980062|NCT00626977|Ropivacaine|ropivacaine|mesh-list
83980063|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
83980064|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
83980065|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980066|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980067|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
83980068|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980070|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83980071|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
83980072|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
83980073|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83980074|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83980075|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83980076|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
83980077|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980078|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980079|NCT04303819|Exenatide|exenatide|mesh-list
83980080|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83980081|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980082|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83980083|NCT04303819|Incretins|incretins|mesh-ancestor
83980084|NCT04303819|Hormones|hormones|mesh-ancestor
83980085|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980086|NCT01301079|Ketamine|ketamine|mesh-list
83980087|NCT01301079|Analgesics|analgesics|mesh-ancestor
83980088|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
83980089|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980090|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980091|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83980092|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83980093|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
83980094|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
83980095|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980096|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83980097|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83980098|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980099|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980100|NCT05271721|Dexamethasone|dexamethasone|mesh-list
83980101|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
83980102|NCT05271721|BB 1101|bb 1101|mesh-list
83980103|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980104|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
83980105|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
83980106|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980107|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980108|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83980109|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
83980110|NCT05271721|Hormones|hormones|mesh-ancestor
83980111|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980112|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83980113|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980114|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
83980115|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980116|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980117|NCT01301001|Gabapentin|gabapentin|mesh-list
83980118|NCT01301001|Analgesics|analgesics|mesh-ancestor
83980119|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
83980120|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980121|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980122|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
83980123|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83980124|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83980125|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980126|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83980127|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83980128|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83980129|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980130|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980131|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
83980132|NCT01035463|Cytarabine|cytarabine|mesh-list
83980133|NCT01035463|Rituximab|rituximab|mesh-list
83980134|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83980135|NCT01035463|Etoposide|etoposide|mesh-list
83980136|NCT01035463|Lenalidomide|lenalidomide|mesh-list
83219454|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83980137|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
83980138|NCT01035463|Melphalan|melphalan|mesh-list
83980139|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
83980140|NCT01035463|Carmustine|carmustine|mesh-list
83980141|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
83980142|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83980143|NCT01035463|Antibodies|antibodies|mesh-list
83980144|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
83980145|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83980146|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
83980147|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980148|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980149|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980150|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83980151|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83980152|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83980153|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980154|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980155|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83980156|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
83980157|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
83980158|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980159|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980160|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83980161|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83980162|NCT01035463|Growth Substances|growth substances|mesh-ancestor
83980163|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
83980164|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83980165|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
83980166|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83980167|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
83980168|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
83980169|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
83980170|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
83980171|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
83980172|NCT01300923|Acamprosate|acamprosate|mesh-list
83980173|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83980174|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
83980175|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
83980176|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980177|NCT02890173|Eplerenone|eplerenone|mesh-list
83980178|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83980179|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
83980180|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980181|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980182|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83980183|NCT02890173|Diuretics|diuretics|mesh-ancestor
83980184|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
83980185|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83980186|NCT01300455|Suvorexant|suvorexant|mesh-list
83980187|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83980188|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83980189|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980190|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980191|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83980192|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980193|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980194|NCT01101178|Oxycodone|oxycodone|mesh-list
83980195|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83980196|NCT01101178|Narcotics|narcotics|mesh-ancestor
83980197|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980198|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980199|NCT01101178|Analgesics|analgesics|mesh-ancestor
83980200|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
83980201|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980202|NCT05637645|Bupivacaine|bupivacaine|mesh-list
83980203|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
83980204|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
83980205|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980206|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980207|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
83980208|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980209|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83980210|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83980211|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980212|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83980213|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83980214|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980215|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980216|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
83980217|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980218|NCT02879110|Sulforaphane|sulforaphane|mesh-list
83980219|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83980220|NCT02879110|Protective Agents|protective agents|mesh-ancestor
83980221|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980222|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980223|NCT04207515|Anesthetics|anesthetics|mesh-list
83980224|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980225|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980226|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
83980227|NCT01100944|Doxorubicin|doxorubicin|mesh-list
83980228|NCT01100944|Belinostat|belinostat|mesh-list
83980229|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980230|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
83980231|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980232|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980233|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83980234|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
83980235|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980236|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980237|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83980238|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83980239|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83980240|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83980241|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980242|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83980243|NCT01100320|Oxycodone|oxycodone|mesh-list
83980244|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83980245|NCT01100320|Narcotics|narcotics|mesh-ancestor
83980246|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980247|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980248|NCT01100320|Analgesics|analgesics|mesh-ancestor
83980249|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
83980250|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980251|NCT04309708|Nimodipine|nimodipine|mesh-list
83980252|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83980253|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83980254|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980255|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980256|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83980257|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980258|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
83980259|NCT01100086|Oxycodone|oxycodone|mesh-list
83980260|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83980261|NCT01100086|Narcotics|narcotics|mesh-ancestor
83980262|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980263|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980264|NCT01100086|Analgesics|analgesics|mesh-ancestor
83980265|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
83980266|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980267|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83980268|NCT00626080|Insulin|insulin|mesh-list
83980269|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83980270|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
83980271|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
83980272|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
83980273|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
83980274|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83980275|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980276|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
83980277|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83980278|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
83980279|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83980280|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83980281|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980282|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980283|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
83980284|NCT01035229|Everolimus|everolimus|mesh-list
83219604|NCT04438811|Anesthetics|anesthetics|mesh-list
83980285|NCT01035229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83980286|NCT01035229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83980287|NCT01035229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980288|NCT01035229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980289|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980290|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
83980291|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980292|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980293|NCT01059799|Insulin|insulin|mesh-list
83980294|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83980295|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
83980296|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83980297|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980298|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83980299|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980300|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
83980301|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83980302|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83980303|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83980304|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980305|NCT01106092|Vaccines|vaccines|mesh-list
83980306|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
83980307|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980308|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
83980309|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83980310|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980311|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980312|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83980313|NCT04307290|Analgesics|analgesics|mesh-ancestor
83980314|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
83980315|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980316|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83980317|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83980318|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83980319|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
83980320|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980321|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980322|NCT01325207|Trastuzumab|trastuzumab|mesh-list
83980323|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83980324|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980325|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83980326|NCT01324349|Hemostatics|hemostatics|mesh-list
83980327|NCT01324349|Coagulants|coagulants|mesh-ancestor
83980328|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83980329|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
83980330|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980331|NCT01095094|Ritonavir|ritonavir|mesh-list
83980332|NCT01095094|Lopinavir|lopinavir|mesh-list
83980333|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83980334|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83980335|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83980336|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980337|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980338|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83980339|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83980340|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
83980341|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980342|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83980343|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83980344|NCT00623285|Pregabalin|pregabalin|mesh-list
83980345|NCT00623285|Analgesics|analgesics|mesh-ancestor
83980346|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
83980347|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980348|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980349|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
83980350|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83980351|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980352|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980353|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83980354|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83980355|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83980356|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980357|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83980358|NCT01097044|Afamelanotide|afamelanotide|mesh-list
83980359|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
83980360|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
83980361|NCT01322009|Probenecid|probenecid|mesh-list
83980362|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83980363|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
83980364|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980365|NCT01322009|Expectorants|expectorants|mesh-ancestor
83980366|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
83980367|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83980368|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
83980369|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980370|NCT01322009|Protective Agents|protective agents|mesh-ancestor
83980371|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980372|NCT01322009|Antidotes|antidotes|mesh-ancestor
83980373|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
83980374|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
83980375|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980376|NCT01320683|Leucovorin|leucovorin|mesh-list
83980377|NCT01320683|Bevacizumab|bevacizumab|mesh-list
83980378|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83980379|NCT01320683|Fluorouracil|fluorouracil|mesh-list
83980380|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
83980381|NCT01320683|Irinotecan|irinotecan|mesh-list
83980382|NCT01320683|Antibodies|antibodies|mesh-list
83980383|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
83980384|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83980385|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
83980386|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980387|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83980388|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83980389|NCT01320683|Growth Substances|growth substances|mesh-ancestor
83980390|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980391|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
83980392|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
83980393|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
83980394|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980395|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83980396|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980397|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83980398|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83980399|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980400|NCT01320683|Antidotes|antidotes|mesh-ancestor
83980401|NCT01320683|Protective Agents|protective agents|mesh-ancestor
83980402|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
83980403|NCT01320683|Vitamins|vitamins|mesh-ancestor
83980404|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
83980405|NCT01320293|Adalimumab|adalimumab|mesh-list
83980406|NCT01320293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83980407|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980408|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980409|NCT01318811|Heparin|heparin|mesh-list
83980410|NCT01318811|Calcium heparin|calcium heparin|mesh-list
83980411|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
83980412|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83980413|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83980414|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980415|NCT05644769|Lisinopril|lisinopril|mesh-list
83980416|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83980417|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
83980418|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980419|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980420|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83980421|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83980422|NCT05644769|Protective Agents|protective agents|mesh-ancestor
83980423|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980424|NCT05644691|Emollients|emollients|mesh-list
83980425|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83980426|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83980427|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
83980428|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980429|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
83980430|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83980431|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83980432|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
83980433|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980434|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980435|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980436|NCT01093534|Urological Agents|urological agents|mesh-ancestor
83980437|NCT01314911|Oseltamivir|oseltamivir|mesh-list
83980438|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
83980439|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980440|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980441|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980442|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83980444|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980445|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83980446|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980447|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980448|NCT02878018|Hormones|hormones|mesh-list
83980449|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
83980450|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83980451|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83980452|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980453|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980454|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980455|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980456|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
83980457|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
83980458|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980459|NCT01313663|Pemetrexed|pemetrexed|mesh-list
83980460|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980461|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980462|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980463|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83980464|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83980465|NCT01092832|Voriconazole|voriconazole|mesh-list
83980466|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
83980467|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980468|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83980469|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83980470|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980471|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980472|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83980473|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
83980474|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980475|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980476|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83980477|NCT02878564|Praziquantel|praziquantel|mesh-list
83980478|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
83980479|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83980480|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980481|NCT04308070|Hemostatics|hemostatics|mesh-list
83980482|NCT04308070|Coagulants|coagulants|mesh-ancestor
83980483|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
83980484|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
83980485|NCT01313273|Lanreotide|lanreotide|mesh-list
83980486|NCT01313273|Androgens|androgens|mesh-list
83980487|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83980488|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83980489|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
83980490|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
83980491|NCT01313273|Hormones|hormones|mesh-ancestor
83980492|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980493|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980494|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
83980495|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980496|NCT01313273|Protective Agents|protective agents|mesh-ancestor
83980497|NCT01313273|Vitamins|vitamins|mesh-ancestor
83980498|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
83980499|NCT01313273|Estrogens|estrogens|mesh-ancestor
83980500|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83980501|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980502|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
83980503|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
83980504|NCT01091974|Modafinil|modafinil|mesh-list
83980505|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83980506|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980507|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83980508|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83980509|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83980510|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980511|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
83980512|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
83980513|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980514|NCT01313117|Protective Agents|protective agents|mesh-ancestor
83980515|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980516|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
83980517|NCT01313117|Vitamins|vitamins|mesh-ancestor
83980518|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
83980519|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83980520|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
83980521|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83980522|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83980523|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980524|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980525|NCT01312961|Fluticasone|fluticasone|mesh-list
83980526|NCT01312961|Xhance|xhance|mesh-list
83980527|NCT01312961|Albuterol|albuterol|mesh-list
83980528|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83980529|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83980530|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83980531|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980532|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83980533|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
83980534|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980535|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980536|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83980537|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
83980538|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83980539|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83980540|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83980541|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83980542|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83980543|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83980544|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980545|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980546|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
83980547|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83980548|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
83980549|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
83980550|NCT01312961|Hormones|hormones|mesh-ancestor
83980551|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980552|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
83980553|NCT00626158|Gemcitabine|gemcitabine|mesh-list
83980554|NCT00626158|Capecitabine|capecitabine|mesh-list
83980555|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83980556|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
83980557|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980558|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980559|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83980560|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83980561|NCT01310777|Brinzolamide|brinzolamide|mesh-list
83980562|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83980563|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83980564|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83980565|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83980566|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83980567|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
83980568|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980569|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980570|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980571|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83980572|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980573|NCT01309997|Rituximab|rituximab|mesh-list
83980574|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
83980575|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83980576|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980577|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
83980578|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980579|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980580|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83980581|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980582|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980583|NCT01309841|Naloxegol|naloxegol|mesh-list
83980584|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83980585|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980586|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
83980587|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980588|NCT01308749|Oxytocin|oxytocin|mesh-list
83980589|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
83980590|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83980591|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980593|NCT01307891|Paclitaxel|paclitaxel|mesh-list
83980594|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980595|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83980596|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
83980597|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
83980598|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
83980599|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980600|NCT05644301|Minocycline|minocycline|mesh-list
83980601|NCT05644301|Celecoxib|celecoxib|mesh-list
83980602|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83980603|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83980604|NCT05644301|Analgesics|analgesics|mesh-ancestor
83980605|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
83980606|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980607|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980608|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980609|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980610|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83980611|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83980612|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980613|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980614|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83980615|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980616|NCT02890745|Empagliflozin|empagliflozin|mesh-list
83980617|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83980618|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980619|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83980620|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980621|NCT01307579|Fluconazole|fluconazole|mesh-list
83980622|NCT01307579|Caspofungin|caspofungin|mesh-list
83980623|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
83980624|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980625|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83980626|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83980627|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980628|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980629|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83980630|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
83980631|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980632|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980633|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83980634|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83980635|NCT01057693|Pregabalin|pregabalin|mesh-list
83980636|NCT01057693|Analgesics|analgesics|mesh-ancestor
83980637|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
83980638|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980639|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980640|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
83980641|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83980642|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980643|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980644|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83980645|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83980646|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83980647|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980648|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83980649|NCT04325009|Atorvastatin|atorvastatin|mesh-list
83980650|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83980651|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83980652|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
83980653|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980654|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83980655|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83980656|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980657|NCT01034137|Methotrexate|methotrexate|mesh-list
83980658|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83980659|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
83980660|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83980661|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980662|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83980663|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
83980664|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980665|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980666|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
83980667|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980668|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83980669|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980670|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
83980671|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980672|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83980673|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
83980674|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83980675|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
83980676|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980677|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980678|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83980679|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83980680|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83980681|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980682|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980683|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980684|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980685|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
83980686|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83980687|NCT02875093|Cytarabine|cytarabine|mesh-list
83980688|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83980689|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
83980690|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980691|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980692|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
83980693|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980694|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980695|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
83980696|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980697|NCT01033825|Ciclesonide|ciclesonide|mesh-list
83980698|NCT01033825|Dexamethasone|dexamethasone|mesh-list
83980699|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
83980700|NCT01033825|BB 1101|bb 1101|mesh-list
83980701|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980702|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
83980703|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
83980704|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980705|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980706|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83980707|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
83980708|NCT01033825|Hormones|hormones|mesh-ancestor
83980709|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980710|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83980711|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980712|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
83980713|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980714|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980715|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83980716|NCT01033747|Deferasirox|deferasirox|mesh-list
83980717|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83980718|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
83980719|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
83980720|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980721|NCT02875015|Lidocaine|lidocaine|mesh-list
83980722|NCT02875015|Bupivacaine|bupivacaine|mesh-list
83980723|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
83980724|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
83980725|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980726|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980727|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
83980728|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980729|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83980730|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83980731|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83980732|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980733|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980734|NCT01091428|Paclitaxel|paclitaxel|mesh-list
83220043|NCT03106597|Amlodipine|amlodipine|mesh-list
83980735|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83980736|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980737|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83980738|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83980739|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83980740|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980741|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
83980742|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83980743|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980744|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980745|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83980746|NCT01096186|Carbidopa|carbidopa|mesh-list
83980747|NCT01096186|Levodopa|levodopa|mesh-list
83980748|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83980749|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
83980750|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980751|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83980752|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83980753|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
83980754|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
83980755|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980756|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980757|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83980758|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980759|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
83980760|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83980761|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83980762|NCT01049503|Fluorides|fluorides|mesh-list
83980763|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
83980764|NCT01049503|Protective Agents|protective agents|mesh-ancestor
83980765|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980766|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
83980767|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83980768|NCT04301557|Capecitabine|capecitabine|mesh-list
83980769|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
83980770|NCT04301557|Antibodies|antibodies|mesh-list
83980771|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
83980772|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980773|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83980774|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
83980775|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980776|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980777|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83980778|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980779|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
83980780|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83980781|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
83980782|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980783|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
83980784|NCT01029535|Protective Agents|protective agents|mesh-ancestor
83980785|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83980786|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83980787|NCT01028053|Flutemetamol|flutemetamol|mesh-list
83980788|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83980789|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980790|NCT01023217|Lamivudine|lamivudine|mesh-list
83980791|NCT01023217|Adefovir|adefovir|mesh-list
83980792|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83980793|NCT01023217|Entecavir|entecavir|mesh-list
83980794|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83980795|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83980796|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980797|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980798|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
83980799|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980800|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83980801|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83980802|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83980803|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83980804|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83980805|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83980806|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124715|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83980807|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980809|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980810|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83980811|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83980812|NCT01023061|Prednisone|prednisone|mesh-list
83980813|NCT01023061|Leuprolide|leuprolide|mesh-list
83980814|NCT01023061|Goserelin|goserelin|mesh-list
83980815|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
83980816|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980817|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
83980818|NCT01023061|Hormones|hormones|mesh-ancestor
83980819|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980820|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980821|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83980822|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980823|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83980824|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
83980825|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83980826|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83980827|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980828|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980829|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
83980830|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83980831|NCT01027897|Doripenem|doripenem|mesh-list
83980832|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83980833|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980834|NCT01027351|Vaccines|vaccines|mesh-list
83980835|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
83980836|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980837|NCT05661045|Anesthetics|anesthetics|mesh-list
83980838|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980839|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980840|NCT01294683|Niacin|niacin|mesh-list
83980841|NCT01294683|Niacinamide|niacinamide|mesh-list
83980842|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
83980843|NCT01294683|Simvastatin|simvastatin|mesh-list
83980844|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83980845|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83980846|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
83980847|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980848|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83980849|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83980850|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980851|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
83980852|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
83980853|NCT01294683|Vitamins|vitamins|mesh-ancestor
83980854|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
83980855|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980856|NCT01294449|Cytarabine|cytarabine|mesh-list
83980857|NCT01294449|Dexamethasone|dexamethasone|mesh-list
83980858|NCT01294449|Methotrexate|methotrexate|mesh-list
83980859|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83980860|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
83980861|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980862|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980863|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
83980864|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980865|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83980866|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
83980867|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980868|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980869|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
83980870|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
83980871|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980872|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83980873|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
83980874|NCT01294449|Hormones|hormones|mesh-ancestor
83980875|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980876|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83980877|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83980878|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
83980879|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83980880|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
83980881|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980882|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83980883|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83980884|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83980886|NCT01293123|Emtricitabine|emtricitabine|mesh-list
83980887|NCT01293123|Efavirenz|efavirenz|mesh-list
83980888|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
83980889|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
83980890|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980891|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83980892|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83980893|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980894|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980895|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83980896|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83980897|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83980898|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83980899|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83980900|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83980901|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83980902|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83980903|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83980904|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83980905|NCT01292187|Calcitonin|calcitonin|mesh-list
83980906|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
83980907|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83980908|NCT01292187|Katacalcin|katacalcin|mesh-list
83980909|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83980910|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980911|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83980912|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
83980913|NCT01026493|Temozolomide|temozolomide|mesh-list
83980914|NCT01026493|Veliparib|veliparib|mesh-list
83980915|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83980916|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
83980917|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980918|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980919|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83980920|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980921|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83980922|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83980923|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980924|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83980925|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83980926|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980927|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980928|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
83980929|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980930|NCT01291017|Palbociclib|palbociclib|mesh-list
83980931|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980932|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83980933|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83980934|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980935|NCT01290315|Dextrans|dextrans|mesh-list
83980936|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83980937|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
83980938|NCT01290315|Hematinics|hematinics|mesh-ancestor
83980939|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
83980940|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
83980941|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
83980942|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
83980943|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83980944|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83980945|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
83980946|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980947|NCT01021813|Suvorexant|suvorexant|mesh-list
83980948|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83980949|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83980950|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83980951|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980952|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83980953|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980954|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980955|NCT01025635|Azelaic acid|azelaic acid|mesh-list
83980956|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980957|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
83980958|NCT01021423|Lenalidomide|lenalidomide|mesh-list
83980959|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
83980960|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980961|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83980962|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83980963|NCT01021423|Growth Substances|growth substances|mesh-ancestor
83980964|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
83980965|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980966|NCT01020877|Metronidazole|metronidazole|mesh-list
83980967|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83980968|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83980969|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83980970|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83980971|NCT01020799|Escitalopram|escitalopram|mesh-list
83980972|NCT01020799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83980973|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83980974|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83980975|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980976|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83980977|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
83980978|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980979|NCT02872597|Dexamethasone|dexamethasone|mesh-list
83980980|NCT02872597|Prednisone|prednisone|mesh-list
83980981|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
83980982|NCT02872597|Prednisolone|prednisolone|mesh-list
83980983|NCT02872597|Albuterol|albuterol|mesh-list
83980984|NCT02872597|Ipratropium|ipratropium|mesh-list
83980985|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83980986|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
83980987|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
83980988|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83980989|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83980990|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83980991|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
83980992|NCT02872597|Hormones|hormones|mesh-ancestor
83980993|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83980994|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83980995|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83980996|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83980997|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83980998|NCT02872597|Protective Agents|protective agents|mesh-ancestor
83980999|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83981000|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83981001|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981002|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
83981003|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83981004|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83981005|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83981006|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83981007|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
83981008|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981009|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83981010|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981011|NCT02873065|Amoxicillin|amoxicillin|mesh-list
83981012|NCT02873065|Clarithromycin|clarithromycin|mesh-list
83981013|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
83981014|NCT02873065|Bismuth|bismuth|mesh-list
83981015|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981016|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83981017|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981018|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83981019|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981020|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83981021|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83981022|NCT02873065|Antacids|antacids|mesh-ancestor
83981023|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83981024|NCT02873065|Diuretics|diuretics|mesh-ancestor
83981025|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
83981026|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981027|NCT02873065|Expectorants|expectorants|mesh-ancestor
83981028|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981029|NCT00628225|Bupropion|bupropion|mesh-list
83981030|NCT00628225|Nicotine|nicotine|mesh-list
83981031|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83981032|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
83981033|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981034|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981035|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83981036|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83981037|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981038|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981039|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981040|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83981041|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
83981042|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83981043|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83981044|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83981045|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83981046|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
83981047|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83981048|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83981049|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981050|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
83981051|NCT01014013|Ertapenem|ertapenem|mesh-list
83981052|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83981053|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981054|NCT01013701|Fluticasone|fluticasone|mesh-list
83981055|NCT01013701|Xhance|xhance|mesh-list
83981056|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981057|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83981058|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
83981059|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981060|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981061|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83981062|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981063|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83981064|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83981065|NCT01020019|Lofexidine|lofexidine|mesh-list
83981066|NCT01020019|Dronabinol|dronabinol|mesh-list
83981067|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
83981068|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981069|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83981070|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981071|NCT01020019|Analgesics|analgesics|mesh-ancestor
83981072|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
83981073|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981074|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83981075|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83981076|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981077|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981078|NCT01020019|Hormones|hormones|mesh-ancestor
83981079|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981080|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83981081|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83981082|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83981083|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83981084|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83981085|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83981086|NCT00627835|Cisplatin|cisplatin|mesh-list
83981087|NCT00627835|Sorafenib|sorafenib|mesh-list
83981088|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981089|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83981090|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981091|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981092|NCT01019317|Cytarabine|cytarabine|mesh-list
83981093|NCT01019317|Fludarabine|fludarabine|mesh-list
83981094|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
83981095|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981096|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83981097|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
83981098|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981099|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83981100|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
83981101|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981102|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
83981103|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981104|NCT02877238|Sevoflurane|sevoflurane|mesh-list
83981105|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
83981106|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981107|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981108|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83981109|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83981110|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
83981111|NCT01288911|Bicalutamide|bicalutamide|mesh-list
83981112|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
83981113|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
83981114|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981115|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981116|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981117|NCT01288443|Atorvastatin|atorvastatin|mesh-list
83981118|NCT01288443|Alirocumab|alirocumab|mesh-list
83981119|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83981120|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83981121|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83981122|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
83981123|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981124|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83981125|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83981126|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981127|NCT01288443|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83981128|NCT01288443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83981129|NCT01288443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83981130|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
83981131|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981132|NCT01288209|Ribavirin|ribavirin|mesh-list
83981133|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83981134|NCT01288209|Simeprevir|simeprevir|mesh-list
83981135|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
83981136|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981137|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
83981138|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981139|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
83981140|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981141|NCT01287195|Omeprazole|omeprazole|mesh-list
83981142|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
83981143|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83981144|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83981145|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83981146|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981147|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981148|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
83981149|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981150|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83981151|NCT01287117|Omalizumab|omalizumab|mesh-list
83981152|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83981153|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83981154|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981155|NCT01287039|Reslizumab|reslizumab|mesh-list
83981156|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83981157|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981158|NCT05572203|Caseins|caseins|mesh-list
83981159|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
83981160|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
83981161|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981162|NCT01285401|Interferons|interferons|mesh-list
83981163|NCT01285401|Interferon-beta|interferon-beta|mesh-list
83981164|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
83981165|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981166|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
83981167|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981168|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
83981169|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981170|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83981171|NCT01285323|Reslizumab|reslizumab|mesh-list
83981172|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83981173|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981174|NCT01284621|Empagliflozin|empagliflozin|mesh-list
83981175|NCT01284621|Ramipril|ramipril|mesh-list
83981176|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83981177|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
83981178|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981179|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981180|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83981181|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83981182|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83981183|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981184|NCT01283139|Sifalimumab|sifalimumab|mesh-list
83981185|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83981186|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
83981187|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981188|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
83981189|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83981191|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
83981192|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83981193|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
83981194|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981195|NCT01281813|Ritonavir|ritonavir|mesh-list
83981196|NCT01281813|Darunavir|darunavir|mesh-list
83981197|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83981198|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83981199|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
83981200|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981201|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981202|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83981203|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83981204|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
83981205|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981206|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83981207|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83981208|NCT01090414|Idelalisib|idelalisib|mesh-list
83981209|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981210|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981211|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981212|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83981213|NCT01090102|Mesalamine|mesalamine|mesh-list
83981214|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981215|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981216|NCT01090102|Analgesics|analgesics|mesh-ancestor
83981217|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
83981218|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981219|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981220|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981221|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981222|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
83981223|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83981224|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981225|NCT01281189|Pramipexole|pramipexole|mesh-list
83981226|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
83981227|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981228|NCT01281189|Protective Agents|protective agents|mesh-ancestor
83981229|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981230|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83981231|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83981232|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
83981233|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
83981234|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981235|NCT04306666|Anesthetics|anesthetics|mesh-list
83981236|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981237|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981238|NCT01280955|Plerixafor|plerixafor|mesh-list
83981239|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83981240|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83981241|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
83981242|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981243|NCT01280721|Tolvaptan|tolvaptan|mesh-list
83981244|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83981245|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981246|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
83981247|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981248|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
83981249|NCT01087762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83981250|NCT01087762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981251|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83981252|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
83981253|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981254|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981255|NCT04306354|Oxytocin|oxytocin|mesh-list
83981256|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
83981257|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83981258|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981259|NCT04306276|Dienogest|dienogest|mesh-list
83981260|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83981261|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
83981262|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83981263|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981264|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83981265|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83981266|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83981267|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83981268|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
83981269|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981270|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83981271|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981272|NCT01078168|Acitretin|acitretin|mesh-list
83981273|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
83981274|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
83981275|NCT01086358|Naproxen|naproxen|mesh-list
83981276|NCT01086358|Sumatriptan|sumatriptan|mesh-list
83981277|NCT01086358|Naratriptan|naratriptan|mesh-list
83981278|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
83981279|NCT01086358|Rizatriptan|rizatriptan|mesh-list
83981280|NCT01086358|Eletriptan|eletriptan|mesh-list
83981281|NCT01086358|Almotriptan|almotriptan|mesh-list
83981282|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981283|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981284|NCT01086358|Analgesics|analgesics|mesh-ancestor
83981285|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
83981286|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981287|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981288|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981289|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981290|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
83981291|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83981292|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981293|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981294|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83981295|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83981296|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83981297|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
83981298|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981299|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83981300|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
83981301|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981302|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
83981303|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83981304|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
83981305|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981306|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981307|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83981308|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981309|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
83981310|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83981311|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981312|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981313|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981314|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83981315|NCT01081834|Canagliflozin|canagliflozin|mesh-list
83981316|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83981317|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981318|NCT01081834|Incretins|incretins|mesh-ancestor
83981319|NCT01081834|Hormones|hormones|mesh-ancestor
83981320|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981321|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83981322|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
83981323|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981324|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981325|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83981326|NCT01079962|Atenolol|atenolol|mesh-list
83981327|NCT01079962|Bisoprolol|bisoprolol|mesh-list
83981328|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83981329|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83981330|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
83981331|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
83981332|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981333|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981334|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83220645|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
83981335|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83981336|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83981337|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
83981338|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981339|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981340|NCT01274637|Dalteparin|dalteparin|mesh-list
83981341|NCT01274637|Tinzaparin|tinzaparin|mesh-list
83981342|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83981343|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
83981344|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83981345|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83981346|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981347|NCT01079806|Entecavir|entecavir|mesh-list
83981348|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
83981349|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981350|NCT02876770|Melatonin|melatonin|mesh-list
83981351|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
83981352|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981353|NCT02876770|Protective Agents|protective agents|mesh-ancestor
83981354|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981355|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981356|NCT01077622|Ofatumumab|ofatumumab|mesh-list
83981357|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981358|NCT01313676|Fluticasone|fluticasone|mesh-list
83981359|NCT01313676|Xhance|xhance|mesh-list
83981360|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981361|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83981362|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
83981363|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981364|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981365|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83981366|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981367|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
83981368|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83981369|NCT00623376|Dronabinol|dronabinol|mesh-list
83981370|NCT00623376|Nabilone|nabilone|mesh-list
83981371|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
83981372|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
83981373|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981374|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981375|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83981376|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83981377|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83981378|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981379|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83981380|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
83981381|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981382|NCT00623376|Analgesics|analgesics|mesh-ancestor
83981383|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
83981384|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83981385|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83981386|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981387|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981388|NCT00623376|Hormones|hormones|mesh-ancestor
83981389|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981390|NCT01313286|Globalagliatin|globalagliatin|mesh-list
83981391|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
83981392|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981393|NCT01313208|Etanercept|etanercept|mesh-list
83981394|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981395|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981396|NCT01313208|Analgesics|analgesics|mesh-ancestor
83981397|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
83981398|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981399|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981400|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981401|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981402|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83981403|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83981404|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
83981405|NCT01075984|Posaconazole|posaconazole|mesh-list
83981406|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
83981407|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981408|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83981409|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83981410|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83220724|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
83981411|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83981412|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83981413|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981414|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981415|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83981416|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
83981417|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981418|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981419|NCT01024231|Nivolumab|nivolumab|mesh-list
83981420|NCT01024231|Ipilimumab|ipilimumab|mesh-list
83981421|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83981422|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981423|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83981424|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981425|NCT01012999|Sufentanil|sufentanil|mesh-list
83981426|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83981427|NCT01012999|Narcotics|narcotics|mesh-ancestor
83981428|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981429|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981430|NCT01012999|Analgesics|analgesics|mesh-ancestor
83981431|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
83981432|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981433|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83981434|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83981435|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
83981436|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
83981437|NCT00637663|Lamivudine|lamivudine|mesh-list
83981438|NCT00637663|Entecavir|entecavir|mesh-list
83981439|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83981440|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83981441|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981442|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981443|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
83981444|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981445|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83981446|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83981447|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
83981448|NCT01016977|Clindamycin|clindamycin|mesh-list
83981449|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
83981450|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
83981451|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83981452|NCT01016977|Tazarotene|tazarotene|mesh-list
83981453|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83981454|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981455|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83981456|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981457|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981458|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
83981459|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
83981460|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
83981461|NCT01016977|Vitamins|vitamins|mesh-ancestor
83981462|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
83981463|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981464|NCT02871661|Amitriptyline|amitriptyline|mesh-list
83981465|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83981466|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
83981467|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83981468|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981469|NCT02871661|Analgesics|analgesics|mesh-ancestor
83981470|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
83981471|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981472|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981473|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83981474|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83981475|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83981476|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981477|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
83981478|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981479|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
83981480|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83981481|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
83981482|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981483|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981484|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84124716|NCT02745431|Oxytocin|oxytocin|mesh-list
83981485|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981486|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
83981487|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83981488|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981489|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981490|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981491|NCT00628459|Micronutrients|micronutrients|mesh-list
83981492|NCT00628459|Trace Elements|trace elements|mesh-list
83981493|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981494|NCT00627913|Anesthetics|anesthetics|mesh-list
83981495|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981496|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981498|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83981499|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83981500|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83981501|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981502|NCT01006291|Insulin|insulin|mesh-list
83981503|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83981504|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
83981505|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
83981506|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83981507|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981508|NCT04296175|Paclitaxel|paclitaxel|mesh-list
83981509|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83981510|NCT04296175|Carboplatin|carboplatin|mesh-list
83981511|NCT04296175|Epirubicin|epirubicin|mesh-list
83981512|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83981513|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981514|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83981515|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83981516|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83981517|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981518|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83981519|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83981520|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83981521|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981522|NCT02871349|Propranolol|propranolol|mesh-list
83981523|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83981524|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83981525|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
83981526|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981527|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981528|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981529|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83981530|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83981531|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
83981532|NCT01012609|Irinotecan|irinotecan|mesh-list
83981533|NCT01012609|Cetuximab|cetuximab|mesh-list
83981534|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83981535|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83981536|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981537|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981538|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981539|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83981540|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83981541|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
83981542|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981543|NCT01012219|Aspirin|aspirin|mesh-list
83981544|NCT01012219|Niacin|niacin|mesh-list
83981545|NCT01012219|Clopidogrel|clopidogrel|mesh-list
83981546|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981547|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981548|NCT01012219|Analgesics|analgesics|mesh-ancestor
83981549|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
83981550|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981551|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981552|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981553|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981554|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83981555|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83981556|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981557|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83981558|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83220885|NCT01680341|Insulin|insulin|mesh-list
83981559|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981560|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
83981561|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83981562|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83981563|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83981564|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
83981565|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981566|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83981567|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
83981568|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83981569|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
83981570|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
83981572|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
83981573|NCT01011907|Varenicline|varenicline|mesh-list
83981574|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83981575|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83981576|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981577|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981578|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981579|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981580|NCT01011673|Ketorolac|ketorolac|mesh-list
83981581|NCT01011673|Metoclopramide|metoclopramide|mesh-list
83981582|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981583|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981584|NCT01011673|Analgesics|analgesics|mesh-ancestor
83981585|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
83981586|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981587|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981588|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981589|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981590|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83981591|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981592|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981593|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
83981594|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
83981595|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83981596|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83981597|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83981598|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
83981599|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981600|NCT01311648|Factor VIII|factor viii|mesh-list
83981601|NCT01311648|Coagulants|coagulants|mesh-ancestor
83981602|NCT01011439|Maleic acid|maleic acid|mesh-list
83981603|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981604|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981605|NCT04406857|Capecitabine|capecitabine|mesh-list
83981606|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
83981607|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83981608|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
83981609|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981610|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981611|NCT01311024|Vaccines|vaccines|mesh-list
83981612|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
83981613|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981614|NCT02871193|Dexamethasone|dexamethasone|mesh-list
83981615|NCT02871193|Ropivacaine|ropivacaine|mesh-list
83981616|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981617|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
83981618|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
83981619|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981620|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981621|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83981622|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
83981623|NCT02871193|Hormones|hormones|mesh-ancestor
83981624|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981625|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83981626|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981627|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
83981628|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
83981629|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981630|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
83981631|NCT01310868|Carmustine|carmustine|mesh-list
83981632|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83981633|NCT01310868|Levulinic acid|levulinic acid|mesh-list
83981634|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83981635|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
83981636|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981637|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981638|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981639|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83981640|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83981641|NCT01273155|Belinostat|belinostat|mesh-list
83981642|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981643|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83981644|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981645|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981646|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
83981647|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83981648|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
83981649|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981650|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981651|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
83981652|NCT01005901|Bromides|bromides|mesh-list
83981653|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
83981654|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83981655|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83981656|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83981657|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981658|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981659|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981660|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981661|NCT02889549|Clopidogrel|clopidogrel|mesh-list
83981662|NCT02889549|Ticagrelor|ticagrelor|mesh-list
83981663|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83981664|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83981665|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83981666|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83981667|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
83981668|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981669|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981670|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981671|NCT05549037|Immunomodulating Agents|immunomodulating agents|mesh-list
83981672|NCT05549037|Immunologic Factors|immunologic factors|mesh-ancestor
83981673|NCT05549037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981674|NCT01309386|Morphine|morphine|mesh-list
83981675|NCT01309386|Tapentadol|tapentadol|mesh-list
83981676|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83981677|NCT01309386|Narcotics|narcotics|mesh-ancestor
83981678|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981679|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981680|NCT01309386|Analgesics|analgesics|mesh-ancestor
83981681|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
83981682|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981683|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83981684|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83981685|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83981686|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981687|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
83981688|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981689|NCT04295317|Capecitabine|capecitabine|mesh-list
83981690|NCT04295317|Antibodies|antibodies|mesh-list
83981691|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
83981692|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
83981693|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981694|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83981695|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
83981696|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981697|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981698|NCT01266603|Aldesleukin|aldesleukin|mesh-list
83981699|NCT01266603|Interleukin-2|interleukin-2|mesh-list
83981700|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981701|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981702|NCT01266603|Analgesics|analgesics|mesh-ancestor
83981703|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
83981704|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981705|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981706|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83981707|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83981708|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
83221025|NCT03175705|Interleukin-2|interleukin-2|mesh-list
83981709|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981711|NCT04295551|Lopinavir|lopinavir|mesh-list
83981712|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83981713|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83981714|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
83981715|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981716|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981717|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83981718|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83981719|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
83981720|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981721|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83981722|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83981723|NCT01266291|Vigabatrin|vigabatrin|mesh-list
83981724|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
83981725|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981726|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981727|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
83981728|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981729|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981730|NCT01004263|Rizatriptan|rizatriptan|mesh-list
83981731|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83981732|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
83981733|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981734|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981735|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981736|NCT01265823|Adalimumab|adalimumab|mesh-list
83981737|NCT01265823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83981738|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981739|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981740|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83981741|NCT01004185|Mesalamine|mesalamine|mesh-list
83981742|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981743|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981744|NCT01004185|Analgesics|analgesics|mesh-ancestor
83981745|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
83981746|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981747|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981748|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981749|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981750|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
83981751|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83981752|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981753|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83981754|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
83981755|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981756|NCT01264965|Acetaminophen|acetaminophen|mesh-list
83981757|NCT01264965|Oxycodone|oxycodone|mesh-list
83981758|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981759|NCT01264965|Analgesics|analgesics|mesh-ancestor
83981760|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
83981761|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981762|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981763|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
83981764|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83981765|NCT01264965|Narcotics|narcotics|mesh-ancestor
83981766|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981767|NCT01264887|Tapentadol|tapentadol|mesh-list
83981768|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83981769|NCT01264887|Narcotics|narcotics|mesh-ancestor
83981770|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981771|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981772|NCT01264887|Analgesics|analgesics|mesh-ancestor
83981773|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
83981774|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981775|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83981776|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83981777|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83981778|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981779|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
83981780|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981781|NCT01011283|Azacitidine|azacitidine|mesh-list
83981782|NCT01011283|Decitabine|decitabine|mesh-list
83981783|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83981784|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
83981785|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981786|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981787|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981788|NCT01263483|Inositol|inositol|mesh-list
83981789|NCT01263483|Alogliptin|alogliptin|mesh-list
83981790|NCT01263483|Voglibose|voglibose|mesh-list
83981791|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83981792|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981793|NCT01263483|Incretins|incretins|mesh-ancestor
83981794|NCT01263483|Hormones|hormones|mesh-ancestor
83981795|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981796|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83981797|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
83981798|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981799|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981800|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83981801|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
83981802|NCT01263483|Vitamins|vitamins|mesh-ancestor
83981803|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
83981804|NCT01011049|Vaccines|vaccines|mesh-list
83981805|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
83981806|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981807|NCT01263093|Clopidogrel|clopidogrel|mesh-list
83981808|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83981809|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83981810|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83981811|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83981812|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
83981813|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981814|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981815|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981816|NCT01010971|Ciclesonide|ciclesonide|mesh-list
83981817|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
83981818|NCT01010971|Hormones|hormones|mesh-ancestor
83981819|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981820|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981821|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83981822|NCT01306656|Vitamin D|vitamin d|mesh-list
83981823|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
83981824|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
83981825|NCT01306656|Vitamins|vitamins|mesh-list
83981826|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
83981827|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981828|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83981829|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83981830|NCT01003639|Aspirin|aspirin|mesh-list
83981831|NCT01003639|Acetaminophen|acetaminophen|mesh-list
83981832|NCT01003639|Ibuprofen|ibuprofen|mesh-list
83981833|NCT01003639|Naproxen|naproxen|mesh-list
83981834|NCT01003639|Acetazolamide|acetazolamide|mesh-list
83981835|NCT01003639|Codeine|codeine|mesh-list
83981836|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981837|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981838|NCT01003639|Analgesics|analgesics|mesh-ancestor
83981839|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
83981840|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981841|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981842|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981843|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981844|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83981845|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83981846|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981847|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83981848|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83981849|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981850|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
83981851|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
83981852|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
83981853|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83981854|NCT01003639|Diuretics|diuretics|mesh-ancestor
83981855|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
83981856|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83981857|NCT01003639|Narcotics|narcotics|mesh-ancestor
83981858|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981859|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
83981860|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
83981861|NCT01003249|Baclofen|baclofen|mesh-list
83981862|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83981863|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981864|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83981865|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981866|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83981867|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
83981868|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
83981869|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981870|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981871|NCT04297033|Lovastatin|lovastatin|mesh-list
83981872|NCT04297033|L 647318|l 647318|mesh-list
83981873|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
83981874|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83981875|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83981876|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
83981877|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981878|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83981879|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83981880|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981881|NCT04294537|Anesthetics|anesthetics|mesh-list
83981882|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981883|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981884|NCT04295629|Anesthetics|anesthetics|mesh-list
83981885|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981886|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981887|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
83981888|NCT01306032|Veliparib|veliparib|mesh-list
83981889|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83981890|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
83981891|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981892|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981893|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83981894|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
83981895|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981896|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981897|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83981898|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83981899|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981900|NCT01263015|Lamivudine|lamivudine|mesh-list
83981901|NCT01263015|Abacavir|abacavir|mesh-list
83981902|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
83981903|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83981904|NCT01263015|Dolutegravir|dolutegravir|mesh-list
83981905|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83981906|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83981907|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981908|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981909|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
83981910|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83981911|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83981912|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83981913|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83981914|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83981915|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
83981916|NCT04322955|Nivolumab|nivolumab|mesh-list
83981917|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83981918|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981919|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83981920|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981921|NCT04322175|Meloxicam|meloxicam|mesh-list
83981922|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83981923|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83981924|NCT04322175|Analgesics|analgesics|mesh-ancestor
83981925|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
83981926|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981927|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981928|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981929|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83981930|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83981931|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83981932|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981933|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981934|NCT04321785|Caffeine|caffeine|mesh-list
84124717|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
83981935|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83981936|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981937|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83981938|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83981939|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981940|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83981941|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83981942|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
83981943|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981944|NCT01305408|Modafinil|modafinil|mesh-list
83981945|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83981946|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981947|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83981948|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83981949|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83981950|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981951|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
83981952|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83981953|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83981954|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83981955|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83981956|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981957|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981958|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981959|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981960|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83981961|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981962|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
83981963|NCT04320693|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83981964|NCT04320693|Immunoconjugates|immunoconjugates|mesh-ancestor
83981965|NCT04320693|Immunologic Factors|immunologic factors|mesh-ancestor
83981966|NCT04320693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981967|NCT00624039|Pilocarpine|pilocarpine|mesh-list
83981968|NCT00624039|Miotics|miotics|mesh-ancestor
83981969|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
83981970|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83981971|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981972|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83981973|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83981974|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
83981975|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83981976|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981977|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83981978|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83981979|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
83981980|NCT01304706|Hormones|hormones|mesh-ancestor
83981981|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83981982|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981983|NCT05661240|Docetaxel|docetaxel|mesh-list
83981984|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981985|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
83981986|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
83981987|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
83981988|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83981989|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83981990|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83981991|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83981992|NCT02889003|Pioglitazone|pioglitazone|mesh-list
83981993|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83981994|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83981995|NCT01008553|Fentanyl|fentanyl|mesh-list
83981996|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83981997|NCT01008553|Narcotics|narcotics|mesh-ancestor
83981998|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83981999|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982000|NCT01008553|Analgesics|analgesics|mesh-ancestor
83982001|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
83982002|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982003|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83982004|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83982005|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
83982006|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
83982007|NCT05226663|Fluorides|fluorides|mesh-list
83221341|NCT02449265|Prednisone|prednisone|mesh-list
83982008|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
83982009|NCT05226663|Protective Agents|protective agents|mesh-ancestor
83982010|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982011|NCT05141877|Anesthetics|anesthetics|mesh-list
83982012|NCT05141877|Propofol|propofol|mesh-list
83982013|NCT05141877|Sevoflurane|sevoflurane|mesh-list
83982014|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982015|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982016|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83982017|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83982018|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
83982019|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83982020|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83982021|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
83982022|NCT04901169|Giapreza|giapreza|mesh-list
83982023|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
83982024|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83982025|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83982026|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
83982027|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982028|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982029|NCT04479267|Prednisone|prednisone|mesh-list
83982030|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
83982031|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83982032|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83982033|NCT04479267|Prednisolone|prednisolone|mesh-list
83982034|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
83982035|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
83982036|NCT04479267|Cortisone|cortisone|mesh-list
83982037|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
83982038|NCT04479267|Rituximab|rituximab|mesh-list
83982039|NCT04479267|Doxorubicin|doxorubicin|mesh-list
83982040|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83982041|NCT04479267|Antibodies|antibodies|mesh-list
83982042|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
83982043|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83982044|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83982045|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
83982046|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
83982047|NCT04479267|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83982048|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982049|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
83982050|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982051|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982052|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83982053|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
83982054|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982055|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982056|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83982057|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982058|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83982059|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83982060|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83982061|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982062|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982063|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
83982064|NCT04479267|Hormones|hormones|mesh-ancestor
83982065|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982066|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83982067|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
83982068|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
83982069|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982070|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982071|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83982072|NCT04479267|Protective Agents|protective agents|mesh-ancestor
83982073|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
83982074|NCT04439799|Testosterone|testosterone|mesh-list
83982075|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
83982076|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
83982077|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83982078|NCT04439799|Androgens|androgens|mesh-ancestor
83982079|NCT04439799|Hormones|hormones|mesh-ancestor
83982080|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982081|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982082|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83221398|NCT03593759|Hormones|hormones|mesh-ancestor
83982083|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982084|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
83982085|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83982086|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83982087|NCT04021017|Estradiol|estradiol|mesh-list
83982088|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83982089|NCT04021017|Estrogens|estrogens|mesh-ancestor
83982090|NCT04021017|Hormones|hormones|mesh-ancestor
83982091|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982092|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982093|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83982094|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
83982095|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83982096|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83982097|NCT03916185|Vaccines|vaccines|mesh-list
83982098|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
83982099|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982100|NCT03764553|Leucovorin|leucovorin|mesh-list
83982101|NCT03764553|Carboplatin|carboplatin|mesh-list
83982102|NCT03764553|Fluorouracil|fluorouracil|mesh-list
83982103|NCT03764553|Capecitabine|capecitabine|mesh-list
83982104|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
83982105|NCT03764553|Irinotecan|irinotecan|mesh-list
83982106|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982107|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
83982108|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982109|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83982110|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982111|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
83982112|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982113|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83982114|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83982115|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982116|NCT03764553|Antidotes|antidotes|mesh-ancestor
83982117|NCT03764553|Protective Agents|protective agents|mesh-ancestor
83982118|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
83982119|NCT03764553|Vitamins|vitamins|mesh-ancestor
83982120|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
83982121|NCT04320225|Dexamethasone|dexamethasone|mesh-list
83982122|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982123|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
83982124|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
83982125|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982126|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982127|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982128|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
83982129|NCT04320225|Hormones|hormones|mesh-ancestor
83982130|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982131|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83982132|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982133|NCT03221751|Prazosin|prazosin|mesh-list
83982134|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83982135|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83982136|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83982137|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83982138|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
83982139|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982140|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982141|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982142|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
83982143|NCT03219177|Narcotics|narcotics|mesh-ancestor
83982144|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982145|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982146|NCT03219177|Analgesics|analgesics|mesh-ancestor
83982147|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
83982148|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982149|NCT01302834|Cetuximab|cetuximab|mesh-list
83982150|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982151|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982152|NCT02866071|Ketamine|ketamine|mesh-list
83982153|NCT02866071|Analgesics|analgesics|mesh-ancestor
83982154|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
83982155|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982156|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982157|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83982158|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83982159|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
83982160|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
83982161|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982162|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83982163|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83982164|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982165|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982166|NCT05507775|Digoxin|digoxin|mesh-list
83982167|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83982168|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83982169|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982170|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982171|NCT05507775|Protective Agents|protective agents|mesh-ancestor
83982172|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982173|NCT02890602|Prednisolone|prednisolone|mesh-list
83982174|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
83982175|NCT02890602|Vincristine|vincristine|mesh-list
83982176|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
83982177|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982178|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
83982179|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982180|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982181|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83982182|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
83982183|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982184|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982185|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83982186|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83982187|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
83982188|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
83982189|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
83982190|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982191|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
83982192|NCT02890602|Hormones|hormones|mesh-ancestor
83982193|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982194|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83982195|NCT02890602|Hematinics|hematinics|mesh-ancestor
83982196|NCT01259115|Ketoconazole|ketoconazole|mesh-list
83982197|NCT01259115|Buprenorphine|buprenorphine|mesh-list
83982198|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83982199|NCT01259115|Narcotics|narcotics|mesh-ancestor
83982200|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982201|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982202|NCT01259115|Analgesics|analgesics|mesh-ancestor
83982203|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
83982204|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982205|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83982206|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
83982207|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982208|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83982209|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83982210|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982211|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982212|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83982213|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
83982214|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982215|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83982216|NCT01302054|Fesoterodine|fesoterodine|mesh-list
83982217|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83982218|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83982219|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
83982220|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982221|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982222|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982223|NCT01302054|Urological Agents|urological agents|mesh-ancestor
83982224|NCT05642910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83982225|NCT05642910|Antiviral Agents|antiviral agents|mesh-ancestor
83982226|NCT05642910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982227|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83982228|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982229|NCT01300572|Cyclosporine|cyclosporine|mesh-list
83982230|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
83982231|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83982232|NCT01300572|Fludarabine|fludarabine|mesh-list
83982233|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
83982234|NCT01300572|Antibodies|antibodies|mesh-list
83982235|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
83982236|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83982237|NCT01300572|Cyclosporins|cyclosporins|mesh-list
83982238|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
83982239|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982240|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982241|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83982242|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
83982243|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982244|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982245|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982246|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
83982247|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982248|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83982249|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982250|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83982251|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83982252|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83982253|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
83982254|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83982255|NCT01077154|Denosumab|denosumab|mesh-list
83982256|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83982257|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982258|NCT01258101|Ribavirin|ribavirin|mesh-list
83982259|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83982260|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
83982261|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
83982262|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982263|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
83982264|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982265|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
83982266|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982267|NCT05640804|Dasatinib|dasatinib|mesh-list
83982268|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982269|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83982270|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982271|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982272|NCT00623688|Imidacloprid|imidacloprid|mesh-list
83982273|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
83982274|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982275|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982276|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982277|NCT01300260|Dulaglutide|dulaglutide|mesh-list
83982278|NCT01300260|Glucagon|glucagon|mesh-list
83982279|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83982280|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982281|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982282|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982283|NCT01300260|Hormones|hormones|mesh-ancestor
83982284|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982285|NCT01300260|Incretins|incretins|mesh-ancestor
83982286|NCT01256385|Sirolimus|sirolimus|mesh-list
83982287|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83982288|NCT01256385|Cetuximab|cetuximab|mesh-list
83982289|NCT01256385|Temsirolimus|temsirolimus|mesh-list
83982290|NCT01256385|MTOR Inhibitors|mtor inhibitors|mesh-list
83982291|NCT01256385|Antibodies|antibodies|mesh-list
83982292|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
83982293|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83982294|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
83982295|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982296|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982297|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83982298|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982299|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83982300|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
83982301|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982302|NCT01256385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83982303|NCT01256385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982304|NCT01256385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982305|NCT00637182|Anastrozole|anastrozole|mesh-list
83982306|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83982307|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982308|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83982309|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83982310|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982311|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982312|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83982313|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
83982314|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982315|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982316|NCT01298778|Acetaminophen|acetaminophen|mesh-list
83982318|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83982319|NCT01298778|Analgesics|analgesics|mesh-ancestor
83982320|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
83982321|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982322|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982323|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
83982324|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83982325|NCT01298778|Narcotics|narcotics|mesh-ancestor
83982326|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982327|NCT01298700|Bimatoprost|bimatoprost|mesh-list
83982328|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83982329|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83982330|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83982331|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83982332|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83982333|NCT01297920|Brinzolamide|brinzolamide|mesh-list
83982334|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83982335|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83982336|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83982337|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83982338|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83982339|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
83982340|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982341|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982342|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982343|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83982344|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982345|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
83982346|NCT01255761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83982347|NCT01255761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982348|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982349|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
83982350|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982351|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982352|NCT01297062|Exenatide|exenatide|mesh-list
83982353|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
83982354|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83982355|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982356|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83982357|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83982358|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982359|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982360|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982361|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982362|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982363|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83982364|NCT01297062|Incretins|incretins|mesh-ancestor
83982365|NCT01297062|Hormones|hormones|mesh-ancestor
83982366|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982367|NCT01296672|Finasteride|finasteride|mesh-list
83982368|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83982369|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83982370|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982371|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982372|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
83982373|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982374|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982375|NCT01296672|Urological Agents|urological agents|mesh-ancestor
83982376|NCT01254669|Vaccines|vaccines|mesh-list
83982377|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
83982378|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982379|NCT04324476|Bevacizumab|bevacizumab|mesh-list
83982380|NCT04324476|Capecitabine|capecitabine|mesh-list
83982381|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
83982382|NCT04324476|Irinotecan|irinotecan|mesh-list
83982383|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982384|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982385|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83221697|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83982386|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83982387|NCT04324476|Growth Substances|growth substances|mesh-ancestor
83982388|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982389|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
83982390|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83982391|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
83982392|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982393|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83982394|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83982395|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982396|NCT01295814|Adalimumab|adalimumab|mesh-list
83982397|NCT01295814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83982398|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982399|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982400|NCT01254045|Oxytocin|oxytocin|mesh-list
83982401|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
83982402|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83982403|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982404|NCT01075282|Metformin|metformin|mesh-list
83982405|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
83982406|NCT01075282|Glimepiride|glimepiride|mesh-list
83982407|NCT01075282|Dulaglutide|dulaglutide|mesh-list
83982408|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982409|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982410|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83982411|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982412|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
83982413|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
83982414|NCT04324086|Calcium|calcium|mesh-list
83982415|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83982416|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982417|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83982418|NCT01295034|Vitamin D|vitamin d|mesh-list
83982419|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
83982420|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
83982421|NCT01295034|Vitamins|vitamins|mesh-list
83982422|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
83982423|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982424|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83982425|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83982426|NCT01253421|Amisulpride|amisulpride|mesh-list
83982427|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83982428|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83982429|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982430|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982431|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83982432|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83982433|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
83982434|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982435|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982436|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83982437|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
83982438|NCT01077076|Omeprazole|omeprazole|mesh-list
83982439|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83982440|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83982441|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982442|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83982443|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982444|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982445|NCT02876224|Bevacizumab|bevacizumab|mesh-list
83982446|NCT02876224|Atezolizumab|atezolizumab|mesh-list
83982447|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982448|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982449|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83982450|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83982451|NCT02876224|Growth Substances|growth substances|mesh-ancestor
83982452|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982453|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
83982454|NCT02876224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83982455|NCT02876224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982456|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
83982457|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83982458|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982459|NCT01253265|Ixekizumab|ixekizumab|mesh-list
83982460|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
83982461|NCT01293006|Suvorexant|suvorexant|mesh-list
83982462|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83982463|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83982464|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982465|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982466|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83982467|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982468|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982469|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
83982470|NCT01253187|Drospirenone|drospirenone|mesh-list
83982471|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83982472|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
83982473|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982474|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982475|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83982476|NCT01253187|Diuretics|diuretics|mesh-ancestor
83982477|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
83982478|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
83982479|NCT01253187|Vitamins|vitamins|mesh-ancestor
83982480|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
83982481|NCT01252563|Amlodipine|amlodipine|mesh-list
83982482|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83982483|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83982484|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83982485|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982486|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83982487|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982488|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
83982489|NCT01292226|Cyclosporine|cyclosporine|mesh-list
83982490|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
83982491|NCT01292226|Antibodies|antibodies|mesh-list
83982492|NCT01292226|Cyclosporins|cyclosporins|mesh-list
83982493|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
83982494|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982495|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982496|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982497|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982498|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
83982499|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982500|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
83982501|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982502|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83982503|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83982504|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982505|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83982506|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
83982507|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83982508|NCT01075048|Irinotecan|irinotecan|mesh-list
83982509|NCT01075048|Cetuximab|cetuximab|mesh-list
83982510|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83982511|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83982512|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982513|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982514|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982515|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982516|NCT01252251|Everolimus|everolimus|mesh-list
83982517|NCT01252251|Pasireotide|pasireotide|mesh-list
83982518|NCT01252251|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83982519|NCT01252251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83982520|NCT01252251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982521|NCT01252251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982522|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982523|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
83982524|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982525|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982526|NCT01252251|Hormones|hormones|mesh-ancestor
83982527|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982528|NCT02888301|Clofarabine|clofarabine|mesh-list
83982529|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83982530|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
83982531|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982532|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982533|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
83982534|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
83221854|NCT03847181|Vitamin K|vitamin k|mesh-list
83982535|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83982536|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83982537|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982538|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982539|NCT00624273|Urological Agents|urological agents|mesh-ancestor
83982541|NCT04305964|Trace Elements|trace elements|mesh-ancestor
83982542|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
83982543|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982544|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
83982545|NCT04306042|Nivolumab|nivolumab|mesh-list
83982546|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982547|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982548|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83982549|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982550|NCT01074502|Apremilast|apremilast|mesh-list
83982551|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83982552|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83982553|NCT01074502|Analgesics|analgesics|mesh-ancestor
83982554|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
83982555|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982556|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982557|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982558|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982559|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83982560|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83982561|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982562|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982563|NCT04303312|Benzydamine|benzydamine|mesh-list
83982564|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982565|NCT01285908|Norepinephrine|norepinephrine|mesh-list
83982566|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83982567|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83982568|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
83982569|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982570|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982571|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982572|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
83982573|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
83982574|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982575|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83982576|NCT01074268|Insulin|insulin|mesh-list
83982577|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83982578|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
83982579|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
83982580|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982581|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982582|NCT01074190|Fentanyl|fentanyl|mesh-list
83982583|NCT01074190|Bupivacaine|bupivacaine|mesh-list
83982584|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
83982585|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
83982586|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982587|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982588|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
83982589|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982590|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83982591|NCT01074190|Narcotics|narcotics|mesh-ancestor
83982592|NCT01074190|Analgesics|analgesics|mesh-ancestor
83982593|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83982594|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83982595|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
83982596|NCT01073566|Insulin|insulin|mesh-list
83982597|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83982598|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982599|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982600|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
83982601|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83982602|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
83982603|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982604|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982605|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83982606|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
83982607|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
83982608|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83221925|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83982609|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
83982610|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982611|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982612|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
83982613|NCT01045096|Lansoprazole|lansoprazole|mesh-list
83982614|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83982615|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982616|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83982617|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982618|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982619|NCT02876146|Albendazole|albendazole|mesh-list
83982620|NCT02876146|Benzimidazole|benzimidazole|mesh-list
83982621|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
83982622|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83982623|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982624|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
83982625|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83982626|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83982627|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83982628|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83982629|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83982630|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982631|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982632|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83982633|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
83982634|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982635|NCT02875756|Ivermectin|ivermectin|mesh-list
83982636|NCT02875756|Selamectin|selamectin|mesh-list
83982637|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83982638|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982639|NCT02874820|Idazoxan|idazoxan|mesh-list
83982640|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83982641|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83982642|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83982643|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
83982644|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982645|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982646|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982647|NCT04305028|Aspirin|aspirin|mesh-list
83982648|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
83982649|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83982650|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83982651|NCT04305028|Analgesics|analgesics|mesh-ancestor
83982652|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
83982653|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982654|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982655|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982656|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982657|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83982658|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83982659|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982660|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83982661|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83982662|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982663|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
83982664|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83982665|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
83982666|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83982667|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
83982668|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
83982669|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
83982670|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
83982671|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982672|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982673|NCT02874664|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83982674|NCT02874664|Immunoconjugates|immunoconjugates|mesh-ancestor
83982675|NCT02874664|Immunologic Factors|immunologic factors|mesh-ancestor
83982676|NCT02874664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982677|NCT01284114|Renin Inhibitors|renin inhibitors|mesh-list
83982678|NCT01284114|Protease Inhibitors|protease inhibitors|mesh-ancestor
83982679|NCT01284114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982680|NCT01284114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982681|NCT01283334|Carboplatin|carboplatin|mesh-list
83982682|NCT01283334|Cetuximab|cetuximab|mesh-list
83982683|NCT01283334|Everolimus|everolimus|mesh-list
83982684|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982685|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982687|NCT01283334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83982688|NCT01283334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982689|NCT01283334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982690|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982691|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
83982692|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982693|NCT04304716|Anesthetics|anesthetics|mesh-list
83982694|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982695|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982696|NCT01282476|Rituximab|rituximab|mesh-list
83982697|NCT01282476|Panobinostat|panobinostat|mesh-list
83982698|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982699|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982700|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
83982701|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982702|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982703|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83982704|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982705|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982706|NCT02889822|Alprostadil|alprostadil|mesh-list
83982707|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83982708|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
83982709|NCT02889822|Urological Agents|urological agents|mesh-ancestor
83982710|NCT01282164|Insulin|insulin|mesh-list
83982711|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83982712|NCT01282164|Glucagon|glucagon|mesh-list
83982713|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83982714|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982715|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982716|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982717|NCT01282164|Hormones|hormones|mesh-ancestor
83982718|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982719|NCT01282164|Incretins|incretins|mesh-ancestor
83982720|NCT01250379|Bevacizumab|bevacizumab|mesh-list
83982721|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982722|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982723|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83982724|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83982725|NCT01250379|Growth Substances|growth substances|mesh-ancestor
83982726|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982727|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
83982728|NCT01072630|Modafinil|modafinil|mesh-list
83982729|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83982730|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982731|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83982732|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83982733|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83982734|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982735|NCT04302532|Ubiquinone|ubiquinone|mesh-list
83982736|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
83982737|NCT04302532|Clomiphene|clomiphene|mesh-list
83982738|NCT04302532|Enclomiphene|enclomiphene|mesh-list
83982739|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
83982740|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83982741|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
83982742|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982743|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982744|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83982745|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
83982746|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83982747|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83982748|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83982749|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
83982750|NCT04302532|Vitamins|vitamins|mesh-ancestor
83982751|NCT01281306|Valsartan|valsartan|mesh-list
83982752|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83982753|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83982754|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83982755|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83982756|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982757|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
83982758|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83982759|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982760|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982761|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982762|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
83982763|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982764|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83982765|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982766|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982767|NCT01250145|Teriparatide|teriparatide|mesh-list
83982768|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83982769|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982770|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83982771|NCT04319601|Rituximab|rituximab|mesh-list
83982772|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83982773|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982774|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
83982775|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982776|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982777|NCT04640896|Lidocaine|lidocaine|mesh-list
83982778|NCT04640896|Bupivacaine|bupivacaine|mesh-list
83982779|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
83982780|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
83982781|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982782|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982783|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
83982784|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982785|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83982786|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83982787|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83982788|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83982789|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982790|NCT01273818|Gentamicins|gentamicins|mesh-list
83982791|NCT01273818|Cefazolin|cefazolin|mesh-list
83982792|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83982793|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982794|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83982795|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982796|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982797|NCT01037218|Udenafil|udenafil|mesh-list
83982798|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83982799|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83982800|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982801|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982802|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83982803|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982804|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83982805|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982806|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982807|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
83982808|NCT01269918|Remifentanil|remifentanil|mesh-list
83982809|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83982810|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982811|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982812|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83982813|NCT01269918|Analgesics|analgesics|mesh-ancestor
83982814|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
83982815|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982816|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83982817|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83982818|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83982819|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83982820|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982821|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982822|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83982823|NCT01269918|Narcotics|narcotics|mesh-ancestor
83982824|NCT01036594|Ketoconazole|ketoconazole|mesh-list
83982825|NCT01036594|Dexamethasone|dexamethasone|mesh-list
83982826|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
83982827|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
83982828|NCT01036594|BB 1101|bb 1101|mesh-list
83982829|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982830|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
83982831|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
83222157|NCT02399137|Paclitaxel|paclitaxel|mesh-list
83982832|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982833|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982834|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83982836|NCT01036594|Hormones|hormones|mesh-ancestor
83982837|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982838|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83982839|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982840|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
83982841|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982842|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982843|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
83982844|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982845|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83982846|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83982847|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83982848|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
83982849|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83982850|NCT04301908|Interferons|interferons|mesh-list
83982851|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982852|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
83982853|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982854|NCT04304248|Paclitaxel|paclitaxel|mesh-list
83982855|NCT04304248|Carboplatin|carboplatin|mesh-list
83982856|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83982857|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83982858|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982859|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
83982860|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
83982861|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
83982862|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982863|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83982864|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83982865|NCT01268046|Estradiol|estradiol|mesh-list
83982866|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83982867|NCT01268046|Estrogens|estrogens|mesh-list
83982868|NCT01268046|Hormones|hormones|mesh-ancestor
83982869|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982870|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982871|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83982872|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
83982873|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83982874|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83982875|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
83982876|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83982877|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
83982878|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982879|NCT04732000|Expectorants|expectorants|mesh-ancestor
83982880|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
83982881|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83982882|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
83982883|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982884|NCT04732000|Protective Agents|protective agents|mesh-ancestor
83982885|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982886|NCT04732000|Antidotes|antidotes|mesh-ancestor
83982887|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
83982888|NCT01267266|Saracatinib|saracatinib|mesh-list
83982889|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982890|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982891|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982892|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982893|NCT01034176|Levofloxacin|levofloxacin|mesh-list
83982894|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83982895|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982896|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83982897|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83982898|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83982899|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982900|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982901|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982902|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83982903|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83982904|NCT02889432|Melatonin|melatonin|mesh-list
83982905|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
83982906|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982908|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982909|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83982910|NCT01033942|Tenofovir|tenofovir|mesh-list
83982911|NCT01033942|Emtricitabine|emtricitabine|mesh-list
83982912|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
83982913|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982914|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83982915|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83982916|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982917|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982918|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83982919|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83982920|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
83982921|NCT01062256|Guaifenesin|guaifenesin|mesh-list
83982922|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83982923|NCT01062256|Expectorants|expectorants|mesh-ancestor
83982924|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83982925|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83982926|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83982927|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83982928|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982929|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982930|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982931|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
83982932|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83982933|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
83982934|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
83982935|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83982936|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
83982937|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83982938|NCT01029886|Liraglutide|liraglutide|mesh-list
83982939|NCT01029886|Exenatide|exenatide|mesh-list
83982940|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982941|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982942|NCT01029886|Incretins|incretins|mesh-ancestor
83982943|NCT01029886|Hormones|hormones|mesh-ancestor
83982944|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982945|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83982946|NCT01244061|Varenicline|varenicline|mesh-list
83982947|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83982948|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83982949|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
83982950|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83982951|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982952|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982953|NCT01243671|Adalimumab|adalimumab|mesh-list
83982954|NCT01243671|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83982955|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982956|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83982957|NCT01240785|Metformin|metformin|mesh-list
83982958|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83982959|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982960|NCT01266876|Alirocumab|alirocumab|mesh-list
83982961|NCT01266876|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83982962|NCT01266876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83982963|NCT01266876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83982964|NCT01266876|Antimetabolites|antimetabolites|mesh-ancestor
83982965|NCT01266876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982966|NCT01266876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83982967|NCT01266876|Protease Inhibitors|protease inhibitors|mesh-ancestor
83982968|NCT01266876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982969|NCT01266876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83982970|NCT01033240|Sorafenib|sorafenib|mesh-list
83982971|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83982972|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83982973|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982974|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982975|NCT01032382|Gentamicins|gentamicins|mesh-list
83982976|NCT01032382|Paromomycin|paromomycin|mesh-list
83982977|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83982978|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83982979|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83982980|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982981|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982982|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83982983|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83982985|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83982986|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83982987|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83982988|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83982989|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83982990|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
83982991|NCT01029652|Hormones|hormones|mesh-ancestor
83982992|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83982993|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83982994|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83982995|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
83982996|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83982997|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83982998|NCT01029340|Factor VIII|factor viii|mesh-list
83982999|NCT01029340|Coagulants|coagulants|mesh-ancestor
83983000|NCT01265550|Baclofen|baclofen|mesh-list
83983001|NCT01265550|Desipramine|desipramine|mesh-list
83983002|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83983003|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983004|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83983005|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983006|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83983007|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
83983008|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
83983009|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983010|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983011|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83983012|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
83983013|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983014|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983015|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83983016|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983017|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983018|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
83983019|NCT01265394|Flutemetamol|flutemetamol|mesh-list
83983020|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83983021|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983022|NCT01029262|Lenalidomide|lenalidomide|mesh-list
83983023|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
83983024|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983025|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83983026|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83983027|NCT01029262|Growth Substances|growth substances|mesh-ancestor
83983028|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
83983029|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983030|NCT01061710|Varenicline|varenicline|mesh-list
83983031|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83983032|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83983033|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
83983034|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983035|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983036|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983037|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
83983038|NCT01028014|Ephedrine|ephedrine|mesh-list
83983039|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
83983040|NCT01028014|Imipramine|imipramine|mesh-list
83983041|NCT01028014|Tamsulosin|tamsulosin|mesh-list
83983042|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
83983043|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83983044|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83983045|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83983046|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
83983047|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983048|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983049|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983050|NCT01028014|Urological Agents|urological agents|mesh-ancestor
83983051|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83983052|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83983053|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
83983054|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83983055|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
83983056|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983057|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83983058|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
83983059|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
83983060|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83983061|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83983062|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
83983063|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83983064|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
83983065|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983066|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83983067|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83983068|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83983069|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983070|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83983071|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983072|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983073|NCT01264770|Adalimumab|adalimumab|mesh-list
83983074|NCT01264770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83983075|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983076|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983077|NCT02873650|Dabrafenib|dabrafenib|mesh-list
83983078|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983079|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983080|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983081|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983082|NCT01302080|Sertraline|sertraline|mesh-list
83983083|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
83983084|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983085|NCT01302080|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83983086|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983087|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983088|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983089|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983090|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
83983091|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983092|NCT01032070|Etoposide|etoposide|mesh-list
83983093|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83983094|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83983095|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983096|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83983097|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83983098|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983099|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983100|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983101|NCT01237899|Eplerenone|eplerenone|mesh-list
83983102|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83983103|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
83983104|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983105|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983106|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83983107|NCT01237899|Diuretics|diuretics|mesh-ancestor
83983108|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
83983109|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83983110|NCT01263444|Timolol|timolol|mesh-list
83983111|NCT01263444|Bimatoprost|bimatoprost|mesh-list
83983112|NCT01263444|Travoprost|travoprost|mesh-list
83983113|NCT01263444|Latanoprost|latanoprost|mesh-list
83983114|NCT01263444|Brinzolamide|brinzolamide|mesh-list
83983115|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83983116|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83983117|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
83983118|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983119|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983120|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983121|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83983122|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83983123|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83983124|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83983125|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83983126|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983127|NCT01031836|Sifalimumab|sifalimumab|mesh-list
83983128|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83222451|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
83983129|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
83983130|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983131|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83983132|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83983133|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983134|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983135|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983136|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983137|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983138|NCT01237587|Analgesics|analgesics|mesh-ancestor
83983139|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
83983140|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983141|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
83983142|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983143|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
83983144|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
83983145|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83983146|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983147|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83983148|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983149|NCT01031446|Paclitaxel|paclitaxel|mesh-list
83983150|NCT01031446|Everolimus|everolimus|mesh-list
83983151|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83983152|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983153|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
83983154|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
83983155|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
83983156|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983157|NCT01031446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83983158|NCT01031446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983159|NCT01031446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983160|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983161|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
83983162|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983163|NCT01030900|Prednisone|prednisone|mesh-list
83983164|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
83983165|NCT01030900|Rituximab|rituximab|mesh-list
83983166|NCT01030900|Doxorubicin|doxorubicin|mesh-list
83983167|NCT01030900|Etoposide|etoposide|mesh-list
83983168|NCT01030900|Vincristine|vincristine|mesh-list
83983169|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
83983170|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983171|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
83983172|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983173|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983174|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83983175|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
83983176|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983177|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983178|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83983179|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83983180|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83983181|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83983182|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83983183|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983184|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983185|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
83983186|NCT01030900|Hormones|hormones|mesh-ancestor
83983187|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983188|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83983189|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83983190|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
83983191|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
83983192|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
83983193|NCT01030822|Vaccines|vaccines|mesh-list
83983194|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83983195|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
83983196|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983197|NCT01026454|Valacyclovir|valacyclovir|mesh-list
83983198|NCT01026454|Acyclovir|acyclovir|mesh-list
83983199|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
83983200|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983201|NCT01026220|Prednisone|prednisone|mesh-list
83983202|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
83983203|NCT01026220|Ifosfamide|ifosfamide|mesh-list
83983204|NCT01026220|Doxorubicin|doxorubicin|mesh-list
83983205|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83983206|NCT01026220|Etoposide|etoposide|mesh-list
83983207|NCT01026220|Vincristine|vincristine|mesh-list
83983208|NCT01026220|Vinorelbine|vinorelbine|mesh-list
83983209|NCT01026220|Bleomycin|bleomycin|mesh-list
83983210|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
83983211|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983212|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
83983213|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983214|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983215|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83983216|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
83983217|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983218|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983219|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83983220|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83983221|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83983222|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83983223|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983224|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983225|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
83983226|NCT01026220|Hormones|hormones|mesh-ancestor
83983227|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983228|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83983229|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83983230|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
83983231|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
83983232|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
83983233|NCT01026142|Capecitabine|capecitabine|mesh-list
83983234|NCT01026142|Trastuzumab|trastuzumab|mesh-list
83983235|NCT01026142|Pertuzumab|pertuzumab|mesh-list
83983236|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83983237|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
83983238|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983239|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983240|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83983241|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
83983242|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83983243|NCT01030666|Doxycycline|doxycycline|mesh-list
83983244|NCT01030666|Ibuprofen|ibuprofen|mesh-list
83983245|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83983246|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83983247|NCT01030666|Analgesics|analgesics|mesh-ancestor
83983248|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
83983249|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983250|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983251|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983252|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983253|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83983254|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983255|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983256|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83983257|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983258|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
83983259|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
83983260|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83983261|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
83983262|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83983263|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83983264|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83983265|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
83983266|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983267|NCT01058668|Cariprazine|cariprazine|mesh-list
83983268|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83983269|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83983270|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983271|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983272|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983273|NCT00623558|Docetaxel|docetaxel|mesh-list
83983274|NCT00623558|Cetuximab|cetuximab|mesh-list
83983275|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983276|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
83983277|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
83983278|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
83983279|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983280|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83983281|NCT01301066|Pravastatin|pravastatin|mesh-list
83983282|NCT01301066|Pitavastatin|pitavastatin|mesh-list
83983283|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83983284|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83983285|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
83983286|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983287|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83983288|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83983289|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983290|NCT01022398|Vitamin D|vitamin d|mesh-list
83983291|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
83983292|NCT01022398|Vitamins|vitamins|mesh-ancestor
83983293|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
83983294|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983295|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83983296|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83983297|NCT05642624|Amphotericin B|amphotericin b|mesh-list
83983298|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83983299|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
83983300|NCT05642624|Amebicides|amebicides|mesh-ancestor
83983301|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83983302|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83983303|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983304|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83983305|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
83983306|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83983307|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83983308|NCT04324346|Paclitaxel|paclitaxel|mesh-list
83983309|NCT04324346|Docetaxel|docetaxel|mesh-list
83983310|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83983311|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983312|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
83983313|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
83983314|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
83983315|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983316|NCT04300114|Fluzoparib|fluzoparib|mesh-list
83983317|NCT04300114|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83983318|NCT04300114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983319|NCT04300114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983320|NCT04300114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983321|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
83983322|NCT02890238|Citric Acid|citric acid|mesh-list
83983323|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
83983324|NCT02890238|Clomiphene|clomiphene|mesh-list
83983325|NCT02890238|Enclomiphene|enclomiphene|mesh-list
83983326|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
83983327|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
83983328|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83983329|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
83983330|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
83983331|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983332|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
83983333|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83983334|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83983335|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983336|NCT02890238|Urological Agents|urological agents|mesh-ancestor
83983337|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83983338|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
83983339|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983340|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983341|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83983342|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
83983343|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83983344|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83983345|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83983346|NCT00627796|Lanreotide|lanreotide|mesh-list
83983347|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983348|NCT01299896|Bupropion|bupropion|mesh-list
83983349|NCT01299896|Nicotine|nicotine|mesh-list
83983350|NCT01299896|Varenicline|varenicline|mesh-list
83983351|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83983352|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
83983353|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983354|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983355|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83222678|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
83983356|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83983357|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
83983358|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983359|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983360|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83983361|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
83983362|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983363|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83983364|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983365|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983366|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
83983367|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83983368|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83983369|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983370|NCT01299584|Remifentanil|remifentanil|mesh-list
83983371|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83983372|NCT01299584|Narcotics|narcotics|mesh-ancestor
83983373|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983374|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983375|NCT01299584|Analgesics|analgesics|mesh-ancestor
83983376|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
83983377|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983378|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
83983379|NCT01236573|Fludarabine|fludarabine|mesh-list
83983380|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983381|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
83983382|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983383|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983384|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83983385|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
83983386|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983387|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983388|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83983389|NCT04323228|Antioxidants|antioxidants|mesh-list
83983390|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983391|NCT04323228|Protective Agents|protective agents|mesh-ancestor
83983392|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983393|NCT04322760|Lidocaine|lidocaine|mesh-list
83983394|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
83983395|NCT04322760|Bupivacaine|bupivacaine|mesh-list
83983396|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
83983397|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
83983398|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983399|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983400|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
83983401|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983402|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83983403|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83983404|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83983405|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983406|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983407|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83983408|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83983409|NCT04322760|Analgesics|analgesics|mesh-ancestor
83983410|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83983411|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83983412|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83983413|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
83983414|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983415|NCT04322214|Cobicistat|cobicistat|mesh-list
83983416|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83983417|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83983418|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
83983419|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983420|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83983421|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83983422|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983423|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983424|NCT01057810|Ipilimumab|ipilimumab|mesh-list
83983425|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83983426|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983427|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83983428|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983429|NCT01262352|Ivacaftor|ivacaftor|mesh-list
83983430|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83983431|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983432|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983433|NCT01299272|Serotonin|serotonin|mesh-list
83983434|NCT01299272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83983435|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83983436|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
83983437|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983438|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983439|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983440|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983441|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983442|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
83983443|NCT01299116|Etonogestrel|etonogestrel|mesh-list
83983444|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
83983445|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83983446|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983447|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83983448|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83983449|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83983450|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83983451|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
83983452|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983453|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983454|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983455|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83983456|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83983457|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83983458|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
83983459|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983460|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83983461|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83983462|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983463|NCT04321278|Azithromycin|azithromycin|mesh-list
83983464|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
83983465|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83983466|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983467|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
83983468|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83983469|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83983470|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983471|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983472|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983473|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
83983474|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83983475|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83983476|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
83983477|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983478|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83983479|NCT01260948|Donepezil|donepezil|mesh-list
83983480|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83983481|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983482|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983483|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
83983484|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983485|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983486|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
83983487|NCT01025284|Lenograstim|lenograstim|mesh-list
83983488|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83983489|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
83983490|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983491|NCT02873026|Triamcinolone|triamcinolone|mesh-list
83983492|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83983493|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83983494|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83983495|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983496|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
83983497|NCT02873026|Hormones|hormones|mesh-ancestor
83983498|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983499|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983500|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983501|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
83983502|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124718|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83983503|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983505|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83983506|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
83983507|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83983508|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83983509|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83983510|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
83983511|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983512|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983513|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983514|NCT01298570|Leucovorin|leucovorin|mesh-list
83983515|NCT01298570|Fluorouracil|fluorouracil|mesh-list
83983516|NCT01298570|Irinotecan|irinotecan|mesh-list
83983517|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
83983518|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
83983519|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983520|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83983521|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983522|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983523|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
83983524|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983525|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83983526|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83983527|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983528|NCT01298570|Antidotes|antidotes|mesh-ancestor
83983529|NCT01298570|Protective Agents|protective agents|mesh-ancestor
83983530|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
83983531|NCT01298570|Vitamins|vitamins|mesh-ancestor
83983532|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
83983533|NCT01259856|Aspirin|aspirin|mesh-list
83983534|NCT01259856|Interferons|interferons|mesh-list
83983535|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
83983536|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
83983537|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83983538|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
83983539|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983540|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
83983541|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983542|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83983543|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83983544|NCT01259856|Analgesics|analgesics|mesh-ancestor
83983545|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
83983546|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983547|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983548|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983549|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983550|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83983551|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83983552|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983553|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83983554|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83983555|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983556|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
83983557|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
83983558|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
83983559|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83983560|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83983561|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83983562|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83983563|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983564|NCT01259466|Nicotine|nicotine|mesh-list
83983565|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83983566|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
83983567|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983568|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983569|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83983570|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83983571|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
83983572|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983573|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983574|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
83983575|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
83983576|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983577|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222901|NCT04198961|Analgesics|analgesics|mesh-ancestor
83983578|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983579|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
83983580|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83983581|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983582|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983583|NCT05525910|Ritonavir|ritonavir|mesh-list
83983584|NCT05525910|Nirmatrelvir|nirmatrelvir|mesh-list
83983585|NCT05525910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83983586|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83983587|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83983588|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
83983589|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983590|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983591|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83983592|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83983593|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
83983594|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983595|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83983596|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83983597|NCT00624078|Antivenins|antivenins|mesh-list
83983598|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
83983599|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983600|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
83983601|NCT05286528|Dasatinib|dasatinib|mesh-list
83983602|NCT05286528|Ponatinib|ponatinib|mesh-list
83983603|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983604|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983605|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983606|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983607|NCT01297244|Tivozanib|tivozanib|mesh-list
83983608|NCT01297244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983609|NCT01297244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983610|NCT01297244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983611|NCT04752696|Leucovorin|leucovorin|mesh-list
83983612|NCT04752696|Fluorouracil|fluorouracil|mesh-list
83983613|NCT04752696|Irinotecan|irinotecan|mesh-list
83983614|NCT04752696|Onvansertib|onvansertib|mesh-list
83983615|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
83983616|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983617|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83983618|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983619|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983620|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
83983621|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983622|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83983623|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83983624|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983625|NCT04752696|Antidotes|antidotes|mesh-ancestor
83983626|NCT04752696|Protective Agents|protective agents|mesh-ancestor
83983627|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
83983628|NCT04752696|Vitamins|vitamins|mesh-ancestor
83983629|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
83983630|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983631|NCT04554732|Mitogens|mitogens|mesh-list
83983632|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
83983633|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983634|NCT04481256|Paclitaxel|paclitaxel|mesh-list
83983635|NCT04481256|Carboplatin|carboplatin|mesh-list
83983636|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83983637|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983638|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
83983639|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
83983640|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
83983641|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983642|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
83983643|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
83983644|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983645|NCT03434418|Osimertinib|osimertinib|mesh-list
83983646|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983647|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983648|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983649|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983650|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
83983651|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83983652|NCT03377478|Velpatasvir|velpatasvir|mesh-list
83983653|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
83983654|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983655|NCT03181932|Vancomycin|vancomycin|mesh-list
83983656|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83983657|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983658|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
83983659|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83983660|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
83983661|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983662|NCT02583672|Expectorants|expectorants|mesh-ancestor
83983663|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
83983664|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83983665|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
83983666|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983667|NCT02583672|Protective Agents|protective agents|mesh-ancestor
83983668|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983669|NCT02583672|Antidotes|antidotes|mesh-ancestor
83983670|NCT02888730|Tobramycin|tobramycin|mesh-list
83983671|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83983672|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983673|NCT01696734|Domperidone|domperidone|mesh-list
83983674|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
83983675|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
83983676|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983677|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983678|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83983679|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83983680|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
83983681|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983682|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983683|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83983684|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83983685|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983686|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983687|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983688|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83476476|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983689|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983690|NCT01598298|Analgesics|analgesics|mesh-ancestor
83983691|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
83983692|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983693|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
83983694|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983695|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
83983696|NCT02888652|Clopidogrel|clopidogrel|mesh-list
83983697|NCT02888652|Ticagrelor|ticagrelor|mesh-list
83983698|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83983699|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83983700|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83983701|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83983702|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
83983703|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983704|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983705|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983706|NCT01235949|Acetaminophen|acetaminophen|mesh-list
83983707|NCT01235949|Ibuprofen|ibuprofen|mesh-list
83983708|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83983709|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83983710|NCT01235949|Analgesics|analgesics|mesh-ancestor
83983711|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
83983712|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983713|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983714|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983715|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983716|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83983717|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983718|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983719|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
83983720|NCT00691158|Pramlintide|pramlintide|mesh-list
83983721|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83983722|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83983723|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983724|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
83983725|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83983726|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83983727|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983728|NCT01235793|Temozolomide|temozolomide|mesh-list
83983729|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83983730|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
83983731|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983732|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983733|NCT05601648|Psilocybin|psilocybin|mesh-list
83983734|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
83983735|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983736|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983737|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83983738|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
83983739|NCT01235715|Coagulants|coagulants|mesh-ancestor
83983740|NCT01235403|Lacosamide|lacosamide|mesh-list
83983741|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
83983742|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83983743|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83983744|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983745|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983746|NCT01024036|Siltuximab|siltuximab|mesh-list
83983747|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983748|NCT01234467|Rituximab|rituximab|mesh-list
83983749|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83983750|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83983751|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983752|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
83983753|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983754|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983755|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83983756|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
83983757|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983758|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
83983759|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83983760|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83983761|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83983762|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983763|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983764|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
83983765|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983766|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983767|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83983768|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983769|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83983770|NCT01233687|Rilotumumab|rilotumumab|mesh-list
83983771|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983772|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983773|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983774|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983775|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83983776|NCT01233609|Valproic Acid|valproic acid|mesh-list
83983777|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
83983778|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983779|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983780|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
83983781|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983782|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983783|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
83983784|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83983785|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983786|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983787|NCT01232283|Apremilast|apremilast|mesh-list
83983788|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83983789|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83983790|NCT01232283|Analgesics|analgesics|mesh-ancestor
83983791|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
83983792|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983793|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983794|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83983795|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983796|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83983797|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83983798|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983799|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983800|NCT01232127|Ritonavir|ritonavir|mesh-list
83983801|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83223126|NCT03416855|Insulin|insulin|mesh-list
83983802|NCT01232127|Tenofovir|tenofovir|mesh-list
83983803|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83983804|NCT01232127|Famotidine|famotidine|mesh-list
83983805|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83983806|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83983807|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
83983808|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983809|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983810|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83983811|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83983812|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
83983813|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983814|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83983815|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83983816|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83983817|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83983818|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83983819|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83983820|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
83983821|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
83983822|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983823|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983824|NCT01258608|Sorafenib|sorafenib|mesh-list
83983825|NCT01258608|Mapatumumab|mapatumumab|mesh-list
83983826|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983827|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983828|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983829|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983830|NCT01231659|Everolimus|everolimus|mesh-list
83983831|NCT01231659|Letrozole|letrozole|mesh-list
83983832|NCT01231659|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83983833|NCT01231659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983834|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983835|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983836|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983837|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
83983838|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983839|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983840|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83983841|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83983842|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83983843|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
83983844|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983845|NCT02875288|Bupivacaine|bupivacaine|mesh-list
83983846|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
83983847|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
83983848|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983849|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983850|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
83983851|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983852|NCT01054222|Fesoterodine|fesoterodine|mesh-list
83983853|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83983854|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83983855|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
83983856|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983857|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983858|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983859|NCT01054222|Urological Agents|urological agents|mesh-ancestor
83983860|NCT01052428|Metoprolol|metoprolol|mesh-list
83983861|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83983862|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83983863|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
83983864|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
83983865|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983866|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983867|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83983868|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83983869|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83983870|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
83983871|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983872|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983873|NCT01052272|Allopurinol|allopurinol|mesh-list
83983874|NCT01052272|Candesartan|candesartan|mesh-list
83983875|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
83983876|NCT01052272|Ramipril|ramipril|mesh-list
83983877|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83983878|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83983879|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83983880|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983881|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
83983882|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983883|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
83983884|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83983885|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83983886|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
83983887|NCT01052272|Protective Agents|protective agents|mesh-ancestor
83983888|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983889|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83983890|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
83983891|NCT01257204|Interferons|interferons|mesh-list
83983892|NCT01257204|Ribavirin|ribavirin|mesh-list
83983893|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
83983894|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
83983895|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83983896|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983897|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
83983898|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983899|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
83983900|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983901|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
83983902|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983903|NCT01231581|Gemcitabine|gemcitabine|mesh-list
83983904|NCT01231581|Trametinib|trametinib|mesh-list
83983905|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83983906|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
83983907|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983908|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983909|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83983910|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983911|NCT01050634|Exemestane|exemestane|mesh-list
83983912|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983913|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83983914|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83983915|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983916|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983917|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83983918|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
83983919|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983920|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983921|NCT01020526|Pregabalin|pregabalin|mesh-list
83983922|NCT01020526|Analgesics|analgesics|mesh-ancestor
83983923|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
83983924|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83983925|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983926|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
83983927|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83983928|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983929|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983930|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83983931|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83983932|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83983933|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83983934|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83983935|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83983936|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
83983937|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83983938|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
83983939|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83983940|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983941|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83983942|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83983943|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983944|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83983945|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83983946|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983947|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
83983948|NCT01256658|Lumefantrine|lumefantrine|mesh-list
83983949|NCT01256658|Artemether|artemether|mesh-list
83983950|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83983951|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
83983952|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83983953|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83983954|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83983955|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83983956|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
83983957|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
83983958|NCT01256190|Coagulants|coagulants|mesh-ancestor
83983959|NCT02888574|Oxytocin|oxytocin|mesh-list
83983960|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
83983961|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83983962|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983963|NCT01231503|Vaccines|vaccines|mesh-list
83983964|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
83983965|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983966|NCT01228071|Testosterone|testosterone|mesh-list
83983967|NCT01228071|Androgens|androgens|mesh-ancestor
83983968|NCT01228071|Hormones|hormones|mesh-ancestor
83983969|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83983970|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983971|NCT04319289|Vitamin D|vitamin d|mesh-list
83983972|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
83983973|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
83983974|NCT04319289|Vitamins|vitamins|mesh-list
83983975|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
83983976|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983977|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83983978|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83983979|NCT01008475|Irinotecan|irinotecan|mesh-list
83983980|NCT01008475|Cetuximab|cetuximab|mesh-list
83983981|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83983982|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83983983|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83983984|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983985|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83983986|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83983987|NCT01226745|Ceralifimod|ceralifimod|mesh-list
83983988|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83983989|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983990|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83983991|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
83983992|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83983993|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83983994|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83983995|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83983996|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83983997|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83983998|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83983999|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984000|NCT01226511|Analgesics|analgesics|mesh-ancestor
83984001|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
83984002|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984003|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
83984004|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984005|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
83984006|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
83984007|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984008|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984009|NCT01001377|Cetuximab|cetuximab|mesh-list
83984010|NCT01001377|Panitumumab|panitumumab|mesh-list
83984011|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984012|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984013|NCT01225887|Nintedanib|nintedanib|mesh-list
83984014|NCT01225887|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83984015|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984016|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83984017|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984018|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984019|NCT01296932|BI 836826|bi 836826|mesh-list
83984020|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984021|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984022|NCT01296698|Nicotine|nicotine|mesh-list
83984023|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83984024|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
83984025|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223353|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984026|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984027|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83984028|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83984029|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
83984030|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984031|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984032|NCT01001221|Gemcitabine|gemcitabine|mesh-list
83984033|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83984034|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
83984035|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984036|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984037|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83984038|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
83984039|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83984040|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83984041|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83984042|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
83984043|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83984044|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984045|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83984046|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83984047|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83984048|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83984049|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984050|NCT04373317|Pimavanserin|pimavanserin|mesh-list
83984051|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83984052|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
83984053|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984054|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83984055|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83984056|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984057|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984058|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83984059|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83984060|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83984061|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83984062|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
83984063|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984064|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984065|NCT01002547|Vitamins|vitamins|mesh-list
83984066|NCT01002547|Vitamin E|vitamin e|mesh-list
83984067|NCT01002547|Tocopherols|tocopherols|mesh-list
83984068|NCT01002547|Tocotrienols|tocotrienols|mesh-list
83984069|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
83984070|NCT01002547|Pioglitazone|pioglitazone|mesh-list
83984071|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
83984072|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984073|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984074|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
83984075|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984076|NCT01002547|Protective Agents|protective agents|mesh-ancestor
83984077|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
83984078|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984079|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83984080|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984081|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984082|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
83984083|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984084|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984085|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83984086|NCT04325659|Lofexidine|lofexidine|mesh-list
83984087|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83984088|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83984089|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984090|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
83984091|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984092|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83984093|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83984094|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83984095|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
83984096|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984097|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223432|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
83984099|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83984100|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83984101|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83984102|NCT04433767|Nicotine|nicotine|mesh-list
83984103|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83984104|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
83984105|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984106|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984107|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83984108|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83984109|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
83984110|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984111|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984112|NCT00998335|Insulin|insulin|mesh-list
83984113|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83984114|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
83984115|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
83984116|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83984117|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
83984118|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984119|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984120|NCT02871505|Penicillins|penicillins|mesh-list
83984121|NCT02871505|Penicillin G|penicillin g|mesh-list
83984122|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83984123|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
83984124|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83984125|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984126|NCT01294670|Etoposide|etoposide|mesh-list
83984127|NCT01294670|Vorinostat|vorinostat|mesh-list
83984128|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83984129|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984130|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83984131|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83984132|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984133|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984134|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83984135|NCT01006603|Glimepiride|glimepiride|mesh-list
83984136|NCT01006603|Saxagliptin|saxagliptin|mesh-list
83984137|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83984138|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984139|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984140|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984141|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
83984142|NCT01006603|Incretins|incretins|mesh-ancestor
83984143|NCT01006603|Hormones|hormones|mesh-ancestor
83984144|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984145|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83984146|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984147|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984148|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984149|NCT00997321|Ketamine|ketamine|mesh-list
83984150|NCT00997321|Propofol|propofol|mesh-list
83984151|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83984152|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984153|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984154|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83984155|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
83984156|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
83984157|NCT00997321|Analgesics|analgesics|mesh-ancestor
83984158|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
83984159|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984160|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83984161|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83984162|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83984163|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984164|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984165|NCT01294592|Tamsulosin|tamsulosin|mesh-list
83984166|NCT01294592|Dutasteride|dutasteride|mesh-list
83984167|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83984168|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83984169|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83984170|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
83984171|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984172|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984173|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984175|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83984176|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83984177|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984178|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
83984179|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984180|NCT00997243|Azacitidine|azacitidine|mesh-list
83984181|NCT00997243|Lintuzumab|lintuzumab|mesh-list
83984182|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83984183|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
83984184|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984185|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984186|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984187|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984188|NCT02869321|Fentanyl|fentanyl|mesh-list
83984189|NCT02869321|Morphine|morphine|mesh-list
83984190|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83984191|NCT02869321|Narcotics|narcotics|mesh-ancestor
83984192|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984193|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984194|NCT02869321|Analgesics|analgesics|mesh-ancestor
83984195|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
83984196|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984197|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83984198|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83984199|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
83984200|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
83984201|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
83984202|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83984203|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984204|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984205|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984206|NCT01294358|Gemcitabine|gemcitabine|mesh-list
83984207|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83984208|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
83984209|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984210|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984211|NCT01224639|Vaccines|vaccines|mesh-list
83984212|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
83984213|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984214|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
83984215|NCT01293968|Promethazine|promethazine|mesh-list
83984216|NCT01293968|Ibuprofen|ibuprofen|mesh-list
83984217|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83984218|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83984219|NCT01293968|Analgesics|analgesics|mesh-ancestor
83984220|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
83984221|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984222|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984223|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83984224|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83984225|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83984226|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984227|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984228|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83984229|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83984230|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984231|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
83984232|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
83984233|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
83984234|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
83984235|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83984236|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83984237|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
83984238|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
83984239|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984240|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83984241|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
83984242|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
83984243|NCT01293032|Tamoxifen|tamoxifen|mesh-list
83984244|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83984245|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984246|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83984247|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
83984248|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984249|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984250|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83984251|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984252|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83984253|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83984254|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83984255|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83984256|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984257|NCT01224171|Vedolizumab|vedolizumab|mesh-list
83984258|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83984259|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83984260|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
83984261|NCT01223937|Coagulants|coagulants|mesh-ancestor
83984262|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83984263|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
83984264|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984265|NCT01223235|Bevacizumab|bevacizumab|mesh-list
83984266|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984267|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984268|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83984269|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83984270|NCT01223235|Growth Substances|growth substances|mesh-ancestor
83984271|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984272|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
83984273|NCT00993967|Idebenone|idebenone|mesh-list
83984274|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
83984275|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984276|NCT00993967|Protective Agents|protective agents|mesh-ancestor
83984277|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984278|NCT04204603|CKD-506|ckd-506|mesh-list
83984279|NCT04204603|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83984280|NCT04204603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984281|NCT04204603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984282|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
83984283|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83984284|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
83984285|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984286|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984287|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83984288|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
83984289|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
83984290|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83984291|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
83984292|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984293|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984294|NCT01221753|Carboplatin|carboplatin|mesh-list
83984295|NCT01221753|Docetaxel|docetaxel|mesh-list
83984296|NCT01221753|Fluorouracil|fluorouracil|mesh-list
83984297|NCT01221753|Cetuximab|cetuximab|mesh-list
83984298|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984299|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
83984300|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
83984301|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
83984302|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984303|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
83984304|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83984305|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984306|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
83984307|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984308|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984309|NCT02888223|Factor VIII|factor viii|mesh-list
83984310|NCT02888223|Coagulants|coagulants|mesh-ancestor
83984311|NCT01014988|Zanamivir|zanamivir|mesh-list
83984312|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
83984313|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984314|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984315|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984316|NCT01019980|Acetaminophen|acetaminophen|mesh-list
83984317|NCT01019980|Diclofenac|diclofenac|mesh-list
83984318|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83984319|NCT01019980|Analgesics|analgesics|mesh-ancestor
83984320|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
83984321|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223654|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83984322|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984323|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
83984324|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83984325|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83984326|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83984327|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83984328|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984329|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984330|NCT00993499|Sirolimus|sirolimus|mesh-list
83984331|NCT00993499|Afatinib|afatinib|mesh-list
83984332|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83984333|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984334|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83984335|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984336|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
83984337|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984338|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
83984339|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984340|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83984341|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984342|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984343|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
83984344|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83984345|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984346|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83984347|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
83984348|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83984349|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984350|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984351|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984352|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83984353|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83984354|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
83984355|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984356|NCT02869165|Estrogens|estrogens|mesh-list
83984357|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83984358|NCT02869165|Hormones|hormones|mesh-ancestor
83984359|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984360|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984361|NCT01219959|Icodextrin|icodextrin|mesh-list
83984362|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
83984363|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83984364|NCT00993421|Sibutramine|sibutramine|mesh-list
83984365|NCT00993421|Metoprolol|metoprolol|mesh-list
83984366|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83984367|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83984368|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
83984369|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
83984370|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984371|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984372|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83984373|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83984374|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83984375|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
83984376|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984377|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984378|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
83984379|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984380|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
83984381|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83984382|NCT01014208|Rituximab|rituximab|mesh-list
83984383|NCT01014208|Ofatumumab|ofatumumab|mesh-list
83984384|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984385|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984386|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
83984387|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984388|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83984389|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83984390|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83984391|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83984392|NCT04205578|Protective Agents|protective agents|mesh-ancestor
83984393|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984394|NCT00991939|Dexamethasone|dexamethasone|mesh-list
83984395|NCT00991939|Prednisone|prednisone|mesh-list
83984396|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83984397|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
83984399|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984400|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984401|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83984402|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
83984403|NCT00991939|Hormones|hormones|mesh-ancestor
83984404|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984405|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83984406|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984407|NCT02868385|Praziquantel|praziquantel|mesh-list
83984408|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
83984409|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83984410|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984411|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
83984412|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83984413|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
83984414|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984415|NCT00993265|Expectorants|expectorants|mesh-ancestor
83984416|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
83984417|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83984418|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
83984419|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984420|NCT00993265|Protective Agents|protective agents|mesh-ancestor
83984421|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984422|NCT00993265|Antidotes|antidotes|mesh-ancestor
83984423|NCT00993031|Ritonavir|ritonavir|mesh-list
83984424|NCT00993031|Lopinavir|lopinavir|mesh-list
83984425|NCT00993031|Lamivudine|lamivudine|mesh-list
83984426|NCT00993031|Zidovudine|zidovudine|mesh-list
83984427|NCT00993031|Efavirenz|efavirenz|mesh-list
83984428|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83984429|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83984430|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984431|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984432|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984433|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83984434|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83984435|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
83984436|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984437|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83984438|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83984439|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83984440|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83984441|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
83984442|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83984443|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83984444|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83984445|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83984446|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83984447|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83984448|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83984449|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83984450|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984451|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984452|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984453|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83984454|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83984455|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
83984456|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984457|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984458|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83984459|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83984460|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
83984461|NCT04291729|Interferons|interferons|mesh-list
83984462|NCT04291729|Ritonavir|ritonavir|mesh-list
83984463|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984464|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
83984465|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984466|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83984467|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83984468|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984469|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984470|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984471|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83984472|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83984473|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83984474|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83984475|NCT02868931|Insulin|insulin|mesh-list
83984476|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984477|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984478|NCT01018810|Interleukin-23|interleukin-23|mesh-list
83984479|NCT01018810|Antibodies|antibodies|mesh-list
83984480|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
83984481|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
83984482|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984483|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83984484|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83984485|NCT01018810|Growth Substances|growth substances|mesh-ancestor
83984486|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
83984487|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984488|NCT02867917|Psyllium|psyllium|mesh-list
83984489|NCT02867917|Cathartics|cathartics|mesh-ancestor
83984490|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83984491|NCT01018732|Lactitol|lactitol|mesh-list
83984492|NCT01018732|Cathartics|cathartics|mesh-ancestor
83984493|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83984494|NCT01218867|Aldesleukin|aldesleukin|mesh-list
83984495|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
83984496|NCT01218867|Fludarabine|fludarabine|mesh-list
83984497|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984498|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
83984499|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984500|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83984501|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83984502|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
83984503|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984504|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984505|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83984506|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83984507|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83984508|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
83984509|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984510|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
83984511|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83984512|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83984513|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
83984514|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984515|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984516|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984517|NCT01018264|Urological Agents|urological agents|mesh-ancestor
83984518|NCT01018186|Fluticasone|fluticasone|mesh-list
83984519|NCT01018186|Xhance|xhance|mesh-list
83984520|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83984521|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83984522|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
83984523|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984524|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984525|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83984526|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
83984527|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
83984528|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83984529|NCT00992407|Risperidone|risperidone|mesh-list
83984530|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83984531|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
83984532|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984533|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984534|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984535|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83984536|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83984537|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984538|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984539|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83984540|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
83984541|NCT00986245|Ropinirole|ropinirole|mesh-list
83984542|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83984543|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83984544|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
83984545|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
83984546|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984547|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984548|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984549|NCT00989833|Budesonide|budesonide|mesh-list
83984550|NCT00989833|Terbutaline|terbutaline|mesh-list
83984551|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
83984552|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83984553|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83984554|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
83984555|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984556|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984557|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83984558|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
83984559|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
83984560|NCT00989833|Hormones|hormones|mesh-ancestor
83984561|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984562|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83984563|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83984564|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83984565|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
83984566|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984567|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984568|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
83984569|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
83984570|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83984571|NCT04292119|Crizotinib|crizotinib|mesh-list
83984572|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984573|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83984574|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984575|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984576|NCT01218477|Dasatinib|dasatinib|mesh-list
83984577|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984578|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83984579|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984580|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984581|NCT01218009|Albuterol|albuterol|mesh-list
83984582|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83984583|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
83984584|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984585|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984586|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83984587|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
83984588|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
83984589|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83984590|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83984591|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83984592|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83984593|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
83984594|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984595|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984596|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
83984597|NCT02868151|Vitamins|vitamins|mesh-ancestor
83984598|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
83984599|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984600|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
83984601|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984602|NCT02868151|Protective Agents|protective agents|mesh-ancestor
83984603|NCT01217307|Metformin|metformin|mesh-list
83984604|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984605|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984606|NCT02868073|Vaccines|vaccines|mesh-list
83984607|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
83984608|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984609|NCT01013740|Capecitabine|capecitabine|mesh-list
83984610|NCT01013740|Vinorelbine|vinorelbine|mesh-list
83984611|NCT01013740|Lapatinib|lapatinib|mesh-list
83984612|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83984613|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
83984614|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984615|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984616|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83984617|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
83984618|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
83984619|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
83984620|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83984621|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984622|NCT01217073|Metformin|metformin|mesh-list
83984623|NCT01217073|Pioglitazone|pioglitazone|mesh-list
83984624|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984625|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984626|NCT00985621|Oxycodone|oxycodone|mesh-list
83984628|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83984629|NCT00985621|Narcotics|narcotics|mesh-ancestor
83984630|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984631|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984632|NCT00985621|Analgesics|analgesics|mesh-ancestor
83984633|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
83984634|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984635|NCT01215981|Vaccines|vaccines|mesh-list
83984636|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
83984637|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984638|NCT01215435|Insulin|insulin|mesh-list
83984639|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83984640|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
83984641|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
83984642|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83984643|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
83984644|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83984645|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
83984646|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984647|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984648|NCT01215357|Ecopipam|ecopipam|mesh-list
83984649|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83984650|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83984651|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984652|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984653|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984654|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83984655|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
83984656|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984657|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984658|NCT01017874|Pemetrexed|pemetrexed|mesh-list
83984659|NCT01017874|Gefitinib|gefitinib|mesh-list
83984660|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984661|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984662|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984663|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83984664|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83984665|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83984666|NCT00627952|Amlodipine|amlodipine|mesh-list
83984667|NCT00627952|Manidipine|manidipine|mesh-list
83984668|NCT00627952|Delapril|delapril|mesh-list
83984669|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83984670|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83984671|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83984672|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984673|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83984674|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984675|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
83984676|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83984677|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984678|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984679|NCT01009840|Bortezomib|bortezomib|mesh-list
83984680|NCT01009840|Busulfan|busulfan|mesh-list
83984681|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984682|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
83984683|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984684|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984685|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
83984686|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984687|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83984688|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83984689|NCT04420936|Benzocaine|benzocaine|mesh-list
83984690|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
83984691|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
83984692|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984693|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984694|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
83984695|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984696|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
83984697|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
83984698|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83984699|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
83984700|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984701|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984702|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83984703|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
83984704|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
83984705|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83984706|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
83984707|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984708|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984709|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83984710|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83984712|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984713|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83984714|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83984715|NCT00982657|Growth Substances|growth substances|mesh-ancestor
83984716|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984717|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
83984718|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83984719|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984720|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984721|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
83984722|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984723|NCT02867293|Anesthetics|anesthetics|mesh-list
83984724|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984725|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984726|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
83984727|NCT01005316|Prednisone|prednisone|mesh-list
83984728|NCT01005316|Tacrolimus|tacrolimus|mesh-list
83984729|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
83984730|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83984731|NCT01005316|Antibodies|antibodies|mesh-list
83984732|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
83984733|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83984734|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83984735|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
83984736|NCT01005316|Hormones|hormones|mesh-ancestor
83984737|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83984738|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984739|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83984740|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984741|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984742|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
83984743|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83984744|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984745|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984746|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83984747|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83984748|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
83984749|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83984750|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984751|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83984752|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
83984753|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83984754|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83984755|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83984756|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984757|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
83984758|NCT01008904|Antacids|antacids|mesh-ancestor
83984759|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984760|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83984761|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
83984762|NCT04290793|Trastuzumab|trastuzumab|mesh-list
83984763|NCT04290793|Epirubicin|epirubicin|mesh-list
83984764|NCT04290793|Taxane|taxane|mesh-list
83984765|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984766|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
83984767|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984768|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83984769|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83984770|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
83984771|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984772|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984773|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83984774|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984775|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83984776|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83984777|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83984778|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984779|NCT01004614|Amlodipine|amlodipine|mesh-list
83984780|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83984781|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83984782|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83984783|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984784|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83984785|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984786|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
83984787|NCT04297462|Oseltamivir|oseltamivir|mesh-list
83984788|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
83984789|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984790|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984791|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984792|NCT00981409|Heparin|heparin|mesh-list
83984793|NCT00981409|Calcium heparin|calcium heparin|mesh-list
83984794|NCT00981409|PENTA|penta|mesh-list
83984795|NCT00981409|Fondaparinux|fondaparinux|mesh-list
83984796|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
83984797|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83984798|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83984799|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984800|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83984801|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
83984802|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83984803|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984804|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984805|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
83984806|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83984807|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
83984808|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83984809|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984810|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984811|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984812|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
83984813|NCT01008748|Nicotine|nicotine|mesh-list
83984814|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83984815|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
83984816|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984817|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984818|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83984819|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83984820|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
83984821|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984822|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984823|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
83984824|NCT00628732|Topotecan|topotecan|mesh-list
83984825|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984826|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
83984827|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984828|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83984829|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83984830|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
83984831|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984832|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984833|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83984834|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83984835|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83984836|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984837|NCT04131829|Fluoxetine|fluoxetine|mesh-list
83984838|NCT04131829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83984839|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83984840|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83984841|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984842|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984843|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
83984844|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984845|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83984846|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
83984847|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984848|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83984849|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83984850|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984851|NCT04205344|Bupivacaine|bupivacaine|mesh-list
83984852|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
83984853|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
83984854|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984855|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984856|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
83984857|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984858|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83984859|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83984860|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83984861|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
83984862|NCT00978757|Ketamine|ketamine|mesh-list
83984863|NCT00978757|Analgesics|analgesics|mesh-ancestor
83984864|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
83984865|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83984866|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984867|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83984868|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83984869|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
83984870|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
83984871|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984872|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83984873|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83984874|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984875|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984876|NCT01214421|Tolvaptan|tolvaptan|mesh-list
83984877|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83984878|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984879|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
83984880|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984881|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
83984882|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
83984883|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984884|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
83984885|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984886|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984887|NCT02866903|Bevacizumab|bevacizumab|mesh-list
83984888|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
83984889|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984890|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984891|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83984892|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83984893|NCT02866903|Growth Substances|growth substances|mesh-ancestor
83984894|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984895|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
83984896|NCT03945019|Infliximab|infliximab|mesh-list
83984897|NCT03945019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83984898|NCT03945019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83984899|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
83984900|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83984901|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83984902|NCT01003990|Ritonavir|ritonavir|mesh-list
83984903|NCT01003990|Lopinavir|lopinavir|mesh-list
83984904|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83984905|NCT01003990|Tenofovir|tenofovir|mesh-list
83984906|NCT01003990|Emtricitabine|emtricitabine|mesh-list
83984907|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83984908|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83984909|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
83984910|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984911|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984912|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83984913|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83984914|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
83984915|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83984916|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83984917|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83984918|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83984919|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83984920|NCT01002820|Ganaxolone|ganaxolone|mesh-list
83984921|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
83984922|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984923|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984924|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984926|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
83984927|NCT01012258|Cetuximab|cetuximab|mesh-list
83984928|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984929|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984930|NCT00628810|Leucovorin|leucovorin|mesh-list
83984931|NCT00628810|Bevacizumab|bevacizumab|mesh-list
83984932|NCT00628810|Fluorouracil|fluorouracil|mesh-list
83984933|NCT00628810|Irinotecan|irinotecan|mesh-list
83984934|NCT00628810|Calcium|calcium|mesh-list
83984935|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
83984936|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83984937|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984938|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83984939|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83984940|NCT00628810|Growth Substances|growth substances|mesh-ancestor
83984941|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984942|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
83984943|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83984944|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
83984945|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984946|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83984947|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83984948|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
83984949|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83984950|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83984951|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83984952|NCT00628810|Antidotes|antidotes|mesh-ancestor
83984953|NCT00628810|Protective Agents|protective agents|mesh-ancestor
83984954|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
83984955|NCT00628810|Vitamins|vitamins|mesh-ancestor
83984956|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
83984957|NCT00975481|Alprazolam|alprazolam|mesh-list
83984958|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83984959|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83984960|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984961|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83476477|NCT02543658|Neostigmine|neostigmine|mesh-list
83984962|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83984963|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83984964|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
83984965|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
83984966|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83984967|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984968|NCT01011868|Empagliflozin|empagliflozin|mesh-list
83984969|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83984970|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984971|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83984972|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984973|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
83984974|NCT04290013|Norethindrone|norethindrone|mesh-list
83984975|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
83984976|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83984977|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83984978|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984979|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
83984980|NCT04290013|Coagulants|coagulants|mesh-ancestor
83984981|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83984982|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83984983|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83984984|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
83984985|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83984986|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83984987|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83984988|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83984989|NCT04288999|Capecitabine|capecitabine|mesh-list
83984990|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83984991|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
83984992|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83984993|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83984994|NCT01213173|Metoprolol|metoprolol|mesh-list
83984995|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83984996|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83984997|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
83984998|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
83224325|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
83984999|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985000|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985001|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83985002|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83985003|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83985004|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83985005|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985006|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985007|NCT04095715|Hemostatics|hemostatics|mesh-list
83985008|NCT04095715|Coagulants|coagulants|mesh-ancestor
83985009|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
83985010|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985011|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
83985012|NCT02866435|Protective Agents|protective agents|mesh-ancestor
83985013|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83985014|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83985015|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985016|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83985017|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
83985018|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83985019|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83985020|NCT01211769|Naltrexone|naltrexone|mesh-list
83985021|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83985022|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83985023|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985024|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
83985025|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985026|NCT04288765|Dexamethasone|dexamethasone|mesh-list
83985027|NCT04288765|Lenalidomide|lenalidomide|mesh-list
83985028|NCT04288765|Daratumumab|daratumumab|mesh-list
83985029|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985030|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
83985031|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
83985032|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985033|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985034|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83985035|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
83985036|NCT04288765|Hormones|hormones|mesh-ancestor
83985037|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985038|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83985039|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985040|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
83985041|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83985042|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83985043|NCT04288765|Growth Substances|growth substances|mesh-ancestor
83985044|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
83985045|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83985046|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
83985047|NCT02863861|Ketamine|ketamine|mesh-list
83985048|NCT02863861|Propofol|propofol|mesh-list
83985049|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83985050|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985051|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985052|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985053|NCT02863861|Analgesics|analgesics|mesh-ancestor
83985054|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
83985055|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985056|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83985057|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83985058|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83985059|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
83985060|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985061|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985062|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83985063|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
83985064|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
83985065|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83985066|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83985067|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83985068|NCT05406765|Bupivacaine|bupivacaine|mesh-list
83985069|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
83985070|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
83985071|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985072|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985073|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
83985074|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985075|NCT03846505|Oxytocin|oxytocin|mesh-list
83985076|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
83985077|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83985078|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985079|NCT01011556|Teriparatide|teriparatide|mesh-list
83985080|NCT01011556|Hormones|hormones|mesh-list
83985081|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
83985082|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985083|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985084|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985085|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83985086|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
83985087|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
83985088|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83985089|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83985090|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
83985091|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985092|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985093|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985094|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985095|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83985096|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985097|NCT00977665|Rasagiline|rasagiline|mesh-list
83985098|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83985099|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985100|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985101|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83985102|NCT00977665|Protective Agents|protective agents|mesh-ancestor
83985103|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985104|NCT04298008|Durvalumab|durvalumab|mesh-list
83985105|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985106|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985107|NCT00628342|Esomeprazole|esomeprazole|mesh-list
83985108|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83985109|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83985110|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83985111|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985112|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985113|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
83985114|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83985115|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985116|NCT04287361|Clonazepam|clonazepam|mesh-list
83985117|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
83985118|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
83985119|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
83985120|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985121|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985122|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985123|NCT00624429|Budesonide|budesonide|mesh-list
83985124|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985125|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83985126|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
83985127|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985128|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985129|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83985130|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
83985131|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
83985132|NCT00624429|Hormones|hormones|mesh-ancestor
83985133|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985134|NCT01001572|Amlodipine|amlodipine|mesh-list
83985135|NCT01001572|Valsartan|valsartan|mesh-list
83985136|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83985137|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83985138|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985139|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985140|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985141|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985142|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
83985143|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83985144|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83985145|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
83985146|NCT04287205|Progestins|progestins|mesh-ancestor
83985147|NCT04287205|Hormones|hormones|mesh-ancestor
84124719|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985148|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985149|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985150|NCT00628576|Heparin|heparin|mesh-list
83985151|NCT00628576|Calcium heparin|calcium heparin|mesh-list
83985152|NCT00628576|Tinzaparin|tinzaparin|mesh-list
83985153|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83985154|NCT00628576|Dalteparin|dalteparin|mesh-list
83985155|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
83985156|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83985157|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83985158|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985159|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
83985160|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985161|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985162|NCT04370548|Clindamycin|clindamycin|mesh-list
83985163|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
83985164|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
83985165|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83985166|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985167|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83985168|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985169|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985170|NCT01208181|Etoricoxib|etoricoxib|mesh-list
83985171|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83985172|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985173|NCT01208181|Analgesics|analgesics|mesh-ancestor
83985174|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
83985175|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985176|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985177|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985178|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985179|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83985180|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83985181|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985182|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985183|NCT01208103|Bevacizumab|bevacizumab|mesh-list
83985184|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83985185|NCT01208103|Capecitabine|capecitabine|mesh-list
83985186|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
83985187|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
83985188|NCT01208103|Antibodies|antibodies|mesh-list
83985189|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
83985190|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83985191|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
83985192|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985193|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83985194|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83985195|NCT01208103|Growth Substances|growth substances|mesh-ancestor
83985196|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985197|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
83985198|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
83985199|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83985200|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
83985201|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985202|NCT01206777|Rituximab|rituximab|mesh-list
83985203|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985204|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985205|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
83985206|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985207|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985208|NCT01001494|Bromides|bromides|mesh-list
83985209|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
83985210|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83985211|NCT01205685|Letrozole|letrozole|mesh-list
83985212|NCT01205685|Goserelin|goserelin|mesh-list
83985213|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985214|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83985215|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985216|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985217|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83985218|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83985219|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83985220|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
83985221|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124720|NCT00682656|Azithromycin|azithromycin|mesh-list
83224547|NCT01374217|Clarithromycin|clarithromycin|mesh-list
83985222|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985223|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83985224|NCT01205529|Procainamide|procainamide|mesh-list
83985225|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83985226|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83985227|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83985228|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985229|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985231|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
83985232|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985233|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83985234|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985235|NCT04294966|Analgesics|analgesics|mesh-ancestor
83985236|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
83985237|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985238|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83985239|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83985240|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985241|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985242|NCT04294966|Hormones|hormones|mesh-ancestor
83985243|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985244|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
83985245|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83985246|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83985247|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83985248|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985249|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985250|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
83985251|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985252|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985253|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83985254|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985255|NCT04294732|Bupivacaine|bupivacaine|mesh-list
83985256|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
83985257|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
83985258|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985259|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985260|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
83985261|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985262|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
83985263|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83985264|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985265|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83985266|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985267|NCT01001104|Dulaglutide|dulaglutide|mesh-list
83985268|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83985269|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985270|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
83985271|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
83985272|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83985273|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985274|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83985275|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83985276|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985277|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985278|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985279|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83985280|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83985281|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83985282|NCT01204671|Vaccines|vaccines|mesh-list
83985283|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
83985284|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985285|NCT01202955|Tolcapone|tolcapone|mesh-list
83985286|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83985287|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83985288|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83985289|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985290|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985291|NCT01202877|Azacitidine|azacitidine|mesh-list
83985292|NCT01202877|Midostaurin|midostaurin|mesh-list
83985293|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83985295|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985296|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985297|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985298|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83985299|NCT01202409|Panitumumab|panitumumab|mesh-list
83985300|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985301|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985302|NCT01202175|Nebivolol|nebivolol|mesh-list
83985303|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83985304|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
83985305|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83985306|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83985307|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83985308|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
83985309|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985310|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985311|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985312|NCT01201785|Aspirin|aspirin|mesh-list
83985313|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83985314|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985315|NCT01201785|Analgesics|analgesics|mesh-ancestor
83985316|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
83985317|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985318|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985319|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985320|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985321|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83985322|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83985323|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985324|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83985325|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83985326|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985327|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
83985328|NCT01200069|Ibuprofen|ibuprofen|mesh-list
83985329|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83985330|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985331|NCT01200069|Analgesics|analgesics|mesh-ancestor
83985332|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
83985333|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985334|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985335|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985336|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985337|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83985338|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985339|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985340|NCT01199289|Brodalumab|brodalumab|mesh-list
83985341|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
83985342|NCT01199055|Paclitaxel|paclitaxel|mesh-list
83985343|NCT01199055|Carboplatin|carboplatin|mesh-list
83985344|NCT01199055|Efatutazone|efatutazone|mesh-list
83985345|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83985346|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985347|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
83985348|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
83985349|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83985350|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985351|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
83985352|NCT01198587|Astringents|astringents|mesh-ancestor
83985353|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985354|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
83985355|NCT01198509|Vancomycin|vancomycin|mesh-list
83985356|NCT01198509|Doxycycline|doxycycline|mesh-list
83985357|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83985358|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985359|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
83985360|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83985361|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83985362|NCT01198275|Amiodarone|amiodarone|mesh-list
83985363|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83985364|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
83985365|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83985366|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985367|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985368|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83985369|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83985370|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83985371|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985372|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83985373|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83985374|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83985375|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
83985376|NCT01197417|Analgesics|analgesics|mesh-ancestor
83985377|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
83985378|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985379|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985380|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
83985381|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985382|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83985383|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
83985384|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83985385|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985386|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985387|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985388|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
83985389|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83985390|NCT00977431|Temozolomide|temozolomide|mesh-list
83985391|NCT00977431|Afatinib|afatinib|mesh-list
83985392|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83985393|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
83985394|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985395|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985396|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83985397|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985398|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
83985399|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83985400|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83985401|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83985402|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985403|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985404|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
83985405|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985406|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985407|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83985408|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985409|NCT02864095|Epinephrine|epinephrine|mesh-list
83985410|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
83985411|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83985412|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83985413|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985414|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
83985415|NCT02864095|Coagulants|coagulants|mesh-ancestor
83985416|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83985417|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83985418|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
83985419|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985420|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985421|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83985422|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83985423|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
83985424|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985425|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83985426|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
83985427|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
83985428|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
83985429|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83985430|NCT00977197|Pregabalin|pregabalin|mesh-list
83985431|NCT00977197|Analgesics|analgesics|mesh-ancestor
83985432|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
83985433|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985434|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985435|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
83985436|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83985437|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985438|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985439|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985440|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83224782|NCT04637555|Valsartan|valsartan|mesh-list
83985441|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83985442|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985443|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83985444|NCT04288219|Nifedipine|nifedipine|mesh-list
83985445|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83985446|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985447|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985448|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985449|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985450|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
83985451|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
83985452|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83985453|NCT00974233|Rituximab|rituximab|mesh-list
83985454|NCT00974233|Lenalidomide|lenalidomide|mesh-list
83985455|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83985456|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985457|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985458|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
83985459|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985460|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985461|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83985462|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83985463|NCT00974233|Growth Substances|growth substances|mesh-ancestor
83985464|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
83985465|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83985466|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
83985467|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985468|NCT00972595|Ondansetron|ondansetron|mesh-list
83985469|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
83985470|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
83985471|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985472|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985473|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83985474|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
83985475|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
83985476|NCT00972595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83985477|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83985478|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
83985479|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985480|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985481|NCT01196091|Antimalarials|antimalarials|mesh-list
83985482|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83985483|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83985484|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83985485|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985486|NCT01196091|Analgesics|analgesics|mesh-ancestor
83985487|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
83985488|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985489|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985490|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985491|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
83985492|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83985493|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83985494|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985495|NCT00972283|Insulin|insulin|mesh-list
83985496|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83985497|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
83985498|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
83985499|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83985500|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985501|NCT05366049|Acetaminophen|acetaminophen|mesh-list
83985502|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985503|NCT05366049|Analgesics|analgesics|mesh-ancestor
83985504|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
83985505|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985506|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985507|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
83985508|NCT00969709|Milnacipran|milnacipran|mesh-list
83985509|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
83985510|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83985511|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83985512|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985513|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985514|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124721|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83985515|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985516|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
83985517|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83985518|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985519|NCT00969709|Analgesics|analgesics|mesh-ancestor
83985520|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
83985521|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985522|NCT01193517|Capecitabine|capecitabine|mesh-list
83985523|NCT01193517|Azacitidine|azacitidine|mesh-list
83985524|NCT01193517|Decitabine|decitabine|mesh-list
83985525|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
83985526|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83985527|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
83985528|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985529|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985530|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985531|NCT02863705|Timolol|timolol|mesh-list
83985532|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83985533|NCT02863705|Bimatoprost|bimatoprost|mesh-list
83985534|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83985535|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83985536|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83985537|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83985538|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
83985539|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985540|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985541|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985542|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83985543|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83985544|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83985545|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83985546|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83985547|NCT01193283|Cyclosporine|cyclosporine|mesh-list
83985548|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
83985549|NCT01193283|Cyclosporins|cyclosporins|mesh-list
83985550|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83985551|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
83985552|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985553|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985554|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83985555|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
83985556|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985557|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985558|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83985559|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985560|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
83985561|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985562|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83985563|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83985564|NCT02863471|Gemcitabine|gemcitabine|mesh-list
83985565|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83985566|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
83985567|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985568|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985569|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83985570|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83985571|NCT01193127|Mydriatics|mydriatics|mesh-list
83985572|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
83985573|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985574|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985575|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83985576|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985577|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83985578|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985579|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985580|NCT01192191|Fluticasone|fluticasone|mesh-list
83985581|NCT01192191|Xhance|xhance|mesh-list
83985582|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985583|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83985584|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
83985585|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985586|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985587|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83985588|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
83985589|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83985590|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83985592|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83985593|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
83985594|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985595|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985596|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
83985597|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985598|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985599|NCT01307111|Misoprostol|misoprostol|mesh-list
83985600|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83985601|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
83985602|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83985603|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985604|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83985605|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83985606|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
83985607|NCT01191801|Cytarabine|cytarabine|mesh-list
83985608|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83985609|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
83985610|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985611|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985612|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
83985613|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985614|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83985615|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
83985616|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985617|NCT01306643|Idelalisib|idelalisib|mesh-list
83985618|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985619|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985620|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985621|NCT05656833|Cysteamine|cysteamine|mesh-list
83985622|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83985623|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985624|NCT01306331|Nonoxynol|nonoxynol|mesh-list
83985625|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83985626|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83985627|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985628|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83985629|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
83985630|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83985631|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83985632|NCT00624663|Rivastigmine|rivastigmine|mesh-list
83985633|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83985634|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985635|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985636|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
83985637|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985638|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985639|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83985640|NCT00624663|Protective Agents|protective agents|mesh-ancestor
83985641|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
83985642|NCT02890823|Vitamin D|vitamin d|mesh-list
83985643|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985644|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985645|NCT02890823|Vitamins|vitamins|mesh-ancestor
83985646|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
83985647|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83985648|NCT02887443|Midazolam|midazolam|mesh-list
83985649|NCT02887443|Idebenone|idebenone|mesh-list
83985650|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83985651|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83985652|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985653|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985654|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83985655|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83985656|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83985657|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83985658|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
83985659|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
83985660|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
83985661|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
83985662|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985663|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985664|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
83985665|NCT02887443|Protective Agents|protective agents|mesh-ancestor
83985666|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
83985667|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83985668|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985669|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83985670|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985672|NCT01305941|Everolimus|everolimus|mesh-list
83985673|NCT01305941|Vinorelbine|vinorelbine|mesh-list
83985674|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985675|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985676|NCT01305941|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83985677|NCT01305941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83985678|NCT01305941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985679|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985680|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83985681|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
83985682|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985683|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83985684|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
83985685|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
83985686|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83985687|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
83985688|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83985689|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
83985690|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985691|NCT05658549|Expectorants|expectorants|mesh-ancestor
83985692|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
83985693|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83985694|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
83985695|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985696|NCT05658549|Protective Agents|protective agents|mesh-ancestor
83985697|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985698|NCT05658549|Antidotes|antidotes|mesh-ancestor
83985699|NCT02887365|Tegafur|tegafur|mesh-list
83985700|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83985701|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
83985702|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985703|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985704|NCT05658159|Vitamin D|vitamin d|mesh-list
83985705|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
83985706|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
83985707|NCT05658159|Vitamins|vitamins|mesh-list
83985708|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
83985709|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985710|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83985711|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985712|NCT01305239|Exemestane|exemestane|mesh-list
83985713|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985714|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83985715|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83985716|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985717|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985718|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83985719|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
83985720|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985721|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985722|NCT04317183|Miconazole|miconazole|mesh-list
83985723|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
83985724|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985725|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83985726|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83985727|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985728|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985729|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83985730|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
83985731|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985732|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985733|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83985734|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83985735|NCT01194219|Apremilast|apremilast|mesh-list
83985736|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83985737|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985738|NCT01194219|Analgesics|analgesics|mesh-ancestor
83985739|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
83985740|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985741|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985742|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985743|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985744|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83985745|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83985746|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985747|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985748|NCT01304693|Ranibizumab|ranibizumab|mesh-list
83985749|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83985750|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83985751|NCT01304693|Growth Substances|growth substances|mesh-ancestor
83985752|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985753|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
83985754|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985755|NCT01304147|Ketamine|ketamine|mesh-list
83985756|NCT01304147|Analgesics|analgesics|mesh-ancestor
83985757|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
83985758|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985759|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985760|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83985761|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83985762|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
83985763|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
83985764|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985765|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83985766|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83985767|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985768|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985769|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
83985770|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83985771|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985772|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985773|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985774|NCT05661227|Analgesics|analgesics|mesh-ancestor
83985775|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
83985776|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985777|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83985778|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83985779|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83985780|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
83985781|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985782|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985783|NCT01303445|Omeprazole|omeprazole|mesh-list
83985784|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83985785|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83985786|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83985787|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83985788|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985789|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985790|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83985791|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83985792|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
83985793|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83985794|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
83985795|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985796|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985797|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
83985798|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985799|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83985800|NCT01302899|Ramipril|ramipril|mesh-list
83985801|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83985802|NCT01302899|Diuretics|diuretics|mesh-ancestor
83985803|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
83985804|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985805|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83985806|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985807|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985808|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83985809|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
83985810|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985811|NCT01187901|Sulindac|sulindac|mesh-list
83985813|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985814|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83985815|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985816|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985817|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83985818|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985819|NCT01187901|Analgesics|analgesics|mesh-ancestor
83985820|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
83985821|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985822|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985823|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83985824|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985825|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83985826|NCT01302119|Tavaborole|tavaborole|mesh-list
83985827|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83985828|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
83985829|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83985830|NCT01301729|Paclitaxel|paclitaxel|mesh-list
83985831|NCT01301729|Docetaxel|docetaxel|mesh-list
83985832|NCT01301729|Trastuzumab|trastuzumab|mesh-list
83985833|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83985834|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985835|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
83985836|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
83985837|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
83985838|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985839|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985840|NCT05643677|Irinotecan|irinotecan|mesh-list
83985841|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83985842|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83985843|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985844|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985845|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985846|NCT02890589|Chromium|chromium|mesh-list
83985847|NCT02890589|Everolimus|everolimus|mesh-list
83985848|NCT02890589|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83985849|NCT02890589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83985850|NCT02890589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985851|NCT02890589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985852|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83985853|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
83985854|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985855|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985856|NCT02890589|Trace Elements|trace elements|mesh-ancestor
83985857|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
83985858|NCT01301027|Pioglitazone|pioglitazone|mesh-list
83985859|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83985860|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985861|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83985862|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83985863|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83985864|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985865|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985866|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985867|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985868|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83985869|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
83985870|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83985871|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83985872|NCT02886897|Antibodies|antibodies|mesh-list
83985873|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
83985874|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985875|NCT05641649|Valproic Acid|valproic acid|mesh-list
83985876|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
83985877|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985878|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985879|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
83985880|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985881|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985882|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
83985883|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83225175|NCT05898633|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83225178|NCT05898451|Cisplatin|cisplatin|mesh-list
83985884|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83985885|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83985886|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83985888|NCT01184859|Coagulants|coagulants|mesh-ancestor
83985889|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83985890|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
83985891|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985892|NCT02890511|Paclitaxel|paclitaxel|mesh-list
83985893|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83985894|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985895|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
83985896|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
83985897|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
83985898|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985899|NCT01184079|Vaccines|vaccines|mesh-list
83985900|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
83985901|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985902|NCT05333289|Vaccines|vaccines|mesh-list
83985903|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
83985904|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985905|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83985906|NCT01289990|Empagliflozin|empagliflozin|mesh-list
83985907|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83985908|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985909|NCT01289990|Incretins|incretins|mesh-ancestor
83985910|NCT01289990|Hormones|hormones|mesh-ancestor
83985911|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985912|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83985913|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
83985914|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985915|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985916|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83985917|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83985918|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83985919|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83985920|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
83985921|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985922|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83985923|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83985924|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83985925|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83985926|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83985927|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985928|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83985929|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985930|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
83985931|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83985932|NCT01300247|Fludarabine|fludarabine|mesh-list
83985933|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
83985934|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83985935|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
83985936|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985937|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83985938|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83985939|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
83985940|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985941|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985942|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83985943|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83985944|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
83985945|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83985946|NCT02890277|Chitosan|chitosan|mesh-list
83985947|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83985948|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83985949|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
83985950|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985951|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83985952|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
83985953|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
83985954|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
83985955|NCT02890277|Coagulants|coagulants|mesh-ancestor
83985956|NCT01289678|Interleukin-2|interleukin-2|mesh-list
83985957|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985958|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83985959|NCT01289678|Analgesics|analgesics|mesh-ancestor
83985960|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
83985961|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83985962|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985963|NCT02890082|Tamoxifen|tamoxifen|mesh-list
83985964|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83985965|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
83985966|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985967|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985968|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83985969|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83985970|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83985971|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83985972|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83985973|NCT01183221|Oxytocin|oxytocin|mesh-list
83985974|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
83985975|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83985976|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985977|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83985978|NCT01183143|Hormones|hormones|mesh-ancestor
83985979|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83985980|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985981|NCT01183065|Folic Acid|folic acid|mesh-list
83985982|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
83985983|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
83985984|NCT01183065|Vitamins|vitamins|mesh-ancestor
83985985|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
83985986|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985987|NCT01183065|Hematinics|hematinics|mesh-ancestor
83985988|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
83985989|NCT01182441|Warfarin|warfarin|mesh-list
83985990|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
83985991|NCT01182285|Valproic Acid|valproic acid|mesh-list
83985992|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
83985993|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83985994|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83985995|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
83985996|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83985997|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83985998|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
83985999|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83986000|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986001|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83986002|NCT04315935|Fentanyl|fentanyl|mesh-list
83986003|NCT04315935|Butorphanol|butorphanol|mesh-list
83986004|NCT04315935|Propofol|propofol|mesh-list
83986005|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83986006|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986007|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986008|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83986009|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
83986010|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
83986011|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83986012|NCT04315935|Narcotics|narcotics|mesh-ancestor
83986013|NCT04315935|Analgesics|analgesics|mesh-ancestor
83986014|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
83986015|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986016|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83986017|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
83986018|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
83986019|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83986020|NCT01182207|Drospirenone|drospirenone|mesh-list
83986021|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83986022|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83986023|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83986024|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83986025|NCT01182207|Estradiol|estradiol|mesh-list
83986026|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83986027|NCT01182207|Estrogens|estrogens|mesh-ancestor
83986028|NCT01182207|Hormones|hormones|mesh-ancestor
83986029|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986030|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986031|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83986032|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
83986033|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83986034|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83986035|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83986036|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83986037|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83986038|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
83986039|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83986040|NCT01182207|Diuretics|diuretics|mesh-ancestor
83986041|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
83986042|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83986043|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83986044|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
83986045|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986046|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986047|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83986048|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
83986049|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83986050|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83986051|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83986052|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
83986053|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986054|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986055|NCT01181271|Sirolimus|sirolimus|mesh-list
83986056|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
83986057|NCT01181271|Busulfan|busulfan|mesh-list
83986058|NCT01181271|Methotrexate|methotrexate|mesh-list
83986059|NCT01181271|Fludarabine|fludarabine|mesh-list
83986060|NCT01181271|Etoposide|etoposide|mesh-list
83986061|NCT01181271|Tacrolimus|tacrolimus|mesh-list
83986062|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986063|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
83986064|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986065|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986066|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83986067|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
83986068|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986069|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986070|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83986071|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83986072|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
83986073|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83986074|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83986075|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
83986076|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
83986077|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986078|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83986079|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83986080|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83986081|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83986082|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83986083|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83986084|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83986085|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986086|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83986087|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
83986088|NCT00624741|Pergolide|pergolide|mesh-list
83986089|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
83986090|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
83986091|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986092|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986093|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986094|NCT01180647|Naltrexone|naltrexone|mesh-list
83986095|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83986096|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83986097|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986098|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
83986099|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986100|NCT03692065|Apixaban|apixaban|mesh-list
83986101|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83986102|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
83986103|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83986104|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
83986105|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225395|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225396|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83986106|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225397|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83986107|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
83986108|NCT01178853|Warfarin|warfarin|mesh-list
83986109|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83986110|NCT01178853|Pitavastatin|pitavastatin|mesh-list
83986111|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83986112|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83986113|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
83986114|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986115|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83986116|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83986117|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986118|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
83986119|NCT04286035|Bupivacaine|bupivacaine|mesh-list
83986120|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
83986121|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
83986122|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986123|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986124|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
83986125|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986126|NCT00629473|Dexamethasone|dexamethasone|mesh-list
83986127|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83986128|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986129|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
83986130|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
83986131|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986132|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986133|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83986134|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
83986135|NCT00629473|Hormones|hormones|mesh-ancestor
83986136|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986137|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83986138|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986139|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
83986140|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986141|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986142|NCT04286503|Ritonavir|ritonavir|mesh-list
83986143|NCT04286503|Lopinavir|lopinavir|mesh-list
83986144|NCT04286503|Chloroquine|chloroquine|mesh-list
83986145|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83986146|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83986147|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83986148|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
83986149|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986150|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986151|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83986152|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83986153|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
83986154|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986155|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83986156|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83986157|NCT04286503|Amebicides|amebicides|mesh-ancestor
83986158|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83986159|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83986160|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
83986161|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986162|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83986163|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986164|NCT04286503|Analgesics|analgesics|mesh-ancestor
83986165|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
83986166|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986167|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986168|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986169|NCT04286503|Filaricides|filaricides|mesh-ancestor
83986170|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
83986171|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
83986172|NCT03792841|Etanercept|etanercept|mesh-list
83986173|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
83986174|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83986175|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986176|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986177|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986178|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83986179|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986180|NCT03792841|Analgesics|analgesics|mesh-ancestor
83986181|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
83986182|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986183|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986184|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986185|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986186|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83986187|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986188|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
83986189|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
83986190|NCT00968617|Hematinics|hematinics|mesh-ancestor
83986191|NCT00968539|Vaccines|vaccines|mesh-list
83986192|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
83986193|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986194|NCT00976573|Paclitaxel|paclitaxel|mesh-list
83986195|NCT00976573|Bevacizumab|bevacizumab|mesh-list
83986196|NCT00976573|Carboplatin|carboplatin|mesh-list
83986197|NCT00976573|Everolimus|everolimus|mesh-list
83986198|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83986199|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986200|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
83986201|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
83986202|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
83986203|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986204|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986205|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83986206|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83986207|NCT00976573|Growth Substances|growth substances|mesh-ancestor
83986208|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986209|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
83986210|NCT00976573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83986211|NCT00976573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986212|NCT00976573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986213|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986214|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
83986215|NCT03661723|Bevacizumab|bevacizumab|mesh-list
83986216|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
83986217|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986218|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986219|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83986220|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83986221|NCT03661723|Growth Substances|growth substances|mesh-ancestor
83986222|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986223|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
83986224|NCT03661723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83986225|NCT03661723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986226|NCT00629863|Fluorouracil|fluorouracil|mesh-list
83986227|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986228|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
83986229|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986230|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83986231|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986232|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
83986233|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986234|NCT02865733|Treprostinil|treprostinil|mesh-list
83986235|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986236|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
83986237|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83986238|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83986239|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986240|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83986241|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986242|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986243|NCT00976495|Diuretics|diuretics|mesh-ancestor
83986244|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
83986245|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83986246|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986247|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
83986248|NCT00630019|Levofloxacin|levofloxacin|mesh-list
83986249|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83986250|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83986251|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83986252|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83986253|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986254|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83986255|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83986256|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986257|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986258|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986259|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83986260|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
83986261|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83986262|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986263|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83986264|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83986265|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83986266|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83986267|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83986268|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83986270|NCT00998296|Afatinib|afatinib|mesh-list
83986271|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986272|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986273|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986274|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986275|NCT01178073|Ambrisentan|ambrisentan|mesh-list
83986276|NCT01178073|Tadalafil|tadalafil|mesh-list
83986277|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
83986278|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83986279|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83986280|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986281|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986282|NCT01178073|Urological Agents|urological agents|mesh-ancestor
83986283|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986284|NCT00997984|Guanfacine|guanfacine|mesh-list
83986285|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986286|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83986287|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83986288|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83986289|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
83986290|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986291|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986292|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986293|NCT01177293|Amlodipine|amlodipine|mesh-list
83986294|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986295|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83986296|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986297|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986298|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83986299|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986300|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
83986301|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
83986302|NCT02886429|Bupivacaine|bupivacaine|mesh-list
83986303|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
83986304|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
83986305|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986306|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986307|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
83986308|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986309|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83986310|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986311|NCT02886429|Analgesics|analgesics|mesh-ancestor
83986312|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83986313|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83986314|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83986315|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
83986316|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986317|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986318|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83986319|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83986320|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83986321|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986322|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986323|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83986324|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83986325|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83986326|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
83986327|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986328|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986329|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83986330|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83986331|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
83986332|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
83986333|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83986334|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
83986335|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
83986336|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986337|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986338|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986339|NCT02886351|Analgesics|analgesics|mesh-ancestor
83986340|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
83986341|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986342|NCT00976027|Vaccines|vaccines|mesh-list
83986343|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
83986344|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986345|NCT01298765|Buprenorphine|buprenorphine|mesh-list
83986346|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83986347|NCT01298765|Narcotics|narcotics|mesh-ancestor
83986348|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986349|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986350|NCT01298765|Analgesics|analgesics|mesh-ancestor
83986351|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
83986352|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986353|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83986354|NCT04296214|Azacitidine|azacitidine|mesh-list
83986355|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83986356|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
83986357|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986358|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986359|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986360|NCT04296370|Apatinib|apatinib|mesh-list
83986361|NCT04296370|Fluzoparib|fluzoparib|mesh-list
83986362|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986363|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986364|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986365|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986366|NCT04296370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83986367|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
83986368|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
83986369|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986370|NCT00997438|Protective Agents|protective agents|mesh-ancestor
83986371|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986372|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
83986373|NCT00997438|Vitamins|vitamins|mesh-ancestor
83986374|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
83986375|NCT00997126|Alfentanil|alfentanil|mesh-list
83986376|NCT00997126|Propofol|propofol|mesh-list
83986377|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83986378|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986379|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986380|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83986381|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
83986382|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
83986383|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83986384|NCT00997126|Narcotics|narcotics|mesh-ancestor
83986385|NCT00997126|Analgesics|analgesics|mesh-ancestor
83986386|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
83986387|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986388|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83986389|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83986390|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
83986391|NCT04433494|Tamoxifen|tamoxifen|mesh-list
83986392|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83986393|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
83986394|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986395|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986396|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83986397|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986398|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83986399|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83986400|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83986401|NCT01000480|Pemetrexed|pemetrexed|mesh-list
83986402|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986403|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986404|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986405|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83986406|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83986407|NCT02862691|Acetaminophen|acetaminophen|mesh-list
83986408|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83986409|NCT02862691|Oxycodone|oxycodone|mesh-list
83986410|NCT02862691|Analgesics|analgesics|mesh-list
83986411|NCT02862691|Bupivacaine|bupivacaine|mesh-list
83986412|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
83986413|NCT02862691|Anesthetics|anesthetics|mesh-list
83986414|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986415|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986416|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
83986417|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986418|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986419|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
83986420|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83986421|NCT02862691|Narcotics|narcotics|mesh-ancestor
83986422|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83986423|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986424|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986425|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
83986426|NCT00965341|Testosterone|testosterone|mesh-list
83986427|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
83986428|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
83986429|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83986430|NCT00965341|Androgens|androgens|mesh-ancestor
83986431|NCT00965341|Hormones|hormones|mesh-ancestor
83986432|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986433|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986434|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83986435|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986436|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
83986437|NCT01175811|Insulin|insulin|mesh-list
83986438|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83986439|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
83986440|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
83986441|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
83986442|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
83986443|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
83986444|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83986445|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986446|NCT00965263|Cocaine|cocaine|mesh-list
83986447|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
83986448|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
83986449|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986450|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986451|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
83986452|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986453|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83986454|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83986455|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83986456|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986457|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986458|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
83986459|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225770|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
83225771|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225772|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225773|NCT05137717|Maribavir|maribavir|mesh-list
83225774|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
83225775|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225776|NCT05079230|Azacitidine|azacitidine|mesh-list
83225777|NCT05079230|Venetoclax|venetoclax|mesh-list
83225778|NCT05079230|Magrolimab|magrolimab|mesh-list
83225779|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83225780|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
83225781|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225782|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225783|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225784|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225785|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
83225786|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225787|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225788|NCT05077709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83225789|NCT05077709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225814|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
83986460|NCT02886195|Pemetrexed|pemetrexed|mesh-list
83986461|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83986462|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986463|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986464|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986465|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83986466|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83986467|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986468|NCT02862769|Lidocaine|lidocaine|mesh-list
83986469|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
83986470|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
83986471|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986472|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986473|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
83986474|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986475|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83986476|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83986477|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83986478|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986479|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986480|NCT00965185|Atorvastatin|atorvastatin|mesh-list
83986481|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83986482|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83986483|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
83986484|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986485|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83986486|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83986487|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986488|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83986489|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986490|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986491|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986492|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986493|NCT01298531|Etanercept|etanercept|mesh-list
83986494|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83986495|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986496|NCT01298531|Analgesics|analgesics|mesh-ancestor
83986497|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
83986498|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986499|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986500|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986501|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986502|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83986503|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986504|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
83986505|NCT02862145|Dexamethasone|dexamethasone|mesh-list
83986506|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986507|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
83986508|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
83986509|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986510|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986511|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83986512|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
83986513|NCT02862145|Hormones|hormones|mesh-ancestor
83986514|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986515|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83986516|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986517|NCT01174173|Ranolazine|ranolazine|mesh-list
83986518|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83986519|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986520|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986521|NCT00964795|Aflibercept|aflibercept|mesh-list
83986522|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83986523|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83986524|NCT00964795|Growth Substances|growth substances|mesh-ancestor
83986525|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986526|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
83986527|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986528|NCT01173471|Niacinamide|niacinamide|mesh-list
83986529|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
83986530|NCT01173471|Vitamins|vitamins|mesh-ancestor
83986531|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
83986532|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225852|NCT04941716|Venetoclax|venetoclax|mesh-list
83986533|NCT01172847|Oseltamivir|oseltamivir|mesh-list
83986534|NCT01172847|Rimantadine|rimantadine|mesh-list
83986535|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
83986536|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986537|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986538|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986539|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83986540|NCT00966355|Octreotide|octreotide|mesh-list
83986541|NCT00966355|Terlipressin|terlipressin|mesh-list
83986542|NCT00966355|Somatostatin|somatostatin|mesh-list
83986543|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83986544|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83986545|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986546|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986547|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83986548|NCT00966355|Hormones|hormones|mesh-ancestor
83986549|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986550|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986551|NCT01172535|Ritonavir|ritonavir|mesh-list
83986552|NCT01172535|Lopinavir|lopinavir|mesh-list
83986553|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83986554|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83986555|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
83986556|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986557|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986558|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83986559|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83986560|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
83986561|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986562|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83986563|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83986564|NCT05160493|Pregabalin|pregabalin|mesh-list
83986565|NCT05160493|Ketamine|ketamine|mesh-list
83986566|NCT05160493|Esketamine|esketamine|mesh-list
83986567|NCT05160493|Analgesics|analgesics|mesh-ancestor
83986568|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
83986569|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986570|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986571|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83986572|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83986573|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
83986574|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
83986575|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986576|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83986577|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83986578|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986579|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986580|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
83986581|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83986582|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986583|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83986584|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83986585|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83986586|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83986587|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
83986588|NCT00966277|Dalteparin|dalteparin|mesh-list
83986589|NCT00966277|Tinzaparin|tinzaparin|mesh-list
83986590|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83986591|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
83986592|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83986593|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83986594|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986595|NCT04324307|Paclitaxel|paclitaxel|mesh-list
83986596|NCT04324307|Gemcitabine|gemcitabine|mesh-list
83986597|NCT04324307|Fluorouracil|fluorouracil|mesh-list
83986598|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
83986599|NCT04324307|Irinotecan|irinotecan|mesh-list
83986600|NCT04324307|Folfirinox|folfirinox|mesh-list
83986601|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83986602|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986603|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
83986604|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
83986605|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
83986606|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986607|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83986608|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
83986609|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986610|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986611|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
83986612|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83986613|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83986614|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986615|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83986616|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83986617|NCT01297517|Brinzolamide|brinzolamide|mesh-list
83986618|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83986619|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986620|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83986621|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83986622|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83986623|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
83986624|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986625|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986626|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986627|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83986628|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986629|NCT01296347|Ketamine|ketamine|mesh-list
83986630|NCT01296347|Analgesics|analgesics|mesh-ancestor
83986631|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
83986632|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986633|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986634|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83986635|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83986636|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
83986637|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
83986638|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986639|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83986640|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83986641|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986642|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986643|NCT01296035|Panitumumab|panitumumab|mesh-list
83986644|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986645|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986646|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
83986647|NCT01294787|Bromides|bromides|mesh-list
83986648|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
83986649|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83986650|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
83986651|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986652|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986653|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83986654|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
83986655|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
83986656|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83986657|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
83986658|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986659|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986660|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
83986661|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83986662|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83986663|NCT01294553|Metformin|metformin|mesh-list
83986664|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
83986665|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83986666|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986667|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83986668|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986669|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986670|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986671|NCT01294397|Denosumab|denosumab|mesh-list
83986672|NCT01294397|Etanercept|etanercept|mesh-list
83986673|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83986674|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986675|NCT01294397|Analgesics|analgesics|mesh-ancestor
83986676|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
83986677|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986678|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986679|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986680|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986681|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83986682|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986683|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
83986684|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83986685|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83986686|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986687|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986688|NCT01293539|Melphalan|melphalan|mesh-list
83986689|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83986690|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
83986691|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986692|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986693|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83986694|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986695|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
83986696|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986697|NCT01292837|Levetiracetam|levetiracetam|mesh-list
83986698|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
83986699|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
83986700|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83986701|NCT00965731|Crizotinib|crizotinib|mesh-list
83986702|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986703|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986704|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986705|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986706|NCT00630175|Zolpidem|zolpidem|mesh-list
83986707|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83986708|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83986709|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986710|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986711|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83986712|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
83986713|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
83986714|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986715|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986716|NCT00965575|Melatonin|melatonin|mesh-list
83986717|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
83986718|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986719|NCT00965575|Protective Agents|protective agents|mesh-ancestor
83986720|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986721|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986722|NCT00965497|Escitalopram|escitalopram|mesh-list
83986723|NCT00965497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83986724|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83986725|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986726|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986727|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986728|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
83986729|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986730|NCT00963937|Sumatriptan|sumatriptan|mesh-list
83986731|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83986732|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83986733|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83986734|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
83986735|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986736|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986737|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986738|NCT01170663|Paclitaxel|paclitaxel|mesh-list
83986739|NCT01170663|Ramucirumab|ramucirumab|mesh-list
83986740|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83986741|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986742|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
83986743|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
83986744|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
83986745|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986746|NCT04315155|Nivolumab|nivolumab|mesh-list
83986747|NCT04315155|Ipilimumab|ipilimumab|mesh-list
83986748|NCT04315155|Belinostat|belinostat|mesh-list
83986749|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986750|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986751|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83986752|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986753|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83986754|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986755|NCT01170273|Vitamin D|vitamin d|mesh-list
83986756|NCT01170273|Vitamins|vitamins|mesh-ancestor
83986757|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
83226074|NCT04432584|Eculizumab|eculizumab|mesh-list
83986758|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986759|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83986761|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83986762|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986763|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986764|NCT01286558|Amlodipine|amlodipine|mesh-list
83986765|NCT01286558|Telmisartan|telmisartan|mesh-list
83986766|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986767|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83986768|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986769|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986770|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83986771|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986772|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
83986773|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83986774|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83986775|NCT01169103|Hormones|hormones|mesh-list
83986776|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986777|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986778|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
83986779|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83986780|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83986781|NCT01286168|Eusol|eusol|mesh-list
83986782|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83986783|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83986784|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986785|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
83986786|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
83986787|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83986788|NCT02889692|Gefitinib|gefitinib|mesh-list
83986789|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986790|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986791|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986792|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986793|NCT05569382|Verapamil|verapamil|mesh-list
83986794|NCT05569382|Bisoprolol|bisoprolol|mesh-list
83986795|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83986796|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83986797|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986798|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986799|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83986800|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986801|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
83986802|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83986803|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
83986804|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
83986805|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986806|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83986807|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83986808|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83986809|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
83986810|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986811|NCT00963547|Trastuzumab|trastuzumab|mesh-list
83986812|NCT00963547|Lapatinib|lapatinib|mesh-list
83986813|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986814|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986815|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986816|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986817|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986818|NCT01285310|Thalidomide|thalidomide|mesh-list
83986819|NCT01285310|Apremilast|apremilast|mesh-list
83986820|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83986821|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986822|NCT01285310|Analgesics|analgesics|mesh-ancestor
83986823|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
83986824|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986825|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986826|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83986827|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986828|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83986829|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83226145|NCT04281108|Xhance|xhance|mesh-list
83986830|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986831|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986832|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986833|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
83986834|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
83986835|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83986836|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986837|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83986838|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83986839|NCT01285310|Growth Substances|growth substances|mesh-ancestor
83986840|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
83986841|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986843|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
83986844|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986845|NCT01253304|Dulaglutide|dulaglutide|mesh-list
83986846|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83986847|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986848|NCT04319484|Lenvatinib|lenvatinib|mesh-list
83986849|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986850|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83986851|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986852|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986853|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83986854|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
83986855|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986856|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83986857|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
83986858|NCT00624312|Hematinics|hematinics|mesh-ancestor
83986859|NCT01250418|Ketamine|ketamine|mesh-list
83986860|NCT01250418|Analgesics|analgesics|mesh-ancestor
83986861|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
83986862|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986863|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986864|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83986865|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83986866|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
83986867|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
83986868|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986869|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83986870|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83986871|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986872|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986873|NCT05491356|Plasminogen|plasminogen|mesh-list
83986874|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83986875|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83986876|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83986877|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986878|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
83986879|NCT01292603|Rituximab|rituximab|mesh-list
83986880|NCT01292603|Fludarabine|fludarabine|mesh-list
83986881|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83986882|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
83986883|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986884|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83986885|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83986886|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
83986887|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986888|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986889|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83986890|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986891|NCT01292057|Aripiprazole|aripiprazole|mesh-list
83986892|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
83986893|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83986894|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83986895|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83986896|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986897|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986898|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
83986899|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
83986900|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986901|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986902|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83986903|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83986904|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
83986905|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83986906|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83986907|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83986908|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83986910|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83986911|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
83986912|NCT01290731|Interferons|interferons|mesh-list
83986913|NCT01290731|Ribavirin|ribavirin|mesh-list
83986914|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83986915|NCT01290731|Simeprevir|simeprevir|mesh-list
83986916|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986917|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
83986918|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986919|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
83986920|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986921|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
83986922|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986923|NCT01290341|Naftifine|naftifine|mesh-list
83986924|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
83986925|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83986926|NCT01290263|Bevacizumab|bevacizumab|mesh-list
83986927|NCT01290263|Trebananib|trebananib|mesh-list
83986928|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83986929|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83986930|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83986931|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83986932|NCT01290263|Growth Substances|growth substances|mesh-ancestor
83986933|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986934|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
83986935|NCT01290029|Cinacalcet|cinacalcet|mesh-list
83986936|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83986937|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986938|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83986939|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
83986940|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83986941|NCT02890199|Lidocaine|lidocaine|mesh-list
83986942|NCT02890199|Bupivacaine|bupivacaine|mesh-list
83986943|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
83986944|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
83986945|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83986946|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986947|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
83986948|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986949|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83986950|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83986951|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83986952|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986953|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986954|NCT01289639|Pioglitazone|pioglitazone|mesh-list
83986955|NCT01289639|Fenofibrate|fenofibrate|mesh-list
83986956|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83986957|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986958|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83986959|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
83986960|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986961|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83986962|NCT01288937|Milnacipran|milnacipran|mesh-list
83986963|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
83986964|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83986965|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83986966|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986967|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986968|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986969|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986970|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83986971|NCT01288937|Analgesics|analgesics|mesh-ancestor
83986972|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
83986973|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83986974|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
83986975|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83986976|NCT01288469|Atorvastatin|atorvastatin|mesh-list
83986977|NCT01288469|Alirocumab|alirocumab|mesh-list
83986978|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83986979|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83986981|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
83986982|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986983|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83986984|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83986985|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83986986|NCT01288469|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83986987|NCT01288469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83986988|NCT01288469|Protease Inhibitors|protease inhibitors|mesh-ancestor
83986989|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
83986990|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986991|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83986992|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83986993|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83986994|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83986995|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83986996|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83986997|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83986998|NCT01288079|Analgesics|analgesics|mesh-ancestor
83986999|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
83987000|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987001|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
83987002|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83987003|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
83987004|NCT01287221|Riboflavin|riboflavin|mesh-list
83987005|NCT01287221|Rifampin|rifampin|mesh-list
83987006|NCT01287221|Vitamins|vitamins|mesh-ancestor
83987007|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
83987008|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987009|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
83987010|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83987011|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
83987012|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83987013|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987014|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
83987015|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83987016|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987017|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987018|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83987019|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83987020|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83987021|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83987022|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83987023|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83987024|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83987025|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987026|NCT05660213|Bevacizumab|bevacizumab|mesh-list
83987027|NCT05660213|Atezolizumab|atezolizumab|mesh-list
83987028|NCT05660213|Apatinib|apatinib|mesh-list
83987029|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987030|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987031|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83987032|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83987033|NCT05660213|Growth Substances|growth substances|mesh-ancestor
83987034|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987035|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
83987036|NCT05660213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83987037|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987038|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987039|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987040|NCT01167153|Amlodipine|amlodipine|mesh-list
83987041|NCT01167153|Valsartan|valsartan|mesh-list
83987042|NCT01167153|Nifedipine|nifedipine|mesh-list
83987043|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83987044|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83987045|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987046|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987047|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987048|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987049|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
83987050|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83987051|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83987052|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
83987053|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83987054|NCT01166763|Vitamin D|vitamin d|mesh-list
83987055|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
83987056|NCT01166763|Vitamins|vitamins|mesh-ancestor
83987057|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
83987058|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987059|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83987060|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987061|NCT02885961|Dabigatran|dabigatran|mesh-list
83987062|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
83987063|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83987064|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
83987065|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987066|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987067|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
83987068|NCT02885727|Durvalumab|durvalumab|mesh-list
83987069|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987070|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987071|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83987072|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
83987073|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987074|NCT00630097|Modafinil|modafinil|mesh-list
83987075|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83987076|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987077|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83987078|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83987079|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83987080|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987081|NCT01165281|Oxycodone|oxycodone|mesh-list
83987082|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83987083|NCT01165281|Narcotics|narcotics|mesh-ancestor
83987084|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83987085|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987086|NCT01165281|Analgesics|analgesics|mesh-ancestor
83987087|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
83987088|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987089|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83987090|NCT02860897|Estrogens|estrogens|mesh-ancestor
83987091|NCT02860897|Hormones|hormones|mesh-ancestor
83987092|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987093|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987094|NCT02860819|Carboplatin|carboplatin|mesh-list
83987095|NCT02860819|Gemcitabine|gemcitabine|mesh-list
83987096|NCT02860819|Veliparib|veliparib|mesh-list
83987097|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987098|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83987099|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
83987100|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987101|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83987102|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987103|NCT04284007|Dexamethasone|dexamethasone|mesh-list
83987104|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
83987105|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
83987106|NCT04284007|BB 1101|bb 1101|mesh-list
83987107|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987108|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
83987109|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
83987110|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987111|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987112|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83987113|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
83987114|NCT04284007|Hormones|hormones|mesh-ancestor
83987115|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987116|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83987117|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987118|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83987119|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987120|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987121|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83987122|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
83987123|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83987124|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
83987125|NCT02965963|Dopamine|dopamine|mesh-list
83987126|NCT02965963|Metoclopramide|metoclopramide|mesh-list
83987127|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
83987128|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
83987129|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987130|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987131|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83987132|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83987133|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83987134|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
83987135|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987136|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987137|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83987138|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
83987139|NCT02965963|Protective Agents|protective agents|mesh-ancestor
83987140|NCT01165203|Vaccines|vaccines|mesh-list
83987141|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
83987142|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987143|NCT00960661|Insulin|insulin|mesh-list
83987144|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83987145|NCT00960661|Metformin|metformin|mesh-list
83987146|NCT00960661|Exenatide|exenatide|mesh-list
83987147|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
83987148|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83987149|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987150|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83987151|NCT00960661|Incretins|incretins|mesh-ancestor
83987152|NCT00960661|Hormones|hormones|mesh-ancestor
83987153|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987154|NCT00960193|Colchicine|colchicine|mesh-list
83987155|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
83987156|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987157|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
83987158|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
83987159|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83987160|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987161|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987162|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
83987163|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
83987164|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987165|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987166|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987167|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83987168|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
83987169|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987170|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987171|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83987172|NCT00959647|Bevacizumab|bevacizumab|mesh-list
83987173|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987174|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987175|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83987176|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83987177|NCT00959647|Growth Substances|growth substances|mesh-ancestor
83987178|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987179|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
83987180|NCT00957853|Cetuximab|cetuximab|mesh-list
83987181|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987182|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987183|NCT02725567|Ivacaftor|ivacaftor|mesh-list
83987184|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83987185|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987186|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987187|NCT02859571|Oxytocin|oxytocin|mesh-list
83987188|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
83987189|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83987190|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987191|NCT00956839|Vitamin D|vitamin d|mesh-list
83987192|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
83987193|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
83226517|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226518|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226519|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
83226520|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226521|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226522|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
83987194|NCT00956839|Vitamins|vitamins|mesh-list
83987195|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
83987196|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987197|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83987198|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987199|NCT00956293|Cyclosporine|cyclosporine|mesh-list
83987200|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
83987201|NCT00956293|Everolimus|everolimus|mesh-list
83987202|NCT00956293|Cyclosporins|cyclosporins|mesh-list
83987203|NCT00956293|Basiliximab|basiliximab|mesh-list
83987204|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987205|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987206|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987207|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
83987208|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987209|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
83987210|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987211|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987212|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987213|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83987214|NCT00956293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83987215|NCT00956293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987216|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987217|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83987218|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83987219|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
83987220|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83987221|NCT04282291|Morphine|morphine|mesh-list
83987222|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83987223|NCT04282291|Narcotics|narcotics|mesh-ancestor
83987224|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83987225|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987226|NCT04282291|Analgesics|analgesics|mesh-ancestor
83987227|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
83987228|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987229|NCT00955825|Immunomodulating Agents|immunomodulating agents|mesh-list
83987230|NCT00955825|Immunologic Factors|immunologic factors|mesh-ancestor
83987231|NCT00955825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987232|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83987233|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83987234|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83987235|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987236|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987237|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987238|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987239|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
83987240|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83987241|NCT02869009|Aspirin|aspirin|mesh-list
83987242|NCT02869009|Clopidogrel|clopidogrel|mesh-list
83987243|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83987244|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83987245|NCT02869009|Analgesics|analgesics|mesh-ancestor
83987246|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
83987247|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987248|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987249|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987250|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987251|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83987252|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83987253|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987254|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83987255|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83987256|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987257|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
83987258|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83987259|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83987260|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83987261|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
83987262|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987263|NCT01164579|Methotrexate|methotrexate|mesh-list
83987264|NCT01164579|Tofacitinib|tofacitinib|mesh-list
83987265|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83987266|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
83987267|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83987268|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987269|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83987270|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
83987271|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987272|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987274|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987275|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83987276|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987277|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
83987278|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987279|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83987280|NCT01164579|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83987281|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987282|NCT02859259|Fostemsavir|fostemsavir|mesh-list
83987283|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83987284|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83987285|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
83987286|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987287|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83987288|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83987289|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987290|NCT02857777|Esketamine|esketamine|mesh-list
83987291|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
83987292|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83987293|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
83987294|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
83987295|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987296|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987297|NCT03202849|Vitamin D|vitamin d|mesh-list
83987298|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
83987299|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
83987300|NCT03202849|Vitamins|vitamins|mesh-list
83987301|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
83987302|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987303|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83987304|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987305|NCT04277533|Calcium|calcium|mesh-list
83987306|NCT04277533|Bilirubin|bilirubin|mesh-list
83987307|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987308|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987309|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
83987310|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987311|NCT04277533|Protective Agents|protective agents|mesh-ancestor
83987312|NCT02445391|Cisplatin|cisplatin|mesh-list
83987313|NCT02445391|Carboplatin|carboplatin|mesh-list
83987314|NCT02445391|Capecitabine|capecitabine|mesh-list
83987315|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987316|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83987317|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
83987318|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987319|NCT01246986|Sorafenib|sorafenib|mesh-list
83987320|NCT01246986|Ramucirumab|ramucirumab|mesh-list
83987321|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987322|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987323|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987324|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987325|NCT01164501|Empagliflozin|empagliflozin|mesh-list
83987326|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83987327|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987328|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83987329|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987330|NCT01163721|Ranolazine|ranolazine|mesh-list
83987331|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83987332|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987333|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987334|NCT03150511|Tesamorelin|tesamorelin|mesh-list
83987335|NCT03150511|Growth Substances|growth substances|mesh-ancestor
83987336|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987337|NCT00958243|Vaccines|vaccines|mesh-list
83987338|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
83987339|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987340|NCT01241760|Interferons|interferons|mesh-list
83987341|NCT01241760|Ribavirin|ribavirin|mesh-list
83987342|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
83987343|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
83987344|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83987345|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987346|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
83987348|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
83987349|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987350|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
83987351|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987352|NCT04280263|Caffeine|caffeine|mesh-list
83987353|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83987354|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987355|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83987356|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987357|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987358|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83987359|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83987360|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
83987361|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987362|NCT02140255|Ritonavir|ritonavir|mesh-list
83987363|NCT02140255|Lopinavir|lopinavir|mesh-list
83987364|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
83987365|NCT02140255|Nevirapine|nevirapine|mesh-list
83987366|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83987367|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83987368|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83987369|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
83987370|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987371|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987372|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83987373|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83987374|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
83987375|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987376|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83987377|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83987378|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83987379|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83987380|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83987381|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83987382|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83987383|NCT00953329|Alefacept|alefacept|mesh-list
83987384|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987385|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
83987386|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987387|NCT02857153|Urapidil|urapidil|mesh-list
83987388|NCT02857153|Phenylephrine|phenylephrine|mesh-list
83987389|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
83987390|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83987391|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
83987392|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
83987393|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987394|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987395|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
83987396|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83987397|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
83987398|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
83987399|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83987400|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83987401|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83987402|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
83987403|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987404|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987405|NCT02857153|Protective Agents|protective agents|mesh-ancestor
83987406|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83987407|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
83987408|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83987409|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
83987410|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83987411|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83987412|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83987413|NCT00953017|Bisacodyl|bisacodyl|mesh-list
83987414|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83987415|NCT00953017|Lubiprostone|lubiprostone|mesh-list
83987416|NCT00953017|Cathartics|cathartics|mesh-ancestor
83987417|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83987418|NCT00953017|Laxatives|laxatives|mesh-ancestor
83987419|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83226774|NCT04564625|Vitamin D|vitamin d|mesh-list
83987420|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987421|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987423|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
83987424|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83987425|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83987426|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987427|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987428|NCT02338609|Everolimus|everolimus|mesh-list
83987429|NCT02338609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83987430|NCT02338609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987431|NCT02338609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987432|NCT02338609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987433|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987434|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
83987435|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987436|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987437|NCT00955279|Golimumab|golimumab|mesh-list
83987438|NCT00955279|Ustekinumab|ustekinumab|mesh-list
83987439|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987440|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83987441|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987442|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987443|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
83987444|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987445|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83987446|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83987447|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
83987448|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987449|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
83987450|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987451|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987452|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83987453|NCT02857309|Diuretics|diuretics|mesh-ancestor
83987454|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
83987455|NCT02857309|Hormones|hormones|mesh-ancestor
83987456|NCT04261231|Anesthetics|anesthetics|mesh-list
83987457|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83987458|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987459|NCT02857465|Dexamethasone|dexamethasone|mesh-list
83987460|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
83987461|NCT02857465|Sufentanil|sufentanil|mesh-list
83987462|NCT02857465|Dsuvia|dsuvia|mesh-list
83987463|NCT02857465|Ropivacaine|ropivacaine|mesh-list
83987464|NCT02857465|BB 1101|bb 1101|mesh-list
83987465|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987466|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
83987467|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
83987468|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987469|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987470|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83987471|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
83987472|NCT02857465|Hormones|hormones|mesh-ancestor
83987473|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987474|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83987475|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987476|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
83987477|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987478|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987479|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
83987480|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
83987481|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83987482|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
83987483|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83987484|NCT02857465|Narcotics|narcotics|mesh-ancestor
83987485|NCT02857465|Analgesics|analgesics|mesh-ancestor
83987486|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83987487|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83987488|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
83987489|NCT04260139|Metronidazole|metronidazole|mesh-list
83987490|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987491|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83987492|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83987493|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83987494|NCT04206618|Denosumab|denosumab|mesh-list
83226813|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
83987495|NCT04206618|Teriparatide|teriparatide|mesh-list
83987496|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83987497|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987498|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987499|NCT01239732|Paclitaxel|paclitaxel|mesh-list
83987500|NCT01239732|Bevacizumab|bevacizumab|mesh-list
83987501|NCT01239732|Carboplatin|carboplatin|mesh-list
83987502|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83987503|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987504|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
83987505|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
83987506|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
83987507|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987508|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987509|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83987510|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83987511|NCT01239732|Growth Substances|growth substances|mesh-ancestor
83987512|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987513|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
83987514|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83987515|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83987516|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83152384|NCT02179567|Docetaxel|docetaxel|mesh-list
83987517|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83987518|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83987519|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83987520|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987521|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987522|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987523|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83987524|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83987525|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987526|NCT00947011|Incretins|incretins|mesh-ancestor
83987527|NCT00947011|Hormones|hormones|mesh-ancestor
83987528|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987529|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83987530|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
83987531|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987532|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987533|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
83987534|NCT02856685|Analgesics|analgesics|mesh-ancestor
83987535|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
83987536|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987537|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987538|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987539|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83987540|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83987541|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987542|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987543|NCT01962415|Fludarabine|fludarabine|mesh-list
83987544|NCT01962415|Melphalan|melphalan|mesh-list
83987545|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
83987546|NCT01962415|Thiotepa|thiotepa|mesh-list
83987547|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
83987548|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987549|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987550|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987551|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
83987552|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987553|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83987554|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
83987555|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83987556|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987557|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
83987558|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987559|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83987560|NCT02860663|Vitamin D|vitamin d|mesh-list
83987561|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
83987562|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
83987563|NCT02860663|Vitamins|vitamins|mesh-list
83987564|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
83987565|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987566|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83987567|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987568|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
84124722|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83987569|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987570|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987572|NCT01239342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83987573|NCT01239342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987574|NCT01239342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987575|NCT01239342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987576|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987577|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
83987578|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987579|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987580|NCT00946309|Sulforaphane|sulforaphane|mesh-list
83987581|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83987582|NCT00946309|Protective Agents|protective agents|mesh-ancestor
83987583|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987584|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987585|NCT02853799|Insulin|insulin|mesh-list
83987586|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83987587|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987588|NCT01236534|Lubiprostone|lubiprostone|mesh-list
83987589|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83987590|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987591|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987592|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
83987593|NCT01235598|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83987594|NCT01235598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987595|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987596|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
83987597|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987598|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987599|NCT01235442|Etanercept|etanercept|mesh-list
83987600|NCT01235442|Clobetasol|clobetasol|mesh-list
83987601|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83987602|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83987603|NCT01235442|Analgesics|analgesics|mesh-ancestor
83987604|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
83987605|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987606|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987607|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987608|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987609|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83987610|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987611|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
83987612|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
83987613|NCT01235442|Hormones|hormones|mesh-ancestor
83987614|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987615|NCT01163253|Tofacitinib|tofacitinib|mesh-list
83987616|NCT01163253|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83987617|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987618|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987619|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987620|NCT01162863|Lubiprostone|lubiprostone|mesh-list
83987621|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83987622|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987623|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987624|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
83987625|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83987626|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
83987627|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987628|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987629|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83987630|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83987631|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83987632|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
83987633|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987634|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987635|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83987636|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
83987637|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
83987638|NCT05304039|Protective Agents|protective agents|mesh-ancestor
83987639|NCT01162473|Caseins|caseins|mesh-list
83987640|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
83987641|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
83226963|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
83987642|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987644|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83987645|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83987646|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
83987647|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987648|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987649|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987650|NCT01161537|Ivacaftor|ivacaftor|mesh-list
83987651|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83987652|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987653|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987654|NCT04314297|Durvalumab|durvalumab|mesh-list
83987655|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987656|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987657|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
83987658|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83987659|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
83987660|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987661|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
83987662|NCT04124133|Protective Agents|protective agents|mesh-ancestor
83987663|NCT01233258|Factor VIII|factor viii|mesh-list
83987664|NCT01233258|Coagulants|coagulants|mesh-ancestor
83987665|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
83987666|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83987667|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
83987668|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987669|NCT01232790|Expectorants|expectorants|mesh-ancestor
83987670|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
83987671|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83987672|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
83987673|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987674|NCT01232790|Protective Agents|protective agents|mesh-ancestor
83987675|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987676|NCT01232790|Antidotes|antidotes|mesh-ancestor
83987677|NCT01232556|Rituximab|rituximab|mesh-list
83987678|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83987679|NCT01232556|Gemcitabine|gemcitabine|mesh-list
83987680|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83987681|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987682|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987683|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
83987684|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987685|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987686|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83987687|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
83987688|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987689|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83987690|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
83987691|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83987692|NCT01232556|Immunotoxins|immunotoxins|mesh-ancestor
83987693|NCT01232556|Immunoconjugates|immunoconjugates|mesh-ancestor
83987694|NCT00946153|Lenvatinib|lenvatinib|mesh-list
83987695|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987696|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987697|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987698|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987699|NCT01914367|Vaccines|vaccines|mesh-list
83987700|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
83987701|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987702|NCT01160289|Tadalafil|tadalafil|mesh-list
83987703|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
83987704|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83987705|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83987706|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987707|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987708|NCT01160289|Urological Agents|urological agents|mesh-ancestor
83987709|NCT01159665|Plasminogen|plasminogen|mesh-list
83987710|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
83987711|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83987712|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83987713|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987714|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83987715|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
83987716|NCT01158261|Coagulants|coagulants|mesh-ancestor
83987717|NCT01157169|Buprenorphine|buprenorphine|mesh-list
83987718|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83987719|NCT01157169|Narcotics|narcotics|mesh-ancestor
83987720|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83987721|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987722|NCT01157169|Analgesics|analgesics|mesh-ancestor
83987723|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
83987724|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987725|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83987726|NCT04313907|Clonazepam|clonazepam|mesh-list
83987727|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
83987728|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
83987729|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
83987730|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987731|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987732|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987733|NCT01231620|Oseltamivir|oseltamivir|mesh-list
83987734|NCT01231620|Zanamivir|zanamivir|mesh-list
83987735|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
83987736|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987737|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987738|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987739|NCT01231464|Fluticasone|fluticasone|mesh-list
83987740|NCT01231464|Xhance|xhance|mesh-list
83987741|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987742|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83987743|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
83987744|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987745|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987746|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83987747|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
83987748|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987749|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83987750|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83987751|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987752|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987753|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
83987754|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987755|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
83987756|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83987757|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83987758|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83987759|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987760|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987761|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
83987762|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987763|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987764|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83987765|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987766|NCT01155531|Sertraline|sertraline|mesh-list
83987767|NCT01155531|Telenzepine|telenzepine|mesh-list
83987768|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
83987769|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83987770|NCT01155531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83987771|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83987772|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987773|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987774|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987775|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
83987776|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987777|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
83987778|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
83987779|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987780|NCT01155219|Latanoprost|latanoprost|mesh-list
83987781|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83987782|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83987783|NCT01098955|Varenicline|varenicline|mesh-list
83987784|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83987785|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83987786|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
83987787|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987788|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987789|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987790|NCT00631033|Metformin|metformin|mesh-list
83987791|NCT00631033|Diazoxide|diazoxide|mesh-list
83987792|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83987793|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987794|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83987795|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
83987796|NCT01155063|Exemestane|exemestane|mesh-list
83987797|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987798|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83987799|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83987800|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987801|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987802|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83987803|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
83987804|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987805|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987806|NCT01154673|Ritonavir|ritonavir|mesh-list
83987807|NCT01154673|Lopinavir|lopinavir|mesh-list
83987808|NCT01154673|Tenofovir|tenofovir|mesh-list
83987809|NCT01154673|Emtricitabine|emtricitabine|mesh-list
83987810|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
83987811|NCT01154673|Maraviroc|maraviroc|mesh-list
83987812|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83987813|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83987814|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
83987815|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987816|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987817|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83987818|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83987819|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
83987820|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987821|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83987822|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83987823|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83987824|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83987825|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83987826|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83987827|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83987828|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83987829|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83987830|NCT02884713|Doxycycline|doxycycline|mesh-list
83987831|NCT02884713|Levofloxacin|levofloxacin|mesh-list
83987832|NCT02884713|Esomeprazole|esomeprazole|mesh-list
83987833|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83987834|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83987835|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83987836|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987837|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987838|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83987839|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987840|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
83987841|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83987842|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83987843|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83987844|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83987845|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83987846|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987847|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83987848|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83987849|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
83987850|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83987851|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83987852|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83987853|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
83987854|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987855|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987856|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987857|NCT01228734|Leucovorin|leucovorin|mesh-list
83987858|NCT01228734|Folic Acid|folic acid|mesh-list
83987859|NCT01228734|Fluorouracil|fluorouracil|mesh-list
83987860|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
83987861|NCT01228734|Cetuximab|cetuximab|mesh-list
83987862|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
83987863|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
83987864|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987865|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83987866|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987867|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227186|NCT02644967|Ipilimumab|ipilimumab|mesh-list
83987868|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
83987869|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987870|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987871|NCT01228734|Antidotes|antidotes|mesh-ancestor
83987872|NCT01228734|Protective Agents|protective agents|mesh-ancestor
83987873|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
83987874|NCT01228734|Vitamins|vitamins|mesh-ancestor
83987875|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
83987876|NCT01228734|Hematinics|hematinics|mesh-ancestor
83987877|NCT01153971|Rituximab|rituximab|mesh-list
83987878|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83987879|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987880|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
83987881|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987882|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987883|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83987884|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
83987885|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987886|NCT00951379|Pioglitazone|pioglitazone|mesh-list
83987887|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83987888|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987889|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
83987890|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83987891|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83987892|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83987893|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83987894|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987895|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
83987896|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987897|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987898|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83987899|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987900|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
83987901|NCT01153425|Teriparatide|teriparatide|mesh-list
83987902|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83987903|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987904|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83987905|NCT01153269|Ritonavir|ritonavir|mesh-list
83987906|NCT01153269|Lopinavir|lopinavir|mesh-list
83987907|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83987908|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83987909|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
83987910|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987911|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987912|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83987913|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83987914|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
83987915|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987916|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83987917|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83987918|NCT02884635|Methotrexate|methotrexate|mesh-list
83987919|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83987920|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
83987921|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83987922|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987923|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83987924|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
83987925|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987926|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987927|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
83987928|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987929|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83987930|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83987931|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
83987932|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83987933|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83987934|NCT02884479|Docetaxel|docetaxel|mesh-list
83987935|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987936|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
83987937|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
83987938|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
83987939|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987940|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
83987941|NCT01152021|Propofol|propofol|mesh-list
83987942|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83987943|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83987944|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987945|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83987946|NCT01152021|Analgesics|analgesics|mesh-ancestor
83987947|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
83987948|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987949|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83987950|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83987951|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83987952|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
83987953|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987954|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987955|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83987956|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
83987957|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
83987958|NCT01151085|Voriconazole|voriconazole|mesh-list
83987959|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
83987960|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83987961|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83987962|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83987963|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987964|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987965|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83987966|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
83987967|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987968|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987969|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83987970|NCT01149369|Aprepitant|aprepitant|mesh-list
83987971|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
83987972|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
83987973|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83987974|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987975|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83987976|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83987977|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83987978|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987979|NCT01740427|Letrozole|letrozole|mesh-list
83987980|NCT01740427|Palbociclib|palbociclib|mesh-list
83987981|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83987982|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83987983|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83987984|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83987985|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83987986|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83987987|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
83987988|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83987989|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83987990|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83987991|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
83987992|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83987993|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83987994|NCT00879931|Prednisolone|prednisolone|mesh-list
83987995|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
83987996|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83987997|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
83987998|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83987999|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
83988000|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
83988001|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988002|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988003|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988004|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
83988005|NCT00879931|Hormones|hormones|mesh-ancestor
83988006|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227339|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227340|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83227341|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83227342|NCT03101579|Hematinics|hematinics|mesh-ancestor
83227343|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
83227344|NCT05071781|Hormones|hormones|mesh-list
83227345|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83227346|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227347|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988007|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83988008|NCT00879931|Protective Agents|protective agents|mesh-ancestor
83988009|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83988010|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988011|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83988012|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
83988013|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83988014|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
83988015|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988016|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
83988017|NCT00739141|Thiotepa|thiotepa|mesh-list
83988018|NCT00739141|Fludarabine|fludarabine|mesh-list
83988019|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83988020|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
83988021|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988022|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83988023|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83988024|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
83988025|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988026|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988027|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83988028|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83988029|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83988030|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988031|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83988032|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83988033|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988034|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988035|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
83988036|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988037|NCT01735825|Paclitaxel|paclitaxel|mesh-list
83988038|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83988039|NCT01735825|Everolimus|everolimus|mesh-list
83988040|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83988041|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988042|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83988043|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83988044|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83988045|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988046|NCT01735825|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83988047|NCT01735825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988048|NCT01735825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988049|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83988050|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
83988051|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988052|NCT01148511|Ranibizumab|ranibizumab|mesh-list
83988053|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83988054|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83988055|NCT01148511|Growth Substances|growth substances|mesh-ancestor
83988056|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988057|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
83988058|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988059|NCT02860117|Ketamine|ketamine|mesh-list
83988060|NCT02860117|Analgesics|analgesics|mesh-ancestor
83988061|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
83988062|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988063|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988064|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83988065|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83988066|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
83988067|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
83988068|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988069|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83988070|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83988071|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988072|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988073|NCT02853253|SMOFlipid|smoflipid|mesh-list
83988074|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83988075|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83988076|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83988077|NCT04269187|Theophylline|theophylline|mesh-list
83988078|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83988079|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
83988080|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988081|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988082|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83988083|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
83988084|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83988085|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988086|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988087|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
83988088|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83988089|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83988090|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
83988091|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988092|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
83988093|NCT04269109|Narcotics|narcotics|mesh-ancestor
83988094|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988095|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988096|NCT04269109|Analgesics|analgesics|mesh-ancestor
83988097|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
83988098|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988099|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
83988100|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988102|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83988103|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988104|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988105|NCT04268563|Incretins|incretins|mesh-ancestor
83988106|NCT04268563|Hormones|hormones|mesh-ancestor
83988107|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988108|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83988109|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
83988110|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988111|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988112|NCT01225146|Ranibizumab|ranibizumab|mesh-list
83988113|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83988114|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83988115|NCT01225146|Growth Substances|growth substances|mesh-ancestor
83988116|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988117|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
83988118|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988119|NCT01223196|Pioglitazone|pioglitazone|mesh-list
83988120|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988121|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988122|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83988123|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988124|NCT00950911|Denosumab|denosumab|mesh-list
83988125|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83988126|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988127|NCT02855515|Anesthetics|anesthetics|mesh-list
83988128|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988129|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988130|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83988131|NCT04206228|Hematinics|hematinics|mesh-ancestor
83988132|NCT01218594|Endostatins|endostatins|mesh-list
83988133|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83988134|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83988135|NCT01218594|Growth Substances|growth substances|mesh-ancestor
83988136|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988137|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
83988138|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988139|NCT01610557|Bevacizumab|bevacizumab|mesh-list
83988140|NCT01610557|Ranibizumab|ranibizumab|mesh-list
83988141|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988142|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988143|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83988144|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83988145|NCT01610557|Growth Substances|growth substances|mesh-ancestor
83988146|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988147|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
83988148|NCT00943735|Fesoterodine|fesoterodine|mesh-list
83988149|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83988150|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83988151|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
83988152|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988153|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988154|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988156|NCT00489307|Dexamethasone|dexamethasone|mesh-list
83988157|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83988158|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
83988159|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
83988160|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988161|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988162|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988163|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
83988164|NCT00489307|Hormones|hormones|mesh-ancestor
83988165|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988166|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83988167|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988168|NCT00943111|Eliglustat|eliglustat|mesh-list
83988169|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988170|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988171|NCT01147497|Misoprostol|misoprostol|mesh-list
83988172|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83988173|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
83988174|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83988175|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988176|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83988177|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988178|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
83988179|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
83988180|NCT01147341|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83988181|NCT01147341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83988182|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83988183|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
83988184|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988185|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83988186|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
83988187|NCT00950755|Antibodies|antibodies|mesh-list
83988188|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
83988189|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988190|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988191|NCT01147107|Efavirenz|efavirenz|mesh-list
83988192|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
83988193|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83988194|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988195|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988196|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988197|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
83988198|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988199|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83988200|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83988201|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83988202|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83988203|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83988204|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83988205|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83988206|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83988207|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83988208|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83988209|NCT01146951|Rufinamide|rufinamide|mesh-list
83988210|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
83988211|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83988212|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83988213|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988214|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988215|NCT01146873|Ritonavir|ritonavir|mesh-list
83988216|NCT01146873|Lopinavir|lopinavir|mesh-list
83988217|NCT01146873|Abacavir|abacavir|mesh-list
83988218|NCT01146873|Stavudine|stavudine|mesh-list
83988219|NCT01146873|Efavirenz|efavirenz|mesh-list
83988220|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83988221|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83988222|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
83988223|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988224|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988225|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83988226|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83988227|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
83988228|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227560|NCT02385019|Immunologic Factors|immunologic factors|mesh-ancestor
83988229|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83988230|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83988231|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83988232|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988233|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83988234|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83988235|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83988236|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83988237|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83988239|NCT01146795|Paclitaxel|paclitaxel|mesh-list
83988240|NCT01146795|Bevacizumab|bevacizumab|mesh-list
83988241|NCT01146795|Carboplatin|carboplatin|mesh-list
83988242|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83988243|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988244|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
83988245|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
83988246|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
83988247|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988248|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988249|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83988250|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83988251|NCT01146795|Growth Substances|growth substances|mesh-ancestor
83988252|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988253|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
83988254|NCT01146561|Tanezumab|tanezumab|mesh-list
83988255|NCT01146561|Analgesics|analgesics|mesh-ancestor
83988256|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
83988257|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988258|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988259|NCT00942175|Esomeprazole|esomeprazole|mesh-list
83988260|NCT00942175|Omeprazole|omeprazole|mesh-list
83988261|NCT00942175|Lansoprazole|lansoprazole|mesh-list
83988262|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
83988263|NCT00942175|Clopidogrel|clopidogrel|mesh-list
83988264|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83988265|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83988266|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83988267|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83988268|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
83988269|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988270|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988271|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988272|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83988273|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988274|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83988275|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988276|NCT01145625|Minoxidil|minoxidil|mesh-list
83988277|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83988278|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
83988279|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
83988280|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988281|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988282|NCT02855203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83988283|NCT02855203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988284|NCT02852083|Pioglitazone|pioglitazone|mesh-list
83988285|NCT02852083|Clarithromycin|clarithromycin|mesh-list
83988286|NCT02852083|Nivolumab|nivolumab|mesh-list
83988287|NCT02852083|Treosulfan|treosulfan|mesh-list
83988288|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988289|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988290|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83988291|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988292|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988293|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988294|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83988295|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988296|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83988297|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988298|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83988299|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83988300|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83227634|NCT02383771|Analgesics|analgesics|mesh-ancestor
83988301|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
83988303|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83988304|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
83988305|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988306|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988307|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83988308|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
83988309|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83988310|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83988311|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988312|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83988313|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
83988314|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83988315|NCT00602407|Protective Agents|protective agents|mesh-ancestor
83988316|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83988317|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83988318|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988319|NCT00950599|Saxagliptin|saxagliptin|mesh-list
83988320|NCT00950599|Incretins|incretins|mesh-ancestor
83988321|NCT00950599|Hormones|hormones|mesh-ancestor
83988322|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988323|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988324|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83988325|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
83988326|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988327|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988328|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988329|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83988330|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
83988331|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83988332|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83988333|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83988334|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
83988335|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83988336|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988337|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83988338|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83988339|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83988340|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83988341|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988342|NCT01143051|Epinephrine|epinephrine|mesh-list
83988343|NCT01143051|Racepinephrine|racepinephrine|mesh-list
83988344|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
83988345|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83988346|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83988347|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83988348|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988349|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988350|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988351|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83988352|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83988353|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
83988354|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988355|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83988356|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
83988357|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
83988358|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
83988359|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83988360|NCT05199597|Atropine|atropine|mesh-list
83988361|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83988362|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83988363|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83988364|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
83988365|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988366|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988367|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83988368|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83988369|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
83988370|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
83988371|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83988372|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83988373|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
83988374|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988375|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988377|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
83988378|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988379|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988380|NCT01139775|Pemetrexed|pemetrexed|mesh-list
83988381|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988382|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988383|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988384|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83988385|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988386|NCT01283516|Ceritinib|ceritinib|mesh-list
83988387|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988388|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988389|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988390|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988391|NCT01283282|Clopidogrel|clopidogrel|mesh-list
83988392|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83988393|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83988394|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83988395|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83988396|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
83988397|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988398|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988399|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988400|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83988401|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83988402|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83988403|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988404|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988405|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988406|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988407|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83988408|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
83988409|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83988410|NCT00941863|Sorafenib|sorafenib|mesh-list
83988411|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988412|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988413|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988414|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988415|NCT00602173|Cilostazol|cilostazol|mesh-list
83988416|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83988417|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
83988418|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988419|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988420|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83988421|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
83988422|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83988423|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83988424|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988425|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83988426|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
83988427|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83988428|NCT00602173|Protective Agents|protective agents|mesh-ancestor
83988429|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83988430|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83988431|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988432|NCT02852239|Dabrafenib|dabrafenib|mesh-list
83988433|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988434|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988435|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988436|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988437|NCT01282424|Idelalisib|idelalisib|mesh-list
83988438|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988439|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988440|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988441|NCT00602251|Terbinafine|terbinafine|mesh-list
83988442|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
83988443|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988444|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227812|NCT01957150|Xhance|xhance|mesh-list
83988445|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988446|NCT01281956|Naluzotan|naluzotan|mesh-list
83988447|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83988448|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83988449|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
83988450|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988451|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988452|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988453|NCT01279850|Pregabalin|pregabalin|mesh-list
83988454|NCT01279850|Analgesics|analgesics|mesh-ancestor
83988455|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
83988456|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988457|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988458|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
83988459|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83988460|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988461|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988462|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83988463|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83988464|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83988465|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988466|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83988467|NCT00604357|Sirolimus|sirolimus|mesh-list
83988468|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83988469|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988470|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83988471|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988472|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
83988473|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83988474|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
83988475|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988476|NCT00602719|Zolpidem|zolpidem|mesh-list
83988477|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83988478|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83988479|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988480|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988481|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83988482|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
83988483|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
83988484|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988485|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988486|NCT00604435|Docetaxel|docetaxel|mesh-list
83988487|NCT00604435|Epirubicin|epirubicin|mesh-list
83988488|NCT00604435|Endostatins|endostatins|mesh-list
83988489|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988490|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83988491|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83988492|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83988493|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988494|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83988495|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83988496|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83988497|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988498|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83988499|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83988500|NCT00604435|Growth Substances|growth substances|mesh-ancestor
83988501|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988502|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
83988503|NCT01136967|Lenvatinib|lenvatinib|mesh-list
83988504|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988505|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988506|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988507|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988508|NCT01218516|Paclitaxel|paclitaxel|mesh-list
83988509|NCT01218516|Carboplatin|carboplatin|mesh-list
83988510|NCT01218516|Pemetrexed|pemetrexed|mesh-list
83988511|NCT01218516|Farletuzumab|farletuzumab|mesh-list
83988512|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83988513|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988514|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
83988515|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
83988516|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
83988517|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988518|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227844|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988519|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83988520|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988521|NCT00938431|Lacosamide|lacosamide|mesh-list
83988522|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
83988523|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83988524|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83988525|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988526|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988527|NCT05381389|Bupivacaine|bupivacaine|mesh-list
83988528|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
83988529|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
83988530|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988531|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988532|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
83988533|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988534|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
83988535|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
83988536|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
83988537|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988538|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83988539|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
83988540|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
83988541|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988542|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988543|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988544|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83988545|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
83988546|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83988547|NCT04312347|Tamoxifen|tamoxifen|mesh-list
83988548|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83988549|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
83988550|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988551|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988552|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83988553|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988554|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83988555|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83988556|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83988557|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
83988558|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988559|NCT05379283|Lidocaine|lidocaine|mesh-list
83988560|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
83988561|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
83988562|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988563|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988564|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
83988565|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988566|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83988567|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83988568|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83988569|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988570|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988571|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83988572|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
83988573|NCT01218438|Antibodies|antibodies|mesh-list
83988574|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
83988575|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83988576|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83988577|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
83988578|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
83988579|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988580|NCT00605995|Simvastatin|simvastatin|mesh-list
83988581|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83988582|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83988583|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
83988584|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988585|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83988586|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83988587|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988588|NCT00604591|Tolcapone|tolcapone|mesh-list
83988589|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83988590|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84124723|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227918|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988591|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83988592|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988593|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988594|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
83988596|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
83988597|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988598|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
83988599|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988600|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988601|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
83988602|NCT02691156|Protective Agents|protective agents|mesh-ancestor
83988603|NCT00603031|Glucagon|glucagon|mesh-list
83988604|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83988605|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988606|NCT00603031|Hormones|hormones|mesh-ancestor
83988607|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988608|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988609|NCT00603031|Incretins|incretins|mesh-ancestor
83988610|NCT05379049|Adalimumab|adalimumab|mesh-list
83988611|NCT05379049|Infliximab|infliximab|mesh-list
83988612|NCT05379049|Etanercept|etanercept|mesh-list
83988613|NCT05379049|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83988614|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83988615|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83988616|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
83988617|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988618|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83988619|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83988620|NCT05379049|Analgesics|analgesics|mesh-ancestor
83988621|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
83988622|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988623|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988624|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83988625|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
83988626|NCT02851459|Vaccines|vaccines|mesh-list
83988627|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
83988628|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988629|NCT00603343|Propiverine|propiverine|mesh-list
83988630|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
83988631|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
83988632|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988633|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988634|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83988635|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83988636|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
83988637|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988638|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988639|NCT00603343|Urological Agents|urological agents|mesh-ancestor
83988640|NCT01277510|Cinacalcet|cinacalcet|mesh-list
83988641|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83988642|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988643|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83988644|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
83988645|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988646|NCT00937495|Bortezomib|bortezomib|mesh-list
83988647|NCT00937495|Vorinostat|vorinostat|mesh-list
83988648|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988649|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83988650|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988651|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988652|NCT04265833|Calcium|calcium|mesh-list
83988653|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83988654|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988655|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83988656|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
83988657|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83988658|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83988659|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83988660|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988661|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988662|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83988663|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83227995|NCT03099785|Rifamycins|rifamycins|mesh-list
83988664|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988665|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988666|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988667|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
83988668|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988669|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83988670|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83988671|NCT05378503|Topiramate|topiramate|mesh-list
83988672|NCT05378503|Phentermine|phentermine|mesh-list
83988673|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
83988674|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988675|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988676|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83988677|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
83988678|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83988679|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
83988680|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
83988681|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988682|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83988683|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988684|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988685|NCT05378191|Vaccines|vaccines|mesh-list
83988686|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
83988687|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988688|NCT00605137|Insulin|insulin|mesh-list
83988689|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83988690|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
83988691|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
83988692|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
83988693|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
83988694|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988695|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988696|NCT00606775|Carvedilol|carvedilol|mesh-list
83988697|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83988698|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83988699|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83988700|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988701|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988702|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988703|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83988704|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
83988705|NCT00606775|Protective Agents|protective agents|mesh-ancestor
83988706|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83988707|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988708|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83988709|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
83988710|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83988711|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83988712|NCT00605371|Lamotrigine|lamotrigine|mesh-list
83988713|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
83988714|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83988715|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988716|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988717|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83988718|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988719|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83988720|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83988721|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988722|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83988723|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83988724|NCT04267549|Paclitaxel|paclitaxel|mesh-list
83988725|NCT04267549|Apatinib|apatinib|mesh-list
83988726|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83988727|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988728|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
83988729|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
83988730|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83988731|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988732|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988733|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988734|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83988735|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83988736|NCT02850913|Doxycycline|doxycycline|mesh-list
83988737|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83228067|NCT03100877|Lenalidomide|lenalidomide|mesh-list
83988738|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988739|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
83988740|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83988741|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83988742|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
83988743|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83988744|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83988745|NCT00934843|Prednisolone|prednisolone|mesh-list
83988746|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
83988747|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83988748|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
83988749|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
83988750|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83988751|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
83988752|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
83988753|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988754|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988755|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988756|NCT00934843|Hormones|hormones|mesh-ancestor
83988757|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988758|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83988759|NCT00934843|Protective Agents|protective agents|mesh-ancestor
83988760|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83988761|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988762|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
83988763|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
83988764|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
83988765|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83988766|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83988767|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988768|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988769|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988770|NCT04267237|Atezolizumab|atezolizumab|mesh-list
83988771|NCT04267237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83988772|NCT04267237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988773|NCT04267237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988774|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988775|NCT00605683|Cabergoline|cabergoline|mesh-list
83988776|NCT00605683|Pramipexole|pramipexole|mesh-list
83988777|NCT00605683|Ropinirole|ropinirole|mesh-list
83988778|NCT00605683|Bromocriptine|bromocriptine|mesh-list
83988779|NCT00605683|Lisuride|lisuride|mesh-list
83988780|NCT00605683|Apomorphine|apomorphine|mesh-list
83988781|NCT00605683|Pergolide|pergolide|mesh-list
83988782|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83988783|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83988784|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
83988785|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
83988786|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988787|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988788|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988789|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
83988790|NCT00605683|Protective Agents|protective agents|mesh-ancestor
83988791|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83988792|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988793|NCT00605683|Emetics|emetics|mesh-ancestor
83988794|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
83988795|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988796|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988797|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83988798|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
83988799|NCT01266902|Rilpivirine|rilpivirine|mesh-list
83988800|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83988801|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988802|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988803|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988804|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
83988805|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988806|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83988807|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83988808|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
83988809|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83988810|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83988811|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
83988812|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
83988813|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83988814|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988815|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
83988816|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988817|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83988818|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
83988819|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988821|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83988822|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83988823|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988824|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988825|NCT01266590|Protective Agents|protective agents|mesh-ancestor
83988826|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988827|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83988828|NCT01265498|Cathartics|cathartics|mesh-ancestor
83988829|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988830|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
83988831|NCT00607711|Ifosfamide|ifosfamide|mesh-list
83988832|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83988833|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
83988834|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988835|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988836|NCT01263782|Bevacizumab|bevacizumab|mesh-list
83988837|NCT01263782|Carboplatin|carboplatin|mesh-list
83988838|NCT01263782|Pemetrexed|pemetrexed|mesh-list
83988839|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988840|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988841|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83988842|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83988843|NCT01263782|Growth Substances|growth substances|mesh-ancestor
83988844|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988845|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
83988846|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988847|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988848|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83988849|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988850|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
83988851|NCT01263704|Rituximab|rituximab|mesh-list
83988852|NCT01263704|Fludarabine|fludarabine|mesh-list
83988853|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83988854|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
83988855|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988856|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83988857|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83988858|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
83988859|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988860|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988861|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83988862|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988863|NCT01263470|Alogliptin|alogliptin|mesh-list
83988864|NCT01263470|Voglibose|voglibose|mesh-list
83988865|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988866|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988867|NCT01263470|Incretins|incretins|mesh-ancestor
83988868|NCT01263470|Hormones|hormones|mesh-ancestor
83988869|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988870|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83988871|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
83988872|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988873|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988874|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83988875|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83988876|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
83988877|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988878|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988879|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
83988880|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
83988881|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988882|NCT04322240|Protective Agents|protective agents|mesh-ancestor
83988883|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988884|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
83988885|NCT04322240|Vitamins|vitamins|mesh-ancestor
83988886|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
83988887|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83988888|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
83988889|NCT01262456|Coagulants|coagulants|mesh-ancestor
83988890|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83988891|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
83988892|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988893|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
83988894|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988895|NCT04321850|Zinc|zinc|mesh-list
83988896|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
83988897|NCT04321850|Trace Elements|trace elements|mesh-ancestor
83988898|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
83988899|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988900|NCT04321850|Astringents|astringents|mesh-ancestor
83988901|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
83988902|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
83988903|NCT04321616|Remdesivir|remdesivir|mesh-list
83988904|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
83988905|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83988906|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83988907|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988908|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988909|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988910|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83988911|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
83988912|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
83988913|NCT00932893|Docetaxel|docetaxel|mesh-list
83988914|NCT00932893|Pemetrexed|pemetrexed|mesh-list
83988915|NCT00932893|Crizotinib|crizotinib|mesh-list
83988916|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988917|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
83988918|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
83988919|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
83988920|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988921|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988922|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83988923|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83988924|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988925|NCT04321070|Clindamycin|clindamycin|mesh-list
83988926|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
83988927|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
83988928|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83988929|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83988930|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83988931|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988932|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988933|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
83988934|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83988935|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83988936|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83988937|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83988938|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83988939|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988940|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988941|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988942|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83988943|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
83988944|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83988945|NCT00939523|Lapatinib|lapatinib|mesh-list
83988946|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988947|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83988948|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83988949|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988950|NCT01260584|Clopidogrel|clopidogrel|mesh-list
83988951|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83988952|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83988953|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83988954|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83988955|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83988956|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
83988957|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83988958|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988959|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988960|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
83988961|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988962|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988963|NCT04262635|Capecitabine|capecitabine|mesh-list
83988964|NCT04262635|Cetuximab|cetuximab|mesh-list
83988965|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83988966|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
83988967|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988968|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988969|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83988970|NCT00608101|Dexamethasone|dexamethasone|mesh-list
83988971|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
83988972|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83988973|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
83988974|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
83988975|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83988976|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988977|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83988978|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
83988979|NCT00608101|Hormones|hormones|mesh-ancestor
83988980|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83988981|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83988982|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988983|NCT04264039|Fludarabine|fludarabine|mesh-list
83988984|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
83988985|NCT04264039|Melphalan|melphalan|mesh-list
83988986|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83988987|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83988988|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83988989|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
83988990|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83988991|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83988992|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83988993|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
83988994|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83988995|NCT00608179|Glimepiride|glimepiride|mesh-list
83988996|NCT00608179|Glyburide|glyburide|mesh-list
83988997|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83988998|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83988999|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989000|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989001|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
83989002|NCT00608335|Micafungin|micafungin|mesh-list
83989003|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
83989004|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989005|NCT00927589|Carboplatin|carboplatin|mesh-list
83989006|NCT00927589|Docetaxel|docetaxel|mesh-list
83989007|NCT00927589|Trastuzumab|trastuzumab|mesh-list
83989008|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989009|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
83989010|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
83989011|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83989012|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989013|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83989014|NCT00932113|Folic Acid|folic acid|mesh-list
83989015|NCT00932113|Adalimumab|adalimumab|mesh-list
83989016|NCT00932113|Methotrexate|methotrexate|mesh-list
83989017|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83989018|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
83989019|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83989020|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989021|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83989022|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
83989023|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989024|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989025|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
83989026|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989027|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83989028|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989029|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
83989030|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83989031|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83989032|NCT00932113|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83989033|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989034|NCT00932113|Hematinics|hematinics|mesh-ancestor
83989035|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
83989036|NCT00932113|Vitamins|vitamins|mesh-ancestor
83989037|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
83989038|NCT00931801|Tenofovir|tenofovir|mesh-list
83989039|NCT00931801|Emtricitabine|emtricitabine|mesh-list
83989040|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
83989041|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83989042|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
83989043|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989044|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83989045|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83989046|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989047|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989048|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83989049|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83989050|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83989051|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83989052|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83989053|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83989054|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
83989055|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83989056|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
83989057|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989058|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83989059|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83989060|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989061|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989062|NCT05025397|Propofol|propofol|mesh-list
83989063|NCT05025397|Sevoflurane|sevoflurane|mesh-list
83989064|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83989065|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989066|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989067|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83989068|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
83989069|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
83989070|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83989071|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83989072|NCT00608803|Doxorubicin|doxorubicin|mesh-list
83989073|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83989074|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989075|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83989076|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83989077|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989078|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989079|NCT00931255|Sirolimus|sirolimus|mesh-list
83989080|NCT00931255|Tacrolimus|tacrolimus|mesh-list
83989081|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989082|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
83989083|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989084|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83989085|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989086|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989087|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83989088|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989089|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83989090|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989091|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
83989092|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83989093|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
83989094|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989095|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83989096|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83989097|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989098|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989099|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
83989100|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83989101|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989102|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
83989103|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83989104|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989105|NCT04262089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83989106|NCT04262089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989107|NCT00609817|Dexamethasone|dexamethasone|mesh-list
83989108|NCT00609817|Bortezomib|bortezomib|mesh-list
83989109|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989110|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
83989111|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
83989112|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989113|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989114|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83989115|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
83228463|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
83989116|NCT00609817|Hormones|hormones|mesh-ancestor
83989117|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989118|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83989119|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989120|NCT00929695|Prednisone|prednisone|mesh-list
83989121|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
83989122|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83989123|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83989124|NCT00929695|Prednisolone|prednisolone|mesh-list
83989125|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
83989126|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83989127|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
83989128|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989129|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
83989130|NCT00929695|Hormones|hormones|mesh-ancestor
83989131|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989132|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989133|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83989134|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989135|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
83989136|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
83989137|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989138|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83989139|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83989140|NCT00929695|Protective Agents|protective agents|mesh-ancestor
83989141|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
83989142|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989143|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989144|NCT04261465|Paclitaxel|paclitaxel|mesh-list
83989145|NCT04261465|Carboplatin|carboplatin|mesh-list
83989146|NCT04261465|Olaparib|olaparib|mesh-list
83989147|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83989148|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989149|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
83989150|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
83989151|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
83989152|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989153|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83989154|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989155|NCT04260607|Ketamine|ketamine|mesh-list
83989156|NCT04260607|Analgesics|analgesics|mesh-ancestor
83989157|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
83989158|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989159|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989160|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83989161|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83989162|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
83989163|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
83989164|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989165|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83989166|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83989167|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989168|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989169|NCT00927355|Pioglitazone|pioglitazone|mesh-list
83989170|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989171|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989172|NCT00923845|Sirolimus|sirolimus|mesh-list
83989173|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
83989174|NCT00923845|Pentostatin|pentostatin|mesh-list
83989175|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989176|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
83989177|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989178|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83989179|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83989180|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
83989181|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989182|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989183|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83989184|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83989185|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989186|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83989187|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
83989188|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989189|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83989190|NCT05052541|Dronabinol|dronabinol|mesh-list
83989191|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
83989192|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989193|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989194|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83989195|NCT05052541|Analgesics|analgesics|mesh-ancestor
83989196|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
83989197|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989198|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83989199|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83989200|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989201|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989202|NCT05052541|Hormones|hormones|mesh-ancestor
83989203|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989204|NCT04260685|Lidocaine|lidocaine|mesh-list
83989205|NCT04260685|Esmolol|esmolol|mesh-list
83989206|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
83989207|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
83989208|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989209|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989210|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
83989211|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989212|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83989213|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83989214|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83989215|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989216|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989217|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83989218|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83989219|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83989220|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
83989221|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989222|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
83989223|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83989224|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
83989225|NCT05013463|Indapamide|indapamide|mesh-list
83989226|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
83989227|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83989228|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83989229|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989230|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989231|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989232|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83989233|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83989234|NCT05013463|Diuretics|diuretics|mesh-ancestor
83989235|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
83989236|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989237|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83989238|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989239|NCT00922987|Pregabalin|pregabalin|mesh-list
83989240|NCT00922987|Analgesics|analgesics|mesh-ancestor
83989241|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
83989242|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989243|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989244|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
83989245|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83989246|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989247|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989248|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83989249|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83989250|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83989251|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989252|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989253|NCT00610909|Paroxetine|paroxetine|mesh-list
83989254|NCT00610909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83989255|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83989256|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989257|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989258|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989259|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
83989260|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989261|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83989262|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
83989263|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989264|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83989265|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83989266|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989267|NCT00927901|Maleic acid|maleic acid|mesh-list
83989268|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989269|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989270|NCT04255771|Cisplatin|cisplatin|mesh-list
83989271|NCT04255771|Gemcitabine|gemcitabine|mesh-list
83989272|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989273|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83989274|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
83989275|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989276|NCT01218204|Atorvastatin|atorvastatin|mesh-list
83989277|NCT01218204|Ezetimibe|ezetimibe|mesh-list
83989278|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83989279|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83989280|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
83989281|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989282|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83989283|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83989284|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989285|NCT00926575|Beclomethasone|beclomethasone|mesh-list
83989286|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989287|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
83989288|NCT00926575|Hormones|hormones|mesh-ancestor
83989289|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989290|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989291|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83989292|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
83532226|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
83989293|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83989294|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83989295|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989296|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989297|NCT01217892|Metformin|metformin|mesh-list
83989298|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
83989299|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989300|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989301|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83989302|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989303|NCT01217814|Leucovorin|leucovorin|mesh-list
83989304|NCT01217814|Folic Acid|folic acid|mesh-list
83989305|NCT01217814|Golimumab|golimumab|mesh-list
83989306|NCT01217814|Methotrexate|methotrexate|mesh-list
83989307|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
83989308|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83989309|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
83989310|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83989311|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989312|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83989313|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
83989314|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989315|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989316|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83989317|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989318|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83989319|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989320|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
83989321|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83989322|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83989323|NCT01217814|Antidotes|antidotes|mesh-ancestor
83989324|NCT01217814|Protective Agents|protective agents|mesh-ancestor
83989325|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
83989326|NCT01217814|Vitamins|vitamins|mesh-ancestor
83989327|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
83989328|NCT01217814|Hematinics|hematinics|mesh-ancestor
83989329|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83989330|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989331|NCT01217190|Ondansetron|ondansetron|mesh-list
83989332|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
83989333|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
83989334|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989335|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989336|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83989337|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
83228688|NCT01970488|Adalimumab|adalimumab|mesh-list
83989338|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
83989339|NCT01217190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83989340|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83989341|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
83989342|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989343|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989344|NCT01136733|Everolimus|everolimus|mesh-list
83989345|NCT01136733|Lenvatinib|lenvatinib|mesh-list
83989346|NCT01136733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83989347|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83989348|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989349|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989350|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989351|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
83989352|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989353|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989354|NCT05178693|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83989355|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83989356|NCT05178693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83989357|NCT05178693|Antimetabolites|antimetabolites|mesh-ancestor
83989358|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989359|NCT05178693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989360|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83989361|NCT01136655|Budesonide|budesonide|mesh-list
83989362|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
83989363|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83989364|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989365|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83989366|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
83989367|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989368|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989369|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83989370|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83989371|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
83989372|NCT01136655|Hormones|hormones|mesh-ancestor
83989373|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989374|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83989375|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83989376|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83989377|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83989378|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989379|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989380|NCT01135017|Dronedarone|dronedarone|mesh-list
83989381|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83989382|NCT01134705|Beclomethasone|beclomethasone|mesh-list
83989383|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989384|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
83989385|NCT01134705|Hormones|hormones|mesh-ancestor
83989386|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989387|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989388|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83989389|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
83989390|NCT01134627|Minocycline|minocycline|mesh-list
83989391|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83989392|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989393|NCT01134393|Amlodipine|amlodipine|mesh-list
83989394|NCT01134393|Telmisartan|telmisartan|mesh-list
83989395|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83989396|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83989397|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83989398|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989399|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989400|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83989401|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989402|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
84124724|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83228759|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83228760|NCT03097445|Nicotine|nicotine|mesh-list
83228761|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83228762|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
83228763|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228764|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228765|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83228766|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83989403|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83989404|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83989406|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989407|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989408|NCT00922441|Valsartan|valsartan|mesh-list
83989409|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83989410|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83989411|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83989412|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989413|NCT01217112|Cannabidiol|cannabidiol|mesh-list
83989414|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
83989415|NCT01216332|Vaccines|vaccines|mesh-list
83989416|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
83989417|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989418|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83989419|NCT00922207|Entecavir|entecavir|mesh-list
83989420|NCT00922207|Adefovir|adefovir|mesh-list
83989421|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
83989422|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989423|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83989424|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83989425|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989426|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989427|NCT01134315|Calcitriol|calcitriol|mesh-list
83989428|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83989429|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989430|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83989431|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83532227|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
83989432|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989433|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83989434|NCT01134315|Vitamins|vitamins|mesh-ancestor
83989435|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
83989436|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83989437|NCT01216176|Anastrozole|anastrozole|mesh-list
83989438|NCT01216176|Saracatinib|saracatinib|mesh-list
83989439|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83989440|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989441|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83989442|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83989443|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989444|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989445|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83989446|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
83989447|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989448|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989449|NCT01133847|Guanfacine|guanfacine|mesh-list
83989450|NCT01133847|Methylphenidate|methylphenidate|mesh-list
83989451|NCT01133847|Amphetamine|amphetamine|mesh-list
83989452|NCT01133847|Adderall|adderall|mesh-list
83989453|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83989454|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83989455|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989456|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83989457|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83989458|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989459|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989460|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
83989461|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989462|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83989463|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
83989464|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
83989465|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
83989466|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989467|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83989468|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83989469|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83989470|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83989471|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
83989472|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989473|NCT01133379|Fluorides|fluorides|mesh-list
83989474|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
83228835|NCT05043233|Methimazole|methimazole|mesh-list
83228836|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
83989475|NCT01133379|Protective Agents|protective agents|mesh-ancestor
83989476|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989477|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83989478|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83989479|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83989480|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
83989481|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989482|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83989483|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83989484|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989485|NCT05154669|Nicotine|nicotine|mesh-list
83989486|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83989487|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
83989488|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989489|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989490|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83989491|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83989492|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
83989493|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989494|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989495|NCT00637455|Fexofenadine|fexofenadine|mesh-list
83989496|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83989497|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83989498|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83989499|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
83989500|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
83989501|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989502|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989503|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989504|NCT00919711|Denosumab|denosumab|mesh-list
83989505|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
83989506|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83989507|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989508|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83989509|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989510|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989511|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83989512|NCT01131585|Ranibizumab|ranibizumab|mesh-list
83989513|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83989514|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83989515|NCT01131585|Growth Substances|growth substances|mesh-ancestor
83989516|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989517|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
83989518|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989519|NCT01131507|Pancrelipase|pancrelipase|mesh-list
83989520|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83989521|NCT00919633|Interferons|interferons|mesh-list
83989522|NCT00919633|Ribavirin|ribavirin|mesh-list
83989523|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
83989524|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
83989525|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83989526|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989527|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989528|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
83989529|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989530|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
83989531|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989532|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
83989533|NCT00926029|Listerine|listerine|mesh-list
83989534|NCT00926029|Triclosan|triclosan|mesh-list
83989535|NCT00926029|Fluorides|fluorides|mesh-list
83989536|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
83989537|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
83989538|NCT00926029|Protective Agents|protective agents|mesh-ancestor
83989539|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989540|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83989541|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989542|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83989543|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83989544|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
83989545|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989546|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83989547|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
83989548|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83989549|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989550|NCT04254913|Edaravone|edaravone|mesh-list
83989551|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83989552|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
83989553|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989554|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83989555|NCT04254913|Protective Agents|protective agents|mesh-ancestor
83989556|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989557|NCT01130493|Levodopa|levodopa|mesh-list
83989558|NCT01130493|Carbidopa|carbidopa|mesh-list
83989559|NCT01130493|Entacapone|entacapone|mesh-list
83989560|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83989561|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83989562|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83989563|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
83989564|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989565|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989566|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989567|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83989568|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989569|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83989570|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83989571|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
83989572|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
83989573|NCT01130337|Capecitabine|capecitabine|mesh-list
83989574|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
83989575|NCT01130337|Trastuzumab|trastuzumab|mesh-list
83989576|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83989577|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
83989578|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989579|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989580|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83989581|NCT04901689|Leronlimab|leronlimab|mesh-list
83989582|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83989583|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83989584|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989585|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83989586|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83989587|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
83989588|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989589|NCT04252963|Streptokinase|streptokinase|mesh-list
83989590|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83989591|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83989592|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989593|NCT04258657|Paclitaxel|paclitaxel|mesh-list
83989594|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83989595|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989596|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
83989597|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
83989598|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83989599|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989600|NCT01130103|Paroxetine|paroxetine|mesh-list
83989601|NCT01130103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83989602|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83989603|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989604|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989605|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989606|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
83989607|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989608|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83989609|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
83989610|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989611|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83989612|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83989613|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989614|NCT04254523|Morphine|morphine|mesh-list
83989615|NCT04254523|Bupivacaine|bupivacaine|mesh-list
83989616|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
83989617|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
83989618|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989619|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989620|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
83989621|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989622|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83989623|NCT04254523|Narcotics|narcotics|mesh-ancestor
83989624|NCT04254523|Analgesics|analgesics|mesh-ancestor
83989625|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83989626|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
83989627|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83989628|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83989629|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83989630|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
83989631|NCT00625209|Protein C|protein c|mesh-list
83989632|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989633|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
83989634|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83989635|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83989636|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989637|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989638|NCT04254601|Erythromycin|erythromycin|mesh-list
83989639|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
83989640|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83989641|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
83989642|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83989643|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989644|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83989645|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83989646|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989647|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989648|NCT01129557|Valsartan|valsartan|mesh-list
83989649|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83989650|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83989651|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83989652|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989653|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
83989654|NCT04254679|Analgesics|analgesics|mesh-list
83989655|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83989656|NCT04254679|Narcotics|narcotics|mesh-ancestor
83989657|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989658|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989659|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
83989660|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989661|NCT01129011|Naproxen|naproxen|mesh-list
83989662|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83989663|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83989664|NCT01129011|Analgesics|analgesics|mesh-ancestor
83989665|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
83989666|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989667|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989668|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989669|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83989670|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
83989671|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83989672|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989673|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989674|NCT04252885|Ritonavir|ritonavir|mesh-list
83989675|NCT04252885|Lopinavir|lopinavir|mesh-list
83989676|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83989677|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83989678|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
83989679|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989680|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989681|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83989682|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83989683|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
83989684|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989685|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83989686|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83989687|NCT04962841|Metformin|metformin|mesh-list
83989688|NCT04962841|Amlodipine|amlodipine|mesh-list
83989689|NCT04962841|Ramipril|ramipril|mesh-list
83989690|NCT04962841|Nebivolol|nebivolol|mesh-list
83989691|NCT04962841|Rivastigmine|rivastigmine|mesh-list
83989692|NCT04962841|Sertraline|sertraline|mesh-list
83989693|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989694|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989695|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83989696|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83989697|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989698|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124725|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83989699|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83989700|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
83989701|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
83989702|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989703|NCT04962841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83989704|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83989705|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989706|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
83989707|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83989708|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
83989709|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989710|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83989711|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83989712|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83989713|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
83989714|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83989715|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
83989716|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83989717|NCT04962841|Protective Agents|protective agents|mesh-ancestor
83989718|NCT00919867|Guanfacine|guanfacine|mesh-list
83989719|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83989720|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83989721|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989722|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83989723|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83532302|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
83989724|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989725|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989726|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
83989727|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989728|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83989729|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83989730|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83989731|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83989732|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
83989733|NCT04252261|Sulforaphane|sulforaphane|mesh-list
83989734|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83989735|NCT04252261|Protective Agents|protective agents|mesh-ancestor
83989736|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989737|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989738|NCT04251871|Interferons|interferons|mesh-list
83989739|NCT04251871|Ritonavir|ritonavir|mesh-list
83989740|NCT04251871|Lopinavir|lopinavir|mesh-list
83989741|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
83989742|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83989743|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989744|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
83989745|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989746|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83989747|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83989748|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
83989749|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989750|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989751|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83989752|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83989753|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83989754|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83989755|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
83989756|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989757|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83989758|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989759|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989760|NCT01128621|Incretins|incretins|mesh-ancestor
83989761|NCT01128621|Hormones|hormones|mesh-ancestor
83989762|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989763|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83989764|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
83989765|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989766|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989767|NCT00918463|Dasatinib|dasatinib|mesh-list
83989768|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989769|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83989770|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989771|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989772|NCT05330065|Bevacizumab|bevacizumab|mesh-list
83989773|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83989774|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989775|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83989776|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83989777|NCT05330065|Growth Substances|growth substances|mesh-ancestor
83989778|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989779|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
83989780|NCT01128543|Vinorelbine|vinorelbine|mesh-list
83989781|NCT01128543|Lapatinib|lapatinib|mesh-list
83989782|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83989783|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989784|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83989785|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83989786|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83989787|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989788|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83989789|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989790|NCT01128387|Panitumumab|panitumumab|mesh-list
83989791|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83989792|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989793|NCT01214850|Vaccines|vaccines|mesh-list
83989794|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
83989795|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989796|NCT01128153|Saxagliptin|saxagliptin|mesh-list
83989797|NCT01128153|Incretins|incretins|mesh-ancestor
83989798|NCT01128153|Hormones|hormones|mesh-ancestor
83989799|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989800|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989801|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83989802|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
83989803|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989804|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989805|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989806|NCT00925015|Irinotecan|irinotecan|mesh-list
83989807|NCT00925015|Cetuximab|cetuximab|mesh-list
83989808|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83989809|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83989810|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83989811|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989812|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989813|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989814|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83989815|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
83989816|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989817|NCT01127763|Carboplatin|carboplatin|mesh-list
83989818|NCT01127763|Everolimus|everolimus|mesh-list
83989819|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989820|NCT01127763|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83989821|NCT01127763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83989822|NCT01127763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989823|NCT01127763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989824|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989825|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
83989826|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989827|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83989828|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83989829|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989830|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83989831|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83989832|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83989833|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989834|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
83989835|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989836|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
83989837|NCT00924781|Hematinics|hematinics|mesh-ancestor
83989838|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
83989839|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989840|NCT01214616|Vinorelbine|vinorelbine|mesh-list
83989841|NCT01214616|Afatinib|afatinib|mesh-list
83989842|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83989843|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989844|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
83989845|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
83989846|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
84124726|NCT05590117|Leucovorin|leucovorin|mesh-list
83989847|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989848|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83989849|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989850|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83989851|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
83989852|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83989853|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83989854|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83989855|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989856|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989857|NCT01213524|Nicotine|nicotine|mesh-list
83989858|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83989859|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
83989860|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989861|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989862|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83989863|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83989864|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
83989865|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989866|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989867|NCT01212588|Mifepristone|mifepristone|mesh-list
83989868|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83989869|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
83989870|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83989871|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989872|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83989873|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83989874|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83989875|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
83989876|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83989877|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83989878|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
83989879|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989880|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
83989881|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83989882|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83989883|NCT00918385|Dasatinib|dasatinib|mesh-list
83989884|NCT00918385|Nilutamide|nilutamide|mesh-list
83989885|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989886|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83989887|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989888|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989889|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
83989890|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
83989891|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989892|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989893|NCT00637819|Leflunomide|leflunomide|mesh-list
83989894|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989895|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989896|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83989897|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
83989898|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989899|NCT00631501|Doxycycline|doxycycline|mesh-list
83989900|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83989901|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989902|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
83989903|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83989904|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83989905|NCT04746547|Dolutegravir|dolutegravir|mesh-list
83989906|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83989907|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83989908|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989909|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989910|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83989911|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83989912|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
83989913|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989914|NCT04782037|Calcium|calcium|mesh-list
83989915|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83989916|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989917|NCT00924469|Prednisone|prednisone|mesh-list
83989918|NCT00924469|Leuprolide|leuprolide|mesh-list
83989919|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989920|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
83989921|NCT00924469|Hormones|hormones|mesh-ancestor
83989922|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83989923|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989924|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83989925|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989926|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83989927|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
83989928|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83989929|NCT00631579|Rasburicase|rasburicase|mesh-list
83989930|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
83989931|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83989932|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83989933|NCT04256473|Saruplase|saruplase|mesh-list
83989934|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83989935|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83989936|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989937|NCT00916357|Insulin|insulin|mesh-list
83989938|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83989939|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
83989940|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83989941|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989942|NCT00916279|Paclitaxel|paclitaxel|mesh-list
83989943|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83989944|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83989945|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
83989946|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
83989947|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
83989948|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989949|NCT01209078|Linezolid|linezolid|mesh-list
83989950|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83989951|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83989952|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83989953|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83989954|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989955|NCT04318158|Fentanyl|fentanyl|mesh-list
83989956|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
83989957|NCT04318158|Bupivacaine|bupivacaine|mesh-list
83989958|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
83989959|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
83989960|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989961|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989962|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
83989963|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989964|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83989965|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83989966|NCT04318158|Analgesics|analgesics|mesh-ancestor
83989967|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83989968|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83989969|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83989970|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83989971|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83989972|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989973|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83989974|NCT04318158|Narcotics|narcotics|mesh-ancestor
83989975|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83989976|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83989977|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
83989978|NCT01207596|Hydromorphone|hydromorphone|mesh-list
83989979|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83989980|NCT01207596|Narcotics|narcotics|mesh-ancestor
83989981|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83989982|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989983|NCT01207596|Analgesics|analgesics|mesh-ancestor
83989984|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
83989985|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83989986|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
83989987|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83989988|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83989989|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83989990|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83989991|NCT04203043|Pycnogenols|pycnogenols|mesh-list
83989992|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83989993|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
83989994|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83989995|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
83989996|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83989997|NCT04203043|Protective Agents|protective agents|mesh-ancestor
83989998|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83989999|NCT04435015|Camostat|camostat|mesh-list
83990000|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
83990001|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990002|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990003|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83990004|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83990005|NCT00631813|Prucalopride|prucalopride|mesh-list
83990006|NCT00631813|Laxatives|laxatives|mesh-ancestor
83990007|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990008|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83990009|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83990010|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
83990011|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990012|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990013|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990014|NCT04404049|UB-421|ub-421|mesh-list
83990015|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83990016|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
83990017|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990018|NCT04911517|Capecitabine|capecitabine|mesh-list
83990019|NCT04911517|Antibodies|antibodies|mesh-list
83990020|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83990021|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
83990022|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990023|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83990024|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
83990025|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990026|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990027|NCT00637897|Paclitaxel|paclitaxel|mesh-list
83990028|NCT00637897|Docetaxel|docetaxel|mesh-list
83990029|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83990030|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83990031|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990032|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990033|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990034|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990035|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990036|NCT03992443|Reteplase|reteplase|mesh-list
83990037|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83990038|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83990039|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990040|NCT04329949|Paclitaxel|paclitaxel|mesh-list
83990041|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83990042|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990043|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990044|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990045|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990046|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990047|NCT04597099|Flutamide|flutamide|mesh-list
83990048|NCT04597099|Estradiol|estradiol|mesh-list
83990049|NCT04597099|Progesterone|progesterone|mesh-list
83990050|NCT04597099|Estrogens|estrogens|mesh-ancestor
83990051|NCT04597099|Hormones|hormones|mesh-ancestor
83990052|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990053|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990054|NCT04597099|Progestins|progestins|mesh-ancestor
83990055|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
83990056|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
83990057|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83990058|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990059|NCT04816513|Ustekinumab|ustekinumab|mesh-list
83990060|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
83990061|NCT04203511|Paclitaxel|paclitaxel|mesh-list
83990062|NCT04203511|Etoposide|etoposide|mesh-list
83990063|NCT04203511|Carboplatin|carboplatin|mesh-list
83990064|NCT04203511|Pemetrexed|pemetrexed|mesh-list
83990065|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83990066|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990067|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990068|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990069|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990070|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990071|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83990072|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83990073|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990074|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83990075|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83990076|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
83990077|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83990078|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83990079|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990080|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
83990081|NCT03690037|Coagulants|coagulants|mesh-ancestor
83990082|NCT00910273|Etanercept|etanercept|mesh-list
83990083|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83990084|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990085|NCT00910273|Analgesics|analgesics|mesh-ancestor
83990086|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
83990087|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990088|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990089|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83990090|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990091|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990092|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83990093|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
83990094|NCT04156087|Gemcitabine|gemcitabine|mesh-list
83990095|NCT04156087|Durvalumab|durvalumab|mesh-list
83990096|NCT04156087|Tremelimumab|tremelimumab|mesh-list
83990097|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83990098|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
83990099|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990100|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990101|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83990102|NCT00910039|Sunitinib|sunitinib|mesh-list
83990103|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990104|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83990105|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83990106|NCT00910039|Growth Substances|growth substances|mesh-ancestor
83990107|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990108|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83990109|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83990110|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990111|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990112|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
83990113|NCT00909181|Oxybutynin|oxybutynin|mesh-list
83990114|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
83990115|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
83990116|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990117|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990118|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83990119|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83990120|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
83990121|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990122|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990123|NCT00909181|Urological Agents|urological agents|mesh-ancestor
83990124|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83990125|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990126|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
83990127|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83990128|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
83990129|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990130|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
83990131|NCT05579665|Protective Agents|protective agents|mesh-ancestor
83990132|NCT01286987|Talazoparib|talazoparib|mesh-list
83990133|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83990134|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990135|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990136|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990137|NCT01286753|Vemurafenib|vemurafenib|mesh-list
83990138|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990139|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83990140|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990141|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990142|NCT01284959|Risperidone|risperidone|mesh-list
83990143|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83990144|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83990145|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
83990146|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990147|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124727|NCT05590117|Fluorouracil|fluorouracil|mesh-list
83990148|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990149|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83990150|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83990151|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990152|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990153|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83990154|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
83990155|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83990156|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83990157|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
83990158|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83990159|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83990160|NCT01283009|Prednisolone|prednisolone|mesh-list
83990161|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
83990162|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83990163|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
83990164|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83990165|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
83990166|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
83990167|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990168|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990169|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990170|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
83990171|NCT01283009|Hormones|hormones|mesh-ancestor
83990172|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990173|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83990174|NCT01283009|Protective Agents|protective agents|mesh-ancestor
83990175|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83990176|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990177|NCT01282463|Docetaxel|docetaxel|mesh-list
83990178|NCT01282463|Ramucirumab|ramucirumab|mesh-list
83990179|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990180|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990181|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990182|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990183|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990184|NCT01281917|Sirolimus|sirolimus|mesh-list
83990185|NCT01281917|Bortezomib|bortezomib|mesh-list
83990186|NCT01281917|Temsirolimus|temsirolimus|mesh-list
83990187|NCT01281917|MTOR Inhibitors|mtor inhibitors|mesh-list
83990188|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990189|NCT01281917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83990190|NCT01281917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990191|NCT01281917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990192|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83990193|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
83990194|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990195|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83990196|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990197|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83990198|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
83990199|NCT01281839|Ribavirin|ribavirin|mesh-list
83990200|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83990201|NCT01281839|Simeprevir|simeprevir|mesh-list
83990202|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
83990203|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990204|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
83990205|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990206|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83990207|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990208|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
83990209|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83990210|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83990211|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990212|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
83990213|NCT01280981|Coagulants|coagulants|mesh-ancestor
83990214|NCT02889653|Anticoagulants|anticoagulants|mesh-list
83990215|NCT01280591|Naproxen|naproxen|mesh-list
83990216|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83990217|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990218|NCT01280591|Analgesics|analgesics|mesh-ancestor
83990219|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
83229591|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
83229594|NCT02350543|Aspirin|aspirin|mesh-list
83990220|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990221|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990222|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83990223|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990224|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
83990225|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83990226|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990227|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990228|NCT04323761|Remdesivir|remdesivir|mesh-list
83990229|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
83990230|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990231|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
83990232|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990233|NCT05566223|Aldesleukin|aldesleukin|mesh-list
83990234|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
83990235|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
83990236|NCT05566223|Fludarabine|fludarabine|mesh-list
83990237|NCT05566223|Interleukin-2|interleukin-2|mesh-list
83990238|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83990239|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
83990240|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990241|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990242|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83990243|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
83990244|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990245|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990246|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83990247|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83990248|NCT05566223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83990249|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990250|NCT05566223|Analgesics|analgesics|mesh-ancestor
83990251|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
83990252|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990253|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83990254|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83990255|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
83990256|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990257|NCT01271933|Pregabalin|pregabalin|mesh-list
83990258|NCT01271933|Analgesics|analgesics|mesh-ancestor
83990259|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
83990260|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990261|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990262|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
83990263|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83990264|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990265|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990266|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83990267|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83990268|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83990269|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990270|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990271|NCT01269125|Leuprolide|leuprolide|mesh-list
83990272|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83990273|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
83990274|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83990275|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990276|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83990277|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990278|NCT01268891|Rasagiline|rasagiline|mesh-list
83990279|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83990280|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990281|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990282|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83990283|NCT01268891|Protective Agents|protective agents|mesh-ancestor
83990284|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990285|NCT04323527|Chloroquine|chloroquine|mesh-list
83990286|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83990287|NCT04323527|Amebicides|amebicides|mesh-ancestor
83990288|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83990289|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83990290|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990291|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
83990292|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990293|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83990294|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990295|NCT04323527|Analgesics|analgesics|mesh-ancestor
83990296|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
83990297|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124728|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
83990298|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990299|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83990300|NCT04323527|Filaricides|filaricides|mesh-ancestor
83990301|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
83990302|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
83990303|NCT02889497|Vaccines|vaccines|mesh-list
83990304|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
83990305|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990306|NCT01266317|Rituximab|rituximab|mesh-list
83990307|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83990308|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990309|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
83990310|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990311|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990312|NCT01266161|Ibuprofen|ibuprofen|mesh-list
83990313|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83990314|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990315|NCT01266161|Analgesics|analgesics|mesh-ancestor
83990316|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
83990317|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990318|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990319|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83990320|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990321|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83990322|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990323|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990324|NCT01265849|Indomethacin|indomethacin|mesh-list
83990325|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
83990326|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83990327|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
83990328|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990329|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990330|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83990331|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
83990332|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990333|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990334|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83990335|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83990336|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990337|NCT01265849|Analgesics|analgesics|mesh-ancestor
83990338|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
83990339|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990340|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83990341|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
83990342|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
83990343|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83990344|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83990345|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990346|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
83990347|NCT01265615|Vitamin D|vitamin d|mesh-list
83990348|NCT01265615|Calcitriol|calcitriol|mesh-list
83990349|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83990350|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990351|NCT01265615|Vitamins|vitamins|mesh-ancestor
83990352|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
83990353|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83990354|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83990355|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990356|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990357|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83990358|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83990359|NCT01264679|Hematinics|hematinics|mesh-ancestor
83990360|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83990361|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83990362|NCT05542667|Fluorides|fluorides|mesh-list
83990363|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
83990364|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
83990365|NCT05542667|Protective Agents|protective agents|mesh-ancestor
83990366|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990367|NCT01263509|Inositol|inositol|mesh-list
83990368|NCT01263509|Alogliptin|alogliptin|mesh-list
83990369|NCT01263509|Voglibose|voglibose|mesh-list
83990370|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83990371|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990372|NCT01263509|Incretins|incretins|mesh-ancestor
83990373|NCT01263509|Hormones|hormones|mesh-ancestor
84124729|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
83990374|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990375|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83990377|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990378|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990379|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83990380|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
83990381|NCT01263509|Vitamins|vitamins|mesh-ancestor
83990382|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
83990383|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
83990384|NCT01263197|Propranolol|propranolol|mesh-list
83990385|NCT01263197|Albuterol|albuterol|mesh-list
83990386|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83990387|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83990388|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
83990389|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990390|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990391|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990392|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83990393|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83990394|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
83990395|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83990396|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
83990397|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990398|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83990399|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
83990400|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
83990401|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83990402|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83990403|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83990404|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83990405|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83990406|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990407|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
83990408|NCT01263119|Warfarin|warfarin|mesh-list
83990409|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
83990410|NCT01262651|Nabiximols|nabiximols|mesh-list
83990411|NCT01262651|Analgesics|analgesics|mesh-ancestor
83990412|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
83990413|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990414|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990415|NCT01261793|Epratuzumab|epratuzumab|mesh-list
83990416|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83990417|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990418|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
83990419|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
83990420|NCT04321655|Ibuprofen|ibuprofen|mesh-list
83990421|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83990422|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990423|NCT04321655|Analgesics|analgesics|mesh-ancestor
83990424|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
83990425|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990426|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990427|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83990428|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990429|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83990430|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990431|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990432|NCT05529251|Carboplatin|carboplatin|mesh-list
83990433|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990434|NCT01261325|Brivaracetam|brivaracetam|mesh-list
83990435|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
83990436|NCT01260467|Memantine|memantine|mesh-list
83990437|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83990438|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83990439|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
83990440|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990441|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990442|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990443|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83990444|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83990445|NCT01260311|Fesoterodine|fesoterodine|mesh-list
83990446|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83990447|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83990448|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
83990449|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990450|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990451|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990452|NCT01260311|Urological Agents|urological agents|mesh-ancestor
83990454|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
83990455|NCT01259375|Amrubicin|amrubicin|mesh-list
83990456|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990457|NCT05536037|Metformin|metformin|mesh-list
83990458|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83990459|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990460|NCT00624143|Voriconazole|voriconazole|mesh-list
83990461|NCT00624143|Amphotericin B|amphotericin b|mesh-list
83990462|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83990463|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
83990464|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990465|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83990466|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83990467|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990468|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990469|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83990470|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
83990471|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990472|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990473|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83990474|NCT00624143|Amebicides|amebicides|mesh-ancestor
83990475|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83990476|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83990477|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83990478|NCT05241275|Xenon|xenon|mesh-list
83990479|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83990480|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
83990481|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
83990482|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990483|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990484|NCT04540835|Calcium|calcium|mesh-list
83990485|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83990486|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990487|NCT04005287|Pirenzepine|pirenzepine|mesh-list
83990488|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83990489|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990490|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83990491|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83990492|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
83990493|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990494|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990495|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990496|NCT04320173|Lidocaine|lidocaine|mesh-list
83990497|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
83990498|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
83990499|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990500|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990501|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
83990502|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990503|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83990504|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83990505|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83990506|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990507|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990508|NCT04321733|Amoxicillin|amoxicillin|mesh-list
83990509|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
83990510|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
83990511|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83990512|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83990513|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990514|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83990515|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990516|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990517|NCT02029001|Everolimus|everolimus|mesh-list
83990518|NCT02029001|Sorafenib|sorafenib|mesh-list
83990519|NCT02029001|Durvalumab|durvalumab|mesh-list
83990520|NCT02029001|Olaparib|olaparib|mesh-list
83229888|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990521|NCT02029001|Lapatinib|lapatinib|mesh-list
83990522|NCT02029001|Tremelimumab|tremelimumab|mesh-list
83990524|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83990525|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990526|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990527|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83990528|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
83990529|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990530|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990531|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83990532|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83990533|NCT01613495|Octreotide|octreotide|mesh-list
83990534|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990535|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83990536|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990537|NCT01321073|Treprostinil|treprostinil|mesh-list
83990538|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83990539|NCT00694733|Anastrozole|anastrozole|mesh-list
83990540|NCT00694733|Leuprolide|leuprolide|mesh-list
83990541|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
83990542|NCT00694733|Estradiol|estradiol|mesh-list
83990543|NCT00694733|Estrogens|estrogens|mesh-list
83990544|NCT00694733|Testosterone|testosterone|mesh-list
83990545|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
83990546|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
83990547|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83990548|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83990549|NCT00694733|Hormones|hormones|mesh-ancestor
83990550|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990551|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990552|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83990553|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83990554|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990555|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83990556|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990557|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990558|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83990559|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
83990560|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83990561|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
83990562|NCT00694733|Androgens|androgens|mesh-ancestor
83990563|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
83990564|NCT01259297|Amlodipine|amlodipine|mesh-list
83990565|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83990566|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83990567|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83990568|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990569|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990570|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83990571|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990572|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
83990573|NCT01259297|Diuretics|diuretics|mesh-ancestor
83990574|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
83990575|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83990576|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
83990577|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83990578|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
83990579|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990580|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990581|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83990582|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83990583|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
83990584|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83990585|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
83990586|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990587|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990588|NCT01258595|Vaccines|vaccines|mesh-list
83990589|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
83990590|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990591|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83990592|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990593|NCT01126359|Lidocaine|lidocaine|mesh-list
83990594|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
83990595|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
83990596|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990597|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990598|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
83990599|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990600|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83990601|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83990602|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83990603|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990604|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990605|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
83990606|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83990607|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83990608|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83990609|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990610|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990611|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
83990612|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990613|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990614|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83990615|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990616|NCT01125813|Factor VIII|factor viii|mesh-list
83990617|NCT01125813|Coagulants|coagulants|mesh-ancestor
83990618|NCT04311645|Charcoal|charcoal|mesh-list
83990619|NCT04311645|Antidotes|antidotes|mesh-ancestor
83990620|NCT04311645|Protective Agents|protective agents|mesh-ancestor
83990621|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990622|NCT01257581|Tamoxifen|tamoxifen|mesh-list
83990623|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83990624|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
83990625|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990626|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990627|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83990628|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990629|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83990630|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83990631|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83990632|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
83990633|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83990634|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990635|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83990636|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
83990637|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83990638|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
83990639|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83990640|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990641|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83990642|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83990643|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990644|NCT00995488|Paclitaxel|paclitaxel|mesh-list
83990645|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83990646|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83990647|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990648|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990649|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990650|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990651|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990652|NCT04293172|Ticagrelor|ticagrelor|mesh-list
83990653|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83990654|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83990655|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83990656|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83990657|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
83990658|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990659|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990660|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990661|NCT01256879|Cimetidine|cimetidine|mesh-list
83990662|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83990663|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990664|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83990665|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
83990666|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
83990667|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990668|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990669|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990670|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83990671|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83990672|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990673|NCT02869672|Vaccines|vaccines|mesh-list
83990674|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
83990675|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990676|NCT01125189|Interferons|interferons|mesh-list
83990677|NCT01125189|Ribavirin|ribavirin|mesh-list
83990678|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
83990679|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
83990680|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83990681|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990682|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
83990683|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990684|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
83990685|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990686|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
83990687|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990688|NCT01256567|Docetaxel|docetaxel|mesh-list
83990689|NCT01256567|Ramucirumab|ramucirumab|mesh-list
83990690|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990691|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990692|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990693|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990694|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990695|NCT00996736|Voriconazole|voriconazole|mesh-list
83990696|NCT00996736|Natamycin|natamycin|mesh-list
83990697|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
83990698|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990699|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83990700|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83990701|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990702|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990703|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83990704|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
83990705|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990706|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990707|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83990708|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83990709|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83990710|NCT00996658|Linagliptin|linagliptin|mesh-list
83990711|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83990712|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990713|NCT00996658|Incretins|incretins|mesh-ancestor
83990714|NCT00996658|Hormones|hormones|mesh-ancestor
83990715|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990716|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83990717|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
83990718|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990719|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990720|NCT04310631|Ranibizumab|ranibizumab|mesh-list
83990721|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83990722|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83990723|NCT04310631|Growth Substances|growth substances|mesh-ancestor
83990724|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990725|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
83990726|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990727|NCT01256411|Amlodipine|amlodipine|mesh-list
83990728|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83990729|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83990730|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83990731|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83990732|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990733|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990734|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83990735|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990736|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
83990737|NCT01256411|Diuretics|diuretics|mesh-ancestor
83990738|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
83990739|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83990740|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83990741|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
83990742|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83230109|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990744|NCT00996580|Estrogens|estrogens|mesh-ancestor
83990745|NCT00996580|Hormones|hormones|mesh-ancestor
83990746|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990747|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990748|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83990749|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
83990750|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83990751|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83990752|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83990753|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83990754|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83990755|NCT01124175|Losartan|losartan|mesh-list
83990756|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83990757|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83990758|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83990759|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83990760|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990761|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83990762|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
83990763|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990764|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83990765|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83990766|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990767|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990768|NCT02882451|Pinaverium|pinaverium|mesh-list
83990769|NCT02882451|Bromides|bromides|mesh-list
83990770|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990771|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990772|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
83990773|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83990774|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990775|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83990776|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
83990777|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
83990778|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990779|NCT00999544|Oxycodone|oxycodone|mesh-list
83990780|NCT00999544|Aprepitant|aprepitant|mesh-list
83990781|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
83990782|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83990783|NCT00999544|Narcotics|narcotics|mesh-ancestor
83990784|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990785|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990786|NCT00999544|Analgesics|analgesics|mesh-ancestor
83990787|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
83990788|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990789|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
83990790|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
83990791|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990792|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83990793|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990794|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990795|NCT02869984|Ramosetron|ramosetron|mesh-list
83990796|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
83990797|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
83990798|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990799|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990800|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83990801|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83990802|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
83990803|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990804|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990805|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83990806|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
83990807|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83990808|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83990809|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990810|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990811|NCT01123395|Colchicine|colchicine|mesh-list
83990812|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
83990813|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83990814|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990815|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990816|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990817|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990818|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990819|NCT01255787|Vortioxetine|vortioxetine|mesh-list
83990820|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
83990821|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990822|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83990823|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83990824|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990825|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990826|NCT01255787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83990827|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83990828|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990829|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990830|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990831|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
83990832|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83990833|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83990834|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83990835|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83990836|NCT01255163|Exenatide|exenatide|mesh-list
83990837|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83990838|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990839|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83990840|NCT01255163|Incretins|incretins|mesh-ancestor
83990841|NCT01255163|Hormones|hormones|mesh-ancestor
83990842|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990843|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
83990844|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
83990845|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990846|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83990847|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
83990848|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83990849|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83990850|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
83990851|NCT01254305|Milnacipran|milnacipran|mesh-list
83990852|NCT01254305|Sertraline|sertraline|mesh-list
83990853|NCT01254305|Fluoxetine|fluoxetine|mesh-list
83990854|NCT01254305|Paroxetine|paroxetine|mesh-list
83990855|NCT01254305|Citalopram|citalopram|mesh-list
83990856|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
83990857|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
83990858|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990859|NCT01254305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83990860|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83990861|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990862|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990863|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990864|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
83990865|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990866|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83990867|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83990868|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83990869|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990870|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990871|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83990872|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83990873|NCT01254305|Analgesics|analgesics|mesh-ancestor
83990874|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
83990875|NCT01122927|Aripiprazole|aripiprazole|mesh-list
83990876|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
83990877|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990878|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83990879|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83990880|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990881|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990882|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
83990883|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
83990884|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990885|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990886|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83990887|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83990888|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
83230259|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990889|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83990890|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83990891|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83990892|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83990893|NCT01254227|Deferasirox|deferasirox|mesh-list
83990894|NCT01254227|Deferoxamine|deferoxamine|mesh-list
83990895|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83990896|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
83990897|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
83990898|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990899|NCT01254227|Siderophores|siderophores|mesh-ancestor
83990900|NCT04311255|Anesthetics|anesthetics|mesh-list
83990901|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990902|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990903|NCT01122381|Ethosuximide|ethosuximide|mesh-list
83990904|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
83990905|NCT00996034|Nicotine|nicotine|mesh-list
83990906|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990907|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83990908|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
83990909|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990910|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83990911|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83990912|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
83990913|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990914|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990915|NCT01121991|Hormones|hormones|mesh-list
83990916|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83990917|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990918|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83990919|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
83990920|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83990921|NCT04292236|Protective Agents|protective agents|mesh-ancestor
83990922|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990923|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990924|NCT01121913|Trazodone|trazodone|mesh-list
83990925|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83990926|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83990927|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990928|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990929|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990930|NCT01121913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83990931|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83990932|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990933|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990934|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990935|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
83990936|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83990937|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
83990938|NCT04310943|Paclitaxel|paclitaxel|mesh-list
83990939|NCT04310943|Tislelizumab|tislelizumab|mesh-list
83990940|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83990941|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990942|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
83990943|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
83990944|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
83990945|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990946|NCT04310943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83990947|NCT02868814|Pregabalin|pregabalin|mesh-list
83990948|NCT02868814|Analgesics|analgesics|mesh-ancestor
83990949|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
83990950|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83990951|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990952|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
83990953|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83990954|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83990955|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990956|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83230332|NCT05917288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230333|NCT05917275|Amlodipine|amlodipine|mesh-list
83230334|NCT05917275|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83990957|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83230335|NCT05917275|Olmesartan|olmesartan|mesh-list
83990958|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83990959|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83990960|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83990961|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
83990962|NCT04292314|Deferoxamine|deferoxamine|mesh-list
83990963|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990964|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
83990965|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990966|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990967|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83990968|NCT04292314|Siderophores|siderophores|mesh-ancestor
83990969|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83990970|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
83990971|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
83990972|NCT01121757|Lenalidomide|lenalidomide|mesh-list
83990973|NCT01121757|Azacitidine|azacitidine|mesh-list
83990974|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
83990975|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990976|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83990977|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83990978|NCT01121757|Growth Substances|growth substances|mesh-ancestor
83990979|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83990980|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990981|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83990982|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
83990983|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990984|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990985|NCT04319471|Capecitabine|capecitabine|mesh-list
83990986|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83990987|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
83990988|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990989|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83990990|NCT02882217|Histamine|histamine|mesh-list
83990991|NCT02882217|Glutarimide|glutarimide|mesh-list
83990992|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
83990993|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
83990994|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83990995|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83990996|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83990997|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83990998|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83990999|NCT01253135|Petrolatum|petrolatum|mesh-list
83991000|NCT01253135|Emollients|emollients|mesh-ancestor
83991001|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
83991002|NCT00993616|Carboplatin|carboplatin|mesh-list
83991003|NCT00993616|Belinostat|belinostat|mesh-list
83991004|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991005|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83991006|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991007|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991008|NCT01120899|Minocycline|minocycline|mesh-list
83991009|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991010|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991011|NCT01120275|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83991012|NCT01120275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83991013|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991014|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991015|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
83991016|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83991017|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991018|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83991019|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
83991020|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991021|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991022|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991023|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991024|NCT01119963|Castor Oil|castor oil|mesh-list
83991025|NCT01119963|Progesterone|progesterone|mesh-list
83991026|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83991027|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83991028|NCT01119963|Progestins|progestins|mesh-ancestor
83991029|NCT01119963|Hormones|hormones|mesh-ancestor
83991030|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991031|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991032|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83991033|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
83991034|NCT01119963|Cathartics|cathartics|mesh-ancestor
83991035|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83991036|NCT01252667|Cyclosporine|cyclosporine|mesh-list
83991037|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
83991038|NCT01252667|Clofarabine|clofarabine|mesh-list
83991039|NCT01252667|Cyclosporins|cyclosporins|mesh-list
83991040|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991041|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991042|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83991043|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
83991044|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991045|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
83991046|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991047|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
83991048|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991049|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83991050|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83991051|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991052|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83991053|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
83991054|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991055|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83991056|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
83991057|NCT02868580|Lamivudine|lamivudine|mesh-list
83991058|NCT02868580|Abacavir|abacavir|mesh-list
83991059|NCT02868580|Dolutegravir|dolutegravir|mesh-list
83991060|NCT02868580|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
83991061|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83991062|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83991063|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991064|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991065|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
83991066|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991067|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83991068|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83991069|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83991070|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83991071|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
83991072|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
83991073|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991074|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83991075|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991076|NCT01119105|Vancomycin|vancomycin|mesh-list
83991077|NCT01119105|Lefamulin|lefamulin|mesh-list
83991078|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991079|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991080|NCT01118949|Lacosamide|lacosamide|mesh-list
83991081|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
83991082|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83991083|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83991084|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991085|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991086|NCT01252355|Interferons|interferons|mesh-list
83991087|NCT01252355|Interferon-beta|interferon-beta|mesh-list
83991088|NCT01252355|Teriflunomide|teriflunomide|mesh-list
83991089|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991090|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
83991091|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991092|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
83991093|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991094|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83991095|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83991096|NCT01252355|Analgesics|analgesics|mesh-ancestor
83991097|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
83991098|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991099|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991100|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991101|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83991102|NCT01118325|Clopidogrel|clopidogrel|mesh-list
83991103|NCT01118325|Ticagrelor|ticagrelor|mesh-list
83991104|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83991105|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83230484|NCT05916469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83991106|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83991107|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83991108|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
83991109|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991110|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991111|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991112|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83991113|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83991114|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83991115|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991116|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991117|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991118|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991119|NCT01117857|Analgesics|analgesics|mesh-ancestor
83991120|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
83991121|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991122|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
83991123|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83991124|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
83991125|NCT00991276|Pregabalin|pregabalin|mesh-list
83991126|NCT00991276|Pramipexole|pramipexole|mesh-list
83991127|NCT00991276|Analgesics|analgesics|mesh-ancestor
83991128|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
83991129|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991130|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991131|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
83991132|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83991133|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991134|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991135|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83991136|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83991137|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83991138|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991139|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83991140|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
83991141|NCT00991276|Protective Agents|protective agents|mesh-ancestor
83991142|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83991143|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83991144|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
83991145|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
83991146|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991147|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83991148|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83991149|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991150|NCT00990652|Temozolomide|temozolomide|mesh-list
83991151|NCT00990652|Bortezomib|bortezomib|mesh-list
83991152|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83991153|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
83991154|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991155|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991156|NCT02867878|Adenosine|adenosine|mesh-list
83991157|NCT02867878|Analgesics|analgesics|mesh-ancestor
83991158|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
83991159|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991160|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991161|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83991162|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
83991163|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83991164|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
83991165|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
83991166|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991167|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991168|NCT01207440|Ponatinib|ponatinib|mesh-list
83991169|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991170|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83991171|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991172|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991173|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83991174|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83991175|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83991176|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
83991177|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991178|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83991179|NCT00990106|Prazosin|prazosin|mesh-list
83991180|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83991181|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83991182|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83991183|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83991184|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
83991185|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991186|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991187|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991188|NCT02867566|Rituximab|rituximab|mesh-list
83991189|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83991190|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991191|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
83991192|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991193|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991194|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83991195|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83991196|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
83991197|NCT02867800|Acetaminophen|acetaminophen|mesh-list
83991198|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
83991199|NCT02867800|Promethazine|promethazine|mesh-list
83991200|NCT02867800|Cyclosporine|cyclosporine|mesh-list
83991201|NCT02867800|Sirolimus|sirolimus|mesh-list
83991202|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
83991203|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
83991204|NCT02867800|Methotrexate|methotrexate|mesh-list
83991205|NCT02867800|Fludarabine|fludarabine|mesh-list
83991206|NCT02867800|Melphalan|melphalan|mesh-list
83991207|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
83991208|NCT02867800|Abatacept|abatacept|mesh-list
83991209|NCT02867800|Thiotepa|thiotepa|mesh-list
83991210|NCT02867800|Meperidine|meperidine|mesh-list
83991211|NCT02867800|Tacrolimus|tacrolimus|mesh-list
83991212|NCT02867800|Cyclosporins|cyclosporins|mesh-list
83991213|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
83991214|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83991215|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
83991216|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83991217|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991218|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83991219|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
83991220|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991221|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991222|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
83991223|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991224|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83991225|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83991226|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
83991227|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991228|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83991229|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83991230|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
83991231|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991232|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83991233|NCT02867800|Analgesics|analgesics|mesh-ancestor
83991234|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
83991235|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991236|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
83991237|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83991238|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83991239|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
83991240|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991241|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991242|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
83991243|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
83991244|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83991245|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
83991246|NCT02867800|Hormones|hormones|mesh-ancestor
83991247|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991248|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83991249|NCT02867800|Protective Agents|protective agents|mesh-ancestor
83991250|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83991251|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
83991252|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83991253|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230643|NCT05915104|Budesonide|budesonide|mesh-list
83991254|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83991255|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83991256|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83991257|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991259|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
83991260|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83991261|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
83991262|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
83991263|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991264|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83991265|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
83991266|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83991267|NCT02867800|Narcotics|narcotics|mesh-ancestor
83991268|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83991269|NCT00629200|Interferons|interferons|mesh-list
83991270|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
83991271|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
83991272|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83991273|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991274|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
83991275|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991276|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
83991277|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991278|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83991279|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83991280|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
83991281|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83991282|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
83991283|NCT02867176|Ketorolac|ketorolac|mesh-list
83991284|NCT02867176|Gabapentin|gabapentin|mesh-list
83991285|NCT02867176|Analgesics|analgesics|mesh-ancestor
83991286|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
83991287|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991288|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991289|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
83991290|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83991291|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83991292|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991293|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83991294|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83991295|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83991296|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991297|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991298|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
83991299|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83991300|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83991301|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991302|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991303|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83991304|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991305|NCT00982228|Insulin|insulin|mesh-list
83991306|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83991307|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
83991308|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
83991309|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83991310|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991311|NCT02867956|Etoposide|etoposide|mesh-list
83991312|NCT02867956|Apatinib|apatinib|mesh-list
83991313|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83991314|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991315|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83991316|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83991317|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991318|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991319|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83991320|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
83991321|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83991322|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991323|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
83991324|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991325|NCT04291066|Expectorants|expectorants|mesh-ancestor
83991326|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
83991327|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83991328|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
83991329|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991330|NCT04291066|Protective Agents|protective agents|mesh-ancestor
83991331|NCT04291066|Antidotes|antidotes|mesh-ancestor
83991332|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
83991333|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
83991334|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991335|NCT01260194|Trastuzumab|trastuzumab|mesh-list
83991336|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83991337|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991338|NCT00629278|Tamoxifen|tamoxifen|mesh-list
83991339|NCT00629278|Docetaxel|docetaxel|mesh-list
83991340|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
83991341|NCT00629278|Doxorubicin|doxorubicin|mesh-list
83991342|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83991343|NCT00629278|Fluorouracil|fluorouracil|mesh-list
83991344|NCT00629278|Trastuzumab|trastuzumab|mesh-list
83991345|NCT00629278|Epirubicin|epirubicin|mesh-list
83991346|NCT00629278|Hormones|hormones|mesh-list
83991347|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83991348|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991349|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83991350|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83991351|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83991352|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991353|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83991354|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
83991355|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991356|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991357|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83991358|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
83991359|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83991360|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83991361|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83991362|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83991363|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991364|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
83991365|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83991366|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83991367|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991368|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83991369|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
83991370|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991371|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83991372|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83991373|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83991374|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83991375|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
83991376|NCT04207112|Linezolid|linezolid|mesh-list
83991377|NCT04207112|Bedaquiline|bedaquiline|mesh-list
83991378|NCT04207112|Clofazimine|clofazimine|mesh-list
83991379|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991380|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991381|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83991382|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83991383|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991384|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991385|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991386|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83991387|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
83991388|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991389|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
83991390|NCT01259492|Methylphenidate|methylphenidate|mesh-list
83991391|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83991392|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991393|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83991394|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83991395|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991396|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991397|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
83991398|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991399|NCT00624026|Memantine|memantine|mesh-list
83991400|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83991401|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83991402|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
83991403|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991404|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991405|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991406|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83991407|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83991408|NCT05512910|Minocycline|minocycline|mesh-list
83991409|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991410|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991411|NCT02888990|Dasatinib|dasatinib|mesh-list
83991412|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991413|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83991414|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991415|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991416|NCT05101928|Prednisone|prednisone|mesh-list
83991417|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991418|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
83991419|NCT05101928|Hormones|hormones|mesh-ancestor
83991420|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991421|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991422|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991423|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991424|NCT04654052|Clopidogrel|clopidogrel|mesh-list
83991425|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83991426|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83991427|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83991428|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83991429|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
83991430|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991431|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991432|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991433|NCT05625308|Folic Acid|folic acid|mesh-list
83991434|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
83991435|NCT05625308|Hydroxocobalamin|hydroxocobalamin|mesh-list
83991436|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83991437|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
83991438|NCT05625308|Vitamins|vitamins|mesh-ancestor
83991439|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
83991440|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991441|NCT05625308|Hematinics|hematinics|mesh-ancestor
83991442|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
83991443|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83991444|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
83991445|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
83991446|NCT05625308|Protective Agents|protective agents|mesh-ancestor
83991447|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
83991448|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991449|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83991450|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83991451|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991452|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83991453|NCT04291664|Prednisone|prednisone|mesh-list
83991454|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
83991455|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991456|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
83991457|NCT04291664|Hormones|hormones|mesh-ancestor
83991458|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991459|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991460|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991461|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991462|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83991463|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991464|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991465|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
83991466|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83991467|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
83991468|NCT04187469|Rifampin|rifampin|mesh-list
83991469|NCT04187469|Isoniazid|isoniazid|mesh-list
83991470|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
83991471|NCT04187469|Ethambutol|ethambutol|mesh-list
83991472|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991473|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991474|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83991475|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83991476|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991477|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991478|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991479|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83991480|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
83991481|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
83991482|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83991483|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83991484|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83991485|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83991486|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83991487|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83991488|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83991489|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83991490|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83991491|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
83991492|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83991493|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
83991494|NCT04187144|Gepotidacin|gepotidacin|mesh-list
83991495|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83991496|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991497|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991498|NCT04187144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83991499|NCT04187144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532915|NCT02389088|Letrozole|letrozole|mesh-list
83991500|NCT04187144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991501|NCT04187144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991502|NCT01116687|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83991503|NCT01116687|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83991504|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991505|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991507|NCT02867020|Goserelin|goserelin|mesh-list
83991508|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991509|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
83991510|NCT02867020|Hormones|hormones|mesh-ancestor
83991511|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991512|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991513|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991514|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991515|NCT03817502|Cariprazine|cariprazine|mesh-list
83991516|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83991517|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83991518|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991519|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991520|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83991521|NCT04319978|Dexamethasone|dexamethasone|mesh-list
83991522|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
83991523|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991524|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
83991525|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
83991526|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991527|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991528|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83991529|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
83991530|NCT04319978|Hormones|hormones|mesh-ancestor
83991531|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991532|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991533|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991534|NCT01114737|Verapamil|verapamil|mesh-list
83991535|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83991536|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83991537|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991538|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991539|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83991540|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991541|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
83991542|NCT00624182|Gemcitabine|gemcitabine|mesh-list
83991543|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83991544|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
83991545|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991546|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991547|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83991548|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991549|NCT00625677|Vaccines|vaccines|mesh-list
83991550|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
83991551|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991552|NCT00979576|Pemetrexed|pemetrexed|mesh-list
83991553|NCT00979576|Nintedanib|nintedanib|mesh-list
83991554|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991555|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991556|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230923|NCT05912946|Interferons|interferons|mesh-list
83991557|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83991558|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83991559|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83991560|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
83991561|NCT02867332|Interleukin-2|interleukin-2|mesh-list
83991562|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83991563|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
83991564|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991565|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991566|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83991567|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
83991568|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991569|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991570|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83991571|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83991572|NCT02867332|Analgesics|analgesics|mesh-ancestor
83991573|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
83991574|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991575|NCT02702180|Molgramostim|molgramostim|mesh-list
83991576|NCT02702180|Sargramostim|sargramostim|mesh-list
83991577|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991578|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
83991579|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991580|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
83991581|NCT00980980|Mupirocin|mupirocin|mesh-list
83991582|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83991583|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991584|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
83991585|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991586|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83991587|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991588|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991589|NCT04128748|Cytarabine|cytarabine|mesh-list
83991590|NCT04128748|Daunorubicin|daunorubicin|mesh-list
83991591|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83991592|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
83991593|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991594|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991595|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
83991596|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991597|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83991598|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
83991599|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991600|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83991601|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83991602|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83991603|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991604|NCT04116502|Interferons|interferons|mesh-list
83991605|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
83991606|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
83991607|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
83991608|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991609|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
83991610|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991611|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
83991612|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991613|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
83991614|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991615|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991616|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83991617|NCT04290442|Ropivacaine|ropivacaine|mesh-list
83991618|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
83991619|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
83991620|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991621|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991622|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
83991623|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991624|NCT02866786|Metformin|metformin|mesh-list
83991625|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
83991626|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83991627|NCT02866786|Estradiol|estradiol|mesh-list
83991628|NCT02866786|Cyproterone|cyproterone|mesh-list
83991629|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83991630|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991631|NCT02866786|Estrogens|estrogens|mesh-ancestor
83991632|NCT02866786|Hormones|hormones|mesh-ancestor
84124730|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991633|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991634|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83991635|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
83991636|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83991637|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83991638|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83991639|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83991640|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
83991641|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
83991642|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991643|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83991644|NCT00979654|Sifalimumab|sifalimumab|mesh-list
83991645|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
83991646|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991647|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83991648|NCT00978562|Hematinics|hematinics|mesh-ancestor
83991649|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83991650|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83991651|NCT04289974|Fulvestrant|fulvestrant|mesh-list
83991652|NCT04289974|Palbociclib|palbociclib|mesh-list
83991653|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991654|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991655|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83991656|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83991657|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
83991658|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991659|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991660|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83991661|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991662|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991663|NCT02865616|Vancomycin|vancomycin|mesh-list
83991664|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991665|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991666|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
83991667|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
83991668|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991669|NCT02865460|Vitamins|vitamins|mesh-ancestor
83991670|NCT01206816|Afatinib|afatinib|mesh-list
83991671|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991672|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83991673|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991674|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991675|NCT01259102|Buprenorphine|buprenorphine|mesh-list
83991676|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83991677|NCT01259102|Narcotics|narcotics|mesh-ancestor
83991678|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991679|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991680|NCT01259102|Analgesics|analgesics|mesh-ancestor
83991681|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
83991682|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991683|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83991684|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
83991685|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
83991686|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991687|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
83991688|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83991689|NCT01259024|Estrogens|estrogens|mesh-ancestor
83991690|NCT01259024|Hormones|hormones|mesh-ancestor
83991691|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991692|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991693|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991694|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991695|NCT04319900|Chloroquine|chloroquine|mesh-list
83991696|NCT04319900|Favipiravir|favipiravir|mesh-list
83991697|NCT04319900|Amebicides|amebicides|mesh-ancestor
83991698|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83991699|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83991700|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991701|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
83991702|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991703|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
83991704|NCT01257698|Timolol|timolol|mesh-list
83991705|NCT01257698|Dorzolamide|dorzolamide|mesh-list
83991706|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83991707|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83991708|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83991709|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
83991710|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991711|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991712|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991713|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83991714|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83991715|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83991716|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991717|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83991718|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
83991719|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
83991720|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
83991721|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83991722|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83991723|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991724|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991725|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991726|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
83991727|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83991728|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
83991729|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991730|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991731|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83991732|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
83991733|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
83991734|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83991735|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
83991736|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991737|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991738|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83991739|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83991740|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
83991741|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991742|NCT01204710|Prednisone|prednisone|mesh-list
83991743|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
83991744|NCT01204710|Olaratumab|olaratumab|mesh-list
83991745|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991746|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
83991747|NCT01204710|Hormones|hormones|mesh-ancestor
83991748|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991749|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991750|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991751|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991752|NCT01204710|Analgesics|analgesics|mesh-ancestor
83991753|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
83991754|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991755|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83991756|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83991757|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991758|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991759|NCT01256450|Buprenorphine|buprenorphine|mesh-list
83991760|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83991761|NCT01256450|Narcotics|narcotics|mesh-ancestor
83991762|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991763|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991764|NCT01256450|Analgesics|analgesics|mesh-ancestor
83991765|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
83991766|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991767|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83991768|NCT01204398|Amlodipine|amlodipine|mesh-list
83991769|NCT01204398|Telmisartan|telmisartan|mesh-list
83991770|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83991771|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83991772|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83991773|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991774|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991775|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83991776|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991777|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
83991778|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83991779|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83991780|NCT01111851|Dexamethasone|dexamethasone|mesh-list
83991781|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
83991782|NCT01111851|Ondansetron|ondansetron|mesh-list
83991783|NCT01111851|Aprepitant|aprepitant|mesh-list
83991784|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
83991785|NCT01111851|BB 1101|bb 1101|mesh-list
83991786|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83991787|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
83991788|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
83991789|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991790|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991791|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83991792|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
83991793|NCT01111851|Hormones|hormones|mesh-ancestor
83991794|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83991795|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83991796|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991797|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
83991798|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991799|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991800|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
83991801|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83991802|NCT01111851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83991803|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83991804|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
83991805|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991806|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83991807|NCT01256294|Tacrolimus|tacrolimus|mesh-list
83991808|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83991809|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
83991810|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991811|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83991812|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991813|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991814|NCT01256060|Oxytocin|oxytocin|mesh-list
83991815|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
83991816|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83991817|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991818|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
83991819|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
83991820|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83991821|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991822|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991823|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83991824|NCT01255904|Analgesics|analgesics|mesh-ancestor
83991825|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
83991826|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991827|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83991828|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83991829|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83991830|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83991831|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991832|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991833|NCT01255670|Metronidazole|metronidazole|mesh-list
83991834|NCT01255670|Penicillins|penicillins|mesh-list
83991835|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991836|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991837|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83991838|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83991839|NCT01203930|Rituximab|rituximab|mesh-list
83991840|NCT01203930|Idelalisib|idelalisib|mesh-list
83991841|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83991842|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991843|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
83991844|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991845|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83991846|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991847|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991848|NCT01254890|Azacitidine|azacitidine|mesh-list
83991849|NCT01254890|Sorafenib|sorafenib|mesh-list
83991850|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83991851|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
83991852|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991853|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991854|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991855|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83991856|NCT01203852|Metoprolol|metoprolol|mesh-list
83231280|NCT05894239|Taxane|taxane|mesh-list
83991857|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
83991858|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83991859|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83991860|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
83991861|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
83991862|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991863|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991864|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83991865|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83991866|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83991867|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
83991868|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991869|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991870|NCT01203852|Diuretics|diuretics|mesh-ancestor
83991871|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
83991872|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83991873|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991874|NCT01203072|Edoxaban|edoxaban|mesh-list
83991875|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83991876|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
83991877|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83991878|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
83991879|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991880|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991881|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
83991882|NCT01105377|Azacitidine|azacitidine|mesh-list
83991883|NCT01105377|Entinostat|entinostat|mesh-list
83991884|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83991885|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83991886|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
83991887|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991888|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991889|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991890|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83991891|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83991892|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83991893|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83991894|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83991895|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
83991896|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991897|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991898|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991899|NCT01111539|Aripiprazole|aripiprazole|mesh-list
83991900|NCT01111539|Escitalopram|escitalopram|mesh-list
83991901|NCT01111539|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83991902|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83991903|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991904|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991905|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991906|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
83991907|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991908|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
83991909|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83991910|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83991911|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83991912|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991913|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
83991914|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
83991915|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83991916|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83991917|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83991918|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83991919|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83991920|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83991921|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
83991922|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83991923|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83991924|NCT02880345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83991925|NCT02880345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991926|NCT02879955|Acarbose|acarbose|mesh-list
83991927|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83991928|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124731|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
83231309|NCT05875857|Narcotics|narcotics|mesh-ancestor
83991929|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991930|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83991931|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991932|NCT02880033|Deferiprone|deferiprone|mesh-list
83991933|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83991934|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
83991935|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
83991936|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991938|NCT00625911|Morphine|morphine|mesh-list
83991939|NCT00625911|Analgesics|analgesics|mesh-ancestor
83991940|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
83991941|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83991942|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991943|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83991944|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83991945|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
83991946|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
83991947|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991948|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83991949|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83991950|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991951|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991952|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83991953|NCT00625911|Narcotics|narcotics|mesh-ancestor
83991954|NCT01111149|Bupropion|bupropion|mesh-list
83991955|NCT01111149|Varenicline|varenicline|mesh-list
83991956|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83991957|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
83991958|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83991959|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83991960|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83991961|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83991962|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991963|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
83991964|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83991965|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991966|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83991967|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83991968|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991969|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83991970|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83991971|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
83991972|NCT01254656|Efavirenz|efavirenz|mesh-list
83991973|NCT01254656|Etravirine|etravirine|mesh-list
83991974|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83991975|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83991976|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83991977|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83991978|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
83991979|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991980|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83991981|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83991982|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83991983|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83991984|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83991985|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83991986|NCT01254344|Metronidazole|metronidazole|mesh-list
83991987|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
83991988|NCT01254344|Ertapenem|ertapenem|mesh-list
83991989|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83991990|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83991991|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83991992|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83991993|NCT05051007|Lidocaine|lidocaine|mesh-list
83991994|NCT05051007|Fentanyl|fentanyl|mesh-list
83991995|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83991996|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
83991997|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83991998|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83991999|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
83992000|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992001|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83231380|NCT05860270|Vitamin D|vitamin d|mesh-list
83992002|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83992003|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83992004|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992005|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992006|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83992007|NCT05051007|Narcotics|narcotics|mesh-ancestor
83992008|NCT05051007|Analgesics|analgesics|mesh-ancestor
83992009|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83992010|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83992011|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
83992012|NCT01102803|Cycloserine|cycloserine|mesh-list
83992013|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83992014|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992015|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83992016|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
83992017|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83992018|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
83992019|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992020|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83992021|NCT01109979|Drospirenone|drospirenone|mesh-list
83992022|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83992023|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83992024|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
83992025|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83992027|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83992028|NCT01109979|Estrogens|estrogens|mesh-ancestor
83992029|NCT01109979|Hormones|hormones|mesh-ancestor
83992030|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992031|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992032|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83992033|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
83992034|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992035|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83992036|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83992037|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83992038|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83992039|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83992040|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83992041|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992042|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83992043|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
83992044|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83992045|NCT01109979|Diuretics|diuretics|mesh-ancestor
83992046|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
83992047|NCT01102491|Ramosetron|ramosetron|mesh-list
83992048|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
83992049|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
83992050|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992051|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992052|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83992053|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83992054|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
83992055|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992056|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992057|NCT01108809|Telmisartan|telmisartan|mesh-list
83992058|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83992059|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83992060|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83992061|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992062|NCT01253408|Dronabinol|dronabinol|mesh-list
83992063|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
83992064|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992065|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992066|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992067|NCT01253408|Analgesics|analgesics|mesh-ancestor
83992068|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
83992069|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992070|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83992071|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83992072|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992073|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992074|NCT01253408|Hormones|hormones|mesh-ancestor
83992075|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992076|NCT05506982|Psilocybin|psilocybin|mesh-list
83992077|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
83992078|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992079|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992080|NCT02879643|Vincristine|vincristine|mesh-list
83992081|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83992082|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992083|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83992084|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83992085|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83992086|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992087|NCT02879721|Candesartan|candesartan|mesh-list
83992088|NCT02879721|Enalapril|enalapril|mesh-list
83992089|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83992090|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83992091|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83992092|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992093|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83992094|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
83992095|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992096|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
83992097|NCT01253174|Drospirenone|drospirenone|mesh-list
83992098|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83992099|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
83992100|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992101|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992102|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83992103|NCT01253174|Diuretics|diuretics|mesh-ancestor
83992104|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
83992105|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
83992106|NCT01253174|Vitamins|vitamins|mesh-ancestor
83992107|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
83992108|NCT01108731|Milnacipran|milnacipran|mesh-list
83992109|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
83992110|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83992111|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83992112|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992113|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992114|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992115|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992116|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992117|NCT01108731|Analgesics|analgesics|mesh-ancestor
83992118|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
83992119|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992120|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
83992121|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992122|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
83992123|NCT04308525|Narcotics|narcotics|mesh-ancestor
83992124|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992125|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992126|NCT04308525|Analgesics|analgesics|mesh-ancestor
83992127|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
83992128|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992129|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83992130|NCT01108341|Ofatumumab|ofatumumab|mesh-list
83992131|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83992132|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
83992133|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992134|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992135|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
83992136|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
83992137|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992138|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83992139|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83992140|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992141|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992142|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83992143|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83992144|NCT01252238|Amlodipine|amlodipine|mesh-list
83992145|NCT01252238|Valsartan|valsartan|mesh-list
83992146|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83992147|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83992148|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992149|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992150|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83992151|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992152|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
83992153|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83992154|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83992156|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83992157|NCT01101321|Narcotics|narcotics|mesh-ancestor
83992158|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992159|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992160|NCT01101321|Analgesics|analgesics|mesh-ancestor
83992161|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
83992162|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992163|NCT04309929|Analgesics|analgesics|mesh-list
83992164|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
83992165|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992166|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992167|NCT01101165|Oxycodone|oxycodone|mesh-list
83992168|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83992169|NCT01101165|Narcotics|narcotics|mesh-ancestor
83992170|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992171|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992172|NCT01101165|Analgesics|analgesics|mesh-ancestor
83992173|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
83992174|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992175|NCT01100853|Naltrexone|naltrexone|mesh-list
83992176|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83992177|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83992178|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992179|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
83992180|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992181|NCT02879097|Paclitaxel|paclitaxel|mesh-list
83992182|NCT02879097|Carboplatin|carboplatin|mesh-list
83992183|NCT02879097|Bevacizumab|bevacizumab|mesh-list
83992184|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83992185|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992186|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
83992187|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
83992188|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
83992189|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992190|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83992191|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83992192|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83992193|NCT02879097|Growth Substances|growth substances|mesh-ancestor
83992194|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992195|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
83992196|NCT02878863|Peoniflorin|peoniflorin|mesh-list
83992197|NCT02878863|Silymarin|silymarin|mesh-list
83992198|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
83992199|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992200|NCT02878863|Protective Agents|protective agents|mesh-ancestor
83992201|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992202|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83992203|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992204|NCT02878863|Analgesics|analgesics|mesh-ancestor
83992205|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
83231602|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
83231603|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231604|NCT05753436|Curcumin|curcumin|mesh-list
83231605|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83231606|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83231607|NCT05753436|Analgesics|analgesics|mesh-ancestor
83231608|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
83231609|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231610|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231611|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231612|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231613|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231614|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231615|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231616|NCT05751265|Paclitaxel|paclitaxel|mesh-list
83231617|NCT05751265|Tislelizumab|tislelizumab|mesh-list
83992206|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992207|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83992208|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992209|NCT02881125|Paclitaxel|paclitaxel|mesh-list
83992210|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83992211|NCT02881125|Nortriptyline|nortriptyline|mesh-list
83992212|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83992213|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992214|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
83992215|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
83992216|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
83992217|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992218|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83992219|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
83992220|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992221|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83992222|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83992223|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992224|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992225|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992226|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992227|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83992228|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83992229|NCT01097577|Pregabalin|pregabalin|mesh-list
83992230|NCT01097577|Analgesics|analgesics|mesh-ancestor
83992231|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
83992232|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992233|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992234|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
83992235|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83992236|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992237|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992238|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83992239|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83992240|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83992241|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992242|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992243|NCT01097421|Pramipexole|pramipexole|mesh-list
83992244|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
83992245|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992246|NCT01097421|Protective Agents|protective agents|mesh-ancestor
83992247|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992248|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83992249|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83992250|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
83992251|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
83992252|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992253|NCT01251614|Adalimumab|adalimumab|mesh-list
83992254|NCT01251614|Methotrexate|methotrexate|mesh-list
83992255|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83992256|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
83992257|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992258|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992259|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83992260|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
83992261|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992262|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992263|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
83992264|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992265|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83992266|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83992267|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
83992268|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992269|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83992270|NCT01251614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83992271|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83992272|NCT01106625|Metformin|metformin|mesh-list
83992273|NCT01106625|Canagliflozin|canagliflozin|mesh-list
83992274|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83992275|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992276|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83992277|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992278|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
83992279|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83992280|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83992281|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83992282|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992283|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992284|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
83992285|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992286|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992287|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83992288|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992290|NCT01251146|Bisoprolol|bisoprolol|mesh-list
83992291|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83992292|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83992293|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
83992294|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
83992295|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992296|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992297|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83992298|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83992299|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83992300|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992301|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992302|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992303|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
83992304|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83992305|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992306|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992307|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992308|NCT02878707|Analgesics|analgesics|mesh-ancestor
83992309|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
83992310|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992311|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83992312|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83992313|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83992314|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992315|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992316|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992317|NCT01096017|Albuterol|albuterol|mesh-list
83992318|NCT01096017|Terbutaline|terbutaline|mesh-list
83992319|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83992320|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
83992321|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992322|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992323|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83992324|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
83992325|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
83992326|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992327|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83992328|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83992329|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83992330|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992331|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992332|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992333|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
83992334|NCT00626223|Folic Acid|folic acid|mesh-list
83992335|NCT00626223|Hematinics|hematinics|mesh-ancestor
83992336|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
83992337|NCT00626223|Vitamins|vitamins|mesh-ancestor
83992338|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
83992339|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992340|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
83992341|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
83992342|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992343|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83992344|NCT04828005|Naloxone|naloxone|mesh-list
83992345|NCT04828005|Nalmefene|nalmefene|mesh-list
83992346|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83992347|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992348|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
83992349|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992350|NCT02878161|Prednisone|prednisone|mesh-list
83992351|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
83992352|NCT02878161|Adalimumab|adalimumab|mesh-list
83992353|NCT02878161|Infliximab|infliximab|mesh-list
83992354|NCT02878161|Etanercept|etanercept|mesh-list
83992355|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83992356|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83992358|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
83992359|NCT02878161|Leflunomide|leflunomide|mesh-list
83992360|NCT02878161|Hormones|hormones|mesh-ancestor
83992361|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992362|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992363|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83992364|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992365|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83992366|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
83992367|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992368|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83992369|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
83992370|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992371|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
83992372|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992373|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83992374|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83992375|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
83992376|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992377|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83992378|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
83992379|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
83992380|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992381|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83992382|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83992383|NCT02878161|Protective Agents|protective agents|mesh-ancestor
83992384|NCT02878161|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83992385|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992386|NCT02878161|Analgesics|analgesics|mesh-ancestor
83992387|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
83992388|NCT01093755|Omeprazole|omeprazole|mesh-list
83992389|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
83992390|NCT01093755|Lansoprazole|lansoprazole|mesh-list
83992391|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83992392|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83992393|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83992394|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992395|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992396|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83992397|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83992398|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83231826|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231827|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231828|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231829|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231830|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231831|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83231832|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
83231833|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83231834|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83231835|NCT05683691|Analgesics|analgesics|mesh-ancestor
83231836|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
83231837|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231838|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231839|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231840|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231841|NCT05676112|Pirfenidone|pirfenidone|mesh-list
83231842|NCT05676112|Nintedanib|nintedanib|mesh-list
83231843|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231844|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83231845|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231846|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231847|NCT05676112|Analgesics|analgesics|mesh-ancestor
83231848|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
83231849|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231850|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231851|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83231852|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83231853|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231854|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992399|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992400|NCT01092663|Incretins|incretins|mesh-ancestor
83992401|NCT01092663|Hormones|hormones|mesh-ancestor
83992402|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992403|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83992404|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83992405|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992406|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992407|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83992408|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83992409|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
83992410|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83992411|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
83992412|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83992413|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
83992414|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992415|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992416|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83992417|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
83992418|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83992419|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83992420|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83992421|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992422|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992423|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992424|NCT01092507|Vaccines|vaccines|mesh-list
83992425|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
83992426|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992427|NCT01078545|Leuprolide|leuprolide|mesh-list
83992428|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83992429|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
83992430|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992431|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992432|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83992433|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992434|NCT01091259|Bevacizumab|bevacizumab|mesh-list
83992435|NCT01091259|Irinotecan|irinotecan|mesh-list
83992436|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83992437|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992438|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83992439|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83992440|NCT01091259|Growth Substances|growth substances|mesh-ancestor
83992441|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992442|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
83992443|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83992444|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83992445|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992446|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992447|NCT01078389|Febuxostat|febuxostat|mesh-list
83992448|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
83992449|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992450|NCT01090323|Deferasirox|deferasirox|mesh-list
83992451|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83992452|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
83231925|NCT05673187|Adagrasib|adagrasib|mesh-list
83231926|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231927|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
83231928|NCT05672459|Fludarabine|fludarabine|mesh-list
83231929|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
83231930|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83231931|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
83231932|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231933|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231934|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83231935|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
83231936|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231937|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231938|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83231939|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83231940|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
83231941|NCT05672342|Dronabinol|dronabinol|mesh-list
83231942|NCT05672342|Cannabidiol|cannabidiol|mesh-list
83231943|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
83231944|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
83231946|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992454|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992455|NCT02876991|Listerine|listerine|mesh-list
83992456|NCT02876991|Fluorides|fluorides|mesh-list
83992457|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
83992458|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
83992459|NCT02876991|Protective Agents|protective agents|mesh-ancestor
83992460|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992461|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83992462|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992463|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83992464|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83992465|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992466|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83992467|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
83992468|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992469|NCT00637611|Fexofenadine|fexofenadine|mesh-list
83992470|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83992471|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83992472|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83992473|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
83992474|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
83992475|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992476|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992477|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992478|NCT00626535|Esomeprazole|esomeprazole|mesh-list
83992479|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83992480|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83992481|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83992482|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992483|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992484|NCT01200810|Bicalutamide|bicalutamide|mesh-list
83992485|NCT01200810|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83992486|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
83992487|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
83992488|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992489|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992490|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992491|NCT01200810|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83992492|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992493|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992494|NCT01200342|Paclitaxel|paclitaxel|mesh-list
83992495|NCT01200342|Carboplatin|carboplatin|mesh-list
83992496|NCT01200342|Oblimersen|oblimersen|mesh-list
83992497|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83992498|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992499|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
83992500|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
83992501|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
83992502|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992503|NCT01198548|Vitamin D|vitamin d|mesh-list
83992504|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
83992505|NCT01198548|Leucovorin|leucovorin|mesh-list
83992506|NCT01198548|Bevacizumab|bevacizumab|mesh-list
83992507|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83992508|NCT01198548|Fluorouracil|fluorouracil|mesh-list
83992509|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
83992510|NCT01198548|Antibodies|antibodies|mesh-list
83992511|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
83992512|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83992513|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
83992514|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992515|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83992516|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83992517|NCT01198548|Growth Substances|growth substances|mesh-ancestor
83992518|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992519|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
83992520|NCT01198548|Vitamins|vitamins|mesh-ancestor
83992521|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
83992522|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
83992523|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83992524|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83992525|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
83992526|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992527|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83992528|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83992529|NCT01198548|Antidotes|antidotes|mesh-ancestor
83992530|NCT01198548|Protective Agents|protective agents|mesh-ancestor
83992531|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
83992532|NCT00977938|Aspirin|aspirin|mesh-list
83992533|NCT00977938|Clopidogrel|clopidogrel|mesh-list
83992534|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83152396|NCT02182453|Empagliflozin|empagliflozin|mesh-list
83992535|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83992536|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992537|NCT00977938|Analgesics|analgesics|mesh-ancestor
83992538|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
83992539|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992540|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992541|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83992542|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992543|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83992544|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83992545|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992546|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83992547|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83992548|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992549|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
83992550|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83992551|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83992552|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83992553|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
83992554|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992555|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83992556|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992557|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83992558|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992559|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992560|NCT04290208|Acetaminophen|acetaminophen|mesh-list
83992561|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992562|NCT04290208|Analgesics|analgesics|mesh-ancestor
83992563|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
83992564|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992565|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992566|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
83992567|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83992568|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992569|NCT01090011|Cetuximab|cetuximab|mesh-list
83992570|NCT01090011|Afatinib|afatinib|mesh-list
83992571|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83992572|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992573|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83992574|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992575|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992576|NCT02877615|S44819|s44819|mesh-list
83992577|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
83992578|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
83992579|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
83992580|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992581|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992582|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992583|NCT02437279|Nivolumab|nivolumab|mesh-list
83992584|NCT02437279|Ipilimumab|ipilimumab|mesh-list
83992585|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232055|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232056|NCT05625932|Tinzaparin|tinzaparin|mesh-list
83232057|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83232058|NCT05625932|Dalteparin|dalteparin|mesh-list
83232059|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
83232060|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83232061|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83232062|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232063|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
83232064|NCT05625594|Fludarabine|fludarabine|mesh-list
83232065|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232066|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
83232067|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232068|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232070|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
83992586|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992587|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83992588|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992590|NCT01251653|Docetaxel|docetaxel|mesh-list
83992591|NCT01251653|Afatinib|afatinib|mesh-list
83992592|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83992593|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
83992594|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992595|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992596|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
83992597|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
83992598|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
83992599|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83992600|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992601|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
83992602|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83992603|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992604|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83992605|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
83992606|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83992607|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992608|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992609|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992610|NCT01077375|Milnacipran|milnacipran|mesh-list
83992611|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
83992612|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83992613|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83992614|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992615|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992616|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992617|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992618|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992619|NCT01077375|Analgesics|analgesics|mesh-ancestor
83992620|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
83992621|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992622|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
83992623|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992624|NCT02877771|Insulin|insulin|mesh-list
83992625|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83992626|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992627|NCT04306653|Betamethasone|betamethasone|mesh-list
83992628|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83992629|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
83992630|NCT04306653|Hormones|hormones|mesh-ancestor
83992631|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992632|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992633|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83992634|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
83992635|NCT04306731|Trimethoprim|trimethoprim|mesh-list
83232132|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232133|NCT05618366|Venetoclax|venetoclax|mesh-list
83232134|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232135|NCT05617820|Estradiol|estradiol|mesh-list
83232136|NCT05617820|Estrogens|estrogens|mesh-ancestor
83232137|NCT05617820|Hormones|hormones|mesh-ancestor
83232138|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232139|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232140|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
83232141|NCT05609968|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83232142|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232143|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232144|NCT05609968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232145|NCT05609968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232146|NCT05609968|Immunoconjugates|immunoconjugates|mesh-ancestor
83232147|NCT05609968|Immunologic Factors|immunologic factors|mesh-ancestor
83232148|NCT05609968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232149|NCT05590377|Daratumumab|daratumumab|mesh-list
83232150|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232151|NCT05587998|Morphine|morphine|mesh-list
83232152|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83232153|NCT05587998|Narcotics|narcotics|mesh-ancestor
83232154|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992636|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83992637|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992638|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
83992639|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83992640|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83992641|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83992642|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992643|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992644|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83992645|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83992646|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83992648|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83992649|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
83992650|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992651|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992652|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83992653|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
83992654|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
83992655|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992656|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83992657|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83992658|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83992659|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992660|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992661|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992662|NCT01250873|Sertraline|sertraline|mesh-list
83992663|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
83992664|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992665|NCT01250873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83992666|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83992667|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992668|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992669|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992670|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
83992671|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992672|NCT02888327|Oseltamivir|oseltamivir|mesh-list
83992673|NCT02888327|Digoxin|digoxin|mesh-list
83992674|NCT02888327|Midazolam|midazolam|mesh-list
83992675|NCT02888327|Pitavastatin|pitavastatin|mesh-list
83992676|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83992677|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83992678|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992679|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992680|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83992681|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83992682|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992683|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83992684|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
83992685|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
83992686|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
83992687|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
83992688|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992689|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992690|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83992691|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83992692|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992693|NCT02888327|Protective Agents|protective agents|mesh-ancestor
83992694|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
83992695|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992696|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83992697|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83992698|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83992699|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
83992700|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83992701|NCT01248065|Vitamin D|vitamin d|mesh-list
83992702|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
83992703|NCT01248065|Ciclesonide|ciclesonide|mesh-list
83992704|NCT01248065|Vitamins|vitamins|mesh-ancestor
83992705|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
83992706|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232211|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
83232212|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232213|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232214|NCT05576077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83992707|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83992708|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83992709|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
83992710|NCT01248065|Hormones|hormones|mesh-ancestor
83992711|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992712|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83992713|NCT01250756|Vaccines|vaccines|mesh-list
83992714|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83992715|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
83992716|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992717|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
83992718|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83992719|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992720|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83992721|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992722|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992723|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
83992724|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83992725|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83992726|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992727|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992728|NCT02865304|Endostar protein|endostar protein|mesh-list
83992729|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83992730|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83992731|NCT02865304|Growth Substances|growth substances|mesh-ancestor
83992732|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992733|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
83992734|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992735|NCT04075474|Listerine|listerine|mesh-list
83992736|NCT04075474|Fluorides|fluorides|mesh-list
83992737|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
83992738|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
83992739|NCT04075474|Protective Agents|protective agents|mesh-ancestor
83992740|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992741|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83992742|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992743|NCT02866396|Pregabalin|pregabalin|mesh-list
83992744|NCT02866396|Analgesics|analgesics|mesh-ancestor
83992745|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
83992746|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992747|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992748|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
83992749|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83992750|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992751|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992752|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83992753|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83992754|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83992755|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992756|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992757|NCT01087203|Tanezumab|tanezumab|mesh-list
83992758|NCT01087203|Analgesics|analgesics|mesh-ancestor
83992759|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
83992760|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992761|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992762|NCT01246583|Tofacitinib|tofacitinib|mesh-list
83992763|NCT01246583|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83992764|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83992765|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992766|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992767|NCT00626613|Risperidone|risperidone|mesh-list
83992768|NCT00626613|Galantamine|galantamine|mesh-list
83992769|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83992770|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
83992771|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992772|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992773|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992774|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83992775|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83992776|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992777|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83992778|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83992779|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
83232284|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83992780|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83992781|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992782|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
83992783|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83992784|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
83992785|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992786|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
83992788|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83992789|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992790|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83992791|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83992792|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83992793|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992794|NCT01079949|Cetrorelix|cetrorelix|mesh-list
83992795|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83992796|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83992797|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83992798|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
83992799|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992800|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992801|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
83992802|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992803|NCT01079949|Hormones|hormones|mesh-ancestor
83992804|NCT00910429|Riociguat|riociguat|mesh-list
83992805|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
83992806|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992807|NCT03432949|Dexamethasone|dexamethasone|mesh-list
83992808|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
83992809|NCT03432949|BB 1101|bb 1101|mesh-list
83992810|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83992811|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
83992812|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
83992813|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992814|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992815|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83992816|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
83992817|NCT03432949|Hormones|hormones|mesh-ancestor
83992818|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992819|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83992820|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992821|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
83992822|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992823|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992824|NCT00909727|Ivacaftor|ivacaftor|mesh-list
83992825|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83992826|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992827|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992828|NCT00977080|Cinacalcet|cinacalcet|mesh-list
83992829|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83992830|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992831|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83992832|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83992833|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992834|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83992835|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83992836|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992837|NCT04083157|Imiquimod|imiquimod|mesh-list
83992838|NCT04083157|Vaccines|vaccines|mesh-list
83992839|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
83992840|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992841|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83992842|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992843|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
83992844|NCT00975286|Metformin|metformin|mesh-list
83992845|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
83992846|NCT00975286|Lixisenatide|lixisenatide|mesh-list
83992847|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83992848|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83992849|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992850|NCT00907777|Vaccines|vaccines|mesh-list
83992851|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83992852|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
83992853|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992854|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83992855|NCT03741517|Edotreotide|edotreotide|mesh-list
83992856|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83992857|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992859|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
83992860|NCT02864758|Dabigatran|dabigatran|mesh-list
83992861|NCT02864758|Vitamins|vitamins|mesh-ancestor
83992862|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
83992863|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992864|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83992865|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
83992866|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83992867|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
83992868|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992869|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992870|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
83992871|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83992872|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83992873|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
83992874|NCT02864758|Coagulants|coagulants|mesh-ancestor
83992875|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
83992876|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83992877|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992878|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992879|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83992880|NCT04204798|Analgesics|analgesics|mesh-ancestor
83992881|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
83992882|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992883|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83992884|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83992885|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83992886|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992887|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992888|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992889|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83992890|NCT00908011|Ezetimibe|ezetimibe|mesh-list
83992891|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83992892|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83992893|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
83992894|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992895|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83992896|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83992897|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992898|NCT00976456|Bevacizumab|bevacizumab|mesh-list
83992899|NCT00976456|Carboplatin|carboplatin|mesh-list
83992900|NCT00976456|Pemetrexed|pemetrexed|mesh-list
83992901|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83992902|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992903|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83992904|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83992905|NCT00976456|Growth Substances|growth substances|mesh-ancestor
83992906|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992907|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
83992908|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992909|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992910|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83992911|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83992912|NCT01243151|Bococizumab|bococizumab|mesh-list
83992913|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83992914|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83992915|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
83992916|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992917|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83992918|NCT00629512|Esomeprazole|esomeprazole|mesh-list
83992919|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83992920|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83992921|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83992922|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992923|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992924|NCT01711021|Amphetamine|amphetamine|mesh-list
83992925|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
83992926|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83992927|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992928|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
83992929|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
83992930|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992931|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
83992932|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83992933|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992934|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
83992935|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83992936|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83992937|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83992938|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83992939|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
83992940|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992941|NCT02864602|Dexamethasone|dexamethasone|mesh-list
83992942|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
83992943|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83992944|NCT02864602|BB 1101|bb 1101|mesh-list
83992945|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83992946|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
83992947|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
83992948|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83992949|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992950|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83992951|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
83992952|NCT02864602|Hormones|hormones|mesh-ancestor
83992953|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992954|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83992955|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992956|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
83992957|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992958|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992959|NCT00993148|Ritonavir|ritonavir|mesh-list
83992960|NCT00993148|Darunavir|darunavir|mesh-list
83992961|NCT00993148|Maraviroc|maraviroc|mesh-list
83992962|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83992963|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83992964|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
83992965|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992966|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992967|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83992968|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83992969|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
83992970|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83992971|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83992972|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83992973|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83992974|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83992975|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83992976|NCT03401047|Estradiol|estradiol|mesh-list
83992977|NCT03401047|Estrogens|estrogens|mesh-ancestor
83992978|NCT03401047|Hormones|hormones|mesh-ancestor
83992979|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83992980|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992981|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83992982|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
83992983|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992984|NCT03531073|Methotrexate|methotrexate|mesh-list
83992985|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83992986|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
83232507|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232527|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83232528|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232529|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232530|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
83232531|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83232532|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232533|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232534|NCT05443555|Gabapentin|gabapentin|mesh-list
83232535|NCT05443555|Analgesics|analgesics|mesh-ancestor
83232536|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
83232537|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232538|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232539|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
83232540|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83232541|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83232542|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83992987|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83992988|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83992989|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83992990|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
83992991|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83992992|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83992993|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
83992994|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83992995|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83992996|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83992997|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
83992998|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83992999|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83993000|NCT00907153|Vitamin D|vitamin d|mesh-list
83993001|NCT00907153|Vitamins|vitamins|mesh-ancestor
83993002|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
83993003|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993004|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83993005|NCT00904033|Calcitriol|calcitriol|mesh-list
83993006|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83993007|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993008|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83993009|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993010|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993011|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83993012|NCT00904033|Vitamins|vitamins|mesh-ancestor
83993013|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
83993014|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83993015|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
83993016|NCT05175625|Paraproteins|paraproteins|mesh-list
83993017|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
83993018|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993019|NCT02555839|Thalidomide|thalidomide|mesh-list
83993020|NCT02555839|Dexamethasone|dexamethasone|mesh-list
83993021|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
83993022|NCT02555839|Bortezomib|bortezomib|mesh-list
83993023|NCT02555839|Pomalidomide|pomalidomide|mesh-list
83993024|NCT02555839|BB 1101|bb 1101|mesh-list
83993025|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993026|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
83993027|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
83993028|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993029|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993030|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993031|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
83993032|NCT02555839|Hormones|hormones|mesh-ancestor
83993033|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993034|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83993035|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993036|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83993037|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993038|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993039|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
83993040|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83993041|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83993042|NCT02555839|Growth Substances|growth substances|mesh-ancestor
83993043|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
83993044|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993045|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
83993046|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83993047|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993048|NCT01241591|Etanercept|etanercept|mesh-list
83993049|NCT01241591|Tofacitinib|tofacitinib|mesh-list
83993050|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993051|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993052|NCT01241591|Analgesics|analgesics|mesh-ancestor
83993053|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
83993054|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993055|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993056|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993057|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993058|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993059|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993060|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
83993061|NCT01241591|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83993062|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83993063|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993064|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993065|NCT03464461|Ketorolac|ketorolac|mesh-list
83993066|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83993067|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993068|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993069|NCT03464461|Analgesics|analgesics|mesh-ancestor
83993070|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
83993071|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993072|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993073|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993074|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993075|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83993076|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993077|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993078|NCT04319705|Azithromycin|azithromycin|mesh-list
83993079|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83993080|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993081|NCT00906373|Sorafenib|sorafenib|mesh-list
83993082|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83993083|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993084|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83993085|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993086|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993087|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
83993088|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993089|NCT02850445|Olanzapine|olanzapine|mesh-list
83993090|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
83993091|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
83993092|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993093|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993094|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993095|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83993096|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83993097|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993098|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83993099|NCT02850445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83993100|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83993101|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993102|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993103|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993104|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
83993105|NCT04220203|Capecitabine|capecitabine|mesh-list
83993106|NCT04220203|Trastuzumab|trastuzumab|mesh-list
83993107|NCT04220203|Tucatinib|tucatinib|mesh-list
83993108|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993109|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
83993110|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993111|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993112|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83993113|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83993114|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993115|NCT02850211|Ibuprofen|ibuprofen|mesh-list
83993116|NCT02850211|Celecoxib|celecoxib|mesh-list
83993117|NCT02850211|Tramadol|tramadol|mesh-list
83993118|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993119|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993120|NCT02850211|Analgesics|analgesics|mesh-ancestor
83993121|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
83993122|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993123|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993124|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993125|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993126|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83993127|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993128|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993129|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83993130|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83993131|NCT02850211|Narcotics|narcotics|mesh-ancestor
83993132|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993133|NCT02850289|Interferons|interferons|mesh-list
83993134|NCT02850289|Ribavirin|ribavirin|mesh-list
83993135|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993136|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
83232656|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
83993137|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993138|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
83993139|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993140|NCT05331781|Morphine|morphine|mesh-list
83993141|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83993142|NCT05331781|Narcotics|narcotics|mesh-ancestor
83993143|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993144|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993145|NCT05331781|Analgesics|analgesics|mesh-ancestor
83993146|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
83993147|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993148|NCT04202887|Fentanyl|fentanyl|mesh-list
83993149|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83993150|NCT04202887|Narcotics|narcotics|mesh-ancestor
83993151|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993152|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993153|NCT04202887|Analgesics|analgesics|mesh-ancestor
83993154|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
83993155|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993156|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83993157|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83993158|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
83993159|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
83993160|NCT05324215|Fentanyl|fentanyl|mesh-list
83993161|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83993162|NCT05324215|Narcotics|narcotics|mesh-ancestor
83993163|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993164|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993165|NCT05324215|Analgesics|analgesics|mesh-ancestor
83993166|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
83993167|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993168|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83993169|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83993170|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
83993171|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
83993172|NCT00905437|Pregabalin|pregabalin|mesh-list
83993173|NCT00905437|Analgesics|analgesics|mesh-ancestor
83993174|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
83993175|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993176|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993177|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
83993178|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83993179|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993180|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993181|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83993182|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83993183|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83993184|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993185|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83993186|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
83993187|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993188|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
83993189|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
83993190|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83993191|NCT01238861|Benralizumab|benralizumab|mesh-list
83993192|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83993193|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
83993194|NCT02888561|Dobutamine|dobutamine|mesh-list
83993195|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83993196|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
83993197|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
83993198|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993199|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993200|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83993201|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83993202|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83993203|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
83993204|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993205|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993206|NCT02888561|Protective Agents|protective agents|mesh-ancestor
83993207|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83232744|NCT05371093|Hormones|hormones|mesh-ancestor
83993209|NCT04319549|Ketorolac|ketorolac|mesh-list
83993210|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83993211|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993212|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993213|NCT04319549|Analgesics|analgesics|mesh-ancestor
83993214|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
83993215|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993216|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993217|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993218|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993219|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83993220|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993221|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993222|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
83993223|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993224|NCT00903409|Simvastatin|simvastatin|mesh-list
83993225|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83993226|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83993227|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
83993228|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993229|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83993230|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83993231|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993232|NCT01237223|Amlodipine|amlodipine|mesh-list
83993233|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83993234|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83993235|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993236|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993237|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83993238|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993239|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
83993240|NCT01236365|Atorvastatin|atorvastatin|mesh-list
83993241|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83993242|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83993243|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
83993244|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993245|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83993246|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83993247|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993248|NCT00903331|Macitentan|macitentan|mesh-list
83993249|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83993250|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83993251|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993252|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83993253|NCT01235741|Pramlintide|pramlintide|mesh-list
83993254|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993255|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993256|NCT02849353|Immunomodulating Agents|immunomodulating agents|mesh-list
83993257|NCT02849353|Immunologic Factors|immunologic factors|mesh-ancestor
83993258|NCT02849353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993259|NCT01235507|Methotrexate|methotrexate|mesh-list
83993260|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83993261|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
83993262|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83993263|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993264|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993265|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
83993266|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993267|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993268|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
83993269|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993270|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83993271|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993272|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
83993273|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993274|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83993275|NCT01868269|Dexamethasone|dexamethasone|mesh-list
83993276|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
83993277|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
83993278|NCT01868269|Rituximab|rituximab|mesh-list
83993279|NCT01868269|BB 1101|bb 1101|mesh-list
83993280|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993281|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
83993282|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232803|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
83232804|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83232805|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993283|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993284|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83993285|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
83993286|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993287|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993288|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83993289|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83993290|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993291|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
83993292|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
83993293|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993294|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993295|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
83993297|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993298|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83993299|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
83993300|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993301|NCT01235351|Clopidogrel|clopidogrel|mesh-list
83993302|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83993303|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83993304|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83993305|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83993306|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
83993307|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993308|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993309|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993310|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
83993311|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83993312|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83993313|NCT01234649|Metformin|metformin|mesh-list
83993314|NCT01234649|Liraglutide|liraglutide|mesh-list
83993315|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993316|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993317|NCT01234649|Incretins|incretins|mesh-ancestor
83993318|NCT01234649|Hormones|hormones|mesh-ancestor
83993319|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993320|NCT02876679|Cyclosporine|cyclosporine|mesh-list
83993321|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
83993322|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
83993323|NCT02876679|Cyclosporins|cyclosporins|mesh-list
83993324|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83993325|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993326|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
83993327|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993328|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993329|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83993330|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
83993331|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993332|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993333|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83993334|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993335|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
83993336|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993337|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
83993338|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83993339|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83993340|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83993341|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
83993342|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83993343|NCT01075815|Hormones|hormones|mesh-list
83993344|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83993345|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232878|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
83232879|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232880|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83232881|NCT05318105|Diuretics|diuretics|mesh-list
83232882|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83232883|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
83232884|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232885|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232886|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232898|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
83993346|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993347|NCT01072149|Fluticasone|fluticasone|mesh-list
83993348|NCT01072149|Xhance|xhance|mesh-list
83993349|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993350|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83993351|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
83993352|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993353|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993354|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83993355|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83993356|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
83993357|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83993358|NCT04413253|Dexamethasone|dexamethasone|mesh-list
83993359|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83993360|NCT04413253|Lifitegrast|lifitegrast|mesh-list
83993361|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83993362|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993363|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
83993364|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
83993365|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993366|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993367|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993368|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
83993369|NCT04413253|Hormones|hormones|mesh-ancestor
83993370|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993371|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83993372|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993373|NCT01679119|Prednisolone|prednisolone|mesh-list
83993374|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
83993375|NCT01679119|Rituximab|rituximab|mesh-list
83993376|NCT01679119|Gemcitabine|gemcitabine|mesh-list
83993377|NCT01679119|Vincristine|vincristine|mesh-list
83993378|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83993379|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993380|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
83993381|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993382|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993383|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83993384|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
83993385|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993386|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993387|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83993388|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83993389|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993390|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
83993391|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83993392|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
83993393|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
83993394|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
83993395|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993396|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
83993397|NCT01679119|Hormones|hormones|mesh-ancestor
83993398|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993399|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83993400|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83993401|NCT01679119|Immunotoxins|immunotoxins|mesh-ancestor
83993402|NCT01679119|Immunoconjugates|immunoconjugates|mesh-ancestor
83993403|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
83993404|NCT04778787|Digoxin|digoxin|mesh-list
83993405|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83993406|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
83993407|NCT04778787|Diuretics|diuretics|mesh-list
83993408|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83993409|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83993410|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993411|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993412|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993413|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83993414|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83993415|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993416|NCT04778787|Protective Agents|protective agents|mesh-ancestor
83993417|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
83993418|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993419|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
83993420|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83993421|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993422|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993423|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993424|NCT04304157|Analgesics|analgesics|mesh-ancestor
83993425|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
83993426|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993427|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83993428|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83993429|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83993430|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
83993431|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993432|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993433|NCT04937413|Evolocumab|evolocumab|mesh-list
83993434|NCT04937413|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83993435|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83993436|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83993437|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
83993438|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993439|NCT04937413|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83993440|NCT04937413|Protease Inhibitors|protease inhibitors|mesh-ancestor
83993441|NCT04937413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993442|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83993443|NCT02875587|Cabergoline|cabergoline|mesh-list
83993444|NCT02875587|Calcium|calcium|mesh-list
83993445|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83993446|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993447|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83993448|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83993449|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
83993450|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
83993451|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993452|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993453|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83993454|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83993455|NCT01070979|Estradiol|estradiol|mesh-list
83993456|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83993457|NCT01070979|Estrogens|estrogens|mesh-list
83993458|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83993459|NCT01070979|Hormones|hormones|mesh-ancestor
83993460|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993461|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993462|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83993463|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
83993464|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83993465|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83993466|NCT01234337|Capecitabine|capecitabine|mesh-list
83993467|NCT01234337|Sorafenib|sorafenib|mesh-list
83993468|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993469|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
83993470|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993471|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993472|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83993473|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993474|NCT02848963|Ketamine|ketamine|mesh-list
83993475|NCT02848963|Propofol|propofol|mesh-list
83993476|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83993477|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993478|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993479|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83993480|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
83993481|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
83993482|NCT02848963|Analgesics|analgesics|mesh-ancestor
83993483|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
83993484|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993485|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83993486|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83993487|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83993488|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993489|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993490|NCT01070043|Amlodipine|amlodipine|mesh-list
83993491|NCT01070043|Valsartan|valsartan|mesh-list
83993492|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83993493|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83993494|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993495|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233056|NCT05214287|Nitrox|nitrox|mesh-list
83993496|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83993497|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993498|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
83993499|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83993500|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83993501|NCT01074255|Aprepitant|aprepitant|mesh-list
83993502|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
83152402|NCT02182531|Ephedrine|ephedrine|mesh-list
83993503|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
83993504|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993505|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993506|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993507|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83993508|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993509|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993510|NCT02962063|Paclitaxel|paclitaxel|mesh-list
83993511|NCT02962063|Carboplatin|carboplatin|mesh-list
83993512|NCT02962063|Durvalumab|durvalumab|mesh-list
83993513|NCT02962063|Tremelimumab|tremelimumab|mesh-list
83993514|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83993515|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993516|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
83993517|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
83993518|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
83993519|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993520|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83993521|NCT01073943|Bisacodyl|bisacodyl|mesh-list
83993522|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
83993523|NCT01073943|Cathartics|cathartics|mesh-ancestor
83993524|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993525|NCT01073943|Laxatives|laxatives|mesh-ancestor
83993526|NCT01073865|Goserelin|goserelin|mesh-list
83993527|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83993528|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993529|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
83993530|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
83993531|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993532|NCT01064635|Letrozole|letrozole|mesh-list
83993533|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993534|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83993535|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83993536|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993537|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993538|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83993539|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
83993540|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993541|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993542|NCT04697485|Eplerenone|eplerenone|mesh-list
83993543|NCT04697485|Bumetanide|bumetanide|mesh-list
83993544|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83993545|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
83993546|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993547|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993548|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83993549|NCT04697485|Diuretics|diuretics|mesh-ancestor
83993550|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
83993551|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83993552|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83993553|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993554|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993555|NCT01073631|Voriconazole|voriconazole|mesh-list
83993556|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
83993557|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993558|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83993559|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83993560|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993561|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993562|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83993563|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
83993564|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993565|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993566|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83233102|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83993567|NCT00626769|Genistein|genistein|mesh-list
83993568|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83993569|NCT00626769|Protective Agents|protective agents|mesh-ancestor
83993570|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993571|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993572|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83993573|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993574|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993575|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
83993576|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83993577|NCT00626769|Estrogens|estrogens|mesh-ancestor
83993578|NCT00626769|Hormones|hormones|mesh-ancestor
83993579|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993580|NCT02875743|Posaconazole|posaconazole|mesh-list
83993581|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
83993582|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993583|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83993584|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83993585|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83993586|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83993587|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83993588|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993589|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993590|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83993591|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
83993592|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993593|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993594|NCT01073163|Rituximab|rituximab|mesh-list
83993595|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83993596|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83993597|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993598|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
83993599|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993600|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993601|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83993602|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
83993603|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993604|NCT02875821|Metformin|metformin|mesh-list
83993605|NCT02875821|Pioglitazone|pioglitazone|mesh-list
83993606|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
83993607|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993608|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993609|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83993610|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993611|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
83993612|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993613|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
83993614|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83993615|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83993616|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993617|NCT04304313|Urological Agents|urological agents|mesh-ancestor
83993618|NCT01072929|Modafinil|modafinil|mesh-list
83993619|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83993620|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993621|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83993622|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83993623|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83993624|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993625|NCT04753749|Aspirin|aspirin|mesh-list
83993626|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993627|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993628|NCT04753749|Analgesics|analgesics|mesh-ancestor
83993629|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
83993630|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993631|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993632|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993633|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993634|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83993635|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83993636|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993637|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83993638|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83993639|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993640|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
83993641|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
83993642|NCT04305015|Narcotics|narcotics|mesh-ancestor
83993643|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993644|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993645|NCT04305015|Analgesics|analgesics|mesh-ancestor
83993646|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
83993647|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993648|NCT01231607|Finasteride|finasteride|mesh-list
83993649|NCT01231607|Dutasteride|dutasteride|mesh-list
83993650|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83993651|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83993652|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993653|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993654|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
83993655|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993656|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993657|NCT01231607|Urological Agents|urological agents|mesh-ancestor
83993658|NCT01231373|Polidocanol|polidocanol|mesh-list
83993659|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83993660|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83993661|NCT00975130|Golimumab|golimumab|mesh-list
83993662|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83993663|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83993664|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993665|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993666|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
83993667|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993668|NCT01230827|Golimumab|golimumab|mesh-list
83993669|NCT01230827|Methotrexate|methotrexate|mesh-list
83993670|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83993671|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
83993672|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83993673|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993674|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993675|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
83993676|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993677|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993678|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83993679|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993680|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83993681|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993682|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
83993683|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993684|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83993685|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83993686|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993687|NCT01230749|Pioglitazone|pioglitazone|mesh-list
83993688|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993689|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993690|NCT00903175|Everolimus|everolimus|mesh-list
83993691|NCT00903175|Sunitinib|sunitinib|mesh-list
83993692|NCT00903175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83993693|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83993694|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993695|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993696|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993697|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
83993698|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993699|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993700|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83993701|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83993702|NCT00903175|Growth Substances|growth substances|mesh-ancestor
83993703|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
83993704|NCT01229735|Topiramate|topiramate|mesh-list
83993705|NCT01229735|Levetiracetam|levetiracetam|mesh-list
83993706|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
83993707|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993708|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993709|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
83993710|NCT03866200|Resveratrol|resveratrol|mesh-list
83993711|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
83993712|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993713|NCT03866200|Protective Agents|protective agents|mesh-ancestor
83993714|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993715|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993716|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83993717|NCT02848183|Cytarabine|cytarabine|mesh-list
83993718|NCT02848183|Etoposide|etoposide|mesh-list
83993719|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
83993720|NCT02848183|Idarubicin|idarubicin|mesh-list
83993721|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83993722|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993723|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83993724|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83993725|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993726|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993727|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993728|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
83993729|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
83993730|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993731|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993732|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
83993733|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993734|NCT02848183|Analgesics|analgesics|mesh-ancestor
83993735|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
83993736|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993737|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83993738|NCT00974974|Levodopa|levodopa|mesh-list
83993739|NCT00974974|Carbidopa|carbidopa|mesh-list
83993740|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83993741|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83993742|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83993743|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
83993744|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993745|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993746|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993747|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83993748|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993749|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83993750|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
83993751|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
83993752|NCT02848417|Curcumin|curcumin|mesh-list
83993753|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993754|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993755|NCT02848417|Analgesics|analgesics|mesh-ancestor
83993756|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
83993757|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993758|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993759|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993760|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993761|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993762|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993763|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993764|NCT02847403|Exenatide|exenatide|mesh-list
83993765|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993766|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993767|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83993768|NCT02847403|Incretins|incretins|mesh-ancestor
83993769|NCT02847403|Hormones|hormones|mesh-ancestor
83993770|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993771|NCT02848339|Aspirin|aspirin|mesh-list
83993772|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993773|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993774|NCT02848339|Analgesics|analgesics|mesh-ancestor
83993775|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
83993776|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993777|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993778|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993779|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993780|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83993781|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83993782|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993783|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83993784|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83993785|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993786|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
83993787|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83993788|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83993789|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993790|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
83993791|NCT04216303|Chrysarobin|chrysarobin|mesh-list
83993792|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993793|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993794|NCT04216303|Analgesics|analgesics|mesh-ancestor
83993795|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
83993796|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993797|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993798|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993799|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993800|NCT02847013|Bupivacaine|bupivacaine|mesh-list
83993801|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
83993802|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
83993803|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993804|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993805|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
83993806|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993807|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
83993808|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993809|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993810|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83993811|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993812|NCT02846935|Decitabine|decitabine|mesh-list
83993813|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
83993814|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993815|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
83993816|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993817|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993818|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993819|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
83993820|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993821|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
83993822|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993823|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993824|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83993825|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
83993826|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993827|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
83993828|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83993829|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83993830|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993831|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
83993832|NCT04201951|Coagulants|coagulants|mesh-ancestor
83993833|NCT04753723|Gentamicins|gentamicins|mesh-list
83993834|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83993835|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993836|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83993837|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993838|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993839|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
83993840|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83993841|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83993842|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
83993843|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993844|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993845|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993846|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
83993847|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
83993848|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993849|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
83993850|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83993851|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
83993852|NCT02844517|Pancrelipase|pancrelipase|mesh-list
83993853|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993854|NCT03901729|Furosemide|furosemide|mesh-list
83993855|NCT03901729|Diuretics|diuretics|mesh-ancestor
83993856|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
83993857|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993858|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83993859|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993860|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993861|NCT02846857|Insulin|insulin|mesh-list
83993862|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83993863|NCT02846857|Glucagon|glucagon|mesh-list
83233404|NCT05073003|Vaccines|vaccines|mesh-list
83993864|NCT02846857|Hormones|hormones|mesh-list
83993865|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83993866|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993867|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993868|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993869|NCT04672525|Rifampin|rifampin|mesh-list
83993870|NCT04672525|Rifabutin|rifabutin|mesh-list
83993871|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83993872|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
83993873|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83993874|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993875|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
83993876|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83993877|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993878|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993879|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83993880|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83993881|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83993882|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83993883|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83993884|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83993885|NCT00992446|Cytarabine|cytarabine|mesh-list
83993886|NCT00992446|Rituximab|rituximab|mesh-list
83993887|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83993888|NCT00992446|Etoposide|etoposide|mesh-list
83993889|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
83993890|NCT00992446|Bortezomib|bortezomib|mesh-list
83993891|NCT00992446|Melphalan|melphalan|mesh-list
83993892|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
83993893|NCT00992446|Vorinostat|vorinostat|mesh-list
83993894|NCT00992446|Carmustine|carmustine|mesh-list
83993895|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
83993896|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83993897|NCT00992446|Antibodies|antibodies|mesh-list
83993898|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
83993899|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83993900|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
83993901|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993902|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993903|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993904|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83993905|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83993906|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83993907|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993908|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993909|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83993910|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
83993911|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
83993912|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993913|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83993914|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83993915|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
83993916|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83993917|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83993918|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
83993919|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83993920|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
83993921|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
83993922|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
83993923|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83993924|NCT04452565|Dexamethasone|dexamethasone|mesh-list
83993925|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
83993926|NCT04452565|BB 1101|bb 1101|mesh-list
83993927|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993928|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
83993929|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
83993930|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993931|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993932|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83993933|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
83993934|NCT04452565|Hormones|hormones|mesh-ancestor
83993935|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83993936|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83993937|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83993938|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
83993939|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233496|NCT05047640|Vaccines|vaccines|mesh-list
83993940|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993941|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83993942|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83993943|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83993944|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83993945|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
83993946|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83993947|NCT02863120|Bupivacaine|bupivacaine|mesh-list
83993948|NCT02863120|Ropivacaine|ropivacaine|mesh-list
83993949|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
83993950|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
83993951|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993952|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993953|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
83993954|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993955|NCT03823534|Acetaminophen|acetaminophen|mesh-list
83993956|NCT03823534|Ketorolac|ketorolac|mesh-list
83993957|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83993958|NCT03823534|Morphine|morphine|mesh-list
83993959|NCT03823534|Oxycodone|oxycodone|mesh-list
83993960|NCT03823534|Hydrocodone|hydrocodone|mesh-list
83993961|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83993962|NCT03823534|Narcotics|narcotics|mesh-ancestor
83993963|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993964|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993965|NCT03823534|Analgesics|analgesics|mesh-ancestor
83993966|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
83993967|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993968|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83993969|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
83993970|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83993971|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83993972|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83993973|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83993974|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83993975|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993976|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
83993977|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
83993978|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83993979|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83993980|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83993981|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83993982|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83993983|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83993984|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993985|NCT02846701|Analgesics|analgesics|mesh-ancestor
83993986|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
83993987|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993988|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
83993989|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83993990|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
83993991|NCT04327063|Ropivacaine|ropivacaine|mesh-list
83993992|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
83993993|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
83993994|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83993995|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83993996|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
83993997|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83993998|NCT04565431|Natalizumab|natalizumab|mesh-list
83993999|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
83994000|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994001|NCT04292704|Clotrimazole|clotrimazole|mesh-list
83994002|NCT04292704|Miconazole|miconazole|mesh-list
83994003|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83994004|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994005|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
83994006|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83994007|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83994008|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994009|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994010|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83994011|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
83994012|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994013|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994014|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83994015|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83994016|NCT05242783|Terlipressin|terlipressin|mesh-list
83994017|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83994018|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83994019|NCT03987685|Topotecan|topotecan|mesh-list
83994020|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83994021|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83994022|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994023|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994024|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994025|NCT00900757|Palonosetron|palonosetron|mesh-list
83994026|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
83994027|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
83994028|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994029|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994030|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994031|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83994032|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83994033|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
83994034|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994035|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994036|NCT04136743|Dexamethasone|dexamethasone|mesh-list
83994037|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994038|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
83994039|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
83994040|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994041|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994042|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994043|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
83994044|NCT04136743|Hormones|hormones|mesh-ancestor
83994045|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994046|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83994047|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994048|NCT03931057|Midazolam|midazolam|mesh-list
83994049|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83994050|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83994051|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994052|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994053|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83994054|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83994055|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83994056|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83994057|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
83994058|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
83994059|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
83994060|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
83994061|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994062|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994063|NCT02846155|Simethicone|simethicone|mesh-list
83994064|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
83994065|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994066|NCT02846155|Emollients|emollients|mesh-ancestor
83994067|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994068|NCT02845843|Interferons|interferons|mesh-list
83994069|NCT02845843|Ritonavir|ritonavir|mesh-list
83994070|NCT02845843|Lopinavir|lopinavir|mesh-list
83994071|NCT02845843|Interferon-beta|interferon-beta|mesh-list
83994072|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
83994073|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994074|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
83994075|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994076|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83994077|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83994078|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
83994079|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994080|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994081|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83994082|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83994083|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83994084|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83994085|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
83994086|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994087|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83994088|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
83994089|NCT02845999|Fludarabine|fludarabine|mesh-list
83994091|NCT02845999|Interleukin-2|interleukin-2|mesh-list
83994092|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994093|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
83533584|NCT03323801|Tretinoin|tretinoin|mesh-list
83994094|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994095|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994096|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83994097|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
83994098|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994099|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994100|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83994101|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994102|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83994103|NCT02845999|Analgesics|analgesics|mesh-ancestor
83994104|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
83994105|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994106|NCT05337085|Midazolam|midazolam|mesh-list
83994107|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
83994108|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83994109|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994110|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994111|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83994112|NCT05337085|Analgesics|analgesics|mesh-ancestor
83994113|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
83994114|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994115|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83994116|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83994117|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83994118|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
83994119|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994120|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994121|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83994122|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83994123|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83994124|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83994125|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83994126|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
83994127|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
83994128|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
83994129|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
83994130|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83994131|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83994132|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994133|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994134|NCT01723579|Estradiol|estradiol|mesh-list
83994135|NCT01723579|Estrogens|estrogens|mesh-ancestor
83994136|NCT01723579|Hormones|hormones|mesh-ancestor
83994137|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994138|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994139|NCT00901927|Rituximab|rituximab|mesh-list
83994140|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83994141|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
83994142|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994143|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994144|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
83994145|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994146|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994147|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83994148|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
83994149|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994150|NCT00901927|Analgesics|analgesics|mesh-ancestor
83994151|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
83994152|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994153|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83994154|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83994155|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994156|NCT05335837|Anesthetics|anesthetics|mesh-list
83994157|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994158|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994159|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
83233710|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83233711|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
83233712|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233715|NCT04907968|Carboplatin|carboplatin|mesh-list
83994160|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994161|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994162|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83994163|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83994164|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83994165|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83994166|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
83994167|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83994168|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994169|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83994170|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83994171|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83994172|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83994173|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83994174|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83994175|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83994176|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83994178|NCT00968968|Lapatinib|lapatinib|mesh-list
83994179|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994180|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994181|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83994182|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994183|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994184|NCT00973102|Estrogens|estrogens|mesh-list
83994185|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83994186|NCT00973102|Hormones|hormones|mesh-ancestor
83994187|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994188|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994189|NCT03691090|Paclitaxel|paclitaxel|mesh-list
83994190|NCT03691090|Cisplatin|cisplatin|mesh-list
83994191|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83994192|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994193|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
83994194|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
83994195|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
83994196|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994197|NCT00783211|Fexofenadine|fexofenadine|mesh-list
83994198|NCT00783211|Desloratadine|desloratadine|mesh-list
83994199|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83994200|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
83994201|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994202|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994203|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994204|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83994205|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83994206|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
83994207|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
83994208|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83994209|NCT03679546|Infliximab|infliximab|mesh-list
83994210|NCT03679546|Vedolizumab|vedolizumab|mesh-list
83994211|NCT03679546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83994212|NCT03679546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994213|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994214|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994215|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994216|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
83994217|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994218|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994219|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83994220|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
83994221|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83994222|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
83994223|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994224|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994225|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83994226|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83994227|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83994228|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
83994229|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994230|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994231|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83233826|NCT04871607|Cytarabine|cytarabine|mesh-list
83994233|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
83994234|NCT03679312|Protective Agents|protective agents|mesh-ancestor
83994235|NCT02842567|Vitamin E|vitamin e|mesh-list
83994236|NCT02842567|Tocopherols|tocopherols|mesh-list
83994237|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
83994238|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83994239|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
83994240|NCT02842567|Vitamins|vitamins|mesh-ancestor
83994241|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
83994242|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994243|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
83994244|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994245|NCT02842567|Protective Agents|protective agents|mesh-ancestor
83994246|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994247|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83994248|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83994249|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
83994250|NCT00705211|Ezetimibe|ezetimibe|mesh-list
83994251|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83994252|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83994253|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
83994254|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994255|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83994256|NCT02839213|Scopolamine|scopolamine|mesh-list
83994257|NCT02839213|Bromides|bromides|mesh-list
83994258|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83994259|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
83994260|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83994261|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
83994262|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
83994263|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994264|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994265|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994266|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
83994267|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83994268|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
83994269|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994270|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994271|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83994272|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
83994273|NCT05334043|Curcumin|curcumin|mesh-list
83994274|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83994275|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83994276|NCT05334043|Analgesics|analgesics|mesh-ancestor
83994277|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
83994278|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994279|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994280|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994281|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994282|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994283|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994284|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994285|NCT02838823|Antibodies|antibodies|mesh-list
83994286|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83994287|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
83994288|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994289|NCT00156091|Olanzapine|olanzapine|mesh-list
83994290|NCT00156091|Asenapine|asenapine|mesh-list
83994291|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
83994292|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
83994293|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994294|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994295|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994296|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83994297|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83994298|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994299|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83994300|NCT00156091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83994301|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83994302|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83994303|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994304|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994305|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
83994306|NCT00140959|Losartan|losartan|mesh-list
83994307|NCT00140959|Atenolol|atenolol|mesh-list
83994308|NCT00140959|Amlodipine|amlodipine|mesh-list
83994309|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83994310|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83994311|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83994312|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994313|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83994314|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994315|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
83994316|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83994317|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83994318|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83994319|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83994320|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994321|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
83994322|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994323|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
83994324|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83994325|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83994326|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83994327|NCT00095017|Etoricoxib|etoricoxib|mesh-list
83994328|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83994329|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83994330|NCT00095017|Analgesics|analgesics|mesh-ancestor
83994331|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
83994332|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994333|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994334|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994335|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994336|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83994337|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83994338|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994339|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994340|NCT00092755|Ibuprofen|ibuprofen|mesh-list
83994341|NCT00092755|Etoricoxib|etoricoxib|mesh-list
83994342|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83994343|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83994344|NCT00092755|Analgesics|analgesics|mesh-ancestor
83994345|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
83994346|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994347|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994348|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994349|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994350|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83994351|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994352|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994353|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83994354|NCT00899431|Rituximab|rituximab|mesh-list
83994355|NCT00899431|Fludarabine|fludarabine|mesh-list
83994356|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
83994357|NCT00899431|Lenalidomide|lenalidomide|mesh-list
83994358|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83994359|NCT00899431|Allopurinol|allopurinol|mesh-list
83994360|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
83994361|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83994362|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994363|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994364|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
83994365|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994366|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994367|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83994368|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
83994369|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994370|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994371|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83994372|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83994373|NCT00899431|Growth Substances|growth substances|mesh-ancestor
83994374|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
83994375|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83994376|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
83994377|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994378|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
83994379|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83994380|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
83994381|NCT00899431|Protective Agents|protective agents|mesh-ancestor
83994382|NCT00898807|Citalopram|citalopram|mesh-list
83994383|NCT00898807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83994384|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83994385|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83994386|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994387|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994388|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
83994389|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994390|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83994391|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
83994392|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83994394|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
83994395|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994396|NCT00897715|Rilonacept|rilonacept|mesh-list
83994397|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994398|NCT01229111|Leucovorin|leucovorin|mesh-list
83994399|NCT01229111|Fluorouracil|fluorouracil|mesh-list
83994400|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
83994401|NCT01229111|Cediranib|cediranib|mesh-list
83994402|NCT01229111|Calcium|calcium|mesh-list
83994403|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
83994404|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83994405|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994406|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
83994407|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994408|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83994409|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994410|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994411|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
83994412|NCT01229111|Antidotes|antidotes|mesh-ancestor
83994413|NCT01229111|Protective Agents|protective agents|mesh-ancestor
83994414|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
83994415|NCT01229111|Vitamins|vitamins|mesh-ancestor
83994416|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
83994417|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994418|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83994419|NCT02843815|Immunomodulating Agents|immunomodulating agents|mesh-list
83994420|NCT02843815|Immunologic Factors|immunologic factors|mesh-ancestor
83994421|NCT02843815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994422|NCT01228175|Riboflavin|riboflavin|mesh-list
83994423|NCT01228175|Varenicline|varenicline|mesh-list
83994424|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83994425|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83994426|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
83994427|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994428|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994429|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994430|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
83994431|NCT01228175|Vitamins|vitamins|mesh-ancestor
83994432|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
83994433|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83994434|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994435|NCT01228019|Niacin|niacin|mesh-list
83994436|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83994437|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
83994438|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994439|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83994440|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
83994441|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
83994442|NCT01228019|Vitamins|vitamins|mesh-ancestor
83994443|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
83994444|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994445|NCT01227707|Leucovorin|leucovorin|mesh-list
83994446|NCT01227707|Bevacizumab|bevacizumab|mesh-list
83994447|NCT01227707|Fluorouracil|fluorouracil|mesh-list
83994448|NCT01227707|Capecitabine|capecitabine|mesh-list
83994449|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994450|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994451|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83994452|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83994453|NCT01227707|Growth Substances|growth substances|mesh-ancestor
83994454|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994455|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83994456|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
83994457|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994458|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83994459|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994460|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
83994461|NCT01227707|Antidotes|antidotes|mesh-ancestor
83994462|NCT01227707|Protective Agents|protective agents|mesh-ancestor
83994463|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
83994464|NCT01227707|Vitamins|vitamins|mesh-ancestor
83994465|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
83994466|NCT00633373|Cyclosporine|cyclosporine|mesh-list
83994467|NCT00633373|Cyclosporins|cyclosporins|mesh-list
83994468|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994469|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994470|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994471|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
83994472|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994473|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
83994474|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994475|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994476|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994477|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83994478|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
83994479|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83994480|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
83994481|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994482|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
83994483|NCT05334745|Protective Agents|protective agents|mesh-ancestor
83994484|NCT02838589|Exenatide|exenatide|mesh-list
83994485|NCT02838589|Glucagon|glucagon|mesh-list
83994486|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83994487|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83994488|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994489|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83994490|NCT02838589|Incretins|incretins|mesh-ancestor
83994491|NCT02838589|Hormones|hormones|mesh-ancestor
83994492|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994493|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994494|NCT02839135|Scopolamine|scopolamine|mesh-list
83994495|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83994496|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83994497|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
83994498|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
83994499|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994500|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994501|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994502|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
83994503|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83994504|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
83994505|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994506|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994507|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83994508|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
83994509|NCT00895843|Ibuprofen|ibuprofen|mesh-list
83994510|NCT00895843|Epinephrine|epinephrine|mesh-list
83994511|NCT00895843|Bupivacaine|bupivacaine|mesh-list
83994512|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
83994513|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
83994514|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994515|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994516|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
83994517|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994518|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83994519|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83994520|NCT00895843|Analgesics|analgesics|mesh-ancestor
83994521|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994522|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994523|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83994524|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994525|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994526|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83994527|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83994528|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
83994529|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994530|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83994531|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83234085|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
83234086|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234091|NCT04708782|Treprostinil|treprostinil|mesh-list
83234092|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83994532|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
83994533|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83994534|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83994535|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
83994536|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
83994537|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83994538|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
83994539|NCT05333809|Disitamab vedotin|disitamab vedotin|mesh-list
83994540|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994541|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994542|NCT05333809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83994543|NCT05333809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994544|NCT05333809|Immunoconjugates|immunoconjugates|mesh-ancestor
83994545|NCT05333809|Immunologic Factors|immunologic factors|mesh-ancestor
83994546|NCT05333809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994547|NCT05333731|Oxytocin|oxytocin|mesh-list
83994548|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
83994549|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83994550|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994551|NCT02843581|Immunomodulating Agents|immunomodulating agents|mesh-list
83994552|NCT02843581|Immunologic Factors|immunologic factors|mesh-ancestor
83994553|NCT02843581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994554|NCT00895453|Iron|iron|mesh-list
83994555|NCT00895453|Itraconazole|itraconazole|mesh-list
83994556|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
83994557|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994558|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83994559|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83994560|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994561|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994562|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83994563|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
83994564|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994565|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994566|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83994567|NCT00895453|Trace Elements|trace elements|mesh-ancestor
83994568|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
83994569|NCT00893737|Naproxen|naproxen|mesh-list
83994570|NCT00893737|Sumatriptan|sumatriptan|mesh-list
83994571|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83994572|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83994573|NCT00893737|Analgesics|analgesics|mesh-ancestor
83994574|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
83994575|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994576|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994577|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994578|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994579|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
83994580|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83994581|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994582|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994583|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83994584|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83994585|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83994586|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
83994587|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994588|NCT00893113|Alfuzosin|alfuzosin|mesh-list
83994589|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83994590|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83994591|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83994592|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83994593|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994594|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994595|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994596|NCT00893113|Urological Agents|urological agents|mesh-ancestor
83994597|NCT02840929|Esomeprazole|esomeprazole|mesh-list
83994598|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83994599|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83994600|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83994601|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994602|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994603|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
83994604|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83994605|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994606|NCT02837965|Doxycycline|doxycycline|mesh-list
83994607|NCT02837965|Prednisone|prednisone|mesh-list
83994608|NCT02837965|Methotrexate|methotrexate|mesh-list
83994609|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994610|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
83994611|NCT02837965|Hormones|hormones|mesh-ancestor
83994612|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994613|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994614|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83994615|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994616|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83994617|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
83994618|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83994619|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83994620|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
83994621|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994622|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994623|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994624|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83994625|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994626|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
83994627|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994628|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83994629|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83994630|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994631|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
83994632|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83994633|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83994634|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83994635|NCT00892957|Thrombin|thrombin|mesh-list
83994636|NCT00892957|Aprotinin|aprotinin|mesh-list
83994637|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
83994638|NCT00892957|Coagulants|coagulants|mesh-ancestor
83994639|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83994640|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83994641|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
83994642|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994643|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994644|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
83994645|NCT05322733|Fludarabine|fludarabine|mesh-list
83994646|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
83994647|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994648|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
83994649|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994650|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994651|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83994652|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
83994653|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994654|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994655|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83994656|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994657|NCT00968812|Metformin|metformin|mesh-list
83994658|NCT00968812|Glimepiride|glimepiride|mesh-list
83994659|NCT00968812|Canagliflozin|canagliflozin|mesh-list
83994660|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83994661|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994662|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83994663|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994664|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
83994665|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83994666|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994667|NCT02834845|Sevoflurane|sevoflurane|mesh-list
83994668|NCT02834845|Desflurane|desflurane|mesh-list
83994669|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83994670|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83994671|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
83994672|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
83994673|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994674|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994675|NCT05197192|Venetoclax|venetoclax|mesh-list
83994676|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
83994677|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
83994678|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994679|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994680|NCT00992056|Metoprolol|metoprolol|mesh-list
83994681|NCT00992056|Nebivolol|nebivolol|mesh-list
83994682|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83234237|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
83994683|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83994684|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
83994685|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
83994686|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994687|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994688|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83994689|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83994690|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83994691|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
83994692|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994693|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994694|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
83994695|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83994696|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83994697|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83994698|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83994699|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83994700|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994701|NCT00967798|Incretins|incretins|mesh-ancestor
83994702|NCT00967798|Hormones|hormones|mesh-ancestor
83994703|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994704|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83994705|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
83994706|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994707|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994708|NCT04248205|Ketamine|ketamine|mesh-list
83994709|NCT04248205|Analgesics|analgesics|mesh-ancestor
83994710|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
83994711|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994712|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994713|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83994714|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83994715|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
83994716|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
83994717|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994718|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83994719|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83994720|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994721|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994722|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
83994723|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83994724|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994725|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83994726|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83994727|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994728|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994729|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994730|NCT02833987|Warfarin|warfarin|mesh-list
83994731|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
83994732|NCT02833987|Dabigatran|dabigatran|mesh-list
83994733|NCT02833987|Apixaban|apixaban|mesh-list
83994734|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
83994735|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83994736|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
83994737|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83994738|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
83994739|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994740|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994741|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
83994742|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83994743|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83994744|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994745|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
83994746|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994747|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994748|NCT00965458|Alefacept|alefacept|mesh-list
83994749|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994750|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
83234319|NCT04573192|Lomustine|lomustine|mesh-list
83234320|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83234321|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
83234322|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234323|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234324|NCT04566328|Dexamethasone|dexamethasone|mesh-list
83234326|NCT04566328|Lenalidomide|lenalidomide|mesh-list
83994751|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994752|NCT04249531|Amikacin|amikacin|mesh-list
83994753|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83994754|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994755|NCT02836639|Etoposide|etoposide|mesh-list
83994756|NCT02836639|Busulfan|busulfan|mesh-list
83994757|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83994758|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83994759|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994760|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83994761|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83994762|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994763|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994764|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
83994765|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994766|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
83994767|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994768|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83994769|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83994770|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
83994771|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83994772|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994773|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83994774|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994775|NCT05333419|Latanoprost|latanoprost|mesh-list
83994776|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83994777|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83994778|NCT02836795|Antibodies|antibodies|mesh-list
83994779|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83994780|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
83994781|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994782|NCT02836483|Linezolid|linezolid|mesh-list
83994783|NCT02836483|Delpazolid|delpazolid|mesh-list
83994784|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
83994785|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83994786|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994787|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83994788|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994789|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994790|NCT02836171|Itraconazole|itraconazole|mesh-list
83994791|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83994792|NCT02836171|Apatinib|apatinib|mesh-list
83994793|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994794|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83994795|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994796|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994797|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
83994798|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994799|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83994800|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83994801|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83994802|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
83994803|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994804|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994805|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83994806|NCT00971932|Carboplatin|carboplatin|mesh-list
83994807|NCT00971932|Fluorouracil|fluorouracil|mesh-list
83994808|NCT00971932|Cetuximab|cetuximab|mesh-list
83994809|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994810|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
83994811|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994812|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83994813|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994814|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
83994815|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994816|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994817|NCT04400929|Molgramostim|molgramostim|mesh-list
83994818|NCT04400929|Sargramostim|sargramostim|mesh-list
83994819|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
83994820|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994821|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994822|NCT05170672|Abatacept|abatacept|mesh-list
83994823|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83994824|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234390|NCT04556773|Trastuzumab|trastuzumab|mesh-list
83994825|NCT05170672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994826|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994827|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83994828|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
83994829|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994830|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83994831|NCT00970684|Bevacizumab|bevacizumab|mesh-list
83994832|NCT00970684|Gemcitabine|gemcitabine|mesh-list
83994833|NCT00970684|Docetaxel|docetaxel|mesh-list
83994834|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994835|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994836|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83994837|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83994838|NCT00970684|Growth Substances|growth substances|mesh-ancestor
83994839|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994840|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83994841|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83994842|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
83994843|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994844|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
83994845|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
83994846|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
83994847|NCT00967330|Bevacizumab|bevacizumab|mesh-list
83994848|NCT00967330|Irinotecan|irinotecan|mesh-list
83994849|NCT00967330|Temozolomide|temozolomide|mesh-list
83994850|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83994851|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994852|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83994853|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83994854|NCT00967330|Growth Substances|growth substances|mesh-ancestor
83994855|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994856|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83994857|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83994858|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83994859|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994860|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994861|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83994862|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
83994863|NCT02863276|Insulin|insulin|mesh-list
83994864|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83994865|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83994866|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994867|NCT04286152|Mirabegron|mirabegron|mesh-list
83994868|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83994869|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83994870|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83994871|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
83994872|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994873|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994874|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994875|NCT04286152|Urological Agents|urological agents|mesh-ancestor
83994876|NCT00966940|Travoprost|travoprost|mesh-list
83994877|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83994878|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83994879|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83994880|NCT00965848|Doripenem|doripenem|mesh-list
83994881|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83994882|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994883|NCT03447574|Ethanol|ethanol|mesh-list
83994884|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83994885|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994886|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994887|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994888|NCT04284826|Mitomycins|mitomycins|mesh-list
83994889|NCT04284826|Mitomycin|mitomycin|mesh-list
83994890|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83994891|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994892|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
83994893|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994894|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83994895|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994896|NCT04285528|Lidocaine|lidocaine|mesh-list
83994897|NCT04285528|Fentanyl|fentanyl|mesh-list
83994898|NCT04285528|Ketamine|ketamine|mesh-list
83994899|NCT04285528|Propofol|propofol|mesh-list
83994900|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
83234448|NCT04528082|Analgesics|analgesics|mesh-ancestor
83994901|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
83994902|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83994903|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994904|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
83994905|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83994906|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83994907|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83994908|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83994909|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83994910|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994911|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83994912|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83994913|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
83994914|NCT04285528|Analgesics|analgesics|mesh-ancestor
83994915|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83994916|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83994917|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83994918|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994919|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83994920|NCT04285528|Narcotics|narcotics|mesh-ancestor
83994921|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83994922|NCT00629824|Interferons|interferons|mesh-list
83994924|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
83994925|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83994926|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994927|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
83994928|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994929|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
83994930|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994931|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
83994932|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994933|NCT00961636|Niacin|niacin|mesh-list
83994934|NCT00961636|Niacinamide|niacinamide|mesh-list
83994935|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
83994936|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83994937|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
83994938|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994939|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83994940|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
83994941|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
83994942|NCT00961636|Vitamins|vitamins|mesh-ancestor
83994943|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
83994944|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994945|NCT00964678|Carvedilol|carvedilol|mesh-list
83994946|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83994947|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83994948|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
83994949|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994950|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994951|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994952|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83994953|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
83994954|NCT00964678|Protective Agents|protective agents|mesh-ancestor
83994955|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83994956|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83994957|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83994958|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
83994959|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83994960|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83994961|NCT00964366|Clindamycin|clindamycin|mesh-list
83994962|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
83994963|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
83994964|NCT00964366|Dapsone|dapsone|mesh-list
83994965|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83994966|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83994967|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83994968|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83994969|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994970|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994971|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
83994972|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
83234519|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234520|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83234521|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83994973|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83994974|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83994975|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83994976|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
83994977|NCT03545464|Prednisone|prednisone|mesh-list
83994978|NCT03545464|Levocetirizine|levocetirizine|mesh-list
83994979|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83994980|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
83994981|NCT03545464|Hormones|hormones|mesh-ancestor
83994982|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83994983|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83994984|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83994985|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994986|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83994987|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83994988|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
83994989|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
83994990|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83994991|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994992|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83994993|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83994994|NCT02860936|Lenvatinib|lenvatinib|mesh-list
83994995|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83994996|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83994997|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83994998|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83994999|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
83995000|NCT00630214|Vitamin D|vitamin d|mesh-list
83995001|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
83995002|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
83995003|NCT00630214|Vitamins|vitamins|mesh-list
83995004|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
83995005|NCT00630214|Calcium|calcium|mesh-list
83995006|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
83995007|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995008|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83995009|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83995010|NCT00630214|Antacids|antacids|mesh-ancestor
83995011|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995012|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995013|NCT02860858|Aflibercept|aflibercept|mesh-list
83995014|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83995015|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83995016|NCT02860858|Growth Substances|growth substances|mesh-ancestor
83995017|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995018|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
83995019|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995020|NCT00960076|Metformin|metformin|mesh-list
83995021|NCT00960076|Saxagliptin|saxagliptin|mesh-list
83995022|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83995023|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995024|NCT00960076|Incretins|incretins|mesh-ancestor
83995025|NCT00960076|Hormones|hormones|mesh-ancestor
83995026|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995027|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83995028|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995029|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995030|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995031|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83995032|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83995033|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995034|NCT04284202|Dasatinib|dasatinib|mesh-list
83995035|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995036|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83995037|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995038|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995039|NCT01227629|Warfarin|warfarin|mesh-list
83995040|NCT01227629|Dabigatran|dabigatran|mesh-list
83995041|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
83995042|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
83995043|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83995044|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995045|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995046|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995047|NCT00963820|Ixazomib|ixazomib|mesh-list
83995048|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995049|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995050|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995051|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995052|NCT03241186|Nivolumab|nivolumab|mesh-list
83995053|NCT03241186|Ipilimumab|ipilimumab|mesh-list
83995054|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83995055|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995056|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83995057|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995058|NCT01227395|Azithromycin|azithromycin|mesh-list
83995059|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83995060|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995061|NCT03237286|Ketamine|ketamine|mesh-list
83995062|NCT03237286|Analgesics|analgesics|mesh-ancestor
83995063|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
83995064|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995065|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995066|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83995067|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83995068|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
83995069|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
83995070|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995071|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83995072|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83995073|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995074|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995075|NCT01226459|Minoxidil|minoxidil|mesh-list
83995076|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83995077|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
83995078|NCT01225991|Milnacipran|milnacipran|mesh-list
83995079|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
83995080|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83995081|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83995082|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995083|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995084|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995085|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995086|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995087|NCT01225991|Analgesics|analgesics|mesh-ancestor
83995088|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
83995089|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995090|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
83995091|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83995092|NCT04283110|Midazolam|midazolam|mesh-list
83995093|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83995094|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83995095|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995096|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995097|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83995098|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83995099|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83995100|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83995101|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
83995102|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
83995103|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
83995104|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
83995105|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995106|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995107|NCT02860780|Prexasertib|prexasertib|mesh-list
83995108|NCT02860780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83995109|NCT02860780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995110|NCT02860780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995111|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83995112|NCT01225835|Cetrorelix|cetrorelix|mesh-list
83995113|NCT01225835|Menotropins|menotropins|mesh-list
83995114|NCT01225835|Progesterone|progesterone|mesh-list
83995115|NCT01225835|Progestins|progestins|mesh-ancestor
83995116|NCT01225835|Hormones|hormones|mesh-ancestor
83995117|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995118|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995119|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83995120|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83995121|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
83995122|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
83995123|NCT04282096|Caseins|caseins|mesh-list
83234671|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
83995124|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
83995125|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
83995126|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995127|NCT02899000|Doxycycline|doxycycline|mesh-list
83995128|NCT02899000|Adapalene|adapalene|mesh-list
83995129|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83995130|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83995131|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995132|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
83995133|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83995134|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83995135|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
83995136|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83995137|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995138|NCT02899000|Analgesics|analgesics|mesh-ancestor
83995139|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
83995140|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995141|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995142|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83995143|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83995144|NCT04281862|Prednisolone|prednisolone|mesh-list
83995145|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83995146|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
83995147|NCT04281862|Hormones|hormones|mesh-ancestor
83995148|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995149|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995150|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83995151|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995152|NCT03122002|Clopidogrel|clopidogrel|mesh-list
83995153|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995154|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995155|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83995156|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83995157|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83995158|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83995159|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
83995160|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995161|NCT02861482|Oxytocin|oxytocin|mesh-list
83995162|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
83995163|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
83995164|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83995165|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995166|NCT02861716|Fentanyl|fentanyl|mesh-list
83995167|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
83995168|NCT02861716|Bupivacaine|bupivacaine|mesh-list
83995169|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
83995170|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
83995171|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995172|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995173|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
83995174|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995175|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83995176|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995177|NCT02861716|Analgesics|analgesics|mesh-ancestor
83995178|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83995179|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83995180|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83995181|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
83995182|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995183|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995184|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83995185|NCT02861716|Narcotics|narcotics|mesh-ancestor
83995186|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83995187|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83995188|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
83995189|NCT00960934|Vitamin D|vitamin d|mesh-list
83995190|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
83995191|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
83995192|NCT00960934|Calcium|calcium|mesh-list
83995193|NCT00960934|Vitamins|vitamins|mesh-ancestor
83995194|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
83995195|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995196|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83995197|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83995198|NCT00960934|Antacids|antacids|mesh-ancestor
83995199|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995200|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995201|NCT00892177|Bevacizumab|bevacizumab|mesh-list
83995202|NCT00892177|Dasatinib|dasatinib|mesh-list
83995203|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83995204|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995205|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83995206|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83995207|NCT00892177|Growth Substances|growth substances|mesh-ancestor
83995208|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995209|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
83995210|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83995211|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995212|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995213|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83995214|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83995215|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83995216|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995217|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995218|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
83995219|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995220|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995221|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
83995222|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83995223|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995224|NCT02821000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83995225|NCT02821000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995226|NCT02860624|Esomeprazole|esomeprazole|mesh-list
83995227|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83995228|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995229|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83995230|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995231|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995232|NCT00892099|Vitamin D|vitamin d|mesh-list
83995233|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
83995234|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
83995235|NCT00892099|Vitamins|vitamins|mesh-list
83995236|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
83995237|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995238|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83995239|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83995240|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
83995241|NCT00960856|Fenofibrate|fenofibrate|mesh-list
83995242|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83995243|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83995244|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
83995245|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995246|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83995247|NCT00958438|Rilonacept|rilonacept|mesh-list
83995248|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83995249|NCT02835469|Menotropins|menotropins|mesh-list
83995250|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83995251|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
83995252|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83995253|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995254|NCT02832973|Ramipril|ramipril|mesh-list
83995255|NCT02832973|Bisoprolol|bisoprolol|mesh-list
83995256|NCT02832973|Amiloride|amiloride|mesh-list
83995257|NCT02832973|Furosemide|furosemide|mesh-list
83995258|NCT02832973|Spironolactone|spironolactone|mesh-list
83995259|NCT02832973|Diuretics|diuretics|mesh-list
83995260|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83995261|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
83995262|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995263|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83995264|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995265|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995266|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83995267|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
83995268|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995269|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83995270|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995271|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995272|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83995273|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
83995274|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
83995275|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995276|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83995277|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83995278|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83995279|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
83995280|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995281|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83995282|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83995283|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83995284|NCT02831491|Docetaxel|docetaxel|mesh-list
83995285|NCT02831491|Ramucirumab|ramucirumab|mesh-list
83995286|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995287|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
83995288|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
83995289|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83995290|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995291|NCT02860234|Capecitabine|capecitabine|mesh-list
83995292|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
83995293|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83995294|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
83995295|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995296|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995297|NCT00630370|ATI 7505|ati 7505|mesh-list
83995298|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83995299|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83995300|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
83995301|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995302|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995303|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995304|NCT04281706|Propofol|propofol|mesh-list
83995305|NCT04281706|Etomidate|etomidate|mesh-list
83995306|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83995307|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995308|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995309|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83995310|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
83995311|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
83995312|NCT02835391|Surgiflo|surgiflo|mesh-list
83995313|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
83995314|NCT02835391|Coagulants|coagulants|mesh-ancestor
83995315|NCT02831101|Sufentanil|sufentanil|mesh-list
83995316|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83995317|NCT02831101|Narcotics|narcotics|mesh-ancestor
83995318|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995319|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995320|NCT02831101|Analgesics|analgesics|mesh-ancestor
83995321|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
83995322|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995323|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83995324|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83995325|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
83995326|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
83995327|NCT04245787|Fluorides|fluorides|mesh-list
83234897|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
83234898|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234899|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234900|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83234901|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
83234902|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234903|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234904|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83234905|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83234906|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83234907|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83234908|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234909|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83234910|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
83234911|NCT04301076|Hormones|hormones|mesh-ancestor
83234912|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234913|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234914|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234915|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234916|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234917|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
83995328|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
83995329|NCT04245787|Protective Agents|protective agents|mesh-ancestor
83995330|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995331|NCT02831179|Capecitabine|capecitabine|mesh-list
83995332|NCT02831179|Temozolomide|temozolomide|mesh-list
83995333|NCT02831179|Veliparib|veliparib|mesh-list
83995334|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83995335|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
83995336|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995337|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995338|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83995339|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
83995340|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83995341|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995342|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
83995343|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
83995344|NCT02830789|Calcium|calcium|mesh-list
83995345|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83995346|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995347|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83995348|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995349|NCT02830789|Antacids|antacids|mesh-ancestor
83995350|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995351|NCT04243993|Calcium|calcium|mesh-list
83995352|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83995353|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995354|NCT04245319|Acitretin|acitretin|mesh-list
83995355|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
83995356|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
83995357|NCT02828059|Ropivacaine|ropivacaine|mesh-list
83995358|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
83995359|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
83995360|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995361|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995362|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
83995363|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995364|NCT02827903|Metformin|metformin|mesh-list
83995365|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83995366|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83995367|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995368|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83995369|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83995370|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
83995371|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995372|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83995373|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83995374|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995375|NCT01243424|Glimepiride|glimepiride|mesh-list
83995376|NCT01243424|Linagliptin|linagliptin|mesh-list
83995377|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83995378|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83995379|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995380|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83995381|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
83995382|NCT01243424|Incretins|incretins|mesh-ancestor
83995383|NCT01243424|Hormones|hormones|mesh-ancestor
83995384|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995385|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83995386|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995387|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995388|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995389|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
83995390|NCT02831023|Piperaquine|piperaquine|mesh-list
83995391|NCT02831023|Primaquine|primaquine|mesh-list
83995392|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
83995393|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83995394|NCT02831023|Amodiaquine|amodiaquine|mesh-list
83995395|NCT02831023|Artenimol|artenimol|mesh-list
83995396|NCT02831023|Methylene Blue|methylene blue|mesh-list
83995397|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
83995398|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83995399|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83995400|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995401|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83995402|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995403|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995404|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83995405|NCT04244695|Dexamethasone|dexamethasone|mesh-list
83995406|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83995407|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
83995408|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
83995409|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995410|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995411|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995412|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
83995413|NCT04244695|Hormones|hormones|mesh-ancestor
83995414|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995415|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83995416|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995417|NCT00887809|Bevacizumab|bevacizumab|mesh-list
83995418|NCT00887809|Gemcitabine|gemcitabine|mesh-list
83995419|NCT00887809|Docetaxel|docetaxel|mesh-list
83995420|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83995421|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995422|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83995423|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83995424|NCT00887809|Growth Substances|growth substances|mesh-ancestor
83995425|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995426|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
83995427|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83995428|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
83995429|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995430|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
83995431|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
83995432|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
83995433|NCT02827747|Vitamin A|vitamin a|mesh-list
83995434|NCT02827747|Antioxidants|antioxidants|mesh-list
83995435|NCT02827747|Vitamins|vitamins|mesh-ancestor
83995436|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
83995437|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995438|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995439|NCT02827747|Protective Agents|protective agents|mesh-ancestor
83995440|NCT04281628|Ketamine|ketamine|mesh-list
83995441|NCT04281628|Analgesics|analgesics|mesh-ancestor
83995442|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
83995443|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995444|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995445|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83995446|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83995447|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
83995448|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
83995449|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995450|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83995451|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83995452|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995453|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995454|NCT00886795|Abatacept|abatacept|mesh-list
83995455|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83995456|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995457|NCT00886795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83995458|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995459|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83995460|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
83995461|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995462|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83995463|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
83995464|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
83995465|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83995466|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83995467|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
83995468|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995469|NCT00953680|Losartan|losartan|mesh-list
83995470|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83995471|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83995472|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83995473|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83995474|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83995475|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235052|NCT04233866|Folic Acid|folic acid|mesh-list
83235053|NCT04233866|Paclitaxel|paclitaxel|mesh-list
83235054|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83995476|NCT00953680|Diuretics|diuretics|mesh-ancestor
83995477|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
83995478|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995479|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83995480|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995481|NCT00890929|Lenalidomide|lenalidomide|mesh-list
83995482|NCT00890929|Azacitidine|azacitidine|mesh-list
83995483|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
83995484|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995485|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83995486|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83995487|NCT00890929|Growth Substances|growth substances|mesh-ancestor
83995488|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
83995489|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995490|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83995491|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
83995492|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995493|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995494|NCT04246567|Fentanyl|fentanyl|mesh-list
83995495|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83995496|NCT04246567|Narcotics|narcotics|mesh-ancestor
83995497|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995498|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995499|NCT04246567|Analgesics|analgesics|mesh-ancestor
83995500|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
83995501|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995502|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83995503|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83995504|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
83995505|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
83995506|NCT02830243|Sevoflurane|sevoflurane|mesh-list
83995507|NCT02830243|Desflurane|desflurane|mesh-list
83995508|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83995509|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83995510|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
83995511|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
83995512|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995513|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995514|NCT00889603|Donepezil|donepezil|mesh-list
83995515|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83995516|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995517|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995518|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
83995519|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995520|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995521|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
83995522|NCT02829385|Apatinib|apatinib|mesh-list
83995523|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995524|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83995525|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995526|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995527|NCT02826343|Xenon|xenon|mesh-list
83995528|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83995529|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83995530|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
83995531|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
83995532|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995533|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995534|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83995535|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
83995536|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995537|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83995538|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
83995539|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
83995540|NCT02826343|Hormones|hormones|mesh-ancestor
83995541|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995542|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
83995543|NCT05660785|Cyclosporine|cyclosporine|mesh-list
83995544|NCT05660785|Cyclosporins|cyclosporins|mesh-list
83995545|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995546|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995547|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83995548|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
83995549|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995550|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
83995551|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995552|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83995553|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83995554|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83995555|NCT04246255|Lidocaine|lidocaine|mesh-list
83995556|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83995557|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
83995558|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995559|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995560|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
83995561|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995562|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83995563|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83995564|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83995565|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995566|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995567|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83995568|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
83995569|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83995570|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83995571|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
83995572|NCT05217589|Hormones|hormones|mesh-ancestor
83995573|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995574|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995575|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995576|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995577|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
83995578|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83995579|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
83995580|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83995581|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995582|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995583|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995584|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
83995585|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
83995586|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83995587|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
83995588|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995589|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
83995590|NCT02826031|Protective Agents|protective agents|mesh-ancestor
83995591|NCT02829697|Ropivacaine|ropivacaine|mesh-list
83995592|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
83995593|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
83995594|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995595|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995596|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
83995597|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995598|NCT02829151|Aspirin|aspirin|mesh-list
83995599|NCT02829151|Cilostazol|cilostazol|mesh-list
83995600|NCT02829151|Clopidogrel|clopidogrel|mesh-list
83995601|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83995602|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995603|NCT02829151|Analgesics|analgesics|mesh-ancestor
83995604|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
83995605|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995606|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995607|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83995608|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83995609|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83995610|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83995611|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995612|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83995613|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83995614|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995615|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
83995616|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83995617|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83995618|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83995619|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
83995620|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995621|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83995622|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
83995623|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83995624|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
83995625|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
83995626|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83995627|NCT02829151|Protective Agents|protective agents|mesh-ancestor
83995628|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83995629|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83995630|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83995631|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83995632|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995633|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
83995634|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
83995635|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83995636|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83995637|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995638|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
83995639|NCT02825719|Coagulants|coagulants|mesh-ancestor
83995640|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83995641|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
83995642|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83995643|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995644|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83995645|NCT04241653|Sevoflurane|sevoflurane|mesh-list
83995646|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83995647|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83995648|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
83995649|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
83995650|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995651|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995652|NCT04241731|Cetuximab|cetuximab|mesh-list
83995653|NCT04241731|Raltitrexed|raltitrexed|mesh-list
83995654|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83995655|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995656|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83995657|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
83995658|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995659|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83995660|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995661|NCT04241887|Anesthetics|anesthetics|mesh-list
83995662|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995663|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995664|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83995665|NCT02825797|Antibodies|antibodies|mesh-list
83995666|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
83995667|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83995668|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
83995669|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995670|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995671|NCT02824315|Simeprevir|simeprevir|mesh-list
83995672|NCT02824315|Odalasvir|odalasvir|mesh-list
83995673|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
83995674|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995675|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995676|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995677|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995678|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
83995679|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995680|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
83995681|NCT02823925|Pamidronate|pamidronate|mesh-list
83995682|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83995683|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995684|NCT04201249|Piroxicam|piroxicam|mesh-list
83995685|NCT04201249|Lidocaine|lidocaine|mesh-list
83995686|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
83995687|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
83995688|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995689|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995690|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
83995691|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995692|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83995693|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83995694|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83995695|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995696|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995697|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83995698|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995699|NCT04201249|Analgesics|analgesics|mesh-ancestor
83995700|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83995701|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83995702|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83995703|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995704|NCT00633685|Fluoxetine|fluoxetine|mesh-list
83995705|NCT00633685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83995706|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83995707|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995708|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995709|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995710|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
83995711|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995712|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83995713|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
83995714|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83995715|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83995716|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83995717|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995718|NCT02823691|Metformin|metformin|mesh-list
83995719|NCT02823691|Lanreotide|lanreotide|mesh-list
83995720|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83995721|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995722|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995723|NCT02825095|Lidocaine|lidocaine|mesh-list
83995724|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
83995725|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
83995726|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995727|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995728|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
83995729|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995730|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83995731|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83995732|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83995733|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83995734|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995735|NCT04195009|Anesthetics|anesthetics|mesh-list
83995736|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995737|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995738|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83995739|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995740|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995741|NCT02822131|Sevelamer|sevelamer|mesh-list
83995742|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
83995743|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
83995744|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995745|NCT04239625|Vitamin A|vitamin a|mesh-list
83995746|NCT04239625|Retinol acetate|retinol acetate|mesh-list
83995747|NCT04239625|Vitamins|vitamins|mesh-ancestor
83995748|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
83995749|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995750|NCT04239625|Protective Agents|protective agents|mesh-ancestor
83995751|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83995752|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995753|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83995754|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
83995755|NCT02821897|Anesthetics|anesthetics|mesh-list
83995756|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83235357|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235358|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
83235359|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235360|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235361|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83235380|NCT04100135|Clopidogrel|clopidogrel|mesh-list
83235381|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83235382|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83235383|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83235384|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83235385|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83235386|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
83235387|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83235388|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235389|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235390|NCT04094584|Naltrexone|naltrexone|mesh-list
83995757|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995758|NCT02820493|Vedolizumab|vedolizumab|mesh-list
83995759|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995760|NCT05659459|Pioglitazone|pioglitazone|mesh-list
83995761|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83995762|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995763|NCT02820259|Tacrolimus|tacrolimus|mesh-list
83995764|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83995765|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
83995766|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995767|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83995768|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995769|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995770|NCT00633763|Fallypride|fallypride|mesh-list
83995771|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83995772|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83995773|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
83995774|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995775|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995776|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995777|NCT02820025|Doxapram|doxapram|mesh-list
83995778|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83995779|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995780|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83995781|NCT02819869|Metformin|metformin|mesh-list
83995782|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83995783|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995784|NCT02820883|Vaccines|vaccines|mesh-list
83995785|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
83995786|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995787|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
83995788|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83995789|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995790|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995791|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995792|NCT02819089|Analgesics|analgesics|mesh-ancestor
83995793|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
83995794|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995795|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83995796|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83995797|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83995798|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
83995799|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995800|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995801|NCT04238923|Vancomycin|vancomycin|mesh-list
83995802|NCT04238923|Gentamicins|gentamicins|mesh-list
83995803|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83995804|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995805|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83995806|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995807|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995808|NCT02815657|Valsartan|valsartan|mesh-list
83995809|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83995810|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83995811|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83995812|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995813|NCT04597333|Dinoprostone|dinoprostone|mesh-list
83995814|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
83995815|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83995816|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995817|NCT00957580|Niacinamide|niacinamide|mesh-list
83995818|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
83995819|NCT00957580|Vitamins|vitamins|mesh-ancestor
83995820|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
83995821|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995822|NCT00957424|Nicotine|nicotine|mesh-list
83235433|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83235434|NCT04083599|Carboplatin|carboplatin|mesh-list
83235435|NCT04083599|Gemcitabine|gemcitabine|mesh-list
83235436|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
83235437|NCT04083599|Pemetrexed|pemetrexed|mesh-list
83235438|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235439|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235440|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235441|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235445|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
83995823|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83995824|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
83995825|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995826|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995827|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83995828|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83995829|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
83995830|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995831|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995832|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
83995833|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83995834|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995835|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995836|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995837|NCT02818621|Analgesics|analgesics|mesh-ancestor
83995838|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
83995839|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995840|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83995841|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83995842|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83995843|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
83995844|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995845|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995846|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
83995847|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83995848|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995849|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995850|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83995851|NCT04642651|Analgesics|analgesics|mesh-ancestor
83995852|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
83995853|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995854|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83995855|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83995856|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83995857|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83995858|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995859|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995861|NCT01061151|Lopinavir|lopinavir|mesh-list
83995862|NCT01061151|Tenofovir|tenofovir|mesh-list
83995863|NCT01061151|Lamivudine|lamivudine|mesh-list
83995864|NCT01061151|Emtricitabine|emtricitabine|mesh-list
83995865|NCT01061151|Zidovudine|zidovudine|mesh-list
83995866|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83995867|NCT01061151|Nevirapine|nevirapine|mesh-list
83995868|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83995869|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83995870|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83995871|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
83995872|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995873|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995874|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83995875|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83995876|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
83995877|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995878|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83995879|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83995880|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83995881|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83995882|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
83995883|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83995884|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83995885|NCT04472143|Granisetron|granisetron|mesh-list
83995886|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
83995887|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
83995888|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995889|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995890|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235510|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235511|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235512|NCT04047472|Aflibercept|aflibercept|mesh-list
83235513|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83235514|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83995891|NCT04472143|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83995892|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83995893|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
83995894|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995895|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995896|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83995897|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
83995898|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995899|NCT04748523|Mirtazapine|mirtazapine|mesh-list
83995900|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
83995901|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83995902|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83995903|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
83995904|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
83995905|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83995906|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995907|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995908|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83995909|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83995910|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83995911|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83995912|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83995913|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83995914|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83995915|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83995916|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83995917|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
83995918|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83995919|NCT02817217|Valsartan|valsartan|mesh-list
83995920|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83995921|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83995922|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83995923|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995924|NCT00948922|Fludarabine|fludarabine|mesh-list
83995925|NCT00948922|Bortezomib|bortezomib|mesh-list
83995926|NCT00948922|Melphalan|melphalan|mesh-list
83995927|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995928|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995929|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83995930|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
83995931|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995932|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83995933|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
83995934|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83995935|NCT00634309|Candesartan|candesartan|mesh-list
83995936|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83235586|NCT04020341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235587|NCT04020341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235588|NCT04012138|Insulin|insulin|mesh-list
83235589|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83235590|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
83235591|NCT04012138|Albuterol|albuterol|mesh-list
83235592|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83235593|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235594|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83235595|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
83235596|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235597|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83235598|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
83235599|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
83235600|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83235601|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83235602|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83235603|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83235604|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
83235605|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83235606|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235607|NCT04011280|Varenicline|varenicline|mesh-list
83235608|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83235609|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83235610|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
83235611|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83235643|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
83995937|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83995938|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83995939|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995940|NCT01239992|Niacin|niacin|mesh-list
83995941|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83995942|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
83995943|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995944|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83995945|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
83995946|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
83995947|NCT01239992|Vitamins|vitamins|mesh-ancestor
83995948|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
83995949|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995950|NCT02816905|Fluorometholone|fluorometholone|mesh-list
83995951|NCT02816905|Dexamethasone|dexamethasone|mesh-list
83995952|NCT02816905|Rimexolone|rimexolone|mesh-list
83995953|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83995954|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
83995955|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
83995956|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83995957|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995958|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83995959|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
83995960|NCT02816905|Hormones|hormones|mesh-ancestor
83995961|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83995962|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83995963|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995964|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83995965|NCT01072539|Tigecycline|tigecycline|mesh-list
83995966|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83995967|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83995968|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83995969|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83995970|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995971|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
83995972|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83995973|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83995974|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995975|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
83995976|NCT05517590|Coagulants|coagulants|mesh-ancestor
83995977|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
83995978|NCT05654077|Fludarabine|fludarabine|mesh-list
83995979|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83995980|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
83995981|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995982|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83995983|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83995984|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
83995985|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995986|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83995987|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83995988|NCT04303767|Calcium|calcium|mesh-list
83995989|NCT04303767|Caseins|caseins|mesh-list
83995990|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83995991|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83995992|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
83995993|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
83995994|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83995995|NCT02874963|Ethanol|ethanol|mesh-list
83995996|NCT02874963|Listerine|listerine|mesh-list
83995997|NCT02874963|Thymol|thymol|mesh-list
83995998|NCT02874963|Eucalyptol|eucalyptol|mesh-list
83995999|NCT02874963|Salicylates|salicylates|mesh-list
83996000|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
83996001|NCT02874963|Menthol|menthol|mesh-list
83996002|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83996003|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996004|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996005|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996006|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
83996007|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
83996008|NCT02874963|Protective Agents|protective agents|mesh-ancestor
83996009|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83996010|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996011|NCT02874963|Analgesics|analgesics|mesh-ancestor
83996012|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
83235662|NCT03989271|Protective Agents|protective agents|mesh-ancestor
83996013|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996014|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83996015|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996016|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83996017|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996018|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996019|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
83996020|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
83996021|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996022|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
83996023|NCT02818309|Lesogaberan|lesogaberan|mesh-list
83996024|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83996025|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83996026|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
83996027|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
83996028|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996029|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996030|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996031|NCT01238822|Methylphenidate|methylphenidate|mesh-list
83996032|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83996033|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996034|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83996035|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83996036|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996037|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996038|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
83996039|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996040|NCT02818387|Midazolam|midazolam|mesh-list
83996041|NCT02818387|Remifentanil|remifentanil|mesh-list
83996042|NCT02818387|Propofol|propofol|mesh-list
83996043|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83996044|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996045|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996046|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83996047|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
83996048|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
83996049|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83996050|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83996051|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83996052|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83996053|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
83996054|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
83996055|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996056|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996057|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83996058|NCT02818387|Narcotics|narcotics|mesh-ancestor
83996059|NCT02818387|Analgesics|analgesics|mesh-ancestor
83996060|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
83996061|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996062|NCT05296629|Doxycycline|doxycycline|mesh-list
83996063|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83996064|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996065|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
83996066|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83996067|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83996068|NCT01238588|Sevelamer|sevelamer|mesh-list
83996069|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
83996070|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
83996071|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996072|NCT00627003|Cabergoline|cabergoline|mesh-list
83996073|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83996074|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83996075|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
83996076|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
83996077|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996078|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996079|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996080|NCT04238221|Doxofylline|doxofylline|mesh-list
83996081|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
83996082|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996083|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83996084|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
83996085|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996086|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996087|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83996088|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83996090|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996091|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83996092|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83996093|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83996094|NCT01238120|Ibuprofen|ibuprofen|mesh-list
83996095|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83996096|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83996097|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996098|NCT01238120|Analgesics|analgesics|mesh-ancestor
83996099|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
83996100|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996101|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996102|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996103|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83996104|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996105|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996106|NCT00634231|Valacyclovir|valacyclovir|mesh-list
83996107|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
83996108|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996109|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83996110|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
83996111|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83996112|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996113|NCT04237987|Cyclosporine|cyclosporine|mesh-list
83996114|NCT04237987|Aldesleukin|aldesleukin|mesh-list
83996115|NCT04237987|Interleukin-2|interleukin-2|mesh-list
83996116|NCT04237987|Cyclosporins|cyclosporins|mesh-list
83996117|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996118|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996119|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83996120|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
83996121|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996122|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
83996123|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996124|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83996125|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996126|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83996127|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996128|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996129|NCT04237987|Analgesics|analgesics|mesh-ancestor
83996130|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
83996131|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996132|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83996133|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83996134|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
83996135|NCT04551547|Vaccines|vaccines|mesh-list
83996136|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
83996137|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996138|NCT01045707|Insulin|insulin|mesh-list
83996139|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83996140|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
83996141|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
83996142|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996143|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996144|NCT04533997|Furosemide|furosemide|mesh-list
83996145|NCT04533997|Diuretics|diuretics|mesh-ancestor
83996146|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
83996147|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996148|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83996149|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996150|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996151|NCT02874807|Empagliflozin|empagliflozin|mesh-list
83996152|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83996153|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996154|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996155|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996156|NCT01054599|Memantine|memantine|mesh-list
83996157|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83996158|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83996159|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
83996160|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996161|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996162|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235812|NCT03866382|Nivolumab|nivolumab|mesh-list
83996163|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83996164|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83996165|NCT05635201|Anesthetics|anesthetics|mesh-list
83996166|NCT05635201|Propofol|propofol|mesh-list
83996167|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996168|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996169|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83996170|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83996171|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
83996172|NCT02813863|Metformin|metformin|mesh-list
83996173|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996174|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996175|NCT02874729|Dimercaprol|dimercaprol|mesh-list
83996176|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
83996177|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
83996178|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996179|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
83996180|NCT04275661|Ketamine|ketamine|mesh-list
83996181|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
83996182|NCT04275661|Analgesics|analgesics|mesh-ancestor
83996183|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
83996184|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996185|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996186|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83996187|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83996188|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
83996189|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
83996190|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996191|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83996192|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83996193|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996194|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996195|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83996196|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
83996197|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83996198|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996199|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83996200|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
83996201|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83996202|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
83996203|NCT00948766|Rivastigmine|rivastigmine|mesh-list
83996204|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83996205|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996206|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996207|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
83996208|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996209|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996210|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83996211|NCT00948766|Protective Agents|protective agents|mesh-ancestor
83996212|NCT01053663|Oseltamivir|oseltamivir|mesh-list
83996213|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
83996214|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996215|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996216|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996217|NCT01235546|Azithromycin|azithromycin|mesh-list
83996218|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83996219|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996220|NCT01053429|Ziprasidone|ziprasidone|mesh-list
83996221|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83996222|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
83996223|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996224|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996225|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996226|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83996227|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83996228|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996229|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83996230|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83996231|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
83235887|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235888|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83235889|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235890|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
83235891|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83996232|NCT01233284|Bromides|bromides|mesh-list
83996233|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
83996234|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83996235|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
83996236|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996237|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996238|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83996239|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996240|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
83996241|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83996242|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
83996243|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996244|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996245|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
83996246|NCT00948688|Vorinostat|vorinostat|mesh-list
83996247|NCT00948688|Fluorouracil|fluorouracil|mesh-list
83996248|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996249|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83996250|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996251|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996252|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
83996253|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83996254|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83996255|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
83996256|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996257|NCT02188264|Cyclosporine|cyclosporine|mesh-list
83996258|NCT02188264|Cyclosporins|cyclosporins|mesh-list
83996259|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996260|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996261|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83996262|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
83996263|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996264|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
83996265|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996266|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
83996267|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996268|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83996269|NCT01233050|Ethanol|ethanol|mesh-list
83996270|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
83996271|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83996272|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83996273|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996274|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996275|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996276|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
83996277|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
83996278|NCT01049217|Pregabalin|pregabalin|mesh-list
83996279|NCT01049217|Analgesics|analgesics|mesh-ancestor
83996280|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
83996281|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996282|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996283|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
83996284|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83996285|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996286|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996287|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83235962|NCT03782064|Nivolumab|nivolumab|mesh-list
83235963|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235964|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235965|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235966|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235987|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
83235988|NCT03766126|Fludarabine|fludarabine|mesh-list
83235989|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235990|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
83235991|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235992|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235993|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235994|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
83235995|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235996|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235997|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83235998|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
83235999|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83996288|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83996289|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83996290|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996291|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83996292|NCT01232738|Rasagiline|rasagiline|mesh-list
83996293|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83996294|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996295|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996296|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83996297|NCT01232738|Protective Agents|protective agents|mesh-ancestor
83996298|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996299|NCT00957268|Alogliptin|alogliptin|mesh-list
83996300|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996301|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996302|NCT00957268|Incretins|incretins|mesh-ancestor
83996303|NCT00957268|Hormones|hormones|mesh-ancestor
83996304|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83996305|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83996306|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
83996307|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996308|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996309|NCT02888444|Varenicline|varenicline|mesh-list
83996310|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83996311|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83996312|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
83996313|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996314|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996315|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996316|NCT01230788|Rituximab|rituximab|mesh-list
83996317|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83996318|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996319|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
83996320|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996321|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996322|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83996323|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996324|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83996325|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996326|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996327|NCT00627081|Remifentanil|remifentanil|mesh-list
83996328|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83996329|NCT00627081|Narcotics|narcotics|mesh-ancestor
83996330|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996331|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996332|NCT00627081|Analgesics|analgesics|mesh-ancestor
83996333|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
83996334|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996335|NCT02888054|Allopurinol|allopurinol|mesh-list
83996336|NCT02888054|Lesinurad|lesinurad|mesh-list
83996337|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
83996338|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996339|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996340|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
83996341|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996342|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83996343|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
83996344|NCT02888054|Protective Agents|protective agents|mesh-ancestor
83996345|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996346|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
83996347|NCT01040793|Olodaterol|olodaterol|mesh-list
83996348|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83996349|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
83996350|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996351|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996352|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83996353|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996354|NCT02811055|Aprepitant|aprepitant|mesh-list
83996355|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
83996356|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
83996357|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996358|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996359|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83996360|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83996361|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996362|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996364|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996365|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
83996366|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83996367|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996368|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996369|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996370|NCT02810899|Analgesics|analgesics|mesh-ancestor
83996371|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
83996372|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996373|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83996374|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83996375|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83996376|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
83996377|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996378|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996379|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
83996380|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996381|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996382|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83996383|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996384|NCT02810275|Leucovorin|leucovorin|mesh-list
83996385|NCT02810275|Folic Acid|folic acid|mesh-list
83996386|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
83996387|NCT02810275|Antidotes|antidotes|mesh-ancestor
83996388|NCT02810275|Protective Agents|protective agents|mesh-ancestor
83996389|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996390|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
83996391|NCT02810275|Vitamins|vitamins|mesh-ancestor
83996392|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
83996393|NCT02810275|Hematinics|hematinics|mesh-ancestor
83996394|NCT00948064|Azacitidine|azacitidine|mesh-list
83996395|NCT00948064|Vorinostat|vorinostat|mesh-list
83996396|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83996397|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
83996398|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996399|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996400|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996401|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83996402|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83996403|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83996404|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
83996405|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83996406|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
83996407|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83996408|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996409|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83996410|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83996411|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996412|NCT02858206|Paclitaxel|paclitaxel|mesh-list
83996413|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
83996414|NCT02858206|Nedaplatin|nedaplatin|mesh-list
83996415|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83996416|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996417|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83996418|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83996419|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83996420|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996421|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83996422|NCT02815189|Acetaminophen|acetaminophen|mesh-list
83996423|NCT02815189|Ibuprofen|ibuprofen|mesh-list
83996424|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83236113|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236114|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
83236115|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83236116|NCT03671525|Nimodipine|nimodipine|mesh-list
83236117|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83236118|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83236119|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83236120|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236121|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83236122|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236123|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
83236139|NCT03654716|Cytarabine|cytarabine|mesh-list
83236140|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236149|NCT03648437|Acetaminophen|acetaminophen|mesh-list
83996425|NCT02815189|Analgesics|analgesics|mesh-ancestor
83996426|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
83996427|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996428|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996429|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
83996430|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83996431|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83996432|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996433|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83996434|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996435|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996436|NCT02809963|Eplerenone|eplerenone|mesh-list
83996437|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83996438|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
83996439|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83996440|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996441|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83996442|NCT02809963|Diuretics|diuretics|mesh-ancestor
83996443|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
83996444|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83996445|NCT02815111|Acetaminophen|acetaminophen|mesh-list
83996446|NCT02815111|Lidocaine|lidocaine|mesh-list
83996447|NCT02815111|Ketamine|ketamine|mesh-list
83996448|NCT02815111|Gabapentin|gabapentin|mesh-list
83996449|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
83996450|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
83996451|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996452|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996453|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
83996454|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996455|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83996456|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83996457|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83996458|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996459|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996460|NCT02815111|Analgesics|analgesics|mesh-ancestor
83996461|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83996462|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83996463|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
83996464|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83996465|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83996466|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996467|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996468|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
83996469|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
83996470|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83996471|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83996472|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83996473|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
83996474|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
83996475|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996476|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996477|NCT02809729|Cefazolin|cefazolin|mesh-list
83996478|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83996479|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996480|NCT04303377|Evolocumab|evolocumab|mesh-list
83996481|NCT04303377|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83996482|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83996483|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83996484|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
83996485|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996486|NCT04303377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83996487|NCT04303377|Protease Inhibitors|protease inhibitors|mesh-ancestor
83996488|NCT04303377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996489|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83996490|NCT00953524|Vaccines|vaccines|mesh-list
83996491|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
83996492|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996493|NCT02809573|Prednisone|prednisone|mesh-list
83996494|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
83236188|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
83236189|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83236190|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236191|NCT03641560|Androgens|androgens|mesh-list
83236192|NCT03641560|Hormones|hormones|mesh-ancestor
83236193|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83996495|NCT02809573|Vincristine|vincristine|mesh-list
83996496|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83996497|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
83996498|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996499|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996500|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83996501|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
83996502|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996503|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996504|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83996505|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83996506|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
83996507|NCT02809573|Hormones|hormones|mesh-ancestor
83996508|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83996509|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83996510|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83996511|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
83996512|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
83996513|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
83996514|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
83996515|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83996516|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
83996517|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996518|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996519|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83996520|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996521|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83996522|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
83996523|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996524|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996525|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83996526|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
83996527|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
83996528|NCT04388683|Protective Agents|protective agents|mesh-ancestor
83996529|NCT01040403|Bromides|bromides|mesh-list
83996530|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
83996531|NCT01040403|Olodaterol|olodaterol|mesh-list
83996532|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83996533|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
83996534|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996535|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996536|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83996537|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996538|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
83996539|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83996540|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
83996541|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996542|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996543|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
83996544|NCT00957034|Testosterone|testosterone|mesh-list
83996545|NCT00957034|Androgens|androgens|mesh-ancestor
83996546|NCT00957034|Hormones|hormones|mesh-ancestor
83996547|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83996548|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996549|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
83996550|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
83996551|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83996552|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996553|NCT02812693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83996554|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996555|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83996556|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996557|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
83996558|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83996559|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
83996560|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048334|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83996561|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
83996562|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83996563|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996564|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996565|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996566|NCT02689999|Rabeprazole|rabeprazole|mesh-list
83996567|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83996568|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83996569|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83996570|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996571|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996573|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83996574|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
83996575|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996576|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83996577|NCT00953056|Vaccines|vaccines|mesh-list
83996578|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
83996579|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996580|NCT02811289|Mirabegron|mirabegron|mesh-list
83996581|NCT02811289|Glycerol|glycerol|mesh-list
83996582|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83996583|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83996584|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83996585|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
83996586|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996587|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996588|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996589|NCT02811289|Urological Agents|urological agents|mesh-ancestor
83996590|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83996591|NCT02811289|Protective Agents|protective agents|mesh-ancestor
83996592|NCT02808949|Dapivirine|dapivirine|mesh-list
83996593|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83996594|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83996595|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
83996596|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996597|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
83996598|NCT04207177|Tacrolimus|tacrolimus|mesh-list
83996599|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83996600|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
83996601|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996602|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83996603|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996604|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996605|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83996606|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996607|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83996608|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
83996609|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83996610|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996611|NCT02812147|Droxidopa|droxidopa|mesh-list
83996612|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83996613|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83996614|NCT04303065|Dexamethasone|dexamethasone|mesh-list
83996615|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83996616|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
83996617|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
83996618|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996619|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996620|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83996621|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
83996622|NCT04303065|Hormones|hormones|mesh-ancestor
83996623|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83996624|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83996625|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996626|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83996627|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996628|NCT00952822|Factor VIII|factor viii|mesh-list
83996629|NCT00952822|Coagulants|coagulants|mesh-ancestor
83996630|NCT02854072|Gemcitabine|gemcitabine|mesh-list
83996631|NCT02854072|Capecitabine|capecitabine|mesh-list
83996632|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83996633|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
83996634|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996635|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996636|NCT02537314|Benzocaine|benzocaine|mesh-list
83996637|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
83996638|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
83996639|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996640|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996641|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
83236342|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83996642|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996643|NCT00631150|Levetiracetam|levetiracetam|mesh-list
83996644|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
83996645|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
83996646|NCT04278040|Melphalan|melphalan|mesh-list
83996647|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83996648|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
83996649|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996650|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996651|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83996652|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83996653|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
83996654|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996655|NCT02856724|Dinoprostone|dinoprostone|mesh-list
83996656|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
83996657|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83996658|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996659|NCT02808325|Polygeline|polygeline|mesh-list
83996660|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
83996661|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
83996662|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83996663|NCT00955474|Citalopram|citalopram|mesh-list
83996664|NCT00955474|Sertraline|sertraline|mesh-list
83996665|NCT00955474|Escitalopram|escitalopram|mesh-list
83996666|NCT00955474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83996667|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83996668|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996669|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996670|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996671|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
83996672|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996673|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83996674|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
83996675|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83996676|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83996677|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83996678|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996679|NCT02808247|Ifosfamide|ifosfamide|mesh-list
83996680|NCT02808247|Nintedanib|nintedanib|mesh-list
83996681|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83996682|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
83996683|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996684|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996685|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83996686|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996687|NCT02808091|Bortezomib|bortezomib|mesh-list
83996688|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996689|NCT02811991|Acetaminophen|acetaminophen|mesh-list
83996690|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996691|NCT02811991|Analgesics|analgesics|mesh-ancestor
83996692|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
83996693|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996694|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996695|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
83996696|NCT04237675|Anesthetics|anesthetics|mesh-list
83996697|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996698|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996699|NCT05598853|Nivolumab|nivolumab|mesh-list
83996700|NCT05598853|Ipilimumab|ipilimumab|mesh-list
83996701|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83996702|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996703|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83996704|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996705|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83996706|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996707|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83996708|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996709|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996710|NCT02804815|Aspirin|aspirin|mesh-list
83996711|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83996712|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996713|NCT02804815|Analgesics|analgesics|mesh-ancestor
83996714|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
83996715|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996716|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996717|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83996718|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996719|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83996720|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83996721|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996722|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83996723|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83996724|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996725|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
83996726|NCT04017247|Oxytocin|oxytocin|mesh-list
83996727|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
83996728|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83996729|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996730|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83996731|NCT02814409|Plasminogen|plasminogen|mesh-list
83996732|NCT02814409|Tenecteplase|tenecteplase|mesh-list
83996733|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83996734|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83996735|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996736|NCT01227902|Ezogabine|ezogabine|mesh-list
83996737|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
83996738|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996739|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996740|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83996741|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83996742|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83996743|NCT00946192|Desogestrel|desogestrel|mesh-list
83996744|NCT00946192|Estradiol|estradiol|mesh-list
83996745|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83996746|NCT00946192|Progesterone|progesterone|mesh-list
83996747|NCT00946192|Estrogens|estrogens|mesh-ancestor
83996748|NCT00946192|Hormones|hormones|mesh-ancestor
83996749|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83996750|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996751|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83996752|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
83996753|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83996754|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83996755|NCT00946192|Progestins|progestins|mesh-ancestor
83996756|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83996757|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83996758|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83996759|NCT01037127|Trametinib|trametinib|mesh-list
83996760|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996761|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83996762|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996763|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996764|NCT02806999|Insulin|insulin|mesh-list
83996765|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83996766|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996767|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996768|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
83996769|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
83996770|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83996771|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83996772|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996773|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996774|NCT00946114|Urological Agents|urological agents|mesh-ancestor
83996775|NCT00627471|Insulin|insulin|mesh-list
83996776|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83996777|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
83996778|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83996779|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996780|NCT04302441|Capecitabine|capecitabine|mesh-list
83996781|NCT04302441|Vinorelbine|vinorelbine|mesh-list
83996782|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83996783|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
83996784|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996785|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048335|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
83996786|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83996787|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83996788|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83996789|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83996790|NCT02800447|Procarbazine|procarbazine|mesh-list
83996791|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996792|NCT05520619|Paclitaxel|paclitaxel|mesh-list
83996793|NCT05520619|Tislelizumab|tislelizumab|mesh-list
83996794|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83996795|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996796|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
83996797|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
83996798|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
83996799|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996800|NCT05520619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83996801|NCT01038921|Melatonin|melatonin|mesh-list
83996802|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
83996803|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996804|NCT01038921|Protective Agents|protective agents|mesh-ancestor
83996805|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996806|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996807|NCT02856568|Cisplatin|cisplatin|mesh-list
83996808|NCT02856568|Gemcitabine|gemcitabine|mesh-list
83996809|NCT02856568|Ricolinostat|ricolinostat|mesh-list
83996810|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996811|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83996812|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
83996813|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996814|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83996815|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996816|NCT04081831|Aspirin|aspirin|mesh-list
83996817|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83996818|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996819|NCT04081831|Analgesics|analgesics|mesh-ancestor
83996820|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
83996821|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996822|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996823|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83996824|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996825|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83996826|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83996827|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996828|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83996829|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83996830|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996831|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
83996832|NCT01081912|Hydrocodone|hydrocodone|mesh-list
83996833|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83996834|NCT01081912|Narcotics|narcotics|mesh-ancestor
83996835|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996836|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996837|NCT01081912|Analgesics|analgesics|mesh-ancestor
83996838|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
83996839|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996840|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
83996841|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996842|NCT01038609|Acetaminophen|acetaminophen|mesh-list
83996843|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83996844|NCT01038609|Morphine|morphine|mesh-list
83996845|NCT01038609|Hydrocodone|hydrocodone|mesh-list
83996846|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83996847|NCT01038609|Narcotics|narcotics|mesh-ancestor
83996848|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996849|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996850|NCT01038609|Analgesics|analgesics|mesh-ancestor
83996851|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
83996852|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996853|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83996854|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
83996855|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
83996856|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
83996857|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83996858|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83996859|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996860|NCT02857582|Metronidazole|metronidazole|mesh-list
83996861|NCT02857582|Vancomycin|vancomycin|mesh-list
83996862|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996863|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83996864|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83996865|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83996866|NCT04301895|Remifentanil|remifentanil|mesh-list
83996867|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83996868|NCT04301895|Narcotics|narcotics|mesh-ancestor
83996869|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996870|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996872|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
83996873|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996874|NCT02853526|Propranolol|propranolol|mesh-list
83996875|NCT02853526|Warfarin|warfarin|mesh-list
83996876|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
83996877|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83996878|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83996879|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
83996880|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996881|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996882|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996883|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83996884|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83996885|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
83996886|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
83996887|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83996888|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996889|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83996890|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83996891|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996892|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996893|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
83996894|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996895|NCT04269460|Bupivacaine|bupivacaine|mesh-list
83996896|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
83996897|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
83996898|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996899|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996900|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
83996901|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996902|NCT04236115|Felypressin|felypressin|mesh-list
83996903|NCT04236115|Carticaine|carticaine|mesh-list
83996904|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
83996905|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
83996906|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996907|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996908|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
83996909|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83996910|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83996911|NCT02853370|Rituximab|rituximab|mesh-list
83996912|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83996913|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83996914|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996915|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
83996916|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996917|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83996918|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83996919|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
83996920|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996921|NCT02690155|Vitamin K|vitamin k|mesh-list
83996922|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
83996923|NCT02690155|Vitamins|vitamins|mesh-ancestor
83996924|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
83996925|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996926|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83996927|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
83996928|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83996929|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
83996930|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996931|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996932|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
83996933|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83996934|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83996935|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
83996936|NCT02690155|Coagulants|coagulants|mesh-ancestor
83996937|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
83996938|NCT02806375|Busulfan|busulfan|mesh-list
83996939|NCT02806375|Fludarabine|fludarabine|mesh-list
83996940|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
83996941|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83996942|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
83996943|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996944|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236647|NCT03214003|Cisplatin|cisplatin|mesh-list
83996945|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83996946|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
83996947|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996948|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83996949|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83996950|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83996951|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
83996952|NCT04273984|Misoprostol|misoprostol|mesh-list
83996953|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83996954|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
83996955|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83996956|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996957|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83996958|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83996959|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
83996960|NCT00943852|Losartan|losartan|mesh-list
83996961|NCT00943852|Isosorbide|isosorbide|mesh-list
83996962|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83996963|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83996964|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83996965|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83996966|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83996967|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83996968|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996969|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83996970|NCT00943852|Diuretics|diuretics|mesh-ancestor
83996971|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
83996972|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996973|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
83996974|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83996975|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
83996976|NCT02853136|BI 409306|bi 409306|mesh-list
83996977|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83996978|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83996979|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83996980|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83996981|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83996982|NCT02853136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83996983|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83996984|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83996985|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83996986|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83996987|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
83996988|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83996989|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
83996990|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83996991|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83996992|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83996993|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83996994|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83996995|NCT02806141|Colistin|colistin|mesh-list
83996996|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83996997|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83996998|NCT04235959|Tirzepatide|tirzepatide|mesh-list
83996999|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997000|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997001|NCT04235959|Incretins|incretins|mesh-ancestor
83997002|NCT04235959|Hormones|hormones|mesh-ancestor
83997003|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997004|NCT00952276|Vaccines|vaccines|mesh-list
83997005|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
83997006|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997007|NCT02805829|Trastuzumab|trastuzumab|mesh-list
83997008|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83997009|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997010|NCT02856178|Caspofungin|caspofungin|mesh-list
83997011|NCT02856178|Olorofim|olorofim|mesh-list
83997012|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
83997013|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997014|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997015|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997016|NCT02800135|Furosemide|furosemide|mesh-list
83997017|NCT02800135|Diuretics|diuretics|mesh-ancestor
83997018|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
83236723|NCT03113500|Prednisone|prednisone|mesh-list
83997019|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997020|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83997021|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83997022|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997023|NCT02799901|Nivolumab|nivolumab|mesh-list
83997024|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83997025|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997026|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83997027|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997028|NCT02802163|Dexamethasone|dexamethasone|mesh-list
83997029|NCT02802163|Lenalidomide|lenalidomide|mesh-list
83997030|NCT02802163|Panobinostat|panobinostat|mesh-list
83997031|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997032|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
83997033|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
83997034|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997035|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997036|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83997037|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
83997038|NCT02802163|Hormones|hormones|mesh-ancestor
83997039|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997040|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997041|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997042|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
83997043|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83997044|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83997045|NCT02802163|Growth Substances|growth substances|mesh-ancestor
83997046|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
83997047|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83997048|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997049|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997050|NCT02805049|Caspofungin|caspofungin|mesh-list
83997051|NCT02805049|Micafungin|micafungin|mesh-list
83997052|NCT02805049|Echinocandins|echinocandins|mesh-list
83997053|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
83997054|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997055|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997056|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997057|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
83997058|NCT02799589|Remifentanil|remifentanil|mesh-list
83997059|NCT02799589|Ropivacaine|ropivacaine|mesh-list
83997060|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83997061|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997062|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997063|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997064|NCT02799589|Analgesics|analgesics|mesh-ancestor
83997065|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
83997066|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997067|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83997068|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83997069|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83997070|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
83997071|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997072|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997073|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
83997074|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
83997075|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83997076|NCT02799589|Narcotics|narcotics|mesh-ancestor
83997077|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83997078|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997079|NCT02801383|Interferons|interferons|mesh-list
83997080|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997081|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
83997082|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997083|NCT02799355|Interferons|interferons|mesh-list
83997084|NCT02799355|Ribavirin|ribavirin|mesh-list
83997085|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
83997086|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997087|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
83236796|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83236797|NCT03087071|Panitumumab|panitumumab|mesh-list
83236798|NCT03087071|Trametinib|trametinib|mesh-list
83236799|NCT03087071|Antibodies|antibodies|mesh-list
83236800|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
83236801|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236802|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
83997088|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997089|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
83997090|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997091|NCT02801305|Diltiazem|diltiazem|mesh-list
83997092|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
83997093|NCT02801305|Petrolatum|petrolatum|mesh-list
83997094|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
83997095|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83997096|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83997097|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83997098|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997099|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83997100|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997101|NCT02801305|Emollients|emollients|mesh-ancestor
83997102|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
83997103|NCT00637975|Pregabalin|pregabalin|mesh-list
83997104|NCT00637975|Oxycodone|oxycodone|mesh-list
83997105|NCT00637975|Analgesics|analgesics|mesh-ancestor
83997106|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
83997107|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997108|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997109|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
83997110|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83997111|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83997112|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997113|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83997114|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83997115|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83997116|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997117|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83997118|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83997119|NCT00637975|Narcotics|narcotics|mesh-ancestor
83997120|NCT02801227|Oxytocin|oxytocin|mesh-list
83997121|NCT02801227|Dinoprostone|dinoprostone|mesh-list
83997122|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
83997123|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83997124|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997125|NCT02795299|Folic Acid|folic acid|mesh-list
83997126|NCT02795299|Methotrexate|methotrexate|mesh-list
83997127|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83997128|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
83997129|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83997130|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997131|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83997132|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
83997133|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997134|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997135|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
83997136|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997137|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83997138|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997139|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
83997140|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997141|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83997142|NCT02795299|Hematinics|hematinics|mesh-ancestor
83997143|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
83997144|NCT02795299|Vitamins|vitamins|mesh-ancestor
83997145|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
83997146|NCT02799277|Testosterone|testosterone|mesh-list
83997147|NCT02799277|Androgens|androgens|mesh-ancestor
83997148|NCT02799277|Hormones|hormones|mesh-ancestor
83997149|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997150|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997151|NCT01198002|Methotrexate|methotrexate|mesh-list
83997152|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83997153|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
83997154|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83997155|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997156|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83997157|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
83997158|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997159|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997160|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
83997161|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997162|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83997163|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997164|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
83997165|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997166|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83997167|NCT02795065|Enoxaparin|enoxaparin|mesh-list
83997168|NCT02795065|Bemiparin|bemiparin|mesh-list
83997169|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
83997170|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83997171|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83997172|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997173|NCT04233697|Romidepsin|romidepsin|mesh-list
83997174|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83997175|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997176|NCT04233697|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83997177|NCT04233697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997178|NCT04233697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997179|NCT05470699|Fluorides|fluorides|mesh-list
83997180|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
83997181|NCT05470699|Protective Agents|protective agents|mesh-ancestor
83997182|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997183|NCT03826303|Ethanol|ethanol|mesh-list
83997184|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83997185|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997186|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997187|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997188|NCT02798653|Progesterone|progesterone|mesh-list
83997189|NCT02798653|Progestins|progestins|mesh-ancestor
83997190|NCT02798653|Hormones|hormones|mesh-ancestor
83997191|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997192|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997193|NCT03863587|Ramucirumab|ramucirumab|mesh-list
83997194|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997195|NCT04233463|Budesonide|budesonide|mesh-list
83997196|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997197|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83997198|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
83997199|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997200|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997201|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83997202|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83997203|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
83997204|NCT04233463|Hormones|hormones|mesh-ancestor
83997205|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997206|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
83997207|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83997208|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
83997209|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997210|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
83997211|NCT02793739|Protective Agents|protective agents|mesh-ancestor
83997212|NCT02793505|Metformin|metformin|mesh-list
83997213|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997214|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997215|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83997216|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83997217|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997218|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
83997219|NCT04234321|Mitogens|mitogens|mesh-list
83997220|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
83997221|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997222|NCT02797717|Prednisone|prednisone|mesh-list
83997223|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
83997224|NCT02797717|Dacarbazine|dacarbazine|mesh-list
83997225|NCT02797717|Doxorubicin|doxorubicin|mesh-list
83997226|NCT02797717|Etoposide|etoposide|mesh-list
83997227|NCT02797717|Vincristine|vincristine|mesh-list
83997228|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997229|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
83997230|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997231|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997232|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83997233|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
84048336|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
83997234|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997235|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997236|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83997237|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83997238|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83997239|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83997240|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997241|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997242|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
83997243|NCT02797717|Hormones|hormones|mesh-ancestor
83997244|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997245|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997246|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83997247|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83997248|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83997249|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83997250|NCT04235569|Enoxaparin|enoxaparin|mesh-list
83997251|NCT04235569|Warfarin|warfarin|mesh-list
83997252|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
83997253|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
83997254|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83997255|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83997256|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997257|NCT01197378|Cysteamine|cysteamine|mesh-list
83997258|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83997259|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997260|NCT02792491|Prednisone|prednisone|mesh-list
83997261|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
83997262|NCT02792491|Rituximab|rituximab|mesh-list
83997263|NCT02792491|Doxorubicin|doxorubicin|mesh-list
83997264|NCT02792491|Vincristine|vincristine|mesh-list
83997265|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997266|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
83997267|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997268|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997269|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83997270|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
83997271|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997272|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997273|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83997274|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83997275|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83997276|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83997277|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83997278|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997279|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997280|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
83997281|NCT02792491|Hormones|hormones|mesh-ancestor
83997282|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997283|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997284|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83997285|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
83997286|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
83997287|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83997288|NCT02792803|Latanoprost|latanoprost|mesh-list
83997289|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83997290|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83997291|NCT02797249|Aspirin|aspirin|mesh-list
83997292|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
83997293|NCT02797249|Salicylates|salicylates|mesh-list
83997294|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83997295|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997296|NCT02797249|Analgesics|analgesics|mesh-ancestor
83997297|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
83997298|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997299|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997300|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997301|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997302|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83997303|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83997304|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997305|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83997306|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83997307|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997308|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
83997309|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997310|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
83997311|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
83997312|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
83997313|NCT02792335|Warfarin|warfarin|mesh-list
83997314|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
83997315|NCT02792335|Dabigatran|dabigatran|mesh-list
83997316|NCT02792335|Apixaban|apixaban|mesh-list
83997317|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
83997318|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83997319|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
83997320|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83997321|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
83997322|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997323|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997324|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
83997325|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83997326|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997327|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
83997328|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83997329|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997330|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997331|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997332|NCT04200235|Analgesics|analgesics|mesh-ancestor
83997333|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
83997334|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997335|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83997336|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83997337|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83997338|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
83997339|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997340|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997341|NCT02791243|Finasteride|finasteride|mesh-list
83997342|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83997343|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83997344|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997345|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997346|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997347|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997348|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997349|NCT02791243|Urological Agents|urological agents|mesh-ancestor
83997350|NCT02797015|Ozanimod|ozanimod|mesh-list
83997351|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83997352|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997353|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997354|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
83997355|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997356|NCT02796859|Siltuximab|siltuximab|mesh-list
83997357|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997358|NCT03803761|Fulvestrant|fulvestrant|mesh-list
83997359|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997360|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997361|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83997362|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83997363|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997364|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997365|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997366|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
83997367|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
83997368|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
83997369|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997370|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997371|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
83997372|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997373|NCT01196988|Vaccines|vaccines|mesh-list
83997374|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
83997375|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997376|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
83997377|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83997378|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997379|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997380|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83997381|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83997382|NCT02796469|Protective Agents|protective agents|mesh-ancestor
83997383|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997384|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
83997385|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83997386|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
83997387|NCT02796157|Everolimus|everolimus|mesh-list
83997388|NCT02796157|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83997389|NCT02796157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237098|NCT02595424|Temozolomide|temozolomide|mesh-list
83997390|NCT02796157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997391|NCT02796157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997392|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997393|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
83997394|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997395|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997396|NCT01196052|Trastuzumab|trastuzumab|mesh-list
83997397|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83997399|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83997400|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997401|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83997402|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
83997403|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
83997404|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
83997405|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997406|NCT01196052|Immunotoxins|immunotoxins|mesh-ancestor
83997407|NCT01196052|Immunoconjugates|immunoconjugates|mesh-ancestor
83997408|NCT01196052|Immunologic Factors|immunologic factors|mesh-ancestor
83997409|NCT01196052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997410|NCT02689921|Trastuzumab|trastuzumab|mesh-list
83997411|NCT02689921|Pertuzumab|pertuzumab|mesh-list
83997412|NCT02689921|Letrozole|letrozole|mesh-list
83997413|NCT02689921|Anastrozole|anastrozole|mesh-list
83997414|NCT02689921|Leuprolide|leuprolide|mesh-list
83997415|NCT02689921|Exemestane|exemestane|mesh-list
83997416|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83997417|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997418|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83997419|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83997420|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997421|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997422|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83997423|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997424|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997425|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997426|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997427|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83997428|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
83997429|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83997430|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
83997431|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
83997432|NCT03116425|Vitamins|vitamins|mesh-ancestor
83997433|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
83997434|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997435|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
83997436|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83997437|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997438|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997439|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997440|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
83997441|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83997442|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83997443|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83997444|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83997445|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997446|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
83997447|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997448|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997449|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83997450|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997451|NCT03028519|Vitamin D|vitamin d|mesh-list
83997452|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
83997453|NCT03028519|Vitamins|vitamins|mesh-ancestor
83997454|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
83997455|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997456|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83997457|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83997458|NCT02786641|Cisplatin|cisplatin|mesh-list
83997459|NCT02786641|Docetaxel|docetaxel|mesh-list
83997460|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997461|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
83997462|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
83997463|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
83997464|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997465|NCT02787967|Beclomethasone|beclomethasone|mesh-list
83997466|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
83997467|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83997468|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
83997469|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997470|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997471|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83997472|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
83997473|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83997474|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83997475|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83997476|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
83997477|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997478|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997479|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997480|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
83997481|NCT02787967|Hormones|hormones|mesh-ancestor
83997482|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997483|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83997484|NCT02788123|Pantoprazole|pantoprazole|mesh-list
83997485|NCT02788123|Bismuth|bismuth|mesh-list
83997486|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83997487|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83997488|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83997489|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997490|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997491|NCT02788123|Antacids|antacids|mesh-ancestor
83997492|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997493|NCT01194804|Eculizumab|eculizumab|mesh-list
83997494|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83997495|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997496|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
83997497|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997498|NCT02785549|Acetaminophen|acetaminophen|mesh-list
83997499|NCT02785549|Amoxicillin|amoxicillin|mesh-list
83997500|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
83997501|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
83997502|NCT02785549|Ibuprofen|ibuprofen|mesh-list
83997503|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997504|NCT02785549|Analgesics|analgesics|mesh-ancestor
83997505|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
83997506|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997507|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997508|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
83997509|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83997510|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997511|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997512|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83997513|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997514|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997515|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83997516|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997517|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83997518|NCT02785705|Vaccines|vaccines|mesh-list
83997519|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
83997520|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997521|NCT02821507|Sirolimus|sirolimus|mesh-list
83997522|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
83997523|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997524|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
83997525|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997526|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997527|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83997528|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
83997529|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997530|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997531|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83997532|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83997533|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997534|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83997535|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
83997536|NCT02785393|Doxazosin|doxazosin|mesh-list
83997537|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83237250|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997538|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83997539|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83997540|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83997541|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
83997542|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997543|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997544|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997545|NCT02787031|Anesthetics|anesthetics|mesh-list
83997546|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997547|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997548|NCT02784223|Choline|choline|mesh-list
83997549|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
83997550|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83997551|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
83997552|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997553|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83997554|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83997555|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
83997556|NCT05262751|Nintedanib|nintedanib|mesh-list
83997557|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997558|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83997559|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997560|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997561|NCT04231123|Anesthetics|anesthetics|mesh-list
83997562|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
83997563|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997564|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997565|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
83997566|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997567|NCT04231279|Secretin|secretin|mesh-list
83997568|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83997569|NCT04231279|Hormones|hormones|mesh-ancestor
83997570|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997571|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997572|NCT02782273|Ketorolac|ketorolac|mesh-list
83997573|NCT02782273|Morphine|morphine|mesh-list
83997574|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83997575|NCT02782273|Narcotics|narcotics|mesh-ancestor
83997576|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997577|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997578|NCT02782273|Analgesics|analgesics|mesh-ancestor
83997579|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
83997580|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997581|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83997582|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997583|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997584|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997585|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83997586|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997587|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997588|NCT05342389|Apatinib|apatinib|mesh-list
83997589|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997590|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83997591|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997592|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997593|NCT02268175|Prednisone|prednisone|mesh-list
83997594|NCT02268175|Leuprolide|leuprolide|mesh-list
83997595|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
83997596|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997597|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
83997598|NCT02268175|Hormones|hormones|mesh-ancestor
83997599|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997600|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997601|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997602|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997603|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83997604|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
83997605|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83997606|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83997607|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048337|NCT04231760|Protective Agents|protective agents|mesh-ancestor
83997608|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997609|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997610|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83997611|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
83997612|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83997613|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
83997614|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997615|NCT02783989|Protective Agents|protective agents|mesh-ancestor
83997616|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997617|NCT02782429|Ketamine|ketamine|mesh-list
83997618|NCT02782429|Analgesics|analgesics|mesh-ancestor
83997619|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
83997620|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997621|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997622|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83997623|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83997624|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
83997625|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
83997626|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997627|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83997628|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83997629|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997630|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997631|NCT04229719|Melatonin|melatonin|mesh-list
83997632|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
83997633|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997634|NCT04229719|Protective Agents|protective agents|mesh-ancestor
83997635|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997636|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997637|NCT01855867|Tenofovir|tenofovir|mesh-list
83997638|NCT01855867|Emtricitabine|emtricitabine|mesh-list
83997639|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
83997640|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997641|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83997642|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83997643|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997644|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997645|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83997646|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83997647|NCT02689843|Metformin|metformin|mesh-list
83997648|NCT02689843|Pioglitazone|pioglitazone|mesh-list
83997649|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
83997650|NCT02689843|Spironolactone|spironolactone|mesh-list
83997651|NCT02689843|Cyproterone|cyproterone|mesh-list
83997652|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997653|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997654|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83997655|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997656|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997657|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83997658|NCT02689843|Diuretics|diuretics|mesh-ancestor
83997659|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
83997660|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
83997661|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997662|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83997663|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
83997664|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83997665|NCT05166577|Valganciclovir|valganciclovir|mesh-list
83997666|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
83997667|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83997668|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997669|NCT05166577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83997670|NCT05166577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997671|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
83997672|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997673|NCT05341999|Ibuprofen|ibuprofen|mesh-list
83997674|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83997675|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997676|NCT05341999|Analgesics|analgesics|mesh-ancestor
83997677|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
83997678|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997679|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997680|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997681|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997682|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83997683|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997684|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997685|NCT02781805|Alendronate|alendronate|mesh-list
83997686|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83997687|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997689|NCT02781493|Laxatives|laxatives|mesh-ancestor
83997690|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83997691|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83997692|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83997693|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
83997694|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997695|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997696|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997697|NCT02783053|Metformin|metformin|mesh-list
83997698|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997699|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997700|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83997701|NCT02781415|Morphine|morphine|mesh-list
83997702|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83997703|NCT02781415|Narcotics|narcotics|mesh-ancestor
83997704|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997705|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997706|NCT02781415|Analgesics|analgesics|mesh-ancestor
83997707|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
83997708|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997709|NCT02785003|Acetaminophen|acetaminophen|mesh-list
83997710|NCT02785003|Ketamine|ketamine|mesh-list
83997711|NCT02785003|Morphine|morphine|mesh-list
83997712|NCT02785003|Narcotics|narcotics|mesh-list
83997713|NCT02785003|Alvimopan|alvimopan|mesh-list
83997714|NCT02785003|Analgesics|analgesics|mesh-ancestor
83997715|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
83997716|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997717|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997718|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83997719|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83997720|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
83997721|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
83997722|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997723|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83997724|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83997725|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997726|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997727|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83997728|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997729|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
83997730|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83997731|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83997732|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83997733|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997734|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997735|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83997736|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997737|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997738|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997739|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
83997740|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83997741|NCT02782897|Antibodies|antibodies|mesh-list
83997742|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
83997743|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997744|NCT00638131|Bosentan|bosentan|mesh-list
83997745|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83997746|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83997747|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997748|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
83997749|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83997750|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83997751|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997752|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
83997753|NCT02780245|Coagulants|coagulants|mesh-ancestor
83997754|NCT05340985|Vitamin D|vitamin d|mesh-list
83997755|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
83997756|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
83997757|NCT05340985|Calcifediol|calcifediol|mesh-list
83997758|NCT05340985|Vitamins|vitamins|mesh-list
83997759|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
83997760|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
83997761|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
83997762|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997763|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83997764|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83997765|NCT05340985|Provitamins|provitamins|mesh-ancestor
83997766|NCT02784457|Cetrorelix|cetrorelix|mesh-list
83997767|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83997768|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
83997769|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83997770|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997771|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997772|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997773|NCT02780323|Celecoxib|celecoxib|mesh-list
83997774|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83997775|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997776|NCT02780323|Analgesics|analgesics|mesh-ancestor
83997777|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
83997778|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997779|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997780|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997781|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83997782|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83997783|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83997784|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997785|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997786|NCT05331859|Insulin|insulin|mesh-list
83997787|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997788|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997789|NCT04229407|Vitamins|vitamins|mesh-list
83997790|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
83997791|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
83997792|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997793|NCT04231435|Metformin|metformin|mesh-list
83997794|NCT04231435|Digoxin|digoxin|mesh-list
83997795|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83997796|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997797|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997798|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83997799|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83997800|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
83997801|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997802|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83997803|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83997804|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997805|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83997806|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83997807|NCT04231435|Protective Agents|protective agents|mesh-ancestor
83997808|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83997809|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83997810|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997811|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997812|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83997813|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83997814|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997815|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83997816|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997817|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
83997818|NCT05028829|Atorvastatin|atorvastatin|mesh-list
83997819|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83997820|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83997821|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
83997822|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997823|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83997824|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83997825|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997826|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83997827|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83997828|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83997829|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997830|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997831|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83997832|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83997833|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997834|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
83997835|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997836|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
83997837|NCT05322031|Aripiprazole|aripiprazole|mesh-list
83997839|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83997840|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83997841|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83997842|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997843|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997844|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
83997845|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
83997846|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997847|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997848|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83997849|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83997850|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
83997851|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83997852|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83997853|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83997854|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83997855|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83997856|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83997857|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997858|NCT02780011|Immunotoxins|immunotoxins|mesh-ancestor
83997859|NCT02780011|Immunoconjugates|immunoconjugates|mesh-ancestor
83997860|NCT02780011|Immunologic Factors|immunologic factors|mesh-ancestor
83997861|NCT02780011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997862|NCT02780479|Dexamethasone|dexamethasone|mesh-list
83997863|NCT02780479|Prednisone|prednisone|mesh-list
83997864|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83997865|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
83997866|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
83997867|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997868|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997869|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83997870|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
83997871|NCT02780479|Hormones|hormones|mesh-ancestor
83997872|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997873|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997874|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997875|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83997876|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
83997877|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83997878|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
83997879|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997880|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83997881|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83997882|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83997883|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997884|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997885|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83997886|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83997887|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83997888|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83997889|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83997890|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997891|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
83997892|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997893|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997894|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83997895|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997896|NCT02779387|Goserelin|goserelin|mesh-list
83997897|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83997898|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997899|NCT04228315|Primaquine|primaquine|mesh-list
83997900|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
83997901|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83997902|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83997903|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997904|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
83997905|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
84048338|NCT04218565|Golimumab|golimumab|mesh-list
83997906|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997907|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83997908|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997909|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83997910|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
83237641|NCT00244933|Genistein|genistein|mesh-list
83997911|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997912|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83997913|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997914|NCT02779777|Tipifarnib|tipifarnib|mesh-list
83997915|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997916|NCT05069545|Insulin|insulin|mesh-list
83997917|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83997918|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
83997919|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997920|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997921|NCT05279833|Sotalol|sotalol|mesh-list
83997922|NCT05279833|Dronedarone|dronedarone|mesh-list
83997923|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83997924|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83997925|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
83997926|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997927|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997928|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997929|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83997930|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
83997931|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
83997932|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997933|NCT01880359|Nimorazole|nimorazole|mesh-list
83997934|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83997935|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83997936|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83997937|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997938|NCT04975555|Siltuximab|siltuximab|mesh-list
83997939|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83997940|NCT05338489|Itraconazole|itraconazole|mesh-list
83997941|NCT05338489|Rifampin|rifampin|mesh-list
83997942|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
83997943|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83997944|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83997945|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83997946|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83997947|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997948|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83997949|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
83997950|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83997951|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997952|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83997953|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83997954|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
83997955|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83997956|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
83997957|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83997958|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83997959|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83997960|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83997961|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83997962|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83997963|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83997964|NCT05266417|Insulin|insulin|mesh-list
83997965|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83997966|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997967|NCT02779465|Vitamin D|vitamin d|mesh-list
83997968|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
83997969|NCT02779465|Vitamins|vitamins|mesh-ancestor
83997970|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
83997971|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997972|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83997973|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83997974|NCT02776189|Midazolam|midazolam|mesh-list
83997975|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
83997976|NCT02776189|Propofol|propofol|mesh-list
83997977|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83997978|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83997979|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83997980|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83997981|NCT02776189|Analgesics|analgesics|mesh-ancestor
83997982|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
83997983|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83997984|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83997985|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83997986|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83997987|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
83997988|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83997989|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83997990|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83997991|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
83997992|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
83997993|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83997994|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83997995|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83997996|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83997997|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
83997998|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
83997999|NCT01194258|Insulin|insulin|mesh-list
83998000|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83998001|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
83998002|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
83998003|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
83998004|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
83998005|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998006|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998007|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
83998008|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
83998009|NCT04883437|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83998010|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998011|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998012|NCT04883437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83998013|NCT04883437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998014|NCT04883437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998015|NCT02775877|Letrozole|letrozole|mesh-list
83998016|NCT02775877|Clomiphene|clomiphene|mesh-list
83998017|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998018|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83998019|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83998020|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998021|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998022|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83998023|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
83998024|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998025|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998026|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83998027|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
83998028|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83998029|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83998030|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83998031|NCT02777671|Gliclazide|gliclazide|mesh-list
83998032|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83998033|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
83998034|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83998035|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83998036|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83998037|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998038|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998039|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998040|NCT02778919|Leuprolide|leuprolide|mesh-list
83998041|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83998042|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
83998043|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83998044|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998045|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83998046|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998047|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83998048|NCT02779153|Hormones|hormones|mesh-ancestor
83998049|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998050|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998051|NCT04226443|Midazolam|midazolam|mesh-list
83998052|NCT04226443|Remifentanil|remifentanil|mesh-list
83998053|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83998054|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83998055|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998056|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998057|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83998058|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83998059|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83998060|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998061|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
83998062|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
83998063|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
83998064|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
83998065|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998066|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998067|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83998068|NCT04226443|Narcotics|narcotics|mesh-ancestor
83998069|NCT04226443|Analgesics|analgesics|mesh-ancestor
83998070|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
83998071|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998072|NCT02776891|Citric Acid|citric acid|mesh-list
83998073|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
83998074|NCT02776891|Gallium citrate|gallium citrate|mesh-list
83998075|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
83998076|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83998077|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
83998078|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
83998079|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998080|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83998081|NCT02776813|Rituximab|rituximab|mesh-list
83998082|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998083|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998084|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
83998085|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998086|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998087|NCT05157997|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83998088|NCT05157997|Antibodies|antibodies|mesh-list
83998089|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
83998090|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998091|NCT05157997|Antiviral Agents|antiviral agents|mesh-ancestor
83998092|NCT05157997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998093|NCT02773147|Pyridoxine|pyridoxine|mesh-list
83998094|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
83998095|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
83998096|NCT02773147|Hematinics|hematinics|mesh-ancestor
83998097|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
83998098|NCT02773147|Vitamins|vitamins|mesh-ancestor
83998099|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
83998100|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998101|NCT02773927|Metformin|metformin|mesh-list
83998102|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998103|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998104|NCT02773459|Capecitabine|capecitabine|mesh-list
83998105|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83998106|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
83998107|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998108|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998109|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
83998110|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83998111|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83998112|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998113|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83998114|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83998115|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998116|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998117|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998118|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83998119|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
83998120|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83998121|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998122|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83998123|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83998124|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83998125|NCT04771741|Acetaminophen|acetaminophen|mesh-list
83998126|NCT04771741|Ketorolac|ketorolac|mesh-list
83998127|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83998128|NCT04771741|Meloxicam|meloxicam|mesh-list
83998129|NCT04771741|Pregabalin|pregabalin|mesh-list
83998130|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
83998131|NCT04771741|Analgesics|analgesics|mesh-ancestor
83998132|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
83998133|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237852|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998134|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998135|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
83998136|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83998137|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83998138|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998139|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83998140|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83998141|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83998142|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998143|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83998144|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83998145|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83998146|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998147|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998148|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83998149|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998150|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
83998151|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83998152|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83998153|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
83998154|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83998155|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83998156|NCT02772601|Metoprolol|metoprolol|mesh-list
83998157|NCT02772601|Midazolam|midazolam|mesh-list
83998158|NCT02772601|Caffeine|caffeine|mesh-list
83998159|NCT02772601|Omeprazole|omeprazole|mesh-list
83998160|NCT02772601|Warfarin|warfarin|mesh-list
83998161|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83998162|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83998163|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998164|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998165|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83998166|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83998167|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83998168|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998169|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
83998170|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
83998171|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
83998172|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
83998173|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998174|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998175|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
83998176|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83998177|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83998178|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998179|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83998180|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83998181|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
83998182|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83998183|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998184|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83998185|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83998186|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83998187|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
83998188|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
83998189|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998190|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83998191|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83998192|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83998193|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
83998194|NCT02772211|Cycloserine|cycloserine|mesh-list
83998195|NCT02772211|Ketamine|ketamine|mesh-list
83998196|NCT02772211|Analgesics|analgesics|mesh-ancestor
83998197|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
83998198|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998199|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998200|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83998201|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998202|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
83998203|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
83998204|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998205|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83998206|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83998207|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998208|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998209|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83998210|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998211|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83237928|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83998213|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83998214|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
83998215|NCT04225195|Amphotericin B|amphotericin b|mesh-list
83998216|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83998217|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
83998218|NCT04225195|Amebicides|amebicides|mesh-ancestor
83998219|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83998220|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83998221|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998222|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83998223|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
83998224|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83998225|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
83998226|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998227|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998228|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83998229|NCT04225195|Protective Agents|protective agents|mesh-ancestor
83998230|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998231|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998232|NCT02771509|Mitogens|mitogens|mesh-list
83998233|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
83998234|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998235|NCT02696941|Metformin|metformin|mesh-list
83998236|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83998237|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998238|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998239|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998240|NCT02767375|Fluorouracil|fluorouracil|mesh-list
83998241|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
83998242|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
83998243|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998244|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83998245|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998246|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998247|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
83998248|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998249|NCT02767219|Dexamethasone|dexamethasone|mesh-list
83998250|NCT02767219|Bevacizumab|bevacizumab|mesh-list
83998251|NCT02767219|Fluorouracil|fluorouracil|mesh-list
83998252|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998253|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998254|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83998255|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83998256|NCT02767219|Growth Substances|growth substances|mesh-ancestor
83998257|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998258|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
83998259|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998260|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
83998261|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
83998262|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998263|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998264|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
83998265|NCT02767219|Hormones|hormones|mesh-ancestor
83998266|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998267|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83998268|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
83998269|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998270|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83998271|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998272|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
83998273|NCT02771587|Ethanol|ethanol|mesh-list
83998274|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83998275|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998276|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998277|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998278|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
83998279|NCT02771743|Ifosfamide|ifosfamide|mesh-list
83998280|NCT02771743|Carboplatin|carboplatin|mesh-list
83998281|NCT02771743|Doxorubicin|doxorubicin|mesh-list
83998282|NCT02771743|Etoposide|etoposide|mesh-list
83998283|NCT02771743|Interleukin-2|interleukin-2|mesh-list
83998284|NCT02771743|Isotretinoin|isotretinoin|mesh-list
83998285|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998286|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
83238006|NCT00002650|Folic Acid|folic acid|mesh-list
83998287|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998288|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998289|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83998290|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
83998291|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998292|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998293|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83998294|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83998295|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83998296|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83998297|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998298|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83998299|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83998301|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
83998302|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998303|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
83998304|NCT02762851|Vaccines|vaccines|mesh-list
83998305|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
83998306|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998307|NCT02767063|Pioglitazone|pioglitazone|mesh-list
83998308|NCT02767063|Avelumab|avelumab|mesh-list
83998309|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998310|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998311|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998312|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998313|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
83998314|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83998315|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
83998316|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998317|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998318|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83998319|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
83998320|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83998321|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
83998322|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998323|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998324|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83998325|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
83998326|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
83998327|NCT04224103|Protective Agents|protective agents|mesh-ancestor
83998328|NCT02766439|Etanercept|etanercept|mesh-list
83998329|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83998330|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83998331|NCT02766439|Analgesics|analgesics|mesh-ancestor
83998332|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
83998333|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998334|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998335|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998336|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998337|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998338|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998339|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
83998340|NCT04701307|Niraparib|niraparib|mesh-list
83998341|NCT04701307|Dostarlimab|dostarlimab|mesh-list
83998342|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
83998343|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
83998344|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
83998345|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998346|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83998347|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998348|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998349|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998350|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
83998351|NCT02765971|Cathartics|cathartics|mesh-ancestor
83998352|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998353|NCT02765815|Ketorolac|ketorolac|mesh-list
83998354|NCT02765815|Epinephrine|epinephrine|mesh-list
83998355|NCT02765815|Racepinephrine|racepinephrine|mesh-list
83998356|NCT02765815|Morphine|morphine|mesh-list
83998357|NCT02765815|Bupivacaine|bupivacaine|mesh-list
83998358|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
83998359|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
83998360|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
83998361|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998362|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998363|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
83998364|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998365|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83998366|NCT02765815|Narcotics|narcotics|mesh-ancestor
83998367|NCT02765815|Analgesics|analgesics|mesh-ancestor
83998368|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83998369|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83998370|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
83998371|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998372|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998373|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83998374|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83998375|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
83998376|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83998377|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
83998378|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
83998379|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
83998380|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83998381|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83998382|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83998383|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998384|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998385|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83998386|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998387|NCT02765347|Metformin|metformin|mesh-list
83998388|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998389|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998390|NCT02770885|Dulaglutide|dulaglutide|mesh-list
83998391|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998392|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998393|NCT02770651|Everolimus|everolimus|mesh-list
83998394|NCT02770651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83998395|NCT02770651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83998396|NCT02770651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998397|NCT02770651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998398|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998399|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
83998400|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998401|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998402|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
83998403|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83998404|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83998405|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998406|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83998407|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83998408|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998409|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998410|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998411|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83998412|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
83998413|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83998414|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998415|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83998416|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83998417|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83998418|NCT02770105|Caffeine|caffeine|mesh-list
83998419|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83998420|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998421|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83998422|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998423|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998424|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83998425|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83998426|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
83998427|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998428|NCT02769793|Levodopa|levodopa|mesh-list
83998429|NCT02769793|Benserazide|benserazide|mesh-list
83998430|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83998431|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83998432|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83998433|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
83998434|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998435|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998436|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998437|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998438|NCT02769325|Ketorolac|ketorolac|mesh-list
83998439|NCT02769325|Atropine|atropine|mesh-list
83998440|NCT02769325|Morphine|morphine|mesh-list
83998441|NCT02769325|Propofol|propofol|mesh-list
83998442|NCT02769325|Sevoflurane|sevoflurane|mesh-list
83998443|NCT02769325|Rocuronium|rocuronium|mesh-list
83998444|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83998445|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998446|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998447|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998448|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
83998449|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
83998450|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83998451|NCT02769325|Narcotics|narcotics|mesh-ancestor
83998452|NCT02769325|Analgesics|analgesics|mesh-ancestor
83998453|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
83998454|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998455|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83998456|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83998457|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83998458|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83998459|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998460|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998461|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83998462|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998463|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998464|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83998465|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83998466|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83998467|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83998468|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83998469|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83998470|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
83998471|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83998472|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
83998473|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
83998474|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
83998475|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83998476|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83998477|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
83998478|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998479|NCT02770261|Candesartan|candesartan|mesh-list
83998480|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
83998481|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83998482|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83998483|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83998484|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
83998485|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998486|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83998487|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83998488|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998489|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83998490|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83998491|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83998492|NCT04224649|Lidocaine|lidocaine|mesh-list
83998493|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
83998494|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
83998495|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
83998496|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998497|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998498|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
83998499|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998500|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83998501|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83998502|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83998503|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83998504|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998505|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83998506|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
83998507|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
83998508|NCT04224649|Protective Agents|protective agents|mesh-ancestor
83998509|NCT02769169|Ranibizumab|ranibizumab|mesh-list
83998510|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83998511|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83998512|NCT02769169|Growth Substances|growth substances|mesh-ancestor
83998513|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998514|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
83998515|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998516|NCT02769013|Praziquantel|praziquantel|mesh-list
83998517|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
83998518|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83998519|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998520|NCT02768545|Ezetimibe|ezetimibe|mesh-list
83998521|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83998522|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83998523|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
83998524|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998525|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83998526|NCT02764723|Bupivacaine|bupivacaine|mesh-list
83998527|NCT02764723|Ropivacaine|ropivacaine|mesh-list
83998528|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
83998529|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
83998530|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998531|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998532|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
83998533|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998534|NCT04664959|Denosumab|denosumab|mesh-list
83998535|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83998536|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998537|NCT00951496|Paclitaxel|paclitaxel|mesh-list
83998538|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83998539|NCT00951496|Bevacizumab|bevacizumab|mesh-list
83998540|NCT00951496|Cisplatin|cisplatin|mesh-list
83998541|NCT00951496|Carboplatin|carboplatin|mesh-list
83998542|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83998543|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
83998544|NCT00951496|Antibodies|antibodies|mesh-list
83998545|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
83998546|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83998547|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
83998548|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83998549|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998550|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
83998551|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
83998552|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
83998553|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998554|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83998555|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83998556|NCT00951496|Growth Substances|growth substances|mesh-ancestor
83998557|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998558|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
83998559|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
83998560|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83998561|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83998562|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83998563|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83998564|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83998565|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
83998566|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998567|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998568|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998569|NCT02768077|Melatonin|melatonin|mesh-list
83998570|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
83998571|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998572|NCT02768077|Protective Agents|protective agents|mesh-ancestor
83998573|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998574|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998575|NCT01193244|Prednisone|prednisone|mesh-list
83998576|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998577|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
83998578|NCT01193244|Hormones|hormones|mesh-ancestor
83998579|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998580|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998581|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83998582|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998583|NCT04224337|Doxorubicin|doxorubicin|mesh-list
83998584|NCT04224337|Durvalumab|durvalumab|mesh-list
83998585|NCT04224337|Ifosfamide|ifosfamide|mesh-list
83998586|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83998587|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238299|NCT05253781|Aspirin|aspirin|mesh-list
83998588|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83998589|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83998590|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998591|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998592|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998593|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83998594|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
83998596|NCT02767999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83998597|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83998598|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83998599|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998600|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998601|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
83998602|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998603|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83998604|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
83998605|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83998606|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83998607|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83998608|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998609|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83998610|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998611|NCT02762617|Tenofovir|tenofovir|mesh-list
83998612|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
83998613|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998614|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83998615|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83998616|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998617|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998618|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83998619|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83998620|NCT01192152|Metformin|metformin|mesh-list
83998621|NCT01192152|Saxagliptin|saxagliptin|mesh-list
83998622|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998623|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998624|NCT01192152|Incretins|incretins|mesh-ancestor
83998625|NCT01192152|Hormones|hormones|mesh-ancestor
83998626|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998627|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83998628|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
83998629|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998630|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998631|NCT04572451|Nivolumab|nivolumab|mesh-list
83998632|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998633|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998634|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83998635|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998636|NCT02758249|Propofol|propofol|mesh-list
83998637|NCT02758249|Sevoflurane|sevoflurane|mesh-list
83998638|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83998639|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998640|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998641|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998642|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
83998643|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
83998644|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83998645|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83998646|NCT02758405|Fentanyl|fentanyl|mesh-list
83998647|NCT02758405|Bupivacaine|bupivacaine|mesh-list
83998648|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
83998649|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
83998650|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998651|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998652|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
83998653|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998654|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83998655|NCT02758405|Narcotics|narcotics|mesh-ancestor
83998656|NCT02758405|Analgesics|analgesics|mesh-ancestor
83998657|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83998658|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998659|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
83998660|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83998661|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83998663|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83998664|NCT02758327|Laxatives|laxatives|mesh-ancestor
83998665|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998666|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
83998667|NCT02763475|Fludarabine|fludarabine|mesh-list
83998668|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998669|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
83998670|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998671|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998672|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83998673|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
83998674|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998675|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998676|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83998677|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83998678|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
83998679|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998680|NCT02758015|Betaine|betaine|mesh-list
83998681|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998682|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
83998683|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83998684|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
83998685|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998686|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83998687|NCT02757703|Terlipressin|terlipressin|mesh-list
83998688|NCT02757703|Pantoprazole|pantoprazole|mesh-list
83998689|NCT02757703|Somatostatin|somatostatin|mesh-list
83998690|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83998691|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998692|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83998693|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998694|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998695|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83998696|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83998697|NCT02757703|Hormones|hormones|mesh-ancestor
83998698|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998699|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998700|NCT02763007|Pioglitazone|pioglitazone|mesh-list
83998701|NCT02763007|Alogliptin|alogliptin|mesh-list
83998702|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83998703|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998704|NCT02763007|Incretins|incretins|mesh-ancestor
83998705|NCT02763007|Hormones|hormones|mesh-ancestor
83998706|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998707|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83998708|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83998709|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998710|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998711|NCT00635323|Capecitabine|capecitabine|mesh-list
83998712|NCT00635323|Irinotecan|irinotecan|mesh-list
83998713|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83998714|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
83998715|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998716|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998717|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83998718|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83998719|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998720|NCT01191840|Vancomycin|vancomycin|mesh-list
83998721|NCT01191840|Cefazolin|cefazolin|mesh-list
83998722|NCT01191840|Daptomycin|daptomycin|mesh-list
83998723|NCT01191840|Cloxacillin|cloxacillin|mesh-list
83998724|NCT01191840|Oxacillin|oxacillin|mesh-list
83998725|NCT01191840|Nafcillin|nafcillin|mesh-list
83998726|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83998727|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998728|NCT02752555|Antioxidants|antioxidants|mesh-list
83998729|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998730|NCT02752555|Protective Agents|protective agents|mesh-ancestor
83998731|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998732|NCT00624546|Lansoprazole|lansoprazole|mesh-list
83998733|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
83998734|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83998735|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83998736|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83998737|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238478|NCT02638259|GP2015|gp2015|mesh-list
83998738|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998739|NCT02757469|Drospirenone|drospirenone|mesh-list
83998740|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83998741|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83998742|NCT02757469|Estradiol|estradiol|mesh-list
83998743|NCT02757469|Estrogens|estrogens|mesh-ancestor
83998744|NCT02757469|Hormones|hormones|mesh-ancestor
83998745|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998746|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998747|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83998748|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
83998749|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83998750|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83998751|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83998752|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83998753|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83998754|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
83998755|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83998756|NCT02757469|Diuretics|diuretics|mesh-ancestor
83998757|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
83998758|NCT02757391|Aldesleukin|aldesleukin|mesh-list
83998759|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
83998760|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
83998761|NCT02757391|Interleukin-2|interleukin-2|mesh-list
83998762|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
83998763|NCT02757391|Immunomodulating Agents|immunomodulating agents|mesh-list
83998764|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998765|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998766|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998767|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83998768|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
83998769|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998770|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998771|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83998772|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998773|NCT02757391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83998774|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83998775|NCT02757391|Analgesics|analgesics|mesh-ancestor
83998776|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
83998777|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998778|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83998779|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83998780|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
83998781|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998782|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
83998783|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998784|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998785|NCT04564417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83998786|NCT04564417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998787|NCT02757079|Melatonin|melatonin|mesh-list
83998788|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
83998789|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998790|NCT02757079|Protective Agents|protective agents|mesh-ancestor
83998791|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998792|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998793|NCT02768389|Bevacizumab|bevacizumab|mesh-list
83998794|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83998795|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998796|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83998797|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83998798|NCT02768389|Growth Substances|growth substances|mesh-ancestor
83998799|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998800|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
83998801|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
83998802|NCT04529005|Giapreza|giapreza|mesh-list
83998803|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
83998804|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83998805|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83998806|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
83998807|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998808|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998809|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
83998810|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83998811|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
83998812|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
83998813|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998814|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998815|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83998817|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
83998818|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998819|NCT00943072|Aflibercept|aflibercept|mesh-list
83998820|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83998821|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83998822|NCT00943072|Growth Substances|growth substances|mesh-ancestor
83998823|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998824|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
83998825|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998826|NCT04222855|Diltiazem|diltiazem|mesh-list
83998827|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83998828|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83998829|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83998830|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998831|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83998832|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998833|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
83998834|NCT00942994|Amlodipine|amlodipine|mesh-list
83998835|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83998836|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83998837|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83998838|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83998839|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998840|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83998841|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998842|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
83998843|NCT00942994|Diuretics|diuretics|mesh-ancestor
83998844|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
83998845|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83998846|NCT04268602|Anesthetics|anesthetics|mesh-list
83998847|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
83998848|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998849|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998850|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
83998851|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998852|NCT04314336|Coal Tar|coal tar|mesh-list
83998853|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
83998854|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
83998855|NCT00624702|Maleic acid|maleic acid|mesh-list
83998856|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998857|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998858|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
83998859|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83998860|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
83998861|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83998862|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998863|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
83998864|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
83998865|NCT02199184|Prednisone|prednisone|mesh-list
83998866|NCT02199184|Cortisone|cortisone|mesh-list
83998867|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
83998868|NCT02199184|Rituximab|rituximab|mesh-list
83998869|NCT02199184|Doxorubicin|doxorubicin|mesh-list
83998870|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83998871|NCT02199184|Etoposide|etoposide|mesh-list
83998872|NCT02199184|Vincristine|vincristine|mesh-list
83998873|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
83998874|NCT02199184|Ofatumumab|ofatumumab|mesh-list
83998875|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
83998876|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83998877|NCT02199184|Antibodies|antibodies|mesh-list
83998878|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
83998879|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83998880|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998881|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
83998882|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998883|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83998884|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83998885|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
83998886|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998887|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998888|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83998889|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83998890|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83998891|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83998892|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998893|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998894|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
83998895|NCT02199184|Hormones|hormones|mesh-ancestor
83998896|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998897|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83998898|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83998899|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
83998900|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
83998901|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
83998902|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
83998903|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
83998904|NCT05378100|Midazolam|midazolam|mesh-list
83998905|NCT05378100|Ketamine|ketamine|mesh-list
83998906|NCT05378100|Analgesics|analgesics|mesh-ancestor
83998907|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
83998908|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998909|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998910|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83998911|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998912|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
83998913|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
83998914|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998915|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83998916|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83998917|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83998918|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998919|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83998920|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83998921|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83998922|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83998923|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83998924|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
83998925|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
83998926|NCT02752477|Anesthetics|anesthetics|mesh-list
83998927|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
83998928|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998929|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998930|NCT04204096|Vaccines|vaccines|mesh-list
83998931|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
83998932|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998933|NCT05376852|Decitabine|decitabine|mesh-list
83998934|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83998935|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
83998936|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998937|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998938|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998939|NCT00061282|Clotrimazole|clotrimazole|mesh-list
83998940|NCT00061282|Miconazole|miconazole|mesh-list
83998941|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83998942|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998943|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
83998944|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83998945|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83998946|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998947|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998948|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83998949|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
83998950|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998951|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998952|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83998953|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83998954|NCT05657496|Triamcinolone|triamcinolone|mesh-list
83998955|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83998956|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83998957|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83998958|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83998959|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
83998960|NCT05657496|Hormones|hormones|mesh-ancestor
83998961|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998962|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998963|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83998964|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
83998965|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83998966|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83998967|NCT04268524|Miltefosine|miltefosine|mesh-list
83998968|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
83998969|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83998970|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83998971|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83998972|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83998973|NCT02855632|Hormones|hormones|mesh-list
83998974|NCT02855632|Progesterone|progesterone|mesh-list
83998975|NCT02855632|Lenograstim|lenograstim|mesh-list
83998976|NCT02855632|Estrogens|estrogens|mesh-list
83998977|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83998978|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998979|NCT02855632|Progestins|progestins|mesh-ancestor
83998980|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83998981|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
83998982|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
83998983|NCT04220281|Propofol|propofol|mesh-list
83998984|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83998985|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998986|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998987|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83998988|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
83998989|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
83998990|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
83998991|NCT02751619|Lidocaine|lidocaine|mesh-list
83998992|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
83998993|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
83998994|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83998995|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83998996|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
83998997|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83998998|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83998999|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83999000|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83999001|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83999002|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999003|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
83999004|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83999005|NCT02751541|Protective Agents|protective agents|mesh-ancestor
83999006|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999007|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999008|NCT02755753|Lansoprazole|lansoprazole|mesh-list
83999009|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
83999010|NCT02755753|Rebamipide|rebamipide|mesh-list
83999011|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83999012|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83999013|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83999014|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999015|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999016|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
83999017|NCT02755753|Protective Agents|protective agents|mesh-ancestor
83999018|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999019|NCT02755909|Anesthetics|anesthetics|mesh-list
83999020|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999021|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999022|NCT02761291|Valganciclovir|valganciclovir|mesh-list
83999023|NCT02761291|Gemcitabine|gemcitabine|mesh-list
83999024|NCT02761291|Valproic Acid|valproic acid|mesh-list
83999025|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83999026|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
83999027|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999028|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999029|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
83999030|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999031|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
83999032|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999033|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999034|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
83999035|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83999036|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999037|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999038|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
83999039|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999040|NCT01187550|Hormones|hormones|mesh-list
83999041|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999042|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999043|NCT02855866|Acetaminophen|acetaminophen|mesh-list
83999044|NCT02855866|Dexamethasone|dexamethasone|mesh-list
83999045|NCT02855866|Cortisone|cortisone|mesh-list
83999046|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
83999047|NCT02855866|BB 1101|bb 1101|mesh-list
83999048|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999049|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
83999050|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
83999051|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999052|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999053|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83999054|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
83999055|NCT02855866|Hormones|hormones|mesh-ancestor
83999056|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999057|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83999058|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999059|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83999060|NCT02855866|Analgesics|analgesics|mesh-ancestor
83999061|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
83999062|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
83999063|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999064|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999065|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999066|NCT02751307|Metformin|metformin|mesh-list
83999067|NCT02751307|Clozapine|clozapine|mesh-list
83999068|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999069|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999070|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83999071|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
83999072|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999073|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999074|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83999075|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83999076|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999077|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999078|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
83999079|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
83999080|NCT00638209|Insulin|insulin|mesh-list
83999081|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83999082|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999083|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999084|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83999085|NCT05429671|Gentamicins|gentamicins|mesh-list
83999086|NCT05429671|Tobramycin|tobramycin|mesh-list
83999087|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999088|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83999089|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999090|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999091|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
83999092|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83999093|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999094|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
83999095|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999096|NCT02754817|Liraglutide|liraglutide|mesh-list
83999097|NCT02754817|Xultophy|xultophy|mesh-list
83999098|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999099|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999100|NCT02754817|Incretins|incretins|mesh-ancestor
83999101|NCT02754817|Hormones|hormones|mesh-ancestor
83999102|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999103|NCT04230031|Daratumumab|daratumumab|mesh-list
83999104|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999105|NCT01186458|Rituximab|rituximab|mesh-list
83999106|NCT01186458|Fludarabine|fludarabine|mesh-list
83999107|NCT01186458|Bortezomib|bortezomib|mesh-list
83999108|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83999109|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999110|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
83999111|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999112|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999113|NCT01185366|Everolimus|everolimus|mesh-list
83238843|NCT02330029|Pinaverium|pinaverium|mesh-list
83999114|NCT01185366|Sunitinib|sunitinib|mesh-list
83999115|NCT01185366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83999116|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999117|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999118|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999119|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999120|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
83999121|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999122|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999123|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83999124|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83999125|NCT01185366|Growth Substances|growth substances|mesh-ancestor
83999126|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
83999127|NCT01185288|Adalimumab|adalimumab|mesh-list
83999128|NCT01185288|Methotrexate|methotrexate|mesh-list
83999129|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83999130|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
83999131|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83999132|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999133|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83999134|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
83999135|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999136|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999137|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999138|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999139|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83999140|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999141|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
83999142|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999143|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83999144|NCT01185288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83999145|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999146|NCT01184118|Fluticasone|fluticasone|mesh-list
83999147|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999148|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83999149|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
83999150|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999151|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999152|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83999153|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
83999154|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999155|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83999156|NCT01183884|Tretinoin|tretinoin|mesh-list
83999157|NCT01183884|Isotretinoin|isotretinoin|mesh-list
83999158|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999159|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
83999160|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999161|NCT05344248|Antibodies|antibodies|mesh-list
83999162|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83999163|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
83999164|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999165|NCT01191762|Sevelamer|sevelamer|mesh-list
83999166|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
83999167|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
83999168|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999169|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
83999170|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83999171|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
83999172|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83999173|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999174|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999175|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999176|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
83999177|NCT01723774|Anastrozole|anastrozole|mesh-list
83999178|NCT01723774|Goserelin|goserelin|mesh-list
83999179|NCT01723774|Palbociclib|palbociclib|mesh-list
83999180|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83999181|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999182|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83999183|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83999184|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999185|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999186|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83999187|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
83999188|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999189|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999190|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999191|NCT02855788|Leucovorin|leucovorin|mesh-list
83999192|NCT02855788|Paclitaxel|paclitaxel|mesh-list
83999193|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
83999194|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83999195|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999196|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
83999197|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
83999198|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
83999199|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999200|NCT02855788|Antidotes|antidotes|mesh-ancestor
83999201|NCT02855788|Protective Agents|protective agents|mesh-ancestor
83999202|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999203|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
83999204|NCT02855788|Vitamins|vitamins|mesh-ancestor
83999205|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
83999206|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83999207|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83999208|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83999209|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83999210|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999211|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999212|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999213|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
83999214|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999215|NCT01190436|Bisoprolol|bisoprolol|mesh-list
83999216|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83999217|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
83999218|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
83999219|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999220|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999221|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83999222|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83999223|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83999224|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83999225|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999226|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999227|NCT02852122|Choline|choline|mesh-list
83999228|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
83999229|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83999230|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
83999231|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999232|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83999233|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83999234|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
83999235|NCT01035255|Enalapril|enalapril|mesh-list
83999236|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83999237|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83999238|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999239|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999240|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999241|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83999242|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83999243|NCT00602524|Pilocarpine|pilocarpine|mesh-list
83999244|NCT00602524|Miotics|miotics|mesh-ancestor
83999245|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
83999246|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999247|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999248|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83999249|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83999250|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
83999251|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999252|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999253|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83999254|NCT01189890|Glimepiride|glimepiride|mesh-list
83999255|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999256|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999257|NCT01189890|Incretins|incretins|mesh-ancestor
83999258|NCT01189890|Hormones|hormones|mesh-ancestor
83999259|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999260|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83999261|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999262|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048339|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83999263|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999264|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83999265|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999266|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
83999267|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
83999268|NCT01189812|Citalopram|citalopram|mesh-list
83999269|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
83999270|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999271|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999272|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999273|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
83999274|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83999275|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999276|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999277|NCT01189812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83999278|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83999279|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83999280|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999281|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
83999282|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83999283|NCT01189500|Tamoxifen|tamoxifen|mesh-list
83999284|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83999285|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83999286|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
83999287|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999288|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999289|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83999290|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999291|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83999292|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83999293|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83999294|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83999295|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83999296|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83999297|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999298|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999299|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
83999300|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999301|NCT00938860|Cyclosporine|cyclosporine|mesh-list
83999302|NCT00938860|Tacrolimus|tacrolimus|mesh-list
83999303|NCT00938860|Cyclosporins|cyclosporins|mesh-list
83999304|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999305|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
83999306|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999307|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83999308|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999309|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999310|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
83999311|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999312|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999313|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999314|NCT00604396|Insulin|insulin|mesh-list
83999315|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83999316|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
83999317|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
83999318|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
83999319|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
83999320|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999321|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999322|NCT00938470|Docetaxel|docetaxel|mesh-list
83999323|NCT00938470|Fluorouracil|fluorouracil|mesh-list
83999324|NCT00938470|Capecitabine|capecitabine|mesh-list
83999325|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
83999326|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999327|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
83999328|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
83999329|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
83999330|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999331|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
83999332|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83999333|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999334|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
83999335|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999336|NCT00602680|Donepezil|donepezil|mesh-list
83999337|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83999338|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999339|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999340|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
83999341|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999342|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999343|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
83999344|NCT00938392|Vaccines|vaccines|mesh-list
83999345|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
83999346|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999347|NCT02851888|Ropivacaine|ropivacaine|mesh-list
83999348|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
83999349|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999350|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999351|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
83999352|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
83999353|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999354|NCT05381428|Indomethacin|indomethacin|mesh-list
83999355|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83999356|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83999357|NCT05381428|Analgesics|analgesics|mesh-ancestor
83999358|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
83999359|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999360|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999361|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999362|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999363|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
83999364|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
83999365|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83999366|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83999367|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999368|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999369|NCT01022853|Nintedanib|nintedanib|mesh-list
83999370|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999371|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999372|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999373|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999374|NCT00937768|Leuprolide|leuprolide|mesh-list
83999375|NCT00937768|Goserelin|goserelin|mesh-list
83999376|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83999377|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
83999378|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83999379|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999380|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83999381|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999382|NCT00631228|Everolimus|everolimus|mesh-list
83999383|NCT00631228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83999384|NCT00631228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999385|NCT00631228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999386|NCT00631228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999387|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999388|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
83999389|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999390|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999391|NCT05381038|Paclitaxel|paclitaxel|mesh-list
83999392|NCT05381038|Docetaxel|docetaxel|mesh-list
83999393|NCT05381038|Irinotecan|irinotecan|mesh-list
83999394|NCT05381038|Azacitidine|azacitidine|mesh-list
83999395|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83999396|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999397|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83999398|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83999399|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83999400|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999401|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83999402|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83999403|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999404|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83999405|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
83999406|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
83999407|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83999408|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83999409|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999410|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
83999411|NCT05380960|Coagulants|coagulants|mesh-ancestor
83999412|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
83999413|NCT00604630|Hematinics|hematinics|mesh-ancestor
83999414|NCT01189266|Vorinostat|vorinostat|mesh-list
83999415|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999416|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83999417|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999418|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999419|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83999420|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83999421|NCT01188798|Methotrexate|methotrexate|mesh-list
83999422|NCT01188798|Pentostatin|pentostatin|mesh-list
83999423|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83999424|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
83999425|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83999426|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999427|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83999428|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
83999429|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999430|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999431|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999432|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999433|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83999434|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999435|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
83999436|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999437|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83999438|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83999439|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83999440|NCT01183104|Glimepiride|glimepiride|mesh-list
83999441|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999442|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999443|NCT01183104|Incretins|incretins|mesh-ancestor
83999444|NCT01183104|Hormones|hormones|mesh-ancestor
83999445|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999446|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83999447|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999448|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999449|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999450|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83999451|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999452|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
83999453|NCT02885688|Insulin|insulin|mesh-list
83999454|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999455|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999456|NCT00950248|Idebenone|idebenone|mesh-list
83999457|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
83999458|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999459|NCT00950248|Protective Agents|protective agents|mesh-ancestor
83999460|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999461|NCT04269928|Epinephrine|epinephrine|mesh-list
83999462|NCT04269928|Racepinephrine|racepinephrine|mesh-list
83999463|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
83999464|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83999465|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83999466|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
83999467|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999468|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999469|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999470|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83999471|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83999472|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
83999473|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999474|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83999475|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
83999476|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
83999477|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
83999478|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83999479|NCT00950170|Factor VIII|factor viii|mesh-list
83999480|NCT00950170|Coagulants|coagulants|mesh-ancestor
83999481|NCT00604864|Infliximab|infliximab|mesh-list
83999482|NCT00604864|Antibodies|antibodies|mesh-list
83999483|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83999484|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
83999485|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999486|NCT00604864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83999487|NCT00604864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999488|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999489|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83999490|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999491|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
83999492|NCT01227824|Dolutegravir|dolutegravir|mesh-list
83999493|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83999494|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83999495|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
83999496|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999497|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83999498|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83999499|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999500|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999501|NCT00949702|Vemurafenib|vemurafenib|mesh-list
83999502|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999503|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999504|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999505|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999506|NCT01034631|Everolimus|everolimus|mesh-list
83999507|NCT01034631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83999508|NCT01034631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999509|NCT01034631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999510|NCT01034631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999511|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999512|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
83999513|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999514|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999515|NCT01227668|Aripiprazole|aripiprazole|mesh-list
83999516|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
83999517|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999518|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83999519|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83999520|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999521|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999522|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
83999523|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
83999524|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999525|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999526|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83999527|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83999528|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
83999529|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83999530|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83999531|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83999532|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83999533|NCT01227512|Tolvaptan|tolvaptan|mesh-list
83999534|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83999535|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999536|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
83999537|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999538|NCT01227278|Benralizumab|benralizumab|mesh-list
83999539|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83999540|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83999541|NCT01227044|Naltrexone|naltrexone|mesh-list
83999542|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83999543|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83999544|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999545|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
83999546|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999547|NCT01034163|Panobinostat|panobinostat|mesh-list
83999548|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999549|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83999550|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999551|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999552|NCT01162122|Vaccines|vaccines|mesh-list
83999553|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
83999554|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999555|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83999556|NCT01033071|Olmesartan|olmesartan|mesh-list
83999557|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83999558|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
83999559|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83999560|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83999561|NCT01033071|Diuretics|diuretics|mesh-ancestor
83999562|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
83999563|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999564|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83999565|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83999566|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999567|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83999568|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83999569|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83999570|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
83999571|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999572|NCT04589325|Ixekizumab|ixekizumab|mesh-list
83999573|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
83999574|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83999575|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999576|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83999577|NCT02873559|Testosterone|testosterone|mesh-list
83999578|NCT02873559|Androgens|androgens|mesh-ancestor
83999579|NCT02873559|Hormones|hormones|mesh-ancestor
83999580|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999581|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999582|NCT01029795|Glyburide|glyburide|mesh-list
83999583|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999584|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999585|NCT02885454|Simeprevir|simeprevir|mesh-list
83999586|NCT02885454|Odalasvir|odalasvir|mesh-list
83999587|NCT02885454|Drospirenone|drospirenone|mesh-list
83999588|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83999589|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83999590|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83999591|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83999592|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83999593|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
83999594|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83999595|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999596|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83999597|NCT02885454|Estrogens|estrogens|mesh-ancestor
83999598|NCT02885454|Hormones|hormones|mesh-ancestor
83999599|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999600|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83999601|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
83999602|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83999603|NCT02885454|Diuretics|diuretics|mesh-ancestor
83999604|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
83999605|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
83999606|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999607|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999608|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999609|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999610|NCT01032837|Oseltamivir|oseltamivir|mesh-list
83999611|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
83999612|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999613|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999614|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999615|NCT01180296|Progesterone|progesterone|mesh-list
83999616|NCT01180296|Progestins|progestins|mesh-ancestor
83999617|NCT01180296|Hormones|hormones|mesh-ancestor
83999618|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999619|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999620|NCT01160640|Metronidazole|metronidazole|mesh-list
83999621|NCT01160640|Doxycycline|doxycycline|mesh-list
83999622|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
83999623|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999624|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83999625|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83999626|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83999627|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
83999628|NCT01160484|Lenalidomide|lenalidomide|mesh-list
83999629|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
83999630|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999631|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83999632|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83999633|NCT01160484|Growth Substances|growth substances|mesh-ancestor
83999634|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
83999635|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999636|NCT01032291|Lenalidomide|lenalidomide|mesh-list
83999637|NCT01032291|Cetuximab|cetuximab|mesh-list
83999638|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
83999639|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999640|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83999641|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83999642|NCT01032291|Growth Substances|growth substances|mesh-ancestor
83999643|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
83999644|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999645|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83999646|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
83999647|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999648|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999649|NCT02873871|Hemostatics|hemostatics|mesh-list
83999650|NCT02873871|Coagulants|coagulants|mesh-ancestor
83999651|NCT04301739|Paclitaxel|paclitaxel|mesh-list
83999652|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
83999653|NCT04301739|Carboplatin|carboplatin|mesh-list
83999654|NCT04301739|Doxorubicin|doxorubicin|mesh-list
83999655|NCT04301739|Epirubicin|epirubicin|mesh-list
83999656|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83999657|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999658|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
83999659|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
83999660|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
83999661|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999662|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999663|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
83999664|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999665|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999666|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83999667|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
83999668|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83999669|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83999670|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83999671|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83999672|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999673|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
83999674|NCT04301583|Procyanidin|procyanidin|mesh-list
83999675|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
83999676|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999677|NCT04301583|Protective Agents|protective agents|mesh-ancestor
83999678|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999679|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83999680|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83999681|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999682|NCT01021683|Itraconazole|itraconazole|mesh-list
83999683|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
83999684|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999685|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83999686|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83999687|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999688|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999689|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83999690|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83999691|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999692|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999693|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83999694|NCT04625725|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83999695|NCT04625725|Antiviral Agents|antiviral agents|mesh-ancestor
83999696|NCT04625725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999697|NCT01021215|Celecoxib|celecoxib|mesh-list
83999698|NCT01021215|Zileuton|zileuton|mesh-list
83999699|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83999700|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83999701|NCT01021215|Analgesics|analgesics|mesh-ancestor
83999702|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
83999703|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999704|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999705|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999706|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999707|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83152429|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
83999708|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83999709|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999710|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999711|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83999712|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83999713|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
83999714|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999715|NCT02760979|Denosumab|denosumab|mesh-list
83999716|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83999717|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999718|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
83999720|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
83999721|NCT02760901|Mannitol|mannitol|mesh-list
83999722|NCT02760901|Acetazolamide|acetazolamide|mesh-list
83999723|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83999724|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
83999725|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999726|NCT02760901|Expectorants|expectorants|mesh-ancestor
83999727|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
83999728|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83999729|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
83999730|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999731|NCT02760901|Protective Agents|protective agents|mesh-ancestor
83999732|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999733|NCT02760901|Antidotes|antidotes|mesh-ancestor
83999734|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83999735|NCT02760901|Diuretics|diuretics|mesh-ancestor
83999736|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
83999737|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
83999738|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83999739|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999740|NCT00635713|Fulvestrant|fulvestrant|mesh-list
83999741|NCT00635713|Anastrozole|anastrozole|mesh-list
83999742|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83999743|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999744|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83999745|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83999746|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
83999747|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999748|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999749|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83999750|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83999751|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999752|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999753|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
83999754|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
83999755|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999756|NCT02760823|Protective Agents|protective agents|mesh-ancestor
83999757|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999758|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
83999759|NCT02760823|Vitamins|vitamins|mesh-ancestor
83999760|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
83999761|NCT01020747|Bevacizumab|bevacizumab|mesh-list
83999762|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83999763|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999764|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83999765|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83999766|NCT01020747|Growth Substances|growth substances|mesh-ancestor
83999767|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999768|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
83999769|NCT02754739|Pravastatin|pravastatin|mesh-list
83999770|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83999771|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83999772|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
83999773|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999774|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83999775|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83999776|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999777|NCT02754583|Azithromycin|azithromycin|mesh-list
83999778|NCT02754583|Tetracycline|tetracycline|mesh-list
83999779|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83999780|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999781|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83999782|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999783|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999784|NCT01031979|Yohimbine|yohimbine|mesh-list
83999785|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
83999786|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
83999787|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999788|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999789|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83999790|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83999791|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83999792|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
83999793|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999794|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999795|NCT01031979|Urological Agents|urological agents|mesh-ancestor
83999796|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
83999797|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999798|NCT02753803|Pioglitazone|pioglitazone|mesh-list
83999799|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999800|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999801|NCT04219579|Antithrombins|antithrombins|mesh-list
83999802|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
83999803|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83999804|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999805|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999806|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999807|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
83999808|NCT00635401|Varenicline|varenicline|mesh-list
83999809|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83999810|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83999811|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
83999812|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999813|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999814|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999815|NCT02753725|Fentanyl|fentanyl|mesh-list
83999816|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83999817|NCT02753725|Narcotics|narcotics|mesh-ancestor
83999818|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999819|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999820|NCT02753725|Analgesics|analgesics|mesh-ancestor
83999821|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
83999822|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999823|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83999824|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83999825|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
83999826|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
83999827|NCT01020123|Glipizide|glipizide|mesh-list
83999828|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999829|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999830|NCT04300959|Cisplatin|cisplatin|mesh-list
83999831|NCT04300959|Gemcitabine|gemcitabine|mesh-list
83999832|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999833|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83999834|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
83999835|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999836|NCT02760355|Ribavirin|ribavirin|mesh-list
83999837|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
83999838|NCT02760355|Ledipasvir|ledipasvir|mesh-list
83999839|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
83999840|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999841|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
83999842|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83999843|NCT01028391|Metformin|metformin|mesh-list
83999844|NCT01028391|Pioglitazone|pioglitazone|mesh-list
83999845|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83999846|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83999847|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999848|NCT01028391|Incretins|incretins|mesh-ancestor
83999849|NCT01028391|Hormones|hormones|mesh-ancestor
83999850|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999851|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83999852|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
83999853|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999854|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999855|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83999856|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83999857|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83999858|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83999859|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999860|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999861|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999862|NCT01179672|Analgesics|analgesics|mesh-ancestor
83999863|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
83999864|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999865|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
83999866|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999867|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
83239596|NCT02031601|Docetaxel|docetaxel|mesh-list
83999868|NCT04301349|Misoprostol|misoprostol|mesh-list
83999869|NCT04301349|Dinoprostone|dinoprostone|mesh-list
83999870|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83999871|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
83999872|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83999873|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999874|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83999875|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83999876|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
83999878|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
83999879|NCT02753647|Rituximab|rituximab|mesh-list
83999880|NCT02753647|Doxorubicin|doxorubicin|mesh-list
83999881|NCT02753647|Vincristine|vincristine|mesh-list
83999882|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83999883|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
83999884|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999885|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999886|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83999887|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
83999888|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999889|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999890|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83999891|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83999892|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83999893|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83999894|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83999895|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999896|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999897|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
83999898|NCT02753647|Hormones|hormones|mesh-ancestor
83999899|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83999900|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83999901|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83999902|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
83999903|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
83999904|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
83999905|NCT02872389|Sevoflurane|sevoflurane|mesh-list
83999906|NCT02872389|Desflurane|desflurane|mesh-list
83999907|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83999908|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83999909|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
83999910|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
83999911|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999912|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999913|NCT01179516|Vortioxetine|vortioxetine|mesh-list
83999914|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
83999915|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83999916|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83999917|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83999918|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83999919|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999920|NCT01179516|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83999921|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83999922|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83999923|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999924|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999925|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
83999926|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83999927|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83999928|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83999929|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83999930|NCT00635791|Sorafenib|sorafenib|mesh-list
83999931|NCT00635791|Vorinostat|vorinostat|mesh-list
83999932|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999933|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999934|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999935|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999936|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83999937|NCT02760121|Acetazolamide|acetazolamide|mesh-list
83999938|NCT02760121|Methazolamide|methazolamide|mesh-list
83999939|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
83999940|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83999941|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999942|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999943|NCT02760121|Diuretics|diuretics|mesh-ancestor
83999944|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
83999945|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999946|NCT05215873|Misoprostol|misoprostol|mesh-list
83999947|NCT05215873|Oxytocin|oxytocin|mesh-list
83999948|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
83999949|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83999950|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999951|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83999952|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
83999953|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83999954|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83999955|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83999956|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83999957|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999958|NCT02750917|Etoricoxib|etoricoxib|mesh-list
83999959|NCT02750917|Lornoxicam|lornoxicam|mesh-list
83999960|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83999961|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83999962|NCT02750917|Analgesics|analgesics|mesh-ancestor
83999963|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
83999964|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83999965|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999966|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83999967|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83999968|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83999969|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83999970|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999971|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999972|NCT02750995|Azacitidine|azacitidine|mesh-list
83999973|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83999974|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
83999975|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999976|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83999977|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83999978|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83999979|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
83999980|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999981|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83999982|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83999983|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83999984|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83999985|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999986|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999987|NCT04299633|Calcium|calcium|mesh-list
83999988|NCT04299633|Sevelamer|sevelamer|mesh-list
83999989|NCT04299633|Calcium acetate|calcium acetate|mesh-list
83999990|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83999991|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83999992|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
83999993|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
83999994|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83999995|NCT02695459|Everolimus|everolimus|mesh-list
83999996|NCT02695459|Cisplatin|cisplatin|mesh-list
83999997|NCT02695459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83999998|NCT02695459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83999999|NCT02695459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000000|NCT02695459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000001|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84000002|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
84000003|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000004|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000005|NCT04288713|Eculizumab|eculizumab|mesh-list
84000006|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84000007|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84000008|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
84000009|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000010|NCT05112991|Lenvatinib|lenvatinib|mesh-list
84000011|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000012|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000013|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000014|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000015|NCT01030341|Insulin|insulin|mesh-list
84000016|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83239739|NCT03013933|Cyclosporins|cyclosporins|mesh-list
84000017|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000018|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000019|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
84000021|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84000022|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000023|NCT02750293|Vitamins|vitamins|mesh-ancestor
84000024|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
84000025|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84000026|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84000027|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84000028|NCT01026831|Timolol|timolol|mesh-list
84000029|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84000030|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84000031|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
84000032|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000033|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000034|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000035|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84000036|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84000037|NCT02750137|Tetracaine|tetracaine|mesh-list
84000038|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000039|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
84000040|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000041|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000042|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
84000043|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000044|NCT02760043|Dexamethasone|dexamethasone|mesh-list
84000045|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000046|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
84000047|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
84000048|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000049|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000050|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84000051|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
84000052|NCT02760043|Hormones|hormones|mesh-ancestor
84000053|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000054|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84000055|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000056|NCT02750059|Tenofovir|tenofovir|mesh-list
84000057|NCT02750059|Lamivudine|lamivudine|mesh-list
84000058|NCT02750059|Efavirenz|efavirenz|mesh-list
84000059|NCT02750059|Telmisartan|telmisartan|mesh-list
84000060|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
84000061|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000062|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84000063|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84000064|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000065|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000066|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84000067|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84000068|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84000069|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84000070|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84000071|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84000072|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84000073|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84000074|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84000075|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84000076|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84000077|NCT03893617|Propranolol|propranolol|mesh-list
84000078|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84000079|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84000080|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
84000081|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000082|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000083|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000084|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84000085|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84000086|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
84000087|NCT02749825|Goserelin|goserelin|mesh-list
84000088|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84000089|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84000090|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000091|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84000092|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000093|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
84000094|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84000095|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
84000096|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84000097|NCT02759107|Dulaglutide|dulaglutide|mesh-list
84000098|NCT02759107|Tirzepatide|tirzepatide|mesh-list
84000099|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000100|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000101|NCT02759107|Incretins|incretins|mesh-ancestor
84000102|NCT02759107|Hormones|hormones|mesh-ancestor
84000103|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000104|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84000105|NCT02758873|Montelukast|montelukast|mesh-list
84000106|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84000107|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
84000108|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000109|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000110|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84000111|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
84000112|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84000113|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84000114|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84000115|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
84000116|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000117|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000118|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84000119|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
84000120|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000121|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84000122|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84000123|NCT02749747|Sulpiride|sulpiride|mesh-list
84000124|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84000125|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84000126|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000127|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000128|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84000129|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84000130|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
84000131|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000132|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000133|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84000134|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
84000135|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
84000136|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84000137|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84000138|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84000139|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84000140|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000141|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
84000142|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000143|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000144|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84000145|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000146|NCT04359979|Tamsulosin|tamsulosin|mesh-list
84000147|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84000148|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84000149|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84000150|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
84000151|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000152|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000153|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000154|NCT04359979|Urological Agents|urological agents|mesh-ancestor
84000155|NCT04180813|Linagliptin|linagliptin|mesh-list
84000156|NCT04180813|Acarbose|acarbose|mesh-list
84000157|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000158|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000159|NCT04180813|Incretins|incretins|mesh-ancestor
84000160|NCT04180813|Hormones|hormones|mesh-ancestor
84000161|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000162|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84000163|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
84000164|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000165|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000166|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84000167|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
84000168|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84000169|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000170|NCT04116775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84000171|NCT04116775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000172|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
84000173|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84000174|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000175|NCT02749123|Lidocaine|lidocaine|mesh-list
84000176|NCT02749123|Menthol|menthol|mesh-list
84000177|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000178|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
84000179|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000180|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000181|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
84000182|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000183|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84000184|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84000185|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84000186|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84000187|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000188|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
84000189|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
84000190|NCT00635557|Carboplatin|carboplatin|mesh-list
84000191|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000192|NCT02748265|Epoprostenol|epoprostenol|mesh-list
84000193|NCT02748265|Phenylephrine|phenylephrine|mesh-list
84000194|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
84000195|NCT02748265|Tezosentan|tezosentan|mesh-list
84000196|NCT02748265|Propofol|propofol|mesh-list
84000197|NCT02748265|Sevoflurane|sevoflurane|mesh-list
84000198|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84000199|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000200|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000201|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84000202|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
84000203|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
84000204|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84000205|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84000206|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84000207|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
84000208|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
84000209|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000210|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
84000211|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84000212|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
84000213|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
84000214|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84000215|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84000216|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84000217|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
84000218|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000219|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000220|NCT02748265|Protective Agents|protective agents|mesh-ancestor
84000221|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84000222|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
84000223|NCT01015833|Doxorubicin|doxorubicin|mesh-list
84000224|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84000225|NCT01015833|Sorafenib|sorafenib|mesh-list
84000226|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84000227|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000228|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84000229|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84000230|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000231|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000232|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000233|NCT03523273|Liraglutide|liraglutide|mesh-list
84000234|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000235|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000236|NCT03523273|Incretins|incretins|mesh-ancestor
84000237|NCT03523273|Hormones|hormones|mesh-ancestor
84000238|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000239|NCT02695381|Etodolac|etodolac|mesh-list
84000241|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000242|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
84000243|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000244|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000245|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
84000246|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000247|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84000248|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84000249|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84000250|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84000251|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000252|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000253|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000254|NCT02695381|Analgesics|analgesics|mesh-ancestor
84000255|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000256|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000257|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84000258|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84000259|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000260|NCT02746783|Vaccines|vaccines|mesh-list
84000261|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
84000262|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000263|NCT02747953|Afatinib|afatinib|mesh-list
84000264|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000265|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000266|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000267|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000268|NCT02735239|Leucovorin|leucovorin|mesh-list
84000269|NCT02735239|Paclitaxel|paclitaxel|mesh-list
84000270|NCT02735239|Docetaxel|docetaxel|mesh-list
84000271|NCT02735239|Carboplatin|carboplatin|mesh-list
84000272|NCT02735239|Fluorouracil|fluorouracil|mesh-list
84000273|NCT02735239|Capecitabine|capecitabine|mesh-list
84000274|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
84000275|NCT02735239|Durvalumab|durvalumab|mesh-list
84000276|NCT02735239|Tremelimumab|tremelimumab|mesh-list
84000277|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84000278|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000279|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
84000280|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
84000281|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
84000282|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000283|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
84000284|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84000285|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84000286|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
84000287|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000288|NCT02735239|Antidotes|antidotes|mesh-ancestor
84000289|NCT02735239|Protective Agents|protective agents|mesh-ancestor
84000290|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
84000291|NCT02735239|Vitamins|vitamins|mesh-ancestor
84000292|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
84000293|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84000294|NCT02655523|Dexamethasone|dexamethasone|mesh-list
84000295|NCT02655523|Triamcinolone|triamcinolone|mesh-list
84000296|NCT02655523|Bupivacaine|bupivacaine|mesh-list
84000297|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000298|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
84000299|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
84000300|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000301|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000302|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84000303|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
84000304|NCT02655523|Hormones|hormones|mesh-ancestor
84000305|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000306|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84000307|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000308|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000309|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
84000310|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000311|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
84000312|NCT02644291|Mebendazole|mebendazole|mesh-list
84000313|NCT02644291|Piperazine|piperazine|mesh-list
84000314|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
84000315|NCT02644291|DMP 777|dmp 777|mesh-list
84000316|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
84000317|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
84000318|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84000319|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000320|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
84000321|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
84000322|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
84000323|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000324|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000325|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000326|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84000327|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84000328|NCT01015677|Estradiol|estradiol|mesh-list
84000329|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84000330|NCT01015677|Estrogens|estrogens|mesh-ancestor
84000331|NCT01015677|Hormones|hormones|mesh-ancestor
84000332|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000333|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000334|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84000335|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
84000336|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84000337|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84000338|NCT02281981|Curcumin|curcumin|mesh-list
84000339|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000340|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000341|NCT02281981|Analgesics|analgesics|mesh-ancestor
84000342|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
84000343|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000344|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000345|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000346|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000347|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000348|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000349|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000350|NCT04297839|Heparin|heparin|mesh-list
84000351|NCT04297839|Calcium heparin|calcium heparin|mesh-list
84000352|NCT04297839|Citric Acid|citric acid|mesh-list
84000353|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
84000354|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
84000355|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84000356|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
84000357|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
84000358|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000359|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84000360|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84000361|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84000362|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84000363|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
84000364|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
84000365|NCT04216459|Vitamin D|vitamin d|mesh-list
84000366|NCT04216459|Thiamine|thiamine|mesh-list
84000367|NCT04216459|Vitamins|vitamins|mesh-ancestor
84000368|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
84000369|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000370|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84000371|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84000372|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
84000373|NCT04216771|Cytarabine|cytarabine|mesh-list
84000374|NCT04216771|Idarubicin|idarubicin|mesh-list
84000375|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84000376|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
84000377|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000378|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000379|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
84000380|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000381|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84000382|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
84000383|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000384|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84000385|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84000386|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84000387|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000388|NCT00636259|Bicalutamide|bicalutamide|mesh-list
84000389|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
84000390|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
84000391|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000392|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000393|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000394|NCT02736019|Celecoxib|celecoxib|mesh-list
84000395|NCT02736019|Tramadol|tramadol|mesh-list
84000396|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000397|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000398|NCT02736019|Analgesics|analgesics|mesh-ancestor
84000399|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
84000400|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000401|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000402|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000403|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000404|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84000405|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84000406|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000407|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000408|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84000409|NCT02736019|Narcotics|narcotics|mesh-ancestor
84000410|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000411|NCT04284397|Aspirin|aspirin|mesh-list
84000412|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000413|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000414|NCT04284397|Analgesics|analgesics|mesh-ancestor
84000415|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
84000416|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000417|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000418|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000419|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000420|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84000421|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84000422|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000423|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84000424|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84000425|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000426|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
84000427|NCT05595889|Irinotecan|irinotecan|mesh-list
84000428|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84000429|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84000430|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000431|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000432|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000433|NCT02735395|Amoxicillin|amoxicillin|mesh-list
84000434|NCT02735395|Metronidazole|metronidazole|mesh-list
84000435|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84000436|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000437|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84000438|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84000439|NCT02741947|Levodopa|levodopa|mesh-list
84000440|NCT02741947|Benserazide|benserazide|mesh-list
84000441|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
84000442|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84000443|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84000444|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
84000445|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000446|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000447|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000448|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000449|NCT02740933|Demeclocycline|demeclocycline|mesh-list
84000450|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84000451|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000452|NCT02739685|Everolimus|everolimus|mesh-list
84000453|NCT02739685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84000454|NCT02739685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000455|NCT02739685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000456|NCT02739685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000457|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84000458|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
84000459|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000460|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000461|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
84000462|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
84000463|NCT02735317|Gentamicins|gentamicins|mesh-list
84000464|NCT02735317|Dexamethasone|dexamethasone|mesh-list
84000465|NCT02735317|Procaine|procaine|mesh-list
84000466|NCT02735317|Vitamins|vitamins|mesh-ancestor
84000467|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
84000468|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000469|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000470|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
84000471|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
84000472|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000473|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84000474|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
84000475|NCT02735317|Hormones|hormones|mesh-ancestor
84000476|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000477|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84000478|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000479|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
84000480|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84000481|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000482|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84000483|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000484|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000485|NCT02735317|Hematinics|hematinics|mesh-ancestor
84000486|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000487|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
84000488|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000489|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
84000490|NCT02739529|genexol-PM|genexol-pm|mesh-list
84000491|NCT02739529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000492|NCT02739529|Tubulin Modulators|tubulin modulators|mesh-ancestor
84000493|NCT02739529|Antimitotic Agents|antimitotic agents|mesh-ancestor
84000494|NCT02739529|Mitosis Modulators|mitosis modulators|mesh-ancestor
84000495|NCT02739529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000496|NCT05544721|Ropivacaine|ropivacaine|mesh-list
84000497|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000498|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
84000499|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000500|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000501|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
84000502|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000503|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84000504|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000505|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000506|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000507|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000508|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
84000509|NCT02739061|Sertraline|sertraline|mesh-list
84000510|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
84000511|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84000512|NCT02739061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84000513|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84000514|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84000515|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000516|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000517|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
84000518|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000519|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84000520|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84000521|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000522|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84000523|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84000524|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84000525|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000526|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84000527|NCT02745925|Ibuprofen|ibuprofen|mesh-list
84000528|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000529|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000530|NCT02745925|Analgesics|analgesics|mesh-ancestor
84000531|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
84000532|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000533|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000534|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000535|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000536|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84000537|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000538|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000539|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84000540|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
84000541|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000542|NCT02738905|Rifaximin|rifaximin|mesh-list
84000543|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84000544|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000545|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84000546|NCT02745691|Gefitinib|gefitinib|mesh-list
84000547|NCT02745691|Crizotinib|crizotinib|mesh-list
84000548|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000549|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000550|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000551|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000552|NCT02745769|Ramucirumab|ramucirumab|mesh-list
84000553|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000554|NCT02734069|Carboplatin|carboplatin|mesh-list
84000555|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000556|NCT02737813|Bupivacaine|bupivacaine|mesh-list
84000557|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000558|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
84000559|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000560|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000561|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
84000562|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000563|NCT00636415|Morphine|morphine|mesh-list
84000564|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84000565|NCT00636415|Narcotics|narcotics|mesh-ancestor
84000566|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000567|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000568|NCT00636415|Analgesics|analgesics|mesh-ancestor
84000569|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
84000570|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000571|NCT02733835|Remifentanil|remifentanil|mesh-list
84000572|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84000573|NCT02733835|Narcotics|narcotics|mesh-ancestor
84000574|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000575|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000576|NCT02733835|Analgesics|analgesics|mesh-ancestor
84000577|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
84000578|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000579|NCT02737423|Vitamin D|vitamin d|mesh-list
84000580|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
84000581|NCT02737423|Vitamins|vitamins|mesh-ancestor
84000582|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
84000583|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000584|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84000585|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84000586|NCT02733679|Metformin|metformin|mesh-list
84000587|NCT02733679|Pioglitazone|pioglitazone|mesh-list
84000588|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000589|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000590|NCT03289741|Octreotide|octreotide|mesh-list
84000591|NCT03289741|Lanreotide|lanreotide|mesh-list
84000592|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84000593|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84000594|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000595|NCT05473585|Nicotine|nicotine|mesh-list
84000596|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84000597|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
84000598|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000599|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000600|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84000601|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84000602|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
84000603|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000604|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000605|NCT05629429|Olaparib|olaparib|mesh-list
84000606|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84000607|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000608|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000609|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000610|NCT02744131|Metformin|metformin|mesh-list
84000611|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
84000612|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
84000613|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
84000614|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84000615|NCT02744131|Estradiol|estradiol|mesh-list
84000616|NCT02744131|Cyproterone|cyproterone|mesh-list
84000617|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000618|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000619|NCT02744131|Estrogens|estrogens|mesh-ancestor
84000620|NCT02744131|Hormones|hormones|mesh-ancestor
84000621|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000622|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84000623|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84000624|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
84000625|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
84000626|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000627|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84000628|NCT03326791|Aspirin|aspirin|mesh-list
84000629|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000630|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000631|NCT03326791|Analgesics|analgesics|mesh-ancestor
84000632|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
84000633|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000634|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000635|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000636|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000637|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84000638|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84000639|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000640|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84000641|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84000642|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000643|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
84000644|NCT02743975|Bevacizumab|bevacizumab|mesh-list
84000645|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84000646|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000647|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84000648|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84000649|NCT02743975|Growth Substances|growth substances|mesh-ancestor
84000650|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000651|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
84000652|NCT02743663|Albuterol|albuterol|mesh-list
84000653|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
84000654|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
84000655|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000656|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000657|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84000658|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
84000659|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
84000660|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84000661|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84000662|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84000663|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84000664|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
84000665|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000666|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000667|NCT02733445|Dasatinib|dasatinib|mesh-list
84000668|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000669|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000670|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000671|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000672|NCT02731105|Clindamycin|clindamycin|mesh-list
84000673|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
84000674|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
84000675|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
84000676|NCT02731105|Tretinoin|tretinoin|mesh-list
84000677|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84000678|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000679|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84000680|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000681|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000682|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000683|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
84000684|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
84000685|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000686|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000687|NCT02731105|Analgesics|analgesics|mesh-ancestor
84000688|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
84000689|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000690|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000691|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000692|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000693|NCT02743429|Dinutuximab|dinutuximab|mesh-list
84000694|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000695|NCT02730949|Folic Acid|folic acid|mesh-list
83240414|NCT03136705|Niacin|niacin|mesh-list
84000697|NCT02730949|Hematinics|hematinics|mesh-ancestor
84000698|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
84000699|NCT02730949|Vitamins|vitamins|mesh-ancestor
84000700|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
84000701|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000702|NCT04205929|Curcumin|curcumin|mesh-list
84000703|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000704|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000705|NCT04205929|Analgesics|analgesics|mesh-ancestor
84000706|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
84000707|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000708|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000709|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000710|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000711|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000712|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000713|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000714|NCT03259867|Nivolumab|nivolumab|mesh-list
84000715|NCT03259867|Tirapazamine|tirapazamine|mesh-list
84000716|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84000717|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000718|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84000719|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000720|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
84000721|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000722|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
84000723|NCT00636493|Hormones|hormones|mesh-ancestor
84000724|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000725|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000726|NCT02730481|Paclitaxel|paclitaxel|mesh-list
84000727|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84000728|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000729|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
84000730|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
84000731|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
84000732|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000733|NCT02730091|Letrozole|letrozole|mesh-list
84000734|NCT02730091|Vinorelbine|vinorelbine|mesh-list
84000735|NCT02730091|Anastrozole|anastrozole|mesh-list
84000736|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000737|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84000738|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84000739|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000740|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000741|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84000742|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
84000743|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000744|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000745|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84000746|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
84000747|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
84000748|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
84000749|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84000750|NCT02742805|Vitamin D|vitamin d|mesh-list
84000751|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
84000752|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
84000753|NCT02742805|Vitamins|vitamins|mesh-list
84000754|NCT02742805|Omalizumab|omalizumab|mesh-list
84000755|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
84000756|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000757|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84000758|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84000759|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84000760|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84000761|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
84000762|NCT02690389|Flumazenil|flumazenil|mesh-list
84000763|NCT02690389|Antidotes|antidotes|mesh-ancestor
84000764|NCT02690389|Protective Agents|protective agents|mesh-ancestor
84000765|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000766|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
84000767|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
84000768|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000769|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000770|NCT02732197|Thiopental|thiopental|mesh-list
84000771|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
84000772|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84000773|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000774|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000775|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84000776|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
84000777|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
84000778|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
84000779|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
84000780|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000781|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000782|NCT02729935|Parecoxib|parecoxib|mesh-list
84000783|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84000784|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84000785|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000786|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000787|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84000788|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84000789|NCT02729935|Analgesics|analgesics|mesh-ancestor
84000790|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
84000791|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000792|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000793|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000794|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84000795|NCT02729467|Itraconazole|itraconazole|mesh-list
84000796|NCT02729467|Rifampin|rifampin|mesh-list
84000797|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
84000798|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000799|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84000800|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84000801|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000802|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000803|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84000804|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
84000805|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84000806|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000807|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84000808|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84000809|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
84000810|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84000811|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
84000812|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84000813|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84000814|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84000815|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84000816|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84000817|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84000818|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84000819|NCT02727205|Rotigotine|rotigotine|mesh-list
84000820|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
84000821|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
84000822|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000823|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000824|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000825|NCT02721433|Denosumab|denosumab|mesh-list
84000826|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
84000827|NCT02721433|Pamidronate|pamidronate|mesh-list
84000828|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84000829|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000830|NCT02721043|Lenalidomide|lenalidomide|mesh-list
84000831|NCT02721043|Vaccines|vaccines|mesh-list
84000832|NCT02721043|Poly ICLC|poly iclc|mesh-list
84000833|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
84000834|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000835|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84000836|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84000837|NCT02721043|Growth Substances|growth substances|mesh-ancestor
84000838|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
84000839|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000840|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
84000841|NCT02728843|Deferiprone|deferiprone|mesh-list
84000842|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84000843|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
83240557|NCT05091775|Analgesics|analgesics|mesh-ancestor
84000844|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
84000845|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000846|NCT02726503|Lenvatinib|lenvatinib|mesh-list
84000847|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000848|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84000849|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000850|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000851|NCT02720965|Anesthetics|anesthetics|mesh-list
84000852|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
84000853|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000854|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000855|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
84000856|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000857|NCT02792413|Denosumab|denosumab|mesh-list
84000858|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84000859|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000860|NCT02726737|Lidocaine|lidocaine|mesh-list
84000861|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000862|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
84000863|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000864|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000865|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
84000866|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000867|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84000868|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84000869|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84000870|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84000871|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000872|NCT02720575|Vitamin D|vitamin d|mesh-list
84000873|NCT02720575|Vitamins|vitamins|mesh-ancestor
84000874|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
84000875|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000876|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84000877|NCT02720341|Armin|armin|mesh-list
84000878|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84000879|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84000880|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000881|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
84000882|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000883|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000884|NCT02728453|Empagliflozin|empagliflozin|mesh-list
84000885|NCT02728453|Glimepiride|glimepiride|mesh-list
84000886|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84000887|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000888|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000889|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000890|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84000891|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84000892|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
84000893|NCT02728687|Mannitol|mannitol|mesh-list
84000894|NCT02728687|Menthol|menthol|mesh-list
84000895|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84000896|NCT02728687|Diuretics|diuretics|mesh-ancestor
84000897|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
84000898|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000899|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
84000900|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
84000901|NCT02726269|Ofloxacin|ofloxacin|mesh-list
84000902|NCT02726269|Levofloxacin|levofloxacin|mesh-list
84000903|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84000904|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000905|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84000906|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84000907|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84000908|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048340|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84000909|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000910|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000911|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84000912|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84000913|NCT02694289|Metformin|metformin|mesh-list
84000914|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84000915|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000916|NCT02719795|Ropivacaine|ropivacaine|mesh-list
84000917|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
84000918|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
84000919|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84000920|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000922|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000923|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84000924|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
84000925|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000926|NCT02726035|Naltrexone|naltrexone|mesh-list
84000927|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84000928|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84000929|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000930|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
84000931|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84000932|NCT02719405|Caseins|caseins|mesh-list
84000933|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
84000934|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
84000935|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000936|NCT02725255|Albendazole|albendazole|mesh-list
84000937|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
84000938|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84000939|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84000940|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
84000941|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84000942|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84000943|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
84000944|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
84000945|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
84000946|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000947|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000948|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
84000949|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84000950|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000951|NCT02719015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84000952|NCT02719015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000953|NCT02725489|Durvalumab|durvalumab|mesh-list
84000954|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84000955|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000956|NCT02718547|Timolol|timolol|mesh-list
84000957|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84000958|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84000959|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
84000960|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84000961|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000962|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84000963|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84000964|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
84000965|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000966|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000967|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84000968|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84000969|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84000970|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84000971|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84000972|NCT02725099|Ticagrelor|ticagrelor|mesh-list
84000973|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84000974|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84000975|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84000976|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84000977|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
84000978|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000979|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000980|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000981|NCT01225211|Ivacaftor|ivacaftor|mesh-list
84000982|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84000983|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84000984|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000985|NCT02685709|Octreotide|octreotide|mesh-list
84000986|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84000987|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84000988|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84000989|NCT02265367|Milnacipran|milnacipran|mesh-list
84000990|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
84000991|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84000992|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84000993|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84000994|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84000995|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84000996|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84000997|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
84000998|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84000999|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001000|NCT02265367|Analgesics|analgesics|mesh-ancestor
84001001|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
84001002|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001003|NCT02718469|Vaccines|vaccines|mesh-list
84001004|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
84001005|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001006|NCT02716285|Peppermint oil|peppermint oil|mesh-list
84001007|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
84001008|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
84001009|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001010|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001011|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001012|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
84001013|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
84001014|NCT01224821|Antibodies|antibodies|mesh-list
84001015|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
84001016|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001017|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001018|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
84001019|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
84001020|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
84001021|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84001022|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001023|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
84001024|NCT02684851|Coagulants|coagulants|mesh-ancestor
84001025|NCT01224431|Lidocaine|lidocaine|mesh-list
84001026|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
84001027|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
84001028|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001029|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001030|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
84001031|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001032|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84001033|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84001034|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84001035|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84001036|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001037|NCT02716129|Morphine|morphine|mesh-list
84001038|NCT02716129|Nalbuphine|nalbuphine|mesh-list
84001039|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84001040|NCT02716129|Narcotics|narcotics|mesh-ancestor
84001041|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001042|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001043|NCT02716129|Analgesics|analgesics|mesh-ancestor
84001044|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
84001045|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001046|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84001047|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
84001048|NCT02718079|Mannitol|mannitol|mesh-list
84001049|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84001050|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001051|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84001052|NCT02718079|Diuretics|diuretics|mesh-ancestor
84001053|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
84001054|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001055|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
84001056|NCT02718079|Expectorants|expectorants|mesh-ancestor
84001057|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
84001058|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84001059|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
84001060|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001061|NCT02718079|Protective Agents|protective agents|mesh-ancestor
84001062|NCT02718079|Antidotes|antidotes|mesh-ancestor
84001063|NCT02717923|Capecitabine|capecitabine|mesh-list
84001064|NCT02717923|Cetuximab|cetuximab|mesh-list
84001065|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84001066|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
84001067|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240783|NCT04262869|Paclitaxel|paclitaxel|mesh-list
84001068|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001069|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84001070|NCT02724163|Cytarabine|cytarabine|mesh-list
84001071|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
84001072|NCT02724163|Busulfan|busulfan|mesh-list
84001073|NCT02724163|Fludarabine|fludarabine|mesh-list
84001074|NCT02724163|Daunorubicin|daunorubicin|mesh-list
84001075|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
84001076|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
84001077|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84001078|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
84001079|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001080|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001081|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84001082|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
84001083|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001084|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001085|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84001086|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84001087|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
84001088|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
84001089|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001090|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84001091|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84001092|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84001093|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001094|NCT02724163|Analgesics|analgesics|mesh-ancestor
84001095|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
84001096|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001097|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84001098|NCT02724163|Immunotoxins|immunotoxins|mesh-ancestor
84001099|NCT02724163|Immunoconjugates|immunoconjugates|mesh-ancestor
84001100|NCT02723461|Oxytocin|oxytocin|mesh-list
84001101|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
84001102|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84001103|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001104|NCT02715193|Volagidemab|volagidemab|mesh-list
84001105|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84001106|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001107|NCT01223027|Sorafenib|sorafenib|mesh-list
84001108|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001109|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84001110|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001111|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001112|NCT02714959|Aldesleukin|aldesleukin|mesh-list
84001113|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001114|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84001115|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84001116|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
84001117|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001118|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
84001119|NCT02714725|Propofol|propofol|mesh-list
84001120|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84001121|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001122|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001123|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001124|NCT02714725|Analgesics|analgesics|mesh-ancestor
84001125|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
84001126|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001127|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84001128|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84001129|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84001130|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
84001131|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001132|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001133|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84001134|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
84001135|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
84001136|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84001137|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84001138|NCT02714179|Acetaminophen|acetaminophen|mesh-list
84001139|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001140|NCT02714179|Analgesics|analgesics|mesh-ancestor
84001141|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
84001142|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001143|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001144|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
84001145|NCT01015131|Alovudine|alovudine|mesh-list
84001146|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
84001147|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001148|NCT02723383|Baclofen|baclofen|mesh-list
84001149|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84001150|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001151|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84001152|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001153|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84001154|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
84001155|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
84001156|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001157|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001158|NCT05269537|Ephedrine|ephedrine|mesh-list
84001159|NCT05269537|Fentanyl|fentanyl|mesh-list
84001160|NCT05269537|Bupivacaine|bupivacaine|mesh-list
84001161|NCT05269537|Oxytocin|oxytocin|mesh-list
84001162|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
84001163|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
84001164|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001165|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001166|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
84001167|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001168|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84001169|NCT05269537|Narcotics|narcotics|mesh-ancestor
84001170|NCT05269537|Analgesics|analgesics|mesh-ancestor
84001171|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84001172|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84001173|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
84001174|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
84001175|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84001176|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84001177|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
84001178|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
84001179|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84001180|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
84001181|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001182|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001183|NCT01222715|Sirolimus|sirolimus|mesh-list
84001184|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
84001185|NCT01222715|Bevacizumab|bevacizumab|mesh-list
84001186|NCT01222715|Temsirolimus|temsirolimus|mesh-list
84001187|NCT01222715|Vinorelbine|vinorelbine|mesh-list
84001188|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84001189|NCT01222715|MTOR Inhibitors|mtor inhibitors|mesh-list
84001190|NCT01222715|Antibodies|antibodies|mesh-list
84001191|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
84001192|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84001193|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
84001194|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
84001195|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84001196|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
84001197|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001198|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001199|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84001200|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
84001201|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001202|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001203|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84001204|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84001205|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84001206|NCT01222715|Growth Substances|growth substances|mesh-ancestor
84001207|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
84001208|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001209|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001210|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84001211|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
84001212|NCT01222715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84001213|NCT01222715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001214|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84001215|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
84001216|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
84001217|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
84001218|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
84001219|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
84001220|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001221|NCT02722759|Chrysarobin|chrysarobin|mesh-list
84001222|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84001223|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001224|NCT02722759|Analgesics|analgesics|mesh-ancestor
84001225|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
84001226|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001227|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001228|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84001229|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001230|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
84001231|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84001232|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
84001233|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84001234|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
84001235|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001236|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001237|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
84001238|NCT01222403|Vaccines|vaccines|mesh-list
84001239|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
84001240|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
84001241|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001242|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84001243|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
84001244|NCT02722369|Carboplatin|carboplatin|mesh-list
84001245|NCT02722369|Gemcitabine|gemcitabine|mesh-list
84001246|NCT02722369|Etoposide|etoposide|mesh-list
84001247|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001248|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84001249|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
84001250|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001251|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84001252|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84001253|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84001254|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001255|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
84001256|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84001257|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84001258|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001259|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001260|NCT01222247|Betamethasone|betamethasone|mesh-list
84001261|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84001262|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
84001263|NCT01222247|Hormones|hormones|mesh-ancestor
84001264|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001265|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001266|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84001267|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
84001268|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
84001269|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84001270|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84001271|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001272|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
84001273|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84001274|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
84001275|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001276|NCT03982537|Expectorants|expectorants|mesh-ancestor
84001277|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
84001278|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84001279|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
84001280|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001281|NCT03982537|Protective Agents|protective agents|mesh-ancestor
84001282|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001283|NCT03982537|Antidotes|antidotes|mesh-ancestor
84001284|NCT05260593|Vitamins|vitamins|mesh-list
84001285|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
84001286|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
84001287|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
84001288|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
84001289|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001290|NCT05260593|Hematinics|hematinics|mesh-ancestor
84001291|NCT02713477|Insulin|insulin|mesh-list
84001292|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84001293|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
84001294|NCT02713477|Lixisenatide|lixisenatide|mesh-list
84001295|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84001296|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001297|NCT01014585|Milnacipran|milnacipran|mesh-list
84001298|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
84001299|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84001300|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84001301|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84001302|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001303|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001304|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001305|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001306|NCT01014585|Analgesics|analgesics|mesh-ancestor
84001307|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
84001308|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001309|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
84001310|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84001311|NCT00611143|Atorvastatin|atorvastatin|mesh-list
84001312|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84001313|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84001314|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
84001315|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001316|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84001317|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84001318|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001319|NCT02712619|Metformin|metformin|mesh-list
84001320|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84001321|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001322|NCT01220609|Epothilones|epothilones|mesh-list
84001323|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
84001324|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
84001325|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
84001326|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001327|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001328|NCT02713087|Phenylephrine|phenylephrine|mesh-list
84001329|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
84001330|NCT02713087|Ephedrine|ephedrine|mesh-list
84001331|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84001332|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
84001333|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
84001334|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001335|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001336|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
84001337|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84001338|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
84001339|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
84001340|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84001341|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84001342|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84001343|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
84001344|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001345|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001346|NCT02713087|Protective Agents|protective agents|mesh-ancestor
84001347|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84001348|NCT02722603|Gabapentin|gabapentin|mesh-list
84001349|NCT02722603|Tramadol|tramadol|mesh-list
84001350|NCT02722603|Analgesics|analgesics|mesh-ancestor
84001351|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
84001352|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001353|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001354|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
84001355|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84001356|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84001357|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001358|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84001359|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84001360|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84001361|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001362|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001363|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
84001364|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84001365|NCT02722603|Narcotics|narcotics|mesh-ancestor
84001366|NCT02712697|Prednisone|prednisone|mesh-list
84001367|NCT02712697|Hormones|hormones|mesh-list
84001368|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84001369|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
84001370|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001371|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001372|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84001373|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001374|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
84001375|NCT01220297|Sirolimus|sirolimus|mesh-list
84001376|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
84001377|NCT01220297|Carmustine|carmustine|mesh-list
84001378|NCT01220297|Etoposide|etoposide|mesh-list
84001379|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
84001380|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84001381|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
84001382|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001383|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001384|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84001385|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
84001386|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001387|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001388|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84001389|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84001390|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84001391|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84001392|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001393|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84001394|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84001395|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
84001396|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001397|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001398|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
84001399|NCT02712775|Minocycline|minocycline|mesh-list
84001400|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001401|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001402|NCT04318847|Ondansetron|ondansetron|mesh-list
84001403|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
84001404|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
84001405|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001406|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001407|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001408|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
84001409|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
84001410|NCT04318847|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84001411|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84001412|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
84001413|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001414|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001415|NCT02721511|Furosemide|furosemide|mesh-list
84001416|NCT02721511|Diuretics|diuretics|mesh-ancestor
84001417|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
84001418|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001419|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84001420|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84001421|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001422|NCT02712307|Penicillins|penicillins|mesh-list
84001423|NCT02712307|Penicillin V|penicillin v|mesh-list
84001424|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001425|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001426|NCT02708251|Lidocaine|lidocaine|mesh-list
84001427|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
84001428|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
84001429|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
84001430|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001431|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001432|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
84001433|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001434|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84001435|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84001436|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84001437|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048341|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84001438|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001439|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
84001440|NCT02708173|Vaccines|vaccines|mesh-list
84001441|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
84001442|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001443|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84001444|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
84001445|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001446|NCT00612625|Glucagon|glucagon|mesh-list
84001447|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84001448|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001449|NCT00612625|Hormones|hormones|mesh-ancestor
84001450|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241172|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
84001451|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001452|NCT00612625|Incretins|incretins|mesh-ancestor
84001453|NCT02711917|Propofol|propofol|mesh-list
84001454|NCT02711917|Etomidate|etomidate|mesh-list
84001455|NCT02711917|Rocuronium|rocuronium|mesh-list
84001456|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84001457|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001458|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001459|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84001460|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
84001461|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
84001462|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84001463|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84001464|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84001465|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001466|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
84001467|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84001468|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84001469|NCT02711449|Prednisolone|prednisolone|mesh-list
84001470|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
84001471|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84001472|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
84001473|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84001474|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
84001475|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
84001476|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001477|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001478|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001479|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
84001480|NCT02711449|Hormones|hormones|mesh-ancestor
84001481|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001482|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84001483|NCT02711449|Protective Agents|protective agents|mesh-ancestor
84001484|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84001485|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001486|NCT00612079|Sertindole|sertindole|mesh-list
84001487|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84001488|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84001489|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001490|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001491|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84001492|NCT00940498|Gedatolisib|gedatolisib|mesh-list
84001493|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84001494|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001495|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001496|NCT03820531|Pancrelipase|pancrelipase|mesh-list
84001497|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001498|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
84001499|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
84001500|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84001501|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84001502|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001503|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001504|NCT02850718|Urological Agents|urological agents|mesh-ancestor
84001505|NCT02707393|Cyclosporine|cyclosporine|mesh-list
84001506|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
84001507|NCT02707393|Fludarabine|fludarabine|mesh-list
84001508|NCT02707393|Melphalan|melphalan|mesh-list
84001509|NCT02707393|Thiotepa|thiotepa|mesh-list
84001510|NCT02707393|Cyclosporins|cyclosporins|mesh-list
84001511|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
84001512|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048342|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
84001513|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001514|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84001515|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
84001516|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001517|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001518|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
84001519|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001520|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
84001521|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001522|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84001523|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84001524|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84001525|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
84001526|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001527|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84001528|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
84001529|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84001531|NCT00940342|Molgramostim|molgramostim|mesh-list
84001532|NCT00940342|Sargramostim|sargramostim|mesh-list
84001533|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84001534|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001535|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
84001536|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001537|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001538|NCT00936910|Amphotericin B|amphotericin b|mesh-list
84001539|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84001540|NCT00936910|Amebicides|amebicides|mesh-ancestor
84001541|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84001542|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84001543|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001544|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001545|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
84001546|NCT02707315|Gemcitabine|gemcitabine|mesh-list
84001547|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84001548|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
84001549|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001550|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001551|NCT00604942|Domperidone|domperidone|mesh-list
84001552|NCT00604942|Esomeprazole|esomeprazole|mesh-list
84001553|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84001554|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001555|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84001556|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001557|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001558|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
84001559|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
84001560|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001561|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001562|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84001563|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
84001564|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001565|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
84001566|NCT02711683|Donepezil|donepezil|mesh-list
84001567|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84001568|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001569|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001570|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
84001571|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001572|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001573|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
84001574|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84001575|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84001576|NCT02711683|Protective Agents|protective agents|mesh-ancestor
84001577|NCT05079061|Misoprostol|misoprostol|mesh-list
84001578|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84001579|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
84001580|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84001581|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001582|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84001583|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001584|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
84001585|NCT00605020|Insulin|insulin|mesh-list
84001586|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84001587|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
84001588|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
84001589|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84001590|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
84001591|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
84001592|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84001593|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001594|NCT02707081|Lidocaine|lidocaine|mesh-list
84001595|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
84001596|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
84001597|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001598|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001599|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
84001600|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001601|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84001602|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84001603|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83241322|NCT04389775|Glucagon|glucagon|mesh-list
84001604|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84001605|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001607|NCT00605098|Lopinavir|lopinavir|mesh-list
84001608|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84001609|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84001610|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
84001611|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001612|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001613|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84001614|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84001615|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
84001616|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001617|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84001618|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84001619|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84001620|NCT02711215|Mirtazapine|mirtazapine|mesh-list
84001621|NCT02711215|Citalopram|citalopram|mesh-list
84001622|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84001623|NCT02711215|Escitalopram|escitalopram|mesh-list
84001624|NCT02711215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84001625|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84001626|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84001627|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001628|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001629|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
84001630|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001631|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001632|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84001633|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
84001634|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84001635|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84001636|NCT02711215|Analgesics|analgesics|mesh-ancestor
84001637|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
84001638|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
84001639|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84001640|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
84001641|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
84001642|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84001643|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84001644|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001645|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84001646|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84001647|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84001648|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
84001649|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84001650|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84001651|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84001652|NCT00603772|Tretinoin|tretinoin|mesh-list
84001653|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001654|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
84001655|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
84001656|NCT02706769|Acetaminophen|acetaminophen|mesh-list
84001657|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001658|NCT02706769|Analgesics|analgesics|mesh-ancestor
84001659|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
84001660|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001661|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001662|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
84001663|NCT05044117|Capecitabine|capecitabine|mesh-list
84001664|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84001665|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
84001666|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001667|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001668|NCT03961165|Scopolamine|scopolamine|mesh-list
84001669|NCT03961165|Bromides|bromides|mesh-list
84001670|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84001671|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
84001672|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
84001673|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
84001674|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001675|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001676|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84001677|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84001678|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
84001679|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001680|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001681|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84001682|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
84001683|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001684|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
84001685|NCT02706535|Itraconazole|itraconazole|mesh-list
84001686|NCT02706535|Rifampin|rifampin|mesh-list
84001687|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
84001688|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001689|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84001690|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84001691|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001692|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001693|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84001694|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
84001695|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001696|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001697|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84001698|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84001699|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
84001700|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001701|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
84001702|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84001703|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84001704|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84001705|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84001706|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84001707|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84001708|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84001709|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
84001710|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84001711|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001712|NCT00612157|Eszopiclone|eszopiclone|mesh-list
84001713|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84001714|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001715|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001716|NCT00936598|Zolpidem|zolpidem|mesh-list
84001717|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84001718|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84001719|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001720|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001721|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84001722|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
84001723|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
84001724|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001725|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001726|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
84001727|NCT01025817|Everolimus|everolimus|mesh-list
84001728|NCT01025817|Tacrolimus|tacrolimus|mesh-list
84001729|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84001730|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
84001731|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001732|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84001733|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001734|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001735|NCT01025817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84001736|NCT01025817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84001737|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001738|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84001739|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84001740|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
84001741|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001742|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001743|NCT00636883|Gemcitabine|gemcitabine|mesh-list
84001744|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
84001745|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84001746|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
84001747|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001748|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001749|NCT00605410|Bromides|bromides|mesh-list
84001750|NCT00605410|Ipratropium|ipratropium|mesh-list
84001751|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
84001752|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84001753|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
84001754|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001755|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001756|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84001757|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
84001758|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84001759|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
84001760|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001761|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001762|NCT04300881|Eplerenone|eplerenone|mesh-list
84001763|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84001764|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
84001765|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001766|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001767|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84001768|NCT04300881|Diuretics|diuretics|mesh-ancestor
84001769|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
84001770|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84001771|NCT03873493|Venetoclax|venetoclax|mesh-list
84001772|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001773|NCT04300309|Lumefantrine|lumefantrine|mesh-list
84001774|NCT04300309|Artemether|artemether|mesh-list
84001775|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
84001776|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84001777|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84001778|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001779|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
84001780|NCT00611689|Vatalanib|vatalanib|mesh-list
84001781|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001782|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84001783|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001784|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001785|NCT05264077|Midazolam|midazolam|mesh-list
84001786|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
84001787|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84001788|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84001789|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001790|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001791|NCT05264077|Analgesics|analgesics|mesh-ancestor
84001792|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
84001793|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001794|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84001795|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84001796|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84001797|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
84001798|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001799|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001800|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84001801|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84001802|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84001803|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84001804|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84001805|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
84001806|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
84001807|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
84001808|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
84001809|NCT00612859|Levetiracetam|levetiracetam|mesh-list
84001810|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
84001811|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
84001812|NCT03872401|Evolocumab|evolocumab|mesh-list
84001813|NCT03872401|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84001814|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84001815|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84001816|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
84001817|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001818|NCT03872401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84001819|NCT03872401|Protease Inhibitors|protease inhibitors|mesh-ancestor
84001820|NCT03872401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001821|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84001822|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
84001823|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
84001824|NCT01010217|Melphalan|melphalan|mesh-list
84001825|NCT01010217|Thiotepa|thiotepa|mesh-list
84001826|NCT01010217|Rituximab|rituximab|mesh-list
84001827|NCT01010217|Fludarabine|fludarabine|mesh-list
84001828|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
84001830|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84001831|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
84001832|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001833|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001834|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84001835|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
84001836|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001837|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001838|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84001839|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84001840|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84001841|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
84001842|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001843|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84001844|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001845|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84001846|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84001847|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
84001848|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001849|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
84001850|NCT04558359|Giapreza|giapreza|mesh-list
84001851|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
84001852|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84001853|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84001854|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
84001855|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001856|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001857|NCT00604006|Spironolactone|spironolactone|mesh-list
84001858|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84001859|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
84001860|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001861|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001862|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84001863|NCT00604006|Diuretics|diuretics|mesh-ancestor
84001864|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
84001865|NCT00604084|Ivermectin|ivermectin|mesh-list
84001866|NCT00604084|Permethrin|permethrin|mesh-list
84001867|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84001868|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001869|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001870|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001871|NCT05379478|Antibodies|antibodies|mesh-list
84001872|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
84001873|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001874|NCT04267042|Budesonide|budesonide|mesh-list
84001875|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84001876|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84001877|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
84001878|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001879|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001880|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84001881|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
84001882|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
84001883|NCT04267042|Hormones|hormones|mesh-ancestor
84001884|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001885|NCT01217957|Dexamethasone|dexamethasone|mesh-list
84001886|NCT01217957|Lenalidomide|lenalidomide|mesh-list
84001887|NCT01217957|Ixazomib|ixazomib|mesh-list
84001888|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84001889|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
84001890|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
84001891|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001892|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001893|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001894|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
84001895|NCT01217957|Hormones|hormones|mesh-ancestor
84001896|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84001897|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84001898|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84001899|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
84001900|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84001901|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84001902|NCT01217957|Growth Substances|growth substances|mesh-ancestor
84001903|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
84001904|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
84001905|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001906|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001907|NCT01217801|Ondansetron|ondansetron|mesh-list
84001908|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
84001909|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
84001910|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001911|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001912|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84001913|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
84001914|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
84001915|NCT01217801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84001916|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84001917|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
84001918|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001919|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001920|NCT00935818|Bupropion|bupropion|mesh-list
84001921|NCT00935818|Varenicline|varenicline|mesh-list
84001922|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84001923|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
84001924|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84001925|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84001926|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84001927|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84001928|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001929|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
84001930|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84001931|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001932|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84001933|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84001934|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001935|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84001936|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84001937|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
84001938|NCT02709265|Amikacin|amikacin|mesh-list
84001939|NCT02709265|Fosfomycin|fosfomycin|mesh-list
84001940|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001941|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001942|NCT00611845|Aprotinin|aprotinin|mesh-list
84001943|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
84001944|NCT00611845|Coagulants|coagulants|mesh-ancestor
84001945|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84001946|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84001947|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
84001948|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001949|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001950|NCT01216163|Acetaminophen|acetaminophen|mesh-list
84001951|NCT01216163|Ibuprofen|ibuprofen|mesh-list
84001952|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84001953|NCT01216163|Analgesics|analgesics|mesh-ancestor
84001954|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
84001955|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84001956|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001957|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
84001958|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84001959|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84001960|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84001961|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84001962|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84001963|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84001964|NCT05260255|Vitamin D|vitamin d|mesh-list
84001965|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
84001966|NCT05260255|Vitamins|vitamins|mesh-ancestor
84001967|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
84001968|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001969|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84001970|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84001971|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
84001972|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84001973|NCT00612469|Listerine|listerine|mesh-list
84001974|NCT00612469|Vancomycin|vancomycin|mesh-list
84001975|NCT00612469|Fluorides|fluorides|mesh-list
84001976|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
84001977|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
84001978|NCT00612469|Protective Agents|protective agents|mesh-ancestor
83241689|NCT04973033|Tofacitinib|tofacitinib|mesh-list
84001979|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001980|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84001981|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84001982|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
84001983|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
84001984|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84001986|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
84001987|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
84001988|NCT00933244|Vitamins|vitamins|mesh-list
84001989|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
84001990|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84001991|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84001992|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84001993|NCT02709187|Candesartan|candesartan|mesh-list
84001994|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
84001995|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84001996|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84001997|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84001998|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
84001999|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002000|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84002001|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84002002|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002003|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84002004|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84002005|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84002006|NCT00930046|Ropivacaine|ropivacaine|mesh-list
84002007|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
84002008|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
84002009|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002010|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002011|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
84002012|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002013|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
84002014|NCT05244031|Narcotics|narcotics|mesh-ancestor
84002015|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002016|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002017|NCT05244031|Analgesics|analgesics|mesh-ancestor
84002018|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
84002019|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002020|NCT04712071|Ketamine|ketamine|mesh-list
84002021|NCT04712071|Analgesics|analgesics|mesh-ancestor
84002022|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
84002023|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002024|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002025|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84002026|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84002027|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
84002028|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
84002029|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002030|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84002031|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84002032|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002033|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002034|NCT05151328|Plecanatide|plecanatide|mesh-list
84002035|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84002036|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
84002037|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002038|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84002039|NCT00609388|Tacrolimus|tacrolimus|mesh-list
84002040|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84002041|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
84002042|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002043|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84002044|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002045|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002046|NCT02709031|Cicletanine|cicletanine|mesh-list
84002047|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84002048|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84002049|NCT02709031|Diuretics|diuretics|mesh-ancestor
84002050|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
84002051|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002052|NCT05225545|Iron|iron|mesh-list
84002053|NCT05225545|Trace Elements|trace elements|mesh-ancestor
84002054|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
84002055|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002056|NCT05378932|Melatonin|melatonin|mesh-list
84002057|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
84002058|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002059|NCT05378932|Protective Agents|protective agents|mesh-ancestor
84002060|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002061|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002062|NCT05222971|Durvalumab|durvalumab|mesh-list
84002063|NCT05222971|Olaparib|olaparib|mesh-list
84002064|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002065|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002066|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84002067|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002068|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002069|NCT00612547|Artesunate|artesunate|mesh-list
84002070|NCT00612547|Amodiaquine|amodiaquine|mesh-list
84002071|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
84002072|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84002073|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84002074|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002075|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002076|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
84002077|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
84002078|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84002079|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
84002080|NCT00606268|Micafungin|micafungin|mesh-list
84002081|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
84002082|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002083|NCT05342857|Aflibercept|aflibercept|mesh-list
84002084|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84002085|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84002086|NCT05342857|Growth Substances|growth substances|mesh-ancestor
84002087|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002088|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
84002089|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002090|NCT04264624|Erythritol|erythritol|mesh-list
84002091|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
84002092|NCT04188691|Vaccines|vaccines|mesh-list
84002093|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
84002094|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002095|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
84002096|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
84002097|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84002098|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002099|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84002100|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84002101|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002102|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002103|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002104|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
84002105|NCT00613093|Temozolomide|temozolomide|mesh-list
84002106|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
84002107|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84002108|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
84002109|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002110|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002111|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002112|NCT00607750|Mecamylamine|mecamylamine|mesh-list
84002113|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84002114|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
84002115|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
84002116|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002117|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002118|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84002119|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84002120|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
84002121|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002122|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002123|NCT00609544|Rilonacept|rilonacept|mesh-list
84002124|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002125|NCT04908475|Apremilast|apremilast|mesh-list
84002126|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84002127|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84002128|NCT04908475|Analgesics|analgesics|mesh-ancestor
84002129|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
84002130|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002131|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002132|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002133|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002134|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84002135|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84002136|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002137|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002138|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
84002139|NCT03513211|Itraconazole|itraconazole|mesh-list
84002140|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
84002141|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84002142|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84002143|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002144|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002145|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002146|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002147|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
84002148|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84002149|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84002150|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84002151|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
84002152|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002153|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002154|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84002155|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
84002156|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002157|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002158|NCT04611139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84002159|NCT04611139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002160|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
84002161|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84002162|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
84002163|NCT05198791|Eplerenone|eplerenone|mesh-list
84002164|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84002165|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
84002166|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002167|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002168|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84002169|NCT05198791|Diuretics|diuretics|mesh-ancestor
84002170|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
84002171|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84002172|NCT01010061|Rituximab|rituximab|mesh-list
84002173|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
84002174|NCT01010061|Chlorambucil|chlorambucil|mesh-list
84002175|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002176|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002177|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
84002178|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002179|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002180|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84002181|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
84002182|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002183|NCT00607984|Melphalan|melphalan|mesh-list
84002184|NCT00607984|Thiotepa|thiotepa|mesh-list
84002185|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84002186|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
84002187|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002188|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002189|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84002190|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84002191|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
84002192|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002193|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84002194|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
84002195|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84002196|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84002197|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
84002198|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002199|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84002200|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002201|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
84002202|NCT00609856|Pioglitazone|pioglitazone|mesh-list
84002203|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84002204|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002206|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002207|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002208|NCT00613249|Dapivirine|dapivirine|mesh-list
84002209|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84002210|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84002211|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
84002212|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002213|NCT00613561|Fludarabine|fludarabine|mesh-list
84002214|NCT00613561|Busulfan|busulfan|mesh-list
84002215|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84002216|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002217|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002218|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84002219|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
84002220|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002221|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
84002222|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84002223|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84002224|NCT01009983|Paclitaxel|paclitaxel|mesh-list
84002225|NCT01009983|Carboplatin|carboplatin|mesh-list
84002226|NCT01009983|Panitumumab|panitumumab|mesh-list
84002227|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84002228|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002229|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
84002230|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
84002231|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
84002232|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002233|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002234|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
84002235|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84002236|NCT04297215|Chitosan|chitosan|mesh-list
84002237|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84002238|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84002239|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
84002240|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002241|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84002242|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
84002243|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
84002244|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
84002245|NCT04297215|Coagulants|coagulants|mesh-ancestor
84002246|NCT02873091|Sufentanil|sufentanil|mesh-list
84002247|NCT02873091|Ropivacaine|ropivacaine|mesh-list
84002248|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
84002249|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
84002250|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002251|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002252|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
84002253|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002254|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84002255|NCT02873091|Narcotics|narcotics|mesh-ancestor
84002256|NCT02873091|Analgesics|analgesics|mesh-ancestor
84002257|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84002258|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84002259|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
84002260|NCT04298775|Morphine|morphine|mesh-list
84002261|NCT04298775|Anesthetics|anesthetics|mesh-list
84002262|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002263|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002264|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84002265|NCT04298775|Narcotics|narcotics|mesh-ancestor
84002266|NCT04298775|Analgesics|analgesics|mesh-ancestor
84002267|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
84002268|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002269|NCT01215227|Rasagiline|rasagiline|mesh-list
84002270|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84002271|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002272|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002273|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84002274|NCT01215227|Protective Agents|protective agents|mesh-ancestor
84002275|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002276|NCT01009515|Paclitaxel|paclitaxel|mesh-list
84002277|NCT01009515|Carboplatin|carboplatin|mesh-list
84002278|NCT01009515|Temozolomide|temozolomide|mesh-list
84002279|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84002280|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002281|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
84002282|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
84002284|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002285|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84002286|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
84002287|NCT04550481|Lisinopril|lisinopril|mesh-list
84002288|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84002289|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
84002290|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002291|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002292|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84002293|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84002294|NCT04550481|Protective Agents|protective agents|mesh-ancestor
84002295|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002296|NCT01214915|Anagrelide|anagrelide|mesh-list
84002297|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84002298|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84002299|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002300|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84002301|NCT01009203|Sirolimus|sirolimus|mesh-list
84002302|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84002303|NCT01009203|Temsirolimus|temsirolimus|mesh-list
84002304|NCT01009203|MTOR Inhibitors|mtor inhibitors|mesh-list
84002305|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002306|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002307|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002308|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002309|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84002310|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
84002311|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002312|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84002313|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002314|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84002315|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
84002316|NCT01009047|Aripiprazole|aripiprazole|mesh-list
84002317|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84002318|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
84002319|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84002320|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84002321|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84002322|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002323|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002324|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
84002325|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
84002326|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002327|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002328|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84002329|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84002330|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
84002331|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84002332|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84002333|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84002334|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84002335|NCT04205097|Neostigmine|neostigmine|mesh-list
84002336|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84002337|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002338|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002339|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
84002340|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002341|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002342|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84002343|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
84002344|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002345|NCT04205565|Oxiracetam|oxiracetam|mesh-list
84002346|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84002347|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
84002348|NCT01025193|Belimumab|belimumab|mesh-list
84002349|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84002350|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
84002351|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002352|NCT01008423|Budesonide|budesonide|mesh-list
84002353|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002354|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84002355|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
84002356|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002357|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002358|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84002359|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
84002360|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
84002361|NCT01008423|Hormones|hormones|mesh-ancestor
84002362|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002363|NCT04735861|Bevacizumab|bevacizumab|mesh-list
84002364|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002365|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002366|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84002367|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84002368|NCT04735861|Growth Substances|growth substances|mesh-ancestor
84002369|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002370|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
84002371|NCT03685747|Vancomycin|vancomycin|mesh-list
84002372|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84002373|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002374|NCT03651271|Nivolumab|nivolumab|mesh-list
84002375|NCT03651271|Ipilimumab|ipilimumab|mesh-list
84002376|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002377|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002378|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84002379|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002380|NCT03586687|Triamcinolone|triamcinolone|mesh-list
84002381|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002382|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
84002383|NCT03586687|Hormones|hormones|mesh-ancestor
84002384|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002385|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002386|NCT01212185|Oxytocin|oxytocin|mesh-list
84002387|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
84002388|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84002389|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002390|NCT00613717|Vitamin D|vitamin d|mesh-list
84002391|NCT00613717|Vitamins|vitamins|mesh-list
84002392|NCT00613717|Folic Acid|folic acid|mesh-list
84002393|NCT00613717|Vitamin A|vitamin a|mesh-list
84002395|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
84002396|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
84002397|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
84002398|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002399|NCT00613717|Trace Elements|trace elements|mesh-ancestor
84002400|NCT00613717|Hematinics|hematinics|mesh-ancestor
84002401|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
84002402|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002403|NCT00613717|Protective Agents|protective agents|mesh-ancestor
84002404|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84002405|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002406|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84002407|NCT04477759|Atezolizumab|atezolizumab|mesh-list
84002408|NCT04477759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84002409|NCT04477759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002410|NCT04477759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002411|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002412|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
84002413|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84002414|NCT03369301|Antibodies|antibodies|mesh-list
84002415|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
84002416|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002417|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
84002418|NCT04865887|Lenvatinib|lenvatinib|mesh-list
84002419|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002420|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002421|NCT04865887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84002422|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002423|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002424|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002425|NCT05345119|Sirolimus|sirolimus|mesh-list
84002426|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
84002427|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84002428|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84002429|NCT05345119|Prednisolone|prednisolone|mesh-list
84002430|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
84002431|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84002432|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
84002433|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84002434|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002435|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84002436|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002437|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
84002438|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84002439|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
84002440|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002441|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002442|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
84002443|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
84002444|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002445|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84002446|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
84002447|NCT05345119|Hormones|hormones|mesh-ancestor
84002448|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002449|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84002450|NCT05345119|Protective Agents|protective agents|mesh-ancestor
84002451|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84002452|NCT03529123|Insulin|insulin|mesh-list
84002453|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84002454|NCT03529123|Metformin|metformin|mesh-list
84002455|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
84002456|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
84002457|NCT03529123|Lixisenatide|lixisenatide|mesh-list
84002458|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84002459|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002460|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
84002461|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84002462|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84002463|NCT04074187|Prednisolone|prednisolone|mesh-list
84002464|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
84002465|NCT04074187|Rituximab|rituximab|mesh-list
84002466|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84002467|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
84002468|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
84002469|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002470|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002471|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
84002472|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002473|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002474|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002475|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
84002476|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
84002477|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002478|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84002479|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
84002480|NCT04074187|Hormones|hormones|mesh-ancestor
84002481|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002482|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84002483|NCT04074187|Protective Agents|protective agents|mesh-ancestor
84002484|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84002485|NCT03128905|Prednisone|prednisone|mesh-list
84002486|NCT03128905|Colchicine|colchicine|mesh-list
84002487|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002488|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
84002489|NCT03128905|Hormones|hormones|mesh-ancestor
84002490|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002491|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002492|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84002493|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002494|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
84002495|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002496|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
84002497|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
84002498|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
84002499|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002500|NCT02430181|Interferons|interferons|mesh-list
84002501|NCT02430181|Ritonavir|ritonavir|mesh-list
84002502|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
84002503|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84002504|NCT02430181|Lonafarnib|lonafarnib|mesh-list
84002505|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002506|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
84002507|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002508|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84002509|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84002510|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
84002511|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002512|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002513|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84002514|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84002515|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84002516|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84002517|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
84002518|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002519|NCT00614653|Bevacizumab|bevacizumab|mesh-list
84002520|NCT00614653|Capecitabine|capecitabine|mesh-list
84002521|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84002522|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002523|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002524|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84002525|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84002526|NCT00614653|Growth Substances|growth substances|mesh-ancestor
84002527|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002528|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
84002529|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84002530|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
84002531|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002532|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002533|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002534|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84002535|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84002536|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002537|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84002538|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002539|NCT03463135|Immunomodulating Agents|immunomodulating agents|mesh-list
84002540|NCT03463135|Immunologic Factors|immunologic factors|mesh-ancestor
84002541|NCT03463135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002542|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
84002543|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84002544|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
84002545|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002546|NCT03596125|Expectorants|expectorants|mesh-ancestor
84002547|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
84002548|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84002549|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
84002550|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002551|NCT03596125|Protective Agents|protective agents|mesh-ancestor
84002552|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002553|NCT03596125|Antidotes|antidotes|mesh-ancestor
84002555|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84002556|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84002557|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
84002558|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002559|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002560|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002561|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84002562|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84002563|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84002564|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
84002565|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84002566|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84002567|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002568|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002569|NCT05343637|Urological Agents|urological agents|mesh-ancestor
84002570|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84002571|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84002572|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002573|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84002574|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002575|NCT00614809|Gefitinib|gefitinib|mesh-list
84002576|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002577|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002578|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002579|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002580|NCT02964013|Carboplatin|carboplatin|mesh-list
84002581|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
84002582|NCT02964013|Etoposide|etoposide|mesh-list
84002583|NCT02964013|Pemetrexed|pemetrexed|mesh-list
84002584|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002585|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002586|NCT02964013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84002587|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002588|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84002589|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84002590|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84002591|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002592|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84002593|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84002594|NCT05343169|Naloxone|naloxone|mesh-list
84002595|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84002596|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002597|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
84002598|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002599|NCT02480803|Levodopa|levodopa|mesh-list
84002600|NCT02480803|Carbidopa|carbidopa|mesh-list
84002601|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84002602|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84002603|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84002604|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
84002605|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002606|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002607|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002608|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84002609|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002610|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84002611|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
84002612|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
84002613|NCT02699437|Antibodies|antibodies|mesh-list
84002614|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
84002615|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
84002616|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002617|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84002618|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002619|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002620|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002621|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002622|NCT00615823|Atorvastatin|atorvastatin|mesh-list
84002623|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84002624|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84002625|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
84002626|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002627|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84002628|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84002629|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002630|NCT02699281|Palmidrol|palmidrol|mesh-list
84002631|NCT02699281|Analgesics|analgesics|mesh-ancestor
84002632|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
84002633|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002634|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002635|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84002636|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84002637|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002638|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002639|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
84002640|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002641|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84002642|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84002643|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002644|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002645|NCT02699281|Hormones|hormones|mesh-ancestor
84002646|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002647|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
84002648|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84002649|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
84002650|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002651|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002652|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84002653|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
84002654|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002655|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002656|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84002657|NCT02704507|Triamcinolone|triamcinolone|mesh-list
84002658|NCT02704507|Tretinoin|tretinoin|mesh-list
84002659|NCT02704507|Emollients|emollients|mesh-list
84002660|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002661|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
84002662|NCT02704507|Hormones|hormones|mesh-ancestor
84002663|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002664|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002665|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002666|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
84002667|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
84002668|NCT01210001|Empagliflozin|empagliflozin|mesh-list
84002669|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84002670|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002671|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84002672|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002673|NCT00624455|Gabapentin|gabapentin|mesh-list
84002674|NCT00624455|Analgesics|analgesics|mesh-ancestor
84002675|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
84002676|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002677|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002678|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
84002679|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84002680|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84002681|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002682|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84002683|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84002684|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84002685|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002686|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002687|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
84002688|NCT01127659|Testosterone|testosterone|mesh-list
84002689|NCT01127659|Androgens|androgens|mesh-ancestor
84002690|NCT01127659|Hormones|hormones|mesh-ancestor
84002691|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002692|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002693|NCT02698969|Atropine|atropine|mesh-list
84002694|NCT02698969|Fentanyl|fentanyl|mesh-list
84002695|NCT02698969|Propofol|propofol|mesh-list
84002696|NCT02698969|Sevoflurane|sevoflurane|mesh-list
84002697|NCT02698969|Rocuronium|rocuronium|mesh-list
84002698|NCT02698969|Neostigmine|neostigmine|mesh-list
84002699|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84002700|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002701|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002702|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84002703|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
84002704|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
84002705|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84002706|NCT02698969|Narcotics|narcotics|mesh-ancestor
84002707|NCT02698969|Analgesics|analgesics|mesh-ancestor
84002708|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
84002709|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002710|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84002711|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84002712|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84002713|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84002714|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84002715|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84002716|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84002717|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84002718|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
84002719|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84002720|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
84002721|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
84002722|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
84002723|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84002724|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84002725|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
84002726|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002727|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002728|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84002729|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002730|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84002731|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
84002732|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84002733|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
84002734|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002735|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002736|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84002737|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
84002738|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84002739|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
84002740|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002741|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002742|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84002743|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
84002744|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
84002745|NCT00848731|Protective Agents|protective agents|mesh-ancestor
84002746|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
84002747|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84002748|NCT01209143|Norethindrone|norethindrone|mesh-list
84002749|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
84002750|NCT01209143|Estradiol|estradiol|mesh-list
84002751|NCT01209143|Estrogens|estrogens|mesh-ancestor
84002752|NCT01209143|Hormones|hormones|mesh-ancestor
84002753|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002754|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002755|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84002756|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
84002757|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84002758|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84002759|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84002760|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84002761|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84002762|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84002763|NCT00454285|Amoxicillin|amoxicillin|mesh-list
84002764|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84002765|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002766|NCT00614965|Irinotecan|irinotecan|mesh-list
84002767|NCT00614965|Pemetrexed|pemetrexed|mesh-list
84002768|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002769|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84002770|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84002771|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002772|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002773|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84002774|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84002775|NCT00390325|Sorafenib|sorafenib|mesh-list
84002776|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002777|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002778|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002779|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002780|NCT00405613|Aspirin|aspirin|mesh-list
84002781|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84002782|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84002783|NCT00405613|Analgesics|analgesics|mesh-ancestor
84002784|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
84002785|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83533742|NCT03220022|Rituximab|rituximab|mesh-list
84002786|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002787|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002788|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002789|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84002790|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84002791|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002792|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84002793|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84002794|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002795|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
84002796|NCT02703961|Cisplatin|cisplatin|mesh-list
84002797|NCT02703961|Docetaxel|docetaxel|mesh-list
84002798|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002799|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
84002800|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
84002801|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
84002802|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002803|NCT02703649|Letrozole|letrozole|mesh-list
84002804|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242530|NCT02655679|Ether|ether|mesh-list
84002805|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84002806|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84002807|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002808|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002809|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84002810|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
84002811|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002812|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002813|NCT02703571|Trametinib|trametinib|mesh-list
84002814|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002815|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002816|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002817|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002818|NCT02703415|Tramadol|tramadol|mesh-list
84002819|NCT02703415|Bupivacaine|bupivacaine|mesh-list
84002820|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
84002821|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
84002822|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002823|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002824|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
84002825|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002826|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84002827|NCT02703415|Narcotics|narcotics|mesh-ancestor
84002828|NCT02703415|Analgesics|analgesics|mesh-ancestor
84002829|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
84002830|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84002831|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002832|NCT04215835|Letrozole|letrozole|mesh-list
84002833|NCT04215835|Misoprostol|misoprostol|mesh-list
84002834|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002835|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84002836|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84002837|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002838|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002839|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84002840|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
84002841|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002842|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002843|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84002844|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
84002845|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84002846|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84002847|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84002848|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
84002849|NCT01208207|Naproxen|naproxen|mesh-list
84002850|NCT01208207|Etoricoxib|etoricoxib|mesh-list
84002851|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84002852|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84002853|NCT01208207|Analgesics|analgesics|mesh-ancestor
84002854|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
84002855|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002856|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002857|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002858|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002859|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
84002860|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84002861|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002862|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002863|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84002864|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
84002865|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84002866|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002867|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84002868|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002869|NCT01012713|Calcitriol|calcitriol|mesh-list
84002870|NCT01012713|Clobetasol|clobetasol|mesh-list
84002871|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002872|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
84002873|NCT01012713|Hormones|hormones|mesh-ancestor
84002874|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84002875|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002876|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84002877|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84002878|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84002879|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002880|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84002882|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
84002883|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84002884|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
84002885|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84002886|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
84002887|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002888|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
84002889|NCT02698813|Protective Agents|protective agents|mesh-ancestor
84002890|NCT02702323|Apatinib|apatinib|mesh-list
84002891|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002892|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84002893|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002894|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002895|NCT01007253|Fluticasone|fluticasone|mesh-list
84002896|NCT01007253|Xhance|xhance|mesh-list
84002897|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
84002898|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84002899|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84002900|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84002901|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84002902|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
84002903|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002904|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002905|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84002906|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
84002907|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
84002908|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84002909|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84002910|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84002911|NCT01007253|Analgesics|analgesics|mesh-ancestor
84002912|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
84002913|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84002914|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84002915|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84002916|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
84002917|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
84002918|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002919|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002920|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
84002921|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84002922|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002923|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84002924|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
84002925|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84002926|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002927|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84002928|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002929|NCT04738123|Xanomeline|xanomeline|mesh-list
84002930|NCT04738123|Trospium chloride|trospium chloride|mesh-list
84002931|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
84002932|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
84002933|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002934|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002935|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84002936|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84002937|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
84002938|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002939|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002940|NCT04738123|Urological Agents|urological agents|mesh-ancestor
84002941|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84002942|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84002943|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84002944|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84002945|NCT01006707|Ondansetron|ondansetron|mesh-list
84002946|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
84002947|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
84002948|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002949|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002950|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84002951|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
84002952|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
84002953|NCT01006707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84002954|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84002955|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
84002956|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002957|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002958|NCT01006629|Palivizumab|palivizumab|mesh-list
84002959|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
84002960|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002961|NCT04214977|Anesthetics|anesthetics|mesh-list
84002962|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002963|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002965|NCT02701933|Analgesics|analgesics|mesh-ancestor
84002966|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
84002967|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84002968|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002969|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84002970|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84002971|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
84002972|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
84002973|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84002974|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84002975|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84002976|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84002977|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002978|NCT04295967|Formaldehyde|formaldehyde|mesh-list
84002979|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
84002980|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84002981|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
84002982|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
84002983|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84002984|NCT02871765|Warfarin|warfarin|mesh-list
84002985|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
84002986|NCT02549209|Paclitaxel|paclitaxel|mesh-list
84002987|NCT02549209|Carboplatin|carboplatin|mesh-list
84002988|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
84002989|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84002990|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84002991|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
84002992|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
84002993|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
84002994|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84002995|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84002996|NCT02549209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84002997|NCT02698267|Itraconazole|itraconazole|mesh-list
84002998|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
84002999|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003000|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84003001|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003002|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003003|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003004|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84003005|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
84003006|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003007|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003008|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84003009|NCT01011465|Oxytocin|oxytocin|mesh-list
84003010|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
84003011|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84003012|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003013|NCT02494141|Curcumin|curcumin|mesh-list
84003014|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84003015|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84003016|NCT02494141|Analgesics|analgesics|mesh-ancestor
84003017|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
84003018|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003019|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003020|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003021|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003022|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003023|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003024|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003025|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
84003026|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83242767|NCT04400201|Propofol|propofol|mesh-list
84003027|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84003028|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003029|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
84003030|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84003031|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
84003032|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
84003033|NCT04214821|Levofloxacin|levofloxacin|mesh-list
84003034|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84003035|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84003036|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84003037|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003038|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84003039|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84003040|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003041|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003042|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003043|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84003044|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84003045|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003046|NCT00616213|Lenograstim|lenograstim|mesh-list
84003047|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84003048|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
84003049|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003050|NCT00615667|Tacrolimus|tacrolimus|mesh-list
84003051|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84003052|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
84003053|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003054|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84003055|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003056|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003057|NCT02697955|Epinephrine|epinephrine|mesh-list
84003058|NCT02697955|Bupivacaine|bupivacaine|mesh-list
84003059|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003060|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
84003061|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003062|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003063|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
84003064|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003065|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84003066|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84003067|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
84003068|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003069|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003070|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84003071|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84003072|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
84003073|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84003074|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
84003075|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
84003076|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
84003077|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84003078|NCT04294329|Bupivacaine|bupivacaine|mesh-list
84003079|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003080|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
84003081|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003082|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003083|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
84003084|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003085|NCT02701309|Iron|iron|mesh-list
84003086|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
84003087|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
84003088|NCT02701309|Trace Elements|trace elements|mesh-ancestor
84003089|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
84003090|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003091|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84003092|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
84003093|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003094|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003095|NCT03250507|Bupivacaine|bupivacaine|mesh-list
84003096|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003097|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
84003098|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003099|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003100|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
83242881|NCT02680561|Xhance|xhance|mesh-list
84003101|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003102|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84003103|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84003104|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84003105|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
84003106|NCT00997893|Estradiol|estradiol|mesh-list
84003107|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84003108|NCT00997893|Estrogens|estrogens|mesh-list
84003109|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
84003110|NCT00997893|Hormones|hormones|mesh-ancestor
84003111|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003112|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003113|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84003114|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
84003115|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84003116|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84003117|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84003118|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84003119|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84003120|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84003121|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84003122|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003123|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84003124|NCT02697877|Regadenoson|regadenoson|mesh-list
84003125|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84003126|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84003127|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
84003128|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
84003129|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003130|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003131|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003132|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
84003133|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
84003134|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003135|NCT04214665|Protective Agents|protective agents|mesh-ancestor
84003136|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003137|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
84003138|NCT04214665|Vitamins|vitamins|mesh-ancestor
84003139|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
84003140|NCT02870673|Triamcinolone|triamcinolone|mesh-list
84003141|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84003142|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84003143|NCT02870673|Lidocaine|lidocaine|mesh-list
84003144|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84003145|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003146|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
84003147|NCT02870673|Hormones|hormones|mesh-ancestor
84003148|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003149|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003150|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84003151|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
84003152|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003153|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003154|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003155|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
84003156|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003157|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
84003158|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003159|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84003160|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84003161|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84003162|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003163|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84003164|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84003165|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84003166|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003167|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003168|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
84003169|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003170|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84003171|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84003172|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
84003173|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84003174|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84003175|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84003176|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003177|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003178|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
84003179|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003180|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003181|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84003182|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003183|NCT02700685|Methylphenidate|methylphenidate|mesh-list
84003184|NCT02700685|Pycnogenols|pycnogenols|mesh-list
84003185|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84003186|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003187|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84003188|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84003189|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003190|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003191|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
84003192|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003193|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84003194|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
84003195|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
84003196|NCT02700685|Protective Agents|protective agents|mesh-ancestor
84003197|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84003198|NCT02700763|Dabrafenib|dabrafenib|mesh-list
84003199|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003200|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003201|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003202|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003203|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
84003204|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
84003205|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84003206|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003207|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84003208|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003209|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
84003210|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003211|NCT03151681|Propranolol|propranolol|mesh-list
84003212|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84003213|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84003214|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
84003215|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003216|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003217|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003218|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84003219|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84003220|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
84003221|NCT04215445|Empagliflozin|empagliflozin|mesh-list
84003222|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84003223|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003224|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84003225|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003226|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84003227|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
84003228|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84003229|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
84003230|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003231|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003232|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84003233|NCT02691871|Docetaxel|docetaxel|mesh-list
84003234|NCT02691871|Apatinib|apatinib|mesh-list
84003235|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003236|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
84003237|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
84003238|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
84003239|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003240|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003241|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003242|NCT02700217|Remifentanil|remifentanil|mesh-list
84003243|NCT02700217|Heroin|heroin|mesh-list
84003244|NCT02700217|Bupivacaine|bupivacaine|mesh-list
84003245|NCT02700217|Propofol|propofol|mesh-list
84003246|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003247|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
83242975|NCT04513639|BB 1101|bb 1101|mesh-list
84003248|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003249|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003250|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
84003251|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003252|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84003253|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84003254|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
84003255|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84003256|NCT02700217|Narcotics|narcotics|mesh-ancestor
84003257|NCT02700217|Analgesics|analgesics|mesh-ancestor
84003258|NCT05323981|Pertuzumab|pertuzumab|mesh-list
84003259|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84003260|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003261|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
84003262|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
84003263|NCT02699827|Analgesics|analgesics|mesh-ancestor
84003264|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
84003265|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003266|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003267|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
84003268|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003269|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84003270|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
84003271|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84003272|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003273|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003274|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84003275|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
84003276|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84003277|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003278|NCT02705989|Branebrutinib|branebrutinib|mesh-list
84003279|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003280|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003281|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003282|NCT02706067|Orlistat|orlistat|mesh-list
84003283|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003284|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003285|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84003286|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84003287|NCT02939287|Olanzapine|olanzapine|mesh-list
84003288|NCT02939287|Aprepitant|aprepitant|mesh-list
84003289|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
84003290|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
84003291|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
84003292|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003293|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003294|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003295|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84003296|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84003297|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003298|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84003299|NCT02939287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84003300|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84003301|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003302|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003303|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003304|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
84003305|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84003306|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
84003307|NCT05323201|Fludarabine|fludarabine|mesh-list
84003308|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84003309|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
84003310|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003311|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003312|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84003313|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
84003314|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003315|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003316|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84003317|NCT01208051|Lenalidomide|lenalidomide|mesh-list
84003318|NCT01208051|Cediranib|cediranib|mesh-list
84003319|NCT01208051|Maleic acid|maleic acid|mesh-list
84003320|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
84003321|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243052|NCT01675141|Lenalidomide|lenalidomide|mesh-list
84003322|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84003323|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84003324|NCT01208051|Growth Substances|growth substances|mesh-ancestor
84003325|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
84003326|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003327|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003328|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003329|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003330|NCT05322889|Telmisartan|telmisartan|mesh-list
84003331|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84003332|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84003333|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84003334|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003335|NCT00616915|Bupropion|bupropion|mesh-list
84003336|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84003337|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
84003338|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84003339|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84003340|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84003341|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003342|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003343|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
84003344|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003345|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003346|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84003347|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003348|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003349|NCT05410223|Amoxicillin|amoxicillin|mesh-list
84003350|NCT05410223|Clarithromycin|clarithromycin|mesh-list
84003351|NCT05410223|Doxycycline|doxycycline|mesh-list
84003352|NCT05410223|Furazolidone|furazolidone|mesh-list
84003353|NCT05410223|Bismuth|bismuth|mesh-list
84003354|NCT05410223|Antibodies|antibodies|mesh-list
84003355|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
84003356|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
84003357|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003358|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84003359|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003360|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84003361|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003362|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003363|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84003364|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003365|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
84003366|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84003367|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84003368|NCT05410223|Antacids|antacids|mesh-ancestor
84003369|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003370|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84003371|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84003372|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84003373|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84003374|NCT01206101|Liraglutide|liraglutide|mesh-list
84003375|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84003376|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003377|NCT01206101|Incretins|incretins|mesh-ancestor
84003378|NCT01206101|Hormones|hormones|mesh-ancestor
84003379|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003380|NCT00997503|Aspirin|aspirin|mesh-list
84003381|NCT00997503|Paclitaxel|paclitaxel|mesh-list
84003382|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84003383|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84003384|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003385|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
84003386|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
84003387|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
84003388|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003389|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84003390|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84003391|NCT00997503|Analgesics|analgesics|mesh-ancestor
84003392|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
84003393|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003394|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003395|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003396|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003397|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84003398|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84003399|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84003400|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84003401|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003402|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
84003403|NCT02705053|Insulin|insulin|mesh-list
84003404|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84003405|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003406|NCT01204775|Metformin|metformin|mesh-list
84003407|NCT01204775|Saxagliptin|saxagliptin|mesh-list
84003408|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84003409|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003410|NCT01204775|Incretins|incretins|mesh-ancestor
84003411|NCT01204775|Hormones|hormones|mesh-ancestor
84003412|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003413|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84003414|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
84003415|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003416|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003417|NCT02844907|Dexamethasone|dexamethasone|mesh-list
84003418|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003419|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
84003420|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
84003421|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003422|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003423|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003424|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
84003425|NCT02844907|Hormones|hormones|mesh-ancestor
84003426|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003427|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84003428|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003429|NCT00628719|Amphotericin B|amphotericin b|mesh-list
84003430|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84003431|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
84003432|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
84003433|NCT00628719|Amebicides|amebicides|mesh-ancestor
84003434|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84003435|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84003436|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003437|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84003438|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
84003439|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84003440|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003441|NCT00616993|Difluprednate|difluprednate|mesh-list
84003442|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
84003443|NCT00616993|Hormones|hormones|mesh-ancestor
84048343|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003444|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003445|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003446|NCT02870361|Insulin|insulin|mesh-list
84003447|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84003448|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003449|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
84003450|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
84003451|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84003452|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84003453|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003454|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003455|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84003456|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84003457|NCT00997035|Voriconazole|voriconazole|mesh-list
84003458|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
84003459|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003460|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84003461|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003462|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003463|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003464|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84003465|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
84003466|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003467|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003468|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84003469|NCT01204697|Docetaxel|docetaxel|mesh-list
84003470|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84003471|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003472|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
84003473|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
84003474|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
84003475|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003476|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003477|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003478|NCT01203917|Gefitinib|gefitinib|mesh-list
84003479|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003480|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003481|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003482|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003483|NCT04213495|Anesthetics|anesthetics|mesh-list
84003484|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003485|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003486|NCT04318223|Palbociclib|palbociclib|mesh-list
84003487|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003488|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003489|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003490|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003491|NCT01202903|Omalizumab|omalizumab|mesh-list
84003492|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84003493|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84003494|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
84003495|NCT00618631|Carfentanil|carfentanil|mesh-list
84003496|NCT00618631|Nicotine|nicotine|mesh-list
84003497|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84003498|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
84003499|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003500|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003501|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84003502|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84003503|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
84003504|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003505|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003506|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84003507|NCT00618631|Narcotics|narcotics|mesh-ancestor
84003508|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003509|NCT00618631|Analgesics|analgesics|mesh-ancestor
84003510|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
84003511|NCT04213573|Fluorides|fluorides|mesh-list
84003512|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
84003513|NCT04213573|Protective Agents|protective agents|mesh-ancestor
84003514|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003515|NCT00620269|Irinotecan|irinotecan|mesh-list
84003516|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84003517|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003518|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84003519|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84003520|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003521|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003522|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003523|NCT04212403|Levofloxacin|levofloxacin|mesh-list
84003524|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84003525|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003526|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84003527|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84003528|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84003529|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003530|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003531|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003532|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84003533|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003534|NCT00637117|Interferons|interferons|mesh-list
84003535|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
84003536|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003537|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
84003538|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003539|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
84003540|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003541|NCT02052193|Vemurafenib|vemurafenib|mesh-list
84003542|NCT02052193|Dabrafenib|dabrafenib|mesh-list
83243287|NCT04930133|Afatinib|afatinib|mesh-list
84003543|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003544|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003545|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003546|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003547|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
84003548|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84003549|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84003550|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
84003551|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003552|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003553|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003554|NCT00619021|Gemcitabine|gemcitabine|mesh-list
84003555|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84003556|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
84003557|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003558|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003559|NCT00620347|Sunitinib|sunitinib|mesh-list
84003560|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003561|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84003562|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84003563|NCT00620347|Growth Substances|growth substances|mesh-ancestor
84003564|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003565|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
84003566|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003567|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003568|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003569|NCT04213105|Denosumab|denosumab|mesh-list
84003570|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84003571|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003572|NCT01887301|Nabiximols|nabiximols|mesh-list
84003573|NCT01887301|Analgesics|analgesics|mesh-ancestor
84003574|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
84003575|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003576|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003577|NCT00996801|Vitamin D|vitamin d|mesh-list
84003578|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
84003579|NCT00996801|Alendronate|alendronate|mesh-list
84003580|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
84003581|NCT00996801|Calcium|calcium|mesh-list
84003582|NCT00996801|Vitamins|vitamins|mesh-ancestor
84003583|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
84003584|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003585|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84003586|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84003587|NCT00996801|Antacids|antacids|mesh-ancestor
84003588|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003589|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003590|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84003591|NCT00619333|Hormones|hormones|mesh-ancestor
84003592|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003593|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003594|NCT04924621|Midazolam|midazolam|mesh-list
84003595|NCT04924621|Sufentanil|sufentanil|mesh-list
84003596|NCT04924621|Propofol|propofol|mesh-list
84003597|NCT04924621|Tetracaine|tetracaine|mesh-list
84003598|NCT04924621|Rocuronium|rocuronium|mesh-list
84003599|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84003600|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003601|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003602|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84003603|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
84003604|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
84003605|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84003606|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84003607|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84003608|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84003609|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
84003610|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
84003611|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003612|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003613|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84003614|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84003615|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84003616|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003617|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84003618|NCT04924621|Narcotics|narcotics|mesh-ancestor
83243353|NCT04910477|Analgesics|analgesics|mesh-ancestor
84003619|NCT04924621|Analgesics|analgesics|mesh-ancestor
84003620|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
84003621|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003622|NCT00516373|Olaparib|olaparib|mesh-list
84003623|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84003624|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003625|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003626|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003627|NCT02213497|Paclitaxel|paclitaxel|mesh-list
84003628|NCT02213497|Carboplatin|carboplatin|mesh-list
84003629|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84003630|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84003631|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003632|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
84003633|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
84003634|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
84003635|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003636|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84003637|NCT02193841|Calcium|calcium|mesh-list
84003638|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84003639|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003640|NCT00618163|Meloxicam|meloxicam|mesh-list
84003641|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84003642|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84003643|NCT00618163|Analgesics|analgesics|mesh-ancestor
84003644|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
84003645|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003646|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003647|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003648|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003649|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84003650|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84003651|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003652|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003653|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
84003654|NCT00618241|Lamotrigine|lamotrigine|mesh-list
84003655|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84003656|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84003657|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
84003658|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003659|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84003660|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84003661|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003662|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003663|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
84003664|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84003665|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003666|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84003667|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003668|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84003669|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84003670|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003671|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84003672|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84003673|NCT00618397|Ketamine|ketamine|mesh-list
84003674|NCT00618397|Analgesics|analgesics|mesh-ancestor
84003675|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
84003676|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003677|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003678|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84003679|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84003680|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
84003681|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
84003682|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003683|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84003684|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84003685|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003686|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003687|NCT04211545|Rabeprazole|rabeprazole|mesh-list
84003688|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84003689|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003690|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84003691|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003692|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243426|NCT04928495|Expectorants|expectorants|mesh-ancestor
84003693|NCT00620581|Paroxetine|paroxetine|mesh-list
84003694|NCT00620581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84003695|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84003696|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003697|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003698|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003699|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
84003700|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003701|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84003702|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
84003703|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84003704|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84003705|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003706|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003707|NCT01000311|Vaccines|vaccines|mesh-list
84003708|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84003709|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
84003710|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003711|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84003712|NCT04209439|Bupivacaine|bupivacaine|mesh-list
84003713|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003714|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
84003715|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003716|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003717|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
84003718|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003719|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84003720|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84003721|NCT04209439|Analgesics|analgesics|mesh-ancestor
84003722|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003723|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003724|NCT05228041|Benralizumab|benralizumab|mesh-list
84003725|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84003726|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
84003727|NCT01003899|Afatinib|afatinib|mesh-list
84003728|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003729|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003730|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003731|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003732|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
84003733|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003734|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003735|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84003736|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84003737|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003738|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003739|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84003740|NCT04160377|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84003741|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84003742|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84003743|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003744|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
84003745|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84003746|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
84003747|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84003748|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003749|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84003750|NCT01000155|Vorinostat|vorinostat|mesh-list
84003751|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003752|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84003753|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003754|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003755|NCT00999921|Tamoxifen|tamoxifen|mesh-list
84003756|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
84003757|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84003758|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
84003759|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003760|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003761|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84003762|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003763|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84003764|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84003765|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84003766|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84003767|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84003768|NCT00999921|Analgesics|analgesics|mesh-ancestor
84003769|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
84003770|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003771|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003772|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003773|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84003774|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
84003775|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003776|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84003777|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
84003778|NCT02869347|Complement C1s|complement c1s|mesh-list
84003779|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
84003780|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
84003781|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
84003782|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003783|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84003784|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84003785|NCT00621673|Factor VIII|factor viii|mesh-list
84003786|NCT00621673|Coagulants|coagulants|mesh-ancestor
84003787|NCT01002573|Acetaminophen|acetaminophen|mesh-list
84003788|NCT01002573|Ibuprofen|ibuprofen|mesh-list
84003789|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84003790|NCT01002573|Analgesics|analgesics|mesh-ancestor
84003791|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
84003792|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003793|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003794|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
84003795|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84003796|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003797|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003798|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84003799|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003800|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003801|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
84003802|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84003803|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84003804|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84003805|NCT04293549|Mitogens|mitogens|mesh-list
84003806|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
84003807|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003808|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84003809|NCT00996333|Gemcitabine|gemcitabine|mesh-list
84003810|NCT00996333|Capecitabine|capecitabine|mesh-list
84003811|NCT00996333|Docetaxel|docetaxel|mesh-list
84003812|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84003813|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
84003814|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003815|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003816|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
84003817|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
84003818|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
84003819|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
84003820|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
84003821|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
84003822|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003823|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003824|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
84003825|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003826|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
84003827|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
84003828|NCT01349101|Busulfan|busulfan|mesh-list
84003829|NCT01349101|Fludarabine|fludarabine|mesh-list
84003830|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
84003831|NCT01349101|Tacrolimus|tacrolimus|mesh-list
84003832|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84003833|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
84003834|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003835|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003836|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84003837|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
84003838|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003839|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003840|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84003841|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84003842|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
84003843|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003844|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84003845|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003846|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84003847|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84003848|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
84003849|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84003850|NCT00620971|Bevacizumab|bevacizumab|mesh-list
84003851|NCT00620971|Cisplatin|cisplatin|mesh-list
84003852|NCT00620971|Gemcitabine|gemcitabine|mesh-list
84003853|NCT00620971|Docetaxel|docetaxel|mesh-list
84003854|NCT00620971|Vinorelbine|vinorelbine|mesh-list
84003855|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84003856|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003857|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84003858|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84003859|NCT00620971|Growth Substances|growth substances|mesh-ancestor
84003860|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003861|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
84003862|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84003863|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
84003864|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003865|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
84003866|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
84003867|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
84003868|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84003869|NCT04223661|Dexamethasone|dexamethasone|mesh-list
84003870|NCT04223661|Lenalidomide|lenalidomide|mesh-list
84003871|NCT04223661|Daratumumab|daratumumab|mesh-list
84003872|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003873|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
84003874|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
84003875|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003876|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003877|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003878|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
84003879|NCT04223661|Hormones|hormones|mesh-ancestor
84003880|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003881|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84003882|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003883|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
84003884|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84003885|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84003886|NCT04223661|Growth Substances|growth substances|mesh-ancestor
84003887|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
84003888|NCT04268277|Rituximab|rituximab|mesh-list
84003889|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
84003890|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84003891|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003892|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
84003893|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003894|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84003895|NCT04268277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84003896|NCT04268277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003897|NCT00622141|Saquinavir|saquinavir|mesh-list
84003898|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84003899|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84003900|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
84003901|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003902|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003903|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84003904|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84003905|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
84003906|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003907|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84003908|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84003909|NCT04210765|Clomiphene|clomiphene|mesh-list
84003910|NCT04210765|Enclomiphene|enclomiphene|mesh-list
84003911|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
84003912|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84003913|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
84003914|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243650|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84003915|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003916|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84003917|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
84003918|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84003919|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84003920|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84003921|NCT03735901|Levodopa|levodopa|mesh-list
84003922|NCT03735901|Carbidopa|carbidopa|mesh-list
84003923|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84003924|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84003925|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
84003926|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003927|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003928|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003929|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84003930|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003931|NCT00621283|Secretin|secretin|mesh-list
84003932|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84003933|NCT00621283|Hormones|hormones|mesh-ancestor
84003934|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003935|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003936|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84003937|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
84003938|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003939|NCT05662189|Exenatide|exenatide|mesh-list
84003940|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84003941|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003942|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84003943|NCT05662189|Incretins|incretins|mesh-ancestor
84003944|NCT05662189|Hormones|hormones|mesh-ancestor
84003945|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003946|NCT00629031|Paromomycin|paromomycin|mesh-list
84003947|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84003948|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84003949|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84003950|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84003951|NCT00621361|Etoposide|etoposide|mesh-list
84003952|NCT00621361|Cediranib|cediranib|mesh-list
84003953|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84003954|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84003955|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84003956|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84003957|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84003958|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003959|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84003960|NCT04208581|Fluticasone|fluticasone|mesh-list
84003961|NCT04208581|Xhance|xhance|mesh-list
84003962|NCT04208581|Budesonide|budesonide|mesh-list
84003963|NCT04208581|Bromides|bromides|mesh-list
84003964|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
84003965|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
84003966|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84003967|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84003968|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84003969|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84003970|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
84003971|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84003972|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003973|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84003974|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
84003975|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
84003976|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84003977|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
84003978|NCT04208581|Hormones|hormones|mesh-ancestor
84003979|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84003980|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84003981|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84003982|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84003983|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
84003984|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84003985|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84003986|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
84003987|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84003988|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
84003989|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
84003990|NCT05368675|Buprenorphine|buprenorphine|mesh-list
84003991|NCT05368675|Methadone|methadone|mesh-list
84003992|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84003993|NCT05368675|Naloxone|naloxone|mesh-list
84003994|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84003995|NCT05368675|Narcotics|narcotics|mesh-ancestor
84003996|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84003997|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84003998|NCT05368675|Analgesics|analgesics|mesh-ancestor
84003999|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
84004000|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004001|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84004002|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
84004003|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
84004004|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
84004005|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004006|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004007|NCT05368207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84004008|NCT05368207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004009|NCT05368051|Capecitabine|capecitabine|mesh-list
84004010|NCT05368051|Antibodies|antibodies|mesh-list
84004011|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84004012|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
84004013|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004014|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004015|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
84004016|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004017|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004018|NCT02641873|Leucovorin|leucovorin|mesh-list
84004019|NCT02641873|Bevacizumab|bevacizumab|mesh-list
84004020|NCT02641873|Irinotecan|irinotecan|mesh-list
84004021|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
84004022|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004023|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004024|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84004025|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84004026|NCT02641873|Growth Substances|growth substances|mesh-ancestor
84004027|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004028|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
84004029|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84004030|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84004031|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004032|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004033|NCT02641873|Antidotes|antidotes|mesh-ancestor
84004034|NCT02641873|Protective Agents|protective agents|mesh-ancestor
84004035|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
84004036|NCT02641873|Vitamins|vitamins|mesh-ancestor
84004037|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
84004038|NCT00998985|Grazoprevir|grazoprevir|mesh-list
84004039|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
84004040|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004041|NCT05240391|Midodrine|midodrine|mesh-list
84004042|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
84004043|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
84004044|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004045|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004046|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84004047|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84004048|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84004049|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84004050|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
84004051|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004052|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004053|NCT00628953|Esomeprazole|esomeprazole|mesh-list
84004054|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84004055|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004056|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84004057|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004058|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004059|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84004060|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84004061|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84004062|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84004063|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004064|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004065|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004066|NCT04294953|Analgesics|analgesics|mesh-ancestor
84004067|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
84004068|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004069|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
84004070|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84004071|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
84004072|NCT02869815|Methylene Blue|methylene blue|mesh-list
84004073|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004074|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004075|NCT04293081|Maleic acid|maleic acid|mesh-list
84004076|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004077|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004078|NCT04205643|Infliximab|infliximab|mesh-list
84004079|NCT04205643|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84004080|NCT04205643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004081|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
84004082|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004083|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004084|NCT02868801|Pregabalin|pregabalin|mesh-list
84004085|NCT02868801|Analgesics|analgesics|mesh-ancestor
84004086|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
84004087|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004088|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004089|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
84004090|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84004091|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84004092|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004093|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84004094|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84004095|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84004096|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004097|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84004098|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
84004099|NCT01002339|Cyclosporine|cyclosporine|mesh-list
84004100|NCT01002339|Prednisone|prednisone|mesh-list
84004101|NCT01002339|Tacrolimus|tacrolimus|mesh-list
84004102|NCT01002339|Basiliximab|basiliximab|mesh-list
84004103|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004104|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
84004105|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004106|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84004107|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004108|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004109|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84004110|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004111|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84004112|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
84004113|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84004114|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004115|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004116|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
84004117|NCT01002339|Hormones|hormones|mesh-ancestor
84004118|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004119|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84004120|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
84004121|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
84004122|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004123|NCT01002105|Baclofen|baclofen|mesh-list
84004124|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84004125|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004126|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84004127|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004128|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84004129|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
84004130|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
84004131|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004132|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004133|NCT02605993|Ravulizumab|ravulizumab|mesh-list
84004134|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84004135|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004136|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
84004137|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004138|NCT00995085|Pyridoxine|pyridoxine|mesh-list
84004139|NCT00995085|Metadoxine|metadoxine|mesh-list
84004140|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84004141|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
84004142|NCT00995085|Vitamins|vitamins|mesh-ancestor
84004143|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
84004144|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004145|NCT00603733|Mesalamine|mesalamine|mesh-list
84004146|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004147|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004148|NCT00603733|Analgesics|analgesics|mesh-ancestor
84004149|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
84004150|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004151|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004152|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004153|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004154|NCT02471911|Dexamethasone|dexamethasone|mesh-list
84004155|NCT02471911|Rituximab|rituximab|mesh-list
84004156|NCT02471911|Carboplatin|carboplatin|mesh-list
84004157|NCT02471911|Etoposide|etoposide|mesh-list
84004158|NCT02471911|Ifosfamide|ifosfamide|mesh-list
84004159|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004160|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004161|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
84004162|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004163|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004164|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004165|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
84004166|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
84004167|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004168|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004169|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
84004170|NCT02471911|Hormones|hormones|mesh-ancestor
84004171|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004172|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84004173|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84004174|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84004175|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84004176|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004177|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004178|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84004179|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
84004180|NCT00622375|Mesalamine|mesalamine|mesh-list
84004181|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004182|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004183|NCT00622375|Analgesics|analgesics|mesh-ancestor
84004184|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
84004185|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004186|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004187|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004188|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004189|NCT02691325|Charcoal|charcoal|mesh-list
84004190|NCT02691325|Nemiralisib|nemiralisib|mesh-list
84004191|NCT02691325|Antidotes|antidotes|mesh-ancestor
84004192|NCT02691325|Protective Agents|protective agents|mesh-ancestor
84004193|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004194|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84004195|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004196|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004197|NCT01678027|Clarithromycin|clarithromycin|mesh-list
84004198|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84004199|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004200|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84004201|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004202|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004203|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84004204|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84004205|NCT02697331|Progesterone|progesterone|mesh-list
84004206|NCT02697331|Progestins|progestins|mesh-ancestor
84004207|NCT02697331|Hormones|hormones|mesh-ancestor
84004208|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004209|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004210|NCT04278625|Acetaminophen|acetaminophen|mesh-list
84004211|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004212|NCT04278625|Analgesics|analgesics|mesh-ancestor
84004213|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
84004214|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004215|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243953|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
84004216|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
84004217|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84004219|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84004220|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
84004221|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004222|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004223|NCT00622687|Iloprost|iloprost|mesh-list
84004224|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84004225|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
84004226|NCT02691403|Bupivacaine|bupivacaine|mesh-list
84004227|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
84004228|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
84004229|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
84004230|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004231|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004232|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
84004233|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004234|NCT00995007|Carboplatin|carboplatin|mesh-list
84004235|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004236|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
84004237|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84004238|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84004239|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004240|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
84004241|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004242|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004243|NCT00639925|Gemcitabine|gemcitabine|mesh-list
84004244|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004245|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
84004246|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004247|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004248|NCT00994461|Celecoxib|celecoxib|mesh-list
84004249|NCT00994461|Loxoprofen|loxoprofen|mesh-list
84004250|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004251|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004252|NCT00994461|Analgesics|analgesics|mesh-ancestor
84004253|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
84004254|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004255|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004256|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004257|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004258|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84004259|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84004260|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004261|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004262|NCT00993915|Atorvastatin|atorvastatin|mesh-list
84004263|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84004264|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84004265|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
84004266|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004267|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84004268|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84004269|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004270|NCT01202591|Fulvestrant|fulvestrant|mesh-list
84004271|NCT01202591|Exemestane|exemestane|mesh-list
84004272|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84004273|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004274|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84004275|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84004276|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
84004277|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004278|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004279|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84004280|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84004281|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004282|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004283|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
84004284|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
84004285|NCT01202279|Guaifenesin|guaifenesin|mesh-list
84004286|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
84004287|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84004288|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
83244033|NCT04913987|Cimetidine|cimetidine|mesh-list
84004289|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004290|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004291|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84004292|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
84004294|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84004295|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
84004296|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
84004297|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004298|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004299|NCT01202279|Expectorants|expectorants|mesh-ancestor
84004300|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84004301|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84004302|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
84004303|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84004304|NCT03877315|Cimetidine|cimetidine|mesh-list
84004305|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84004306|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004307|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84004308|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
84004309|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
84004310|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004311|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004312|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004313|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84004314|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84004315|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004316|NCT02687347|Morphine|morphine|mesh-list
84004317|NCT02687347|Methadone|methadone|mesh-list
84004318|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84004319|NCT02687347|Narcotics|narcotics|mesh-ancestor
84004320|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004321|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004322|NCT02687347|Analgesics|analgesics|mesh-ancestor
84004323|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
84004324|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004325|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
84004326|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
84004327|NCT02687425|Pioglitazone|pioglitazone|mesh-list
84004328|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
84004329|NCT02687425|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
84004330|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84004331|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004332|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004333|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84004334|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004335|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004336|NCT02687269|Ranolazine|ranolazine|mesh-list
84004337|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84004338|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84004339|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004340|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
84004341|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
84004342|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
84004343|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004344|NCT04185805|Fexuprazan|fexuprazan|mesh-list
84004345|NCT04185805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004346|NCT01201811|Azacitidine|azacitidine|mesh-list
84004347|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004348|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
84004349|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004350|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004351|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004352|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
84004353|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004354|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
84004355|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
84004356|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
84004357|NCT05392127|Vitamin K|vitamin k|mesh-list
84004358|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
84004359|NCT05392127|Repaglinide|repaglinide|mesh-list
84004360|NCT05392127|Midazolam|midazolam|mesh-list
84004361|NCT05392127|Omeprazole|omeprazole|mesh-list
84004362|NCT05392127|Warfarin|warfarin|mesh-list
84004363|NCT05392127|Vitamins|vitamins|mesh-ancestor
84004364|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
84004365|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004366|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84004367|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84004368|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004369|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84004370|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84004371|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84004372|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84004373|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
84004374|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
84004375|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
84004376|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
84004377|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004378|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004379|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
84004380|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84004381|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004382|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84004383|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004384|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84004385|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84004386|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
84004387|NCT05392127|Coagulants|coagulants|mesh-ancestor
84004388|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84004389|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84004390|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84004391|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84004392|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84004393|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004394|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004395|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
84004396|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004397|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84004398|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84004399|NCT04379011|Brivaracetam|brivaracetam|mesh-list
84004400|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
84004401|NCT02685163|Antioxidants|antioxidants|mesh-list
84004402|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004403|NCT02685163|Protective Agents|protective agents|mesh-ancestor
84004404|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004405|NCT00640003|Baclofen|baclofen|mesh-list
84004406|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84004407|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004408|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84004409|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004410|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84004411|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
84004412|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
84004413|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004414|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004415|NCT01201343|Interferons|interferons|mesh-list
84004416|NCT01201343|Interferon-beta|interferon-beta|mesh-list
84004417|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
84004418|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004419|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
84004420|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004421|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
84004422|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004423|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84004424|NCT04185649|Capecitabine|capecitabine|mesh-list
84004425|NCT04185649|Lapatinib|lapatinib|mesh-list
84004426|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004427|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
84004428|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004429|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004430|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84004431|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004432|NCT01201265|Bevacizumab|bevacizumab|mesh-list
84004433|NCT01201265|Carboplatin|carboplatin|mesh-list
84004434|NCT01201265|Gemcitabine|gemcitabine|mesh-list
84004435|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004436|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004437|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84004438|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84004439|NCT01201265|Growth Substances|growth substances|mesh-ancestor
84004440|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004441|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
84004442|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004444|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004445|NCT04246801|Clobetasol|clobetasol|mesh-list
84004446|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004447|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
84004448|NCT04246801|Hormones|hormones|mesh-ancestor
84004449|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004450|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004451|NCT00638677|Sorbitol|sorbitol|mesh-list
84004452|NCT00638677|Cathartics|cathartics|mesh-ancestor
84004453|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004454|NCT01200485|Allopurinol|allopurinol|mesh-list
84004455|NCT01200485|Rasburicase|rasburicase|mesh-list
84004456|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
84004457|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004458|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004459|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
84004460|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004461|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84004462|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
84004463|NCT01200485|Protective Agents|protective agents|mesh-ancestor
84004464|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004465|NCT02688907|Adavosertib|adavosertib|mesh-list
84004466|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004467|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004468|NCT02686645|Metronidazole|metronidazole|mesh-list
84004469|NCT02686645|Vancomycin|vancomycin|mesh-list
84004470|NCT02686645|Loperamide|loperamide|mesh-list
84004471|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
84004472|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004473|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84004474|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84004475|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84004476|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004477|NCT04318067|Melatonin|melatonin|mesh-list
84004478|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
84004479|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004480|NCT04318067|Protective Agents|protective agents|mesh-ancestor
84004481|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004482|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004483|NCT01200407|Amlodipine|amlodipine|mesh-list
84004484|NCT01200407|Olmesartan|olmesartan|mesh-list
84004485|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84004486|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84004487|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84004488|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048344|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
84004489|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004490|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84004491|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004492|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
84004493|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84004494|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84004495|NCT02685085|Misoprostol|misoprostol|mesh-list
84004496|NCT02685085|Dinoprostone|dinoprostone|mesh-list
84004497|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84004498|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
84004499|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84004500|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004501|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84004502|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004503|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
84004504|NCT02688595|Anesthetics|anesthetics|mesh-list
84004505|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004506|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004507|NCT01200329|Gemcitabine|gemcitabine|mesh-list
84004508|NCT01200329|Melphalan|melphalan|mesh-list
84004509|NCT01200329|Busulfan|busulfan|mesh-list
84004510|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004511|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
84004512|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004513|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004514|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84004515|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
84004516|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83244254|NCT04882163|Dexamethasone|dexamethasone|mesh-list
84004517|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004518|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
84004519|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004520|NCT01199939|Ritonavir|ritonavir|mesh-list
84004521|NCT01199939|Darunavir|darunavir|mesh-list
84004522|NCT01199939|Etravirine|etravirine|mesh-list
84004523|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84004524|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84004525|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
84004526|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004527|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004528|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84004529|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84004530|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
84004531|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004532|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84004533|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84004534|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84004535|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84004536|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
84004537|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84004538|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84004539|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
84004540|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004541|NCT02688361|Expectorants|expectorants|mesh-ancestor
84004542|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
84004543|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84004544|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
84004545|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004546|NCT02688361|Protective Agents|protective agents|mesh-ancestor
84004547|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004548|NCT02688361|Antidotes|antidotes|mesh-ancestor
84004549|NCT01199861|Vaccines|vaccines|mesh-list
84004550|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
84004551|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
84004552|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004553|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84004554|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004555|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004556|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
84004557|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84004558|NCT00640081|Leucovorin|leucovorin|mesh-list
84004559|NCT00640081|Fluorouracil|fluorouracil|mesh-list
84004560|NCT00640081|Capecitabine|capecitabine|mesh-list
84004561|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
84004562|NCT00640081|Cetuximab|cetuximab|mesh-list
84004563|NCT00640081|Calcium|calcium|mesh-list
84004564|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
84004565|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84004566|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004567|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
84004568|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004569|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004570|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004571|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004572|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
84004573|NCT00640081|Antidotes|antidotes|mesh-ancestor
84004574|NCT00640081|Protective Agents|protective agents|mesh-ancestor
84004575|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
84004576|NCT00640081|Vitamins|vitamins|mesh-ancestor
84004577|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
84004578|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004579|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
84004580|NCT01199705|Antibodies|antibodies|mesh-list
84004581|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
84004582|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84004583|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84004584|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
84004585|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004586|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
84004587|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84004588|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84004589|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004590|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
84004591|NCT02688127|Coagulants|coagulants|mesh-ancestor
84004592|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84004593|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004594|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84004595|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004596|NCT00638833|Memantine|memantine|mesh-list
84004597|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84004598|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84004599|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
84004600|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004601|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004602|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004603|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84004604|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84004605|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
84004606|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004607|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004608|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004609|NCT01198145|Analgesics|analgesics|mesh-ancestor
84004610|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
84004611|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004612|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004613|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004614|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004615|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84004616|NCT01179048|Liraglutide|liraglutide|mesh-list
84004617|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84004618|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004619|NCT01179048|Incretins|incretins|mesh-ancestor
84004620|NCT01179048|Hormones|hormones|mesh-ancestor
84004621|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004622|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84004623|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84004624|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84004625|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84004626|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004627|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004628|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004629|NCT00603265|Analgesics|analgesics|mesh-ancestor
84004630|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
84004631|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004632|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
84004633|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84004634|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
84004635|NCT02686177|Metformin|metformin|mesh-list
84004636|NCT02686177|Liraglutide|liraglutide|mesh-list
84004637|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84004638|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004639|NCT02686177|Incretins|incretins|mesh-ancestor
84004640|NCT02686177|Hormones|hormones|mesh-ancestor
84004641|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004642|NCT02686021|Dipyrone|dipyrone|mesh-list
84004643|NCT02686021|Ibuprofen|ibuprofen|mesh-list
84004644|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004645|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004646|NCT02686021|Analgesics|analgesics|mesh-ancestor
84004647|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
84004648|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004649|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004650|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004651|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004652|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84004653|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004654|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004655|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
84004656|NCT01158534|Interferons|interferons|mesh-list
84004657|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
84004658|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
84004659|NCT01158534|Celecoxib|celecoxib|mesh-list
84004660|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004661|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
84004662|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004663|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
84004664|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004665|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004666|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004667|NCT01158534|Analgesics|analgesics|mesh-ancestor
84004668|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
84004669|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004670|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004671|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004672|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84004673|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84004674|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004675|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004676|NCT02687971|Miltefosine|miltefosine|mesh-list
84004677|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
84004678|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004679|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004680|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84004681|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84004682|NCT05272878|Irbesartan|irbesartan|mesh-list
84004683|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84004684|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84004685|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84004686|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004687|NCT02683213|Fluoxetine|fluoxetine|mesh-list
84004688|NCT02683213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84004689|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84004690|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84004691|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004692|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004693|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
84004694|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004695|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84004696|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
84004697|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84004698|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84004699|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84004700|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004701|NCT04185103|Valsartan|valsartan|mesh-list
84004702|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84004703|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84004704|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84004705|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84004706|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004707|NCT04033939|Propofol|propofol|mesh-list
84004708|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84004709|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004710|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004711|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84004712|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
84004713|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
84004714|NCT00639691|Omalizumab|omalizumab|mesh-list
84004715|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84004716|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84004717|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
84004718|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
84004719|NCT02684071|Methotrexate|methotrexate|mesh-list
84004720|NCT02684071|Topotecan|topotecan|mesh-list
84004721|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004722|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
84004723|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004724|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004725|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84004726|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
84004727|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004728|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004729|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84004730|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84004731|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
84004732|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84004733|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004734|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
84004735|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
84004736|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004737|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84004738|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84004739|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84004740|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84004741|NCT00640159|Selegiline|selegiline|mesh-list
84004742|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
84004743|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84004744|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84004745|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84004746|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84004747|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004748|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004749|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84004750|NCT00640159|Protective Agents|protective agents|mesh-ancestor
84004751|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004752|NCT00640861|Vaccines|vaccines|mesh-list
84004753|NCT00640861|Sargramostim|sargramostim|mesh-list
84004754|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
84004755|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
84004756|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004757|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84004758|NCT00602797|Paclitaxel|paclitaxel|mesh-list
84004759|NCT00602797|Vinorelbine|vinorelbine|mesh-list
84004760|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84004761|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84004762|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004763|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
84004764|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
84004765|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
84004766|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004767|NCT01158222|Sunitinib|sunitinib|mesh-list
84004768|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004769|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84004770|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84004771|NCT01158222|Growth Substances|growth substances|mesh-ancestor
84004772|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004773|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
84004774|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84004775|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004776|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004777|NCT02684305|Oxytocin|oxytocin|mesh-list
84004778|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
84004779|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84004780|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004781|NCT02940769|Methamphetamine|methamphetamine|mesh-list
84004782|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84004783|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004784|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
84004785|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
84004786|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004787|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
84004788|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004789|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004790|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
84004791|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84004792|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84004793|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84004794|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84004795|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
84004796|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84004797|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
84004798|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84004799|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004800|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004801|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
84004802|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
84004803|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004804|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
84004805|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84004806|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
84004807|NCT02683291|Sirolimus|sirolimus|mesh-list
84004808|NCT02683291|Prednisone|prednisone|mesh-list
84004809|NCT02683291|Tacrolimus|tacrolimus|mesh-list
84004810|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
84004811|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84004812|NCT02683291|Basiliximab|basiliximab|mesh-list
84004813|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004814|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
83244557|NCT03047837|Analgesics|analgesics|mesh-ancestor
84004815|NCT02683291|Hormones|hormones|mesh-ancestor
84004816|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004817|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004818|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84004820|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004821|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
84004822|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84004823|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004824|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004825|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84004826|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84004827|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
84004828|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84004829|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004830|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
84004831|NCT02685397|Leuprolide|leuprolide|mesh-list
84004832|NCT02685397|Goserelin|goserelin|mesh-list
84004833|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84004834|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84004835|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
84004836|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84004837|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004838|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84004839|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004840|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
84004841|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84004842|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
84004843|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84004844|NCT02683837|Remifentanil|remifentanil|mesh-list
84004845|NCT02683837|Sevoflurane|sevoflurane|mesh-list
84004846|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84004847|NCT02683837|Narcotics|narcotics|mesh-ancestor
84004848|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004849|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004850|NCT02683837|Analgesics|analgesics|mesh-ancestor
84004851|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
84004852|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004853|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84004854|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84004855|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
84004856|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
84004857|NCT02680951|Cytarabine|cytarabine|mesh-list
84004858|NCT02680951|Fludarabine|fludarabine|mesh-list
84004859|NCT02680951|Dasatinib|dasatinib|mesh-list
84004860|NCT02680951|Idarubicin|idarubicin|mesh-list
84004861|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004862|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004863|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
84004864|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004865|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004866|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
84004867|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004868|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
84004869|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84004870|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84004871|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004872|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84004873|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84004874|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84004875|NCT02680717|Clobetasol|clobetasol|mesh-list
84004876|NCT02680717|Calcipotriene|calcipotriene|mesh-list
84004877|NCT02680717|Tacrolimus|tacrolimus|mesh-list
84004878|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004879|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
84004880|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004881|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84004882|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004883|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004884|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004885|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
84004886|NCT02680717|Hormones|hormones|mesh-ancestor
84004887|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84004888|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
84004889|NCT02680795|Belinostat|belinostat|mesh-list
84004890|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004891|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84004892|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004893|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004894|NCT00640237|Calcifediol|calcifediol|mesh-list
84004895|NCT00640237|Vitamins|vitamins|mesh-ancestor
84004896|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
84004897|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004898|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84004899|NCT02683759|Curcumin|curcumin|mesh-list
84004900|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004901|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004902|NCT02683759|Analgesics|analgesics|mesh-ancestor
84004903|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
84004904|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004905|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004906|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004907|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004908|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004909|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004910|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004911|NCT04292691|Ropivacaine|ropivacaine|mesh-list
84004912|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
84004913|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
84004914|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84004915|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004916|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
84004917|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004918|NCT00990249|Busulfan|busulfan|mesh-list
84004919|NCT00990249|Clofarabine|clofarabine|mesh-list
84004920|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
84004921|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84004922|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
84004923|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004924|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004925|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
84004926|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004927|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84004928|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004929|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84004930|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004931|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
84004932|NCT02846545|Golimumab|golimumab|mesh-list
84004933|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84004934|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004935|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004936|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
84004937|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004938|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
84004939|NCT04291755|Nivolumab|nivolumab|mesh-list
84004940|NCT04291755|Ipilimumab|ipilimumab|mesh-list
84004941|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004942|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004943|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84004944|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004945|NCT04292769|Decitabine|decitabine|mesh-list
84004946|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004947|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
84004948|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004949|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004950|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004951|NCT00640939|Diclofenac|diclofenac|mesh-list
84004952|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84004953|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84004954|NCT00640939|Analgesics|analgesics|mesh-ancestor
84004955|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
84004956|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84004957|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004958|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84004959|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004960|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84004961|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004962|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004963|NCT05663749|Metformin|metformin|mesh-list
84004964|NCT05663749|Topiramate|topiramate|mesh-list
84004965|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84004966|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004967|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
84004968|NCT02867553|Rituximab|rituximab|mesh-list
84004969|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004970|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004971|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
84004972|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004973|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84004974|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
84004975|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84004976|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004977|NCT00642577|Leucovorin|leucovorin|mesh-list
84004978|NCT00642577|Bevacizumab|bevacizumab|mesh-list
84004979|NCT00642577|Fluorouracil|fluorouracil|mesh-list
84004980|NCT00642577|Irinotecan|irinotecan|mesh-list
84004981|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84004982|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84004983|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84004984|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84004985|NCT00642577|Growth Substances|growth substances|mesh-ancestor
84004986|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84004987|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
84004988|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
84004989|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84004990|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84004991|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84004992|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
84004993|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84004994|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84004995|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84004996|NCT00642577|Antidotes|antidotes|mesh-ancestor
84004997|NCT00642577|Protective Agents|protective agents|mesh-ancestor
84004998|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
84004999|NCT00642577|Vitamins|vitamins|mesh-ancestor
84005000|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
84005001|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84005002|NCT02682121|Metformin|metformin|mesh-list
84005003|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84005004|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005005|NCT02683603|Imipenem|imipenem|mesh-list
84005006|NCT02683603|Colistin|colistin|mesh-list
84005007|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84005008|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005009|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
84005010|NCT00641095|Rituximab|rituximab|mesh-list
84005011|NCT00641095|Fludarabine|fludarabine|mesh-list
84005012|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005013|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
84005014|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005015|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005016|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005017|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
84005018|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005019|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005020|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84005021|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84005022|NCT01196975|Vaccines|vaccines|mesh-list
84005023|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
84005024|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005025|NCT00992589|Rabeprazole|rabeprazole|mesh-list
84005026|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84005027|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005028|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84005029|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005030|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005031|NCT01196741|Paclitaxel|paclitaxel|mesh-list
84005032|NCT01196741|Saracatinib|saracatinib|mesh-list
84005033|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84005034|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005035|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
84005036|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
84005037|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
84005038|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005039|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005040|NCT00629187|Temozolomide|temozolomide|mesh-list
84005041|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005042|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
84005043|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005044|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005045|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
84005046|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84005047|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005048|NCT00983385|Tapentadol|tapentadol|mesh-list
84005049|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84005050|NCT00983385|Narcotics|narcotics|mesh-ancestor
84005051|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005052|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005053|NCT00983385|Analgesics|analgesics|mesh-ancestor
84005054|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
84005055|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005056|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84005057|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84005058|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005059|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005060|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
84005061|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005062|NCT00992511|Vaccines|vaccines|mesh-list
84005063|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
84005064|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005065|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84005066|NCT02869035|Escitalopram|escitalopram|mesh-list
84005067|NCT02869035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84005068|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84005069|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005070|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005071|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005072|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
84005073|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005074|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005075|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
84005076|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005077|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84005078|NCT02869035|Analgesics|analgesics|mesh-ancestor
84005079|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
84005080|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
84005081|NCT04290819|Caffeine|caffeine|mesh-list
84005082|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84005083|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005084|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84005085|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005086|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005087|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84005088|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84005089|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
84005090|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005091|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
84005092|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84005093|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005094|NCT04157517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84005095|NCT04157517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005096|NCT01196429|Sirolimus|sirolimus|mesh-list
84005097|NCT01196429|Paclitaxel|paclitaxel|mesh-list
84005098|NCT01196429|Docetaxel|docetaxel|mesh-list
84005099|NCT01196429|Carboplatin|carboplatin|mesh-list
84005100|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84005101|NCT01196429|Temsirolimus|temsirolimus|mesh-list
84005102|NCT01196429|MTOR Inhibitors|mtor inhibitors|mesh-list
84005103|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84005104|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005105|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
84005106|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
84005107|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
84005108|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005109|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84005110|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005111|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84005112|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
84005113|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005114|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
84005115|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005116|NCT01196429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244861|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84005117|NCT01196429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005118|NCT01157364|Bimatoprost|bimatoprost|mesh-list
84005119|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84005120|NCT01195415|Gemcitabine|gemcitabine|mesh-list
84005121|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005122|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
84005123|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005124|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005125|NCT01195103|Fentanyl|fentanyl|mesh-list
84005126|NCT01195103|Midazolam|midazolam|mesh-list
84005127|NCT01195103|Propofol|propofol|mesh-list
84005128|NCT01195103|Fospropofol|fospropofol|mesh-list
84005129|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84005130|NCT01195103|Narcotics|narcotics|mesh-ancestor
84005131|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005132|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005133|NCT01195103|Analgesics|analgesics|mesh-ancestor
84005134|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
84005135|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005136|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84005137|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84005138|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
84005139|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
84005140|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84005141|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84005142|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84005143|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005144|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
84005145|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
84005146|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005147|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005148|NCT01194869|Paclitaxel|paclitaxel|mesh-list
84005149|NCT01194869|Cisplatin|cisplatin|mesh-list
84005150|NCT01194869|Sorafenib|sorafenib|mesh-list
84005151|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84005152|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005153|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
84005154|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
84005155|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
84005156|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005157|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84005158|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005159|NCT01177800|Infliximab|infliximab|mesh-list
84005160|NCT01177800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84005161|NCT01177800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005162|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
84005163|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005164|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005165|NCT01177722|Vaccines|vaccines|mesh-list
84005166|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
84005167|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005168|NCT02884986|Etoricoxib|etoricoxib|mesh-list
84005169|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84005170|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005171|NCT02884986|Analgesics|analgesics|mesh-ancestor
84005172|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
84005173|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005174|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005175|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005176|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005177|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84005178|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84005179|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005180|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005181|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
84005182|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84005183|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
84005184|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
84005185|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005186|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005187|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005188|NCT04124562|Analgesics|analgesics|mesh-ancestor
84005189|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
84005190|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005191|NCT01177410|Mesalamine|mesalamine|mesh-list
84005192|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84005193|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005194|NCT01177410|Analgesics|analgesics|mesh-ancestor
84005195|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
84005196|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005197|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005198|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005199|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005200|NCT02884596|Serotonin|serotonin|mesh-list
84005201|NCT02884596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
84005202|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84005203|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
84005204|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005205|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005206|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005207|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84005208|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005209|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
84005210|NCT04205916|Dexamethasone|dexamethasone|mesh-list
84005211|NCT04205916|Ketorolac|ketorolac|mesh-list
84005212|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005213|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
84005214|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
84005215|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005216|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005217|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005218|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
84005219|NCT04205916|Hormones|hormones|mesh-ancestor
84005220|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84005221|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84005222|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005223|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84005224|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005225|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84005226|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84005227|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005228|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005229|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84005230|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005231|NCT04205916|Analgesics|analgesics|mesh-ancestor
84005232|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
84005233|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005234|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84005235|NCT01176240|Mannitol|mannitol|mesh-list
84005236|NCT01176240|Droxidopa|droxidopa|mesh-list
84005237|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84005238|NCT01176240|Diuretics|diuretics|mesh-ancestor
84005239|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
84005240|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005241|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84005242|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84005243|NCT01149096|Lenograstim|lenograstim|mesh-list
84005244|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84005245|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
84005246|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005247|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
84005248|NCT02867397|Epirubicin|epirubicin|mesh-list
84005249|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005250|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84005251|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84005252|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84005253|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005254|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005255|NCT01175382|Tamsulosin|tamsulosin|mesh-list
84005256|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84005257|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84005258|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84005259|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84005260|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
84005261|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005262|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005263|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005264|NCT01175382|Urological Agents|urological agents|mesh-ancestor
84005265|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84005266|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84005267|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
84005268|NCT01194245|Insulin|insulin|mesh-list
84005269|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84005270|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
84005271|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
84005272|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
84005273|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
84005274|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84005275|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005276|NCT00979407|Vaccines|vaccines|mesh-list
84005277|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
84005278|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005279|NCT04290429|Teduglutide|teduglutide|mesh-list
84005280|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005281|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84005282|NCT04290429|Protective Agents|protective agents|mesh-ancestor
84005283|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005284|NCT00975975|Basiliximab|basiliximab|mesh-list
84005285|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005286|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
84005287|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005288|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84005289|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84005290|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84005291|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005292|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005293|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005294|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84005295|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84005296|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
84005297|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005298|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005299|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84005300|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84005301|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
84005302|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
84005303|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005304|NCT04289883|Calcium|calcium|mesh-list
84005305|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84005306|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005307|NCT02865369|Asunaprevir|asunaprevir|mesh-list
84005308|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
84005309|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005310|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005311|NCT01192295|Oxycodone|oxycodone|mesh-list
84005312|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84005313|NCT01192295|Narcotics|narcotics|mesh-ancestor
84005314|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005315|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005316|NCT01192295|Analgesics|analgesics|mesh-ancestor
84005317|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
84005318|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005319|NCT04289103|Inolimomab|inolimomab|mesh-list
84005320|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005321|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
84005322|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005323|NCT01154166|Ropinirole|ropinirole|mesh-list
84005324|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84005325|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84005326|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
84005327|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
84005328|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005329|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005330|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005331|NCT04290195|Aflibercept|aflibercept|mesh-list
84005332|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84005333|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84005334|NCT04290195|Growth Substances|growth substances|mesh-ancestor
84005335|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005336|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
84005337|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005338|NCT05656703|Anesthetics|anesthetics|mesh-list
84005339|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005340|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005341|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
84005342|NCT05656079|Docetaxel|docetaxel|mesh-list
84005343|NCT05656079|Doxorubicin|doxorubicin|mesh-list
84005344|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84005345|NCT05656079|Trastuzumab|trastuzumab|mesh-list
84005346|NCT05656079|Epirubicin|epirubicin|mesh-list
84005347|NCT05656079|Pertuzumab|pertuzumab|mesh-list
84005348|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005349|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
84005350|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005351|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005352|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005353|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
84005354|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005355|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005356|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84005357|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
84005358|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
84005359|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
84005360|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84005361|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84005362|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84005363|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005364|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84005365|NCT01181921|Galantamine|galantamine|mesh-list
84005366|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84005367|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005368|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005369|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
84005370|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005371|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005372|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84005373|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
84005374|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005375|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
84005376|NCT00932698|Ixazomib|ixazomib|mesh-list
84005377|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005378|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
84005379|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005380|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005381|NCT00978627|Insulin|insulin|mesh-list
84005382|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84005383|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
84005384|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
84005385|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84005386|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
84005387|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84005388|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005389|NCT01181609|Bevacizumab|bevacizumab|mesh-list
84005390|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84005391|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005392|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84005393|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84005394|NCT01181609|Growth Substances|growth substances|mesh-ancestor
84005395|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005396|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
84005397|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
84005398|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84005399|NCT04261426|Antibodies|antibodies|mesh-list
84005400|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
84005401|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84005402|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
84005403|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005404|NCT04264078|Fludarabine|fludarabine|mesh-list
84005405|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
84005406|NCT04264078|Melphalan|melphalan|mesh-list
84005407|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005408|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005409|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005410|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
84005411|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005412|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005413|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005414|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
84005415|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84005416|NCT01153698|Dabigatran|dabigatran|mesh-list
84005417|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
84005418|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84005419|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
84005420|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005421|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005422|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
84005423|NCT00608218|Ciclesonide|ciclesonide|mesh-list
84005424|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
84005425|NCT00608218|Hormones|hormones|mesh-ancestor
84005426|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84005427|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005428|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84005429|NCT02884050|Topiramate|topiramate|mesh-list
84005430|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
84005431|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84005432|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005433|NCT00609934|Sorafenib|sorafenib|mesh-list
84005434|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005435|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84005436|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005437|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005438|NCT01147926|Prucalopride|prucalopride|mesh-list
84005439|NCT01147926|Laxatives|laxatives|mesh-ancestor
84005440|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005441|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
84005442|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84005443|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
84005444|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005445|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005446|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005447|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
84005448|NCT05115136|Promethazine|promethazine|mesh-list
84005449|NCT05115136|Doxepin|doxepin|mesh-list
84005450|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84005451|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84005452|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005453|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005454|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
84005455|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
84005456|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
84005457|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005458|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
84005459|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
84005460|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005461|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84005462|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
84005463|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
84005464|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005465|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005466|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84005467|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
84005468|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
84005469|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84005470|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
84005471|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005472|NCT00608374|Fludarabine|fludarabine|mesh-list
84005473|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
84005474|NCT00608374|Chlorambucil|chlorambucil|mesh-list
84005475|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005476|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005477|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
84005478|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005479|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005480|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
84005481|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005482|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005483|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
84005484|NCT00625014|Haloperidol|haloperidol|mesh-list
84005485|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
84005486|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
84005487|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
84005488|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005489|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005490|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005491|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84005492|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84005493|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005494|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005495|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84005496|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
84005497|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005498|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005499|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84005501|NCT01147848|Xhance|xhance|mesh-list
84005502|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84005503|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005504|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84005505|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
84005506|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005507|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005508|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84005509|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
84005510|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
84005511|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84005512|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84005513|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84005514|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84005515|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
84005516|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005517|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005518|NCT04261270|Ritonavir|ritonavir|mesh-list
84005519|NCT04261270|Oseltamivir|oseltamivir|mesh-list
84005520|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84005521|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84005522|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
84005523|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005524|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005525|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84005526|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84005527|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
84005528|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005529|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84005530|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84005531|NCT01152996|Vortioxetine|vortioxetine|mesh-list
84005532|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
84005533|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005534|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84005535|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84005536|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005537|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005538|NCT01152996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84005539|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84005540|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005541|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005542|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005543|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
84005544|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84005545|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84005546|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84005547|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84005548|NCT00624936|Azacitidine|azacitidine|mesh-list
84005549|NCT00624936|Bortezomib|bortezomib|mesh-list
84005550|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005551|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
84005552|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005553|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005554|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005555|NCT00979953|Oxycodone|oxycodone|mesh-list
84005556|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84005557|NCT00979953|Narcotics|narcotics|mesh-ancestor
84005558|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005559|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005560|NCT00979953|Analgesics|analgesics|mesh-ancestor
84005561|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
84005562|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005563|NCT01181531|Vitamin D|vitamin d|mesh-list
84005564|NCT01181531|Cinacalcet|cinacalcet|mesh-list
84005565|NCT01181531|Vitamins|vitamins|mesh-ancestor
84005566|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
84005567|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005568|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84005569|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84005570|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
84005571|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
84005572|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84005573|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
84005574|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84005575|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
84005576|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005577|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005578|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84005579|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
84005580|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
84005581|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84005582|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
84005583|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005584|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005586|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005587|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84005588|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005589|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005590|NCT01181141|Enoxaparin|enoxaparin|mesh-list
84005591|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
84005592|NCT01181141|Edoxaban|edoxaban|mesh-list
84005593|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
84005594|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84005595|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84005596|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005597|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84005598|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
84005599|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84005600|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
84005601|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005602|NCT00606814|Docetaxel|docetaxel|mesh-list
84005603|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005604|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
84005605|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
84005606|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
84005607|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005608|NCT01173120|Abatacept|abatacept|mesh-list
84005609|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84005610|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005611|NCT01173120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84005612|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005613|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005614|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
84005615|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005616|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005617|NCT00977379|Capecitabine|capecitabine|mesh-list
84005618|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005619|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
84005620|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005621|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005622|NCT04263844|Midazolam|midazolam|mesh-list
84005623|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
84005624|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84005625|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005626|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005627|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005628|NCT04263844|Analgesics|analgesics|mesh-ancestor
84005629|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
84005630|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005631|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84005632|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84005633|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84005634|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
84005635|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005636|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005637|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84005638|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84005639|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84005640|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005641|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84005642|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
84005643|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
84005644|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
84005645|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
84005646|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
84005647|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84005648|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84005649|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005650|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
84005651|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
84005652|NCT04067115|Alovudine|alovudine|mesh-list
84005653|NCT04067115|Irinotecan|irinotecan|mesh-list
84005654|NCT04067115|Trabectedin|trabectedin|mesh-list
84005655|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84005656|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84005657|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005658|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005659|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005660|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005661|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
84005662|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
84005663|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005664|NCT02884128|Leucovorin|leucovorin|mesh-list
84005665|NCT02884128|Fluorouracil|fluorouracil|mesh-list
84005666|NCT02884128|Irinotecan|irinotecan|mesh-list
84005667|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
84005668|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005669|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005670|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005671|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005672|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
84005673|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005674|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84005675|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84005676|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005677|NCT02884128|Antidotes|antidotes|mesh-ancestor
84005678|NCT02884128|Protective Agents|protective agents|mesh-ancestor
84005679|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
84005680|NCT02884128|Vitamins|vitamins|mesh-ancestor
84005681|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
84005682|NCT00629343|Azacitidine|azacitidine|mesh-list
84005683|NCT00629343|Temozolomide|temozolomide|mesh-list
84005684|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005685|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
84005686|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005687|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005688|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005689|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005690|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
84005691|NCT01180049|Sirolimus|sirolimus|mesh-list
84005692|NCT01180049|Temsirolimus|temsirolimus|mesh-list
84005693|NCT01180049|MTOR Inhibitors|mtor inhibitors|mesh-list
84005694|NCT01180049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84005695|NCT01180049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005696|NCT01180049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005697|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005698|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
84005699|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005700|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005701|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84005702|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005703|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84005704|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
84005705|NCT01147458|Naproxen|naproxen|mesh-list
84005706|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84005707|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005708|NCT01147458|Analgesics|analgesics|mesh-ancestor
84005709|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
84005710|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005711|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005712|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005713|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005714|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
84005715|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84005716|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005717|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005718|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
84005719|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84005720|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84005721|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
84005722|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005723|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005724|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84005725|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
84005726|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
84005727|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84005728|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
84005729|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005730|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005731|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84005732|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84005733|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84005734|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
84005735|NCT04315194|Clarithromycin|clarithromycin|mesh-list
84005736|NCT04315194|Oseltamivir|oseltamivir|mesh-list
84005737|NCT04315194|Naproxen|naproxen|mesh-list
84005738|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84005739|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005740|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84005741|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005742|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005743|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84005744|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84005745|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84005746|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005747|NCT04315194|Analgesics|analgesics|mesh-ancestor
84005748|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
84005749|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005750|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005751|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005752|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005753|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
84005754|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84005755|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
84005756|NCT04066491|Gemcitabine|gemcitabine|mesh-list
84005757|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005758|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005759|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
84005760|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005761|NCT01149486|Losartan|losartan|mesh-list
84005762|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84005763|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84005764|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84005765|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84005766|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84005767|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005768|NCT01149486|Diuretics|diuretics|mesh-ancestor
84005769|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
84005770|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005771|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84005772|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005773|NCT00640471|Cetuximab|cetuximab|mesh-list
84005774|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84005775|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005776|NCT00601705|Fluorouracil|fluorouracil|mesh-list
84005777|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
84005778|NCT00601705|Epirubicin|epirubicin|mesh-list
84005779|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005780|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
84005781|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005782|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005783|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005784|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
84005785|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005786|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84005787|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84005788|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84005789|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005790|NCT00641173|Paroxetine|paroxetine|mesh-list
84005791|NCT00641173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84005792|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84005793|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005794|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005795|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005796|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
84005797|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245545|NCT04850417|Aspirin|aspirin|mesh-list
84005798|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84005799|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
84005800|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84005801|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84005802|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84005803|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005804|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
84005805|NCT00929110|Bromides|bromides|mesh-list
84005806|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
84005807|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84005808|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
84005809|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005810|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005811|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84005812|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
84005813|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
84005814|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84005815|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
84005816|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005817|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005818|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
84005819|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84005820|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84005821|NCT00922519|Listerine|listerine|mesh-list
84005822|NCT00922519|Fluorides|fluorides|mesh-list
84005823|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
84005824|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
84005825|NCT00922519|Protective Agents|protective agents|mesh-ancestor
84005826|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005827|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84005828|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005829|NCT00640549|Atorvastatin|atorvastatin|mesh-list
84005830|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84005831|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84005832|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
84005833|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005834|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84005835|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84005836|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005837|NCT02683369|Iron|iron|mesh-list
84005838|NCT02683369|Trace Elements|trace elements|mesh-ancestor
84005839|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
84005840|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005841|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
84005842|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
84005843|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
84005844|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005845|NCT01147068|Coagulants|coagulants|mesh-ancestor
84005846|NCT00640627|Celecoxib|celecoxib|mesh-list
84005847|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84005848|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005849|NCT00640627|Analgesics|analgesics|mesh-ancestor
84005850|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
84005851|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005852|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005853|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005854|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005855|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84005856|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84005857|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005858|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005859|NCT02681887|Melatonin|melatonin|mesh-list
84005860|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
84005861|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005862|NCT02681887|Protective Agents|protective agents|mesh-ancestor
84005863|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005864|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84005865|NCT01134042|Fluticasone|fluticasone|mesh-list
84005866|NCT01134042|Xhance|xhance|mesh-list
84005867|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005868|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84005869|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
84005870|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245615|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005871|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005872|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84005873|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
84005874|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
84005875|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84005876|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
84005877|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84005878|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
84005879|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005880|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005881|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84005882|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
84005883|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
84005884|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84005885|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
84005886|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005887|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005888|NCT01146288|Furosemide|furosemide|mesh-list
84005889|NCT01146288|Acetazolamide|acetazolamide|mesh-list
84005890|NCT01146288|Diuretics|diuretics|mesh-ancestor
84005891|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
84005892|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005893|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84005894|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84005895|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005896|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
84005897|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84005898|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005899|NCT01146054|Gemcitabine|gemcitabine|mesh-list
84005900|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84005901|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005902|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
84005903|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005904|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005905|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84005906|NCT00640705|Diclofenac|diclofenac|mesh-list
84005907|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84005908|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84005909|NCT00640705|Analgesics|analgesics|mesh-ancestor
84005910|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
84005911|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84005912|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005913|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84005914|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005915|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84005916|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005917|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005918|NCT01145898|Timolol|timolol|mesh-list
84005919|NCT01145898|Dorzolamide|dorzolamide|mesh-list
84005920|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84005921|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84005922|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
84005923|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84005924|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005925|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005926|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84005927|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84005928|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84005929|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005930|NCT02681653|Atorvastatin|atorvastatin|mesh-list
84005931|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84005932|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84005933|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
84005934|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005935|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84005936|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84005937|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005938|NCT04315116|Loperamide|loperamide|mesh-list
84005939|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
84005940|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84005941|NCT02883114|Itraconazole|itraconazole|mesh-list
84005942|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
84005943|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84005944|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84005945|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84005946|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005947|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005948|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84005949|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
84005950|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84005951|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005952|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84005953|NCT04183387|Simvastatin|simvastatin|mesh-list
84005954|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84005955|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84005956|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
84005957|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005958|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84005959|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84005960|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005961|NCT00625092|Leucovorin|leucovorin|mesh-list
84005962|NCT00625092|Fluorouracil|fluorouracil|mesh-list
84005963|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
84005964|NCT00625092|Calcium|calcium|mesh-list
84005965|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
84005966|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84005967|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005968|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
84005969|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005970|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84005971|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005972|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005973|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
84005974|NCT00625092|Antidotes|antidotes|mesh-ancestor
84005975|NCT00625092|Protective Agents|protective agents|mesh-ancestor
84005976|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
84005977|NCT00625092|Vitamins|vitamins|mesh-ancestor
84005978|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
84005979|NCT00931918|Prednisone|prednisone|mesh-list
84005980|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
84005981|NCT00931918|Rituximab|rituximab|mesh-list
84005982|NCT00931918|Doxorubicin|doxorubicin|mesh-list
84005983|NCT00931918|Vincristine|vincristine|mesh-list
84005984|NCT00931918|Bortezomib|bortezomib|mesh-list
84005985|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84005986|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
84005987|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84005988|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84005989|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84005990|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
84005991|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84005992|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84005993|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84005994|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84005995|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84005996|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84005997|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84005998|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84005999|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006000|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
84006001|NCT00931918|Hormones|hormones|mesh-ancestor
84006002|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006003|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84006004|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84006005|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
84006006|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
84006007|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
84006008|NCT04183075|Vitamins|vitamins|mesh-list
84006009|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
84006010|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
84006011|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006012|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
84006013|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245767|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83245768|NCT04860167|Analgesics|analgesics|mesh-ancestor
84006014|NCT04183075|Protective Agents|protective agents|mesh-ancestor
83245769|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
83245770|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245771|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245772|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006015|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
84006016|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006017|NCT02678221|Aspirin|aspirin|mesh-list
84006018|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
84006019|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84006020|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006021|NCT02678221|Analgesics|analgesics|mesh-ancestor
84006022|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
84006023|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006024|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006025|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006026|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006027|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84006028|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84006029|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006030|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84006031|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84006032|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006033|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
84006034|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
84006035|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84006036|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84006037|NCT02678221|Urological Agents|urological agents|mesh-ancestor
84006038|NCT00641329|Clonidine|clonidine|mesh-list
84006039|NCT00641329|Analgesics|analgesics|mesh-ancestor
84006040|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
84006041|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006042|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006043|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84006044|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
84006045|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
84006046|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84006047|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84006048|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84006049|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
84006050|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006051|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006052|NCT01179191|Naltrexone|naltrexone|mesh-list
84006053|NCT01179191|Morphine|morphine|mesh-list
84006054|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84006055|NCT01179191|Narcotics|narcotics|mesh-ancestor
84006056|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006057|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006058|NCT01179191|Analgesics|analgesics|mesh-ancestor
84006059|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
84006060|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006061|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84006062|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84006063|NCT00642421|Octreotide|octreotide|mesh-list
84006064|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006065|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84006066|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006067|NCT00642187|Budesonide|budesonide|mesh-list
84006068|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006069|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84006070|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
84006071|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006072|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006073|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84006074|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
84006075|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
84006076|NCT00642187|Hormones|hormones|mesh-ancestor
84006077|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006078|NCT05663125|Temozolomide|temozolomide|mesh-list
84006079|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84006080|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
84006081|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006082|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006083|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
84006084|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
84006085|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84006086|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84006087|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006088|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006089|NCT01132482|Urological Agents|urological agents|mesh-ancestor
84006090|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84006092|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84006093|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84006094|NCT00931762|Panobinostat|panobinostat|mesh-list
84006095|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006096|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84006097|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006098|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006099|NCT00641407|Insulin|insulin|mesh-list
84006100|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84006101|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
84006102|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84006103|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006104|NCT02677597|Paclitaxel|paclitaxel|mesh-list
84006105|NCT02677597|Cisplatin|cisplatin|mesh-list
84006106|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84006107|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006108|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
84006109|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
84006110|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
84006111|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006112|NCT01132326|Droxidopa|droxidopa|mesh-list
84006113|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84006114|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84006115|NCT02681263|Temocillin|temocillin|mesh-list
84006116|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84006117|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006118|NCT02677519|Methylphenidate|methylphenidate|mesh-list
84006119|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84006120|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006121|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84006122|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84006123|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84006124|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006125|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
84006126|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006127|NCT01145508|Metronidazole|metronidazole|mesh-list
84006128|NCT01145508|Prednisone|prednisone|mesh-list
84006129|NCT01145508|Cortisone|cortisone|mesh-list
84006130|NCT01145508|Docetaxel|docetaxel|mesh-list
84006131|NCT01145508|Vaccines|vaccines|mesh-list
84006132|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
84006133|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006134|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006135|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
84006136|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
84006137|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
84006138|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006139|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006140|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
84006141|NCT01145508|Hormones|hormones|mesh-ancestor
84006142|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006143|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84006144|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006145|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84006146|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84006147|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84006148|NCT00931528|Tadalafil|tadalafil|mesh-list
84006149|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
84006150|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84006151|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84006152|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006153|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006154|NCT00931528|Urological Agents|urological agents|mesh-ancestor
84006155|NCT04181749|Aspirin|aspirin|mesh-list
84006156|NCT04181749|Atorvastatin|atorvastatin|mesh-list
84006157|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84006158|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006159|NCT04181749|Analgesics|analgesics|mesh-ancestor
84006160|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
84006161|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006162|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006163|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006164|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006165|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84006166|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84006167|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006168|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84006169|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84006170|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006171|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
84006172|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84006173|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84006174|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
84006175|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84006176|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84006177|NCT04312152|Vitamins|vitamins|mesh-list
84006178|NCT04312152|Vitamin E|vitamin e|mesh-list
84006179|NCT04312152|Tocopherols|tocopherols|mesh-list
84006180|NCT04312152|Folic Acid|folic acid|mesh-list
84006181|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
84006182|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
84006183|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006184|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
84006185|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006186|NCT04312152|Protective Agents|protective agents|mesh-ancestor
84006187|NCT04312152|Hematinics|hematinics|mesh-ancestor
84006188|NCT00975195|Fluticasone|fluticasone|mesh-list
84006189|NCT00975195|Xhance|xhance|mesh-list
84006190|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
84006191|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84006192|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006193|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84006194|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
84006195|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006196|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006197|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84006198|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
84006199|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
84006200|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84006201|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
84006202|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84006203|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
84006204|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006205|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006206|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84006207|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84006208|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84006209|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
84006210|NCT00642499|Dronabinol|dronabinol|mesh-list
84006211|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
84006212|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006213|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84006214|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006215|NCT00642499|Analgesics|analgesics|mesh-ancestor
84006216|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
84006217|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006218|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84006219|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84006220|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006221|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006222|NCT00642499|Hormones|hormones|mesh-ancestor
84006223|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006224|NCT00644215|Mitomycins|mitomycins|mesh-list
84006225|NCT00644215|Mitomycin|mitomycin|mesh-list
84006226|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84006227|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006228|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
84006229|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006230|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84006231|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006232|NCT01145352|Etanercept|etanercept|mesh-list
84006233|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84006234|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006235|NCT01145352|Analgesics|analgesics|mesh-ancestor
84006236|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
84006237|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006238|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006239|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006240|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006241|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006242|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006244|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84006245|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84006246|NCT02673463|Spironolactone|spironolactone|mesh-list
84006247|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84006248|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
84006249|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006250|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006251|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84006252|NCT02673463|Diuretics|diuretics|mesh-ancestor
84006253|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
84006254|NCT01169532|Vorinostat|vorinostat|mesh-list
84006255|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006256|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84006257|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006258|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006259|NCT02537353|Epinephrine|epinephrine|mesh-list
84006260|NCT02537353|Racepinephrine|racepinephrine|mesh-list
84006261|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
84006262|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84006263|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84006264|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
84006265|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006266|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006267|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006268|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84006269|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84006270|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
84006271|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006272|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84006273|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
84006274|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
84006275|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
84006276|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84006277|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
84006278|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84006279|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
84006280|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
84006281|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006282|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006283|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006284|NCT00643357|Analgesics|analgesics|mesh-ancestor
84006285|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
84006286|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006287|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84006288|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84006289|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84006290|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84006291|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006292|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
84006293|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006294|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006295|NCT04178785|Remifentanil|remifentanil|mesh-list
84006296|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84006297|NCT04178785|Narcotics|narcotics|mesh-ancestor
84006298|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006299|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006300|NCT04178785|Analgesics|analgesics|mesh-ancestor
84006301|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
84006302|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006303|NCT00928486|Dexamethasone|dexamethasone|mesh-list
84006304|NCT00928486|Lenalidomide|lenalidomide|mesh-list
84006305|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006306|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
84006307|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
84006308|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006309|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006310|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006311|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
84006312|NCT00928486|Hormones|hormones|mesh-ancestor
84006313|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006314|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84006315|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006316|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
84006318|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84006319|NCT00928486|Growth Substances|growth substances|mesh-ancestor
84006320|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
84006321|NCT03867357|Goserelin|goserelin|mesh-list
84006322|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84006323|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006324|NCT05655221|Mitogens|mitogens|mesh-list
84006325|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
84006326|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006327|NCT00610792|Doxorubicin|doxorubicin|mesh-list
84006328|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84006329|NCT00610792|Bortezomib|bortezomib|mesh-list
84006330|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84006331|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006332|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84006333|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84006334|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006335|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006336|NCT00610870|Atorvastatin|atorvastatin|mesh-list
84006337|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84006338|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84006339|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
84006340|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006341|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84006342|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84006343|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006344|NCT01168596|Rasagiline|rasagiline|mesh-list
84006345|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84006346|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006347|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006348|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84006349|NCT01168596|Protective Agents|protective agents|mesh-ancestor
84006350|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006351|NCT02675647|Heparin|heparin|mesh-list
84006352|NCT02675647|Protamines|protamines|mesh-list
84006353|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
84006354|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84006355|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84006356|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006357|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
84006358|NCT02675647|Coagulants|coagulants|mesh-ancestor
84006359|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
84006360|NCT05370898|Antacids|antacids|mesh-ancestor
84006361|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006362|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006363|NCT00610948|Leucovorin|leucovorin|mesh-list
84006364|NCT00610948|Fluorouracil|fluorouracil|mesh-list
84006365|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
84006366|NCT00610948|Everolimus|everolimus|mesh-list
84006367|NCT00610948|Panitumumab|panitumumab|mesh-list
84006368|NCT00610948|Calcium|calcium|mesh-list
84006369|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
84006370|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84006371|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006372|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
84006373|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006374|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84006375|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006376|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006377|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
84006378|NCT00610948|Antidotes|antidotes|mesh-ancestor
84006379|NCT00610948|Protective Agents|protective agents|mesh-ancestor
84006380|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
84006381|NCT00610948|Vitamins|vitamins|mesh-ancestor
84006382|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
84006383|NCT00610948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84006384|NCT00610948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84006385|NCT00610948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006386|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006387|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84006388|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
84006389|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006390|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
83246144|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
84006391|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006392|NCT00928408|Cinacalcet|cinacalcet|mesh-list
84006393|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84006394|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006395|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
84006396|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
84006397|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006398|NCT00928252|Fluorides|fluorides|mesh-list
84006399|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
84006400|NCT00928252|Protective Agents|protective agents|mesh-ancestor
84006401|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006402|NCT02673229|Bacitracin|bacitracin|mesh-list
84006403|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84006404|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006405|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84006406|NCT00644293|Azithromycin|azithromycin|mesh-list
84006407|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84006408|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006409|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
84006410|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84006411|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006412|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84006413|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84006414|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006415|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006416|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006417|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84006418|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84006419|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
84006420|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84006421|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
84006422|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006423|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
84006424|NCT01176773|Protective Agents|protective agents|mesh-ancestor
84006425|NCT02887625|Insulin|insulin|mesh-list
84006426|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
84006427|NCT02887625|Pioglitazone|pioglitazone|mesh-list
84006428|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
84006429|NCT02887625|Exenatide|exenatide|mesh-list
84006430|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84006431|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006432|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84006433|NCT02887625|Incretins|incretins|mesh-ancestor
84006434|NCT02887625|Hormones|hormones|mesh-ancestor
84006435|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006436|NCT02886377|Antibodies|antibodies|mesh-list
84006437|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
84006438|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006439|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84006440|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84006441|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006442|NCT02675335|Incretins|incretins|mesh-ancestor
84006443|NCT02675335|Hormones|hormones|mesh-ancestor
84006444|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006445|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84006446|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
84006447|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006448|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006449|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
84006450|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84006451|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84006452|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
84006453|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006454|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84006455|NCT00928018|Cyclosporine|cyclosporine|mesh-list
84006456|NCT00928018|Sirolimus|sirolimus|mesh-list
84006457|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
84006458|NCT00928018|Methotrexate|methotrexate|mesh-list
84006459|NCT00928018|Tacrolimus|tacrolimus|mesh-list
84006460|NCT00928018|Cyclosporins|cyclosporins|mesh-list
84006461|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84006462|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
84006463|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84006464|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006465|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84006466|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
84006467|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006468|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006469|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
84006470|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006471|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84006472|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006473|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
84006474|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006475|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84006476|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84006477|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
84006478|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006479|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84006480|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84006481|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
84006482|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84006483|NCT02672839|Betadex|betadex|mesh-list
84006484|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
84006485|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006486|NCT00609154|Glucagon|glucagon|mesh-list
84006487|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84006488|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006489|NCT00609154|Hormones|hormones|mesh-ancestor
84006490|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006491|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006492|NCT00609154|Incretins|incretins|mesh-ancestor
84006493|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
84006494|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006495|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006496|NCT00927862|Warfarin|warfarin|mesh-list
84006497|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
84006498|NCT02672527|Dexamethasone|dexamethasone|mesh-list
84006499|NCT02672527|Trabectedin|trabectedin|mesh-list
84006500|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006501|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
84006502|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
84006503|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006504|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006505|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006506|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
84006507|NCT02672527|Hormones|hormones|mesh-ancestor
84006508|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006509|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84006510|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006511|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84006512|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
84006513|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006514|NCT00976989|Docetaxel|docetaxel|mesh-list
84006515|NCT00976989|Trastuzumab|trastuzumab|mesh-list
84006516|NCT00976989|Pertuzumab|pertuzumab|mesh-list
84006517|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006518|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
84006519|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
84006520|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
84006521|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006522|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006523|NCT05449171|Vitamin D|vitamin d|mesh-list
84006524|NCT05449171|Vitamins|vitamins|mesh-list
84006525|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
84006526|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
84006527|NCT05449171|Pyridoxal|pyridoxal|mesh-list
84006528|NCT05449171|Pyridoxine|pyridoxine|mesh-list
84006529|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
84006530|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
84006531|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006532|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84006533|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84006534|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
84006535|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
84006536|NCT05449171|Protective Agents|protective agents|mesh-ancestor
84006537|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
84006538|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
84006539|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006540|NCT02675023|Adalimumab|adalimumab|mesh-list
84006541|NCT02675023|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84006542|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006543|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006544|NCT00644371|Rituximab|rituximab|mesh-list
84006545|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006546|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006547|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
84006548|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006549|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006550|NCT02864199|Ribavirin|ribavirin|mesh-list
84006551|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84006552|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
84006553|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006554|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
84006555|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006556|NCT05911126|Celecoxib|celecoxib|mesh-list
84006557|NCT05911126|Scopolamine|scopolamine|mesh-list
84006558|NCT05911126|Bromides|bromides|mesh-list
84006559|NCT05911126|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84006560|NCT05911126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84006561|NCT05911126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006562|NCT05911126|Analgesics|analgesics|mesh-ancestor
84006563|NCT05911126|Sensory System Agents|sensory system agents|mesh-ancestor
84006564|NCT05911126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006565|NCT05911126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006566|NCT05911126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006567|NCT05911126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006568|NCT05911126|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84006569|NCT05911126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84006570|NCT05911126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006571|NCT05911126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006572|NCT05911126|Anticonvulsants|anticonvulsants|mesh-ancestor
84006573|NCT05911126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84006574|NCT05911126|Antiemetics|antiemetics|mesh-ancestor
84006575|NCT05911126|Autonomic Agents|autonomic agents|mesh-ancestor
84006576|NCT05911126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006577|NCT05911126|Mydriatics|mydriatics|mesh-ancestor
84006578|NCT05911126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84006579|NCT05911126|Cholinergic Agents|cholinergic agents|mesh-ancestor
84006580|NCT05911126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006581|NCT05911126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84006582|NCT05911126|Parasympatholytics|parasympatholytics|mesh-ancestor
84006583|NCT05911061|Vaccines|vaccines|mesh-list
84006584|NCT05911061|Immunologic Factors|immunologic factors|mesh-ancestor
84006585|NCT05911061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006586|NCT05911048|Vaccines|vaccines|mesh-list
84006587|NCT05911048|Immunologic Factors|immunologic factors|mesh-ancestor
84006588|NCT05911048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006589|NCT05908526|Suvorexant|suvorexant|mesh-list
84006590|NCT05908526|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84006591|NCT05908526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84006592|NCT05908526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006593|NCT05908526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006594|NCT05908526|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84006595|NCT05908526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006596|NCT05908526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006597|NCT05908513|Acetylcysteine|acetylcysteine|mesh-list
84006598|NCT05908513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84006599|NCT05908513|Antiviral Agents|antiviral agents|mesh-ancestor
84006600|NCT05908513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006601|NCT05908513|Expectorants|expectorants|mesh-ancestor
84006602|NCT05908513|Respiratory System Agents|respiratory system agents|mesh-ancestor
84006603|NCT05908513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84006604|NCT05908513|Antioxidants|antioxidants|mesh-ancestor
84006605|NCT05908513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006606|NCT05908513|Protective Agents|protective agents|mesh-ancestor
84006607|NCT05908513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006608|NCT05908513|Antidotes|antidotes|mesh-ancestor
84006609|NCT05908305|Epinephrine|epinephrine|mesh-list
84006610|NCT05908305|Racepinephrine|racepinephrine|mesh-list
84006611|NCT05908305|Anesthetics|anesthetics|mesh-list
84006612|NCT05908305|Carticaine|carticaine|mesh-list
84006613|NCT05908305|Mepivacaine|mepivacaine|mesh-list
84006614|NCT05908305|Epinephryl borate|epinephryl borate|mesh-list
84006615|NCT05908305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006616|NCT05908305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006617|NCT05908305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84006618|NCT05908305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84006619|NCT05908305|Adrenergic Agents|adrenergic agents|mesh-ancestor
83246370|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006620|NCT05908305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006621|NCT05908305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006622|NCT05908305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84006623|NCT05908305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84006624|NCT05908305|Autonomic Agents|autonomic agents|mesh-ancestor
84006625|NCT05908305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006626|NCT05908305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84006627|NCT05908305|Respiratory System Agents|respiratory system agents|mesh-ancestor
84006628|NCT05908305|Mydriatics|mydriatics|mesh-ancestor
84006629|NCT05908305|Sympathomimetics|sympathomimetics|mesh-ancestor
84006630|NCT05908305|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84006631|NCT05908305|Anesthetics, Local|anesthetics, local|mesh-ancestor
84006632|NCT05908305|Sensory System Agents|sensory system agents|mesh-ancestor
84006633|NCT02672995|Bevacizumab|bevacizumab|mesh-list
84006634|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006635|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006636|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84006637|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84006638|NCT02672995|Growth Substances|growth substances|mesh-ancestor
84006639|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006640|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
84006641|NCT05907980|Atezolizumab|atezolizumab|mesh-list
84006642|NCT05907980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84006643|NCT05907980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006644|NCT05907980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006645|NCT05907980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006646|NCT05907902|Aspirin|aspirin|mesh-list
84006647|NCT05907902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84006648|NCT05907902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006649|NCT05907902|Analgesics|analgesics|mesh-ancestor
84006650|NCT05907902|Sensory System Agents|sensory system agents|mesh-ancestor
84006651|NCT05907902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006652|NCT05907902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006653|NCT05907902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006654|NCT05907902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006655|NCT05907902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84006656|NCT05907902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84006657|NCT05907902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006658|NCT05907902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84006659|NCT05907902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84006660|NCT05907902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006661|NCT05907902|Antipyretics|antipyretics|mesh-ancestor
84006662|NCT05907850|Riboflavin|riboflavin|mesh-list
84006663|NCT05907850|Vitamin B Complex|vitamin b complex|mesh-ancestor
84006664|NCT05907850|Vitamins|vitamins|mesh-ancestor
84006665|NCT05907850|Micronutrients|micronutrients|mesh-ancestor
84006666|NCT05907850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006667|NCT05907850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84006668|NCT05907850|Dermatologic Agents|dermatologic agents|mesh-ancestor
84006669|NCT05907733|Mitogens|mitogens|mesh-list
84006670|NCT05907733|Mitosis Modulators|mitosis modulators|mesh-ancestor
84006671|NCT05907733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006672|NCT05907499|Decitabine|decitabine|mesh-list
84006673|NCT05907499|Epoetin Alfa|epoetin alfa|mesh-list
84006674|NCT05907499|Lenograstim|lenograstim|mesh-list
84006675|NCT05907499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84006676|NCT05907499|Antimetabolites|antimetabolites|mesh-ancestor
84006677|NCT05907499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006678|NCT05907499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006679|NCT05907499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006680|NCT05907499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84006681|NCT05907499|Immunologic Factors|immunologic factors|mesh-ancestor
84006682|NCT05907499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006683|NCT05907499|Hematinics|hematinics|mesh-ancestor
84006684|NCT05907486|Cytarabine|cytarabine|mesh-list
84006685|NCT05907486|Acetylcysteine|acetylcysteine|mesh-list
84006686|NCT05907486|Cyclophosphamide|cyclophosphamide|mesh-list
84006687|NCT05907486|Busulfan|busulfan|mesh-list
84006688|NCT05907486|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84006689|NCT05907486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006690|NCT05907486|Immunologic Factors|immunologic factors|mesh-ancestor
84006691|NCT05907486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006692|NCT05907486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006693|NCT05907486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84006694|NCT05907486|Alkylating Agents|alkylating agents|mesh-ancestor
84006695|NCT05907486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006696|NCT05907486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006697|NCT05907486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84006698|NCT05907486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84006699|NCT05907486|Antimetabolites|antimetabolites|mesh-ancestor
84006700|NCT05907486|Antiviral Agents|antiviral agents|mesh-ancestor
84006701|NCT05907486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006702|NCT05907486|Expectorants|expectorants|mesh-ancestor
84006703|NCT05907486|Respiratory System Agents|respiratory system agents|mesh-ancestor
84006704|NCT05907486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84006705|NCT05907486|Antioxidants|antioxidants|mesh-ancestor
84006706|NCT05907486|Protective Agents|protective agents|mesh-ancestor
84006707|NCT05907486|Antidotes|antidotes|mesh-ancestor
84006708|NCT05907213|Ketamine|ketamine|mesh-list
84006709|NCT05907213|Analgesics|analgesics|mesh-ancestor
84006710|NCT05907213|Sensory System Agents|sensory system agents|mesh-ancestor
84006711|NCT05907213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006712|NCT05907213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006713|NCT05907213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84006714|NCT05907213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84006715|NCT05907213|Anesthetics, General|anesthetics, general|mesh-ancestor
84006716|NCT05907213|Anesthetics|anesthetics|mesh-ancestor
84006717|NCT05907213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006718|NCT05907213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84006719|NCT05907213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84006720|NCT05907213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006721|NCT05907213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006722|NCT05907122|Nivolumab|nivolumab|mesh-list
84006723|NCT05907122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006724|NCT05907122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006725|NCT05907122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84006726|NCT05907122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006727|NCT05907057|Azacitidine|azacitidine|mesh-list
84006728|NCT05907057|Ivosidenib|ivosidenib|mesh-list
84006729|NCT05907057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84006730|NCT05907057|Antimetabolites|antimetabolites|mesh-ancestor
84006731|NCT05907057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006732|NCT05907057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006733|NCT05907057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006734|NCT05906992|Ocrelizumab|ocrelizumab|mesh-list
84006735|NCT05906992|Immunologic Factors|immunologic factors|mesh-ancestor
84006736|NCT05906992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006737|NCT05906914|Cytarabine|cytarabine|mesh-list
84006738|NCT05906914|Cladribine|cladribine|mesh-list
84006739|NCT05906914|Homoharringtonine|homoharringtonine|mesh-list
84006740|NCT05906914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84006741|NCT05906914|Antimetabolites|antimetabolites|mesh-ancestor
84006742|NCT05906914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006743|NCT05906914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006744|NCT05906914|Antiviral Agents|antiviral agents|mesh-ancestor
84006745|NCT05906914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006746|NCT05906914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006747|NCT05906914|Immunologic Factors|immunologic factors|mesh-ancestor
84006748|NCT05906914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006749|NCT05906914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84006750|NCT05906914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84006751|NCT05906914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006752|NCT05906836|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84006753|NCT05906836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84006754|NCT05906836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84006755|NCT05906836|Antimetabolites|antimetabolites|mesh-ancestor
84006756|NCT05906836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006757|NCT05906836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84006758|NCT05906836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84006759|NCT05906836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006760|NCT05906615|Lidocaine|lidocaine|mesh-list
84006761|NCT05906615|Anesthetics, Local|anesthetics, local|mesh-ancestor
84006762|NCT05906615|Anesthetics|anesthetics|mesh-ancestor
84006763|NCT05906615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006764|NCT05906615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006765|NCT05906615|Sensory System Agents|sensory system agents|mesh-ancestor
84006766|NCT05906615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006767|NCT05906615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84006768|NCT05906615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84006769|NCT05906615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84006770|NCT05906615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84006771|NCT05906615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006772|NCT05906589|Psyllium|psyllium|mesh-list
83246521|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
84006773|NCT05906589|Cathartics|cathartics|mesh-ancestor
84006774|NCT05906589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006775|NCT05906576|Infliximab|infliximab|mesh-list
84006776|NCT05906576|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84006777|NCT05906576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006778|NCT05906576|Dermatologic Agents|dermatologic agents|mesh-ancestor
84006779|NCT05906576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006780|NCT05906576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006781|NCT05906563|Metformin|metformin|mesh-list
84006782|NCT05906563|Melatonin|melatonin|mesh-list
84006783|NCT05906563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84006784|NCT05906563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006785|NCT05906563|Antioxidants|antioxidants|mesh-ancestor
84006786|NCT05906563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006787|NCT05906563|Protective Agents|protective agents|mesh-ancestor
84006788|NCT05906563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006789|NCT05906524|Bevacizumab|bevacizumab|mesh-list
84006790|NCT05906524|Tislelizumab|tislelizumab|mesh-list
84006791|NCT05906524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006792|NCT05906524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006793|NCT05906524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84006794|NCT05906524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84006795|NCT05906524|Growth Substances|growth substances|mesh-ancestor
84006796|NCT05906524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006797|NCT05906524|Growth Inhibitors|growth inhibitors|mesh-ancestor
84006798|NCT05906511|Dronabinol|dronabinol|mesh-list
84006799|NCT05906511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84006800|NCT05906511|Hallucinogens|hallucinogens|mesh-ancestor
84006801|NCT05906511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006802|NCT05906511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84006803|NCT05906511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84006804|NCT05906511|Analgesics|analgesics|mesh-ancestor
84006805|NCT05906511|Sensory System Agents|sensory system agents|mesh-ancestor
84006806|NCT05906511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006807|NCT05906511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84006808|NCT05906511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84006809|NCT05906511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006810|NCT05906511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006811|NCT05906511|Hormones|hormones|mesh-ancestor
84006812|NCT05906511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006813|NCT05906498|Vitamin E|vitamin e|mesh-list
84006814|NCT05906498|Acetylcysteine|acetylcysteine|mesh-list
84006815|NCT05906498|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84006816|NCT05906498|Vitamins|vitamins|mesh-ancestor
84006817|NCT05906498|Micronutrients|micronutrients|mesh-ancestor
84006818|NCT05906498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006819|NCT05906498|Antioxidants|antioxidants|mesh-ancestor
84006820|NCT05906498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006821|NCT05906498|Protective Agents|protective agents|mesh-ancestor
84006822|NCT05906498|Antiviral Agents|antiviral agents|mesh-ancestor
84006823|NCT05906498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006824|NCT05906498|Expectorants|expectorants|mesh-ancestor
84006825|NCT05906498|Respiratory System Agents|respiratory system agents|mesh-ancestor
84006826|NCT05906498|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84006827|NCT05906498|Antidotes|antidotes|mesh-ancestor
84006828|NCT05901974|Venetoclax|venetoclax|mesh-list
84006829|NCT05901974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006830|NCT05901961|Zinc|zinc|mesh-list
84006831|NCT05901961|Zinc Oxide|zinc oxide|mesh-list
84006832|NCT05901961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84006833|NCT05901961|Trace Elements|trace elements|mesh-ancestor
84006834|NCT05901961|Micronutrients|micronutrients|mesh-ancestor
84006835|NCT05901961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006836|NCT05901961|Dermatologic Agents|dermatologic agents|mesh-ancestor
84006837|NCT05901961|Sunscreening Agents|sunscreening agents|mesh-ancestor
84006838|NCT05901961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84006839|NCT05901961|Protective Agents|protective agents|mesh-ancestor
84006840|NCT05895955|Vaccines|vaccines|mesh-list
84006841|NCT05895955|Immunologic Factors|immunologic factors|mesh-ancestor
84006842|NCT05895955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006843|NCT05893797|Insulin Lispro|insulin lispro|mesh-list
84006844|NCT05893797|TEMPO|tempo|mesh-list
84006845|NCT05893797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84006846|NCT05893797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006847|NCT05893797|Antioxidants|antioxidants|mesh-ancestor
84006848|NCT05893797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006849|NCT05893797|Protective Agents|protective agents|mesh-ancestor
84006850|NCT05892510|Tenecteplase|tenecteplase|mesh-list
84006851|NCT05892510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84006853|NCT05892510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006854|NCT05886972|Propofol|propofol|mesh-list
84006855|NCT05886972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84006856|NCT05886972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006857|NCT05886972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006858|NCT05886972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84006859|NCT05886972|Anesthetics, General|anesthetics, general|mesh-ancestor
84006860|NCT05886972|Anesthetics|anesthetics|mesh-ancestor
84006861|NCT05879835|Heparin|heparin|mesh-list
84006862|NCT05879835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84006863|NCT05879835|Anticoagulants|anticoagulants|mesh-ancestor
84006864|NCT05879835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84006865|NCT05879835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84006866|NCT05879835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006867|NCT05878769|Astegolimab|astegolimab|mesh-list
84006868|NCT05878769|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84006869|NCT05878769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84006870|NCT05878769|Antiviral Agents|antiviral agents|mesh-ancestor
84006871|NCT05878769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006872|NCT05878184|Cyclophosphamide|cyclophosphamide|mesh-list
84006873|NCT05878184|Fludarabine|fludarabine|mesh-list
84006874|NCT05878184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006875|NCT05878184|Immunologic Factors|immunologic factors|mesh-ancestor
84006876|NCT05878184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006877|NCT05878184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84006878|NCT05878184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84006879|NCT05878184|Alkylating Agents|alkylating agents|mesh-ancestor
84006880|NCT05878184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006881|NCT05878184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006882|NCT05878184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84006883|NCT05874401|Topotecan|topotecan|mesh-list
84006884|NCT05874401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84006885|NCT05874401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84006886|NCT05874401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006887|NCT05874401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006888|NCT05874401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006889|NCT05866367|Insulin|insulin|mesh-list
84006890|NCT05866367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84006891|NCT05866367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84006892|NCT05866367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006893|NCT05858957|Magnesium Sulfate|magnesium sulfate|mesh-list
84006894|NCT05858957|Analgesics|analgesics|mesh-ancestor
84006895|NCT05858957|Sensory System Agents|sensory system agents|mesh-ancestor
84006896|NCT05858957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006897|NCT05858957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006898|NCT05858957|Anesthetics|anesthetics|mesh-ancestor
84006899|NCT05858957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84006900|NCT05858957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84006901|NCT05858957|Anticonvulsants|anticonvulsants|mesh-ancestor
84006902|NCT05858957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84006903|NCT05858957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84006904|NCT05858957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006905|NCT05858957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84006906|NCT05858957|Tocolytic Agents|tocolytic agents|mesh-ancestor
84006907|NCT05858957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84006908|NCT05826964|Tamoxifen|tamoxifen|mesh-list
84006909|NCT05826964|Sirolimus|sirolimus|mesh-list
84006910|NCT05826964|Capecitabine|capecitabine|mesh-list
84006911|NCT05826964|Everolimus|everolimus|mesh-list
84006912|NCT05826964|Letrozole|letrozole|mesh-list
84006913|NCT05826964|Vinorelbine|vinorelbine|mesh-list
84006914|NCT05826964|Fulvestrant|fulvestrant|mesh-list
84006915|NCT05826964|Palbociclib|palbociclib|mesh-list
84006916|NCT05826964|Anastrozole|anastrozole|mesh-list
84006917|NCT05826964|Exemestane|exemestane|mesh-list
84006918|NCT05826964|Temsirolimus|temsirolimus|mesh-list
84006919|NCT05826964|MTOR Inhibitors|mtor inhibitors|mesh-list
84006920|NCT05826964|Elafin|elafin|mesh-list
84006921|NCT05826964|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84006922|NCT05826964|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
84006923|NCT05826964|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
84006924|NCT05826964|Estrogens|estrogens|mesh-list
84006925|NCT05826964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84006926|NCT05826964|Antimetabolites|antimetabolites|mesh-ancestor
84006927|NCT05826964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006928|NCT05826964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006929|NCT05826964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84006930|NCT05826964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006931|NCT05826964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84006932|NCT05826964|Immunologic Factors|immunologic factors|mesh-ancestor
84006933|NCT05826964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006934|NCT05826964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84006935|NCT05826964|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84006936|NCT05826964|Hormone Antagonists|hormone antagonists|mesh-ancestor
84006937|NCT05826964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84006938|NCT05826964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84006939|NCT05826964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006940|NCT05826964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84006941|NCT05826964|Antifungal Agents|antifungal agents|mesh-ancestor
84006942|NCT05826964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84006943|NCT05826964|Tubulin Modulators|tubulin modulators|mesh-ancestor
84006944|NCT05826964|Antimitotic Agents|antimitotic agents|mesh-ancestor
84006945|NCT05826964|Mitosis Modulators|mitosis modulators|mesh-ancestor
84006946|NCT05826964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84006947|NCT05826964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84006948|NCT05826964|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84006949|NCT05826964|Hormones|hormones|mesh-ancestor
84006950|NCT05826964|Protease Inhibitors|protease inhibitors|mesh-ancestor
84006951|NCT05806164|Mirabegron|mirabegron|mesh-list
84006952|NCT05806164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84006953|NCT05806164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84006954|NCT05806164|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
84006955|NCT05806164|Adrenergic Agents|adrenergic agents|mesh-list
84006956|NCT05806164|Adrenergic Agonists|adrenergic agonists|mesh-list
84006957|NCT05806164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84006958|NCT05806164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006959|NCT05806164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006960|NCT05806164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84006961|NCT05806164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84006962|NCT05806164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006963|NCT05806164|Cholinergic Agents|cholinergic agents|mesh-ancestor
84006964|NCT05806164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84006965|NCT05806164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84006966|NCT05806164|Urological Agents|urological agents|mesh-ancestor
84006967|NCT05805501|Pembrolizumab|pembrolizumab|mesh-list
84006968|NCT05805501|Axitinib|axitinib|mesh-list
84006969|NCT05805501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006970|NCT05805501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006971|NCT05805501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84006972|NCT05805501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84006973|NCT05805501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84006974|NCT05805501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84006975|NCT05772429|Cannabidiol|cannabidiol|mesh-list
84006976|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
84006977|NCT05760807|Oxytocin|oxytocin|mesh-list
84006978|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
84006979|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84006980|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006981|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
84006982|NCT05754996|Lactulose|lactulose|mesh-list
84006983|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84006984|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84006985|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84006986|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84006987|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84006988|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84006989|NCT05748171|Immunotoxins|immunotoxins|mesh-ancestor
84006990|NCT05748171|Immunoconjugates|immunoconjugates|mesh-ancestor
84006991|NCT05748171|Immunologic Factors|immunologic factors|mesh-ancestor
84006992|NCT05748171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006993|NCT05746442|Nicotine|nicotine|mesh-list
84006994|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84006995|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
84006996|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84006997|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84006998|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84006999|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84007000|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
84007001|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007002|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007003|NCT05736874|Fluticasone|fluticasone|mesh-list
84007004|NCT05736874|Xhance|xhance|mesh-list
84007005|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84007006|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84007007|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
84007008|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007009|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007010|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84007011|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
84007012|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
84007013|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84007014|NCT05730036|Dexamethasone|dexamethasone|mesh-list
84007015|NCT05730036|Pomalidomide|pomalidomide|mesh-list
84007016|NCT05730036|Elotuzumab|elotuzumab|mesh-list
84007017|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84007018|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
84007019|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
84007020|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007021|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007022|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84007023|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
84007024|NCT05730036|Hormones|hormones|mesh-ancestor
84007025|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007026|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84007027|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007028|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
84007029|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007030|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007031|NCT05730036|Growth Substances|growth substances|mesh-ancestor
84007032|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007033|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
84007034|NCT05699655|Apatinib|apatinib|mesh-list
84007035|NCT05699655|Tislelizumab|tislelizumab|mesh-list
84007036|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007037|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007038|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007039|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007040|NCT05699655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007041|NCT05692180|Benralizumab|benralizumab|mesh-list
84007042|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84007043|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
84007044|NCT05687500|Glyburide|glyburide|mesh-list
84007045|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84007046|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007047|NCT05681611|Rocuronium|rocuronium|mesh-list
84007048|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84007049|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84007050|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84007051|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007052|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007053|NCT05675163|Vitamin K|vitamin k|mesh-list
84007054|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
84007055|NCT05675163|Vitamins|vitamins|mesh-ancestor
84007056|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
84007057|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007058|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84007059|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84007060|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007061|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
84007062|NCT05675163|Coagulants|coagulants|mesh-ancestor
84007063|NCT05669482|Paclitaxel|paclitaxel|mesh-list
84007064|NCT05669482|Gemcitabine|gemcitabine|mesh-list
84007065|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84007066|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007067|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
84007068|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
84007069|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
84007070|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007071|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007072|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
84007073|NCT05660538|Pregabalin|pregabalin|mesh-list
84007074|NCT05660538|Analgesics|analgesics|mesh-ancestor
84007075|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
84007076|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007077|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007078|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
84007079|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84007080|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83246827|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
84007081|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007082|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84007083|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84007084|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84007085|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84007086|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84007087|NCT05659381|Cisplatin|cisplatin|mesh-list
84007088|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007089|NCT05656170|Bupivacaine|bupivacaine|mesh-list
84007090|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
84007091|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
84007092|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84007093|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007094|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
84007095|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007096|NCT05650879|Trastuzumab|trastuzumab|mesh-list
84007097|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84007098|NCT05650879|Maytansine|maytansine|mesh-list
84007099|NCT05650879|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
84007100|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007101|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007102|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84007103|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
84007104|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
84007105|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
84007106|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007107|NCT05650879|Immunotoxins|immunotoxins|mesh-ancestor
84007108|NCT05650879|Immunoconjugates|immunoconjugates|mesh-ancestor
84007109|NCT05650879|Immunologic Factors|immunologic factors|mesh-ancestor
84007110|NCT05650879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007111|NCT05627557|Acetaminophen|acetaminophen|mesh-list
84007112|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
84007113|NCT05627557|Promethazine|promethazine|mesh-list
84007114|NCT05627557|Prednisone|prednisone|mesh-list
84007115|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
84007116|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
84007117|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84007118|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
84007119|NCT05627557|Hormones|hormones|mesh-ancestor
84007120|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007121|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007122|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84007123|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007124|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84007125|NCT05627557|Analgesics|analgesics|mesh-ancestor
84007126|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
84007127|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007128|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
84007129|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
84007130|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
84007131|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84007132|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84007133|NCT05627557|Protective Agents|protective agents|mesh-ancestor
84007134|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007135|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84007136|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84007137|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84007138|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
84007139|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
84007140|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84007141|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
84007142|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
84007143|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007144|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007145|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84007146|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
84007147|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
84007148|NCT05605964|Leuprolide|leuprolide|mesh-list
84007149|NCT05605964|Relugolix|relugolix|mesh-list
84007150|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84007151|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
84007152|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84007153|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007154|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84007155|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007156|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
84007157|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
84007158|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007159|NCT05596786|Rituximab|rituximab|mesh-list
84007160|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007161|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007162|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
84007163|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007164|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007165|NCT05590728|Apramycin|apramycin|mesh-list
84007166|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84007167|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007168|NCT05584657|Amoxicillin|amoxicillin|mesh-list
84007169|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
84007170|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
84007171|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84007172|NCT05584657|Lactams|lactams|mesh-list
84007173|NCT05584657|Probenecid|probenecid|mesh-list
84007174|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84007175|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007176|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84007177|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007178|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007179|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
84007180|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
84007181|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007182|NCT05582707|Pioglitazone|pioglitazone|mesh-list
84007183|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84007184|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007185|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
84007186|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
84007187|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
84007188|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
84007189|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007190|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84007191|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007192|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007193|NCT05564611|Omalizumab|omalizumab|mesh-list
84007194|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84007195|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84007196|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
84007197|NCT05559164|Atorvastatin|atorvastatin|mesh-list
84007198|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84007199|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84007200|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
84007201|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007202|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84007203|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84007204|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007205|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
84007206|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84007207|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007208|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84007209|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007210|NCT05558007|Tadalafil|tadalafil|mesh-list
84007211|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
84007212|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84007213|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84007214|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007215|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007216|NCT05558007|Urological Agents|urological agents|mesh-ancestor
84007217|NCT05554328|Olaparib|olaparib|mesh-list
84007218|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84007219|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007220|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007221|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007222|NCT05553704|Metformin|metformin|mesh-list
84007223|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84007224|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007225|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84007226|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84007227|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84007228|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84007229|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
84007230|NCT05545280|Neostigmine|neostigmine|mesh-list
84007231|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84007232|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007233|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007234|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
84007235|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007236|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007237|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84007238|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
84007239|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007240|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84007241|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84007242|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84007243|NCT05536349|Valacyclovir|valacyclovir|mesh-list
84007244|NCT05536349|Venetoclax|venetoclax|mesh-list
84007245|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
84007246|NCT05536349|Allopurinol|allopurinol|mesh-list
84007247|NCT05536349|Pirtobrutinib|pirtobrutinib|mesh-list
84007248|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007249|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007250|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
84007251|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007252|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007253|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
84007254|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007255|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84007256|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
84007257|NCT05536349|Protective Agents|protective agents|mesh-ancestor
84007258|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007259|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
84007260|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007261|NCT05536349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007262|NCT05518903|FAPI-46|fapi-46|mesh-list
84007263|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84007264|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007265|NCT05517642|Vaccines|vaccines|mesh-list
84007266|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
84007267|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007268|NCT05514132|Durvalumab|durvalumab|mesh-list
84007269|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84007270|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007271|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007272|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
84007273|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007274|NCT05487261|Valsartan|valsartan|mesh-list
84007275|NCT05487261|Enalapril|enalapril|mesh-list
84007276|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84007277|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84007278|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84007279|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84007280|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007281|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84007282|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
84007283|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007284|NCT05479240|Capecitabine|capecitabine|mesh-list
84007285|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
84007286|NCT05479240|Tislelizumab|tislelizumab|mesh-list
84007287|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007288|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
84007289|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007290|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007291|NCT05479240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007292|NCT05471830|Apixaban|apixaban|mesh-list
84007293|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84007294|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
84007295|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84007296|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
84007297|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007298|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007299|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
84007300|NCT05468619|Valacyclovir|valacyclovir|mesh-list
84007301|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
84007302|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007303|NCT05467176|Relugolix|relugolix|mesh-list
84007304|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
84007305|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
84007306|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007307|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007308|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
84007309|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007310|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007311|NCT05465954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007312|NCT05465954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007313|NCT05465941|Irinotecan|irinotecan|mesh-list
84007314|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84007315|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84007316|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007317|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007318|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007319|NCT05461573|Drospirenone|drospirenone|mesh-list
84007320|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84007321|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
84007322|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007323|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007324|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84007325|NCT05461573|Diuretics|diuretics|mesh-ancestor
84007326|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
84007327|NCT05457972|Estradiol|estradiol|mesh-list
84007328|NCT05457972|Estrogens|estrogens|mesh-ancestor
84007329|NCT05457972|Hormones|hormones|mesh-ancestor
84007330|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007331|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007332|NCT05452772|Niacin|niacin|mesh-list
84007333|NCT05452772|Psilocybin|psilocybin|mesh-list
84007334|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84007335|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
84007336|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007337|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84007338|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
84007339|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
84007340|NCT05452772|Vitamins|vitamins|mesh-ancestor
84007341|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
84007342|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007343|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
84007344|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84007345|NCT05442684|Vaccines|vaccines|mesh-list
84007346|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
84007347|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007348|NCT05413161|Omalizumab|omalizumab|mesh-list
84007349|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84007350|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84007351|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84007352|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
84007353|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
84007354|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007355|NCT05401565|Balovaptan|balovaptan|mesh-list
84007356|NCT05401565|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84007357|NCT05401565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007358|NCT05401565|Natriuretic Agents|natriuretic agents|mesh-ancestor
84007359|NCT05401565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007360|NCT05380388|Vaccines|vaccines|mesh-list
84007361|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
84007362|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007363|NCT05369819|Midazolam|midazolam|mesh-list
84007364|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84007365|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84007366|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84007367|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007368|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84007369|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84007370|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84007371|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84007372|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
84007373|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
84007374|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
84007375|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
84007376|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007377|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007378|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
84007379|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007380|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007381|NCT05332561|Trastuzumab|trastuzumab|mesh-list
84007382|NCT05332561|Atezolizumab|atezolizumab|mesh-list
84007383|NCT05332561|Pertuzumab|pertuzumab|mesh-list
84007384|NCT05332561|Olaparib|olaparib|mesh-list
84007385|NCT05332561|Ipatasertib|ipatasertib|mesh-list
84007386|NCT05332561|Inavolisib|inavolisib|mesh-list
84007387|NCT05332561|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84007388|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007389|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007390|NCT05332561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007391|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007392|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84007393|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007394|NCT05332561|Immunoconjugates|immunoconjugates|mesh-ancestor
84007395|NCT05332561|Immunologic Factors|immunologic factors|mesh-ancestor
84007396|NCT05332561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007397|NCT05332561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007398|NCT05332561|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
84007399|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84007400|NCT05332444|Amoxicillin|amoxicillin|mesh-list
84007401|NCT05332444|Metronidazole|metronidazole|mesh-list
84007402|NCT05332444|Clarithromycin|clarithromycin|mesh-list
84007403|NCT05332444|Levofloxacin|levofloxacin|mesh-list
84007404|NCT05332444|Tetracycline|tetracycline|mesh-list
84007405|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84007406|NCT05332444|Rabeprazole|rabeprazole|mesh-list
84007407|NCT05332444|Bismuth|bismuth|mesh-list
84007408|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84007409|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007410|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
84007411|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84007412|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84007413|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84007414|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007415|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007416|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84007417|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84007418|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84007419|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84007420|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84007421|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007422|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84007423|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84007424|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84007425|NCT05332444|Antacids|antacids|mesh-ancestor
84007426|NCT05331183|Ivacaftor|ivacaftor|mesh-list
84007427|NCT05331183|Elexacaftor|elexacaftor|mesh-list
84007428|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84007429|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84007430|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007431|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
84007432|NCT05327023|Sirolimus|sirolimus|mesh-list
84007433|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
84007434|NCT05327023|Busulfan|busulfan|mesh-list
84007435|NCT05327023|Fludarabine|fludarabine|mesh-list
84007436|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007437|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
84007438|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007439|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007440|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84007441|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
84007442|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007443|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007444|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84007445|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84007446|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84007447|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
84007448|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84007449|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007450|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007451|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
84007452|NCT05307705|Paclitaxel|paclitaxel|mesh-list
84007453|NCT05307705|Letrozole|letrozole|mesh-list
84007454|NCT05307705|Fulvestrant|fulvestrant|mesh-list
84007455|NCT05307705|Anastrozole|anastrozole|mesh-list
84007456|NCT05307705|Exemestane|exemestane|mesh-list
84007457|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84007458|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007459|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
84007460|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
84007461|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
83247207|NCT05014711|Fentanyl|fentanyl|mesh-list
84007462|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007463|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84007464|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84007465|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007466|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84007467|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
84007468|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007469|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007470|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84007471|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84007472|NCT05290740|Norepinephrine|norepinephrine|mesh-list
84007473|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84007474|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84007475|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
84007476|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007477|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007478|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007479|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
84007480|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
84007481|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007482|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84007483|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
84007484|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
84007485|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007486|NCT05260684|Trametinib|trametinib|mesh-list
84007487|NCT05260684|Vemurafenib|vemurafenib|mesh-list
84007488|NCT05260684|Dabrafenib|dabrafenib|mesh-list
84007489|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007490|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007491|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007492|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007493|NCT05252390|Olaparib|olaparib|mesh-list
84007494|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84007495|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007496|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007497|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007498|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84007499|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84007500|NCT05212311|Chitosan|chitosan|mesh-list
84007501|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84007502|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84007503|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
84007504|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007505|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84007506|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
84007507|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
84007508|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
84007509|NCT05212311|Coagulants|coagulants|mesh-ancestor
84007510|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84007511|NCT05194293|Durvalumab|durvalumab|mesh-list
84007512|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
84007513|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84007514|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
84007515|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007516|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007517|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
84007518|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007519|NCT05182840|Empagliflozin|empagliflozin|mesh-list
84007520|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84007521|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007522|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84007523|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007524|NCT05159752|Afamelanotide|afamelanotide|mesh-list
84007525|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
84007526|NCT05141721|Leucovorin|leucovorin|mesh-list
84007527|NCT05141721|Bevacizumab|bevacizumab|mesh-list
84007528|NCT05141721|Ipilimumab|ipilimumab|mesh-list
84007529|NCT05141721|Atezolizumab|atezolizumab|mesh-list
84007530|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007531|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007532|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007533|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007534|NCT05141721|Growth Substances|growth substances|mesh-ancestor
84007535|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007536|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007537|NCT05141721|Antidotes|antidotes|mesh-ancestor
84007538|NCT05141721|Protective Agents|protective agents|mesh-ancestor
84007539|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
84007540|NCT05141721|Vitamins|vitamins|mesh-ancestor
84007541|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
84007542|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007543|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007544|NCT05104723|Tofacitinib|tofacitinib|mesh-list
84007545|NCT05104723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84007546|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007547|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007548|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007549|NCT05095116|Fluticasone|fluticasone|mesh-list
84007551|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84007552|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84007553|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
84007554|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007555|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007556|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84007557|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
84007558|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
84007559|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84007560|NCT05093322|Gemcitabine|gemcitabine|mesh-list
84007561|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007562|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
84007563|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007564|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007565|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
84007566|NCT05092451|Fludarabine|fludarabine|mesh-list
84007567|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
84007568|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007569|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
84007570|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007571|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007572|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84007573|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
84007574|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007575|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007576|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84007577|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007578|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
84007579|NCT05074355|Azacitidine|azacitidine|mesh-list
84007580|NCT05074355|Venetoclax|venetoclax|mesh-list
84007581|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007582|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
84007583|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007584|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007585|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007586|NCT05039801|Paclitaxel|paclitaxel|mesh-list
84007587|NCT05039801|Bevacizumab|bevacizumab|mesh-list
84007588|NCT05039801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84007589|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84007590|NCT05039801|Endothelial Growth Factors|endothelial growth factors|mesh-list
84007591|NCT05039801|Antibodies|antibodies|mesh-list
84007592|NCT05039801|Immunoglobulins|immunoglobulins|mesh-list
84007593|NCT05039801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84007594|NCT05039801|Immunoglobulin G|immunoglobulin g|mesh-list
84007595|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84007596|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007597|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
84007598|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
84007599|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
84007600|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007601|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007602|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007603|NCT05039801|Growth Substances|growth substances|mesh-ancestor
84007604|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007605|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007606|NCT05039801|Immunologic Factors|immunologic factors|mesh-ancestor
84007607|NCT05020860|Paclitaxel|paclitaxel|mesh-list
84007608|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
84007609|NCT05020860|Carboplatin|carboplatin|mesh-list
84007610|NCT05020860|Doxorubicin|doxorubicin|mesh-list
84007611|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
84007612|NCT05020860|Trastuzumab|trastuzumab|mesh-list
84007613|NCT05020860|Pertuzumab|pertuzumab|mesh-list
84007614|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84007615|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007616|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
84007617|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
84007618|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
84007619|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007620|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007621|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
84007622|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007623|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007624|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84007625|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
84007626|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84007627|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84007628|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84007629|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84007630|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007631|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007632|NCT05020860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007633|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84007634|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84007635|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007636|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007637|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84007638|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84007639|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007640|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
84007641|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007642|NCT05001152|Ozanimod|ozanimod|mesh-list
84007643|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84007644|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007645|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007646|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
84007647|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007648|NCT04963296|Acetaminophen|acetaminophen|mesh-list
84007649|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
84007650|NCT04963296|Promethazine|promethazine|mesh-list
84007651|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
84007652|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
84007653|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84007654|NCT04963296|Analgesics|analgesics|mesh-ancestor
84007655|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
84007656|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84007657|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007658|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
84007659|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84007660|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
84007661|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
84007662|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84007663|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
84007664|NCT04963296|Hormones|hormones|mesh-ancestor
84007665|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007666|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84007667|NCT04963296|Protective Agents|protective agents|mesh-ancestor
84007668|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007669|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007670|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84007671|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84007672|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84007673|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
84007674|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
84007675|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84007676|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
84007677|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
84007678|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007679|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007680|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84007681|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
84007682|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
84007683|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
84007684|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
84007685|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
84007686|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
84007687|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007688|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007689|NCT04929808|Emollients|emollients|mesh-list
84007690|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
84007691|NCT04929392|Paclitaxel|paclitaxel|mesh-list
84007692|NCT04929392|Carboplatin|carboplatin|mesh-list
84007693|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
84007694|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84007695|NCT04929392|Lenvatinib|lenvatinib|mesh-list
84007696|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84007697|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007698|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
84007699|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
84007700|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
84007701|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007702|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007703|NCT04929392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007704|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007705|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007706|NCT04919629|Bevacizumab|bevacizumab|mesh-list
84007707|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84007708|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
84007709|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
84007710|NCT04919629|Antibodies|antibodies|mesh-list
84007711|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
84007712|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84007713|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
84007714|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007715|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007716|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007717|NCT04919629|Growth Substances|growth substances|mesh-ancestor
84007718|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007719|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007720|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
84007721|NCT04919629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007722|NCT04919629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007723|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
84007724|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
84007725|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84007726|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
84007727|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007728|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007729|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
84007730|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
84007731|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84007732|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007733|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
84007734|NCT04880434|Fludarabine|fludarabine|mesh-list
84007735|NCT04880434|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
84007736|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007737|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
84007738|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007739|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007740|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84007741|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
84007742|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007743|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007744|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84007745|NCT04880434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007746|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
84007747|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007748|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007749|NCT04849910|Immunotoxins|immunotoxins|mesh-ancestor
84007750|NCT04849910|Immunoconjugates|immunoconjugates|mesh-ancestor
84007751|NCT04849910|Immunologic Factors|immunologic factors|mesh-ancestor
84007752|NCT04849910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007753|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
84007754|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007755|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007756|NCT04840394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007757|NCT04840394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007758|NCT04839549|Fluorometholone|fluorometholone|mesh-list
84007759|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84007760|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007761|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
84007762|NCT04839549|Hormones|hormones|mesh-ancestor
84007763|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84007764|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84007765|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84007766|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84007767|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84007768|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007769|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
84007770|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007771|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007773|NCT04802161|Daunorubicin|daunorubicin|mesh-list
84007774|NCT04802161|Pomalidomide|pomalidomide|mesh-list
84007775|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007776|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
84007777|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007778|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007779|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
84007780|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007781|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007782|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
84007783|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007784|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84007785|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84007786|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84007787|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007788|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007789|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007790|NCT04802161|Growth Substances|growth substances|mesh-ancestor
84007791|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007792|NCT04794569|Tinzaparin|tinzaparin|mesh-list
84007793|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84007794|NCT04794569|Dalteparin|dalteparin|mesh-list
84007795|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
84007796|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84007797|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
84007798|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84007799|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
84007800|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007801|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007802|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
84007803|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84007804|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84007805|NCT04790370|Heparin|heparin|mesh-list
84007806|NCT04790370|Calcium heparin|calcium heparin|mesh-list
84007807|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
84007808|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84007809|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84007810|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007811|NCT04787042|Pembrolizumab|pembrolizumab|mesh-list
84007812|NCT04787042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007813|NCT04787042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007814|NCT04787042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007815|NCT04787042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007816|NCT04781322|Alirocumab|alirocumab|mesh-list
84007817|NCT04781322|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84007818|NCT04781322|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84007819|NCT04781322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84007820|NCT04781322|Antimetabolites|antimetabolites|mesh-ancestor
84007821|NCT04781322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007822|NCT04781322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84007823|NCT04781322|Protease Inhibitors|protease inhibitors|mesh-ancestor
84007824|NCT04781322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007825|NCT04781322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84007826|NCT04712097|Rituximab|rituximab|mesh-list
84007827|NCT04712097|Lenalidomide|lenalidomide|mesh-list
84007828|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007829|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007830|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
84007831|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007832|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007833|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007834|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007835|NCT04712097|Growth Substances|growth substances|mesh-ancestor
84007836|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007837|NCT04661358|Fenofibrate|fenofibrate|mesh-list
84007838|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83247587|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
84007839|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
84007840|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007841|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84007842|NCT04652700|Tenofovir|tenofovir|mesh-list
84007843|NCT04652700|Emtricitabine|emtricitabine|mesh-list
84007844|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84007845|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84007846|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
84007847|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007848|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84007849|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84007850|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007851|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007852|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84007853|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84007854|NCT04630808|Latanoprost|latanoprost|mesh-list
84007855|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84007856|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84007857|NCT04624230|Tofacitinib|tofacitinib|mesh-list
84007858|NCT04624230|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84007859|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007860|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007861|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007862|NCT04624178|Nivolumab|nivolumab|mesh-list
84007863|NCT04624178|Rucaparib|rucaparib|mesh-list
84007864|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007865|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007866|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007867|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007868|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84007869|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007870|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
84007871|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84007872|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
84007873|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007874|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007875|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007876|NCT04563338|Bevacizumab|bevacizumab|mesh-list
84007877|NCT04563338|Atezolizumab|atezolizumab|mesh-list
84007878|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007879|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007880|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007881|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007882|NCT04563338|Growth Substances|growth substances|mesh-ancestor
84007883|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007884|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007885|NCT04563338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007886|NCT04563338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007887|NCT04531982|Pimavanserin|pimavanserin|mesh-list
84007888|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84007889|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84007890|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84007891|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84007892|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84007893|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007894|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84007895|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84007896|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84007897|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
84007898|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84007899|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007900|NCT04524910|Aflibercept|aflibercept|mesh-list
84007901|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007902|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007903|NCT04524910|Growth Substances|growth substances|mesh-ancestor
84007904|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007905|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007906|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007907|NCT04513522|Nivolumab|nivolumab|mesh-list
84007908|NCT04513522|Ipilimumab|ipilimumab|mesh-list
84007909|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007910|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007911|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83247669|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
84007912|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007914|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007915|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84007916|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007917|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007918|NCT04384484|Rituximab|rituximab|mesh-list
84007919|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
84007920|NCT04384484|Gemcitabine|gemcitabine|mesh-list
84007921|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
84007922|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007923|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007924|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
84007925|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007926|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007927|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007928|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
84007929|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007930|NCT04377087|Olaparib|olaparib|mesh-list
84007931|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84007932|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007933|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007934|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007935|NCT04341779|Tenofovir|tenofovir|mesh-list
84007936|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
84007937|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007938|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84007939|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84007940|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007941|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007942|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84007943|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84007944|NCT04246086|Lenalidomide|lenalidomide|mesh-list
84007945|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
84007946|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007947|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84007948|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84007949|NCT04246086|Growth Substances|growth substances|mesh-ancestor
84007950|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
84007951|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007952|NCT04216290|Cisplatin|cisplatin|mesh-list
84007953|NCT04216290|Gemcitabine|gemcitabine|mesh-list
84007954|NCT04216290|Fluorouracil|fluorouracil|mesh-list
84007955|NCT04216290|Durvalumab|durvalumab|mesh-list
84007956|NCT04216290|Mitomycins|mitomycins|mesh-list
84007957|NCT04216290|Mitomycin|mitomycin|mesh-list
84007958|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
84007959|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84007960|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
84007961|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007962|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007963|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
84007964|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007965|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007966|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
84007967|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007968|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007969|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84007970|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
84007971|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84007972|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84007973|NCT04205838|Vidarabine|vidarabine|mesh-list
84007974|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
84007975|NCT04205838|Fludarabine|fludarabine|mesh-list
84007976|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
84007977|NCT04205838|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
84007978|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84007979|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84007980|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
84007981|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84007982|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84007983|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84007984|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
84007985|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007986|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007987|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84007988|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84007989|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
84007990|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
84007991|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84007992|NCT04205838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007993|NCT04196530|Atezolizumab|atezolizumab|mesh-list
84007994|NCT04196530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84007995|NCT04196530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84007996|NCT04196530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84007997|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84007998|NCT04190056|Tamoxifen|tamoxifen|mesh-list
84007999|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
84008000|NCT04190056|Vorinostat|vorinostat|mesh-list
84008001|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008002|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008003|NCT04190056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008004|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008005|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84008006|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008007|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008008|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008009|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008010|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84008011|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84008012|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84008013|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84008014|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008015|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
84008016|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84008017|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008018|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84008019|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008020|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
84008021|NCT04163016|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84008022|NCT04163016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008023|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008024|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
84008025|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008026|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008027|NCT04147013|Celecoxib|celecoxib|mesh-list
84008028|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84008029|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84008030|NCT04147013|Analgesics|analgesics|mesh-ancestor
84008031|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
84008032|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008033|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008034|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008035|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008036|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84008037|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84008038|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008039|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008040|NCT04086485|Olaparib|olaparib|mesh-list
84008041|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84008042|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008043|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008044|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008045|NCT04084717|Crizotinib|crizotinib|mesh-list
84008046|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008047|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008048|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008049|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008050|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
84008051|NCT04042701|Trastuzumab|trastuzumab|mesh-list
84008052|NCT04042701|Camptothecin|camptothecin|mesh-list
84008053|NCT04042701|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
84008054|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
84008055|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008056|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008057|NCT04042701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008058|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008059|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
84008060|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008061|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008062|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84008063|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008064|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008065|NCT04016389|Paclitaxel|paclitaxel|mesh-list
84008066|NCT04016389|Carboplatin|carboplatin|mesh-list
84008067|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008068|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008069|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008070|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008071|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008072|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008073|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
84008074|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008075|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008076|NCT03991819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008077|NCT03991819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008078|NCT03954041|Glyburide|glyburide|mesh-list
84008079|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84008080|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008081|NCT03945513|Dienogest|dienogest|mesh-list
84008082|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84008083|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84008084|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84008085|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84008086|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
84008087|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84008088|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008089|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84008090|NCT03945513|Estrogens|estrogens|mesh-ancestor
84008091|NCT03945513|Hormones|hormones|mesh-ancestor
84008092|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008093|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84008094|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008095|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008096|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008097|NCT03944772|Carboplatin|carboplatin|mesh-list
84008098|NCT03944772|Etoposide|etoposide|mesh-list
84008099|NCT03944772|Pemetrexed|pemetrexed|mesh-list
84008100|NCT03944772|Durvalumab|durvalumab|mesh-list
84008101|NCT03944772|Gefitinib|gefitinib|mesh-list
84008102|NCT03944772|Osimertinib|osimertinib|mesh-list
84008103|NCT03944772|Necitumumab|necitumumab|mesh-list
84008104|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008105|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008106|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84008107|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008108|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008109|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008110|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84008111|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84008112|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008113|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008114|NCT03919552|Cisplatin|cisplatin|mesh-list
84008115|NCT03919552|Carboplatin|carboplatin|mesh-list
84008116|NCT03919552|Docetaxel|docetaxel|mesh-list
84008117|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008118|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008119|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008120|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008121|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008122|NCT03901469|Talazoparib|talazoparib|mesh-list
84008123|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84008124|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008125|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008126|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008127|NCT03901339|Gemcitabine|gemcitabine|mesh-list
84008128|NCT03901339|Capecitabine|capecitabine|mesh-list
84008129|NCT03901339|Vinorelbine|vinorelbine|mesh-list
84008130|NCT03901339|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84008131|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008132|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
84008133|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008134|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008135|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008137|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008138|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008139|NCT03901339|Immunoconjugates|immunoconjugates|mesh-ancestor
84008140|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
84008141|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008142|NCT03897998|Naloxone|naloxone|mesh-list
84008143|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84008144|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008145|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
84008146|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008147|NCT03853707|Paclitaxel|paclitaxel|mesh-list
84008148|NCT03853707|Carboplatin|carboplatin|mesh-list
84008149|NCT03853707|Capecitabine|capecitabine|mesh-list
84008150|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84008151|NCT03853707|Atezolizumab|atezolizumab|mesh-list
84008152|NCT03853707|Ipatasertib|ipatasertib|mesh-list
84008153|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84008154|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008155|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008156|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008157|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008158|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008159|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008160|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008161|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
84008162|NCT03853707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008163|NCT03853707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008164|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
84008165|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008166|NCT03853707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008167|NCT03853707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008168|NCT03836209|Cytarabine|cytarabine|mesh-list
84008169|NCT03836209|Daunorubicin|daunorubicin|mesh-list
84008170|NCT03836209|Midostaurin|midostaurin|mesh-list
84008171|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008172|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
84008173|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008174|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008175|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
84008176|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84008177|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008178|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
84008179|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008180|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84008181|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84008182|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008183|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008184|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008185|NCT03834506|Dexamethasone|dexamethasone|mesh-list
84008186|NCT03834506|Prednisone|prednisone|mesh-list
84008187|NCT03834506|Docetaxel|docetaxel|mesh-list
84008188|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
84008189|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008190|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
84008191|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
84008192|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008193|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008194|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84008195|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
84008196|NCT03834506|Hormones|hormones|mesh-ancestor
84008197|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008198|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008199|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008200|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008201|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008202|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008203|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008204|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008205|NCT03834506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008206|NCT03824808|Lidocaine|lidocaine|mesh-list
84008207|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
84008208|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
84008209|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84008210|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008211|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
84008212|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008213|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84008214|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84008215|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84008216|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84008217|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008218|NCT03822962|Acetaminophen|acetaminophen|mesh-list
84008219|NCT03822962|Ibuprofen|ibuprofen|mesh-list
84008220|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84008221|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84008222|NCT03822962|Analgesics|analgesics|mesh-ancestor
84008223|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
84008224|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008225|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008226|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008227|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008228|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84008229|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008230|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008231|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
84008232|NCT03785405|Valsartan|valsartan|mesh-list
84008233|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84008234|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84008235|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84008236|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84008237|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008238|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
84008239|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008240|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008241|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84008242|NCT03749460|Nivolumab|nivolumab|mesh-list
84008243|NCT03749460|Ipilimumab|ipilimumab|mesh-list
84008244|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008245|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008246|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008247|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008248|NCT03725007|Upadacitinib|upadacitinib|mesh-list
84008249|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84008250|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008251|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008252|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008253|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008254|NCT03712098|Liraglutide|liraglutide|mesh-list
84008255|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84008256|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008257|NCT03712098|Incretins|incretins|mesh-ancestor
84008258|NCT03712098|Hormones|hormones|mesh-ancestor
84008259|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008260|NCT03711279|Apatinib|apatinib|mesh-list
84008261|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008262|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008263|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008264|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008265|NCT03703297|Durvalumab|durvalumab|mesh-list
84008266|NCT03703297|Tremelimumab|tremelimumab|mesh-list
84008267|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008268|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008269|NCT03641456|Dexamethasone|dexamethasone|mesh-list
84008270|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
84008271|NCT03641456|Lenalidomide|lenalidomide|mesh-list
84008272|NCT03641456|Bortezomib|bortezomib|mesh-list
84008273|NCT03641456|BB 1101|bb 1101|mesh-list
84008274|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008275|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
84008276|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
84008277|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008278|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008279|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248038|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83248039|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
83248040|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248041|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83248042|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84008280|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
84008281|NCT03641456|Hormones|hormones|mesh-ancestor
84008282|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008283|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008284|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008285|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
84008286|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008287|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008288|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
84008289|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84008290|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84008291|NCT03641456|Growth Substances|growth substances|mesh-ancestor
84008292|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
84008293|NCT03582176|Ketotifen|ketotifen|mesh-list
84008294|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
84008295|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008296|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84008297|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
84008298|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
84008299|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84008300|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008301|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008302|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84008303|NCT03512197|Midostaurin|midostaurin|mesh-list
84008304|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008305|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008306|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008307|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008308|NCT03493152|Everolimus|everolimus|mesh-list
84008309|NCT03493152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84008310|NCT03493152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008311|NCT03493152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008312|NCT03493152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008313|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008314|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
84008315|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008316|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008317|NCT03492671|Paclitaxel|paclitaxel|mesh-list
84008318|NCT03492671|Gemcitabine|gemcitabine|mesh-list
84008319|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008320|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008321|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008322|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008323|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008324|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008325|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008326|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
84008327|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
84008328|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008329|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008330|NCT03486301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008331|NCT03486301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008332|NCT03391479|Avelumab|avelumab|mesh-list
84008333|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008334|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008335|NCT04218851|Posaconazole|posaconazole|mesh-list
84008336|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
84008337|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84008338|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84008339|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84008340|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84008341|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84008342|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84008343|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008344|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008345|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84008346|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008347|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008348|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008349|NCT03387423|Tofacitinib|tofacitinib|mesh-list
84008350|NCT03387423|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84008351|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008352|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248117|NCT04989127|Penicillins|penicillins|mesh-list
84008353|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008354|NCT03355300|Cannabidiol|cannabidiol|mesh-list
84008355|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
84008356|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
84008357|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008358|NCT03199040|Durvalumab|durvalumab|mesh-list
84008359|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008360|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008361|NCT03190954|Raclopride|raclopride|mesh-list
84008362|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84008363|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84008364|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84008365|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008366|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84008367|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84008368|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
84008369|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84008370|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008371|NCT03178552|Bevacizumab|bevacizumab|mesh-list
84008372|NCT03178552|Atezolizumab|atezolizumab|mesh-list
84008373|NCT03178552|Carboplatin|carboplatin|mesh-list
84008374|NCT03178552|Gemcitabine|gemcitabine|mesh-list
84008375|NCT03178552|Docetaxel|docetaxel|mesh-list
84008376|NCT03178552|Pemetrexed|pemetrexed|mesh-list
84008377|NCT03178552|Vemurafenib|vemurafenib|mesh-list
84008378|NCT03178552|Entrectinib|entrectinib|mesh-list
84008379|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008380|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008381|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84008382|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84008383|NCT03178552|Growth Substances|growth substances|mesh-ancestor
84008384|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008385|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
84008386|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008387|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
84008388|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008389|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008390|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008391|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008392|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008393|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84008394|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84008395|NCT03178552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008396|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008397|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84008398|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84008399|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008400|NCT03121586|Pimavanserin|pimavanserin|mesh-list
84008401|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84008402|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84008403|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84008404|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84008405|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84008406|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008407|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84008408|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84008409|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84008410|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
84008411|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84008412|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008413|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
84008414|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008415|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008416|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
84008417|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008418|NCT03087903|Protective Agents|protective agents|mesh-ancestor
84008419|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008420|NCT03074045|Drospirenone|drospirenone|mesh-list
84008421|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
84008422|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84008423|NCT03074045|Estradiol|estradiol|mesh-list
84008424|NCT03074045|Estrogens|estrogens|mesh-ancestor
84008425|NCT03074045|Hormones|hormones|mesh-ancestor
84008426|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008427|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008428|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84008429|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
84008430|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84008431|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84008432|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84008433|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84008434|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84008435|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84008436|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008437|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84008438|NCT03074045|Diuretics|diuretics|mesh-ancestor
84008439|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
84008440|NCT03000439|Tofacitinib|tofacitinib|mesh-list
84008441|NCT03000439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84008442|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008443|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008444|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008446|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
84008447|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008448|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
84008449|NCT02960022|Hormones|hormones|mesh-ancestor
84008450|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008451|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008452|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008453|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008454|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84008455|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008456|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008457|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008458|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84008459|NCT02948543|Mitomycins|mitomycins|mesh-list
84008460|NCT02948543|Mitomycin|mitomycin|mesh-list
84008461|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84008462|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008463|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
84008464|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008465|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84008466|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008467|NCT02901184|Spironolactone|spironolactone|mesh-list
84008468|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84008469|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008470|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008471|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008472|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84008473|NCT02901184|Diuretics|diuretics|mesh-ancestor
84008474|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
84008475|NCT02901041|Zonisamide|zonisamide|mesh-list
84008476|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
84008477|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84008478|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84008479|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008480|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84008481|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008482|NCT02840227|Anesthetics|anesthetics|mesh-list
84008483|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84008484|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008485|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
84008486|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008487|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008488|NCT02830594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008489|NCT02830594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008490|NCT02705508|Gemcitabine|gemcitabine|mesh-list
84008491|NCT02705508|Etoposide|etoposide|mesh-list
84008492|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
84008493|NCT02705508|Pegaspargase|pegaspargase|mesh-list
84008494|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008495|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
84008496|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008497|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008498|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008499|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83248272|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84008500|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008501|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008502|NCT02700841|Melphalan|melphalan|mesh-list
84008503|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
84008504|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008505|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
84008506|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008507|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008508|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008509|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008510|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
84008511|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008512|NCT02672917|Paclitaxel|paclitaxel|mesh-list
84008513|NCT02672917|Gemcitabine|gemcitabine|mesh-list
84008514|NCT02672917|Folfirinox|folfirinox|mesh-list
84008515|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008516|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008517|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008518|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008519|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008520|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008521|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008522|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
84008523|NCT02636322|Prednisone|prednisone|mesh-list
84008524|NCT02636322|Cortisone|cortisone|mesh-list
84008525|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
84008526|NCT02636322|Rituximab|rituximab|mesh-list
84008527|NCT02636322|Doxorubicin|doxorubicin|mesh-list
84008528|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84008529|NCT02636322|Etoposide|etoposide|mesh-list
84008530|NCT02636322|Vincristine|vincristine|mesh-list
84008531|NCT02636322|Lenalidomide|lenalidomide|mesh-list
84008532|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
84008533|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
84008534|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84008535|NCT02636322|Antibodies|antibodies|mesh-list
84008536|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
84008537|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84008538|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008539|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
84008540|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008541|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008542|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008543|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
84008544|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008545|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008546|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008547|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84008548|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84008549|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008550|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008551|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008552|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
84008553|NCT02636322|Hormones|hormones|mesh-ancestor
84008554|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008555|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008556|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008557|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008558|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008559|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008560|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84008561|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84008562|NCT02636322|Growth Substances|growth substances|mesh-ancestor
84008563|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
84008564|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
84008565|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008566|NCT02547987|Carboplatin|carboplatin|mesh-list
84008567|NCT02547987|Docetaxel|docetaxel|mesh-list
84008568|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008569|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008570|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008571|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008572|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008573|NCT02530489|Paclitaxel|paclitaxel|mesh-list
84008574|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84008575|NCT02530489|Atezolizumab|atezolizumab|mesh-list
84008576|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84008577|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008578|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008579|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008580|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008581|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008582|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008583|NCT02530489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008584|NCT02530489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008585|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
84008586|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008587|NCT02523040|Lenalidomide|lenalidomide|mesh-list
84008588|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
84008589|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008590|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84008591|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84008592|NCT02523040|Growth Substances|growth substances|mesh-ancestor
84008593|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
84008594|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008595|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
84008596|NCT02419495|Leucovorin|leucovorin|mesh-list
84008597|NCT02419495|Folic Acid|folic acid|mesh-list
84008598|NCT02419495|Paclitaxel|paclitaxel|mesh-list
84008599|NCT02419495|Camptothecin|camptothecin|mesh-list
84008600|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
84008601|NCT02419495|Carboplatin|carboplatin|mesh-list
84008602|NCT02419495|Doxorubicin|doxorubicin|mesh-list
84008603|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84008604|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
84008605|NCT02419495|Fluorouracil|fluorouracil|mesh-list
84008606|NCT02419495|Capecitabine|capecitabine|mesh-list
84008607|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
84008608|NCT02419495|Nivolumab|nivolumab|mesh-list
84008609|NCT02419495|Irinotecan|irinotecan|mesh-list
84008610|NCT02419495|Pemetrexed|pemetrexed|mesh-list
84008611|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84008612|NCT02419495|Ipilimumab|ipilimumab|mesh-list
84008613|NCT02419495|Daunorubicin|daunorubicin|mesh-list
84008614|NCT02419495|Topotecan|topotecan|mesh-list
84008615|NCT02419495|Olaparib|olaparib|mesh-list
84008616|NCT02419495|Calcium|calcium|mesh-list
84008617|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
84008618|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008619|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008620|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008621|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008622|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008623|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008624|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008625|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
84008626|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008627|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008628|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008629|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
84008630|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008631|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84008632|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84008633|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008634|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008635|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008636|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008637|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84008638|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84008639|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
84008640|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008641|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84008642|NCT02419495|Antidotes|antidotes|mesh-ancestor
84008643|NCT02419495|Protective Agents|protective agents|mesh-ancestor
84008644|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
84008645|NCT02419495|Vitamins|vitamins|mesh-ancestor
84008646|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
84008647|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84008648|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84008649|NCT02419495|Hematinics|hematinics|mesh-ancestor
84008650|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84008651|NCT02396043|Cytarabine|cytarabine|mesh-list
84008652|NCT02396043|Dexamethasone|dexamethasone|mesh-list
84008653|NCT02396043|Prednisone|prednisone|mesh-list
84008654|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
84008655|NCT02396043|Methotrexate|methotrexate|mesh-list
84008656|NCT02396043|Vincristine|vincristine|mesh-list
84008657|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
84008658|NCT02396043|Pegaspargase|pegaspargase|mesh-list
84008660|NCT02396043|Pirarubicin|pirarubicin|mesh-list
84008661|NCT02396043|Doxorubicin|doxorubicin|mesh-list
84008662|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008663|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
84008664|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008665|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008666|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008667|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
84008668|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008669|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008670|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008671|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008672|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
84008673|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
84008674|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008675|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84008676|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
84008677|NCT02396043|Hormones|hormones|mesh-ancestor
84008678|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008679|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008680|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008681|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84008682|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
84008683|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84008684|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008685|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
84008686|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008687|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84008688|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84008689|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
84008690|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84008691|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008692|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008693|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008694|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008695|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84008696|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84008697|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008698|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84008699|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
84008700|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008701|NCT02203604|Aldesleukin|aldesleukin|mesh-list
84008702|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84008703|NCT02203604|Ipilimumab|ipilimumab|mesh-list
84008704|NCT02203604|Interleukin-2|interleukin-2|mesh-list
84008705|NCT02203604|Antibodies|antibodies|mesh-list
84008706|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
84008707|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84008708|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
84008709|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008710|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008711|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84008712|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008713|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84008714|NCT02203604|Analgesics|analgesics|mesh-ancestor
84008715|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
84008716|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008717|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84008718|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84008719|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
84008720|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84008721|NCT02181413|Ixazomib|ixazomib|mesh-list
84008722|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008723|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008724|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
84008725|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008726|NCT02151981|Osimertinib|osimertinib|mesh-list
84008727|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008728|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008729|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008730|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008731|NCT02097134|Melphalan|melphalan|mesh-list
84008732|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
83248486|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008733|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
84008734|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008735|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
84008736|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008737|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008738|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008739|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008740|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
84008741|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008742|NCT01525966|Paclitaxel|paclitaxel|mesh-list
84008743|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84008744|NCT01525966|Carboplatin|carboplatin|mesh-list
84008745|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008746|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008747|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008748|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008749|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008750|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008751|NCT01273610|Trastuzumab|trastuzumab|mesh-list
84008752|NCT01273610|Lapatinib|lapatinib|mesh-list
84008753|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008754|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008755|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008756|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008757|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008758|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
84008759|NCT01231906|Ifosfamide|ifosfamide|mesh-list
84008760|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
84008761|NCT01231906|Doxorubicin|doxorubicin|mesh-list
84008762|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84008763|NCT01231906|Etoposide|etoposide|mesh-list
84008764|NCT01231906|Vincristine|vincristine|mesh-list
84008765|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
84008766|NCT01231906|Topotecan|topotecan|mesh-list
84008767|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
84008768|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
84008769|NCT01231906|Razoxane|razoxane|mesh-list
84008770|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
84008771|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008772|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
84008773|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008774|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008775|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008776|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
84008777|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008778|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008779|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008780|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84008781|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84008782|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008783|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008784|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008785|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008786|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008787|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008788|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84008789|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
84008790|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008791|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84008792|NCT01231906|Protective Agents|protective agents|mesh-ancestor
84008793|NCT00999804|Trastuzumab|trastuzumab|mesh-list
84008794|NCT00999804|Letrozole|letrozole|mesh-list
84008795|NCT00999804|Lapatinib|lapatinib|mesh-list
84008796|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008797|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008798|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84008799|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84008800|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008801|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008802|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84008803|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008804|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008805|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008806|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008807|NCT00544830|Leuprolide|leuprolide|mesh-list
84008808|NCT00544830|Goserelin|goserelin|mesh-list
84008810|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84008811|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
84008812|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84008813|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008814|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008815|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008816|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
84008817|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
84008818|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008819|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
84008820|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84008821|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84008822|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84008823|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
84008824|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008825|NCT00077129|Paclitaxel|paclitaxel|mesh-list
84008826|NCT00077129|Carboplatin|carboplatin|mesh-list
84008827|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008828|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008829|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008830|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008831|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008832|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008833|NCT00052884|Melphalan|melphalan|mesh-list
84008834|NCT00052884|Amifostine|amifostine|mesh-list
84008835|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
84008836|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008837|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008838|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
84008839|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008840|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008841|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008842|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008843|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84008844|NCT00052884|Protective Agents|protective agents|mesh-ancestor
84008845|NCT00040807|Docetaxel|docetaxel|mesh-list
84008846|NCT00040807|Irinotecan|irinotecan|mesh-list
84008847|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008848|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008849|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008850|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008851|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008852|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84008853|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008854|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008855|NCT00028678|Dalteparin|dalteparin|mesh-list
84008856|NCT00028678|Tinzaparin|tinzaparin|mesh-list
84008857|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84008858|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
84008859|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84008860|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84008861|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008862|NCT00004223|Gemcitabine|gemcitabine|mesh-list
84008863|NCT00004223|Docetaxel|docetaxel|mesh-list
84008864|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008865|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
84008866|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008867|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008868|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008869|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008870|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008871|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
84008872|NCT00003764|Fludarabine|fludarabine|mesh-list
84008873|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
84008874|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008875|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
84008876|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008877|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008878|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008879|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
84008880|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008881|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008882|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83248637|NCT04798703|Paclitaxel|paclitaxel|mesh-list
83248650|NCT04798313|Denosumab|denosumab|mesh-list
84008883|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008884|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
84008885|NCT00003601|Tretinoin|tretinoin|mesh-list
84008886|NCT00003601|Fenretinide|fenretinide|mesh-list
84008887|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008888|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
84008889|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008890|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84008891|NCT00003601|Protective Agents|protective agents|mesh-ancestor
84008892|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008893|NCT00003266|Methylphenidate|methylphenidate|mesh-list
84008894|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84008895|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008896|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84008897|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84008898|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84008899|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008900|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
84008901|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84008902|NCT00003236|ISIS 5132|isis 5132|mesh-list
84008903|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008904|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008905|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008906|NCT00003057|Octreotide|octreotide|mesh-list
84008907|NCT00003057|Loperamide|loperamide|mesh-list
84008908|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
84008909|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84008910|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008911|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008912|NCT00002922|Paclitaxel|paclitaxel|mesh-list
84008913|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008914|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008915|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008916|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008917|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008918|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008919|NCT00002514|Leucovorin|leucovorin|mesh-list
84008920|NCT00002514|Cytarabine|cytarabine|mesh-list
84008921|NCT00002514|Dexamethasone|dexamethasone|mesh-list
84008922|NCT00002514|Prednisone|prednisone|mesh-list
84008923|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
84008924|NCT00002514|Methotrexate|methotrexate|mesh-list
84008925|NCT00002514|Etoposide|etoposide|mesh-list
84008926|NCT00002514|Vincristine|vincristine|mesh-list
84008927|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
84008928|NCT00002514|Daunorubicin|daunorubicin|mesh-list
84008929|NCT00002514|Asparaginase|asparaginase|mesh-list
84008930|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
84008931|NCT00002514|Thioguanine|thioguanine|mesh-list
84008932|NCT00002514|Sargramostim|sargramostim|mesh-list
84008933|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
84008934|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84008935|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
84008936|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008937|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008938|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84008939|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
84008940|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008941|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008942|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84008943|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84008944|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
84008945|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
84008946|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84008947|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84008948|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
84008949|NCT00002514|Hormones|hormones|mesh-ancestor
84008950|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84008951|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84008952|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84008953|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
84008954|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84008955|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008956|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
84008957|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
84008958|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008959|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84008960|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84008961|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84008962|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84008963|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84008964|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
84008965|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84008966|NCT00002514|Antidotes|antidotes|mesh-ancestor
84008967|NCT00002514|Protective Agents|protective agents|mesh-ancestor
84008968|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
84008970|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
84008971|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
84008972|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
84008973|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
84008974|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84008975|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84008976|NCT00607282|Udenafil|udenafil|mesh-list
84008977|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84008978|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84008979|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008980|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008981|NCT00927472|Permethrin|permethrin|mesh-list
84008982|NCT00927472|Malathion|malathion|mesh-list
84008983|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84008984|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84008985|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84008986|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
84008987|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84008988|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008989|NCT00642655|Rituximab|rituximab|mesh-list
84008990|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84008991|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84008992|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
84008993|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84008994|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84008995|NCT00642733|Gemcitabine|gemcitabine|mesh-list
84008996|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84008997|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84008998|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
84008999|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009000|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009001|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009002|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009003|NCT00927394|Valsartan|valsartan|mesh-list
84009004|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84009005|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84009006|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84009007|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009008|NCT00643825|Temozolomide|temozolomide|mesh-list
84009009|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84009010|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
84009011|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009012|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009013|NCT04178863|Timolol|timolol|mesh-list
84009014|NCT04178863|Latanoprost|latanoprost|mesh-list
84009015|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84009016|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84009017|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
84009018|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009019|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009020|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009021|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84009022|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84009023|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84009024|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84009025|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
84009026|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84009027|NCT04264858|Antibodies|antibodies|mesh-list
84009028|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
84009029|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
84009030|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009031|NCT00976911|Paclitaxel|paclitaxel|mesh-list
84009032|NCT00976911|Bevacizumab|bevacizumab|mesh-list
84009033|NCT00976911|Doxorubicin|doxorubicin|mesh-list
84009034|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83248789|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
84009035|NCT00976911|Topotecan|topotecan|mesh-list
84009036|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84009037|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009038|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
84009039|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
84009040|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
84009041|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009042|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84009043|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84009044|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84009045|NCT00976911|Growth Substances|growth substances|mesh-ancestor
84009046|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009047|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
84009048|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84009049|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84009050|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84009051|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009052|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84009053|NCT05336968|Triamcinolone|triamcinolone|mesh-list
84009054|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84009055|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84009056|NCT05336968|Ketorolac|ketorolac|mesh-list
84009057|NCT05336968|Ropivacaine|ropivacaine|mesh-list
84009058|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84009059|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
84009060|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
84009061|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009062|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009063|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
84009064|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009065|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009066|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
84009067|NCT05336968|Hormones|hormones|mesh-ancestor
84009068|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009069|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009070|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
84009071|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009072|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009073|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84009074|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84009075|NCT05336968|Analgesics|analgesics|mesh-ancestor
84009076|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84009077|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84009078|NCT02674555|Naquotinib|naquotinib|mesh-list
84009079|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009080|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009081|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009082|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009083|NCT00934648|Rituximab|rituximab|mesh-list
84009084|NCT00934648|Methotrexate|methotrexate|mesh-list
84009085|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84009086|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009087|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
84009088|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009089|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84009090|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84009091|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
84009092|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84009093|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009094|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
84009095|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009096|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
84009097|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009098|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84009099|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009100|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84009101|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84009102|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
84009103|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84009104|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
84009105|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009106|NCT00644449|Azithromycin|azithromycin|mesh-list
84009107|NCT00644449|Levofloxacin|levofloxacin|mesh-list
84009108|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009109|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009110|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84009111|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84009112|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84009113|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009114|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009115|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009116|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84009117|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84009118|NCT04287777|Mupirocin|mupirocin|mesh-list
84009119|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009120|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009121|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84009122|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009123|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009124|NCT04180657|Protein C|protein c|mesh-list
84009125|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
84009126|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84009127|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84009128|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009129|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84009130|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
84009131|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009132|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
84009133|NCT02674243|Povidone|povidone|mesh-list
84009134|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84009135|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
84009136|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
84009137|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84009138|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009139|NCT04256200|Dienogest|dienogest|mesh-list
84009140|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
84009141|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
84009142|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84009143|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84009144|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009145|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84009146|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84009147|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84009148|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84009149|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
84009150|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009151|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84009152|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009153|NCT02676739|Adderall|adderall|mesh-list
84009154|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84009155|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009156|NCT00976677|Paclitaxel|paclitaxel|mesh-list
84009157|NCT00976677|Bevacizumab|bevacizumab|mesh-list
84009158|NCT00976677|Carboplatin|carboplatin|mesh-list
84009159|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84009160|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84009161|NCT00976677|Antibodies|antibodies|mesh-list
84009162|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
84009163|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84009164|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84009165|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009166|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
84009167|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
84009168|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
84009169|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009170|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84009171|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84009172|NCT00976677|Growth Substances|growth substances|mesh-ancestor
84009173|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009174|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
84009175|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
84009176|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009177|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009178|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
84009179|NCT00642967|Hematinics|hematinics|mesh-ancestor
84009180|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
84009181|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84009182|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009183|NCT04287543|Melatonin|melatonin|mesh-list
83248935|NCT05170113|Caffeine|caffeine|mesh-list
84009184|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
84009185|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009186|NCT04287543|Protective Agents|protective agents|mesh-ancestor
84009187|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009188|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009190|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84009191|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
84009192|NCT04287387|Metformin|metformin|mesh-list
84009193|NCT04287387|Glimepiride|glimepiride|mesh-list
84009194|NCT04287387|Acarbose|acarbose|mesh-list
84009195|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84009196|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009197|NCT04287387|Incretins|incretins|mesh-ancestor
84009198|NCT04287387|Hormones|hormones|mesh-ancestor
84009199|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009200|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84009201|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
84009202|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009203|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009204|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84009205|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84009206|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009207|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
84009208|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84009209|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
84009210|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
84009211|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84009212|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84009213|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009214|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009215|NCT00644605|Urological Agents|urological agents|mesh-ancestor
84009216|NCT02865681|Letrozole|letrozole|mesh-list
84009217|NCT02865681|Clomiphene|clomiphene|mesh-list
84009218|NCT02865681|Enclomiphene|enclomiphene|mesh-list
84009219|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
84009220|NCT02865681|Menotropins|menotropins|mesh-list
84009221|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009222|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009223|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84009224|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84009225|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009226|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84009227|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
84009228|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009229|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009230|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84009231|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
84009232|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84009233|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84009234|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84009235|NCT00644137|Pregabalin|pregabalin|mesh-list
84009236|NCT00644137|Analgesics|analgesics|mesh-ancestor
84009237|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
84009238|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009239|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009240|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
84009241|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84009242|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84009243|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009244|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84009245|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84009246|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84009247|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009248|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84009249|NCT00910195|Acetaminophen|acetaminophen|mesh-list
84009250|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84009251|NCT00910195|Analgesics|analgesics|mesh-ancestor
84009252|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
84009253|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009254|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009255|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
84009256|NCT04176367|Nicergoline|nicergoline|mesh-list
84009257|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84009258|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84009260|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009261|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009262|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009263|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
84009264|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
84009265|NCT04259476|Ketamine|ketamine|mesh-list
84009266|NCT04259476|Analgesics|analgesics|mesh-ancestor
84009267|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
84009268|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009269|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009270|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84009271|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84009272|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
84009273|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
84009274|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009275|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84009276|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84009277|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009278|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009279|NCT05319574|Tislelizumab|tislelizumab|mesh-list
84009280|NCT05319574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84009281|NCT05319574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009282|NCT00970281|Olanzapine|olanzapine|mesh-list
84009283|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
84009284|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
84009285|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009286|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009287|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009288|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84009289|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84009290|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009291|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84009292|NCT00970281|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84009293|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84009294|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84009295|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009296|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009297|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
84009298|NCT00607438|Paclitaxel|paclitaxel|mesh-list
84009299|NCT00607438|Sorafenib|sorafenib|mesh-list
84009300|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84009301|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84009302|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009303|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
84009304|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
84009305|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
84009306|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009307|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009308|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009309|NCT00976209|Phenylephrine|phenylephrine|mesh-list
84009310|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
84009311|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84009312|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
84009313|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
84009314|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009315|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009316|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
84009317|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84009318|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
84009319|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
84009320|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84009321|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84009322|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84009323|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
84009324|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009325|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009326|NCT00976209|Protective Agents|protective agents|mesh-ancestor
84009327|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
84009328|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84009329|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
84009330|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84009331|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
84009332|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009333|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009334|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
84009335|NCT00925990|Ribavirin|ribavirin|mesh-list
84009336|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
84009337|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009338|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
84009339|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009340|NCT02670655|Lidocaine|lidocaine|mesh-list
84009341|NCT02670655|Prilocaine|prilocaine|mesh-list
84009342|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
84009343|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
84009344|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
84009345|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009346|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009347|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
84009348|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009349|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84009350|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84009351|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84009352|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84009353|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009354|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
84009355|NCT01131078|Bevacizumab|bevacizumab|mesh-list
84009356|NCT01131078|Capecitabine|capecitabine|mesh-list
84009357|NCT01131078|Irinotecan|irinotecan|mesh-list
84009358|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84009359|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009360|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84009361|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84009362|NCT01131078|Growth Substances|growth substances|mesh-ancestor
84009363|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009364|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
84009365|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009366|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
84009367|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009368|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84009369|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84009370|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009371|NCT03709017|Ponatinib|ponatinib|mesh-list
84009372|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009373|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009374|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009375|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009376|NCT03695445|Norepinephrine|norepinephrine|mesh-list
84009377|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84009378|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84009379|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
84009380|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009381|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009382|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009383|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
84009384|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
84009385|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009386|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84009387|NCT04177303|Metformin|metformin|mesh-list
84009388|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84009389|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009390|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
84009391|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
84009392|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84009393|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
84009394|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009395|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009396|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84009397|NCT02862873|Ondansetron|ondansetron|mesh-list
84009398|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009399|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
84009400|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
84009401|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009402|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009403|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
84009404|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
84009405|NCT02862873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84009406|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83249161|NCT04426487|Progesterone|progesterone|mesh-list
84009407|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
84009408|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009409|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009410|NCT03814005|Paclitaxel|paclitaxel|mesh-list
84009411|NCT03814005|Docetaxel|docetaxel|mesh-list
84009412|NCT03814005|Carboplatin|carboplatin|mesh-list
84009413|NCT03814005|Azacitidine|azacitidine|mesh-list
84009414|NCT03814005|Pevonedistat|pevonedistat|mesh-list
84009415|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84009416|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009417|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
84009418|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
84009419|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
84009420|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009421|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009422|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
84009423|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009424|NCT03683433|Azacitidine|azacitidine|mesh-list
84009425|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009426|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
84009427|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009428|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009429|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009430|NCT03449901|Gemcitabine|gemcitabine|mesh-list
84009431|NCT03449901|Docetaxel|docetaxel|mesh-list
84009432|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009433|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
84009434|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009435|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009436|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
84009437|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
84009438|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
84009439|NCT00968799|Cisplatin|cisplatin|mesh-list
84009440|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009441|NCT04016233|Tenofovir|tenofovir|mesh-list
84009442|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
84009443|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009444|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84009445|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84009446|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009447|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009448|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84009449|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84009450|NCT04033471|Midazolam|midazolam|mesh-list
84009451|NCT04033471|Morphine|morphine|mesh-list
84009452|NCT04033471|Bupivacaine|bupivacaine|mesh-list
84009453|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
84009454|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
84009455|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009456|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009457|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
84009458|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009459|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84009460|NCT04033471|Narcotics|narcotics|mesh-ancestor
84009461|NCT04033471|Analgesics|analgesics|mesh-ancestor
84009462|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84009463|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84009464|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84009465|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84009466|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84009467|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84009468|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
84009469|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
84009470|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
84009471|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009472|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009473|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
84009474|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009475|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009476|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84009477|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84009478|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009479|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009480|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009481|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84009482|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84009483|NCT04175587|Tretinoin|tretinoin|mesh-list
84009484|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
84009485|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009486|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
84009487|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
84009489|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
84009490|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
84009491|NCT02668159|Vitamins|vitamins|mesh-list
84009492|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
84009493|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009494|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84009495|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84009496|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
84009497|NCT02670109|Busulfan|busulfan|mesh-list
84009498|NCT02670109|Carmustine|carmustine|mesh-list
84009499|NCT02670109|Carboplatin|carboplatin|mesh-list
84009500|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009501|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
84009502|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009503|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84009504|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84009505|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
84009506|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009507|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009508|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84009509|NCT00922636|Methylphenidate|methylphenidate|mesh-list
84009510|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84009511|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009512|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84009513|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84009514|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84009515|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009516|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
84009517|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009518|NCT02667925|Cisplatin|cisplatin|mesh-list
84009519|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009520|NCT02669719|Carboplatin|carboplatin|mesh-list
84009521|NCT02669719|Pemetrexed|pemetrexed|mesh-list
84009522|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009523|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009524|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009525|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84009526|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84009527|NCT00644761|Adefovir|adefovir|mesh-list
84009528|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84009529|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
84009530|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009531|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84009532|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84009533|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009534|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009535|NCT00645073|Levofloxacin|levofloxacin|mesh-list
84009536|NCT00645073|Cefdinir|cefdinir|mesh-list
84009537|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84009538|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009539|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009540|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84009541|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84009542|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009543|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009544|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009545|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84009546|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84009547|NCT04259008|Manganese|manganese|mesh-list
84009548|NCT04259008|Trace Elements|trace elements|mesh-ancestor
84009549|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
84009550|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009551|NCT04258930|Calcium|calcium|mesh-list
84009552|NCT04258930|Calcium acetate|calcium acetate|mesh-list
84009553|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
84009554|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84009555|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009556|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
84009557|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
84009558|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009559|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84009560|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
84009561|NCT01175135|Risperidone|risperidone|mesh-list
84009562|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84009563|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
84009564|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009565|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009566|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009567|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84009568|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84009569|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009570|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84009571|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84009572|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
84009573|NCT02669641|Choline|choline|mesh-list
84009574|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
84009575|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84009576|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
84009577|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009578|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009579|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84009580|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
84009581|NCT00922480|Losartan|losartan|mesh-list
84009582|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84009583|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84009584|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84009585|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84009586|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009587|NCT04963036|Anesthetics|anesthetics|mesh-list
84009588|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009589|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009590|NCT00973479|Golimumab|golimumab|mesh-list
84009591|NCT00973479|Methotrexate|methotrexate|mesh-list
84009592|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84009593|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
84009594|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84009595|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009596|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009597|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
84009598|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009599|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009600|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
84009601|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009602|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84009603|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009604|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
84009605|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84009606|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84009607|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84009608|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009609|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84009610|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009611|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009612|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009613|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009614|NCT04315493|Maleic acid|maleic acid|mesh-list
84009615|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009616|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009617|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
84009618|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84009619|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84009620|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009621|NCT02862483|Tadalafil|tadalafil|mesh-list
84009622|NCT02862483|Tamsulosin|tamsulosin|mesh-list
84009623|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
84009624|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84009625|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84009626|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009627|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009628|NCT02862483|Urological Agents|urological agents|mesh-ancestor
84009629|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84009630|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83249385|NCT03775629|Tramadol|tramadol|mesh-list
84009631|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84009632|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
84009633|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009634|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009635|NCT02667535|Isosorbide|isosorbide|mesh-list
84009636|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84009637|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84009638|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84009639|NCT02667535|Diuretics|diuretics|mesh-ancestor
84009640|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
84009641|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009642|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
84009643|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84009644|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009645|NCT04286841|Immunomodulating Agents|immunomodulating agents|mesh-list
84009646|NCT04286841|Immunologic Factors|immunologic factors|mesh-ancestor
84009647|NCT04286841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009648|NCT00645151|Atorvastatin|atorvastatin|mesh-list
84009649|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84009650|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84009651|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
84009652|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009653|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84009654|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84009655|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009656|NCT00645229|Ziprasidone|ziprasidone|mesh-list
84009657|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84009658|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
84009659|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009660|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009661|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009662|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84009663|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84009664|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009665|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84009666|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84009667|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
84009668|NCT01172873|Cycloserine|cycloserine|mesh-list
84009669|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84009670|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009671|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84009672|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
84009673|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009674|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
84009675|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009676|NCT02886299|Simvastatin|simvastatin|mesh-list
84009677|NCT02886299|Fenofibrate|fenofibrate|mesh-list
84009678|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84009679|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84009680|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
84009681|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009682|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84009683|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84009684|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009685|NCT00925600|Denosumab|denosumab|mesh-list
84009686|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84009687|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009688|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84009689|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84009690|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84009691|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009692|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009693|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84009694|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84009695|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84009696|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
84009697|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009698|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009699|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84009700|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84009701|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
84009702|NCT02668861|Vitamin D|vitamin d|mesh-list
84009703|NCT02668861|Budesonide|budesonide|mesh-list
84009704|NCT02668861|Vitamins|vitamins|mesh-ancestor
83249472|NCT01670539|Hormones|hormones|mesh-ancestor
84009705|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
84009706|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009707|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84009708|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009709|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84009710|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
84009711|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009712|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84009713|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
84009714|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
84009715|NCT02668861|Hormones|hormones|mesh-ancestor
84009716|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009717|NCT00968253|Cytarabine|cytarabine|mesh-list
84009718|NCT00968253|Dexamethasone|dexamethasone|mesh-list
84009719|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
84009720|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84009721|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84009722|NCT00968253|Prednisolone|prednisolone|mesh-list
84009723|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
84009724|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
84009725|NCT00968253|Doxorubicin|doxorubicin|mesh-list
84009726|NCT00968253|Methotrexate|methotrexate|mesh-list
84009727|NCT00968253|Vincristine|vincristine|mesh-list
84009728|NCT00968253|Everolimus|everolimus|mesh-list
84009729|NCT00968253|Lenograstim|lenograstim|mesh-list
84009730|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84009731|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
84009732|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009733|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
84009734|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009735|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84009736|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84009737|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
84009738|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009739|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009740|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84009741|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009742|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
84009743|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
84009744|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009745|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009746|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
84009747|NCT00968253|Hormones|hormones|mesh-ancestor
84009748|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009749|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84009750|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84009751|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84009752|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84009753|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009754|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84009755|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
84009756|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84009757|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009758|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
84009759|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
84009760|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84009761|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84009762|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
84009763|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009764|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84009765|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
84009766|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
84009767|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
84009768|NCT00968253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84009769|NCT00968253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009770|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84009771|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84009772|NCT00968253|Protective Agents|protective agents|mesh-ancestor
84009773|NCT00646009|Fluticasone|fluticasone|mesh-list
84009774|NCT00646009|Budesonide|budesonide|mesh-list
84009775|NCT00646009|Albuterol|albuterol|mesh-list
84009776|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
84009777|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84009778|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83249534|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
84009779|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009780|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84009782|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009783|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009784|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84009785|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
84009786|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
84009787|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84009788|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
84009789|NCT00646009|Hormones|hormones|mesh-ancestor
84009790|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009791|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84009792|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84009793|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84009794|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
84009795|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009796|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009797|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
84009798|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84009799|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
84009800|NCT00646087|Ketamine|ketamine|mesh-list
84009801|NCT00646087|Analgesics|analgesics|mesh-ancestor
84009802|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
84009803|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009804|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009805|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84009806|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84009807|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
84009808|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
84009809|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009810|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84009811|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84009812|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009813|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009814|NCT04255576|Vitamin D|vitamin d|mesh-list
84009815|NCT04255576|Calcium|calcium|mesh-list
84009816|NCT04255576|Vitamins|vitamins|mesh-ancestor
84009817|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
84009818|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009819|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84009820|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84009821|NCT04255498|Etanercept|etanercept|mesh-list
84009822|NCT04255498|Mifepristone|mifepristone|mesh-list
84009823|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84009824|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84009825|NCT04255498|Analgesics|analgesics|mesh-ancestor
84009826|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
84009827|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009828|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009829|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009830|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84009831|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009832|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009833|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
84009834|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84009835|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
84009836|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84009837|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84009838|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84009839|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84009840|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
84009841|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84009842|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84009843|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
84009844|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009845|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
84009846|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84009847|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84009848|NCT02666209|Dexamethasone|dexamethasone|mesh-list
84009849|NCT02666209|Lenalidomide|lenalidomide|mesh-list
84009850|NCT02666209|Bortezomib|bortezomib|mesh-list
84009851|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009852|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
84009853|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
84009854|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009855|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009856|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009858|NCT02666209|Hormones|hormones|mesh-ancestor
84009859|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009860|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84009861|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009862|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
84009863|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84009864|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84009865|NCT02666209|Growth Substances|growth substances|mesh-ancestor
84009866|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
84009867|NCT00964743|Cytarabine|cytarabine|mesh-list
84009868|NCT00964743|Sorafenib|sorafenib|mesh-list
84009869|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84009870|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
84009871|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009872|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009873|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
84009874|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009875|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84009876|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
84009877|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009878|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84009879|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009880|NCT02862327|Dexamethasone|dexamethasone|mesh-list
84009881|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
84009882|NCT02862327|Ropivacaine|ropivacaine|mesh-list
84009883|NCT02862327|BB 1101|bb 1101|mesh-list
84009884|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009885|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
84009886|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
84009887|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009888|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009889|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009890|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
84009891|NCT02862327|Hormones|hormones|mesh-ancestor
84009892|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009893|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84009894|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009895|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
84009896|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009897|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009898|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
84009899|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
84009900|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009901|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
84009902|NCT04945720|Durvalumab|durvalumab|mesh-list
84009903|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84009904|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84009905|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009906|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
84009907|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009908|NCT02666365|Cefazolin|cefazolin|mesh-list
84009909|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009910|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009911|NCT02666443|Dexamethasone|dexamethasone|mesh-list
84009912|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
84009913|NCT02666443|BB 1101|bb 1101|mesh-list
84009914|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009915|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
84009916|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
84009917|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84009918|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009919|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84009920|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
84009921|NCT02666443|Hormones|hormones|mesh-ancestor
84009922|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84009923|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84009924|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009925|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
84009926|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009927|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249695|NCT00660673|Levodopa|levodopa|mesh-list
84009928|NCT01130532|Tadalafil|tadalafil|mesh-list
84009929|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
84009930|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84009931|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84009933|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009934|NCT01130532|Urological Agents|urological agents|mesh-ancestor
84009935|NCT04258306|Resveratrol|resveratrol|mesh-list
84009936|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
84009937|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009938|NCT04258306|Protective Agents|protective agents|mesh-ancestor
84009939|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009940|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009941|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84009942|NCT00646711|Valproic Acid|valproic acid|mesh-list
84009943|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
84009944|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009945|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009946|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
84009947|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84009948|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009949|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
84009950|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84009951|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84009952|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84009953|NCT00972777|Besifloxacin|besifloxacin|mesh-list
84009954|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009955|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009956|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84009957|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84009958|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009959|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009960|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009961|NCT04254874|Interferons|interferons|mesh-list
84009962|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84009963|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
84009964|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009965|NCT02667223|Bococizumab|bococizumab|mesh-list
84009966|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84009967|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84009968|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
84009969|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009970|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84009971|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
84009972|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84009973|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
84009974|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84009975|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
84009976|NCT00918736|Protective Agents|protective agents|mesh-ancestor
84009977|NCT02666053|Fostemsavir|fostemsavir|mesh-list
84009978|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84009979|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84009980|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
84009981|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009982|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84009983|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84009984|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009985|NCT04257838|Meropenem|meropenem|mesh-list
84009986|NCT04257838|Tazobactam|tazobactam|mesh-list
84009987|NCT04257838|Piperacillin|piperacillin|mesh-list
84009988|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84009989|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84009990|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84009991|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84009992|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84009993|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84009994|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
84009995|NCT01172639|Prednisone|prednisone|mesh-list
84009996|NCT01172639|Methotrexate|methotrexate|mesh-list
84009997|NCT01172639|Leflunomide|leflunomide|mesh-list
84009998|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84009999|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
84010000|NCT01172639|Hormones|hormones|mesh-ancestor
84010001|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010002|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010003|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83249759|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84010004|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010005|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84010006|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
84010007|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84010008|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010009|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
84010010|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010011|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
84010012|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010013|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84010014|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010015|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
84010016|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84010017|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84010018|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010019|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84010020|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84010021|NCT01172639|Analgesics|analgesics|mesh-ancestor
84010022|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
84010023|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010024|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010025|NCT01225562|Ticagrelor|ticagrelor|mesh-list
84010026|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84010027|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84010028|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84010029|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84010030|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
84010031|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010032|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010033|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010034|NCT00925288|Vaccines|vaccines|mesh-list
84010035|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
84010036|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010037|NCT01143714|Petrolatum|petrolatum|mesh-list
84010038|NCT01143714|Emollients|emollients|mesh-ancestor
84010039|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
84010040|NCT04920682|Iodine|iodine|mesh-list
84010041|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84010042|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010043|NCT04920682|Trace Elements|trace elements|mesh-ancestor
84010044|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
84010045|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010046|NCT04174339|Apatinib|apatinib|mesh-list
84010047|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010048|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84010049|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010050|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010051|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84010052|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
84010053|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010054|NCT00925132|Temozolomide|temozolomide|mesh-list
84010055|NCT00925132|Decitabine|decitabine|mesh-list
84010056|NCT00925132|Panobinostat|panobinostat|mesh-list
84010057|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84010058|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
84010059|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010060|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010061|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010062|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
84010063|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010064|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84010065|NCT02862015|Gemcitabine|gemcitabine|mesh-list
84010066|NCT02862015|Folfirinox|folfirinox|mesh-list
84010067|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010068|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
84010069|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010070|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010071|NCT01143402|Temozolomide|temozolomide|mesh-list
84010072|NCT01143402|Dacarbazine|dacarbazine|mesh-list
84010073|NCT01143402|Imidazole|imidazole|mesh-list
84010074|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84010075|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
84010076|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010077|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010078|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010080|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84010081|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
84010082|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
84010083|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010084|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010085|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84010086|NCT00646945|Analgesics|analgesics|mesh-ancestor
84010087|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
84010088|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010089|NCT00629889|Pregabalin|pregabalin|mesh-list
84010090|NCT00629889|Levetiracetam|levetiracetam|mesh-list
84010091|NCT00629889|Analgesics|analgesics|mesh-ancestor
84010092|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
84010093|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010094|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010095|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
84010096|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84010097|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010098|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010099|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84010100|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84010101|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84010102|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010103|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010104|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
84010105|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
84010106|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84010107|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84010108|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84010109|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010110|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010111|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
84010112|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010113|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010114|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84010115|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010116|NCT00630045|Capecitabine|capecitabine|mesh-list
84010117|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
84010118|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010119|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
84010120|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010121|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010122|NCT02861859|Olanzapine|olanzapine|mesh-list
84010123|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
84010124|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
84010125|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010126|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010127|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010128|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84010129|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84010130|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010131|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010132|NCT02861859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84010133|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84010134|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010135|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010136|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010137|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
84010138|NCT00647023|Metformin|metformin|mesh-list
84010139|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010140|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010141|NCT00924898|Tenofovir|tenofovir|mesh-list
84010142|NCT00924898|Emtricitabine|emtricitabine|mesh-list
84010143|NCT00924898|Efavirenz|efavirenz|mesh-list
84010144|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
84010145|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010146|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84010147|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84010148|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010149|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010150|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84010151|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83249913|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010152|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84010153|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84010154|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84010155|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84010156|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84010157|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84010159|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010160|NCT00646321|Budesonide|budesonide|mesh-list
84010161|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
84010162|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84010163|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010164|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84010165|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
84010166|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010167|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010168|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84010169|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
84010170|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
84010171|NCT00646321|Hormones|hormones|mesh-ancestor
84010172|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010173|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84010174|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84010175|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84010176|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010177|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010178|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010179|NCT00647101|Latanoprost|latanoprost|mesh-list
84010180|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84010181|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84010182|NCT01166958|Teriparatide|teriparatide|mesh-list
84010183|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
84010184|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84010185|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010186|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84010187|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84010188|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
84010189|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010190|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84010191|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84010192|NCT01170221|Linezolid|linezolid|mesh-list
84010193|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
84010194|NCT01170221|Tedizolid|tedizolid|mesh-list
84010195|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84010196|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010197|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84010198|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010199|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010200|NCT04254640|Cytarabine|cytarabine|mesh-list
84010201|NCT04254640|Cladribine|cladribine|mesh-list
84010202|NCT04254640|Aclarubicin|aclarubicin|mesh-list
84010203|NCT04254640|Lenograstim|lenograstim|mesh-list
84010204|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010205|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
84010206|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010207|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010208|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
84010209|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010210|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010211|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
84010212|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010213|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84010214|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84010215|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84010216|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84010217|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010218|NCT01166646|Clobetasol|clobetasol|mesh-list
84010219|NCT01166646|Halobetasol|halobetasol|mesh-list
84010220|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84010221|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010222|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
84010223|NCT01166646|Hormones|hormones|mesh-ancestor
84010224|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010225|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010226|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
84010227|NCT01129284|Hormones|hormones|mesh-ancestor
84010228|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010229|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010230|NCT00647257|Losartan|losartan|mesh-list
84010231|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84010232|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84010233|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84010234|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84010235|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010236|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
84010237|NCT04895761|Letrozole|letrozole|mesh-list
84010238|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010239|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
84010240|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010241|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84010242|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84010243|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
84010244|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010245|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010246|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84010247|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84010248|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84010249|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010250|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84010251|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
84010252|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010253|NCT01166178|Vitamin D|vitamin d|mesh-list
84010254|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
84010255|NCT01166178|Calcium|calcium|mesh-list
84010256|NCT01166178|Vitamins|vitamins|mesh-ancestor
84010257|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
84010258|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010259|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84010260|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84010261|NCT00924820|Bevacizumab|bevacizumab|mesh-list
84010262|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84010263|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010264|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84010265|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84010266|NCT00924820|Growth Substances|growth substances|mesh-ancestor
84010267|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010268|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
84010269|NCT01225172|Letrozole|letrozole|mesh-list
84010270|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010271|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84010272|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84010273|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010274|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010275|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84010276|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048345|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84010277|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010278|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010279|NCT02665039|Carboplatin|carboplatin|mesh-list
84010280|NCT02665039|Gemcitabine|gemcitabine|mesh-list
84010281|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010282|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010283|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
84010284|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010285|NCT00647491|Adalimumab|adalimumab|mesh-list
84010286|NCT00647491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84010287|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010288|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84010289|NCT04252456|Leucovorin|leucovorin|mesh-list
84010290|NCT04252456|Folic Acid|folic acid|mesh-list
84010291|NCT04252456|Fluorouracil|fluorouracil|mesh-list
84010292|NCT04252456|Aflibercept|aflibercept|mesh-list
84010293|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
84010294|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
84010295|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010296|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010297|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010298|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010299|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
84010300|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010301|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84010302|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84010303|NCT04252456|Growth Substances|growth substances|mesh-ancestor
84010304|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
84010305|NCT04252456|Antidotes|antidotes|mesh-ancestor
84010306|NCT04252456|Protective Agents|protective agents|mesh-ancestor
84010307|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
84010308|NCT04252456|Vitamins|vitamins|mesh-ancestor
84010309|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
84010310|NCT04252456|Hematinics|hematinics|mesh-ancestor
84010311|NCT02665351|Peramivir|peramivir|mesh-list
84010312|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
84010313|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010314|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010315|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010316|NCT01222520|Amlodipine|amlodipine|mesh-list
84010317|NCT01222520|Telmisartan|telmisartan|mesh-list
84010318|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
84010319|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84010320|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84010321|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010322|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010323|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84010324|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010325|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
84010326|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84010327|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84010328|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
84010329|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
84010330|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010331|NCT01221350|Protective Agents|protective agents|mesh-ancestor
84010332|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010333|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
84010334|NCT01221350|Vitamins|vitamins|mesh-ancestor
84010335|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
84010336|NCT00647647|Terbinafine|terbinafine|mesh-list
84010337|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
84010338|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010339|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010340|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010341|NCT01221272|Ranolazine|ranolazine|mesh-list
84010342|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84010343|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010344|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010345|NCT01220414|Naltrexone|naltrexone|mesh-list
84010346|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84010347|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84010348|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010349|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
84010350|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010351|NCT01128894|Liraglutide|liraglutide|mesh-list
84010352|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
84010353|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010354|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010355|NCT01128894|Incretins|incretins|mesh-ancestor
84010356|NCT01128894|Hormones|hormones|mesh-ancestor
84010357|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010358|NCT01220180|Pregabalin|pregabalin|mesh-list
84010359|NCT01220180|Analgesics|analgesics|mesh-ancestor
84010360|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
84010361|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010362|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010363|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
84010364|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84010365|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010366|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010367|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84010368|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84010369|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84010370|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010371|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010372|NCT01220024|Bupivacaine|bupivacaine|mesh-list
84010373|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
84010374|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
84010375|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010376|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010377|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
84010378|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010379|NCT00625248|Anticoagulants|anticoagulants|mesh-list
84010380|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84010381|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84010382|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84010383|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84010384|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010385|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010386|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010387|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84010388|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84010389|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84010390|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010391|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010392|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010393|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84010394|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84010395|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
84010396|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84010397|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84010398|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
84010399|NCT05125146|Trazodone|trazodone|mesh-list
84010400|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84010401|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84010402|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010403|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010404|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010405|NCT05125146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84010406|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84010407|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010408|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010409|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010410|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
84010411|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84010412|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
84010413|NCT01165554|Flutemetamol|flutemetamol|mesh-list
84010414|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84010415|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010416|NCT01218308|Vaccines|vaccines|mesh-list
84010417|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
84010418|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010419|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
84010420|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84010421|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84010422|NCT02887976|Prednisolone|prednisolone|mesh-list
84010423|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
84010424|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
84010425|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84010426|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
84010427|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010428|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
84010429|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
84010430|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010431|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010432|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010433|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
84010434|NCT02887976|Hormones|hormones|mesh-ancestor
84010435|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010436|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84010437|NCT02887976|Protective Agents|protective agents|mesh-ancestor
84010438|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84010439|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010440|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84010441|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010442|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010443|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
84010444|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84010445|NCT01165320|Caspofungin|caspofungin|mesh-list
84010446|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
83250218|NCT02476617|Ritonavir|ritonavir|mesh-list
84010447|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010448|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010449|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010450|NCT01217606|Timolol|timolol|mesh-list
84010451|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84010452|NCT01217606|Bimatoprost|bimatoprost|mesh-list
84010453|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84010454|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84010455|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84010456|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84010457|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010458|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010459|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010460|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010461|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84010462|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84010463|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84010464|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84010465|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84010466|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84010467|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
84010468|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010469|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84010470|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84010471|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010472|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010473|NCT01217060|Dexamethasone|dexamethasone|mesh-list
84010474|NCT01217060|Docetaxel|docetaxel|mesh-list
84010475|NCT01217060|Fluorouracil|fluorouracil|mesh-list
84010476|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010477|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
84010478|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
84010479|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010480|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010481|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010482|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
84010483|NCT01217060|Hormones|hormones|mesh-ancestor
84010484|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010485|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84010486|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010487|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
84010488|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
84010489|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
84010490|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010491|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
84010492|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010493|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010494|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
84010495|NCT01170065|Nintedanib|nintedanib|mesh-list
84010496|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010497|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84010498|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010499|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010500|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84010501|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010502|NCT00966693|Thalidomide|thalidomide|mesh-list
84010503|NCT00966693|Dexamethasone|dexamethasone|mesh-list
84010504|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
84010505|NCT00966693|Lenalidomide|lenalidomide|mesh-list
84010506|NCT00966693|Ichthammol|ichthammol|mesh-list
84010507|NCT00966693|BB 1101|bb 1101|mesh-list
84010508|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010509|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
84010510|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
84010511|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010512|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010513|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010514|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
84010515|NCT00966693|Hormones|hormones|mesh-ancestor
84010516|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010517|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84010518|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010519|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
84010520|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84010521|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84010522|NCT00966693|Growth Substances|growth substances|mesh-ancestor
84010523|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
84010524|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010525|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
84010526|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84010527|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010528|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
84010529|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010530|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010531|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
84010532|NCT01215968|Dulaglutide|dulaglutide|mesh-list
84010533|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010534|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010535|NCT02663713|Clopidogrel|clopidogrel|mesh-list
84010536|NCT02663713|Ticagrelor|ticagrelor|mesh-list
84010537|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84010538|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84010539|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84010540|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84010541|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
84010542|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010543|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010544|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010545|NCT02664649|Apixaban|apixaban|mesh-list
84010546|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
84010547|NCT02664649|Anticoagulants|anticoagulants|mesh-list
84010548|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
84010549|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84010550|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
84010551|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010552|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010553|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
84010554|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84010555|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84010556|NCT02664493|Prednisolone|prednisolone|mesh-list
84010557|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
84010558|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84010559|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
84010560|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010561|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
84010562|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
84010563|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010564|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010565|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010566|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
84010567|NCT02664493|Hormones|hormones|mesh-ancestor
84010568|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010569|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84010570|NCT02664493|Protective Agents|protective agents|mesh-ancestor
84010571|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84010572|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010573|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
84010574|NCT00963807|Alovudine|alovudine|mesh-list
84010575|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
84010576|NCT00963807|Cisplatin|cisplatin|mesh-list
84010577|NCT00963807|Docetaxel|docetaxel|mesh-list
84010578|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84010579|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010580|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
84010581|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
84010582|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
84010583|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010584|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84010585|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
84010586|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
84010587|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010588|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84010589|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84010590|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010591|NCT01142466|Interferons|interferons|mesh-list
84010592|NCT01142466|Interferon-beta|interferon-beta|mesh-list
84010593|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
84010594|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010595|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
84010596|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010597|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
84010598|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010599|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84010600|NCT00648505|Metformin|metformin|mesh-list
84010601|NCT00648505|Glipizide|glipizide|mesh-list
84010602|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010603|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010604|NCT01215734|Vaccines|vaccines|mesh-list
84010605|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
84010606|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010607|NCT04172311|Levetiracetam|levetiracetam|mesh-list
84010608|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
84010609|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
84010610|NCT02863185|Atorvastatin|atorvastatin|mesh-list
84010611|NCT02863185|Pitavastatin|pitavastatin|mesh-list
84010612|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84010613|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84010614|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
84010615|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010616|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84010617|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84010618|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010619|NCT00647881|Paroxetine|paroxetine|mesh-list
84010620|NCT00647881|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84010621|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84010622|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010623|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010624|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010625|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
84010626|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010627|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84010628|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
84010629|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010630|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84010631|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84010632|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010633|NCT04174261|Clopidogrel|clopidogrel|mesh-list
84010634|NCT04174261|Ticagrelor|ticagrelor|mesh-list
84010635|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84010636|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84010637|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84010638|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84010639|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
84010640|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010641|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010642|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010643|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
84010644|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010645|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010646|NCT01142388|Paclitaxel|paclitaxel|mesh-list
84010647|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84010648|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84010649|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84010650|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010651|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
84010652|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
84010653|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
84010654|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010655|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
84010656|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010657|NCT00910741|Gemcitabine|gemcitabine|mesh-list
84010658|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010659|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
84010660|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010661|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010662|NCT00647959|Doxycycline|doxycycline|mesh-list
84010663|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84010664|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010665|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
84010666|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84010667|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84010668|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
84010669|NCT03602235|Melphalan|melphalan|mesh-list
84010670|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84010671|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
84010672|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010673|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010674|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84010675|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010676|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
84010677|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010679|NCT03602235|Protective Agents|protective agents|mesh-ancestor
84010680|NCT03602235|Vitamins|vitamins|mesh-ancestor
84010681|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
84010682|NCT00648583|Ondansetron|ondansetron|mesh-list
84010683|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
84010684|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
84010685|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010686|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010687|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010688|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
84010689|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
84010690|NCT00648583|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84010691|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84010692|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
84010693|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010694|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010695|NCT03809481|Danaparoid|danaparoid|mesh-list
84010696|NCT03809481|Argatroban|argatroban|mesh-list
84010697|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
84010698|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84010699|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
84010700|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010701|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010702|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
84010703|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84010704|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84010705|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84010706|NCT00649129|Oxybutynin|oxybutynin|mesh-list
84010707|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
84010708|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
84010709|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010710|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010711|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84010712|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84010713|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
84010714|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010715|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010716|NCT00649129|Urological Agents|urological agents|mesh-ancestor
84010717|NCT01127646|Methylphenidate|methylphenidate|mesh-list
84010718|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84010719|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84010720|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010721|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84010722|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84010723|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010724|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010725|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
84010726|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010727|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84010728|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010729|NCT02660047|Liraglutide|liraglutide|mesh-list
84010730|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010731|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010732|NCT02660047|Incretins|incretins|mesh-ancestor
84010733|NCT02660047|Hormones|hormones|mesh-ancestor
84010734|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010735|NCT00648661|Dexetimide|dexetimide|mesh-list
84010736|NCT00648661|Citalopram|citalopram|mesh-list
84010737|NCT00648661|Escitalopram|escitalopram|mesh-list
84010738|NCT00648661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84010739|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84010740|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010741|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010742|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010743|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
84010744|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010745|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84010746|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84010747|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
83250514|NCT04224415|Irinotecan|irinotecan|mesh-list
84010748|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
84010749|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010750|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84010751|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84010752|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
84010753|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84010754|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
84010755|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010756|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
84010757|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84010758|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010759|NCT04171687|Clopidogrel|clopidogrel|mesh-list
84010760|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84010761|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84010762|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84010763|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84010764|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
84010765|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010766|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010767|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010769|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
84010770|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010771|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84010772|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84010773|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010774|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010775|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84010776|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84010777|NCT03391869|Nivolumab|nivolumab|mesh-list
84010778|NCT03391869|Ipilimumab|ipilimumab|mesh-list
84010779|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84010780|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010781|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84010782|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010783|NCT02663323|Sirolimus|sirolimus|mesh-list
84010784|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84010785|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010786|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84010787|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010788|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
84010789|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010790|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
84010791|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010792|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84010793|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
84010794|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010795|NCT04285281|Gabapentin|gabapentin|mesh-list
84010796|NCT04285281|Analgesics|analgesics|mesh-ancestor
84010797|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
84010798|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010799|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010800|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
84010801|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84010802|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84010803|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010804|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010805|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84010806|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84010807|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010808|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010809|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
84010810|NCT02659657|Interleukin-2|interleukin-2|mesh-list
84010811|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010812|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84010813|NCT02659657|Analgesics|analgesics|mesh-ancestor
84010814|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
84010815|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010816|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010817|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84010818|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
84010819|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010820|NCT05438498|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
84010822|NCT05438498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010823|NCT00648193|Paroxetine|paroxetine|mesh-list
84010824|NCT00648193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84010825|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84010826|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010827|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010828|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010829|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
84010830|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010831|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84010832|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
84010833|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010834|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84010835|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84010836|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010837|NCT01215032|Metformin|metformin|mesh-list
84010838|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010839|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010840|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84010841|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
84010842|NCT02664103|Capecitabine|capecitabine|mesh-list
84010843|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84010844|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
84010845|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010846|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84010847|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84010848|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
84010849|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010850|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010851|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84010852|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84010853|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
84010854|NCT02662855|Favipiravir|favipiravir|mesh-list
84010855|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
84010856|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010857|NCT00648271|Metoprolol|metoprolol|mesh-list
84010858|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84010859|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84010860|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
84010861|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
84010862|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010863|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010864|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84010865|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84010866|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84010867|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010868|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010869|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010870|NCT00648349|Rabeprazole|rabeprazole|mesh-list
84010871|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84010872|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010873|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84010874|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010875|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010876|NCT00649207|Veliparib|veliparib|mesh-list
84010877|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84010878|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010879|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010880|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010881|NCT00920686|Sumatriptan|sumatriptan|mesh-list
84010882|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84010883|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84010884|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84010885|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
84010886|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010887|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010888|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010889|NCT00648427|Paroxetine|paroxetine|mesh-list
84010890|NCT00648427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84010891|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84010892|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84010893|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010895|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
84010896|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010897|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84010898|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
84010899|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84010900|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84010901|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84010902|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010903|NCT04170751|Vasopressins|vasopressins|mesh-list
84010904|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
84010905|NCT04170751|Norepinephrine|norepinephrine|mesh-list
84010906|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84010907|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84010908|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010909|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010910|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010911|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010912|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
84010913|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
84010914|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010915|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84010916|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
84010917|NCT04170751|Coagulants|coagulants|mesh-ancestor
84010918|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84010919|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
84010920|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
84010921|NCT02659033|Cephalosporins|cephalosporins|mesh-list
84010922|NCT02659033|Cefotaxime|cefotaxime|mesh-list
84010923|NCT02659033|Cefoxitin|cefoxitin|mesh-list
84010924|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84010925|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84010926|NCT04170595|Trastuzumab|trastuzumab|mesh-list
84010927|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84010928|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010929|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
84010930|NCT00648973|Promethazine|promethazine|mesh-list
84010931|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
84010932|NCT00648973|Ephedrine|ephedrine|mesh-list
84010933|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84010934|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84010935|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84010936|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010937|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
84010938|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
84010939|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
84010940|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010941|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
84010942|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
84010943|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84010944|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84010945|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
84010946|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
84010947|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010948|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010949|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84010950|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
84010951|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
84010952|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84010953|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84010954|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
84010955|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
84010956|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84010957|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84010958|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
84010959|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010960|NCT02662309|Atezolizumab|atezolizumab|mesh-list
84010961|NCT02662309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84010962|NCT02662309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010963|NCT02662309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84010964|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84010965|NCT04032691|Clonidine|clonidine|mesh-list
84010966|NCT04032691|Analgesics|analgesics|mesh-ancestor
84010967|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
84010968|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010969|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010970|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84010971|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
84010972|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
84010973|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84010974|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84010975|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84010976|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
84010977|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84010978|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010979|NCT02658799|Diclofenac|diclofenac|mesh-list
84010980|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84010981|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84010982|NCT02658799|Analgesics|analgesics|mesh-ancestor
84010983|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
84010984|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84010985|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010986|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84010987|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84010988|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84010989|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84010990|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84010991|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84010992|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84010993|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84010994|NCT02655757|Incretins|incretins|mesh-ancestor
84010995|NCT02655757|Hormones|hormones|mesh-ancestor
84010996|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84010997|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84010998|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
84010999|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011000|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011001|NCT01214720|Bevacizumab|bevacizumab|mesh-list
84011002|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84011003|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011004|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84011005|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84011006|NCT01214720|Growth Substances|growth substances|mesh-ancestor
84011007|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011008|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
84011009|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
84011010|NCT02655913|Vitamins|vitamins|mesh-ancestor
84011011|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
84011012|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011013|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
84011014|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011015|NCT02655913|Protective Agents|protective agents|mesh-ancestor
84011016|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
84011017|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84011018|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011019|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011020|NCT04169269|Enoxaparin|enoxaparin|mesh-list
84011021|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
84011022|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84011023|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
84011024|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84011025|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
84011026|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011027|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011028|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
84011029|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84011030|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84011031|NCT02661373|Cobicistat|cobicistat|mesh-list
84011032|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84011033|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84011034|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
84011035|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011036|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84011037|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84011038|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011039|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011040|NCT00649051|Metolazone|metolazone|mesh-list
84011041|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84011042|NCT00649051|Diuretics|diuretics|mesh-ancestor
83250822|NCT05697185|Evolocumab|evolocumab|mesh-list
84011043|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
84011044|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011045|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84011046|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011047|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011048|NCT04168879|Bupivacaine|bupivacaine|mesh-list
84011049|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
84011050|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
84011051|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011052|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011053|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
84011054|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011055|NCT00649987|Albuterol|albuterol|mesh-list
84011056|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84011057|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
84011058|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011059|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011060|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84011061|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
84011062|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
84011063|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84011064|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84011065|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84011066|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84011067|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
84011068|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011069|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011070|NCT01142232|Lenalidomide|lenalidomide|mesh-list
84011071|NCT01142232|Melphalan|melphalan|mesh-list
84011072|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
84011073|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011074|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84011075|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84011076|NCT01142232|Growth Substances|growth substances|mesh-ancestor
84011077|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
84011078|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011079|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84011080|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
84011081|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011082|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84011083|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84011084|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
84011085|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84011086|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
84011087|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011088|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
84011089|NCT02536807|Protective Agents|protective agents|mesh-ancestor
84011090|NCT02536495|Docetaxel|docetaxel|mesh-list
84011091|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011092|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
84011093|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
84011094|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
84011095|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011096|NCT02536417|Melatonin|melatonin|mesh-list
84011097|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
84011098|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011099|NCT02536417|Protective Agents|protective agents|mesh-ancestor
84011100|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011101|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011102|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84011103|NCT01140906|Vortioxetine|vortioxetine|mesh-list
84011104|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84011105|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84011106|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011107|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011108|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011109|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011110|NCT01140906|Analgesics|analgesics|mesh-ancestor
84011111|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
84011112|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011113|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
84011114|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84011115|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
84011116|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84011117|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84011118|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011119|NCT01140906|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84011121|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84011122|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84011123|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84011124|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84011125|NCT00650065|Cetirizine|cetirizine|mesh-list
84011126|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84011127|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84011128|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84011129|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
84011130|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
84011131|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011132|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011133|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011134|NCT04170439|Chromium|chromium|mesh-list
84011135|NCT04170439|Metformin|metformin|mesh-list
84011136|NCT04170439|Citric Acid|citric acid|mesh-list
84011137|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
84011138|NCT04170439|Clomiphene|clomiphene|mesh-list
84011139|NCT04170439|Enclomiphene|enclomiphene|mesh-list
84011140|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
84011141|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84011142|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011143|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
84011144|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84011145|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
84011146|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
84011147|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011148|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84011149|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
84011150|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011151|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84011152|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
84011153|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84011154|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84011155|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84011156|NCT04170439|Trace Elements|trace elements|mesh-ancestor
84011157|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
84011158|NCT00649363|Ondansetron|ondansetron|mesh-list
84011159|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
84011160|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
84011161|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011162|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011163|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84011164|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
84011165|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
84011166|NCT00649363|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84011167|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84011168|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
84011169|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011170|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011171|NCT03531645|Fulvestrant|fulvestrant|mesh-list
84011172|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84011173|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011174|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84011175|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84011176|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
84011177|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011178|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011179|NCT02654743|Sulforaphane|sulforaphane|mesh-list
84011180|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84011181|NCT02654743|Protective Agents|protective agents|mesh-ancestor
84011182|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011183|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011184|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
84011185|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84011186|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011187|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011188|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84011189|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84011190|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011191|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011192|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011193|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84011194|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
84011195|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84011196|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011197|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84011198|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84011199|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84011200|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84011201|NCT00649441|Quinapril|quinapril|mesh-list
84011202|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84011203|NCT00649441|Diuretics|diuretics|mesh-ancestor
84011204|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
84011205|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011206|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84011207|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011208|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011209|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84011210|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
84011211|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011212|NCT02654665|Liraglutide|liraglutide|mesh-list
84011213|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84011214|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011215|NCT02654665|Incretins|incretins|mesh-ancestor
84011216|NCT02654665|Hormones|hormones|mesh-ancestor
84011217|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011218|NCT02658721|Diclofenac|diclofenac|mesh-list
84011219|NCT02658721|Lidocaine|lidocaine|mesh-list
84011220|NCT02658721|Atropine|atropine|mesh-list
84011221|NCT02658721|Ephedrine|ephedrine|mesh-list
84011222|NCT02658721|Fentanyl|fentanyl|mesh-list
84011223|NCT02658721|Midazolam|midazolam|mesh-list
84011224|NCT02658721|Tramadol|tramadol|mesh-list
84011225|NCT02658721|Ondansetron|ondansetron|mesh-list
84011226|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
84011227|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
84011228|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011229|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011230|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
84011231|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011232|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84011233|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84011234|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84011235|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011236|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011237|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84011238|NCT02658721|Narcotics|narcotics|mesh-ancestor
84011239|NCT02658721|Analgesics|analgesics|mesh-ancestor
84011240|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84011241|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84011242|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
84011243|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84011244|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84011245|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84011246|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84011247|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
84011248|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
84011249|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011250|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
84011251|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
84011252|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84011253|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
84011254|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
84011255|NCT02658721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84011256|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84011257|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
84011258|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84011259|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84011260|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84011261|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84011262|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84011263|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251046|NCT05674253|Analgesics|analgesics|mesh-ancestor
84011264|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84011265|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84011266|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
84011267|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
84011268|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
84011269|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84011270|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84011271|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
84011272|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84011273|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
84011274|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84011275|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
84011276|NCT00629967|Interferons|interferons|mesh-list
84011277|NCT00629967|Ribavirin|ribavirin|mesh-list
84011278|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
84011279|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
84011280|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84011281|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011282|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
84011283|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011284|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
84011285|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011286|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
84011287|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011288|NCT02654587|Docetaxel|docetaxel|mesh-list
84011289|NCT02654587|Pemetrexed|pemetrexed|mesh-list
84011290|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011291|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
84011292|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
84011293|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
84011294|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011295|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011296|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84011297|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84011298|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
84011299|NCT01122264|Tadalafil|tadalafil|mesh-list
84011300|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011301|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
84011302|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84011303|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84011304|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011305|NCT01122264|Urological Agents|urological agents|mesh-ancestor
84011306|NCT03288675|Serotonin|serotonin|mesh-list
84011307|NCT03288675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
84011308|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84011309|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
84011310|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011311|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011312|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011313|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84011314|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011315|NCT00920218|Vaccines|vaccines|mesh-list
84011316|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
84011317|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011318|NCT00649519|Amlodipine|amlodipine|mesh-list
84011319|NCT00649519|Benazepril|benazepril|mesh-list
84011320|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84011321|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84011322|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011323|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011324|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84011325|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011326|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
84011327|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84011328|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
84011329|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011330|NCT00629811|Mitogens|mitogens|mesh-list
84011331|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
84011332|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011333|NCT02652091|Interferons|interferons|mesh-list
84011334|NCT02652091|Interferon-beta|interferon-beta|mesh-list
84011335|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
84011336|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011337|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
84011338|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011339|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
84011340|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011341|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84011342|NCT00625560|Lamivudine|lamivudine|mesh-list
84011343|NCT00625560|Entecavir|entecavir|mesh-list
84011344|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84011345|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84011346|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011347|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011348|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
84011349|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011350|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84011351|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84011352|NCT00650455|Naproxen|naproxen|mesh-list
84011353|NCT00650455|Valdecoxib|valdecoxib|mesh-list
84011354|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84011355|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84011356|NCT00650455|Analgesics|analgesics|mesh-ancestor
84011357|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
84011358|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011359|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011360|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84011361|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84011362|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
84011363|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84011364|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011365|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011366|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84011367|NCT02654041|Methimazole|methimazole|mesh-list
84011368|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
84011369|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
84011370|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011371|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011372|NCT02658409|Vaccines|vaccines|mesh-list
84011373|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
84011374|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011375|NCT01121562|Sunitinib|sunitinib|mesh-list
84011376|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011377|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84011378|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84011379|NCT01121562|Growth Substances|growth substances|mesh-ancestor
84011380|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011381|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
84011382|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84011383|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011384|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011385|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84011386|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84011387|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
84011388|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011389|NCT02658253|Antacids|antacids|mesh-ancestor
84011390|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011391|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84011392|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
84011393|NCT02651623|Sertraline|sertraline|mesh-list
84011394|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011395|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011396|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84011397|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84011398|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011399|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011400|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011401|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011402|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
84011403|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84011404|NCT02651623|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84011405|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84011406|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011407|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011408|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
84011409|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84011410|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84011411|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84011412|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011413|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011414|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011415|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011417|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84011418|NCT00650221|Pravastatin|pravastatin|mesh-list
84011419|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84011420|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84011421|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
84011422|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011423|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84011424|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84011425|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011426|NCT01169675|Pemetrexed|pemetrexed|mesh-list
84011427|NCT01169675|Afatinib|afatinib|mesh-list
84011428|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011429|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011430|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011431|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84011432|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84011433|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84011434|NCT00650533|Glimepiride|glimepiride|mesh-list
84011435|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84011436|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84011437|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011438|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84011439|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
84011440|NCT02881866|Furosemide|furosemide|mesh-list
84011441|NCT02881866|Diuretics|diuretics|mesh-ancestor
84011442|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
84011443|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011444|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84011445|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011446|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011447|NCT00924664|Tanezumab|tanezumab|mesh-list
84011448|NCT00924664|Analgesics|analgesics|mesh-ancestor
84011449|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
84011450|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011451|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011452|NCT02653651|Lidocaine|lidocaine|mesh-list
84011453|NCT02653651|Ketamine|ketamine|mesh-list
84011454|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
84011455|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
84011456|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011457|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011458|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
84011459|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011460|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84011461|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84011462|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84011463|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011464|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011465|NCT02653651|Analgesics|analgesics|mesh-ancestor
84011466|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84011467|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84011468|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
84011469|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84011470|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84011471|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011472|NCT02651311|Ibuprofen|ibuprofen|mesh-list
84011473|NCT02651311|Fentanyl|fentanyl|mesh-list
84011474|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84011475|NCT02651311|Narcotics|narcotics|mesh-ancestor
84011476|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011477|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011478|NCT02651311|Analgesics|analgesics|mesh-ancestor
84011479|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
84011480|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011481|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84011482|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84011483|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
84011484|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
84011485|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84011486|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84011487|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84011488|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84011490|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011491|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011492|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
84011493|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84011494|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84011495|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011496|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
84011497|NCT02653261|Coagulants|coagulants|mesh-ancestor
84011498|NCT02653339|Loratadine|loratadine|mesh-list
84011499|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
84011500|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
84011501|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84011502|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84011503|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84011504|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
84011505|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
84011506|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011507|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011508|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011509|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84011510|NCT00649597|Benazepril|benazepril|mesh-list
84011511|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84011512|NCT00649597|Diuretics|diuretics|mesh-ancestor
84011513|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
84011514|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011515|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84011516|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011517|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011518|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84011519|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
84011520|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011521|NCT02653027|Ivacaftor|ivacaftor|mesh-list
84011522|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84011523|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011524|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011525|NCT02652793|Lamivudine|lamivudine|mesh-list
84011526|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84011527|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84011528|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84011529|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011530|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011531|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
84011532|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011533|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84011534|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84011535|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84011536|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84011537|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
84011538|NCT00650611|Ziprasidone|ziprasidone|mesh-list
84011539|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84011540|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
84011541|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011542|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011543|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011544|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84011545|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84011546|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011547|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84011548|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84011549|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
84011550|NCT00600067|Topiramate|topiramate|mesh-list
84011551|NCT00600067|Phentermine|phentermine|mesh-list
84011552|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
84011553|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84011554|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011555|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84011556|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
84011557|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84011558|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
84011559|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
84011560|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011561|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
84011562|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011563|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011564|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
84011565|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84011566|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84011568|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
84011569|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84011570|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
84011571|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84011572|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
84011573|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
84011574|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011575|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011576|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84011577|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
84011578|NCT02650609|Hormones|hormones|mesh-ancestor
84011579|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011580|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84011581|NCT02650609|Protective Agents|protective agents|mesh-ancestor
84011582|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84011583|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011584|NCT02652871|Cytarabine|cytarabine|mesh-list
84011585|NCT02652871|Idarubicin|idarubicin|mesh-list
84011586|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84011587|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
84011588|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011589|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011590|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
84011591|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011592|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84011593|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
84011594|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011595|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84011596|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84011597|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84011598|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011599|NCT00650299|Alprazolam|alprazolam|mesh-list
84011600|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84011601|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011602|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011603|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84011604|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84011605|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84011606|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
84011607|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
84011608|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011609|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011610|NCT04168099|Cefotaxime|cefotaxime|mesh-list
84011611|NCT04168099|Cefoxitin|cefoxitin|mesh-list
84011612|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
84011613|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011614|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011615|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84011616|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84011617|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011618|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011619|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011620|NCT04283877|Methylphenidate|methylphenidate|mesh-list
84011621|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84011622|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011623|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84011624|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84011625|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011626|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011627|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
84011628|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011629|NCT04283487|Levan|levan|mesh-list
84011630|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011631|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
84011632|NCT04283331|Propoxycaine|propoxycaine|mesh-list
84011633|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
84011634|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
84011635|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011636|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011637|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
84011638|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011639|NCT02657473|Tobramycin|tobramycin|mesh-list
84011640|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84011641|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011642|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011643|NCT02652637|Metronidazole|metronidazole|mesh-list
84011644|NCT02652637|Neomycin|neomycin|mesh-list
84011645|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011646|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011647|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84011648|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84011649|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84011650|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011651|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011652|NCT00649675|Meloxicam|meloxicam|mesh-list
84011653|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84011654|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84011655|NCT00649675|Analgesics|analgesics|mesh-ancestor
84011656|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
84011657|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011658|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011659|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84011660|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84011661|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84011662|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84011663|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011664|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011665|NCT02860923|Exenatide|exenatide|mesh-list
84011666|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84011667|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011668|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84011669|NCT02860923|Incretins|incretins|mesh-ancestor
84011670|NCT02860923|Hormones|hormones|mesh-ancestor
84011671|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011672|NCT01121406|Paclitaxel|paclitaxel|mesh-list
84011673|NCT01121406|Gemcitabine|gemcitabine|mesh-list
84011674|NCT01121406|Doxorubicin|doxorubicin|mesh-list
84011675|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84011676|NCT01121406|Topotecan|topotecan|mesh-list
84011677|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84011678|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011679|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
84011680|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
84011681|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
84011682|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011683|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84011684|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
84011685|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84011686|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84011687|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84011688|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011689|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84011690|NCT02652325|Iodine|iodine|mesh-list
84011691|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
84011692|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
84011693|NCT02652325|Povidone|povidone|mesh-list
84011694|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84011695|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011696|NCT02652325|Trace Elements|trace elements|mesh-ancestor
84011697|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
84011698|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011699|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
84011700|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
84011701|NCT00960687|Fenofibrate|fenofibrate|mesh-list
84011702|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
84011703|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84011704|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
84011705|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011706|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84011707|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84011708|NCT00920140|Trametinib|trametinib|mesh-list
84011709|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011710|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84011711|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011712|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011713|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
84011714|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84011715|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011716|NCT04032847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84011717|NCT04032847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011718|NCT01120626|Donepezil|donepezil|mesh-list
84011719|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84011720|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011721|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011722|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
84011723|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011724|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011725|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
84011726|NCT00650377|Finasteride|finasteride|mesh-list
84011727|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84011728|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84011729|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011730|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011731|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
84011732|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011733|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011734|NCT00650377|Urological Agents|urological agents|mesh-ancestor
84011735|NCT02649751|Roscovitine|roscovitine|mesh-list
84011736|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011737|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
84011738|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011739|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84011740|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011741|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011742|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84011743|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84011744|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84011745|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
84011746|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011747|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84011748|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84011749|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011750|NCT00924508|Triamcinolone|triamcinolone|mesh-list
84011751|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84011752|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84011753|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84011754|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84011755|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
84011756|NCT00924508|Hormones|hormones|mesh-ancestor
84011757|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011758|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011759|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84011760|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
84011761|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011762|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011763|NCT00650923|Temozolomide|temozolomide|mesh-list
84011764|NCT00650923|Aflibercept|aflibercept|mesh-list
84011765|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
84011766|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84011767|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
84011768|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011769|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011770|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84011771|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84011772|NCT00650923|Growth Substances|growth substances|mesh-ancestor
84011773|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011774|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
84011775|NCT00637858|Lycopene|lycopene|mesh-list
84011776|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84011777|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
84011778|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011779|NCT00637858|Protective Agents|protective agents|mesh-ancestor
84011780|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011781|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84011782|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84011783|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011784|NCT02657161|Vaccines|vaccines|mesh-list
84011785|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
84011786|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011787|NCT01139580|Calcipotriene|calcipotriene|mesh-list
84011788|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
84011789|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
84011790|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
84011791|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
84011792|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
84011793|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
84011794|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011795|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84011796|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
84011797|NCT04251832|Antidotes|antidotes|mesh-ancestor
84011798|NCT04251832|Protective Agents|protective agents|mesh-ancestor
84011799|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011800|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
84011801|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011802|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
84011803|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011804|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011805|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
84011806|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
84011807|NCT02656771|Metronidazole|metronidazole|mesh-list
84011808|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011809|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011810|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84011811|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84011812|NCT00917644|Atorvastatin|atorvastatin|mesh-list
84011813|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84011814|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84011815|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
84011816|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011817|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84011818|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84011819|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011820|NCT00625170|Haloperidol|haloperidol|mesh-list
84011821|NCT00625170|Olanzapine|olanzapine|mesh-list
84011822|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
84011823|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
84011824|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
84011825|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011826|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011827|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84011828|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84011829|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84011830|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011831|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84011832|NCT00625170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84011833|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84011834|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011835|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011836|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011837|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
84011838|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84011839|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
84011840|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84011841|NCT00599755|Carboplatin|carboplatin|mesh-list
84011842|NCT00599755|Gemcitabine|gemcitabine|mesh-list
84011843|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011844|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84011845|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
84011846|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011847|NCT04251364|Acetazolamide|acetazolamide|mesh-list
84011848|NCT04251364|Atorvastatin|atorvastatin|mesh-list
84011849|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84011850|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84011851|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
84011852|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011853|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84011854|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84011855|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011856|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
84011857|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84011858|NCT04251364|Diuretics|diuretics|mesh-ancestor
84011859|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
84011860|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011861|NCT04811014|Buprenorphine|buprenorphine|mesh-list
84011862|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84011863|NCT04811014|Naloxone|naloxone|mesh-list
84011864|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84011865|NCT04811014|Narcotics|narcotics|mesh-ancestor
84011866|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011867|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011868|NCT04811014|Analgesics|analgesics|mesh-ancestor
84011869|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
84011870|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011871|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84011872|NCT02648425|Leucovorin|leucovorin|mesh-list
84011873|NCT02648425|Cisplatin|cisplatin|mesh-list
84011874|NCT02648425|Fluorouracil|fluorouracil|mesh-list
84011875|NCT02648425|Capecitabine|capecitabine|mesh-list
84011876|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011877|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
84011878|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011879|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84011880|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84011881|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
84011882|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011883|NCT02648425|Antidotes|antidotes|mesh-ancestor
84011884|NCT02648425|Protective Agents|protective agents|mesh-ancestor
84011885|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
84011886|NCT02648425|Vitamins|vitamins|mesh-ancestor
84011887|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
84011888|NCT02648503|Atropine|atropine|mesh-list
84011889|NCT02648503|Rocuronium|rocuronium|mesh-list
84011890|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84011891|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84011892|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84011893|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
84011894|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011895|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011896|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84011897|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
84011898|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
84011899|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
84011900|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84011901|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84011902|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
84011903|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011904|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011905|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84011906|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84011907|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84011908|NCT05253508|Lidocaine|lidocaine|mesh-list
84011909|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
84011910|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
84011911|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011912|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011913|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
84011914|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011915|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84011916|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84011917|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84011918|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011919|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011920|NCT04524130|Lidocaine|lidocaine|mesh-list
84011921|NCT04524130|Ketamine|ketamine|mesh-list
84011922|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
84011923|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
84011924|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84011925|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011926|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
84011927|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011928|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84011929|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84011930|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84011931|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84011932|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011933|NCT04524130|Analgesics|analgesics|mesh-ancestor
84011934|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84011935|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84011936|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
84011937|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84011938|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84011939|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011940|NCT00649831|Amoxicillin|amoxicillin|mesh-list
84011941|NCT00649831|Azithromycin|azithromycin|mesh-list
84011942|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011943|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011944|NCT02648659|Amoxicillin|amoxicillin|mesh-list
84011945|NCT02648659|Metronidazole|metronidazole|mesh-list
84011946|NCT02648659|Clarithromycin|clarithromycin|mesh-list
84011947|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84011948|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84011949|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84011950|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84011951|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84011952|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011953|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011954|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84011955|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84011956|NCT01125930|Tretinoin|tretinoin|mesh-list
84011957|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011958|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
84011959|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
84011960|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
84011961|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84011962|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84011963|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84011964|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011965|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
84011966|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84011967|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011968|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84011969|NCT00651235|Losartan|losartan|mesh-list
84011970|NCT00651235|Propranolol|propranolol|mesh-list
84011971|NCT00651235|Atenolol|atenolol|mesh-list
84011972|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84011973|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84011974|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84011975|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84011976|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011977|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84011978|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84011979|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
84011980|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84011981|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011982|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
84011983|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
84011984|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
84011985|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84011986|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84011987|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
84011988|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84011989|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
84011990|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011991|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84011992|NCT04015219|Lifitegrast|lifitegrast|mesh-list
84011993|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84011994|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
84011995|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84011996|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84011997|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84011998|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84011999|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
84012000|NCT01168973|Docetaxel|docetaxel|mesh-list
84012001|NCT01168973|Ramucirumab|ramucirumab|mesh-list
84012002|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84012003|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012004|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
84012005|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
84012006|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
84012007|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012008|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
84012009|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012010|NCT04747912|Dexamethasone|dexamethasone|mesh-list
84012011|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
84012012|NCT04747912|Methotrexate|methotrexate|mesh-list
84012013|NCT04747912|Vincristine|vincristine|mesh-list
84012014|NCT04747912|Dasatinib|dasatinib|mesh-list
84012015|NCT04747912|Ponatinib|ponatinib|mesh-list
84012016|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84012017|NCT04747912|BB 1101|bb 1101|mesh-list
84012018|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012019|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
84012020|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
84012021|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012022|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012023|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012024|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
84012025|NCT04747912|Hormones|hormones|mesh-ancestor
84012026|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012027|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84012028|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012029|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
84012030|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012031|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012032|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84012033|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
84012034|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84012035|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84012036|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
84012037|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
84012038|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84012039|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012040|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
84012041|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012042|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84012043|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84012044|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
84012045|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
84012046|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
84012047|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84012048|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012049|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84012050|NCT04747912|Immunotoxins|immunotoxins|mesh-ancestor
84012051|NCT04747912|Immunoconjugates|immunoconjugates|mesh-ancestor
84012052|NCT00631618|Sunitinib|sunitinib|mesh-list
84012053|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012054|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84012055|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84012056|NCT00631618|Growth Substances|growth substances|mesh-ancestor
84012057|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012058|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
84012059|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84012060|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012061|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012062|NCT04431778|Ethosuximide|ethosuximide|mesh-list
84012063|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
84012064|NCT04669132|Olanzapine|olanzapine|mesh-list
84012065|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
84012066|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
84012067|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012068|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012069|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012070|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84012071|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84012072|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012073|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84012074|NCT04669132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84012075|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84012076|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012077|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012078|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012079|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
84012080|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
84012081|NCT01168349|Hematinics|hematinics|mesh-ancestor
84012082|NCT00915772|Metformin|metformin|mesh-list
84012083|NCT00915772|Linagliptin|linagliptin|mesh-list
84012084|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012085|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012086|NCT00915772|Incretins|incretins|mesh-ancestor
84012087|NCT00915772|Hormones|hormones|mesh-ancestor
84012088|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012089|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84012090|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
84012091|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012092|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012094|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84012095|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84012096|NCT00632086|Analgesics|analgesics|mesh-ancestor
84012097|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
84012098|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012099|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012100|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012101|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012102|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84012103|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84012104|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012105|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84012106|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84012107|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012108|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
84012109|NCT00912964|Mirabegron|mirabegron|mesh-list
84012110|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84012111|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84012112|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84012113|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
84012114|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012115|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012116|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012117|NCT00912964|Urological Agents|urological agents|mesh-ancestor
84012118|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
84012119|NCT02641639|Combretastatin|combretastatin|mesh-list
84012120|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84012121|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012122|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
84012123|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
84012124|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
84012125|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012126|NCT02647567|Caffeine|caffeine|mesh-list
84012127|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84012128|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012129|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84012130|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012131|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012132|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84012133|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84012134|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
84012135|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012136|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84012137|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84012138|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
84012139|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012140|NCT02647489|Antacids|antacids|mesh-ancestor
84012141|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012142|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012143|NCT04577716|Listerine|listerine|mesh-list
84012144|NCT04577716|Fluorides|fluorides|mesh-list
84012145|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
84012146|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
84012147|NCT04577716|Protective Agents|protective agents|mesh-ancestor
84012148|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012149|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84012150|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012151|NCT00910897|Thalidomide|thalidomide|mesh-list
84012152|NCT00910897|Dexamethasone|dexamethasone|mesh-list
84012153|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
84012154|NCT00910897|Bortezomib|bortezomib|mesh-list
84012155|NCT00910897|BB 1101|bb 1101|mesh-list
84012156|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012157|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
84012158|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
84012159|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012160|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012161|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012162|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
84012163|NCT00910897|Hormones|hormones|mesh-ancestor
84012164|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012165|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84012166|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012167|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
84012168|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012169|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012170|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012171|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
84012172|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
84012173|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84012174|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012175|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84012176|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84012177|NCT00910897|Growth Substances|growth substances|mesh-ancestor
84012178|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
84012179|NCT00651547|Budesonide|budesonide|mesh-list
84012180|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
84012181|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012182|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84012183|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
84012184|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012185|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012186|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84012187|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
84012188|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
84012189|NCT00651547|Hormones|hormones|mesh-ancestor
84012190|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012191|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84012192|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84012193|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84012194|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
84012195|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012196|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012197|NCT00912808|Donepezil|donepezil|mesh-list
84012198|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84012199|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012200|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012201|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
84012202|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012203|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012204|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
84012205|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
84012206|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84012207|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84012208|NCT02647255|Prednisolone|prednisolone|mesh-list
84012209|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
84012210|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84012211|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
84012212|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012213|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
84012214|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
84012215|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012216|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012217|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012218|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
84012219|NCT02647255|Hormones|hormones|mesh-ancestor
84012220|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012221|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84012222|NCT02647255|Protective Agents|protective agents|mesh-ancestor
84012223|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84012224|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012225|NCT04329442|Tenofovir|tenofovir|mesh-list
84012226|NCT04329442|Emtricitabine|emtricitabine|mesh-list
84012227|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
84012228|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012229|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84012230|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84012231|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012232|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012233|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84012234|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84012235|NCT04414228|Anesthetics|anesthetics|mesh-list
84012236|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012237|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012238|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
84012239|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84012240|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
84012241|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012242|NCT03017833|Metformin|metformin|mesh-list
84012243|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012244|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012245|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
84012246|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84012247|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
84012248|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012249|NCT00652639|Clonazepam|clonazepam|mesh-list
84012250|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
84012251|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
84012252|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
84012253|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012254|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012255|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012256|NCT02644915|Edaravone|edaravone|mesh-list
84012257|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84012258|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
84012259|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012260|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84012261|NCT02644915|Protective Agents|protective agents|mesh-ancestor
84012262|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012263|NCT00651703|Imiquimod|imiquimod|mesh-list
84012264|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84012265|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84012266|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
84012267|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012268|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012269|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
84012270|NCT02964585|Canagliflozin|canagliflozin|mesh-list
84012271|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84012272|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012273|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012274|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012275|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84012276|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
84012277|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012278|NCT00651781|Bortezomib|bortezomib|mesh-list
84012279|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012280|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
84012281|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84012282|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84012283|NCT00957801|Prednisolone|prednisolone|mesh-list
84012284|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
84012285|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
84012286|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84012287|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
84012288|NCT00957801|Testosterone|testosterone|mesh-list
84012289|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
84012290|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
84012291|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84012292|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012293|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
84012294|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
84012295|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012296|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012297|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012298|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
84012299|NCT00957801|Hormones|hormones|mesh-ancestor
84012300|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012301|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84012302|NCT00957801|Protective Agents|protective agents|mesh-ancestor
84012303|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84012304|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012305|NCT00957801|Androgens|androgens|mesh-ancestor
84012306|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
84012307|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
84012308|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84012309|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84012310|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012311|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
84012312|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
84012313|NCT02646709|Ketamine|ketamine|mesh-list
84012314|NCT02646709|Rocuronium|rocuronium|mesh-list
84012315|NCT02646709|Analgesics|analgesics|mesh-ancestor
84012316|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
83252097|NCT03056599|Docetaxel|docetaxel|mesh-list
84012317|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012318|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012319|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84012320|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84012321|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
84012322|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
84012323|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012324|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84012325|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84012326|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012327|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012328|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84012329|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84012330|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84012331|NCT00651859|Bimatoprost|bimatoprost|mesh-list
84012332|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84012333|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84012334|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84012335|NCT02640313|Choline|choline|mesh-list
84012336|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
84012337|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84012338|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
84012339|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012340|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012341|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84012342|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
84012343|NCT02955823|Dexamethasone|dexamethasone|mesh-list
84012344|NCT02955823|Rituximab|rituximab|mesh-list
84012345|NCT02955823|Lenalidomide|lenalidomide|mesh-list
84012346|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012347|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012348|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
84012349|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012350|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012351|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012352|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
84012353|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
84012354|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012355|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012356|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
84012357|NCT02955823|Hormones|hormones|mesh-ancestor
84012358|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012359|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84012360|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84012361|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84012362|NCT02955823|Growth Substances|growth substances|mesh-ancestor
84012363|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
84012364|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84012365|NCT02646397|Fosinopril|fosinopril|mesh-list
84012366|NCT02646397|Benidipine|benidipine|mesh-list
84012367|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84012368|NCT02646397|Diuretics|diuretics|mesh-ancestor
84012369|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
84012370|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012371|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84012372|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048346|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012373|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012374|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84012375|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
84012376|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012377|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84012378|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84012379|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
84012380|NCT00652795|Doxycycline|doxycycline|mesh-list
84012381|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84012382|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012383|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
84012384|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84012385|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84012386|NCT00911170|Bevacizumab|bevacizumab|mesh-list
84012387|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012388|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012389|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84012390|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84012391|NCT00911170|Growth Substances|growth substances|mesh-ancestor
84012392|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012393|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
84012395|NCT00910975|Ribavirin|ribavirin|mesh-list
84012396|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
84012397|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
84012398|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84012399|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012400|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
84012401|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012402|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
84012403|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012404|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
84012405|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012406|NCT01167881|Glimepiride|glimepiride|mesh-list
84012407|NCT01167881|Empagliflozin|empagliflozin|mesh-list
84012408|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84012409|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012410|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012411|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012412|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
84012413|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84012414|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012415|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
84012416|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84012417|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012418|NCT02639767|Pemetrexed|pemetrexed|mesh-list
84012419|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012420|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012421|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012422|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84012423|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84012424|NCT04829344|Carticaine|carticaine|mesh-list
84012425|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
84012426|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
84012427|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012428|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012429|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
84012430|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012431|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
84012432|NCT00960063|Temozolomide|temozolomide|mesh-list
84012433|NCT00960063|Ifosfamide|ifosfamide|mesh-list
84012434|NCT00960063|Doxorubicin|doxorubicin|mesh-list
84012435|NCT00960063|Irinotecan|irinotecan|mesh-list
84012436|NCT00960063|Etoposide|etoposide|mesh-list
84012437|NCT00960063|Vincristine|vincristine|mesh-list
84012438|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012439|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
84012440|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012441|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012442|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84012443|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
84012444|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012445|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012446|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84012447|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83534961|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
84012448|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84012449|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84012450|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012451|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84012452|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84012453|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
84012454|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
84012455|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
84012456|NCT02646319|Sirolimus|sirolimus|mesh-list
84012457|NCT02646319|Temsirolimus|temsirolimus|mesh-list
84012458|NCT02646319|MTOR Inhibitors|mtor inhibitors|mesh-list
84012459|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84012460|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012461|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84012462|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012463|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
84012464|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012465|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
84012466|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012467|NCT02646319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84012468|NCT02646319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012469|NCT02646319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012470|NCT00653965|Atorvastatin|atorvastatin|mesh-list
84012471|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84012472|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84012473|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84012474|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
84012475|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012476|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84012477|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84012478|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012479|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
84012480|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84012481|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84012482|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84012483|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84012484|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012485|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012486|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
84012487|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012488|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012489|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84012490|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012491|NCT00912340|Trastuzumab|trastuzumab|mesh-list
84012492|NCT00912340|Everolimus|everolimus|mesh-list
84012493|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012494|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012495|NCT00912340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84012496|NCT00912340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84012497|NCT00912340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012498|NCT00912340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012499|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012500|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
84012501|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012502|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
84012503|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84012504|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84012505|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84012506|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012507|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012508|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
84012509|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012510|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012511|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84012512|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012513|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84012514|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012515|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012516|NCT01119846|Incretins|incretins|mesh-ancestor
84012517|NCT01119846|Hormones|hormones|mesh-ancestor
84012518|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012519|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84012520|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
84012521|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012522|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012523|NCT03775525|Capecitabine|capecitabine|mesh-list
84012524|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84012525|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
84012526|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012527|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012528|NCT00654043|Torsemide|torsemide|mesh-list
84012529|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84012530|NCT00654043|Diuretics|diuretics|mesh-ancestor
84012531|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
84012532|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012533|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84012534|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012535|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012536|NCT04167007|Gemcitabine|gemcitabine|mesh-list
84012537|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84012538|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
84012539|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012540|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012541|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84012542|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84012544|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84012545|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012546|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012547|NCT03421288|Leucovorin|leucovorin|mesh-list
84012548|NCT03421288|Docetaxel|docetaxel|mesh-list
84012549|NCT03421288|Fluorouracil|fluorouracil|mesh-list
84012550|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
84012551|NCT03421288|Atezolizumab|atezolizumab|mesh-list
84012552|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012553|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
84012554|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
84012555|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
84012556|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012557|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
84012558|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84012559|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012560|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
84012561|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012562|NCT03421288|Antidotes|antidotes|mesh-ancestor
84012563|NCT03421288|Protective Agents|protective agents|mesh-ancestor
84012564|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
84012565|NCT03421288|Vitamins|vitamins|mesh-ancestor
84012566|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
84012567|NCT03421288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84012568|NCT03421288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012569|NCT01166945|Amoxicillin|amoxicillin|mesh-list
84012570|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
84012571|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
84012572|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84012573|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84012574|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012575|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84012576|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012577|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012578|NCT02639533|Pregabalin|pregabalin|mesh-list
84012579|NCT02639533|Analgesics|analgesics|mesh-ancestor
84012580|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
84012581|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012582|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012583|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
84012584|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84012585|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012586|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012587|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84012588|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84012589|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84012590|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012591|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84012592|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
84012593|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84012594|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83535638|NCT05922982|Adrenergic Agents|adrenergic agents|mesh-ancestor
84012595|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012596|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
84012597|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
84012598|NCT00910000|Carboplatin|carboplatin|mesh-list
84012599|NCT00910000|Gemcitabine|gemcitabine|mesh-list
84012600|NCT00910000|Vorinostat|vorinostat|mesh-list
84012601|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012602|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84012603|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
84012604|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012605|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84012606|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012607|NCT02885909|Insulin|insulin|mesh-list
84012608|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012609|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012610|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
84012611|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84012612|NCT05657171|Estradiol|estradiol|mesh-list
84012613|NCT05657171|Cyproterone|cyproterone|mesh-list
84012614|NCT05657171|Estrogens|estrogens|mesh-ancestor
84012615|NCT05657171|Hormones|hormones|mesh-ancestor
84012616|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012617|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012618|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84012619|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
84012620|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84012621|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84012622|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84012623|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84012624|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
84012625|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
84012626|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012627|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84012628|NCT00652873|Cabergoline|cabergoline|mesh-list
84012629|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84012630|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84012631|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
84012632|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
84012633|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012634|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012635|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012636|NCT00652171|Lamotrigine|lamotrigine|mesh-list
84012637|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
84012638|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84012639|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012640|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012641|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84012642|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012643|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84012644|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84012645|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012646|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84012647|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84012648|NCT01119768|Esomeprazole|esomeprazole|mesh-list
84012649|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84012650|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012651|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84012652|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012653|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012654|NCT01165307|Naproxen|naproxen|mesh-list
84012655|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
84012656|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
84012657|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
84012658|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84012659|NCT01165307|Estradiol|estradiol|mesh-list
84012660|NCT01165307|Estrogens|estrogens|mesh-ancestor
84012661|NCT01165307|Hormones|hormones|mesh-ancestor
84012662|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012663|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012664|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84012665|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84012666|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84012667|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84012668|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84012669|NCT01165307|Analgesics|analgesics|mesh-ancestor
84012670|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
84012671|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012672|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012673|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012674|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
84012675|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84012676|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012677|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012678|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84012679|NCT02639143|Clopidogrel|clopidogrel|mesh-list
84012680|NCT02639143|Ticagrelor|ticagrelor|mesh-list
84012681|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84012682|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84012683|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84012684|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84012685|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
84012686|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012687|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012688|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012689|NCT02644057|Dobutamine|dobutamine|mesh-list
84012690|NCT02644057|Milrinone|milrinone|mesh-list
84012691|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84012692|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
84012693|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
84012694|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012695|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012696|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84012697|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84012698|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84012699|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
84012700|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012701|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012702|NCT02644057|Protective Agents|protective agents|mesh-ancestor
84012703|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84012704|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
84012705|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84012706|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84012707|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012708|NCT00654277|Ondansetron|ondansetron|mesh-list
84012709|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
84012710|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
84012711|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012712|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012713|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012714|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
84012715|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
84012716|NCT00654277|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84012717|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84012718|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
84012719|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012720|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012721|NCT01124838|Prednisone|prednisone|mesh-list
84012722|NCT01124838|Adalimumab|adalimumab|mesh-list
84012723|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012724|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
84012725|NCT01124838|Hormones|hormones|mesh-ancestor
84012726|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012727|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012728|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84012729|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012730|NCT01124838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84012731|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012732|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84012733|NCT00630435|Estrogens|estrogens|mesh-ancestor
84012734|NCT00630435|Hormones|hormones|mesh-ancestor
84012735|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012736|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012737|NCT02858193|Carbocysteine|carbocysteine|mesh-list
84012738|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84012739|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012740|NCT02858193|Expectorants|expectorants|mesh-ancestor
84012741|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
84012742|NCT02581215|Ramucirumab|ramucirumab|mesh-list
84012743|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012744|NCT04282941|Ibuprofen|ibuprofen|mesh-list
84012745|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84012746|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84012747|NCT04282941|Analgesics|analgesics|mesh-ancestor
84012748|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
84012749|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012750|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012751|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012752|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012753|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84012754|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012755|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012756|NCT00910858|Lenalidomide|lenalidomide|mesh-list
84012757|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
84012758|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
84012759|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012760|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84012761|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84012762|NCT00910858|Growth Substances|growth substances|mesh-ancestor
84012763|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
84012764|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012765|NCT00910858|Hematinics|hematinics|mesh-ancestor
84012766|NCT02567253|Cisplatin|cisplatin|mesh-list
84012767|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012768|NCT02859285|Estradiol|estradiol|mesh-list
84012769|NCT02859285|Estrogens|estrogens|mesh-ancestor
84012770|NCT02859285|Hormones|hormones|mesh-ancestor
84012771|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012772|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012773|NCT04260412|Psyllium|psyllium|mesh-list
84012774|NCT04260412|Cathartics|cathartics|mesh-ancestor
84012775|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012776|NCT03223155|Nivolumab|nivolumab|mesh-list
84012777|NCT03223155|Ipilimumab|ipilimumab|mesh-list
84012778|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012779|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012780|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84012781|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012782|NCT04476550|Lenograstim|lenograstim|mesh-list
84012783|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84012784|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
84012785|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012786|NCT00598975|Irinotecan|irinotecan|mesh-list
84012787|NCT00598975|Cetuximab|cetuximab|mesh-list
84012788|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
84012789|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84012790|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84012791|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012792|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012793|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012794|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012795|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84012796|NCT01124604|Tapentadol|tapentadol|mesh-list
84012797|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84012798|NCT01124604|Narcotics|narcotics|mesh-ancestor
84012799|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012800|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012801|NCT01124604|Analgesics|analgesics|mesh-ancestor
84012802|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
84012803|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012804|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84012805|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84012806|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012807|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012808|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
84012809|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012810|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84012811|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
84012812|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84012813|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
84012814|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84012815|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012816|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84012817|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84012818|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012819|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
84012820|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
84012821|NCT01124448|Growth Substances|growth substances|mesh-ancestor
84012822|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012823|NCT02638909|Ceritinib|ceritinib|mesh-list
84012824|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012825|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84012826|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012827|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012828|NCT02643823|Methotrexate|methotrexate|mesh-list
84012829|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
84012830|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84012831|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
84012832|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84012833|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012834|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84012835|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
84012836|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012837|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012838|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
84012839|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252624|NCT04905667|Trastuzumab|trastuzumab|mesh-list
84012840|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84012841|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012842|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
84012843|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84012845|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84012846|NCT02638831|Ketoprofen|ketoprofen|mesh-list
84012847|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84012848|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84012849|NCT02638831|Analgesics|analgesics|mesh-ancestor
84012850|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
84012851|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012852|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012853|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012854|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012855|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84012856|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012857|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012858|NCT01136772|Haloperidol|haloperidol|mesh-list
84012859|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84012860|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
84012861|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84012862|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84012863|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84012864|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012865|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84012866|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84012867|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84012868|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
84012869|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012870|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012871|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84012872|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84012873|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
84012874|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
84012875|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
84012876|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012877|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84012878|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84012879|NCT00909532|Ivacaftor|ivacaftor|mesh-list
84012880|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84012881|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84012882|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012883|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
84012884|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012885|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012886|NCT01136382|Budesonide|budesonide|mesh-list
84012887|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012888|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84012889|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
84012890|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012891|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012892|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84012893|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
84012894|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
84012895|NCT01136382|Hormones|hormones|mesh-ancestor
84012896|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012897|NCT03513562|Venetoclax|venetoclax|mesh-list
84012898|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012899|NCT02731729|Nivolumab|nivolumab|mesh-list
84012900|NCT02731729|Ipilimumab|ipilimumab|mesh-list
84012901|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84012902|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012903|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84012904|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012905|NCT02645461|Palmidrol|palmidrol|mesh-list
84012906|NCT02645461|Riluzole|riluzole|mesh-list
84012907|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
84012908|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84012909|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84012910|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012911|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012912|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012913|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84012915|NCT02645461|Analgesics|analgesics|mesh-ancestor
84012916|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
84012917|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84012918|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84012919|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84012920|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84012921|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012922|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
84012923|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012924|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84012925|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84012926|NCT02645461|Hormones|hormones|mesh-ancestor
84012927|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84012928|NCT00654589|Deferasirox|deferasirox|mesh-list
84012929|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84012930|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
84012931|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
84012932|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012933|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84012934|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84012935|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84012936|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
84012937|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012938|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84012939|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84012940|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012941|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84012942|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84012943|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84012944|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84012945|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84012946|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84012947|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84012948|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
84012949|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84012950|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012951|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012952|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
84012953|NCT01119066|Melphalan|melphalan|mesh-list
84012954|NCT01119066|Busulfan|busulfan|mesh-list
84012955|NCT01119066|Thiotepa|thiotepa|mesh-list
84012956|NCT01119066|Fludarabine|fludarabine|mesh-list
84012957|NCT01119066|Clofarabine|clofarabine|mesh-list
84012958|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012959|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
84012960|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012961|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84012962|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84012963|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
84012964|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012965|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84012966|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84012967|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84012968|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
84012969|NCT00910624|Ribavirin|ribavirin|mesh-list
84012970|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84012971|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
84012972|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012973|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
84012974|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84012975|NCT00654667|Resveratrol|resveratrol|mesh-list
84012976|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
84012977|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84012978|NCT00654667|Protective Agents|protective agents|mesh-ancestor
84012979|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012980|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84012981|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84012982|NCT01123980|Insulin|insulin|mesh-list
84012983|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84012984|NCT01123980|Metformin|metformin|mesh-list
84012985|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
84012986|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
84012987|NCT01123980|Glimepiride|glimepiride|mesh-list
84012988|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
84012989|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84012990|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84012991|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84012992|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84012993|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84012994|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
84012995|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
84012996|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84012997|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84012998|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84012999|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
84013000|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013001|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84013002|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84013003|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013004|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84013005|NCT04164823|Analgesics|analgesics|mesh-list
84013006|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
84013007|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013008|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013009|NCT02857959|Penicillins|penicillins|mesh-list
84013010|NCT02857959|Penicillin G|penicillin g|mesh-list
84013011|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
84013012|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
84013013|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013014|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013015|NCT02643433|Vaccines|vaccines|mesh-list
84013016|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
84013017|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013018|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
84013019|NCT00632476|Vitamins|vitamins|mesh-ancestor
84013020|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
84013021|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013022|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
84013023|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013024|NCT00632476|Protective Agents|protective agents|mesh-ancestor
84013025|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
84013026|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013027|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013028|NCT04164745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84013029|NCT04164745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013030|NCT01198522|Gemcitabine|gemcitabine|mesh-list
84013031|NCT01198522|Antibodies|antibodies|mesh-list
84013032|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84013033|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
84013034|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013035|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84013036|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
84013037|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013038|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013039|NCT02638285|Clomiphene|clomiphene|mesh-list
84013040|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84013041|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
84013042|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013043|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013044|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84013045|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
84013046|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84013047|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84013048|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84013049|NCT01134250|Paclitaxel|paclitaxel|mesh-list
84013050|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84013051|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013052|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
84013053|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
84013054|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
84013055|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013056|NCT01118520|Amlodipine|amlodipine|mesh-list
84013057|NCT01118520|Perindopril|perindopril|mesh-list
84013058|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84013059|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84013060|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84013061|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252853|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
84013062|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84013063|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013065|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84013066|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
84013067|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013068|NCT01135992|Insulin|insulin|mesh-list
84013069|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84013070|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
84013071|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84013072|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013073|NCT03734770|Progesterone|progesterone|mesh-list
84013074|NCT03734770|Progestins|progestins|mesh-ancestor
84013075|NCT03734770|Hormones|hormones|mesh-ancestor
84013076|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013077|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013078|NCT00959049|Vaccines|vaccines|mesh-list
84013079|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
84013080|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013081|NCT00956943|Nicotine|nicotine|mesh-list
84013082|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84013083|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
84013084|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013085|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013086|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84013087|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84013088|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
84013089|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013090|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013091|NCT01135914|Ranibizumab|ranibizumab|mesh-list
84013092|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013093|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013094|NCT01135914|Growth Substances|growth substances|mesh-ancestor
84013095|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013096|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013097|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013098|NCT00907738|Vorinostat|vorinostat|mesh-list
84013099|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013100|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84013101|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013102|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013103|NCT02829723|Spartalizumab|spartalizumab|mesh-list
84013104|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84013105|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013106|NCT02829723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013107|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013108|NCT01123356|Lenalidomide|lenalidomide|mesh-list
84013109|NCT01123356|Ofatumumab|ofatumumab|mesh-list
84013110|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
84013111|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013112|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013113|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013114|NCT01123356|Growth Substances|growth substances|mesh-ancestor
84013115|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013116|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013117|NCT00630357|Levetiracetam|levetiracetam|mesh-list
84013118|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
84013119|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
84013120|NCT02858817|Atovaquone|atovaquone|mesh-list
84013121|NCT02858817|Proguanil|proguanil|mesh-list
84013122|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
84013123|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013124|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
84013125|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84013126|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84013127|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013128|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013129|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
84013130|NCT02883192|Ondansetron|ondansetron|mesh-list
84013131|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
84013132|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
84013133|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013134|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013135|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84013136|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
84013137|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
84013138|NCT02883192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84013139|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84013140|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
84013141|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013142|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013143|NCT03116529|Immunomodulating Agents|immunomodulating agents|mesh-list
84013144|NCT03116529|Immunologic Factors|immunologic factors|mesh-ancestor
84013145|NCT03116529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013146|NCT00632554|Prednisolone|prednisolone|mesh-list
84013147|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84013148|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
84013149|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84013150|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
84013151|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84013152|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
84013153|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84013154|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
84013155|NCT00632554|Hormones|hormones|mesh-ancestor
84013156|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013157|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013158|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84013159|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013160|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
84013161|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
84013162|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013163|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84013164|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84013165|NCT00632554|Protective Agents|protective agents|mesh-ancestor
84013166|NCT03082209|Bevacizumab|bevacizumab|mesh-list
84013167|NCT03082209|Venetoclax|venetoclax|mesh-list
84013168|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013169|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013170|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013171|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013172|NCT03082209|Growth Substances|growth substances|mesh-ancestor
84013173|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013174|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013175|NCT02224144|Vitamin D|vitamin d|mesh-list
84013176|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
84013177|NCT02224144|Calcitriol|calcitriol|mesh-list
84013178|NCT02224144|Vitamins|vitamins|mesh-ancestor
84013179|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
84013180|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013181|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84013182|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84013183|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84013184|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84013185|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013186|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84013187|NCT05419180|Stiripentol|stiripentol|mesh-list
84013188|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
84013189|NCT04280289|Cannabidiol|cannabidiol|mesh-list
84013190|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
84013191|NCT03302728|Lenalidomide|lenalidomide|mesh-list
84013192|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84013193|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
84013194|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013195|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013196|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013197|NCT03302728|Growth Substances|growth substances|mesh-ancestor
84013198|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013199|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013200|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013201|NCT03302728|Immunotoxins|immunotoxins|mesh-ancestor
84013202|NCT03302728|Immunoconjugates|immunoconjugates|mesh-ancestor
84013203|NCT03832972|Estrogens|estrogens|mesh-list
84013204|NCT03832972|Hormones|hormones|mesh-ancestor
84013205|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013206|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013207|NCT02860299|Heparin|heparin|mesh-list
84013208|NCT02860299|Calcium heparin|calcium heparin|mesh-list
84013209|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
84013210|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013211|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84013212|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83253025|NCT05474183|Ketamine|ketamine|mesh-list
84013213|NCT05374564|Flutemetamol|flutemetamol|mesh-list
84013214|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84013215|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013217|NCT02858505|Trace Elements|trace elements|mesh-ancestor
84013218|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
84013219|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013220|NCT01518556|Idarubicin|idarubicin|mesh-list
84013221|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84013222|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013223|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84013224|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84013225|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013226|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013227|NCT02994069|Cisplatin|cisplatin|mesh-list
84013228|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013229|NCT02860221|Epinephrine|epinephrine|mesh-list
84013230|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
84013231|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84013232|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84013233|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013234|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
84013235|NCT02860221|Coagulants|coagulants|mesh-ancestor
84013236|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84013237|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84013238|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
84013239|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013240|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013241|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84013242|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84013243|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
84013244|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013245|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84013246|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
84013247|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
84013248|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
84013249|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84013250|NCT01874353|Olaparib|olaparib|mesh-list
84013251|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84013252|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013253|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013254|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013255|NCT02857569|Nivolumab|nivolumab|mesh-list
84013256|NCT02857569|Ipilimumab|ipilimumab|mesh-list
84013257|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013258|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013259|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84013260|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013261|NCT04164355|Tadalafil|tadalafil|mesh-list
84013262|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
84013263|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84013264|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84013265|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013266|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013267|NCT04164355|Urological Agents|urological agents|mesh-ancestor
84013268|NCT01605253|Eszopiclone|eszopiclone|mesh-list
84013269|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84013270|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013271|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013272|NCT00655135|Vedolizumab|vedolizumab|mesh-list
84013273|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84013274|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
84013275|NCT02635867|Calcium|calcium|mesh-list
84013276|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84013277|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013278|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84013279|NCT00955305|Paclitaxel|paclitaxel|mesh-list
84013280|NCT00955305|Bevacizumab|bevacizumab|mesh-list
84013281|NCT00955305|Carboplatin|carboplatin|mesh-list
84013282|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84013283|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013284|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
84013285|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
84013286|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
84013287|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013288|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013289|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013290|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013291|NCT00955305|Growth Substances|growth substances|mesh-ancestor
84013292|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013293|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013294|NCT00656695|Cyclosporine|cyclosporine|mesh-list
84013295|NCT00656695|Cyclosporins|cyclosporins|mesh-list
84013296|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
84013297|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013298|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
84013299|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013300|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013301|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84013302|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
84013303|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013304|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013305|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84013306|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
84013307|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84013308|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
84013309|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013310|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
84013311|NCT04204083|Protective Agents|protective agents|mesh-ancestor
84013312|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
84013313|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
84013314|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84013315|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84013316|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013317|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013318|NCT00598585|Urological Agents|urological agents|mesh-ancestor
84013319|NCT02635243|Glucagon|glucagon|mesh-list
84013320|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013321|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84013322|NCT02635243|Hormones|hormones|mesh-ancestor
84013323|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013324|NCT00953667|Niacin|niacin|mesh-list
84013325|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84013326|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
84013327|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013328|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84013329|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
84013330|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
84013331|NCT00953667|Vitamins|vitamins|mesh-ancestor
84013332|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
84013333|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013334|NCT02857491|Ranibizumab|ranibizumab|mesh-list
84013335|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013336|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013337|NCT02857491|Growth Substances|growth substances|mesh-ancestor
84013338|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013339|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013340|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013341|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
84013342|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
84013343|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84013344|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
84013345|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013346|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013347|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84013348|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
84013349|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013350|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013351|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84013352|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84013353|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84013354|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
84013355|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013356|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013357|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013358|NCT02856867|Leucovorin|leucovorin|mesh-list
84013359|NCT02856867|Fluorouracil|fluorouracil|mesh-list
84013360|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
84013361|NCT02856867|Nintedanib|nintedanib|mesh-list
84013362|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
84013363|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013364|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84013366|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84013367|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
84013368|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013369|NCT02856867|Antidotes|antidotes|mesh-ancestor
84013370|NCT02856867|Protective Agents|protective agents|mesh-ancestor
84013371|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
84013372|NCT02856867|Vitamins|vitamins|mesh-ancestor
84013373|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
84013374|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84013375|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013376|NCT00630513|Ampicillin|ampicillin|mesh-list
84013377|NCT00630513|Ertapenem|ertapenem|mesh-list
84013378|NCT00630513|Sulbactam|sulbactam|mesh-list
84013379|NCT00630513|Sultamicillin|sultamicillin|mesh-list
84013380|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013381|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013382|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84013383|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013384|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013385|NCT02157051|Vaccines|vaccines|mesh-list
84013386|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
84013387|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013388|NCT05287360|Apatinib|apatinib|mesh-list
84013389|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013390|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84013391|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013392|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013393|NCT00954447|Linagliptin|linagliptin|mesh-list
84013394|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84013395|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013396|NCT00954447|Incretins|incretins|mesh-ancestor
84013397|NCT00954447|Hormones|hormones|mesh-ancestor
84013398|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013399|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84013400|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
84013401|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013402|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013403|NCT00903760|Decitabine|decitabine|mesh-list
84013404|NCT00903760|Clofarabine|clofarabine|mesh-list
84013405|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84013406|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
84013407|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013408|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013409|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013410|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
84013411|NCT05273554|Lenvatinib|lenvatinib|mesh-list
84013412|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013413|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013414|NCT05273554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84013415|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013416|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84013417|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013418|NCT05177614|Micronutrients|micronutrients|mesh-list
84013419|NCT05177614|Trace Elements|trace elements|mesh-list
84013420|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013421|NCT04202536|Tenofovir|tenofovir|mesh-list
84013422|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
84013423|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013424|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84013425|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84013426|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013427|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013428|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84013429|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84013430|NCT02794402|Exenatide|exenatide|mesh-list
84013431|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84013432|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013433|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84013434|NCT02794402|Incretins|incretins|mesh-ancestor
84013435|NCT02794402|Hormones|hormones|mesh-ancestor
84013436|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013437|NCT00883051|Lasmiditan|lasmiditan|mesh-list
84013438|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84013439|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
84013440|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013441|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013442|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013443|NCT03395587|Temozolomide|temozolomide|mesh-list
84013444|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84013445|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
84013446|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013447|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013448|NCT00903682|Efavirenz|efavirenz|mesh-list
84013449|NCT00903682|Etravirine|etravirine|mesh-list
84013450|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84013451|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84013452|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013453|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013454|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
84013455|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013456|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84013457|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84013458|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84013459|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84013460|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84013461|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84013462|NCT00655603|Pancrelipase|pancrelipase|mesh-list
84013463|NCT00655603|Hormones|hormones|mesh-list
84013464|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013465|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013466|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84013467|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84013468|NCT00655681|Pamidronate|pamidronate|mesh-list
84013469|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84013470|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013471|NCT04221568|Fentanyl|fentanyl|mesh-list
84013472|NCT04221568|Bupivacaine|bupivacaine|mesh-list
84013473|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
84013474|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
84013475|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
84013476|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013477|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013478|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
84013479|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013480|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84013481|NCT04221568|Narcotics|narcotics|mesh-ancestor
84013482|NCT04221568|Analgesics|analgesics|mesh-ancestor
84013483|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84013484|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84013485|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
84013486|NCT01135524|Buprenorphine|buprenorphine|mesh-list
84013487|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84013488|NCT01135524|Narcotics|narcotics|mesh-ancestor
84013489|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013490|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013491|NCT01135524|Analgesics|analgesics|mesh-ancestor
84013492|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
84013493|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013494|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84013495|NCT00948675|Paclitaxel|paclitaxel|mesh-list
84013496|NCT00948675|Bevacizumab|bevacizumab|mesh-list
84013497|NCT00948675|Carboplatin|carboplatin|mesh-list
84013498|NCT00948675|Pemetrexed|pemetrexed|mesh-list
84013499|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84013500|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013501|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
84013502|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
84013503|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
84013504|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013505|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013506|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013507|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013508|NCT00948675|Growth Substances|growth substances|mesh-ancestor
84013509|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013510|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013511|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013512|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84013513|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84013514|NCT02642497|Ketamine|ketamine|mesh-list
84013515|NCT02642497|Analgesics|analgesics|mesh-ancestor
84013516|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
84013517|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013518|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013519|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84013520|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84013521|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
84013522|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
84013523|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013524|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84013525|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84013526|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013527|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013528|NCT04273581|Thalidomide|thalidomide|mesh-list
84013529|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84013530|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
84013531|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013532|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
84013533|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013534|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013535|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013536|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013537|NCT04273581|Growth Substances|growth substances|mesh-ancestor
84013538|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013539|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013540|NCT01110408|Amoxicillin|amoxicillin|mesh-list
84013541|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
84013542|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
84013543|NCT01110408|Cefepime|cefepime|mesh-list
84013544|NCT01110408|Doripenem|doripenem|mesh-list
84013545|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84013546|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013547|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013548|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84013549|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013550|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013551|NCT00953043|Lubiprostone|lubiprostone|mesh-list
84013552|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84013553|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84013554|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013555|NCT02850484|Budesonide|budesonide|mesh-list
84013556|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
84013557|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84013558|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84013559|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
84013560|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013561|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013562|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84013563|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
84013564|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
84013565|NCT02850484|Hormones|hormones|mesh-ancestor
84013566|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013567|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84013568|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84013569|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84013570|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
84013571|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013572|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013573|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
84013574|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84013575|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
84013576|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84013577|NCT00948441|Ethanol|ethanol|mesh-list
84013578|NCT00948441|Heparin|heparin|mesh-list
84013579|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
84013580|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84013581|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84013582|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013583|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84013584|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253377|NCT05526911|Dolutegravir|dolutegravir|mesh-list
83253378|NCT05526911|Digoxin|digoxin|mesh-list
83253379|NCT05526911|Midazolam|midazolam|mesh-list
83253380|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83253381|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83253384|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84013585|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013586|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013587|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
84013588|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84013589|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84013590|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013591|NCT00630903|Methoxsalen|methoxsalen|mesh-list
84013592|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84013593|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
84013594|NCT02883426|Vaccines|vaccines|mesh-list
84013595|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
84013596|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013597|NCT02849314|Immunomodulating Agents|immunomodulating agents|mesh-list
84013598|NCT02849314|Immunologic Factors|immunologic factors|mesh-ancestor
84013599|NCT02849314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013600|NCT02849236|Ropivacaine|ropivacaine|mesh-list
84013601|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
84013602|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
84013603|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013604|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013605|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
84013606|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013607|NCT02856789|Hemostatics|hemostatics|mesh-list
84013608|NCT02856789|Coagulants|coagulants|mesh-ancestor
84013609|NCT01117350|Metformin|metformin|mesh-list
84013610|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
84013611|NCT01117350|Liraglutide|liraglutide|mesh-list
84013612|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84013613|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013614|NCT01117350|Incretins|incretins|mesh-ancestor
84013615|NCT01117350|Hormones|hormones|mesh-ancestor
84013616|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013617|NCT00952731|Tamoxifen|tamoxifen|mesh-list
84013618|NCT00952731|Afimoxifene|afimoxifene|mesh-list
84013619|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84013620|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
84013621|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013622|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013623|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84013624|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013625|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84013626|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84013627|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84013628|NCT04202224|Acetaminophen|acetaminophen|mesh-list
84013629|NCT04202224|Ibuprofen|ibuprofen|mesh-list
84013630|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84013631|NCT04202224|Analgesics|analgesics|mesh-ancestor
84013632|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
84013633|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013634|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013635|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
84013636|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84013637|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84013638|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013639|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84013640|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013641|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013642|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84013643|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
83535790|NCT05922306|Interferon-alpha|interferon-alpha|mesh-list
84013644|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013645|NCT02848612|Heparin|heparin|mesh-list
84013646|NCT02848612|Calcium heparin|calcium heparin|mesh-list
84013647|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
84013648|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84013649|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83253465|NCT05522231|Everolimus|everolimus|mesh-list
83253466|NCT05522231|Axitinib|axitinib|mesh-list
83253467|NCT05522231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83253468|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83253469|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253470|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253471|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253472|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
83253473|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253474|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253475|NCT04877509|Vitamin D|vitamin d|mesh-list
84013650|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013651|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
84013652|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84013653|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84013654|NCT04235062|Furosemide|furosemide|mesh-list
84013655|NCT04235062|Calcium|calcium|mesh-list
84013656|NCT04235062|Diuretics|diuretics|mesh-list
84013657|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
84013658|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84013659|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013660|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
84013661|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84013662|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013663|NCT02848768|Sunitinib|sunitinib|mesh-list
84013664|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013665|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84013666|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84013667|NCT02848768|Growth Substances|growth substances|mesh-ancestor
84013668|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013669|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
84013670|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84013671|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013672|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013673|NCT02848300|Bimatoprost|bimatoprost|mesh-list
84013674|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84013675|NCT00953745|Aripiprazole|aripiprazole|mesh-list
84013676|NCT00953745|Escitalopram|escitalopram|mesh-list
84013677|NCT00953745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84013678|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84013679|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84013680|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013681|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013682|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
84013683|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013684|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
84013685|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84013686|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84013687|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84013688|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013689|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
84013690|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
84013691|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84013692|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84013693|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84013694|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84013695|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84013696|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84013697|NCT04202380|Azithromycin|azithromycin|mesh-list
84013698|NCT04202380|Ampicillin|ampicillin|mesh-list
84013699|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013700|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013701|NCT02847442|Levodopa|levodopa|mesh-list
84013702|NCT02847442|Opicapone|opicapone|mesh-list
84013703|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
84013704|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
84013705|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84013706|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84013707|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
84013708|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013709|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013710|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013711|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84013712|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013713|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84013714|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
84013715|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84013716|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
84013717|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84013718|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013719|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84013720|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84013721|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253531|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84013722|NCT01478698|Plasminogen|plasminogen|mesh-list
84013723|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84013724|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84013725|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84013726|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013727|NCT01199380|Nicotine|nicotine|mesh-list
84013728|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84013729|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
84013730|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013731|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013732|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84013733|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84013734|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
84013735|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013736|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013737|NCT02847286|Dapivirine|dapivirine|mesh-list
84013738|NCT02847286|Clotrimazole|clotrimazole|mesh-list
84013739|NCT02847286|Miconazole|miconazole|mesh-list
84013740|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84013741|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84013742|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
84013743|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013744|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84013745|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
84013746|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84013747|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84013748|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013749|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013750|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84013751|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
84013752|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013753|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013754|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84013755|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84013756|NCT00902668|Lovastatin|lovastatin|mesh-list
84013757|NCT00902668|L 647318|l 647318|mesh-list
84013758|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
84013759|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84013760|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84013761|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
84013762|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013763|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84013764|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84013765|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013766|NCT00433420|Paclitaxel|paclitaxel|mesh-list
84013767|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
84013768|NCT00433420|Fluorouracil|fluorouracil|mesh-list
84013769|NCT00433420|Epirubicin|epirubicin|mesh-list
84013770|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84013771|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013772|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
84013773|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
84013774|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
84013775|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013776|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84013777|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
84013778|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013779|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013780|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84013781|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
84013782|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84013783|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
84013784|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84013785|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84013786|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84013787|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84013788|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013789|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
84013790|NCT04202068|Sulbactam|sulbactam|mesh-list
84013791|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013792|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013793|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84013794|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013795|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253608|NCT04876261|Protective Agents|protective agents|mesh-ancestor
84013797|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
84013798|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013799|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013800|NCT05012644|Palbociclib|palbociclib|mesh-list
84013801|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84013802|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013803|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84013804|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013805|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013806|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84013807|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84013808|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
84013809|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013810|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013811|NCT02846506|Metformin|metformin|mesh-list
84013812|NCT02846506|Canagliflozin|canagliflozin|mesh-list
84013813|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84013814|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013815|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84013816|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013817|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
84013818|NCT02846428|Docetaxel|docetaxel|mesh-list
84013819|NCT02846428|Fluorouracil|fluorouracil|mesh-list
84013820|NCT02846428|Capecitabine|capecitabine|mesh-list
84013821|NCT02846428|Epirubicin|epirubicin|mesh-list
84013822|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84013823|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
84013824|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013825|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013826|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84013827|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
84013828|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013829|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013830|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84013831|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
84013832|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
84013833|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
84013834|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
84013835|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84013836|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84013837|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84013838|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84013839|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013840|NCT03561376|Petrolatum|petrolatum|mesh-list
84013841|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
84013842|NCT03561376|Emollients|emollients|mesh-ancestor
84013843|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
84013844|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
84013845|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84013846|NCT03561376|Protective Agents|protective agents|mesh-ancestor
84013847|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013848|NCT02844712|beta-Lactams|beta-lactams|mesh-list
84013849|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013850|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013851|NCT00947349|Interferons|interferons|mesh-list
84013852|NCT00947349|Ribavirin|ribavirin|mesh-list
84013853|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013854|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
84013855|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013856|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
84013857|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013858|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84013859|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84013860|NCT03425812|Analgesics|analgesics|mesh-ancestor
84013861|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
84013862|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013863|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013864|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84013865|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013866|NCT02845804|Everolimus|everolimus|mesh-list
84013867|NCT02845804|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84013868|NCT02845804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84013869|NCT02845804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013870|NCT02845804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013871|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84013872|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
84013873|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013874|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013875|NCT02844634|Tenofovir|tenofovir|mesh-list
84013876|NCT02844634|Emtricitabine|emtricitabine|mesh-list
84013877|NCT02844634|Doxycycline|doxycycline|mesh-list
84013878|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
84013879|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013880|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84013881|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84013882|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013883|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013884|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84013885|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84013886|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013887|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
84013888|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84013889|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84013890|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
84013891|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
84013892|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013893|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013894|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013895|NCT00952419|Vaccines|vaccines|mesh-list
84013896|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
84013897|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013898|NCT02844322|Rituximab|rituximab|mesh-list
84013899|NCT02844322|Bortezomib|bortezomib|mesh-list
84013900|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84013901|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013902|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
84013903|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013904|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013905|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84013906|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84013907|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013908|NCT01996605|Oxytocin|oxytocin|mesh-list
84013909|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
84013910|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84013911|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013912|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84013913|NCT00630981|Escitalopram|escitalopram|mesh-list
84013914|NCT00630981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84013915|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84013916|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84013917|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013918|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013919|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
84013920|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013921|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
84013922|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84013923|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84013924|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84013925|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013926|NCT00952341|Dexamethasone|dexamethasone|mesh-list
84013927|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
84013928|NCT00952341|Aprepitant|aprepitant|mesh-list
84013929|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
84013930|NCT00952341|Granisetron|granisetron|mesh-list
84013931|NCT00952341|BB 1101|bb 1101|mesh-list
84013932|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84013933|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
84013934|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
84013935|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013936|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013937|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84013938|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
84013939|NCT00952341|Hormones|hormones|mesh-ancestor
84013940|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84013941|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84013942|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84013943|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
84013944|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013945|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013946|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84013947|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84013948|NCT00952341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84013949|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84013950|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
84013951|NCT02845024|Doxycycline|doxycycline|mesh-list
84013952|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84013953|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013954|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
84013955|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84013956|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84013957|NCT02853903|Immunomodulating Agents|immunomodulating agents|mesh-list
84013958|NCT02853903|Immunologic Factors|immunologic factors|mesh-ancestor
84013959|NCT02853903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013960|NCT05242120|Anesthetics|anesthetics|mesh-list
84013961|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013962|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013963|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
84013964|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
84013965|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
84013966|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84013967|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013968|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
84013969|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013970|NCT02844790|Insulin|insulin|mesh-list
84013971|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
84013972|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84013973|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013974|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
84013975|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84013976|NCT04410328|Aspirin|aspirin|mesh-list
84013977|NCT04410328|Dipyridamole|dipyridamole|mesh-list
84013978|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84013979|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84013980|NCT04410328|Analgesics|analgesics|mesh-ancestor
84013981|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
84013982|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84013983|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84013984|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84013985|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84013986|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84013987|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84013988|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84013989|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84013990|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84013991|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84013992|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
84013993|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84013994|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
84013995|NCT02852577|Clonazepam|clonazepam|mesh-list
84013996|NCT02852577|Paroxetine|paroxetine|mesh-list
84013997|NCT02852577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84013998|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84013999|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014000|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014001|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014002|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
84014003|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014004|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84014005|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
84014006|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014007|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84014008|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84014009|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014010|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
84014011|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
84014012|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
84014013|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
84014014|NCT00902044|Fludarabine|fludarabine|mesh-list
84014015|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84014016|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
84014017|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014018|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014019|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84014020|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
84014021|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014022|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014023|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84014024|NCT04201990|Apatinib|apatinib|mesh-list
84014025|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014026|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84014027|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014028|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014029|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
84014030|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
84014031|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84014032|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84014033|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014034|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014035|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014036|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014037|NCT00901186|Ranibizumab|ranibizumab|mesh-list
84014038|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84014039|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84014040|NCT00901186|Growth Substances|growth substances|mesh-ancestor
84014041|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014042|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
84014043|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014044|NCT05040880|Telmisartan|telmisartan|mesh-list
84014045|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84014046|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84014047|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84014048|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014049|NCT04073290|Rifaximin|rifaximin|mesh-list
84014050|NCT04073290|Lactulose|lactulose|mesh-list
84014051|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84014052|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014053|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014054|NCT03763162|Dexamethasone|dexamethasone|mesh-list
84014055|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
84014056|NCT03763162|Bortezomib|bortezomib|mesh-list
84014057|NCT03763162|Daratumumab|daratumumab|mesh-list
84014058|NCT03763162|Ixazomib|ixazomib|mesh-list
84014059|NCT03763162|Ichthammol|ichthammol|mesh-list
84014060|NCT03763162|BB 1101|bb 1101|mesh-list
84014061|NCT03763162|Glycine|glycine|mesh-list
84014062|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014063|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
84014064|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
84014065|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014066|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014067|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014068|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
84014069|NCT03763162|Hormones|hormones|mesh-ancestor
84014070|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014071|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84014072|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014073|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
84014074|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014075|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014076|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
84014077|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
84014078|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014079|NCT03936790|Fentanyl|fentanyl|mesh-list
84014080|NCT03936790|Ropivacaine|ropivacaine|mesh-list
84014081|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
84014082|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
84014083|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014084|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014085|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
84014086|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014087|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84014088|NCT03936790|Narcotics|narcotics|mesh-ancestor
84014089|NCT03936790|Analgesics|analgesics|mesh-ancestor
84014090|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84014091|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84014092|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
84014093|NCT04782700|Prednisone|prednisone|mesh-list
84014094|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014095|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
84014096|NCT04782700|Hormones|hormones|mesh-ancestor
84014097|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014098|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014099|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84014100|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014101|NCT03711448|Prednisone|prednisone|mesh-list
84014102|NCT03711448|Ustekinumab|ustekinumab|mesh-list
84014103|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014104|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
84014105|NCT03711448|Hormones|hormones|mesh-ancestor
84014106|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014107|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014108|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84014109|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014110|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
84014111|NCT00885703|Fluconazole|fluconazole|mesh-list
84014112|NCT00885703|Amphotericin B|amphotericin b|mesh-list
84014113|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84014114|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
84014115|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
84014116|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
84014117|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014118|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84014119|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84014120|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014121|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014122|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84014123|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
84014124|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014125|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014126|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84014127|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84014128|NCT00885703|Amebicides|amebicides|mesh-ancestor
84014129|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84014130|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84014131|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84014132|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84014133|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014134|NCT02642419|Aspirin|aspirin|mesh-list
84014135|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
84014136|NCT02642419|Clopidogrel|clopidogrel|mesh-list
84014137|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84014138|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84014139|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84014140|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014141|NCT02642419|Analgesics|analgesics|mesh-ancestor
84014142|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
84014143|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014144|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014145|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014146|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014147|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84014148|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84014149|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014150|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84014151|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014152|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
84014153|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84014154|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84014155|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84014156|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
84014157|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014158|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84014159|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
84014160|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84014161|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
84014162|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
84014163|NCT00901576|Methylphenidate|methylphenidate|mesh-list
84014164|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84014165|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014166|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84014167|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84014168|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014169|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014170|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
84014171|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014172|NCT00655837|Rituximab|rituximab|mesh-list
84014173|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
84014174|NCT00655837|Gemcitabine|gemcitabine|mesh-list
84014175|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84014176|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014177|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
84014178|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014179|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014180|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84014181|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
84014182|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014183|NCT00655915|Betamethasone|betamethasone|mesh-list
84014184|NCT00655915|Lidocaine|lidocaine|mesh-list
84014185|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
84014186|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
84014187|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014188|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014189|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
84014190|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014191|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84014192|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84014193|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84014194|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014195|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014196|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014197|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
84014198|NCT00655915|Hormones|hormones|mesh-ancestor
84014199|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014200|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84014201|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
84014202|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
84014203|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84014204|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84014205|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014206|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84014207|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84014208|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014209|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014210|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014211|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014212|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84014213|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84014214|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014215|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014216|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84014217|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
84014218|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014219|NCT00656773|Sufentanil|sufentanil|mesh-list
84014220|NCT00656773|Morphine|morphine|mesh-list
84014221|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84014222|NCT00656773|Narcotics|narcotics|mesh-ancestor
84014223|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014224|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014225|NCT00656773|Analgesics|analgesics|mesh-ancestor
84014226|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
84014227|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014228|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84014229|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84014230|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
84014231|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
84014232|NCT00882583|Cisplatin|cisplatin|mesh-list
84014233|NCT00882583|Cetuximab|cetuximab|mesh-list
84014234|NCT00882583|Dasatinib|dasatinib|mesh-list
84014235|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014236|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84014237|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84014238|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014239|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014240|NCT04481308|Fentanyl|fentanyl|mesh-list
84014241|NCT04481308|Propofol|propofol|mesh-list
84014242|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84014243|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014244|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014245|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84014246|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
84014247|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
84014248|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84014250|NCT04481308|Analgesics|analgesics|mesh-ancestor
84014251|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
84014252|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014253|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84014254|NCT02634541|Adalimumab|adalimumab|mesh-list
84014255|NCT02634541|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84014256|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014257|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014258|NCT04475848|Midazolam|midazolam|mesh-list
84014259|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84014260|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84014261|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014262|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014263|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84014264|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84014265|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014266|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84014267|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
84014268|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
84014269|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
84014270|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
84014271|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014272|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014273|NCT00599521|Adapalene|adapalene|mesh-list
84014274|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84014275|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014276|NCT00599521|Analgesics|analgesics|mesh-ancestor
84014277|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
84014278|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014279|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014280|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014281|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014282|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
84014283|NCT04201678|Anesthetics|anesthetics|mesh-list
84014284|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014285|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014286|NCT00653341|Insulin|insulin|mesh-list
84014287|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84014288|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
84014289|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
84014290|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
84014291|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
84014292|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84014293|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014294|NCT02642263|Carbetocin|carbetocin|mesh-list
84014295|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
84014296|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84014297|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014298|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
84014299|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014300|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
84014301|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84014302|NCT02636803|Albendazole|albendazole|mesh-list
84014303|NCT02636803|Oxfendazole|oxfendazole|mesh-list
84014304|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
84014305|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84014306|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014307|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
84014308|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84014309|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84014310|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
84014311|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
84014312|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
84014313|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014314|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014315|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
84014316|NCT02634463|Olanzapine|olanzapine|mesh-list
84014317|NCT02634463|Risperidone|risperidone|mesh-list
84014318|NCT02634463|Aripiprazole|aripiprazole|mesh-list
84014319|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84014320|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84014321|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
84014322|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014323|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014324|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014325|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84014326|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84014327|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014328|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014329|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84014330|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
84014331|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
84014332|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
84014333|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014334|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014335|NCT02634463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84014336|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84014337|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014338|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
84014339|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
84014340|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84014341|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84014342|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84014343|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84014344|NCT00882115|Sulforaphane|sulforaphane|mesh-list
84014345|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84014346|NCT00882115|Protective Agents|protective agents|mesh-ancestor
84014347|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014348|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014349|NCT00653419|Buspirone|buspirone|mesh-list
84014350|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84014351|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84014352|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014353|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014354|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014355|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84014356|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
84014357|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014358|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014359|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
84014360|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84014361|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84014362|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014363|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
84014364|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84014365|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
84014366|NCT00656929|Vitamin D|vitamin d|mesh-list
84014367|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
84014368|NCT00656929|Vitamins|vitamins|mesh-ancestor
84014369|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
84014370|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014371|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84014372|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84014373|NCT00884221|Menotropins|menotropins|mesh-list
84014374|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84014375|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
84014376|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84014377|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014378|NCT02153632|Amantadine|amantadine|mesh-list
84014379|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84014380|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84014381|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
84014382|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014383|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
84014384|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014385|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014386|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014387|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014388|NCT02153632|Analgesics|analgesics|mesh-ancestor
84014389|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
84014390|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014391|NCT01934452|Sunitinib|sunitinib|mesh-list
84014392|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014393|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84014394|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84014395|NCT01934452|Growth Substances|growth substances|mesh-ancestor
84014396|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014397|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
84014398|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84014399|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014400|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014401|NCT03524326|Cetuximab|cetuximab|mesh-list
84014403|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84014404|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014405|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84014406|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014407|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014408|NCT01236430|Atorvastatin|atorvastatin|mesh-list
84014409|NCT01236430|Ezetimibe|ezetimibe|mesh-list
84014410|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84014411|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84014412|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
84014413|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014414|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84014415|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84014416|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014417|NCT00726856|Ezetimibe|ezetimibe|mesh-list
84014418|NCT00726856|Fenofibrate|fenofibrate|mesh-list
84014419|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84014420|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84014421|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
84014422|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014423|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84014424|NCT00651274|Ezetimibe|ezetimibe|mesh-list
84014425|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84014426|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84014427|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
84014428|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014429|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84014430|NCT04608448|Sirolimus|sirolimus|mesh-list
84014431|NCT04608448|Petrolatum|petrolatum|mesh-list
84014432|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84014433|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014434|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84014435|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014436|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
84014437|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84014438|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
84014439|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014440|NCT04608448|Emollients|emollients|mesh-ancestor
84014441|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
84014442|NCT00212836|Olanzapine|olanzapine|mesh-list
84014443|NCT00212836|Asenapine|asenapine|mesh-list
84014444|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
84014445|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
84014446|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014447|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014448|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014449|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84014450|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84014451|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014452|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014453|NCT00212836|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84014454|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84014455|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014456|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014457|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014458|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
84014459|NCT00805324|Desloratadine|desloratadine|mesh-list
84014460|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84014461|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
84014462|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014463|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014464|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014465|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84014466|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84014467|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
84014468|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
84014469|NCT00157924|Atorvastatin|atorvastatin|mesh-list
84014470|NCT00157924|Simvastatin|simvastatin|mesh-list
84014471|NCT00157924|Ezetimibe|ezetimibe|mesh-list
84014472|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84014473|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84014474|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
84014475|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014476|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84014477|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84014478|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014480|NCT00794794|Desloratadine|desloratadine|mesh-list
84014481|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84014482|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84014483|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84014484|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
84014485|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
84014486|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014487|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014488|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014489|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84014490|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
84014491|NCT03612466|Plerixafor|plerixafor|mesh-list
84014492|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
84014493|NCT03612466|Calcium|calcium|mesh-list
84014494|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84014495|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014496|NCT03612466|Antacids|antacids|mesh-ancestor
84014497|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014498|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014499|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84014500|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84014501|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
84014502|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014503|NCT00142558|Indomethacin|indomethacin|mesh-list
84014504|NCT00142558|Etoricoxib|etoricoxib|mesh-list
84014505|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014506|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014507|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014508|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84014509|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014510|NCT00142558|Analgesics|analgesics|mesh-ancestor
84014511|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
84014512|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014513|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014514|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
84014515|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
84014516|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84014517|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84014518|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014519|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84014520|NCT02842294|Bevacizumab|bevacizumab|mesh-list
84014521|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84014522|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014523|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84014524|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84014525|NCT02842294|Growth Substances|growth substances|mesh-ancestor
84014526|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014527|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
84014528|NCT02841982|Morphine|morphine|mesh-list
84014529|NCT02841982|Ropivacaine|ropivacaine|mesh-list
84014530|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84014531|NCT02841982|Narcotics|narcotics|mesh-ancestor
84014532|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014533|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014534|NCT02841982|Analgesics|analgesics|mesh-ancestor
84014535|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
84014536|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014537|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
84014538|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
84014539|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
84014540|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84014541|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014542|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014543|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014544|NCT02843698|Analgesics|analgesics|mesh-ancestor
84014545|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
84014546|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014547|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84014548|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84014549|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84014550|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
84014551|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014552|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014553|NCT00690898|Lanreotide|lanreotide|mesh-list
84014554|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014555|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
84014556|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
84014557|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84014558|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84014559|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014560|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84014561|NCT00895414|Doxorubicin|doxorubicin|mesh-list
84014562|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84014563|NCT00895414|Enalapril|enalapril|mesh-list
84014564|NCT00895414|Enalaprilat|enalaprilat|mesh-list
84014565|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84014566|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014567|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84014568|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84014569|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014570|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014571|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84014572|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
84014573|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84014574|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84014575|NCT01822288|Tibolone|tibolone|mesh-list
84014576|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
84014577|NCT01822288|Estradiol|estradiol|mesh-list
84014578|NCT01822288|Estrogens|estrogens|mesh-ancestor
84014579|NCT01822288|Hormones|hormones|mesh-ancestor
84014580|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014581|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014582|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84014583|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
84014584|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84014585|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84014586|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84014587|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84014588|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84014589|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84014590|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84014591|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014592|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
84014593|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
84014594|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84014595|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84014596|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
84014597|NCT01328626|Venetoclax|venetoclax|mesh-list
84014598|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014599|NCT02840812|Nemonoxacin|nemonoxacin|mesh-list
84014600|NCT02840812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84014601|NCT02840812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014602|NCT01212770|Thalidomide|thalidomide|mesh-list
84014603|NCT01212770|Apremilast|apremilast|mesh-list
84014604|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84014605|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014606|NCT01212770|Analgesics|analgesics|mesh-ancestor
84014607|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
84014608|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014609|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014610|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014611|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014612|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84014613|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84014614|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014615|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014616|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84014617|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
84014618|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
84014619|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84014620|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014621|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84014622|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84014623|NCT01212770|Growth Substances|growth substances|mesh-ancestor
84014624|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
83254433|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014625|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014626|NCT05334316|Dexamethasone|dexamethasone|mesh-list
84014627|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014628|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
84014629|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
84014630|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014631|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014632|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014633|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
84014634|NCT05334316|Hormones|hormones|mesh-ancestor
84014635|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014636|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84014637|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014638|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
84014639|NCT00598273|Hematinics|hematinics|mesh-ancestor
84014640|NCT02636491|Insulin|insulin|mesh-list
84014641|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84014642|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84014643|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014644|NCT00657007|Belimumab|belimumab|mesh-list
84014645|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84014646|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
84014647|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014648|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
84014649|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84014650|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84014651|NCT04318652|Prednisolone|prednisolone|mesh-list
84014652|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
84014653|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84014654|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84014655|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
84014656|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014657|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
84014658|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
84014659|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014660|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014661|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014662|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
84014663|NCT04318652|Hormones|hormones|mesh-ancestor
84014664|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014665|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84014666|NCT04318652|Protective Agents|protective agents|mesh-ancestor
84014667|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84014668|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014669|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84014670|NCT02633995|Anesthetics|anesthetics|mesh-list
84014671|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014672|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014673|NCT02633683|Gabapentin|gabapentin|mesh-list
84014674|NCT02633683|Analgesics|analgesics|mesh-ancestor
84014675|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
84014676|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014677|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014678|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
84014679|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84014680|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84014681|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014682|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014683|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84014684|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84014685|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014686|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014687|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
84014688|NCT01211522|Haloperidol|haloperidol|mesh-list
84014689|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
84014690|NCT01211522|Ziprasidone|ziprasidone|mesh-list
84014691|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
84014692|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
84014693|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014694|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014695|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014696|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84014697|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84014698|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014699|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014700|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84014701|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
84014702|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014703|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014704|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84014705|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84014706|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
84014707|NCT05404724|Itraconazole|itraconazole|mesh-list
84014708|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
84014709|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014710|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84014711|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84014712|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014713|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014714|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84014715|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
84014716|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014717|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014718|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84014719|NCT03314935|Leucovorin|leucovorin|mesh-list
84014720|NCT03314935|Paclitaxel|paclitaxel|mesh-list
84014721|NCT03314935|Gemcitabine|gemcitabine|mesh-list
84014722|NCT03314935|Fluorouracil|fluorouracil|mesh-list
84014723|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
84014724|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84014725|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014726|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
84014727|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
84014728|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
84014729|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014730|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84014731|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
84014732|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84014733|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
84014734|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014735|NCT03314935|Antidotes|antidotes|mesh-ancestor
84014736|NCT03314935|Protective Agents|protective agents|mesh-ancestor
84014737|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
84014738|NCT03314935|Vitamins|vitamins|mesh-ancestor
84014739|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
84014740|NCT02633761|Misoprostol|misoprostol|mesh-list
84014741|NCT02633761|Mifepristone|mifepristone|mesh-list
84014742|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84014743|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
84014744|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84014745|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014746|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84014747|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84014748|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
84014749|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84014750|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84014751|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84014752|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84014753|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
84014754|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84014755|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84014756|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
84014757|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014758|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
84014759|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84014760|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84014761|NCT02633839|Carbidopa|carbidopa|mesh-list
84014762|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84014763|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84014764|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
84014765|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014766|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014767|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014768|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84014769|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014770|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
84014771|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83254578|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84014772|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014773|NCT00657397|Methadone|methadone|mesh-list
83254579|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83254580|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84014774|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84014776|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014777|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014778|NCT00657397|Analgesics|analgesics|mesh-ancestor
84014779|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
84014780|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014781|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
84014782|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
84014783|NCT04160611|Midazolam|midazolam|mesh-list
84014784|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84014785|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84014786|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014787|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014788|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84014789|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84014790|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014791|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84014792|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
84014793|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
84014794|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
84014795|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
84014796|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014797|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014798|NCT04161001|Amlodipine|amlodipine|mesh-list
84014799|NCT04161001|Olmesartan|olmesartan|mesh-list
84014800|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84014801|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
84014802|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84014803|NCT04161001|Ezetimibe|ezetimibe|mesh-list
84014804|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84014805|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84014806|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014807|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014808|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84014809|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014810|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
84014811|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84014812|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84014813|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
84014814|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84014815|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84014816|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014817|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84014818|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84014819|NCT00881569|Efatutazone|efatutazone|mesh-list
84014820|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014821|NCT00657163|Fluoxetine|fluoxetine|mesh-list
84014822|NCT00657163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84014823|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84014824|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84014825|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014826|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014827|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
84014828|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014829|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84014830|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
84014831|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84014832|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84014833|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84014834|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014835|NCT02636101|Betamethasone|betamethasone|mesh-list
84014836|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
84014837|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84014838|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
84014839|NCT02636101|Calcipotriene|calcipotriene|mesh-list
84014840|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84014841|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014842|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
84014843|NCT02636101|Hormones|hormones|mesh-ancestor
84014844|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014845|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014846|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84014847|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
84014848|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
84014849|NCT00657475|Heparin|heparin|mesh-list
84014850|NCT00657475|Calcium heparin|calcium heparin|mesh-list
84014851|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
84014852|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84014853|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84014854|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014855|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
84014856|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
84014857|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84014858|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84014859|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014860|NCT04159597|Upadacitinib|upadacitinib|mesh-list
84014861|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84014862|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84014863|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014864|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014865|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014866|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84014867|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
84014868|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84014869|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84014870|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014871|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014872|NCT00661219|Urological Agents|urological agents|mesh-ancestor
84014873|NCT00665743|Naproxen|naproxen|mesh-list
84014874|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84014875|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014876|NCT00665743|Analgesics|analgesics|mesh-ancestor
84014877|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
84014878|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014879|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014880|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014881|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014882|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
84014883|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84014884|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014885|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014886|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84014887|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
84014888|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84014889|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84014890|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014891|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014892|NCT00661297|Urological Agents|urological agents|mesh-ancestor
84014893|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
84014894|NCT00879775|Caffeine|caffeine|mesh-list
84014895|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84014896|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014897|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84014898|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014899|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014900|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84014901|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84014902|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
84014903|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84014904|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
84014905|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014906|NCT00894790|Celecoxib|celecoxib|mesh-list
84014907|NCT00894790|Diclofenac|diclofenac|mesh-list
84014908|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84014909|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84014910|NCT00894790|Analgesics|analgesics|mesh-ancestor
84014911|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
84014912|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014913|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014914|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014915|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84014916|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84014917|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84014918|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014919|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014920|NCT00665977|Triamcinolone|triamcinolone|mesh-list
84014921|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84014922|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84014923|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84014924|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84014925|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
84014926|NCT00665977|Hormones|hormones|mesh-ancestor
84014927|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84014928|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014929|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84014930|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
84014931|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014932|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014933|NCT00666055|Ritonavir|ritonavir|mesh-list
84014934|NCT00666055|Lopinavir|lopinavir|mesh-list
84014935|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84014936|NCT00666055|Tenofovir|tenofovir|mesh-list
84014937|NCT00666055|Lamivudine|lamivudine|mesh-list
84014938|NCT00666055|Emtricitabine|emtricitabine|mesh-list
84014939|NCT00666055|Zidovudine|zidovudine|mesh-list
84014940|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
84014941|NCT00666055|Maraviroc|maraviroc|mesh-list
84014942|NCT00666055|Efavirenz|efavirenz|mesh-list
84014943|NCT00666055|Etravirine|etravirine|mesh-list
84014944|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84014945|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84014946|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
84014947|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014948|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014949|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84014950|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84014951|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
84014952|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014953|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84014954|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84014955|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84014956|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84014957|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
84014958|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84014959|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84014960|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84014961|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84014962|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84014963|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84014964|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84014965|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84014966|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84014967|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84014968|NCT00661375|Sorafenib|sorafenib|mesh-list
84014969|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84014970|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84014971|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84014972|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014973|NCT00911287|Oxymorphone|oxymorphone|mesh-list
84014974|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84014975|NCT00911287|Narcotics|narcotics|mesh-ancestor
84014976|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014977|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014978|NCT00911287|Analgesics|analgesics|mesh-ancestor
84014979|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
84014980|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014981|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84014982|NCT04494880|Bupivacaine|bupivacaine|mesh-list
84014983|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
84014984|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
84014985|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84014986|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84014987|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
84014988|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84014989|NCT02631031|Valsartan|valsartan|mesh-list
84014990|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84014991|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83254796|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
84014992|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84014993|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84014994|NCT02839408|Azithromycin|azithromycin|mesh-list
84014995|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84014996|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84014997|NCT02837614|Acetaminophen|acetaminophen|mesh-list
84014998|NCT02837614|Amoxicillin|amoxicillin|mesh-list
84014999|NCT02837614|Dexamethasone|dexamethasone|mesh-list
84015000|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
84015001|NCT02837614|BB 1101|bb 1101|mesh-list
84015002|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015003|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
84015004|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
84015005|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015006|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015007|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015008|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
84015009|NCT02837614|Hormones|hormones|mesh-ancestor
84015010|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015011|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84015012|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015013|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
84015014|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015015|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015016|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015017|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015018|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015019|NCT02837614|Analgesics|analgesics|mesh-ancestor
84015020|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
84015021|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
84015022|NCT02839486|Vancomycin|vancomycin|mesh-list
84015023|NCT02839486|Cefoxitin|cefoxitin|mesh-list
84015024|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015025|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015026|NCT00879229|Ambrisentan|ambrisentan|mesh-list
84015027|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84015028|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
84015029|NCT04249570|Povidone|povidone|mesh-list
84015030|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
84015031|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
84015032|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84015033|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015034|NCT02837770|Diclofenac|diclofenac|mesh-list
84015035|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84015036|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
84015037|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84015038|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84015039|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015040|NCT02837770|Analgesics|analgesics|mesh-ancestor
84015041|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
84015042|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015043|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015044|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015045|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015046|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84015047|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015048|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015049|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
84015050|NCT00878995|Testosterone|testosterone|mesh-list
84015051|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
84015052|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
84015053|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84015054|NCT00878995|Androgens|androgens|mesh-ancestor
84015055|NCT00878995|Hormones|hormones|mesh-ancestor
84015056|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015057|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015058|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84015059|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015060|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
84015061|NCT02837146|Methotrexate|methotrexate|mesh-list
84015062|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84015063|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
84015064|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84015065|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015066|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84015067|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
83254871|NCT01652703|Protease Inhibitors|protease inhibitors|mesh-ancestor
84015068|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015069|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015070|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
84015072|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84015073|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015074|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
84015075|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015076|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84015077|NCT00657865|Ramipril|ramipril|mesh-list
84015078|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84015079|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
84015080|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015081|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015082|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84015083|NCT00661765|Varenicline|varenicline|mesh-list
84015084|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84015085|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84015086|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
84015087|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015088|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015089|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015090|NCT00657943|Insulin|insulin|mesh-list
84015091|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84015092|NCT00657943|Metformin|metformin|mesh-list
84015093|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
84015094|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
84015095|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84015096|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
84015097|NCT00657943|Protamines|protamines|mesh-list
84015098|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84015099|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015100|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
84015101|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015102|NCT00657943|Coagulants|coagulants|mesh-ancestor
84015103|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
84015104|NCT04249804|Analgesics|analgesics|mesh-ancestor
84015105|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
84015106|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015107|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015108|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
84015109|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015110|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84015111|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
84015112|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84015113|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84015114|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015115|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84015116|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
84015117|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84015118|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
84015119|NCT02631109|Doxorubicin|doxorubicin|mesh-list
84015120|NCT02631109|Etoposide|etoposide|mesh-list
84015121|NCT02631109|Pegaspargase|pegaspargase|mesh-list
84015122|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84015123|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015124|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84015125|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84015126|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015127|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015128|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84015129|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015130|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
84015131|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
84015132|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015133|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015134|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015135|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
84015136|NCT02631109|Hormones|hormones|mesh-ancestor
84015137|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015138|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84015139|NCT02631109|Protective Agents|protective agents|mesh-ancestor
84015140|NCT02630485|Inositol|inositol|mesh-list
84015141|NCT02630485|Letrozole|letrozole|mesh-list
84015142|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015143|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84015144|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84015145|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015146|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015147|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84015148|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
84015149|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015150|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015151|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
84015153|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
84015154|NCT00894556|Sumatriptan|sumatriptan|mesh-list
84015155|NCT00894556|Rizatriptan|rizatriptan|mesh-list
84015156|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84015157|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84015158|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84015159|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
84015160|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015161|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015162|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015163|NCT01210352|Oxymorphone|oxymorphone|mesh-list
84015164|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84015165|NCT01210352|Narcotics|narcotics|mesh-ancestor
84015166|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015167|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015168|NCT01210352|Analgesics|analgesics|mesh-ancestor
84015169|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
84015170|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015171|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84015172|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
84015173|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015174|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015175|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84015176|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84015177|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015178|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015179|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015180|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
84015181|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84015182|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015183|NCT00658099|Insulin|insulin|mesh-list
84015184|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84015185|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
84015186|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
84015187|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
84015188|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
84015189|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84015190|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015191|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84015192|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
84015193|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84015194|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84015195|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015196|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015197|NCT00658177|Urological Agents|urological agents|mesh-ancestor
84015198|NCT00658255|Budesonide|budesonide|mesh-list
84015199|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
84015200|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015201|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84015202|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
84015203|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015204|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015205|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84015206|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
84015207|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
84015208|NCT00658255|Hormones|hormones|mesh-ancestor
84015209|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015210|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84015211|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84015212|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84015213|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
84015214|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015215|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015216|NCT02836288|Ketamine|ketamine|mesh-list
84015217|NCT02836288|Analgesics|analgesics|mesh-ancestor
84015218|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
84015219|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015220|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015221|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84015222|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84015223|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
84015224|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
84015225|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015226|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84015227|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84015228|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015229|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015230|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84015231|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
84015232|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84015233|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84015234|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84015235|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015236|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015237|NCT01208402|Esmolol|esmolol|mesh-list
84015238|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84015239|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84015240|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84015241|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
84015242|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015243|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015244|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015245|NCT01208324|Estrogens|estrogens|mesh-list
84015246|NCT01208324|Hormones|hormones|mesh-ancestor
84015247|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015248|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015249|NCT02838940|Cefazolin|cefazolin|mesh-list
84015250|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015251|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015252|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
84015253|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84015254|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015255|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015256|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84015257|NCT02835742|Sargramostim|sargramostim|mesh-list
84015258|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
84015259|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015260|NCT05326360|Ramosetron|ramosetron|mesh-list
84015261|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
84015262|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
84015263|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015264|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015265|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015266|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84015267|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
84015268|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015269|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015270|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
84015271|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015272|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015273|NCT01207388|Blinatumomab|blinatumomab|mesh-list
84015274|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015275|NCT02835664|Niacinamide|niacinamide|mesh-list
84015276|NCT02835664|Niacin|niacin|mesh-list
84015277|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
84015278|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
84015279|NCT02835664|Vitamins|vitamins|mesh-ancestor
84015280|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
84015281|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015282|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84015283|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
84015284|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015285|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84015286|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
84015287|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
84015288|NCT02838472|Vitamins|vitamins|mesh-ancestor
84015289|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
84015290|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015291|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
84015292|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015293|NCT02838472|Protective Agents|protective agents|mesh-ancestor
84015294|NCT00666991|Paclitaxel|paclitaxel|mesh-list
84015295|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84015296|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015297|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
84015298|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
84015299|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
84015300|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015301|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84015302|NCT00667147|Paclitaxel|paclitaxel|mesh-list
84015303|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015304|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84015305|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
84015306|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
84015307|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
84015308|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015309|NCT02835586|Paclitaxel|paclitaxel|mesh-list
84015310|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84015311|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015312|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
84015313|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
84015314|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
84015315|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015316|NCT00667303|Antibodies|antibodies|mesh-list
84015317|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
84015318|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015319|NCT02838238|Capecitabine|capecitabine|mesh-list
84015320|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84015321|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
84015322|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015323|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015324|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84015325|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015326|NCT00667771|Naltrexone|naltrexone|mesh-list
84015327|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84015328|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84015329|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015330|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
84015331|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015332|NCT01206764|Everolimus|everolimus|mesh-list
84015333|NCT01206764|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84015334|NCT01206764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84015335|NCT01206764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015336|NCT01206764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015337|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015338|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
84015339|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015340|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015341|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
84015342|NCT00667927|Busulfan|busulfan|mesh-list
84015343|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015344|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
84015345|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015346|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015347|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84015348|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
84015349|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015350|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015351|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84015352|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84015353|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
84015354|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84015355|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84015356|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015357|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015358|NCT00668005|Urological Agents|urological agents|mesh-ancestor
84015359|NCT00668239|Triamcinolone|triamcinolone|mesh-list
84015360|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015361|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
84015362|NCT00668239|Hormones|hormones|mesh-ancestor
84015363|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015364|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015365|NCT02631499|Epirubicin|epirubicin|mesh-list
84015366|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
84015367|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84015368|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015369|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83255169|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
84015370|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84015371|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015372|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015373|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
84015374|NCT00662233|Ifosfamide|ifosfamide|mesh-list
84015375|NCT00662233|Doxorubicin|doxorubicin|mesh-list
84015376|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84015377|NCT00662233|Etoposide|etoposide|mesh-list
84015378|NCT00662233|Vincristine|vincristine|mesh-list
84015379|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015380|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
84015381|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015382|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015383|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84015384|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
84015385|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015386|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015387|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84015388|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84015389|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84015390|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84015391|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015392|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84015393|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
84015394|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
84015395|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
84015396|NCT00658957|Gentamicins|gentamicins|mesh-list
84015397|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015398|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015399|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84015400|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015401|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015402|NCT00662467|Aspirin|aspirin|mesh-list
84015403|NCT00662467|Warfarin|warfarin|mesh-list
84015404|NCT00662467|Clopidogrel|clopidogrel|mesh-list
84015405|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84015406|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015407|NCT00662467|Analgesics|analgesics|mesh-ancestor
84015408|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
84015409|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015410|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015411|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015412|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015413|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84015414|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84015415|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015416|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84015417|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84015418|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015419|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
84015420|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84015421|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84015422|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84015423|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
84015424|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015425|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
84015426|NCT00668941|Vitamin D|vitamin d|mesh-list
84015427|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
84015428|NCT00668941|Alendronate|alendronate|mesh-list
84015429|NCT00668941|Teriparatide|teriparatide|mesh-list
84015430|NCT00668941|Calcium|calcium|mesh-list
84015431|NCT00668941|Vitamins|vitamins|mesh-ancestor
84015432|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
84015433|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015434|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84015435|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84015436|NCT00894322|Exenatide|exenatide|mesh-list
84015437|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84015438|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015439|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84015440|NCT00894322|Incretins|incretins|mesh-ancestor
84015441|NCT00894322|Hormones|hormones|mesh-ancestor
84015442|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015443|NCT00633412|Esomeprazole|esomeprazole|mesh-list
84015444|NCT00633412|Ranitidine|ranitidine|mesh-list
84015445|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84015446|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84015447|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015448|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84015449|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015450|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015451|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84015452|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
84015453|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
84015454|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015455|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015456|NCT04250116|Apixaban|apixaban|mesh-list
84015457|NCT04250116|Clopidogrel|clopidogrel|mesh-list
84015458|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84015459|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84015460|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84015461|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84015462|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
84015463|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015464|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015465|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015466|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84015467|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
84015468|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84015469|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
84015470|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015471|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
84015472|NCT00659113|Tegafur|tegafur|mesh-list
84015473|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015474|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84015475|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
84015476|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015477|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
84015478|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84015479|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
84015480|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015481|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015482|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84015483|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
84015484|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84015485|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84015486|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84015487|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
84015488|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015489|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015490|NCT02630095|Nadroparin|nadroparin|mesh-list
84015491|NCT02630095|Warfarin|warfarin|mesh-list
84015492|NCT02630095|Calcium|calcium|mesh-list
84015493|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84015494|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015495|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
84015496|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84015497|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84015498|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015499|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84015500|NCT00669487|Lamivudine|lamivudine|mesh-list
84015501|NCT00669487|Stavudine|stavudine|mesh-list
84015502|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84015503|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84015504|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015505|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015506|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
84015507|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015508|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84015509|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84015510|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
84015511|NCT00669565|Bavituximab|bavituximab|mesh-list
84015512|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84015513|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015514|NCT00669643|Rifampin|rifampin|mesh-list
84015515|NCT00669643|Dapsone|dapsone|mesh-list
84015516|NCT00669643|Clofazimine|clofazimine|mesh-list
84015517|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84015518|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
83255326|NCT04796623|Fulvestrant|fulvestrant|mesh-list
84015519|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015520|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015521|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
84015522|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84015523|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015524|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015525|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84015526|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84015527|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84015528|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84015529|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84015530|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84015531|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
84015532|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84015533|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84015534|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84015535|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015536|NCT00669721|Heparin|heparin|mesh-list
84015537|NCT00669721|Calcium heparin|calcium heparin|mesh-list
84015538|NCT00669721|Nadroparin|nadroparin|mesh-list
84015539|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
84015540|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84015541|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84015542|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015543|NCT00894166|Bupropion|bupropion|mesh-list
84015544|NCT00894166|Nicotine|nicotine|mesh-list
84015545|NCT00894166|Varenicline|varenicline|mesh-list
84015546|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84015547|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
84015548|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015549|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015550|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84015551|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84015552|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
84015553|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015554|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015555|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84015556|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
84015557|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84015558|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84015559|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84015560|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84015561|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
84015562|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84015563|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84015564|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015565|NCT00659503|Ciclesonide|ciclesonide|mesh-list
84015566|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
84015567|NCT00659503|Hormones|hormones|mesh-ancestor
84015568|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015569|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015570|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84015571|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
84015572|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84015573|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84015574|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015575|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
84015576|NCT00670345|Coagulants|coagulants|mesh-ancestor
84015577|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
84015578|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84015579|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015580|NCT00670423|Sirolimus|sirolimus|mesh-list
84015581|NCT00670423|Bortezomib|bortezomib|mesh-list
84015582|NCT00670423|Tacrolimus|tacrolimus|mesh-list
84015583|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015584|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
84015585|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015586|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84015587|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015588|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015589|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015590|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015591|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015592|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84015593|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
83255393|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
84015594|NCT00659659|Benralizumab|benralizumab|mesh-list
84015595|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84015596|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
84015597|NCT00670501|Vitamin D|vitamin d|mesh-list
84015598|NCT00670501|Teriparatide|teriparatide|mesh-list
84015599|NCT00670501|Calcium|calcium|mesh-list
84015600|NCT00670501|Vitamins|vitamins|mesh-ancestor
84015601|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
84015602|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015603|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84015604|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84015605|NCT00663247|Mesalamine|mesalamine|mesh-list
84015606|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84015607|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015608|NCT00663247|Analgesics|analgesics|mesh-ancestor
84015609|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
84015610|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015611|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015612|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015613|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015614|NCT01163747|Methotrexate|methotrexate|mesh-list
84015615|NCT01163747|Vaccines|vaccines|mesh-list
84015616|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84015617|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
84015618|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015619|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84015620|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
84015621|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84015622|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84015623|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
84015624|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015625|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015626|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
84015627|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015628|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84015629|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015630|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015631|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84015632|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84015633|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
84015634|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015635|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84015636|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84015637|NCT05657015|Simvastatin|simvastatin|mesh-list
84015638|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84015639|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84015640|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
84015641|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015642|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84015643|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84015644|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015645|NCT02887313|Leucovorin|leucovorin|mesh-list
84015646|NCT02887313|Fluorouracil|fluorouracil|mesh-list
84015647|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
84015648|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
84015649|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015650|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84015651|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015652|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015653|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
84015654|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015655|NCT02887313|Antidotes|antidotes|mesh-ancestor
84015656|NCT02887313|Protective Agents|protective agents|mesh-ancestor
84015657|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
84015658|NCT02887313|Vitamins|vitamins|mesh-ancestor
84015659|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
84015660|NCT01206140|Sirolimus|sirolimus|mesh-list
84015661|NCT01206140|Temsirolimus|temsirolimus|mesh-list
84015662|NCT01206140|MTOR Inhibitors|mtor inhibitors|mesh-list
84015663|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015664|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015665|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84015666|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015667|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
84015668|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015669|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
84015670|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015671|NCT01206140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84015672|NCT01206140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015673|NCT01206140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015674|NCT01162421|Adalimumab|adalimumab|mesh-list
84015675|NCT01162421|Methotrexate|methotrexate|mesh-list
84015676|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84015677|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
84015678|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84015679|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015680|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84015681|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
84015682|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015683|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015684|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
84015685|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015686|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84015687|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015688|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
84015689|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015690|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84015691|NCT01162421|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84015692|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015693|NCT02885441|Ketorolac|ketorolac|mesh-list
84015694|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84015695|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015696|NCT02885441|Analgesics|analgesics|mesh-ancestor
84015697|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
84015698|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015699|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015700|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015701|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015702|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84015703|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015704|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015705|NCT02885597|Methotrexate|methotrexate|mesh-list
84015706|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84015707|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
84015708|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84015709|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015710|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84015711|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
84015712|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015713|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015714|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
84015715|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015716|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84015717|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015718|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
84015719|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015720|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84015721|NCT01188551|Fentanyl|fentanyl|mesh-list
84015722|NCT01188551|Midazolam|midazolam|mesh-list
84015723|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
84015724|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84015725|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015726|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015727|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015728|NCT01188551|Analgesics|analgesics|mesh-ancestor
84015729|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
84015730|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015731|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84015732|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84015733|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84015734|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
84015735|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015736|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015737|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84015738|NCT01188551|Narcotics|narcotics|mesh-ancestor
84015739|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84015740|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84015741|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
84015742|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
84015743|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84015744|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84015745|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84015746|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
84015748|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
84015749|NCT01161407|Calcium|calcium|mesh-list
84015750|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84015751|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015752|NCT01161407|Antacids|antacids|mesh-ancestor
84015753|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015754|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015755|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84015756|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015757|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84015758|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015759|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015760|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
84015761|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84015762|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84015763|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84015764|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015765|NCT01159769|Analgesics|analgesics|mesh-ancestor
84015766|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
84015767|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015768|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015769|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015770|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015771|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84015772|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84015773|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84015774|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
84015775|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
84015776|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015777|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015778|NCT01185821|Siponimod|siponimod|mesh-list
84015779|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84015780|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015781|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84015782|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
84015783|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015784|NCT00893464|Ixazomib|ixazomib|mesh-list
84015785|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015786|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
84015787|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015788|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015789|NCT00891904|Cetuximab|cetuximab|mesh-list
84015790|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84015791|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015792|NCT02834260|Dexamethasone|dexamethasone|mesh-list
84015793|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015794|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
84015795|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
84015796|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015797|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015798|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015799|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
84015800|NCT02834260|Hormones|hormones|mesh-ancestor
84015801|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015802|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84015803|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015804|NCT01157351|Olanzapine|olanzapine|mesh-list
84015805|NCT01157351|Risperidone|risperidone|mesh-list
84015806|NCT01157351|Aripiprazole|aripiprazole|mesh-list
84015807|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84015808|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84015809|NCT01157351|Perphenazine|perphenazine|mesh-list
84015810|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84015811|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
84015812|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015813|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015814|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015815|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84015816|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84015817|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015818|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83255622|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84015819|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84015820|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
84015821|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
84015822|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
84015823|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015824|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015825|NCT01157351|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84015826|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84015827|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84015828|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
84015829|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
84015830|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84015831|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84015832|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84015833|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84015834|NCT02831686|Dexamethasone|dexamethasone|mesh-list
84015835|NCT02831686|Ixazomib|ixazomib|mesh-list
84015836|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015837|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
84015838|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
84015839|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015840|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015841|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015842|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
84015843|NCT02831686|Hormones|hormones|mesh-ancestor
84015844|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015845|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84015846|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015847|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
84015848|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015849|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015850|NCT00633490|Apatinib|apatinib|mesh-list
84015851|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015852|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84015853|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015854|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015855|NCT02831374|Anesthetics|anesthetics|mesh-list
84015856|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015857|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015858|NCT02831218|Aspirin|aspirin|mesh-list
84015859|NCT02831218|Clopidogrel|clopidogrel|mesh-list
84015860|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84015861|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84015862|NCT02831218|Analgesics|analgesics|mesh-ancestor
84015863|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
84015864|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015865|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015866|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015867|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84015868|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84015869|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84015870|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015871|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84015872|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84015873|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015874|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
84015875|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84015876|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84015877|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84015878|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
84015879|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015880|NCT02833480|Fluticasone|fluticasone|mesh-list
84015881|NCT02833480|Budesonide|budesonide|mesh-list
84015882|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
84015883|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84015884|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84015885|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
84015886|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015887|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015888|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84015889|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
84015890|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
84015891|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84015892|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
84015893|NCT02833480|Hormones|hormones|mesh-ancestor
84015894|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015895|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84015896|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84015897|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84015898|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
84015899|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015900|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015901|NCT04201054|Fluconazole|fluconazole|mesh-list
84015902|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
84015903|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015904|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84015905|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84015906|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015907|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015908|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84015909|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
84015910|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84015911|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015912|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84015913|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84015915|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84015916|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84015917|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84015918|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
84015919|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
84015920|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015921|NCT00891202|Eliglustat|eliglustat|mesh-list
84015922|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015923|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015924|NCT02830906|Ondansetron|ondansetron|mesh-list
84015925|NCT02830906|Ramosetron|ramosetron|mesh-list
84015926|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
84015927|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
84015928|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015929|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015930|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84015931|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
84015932|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
84015933|NCT02830906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84015934|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84015935|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
84015936|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84015937|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015938|NCT02832778|Tenofovir|tenofovir|mesh-list
84015939|NCT02832778|Lamivudine|lamivudine|mesh-list
84015940|NCT02832778|Emtricitabine|emtricitabine|mesh-list
84015941|NCT02832778|Zidovudine|zidovudine|mesh-list
84015942|NCT02832778|Efavirenz|efavirenz|mesh-list
84015943|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
84015944|NCT02832778|Isoniazid|isoniazid|mesh-list
84015945|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
84015946|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84015947|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84015948|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84015949|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84015950|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015951|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84015952|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84015953|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
84015954|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84015955|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84015956|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84015957|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84015958|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84015959|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84015960|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
84015961|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84015962|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84015963|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84015964|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84015965|NCT01185509|Trastuzumab|trastuzumab|mesh-list
83255771|NCT05613361|Analgesics|analgesics|mesh-ancestor
84015966|NCT01185509|Vinorelbine|vinorelbine|mesh-list
84015967|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84015968|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015969|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84015970|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
84015971|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
84015972|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
84015973|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015974|NCT04247230|Tetracaine|tetracaine|mesh-list
84015975|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
84015976|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
84015977|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015978|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015979|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
84015980|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84015981|NCT02832700|Caseins|caseins|mesh-list
84015982|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
84015983|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
84015984|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84015985|NCT02831842|Bevacizumab|bevacizumab|mesh-list
84015986|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84015987|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84015988|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84015989|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84015990|NCT02831842|Growth Substances|growth substances|mesh-ancestor
84015991|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015992|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
84015993|NCT02830048|Glyburide|glyburide|mesh-list
84015994|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84015995|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015996|NCT02830126|Anesthetics|anesthetics|mesh-list
84015997|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84015998|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84015999|NCT02828566|Ketamine|ketamine|mesh-list
84016000|NCT02828566|Analgesics|analgesics|mesh-ancestor
84016001|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
84016002|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016003|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016004|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84016005|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84016006|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
84016007|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
84016008|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016009|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84016010|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84016011|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016012|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016013|NCT04245046|Amlodipine|amlodipine|mesh-list
84016014|NCT04245046|Candesartan|candesartan|mesh-list
84016015|NCT04245046|Atorvastatin|atorvastatin|mesh-list
84016016|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84016017|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84016018|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
84016019|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016020|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84016021|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84016022|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016023|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84016024|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84016025|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84016026|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84016027|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016028|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
84016029|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84016030|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84016031|NCT02828176|Anesthetics|anesthetics|mesh-list
84016032|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016033|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016034|NCT00633568|Cisplatin|cisplatin|mesh-list
84016035|NCT00633568|Docetaxel|docetaxel|mesh-list
84016036|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016037|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
84016038|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
84016039|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
84016040|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016041|NCT02829424|Methotrexate|methotrexate|mesh-list
84016042|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84016043|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
84016044|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84016045|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016046|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84016047|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
84016048|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016049|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016050|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
84016051|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016052|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84016053|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84016054|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
84016055|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84016056|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84016057|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
84016058|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84016059|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84016060|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016061|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
84016062|NCT02829346|Coagulants|coagulants|mesh-ancestor
84016063|NCT05210764|Ketamine|ketamine|mesh-list
84016064|NCT05210764|Anesthetics|anesthetics|mesh-list
84016065|NCT05210764|Propofol|propofol|mesh-list
84016066|NCT05210764|Sevoflurane|sevoflurane|mesh-list
84016067|NCT05210764|Esketamine|esketamine|mesh-list
84016068|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016069|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016070|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84016071|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84016072|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
84016073|NCT05210764|Analgesics|analgesics|mesh-ancestor
84016074|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
84016075|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016076|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84016077|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84016078|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84016079|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016080|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016081|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84016082|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84016083|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016084|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016085|NCT00889720|Varenicline|varenicline|mesh-list
84016086|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84016087|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84016088|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
84016089|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016090|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016091|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016092|NCT01116648|Olaparib|olaparib|mesh-list
84016093|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84016094|NCT01116648|Cediranib|cediranib|mesh-list
84016095|NCT01116648|Maleic acid|maleic acid|mesh-list
84016096|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016097|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016098|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016099|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84016100|NCT04243954|Morphine|morphine|mesh-list
84016101|NCT04243954|Hydromorphone|hydromorphone|mesh-list
84016102|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84016103|NCT04243954|Narcotics|narcotics|mesh-ancestor
84016104|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016105|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016106|NCT04243954|Analgesics|analgesics|mesh-ancestor
84016107|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
84016108|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016109|NCT02827942|Amoxicillin|amoxicillin|mesh-list
84016110|NCT02827942|Metronidazole|metronidazole|mesh-list
84016111|NCT02827942|Clarithromycin|clarithromycin|mesh-list
84016112|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016113|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016114|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84016115|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84016116|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84016117|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016118|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016119|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84016120|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84016122|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
84016123|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
84016124|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84016125|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
84016126|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
84016127|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016128|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016129|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016130|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84016131|NCT00670813|Modafinil|modafinil|mesh-list
84016132|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84016133|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016134|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84016135|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84016136|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84016137|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016138|NCT01110330|Ketoconazole|ketoconazole|mesh-list
84016139|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
84016140|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016141|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84016142|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84016143|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016144|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016145|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84016146|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
84016147|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84016148|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016149|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84016150|NCT00663481|Leucovorin|leucovorin|mesh-list
84016151|NCT00663481|Antidotes|antidotes|mesh-ancestor
84016152|NCT00663481|Protective Agents|protective agents|mesh-ancestor
84016153|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016154|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
84016155|NCT00663481|Vitamins|vitamins|mesh-ancestor
84016156|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
84016157|NCT04308954|Flumazenil|flumazenil|mesh-list
84016158|NCT04308954|Antidotes|antidotes|mesh-ancestor
84016159|NCT04308954|Protective Agents|protective agents|mesh-ancestor
84016160|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016161|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
84016162|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
84016163|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016164|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016165|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
84016166|NCT00596947|Prednisone|prednisone|mesh-list
84016167|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
84016168|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84016169|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84016170|NCT00596947|Prednisolone|prednisolone|mesh-list
84016171|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
84016172|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84016173|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
84016174|NCT00596947|Tacrolimus|tacrolimus|mesh-list
84016175|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
84016176|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84016177|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84016178|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
84016179|NCT00596947|Hormones|hormones|mesh-ancestor
84016180|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84016181|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016182|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84016183|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016184|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84016185|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
84016186|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84016187|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016188|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255992|NCT01650519|Ibuprofen|ibuprofen|mesh-list
84016189|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84016190|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84016191|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
84016192|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016193|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016194|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
84016195|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
84016196|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016197|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84016198|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84016199|NCT00596947|Protective Agents|protective agents|mesh-ancestor
84016200|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
84016201|NCT04155697|Ethanol|ethanol|mesh-list
84016202|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84016203|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016204|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
84016205|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016206|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016207|NCT00663559|Sunitinib|sunitinib|mesh-list
84016208|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016209|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84016210|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84016211|NCT00663559|Growth Substances|growth substances|mesh-ancestor
84016212|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016213|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
84016214|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84016215|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016216|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016217|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
84016218|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016219|NCT00888940|Ecallantide|ecallantide|mesh-list
84016220|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
84016221|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84016222|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84016223|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016224|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
84016225|NCT00888940|Coagulants|coagulants|mesh-ancestor
84016226|NCT00888940|Analgesics|analgesics|mesh-ancestor
84016227|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
84016228|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016229|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016230|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84016231|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84016232|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84016233|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84016234|NCT02826070|Adefovir|adefovir|mesh-list
84016235|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84016236|NCT02826070|Telbivudine|telbivudine|mesh-list
84016237|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
84016238|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016239|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84016240|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84016241|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016242|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016243|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
84016244|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
84016245|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016246|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016247|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84016248|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
84016249|NCT00671203|Erythromycin|erythromycin|mesh-list
84016250|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
84016251|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84016252|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
84016253|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016254|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016255|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84016256|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84016257|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016258|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016259|NCT04157803|Acetic Acid|acetic acid|mesh-list
84016260|NCT04157803|Retinol acetate|retinol acetate|mesh-list
84016261|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016262|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016263|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84016264|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
84016265|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016266|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84016267|NCT04157803|Protective Agents|protective agents|mesh-ancestor
84016268|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016269|NCT04157959|Febuxostat|febuxostat|mesh-list
84016270|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
84016271|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84016272|NCT00660283|Temozolomide|temozolomide|mesh-list
84016273|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84016274|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
84016275|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016276|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016277|NCT00663949|Captopril|captopril|mesh-list
84016278|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
84016279|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84016280|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016281|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016282|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84016283|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84016284|NCT00663949|Protective Agents|protective agents|mesh-ancestor
84016285|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016286|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
84016287|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84016288|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
84016289|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84016290|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
84016291|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84016292|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84016293|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016294|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016295|NCT00888238|Incretins|incretins|mesh-ancestor
84016296|NCT00888238|Hormones|hormones|mesh-ancestor
84016297|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83536098|NCT05919173|Dexmedetomidine|dexmedetomidine|mesh-list
84016298|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84016299|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
84016300|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016301|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016302|NCT05660356|Hormones|hormones|mesh-list
84016303|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84016304|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016305|NCT02825914|Caseins|caseins|mesh-list
84016306|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
84016307|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
84016308|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016309|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
84016310|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84016311|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84016312|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016313|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
84016314|NCT00671281|Coagulants|coagulants|mesh-ancestor
84016315|NCT04155229|Acetaminophen|acetaminophen|mesh-list
84016316|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
84016317|NCT04155229|Oxycodone|oxycodone|mesh-list
84016318|NCT04155229|Hydrocodone|hydrocodone|mesh-list
84016319|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84016320|NCT04155229|Analgesics|analgesics|mesh-ancestor
84016321|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
84016322|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016323|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016324|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
84016325|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84016326|NCT04155229|Narcotics|narcotics|mesh-ancestor
84016327|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016328|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
84016329|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
84016330|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84016331|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84016332|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84016333|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
84016334|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016335|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016336|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
84016337|NCT04153201|Antimalarials|antimalarials|mesh-list
84016338|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84016339|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84016340|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016341|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016342|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016343|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84016344|NCT05660278|Caseins|caseins|mesh-list
84016345|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
84016346|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
84016347|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016348|NCT04153123|Epinephrine|epinephrine|mesh-list
84016349|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84016350|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84016351|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
84016352|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016353|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016354|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016355|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84016356|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84016357|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
84016358|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016359|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84016360|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
84016361|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
84016362|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
84016363|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84016364|NCT00671593|Phenol|phenol|mesh-list
84016365|NCT00671593|Glycerol|glycerol|mesh-list
84016366|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84016367|NCT00671593|Protective Agents|protective agents|mesh-ancestor
84016368|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016369|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84016370|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016371|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
84016372|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
84016373|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84016374|NCT01104870|Treprostinil|treprostinil|mesh-list
84016375|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84016376|NCT02632279|Tryptophan|tryptophan|mesh-list
84016377|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84016378|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016379|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016380|NCT00664417|Vaccines|vaccines|mesh-list
84016381|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
84016382|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016383|NCT04031755|Minocycline|minocycline|mesh-list
84016384|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016385|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016386|NCT01104792|Cariprazine|cariprazine|mesh-list
84016387|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84016388|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84016389|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016390|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016391|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016392|NCT01205126|Oxycodone|oxycodone|mesh-list
84016393|NCT01205126|Hydromorphone|hydromorphone|mesh-list
84016394|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84016395|NCT01205126|Narcotics|narcotics|mesh-ancestor
84016396|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016397|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016398|NCT01205126|Analgesics|analgesics|mesh-ancestor
84016399|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
84016400|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016401|NCT02629627|Metformin|metformin|mesh-list
84016402|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016403|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016404|NCT00946647|Azacitidine|azacitidine|mesh-list
84016405|NCT00946647|Panobinostat|panobinostat|mesh-list
84016406|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84016407|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
84016408|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016409|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016410|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016411|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84016412|NCT05117736|Valsartan|valsartan|mesh-list
84016413|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84016414|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83256236|NCT01666951|Tacrolimus|tacrolimus|mesh-list
84016415|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84016416|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84016417|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016419|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
84016420|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016421|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84016422|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84016423|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84016424|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84016425|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016426|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016427|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016428|NCT00660751|Analgesics|analgesics|mesh-ancestor
84016429|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
84016430|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016431|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016432|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016433|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
84016434|NCT00664963|Sirolimus|sirolimus|mesh-list
84016435|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016436|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016437|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84016438|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016439|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
84016440|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84016441|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
84016442|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016443|NCT00672295|Paclitaxel|paclitaxel|mesh-list
84016444|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84016445|NCT00672295|Carboplatin|carboplatin|mesh-list
84016446|NCT00672295|Dasatinib|dasatinib|mesh-list
84016447|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84016448|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016449|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
84016450|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
84016451|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
84016452|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016453|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84016454|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016455|NCT00665041|Quinagolide|quinagolide|mesh-list
84016456|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
84016457|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
84016458|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016459|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016460|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016461|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
84016462|NCT04152655|Idebenone|idebenone|mesh-list
84016463|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
84016464|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016465|NCT04152655|Vitamins|vitamins|mesh-ancestor
84016466|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
84016467|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016468|NCT04152655|Protective Agents|protective agents|mesh-ancestor
84016469|NCT00665119|Remifentanil|remifentanil|mesh-list
84016470|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84016471|NCT00665119|Narcotics|narcotics|mesh-ancestor
84016472|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016473|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016474|NCT00665119|Analgesics|analgesics|mesh-ancestor
84016475|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
84016476|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016477|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84016478|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84016479|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84016480|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84016481|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016482|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016483|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016484|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016485|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83256290|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256291|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83256292|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
84016486|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
84016487|NCT00672763|Vitamin D|vitamin d|mesh-list
84016488|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
84016489|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
84016490|NCT00672763|Vitamins|vitamins|mesh-list
84016491|NCT00672763|Calcium|calcium|mesh-list
84016492|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
84016493|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016494|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84016495|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84016496|NCT04154449|Insulin|insulin|mesh-list
84016497|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016498|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016499|NCT00661063|Clonidine|clonidine|mesh-list
84016500|NCT00661063|Ketamine|ketamine|mesh-list
84016501|NCT00661063|Analgesics|analgesics|mesh-ancestor
84016502|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
84016503|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016504|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016505|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84016506|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84016507|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
84016508|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
84016509|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016510|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84016511|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84016512|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016513|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016514|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84016515|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
84016516|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
84016517|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84016518|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84016519|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84016520|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
84016521|NCT00672919|Pioglitazone|pioglitazone|mesh-list
84016522|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016523|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016524|NCT01109316|Insulin|insulin|mesh-list
84016525|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84016526|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
84016527|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
84016528|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016529|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016530|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84016531|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84016532|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
84016533|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84016534|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
84016535|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84016536|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016537|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84016538|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84016539|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016540|NCT00675961|Naltrexone|naltrexone|mesh-list
84016541|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84016542|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84016543|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016544|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
84016545|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016546|NCT00887068|Azacitidine|azacitidine|mesh-list
84016547|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84016548|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
84016549|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016550|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016551|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016552|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84016553|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
84016554|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016555|NCT00886834|Misoprostol|misoprostol|mesh-list
84016556|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84016557|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
84016558|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84016559|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016560|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84016561|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256369|NCT05461261|Prednisolone|prednisolone|mesh-list
84016563|NCT00880009|Letrozole|letrozole|mesh-list
84016564|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016565|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84016566|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84016567|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016568|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016569|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84016570|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
84016571|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84016572|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016573|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84016574|NCT00676039|Citalopram|citalopram|mesh-list
84016575|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84016576|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84016577|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84016578|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016579|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016580|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016581|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84016582|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016583|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016584|NCT00676039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84016585|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
84016586|NCT01104636|Varenicline|varenicline|mesh-list
84016587|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84016588|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84016589|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
84016590|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016591|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016592|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016593|NCT04931602|Vitamin D|vitamin d|mesh-list
84016594|NCT04931602|Vitamins|vitamins|mesh-ancestor
84016595|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
84016596|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016597|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84016598|NCT04157257|Tenofovir|tenofovir|mesh-list
84016599|NCT04157257|Entecavir|entecavir|mesh-list
84016600|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
84016601|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016602|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84016603|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84016604|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016605|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016606|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84016607|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84016608|NCT04152889|Docetaxel|docetaxel|mesh-list
84016609|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016610|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
84016611|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
84016612|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
84016613|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016614|NCT00602511|Thalidomide|thalidomide|mesh-list
84016615|NCT00602511|Bortezomib|bortezomib|mesh-list
84016616|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016617|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84016618|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
84016619|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016620|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
84016621|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016622|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016623|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84016624|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84016625|NCT00602511|Growth Substances|growth substances|mesh-ancestor
84016626|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
84016627|NCT02826616|Trimetazidine|trimetazidine|mesh-list
84016628|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
84016629|NCT00676117|Loxoprofen|loxoprofen|mesh-list
84016630|NCT00676117|Esomeprazole|esomeprazole|mesh-list
84016631|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84016632|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84016633|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84016634|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016635|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016636|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84016637|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84016638|NCT00676117|Analgesics|analgesics|mesh-ancestor
84016639|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
84016640|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016641|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016642|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84016643|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84016644|NCT01104558|Bisoprolol|bisoprolol|mesh-list
84016645|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84016646|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
84016647|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
84016648|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016649|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016650|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84016651|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84016652|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84016653|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
84016654|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016655|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016656|NCT00602589|Levofloxacin|levofloxacin|mesh-list
84016657|NCT00602589|Ofloxacin|ofloxacin|mesh-list
84016658|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84016659|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016660|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84016661|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84016662|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84016663|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016664|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016665|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016666|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84016667|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84016668|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
84016669|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
84016670|NCT02856087|Remifentanil|remifentanil|mesh-list
84016671|NCT02856087|Naloxone|naloxone|mesh-list
84016672|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84016673|NCT02856087|Narcotics|narcotics|mesh-ancestor
84016674|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016675|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016676|NCT02856087|Analgesics|analgesics|mesh-ancestor
84016677|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
84016678|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016679|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84016680|NCT00676429|Ziprasidone|ziprasidone|mesh-list
84016681|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84016682|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
84016683|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016684|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016685|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016686|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84016687|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84016688|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016689|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016690|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84016691|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
84016692|NCT02629315|Formaldehyde|formaldehyde|mesh-list
84016693|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
84016694|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016695|NCT01204658|Vaccines|vaccines|mesh-list
84016696|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84016697|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
84016698|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016699|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84016700|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016701|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016702|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84016703|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84016704|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016705|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016706|NCT01104246|Testosterone|testosterone|mesh-list
84016707|NCT01104246|Androgens|androgens|mesh-ancestor
84016708|NCT01104246|Hormones|hormones|mesh-ancestor
84016709|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256519|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84016710|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016711|NCT00676741|Insulin|insulin|mesh-list
84016712|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84016713|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
84016714|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
84016715|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84016716|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
84016717|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
84016718|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84016719|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016720|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016721|NCT01103778|Bortezomib|bortezomib|mesh-list
84016722|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016723|NCT00673621|Albuterol|albuterol|mesh-list
84016724|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
84016725|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016726|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84016727|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
84016728|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016729|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84016730|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
84016731|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
84016732|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84016733|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84016734|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84016735|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84016736|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
84016737|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016738|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016739|NCT00673621|Miotics|miotics|mesh-ancestor
84016740|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84016741|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
84016742|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84016743|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84016744|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
84016745|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
84016746|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84016747|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
84016748|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84016749|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
84016750|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016751|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016752|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
84016753|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84016754|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84016755|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84016756|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84016757|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016758|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016759|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016760|NCT00945945|Analgesics|analgesics|mesh-ancestor
84016761|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
84016762|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016763|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016764|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016765|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
84016766|NCT01112982|Colchicine|colchicine|mesh-list
84016767|NCT01112982|Febuxostat|febuxostat|mesh-list
84016768|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
84016769|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84016770|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
84016771|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
84016772|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
84016773|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016774|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016775|NCT01203878|Imiquimod|imiquimod|mesh-list
84016776|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84016777|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84016778|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
84016779|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016780|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016781|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
84016782|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84016783|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
84016784|NCT00676819|Insulin|insulin|mesh-list
84016785|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84016786|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
84016787|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016788|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016789|NCT00625794|Nicotine|nicotine|mesh-list
84016790|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84016791|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
84016792|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016793|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016794|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84016795|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84016796|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
84016797|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016798|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016799|NCT01203098|Enoxaparin|enoxaparin|mesh-list
84016800|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
84016801|NCT01203098|Edoxaban|edoxaban|mesh-list
84016802|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
84016803|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84016804|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84016805|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016806|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84016807|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
84016808|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84016809|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
84016810|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016811|NCT05032794|Bisacodyl|bisacodyl|mesh-list
84016812|NCT05032794|Cathartics|cathartics|mesh-ancestor
84016813|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84016814|NCT05032794|Laxatives|laxatives|mesh-ancestor
84016815|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84016816|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016817|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84016818|NCT01108458|Pertuzumab|pertuzumab|mesh-list
84016819|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016820|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84016821|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016822|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016823|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84016824|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84016825|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016826|NCT00680485|Ketoconazole|ketoconazole|mesh-list
84016827|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
84016828|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84016829|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84016830|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84016831|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016832|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016833|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84016834|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
84016835|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84016836|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016837|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84016838|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
84016839|NCT00680563|Hematinics|hematinics|mesh-ancestor
84016840|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
84016841|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016842|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
84016843|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016844|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016845|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
84016846|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84016847|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016848|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016849|NCT00680641|Simvastatin|simvastatin|mesh-list
84016850|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84016851|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84016852|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
84016853|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016854|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84016855|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84016856|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016857|NCT01201850|Bevacizumab|bevacizumab|mesh-list
84016858|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84016859|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256668|NCT05579509|Fentanyl|fentanyl|mesh-list
84016860|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84016861|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84016862|NCT01201850|Growth Substances|growth substances|mesh-ancestor
84016863|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016864|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
84016865|NCT05660122|Fexuprazan|fexuprazan|mesh-list
84016866|NCT05660122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84016867|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
84016868|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84016869|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84016870|NCT02825056|Morphine|morphine|mesh-list
84016871|NCT02825056|Bupivacaine|bupivacaine|mesh-list
84016872|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
84016873|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
84016874|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016875|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016876|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
84016877|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016878|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84016879|NCT02825056|Narcotics|narcotics|mesh-ancestor
84016880|NCT02825056|Analgesics|analgesics|mesh-ancestor
84016881|NCT02826772|Androgens|androgens|mesh-list
84016882|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
84016883|NCT02826772|Hormones|hormones|mesh-ancestor
84016884|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84016885|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016886|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
84016887|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
84016888|NCT00674011|Bevacizumab|bevacizumab|mesh-list
84016889|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84016890|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016891|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84016892|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83536099|NCT05919173|Bupivacaine|bupivacaine|mesh-list
84016893|NCT00674011|Growth Substances|growth substances|mesh-ancestor
84016894|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016895|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
84016896|NCT00674089|Vitamin A|vitamin a|mesh-list
84016897|NCT00674089|Vitamins|vitamins|mesh-ancestor
84016898|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
84016899|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016900|NCT01200992|Mitomycins|mitomycins|mesh-list
84016901|NCT01200992|Mitomycin|mitomycin|mesh-list
84016902|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84016903|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016904|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
84016905|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016906|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84016907|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016908|NCT02824666|Fallypride|fallypride|mesh-list
84016909|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84016910|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84016911|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
84016912|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016913|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016914|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016915|NCT00674167|Docetaxel|docetaxel|mesh-list
84016916|NCT00674167|Capecitabine|capecitabine|mesh-list
84016917|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016918|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
84016919|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
84016920|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
84016921|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016922|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84016923|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
84016924|NCT00912145|Alprazolam|alprazolam|mesh-list
84016925|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84016926|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84016927|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016928|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84016929|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84016930|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84016931|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
84016932|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
84016933|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016934|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016935|NCT02824510|Insulin|insulin|mesh-list
84016936|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84016937|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
84016938|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016939|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016940|NCT00674245|Pantoprazole|pantoprazole|mesh-list
84016941|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84016942|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84016943|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84016944|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016945|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016946|NCT00878215|Liver Extracts|liver extracts|mesh-list
84016947|NCT00878215|Hematinics|hematinics|mesh-ancestor
84016948|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
84016949|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016950|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
84016951|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84016952|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84016953|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016954|NCT02628847|Urological Agents|urological agents|mesh-ancestor
84016955|NCT00677443|Capecitabine|capecitabine|mesh-list
84016956|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
84016957|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84016958|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
84016959|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016960|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016961|NCT00674557|Exemestane|exemestane|mesh-list
84016962|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
84016963|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84016964|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84016965|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84016966|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016967|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016968|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84016969|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
84016970|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84016971|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016972|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
84016973|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
84016974|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84016975|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84016976|NCT00674557|Growth Substances|growth substances|mesh-ancestor
84016977|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
84016978|NCT00677521|Acarbose|acarbose|mesh-list
84016979|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84016980|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84016981|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016982|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84016983|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016984|NCT00674713|Ondansetron|ondansetron|mesh-list
84016985|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84016986|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
84016987|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
84016988|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84016989|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84016990|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84016991|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
84016992|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
84016993|NCT00674713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84016994|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84016995|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
84016996|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84016997|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84016998|NCT04241380|Heparin|heparin|mesh-list
84016999|NCT04241380|Anticoagulants|anticoagulants|mesh-list
84017000|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84017001|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84017002|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84017003|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017004|NCT02824354|Nalmefene|nalmefene|mesh-list
84017005|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84017006|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017007|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
84017008|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256817|NCT05867251|Carboplatin|carboplatin|mesh-list
84017009|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
84017010|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84017011|NCT02823496|Protective Agents|protective agents|mesh-ancestor
84017012|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017013|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
84017015|NCT00677755|Mifepristone|mifepristone|mesh-list
84017016|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84017017|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
84017018|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84017019|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017020|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84017021|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017022|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
84017023|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84017024|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84017025|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84017026|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84017027|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
84017028|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84017029|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84017030|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
84017031|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017032|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
84017033|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84017034|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84017035|NCT00674947|huB3F6-SPDB-DM4 immunoconjugate|hub3f6-spdb-dm4 immunoconjugate|mesh-list
84017036|NCT00674947|Immunoconjugates|immunoconjugates|mesh-ancestor
84017037|NCT00674947|Immunologic Factors|immunologic factors|mesh-ancestor
84017038|NCT00674947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017039|NCT02824042|Itraconazole|itraconazole|mesh-list
84017040|NCT02824042|Maytansine|maytansine|mesh-list
84017041|NCT02824042|Anetumab ravtansine|anetumab ravtansine|mesh-list
84017042|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
84017043|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017044|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84017045|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84017046|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017047|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017048|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84017049|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
84017050|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017051|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017052|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84017053|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84017054|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017055|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
84017056|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017057|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
84017058|NCT02824042|Immunoconjugates|immunoconjugates|mesh-ancestor
84017059|NCT02824042|Immunologic Factors|immunologic factors|mesh-ancestor
84017060|NCT00675181|Melatonin|melatonin|mesh-list
84017061|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
84017062|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017063|NCT00675181|Protective Agents|protective agents|mesh-ancestor
84017064|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017065|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017066|NCT04241458|Midazolam|midazolam|mesh-list
84017067|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84017068|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84017069|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017070|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017071|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84017072|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84017073|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84017074|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84017075|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
84017076|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
84017077|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
84017078|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
84017079|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017080|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017081|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
84017082|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
84017083|NCT00681343|Daclizumab|daclizumab|mesh-list
84017084|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
84017085|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017086|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017087|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017088|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017089|NCT02823808|Glimepiride|glimepiride|mesh-list
84017090|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84017091|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84017092|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017093|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017094|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
84017095|NCT04151719|Bromides|bromides|mesh-list
84017096|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
84017097|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
84017098|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84017099|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017100|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
84017101|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017102|NCT02822482|Cetuximab|cetuximab|mesh-list
84017103|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017104|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017105|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
84017106|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
84017107|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84017108|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84017109|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017110|NCT04240834|Aspirin|aspirin|mesh-list
84017111|NCT04240834|Ticagrelor|ticagrelor|mesh-list
84017112|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84017113|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017114|NCT04240834|Analgesics|analgesics|mesh-ancestor
84017115|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
84017116|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017117|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017118|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017119|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017120|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84017121|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84017122|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017123|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84017124|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84017125|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017126|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
84017127|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84017128|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84017129|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84017130|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
84017131|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017132|NCT01200758|Prednisone|prednisone|mesh-list
84017133|NCT01200758|Prednisolone|prednisolone|mesh-list
84017134|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
84017135|NCT01200758|Rituximab|rituximab|mesh-list
84017136|NCT01200758|Doxorubicin|doxorubicin|mesh-list
84017137|NCT01200758|Vincristine|vincristine|mesh-list
84017138|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017139|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
84017140|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017141|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017142|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84017143|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
84017144|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017145|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017146|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84017147|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017148|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84017149|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84017150|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84017151|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017152|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017153|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
84017154|NCT01200758|Hormones|hormones|mesh-ancestor
84017155|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017156|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84017157|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84017158|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
84017159|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017160|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
84017162|NCT02823106|Choline|choline|mesh-list
84017163|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
84017164|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
84017165|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84017166|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
84017167|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017168|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017169|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84017170|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
84017171|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84017172|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84017173|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84017174|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84017175|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017176|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
84017177|NCT02821858|Odalasvir|odalasvir|mesh-list
84017178|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
84017179|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017180|NCT00876343|Aripiprazole|aripiprazole|mesh-list
84017181|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
84017182|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84017183|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84017184|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84017185|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017186|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017187|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
84017188|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
84017189|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017190|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017191|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84017192|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84017193|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
84017194|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84017195|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84017196|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84017197|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84017198|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
84017199|NCT02627989|Diflucortolone|diflucortolone|mesh-list
84017200|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017201|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
84017202|NCT02627989|Hormones|hormones|mesh-ancestor
84017203|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017204|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017205|NCT00675649|Golimumab|golimumab|mesh-list
84017206|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84017207|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017208|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017209|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
84017210|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017211|NCT01107912|Clopidogrel|clopidogrel|mesh-list
84017212|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84017213|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84017214|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84017215|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84017216|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84017217|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
84017218|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017219|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017220|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017221|NCT00678145|Epinephrine|epinephrine|mesh-list
84017222|NCT00678145|Morphine|morphine|mesh-list
84017223|NCT00678145|Naloxone|naloxone|mesh-list
84017224|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017225|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84017226|NCT00678145|Narcotics|narcotics|mesh-ancestor
84017227|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017228|NCT00678145|Analgesics|analgesics|mesh-ancestor
84017229|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
84017230|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017231|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84017232|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84017233|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83257039|NCT05781217|Leuprolide|leuprolide|mesh-list
84017234|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017235|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017236|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84017237|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84017238|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
84017239|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84017240|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
84017241|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
84017242|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
84017243|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84017244|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84017245|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
84017246|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
84017247|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
84017248|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017249|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017250|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
84017251|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017252|NCT02690506|Pregabalin|pregabalin|mesh-list
84017253|NCT02690506|Analgesics|analgesics|mesh-ancestor
84017254|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
84017255|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017256|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017257|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
84017258|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84017259|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84017260|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017261|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84017262|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84017263|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84017264|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017265|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84017266|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
84017267|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84017268|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017269|NCT04239586|Glyburide|glyburide|mesh-list
84017270|NCT04239586|Glipizide|glipizide|mesh-list
84017271|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84017272|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017273|NCT02628613|Paclitaxel|paclitaxel|mesh-list
84017274|NCT02628613|Vinorelbine|vinorelbine|mesh-list
84017275|NCT02628613|Epirubicin|epirubicin|mesh-list
84017276|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84017277|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017278|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
84017279|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017280|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
84017281|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017282|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84017283|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84017284|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84017285|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017286|NCT01100034|Etanercept|etanercept|mesh-list
84017287|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84017288|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017289|NCT01100034|Analgesics|analgesics|mesh-ancestor
84017290|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
84017291|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017292|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017293|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017294|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017295|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017296|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017297|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
84017298|NCT04148833|Paclitaxel|paclitaxel|mesh-list
84017299|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84017300|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017301|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
84017302|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017303|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
84017304|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017305|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84017306|NCT02821468|Acetaminophen|acetaminophen|mesh-list
84017307|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83257120|NCT05677295|Imipramine|imipramine|mesh-list
84017308|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017309|NCT02821468|Analgesics|analgesics|mesh-ancestor
84017310|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
84017311|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017312|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017313|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
84017314|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84017315|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017316|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017317|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84017318|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017319|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017320|NCT04964622|Ibuprofen|ibuprofen|mesh-list
84017321|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84017322|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017323|NCT04964622|Analgesics|analgesics|mesh-ancestor
84017324|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
84017325|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017326|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017327|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017328|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017329|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84017330|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017331|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017332|NCT04769050|Docetaxel|docetaxel|mesh-list
84017333|NCT04769050|Capecitabine|capecitabine|mesh-list
84017334|NCT04769050|Trastuzumab|trastuzumab|mesh-list
84017335|NCT04769050|Pertuzumab|pertuzumab|mesh-list
84017336|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017337|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
84017338|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017339|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
84017340|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017341|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84017342|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
84017343|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017344|NCT02821390|Nepafenac|nepafenac|mesh-list
84017345|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84017346|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
84017347|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84017348|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84017349|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017350|NCT02821390|Analgesics|analgesics|mesh-ancestor
84017351|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
84017352|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017353|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017354|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017355|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017356|NCT02821312|DA-8010|da-8010|mesh-list
84017357|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84017358|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84017359|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
84017360|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017361|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017362|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017363|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
84017364|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84017365|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
84017366|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017367|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017368|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84017369|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
84017370|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84017371|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
84017372|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017373|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017374|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84017375|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
84017376|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
84017377|NCT02821156|Protective Agents|protective agents|mesh-ancestor
84017378|NCT02820922|Anesthetics|anesthetics|mesh-list
84017379|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017380|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257187|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257189|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017381|NCT00633958|Alovudine|alovudine|mesh-list
84017382|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
84017383|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017384|NCT02820688|Bupivacaine|bupivacaine|mesh-list
84017385|NCT02820688|Prilocaine|prilocaine|mesh-list
84017386|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
84017387|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
84017388|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017389|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017390|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
84017391|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017392|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84017393|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84017394|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84017395|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84017396|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84017397|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84017398|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84017399|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84017400|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
84017401|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017402|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017403|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017404|NCT02818816|Laxatives|laxatives|mesh-ancestor
84017405|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017406|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
84017407|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
84017408|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84017409|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017410|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017411|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017412|NCT02820610|Analgesics|analgesics|mesh-ancestor
84017413|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
84017414|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017415|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84017416|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84017417|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84017418|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
84017419|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017420|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017421|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
84017422|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84017423|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
84017424|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84017425|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84017426|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84017427|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
84017428|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84017429|NCT04745728|Prednisone|prednisone|mesh-list
84017430|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
84017431|NCT04745728|Rituximab|rituximab|mesh-list
84017432|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017433|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
84017434|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017435|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017436|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84017437|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
84017438|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017439|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017440|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84017441|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017442|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017443|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
84017444|NCT04745728|Hormones|hormones|mesh-ancestor
84017445|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017446|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84017447|NCT02818660|Cosyntropin|cosyntropin|mesh-list
84017448|NCT02818660|Hormones|hormones|mesh-ancestor
84017449|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017450|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017451|NCT05659186|Tislelizumab|tislelizumab|mesh-list
84017452|NCT05659186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017453|NCT05659186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017454|NCT01107444|Docetaxel|docetaxel|mesh-list
83257262|NCT05465226|Analgesics|analgesics|mesh-ancestor
84017455|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017456|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
84017457|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017458|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
84017459|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017460|NCT04238806|Desflurane|desflurane|mesh-list
84017461|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84017462|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
84017463|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
84017464|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017465|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017466|NCT00876187|Naproxen|naproxen|mesh-list
84017467|NCT00876187|Tanezumab|tanezumab|mesh-list
84017468|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84017469|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017470|NCT00876187|Analgesics|analgesics|mesh-ancestor
84017471|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
84017472|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017473|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017474|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017475|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017476|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
84017477|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84017478|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017479|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017480|NCT04238884|Voriconazole|voriconazole|mesh-list
84017481|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
84017482|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017483|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84017484|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84017485|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017486|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017487|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84017488|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
84017489|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017490|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017491|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84017492|NCT01102374|Vitamin D|vitamin d|mesh-list
84017493|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
84017494|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
84017495|NCT01102374|Vitamins|vitamins|mesh-list
84017496|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
84017497|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017498|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84017499|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84017500|NCT05658640|Cytarabine|cytarabine|mesh-list
84017501|NCT05658640|Dexamethasone|dexamethasone|mesh-list
84017502|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
84017503|NCT05658640|Trametinib|trametinib|mesh-list
84017504|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017505|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
84017506|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017507|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017508|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84017509|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
84017510|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017511|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017512|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84017513|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017514|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
84017515|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
84017516|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017517|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017518|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
84017519|NCT05658640|Hormones|hormones|mesh-ancestor
84017520|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017521|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84017522|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84017523|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
84017524|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
84017525|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017526|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84017527|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017528|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
83257340|NCT05227742|Psilocybin|psilocybin|mesh-list
84017530|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84017531|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
84017532|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017533|NCT02818270|Expectorants|expectorants|mesh-ancestor
84017534|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
84017535|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84017536|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
84017537|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017538|NCT02818270|Protective Agents|protective agents|mesh-ancestor
84017539|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017540|NCT02818270|Antidotes|antidotes|mesh-ancestor
84017541|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84017542|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
84017543|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017544|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84017545|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
84017546|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84017547|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84017548|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84017549|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84017550|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
84017551|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017552|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
84017553|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017554|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017555|NCT02879760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84017556|NCT02879760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017557|NCT02818348|Darunavir|darunavir|mesh-list
84017558|NCT02818348|Cobicistat|cobicistat|mesh-list
84017559|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
84017560|NCT02818348|Etravirine|etravirine|mesh-list
84017561|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84017562|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83536101|NCT05919173|Anesthetics|anesthetics|mesh-ancestor
84017563|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
84017564|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017565|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017566|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84017567|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84017568|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
84017569|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017570|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84017571|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84017572|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84017573|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84017574|NCT00634192|Tobramycin|tobramycin|mesh-list
84017575|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017576|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017577|NCT00684463|Palonosetron|palonosetron|mesh-list
84017578|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
84017579|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
84017580|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017581|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017582|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017583|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84017584|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84017585|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
84017586|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017587|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017588|NCT00678457|Ondansetron|ondansetron|mesh-list
84017589|NCT00678457|Olanzapine|olanzapine|mesh-list
84017590|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
84017591|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
84017592|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017593|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017594|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017595|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
84017596|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
84017597|NCT00678457|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84017598|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84017599|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
84017600|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017601|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017602|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84017603|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84017604|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017605|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84017606|NCT00678457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84017607|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84017608|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84017609|NCT00678613|Norfloxacin|norfloxacin|mesh-list
84017610|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017611|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017612|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84017613|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84017614|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017615|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017616|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017617|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84017618|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84017619|NCT00678769|Sirolimus|sirolimus|mesh-list
84017620|NCT00678769|Temsirolimus|temsirolimus|mesh-list
84017621|NCT00678769|MTOR Inhibitors|mtor inhibitors|mesh-list
84017622|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84017623|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017624|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017625|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84017626|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017627|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
84017628|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017629|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
84017630|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017631|NCT00678769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84017632|NCT00678769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017633|NCT00678769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017634|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84017635|NCT04146883|Cephalexin|cephalexin|mesh-list
84017636|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017637|NCT02817256|Vitamins|vitamins|mesh-list
84017638|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
84017639|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017640|NCT02817100|Itraconazole|itraconazole|mesh-list
84017641|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
84017642|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017643|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84017644|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84017645|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017646|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017647|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84017648|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
84017649|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017650|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017651|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84017652|NCT00684853|Bevacizumab|bevacizumab|mesh-list
84017653|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017654|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017655|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84017656|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84017657|NCT00684853|Growth Substances|growth substances|mesh-ancestor
84017658|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017659|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
84017660|NCT02816476|Daratumumab|daratumumab|mesh-list
84017661|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017662|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
84017663|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
84017664|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017665|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017666|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84017667|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84017668|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84017669|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
83257487|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257488|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257489|NCT04729387|Paclitaxel|paclitaxel|mesh-list
83257490|NCT04729387|Doxorubicin|doxorubicin|mesh-list
83257491|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83257492|NCT04729387|Olaparib|olaparib|mesh-list
83257493|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84017670|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017671|NCT00685009|Hormones|hormones|mesh-list
84017672|NCT00685009|Progesterone|progesterone|mesh-list
84017673|NCT00685009|Estrogens|estrogens|mesh-list
84017674|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017675|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017676|NCT00685009|Progestins|progestins|mesh-ancestor
84017677|NCT00679237|Metformin|metformin|mesh-list
84017678|NCT00679237|Glimepiride|glimepiride|mesh-list
84017679|NCT00679237|Ezetimibe|ezetimibe|mesh-list
84017680|NCT00679237|Diuretics|diuretics|mesh-list
84017681|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84017682|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017683|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84017684|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84017685|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
84017686|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017687|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84017688|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84017689|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017690|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
84017691|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
84017692|NCT00681733|Pioglitazone|pioglitazone|mesh-list
84017693|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
84017694|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84017695|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017696|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84017697|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017698|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017699|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84017700|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84017701|NCT00681733|Protective Agents|protective agents|mesh-ancestor
84017702|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
84017703|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84017704|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
84017705|NCT00679315|Alfuzosin|alfuzosin|mesh-list
84017706|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84017707|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84017708|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84017709|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
84017710|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017711|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017712|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017713|NCT00679315|Urological Agents|urological agents|mesh-ancestor
84017714|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84017715|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
84017716|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017717|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84017718|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
84017719|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017720|NCT00633802|Risperidone|risperidone|mesh-list
84017721|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84017722|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
84017723|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017724|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017725|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017726|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84017727|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84017728|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017729|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84017730|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84017731|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
84017732|NCT04460248|Rituximab|rituximab|mesh-list
84017733|NCT04460248|Lenalidomide|lenalidomide|mesh-list
84017734|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
84017735|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017736|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017737|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
84017738|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017739|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017740|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83257564|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83257565|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257566|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257567|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017741|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84017742|NCT04460248|Growth Substances|growth substances|mesh-ancestor
84017743|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
84017744|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84017745|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017746|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017747|NCT05658874|Methenamine|methenamine|mesh-list
84017748|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
84017749|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
84017751|NCT05658874|Amitriptyline|amitriptyline|mesh-list
84017752|NCT05658874|Mirabegron|mirabegron|mesh-list
84017753|NCT05658874|Oxybutynin|oxybutynin|mesh-list
84017754|NCT05658874|Estrogens|estrogens|mesh-list
84017755|NCT05658874|Analgesics|analgesics|mesh-ancestor
84017756|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
84017757|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017758|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017759|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
84017760|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84017761|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84017762|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017763|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84017764|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84017765|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84017766|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017767|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017768|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
84017769|NCT05658874|Hormones|hormones|mesh-ancestor
84017770|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017771|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84017772|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84017773|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84017774|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
84017775|NCT05658874|Urological Agents|urological agents|mesh-ancestor
84017776|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84017777|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
84017778|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84017779|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84017780|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84017781|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84017782|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
84017783|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
84017784|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84017785|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84017786|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
84017787|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84017788|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017789|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017790|NCT01106898|Paclitaxel|paclitaxel|mesh-list
84017791|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
84017792|NCT01106898|Trastuzumab|trastuzumab|mesh-list
84017793|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84017794|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017795|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
84017796|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
84017797|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
84017798|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017799|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017800|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
84017801|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017802|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017803|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84017804|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
84017805|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84017806|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84017807|NCT04425538|Infliximab|infliximab|mesh-list
84017808|NCT04425538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84017809|NCT04425538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017810|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
84017811|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84017812|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017813|NCT02627521|Ticagrelor|ticagrelor|mesh-list
84017814|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84017815|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84017816|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84017817|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84017818|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
84017819|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017820|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017821|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017822|NCT00681967|Gefitinib|gefitinib|mesh-list
84017823|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017824|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84017825|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017826|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017827|NCT04239118|Hemostatics|hemostatics|mesh-list
84017828|NCT04239118|Coagulants|coagulants|mesh-ancestor
84017829|NCT04139941|Antibodies|antibodies|mesh-list
84017830|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
84017831|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
84017832|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017833|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
84017834|NCT00875017|Sevelamer|sevelamer|mesh-list
84017835|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
84017836|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
84017837|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017838|NCT00679705|Atosiban|atosiban|mesh-list
84017839|NCT00679705|Ritodrine|ritodrine|mesh-list
84017840|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
84017841|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017842|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017843|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
84017844|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84017845|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
84017846|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
84017847|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017848|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84017849|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84017850|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84017851|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
84017852|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017853|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017854|NCT00685633|Bicalutamide|bicalutamide|mesh-list
84017855|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
84017856|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
84017857|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017858|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017859|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017860|NCT04371952|Doxycycline|doxycycline|mesh-list
84017861|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017862|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017863|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
84017864|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84017865|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84017866|NCT04329832|Azithromycin|azithromycin|mesh-list
84017867|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
84017868|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017869|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017870|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
84017871|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84017872|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84017873|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017874|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017875|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84017876|NCT04237246|Tacrolimus|tacrolimus|mesh-list
84017877|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84017878|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
84017879|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017880|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84017881|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017882|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017883|NCT00680095|Tavaborole|tavaborole|mesh-list
84017884|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
84017885|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017886|NCT02814058|Zolpidem|zolpidem|mesh-list
84017887|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84017888|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84017889|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017890|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257721|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
84017891|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84017892|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
84017893|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
84017894|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017895|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017896|NCT00680173|Interferons|interferons|mesh-list
84017897|NCT00680173|Ribavirin|ribavirin|mesh-list
84017898|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
84017899|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
84017900|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84017901|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017902|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
84017903|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017904|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
84017905|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017906|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
84017907|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017908|NCT00682279|Topotecan|topotecan|mesh-list
84017909|NCT00682279|Lapatinib|lapatinib|mesh-list
84017910|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84017911|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84017912|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017913|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017914|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017915|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84017916|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
84017917|NCT02811484|Exenatide|exenatide|mesh-list
84017918|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84017919|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017920|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84017921|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017922|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84017923|NCT02811484|Incretins|incretins|mesh-ancestor
84017924|NCT02811484|Hormones|hormones|mesh-ancestor
84017925|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017926|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
84017927|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017928|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017929|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84017930|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84017931|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017932|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017933|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017934|NCT00922597|Factor VIII|factor viii|mesh-list
84017935|NCT00922597|Coagulants|coagulants|mesh-ancestor
84017936|NCT00874939|Donepezil|donepezil|mesh-list
84017937|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84017938|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017939|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017940|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
84017941|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017942|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017943|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
84017944|NCT00634348|Aripiprazole|aripiprazole|mesh-list
84017945|NCT00634348|Ziprasidone|ziprasidone|mesh-list
84017946|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
84017947|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84017948|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84017949|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84017950|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84017951|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017952|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
84017953|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
84017954|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017955|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017956|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84017957|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84017958|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
84017959|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84017960|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84017961|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84017962|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84017963|NCT00680329|Timolol|timolol|mesh-list
84017964|NCT00680329|Travoprost|travoprost|mesh-list
84017965|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84017966|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84017967|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84017968|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84017969|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
84017970|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84017971|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017972|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017973|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84017974|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84017975|NCT02811016|Budesonide|budesonide|mesh-list
84017976|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84017977|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84017978|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
84017979|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84017980|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017981|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84017982|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
84017983|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
84017984|NCT02811016|Hormones|hormones|mesh-ancestor
84017985|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84017986|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
84017987|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84017988|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84017989|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84017990|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84017991|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84017992|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84017993|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84017994|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84017995|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84017996|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
84017997|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84017998|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84017999|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84018000|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84018001|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84018002|NCT04237480|Vitamin D|vitamin d|mesh-list
84018003|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
84018004|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
84018005|NCT04237480|Vitamins|vitamins|mesh-list
84018006|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
84018007|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018008|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84018009|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84018010|NCT02810782|Morphine|morphine|mesh-list
84018011|NCT02810782|Phenobarbital|phenobarbital|mesh-list
84018012|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
84018013|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84018014|NCT02810782|Narcotics|narcotics|mesh-ancestor
84018015|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018016|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018017|NCT02810782|Analgesics|analgesics|mesh-ancestor
84018018|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
84018019|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018020|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
84018021|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84018022|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84018023|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84018024|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018025|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018026|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
84018027|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
84018028|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84018029|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84018030|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84018031|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
84018032|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
84018033|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84018034|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84018035|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84018036|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84018037|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84018038|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
84018039|NCT02810548|Mitogens|mitogens|mesh-list
84018040|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257865|NCT03516617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257866|NCT03516617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018041|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018042|NCT01155869|Naltrexone|naltrexone|mesh-list
84018043|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84018044|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84018045|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018046|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
84018047|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018048|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
84018049|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84018050|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018051|NCT02625415|Vitamins|vitamins|mesh-list
84018052|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
84018053|NCT02625415|Pyridoxal|pyridoxal|mesh-list
84018054|NCT02625415|Pyridoxine|pyridoxine|mesh-list
84018055|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
84018056|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
84018057|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018058|NCT02809768|Itraconazole|itraconazole|mesh-list
84018059|NCT02809768|Fluconazole|fluconazole|mesh-list
84018060|NCT02809768|Rifampin|rifampin|mesh-list
84018061|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
84018062|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018063|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84018064|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84018065|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018066|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018067|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84018068|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
84018069|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018070|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018071|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84018072|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84018073|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
84018074|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84018075|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
84018076|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84018077|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84018078|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84018079|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84018080|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84018081|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84018082|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84018083|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84018084|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84018085|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
84018086|NCT04237090|Promethazine|promethazine|mesh-list
84018087|NCT04237090|Cetirizine|cetirizine|mesh-list
84018088|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84018089|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84018090|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018091|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018092|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
84018093|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
84018094|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
84018095|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018096|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
84018097|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
84018098|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84018099|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84018100|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
84018101|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
84018102|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018103|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018104|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84018105|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
84018106|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
84018107|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84018108|NCT00690781|Caseins|caseins|mesh-list
84018109|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
84018110|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
84018111|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018112|NCT00682825|Anesthetics|anesthetics|mesh-list
84018113|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
84018114|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018115|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018116|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
84018117|NCT04187248|Asparaginase|asparaginase|mesh-list
84018118|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018119|NCT00912379|Chrysarobin|chrysarobin|mesh-list
84018120|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84018121|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84018122|NCT00912379|Analgesics|analgesics|mesh-ancestor
84018123|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
84018124|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018125|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018126|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018127|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84018128|NCT02809378|Remifentanil|remifentanil|mesh-list
84018129|NCT02809378|Thiopental|thiopental|mesh-list
84018130|NCT02809378|Palonosetron|palonosetron|mesh-list
84018131|NCT02809378|Propofol|propofol|mesh-list
84018132|NCT02809378|Sevoflurane|sevoflurane|mesh-list
84018133|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84018134|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018135|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018136|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84018137|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
84018138|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
84018139|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84018140|NCT02809378|Narcotics|narcotics|mesh-ancestor
84018141|NCT02809378|Analgesics|analgesics|mesh-ancestor
84018142|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
84018143|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018144|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84018145|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84018146|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
84018147|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
84018148|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84018149|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84018150|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84018151|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
84018152|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018153|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018154|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
84018155|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
84018156|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
84018157|NCT00683059|Paclitaxel|paclitaxel|mesh-list
84018158|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84018159|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018160|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
84018161|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
84018162|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
84018163|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018164|NCT01185353|Methotrexate|methotrexate|mesh-list
84018165|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84018166|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
84018167|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84018168|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018169|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84018170|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
84018171|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018172|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018173|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
84018174|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018175|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84018176|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84018177|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
84018178|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84018179|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84018180|NCT00683137|Valdecoxib|valdecoxib|mesh-list
84018181|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84018182|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84018183|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018184|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018185|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84018186|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84018187|NCT00683137|Analgesics|analgesics|mesh-ancestor
84018188|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
84018189|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258021|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
84018190|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018191|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018192|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84018193|NCT02809456|Nicorandil|nicorandil|mesh-list
84018194|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84018195|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84018196|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
84018197|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
84018198|NCT02809456|Vitamins|vitamins|mesh-ancestor
84018199|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
84018200|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018201|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
84018202|NCT05576740|Hormones|hormones|mesh-list
84018203|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018204|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018205|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84018206|NCT04139629|Antibodies|antibodies|mesh-list
84018207|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
84018208|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018209|NCT02813044|Anesthetics|anesthetics|mesh-list
84018210|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018211|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018212|NCT04236778|Vancomycin|vancomycin|mesh-list
84018213|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84018214|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018215|NCT02812888|Propranolol|propranolol|mesh-list
84018216|NCT02812888|Methimazole|methimazole|mesh-list
84018217|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
84018218|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84018219|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84018220|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018221|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018222|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018223|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018224|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84018225|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84018226|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
84018227|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
84018228|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
84018229|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018230|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
84018231|NCT00687661|Diphosphonates|diphosphonates|mesh-list
84018232|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84018233|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018234|NCT00687817|Paclitaxel|paclitaxel|mesh-list
84018235|NCT00687817|Carboplatin|carboplatin|mesh-list
84018236|NCT00687817|Bavituximab|bavituximab|mesh-list
84018237|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84018238|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018239|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
84018240|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
84018241|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
84018242|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018243|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018244|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
84018245|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84018246|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018247|NCT02625805|Methylphenidate|methylphenidate|mesh-list
84018248|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84018249|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018250|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84018251|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84018252|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84018253|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018254|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
84018255|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018256|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
84018257|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84018258|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018259|NCT02880462|Sulforaphane|sulforaphane|mesh-list
84018260|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84018261|NCT02880462|Protective Agents|protective agents|mesh-ancestor
84018262|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018263|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018264|NCT00688363|Chrysarobin|chrysarobin|mesh-list
84018265|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84018266|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84018267|NCT00688363|Analgesics|analgesics|mesh-ancestor
84018268|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
84018269|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018270|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018271|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018272|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84018273|NCT02812654|Doxorubicin|doxorubicin|mesh-list
84018274|NCT02812654|Ifosfamide|ifosfamide|mesh-list
84018275|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84018276|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018277|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84018278|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84018279|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018280|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018281|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84018282|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
84018283|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
84018284|NCT02809066|Calcium|calcium|mesh-list
84018285|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84018286|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018287|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84018288|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
84018289|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018290|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018291|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018292|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018293|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
84018294|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018295|NCT02808676|Vitamin D|vitamin d|mesh-list
84018296|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
84018297|NCT02808676|Vitamins|vitamins|mesh-ancestor
84018298|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
84018299|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018300|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84018301|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84018302|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84018303|NCT00690937|Sevelamer|sevelamer|mesh-list
84018304|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
84018305|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
84018306|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018307|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84018308|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84018309|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
84018310|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84018311|NCT00689143|Sargramostim|sargramostim|mesh-list
84018312|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
84018313|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018314|NCT00912457|Donepezil|donepezil|mesh-list
84018315|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84018316|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018317|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018318|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
84018319|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018320|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018321|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
84018322|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
84018323|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84018324|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018325|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84018326|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018327|NCT02625103|Clozapine|clozapine|mesh-list
84018328|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84018329|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
84018330|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018331|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018332|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018333|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84018334|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84018335|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018336|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84018337|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
84018338|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
84018339|NCT01155479|Rasagiline|rasagiline|mesh-list
84018340|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84018341|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018342|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018343|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84018344|NCT01155479|Protective Agents|protective agents|mesh-ancestor
84018345|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018346|NCT02807272|Tipifarnib|tipifarnib|mesh-list
84018347|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018348|NCT02807194|Anesthetics|anesthetics|mesh-list
84018349|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018350|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018351|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84018352|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
84018353|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84018354|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84018355|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84018356|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018357|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018358|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
84018359|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84018360|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
84018361|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018362|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
84018363|NCT02625727|Protective Agents|protective agents|mesh-ancestor
84018364|NCT02807116|Rifampin|rifampin|mesh-list
84018365|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84018366|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
84018367|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84018368|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018369|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
84018370|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84018371|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018372|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018373|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84018374|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84018375|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84018376|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84018377|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84018378|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84018379|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84018380|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
84018381|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018382|NCT01155167|Lidocaine|lidocaine|mesh-list
84018383|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
84018384|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
84018385|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
84018386|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018387|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018388|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
84018389|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018390|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84018391|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84018392|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84018393|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84018394|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018395|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
84018396|NCT05238155|Antimetabolites|antimetabolites|mesh-list
84018397|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018398|NCT01106586|Ritonavir|ritonavir|mesh-list
84018399|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84018400|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84018401|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84018402|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
84018403|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018404|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018405|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84018406|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84018407|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
84018408|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018409|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84018410|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84018411|NCT00683995|Fentanyl|fentanyl|mesh-list
84018412|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84018413|NCT00683995|Narcotics|narcotics|mesh-ancestor
84018414|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018415|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018416|NCT00683995|Analgesics|analgesics|mesh-ancestor
84018417|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
84018418|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018419|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84018420|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84018421|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
84018422|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
84018423|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
84018424|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84018425|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018426|NCT02884817|Listerine|listerine|mesh-list
84018427|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84018428|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018429|NCT02806804|Vaccines|vaccines|mesh-list
84018430|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
84018431|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018432|NCT02879292|Anesthetics|anesthetics|mesh-list
84018433|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018434|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018435|NCT02806648|Palbociclib|palbociclib|mesh-list
84018436|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018437|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018438|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018439|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018440|NCT00689845|Cytarabine|cytarabine|mesh-list
84018441|NCT00689845|Prednisone|prednisone|mesh-list
84018442|NCT00689845|Prednisolone|prednisolone|mesh-list
84018443|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
84018444|NCT00689845|Ifosfamide|ifosfamide|mesh-list
84018445|NCT00689845|Rituximab|rituximab|mesh-list
84018446|NCT00689845|Doxorubicin|doxorubicin|mesh-list
84018447|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84018448|NCT00689845|Methotrexate|methotrexate|mesh-list
84018449|NCT00689845|Etoposide|etoposide|mesh-list
84018450|NCT00689845|Vincristine|vincristine|mesh-list
84018451|NCT00689845|Bleomycin|bleomycin|mesh-list
84018452|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
84018453|NCT00689845|Vindesine|vindesine|mesh-list
84018454|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84018455|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
84018456|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018457|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84018458|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84018459|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
84018460|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018461|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018462|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84018463|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018464|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84018465|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84018466|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84018467|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018468|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018469|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
84018470|NCT00689845|Hormones|hormones|mesh-ancestor
84018471|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018472|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84018473|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84018474|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
84018475|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84018476|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84018477|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
84018478|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
84018479|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84018480|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84018481|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84018482|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
84018483|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018484|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
84018485|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
84018486|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
84018487|NCT00624767|Insulin|insulin|mesh-list
84018488|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84018489|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
84018491|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018492|NCT02806492|Phenylephrine|phenylephrine|mesh-list
84018493|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
84018494|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84018495|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
84018496|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
84018497|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018498|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018499|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
84018500|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84018501|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
84018502|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
84018503|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84018504|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84018505|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84018506|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018507|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018508|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018509|NCT02806492|Protective Agents|protective agents|mesh-ancestor
84018510|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84018511|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
84018512|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84018513|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
84018514|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018515|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018516|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84018517|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
84018518|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84018519|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84018520|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84018521|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018522|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018523|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018524|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84018525|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84018526|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84018527|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84018528|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84018529|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018530|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018531|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018532|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018533|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84018534|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84018535|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
84018536|NCT02804776|Gefitinib|gefitinib|mesh-list
84018537|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018538|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018539|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018540|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018541|NCT01154153|Loratadine|loratadine|mesh-list
84018542|NCT01154153|Triamcinolone|triamcinolone|mesh-list
84018543|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84018544|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84018545|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84018546|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018547|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
84018548|NCT01154153|Hormones|hormones|mesh-ancestor
84018549|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018550|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018551|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84018552|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
84018553|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018554|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018555|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
84018556|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
84018557|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84018558|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84018559|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84018560|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
84018561|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
83258392|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
84018562|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018564|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018565|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018566|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
84018567|NCT00874237|Loxapine|loxapine|mesh-list
84018568|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84018569|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018570|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84018571|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84018572|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018573|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018574|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018575|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018576|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84018577|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84018578|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018579|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84018580|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84018581|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
84018582|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018583|NCT02805946|Posaconazole|posaconazole|mesh-list
84018584|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
84018585|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018586|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84018587|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84018588|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84018589|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84018590|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84018591|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018592|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018593|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84018594|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
84018595|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018596|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018597|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
84018598|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
84018599|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018600|NCT02805868|Siltuximab|siltuximab|mesh-list
84018601|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84018602|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018603|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
84018604|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018605|NCT00684385|Gefitinib|gefitinib|mesh-list
84018606|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018607|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018608|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018609|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018610|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
84018611|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84018612|NCT02690038|Antibodies|antibodies|mesh-list
84018613|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
84018614|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84018615|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
84018616|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018617|NCT00691795|Clonidine|clonidine|mesh-list
84018618|NCT00691795|Fentanyl|fentanyl|mesh-list
84018619|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84018620|NCT00691795|Narcotics|narcotics|mesh-ancestor
84018621|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018622|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018623|NCT00691795|Analgesics|analgesics|mesh-ancestor
84018624|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
84018625|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018626|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84018627|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84018628|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
84018629|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
84018630|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84018631|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
84018632|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
84018633|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84018634|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84018635|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84018636|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018637|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018638|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018639|NCT02805556|Fostemsavir|fostemsavir|mesh-list
84018640|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84018641|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84018642|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
84018643|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018644|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84018645|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84018646|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018647|NCT04032964|Doxorubicin|doxorubicin|mesh-list
84018648|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84018649|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018650|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84018651|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84018652|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018653|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018654|NCT00694291|Sorafenib|sorafenib|mesh-list
84018655|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018656|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018657|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018658|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018659|NCT01153763|Dabrafenib|dabrafenib|mesh-list
84018660|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018661|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018662|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018663|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018664|NCT00691873|Omalizumab|omalizumab|mesh-list
84018665|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84018666|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84018667|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
84018668|NCT05538052|Lidocaine|lidocaine|mesh-list
84018669|NCT05538052|Tramadol|tramadol|mesh-list
84018670|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
84018671|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
84018672|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018673|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018674|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
84018675|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018676|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84018677|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84018678|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84018679|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84018680|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018681|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84018682|NCT05538052|Narcotics|narcotics|mesh-ancestor
84018683|NCT05538052|Analgesics|analgesics|mesh-ancestor
84018684|NCT05298475|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
84018685|NCT05298475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84018686|NCT05298475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84018687|NCT05298475|Antimetabolites|antimetabolites|mesh-ancestor
84018688|NCT05298475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018689|NCT05298475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84018690|NCT05298475|Protease Inhibitors|protease inhibitors|mesh-ancestor
84018691|NCT05298475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018692|NCT05298475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84018693|NCT00691951|Budesonide|budesonide|mesh-list
84018694|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
84018695|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018696|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84018697|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
84018698|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018699|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018700|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84018701|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
84018702|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
84018703|NCT00691951|Hormones|hormones|mesh-ancestor
84018704|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018705|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84018706|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84018707|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84018708|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018709|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018710|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258541|NCT02340819|Protective Agents|protective agents|mesh-ancestor
84018711|NCT04316351|Pemetrexed|pemetrexed|mesh-list
84018712|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018713|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018714|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018715|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84018716|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84018717|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
84018718|NCT02625337|Trametinib|trametinib|mesh-list
84018719|NCT02625337|Dabrafenib|dabrafenib|mesh-list
84018720|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018721|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018722|NCT02625337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84018723|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018724|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018725|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018726|NCT04236310|Trastuzumab|trastuzumab|mesh-list
84018727|NCT04236310|Anastrozole|anastrozole|mesh-list
84018728|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018729|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018730|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84018731|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84018732|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84018733|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018734|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018735|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84018736|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
84018737|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018738|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018739|NCT02621515|Nivolumab|nivolumab|mesh-list
84018740|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018741|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018742|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84018743|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018744|NCT02803918|Metformin|metformin|mesh-list
84018745|NCT02803918|Lixisenatide|lixisenatide|mesh-list
84018746|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84018747|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018748|NCT02805010|Abatacept|abatacept|mesh-list
84018749|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84018750|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018751|NCT02805010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018752|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018753|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84018754|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
84018755|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018756|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84018757|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
84018758|NCT02800408|Provitamins|provitamins|mesh-ancestor
84018759|NCT02800408|Vitamins|vitamins|mesh-ancestor
84018760|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
84018761|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018762|NCT00692263|Tramadol|tramadol|mesh-list
84018763|NCT00692263|Escitalopram|escitalopram|mesh-list
84018764|NCT00692263|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84018765|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84018766|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84018767|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018768|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018769|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
84018770|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018771|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018772|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84018773|NCT00692263|Narcotics|narcotics|mesh-ancestor
84018774|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018775|NCT00692263|Analgesics|analgesics|mesh-ancestor
84018776|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
84018777|NCT02800486|Cetuximab|cetuximab|mesh-list
84018778|NCT02800486|Mannitol|mannitol|mesh-list
84018779|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018780|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018781|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84018782|NCT02800486|Diuretics|diuretics|mesh-ancestor
84018783|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
84018784|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018785|NCT00694759|Metformin|metformin|mesh-list
84018786|NCT00694759|Pioglitazone|pioglitazone|mesh-list
84018787|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84018788|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018789|NCT00694837|Nelfinavir|nelfinavir|mesh-list
84018790|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84018791|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84018792|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
84018793|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018794|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018795|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84018796|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84018797|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
84018798|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018799|NCT02800252|Aspirin|aspirin|mesh-list
84018800|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84018801|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84018802|NCT02800252|Analgesics|analgesics|mesh-ancestor
84018803|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
84018804|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018805|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018806|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84018807|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84018808|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84018809|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84018810|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018811|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84018812|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84018813|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018814|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
84018815|NCT02621359|Doxycycline|doxycycline|mesh-list
84018816|NCT02621359|Levofloxacin|levofloxacin|mesh-list
84018817|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
84018818|NCT02621359|Omeprazole|omeprazole|mesh-list
84018819|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84018820|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84018821|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84018822|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018823|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018824|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84018825|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018826|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
84018827|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84018828|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84018829|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84018830|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84018831|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84018832|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018833|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84018834|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84018835|NCT01152437|Cetuximab|cetuximab|mesh-list
84018836|NCT01152437|Afatinib|afatinib|mesh-list
84018837|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018838|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018839|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84018840|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018841|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018842|NCT02800174|Clopidogrel|clopidogrel|mesh-list
84018843|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84018844|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018845|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018846|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84018847|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84018848|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84018849|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
84018850|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018851|NCT02800330|Esomeprazole|esomeprazole|mesh-list
84018852|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84018853|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84018854|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84018855|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018856|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018857|NCT02799862|Paclitaxel|paclitaxel|mesh-list
84018858|NCT02799862|Carboplatin|carboplatin|mesh-list
84018859|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84018860|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018861|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
84018862|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
84018863|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
84018864|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018865|NCT01151579|Albuterol|albuterol|mesh-list
84018866|NCT01151579|Ipratropium|ipratropium|mesh-list
84018867|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84018868|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
84018869|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018870|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018871|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84018872|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
84018873|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
84018874|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84018875|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84018876|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84018877|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84018878|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018879|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018880|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018881|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84018882|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
84018883|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
84018884|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84018885|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
84018886|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018887|NCT01097616|Suvorexant|suvorexant|mesh-list
84018888|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84018889|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84018890|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018891|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478020|NCT01393717|Immunotoxins|immunotoxins|mesh-ancestor
84018892|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84018893|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018894|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018895|NCT00695071|Itraconazole|itraconazole|mesh-list
84018896|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
84018897|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018898|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84018899|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84018900|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018901|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018902|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84018903|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
84018904|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018905|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018906|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84018907|NCT04939428|Molnupiravir|molnupiravir|mesh-list
84018908|NCT04939428|Antiviral Agents|antiviral agents|mesh-ancestor
84018909|NCT04939428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018910|NCT02803216|Amoxicillin|amoxicillin|mesh-list
84018911|NCT02803216|Clarithromycin|clarithromycin|mesh-list
84018912|NCT02803216|Omeprazole|omeprazole|mesh-list
84018913|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84018914|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84018915|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84018916|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84018917|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84018918|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018919|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018920|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84018921|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84018922|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84018923|NCT02799316|Antibodies|antibodies|mesh-list
84018924|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
84018925|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018926|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
84018927|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84018928|NCT02799238|Temozolomide|temozolomide|mesh-list
84018929|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84018930|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
84018931|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018932|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018933|NCT02620813|Tretinoin|tretinoin|mesh-list
83258766|NCT05514925|Bevacizumab|bevacizumab|mesh-list
84018934|NCT02620813|Isotretinoin|isotretinoin|mesh-list
84018935|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
84018936|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018937|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
84018938|NCT00692731|Caffeine|caffeine|mesh-list
84018939|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84018940|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018941|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84018942|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018943|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018944|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84018945|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84018946|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
84018947|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018948|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
84018949|NCT02624401|Ketamine|ketamine|mesh-list
84018950|NCT02624401|Propofol|propofol|mesh-list
84018951|NCT02624401|Sevoflurane|sevoflurane|mesh-list
84018952|NCT02624401|Esketamine|esketamine|mesh-list
84018953|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84018954|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84018955|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018956|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84018957|NCT02624401|Analgesics|analgesics|mesh-ancestor
84018958|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
84018959|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84018960|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84018961|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84018962|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84018963|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
84018964|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84018965|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018966|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84018967|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
84018968|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
84018969|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84018970|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84018971|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84018972|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84018973|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84018974|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
84018975|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84018976|NCT02802748|Letrozole|letrozole|mesh-list
84018977|NCT02802748|Vinorelbine|vinorelbine|mesh-list
84018978|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018979|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84018980|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84018981|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84018982|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018983|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84018984|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
84018985|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84018986|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84018987|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84018988|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
84018989|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
84018990|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
84018991|NCT05502250|Gemcitabine|gemcitabine|mesh-list
84018992|NCT05502250|Tislelizumab|tislelizumab|mesh-list
84018993|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84018994|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84018995|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
84018996|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84018997|NCT05502250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84018998|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
84018999|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84019000|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84019001|NCT02798068|Prednisolone|prednisolone|mesh-list
84019002|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
84019003|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84019004|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
84019005|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84019006|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
84019007|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
84019008|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019009|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019010|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019011|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
84019012|NCT02798068|Hormones|hormones|mesh-ancestor
84019013|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019014|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84019015|NCT02798068|Protective Agents|protective agents|mesh-ancestor
84019016|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84019017|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019018|NCT00593827|Epothilones|epothilones|mesh-list
84019019|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019020|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019021|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019022|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019023|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019024|NCT04135885|Folic Acid|folic acid|mesh-list
84019025|NCT04135885|Hematinics|hematinics|mesh-ancestor
84019026|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
84019027|NCT04135885|Vitamins|vitamins|mesh-ancestor
84019028|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
84019029|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019030|NCT00693043|Lidocaine|lidocaine|mesh-list
84019031|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019032|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
84019033|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019034|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019035|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
84019036|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019037|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84019038|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84019039|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84019040|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019041|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019042|NCT00695929|Simendan|simendan|mesh-list
84019043|NCT00695929|Milrinone|milrinone|mesh-list
84019044|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84019045|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
84019046|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84019047|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84019048|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019049|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019050|NCT00695929|Protective Agents|protective agents|mesh-ancestor
84019051|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019052|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84019053|NCT04235296|Mitogens|mitogens|mesh-list
84019054|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019055|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019056|NCT02620501|Lidocaine|lidocaine|mesh-list
84019057|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019058|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
84019059|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019060|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019061|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
84019062|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019063|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84019064|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84019065|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84019066|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019067|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019068|NCT00693121|Amantadine|amantadine|mesh-list
84019069|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84019070|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84019071|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
84019072|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019073|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
84019074|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019075|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019076|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019077|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84019078|NCT00693121|Analgesics|analgesics|mesh-ancestor
84019079|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
83258910|NCT05506501|Anesthetics|anesthetics|mesh-list
84019080|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019081|NCT02620423|Leucovorin|leucovorin|mesh-list
84019082|NCT02620423|Gemcitabine|gemcitabine|mesh-list
84019083|NCT02620423|Fluorouracil|fluorouracil|mesh-list
84019084|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
84019085|NCT02620423|Irinotecan|irinotecan|mesh-list
84019086|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84019087|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
84019088|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019089|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019090|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84019091|NCT02620423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84019092|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019093|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
84019094|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019095|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84019096|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019097|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019098|NCT02620423|Antidotes|antidotes|mesh-ancestor
84019099|NCT02620423|Protective Agents|protective agents|mesh-ancestor
84019100|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
84019101|NCT02620423|Vitamins|vitamins|mesh-ancestor
84019102|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
84019103|NCT00696007|Gemcitabine|gemcitabine|mesh-list
84019104|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019105|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84019106|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
84019107|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019108|NCT02624089|Ropivacaine|ropivacaine|mesh-list
84019109|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019110|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
84019111|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019112|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478021|NCT01460875|Interferons|interferons|mesh-list
84019113|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
84019114|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019115|NCT02796196|Coal Tar|coal tar|mesh-list
84019116|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
84019117|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
84019118|NCT00693199|Amlodipine|amlodipine|mesh-list
84019119|NCT00693199|Prazosin|prazosin|mesh-list
84019120|NCT00693199|Terazosin|terazosin|mesh-list
84019121|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84019122|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84019123|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019124|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019125|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84019126|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019127|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
84019128|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84019129|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84019130|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84019131|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
84019132|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019133|NCT00693199|Urological Agents|urological agents|mesh-ancestor
84019134|NCT02795884|Cisplatin|cisplatin|mesh-list
84019135|NCT02795884|Pemetrexed|pemetrexed|mesh-list
84019136|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84019137|NCT02795884|Vinorelbine|vinorelbine|mesh-list
84019138|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019139|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019140|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019141|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84019142|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84019143|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019144|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84019145|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019146|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019147|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019148|NCT02795572|Vitamin D|vitamin d|mesh-list
84019149|NCT02795572|Vitamins|vitamins|mesh-list
84019150|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
84019151|NCT02795572|Hydroxocobalamin|hydroxocobalamin|mesh-list
84019152|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
84019153|NCT02795572|Pyridoxal|pyridoxal|mesh-list
84019154|NCT02795572|Pyridoxine|pyridoxine|mesh-list
84019155|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
84019156|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
84019157|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019158|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84019159|NCT02795572|Hematinics|hematinics|mesh-ancestor
84019160|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
84019161|NCT02801188|Bupivacaine|bupivacaine|mesh-list
84019162|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019163|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
84019164|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019165|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019166|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
84019167|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019168|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84019169|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84019170|NCT02801188|Analgesics|analgesics|mesh-ancestor
84019171|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84019172|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84019173|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84019174|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
84019175|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019176|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019177|NCT02801032|Tadalafil|tadalafil|mesh-list
84019178|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
84019179|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84019180|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84019181|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019182|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019183|NCT02801032|Urological Agents|urological agents|mesh-ancestor
84019184|NCT05442190|Hypericin|hypericin|mesh-list
84019185|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
84019186|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84019187|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019188|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
84019189|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019190|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019191|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019192|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019193|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
84019194|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019195|NCT02689960|Prednisone|prednisone|mesh-list
84019196|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84019197|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
84019198|NCT02689960|Hormones|hormones|mesh-ancestor
84019199|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019200|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019201|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84019202|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019203|NCT01150097|Everolimus|everolimus|mesh-list
84019204|NCT01150097|Tacrolimus|tacrolimus|mesh-list
84019205|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019206|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
84019207|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019208|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84019209|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019210|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019211|NCT01150097|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84019212|NCT01150097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019213|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019214|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84019215|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84019216|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
84019217|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019218|NCT01149863|Plerixafor|plerixafor|mesh-list
84019219|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84019220|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84019221|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
84019222|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019223|NCT02794792|Metformin|metformin|mesh-list
84019224|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
84019225|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84019226|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019227|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84019228|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019229|NCT01149473|Losartan|losartan|mesh-list
84019230|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84019231|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84019232|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84019233|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84019234|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84019235|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019237|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
84019238|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019239|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84019240|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019241|NCT00872989|Docetaxel|docetaxel|mesh-list
84019242|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019243|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019244|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019245|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019246|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019247|NCT02794714|Rocuronium|rocuronium|mesh-list
84019248|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84019249|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84019250|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84019251|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019252|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019253|NCT01148771|Ertapenem|ertapenem|mesh-list
84019254|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019255|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019256|NCT01148693|Gentamicins|gentamicins|mesh-list
84019257|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019258|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019259|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84019260|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019261|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019262|NCT00693355|Butyric Acid|butyric acid|mesh-list
84019263|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
84019264|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
84019265|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019266|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019267|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019268|NCT00693433|Sirolimus|sirolimus|mesh-list
84019269|NCT00693433|Dexamethasone|dexamethasone|mesh-list
84019270|NCT00693433|Temsirolimus|temsirolimus|mesh-list
84019271|NCT00693433|MTOR Inhibitors|mtor inhibitors|mesh-list
84019272|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84019273|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
84019274|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
84019275|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019276|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019277|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019278|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
84019279|NCT00693433|Hormones|hormones|mesh-ancestor
84019280|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019281|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84019282|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019283|NCT00693433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019284|NCT00693433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019285|NCT00693433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019286|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019287|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
84019288|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019289|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019290|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84019291|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
84019292|NCT05414422|Ketamine|ketamine|mesh-list
84019293|NCT05414422|Analgesics|analgesics|mesh-ancestor
84019294|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
84019295|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019296|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019297|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84019298|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84019299|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
84019300|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
84019301|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019302|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84019303|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84019304|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019305|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019306|NCT00872599|Fenofibrate|fenofibrate|mesh-list
84019307|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84019308|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
84019309|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019310|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84019311|NCT02623621|Bevacizumab|bevacizumab|mesh-list
84019312|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84019313|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019314|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84019315|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84019316|NCT02623621|Growth Substances|growth substances|mesh-ancestor
84019317|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019318|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
84019319|NCT00693589|Folic Acid|folic acid|mesh-list
84019320|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
84019321|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
84019322|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84019323|NCT00693589|Vitamins|vitamins|mesh-ancestor
84019324|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
84019325|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019326|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84019327|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84019328|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
84019329|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019330|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84019331|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84019332|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019333|NCT00693589|Hematinics|hematinics|mesh-ancestor
84019334|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
84019335|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
84019336|NCT01148537|Buprenorphine|buprenorphine|mesh-list
84019337|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84019338|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019339|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019340|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84019341|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019342|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019343|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019344|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019345|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84019346|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
84019347|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84019348|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019349|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84019350|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84019351|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84019352|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84019353|NCT01148537|Narcotics|narcotics|mesh-ancestor
84019354|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019355|NCT01148537|Analgesics|analgesics|mesh-ancestor
84019356|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
84019357|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019358|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84019359|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
84019360|NCT02793544|Sirolimus|sirolimus|mesh-list
84019361|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
84019362|NCT02793544|Busulfan|busulfan|mesh-list
84019363|NCT02793544|Fludarabine|fludarabine|mesh-list
84019364|NCT02793544|Mesna|mesna|mesh-list
84019365|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019366|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
84019367|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019368|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84019369|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84019370|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
84019371|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019372|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019373|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84019374|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84019375|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84019376|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
84019377|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019378|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019379|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019380|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
84019381|NCT02793544|Protective Agents|protective agents|mesh-ancestor
84019382|NCT02793388|Primaquine|primaquine|mesh-list
84019383|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
84019384|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84019385|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84019386|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019387|NCT02689882|Niacinamide|niacinamide|mesh-list
84019388|NCT02689882|Niacin|niacin|mesh-list
84019389|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
84019390|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
84019391|NCT02689882|Vitamins|vitamins|mesh-ancestor
84019392|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
84019393|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019394|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84019395|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
84019396|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019397|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84019398|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
84019399|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84019400|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84019401|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019402|NCT04234594|Panitumumab|panitumumab|mesh-list
84019403|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84019404|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019405|NCT02789488|Fenugreek seed meal|fenugreek seed meal|mesh-list
84019406|NCT02789488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84019407|NCT02789488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019408|NCT04233346|Ponatinib|ponatinib|mesh-list
84019409|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019410|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019411|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019412|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019413|NCT01148459|Vaccines|vaccines|mesh-list
84019414|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
83152497|NCT03536611|Warfarin|warfarin|mesh-list
84019415|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019416|NCT03913234|Trastuzumab|trastuzumab|mesh-list
84019417|NCT03913234|Letrozole|letrozole|mesh-list
84019418|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84019419|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019420|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84019421|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84019422|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019423|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019424|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84019425|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
84019426|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019427|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019428|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84019429|NCT03854500|Tenecteplase|tenecteplase|mesh-list
84019430|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84019431|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84019432|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019433|NCT02789332|Paclitaxel|paclitaxel|mesh-list
84019434|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84019435|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
84019436|NCT02789332|Carboplatin|carboplatin|mesh-list
84019437|NCT02789332|Epirubicin|epirubicin|mesh-list
84019438|NCT02789332|Olaparib|olaparib|mesh-list
84019439|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84019440|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019441|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019442|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019443|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019444|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019445|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019446|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
84019447|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019448|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84019449|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84019450|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
84019451|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84019452|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84019453|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84019454|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019455|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019456|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84019457|NCT02792140|Naltrexone|naltrexone|mesh-list
84019458|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84019459|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84019460|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019461|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
84019462|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019463|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
84019464|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84019465|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019466|NCT02791594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84019467|NCT02791594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019468|NCT04234516|Morphine|morphine|mesh-list
84019469|NCT04234516|Buprenorphine|buprenorphine|mesh-list
84019470|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84019471|NCT04234516|Naloxone|naloxone|mesh-list
84019472|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84019473|NCT04234516|Narcotics|narcotics|mesh-ancestor
84019474|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019475|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019476|NCT04234516|Analgesics|analgesics|mesh-ancestor
84019477|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
84019478|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019479|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84019480|NCT02789566|Primaquine|primaquine|mesh-list
84019481|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
84019482|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84019483|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84019484|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019485|NCT00697021|Aspirin|aspirin|mesh-list
84019486|NCT00697021|Clopidogrel|clopidogrel|mesh-list
84019487|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84019488|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84019489|NCT00697021|Analgesics|analgesics|mesh-ancestor
84019490|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
84019491|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019492|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019493|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84019494|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84019495|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84019496|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84019497|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019498|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84019499|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84019500|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019501|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
84019502|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84019503|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84019504|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84019505|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
84019506|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019507|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
84019508|NCT02620345|Progestins|progestins|mesh-ancestor
84019509|NCT02620345|Hormones|hormones|mesh-ancestor
84019510|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019511|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019512|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
84019513|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
84019514|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84019515|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84019516|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019517|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
84019518|NCT02790580|Doxorubicin|doxorubicin|mesh-list
84019519|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84019520|NCT02790580|Sunitinib|sunitinib|mesh-list
84019521|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019522|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
84019523|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019524|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84019525|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84019526|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
84019527|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019528|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019529|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84019530|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84019531|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84019532|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019533|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019534|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84019535|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84019536|NCT02790580|Growth Substances|growth substances|mesh-ancestor
84019537|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
84019538|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019539|NCT02788864|Piperaquine|piperaquine|mesh-list
84019540|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
84019541|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84019542|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84019543|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019544|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
84019545|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84019546|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
84019547|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84019548|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019549|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
84019550|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
84019551|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
84019552|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84019553|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019554|NCT00693979|Paclitaxel|paclitaxel|mesh-list
84019555|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84019556|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019557|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019558|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019559|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019560|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019561|NCT04232800|Riboflavin|riboflavin|mesh-list
84019562|NCT04232800|Vitamins|vitamins|mesh-ancestor
84019563|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
84019564|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019565|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
84019566|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84019567|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
84019568|NCT01148225|Adalimumab|adalimumab|mesh-list
84019569|NCT01148225|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84019570|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84019571|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84019572|NCT02788240|Meropenem|meropenem|mesh-list
84019573|NCT02788240|Terlipressin|terlipressin|mesh-list
84019574|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019575|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019576|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84019577|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84019578|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
84019579|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
84019580|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84019581|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019582|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84019583|NCT02884115|Penicillins|penicillins|mesh-list
84019584|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
84019585|NCT02884115|Penicillin G|penicillin g|mesh-list
84019586|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
84019587|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019588|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019589|NCT01190813|Levodopa|levodopa|mesh-list
84019590|NCT01190813|Carbidopa|carbidopa|mesh-list
84019591|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84019592|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84019593|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
84019594|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019595|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019596|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019597|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84019598|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019599|NCT03641326|Sunitinib|sunitinib|mesh-list
84019600|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019601|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84019602|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84019603|NCT03641326|Growth Substances|growth substances|mesh-ancestor
84019604|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019605|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
84019606|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019607|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019608|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019609|NCT00870727|Aripiprazole|aripiprazole|mesh-list
84019610|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
84019611|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84019612|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84019613|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84019614|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019615|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019616|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
84019617|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
84019618|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019619|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019620|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84019621|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84019622|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
84019623|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84019624|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84019625|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84019626|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84019627|NCT02787928|Hydromorphone|hydromorphone|mesh-list
84019628|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84019629|NCT02787928|Narcotics|narcotics|mesh-ancestor
84019630|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019631|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019632|NCT02787928|Analgesics|analgesics|mesh-ancestor
84019633|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
84019634|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019635|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
84019636|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84019637|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019638|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019639|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
84019640|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152498|NCT03536611|Dabigatran|dabigatran|mesh-list
84019641|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019642|NCT02788552|Vitamins|vitamins|mesh-list
84019643|NCT02788552|Thiamine|thiamine|mesh-list
84019644|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
84019645|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019646|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
84019647|NCT01147055|Rifampin|rifampin|mesh-list
84019648|NCT01147055|Crizotinib|crizotinib|mesh-list
84019649|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84019650|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
84019651|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019652|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019653|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
84019654|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84019655|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019656|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019657|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84019658|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84019659|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84019660|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84019661|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84019662|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84019663|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019664|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019665|NCT02623231|Escitalopram|escitalopram|mesh-list
84019666|NCT02623231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84019667|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84019668|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019669|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019670|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019671|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
84019672|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019673|NCT02623153|Docetaxel|docetaxel|mesh-list
84019674|NCT02623153|Capecitabine|capecitabine|mesh-list
84019675|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
84019676|NCT02623153|Tegafur|tegafur|mesh-list
84019677|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019678|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019679|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019680|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019681|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019682|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84019683|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
84019684|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
84019685|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019686|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019687|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84019688|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019689|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019690|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019691|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019692|NCT02884037|Rifaximin|rifaximin|mesh-list
84019693|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019694|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019695|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019696|NCT04233502|Melatonin|melatonin|mesh-list
84019697|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
84019698|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019699|NCT04233502|Protective Agents|protective agents|mesh-ancestor
84019700|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019701|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019702|NCT00696475|Diazoxide|diazoxide|mesh-list
84019703|NCT00696475|Choline|choline|mesh-list
84019704|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
84019705|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84019706|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
84019707|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019708|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019709|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84019710|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
84019711|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84019712|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
84019713|NCT03628066|Letrozole|letrozole|mesh-list
84019714|NCT03628066|Palbociclib|palbociclib|mesh-list
84019715|NCT03628066|Goserelin|goserelin|mesh-list
84019716|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019717|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84019718|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84019719|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019720|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019721|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84019722|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
84019723|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019724|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019725|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019726|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84019727|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
84019728|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
84019729|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84019730|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84019731|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019732|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019733|NCT00625079|Urological Agents|urological agents|mesh-ancestor
84019734|NCT02786992|Misoprostol|misoprostol|mesh-list
84019735|NCT02786992|Oxytocin|oxytocin|mesh-list
84019736|NCT02786992|Carbetocin|carbetocin|mesh-list
84019737|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
84019738|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84019739|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019740|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84019741|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
84019742|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84019743|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019744|NCT04232644|Amphetamine|amphetamine|mesh-list
84019745|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
84019746|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84019747|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019748|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
84019749|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
84019750|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019751|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
84019752|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84019753|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019754|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
84019755|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84019756|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84019757|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019758|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84019759|NCT03557788|Rifaximin|rifaximin|mesh-list
84019760|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019761|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019762|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019763|NCT04133155|Paclitaxel|paclitaxel|mesh-list
84019764|NCT04133155|Gemcitabine|gemcitabine|mesh-list
84019765|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84019766|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019767|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019768|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019769|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019770|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019771|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84019772|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
84019773|NCT01190267|Asenapine|asenapine|mesh-list
84019774|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84019775|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84019776|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019777|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019778|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84019779|NCT00869089|Apremilast|apremilast|mesh-list
84019780|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84019781|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84019782|NCT00869089|Analgesics|analgesics|mesh-ancestor
84019783|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
84019784|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019785|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019786|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84019787|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84019788|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84019789|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84019790|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019791|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019792|NCT02616367|Bupivacaine|bupivacaine|mesh-list
84019793|NCT02616367|Ropivacaine|ropivacaine|mesh-list
84019794|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019795|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
84019796|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019797|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019798|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
84019799|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019800|NCT04200040|Dacarbazine|dacarbazine|mesh-list
84019801|NCT04200040|Molgramostim|molgramostim|mesh-list
84019802|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84019803|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
84019804|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019805|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019806|NCT04232722|Sorafenib|sorafenib|mesh-list
84019807|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019808|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84019809|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019810|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019811|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84019812|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84019813|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019814|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
84019815|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84019816|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019817|NCT02787226|Bupivacaine|bupivacaine|mesh-list
84019818|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019819|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
84019820|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019821|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019822|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
84019823|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019824|NCT00697567|Vaccines|vaccines|mesh-list
84019825|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
84019826|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019827|NCT02616289|Emollients|emollients|mesh-list
84019828|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
84019829|NCT03421756|Sirolimus|sirolimus|mesh-list
84019830|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
84019831|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019832|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019833|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84019834|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019835|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
84019836|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019837|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
84019838|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019839|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84019840|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
84019841|NCT00870103|Dexamethasone|dexamethasone|mesh-list
84019842|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84019843|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84019844|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
84019845|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
84019846|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019847|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019848|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84019849|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
84019850|NCT00870103|Hormones|hormones|mesh-ancestor
84019851|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019852|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84019853|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019854|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019855|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019856|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84019857|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019858|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019859|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019860|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84019861|NCT03365752|Anesthetics|anesthetics|mesh-list
84019862|NCT03365752|Mepivacaine|mepivacaine|mesh-list
84019863|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
84019864|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
84019865|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019866|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019867|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019868|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
84019869|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019870|NCT02785666|Ribavirin|ribavirin|mesh-list
84019871|NCT02785666|Grazoprevir|grazoprevir|mesh-list
84019872|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
84019873|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
84019874|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019875|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
84019876|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019877|NCT01145417|Pregabalin|pregabalin|mesh-list
84019878|NCT01145417|Analgesics|analgesics|mesh-ancestor
84019879|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
84019880|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019881|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019882|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
84019883|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84019884|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84019885|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019886|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84019887|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84019888|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84019889|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019890|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84019891|NCT04232332|Mitogens|mitogens|mesh-list
84019892|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019893|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019894|NCT02785276|Ropivacaine|ropivacaine|mesh-list
84019895|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
84019896|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
84019897|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019898|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019899|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
84019900|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019901|NCT04316039|Temozolomide|temozolomide|mesh-list
84019902|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84019903|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
84019904|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019905|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019906|NCT00696631|Dronedarone|dronedarone|mesh-list
84019907|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84019908|NCT02615977|Ethanol|ethanol|mesh-list
84019909|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84019910|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019911|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84019912|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019913|NCT01189487|Ampicillin|ampicillin|mesh-list
84019914|NCT01189487|Sulbactam|sulbactam|mesh-list
84019915|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84019916|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019917|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84019918|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019919|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019920|NCT02621905|Itraconazole|itraconazole|mesh-list
84019921|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
84019922|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
84019923|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019924|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84019925|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84019926|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019927|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019928|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84019929|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
84019930|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84019931|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019932|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84019933|NCT01106352|Docetaxel|docetaxel|mesh-list
84019934|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84019935|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019936|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
84019937|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
84019938|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
84019939|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019940|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
84019941|NCT01144403|Rituximab|rituximab|mesh-list
84019942|NCT01144403|Fludarabine|fludarabine|mesh-list
84019943|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
84019944|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84019945|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
84019946|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019947|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84019948|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84019949|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
84019950|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019951|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019952|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84019953|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84019954|NCT01144403|Analgesics|analgesics|mesh-ancestor
84019955|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
84019956|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019957|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84019958|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019959|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019960|NCT03071926|Doxorubicin|doxorubicin|mesh-list
84019961|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84019962|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84019963|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84019964|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84019965|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84019966|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019967|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019968|NCT02883647|Tenofovir|tenofovir|mesh-list
84019969|NCT02883647|Entecavir|entecavir|mesh-list
84019970|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
84019971|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84019972|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84019973|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84019974|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84019975|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84019976|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84019977|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84019978|NCT02621827|Calcifediol|calcifediol|mesh-list
84019979|NCT02621827|Vitamins|vitamins|mesh-ancestor
84019980|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
84019981|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019982|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84019983|NCT01143389|Riboflavin|riboflavin|mesh-list
84019984|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
84019985|NCT01143389|Vitamins|vitamins|mesh-ancestor
84019986|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
84019987|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019988|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84019989|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
84019990|NCT00868231|Bromides|bromides|mesh-list
83259813|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84019992|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84019993|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
84019994|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84019995|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84019996|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84019997|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
84019998|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
84019999|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84020000|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
84020001|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020002|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020003|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
84020004|NCT04231864|Durvalumab|durvalumab|mesh-list
84020005|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
84020006|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84020007|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
84020008|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84020009|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020010|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
84020011|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020012|NCT01101438|Metformin|metformin|mesh-list
84020013|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84020014|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020015|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84020016|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84020017|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84020018|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020019|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020020|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84020021|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84020022|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84020023|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84020024|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
84020025|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020026|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020027|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84020028|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84020029|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
84020030|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84020031|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84020032|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
84020033|NCT02786446|Naproxen|naproxen|mesh-list
84020034|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84020035|NCT02786446|Lidocaine|lidocaine|mesh-list
84020036|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
84020037|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
84020038|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020039|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020040|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
84020041|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020042|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84020043|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84020044|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84020045|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020046|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020047|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020048|NCT02786446|Analgesics|analgesics|mesh-ancestor
84020049|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020050|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020051|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
84020052|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84020053|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020054|NCT02619019|Dexamethasone|dexamethasone|mesh-list
84020055|NCT02619019|Meperidine|meperidine|mesh-list
84020056|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020057|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
84020058|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
84020059|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020060|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020061|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020062|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
84020063|NCT02619019|Hormones|hormones|mesh-ancestor
84020064|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020065|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84020066|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020067|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84020068|NCT02619019|Narcotics|narcotics|mesh-ancestor
84020069|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020070|NCT02619019|Analgesics|analgesics|mesh-ancestor
84020071|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
84020072|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84020073|NCT02957032|Cytarabine|cytarabine|mesh-list
84020074|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84020075|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
84020076|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020077|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020078|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
84020079|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020080|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84020081|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
84020082|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020083|NCT02947516|Liver Extracts|liver extracts|mesh-list
84020084|NCT02947516|Hematinics|hematinics|mesh-ancestor
84020085|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84020086|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
84020087|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84020088|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84020089|NCT00864721|Sunitinib|sunitinib|mesh-list
84020090|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020091|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84020092|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84020093|NCT00864721|Growth Substances|growth substances|mesh-ancestor
84020094|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020095|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
84020096|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84020097|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020098|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020099|NCT05308420|Morphine|morphine|mesh-list
84020100|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020101|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020102|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84020103|NCT05308420|Narcotics|narcotics|mesh-ancestor
84020104|NCT05308420|Analgesics|analgesics|mesh-ancestor
84020105|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
84020106|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020107|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
84020108|NCT02897050|Docetaxel|docetaxel|mesh-list
84020109|NCT02897050|Fluorouracil|fluorouracil|mesh-list
84020110|NCT02897050|Capecitabine|capecitabine|mesh-list
84020111|NCT02897050|Epirubicin|epirubicin|mesh-list
84020112|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84020113|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
84020114|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020115|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020116|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84020117|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
84020118|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020119|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020120|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84020121|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
84020122|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
84020123|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
84020124|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
84020125|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84020126|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84020127|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84020128|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84020129|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020130|NCT01095666|Metformin|metformin|mesh-list
84020131|NCT01095666|Pioglitazone|pioglitazone|mesh-list
84020132|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
84020133|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84020134|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020135|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84020136|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020137|NCT01100658|Methylphenidate|methylphenidate|mesh-list
84020138|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84020139|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020140|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84020141|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84020142|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020143|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020144|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
84020145|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020146|NCT05276908|Bupivacaine|bupivacaine|mesh-list
84020147|NCT05276908|Anesthetics|anesthetics|mesh-list
84020148|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
84020149|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020150|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020151|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
84020152|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020154|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84020155|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84020156|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
84020157|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020158|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020159|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020160|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
84020161|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84020162|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020163|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020164|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020165|NCT02786212|Analgesics|analgesics|mesh-ancestor
84020166|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
84020167|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020168|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84020169|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84020170|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84020171|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
84020172|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020173|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020174|NCT05273710|Folic Acid|folic acid|mesh-list
84020175|NCT05273710|Hematinics|hematinics|mesh-ancestor
84020176|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
84020177|NCT05273710|Vitamins|vitamins|mesh-ancestor
84020178|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
84020179|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020180|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
84020181|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
84020182|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84020183|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020184|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84020185|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84020186|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020187|NCT01100502|Immunotoxins|immunotoxins|mesh-ancestor
84020188|NCT01100502|Immunoconjugates|immunoconjugates|mesh-ancestor
84020189|NCT01100502|Immunologic Factors|immunologic factors|mesh-ancestor
84020190|NCT01100502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020191|NCT02784340|Dexamethasone|dexamethasone|mesh-list
84020192|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
84020193|NCT02784340|Bupivacaine|bupivacaine|mesh-list
84020194|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84020195|NCT02784340|BB 1101|bb 1101|mesh-list
84020196|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020197|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
84020198|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
84020199|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020200|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020201|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020202|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
84020203|NCT02784340|Hormones|hormones|mesh-ancestor
84020204|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020205|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84020206|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020207|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
84020208|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020209|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020210|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
84020211|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
84020212|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020213|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
84020214|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83260040|NCT05563571|Prednisolone|prednisolone|mesh-list
84020216|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
84020217|NCT02389036|Tobramycin|tobramycin|mesh-list
84020218|NCT02389036|Colistin|colistin|mesh-list
84020219|NCT02389036|Nystatin|nystatin|mesh-list
84020220|NCT02389036|Cefotaxime|cefotaxime|mesh-list
84020221|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020222|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84020223|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84020224|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020225|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020226|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020227|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84020228|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84020229|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
84020230|NCT02389036|Ionophores|ionophores|mesh-ancestor
84020231|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020232|NCT02878512|Anesthetics|anesthetics|mesh-list
84020233|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020234|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020235|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
84020236|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84020237|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
84020238|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84020239|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
83478022|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
84020240|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020241|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020242|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
84020243|NCT01094808|Pregabalin|pregabalin|mesh-list
84020244|NCT01094808|Analgesics|analgesics|mesh-ancestor
84020245|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
84020246|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020247|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020248|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
84020249|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84020250|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020251|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020252|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84020253|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84020254|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84020255|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020256|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84020257|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84020258|NCT00864253|Dacarbazine|dacarbazine|mesh-list
84020259|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020260|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84020261|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
84020262|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020263|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84020264|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84020265|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
84020266|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020267|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020268|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84020269|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
84020270|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
84020271|NCT02782312|Hormones|hormones|mesh-ancestor
84020272|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020273|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
84020274|NCT04229758|Anticoagulants|anticoagulants|mesh-list
84020275|NCT00698425|Citric Acid|citric acid|mesh-list
84020276|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
84020277|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
84020278|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84020279|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
84020280|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
84020281|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020282|NCT05342272|Lactoferrin|lactoferrin|mesh-list
84020283|NCT05342272|Muramidase|muramidase|mesh-list
84020284|NCT05342272|Betaine|betaine|mesh-list
84020285|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020286|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020287|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
84020288|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83260125|NCT05562869|Abatacept|abatacept|mesh-list
84020289|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
84020290|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020291|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84020293|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84020294|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020295|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020296|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020297|NCT02783638|Pregabalin|pregabalin|mesh-list
84020298|NCT02783638|Analgesics|analgesics|mesh-ancestor
84020299|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
84020300|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020301|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020302|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
84020303|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84020304|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020305|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020306|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84020307|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84020308|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84020309|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020310|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84020311|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84020312|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84020313|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
84020314|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84020315|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84020316|NCT04230070|Estradiol|estradiol|mesh-list
84020317|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84020318|NCT04230070|Estrogens|estrogens|mesh-ancestor
84020319|NCT04230070|Hormones|hormones|mesh-ancestor
84020320|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020321|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020322|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84020323|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
84020324|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84020325|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84020326|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84020327|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84020328|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84020329|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84020330|NCT02782078|Clindamycin|clindamycin|mesh-list
84020331|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
84020332|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
84020333|NCT02782078|Rifampin|rifampin|mesh-list
84020334|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84020335|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020336|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84020337|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020338|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020339|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84020340|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
84020341|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
84020342|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84020343|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84020344|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84020345|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84020346|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84020347|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84020348|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84020349|NCT01293682|Calcitriol|calcitriol|mesh-list
84020350|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84020351|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020352|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84020353|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020354|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020355|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84020356|NCT01293682|Vitamins|vitamins|mesh-ancestor
84020357|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
84020358|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84020359|NCT00864097|Diclofenac|diclofenac|mesh-list
84020360|NCT00864097|Tanezumab|tanezumab|mesh-list
84020361|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84020362|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020364|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
84020365|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020366|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020367|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020368|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020369|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84020370|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020371|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020372|NCT02782624|Empagliflozin|empagliflozin|mesh-list
84020373|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84020374|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020375|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84020376|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020377|NCT02781766|Thrombin|thrombin|mesh-list
84020378|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
84020379|NCT02781766|Coagulants|coagulants|mesh-ancestor
84020380|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
84020381|NCT00887536|Bevacizumab|bevacizumab|mesh-list
84020382|NCT00887536|Docetaxel|docetaxel|mesh-list
84020383|NCT00887536|Doxorubicin|doxorubicin|mesh-list
84020384|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84020385|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
84020386|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020387|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020388|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84020389|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
84020390|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020391|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020392|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84020393|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84020394|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84020395|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84020396|NCT00887536|Growth Substances|growth substances|mesh-ancestor
84020397|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
84020398|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
84020399|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
84020400|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
84020401|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84020402|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84020403|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84020404|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020405|NCT02614339|Metformin|metformin|mesh-list
84020406|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84020407|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020408|NCT02618395|Hydrocodone|hydrocodone|mesh-list
84020409|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84020410|NCT02618395|Narcotics|narcotics|mesh-ancestor
84020411|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020412|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020413|NCT02618395|Analgesics|analgesics|mesh-ancestor
84020414|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
84020415|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020416|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
84020417|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
84020418|NCT01183013|Pioglitazone|pioglitazone|mesh-list
84020419|NCT01183013|Linagliptin|linagliptin|mesh-list
84020420|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84020421|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020422|NCT01183013|Incretins|incretins|mesh-ancestor
84020423|NCT01183013|Hormones|hormones|mesh-ancestor
84020424|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020425|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84020426|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
84020427|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020428|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020429|NCT04229212|Cimetidine|cimetidine|mesh-list
84020430|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84020431|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020432|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84020433|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
84020434|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
84020435|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020436|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020437|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020438|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84020439|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84020440|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020442|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84020443|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020444|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84020445|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84020446|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84020447|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020448|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020449|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020450|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020451|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84020452|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
84020453|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84020454|NCT05298163|Calcitriol|calcitriol|mesh-list
84020455|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84020456|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020457|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84020458|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84020459|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020460|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84020461|NCT05298163|Vitamins|vitamins|mesh-ancestor
84020462|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
84020463|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84020464|NCT01141283|Buprenorphine|buprenorphine|mesh-list
84020465|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84020466|NCT01141283|Narcotics|narcotics|mesh-ancestor
84020467|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020468|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020469|NCT01141283|Analgesics|analgesics|mesh-ancestor
84020470|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
84020471|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020472|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84020473|NCT05340946|Anesthetics|anesthetics|mesh-list
84020474|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020475|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020476|NCT00863707|Regadenoson|regadenoson|mesh-list
84020477|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84020478|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84020479|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
84020480|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
84020481|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020482|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020483|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020484|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
84020485|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
84020486|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84020487|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020488|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84020489|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84020490|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020491|NCT04187807|Melatonin|melatonin|mesh-list
84020492|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
84020493|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020494|NCT04187807|Protective Agents|protective agents|mesh-ancestor
84020495|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020496|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020497|NCT01094184|Paclitaxel|paclitaxel|mesh-list
84020498|NCT01094184|Docetaxel|docetaxel|mesh-list
84020499|NCT01094184|Bevacizumab|bevacizumab|mesh-list
84020500|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84020501|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020502|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
84020503|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
84020504|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
84020505|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020506|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84020507|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83260340|NCT02545075|Ipilimumab|ipilimumab|mesh-list
84020508|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84020509|NCT01094184|Growth Substances|growth substances|mesh-ancestor
84020510|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020511|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
84020512|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84020513|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020514|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020515|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84020516|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84020517|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020518|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84020519|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020520|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020521|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84020522|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84020523|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84020524|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
84020525|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020526|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84020527|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84020528|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
84020530|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
84020531|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
84020532|NCT02618317|Minocycline|minocycline|mesh-list
84020533|NCT02618317|Heparin|heparin|mesh-list
84020534|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
84020535|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020536|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84020537|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84020538|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84020539|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020540|NCT01140503|Apremilast|apremilast|mesh-list
84020541|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84020542|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020543|NCT01140503|Analgesics|analgesics|mesh-ancestor
84020544|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
84020545|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020546|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020547|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020548|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020549|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84020550|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84020551|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020552|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020553|NCT02689726|Imiquimod|imiquimod|mesh-list
84020554|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84020555|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
84020556|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020557|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020558|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
84020559|NCT00863317|Montelukast|montelukast|mesh-list
84020560|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84020561|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
84020562|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84020563|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
84020564|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020565|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020566|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84020567|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84020568|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020569|NCT02744092|Enoxaparin|enoxaparin|mesh-list
84020570|NCT02744092|Dalteparin|dalteparin|mesh-list
84020571|NCT02744092|PENTA|penta|mesh-list
84020572|NCT02744092|Warfarin|warfarin|mesh-list
84020573|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
84020574|NCT02744092|Dabigatran|dabigatran|mesh-list
84020575|NCT02744092|Apixaban|apixaban|mesh-list
84020576|NCT02744092|Edoxaban|edoxaban|mesh-list
84020577|NCT02744092|Fondaparinux|fondaparinux|mesh-list
84020578|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
84020579|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84020580|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
84020581|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84020582|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
84020583|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020584|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020585|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84020586|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84020587|NCT01200368|Vaccines|vaccines|mesh-list
84020588|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84020589|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
84020590|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020591|NCT04125121|Propofol|propofol|mesh-list
84020592|NCT04125121|Sevoflurane|sevoflurane|mesh-list
84020593|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84020594|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020595|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020596|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84020597|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
84020598|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
84020599|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84020600|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84020601|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84020602|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84020603|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
84020604|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020605|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020606|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84020607|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
84020608|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84020609|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84020610|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84020611|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
84020612|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020613|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020614|NCT01078974|Dexamethasone|dexamethasone|mesh-list
84020615|NCT01078974|Rituximab|rituximab|mesh-list
84020616|NCT01078974|Pomalidomide|pomalidomide|mesh-list
84020617|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84020618|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020619|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
84020620|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020621|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020622|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020623|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
84020624|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
84020625|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020626|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020627|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
84020628|NCT01078974|Hormones|hormones|mesh-ancestor
84020629|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020630|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84020631|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84020632|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84020633|NCT01078974|Growth Substances|growth substances|mesh-ancestor
84020634|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
84020635|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
84020636|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
84020637|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020638|NCT02878200|Piperaquine|piperaquine|mesh-list
84020639|NCT02878200|Artenimol|artenimol|mesh-list
84020640|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
84020641|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84020642|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84020643|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020644|NCT04302012|Mydriatics|mydriatics|mesh-list
84020645|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
84020646|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020647|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020648|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84020649|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84020650|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84020651|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84020652|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020653|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020654|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
84020655|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020656|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84020657|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84020659|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84020660|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84020661|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
84020662|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020663|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84020664|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84020665|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020666|NCT04205682|Cannabidiol|cannabidiol|mesh-list
84020667|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
84020668|NCT01134263|Vaccines|vaccines|mesh-list
84020669|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
84020670|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020671|NCT01199822|Olaratumab|olaratumab|mesh-list
84020672|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020673|NCT01096056|Vaccines|vaccines|mesh-list
84020674|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
84020675|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020676|NCT00866359|Apremilast|apremilast|mesh-list
84020677|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84020678|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020679|NCT00866359|Analgesics|analgesics|mesh-ancestor
84020680|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
84020681|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020682|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020683|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020684|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020685|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84020686|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84020687|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020688|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020689|NCT01199198|Tolvaptan|tolvaptan|mesh-list
84020690|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84020691|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020692|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
84020693|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020694|NCT05089708|Trifarotene|trifarotene|mesh-list
84020695|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
84020696|NCT01095978|Clarithromycin|clarithromycin|mesh-list
84020697|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84020698|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020699|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84020700|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020701|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020702|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84020703|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84020704|NCT01134107|Insulin|insulin|mesh-list
84020705|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84020706|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
84020707|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
84020708|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84020709|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020710|NCT01198574|Vitamins|vitamins|mesh-list
84020711|NCT01198574|Folic Acid|folic acid|mesh-list
84020712|NCT01198574|Vitamin A|vitamin a|mesh-list
84020713|NCT01198574|Iron|iron|mesh-list
84020714|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
84020715|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
84020716|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020717|NCT01198574|Trace Elements|trace elements|mesh-ancestor
84020718|NCT01198574|Hematinics|hematinics|mesh-ancestor
84020719|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
84020720|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
84020721|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020722|NCT01198574|Protective Agents|protective agents|mesh-ancestor
84020723|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84020724|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020725|NCT02580994|Carboplatin|carboplatin|mesh-list
84020726|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
84020727|NCT02580994|Etoposide|etoposide|mesh-list
84020728|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020729|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84020730|NCT02580994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84020731|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020732|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84020733|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84020734|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84020735|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020736|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84020737|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020738|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84020739|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020740|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020741|NCT01092780|Modafinil|modafinil|mesh-list
84020742|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84020743|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020744|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84020745|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84020746|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84020747|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020748|NCT05338606|Bimatoprost|bimatoprost|mesh-list
84020749|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84020750|NCT01092702|Varenicline|varenicline|mesh-list
84020751|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84020752|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84020753|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
84020754|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020755|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020756|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020757|NCT01092546|Flutemetamol|flutemetamol|mesh-list
84020758|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84048347|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020759|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020760|NCT02779348|Warfarin|warfarin|mesh-list
84020761|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
84020762|NCT02779582|Progesterone|progesterone|mesh-list
84020763|NCT02779582|Progestins|progestins|mesh-ancestor
84020764|NCT02779582|Hormones|hormones|mesh-ancestor
84020765|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020766|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020767|NCT04878432|Azacitidine|azacitidine|mesh-list
84020768|NCT04878432|Decitabine|decitabine|mesh-list
84020769|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84020770|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
84020771|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020772|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020773|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020774|NCT00634894|Letrozole|letrozole|mesh-list
84020775|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020776|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84020777|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84020778|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020779|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020780|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84020781|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
84020782|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020783|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020784|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
84020785|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84020786|NCT02779270|Protective Agents|protective agents|mesh-ancestor
84020787|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020788|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
84020789|NCT01078662|Olaparib|olaparib|mesh-list
84020790|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84020791|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020792|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020793|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020794|NCT04227886|Capecitabine|capecitabine|mesh-list
84020795|NCT04227886|Irinotecan|irinotecan|mesh-list
84020796|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84020797|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
84020798|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020799|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020800|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84020801|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84020802|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020803|NCT02200978|Cytarabine|cytarabine|mesh-list
84020804|NCT02200978|Methotrexate|methotrexate|mesh-list
84020805|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
84020806|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
84020807|NCT02200978|Tretinoin|tretinoin|mesh-list
84020808|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
84020809|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84020810|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
84020811|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84020812|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020813|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84020815|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020816|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020817|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
84020818|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020819|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84020820|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84020821|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
84020822|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020823|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84020824|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
84020825|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020826|NCT02200978|Analgesics|analgesics|mesh-ancestor
84020827|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
84020828|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020829|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84020830|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84020831|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
84020832|NCT02779192|Ebselen|ebselen|mesh-list
84020833|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84020834|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020835|NCT02779192|Analgesics|analgesics|mesh-ancestor
84020836|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
84020837|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020838|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020839|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020840|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020841|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84020842|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020843|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
84020844|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020845|NCT02779192|Protective Agents|protective agents|mesh-ancestor
84020846|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84020847|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020848|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84020849|NCT05020210|Sivelestat|sivelestat|mesh-list
84020850|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84020851|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
84020852|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020853|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020854|NCT04227808|Lenvatinib|lenvatinib|mesh-list
84020855|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020856|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84020857|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020858|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020859|NCT01091454|Cisplatin|cisplatin|mesh-list
84020860|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020861|NCT01140347|Ramucirumab|ramucirumab|mesh-list
84020862|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020863|NCT04227652|Ibuprofen|ibuprofen|mesh-list
84020864|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84020865|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020866|NCT04227652|Analgesics|analgesics|mesh-ancestor
84020867|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
84020868|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020869|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020870|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020871|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020872|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84020873|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020874|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020875|NCT02883569|Ibuprofen|ibuprofen|mesh-list
84020876|NCT02883569|Aceclofenac|aceclofenac|mesh-list
84020877|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
84020878|NCT02883569|Tramadol|tramadol|mesh-list
84020879|NCT02883569|Codeine|codeine|mesh-list
84020880|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84020881|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020882|NCT02883569|Analgesics|analgesics|mesh-ancestor
84020883|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
84020884|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020885|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020886|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020887|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020888|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84020889|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020890|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020891|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84020892|NCT02883569|Narcotics|narcotics|mesh-ancestor
84020893|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020894|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
84020895|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
84020896|NCT02883023|Bleomycin|bleomycin|mesh-list
84020897|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84020898|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020899|NCT02778958|Acetaminophen|acetaminophen|mesh-list
84020900|NCT02778958|Ibuprofen|ibuprofen|mesh-list
84020901|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84020902|NCT02778958|Analgesics|analgesics|mesh-ancestor
84020903|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
84020904|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020905|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020906|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
84020907|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84020908|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020909|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020910|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84020911|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020912|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020913|NCT01197560|Rituximab|rituximab|mesh-list
84020914|NCT01197560|Gemcitabine|gemcitabine|mesh-list
84020915|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
84020916|NCT01197560|Etoposide|etoposide|mesh-list
84020917|NCT01197560|Lenalidomide|lenalidomide|mesh-list
84020918|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84020919|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020920|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
84020921|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020922|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84020923|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84020924|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
84020925|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020926|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84020927|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84020928|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84020929|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020930|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84020931|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84020932|NCT01197560|Growth Substances|growth substances|mesh-ancestor
84020933|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
84020934|NCT04940572|Valproic Acid|valproic acid|mesh-list
84020935|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
84020936|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020937|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020938|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
84020939|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020940|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020941|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
84020942|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84020943|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84020944|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84020945|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84020946|NCT01196078|Vinorelbine|vinorelbine|mesh-list
84020947|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020948|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84020949|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020950|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020951|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84020952|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
84020953|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
84020954|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
84020955|NCT05314660|Fluorides|fluorides|mesh-list
84020956|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
84020957|NCT05314660|Protective Agents|protective agents|mesh-ancestor
84020958|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020959|NCT04920292|Oxfendazole|oxfendazole|mesh-list
84020960|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
84020961|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84020962|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84020963|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
84020964|NCT04317872|Dexamethasone|dexamethasone|mesh-list
84020965|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
84020966|NCT04317872|BB 1101|bb 1101|mesh-list
84020967|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84020968|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
84020969|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
84020970|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84020971|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020972|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020973|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
84020974|NCT04317872|Hormones|hormones|mesh-ancestor
84020975|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84020976|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84020977|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84020978|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
84020979|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84020980|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020981|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
84020982|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
84020983|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
84020984|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84020985|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84020986|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
84020987|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
84020988|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84020989|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84020990|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020991|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84020992|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
84020993|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84020994|NCT01194830|Linagliptin|linagliptin|mesh-list
84020995|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84020996|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84020997|NCT01194830|Incretins|incretins|mesh-ancestor
84020998|NCT01194830|Hormones|hormones|mesh-ancestor
84020999|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021000|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84021001|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
84021002|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021003|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021004|NCT02778178|Clonidine|clonidine|mesh-list
84021005|NCT02778178|Ropivacaine|ropivacaine|mesh-list
84021006|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
84021007|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
84021008|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021009|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021010|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
84021011|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021012|NCT02778178|Analgesics|analgesics|mesh-ancestor
84021013|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84021014|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
84021015|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
84021016|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84021017|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84021018|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84021019|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021020|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021021|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021022|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
84021023|NCT01194440|Letrozole|letrozole|mesh-list
84021024|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021025|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84021026|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84021027|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021028|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021029|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84021030|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
84021031|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021032|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021033|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84021034|NCT04823052|Sulindac|sulindac|mesh-list
84021035|NCT04823052|Gaboxadol|gaboxadol|mesh-list
84021036|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021037|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021038|NCT04823052|Analgesics|analgesics|mesh-ancestor
84021039|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
84021040|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021041|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021042|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021043|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021044|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021045|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021046|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021047|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021048|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
84021049|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
84021050|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
84021051|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021052|NCT00951015|Efavirenz|efavirenz|mesh-list
84021053|NCT00951015|Dolutegravir|dolutegravir|mesh-list
84021054|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84021055|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84021056|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021057|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021058|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
84021059|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021060|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84021061|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84021062|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84021063|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84021064|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84021065|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84021066|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84021067|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84021068|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84021069|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84021070|NCT02777866|Bupivacaine|bupivacaine|mesh-list
84021071|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
84021072|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
84021073|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021074|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021075|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
84021076|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021077|NCT00626262|Esomeprazole|esomeprazole|mesh-list
84021078|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84021079|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84021080|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84021081|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021082|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021083|NCT02876796|Firsocostat|firsocostat|mesh-list
84021084|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021085|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021086|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
84021087|NCT01193660|Hematinics|hematinics|mesh-ancestor
84021088|NCT02777788|Paclitaxel|paclitaxel|mesh-list
84021089|NCT02777788|Vinorelbine|vinorelbine|mesh-list
84021090|NCT02777788|Docetaxel|docetaxel|mesh-list
84021091|NCT02777788|Carboplatin|carboplatin|mesh-list
84021092|NCT02777788|Gemcitabine|gemcitabine|mesh-list
84021093|NCT02777788|Pemetrexed|pemetrexed|mesh-list
84021094|NCT02777788|Cisplatin|cisplatin|mesh-list
84021095|NCT02777788|Nedaplatin|nedaplatin|mesh-list
84021096|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84021097|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021098|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
84021099|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
84021100|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
84021101|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021102|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84021103|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
84021104|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021105|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84021106|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84021107|NCT01076166|Clarithromycin|clarithromycin|mesh-list
84021108|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84021109|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021110|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84021111|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021112|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021113|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84021114|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84021115|NCT02777710|Durvalumab|durvalumab|mesh-list
84021116|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84021117|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021118|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84021119|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
84021120|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021121|NCT00602901|Naproxen|naproxen|mesh-list
84021122|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021123|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021124|NCT00602901|Analgesics|analgesics|mesh-ancestor
84021125|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
84021126|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021127|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021128|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021129|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021130|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
84021131|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021132|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021133|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021134|NCT01076088|Metformin|metformin|mesh-list
84021135|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84021136|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84021137|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021138|NCT01076088|Incretins|incretins|mesh-ancestor
84021139|NCT01076088|Hormones|hormones|mesh-ancestor
84021140|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021141|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84021142|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
84021143|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021144|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021145|NCT02777320|Acetaminophen|acetaminophen|mesh-list
84021146|NCT02777320|Ibuprofen|ibuprofen|mesh-list
84021147|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021148|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021149|NCT02777320|Analgesics|analgesics|mesh-ancestor
84021150|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
84021151|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021152|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021153|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021154|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021155|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021156|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021157|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021158|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
84021159|NCT01193348|Eculizumab|eculizumab|mesh-list
84021160|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84021161|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021162|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
84021163|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021164|NCT00945321|Aprepitant|aprepitant|mesh-list
84021165|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
84021166|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
84021167|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
84021168|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021169|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021170|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84021171|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84021172|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021173|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021174|NCT02776228|Brotizolam|brotizolam|mesh-list
84021175|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84021176|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021177|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021178|NCT04872790|Prednisone|prednisone|mesh-list
84021179|NCT04872790|Cortisone|cortisone|mesh-list
84021180|NCT04872790|Rituximab|rituximab|mesh-list
84021181|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84021182|NCT04872790|Methotrexate|methotrexate|mesh-list
84021183|NCT04872790|Venetoclax|venetoclax|mesh-list
84021184|NCT04872790|Dasatinib|dasatinib|mesh-list
84021185|NCT04872790|Antibodies|antibodies|mesh-list
84021186|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
84021187|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84021188|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
84021189|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021190|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021191|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021192|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021193|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
84021194|NCT04872790|Hormones|hormones|mesh-ancestor
84021195|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021196|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84021197|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84021198|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
84021199|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84021200|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84021201|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
84021202|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021203|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
84021204|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021205|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84021206|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021207|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84021208|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021209|NCT05382728|Osimertinib|osimertinib|mesh-list
84021210|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021211|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021212|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021213|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021214|NCT01192178|Fluticasone|fluticasone|mesh-list
84021215|NCT01192178|Xhance|xhance|mesh-list
84021216|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84021217|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84021218|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021219|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84021220|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
84021221|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021222|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021223|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84021224|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
84021225|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
84021226|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84021227|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84021228|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84021229|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84021230|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021231|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021232|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021233|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
84021234|NCT01192178|Hormones|hormones|mesh-ancestor
84021235|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021236|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
84021237|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
84021238|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84021239|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021240|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84021241|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021242|NCT00869401|Temozolomide|temozolomide|mesh-list
84021243|NCT00869401|Dasatinib|dasatinib|mesh-list
84021244|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84021245|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
84021246|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021247|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021248|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021249|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021250|NCT01076010|Sorafenib|sorafenib|mesh-list
84021251|NCT01076010|Tivozanib|tivozanib|mesh-list
84021252|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021253|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021254|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021255|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021256|NCT04225780|Ganciclovir|ganciclovir|mesh-list
84021257|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
84021258|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
83261092|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84021259|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021260|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84021261|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021262|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021263|NCT04045171|Tacrolimus|tacrolimus|mesh-list
84021264|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021265|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
84021266|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021267|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84021268|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021269|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021270|NCT01075152|Lamivudine|lamivudine|mesh-list
84021271|NCT01075152|Zidovudine|zidovudine|mesh-list
84021272|NCT01075152|Efavirenz|efavirenz|mesh-list
84021273|NCT01075152|Stavudine|stavudine|mesh-list
84021274|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84021275|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84021276|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021277|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021278|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
84021279|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021280|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84021281|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84021282|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
84021283|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84021284|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84021285|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84021286|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84021287|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84021288|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84021289|NCT04134637|Bupivacaine|bupivacaine|mesh-list
84021290|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
84021291|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
84021292|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021293|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021294|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
84021295|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021296|NCT02617849|Paclitaxel|paclitaxel|mesh-list
84021297|NCT02617849|Carboplatin|carboplatin|mesh-list
84021298|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
84021299|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84021300|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021301|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
84021302|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
84021303|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
84021304|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021305|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84021306|NCT02617849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84021307|NCT00950859|Dolutegravir|dolutegravir|mesh-list
84021308|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84021309|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84021310|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021311|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021312|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84021313|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84021314|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
84021315|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021316|NCT02775292|Aldesleukin|aldesleukin|mesh-list
84021317|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
84021318|NCT02775292|Nivolumab|nivolumab|mesh-list
84021319|NCT02775292|Fludarabine|fludarabine|mesh-list
84021320|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
84021321|NCT02775292|Interleukin-2|interleukin-2|mesh-list
84021322|NCT02775292|Vaccines|vaccines|mesh-list
84021323|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
84021324|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021325|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021326|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021327|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84021328|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
84021329|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021330|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021331|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84021332|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84021333|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84021334|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84021336|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021337|NCT02775292|Analgesics|analgesics|mesh-ancestor
84021338|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
84021339|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021340|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84021341|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84021342|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
84021343|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021344|NCT00862849|Insulin|insulin|mesh-list
84021345|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84021346|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
84021347|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84021348|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021349|NCT01090050|Naproxen|naproxen|mesh-list
84021350|NCT01090050|Sumatriptan|sumatriptan|mesh-list
84021351|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021352|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021353|NCT01090050|Analgesics|analgesics|mesh-ancestor
84021354|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
84021355|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021356|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021357|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021358|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021359|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
84021360|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021361|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021362|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021363|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84021364|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84021365|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84021366|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
84021367|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021368|NCT02775370|Apatinib|apatinib|mesh-list
84021369|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021370|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021371|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021372|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021373|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
84021374|NCT04225468|Narcotics|narcotics|mesh-ancestor
84021375|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021376|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021377|NCT04225468|Analgesics|analgesics|mesh-ancestor
84021378|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
84021379|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021380|NCT02855307|Insulin|insulin|mesh-list
84021381|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84021382|NCT02855307|Hormones|hormones|mesh-list
84021383|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84021384|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021385|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021386|NCT01077960|Hormones|hormones|mesh-list
84021387|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021388|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021389|NCT04269369|Fluorouracil|fluorouracil|mesh-list
84021390|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
84021391|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021392|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84021393|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021394|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021395|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
84021396|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021397|NCT02776540|Aspirin|aspirin|mesh-list
84021398|NCT02776540|Clopidogrel|clopidogrel|mesh-list
84021399|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021400|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021401|NCT02776540|Analgesics|analgesics|mesh-ancestor
84021402|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
84021403|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021404|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021405|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021406|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021407|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83261246|NCT02088541|Cytarabine|cytarabine|mesh-list
84021409|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021410|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84021411|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021412|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021413|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
84021414|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84021415|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84021416|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84021417|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
84021418|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021419|NCT00944697|Oxycodone|oxycodone|mesh-list
84021420|NCT00944697|Naloxone|naloxone|mesh-list
84021421|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84021422|NCT00944697|Narcotics|narcotics|mesh-ancestor
84021423|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021424|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021425|NCT00944697|Analgesics|analgesics|mesh-ancestor
84021426|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
84021427|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021428|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84021429|NCT02878122|Carboplatin|carboplatin|mesh-list
84021430|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021431|NCT04807348|Metformin|metformin|mesh-list
84021432|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84021433|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021434|NCT04224922|Paclitaxel|paclitaxel|mesh-list
84021435|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
84021436|NCT04224922|Epirubicin|epirubicin|mesh-list
84021437|NCT04224922|Carboplatin|carboplatin|mesh-list
84021438|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84021439|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021440|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
84021441|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
84021442|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
84021443|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021444|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021445|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
84021446|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021447|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021448|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84021449|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
84021450|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84021451|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84021452|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84021453|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84021454|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021455|NCT02877888|Fluorides|fluorides|mesh-list
84021456|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
84021457|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
84021458|NCT02877888|Protective Agents|protective agents|mesh-ancestor
84021459|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021460|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84021461|NCT02772640|Ezetimibe|ezetimibe|mesh-list
84021462|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84021463|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84021464|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
84021465|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021466|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84021467|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84021468|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021469|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84021470|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
84021471|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021472|NCT00866281|Midostaurin|midostaurin|mesh-list
84021473|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021474|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021475|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021476|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021477|NCT04121611|Aspirin|aspirin|mesh-list
84021478|NCT04121611|Heparin|heparin|mesh-list
84021479|NCT04121611|Calcium heparin|calcium heparin|mesh-list
84021480|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
83261312|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84021481|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84021482|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84021483|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021484|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021485|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021486|NCT04121611|Analgesics|analgesics|mesh-ancestor
84021487|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
84021488|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021489|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021490|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021491|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021492|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84021493|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021494|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021495|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
84021496|NCT02771860|Denosumab|denosumab|mesh-list
84021497|NCT02771860|Calcium|calcium|mesh-list
84021498|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84021499|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021500|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84021501|NCT02771782|Vaccines|vaccines|mesh-list
84021502|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
84021503|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
84021504|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021505|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84021506|NCT02771392|Tetracaine|tetracaine|mesh-list
84021507|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84021508|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
84021509|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
84021510|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021511|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021512|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
84021513|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021515|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
84021516|NCT02771704|Fluorides|fluorides|mesh-list
84021517|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
84021518|NCT02771704|Protective Agents|protective agents|mesh-ancestor
84021519|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021520|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84021521|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021522|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
84021523|NCT02771704|Trace Elements|trace elements|mesh-ancestor
84021524|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
84021525|NCT02771314|Osimertinib|osimertinib|mesh-list
84021526|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021527|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021528|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021529|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021530|NCT02771158|Midodrine|midodrine|mesh-list
84021531|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
84021532|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
84021533|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021534|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021535|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84021536|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84021537|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84021538|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84021539|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021540|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021541|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021542|NCT02770690|Lidocaine|lidocaine|mesh-list
84021543|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
84021544|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
84021545|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
84021546|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021547|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021548|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
84021549|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021550|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84021551|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84021552|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84021553|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84021554|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021555|NCT02770378|Ritonavir|ritonavir|mesh-list
84021556|NCT02770378|Itraconazole|itraconazole|mesh-list
84021557|NCT02770378|Minocycline|minocycline|mesh-list
84021558|NCT02770378|Celecoxib|celecoxib|mesh-list
84021560|NCT02770378|Auranofin|auranofin|mesh-list
84021561|NCT02770378|Captopril|captopril|mesh-list
84021562|NCT02770378|Disulfiram|disulfiram|mesh-list
84021563|NCT02770378|Aprepitant|aprepitant|mesh-list
84021564|NCT02770378|Sertraline|sertraline|mesh-list
84021565|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84021566|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84021567|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
84021568|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021569|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021570|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84021571|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84021572|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
84021573|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021574|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84021575|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84021576|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84021577|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
84021578|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021579|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021580|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021581|NCT02770378|Analgesics|analgesics|mesh-ancestor
84021582|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
84021583|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021584|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021585|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021586|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021587|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84021588|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021589|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
84021590|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84021591|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84021592|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
84021593|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021594|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
84021595|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84021596|NCT02770378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84021597|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84021598|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84021599|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021600|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
84021601|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84021602|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
84021603|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
84021604|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84021605|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84021606|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84021607|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
84021608|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84021609|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84021610|NCT02770222|Rifampin|rifampin|mesh-list
84021611|NCT02770222|Selexipag|selexipag|mesh-list
84021612|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
84021613|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84021614|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
84021615|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84021616|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021617|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
84021618|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84021619|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021620|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021621|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84021622|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84021623|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84021624|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84021625|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84021626|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84021627|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84021628|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
84021629|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84021630|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84021631|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84021632|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84021634|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84021635|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021636|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84021637|NCT00943917|Incretins|incretins|mesh-ancestor
84021638|NCT00943917|Hormones|hormones|mesh-ancestor
84021639|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021640|NCT02769832|Paclitaxel|paclitaxel|mesh-list
84021641|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84021642|NCT02769832|Gemcitabine|gemcitabine|mesh-list
84021643|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84021644|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021645|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
84021646|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
84021647|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
84021648|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021649|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84021650|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
84021651|NCT02876250|Cyclosporine|cyclosporine|mesh-list
84021652|NCT02876250|Cyclosporins|cyclosporins|mesh-list
84021653|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021654|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021655|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021656|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
84021657|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021658|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
84021659|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021660|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
84021661|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021662|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84021663|NCT02769910|Capsaicin|capsaicin|mesh-list
84021664|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
84021665|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
84021666|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
84021667|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021668|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021669|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
84021670|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84021671|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84021672|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84021673|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
84021674|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021675|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84021676|NCT02876484|Cathartics|cathartics|mesh-ancestor
84021677|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84021678|NCT02876094|Celecoxib|celecoxib|mesh-list
84021679|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021680|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021681|NCT02876094|Analgesics|analgesics|mesh-ancestor
84021682|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
84021683|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021684|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021685|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021686|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021687|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84021688|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84021689|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021690|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021691|NCT00603135|Levetiracetam|levetiracetam|mesh-list
84021692|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
84021693|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
84021694|NCT02769286|Osimertinib|osimertinib|mesh-list
84021695|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021696|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021697|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021698|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021699|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
84021700|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84021701|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
84021702|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021703|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
84021704|NCT02855073|Protective Agents|protective agents|mesh-ancestor
84021705|NCT02769130|Losartan|losartan|mesh-list
84021706|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84021707|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84021708|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84021709|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84021710|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021711|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
84021712|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84021713|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84021714|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84021715|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021717|NCT02851095|Canagliflozin|canagliflozin|mesh-list
84021718|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84021719|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021720|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84021721|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021722|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
84021723|NCT00580047|Vitamin D|vitamin d|mesh-list
84021724|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
84021725|NCT00580047|Alendronate|alendronate|mesh-list
84021726|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
84021727|NCT00580047|Calcium|calcium|mesh-list
84021728|NCT00580047|Vitamins|vitamins|mesh-ancestor
84021729|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
84021730|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021731|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84021732|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84021733|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021734|NCT00580047|Antacids|antacids|mesh-ancestor
84021735|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84021736|NCT01074450|Pramipexole|pramipexole|mesh-list
84021737|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
84021738|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021739|NCT01074450|Protective Agents|protective agents|mesh-ancestor
84021740|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021741|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84021742|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84021743|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
84021744|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
84021745|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021746|NCT02768116|Sirolimus|sirolimus|mesh-list
84021747|NCT02768116|Temsirolimus|temsirolimus|mesh-list
84021748|NCT02768116|MTOR Inhibitors|mtor inhibitors|mesh-list
84021749|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84021750|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021751|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84021752|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021753|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
84021754|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021755|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
84021756|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021757|NCT02768116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021758|NCT02768116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021759|NCT02768116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021760|NCT00635284|Sirolimus|sirolimus|mesh-list
84021761|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84021762|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021763|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84021764|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021765|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
84021766|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021767|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
84021768|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021769|NCT04131595|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84021770|NCT04131595|Antiviral Agents|antiviral agents|mesh-ancestor
84021771|NCT04131595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021772|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
84021773|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
84021774|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84021775|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84021776|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
84021777|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021778|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021779|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021780|NCT00699049|Urological Agents|urological agents|mesh-ancestor
84021781|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84021782|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021783|NCT04131283|Epinephrine|epinephrine|mesh-list
84021784|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84021785|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84021786|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021787|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021788|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021789|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021790|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84021791|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84021792|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
84021793|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021794|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84021795|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
84021796|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
84021797|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
84021798|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84021799|NCT00943761|Interferons|interferons|mesh-list
84021800|NCT00943761|Ribavirin|ribavirin|mesh-list
84021801|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021802|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
84021803|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021804|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
84021805|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021806|NCT02617771|Vitamin D|vitamin d|mesh-list
84021807|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
84021808|NCT02617771|Vitamins|vitamins|mesh-ancestor
84021809|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
84021810|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021811|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84021812|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84021813|NCT02696590|Vitamin D|vitamin d|mesh-list
84021814|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
84021815|NCT02696590|Vitamins|vitamins|mesh-ancestor
84021816|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
84021817|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021818|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84021819|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84021820|NCT02617459|Betaxolol|betaxolol|mesh-list
84021821|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84021822|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84021823|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84021824|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
84021825|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
84021826|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021827|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021828|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84021829|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84021830|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84021831|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021832|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021833|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021834|NCT02854995|Triamcinolone|triamcinolone|mesh-list
84021835|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021836|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
84021837|NCT02854995|Hormones|hormones|mesh-ancestor
84021838|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84021839|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021840|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
84021841|NCT02696512|Minocycline|minocycline|mesh-list
84021842|NCT02696512|Lamotrigine|lamotrigine|mesh-list
84021843|NCT02696512|Flumazenil|flumazenil|mesh-list
84021844|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84021845|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021846|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
84021847|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84021848|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84021849|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021850|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84021851|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021852|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84021853|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84021854|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021855|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84021856|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84021857|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
84021858|NCT02696512|Protective Agents|protective agents|mesh-ancestor
84021859|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
84021861|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
84021862|NCT02696512|Antidotes|antidotes|mesh-ancestor
84021863|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
84021864|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
84021865|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021866|NCT00949533|Oseltamivir|oseltamivir|mesh-list
84021867|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
84021868|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021869|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021870|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021871|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
84021872|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84021873|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84021874|NCT02854761|Vitamin D|vitamin d|mesh-list
84021875|NCT02854761|Vitamins|vitamins|mesh-ancestor
84021876|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
84021877|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021878|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84021879|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84021880|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84021881|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021882|NCT00866047|Immunotoxins|immunotoxins|mesh-ancestor
84021883|NCT00866047|Immunoconjugates|immunoconjugates|mesh-ancestor
84021884|NCT00866047|Immunologic Factors|immunologic factors|mesh-ancestor
84021885|NCT00866047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021886|NCT01706692|Cyclosporine|cyclosporine|mesh-list
84021887|NCT01706692|Adalimumab|adalimumab|mesh-list
84021888|NCT01706692|Infliximab|infliximab|mesh-list
84021889|NCT01706692|Etanercept|etanercept|mesh-list
84021890|NCT01706692|Methotrexate|methotrexate|mesh-list
84021891|NCT01706692|Ustekinumab|ustekinumab|mesh-list
84021892|NCT01706692|Cyclosporins|cyclosporins|mesh-list
84021893|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84021894|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
84021895|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84021896|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021897|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84021898|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
84021899|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021900|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021901|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
84021902|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021903|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84021904|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84021905|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
84021906|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021907|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84021908|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
84021909|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021910|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84021911|NCT01706692|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84021912|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84021913|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84021914|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84021915|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021916|NCT01706692|Analgesics|analgesics|mesh-ancestor
84021917|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
84021918|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021919|NCT00869323|Rituximab|rituximab|mesh-list
84021920|NCT00869323|Bortezomib|bortezomib|mesh-list
84021921|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84021922|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021923|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
84021924|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021925|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84021926|NCT02767102|Melatonin|melatonin|mesh-list
84021927|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
84021928|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021929|NCT02767102|Protective Agents|protective agents|mesh-ancestor
84021930|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261764|NCT05004805|Methylene Blue|methylene blue|mesh-list
84021931|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021932|NCT02774902|Clarithromycin|clarithromycin|mesh-list
84021933|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84021934|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84021935|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84021936|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021937|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021938|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84021939|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84021941|NCT02767024|Dobutamine|dobutamine|mesh-list
84021942|NCT02767024|Furosemide|furosemide|mesh-list
84021943|NCT02767024|Diuretics|diuretics|mesh-ancestor
84021944|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
84021945|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021946|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84021947|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84021948|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021949|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84021950|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
84021951|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
84021952|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021953|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84021954|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84021955|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84021956|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021957|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021958|NCT02767024|Protective Agents|protective agents|mesh-ancestor
84021959|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84021960|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
84021961|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84021962|NCT02774200|Apatinib|apatinib|mesh-list
84021963|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84021964|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84021965|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84021966|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021967|NCT02766634|Lenograstim|lenograstim|mesh-list
84021968|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84021969|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
84021970|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021971|NCT02774044|Beractant|beractant|mesh-list
84021972|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
84021973|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
84021974|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
84021975|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
84021976|NCT02766556|Ropivacaine|ropivacaine|mesh-list
84021977|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84021978|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84021979|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021980|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84021981|NCT02766556|Analgesics|analgesics|mesh-ancestor
84021982|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
84021983|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84021984|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84021985|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84021986|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84021987|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
84021988|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84021989|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021990|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
84021991|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
84021992|NCT01191944|Pramipexole|pramipexole|mesh-list
84021993|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
84021994|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84021995|NCT01191944|Protective Agents|protective agents|mesh-ancestor
84021996|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84021997|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84021998|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84021999|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
84022000|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
84022001|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022002|NCT00940875|Gemcitabine|gemcitabine|mesh-list
84022003|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84022004|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84022005|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
84022006|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022007|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022008|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022009|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022010|NCT02766322|Ethanol|ethanol|mesh-list
84022011|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84022012|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022013|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022014|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022015|NCT05655728|Metformin|metformin|mesh-list
84022016|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84022017|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022018|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84022019|NCT00940485|Entecavir|entecavir|mesh-list
84022020|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
84022021|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022022|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
84022023|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84022024|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
84022025|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022026|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022027|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84022028|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
84022029|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022030|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022031|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84022032|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84022033|NCT05655338|Amoxicillin|amoxicillin|mesh-list
84022034|NCT05655338|Metronidazole|metronidazole|mesh-list
84022035|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
84022036|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84022037|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84022038|NCT01132313|Ribavirin|ribavirin|mesh-list
84022039|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
84022040|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022041|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
84022042|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022043|NCT00422565|Sirolimus|sirolimus|mesh-list
84022044|NCT00422565|Paclitaxel|paclitaxel|mesh-list
84022045|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84022046|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022047|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
84022048|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
84022049|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
84022050|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022051|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84022052|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022053|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84022054|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
84022055|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84022056|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
84022057|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022058|NCT04316936|Dexamethasone|dexamethasone|mesh-list
84022059|NCT04316936|Prednisolone|prednisolone|mesh-list
84022060|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84022061|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
84022062|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84022063|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
84022064|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84022065|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
84022066|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022067|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
84022068|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
84022069|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022070|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022071|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022072|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
84022073|NCT04316936|Hormones|hormones|mesh-ancestor
84022074|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022075|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022076|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022077|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84022078|NCT04316936|Protective Agents|protective agents|mesh-ancestor
84022079|NCT00861757|Tadalafil|tadalafil|mesh-list
84022080|NCT00861757|Tamsulosin|tamsulosin|mesh-list
84022081|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
84022082|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84022083|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84022084|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022085|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022086|NCT00861757|Urological Agents|urological agents|mesh-ancestor
84022087|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84022088|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84022089|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84022090|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
84022091|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022092|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022094|NCT02762812|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84022095|NCT02762812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022096|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
84022097|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022098|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022099|NCT02762890|Iodine|iodine|mesh-list
84022100|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84022101|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022102|NCT02762890|Trace Elements|trace elements|mesh-ancestor
84022103|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
84022104|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022105|NCT02613715|Ethanol|ethanol|mesh-list
84022106|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84022107|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022108|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022109|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022110|NCT02762656|Lidocaine|lidocaine|mesh-list
84022111|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
84022112|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
84022113|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022114|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022115|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
84022116|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022117|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84022118|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83152505|NCT02630459|Erenumab|erenumab|mesh-list
84022119|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84022120|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022121|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022122|NCT00637325|Trastuzumab|trastuzumab|mesh-list
84022123|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84022124|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022125|NCT02762344|Heparin|heparin|mesh-list
84022126|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
84022127|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84022128|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84022129|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022130|NCT04663282|Insulin|insulin|mesh-list
84022131|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84022132|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022133|NCT01130597|Spironolactone|spironolactone|mesh-list
84022134|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84022135|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
84022136|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022137|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022138|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84022139|NCT01130597|Diuretics|diuretics|mesh-ancestor
84022140|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
84022141|NCT00939003|Adalimumab|adalimumab|mesh-list
84022142|NCT00939003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84022143|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022144|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022145|NCT01188668|Aripiprazole|aripiprazole|mesh-list
84022146|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84022147|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
84022148|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84022149|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84022150|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84022151|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022152|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022153|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
84022154|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
84022155|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022156|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022157|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84022158|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84022159|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
84022160|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84022161|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84022162|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84022163|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84022164|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84022165|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84022166|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022167|NCT01130051|Colchicine|colchicine|mesh-list
84022168|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
84022169|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022170|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
84022171|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
84022172|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
84022173|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022174|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022175|NCT00865189|Leucovorin|leucovorin|mesh-list
84022176|NCT00865189|Folic Acid|folic acid|mesh-list
84022177|NCT00865189|Bevacizumab|bevacizumab|mesh-list
84022178|NCT00865189|Fluorouracil|fluorouracil|mesh-list
84022179|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
84022180|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
84022181|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84022182|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022183|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84022184|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84022185|NCT00865189|Growth Substances|growth substances|mesh-ancestor
84022186|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022187|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
84022188|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
84022189|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022190|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84022191|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84022192|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
84022193|NCT00865189|Antidotes|antidotes|mesh-ancestor
84022194|NCT00865189|Protective Agents|protective agents|mesh-ancestor
84022195|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
84022196|NCT00865189|Vitamins|vitamins|mesh-ancestor
84022197|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
84022198|NCT00865189|Hematinics|hematinics|mesh-ancestor
84022199|NCT05362292|Mirabegron|mirabegron|mesh-list
84022200|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84022201|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84022202|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84022203|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84022204|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
84022205|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022206|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022207|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022208|NCT05362292|Urological Agents|urological agents|mesh-ancestor
84022209|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84022210|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84022211|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
84022212|NCT00698269|Insulin|insulin|mesh-list
84022213|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84022214|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
84022215|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
84022216|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84022217|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
84022218|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
84022219|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84022220|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84022221|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022222|NCT01182194|Drospirenone|drospirenone|mesh-list
84022223|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84022224|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84022225|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84022226|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
84022227|NCT01182194|Estradiol|estradiol|mesh-list
84022228|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84022229|NCT01182194|Estrogens|estrogens|mesh-ancestor
84022230|NCT01182194|Hormones|hormones|mesh-ancestor
84022231|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022232|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022233|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84022234|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
84022235|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84022236|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84022237|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84022238|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84022239|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84022240|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
84022241|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84022242|NCT01182194|Diuretics|diuretics|mesh-ancestor
84022243|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
84022244|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84022245|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84022246|NCT01181726|Norethindrone|norethindrone|mesh-list
84022247|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
84022248|NCT01181726|Estradiol|estradiol|mesh-list
84022249|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84022250|NCT01181726|Estrogens|estrogens|mesh-ancestor
84022251|NCT01181726|Hormones|hormones|mesh-ancestor
84022252|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022253|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022254|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84022255|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
84022256|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84022257|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84022258|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84022259|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84022260|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84022261|NCT01137071|Antibodies|antibodies|mesh-list
84022262|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84022263|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
84022264|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022265|NCT00603759|Celecoxib|celecoxib|mesh-list
84022266|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84022267|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84022268|NCT00603759|Analgesics|analgesics|mesh-ancestor
84022269|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
84022270|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022271|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022272|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022273|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022274|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84022275|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84022276|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022277|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022278|NCT04130815|Furosemide|furosemide|mesh-list
84022279|NCT04130815|Diuretics|diuretics|mesh-ancestor
84022280|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
84022281|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022282|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84022283|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022284|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022285|NCT04256265|Risdiplam|risdiplam|mesh-list
84022286|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84022287|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022288|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022289|NCT04312061|Tramadol|tramadol|mesh-list
84022290|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84022291|NCT04312061|Narcotics|narcotics|mesh-ancestor
84022292|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022293|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022294|NCT04312061|Analgesics|analgesics|mesh-ancestor
84022295|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
84022296|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022297|NCT00860743|Antioxidants|antioxidants|mesh-list
84022298|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022299|NCT00860743|Protective Agents|protective agents|mesh-ancestor
84022300|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022301|NCT01186796|Fulvestrant|fulvestrant|mesh-list
84022302|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022303|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022304|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84022305|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84022306|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
84022307|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022308|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022309|NCT05383131|Pirfenidone|pirfenidone|mesh-list
84022311|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022312|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022313|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022314|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022315|NCT05383131|Analgesics|analgesics|mesh-ancestor
84022316|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
84022317|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022318|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022319|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84022320|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84022321|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022322|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022323|NCT02761486|Aspirin|aspirin|mesh-list
84022324|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84022325|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84022326|NCT02761486|Analgesics|analgesics|mesh-ancestor
84022327|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
84022328|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022329|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022330|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022331|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022332|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84022333|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84022334|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022335|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84022336|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84022337|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022338|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
84022339|NCT02882789|Delpazolid|delpazolid|mesh-list
84022340|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
84022341|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84022342|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022343|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84022344|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022345|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022346|NCT00940017|Voriconazole|voriconazole|mesh-list
84022347|NCT00940017|Anidulafungin|anidulafungin|mesh-list
84022348|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
84022349|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022350|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84022351|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84022352|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022353|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022354|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84022355|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
84022356|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022357|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022358|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84022359|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
84022360|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84022361|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84022362|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84022363|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022364|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022365|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
84022366|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022367|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022368|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84022369|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022370|NCT01186328|Cytarabine|cytarabine|mesh-list
84022371|NCT01186328|Prednisone|prednisone|mesh-list
84022372|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
84022373|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84022374|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84022375|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84022376|NCT01186328|Cortisone|cortisone|mesh-list
84022377|NCT01186328|Doxorubicin|doxorubicin|mesh-list
84022378|NCT01186328|Methotrexate|methotrexate|mesh-list
84022379|NCT01186328|Vincristine|vincristine|mesh-list
84022380|NCT01186328|Asparaginase|asparaginase|mesh-list
84022381|NCT01186328|Pegaspargase|pegaspargase|mesh-list
84022382|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84022383|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022384|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84022385|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84022386|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022387|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022388|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022389|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
84022390|NCT01186328|Hormones|hormones|mesh-ancestor
84022391|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022392|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022393|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022394|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84022395|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
84022396|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84022397|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84022398|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
84022399|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
84022400|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84022401|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84022402|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
84022403|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022404|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84022405|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
84022406|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022407|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84022408|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
84022409|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
84022410|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
84022411|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
84022412|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
84022413|NCT00848497|Testosterone|testosterone|mesh-list
84022414|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
84022415|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
84022416|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84022417|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022418|NCT00848497|Androgens|androgens|mesh-ancestor
84022419|NCT00848497|Hormones|hormones|mesh-ancestor
84022420|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022421|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022422|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022423|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022424|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
84022425|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
84022426|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84022427|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84022428|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022429|NCT00848497|Urological Agents|urological agents|mesh-ancestor
84022430|NCT02763592|Lidocaine|lidocaine|mesh-list
84022431|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
84022432|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
84022433|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022434|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022435|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
84022436|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022437|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84022438|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84022439|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84022440|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022441|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022442|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
84022443|NCT01185782|Hormones|hormones|mesh-list
84022444|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84022445|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022446|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022447|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84022448|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
84022449|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84022450|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
84022451|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84022452|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84022453|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84022454|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84022455|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84022456|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
84022457|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022458|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022459|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022460|NCT02882555|Capsaicin|capsaicin|mesh-list
84022461|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
84022462|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
84022463|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
84022464|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022465|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022466|NCT00699361|Pantoprazole|pantoprazole|mesh-list
84022467|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84022468|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022469|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84022470|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022471|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022472|NCT01185704|Cetrorelix|cetrorelix|mesh-list
84022473|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84022474|NCT01185704|Hormones|hormones|mesh-list
84022475|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84022476|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022477|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022478|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84022479|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
84022480|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84022481|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
84022482|NCT01128959|Carbamazepine|carbamazepine|mesh-list
84022483|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
84022484|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
84022485|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84022486|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022487|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022488|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84022489|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84022490|NCT01128959|Analgesics|analgesics|mesh-ancestor
84022491|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
84022492|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022493|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84022494|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022495|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022496|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84022497|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84022498|NCT04119739|Ibuprofen|ibuprofen|mesh-list
84022499|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84022500|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84022501|NCT04119739|Analgesics|analgesics|mesh-ancestor
84022502|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
84022503|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022504|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022505|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022506|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022507|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84022508|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022509|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022510|NCT00859573|Modafinil|modafinil|mesh-list
84022511|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84022512|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022513|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84022514|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84022515|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84022516|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022517|NCT02758444|Micronutrients|micronutrients|mesh-list
84022518|NCT02758444|Trace Elements|trace elements|mesh-list
84022519|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022520|NCT01185548|Tolbutamide|tolbutamide|mesh-list
84022521|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84022522|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022523|NCT01128569|Fluticasone|fluticasone|mesh-list
84022524|NCT01128569|Xhance|xhance|mesh-list
84022525|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022526|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84022527|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
84022528|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022529|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022530|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84022531|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
84022532|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
84022533|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84022534|NCT04582942|Lactulose|lactulose|mesh-list
84022535|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022536|NCT02883179|Lidocaine|lidocaine|mesh-list
84022537|NCT02883179|Prilocaine|prilocaine|mesh-list
84022538|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
84022539|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
84022540|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
84022541|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022542|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022543|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
84022544|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022545|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84022546|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84022547|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84022548|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022549|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022550|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
84022551|NCT02758366|Doxorubicin|doxorubicin|mesh-list
84022552|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84022553|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022554|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84022555|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84022556|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022557|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022558|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
84022559|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84022560|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
84022561|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022562|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022563|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84022564|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
84022565|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022566|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022567|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84022568|NCT00637403|Megestrol|megestrol|mesh-list
84022569|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
84022570|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84022571|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84022572|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84022573|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
84022574|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84022575|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022576|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84022577|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84022578|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022579|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022580|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
84022581|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84022582|NCT01185080|Adenosine|adenosine|mesh-list
84022583|NCT01185080|Analgesics|analgesics|mesh-ancestor
84022584|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
84022585|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022586|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022587|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84022588|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
84022589|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84022590|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
84022591|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
84022592|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022593|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022594|NCT01181102|Enoxaparin|enoxaparin|mesh-list
84022595|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
84022596|NCT01181102|Edoxaban|edoxaban|mesh-list
84022597|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
84022598|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84022599|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84022600|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022601|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84022602|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
83262429|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022603|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84022604|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
84022605|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022606|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
84022607|NCT00858637|Simvastatin|simvastatin|mesh-list
84022608|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84022609|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84022610|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
84022611|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022612|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84022613|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84022614|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022615|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022616|NCT02760316|Prednisolone|prednisolone|mesh-list
84022617|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84022618|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
84022619|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84022620|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
84022621|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84022622|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
84022623|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022624|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
84022625|NCT02760316|Hormones|hormones|mesh-ancestor
84022626|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022627|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022628|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022629|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022630|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
84022631|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
84022632|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022633|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022634|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84022635|NCT02760316|Protective Agents|protective agents|mesh-ancestor
84022636|NCT00858403|Dasatinib|dasatinib|mesh-list
84022637|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022638|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022639|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022640|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022641|NCT02760472|SMOFlipid|smoflipid|mesh-list
84022642|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84022643|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84022644|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84022645|NCT00858247|Vitamin D|vitamin d|mesh-list
84022646|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
84022647|NCT00858247|Vitamins|vitamins|mesh-ancestor
84022648|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
84022649|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022650|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84022651|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84022652|NCT04222348|Metformin|metformin|mesh-list
84022653|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
84022654|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84022655|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022656|NCT04222114|Catumaxomab|catumaxomab|mesh-list
84022657|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022658|NCT00838435|Verapamil|verapamil|mesh-list
84022659|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84022660|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84022661|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022662|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022663|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84022664|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022665|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
84022666|NCT02757508|Vitamins|vitamins|mesh-list
84022667|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
84022668|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022669|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
84022670|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
84022671|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
84022672|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022673|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022674|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022675|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
84022676|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84022677|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84022678|NCT02757196|Prednisolone|prednisolone|mesh-list
84022679|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
84022681|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84022682|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
84022683|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84022684|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022685|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
84022686|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022687|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022688|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022689|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
84022690|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
84022691|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022692|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022693|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
84022694|NCT02757196|Hormones|hormones|mesh-ancestor
84022695|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022696|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84022697|NCT02757196|Protective Agents|protective agents|mesh-ancestor
84022698|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022699|NCT04403698|Alendronate|alendronate|mesh-list
84022700|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84022701|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022702|NCT02759926|Quinine|quinine|mesh-list
84022703|NCT02759926|Denatonium|denatonium|mesh-list
84022704|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
84022705|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84022706|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84022707|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022708|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84022709|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022710|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84022711|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022712|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84022713|NCT02759926|Analgesics|analgesics|mesh-ancestor
84022714|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
84022715|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
84022716|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022717|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
84022718|NCT04221256|Escitalopram|escitalopram|mesh-list
84022719|NCT04221256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84022720|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84022721|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84022722|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022723|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022724|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
84022725|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022726|NCT00838201|Denosumab|denosumab|mesh-list
84022727|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84022728|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022729|NCT00837967|Terbutaline|terbutaline|mesh-list
84022730|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84022731|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84022732|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
84022733|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84022734|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
84022735|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022736|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022737|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
84022738|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
84022739|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84022740|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84022741|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84022742|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84022743|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
84022744|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022745|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022746|NCT02759614|Bevacizumab|bevacizumab|mesh-list
84022747|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84022748|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84022749|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022750|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84022751|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84022752|NCT02759614|Growth Substances|growth substances|mesh-ancestor
83262577|NCT05174611|Vitamins|vitamins|mesh-ancestor
84022753|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022754|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
84022755|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022756|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022757|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022759|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022760|NCT02759224|Irsogladine|irsogladine|mesh-list
84022761|NCT02759224|Lafutidine|lafutidine|mesh-list
84022762|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022763|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84022764|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022765|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84022766|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
84022767|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
84022768|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022769|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022770|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022771|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84022772|NCT02759224|Protective Agents|protective agents|mesh-ancestor
84022773|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84022774|NCT02756728|Melphalan|melphalan|mesh-list
84022775|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84022776|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
84022777|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022778|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022779|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84022780|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84022781|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
84022782|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022783|NCT04586920|Itraconazole|itraconazole|mesh-list
84022784|NCT04586920|Midazolam|midazolam|mesh-list
84022785|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84022786|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84022787|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022788|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022789|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84022790|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84022791|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84022792|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84022793|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
84022794|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
84022795|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
84022796|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
84022797|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022798|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022799|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
84022800|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84022801|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84022802|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84022803|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022804|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84022805|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
84022806|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022807|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84022808|NCT02758990|Vitamin D|vitamin d|mesh-list
84022809|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
84022810|NCT02758990|Vitamins|vitamins|mesh-list
84022811|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
84022812|NCT02758990|Vitamin E|vitamin e|mesh-list
84022813|NCT02758990|Tocopherols|tocopherols|mesh-list
84022814|NCT02758990|Vitamin A|vitamin a|mesh-list
84022815|NCT02758990|Niacinamide|niacinamide|mesh-list
84022816|NCT02758990|Niacin|niacin|mesh-list
84022817|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
84022818|NCT02758990|Pyridoxine|pyridoxine|mesh-list
84022819|NCT02758990|Pyridoxal|pyridoxal|mesh-list
84022820|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
84022821|NCT02758990|Caffeine|caffeine|mesh-list
84022822|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
84022823|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022824|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84022825|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83262656|NCT05073679|Naltrexone|naltrexone|mesh-list
84022826|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84022827|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84022828|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022829|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022830|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84022831|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84022832|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
84022833|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022834|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
84022835|NCT02758990|Protective Agents|protective agents|mesh-ancestor
84022836|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
84022837|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84022838|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
84022839|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84022840|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
84022841|NCT02756104|Vitamin D|vitamin d|mesh-list
84022842|NCT02756104|Vitamins|vitamins|mesh-ancestor
84022843|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
84022844|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022845|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84022846|NCT02756026|Micronutrients|micronutrients|mesh-list
84022847|NCT02756026|Trace Elements|trace elements|mesh-list
84022848|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022849|NCT02755714|Bromides|bromides|mesh-list
84022850|NCT02755714|Ipratropium|ipratropium|mesh-list
84022851|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
84022852|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84022853|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
84022854|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022855|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022856|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84022857|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
84022858|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84022859|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
84022860|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022861|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022862|NCT02758522|Insulin|insulin|mesh-list
84022863|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84022864|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84022865|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022866|NCT00942357|Paclitaxel|paclitaxel|mesh-list
84022867|NCT00942357|Cisplatin|cisplatin|mesh-list
84022868|NCT00942357|Carboplatin|carboplatin|mesh-list
84022869|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84022870|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84022871|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022872|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
84022873|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
84022874|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
84022875|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022876|NCT02752828|Insulin|insulin|mesh-list
84022877|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84022878|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
84022879|NCT02752828|Lixisenatide|lixisenatide|mesh-list
84022880|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84022881|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022882|NCT02753062|Rituximab|rituximab|mesh-list
84022883|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84022884|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84022885|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022886|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
84022887|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022888|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022889|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84022890|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
84022891|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022892|NCT02752204|Rituximab|rituximab|mesh-list
84022893|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84022894|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022895|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
84022896|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022897|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84022898|NCT04220398|Hormones|hormones|mesh-list
84022899|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022900|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022901|NCT04220632|Prednisone|prednisone|mesh-list
84022902|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
84022903|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83262733|NCT05057767|Midazolam|midazolam|mesh-list
84022904|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84022905|NCT04220632|Prednisolone|prednisolone|mesh-list
84022906|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
84022907|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84022908|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
84022909|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022910|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
84022912|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022913|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022914|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022915|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022916|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
84022917|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
84022918|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022919|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84022920|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84022921|NCT04220632|Protective Agents|protective agents|mesh-ancestor
84022922|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84022923|NCT00939627|Cetuximab|cetuximab|mesh-list
84022924|NCT00939627|Sorafenib|sorafenib|mesh-list
84022925|NCT00939627|Antibodies|antibodies|mesh-list
84022926|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
84022927|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84022928|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
84022929|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022930|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022931|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022932|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022933|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022934|NCT05382741|Durvalumab|durvalumab|mesh-list
84022935|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84022936|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022937|NCT04220476|Letrozole|letrozole|mesh-list
84022938|NCT04220476|Palbociclib|palbociclib|mesh-list
84022939|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022940|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84022941|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84022942|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022943|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022944|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84022945|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
84022946|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022947|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022948|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022949|NCT02695810|Metformin|metformin|mesh-list
84022950|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
84022951|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84022952|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022953|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84022954|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022955|NCT02753764|Prednisone|prednisone|mesh-list
84022956|NCT02753764|AZD7624|azd7624|mesh-list
84022957|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84022958|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
84022959|NCT02753764|Hormones|hormones|mesh-ancestor
84022960|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84022961|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022962|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84022963|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84022964|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022965|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022966|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022967|NCT02695654|Clonidine|clonidine|mesh-list
84022968|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
84022969|NCT02695654|Analgesics|analgesics|mesh-ancestor
84022970|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
84022971|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84022972|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022973|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84022974|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
84022975|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
84022976|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84022977|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84022978|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84022979|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
84022980|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84022981|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022982|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
84022984|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022985|NCT02696122|Anesthetics|anesthetics|mesh-list
84022986|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84022987|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022988|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84022989|NCT01135511|Tofacitinib|tofacitinib|mesh-list
84022990|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
84022991|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84022992|NCT01135511|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84022993|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84022994|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84022995|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84022996|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84022997|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
84022998|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84022999|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
84023000|NCT01135511|Protective Agents|protective agents|mesh-ancestor
84023001|NCT02753140|Docetaxel|docetaxel|mesh-list
84023002|NCT02753140|Cetuximab|cetuximab|mesh-list
84023003|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023004|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
84023005|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
84023006|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
84023007|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023008|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023009|NCT02753218|Midazolam|midazolam|mesh-list
84023010|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83478025|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
84023011|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84023012|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023013|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023014|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84023015|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84023016|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84023017|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023018|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
84023019|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
84023020|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
84023021|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
84023022|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023023|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023024|NCT05429554|Vildagliptin|vildagliptin|mesh-list
84023025|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023026|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023027|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84023028|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
84023029|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023030|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023031|NCT05429086|Propofol|propofol|mesh-list
84023032|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84023033|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023034|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023035|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023036|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
84023037|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
84023038|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
84023039|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84023040|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84023041|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023042|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
84023043|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84023044|NCT01180790|Interferons|interferons|mesh-list
84023045|NCT01180790|Ribavirin|ribavirin|mesh-list
84023046|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
84023047|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
84023048|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84023049|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023050|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
84023051|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023052|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
84023053|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262879|NCT02316171|Mitomycins|mitomycins|mesh-list
84023054|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
84023055|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023056|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
84023057|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84023058|NCT01184846|Antibodies|antibodies|mesh-list
84023059|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
84023060|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023061|NCT01191086|Topiramate|topiramate|mesh-list
84023062|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
84023063|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023064|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023065|NCT01076400|Topotecan|topotecan|mesh-list
84023066|NCT01076400|Adavosertib|adavosertib|mesh-list
84023067|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023068|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84023069|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84023070|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023071|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023072|NCT05318560|Lidocaine|lidocaine|mesh-list
84023073|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
84023074|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
84023075|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023076|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023077|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
84023078|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023079|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84023080|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84023081|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84023082|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023083|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023084|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
84023085|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84023086|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84023087|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84023088|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023089|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023090|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
84023091|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023092|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023093|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84023094|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023095|NCT01086384|Fluticasone|fluticasone|mesh-list
84023096|NCT01086384|Xhance|xhance|mesh-list
84023097|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023098|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84023099|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
84023100|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023101|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023102|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84023103|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
84023104|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
84023105|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84023106|NCT04115644|Triamcinolone|triamcinolone|mesh-list
84023107|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84023108|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84023109|NCT04115644|Ketorolac|ketorolac|mesh-list
84023110|NCT04115644|Bupivacaine|bupivacaine|mesh-list
84023111|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84023112|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
84023113|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
84023114|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023115|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023116|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
84023117|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023118|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023119|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
84023120|NCT04115644|Hormones|hormones|mesh-ancestor
84023121|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023122|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023123|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
84023124|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023125|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023126|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84023127|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84023128|NCT04115644|Analgesics|analgesics|mesh-ancestor
84023129|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023130|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84023131|NCT00635986|Fentanyl|fentanyl|mesh-list
84023132|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84023133|NCT00635986|Narcotics|narcotics|mesh-ancestor
84023134|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023135|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023136|NCT00635986|Analgesics|analgesics|mesh-ancestor
84023137|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
84023138|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023139|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84023140|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023141|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
84023142|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
84023143|NCT04799626|Levofloxacin|levofloxacin|mesh-list
84023144|NCT04799626|Meropenem|meropenem|mesh-list
84023145|NCT04799626|Tazobactam|tazobactam|mesh-list
84023146|NCT04799626|Piperacillin|piperacillin|mesh-list
84023147|NCT04799626|Tigecycline|tigecycline|mesh-list
84023148|NCT04799626|Biapenem|biapenem|mesh-list
84023149|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84023150|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023151|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84023152|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84023153|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84023154|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023155|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023156|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023157|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84023158|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84023159|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84023160|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84023161|NCT00636064|Parecoxib|parecoxib|mesh-list
84023162|NCT00636064|Valdecoxib|valdecoxib|mesh-list
84023163|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84023164|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84023165|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023166|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023167|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84023168|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84023169|NCT00636064|Analgesics|analgesics|mesh-ancestor
84023170|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
84023171|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023172|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023173|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023174|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023175|NCT02751034|Lidocaine|lidocaine|mesh-list
84023176|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
84023177|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
84023178|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023179|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023180|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
84023181|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023182|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84023183|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84023184|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84023185|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023186|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023187|NCT04217668|Isosorbide|isosorbide|mesh-list
84023188|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84023189|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84023190|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84023191|NCT04217668|Diuretics|diuretics|mesh-ancestor
84023192|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
84023193|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023194|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
84023195|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84023196|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023197|NCT01127165|Zonisamide|zonisamide|mesh-list
84023198|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
84023199|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84023200|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023201|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023202|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84023203|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023204|NCT04335292|Pemetrexed|pemetrexed|mesh-list
84023205|NCT04335292|Osimertinib|osimertinib|mesh-list
84023206|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023207|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023208|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023209|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84023210|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84023211|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84023212|NCT04278508|Progesterone|progesterone|mesh-list
84023213|NCT04278508|Progestins|progestins|mesh-ancestor
84023214|NCT04278508|Hormones|hormones|mesh-ancestor
84023215|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023216|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023217|NCT05382351|Tenofovir|tenofovir|mesh-list
84023218|NCT05382351|Entecavir|entecavir|mesh-list
84023219|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
84023220|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023221|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84023222|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84023223|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023224|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023225|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84023226|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84023227|NCT04218760|Isosorbide|isosorbide|mesh-list
84023228|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84023229|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84023230|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84023231|NCT04218760|Diuretics|diuretics|mesh-ancestor
84023232|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
84023233|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023234|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
84023235|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84023236|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023237|NCT02750254|Plerixafor|plerixafor|mesh-list
84023238|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
84023239|NCT02750254|Melphalan|melphalan|mesh-list
84023240|NCT02750254|Busulfan|busulfan|mesh-list
84023241|NCT02750254|Fludarabine|fludarabine|mesh-list
84023242|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
84023243|NCT02750254|Azacitidine|azacitidine|mesh-list
84023244|NCT02750254|Lenograstim|lenograstim|mesh-list
84023245|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023246|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
84023247|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023248|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023249|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84023250|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
84023251|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023252|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023253|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84023254|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84023255|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
84023256|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023257|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84023258|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84023259|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84023260|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
84023261|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023262|NCT00941655|Leucovorin|leucovorin|mesh-list
84023263|NCT00941655|Fluorouracil|fluorouracil|mesh-list
84023264|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
84023265|NCT00941655|Irinotecan|irinotecan|mesh-list
84023266|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
84023267|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023268|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84023269|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023270|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023271|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
84023272|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023273|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84023274|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84023275|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023276|NCT00941655|Antidotes|antidotes|mesh-ancestor
84023277|NCT00941655|Protective Agents|protective agents|mesh-ancestor
84023278|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
84023279|NCT00941655|Vitamins|vitamins|mesh-ancestor
84023280|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
84023281|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
84023283|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023284|NCT00605787|Protective Agents|protective agents|mesh-ancestor
84023285|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023286|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84023287|NCT00936117|Posaconazole|posaconazole|mesh-list
84023288|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
84023289|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023290|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84023291|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84023292|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84023293|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84023294|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84023295|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023296|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023297|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84023298|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
84023299|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023300|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023301|NCT04267653|Lactoferrin|lactoferrin|mesh-list
84023302|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023303|NCT04088500|Nivolumab|nivolumab|mesh-list
84023304|NCT04088500|Ipilimumab|ipilimumab|mesh-list
84023305|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023306|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023307|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84023308|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023309|NCT01082874|Clonidine|clonidine|mesh-list
84023310|NCT01082874|Analgesics|analgesics|mesh-ancestor
84023311|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
84023312|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023313|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023314|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023315|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84023316|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
84023317|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
84023318|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84023319|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84023320|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84023321|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
84023322|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023323|NCT00607503|Terbutaline|terbutaline|mesh-list
84023324|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84023325|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
84023326|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023327|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023328|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84023329|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
84023330|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
84023331|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
84023332|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84023333|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84023334|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84023335|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84023336|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
84023337|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023338|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023339|NCT04217512|Pantoprazole|pantoprazole|mesh-list
84023340|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84023341|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84023342|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84023343|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023344|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023345|NCT01079988|Cyclosporine|cyclosporine|mesh-list
84023346|NCT01079988|Methotrexate|methotrexate|mesh-list
84023347|NCT01079988|Cyclosporins|cyclosporins|mesh-list
84023348|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84023349|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
84023350|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84023351|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023352|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84023353|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
84023354|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023355|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023356|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
84023357|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023358|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84023359|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023360|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
84023361|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023362|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84023363|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
84023364|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023365|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84023366|NCT03974152|Nicotine|nicotine|mesh-list
84023367|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84023368|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
84023369|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023370|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023371|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84023372|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84023373|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
84023374|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023375|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023376|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
84023377|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84023378|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
84023379|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84023380|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
84023381|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023382|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023383|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
84023384|NCT03508570|Nivolumab|nivolumab|mesh-list
84023385|NCT03508570|Ipilimumab|ipilimumab|mesh-list
84023386|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023387|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023388|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84023389|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023390|NCT01074216|Vitamin D|vitamin d|mesh-list
84023391|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
84023392|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
84023393|NCT01074216|Vitamins|vitamins|mesh-list
84023394|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
84023395|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023396|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84023397|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84023398|NCT00636142|Infliximab|infliximab|mesh-list
84023399|NCT00636142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84023400|NCT00636142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023401|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
84023402|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84023403|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023404|NCT02499562|Entecavir|entecavir|mesh-list
84023405|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
84023406|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023407|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
84023408|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
84023409|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84023410|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023411|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023412|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023413|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
84023414|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023415|NCT02875002|Belinostat|belinostat|mesh-list
84023416|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023417|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84023418|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023419|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023420|NCT02749396|Interferons|interferons|mesh-list
84023421|NCT02749396|Interferon-beta|interferon-beta|mesh-list
84023422|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
84023423|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
84023424|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023425|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
84023426|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023427|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
84023428|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263246|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023429|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84023430|NCT04745910|Rasburicase|rasburicase|mesh-list
84023432|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
84023433|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023434|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
84023435|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023436|NCT04745910|Protective Agents|protective agents|mesh-ancestor
84023437|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023438|NCT02749162|Acetaminophen|acetaminophen|mesh-list
84023439|NCT02749162|Dexamethasone|dexamethasone|mesh-list
84023440|NCT02749162|Lidocaine|lidocaine|mesh-list
84023441|NCT02749162|Morphine|morphine|mesh-list
84023442|NCT02749162|Ropivacaine|ropivacaine|mesh-list
84023443|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84023444|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023445|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
84023446|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
84023447|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023448|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023449|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84023450|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
84023451|NCT02749162|Hormones|hormones|mesh-ancestor
84023452|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023453|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84023454|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023455|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
84023456|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
84023457|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023458|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
84023459|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84023460|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84023461|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84023462|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023463|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023464|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84023465|NCT02749162|Narcotics|narcotics|mesh-ancestor
84023466|NCT02749162|Analgesics|analgesics|mesh-ancestor
84023467|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84023468|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
84023469|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84023470|NCT02041234|Liraglutide|liraglutide|mesh-list
84023471|NCT02041234|Empagliflozin|empagliflozin|mesh-list
84023472|NCT02041234|Linagliptin|linagliptin|mesh-list
84023473|NCT02041234|Canagliflozin|canagliflozin|mesh-list
84023474|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
84023475|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84023476|NCT02041234|Orlistat|orlistat|mesh-list
84023477|NCT02041234|Incretins|incretins|mesh-list
84023478|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023479|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023480|NCT02041234|Hormones|hormones|mesh-ancestor
84023481|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023482|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
84023483|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023484|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023485|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84023486|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84023487|NCT02695732|Carvedilol|carvedilol|mesh-list
84023488|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84023489|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84023490|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
84023491|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023492|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023493|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023494|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84023495|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
84023496|NCT02695732|Protective Agents|protective agents|mesh-ancestor
84023497|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84023498|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023499|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84023500|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
84023501|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84023502|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84023503|NCT02751268|Ropivacaine|ropivacaine|mesh-list
84023504|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
84023505|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
84023506|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023507|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023508|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
84023509|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023510|NCT02748772|Thalidomide|thalidomide|mesh-list
84023511|NCT02748772|Endostar protein|endostar protein|mesh-list
84023512|NCT02748772|Endostatins|endostatins|mesh-list
84023513|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023514|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
84023515|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023516|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
84023517|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84023518|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023519|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84023520|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84023521|NCT02748772|Growth Substances|growth substances|mesh-ancestor
84023522|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
84023523|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023524|NCT04406272|Bevacizumab|bevacizumab|mesh-list
84023525|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023526|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023527|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84023528|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84023529|NCT04406272|Growth Substances|growth substances|mesh-ancestor
84023530|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023531|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
84023532|NCT04216888|Ketamine|ketamine|mesh-list
84023533|NCT04216888|Analgesics|analgesics|mesh-ancestor
84023534|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
84023535|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023536|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023537|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84023538|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023539|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
84023540|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
84023541|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023542|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84023543|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84023544|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023545|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023546|NCT02746744|Rituximab|rituximab|mesh-list
84023547|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84023548|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023549|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023550|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
84023551|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023552|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023553|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
84023554|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023555|NCT02748304|Aspirin|aspirin|mesh-list
84023556|NCT02748304|Sorafenib|sorafenib|mesh-list
84023557|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84023558|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84023559|NCT02748304|Analgesics|analgesics|mesh-ancestor
84023560|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
84023561|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023562|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023563|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023564|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023565|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84023566|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84023567|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023568|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84023569|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84023570|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023571|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
84023572|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023573|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84023574|NCT02746276|Metronidazole|metronidazole|mesh-list
84023575|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
84023576|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023577|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84023578|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84023579|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84023580|NCT02745886|Metformin|metformin|mesh-list
84023581|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023582|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023583|NCT02742142|Fluorides|fluorides|mesh-list
84023584|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
84023585|NCT02742142|Protective Agents|protective agents|mesh-ancestor
84023586|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023587|NCT00636298|Bevacizumab|bevacizumab|mesh-list
84023588|NCT00636298|Cetuximab|cetuximab|mesh-list
84023589|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023590|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023591|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84023592|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84023593|NCT00636298|Growth Substances|growth substances|mesh-ancestor
84023594|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023595|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
84023596|NCT02744716|Aspirin|aspirin|mesh-list
84023597|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84023598|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84023599|NCT02744716|Analgesics|analgesics|mesh-ancestor
84023600|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
84023601|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023602|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023603|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023604|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023605|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84023606|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84023607|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023608|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84023609|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84023610|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023611|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
84023612|NCT02744872|Felodipine|felodipine|mesh-list
84023613|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84023614|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84023615|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84023616|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023617|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023618|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84023619|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023620|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
84023621|NCT02744638|Metronidazole|metronidazole|mesh-list
84023622|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023623|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84023624|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84023625|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84023626|NCT02740894|Gefitinib|gefitinib|mesh-list
84023627|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023628|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84023629|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023630|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023631|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
84023632|NCT00857389|Busulfan|busulfan|mesh-list
84023633|NCT00857389|Thiotepa|thiotepa|mesh-list
84023634|NCT00857389|Methotrexate|methotrexate|mesh-list
84023635|NCT00857389|Clofarabine|clofarabine|mesh-list
84023636|NCT00857389|Tacrolimus|tacrolimus|mesh-list
84023637|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
84023638|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84023639|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023640|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
84023641|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023642|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023643|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84023644|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
84023645|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023646|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023647|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84023648|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84023649|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
84023650|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84023651|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84023652|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
84023653|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
84023654|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023655|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84023656|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84023657|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84023658|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
84023659|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84023660|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023661|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023662|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84023663|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023664|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84023666|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023667|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023668|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
84023669|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023670|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023671|NCT00857311|Vaccines|vaccines|mesh-list
84023672|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
84023673|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023674|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
84023675|NCT02874768|Propofol|propofol|mesh-list
84023676|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84023677|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023678|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023679|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84023680|NCT02874768|Analgesics|analgesics|mesh-ancestor
84023681|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
84023682|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023683|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84023684|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84023685|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84023686|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
84023687|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152509|NCT02630459|Analgesics|analgesics|mesh-ancestor
84023688|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023689|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023690|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
84023691|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
84023692|NCT00857233|Memantine|memantine|mesh-list
84023693|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84023694|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84023695|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
84023696|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023697|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023698|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023699|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84023700|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84023701|NCT02740426|Pirarubicin|pirarubicin|mesh-list
84023702|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023703|NCT02743234|Vancomycin|vancomycin|mesh-list
84023704|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
84023705|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84023706|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023707|NCT02740270|Spartalizumab|spartalizumab|mesh-list
84023708|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84023709|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023710|NCT02740270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84023711|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023712|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
84023713|NCT00856843|Laxatives|laxatives|mesh-ancestor
84023714|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84023715|NCT02740192|Bupivacaine|bupivacaine|mesh-list
84023716|NCT02740192|Ropivacaine|ropivacaine|mesh-list
84023717|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
84023718|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
84023719|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023720|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023721|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
84023722|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023723|NCT02743390|Infliximab|infliximab|mesh-list
84023724|NCT02743390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84023725|NCT02743390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023726|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
84023727|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84023728|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84023729|NCT00856609|Exenatide|exenatide|mesh-list
84023730|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023731|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023732|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83263552|NCT02450539|Docetaxel|docetaxel|mesh-list
84023733|NCT00856609|Incretins|incretins|mesh-ancestor
84023734|NCT00856609|Hormones|hormones|mesh-ancestor
84023735|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023736|NCT02739958|Propofol|propofol|mesh-list
84023737|NCT02739958|Isoflurane|isoflurane|mesh-list
84023738|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84023739|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023740|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023741|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023742|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
84023743|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
84023744|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84023745|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
84023746|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84023747|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
84023748|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023749|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
84023750|NCT02739880|Protective Agents|protective agents|mesh-ancestor
84023751|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
84023752|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84023753|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84023754|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84023755|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023756|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023757|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
84023758|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023759|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023760|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84023761|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023762|NCT00856375|Irinotecan|irinotecan|mesh-list
84023763|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
84023764|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84023765|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84023766|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023767|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023768|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023769|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84023770|NCT01070784|Budesonide|budesonide|mesh-list
84023771|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
84023772|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84023773|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84023774|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84023775|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
84023776|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023777|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023778|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84023779|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
84023780|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
84023781|NCT01070784|Hormones|hormones|mesh-ancestor
84023782|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023783|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84023784|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84023785|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84023786|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
84023787|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023788|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023789|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
84023790|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023791|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023792|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84023793|NCT00837577|Voglibose|voglibose|mesh-list
84023794|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023795|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023796|NCT00837577|Incretins|incretins|mesh-ancestor
84023797|NCT00837577|Hormones|hormones|mesh-ancestor
84023798|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84023799|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84023800|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
84023801|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023802|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023803|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84023804|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84023805|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
84023806|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023807|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84023808|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
84023809|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84023810|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
84023811|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84023812|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023813|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84023814|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84023815|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023816|NCT00848107|Treprostinil|treprostinil|mesh-list
84023817|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84023818|NCT04030741|Metronidazole|metronidazole|mesh-list
84023819|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023820|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84023821|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84023822|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84023823|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
84023824|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84023825|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
84023826|NCT05620108|Rocuronium|rocuronium|mesh-list
84023827|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84023828|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84023829|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84023830|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023831|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023832|NCT00856297|Vaccines|vaccines|mesh-list
84023833|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
84023834|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023835|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
84023836|NCT02736604|Anesthetics|anesthetics|mesh-list
84023837|NCT02736604|Sevoflurane|sevoflurane|mesh-list
84023838|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023839|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023840|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84023841|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84023842|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
84023843|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84023844|NCT02736604|Analgesics|analgesics|mesh-ancestor
84023845|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
84023846|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023847|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
84023848|NCT02613013|Pilocarpine|pilocarpine|mesh-list
84023849|NCT02613013|Miotics|miotics|mesh-ancestor
84023850|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
84023851|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023852|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023853|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84023854|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84023855|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
84023856|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023857|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023858|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
84023859|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
84023860|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023861|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
84023862|NCT04306510|Antibodies|antibodies|mesh-list
84023863|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
84023864|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84023865|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
84023866|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023867|NCT02611921|Ketamine|ketamine|mesh-list
84023868|NCT02611921|Analgesics|analgesics|mesh-ancestor
84023869|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
84023870|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023871|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023872|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84023873|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023874|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
84023875|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
84023876|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023877|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84023878|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84023879|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023880|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023881|NCT02736448|Capecitabine|capecitabine|mesh-list
84023882|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84023883|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
84023884|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023885|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023886|NCT00703651|Vaccines|vaccines|mesh-list
84023887|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
84023888|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023889|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
84023890|NCT01046136|Guaifenesin|guaifenesin|mesh-list
84023891|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
84023892|NCT01046136|Expectorants|expectorants|mesh-ancestor
84023893|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
84023894|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84023895|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84023896|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
84023897|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023898|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023899|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023900|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
84023901|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84023902|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
84023903|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
84023904|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023905|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
84023906|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84023907|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84023908|NCT02736682|Metronidazole|metronidazole|mesh-list
84023909|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84023910|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84023911|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
84023912|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84023913|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84023914|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
84023915|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84023916|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023917|NCT02874690|Methylphenidate|methylphenidate|mesh-list
84023918|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84023919|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023920|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84023921|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84023922|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023923|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023924|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
84023925|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023926|NCT02738632|Amlodipine|amlodipine|mesh-list
84023927|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84023928|NCT02738632|Telmisartan|telmisartan|mesh-list
84023929|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
84023930|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84023931|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84023932|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023933|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023934|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84023935|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023936|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
84023937|NCT02738632|Diuretics|diuretics|mesh-ancestor
84023938|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
84023939|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84023940|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84023941|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84023942|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84023943|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84023944|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023945|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84023946|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84023947|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023948|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023949|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
84023950|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023951|NCT00703807|Everolimus|everolimus|mesh-list
84023952|NCT00703807|Topotecan|topotecan|mesh-list
84023953|NCT00703807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84023954|NCT00703807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84023955|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023956|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023957|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023958|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
84023959|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023960|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023961|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84023962|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84023963|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
84023964|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023965|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023966|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023967|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84023968|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
84023969|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84023970|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84023971|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023972|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
84023973|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023974|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023976|NCT03633058|Analgesics|analgesics|mesh-ancestor
84023977|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
84023978|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84023979|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023980|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84023981|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84023982|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
84023983|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
84023984|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84023985|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84023986|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84023987|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84023988|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023989|NCT01070316|Everolimus|everolimus|mesh-list
84023990|NCT01070316|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84023991|NCT01070316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84023992|NCT01070316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84023993|NCT01070316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84023994|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84023995|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
84023996|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84023997|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84023998|NCT02737774|Carboplatin|carboplatin|mesh-list
84023999|NCT02737774|Pemetrexed|pemetrexed|mesh-list
84024000|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024001|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024002|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024003|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84024004|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024005|NCT02735590|Isoniazid|isoniazid|mesh-list
84024006|NCT02735590|Rifapentine|rifapentine|mesh-list
84024007|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
84024008|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84024009|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024010|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84024011|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84024012|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
84024013|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024014|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84024015|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84024016|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
84024017|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
84024018|NCT05626348|Adalimumab|adalimumab|mesh-list
84024019|NCT05626348|Methotrexate|methotrexate|mesh-list
84024020|NCT05626348|Leflunomide|leflunomide|mesh-list
84024021|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84024022|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
84024023|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84024024|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024025|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024026|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
84024027|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024028|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024029|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024030|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024031|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84024032|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84024033|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
84024034|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024035|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024036|NCT05626348|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84024037|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024038|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
84024039|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84024040|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84024041|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024042|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
84024043|NCT02737696|Narcotics|narcotics|mesh-ancestor
84024044|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024045|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024046|NCT02737696|Analgesics|analgesics|mesh-ancestor
84024047|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
84024048|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024049|NCT02737228|Gemcitabine|gemcitabine|mesh-list
84024050|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84024051|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024052|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
84024053|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024054|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024055|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024056|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024057|NCT01126541|Rituximab|rituximab|mesh-list
84024058|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84024059|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024060|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
84024061|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024062|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024063|NCT02737150|Anesthetics|anesthetics|mesh-list
84024064|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024065|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024066|NCT02735356|Itraconazole|itraconazole|mesh-list
84024067|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
84024068|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024069|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84024070|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84024071|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024072|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024073|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84024074|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
84024075|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024076|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024077|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84024078|NCT00625469|Bosentan|bosentan|mesh-list
84024079|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84024080|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84024081|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024082|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84024083|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84024084|NCT00637481|Atorvastatin|atorvastatin|mesh-list
84024085|NCT00637481|Calcium|calcium|mesh-list
84024086|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84024087|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024088|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84024089|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84024090|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
84024091|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024092|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84024093|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84024094|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024095|NCT00637559|Esomeprazole|esomeprazole|mesh-list
84024096|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84024097|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84024098|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84024099|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024100|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263929|NCT02463097|Insulin|insulin|mesh-list
84024101|NCT00836875|Voriconazole|voriconazole|mesh-list
84024102|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
84024103|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024104|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84024105|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84024106|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024107|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024108|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84024109|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
84024110|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024111|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024112|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84024113|NCT02732314|Desonide|desonide|mesh-list
84024114|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024115|NCT01125917|Buprenorphine|buprenorphine|mesh-list
84024116|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84024117|NCT01125917|Narcotics|narcotics|mesh-ancestor
84024118|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024119|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024120|NCT01125917|Analgesics|analgesics|mesh-ancestor
84024121|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
84024122|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024123|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84024124|NCT02732236|Rituximab|rituximab|mesh-list
84024125|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84024126|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024127|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
84024128|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024129|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024130|NCT01121549|Exemestane|exemestane|mesh-list
84024131|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024132|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84024133|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84024134|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024135|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024136|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84024137|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
84024138|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024139|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024140|NCT00847405|Sumatriptan|sumatriptan|mesh-list
84024141|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84024142|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84024143|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84024144|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
84024145|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024146|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024147|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024148|NCT02731846|Fluticasone|fluticasone|mesh-list
84024149|NCT02731846|Xhance|xhance|mesh-list
84024150|NCT02731846|Albuterol|albuterol|mesh-list
84024151|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024152|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84024153|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
84024154|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024155|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024156|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84024157|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
84024158|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024159|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84024160|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
84024161|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84024162|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84024163|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84024164|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84024165|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
84024166|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024167|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024168|NCT04248712|Loratadine|loratadine|mesh-list
84024169|NCT04248712|Famotidine|famotidine|mesh-list
84024170|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84024171|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84024172|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84024173|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
84024174|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
83264002|NCT02120807|Pemetrexed|pemetrexed|mesh-list
84024175|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024176|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024177|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024178|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
84024179|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024180|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84024181|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84024182|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84024183|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
84024184|NCT02734732|Trimethoprim|trimethoprim|mesh-list
84024185|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
84024186|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84024187|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024188|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84024189|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84024190|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024191|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024192|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024193|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84024194|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84024195|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84024196|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
84024197|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84024198|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84024199|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84024200|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84024201|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84024202|NCT02731378|Iron|iron|mesh-list
84024203|NCT02731378|Dextrans|dextrans|mesh-list
84024204|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
84024205|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
84024206|NCT02731378|Trace Elements|trace elements|mesh-ancestor
84024207|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
84024208|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024209|NCT02731378|Hematinics|hematinics|mesh-ancestor
84024210|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
84024211|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
84024212|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
84024213|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84024214|NCT02731534|Hematinics|hematinics|mesh-ancestor
84024215|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
84024216|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
84024217|NCT02734420|Coagulants|coagulants|mesh-ancestor
84024218|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
84024219|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024220|NCT00704275|Cyclosporine|cyclosporine|mesh-list
84024221|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84024222|NCT00704275|Cyclosporins|cyclosporins|mesh-list
84024223|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024224|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024225|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84024226|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
84024227|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024228|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
84024229|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024230|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024231|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024232|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84024233|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84024234|NCT00847015|Gemcitabine|gemcitabine|mesh-list
84024235|NCT00847015|Sunitinib|sunitinib|mesh-list
84024236|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024237|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024238|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
84024239|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024240|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84024241|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84024242|NCT00847015|Growth Substances|growth substances|mesh-ancestor
84024243|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024244|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
84024245|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024246|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024247|NCT00627354|Prednisone|prednisone|mesh-list
84024248|NCT00627354|Etoposide|etoposide|mesh-list
84024249|NCT00627354|Vinorelbine|vinorelbine|mesh-list
83264076|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
84024250|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
84024251|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024252|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
84024253|NCT00627354|Hormones|hormones|mesh-ancestor
84024254|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024255|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024256|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84024257|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024258|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84024259|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84024260|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84024261|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024262|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024263|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
84024264|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
84024265|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
84024266|NCT00627354|Analgesics|analgesics|mesh-ancestor
84024267|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
84024268|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024269|NCT00704431|Darapladib|darapladib|mesh-list
84024270|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
84024271|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024272|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024273|NCT02734186|Praziquantel|praziquantel|mesh-list
84024274|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
84024275|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84024276|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024277|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84024278|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
84024279|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84024280|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84024281|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84024282|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024283|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024284|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
84024285|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84024286|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84024287|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024288|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
84024289|NCT02733952|Coagulants|coagulants|mesh-ancestor
84024290|NCT02733640|Pantoprazole|pantoprazole|mesh-list
84024291|NCT02733640|Ranitidine|ranitidine|mesh-list
84024292|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84024293|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84024294|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84024295|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84024296|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024297|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024298|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84024299|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
84024300|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
84024301|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024302|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024303|NCT02730676|Menthol|menthol|mesh-list
84024304|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
84024305|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024306|NCT00855595|Metronidazole|metronidazole|mesh-list
84024307|NCT00855595|Doxycycline|doxycycline|mesh-list
84024308|NCT00855595|Azelaic acid|azelaic acid|mesh-list
84024309|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024310|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84024311|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84024312|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84024313|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
84024314|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024315|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024316|NCT05433532|Azacitidine|azacitidine|mesh-list
84024317|NCT05433532|Venetoclax|venetoclax|mesh-list
84024318|NCT05433532|Flumatinib|flumatinib|mesh-list
84024319|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024320|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
84024321|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024322|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024323|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024324|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024325|NCT00855439|Exenatide|exenatide|mesh-list
84024326|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84024327|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024328|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84024329|NCT00855439|Incretins|incretins|mesh-ancestor
84024330|NCT00855439|Hormones|hormones|mesh-ancestor
84024331|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024332|NCT01064856|Adalimumab|adalimumab|mesh-list
84024333|NCT01064856|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84024334|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024335|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024336|NCT02730442|Fluconazole|fluconazole|mesh-list
84024337|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
84024338|NCT02730442|Clotrimazole|clotrimazole|mesh-list
84024339|NCT02730442|Miconazole|miconazole|mesh-list
84024340|NCT02730442|Olorofim|olorofim|mesh-list
84024341|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024342|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84024343|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84024344|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024345|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024346|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84024347|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
84024348|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024349|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024350|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84024351|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84024352|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84024353|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84024354|NCT02733874|Betamethasone|betamethasone|mesh-list
84024355|NCT02733874|Clobetasol|clobetasol|mesh-list
84024356|NCT02733874|Calcipotriene|calcipotriene|mesh-list
84024357|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024358|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
84024359|NCT02733874|Hormones|hormones|mesh-ancestor
84024360|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024361|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024362|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84024363|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
84024364|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024365|NCT02730364|Acetaminophen|acetaminophen|mesh-list
84024366|NCT02730364|Pheniramine|pheniramine|mesh-list
84024367|NCT02730364|Phenylephrine|phenylephrine|mesh-list
84024368|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
84024369|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024370|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84024371|NCT02730364|Analgesics|analgesics|mesh-ancestor
84024372|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
84024373|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024374|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
84024375|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024376|NCT02730364|Protective Agents|protective agents|mesh-ancestor
84024377|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84024378|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
84024379|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
84024380|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
84024381|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84024382|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
84024383|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
84024384|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84024385|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84024386|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84024387|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
84024388|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024389|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
84024390|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024391|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84024392|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
84024393|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
84024394|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84024395|NCT01042392|Ramipril|ramipril|mesh-list
84024396|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84024397|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
84024398|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024399|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024400|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84024401|NCT00704665|Methocarbamol|methocarbamol|mesh-list
84024402|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84024403|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024404|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84024405|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024406|NCT00913315|Tamsulosin|tamsulosin|mesh-list
84024407|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84024408|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84024409|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84024410|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84024411|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
84024412|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024413|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024414|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024415|NCT00913315|Urological Agents|urological agents|mesh-ancestor
84024416|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84024417|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84024418|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
84024419|NCT00701857|Pemetrexed|pemetrexed|mesh-list
84024420|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024421|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024422|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024423|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84024424|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024425|NCT02729662|Tolvaptan|tolvaptan|mesh-list
84024426|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84024427|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024428|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
84024429|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024430|NCT02733250|Paclitaxel|paclitaxel|mesh-list
84024431|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
84024432|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84024433|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024434|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
84024435|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
84024436|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
84024437|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024438|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84024439|NCT02733250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84024440|NCT03188068|Sirolimus|sirolimus|mesh-list
84024441|NCT03188068|Prednisolone|prednisolone|mesh-list
84024442|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84024443|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024444|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84024445|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024446|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
84024447|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84024448|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
84024449|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024450|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024451|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
84024452|NCT03188068|Hormones|hormones|mesh-ancestor
84024453|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024454|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84024455|NCT01064310|Sunitinib|sunitinib|mesh-list
84024456|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024457|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84024458|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84024459|NCT01064310|Growth Substances|growth substances|mesh-ancestor
84024460|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024461|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
84024462|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024463|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024464|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024465|NCT02726854|Apatinib|apatinib|mesh-list
84024466|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024467|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024468|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024469|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024470|NCT04724928|Immunomodulating Agents|immunomodulating agents|mesh-list
84024471|NCT04724928|Immunologic Factors|immunologic factors|mesh-ancestor
84024472|NCT04724928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024473|NCT02728492|Paclitaxel|paclitaxel|mesh-list
84024474|NCT02728492|Carboplatin|carboplatin|mesh-list
84024475|NCT02728492|Gemcitabine|gemcitabine|mesh-list
84024476|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84024477|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264311|NCT05429463|Paclitaxel|paclitaxel|mesh-list
84024478|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
84024479|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
84024480|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
84024481|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024482|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024483|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
84024484|NCT02726308|Dexamethasone|dexamethasone|mesh-list
84024485|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024486|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
84024487|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
84024488|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024489|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024490|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84024491|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
84024492|NCT02726308|Hormones|hormones|mesh-ancestor
84024493|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024494|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84024495|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024496|NCT01037244|Udenafil|udenafil|mesh-list
84024497|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84024498|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84024499|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024500|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024501|NCT00627432|Gemcitabine|gemcitabine|mesh-list
84024502|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
84024503|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024504|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
84024505|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024506|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024507|NCT02727712|Anesthetics|anesthetics|mesh-list
84024508|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024509|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024510|NCT01042236|Fesoterodine|fesoterodine|mesh-list
84024511|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84024512|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84024513|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
84024514|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024515|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024516|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024517|NCT01042236|Urological Agents|urological agents|mesh-ancestor
84024518|NCT02725918|Pemetrexed|pemetrexed|mesh-list
84024519|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024520|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024521|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024522|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84024523|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024524|NCT00592501|Fluorouracil|fluorouracil|mesh-list
84024525|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024526|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
84024527|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024528|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024529|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84024530|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
84024531|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024532|NCT01040832|Cetuximab|cetuximab|mesh-list
84024533|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84024534|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024535|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
84024536|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84024537|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84024538|NCT04304196|TEMPO|tempo|mesh-list
84024539|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
84024540|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024541|NCT04304196|Protective Agents|protective agents|mesh-ancestor
84024542|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024543|NCT02720770|Hormones|hormones|mesh-list
84024544|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024545|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024546|NCT02720926|Capecitabine|capecitabine|mesh-list
84024547|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
84024548|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024549|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
84024550|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024551|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024552|NCT00854581|Interferons|interferons|mesh-list
84024553|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
84024554|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
84024555|NCT00854581|Zidovudine|zidovudine|mesh-list
84024556|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84024557|NCT00854581|Valproic Acid|valproic acid|mesh-list
84024558|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024559|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
84024560|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024561|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
84024562|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024563|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
84024564|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024565|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84024566|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024567|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024568|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84024569|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84024570|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
84024571|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
84024572|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024573|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
84024574|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84024575|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024576|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84024577|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84024578|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024579|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024580|NCT00833911|Tramadol|tramadol|mesh-list
84024581|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84024582|NCT00833911|Narcotics|narcotics|mesh-ancestor
84024583|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024584|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024585|NCT00833911|Analgesics|analgesics|mesh-ancestor
84024586|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
84024587|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024588|NCT02719756|Metformin|metformin|mesh-list
84024589|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
84024590|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84024591|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024592|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84024593|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024594|NCT01125293|Rituximab|rituximab|mesh-list
84024595|NCT01125293|Everolimus|everolimus|mesh-list
84024596|NCT01125293|Bortezomib|bortezomib|mesh-list
84024597|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84024598|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024599|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
84024600|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024601|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024602|NCT01125293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84024603|NCT01125293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024604|NCT01125293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024605|NCT01125293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024606|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84024607|NCT02719834|Acetaminophen|acetaminophen|mesh-list
84024608|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84024609|NCT02719834|Analgesics|analgesics|mesh-ancestor
84024610|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
84024611|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024612|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024613|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
84024614|NCT02719210|Mannitol|mannitol|mesh-list
84024615|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84024616|NCT02719210|Diuretics|diuretics|mesh-ancestor
84024617|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
84024618|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024619|NCT02719132|Metformin|metformin|mesh-list
84024620|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
84024621|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84024622|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024623|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84024624|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024625|NCT02718820|Docetaxel|docetaxel|mesh-list
84024626|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
84024627|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024628|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
84024629|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
84024630|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
84024631|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024632|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84024633|NCT02718820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84024634|NCT02718976|Lidocaine|lidocaine|mesh-list
84024635|NCT02718976|Epinephrine|epinephrine|mesh-list
84024636|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
84024637|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
84024638|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
84024639|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024640|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024641|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
84024642|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024643|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84024644|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84024645|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84024646|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84024647|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024648|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84024649|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84024650|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
84024651|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024652|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84024653|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84024654|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
84024655|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84024656|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
84024657|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
84024658|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
84024659|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84024660|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
84024661|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
84024662|NCT02718742|Paclitaxel|paclitaxel|mesh-list
84024663|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84024664|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84024665|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024666|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
84024667|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
84024668|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
84024669|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024670|NCT02717884|Cytarabine|cytarabine|mesh-list
84024671|NCT02717884|Tretinoin|tretinoin|mesh-list
84024672|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
84024673|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024674|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
84024675|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024676|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024677|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
84024678|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024679|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84024680|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
84024681|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024682|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
84024683|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024684|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
84024685|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84024686|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84024687|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024688|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84024689|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84024690|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024691|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84024692|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84024693|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024694|NCT01121393|Gemcitabine|gemcitabine|mesh-list
84024695|NCT01121393|Afatinib|afatinib|mesh-list
84024696|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024697|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024698|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
84024699|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024700|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024701|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024702|NCT02882477|Metformin|metformin|mesh-list
84024703|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84024704|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
84024705|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84024707|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84024708|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024709|NCT02882477|Incretins|incretins|mesh-ancestor
84024710|NCT02882477|Hormones|hormones|mesh-ancestor
84024711|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024712|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84024713|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
84024714|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024715|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024716|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
84024717|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024718|NCT02882477|Expectorants|expectorants|mesh-ancestor
84024719|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
84024720|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84024721|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
84024722|NCT02882477|Protective Agents|protective agents|mesh-ancestor
84024723|NCT02882477|Antidotes|antidotes|mesh-ancestor
84024724|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84024725|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
84024726|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
84024727|NCT04163224|Imidacloprid|imidacloprid|mesh-list
84024728|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
84024729|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024730|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024731|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024732|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
84024733|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84024734|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024735|NCT04964284|Hormones|hormones|mesh-list
84024736|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024737|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024738|NCT02716090|Adapalene|adapalene|mesh-list
84024739|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84024740|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024741|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84024742|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84024743|NCT02716090|Analgesics|analgesics|mesh-ancestor
84024744|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
84024745|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024746|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024747|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024748|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024749|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84024750|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84024751|NCT01227616|Hematinics|hematinics|mesh-ancestor
84024752|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84024753|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84024754|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84024755|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
84024756|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024757|NCT02714998|Methotrexate|methotrexate|mesh-list
84024758|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84024759|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
84024760|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84024761|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024762|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84024763|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
84024764|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024765|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024766|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024767|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024768|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84024769|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84024770|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
84024771|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024772|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024773|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
84024774|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
84024775|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024776|NCT00765310|Protective Agents|protective agents|mesh-ancestor
84024777|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024778|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
84024779|NCT00765310|Vitamins|vitamins|mesh-ancestor
84024780|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
84024781|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
84024782|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84024783|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024784|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024785|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84024786|NCT02715154|Analgesics|analgesics|mesh-ancestor
84024787|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
84024788|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024789|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84024790|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84024791|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84024792|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
84024793|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024794|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024795|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84024796|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
84024797|NCT02715232|Lynestrenol|lynestrenol|mesh-list
84024798|NCT02715232|Estradiol|estradiol|mesh-list
84024799|NCT02715232|Testosterone|testosterone|mesh-list
84024800|NCT02715232|Cyproterone|cyproterone|mesh-list
84024801|NCT02715232|Estrogens|estrogens|mesh-ancestor
84024802|NCT02715232|Hormones|hormones|mesh-ancestor
84024803|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024804|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024805|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84024806|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
84024807|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84024808|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84024809|NCT02715232|Androgens|androgens|mesh-ancestor
84024810|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84024811|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024812|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
84024813|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
84024814|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
84024815|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84024816|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84024817|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84024818|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84024819|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84024820|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
84024821|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024822|NCT02714842|Diclofenac|diclofenac|mesh-list
84024823|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84024824|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84024825|NCT02714842|Analgesics|analgesics|mesh-ancestor
84024826|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
84024827|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024828|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024829|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84024830|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84024831|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84024832|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024833|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024834|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84024835|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024836|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84024837|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024838|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024839|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
84024840|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84024841|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024842|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84024843|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84024844|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
84024845|NCT04000906|Paclitaxel|paclitaxel|mesh-list
84024846|NCT04000906|Cisplatin|cisplatin|mesh-list
84024847|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84024848|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024849|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
84024850|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
84024851|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
84024852|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024853|NCT00636766|Metformin|metformin|mesh-list
84024854|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
84024855|NCT00636766|Rimonabant|rimonabant|mesh-list
84024856|NCT00636766|Atorvastatin|atorvastatin|mesh-list
84024857|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84024858|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024859|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84024860|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84024861|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
84024862|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024863|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84024864|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84024865|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024866|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84024867|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
84024868|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84024869|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024870|NCT00636766|Hormones|hormones|mesh-ancestor
84024871|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84024872|NCT03998176|Tenofovir|tenofovir|mesh-list
84024873|NCT03998176|Emtricitabine|emtricitabine|mesh-list
84024874|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84024875|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
84024876|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024877|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84024878|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024879|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024880|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024881|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84024882|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84024883|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84024884|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84024885|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84024886|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84024887|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024888|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84024889|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84024890|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84024891|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
84024892|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024893|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024894|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84024895|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84024896|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
84024897|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
84024898|NCT00611416|Caffeine|caffeine|mesh-list
84024899|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84024900|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024901|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84024902|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024903|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024904|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84024905|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84024906|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
84024907|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024908|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
84024909|NCT00611416|Protective Agents|protective agents|mesh-ancestor
84024910|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84024911|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84024912|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024913|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84024914|NCT02712658|Terbutaline|terbutaline|mesh-list
84024915|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84024916|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
84024917|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84024918|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024919|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84024920|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
84024921|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
84024922|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
84024923|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84024924|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84024925|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84024926|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84024927|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
84024928|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024929|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024930|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
84024931|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84024932|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024933|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84024934|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
84024935|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84024936|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024937|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024938|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024939|NCT02712502|Amoxicillin|amoxicillin|mesh-list
84024940|NCT02712502|Levofloxacin|levofloxacin|mesh-list
84024941|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
84024942|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
84024943|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84024944|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84024945|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024946|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84024947|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84024948|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84024949|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024950|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024951|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024952|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84024953|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84024954|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84024955|NCT02712346|Ambrisentan|ambrisentan|mesh-list
84024956|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84024957|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
84024958|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024959|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
84024960|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024961|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024962|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84024963|NCT02711410|Clopidogrel|clopidogrel|mesh-list
84024964|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84024965|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84024966|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84024967|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84024968|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
84024969|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84024970|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024971|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024972|NCT02711176|Amoxicillin|amoxicillin|mesh-list
84024973|NCT02711176|Clarithromycin|clarithromycin|mesh-list
84024974|NCT02711176|Tinidazole|tinidazole|mesh-list
84024975|NCT02711176|Esomeprazole|esomeprazole|mesh-list
84024976|NCT02711176|Lansoprazole|lansoprazole|mesh-list
84024977|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84024978|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84024979|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84024980|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84024981|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84024982|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84024983|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024984|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84024985|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84024986|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84024987|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
84024988|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84024989|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84024990|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84024991|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
84024992|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
84024993|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84024994|NCT00611650|Protective Agents|protective agents|mesh-ancestor
84024995|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84024996|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84024997|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84024998|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84024999|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84025000|NCT02710552|Amlodipine|amlodipine|mesh-list
84025001|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
84025002|NCT02710552|Perindopril|perindopril|mesh-list
84025004|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84025005|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025006|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025007|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84025008|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025009|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
84025010|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84025011|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
84025012|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025013|NCT02710552|Diuretics|diuretics|mesh-ancestor
84025014|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
84025015|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84025016|NCT02710396|Paclitaxel|paclitaxel|mesh-list
84025017|NCT02710396|Carboplatin|carboplatin|mesh-list
84025018|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
84025019|NCT02710396|Pemetrexed|pemetrexed|mesh-list
84025020|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84025021|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025022|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
84025023|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
84025024|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
84025025|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025026|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84025027|NCT02710396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84025028|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025029|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84025030|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025031|NCT02710162|Capsaicin|capsaicin|mesh-list
84025032|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
84025033|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
84025034|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
84025035|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025036|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025037|NCT00611728|Irinotecan|irinotecan|mesh-list
84025038|NCT00611728|Sunitinib|sunitinib|mesh-list
84025039|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84025040|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84025041|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025042|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025043|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025044|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84025045|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84025046|NCT00611728|Growth Substances|growth substances|mesh-ancestor
84025047|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025048|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
84025049|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025050|NCT02709304|Lidocaine|lidocaine|mesh-list
84025051|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
84025052|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
84025053|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025054|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025055|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
84025056|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025057|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84025058|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84025059|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84025060|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025061|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025062|NCT04189666|Melatonin|melatonin|mesh-list
84025063|NCT04189666|Rivastigmine|rivastigmine|mesh-list
84025064|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
84025065|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025066|NCT04189666|Protective Agents|protective agents|mesh-ancestor
84025067|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025068|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025069|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84025070|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025071|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
84025072|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025073|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84025074|NCT03944512|Pravastatin|pravastatin|mesh-list
84025075|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84025076|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84025077|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
84025078|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025079|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84025080|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84025081|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025082|NCT00937521|Antipyretics|antipyretics|mesh-list
84025083|NCT00937521|Vaccines|vaccines|mesh-list
84025084|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
84025085|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025086|NCT02709382|Tazobactam|tazobactam|mesh-list
84025087|NCT02709382|Cefepime|cefepime|mesh-list
84025088|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025089|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025090|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84025091|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025092|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025093|NCT02708992|Azithromycin|azithromycin|mesh-list
84025094|NCT02708992|Cefixime|cefixime|mesh-list
84025095|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025096|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025097|NCT00611962|Paclitaxel|paclitaxel|mesh-list
84025098|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
84025099|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84025100|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025101|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
84025102|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
84025103|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
84025104|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025105|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
84025106|NCT05380713|Durvalumab|durvalumab|mesh-list
84025107|NCT05380713|Tremelimumab|tremelimumab|mesh-list
84025108|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025109|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
84025110|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025111|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025112|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84025113|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
84025114|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025115|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025116|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84025117|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84025118|NCT00606099|Adefovir|adefovir|mesh-list
84025119|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84025120|NCT00606099|Telbivudine|telbivudine|mesh-list
84025121|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
84025122|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025123|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84025124|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025125|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025126|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025127|NCT00935883|Eculizumab|eculizumab|mesh-list
84025128|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84025129|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025130|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
84025131|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025132|NCT02708446|Misoprostol|misoprostol|mesh-list
84025133|NCT02708446|Mifepristone|mifepristone|mesh-list
84025134|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84025135|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
84025136|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025137|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025138|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84025139|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84025140|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
84025141|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84025142|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84025143|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84025144|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84025145|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
84025146|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84025147|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84025148|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
84025149|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025150|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
84025151|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84025152|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84025153|NCT05378919|Folic Acid|folic acid|mesh-list
84025154|NCT05378919|Leucovorin|leucovorin|mesh-list
84025155|NCT05378919|Fluorouracil|fluorouracil|mesh-list
84025156|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
84025157|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
84025158|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
84025159|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025160|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84025161|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025162|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025163|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
84025164|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025165|NCT05378919|Hematinics|hematinics|mesh-ancestor
84025166|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
84025167|NCT05378919|Vitamins|vitamins|mesh-ancestor
84025168|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
84025169|NCT05378919|Antidotes|antidotes|mesh-ancestor
84025170|NCT05378919|Protective Agents|protective agents|mesh-ancestor
84025171|NCT00607581|Dexamethasone|dexamethasone|mesh-list
84025172|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
84025173|NCT00607581|Lenalidomide|lenalidomide|mesh-list
84025174|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025175|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
84025176|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025177|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025178|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84025179|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
84025180|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025181|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025182|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84025183|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84025184|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
84025185|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
84025186|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025187|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84025188|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
84025189|NCT00607581|Hormones|hormones|mesh-ancestor
84025190|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025191|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84025192|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84025193|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84025194|NCT00607581|Growth Substances|growth substances|mesh-ancestor
84025195|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
84025196|NCT02707900|Vorinostat|vorinostat|mesh-list
84025197|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025198|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84025199|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025200|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025201|NCT05380479|Megestrol|megestrol|mesh-list
84025202|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
84025203|NCT05380479|Mirtazapine|mirtazapine|mesh-list
84025204|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
84025205|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84025206|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84025207|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
84025208|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
84025209|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025210|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025211|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025212|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84025213|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84025214|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025215|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84025216|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84025217|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84025218|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
84025219|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84025220|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84025221|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
84025222|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84025223|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84025224|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84025225|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84025226|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
84025227|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025228|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84025229|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84025230|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84025231|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025232|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
84025233|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84025234|NCT00936975|Listerine|listerine|mesh-list
84025235|NCT00936975|Fluorides|fluorides|mesh-list
84025236|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
84025237|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
84025238|NCT00936975|Protective Agents|protective agents|mesh-ancestor
84025239|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025240|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84025241|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025242|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84025243|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
84025244|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84025245|NCT02693470|Ustekinumab|ustekinumab|mesh-list
84025246|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
84025247|NCT00936897|Denosumab|denosumab|mesh-list
84025248|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
84025249|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84025250|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025251|NCT05265676|Enoxaparin|enoxaparin|mesh-list
84025252|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
84025253|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
84025254|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84025255|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84025256|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025257|NCT00606333|Sirolimus|sirolimus|mesh-list
84025258|NCT00606333|Paclitaxel|paclitaxel|mesh-list
84025259|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84025260|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84025261|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025262|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
84025263|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
84025264|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
84025265|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025266|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025267|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025268|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84025269|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
84025270|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025271|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
84025272|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025273|NCT05265442|Methadone|methadone|mesh-list
84025274|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84025275|NCT05265442|Narcotics|narcotics|mesh-ancestor
84025276|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025277|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025278|NCT05265442|Analgesics|analgesics|mesh-ancestor
84025279|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
84025280|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025281|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
84025282|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
84025283|NCT00606411|Topiramate|topiramate|mesh-list
84025284|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
84025285|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84025286|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025287|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
84025288|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84025289|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025290|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
84025291|NCT01120691|Albuterol|albuterol|mesh-list
84025292|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
84025293|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84025294|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
84025295|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025296|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025297|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84025298|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
84025299|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
84025300|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84025301|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
84025302|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025303|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025304|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
84025305|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025306|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84025307|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84025308|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84025309|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
84025310|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84025311|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84025313|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84025314|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84025315|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84025316|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84025317|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
84025318|NCT04231318|Hormones|hormones|mesh-ancestor
84025319|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025320|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025321|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025322|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
84025323|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025324|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025325|NCT00612274|Sirolimus|sirolimus|mesh-list
84025326|NCT00612274|Methotrexate|methotrexate|mesh-list
84025327|NCT00612274|Tacrolimus|tacrolimus|mesh-list
84025328|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84025329|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
84025330|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025331|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025332|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84025333|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
84025334|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025335|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025336|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
84025337|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025338|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84025339|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025340|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
84025341|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025342|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025343|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84025344|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025345|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025346|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84025347|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
84025348|NCT05263882|Gemcitabine|gemcitabine|mesh-list
84025349|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84025350|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
84025351|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025352|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025353|NCT02724904|Methotrexate|methotrexate|mesh-list
84025354|NCT02724904|Fludarabine|fludarabine|mesh-list
84025355|NCT02724904|Thiotepa|thiotepa|mesh-list
84025356|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84025357|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
84025358|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025359|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025360|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84025361|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
84025362|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025363|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025364|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
84025365|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025366|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84025367|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025368|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
84025369|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025370|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025371|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84025372|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
84025373|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84025374|NCT00935493|Guanfacine|guanfacine|mesh-list
84025375|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84025376|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84025377|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84025378|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84025379|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
84025380|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025381|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025382|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025383|NCT05380245|Clarithromycin|clarithromycin|mesh-list
84025384|NCT05380245|Voriconazole|voriconazole|mesh-list
84025385|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025386|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025387|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84025388|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025389|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025390|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84025391|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84025392|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
84025393|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84025394|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84025395|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
84025396|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025397|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025398|NCT00935259|Simvastatin|simvastatin|mesh-list
84025399|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84025400|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84025401|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
84025402|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025403|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84025404|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84025405|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025406|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
84025407|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
84025408|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84025409|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
84025410|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025411|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025412|NCT02937766|Progestins|progestins|mesh-ancestor
84025413|NCT02937766|Hormones|hormones|mesh-ancestor
84025414|NCT00607971|Renzapride|renzapride|mesh-list
84025415|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84025416|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
84025417|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025418|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025419|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025420|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
84025421|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84025422|NCT02724358|Estrogens|estrogens|mesh-ancestor
84025423|NCT02724358|Hormones|hormones|mesh-ancestor
84025424|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025425|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025426|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84025427|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025428|NCT02724202|Curcumin|curcumin|mesh-list
84025429|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84025430|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84025431|NCT02724202|Analgesics|analgesics|mesh-ancestor
84025432|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
84025433|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025434|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025435|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84025436|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025437|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025438|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025439|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025440|NCT00605397|Trastuzumab|trastuzumab|mesh-list
84025441|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84025442|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025443|NCT00625547|Levodopa|levodopa|mesh-list
84025444|NCT00625547|Cabergoline|cabergoline|mesh-list
84025445|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84025446|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84025447|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
84025448|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025449|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025450|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025451|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
84025452|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84025453|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025454|NCT05241340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84025455|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025456|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
84025457|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025458|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025459|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84025460|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84025461|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025462|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025463|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025464|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84025465|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84025466|NCT01124045|Prednisolone|prednisolone|mesh-list
84025467|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84025468|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
84025469|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84025470|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
84025471|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84025472|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
84025473|NCT01124045|Difluprednate|difluprednate|mesh-list
84025474|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84025475|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
84025476|NCT01124045|Hormones|hormones|mesh-ancestor
84025477|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025478|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025479|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84025480|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025481|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
84025482|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
84025483|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025484|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84025485|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84025486|NCT01124045|Protective Agents|protective agents|mesh-ancestor
84025487|NCT01123889|Lidocaine|lidocaine|mesh-list
84025488|NCT01123889|Ropivacaine|ropivacaine|mesh-list
84025489|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
84025490|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
84025491|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025492|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025493|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
84025494|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025495|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84025496|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84025497|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84025498|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025499|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025500|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84025501|NCT00606957|Vitamin D|vitamin d|mesh-list
84025502|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
84025503|NCT00606957|Vitamins|vitamins|mesh-ancestor
84025504|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
84025505|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025506|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84025507|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84025508|NCT00934947|Propranolol|propranolol|mesh-list
84025509|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84025510|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84025511|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
84025512|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025513|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025514|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025515|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84025516|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84025517|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
84025518|NCT02723578|Pemetrexed|pemetrexed|mesh-list
84025519|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84025520|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025521|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025522|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265352|NCT01632345|Efavirenz|efavirenz|mesh-list
84025523|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84025524|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025525|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025526|NCT04189198|Bupivacaine|bupivacaine|mesh-list
84025527|NCT04189198|Carticaine|carticaine|mesh-list
84025528|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
84025529|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
84025530|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025531|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025532|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
84025533|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025534|NCT00608361|Dasatinib|dasatinib|mesh-list
84025535|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025536|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025537|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025538|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025539|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
84025540|NCT00934791|Sirolimus|sirolimus|mesh-list
84025541|NCT00934791|Prednisone|prednisone|mesh-list
84025542|NCT00934791|Tacrolimus|tacrolimus|mesh-list
84025543|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84025544|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
84025545|NCT00934791|Hormones|hormones|mesh-ancestor
84025546|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025547|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025548|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84025549|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025550|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025551|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
84025552|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84025553|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025554|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025555|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84025556|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84025557|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
84025558|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025559|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025560|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
84025561|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84025562|NCT00607035|Olmesartan|olmesartan|mesh-list
84025563|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84025564|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84025565|NCT00607035|Diuretics|diuretics|mesh-ancestor
84025566|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
84025567|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025568|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84025569|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025570|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025571|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84025572|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84025573|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
84025574|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
84025575|NCT02723266|Protective Agents|protective agents|mesh-ancestor
84025576|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025577|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
84025578|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84025579|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025580|NCT02722954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84025581|NCT02722954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025582|NCT00625859|Bupropion|bupropion|mesh-list
84025583|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84025584|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
84025585|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84025586|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84025587|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84025588|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025589|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025590|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
84025591|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025592|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025593|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84025594|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84025595|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265422|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
84025596|NCT02691195|Ropivacaine|ropivacaine|mesh-list
84025597|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
84025598|NCT02691195|Anesthetics|anesthetics|mesh-list
84025599|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025600|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025601|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
84025602|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025603|NCT03808090|Calcium|calcium|mesh-list
84025604|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84025605|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025606|NCT01111019|Hormones|hormones|mesh-list
84025607|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025608|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025609|NCT02883400|Spironolactone|spironolactone|mesh-list
84025610|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84025611|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
84025612|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025613|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025614|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84025615|NCT02883400|Diuretics|diuretics|mesh-ancestor
84025616|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
84025617|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
84025618|NCT01119287|Dexamethasone|dexamethasone|mesh-list
84025619|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84025620|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84025621|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
84025622|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
84025623|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025624|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025625|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84025626|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
84025627|NCT01119287|Hormones|hormones|mesh-ancestor
84025628|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025629|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84025630|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025631|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84025632|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84025633|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84025634|NCT01119287|Analgesics|analgesics|mesh-ancestor
84025635|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
84025636|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025637|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84025638|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84025639|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84025640|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
84025641|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
84025642|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025643|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025644|NCT01110707|Hormones|hormones|mesh-list
84025645|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84025646|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84025647|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025648|NCT04931368|Rituximab|rituximab|mesh-list
84025649|NCT04931368|Methotrexate|methotrexate|mesh-list
84025650|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84025651|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025652|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
84025653|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025654|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025655|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84025656|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
84025657|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025658|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84025659|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
84025660|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025661|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
84025662|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025663|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84025664|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025665|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025666|NCT01119131|Vitamin D|vitamin d|mesh-list
84025667|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
84025668|NCT01119131|Calcium|calcium|mesh-list
84025669|NCT01119131|Vitamins|vitamins|mesh-ancestor
84025670|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
84025671|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025672|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84025673|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84025674|NCT00636922|Everolimus|everolimus|mesh-list
84025675|NCT00636922|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84025676|NCT00636922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025677|NCT00636922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025678|NCT00636922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025679|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025680|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
84025681|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025682|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025683|NCT02722096|Lidocaine|lidocaine|mesh-list
84025684|NCT02722096|Ropivacaine|ropivacaine|mesh-list
84025685|NCT02722096|Anesthetics|anesthetics|mesh-list
84025686|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
84025687|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025688|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025689|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
84025690|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025691|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84025692|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84025693|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84025694|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025695|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025696|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84025697|NCT04862962|Ezetimibe|ezetimibe|mesh-list
84025698|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84025699|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84025700|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
84025701|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025702|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84025703|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84025704|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025705|NCT01118975|Lapatinib|lapatinib|mesh-list
84025706|NCT01118975|Vorinostat|vorinostat|mesh-list
84025707|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025708|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025709|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025710|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025711|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84025712|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
84025713|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84025714|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025715|NCT04829422|Lazertinib|lazertinib|mesh-list
84025716|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025717|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025718|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025719|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84025720|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84025721|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84025722|NCT00612898|Lamivudine|lamivudine|mesh-list
84025723|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84025724|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025725|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025726|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025727|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
84025728|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025729|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84025730|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84025731|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
84025732|NCT01118663|Edetic Acid|edetic acid|mesh-list
84025733|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84025734|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
84025735|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
84025736|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025737|NCT01118663|Expectorants|expectorants|mesh-ancestor
84025738|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
84025739|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84025740|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
84025741|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025742|NCT01118663|Protective Agents|protective agents|mesh-ancestor
84025743|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025744|NCT01118663|Antidotes|antidotes|mesh-ancestor
84025745|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
84025746|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84025747|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
84025748|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
84025749|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84025750|NCT01118351|Sunitinib|sunitinib|mesh-list
84025751|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025752|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84025753|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84025754|NCT01118351|Growth Substances|growth substances|mesh-ancestor
84025755|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025756|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
84025757|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025758|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025759|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025760|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84025761|NCT02693392|Metformin|metformin|mesh-list
84025762|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84025763|NCT02693392|Fenugreek seed meal|fenugreek seed meal|mesh-list
84025764|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025765|NCT04175626|Sirolimus|sirolimus|mesh-list
84025766|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025767|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025768|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84025769|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025770|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
84025771|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025772|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
84025773|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025774|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
84025775|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
84025776|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025777|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025778|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025779|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025780|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
84025781|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025782|NCT00613132|Everolimus|everolimus|mesh-list
84025783|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
84025784|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
84025785|NCT00613132|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84025786|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025787|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025788|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025789|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025790|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
84025791|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025792|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025793|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
84025794|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025795|NCT04558216|Rifampin|rifampin|mesh-list
84025796|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84025797|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
84025798|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025799|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025800|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
84025801|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025802|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025803|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025804|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84025805|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84025806|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84025807|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84025808|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84025809|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84025810|NCT04120870|Ketamine|ketamine|mesh-list
84025811|NCT04120870|Etomidate|etomidate|mesh-list
84025812|NCT04120870|Analgesics|analgesics|mesh-ancestor
84025813|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
84025814|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025815|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025816|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84025817|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84025818|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
84025820|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025821|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84025822|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84025823|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025824|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025825|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84025826|NCT03747562|Gabapentin|gabapentin|mesh-list
84025827|NCT03747562|Analgesics|analgesics|mesh-ancestor
84025828|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
84025829|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025830|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025831|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
84025832|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84025833|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84025834|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025835|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84025836|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84025837|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84025838|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025839|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025840|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
84025841|NCT01109849|Methylphenidate|methylphenidate|mesh-list
84025842|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
84025843|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025844|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84025845|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84025846|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025847|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025848|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
84025849|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025850|NCT01061736|Folic Acid|folic acid|mesh-list
84025851|NCT01061736|Methotrexate|methotrexate|mesh-list
84025852|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84025853|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
84025854|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025855|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025856|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84025857|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
84025858|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025859|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025860|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
84025861|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025862|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84025863|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025864|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
84025865|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025866|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025867|NCT01061736|Hematinics|hematinics|mesh-ancestor
84025868|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
84025869|NCT01061736|Vitamins|vitamins|mesh-ancestor
84025870|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
84025871|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
84025872|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84025873|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025874|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025875|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84025876|NCT02874378|Analgesics|analgesics|mesh-ancestor
84025877|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
84025878|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025879|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84025880|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84025881|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84025882|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
84025883|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025884|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025885|NCT01117181|Methylphenidate|methylphenidate|mesh-list
84025886|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84025887|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025888|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84025889|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84025890|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025891|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025892|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
84025893|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025894|NCT02881619|Etodolac|etodolac|mesh-list
84025895|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84025896|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84025897|NCT02881619|Analgesics|analgesics|mesh-ancestor
84025898|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
84025899|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025900|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025901|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84025902|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025903|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84025904|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84025905|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025906|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025907|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84025908|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84025909|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84025910|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
84025911|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025912|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84025913|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84025914|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025915|NCT02882087|Methotrexate|methotrexate|mesh-list
84025916|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84025917|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
84025918|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84025919|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025920|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84025921|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
84025922|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025923|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025924|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
84025925|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025926|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84025927|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84025928|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
84025929|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84025930|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84025931|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
84025932|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84025933|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025934|NCT04303884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84025935|NCT04303884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025936|NCT01040130|Olodaterol|olodaterol|mesh-list
84025937|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84025938|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
84025939|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84025940|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025941|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84025942|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
84025943|NCT00932451|Crizotinib|crizotinib|mesh-list
84025944|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025945|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84025946|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025947|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025948|NCT01039584|Butoconazole|butoconazole|mesh-list
84025949|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
84025950|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025951|NCT05297682|Propofol|propofol|mesh-list
84025952|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
84025953|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84025954|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025955|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84025956|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84025957|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
84025958|NCT01108055|Paclitaxel|paclitaxel|mesh-list
84025959|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84025960|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84025961|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
84025962|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
84025963|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83265805|NCT02393755|Nintedanib|nintedanib|mesh-list
84025964|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025966|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84025967|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84025968|NCT01107899|Clopidogrel|clopidogrel|mesh-list
84025969|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84025970|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84025971|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84025972|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84025973|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84025974|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
84025975|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84025976|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025977|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025978|NCT01107743|Amlodipine|amlodipine|mesh-list
84025979|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
84025980|NCT01107743|Atorvastatin|atorvastatin|mesh-list
84025981|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84025982|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84025983|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
84025984|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84025985|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84025986|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84025987|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84025988|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84025989|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84025990|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84025991|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84025992|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84025993|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
84025994|NCT01059864|Atorvastatin|atorvastatin|mesh-list
84025995|NCT01059864|Tofacitinib|tofacitinib|mesh-list
84025996|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84025997|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84025998|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
84025999|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026000|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84026001|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84026002|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026003|NCT01059864|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84026004|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026005|NCT01035138|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
84026006|NCT01035138|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84026007|NCT01035138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026008|NCT01035138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026009|NCT03739840|Padsevonil|padsevonil|mesh-list
84026010|NCT03739840|Anticonvulsants|anticonvulsants|mesh-ancestor
84026011|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
84026012|NCT00613600|Cathartics|cathartics|mesh-ancestor
84026013|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84026014|NCT04302402|Rifaximin|rifaximin|mesh-list
84026015|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84026016|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026017|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84026018|NCT03931408|Gentamicins|gentamicins|mesh-list
84026019|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84026020|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026021|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84026022|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026023|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026024|NCT03398824|Metformin|metformin|mesh-list
84026025|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84026026|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026027|NCT01033734|Oseltamivir|oseltamivir|mesh-list
84026028|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
84026029|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026030|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026031|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026032|NCT03792256|Cytarabine|cytarabine|mesh-list
84026033|NCT03792256|Prednisone|prednisone|mesh-list
84026034|NCT03792256|Prednisolone|prednisolone|mesh-list
84026035|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
84026036|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84026037|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84026038|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84026039|NCT03792256|Doxorubicin|doxorubicin|mesh-list
84026040|NCT03792256|Methotrexate|methotrexate|mesh-list
84026041|NCT03792256|Vincristine|vincristine|mesh-list
84026042|NCT03792256|Palbociclib|palbociclib|mesh-list
84026043|NCT03792256|Pegaspargase|pegaspargase|mesh-list
84026044|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84026045|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026046|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84026047|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84026048|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026049|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026050|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026051|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
84026052|NCT03792256|Hormones|hormones|mesh-ancestor
84026053|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026054|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026055|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84026056|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84026057|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
84026058|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84026059|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84026060|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
84026061|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
84026062|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84026063|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026064|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
84026065|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026066|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84026067|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
84026068|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026069|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84026070|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
84026071|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
84026072|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
84026073|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026074|NCT00613288|Testosterone|testosterone|mesh-list
84026075|NCT00613288|Androgens|androgens|mesh-ancestor
84026076|NCT00613288|Hormones|hormones|mesh-ancestor
84026077|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026078|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026079|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
84026080|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84026081|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
84026082|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026083|NCT03711838|Expectorants|expectorants|mesh-ancestor
84026084|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
84026085|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84026086|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
84026087|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026088|NCT03711838|Protective Agents|protective agents|mesh-ancestor
84026089|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026090|NCT03711838|Antidotes|antidotes|mesh-ancestor
84026091|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
84026092|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
84026093|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84026094|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84026095|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026096|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026097|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026098|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026099|NCT01115855|Eplerenone|eplerenone|mesh-list
84026100|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84026101|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
84026102|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026103|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026104|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84026105|NCT01115855|Diuretics|diuretics|mesh-ancestor
84026106|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
84026107|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84026108|NCT03615508|Phenylephrine|phenylephrine|mesh-list
84026109|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
84026110|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84026111|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
84026113|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026114|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026115|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
84026116|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84026117|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
84026118|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
84026119|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84026120|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84026121|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84026122|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
84026123|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026124|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026125|NCT03615508|Protective Agents|protective agents|mesh-ancestor
84026126|NCT02880995|Amisulpride|amisulpride|mesh-list
84026127|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84026128|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84026129|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026130|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026131|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026132|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84026133|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
84026134|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026135|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026136|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84026137|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
84026138|NCT03522064|Carboplatin|carboplatin|mesh-list
84026139|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
84026140|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84026141|NCT03522064|Testosterone|testosterone|mesh-list
84026142|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
84026143|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
84026144|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84026145|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026146|NCT03522064|Androgens|androgens|mesh-ancestor
84026147|NCT03522064|Hormones|hormones|mesh-ancestor
84026148|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026149|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026150|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84026151|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
84026152|NCT04310579|Midazolam|midazolam|mesh-list
84026153|NCT04310579|Oxycodone|oxycodone|mesh-list
84026154|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84026155|NCT04310579|Paroxetine|paroxetine|mesh-list
84026156|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84026157|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84026158|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026159|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026160|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84026161|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84026162|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026163|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84026164|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
84026165|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
84026166|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
84026167|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
84026168|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026169|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026170|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84026171|NCT04310579|Narcotics|narcotics|mesh-ancestor
84026172|NCT04310579|Analgesics|analgesics|mesh-ancestor
84026173|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
84026174|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026175|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
84026176|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84026177|NCT04310579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84026178|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026179|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026180|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
84026181|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84026182|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84026183|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84026184|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026185|NCT05244538|Remifentanil|remifentanil|mesh-list
84026186|NCT05244538|Propofol|propofol|mesh-list
84026187|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84026188|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026189|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026190|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84026191|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
84026192|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
84026193|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84026194|NCT05244538|Narcotics|narcotics|mesh-ancestor
84026195|NCT05244538|Analgesics|analgesics|mesh-ancestor
84026196|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
84026197|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026198|NCT03638128|Denosumab|denosumab|mesh-list
84026199|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84026200|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026201|NCT05042440|Factor VIII|factor viii|mesh-list
84026202|NCT05042440|BAX 855|bax 855|mesh-list
84026203|NCT05042440|Coagulants|coagulants|mesh-ancestor
84026204|NCT03481660|Aflibercept|aflibercept|mesh-list
84026205|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84026206|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84026207|NCT03481660|Growth Substances|growth substances|mesh-ancestor
84026208|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026209|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
84026210|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026211|NCT05345236|Aflibercept|aflibercept|mesh-list
84026212|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84026213|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84026214|NCT05345236|Growth Substances|growth substances|mesh-ancestor
84026215|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026216|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
84026217|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026218|NCT02692534|Cocaine|cocaine|mesh-list
84026219|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
84026220|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
84026221|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026222|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026223|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
84026224|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026225|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84026226|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84026227|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026228|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026229|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026230|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
84026231|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026232|NCT00614536|Rabeprazole|rabeprazole|mesh-list
84026233|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84026234|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84026235|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84026236|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026237|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026238|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
84026239|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
84026240|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84026241|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84026242|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026243|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026244|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026245|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026246|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84026247|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
84026248|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84026249|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
84026250|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026251|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026252|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84026253|NCT04142086|Vaccines|vaccines|mesh-list
84026254|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
84026255|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026256|NCT03664882|Fexofenadine|fexofenadine|mesh-list
84026257|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84026258|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84026259|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84026260|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
84026261|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
84026262|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026263|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026264|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026265|NCT03951142|Losartan|losartan|mesh-list
84026266|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84026267|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84026268|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84026269|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84026270|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026271|NCT03903016|Insulin|insulin|mesh-list
84026272|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84026273|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
84026274|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84026275|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026276|NCT03514732|Melatonin|melatonin|mesh-list
84026277|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
84026278|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026279|NCT03514732|Protective Agents|protective agents|mesh-ancestor
84026280|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026281|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026282|NCT03800836|Paclitaxel|paclitaxel|mesh-list
84026283|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84026284|NCT03800836|Atezolizumab|atezolizumab|mesh-list
84026285|NCT03800836|Ipatasertib|ipatasertib|mesh-list
84026286|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84026287|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026288|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
84026289|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
84026290|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
84026291|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026292|NCT03800836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84026293|NCT03800836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84026294|NCT03800836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026295|NCT03800836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026296|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
84026297|NCT01976182|Methotrexate|methotrexate|mesh-list
84026298|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026299|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
84026300|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026301|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026302|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84026303|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
84026304|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026305|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026306|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84026307|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84026308|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
84026309|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84026310|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84026311|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
84026312|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
84026313|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026314|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84026315|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84026316|NCT00932373|Trastuzumab|trastuzumab|mesh-list
84026317|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84026318|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84026319|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026320|NCT00932373|Immunotoxins|immunotoxins|mesh-ancestor
84026321|NCT00932373|Immunoconjugates|immunoconjugates|mesh-ancestor
84026322|NCT00932373|Immunologic Factors|immunologic factors|mesh-ancestor
84026323|NCT00932373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026324|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
84026325|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
84026326|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
84026327|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026328|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
84026329|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84026330|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
84026331|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026332|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
84026333|NCT04265001|Protective Agents|protective agents|mesh-ancestor
84026334|NCT00608595|Celecoxib|celecoxib|mesh-list
84026335|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83266174|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84026336|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026338|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
84026339|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026340|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026341|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026342|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026343|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84026344|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84026345|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026346|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026347|NCT03761134|Metformin|metformin|mesh-list
84026348|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84026349|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84026350|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026351|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84026352|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026353|NCT01055496|Dexamethasone|dexamethasone|mesh-list
84026354|NCT01055496|Prednisone|prednisone|mesh-list
84026355|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
84026356|NCT01055496|Rituximab|rituximab|mesh-list
84026357|NCT01055496|Gemcitabine|gemcitabine|mesh-list
84026358|NCT01055496|Vincristine|vincristine|mesh-list
84026359|NCT01055496|Cisplatin|cisplatin|mesh-list
84026360|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84026361|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026362|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
84026363|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026364|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026365|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84026366|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
84026367|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026368|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026369|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84026370|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84026371|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026372|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
84026373|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
84026374|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026375|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84026376|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
84026377|NCT01055496|Hormones|hormones|mesh-ancestor
84026378|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026379|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84026380|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84026381|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
84026382|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84026383|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
84026384|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
84026385|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
84026386|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84026387|NCT01055496|Immunotoxins|immunotoxins|mesh-ancestor
84026388|NCT01055496|Immunoconjugates|immunoconjugates|mesh-ancestor
84026389|NCT03436498|Insulin|insulin|mesh-list
84026390|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84026391|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
84026392|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
84026393|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84026394|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84026395|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026396|NCT03435952|Doxycycline|doxycycline|mesh-list
84026397|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
84026398|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84026399|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026400|NCT03435952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84026401|NCT03435952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026402|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84026403|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026404|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
84026405|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84026406|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84026407|NCT04262193|Suvorexant|suvorexant|mesh-list
84026408|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83266252|NCT02210091|Factor VIII|factor viii|mesh-list
84026409|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84026410|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026411|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026412|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84026413|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026414|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026416|NCT00609531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84026417|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026418|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026419|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026420|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026421|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
84026422|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026423|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84026424|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
84026425|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026426|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
84026427|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84026428|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026429|NCT01052844|Gabapentin|gabapentin|mesh-list
84026430|NCT01052844|Analgesics|analgesics|mesh-ancestor
84026431|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
84026432|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026433|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026434|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
84026435|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84026436|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84026437|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026438|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026439|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84026440|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84026441|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026442|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026443|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
84026444|NCT02932618|Factor VIII|factor viii|mesh-list
84026445|NCT02932618|Coagulants|coagulants|mesh-ancestor
84026446|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
84026447|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84026448|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026449|NCT02584426|Cefazolin|cefazolin|mesh-list
84026450|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84026451|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026452|NCT00934089|Latanoprost|latanoprost|mesh-list
84026453|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84026454|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84026455|NCT01032174|Azithromycin|azithromycin|mesh-list
84026456|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84026457|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026458|NCT02704780|Misoprostol|misoprostol|mesh-list
84026459|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84026460|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
84026461|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84026462|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026463|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84026464|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84026465|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
84026466|NCT02704546|Methylphenidate|methylphenidate|mesh-list
84026467|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84026468|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026469|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84026470|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026471|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026472|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026473|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
84026474|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026475|NCT01032018|Bupropion|bupropion|mesh-list
84026476|NCT01032018|Citalopram|citalopram|mesh-list
84026477|NCT01032018|Sertraline|sertraline|mesh-list
84026478|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84026479|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
84026480|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026481|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83266326|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
84026482|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026483|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026484|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026485|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
84026486|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026487|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026488|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84026489|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84026490|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026491|NCT01032018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84026492|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
84026494|NCT00927069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84026495|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026496|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026497|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
84026498|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026499|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026500|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026501|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026502|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
84026503|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026504|NCT00608673|Betamethasone|betamethasone|mesh-list
84026505|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
84026506|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84026507|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
84026508|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
84026509|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84026510|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026511|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
84026512|NCT00608673|Hormones|hormones|mesh-ancestor
84026513|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026514|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026515|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84026516|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
84026517|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84026518|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026519|NCT00608673|Analgesics|analgesics|mesh-ancestor
84026520|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
84026521|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026522|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026523|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
84026524|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026525|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
84026526|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84026527|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026528|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026529|NCT04263519|Tacrolimus|tacrolimus|mesh-list
84026530|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026531|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
84026532|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026533|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84026534|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026535|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026536|NCT00637767|Melphalan|melphalan|mesh-list
84026537|NCT00637767|Antibodies|antibodies|mesh-list
84026538|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84026539|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
84026540|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026541|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84026542|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
84026543|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026544|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026545|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84026546|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026547|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
84026548|NCT05101629|Lenvatinib|lenvatinib|mesh-list
84026549|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84026550|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026551|NCT05101629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84026552|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026553|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026554|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026555|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84026556|NCT00609999|Dasatinib|dasatinib|mesh-list
84026557|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026558|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026559|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026560|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026561|NCT00627250|Amantadine|amantadine|mesh-list
84026562|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84026563|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84026564|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
84026565|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026566|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
84026567|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026568|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026569|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026570|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026571|NCT00627250|Analgesics|analgesics|mesh-ancestor
84026572|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
84026573|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026574|NCT04300374|Anesthetics|anesthetics|mesh-list
84026575|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026576|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026577|NCT02703376|Prednisone|prednisone|mesh-list
84026578|NCT02703376|Prednisolone|prednisolone|mesh-list
84026579|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026580|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
84026581|NCT02703376|Hormones|hormones|mesh-ancestor
84026582|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026583|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026584|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84026585|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026586|NCT00610077|Letrozole|letrozole|mesh-list
84026587|NCT00610077|Clomiphene|clomiphene|mesh-list
84026588|NCT00610077|Enclomiphene|enclomiphene|mesh-list
84026589|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
84026590|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026591|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026592|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84026593|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84026594|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026595|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84026596|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
84026597|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026598|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026599|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84026600|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
84026601|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84026602|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84026603|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84026604|NCT00823576|Ropivacaine|ropivacaine|mesh-list
84026605|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
84026606|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
84026607|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026608|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026609|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
84026610|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026611|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84026612|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84026613|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026614|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026615|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026616|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026617|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026618|NCT01028352|Analgesics|analgesics|mesh-ancestor
84026619|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
84026620|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026621|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
84026622|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026623|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
84026624|NCT03172780|Diclofenac|diclofenac|mesh-list
84026625|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84026626|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026627|NCT03172780|Analgesics|analgesics|mesh-ancestor
84026628|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
84026629|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026630|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026631|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026632|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026633|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84026634|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026635|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026636|NCT05011617|Anesthetics|anesthetics|mesh-list
84026637|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026638|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026639|NCT03169972|Factor VIII|factor viii|mesh-list
84026640|NCT03169972|BAX 855|bax 855|mesh-list
84026641|NCT03169972|Coagulants|coagulants|mesh-ancestor
84026642|NCT00926367|Clindamycin|clindamycin|mesh-list
84026643|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
84026644|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
84026645|NCT00926367|Adapalene|adapalene|mesh-list
84026646|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84026647|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84026648|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026649|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84026650|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026651|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026652|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
84026653|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84026654|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026655|NCT00926367|Analgesics|analgesics|mesh-ancestor
84026656|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
84026657|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026658|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026659|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026660|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026661|NCT04261023|Abatacept|abatacept|mesh-list
84026662|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84026663|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026664|NCT04261023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84026665|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026666|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026667|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
84026668|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026669|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026670|NCT01114529|Cyclosporine|cyclosporine|mesh-list
84026671|NCT01114529|Everolimus|everolimus|mesh-list
84026672|NCT01114529|Tacrolimus|tacrolimus|mesh-list
84026673|NCT01114529|Cyclosporins|cyclosporins|mesh-list
84026674|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026675|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
84026676|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026677|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84026678|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026679|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026680|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
84026681|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84026682|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
84026683|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026684|NCT01114529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84026685|NCT01114529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026686|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026687|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84026688|NCT00926289|Telmisartan|telmisartan|mesh-list
84026689|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84026690|NCT00926289|Diuretics|diuretics|mesh-ancestor
84026691|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
84026692|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026693|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84026694|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026695|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026696|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84026697|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84026698|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
84026699|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84026700|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
84026701|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
84026702|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84026703|NCT04309643|Estradiol|estradiol|mesh-list
84026704|NCT04309643|Estrogens|estrogens|mesh-ancestor
84026705|NCT04309643|Hormones|hormones|mesh-ancestor
84026706|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026707|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026708|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84026709|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84026710|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84026711|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84026712|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84026713|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84026714|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84026715|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84026716|NCT04259073|Pregabalin|pregabalin|mesh-list
84026717|NCT04259073|Analgesics|analgesics|mesh-ancestor
84026718|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
84026719|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026720|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026721|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
84026722|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84026723|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026724|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026725|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84026726|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84026727|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84026728|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026729|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026730|NCT00609063|Atorvastatin|atorvastatin|mesh-list
84026731|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84026732|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84026733|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
84026734|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026735|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84026736|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84026737|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026738|NCT02703064|Fenugreek seed meal|fenugreek seed meal|mesh-list
84026739|NCT02703064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84026740|NCT02703064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026741|NCT01114373|Melatonin|melatonin|mesh-list
84026742|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
84026743|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026744|NCT01114373|Protective Agents|protective agents|mesh-ancestor
84026745|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026746|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026747|NCT00925899|Melatonin|melatonin|mesh-list
84026748|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
84026749|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026750|NCT00925899|Protective Agents|protective agents|mesh-ancestor
84026751|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026752|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026753|NCT02601586|Oxycodone|oxycodone|mesh-list
84026754|NCT02601586|Levodopa|levodopa|mesh-list
84026755|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84026756|NCT02601586|Narcotics|narcotics|mesh-ancestor
84026757|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026758|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026759|NCT02601586|Analgesics|analgesics|mesh-ancestor
84026760|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
84026761|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026762|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84026763|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84026764|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
84026765|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026766|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026767|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84026768|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
84026769|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026770|NCT00610389|Immunomodulating Agents|immunomodulating agents|mesh-list
84026771|NCT00610389|Immunologic Factors|immunologic factors|mesh-ancestor
84026772|NCT00610389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026773|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84026774|NCT01114217|Hematinics|hematinics|mesh-ancestor
84026775|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84026776|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84026777|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
84026778|NCT01030536|Immunotoxins|immunotoxins|mesh-ancestor
84026780|NCT01030536|Immunologic Factors|immunologic factors|mesh-ancestor
84026781|NCT01030536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026782|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026783|NCT01030458|Amlodipine|amlodipine|mesh-list
84026784|NCT01030458|Valsartan|valsartan|mesh-list
84026785|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84026786|NCT01030458|Bisoprolol|bisoprolol|mesh-list
84026787|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84026788|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84026789|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026790|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026791|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84026792|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026793|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
84026794|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84026795|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84026796|NCT01030458|Diuretics|diuretics|mesh-ancestor
84026797|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
84026798|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84026799|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
84026800|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
84026801|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026802|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84026803|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84026804|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84026805|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
84026806|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026807|NCT02702674|Propranolol|propranolol|mesh-list
84026808|NCT02702674|Oxytocin|oxytocin|mesh-list
84026809|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
84026810|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84026811|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026812|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84026813|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84026814|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
84026815|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026816|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026817|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84026818|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84026819|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
84026820|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84026821|NCT01114139|Hematinics|hematinics|mesh-ancestor
84026822|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84026823|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84026824|NCT01027884|Idebenone|idebenone|mesh-list
84026825|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
84026826|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026827|NCT01027884|Protective Agents|protective agents|mesh-ancestor
84026828|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026829|NCT02699008|Clopidogrel|clopidogrel|mesh-list
84026830|NCT02699008|Ticagrelor|ticagrelor|mesh-list
84026831|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84026832|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84026833|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84026834|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84026835|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
84026836|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026837|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026838|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026839|NCT00627666|Leucovorin|leucovorin|mesh-list
84026840|NCT00627666|Methotrexate|methotrexate|mesh-list
84026841|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
84026842|NCT00627666|Fludarabine|fludarabine|mesh-list
84026843|NCT00627666|Busulfan|busulfan|mesh-list
84026844|NCT00627666|Calcium|calcium|mesh-list
84026845|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84026846|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
84026847|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84026848|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026849|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84026850|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
84026851|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84026852|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84026853|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
84026854|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026855|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026856|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
84026857|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026858|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84026859|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84026860|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
84026861|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026862|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84026863|NCT00627666|Antidotes|antidotes|mesh-ancestor
84026864|NCT00627666|Protective Agents|protective agents|mesh-ancestor
84026865|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
84026866|NCT00627666|Vitamins|vitamins|mesh-ancestor
84026867|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
84026868|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
84026869|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84026870|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84026871|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
84026872|NCT01022580|Calfactant|calfactant|mesh-list
84026873|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
84026874|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
84026875|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84026876|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026877|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026878|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026879|NCT02698930|Analgesics|analgesics|mesh-ancestor
84026880|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
84026881|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026882|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84026883|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84026884|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84026885|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
84026886|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026887|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026888|NCT01107353|Imipramine|imipramine|mesh-list
84026889|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84026890|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
84026891|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84026892|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84026893|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026894|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026895|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026896|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
84026897|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026898|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026899|NCT02702206|Triamcinolone|triamcinolone|mesh-list
84026900|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
84026901|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026902|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
84026903|NCT02702206|Hormones|hormones|mesh-ancestor
84026904|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026905|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026906|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
84026907|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84026908|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
84026909|NCT02702206|Protective Agents|protective agents|mesh-ancestor
84026910|NCT04216186|Ubiquinone|ubiquinone|mesh-list
84026911|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
84026912|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84026913|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84026914|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84026915|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026916|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026917|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
84026918|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84026919|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026920|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
84026921|NCT04216186|Vitamins|vitamins|mesh-ancestor
84026922|NCT01989598|Trametinib|trametinib|mesh-list
84026923|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026924|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026925|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026926|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026927|NCT04214938|Lidocaine|lidocaine|mesh-list
84026928|NCT04214938|Xylometazoline|xylometazoline|mesh-list
84026929|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
84026930|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
84026931|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026932|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026933|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
84026934|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026935|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84026936|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84026937|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84026938|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84026939|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026940|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
84026941|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84026942|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
84026943|NCT00615160|Dacarbazine|dacarbazine|mesh-list
84026944|NCT00615160|Vatalanib|vatalanib|mesh-list
84026945|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84026946|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
84026947|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026948|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026949|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84026950|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026951|NCT01112267|Acetaminophen|acetaminophen|mesh-list
84026952|NCT01112267|Tramadol|tramadol|mesh-list
84026953|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026954|NCT01112267|Analgesics|analgesics|mesh-ancestor
84026955|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
84026956|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026957|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026958|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
84026959|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84026960|NCT01112267|Narcotics|narcotics|mesh-ancestor
84026961|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026962|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
84026963|NCT00925587|Hematinics|hematinics|mesh-ancestor
84026964|NCT02698306|Dexamethasone|dexamethasone|mesh-list
84026965|NCT02698306|Diclofenac|diclofenac|mesh-list
84026966|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84026967|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
84026968|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
84026969|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026970|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026971|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84026972|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
84026973|NCT02698306|Hormones|hormones|mesh-ancestor
84026974|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84026975|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84026976|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84026977|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84026978|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84026979|NCT02698306|Analgesics|analgesics|mesh-ancestor
84026980|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
84026981|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84026982|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84026983|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84026984|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84026985|NCT02698228|Morphine|morphine|mesh-list
84026986|NCT02698228|Bupivacaine|bupivacaine|mesh-list
84026987|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
84026988|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
84026989|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84026990|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84026991|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
84026992|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84026993|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84026994|NCT02698228|Narcotics|narcotics|mesh-ancestor
84026995|NCT02698228|Analgesics|analgesics|mesh-ancestor
84026996|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
84026997|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84026998|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84026999|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027000|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
84027001|NCT02702128|Coagulants|coagulants|mesh-ancestor
84027002|NCT00610545|Atorvastatin|atorvastatin|mesh-list
84027003|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84027004|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84027005|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
84027006|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027007|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84027008|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84027009|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027010|NCT00193414|Gemcitabine|gemcitabine|mesh-list
84027011|NCT00193414|Pemetrexed|pemetrexed|mesh-list
84027012|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84027013|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
84027014|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027015|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027016|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027017|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84027018|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84027019|NCT04260711|Interferons|interferons|mesh-list
84027020|NCT04260711|Teriflunomide|teriflunomide|mesh-list
84027021|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
84027022|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84027023|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
84027024|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027025|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
84027026|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027027|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84027028|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
84027029|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027030|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027031|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027032|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84027033|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027034|NCT04260711|Analgesics|analgesics|mesh-ancestor
84027035|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
84027036|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027037|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027038|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027039|NCT00610623|Azithromycin|azithromycin|mesh-list
84027040|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84027041|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027042|NCT02697838|Paclitaxel|paclitaxel|mesh-list
84027043|NCT02697838|Apatinib|apatinib|mesh-list
84027044|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84027045|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027046|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
84027047|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
84027048|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
84027049|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027050|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84027051|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027052|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
84027053|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
84027054|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027055|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
84027056|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027057|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027058|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84027059|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84027060|NCT04956705|Vitamin D|vitamin d|mesh-list
84027061|NCT04956705|Calcium|calcium|mesh-list
84027062|NCT04956705|Vitamins|vitamins|mesh-ancestor
84027063|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
84027064|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027065|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027066|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84027067|NCT02705950|Baclofen|baclofen|mesh-list
84027068|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84027069|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027070|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84027071|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027072|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84027073|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
84027074|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
84027075|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027076|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027077|NCT04951323|Vaccines|vaccines|mesh-list
84027078|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
84027079|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027080|NCT02705872|Sufentanil|sufentanil|mesh-list
84027081|NCT02705872|Dsuvia|dsuvia|mesh-list
84027083|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84027084|NCT02705872|Narcotics|narcotics|mesh-ancestor
84027085|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027086|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027087|NCT02705872|Analgesics|analgesics|mesh-ancestor
84027088|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
84027089|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027090|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84027091|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84027092|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
84027093|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
84027094|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
84027095|NCT02701348|Letrozole|letrozole|mesh-list
84027096|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84027097|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027098|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84027099|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027100|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027101|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84027102|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
84027103|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027104|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027105|NCT05324800|Turmeric extract|turmeric extract|mesh-list
84027106|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
84027107|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027108|NCT05324800|Protective Agents|protective agents|mesh-ancestor
84027109|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027110|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
84027111|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84027112|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027113|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027114|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027115|NCT00930579|Metformin|metformin|mesh-list
84027116|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027117|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027118|NCT03367156|Dexamethasone|dexamethasone|mesh-list
84027119|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
84027120|NCT03367156|Ichthammol|ichthammol|mesh-list
84027121|NCT03367156|BB 1101|bb 1101|mesh-list
84027122|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027123|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
84027124|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
84027125|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027126|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027127|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027128|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
84027129|NCT03367156|Hormones|hormones|mesh-ancestor
84027130|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027131|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027132|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027133|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
84027134|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027135|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027136|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027137|NCT02700568|Axitinib|axitinib|mesh-list
84027138|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027139|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84027140|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027141|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027142|NCT00925353|Lidocaine|lidocaine|mesh-list
84027143|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
84027144|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
84027145|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027146|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027147|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
84027148|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027149|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84027150|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84027151|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84027152|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027153|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027154|NCT02705482|Durvalumab|durvalumab|mesh-list
84027155|NCT02705482|Tremelimumab|tremelimumab|mesh-list
84027156|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84027157|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027159|NCT02705638|Lenalidomide|lenalidomide|mesh-list
84027160|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84027161|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027162|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
84027163|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027164|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027165|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84027166|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84027167|NCT02705638|Growth Substances|growth substances|mesh-ancestor
84027168|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
84027169|NCT02691910|Chloroquine|chloroquine|mesh-list
84027170|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
84027171|NCT02691910|Primaquine|primaquine|mesh-list
84027172|NCT02691910|Amebicides|amebicides|mesh-ancestor
84027173|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84027174|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84027175|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027176|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
84027177|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027178|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84027179|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027180|NCT02691910|Analgesics|analgesics|mesh-ancestor
84027181|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
84027182|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027183|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027184|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027185|NCT02691910|Filaricides|filaricides|mesh-ancestor
84027186|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
84027187|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
84027188|NCT02705014|Hormones|hormones|mesh-list
84027189|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027190|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027191|NCT02704624|Vitamin D|vitamin d|mesh-list
84027192|NCT02704624|Vitamins|vitamins|mesh-ancestor
84027193|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
84027194|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027195|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84027196|NCT02700022|Prednisone|prednisone|mesh-list
84027197|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
84027198|NCT02700022|Doxorubicin|doxorubicin|mesh-list
84027199|NCT02700022|Etoposide|etoposide|mesh-list
84027200|NCT02700022|Vincristine|vincristine|mesh-list
84027201|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027202|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
84027203|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027204|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027205|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84027206|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
84027207|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027208|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027209|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84027210|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84027211|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84027212|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84027213|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027214|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027215|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
84027216|NCT02700022|Hormones|hormones|mesh-ancestor
84027217|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027218|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027219|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84027220|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
84027221|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
84027222|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
84027223|NCT02699710|Folic Acid|folic acid|mesh-list
84027224|NCT02699710|Methotrexate|methotrexate|mesh-list
84027225|NCT02699710|Rabeprazole|rabeprazole|mesh-list
84027226|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84027227|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
83267086|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
84027228|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84027229|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027230|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84027231|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
84027232|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027233|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027234|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027235|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027236|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84027237|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027238|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
84027239|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027240|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84027241|NCT02699710|Hematinics|hematinics|mesh-ancestor
84027242|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
84027244|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
84027245|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84027246|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027247|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84027248|NCT03140488|Oxytocin|oxytocin|mesh-list
84027249|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
84027250|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84027251|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027252|NCT00616408|Octreotide|octreotide|mesh-list
84027253|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027254|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027255|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027256|NCT02691754|Acetaminophen|acetaminophen|mesh-list
84027257|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027258|NCT02691754|Analgesics|analgesics|mesh-ancestor
84027259|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
84027260|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027261|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027262|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
84027263|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
84027264|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84027265|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84027266|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84027267|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84027268|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84027269|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027270|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027271|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84027272|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84027273|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84027274|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
84027275|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027276|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027277|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84027278|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84027279|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
84027280|NCT01106651|Canagliflozin|canagliflozin|mesh-list
84027281|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84027282|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84027283|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027284|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027285|NCT00637078|Amlodipine|amlodipine|mesh-list
84027286|NCT00637078|Spironolactone|spironolactone|mesh-list
84027287|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84027288|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84027289|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027290|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027291|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027292|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027293|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
84027294|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84027295|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
84027296|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027297|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84027298|NCT00637078|Diuretics|diuretics|mesh-ancestor
84027299|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
84027300|NCT00625781|Insulin|insulin|mesh-list
84027301|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84027302|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
84027303|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027304|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027305|NCT01027650|Dexamethasone|dexamethasone|mesh-list
84027306|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027307|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
84027308|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
84027309|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027310|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027311|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027312|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
84027313|NCT01027650|Hormones|hormones|mesh-ancestor
84027314|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027315|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027316|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027317|NCT00616876|Lactulose|lactulose|mesh-list
84027318|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027319|NCT01106027|Eculizumab|eculizumab|mesh-list
84027320|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84027321|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027322|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
84027323|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027324|NCT01027416|Tamoxifen|tamoxifen|mesh-list
84027325|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84027326|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
84027327|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027328|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027329|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027330|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027331|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84027332|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84027333|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84027334|NCT02873520|Immunomodulating Agents|immunomodulating agents|mesh-list
84027335|NCT02873520|Immunologic Factors|immunologic factors|mesh-ancestor
84027336|NCT02873520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027337|NCT05026203|Midazolam|midazolam|mesh-list
84027338|NCT05026203|Ketamine|ketamine|mesh-list
84027339|NCT05026203|Analgesics|analgesics|mesh-ancestor
84027340|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
84027341|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027342|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027343|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84027344|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84027345|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
84027346|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
84027347|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027348|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84027349|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84027350|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027351|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027352|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84027353|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84027354|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84027355|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84027356|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84027357|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
84027358|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
84027359|NCT01015638|Clindamycin|clindamycin|mesh-list
84027360|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
84027361|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
84027362|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84027363|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84027364|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027365|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84027366|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027367|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027368|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027369|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84027370|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027371|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027372|NCT00627744|Incretins|incretins|mesh-ancestor
84027373|NCT00627744|Hormones|hormones|mesh-ancestor
84027374|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027375|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84027376|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
84027377|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027378|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027379|NCT01105091|Epoprostenol|epoprostenol|mesh-list
84027380|NCT01105091|Tezosentan|tezosentan|mesh-list
84027381|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84027382|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84027383|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
84027384|NCT00628056|Perhexiline|perhexiline|mesh-list
84027385|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84027386|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027387|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027388|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027389|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027390|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
84027391|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
84027392|NCT00924729|Besifloxacin|besifloxacin|mesh-list
84027393|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84027394|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84027395|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84027396|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027397|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84027398|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84027399|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027400|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027401|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027402|NCT01099709|Oxycodone|oxycodone|mesh-list
84027403|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84027404|NCT01099709|Narcotics|narcotics|mesh-ancestor
84027405|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027406|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027407|NCT01099709|Analgesics|analgesics|mesh-ancestor
84027408|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
84027409|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027410|NCT04907019|Rifampin|rifampin|mesh-list
84027411|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84027412|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
84027413|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84027414|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027415|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
84027416|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84027417|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027418|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027419|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84027420|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84027421|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84027422|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84027423|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84027424|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84027425|NCT01022424|Tolvaptan|tolvaptan|mesh-list
84027426|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84027427|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027428|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
84027429|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027430|NCT05329857|Metformin|metformin|mesh-list
84027431|NCT05329857|Vildagliptin|vildagliptin|mesh-list
84027432|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027433|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027434|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84027435|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
84027436|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027437|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027438|NCT04981041|Clopidogrel|clopidogrel|mesh-list
84027439|NCT04981041|Ticagrelor|ticagrelor|mesh-list
84027440|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84027441|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84027442|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84027443|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84027444|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84027445|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
84027446|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027447|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027448|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027449|NCT01026948|Dinoprostone|dinoprostone|mesh-list
84027450|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
84027451|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84027452|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027453|NCT01104779|Cariprazine|cariprazine|mesh-list
84027454|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84027455|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84027456|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027457|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027458|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84027459|NCT00918957|Tobramycin|tobramycin|mesh-list
84027460|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84027461|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027462|NCT04308161|Vitamin D|vitamin d|mesh-list
84027463|NCT04308161|Miconazole|miconazole|mesh-list
84027464|NCT04308161|Vitamins|vitamins|mesh-ancestor
84027465|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
84027466|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027467|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84027468|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
84027469|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027470|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84027471|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84027472|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027473|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027474|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84027475|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
84027476|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027477|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84027478|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84027479|NCT04939467|Pirfenidone|pirfenidone|mesh-list
84027480|NCT04939467|Nintedanib|nintedanib|mesh-list
84027481|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027482|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84027483|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027484|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027485|NCT04939467|Analgesics|analgesics|mesh-ancestor
84027486|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
84027487|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027488|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027489|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84027490|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027491|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027492|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027493|NCT01015560|Antibodies|antibodies|mesh-list
84027494|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84027495|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
84027496|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027497|NCT04253223|Volagidemab|volagidemab|mesh-list
84027498|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027499|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027500|NCT00918879|Saxagliptin|saxagliptin|mesh-list
84027501|NCT00918879|Incretins|incretins|mesh-ancestor
84027502|NCT00918879|Hormones|hormones|mesh-ancestor
84027503|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027504|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027505|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84027506|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
84027507|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027508|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027509|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027510|NCT01026792|Sirolimus|sirolimus|mesh-list
84027511|NCT01026792|Temsirolimus|temsirolimus|mesh-list
84027512|NCT01026792|MTOR Inhibitors|mtor inhibitors|mesh-list
84027513|NCT01026792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84027514|NCT01026792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027515|NCT01026792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027516|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027517|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
84027518|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027519|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027520|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84027521|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027522|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84027523|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
84027524|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
84027525|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84027526|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027527|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027528|NCT04300686|Adalimumab|adalimumab|mesh-list
84027530|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
84027531|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
84027532|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027533|NCT04300686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84027534|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027535|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027536|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84027537|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
84027538|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027539|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027540|NCT01098539|Incretins|incretins|mesh-ancestor
84027541|NCT01098539|Hormones|hormones|mesh-ancestor
84027542|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027543|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84027544|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
84027545|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027546|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027547|NCT04922723|Daratumumab|daratumumab|mesh-list
84027548|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027549|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
84027550|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84027551|NCT01098461|Incretins|incretins|mesh-ancestor
84027552|NCT01098461|Hormones|hormones|mesh-ancestor
84027553|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027554|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027555|NCT01098305|Varenicline|varenicline|mesh-list
84027556|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84027557|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84027558|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
84027559|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027560|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027561|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027562|NCT00833833|Aspirin|aspirin|mesh-list
84027563|NCT00833833|Dexamethasone|dexamethasone|mesh-list
84027564|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
84027565|NCT00833833|Pomalidomide|pomalidomide|mesh-list
84027566|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84027567|NCT00833833|BB 1101|bb 1101|mesh-list
84027568|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027569|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
84027570|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
84027571|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027572|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027573|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027574|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
84027575|NCT00833833|Hormones|hormones|mesh-ancestor
84027576|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027577|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027578|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027579|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
84027580|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027581|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027582|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84027583|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027584|NCT00833833|Analgesics|analgesics|mesh-ancestor
84027585|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
84027586|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027587|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84027588|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84027589|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84027590|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84027591|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
84027592|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
84027593|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84027594|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84027595|NCT00833833|Growth Substances|growth substances|mesh-ancestor
84027596|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
84027597|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
84027598|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027599|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027600|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84027601|NCT02612545|Piperaquine|piperaquine|mesh-list
84027602|NCT02612545|Artenimol|artenimol|mesh-list
84027603|NCT02612545|Mefloquine|mefloquine|mesh-list
84027604|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
83267440|NCT05319431|Lenvatinib|lenvatinib|mesh-list
84027605|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84027606|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84027607|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027608|NCT00704743|Calpastatin|calpastatin|mesh-list
84027609|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
84027610|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
84027611|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027612|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027613|NCT01097057|Plerixafor|plerixafor|mesh-list
84027614|NCT01097057|Rituximab|rituximab|mesh-list
84027615|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84027616|NCT01097057|Carboplatin|carboplatin|mesh-list
84027617|NCT01097057|Etoposide|etoposide|mesh-list
84027618|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
84027619|NCT01097057|Ifosfamide|ifosfamide|mesh-list
84027620|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
84027621|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
84027622|NCT01097057|Antibodies|antibodies|mesh-list
84027623|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
84027624|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84027625|NCT01097057|Lenograstim|lenograstim|mesh-list
84027626|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
84027627|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027628|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027629|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027630|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84027631|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84027632|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84027633|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027634|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027635|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84027636|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84027637|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
84027638|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84027639|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84027640|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
84027641|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027642|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
84027643|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027644|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
84027645|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
84027646|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
84027647|NCT02612701|Nicotine|nicotine|mesh-list
84027648|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84027649|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
84027650|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027651|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027652|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84027653|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84027654|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
84027655|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027656|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027657|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
84027658|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84027659|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84027660|NCT01096667|Diuretics|diuretics|mesh-ancestor
84027661|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
84027662|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027663|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84027664|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027665|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027666|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84027667|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027668|NCT01014624|Clopidogrel|clopidogrel|mesh-list
84027669|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84027670|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84027671|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84027672|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84027673|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84027674|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
84027675|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027676|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027677|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027678|NCT01021878|Icodextrin|icodextrin|mesh-list
84027679|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
84027680|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84027681|NCT02872428|Valproic Acid|valproic acid|mesh-list
84027682|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
84027683|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027684|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027685|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
84027686|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027687|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027688|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
84027689|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84027690|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027691|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84027692|NCT02873364|Vitamin D|vitamin d|mesh-list
84027693|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
84027694|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
84027695|NCT02873364|Vitamins|vitamins|mesh-list
84027696|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
84027697|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027698|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84027699|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027700|NCT00628290|Cannabidiol|cannabidiol|mesh-list
84027701|NCT00628290|Amisulpride|amisulpride|mesh-list
84027702|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
84027703|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84027704|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84027705|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027706|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027707|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84027708|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84027709|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
84027710|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027711|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027712|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84027713|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
84027714|NCT04559412|Etanercept|etanercept|mesh-list
84027715|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84027716|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027717|NCT04559412|Analgesics|analgesics|mesh-ancestor
84027718|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
84027719|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027720|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027721|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027722|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027723|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027724|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027725|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
84027726|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84027727|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027728|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027729|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027730|NCT02872584|Prednisone|prednisone|mesh-list
84027731|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027732|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
84027733|NCT02872584|Hormones|hormones|mesh-ancestor
84027734|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027735|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027736|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027737|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027738|NCT00704821|Docetaxel|docetaxel|mesh-list
84027739|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027740|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
84027741|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
84027742|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
84027743|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027744|NCT00704899|Amitriptyline|amitriptyline|mesh-list
84027745|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84027746|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
84027747|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84027748|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027749|NCT00704899|Analgesics|analgesics|mesh-ancestor
84027750|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
84027751|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027752|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027753|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84027754|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83267639|NCT02175771|Xhance|xhance|mesh-list
84027755|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027756|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027757|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
84027758|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027759|NCT01104701|Exenatide|exenatide|mesh-list
84027760|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027761|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027762|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84027763|NCT01104701|Incretins|incretins|mesh-ancestor
84027764|NCT01104701|Hormones|hormones|mesh-ancestor
84027765|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027766|NCT00833755|Ketamine|ketamine|mesh-list
84027767|NCT00833755|Analgesics|analgesics|mesh-ancestor
84027768|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
84027769|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027770|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027771|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84027772|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84027773|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
84027774|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
84027775|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027776|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84027777|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84027778|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027779|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027780|NCT01021332|Tamsulosin|tamsulosin|mesh-list
84027781|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
84027782|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84027783|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84027784|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84027785|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
84027786|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84027787|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027788|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027789|NCT01021332|Urological Agents|urological agents|mesh-ancestor
84027790|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84027791|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84027792|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
84027793|NCT00923091|Amlodipine|amlodipine|mesh-list
84027794|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84027795|NCT00923091|Olmesartan|olmesartan|mesh-list
84027796|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84027797|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
84027798|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84027799|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84027800|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027801|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027802|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027803|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027804|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
84027805|NCT00923091|Diuretics|diuretics|mesh-ancestor
84027806|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
84027807|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84027808|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84027809|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84027810|NCT00853957|Amlodipine|amlodipine|mesh-list
84027811|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84027812|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84027813|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027814|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027815|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027816|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027817|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
84027818|NCT01021020|Colchicine|colchicine|mesh-list
84027819|NCT01021020|Probenecid|probenecid|mesh-list
84027820|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
84027821|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027822|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
84027823|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
84027824|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
84027825|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027826|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027827|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
84027828|NCT00833053|Infliximab|infliximab|mesh-list
84027829|NCT00833053|Methotrexate|methotrexate|mesh-list
84027830|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84027831|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
84027832|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84027833|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027834|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84027835|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
84027836|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027837|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027838|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027839|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027840|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84027841|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027842|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
84027843|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027844|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84027845|NCT00833053|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84027846|NCT00833053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027847|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84027848|NCT01020786|Carboplatin|carboplatin|mesh-list
84027849|NCT01020786|Pemetrexed|pemetrexed|mesh-list
84027850|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027851|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027852|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027853|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84027854|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84027855|NCT00918645|Calcium|calcium|mesh-list
84027856|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027857|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027858|NCT01020474|Pregabalin|pregabalin|mesh-list
84027859|NCT01020474|Analgesics|analgesics|mesh-ancestor
84027860|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
84027861|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027862|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027863|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
84027864|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84027865|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84027866|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027867|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84027868|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84027869|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84027870|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84027871|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84027872|NCT02872818|Metformin|metformin|mesh-list
84027873|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84027874|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84027875|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84027876|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
84027877|NCT02872818|Estradiol|estradiol|mesh-list
84027878|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84027879|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84027880|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027881|NCT02872818|Estrogens|estrogens|mesh-ancestor
84027882|NCT02872818|Hormones|hormones|mesh-ancestor
84027883|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84027884|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84027885|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
84027886|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84027887|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84027888|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84027889|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84027890|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84027891|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84027892|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84027893|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027894|NCT00922779|Ribavirin|ribavirin|mesh-list
84027895|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84027896|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
84027897|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027898|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
84027899|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027900|NCT04528680|Paclitaxel|paclitaxel|mesh-list
84027901|NCT04528680|Carboplatin|carboplatin|mesh-list
84027902|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84027903|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84027905|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
84027906|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
84027907|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
84027908|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027909|NCT04570410|Gemcitabine|gemcitabine|mesh-list
84027910|NCT04570410|Tislelizumab|tislelizumab|mesh-list
84027911|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027912|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84027913|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
84027914|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027915|NCT04570410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84027916|NCT04203771|Ibuprofen|ibuprofen|mesh-list
84027917|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84027918|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84027919|NCT04203771|Analgesics|analgesics|mesh-ancestor
84027920|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
84027921|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027922|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027923|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84027924|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84027925|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84027926|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027927|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027928|NCT04256733|Capsaicin|capsaicin|mesh-list
84027929|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
84027930|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
84027931|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
84027932|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027933|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027934|NCT01025232|Ranibizumab|ranibizumab|mesh-list
84027935|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84027936|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84027937|NCT01025232|Growth Substances|growth substances|mesh-ancestor
84027938|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027939|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
84027940|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027941|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
84027942|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84027943|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84027944|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027945|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
84027946|NCT05321199|Coagulants|coagulants|mesh-ancestor
84027947|NCT04300452|Carbetocin|carbetocin|mesh-list
84027948|NCT04300452|Ergonovine|ergonovine|mesh-list
84027949|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
84027950|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84027951|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027952|NCT01025154|Cytarabine|cytarabine|mesh-list
84027953|NCT01025154|Clofarabine|clofarabine|mesh-list
84027954|NCT01025154|Idarubicin|idarubicin|mesh-list
84027955|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84027956|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
84027957|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027958|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027959|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
84027960|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84027961|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84027962|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
84027963|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027964|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84027965|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84027966|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84027967|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027968|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
84027969|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84027970|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027971|NCT04252365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84027972|NCT04252365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027973|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
84027974|NCT04252443|Analgesics|analgesics|mesh-list
84027975|NCT04252443|Narcotics|narcotics|mesh-ancestor
84027976|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267814|NCT02114931|Adalimumab|adalimumab|mesh-list
84027977|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027978|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
84027979|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027981|NCT00832819|Carboplatin|carboplatin|mesh-list
84027982|NCT00832819|Lenvatinib|lenvatinib|mesh-list
84027983|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84027984|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84027985|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
84027986|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
84027987|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
84027988|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84027989|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84027990|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84027991|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
84027992|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
84027993|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84027994|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84027995|NCT00853723|Teriparatide|teriparatide|mesh-list
84027996|NCT00853723|Hormones|hormones|mesh-list
84027997|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
84027998|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
84027999|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028000|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028001|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84028002|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84028003|NCT00918255|Adalimumab|adalimumab|mesh-list
84028004|NCT00918255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84028005|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028006|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028007|NCT01096589|Monensin|monensin|mesh-list
84028008|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
84028009|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028010|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84028011|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84028012|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
84028013|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
84028014|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
84028015|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028016|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028017|NCT01096589|Ionophores|ionophores|mesh-ancestor
84028018|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028019|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
84028020|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84028021|NCT04252521|Ketoprofen|ketoprofen|mesh-list
84028022|NCT04252521|Metoclopramide|metoclopramide|mesh-list
84028023|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
84028024|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
84028025|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028026|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028027|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84028028|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84028029|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84028030|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
84028031|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028032|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028033|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84028034|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84028035|NCT04252521|Analgesics|analgesics|mesh-ancestor
84028036|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
84028037|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028038|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028039|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84028040|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028041|NCT00845065|Ribavirin|ribavirin|mesh-list
84028042|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84028043|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
84028044|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028045|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
84028046|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028047|NCT04772001|Carboplatin|carboplatin|mesh-list
84028048|NCT04772001|Cisplatin|cisplatin|mesh-list
84028049|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028050|NCT00702091|Ramipril|ramipril|mesh-list
84028051|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84028052|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
84028053|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028054|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028055|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84028056|NCT00832585|Alefacept|alefacept|mesh-list
84028057|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
84028058|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
84028059|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028060|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84028061|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84028062|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84028063|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028064|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028065|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028066|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028067|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028068|NCT05252325|Lidocaine|lidocaine|mesh-list
84028069|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
84028070|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
84028071|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
84028072|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028073|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028074|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
84028075|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028076|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84028077|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84028078|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84028079|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028080|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028081|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84028082|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
84028083|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
84028084|NCT05252325|Protective Agents|protective agents|mesh-ancestor
84028085|NCT01024920|Sunitinib|sunitinib|mesh-list
84028086|NCT01024920|Nintedanib|nintedanib|mesh-list
84028087|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028088|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84028089|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84028090|NCT01024920|Growth Substances|growth substances|mesh-ancestor
84028091|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028092|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
84028093|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84028094|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028095|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028096|NCT00832117|Cisplatin|cisplatin|mesh-list
84028097|NCT00832117|Epothilones|epothilones|mesh-list
84028098|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028099|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028100|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028101|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028102|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028103|NCT02872272|Amikacin|amikacin|mesh-list
84028104|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84028105|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028106|NCT00831493|Vorinostat|vorinostat|mesh-list
84028107|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028108|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84028109|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028110|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028111|NCT00705445|Zinc|zinc|mesh-list
84028112|NCT00705445|Trace Elements|trace elements|mesh-list
84028113|NCT00705445|Micronutrients|micronutrients|mesh-list
84028114|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028115|NCT02879981|Trimethoprim|trimethoprim|mesh-list
84028116|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
84028117|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
84028118|NCT02879981|Guaifenesin|guaifenesin|mesh-list
84028119|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
84028120|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84028121|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028122|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
84028123|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84028124|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84028125|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84028126|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028127|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028128|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84028129|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84028130|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84028131|NCT02879981|Expectorants|expectorants|mesh-ancestor
84028132|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
84028133|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84028134|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84028135|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028136|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028137|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028138|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
84028139|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84028140|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
84028141|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
84028142|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028143|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
84028144|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84028145|NCT04307693|Ritonavir|ritonavir|mesh-list
84028146|NCT04307693|Lopinavir|lopinavir|mesh-list
84028147|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
84028148|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84028149|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84028150|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
84028151|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028152|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028153|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84028154|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84028155|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
84028156|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028157|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84028158|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84028159|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
84028160|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84028161|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84028162|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028163|NCT02878421|Nicotine|nicotine|mesh-list
84028164|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84028165|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
84028166|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028167|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028168|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84028169|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84028170|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
84028171|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028172|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028173|NCT01019694|Albuterol|albuterol|mesh-list
84028174|NCT01019694|Ipratropium|ipratropium|mesh-list
84028175|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84028176|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
84028177|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028178|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028179|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84028180|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
84028181|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
84028182|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84028183|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84028184|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84028185|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84028186|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028187|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028188|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028189|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84028190|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
84028191|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84028192|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84028193|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84028194|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028195|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028196|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028197|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028198|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
84028199|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84028200|NCT01095653|Metformin|metformin|mesh-list
84028201|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
83268036|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
84028202|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84028203|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028204|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84028205|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028206|NCT00920907|Ipilimumab|ipilimumab|mesh-list
84028207|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84028208|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028209|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84028210|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028211|NCT00700297|Colchicine|colchicine|mesh-list
84028212|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
84028213|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028214|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028215|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028216|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028217|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028218|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028219|NCT04307147|Capecitabine|capecitabine|mesh-list
84028220|NCT04307147|Vinorelbine|vinorelbine|mesh-list
84028221|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84028222|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
84028223|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028224|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028225|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028226|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028227|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028228|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028229|NCT00844831|Lubiprostone|lubiprostone|mesh-list
84028230|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84028231|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028232|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028233|NCT00920829|Naltrexone|naltrexone|mesh-list
84028234|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84028235|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84028236|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028237|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
84028238|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028239|NCT05010876|Icatibant|icatibant|mesh-list
84028240|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
84028241|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84028242|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84028243|NCT05010876|Analgesics|analgesics|mesh-ancestor
84028244|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
84028245|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028246|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028247|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028248|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028249|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
84028250|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
84028251|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028252|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84028253|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028254|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
84028255|NCT04307069|Oxytocin|oxytocin|mesh-list
84028256|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
84028257|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84028258|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028259|NCT04251741|Adalimumab|adalimumab|mesh-list
84028260|NCT04251741|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84028261|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028262|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028263|NCT02878265|Vitamins|vitamins|mesh-list
84028264|NCT02878265|Vitamin A|vitamin a|mesh-list
84028265|NCT02878265|Zinc|zinc|mesh-list
84028266|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
84028267|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
84028268|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028269|NCT02878265|Trace Elements|trace elements|mesh-ancestor
84028270|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
84028271|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028272|NCT02878265|Protective Agents|protective agents|mesh-ancestor
84028273|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84028274|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028275|NCT00831181|Leucovorin|leucovorin|mesh-list
84028276|NCT00831181|Fluorouracil|fluorouracil|mesh-list
84028278|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
84028279|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028280|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84028281|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028282|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028283|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
84028284|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028285|NCT00831181|Antidotes|antidotes|mesh-ancestor
84028286|NCT00831181|Protective Agents|protective agents|mesh-ancestor
84028287|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
84028288|NCT00831181|Vitamins|vitamins|mesh-ancestor
84028289|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
84028290|NCT01023672|Modafinil|modafinil|mesh-list
84028291|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84028292|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028293|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84028294|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84028295|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84028296|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028297|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84028298|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84028299|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
84028300|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028301|NCT00705835|Antacids|antacids|mesh-ancestor
84028302|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028303|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84028304|NCT00702637|Modafinil|modafinil|mesh-list
84028305|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84028306|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028307|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84028308|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84028309|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84028310|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028311|NCT04786275|Fentanyl|fentanyl|mesh-list
84028312|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84028313|NCT04786275|Narcotics|narcotics|mesh-ancestor
84028314|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028315|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028316|NCT04786275|Analgesics|analgesics|mesh-ancestor
84028317|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
84028318|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028319|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84028320|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84028321|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
84028322|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
84028323|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84028324|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84028325|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84028326|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028327|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028328|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028329|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028330|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028331|NCT05525611|Cabergoline|cabergoline|mesh-list
84028332|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84028333|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84028334|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
84028335|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
84028336|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028337|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028338|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028339|NCT00917553|Doxycycline|doxycycline|mesh-list
84028340|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84028341|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028342|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
84028343|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84028344|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84028345|NCT04255251|Fluorides|fluorides|mesh-list
84028346|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
84028347|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
84028348|NCT04255251|Protective Agents|protective agents|mesh-ancestor
84028349|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268182|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
84028351|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84028352|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84028353|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028354|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028355|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028356|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028357|NCT01018680|Analgesics|analgesics|mesh-ancestor
84028358|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
84028359|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028360|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
84028361|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84028362|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
84028363|NCT04255017|Ritonavir|ritonavir|mesh-list
84028364|NCT04255017|Lopinavir|lopinavir|mesh-list
84028365|NCT04255017|Oseltamivir|oseltamivir|mesh-list
84028366|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84028367|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84028368|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
84028369|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028370|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028371|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84028372|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84028373|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
84028374|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028375|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84028376|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84028377|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
84028378|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
84028379|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
84028380|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028381|NCT01017120|Tazarotene|tazarotene|mesh-list
84028382|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
84028383|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
84028384|NCT02872038|Cefazolin|cefazolin|mesh-list
84028385|NCT02872038|Ceftazidime|ceftazidime|mesh-list
84028386|NCT02872038|Cefepime|cefepime|mesh-list
84028387|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84028388|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028389|NCT00627900|Sirolimus|sirolimus|mesh-list
84028390|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84028391|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028392|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84028393|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028394|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
84028395|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028396|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
84028397|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028398|NCT02996110|Nivolumab|nivolumab|mesh-list
84028399|NCT02996110|Ipilimumab|ipilimumab|mesh-list
84028400|NCT02996110|Relatlimab|relatlimab|mesh-list
84028401|NCT02996110|Linrodostat|linrodostat|mesh-list
84028402|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84028403|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028404|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84028405|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028406|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028407|NCT01103063|Azithromycin|azithromycin|mesh-list
84028408|NCT01103063|Chloroquine|chloroquine|mesh-list
84028409|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
84028410|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
84028411|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84028412|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84028413|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028414|NCT01103063|Amebicides|amebicides|mesh-ancestor
84028415|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84028416|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84028417|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
84028418|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028419|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84028420|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028421|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028422|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84028423|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
84028424|NCT02987998|Etoposide|etoposide|mesh-list
84028425|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028426|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84028427|NCT02987998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84028428|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028429|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028430|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84028432|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028433|NCT04213378|Paclitaxel|paclitaxel|mesh-list
84028434|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84028435|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028436|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028437|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028438|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028439|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028440|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028441|NCT04213924|Ibuprofen|ibuprofen|mesh-list
84028442|NCT04213924|Lidocaine|lidocaine|mesh-list
84028443|NCT04213924|Bupivacaine|bupivacaine|mesh-list
84028444|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
84028445|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
84028446|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028447|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028448|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
84028449|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028450|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84028451|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84028452|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84028453|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028454|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028455|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84028456|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84028457|NCT04213924|Analgesics|analgesics|mesh-ancestor
84028458|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028459|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028460|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84028461|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028462|NCT00616720|Interferons|interferons|mesh-list
84028463|NCT00616720|Aldesleukin|aldesleukin|mesh-list
84028464|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
84028465|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028466|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
84028467|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028468|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84028469|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84028470|NCT01091675|Etoricoxib|etoricoxib|mesh-list
84028471|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84028472|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84028473|NCT01091675|Analgesics|analgesics|mesh-ancestor
84028474|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
84028475|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028476|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028477|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028478|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028479|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84028480|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84028481|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028482|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028483|NCT02739412|Aldesleukin|aldesleukin|mesh-list
84028484|NCT02739412|Interleukin-2|interleukin-2|mesh-list
84028485|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028486|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84028487|NCT02739412|Analgesics|analgesics|mesh-ancestor
84028488|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
84028489|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028490|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028491|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84028492|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84028493|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
84028494|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028495|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
84028496|NCT04213612|Doxorubicin|doxorubicin|mesh-list
84028497|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84028498|NCT04213612|Vincristine|vincristine|mesh-list
84028499|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028500|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
84028501|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028502|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028503|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84028504|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
84028505|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028506|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028507|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84028508|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84028509|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84028510|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84028511|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028512|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028513|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028514|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028515|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028517|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84028518|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84028519|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
84028520|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028521|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028522|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028523|NCT01091519|Urological Agents|urological agents|mesh-ancestor
84028524|NCT02703220|Acetazolamide|acetazolamide|mesh-list
84028525|NCT02703220|Finasteride|finasteride|mesh-list
84028526|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
84028527|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84028528|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028529|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028530|NCT02703220|Diuretics|diuretics|mesh-ancestor
84028531|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
84028532|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028533|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84028534|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84028535|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
84028536|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028537|NCT02703220|Urological Agents|urological agents|mesh-ancestor
84028538|NCT02878031|Amoxicillin|amoxicillin|mesh-list
84028539|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84028540|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028541|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
84028542|NCT02879669|Carboplatin|carboplatin|mesh-list
84028543|NCT02879669|Pemetrexed|pemetrexed|mesh-list
84028544|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028545|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
84028546|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028547|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028548|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84028549|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
84028550|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028551|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028552|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84028553|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028554|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84028555|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84028556|NCT00516724|Paclitaxel|paclitaxel|mesh-list
84028557|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84028558|NCT00516724|Carboplatin|carboplatin|mesh-list
84028559|NCT00516724|Olaparib|olaparib|mesh-list
84028560|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84028561|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028562|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028563|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028564|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028565|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028566|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028567|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028568|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84028569|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
84028570|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028571|NCT00918333|Everolimus|everolimus|mesh-list
84028572|NCT00918333|Panobinostat|panobinostat|mesh-list
84028573|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84028574|NCT00918333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84028575|NCT00918333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84028576|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028577|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028578|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028579|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
84028580|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028581|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028582|NCT01090973|Panobinostat|panobinostat|mesh-list
84028583|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84028584|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028585|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028586|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028587|NCT02607904|Cannabidiol|cannabidiol|mesh-list
84028588|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
84028589|NCT05295394|Lamivudine|lamivudine|mesh-list
84028590|NCT05295394|Dolutegravir|dolutegravir|mesh-list
84028591|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84028592|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84028593|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028594|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028595|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
84028596|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028597|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84028598|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84028599|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84028600|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84028601|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
84028602|NCT02871648|Eplerenone|eplerenone|mesh-list
84028603|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84028604|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
84028605|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028606|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028607|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84028608|NCT02871648|Diuretics|diuretics|mesh-ancestor
84028609|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
84028610|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84028611|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028612|NCT00637845|Esomeprazole|esomeprazole|mesh-list
84028613|NCT00637845|Lansoprazole|lansoprazole|mesh-list
84028614|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
84028615|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84028616|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84028617|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84028618|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028619|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028620|NCT04738695|Antibodies|antibodies|mesh-list
84028621|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
84028622|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028623|NCT02497300|Amiloride|amiloride|mesh-list
84028624|NCT02497300|Spironolactone|spironolactone|mesh-list
84028625|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84028626|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
84028627|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028628|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028629|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84028630|NCT02497300|Diuretics|diuretics|mesh-ancestor
84028631|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
84028632|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
84028633|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84028634|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028635|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028636|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
84028637|NCT04254471|Carboplatin|carboplatin|mesh-list
84028638|NCT04254471|Etoposide|etoposide|mesh-list
84028639|NCT04254471|Rabeprazole|rabeprazole|mesh-list
84028640|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028641|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028642|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84028643|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84028644|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028645|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028646|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84028647|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84028648|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84028650|NCT00631527|Leuprolide|leuprolide|mesh-list
84028651|NCT00631527|Goserelin|goserelin|mesh-list
84028652|NCT00631527|Bicalutamide|bicalutamide|mesh-list
84028653|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028654|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84028655|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84028656|NCT00631527|Growth Substances|growth substances|mesh-ancestor
84028657|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028658|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
84028659|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84028660|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028661|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028662|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84028663|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
84028664|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84028665|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84028666|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
84028667|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
84028668|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028669|NCT00620620|Zaleplon|zaleplon|mesh-list
84028670|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
84028671|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84028672|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028673|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028674|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
84028675|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
84028676|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028677|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028678|NCT00916383|Donepezil|donepezil|mesh-list
84028679|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84028680|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028681|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028682|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
84028683|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028684|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028685|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
84028686|NCT00617500|Hormones|hormones|mesh-list
84028687|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028688|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028689|NCT04254081|Lidocaine|lidocaine|mesh-list
84028690|NCT04254081|Buprenorphine|buprenorphine|mesh-list
84028691|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
84028692|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
84028693|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028694|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028695|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
84028696|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028697|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84028698|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84028699|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84028700|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028701|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028702|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84028703|NCT04254081|Narcotics|narcotics|mesh-ancestor
84028704|NCT04254081|Analgesics|analgesics|mesh-ancestor
84028705|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84028706|NCT04209478|Morphine|morphine|mesh-list
84028707|NCT04209478|Tramadol|tramadol|mesh-list
84028708|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84028709|NCT04209478|Narcotics|narcotics|mesh-ancestor
84028710|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028711|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028712|NCT04209478|Analgesics|analgesics|mesh-ancestor
84028713|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
84028714|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028715|NCT05252715|Vaccines|vaccines|mesh-list
84028716|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
84028717|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028718|NCT04209166|Norepinephrine|norepinephrine|mesh-list
84028719|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83268557|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
84028720|NCT04209166|Serotonin|serotonin|mesh-list
84028721|NCT04209166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
84028722|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
84028723|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
84028724|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84028725|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84028726|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84028727|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028728|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028729|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84028730|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84028731|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028732|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028733|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028734|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
84028735|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
84028736|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028737|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84028738|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84028739|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028740|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
84028741|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84028742|NCT04766008|Metformin|metformin|mesh-list
84028743|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84028744|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028745|NCT00916149|Lamotrigine|lamotrigine|mesh-list
84028746|NCT00916149|Levetiracetam|levetiracetam|mesh-list
84028747|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
84028748|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
84028749|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84028750|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028751|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028752|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84028753|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028754|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84028755|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84028756|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028757|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84028758|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84028759|NCT00617656|Cisplatin|cisplatin|mesh-list
84028760|NCT00617656|Gemcitabine|gemcitabine|mesh-list
84028761|NCT00617656|Docetaxel|docetaxel|mesh-list
84028762|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028763|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84028764|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
84028765|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028766|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028767|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028768|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028769|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
84028770|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
84028771|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84028772|NCT00175162|Protective Agents|protective agents|mesh-ancestor
84028773|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028774|NCT04648540|Acetaminophen|acetaminophen|mesh-list
84028775|NCT04648540|Celecoxib|celecoxib|mesh-list
84028776|NCT04648540|Ketorolac|ketorolac|mesh-list
84028777|NCT04648540|Lidocaine|lidocaine|mesh-list
84028778|NCT04648540|Pregabalin|pregabalin|mesh-list
84028779|NCT04648540|Fentanyl|fentanyl|mesh-list
84028780|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
84028781|NCT04648540|Morphine|morphine|mesh-list
84028782|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
84028783|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
84028784|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028785|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028786|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
84028787|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028788|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84028789|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84028790|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84028791|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028792|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028793|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84028794|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84028795|NCT04648540|Analgesics|analgesics|mesh-ancestor
84028796|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84028797|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84028798|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84028799|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028800|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028801|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84028803|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84028804|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84028805|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
84028806|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
84028807|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
84028808|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84028809|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84028810|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84028811|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84028812|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84028813|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84028814|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028815|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028816|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84028817|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84028818|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028819|NCT04213222|Bevacizumab|bevacizumab|mesh-list
84028820|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84028821|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028822|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84028823|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84028824|NCT04213222|Growth Substances|growth substances|mesh-ancestor
84028825|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028826|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
84028827|NCT00621166|Ritonavir|ritonavir|mesh-list
84028828|NCT00621166|Lopinavir|lopinavir|mesh-list
84028829|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84028830|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84028831|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
84028832|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028833|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028834|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84028835|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84028836|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
84028837|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028838|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84028839|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84028840|NCT04555798|Meropenem|meropenem|mesh-list
84028841|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84028842|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84028843|NCT00617968|Docetaxel|docetaxel|mesh-list
84028844|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028845|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028846|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028847|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028848|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028849|NCT00621400|Dexamethasone|dexamethasone|mesh-list
84028850|NCT00621400|Lenalidomide|lenalidomide|mesh-list
84028851|NCT00621400|Melphalan|melphalan|mesh-list
84028852|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028853|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
84028854|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
84028855|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028856|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028857|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84028858|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
84028859|NCT00621400|Hormones|hormones|mesh-ancestor
84028860|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028861|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84028862|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028863|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
84028864|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84028865|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84028866|NCT00621400|Growth Substances|growth substances|mesh-ancestor
84028867|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
84028868|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84028869|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
84028870|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028871|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83268701|NCT02481947|Laxatives|laxatives|mesh-list
84028872|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028873|NCT04208854|Vinorelbine|vinorelbine|mesh-list
84028874|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028875|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028876|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028877|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028878|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028879|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028880|NCT01090427|Ustekinumab|ustekinumab|mesh-list
84028881|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
84028882|NCT04208776|Propranolol|propranolol|mesh-list
84028883|NCT04208776|Midodrine|midodrine|mesh-list
84028884|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84028885|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84028886|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028887|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028888|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028889|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028890|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84028891|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84028892|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
84028893|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
84028894|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
84028895|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028896|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84028897|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84028898|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84028899|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84028900|NCT02879435|Bupivacaine|bupivacaine|mesh-list
84028901|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
84028902|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
84028903|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028904|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028905|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
84028906|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028907|NCT02879513|Paclitaxel|paclitaxel|mesh-list
84028908|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
84028909|NCT02879513|Epirubicin|epirubicin|mesh-list
84028910|NCT02879513|Fluorouracil|fluorouracil|mesh-list
84028911|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84028912|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84028913|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
84028914|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
84028915|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
84028916|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028917|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84028918|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
84028919|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028920|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028921|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84028922|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
84028923|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84028924|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84028925|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84028926|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84028927|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028928|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
84028929|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84028930|NCT00621478|Diazepam|diazepam|mesh-list
84028931|NCT00621478|Lorazepam|lorazepam|mesh-list
84028932|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
84028933|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
84028934|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
84028935|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028936|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028937|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84028938|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84028939|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84028940|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84028941|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84028942|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84028943|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
84028944|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
84028945|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028946|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028947|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84028948|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84028949|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84028950|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84028951|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
84028952|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
84028954|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84028955|NCT00621556|Hormones|hormones|mesh-ancestor
84028956|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84028957|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028958|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
84028959|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
84028960|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84028961|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84028962|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028963|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028964|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84028965|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84028966|NCT04308551|Aspirin|aspirin|mesh-list
84028967|NCT04308551|Indobufen|indobufen|mesh-list
84028968|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84028969|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84028970|NCT04308551|Analgesics|analgesics|mesh-ancestor
84028971|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
84028972|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84028973|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028974|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84028975|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84028976|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84028977|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84028978|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028979|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84028980|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84028981|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84028982|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
84028983|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
84028984|NCT04306913|Esmolol|esmolol|mesh-list
84028985|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84028986|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84028987|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84028988|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
84028989|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84028990|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028991|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84028992|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84028993|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
84028994|NCT02299414|Nifedipine|nifedipine|mesh-list
84028995|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84028996|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84028997|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84028998|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84028999|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029000|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
84029001|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
84029002|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84029003|NCT01016262|Mesalamine|mesalamine|mesh-list
84029004|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84029005|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84029006|NCT01016262|Analgesics|analgesics|mesh-ancestor
84029007|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
84029008|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029009|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029010|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84029011|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029012|NCT00625937|Docetaxel|docetaxel|mesh-list
84029013|NCT00625937|Tegafur|tegafur|mesh-list
84029014|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029015|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029016|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029017|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029018|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029019|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029020|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
84029021|NCT01001910|Carboplatin|carboplatin|mesh-list
84029022|NCT01001910|Pemetrexed|pemetrexed|mesh-list
84029023|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029024|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029025|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029026|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84029027|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84029028|NCT04308317|Tetrandrine|tetrandrine|mesh-list
84029029|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
84029030|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84029031|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84029032|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029033|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84029034|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029035|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
84029036|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84029037|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84029038|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029039|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84029040|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029041|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029042|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
84029043|NCT01009554|Listerine|listerine|mesh-list
84029044|NCT01009554|Fluorides|fluorides|mesh-list
84029045|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
84029046|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
84029047|NCT01009554|Protective Agents|protective agents|mesh-ancestor
84029048|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029049|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84029050|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029051|NCT04211896|Nivolumab|nivolumab|mesh-list
84029052|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029053|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029054|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84029055|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029056|NCT04188184|Epinephrine|epinephrine|mesh-list
84029057|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
84029058|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84029059|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84029060|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029061|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
84029062|NCT04188184|Coagulants|coagulants|mesh-ancestor
84029063|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84029064|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84029065|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
84029066|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029067|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029068|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84029069|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84029070|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
84029071|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029072|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84029073|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
84029074|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
84029075|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
84029076|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84029077|NCT01006590|Metformin|metformin|mesh-list
84029078|NCT01006590|Saxagliptin|saxagliptin|mesh-list
84029079|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84029080|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029081|NCT01006590|Incretins|incretins|mesh-ancestor
84029082|NCT01006590|Hormones|hormones|mesh-ancestor
84029083|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84029084|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84029085|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
84029086|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029087|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029088|NCT04212832|Bupivacaine|bupivacaine|mesh-list
84029089|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
84029090|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
84029091|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029092|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029093|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
84029094|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029095|NCT00621790|Fenoldopam|fenoldopam|mesh-list
84029096|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84029097|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
84029098|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
84029099|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
84029100|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029101|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029102|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029103|NCT00618124|Capecitabine|capecitabine|mesh-list
84029104|NCT00618124|Sunitinib|sunitinib|mesh-list
84029105|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029106|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
84029107|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029108|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029109|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84029110|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84029111|NCT00618124|Growth Substances|growth substances|mesh-ancestor
84029112|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029113|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
84029114|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029115|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029116|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
84029117|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84029118|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029119|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84029120|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029121|NCT01882660|Decitabine|decitabine|mesh-list
84029122|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029123|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
84029124|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029125|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029126|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029127|NCT01001832|Abatacept|abatacept|mesh-list
84029128|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84029129|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029130|NCT01001832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029131|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029132|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029133|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
84029134|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029135|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029136|NCT01001598|Danazol|danazol|mesh-list
84029137|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84029138|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
84029139|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84029140|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029141|NCT01006356|Hydromorphone|hydromorphone|mesh-list
84029142|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84029143|NCT01006356|Narcotics|narcotics|mesh-ancestor
84029144|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029145|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029146|NCT01006356|Analgesics|analgesics|mesh-ancestor
84029147|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
84029148|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029149|NCT01089725|Tanezumab|tanezumab|mesh-list
84029150|NCT01089725|Analgesics|analgesics|mesh-ancestor
84029151|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
84029152|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029153|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029154|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
84029155|NCT01190930|Leucovorin|leucovorin|mesh-list
84029156|NCT01190930|Folic Acid|folic acid|mesh-list
84029157|NCT01190930|Cytarabine|cytarabine|mesh-list
84029158|NCT01190930|Dexamethasone|dexamethasone|mesh-list
84029159|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
84029160|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
84029161|NCT01190930|Doxorubicin|doxorubicin|mesh-list
84029162|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84029163|NCT01190930|Methotrexate|methotrexate|mesh-list
84029164|NCT01190930|Vincristine|vincristine|mesh-list
84029165|NCT01190930|Asparaginase|asparaginase|mesh-list
84029166|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
84029167|NCT01190930|Pegaspargase|pegaspargase|mesh-list
84029168|NCT01190930|Thioguanine|thioguanine|mesh-list
84029169|NCT01190930|BB 1101|bb 1101|mesh-list
84029170|NCT01190930|Calcium|calcium|mesh-list
84029171|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
83269000|NCT01906372|Hormones|hormones|mesh-list
84029172|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
84029173|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029174|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
84029175|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029176|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029177|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029178|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
84029179|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029180|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029181|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84029182|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84029183|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
84029184|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
84029185|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029186|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84029187|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
84029188|NCT01190930|Hormones|hormones|mesh-ancestor
84029189|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84029190|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84029191|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
84029192|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029193|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84029194|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84029195|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84029196|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84029197|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84029198|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84029199|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
84029200|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84029201|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029202|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
84029203|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029204|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84029205|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84029206|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
84029207|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029208|NCT01190930|Antidotes|antidotes|mesh-ancestor
84029209|NCT01190930|Protective Agents|protective agents|mesh-ancestor
84029210|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
84029211|NCT01190930|Vitamins|vitamins|mesh-ancestor
84029212|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
84029213|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84029214|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029215|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029216|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029217|NCT01190930|Hematinics|hematinics|mesh-ancestor
84029218|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
84029219|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84029220|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029221|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84029222|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
84029223|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84029224|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029225|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029226|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029227|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
84029228|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
84029229|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029230|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029231|NCT00618202|Balsalazide|balsalazide|mesh-list
84029232|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84029233|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84029234|NCT00618202|Analgesics|analgesics|mesh-ancestor
84029235|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
84029236|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029237|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029238|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84029239|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029240|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84029241|NCT00626015|Temozolomide|temozolomide|mesh-list
84029242|NCT00626015|Daclizumab|daclizumab|mesh-list
84029243|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029244|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
84029245|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029246|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029247|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029248|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
84029249|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029250|NCT00618280|Nicotine|nicotine|mesh-list
84029251|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84029252|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
84029253|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029254|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029255|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84029256|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84029257|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
84029258|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029259|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029260|NCT01101191|Oxycodone|oxycodone|mesh-list
84029261|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84029262|NCT01101191|Narcotics|narcotics|mesh-ancestor
84029263|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029264|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029265|NCT01101191|Analgesics|analgesics|mesh-ancestor
84029266|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
84029267|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029268|NCT00622258|Everolimus|everolimus|mesh-list
84029269|NCT00622258|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84029270|NCT00622258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029271|NCT00622258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029272|NCT00622258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029273|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029274|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
84029275|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029276|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029277|NCT01812616|Nabiximols|nabiximols|mesh-list
84029278|NCT01812616|Analgesics|analgesics|mesh-ancestor
84029279|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
84029280|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029281|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029282|NCT00618358|Thrombin|thrombin|mesh-list
84029283|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
84029284|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
84029285|NCT00618358|Coagulants|coagulants|mesh-ancestor
84029286|NCT01178762|Azithromycin|azithromycin|mesh-list
84029287|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84029288|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029289|NCT03563560|Cytarabine|cytarabine|mesh-list
84029290|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
84029291|NCT03563560|Alvocidib|alvocidib|mesh-list
84029292|NCT03563560|Daunorubicin|daunorubicin|mesh-list
84029293|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029294|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
84029295|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029296|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029297|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
84029298|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029299|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029300|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
84029301|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029302|NCT03563560|Analgesics|analgesics|mesh-ancestor
84029303|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
84029304|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029305|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84029306|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84029307|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029308|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
84029309|NCT03563560|Growth Substances|growth substances|mesh-ancestor
84029310|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029311|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84029312|NCT01178138|Prazosin|prazosin|mesh-list
84029313|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84029314|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84029315|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84029316|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84029317|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
84029318|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029319|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029320|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029321|NCT01190228|Vaccines|vaccines|mesh-list
84029322|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
84029323|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029324|NCT01009086|Ustekinumab|ustekinumab|mesh-list
84029325|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029326|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
84029327|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84029329|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029330|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
84029331|NCT01190150|Coagulants|coagulants|mesh-ancestor
84029332|NCT04315688|Insulin|insulin|mesh-list
84029333|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84029334|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029335|NCT05210062|Succinylcholine|succinylcholine|mesh-list
84029336|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
84029337|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84029338|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84029339|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029340|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029341|NCT01001520|Tolcapone|tolcapone|mesh-list
84029342|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84029343|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84029344|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84029345|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029346|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029347|NCT00619840|Methylphenidate|methylphenidate|mesh-list
84029348|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84029349|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029350|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84029351|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84029352|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84029353|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029354|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
84029355|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029356|NCT01189604|Propofol|propofol|mesh-list
84029357|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84029358|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029359|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029360|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84029361|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
84029362|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
84029363|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
84029364|NCT02697058|Leucovorin|leucovorin|mesh-list
84029365|NCT02697058|Fluorouracil|fluorouracil|mesh-list
84029366|NCT02697058|Calcium|calcium|mesh-list
84029367|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
84029368|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84029369|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029370|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84029371|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
84029372|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029373|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029374|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029375|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029376|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
84029377|NCT02697058|Antidotes|antidotes|mesh-ancestor
84029378|NCT02697058|Protective Agents|protective agents|mesh-ancestor
84029379|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
84029380|NCT02697058|Vitamins|vitamins|mesh-ancestor
84029381|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
84029382|NCT00622414|Aflibercept|aflibercept|mesh-list
84029383|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
84029384|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84029385|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84029386|NCT00622414|Growth Substances|growth substances|mesh-ancestor
84029387|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029388|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
84029389|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029390|NCT01008696|Rabeprazole|rabeprazole|mesh-list
84029391|NCT01008696|Lansoprazole|lansoprazole|mesh-list
84029392|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
84029393|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84029394|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84029395|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84029396|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029397|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029398|NCT01955980|Budesonide|budesonide|mesh-list
84029399|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84029400|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84029401|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
84029402|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029403|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029404|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84029405|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
84029406|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
84029407|NCT01955980|Hormones|hormones|mesh-ancestor
84029408|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84029409|NCT02870478|Atropine|atropine|mesh-list
84029410|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84029411|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84029412|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84029413|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84029414|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84029415|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
84029416|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029417|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029418|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84029419|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
84029420|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
84029421|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
84029422|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84029423|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84029424|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
84029425|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029426|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029427|NCT04296162|Capecitabine|capecitabine|mesh-list
84029428|NCT04296162|Trastuzumab|trastuzumab|mesh-list
84029429|NCT04296162|Vinorelbine|vinorelbine|mesh-list
84029430|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029431|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
84029432|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029433|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029434|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029435|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84029436|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029437|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029438|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029439|NCT00619996|Docetaxel|docetaxel|mesh-list
84029440|NCT00619996|Sorafenib|sorafenib|mesh-list
84029441|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029442|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029443|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029444|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029445|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029446|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029447|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029448|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84029449|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84029450|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84029451|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029452|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029453|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
84029454|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029455|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84029456|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84029457|NCT00622570|Pentobarbital|pentobarbital|mesh-list
84029458|NCT00622570|Thiopental|thiopental|mesh-list
84029459|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
84029460|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84029461|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029462|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029463|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84029464|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
84029465|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
84029466|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
84029467|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
84029468|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029469|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029470|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84029471|NCT00890266|Riboflavin|riboflavin|mesh-list
84029472|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
84029473|NCT00890266|Vitamins|vitamins|mesh-ancestor
84029474|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
84029475|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029476|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84029477|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
83269297|NCT02098395|Liraglutide|liraglutide|mesh-list
84029478|NCT01176968|Eplerenone|eplerenone|mesh-list
84029479|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84029480|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
84029481|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84029482|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029483|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84029484|NCT01176968|Diuretics|diuretics|mesh-ancestor
84029485|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
84029486|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84029487|NCT02697370|Factor VIII|factor viii|mesh-list
84029488|NCT02697370|Coagulants|coagulants|mesh-ancestor
84029489|NCT02691442|Epinephrine|epinephrine|mesh-list
84029490|NCT02691442|Ropivacaine|ropivacaine|mesh-list
84029491|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
84029492|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
84029493|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
84029494|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029495|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029496|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
84029497|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029498|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84029499|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84029500|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
84029501|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029502|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029503|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84029504|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84029505|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
84029506|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84029507|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
84029508|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
84029509|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
84029510|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84029511|NCT00622648|Enoxaparin|enoxaparin|mesh-list
84029512|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
84029513|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84029514|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84029515|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029516|NCT02687854|Vitamin K|vitamin k|mesh-list
84029517|NCT02687854|Apixaban|apixaban|mesh-list
84029518|NCT02687854|Vitamins|vitamins|mesh-ancestor
84029519|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
84029520|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029521|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84029522|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
84029523|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84029524|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
84029525|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029526|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029527|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
84029528|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84029529|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84029530|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
84029531|NCT02687854|Coagulants|coagulants|mesh-ancestor
84029532|NCT01005966|Listerine|listerine|mesh-list
84029533|NCT01005966|Fluorides|fluorides|mesh-list
84029534|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
84029535|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
84029536|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
84029537|NCT01005966|Protective Agents|protective agents|mesh-ancestor
84029538|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029539|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84029540|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029541|NCT00628680|Heparin|heparin|mesh-list
84029542|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
84029543|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84029544|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84029545|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029546|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
84029547|NCT00603304|Urological Agents|urological agents|mesh-ancestor
84029548|NCT01176032|Losartan|losartan|mesh-list
84029549|NCT01176032|Amlodipine|amlodipine|mesh-list
84029550|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84029551|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84029552|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84029553|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84029554|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029555|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84029556|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029557|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
84029558|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84029559|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84029560|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84029561|NCT01176032|Diuretics|diuretics|mesh-ancestor
84029562|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
84029563|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84029564|NCT01008618|Fentanyl|fentanyl|mesh-list
84029565|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84029566|NCT01008618|Narcotics|narcotics|mesh-ancestor
84029567|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029568|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029569|NCT01008618|Analgesics|analgesics|mesh-ancestor
84029570|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
84029571|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029572|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84029573|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84029574|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
84029575|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
84029576|NCT01001208|Etanercept|etanercept|mesh-list
84029577|NCT01001208|Methotrexate|methotrexate|mesh-list
84029578|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84029579|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
84029580|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84029581|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029582|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029583|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
84029584|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029585|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029586|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029587|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029588|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84029589|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029590|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
84029591|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029592|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84029593|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84029594|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84029595|NCT01001208|Analgesics|analgesics|mesh-ancestor
84029596|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
84029597|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029598|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84029599|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84029600|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84029601|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
84029602|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029603|NCT01193842|Prednisone|prednisone|mesh-list
84029604|NCT01193842|Cortisone|cortisone|mesh-list
84029605|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
84029606|NCT01193842|Rituximab|rituximab|mesh-list
84029607|NCT01193842|Doxorubicin|doxorubicin|mesh-list
84029608|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84029609|NCT01193842|Etoposide|etoposide|mesh-list
84029610|NCT01193842|Vincristine|vincristine|mesh-list
84029611|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
84029612|NCT01193842|Vorinostat|vorinostat|mesh-list
84029613|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
84029614|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84029615|NCT01193842|Antibodies|antibodies|mesh-list
84029616|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
84029617|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84029618|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029619|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
84029620|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029621|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029622|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029623|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
84029624|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029625|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029626|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84029627|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84029628|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84029629|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84029630|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029631|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84029632|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
84029633|NCT01193842|Hormones|hormones|mesh-ancestor
84029634|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84029635|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84029636|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84029637|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029638|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029639|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029640|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84029641|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
84029642|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029643|NCT04401774|Nivolumab|nivolumab|mesh-list
84029644|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029645|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029646|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84029647|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029648|NCT01004406|Atorvastatin|atorvastatin|mesh-list
84029649|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
84029650|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84029651|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84029652|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
84029653|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029654|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84029655|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029656|NCT01093612|Copper|copper|mesh-list
84029657|NCT01093612|Trastuzumab|trastuzumab|mesh-list
84029658|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029659|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029660|NCT01093612|Trace Elements|trace elements|mesh-ancestor
84029661|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
84029662|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029663|NCT01182350|Bevacizumab|bevacizumab|mesh-list
84029664|NCT01182350|Temozolomide|temozolomide|mesh-list
84029665|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84029666|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029667|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029668|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84029669|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84029670|NCT01182350|Growth Substances|growth substances|mesh-ancestor
84029671|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029672|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
84029673|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029674|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
84029675|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029676|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029677|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029678|NCT00603538|Paclitaxel|paclitaxel|mesh-list
84029679|NCT00603538|Carboplatin|carboplatin|mesh-list
84029680|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84029681|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029682|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029683|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029684|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029685|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029686|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84029687|NCT02537860|Fentanyl|fentanyl|mesh-list
84029688|NCT02537860|Bupivacaine|bupivacaine|mesh-list
84029689|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
84029690|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
84029691|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029692|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029693|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
84029694|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029695|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84029696|NCT02537860|Narcotics|narcotics|mesh-ancestor
84029697|NCT02537860|Analgesics|analgesics|mesh-ancestor
84029698|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84029699|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84029700|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
84029701|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
84029702|NCT03844750|Vactosertib|vactosertib|mesh-list
84029703|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029704|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029705|NCT03844750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84029706|NCT03844750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029707|NCT03844750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029709|NCT03797014|Tenofovir|tenofovir|mesh-list
84029710|NCT03797014|Emtricitabine|emtricitabine|mesh-list
84029711|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84029712|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
84029713|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029714|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84029715|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84029716|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029717|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029718|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84029719|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84029720|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
84029721|NCT04521946|Fludarabine|fludarabine|mesh-list
84029722|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
84029723|NCT04521946|Etoposide|etoposide|mesh-list
84029724|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
84029725|NCT04521946|Melphalan|melphalan|mesh-list
84029726|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
84029727|NCT04521946|Thiotepa|thiotepa|mesh-list
84029728|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
84029729|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
84029730|NCT04521946|Tacrolimus|tacrolimus|mesh-list
84029731|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
84029732|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83152528|NCT02183155|Meloxicam|meloxicam|mesh-list
84029733|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
84029734|NCT04521946|Antibodies|antibodies|mesh-list
84029735|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
84029736|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84029737|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84029738|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029739|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029740|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
84029741|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029742|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029743|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
84029744|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029745|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84029746|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84029747|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84029748|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029749|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84029750|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84029751|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84029752|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
84029753|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84029754|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029755|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029756|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
84029757|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84029758|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
84029759|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029760|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029761|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029762|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029763|NCT01162304|Oxycodone|oxycodone|mesh-list
84029764|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84029765|NCT01162304|Narcotics|narcotics|mesh-ancestor
84029766|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029767|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029768|NCT01162304|Analgesics|analgesics|mesh-ancestor
84029769|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
84029770|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029771|NCT04515394|Cetuximab|cetuximab|mesh-list
84029772|NCT04515394|Tepotinib|tepotinib|mesh-list
84029773|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029774|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029775|NCT04206176|Ticagrelor|ticagrelor|mesh-list
84029776|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84029777|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84029778|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84029779|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84029780|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
84029781|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029782|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029783|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269612|NCT01613326|Albuterol|albuterol|mesh-list
84029784|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84029785|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029786|NCT00638326|Clopidogrel|clopidogrel|mesh-list
84029787|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84029788|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84029789|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84029790|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84029791|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
84029792|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84029793|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029794|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029795|NCT04314674|Mannitol|mannitol|mesh-list
84029796|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84029797|NCT04314674|Diuretics|diuretics|mesh-ancestor
84029798|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
84029799|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029800|NCT00639262|Temozolomide|temozolomide|mesh-list
84029801|NCT00639262|Sorafenib|sorafenib|mesh-list
84029802|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029803|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
84029804|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029805|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029806|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029807|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029808|NCT02885558|Efonidipine|efonidipine|mesh-list
84029809|NCT02885558|Nifedipine|nifedipine|mesh-list
84029810|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84029811|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84029812|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029813|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84029814|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029815|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
84029816|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
84029817|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84029818|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84029819|NCT02885558|Diuretics|diuretics|mesh-ancestor
84029820|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
84029821|NCT01008150|Paclitaxel|paclitaxel|mesh-list
84029822|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
84029823|NCT01008150|Doxorubicin|doxorubicin|mesh-list
84029824|NCT01008150|Trastuzumab|trastuzumab|mesh-list
84029825|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84029826|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029827|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
84029828|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
84029829|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
84029830|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029831|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029832|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
84029833|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029834|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029835|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029836|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
84029837|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84029838|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84029839|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84029840|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84029841|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029842|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029843|NCT04186936|Simethicone|simethicone|mesh-list
84029844|NCT04186936|Loperamide|loperamide|mesh-list
84029845|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
84029846|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84029847|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
84029848|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029849|NCT04186936|Emollients|emollients|mesh-ancestor
84029850|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029851|NCT02689180|Furosemide|furosemide|mesh-list
84029852|NCT02689180|Diuretics|diuretics|mesh-ancestor
84029853|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
84029854|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029855|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84029856|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84029857|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269672|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
84029858|NCT02689336|Temozolomide|temozolomide|mesh-list
84029859|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84029860|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84029861|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
84029862|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029863|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029864|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84029865|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029866|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
84029867|NCT03650764|Ramucirumab|ramucirumab|mesh-list
84029868|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029869|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029870|NCT03650764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84029871|NCT03650764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029872|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84029873|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84029874|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029875|NCT01007448|Bexarotene|bexarotene|mesh-list
84029876|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029877|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84029878|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
84029879|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84029880|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
84029881|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029882|NCT04294056|Propofol|propofol|mesh-list
84029883|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84029884|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029885|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029886|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84029887|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
84029888|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
84029889|NCT04186702|Ranibizumab|ranibizumab|mesh-list
84029890|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84029891|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84029892|NCT04186702|Growth Substances|growth substances|mesh-ancestor
84029893|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029894|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
84029895|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029896|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
84029897|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
84029898|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84029899|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84029900|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029901|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
84029902|NCT04187014|Coagulants|coagulants|mesh-ancestor
84029903|NCT02686840|Misoprostol|misoprostol|mesh-list
84029904|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84029905|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
84029906|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84029907|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029908|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84029909|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84029910|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
84029911|NCT02689024|Acetaminophen|acetaminophen|mesh-list
84029912|NCT02689024|Dipyrone|dipyrone|mesh-list
84029913|NCT02689024|Ibuprofen|ibuprofen|mesh-list
84029914|NCT02689024|Diclofenac|diclofenac|mesh-list
84029915|NCT02689024|Naproxen|naproxen|mesh-list
84029916|NCT02689024|Fentanyl|fentanyl|mesh-list
84029917|NCT02689024|Morphine|morphine|mesh-list
84029918|NCT02689024|Bupivacaine|bupivacaine|mesh-list
84029919|NCT02689024|Ropivacaine|ropivacaine|mesh-list
84029920|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
84029921|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
84029922|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
84029923|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84029924|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029925|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
84029926|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84029927|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84029928|NCT02689024|Narcotics|narcotics|mesh-ancestor
84029929|NCT02689024|Analgesics|analgesics|mesh-ancestor
84029930|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84029931|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84029932|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
84029933|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84029934|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
84029935|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84029936|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84029937|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84029938|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84029939|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029940|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029941|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
84029942|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84029943|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84029944|NCT00638482|Diuretics|diuretics|mesh-ancestor
84029945|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
84029946|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029947|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84029948|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84029949|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029950|NCT00638560|Vitamins|vitamins|mesh-list
84029951|NCT00638560|Vitamin E|vitamin e|mesh-list
84029952|NCT00638560|Antioxidants|antioxidants|mesh-list
84029953|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
84029954|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029955|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029956|NCT00638560|Protective Agents|protective agents|mesh-ancestor
84029957|NCT00638638|Abciximab|abciximab|mesh-list
84029958|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
84029959|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84029960|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
84029961|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84029962|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84029963|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029964|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
84029965|NCT02684812|Coagulants|coagulants|mesh-ancestor
84029966|NCT04203160|Cisplatin|cisplatin|mesh-list
84029967|NCT04203160|Gemcitabine|gemcitabine|mesh-list
84029968|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029969|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84029970|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
84029971|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029972|NCT01004250|Bevacizumab|bevacizumab|mesh-list
84029973|NCT01004250|Pemetrexed|pemetrexed|mesh-list
84029974|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84029975|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84029976|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84029977|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84029978|NCT01004250|Growth Substances|growth substances|mesh-ancestor
84029979|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029980|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
84029981|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84029982|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029983|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84029984|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84029985|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84029986|NCT02688634|Amoxicillin|amoxicillin|mesh-list
84029987|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029988|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
84029989|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84029990|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
84029991|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84029992|NCT00639496|Expectorants|expectorants|mesh-ancestor
84029993|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
84029994|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84029995|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
84029996|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84029997|NCT00639496|Protective Agents|protective agents|mesh-ancestor
84029998|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84029999|NCT00639496|Antidotes|antidotes|mesh-ancestor
84030000|NCT02688400|Celecoxib|celecoxib|mesh-list
84030001|NCT02688400|Diacerein|diacerein|mesh-list
84030002|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84030003|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030004|NCT02688400|Analgesics|analgesics|mesh-ancestor
84030005|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
84030006|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030007|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030008|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030009|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030010|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84030011|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84030012|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030013|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030014|NCT00639574|Nefopam|nefopam|mesh-list
84030015|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030016|NCT00639574|Analgesics|analgesics|mesh-ancestor
84030017|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
84030018|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030019|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030020|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
84030021|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030022|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84030023|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030024|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030025|NCT01004172|Bevacizumab|bevacizumab|mesh-list
84030026|NCT01004172|Trastuzumab|trastuzumab|mesh-list
84030027|NCT01004172|Carboplatin|carboplatin|mesh-list
84030028|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030029|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030030|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84030031|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84030032|NCT01004172|Growth Substances|growth substances|mesh-ancestor
84030033|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030034|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
84030035|NCT02688322|Sulbactam|sulbactam|mesh-list
84030036|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030037|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030038|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84030039|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030040|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030041|NCT02685748|Aspirin|aspirin|mesh-list
84030042|NCT02685748|Pantoprazole|pantoprazole|mesh-list
84030043|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84030044|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030045|NCT02685748|Analgesics|analgesics|mesh-ancestor
84030046|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
84030047|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030048|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030049|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030050|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030051|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84030052|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84030053|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030054|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84030055|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84030056|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030057|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
84030058|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84030059|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030060|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84030061|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
84030062|NCT02685670|Fludarabine|fludarabine|mesh-list
84030063|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030064|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
84030065|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030066|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030067|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030068|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
84030069|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030070|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030071|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84030072|NCT02687932|Valsartan|valsartan|mesh-list
84030073|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84030074|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84030075|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84030076|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84030077|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030078|NCT00641602|Esomeprazole|esomeprazole|mesh-list
84030079|NCT00641602|Lansoprazole|lansoprazole|mesh-list
84030080|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
84030081|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84030082|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030083|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84030084|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030085|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030086|NCT05663944|Sirolimus|sirolimus|mesh-list
84030087|NCT05663944|Liver Extracts|liver extracts|mesh-list
84030088|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030089|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030090|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84030091|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030092|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
84030093|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030094|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
84030095|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030096|NCT05663944|Hematinics|hematinics|mesh-ancestor
84030097|NCT02682862|Bromides|bromides|mesh-list
84030098|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
84030099|NCT02682862|Olodaterol|olodaterol|mesh-list
84030100|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84030101|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
84030102|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030103|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030104|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84030105|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030106|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
84030107|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84030108|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
84030109|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030110|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030111|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
84030112|NCT02073838|Ribavirin|ribavirin|mesh-list
84030113|NCT02073838|Decitabine|decitabine|mesh-list
84030114|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
84030115|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030116|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
84030117|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030118|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84030119|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030120|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030121|NCT00640198|Memantine|memantine|mesh-list
84030122|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84030123|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84030124|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
84030125|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030126|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030127|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030128|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84030129|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84030130|NCT02031250|Carboplatin|carboplatin|mesh-list
84030131|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030132|NCT04293822|Cetirizine|cetirizine|mesh-list
84030133|NCT04293822|Minoxidil|minoxidil|mesh-list
84030134|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84030135|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84030136|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84030137|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
84030138|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
84030139|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030140|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030141|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030142|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84030143|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
84030144|NCT02680600|Cefepime|cefepime|mesh-list
84030145|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030146|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030147|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84030148|NCT04182724|Paclitaxel|paclitaxel|mesh-list
84030149|NCT04182724|Apatinib|apatinib|mesh-list
84030150|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84030151|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030152|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
84030153|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
84030154|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
84030155|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030156|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84030157|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030158|NCT04184518|Durvalumab|durvalumab|mesh-list
84030159|NCT04184518|Cediranib|cediranib|mesh-list
84030160|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030161|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030162|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030163|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030164|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84030165|NCT01174238|Paclitaxel|paclitaxel|mesh-list
84030166|NCT01174238|Carboplatin|carboplatin|mesh-list
84030167|NCT01174238|Axitinib|axitinib|mesh-list
84030168|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84030169|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030170|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
84030171|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
84030172|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
84030173|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030174|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84030175|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030176|NCT05663710|Nivolumab|nivolumab|mesh-list
84030177|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030178|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030179|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84030180|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030181|NCT02928406|Atezolizumab|atezolizumab|mesh-list
84030182|NCT02928406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84030183|NCT02928406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030184|NCT02928406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030185|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030186|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
84030187|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
84030188|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
84030189|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030190|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030191|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
84030192|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030193|NCT01161446|Antibodies|antibodies|mesh-list
84030194|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
84030195|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
84030196|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030197|NCT00641680|Fluticasone|fluticasone|mesh-list
84030198|NCT00641680|Xhance|xhance|mesh-list
84030199|NCT00641680|Budesonide|budesonide|mesh-list
84030200|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030201|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84030202|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
84030203|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030204|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030205|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84030206|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030207|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
84030208|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84030209|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
84030210|NCT00641680|Hormones|hormones|mesh-ancestor
84030211|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84030212|NCT01174004|Pimavanserin|pimavanserin|mesh-list
84030213|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84030214|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84030215|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84030216|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84030217|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030218|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030219|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84030220|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84030221|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84030222|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
84030223|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030224|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030225|NCT01173692|Minocycline|minocycline|mesh-list
84030226|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030227|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030228|NCT00641758|Pycnogenols|pycnogenols|mesh-list
84030229|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84030230|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
84030231|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030232|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
84030233|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030234|NCT00641758|Protective Agents|protective agents|mesh-ancestor
84030235|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84030236|NCT00640276|Pitavastatin|pitavastatin|mesh-list
84030237|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84030238|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84030239|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84030240|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
84030241|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030242|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030243|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84030244|NCT02680132|Esomeprazole|esomeprazole|mesh-list
84030245|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84030246|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030247|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84030248|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030249|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030250|NCT02683564|Infliximab|infliximab|mesh-list
84030251|NCT02683564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84030252|NCT02683564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030253|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
84030254|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030255|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030256|NCT01101035|Allopurinol|allopurinol|mesh-list
84030257|NCT01101035|Febuxostat|febuxostat|mesh-list
84030258|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
83478029|NCT01481545|Leucovorin|leucovorin|mesh-list
84030259|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030260|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030261|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
84030262|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030263|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84030264|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
84030265|NCT01101035|Protective Agents|protective agents|mesh-ancestor
84030266|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030267|NCT01160822|Naproxen|naproxen|mesh-list
84030268|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84030269|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84030270|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030271|NCT01160822|Analgesics|analgesics|mesh-ancestor
84030272|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
84030273|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030274|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030275|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030276|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030277|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
84030278|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84030279|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030280|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030281|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
84030282|NCT01006980|Dacarbazine|dacarbazine|mesh-list
84030283|NCT01006980|Vemurafenib|vemurafenib|mesh-list
84030284|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030285|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
84030286|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030287|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030288|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84030289|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030290|NCT04296240|Capecitabine|capecitabine|mesh-list
84030291|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
84030292|NCT04296240|Antiemetics|antiemetics|mesh-list
84030293|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84030294|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
84030295|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030296|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030297|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
84030298|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030299|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030300|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030301|NCT04205058|Caffeine|caffeine|mesh-list
84030302|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84030303|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030304|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84030305|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030306|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030307|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84030308|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84030309|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
83270120|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030310|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030311|NCT04183738|Ritonavir|ritonavir|mesh-list
84030312|NCT04183738|Darunavir|darunavir|mesh-list
84030313|NCT04183738|Dolutegravir|dolutegravir|mesh-list
84030314|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84030315|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84030317|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030318|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030319|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84030320|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84030321|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
84030322|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030323|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84030324|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84030325|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84030326|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84030327|NCT02682082|Bupivacaine|bupivacaine|mesh-list
84030328|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
84030329|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
84030330|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030331|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030332|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
84030333|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030334|NCT00640432|Celecoxib|celecoxib|mesh-list
84030335|NCT00640432|Diclofenac|diclofenac|mesh-list
84030336|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84030337|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030338|NCT00640432|Analgesics|analgesics|mesh-ancestor
84030339|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
84030340|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030341|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030342|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030343|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030344|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84030345|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84030346|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030347|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030348|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84030349|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84030350|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84030351|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
84030352|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030353|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84030354|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84030355|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030356|NCT00641212|Budesonide|budesonide|mesh-list
84030357|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030358|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84030359|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
84030360|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030361|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030362|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84030363|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030364|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
84030365|NCT00641212|Hormones|hormones|mesh-ancestor
84030366|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84030367|NCT04183192|Reslizumab|reslizumab|mesh-list
84030368|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84030369|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030370|NCT02681848|Nicotine|nicotine|mesh-list
84030371|NCT02681848|Varenicline|varenicline|mesh-list
84030372|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84030373|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
84030374|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030375|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030376|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84030377|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84030378|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
84030379|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030380|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030381|NCT00997386|Melphalan|melphalan|mesh-list
84030382|NCT00997386|Busulfan|busulfan|mesh-list
84030383|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
84030384|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030385|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
84030386|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030387|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030388|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84030389|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030390|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
84030391|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030392|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030393|NCT02679820|Copper|copper|mesh-list
84030394|NCT02679820|Trace Elements|trace elements|mesh-ancestor
84030395|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
84030396|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030397|NCT00641914|Budesonide|budesonide|mesh-list
84030398|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030399|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84030400|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
84030401|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030402|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030403|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84030404|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030405|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
84030406|NCT00641914|Hormones|hormones|mesh-ancestor
84030407|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84030408|NCT00640588|Adefovir|adefovir|mesh-list
84030409|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84030410|NCT00640588|Telbivudine|telbivudine|mesh-list
84030411|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
84030412|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030413|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84030414|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84030415|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030416|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030417|NCT05663398|Ibuprofen|ibuprofen|mesh-list
84030418|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84030419|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030420|NCT05663398|Analgesics|analgesics|mesh-ancestor
84030421|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
84030422|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030423|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030424|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030425|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030426|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84030427|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030428|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030429|NCT00640744|Atorvastatin|atorvastatin|mesh-list
84030430|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84030431|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84030432|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
84030433|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030434|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84030435|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84030436|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030437|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
84030438|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84030439|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84030440|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030441|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
84030442|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
84030443|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84030444|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
84030445|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
84030446|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84030447|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84030448|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030449|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
84030450|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84030451|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84030452|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84030453|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030454|NCT04183114|Vaccines|vaccines|mesh-list
84030455|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
84030456|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030457|NCT00996996|Iodine|iodine|mesh-list
84030458|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
84030459|NCT00996996|Antibodies|antibodies|mesh-list
84030460|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
84030461|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
84030462|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270300|NCT01891864|GP2015|gp2015|mesh-list
84030463|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84030464|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030465|NCT00996996|Trace Elements|trace elements|mesh-ancestor
84030466|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
84030467|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030468|NCT04182568|Paclitaxel|paclitaxel|mesh-list
84030469|NCT04182568|Docetaxel|docetaxel|mesh-list
84030470|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
84030471|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84030472|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030473|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
84030474|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
84030475|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
84030476|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030477|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030478|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
84030479|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030480|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030481|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030482|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
84030483|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84030484|NCT00641446|Budesonide|budesonide|mesh-list
84030485|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030486|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84030487|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
84030488|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030489|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030490|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84030491|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030492|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
84030493|NCT00641446|Hormones|hormones|mesh-ancestor
84030494|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84030495|NCT02679040|Trastuzumab|trastuzumab|mesh-list
84030496|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030497|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030498|NCT05663164|Thiamine|thiamine|mesh-list
84030499|NCT05663164|Vitamins|vitamins|mesh-ancestor
84030500|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
84030501|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030502|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
84030503|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
84030504|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84030505|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030506|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84030507|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030508|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
84030509|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84030510|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030511|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030512|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030513|NCT02678728|Analgesics|analgesics|mesh-ancestor
84030514|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
84030515|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030516|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84030517|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84030518|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84030519|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
84030520|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030521|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030522|NCT04180072|Bevacizumab|bevacizumab|mesh-list
84030523|NCT04180072|Atezolizumab|atezolizumab|mesh-list
84030524|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030525|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030526|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84030527|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84030528|NCT04180072|Growth Substances|growth substances|mesh-ancestor
84030529|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030530|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
84030531|NCT04180072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84030532|NCT04180072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030533|NCT02678650|Anesthetics|anesthetics|mesh-list
84030534|NCT02678650|Propofol|propofol|mesh-list
84030535|NCT02678650|Isoflurane|isoflurane|mesh-list
84030536|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030537|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030538|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84030539|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84030540|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
84030541|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84030542|NCT04180150|Entecavir|entecavir|mesh-list
84030543|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
84030544|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030545|NCT02678338|Magrolimab|magrolimab|mesh-list
84030546|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030547|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030548|NCT00642226|Triamcinolone|triamcinolone|mesh-list
84030549|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030550|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
84030551|NCT00642226|Hormones|hormones|mesh-ancestor
84030552|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84030553|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030554|NCT05511610|Sevoflurane|sevoflurane|mesh-list
84030555|NCT05511610|Desflurane|desflurane|mesh-list
84030556|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84030557|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84030558|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
84030559|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
84030560|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030561|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030562|NCT02675530|Ketamine|ketamine|mesh-list
84030563|NCT02675530|Analgesics|analgesics|mesh-ancestor
84030564|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
84030565|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030566|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030567|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84030568|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84030569|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
84030570|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
84030571|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030572|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84030573|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84030574|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030575|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030576|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
84030577|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84030578|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
84030579|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
84030580|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030581|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030582|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030583|NCT02678260|Spartalizumab|spartalizumab|mesh-list
84030584|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84030585|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030586|NCT02678260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030587|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030588|NCT04179604|Simendan|simendan|mesh-list
84030589|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84030590|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
84030591|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84030592|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84030593|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030594|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030595|NCT04179604|Protective Agents|protective agents|mesh-ancestor
84030596|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030597|NCT02675140|Vitamins|vitamins|mesh-list
84030598|NCT02675140|Vitamin A|vitamin a|mesh-list
84030599|NCT02675140|Albendazole|albendazole|mesh-list
84030600|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
84030601|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
84030602|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030603|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
84030604|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030605|NCT02675140|Protective Agents|protective agents|mesh-ancestor
84030606|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84030607|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030608|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
84030609|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84030610|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030611|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
84030612|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83270421|NCT02340962|Ribavirin|ribavirin|mesh-list
84030614|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
84030615|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
84030616|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
84030617|NCT02674906|Heparin|heparin|mesh-list
84030618|NCT02674906|Calcium heparin|calcium heparin|mesh-list
84030619|NCT02674906|Anticoagulants|anticoagulants|mesh-list
84030620|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030621|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84030622|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84030623|NCT01160744|Carboplatin|carboplatin|mesh-list
84030624|NCT01160744|Gemcitabine|gemcitabine|mesh-list
84030625|NCT01160744|Pemetrexed|pemetrexed|mesh-list
84030626|NCT01160744|Ramucirumab|ramucirumab|mesh-list
84030627|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84030628|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030629|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84030630|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
84030631|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030632|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030633|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84030634|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84030635|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
84030636|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030637|NCT02677246|Denosumab|denosumab|mesh-list
84030638|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84030639|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030640|NCT01160354|Plerixafor|plerixafor|mesh-list
84030641|NCT01160354|Clofarabine|clofarabine|mesh-list
84030642|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84030643|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
84030644|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030645|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030646|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84030647|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84030648|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
84030649|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030650|NCT04178512|Dexamethasone|dexamethasone|mesh-list
84030651|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
84030652|NCT04178512|Fentanyl|fentanyl|mesh-list
84030653|NCT04178512|BB 1101|bb 1101|mesh-list
84030654|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030655|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
84030656|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
84030657|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030658|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030659|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030660|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
84030661|NCT04178512|Hormones|hormones|mesh-ancestor
84030662|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84030663|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84030664|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030665|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
84030666|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030667|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030668|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84030669|NCT04178512|Narcotics|narcotics|mesh-ancestor
84030670|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030671|NCT04178512|Analgesics|analgesics|mesh-ancestor
84030672|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
84030673|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84030674|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84030675|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
84030676|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
84030677|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
84030678|NCT01160198|Chelating Agents|chelating agents|mesh-list
84030679|NCT01160198|Glycine|glycine|mesh-list
84030680|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
84030681|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030682|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
84030683|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030684|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030685|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
84030686|NCT01160198|Protective Agents|protective agents|mesh-ancestor
84030687|NCT01160198|Vitamins|vitamins|mesh-ancestor
84030688|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
84030689|NCT02676934|Anesthetics|anesthetics|mesh-list
84030690|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030691|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030693|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84030694|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
84030695|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
84030696|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030697|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030698|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030699|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84030700|NCT05351086|Analgesics|analgesics|mesh-ancestor
84030701|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
84030702|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030703|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
84030704|NCT02885168|Phenylephrine|phenylephrine|mesh-list
84030705|NCT02885168|Protein C|protein c|mesh-list
84030706|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
84030707|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84030708|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
84030709|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
84030710|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030711|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030712|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
84030713|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84030714|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
84030715|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030716|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84030717|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84030718|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84030719|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
84030720|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030721|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030722|NCT02885168|Protective Agents|protective agents|mesh-ancestor
84030723|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
84030724|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84030725|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84030726|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030727|NCT01159574|Clarithromycin|clarithromycin|mesh-list
84030728|NCT01159574|Dexamethasone|dexamethasone|mesh-list
84030729|NCT01159574|Pomalidomide|pomalidomide|mesh-list
84030730|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84030731|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
84030732|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
84030733|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030734|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030735|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030736|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
84030737|NCT01159574|Hormones|hormones|mesh-ancestor
84030738|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84030739|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84030740|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030741|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030742|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030743|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84030744|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030745|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030746|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84030747|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84030748|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
84030749|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84030750|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84030751|NCT01159574|Growth Substances|growth substances|mesh-ancestor
84030752|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
84030753|NCT01158950|Tolcapone|tolcapone|mesh-list
84030754|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84030755|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84030756|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84030757|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030758|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030759|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
84030760|NCT00910234|Hematinics|hematinics|mesh-ancestor
84030761|NCT05652322|Furosemide|furosemide|mesh-list
84030762|NCT05652322|Diuretics|diuretics|mesh-ancestor
84030763|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
84030764|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030765|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84030766|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84030767|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030768|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
84030769|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84030770|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
84030771|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030772|NCT01172288|Expectorants|expectorants|mesh-ancestor
84030773|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
84030774|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84030775|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
84030776|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030777|NCT01172288|Protective Agents|protective agents|mesh-ancestor
84030778|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030779|NCT01172288|Antidotes|antidotes|mesh-ancestor
84030780|NCT02676622|Aldesleukin|aldesleukin|mesh-list
84030781|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
84030782|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
84030783|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030784|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
84030785|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030786|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030787|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030788|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
84030789|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030790|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030791|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84030792|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84030793|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84030794|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
84030795|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030796|NCT00644020|Fluorouracil|fluorouracil|mesh-list
84030797|NCT00644020|Mitomycins|mitomycins|mesh-list
84030798|NCT00644020|Mitomycin|mitomycin|mesh-list
84030799|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
84030800|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030801|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84030802|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030803|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030804|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
84030805|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030806|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84030807|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
84030808|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84030809|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030810|NCT04178980|Simvastatin|simvastatin|mesh-list
84030811|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84030812|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84030813|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
84030814|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030815|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84030816|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84030817|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030818|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
84030819|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84030820|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
84030821|NCT02672566|Enoxaparin|enoxaparin|mesh-list
84030822|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
84030823|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84030824|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84030825|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030826|NCT02672488|Metformin|metformin|mesh-list
84030827|NCT02672488|Sorafenib|sorafenib|mesh-list
84030828|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84030829|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030830|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030831|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84030832|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030833|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030834|NCT02537392|Folic Acid|folic acid|mesh-list
84030835|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
84030836|NCT02537392|Vitamins|vitamins|mesh-ancestor
84030837|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
84030838|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030839|NCT02537392|Hematinics|hematinics|mesh-ancestor
84030840|NCT02673814|Durvalumab|durvalumab|mesh-list
84030841|NCT02673814|Bavituximab|bavituximab|mesh-list
84030842|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030843|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030844|NCT00644176|Azithromycin|azithromycin|mesh-list
84030845|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030846|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030847|NCT04178200|Lidocaine|lidocaine|mesh-list
84030848|NCT04178200|Bupivacaine|bupivacaine|mesh-list
84030849|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84030850|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
84030851|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
84030852|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030853|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030854|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
84030855|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030856|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84030857|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84030858|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84030859|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84030860|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030861|NCT02537158|Sorafenib|sorafenib|mesh-list
84030862|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030863|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84030864|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030865|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030866|NCT02676154|Fesoterodine|fesoterodine|mesh-list
84030867|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84030868|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84030869|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
84030870|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030871|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030872|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030873|NCT02676154|Urological Agents|urological agents|mesh-ancestor
84030874|NCT02676310|Bimatoprost|bimatoprost|mesh-list
84030875|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84030876|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
84030877|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84030878|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84030879|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030880|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
84030881|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030882|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030883|NCT04180384|Paclitaxel|paclitaxel|mesh-list
84030884|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84030885|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84030886|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030887|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
84030888|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
84030889|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
84030890|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030891|NCT00643240|Antibodies|antibodies|mesh-list
84030892|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84030893|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
84030894|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030895|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
84030896|NCT02671708|Busulfan|busulfan|mesh-list
84030897|NCT02671708|Idarubicin|idarubicin|mesh-list
84030898|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030899|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
84030900|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030901|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030902|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030903|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
84030904|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030905|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030906|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84030907|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84030908|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84030909|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84030910|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84030911|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84030912|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030913|NCT04176328|Teicoplanin|teicoplanin|mesh-list
84030914|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030915|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030916|NCT04177342|Fentanyl|fentanyl|mesh-list
84030917|NCT04177342|Oxycodone|oxycodone|mesh-list
84030918|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84030919|NCT04177342|Narcotics|narcotics|mesh-ancestor
84030920|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030921|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030922|NCT04177342|Analgesics|analgesics|mesh-ancestor
84030923|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
84030924|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84030925|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84030926|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84030927|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
84030928|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
84030929|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
84030930|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030931|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
84030932|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030933|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030934|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030935|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
84030936|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030937|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030938|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84030939|NCT04175158|Bevacizumab|bevacizumab|mesh-list
84030940|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
84030941|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030942|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030943|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84030944|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84030945|NCT04175158|Growth Substances|growth substances|mesh-ancestor
84030946|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030947|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
84030948|NCT02671318|Sirolimus|sirolimus|mesh-list
84030949|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84030950|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84030951|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84030952|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030953|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
84030954|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030955|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
84030956|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030957|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
84030958|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
84030959|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
84030960|NCT02668588|Octreotide|octreotide|mesh-list
84030961|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84030962|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84030963|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030964|NCT02671084|Sevoflurane|sevoflurane|mesh-list
84030965|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84030966|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84030967|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
84030968|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
84030969|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030970|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030971|NCT00644800|Ziprasidone|ziprasidone|mesh-list
84030972|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84030973|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
84030974|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84030975|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030976|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84030977|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84030978|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84030979|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84030980|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84030981|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84030982|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
84030983|NCT02670616|Prednisolone|prednisolone|mesh-list
84030984|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
84030985|NCT02670616|Rituximab|rituximab|mesh-list
84030986|NCT02670616|Doxorubicin|doxorubicin|mesh-list
84030987|NCT02670616|Vincristine|vincristine|mesh-list
84030988|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84030989|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
84030990|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270786|NCT02358668|PAZ320|paz320|mesh-list
84030991|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84030992|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84030993|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
84030994|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84030995|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84030996|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84030997|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84030998|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84030999|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84031000|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84031001|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031002|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84031003|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
84031004|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
84031005|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
84031006|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031008|NCT02670616|Hormones|hormones|mesh-ancestor
84031009|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031010|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84031011|NCT00645502|Risperidone|risperidone|mesh-list
84031012|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84031013|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
84031014|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031015|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031016|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031017|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84031018|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84031019|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031020|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84031021|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84031022|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
84031023|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
84031024|NCT00644956|Tadalafil|tadalafil|mesh-list
84031025|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031026|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84031027|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84031028|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031029|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031030|NCT00644956|Urological Agents|urological agents|mesh-ancestor
84031031|NCT04175002|Progesterone|progesterone|mesh-list
84031032|NCT04175002|Progestins|progestins|mesh-ancestor
84031033|NCT04175002|Hormones|hormones|mesh-ancestor
84031034|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031035|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031036|NCT02670772|Tenofovir|tenofovir|mesh-list
84031037|NCT02670772|Stavudine|stavudine|mesh-list
84031038|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
84031039|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031040|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84031041|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84031042|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031043|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031044|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84031045|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84031046|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
84031047|NCT02667730|Acetaminophen|acetaminophen|mesh-list
84031048|NCT02667730|Celecoxib|celecoxib|mesh-list
84031049|NCT02667730|Naproxen|naproxen|mesh-list
84031050|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84031051|NCT02667730|Analgesics|analgesics|mesh-ancestor
84031052|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
84031053|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031054|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031055|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
84031056|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84031057|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031058|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031059|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84031060|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84031061|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031062|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031063|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
84031064|NCT04294992|Ondansetron|ondansetron|mesh-list
84031065|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
84031066|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
84031067|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270861|NCT02395172|Docetaxel|docetaxel|mesh-list
84031068|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031069|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84031070|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
84031071|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
84031072|NCT04294992|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84031073|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84031074|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
84031075|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031076|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031077|NCT00628914|Dexetimide|dexetimide|mesh-list
84031078|NCT00628914|Eszopiclone|eszopiclone|mesh-list
84031079|NCT00628914|Citalopram|citalopram|mesh-list
84031080|NCT00628914|Escitalopram|escitalopram|mesh-list
84031081|NCT00628914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84031082|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84031083|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031084|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031085|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031086|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
84031087|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031088|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84031089|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84031090|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
84031091|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
84031092|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031093|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84031094|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84031095|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
84031096|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84031097|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
84031098|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84031099|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84031100|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031102|NCT02870634|Trace Elements|trace elements|mesh-ancestor
84031103|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
84031104|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031105|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
84031106|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84031107|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84031108|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031109|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031110|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84031111|NCT00645580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84031112|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84031113|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031114|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031115|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031116|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
84031117|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84031118|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
84031119|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84031120|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84031121|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031122|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84031123|NCT02670304|Aspirin|aspirin|mesh-list
84031124|NCT02670304|Letrozole|letrozole|mesh-list
84031125|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84031126|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84031127|NCT02670304|Analgesics|analgesics|mesh-ancestor
84031128|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
84031129|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031130|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031131|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031132|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031133|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84031134|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84031135|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031136|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84031137|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84031138|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031139|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
84031140|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031141|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84031142|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84031143|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84031144|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
84031145|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031147|NCT00998946|Folic Acid|folic acid|mesh-list
84031148|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
84031149|NCT00998946|Hydroxocobalamin|hydroxocobalamin|mesh-list
84031150|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
84031151|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
84031152|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
84031153|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031154|NCT00998946|Hematinics|hematinics|mesh-ancestor
84031155|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031156|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84031157|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031158|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031159|NCT01158404|LY900009|ly900009|mesh-list
84031160|NCT01158404|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84031161|NCT01158404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031162|NCT01158404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031163|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84031164|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84031165|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84031166|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
84031167|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031168|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84031169|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84031170|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031171|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
84031172|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031173|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84031174|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84031175|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031176|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031177|NCT00645034|Urological Agents|urological agents|mesh-ancestor
84031178|NCT04173832|Amantadine|amantadine|mesh-list
84031179|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84031180|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84031181|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
84031182|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031183|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
84031184|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031185|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031186|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031187|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84031188|NCT04173832|Analgesics|analgesics|mesh-ancestor
84031189|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
84031190|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031191|NCT00645658|Testosterone|testosterone|mesh-list
84031192|NCT00645658|Androgens|androgens|mesh-ancestor
84031193|NCT00645658|Hormones|hormones|mesh-ancestor
84031194|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031195|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031196|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
84031197|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
84031198|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031199|NCT02666170|Protective Agents|protective agents|mesh-ancestor
84031200|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031201|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
84031202|NCT02666170|Vitamins|vitamins|mesh-ancestor
84031203|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
84031204|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
84031205|NCT02667262|Narcotics|narcotics|mesh-ancestor
84031206|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031207|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031208|NCT02667262|Analgesics|analgesics|mesh-ancestor
84031209|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
84031210|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031211|NCT00646126|Artesunate|artesunate|mesh-list
84031212|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
84031213|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
84031214|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
84031215|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83271017|NCT05648071|Pemetrexed|pemetrexed|mesh-list
84031216|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84031217|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031218|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031219|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
84031220|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
84031221|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84031222|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
84031223|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84031224|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031225|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031226|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84031227|NCT02537080|Nimodipine|nimodipine|mesh-list
84031228|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84031229|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84031230|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031231|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031232|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84031233|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031234|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031235|NCT02667496|Sargramostim|sargramostim|mesh-list
84031236|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
84031237|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031238|NCT00645112|Azithromycin|azithromycin|mesh-list
84031239|NCT00645112|Cefdinir|cefdinir|mesh-list
84031240|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84031241|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031242|NCT02666092|Antibodies|antibodies|mesh-list
84031243|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
84031244|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031245|NCT00645814|Adalimumab|adalimumab|mesh-list
84031246|NCT00645814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84031247|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031248|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031249|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84031250|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
84031251|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84031252|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
84031253|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84031254|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031255|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84031256|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84031257|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031258|NCT00645892|Adalimumab|adalimumab|mesh-list
84031259|NCT00645892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84031260|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031261|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031262|NCT00645190|Galantamine|galantamine|mesh-list
84031263|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84031264|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031265|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031266|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
84031267|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031268|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031269|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84031270|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
84031271|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031272|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
84031273|NCT00910390|Ethylene|ethylene|mesh-list
84031274|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
84031275|NCT00910390|Growth Substances|growth substances|mesh-ancestor
84031276|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031277|NCT02665936|Dexamethasone|dexamethasone|mesh-list
84031278|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
84031279|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
84031280|NCT02665936|BB 1101|bb 1101|mesh-list
84031281|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031282|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
84031283|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
84031284|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031285|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031286|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84031287|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
84031288|NCT02665936|Hormones|hormones|mesh-ancestor
84031289|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031290|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84031291|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031292|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
84031293|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031294|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031295|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
84031296|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
84031297|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031298|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
84031299|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
84031300|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84031301|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031303|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031304|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84031305|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
84031306|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031307|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84031308|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031309|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84031310|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84031311|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84031312|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
84031313|NCT04292418|Tacrolimus|tacrolimus|mesh-list
84031314|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84031315|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
84031316|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031317|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84031318|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031319|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031320|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84031321|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031322|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84031323|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
84031324|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84031325|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031326|NCT02666716|Fluconazole|fluconazole|mesh-list
84031327|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
84031328|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031329|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84031330|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84031331|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031332|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031333|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84031334|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
84031335|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031336|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031337|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84031338|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84031339|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84031340|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84031341|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84031342|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031343|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031344|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84031345|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84031346|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84031347|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
84031348|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031349|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031350|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84031351|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84031352|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
84031353|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
84031354|NCT02669368|Rocuronium|rocuronium|mesh-list
84031355|NCT02669368|Analgesics|analgesics|mesh-ancestor
84031356|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
84031357|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031358|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031359|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
84031360|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031361|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84031362|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
83271159|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84031363|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84031364|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031365|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031366|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84031367|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
84031368|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84031369|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84031370|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84031371|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84031372|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
84031373|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031374|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84031375|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84031376|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031377|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031378|NCT00645268|Urological Agents|urological agents|mesh-ancestor
84031379|NCT02666014|Neostigmine|neostigmine|mesh-list
84031380|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84031381|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031382|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031383|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
84031384|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031385|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031386|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84031387|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
84031388|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031389|NCT02665702|Cisplatin|cisplatin|mesh-list
84031390|NCT02665702|Vinorelbine|vinorelbine|mesh-list
84031391|NCT02665702|Endostar protein|endostar protein|mesh-list
84031392|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031393|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84031394|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
84031395|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
84031396|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
84031397|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031398|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84031399|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84031400|NCT02665702|Growth Substances|growth substances|mesh-ancestor
84031401|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031402|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
84031403|NCT00646750|Rituximab|rituximab|mesh-list
84031404|NCT00646750|Melphalan|melphalan|mesh-list
84031405|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84031406|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031407|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
84031408|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031409|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031410|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84031411|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
84031412|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031413|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84031414|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84031415|NCT00646516|Budesonide|budesonide|mesh-list
84031416|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
84031417|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84031418|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031419|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84031420|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
84031421|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031422|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031423|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84031424|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
84031425|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
84031426|NCT00646516|Hormones|hormones|mesh-ancestor
84031427|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031428|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84031429|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84031430|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84031431|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
84031432|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031433|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031434|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
83271234|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
84031436|NCT02665624|Senna Extract|senna extract|mesh-list
84031437|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84031438|NCT02665624|Calcium|calcium|mesh-list
84031439|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84031440|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031441|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84031442|NCT02665624|Laxatives|laxatives|mesh-ancestor
84031443|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84031444|NCT02665624|Cathartics|cathartics|mesh-ancestor
84031445|NCT00646594|Fluticasone|fluticasone|mesh-list
84031446|NCT00646594|Budesonide|budesonide|mesh-list
84031447|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
84031448|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84031449|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84031450|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84031451|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031452|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84031453|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
84031454|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031455|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031456|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84031457|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
84031458|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
84031459|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84031460|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
84031461|NCT00646594|Hormones|hormones|mesh-ancestor
84031462|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031463|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84031464|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84031465|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84031466|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
84031467|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031468|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031469|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
84031470|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84031471|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
84031472|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031473|NCT04773184|Capsaicin|capsaicin|mesh-list
84031474|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
84031475|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
84031476|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
84031477|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031478|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031479|NCT00647140|Levodopa|levodopa|mesh-list
84031480|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
84031481|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031482|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031483|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031484|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84031485|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84031486|NCT00647218|Paclitaxel|paclitaxel|mesh-list
84031487|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84031488|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031489|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
84031490|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
84031491|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
84031492|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031493|NCT00994890|Tanezumab|tanezumab|mesh-list
84031494|NCT00994890|Analgesics|analgesics|mesh-ancestor
84031495|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
84031496|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031497|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031498|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
84031499|NCT02663830|Clomiphene|clomiphene|mesh-list
84031500|NCT02663830|Enclomiphene|enclomiphene|mesh-list
84031501|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
84031502|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031503|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031504|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84031505|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84031506|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031507|NCT02663830|Urological Agents|urological agents|mesh-ancestor
84031508|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84031509|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
83271311|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84031510|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031511|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031512|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84031514|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84031515|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84031516|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84031517|NCT00648544|Pravastatin|pravastatin|mesh-list
84031518|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84031519|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84031520|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
84031521|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031522|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84031523|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84031524|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031525|NCT00648622|Carvedilol|carvedilol|mesh-list
84031526|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84031527|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84031528|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
84031529|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031530|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031531|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031532|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84031533|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
84031534|NCT00648622|Protective Agents|protective agents|mesh-ancestor
84031535|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84031536|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031537|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84031538|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031539|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84031540|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84031541|NCT00994422|Ivermectin|ivermectin|mesh-list
84031542|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84031543|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031544|NCT00648778|Loxapine|loxapine|mesh-list
84031545|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84031546|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84031547|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031548|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031549|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84031550|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84031551|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
84031552|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031553|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031554|NCT00645424|Atorvastatin|atorvastatin|mesh-list
84031555|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84031556|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84031557|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
84031558|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031559|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84031560|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84031561|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031562|NCT04172740|Calcium|calcium|mesh-list
84031563|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84031564|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031565|NCT02663596|Vancomycin|vancomycin|mesh-list
84031566|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84031567|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031568|NCT00647530|Fluorouracil|fluorouracil|mesh-list
84031569|NCT00647530|Capecitabine|capecitabine|mesh-list
84031570|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
84031571|NCT00647530|Panitumumab|panitumumab|mesh-list
84031572|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
84031573|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031574|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84031575|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031576|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84031577|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
84031578|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031579|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84031580|NCT00647608|Propranolol|propranolol|mesh-list
84031581|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84031582|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84031583|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
84031584|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031585|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031586|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031587|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84031588|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84031589|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031591|NCT02663440|Molgramostim|molgramostim|mesh-list
84031592|NCT02663440|Sargramostim|sargramostim|mesh-list
84031593|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84031594|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
84031595|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031596|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031597|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
84031598|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031599|NCT04171180|Budesonide|budesonide|mesh-list
84031600|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
84031601|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031602|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84031603|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
84031604|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031605|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031606|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84031607|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
84031608|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
84031609|NCT04171180|Hormones|hormones|mesh-ancestor
84031610|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031611|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84031612|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84031613|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84031614|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
84031615|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031616|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031617|NCT02660008|Glucagon|glucagon|mesh-list
84031618|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84031619|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84031620|NCT02660008|Hormones|hormones|mesh-ancestor
84031621|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031622|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031623|NCT02660008|Incretins|incretins|mesh-ancestor
84031624|NCT00649168|Bromocriptine|bromocriptine|mesh-list
84031625|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84031626|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84031627|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
84031628|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031629|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031630|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
84031631|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
84031632|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031633|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031634|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
84031635|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84031636|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031637|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031638|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
84031639|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031640|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031641|NCT02663284|Ropivacaine|ropivacaine|mesh-list
84031642|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
84031643|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
84031644|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031645|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031646|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
84031647|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031648|NCT00647686|Fentanyl|fentanyl|mesh-list
84031649|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84031650|NCT00647686|Narcotics|narcotics|mesh-ancestor
84031651|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031652|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031653|NCT00647686|Analgesics|analgesics|mesh-ancestor
84031654|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
84031655|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031656|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84031657|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84031658|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
84031659|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
84031660|NCT02663050|Diclofenac|diclofenac|mesh-list
84031661|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84031662|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84031663|NCT02663050|Analgesics|analgesics|mesh-ancestor
84031664|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
84031665|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031666|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031667|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031668|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031669|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84031670|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031671|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031672|NCT00648856|Sertraline|sertraline|mesh-list
84031673|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
84031674|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84031675|NCT00648856|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84031676|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84031677|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031678|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031679|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031680|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
84031681|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031682|NCT01171976|Ranibizumab|ranibizumab|mesh-list
84031683|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84031684|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84031685|NCT01171976|Growth Substances|growth substances|mesh-ancestor
84031686|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031687|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
84031688|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031689|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
84031690|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031691|NCT00647842|Fentanyl|fentanyl|mesh-list
84031692|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84031693|NCT00647842|Narcotics|narcotics|mesh-ancestor
84031694|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031695|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031696|NCT00647842|Analgesics|analgesics|mesh-ancestor
84031697|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
84031698|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031699|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84031700|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84031701|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
84031702|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
84031703|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
84031704|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84031705|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84031706|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84031707|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031708|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031709|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
84031710|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031711|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031712|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84031713|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031714|NCT02662894|Valsartan|valsartan|mesh-list
84031715|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84031716|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84031717|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84031718|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
84031719|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031720|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84031721|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84031722|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031723|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84031724|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84031725|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84031726|NCT04291794|Propofol|propofol|mesh-list
84031727|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84031728|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031729|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031730|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84031731|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
84031732|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
84031733|NCT02662660|Acetaminophen|acetaminophen|mesh-list
84031734|NCT02662660|Dipyrone|dipyrone|mesh-list
84031735|NCT02662660|Bupivacaine|bupivacaine|mesh-list
84031736|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
84031737|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
84031738|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
84031739|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031740|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031741|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
84031742|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031743|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84031744|NCT02662660|Analgesics|analgesics|mesh-ancestor
84031745|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
84031746|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84031747|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031748|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031749|NCT02868606|Insulin|insulin|mesh-list
84031750|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84031751|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84031752|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031753|NCT00647920|Adalimumab|adalimumab|mesh-list
84031754|NCT00647920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84031755|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031756|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031757|NCT00830869|Ixazomib|ixazomib|mesh-list
84031758|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031759|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
84031760|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031761|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031762|NCT02662504|Cisplatin|cisplatin|mesh-list
84031763|NCT02662504|Pemetrexed|pemetrexed|mesh-list
84031764|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
84031765|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031766|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031767|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031768|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84031769|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84031770|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
84031771|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84031772|NCT00648934|Topiramate|topiramate|mesh-list
84031773|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
84031774|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84031775|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031776|NCT02659228|Anesthetics|anesthetics|mesh-list
84031777|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
84031778|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031779|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031780|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
84031781|NCT00844519|Maraviroc|maraviroc|mesh-list
84031782|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84031783|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84031784|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031785|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84031786|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84031787|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
84031788|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031789|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84031790|NCT00702793|Varenicline|varenicline|mesh-list
84031791|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84031792|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84031793|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
84031794|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031795|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031796|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031797|NCT02662426|Oseltamivir|oseltamivir|mesh-list
84031798|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
84031799|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031800|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031801|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031802|NCT00994110|Pasireotide|pasireotide|mesh-list
84031803|NCT00994110|Hormones|hormones|mesh-ancestor
84031804|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031805|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031806|NCT02662348|Aldesleukin|aldesleukin|mesh-list
84031807|NCT02662348|Interleukin-2|interleukin-2|mesh-list
84031808|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031809|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84031810|NCT02662348|Analgesics|analgesics|mesh-ancestor
84031811|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
84031812|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031813|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031814|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84031815|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84031816|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
84031817|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031818|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
84031819|NCT02868372|Povidone|povidone|mesh-list
84031820|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
84031821|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
84031822|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84031823|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84031824|NCT00629148|Capecitabine|capecitabine|mesh-list
84031825|NCT00629148|Vinorelbine|vinorelbine|mesh-list
84031826|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84031827|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
84031828|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031829|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031830|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84031831|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
84031832|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
84031833|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
84031834|NCT01157234|Metoprolol|metoprolol|mesh-list
84031835|NCT01157234|Nebivolol|nebivolol|mesh-list
84031836|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84031837|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84031838|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
84031839|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
84031840|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031841|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031842|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84031843|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84031844|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84031845|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
84031846|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031847|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031848|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031849|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84031850|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84031851|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84031852|NCT04170790|Saxagliptin|saxagliptin|mesh-list
84031853|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
84031854|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
84031855|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84031856|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84031857|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031858|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031859|NCT04170790|Urological Agents|urological agents|mesh-ancestor
84031860|NCT04170790|Incretins|incretins|mesh-ancestor
84031861|NCT04170790|Hormones|hormones|mesh-ancestor
84031862|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031863|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031864|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84031865|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
84031866|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84031867|NCT00995670|Sevoflurane|sevoflurane|mesh-list
84031868|NCT00995670|Simvastatin|simvastatin|mesh-list
84031869|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031870|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84031871|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84031872|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
84031873|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031874|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84031875|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84031876|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031877|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84031878|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84031879|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
84031880|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
84031881|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031883|NCT02658838|Calcium heparin|calcium heparin|mesh-list
84031884|NCT02658838|Enoxaparin|enoxaparin|mesh-list
84031885|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84031886|NCT02658838|Tinzaparin|tinzaparin|mesh-list
84031887|NCT02658838|Dalteparin|dalteparin|mesh-list
84031888|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
84031889|NCT02658838|Ticagrelor|ticagrelor|mesh-list
84031890|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84031891|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
84031892|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84031893|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84031894|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031895|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84031896|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84031897|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84031898|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
84031899|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031900|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031901|NCT00648076|Valproic Acid|valproic acid|mesh-list
84031902|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
84031903|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031904|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031905|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
84031906|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031907|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031908|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
84031909|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84031910|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031911|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84031912|NCT00649012|Pioglitazone|pioglitazone|mesh-list
84031913|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84031914|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031915|NCT04685590|Dasatinib|dasatinib|mesh-list
84031916|NCT04685590|Quercetin|quercetin|mesh-list
84031917|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031918|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84031919|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031920|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031921|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
84031922|NCT04685590|Protective Agents|protective agents|mesh-ancestor
84031923|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031924|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
84031925|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84031926|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84031927|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031928|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
84031929|NCT04170088|Coagulants|coagulants|mesh-ancestor
84031930|NCT00648154|Letrozole|letrozole|mesh-list
84031931|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031932|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84031933|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84031934|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031935|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031936|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84031937|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
84031938|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031939|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031940|NCT02664142|Anesthetics|anesthetics|mesh-list
84031941|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031942|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031943|NCT04169854|Lidocaine|lidocaine|mesh-list
84031944|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
84031945|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
84031946|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84031947|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031948|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
84031949|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84031950|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84031951|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84031952|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84031953|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84031954|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031955|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
84031956|NCT02661100|Poly ICLC|poly iclc|mesh-list
84031957|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84031958|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84031959|NCT02661100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84031960|NCT02661100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031961|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
84031962|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
84031963|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031964|NCT00601354|Orlistat|orlistat|mesh-list
84031965|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84031966|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031967|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84031968|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84031969|NCT02660866|Vorapaxar|vorapaxar|mesh-list
84031970|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84031971|NCT00853099|Adalimumab|adalimumab|mesh-list
84031972|NCT00853099|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84031973|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84031974|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84031975|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84031976|NCT00648310|Estrogens|estrogens|mesh-list
84031977|NCT00648310|Hormones|hormones|mesh-ancestor
84031978|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84031979|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031980|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84031981|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84031982|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
84031983|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031984|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031985|NCT00648310|Urological Agents|urological agents|mesh-ancestor
84031986|NCT00702871|Ranitidine|ranitidine|mesh-list
84031987|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84031988|NCT00702871|Sucralfate|sucralfate|mesh-list
84031989|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84031990|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84031991|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84031992|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
84031993|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
84031994|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84031995|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84031996|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84031997|NCT00830167|Pregabalin|pregabalin|mesh-list
84031998|NCT00830167|Analgesics|analgesics|mesh-ancestor
84031999|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
84032000|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032001|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032002|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
84032003|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84032004|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032005|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032006|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84032007|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84032008|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84032009|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032010|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032011|NCT00992394|Etanercept|etanercept|mesh-list
84032012|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84032013|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84032014|NCT00992394|Analgesics|analgesics|mesh-ancestor
84032015|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
84032016|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032017|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032018|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032019|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84032020|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032021|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032022|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
84032023|NCT00829933|Warfarin|warfarin|mesh-list
84032024|NCT00829933|Edoxaban|edoxaban|mesh-list
84032025|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
84032026|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84032027|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
84032028|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84032029|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
84032030|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032031|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032033|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84032034|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
84032035|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032036|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
84032037|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032038|NCT00843193|Fluticasone|fluticasone|mesh-list
84032039|NCT00843193|Xhance|xhance|mesh-list
84032040|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032041|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84032042|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
84032043|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032044|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032045|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84032046|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
84032047|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
84032048|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84032049|NCT00853021|Aldesleukin|aldesleukin|mesh-list
84032050|NCT00853021|Bevacizumab|bevacizumab|mesh-list
84032051|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84032052|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032053|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84032054|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84032055|NCT00853021|Growth Substances|growth substances|mesh-ancestor
84032056|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032057|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
84032058|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84032059|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84032060|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
84032061|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032062|NCT00913237|Desipramine|desipramine|mesh-list
84032063|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84032064|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
84032065|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032066|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032067|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032068|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84032069|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84032070|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032071|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
84032072|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032073|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032074|NCT05367284|Testosterone|testosterone|mesh-list
84032075|NCT05367284|Androgens|androgens|mesh-ancestor
84032076|NCT05367284|Hormones|hormones|mesh-ancestor
84032077|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032078|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032079|NCT00843115|Donepezil|donepezil|mesh-list
84032080|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84032081|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032082|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032083|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
84032084|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032085|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032086|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
84032087|NCT01156376|Listerine|listerine|mesh-list
84032088|NCT01156376|Fluorides|fluorides|mesh-list
84032089|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
84032090|NCT01156376|Protective Agents|protective agents|mesh-ancestor
84032091|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032092|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84032093|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032094|NCT01156142|Doxepin|doxepin|mesh-list
84032095|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84032096|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84032097|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032098|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032099|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84032100|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
84032101|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032102|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
84032103|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
84032104|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032105|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032106|NCT00842257|Panitumumab|panitumumab|mesh-list
84032107|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84032109|NCT00706069|Capecitabine|capecitabine|mesh-list
84032110|NCT00706069|Vinorelbine|vinorelbine|mesh-list
84032111|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84032112|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
84032113|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032114|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032115|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84032116|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
84032117|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
84032118|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
84032119|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84032120|NCT01155284|Lansoprazole|lansoprazole|mesh-list
84032121|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
84032122|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84032123|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032124|NCT01155284|Incretins|incretins|mesh-ancestor
84032125|NCT01155284|Hormones|hormones|mesh-ancestor
84032126|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032127|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84032128|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
84032129|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032130|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032131|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84032132|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032133|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84032134|NCT00852397|Apixaban|apixaban|mesh-list
84032135|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84032136|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
84032137|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84032138|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
84032139|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032140|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032141|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
84032142|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
84032143|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84032144|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
84032145|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032146|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
84032147|NCT00852241|Protective Agents|protective agents|mesh-ancestor
84032148|NCT02612233|Pregabalin|pregabalin|mesh-list
84032149|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84032150|NCT02612233|Analgesics|analgesics|mesh-ancestor
84032151|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
84032152|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032153|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032154|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
84032155|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84032156|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032157|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032158|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84032159|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84032160|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84032161|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032162|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032163|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84032164|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84032165|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032166|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
84032167|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
84032168|NCT01169636|Carboplatin|carboplatin|mesh-list
84032169|NCT01169636|Etoposide|etoposide|mesh-list
84032170|NCT01169636|Ifosfamide|ifosfamide|mesh-list
84032171|NCT01169636|Panobinostat|panobinostat|mesh-list
84032172|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032173|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84032174|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84032175|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84032176|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032177|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032178|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83271982|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
84032179|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
84032180|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84032181|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
84032182|NCT00706225|Estrogens|estrogens|mesh-list
84032183|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84032184|NCT00706225|Hormones|hormones|mesh-ancestor
84032185|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032186|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032187|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84032188|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84032189|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
84032190|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84032191|NCT04117009|Remifentanil|remifentanil|mesh-list
84032192|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84032193|NCT04117009|Narcotics|narcotics|mesh-ancestor
84032194|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032195|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032196|NCT04117009|Analgesics|analgesics|mesh-ancestor
84032197|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
84032198|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032199|NCT04117243|Misoprostol|misoprostol|mesh-list
84032200|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
84032201|NCT04117243|Oxytocin|oxytocin|mesh-list
84032202|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
84032203|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84032204|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032205|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84032206|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84032207|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032208|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
84032209|NCT04117243|Coagulants|coagulants|mesh-ancestor
84032210|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84032211|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
84032212|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84032213|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032214|NCT01169558|Bevacizumab|bevacizumab|mesh-list
84032215|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84032216|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032217|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84032218|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84032219|NCT01169558|Growth Substances|growth substances|mesh-ancestor
84032220|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032221|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
84032222|NCT00700687|Aspirin|aspirin|mesh-list
84032223|NCT00700687|Celecoxib|celecoxib|mesh-list
84032224|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84032225|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84032226|NCT00700687|Analgesics|analgesics|mesh-ancestor
84032227|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
84032228|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032229|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032230|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032231|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84032232|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84032233|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84032234|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032235|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84032236|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84032237|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032238|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
84032239|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84032240|NCT00840463|Ambrisentan|ambrisentan|mesh-list
84032241|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032242|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
84032243|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84032244|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032245|NCT00839527|Metformin|metformin|mesh-list
84032246|NCT00839527|Pioglitazone|pioglitazone|mesh-list
84032247|NCT00839527|Glimepiride|glimepiride|mesh-list
84032248|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
84032249|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84032250|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84032251|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032252|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84032253|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032254|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
84032255|NCT00839527|Incretins|incretins|mesh-ancestor
83272078|NCT01817764|Xhance|xhance|mesh-list
84032256|NCT00839527|Hormones|hormones|mesh-ancestor
84032257|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032258|NCT00706927|Timolol|timolol|mesh-list
84032259|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84032260|NCT00706927|Latanoprost|latanoprost|mesh-list
84032261|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84032262|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84032263|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
84032264|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032265|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032266|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032267|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84032268|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032269|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84032270|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84032271|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84032272|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84032273|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84032274|NCT00707083|Dexamethasone|dexamethasone|mesh-list
84032275|NCT00707083|Methotrexate|methotrexate|mesh-list
84032276|NCT00707083|Vincristine|vincristine|mesh-list
84032277|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
84032278|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032279|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
84032280|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
84032281|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032282|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032283|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032284|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
84032285|NCT00707083|Hormones|hormones|mesh-ancestor
84032286|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032287|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84032288|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032289|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84032290|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
84032291|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84032292|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84032293|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
84032294|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032295|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
84032296|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032297|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84032298|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032299|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
84032300|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84032301|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84032302|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84032303|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
84032304|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
84032305|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
84032306|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
84032307|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84032308|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032309|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032310|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84032311|NCT05500261|Analgesics|analgesics|mesh-ancestor
84032312|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
84032313|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032314|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84032315|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84032316|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84032317|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
84032318|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032319|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032320|NCT04116931|Clopidogrel|clopidogrel|mesh-list
84032321|NCT04116931|Ticagrelor|ticagrelor|mesh-list
84032322|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84032323|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84032324|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84032325|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84032326|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
84032327|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272131|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
84032328|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032329|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032331|NCT00600886|Pasireotide|pasireotide|mesh-list
84032332|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032333|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84032334|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032335|NCT00600886|Hormones|hormones|mesh-ancestor
84032336|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032337|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032338|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84032339|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032340|NCT00649324|Diuretics|diuretics|mesh-ancestor
84032341|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
84032342|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032343|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84032344|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032345|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032346|NCT00648388|Cilostazol|cilostazol|mesh-list
84032347|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84032348|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
84032349|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032350|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032351|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84032352|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
84032353|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84032354|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84032355|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032356|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84032357|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
84032358|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84032359|NCT00648388|Protective Agents|protective agents|mesh-ancestor
84032360|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84032361|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84032362|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032363|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
84032364|NCT02658760|Bupivacaine|bupivacaine|mesh-list
84032365|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
84032366|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
84032367|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032368|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032369|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
84032370|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032371|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84032372|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84032373|NCT02658760|Analgesics|analgesics|mesh-ancestor
84032374|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84032375|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84032376|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84032377|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
84032378|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032379|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032380|NCT02536690|Midazolam|midazolam|mesh-list
84032381|NCT02536690|Remifentanil|remifentanil|mesh-list
84032382|NCT02536690|Propofol|propofol|mesh-list
84032383|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84032384|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032385|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032386|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84032387|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
84032388|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
84032389|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84032390|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84032391|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84032392|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032393|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
84032394|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
84032395|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032396|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032397|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84032398|NCT02536690|Narcotics|narcotics|mesh-ancestor
84032399|NCT02536690|Analgesics|analgesics|mesh-ancestor
84032400|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
84032401|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032402|NCT00649090|Exemestane|exemestane|mesh-list
84032403|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032404|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84032405|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84032406|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032407|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032408|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84032409|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
84032410|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032411|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032412|NCT00838903|Metformin|metformin|mesh-list
84032413|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84032414|NCT00838903|Glimepiride|glimepiride|mesh-list
84032415|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
84032416|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84032417|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84032418|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032419|NCT00838903|Incretins|incretins|mesh-ancestor
84032420|NCT00838903|Hormones|hormones|mesh-ancestor
84032421|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032422|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84032423|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
84032424|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032425|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032426|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84032427|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032428|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
84032429|NCT00648466|Sumatriptan|sumatriptan|mesh-list
84032430|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84032431|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84032432|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84032433|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
84032434|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032435|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032436|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032437|NCT00649402|Amlodipine|amlodipine|mesh-list
84032438|NCT00649402|Benazepril|benazepril|mesh-list
84032439|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032440|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84032441|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032442|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032443|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84032444|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032445|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
84032446|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84032447|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
84032448|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032449|NCT04477486|Venetoclax|venetoclax|mesh-list
84032450|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032451|NCT00649480|Balsalazide|balsalazide|mesh-list
84032452|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84032453|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84032454|NCT00649480|Analgesics|analgesics|mesh-ancestor
84032455|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
84032456|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032457|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032458|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032459|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84032460|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032461|NCT02656342|Cycloserine|cycloserine|mesh-list
84032462|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84032463|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032464|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84032465|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
84032466|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84032467|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
84032468|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032469|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
84032470|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
84032471|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032472|NCT00650416|Carvedilol|carvedilol|mesh-list
84032473|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84032474|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84032475|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
84032476|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032477|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032478|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032479|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032480|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
84032481|NCT00650416|Protective Agents|protective agents|mesh-ancestor
84032482|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84032483|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032484|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84032485|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
84032486|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84032487|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84032488|NCT00649948|Metformin|metformin|mesh-list
84032489|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84032490|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032491|NCT04167982|Isotretinoin|isotretinoin|mesh-list
84032492|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84032493|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
84032494|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84032495|NCT00649558|Pioglitazone|pioglitazone|mesh-list
84032496|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84032497|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032498|NCT02658526|Anesthetics|anesthetics|mesh-list
84032499|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032500|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032501|NCT00650494|Valacyclovir|valacyclovir|mesh-list
84032502|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
84032503|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032504|NCT02655874|Vaccines|vaccines|mesh-list
84032505|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
84032506|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032507|NCT00828139|Aflibercept|aflibercept|mesh-list
84032508|NCT00828139|Topotecan|topotecan|mesh-list
84032509|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
84032510|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84032511|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84032512|NCT00828139|Growth Substances|growth substances|mesh-ancestor
84032513|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032514|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
84032515|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032516|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84032517|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84032518|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032519|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032520|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
84032521|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032522|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
84032523|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032524|NCT02658214|Leucovorin|leucovorin|mesh-list
84032525|NCT02658214|Folic Acid|folic acid|mesh-list
84032526|NCT02658214|Paclitaxel|paclitaxel|mesh-list
84032527|NCT02658214|Etoposide|etoposide|mesh-list
84032528|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84032529|NCT02658214|Carboplatin|carboplatin|mesh-list
84032530|NCT02658214|Gemcitabine|gemcitabine|mesh-list
84032531|NCT02658214|Fluorouracil|fluorouracil|mesh-list
84032532|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
84032533|NCT02658214|Durvalumab|durvalumab|mesh-list
84032534|NCT02658214|Tremelimumab|tremelimumab|mesh-list
84032535|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
84032536|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84032537|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032538|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
84032539|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
84032540|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
84032541|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032542|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84032543|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
84032544|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032545|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032546|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
84032547|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84032548|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84032549|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032550|NCT02658214|Antidotes|antidotes|mesh-ancestor
84032551|NCT02658214|Protective Agents|protective agents|mesh-ancestor
84032552|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
84032553|NCT02658214|Vitamins|vitamins|mesh-ancestor
84032554|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
84032555|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84032556|NCT02658214|Hematinics|hematinics|mesh-ancestor
84032557|NCT04169230|Citalopram|citalopram|mesh-list
84032558|NCT04169230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84032559|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84032560|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032561|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032562|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032563|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
84032564|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032565|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84032566|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
84032567|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032568|NCT04201756|Afatinib|afatinib|mesh-list
84032569|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032570|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84032571|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032572|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032573|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
84032574|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84032575|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84032576|NCT02651350|Prednisolone|prednisolone|mesh-list
84032577|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
84032578|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84032579|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
84032580|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032581|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
84032582|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
84032583|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032584|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032585|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032586|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
84032587|NCT02651350|Hormones|hormones|mesh-ancestor
84032588|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032589|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84032590|NCT02651350|Protective Agents|protective agents|mesh-ancestor
84032591|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84032592|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032593|NCT02658292|Naftifine|naftifine|mesh-list
84032594|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
84032595|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032596|NCT02651038|Micafungin|micafungin|mesh-list
84032597|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
84032598|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032599|NCT00650026|Adalimumab|adalimumab|mesh-list
84032600|NCT00650026|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84032601|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032602|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84032603|NCT00838513|Eculizumab|eculizumab|mesh-list
84032604|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84032605|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032606|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
84032607|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032608|NCT00649636|Fluoxetine|fluoxetine|mesh-list
84032609|NCT00649636|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84032610|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84032611|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032612|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032613|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032614|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
84032615|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032616|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84032617|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
84032618|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032619|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84032620|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84032621|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032622|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
84032623|NCT04030663|Papaverine|papaverine|mesh-list
84032624|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
84032625|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84032626|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032627|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032628|NCT04030663|Urological Agents|urological agents|mesh-ancestor
84032629|NCT00700921|Lovastatin|lovastatin|mesh-list
84032630|NCT00700921|L 647318|l 647318|mesh-list
84032631|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
84032632|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84032633|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84032635|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032636|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84032637|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84032638|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032639|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
84032640|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032641|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032642|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
84032643|NCT02657512|Charcoal|charcoal|mesh-list
84032644|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84032645|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
84032646|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84032647|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
84032648|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032649|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032650|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
84032651|NCT02657512|Antidotes|antidotes|mesh-ancestor
84032652|NCT02657512|Protective Agents|protective agents|mesh-ancestor
84032653|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032654|NCT00818779|Amlodipine|amlodipine|mesh-list
84032655|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032656|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84032657|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032658|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032659|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84032660|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032661|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
84032662|NCT00649714|Zonisamide|zonisamide|mesh-list
84032663|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
84032664|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84032665|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032666|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032667|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84032668|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032669|NCT00600028|Thalidomide|thalidomide|mesh-list
84032670|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032671|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
84032672|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032673|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
84032674|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84032675|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032676|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84032677|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84032678|NCT00600028|Growth Substances|growth substances|mesh-ancestor
84032679|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
84032680|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032681|NCT02650102|Olanzapine|olanzapine|mesh-list
84032682|NCT02650102|Risperidone|risperidone|mesh-list
84032683|NCT02650102|Aripiprazole|aripiprazole|mesh-list
84032684|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84032685|NCT02650102|Ziprasidone|ziprasidone|mesh-list
84032686|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84032687|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
84032688|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032689|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032690|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032691|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84032692|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84032693|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032694|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032695|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84032696|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
84032697|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
84032698|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
84032699|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032700|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032701|NCT02650102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84032702|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84032703|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032704|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
83272502|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
84032705|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
84032706|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84032707|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84032708|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84032709|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84032710|NCT00650182|Fentanyl|fentanyl|mesh-list
84032711|NCT00650182|Naltrexone|naltrexone|mesh-list
84032712|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84032713|NCT00650182|Narcotics|narcotics|mesh-ancestor
84032714|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032715|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032716|NCT00650182|Analgesics|analgesics|mesh-ancestor
84032717|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
84032718|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032719|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84032720|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84032721|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
84032722|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
84032723|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84032724|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84032725|NCT00910780|Olanzapine|olanzapine|mesh-list
84032726|NCT00910780|Aripiprazole|aripiprazole|mesh-list
84032727|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
84032728|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032729|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84032730|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84032731|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032732|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032733|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
84032734|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
84032735|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032736|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032737|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84032738|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84032739|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
84032740|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84032741|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84032742|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84032743|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84032744|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
84032745|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
84032746|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032747|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032748|NCT00910780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84032749|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84032750|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032751|NCT02656810|Teriparatide|teriparatide|mesh-list
84032752|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84032753|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032754|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84032755|NCT02649478|Fluticasone|fluticasone|mesh-list
84032756|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84032757|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84032758|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032759|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84032760|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
84032761|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032762|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032763|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84032764|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
84032765|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
84032766|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84032767|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84032768|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84032769|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84032770|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
84032771|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032772|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032773|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
84032774|NCT02649478|Hormones|hormones|mesh-ancestor
84032775|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032776|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
84032777|NCT04167592|Benzydamine|benzydamine|mesh-list
84032778|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032779|NCT04168294|Propofol|propofol|mesh-list
84032780|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84032781|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032782|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032783|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84032784|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
84032785|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
84032786|NCT04168138|Cytarabine|cytarabine|mesh-list
84032787|NCT04168138|Decitabine|decitabine|mesh-list
84032788|NCT04168138|Aclarubicin|aclarubicin|mesh-list
84032789|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84032790|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
84032791|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032792|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032793|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
84032794|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032795|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032796|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
84032797|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032798|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032799|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84032800|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84032801|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84032802|NCT04059562|Irinotecan|irinotecan|mesh-list
84032803|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84032804|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84032805|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032806|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032807|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032808|NCT00649870|Valacyclovir|valacyclovir|mesh-list
84032809|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
84032810|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032811|NCT04167280|Ipratropium|ipratropium|mesh-list
84032812|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84032813|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
84032814|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032815|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032816|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84032817|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
84032818|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84032819|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
84032820|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032821|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032822|NCT02648854|Metformin|metformin|mesh-list
84032823|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84032824|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032825|NCT03978520|Upadacitinib|upadacitinib|mesh-list
84032826|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84032827|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84032828|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032829|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032830|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84032831|NCT02652598|Tolcapone|tolcapone|mesh-list
84032832|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84032833|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84032834|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84032835|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032836|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032837|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84032838|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032839|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032840|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
84032841|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
84032842|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84032843|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84032844|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032845|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032846|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032847|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84032848|NCT02645032|Vaccines|vaccines|mesh-list
84032849|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
84032850|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032851|NCT02644954|Metformin|metformin|mesh-list
84032852|NCT02644954|Calcipotriene|calcipotriene|mesh-list
84032853|NCT02644954|Coal Tar|coal tar|mesh-list
84032854|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83272667|NCT01772368|Xhance|xhance|mesh-list
84032855|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032856|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
84032857|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
84032858|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84032859|NCT00650338|Latanoprost|latanoprost|mesh-list
84032860|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84032861|NCT02644720|Dexamethasone|dexamethasone|mesh-list
84032862|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032863|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
84032864|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
84032865|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032866|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032867|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032868|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
84032869|NCT02644720|Hormones|hormones|mesh-ancestor
84032870|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032871|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84032872|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032873|NCT03542266|Azacitidine|azacitidine|mesh-list
84032874|NCT03542266|Cc-486|cc-486|mesh-list
84032875|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84032876|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
84032877|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032878|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032879|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032880|NCT00652600|Propranolol|propranolol|mesh-list
84032881|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84032882|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84032883|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
84032884|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032885|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032886|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032887|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84032888|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032889|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
84032890|NCT03201250|Dexamethasone|dexamethasone|mesh-list
84032891|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84032892|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
84032893|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
84032894|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032895|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032896|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84032897|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
84032898|NCT03201250|Hormones|hormones|mesh-ancestor
84032899|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84032900|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84032901|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032902|NCT04166578|Lidocaine|lidocaine|mesh-list
84032903|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
84032904|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
84032905|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032906|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032907|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
84032908|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032909|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84032910|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84032911|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84032912|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84032913|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032914|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
84032915|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84032916|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032917|NCT04166734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84032918|NCT04166734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032919|NCT00651352|Nicotine|nicotine|mesh-list
84032920|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84032921|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
84032922|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032923|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032924|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84032925|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84032926|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
84032927|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032928|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032929|NCT02641210|Albendazole|albendazole|mesh-list
84032930|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
84032931|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84032932|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84032933|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
84032934|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84032935|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84032936|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
84032937|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
84032938|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
84032939|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032940|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032941|NCT02644408|Megestrol|megestrol|mesh-list
84032942|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84032943|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84032944|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84032945|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
84032946|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84032947|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032948|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84032949|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84032950|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84032951|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032952|NCT05758597|Midazolam|midazolam|mesh-list
84032953|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84032954|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84032955|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032956|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032957|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84032958|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84032959|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84032960|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84032961|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
84032962|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
84032963|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
84032964|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
84032965|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84032966|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032967|NCT02644486|Irbesartan|irbesartan|mesh-list
84032968|NCT02644486|Sevelamer|sevelamer|mesh-list
84032969|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84032970|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84032971|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84032972|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032973|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
84032974|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
84032975|NCT00827359|Everolimus|everolimus|mesh-list
84032976|NCT00827359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84032977|NCT00827359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84032978|NCT00827359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032979|NCT00827359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84032980|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84032981|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
84032982|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032983|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032984|NCT02641288|Ropivacaine|ropivacaine|mesh-list
84032985|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
84032986|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
84032987|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84032988|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032989|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
84032990|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84032991|NCT04165174|Apatinib|apatinib|mesh-list
84032992|NCT04165174|Antibodies|antibodies|mesh-list
84032993|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84032994|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
84032995|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84032996|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84032997|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84032998|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84032999|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033000|NCT02613247|Hylan|hylan|mesh-list
84033001|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
84033002|NCT02613247|Protective Agents|protective agents|mesh-ancestor
84033003|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033004|NCT02641132|Mitomycins|mitomycins|mesh-list
84033005|NCT02641132|Mitomycin|mitomycin|mesh-list
84033006|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84033007|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033008|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
84033009|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033010|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84033011|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033012|NCT00653614|Drospirenone|drospirenone|mesh-list
84033013|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84033014|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
84033015|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033016|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033017|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84033018|NCT00653614|Diuretics|diuretics|mesh-ancestor
84033019|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
84033020|NCT02644252|Tocotrienols|tocotrienols|mesh-list
84033021|NCT02644252|Vitamin E|vitamin e|mesh-list
84033022|NCT02644252|Tocopherols|tocopherols|mesh-list
84033023|NCT02644252|Carboplatin|carboplatin|mesh-list
84033024|NCT02644252|Vinorelbine|vinorelbine|mesh-list
84033025|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033026|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84033027|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
84033028|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
84033029|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
84033030|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033031|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
84033032|NCT02644252|Protective Agents|protective agents|mesh-ancestor
84033033|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033034|NCT02644252|Vitamins|vitamins|mesh-ancestor
84033035|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
84033036|NCT00818389|Riluzole|riluzole|mesh-list
84033037|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
84033038|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
84033039|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84033040|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033041|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033042|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
84033043|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84033044|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033045|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033046|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
84033047|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84033048|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84033049|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033050|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84033051|NCT00818389|Protective Agents|protective agents|mesh-ancestor
84033052|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84033053|NCT02640976|Cetrorelix|cetrorelix|mesh-list
84033054|NCT02640976|Menotropins|menotropins|mesh-list
84033055|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84033056|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033057|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84033058|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
84033059|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
84033060|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033061|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
84033062|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
84033063|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033064|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84033065|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84033066|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033067|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84033068|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033069|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84033070|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84033071|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033072|NCT02535988|Thymalfasin|thymalfasin|mesh-list
84033073|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84033074|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
84033075|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033076|NCT02640898|Docetaxel|docetaxel|mesh-list
84033077|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272882|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
84033078|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
84033079|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
84033080|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
84033081|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033082|NCT02535910|Vitamin D|vitamin d|mesh-list
84033083|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
84033084|NCT02535910|Calcifediol|calcifediol|mesh-list
84033085|NCT02535910|Vitamins|vitamins|mesh-ancestor
84033086|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
84033087|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033088|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84033089|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84033090|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84033091|NCT00849901|Fluoxetine|fluoxetine|mesh-list
84033092|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84033093|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84033094|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033095|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033096|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033097|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033098|NCT00849901|Analgesics|analgesics|mesh-ancestor
84033099|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
84033100|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033101|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
84033102|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84033103|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
84033104|NCT00849901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84033105|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
84033106|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84033107|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84033108|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84033109|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033110|NCT02641054|Levodopa|levodopa|mesh-list
84033111|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84033112|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84033113|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
84033114|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033115|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033116|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033117|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84033118|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84033119|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84033120|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
84033121|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033122|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84033123|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84033124|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033125|NCT04166890|Epinephrine|epinephrine|mesh-list
84033126|NCT04166890|Carticaine|carticaine|mesh-list
84033127|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84033128|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84033129|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
84033130|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033131|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033132|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033133|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84033134|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84033135|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
84033136|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033137|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84033138|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
84033139|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
84033140|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
84033141|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84033142|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
84033143|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
84033144|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033145|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
84033146|NCT00652912|Clonazepam|clonazepam|mesh-list
84033147|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
84033148|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
84033149|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
84033150|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033151|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033152|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033153|NCT01168232|Epothilones|epothilones|mesh-list
84033154|NCT01168232|Epothilone B|epothilone b|mesh-list
84033155|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
84033156|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
84033157|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
84033158|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033159|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033161|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033162|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84033163|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033164|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033165|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
84033166|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
84033167|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84033168|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84033169|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033170|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033171|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84033172|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84033173|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033174|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033175|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033176|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84033177|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84033178|NCT02640508|Lenvatinib|lenvatinib|mesh-list
84033179|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033180|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84033181|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033182|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033183|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
84033184|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84033185|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84033186|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033187|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
84033188|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
84033189|NCT05259566|Menthol|menthol|mesh-list
84033190|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
84033191|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
84033192|NCT02643550|Cetuximab|cetuximab|mesh-list
84033193|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84033194|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033195|NCT00817063|Alitretinoin|alitretinoin|mesh-list
84033196|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033197|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
84033198|NCT04313270|Evolocumab|evolocumab|mesh-list
84033199|NCT04313270|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84033200|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84033201|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84033202|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
84033203|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033204|NCT04313270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84033205|NCT04313270|Protease Inhibitors|protease inhibitors|mesh-ancestor
84033206|NCT04313270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033207|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84033208|NCT02640118|Lixisenatide|lixisenatide|mesh-list
84033209|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84033210|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033211|NCT00826267|Trastuzumab|trastuzumab|mesh-list
84033212|NCT00826267|Lapatinib|lapatinib|mesh-list
84033213|NCT00826267|Afatinib|afatinib|mesh-list
84033214|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84033215|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033216|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84033217|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033218|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033219|NCT00653848|Docetaxel|docetaxel|mesh-list
84033220|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033221|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
84033222|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
84033223|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
84033224|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033225|NCT00707551|Ketoconazole|ketoconazole|mesh-list
83273037|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
84033226|NCT00707551|Verapamil|verapamil|mesh-list
84033227|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
84033228|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033229|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84033230|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84033231|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033232|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033233|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84033234|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
84033235|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033236|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033237|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84033238|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84033239|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84033240|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033241|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84033242|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
84033243|NCT00986154|Heparin|heparin|mesh-list
84033244|NCT00986154|Calcium heparin|calcium heparin|mesh-list
84033245|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84033246|NCT00986154|Tinzaparin|tinzaparin|mesh-list
84033247|NCT00986154|Dalteparin|dalteparin|mesh-list
84033248|NCT00986154|Warfarin|warfarin|mesh-list
84033249|NCT00986154|Edoxaban|edoxaban|mesh-list
84033250|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
84033251|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84033252|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84033253|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033254|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84033255|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
84033256|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84033257|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
84033258|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033259|NCT00653926|Epinephrine|epinephrine|mesh-list
84033260|NCT00653926|Ropivacaine|ropivacaine|mesh-list
84033261|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
84033262|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
84033263|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033264|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033265|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
84033266|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033267|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84033268|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84033269|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
84033270|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033271|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033272|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84033273|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84033274|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
84033275|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84033276|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
84033277|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
84033278|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
84033279|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84033280|NCT02613091|Clemastine|clemastine|mesh-list
84033281|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
84033282|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
84033283|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84033284|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
84033285|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
84033286|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033287|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033288|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033289|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84033290|NCT02639806|Lidocaine|lidocaine|mesh-list
84033291|NCT02639806|Sevoflurane|sevoflurane|mesh-list
84033292|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
84033293|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
84033294|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033295|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033296|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
84033297|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033298|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84033299|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83273109|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
84033300|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84033301|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033302|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033303|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84033304|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84033305|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
84033306|NCT02646904|Beclomethasone|beclomethasone|mesh-list
84033307|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84033308|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
84033309|NCT02646904|Hormones|hormones|mesh-ancestor
84033310|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033311|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033312|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84033313|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
84033314|NCT00848965|Fluticasone|fluticasone|mesh-list
84033315|NCT00848965|Xhance|xhance|mesh-list
84033316|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84033317|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84033318|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
84033319|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033320|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033321|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84033322|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
84033323|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
84033324|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84033325|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
84033326|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
84033327|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84033328|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84033329|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033330|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033331|NCT00654082|Urological Agents|urological agents|mesh-ancestor
84033332|NCT00654160|Leucovorin|leucovorin|mesh-list
84033333|NCT00654160|Fluorouracil|fluorouracil|mesh-list
84033334|NCT00654160|Irinotecan|irinotecan|mesh-list
84033335|NCT00654160|Calcium|calcium|mesh-list
84033336|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
84033337|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84033338|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033339|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
84033340|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033341|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84033342|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033343|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84033344|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
84033345|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84033346|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84033347|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033348|NCT00654160|Antidotes|antidotes|mesh-ancestor
84033349|NCT00654160|Protective Agents|protective agents|mesh-ancestor
84033350|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
84033351|NCT00654160|Vitamins|vitamins|mesh-ancestor
84033352|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
84033353|NCT02642380|Dexamethasone|dexamethasone|mesh-list
84033354|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
84033355|NCT02642380|BB 1101|bb 1101|mesh-list
84033356|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84033357|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
84033358|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
84033359|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033360|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033361|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84033362|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
84033363|NCT02642380|Hormones|hormones|mesh-ancestor
84033364|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033365|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84033366|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033367|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
84033368|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033369|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033370|NCT01154036|Atorvastatin|atorvastatin|mesh-list
84033371|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84033372|NCT01154036|Ezetimibe|ezetimibe|mesh-list
84033373|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84033374|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83273197|NCT01768858|Adalimumab|adalimumab|mesh-list
84033375|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
84033376|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033377|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84033378|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84033379|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033380|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
84033382|NCT00816595|Rituximab|rituximab|mesh-list
84033383|NCT00816595|Pentostatin|pentostatin|mesh-list
84033384|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84033385|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
84033386|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033387|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84033388|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84033389|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
84033390|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033391|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033392|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84033393|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84033394|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84033395|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84033396|NCT00816595|Growth Substances|growth substances|mesh-ancestor
84033397|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
84033398|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
84033399|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033400|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
84033401|NCT01166438|Trospium chloride|trospium chloride|mesh-list
84033402|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
84033403|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84033404|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84033405|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84033406|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033407|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033408|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
84033409|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033410|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033411|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84033412|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033413|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84033414|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84033415|NCT01166438|Urological Agents|urological agents|mesh-ancestor
84033416|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
84033417|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
84033418|NCT00707707|Paclitaxel|paclitaxel|mesh-list
84033419|NCT00707707|Olaparib|olaparib|mesh-list
84033420|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84033421|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033422|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
84033423|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
84033424|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
84033425|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033426|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84033427|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033428|NCT01153958|Metronidazole|metronidazole|mesh-list
84033429|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
84033430|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033431|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033432|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84033433|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84033434|NCT00707785|Vitamin A|vitamin a|mesh-list
84033435|NCT00707785|Vitamins|vitamins|mesh-ancestor
84033436|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
84033437|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033438|NCT00599638|Pregabalin|pregabalin|mesh-list
84033439|NCT00599638|Analgesics|analgesics|mesh-ancestor
84033440|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
84033441|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033442|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033443|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
84033444|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84033445|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033446|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033447|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84033448|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84033449|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84033450|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033451|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84033452|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
84033453|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
84033454|NCT02642146|Calcium|calcium|mesh-list
84033455|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
84033456|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84033457|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033458|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033459|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033460|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033461|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84033462|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84033463|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84033464|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
84033465|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033466|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84033467|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84033468|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033469|NCT00653302|Metformin|metformin|mesh-list
84033470|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
84033471|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84033472|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033473|NCT02638870|Amitriptyline|amitriptyline|mesh-list
84033474|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84033475|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
84033476|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84033477|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84033478|NCT02638870|Analgesics|analgesics|mesh-ancestor
84033479|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
84033480|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033481|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033482|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84033483|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84033484|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033485|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033486|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
84033487|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033488|NCT02641990|Exenatide|exenatide|mesh-list
84033489|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84033490|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033491|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84033492|NCT02641990|Incretins|incretins|mesh-ancestor
84033493|NCT02641990|Hormones|hormones|mesh-ancestor
84033494|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033495|NCT00653380|Doxycycline|doxycycline|mesh-list
84033496|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033497|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033498|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
84033499|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84033500|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84033501|NCT02646592|Alfentanil|alfentanil|mesh-list
84033502|NCT02646592|Propofol|propofol|mesh-list
84033503|NCT02646592|Sevoflurane|sevoflurane|mesh-list
84033504|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84033505|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033506|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033507|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84033508|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
84033509|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
84033510|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84033511|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84033512|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84033513|NCT02646592|Narcotics|narcotics|mesh-ancestor
84033514|NCT02646592|Analgesics|analgesics|mesh-ancestor
84033515|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
84033516|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033517|NCT02646670|Ranibizumab|ranibizumab|mesh-list
84033518|NCT02646670|Aflibercept|aflibercept|mesh-list
84033519|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84033520|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84033521|NCT02646670|Growth Substances|growth substances|mesh-ancestor
84033522|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033523|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
84033524|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033525|NCT00651976|Letrozole|letrozole|mesh-list
84033526|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033527|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84033528|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84033529|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033530|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033531|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84033532|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
84033533|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033534|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033535|NCT01166282|Adalimumab|adalimumab|mesh-list
84033536|NCT01166282|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84033537|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84033538|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84033539|NCT01153724|Fluconazole|fluconazole|mesh-list
84033540|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
84033541|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033542|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84033543|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84033544|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033545|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033546|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84033547|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
84033548|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033549|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033550|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84033551|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84033552|NCT02884388|Anesthetics|anesthetics|mesh-list
84033553|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033554|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033555|NCT02885948|Naloxone|naloxone|mesh-list
84033556|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84033557|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033558|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
84033559|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033560|NCT01152788|Dacarbazine|dacarbazine|mesh-list
84033561|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84033562|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
84033563|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033564|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033565|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
84033566|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84033567|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
84033568|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84033569|NCT00598702|Acetaminophen|acetaminophen|mesh-list
84033570|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84033571|NCT00598702|Analgesics|analgesics|mesh-ancestor
84033572|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
84033573|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033574|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033575|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
84033576|NCT01148810|Siponimod|siponimod|mesh-list
84033577|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84033578|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033579|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84033580|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
84033581|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033582|NCT02884310|Remifentanil|remifentanil|mesh-list
84033583|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84033584|NCT02884310|Narcotics|narcotics|mesh-ancestor
84033585|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033586|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033587|NCT02884310|Analgesics|analgesics|mesh-ancestor
84033588|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
84033589|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033590|NCT01164956|Methylphenidate|methylphenidate|mesh-list
84033591|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84033592|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033593|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84033594|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84033595|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033596|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033597|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
84033598|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033599|NCT01151540|Rufinamide|rufinamide|mesh-list
84033600|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
84033601|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84033602|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84033603|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033604|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033605|NCT01163786|Bortezomib|bortezomib|mesh-list
84033606|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033607|NCT05367362|Minocycline|minocycline|mesh-list
84033608|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033609|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033610|NCT00984282|Sorafenib|sorafenib|mesh-list
84033611|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033612|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84033613|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033614|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033615|NCT04187196|Propofol|propofol|mesh-list
84033616|NCT04187196|Methohexital|methohexital|mesh-list
84033617|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84033618|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033619|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033620|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84033621|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
84033622|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
84033623|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
84033624|NCT04292184|Antidotes|antidotes|mesh-ancestor
84033625|NCT04292184|Protective Agents|protective agents|mesh-ancestor
84033626|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033627|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
84033628|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033629|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
84033630|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033631|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033632|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
84033633|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
84033634|NCT01147640|Metronidazole|metronidazole|mesh-list
84033635|NCT01147640|Meropenem|meropenem|mesh-list
84033636|NCT01147640|Tazobactam|tazobactam|mesh-list
84033637|NCT01147640|Ceftolozane|ceftolozane|mesh-list
84033638|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033639|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033640|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84033641|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84033642|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84033643|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033644|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033645|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84033646|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033647|NCT01121900|Trazodone|trazodone|mesh-list
84033648|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84033649|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84033650|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033651|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033652|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84033653|NCT01121900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84033654|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84033655|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84033656|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033657|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033658|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
84033659|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84033660|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
84033661|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84033662|NCT01121666|Hormones|hormones|mesh-ancestor
84033663|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033664|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033665|NCT00984126|Factor VIII|factor viii|mesh-list
84033666|NCT00984126|Coagulants|coagulants|mesh-ancestor
84033667|NCT02868996|Kallikreins|kallikreins|mesh-list
84033668|NCT02868996|Coagulants|coagulants|mesh-ancestor
84033669|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
84033670|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
84033671|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84033672|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033673|NCT00629226|Cetuximab|cetuximab|mesh-list
83273476|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
84033674|NCT00629226|Bortezomib|bortezomib|mesh-list
84033675|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033676|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84033677|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
84033678|NCT00629304|Antithrombins|antithrombins|mesh-list
84033679|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84033680|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
84033681|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033682|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033683|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
84033684|NCT05297929|Irbesartan|irbesartan|mesh-list
84033685|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84033686|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84033687|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84033688|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033689|NCT00826111|Eszopiclone|eszopiclone|mesh-list
84033690|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84033691|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033692|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033693|NCT00982644|Insulin|insulin|mesh-list
84033694|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84033695|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
84033696|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84033697|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033698|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84033699|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84033700|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84033701|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
84033702|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033703|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84033704|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84033705|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033706|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
84033707|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84033708|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84033709|NCT02867904|Prednisolone|prednisolone|mesh-list
84033710|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
84033711|NCT02867904|Bupivacaine|bupivacaine|mesh-list
84033712|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84033713|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
84033714|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84033715|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
84033716|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
84033717|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033718|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033719|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84033720|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
84033721|NCT02867904|Hormones|hormones|mesh-ancestor
84033722|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033723|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84033724|NCT02867904|Protective Agents|protective agents|mesh-ancestor
84033725|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84033726|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033727|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
84033728|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
84033729|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033730|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
84033731|NCT04290936|Tenofovir|tenofovir|mesh-list
84033732|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
84033733|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033734|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84033735|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84033736|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033737|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033738|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84033739|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84033740|NCT00707941|Oseltamivir|oseltamivir|mesh-list
84033741|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
84033742|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033743|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033744|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033745|NCT00824473|Azelastine|azelastine|mesh-list
84033746|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84033747|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
84033748|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033749|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033750|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84033751|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
84033752|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84033753|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033754|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033755|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84033756|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84033757|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84033758|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
84033759|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
84033760|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033761|NCT04291092|Immunomodulating Agents|immunomodulating agents|mesh-list
84033762|NCT04291092|Immunologic Factors|immunologic factors|mesh-ancestor
84033763|NCT04291092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033764|NCT02867280|Sorafenib|sorafenib|mesh-list
84033765|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033766|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84033767|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033768|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033769|NCT04290390|Itraconazole|itraconazole|mesh-list
84033770|NCT04290390|Rifampin|rifampin|mesh-list
84033771|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84033772|NCT04290390|Estradiol|estradiol|mesh-list
84033773|NCT04290390|Estrogens|estrogens|mesh-ancestor
84033774|NCT04290390|Hormones|hormones|mesh-ancestor
84033775|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033776|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033777|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84033778|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
84033779|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84033780|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84033781|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
84033782|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033783|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84033784|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84033785|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033786|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033787|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84033788|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
84033789|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84033790|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84033791|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
84033792|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033793|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
84033794|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84033795|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84033796|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84033797|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84033798|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84033799|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84033800|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84033801|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84033802|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84033803|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
84033804|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84033805|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
84033806|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033807|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033808|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84033809|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
84033810|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84033811|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
84033812|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033813|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033814|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84033815|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
84033816|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
84033817|NCT04290858|Protective Agents|protective agents|mesh-ancestor
84033818|NCT05326555|Imidacloprid|imidacloprid|mesh-list
84033819|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
84033820|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033821|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033822|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033823|NCT02610829|Vitamin E|vitamin e|mesh-list
84033824|NCT02610829|Tocopherols|tocopherols|mesh-list
84033825|NCT02610829|Tocotrienols|tocotrienols|mesh-list
84033826|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
84033827|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
84033828|NCT02610829|Vitamins|vitamins|mesh-ancestor
84033829|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
84033830|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033831|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
84033832|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033833|NCT02610829|Protective Agents|protective agents|mesh-ancestor
84033834|NCT04104672|Paclitaxel|paclitaxel|mesh-list
84033835|NCT04104672|Gemcitabine|gemcitabine|mesh-list
84033836|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84033837|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033838|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
84033839|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
84033840|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
84033841|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033842|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84033843|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
84033844|NCT02865564|Gentamicins|gentamicins|mesh-list
84033845|NCT02865564|Ampicillin|ampicillin|mesh-list
84033846|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033847|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033848|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84033849|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033850|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033851|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
84033852|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84033853|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84033854|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84033855|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
84033856|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033857|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84033858|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84033859|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033860|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033861|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84033862|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84033863|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
84033864|NCT00814801|Galantamine|galantamine|mesh-list
84033865|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84033866|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033867|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033868|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
84033869|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033870|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033871|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84033872|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
84033873|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033874|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
84033875|NCT00653458|Ondansetron|ondansetron|mesh-list
84033876|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
84033877|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
84033878|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033879|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033880|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84033881|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
84033882|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
84033883|NCT00653458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84033884|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84033885|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
84033886|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033887|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033888|NCT02708836|Anesthetics|anesthetics|mesh-list
84033889|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033890|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033891|NCT00708565|Iloprost|iloprost|mesh-list
84033892|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84033893|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
84033894|NCT00812461|Nalmefene|nalmefene|mesh-list
84033895|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84033896|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033897|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
84033898|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033899|NCT00599326|Deferasirox|deferasirox|mesh-list
84033900|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84033901|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
84033902|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
84033903|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033904|NCT00978432|Everolimus|everolimus|mesh-list
84033905|NCT00978432|Panobinostat|panobinostat|mesh-list
84033906|NCT00978432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84033907|NCT00978432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84033908|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84033909|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033910|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84033911|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
84033912|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033913|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033914|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84033915|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
84033916|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84033917|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
84033918|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033919|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033920|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84033921|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
84033922|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84033923|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
84033924|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033925|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84033926|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84033927|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
84033928|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
84033929|NCT04166812|Protective Agents|protective agents|mesh-ancestor
84033930|NCT00708799|Azithromycin|azithromycin|mesh-list
84033931|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84033932|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033933|NCT02610127|Factor VIII|factor viii|mesh-list
84033934|NCT02610127|Coagulants|coagulants|mesh-ancestor
84033935|NCT00814333|Thrombin|thrombin|mesh-list
84033936|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
84033937|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
84033938|NCT00814333|Coagulants|coagulants|mesh-ancestor
84033939|NCT01147250|Lixisenatide|lixisenatide|mesh-list
84033940|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84033941|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033942|NCT00813943|Temozolomide|temozolomide|mesh-list
84033943|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84033944|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
84033945|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033946|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033947|NCT00821509|Disinfectants|disinfectants|mesh-list
84033948|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84033949|NCT01134614|Ipilimumab|ipilimumab|mesh-list
84033950|NCT01134614|Sargramostim|sargramostim|mesh-list
84033951|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84033952|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84033953|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84033954|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84033955|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
84033956|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033957|NCT00913861|Fentanyl|fentanyl|mesh-list
84033958|NCT00913861|Propofol|propofol|mesh-list
84033959|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84033960|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84033961|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033962|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84033963|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
84033964|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
84033965|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84033966|NCT00913861|Narcotics|narcotics|mesh-ancestor
84033967|NCT00913861|Analgesics|analgesics|mesh-ancestor
84033968|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
84033969|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84033970|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84033971|NCT00709189|Folic Acid|folic acid|mesh-list
84033972|NCT00709189|Norgestimate|norgestimate|mesh-list
84033973|NCT00709189|Estradiol|estradiol|mesh-list
84033974|NCT00709189|Estrogens|estrogens|mesh-ancestor
84033975|NCT00709189|Hormones|hormones|mesh-ancestor
84033976|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84033977|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033978|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84033979|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
84033980|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84033981|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84033982|NCT00709189|Hematinics|hematinics|mesh-ancestor
84033983|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
84033984|NCT00709189|Vitamins|vitamins|mesh-ancestor
84033985|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
84033986|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84033987|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84033988|NCT00709267|Folic Acid|folic acid|mesh-list
84033989|NCT00709267|Hematinics|hematinics|mesh-ancestor
84033990|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
84033991|NCT00709267|Vitamins|vitamins|mesh-ancestor
84033992|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
84033993|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033994|NCT00591565|Acamprosate|acamprosate|mesh-list
84033995|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84033996|NCT00978120|Vaccines|vaccines|mesh-list
84033997|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
84033998|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84033999|NCT01133678|Paclitaxel|paclitaxel|mesh-list
84034000|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84034001|NCT01133678|Cisplatin|cisplatin|mesh-list
84034002|NCT01133678|Cetuximab|cetuximab|mesh-list
84034003|NCT01133678|Everolimus|everolimus|mesh-list
84034004|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84034005|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034006|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
84034007|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
84034008|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
84034009|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034010|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034011|NCT01133678|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84034012|NCT01133678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84034013|NCT01133678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034014|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034015|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
84034016|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034017|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
84034018|NCT00652132|Antidotes|antidotes|mesh-ancestor
84034019|NCT00652132|Protective Agents|protective agents|mesh-ancestor
84034020|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034021|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
84034022|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034023|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
84034024|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84034025|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034026|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
84034027|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
84034028|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
84034029|NCT00655174|Sertraline|sertraline|mesh-list
84034030|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
84034031|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84034032|NCT00655174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84034033|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84034034|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84034035|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034036|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034037|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
84034038|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034039|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84034040|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84034041|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034042|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84034043|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84034044|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84034045|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034046|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84034047|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
84034048|NCT00655018|Tocopherols|tocopherols|mesh-list
84034049|NCT00655018|Vitamin E|vitamin e|mesh-list
84034050|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
83273855|NCT04673175|Tazobactam|tazobactam|mesh-list
84034051|NCT00655018|Vitamins|vitamins|mesh-ancestor
84034052|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
84034053|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034054|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
84034055|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034056|NCT00655018|Protective Agents|protective agents|mesh-ancestor
84034057|NCT02635750|Donepezil|donepezil|mesh-list
84034058|NCT02635750|BI 409306|bi 409306|mesh-list
84034059|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84034060|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034061|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034062|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
84034063|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034064|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034065|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
84034066|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84034067|NCT04164238|Paclitaxel|paclitaxel|mesh-list
84034068|NCT04164238|Carboplatin|carboplatin|mesh-list
84034069|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84034070|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034071|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
84034072|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
84034073|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
84034074|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034075|NCT02645734|Bevacizumab|bevacizumab|mesh-list
84034076|NCT02645734|Aflibercept|aflibercept|mesh-list
84034077|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034078|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034079|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84034080|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84034081|NCT02645734|Growth Substances|growth substances|mesh-ancestor
84034082|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034083|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
84034084|NCT01133522|Evolocumab|evolocumab|mesh-list
84034085|NCT01133522|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84034086|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84034087|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84034088|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
84034089|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034090|NCT01133522|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84034091|NCT01133522|Protease Inhibitors|protease inhibitors|mesh-ancestor
84034092|NCT01133522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034093|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84034094|NCT00682318|Ethanol|ethanol|mesh-list
84034095|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84034096|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034097|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034098|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034099|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
84034100|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84034101|NCT00655252|Everolimus|everolimus|mesh-list
84034102|NCT00655252|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84034103|NCT00655252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84034104|NCT00655252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034105|NCT00655252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034106|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034107|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
84034108|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034109|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034110|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
84034111|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84034112|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84034113|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034114|NCT02645656|Curcumin|curcumin|mesh-list
84034115|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84034116|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84034117|NCT02645656|Analgesics|analgesics|mesh-ancestor
84034118|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
84034119|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034120|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034121|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034122|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84034123|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034124|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034125|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034126|NCT01132820|Cediranib|cediranib|mesh-list
84034127|NCT01132820|Maleic acid|maleic acid|mesh-list
84034128|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034129|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034130|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034131|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84034133|NCT00655330|Probucol|probucol|mesh-list
84034134|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84034135|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84034136|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84034137|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034138|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84034139|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84034140|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
84034141|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84034142|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
84034143|NCT00655330|Protective Agents|protective agents|mesh-ancestor
84034144|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034145|NCT00655408|Iron|iron|mesh-list
84034146|NCT00655408|Trace Elements|trace elements|mesh-ancestor
84034147|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
84034148|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034149|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
84034150|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84034151|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84034152|NCT04163536|Prednisolone|prednisolone|mesh-list
84034153|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
84034154|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84034155|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
84034156|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034157|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
84034158|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
84034159|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034160|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034161|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84034162|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
84034163|NCT04163536|Hormones|hormones|mesh-ancestor
84034164|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034165|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84034166|NCT04163536|Protective Agents|protective agents|mesh-ancestor
84034167|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84034168|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034169|NCT00652288|Insulin|insulin|mesh-list
84034170|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84034171|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
84034172|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
84034173|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
84034174|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84034175|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
84034176|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
84034177|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034178|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034179|NCT00911092|Fluorouracil|fluorouracil|mesh-list
84034180|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034181|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
84034182|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034183|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034184|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034185|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
84034186|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034187|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
84034188|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034189|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034190|NCT02635360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84034191|NCT02635360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034192|NCT02635282|Fentanyl|fentanyl|mesh-list
84034193|NCT02635282|Midazolam|midazolam|mesh-list
84034194|NCT02635282|Ketamine|ketamine|mesh-list
84034195|NCT02635282|Analgesics|analgesics|mesh-ancestor
84034196|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
84034197|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034198|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034199|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84034200|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84034201|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
84034202|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
84034203|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034204|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84034205|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84034206|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034207|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034208|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84034209|NCT02635282|Narcotics|narcotics|mesh-ancestor
84034210|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84034211|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84034212|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84034213|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84034214|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84034215|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
84034216|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
84034217|NCT00655798|Antioxidants|antioxidants|mesh-list
84034218|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034219|NCT00655798|Protective Agents|protective agents|mesh-ancestor
84034220|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034221|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
84034222|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84034223|NCT02637700|Antibodies|antibodies|mesh-list
84034224|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
84034225|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84034226|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
84034227|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034228|NCT02637466|Vortioxetine|vortioxetine|mesh-list
84034229|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
84034230|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84034231|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84034232|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84034233|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034234|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034235|NCT02637466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84034236|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84034237|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84034238|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034239|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034240|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
84034241|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84034242|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84034243|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84034244|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84034245|NCT02634970|Ranibizumab|ranibizumab|mesh-list
84034246|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84034247|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84034248|NCT02634970|Growth Substances|growth substances|mesh-ancestor
84034249|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034250|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
84034251|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034252|NCT00885352|Metformin|metformin|mesh-list
84034253|NCT00885352|Pioglitazone|pioglitazone|mesh-list
84034254|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84034255|NCT00885352|Glipizide|glipizide|mesh-list
84034256|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034257|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034258|NCT00885352|Incretins|incretins|mesh-ancestor
84034259|NCT00885352|Hormones|hormones|mesh-ancestor
84034260|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034261|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84034262|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
84034263|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034264|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034265|NCT00656032|Cinacalcet|cinacalcet|mesh-list
84034266|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84034267|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034268|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
84034269|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
84034270|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034271|NCT00885118|Empagliflozin|empagliflozin|mesh-list
84034272|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84034273|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034274|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034275|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034276|NCT00656812|Rituximab|rituximab|mesh-list
84034277|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034278|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034279|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
84034280|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034282|NCT00656110|Ethanol|ethanol|mesh-list
84034283|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
84034284|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84034285|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84034286|NCT00656110|Prednisolone|prednisolone|mesh-list
84034287|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
84034288|NCT00656110|Lidocaine|lidocaine|mesh-list
84034289|NCT00656110|Bupivacaine|bupivacaine|mesh-list
84034290|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84034291|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
84034292|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
84034293|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
84034294|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034295|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034296|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
84034297|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034298|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84034299|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84034300|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84034301|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84034302|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034303|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034304|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
84034305|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
84034306|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84034307|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
84034308|NCT00656110|Hormones|hormones|mesh-ancestor
84034309|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034310|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84034311|NCT00656110|Protective Agents|protective agents|mesh-ancestor
84034312|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84034313|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034314|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84034315|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034316|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84034317|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
84034318|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84034319|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84034320|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034321|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034322|NCT00656188|Urological Agents|urological agents|mesh-ancestor
84034323|NCT00880906|Fluticasone|fluticasone|mesh-list
84034324|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84034325|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034326|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84034327|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
84034328|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034329|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034330|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84034331|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
84034332|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
84034333|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84034334|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034335|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034336|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
84034337|NCT04160026|Piperaquine|piperaquine|mesh-list
84034338|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
84034339|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84034340|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
84034341|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84034342|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84034343|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034344|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84034345|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034346|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034347|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84034348|NCT04159870|Rifaximin|rifaximin|mesh-list
84034349|NCT04159870|Norfloxacin|norfloxacin|mesh-list
84034350|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84034351|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034352|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84034353|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83274164|NCT04672005|Vitamins|vitamins|mesh-ancestor
84034354|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84034355|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034356|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034357|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034358|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84034359|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84034360|NCT00657514|Ranolazine|ranolazine|mesh-list
84034361|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84034362|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84034363|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034364|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
84034365|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84034366|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034367|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84034368|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
84034369|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84034370|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034371|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034372|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034373|NCT00882310|Gemcitabine|gemcitabine|mesh-list
84034374|NCT00882310|Capecitabine|capecitabine|mesh-list
84034375|NCT00882310|Docetaxel|docetaxel|mesh-list
84034376|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034377|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
84034378|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034379|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034380|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
84034381|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
84034382|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
84034383|NCT00884650|Analgesics|analgesics|mesh-list
84034384|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
84034385|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034386|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034387|NCT02636842|Aripiprazole|aripiprazole|mesh-list
84034388|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
84034389|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
84034390|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84034391|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84034392|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84034393|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034394|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034395|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
84034396|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
84034397|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034398|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034399|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84034400|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84034401|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
84034402|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84034403|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84034404|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84034405|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84034406|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
84034407|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034408|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034409|NCT00656422|Insulin|insulin|mesh-list
84034410|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84034411|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
84034412|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034413|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034414|NCT02634034|Pitavastatin|pitavastatin|mesh-list
84034415|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84034416|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84034417|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84034418|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
84034419|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034420|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034421|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84034422|NCT00657748|Triacetin|triacetin|mesh-list
84034423|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
84034424|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
84034425|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84034426|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034427|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034428|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
84034429|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84034430|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034431|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034432|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
84034433|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034434|NCT04161586|Prilocaine|prilocaine|mesh-list
84034435|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
84034436|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
84034437|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034438|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034439|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
84034440|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034441|NCT02636218|Ketamine|ketamine|mesh-list
84034442|NCT02636218|Analgesics|analgesics|mesh-ancestor
84034443|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
84034444|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152538|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
84034445|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034446|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84034447|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84034448|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
84034449|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
84034450|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034451|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84034452|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84034453|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034454|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034455|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
84034456|NCT04161508|Neostigmine|neostigmine|mesh-list
84034457|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84034458|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034459|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034460|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
84034461|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034462|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034463|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84034464|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
84034465|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034466|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84034467|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84034468|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84034469|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
84034470|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84034471|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84034472|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
84034473|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
84034474|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034475|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034476|NCT00883558|Insulin|insulin|mesh-list
84034477|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84034478|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
84034479|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
84034480|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034481|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034482|NCT04162834|Papaverine|papaverine|mesh-list
84034483|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84034484|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034485|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034486|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
84034487|NCT04162834|Urological Agents|urological agents|mesh-ancestor
84034488|NCT00657904|Bicalutamide|bicalutamide|mesh-list
84034489|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
84034490|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
84034491|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034492|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034493|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034494|NCT02633878|Progesterone|progesterone|mesh-list
84034495|NCT02633878|Progestins|progestins|mesh-ancestor
84034496|NCT02633878|Hormones|hormones|mesh-ancestor
84034497|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034498|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034499|NCT00597766|Triamcinolone|triamcinolone|mesh-list
84034500|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84034501|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84034502|NCT00597766|Lidocaine|lidocaine|mesh-list
83274312|NCT01639729|Sufentanil|sufentanil|mesh-list
84034503|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84034504|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
84034505|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
84034506|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034507|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034508|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
84034509|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034510|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84034511|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84034512|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84034513|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84034514|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034515|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034516|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
84034517|NCT00597766|Hormones|hormones|mesh-ancestor
84034518|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034519|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034520|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
84034521|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034522|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
84034523|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84034524|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034525|NCT00657982|Everolimus|everolimus|mesh-list
84034526|NCT00657982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84034527|NCT00657982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84034528|NCT00657982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034529|NCT00657982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034530|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034531|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
84034532|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034533|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034534|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
84034535|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
84034536|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034537|NCT00979992|Sunitinib|sunitinib|mesh-list
84034538|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034539|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84034540|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84034541|NCT00979992|Growth Substances|growth substances|mesh-ancestor
84034542|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034543|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
84034544|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84034545|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034546|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034547|NCT01079741|Poly I-C|poly i-c|mesh-list
84034548|NCT01079741|Mineral Oil|mineral oil|mesh-list
84034549|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84034550|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84034551|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
84034552|NCT01079741|Poly ICLC|poly iclc|mesh-list
84034553|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84034554|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
84034555|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034556|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
84034557|NCT01079741|Laxatives|laxatives|mesh-ancestor
84034558|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84034559|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
84034560|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034561|NCT01079741|Emollients|emollients|mesh-ancestor
84034562|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
84034563|NCT02877641|Vitamin D|vitamin d|mesh-list
84034564|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
84034565|NCT02877641|Vitamins|vitamins|mesh-list
84034566|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
84034567|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034568|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84034569|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84034570|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
84034571|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84034572|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034573|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
84034574|NCT02867046|Dexamethasone|dexamethasone|mesh-list
84034575|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034576|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
84034577|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
84034578|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034579|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034580|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84034582|NCT02867046|Hormones|hormones|mesh-ancestor
84034583|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034584|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84034585|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034586|NCT02865174|Heparin|heparin|mesh-list
84034587|NCT02865174|Enoxaparin|enoxaparin|mesh-list
84034588|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84034589|NCT02865174|Tinzaparin|tinzaparin|mesh-list
84034590|NCT02865174|Dalteparin|dalteparin|mesh-list
84034591|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
84034592|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
84034593|NCT02865174|Thrombin|thrombin|mesh-list
84034594|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
84034595|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84034596|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84034597|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034598|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84034599|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
84034600|NCT02865174|Coagulants|coagulants|mesh-ancestor
84034601|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
84034602|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84034603|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84034604|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034605|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84034606|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84034607|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034608|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034609|NCT00879814|Vaccines|vaccines|mesh-list
84034610|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
84034611|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034612|NCT02633176|Docetaxel|docetaxel|mesh-list
84034613|NCT02633176|Capecitabine|capecitabine|mesh-list
84034614|NCT02633176|Cetuximab|cetuximab|mesh-list
84034615|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034616|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
84034617|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
84034618|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
84034619|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034620|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034621|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
84034622|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034623|NCT04156984|Golimumab|golimumab|mesh-list
84034624|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84034625|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034626|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034627|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
84034628|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034629|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
84034630|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
84034631|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034632|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84034633|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
84034634|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034635|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034636|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84034637|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84034638|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84034639|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
84034640|NCT01132664|Capecitabine|capecitabine|mesh-list
84034641|NCT01132664|Trastuzumab|trastuzumab|mesh-list
84034642|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034643|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
84034644|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034645|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034646|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034647|NCT01078805|Teriparatide|teriparatide|mesh-list
84034648|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84034649|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034650|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84034651|NCT00820027|Ibuprofen|ibuprofen|mesh-list
84034652|NCT00820027|Etoricoxib|etoricoxib|mesh-list
84034653|NCT00820027|Morphine|morphine|mesh-list
84034654|NCT00820027|Oxycodone|oxycodone|mesh-list
84034655|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84034656|NCT00820027|Narcotics|narcotics|mesh-ancestor
84034657|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034658|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034659|NCT00820027|Analgesics|analgesics|mesh-ancestor
84034660|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
84034661|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034662|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84034663|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84034664|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034665|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84034666|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84034667|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034668|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034669|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84034670|NCT02876549|Chloroquine|chloroquine|mesh-list
84034671|NCT02876549|Primaquine|primaquine|mesh-list
84034672|NCT02876549|Amebicides|amebicides|mesh-ancestor
84034673|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84034674|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84034675|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034676|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
84034677|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84034678|NCT00913549|Clemastine|clemastine|mesh-list
84034679|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
84034680|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
84034681|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84034682|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
84034683|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
84034684|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034685|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034686|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034687|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84034688|NCT01076153|Clarithromycin|clarithromycin|mesh-list
84034689|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84034690|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034691|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84034692|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034693|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034694|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84034695|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84034696|NCT01076075|Metformin|metformin|mesh-list
84034697|NCT01076075|Pioglitazone|pioglitazone|mesh-list
84034698|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84034699|NCT01076075|Glimepiride|glimepiride|mesh-list
84034700|NCT01076075|Gliclazide|gliclazide|mesh-list
84034701|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034702|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034703|NCT01076075|Incretins|incretins|mesh-ancestor
84034704|NCT01076075|Hormones|hormones|mesh-ancestor
84034705|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034706|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84034707|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
84034708|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034709|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034710|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84034711|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034712|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
84034713|NCT01075763|Interferons|interferons|mesh-list
84034714|NCT01075763|Interferon-beta|interferon-beta|mesh-list
84034715|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
84034716|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034717|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
84034718|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034719|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
84034720|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034721|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84034722|NCT00881530|Metformin|metformin|mesh-list
84034723|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84034724|NCT00881530|Empagliflozin|empagliflozin|mesh-list
84034725|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034726|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034727|NCT00881530|Incretins|incretins|mesh-ancestor
84034728|NCT00881530|Hormones|hormones|mesh-ancestor
84034729|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034730|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84034731|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
84034732|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034733|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034734|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84034735|NCT02632474|Tenofovir|tenofovir|mesh-list
84034736|NCT02632474|Lamivudine|lamivudine|mesh-list
84034737|NCT02632474|Efavirenz|efavirenz|mesh-list
84034738|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
84034739|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034740|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84034741|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84034742|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034743|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034744|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84034745|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84034746|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84034747|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84034748|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84034749|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84034750|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84034751|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84034752|NCT04156750|Metformin|metformin|mesh-list
84034753|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84034754|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034755|NCT02877173|Alprostadil|alprostadil|mesh-list
84034756|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84034757|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
84034758|NCT02877173|Urological Agents|urological agents|mesh-ancestor
84034759|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84034760|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84034761|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84034762|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034763|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034764|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84034765|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84034766|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034767|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
84034768|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034769|NCT00661180|Sorafenib|sorafenib|mesh-list
84034770|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034771|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84034772|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034773|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034774|NCT01078571|Adalimumab|adalimumab|mesh-list
84034775|NCT01078571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84034776|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034777|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84034778|NCT04160416|Capecitabine|capecitabine|mesh-list
84034779|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
84034780|NCT04160416|Irinotecan|irinotecan|mesh-list
84034781|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034782|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
84034783|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034784|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034785|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84034786|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84034787|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034788|NCT00661336|Melphalan|melphalan|mesh-list
84034789|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
84034790|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84034791|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
84034792|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034793|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034794|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84034795|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034796|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
84034797|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034798|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
84034799|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034800|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034801|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84034802|NCT00661336|Protective Agents|protective agents|mesh-ancestor
84034803|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
84034804|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034805|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274604|NCT01999179|Dabigatran|dabigatran|mesh-list
84034806|NCT04158700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84034807|NCT04158700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034809|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84034810|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84034811|NCT00657202|Growth Substances|growth substances|mesh-ancestor
84034812|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034813|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
84034814|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034815|NCT00626483|Basiliximab|basiliximab|mesh-list
84034816|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034817|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
84034818|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034819|NCT00626717|Riboflavin|riboflavin|mesh-list
84034820|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
84034821|NCT00626717|Vitamins|vitamins|mesh-ancestor
84034822|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
84034823|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034824|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84034825|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
84034826|NCT04156204|Tacrolimus|tacrolimus|mesh-list
84034827|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034828|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
84034829|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034830|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84034831|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034832|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034833|NCT02631694|Propranolol|propranolol|mesh-list
84034834|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84034835|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84034836|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
84034837|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034838|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034839|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034840|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84034841|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84034842|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
84034843|NCT04305587|Clopidogrel|clopidogrel|mesh-list
84034844|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84034845|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84034846|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84034847|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84034848|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
84034849|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034850|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034851|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034852|NCT00658840|Capecitabine|capecitabine|mesh-list
84034853|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034854|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
84034855|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034856|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034857|NCT00658918|Ciclesonide|ciclesonide|mesh-list
84034858|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
84034859|NCT00658918|Hormones|hormones|mesh-ancestor
84034860|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034861|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034862|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84034863|NCT02876081|Afatinib|afatinib|mesh-list
84034864|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034865|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84034866|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034867|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034868|NCT02631616|Somatostatin|somatostatin|mesh-list
84034869|NCT02631616|Hormones|hormones|mesh-ancestor
84034870|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034871|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034872|NCT00661648|Pancrelipase|pancrelipase|mesh-list
84034873|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84034874|NCT00659074|Ondansetron|ondansetron|mesh-list
84034875|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
84034876|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
84034877|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034878|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274685|NCT01729156|Metformin|metformin|mesh-list
84034879|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84034880|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
84034881|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
84034882|NCT00659074|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84034883|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84034884|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
84034885|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84034886|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034888|NCT01077713|Gemcitabine|gemcitabine|mesh-list
84034889|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034890|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034891|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84034892|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84034893|NCT01077713|Growth Substances|growth substances|mesh-ancestor
84034894|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034895|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
84034896|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84034897|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
84034898|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034899|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
84034900|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84034901|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
84034902|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034903|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034904|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
84034905|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034906|NCT01077323|Exenatide|exenatide|mesh-list
84034907|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84034908|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034909|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84034910|NCT01077323|Incretins|incretins|mesh-ancestor
84034911|NCT01077323|Hormones|hormones|mesh-ancestor
84034912|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034913|NCT03870438|Lamivudine|lamivudine|mesh-list
84034914|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84034915|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84034916|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034917|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034918|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
84034919|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034920|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84034921|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84034922|NCT05758831|Rituximab|rituximab|mesh-list
84034923|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
84034924|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034925|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034926|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
84034927|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034928|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84034929|NCT04287894|Pemetrexed|pemetrexed|mesh-list
84034930|NCT04287894|Durvalumab|durvalumab|mesh-list
84034931|NCT04287894|Tremelimumab|tremelimumab|mesh-list
84034932|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034933|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034934|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034935|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84034936|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84034937|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84034938|NCT04287426|Remifentanil|remifentanil|mesh-list
84034939|NCT04287426|Rocuronium|rocuronium|mesh-list
84034940|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84034941|NCT04287426|Narcotics|narcotics|mesh-ancestor
84034942|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84034943|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034944|NCT04287426|Analgesics|analgesics|mesh-ancestor
84034945|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
84034946|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034947|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84034948|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84034949|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84034950|NCT04047576|Sirolimus|sirolimus|mesh-list
84034951|NCT04047576|Prednisone|prednisone|mesh-list
84034952|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034953|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
84034954|NCT04047576|Hormones|hormones|mesh-ancestor
84034955|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84034956|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034957|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84034958|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84034959|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84034960|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034961|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84034962|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
84034963|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84034964|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
84034965|NCT00976950|Ritonavir|ritonavir|mesh-list
84034966|NCT00976950|Tipranavir|tipranavir|mesh-list
84034967|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84034968|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84034969|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
84034970|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034971|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034972|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84034973|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84034974|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
84034975|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034976|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84034977|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84034978|NCT00629382|Polymyxins|polymyxins|mesh-list
84034979|NCT00629382|Polymyxin B|polymyxin b|mesh-list
84034980|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84034981|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034982|NCT02866032|Ciclopirox|ciclopirox|mesh-list
84034983|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
84034984|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84034985|NCT00976716|Celecoxib|celecoxib|mesh-list
84034986|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84034987|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84034988|NCT00976716|Analgesics|analgesics|mesh-ancestor
84034989|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
84034990|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84034991|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84034992|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84034993|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84034994|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84034995|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84034996|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84034997|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84034998|NCT00973674|Estrogens|estrogens|mesh-list
84034999|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84035000|NCT00973674|Hormones|hormones|mesh-ancestor
84035001|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035002|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035003|NCT00819091|Linagliptin|linagliptin|mesh-list
84035004|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84035005|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035006|NCT00819091|Incretins|incretins|mesh-ancestor
84035007|NCT00819091|Hormones|hormones|mesh-ancestor
84035008|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035009|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84035010|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
84035011|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035012|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035013|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
84035014|NCT02864784|Calcium|calcium|mesh-list
84035015|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84035016|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035017|NCT02864784|Antacids|antacids|mesh-ancestor
84035018|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035019|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035020|NCT00819013|Vaccines|vaccines|mesh-list
84035021|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
84035022|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035023|NCT04868461|Caseins|caseins|mesh-list
84035024|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
84035025|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
84035026|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035027|NCT02865642|Escitalopram|escitalopram|mesh-list
84035028|NCT02865642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
84035030|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84035031|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035032|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035033|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035034|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
84035035|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035036|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84035037|NCT03762564|Paclitaxel|paclitaxel|mesh-list
84035038|NCT03762564|Ramucirumab|ramucirumab|mesh-list
84035039|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84035040|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035041|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035042|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035043|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035044|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035045|NCT00629616|Fulvestrant|fulvestrant|mesh-list
84035046|NCT00629616|Anastrozole|anastrozole|mesh-list
84035047|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84035048|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035049|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84035050|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84035051|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
84035052|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035053|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035054|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84035055|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84035056|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035057|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035058|NCT02864628|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84035059|NCT02864628|Antiviral Agents|antiviral agents|mesh-ancestor
84035060|NCT02864628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035061|NCT01120184|Paclitaxel|paclitaxel|mesh-list
84035062|NCT01120184|Maytansine|maytansine|mesh-list
84035063|NCT01120184|Docetaxel|docetaxel|mesh-list
84035064|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84035065|NCT01120184|Trastuzumab|trastuzumab|mesh-list
84035066|NCT01120184|Pertuzumab|pertuzumab|mesh-list
84035067|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84035068|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035069|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035070|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035071|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035072|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035073|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035074|NCT01120184|Immunotoxins|immunotoxins|mesh-ancestor
84035075|NCT01120184|Immunoconjugates|immunoconjugates|mesh-ancestor
84035076|NCT01120184|Immunologic Factors|immunologic factors|mesh-ancestor
84035077|NCT01120184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035078|NCT01120028|Sirolimus|sirolimus|mesh-list
84035079|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
84035080|NCT01120028|Tacrolimus|tacrolimus|mesh-list
84035081|NCT01120028|Basiliximab|basiliximab|mesh-list
84035082|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84035083|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
84035084|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035085|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84035086|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035087|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035088|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84035089|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035090|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84035091|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035092|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
84035093|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035094|NCT00878800|Doxorubicin|doxorubicin|mesh-list
84035095|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84035096|NCT00878800|Belinostat|belinostat|mesh-list
84035097|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84035098|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035099|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84035100|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84035101|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035102|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035103|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84035104|NCT00662272|Vaccines|vaccines|mesh-list
84035105|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
84035106|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035107|NCT04158856|Trastuzumab|trastuzumab|mesh-list
84035108|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035109|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035110|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
84035111|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84035112|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84035113|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84035114|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
84035115|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035116|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035117|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035118|NCT02882828|Tacrolimus|tacrolimus|mesh-list
84035119|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84035120|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
84035121|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035122|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84035123|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035124|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035125|NCT02882126|Treprostinil|treprostinil|mesh-list
84035126|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84035127|NCT01145222|Midazolam|midazolam|mesh-list
84035128|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84035129|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84035130|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035131|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035132|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84035133|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84035134|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84035135|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84035136|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
84035137|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
84035138|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
84035139|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
84035140|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035141|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035142|NCT01145066|Borage oil|borage oil|mesh-list
84035143|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035144|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
84035145|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
84035146|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84035147|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84035148|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035149|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035150|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035151|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035152|NCT00637442|Galantamine|galantamine|mesh-list
84035153|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84035154|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035155|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035156|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
84035157|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035158|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035159|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84035160|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
84035161|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035162|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
84035163|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84035164|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84035165|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84035166|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035167|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035168|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035169|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035170|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035171|NCT02864472|Ranibizumab|ranibizumab|mesh-list
84035172|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84035173|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84035174|NCT02864472|Growth Substances|growth substances|mesh-ancestor
84035175|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035176|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
83274977|NCT05813561|Fexuprazan|fexuprazan|mesh-list
84035177|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035179|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84035180|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035181|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
84035182|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
84035183|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035184|NCT02863614|Ibuprofen|ibuprofen|mesh-list
84035185|NCT02863614|Lorazepam|lorazepam|mesh-list
84035186|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84035187|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84035188|NCT02863614|Analgesics|analgesics|mesh-ancestor
84035189|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
84035190|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035191|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035192|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035193|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035194|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84035195|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035196|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035197|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
84035198|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
84035199|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
84035200|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035201|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84035202|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035203|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84035204|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84035205|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84035206|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
84035207|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
84035208|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035209|NCT00974922|Vitamin D|vitamin d|mesh-list
84035210|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
84035211|NCT00974922|Vitamins|vitamins|mesh-ancestor
84035212|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
84035213|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035214|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84035215|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84035216|NCT00972504|Cetirizine|cetirizine|mesh-list
84035217|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84035218|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84035219|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84035220|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
84035221|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
84035222|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035223|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035224|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035225|NCT00969150|Milnacipran|milnacipran|mesh-list
84035226|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
84035227|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84035228|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84035229|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035230|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035231|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035232|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035233|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
84035234|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84035235|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84035236|NCT00969150|Analgesics|analgesics|mesh-ancestor
84035237|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
84035238|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035239|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84035240|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035241|NCT00974220|Fentanyl|fentanyl|mesh-list
84035242|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84035243|NCT00974220|Narcotics|narcotics|mesh-ancestor
84035244|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035245|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035246|NCT00974220|Analgesics|analgesics|mesh-ancestor
84035247|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
84035248|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035249|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84035250|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84035251|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
84035252|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
84035253|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
84035254|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84035255|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035256|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035257|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84035258|NCT00971178|Analgesics|analgesics|mesh-ancestor
84035259|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
84035260|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035261|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84035262|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84035263|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84035264|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035265|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035266|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035267|NCT00970944|Amantadine|amantadine|mesh-list
84035268|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84035269|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84035270|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
84035271|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035272|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
84035273|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035274|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035275|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035276|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84035277|NCT00970944|Analgesics|analgesics|mesh-ancestor
84035278|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
84035279|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035280|NCT05780723|Mesalamine|mesalamine|mesh-list
84035281|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84035282|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84035283|NCT05780723|Analgesics|analgesics|mesh-ancestor
84035284|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
84035285|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035286|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035287|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035288|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035289|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
84035290|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
84035291|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
84035292|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035293|NCT05780489|Estradiol|estradiol|mesh-list
84035294|NCT05780489|Progesterone|progesterone|mesh-list
84035295|NCT05780489|Estrogens|estrogens|mesh-ancestor
84035296|NCT05780489|Hormones|hormones|mesh-ancestor
84035297|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035298|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035299|NCT05780489|Progestins|progestins|mesh-ancestor
84035300|NCT05780320|Amiodarone|amiodarone|mesh-list
84035301|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84035302|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
84035303|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84035304|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035305|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035306|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84035307|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84035308|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84035309|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035310|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84035311|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84035312|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84035313|NCT05780294|Asparaginase|asparaginase|mesh-list
84035314|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035315|NCT05780229|Analgesics|analgesics|mesh-list
84035316|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
84035317|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035318|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035319|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
84035320|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84035321|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035322|NCT05780086|Icodextrin|icodextrin|mesh-list
84035323|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
84035324|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83275131|NCT05787613|Paclitaxel|paclitaxel|mesh-list
84035326|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035327|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84035328|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035329|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035330|NCT05779514|Mirabegron|mirabegron|mesh-list
84035331|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84035332|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84035333|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84035334|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035335|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035336|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035337|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035338|NCT05779514|Urological Agents|urological agents|mesh-ancestor
84035339|NCT05779423|Nivolumab|nivolumab|mesh-list
84035340|NCT05779423|Ipilimumab|ipilimumab|mesh-list
84035341|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035342|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035343|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84035344|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035345|NCT05779410|Vitamin D|vitamin d|mesh-list
84035346|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
84035347|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
84035348|NCT05779410|Vitamins|vitamins|mesh-list
84035349|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
84035350|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035351|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84035352|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84035353|NCT05779254|Metronidazole|metronidazole|mesh-list
84035354|NCT05779254|Neomycin|neomycin|mesh-list
84035355|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035356|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84035357|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84035358|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84035359|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84035360|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035361|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035362|NCT05779059|Ticagrelor|ticagrelor|mesh-list
84035363|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84035364|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84035365|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84035366|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84035367|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84035368|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
84035369|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035370|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035371|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035372|NCT05778422|Anesthetics|anesthetics|mesh-list
84035373|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
84035374|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035375|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035376|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
84035377|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035378|NCT05774366|Desflurane|desflurane|mesh-list
84035379|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84035380|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
84035381|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
84035382|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035383|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035384|NCT05774067|Terlipressin|terlipressin|mesh-list
84035385|NCT05774067|Vasopressins|vasopressins|mesh-list
84035386|NCT05774067|Norepinephrine|norepinephrine|mesh-list
84035387|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84035388|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84035389|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035390|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035391|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035392|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035393|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
84035394|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
84035395|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035396|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84035397|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
84035398|NCT05774067|Coagulants|coagulants|mesh-ancestor
84035399|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84035401|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84035402|NCT05769842|Propofol|propofol|mesh-list
84035403|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84035404|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035405|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035406|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84035407|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
84035408|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
84035409|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
84035410|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84035411|NCT05755997|Protective Agents|protective agents|mesh-ancestor
84035412|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035413|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
84035414|NCT05739929|Colchicine|colchicine|mesh-list
84035415|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
84035416|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035417|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035418|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035419|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035420|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035421|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035422|NCT05734508|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84035423|NCT05734508|Antiviral Agents|antiviral agents|mesh-ancestor
84035424|NCT05734508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035425|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
84035426|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84035427|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84035428|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035429|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035430|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84035431|NCT05712265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84035432|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84035433|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035434|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035435|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035436|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
84035437|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84035438|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
84035439|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84035440|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84035441|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035442|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84035443|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84035444|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84035445|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035446|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84035447|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84035448|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84035449|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
84035450|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035451|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84035452|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84035453|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035454|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
84035455|NCT05635604|Growth Substances|growth substances|mesh-ancestor
84035456|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035457|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
84035458|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035459|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035460|NCT05620784|Furosemide|furosemide|mesh-list
84035461|NCT05620784|Diuretics|diuretics|mesh-list
84035462|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
84035463|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
84035464|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035465|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035466|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035467|NCT05617859|Lenvatinib|lenvatinib|mesh-list
84035468|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035469|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84035470|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035471|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035472|NCT05616494|Docetaxel|docetaxel|mesh-list
84035473|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035474|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035475|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035476|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035477|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035478|NCT05614609|Lidocaine|lidocaine|mesh-list
84035479|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
84035480|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
84035481|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035482|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035483|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
84035484|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035485|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84035486|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84035487|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84035488|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035489|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035490|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
84035491|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
84035492|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035493|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035494|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84035495|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84035496|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84035497|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
84035498|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035499|NCT05598957|Vitamin D|vitamin d|mesh-list
84035500|NCT05598957|Vitamins|vitamins|mesh-ancestor
84035501|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
84035502|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035503|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84035504|NCT05567068|Mesalamine|mesalamine|mesh-list
84035505|NCT05567068|Atorvastatin|atorvastatin|mesh-list
84035506|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84035507|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84035508|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
84035509|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035510|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84035511|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84035512|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035513|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84035514|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84035515|NCT05567068|Analgesics|analgesics|mesh-ancestor
84035516|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
84035517|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035518|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035519|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035520|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035521|NCT05565001|Cromakalim|cromakalim|mesh-list
84035522|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84035523|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84035524|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
84035525|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035526|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035527|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84035528|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
84035529|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
84035530|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
84035531|NCT05561062|Atorvastatin|atorvastatin|mesh-list
84035532|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84035533|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84035534|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
84035535|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035536|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84035537|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84035538|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035539|NCT05550402|Bromides|bromides|mesh-list
84035540|NCT05550402|Albuterol|albuterol|mesh-list
84035541|NCT05550402|Ipratropium|ipratropium|mesh-list
84035542|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
84035543|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84035544|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
84035545|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035546|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035547|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84035548|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
84035549|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
84035550|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84035551|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84035552|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84035553|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84035554|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035555|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035556|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035557|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84035558|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
84035560|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
84035561|NCT05444946|Prednisone|prednisone|mesh-list
84035562|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035563|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
84035564|NCT05444946|Hormones|hormones|mesh-ancestor
84035565|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035566|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035567|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84035568|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035569|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
84035570|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035571|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84035572|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84035573|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035574|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035575|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84035576|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
84035577|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84035578|NCT05409157|Bisacodyl|bisacodyl|mesh-list
84035579|NCT05409157|Cathartics|cathartics|mesh-ancestor
84035580|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035581|NCT05409157|Laxatives|laxatives|mesh-ancestor
84035582|NCT05407519|Tislelizumab|tislelizumab|mesh-list
84035583|NCT05407519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035584|NCT05407519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035585|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
84035586|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035587|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035588|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
84035589|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
84035590|NCT05355311|Vitamins|vitamins|mesh-ancestor
84035591|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
84035592|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035593|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
84035594|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
84035595|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84035596|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84035597|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035598|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
84035599|NCT05311033|Coagulants|coagulants|mesh-ancestor
84035600|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
84035601|NCT05281562|Vitamins|vitamins|mesh-ancestor
84035602|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
84035603|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035604|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
84035605|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035606|NCT05281562|Protective Agents|protective agents|mesh-ancestor
84035607|NCT05276596|Norepinephrine|norepinephrine|mesh-list
84035608|NCT05276596|Ephedrine|ephedrine|mesh-list
84035609|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84035610|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84035611|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035612|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035613|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035614|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035615|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
84035616|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
84035617|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035618|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84035619|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84035620|NCT05269706|Cannabidiol|cannabidiol|mesh-list
84035621|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
84035622|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
84035623|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84035624|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
84035625|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035626|NCT05241262|Expectorants|expectorants|mesh-ancestor
84035627|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
84035628|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84035629|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
84035630|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035631|NCT05241262|Protective Agents|protective agents|mesh-ancestor
84035632|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035633|NCT05241262|Antidotes|antidotes|mesh-ancestor
84035634|NCT05188677|Vaccines|vaccines|mesh-list
84035635|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
84035636|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035637|NCT05178849|Anesthetics|anesthetics|mesh-list
84035638|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
84035639|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035640|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035641|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
84035642|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035643|NCT05161936|Lumasiran|lumasiran|mesh-list
84035644|NCT05161936|Renal Agents|renal agents|mesh-ancestor
84035645|NCT05143424|Morphine|morphine|mesh-list
84035646|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84035647|NCT05143424|Narcotics|narcotics|mesh-ancestor
84035648|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035649|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035650|NCT05143424|Analgesics|analgesics|mesh-ancestor
84035651|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
84035652|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035653|NCT05137067|Cisplatin|cisplatin|mesh-list
84035654|NCT05137067|Docetaxel|docetaxel|mesh-list
84035655|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
84035656|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035657|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035658|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035659|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035660|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
84035661|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
84035662|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84035663|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035664|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035665|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
84035666|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84035667|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035668|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035669|NCT05108649|Nicotine|nicotine|mesh-list
84035670|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84035671|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
84035672|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035673|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035674|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84035675|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84035676|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
84035677|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035678|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035679|NCT05023070|Cannabidiol|cannabidiol|mesh-list
84035680|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
84035681|NCT05003713|Prednisone|prednisone|mesh-list
84035682|NCT05003713|Cortisone|cortisone|mesh-list
84035683|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035684|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
84035685|NCT05003713|Hormones|hormones|mesh-ancestor
84035686|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035687|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035688|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84035689|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035690|NCT04990128|Triamcinolone|triamcinolone|mesh-list
84035691|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035692|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
84035693|NCT04990128|Hormones|hormones|mesh-ancestor
84035694|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275500|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
84035695|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035696|NCT04907370|Cisplatin|cisplatin|mesh-list
84035697|NCT04907370|Gemcitabine|gemcitabine|mesh-list
84035699|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
84035700|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
84035701|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035702|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035703|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84035704|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
84035705|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035706|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
84035707|NCT04903054|Prednisone|prednisone|mesh-list
84035708|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
84035709|NCT04903054|Tacrolimus|tacrolimus|mesh-list
84035710|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
84035711|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84035712|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035713|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
84035714|NCT04903054|Hormones|hormones|mesh-ancestor
84035715|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035716|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035717|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84035718|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035719|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84035720|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
84035721|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84035722|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035723|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035724|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84035725|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84035726|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
84035727|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84035728|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035729|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
84035730|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
84035731|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035732|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035733|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84035734|NCT04903054|Protective Agents|protective agents|mesh-ancestor
84035735|NCT04901702|Irinotecan|irinotecan|mesh-list
84035736|NCT04901702|Temozolomide|temozolomide|mesh-list
84035737|NCT04901702|Talazoparib|talazoparib|mesh-list
84035738|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84035739|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84035740|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035741|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035742|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035743|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84035744|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
84035745|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84035746|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
84035747|NCT04897321|Fludarabine|fludarabine|mesh-list
84035748|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84035749|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
84035750|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035751|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035752|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84035753|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
84035754|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035755|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035756|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84035757|NCT04879225|Menthol|menthol|mesh-list
84035758|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
84035759|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
84035760|NCT04834557|Digoxin|digoxin|mesh-list
84035761|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84035762|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84035763|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84035764|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035765|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035766|NCT04834557|Protective Agents|protective agents|mesh-ancestor
84035767|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035768|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84035769|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035770|NCT04825093|Vitamin D|vitamin d|mesh-list
84035771|NCT04825093|Vitamins|vitamins|mesh-ancestor
84035772|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
84035773|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035774|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84035775|NCT04793152|Vancomycin|vancomycin|mesh-list
84035776|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84035777|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035778|NCT04770493|Lamotrigine|lamotrigine|mesh-list
84035779|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
84035780|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84035781|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035782|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035783|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84035784|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035785|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84035786|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84035787|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035788|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84035789|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84035790|NCT04741464|Tinzaparin|tinzaparin|mesh-list
84035791|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84035792|NCT04741464|Dalteparin|dalteparin|mesh-list
84035793|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
84035794|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84035795|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84035796|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035797|NCT04663555|Dexamethasone|dexamethasone|mesh-list
84035798|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035799|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
84035800|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
84035801|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035802|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035803|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035804|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
84035805|NCT04663555|Hormones|hormones|mesh-ancestor
84035806|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035807|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84035808|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035809|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
84035810|NCT04637763|Fludarabine|fludarabine|mesh-list
84035811|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84035812|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
84035813|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035814|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84035815|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84035816|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
84035817|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035818|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035819|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84035820|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84035821|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84035822|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84035823|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84035824|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035825|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035826|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035827|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035828|NCT04501861|Vasopressins|vasopressins|mesh-list
84035829|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
84035830|NCT04501861|Norepinephrine|norepinephrine|mesh-list
84035831|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84035832|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84035833|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
84035834|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84035835|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035836|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035837|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
84035838|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
84035839|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035840|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84035841|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
84035842|NCT04501861|Coagulants|coagulants|mesh-ancestor
84035843|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84035844|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
84035845|NCT04496024|Ofloxacin|ofloxacin|mesh-list
84035846|NCT04496024|Levofloxacin|levofloxacin|mesh-list
84035847|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84035848|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035849|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84035850|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84035851|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84035852|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035853|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035854|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035855|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84035856|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84035857|NCT04425473|Esketamine|esketamine|mesh-list
84035858|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
84035859|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84035860|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84035861|NCT04387071|Antibodies|antibodies|mesh-list
84035862|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
84035863|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84035864|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
84035865|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035866|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035867|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84035868|NCT04350502|Amoxicillin|amoxicillin|mesh-list
84035869|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
84035870|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
84035871|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84035872|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035873|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035874|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035875|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84035876|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
84035877|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84035878|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
84035879|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035880|NCT04300920|Expectorants|expectorants|mesh-ancestor
84035881|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
84035882|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84035883|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
84035884|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035885|NCT04300920|Protective Agents|protective agents|mesh-ancestor
84035886|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035887|NCT04300920|Antidotes|antidotes|mesh-ancestor
84035888|NCT04252768|Paclitaxel|paclitaxel|mesh-list
84035889|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84035890|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035891|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035892|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035893|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035894|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035895|NCT04222010|Anesthetics|anesthetics|mesh-list
84035896|NCT04222010|Ropivacaine|ropivacaine|mesh-list
84035897|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035898|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035899|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
84035900|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
84035901|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035902|NCT04200651|Dexamethasone|dexamethasone|mesh-list
84035903|NCT04200651|Prednisolone|prednisolone|mesh-list
84035904|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84035905|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
84035906|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84035907|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
84035908|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84035909|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
84035910|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84035911|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
84035912|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
84035913|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84035914|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035915|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035916|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
84035917|NCT04200651|Hormones|hormones|mesh-ancestor
84035918|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035919|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84035920|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035921|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84035922|NCT04200651|Protective Agents|protective agents|mesh-ancestor
84035923|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
83275729|NCT04405167|Hormones|hormones|mesh-ancestor
84035924|NCT04150900|Bavituximab|bavituximab|mesh-list
84035925|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035926|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035927|NCT04150900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84035928|NCT04150900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035929|NCT04084171|Insulin|insulin|mesh-list
84035930|NCT04084171|Pancrelipase|pancrelipase|mesh-list
84035931|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84035932|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035933|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035934|NCT04055428|Valsartan|valsartan|mesh-list
84035935|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84035936|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84035937|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84035938|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84035939|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035940|NCT04047706|Nivolumab|nivolumab|mesh-list
84035941|NCT04047706|Temozolomide|temozolomide|mesh-list
84035942|NCT04047706|Linrodostat|linrodostat|mesh-list
84035943|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035944|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035945|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84035946|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035947|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84035948|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
84035949|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84035950|NCT04034251|Paclitaxel|paclitaxel|mesh-list
84035951|NCT04034251|Capecitabine|capecitabine|mesh-list
84035952|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84035953|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035954|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035955|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035956|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035957|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035958|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84035959|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
84035960|NCT03967249|Octreotide|octreotide|mesh-list
84035961|NCT03967249|Lanreotide|lanreotide|mesh-list
84035962|NCT03967249|Somatostatin|somatostatin|mesh-list
84035963|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84035964|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84035965|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035966|NCT03967249|Hormones|hormones|mesh-ancestor
84035967|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84035968|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035969|NCT03935139|Glycerol|glycerol|mesh-list
84035970|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84035971|NCT03935139|Protective Agents|protective agents|mesh-ancestor
84035972|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035973|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84035974|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84035975|NCT03927079|Dimercaprol|dimercaprol|mesh-list
84035976|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84035977|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
84035978|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
84035979|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
84035980|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035981|NCT03926403|Anesthetics|anesthetics|mesh-list
84035982|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84035983|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84035984|NCT03884101|Paclitaxel|paclitaxel|mesh-list
84035985|NCT03884101|Carboplatin|carboplatin|mesh-list
84035986|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
84035987|NCT03884101|Lenvatinib|lenvatinib|mesh-list
84035988|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84035989|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84035990|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
84035991|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
84035992|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
84035993|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84035994|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84035995|NCT03884101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84035996|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84035997|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275803|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
84035999|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
84036000|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
84036001|NCT03871621|Meglitinide|meglitinide|mesh-list
84036002|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84036003|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036004|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84036005|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036006|NCT03867188|Bupivacaine|bupivacaine|mesh-list
84036007|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
84036008|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
84036009|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036010|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036011|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
84036012|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036013|NCT03796884|Linaclotide|linaclotide|mesh-list
84036014|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84036015|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
84036016|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036017|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84036018|NCT03753074|Tenofovir|tenofovir|mesh-list
84036019|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
84036020|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036021|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84036022|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84036023|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036024|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036025|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84036026|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84036027|NCT03745040|Bupivacaine|bupivacaine|mesh-list
84036028|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
84036029|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
84036030|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036031|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036032|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
84036033|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036034|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84036035|NCT03740737|Hormones|hormones|mesh-ancestor
84036036|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036037|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036038|NCT03686345|Midostaurin|midostaurin|mesh-list
84036039|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036040|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84036041|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036042|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036043|NCT03671967|Meropenem|meropenem|mesh-list
84036044|NCT03671967|Tazobactam|tazobactam|mesh-list
84036045|NCT03671967|Piperacillin|piperacillin|mesh-list
84036046|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84036047|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84036048|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036049|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84036050|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036051|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036052|NCT03657810|Acetaminophen|acetaminophen|mesh-list
84036053|NCT03657810|Promethazine|promethazine|mesh-list
84036054|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
84036055|NCT03657810|Hydrocodone|hydrocodone|mesh-list
84036056|NCT03657810|Oxycodone|oxycodone|mesh-list
84036057|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036058|NCT03657810|Analgesics|analgesics|mesh-ancestor
84036059|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
84036060|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036061|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036062|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
84036063|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84036064|NCT03657810|Narcotics|narcotics|mesh-ancestor
84036065|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036066|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
84036067|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
84036068|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
84036069|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
84036070|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84036071|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
84036072|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
84036073|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036074|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036075|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84036076|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036077|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036078|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036079|NCT03640026|Tacrolimus|tacrolimus|mesh-list
84036080|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036081|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
84036082|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036083|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84036084|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036085|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036086|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
84036087|NCT03638297|Antibodies|antibodies|mesh-list
84036088|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
84036089|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036090|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036091|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036092|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036093|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036094|NCT03638297|Analgesics|analgesics|mesh-ancestor
84036095|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
84036096|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036097|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036098|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036099|NCT03544736|Paclitaxel|paclitaxel|mesh-list
84036100|NCT03544736|Carboplatin|carboplatin|mesh-list
84036101|NCT03544736|Nivolumab|nivolumab|mesh-list
84036102|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84036103|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036104|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
84036105|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
84036106|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
84036107|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036108|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036109|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84036110|NCT03533010|Vitamin D|vitamin d|mesh-list
84036111|NCT03533010|Vitamins|vitamins|mesh-ancestor
84036112|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
84036113|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036114|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84036115|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
84036116|NCT03409198|Doxorubicin|doxorubicin|mesh-list
84036117|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84036118|NCT03409198|Nivolumab|nivolumab|mesh-list
84036119|NCT03409198|Ipilimumab|ipilimumab|mesh-list
84036120|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036121|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
84036122|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036123|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036124|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84036125|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
84036126|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036127|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036128|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84036129|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84036130|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84036131|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84036132|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036133|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036134|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84036135|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84036136|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84036137|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036138|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
84036139|NCT03326245|Methylphenidate|methylphenidate|mesh-list
84036140|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84036141|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036142|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84036143|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84036144|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036145|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275951|NCT03896269|Daunorubicin|daunorubicin|mesh-list
84036147|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036148|NCT03321656|Tacrolimus|tacrolimus|mesh-list
84036149|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036150|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
84036151|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036152|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84036153|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036154|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036155|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
84036156|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036157|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036158|NCT03277638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84036159|NCT03277638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036160|NCT03236987|Azithromycin|azithromycin|mesh-list
84036161|NCT03236987|Clarithromycin|clarithromycin|mesh-list
84036162|NCT03236987|Rifampin|rifampin|mesh-list
84036163|NCT03236987|Ethambutol|ethambutol|mesh-list
84036164|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84036165|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036166|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84036167|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036168|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036169|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84036170|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84036171|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84036172|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
84036173|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
84036174|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84036175|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84036176|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84036177|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84036178|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84036179|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84036180|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84036181|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
84036182|NCT03094637|Azacitidine|azacitidine|mesh-list
84036183|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036184|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036185|NCT03094637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84036186|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036187|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036188|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
84036189|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036190|NCT03055507|Acetaminophen|acetaminophen|mesh-list
84036191|NCT03055507|Ibuprofen|ibuprofen|mesh-list
84036192|NCT03055507|Oxycodone|oxycodone|mesh-list
84036193|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036194|NCT03055507|Analgesics|analgesics|mesh-ancestor
84036195|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
84036196|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036197|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036198|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
84036199|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036200|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036201|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036202|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84036203|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036204|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036205|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84036206|NCT03055507|Narcotics|narcotics|mesh-ancestor
84036207|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036208|NCT03038256|Capecitabine|capecitabine|mesh-list
84036209|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036210|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
84036211|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036212|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036213|NCT03009981|Prednisone|prednisone|mesh-list
84036214|NCT03009981|Leuprolide|leuprolide|mesh-list
84036215|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
84036216|NCT03009981|Bicalutamide|bicalutamide|mesh-list
84036217|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036218|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
84036219|NCT03009981|Hormones|hormones|mesh-ancestor
84036220|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036221|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036222|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84036223|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036224|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84036225|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
84036226|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84036227|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84036228|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036229|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036230|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
84036231|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84036232|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
84036233|NCT02870738|Triamcinolone|triamcinolone|mesh-list
84036234|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036235|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
84036236|NCT02870738|Hormones|hormones|mesh-ancestor
84036237|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036238|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036239|NCT02789982|Propranolol|propranolol|mesh-list
84036240|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
84036241|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
84036242|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84036243|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036244|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036245|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036246|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84036247|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84036248|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
84036249|NCT02667886|Axitinib|axitinib|mesh-list
84036250|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036251|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84036252|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036253|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036254|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
84036255|NCT02623972|Doxorubicin|doxorubicin|mesh-list
84036256|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84036257|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036258|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
84036259|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036260|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036261|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84036262|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
84036263|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036264|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036265|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84036266|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84036267|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84036268|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84036269|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036270|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
84036271|NCT02614066|Fludarabine|fludarabine|mesh-list
84036272|NCT02614066|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
84036273|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036274|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
84036275|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036276|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036277|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84036278|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
84036279|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036280|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036281|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84036282|NCT02614066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036283|NCT02587195|Teriflunomide|teriflunomide|mesh-list
84036284|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036285|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036286|NCT02587195|Analgesics|analgesics|mesh-ancestor
84036287|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
84036288|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036289|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036290|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036291|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036292|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036293|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
84036295|NCT02582008|Nicotine|nicotine|mesh-list
84036296|NCT02582008|Varenicline|varenicline|mesh-list
84036297|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84036298|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
84036299|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036300|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036301|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84036302|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84036303|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
84036304|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036305|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036306|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84036307|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
84036308|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84036309|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84036310|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84036311|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036312|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
84036313|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84036314|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84036315|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036316|NCT02502799|Methylphenidate|methylphenidate|mesh-list
84036317|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84036318|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036319|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84036320|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84036321|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036322|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036323|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
84036324|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036325|NCT02135133|Ofatumumab|ofatumumab|mesh-list
84036326|NCT02135133|Idelalisib|idelalisib|mesh-list
84036327|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036328|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036329|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036330|NCT01993836|Anesthetics|anesthetics|mesh-list
84036331|NCT01993836|Propofol|propofol|mesh-list
84036332|NCT01993836|Isoflurane|isoflurane|mesh-list
84036333|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036334|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036335|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84036336|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84036337|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
84036338|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84036339|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84036340|NCT01717586|Pravastatin|pravastatin|mesh-list
84036341|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84036342|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84036343|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
84036344|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036345|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84036346|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84036347|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036348|NCT01523977|Prednisone|prednisone|mesh-list
84036349|NCT01523977|Doxorubicin|doxorubicin|mesh-list
84036350|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
84036351|NCT01523977|Vincristine|vincristine|mesh-list
84036352|NCT01523977|Everolimus|everolimus|mesh-list
84036353|NCT01523977|Asparaginase|asparaginase|mesh-list
84036354|NCT01523977|Pegaspargase|pegaspargase|mesh-list
84036355|NCT01523977|Razoxane|razoxane|mesh-list
84036356|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84036357|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036358|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84036359|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84036360|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036361|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036362|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036363|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
84036364|NCT01523977|Hormones|hormones|mesh-ancestor
84036365|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036366|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036367|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84036368|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84036369|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
84036370|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
84036371|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
84036372|NCT01523977|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84036373|NCT01523977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84036374|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036375|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
84036376|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84036377|NCT01523977|Protective Agents|protective agents|mesh-ancestor
84036378|NCT01107717|Metformin|metformin|mesh-list
84036379|NCT01107717|Pioglitazone|pioglitazone|mesh-list
84036380|NCT01107717|Exenatide|exenatide|mesh-list
84036381|NCT01107717|Glyburide|glyburide|mesh-list
84036382|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84036383|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036384|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84036385|NCT01107717|Incretins|incretins|mesh-ancestor
84036386|NCT01107717|Hormones|hormones|mesh-ancestor
84036387|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036388|NCT00782574|Olaparib|olaparib|mesh-list
84036389|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036390|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84036391|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036392|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036393|NCT00753545|Olaparib|olaparib|mesh-list
84036394|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84036395|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036396|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036397|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036398|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
84036399|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84036400|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
84036401|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84036402|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036403|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84036404|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84036405|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84036406|NCT00408447|Fludarabine|fludarabine|mesh-list
84036407|NCT00408447|Busulfan|busulfan|mesh-list
84036408|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
84036409|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036410|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036411|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036412|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
84036413|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036414|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
84036415|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84036416|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84036417|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036418|NCT00278915|Fulvestrant|fulvestrant|mesh-list
84036419|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84036420|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036421|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84036422|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84036423|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
84036424|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036425|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036426|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84036427|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84036428|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036429|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
84036430|NCT00970632|Tadalafil|tadalafil|mesh-list
84036431|NCT00970632|Tamsulosin|tamsulosin|mesh-list
84036432|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
84036433|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84036434|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84036435|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036436|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036437|NCT00970632|Urological Agents|urological agents|mesh-ancestor
84036438|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84036439|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84036440|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84036441|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
84036442|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036443|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036444|NCT01144364|Rituximab|rituximab|mesh-list
84036445|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036446|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036447|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
84036448|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036449|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036450|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
84036451|NCT00965094|Everolimus|everolimus|mesh-list
84036452|NCT00965094|Tacrolimus|tacrolimus|mesh-list
84036453|NCT00965094|Basiliximab|basiliximab|mesh-list
84036454|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036455|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
84036456|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036457|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84036458|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036459|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036460|NCT00965094|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84036461|NCT00965094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84036462|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036463|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84036464|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84036465|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
84036466|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84036467|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036468|NCT01131182|Metformin|metformin|mesh-list
84036469|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84036470|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84036471|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036472|NCT01131182|Incretins|incretins|mesh-ancestor
84036473|NCT01131182|Hormones|hormones|mesh-ancestor
84036474|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036475|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84036476|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
84036477|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036478|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036479|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
84036480|NCT01131104|Tadalafil|tadalafil|mesh-list
84036481|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84036482|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
84036483|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
84036484|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84036485|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036486|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036487|NCT01131104|Urological Agents|urological agents|mesh-ancestor
84036488|NCT04264884|Daratumumab|daratumumab|mesh-list
84036489|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036490|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84036491|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84036492|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84036493|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036494|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036495|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036496|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036497|NCT01118780|Analgesics|analgesics|mesh-ancestor
84036498|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
84036499|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036500|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
84036501|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84036502|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
84036503|NCT00629928|Esomeprazole|esomeprazole|mesh-list
84036504|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84036505|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84036506|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84036507|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036508|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036509|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
84036510|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
84036511|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84036512|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84036513|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036514|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036515|NCT00964782|Urological Agents|urological agents|mesh-ancestor
84036516|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84036517|NCT02882984|Gefitinib|gefitinib|mesh-list
84036518|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036519|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84036520|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036521|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036522|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84036523|NCT00966654|Incretins|incretins|mesh-ancestor
84036524|NCT00966654|Hormones|hormones|mesh-ancestor
84036525|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036526|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036527|NCT00625196|Fluticasone|fluticasone|mesh-list
84036528|NCT00625196|Xhance|xhance|mesh-list
84036529|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036530|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84036531|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
84036532|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036533|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036534|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84036535|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
84036536|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
84036537|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84036538|NCT03262116|Insulin|insulin|mesh-list
84036539|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84036540|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
84036541|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
84036542|NCT03262116|Pancrelipase|pancrelipase|mesh-list
84036543|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84036544|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036545|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84036546|NCT01130168|Amlodipine|amlodipine|mesh-list
84036547|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84036548|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84036549|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036550|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036551|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84036552|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036553|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
84036554|NCT04284852|Niraparib|niraparib|mesh-list
84036555|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84036556|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036557|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036558|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036559|NCT04283292|Capsaicin|capsaicin|mesh-list
84036560|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
84036561|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
84036562|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
84036563|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036564|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036565|NCT01144052|Interferons|interferons|mesh-list
84036566|NCT01144052|Interferon-beta|interferon-beta|mesh-list
84036567|NCT01144052|Natalizumab|natalizumab|mesh-list
84036568|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
84036569|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036570|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
84036571|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036572|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
84036573|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036574|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84036575|NCT04283526|Decitabine|decitabine|mesh-list
84036576|NCT04283526|Spartalizumab|spartalizumab|mesh-list
84036577|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036578|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
84036579|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036580|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036581|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036582|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84036583|NCT04283526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036584|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
84036585|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036586|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
84036587|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84036588|NCT01117766|Pregabalin|pregabalin|mesh-list
84036589|NCT01117766|Analgesics|analgesics|mesh-ancestor
84036590|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
84036591|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036592|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036593|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
84036594|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84036595|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036596|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036597|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84036598|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84036599|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84036600|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036601|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84036603|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84036604|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84036605|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036606|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
84036607|NCT04312880|Coagulants|coagulants|mesh-ancestor
84036608|NCT01117454|Flecainide|flecainide|mesh-list
84036609|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84036610|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84036611|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
84036612|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036613|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036614|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036615|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84036616|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84036617|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84036618|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036619|NCT01129622|Letrozole|letrozole|mesh-list
84036620|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036621|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84036622|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84036623|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036624|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036625|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84036626|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
84036627|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84036628|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036629|NCT01128842|Capecitabine|capecitabine|mesh-list
84036630|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036631|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
84036632|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036633|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036634|NCT00625274|Esomeprazole|esomeprazole|mesh-list
84036635|NCT00625274|Pantoprazole|pantoprazole|mesh-list
84036636|NCT00625274|Lansoprazole|lansoprazole|mesh-list
84036637|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
84036638|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84036639|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84036640|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84036641|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036642|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036643|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
84036644|NCT03624036|Fludarabine|fludarabine|mesh-list
84036645|NCT03624036|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
84036646|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036647|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
84036648|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036649|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036650|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84036651|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
84036652|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036653|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036654|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84036655|NCT03624036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036656|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
84036657|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84036658|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84036659|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84036660|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036661|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036662|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
84036663|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036664|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036665|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84036666|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036667|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84036668|NCT04669041|Ezetimibe|ezetimibe|mesh-list
84036669|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84036670|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84036671|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
84036672|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036673|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84036674|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84036675|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036676|NCT05132595|Ketorolac|ketorolac|mesh-list
84036677|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84036678|NCT05132595|Esketamine|esketamine|mesh-list
84036679|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036680|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036681|NCT05132595|Analgesics|analgesics|mesh-ancestor
84036682|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
84036683|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036684|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036685|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036686|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036687|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84036688|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036689|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036690|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
84036691|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84036692|NCT01074047|Azacitidine|azacitidine|mesh-list
84036693|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036694|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
84036695|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036696|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036697|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036698|NCT05226117|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84036699|NCT05226117|Immunoconjugates|immunoconjugates|mesh-ancestor
84036700|NCT05226117|Immunologic Factors|immunologic factors|mesh-ancestor
84036701|NCT05226117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036702|NCT01142726|Methotrexate|methotrexate|mesh-list
84036703|NCT01142726|Abatacept|abatacept|mesh-list
84036704|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84036705|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
84036706|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84036707|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036708|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036709|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
84036710|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036711|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036712|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
84036713|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036714|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84036715|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036716|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
84036717|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036718|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84036719|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84036720|NCT01142726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036721|NCT04472637|Atorvastatin|atorvastatin|mesh-list
84036722|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84036723|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84036724|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
84036725|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036726|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84036727|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84036728|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036729|NCT01142336|Simvastatin|simvastatin|mesh-list
84036730|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84036731|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84036732|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
84036733|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036734|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84036735|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84036736|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036737|NCT00915681|Silybin|silybin|mesh-list
84036738|NCT00915681|Protective Agents|protective agents|mesh-ancestor
84036739|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036740|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84036741|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036743|NCT01128296|Gemcitabine|gemcitabine|mesh-list
84036744|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036745|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
84036746|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036747|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036748|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
84036749|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84036750|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84036751|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036752|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036753|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036754|NCT05082909|Probenecid|probenecid|mesh-list
84036755|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
84036756|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
84036757|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036758|NCT04253145|Atezolizumab|atezolizumab|mesh-list
84036759|NCT04253145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84036760|NCT04253145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036761|NCT04253145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84036762|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036763|NCT04240509|Tenofovir|tenofovir|mesh-list
84036764|NCT04240509|Emtricitabine|emtricitabine|mesh-list
84036765|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
84036766|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036767|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84036768|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84036769|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036770|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036771|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84036772|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84036773|NCT04450329|Aflibercept|aflibercept|mesh-list
84036774|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84036775|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84036776|NCT04450329|Growth Substances|growth substances|mesh-ancestor
84036777|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036778|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
84036779|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036780|NCT01115738|Clopidogrel|clopidogrel|mesh-list
84036781|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84036782|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84036783|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84036784|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84036785|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84036786|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
84036787|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036788|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036789|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036790|NCT00632073|Maleic acid|maleic acid|mesh-list
84036791|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036792|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036793|NCT01141478|Sorafenib|sorafenib|mesh-list
84036794|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036795|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84036796|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036797|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036798|NCT01114880|Adalimumab|adalimumab|mesh-list
84036799|NCT01114880|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84036800|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036801|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036802|NCT00625352|Gemcitabine|gemcitabine|mesh-list
84036803|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036804|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
84036805|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036806|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036807|NCT04539873|Colchicine|colchicine|mesh-list
84036808|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
84036809|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036810|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
84036811|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
84036812|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
84036813|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036814|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036815|NCT02861040|Vincristine|vincristine|mesh-list
84036816|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84036817|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036818|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
84036819|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
84036820|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
84036821|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036823|NCT04646187|Infliximab|infliximab|mesh-list
84036824|NCT04646187|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84036825|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036826|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036827|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
84036828|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84036829|NCT04282902|Pirfenidone|pirfenidone|mesh-list
84036830|NCT04282902|Analgesics|analgesics|mesh-ancestor
84036831|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
84036832|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036833|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036834|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036835|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036836|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036837|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036838|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036839|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
84036840|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
84036841|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
84036842|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84036843|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84036844|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036845|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036846|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036847|NCT04432623|Benserazide|benserazide|mesh-list
84036848|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84036849|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84036850|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036851|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036852|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
84036853|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036854|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036855|NCT00878722|Idarubicin|idarubicin|mesh-list
84036856|NCT00878722|Belinostat|belinostat|mesh-list
84036857|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84036858|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036859|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84036860|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84036861|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036862|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036863|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84036864|NCT03432897|Olaparib|olaparib|mesh-list
84036865|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84036866|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036867|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036868|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036869|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
84036870|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84036871|NCT00659386|Antibodies|antibodies|mesh-list
84036872|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
84036873|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84036874|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
84036875|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036876|NCT04160325|Azathioprine|azathioprine|mesh-list
84036877|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
84036878|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036879|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84036880|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036881|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84036882|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
84036883|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036884|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036885|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84036886|NCT04155814|Hematinics|hematinics|mesh-ancestor
84036887|NCT04547439|Melatonin|melatonin|mesh-list
84036888|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
84036889|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036890|NCT04547439|Protective Agents|protective agents|mesh-ancestor
84036891|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036892|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036893|NCT04158076|Amlodipine|amlodipine|mesh-list
84036894|NCT04158076|Telmisartan|telmisartan|mesh-list
84036895|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
84036896|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84036897|NCT04158076|Ezetimibe|ezetimibe|mesh-list
84036898|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84036899|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84036900|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84036901|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036902|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84036903|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036904|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
84036905|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84036906|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84036907|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
84036908|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84036909|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84036910|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036911|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84036912|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84036913|NCT00961350|Aspirin|aspirin|mesh-list
84036914|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036915|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036916|NCT00961350|Analgesics|analgesics|mesh-ancestor
84036917|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
84036918|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036919|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036920|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036921|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036922|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84036923|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84036924|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036925|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84036926|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84036927|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036928|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
84036929|NCT03537690|Paclitaxel|paclitaxel|mesh-list
84036930|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84036931|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84036932|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84036933|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
84036934|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
84036935|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
84036936|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036937|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
84036938|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84036939|NCT04032184|Fluorides|fluorides|mesh-list
84036940|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
84036941|NCT04032184|Protective Agents|protective agents|mesh-ancestor
84036942|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036943|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84036944|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036945|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
84036946|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
84036947|NCT04246437|Carbidopa|carbidopa|mesh-list
84036948|NCT04246437|Entacapone|entacapone|mesh-list
84036949|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84036950|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84036951|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
84036952|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84036953|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036954|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036955|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84036956|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036957|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84036958|NCT00662896|Ibuprofen|ibuprofen|mesh-list
84036959|NCT00662896|Naproxen|naproxen|mesh-list
84036960|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
84036961|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84036962|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84036964|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
84036965|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036966|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036967|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84036968|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84036969|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84036970|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84036971|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036972|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
84036973|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84036974|NCT00963924|Cycloserine|cycloserine|mesh-list
84036975|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84036976|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84036977|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84036978|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
84036979|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84036980|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
84036981|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84036982|NCT04155658|Fluorides|fluorides|mesh-list
84036983|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
84036984|NCT04155658|Protective Agents|protective agents|mesh-ancestor
84036985|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036986|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
84036987|NCT02861976|Narcotics|narcotics|mesh-ancestor
84036988|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84036989|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84036990|NCT02861976|Analgesics|analgesics|mesh-ancestor
84036991|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
84036992|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84036993|NCT00666484|Prednisolone|prednisolone|mesh-list
84036994|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
84036995|NCT00666484|Doxorubicin|doxorubicin|mesh-list
84036996|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84036997|NCT00666484|Etoposide|etoposide|mesh-list
84036998|NCT00666484|Vincristine|vincristine|mesh-list
84036999|NCT00666484|Procarbazine|procarbazine|mesh-list
84037000|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037001|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
84037002|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037003|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037004|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84037005|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
84037006|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037007|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037008|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84037009|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84037010|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84037011|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84037012|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037013|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84037014|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
84037015|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
84037016|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
84037017|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037018|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
84037019|NCT00666484|Hormones|hormones|mesh-ancestor
84037020|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037021|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84037022|NCT00663130|Tadalafil|tadalafil|mesh-list
84037023|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84037024|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
84037025|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84037026|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84037027|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037028|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037029|NCT00663130|Urological Agents|urological agents|mesh-ancestor
84037030|NCT00965562|Fluoxetine|fluoxetine|mesh-list
84037031|NCT00965562|Calcium|calcium|mesh-list
84037032|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84037033|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037034|NCT00965562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84037035|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84037036|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037037|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037038|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037039|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
84037040|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84037041|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
84037042|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84037043|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84037044|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84037045|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037046|NCT00659698|Pancrelipase|pancrelipase|mesh-list
84037047|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84037048|NCT00666796|Ethanol|ethanol|mesh-list
84037049|NCT00666796|Gabapentin|gabapentin|mesh-list
84037050|NCT00666796|Analgesics|analgesics|mesh-ancestor
84037051|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
84037052|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037053|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037054|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
84037055|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84037056|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84037057|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037058|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84037059|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84037060|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84037061|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037062|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037063|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
84037064|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84037065|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037066|NCT00912093|Icatibant|icatibant|mesh-list
84037067|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84037068|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037069|NCT00912093|Analgesics|analgesics|mesh-ancestor
84037070|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
84037071|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037072|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037073|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037074|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037075|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
84037076|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
84037077|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037078|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84037079|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037080|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
84037081|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84037082|NCT00659776|Hematinics|hematinics|mesh-ancestor
84037083|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84037084|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84037085|NCT03500484|Liraglutide|liraglutide|mesh-list
84037086|NCT03500484|Glucagon|glucagon|mesh-list
84037087|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84037088|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037089|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037090|NCT03500484|Incretins|incretins|mesh-ancestor
84037091|NCT03500484|Hormones|hormones|mesh-ancestor
84037092|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037093|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84037094|NCT03929601|Rituximab|rituximab|mesh-list
84037095|NCT03929601|Abatacept|abatacept|mesh-list
84037096|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037097|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037098|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
84037099|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037100|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037101|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84037102|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037103|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037104|NCT02631460|Carboplatin|carboplatin|mesh-list
84037105|NCT02631460|Pemetrexed|pemetrexed|mesh-list
84037106|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037107|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037108|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037109|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84037110|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84037111|NCT04282824|Edetic Acid|edetic acid|mesh-list
84037112|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84037113|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
84037114|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
84037115|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037116|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
84037117|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84037118|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84037119|NCT00663286|Clindamycin|clindamycin|mesh-list
84037120|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
84037121|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
84037122|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84037123|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037124|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037125|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84037126|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037127|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037128|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
84037129|NCT03237702|Carotenoids|carotenoids|mesh-list
84037130|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
84037131|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037132|NCT03237702|Protective Agents|protective agents|mesh-ancestor
84037133|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037134|NCT00667108|Gabapentin|gabapentin|mesh-list
84037135|NCT00667108|Analgesics|analgesics|mesh-ancestor
84037136|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
84037137|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037138|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037139|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
84037140|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84037141|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84037142|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037143|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84037144|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84037145|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84037146|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037147|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037148|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
84037149|NCT00961116|Fenofibrate|fenofibrate|mesh-list
84037150|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
84037151|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84037152|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
84037153|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037154|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84037155|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84037156|NCT04158388|Tryptophan|tryptophan|mesh-list
84037157|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84037158|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
84037159|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84037160|NCT04283136|Padsevonil|padsevonil|mesh-list
84037161|NCT04283136|Anticonvulsants|anticonvulsants|mesh-ancestor
84037162|NCT04283058|Ketamine|ketamine|mesh-list
84037163|NCT04283058|Anesthetics|anesthetics|mesh-list
84037164|NCT04283058|Analgesics|analgesics|mesh-ancestor
84037165|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
84037166|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037167|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037168|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84037169|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84037170|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
84037171|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037172|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84037173|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84037174|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037175|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037176|NCT00631995|Vaccines|vaccines|mesh-list
84037177|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
84037178|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037179|NCT00663442|Methylphenidate|methylphenidate|mesh-list
84037180|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84037181|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037182|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84037183|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84037184|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037185|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037187|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037188|NCT00912015|Tramadol|tramadol|mesh-list
84037189|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84037190|NCT00912015|Narcotics|narcotics|mesh-ancestor
84037191|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037192|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037193|NCT00912015|Analgesics|analgesics|mesh-ancestor
84037194|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
84037195|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037196|NCT00960804|Tanezumab|tanezumab|mesh-list
84037197|NCT00960804|Analgesics|analgesics|mesh-ancestor
84037198|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
84037199|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037200|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037201|NCT01126580|Metformin|metformin|mesh-list
84037202|NCT01126580|Dulaglutide|dulaglutide|mesh-list
84037203|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037204|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037205|NCT00911157|Heparin|heparin|mesh-list
84037206|NCT00911157|Calcium heparin|calcium heparin|mesh-list
84037207|NCT00911157|PENTA|penta|mesh-list
84037208|NCT00911157|Fondaparinux|fondaparinux|mesh-list
84037209|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
84037210|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84037211|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84037212|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037213|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84037214|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
84037215|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84037216|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
84037217|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037218|NCT00960570|Efavirenz|efavirenz|mesh-list
84037219|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
84037220|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84037221|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84037222|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037223|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037224|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
84037225|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037226|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84037227|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84037228|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84037229|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84037230|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84037231|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84037232|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84037233|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84037234|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
84037235|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84037236|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
84037237|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84037238|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
84037239|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037240|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
84037241|NCT04204278|Protective Agents|protective agents|mesh-ancestor
84037242|NCT00625430|Fludarabine|fludarabine|mesh-list
84037243|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
84037244|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037245|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037246|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
84037247|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037248|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037249|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
84037250|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037251|NCT04282746|Ketamine|ketamine|mesh-list
84037252|NCT04282746|Analgesics|analgesics|mesh-ancestor
84037253|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
84037254|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037255|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037256|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84037257|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84037258|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
84037259|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
84037260|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037261|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84037262|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84037263|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037264|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037266|NCT03773445|Antibodies|antibodies|mesh-list
84037267|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84037268|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
84037269|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037270|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84037271|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037272|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037273|NCT00630084|Interferons|interferons|mesh-list
84037274|NCT00630084|Ribavirin|ribavirin|mesh-list
84037275|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
84037276|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
84037277|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84037278|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037279|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
84037280|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037281|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
84037282|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037283|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
84037284|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037285|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
84037286|NCT01126424|Oxybutynin|oxybutynin|mesh-list
84037287|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84037288|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84037289|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
84037290|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037291|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037292|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037293|NCT01126424|Urological Agents|urological agents|mesh-ancestor
84037294|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
84037295|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
84037296|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037297|NCT04204902|Tepotinib|tepotinib|mesh-list
84037298|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037299|NCT01126268|Retapamulin|retapamulin|mesh-list
84037300|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037301|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037302|NCT04284150|Midazolam|midazolam|mesh-list
84037303|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
84037304|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84037305|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037306|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037307|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037308|NCT04284150|Analgesics|analgesics|mesh-ancestor
84037309|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
84037310|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037311|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84037312|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84037313|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84037314|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
84037315|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037316|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037317|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84037318|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84037319|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84037320|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84037321|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84037322|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
84037323|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
84037324|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
84037325|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
84037326|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
84037327|NCT03311334|Nivolumab|nivolumab|mesh-list
84037328|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037329|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037330|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84037331|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037332|NCT04313036|Defibrotide|defibrotide|mesh-list
84037333|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84037334|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84037335|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037336|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84037337|NCT00879658|Siponimod|siponimod|mesh-list
84037338|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84037339|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037340|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037341|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
84037342|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037343|NCT00959946|Capecitabine|capecitabine|mesh-list
84037344|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037345|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
84037346|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037347|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037348|NCT00667264|Ropivacaine|ropivacaine|mesh-list
84037349|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
84037350|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
84037351|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037352|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037353|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
84037354|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037355|NCT00660244|Anastrozole|anastrozole|mesh-list
84037356|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84037357|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037358|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84037359|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84037360|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037361|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037362|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84037363|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
84037364|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037365|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037366|NCT04282200|Ketorolac|ketorolac|mesh-list
84037367|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84037368|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037369|NCT04282200|Analgesics|analgesics|mesh-ancestor
84037370|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
84037371|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037372|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037373|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037374|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037375|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84037376|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037377|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037378|NCT00667498|Metformin|metformin|mesh-list
84037379|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037380|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037381|NCT02860650|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84037382|NCT02860650|Antiviral Agents|antiviral agents|mesh-ancestor
84037383|NCT02860650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037384|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84037385|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
84037386|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84037387|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84037388|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037389|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037390|NCT00667966|Urological Agents|urological agents|mesh-ancestor
84037391|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
84037392|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84037393|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037394|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037395|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
84037396|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037397|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037398|NCT00911937|Fesoterodine|fesoterodine|mesh-list
84037399|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84037400|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84037401|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
84037402|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037403|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037404|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037405|NCT00911937|Urological Agents|urological agents|mesh-ancestor
84037406|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84037407|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
84037408|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84037409|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84037410|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037411|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037412|NCT00663598|Urological Agents|urological agents|mesh-ancestor
84037413|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
84037414|NCT04166877|Analgesics|analgesics|mesh-ancestor
84037415|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
84037416|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037417|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037418|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
84037419|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037420|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84037421|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
84037422|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84037423|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037424|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037425|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84037426|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
84037427|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84037428|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84037429|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84037430|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84037431|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
84037432|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037433|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84037434|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84037435|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037436|NCT01076543|Sirolimus|sirolimus|mesh-list
84037437|NCT01076543|Lenalidomide|lenalidomide|mesh-list
84037438|NCT01076543|Temsirolimus|temsirolimus|mesh-list
84037439|NCT01076543|MTOR Inhibitors|mtor inhibitors|mesh-list
84037440|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
84037441|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037442|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84037443|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84037444|NCT01076543|Growth Substances|growth substances|mesh-ancestor
84037445|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
84037446|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037447|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037448|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037449|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84037450|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
84037451|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037452|NCT01076543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84037453|NCT01076543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037454|NCT01076543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037455|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
84037456|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037457|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037458|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84037459|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84037460|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037461|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037462|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037463|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84037464|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84037465|NCT02860494|Everolimus|everolimus|mesh-list
84037466|NCT02860494|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84037467|NCT02860494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84037468|NCT02860494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037469|NCT02860494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037470|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037471|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
84037472|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037473|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037474|NCT00663832|Panobinostat|panobinostat|mesh-list
84037475|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037476|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84037477|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037478|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037479|NCT04281576|Capecitabine|capecitabine|mesh-list
84037480|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
84037481|NCT04281576|Trastuzumab|trastuzumab|mesh-list
84037482|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037484|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037485|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037486|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037487|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
84037488|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037489|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037490|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84037491|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84037492|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037493|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037494|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037495|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84037496|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84037497|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84037498|NCT04304807|Melatonin|melatonin|mesh-list
84037499|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037500|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
84037501|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037502|NCT04304807|Protective Agents|protective agents|mesh-ancestor
84037503|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037504|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037505|NCT04280874|Dinoprostone|dinoprostone|mesh-list
84037506|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
84037507|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84037508|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037509|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84037510|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84037511|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
84037512|NCT04157998|Metoclopramide|metoclopramide|mesh-list
84037513|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
84037514|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
84037515|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037516|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037517|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84037518|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84037519|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84037520|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
84037521|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037522|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037523|NCT01072877|Polidocanol|polidocanol|mesh-list
84037524|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
84037525|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84037526|NCT00630474|Xylometazoline|xylometazoline|mesh-list
84037527|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
84037528|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84037529|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
84037530|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
84037531|NCT00957528|Testosterone|testosterone|mesh-list
84037532|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
84037533|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
84037534|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84037535|NCT00957528|Androgens|androgens|mesh-ancestor
84037536|NCT00957528|Hormones|hormones|mesh-ancestor
84037537|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037538|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037539|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84037540|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037541|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
84037542|NCT02857062|Emollients|emollients|mesh-list
84037543|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
84037544|NCT00958776|Peramivir|peramivir|mesh-list
84037545|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
84037546|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037547|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037548|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037549|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
84037550|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037551|NCT02858856|Mitogens|mitogens|mesh-ancestor
84037552|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
84037553|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037554|NCT02858622|Fentanyl|fentanyl|mesh-list
84037555|NCT02858622|Meperidine|meperidine|mesh-list
84037556|NCT02858622|Bupivacaine|bupivacaine|mesh-list
84037557|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
84037558|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
84037559|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037560|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037561|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
84037562|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037563|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84037564|NCT02858622|Narcotics|narcotics|mesh-ancestor
84037565|NCT02858622|Analgesics|analgesics|mesh-ancestor
84037566|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84037567|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84037568|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
84037569|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
84037571|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037572|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037573|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
84037574|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037575|NCT00596830|Paclitaxel|paclitaxel|mesh-list
84037576|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84037577|NCT00596830|Carboplatin|carboplatin|mesh-list
84037578|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84037579|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037580|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
84037581|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
84037582|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
84037583|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037584|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
84037585|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
84037586|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84037587|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84037588|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037589|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037590|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84037591|NCT05143164|Gentamicins|gentamicins|mesh-list
84037592|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037593|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037594|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84037595|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037596|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037597|NCT00664144|Rasburicase|rasburicase|mesh-list
84037598|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
84037599|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037600|NCT02819856|Ebselen|ebselen|mesh-list
84037601|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84037602|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037603|NCT02819856|Analgesics|analgesics|mesh-ancestor
84037604|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
84037605|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037606|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037607|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037608|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037609|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84037610|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84037611|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
84037612|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037613|NCT02819856|Protective Agents|protective agents|mesh-ancestor
84037614|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84037615|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037616|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84037617|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
84037618|NCT02630290|Ropivacaine|ropivacaine|mesh-list
84037619|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84037620|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037621|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037622|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037623|NCT02630290|Analgesics|analgesics|mesh-ancestor
84037624|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
84037625|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037626|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84037627|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84037628|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84037629|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
84037630|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037631|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037632|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
84037633|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
84037634|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
84037635|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037636|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
84037637|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
84037638|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
84037640|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
84037641|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037642|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84037643|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84037644|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037645|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
84037646|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037647|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84037648|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84037649|NCT00664222|Furosemide|furosemide|mesh-list
84037650|NCT00664222|Spironolactone|spironolactone|mesh-list
84037651|NCT00664222|Diuretics|diuretics|mesh-ancestor
84037652|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
84037653|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037654|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84037655|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037656|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037657|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84037658|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
84037659|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037660|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84037661|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
84037662|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037663|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
84037664|NCT00952614|Hormones|hormones|mesh-ancestor
84037665|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037666|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037667|NCT00911859|Prednisone|prednisone|mesh-list
84037668|NCT00911859|Bortezomib|bortezomib|mesh-list
84037669|NCT00911859|Melphalan|melphalan|mesh-list
84037670|NCT00911859|Siltuximab|siltuximab|mesh-list
84037671|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84037672|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037673|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
84037674|NCT00911859|Hormones|hormones|mesh-ancestor
84037675|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037676|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037677|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84037678|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037679|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84037680|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
84037681|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037682|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84037683|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037684|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
84037685|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84037686|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
84037687|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037688|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
84037689|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84037690|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037691|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037692|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037693|NCT00911625|Insulin|insulin|mesh-list
84037694|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84037695|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
84037696|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
84037697|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037698|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037699|NCT00596752|Alprostadil|alprostadil|mesh-list
84037700|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84037701|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
84037702|NCT00596752|Urological Agents|urological agents|mesh-ancestor
84037703|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84037704|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037705|NCT00958074|Vorinostat|vorinostat|mesh-list
84037706|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037707|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84037709|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037710|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
84037711|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84037712|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037713|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037714|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84037715|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84037716|NCT00660868|Protective Agents|protective agents|mesh-ancestor
84037717|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037718|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
84037719|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84037720|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
84037721|NCT00664690|Celecoxib|celecoxib|mesh-list
84037722|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84037723|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037724|NCT00664690|Analgesics|analgesics|mesh-ancestor
84037725|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
84037726|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037727|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037728|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037729|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037730|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84037731|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84037732|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037733|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037734|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
84037735|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84037736|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
84037737|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84037738|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
84037739|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037740|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037741|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
84037742|NCT04338165|Evolocumab|evolocumab|mesh-list
84037743|NCT04338165|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84037744|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84037745|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84037746|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
84037747|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037748|NCT04338165|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84037749|NCT04338165|Protease Inhibitors|protease inhibitors|mesh-ancestor
84037750|NCT04338165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037751|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84037752|NCT00664846|Aspirin|aspirin|mesh-list
84037753|NCT00664846|Clopidogrel|clopidogrel|mesh-list
84037754|NCT00664846|Atorvastatin|atorvastatin|mesh-list
84037755|NCT00664846|Simvastatin|simvastatin|mesh-list
84037756|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84037757|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037758|NCT00664846|Analgesics|analgesics|mesh-ancestor
84037759|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
84037760|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037761|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037762|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037763|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037764|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84037765|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84037766|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037767|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84037768|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84037769|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037770|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
84037771|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84037772|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84037773|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
84037774|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84037775|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84037776|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84037777|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84037778|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84037779|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
84037780|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037781|NCT00913783|Clomipramine|clomipramine|mesh-list
84037782|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84037783|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
84037784|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84037785|NCT00913783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84037786|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84037787|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037788|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037789|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037790|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
84037791|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037792|NCT00661102|Capecitabine|capecitabine|mesh-list
84037793|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037794|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
84037795|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037796|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037797|NCT00669370|Docetaxel|docetaxel|mesh-list
84037798|NCT00669370|Capecitabine|capecitabine|mesh-list
84037799|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037800|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
84037801|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
84037802|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
84037803|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037804|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037805|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
84037806|NCT00665314|Plerixafor|plerixafor|mesh-list
84037807|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84037808|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84037809|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
84037810|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037811|NCT04154722|Azithromycin|azithromycin|mesh-list
84037812|NCT04154722|Meropenem|meropenem|mesh-list
84037813|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037814|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037815|NCT02631928|Insulin|insulin|mesh-list
84037816|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84037817|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
84037818|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037819|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037820|NCT00632385|Eletriptan|eletriptan|mesh-list
84037821|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84037822|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
84037823|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037824|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037825|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037826|NCT00910689|Propranolol|propranolol|mesh-list
84037827|NCT00910689|Nadolol|nadolol|mesh-list
84037828|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84037829|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84037830|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
84037831|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037832|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037833|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037834|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84037835|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84037836|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
84037837|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
84037838|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
84037839|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037840|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
84037841|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037842|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037843|NCT04164979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84037844|NCT04164979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037845|NCT04669717|Amoxicillin|amoxicillin|mesh-list
84037846|NCT04669717|Azithromycin|azithromycin|mesh-list
84037847|NCT04669717|Metronidazole|metronidazole|mesh-list
84037848|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84037849|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037850|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84037851|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84037852|NCT00809341|Prednisone|prednisone|mesh-list
84037853|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
84037854|NCT00809341|Ifosfamide|ifosfamide|mesh-list
83277669|NCT02318693|Hormones|hormones|mesh-ancestor
84037855|NCT00809341|Rituximab|rituximab|mesh-list
84037856|NCT00809341|Carboplatin|carboplatin|mesh-list
84037857|NCT00809341|Doxorubicin|doxorubicin|mesh-list
84037858|NCT00809341|Etoposide|etoposide|mesh-list
84037859|NCT00809341|Vincristine|vincristine|mesh-list
84037860|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037861|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
84037862|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037863|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037864|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84037865|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
84037866|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037867|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037868|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84037869|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037870|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84037871|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84037872|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84037873|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037874|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037875|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
84037877|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037878|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84037879|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84037880|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
84037881|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
84037882|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
84037883|NCT02609581|Immunomodulating Agents|immunomodulating agents|mesh-list
84037884|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
84037885|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037886|NCT00811135|Bevacizumab|bevacizumab|mesh-list
84037887|NCT00811135|Trastuzumab|trastuzumab|mesh-list
84037888|NCT00811135|Capecitabine|capecitabine|mesh-list
84037889|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037890|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037891|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84037892|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84037893|NCT00811135|Growth Substances|growth substances|mesh-ancestor
84037894|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037895|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
84037896|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037897|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
84037898|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037899|NCT00811057|Indomethacin|indomethacin|mesh-list
84037900|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
84037901|NCT00811057|Nifedipine|nifedipine|mesh-list
84037902|NCT00811057|Analgesics|analgesics|mesh-ancestor
84037903|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
84037904|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84037905|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037906|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
84037907|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84037908|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84037909|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
84037910|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84037911|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84037912|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037913|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84037914|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
84037915|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84037916|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
84037917|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84037918|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84037919|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84037920|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037921|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
84037922|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84037923|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037924|NCT00879970|Vitamin D|vitamin d|mesh-list
84037925|NCT00879970|Pioglitazone|pioglitazone|mesh-list
84037926|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
84037927|NCT00879970|Vitamins|vitamins|mesh-ancestor
84037928|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
84037929|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037930|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84037931|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037932|NCT00808639|Doxorubicin|doxorubicin|mesh-list
84037933|NCT00808639|Methotrexate|methotrexate|mesh-list
84037935|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037936|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84037937|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84037938|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84037939|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84037940|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037941|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84037942|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
84037943|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84037944|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037945|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037946|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
84037947|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
84037948|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84037949|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84037950|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
84037951|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84037952|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84037953|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84037954|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
84037955|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
84037956|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
84037957|NCT00910299|Clopidogrel|clopidogrel|mesh-list
84037958|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84037959|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84037960|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84037961|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84037962|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84037963|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
84037964|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84037965|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037966|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037967|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
84037968|NCT03007329|Exenatide|exenatide|mesh-list
84037969|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84037970|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037971|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84037972|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037973|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84037974|NCT03007329|Incretins|incretins|mesh-ancestor
84037975|NCT03007329|Hormones|hormones|mesh-ancestor
84037976|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84037977|NCT04072341|Propolis|propolis|mesh-list
84037978|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037979|NCT04030039|Interferons|interferons|mesh-list
84037980|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037981|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
84037982|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84037983|NCT02628574|Gemcitabine|gemcitabine|mesh-list
84037984|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
84037985|NCT02628574|Nivolumab|nivolumab|mesh-list
84037986|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84037987|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
84037988|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84037989|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037990|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037991|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84037992|NCT00596362|Bevacizumab|bevacizumab|mesh-list
84037993|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84037994|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84037995|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84037996|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84037997|NCT00596362|Growth Substances|growth substances|mesh-ancestor
84037998|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84037999|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
84038000|NCT00907803|Tecovirimat|tecovirimat|mesh-list
84038001|NCT00907803|Antiviral Agents|antiviral agents|mesh-ancestor
84038002|NCT00907803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038003|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
84038004|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84038005|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038006|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83277817|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84038007|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84038008|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038009|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038010|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038011|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84038012|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84038013|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84038014|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038015|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
84038016|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
84038017|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038018|NCT00676156|Protective Agents|protective agents|mesh-ancestor
84038019|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038020|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
84038021|NCT00676156|Vitamins|vitamins|mesh-ancestor
84038022|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
84038023|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
84038024|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038025|NCT00914017|Atorvastatin|atorvastatin|mesh-list
84038026|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84038027|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84038028|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
84038029|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038030|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84038031|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84038032|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038033|NCT00671320|Diclofenac|diclofenac|mesh-list
84038034|NCT00671320|Valdecoxib|valdecoxib|mesh-list
84038035|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84038036|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84038037|NCT00671320|Analgesics|analgesics|mesh-ancestor
84038038|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
84038039|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038040|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038041|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038042|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038043|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84038044|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038045|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038046|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84038047|NCT00676468|Montelukast|montelukast|mesh-list
84038048|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84038049|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
84038050|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84038051|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
84038052|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038053|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038054|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84038055|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84038056|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038057|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84038058|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84038059|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84038060|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038061|NCT00676702|Vitamin K|vitamin k|mesh-list
84038062|NCT00676702|Pancrelipase|pancrelipase|mesh-list
84038063|NCT00676702|Pancreatin|pancreatin|mesh-list
84038064|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038065|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84038066|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84038067|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038068|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
84038069|NCT00676702|Coagulants|coagulants|mesh-ancestor
84038070|NCT00676702|Vitamins|vitamins|mesh-ancestor
84038071|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
84038072|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038073|NCT05753371|Metformin|metformin|mesh-list
84038074|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84038075|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038076|NCT00671476|Doxorubicin|doxorubicin|mesh-list
84038077|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84038078|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84038079|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038080|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84038081|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84038082|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038083|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038084|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
84038085|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84038086|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84038087|NCT00908583|Prednisolone|prednisolone|mesh-list
84038088|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
84038089|NCT00908583|Rituximab|rituximab|mesh-list
84038090|NCT00908583|Bortezomib|bortezomib|mesh-list
84038091|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84038092|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
84038093|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84038094|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038095|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
84038096|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038097|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038098|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038099|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
84038100|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
84038101|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038102|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038103|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
84038104|NCT00908583|Hormones|hormones|mesh-ancestor
84038105|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038106|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84038107|NCT00908583|Protective Agents|protective agents|mesh-ancestor
84038108|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84038109|NCT05519241|Paclitaxel|paclitaxel|mesh-list
84038110|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84038111|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038112|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038113|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038114|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038115|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038116|NCT00671632|Triazolam|triazolam|mesh-list
84038117|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84038118|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84038119|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84038120|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84038121|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038122|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84038123|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
84038124|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
84038125|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038126|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038127|NCT04153708|Antibodies|antibodies|mesh-list
84038128|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
84038129|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
84038130|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
84038131|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038132|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
84038133|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84038134|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84038135|NCT00676936|Prednisolone|prednisolone|mesh-list
84038136|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
84038137|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84038138|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
84038139|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038140|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
84038141|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
84038142|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038143|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038144|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038145|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
84038146|NCT00676936|Hormones|hormones|mesh-ancestor
84038147|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038148|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84038149|NCT00676936|Protective Agents|protective agents|mesh-ancestor
84038150|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84038151|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038152|NCT02629744|Etrolizumab|etrolizumab|mesh-list
84038153|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038154|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
84038155|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038156|NCT00677170|Pevonedistat|pevonedistat|mesh-list
84038157|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038158|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038160|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
84038161|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84038162|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84038163|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038164|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038165|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84038166|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84038167|NCT01125566|Trastuzumab|trastuzumab|mesh-list
84038168|NCT01125566|Vinorelbine|vinorelbine|mesh-list
84038169|NCT01125566|Afatinib|afatinib|mesh-list
84038170|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84038171|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038172|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84038173|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038174|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038175|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038176|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038177|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84038178|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038179|NCT04031872|Capecitabine|capecitabine|mesh-list
84038180|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84038181|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
84038182|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038183|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038184|NCT00670696|Tetracaine|tetracaine|mesh-list
84038185|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
84038186|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
84038187|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84038188|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038189|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
84038190|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038191|NCT00677248|Ezetimibe|ezetimibe|mesh-list
84038192|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84038193|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84038194|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
84038195|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038196|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84038197|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84038198|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84038199|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
84038200|NCT00671008|Insulin|insulin|mesh-list
84038201|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84038202|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
84038203|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
84038204|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
84038205|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84038206|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84038207|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038208|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
84038209|NCT00911716|Bevacizumab|bevacizumab|mesh-list
84038210|NCT00911716|Docetaxel|docetaxel|mesh-list
84038211|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038212|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
84038213|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038214|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038215|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84038216|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
84038217|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038218|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038219|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84038220|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84038221|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84038222|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84038223|NCT00911716|Growth Substances|growth substances|mesh-ancestor
84038224|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
84038225|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038226|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038227|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038228|NCT00595582|Curcumin|curcumin|mesh-list
84038229|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84038230|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84038231|NCT00595582|Analgesics|analgesics|mesh-ancestor
84038232|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
84038233|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038234|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038235|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038236|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038237|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038238|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038239|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038240|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
84038241|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84038242|NCT00680446|Antibodies|antibodies|mesh-list
84038243|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
84038244|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
84038245|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038246|NCT00672022|Miglustat|miglustat|mesh-list
84038247|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038248|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038249|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84038250|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84038251|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
84038252|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038253|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84038254|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84038255|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038256|NCT00680602|Sertraline|sertraline|mesh-list
84038257|NCT00680602|Fluoxetine|fluoxetine|mesh-list
84038258|NCT00680602|Paroxetine|paroxetine|mesh-list
84038259|NCT00680602|Citalopram|citalopram|mesh-list
84038260|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
84038261|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84038262|NCT00680602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84038263|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84038264|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038265|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038266|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038267|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
84038268|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038269|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84038270|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84038271|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84038272|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038273|NCT00680680|Dutasteride|dutasteride|mesh-list
84038274|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84038275|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84038276|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038277|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038278|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
84038279|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038280|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038281|NCT00808015|Varenicline|varenicline|mesh-list
84038282|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84038283|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84038284|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
84038285|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038286|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038287|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038288|NCT00680758|Paclitaxel|paclitaxel|mesh-list
84038289|NCT00680758|Everolimus|everolimus|mesh-list
84038290|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84038291|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038292|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038293|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038294|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038295|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038296|NCT00680758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84038297|NCT00680758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84038298|NCT00680758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038299|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038300|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
84038301|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038302|NCT00678106|Dalbavancin|dalbavancin|mesh-list
84038303|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84038304|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038305|NCT00810199|Methotrexate|methotrexate|mesh-list
84038306|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84038307|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
84038308|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84038309|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038310|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84038311|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
84038312|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038313|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038314|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
84038315|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038316|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84038317|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038318|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
84038319|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038320|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84038321|NCT00877006|Prednisone|prednisone|mesh-list
84038322|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
84038323|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84038324|NCT00877006|Rituximab|rituximab|mesh-list
84038325|NCT00877006|Doxorubicin|doxorubicin|mesh-list
84038326|NCT00877006|Vincristine|vincristine|mesh-list
84038327|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038328|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
84038329|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038330|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038331|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84038332|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
84038333|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038334|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038335|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84038336|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84038337|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84038338|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84038339|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84038340|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038341|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038342|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
84038343|NCT00877006|Hormones|hormones|mesh-ancestor
84038344|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038345|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84038346|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84038347|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038348|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038349|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038350|NCT00678184|Atorvastatin|atorvastatin|mesh-list
84038351|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84038352|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84038353|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
84038354|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038355|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84038356|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84038357|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038358|NCT00876928|Vitamin D|vitamin d|mesh-list
84038359|NCT00876928|Vitamins|vitamins|mesh-ancestor
84038360|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
84038361|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038362|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84038363|NCT02627950|Metoclopramide|metoclopramide|mesh-list
84038364|NCT02627950|Ticagrelor|ticagrelor|mesh-list
84038365|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84038366|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84038367|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84038368|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84038369|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
84038370|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038371|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038372|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038373|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
84038374|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
84038375|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038376|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038377|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84038378|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84038379|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
84038381|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
84038382|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
84038383|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
84038384|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038385|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038386|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038387|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84038388|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84038389|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84038390|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84038391|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84038392|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
84038393|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
84038394|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038395|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038396|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84038397|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84038398|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038399|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038400|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84038401|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038402|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038403|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
84038404|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038405|NCT04935229|Nivolumab|nivolumab|mesh-list
84038406|NCT04935229|Ipilimumab|ipilimumab|mesh-list
84038407|NCT04935229|Relatlimab|relatlimab|mesh-list
84038408|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84038409|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038410|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84038411|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038412|NCT00681226|Ramipril|ramipril|mesh-list
84038413|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84038414|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
84038415|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038416|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038417|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84038418|NCT00678964|Carboplatin|carboplatin|mesh-list
84038419|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84038420|NCT00678964|Vinorelbine|vinorelbine|mesh-list
84038421|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038422|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84038423|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038424|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038425|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84038426|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038427|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038428|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038429|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
84038430|NCT02627248|Docetaxel|docetaxel|mesh-list
84038431|NCT02627248|Epirubicin|epirubicin|mesh-list
84038432|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038433|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
84038434|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038435|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038436|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84038437|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
84038438|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038439|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038440|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84038441|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038442|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038443|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038444|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84038445|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84038446|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84038447|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038448|NCT03993535|Serotonin|serotonin|mesh-list
84038449|NCT03993535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
84038450|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84038451|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
84038452|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038453|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038454|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038455|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84038456|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038457|NCT02626936|Insulin|insulin|mesh-list
84038458|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84038459|NCT02626936|Glucagon|glucagon|mesh-list
84038460|NCT02626936|Hormones|hormones|mesh-list
84038461|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84038462|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038463|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038464|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038465|NCT00912262|Capsaicin|capsaicin|mesh-list
84038466|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
84038467|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
84038468|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
84038469|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038470|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038471|NCT00906945|Cytarabine|cytarabine|mesh-list
84038472|NCT00906945|Plerixafor|plerixafor|mesh-list
84038473|NCT00906945|Etoposide|etoposide|mesh-list
84038474|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
84038475|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84038476|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038477|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84038478|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84038479|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038480|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038481|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84038482|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
84038483|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
84038484|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038485|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038486|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
84038487|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038488|NCT00906945|Analgesics|analgesics|mesh-ancestor
84038489|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
84038490|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038491|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84038492|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84038493|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
84038494|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
84038495|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
84038496|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84038497|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84038498|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038499|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
84038500|NCT02627560|Coagulants|coagulants|mesh-ancestor
84038501|NCT00681460|Metformin|metformin|mesh-list
84038502|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84038503|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038504|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84038505|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84038506|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
84038507|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038508|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038509|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84038510|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
84038511|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84038512|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84038513|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84038514|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
84038515|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038516|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038517|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
84038518|NCT05752903|Ketamine|ketamine|mesh-list
84038519|NCT05752903|Propofol|propofol|mesh-list
84038520|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84038521|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84038522|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038523|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84038524|NCT05752903|Analgesics|analgesics|mesh-ancestor
84038525|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
84038526|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038527|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84038528|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84038529|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84038530|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
84038531|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038532|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038533|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84038534|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
84038535|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
84038536|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84038537|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84038538|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84038539|NCT00590317|Ondansetron|ondansetron|mesh-list
84038540|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
84038541|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
84038542|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
84038543|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038544|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038545|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038546|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
84038547|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
84038548|NCT00590317|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84038549|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84038550|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
84038551|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038552|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038553|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84038554|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84038555|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84038556|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84038557|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84038558|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
84038559|NCT01139762|Tadalafil|tadalafil|mesh-list
84038560|NCT01139762|Finasteride|finasteride|mesh-list
84038561|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
84038562|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84038563|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84038564|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038565|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038566|NCT01139762|Urological Agents|urological agents|mesh-ancestor
84038567|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84038568|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84038569|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
84038570|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038571|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038572|NCT00805285|Budesonide|budesonide|mesh-list
84038573|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
84038574|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038575|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84038576|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
84038577|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038578|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038579|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84038580|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
84038581|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
84038582|NCT00805285|Hormones|hormones|mesh-ancestor
84038583|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038584|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
84038585|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
84038586|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038587|NCT02606773|Protective Agents|protective agents|mesh-ancestor
84038588|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038589|NCT02606773|Vitamins|vitamins|mesh-ancestor
84038590|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
84038591|NCT04310774|Tegafur|tegafur|mesh-list
84038592|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84038593|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
84038594|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038595|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038596|NCT01139450|Tacrolimus|tacrolimus|mesh-list
84038597|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278413|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83278414|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83278415|NCT02196259|Ketamine|ketamine|mesh-list
83278416|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
83278417|NCT02196259|Anesthetics|anesthetics|mesh-list
83278418|NCT02196259|Analgesics|analgesics|mesh-ancestor
83278430|NCT02294396|Mirabegron|mirabegron|mesh-list
84038598|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
84038599|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038600|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84038601|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038602|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038603|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
84038604|NCT05110742|Fludarabine|fludarabine|mesh-list
84038605|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
84038606|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038607|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
84038608|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038609|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038610|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84038611|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
84038612|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038613|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038614|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84038615|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84038616|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
84038617|NCT00805207|Estradiol|estradiol|mesh-list
84038618|NCT00805207|Estrogens|estrogens|mesh-list
84038619|NCT00805207|Testosterone|testosterone|mesh-list
84038620|NCT00805207|Progesterone|progesterone|mesh-list
84038621|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
84038622|NCT00805207|Hormones|hormones|mesh-ancestor
84038623|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038624|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038625|NCT00805207|Androgens|androgens|mesh-ancestor
84038626|NCT00805207|Progestins|progestins|mesh-ancestor
84038627|NCT00805675|Tenofovir|tenofovir|mesh-list
84038628|NCT00805675|Telbivudine|telbivudine|mesh-list
84038629|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
84038630|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038631|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84038632|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84038633|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038634|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038635|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84038636|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84038637|NCT03958201|Rocuronium|rocuronium|mesh-list
84038638|NCT03958201|Neostigmine|neostigmine|mesh-list
84038639|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84038640|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84038641|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84038642|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038643|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038644|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84038645|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038646|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038647|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
84038648|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038649|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84038650|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
84038651|NCT00589303|Metoprolol|metoprolol|mesh-list
84038652|NCT00589303|Amiodarone|amiodarone|mesh-list
84038653|NCT00589303|Verapamil|verapamil|mesh-list
84038654|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84038655|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84038656|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
84038657|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
84038658|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038659|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038660|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84038661|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84038662|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84038663|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
84038664|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038665|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038666|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
84038667|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84038668|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038669|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84038670|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84038671|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84038672|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038673|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84038674|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84038675|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84038677|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84038678|NCT02607943|Insulin|insulin|mesh-list
84038679|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84038680|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
84038681|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84038682|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038683|NCT02606617|Mosapride|mosapride|mesh-list
84038684|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038685|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84038686|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
84038687|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038688|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038689|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038690|NCT00914095|Methylphenidate|methylphenidate|mesh-list
84038691|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84038692|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038693|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84038694|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84038695|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038696|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038697|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
84038698|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038699|NCT03903835|Prednisone|prednisone|mesh-list
84038700|NCT03903835|Carboplatin|carboplatin|mesh-list
84038701|NCT03903835|Docetaxel|docetaxel|mesh-list
84038702|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
84038703|NCT03903835|Niraparib|niraparib|mesh-list
84038704|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84038705|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84038706|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038707|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038708|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038709|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038710|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038711|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038712|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
84038713|NCT03903835|Hormones|hormones|mesh-ancestor
84038714|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038715|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038716|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84038717|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84038718|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038719|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
84038720|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84038721|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84038722|NCT05745337|Metoprolol|metoprolol|mesh-list
84038723|NCT05745337|Verapamil|verapamil|mesh-list
84038724|NCT05745337|Diltiazem|diltiazem|mesh-list
84038725|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
84038726|NCT05745337|Calcium|calcium|mesh-list
84038727|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84038728|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84038729|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038730|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84038731|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84038732|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
84038733|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
84038734|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038735|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84038736|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84038737|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
84038738|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038739|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038740|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038741|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
84038742|NCT00952380|Dalteparin|dalteparin|mesh-list
84038743|NCT00952380|Tinzaparin|tinzaparin|mesh-list
84038744|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84038745|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
84038746|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84038747|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84038748|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038750|NCT03859921|Progestins|progestins|mesh-ancestor
84038751|NCT03859921|Hormones|hormones|mesh-ancestor
84038752|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038753|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038754|NCT02856750|Gabapentin|gabapentin|mesh-list
84038755|NCT02856750|Analgesics|analgesics|mesh-ancestor
84038756|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
84038757|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038758|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038759|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
84038760|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84038761|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84038762|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84038763|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84038764|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84038765|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84038766|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038767|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038768|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
84038769|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84038770|NCT05751967|Fenofibrate|fenofibrate|mesh-list
84038771|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84038772|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
84038773|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038774|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84038775|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84038776|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038777|NCT02857920|Bevacizumab|bevacizumab|mesh-list
84038778|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84038779|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038780|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84038781|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84038782|NCT02857920|Growth Substances|growth substances|mesh-ancestor
84038783|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038784|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
84038785|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
84038786|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84038787|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038788|NCT02607631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84038789|NCT02607631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038790|NCT02857842|Prednisolone|prednisolone|mesh-list
84038791|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038792|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
84038793|NCT02857842|Hormones|hormones|mesh-ancestor
84038794|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038795|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038796|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84038797|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038798|NCT03635437|Alprazolam|alprazolam|mesh-list
84038799|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
84038800|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84038801|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84038802|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038803|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84038804|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84038805|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84038806|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
84038807|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
84038808|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038809|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038810|NCT00803179|Hormones|hormones|mesh-list
84038811|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038812|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038813|NCT00804193|Ciclopirox|ciclopirox|mesh-list
84038814|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
84038815|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038816|NCT05697211|Ferric maltol|ferric maltol|mesh-list
84038817|NCT05697211|Hematinics|hematinics|mesh-ancestor
84038818|NCT00957996|Peramivir|peramivir|mesh-list
84038819|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
84038820|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038821|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038822|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038823|NCT02606539|Leucovorin|leucovorin|mesh-list
84038824|NCT02606539|Folic Acid|folic acid|mesh-list
84038825|NCT02606539|Methotrexate|methotrexate|mesh-list
84038826|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
84038827|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84038828|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
84038829|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84038830|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152758|NCT04300790|Fulvestrant|fulvestrant|mesh-list
84038831|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84038832|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
84038833|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038834|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038835|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
84038836|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038837|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84038838|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038839|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
84038840|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038841|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84038842|NCT02606539|Antidotes|antidotes|mesh-ancestor
84038843|NCT02606539|Protective Agents|protective agents|mesh-ancestor
84038844|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
84038845|NCT02606539|Vitamins|vitamins|mesh-ancestor
84038846|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
84038847|NCT02606539|Hematinics|hematinics|mesh-ancestor
84038848|NCT00589693|Imipenem|imipenem|mesh-list
84038849|NCT00589693|Doripenem|doripenem|mesh-list
84038850|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
84038851|NCT00589693|Cilastatin|cilastatin|mesh-list
84038852|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84038853|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038854|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
84038855|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038856|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038857|NCT02606383|Ketoconazole|ketoconazole|mesh-list
84038858|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
84038859|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038860|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84038861|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84038862|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038863|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038864|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84038865|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
84038866|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038867|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038868|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84038869|NCT05660473|Cytarabine|cytarabine|mesh-list
84038870|NCT05660473|Dexamethasone|dexamethasone|mesh-list
84038871|NCT05660473|Prednisone|prednisone|mesh-list
84038872|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
84038873|NCT05660473|Methotrexate|methotrexate|mesh-list
84038874|NCT05660473|Vincristine|vincristine|mesh-list
84038875|NCT05660473|Daunorubicin|daunorubicin|mesh-list
84038876|NCT05660473|Venetoclax|venetoclax|mesh-list
84038877|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
84038878|NCT05660473|Pegaspargase|pegaspargase|mesh-list
84038879|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84038880|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
84038881|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038882|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84038883|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84038884|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
84038885|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038886|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038887|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84038888|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038889|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
84038890|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
84038891|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84038892|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84038893|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
84038894|NCT05660473|Hormones|hormones|mesh-ancestor
84038895|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038896|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84038897|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84038898|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
84038899|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84038900|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84038901|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
84038902|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
84038903|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038904|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84038905|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84038906|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
84038907|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84038908|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84038909|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
84038910|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
84038911|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
84038912|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84038913|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84038914|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84038915|NCT00803101|Protein C|protein c|mesh-list
84038916|NCT00803101|Protein S|protein s|mesh-list
84038917|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
84038918|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84038919|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84038920|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038921|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84038922|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84038923|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038924|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84038925|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84038926|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84038927|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038928|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
84038929|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038930|NCT04269954|Heparin|heparin|mesh-list
84038931|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84038932|NCT04269954|Tinzaparin|tinzaparin|mesh-list
84038933|NCT04269954|Dalteparin|dalteparin|mesh-list
84038934|NCT04269954|Batroxobin|batroxobin|mesh-list
84038935|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
84038936|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84038937|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84038938|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038939|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
84038940|NCT04269954|Coagulants|coagulants|mesh-ancestor
84038941|NCT00630630|Levetiracetam|levetiracetam|mesh-list
84038942|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
84038943|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
84038944|NCT01254864|Prednisone|prednisone|mesh-list
84038945|NCT01254864|Sunitinib|sunitinib|mesh-list
84038946|NCT01254864|Dasatinib|dasatinib|mesh-list
84038947|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
84038948|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84038949|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
84038950|NCT01254864|Hormones|hormones|mesh-ancestor
84038951|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038952|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038953|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84038954|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84038955|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83152869|NCT02177851|Iron|iron|mesh-list
84038956|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84038957|NCT01254864|Growth Substances|growth substances|mesh-ancestor
84038958|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
84038959|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84038960|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038961|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038962|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84038963|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
84038964|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84038965|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
84038966|NCT02854722|Vitamin D|vitamin d|mesh-list
84038967|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
84038968|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
84038969|NCT02854722|Vitamins|vitamins|mesh-list
84038970|NCT02854722|Calcium|calcium|mesh-list
84038971|NCT02854722|Deferasirox|deferasirox|mesh-list
84038972|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
84038973|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038974|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84038975|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84038976|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84038977|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
84038978|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
84038979|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038980|NCT00800683|Linagliptin|linagliptin|mesh-list
84038981|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84038982|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038983|NCT00800683|Incretins|incretins|mesh-ancestor
84038984|NCT00800683|Hormones|hormones|mesh-ancestor
84038985|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84038986|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84038987|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
84038988|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84038989|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038990|NCT01113710|Rotigotine|rotigotine|mesh-list
84038991|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
84038992|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
84038993|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84038994|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84038995|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84038996|NCT01124162|Losartan|losartan|mesh-list
84038997|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84038998|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84038999|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84039000|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84039001|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039002|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84039003|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039004|NCT00923533|Diuretics|diuretics|mesh-ancestor
84039005|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
84039006|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039007|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84039008|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039009|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039010|NCT00906399|Interferons|interferons|mesh-list
84039011|NCT00906399|Interferon-beta|interferon-beta|mesh-list
84039012|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
84039013|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039014|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
84039015|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039016|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
84039017|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039018|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84039019|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84039020|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039021|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039022|NCT00947856|Immunotoxins|immunotoxins|mesh-ancestor
84039023|NCT00947856|Immunoconjugates|immunoconjugates|mesh-ancestor
84039024|NCT00947856|Immunologic Factors|immunologic factors|mesh-ancestor
84039025|NCT00947856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039026|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
84039027|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039028|NCT00907335|Tretinoin|tretinoin|mesh-list
84039029|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84039030|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039031|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
84039032|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
84039033|NCT00947154|Aripiprazole|aripiprazole|mesh-list
84039034|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
84039035|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039036|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84039037|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84039038|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039039|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039040|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
84039041|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
84039042|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039043|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039044|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84039045|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84039046|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
84039047|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84039048|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84039049|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84039050|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84039051|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
84039053|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84039054|NCT00952068|Narcotics|narcotics|mesh-ancestor
84039055|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039056|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039057|NCT00952068|Analgesics|analgesics|mesh-ancestor
84039058|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
84039059|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039060|NCT00951912|Genistein|genistein|mesh-list
84039061|NCT00951912|Daidzein|daidzein|mesh-list
83152961|NCT02184247|Theophylline|theophylline|mesh-list
84039062|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84039063|NCT00951912|Protective Agents|protective agents|mesh-ancestor
84039064|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039065|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039066|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039067|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039068|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039069|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
84039070|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84039071|NCT00951912|Estrogens|estrogens|mesh-ancestor
84039072|NCT00951912|Hormones|hormones|mesh-ancestor
84039073|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039074|NCT02882594|Anesthetics|anesthetics|mesh-list
84039075|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039076|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039077|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84039078|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
84039079|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84039080|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
84039081|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84039082|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039083|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84039084|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039085|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039086|NCT03844815|Decitabine|decitabine|mesh-list
84039087|NCT03844815|Venetoclax|venetoclax|mesh-list
84039088|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153017|NCT02181361|Aspirin|aspirin|mesh-list
84039089|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
84039090|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039091|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039092|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039093|NCT01123070|Rituximab|rituximab|mesh-list
84039094|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039095|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039096|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
84039097|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039098|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84039099|NCT02857686|Anesthetics|anesthetics|mesh-list
84039100|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039101|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039102|NCT03198741|Aspirin|aspirin|mesh-list
84039103|NCT03198741|Clopidogrel|clopidogrel|mesh-list
84039104|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84039105|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84039106|NCT03198741|Analgesics|analgesics|mesh-ancestor
84039107|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
84039108|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039109|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039110|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84039111|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84039112|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84039113|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84039114|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039115|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84039116|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84039117|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039118|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
84039119|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84039120|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84039121|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84039122|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
84039123|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039124|NCT01122680|Bromides|bromides|mesh-list
84039125|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
84039126|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84039127|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
84039128|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039129|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039130|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84039131|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
84039132|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
84039133|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84039134|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
84039135|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039136|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039137|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
84039139|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
84039140|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039141|NCT00946998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84039142|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84039143|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039144|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039145|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039146|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
84039147|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039148|NCT01138826|Amlodipine|amlodipine|mesh-list
84039149|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039150|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84039151|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039152|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039153|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84039154|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039155|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
84039156|NCT00906087|Timolol|timolol|mesh-list
84039157|NCT00906087|Dorzolamide|dorzolamide|mesh-list
84039158|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84039159|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84039160|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84039161|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
84039162|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039163|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039164|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039165|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84039166|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039167|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84039168|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039169|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84039170|NCT03525795|Ipilimumab|ipilimumab|mesh-list
84039171|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
84039172|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039173|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039174|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84039175|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039176|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039177|NCT03522831|Albuterol|albuterol|mesh-list
84039178|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84039179|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
84039180|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039181|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039182|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84039183|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
84039184|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
84039185|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84039186|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84039187|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84039188|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84039189|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
84039190|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039191|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039192|NCT03504501|Lamotrigine|lamotrigine|mesh-list
84039193|NCT03504501|Lovastatin|lovastatin|mesh-list
84039194|NCT03504501|L 647318|l 647318|mesh-list
83279015|NCT01738594|Romidepsin|romidepsin|mesh-list
84039195|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
84039196|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
84039197|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84039198|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039199|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039200|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84039201|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039202|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84039203|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84039204|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039205|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039206|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84039207|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84039208|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84039209|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
84039210|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84039211|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84039212|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039213|NCT02420574|Albendazole|albendazole|mesh-list
84039214|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
84039215|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84039216|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039217|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
84039218|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84039219|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84039220|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
84039221|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
84039222|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
84039223|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039224|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039225|NCT02855502|Prednisolone|prednisolone|mesh-list
84039226|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84039227|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
84039228|NCT02855502|Hormones|hormones|mesh-ancestor
84039229|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039230|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039231|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039232|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039233|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
84039234|NCT02853864|Propofol|propofol|mesh-list
84039235|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84039236|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039237|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039238|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84039239|NCT02853864|Analgesics|analgesics|mesh-ancestor
84039240|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
84039241|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039242|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84039243|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84039244|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84039245|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
84039246|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039247|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039248|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84039249|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
84039250|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
84039251|NCT00907257|Tretinoin|tretinoin|mesh-list
84039252|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84039253|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
84039254|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039255|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
84039256|NCT01138046|Paclitaxel|paclitaxel|mesh-list
84039257|NCT01138046|Lapatinib|lapatinib|mesh-list
84039258|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84039259|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039260|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
84039261|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
84039262|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
84039263|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039264|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039265|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039266|NCT02350764|Nivolumab|nivolumab|mesh-list
84039267|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039268|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039269|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84039270|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039271|NCT00876460|Docetaxel|docetaxel|mesh-list
84039272|NCT00876460|Nintedanib|nintedanib|mesh-list
84039273|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039274|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
84039275|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
84039276|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
84039277|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039278|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039279|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039280|NCT01137812|Metformin|metformin|mesh-list
84039281|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84039282|NCT01137812|Canagliflozin|canagliflozin|mesh-list
84039283|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84039284|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039285|NCT01137812|Incretins|incretins|mesh-ancestor
84039286|NCT01137812|Hormones|hormones|mesh-ancestor
84039287|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039288|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84039289|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
84039290|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039291|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039292|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84039293|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84039294|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84039295|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84039296|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
83153217|NCT02186899|Anesthetics|anesthetics|mesh-list
84039297|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039298|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84039299|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84039300|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039301|NCT04146220|Prednisolone|prednisolone|mesh-list
84039302|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84039303|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
84039304|NCT04146220|Hormones|hormones|mesh-ancestor
84039305|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039306|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039307|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039308|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039309|NCT00679666|Riboflavin|riboflavin|mesh-list
84039310|NCT00679666|Vitamins|vitamins|mesh-ancestor
84039311|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
84039312|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039313|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
84039314|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84039315|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
84039316|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
84039317|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
84039318|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84039319|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84039320|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039321|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84039322|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039323|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039324|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84039325|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
84039326|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84039327|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84039328|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039329|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039330|NCT00681772|Urological Agents|urological agents|mesh-ancestor
84039331|NCT00946920|Goserelin|goserelin|mesh-list
84039332|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039333|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039334|NCT00679900|SR 46349B|sr 46349b|mesh-list
84039335|NCT00679900|Lormetazepam|lormetazepam|mesh-list
84039336|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84039337|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84039338|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039339|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84039340|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84039341|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
84039342|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039343|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279167|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
84039345|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039346|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
84039347|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84039348|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84039349|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039350|NCT00681928|Letrozole|letrozole|mesh-list
84039351|NCT00681928|Anastrozole|anastrozole|mesh-list
84039352|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039353|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84039354|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84039355|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039356|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039357|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84039358|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
84039359|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039360|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039361|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039362|NCT00594646|Tenofovir|tenofovir|mesh-list
84039363|NCT00594646|Emtricitabine|emtricitabine|mesh-list
84039364|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
84039365|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84039366|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
84039367|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039368|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84039369|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84039370|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039371|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039372|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84039373|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84039374|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84039375|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84039376|NCT00680134|Tavaborole|tavaborole|mesh-list
84039377|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
84039378|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039379|NCT00680212|Beta Carotene|beta carotene|mesh-list
84039380|NCT00680212|Carotenoids|carotenoids|mesh-list
84039381|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
84039382|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039383|NCT00680212|Protective Agents|protective agents|mesh-ancestor
84039384|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039385|NCT00680212|Provitamins|provitamins|mesh-ancestor
84039386|NCT00680212|Vitamins|vitamins|mesh-ancestor
84039387|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
84039388|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
84039389|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84039390|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84039391|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039392|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
84039393|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
84039394|NCT02855346|Dapivirine|dapivirine|mesh-list
84039395|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
84039396|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84039397|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
84039398|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84039399|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039400|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84039401|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84039402|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84039403|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84039404|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84039405|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
84039406|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039407|NCT01111604|Ramucirumab|ramucirumab|mesh-list
84039408|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039409|NCT00950742|Trastuzumab|trastuzumab|mesh-list
84039410|NCT00950742|Afatinib|afatinib|mesh-list
84039411|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039412|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039413|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039414|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039415|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039416|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
84039417|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039418|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
84039419|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84039420|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84039421|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039422|NCT05061368|Urological Agents|urological agents|mesh-ancestor
84039423|NCT04310228|Favipiravir|favipiravir|mesh-list
84039424|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
84039425|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039426|NCT00955110|Oxymorphone|oxymorphone|mesh-list
84039427|NCT00955110|Oxycodone|oxycodone|mesh-list
84039428|NCT00955110|Hydromorphone|hydromorphone|mesh-list
84039429|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84039430|NCT00955110|Narcotics|narcotics|mesh-ancestor
84039431|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039432|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039433|NCT00955110|Analgesics|analgesics|mesh-ancestor
84039434|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
84039435|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039436|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84039437|NCT05056142|Anesthetics|anesthetics|mesh-list
84039438|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039439|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039440|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84039441|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84039442|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84039443|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039444|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039445|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84039446|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039447|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039448|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
84039449|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039450|NCT01111526|Panobinostat|panobinostat|mesh-list
84039451|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039452|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84039453|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039454|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039455|NCT02881346|Betamethasone|betamethasone|mesh-list
84039456|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
84039457|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84039458|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
84039459|NCT02881346|Calcipotriene|calcipotriene|mesh-list
84039460|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84039461|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84039462|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
84039463|NCT02881346|Hormones|hormones|mesh-ancestor
84039464|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039465|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039466|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84039467|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
84039468|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
84039469|NCT00630708|Losartan|losartan|mesh-list
84039470|NCT00630708|Benazepril|benazepril|mesh-list
84039471|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84039472|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039473|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83153378|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
84039474|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84039475|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039476|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84039477|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
84039478|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039479|NCT01111292|Inositol|inositol|mesh-list
84039480|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
84039481|NCT01111292|Vitamins|vitamins|mesh-ancestor
84039482|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
84039483|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039484|NCT02853630|Metformin|metformin|mesh-list
84039485|NCT02853630|Vildagliptin|vildagliptin|mesh-list
84039486|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84039487|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039488|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84039489|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
84039490|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039491|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039492|NCT04309838|Treprostinil|treprostinil|mesh-list
84039493|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039494|NCT05367206|Paclitaxel|paclitaxel|mesh-list
84039495|NCT05367206|Carboplatin|carboplatin|mesh-list
84039496|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84039497|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84039498|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039499|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
84039500|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
84039501|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
84039502|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039503|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
84039504|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84039505|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84039506|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
84039507|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039508|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039509|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039510|NCT00944658|Apremilast|apremilast|mesh-list
84039511|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84039512|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84039513|NCT00944658|Analgesics|analgesics|mesh-ancestor
84039514|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
84039515|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039516|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039517|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84039518|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84039519|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84039520|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84039521|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039522|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039523|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84039524|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84039525|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84039526|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
84039527|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039528|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039529|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84039530|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
84039531|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84039532|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84039533|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84039534|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
84039535|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039536|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039537|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
84039538|NCT01110200|Hormones|hormones|mesh-ancestor
84039539|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039540|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
84039541|NCT05182112|Gemcitabine|gemcitabine|mesh-list
84039542|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039543|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84039544|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
84039545|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039546|NCT01136954|Zonisamide|zonisamide|mesh-list
84039547|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
84039548|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84039549|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039550|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039551|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84039552|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039553|NCT01108094|Itraconazole|itraconazole|mesh-list
84039554|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
84039555|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039556|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84039557|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84039558|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039559|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039560|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84039561|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
84039562|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039563|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039564|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83279390|NCT04589546|Vitamins|vitamins|mesh-ancestor
84039565|NCT00954174|Paclitaxel|paclitaxel|mesh-list
84039566|NCT00954174|Carboplatin|carboplatin|mesh-list
84039567|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84039568|NCT00954174|Ifosfamide|ifosfamide|mesh-list
84039569|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
84039570|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84039571|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039572|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
84039573|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
84039574|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
84039575|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039576|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84039577|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
84039578|NCT01107626|Paclitaxel|paclitaxel|mesh-list
84039579|NCT01107626|Bevacizumab|bevacizumab|mesh-list
84039580|NCT01107626|Carboplatin|carboplatin|mesh-list
84039581|NCT01107626|Pemetrexed|pemetrexed|mesh-list
84039582|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84039583|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039584|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
84039585|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
84039586|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
84039587|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039588|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039589|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84039590|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84039591|NCT01107626|Growth Substances|growth substances|mesh-ancestor
84039592|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039593|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
84039594|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039595|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84039596|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84039597|NCT04309058|Vitamin D|vitamin d|mesh-list
84039598|NCT04309058|Vitamins|vitamins|mesh-ancestor
84039599|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
84039600|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039601|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84039602|NCT01136408|Warfarin|warfarin|mesh-list
84039603|NCT01136408|Dabigatran|dabigatran|mesh-list
84039604|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
84039605|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
84039606|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84039607|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
84039608|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039609|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039610|NCT01136174|Nintedanib|nintedanib|mesh-list
84039611|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039612|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039613|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039614|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039615|NCT01135394|Pioglitazone|pioglitazone|mesh-list
84039616|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84039617|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039618|NCT00949884|Losartan|losartan|mesh-list
84039619|NCT00949884|Olmesartan|olmesartan|mesh-list
84039620|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84039621|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84039622|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039623|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84039624|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84039625|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039626|NCT00949650|Pemetrexed|pemetrexed|mesh-list
84039627|NCT00949650|Afatinib|afatinib|mesh-list
84039628|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039629|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039630|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039631|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84039632|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84039633|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039634|NCT03082755|Gabapentin|gabapentin|mesh-list
84039635|NCT03082755|Analgesics|analgesics|mesh-ancestor
84039636|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
84039637|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039638|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039639|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
83279465|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
84039640|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84039641|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84039642|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039643|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039644|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84039645|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84039646|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039647|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039649|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
84039650|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84039651|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
84039652|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039653|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84039654|NCT00904215|Telmisartan|telmisartan|mesh-list
84039655|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039656|NCT00904215|Diuretics|diuretics|mesh-ancestor
84039657|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
84039658|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039659|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84039660|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039661|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039662|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84039663|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84039664|NCT05317689|Psilocybin|psilocybin|mesh-list
84039665|NCT05317689|Psilocin|psilocin|mesh-list
84039666|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
83153629|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039667|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039668|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039669|NCT05293665|Vaccines|vaccines|mesh-list
84039670|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
84039671|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039672|NCT00905307|Aripiprazole|aripiprazole|mesh-list
84039673|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
84039674|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039675|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84039676|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84039677|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039678|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039679|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
84039680|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
84039681|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039682|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039683|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84039684|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84039685|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
84039686|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84039687|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84039688|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84039689|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84039690|NCT00904839|Bevacizumab|bevacizumab|mesh-list
84039691|NCT00904839|Nintedanib|nintedanib|mesh-list
84039692|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039693|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039694|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84039695|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84039696|NCT00904839|Growth Substances|growth substances|mesh-ancestor
84039697|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039698|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
84039699|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039700|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039701|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039702|NCT04985955|Tofacitinib|tofacitinib|mesh-list
84039703|NCT04985955|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84039704|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84039705|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039706|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039707|NCT02821923|Erythritol|erythritol|mesh-list
84039708|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
84039709|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
84039710|NCT00903357|Montelukast|montelukast|mesh-list
84039711|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84039712|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
83153681|NCT05509478|Lenvatinib|lenvatinib|mesh-list
84039713|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84039714|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
84039715|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039716|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039717|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84039718|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84039719|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039720|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
84039721|NCT00903357|Protective Agents|protective agents|mesh-ancestor
84039722|NCT00903357|Vitamins|vitamins|mesh-ancestor
84039723|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
84039724|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
84039725|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84039726|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84039727|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039728|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039729|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039730|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
84039731|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
84039732|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039733|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039734|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
84039735|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
84039736|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84039737|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039738|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84039739|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84039740|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
84039741|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84039742|NCT02122185|Metformin|metformin|mesh-list
84039743|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84039744|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039745|NCT02087865|Donepezil|donepezil|mesh-list
84039746|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84039747|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039748|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039749|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
84039750|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039751|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039752|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
84039753|NCT01889199|Flutamide|flutamide|mesh-list
84039754|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
84039755|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
84039756|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039757|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039758|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039759|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039760|NCT01730313|Pyridoxine|pyridoxine|mesh-list
84039761|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
84039762|NCT01730313|Phenytoin|phenytoin|mesh-list
84039763|NCT01730313|Valproic Acid|valproic acid|mesh-list
84039764|NCT01730313|Vitamins|vitamins|mesh-ancestor
84039765|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
84039766|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039767|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
84039768|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
84039769|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039770|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039771|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
84039772|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039773|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
84039774|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84039775|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039776|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84039777|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84039778|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84039779|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039780|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84039781|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84039782|NCT02849379|Immunomodulating Agents|immunomodulating agents|mesh-list
84039783|NCT02849379|Immunologic Factors|immunologic factors|mesh-ancestor
84039784|NCT02849379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039785|NCT01104662|Vancomycin|vancomycin|mesh-list
84039786|NCT01104662|Daptomycin|daptomycin|mesh-list
84039787|NCT01104662|Penicillins|penicillins|mesh-list
84039788|NCT01104662|Cloxacillin|cloxacillin|mesh-list
84039789|NCT01104662|Oxacillin|oxacillin|mesh-list
84039790|NCT01104662|Nafcillin|nafcillin|mesh-list
84039791|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84039792|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039793|NCT05062785|Insulin|insulin|mesh-list
84039794|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84039795|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039796|NCT01103960|Amlodipine|amlodipine|mesh-list
84039797|NCT01103960|Telmisartan|telmisartan|mesh-list
84039798|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84039799|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84039800|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039801|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039802|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84039803|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039804|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
84039805|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84039806|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84039807|NCT04413279|Dexamethasone|dexamethasone|mesh-list
84039808|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84039809|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
84039810|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
84039811|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039812|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039813|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84039814|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
84039815|NCT04413279|Hormones|hormones|mesh-ancestor
84039816|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039817|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039818|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039819|NCT04975256|Adagrasib|adagrasib|mesh-list
84039820|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039821|NCT02880800|Morphine|morphine|mesh-list
84039822|NCT02880800|Hydromorphone|hydromorphone|mesh-list
84039823|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84039824|NCT02880800|Narcotics|narcotics|mesh-ancestor
84039825|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039826|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039827|NCT02880800|Analgesics|analgesics|mesh-ancestor
84039828|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
84039829|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039830|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
84039831|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84039832|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84039833|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84039834|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039835|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039836|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
84039837|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039838|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039839|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84039840|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039841|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
84039842|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84039843|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
84039844|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039845|NCT01106846|Ketamine|ketamine|mesh-list
84039846|NCT01106846|Analgesics|analgesics|mesh-ancestor
84039847|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
84039848|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039849|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039850|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84039851|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84039852|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
84039853|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
84039854|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039855|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84039856|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84039857|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039858|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039859|NCT05034783|Exenatide|exenatide|mesh-list
83153862|NCT02195557|Hylan|hylan|mesh-list
84039860|NCT05034783|Edetic Acid|edetic acid|mesh-list
84039861|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
84039862|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
84039863|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039864|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
84039865|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84039866|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84039867|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039868|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84039869|NCT05034783|Incretins|incretins|mesh-ancestor
84039870|NCT05034783|Hormones|hormones|mesh-ancestor
84039871|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039872|NCT00902577|Misonidazole|misonidazole|mesh-list
84039873|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039874|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84039875|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84039876|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039877|NCT04202367|Bupivacaine|bupivacaine|mesh-list
84039878|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
84039879|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
84039880|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84039881|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039882|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
84039883|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039884|NCT02846493|Dexamethasone|dexamethasone|mesh-list
84039885|NCT02846493|Bromocriptine|bromocriptine|mesh-list
84039886|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84039887|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
84039888|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
84039889|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039890|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039891|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84039892|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
84039893|NCT02846493|Hormones|hormones|mesh-ancestor
84048348|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039894|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039895|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84039896|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039897|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84039898|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84039899|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
84039900|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
84039901|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
84039902|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039903|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039904|NCT01106690|Metformin|metformin|mesh-list
84039905|NCT01106690|Pioglitazone|pioglitazone|mesh-list
84039906|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84039907|NCT01106690|Canagliflozin|canagliflozin|mesh-list
84039908|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84039909|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039910|NCT01106690|Incretins|incretins|mesh-ancestor
84039911|NCT01106690|Hormones|hormones|mesh-ancestor
84039912|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84039913|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84039914|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
84039915|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039916|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039917|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84039918|NCT04286529|Calcitriol|calcitriol|mesh-list
84039919|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84039920|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039921|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84039922|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039923|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039924|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84039925|NCT04286529|Vitamins|vitamins|mesh-ancestor
84039926|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
84039927|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84039928|NCT01103180|Escitalopram|escitalopram|mesh-list
84039929|NCT01103180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84039930|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84039931|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84039932|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039933|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84039934|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
84039935|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039936|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
84039937|NCT00625898|Bevacizumab|bevacizumab|mesh-list
84039938|NCT00625898|Carboplatin|carboplatin|mesh-list
84039939|NCT00625898|Docetaxel|docetaxel|mesh-list
83279767|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
84039940|NCT00625898|Fluorouracil|fluorouracil|mesh-list
83153919|NCT03533179|Glucagon|glucagon|mesh-list
84039941|NCT00625898|Trastuzumab|trastuzumab|mesh-list
84039942|NCT00625898|Epirubicin|epirubicin|mesh-list
84039943|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84039944|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
84039945|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039946|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84039947|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84039948|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
84039949|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039950|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84039951|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84039952|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84039953|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84039954|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84039955|NCT00625898|Growth Substances|growth substances|mesh-ancestor
83153934|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
84039956|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
84039957|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
84039958|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
84039959|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
84039960|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
84039961|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84039962|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84039963|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84039964|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84039965|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039966|NCT02853552|Misoprostol|misoprostol|mesh-list
84039967|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84039968|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
84039969|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84039970|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84039971|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84039972|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84039973|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
84039974|NCT04268472|Darunavir|darunavir|mesh-list
84039975|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84039976|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84039977|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
84039978|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039979|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039980|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84039981|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84039982|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
84039983|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84039984|NCT02844621|Omeprazole|omeprazole|mesh-list
84039985|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84039986|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84039987|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84039988|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84039989|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84039990|NCT01106534|Aspirin|aspirin|mesh-list
84039991|NCT01106534|Everolimus|everolimus|mesh-list
84039992|NCT01106534|Clopidogrel|clopidogrel|mesh-list
84039993|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84039994|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84039995|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84039996|NCT01106534|Analgesics|analgesics|mesh-ancestor
84039997|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
84039998|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84039999|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040000|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040001|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040002|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83153989|NCT02206789|Cyclosporins|cyclosporins|mesh-list
84040003|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84040004|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040005|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84040006|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84040007|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040008|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
84040009|NCT01106534|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84040010|NCT01106534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84040011|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84040012|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
84040013|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040014|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84040015|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84040016|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83154019|NCT02206867|Adalimumab|adalimumab|mesh-list
84040017|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
84040018|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040019|NCT00941304|Oxycodone|oxycodone|mesh-list
84040020|NCT00941304|Buprenorphine|buprenorphine|mesh-list
84040021|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84040022|NCT00941304|Narcotics|narcotics|mesh-ancestor
84040023|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040024|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040025|NCT00941304|Analgesics|analgesics|mesh-ancestor
84040026|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
84040027|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040028|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84040029|NCT02846025|Folic Acid|folic acid|mesh-list
84040030|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
84040031|NCT02846025|Antioxidants|antioxidants|mesh-list
84040032|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040033|NCT02846025|Protective Agents|protective agents|mesh-ancestor
84040034|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040035|NCT02846025|Hematinics|hematinics|mesh-ancestor
84040036|NCT02846025|Vitamins|vitamins|mesh-ancestor
84040037|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
84040038|NCT02880410|Temozolomide|temozolomide|mesh-list
84040039|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84040040|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
84040041|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040042|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040043|NCT02879006|Omalizumab|omalizumab|mesh-list
84040044|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84040045|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84040046|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
84040047|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84040048|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84040049|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040050|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84040051|NCT02857218|Hematinics|hematinics|mesh-ancestor
84040052|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84040053|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84040054|NCT00602316|Chelating Agents|chelating agents|mesh-list
84040055|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
84040056|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040057|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
84040058|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
84040059|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84040060|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040061|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040062|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
84040063|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84040064|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040065|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040066|NCT04956302|Dexamethasone|dexamethasone|mesh-list
84040067|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
84040068|NCT04956302|Bortezomib|bortezomib|mesh-list
84040069|NCT04956302|Daratumumab|daratumumab|mesh-list
84040070|NCT04956302|Panobinostat|panobinostat|mesh-list
84040071|NCT04956302|Ichthammol|ichthammol|mesh-list
84040072|NCT04956302|BB 1101|bb 1101|mesh-list
84040073|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84040074|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040075|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
84040076|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
84040077|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040078|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040079|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84040080|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
84040081|NCT04956302|Hormones|hormones|mesh-ancestor
84040082|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040083|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84040084|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040085|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
84040086|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040087|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040088|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
84040089|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84040090|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
84040091|NCT02848443|Trifluridine|trifluridine|mesh-list
84040092|NCT02848443|Bevacizumab|bevacizumab|mesh-list
84040093|NCT02848443|Nivolumab|nivolumab|mesh-list
84040094|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
84040095|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84040096|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040097|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84040098|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84040099|NCT02848443|Growth Substances|growth substances|mesh-ancestor
84040100|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040101|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
84040102|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84040103|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040104|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
84040105|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
84040106|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040107|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
84040108|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84040109|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040110|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040111|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84040112|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84040113|NCT00632697|Protective Agents|protective agents|mesh-ancestor
84040114|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040115|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
84040116|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84040117|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
84040119|NCT02848209|Croton Oil|croton oil|mesh-list
84040120|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84040121|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040122|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
84040123|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
84040124|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84040125|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
84040126|NCT05337969|Metformin|metformin|mesh-list
84040127|NCT05337969|Vildagliptin|vildagliptin|mesh-list
84040128|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040129|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040130|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84040131|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
84040132|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040133|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040134|NCT02844153|Metformin|metformin|mesh-list
84040135|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040136|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040137|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84040138|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
84040139|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84040140|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040141|NCT02844075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84040142|NCT02844075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040143|NCT02844309|Thalidomide|thalidomide|mesh-list
84040144|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84040145|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
84040146|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040147|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
84040148|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84040149|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040150|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84040151|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84040152|NCT02844309|Growth Substances|growth substances|mesh-ancestor
84040153|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
84040154|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040155|NCT02845713|Ivermectin|ivermectin|mesh-list
84040156|NCT02845713|Albendazole|albendazole|mesh-list
84040157|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
84040158|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84040159|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040160|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
84040161|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
84040162|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84040163|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84040164|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
84040165|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
84040166|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
84040167|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040168|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040169|NCT02845713|Filaricides|filaricides|mesh-ancestor
84040170|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
84040171|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84040172|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040173|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
84040174|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
84040175|NCT00902265|Coagulants|coagulants|mesh-ancestor
84040176|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84040177|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
84040178|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040179|NCT02848287|Ropivacaine|ropivacaine|mesh-list
84040180|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
84040181|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
84040182|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040183|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040184|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
84040185|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040186|NCT05337657|Letrozole|letrozole|mesh-list
84040187|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040188|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84040189|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84040190|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040191|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040192|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84040193|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
84040194|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040195|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040196|NCT02690883|Exenatide|exenatide|mesh-list
84040197|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040198|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040199|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84040200|NCT02690883|Incretins|incretins|mesh-ancestor
84040201|NCT02690883|Hormones|hormones|mesh-ancestor
84040202|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040203|NCT02844933|Cannabidiol|cannabidiol|mesh-list
84040204|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
84040205|NCT05104047|Lobeline|lobeline|mesh-list
84040206|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84040207|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
84040208|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040209|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040210|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84040211|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84040212|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
84040213|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040214|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040215|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
84040216|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
84040217|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84040218|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040219|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040220|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040221|NCT02847429|Crenolanib|crenolanib|mesh-list
84040222|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040223|NCT04750005|Listerine|listerine|mesh-list
84040224|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84040225|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040226|NCT05336721|Capecitabine|capecitabine|mesh-list
84040227|NCT05336721|Chiauranib|chiauranib|mesh-list
84040228|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84040229|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
84040230|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040231|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040232|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84040233|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040234|NCT04646655|Enoxaparin|enoxaparin|mesh-list
84040235|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
84040236|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84040237|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84040238|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040239|NCT00653913|Ezetimibe|ezetimibe|mesh-list
84040240|NCT00653913|Pitavastatin|pitavastatin|mesh-list
84040241|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84040242|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040243|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
84040244|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280060|NCT01635764|Adalimumab|adalimumab|mesh-list
84040245|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040246|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84040247|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040248|NCT00652431|Niacin|niacin|mesh-list
84040249|NCT00652431|Niacinamide|niacinamide|mesh-list
84040250|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
84040251|NCT00652431|Simvastatin|simvastatin|mesh-list
84040252|NCT00652431|Ezetimibe|ezetimibe|mesh-list
84040253|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
84040254|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84040255|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040256|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
84040257|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040258|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040259|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84040260|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040261|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
84040262|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
84040263|NCT00652431|Vitamins|vitamins|mesh-ancestor
84040264|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
84040265|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040266|NCT00380523|Etoricoxib|etoricoxib|mesh-list
84040267|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84040268|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84040269|NCT00380523|Analgesics|analgesics|mesh-ancestor
84040270|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
84040271|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040272|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040273|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040274|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040275|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84040276|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84040277|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040278|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040279|NCT00319995|Loratadine|loratadine|mesh-list
84040280|NCT00319995|Montelukast|montelukast|mesh-list
84040281|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84040282|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
84040283|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84040284|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
84040285|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040286|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040287|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84040288|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84040289|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040290|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
84040291|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
84040292|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84040293|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84040294|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84040295|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
84040296|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
84040297|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040298|NCT03304821|Sargramostim|sargramostim|mesh-list
84040299|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
84040300|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040301|NCT02842281|Levan|levan|mesh-list
84040302|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040303|NCT03721341|Hormones|hormones|mesh-list
84040304|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048349|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
84040305|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040306|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
84040307|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84040308|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040309|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040310|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84040311|NCT02842437|Analgesics|analgesics|mesh-ancestor
84040312|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
84040313|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040314|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84040315|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84040316|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84040317|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
84040318|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040319|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040321|NCT00157911|Ezetimibe|ezetimibe|mesh-list
84040322|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84040323|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040324|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
84040325|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040326|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040327|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84040328|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040329|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
84040330|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84040331|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
84040332|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
84040333|NCT02842125|Nivolumab|nivolumab|mesh-list
84040334|NCT02842125|Capecitabine|capecitabine|mesh-list
84040335|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84040336|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040337|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84040338|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040339|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84040340|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
84040341|NCT03708549|Metformin|metformin|mesh-list
84040342|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040343|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040344|NCT00156117|Olanzapine|olanzapine|mesh-list
84040345|NCT00156117|Asenapine|asenapine|mesh-list
84040346|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
84040347|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
84040348|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040349|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040350|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84040351|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84040352|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84040353|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040354|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84040355|NCT00156117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84040356|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84040357|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84040358|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040359|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040360|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
84040361|NCT00140985|Losartan|losartan|mesh-list
84040362|NCT00140985|Amlodipine|amlodipine|mesh-list
84040363|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84040364|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84040365|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84040366|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040367|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84040368|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040369|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
84040370|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84040371|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84040372|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84040373|NCT00140907|Losartan|losartan|mesh-list
84040374|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84040375|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84040376|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84040377|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84040378|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040379|NCT00132717|Atorvastatin|atorvastatin|mesh-list
84040380|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84040381|NCT00132717|Simvastatin|simvastatin|mesh-list
84040382|NCT00132717|Ezetimibe|ezetimibe|mesh-list
84040383|NCT00132717|Pravastatin|pravastatin|mesh-list
84040384|NCT00132717|Lovastatin|lovastatin|mesh-list
84040385|NCT00132717|L 647318|l 647318|mesh-list
84040386|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
83154363|NCT05262985|Durvalumab|durvalumab|mesh-list
84040387|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84040388|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040389|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
84040390|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040391|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040392|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84040393|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040394|NCT00127179|Finasteride|finasteride|mesh-list
84040395|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040396|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040397|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84040398|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84040399|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040400|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
84040401|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040402|NCT00127179|Urological Agents|urological agents|mesh-ancestor
84040403|NCT00953706|Ivacaftor|ivacaftor|mesh-list
84040404|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84040405|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84040406|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040407|NCT02852382|Morphine|morphine|mesh-list
84040408|NCT02852382|Bupivacaine|bupivacaine|mesh-list
84040409|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
84040410|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
84040411|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040412|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040413|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
84040414|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040415|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84040416|NCT02852382|Narcotics|narcotics|mesh-ancestor
84040417|NCT02852382|Analgesics|analgesics|mesh-ancestor
84040418|NCT00630942|Minocycline|minocycline|mesh-list
83154401|NCT02205541|Eculizumab|eculizumab|mesh-list
84040419|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84040420|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040421|NCT00602550|Zidovudine|zidovudine|mesh-list
84040422|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
84040423|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040424|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84040425|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84040426|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040427|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
84040428|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040429|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84040430|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84040431|NCT00602706|Melphalan|melphalan|mesh-list
84040432|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
84040433|NCT00602706|Sargramostim|sargramostim|mesh-list
84040434|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84040435|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
84040436|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040437|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040438|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84040439|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84040440|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
84040441|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040442|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84040443|NCT00602706|Analgesics|analgesics|mesh-ancestor
84040444|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
84040445|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040446|NCT00604344|Insulin|insulin|mesh-list
84040447|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84040448|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
84040449|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
84040450|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
84040451|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
84040452|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040453|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040454|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
84040455|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
84040456|NCT02851914|Serotonin|serotonin|mesh-list
84040457|NCT02851914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
84040458|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84040459|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84040460|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
84040461|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040462|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040463|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040464|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84040465|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84040466|NCT00938964|Lidocaine|lidocaine|mesh-list
84040467|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
84040468|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
84040469|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040470|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040471|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
84040472|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040473|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84040474|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84040475|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84040476|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84040477|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040478|NCT00938886|Naltrexone|naltrexone|mesh-list
84040479|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84040480|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84040481|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040482|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
84040483|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040484|NCT02852070|Dimercaprol|dimercaprol|mesh-list
84040485|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
84040486|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
84040487|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040488|NCT00602862|Bevacizumab|bevacizumab|mesh-list
84040489|NCT00602862|Sorafenib|sorafenib|mesh-list
84040490|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84040491|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040492|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84040493|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84040494|NCT00602862|Growth Substances|growth substances|mesh-ancestor
84040495|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040496|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
84040497|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84040498|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040499|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040500|NCT00942708|Fluoxetine|fluoxetine|mesh-list
84040501|NCT00942708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84040502|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84040503|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84040504|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040505|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040506|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
84040507|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040508|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84040509|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
84040510|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84040511|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84040512|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84040513|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040514|NCT00942084|Acyclovir|acyclovir|mesh-list
84040515|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
84040516|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040517|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
84040518|NCT00941928|Fludarabine|fludarabine|mesh-list
84040519|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
83154532|NCT04528004|Niacin|niacin|mesh-list
84040520|NCT00941928|Interleukin-2|interleukin-2|mesh-list
84040521|NCT00941928|Epratuzumab|epratuzumab|mesh-list
84040522|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84040523|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
84040524|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040525|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040526|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84040527|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
84040528|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040529|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040530|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84040531|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84040532|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
84040533|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84040534|NCT00941928|Analgesics|analgesics|mesh-ancestor
84040535|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
84040536|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040537|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84040538|NCT02852694|Adalimumab|adalimumab|mesh-list
84040539|NCT02852694|Methotrexate|methotrexate|mesh-list
84040540|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
83280363|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040541|NCT02852694|Azathioprine|azathioprine|mesh-list
84040542|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84040543|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
84040544|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84040545|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040546|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84040547|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
84040548|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040549|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040550|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
84040551|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040552|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84040553|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84040554|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
84040555|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040556|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84040557|NCT02852694|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84040558|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040559|NCT00604578|Pioglitazone|pioglitazone|mesh-list
84040560|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040561|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040562|NCT00937560|Paclitaxel|paclitaxel|mesh-list
84040563|NCT00937560|Bevacizumab|bevacizumab|mesh-list
84040564|NCT00937560|Carboplatin|carboplatin|mesh-list
84040565|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84040566|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040567|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
84040568|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
84040569|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
84040570|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040571|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84040572|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84040573|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84040574|NCT00937560|Growth Substances|growth substances|mesh-ancestor
84040575|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040576|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
84040577|NCT04268394|Metformin|metformin|mesh-list
84040578|NCT04268394|Itraconazole|itraconazole|mesh-list
84040579|NCT04268394|Rifampin|rifampin|mesh-list
84040580|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
84040581|NCT04268394|Methotrexate|methotrexate|mesh-list
84040582|NCT04268394|Digoxin|digoxin|mesh-list
84040583|NCT04268394|Midazolam|midazolam|mesh-list
84040584|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84040585|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040586|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040587|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84040588|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
84040589|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84040590|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84040591|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
84040592|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040593|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040594|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
84040595|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040596|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84040597|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84040598|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
84040599|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040600|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84040601|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84040602|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84040603|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040604|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84040605|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84040606|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84040607|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84040608|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
84040609|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
84040610|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
84040611|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
84040612|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040613|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84040614|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040615|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040616|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84040617|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
84040618|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040619|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84040620|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84040621|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84040622|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
84040623|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040624|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84040625|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84040626|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
84040627|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84040628|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
84040629|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84040630|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84040631|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84040632|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84040633|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84040634|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84040635|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84040636|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84040637|NCT04268394|Protective Agents|protective agents|mesh-ancestor
84040638|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84040639|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84040641|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
84040642|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040643|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040644|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84040645|NCT02851212|Metformin|metformin|mesh-list
84040646|NCT02851212|Canagliflozin|canagliflozin|mesh-list
84040647|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040648|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040649|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84040650|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040651|NCT00594568|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
84040652|NCT00594568|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84040653|NCT00594568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040654|NCT00594568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040655|NCT04143802|Dulaglutide|dulaglutide|mesh-list
84040656|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040657|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040658|NCT00682630|Artesunate|artesunate|mesh-list
84040659|NCT00682630|Pyronaridine|pyronaridine|mesh-list
84040660|NCT00682630|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
84040661|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
84040662|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84040663|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84040664|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040665|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040666|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
84040667|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
84040668|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84040669|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
84040670|NCT00875056|Vorinostat|vorinostat|mesh-list
84040671|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040672|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84040673|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040674|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040675|NCT00685594|Vitamin D|vitamin d|mesh-list
84040676|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
84040677|NCT00685594|Vitamins|vitamins|mesh-ancestor
84040678|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
84040679|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040680|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84040681|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84040682|NCT00685672|Epinephrine|epinephrine|mesh-list
84040683|NCT00685672|Racepinephrine|racepinephrine|mesh-list
84040684|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
84040685|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84040686|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83280513|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84040687|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
84040688|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040689|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040690|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040691|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84040692|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84040693|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
84040694|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040695|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84040696|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
84040697|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
84040698|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
84040699|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84040700|NCT00683176|Choline|choline|mesh-list
84040701|NCT00683176|Fenofibrate|fenofibrate|mesh-list
84040702|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040703|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
84040704|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040705|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040706|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
84040707|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84040708|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
84040709|NCT02626234|Digoxin|digoxin|mesh-list
84040710|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84040711|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84040712|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040713|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
84040714|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040715|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040716|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84040717|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040718|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84040719|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84040720|NCT02626234|Protective Agents|protective agents|mesh-ancestor
84040721|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040722|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
84040723|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040724|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84040725|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040726|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040727|NCT00685906|Ticagrelor|ticagrelor|mesh-list
84040728|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
84040729|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84040730|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84040731|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
84040732|NCT00685906|Estradiol|estradiol|mesh-list
84040733|NCT00685906|Estrogens|estrogens|mesh-ancestor
84040734|NCT00685906|Hormones|hormones|mesh-ancestor
84040735|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040736|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040737|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84040738|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
84040739|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84040740|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84040741|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84040742|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84040743|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84040744|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84040745|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84040746|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84040747|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84040748|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
84040749|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040750|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040751|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84040752|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
84040753|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84040754|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84040755|NCT04139824|Naproxen|naproxen|mesh-list
84040756|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84040757|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84040758|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83280591|NCT01691092|Ketamine|ketamine|mesh-list
84040759|NCT04139824|Analgesics|analgesics|mesh-ancestor
84040760|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
84040761|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040762|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040763|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040764|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
84040765|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84040766|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040767|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040768|NCT00940602|Deferasirox|deferasirox|mesh-list
84040769|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84040770|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
84040771|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
84040772|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040774|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84040775|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84040776|NCT00686140|Analgesics|analgesics|mesh-ancestor
84040777|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
84040778|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040779|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040780|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040781|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040782|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84040783|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84040784|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040785|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040786|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
84040787|NCT00686218|Panobinostat|panobinostat|mesh-list
84040788|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84040789|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040790|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84040791|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040792|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040793|NCT00683956|Propofol|propofol|mesh-list
84040794|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
84040795|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040796|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040797|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84040798|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84040799|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
84040800|NCT02850744|Temozolomide|temozolomide|mesh-list
84040801|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84040802|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
84040803|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040804|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040805|NCT04139668|Naltrexone|naltrexone|mesh-list
84040806|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84040807|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84040808|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040809|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
84040810|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040811|NCT04266756|Selexipag|selexipag|mesh-list
84040812|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84040813|NCT00606060|Factor VIII|factor viii|mesh-list
84040814|NCT00606060|Coagulants|coagulants|mesh-ancestor
84040815|NCT00875524|Vaccines|vaccines|mesh-list
84040816|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
84040817|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040818|NCT01094288|Docetaxel|docetaxel|mesh-list
84040819|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040820|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
84040821|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
84040822|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
83154885|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
84040823|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040824|NCT05380986|Apatinib|apatinib|mesh-list
84040825|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040826|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84040827|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040828|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040829|NCT00684112|Gabapentin|gabapentin|mesh-list
84040830|NCT00684112|Analgesics|analgesics|mesh-ancestor
84040831|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
84040832|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040833|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040835|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84040836|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84040837|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84040838|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84040839|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84040840|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84040841|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040842|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040843|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
83154934|NCT02141477|Decitabine|decitabine|mesh-list
84040844|NCT00684190|Esomeprazole|esomeprazole|mesh-list
84040845|NCT00684190|Lesogaberan|lesogaberan|mesh-list
84040846|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84040847|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84040848|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84040849|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040850|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040851|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84040852|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
84040853|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
84040854|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040855|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040856|NCT00684268|Silybin|silybin|mesh-list
84040857|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84040858|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040859|NCT00684268|Protective Agents|protective agents|mesh-ancestor
84040860|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040861|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
84040862|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040863|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040864|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84040865|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84040866|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040867|NCT00874120|Phenylephrine|phenylephrine|mesh-list
84040868|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
84040869|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84040870|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
84040871|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
84040872|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040873|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040874|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
84040875|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84040876|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
84040877|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
84040878|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84040879|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84040880|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84040881|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
84040882|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040883|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040884|NCT00874120|Protective Agents|protective agents|mesh-ancestor
84040885|NCT00939822|Simvastatin|simvastatin|mesh-list
84040886|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84040887|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84040888|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
84040889|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040890|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84040891|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84040892|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040893|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84040894|NCT00685126|Albuterol|albuterol|mesh-list
84040895|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84040896|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
84040897|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040898|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040899|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84040900|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
84040901|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
84040902|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84040903|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84040904|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84040905|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84040906|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
84040907|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040908|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040909|NCT00687388|Celecoxib|celecoxib|mesh-list
84040910|NCT00687388|Doxazosin|doxazosin|mesh-list
84040911|NCT00687388|Prazosin|prazosin|mesh-list
84040912|NCT00687388|Tamsulosin|tamsulosin|mesh-list
84040913|NCT00687388|Alfuzosin|alfuzosin|mesh-list
84040914|NCT00687388|Terazosin|terazosin|mesh-list
84040915|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83155095|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
84040916|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84040917|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84040918|NCT00687388|Analgesics|analgesics|mesh-ancestor
84040919|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
84040920|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040921|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040922|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040923|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84040924|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84040925|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84040926|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040927|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040928|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84040929|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84040930|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
84040931|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040932|NCT00687388|Urological Agents|urological agents|mesh-ancestor
84040933|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84040934|NCT00939510|Lenalidomide|lenalidomide|mesh-list
84040935|NCT00939510|Sargramostim|sargramostim|mesh-list
84040936|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
84040937|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040938|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84040939|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84040940|NCT00939510|Growth Substances|growth substances|mesh-ancestor
84040941|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
84040942|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040943|NCT00687466|Insulin|insulin|mesh-list
84040944|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040945|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040946|NCT04266288|Ketamine|ketamine|mesh-list
84040947|NCT04266288|Analgesics|analgesics|mesh-ancestor
84040948|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
84040949|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84040950|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040951|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84040952|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84040953|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
84040954|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
84040955|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155133|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
84040956|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84040957|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84040958|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040959|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040960|NCT00687622|Trametinib|trametinib|mesh-list
84040961|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040962|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84040963|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84040964|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040965|NCT00687700|Propranolol|propranolol|mesh-list
84040966|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84040967|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84040968|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
84040969|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84040970|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84040971|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040972|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84040973|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84040974|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
84040975|NCT00935532|Insulin|insulin|mesh-list
84040976|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84040977|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
84040978|NCT00935532|Exenatide|exenatide|mesh-list
84040979|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84040980|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280807|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84040981|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84040982|NCT00935532|Incretins|incretins|mesh-ancestor
84040983|NCT00935532|Hormones|hormones|mesh-ancestor
84040984|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84040985|NCT04138420|Bevacizumab|bevacizumab|mesh-list
84040986|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84040987|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040988|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84040989|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84040990|NCT04138420|Growth Substances|growth substances|mesh-ancestor
84040991|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84040992|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
84040993|NCT05378646|Interferons|interferons|mesh-list
84040994|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
84040995|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84040996|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
84040997|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84040998|NCT01093586|Cyclosporine|cyclosporine|mesh-list
84040999|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
84041000|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
84041001|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84041002|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84041003|NCT01093586|Prednisolone|prednisolone|mesh-list
84041004|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
84041005|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
84041006|NCT01093586|Busulfan|busulfan|mesh-list
84041007|NCT01093586|Cyclosporins|cyclosporins|mesh-list
84041008|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
84041009|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84041010|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84041011|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
84041012|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041013|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
84041014|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041015|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041016|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84041017|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
84041018|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041019|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041020|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84041021|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041022|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
84041023|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041024|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
84041025|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84041026|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84041027|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84041028|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
84041029|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84041030|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041031|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
84041032|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
84041033|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155210|NCT02228083|Lidocaine|lidocaine|mesh-list
84041034|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041035|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
84041036|NCT01093586|Hormones|hormones|mesh-ancestor
84041037|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041038|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84041039|NCT01093586|Protective Agents|protective agents|mesh-ancestor
84041040|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84041041|NCT04266132|Bupivacaine|bupivacaine|mesh-list
84041042|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
84041043|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
84041044|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84041045|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041046|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
84041047|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041048|NCT02625454|Acetaminophen|acetaminophen|mesh-list
84041049|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84041050|NCT02625454|Analgesics|analgesics|mesh-ancestor
84041051|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
84041052|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041053|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041054|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
84041055|NCT00606450|Thalidomide|thalidomide|mesh-list
84041056|NCT00606450|Apremilast|apremilast|mesh-list
83155244|NCT02228239|Mirtazapine|mirtazapine|mesh-list
84041057|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83280933|NCT02151643|Iron|iron|mesh-list
84041058|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84041059|NCT00606450|Analgesics|analgesics|mesh-ancestor
84041060|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
84041061|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041062|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041063|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041064|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041065|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84041066|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84041067|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041068|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041069|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041070|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
84041071|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
84041072|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84041073|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041074|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84041075|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84041076|NCT00606450|Growth Substances|growth substances|mesh-ancestor
84041077|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
84041078|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041079|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84041081|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84041082|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84041083|NCT04138888|Diuretics|diuretics|mesh-ancestor
84041084|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
84041085|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041086|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84041087|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84041088|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041089|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84041090|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84041091|NCT01098110|Asenapine|asenapine|mesh-list
84041092|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84041093|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84041094|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84041095|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041096|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84041097|NCT00688402|Lesogaberan|lesogaberan|mesh-list
84041098|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041099|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84041100|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
84041101|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
84041102|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041103|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041104|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041105|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
84041106|NCT04138264|Narcotics|narcotics|mesh-ancestor
84041107|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84041108|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041109|NCT04138264|Analgesics|analgesics|mesh-ancestor
84041110|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
84041111|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041112|NCT00688480|Allopurinol|allopurinol|mesh-list
84041113|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
84041114|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041115|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041116|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
84041117|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041118|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84041119|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
84041120|NCT00688480|Protective Agents|protective agents|mesh-ancestor
84041121|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041122|NCT01092728|Dasatinib|dasatinib|mesh-list
84041123|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041124|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041125|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041126|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041127|NCT00688558|Simvastatin|simvastatin|mesh-list
84041128|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
84041129|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84041130|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84041131|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
84041132|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041133|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84041134|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84041135|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041136|NCT02625376|Resveratrol|resveratrol|mesh-list
84041137|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
84041138|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041139|NCT02625376|Protective Agents|protective agents|mesh-ancestor
84041140|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041141|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041142|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83155387|NCT02782169|Pregabalin|pregabalin|mesh-list
84041143|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
84041144|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
84041145|NCT04153084|Cathartics|cathartics|mesh-ancestor
84041146|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041147|NCT04153084|Laxatives|laxatives|mesh-ancestor
84041148|NCT00688948|Alfuzosin|alfuzosin|mesh-list
84041149|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84041150|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84041151|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84041152|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
84041153|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041154|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041155|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041156|NCT00688948|Urological Agents|urological agents|mesh-ancestor
84041157|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
84041158|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84041159|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041160|NCT00873730|Etanercept|etanercept|mesh-list
84041161|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84041162|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84041163|NCT00873730|Analgesics|analgesics|mesh-ancestor
84041164|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
84041165|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041166|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041167|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041168|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041169|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041170|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041171|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
84041172|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84041173|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84041174|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84041175|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
84041176|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041177|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84041178|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84041179|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041180|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
84041181|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84041182|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
84041183|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84041184|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041185|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84041186|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84041187|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84041188|NCT00672568|Capsaicin|capsaicin|mesh-list
84041189|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
84041190|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
84041191|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
83155477|NCT02043847|Melphalan|melphalan|mesh-list
84041192|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041193|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041194|NCT00604032|Tretinoin|tretinoin|mesh-list
84041195|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041196|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
84041197|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
84041198|NCT00874432|Lisinopril|lisinopril|mesh-list
84041199|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
84041200|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
84041201|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
84041202|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041203|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84041204|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84041205|NCT00874432|Protective Agents|protective agents|mesh-ancestor
84041206|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041207|NCT00935220|Linagliptin|linagliptin|mesh-list
83281034|NCT01588990|Growth Substances|growth substances|mesh-ancestor
84041208|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041209|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041210|NCT00935220|Incretins|incretins|mesh-ancestor
84041211|NCT00935220|Hormones|hormones|mesh-ancestor
84041212|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041213|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84041214|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
84041215|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048350|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84041216|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041217|NCT00691912|Paclitaxel|paclitaxel|mesh-list
84041218|NCT00691912|Doxorubicin|doxorubicin|mesh-list
84041219|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84041220|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84041221|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041222|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
84041223|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
84041224|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
84041225|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041226|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84041227|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84041228|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84041229|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041230|NCT05382390|Cytarabine|cytarabine|mesh-list
84041231|NCT05382390|Decitabine|decitabine|mesh-list
84041232|NCT05382390|Aclarubicin|aclarubicin|mesh-list
84041233|NCT05382390|Lenograstim|lenograstim|mesh-list
84041234|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84041235|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
84041236|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041237|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041238|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
84041239|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041240|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041241|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
84041242|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041243|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84041244|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041245|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84041246|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84041247|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84041248|NCT00689806|Lovastatin|lovastatin|mesh-list
84041249|NCT00689806|L 647318|l 647318|mesh-list
84041250|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
84041251|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84041252|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84041253|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
84041254|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041255|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84041256|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84041257|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041258|NCT00594958|Vaccines|vaccines|mesh-list
84041259|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
84041260|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041261|NCT04204044|Folic Acid|folic acid|mesh-list
84041262|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
84041263|NCT04204044|Inositol|inositol|mesh-list
84041264|NCT04204044|Metformin|metformin|mesh-list
84041265|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041266|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041267|NCT04204044|Hematinics|hematinics|mesh-ancestor
84041268|NCT04204044|Vitamins|vitamins|mesh-ancestor
84041269|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
84041270|NCT04267614|Etanercept|etanercept|mesh-list
84041271|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84041272|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84041273|NCT04267614|Analgesics|analgesics|mesh-ancestor
84041274|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
84041275|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041276|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041277|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041278|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041279|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041280|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041281|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
84041282|NCT00594880|Interferons|interferons|mesh-list
84041283|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
84041284|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
84041285|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84041286|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041287|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
84041288|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041289|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
84041290|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041291|NCT00690118|Pioglitazone|pioglitazone|mesh-list
84041292|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041293|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041294|NCT00694252|Lapatinib|lapatinib|mesh-list
84041295|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041296|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041297|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041298|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041299|NCT00871858|Fulvestrant|fulvestrant|mesh-list
84041300|NCT00871858|Anastrozole|anastrozole|mesh-list
84041301|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84041302|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041303|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84041304|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84041305|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
84041306|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041307|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041308|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84041309|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84041310|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041311|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041312|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
84041313|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84041314|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84041315|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84041316|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
84041317|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041318|NCT00871780|Natalizumab|natalizumab|mesh-list
84041319|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
84041320|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041321|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
84041322|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84041323|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84041324|NCT00694408|Prednisolone|prednisolone|mesh-list
84041325|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
84041326|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
84041327|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84041328|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84041329|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84041330|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84041331|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
84041332|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041333|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
84041334|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
84041335|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041336|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041337|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041338|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
84041339|NCT00694408|Hormones|hormones|mesh-ancestor
84041340|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041341|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84041342|NCT00694408|Protective Agents|protective agents|mesh-ancestor
84041343|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84041344|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041345|NCT04136782|Paclitaxel|paclitaxel|mesh-list
84041346|NCT04136782|Docetaxel|docetaxel|mesh-list
84041347|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84041348|NCT04136782|Carboplatin|carboplatin|mesh-list
84041349|NCT04136782|Epirubicin|epirubicin|mesh-list
84041350|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84041351|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041352|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
84041353|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
84041354|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
84041355|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041356|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84041357|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84041358|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84041359|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041360|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
84041361|NCT04137640|Docetaxel|docetaxel|mesh-list
84041362|NCT04137640|Letrozole|letrozole|mesh-list
84041363|NCT04137640|Epirubicin|epirubicin|mesh-list
84041364|NCT04137640|Palbociclib|palbociclib|mesh-list
84041365|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041366|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
84048351|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
84041367|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041368|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041369|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84041370|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
84041371|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041372|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041373|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84041374|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
84041375|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
84041376|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
84041377|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84041378|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84041379|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041380|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84041381|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
84041382|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041383|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84041384|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84041385|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84041386|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041387|NCT02624830|Glyburide|glyburide|mesh-list
84041388|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041389|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041390|NCT02629042|Prednisolone|prednisolone|mesh-list
84041391|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041392|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041393|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
84041394|NCT02629042|Hormones|hormones|mesh-ancestor
84041395|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041396|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84041397|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041398|NCT00692614|Triamcinolone|triamcinolone|mesh-list
84041399|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84041400|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84041401|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84041402|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041403|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
84041404|NCT00692614|Hormones|hormones|mesh-ancestor
84041405|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041406|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041407|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041408|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
84041409|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041410|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041411|NCT04136470|Nivolumab|nivolumab|mesh-list
84041412|NCT04136470|Ipilimumab|ipilimumab|mesh-list
84041413|NCT04136470|Atezolizumab|atezolizumab|mesh-list
84041414|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84041415|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041416|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84041417|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041418|NCT00673426|Enoxaparin|enoxaparin|mesh-list
84041419|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
84041420|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84041421|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84041422|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041423|NCT00673504|Gemcitabine|gemcitabine|mesh-list
84041424|NCT00673504|Sunitinib|sunitinib|mesh-list
84041425|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84041426|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
84041427|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041428|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041429|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84041430|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84041431|NCT00673504|Growth Substances|growth substances|mesh-ancestor
84041432|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041433|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
84041434|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041435|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041436|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84041437|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84041438|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84041439|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
84041440|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041441|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84041442|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84041443|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041444|NCT00912574|Molgramostim|molgramostim|mesh-list
84041445|NCT00912574|Sargramostim|sargramostim|mesh-list
84041446|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84041447|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
84041448|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
84041449|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041450|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041451|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84041452|NCT00695032|Ifosfamide|ifosfamide|mesh-list
84041453|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041454|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84041455|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
84041456|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041457|NCT04137328|Liraglutide|liraglutide|mesh-list
84041458|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041459|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041460|NCT04137328|Incretins|incretins|mesh-ancestor
84041461|NCT04137328|Hormones|hormones|mesh-ancestor
84041462|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041463|NCT00693004|Donepezil|donepezil|mesh-list
84041464|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84041465|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041466|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041467|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
84041468|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041469|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041470|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
84041471|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
84041472|NCT00695344|Everolimus|everolimus|mesh-list
84041473|NCT00695344|Azathioprine|azathioprine|mesh-list
84041474|NCT00695344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84041475|NCT00695344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041476|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041477|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041478|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041479|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
84041480|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041481|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041482|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84041483|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84041484|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
84041485|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84041486|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041487|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
84041488|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84041489|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041490|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
84041491|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84041492|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041493|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
84041494|NCT00607542|Baclofen|baclofen|mesh-list
84041495|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84041496|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041497|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84041498|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041499|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84041500|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
84041501|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
84041502|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041503|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041504|NCT00936858|Everolimus|everolimus|mesh-list
84041505|NCT00936858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84041506|NCT00936858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041507|NCT00936858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041508|NCT00936858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041509|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041510|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
84041511|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041512|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041514|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84041515|NCT02624440|Trimethoprim|trimethoprim|mesh-list
84041516|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
84041517|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84041518|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041519|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84041520|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041521|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041522|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84041523|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84041524|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84041525|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
84041526|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84041527|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84041528|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84041529|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84041530|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84041531|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
84041532|NCT00693862|Levodopa|levodopa|mesh-list
84041533|NCT00693862|Carbidopa|carbidopa|mesh-list
84041534|NCT00693862|Entacapone|entacapone|mesh-list
84041535|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84041536|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84041537|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
84041538|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041539|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041540|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041541|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84041542|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041543|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84041544|NCT05377788|Lazertinib|lazertinib|mesh-list
84041545|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041546|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041547|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041548|NCT00674050|Fluticasone|fluticasone|mesh-list
84041549|NCT00674050|Albuterol|albuterol|mesh-list
84041550|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041551|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041552|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84041553|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
84041554|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041555|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84041556|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
84041557|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
84041558|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84041559|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
84041560|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84041561|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84041562|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84041563|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84041564|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
84041565|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041566|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041567|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
84041568|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
84041569|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84041570|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84041571|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041572|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041573|NCT00872170|Urological Agents|urological agents|mesh-ancestor
84041574|NCT00936702|Paclitaxel|paclitaxel|mesh-list
84041575|NCT00936702|Carboplatin|carboplatin|mesh-list
84041576|NCT00936702|Everolimus|everolimus|mesh-list
84041577|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84041578|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041579|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
84041580|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
84041581|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
84041582|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041583|NCT00936702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84041584|NCT00936702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041585|NCT00936702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041586|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041587|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
84041588|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041589|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84041590|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
84041591|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84041592|NCT00607932|Protective Agents|protective agents|mesh-ancestor
84041593|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041594|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041596|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84041597|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
84041598|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041599|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041600|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84041601|NCT00674674|Topotecan|topotecan|mesh-list
84041602|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84041603|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84041604|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041605|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041606|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041607|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84041608|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
84041609|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041610|NCT04265508|Hemostatics|hemostatics|mesh-list
84041611|NCT04265508|Coagulants|coagulants|mesh-ancestor
84041612|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84041613|NCT02623738|Latanoprost|latanoprost|mesh-list
84041614|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84041615|NCT00607074|Albendazole|albendazole|mesh-list
84041616|NCT00607074|Anthelmintics|anthelmintics|mesh-list
84041617|NCT00607074|Secnidazole|secnidazole|mesh-list
84041618|NCT00607074|Metronidazole|metronidazole|mesh-list
84041619|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84041620|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041621|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
84041622|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84041623|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84041624|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
84041625|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
84041626|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
84041627|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041628|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041629|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84041630|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
84041631|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041632|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
84041633|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041634|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041635|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84041636|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
84041637|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041638|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041639|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84041640|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
84041641|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84041642|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
84041643|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84041644|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041645|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84041646|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84041647|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84041648|NCT00674752|Gabapentin|gabapentin|mesh-list
84041649|NCT00674752|Analgesics|analgesics|mesh-ancestor
84041650|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
84041651|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041652|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041653|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
84041654|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84041655|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84041656|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84041657|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84041658|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84041659|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84041660|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041661|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041662|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
84041663|NCT04265274|Copper|copper|mesh-list
84041664|NCT04265274|Disulfiram|disulfiram|mesh-list
84041665|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041666|NCT04265274|Trace Elements|trace elements|mesh-ancestor
84041667|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
84041668|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041669|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84041670|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
84041671|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041672|NCT00607152|Allopurinol|allopurinol|mesh-list
84041673|NCT00607152|Rasburicase|rasburicase|mesh-list
84041674|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
84041675|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041676|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041677|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
84041678|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041679|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84041680|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
84041681|NCT00607152|Protective Agents|protective agents|mesh-ancestor
84041682|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041683|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
84041684|NCT00696748|Testosterone|testosterone|mesh-list
84041685|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
84041686|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
84041687|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84041688|NCT00696748|Androgens|androgens|mesh-ancestor
84041689|NCT00696748|Hormones|hormones|mesh-ancestor
84041690|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041691|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041692|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84041693|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041694|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
84041695|NCT02621554|Resveratrol|resveratrol|mesh-list
84041696|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
84041697|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041698|NCT02621554|Protective Agents|protective agents|mesh-ancestor
84041699|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041700|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041701|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84041702|NCT02623036|Enalapril|enalapril|mesh-list
84041703|NCT02623036|Lisinopril|lisinopril|mesh-list
84041704|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84041705|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
84041706|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041707|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041708|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84041709|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84041710|NCT02623036|Protective Agents|protective agents|mesh-ancestor
84041711|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041712|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84041713|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041714|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041715|NCT00696826|Incretins|incretins|mesh-ancestor
84041716|NCT00696826|Hormones|hormones|mesh-ancestor
84041717|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041718|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84041719|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
84041720|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041721|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041722|NCT01092182|Prednisone|prednisone|mesh-list
84041723|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
84041724|NCT01092182|Rituximab|rituximab|mesh-list
84041725|NCT01092182|Doxorubicin|doxorubicin|mesh-list
84041726|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84041727|NCT01092182|Etoposide|etoposide|mesh-list
84041728|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
84041729|NCT01092182|Vincristine|vincristine|mesh-list
84041730|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84041731|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
84041732|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041733|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041734|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84041735|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
84041736|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041737|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041738|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84041739|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84041740|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84041741|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84041742|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84041743|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041744|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041745|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
84041746|NCT01092182|Hormones|hormones|mesh-ancestor
84041747|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041748|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84041749|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84041750|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
84041751|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
84041752|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
84041753|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
84041754|NCT04135378|Vitamins|vitamins|mesh-ancestor
84041755|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
84041756|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041757|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
84041758|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041759|NCT04135378|Protective Agents|protective agents|mesh-ancestor
84041760|NCT04135690|Sorafenib|sorafenib|mesh-list
84041761|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041762|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84041763|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041764|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041765|NCT02878772|Aspirin|aspirin|mesh-list
84041766|NCT02878772|Vinpocetine|vinpocetine|mesh-list
84041767|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84041768|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84041769|NCT02878772|Analgesics|analgesics|mesh-ancestor
84041770|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
84041771|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041772|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041773|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041774|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041775|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84041776|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84041777|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041778|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84041779|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84041780|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041781|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
84041782|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84041783|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
84041784|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84041785|NCT02878772|Protective Agents|protective agents|mesh-ancestor
83156548|NCT02233387|Imidazole|imidazole|mesh-list
84041786|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
84041787|NCT02623114|Methylphenidate|methylphenidate|mesh-list
84041788|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84041789|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84041790|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041791|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84041792|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84041793|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84041794|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041795|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
84041796|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041797|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84041798|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
84041799|NCT00932646|Olodaterol|olodaterol|mesh-list
84041800|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
84041801|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84041802|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
84041803|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041804|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041805|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84041806|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
84041807|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84041808|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84041809|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84041810|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
84041811|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041812|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041813|NCT00871234|Etravirine|etravirine|mesh-list
84041814|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84041815|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84041816|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041817|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041818|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
84041819|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041820|NCT04267224|Ticagrelor|ticagrelor|mesh-list
84041821|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84041822|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83156597|NCT05483894|Atorvastatin|atorvastatin|mesh-list
84041823|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84041824|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84041825|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
84041826|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84041827|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041828|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041829|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
84041830|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041831|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041832|NCT04264260|Colchicine|colchicine|mesh-list
84041833|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
84041834|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041835|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
84041836|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
84041837|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
84041838|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041839|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041840|NCT04267146|Nivolumab|nivolumab|mesh-list
84041841|NCT04267146|Temozolomide|temozolomide|mesh-list
84041842|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84041843|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041844|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84041845|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041846|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84041847|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
84041848|NCT02691078|Octreotide|octreotide|mesh-list
84041849|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041850|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84041851|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041852|NCT02621320|Vitamin D|vitamin d|mesh-list
84041853|NCT02621320|Vitamins|vitamins|mesh-ancestor
84041854|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
84041855|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041856|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84041857|NCT01097330|Amiodarone|amiodarone|mesh-list
84041858|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84041859|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
84041860|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83156630|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
84041861|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84041862|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041863|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84041864|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84041865|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84041866|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041867|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84041868|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84041869|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84041870|NCT00934440|Bevacizumab|bevacizumab|mesh-list
84041871|NCT00934440|Azacitidine|azacitidine|mesh-list
84041872|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84041873|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041874|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84041875|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84041876|NCT00934440|Growth Substances|growth substances|mesh-ancestor
84041877|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041878|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
84041879|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84041880|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
84041881|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041882|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281714|NCT04615949|Cannabidiol|cannabidiol|mesh-list
84041883|NCT02622802|Acetaminophen|acetaminophen|mesh-list
84041884|NCT02622802|Azithromycin|azithromycin|mesh-list
84041885|NCT02622802|Erythromycin|erythromycin|mesh-list
84041886|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
84041887|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84041888|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
84041889|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84041890|NCT02622802|Analgesics|analgesics|mesh-ancestor
84041891|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
84041892|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041893|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041894|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
84041895|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84041896|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041897|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84041898|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84041899|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041900|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041901|NCT05158374|Aspirin|aspirin|mesh-list
84041902|NCT05158374|Metformin|metformin|mesh-list
84041903|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84041904|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041905|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84041906|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84041907|NCT05158374|Analgesics|analgesics|mesh-ancestor
84041908|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
84041909|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041910|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041911|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84041912|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84041913|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84041914|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041915|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84041916|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84041917|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84041918|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
84041919|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
84041920|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
84041921|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
84041922|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
84041923|NCT00675688|Estrogens|estrogens|mesh-list
84041924|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84041925|NCT00675688|Hormones|hormones|mesh-ancestor
84041926|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84041927|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041928|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84041929|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
84041930|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84041931|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84041932|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84041933|NCT02622334|Latanoprost|latanoprost|mesh-list
84041934|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84041935|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84041936|NCT00696514|Vitamin D|vitamin d|mesh-list
84041937|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
84041938|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
84041939|NCT00696514|Vitamins|vitamins|mesh-list
84041940|NCT00696514|Folic Acid|folic acid|mesh-list
84041941|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
84041942|NCT00696514|Hydroxocobalamin|hydroxocobalamin|mesh-list
84041943|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
84041944|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041945|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84041946|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84041947|NCT00696514|Hematinics|hematinics|mesh-ancestor
84041948|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
84041949|NCT04263870|Capecitabine|capecitabine|mesh-list
84041950|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
84041951|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84041952|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
84048352|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041953|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041954|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041955|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
84041956|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84041957|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
84041958|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
84041959|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
84041960|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
84041962|NCT00871000|Protective Agents|protective agents|mesh-ancestor
84041963|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041964|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
84041965|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
84041966|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84041967|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84041968|NCT01096784|Mecasermin|mecasermin|mesh-list
84041969|NCT01096784|Growth Substances|growth substances|mesh-ancestor
84041970|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041971|NCT00696592|Bevacizumab|bevacizumab|mesh-list
84041972|NCT00696592|Verteporfin|verteporfin|mesh-list
84041973|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84041974|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84041975|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84041976|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84041977|NCT00696592|Growth Substances|growth substances|mesh-ancestor
84041978|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041979|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
84041980|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84041981|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
84041982|NCT02622022|Morphine|morphine|mesh-list
84041983|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84041984|NCT02622022|Narcotics|narcotics|mesh-ancestor
84041985|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84041986|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041987|NCT02622022|Analgesics|analgesics|mesh-ancestor
84041988|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
84041989|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84041990|NCT00934050|Inositol|inositol|mesh-list
84041991|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
84041992|NCT00934050|Vitamins|vitamins|mesh-ancestor
84041993|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
84041994|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84041995|NCT02620618|Infliximab|infliximab|mesh-list
84041996|NCT02620618|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84041997|NCT02620618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84041998|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
84041999|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042000|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042001|NCT04135456|Mannitol|mannitol|mesh-list
84042002|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84042003|NCT04135456|Diuretics|diuretics|mesh-ancestor
84042004|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
84042005|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042006|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
84042007|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042008|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
84042009|NCT05321576|Narcotics|narcotics|mesh-ancestor
84042010|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042011|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042012|NCT05321576|Analgesics|analgesics|mesh-ancestor
84042013|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
84042014|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042015|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84042016|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
84042017|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84042018|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157046|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042019|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042020|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84042021|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84042022|NCT00864916|Protective Agents|protective agents|mesh-ancestor
84042023|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042024|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
84042025|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84042026|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
84042027|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
84042028|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042029|NCT00864682|Lidocaine|lidocaine|mesh-list
84042030|NCT00864682|Propofol|propofol|mesh-list
84042031|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
84042032|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
84042033|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042034|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042035|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
84042036|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042037|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84042038|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84042040|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84042041|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042042|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84042043|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84042044|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
84042045|NCT00931944|Pramipexole|pramipexole|mesh-list
84042046|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
84042047|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042048|NCT00931944|Protective Agents|protective agents|mesh-ancestor
84042049|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042050|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84042051|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84042052|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
84042053|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
84042054|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042055|NCT02614456|Interferons|interferons|mesh-list
84042056|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
84042057|NCT02614456|Nivolumab|nivolumab|mesh-list
84042058|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042059|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042060|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84042061|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042062|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
84042063|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042064|NCT04130230|Choline|choline|mesh-list
84042065|NCT04130230|Neostigmine|neostigmine|mesh-list
83157250|NCT02264743|Estradiol|estradiol|mesh-list
84042066|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84042067|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042068|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042069|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
84042070|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042071|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042072|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84042073|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
84042074|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042075|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
84042076|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84042077|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
84042078|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042079|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84042080|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
84042081|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84042082|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84042083|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042084|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
84042085|NCT02616874|Romidepsin|romidepsin|mesh-list
84042086|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84042087|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042088|NCT02616874|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84042089|NCT02616874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042090|NCT02616874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042091|NCT04133428|Valsartan|valsartan|mesh-list
84042092|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84042093|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84042094|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84042095|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84042096|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042097|NCT00869050|Capecitabine|capecitabine|mesh-list
84042098|NCT00869050|Temozolomide|temozolomide|mesh-list
84042099|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84042100|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
84042101|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042102|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042103|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84042104|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
84042105|NCT04133506|Aspirin|aspirin|mesh-list
84042106|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84042107|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84042108|NCT04133506|Analgesics|analgesics|mesh-ancestor
84042109|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
84042110|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157336|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
84042112|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042113|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042114|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84042115|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84042116|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042117|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84042118|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84042119|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042120|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
84042121|NCT04872218|Abatacept|abatacept|mesh-list
84042122|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
84042123|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042124|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84042125|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042126|NCT04872218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042127|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042128|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042129|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042130|NCT04133194|Mesalamine|mesalamine|mesh-list
84042131|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84042132|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84042133|NCT04133194|Analgesics|analgesics|mesh-ancestor
84042134|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
84042135|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042136|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042137|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042138|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042139|NCT00698464|Pasireotide|pasireotide|mesh-list
84042140|NCT00698464|Hormones|hormones|mesh-ancestor
84042141|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042142|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042143|NCT04933682|Rifampin|rifampin|mesh-list
84042144|NCT04933682|Fluconazole|fluconazole|mesh-list
84042145|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84042146|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
84042147|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84042148|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042149|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
84042150|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84042151|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042152|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042153|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84042154|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84042155|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84042156|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84042157|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84042158|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84042159|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
84042160|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84042161|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84042162|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84042163|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
84042164|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042165|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042166|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84042167|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84042168|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
84042169|NCT00927186|Teriparatide|teriparatide|mesh-list
84042170|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84042171|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042172|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042173|NCT00593554|Fludarabine|fludarabine|mesh-list
84042174|NCT00593554|Thiotepa|thiotepa|mesh-list
84042175|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
84042176|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84042177|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042178|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042179|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042180|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
84042181|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042182|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84042183|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
84042184|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84042185|NCT01101308|Oxycodone|oxycodone|mesh-list
84042186|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84042187|NCT01101308|Narcotics|narcotics|mesh-ancestor
84042188|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042189|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042190|NCT01101308|Analgesics|analgesics|mesh-ancestor
84042191|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
84042192|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042193|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84042194|NCT00926796|Azithromycin|azithromycin|mesh-list
84042195|NCT00926796|Gentamicins|gentamicins|mesh-list
84042196|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
84042197|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84042198|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042199|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84042200|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042201|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042202|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84042203|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84042204|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042205|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84042206|NCT00696982|Glyburide|glyburide|mesh-list
84042207|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84042208|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042209|NCT00696982|Incretins|incretins|mesh-ancestor
84042210|NCT00696982|Hormones|hormones|mesh-ancestor
84042211|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042212|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84042213|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
84042214|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042215|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042216|NCT01087736|Topiramate|topiramate|mesh-list
84042217|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
84042218|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84042219|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042220|NCT04262388|Durvalumab|durvalumab|mesh-list
84042221|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042222|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042223|NCT00608712|Esomeprazole|esomeprazole|mesh-list
84042224|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84042225|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042226|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84042227|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042228|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042229|NCT01079936|Lenalidomide|lenalidomide|mesh-list
84042230|NCT01079936|Melphalan|melphalan|mesh-list
84042231|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
84042232|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042233|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84042234|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84042235|NCT01079936|Growth Substances|growth substances|mesh-ancestor
84042236|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
84042237|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042238|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84042239|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
84042240|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042241|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84042242|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042243|NCT00931710|Losartan|losartan|mesh-list
84042244|NCT00931710|Amlodipine|amlodipine|mesh-list
84042245|NCT00931710|Valsartan|valsartan|mesh-list
84042246|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84042247|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84042248|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84042249|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84042250|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042251|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042252|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042253|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
84042254|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84042255|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84042256|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84042257|NCT00931710|Diuretics|diuretics|mesh-ancestor
84042258|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
84042259|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84042260|NCT01100528|Interferons|interferons|mesh-list
84042261|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
84042262|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
84042263|NCT01100528|Dacarbazine|dacarbazine|mesh-list
84042264|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042265|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
84042266|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042267|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
84042268|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042269|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84042270|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
84042271|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042272|NCT01079234|Insulin|insulin|mesh-list
84042273|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84042274|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
84042275|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
84042276|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84042277|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042278|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
84042279|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84042280|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
84042281|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042282|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042283|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84042284|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
84042285|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84042286|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
84042287|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042288|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042289|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84042290|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
84042291|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
84042292|NCT00931632|Protective Agents|protective agents|mesh-ancestor
84042293|NCT00608790|Albuterol|albuterol|mesh-list
84042294|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84042295|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
84042296|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042297|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042298|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84042299|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
84042300|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
84042301|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84042302|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84042303|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84042304|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84042305|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
84042306|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042307|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042308|NCT01078922|Ofatumumab|ofatumumab|mesh-list
84042309|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042310|NCT00609570|Calcium|calcium|mesh-list
84042311|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042312|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042313|NCT00863746|Sorafenib|sorafenib|mesh-list
84042314|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042315|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042316|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042317|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042318|NCT04992156|Palbociclib|palbociclib|mesh-list
84042319|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042320|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042321|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042322|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042323|NCT00608946|Copper|copper|mesh-list
84042324|NCT00608946|Trace Elements|trace elements|mesh-ancestor
84042325|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
84042326|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282166|NCT02164916|Antibodies|antibodies|mesh-list
83282167|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
83282168|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83282169|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
83282170|NCT02164916|Mitogens|mitogens|mesh-list
83282171|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
84042327|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
84042329|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84042330|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84042331|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042332|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042333|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042334|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042335|NCT00926328|Triclosan|triclosan|mesh-list
84042336|NCT00926328|Fluorides|fluorides|mesh-list
84042337|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
84042338|NCT00926328|Protective Agents|protective agents|mesh-ancestor
84042339|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042340|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84042341|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042342|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84042343|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84042344|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
84042345|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042346|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84042347|NCT04203732|Anesthetics|anesthetics|mesh-list
84042348|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042349|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042350|NCT00863512|Gemcitabine|gemcitabine|mesh-list
84042351|NCT00863512|Docetaxel|docetaxel|mesh-list
84042352|NCT00863512|Pemetrexed|pemetrexed|mesh-list
84042353|NCT00863512|Vinorelbine|vinorelbine|mesh-list
84042354|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042355|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84042356|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
84042357|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042358|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
84042359|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
84042360|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
84042361|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042362|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84042363|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84042364|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84042365|NCT02619994|Levofloxacin|levofloxacin|mesh-list
84042366|NCT02619994|Linezolid|linezolid|mesh-list
84042367|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
84042368|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84042369|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042370|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84042371|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84042372|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84042373|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042374|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042375|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042376|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84042377|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84042378|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84042379|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
84042380|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
84042381|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84042382|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84042383|NCT04263402|Prednisolone|prednisolone|mesh-list
84042384|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
84042385|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84042386|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
84042387|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042388|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
84042389|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
83158201|NCT02547038|Bismuth|bismuth|mesh-list
84042390|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042391|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042392|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042393|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
84042394|NCT04263402|Hormones|hormones|mesh-ancestor
84042395|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042396|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84042397|NCT04263402|Protective Agents|protective agents|mesh-ancestor
83282247|NCT02188784|Iron|iron|mesh-list
83282248|NCT02188784|Trace Elements|trace elements|mesh-ancestor
83282249|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
83282250|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282251|NCT02222246|Morphine|morphine|mesh-list
83282252|NCT02222246|Hydromorphone|hydromorphone|mesh-list
84042398|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84042399|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042401|NCT00868192|Pemetrexed|pemetrexed|mesh-list
83158236|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
84042402|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042403|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042404|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84042405|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84042406|NCT00868192|Growth Substances|growth substances|mesh-ancestor
84042407|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042408|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
84042409|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042410|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042411|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84042412|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84042413|NCT02615782|Tadalafil|tadalafil|mesh-list
84042414|NCT02615782|Tamsulosin|tamsulosin|mesh-list
84042415|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
84042416|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84042417|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84042418|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042419|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042420|NCT02615782|Urological Agents|urological agents|mesh-ancestor
84042421|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84042422|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84042423|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84042424|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
84042425|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042426|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042427|NCT00930930|Paclitaxel|paclitaxel|mesh-list
84042428|NCT00930930|Everolimus|everolimus|mesh-list
84042429|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84042430|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042431|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
84042432|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
84042433|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
84042434|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042435|NCT00930930|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84042436|NCT00930930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042437|NCT00930930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042438|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042439|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
84042440|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042441|NCT00698776|Lenalidomide|lenalidomide|mesh-list
84042442|NCT00698776|KRN 7000|krn 7000|mesh-list
84042443|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
84042444|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042445|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84042446|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84042447|NCT00698776|Growth Substances|growth substances|mesh-ancestor
84042448|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
84042449|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042450|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84042451|NCT04122040|Roxithromycin|roxithromycin|mesh-list
84042452|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84042453|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042454|NCT04258956|Avelumab|avelumab|mesh-list
84042455|NCT04258956|Axitinib|axitinib|mesh-list
84042456|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042457|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042458|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042459|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042460|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042461|NCT00862654|Ketoconazole|ketoconazole|mesh-list
84042462|NCT00862654|Clobetasol|clobetasol|mesh-list
84042463|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
84042464|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042465|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84042466|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84042467|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042468|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042469|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84042470|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
84042471|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042472|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042473|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84042474|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042475|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
84042476|NCT00862654|Hormones|hormones|mesh-ancestor
84042477|NCT00609180|Antioxidants|antioxidants|mesh-list
84042478|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042479|NCT00609180|Protective Agents|protective agents|mesh-ancestor
84042480|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042481|NCT00867490|Amlodipine|amlodipine|mesh-list
84042482|NCT00867490|Candesartan|candesartan|mesh-list
84042483|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84042484|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84042485|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84042486|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84042487|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048353|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042488|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042489|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042490|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
84042491|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84042492|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84042493|NCT00867490|Diuretics|diuretics|mesh-ancestor
84042494|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
84042495|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84042496|NCT00697060|Docetaxel|docetaxel|mesh-list
84042497|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042498|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
84042499|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
84042500|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
84042501|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042502|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
84042503|NCT00867334|Panitumumab|panitumumab|mesh-list
84042504|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042505|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042506|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042507|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158516|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042508|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042509|NCT00925704|Calcitriol|calcitriol|mesh-list
84042510|NCT00925704|Sevelamer|sevelamer|mesh-list
84042511|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042512|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042513|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84042514|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84042515|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042516|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84042517|NCT00925704|Vitamins|vitamins|mesh-ancestor
84042518|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
84042519|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84042520|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
84042521|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
84042522|NCT00697138|Amphetamine|amphetamine|mesh-list
84042523|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
84042524|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84042525|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84042526|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84042527|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84042528|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042529|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
84042530|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042531|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042532|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84042533|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
84042534|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
84042535|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042536|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
84042537|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84042538|NCT00609960|Midazolam|midazolam|mesh-list
84042539|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84042540|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84042541|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042542|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042543|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84042544|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84042545|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84042546|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84042547|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
84042548|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
84042549|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
84042550|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
84042551|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042552|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042553|NCT04879134|Apomorphine|apomorphine|mesh-list
84042554|NCT04879134|Emetics|emetics|mesh-ancestor
84042555|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042556|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
84042557|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042558|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042559|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
84042560|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
84042561|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042562|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042563|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
84042564|NCT04134130|Testosterone|testosterone|mesh-list
84042565|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
84042566|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
84042567|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84042568|NCT04134130|Androgens|androgens|mesh-ancestor
84042569|NCT04134130|Hormones|hormones|mesh-ancestor
84042570|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042571|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042572|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84042573|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042574|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
84042575|NCT04258644|Paclitaxel|paclitaxel|mesh-list
84042576|NCT04258644|Apatinib|apatinib|mesh-list
84042577|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84042578|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042579|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
84042580|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
84042581|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
84042582|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042583|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042584|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042585|NCT02619448|Paclitaxel|paclitaxel|mesh-list
84042586|NCT02619448|Carboplatin|carboplatin|mesh-list
84042587|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84042588|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042589|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
84042590|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
84042591|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158875|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042592|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042593|NCT00610038|Glyburide|glyburide|mesh-list
84042594|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84042595|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042596|NCT02619526|Carvedilol|carvedilol|mesh-list
84042597|NCT02619526|Nebivolol|nebivolol|mesh-list
84042598|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84042599|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84042600|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
84042601|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042602|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042603|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042604|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84042605|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
84042606|NCT02619526|Protective Agents|protective agents|mesh-ancestor
84042607|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84042608|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84042609|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042610|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
84042611|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84042612|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84042613|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84042614|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84042615|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84042616|NCT04119622|Capecitabine|capecitabine|mesh-list
84042617|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
84042618|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84042619|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
83158941|NCT02162303|Colchicine|colchicine|mesh-list
84042620|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042621|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042622|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
84042623|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042624|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
84042625|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042626|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042627|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84042628|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
84042629|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042630|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042631|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84042632|NCT00866788|Omalizumab|omalizumab|mesh-list
84042633|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
84042634|NCT00866788|Promethazine|promethazine|mesh-list
84042635|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
84042636|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
84042637|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84042638|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84042639|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
84042640|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84042641|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84042642|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042643|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042644|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
84042645|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
84042646|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
84042647|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042648|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
84042649|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
84042650|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042651|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
84042652|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042653|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042654|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
84042655|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
84042656|NCT04132570|Budesonide|budesonide|mesh-list
84042657|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042658|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84042659|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
84042660|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042661|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042662|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84042663|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
84042664|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
84042665|NCT04132570|Hormones|hormones|mesh-ancestor
84042666|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042667|NCT00699244|Anesthetics|anesthetics|mesh-list
84042668|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042669|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042670|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84042671|NCT00699322|Glimepiride|glimepiride|mesh-list
84042672|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84042673|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042674|NCT00699322|Incretins|incretins|mesh-ancestor
84042675|NCT00699322|Hormones|hormones|mesh-ancestor
84042676|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042677|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84042678|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
84042679|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042680|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042681|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84042682|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042683|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
84042684|NCT00860470|Iron|iron|mesh-list
84042685|NCT00860470|Trace Elements|trace elements|mesh-list
84042686|NCT00860470|Folic Acid|folic acid|mesh-list
84042687|NCT00860470|Micronutrients|micronutrients|mesh-list
84042688|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042689|NCT00860470|Hematinics|hematinics|mesh-ancestor
84042690|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
84042691|NCT00860470|Vitamins|vitamins|mesh-ancestor
84042692|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
84042693|NCT00923364|Fludarabine|fludarabine|mesh-list
84042694|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
84042695|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84042696|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042697|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
84042698|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042699|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042700|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84042701|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
84042702|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042703|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042704|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84042705|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84042706|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
84042707|NCT02613676|Bilirubin|bilirubin|mesh-list
84042708|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
84042709|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042710|NCT02613676|Protective Agents|protective agents|mesh-ancestor
84042711|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042712|NCT00860158|Dasatinib|dasatinib|mesh-list
84042713|NCT00860158|Leuprolide|leuprolide|mesh-list
84042714|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042715|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042716|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042717|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042718|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84042719|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
84042720|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84042721|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042722|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84042723|NCT02878538|Deferiprone|deferiprone|mesh-list
84042724|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84042725|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
84042726|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
84042727|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042728|NCT04134598|Tamoxifen|tamoxifen|mesh-list
84042729|NCT04134598|Letrozole|letrozole|mesh-list
84042730|NCT04134598|Anastrozole|anastrozole|mesh-list
84042731|NCT04134598|Exemestane|exemestane|mesh-list
84042732|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042733|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84042734|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84042735|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042736|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042737|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83159340|NCT03134443|Analgesics|analgesics|mesh-ancestor
84042738|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
84042739|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042740|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042741|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84042742|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84042743|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84042744|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84042745|NCT04134052|Midazolam|midazolam|mesh-list
84042746|NCT04134052|Ketamine|ketamine|mesh-list
84042747|NCT04134052|Analgesics|analgesics|mesh-ancestor
84042748|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
84042749|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159400|NCT00835549|Cefdinir|cefdinir|mesh-list
84042750|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042751|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84042752|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84042753|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
84042754|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
84042755|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042756|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84042757|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84042758|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042759|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042760|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84042761|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84042762|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84042763|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84042764|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84042765|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
84042766|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
84042767|NCT02615080|Pemirolast|pemirolast|mesh-list
84042768|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
84042769|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
84042770|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042771|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042772|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042773|NCT00859456|Sunitinib|sunitinib|mesh-list
84042774|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042775|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84042776|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84042777|NCT00859456|Growth Substances|growth substances|mesh-ancestor
84042778|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042779|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
84042780|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84042781|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042782|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042783|NCT01075646|Ropivacaine|ropivacaine|mesh-list
84042784|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84042785|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
84042786|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
84042787|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042788|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042789|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
84042790|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042791|NCT00799903|Darapladib|darapladib|mesh-list
84042792|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
84042793|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042794|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042795|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
84042796|NCT01075256|Calcium|calcium|mesh-list
84042797|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042798|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042799|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84042800|NCT02876432|Diclofenac|diclofenac|mesh-list
84042801|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84042802|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84042803|NCT02876432|Analgesics|analgesics|mesh-ancestor
84042804|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
84042805|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042806|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042807|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042808|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042809|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84042810|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042811|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042812|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
84042813|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84042814|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
84042815|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159658|NCT02169167|Octenidine|octenidine|mesh-list
84042816|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
84042817|NCT02876276|Protective Agents|protective agents|mesh-ancestor
84042818|NCT00923130|Bevacizumab|bevacizumab|mesh-list
84042819|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042820|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042821|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84042822|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84042823|NCT00923130|Growth Substances|growth substances|mesh-ancestor
84042824|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042825|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
84042826|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84042827|NCT04258098|Metronidazole|metronidazole|mesh-list
84042828|NCT04258098|Streptomycin|streptomycin|mesh-list
84042829|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042830|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84042831|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84042832|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84042833|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042834|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042835|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
84042836|NCT02605915|Carboplatin|carboplatin|mesh-list
84042837|NCT02605915|Docetaxel|docetaxel|mesh-list
84042838|NCT02605915|Doxorubicin|doxorubicin|mesh-list
84042839|NCT02605915|Trastuzumab|trastuzumab|mesh-list
84042840|NCT02605915|Atezolizumab|atezolizumab|mesh-list
84042841|NCT02605915|Pertuzumab|pertuzumab|mesh-list
84042842|NCT02605915|Maytansine|maytansine|mesh-list
84042843|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84042844|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042845|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
83159759|NCT02165033|Budesonide|budesonide|mesh-list
84042846|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042847|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042848|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84042849|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
84042850|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042851|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042852|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84042853|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
84042854|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
84042855|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
84042856|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84042857|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84042858|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84042859|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042860|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042861|NCT02605915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84042862|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84042863|NCT02605915|Immunotoxins|immunotoxins|mesh-ancestor
84042864|NCT02605915|Immunoconjugates|immunoconjugates|mesh-ancestor
84042865|NCT04028323|Octreotide|octreotide|mesh-list
84042866|NCT04028323|Terlipressin|terlipressin|mesh-list
84042867|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042868|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84042869|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042870|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84042871|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84042872|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
84042873|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84042874|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042875|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159882|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042876|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84042877|NCT02607163|Analgesics|analgesics|mesh-ancestor
84042878|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
84042879|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042880|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84042881|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84042882|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84042883|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
84042884|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042885|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042886|NCT01075100|Carboplatin|carboplatin|mesh-list
84042887|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042888|NCT02876354|Vitamin K|vitamin k|mesh-list
84042889|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
84042890|NCT02876354|Vitamins|vitamins|mesh-ancestor
84042891|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
84042892|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042893|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84042894|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84042895|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042896|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
84042897|NCT02876354|Coagulants|coagulants|mesh-ancestor
84042898|NCT00626678|Prednisone|prednisone|mesh-list
84042899|NCT00626678|Azathioprine|azathioprine|mesh-list
84042900|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042901|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
84042902|NCT00626678|Hormones|hormones|mesh-ancestor
84042903|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042904|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042905|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84042906|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042907|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
84042908|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159987|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042909|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84042910|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84042911|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
84042912|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84042913|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
84042914|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84042915|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84042916|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
84042917|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
84042918|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84042919|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042920|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
84042921|NCT03076021|Isotretinoin|isotretinoin|mesh-list
83282773|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
84042922|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
84042923|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
84042924|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84042925|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84042926|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042927|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042928|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042929|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
84042930|NCT00859222|Bevacizumab|bevacizumab|mesh-list
84042931|NCT00859222|Panobinostat|panobinostat|mesh-list
84042932|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042933|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042934|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84042935|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84042936|NCT00859222|Growth Substances|growth substances|mesh-ancestor
84042937|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042938|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
84042939|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84042940|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042941|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042942|NCT00858988|Rifaximin|rifaximin|mesh-list
84042943|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84042944|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84042945|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84042946|NCT00858832|Methylergonovine|methylergonovine|mesh-list
84042947|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
84042948|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84042949|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042950|NCT01071512|Natalizumab|natalizumab|mesh-list
84042951|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
84042952|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042953|NCT00626834|Vigabatrin|vigabatrin|mesh-list
84042954|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
84042955|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042956|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042957|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
84042958|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84042959|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042960|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
84042961|NCT04255992|Vitamin D|vitamin d|mesh-list
84042962|NCT04255992|Calcium|calcium|mesh-list
84042963|NCT04255992|Vitamins|vitamins|mesh-ancestor
84042964|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
84042965|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042966|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84042967|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84042968|NCT02618824|Tryptophan|tryptophan|mesh-list
84042969|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84042970|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
84042971|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84042972|NCT00610350|Simendan|simendan|mesh-list
84042973|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84042974|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
84042975|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84042976|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84042977|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84042978|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84042979|NCT00610350|Protective Agents|protective agents|mesh-ancestor
84042980|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042981|NCT01071200|Hormones|hormones|mesh-list
84042982|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84042983|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84042984|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042985|NCT04255836|Durvalumab|durvalumab|mesh-list
84042986|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84042987|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84042988|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
84042989|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
84042990|NCT00699478|Vitamins|vitamins|mesh-ancestor
84042991|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
84042992|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84042993|NCT01070888|Budesonide|budesonide|mesh-list
84042994|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
84042995|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84042996|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84042997|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
84042998|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84042999|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043000|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84043001|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
84043002|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
84043003|NCT01070888|Hormones|hormones|mesh-ancestor
84043004|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043005|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84043006|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84043007|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84043008|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
84043009|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043010|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043011|NCT00857896|Fesoterodine|fesoterodine|mesh-list
84043012|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84043013|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84043014|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
84043015|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043016|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043017|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043018|NCT00857896|Urological Agents|urological agents|mesh-ancestor
84043019|NCT05652673|Nivolumab|nivolumab|mesh-list
84043020|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043021|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043022|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84043023|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043024|NCT00857818|Risperidone|risperidone|mesh-list
84043025|NCT00857818|Aripiprazole|aripiprazole|mesh-list
84043026|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84043027|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84043028|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
84043029|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043030|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043031|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043032|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84043033|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043034|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043035|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043036|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84043037|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
84043038|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
84043039|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
84043040|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84043041|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84043042|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84043043|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84043044|NCT02618668|Ketamine|ketamine|mesh-list
84043045|NCT02618668|Propofol|propofol|mesh-list
84043046|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043047|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043048|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043049|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84043050|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
84043051|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
84043052|NCT02618668|Analgesics|analgesics|mesh-ancestor
84043053|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
84043054|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043055|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84043056|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84043057|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84043058|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043059|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043060|NCT01074944|Eliglustat|eliglustat|mesh-list
84043061|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043062|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043063|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
84043064|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043065|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84043066|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84043067|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043068|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043069|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84043070|NCT01074554|Azithromycin|azithromycin|mesh-list
84043071|NCT01074554|Levofloxacin|levofloxacin|mesh-list
84043072|NCT01074554|Rifampin|rifampin|mesh-list
84043073|NCT01074554|Ethambutol|ethambutol|mesh-list
84043074|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043075|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84043076|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
84043077|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84043078|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84043079|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84043080|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043081|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043082|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043083|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84043084|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84043085|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
84043086|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84043087|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84043088|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84043089|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84043090|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84043091|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84043092|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84043093|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84043094|NCT00857584|Sertraline|sertraline|mesh-list
84043095|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
84043096|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043097|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84043098|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043099|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043100|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043101|NCT00857584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84043102|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83160410|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84043103|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84043104|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043105|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043106|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
84043107|NCT00798967|Teduglutide|teduglutide|mesh-list
84043108|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043109|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84043110|NCT00798967|Protective Agents|protective agents|mesh-ancestor
83160466|NCT02741713|Lidocaine|lidocaine|mesh-list
84043111|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043112|NCT04132102|Afatinib|afatinib|mesh-list
84043113|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043114|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043115|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043116|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043117|NCT02618356|Raltitrexed|raltitrexed|mesh-list
84043118|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84043119|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
84043120|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043121|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043122|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84043123|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043124|NCT00697996|Rituximab|rituximab|mesh-list
84043125|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043126|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043127|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
84043128|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043129|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043130|NCT04118842|Rifampin|rifampin|mesh-list
84043131|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84043132|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
84043133|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043134|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043135|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
84043136|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84043137|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043138|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043139|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84043140|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84043141|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84043142|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84043143|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84043144|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84043145|NCT00699634|Nabilone|nabilone|mesh-list
84043146|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
84043147|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
84043148|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043149|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043150|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043151|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84043152|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043153|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043154|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043155|NCT00798889|Sunitinib|sunitinib|mesh-list
84043156|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043157|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84043158|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84043159|NCT00798889|Growth Substances|growth substances|mesh-ancestor
84043160|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043161|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
84043162|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043163|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043164|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043165|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
84043166|NCT04113889|Metformin|metformin|mesh-list
84043167|NCT04113889|Pioglitazone|pioglitazone|mesh-list
84043168|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84043169|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043170|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
84043171|NCT04113889|Vitamins|vitamins|mesh-ancestor
84043172|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
84043173|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
84043174|NCT00796861|Sunitinib|sunitinib|mesh-list
84043175|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043176|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84043177|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84043178|NCT00796861|Growth Substances|growth substances|mesh-ancestor
84043179|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043180|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
84043181|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043182|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043183|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043184|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
84043185|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
84043186|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043187|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160630|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
84043188|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043189|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
84043190|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043191|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043192|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043193|NCT00914797|Terbutaline|terbutaline|mesh-list
84043194|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84043195|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
84043196|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043197|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043198|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84043199|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
84043200|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
84043201|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
84043202|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84043203|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84043204|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84043205|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84043206|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
84043207|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043208|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043209|NCT00798655|Cisplatin|cisplatin|mesh-list
84043210|NCT00798655|Panitumumab|panitumumab|mesh-list
84043211|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043212|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043213|NCT00914641|Apixaban|apixaban|mesh-list
84043214|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84043215|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
84043216|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84043217|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
84043218|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043219|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043220|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
83283068|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
84043222|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043223|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043224|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043225|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043226|NCT00856492|Paclitaxel|paclitaxel|mesh-list
84043227|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
84043228|NCT00856492|Bevacizumab|bevacizumab|mesh-list
84043229|NCT00856492|Doxorubicin|doxorubicin|mesh-list
84043230|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84043231|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84043232|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84043233|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043234|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
84043235|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
84043236|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
84043237|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043238|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043239|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
84043240|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043241|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043242|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84043243|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
84043244|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84043245|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043246|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84043247|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84043248|NCT00856492|Growth Substances|growth substances|mesh-ancestor
84043249|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
84043250|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84043251|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84043252|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84043253|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043254|NCT04111159|Propofol|propofol|mesh-list
84043255|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043256|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043257|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043258|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84043259|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
84043260|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
84043261|NCT00697372|Sirolimus|sirolimus|mesh-list
84043262|NCT00697372|Everolimus|everolimus|mesh-list
84043263|NCT00697372|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84043264|NCT00697372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043265|NCT00697372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043266|NCT00697372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043267|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043268|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
84043269|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043270|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043271|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043272|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043273|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84043274|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
84043275|NCT04111003|Anesthetics|anesthetics|mesh-list
84043276|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043277|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043278|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
84043279|NCT00856180|Bevacizumab|bevacizumab|mesh-list
84043280|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043281|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
84043282|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043283|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160903|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
84043284|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84043285|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
84043286|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043287|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043288|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84043289|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043290|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84043291|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84043292|NCT00856180|Growth Substances|growth substances|mesh-ancestor
84043293|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
84043294|NCT02605213|Vancomycin|vancomycin|mesh-list
84043295|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043296|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043297|NCT00900627|Paclitaxel|paclitaxel|mesh-list
84043298|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84043299|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043300|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
84043301|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
84043302|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
84043303|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043304|NCT00866320|Sorafenib|sorafenib|mesh-list
84043305|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043306|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043307|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043308|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043309|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
84043310|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043311|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160952|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
84043312|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043313|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043314|NCT04115449|Analgesics|analgesics|mesh-ancestor
84043315|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
84043316|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043317|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84043318|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84043319|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84043320|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
84043321|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043322|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043323|NCT04133974|Methadone|methadone|mesh-list
84043324|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84043325|NCT04133974|Narcotics|narcotics|mesh-ancestor
84043326|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043327|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043328|NCT04133974|Analgesics|analgesics|mesh-ancestor
84043329|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
84043330|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043331|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
84043332|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
84043333|NCT03679611|Neostigmine|neostigmine|mesh-list
84043334|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84043335|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048354|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84043336|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043337|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
84043338|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043339|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043340|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84043341|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
84043342|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043343|NCT00914953|Oxytocin|oxytocin|mesh-list
84043344|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
84043345|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84043346|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043347|NCT00869518|Trimethoprim|trimethoprim|mesh-list
84043348|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84043349|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
84043350|NCT00869518|Rifabutin|rifabutin|mesh-list
84043351|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84043352|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043353|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
84043354|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84043355|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84043356|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84043357|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043358|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161121|NCT05149365|Hormones|hormones|mesh-ancestor
84043359|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84043360|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84043361|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84043362|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043363|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84043364|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
84043365|NCT00869440|Midazolam|midazolam|mesh-list
84043366|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84043367|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043368|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043369|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043370|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84043371|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043372|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043373|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84043374|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
84043375|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
84043376|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
84043377|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
84043378|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043379|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043380|NCT00895947|Interferons|interferons|mesh-list
84043381|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
84043382|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043383|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
84043384|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043385|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
84043386|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043387|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84043388|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
84043389|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043390|NCT02841579|Osimertinib|osimertinib|mesh-list
84043391|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043392|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043393|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043394|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043395|NCT00588445|Gefitinib|gefitinib|mesh-list
84043396|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043397|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043398|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043399|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043400|NCT00092781|Celecoxib|celecoxib|mesh-list
84043401|NCT00092781|Etoricoxib|etoricoxib|mesh-list
84043402|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84043403|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043404|NCT00092781|Analgesics|analgesics|mesh-ancestor
84043405|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
84043406|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043407|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043408|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043409|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043410|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84043411|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84043412|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043413|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043414|NCT00092703|Diclofenac|diclofenac|mesh-list
84043415|NCT00092703|Etoricoxib|etoricoxib|mesh-list
84043416|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84043417|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043418|NCT00092703|Analgesics|analgesics|mesh-ancestor
84043419|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
84043420|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043421|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043422|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043423|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043424|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84043425|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043426|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043427|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84043428|NCT00699946|Olanzapine|olanzapine|mesh-list
84043429|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
84043430|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
84043431|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043432|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043433|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043434|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84043435|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043436|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043437|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043438|NCT00699946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84043439|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84043440|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84043441|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043442|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043443|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
84043444|NCT00796315|Doxylamine|doxylamine|mesh-list
84043445|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
84043446|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
84043447|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
84043448|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043449|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043450|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043451|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84043452|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
84043453|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
84043454|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043455|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043456|NCT00855166|Metformin|metformin|mesh-list
84043457|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84043458|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
84043459|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84043460|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043461|NCT00855166|Incretins|incretins|mesh-ancestor
84043462|NCT00855166|Hormones|hormones|mesh-ancestor
84043463|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043464|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84043465|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
84043466|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043467|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043468|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84043469|NCT00854620|Sorafenib|sorafenib|mesh-list
84043470|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043471|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043472|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043473|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043474|NCT00793585|Allopurinol|allopurinol|mesh-list
84043475|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
84043476|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043477|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043478|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
84043479|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043480|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84043481|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
84043482|NCT00793585|Protective Agents|protective agents|mesh-ancestor
84043483|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043484|NCT02013141|Telavancin|telavancin|mesh-list
84043485|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043486|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043487|NCT04107103|Nivolumab|nivolumab|mesh-list
84043488|NCT04107103|Pemetrexed|pemetrexed|mesh-list
84043489|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043490|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043491|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84043492|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043493|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043494|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84043495|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84043496|NCT02617810|Midazolam|midazolam|mesh-list
84043497|NCT02617810|Warfarin|warfarin|mesh-list
84043498|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84043499|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043500|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043501|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043502|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84043503|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043504|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043505|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84043506|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
84043507|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
84043508|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
84043509|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
84043510|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043511|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043512|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
84043513|NCT00898443|Anesthetics|anesthetics|mesh-list
84043514|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043515|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043516|NCT02614612|Prednisone|prednisone|mesh-list
84043517|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
84043518|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84043519|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84043520|NCT02614612|Prednisolone|prednisolone|mesh-list
84043521|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
84043522|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84043523|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
84043524|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043525|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
84043526|NCT02614612|Hormones|hormones|mesh-ancestor
84043527|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043528|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043529|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84043530|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043531|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
84043532|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
84043533|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043534|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043535|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84043536|NCT02614612|Protective Agents|protective agents|mesh-ancestor
84043537|NCT00900159|Eszopiclone|eszopiclone|mesh-list
84043538|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043539|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043540|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043541|NCT01689909|Zolpidem|zolpidem|mesh-list
84043542|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84043543|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043544|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043545|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043546|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84043547|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
84043548|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
84043549|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043550|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043551|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84043552|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161600|NCT05064449|Analgesics|analgesics|mesh-ancestor
84043553|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043554|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043555|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043556|NCT00592852|Fluoxetine|fluoxetine|mesh-list
84043557|NCT00592852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84043558|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84043559|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84043560|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043561|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043562|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
84043563|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043564|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84043565|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
84043566|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043567|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84043568|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84043569|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043570|NCT00895245|Dexamethasone|dexamethasone|mesh-list
84043571|NCT00895245|Palonosetron|palonosetron|mesh-list
84043572|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
84043573|NCT00895245|Aprepitant|aprepitant|mesh-list
84043574|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043575|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
84043576|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
84043577|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043578|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043579|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043580|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
84043581|NCT00895245|Hormones|hormones|mesh-ancestor
84043582|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043583|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84043584|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043585|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84043586|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84043587|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
84043588|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043589|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043590|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84043591|NCT03172377|Adalimumab|adalimumab|mesh-list
84043592|NCT03172377|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84043593|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043594|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043596|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84043597|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043598|NCT02617654|Incretins|incretins|mesh-ancestor
84043599|NCT02617654|Hormones|hormones|mesh-ancestor
84043600|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043601|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
84043602|NCT00700024|Testosterone|testosterone|mesh-list
84043603|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
84043604|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
84043605|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84043606|NCT00700024|Androgens|androgens|mesh-ancestor
84043607|NCT00700024|Hormones|hormones|mesh-ancestor
84043608|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043609|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043610|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84043611|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043612|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
84043613|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
84043614|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84043615|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043616|NCT00796003|Decitabine|decitabine|mesh-list
84043617|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84043618|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
84043619|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043620|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043621|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043622|NCT04110535|Midazolam|midazolam|mesh-list
84043623|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84043624|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043625|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043626|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043627|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84043628|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043629|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043630|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84043631|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
84043632|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
84043633|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
84043634|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
84043635|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043636|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043637|NCT04025203|Ibuprofen|ibuprofen|mesh-list
84043638|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
84043639|NCT04025203|Gabapentin|gabapentin|mesh-list
84043640|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84043641|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043642|NCT04025203|Analgesics|analgesics|mesh-ancestor
84043643|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
84043644|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043645|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043646|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043647|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043648|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84043649|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043650|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043651|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
84043652|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84043653|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84043654|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043655|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043656|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84043657|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84043658|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043659|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
84043660|NCT02843607|Immunomodulating Agents|immunomodulating agents|mesh-list
84043661|NCT02843607|Immunologic Factors|immunologic factors|mesh-ancestor
84043662|NCT02843607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043663|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
84043664|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043665|NCT00915577|Interferons|interferons|mesh-list
84043666|NCT00915577|Interferon-beta|interferon-beta|mesh-list
84043667|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
84043668|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043669|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
84043670|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043671|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
84043672|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043673|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84043675|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
84043676|NCT00899847|Promethazine|promethazine|mesh-list
84043677|NCT00899847|Cyclosporine|cyclosporine|mesh-list
84043678|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
84043679|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
84043680|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84043681|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
84043682|NCT00899847|Melphalan|melphalan|mesh-list
84043683|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
84043684|NCT00899847|Cyclosporins|cyclosporins|mesh-list
84043685|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
84043686|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84043687|NCT00899847|Lenograstim|lenograstim|mesh-list
84043688|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043689|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
84043690|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043691|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043692|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84043693|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
84043694|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043695|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043696|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84043697|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84043698|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043699|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
84043700|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043701|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
84043702|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84043703|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043704|NCT00899847|Analgesics|analgesics|mesh-ancestor
84043705|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
84043706|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043707|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
84043708|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84043709|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84043710|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
84043711|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043712|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043713|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84043714|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84043715|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84043716|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
84043717|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
84043718|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
84043719|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
84043720|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043721|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84043722|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
84043723|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
84043724|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043725|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84043726|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
84043727|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
84043728|NCT00899847|Hormones|hormones|mesh-ancestor
84043729|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043730|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84043731|NCT00899847|Protective Agents|protective agents|mesh-ancestor
84043732|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84043733|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
84043734|NCT00529113|Gemcitabine|gemcitabine|mesh-list
84043735|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84043736|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
84043737|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043738|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043739|NCT04106557|Gaboxadol|gaboxadol|mesh-list
84043740|NCT04106557|Analgesics|analgesics|mesh-ancestor
84043741|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
84043742|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043743|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043744|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
84043745|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
84043746|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
84043747|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043748|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043750|NCT04117750|Vitamin D|vitamin d|mesh-list
84043751|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
84043752|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84043753|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043754|NCT04117750|Vitamins|vitamins|mesh-ancestor
84043755|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
84043756|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84043757|NCT04117750|Antacids|antacids|mesh-ancestor
84043758|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043759|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043760|NCT04131322|Adalimumab|adalimumab|mesh-list
84043761|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84043762|NCT04131322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84043763|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043764|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043765|NCT02840175|Adalimumab|adalimumab|mesh-list
84043766|NCT02840175|Etanercept|etanercept|mesh-list
84043767|NCT02840175|Abatacept|abatacept|mesh-list
84043768|NCT02840175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84043769|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043770|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043771|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84043772|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043773|NCT02840175|Analgesics|analgesics|mesh-ancestor
84043774|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
84043775|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043776|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043777|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043778|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043779|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
84043780|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84043781|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043782|NCT02840175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043783|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043784|NCT02603497|Peficitinib|peficitinib|mesh-list
84043785|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043786|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043787|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043788|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
84043789|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043790|NCT02840409|Bevacizumab|bevacizumab|mesh-list
84043791|NCT02840409|Vinblastine|vinblastine|mesh-list
84043792|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043793|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043794|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84043795|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84043796|NCT02840409|Growth Substances|growth substances|mesh-ancestor
84043797|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043798|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
84043799|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84043800|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
84043801|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
84043802|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
84043803|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043804|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
84043805|NCT02839941|Tacrolimus|tacrolimus|mesh-list
84043806|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
84043807|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043808|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
84043809|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043810|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84043811|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043812|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043813|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84043814|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043815|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84043816|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
84043817|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043818|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043819|NCT02839941|Hormones|hormones|mesh-ancestor
84043820|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043821|NCT02842983|Esmolol|esmolol|mesh-list
84043822|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84043823|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84043824|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
84043825|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043826|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043827|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043828|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84043829|NCT02839785|Ibuprofen|ibuprofen|mesh-list
84043830|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84043831|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043832|NCT02839785|Analgesics|analgesics|mesh-ancestor
84043833|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
84043834|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043835|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043836|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043837|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043838|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84043839|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043840|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043841|NCT02843061|Rituximab|rituximab|mesh-list
84043842|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84043843|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043844|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
84043845|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043846|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043847|NCT02839239|Vitamin D|vitamin d|mesh-list
84043848|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
84043849|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
84043850|NCT02839239|Vitamins|vitamins|mesh-list
84043851|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
84043852|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043853|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84043854|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84043855|NCT02837835|Ceftazidime|ceftazidime|mesh-list
84043856|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84043857|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043858|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84043859|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84043860|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
84043861|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043862|NCT02839161|Antacids|antacids|mesh-ancestor
84043863|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043864|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043865|NCT04249713|Brodalumab|brodalumab|mesh-list
84043866|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
84043867|NCT00610506|Dexetimide|dexetimide|mesh-list
84043868|NCT00610506|Citalopram|citalopram|mesh-list
84043869|NCT00610506|Escitalopram|escitalopram|mesh-list
84043870|NCT00610506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84043871|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84043872|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84043873|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043874|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043875|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
84043876|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043877|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84043878|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84043879|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
84043880|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
84043881|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043882|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84043883|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84043884|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
84043885|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84043886|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
84043887|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84043888|NCT04260828|Aspirin|aspirin|mesh-list
84043889|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84043890|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84043891|NCT04260828|Analgesics|analgesics|mesh-ancestor
84043892|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
84043893|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043894|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043895|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283745|NCT02073448|Adapalene|adapalene|mesh-list
84043896|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043897|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84043898|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84043899|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043900|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84043901|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84043902|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043903|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
84043904|NCT00928746|Bromides|bromides|mesh-list
84043905|NCT00928746|Ipratropium|ipratropium|mesh-list
84043906|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
84043907|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84043908|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
84043909|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043910|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043911|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84043912|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
84043913|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84043914|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
84043915|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043916|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043917|NCT04468815|Esomeprazole|esomeprazole|mesh-list
84043918|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84043919|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043920|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84043921|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043922|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043923|NCT00610584|Cetirizine|cetirizine|mesh-list
84043924|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84043925|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84043926|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84043927|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
84043928|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
84043929|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043930|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043931|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043932|NCT00894543|Escitalopram|escitalopram|mesh-list
84043933|NCT00894543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84043934|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83161832|NCT00355849|Insulin|insulin|mesh-list
84043935|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84043936|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043937|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043938|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
84043939|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043940|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84043941|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84043942|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043943|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84043944|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84043945|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84043946|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043947|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
84043948|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84043949|NCT00853372|Sunitinib|sunitinib|mesh-list
84043950|NCT00853372|Trebananib|trebananib|mesh-list
84043951|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
84043952|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043953|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84043954|NCT00853372|Growth Substances|growth substances|mesh-ancestor
84043955|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043956|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
83161873|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84043957|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84043958|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043959|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043960|NCT02836977|Tegafur|tegafur|mesh-list
84043961|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84043962|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
84043963|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043964|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043965|NCT04988256|Cyclosporine|cyclosporine|mesh-list
84043966|NCT04988256|Prednisone|prednisone|mesh-list
84043967|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
83283817|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043968|NCT04988256|Cyclosporins|cyclosporins|mesh-list
84043969|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84043970|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
84043971|NCT04988256|Hormones|hormones|mesh-ancestor
83161925|NCT00097357|Enoxaparin|enoxaparin|mesh-list
84043972|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84043973|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84043974|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84043975|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84043976|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84043977|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84043978|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84043979|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
84043980|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
84043981|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84043982|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
84043983|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84043984|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84043985|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
84043986|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
84043987|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84043988|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84043989|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84043990|NCT04988256|Protective Agents|protective agents|mesh-ancestor
84043991|NCT00848536|Travoprost|travoprost|mesh-list
84043992|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84043993|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84043994|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84043995|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
84043996|NCT00922116|Hematinics|hematinics|mesh-ancestor
84043997|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
84043998|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84043999|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
84044000|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044001|NCT04260516|Expectorants|expectorants|mesh-ancestor
84044002|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
84044003|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84044004|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
84044005|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044006|NCT04260516|Protective Agents|protective agents|mesh-ancestor
84044007|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044008|NCT04260516|Antidotes|antidotes|mesh-ancestor
84044009|NCT00921024|Ceftazidime|ceftazidime|mesh-list
84044010|NCT00921024|Ceftolozane|ceftolozane|mesh-list
84044011|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84044012|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044013|NCT00928668|Olodaterol|olodaterol|mesh-list
84044014|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84044015|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
84044016|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044017|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044018|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84044019|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
84044020|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
84044021|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84044022|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044023|NCT00700492|Progesterone|progesterone|mesh-list
84044024|NCT00700492|Progestins|progestins|mesh-ancestor
84044025|NCT00700492|Hormones|hormones|mesh-ancestor
84044026|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044027|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044028|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
84044029|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84044030|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044031|NCT00703300|Bortezomib|bortezomib|mesh-list
84044032|NCT00703300|Decitabine|decitabine|mesh-list
84044033|NCT00703300|Azacitidine|azacitidine|mesh-list
84044034|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044035|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84044036|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
84044037|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044038|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044039|NCT00703378|Docetaxel|docetaxel|mesh-list
84044040|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044041|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
84044042|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
84044043|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
84044044|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044045|NCT00852202|Cariprazine|cariprazine|mesh-list
84044046|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84044047|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84044048|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044049|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044050|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84044052|NCT01074008|Ribavirin|ribavirin|mesh-list
84044053|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84044054|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84044055|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83162146|NCT00315757|Bortezomib|bortezomib|mesh-list
84044056|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
84044057|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044058|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044059|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84044060|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84044061|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
84044062|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044063|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84044064|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84044065|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
84044066|NCT02613052|Propofol|propofol|mesh-list
84044067|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84044068|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044069|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044070|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84044071|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
84044072|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
84044073|NCT01073930|Bisacodyl|bisacodyl|mesh-list
84044074|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
84044075|NCT01073930|Cathartics|cathartics|mesh-ancestor
84044076|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84044077|NCT01073930|Laxatives|laxatives|mesh-ancestor
84044078|NCT01073618|Voriconazole|voriconazole|mesh-list
84044079|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
84044080|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044081|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84044082|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84044083|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044084|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044085|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84044086|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
84044087|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044088|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044089|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84044090|NCT00789373|Pemetrexed|pemetrexed|mesh-list
84044091|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044092|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044093|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044094|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84044095|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84044096|NCT00851890|Interferons|interferons|mesh-list
84044097|NCT00851890|Ribavirin|ribavirin|mesh-list
84044098|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044099|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
84044100|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044101|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
84044102|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044103|NCT00592072|Decanoic acid|decanoic acid|mesh-list
84044104|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
84044105|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044106|NCT00626288|Mesalamine|mesalamine|mesh-list
84044107|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84044108|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84044109|NCT00626288|Analgesics|analgesics|mesh-ancestor
84044110|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
84044111|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044112|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044113|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044114|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044115|NCT00792571|Epoprostenol|epoprostenol|mesh-list
84044116|NCT00792571|Beraprost|beraprost|mesh-list
84044117|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84044118|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
83283969|NCT01504204|Analgesics|analgesics|mesh-ancestor
84044119|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84044120|NCT00794365|Varenicline|varenicline|mesh-list
84044121|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84044122|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84044123|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
84044124|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044125|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044126|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044128|NCT01067144|Lorazepam|lorazepam|mesh-list
84044129|NCT01067144|Analgesics|analgesics|mesh-ancestor
84044130|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
84044131|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044132|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044133|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
84044134|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84044135|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84044136|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044137|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84044138|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84044139|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84044140|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044141|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044142|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
84044143|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
84044144|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
84044145|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84044146|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84044147|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
84044148|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
84044149|NCT01078298|Varenicline|varenicline|mesh-list
84044150|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84044151|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84044152|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
84044153|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044154|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044155|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044156|NCT00788593|Pancreatin|pancreatin|mesh-list
84044157|NCT00788593|Pancrelipase|pancrelipase|mesh-list
84044158|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84044159|NCT04106011|Gabapentin|gabapentin|mesh-list
84044160|NCT04106011|Analgesics|analgesics|mesh-ancestor
84044161|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
84044162|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044163|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044164|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
84044165|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84044166|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84044167|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044168|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84044169|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84044170|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84044171|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044172|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044173|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
84044174|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84044175|NCT02875886|Amiloride|amiloride|mesh-list
84044176|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84044177|NCT02875886|Diuretics|diuretics|mesh-ancestor
84044178|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
84044179|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044180|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84044181|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84044182|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044183|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
84044184|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84044185|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
84044186|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84044187|NCT00793819|Silodosin|silodosin|mesh-list
84044188|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84044189|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84044190|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84044191|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
84044192|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162541|NCT00232141|Analgesics|analgesics|mesh-ancestor
84044193|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044194|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044195|NCT00793819|Urological Agents|urological agents|mesh-ancestor
84044196|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84044197|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044198|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
84044199|NCT02836821|Rifampin|rifampin|mesh-list
84044200|NCT02836821|Apatinib|apatinib|mesh-list
84044201|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044202|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044203|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044204|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044205|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84044206|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
84044207|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84044208|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044209|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
84044210|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84044211|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84044212|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84044213|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84044214|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84044215|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84044216|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84044217|NCT02836743|Melatonin|melatonin|mesh-list
84044218|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
84044219|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044220|NCT02836743|Protective Agents|protective agents|mesh-ancestor
84044221|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044222|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044223|NCT04255368|Choline|choline|mesh-list
84044224|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
84044225|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84044226|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
84044227|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044228|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84044229|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84044230|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
84044231|NCT00610818|Mitogens|mitogens|mesh-list
84044232|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
84044233|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044234|NCT00787891|Rabeprazole|rabeprazole|mesh-list
84044235|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84044236|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83162722|NCT02198261|Minoxidil|minoxidil|mesh-list
84044237|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84044238|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044239|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044240|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84044241|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84044242|NCT00892437|Cobicistat|cobicistat|mesh-list
84044243|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84044244|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84044245|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044246|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044247|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
84044248|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044249|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84044250|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84044251|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84044252|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84044253|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
84044254|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84044255|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84044256|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
84044257|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84044258|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
84044259|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044260|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044261|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044262|NCT02836509|Acetaminophen|acetaminophen|mesh-list
84044263|NCT02836509|Ibuprofen|ibuprofen|mesh-list
84044264|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84044265|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84044266|NCT02836509|Analgesics|analgesics|mesh-ancestor
83284124|NCT02132312|Phenylephrine|phenylephrine|mesh-list
84044267|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
84044268|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162777|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84044269|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044270|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044271|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044272|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84044273|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044274|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044275|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
84044276|NCT05306379|Simvastatin|simvastatin|mesh-list
84044277|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84044278|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84044279|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
84044280|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044281|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84044282|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84044283|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044285|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044286|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
83162815|NCT02198339|Analgesics|analgesics|mesh-ancestor
84044287|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044288|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044289|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
84044290|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84044291|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044292|NCT04109755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84044293|NCT04109755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044294|NCT04248309|Progesterone|progesterone|mesh-list
84044295|NCT04248309|Progestins|progestins|mesh-ancestor
84044296|NCT04248309|Hormones|hormones|mesh-ancestor
84044297|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044298|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044299|NCT00892281|Doxycycline|doxycycline|mesh-list
84044300|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84044301|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044302|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
84044303|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84044304|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84044305|NCT02836353|Rifaximin|rifaximin|mesh-list
84044306|NCT02836353|Somatostatin|somatostatin|mesh-list
84044307|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84044308|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044309|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84044310|NCT02836353|Hormones|hormones|mesh-ancestor
84044311|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044312|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044313|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
84044314|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84044315|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044316|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044317|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84044318|NCT02836431|Analgesics|analgesics|mesh-ancestor
84044319|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
84044320|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044321|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84044322|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84044323|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84044324|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
84044325|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044326|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044327|NCT05326425|Lazertinib|lazertinib|mesh-list
84044328|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044329|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044330|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044331|NCT00784693|Tanezumab|tanezumab|mesh-list
84044332|NCT00784693|Analgesics|analgesics|mesh-ancestor
84044333|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
84044334|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044335|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044336|NCT00915811|Fludarabine|fludarabine|mesh-list
84044337|NCT00915811|Busulfan|busulfan|mesh-list
84044338|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
84044339|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83284194|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044340|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044341|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044342|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044344|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044345|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
84044346|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044347|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84044348|NCT00892047|Aripiprazole|aripiprazole|mesh-list
84044349|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84044350|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
84044351|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84044352|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84044353|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84044354|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044355|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044356|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
84044357|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
84044358|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044359|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044360|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84044361|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84044362|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
84044363|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84044364|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83163112|NCT05723731|Laxatives|laxatives|mesh-list
84044365|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84044366|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84044367|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84044368|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84044369|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84044370|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84044371|NCT02835729|Cytarabine|cytarabine|mesh-list
84044372|NCT02835729|Idarubicin|idarubicin|mesh-list
84044373|NCT02835729|Tryptophan|tryptophan|mesh-list
84044374|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84044375|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
84044376|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044377|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044378|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
84044379|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044380|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044381|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
84044382|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044383|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84044384|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84044385|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84044386|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044387|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84044388|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
84044389|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84044390|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
84044391|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044392|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044393|NCT00787267|Dasatinib|dasatinib|mesh-list
84044394|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044395|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044396|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044397|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044398|NCT02838615|Dexamethasone|dexamethasone|mesh-list
84044399|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044400|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
84044401|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
84044402|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044403|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044404|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84044405|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
84044406|NCT02838615|Hormones|hormones|mesh-ancestor
84044407|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044408|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84044409|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044410|NCT02833701|Vitamins|vitamins|mesh-list
84044411|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
84044412|NCT02833701|Bevacizumab|bevacizumab|mesh-list
84044413|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84044414|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
84044415|NCT02833701|Antibodies|antibodies|mesh-list
84044416|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
84044417|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84044418|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
84044419|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044420|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84044421|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84044422|NCT02833701|Growth Substances|growth substances|mesh-ancestor
84044423|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044424|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
84044425|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
84044426|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
84044427|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
84044428|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044429|NCT02833701|Protective Agents|protective agents|mesh-ancestor
84044430|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
84044431|NCT02838225|Docetaxel|docetaxel|mesh-list
84044432|NCT02838225|Doxorubicin|doxorubicin|mesh-list
84044433|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84044434|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044435|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
84044436|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044437|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044438|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044439|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
84044440|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044441|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163347|NCT05790499|Atorvastatin|atorvastatin|mesh-list
84044442|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84044443|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
84044444|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
84044445|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
84044446|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84044447|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84044448|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84044449|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044450|NCT00928434|Leuprolide|leuprolide|mesh-list
84044451|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84044452|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
84044453|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84044454|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044455|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84044456|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044457|NCT04248621|Goserelin|goserelin|mesh-list
84044458|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84044459|NCT04248621|Leuprolide|leuprolide|mesh-list
84044460|NCT04248621|Flutamide|flutamide|mesh-list
84044461|NCT04248621|Bicalutamide|bicalutamide|mesh-list
84044462|NCT04248621|Androgens|androgens|mesh-list
84044463|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
84044464|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84044465|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044466|NCT04248621|Hormones|hormones|mesh-ancestor
84044467|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044468|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044469|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
84044470|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
84044471|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84044472|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
84044473|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84044474|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84044475|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84044476|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
84044477|NCT00784459|Abatacept|abatacept|mesh-list
84044478|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84044479|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044480|NCT00784459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84044481|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044482|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044483|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
84044484|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044485|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044486|NCT02835183|Insulin|insulin|mesh-list
84044487|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84044488|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044489|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
84044490|NCT02602483|Ibuprofen|ibuprofen|mesh-list
84044491|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84044492|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84044493|NCT02602483|Analgesics|analgesics|mesh-ancestor
84044494|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
84044495|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044496|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044497|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044498|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044499|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84044500|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044501|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044502|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
84044503|NCT02602483|Protective Agents|protective agents|mesh-ancestor
84044504|NCT02602483|Vitamins|vitamins|mesh-ancestor
84044505|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
84044506|NCT00784147|Ibalizumab|ibalizumab|mesh-list
84044507|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84044508|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84044509|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84044510|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
84044511|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044512|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
84044513|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044514|NCT04260360|Docetaxel|docetaxel|mesh-list
84044515|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044516|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
84044517|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
84044518|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
84044519|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044520|NCT04254822|Carvedilol|carvedilol|mesh-list
84044521|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84044522|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84044523|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
84044524|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044525|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044526|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044527|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84044528|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
84044529|NCT04254822|Protective Agents|protective agents|mesh-ancestor
84044530|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84044531|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84044532|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84044533|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
84044534|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84044535|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84044536|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
84044537|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84044538|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044539|NCT00891813|Vitamins|vitamins|mesh-ancestor
84044540|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
84044541|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84044542|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
84044543|NCT04255056|Epirubicin|epirubicin|mesh-list
84044544|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044545|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
84044546|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044547|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044548|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044549|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
84044550|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044551|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044552|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84044553|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84044554|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84044555|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84044556|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044557|NCT00783835|Methylphenidate|methylphenidate|mesh-list
84044558|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84044559|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044560|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84044561|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84044562|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84044563|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044564|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
84044565|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044567|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84044568|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84044569|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
84044570|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
83163676|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
84044571|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044572|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044573|NCT02831361|Metformin|metformin|mesh-list
84044574|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84044575|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044576|NCT04103905|Antibodies|antibodies|mesh-list
84044577|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84044578|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
84044579|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044580|NCT02831205|Cobalt|cobalt|mesh-list
84044581|NCT02831205|Chromium|chromium|mesh-list
84044582|NCT02831205|Everolimus|everolimus|mesh-list
84044583|NCT02831205|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84044584|NCT02831205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044585|NCT02831205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044586|NCT02831205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044587|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044588|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
84044589|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044590|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044591|NCT02831205|Trace Elements|trace elements|mesh-ancestor
84044592|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
84044593|NCT00783289|Benralizumab|benralizumab|mesh-list
84044594|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84044595|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
84044596|NCT02828163|Triamcinolone|triamcinolone|mesh-list
84044597|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84044598|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84044599|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84044600|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044601|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
84044602|NCT02828163|Hormones|hormones|mesh-ancestor
84044603|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044604|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044605|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044606|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
84044607|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163727|NCT04861064|Sirolimus|sirolimus|mesh-list
84044608|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044609|NCT04107805|Midazolam|midazolam|mesh-list
84044610|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84044611|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84044612|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044613|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044614|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84044615|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84044616|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84044617|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84044618|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
84044619|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
84044620|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
84044621|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
84044622|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044623|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044624|NCT02833155|Exemestane|exemestane|mesh-list
84044625|NCT02833155|Entinostat|entinostat|mesh-list
84044626|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044627|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84044628|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84044629|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044630|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044631|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84044632|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
84044633|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044634|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044635|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84044636|NCT04672460|Talazoparib|talazoparib|mesh-list
84044637|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83163779|NCT04597190|Serotonin|serotonin|mesh-list
84044638|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284493|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044639|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044640|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044641|NCT00847912|Fluorouracil|fluorouracil|mesh-list
84044642|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
84044643|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044644|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84044645|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044646|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044647|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
84044648|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044649|NCT00850564|Hormones|hormones|mesh-list
84044650|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
84044651|NCT00850564|Tesamorelin|tesamorelin|mesh-list
84044652|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044653|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044654|NCT00850564|Growth Substances|growth substances|mesh-ancestor
84044655|NCT00837148|Sorafenib|sorafenib|mesh-list
84044656|NCT00837148|Dacarbazine|dacarbazine|mesh-list
84044657|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044658|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044659|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044660|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044661|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044662|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
84044663|NCT00703690|Fenofibrate|fenofibrate|mesh-list
84044664|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84044665|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
84044666|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044667|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84044668|NCT05297968|Oseltamivir|oseltamivir|mesh-list
84044669|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
84044670|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044671|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044672|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044673|NCT02613130|Fluorides|fluorides|mesh-list
84044674|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
84044675|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
84044676|NCT02613130|Protective Agents|protective agents|mesh-ancestor
84044677|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044678|NCT00849472|Paclitaxel|paclitaxel|mesh-list
84044679|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
84044680|NCT00849472|Doxorubicin|doxorubicin|mesh-list
84044681|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84044682|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044683|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
84044684|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
84044685|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
84044686|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044687|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044688|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
84044689|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044690|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044691|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044692|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
84044693|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84044694|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84044695|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84044696|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84044697|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044698|NCT00782509|Olodaterol|olodaterol|mesh-list
84044699|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84044700|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
84044701|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044702|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044703|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84044704|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
84044705|NCT00701428|Losartan|losartan|mesh-list
84044706|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84044707|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84044708|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84044709|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84044710|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044711|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83163914|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
84044712|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84044713|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044714|NCT00848926|Immunotoxins|immunotoxins|mesh-ancestor
84044715|NCT00848926|Immunoconjugates|immunoconjugates|mesh-ancestor
84044716|NCT00848926|Immunologic Factors|immunologic factors|mesh-ancestor
84044717|NCT00848926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044718|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
84044719|NCT00706888|Pyridoxal|pyridoxal|mesh-list
84044720|NCT00706888|Pyridoxine|pyridoxine|mesh-list
84044721|NCT00706888|Vitamins|vitamins|mesh-ancestor
84044722|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
84044723|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044724|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
84044725|NCT05019534|Cetuximab|cetuximab|mesh-list
84044726|NCT05019534|Vemurafenib|vemurafenib|mesh-list
84044727|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84044728|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044729|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044730|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044731|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044732|NCT04254042|Perindopril|perindopril|mesh-list
84044733|NCT04254042|Zofenopril|zofenopril|mesh-list
84044734|NCT04254042|Captopril|captopril|mesh-list
84044735|NCT04254042|Calcium|calcium|mesh-list
84044736|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84044737|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044738|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84044739|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
84044740|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044741|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044742|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84044743|NCT00918138|Metformin|metformin|mesh-list
84044744|NCT00918138|Saxagliptin|saxagliptin|mesh-list
84044745|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84044746|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044747|NCT00918138|Incretins|incretins|mesh-ancestor
84044748|NCT00918138|Hormones|hormones|mesh-ancestor
84044749|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044750|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84044751|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
84044752|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044753|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044754|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84044755|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84044756|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044757|NCT00782275|Sirolimus|sirolimus|mesh-list
84044758|NCT00782275|Bevacizumab|bevacizumab|mesh-list
84044759|NCT00782275|Temsirolimus|temsirolimus|mesh-list
84044760|NCT00782275|MTOR Inhibitors|mtor inhibitors|mesh-list
84044761|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84044762|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044763|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84044764|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84044765|NCT00782275|Growth Substances|growth substances|mesh-ancestor
84044766|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044767|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
84044768|NCT00782275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044769|NCT00782275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044770|NCT00782275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044771|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044772|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
84044773|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84044774|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044775|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84044776|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
84044777|NCT00791557|Infliximab|infliximab|mesh-list
84044778|NCT00791557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84044779|NCT00791557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044780|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
84044781|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84044782|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84044783|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
84044784|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044785|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84044786|NCT05176314|Pirtobrutinib|pirtobrutinib|mesh-list
84044787|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83284645|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84044788|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84044789|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
84044790|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044791|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84044792|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84044793|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044794|NCT05176314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044795|NCT00920556|Bortezomib|bortezomib|mesh-list
84044796|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044797|NCT00781885|Beraprost|beraprost|mesh-list
84044798|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84044799|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
84044800|NCT04901676|Leronlimab|leronlimab|mesh-list
84044801|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84044802|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84044803|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044804|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84044805|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84044806|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
84044807|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044808|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
84044809|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84044810|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044811|NCT02603965|Copper|copper|mesh-list
84044812|NCT02603965|Trace Elements|trace elements|mesh-ancestor
84044813|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
84044814|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044815|NCT00918684|Escitalopram|escitalopram|mesh-list
84044816|NCT00918684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84044817|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84044818|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84044819|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044820|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044821|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
84044822|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044823|NCT00919854|Ritonavir|ritonavir|mesh-list
84044824|NCT00919854|Darunavir|darunavir|mesh-list
84044825|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84044826|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84044827|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
83164165|NCT02367846|NuvaRing|nuvaring|mesh-list
84044828|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044829|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044830|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84044831|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84044832|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
84044833|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044834|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84044835|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84044836|NCT04669782|Teriparatide|teriparatide|mesh-list
84044837|NCT04669782|Vitamin K|vitamin k|mesh-list
84044838|NCT04669782|Vitamins|vitamins|mesh-ancestor
84044839|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
84044840|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044841|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84044842|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84044843|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044844|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
84044845|NCT04669782|Coagulants|coagulants|mesh-ancestor
84044846|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84044847|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84044848|NCT00891735|Ranibizumab|ranibizumab|mesh-list
84044849|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84044850|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84044851|NCT00891735|Growth Substances|growth substances|mesh-ancestor
84044852|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044853|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
84044854|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044855|NCT04252248|Decitabine|decitabine|mesh-list
84044856|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84044857|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
84044858|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044859|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044860|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044861|NCT04247373|Ropivacaine|ropivacaine|mesh-list
84044862|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
84044863|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
83284719|NCT02068508|Pioglitazone|pioglitazone|mesh-list
84044864|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044865|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044866|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
84044867|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044868|NCT02832999|Liraglutide|liraglutide|mesh-list
84044869|NCT02832999|Vildagliptin|vildagliptin|mesh-list
84044870|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84044871|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044872|NCT02832999|Incretins|incretins|mesh-ancestor
84044873|NCT02832999|Hormones|hormones|mesh-ancestor
84044874|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84044875|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84044876|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
84044877|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044878|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044879|NCT04245033|Piperaquine|piperaquine|mesh-list
84044880|NCT04245033|Artenimol|artenimol|mesh-list
84044881|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
84044882|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84044883|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84044884|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044885|NCT00915018|Paclitaxel|paclitaxel|mesh-list
84044886|NCT00915018|Trastuzumab|trastuzumab|mesh-list
84044887|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84044888|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84044889|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164265|NCT01371630|Methotrexate|methotrexate|mesh-list
84044890|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
84044891|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
84044892|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
84044893|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044894|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84044895|NCT04246905|Sulforaphane|sulforaphane|mesh-list
84044896|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84044897|NCT04246905|Protective Agents|protective agents|mesh-ancestor
84044898|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044899|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044900|NCT02830347|Amoxicillin|amoxicillin|mesh-list
84044901|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84044902|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044903|NCT00916578|Capecitabine|capecitabine|mesh-list
84044904|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84044905|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
84044906|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044907|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044908|NCT04675866|Paclitaxel|paclitaxel|mesh-list
84044909|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84044910|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84044911|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044912|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
84044913|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
84044914|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164308|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84044915|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044916|NCT02829879|Listerine|listerine|mesh-list
84044917|NCT02829879|Fluorides|fluorides|mesh-list
84044918|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
84044919|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
84044920|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
84044921|NCT02829879|Protective Agents|protective agents|mesh-ancestor
84044922|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044923|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84044924|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044925|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
84044926|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84044927|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84044928|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044929|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84044930|NCT05246007|Analgesics|analgesics|mesh-ancestor
84044931|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
84044932|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84044933|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84044934|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84044935|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84044936|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
84044937|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84044938|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044940|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
84044941|NCT00914940|Thiotepa|thiotepa|mesh-list
84044942|NCT00914940|Tacrolimus|tacrolimus|mesh-list
84044943|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044944|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84044945|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
84044946|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044947|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84044948|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
84044949|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044950|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84044951|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044952|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044953|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
84044954|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84044955|NCT00835978|Axitinib|axitinib|mesh-list
84044956|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044957|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84044958|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044959|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044960|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84044961|NCT01077518|Ofatumumab|ofatumumab|mesh-list
84044962|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84044963|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84044964|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
84044965|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044966|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84044967|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
84044968|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044969|NCT04203186|Lumefantrine|lumefantrine|mesh-list
84044970|NCT04203186|Artemether|artemether|mesh-list
84044971|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84044972|NCT04203186|Atovaquone|atovaquone|mesh-list
84044973|NCT04203186|Proguanil|proguanil|mesh-list
84044974|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
84044975|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
84044976|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84044977|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84044978|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84044979|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84044980|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044981|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
84044982|NCT00835120|Pioglitazone|pioglitazone|mesh-list
84044983|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84044984|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044985|NCT00914316|Ranolazine|ranolazine|mesh-list
84044986|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84044987|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84044988|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84044989|NCT00701740|Isotretinoin|isotretinoin|mesh-list
84044990|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
84044991|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
84044992|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
84044993|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84044994|NCT00701740|Protective Agents|protective agents|mesh-ancestor
84044995|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84044996|NCT04938882|Lidocaine|lidocaine|mesh-list
84044997|NCT04938882|Ropivacaine|ropivacaine|mesh-list
84044998|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
84044999|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
84045000|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045001|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045002|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
84045003|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045004|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84045005|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84045006|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84045007|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83164575|NCT04441021|Penicillins|penicillins|mesh-list
84045008|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045009|NCT00704080|Temozolomide|temozolomide|mesh-list
84045010|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84045011|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
84045012|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045013|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045014|NCT05253066|Docetaxel|docetaxel|mesh-list
84045015|NCT05253066|Epirubicin|epirubicin|mesh-list
84045016|NCT05253066|Exemestane|exemestane|mesh-list
84045017|NCT05253066|Goserelin|goserelin|mesh-list
84045018|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045019|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
84045020|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
84045021|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
84045022|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045023|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84045024|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84045025|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84045026|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045027|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83164705|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045028|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84045029|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84045030|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
84045031|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045032|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045033|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84045034|NCT04303598|Tenofovir|tenofovir|mesh-list
84045035|NCT04303598|Lamivudine|lamivudine|mesh-list
84045036|NCT04303598|Efavirenz|efavirenz|mesh-list
84045037|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
84045038|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045039|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84045040|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84045041|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045042|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045043|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84045044|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84045045|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84045046|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84045047|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84045048|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84045049|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84045050|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84045051|NCT04607460|Coal Tar|coal tar|mesh-list
84045052|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
84045053|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
84045054|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
84045055|NCT04636086|Vitamin D|vitamin d|mesh-list
84045056|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84045057|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045058|NCT04636086|Vitamins|vitamins|mesh-ancestor
84045059|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
84045060|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84045061|NCT00827242|Tadalafil|tadalafil|mesh-list
84045062|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
84045063|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84045064|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84045065|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045066|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045067|NCT00827242|Urological Agents|urological agents|mesh-ancestor
84045068|NCT01077362|Ustekinumab|ustekinumab|mesh-list
84045069|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
84045070|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
84045071|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84045072|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
84045073|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045074|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045075|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84045076|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
84045077|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
84045078|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84045079|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
84045080|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045081|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045082|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
84045083|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045084|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84045085|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045086|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045087|NCT00707278|Capecitabine|capecitabine|mesh-list
84045089|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84045090|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
84045091|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045092|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045093|NCT01077284|Allopurinol|allopurinol|mesh-list
84045094|NCT01077284|Febuxostat|febuxostat|mesh-list
84045095|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
84048355|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
84045096|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045097|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045098|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
84045099|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045100|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84045101|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
84045102|NCT01077284|Protective Agents|protective agents|mesh-ancestor
84045103|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045104|NCT00704314|Simvastatin|simvastatin|mesh-list
84045105|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84045106|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84045107|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
84045108|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045109|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84045110|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84045111|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045112|NCT00704392|XL647|xl647|mesh-list
84045113|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045114|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84045115|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045116|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045117|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
84045118|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84045119|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
84045120|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045121|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
84045122|NCT04103125|Protective Agents|protective agents|mesh-ancestor
84045123|NCT00826618|Ranibizumab|ranibizumab|mesh-list
84045124|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045125|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045126|NCT00826618|Growth Substances|growth substances|mesh-ancestor
84045127|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045128|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045129|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045130|NCT02876822|Vitamin D|vitamin d|mesh-list
84045131|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
84045132|NCT02876822|Vitamins|vitamins|mesh-ancestor
84045133|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
84045134|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045135|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84045136|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84045137|NCT00826540|Bevacizumab|bevacizumab|mesh-list
84045138|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84045139|NCT00826540|Sorafenib|sorafenib|mesh-list
84045140|NCT00826540|Antibodies|antibodies|mesh-list
84045141|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
84045142|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84045143|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045144|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045145|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045146|NCT00826540|Growth Substances|growth substances|mesh-ancestor
84045147|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045148|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045149|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
84045150|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84045151|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045152|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045153|NCT04303130|Endostar protein|endostar protein|mesh-list
84045154|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045155|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045156|NCT04303130|Growth Substances|growth substances|mesh-ancestor
84045157|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045158|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045159|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045160|NCT00626600|Oxycodone|oxycodone|mesh-list
84045161|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84045162|NCT00626600|Narcotics|narcotics|mesh-ancestor
84045163|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045164|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045166|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
84045167|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045168|NCT00707512|Natalizumab|natalizumab|mesh-list
84045169|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
84045170|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045171|NCT00704548|Simvastatin|simvastatin|mesh-list
84045172|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84045173|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84045174|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
83165264|NCT02361723|Pamiparib|pamiparib|mesh-list
84045175|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045176|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84045177|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84045178|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045179|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84045180|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84045181|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84045182|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045183|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045184|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045185|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045186|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84045187|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
84045188|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84045189|NCT00846040|Fallypride|fallypride|mesh-list
84045190|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84045191|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84045192|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
84045193|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045194|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045195|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045196|NCT02611336|Tadalafil|tadalafil|mesh-list
84045197|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
84045198|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84045199|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84045200|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045201|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045202|NCT02611336|Urological Agents|urological agents|mesh-ancestor
84045203|NCT00704704|Thalidomide|thalidomide|mesh-list
84045204|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045205|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
84045206|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045207|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
84045208|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84045209|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045210|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045211|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045212|NCT00704704|Growth Substances|growth substances|mesh-ancestor
84045213|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045214|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045215|NCT00707824|Nalbuphine|nalbuphine|mesh-list
84045216|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84045217|NCT00707824|Narcotics|narcotics|mesh-ancestor
84045218|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045219|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045220|NCT00707824|Analgesics|analgesics|mesh-ancestor
84045221|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
84045222|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045223|NCT00826228|Teriparatide|teriparatide|mesh-list
84045224|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84045225|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045226|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84045227|NCT00791479|Dulaglutide|dulaglutide|mesh-list
84045228|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83165518|NCT02360007|Analgesics|analgesics|mesh-ancestor
84045229|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045230|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84045231|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84045232|NCT02831751|Vaccines|vaccines|mesh-list
84045233|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
84045234|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045235|NCT00913458|Etanercept|etanercept|mesh-list
84045236|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84045237|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84045238|NCT00913458|Analgesics|analgesics|mesh-ancestor
84045239|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
84045240|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045241|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045242|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84045243|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045244|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84045245|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045246|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
84045247|NCT05208333|Albendazole|albendazole|mesh-list
84045248|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
84045249|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84045250|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045251|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
84045252|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84045253|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84045254|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
84045255|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
84045256|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
84045257|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045258|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045259|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84045260|NCT04309773|Bezafibrate|bezafibrate|mesh-list
84045261|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84045262|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84045263|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84045264|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
84045265|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045266|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84045267|NCT02829333|Anesthetics|anesthetics|mesh-list
84045268|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045269|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045270|NCT05251662|Bevacizumab|bevacizumab|mesh-list
84045271|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165752|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
84045272|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045273|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045274|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045275|NCT05251662|Growth Substances|growth substances|mesh-ancestor
84045276|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045277|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045278|NCT02829177|Allopurinol|allopurinol|mesh-list
84045279|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
84045280|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045281|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045282|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
84045283|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045284|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84045285|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
84045286|NCT02829177|Protective Agents|protective agents|mesh-ancestor
84045287|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045288|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
84045289|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84045290|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84045291|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84045292|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045293|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045294|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
84045295|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045296|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045297|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84045298|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045299|NCT04244097|Bupivacaine|bupivacaine|mesh-list
84045300|NCT04244097|Neostigmine|neostigmine|mesh-list
84045301|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
84045302|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
84045303|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045304|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045305|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
84045306|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045307|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84045308|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045309|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045310|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
84045311|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045312|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84045313|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
84045314|NCT00785629|Calcium|calcium|mesh-list
84045315|NCT00785629|Sevelamer|sevelamer|mesh-list
84045316|NCT00785629|Calcium acetate|calcium acetate|mesh-list
84045317|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84045318|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045319|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
84045320|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
84045321|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045322|NCT00915733|Aspirin|aspirin|mesh-list
84045323|NCT00915733|Cilostazol|cilostazol|mesh-list
83165951|NCT02355639|Clobetasol|clobetasol|mesh-list
84045324|NCT00915733|Clopidogrel|clopidogrel|mesh-list
84045325|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84045326|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84045327|NCT00915733|Analgesics|analgesics|mesh-ancestor
84045328|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
84045329|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045330|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045331|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84045332|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045333|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84045334|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84045335|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045336|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84045337|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84045338|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045339|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
84045340|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84045341|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84045342|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84045343|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
84045344|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045345|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84045346|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
84045347|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84045348|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
84045349|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
84045350|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84045351|NCT00915733|Protective Agents|protective agents|mesh-ancestor
84045352|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84045353|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84045354|NCT00913770|Buprenorphine|buprenorphine|mesh-list
84045355|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84045356|NCT00913770|Narcotics|narcotics|mesh-ancestor
84045357|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045358|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045359|NCT00913770|Analgesics|analgesics|mesh-ancestor
84045360|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
84045361|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045362|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84045363|NCT00912912|Sunitinib|sunitinib|mesh-list
84045364|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045365|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045366|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045367|NCT00912912|Growth Substances|growth substances|mesh-ancestor
84045368|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045369|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045370|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84045371|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045372|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045373|NCT00913692|Glycine|glycine|mesh-list
84045374|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
84045375|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045376|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045377|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045378|NCT00784927|Dexamethasone|dexamethasone|mesh-list
84045379|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
84045380|NCT00784927|Rituximab|rituximab|mesh-list
84045381|NCT00784927|Lenalidomide|lenalidomide|mesh-list
84045382|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045383|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
84045384|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045385|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045386|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84045387|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
84045388|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045389|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045390|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84045391|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84045392|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84045393|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
84045394|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
84045395|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045396|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84045397|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
84045398|NCT00784927|Hormones|hormones|mesh-ancestor
84045399|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045400|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84045401|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045402|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045403|NCT00784927|Growth Substances|growth substances|mesh-ancestor
84045404|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045405|NCT00637884|Fexofenadine|fexofenadine|mesh-list
84045406|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84045407|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84045408|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83166311|NCT02232347|Sufentanil|sufentanil|mesh-list
84045409|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
84045410|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
84045411|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045412|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045413|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045414|NCT04203342|Ketoconazole|ketoconazole|mesh-list
84045415|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
84045416|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045417|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84045418|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84045419|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045420|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045421|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84045422|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
84045423|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045424|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045425|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84045426|NCT05539729|Vancomycin|vancomycin|mesh-list
84045427|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84045428|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045429|NCT04834206|Docetaxel|docetaxel|mesh-list
84045430|NCT04834206|Fluorouracil|fluorouracil|mesh-list
84045431|NCT04834206|Nedaplatin|nedaplatin|mesh-list
84045432|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045433|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
84045434|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
84045435|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
84045436|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045437|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
84045438|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84045439|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045440|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
84045441|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045442|NCT00631722|Haloperidol|haloperidol|mesh-list
84045443|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
84045444|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
84045445|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
84045446|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045447|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045448|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84045449|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84045450|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84045451|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045452|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84045453|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84045454|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
84045455|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045456|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045457|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84045458|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
84045459|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84045460|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
84045461|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045462|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045463|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84045464|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
84045465|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
84045466|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84045467|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
84045468|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045469|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045470|NCT00779467|Fentanyl|fentanyl|mesh-list
84045471|NCT00779467|Bupivacaine|bupivacaine|mesh-list
84045472|NCT00779467|Neostigmine|neostigmine|mesh-list
84045473|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
84045474|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
84045475|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045476|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045477|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
84045478|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045479|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84045480|NCT00779467|Narcotics|narcotics|mesh-ancestor
84045481|NCT00779467|Analgesics|analgesics|mesh-ancestor
84045482|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84045483|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84045484|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
84045485|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84045486|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045487|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045488|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
84045489|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045490|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84045491|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
84045492|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
84045493|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
84045494|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045495|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
84045496|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045497|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045498|NCT00778921|Amlodipine|amlodipine|mesh-list
84045499|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84045500|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84045501|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045502|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045503|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84045504|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045505|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
84045506|NCT04173312|Bupivacaine|bupivacaine|mesh-list
84045507|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
84045508|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
84045509|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045510|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045511|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
84045512|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045513|NCT00587431|Docetaxel|docetaxel|mesh-list
84045514|NCT00587431|Leuprolide|leuprolide|mesh-list
84045515|NCT00587431|Testosterone|testosterone|mesh-list
84045516|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045517|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
84045518|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
84045519|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
84045520|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045521|NCT00587431|Androgens|androgens|mesh-ancestor
84045522|NCT00587431|Hormones|hormones|mesh-ancestor
84045523|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045524|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045525|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84045526|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84045527|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
84045528|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84045529|NCT00776659|Exemestane|exemestane|mesh-list
84045530|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045531|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84045532|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84045533|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045534|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045535|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84045536|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
84045537|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045538|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045540|NCT00632268|Everolimus|everolimus|mesh-list
84045541|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045542|NCT00632268|Antidotes|antidotes|mesh-ancestor
84045543|NCT00632268|Protective Agents|protective agents|mesh-ancestor
84045544|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045545|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
84045546|NCT00632268|Vitamins|vitamins|mesh-ancestor
84045547|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
84045548|NCT00632268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84045549|NCT00632268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84045550|NCT00632268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045551|NCT00632268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045552|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045553|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
84045554|NCT04145076|Citalopram|citalopram|mesh-list
84045555|NCT04145076|Tianeptine|tianeptine|mesh-list
84045556|NCT04145076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84045557|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84045558|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045559|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045560|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045561|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
84045562|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045563|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84045564|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
84045565|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84045566|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84045567|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
84045568|NCT00707902|Lidocaine|lidocaine|mesh-list
84045569|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
84045570|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
84045571|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045572|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045573|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
84045574|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045575|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84045576|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84045577|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84045578|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045579|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045580|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84045581|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045582|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
84045583|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
84045584|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84045585|NCT05511337|Citric Acid|citric acid|mesh-list
84045586|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
84045587|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
84045588|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84045589|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
84045590|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
84045591|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045592|NCT00833794|Tramadol|tramadol|mesh-list
84045593|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84045594|NCT00833794|Narcotics|narcotics|mesh-ancestor
84045595|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045596|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045597|NCT00833794|Analgesics|analgesics|mesh-ancestor
84045598|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
84045599|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045600|NCT00778375|Cytarabine|cytarabine|mesh-list
84045601|NCT00778375|Decitabine|decitabine|mesh-list
84045602|NCT00778375|Clofarabine|clofarabine|mesh-list
84045603|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84045604|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
84045605|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045606|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045607|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
84045608|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045609|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045610|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
84045611|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045613|NCT04102267|Epinephrine|epinephrine|mesh-list
84045614|NCT04102267|Bupivacaine|bupivacaine|mesh-list
84045615|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
84045616|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
84045617|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045618|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045619|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
84045620|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045621|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84045622|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84045623|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
84045624|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045625|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045626|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84045627|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84045628|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
84045629|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83167142|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
84045630|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
84045631|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
84045632|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
84045633|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84045634|NCT00777829|Zolpidem|zolpidem|mesh-list
84045635|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84045636|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84045637|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045638|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045639|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84045640|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
84045641|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
84045642|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045643|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045644|NCT00916045|Vidarabine|vidarabine|mesh-list
84045645|NCT00916045|Cyclosporine|cyclosporine|mesh-list
84045646|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
84045647|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
84045648|NCT00916045|Melphalan|melphalan|mesh-list
84045649|NCT00916045|Busulfan|busulfan|mesh-list
84045650|NCT00916045|Thiotepa|thiotepa|mesh-list
84045651|NCT00916045|Fludarabine|fludarabine|mesh-list
84045652|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
84045653|NCT00916045|Cyclosporins|cyclosporins|mesh-list
84045654|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
84045655|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84045656|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045657|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
84045658|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045659|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045660|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84045661|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
84045662|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045663|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045664|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84045665|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84045666|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
84045667|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
84045668|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045669|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045670|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
84045671|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
84045672|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84045673|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84045674|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84045675|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
84045676|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84045677|NCT00916123|Prednisone|prednisone|mesh-list
84045678|NCT00916123|Docetaxel|docetaxel|mesh-list
84045679|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045680|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
84045681|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
84045682|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167462|NCT02301091|Pirarubicin|pirarubicin|mesh-list
84045683|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045684|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84045685|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
84045686|NCT00916123|Hormones|hormones|mesh-ancestor
84045687|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045688|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045689|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84045690|NCT00916201|Cannabidiol|cannabidiol|mesh-list
84045691|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
84045692|NCT00833638|Tadalafil|tadalafil|mesh-list
84045693|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
84045694|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84045695|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84045696|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045697|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045698|NCT00833638|Urological Agents|urological agents|mesh-ancestor
84045699|NCT01041404|Fluorouracil|fluorouracil|mesh-list
84045700|NCT01041404|Capecitabine|capecitabine|mesh-list
84045701|NCT01041404|Trastuzumab|trastuzumab|mesh-list
84045702|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045703|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
84045704|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045705|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84045706|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045707|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
84045708|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045709|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84045710|NCT00777049|Panobinostat|panobinostat|mesh-list
84045711|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045712|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84045713|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045714|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045715|NCT00774787|Imiquimod|imiquimod|mesh-list
84045716|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84045717|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
84045718|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045719|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045720|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
84045721|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
84045722|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045723|NCT01040780|Gefitinib|gefitinib|mesh-list
84045724|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045725|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84045726|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045727|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045728|NCT04303988|Bevacizumab|bevacizumab|mesh-list
84045729|NCT04303988|Carboplatin|carboplatin|mesh-list
84045730|NCT04303988|Temozolomide|temozolomide|mesh-list
84045731|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84045732|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045733|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84045734|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84045735|NCT04303988|Growth Substances|growth substances|mesh-ancestor
84045736|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045737|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
84045738|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84045739|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
84045740|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045741|NCT04991493|Tramadol|tramadol|mesh-list
84045742|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84045743|NCT04991493|Narcotics|narcotics|mesh-ancestor
84045744|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045745|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045746|NCT04991493|Analgesics|analgesics|mesh-ancestor
84045747|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
84045748|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045749|NCT01059812|Insulin|insulin|mesh-list
84045750|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84045751|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
84045752|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
84045753|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84045754|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
84045755|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84045756|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84045757|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045758|NCT00888615|Paclitaxel|paclitaxel|mesh-list
84045759|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84045760|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84045761|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045762|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
84045763|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
84045764|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
84045765|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045766|NCT04241601|Aldesleukin|aldesleukin|mesh-list
84045767|NCT04241601|Interleukin-2|interleukin-2|mesh-list
84045768|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045769|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84045770|NCT04241601|Analgesics|analgesics|mesh-ancestor
84045771|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
84045772|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045773|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045774|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84045775|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84045776|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
84045777|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045778|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
84045779|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
84045780|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84045781|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84045782|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
84045783|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045784|NCT00888381|Vaccines|vaccines|mesh-list
84045785|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
84045786|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045787|NCT00833560|Dexamethasone|dexamethasone|mesh-list
84045788|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
84045789|NCT00833560|Bortezomib|bortezomib|mesh-list
84045790|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84045791|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
84045792|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045793|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045794|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84045795|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
83167813|NCT02337855|Antacids|antacids|mesh-ancestor
84045796|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045797|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045798|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84045799|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84045800|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
84045801|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
84045802|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045803|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84045804|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
84045805|NCT00833560|Hormones|hormones|mesh-ancestor
84045806|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045807|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84045808|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
84045809|NCT04242927|Niacin|niacin|mesh-list
84045810|NCT04242927|Niacinamide|niacinamide|mesh-list
84045811|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
84045812|NCT04242927|Vitamins|vitamins|mesh-ancestor
84045813|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
84045814|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045815|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84045816|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
84045817|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045818|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84045819|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
84045820|NCT00887679|Escitalopram|escitalopram|mesh-list
84045821|NCT00887679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84045822|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84045823|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045824|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045825|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045826|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
84045827|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045828|NCT04241523|Lenvatinib|lenvatinib|mesh-list
84045829|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045830|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84045831|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168005|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
84045832|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045833|NCT00833482|Ritonavir|ritonavir|mesh-list
84045834|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84045835|NCT00833482|Voriconazole|voriconazole|mesh-list
84045836|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84045837|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83285703|NCT01454596|Mitogens|mitogens|mesh-list
84045838|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
84045839|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045840|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045841|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84045842|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84045843|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
84045844|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045845|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84045846|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84045847|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
84045848|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84045849|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84045850|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
84045851|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168129|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
84045852|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045853|NCT00845182|Pioglitazone|pioglitazone|mesh-list
84045854|NCT00845182|Exenatide|exenatide|mesh-list
84045855|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84045856|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045857|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84045858|NCT00845182|Incretins|incretins|mesh-ancestor
84045859|NCT00845182|Hormones|hormones|mesh-ancestor
84045860|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045861|NCT00833248|Goserelin|goserelin|mesh-list
84045862|NCT00833248|Bicalutamide|bicalutamide|mesh-list
84045863|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84045864|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045865|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
84045866|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
84045867|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045868|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045869|NCT00702130|Pravastatin|pravastatin|mesh-list
84045870|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84045871|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84045872|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
84048356|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84045873|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045874|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84045875|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84045876|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045877|NCT00823264|Charcoal|charcoal|mesh-list
84045878|NCT00823264|Antidotes|antidotes|mesh-ancestor
84045879|NCT00823264|Protective Agents|protective agents|mesh-ancestor
84045880|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045881|NCT04241211|Denosumab|denosumab|mesh-list
83168319|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
84045882|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84045883|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045884|NCT00702442|Droperidol|droperidol|mesh-list
84045885|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84045886|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
84045887|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
84045888|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045889|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045890|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84045891|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84045892|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84045893|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045894|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84045895|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84045896|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84045897|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
84048357|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
84045898|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045899|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045900|NCT02612272|Ketorolac|ketorolac|mesh-list
84045901|NCT02612272|Betamethasone|betamethasone|mesh-list
84045902|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84045903|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84045904|NCT02612272|Analgesics|analgesics|mesh-ancestor
84045905|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
84045906|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045907|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045908|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84045909|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84045910|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84045911|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045912|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045913|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
84045915|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045916|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84045917|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
84045918|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84045919|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84045920|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045921|NCT00832624|Incretins|incretins|mesh-ancestor
84045922|NCT00832624|Hormones|hormones|mesh-ancestor
84045923|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84045924|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84045925|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
84045926|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045927|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045928|NCT00913120|Enoxaparin|enoxaparin|mesh-list
84045929|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
84045930|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83168459|NCT03132259|Analgesics|analgesics|mesh-ancestor
84045931|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84045932|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045933|NCT00822172|Cilostazol|cilostazol|mesh-list
84045934|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84045935|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
84045936|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045937|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045938|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84045939|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
83168516|NCT02324491|CKD732|ckd732|mesh-list
84045940|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84045941|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84045942|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045943|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84045944|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
84045945|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84045946|NCT00822172|Protective Agents|protective agents|mesh-ancestor
84045947|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84045948|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84045949|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84045950|NCT00832000|Mexiletine|mexiletine|mesh-list
84045951|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84045952|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84045953|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84045954|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045955|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045956|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
84045957|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
84045958|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045959|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
84045960|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84045961|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
84045962|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
84045963|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
84045964|NCT04166292|Lidocaine|lidocaine|mesh-list
84045965|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
84045966|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
84045967|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045968|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045969|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
83168688|NCT03136627|Nivolumab|nivolumab|mesh-list
84045970|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045971|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84045972|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84045973|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84045974|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84045975|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045976|NCT04099771|Ketamine|ketamine|mesh-list
84045977|NCT04099771|Analgesics|analgesics|mesh-ancestor
84045978|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
84045979|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84045980|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84045981|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84045982|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84045983|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
84045984|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
84045985|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84045986|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84045987|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84045988|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84045989|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045990|NCT00768469|Paclitaxel|paclitaxel|mesh-list
84045991|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84045992|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84045993|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
84045994|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
84045995|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
84045996|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84045998|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84045999|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046000|NCT02825121|Trace Elements|trace elements|mesh-ancestor
84046001|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
84046002|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046003|NCT02825199|Caffeine|caffeine|mesh-list
84046004|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84046005|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168878|NCT02749799|Hormones|hormones|mesh-ancestor
84046006|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84046007|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046008|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046009|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84046010|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84046011|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
84046012|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046013|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
84046014|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046015|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046016|NCT02824965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84046017|NCT02824965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046018|NCT00886743|Oprelvekin|oprelvekin|mesh-list
84046019|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046020|NCT02826759|Insulin|insulin|mesh-list
84046021|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84046022|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046023|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83169046|NCT02262533|Atenolol|atenolol|mesh-list
84046024|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
84046025|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046026|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
84046027|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046028|NCT02826837|Bevacizumab|bevacizumab|mesh-list
84046029|NCT02826837|Cetuximab|cetuximab|mesh-list
84046030|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046031|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046032|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84046033|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84046034|NCT02826837|Growth Substances|growth substances|mesh-ancestor
84046035|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046036|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
84046037|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84046038|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
84046039|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046040|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
84046041|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84046042|NCT02823483|Protective Agents|protective agents|mesh-ancestor
84046043|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046044|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
84046045|NCT04848597|Paclitaxel|paclitaxel|mesh-list
84046046|NCT04848597|Antibodies|antibodies|mesh-list
84046047|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83285918|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285919|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
83285920|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285921|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285922|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83285923|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
83285924|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285925|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285926|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83285927|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83285928|NCT04418219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83285929|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
83285930|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046048|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84046049|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046050|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
84046051|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
84046052|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
84046053|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046054|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046055|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
84046056|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84046057|NCT05037045|Incretins|incretins|mesh-ancestor
84046058|NCT05037045|Hormones|hormones|mesh-ancestor
84046059|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046060|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046061|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84046062|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
84046063|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046064|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046065|NCT02823405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84046066|NCT02823405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046067|NCT02823249|Erythritol|erythritol|mesh-list
84046068|NCT02823249|Tryptophan|tryptophan|mesh-list
84046069|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84046070|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
84046071|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84046072|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
84046073|NCT00768079|Benralizumab|benralizumab|mesh-list
84046074|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84046075|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
84046076|NCT02603575|Caspofungin|caspofungin|mesh-list
84046077|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
84046078|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
84046079|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
84046080|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046081|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
84046082|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
84046083|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046084|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046085|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84046086|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
84046087|NCT02603575|Hormones|hormones|mesh-ancestor
84046088|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046089|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84046090|NCT02603575|Protective Agents|protective agents|mesh-ancestor
84046091|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
84046092|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046093|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046094|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046095|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84046096|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
84046097|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
84046098|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84046099|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046100|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046101|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
84046102|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84046103|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046104|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046105|NCT02822157|Paclitaxel|paclitaxel|mesh-list
84046106|NCT02822157|Carboplatin|carboplatin|mesh-list
84046107|NCT02822157|Gemcitabine|gemcitabine|mesh-list
84046108|NCT02822157|Doxorubicin|doxorubicin|mesh-list
84046109|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84046110|NCT02822157|Topotecan|topotecan|mesh-list
84046111|NCT02822157|Olaparib|olaparib|mesh-list
83169511|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
84046112|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84046113|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046114|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
84046115|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
84046116|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
84046117|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046118|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84046119|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
84046120|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84046121|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84046122|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84046123|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046124|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84046125|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84046126|NCT02822937|Triazolam|triazolam|mesh-list
84046127|NCT02822937|Methylphenidate|methylphenidate|mesh-list
84046128|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84046129|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046130|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84046131|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84046132|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046133|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046134|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
84046135|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046136|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84046137|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84046138|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84046139|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046140|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84046141|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
84046142|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
84046143|NCT04200885|Dexamethasone|dexamethasone|mesh-list
84046144|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84046145|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84046146|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046147|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
84046148|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
84046149|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046150|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046151|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84046152|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
84046153|NCT04200885|Hormones|hormones|mesh-ancestor
84046154|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046155|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84046156|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046157|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84046158|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84046159|NCT04200885|Analgesics|analgesics|mesh-ancestor
84046160|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
84046161|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046162|NCT05659251|Paclitaxel|paclitaxel|mesh-list
84046163|NCT05659251|Carboplatin|carboplatin|mesh-list
84046164|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84046165|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046166|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
84046167|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
84046168|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
84046169|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046170|NCT00766831|Hydromorphone|hydromorphone|mesh-list
84046171|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046172|NCT00766831|Narcotics|narcotics|mesh-ancestor
84046173|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046174|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046175|NCT00766831|Analgesics|analgesics|mesh-ancestor
84046176|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
84046177|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046178|NCT02821689|Pirfenidone|pirfenidone|mesh-list
84046179|NCT02821689|Analgesics|analgesics|mesh-ancestor
84046180|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
84046181|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046182|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046183|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84046184|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84046185|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046186|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046187|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046188|NCT02821533|Cisplatin|cisplatin|mesh-list
84046189|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
84046190|NCT05659407|Rituximab|rituximab|mesh-list
84046191|NCT05659407|Belimumab|belimumab|mesh-list
84046192|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046193|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046194|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
84046195|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046196|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046197|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046198|NCT00766675|Acetaminophen|acetaminophen|mesh-list
84046199|NCT00766675|Tramadol|tramadol|mesh-list
84046200|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84046202|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
84046203|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046204|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046205|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
84046206|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046207|NCT00766675|Narcotics|narcotics|mesh-ancestor
84046208|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046209|NCT02820441|Zopiclone|zopiclone|mesh-list
84046210|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84046211|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046212|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046213|NCT02821377|Furosemide|furosemide|mesh-list
84046214|NCT02821377|Diuretics|diuretics|mesh-ancestor
84046215|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
84046216|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046217|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84046218|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046219|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046220|NCT02820987|Meropenem|meropenem|mesh-list
84046221|NCT02820987|Tazobactam|tazobactam|mesh-list
84046222|NCT02820987|Piperacillin|piperacillin|mesh-list
84046223|NCT02820987|Cefepime|cefepime|mesh-list
84046224|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84046225|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83169938|NCT05398874|Acetaminophen|acetaminophen|mesh-list
84046226|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046227|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84046228|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046229|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046230|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
84046231|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046232|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
84046233|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
84046234|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
84046235|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83169992|NCT05533229|Fentanyl|fentanyl|mesh-list
84046236|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046237|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84046238|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046239|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046240|NCT02818881|Methamphetamine|methamphetamine|mesh-list
84046241|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84046242|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046243|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
84046244|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
84046245|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046246|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
84046247|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046248|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046249|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
84046250|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84046251|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84046252|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046253|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84046254|NCT02818803|Propolis|propolis|mesh-list
84046255|NCT02818803|Miconazole|miconazole|mesh-list
84046256|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046257|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
84046258|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84046259|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84046260|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046261|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046262|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84046263|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
84046264|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046265|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046266|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84046267|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84046268|NCT02818725|Cisplatin|cisplatin|mesh-list
84046269|NCT02818725|Doxorubicin|doxorubicin|mesh-list
84046270|NCT02818725|Methotrexate|methotrexate|mesh-list
84046271|NCT02818725|Panitumumab|panitumumab|mesh-list
84046272|NCT02818725|Vinblastine|vinblastine|mesh-list
83286152|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
84046273|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046274|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84046275|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84046276|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84046277|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046278|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046279|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84046280|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
84046281|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84046282|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046283|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84046284|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
84046285|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
84046286|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84046287|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046288|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
84046289|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046290|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84046291|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046292|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84046293|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
84046294|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
84046295|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
84046296|NCT02820051|Lidocaine|lidocaine|mesh-list
84046297|NCT02820051|Midazolam|midazolam|mesh-list
84046298|NCT02820051|Nalbuphine|nalbuphine|mesh-list
84046299|NCT02820051|Propofol|propofol|mesh-list
84046300|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
84046301|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
84046302|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046303|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046304|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
84046305|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046306|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84046307|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84046308|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84046309|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046310|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046311|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84046312|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84046313|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
84046314|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84046315|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84046316|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84046317|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84046318|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
84046319|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
84046320|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046321|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046322|NCT02820051|Narcotics|narcotics|mesh-ancestor
84046323|NCT02820051|Analgesics|analgesics|mesh-ancestor
84046324|NCT02817243|Simvastatin|simvastatin|mesh-list
84046325|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84046326|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84046327|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
84046328|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046329|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84046330|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84046331|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046332|NCT00766363|Rivastigmine|rivastigmine|mesh-list
84046333|NCT00766363|Donepezil|donepezil|mesh-list
84046334|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84046335|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046336|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046337|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
84046338|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046339|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046340|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
84046341|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84046342|NCT00766363|Protective Agents|protective agents|mesh-ancestor
84046343|NCT02636946|Bimatoprost|bimatoprost|mesh-list
84046344|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83286213|NCT02111785|Dexamethasone|dexamethasone|mesh-list
84046345|NCT02819661|Morphine|morphine|mesh-list
84046346|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046347|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046348|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046349|NCT02819661|Narcotics|narcotics|mesh-ancestor
84046350|NCT02819661|Analgesics|analgesics|mesh-ancestor
84046351|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
84046352|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046353|NCT00765817|Exenatide|exenatide|mesh-list
84046354|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84046355|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046356|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84046357|NCT00765817|Incretins|incretins|mesh-ancestor
84046358|NCT00765817|Hormones|hormones|mesh-ancestor
84046359|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046360|NCT02818491|Dexamethasone|dexamethasone|mesh-list
84046361|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
84046362|NCT02818491|Ropivacaine|ropivacaine|mesh-list
84046363|NCT02818491|BB 1101|bb 1101|mesh-list
84046364|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046365|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
84046366|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
84046367|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046368|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046369|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84046370|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
84046371|NCT02818491|Hormones|hormones|mesh-ancestor
84046372|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046373|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84046374|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046375|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
84046376|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046377|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046378|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
84046379|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
84046380|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046381|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
84046382|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
84046383|NCT02816853|Domperidone|domperidone|mesh-list
84046384|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84046385|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046386|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84046387|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84046388|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046389|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046390|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046391|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046392|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
84046393|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
84046394|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046395|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84046396|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84046397|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
83170358|NCT02328651|Ribavirin|ribavirin|mesh-list
84046398|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046399|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
84046400|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
84046401|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84046402|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84046403|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046404|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046405|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84046406|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84046407|NCT05658861|Caseins|caseins|mesh-list
84046408|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
84046409|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
84046410|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046411|NCT00772447|Vancomycin|vancomycin|mesh-list
84046412|NCT00772447|Daptomycin|daptomycin|mesh-list
84046413|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84046414|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046415|NCT04238169|Bevacizumab|bevacizumab|mesh-list
84046416|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046417|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046418|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84046419|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84046420|NCT04238169|Growth Substances|growth substances|mesh-ancestor
84046421|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170414|NCT05303792|Cytarabine|cytarabine|mesh-list
84046422|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
84046423|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84046424|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
84046425|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046426|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84046427|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
84046428|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84046429|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
84046430|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84046431|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046432|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84046433|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84046434|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84046435|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84046436|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84046437|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
84046438|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84046439|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84046440|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84046441|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
84046442|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84046443|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84046444|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84046445|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046446|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046448|NCT02817477|Morphine|morphine|mesh-list
84046449|NCT02817477|Analgesics|analgesics|mesh-ancestor
84046450|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
84046451|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046452|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046453|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84046454|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84046455|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
84046456|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
84046457|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046458|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84046459|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84046460|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046461|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046462|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046463|NCT02817477|Narcotics|narcotics|mesh-ancestor
84046464|NCT02819115|Vaccines|vaccines|mesh-list
84046465|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
84046466|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046467|NCT04099069|Anesthetics|anesthetics|mesh-list
84046468|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046469|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046470|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84046471|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84046472|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84046473|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046474|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046475|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84046476|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046477|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046478|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
84046479|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046480|NCT04101019|Lidocaine|lidocaine|mesh-list
84046481|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
84046482|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
84046483|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046484|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046485|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
84046486|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046487|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84046488|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84046489|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84046490|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046491|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046492|NCT02817321|Morphine|morphine|mesh-list
84046493|NCT02817321|Ropivacaine|ropivacaine|mesh-list
84046494|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046495|NCT02817321|Narcotics|narcotics|mesh-ancestor
84046496|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046497|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046498|NCT02817321|Analgesics|analgesics|mesh-ancestor
84046499|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
84046500|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046501|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
84046502|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
84046503|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
84046504|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84046505|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046506|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
84046507|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
84046508|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046509|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
84046510|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046511|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84046512|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84046513|NCT00705562|Caseins|caseins|mesh-list
84046514|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
84046515|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
84046516|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046517|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
84046518|NCT00843856|Tacrolimus|tacrolimus|mesh-list
84046519|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046520|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
84046521|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046522|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84046523|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046524|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046525|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84046526|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046527|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84046528|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
84046529|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84046530|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046531|NCT04480125|Azacitidine|azacitidine|mesh-list
84046532|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84046533|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
84046534|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046535|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046536|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046537|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
84046538|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84046539|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
84046540|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046541|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
84046542|NCT00705796|Testosterone|testosterone|mesh-list
84046543|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
84046544|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
84046545|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84046546|NCT00705796|Androgens|androgens|mesh-ancestor
84046547|NCT00705796|Hormones|hormones|mesh-ancestor
84046548|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046549|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046550|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84046551|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046552|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
84046553|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
84046554|NCT00843778|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84046555|NCT00843778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046556|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046557|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
84046558|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046559|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046560|NCT04432935|Lactoferrin|lactoferrin|mesh-list
84046561|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046562|NCT00591370|Temozolomide|temozolomide|mesh-list
84046563|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84046564|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
84046565|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046566|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046567|NCT05631249|Sotorasib|sotorasib|mesh-list
84046568|NCT05631249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84046569|NCT05631249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046570|NCT05631249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046571|NCT05631249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046572|NCT05629923|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
84046573|NCT05629923|Antiviral Agents|antiviral agents|mesh-ancestor
84046574|NCT05629923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046575|NCT00820222|Capecitabine|capecitabine|mesh-list
84046576|NCT00820222|Trastuzumab|trastuzumab|mesh-list
84046577|NCT00820222|Lapatinib|lapatinib|mesh-list
84046578|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84046579|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
84046580|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046581|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046582|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046583|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84046584|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046585|NCT02815449|Iron|iron|mesh-list
84046586|NCT02815449|Trace Elements|trace elements|mesh-ancestor
84046587|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
84046588|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046589|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
84046590|NCT01039688|Tofacitinib|tofacitinib|mesh-list
84046591|NCT01039688|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84046592|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84046593|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046594|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046595|NCT02237508|Budesonide|budesonide|mesh-list
84046596|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
84046597|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84046598|NCT02237508|Charcoal|charcoal|mesh-list
84046599|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046600|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84046601|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
83170977|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046602|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046603|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046604|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84046605|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
84046606|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
84046607|NCT02237508|Hormones|hormones|mesh-ancestor
84046608|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046609|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84046610|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84046611|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84046612|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
84046613|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046614|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046615|NCT02237508|Antidotes|antidotes|mesh-ancestor
84046616|NCT02237508|Protective Agents|protective agents|mesh-ancestor
84046617|NCT04237935|Clopidogrel|clopidogrel|mesh-list
84046618|NCT04237935|Ticagrelor|ticagrelor|mesh-list
84046619|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84046620|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84046621|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84046622|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84046623|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
84046624|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046625|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046626|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046627|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
84046628|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84046629|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84046630|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84046631|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
84046632|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84046633|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046634|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84046635|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84046636|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
84046637|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84046638|NCT02809755|Lidocaine|lidocaine|mesh-list
84046639|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
84046640|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
84046641|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046642|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046643|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
84046644|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046645|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84046646|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84046647|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83171097|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046648|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046649|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046650|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
84046651|NCT02812719|Salicylates|salicylates|mesh-list
84046652|NCT02812719|Glycolic acid|glycolic acid|mesh-list
84046653|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046654|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
84046655|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
84046656|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
84046657|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84046658|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84046659|NCT02812719|Analgesics|analgesics|mesh-ancestor
84046660|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
84046661|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046662|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046663|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046664|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046665|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84046666|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046667|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046668|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
84046669|NCT02876978|Fludarabine|fludarabine|mesh-list
84046670|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046671|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
84046672|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046673|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046674|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84046675|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
84046676|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046677|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046678|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84046679|NCT00909480|Insulin|insulin|mesh-list
84046680|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84046681|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
84046682|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
84046683|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84046684|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046685|NCT05642715|Varenicline|varenicline|mesh-list
84046686|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84046687|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84046688|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
84046689|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046690|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046691|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046692|NCT02874326|Octreotide|octreotide|mesh-list
84046693|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84046694|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84046695|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046696|NCT02812641|Bevacizumab|bevacizumab|mesh-list
84046697|NCT02812641|Cisplatin|cisplatin|mesh-list
84046698|NCT02812641|Fluorouracil|fluorouracil|mesh-list
84046699|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046700|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046701|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84046702|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84046703|NCT02812641|Growth Substances|growth substances|mesh-ancestor
84046704|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046705|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
84046706|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
84046707|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171260|NCT05247320|Sotalol|sotalol|mesh-list
84046708|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84046709|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046710|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
84046711|NCT01058096|Cariprazine|cariprazine|mesh-list
84046712|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84046713|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84046714|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046715|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046716|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84046717|NCT00626990|Temozolomide|temozolomide|mesh-list
84046718|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84046720|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046721|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046722|NCT01057862|Naltrexone|naltrexone|mesh-list
84046723|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84046724|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84046725|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046726|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
84046727|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046728|NCT01038128|Memantine|memantine|mesh-list
84046729|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84046730|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84046731|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
84046732|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046733|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171304|NCT02283658|Everolimus|everolimus|mesh-list
84046734|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046735|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84046736|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84046737|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
84046738|NCT04303520|Fludarabine|fludarabine|mesh-list
84046739|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046740|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
84046741|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046742|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046743|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84046744|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
84046745|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046746|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046747|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84046748|NCT02562378|Doxorubicin|doxorubicin|mesh-list
84046749|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84046750|NCT02562378|Trastuzumab|trastuzumab|mesh-list
84046751|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84046752|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046753|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84046754|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84046755|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046756|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046757|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046758|NCT00842530|Vaccines|vaccines|mesh-list
84046759|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
84046760|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046761|NCT05580510|Empagliflozin|empagliflozin|mesh-list
84046762|NCT05580510|Valsartan|valsartan|mesh-list
84046763|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84046764|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84046765|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84046766|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84046767|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046768|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84046769|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84046770|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046771|NCT02811627|Memantine|memantine|mesh-list
84046772|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84046773|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84046774|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
84046775|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046776|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046777|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046778|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84046779|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84046780|NCT00634413|Budesonide|budesonide|mesh-list
84046781|NCT00634413|Theophylline|theophylline|mesh-list
84046782|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046783|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84046784|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
84046785|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046786|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046787|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84046788|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
84046789|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
84046790|NCT00634413|Hormones|hormones|mesh-ancestor
83286663|NCT02047045|Serotonin|serotonin|mesh-list
84046791|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046792|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84046793|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046794|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046795|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
84046796|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84046797|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84046798|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
84046799|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046800|NCT02815059|Prednisone|prednisone|mesh-list
84046801|NCT02815059|Dasatinib|dasatinib|mesh-list
84046802|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046803|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
84046804|NCT02815059|Hormones|hormones|mesh-ancestor
84046805|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84046806|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046807|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84046808|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046809|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84046810|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046811|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046812|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
84046813|NCT00819910|Fenofibrate|fenofibrate|mesh-list
84046814|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84046815|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046816|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84046817|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
84046818|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046819|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84046820|NCT02808117|Micronutrients|micronutrients|mesh-list
84046821|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046822|NCT04321395|Vigabatrin|vigabatrin|mesh-list
84046823|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
84046824|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046825|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046826|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
84046827|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046828|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046829|NCT02814669|Atezolizumab|atezolizumab|mesh-list
84046830|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84046831|NCT02814669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84046832|NCT02814669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046833|NCT02814669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046834|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046835|NCT02808741|Olorofim|olorofim|mesh-list
84046836|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
84046837|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046838|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84046839|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84046840|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84046841|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84046842|NCT02807415|Ivacaftor|ivacaftor|mesh-list
84046843|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84046844|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046845|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046846|NCT02804841|Vitamin D|vitamin d|mesh-list
84046847|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
84046848|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
84046849|NCT02804841|Vitamins|vitamins|mesh-list
84046850|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
84046851|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046852|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84046853|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84046854|NCT00634491|Acetazolamide|acetazolamide|mesh-list
84046855|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
84046856|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84046857|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046858|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046859|NCT00634491|Diuretics|diuretics|mesh-ancestor
84046860|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
84046861|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046862|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
84046863|NCT02807103|Rituximab|rituximab|mesh-list
84046864|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84046865|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
84046866|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046867|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046868|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84046869|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
84046870|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046871|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046872|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84046873|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046874|NCT02806791|Lenograstim|lenograstim|mesh-list
84046875|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84046876|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
84046877|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046878|NCT00830128|Pregabalin|pregabalin|mesh-list
84046879|NCT00830128|Analgesics|analgesics|mesh-ancestor
84046880|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
84046881|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046882|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046883|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
84046884|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84046885|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046886|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046887|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84046888|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84046889|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84046890|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046891|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84046892|NCT05498103|Methazolamide|methazolamide|mesh-list
84046893|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84046894|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046895|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046896|NCT05498103|Diuretics|diuretics|mesh-ancestor
84046897|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
84046898|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046899|NCT00771667|Ustekinumab|ustekinumab|mesh-list
84046900|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
84046901|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
84046902|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84046903|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046904|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046905|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84046906|NCT05579964|Analgesics|analgesics|mesh-ancestor
84046907|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
84046908|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046909|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84046910|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84046911|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84046912|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
84046913|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84046914|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046915|NCT03893175|Acetaminophen|acetaminophen|mesh-list
84046916|NCT03893175|Ibuprofen|ibuprofen|mesh-list
84046917|NCT03893175|Oxycodone|oxycodone|mesh-list
84046918|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84046919|NCT03893175|Analgesics|analgesics|mesh-ancestor
84046920|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
84046921|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046922|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046923|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
84046924|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84046925|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84046926|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046927|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84046928|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046929|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046930|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84046931|NCT03893175|Narcotics|narcotics|mesh-ancestor
84046932|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84046933|NCT04236453|Tenofovir|tenofovir|mesh-list
84046934|NCT04236453|Emtricitabine|emtricitabine|mesh-list
84046935|NCT04236453|Darunavir|darunavir|mesh-list
84046936|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84046937|NCT04236453|Cobicistat|cobicistat|mesh-list
84046938|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84046939|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
84046940|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
84046941|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84046942|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84046943|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84046944|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84046945|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046946|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84046947|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84046948|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84046949|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84046950|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
84046951|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84046952|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84046953|NCT02807571|Anesthetics|anesthetics|mesh-list
84046954|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171750|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84046955|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046956|NCT05333250|Modafinil|modafinil|mesh-list
84046957|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84046958|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046959|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84046960|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84046961|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84046962|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046963|NCT05461339|Ranibizumab|ranibizumab|mesh-list
84046964|NCT05461339|Antibodies|antibodies|mesh-list
84046965|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84046966|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
84046967|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046968|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84046969|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84046970|NCT05461339|Growth Substances|growth substances|mesh-ancestor
84046971|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
84046972|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046973|NCT03409848|Nivolumab|nivolumab|mesh-list
84046974|NCT03409848|Ipilimumab|ipilimumab|mesh-list
84046975|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84046976|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84046977|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84046978|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046979|NCT00763555|Calcitriol|calcitriol|mesh-list
84046980|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84046981|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046982|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84046983|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84046984|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84046985|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84046986|NCT00763555|Vitamins|vitamins|mesh-ancestor
84046987|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
84046988|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84046989|NCT02804373|Oxytocin|oxytocin|mesh-list
84046990|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
84046991|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84046992|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84046993|NCT00763321|Acetaminophen|acetaminophen|mesh-list
84046994|NCT00763321|Hydrocodone|hydrocodone|mesh-list
84046995|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84046996|NCT00763321|Analgesics|analgesics|mesh-ancestor
84046997|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
84046998|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84046999|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047000|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
84047001|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84047002|NCT00763321|Narcotics|narcotics|mesh-ancestor
84047003|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047004|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
84047005|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
84047006|NCT02799927|Calcium|calcium|mesh-list
84047007|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84047008|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047009|NCT00770653|Metformin|metformin|mesh-list
84047010|NCT00770653|Pioglitazone|pioglitazone|mesh-list
83286885|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047011|NCT00770653|Glimepiride|glimepiride|mesh-list
84047012|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84047013|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047014|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84047015|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047016|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
84047017|NCT02799615|Infliximab|infliximab|mesh-list
84047018|NCT02799615|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84047019|NCT02799615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047020|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
84047021|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047022|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047023|NCT00819052|Nevirapine|nevirapine|mesh-list
84047024|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84047025|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84047026|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047027|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047028|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
84047029|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047030|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84047031|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84047032|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84047033|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84047034|NCT00763009|Dipyridamole|dipyridamole|mesh-list
84047035|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84047036|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047037|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047038|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84047039|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
84047040|NCT02799459|Anesthetics|anesthetics|mesh-list
84047041|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047042|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047043|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
84047044|NCT05477589|Melphalan|melphalan|mesh-list
84047045|NCT05477589|Busulfan|busulfan|mesh-list
84047046|NCT05477589|Fludarabine|fludarabine|mesh-list
84047047|NCT05477589|Clofarabine|clofarabine|mesh-list
84047048|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047049|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
84047050|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047051|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047052|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84047053|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
84047054|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047055|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047056|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84047057|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047058|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
84047059|NCT00841672|Amlodipine|amlodipine|mesh-list
84047060|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84047061|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84047062|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84047063|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047064|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84047065|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047066|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
84047067|NCT05549115|Amoxicillin|amoxicillin|mesh-list
84047068|NCT05549115|Clarithromycin|clarithromycin|mesh-list
84047069|NCT05549115|Levofloxacin|levofloxacin|mesh-list
84047070|NCT05549115|Ofloxacin|ofloxacin|mesh-list
84047071|NCT05549115|Furazolidone|furazolidone|mesh-list
84047072|NCT05549115|Bismuth|bismuth|mesh-list
84047073|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84047074|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047075|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84047076|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047077|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047078|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84047079|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84047080|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83172004|NCT02370238|Paclitaxel|paclitaxel|mesh-list
84047081|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84047082|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84047083|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047084|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84047085|NCT05549115|Antacids|antacids|mesh-ancestor
84047086|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286963|NCT01628549|Sarecycline|sarecycline|mesh-list
84047087|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84047088|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84047089|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84047090|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84047091|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84047092|NCT04236219|Rasburicase|rasburicase|mesh-list
84047093|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
84047094|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047095|NCT00908232|Dexamethasone|dexamethasone|mesh-list
84047096|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
84047097|NCT00908232|Lenalidomide|lenalidomide|mesh-list
84047098|NCT00908232|Bortezomib|bortezomib|mesh-list
84047099|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047100|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
84047101|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047102|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047103|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84047104|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
84047105|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047106|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047107|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84047108|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047109|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
84047110|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
84047111|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047112|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047113|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
84047114|NCT00908232|Hormones|hormones|mesh-ancestor
84047115|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84047116|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84047117|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84047118|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84047119|NCT00908232|Growth Substances|growth substances|mesh-ancestor
84047120|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
84047121|NCT00770341|Vancomycin|vancomycin|mesh-list
84047122|NCT00770341|Daptomycin|daptomycin|mesh-list
84047123|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84047124|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047125|NCT05472753|Selenium|selenium|mesh-list
84047126|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
84047127|NCT05472753|Curcumin|curcumin|mesh-list
84047128|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84047129|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84047130|NCT05472753|Analgesics|analgesics|mesh-ancestor
84047131|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
84047132|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047133|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047134|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047135|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047136|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047137|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047138|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047139|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
84047140|NCT05472753|Protective Agents|protective agents|mesh-ancestor
84047141|NCT05472753|Trace Elements|trace elements|mesh-ancestor
84047142|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
84047143|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047144|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84047145|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84047146|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84047147|NCT03396276|Narcotics|narcotics|mesh-ancestor
84047148|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047149|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047150|NCT03396276|Analgesics|analgesics|mesh-ancestor
84047151|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
84047152|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047153|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84047154|NCT02799147|Fludarabine|fludarabine|mesh-list
84047155|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
84047156|NCT02799147|Busulfan|busulfan|mesh-list
84047157|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84047158|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047159|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047160|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
83287042|NCT04700839|Metformin|metformin|mesh-list
84047161|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047162|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047163|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
84047164|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047165|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
84047166|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84047167|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84047168|NCT02798913|Clopidogrel|clopidogrel|mesh-list
84047169|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84047170|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84047171|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84047172|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84047173|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
84047174|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047175|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047176|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047177|NCT00762463|Celecoxib|celecoxib|mesh-list
84047178|NCT00762463|Diclofenac|diclofenac|mesh-list
84047179|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84047180|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84047181|NCT00762463|Analgesics|analgesics|mesh-ancestor
84047182|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
84047183|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047184|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047185|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047186|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047187|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84047188|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84047189|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047190|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047191|NCT03326310|Azacitidine|azacitidine|mesh-list
84047192|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047193|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
84047194|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047195|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047196|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047197|NCT05511909|Lofexidine|lofexidine|mesh-list
84047198|NCT05511909|Buspirone|buspirone|mesh-list
84047199|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84047200|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84047201|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047202|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047203|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83172245|NCT04209218|Hormones|hormones|mesh-ancestor
84047204|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84047205|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
84047206|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047207|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047208|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84047209|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84047210|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
84047211|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047212|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84047213|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84047214|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84047215|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
84047216|NCT00906282|Carboplatin|carboplatin|mesh-list
84047217|NCT00906282|Pemetrexed|pemetrexed|mesh-list
84047218|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047219|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047220|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047221|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84047222|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84047223|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
84047224|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84047225|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047226|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84047227|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047228|NCT02798367|Melatonin|melatonin|mesh-list
84047229|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
84047230|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047231|NCT02798367|Protective Agents|protective agents|mesh-ancestor
84047232|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047233|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047234|NCT00762229|Ezetimibe|ezetimibe|mesh-list
84047235|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84047236|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84047237|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
84047238|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047239|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84047241|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84047242|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
84047243|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047244|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047245|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84047246|NCT02805231|Vitamin D|vitamin d|mesh-list
84047247|NCT02805231|Vitamins|vitamins|mesh-ancestor
84047248|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
84047249|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047250|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84047251|NCT03230604|Z 350|z 350|mesh-list
84047252|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84047253|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84047254|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047255|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047256|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
84047257|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84047258|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047259|NCT02798055|Bosentan|bosentan|mesh-list
84047260|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84047261|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84047262|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047263|NCT05331768|Terlipressin|terlipressin|mesh-list
84047264|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84047265|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84047266|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
84047267|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84047268|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047269|NCT02640222|Vitamin K|vitamin k|mesh-list
84047270|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
84047271|NCT02640222|Apixaban|apixaban|mesh-list
84047272|NCT02640222|Dabigatran|dabigatran|mesh-list
84047273|NCT02640222|Vitamins|vitamins|mesh-ancestor
84047274|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
84047275|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047276|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84047277|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
84047278|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84047279|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
84047280|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047281|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047282|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
84047283|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84047284|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84047285|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
84047286|NCT02640222|Coagulants|coagulants|mesh-ancestor
84047287|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84047288|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
84047289|NCT00818662|Antibodies|antibodies|mesh-list
84047290|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
84047291|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84047292|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84047293|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
84047294|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
84047295|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047296|NCT03983031|Rituximab|rituximab|mesh-list
84047297|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047298|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047299|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
84047300|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047301|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047302|NCT00703066|Vaccines|vaccines|mesh-list
84047303|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
84047304|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047305|NCT00762073|Budesonide|budesonide|mesh-list
84047306|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047307|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84047308|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
84047309|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047310|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047311|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84047312|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
84047314|NCT00762073|Hormones|hormones|mesh-ancestor
84047315|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84047316|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84047317|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
84047318|NCT03847857|Coagulants|coagulants|mesh-ancestor
84047319|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
84047320|NCT02630628|Tacrolimus|tacrolimus|mesh-list
84047321|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047322|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
84047323|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047324|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84047325|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047326|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047327|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84047328|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047329|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84047330|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
84047331|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84047332|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047333|NCT00913588|Fluoxetine|fluoxetine|mesh-list
84047334|NCT00913588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84047335|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84047336|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84047337|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047338|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047339|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
84047340|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047341|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84047342|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
84047343|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047344|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84047345|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84047346|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047347|NCT02797587|Nicotine|nicotine|mesh-list
84047348|NCT02797587|Varenicline|varenicline|mesh-list
84047349|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84047350|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
84047351|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047352|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047353|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84047354|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84047355|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
84047356|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047357|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047358|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84047359|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84047360|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84047361|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047362|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047363|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047364|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84047365|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83172489|NCT02452190|Reslizumab|reslizumab|mesh-list
84047366|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
84047367|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047368|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047369|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84047370|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84047371|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
84047372|NCT00761527|Desloratadine|desloratadine|mesh-list
84047373|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84047374|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
84047375|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047376|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047377|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047378|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84047379|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84047380|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
84047381|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
84047382|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
84047383|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84047384|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84047385|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84047386|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84047387|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84047388|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047389|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
84047390|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047391|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047392|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84047393|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047394|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
84047395|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84047396|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84047397|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047398|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
84047399|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
84047400|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
84047401|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047402|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
84047403|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
84047404|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
84047405|NCT02797041|Bortezomib|bortezomib|mesh-list
84047406|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047407|NCT02794779|Oxytocin|oxytocin|mesh-list
84047408|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
84047409|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84047410|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047411|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
84047412|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84047413|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047414|NCT05805098|Cytarabine|cytarabine|mesh-list
84047415|NCT05805098|Venetoclax|venetoclax|mesh-list
84047416|NCT05805098|Homoharringtonine|homoharringtonine|mesh-list
84047417|NCT05805098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047418|NCT05805098|Antimetabolites|antimetabolites|mesh-ancestor
84047419|NCT05805098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047420|NCT05805098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047421|NCT05805098|Antiviral Agents|antiviral agents|mesh-ancestor
84047422|NCT05805098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047423|NCT05805098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047424|NCT05805098|Immunologic Factors|immunologic factors|mesh-ancestor
84047425|NCT05805098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047426|NCT05805098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84047427|NCT05805098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84047428|NCT05805098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047429|NCT05804903|Fexofenadine|fexofenadine|mesh-list
84047430|NCT05804903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84047431|NCT05804903|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84047432|NCT05804903|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84047433|NCT05804903|Histamine Antagonists|histamine antagonists|mesh-ancestor
84047434|NCT05804903|Histamine Agents|histamine agents|mesh-ancestor
84047435|NCT05804903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047436|NCT05804903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047437|NCT05804903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047438|NCT05804734|Vitamin K|vitamin k|mesh-list
84047439|NCT05804734|Anticoagulants|anticoagulants|mesh-list
84047440|NCT05804734|Vitamins|vitamins|mesh-ancestor
84047441|NCT05804734|Micronutrients|micronutrients|mesh-ancestor
84047442|NCT05804734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047443|NCT05804734|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84047444|NCT05804734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84047445|NCT05804734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047446|NCT05804734|Hemostatics|hemostatics|mesh-ancestor
84047447|NCT05804734|Coagulants|coagulants|mesh-ancestor
84047448|NCT05804721|Aripiprazole|aripiprazole|mesh-list
84047449|NCT05804721|Antidepressive Agents|antidepressive agents|mesh-ancestor
84047450|NCT05804721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047451|NCT05804721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84047452|NCT05804721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84047453|NCT05804721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047454|NCT05804721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047455|NCT05804721|Dopamine Agonists|dopamine agonists|mesh-ancestor
84047456|NCT05804721|Dopamine Agents|dopamine agents|mesh-ancestor
84047457|NCT05804721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047458|NCT05804721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047459|NCT05804721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83287354|NCT02064920|Donepezil|donepezil|mesh-list
84047460|NCT05804721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84047461|NCT05804721|Serotonin Agents|serotonin agents|mesh-ancestor
84047462|NCT05804721|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84047463|NCT05804721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84047464|NCT05804721|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84047465|NCT05804721|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84047466|NCT05804630|Lidocaine|lidocaine|mesh-list
84047467|NCT05804630|Anesthetics|anesthetics|mesh-list
84047468|NCT05804630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047469|NCT05804630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047470|NCT05804630|Anesthetics, Local|anesthetics, local|mesh-ancestor
84047471|NCT05804630|Sensory System Agents|sensory system agents|mesh-ancestor
84047472|NCT05804630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047473|NCT05804630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84047474|NCT05804630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84047475|NCT05804630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84047476|NCT05804630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84047477|NCT05804630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047478|NCT05804591|Pregabalin|pregabalin|mesh-list
84047479|NCT05804591|Analgesics|analgesics|mesh-ancestor
84047480|NCT05804591|Sensory System Agents|sensory system agents|mesh-ancestor
84047481|NCT05804591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047482|NCT05804591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047483|NCT05804591|Anticonvulsants|anticonvulsants|mesh-ancestor
84047484|NCT05804591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84047485|NCT05804591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84047486|NCT05804591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047487|NCT05804591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84047488|NCT05804591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84047489|NCT05804591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84047490|NCT05804591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047491|NCT05804591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047492|NCT05804370|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84047493|NCT05804370|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84047494|NCT05804370|Dermatologic Agents|dermatologic agents|mesh-ancestor
84047495|NCT05804305|Misoprostol|misoprostol|mesh-list
84047496|NCT05804305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84047497|NCT05804305|Abortifacient Agents|abortifacient agents|mesh-ancestor
84047498|NCT05804305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84047499|NCT05804305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047500|NCT05804305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84047501|NCT05804305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047502|NCT05804305|Oxytocics|oxytocics|mesh-ancestor
84047503|NCT05803863|Atropine|atropine|mesh-list
84047504|NCT05803863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84047505|NCT05803863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84047506|NCT05803863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84047507|NCT05803863|Autonomic Agents|autonomic agents|mesh-ancestor
84047508|NCT05803863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047509|NCT05803863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047510|NCT05803863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84047511|NCT05803863|Respiratory System Agents|respiratory system agents|mesh-ancestor
84047512|NCT05803863|Mydriatics|mydriatics|mesh-ancestor
84047513|NCT05803863|Parasympatholytics|parasympatholytics|mesh-ancestor
84047514|NCT05803863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84047515|NCT05803863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84047516|NCT05803863|Cholinergic Agents|cholinergic agents|mesh-ancestor
84047517|NCT05803863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047518|NCT05803863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047519|NCT05803811|Riboflavin|riboflavin|mesh-list
84047520|NCT05803811|Vitamin B Complex|vitamin b complex|mesh-ancestor
84047521|NCT05803811|Vitamins|vitamins|mesh-ancestor
84047522|NCT05803811|Micronutrients|micronutrients|mesh-ancestor
84047523|NCT05803811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047524|NCT05803811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84047525|NCT05803811|Dermatologic Agents|dermatologic agents|mesh-ancestor
84047526|NCT05803746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84047527|NCT05803746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84047528|NCT05803746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047529|NCT05803642|Haloperidol|haloperidol|mesh-list
84047530|NCT05803642|Olanzapine|olanzapine|mesh-list
84047531|NCT05803642|Haloperidol decanoate|haloperidol decanoate|mesh-list
84047532|NCT05803642|Antiemetics|antiemetics|mesh-ancestor
84047533|NCT05803642|Autonomic Agents|autonomic agents|mesh-ancestor
84047534|NCT05803642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047535|NCT05803642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047536|NCT05803642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047537|NCT05803642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84047538|NCT05803642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84047539|NCT05803642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047540|NCT05803642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047541|NCT05803642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84047542|NCT05803642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84047543|NCT05803642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84047544|NCT05803642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047545|NCT05803642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047546|NCT05803642|Serotonin Agents|serotonin agents|mesh-ancestor
84047547|NCT05803642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84047548|NCT05803642|Dopamine Agents|dopamine agents|mesh-ancestor
84047549|NCT05803642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84047550|NCT05803590|Chlorhexidine|chlorhexidine|mesh-list
84047551|NCT05803590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84047552|NCT05803590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047553|NCT05803590|Disinfectants|disinfectants|mesh-ancestor
84047554|NCT05803148|Midodrine|midodrine|mesh-list
84047555|NCT05803148|Sympathomimetics|sympathomimetics|mesh-ancestor
84047556|NCT05803148|Autonomic Agents|autonomic agents|mesh-ancestor
84047557|NCT05803148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047558|NCT05803148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047559|NCT05803148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84047560|NCT05803148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84047561|NCT05803148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84047562|NCT05803148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84047563|NCT05803148|Adrenergic Agents|adrenergic agents|mesh-ancestor
84047564|NCT05803148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047565|NCT05803148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047566|NCT05803135|Tofacitinib|tofacitinib|mesh-list
84047567|NCT05803135|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84047568|NCT05803135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84047569|NCT05803135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047570|NCT05803135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047571|NCT05803096|Nitrous Oxide|nitrous oxide|mesh-list
84047572|NCT05803096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84047573|NCT05803096|Anesthetics, General|anesthetics, general|mesh-ancestor
84047574|NCT05803096|Anesthetics|anesthetics|mesh-ancestor
84047575|NCT05803096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047576|NCT05803096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047577|NCT05803096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84047578|NCT05803096|Analgesics|analgesics|mesh-ancestor
84047579|NCT05803096|Sensory System Agents|sensory system agents|mesh-ancestor
84047580|NCT05803096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047581|NCT05803083|Hyaluronic Acid|hyaluronic acid|mesh-list
84047582|NCT05803083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84047583|NCT05803083|Immunologic Factors|immunologic factors|mesh-ancestor
84047584|NCT05803083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047585|NCT05803083|Viscosupplements|viscosupplements|mesh-ancestor
84047586|NCT05803083|Protective Agents|protective agents|mesh-ancestor
84047587|NCT05803070|Cetirizine|cetirizine|mesh-list
84047588|NCT05803070|Betamethasone|betamethasone|mesh-list
84047589|NCT05803070|Betamethasone Valerate|betamethasone valerate|mesh-list
84047590|NCT05803070|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84047591|NCT05803070|Betamethasone benzoate|betamethasone benzoate|mesh-list
84047592|NCT05803070|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84047593|NCT05803070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047594|NCT05803070|Glucocorticoids|glucocorticoids|mesh-ancestor
84047595|NCT05803070|Hormones|hormones|mesh-ancestor
84047596|NCT05803070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84047597|NCT05803070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047598|NCT05803070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84047599|NCT05803070|Respiratory System Agents|respiratory system agents|mesh-ancestor
84047600|NCT05803070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84047601|NCT05803070|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84047602|NCT05803070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84047603|NCT05803070|Histamine Antagonists|histamine antagonists|mesh-ancestor
84047604|NCT05803070|Histamine Agents|histamine agents|mesh-ancestor
84047605|NCT05803070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047606|NCT05803070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047607|NCT05803031|Tea Tree Oil|tea tree oil|mesh-list
84047608|NCT05803031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84047609|NCT05803031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047610|NCT05802992|Dexamethasone|dexamethasone|mesh-list
84047611|NCT05802992|Dexamethasone acetate|dexamethasone acetate|mesh-list
84047612|NCT05802992|Lenalidomide|lenalidomide|mesh-list
84047613|NCT05802992|Colchicine|colchicine|mesh-list
84047614|NCT05802992|BB 1101|bb 1101|mesh-list
84047615|NCT05802992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047616|NCT05802992|Antiemetics|antiemetics|mesh-ancestor
84047617|NCT05802992|Autonomic Agents|autonomic agents|mesh-ancestor
84047618|NCT05802992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047619|NCT05802992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047620|NCT05802992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047621|NCT05802992|Glucocorticoids|glucocorticoids|mesh-ancestor
84047622|NCT05802992|Hormones|hormones|mesh-ancestor
84047623|NCT05802992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84047624|NCT05802992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84047625|NCT05802992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047626|NCT05802992|Protease Inhibitors|protease inhibitors|mesh-ancestor
84047627|NCT05802992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047628|NCT05802992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047629|NCT05802992|Immunologic Factors|immunologic factors|mesh-ancestor
84047630|NCT05802992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84047631|NCT05802992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84047632|NCT05802992|Growth Substances|growth substances|mesh-ancestor
84047633|NCT05802992|Growth Inhibitors|growth inhibitors|mesh-ancestor
84047634|NCT05802992|Gout Suppressants|gout suppressants|mesh-ancestor
84047635|NCT05802992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047636|NCT05802992|Tubulin Modulators|tubulin modulators|mesh-ancestor
84047637|NCT05802992|Antimitotic Agents|antimitotic agents|mesh-ancestor
84047638|NCT05802992|Mitosis Modulators|mitosis modulators|mesh-ancestor
84047639|NCT05802979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-list
84047640|NCT05802888|Amoxicillin|amoxicillin|mesh-list
84047641|NCT05802888|Tetracycline|tetracycline|mesh-list
84047642|NCT05802888|Esomeprazole|esomeprazole|mesh-list
84047643|NCT05802888|Bismuth|bismuth|mesh-list
84047644|NCT05802888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84047645|NCT05802888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047646|NCT05802888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84047647|NCT05802888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047648|NCT05802888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84047649|NCT05802888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047650|NCT05802888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047651|NCT05802888|Antacids|antacids|mesh-ancestor
84047652|NCT05802888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84047653|NCT05802862|Insulin|insulin|mesh-list
84047654|NCT05802862|Insulin Aspart|insulin aspart|mesh-list
84047655|NCT05802862|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84047656|NCT05802862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84047657|NCT05802862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047658|NCT05800574|Cisplatin|cisplatin|mesh-list
84047659|NCT05800574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047660|NCT05776875|Bevacizumab|bevacizumab|mesh-list
84047661|NCT05776875|Atezolizumab|atezolizumab|mesh-list
84047662|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047663|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047664|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84047665|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84047666|NCT05776875|Growth Substances|growth substances|mesh-ancestor
84047667|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047668|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
84047669|NCT05776875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84047670|NCT05776875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047671|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
84047672|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84047673|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
84047674|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047675|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
84047676|NCT05776290|Protective Agents|protective agents|mesh-ancestor
84047677|NCT05768711|Venetoclax|venetoclax|mesh-list
84047678|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047679|NCT05766670|Vancomycin|vancomycin|mesh-list
84047680|NCT05766670|Gentamicins|gentamicins|mesh-list
84047681|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84047682|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047683|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84047684|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047685|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047686|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84047687|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84047688|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047690|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84047691|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84047692|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
84047693|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047694|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84047695|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84047696|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047697|NCT05758948|Formaldehyde|formaldehyde|mesh-list
84047698|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
84047699|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047700|NCT05757791|Empagliflozin|empagliflozin|mesh-list
84047701|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84047702|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047703|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84047704|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047705|NCT05752734|Dexamethasone|dexamethasone|mesh-list
84047706|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84047707|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
84047708|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
84047709|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047710|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047711|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047712|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
84047713|NCT05752734|Hormones|hormones|mesh-ancestor
84047714|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84047715|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84047716|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047717|NCT05728775|Propofol|propofol|mesh-list
84047718|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84047719|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047720|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047721|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84047722|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
84047723|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
84047724|NCT05715671|Esketamine|esketamine|mesh-list
84047725|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
84047726|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047727|NCT05705089|Warfarin|warfarin|mesh-list
84047728|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
84047729|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
84047730|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84047731|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
84047732|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84047733|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
84047734|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047735|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047736|NCT05701917|Heparin|heparin|mesh-list
84047737|NCT05701917|Calcium heparin|calcium heparin|mesh-list
84047738|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
84047739|NCT05701917|Apixaban|apixaban|mesh-list
84047740|NCT05701917|Warfarin|warfarin|mesh-list
84047741|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
84047742|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84047743|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84047744|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047745|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84047746|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
84047747|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84047748|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
84047749|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047750|NCT05693766|Capecitabine|capecitabine|mesh-list
84047751|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047752|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
84047753|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047754|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047755|NCT05687721|Avelumab|avelumab|mesh-list
84047756|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047757|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047758|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
84047759|NCT05672901|Estradiol|estradiol|mesh-list
84047760|NCT05672901|Estrogens|estrogens|mesh-ancestor
84047761|NCT05672901|Hormones|hormones|mesh-ancestor
84047762|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84047763|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047764|NCT05671822|Capecitabine|capecitabine|mesh-list
84047765|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
84047766|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047767|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
84047768|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047769|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047770|NCT05649540|Amoxicillin|amoxicillin|mesh-list
84047771|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84047772|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047773|NCT05646693|Sertraline|sertraline|mesh-list
84047774|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
84047775|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
84047776|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047777|NCT05646693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84047778|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84047779|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84047780|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047781|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047782|NCT05646693|Serotonin Agents|serotonin agents|mesh-ancestor
84047783|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047784|NCT05646693|Antacids|antacids|mesh-ancestor
84047785|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84047786|NCT05624359|Ropivacaine|ropivacaine|mesh-list
84047787|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
84047788|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
84047789|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047790|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047791|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
84047792|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047793|NCT05616624|Gemcitabine|gemcitabine|mesh-list
84047794|NCT05616624|Docetaxel|docetaxel|mesh-list
84047795|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047796|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
84047797|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047798|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047799|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
84047800|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
84047801|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
84047802|NCT05601817|Tocopherols|tocopherols|mesh-list
84047803|NCT05601817|Vitamin E|vitamin e|mesh-list
84047804|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
84047805|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
84047806|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047807|NCT05601817|Protective Agents|protective agents|mesh-ancestor
84047808|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047809|NCT05601817|Vitamins|vitamins|mesh-ancestor
84047810|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
84047811|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
84047812|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047813|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047814|NCT05594043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84047815|NCT05594043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047816|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
84047817|NCT05558124|Cytarabine|cytarabine|mesh-list
84047818|NCT05558124|Daunorubicin|daunorubicin|mesh-list
84047819|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
84047820|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047821|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
84047822|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047823|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047824|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
84047825|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047826|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047827|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
84047828|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047829|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84047830|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84047831|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84047832|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047833|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047834|NCT05558124|Immunotoxins|immunotoxins|mesh-ancestor
84047835|NCT05558124|Immunoconjugates|immunoconjugates|mesh-ancestor
84047836|NCT05535023|Cemiplimab|cemiplimab|mesh-list
84047837|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047838|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047839|NCT05519579|Methotrexate|methotrexate|mesh-list
84047840|NCT05519579|Blinatumomab|blinatumomab|mesh-list
84047841|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84047842|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
84047843|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84047844|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047845|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047846|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
84047847|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047848|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047849|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
84047850|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047851|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84047852|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047853|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
84047854|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047855|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84047856|NCT05515978|Metformin|metformin|mesh-list
84047857|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84047858|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047859|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
84047860|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84047861|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047862|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
84047863|NCT05501548|Olaparib|olaparib|mesh-list
84047864|NCT05501548|Vitamins|vitamins|mesh-ancestor
84047865|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
84047866|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047867|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
84047868|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047869|NCT05501548|Protective Agents|protective agents|mesh-ancestor
84047870|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84047871|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047872|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047873|NCT05494593|Rituximab|rituximab|mesh-list
84047874|NCT05494593|Methotrexate|methotrexate|mesh-list
84047875|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
84047876|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84047877|NCT05494593|Antibodies|antibodies|mesh-list
84047878|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
84047879|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84047880|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047881|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047882|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
84047883|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047884|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84047885|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84047886|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
84047887|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84047888|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047889|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
84047890|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047891|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
84047892|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047893|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84047894|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047895|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84047896|NCT05484349|Clonidine|clonidine|mesh-list
84047897|NCT05484349|Tizanidine|tizanidine|mesh-list
84047898|NCT05484349|Analgesics|analgesics|mesh-ancestor
84047899|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
84047900|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047901|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047902|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
84047903|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84047904|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84047905|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
84047906|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
84047907|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84047908|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84047909|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84047910|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
84047911|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047912|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047913|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84047914|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
84047915|NCT05470244|Analgesics|analgesics|mesh-list
84047916|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
84047917|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84047918|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047919|NCT05449548|Lenalidomide|lenalidomide|mesh-list
84047920|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
84047921|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047922|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84047923|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84047924|NCT05449548|Growth Substances|growth substances|mesh-ancestor
84047925|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
84047926|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047927|NCT05438264|Donepezil|donepezil|mesh-list
84047928|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84047929|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047930|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047931|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
84047932|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047933|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047934|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
84047935|NCT05365035|Cytarabine|cytarabine|mesh-list
84047936|NCT05365035|Azacitidine|azacitidine|mesh-list
84047937|NCT05365035|Venetoclax|venetoclax|mesh-list
84047938|NCT05365035|Cladribine|cladribine|mesh-list
84047939|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84047940|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
84047941|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047942|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047943|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
84047944|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84047945|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84047946|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
84047947|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047948|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84047949|NCT05359861|Bevacizumab|bevacizumab|mesh-list
84047950|NCT05359861|Atezolizumab|atezolizumab|mesh-list
84047951|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84047952|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84047953|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84047954|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84047955|NCT05359861|Growth Substances|growth substances|mesh-ancestor
84047956|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047957|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
84047958|NCT05359861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84047959|NCT05359861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047960|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84047961|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84047962|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047963|NCT05350085|Midazolam|midazolam|mesh-list
84047964|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84047965|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84047966|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047967|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047968|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84047969|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84047970|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047971|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84047972|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
84047973|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
84047974|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
84047975|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
84047976|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047977|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047978|NCT05313308|Midazolam|midazolam|mesh-list
84047979|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84047980|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84047981|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047982|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047983|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84047984|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84047985|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84047986|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84047987|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
84047988|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
84047989|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
84047990|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
84047991|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84047992|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84047993|NCT05289349|Propofol|propofol|mesh-list
84047994|NCT05289349|Sevoflurane|sevoflurane|mesh-list
84047995|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84047996|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84047997|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84047998|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84047999|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
84048000|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
84048001|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84048002|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84048003|NCT05273359|Benralizumab|benralizumab|mesh-list
84048004|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84048005|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
84048006|NCT05226455|Azacitidine|azacitidine|mesh-list
84048007|NCT05226455|Venetoclax|venetoclax|mesh-list
84048008|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048009|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
84048010|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048011|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048012|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048013|NCT05169905|Vaccines|vaccines|mesh-list
84048014|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
84048015|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048016|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
84048017|NCT05163223|Capecitabine|capecitabine|mesh-list
84048018|NCT05163223|Sargramostim|sargramostim|mesh-list
84048019|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048020|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048021|NCT05163223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048022|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048023|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048024|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
84048025|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
84048026|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048027|NCT05101122|Dronabinol|dronabinol|mesh-list
84048028|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84048029|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84048030|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84048031|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048032|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048033|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
84048034|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048035|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048036|NCT05101122|Hallucinogens|hallucinogens|mesh-ancestor
84048037|NCT05101122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84048038|NCT05101122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84048039|NCT05101122|Analgesics|analgesics|mesh-ancestor
84048040|NCT05101122|Sensory System Agents|sensory system agents|mesh-ancestor
84048041|NCT05101122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048042|NCT05101122|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84048043|NCT05101122|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84048044|NCT05101122|Hormones|hormones|mesh-ancestor
84048045|NCT05101122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048046|NCT05092945|Niacin|niacin|mesh-list
84048047|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
84048048|NCT05092945|Niacinamide|niacinamide|mesh-list
84048049|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84048050|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
84048051|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048052|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84048053|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
84048054|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
84048055|NCT05092945|Vitamins|vitamins|mesh-ancestor
84048056|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
84048057|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048058|NCT05087771|Naltrexone|naltrexone|mesh-list
84048059|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84048060|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84048061|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048062|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
84048063|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048064|NCT05084235|Empagliflozin|empagliflozin|mesh-list
84048065|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84048066|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048067|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84048068|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048070|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84048071|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84048072|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048073|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
84048074|NCT05082142|Coagulants|coagulants|mesh-ancestor
84048075|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
84048076|NCT05061017|Nivolumab|nivolumab|mesh-list
84048077|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84048078|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
83173096|NCT00772343|Vaccines|vaccines|mesh-list
84048079|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048080|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048081|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84048082|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
84048083|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048084|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048085|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84048086|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048087|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048088|NCT05048901|Lanreotide|lanreotide|mesh-list
84048089|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048090|NCT05042973|Empagliflozin|empagliflozin|mesh-list
84048091|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84048092|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048093|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84048094|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048095|NCT05030272|Nicotine|nicotine|mesh-list
84048096|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84048097|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
84048098|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048099|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048100|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84048101|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84048102|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
84048103|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048104|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048105|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84048106|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84048107|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048108|NCT04954365|Amisulpride|amisulpride|mesh-list
84048109|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84048110|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84048111|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048112|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048113|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84048114|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84048115|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
84048116|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048117|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048118|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84048119|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
84048120|NCT04952389|Budesonide|budesonide|mesh-list
84048121|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048122|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84048123|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
84048124|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048125|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048126|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84048127|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
84048128|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
84048129|NCT04952389|Hormones|hormones|mesh-ancestor
84048130|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048131|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
84048132|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
84048133|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84048134|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
84048135|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173099|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
84048136|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048137|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84048138|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
84048139|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048140|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048141|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84048142|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048143|NCT04920617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048144|NCT04860804|Aspirin|aspirin|mesh-list
84048145|NCT04860804|Ketamine|ketamine|mesh-list
84048146|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84048147|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84048148|NCT04860804|Analgesics|analgesics|mesh-ancestor
84048149|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
84048150|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048151|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048152|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048153|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048154|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84048155|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84048156|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048157|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84048158|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84048159|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048160|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
84048161|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84048162|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84048163|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
84048164|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
84048165|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048166|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84048167|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84048168|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048169|NCT04817345|Plerixafor|plerixafor|mesh-list
84048170|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84048171|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84048172|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
84048173|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048174|NCT04764396|Heparin|heparin|mesh-list
84048175|NCT04764396|Calcium heparin|calcium heparin|mesh-list
84048176|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
84048177|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84048178|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84048179|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048180|NCT04684589|Tadalafil|tadalafil|mesh-list
84048181|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
84048182|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84048183|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84048184|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048185|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048186|NCT04684589|Urological Agents|urological agents|mesh-ancestor
84048187|NCT04626141|Abaloparatide|abaloparatide|mesh-list
84048188|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84048189|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048190|NCT04609514|Nicotine|nicotine|mesh-list
84048191|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84048192|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
84048193|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048194|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048195|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84048196|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84048197|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
84048198|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048199|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048200|NCT04580121|Acetaminophen|acetaminophen|mesh-list
84048201|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
84048202|NCT04580121|Promethazine|promethazine|mesh-list
84048203|NCT04580121|Dexamethasone|dexamethasone|mesh-list
84048204|NCT04580121|Dasatinib|dasatinib|mesh-list
84048205|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048206|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
84048207|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
84048208|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048209|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048210|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84048211|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
84048212|NCT04580121|Hormones|hormones|mesh-ancestor
84048213|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048214|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84048215|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048216|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84048217|NCT04580121|Analgesics|analgesics|mesh-ancestor
84048219|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
84048220|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84048221|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048222|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048223|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84048224|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84048225|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048226|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
84048227|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
84048228|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84048229|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
84048230|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
84048231|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048232|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84048233|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
84048234|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
84048235|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
84048236|NCT04569461|Androgens|androgens|mesh-list
84048237|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048238|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048239|NCT04569461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048240|NCT04569461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048241|NCT04569461|Hormones|hormones|mesh-ancestor
84048242|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048243|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048244|NCT04527289|Amantadine|amantadine|mesh-list
84048245|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84048246|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84048247|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
84048248|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048249|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
84048250|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048251|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048252|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048253|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84048254|NCT04527289|Analgesics|analgesics|mesh-ancestor
84048255|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
84048256|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048257|NCT04505735|Corticosterone|corticosterone|mesh-list
84048258|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048259|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
84048260|NCT04460872|Testosterone|testosterone|mesh-list
84048261|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
84048262|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
84048263|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84048264|NCT04460872|Androgens|androgens|mesh-ancestor
84048265|NCT04460872|Hormones|hormones|mesh-ancestor
84048266|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048267|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173175|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
84048268|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84048269|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048270|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
84048271|NCT04446351|Dostarlimab|dostarlimab|mesh-list
84048272|NCT04446351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048273|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84048274|NCT04428866|Glucagon|glucagon|mesh-list
84048275|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84048276|NCT04428866|Hormones|hormones|mesh-ancestor
84048277|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048278|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048279|NCT04703920|Talazoparib|talazoparib|mesh-list
84048280|NCT04703920|Belinostat|belinostat|mesh-list
84048281|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84048282|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048283|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048284|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048285|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84048286|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
84048287|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
84048288|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
84048289|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048290|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048291|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
83288160|NCT05882643|Iodine|iodine|mesh-list
84048292|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048293|NCT04413617|Tofacitinib|tofacitinib|mesh-list
84048294|NCT04413617|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84048295|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84048296|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048297|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048299|NCT04408625|Prednisone|prednisone|mesh-list
84048300|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
84048301|NCT04408625|Rituximab|rituximab|mesh-list
84048302|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048303|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048304|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
84048305|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048306|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048307|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048308|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
84048309|NCT04408625|Hormones|hormones|mesh-ancestor
83173210|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048368|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048369|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84048370|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84048372|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
84048373|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
84048374|NCT04114136|Nivolumab|nivolumab|mesh-list
84048375|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84048376|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048377|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048378|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048379|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048380|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048381|NCT04102020|Azacitidine|azacitidine|mesh-list
84048382|NCT04102020|Venetoclax|venetoclax|mesh-list
84048383|NCT04102020|Cc-486|cc-486|mesh-list
84048384|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048385|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
84048386|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048387|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048388|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048389|NCT04093362|Gemcitabine|gemcitabine|mesh-list
84048390|NCT04093362|Futibatinib|futibatinib|mesh-list
84048391|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048392|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048393|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
84048394|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048395|NCT04060849|Ethanol|ethanol|mesh-list
83173507|NCT05647408|Dexamethasone|dexamethasone|mesh-list
84048396|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84048397|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84048398|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048399|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048400|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048401|NCT04055116|Lidocaine|lidocaine|mesh-list
84048402|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
84048403|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
84048404|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048405|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048406|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
84048407|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048408|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84048409|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84048410|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83173570|NCT03069937|Docetaxel|docetaxel|mesh-list
84048411|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048412|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048413|NCT04045028|Rituximab|rituximab|mesh-list
84048414|NCT04045028|Atezolizumab|atezolizumab|mesh-list
84048415|NCT04045028|Daratumumab|daratumumab|mesh-list
84048416|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048417|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048418|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
84048419|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048420|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048421|NCT04045028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048422|NCT04045028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048423|NCT04039867|Gemcitabine|gemcitabine|mesh-list
84048424|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
84048425|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048426|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
84048427|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048428|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048429|NCT03990623|Liver Extracts|liver extracts|mesh-list
84048430|NCT03990623|Hematinics|hematinics|mesh-ancestor
84048431|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84048432|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84048433|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
84048434|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84048435|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048436|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84048437|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84048438|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84048439|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048440|NCT03876769|Tisagenlecleucel|tisagenlecleucel|mesh-list
84048441|NCT03876769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048442|NCT03876769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048443|NCT03867500|Niacin|niacin|mesh-list
84048444|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84048445|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
83173769|NCT01530997|Cisplatin|cisplatin|mesh-list
84048446|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048447|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84048448|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
84048449|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
84048450|NCT03867500|Vitamins|vitamins|mesh-ancestor
84048451|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
84048452|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048453|NCT03839446|Etoposide|etoposide|mesh-list
84048454|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
84048455|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
84048456|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84048457|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048458|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84048459|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84048460|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048461|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048462|NCT03839446|Analgesics|analgesics|mesh-ancestor
84048463|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
84048464|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048465|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048466|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048467|NCT03839446|Immunotoxins|immunotoxins|mesh-ancestor
84048468|NCT03839446|Immunoconjugates|immunoconjugates|mesh-ancestor
84048469|NCT03839446|Immunologic Factors|immunologic factors|mesh-ancestor
84048470|NCT03781986|Carboplatin|carboplatin|mesh-list
84048471|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048472|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
84048473|NCT03743402|Narcotics|narcotics|mesh-ancestor
84048474|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048475|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048476|NCT03743402|Analgesics|analgesics|mesh-ancestor
84048477|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
84048478|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174016|NCT00569387|Vaccines|vaccines|mesh-list
84048479|NCT03735433|Aspirin|aspirin|mesh-list
84048480|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84048481|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84048482|NCT03735433|Analgesics|analgesics|mesh-ancestor
84048483|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
84048484|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048485|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048486|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174089|NCT00489203|Beclomethasone|beclomethasone|mesh-list
84048487|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048488|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84048489|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84048490|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048491|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84048492|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84048493|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048494|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
84048495|NCT03729401|Aspirin|aspirin|mesh-list
84048496|NCT03729401|Clopidogrel|clopidogrel|mesh-list
84048497|NCT03729401|Ticagrelor|ticagrelor|mesh-list
84048498|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84048499|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84048500|NCT03729401|Analgesics|analgesics|mesh-ancestor
84048501|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
84048502|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048503|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048504|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048505|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048506|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84048507|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84048508|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048509|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84048510|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84048511|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048512|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
84048513|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84048514|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84048515|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84048516|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
84048517|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048518|NCT03562416|Nintedanib|nintedanib|mesh-list
84048519|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048520|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84048521|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048522|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048523|NCT03512262|Abaloparatide|abaloparatide|mesh-list
84048524|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
84048525|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84048526|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048527|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84048528|NCT03503058|Chloroquine|chloroquine|mesh-list
84048529|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
84048530|NCT03503058|Amebicides|amebicides|mesh-ancestor
84048531|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84048532|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84048533|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048534|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
84048535|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048536|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84048537|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84048538|NCT03503058|Analgesics|analgesics|mesh-ancestor
84048539|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
84048540|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048541|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048542|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048543|NCT03503058|Filaricides|filaricides|mesh-ancestor
84048544|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
84048545|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
84048546|NCT03396211|Nivolumab|nivolumab|mesh-list
84048547|NCT03396211|Apatinib|apatinib|mesh-list
84048548|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048549|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048550|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048551|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048552|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84048553|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048554|NCT03301896|Spartalizumab|spartalizumab|mesh-list
84048555|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048556|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048557|NCT03301896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048558|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048559|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
84048560|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048561|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048562|NCT03260322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048563|NCT03260322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048564|NCT03257761|Durvalumab|durvalumab|mesh-list
84048565|NCT03257761|Guadecitabine|guadecitabine|mesh-list
84048566|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048567|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048568|NCT03218085|Tenofovir|tenofovir|mesh-list
84048569|NCT03218085|Emtricitabine|emtricitabine|mesh-list
84048570|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
84048571|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048572|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84048573|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84048574|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048575|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048576|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84048577|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84048578|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
84048579|NCT03197077|Desogestrel|desogestrel|mesh-list
84048580|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
84048581|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84048582|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84048583|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84048584|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048585|NCT03197077|Hormones|hormones|mesh-ancestor
84048586|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048587|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84048588|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84048589|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84048590|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84048591|NCT03197077|Progestins|progestins|mesh-ancestor
84048592|NCT03153280|Capecitabine|capecitabine|mesh-list
84048593|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
84048594|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048595|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
84048596|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048597|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048598|NCT03098836|Prednisone|prednisone|mesh-list
84048599|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
84048600|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048601|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
84048602|NCT03098836|Hormones|hormones|mesh-ancestor
84048603|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048604|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048605|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84048606|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048607|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84048608|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048609|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048610|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048611|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84048612|NCT03078855|Vitamin D|vitamin d|mesh-list
84048613|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
84048614|NCT03078855|Rituximab|rituximab|mesh-list
84048615|NCT03078855|Vitamins|vitamins|mesh-ancestor
84048616|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
84048617|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048618|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048619|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048620|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
84048621|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048622|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84048623|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84048624|NCT03007979|Letrozole|letrozole|mesh-list
84048625|NCT03007979|Fulvestrant|fulvestrant|mesh-list
84048626|NCT03007979|Palbociclib|palbociclib|mesh-list
84048627|NCT03007979|Goserelin|goserelin|mesh-list
84048628|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048629|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84048630|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84048631|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048632|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048633|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84048634|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048635|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048636|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048637|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84048638|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84048639|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84048640|NCT02912572|Avelumab|avelumab|mesh-list
84048641|NCT02912572|Axitinib|axitinib|mesh-list
84048642|NCT02912572|Talazoparib|talazoparib|mesh-list
84048643|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048644|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048645|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83174763|NCT02285075|Temocillin|temocillin|mesh-list
84048646|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048647|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048648|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84048649|NCT02910414|Ethanol|ethanol|mesh-list
84048650|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84048651|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048652|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048653|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048654|NCT02867813|Evolocumab|evolocumab|mesh-list
84048655|NCT02867813|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84048656|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84048657|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84048658|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
84048659|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048660|NCT02867813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84048661|NCT02867813|Protease Inhibitors|protease inhibitors|mesh-ancestor
84048662|NCT02867813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048663|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84048664|NCT02845596|Cyclosporine|cyclosporine|mesh-list
84048665|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
84048666|NCT02845596|Methotrexate|methotrexate|mesh-list
84048668|NCT02845596|Cyclosporins|cyclosporins|mesh-list
84048669|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
84048670|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84048671|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
84048672|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
84048673|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174953|NCT00254579|Tremelimumab|tremelimumab|mesh-list
84048674|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048675|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84048676|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
84048677|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048678|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048679|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84048680|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84048681|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
84048682|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84048683|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048684|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
84048685|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
84048686|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048687|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84048688|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84048689|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
84048690|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048691|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84048692|NCT02775695|Doxycycline|doxycycline|mesh-list
84048693|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84048694|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048695|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
84048696|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84048697|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84048698|NCT02737787|Nivolumab|nivolumab|mesh-list
84048699|NCT02737787|Vaccines|vaccines|mesh-list
84048700|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
84048701|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048702|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048703|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048704|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048705|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048706|NCT02646839|Biotin|biotin|mesh-list
84048707|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
84048708|NCT02646839|Vitamins|vitamins|mesh-ancestor
84048709|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
84048710|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048711|NCT02494570|Sirolimus|sirolimus|mesh-list
84048712|NCT02494570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84048713|NCT02494570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048714|NCT02494570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84048715|NCT02494570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048716|NCT02494570|Antifungal Agents|antifungal agents|mesh-ancestor
84048717|NCT02494570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84048718|NCT02494570|Immunologic Factors|immunologic factors|mesh-ancestor
84048719|NCT02494570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048720|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
84048721|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048722|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048723|NCT02437071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048724|NCT02437071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048725|NCT02341274|Tacrolimus|tacrolimus|mesh-list
84048726|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84048727|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
84048728|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048729|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84048730|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048731|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048732|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
84048733|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048734|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048735|NCT02289209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84048736|NCT02289209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048737|NCT02256865|Ketoconazole|ketoconazole|mesh-list
84048738|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
84048739|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84048740|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84048741|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84048742|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
84048744|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
84048745|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
83175256|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
84048746|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84048747|NCT02256865|Androgens|androgens|mesh-ancestor
84048748|NCT02256865|Hormones|hormones|mesh-ancestor
84048749|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048750|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048751|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84048752|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048753|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
84048754|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048755|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
84048756|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048757|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84048758|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84048759|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048760|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048761|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84048762|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048763|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84048764|NCT02231879|Plerixafor|plerixafor|mesh-list
84048765|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84048766|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84048767|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
84048768|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048769|NCT01968460|Pramipexole|pramipexole|mesh-list
84048770|NCT01968460|Rasagiline|rasagiline|mesh-list
84048771|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
84048772|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048773|NCT01968460|Protective Agents|protective agents|mesh-ancestor
84048774|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048775|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84048776|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84048777|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
84048778|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
84048779|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048780|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84048781|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048782|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84048783|NCT01906853|Vaccines|vaccines|mesh-list
84048784|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
84048785|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
84048786|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048787|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84048788|NCT01712490|Doxorubicin|doxorubicin|mesh-list
84048789|NCT01712490|Bleomycin|bleomycin|mesh-list
84048790|NCT01712490|Dacarbazine|dacarbazine|mesh-list
84048791|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83175495|NCT04848220|APD791|apd791|mesh-list
84048792|NCT01712490|Vinblastine|vinblastine|mesh-list
84048793|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84048794|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048795|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84048796|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84048797|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048798|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048799|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84048800|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
84048801|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048802|NCT01712490|Immunotoxins|immunotoxins|mesh-ancestor
84048803|NCT01712490|Immunoconjugates|immunoconjugates|mesh-ancestor
84048804|NCT01712490|Immunologic Factors|immunologic factors|mesh-ancestor
84048805|NCT01712490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048806|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84048807|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
84048808|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
84048809|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
84048810|NCT01527747|Saxagliptin|saxagliptin|mesh-list
83175502|NCT05642182|Vitamin D|vitamin d|mesh-list
84048811|NCT01527747|Incretins|incretins|mesh-ancestor
84048812|NCT01527747|Hormones|hormones|mesh-ancestor
84048813|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048814|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048815|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84048816|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
84048817|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048818|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048819|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84048820|NCT01439802|Copper|copper|mesh-list
84048821|NCT01439802|Trace Elements|trace elements|mesh-ancestor
84048822|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
84048823|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048824|NCT01434316|Veliparib|veliparib|mesh-list
84048825|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84048826|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048827|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048828|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048829|NCT00646230|Fenretinide|fenretinide|mesh-list
84048830|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048831|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84048832|NCT00646230|Protective Agents|protective agents|mesh-ancestor
84048833|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048834|NCT00544414|Leucovorin|leucovorin|mesh-list
84048835|NCT00544414|Gemcitabine|gemcitabine|mesh-list
84048836|NCT00544414|Docetaxel|docetaxel|mesh-list
84048837|NCT00544414|Fluorouracil|fluorouracil|mesh-list
84048838|NCT00544414|Calcium|calcium|mesh-list
84048839|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
83175626|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
84048840|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048841|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048842|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
84048843|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048844|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
84048845|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
84048846|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
84048847|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84048848|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048849|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84048850|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
84048851|NCT00544414|Antidotes|antidotes|mesh-ancestor
84048852|NCT00544414|Protective Agents|protective agents|mesh-ancestor
84048853|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
84048854|NCT00544414|Vitamins|vitamins|mesh-ancestor
84048855|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
84048856|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84048857|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84048858|NCT00816556|Estradiol|estradiol|mesh-list
84048859|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84048860|NCT00816556|Estrogens|estrogens|mesh-ancestor
84048861|NCT00816556|Hormones|hormones|mesh-ancestor
83175750|NCT00002411|Lamivudine|lamivudine|mesh-list
84048862|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048863|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048864|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84048865|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
84048866|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84048867|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84048868|NCT04100473|Insulin|insulin|mesh-list
84048869|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84048870|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
84048871|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84048872|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048873|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84048874|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84048875|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048876|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83175827|NCT03529175|Paclitaxel|paclitaxel|mesh-list
84048877|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84048878|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84048879|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84048880|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048881|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
84048882|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84048883|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048884|NCT00760669|Infliximab|infliximab|mesh-list
84048885|NCT00760669|Methotrexate|methotrexate|mesh-list
84048886|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84048887|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
84048888|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84048889|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048890|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84048891|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
83288757|NCT05243342|Daratumumab|daratumumab|mesh-list
84048892|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048893|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048894|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
84048895|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048896|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84048897|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84048898|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
84048899|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84048900|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84048901|NCT00760669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84048902|NCT00760669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84048903|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84048905|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84048906|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048907|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84048908|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84048909|NCT02796183|Growth Substances|growth substances|mesh-ancestor
84048910|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048911|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
84048912|NCT02796105|Ganirelix|ganirelix|mesh-list
84048913|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
84048914|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84048915|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048916|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84048917|NCT02795949|Amoxicillin|amoxicillin|mesh-list
84048918|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
84048919|NCT02795949|Meropenem|meropenem|mesh-list
84048920|NCT02795949|Tazobactam|tazobactam|mesh-list
84048921|NCT02795949|Piperacillin|piperacillin|mesh-list
84048922|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
84048923|NCT02795949|Imipenem|imipenem|mesh-list
84048924|NCT02795949|Ceftazidime|ceftazidime|mesh-list
84048925|NCT02795949|Ampicillin|ampicillin|mesh-list
84048926|NCT02795949|Cefuroxime|cefuroxime|mesh-list
84048927|NCT02795949|Ertapenem|ertapenem|mesh-list
84048928|NCT02795949|Cefepime|cefepime|mesh-list
84048929|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84048930|NCT02795949|Lactams|lactams|mesh-list
84048931|NCT02795949|Aztreonam|aztreonam|mesh-list
84048932|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84048933|NCT02795949|beta-Lactams|beta-lactams|mesh-list
83175996|NCT04440917|Apatinib|apatinib|mesh-list
84048934|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84048935|NCT02795949|Trimethoprim|trimethoprim|mesh-list
84048936|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
84048937|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048938|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
84048939|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84048940|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84048941|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048942|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048943|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048944|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84048945|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84048946|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84048947|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84048948|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
84048949|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84048950|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84048951|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84048952|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84048953|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84048954|NCT00769483|Gemcitabine|gemcitabine|mesh-list
84048955|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84048956|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83288829|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83288830|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288831|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
83288832|NCT05095922|Coagulants|coagulants|mesh-ancestor
83288833|NCT05084222|Budesonide|budesonide|mesh-list
83288834|NCT05084222|Albuterol|albuterol|mesh-list
83288835|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
83288836|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83288837|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83288838|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
83288839|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288840|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048957|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
84048958|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048959|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84048960|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84048961|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048962|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
84048963|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84048964|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
84048965|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84048966|NCT02794389|Expectorants|expectorants|mesh-ancestor
84048967|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
84048968|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84048969|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
84048970|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048971|NCT02794389|Protective Agents|protective agents|mesh-ancestor
84048972|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048973|NCT02794389|Antidotes|antidotes|mesh-ancestor
84048974|NCT02601703|Tacrolimus|tacrolimus|mesh-list
84048975|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84048976|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
84048977|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048978|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84048979|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84048980|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84048981|NCT04234191|Buprenorphine|buprenorphine|mesh-list
84048982|NCT04234191|Hydromorphone|hydromorphone|mesh-list
84048983|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84048984|NCT04234191|Naloxone|naloxone|mesh-list
84048985|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84048986|NCT04234191|Narcotics|narcotics|mesh-ancestor
84048987|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048988|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048989|NCT04234191|Analgesics|analgesics|mesh-ancestor
84048990|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
84048991|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84048992|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84048993|NCT02801799|Ropivacaine|ropivacaine|mesh-list
84048994|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
84048995|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
84048996|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84048997|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84048998|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
84048999|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049000|NCT02690103|Ribavirin|ribavirin|mesh-list
84049001|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
84049002|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049003|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
84049004|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049005|NCT02790099|Morphine|morphine|mesh-list
84049006|NCT02790099|Bupivacaine|bupivacaine|mesh-list
84049007|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
84049008|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
84049009|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049010|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049011|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
84049012|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049013|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84049014|NCT02790099|Narcotics|narcotics|mesh-ancestor
84049015|NCT02790099|Analgesics|analgesics|mesh-ancestor
84049016|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
84049017|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84049018|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
84049019|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049020|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
84049021|NCT02790177|Protective Agents|protective agents|mesh-ancestor
84049022|NCT04100083|Spironolactone|spironolactone|mesh-list
84049023|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84049024|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
84131337|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84049025|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049026|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049027|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84049028|NCT04100083|Diuretics|diuretics|mesh-ancestor
84049029|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
84049030|NCT02794155|Insulin|insulin|mesh-list
84049031|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84049032|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
84049033|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84049034|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049036|NCT02793843|Ondansetron|ondansetron|mesh-list
84049037|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049038|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
84049039|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
84049040|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049041|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049042|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049043|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
84049044|NCT02793843|Hormones|hormones|mesh-ancestor
84049045|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049046|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84049047|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049048|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049049|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
84049050|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
84049051|NCT02793843|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84049052|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84049053|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
84049054|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049055|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
84049056|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
84049057|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049058|NCT02793687|Protective Agents|protective agents|mesh-ancestor
84049059|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049060|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84049061|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84049062|NCT02801487|Cisplatin|cisplatin|mesh-list
84049063|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049064|NCT02793765|Docetaxel|docetaxel|mesh-list
84049065|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049066|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049067|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
84049068|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049069|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049070|NCT02793219|Docetaxel|docetaxel|mesh-list
84049071|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049072|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049073|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
84049074|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049075|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049076|NCT02801409|Anesthetics|anesthetics|mesh-list
84049077|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049078|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049079|NCT03787251|Apatinib|apatinib|mesh-list
84049080|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049081|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84049082|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131338|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049083|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049084|NCT02789865|Metronidazole|metronidazole|mesh-list
84049085|NCT02789865|Levofloxacin|levofloxacin|mesh-list
84049086|NCT02789865|Ertapenem|ertapenem|mesh-list
84049087|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049088|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84049089|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84049090|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84049091|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84049092|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84049093|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84049094|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049095|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049096|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049097|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84049098|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84049099|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
83288982|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288983|NCT04907253|Protective Agents|protective agents|mesh-ancestor
83288984|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288985|NCT04902443|Nivolumab|nivolumab|mesh-list
83288986|NCT04902443|Pomalidomide|pomalidomide|mesh-list
83288987|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288988|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288989|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288991|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
84049100|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84049101|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
84049102|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049103|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
84049104|NCT02792673|Protective Agents|protective agents|mesh-ancestor
84049105|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
84049106|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84049107|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
84049108|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049109|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84049110|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
84049111|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84049112|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
84049113|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049114|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049115|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84049116|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
84049117|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049118|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049119|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84049120|NCT02791737|Coal Tar|coal tar|mesh-list
84049121|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
84049122|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
84049123|NCT02535936|Anesthetics|anesthetics|mesh-list
84049124|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049125|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049126|NCT05332470|Lamivudine|lamivudine|mesh-list
84049127|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84049128|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84049129|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049130|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049131|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
84049132|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049133|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84049134|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84049135|NCT02791815|Selexipag|selexipag|mesh-list
84049136|NCT02791815|Midazolam|midazolam|mesh-list
84049137|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84049138|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84049139|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049140|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049141|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84049142|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84049143|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84049144|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84049145|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
84049146|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
84049147|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
84049148|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
84049149|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177112|NCT00159783|Olanzapine|olanzapine|mesh-list
84049150|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049151|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84049152|NCT02389374|Chloroquine|chloroquine|mesh-list
84049153|NCT02389374|Lumefantrine|lumefantrine|mesh-list
84049154|NCT02389374|Artemether|artemether|mesh-list
84049155|NCT02389374|Primaquine|primaquine|mesh-list
84049156|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84049157|NCT02389374|Amebicides|amebicides|mesh-ancestor
84049158|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83177211|NCT03522935|Elafin|elafin|mesh-list
84049159|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84049160|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049161|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
84049162|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049163|NCT02789475|Amlodipine|amlodipine|mesh-list
84049164|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84049165|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84049166|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84049167|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131339|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84049168|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049169|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84049170|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049171|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
84049172|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84049173|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83289057|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
84049174|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
84049175|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84049176|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84049177|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049178|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
84049179|NCT04202484|Tegafur|tegafur|mesh-list
84049180|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049181|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049182|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
84049183|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049184|NCT03068910|Spironolactone|spironolactone|mesh-list
84049185|NCT03068910|Progesterone|progesterone|mesh-list
84049186|NCT03068910|Progestins|progestins|mesh-ancestor
84049187|NCT03068910|Hormones|hormones|mesh-ancestor
84049188|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049189|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049190|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84049191|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
84049192|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84049193|NCT03068910|Diuretics|diuretics|mesh-ancestor
84049194|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
84049195|NCT02790957|Plerixafor|plerixafor|mesh-list
84049196|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84049197|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84049198|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
84049199|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049200|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84049201|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
84049202|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84049203|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84049204|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049205|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84049206|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84049207|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84049208|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049209|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
84049210|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049211|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
84049212|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84049213|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049214|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84049215|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049216|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
84049217|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049218|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049219|NCT03753243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84049220|NCT03753243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049221|NCT02339532|Carboplatin|carboplatin|mesh-list
84049222|NCT02339532|Docetaxel|docetaxel|mesh-list
84049223|NCT02339532|Trastuzumab|trastuzumab|mesh-list
84049224|NCT02339532|Pertuzumab|pertuzumab|mesh-list
84049225|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049226|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049227|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
84049228|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049229|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049230|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049231|NCT00632580|Ropivacaine|ropivacaine|mesh-list
84049232|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
84049233|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
84049234|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049235|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049236|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
84049237|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049238|NCT02789397|Rituximab|rituximab|mesh-list
84049239|NCT02789397|Azathioprine|azathioprine|mesh-list
84049240|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049241|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049242|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
84049243|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049244|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049245|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
84049246|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049247|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049248|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84049249|NCT03485274|Vortioxetine|vortioxetine|mesh-list
84049250|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
84049251|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84049252|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84049253|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84049254|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049255|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049256|NCT03485274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84049257|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84049258|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84049259|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049260|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049261|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
83177598|NCT02461160|Midazolam|midazolam|mesh-list
84049262|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84049263|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84049264|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84049265|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84049267|NCT00816166|Clopidogrel|clopidogrel|mesh-list
84049268|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84049269|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049270|NCT00816166|Analgesics|analgesics|mesh-ancestor
84049271|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
84049272|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049273|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049274|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049275|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049276|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84049277|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84049278|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049279|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84049280|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84049281|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049282|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
84049283|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84049284|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84049285|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84049286|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
84049287|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049288|NCT02788851|Guanfacine|guanfacine|mesh-list
84049289|NCT02788851|Methylphenidate|methylphenidate|mesh-list
84049290|NCT02788851|Amphetamine|amphetamine|mesh-list
84049291|NCT02788851|Adderall|adderall|mesh-list
84049292|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
83177728|NCT02493764|Linezolid|linezolid|mesh-list
84049293|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84049294|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84049295|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049296|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84049297|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84049298|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84049299|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049300|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
84049301|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049302|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
84049303|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
83177783|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84049304|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049305|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
84049306|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84049307|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84049308|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84049309|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84049310|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84049311|NCT02786823|Folic Acid|folic acid|mesh-list
84049312|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
84049313|NCT02786823|Hydroxocobalamin|hydroxocobalamin|mesh-list
84049314|NCT02786823|Metformin|metformin|mesh-list
84049315|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84049316|NCT02786823|Vitamins|vitamins|mesh-ancestor
84049317|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
83289207|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289208|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289209|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
83289216|NCT04567303|Ranibizumab|ranibizumab|mesh-list
83289217|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83289223|NCT04544293|Molgramostim|molgramostim|mesh-list
84049318|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049319|NCT02786823|Hematinics|hematinics|mesh-ancestor
84049320|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
84049321|NCT05332314|Ibuprofen|ibuprofen|mesh-list
84049322|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84049323|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049324|NCT05332314|Analgesics|analgesics|mesh-ancestor
84049325|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
84049326|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049327|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049328|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049329|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049330|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84049331|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049332|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049333|NCT00815308|Paclitaxel|paclitaxel|mesh-list
84049334|NCT00815308|Cetuximab|cetuximab|mesh-list
84049335|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83177926|NCT01190787|Prednisone|prednisone|mesh-list
84049336|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049337|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049338|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
84049339|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049340|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049341|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049342|NCT01039376|Ofatumumab|ofatumumab|mesh-list
84049343|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049344|NCT02610712|Ketamine|ketamine|mesh-list
84049345|NCT02610712|Analgesics|analgesics|mesh-ancestor
83177967|NCT01679613|Ketoconazole|ketoconazole|mesh-list
84049346|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
84049347|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049348|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049349|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84049350|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84049351|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
84049352|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
84049353|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178027|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
84049354|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84049355|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84049356|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049357|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049358|NCT00905034|Dexamethasone|dexamethasone|mesh-list
84049359|NCT00905034|Rituximab|rituximab|mesh-list
84049360|NCT00905034|Methotrexate|methotrexate|mesh-list
84049361|NCT00905034|Vincristine|vincristine|mesh-list
84049362|NCT00905034|Asparaginase|asparaginase|mesh-list
84049363|NCT00905034|Pegaspargase|pegaspargase|mesh-list
84049364|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049365|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049366|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
84049367|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049368|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049369|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049370|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
84049371|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
84049372|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049373|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049374|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
84049375|NCT00905034|Hormones|hormones|mesh-ancestor
84049376|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049377|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84049378|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84049379|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
84049380|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049381|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049382|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
84049383|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049384|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
84049385|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049386|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84049387|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84049388|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84049389|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84049390|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049391|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289285|NCT04224493|Rituximab|rituximab|mesh-list
84049392|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049393|NCT02611804|Diclofenac|diclofenac|mesh-list
84049394|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84049395|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049396|NCT02611804|Analgesics|analgesics|mesh-ancestor
84049397|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
83178207|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049398|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049399|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049400|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049401|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049402|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84049403|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049404|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049405|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
84049406|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84049407|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84049408|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
84049409|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
84049410|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049411|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049412|NCT02611492|Cytarabine|cytarabine|mesh-list
84049413|NCT02611492|Dexamethasone|dexamethasone|mesh-list
84049414|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84049415|NCT02611492|Methotrexate|methotrexate|mesh-list
84049416|NCT02611492|Vincristine|vincristine|mesh-list
84049417|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
84049418|NCT02611492|Lenograstim|lenograstim|mesh-list
84049419|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049420|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
84049421|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
84049422|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049423|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049424|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049425|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
84049426|NCT02611492|Hormones|hormones|mesh-ancestor
84049427|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049428|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84049429|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049430|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84049431|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
84049432|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049433|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049434|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
84049435|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049436|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
84049437|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049438|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84049439|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84049440|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
84049441|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049442|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84049443|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84049444|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049445|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
84049446|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049447|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84049448|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
84049449|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049450|NCT00706576|Mitogens|mitogens|mesh-list
84049451|NCT00706576|Enkephalins|enkephalins|mesh-list
84049452|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049453|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049454|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049455|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049456|NCT00828568|Imiquimod|imiquimod|mesh-list
83178385|NCT05158699|Analgesics|analgesics|mesh-ancestor
84049457|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84049458|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
84049459|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049460|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049461|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
84049462|NCT01038752|Suramin|suramin|mesh-list
84049463|NCT01038752|Carboplatin|carboplatin|mesh-list
84049464|NCT01038752|Docetaxel|docetaxel|mesh-list
84049465|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049466|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049467|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
84049468|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049469|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049470|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
84049471|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
84049472|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84049473|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049474|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84049475|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84049476|NCT04233021|Osimertinib|osimertinib|mesh-list
84049477|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049478|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84049479|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049480|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049481|NCT00903630|Doxorubicin|doxorubicin|mesh-list
84049482|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84049483|NCT00903630|Lenalidomide|lenalidomide|mesh-list
84049484|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84049485|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049486|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84049487|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84049488|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049489|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049490|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
84049491|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049492|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84049493|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84049494|NCT00903630|Growth Substances|growth substances|mesh-ancestor
84049495|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
84049496|NCT04302584|Vasopressins|vasopressins|mesh-list
84049497|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
84049498|NCT04302584|Norepinephrine|norepinephrine|mesh-list
84049499|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84049500|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84049501|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
84049502|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049503|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049504|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049505|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
84049506|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
84049507|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049508|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84049509|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
84049510|NCT04302584|Coagulants|coagulants|mesh-ancestor
84049511|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84049512|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
84049513|NCT00703144|Tazobactam|tazobactam|mesh-list
84049514|NCT00703144|Piperacillin|piperacillin|mesh-list
84049515|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84049516|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84049517|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049518|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84049519|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049520|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049521|NCT01054820|Diclofenac|diclofenac|mesh-list
84049522|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83178616|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
84049523|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84049524|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049525|NCT01054820|Analgesics|analgesics|mesh-ancestor
84049526|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
84049527|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049528|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049529|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049530|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049531|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84049532|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049533|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049534|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
84049535|NCT03105843|Miotics|miotics|mesh-ancestor
84049536|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
84049537|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049538|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049539|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83289433|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83178740|NCT04463459|Protective Agents|protective agents|mesh-ancestor
84049540|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
84049541|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
84049542|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84049543|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84049544|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
84049545|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049546|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049547|NCT02874248|Drospirenone|drospirenone|mesh-list
84049548|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84049549|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
84049550|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049551|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049552|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84049553|NCT02874248|Diuretics|diuretics|mesh-ancestor
84049554|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
84049555|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84049556|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049557|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
84049558|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
84049559|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
84049560|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049561|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049562|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
84049563|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049564|NCT02788305|Misoprostol|misoprostol|mesh-list
84049565|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84049566|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
84049567|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049568|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049569|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84049570|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049571|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
84049572|NCT05758012|Oxytocin|oxytocin|mesh-list
84049573|NCT05758012|Carbetocin|carbetocin|mesh-list
84049574|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
84049575|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049576|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049577|NCT02786667|Rotigotine|rotigotine|mesh-list
84049578|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
84049579|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
84049580|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049581|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049582|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049583|NCT00913276|Propofol|propofol|mesh-list
84049584|NCT00913276|Sevoflurane|sevoflurane|mesh-list
84049585|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84049586|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049587|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049588|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84049589|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
84049590|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
84049591|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84049592|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84049593|NCT04302116|Prednisolone|prednisolone|mesh-list
84049594|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84049595|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
84049596|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84049597|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
84049598|NCT04302116|Vigabatrin|vigabatrin|mesh-list
84049599|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84049600|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
84049601|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049602|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
84049603|NCT04302116|Hormones|hormones|mesh-ancestor
84049604|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049605|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049606|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84049607|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049608|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
84049609|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
83178988|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
84049610|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049611|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049612|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84049613|NCT04302116|Protective Agents|protective agents|mesh-ancestor
84049614|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
84049615|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049616|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049617|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
84049618|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049619|NCT05756998|Copper|copper|mesh-list
84049620|NCT05756998|Trace Elements|trace elements|mesh-ancestor
84049621|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
84049622|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049623|NCT02890212|Selenium|selenium|mesh-list
84049624|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
84049625|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049626|NCT02890212|Protective Agents|protective agents|mesh-ancestor
84049627|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049628|NCT02890212|Trace Elements|trace elements|mesh-ancestor
83179041|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
84049629|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
84049630|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84049631|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84049632|NCT05387577|Estradiol|estradiol|mesh-list
84049633|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84049634|NCT05387577|Estrogens|estrogens|mesh-ancestor
84049635|NCT05387577|Hormones|hormones|mesh-ancestor
84049636|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049637|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049638|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84049639|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
84049640|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049641|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84049642|NCT03044613|Paclitaxel|paclitaxel|mesh-list
84049643|NCT03044613|Carboplatin|carboplatin|mesh-list
84049644|NCT03044613|Nivolumab|nivolumab|mesh-list
84049645|NCT03044613|Relatlimab|relatlimab|mesh-list
84049646|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84049647|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049648|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
84049649|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
84049650|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
84049651|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049652|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049653|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84049654|NCT01372254|Nicotine|nicotine|mesh-list
84049655|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84049656|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
84049657|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049658|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049659|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84049660|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84049661|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
84049662|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049663|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049664|NCT02785653|Sevoflurane|sevoflurane|mesh-list
84049665|NCT02785653|Rocuronium|rocuronium|mesh-list
84049666|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84049667|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84049668|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
84049669|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
84049670|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049671|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049672|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84049673|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84049674|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84049675|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049676|NCT02787447|Gefitinib|gefitinib|mesh-list
84049677|NCT02787447|Thymalfasin|thymalfasin|mesh-list
84049678|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049679|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84049680|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049681|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049682|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84049683|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
84049684|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049685|NCT00904722|Rituximab|rituximab|mesh-list
84049686|NCT00904722|Pidilizumab|pidilizumab|mesh-list
84049687|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049688|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049689|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
84049690|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049691|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049692|NCT02909361|Fulvestrant|fulvestrant|mesh-list
83289582|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
84049693|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84049694|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049695|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84049696|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84049697|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
84049698|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049699|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049700|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
84049701|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84049702|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
84049703|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
84049704|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049705|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049706|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049707|NCT04301024|Analgesics|analgesics|mesh-ancestor
84049708|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
84049709|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049710|NCT01340430|Trastuzumab|trastuzumab|mesh-list
84049711|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049712|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049713|NCT01029782|Cefazolin|cefazolin|mesh-list
84049714|NCT01029782|Cephalexin|cephalexin|mesh-list
84049715|NCT01029782|Probenecid|probenecid|mesh-list
84049716|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84049717|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049718|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
84049719|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
84049720|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83179333|NCT04456777|Vortioxetine|vortioxetine|mesh-list
84049721|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
84049722|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84049723|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84049724|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049725|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
84049726|NCT02849730|Fentanyl|fentanyl|mesh-list
84049727|NCT02849730|Analgesics|analgesics|mesh-list
84049728|NCT02849730|Ropivacaine|ropivacaine|mesh-list
84049729|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
84049730|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
84049731|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049732|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049733|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
84049734|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049735|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84049736|NCT02849730|Narcotics|narcotics|mesh-ancestor
84049737|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84049738|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84049739|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
84049740|NCT02849340|Immunomodulating Agents|immunomodulating agents|mesh-list
84049741|NCT02849340|Immunologic Factors|immunologic factors|mesh-ancestor
84049742|NCT02849340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049743|NCT03936192|Meloxicam|meloxicam|mesh-list
84049744|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84049745|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049746|NCT03936192|Analgesics|analgesics|mesh-ancestor
84049747|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
84049748|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049749|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049750|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049751|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049752|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84049753|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84049754|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049755|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049756|NCT00930228|Flutamide|flutamide|mesh-list
84049757|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
84049758|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
84049759|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049760|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049761|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84049762|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049763|NCT05043870|Infliximab|infliximab|mesh-list
84049764|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
84049765|NCT05043870|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84049766|NCT05043870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049767|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
84049768|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049769|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049770|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
84049771|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049772|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84049773|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049774|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84049775|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049776|NCT02786979|Aspirin|aspirin|mesh-list
84049777|NCT02786979|Beraprost|beraprost|mesh-list
84049778|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84049779|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049780|NCT02786979|Analgesics|analgesics|mesh-ancestor
84049781|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
84049782|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179634|NCT02813655|Cosyntropin|cosyntropin|mesh-list
84049783|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049784|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049785|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049786|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84049787|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84049788|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049789|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84049790|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84049791|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049792|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
84049793|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
84049794|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
84049795|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049796|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049797|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
84049798|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
84049799|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049800|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049801|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84049802|NCT00221988|Levetiracetam|levetiracetam|mesh-list
84049803|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
84049804|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
84049805|NCT02341911|Carboplatin|carboplatin|mesh-list
84049806|NCT02341911|Gemcitabine|gemcitabine|mesh-list
84049807|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049808|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049809|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
84049810|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049811|NCT02847000|Decitabine|decitabine|mesh-list
84049812|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
84049813|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049814|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
84049815|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049816|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049817|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049818|NCT02784327|Ropivacaine|ropivacaine|mesh-list
84049819|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
84049820|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
84049821|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049822|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049823|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
84049824|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049825|NCT02845050|Cisplatin|cisplatin|mesh-list
84049826|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049827|NCT02690922|Dexamethasone|dexamethasone|mesh-list
84049828|NCT02690922|Prednisone|prednisone|mesh-list
84049829|NCT02690922|Methotrexate|methotrexate|mesh-list
84049830|NCT02690922|Dasatinib|dasatinib|mesh-list
83179817|NCT02315495|Acarbose|acarbose|mesh-list
84049831|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049832|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
84049833|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
84049834|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049835|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049836|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049837|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
84049838|NCT02690922|Hormones|hormones|mesh-ancestor
84049839|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049840|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84049841|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049842|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84049843|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
83179873|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
84049844|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049845|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049846|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
84049847|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049848|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
84049849|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049850|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84049851|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84049852|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
84049853|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049854|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84049855|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84049856|NCT02848950|Metformin|metformin|mesh-list
84049857|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84049858|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049859|NCT04202406|Acetaminophen|acetaminophen|mesh-list
84049860|NCT04202406|Codeine|codeine|mesh-list
84049861|NCT04202406|Caffeine|caffeine|mesh-list
84049862|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049863|NCT04202406|Analgesics|analgesics|mesh-ancestor
84049864|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
84049865|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049866|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049867|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
84049868|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84049869|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84049870|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049871|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049872|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84049873|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83180069|NCT03109691|Hormones|hormones|mesh-ancestor
84049874|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
84049875|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049876|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84049877|NCT04202406|Narcotics|narcotics|mesh-ancestor
84049878|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84049879|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
84049880|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
84049881|NCT02846766|Lenvatinib|lenvatinib|mesh-list
84049882|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049883|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84049884|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049885|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049886|NCT00839956|Bortezomib|bortezomib|mesh-list
84049887|NCT00839956|Vorinostat|vorinostat|mesh-list
84049888|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049889|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84049890|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049891|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049892|NCT00839800|Terbutaline|terbutaline|mesh-list
84049893|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84049894|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84049895|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
84049896|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84049897|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
84049898|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049899|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049900|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
84049901|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
84049902|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84049903|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84049904|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84049905|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84049906|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
84049907|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049908|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049909|NCT00867321|Bevacizumab|bevacizumab|mesh-list
84049910|NCT00867321|Sorafenib|sorafenib|mesh-list
84049911|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84049912|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049913|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84049914|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84049915|NCT00867321|Growth Substances|growth substances|mesh-ancestor
84049916|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049917|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
84049918|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84049919|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049920|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049921|NCT00913666|Interferons|interferons|mesh-list
84049922|NCT00913666|Interferon-beta|interferon-beta|mesh-list
84049923|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
84049924|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049925|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
84049926|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84049927|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
84049928|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049929|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84049930|NCT05756764|Liraglutide|liraglutide|mesh-list
84049931|NCT05756764|Topiramate|topiramate|mesh-list
84049932|NCT05756764|Phentermine|phentermine|mesh-list
84049933|NCT05756764|Glucagon|glucagon|mesh-list
84049934|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84049935|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84049936|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049937|NCT05756764|Incretins|incretins|mesh-ancestor
84049938|NCT05756764|Hormones|hormones|mesh-ancestor
84049939|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84049940|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
84049941|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84049942|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84049943|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
84049944|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84049945|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
84049946|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
84049947|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049948|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
84049949|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049950|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049951|NCT05190471|Decitabine|decitabine|mesh-list
84049952|NCT05190471|Oblimersen|oblimersen|mesh-list
84049953|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84049954|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
84049955|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049956|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84049957|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049958|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84049959|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049960|NCT02601157|Aspirin|aspirin|mesh-list
84049961|NCT02601157|Clopidogrel|clopidogrel|mesh-list
84049962|NCT02601157|Ticagrelor|ticagrelor|mesh-list
84049963|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84049964|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84049965|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84049966|NCT02601157|Analgesics|analgesics|mesh-ancestor
84049967|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
84049968|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84049969|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84049970|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84049971|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84049972|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84049973|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84049974|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049975|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84049976|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84049977|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049978|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
84049979|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84049980|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84049981|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84049982|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
84049983|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84049984|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
84049985|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84049986|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
84049987|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84049988|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
84049989|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84049990|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84049991|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
84049992|NCT00902304|Amlodipine|amlodipine|mesh-list
84049993|NCT00902304|Valsartan|valsartan|mesh-list
84049994|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84049995|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
84049996|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84049997|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84049998|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84049999|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050000|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84050001|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050002|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
84050003|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84050004|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84050005|NCT00902304|Diuretics|diuretics|mesh-ancestor
84050006|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
84050007|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84050008|NCT02784795|Carboplatin|carboplatin|mesh-list
84050009|NCT02784795|Gemcitabine|gemcitabine|mesh-list
84050010|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050011|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050012|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
84050013|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050014|NCT05282277|Raclopride|raclopride|mesh-list
84050015|NCT05282277|Estradiol|estradiol|mesh-list
84050016|NCT05282277|Progesterone|progesterone|mesh-list
84050017|NCT05282277|Estrogens|estrogens|mesh-ancestor
84050018|NCT05282277|Hormones|hormones|mesh-ancestor
84050019|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050020|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050021|NCT05282277|Progestins|progestins|mesh-ancestor
84050022|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84050023|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84050024|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050025|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84050026|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84050027|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
84050028|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050029|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050030|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84050031|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
84050032|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050033|NCT02848794|Irinotecan|irinotecan|mesh-list
84050034|NCT02848794|Apatinib|apatinib|mesh-list
84050035|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84050036|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84050037|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050038|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050039|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050040|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050041|NCT04096027|Cabergoline|cabergoline|mesh-list
84050042|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84050043|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84050044|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
84050045|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
84050046|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050047|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050048|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050049|NCT04216134|Edetic Acid|edetic acid|mesh-list
84050050|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84050051|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
84050052|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
84050053|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050054|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
84050055|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84050056|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84050057|NCT00638079|Megestrol|megestrol|mesh-list
84050058|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
84050059|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84050060|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84050061|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84050062|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
84050063|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84050064|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050065|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84050066|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84050067|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84050068|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050069|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
84050070|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84050071|NCT00759031|Listerine|listerine|mesh-list
84050072|NCT00759031|Triclosan|triclosan|mesh-list
84050073|NCT00759031|Fluorides|fluorides|mesh-list
84050074|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
84050075|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
84050076|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
84050077|NCT00759031|Protective Agents|protective agents|mesh-ancestor
84050078|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050079|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84050080|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050081|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84050082|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84050083|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
84050084|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050085|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84050086|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
84050087|NCT04197219|Axitinib|axitinib|mesh-list
84050088|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050089|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050090|NCT04197219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84050091|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050092|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050093|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050094|NCT04834908|Immune Sera|immune sera|mesh-list
84050095|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
84050096|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050097|NCT02512497|Fludarabine|fludarabine|mesh-list
84050098|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
84050099|NCT02512497|Busulfan|busulfan|mesh-list
84050100|NCT02512497|Romidepsin|romidepsin|mesh-list
84050101|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
84050102|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84050103|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050104|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050105|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
84050106|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050107|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050108|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
84050109|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050110|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
84050111|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84050112|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84050113|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84050114|NCT02512497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84050115|NCT02512497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050116|NCT00916669|Etoposide|etoposide|mesh-list
84050117|NCT00916669|Enoxaparin|enoxaparin|mesh-list
84050118|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
84050119|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050120|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84050121|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84050122|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84050123|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050124|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050125|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
84050126|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83180730|NCT05359315|Interferons|interferons|mesh-list
84050127|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84050128|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
84050129|NCT02784015|Melphalan|melphalan|mesh-list
84050130|NCT02784015|Ifosfamide|ifosfamide|mesh-list
84050131|NCT02784015|Thiotepa|thiotepa|mesh-list
84050132|NCT02784015|Carboplatin|carboplatin|mesh-list
84050133|NCT02784015|Doxorubicin|doxorubicin|mesh-list
84050134|NCT02784015|Etoposide|etoposide|mesh-list
84050135|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050136|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
84050137|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050138|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84050139|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84050140|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
84050141|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050142|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050143|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84050144|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84050145|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84050146|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84050147|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050148|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84050149|NCT02601235|Pyrilamine|pyrilamine|mesh-list
84050150|NCT02601235|Phenylephrine|phenylephrine|mesh-list
84050151|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
84050152|NCT02601235|Naphazoline|naphazoline|mesh-list
84050153|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050154|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84050155|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84050156|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
84050157|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050158|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050159|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
84050160|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
84050161|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050162|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
84050163|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84050164|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
84050165|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84050166|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
83180848|NCT03130153|Aspirin|aspirin|mesh-list
84050167|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84050168|NCT02601235|Protective Agents|protective agents|mesh-ancestor
84050169|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84050170|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84050171|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050172|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84050173|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
84050174|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
84050175|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84050176|NCT02783937|Lenograstim|lenograstim|mesh-list
84050177|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84050178|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
84050179|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050180|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
84050181|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84050182|NCT02846142|Estradiol|estradiol|mesh-list
84050183|NCT02846142|Estrogens|estrogens|mesh-ancestor
84050184|NCT02846142|Hormones|hormones|mesh-ancestor
84050185|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050186|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050187|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84050188|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
84050189|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84050190|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84050191|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84050192|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84050193|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84050194|NCT00757783|Ritonavir|ritonavir|mesh-list
84050195|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84050196|NCT00757783|Darunavir|darunavir|mesh-list
84050197|NCT00757783|Tenofovir|tenofovir|mesh-list
84050198|NCT00757783|Emtricitabine|emtricitabine|mesh-list
84050199|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84050200|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84050201|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
84050202|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050203|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050204|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84050205|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84050206|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
84050207|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050208|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84050209|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84050210|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84050211|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84050212|NCT05242926|Docetaxel|docetaxel|mesh-list
84050213|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050214|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
84050215|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
84050216|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
84050217|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050218|NCT02782221|Hormones|hormones|mesh-list
84050219|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050220|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050221|NCT04231617|Glyburide|glyburide|mesh-list
84050222|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84050223|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290109|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
84050224|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84050225|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84050226|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84050227|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050228|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050229|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84050230|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84050231|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84050232|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
84050233|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050234|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050235|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84050236|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84050237|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
84050238|NCT02845908|Leucovorin|leucovorin|mesh-list
84050239|NCT02845908|Fluorouracil|fluorouracil|mesh-list
84050240|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
84050241|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
84050242|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050243|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050244|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050245|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050246|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
84050247|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050248|NCT02845908|Antidotes|antidotes|mesh-ancestor
84050249|NCT02845908|Protective Agents|protective agents|mesh-ancestor
84050250|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
84050251|NCT02845908|Vitamins|vitamins|mesh-ancestor
84050252|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
84050253|NCT02784483|Atezolizumab|atezolizumab|mesh-list
84050254|NCT02784483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84050255|NCT02784483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050256|NCT02784483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050257|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050258|NCT02784561|Cytarabine|cytarabine|mesh-list
84050259|NCT02784561|Fludarabine|fludarabine|mesh-list
84050260|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
84050261|NCT02784561|Busulfan|busulfan|mesh-list
84050262|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
84050263|NCT02784561|Lenograstim|lenograstim|mesh-list
84050264|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050265|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050266|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
84050267|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050268|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050269|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
83181179|NCT02249182|Ribavirin|ribavirin|mesh-list
84050270|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050271|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
84050272|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050273|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
84050274|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84050275|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84050276|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84050277|NCT00757627|Etoricoxib|etoricoxib|mesh-list
83181244|NCT00701207|Nicotine|nicotine|mesh-list
84050278|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84050279|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050280|NCT00757627|Analgesics|analgesics|mesh-ancestor
84050281|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
84050282|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050283|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050284|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050285|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84050286|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84050287|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84050288|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050289|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050290|NCT02600455|Abatacept|abatacept|mesh-list
84050291|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84050292|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050293|NCT02600455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050294|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050295|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050296|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
84050297|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050298|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290185|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050299|NCT01023308|Dexamethasone|dexamethasone|mesh-list
84050300|NCT01023308|Bortezomib|bortezomib|mesh-list
84050301|NCT01023308|Panobinostat|panobinostat|mesh-list
84050302|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050303|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
84050304|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
84050305|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050306|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050307|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84050308|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
84050309|NCT01023308|Hormones|hormones|mesh-ancestor
84050310|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050311|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83181395|NCT03484091|Hylan|hylan|mesh-list
84050312|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050313|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84050314|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050315|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050316|NCT02781909|Ibuprofen|ibuprofen|mesh-list
84050317|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84050318|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050319|NCT02781909|Analgesics|analgesics|mesh-ancestor
84050320|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
84050321|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050322|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050323|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181416|NCT03483389|Ethanol|ethanol|mesh-list
84050324|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84050325|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84050326|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050327|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050328|NCT01022996|Everolimus|everolimus|mesh-list
84050329|NCT01022996|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84050330|NCT01022996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050331|NCT01022996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050332|NCT01022996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050333|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050334|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
84050335|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050336|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050337|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
84050338|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84050339|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84050340|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050341|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
84050342|NCT02781597|Coagulants|coagulants|mesh-ancestor
84050343|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84050344|NCT00757237|Tobramycin|tobramycin|mesh-list
84050345|NCT00757237|Aztreonam|aztreonam|mesh-list
84050346|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84050347|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84050348|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050349|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
84050350|NCT01029392|Vitamin D|vitamin d|mesh-list
84050351|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
84050352|NCT01029392|Vitamins|vitamins|mesh-ancestor
84050353|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
84050354|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050355|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84050356|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84050357|NCT02781753|Interferons|interferons|mesh-list
84050358|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
84050359|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
84050360|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050361|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
84050362|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050363|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
84050364|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050365|NCT00903006|Dasatinib|dasatinib|mesh-list
84050366|NCT00903006|Fulvestrant|fulvestrant|mesh-list
84050367|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050368|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050369|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050370|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050371|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84050372|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84050373|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84050374|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
84050375|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050376|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050377|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
84050378|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84050379|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
84050380|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050381|NCT00839332|Gemcitabine|gemcitabine|mesh-list
84050382|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050383|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
84050384|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050385|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050386|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
84050387|NCT04095169|Complement C3|complement c3|mesh-list
84050388|NCT04095169|Complement C3d|complement c3d|mesh-list
84050389|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
84050390|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050392|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84050393|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
84050394|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
84050395|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050396|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050397|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84050398|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84050399|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84050400|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
84050401|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050402|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050403|NCT05241912|Protective Agents|protective agents|mesh-ancestor
84050404|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
84050405|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84050406|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050407|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84050408|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050409|NCT04229355|Sorafenib|sorafenib|mesh-list
84050410|NCT04229355|Lenvatinib|lenvatinib|mesh-list
84050411|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
84050412|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84050413|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050414|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050415|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050416|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050417|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84050418|NCT04229355|Estrogens|estrogens|mesh-ancestor
84050419|NCT04229355|Hormones|hormones|mesh-ancestor
84050420|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050421|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050422|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84050423|NCT04229355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050424|NCT02848170|Olmesartan|olmesartan|mesh-list
84050425|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84050426|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84050427|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84050428|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84050429|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050430|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
84050431|NCT04420884|Fluorouracil|fluorouracil|mesh-list
84050432|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050433|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050434|NCT04420884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84050435|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050436|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
84050437|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050438|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050439|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
84050440|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050441|NCT05341401|Prednisolone|prednisolone|mesh-list
84050442|NCT05341401|Budesonide|budesonide|mesh-list
84050443|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050444|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
84050445|NCT05341401|Hormones|hormones|mesh-ancestor
84050446|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050447|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050448|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84050449|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050450|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
84050451|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050452|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84050453|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84050454|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
84050455|NCT05340153|Lumefantrine|lumefantrine|mesh-list
84050456|NCT05340153|Artemether|artemether|mesh-list
84050457|NCT05340153|Piperaquine|piperaquine|mesh-list
84050458|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84050459|NCT05340153|Artenimol|artenimol|mesh-list
84050460|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
84050461|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84050462|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84050463|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050464|NCT05078502|Vitamin D|vitamin d|mesh-list
84050465|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
84050466|NCT05078502|Vitamins|vitamins|mesh-ancestor
84050467|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
84050468|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050469|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84050470|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84050471|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
84050472|NCT02844894|Esmolol|esmolol|mesh-list
84050473|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84050474|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050475|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050476|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050477|NCT02844894|Analgesics|analgesics|mesh-ancestor
84050478|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
84050479|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050480|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84050481|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84050482|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84050483|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
84050484|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050485|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050486|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84050487|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84050488|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84050489|NCT04778904|Nivolumab|nivolumab|mesh-list
84050490|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050491|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050492|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84050493|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050494|NCT00634725|Gemcitabine|gemcitabine|mesh-list
84050495|NCT00634725|Capecitabine|capecitabine|mesh-list
84050496|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84050497|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050498|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
84050499|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050500|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050501|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050502|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050503|NCT05325489|Budesonide|budesonide|mesh-list
84050504|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050505|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84050506|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
84050507|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050508|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050509|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84050510|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
84050511|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
84050512|NCT05325489|Hormones|hormones|mesh-ancestor
84050513|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050514|NCT00902538|Amlodipine|amlodipine|mesh-list
84050515|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84050516|NCT00902538|Olmesartan|olmesartan|mesh-list
84050517|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84050518|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84050519|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84050520|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84050521|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050522|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84050523|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050524|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
83182051|NCT05390255|Omalizumab|omalizumab|mesh-list
84050525|NCT00902538|Diuretics|diuretics|mesh-ancestor
84050526|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
84050527|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84050528|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84050529|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84050530|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
84050531|NCT02780505|Vitamins|vitamins|mesh-ancestor
84050532|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
84050533|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050534|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
84050535|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050536|NCT02780505|Protective Agents|protective agents|mesh-ancestor
84050537|NCT02690844|Clonazepam|clonazepam|mesh-list
84050538|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
84050539|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
84050540|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
84050541|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050542|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050543|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050544|NCT04201860|Hemostatics|hemostatics|mesh-list
84050545|NCT04201860|Coagulants|coagulants|mesh-ancestor
84050546|NCT02847702|Naproxen|naproxen|mesh-list
84050547|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84050548|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050549|NCT02847702|Analgesics|analgesics|mesh-ancestor
84050550|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
84050551|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050552|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050553|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050554|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84050555|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
84050556|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84050557|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050558|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050559|NCT02779413|Insulin|insulin|mesh-list
84050560|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84050561|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050562|NCT04887402|Clomiphene|clomiphene|mesh-list
84050563|NCT04887402|Enclomiphene|enclomiphene|mesh-list
84050564|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
84050565|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84050566|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
83182167|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
84050567|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050568|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050569|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84050570|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
84050571|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84050572|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84050573|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84050574|NCT04793568|Interferons|interferons|mesh-list
84050575|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
84050576|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050577|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
84050578|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050579|NCT01979211|Cetuximab|cetuximab|mesh-list
84050580|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050581|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050582|NCT05339217|Aldesleukin|aldesleukin|mesh-list
84050583|NCT05339217|Interleukin-2|interleukin-2|mesh-list
84050584|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050585|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050586|NCT05339217|Analgesics|analgesics|mesh-ancestor
84050587|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
84050588|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050589|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050590|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84050591|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84050592|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
84050593|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050594|NCT04793490|Acetaminophen|acetaminophen|mesh-list
84050595|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83290488|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
84050596|NCT04793490|Analgesics|analgesics|mesh-ancestor
84050597|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
84050598|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050599|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050600|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
84050601|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
84050602|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84050603|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84050604|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050605|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84050606|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84050607|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050608|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050609|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050610|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84050611|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
84050612|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84050613|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050614|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84050615|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84050616|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84050617|NCT05319093|Ozanimod|ozanimod|mesh-list
84050618|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84050619|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050620|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050621|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
84050622|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050623|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
84050624|NCT00752557|Vitamin D|vitamin d|mesh-list
84050625|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
84050626|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
84050627|NCT00752557|Diphosphonates|diphosphonates|mesh-list
84050628|NCT00752557|Vitamins|vitamins|mesh-list
84050629|NCT00752557|Calcium|calcium|mesh-list
84050630|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
84050631|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050632|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84050633|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84050634|NCT04570176|Epinephrine|epinephrine|mesh-list
84050635|NCT04570176|Racepinephrine|racepinephrine|mesh-list
84050636|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
84050637|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84050638|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84050639|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
84050640|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050641|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050642|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050643|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84050644|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84050645|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
84050646|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050647|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84050648|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
84050649|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
84050650|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
84050651|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84050652|NCT00751218|Cetirizine|cetirizine|mesh-list
84050653|NCT00751218|Desloratadine|desloratadine|mesh-list
84050654|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84050655|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84050656|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84050657|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
84050658|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
84050659|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050660|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050661|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050662|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84050663|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
84050664|NCT02779569|Decitabine|decitabine|mesh-list
84050665|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84050666|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
84050667|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050668|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182373|NCT05322499|Paclitaxel|paclitaxel|mesh-list
84050669|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050670|NCT04095013|Fentanyl|fentanyl|mesh-list
84050671|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
84050672|NCT04095013|Bupivacaine|bupivacaine|mesh-list
84050673|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
84050674|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
84050675|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050676|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050677|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
84050678|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050679|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84050680|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050682|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84050683|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84050684|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84050685|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
84050686|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050687|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050688|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84050689|NCT04095013|Narcotics|narcotics|mesh-ancestor
84050690|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84050691|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83182428|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
84050692|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
84050693|NCT02779881|Caseins|caseins|mesh-list
84050694|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
84050695|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
84050696|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050697|NCT00651378|Atorvastatin|atorvastatin|mesh-list
84050698|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84050699|NCT00651378|Ezetimibe|ezetimibe|mesh-list
84050700|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84050701|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84050702|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
84050703|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050704|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84050705|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84050706|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050707|NCT00747643|Varenicline|varenicline|mesh-list
84050708|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84050709|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84050710|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
84050711|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050712|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050713|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050714|NCT00627692|Prucalopride|prucalopride|mesh-list
84050715|NCT00627692|Laxatives|laxatives|mesh-ancestor
84050716|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84050717|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
84050718|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84050719|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
84050720|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050721|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050722|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050723|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
84050724|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050725|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050726|NCT04301882|Interferons|interferons|mesh-list
84050727|NCT04301882|Ribavirin|ribavirin|mesh-list
84050728|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
84050729|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050730|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050731|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
84050732|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050733|NCT04300322|Progesterone|progesterone|mesh-list
84050734|NCT04300322|Progestins|progestins|mesh-ancestor
84050735|NCT04300322|Hormones|hormones|mesh-ancestor
84050736|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050737|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050738|NCT01022762|Repaglinide|repaglinide|mesh-list
84050739|NCT01022762|Gliclazide|gliclazide|mesh-list
84050740|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84050741|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050742|NCT05338671|Anesthetics|anesthetics|mesh-list
84050743|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
84050744|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050745|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050746|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
84050747|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050748|NCT00311844|Desloratadine|desloratadine|mesh-list
83290648|NCT01814553|Afatinib|afatinib|mesh-list
84050749|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84050750|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
84050751|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050752|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050753|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050754|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84050755|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84050756|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
84050757|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
84050759|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
84050760|NCT02599675|Vitamins|vitamins|mesh-ancestor
84050761|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
84050762|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050763|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84050764|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84050765|NCT02778789|Adalimumab|adalimumab|mesh-list
84050766|NCT02778789|Infliximab|infliximab|mesh-list
84050767|NCT02778789|Golimumab|golimumab|mesh-list
84050768|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
84050769|NCT02778789|Etanercept|etanercept|mesh-list
84050770|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84050771|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050772|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84050773|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
84050774|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84050775|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84050776|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050777|NCT02778789|Analgesics|analgesics|mesh-ancestor
84050778|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
84050779|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050780|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182709|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
84050781|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050782|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
84050783|NCT00212784|Olanzapine|olanzapine|mesh-list
84050784|NCT00212784|Asenapine|asenapine|mesh-list
84050785|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
84050786|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
84050787|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050788|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050789|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84050790|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84050791|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84050792|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050793|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84050794|NCT00212784|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84050795|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84050796|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84050797|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050798|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050799|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
84050800|NCT00751933|Vaccines|vaccines|mesh-list
84050801|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
84050802|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050803|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
84050804|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
84050805|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050806|NCT02778945|Rocuronium|rocuronium|mesh-list
84050807|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84050808|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84050809|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84050810|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050811|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050812|NCT02721342|Ramipril|ramipril|mesh-list
84050813|NCT02721342|Irbesartan|irbesartan|mesh-list
84050814|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84050815|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
84050816|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050817|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050818|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84050819|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84050820|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84050821|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
84050822|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050823|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050824|NCT02779101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84050825|NCT02779101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050826|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
84050827|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
84050828|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
84050829|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050830|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050831|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84050832|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84050833|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84050834|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050835|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84050836|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84050837|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
84050838|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050839|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050840|NCT05335278|Nintedanib|nintedanib|mesh-list
84050841|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050842|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050843|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050844|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050845|NCT00092898|Ezetimibe|ezetimibe|mesh-list
84050846|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84050847|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84050848|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
84050849|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050850|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84050851|NCT04094467|Leuprolide|leuprolide|mesh-list
84050852|NCT04094467|Cetrorelix|cetrorelix|mesh-list
84050853|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84050854|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
84050855|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84050856|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050857|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84050858|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050859|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
84050860|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050861|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84050862|NCT00092820|Ezetimibe|ezetimibe|mesh-list
84050863|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84050864|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84050865|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
84050866|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050867|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84050868|NCT04228263|Aspirin|aspirin|mesh-list
84050869|NCT04228263|Folic Acid|folic acid|mesh-list
84050870|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
84050871|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84050872|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050873|NCT04228263|Analgesics|analgesics|mesh-ancestor
84050874|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
84050875|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050876|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050877|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050878|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84050879|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84050880|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84050881|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050882|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84050883|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84050884|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050885|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
84050886|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
84050887|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84050888|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84050889|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050890|NCT04228263|Hematinics|hematinics|mesh-ancestor
84050891|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
84050892|NCT04228263|Vitamins|vitamins|mesh-ancestor
84050893|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
84050894|NCT00092742|Diclofenac|diclofenac|mesh-list
84050895|NCT00092742|Etoricoxib|etoricoxib|mesh-list
84050896|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84050897|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050898|NCT00092742|Analgesics|analgesics|mesh-ancestor
84050899|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
84050900|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050901|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050902|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050903|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84050904|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84050905|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84050906|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050907|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84050908|NCT02844270|Sirolimus|sirolimus|mesh-list
84050909|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84050910|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050911|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84050912|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050913|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
84050914|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84050915|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
84050916|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050917|NCT00634959|Maraviroc|maraviroc|mesh-list
84050918|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84050919|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84050920|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050921|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84050922|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84050923|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
84050924|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84050925|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84050926|NCT02598427|Trastuzumab|trastuzumab|mesh-list
84050927|NCT02598427|Pertuzumab|pertuzumab|mesh-list
84050928|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84050929|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050930|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84050931|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84050932|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84050933|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
84050934|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050935|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84050936|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84050937|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183300|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050938|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
84050939|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
84050940|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
84050941|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050942|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
84050943|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84050944|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050945|NCT01028222|Dacarbazine|dacarbazine|mesh-list
84050946|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84050947|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
84050948|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050949|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050950|NCT00586495|Sorafenib|sorafenib|mesh-list
84050951|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050952|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84050953|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183369|NCT04452929|Analgesics|analgesics|mesh-ancestor
84050954|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050955|NCT02776137|Docetaxel|docetaxel|mesh-list
84050956|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050957|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
84050958|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
84050959|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
84050960|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050961|NCT01027754|Varenicline|varenicline|mesh-list
84050962|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84050963|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84050964|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
84050965|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131340|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84050966|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050967|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050968|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
84050969|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84050970|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84050971|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050972|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84050973|NCT02773017|Analgesics|analgesics|mesh-ancestor
84050974|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
84050975|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84050976|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84050977|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84050978|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84050979|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
84050980|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84050981|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84050982|NCT02776059|Prednisolone|prednisolone|mesh-list
84050983|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84050984|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
84050985|NCT02776059|Hormones|hormones|mesh-ancestor
84050986|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050987|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050988|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84050989|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050990|NCT00774930|Lanreotide|lanreotide|mesh-list
84050991|NCT00774930|Somatostatin|somatostatin|mesh-list
84050992|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84050993|NCT00774930|Hormones|hormones|mesh-ancestor
84050994|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84050995|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84050996|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84050997|NCT02841774|Pravastatin|pravastatin|mesh-list
84050998|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84050999|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84051000|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
84051001|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051002|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84051003|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84051004|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051005|NCT02772237|Riboflavin|riboflavin|mesh-list
84051006|NCT02772237|Vitamins|vitamins|mesh-ancestor
84051007|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
84051008|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051009|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
84051010|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84051011|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051012|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84051013|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84051014|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051015|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
84051016|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051017|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84051018|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051019|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051020|NCT02771925|Gabapentin|gabapentin|mesh-list
84051021|NCT02771925|Analgesics|analgesics|mesh-ancestor
84051022|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
84051023|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051024|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051025|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
84051026|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84051027|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84051028|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051029|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051030|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84051031|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84051032|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051033|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051034|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
84051035|NCT03205956|Levodopa|levodopa|mesh-list
84051036|NCT03205956|Carbidopa|carbidopa|mesh-list
84051037|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84051038|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84051039|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
84051040|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051041|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051042|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051043|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84051044|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051045|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
84051046|NCT02840994|Nivolumab|nivolumab|mesh-list
83183796|NCT03448835|Atezolizumab|atezolizumab|mesh-list
84051047|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84051048|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051049|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84051050|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051051|NCT02771457|Infliximab|infliximab|mesh-list
84051052|NCT02771457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84051053|NCT02771457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051054|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051055|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051056|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84051057|NCT02843802|Immunomodulating Agents|immunomodulating agents|mesh-list
84051058|NCT02843802|Immunologic Factors|immunologic factors|mesh-ancestor
84131341|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051059|NCT02843802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051060|NCT02771379|Idebenone|idebenone|mesh-list
84051061|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
84051062|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051063|NCT02771379|Protective Agents|protective agents|mesh-ancestor
84051064|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051065|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
84051066|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051067|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051068|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84051069|NCT02844114|Cisplatin|cisplatin|mesh-list
84051070|NCT02844114|Gemcitabine|gemcitabine|mesh-list
84051071|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051072|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84051073|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
84051074|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051075|NCT02696733|Cephalosporins|cephalosporins|mesh-list
84051076|NCT02696733|Lidocaine|lidocaine|mesh-list
84051077|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
84051078|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
84051079|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051080|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051081|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
84051082|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051083|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84051084|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84051085|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84051086|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84051087|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051088|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84051089|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051090|NCT00897390|Metformin|metformin|mesh-list
84051091|NCT00897390|Saxagliptin|saxagliptin|mesh-list
84051092|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84051093|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051094|NCT00897390|Incretins|incretins|mesh-ancestor
84051095|NCT00897390|Hormones|hormones|mesh-ancestor
84051096|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051097|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84051098|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
84051099|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051100|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051101|NCT01034462|Milnacipran|milnacipran|mesh-list
84051102|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
84051103|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84051104|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84051105|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84051106|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051107|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051108|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051109|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
84051110|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051111|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84051112|NCT01034462|Analgesics|analgesics|mesh-ancestor
84051113|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
84051114|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051115|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84051116|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
83184169|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
84051117|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051118|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
84051119|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051120|NCT02774811|Bimatoprost|bimatoprost|mesh-list
84051121|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84051122|NCT00817050|Fluticasone|fluticasone|mesh-list
84051123|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
84051124|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051125|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84051126|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
84051127|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051128|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051129|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84051130|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
84051131|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051132|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84051133|NCT04224831|Mitogens|mitogens|mesh-list
84051134|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
84051135|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051136|NCT00816972|Loratadine|loratadine|mesh-list
84051137|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
84051138|NCT00816972|Oxybutynin|oxybutynin|mesh-list
84051139|NCT00816972|Desloratadine|desloratadine|mesh-list
84051140|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
84051141|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
84051142|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051143|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051144|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84051145|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84051146|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
84051147|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051148|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051149|NCT00816972|Urological Agents|urological agents|mesh-ancestor
84051150|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84051151|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051152|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84051153|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84051154|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
84051155|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
84051156|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
84051157|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051158|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84051159|NCT02774499|Methadone|methadone|mesh-list
84051160|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84051161|NCT02774499|Narcotics|narcotics|mesh-ancestor
84051162|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051163|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184425|NCT05112471|Erythritol|erythritol|mesh-list
84051164|NCT02774499|Analgesics|analgesics|mesh-ancestor
84051165|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
84051166|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051167|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
84051168|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
84051169|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84051170|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84051171|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051172|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051173|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051174|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051175|NCT02774187|Leucovorin|leucovorin|mesh-list
84051176|NCT02774187|Fluorouracil|fluorouracil|mesh-list
84051177|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
84051178|NCT02774187|Sorafenib|sorafenib|mesh-list
84051179|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
84051180|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051181|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84051182|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051183|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83184562|NCT02416934|Hormones|hormones|mesh-ancestor
84051184|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
84051185|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051186|NCT02774187|Antidotes|antidotes|mesh-ancestor
84051187|NCT02774187|Protective Agents|protective agents|mesh-ancestor
84051188|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
84051189|NCT02774187|Vitamins|vitamins|mesh-ancestor
84051190|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
84051191|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84051192|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051193|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
84051194|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84051195|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051196|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051197|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84051198|NCT02773797|Analgesics|analgesics|mesh-ancestor
84051199|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
84051200|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051201|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84051202|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83184727|NCT03428633|Morphine|morphine|mesh-list
84051203|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84051204|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051205|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051206|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051207|NCT02773875|Pancrelipase|pancrelipase|mesh-list
84051208|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051209|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
84051210|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
84051211|NCT02768961|Ledipasvir|ledipasvir|mesh-list
84051212|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
84051213|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051214|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
84051215|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84051216|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84051217|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84051218|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84051219|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051220|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
84051221|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184815|NCT03427229|Vancomycin|vancomycin|mesh-list
84051222|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051223|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84051224|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051225|NCT02768805|Vaccines|vaccines|mesh-list
84051226|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
84051227|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051228|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84051229|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
84051230|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84051231|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
84051232|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051233|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
84051234|NCT02773251|Protective Agents|protective agents|mesh-ancestor
84051235|NCT02773251|Laxatives|laxatives|mesh-ancestor
84051236|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051237|NCT02768649|Risperidone|risperidone|mesh-list
84051238|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84051239|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
84051240|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051241|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051242|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051243|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84051244|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83184948|NCT02535325|Cisplatin|cisplatin|mesh-list
84051245|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051246|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051247|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84051248|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
84051249|NCT02773407|Azithromycin|azithromycin|mesh-list
84051250|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84051251|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84051252|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051253|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83185017|NCT03437629|Calcium|calcium|mesh-list
84051254|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
84051255|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84051256|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84051257|NCT04224675|Atenolol|atenolol|mesh-list
84051258|NCT04224675|Captopril|captopril|mesh-list
84051259|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84051260|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84051261|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
84051262|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
84051263|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051264|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185075|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051265|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84051266|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84051267|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84051268|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051269|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051270|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051271|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84051272|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291164|NCT01967173|Xhance|xhance|mesh-list
84051273|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051274|NCT02768493|Ropivacaine|ropivacaine|mesh-list
84051275|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
84051276|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
84051277|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051278|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051279|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
84051280|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051281|NCT02768415|Apatinib|apatinib|mesh-list
84051282|NCT02768415|Vinorelbine|vinorelbine|mesh-list
84051283|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051284|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84051285|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051286|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051287|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84051288|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
84051289|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
84051290|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
84051291|NCT02773095|Lactitol|lactitol|mesh-list
84051292|NCT02773095|Cathartics|cathartics|mesh-ancestor
84051293|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051294|NCT02768337|Afatinib|afatinib|mesh-list
84051295|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051296|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84051297|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051298|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051299|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
84051300|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84051301|NCT02768571|Protective Agents|protective agents|mesh-ancestor
84051302|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051303|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
84051304|NCT02767713|Dexamethasone|dexamethasone|mesh-list
84051305|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051306|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
84051307|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
84051308|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051309|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051310|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051311|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
84051312|NCT02767713|Hormones|hormones|mesh-ancestor
84051313|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051314|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84051315|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051316|NCT02767245|Thiamine|thiamine|mesh-list
84051317|NCT02767245|Vitamins|vitamins|mesh-ancestor
84051318|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
84051319|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051320|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
84051321|NCT02767401|Aspirin|aspirin|mesh-list
84051322|NCT02767401|Metoprolol|metoprolol|mesh-list
84051323|NCT02767401|Clopidogrel|clopidogrel|mesh-list
84051324|NCT02767401|Ticagrelor|ticagrelor|mesh-list
84051325|NCT02767401|Atorvastatin|atorvastatin|mesh-list
84051326|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84051327|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84051328|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84051329|NCT02767401|Analgesics|analgesics|mesh-ancestor
84051330|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
84051331|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051332|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051333|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051334|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84051335|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84051336|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84051337|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051338|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84051339|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84051340|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051341|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
84051342|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84051343|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84051344|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
84051345|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84051346|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84051347|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84051348|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84051349|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84051350|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
84051351|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051352|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84051353|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84051354|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
84051355|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
83185385|NCT03179605|Hormones|hormones|mesh-ancestor
84051356|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84051357|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84051358|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84051359|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051360|NCT02767479|Esomeprazole|esomeprazole|mesh-list
84051361|NCT02767479|Rabeprazole|rabeprazole|mesh-list
84051362|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84051363|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051364|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84051365|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051366|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051367|NCT02767635|Triamcinolone|triamcinolone|mesh-list
84051368|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84051369|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84051370|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84051371|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84051372|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84051373|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84051374|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051375|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051376|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84051377|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84051378|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051379|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
84051380|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051381|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051382|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
84051383|NCT02767635|Hormones|hormones|mesh-ancestor
84051384|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051385|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84051386|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
84051387|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051388|NCT04224441|Temozolomide|temozolomide|mesh-list
84051389|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
84051390|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84051391|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
84051392|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051393|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051394|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
84051395|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
84051396|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051397|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051398|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051399|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84051400|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84051401|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051402|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051403|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84051404|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
84051405|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051406|NCT02767089|Prednisone|prednisone|mesh-list
84051407|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051408|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
84051409|NCT02767089|Hormones|hormones|mesh-ancestor
84051410|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051411|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051412|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84051413|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051414|NCT02766855|Cysteamine|cysteamine|mesh-list
84051415|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
84051416|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051417|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
84051418|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84051419|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
84051420|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051421|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051422|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84051423|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84051424|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84051425|NCT04224051|Metformin|metformin|mesh-list
84051426|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84051427|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051428|NCT02762253|Riboflavin|riboflavin|mesh-list
84051429|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
84051430|NCT02762253|Vitamins|vitamins|mesh-ancestor
84051431|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
84051432|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051433|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84051434|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051435|NCT00746941|Mefloquine|mefloquine|mesh-list
84051436|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
84051437|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84051438|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84051439|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051440|NCT04532463|Fluconazole|fluconazole|mesh-list
84051441|NCT04532463|Amphotericin B|amphotericin b|mesh-list
84051442|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84051443|NCT04532463|Flucytosine|flucytosine|mesh-list
84051444|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
84051445|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051446|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84051447|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84051448|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051449|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051450|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84051451|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
84051452|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051453|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051454|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84051455|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84051456|NCT04532463|Amebicides|amebicides|mesh-ancestor
84051457|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84051458|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84051459|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84051460|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
84051461|NCT04091971|Ketamine|ketamine|mesh-list
84051462|NCT04091971|Analgesics|analgesics|mesh-ancestor
84051463|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
84051464|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051465|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051466|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84051467|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84051468|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
84051469|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
84051470|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051471|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84051472|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84051473|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051474|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051475|NCT04091815|Anesthetics|anesthetics|mesh-list
84051476|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051477|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051478|NCT00746785|Olanzapine|olanzapine|mesh-list
84051479|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
84051480|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
84051481|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051482|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051483|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051484|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84051485|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84051486|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051487|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83185831|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
84051488|NCT00746785|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84051489|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84051490|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84051491|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051492|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051493|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
84051494|NCT04090021|Amoxicillin|amoxicillin|mesh-list
84051495|NCT04090021|Metronidazole|metronidazole|mesh-list
84051496|NCT04090021|Clarithromycin|clarithromycin|mesh-list
84051497|NCT04090021|Levofloxacin|levofloxacin|mesh-list
84051498|NCT04090021|Rifabutin|rifabutin|mesh-list
84051499|NCT04090021|Esomeprazole|esomeprazole|mesh-list
84051500|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84051501|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051502|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84051503|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84051504|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84051505|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051506|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84051507|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051508|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051509|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84051510|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84051511|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84051512|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84051513|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84051514|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84051515|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051516|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84051517|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84051518|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
84051519|NCT04223973|Insulin|insulin|mesh-list
84051520|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84051521|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051522|NCT00750919|Mirtazapine|mirtazapine|mesh-list
84051523|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
84051524|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051525|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84051526|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
84051527|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
84051528|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051529|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051530|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051531|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84051532|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84051533|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051534|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84051535|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84051536|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84051537|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051538|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84051539|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84051540|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
84051541|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84051542|NCT02761161|Mianserin|mianserin|mesh-list
84051543|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84051544|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84051545|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051546|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186080|NCT01328093|Aripiprazole|aripiprazole|mesh-list
84051547|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051548|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051549|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84051550|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
84051551|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
84051552|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84051553|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
84051554|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84051555|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
84051556|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051557|NCT02761395|Deferasirox|deferasirox|mesh-list
84051558|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84051559|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
84051560|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
84051561|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051562|NCT02761317|Bisacodyl|bisacodyl|mesh-list
84051563|NCT02761317|Cathartics|cathartics|mesh-ancestor
84051564|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051565|NCT02761317|Laxatives|laxatives|mesh-ancestor
84051566|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84051567|NCT00746551|Hematinics|hematinics|mesh-ancestor
84051568|NCT02696577|Aspirin|aspirin|mesh-list
84051569|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84051570|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84051571|NCT02696577|Analgesics|analgesics|mesh-ancestor
84051572|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
84051573|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051574|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051575|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051576|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84051577|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84051578|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84051579|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051580|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84051581|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84051582|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051584|NCT04222491|Immunomodulating Agents|immunomodulating agents|mesh-list
84051585|NCT04222491|Immunologic Factors|immunologic factors|mesh-ancestor
84051586|NCT04222491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051587|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
84051588|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
84051589|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051590|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051591|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051592|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
84051593|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84051594|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051595|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051596|NCT04223739|Amiodarone|amiodarone|mesh-list
84051597|NCT04223739|Landiolol|landiolol|mesh-list
83186260|NCT03412513|Mirabegron|mirabegron|mesh-list
84051598|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84051599|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
84051600|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84051601|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84051602|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051603|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84051604|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84051605|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84051606|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051607|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84051608|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84051609|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84051610|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84051611|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84051612|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051613|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051614|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051615|NCT02765373|Letrozole|letrozole|mesh-list
84051616|NCT02765373|Anastrozole|anastrozole|mesh-list
84051617|NCT02765373|Exemestane|exemestane|mesh-list
84051618|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051619|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84051620|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84051621|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051622|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051623|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84051624|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
84051625|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051626|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051627|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84051628|NCT02760615|Losartan|losartan|mesh-list
84051629|NCT02760615|Midazolam|midazolam|mesh-list
84051630|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
84051631|NCT02760615|Caffeine|caffeine|mesh-list
84051632|NCT02760615|Omeprazole|omeprazole|mesh-list
84051633|NCT02760615|Vedolizumab|vedolizumab|mesh-list
84051634|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84051635|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84051636|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051637|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291531|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291532|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
83291533|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
83291534|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291535|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
83291536|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291537|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291538|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186371|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
83291539|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84051639|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84051640|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051641|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84051642|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
84051643|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
84051644|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
84051645|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
84051646|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186415|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84051647|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051648|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84051649|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84051650|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84051651|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84051652|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84051653|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84051654|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051655|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84051656|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84051657|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
84051658|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84051659|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051660|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84051661|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
84051662|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
84051663|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84051664|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84051665|NCT02760459|Dexamethasone|dexamethasone|mesh-list
84051666|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051667|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
84051668|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
84051669|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051670|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051671|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051672|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
84051673|NCT02760459|Hormones|hormones|mesh-ancestor
84051674|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051675|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84051676|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051677|NCT02765217|Amoxicillin|amoxicillin|mesh-list
84051678|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
84051679|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
84051680|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84051681|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84051682|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051683|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051684|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051685|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84051686|NCT02760381|Acetic Acid|acetic acid|mesh-list
84051687|NCT02760381|Retinol acetate|retinol acetate|mesh-list
84051688|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84051689|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051690|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84051691|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
84051692|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051693|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84051694|NCT02760381|Protective Agents|protective agents|mesh-ancestor
84051695|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051696|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
84051697|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84051698|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051699|NCT02760225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84051700|NCT02760225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051701|NCT00744757|Decitabine|decitabine|mesh-list
84051702|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84051703|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
84051704|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051705|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051706|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051707|NCT00917527|Atorvastatin|atorvastatin|mesh-list
84051708|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84051709|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84051710|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
83291621|NCT04687514|Dulaglutide|dulaglutide|mesh-list
84051711|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051712|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84051713|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84051714|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051715|NCT00745849|Esomeprazole|esomeprazole|mesh-list
84051716|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84051717|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051718|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84051719|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051720|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051721|NCT02759991|Vaccines|vaccines|mesh-list
84051722|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
84051723|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051724|NCT04112277|Morphine|morphine|mesh-list
84051725|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84051726|NCT04112277|Narcotics|narcotics|mesh-ancestor
84051727|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051728|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051729|NCT04112277|Analgesics|analgesics|mesh-ancestor
84051730|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
84051731|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051732|NCT00749203|Midazolam|midazolam|mesh-list
84051733|NCT00749203|Ketamine|ketamine|mesh-list
84051734|NCT00749203|Analgesics|analgesics|mesh-ancestor
84051735|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
84051736|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051737|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051738|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84051739|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84051740|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
84051741|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
84051742|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051743|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84051744|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84051745|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051746|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051747|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84051748|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84051749|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84051750|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84051751|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84051752|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
84051753|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
84051754|NCT02764515|Methotrexate|methotrexate|mesh-list
84051755|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84051756|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
84051757|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84051758|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051759|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84051760|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
84051761|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051762|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051763|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051764|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051765|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84051766|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84051767|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
84051768|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84051769|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84051770|NCT02764749|Phenol|phenol|mesh-list
84051771|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84051772|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051773|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
84051774|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
84051775|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84051776|NCT02764359|Vancomycin|vancomycin|mesh-list
84051777|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84051778|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051779|NCT02764125|Levodopa|levodopa|mesh-list
84051780|NCT02764125|Carbidopa|carbidopa|mesh-list
84051781|NCT02764125|Entacapone|entacapone|mesh-list
84051782|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84051783|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84051784|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
84051785|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051786|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051787|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051788|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84051789|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051790|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84051792|NCT02764281|Methotrexate|methotrexate|mesh-list
84051793|NCT02764281|Etoposide|etoposide|mesh-list
84051794|NCT02764281|Pegaspargase|pegaspargase|mesh-list
84051795|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051796|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
84051797|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
84051798|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051799|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051800|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051801|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
84051802|NCT02764281|Hormones|hormones|mesh-ancestor
84051803|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051804|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84051805|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051806|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051807|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051808|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84051809|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
84051810|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84051811|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84051812|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
84051813|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051814|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84051815|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84051816|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
84051817|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84051818|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84051819|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84051820|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84051821|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84051822|NCT02763969|Interferons|interferons|mesh-list
84051823|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
84051824|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
84051825|NCT02763969|Ustekinumab|ustekinumab|mesh-list
84051826|NCT02763969|Famotidine|famotidine|mesh-list
84051827|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051828|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
84051829|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051830|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
84051831|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051832|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051833|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84051834|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84051835|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84051836|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
84051837|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
84051838|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051839|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051840|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
84051841|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84051842|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051843|NCT04660929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84051844|NCT04660929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051845|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
84051846|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84051847|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051848|NCT02758587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84051849|NCT02758587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051850|NCT02758509|Interferons|interferons|mesh-list
84051851|NCT02758509|Ritonavir|ritonavir|mesh-list
84051852|NCT02758509|Ribavirin|ribavirin|mesh-list
84051853|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
84051854|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
84051855|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
84051856|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84051857|NCT02758509|Ledipasvir|ledipasvir|mesh-list
84051858|NCT02758509|Simeprevir|simeprevir|mesh-list
84051859|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83291766|NCT01802073|Vancomycin|vancomycin|mesh-list
84051860|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051861|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
84051862|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051863|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83187039|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051864|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84051865|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
84051866|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051867|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051868|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84051869|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84051870|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84051871|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84051872|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
84051873|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
84051874|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051875|NCT02762955|Adalimumab|adalimumab|mesh-list
84051876|NCT02762955|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84051877|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051878|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84051879|NCT04191681|Valsartan|valsartan|mesh-list
84051880|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84051881|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84051882|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84051883|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84051884|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051885|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84051886|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84051887|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051888|NCT02752503|Nalmefene|nalmefene|mesh-list
84051889|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84051890|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051891|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
84051892|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051893|NCT04479579|Apixaban|apixaban|mesh-list
84051894|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84051895|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
84051896|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84051897|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
84051898|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051899|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051900|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
84051901|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
84051902|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84051903|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051904|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051905|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84051906|NCT02757495|Analgesics|analgesics|mesh-ancestor
84051907|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
84051908|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051909|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84051910|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84051911|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84051912|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
84051913|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051914|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124732|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124733|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84124734|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124735|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84124736|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
84124737|NCT05590117|Antidotes|antidotes|mesh-ancestor
84124738|NCT05590117|Protective Agents|protective agents|mesh-ancestor
84124739|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
84124740|NCT05590117|Vitamins|vitamins|mesh-ancestor
84124741|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
84124742|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84124743|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124744|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84124745|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84124746|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
83187289|NCT03395171|Vitamin D|vitamin d|mesh-list
84124747|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84124748|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
84124749|NCT00636311|Gemcitabine|gemcitabine|mesh-list
84124750|NCT00636311|Bortezomib|bortezomib|mesh-list
84124751|NCT00636311|Vinorelbine|vinorelbine|mesh-list
84124752|NCT00636311|Ifosfamide|ifosfamide|mesh-list
84124753|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84051915|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
84051916|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051917|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
84051918|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
84051919|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051920|NCT02752113|Metformin|metformin|mesh-list
84051921|NCT02752113|Empagliflozin|empagliflozin|mesh-list
84051922|NCT02752113|Linagliptin|linagliptin|mesh-list
84051923|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84051924|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051925|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84051926|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051927|NCT02752113|Incretins|incretins|mesh-ancestor
84051928|NCT02752113|Hormones|hormones|mesh-ancestor
84051929|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051930|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84051931|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
84051932|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051933|NCT02756715|Propofol|propofol|mesh-list
84051934|NCT02756715|Desflurane|desflurane|mesh-list
84051935|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84051936|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84051937|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051938|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84051939|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
84051940|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
84051941|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84051942|NCT04221321|Atorvastatin|atorvastatin|mesh-list
84051943|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84051944|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84051945|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
84051946|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051947|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84051948|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84051949|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051950|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
83187393|NCT03398837|Dronabinol|dronabinol|mesh-list
84051951|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84051952|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84051953|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051954|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
84051955|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84051956|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051957|NCT02755857|Itraconazole|itraconazole|mesh-list
84051958|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
84051959|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051960|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84051961|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84051962|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051963|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051964|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84051965|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
84051966|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051967|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051968|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84051969|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
84051970|NCT02755545|Adapalene|adapalene|mesh-list
84051971|NCT02755545|Salicylates|salicylates|mesh-list
84051972|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84051973|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84051974|NCT02755545|Analgesics|analgesics|mesh-ancestor
84051975|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
84051976|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84051977|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051978|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84051979|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84051980|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
84051981|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84051982|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
84051983|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
84051984|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84051985|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84051986|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84051987|NCT02695797|Prednisolone|prednisolone|mesh-list
84051988|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83187640|NCT03395665|Estradiol|estradiol|mesh-list
84051989|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
84051991|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84051992|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84051993|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84051994|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84051995|NCT02755311|Cisplatin|cisplatin|mesh-list
84051996|NCT02755311|Carboplatin|carboplatin|mesh-list
84051997|NCT02755311|Fluorouracil|fluorouracil|mesh-list
84051998|NCT02755311|Epirubicin|epirubicin|mesh-list
84051999|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
84052000|NCT02755311|Pirarubicin|pirarubicin|mesh-list
84052001|NCT02755311|Doxorubicin|doxorubicin|mesh-list
84052002|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
84052003|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052004|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
84052005|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052006|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84052007|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84052008|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
83187769|NCT03392051|Clopidogrel|clopidogrel|mesh-list
84052009|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052010|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84052011|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84052012|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84052013|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052014|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
84052015|NCT02755311|Coagulants|coagulants|mesh-ancestor
84052016|NCT04554771|Paclitaxel|paclitaxel|mesh-list
84052017|NCT04554771|Carboplatin|carboplatin|mesh-list
84052018|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84052019|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052020|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
84052021|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
84052022|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
84052023|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052024|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
84052025|NCT02754765|Levofloxacin|levofloxacin|mesh-list
84052026|NCT02754765|Linezolid|linezolid|mesh-list
84052027|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
84052028|NCT02754765|Bedaquiline|bedaquiline|mesh-list
84052029|NCT02754765|Clofazimine|clofazimine|mesh-list
84052030|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84052031|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052032|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84052033|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84052034|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052035|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052036|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052037|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84052038|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84052039|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84052040|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84052041|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
83187973|NCT04448717|Antibodies|antibodies|mesh-list
84052042|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052043|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
84052044|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
84052045|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84052046|NCT04090801|Ethanol|ethanol|mesh-list
84052047|NCT04090801|Minoxidil|minoxidil|mesh-list
84052048|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84052049|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052050|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052051|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052052|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83188029|NCT02520817|Vitamin A|vitamin a|mesh-list
84052053|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
84052054|NCT04089631|Capecitabine|capecitabine|mesh-list
84052055|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84052056|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
84052057|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052058|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052059|NCT00917059|Bupropion|bupropion|mesh-list
84052060|NCT00917059|Escitalopram|escitalopram|mesh-list
84052061|NCT00917059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84052062|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84052063|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84052064|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052065|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052066|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
84052067|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188099|NCT03383315|Tramadol|tramadol|mesh-list
84052068|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84052069|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
84052070|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84052071|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84052072|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
84052073|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84052074|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84052075|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052076|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
84052077|NCT02754687|Nandrolone|nandrolone|mesh-list
84052078|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
84052079|NCT02754687|Androgens|androgens|mesh-ancestor
84052080|NCT02754687|Hormones|hormones|mesh-ancestor
84052081|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052082|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052083|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
84052084|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84052085|NCT05429775|Budesonide|budesonide|mesh-list
84052086|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052087|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84052088|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
84052089|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052090|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052091|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84052092|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188156|NCT03387241|Hormones|hormones|mesh-ancestor
84052093|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
84052094|NCT05429775|Hormones|hormones|mesh-ancestor
84052095|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052096|NCT04220073|Antibodies|antibodies|mesh-list
84052097|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84052098|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
84052099|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052100|NCT05429151|Acyclovir|acyclovir|mesh-list
84052101|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
84052102|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052103|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
84052104|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84052105|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84052106|NCT04219995|Prednisolone|prednisolone|mesh-list
84052107|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
84052108|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84052109|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
84052110|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052111|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
84052112|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
84052113|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052114|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052115|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84052116|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
84052117|NCT04219995|Hormones|hormones|mesh-ancestor
84052118|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052119|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84052120|NCT04219995|Protective Agents|protective agents|mesh-ancestor
84052121|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83188262|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
84052122|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052123|NCT04544475|Estrogens|estrogens|mesh-list
84052124|NCT04544475|Estradiol|estradiol|mesh-list
84052125|NCT04544475|Hormones|hormones|mesh-ancestor
84052126|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052127|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052128|NCT04200417|Mitomycins|mitomycins|mesh-list
84052129|NCT04200417|Mitomycin|mitomycin|mesh-list
84052130|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
84052131|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84052132|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052133|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
84052134|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052135|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84052136|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052137|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
84052138|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84052139|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052140|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052141|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052143|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
84052144|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052145|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84052146|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84052147|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84052148|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
84052149|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052150|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052151|NCT04188873|Varenicline|varenicline|mesh-list
84052152|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052153|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052154|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052155|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84052156|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84052157|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
84052158|NCT02695641|Bevacizumab|bevacizumab|mesh-list
84052159|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84052160|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052161|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84052162|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84052163|NCT02695641|Growth Substances|growth substances|mesh-ancestor
84052164|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052165|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
84052166|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
84052167|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84052168|NCT02750475|Protective Agents|protective agents|mesh-ancestor
84052169|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052170|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
84052171|NCT04217265|Letrozole|letrozole|mesh-list
84052172|NCT04217265|Misoprostol|misoprostol|mesh-list
84052173|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052174|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84052175|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84052176|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052177|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052178|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84052179|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052180|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052181|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052182|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84052183|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
84052184|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84052185|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84052186|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84052187|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
84052188|NCT00635973|Gefitinib|gefitinib|mesh-list
84052189|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052190|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84052191|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052192|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052193|NCT02752971|Diclofenac|diclofenac|mesh-list
84052194|NCT02752971|Bupivacaine|bupivacaine|mesh-list
84052195|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
84052196|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
84052197|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052198|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052199|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
84052200|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052201|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84052202|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052203|NCT02752971|Analgesics|analgesics|mesh-ancestor
84052204|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052205|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052206|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84052207|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052208|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052209|NCT02750163|Acetaminophen|acetaminophen|mesh-list
84052210|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052211|NCT02750163|Analgesics|analgesics|mesh-ancestor
84052212|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
84052213|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292166|NCT02066129|Xhance|xhance|mesh-list
84052214|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052215|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
83188711|NCT03373903|Everolimus|everolimus|mesh-list
84052216|NCT04217421|Allopurinol|allopurinol|mesh-list
84052217|NCT04217421|Mannitol|mannitol|mesh-list
84052218|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
84052219|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052220|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052221|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
84052222|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052223|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84052224|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
83188761|NCT03373669|Vaccines|vaccines|mesh-list
84052225|NCT04217421|Protective Agents|protective agents|mesh-ancestor
84052226|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052227|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84052228|NCT04217421|Diuretics|diuretics|mesh-ancestor
84052229|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
84052230|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
84052231|NCT04036929|Estrogens|estrogens|mesh-list
84052232|NCT04036929|Hormones|hormones|mesh-ancestor
84052233|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052234|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188827|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052235|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84052236|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84052237|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052238|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84052239|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84052240|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052241|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
84052242|NCT04218981|Paroxetine|paroxetine|mesh-list
84052243|NCT04218981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84052244|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84052245|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84052246|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052247|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052248|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
84052249|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052250|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84052251|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
84052252|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84052253|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84052254|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84052255|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052256|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84052257|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052258|NCT04218513|Edaravone|edaravone|mesh-list
84052259|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84052260|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
84052261|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052262|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84052263|NCT04218513|Protective Agents|protective agents|mesh-ancestor
84052264|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052265|NCT04218435|Valsartan|valsartan|mesh-list
84052266|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84052267|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84052268|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84052269|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84052270|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052271|NCT04138875|Rituximab|rituximab|mesh-list
84052272|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84052273|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84052274|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84052275|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052276|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
84052277|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052278|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052279|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84052280|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
84052281|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052282|NCT04138875|Immunotoxins|immunotoxins|mesh-ancestor
84052283|NCT04138875|Immunoconjugates|immunoconjugates|mesh-ancestor
84052284|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84052285|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
84052286|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052287|NCT02695563|Lactoferrin|lactoferrin|mesh-list
84052288|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052289|NCT02747823|Bevacizumab|bevacizumab|mesh-list
84052290|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84052291|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052292|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84052293|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84052294|NCT02747823|Growth Substances|growth substances|mesh-ancestor
84052295|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052296|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
84052297|NCT02747511|Haloperidol|haloperidol|mesh-list
84052298|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
84052299|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
84052300|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
84052301|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052302|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052303|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84052304|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84052305|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84052306|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052307|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84052308|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84052309|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
84052310|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189203|NCT04521049|Saxagliptin|saxagliptin|mesh-list
84052311|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052312|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84052313|NCT04217733|Ethosuximide|ethosuximide|mesh-list
84052314|NCT04217733|Mebeverine|mebeverine|mesh-list
84052315|NCT04217733|Alverine|alverine|mesh-list
84052316|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
84052317|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
84052318|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
84052319|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052320|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052321|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84052322|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
84052323|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052324|NCT02746185|Heparin|heparin|mesh-list
84052325|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84052326|NCT02746185|Tinzaparin|tinzaparin|mesh-list
84052327|NCT02746185|Dalteparin|dalteparin|mesh-list
84052328|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
84052329|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
84052330|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84052331|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84052332|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052333|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84052334|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
84052335|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84052336|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
83189339|NCT05123781|Metformin|metformin|mesh-list
84052337|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052338|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
84052339|NCT02742051|Fluorouracil|fluorouracil|mesh-list
84052340|NCT02742051|Everolimus|everolimus|mesh-list
84052341|NCT02742051|Letrozole|letrozole|mesh-list
84052342|NCT02742051|Epirubicin|epirubicin|mesh-list
84052343|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84052344|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
84052345|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052346|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052347|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84052348|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
84052349|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052350|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052351|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84052352|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
84052353|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84052354|NCT02742051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84052355|NCT02742051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84052356|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052357|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84052358|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84052359|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84052360|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052361|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189396|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
84052362|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83292280|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
84052363|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84052364|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84052365|NCT02741817|Aspirin|aspirin|mesh-list
84052366|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84052367|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052368|NCT02741817|Analgesics|analgesics|mesh-ancestor
84052369|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
84052370|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052371|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052372|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052373|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052374|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84052375|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84052376|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052377|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84052378|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84052379|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052380|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
84052381|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
84052382|NCT02745873|Vitamins|vitamins|mesh-ancestor
84052383|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
84052384|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052385|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
84052386|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052387|NCT02745873|Protective Agents|protective agents|mesh-ancestor
84052388|NCT02745639|Capecitabine|capecitabine|mesh-list
84052389|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
84052390|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84052391|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
84052392|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052393|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052394|NCT02745717|Cyclosporine|cyclosporine|mesh-list
84052395|NCT02745717|Cyclosporins|cyclosporins|mesh-list
84052396|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
84052397|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84052398|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052399|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189647|NCT03364075|Analgesics|analgesics|mesh-ancestor
84052400|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84052401|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
84052402|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052403|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
84052404|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052405|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
84052406|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052407|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84052408|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
84052409|NCT02745561|Endostatins|endostatins|mesh-list
84052410|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052411|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84052412|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84052413|NCT02745561|Growth Substances|growth substances|mesh-ancestor
84052414|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052415|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
84052416|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
84052417|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84052418|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052419|NCT02745093|Misoprostol|misoprostol|mesh-list
84052420|NCT02745093|Mifepristone|mifepristone|mesh-list
84052421|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84052422|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
84052423|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84052424|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052425|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84052426|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84052427|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
84052428|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84052429|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84052430|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84052431|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84052432|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
84052433|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84052434|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84052435|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052436|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052437|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
84124754|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
83292362|NCT02005484|Trastuzumab|trastuzumab|mesh-list
84052438|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84052439|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84052440|NCT00839254|Vaccines|vaccines|mesh-list
84052441|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84052442|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
84052443|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052444|NCT02741115|Udenafil|udenafil|mesh-list
84052445|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84052446|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84052447|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189898|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052448|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052449|NCT02740803|Listerine|listerine|mesh-list
84052450|NCT02740803|Fluorides|fluorides|mesh-list
84052451|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
84052452|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
84052453|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
84052454|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
84052455|NCT02740803|Protective Agents|protective agents|mesh-ancestor
84052456|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052457|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84052458|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052459|NCT02740647|Amoxicillin|amoxicillin|mesh-list
84052460|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
84052461|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
84052462|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84052463|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84052464|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052465|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84052466|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052467|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052468|NCT03737253|Menotropins|menotropins|mesh-list
84052469|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84052470|NCT03737253|Hormones|hormones|mesh-ancestor
84052471|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052472|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052473|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84052474|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
84052475|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84052476|NCT00812968|Lenalidomide|lenalidomide|mesh-list
84052477|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
84052478|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052479|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84052480|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84052481|NCT00812968|Growth Substances|growth substances|mesh-ancestor
84052482|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
84052483|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052484|NCT02744703|Capecitabine|capecitabine|mesh-list
84052485|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84052486|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84052487|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
84052488|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052489|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052490|NCT02744937|Aspirin|aspirin|mesh-list
84052491|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84052492|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052493|NCT02744937|Analgesics|analgesics|mesh-ancestor
84052494|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
84052495|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052496|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052497|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052498|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052499|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84052500|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84052501|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052502|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84052503|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84052504|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052505|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
84052506|NCT05394337|Atezolizumab|atezolizumab|mesh-list
84052507|NCT05394337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84052508|NCT05394337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052509|NCT05394337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84052510|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052511|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
84052512|NCT02744625|Propofol|propofol|mesh-list
84052513|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84052514|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052515|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052516|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84052517|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
84052518|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
84052519|NCT02610556|Cisplatin|cisplatin|mesh-list
84052520|NCT02610556|Docetaxel|docetaxel|mesh-list
84052521|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052522|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
84052523|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
84052524|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
84052525|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052526|NCT02740101|Oxytocin|oxytocin|mesh-list
84052527|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
84052528|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84052529|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052530|NCT02612116|Ticagrelor|ticagrelor|mesh-list
84052531|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84052532|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84052533|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84052534|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84052535|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
84052536|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052537|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052538|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052539|NCT00813748|Omalizumab|omalizumab|mesh-list
84052540|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84052541|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84052542|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
84052543|NCT00813592|Pasireotide|pasireotide|mesh-list
84052544|NCT00813592|Hormones|hormones|mesh-ancestor
84052545|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052546|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052547|NCT02739633|Paclitaxel|paclitaxel|mesh-list
84052548|NCT02739633|genexol-PM|genexol-pm|mesh-list
84052549|NCT02739633|Gemcitabine|gemcitabine|mesh-list
84052550|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84052551|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052552|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
84052553|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
84052554|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
84052555|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052556|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84052557|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
84052558|NCT02739477|Favipiravir|favipiravir|mesh-list
84052559|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
84052560|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052561|NCT02739399|Phenylephrine|phenylephrine|mesh-list
84052562|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
84052563|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84052564|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
84052565|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
84052566|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052567|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052568|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
84052569|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84052570|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
84052571|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
84052572|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84052573|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84052574|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84052575|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
84052576|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052577|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052578|NCT02739399|Protective Agents|protective agents|mesh-ancestor
84052579|NCT02743065|Doxorubicin|doxorubicin|mesh-list
84052580|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84052581|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052582|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84052583|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84052584|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190437|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052585|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052586|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84052587|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
83292506|NCT02057393|Methylene Blue|methylene blue|mesh-list
84052588|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052589|NCT02742675|Leuprolide|leuprolide|mesh-list
84052590|NCT02742675|Goserelin|goserelin|mesh-list
84052591|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84052592|NCT02742675|Flutamide|flutamide|mesh-list
84052593|NCT02742675|Bicalutamide|bicalutamide|mesh-list
84052594|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84052595|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
84052596|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84052597|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052598|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84052599|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052600|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
84052601|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052602|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190505|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
84052603|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
84052604|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84052605|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
84052606|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84052607|NCT00812812|Paroxetine|paroxetine|mesh-list
84052608|NCT00812812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84052609|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84052610|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84052611|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052612|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190565|NCT05555797|Betamethasone|betamethasone|mesh-list
84052613|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
84052614|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052615|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84052616|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
84052617|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84052618|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84052619|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84052620|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052621|NCT02742285|Lumefantrine|lumefantrine|mesh-list
84052622|NCT02742285|Artemether|artemether|mesh-list
84052623|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84052624|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
84052625|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84052626|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84052627|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052628|NCT03673527|Tacrolimus|tacrolimus|mesh-list
84052629|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84052630|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
84052631|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052632|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84052633|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052634|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052635|NCT02738931|Lamivudine|lamivudine|mesh-list
84052636|NCT02738931|Dolutegravir|dolutegravir|mesh-list
84052637|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84052638|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84052639|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052640|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052641|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
84052642|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052643|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84052644|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84052645|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84052646|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84052647|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
84052648|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84052649|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052650|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052651|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052652|NCT05208892|Analgesics|analgesics|mesh-ancestor
83190826|NCT02507479|Thiotepa|thiotepa|mesh-list
84052653|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
84052654|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052655|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84052656|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84052657|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84052658|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
84052659|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052660|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052661|NCT02738619|Vitamin D|vitamin d|mesh-list
84052663|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
84052664|NCT02738619|Vitamins|vitamins|mesh-list
84052665|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
84052666|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052667|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84052668|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84052669|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
84052670|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84052671|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052672|NCT04016116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84052673|NCT04016116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052674|NCT02736591|Hormones|hormones|mesh-list
84052675|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
84052676|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052677|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052678|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84052679|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84052680|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
84052681|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052682|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052683|NCT02736513|Osimertinib|osimertinib|mesh-list
84052684|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191023|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
84052685|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84052686|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052687|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052688|NCT02736435|Leuprolide|leuprolide|mesh-list
84052689|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84052690|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
84052691|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84052692|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052693|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84052694|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052695|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84052696|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
84052697|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84052698|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
84052699|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052700|NCT00748189|Ofatumumab|ofatumumab|mesh-list
84052701|NCT00748189|Chlorambucil|chlorambucil|mesh-list
84052702|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052703|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84052704|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
84052705|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052706|NCT02609230|TIC10 compound|tic10 compound|mesh-list
84052707|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052708|NCT00913822|Desipramine|desipramine|mesh-list
84052709|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84052710|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
83191139|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
84052711|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84052712|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052713|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052714|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84052715|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84052716|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84052717|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
84052718|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052719|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052720|NCT02736123|Nivolumab|nivolumab|mesh-list
84052721|NCT02736123|Ipilimumab|ipilimumab|mesh-list
84052722|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84052723|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052724|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84052725|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052726|NCT00744055|Prazosin|prazosin|mesh-list
84052727|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84052728|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84052729|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84052730|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84052731|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
84052732|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191206|NCT02504359|Tacrolimus|tacrolimus|mesh-list
84052733|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052734|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052735|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
84052736|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84052737|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84052738|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052739|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
84052740|NCT02738073|Coagulants|coagulants|mesh-ancestor
84052741|NCT03967483|Indomethacin|indomethacin|mesh-list
84052742|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84052743|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052744|NCT03967483|Analgesics|analgesics|mesh-ancestor
84052745|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
84052746|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052747|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052748|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052749|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052750|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
84052751|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
84052752|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84052753|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84052754|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052755|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052756|NCT00740779|Silodosin|silodosin|mesh-list
83191318|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
84052757|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84052758|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84052759|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84052760|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
84052761|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052762|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052763|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052764|NCT00740779|Urological Agents|urological agents|mesh-ancestor
84052765|NCT00735475|Vaccines|vaccines|mesh-list
84052766|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
84052767|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052768|NCT01026818|Tadalafil|tadalafil|mesh-list
84052769|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
84052770|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84052771|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84052772|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052773|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052774|NCT01026818|Urological Agents|urological agents|mesh-ancestor
84052775|NCT02593747|Loratadine|loratadine|mesh-list
84052776|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
84052777|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
84052778|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84052779|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84052780|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84052781|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
84052782|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
84052783|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052784|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052785|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052786|NCT00743509|Sirolimus|sirolimus|mesh-list
84052787|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
84052788|NCT00743509|Temsirolimus|temsirolimus|mesh-list
84052789|NCT00743509|MTOR Inhibitors|mtor inhibitors|mesh-list
84052790|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84052791|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
84052792|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052793|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052794|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84052795|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
84052796|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052797|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052798|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84052799|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84052800|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052801|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84052802|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
84052803|NCT00743509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84052804|NCT00743509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052805|NCT00734929|Dexamethasone|dexamethasone|mesh-list
84052806|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
84052807|NCT00734929|Ondansetron|ondansetron|mesh-list
83292733|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
84052808|NCT00734929|Aprepitant|aprepitant|mesh-list
84052809|NCT00734929|BB 1101|bb 1101|mesh-list
84052810|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052811|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
84052812|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
84052813|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052814|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052815|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84052816|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
84052817|NCT00734929|Hormones|hormones|mesh-ancestor
84131342|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052818|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052819|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84052820|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052821|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
84052822|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052823|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052824|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
84052825|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
84052826|NCT00734929|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84052827|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84052828|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
84052829|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052830|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84052831|NCT00734851|Docetaxel|docetaxel|mesh-list
84052832|NCT00734851|Sunitinib|sunitinib|mesh-list
84052833|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052834|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
84052835|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
84052836|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131343|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
84052837|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052838|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84052839|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84052840|NCT00734851|Growth Substances|growth substances|mesh-ancestor
84052841|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052842|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
84052843|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84052844|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052845|NCT00734617|Nicotine|nicotine|mesh-list
84052846|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84052847|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
84052848|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052849|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052850|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84052851|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84052852|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
84052853|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84052854|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052855|NCT00743431|Doxorubicin|doxorubicin|mesh-list
84052856|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84052857|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052858|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84052859|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84052860|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052861|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052862|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84052863|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
84052864|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052865|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
84052866|NCT02737605|Esketamine|esketamine|mesh-list
84052867|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84052868|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052869|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84052870|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84052871|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052872|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052873|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052874|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
84052875|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84052876|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
84052877|NCT02737371|Clotrimazole|clotrimazole|mesh-list
84052878|NCT02737371|Miconazole|miconazole|mesh-list
84052879|NCT02737371|Olorofim|olorofim|mesh-list
84052880|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052881|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84052882|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84052883|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84052884|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052885|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052886|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84052887|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052888|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052889|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052890|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84052891|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84052892|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
84052893|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
84052894|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
84052895|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052896|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052897|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
84052898|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052899|NCT00734539|Fluconazole|fluconazole|mesh-list
84052900|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
84052901|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052902|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84052903|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84052904|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052905|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052906|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84052907|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
84052908|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052909|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052910|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84052911|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84052912|NCT02737059|Codeine|codeine|mesh-list
84052913|NCT02737059|Naloxegol|naloxegol|mesh-list
84052914|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84052915|NCT02737059|Narcotics|narcotics|mesh-ancestor
84052916|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84052917|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052918|NCT02737059|Analgesics|analgesics|mesh-ancestor
84052919|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
84052920|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052921|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
84052922|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
84052923|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84052924|NCT02731911|Dexamethasone|dexamethasone|mesh-list
84052925|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052926|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
84052927|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
84052928|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052929|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052930|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192141|NCT03102801|Insulin|insulin|mesh-list
84052931|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
84052932|NCT02731911|Hormones|hormones|mesh-ancestor
84052933|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052934|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84052935|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052936|NCT00734149|Prednisone|prednisone|mesh-list
84052937|NCT00734149|Bortezomib|bortezomib|mesh-list
84052938|NCT00734149|Melphalan|melphalan|mesh-list
84052939|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052940|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
84052941|NCT00734149|Hormones|hormones|mesh-ancestor
84052942|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84052943|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052944|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84052945|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84052946|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84052947|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
84052948|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052949|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84052950|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84052951|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
84052952|NCT04089163|Flucytosine|flucytosine|mesh-list
84052953|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
84052954|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84052955|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
83292890|NCT04659044|Rituximab|rituximab|mesh-list
84052956|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052957|NCT00743197|Aspirin|aspirin|mesh-list
84052958|NCT00743197|Lisinopril|lisinopril|mesh-list
84052959|NCT00743197|Simvastatin|simvastatin|mesh-list
84052960|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84052961|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84052962|NCT00743197|Analgesics|analgesics|mesh-ancestor
84052963|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
84052964|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84052965|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052966|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84052967|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84052968|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84052969|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84052970|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052971|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84052972|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84052973|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84052974|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
84052975|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84052976|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84052977|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
84052978|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84052979|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84052980|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84052981|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
84052982|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84052983|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84052984|NCT00743197|Protective Agents|protective agents|mesh-ancestor
84052985|NCT02731287|Timolol|timolol|mesh-list
84052986|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84052987|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84052988|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84052989|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
84052990|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192385|NCT02485015|Apatinib|apatinib|mesh-list
84052991|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84052992|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84052993|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84052994|NCT02735343|Ketamine|ketamine|mesh-list
84052995|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
84052996|NCT02735343|Analgesics|analgesics|mesh-ancestor
84052997|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
84052998|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192444|NCT02486341|Insulin|insulin|mesh-list
84052999|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053000|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84053001|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84053002|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
84053003|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
84053004|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053005|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84053006|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84053007|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053008|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053009|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
84053010|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
84053011|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84053012|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84053013|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84053014|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84053015|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84053016|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
84053017|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
84053018|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053019|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84053020|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053021|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053022|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
84053023|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053024|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053025|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84053026|NCT00734071|Vortioxetine|vortioxetine|mesh-list
84053027|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
83292958|NCT01972724|Metformin|metformin|mesh-list
84053028|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83192651|NCT03320707|Daratumumab|daratumumab|mesh-list
84053030|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84053031|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053032|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053033|NCT00734071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84053034|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84053035|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053036|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053037|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053038|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
84131344|NCT03462017|Acetylcholine|acetylcholine|mesh-list
84053039|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84053040|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84053041|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84053042|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84053043|NCT03255915|Tenofovir|tenofovir|mesh-list
84053044|NCT03255915|Emtricitabine|emtricitabine|mesh-list
84053045|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
84053046|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053047|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84053048|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84053049|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053050|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053051|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84053052|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84053053|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
84053054|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84053055|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053056|NCT04188951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84053057|NCT04188951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053058|NCT00739297|Montelukast|montelukast|mesh-list
84053059|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84053060|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
84053061|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84053062|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
84053063|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053064|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053065|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84053066|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84053067|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053068|NCT05430243|Empagliflozin|empagliflozin|mesh-list
84053069|NCT05430243|Diuretics|diuretics|mesh-list
84053070|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84053071|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053072|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84053073|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053074|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
84053075|NCT02730117|Cephalosporins|cephalosporins|mesh-list
84053076|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84053077|NCT02730117|Dobutamine|dobutamine|mesh-list
84053078|NCT02730117|Dopamine|dopamine|mesh-list
84053079|NCT02730117|Milrinone|milrinone|mesh-list
84053080|NCT02730117|Norepinephrine|norepinephrine|mesh-list
84053081|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
84053082|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84053083|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84053084|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
84053085|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192964|NCT02479165|Analgesics|analgesics|mesh-ancestor
84053086|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053087|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053088|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
84053089|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
84053090|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053091|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84053092|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83193032|NCT02475499|Incretins|incretins|mesh-list
84053093|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84053094|NCT02730117|Protective Agents|protective agents|mesh-ancestor
84053095|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
84053096|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84053097|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
84053098|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84053099|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84053100|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053101|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053102|NCT02595463|Lidocaine|lidocaine|mesh-list
84053103|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053104|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
84053105|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053106|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053107|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
84053108|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053109|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84053110|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84053111|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84053112|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053113|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053114|NCT02593669|Dexamethasone|dexamethasone|mesh-list
84053115|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84053116|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
83193230|NCT02474563|Prednisone|prednisone|mesh-list
84053117|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
84053118|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053119|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053120|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84053121|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
84053122|NCT02593669|Hormones|hormones|mesh-ancestor
84053123|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053124|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84053125|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053126|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84053127|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84053128|NCT02729961|Ceritinib|ceritinib|mesh-list
84053129|NCT02729961|Antibodies|antibodies|mesh-list
84053130|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
84053131|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84053132|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
84053133|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
84053134|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053135|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053136|NCT02729961|Immunotoxins|immunotoxins|mesh-ancestor
84053137|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84053138|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053139|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053140|NCT02735031|Exenatide|exenatide|mesh-list
84053141|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84053142|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053143|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84053144|NCT02735031|Incretins|incretins|mesh-ancestor
84053145|NCT02735031|Hormones|hormones|mesh-ancestor
84053146|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053147|NCT02595541|Milrinone|milrinone|mesh-list
84053148|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
84053149|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
84053150|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84053151|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84053152|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053153|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053154|NCT02595541|Urological Agents|urological agents|mesh-ancestor
83193357|NCT03099213|Ramipril|ramipril|mesh-list
84053155|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84053156|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84053157|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84053158|NCT02595541|Protective Agents|protective agents|mesh-ancestor
84053159|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053160|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84053161|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053162|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84053163|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053164|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053165|NCT01026194|Pioglitazone|pioglitazone|mesh-list
84053166|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84053167|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053168|NCT02734875|Anticoagulants|anticoagulants|mesh-list
84053169|NCT04088461|Metformin|metformin|mesh-list
84053170|NCT04088461|Linagliptin|linagliptin|mesh-list
84053171|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84053172|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053173|NCT04088461|Incretins|incretins|mesh-ancestor
84053174|NCT04088461|Hormones|hormones|mesh-ancestor
84053175|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053176|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84053177|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
84053178|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053179|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053180|NCT00636519|Antitoxins|antitoxins|mesh-list
84053181|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
84053182|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
84053183|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053184|NCT05377333|Dulaglutide|dulaglutide|mesh-list
84053185|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84053186|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053187|NCT00811954|Ritonavir|ritonavir|mesh-list
84053188|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84053189|NCT00811954|Darunavir|darunavir|mesh-list
84053190|NCT00811954|Tenofovir|tenofovir|mesh-list
84053191|NCT00811954|Emtricitabine|emtricitabine|mesh-list
84053192|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
84053193|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84053194|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84053195|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84053196|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
84053197|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053198|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053199|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84053200|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84053201|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
84053202|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053203|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84053204|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84053205|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84053206|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84053207|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84053208|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84053209|NCT00917839|Lamotrigine|lamotrigine|mesh-list
84053210|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
84053211|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84053212|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053213|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053214|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84053215|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053216|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84053217|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84053218|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053219|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84053220|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84053221|NCT01032200|Modafinil|modafinil|mesh-list
84053222|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84053223|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131345|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
84053224|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84053225|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84053226|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84053227|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053228|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
84053229|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84053230|NCT00586105|Sorafenib|sorafenib|mesh-list
84053231|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053232|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84053233|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053234|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053235|NCT05510427|Bevacizumab|bevacizumab|mesh-list
84053236|NCT05510427|Atezolizumab|atezolizumab|mesh-list
84053237|NCT05510427|Infigratinib|infigratinib|mesh-list
83193650|NCT02299999|Cisplatin|cisplatin|mesh-list
84053238|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84053239|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053240|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84053241|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84053242|NCT05510427|Growth Substances|growth substances|mesh-ancestor
84053243|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053244|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
84053245|NCT05510427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84053246|NCT05510427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053247|NCT05757310|Vidarabine|vidarabine|mesh-list
84053248|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
84053249|NCT05757310|Pentostatin|pentostatin|mesh-list
84053250|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84053251|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84053252|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
84053253|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053254|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84053255|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84053256|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
84053257|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053258|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053259|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84053260|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
84053261|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053262|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
84053263|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
84053264|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053265|NCT00743119|Dronabinol|dronabinol|mesh-list
84053266|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
84053267|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053268|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84053269|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84053270|NCT00743119|Analgesics|analgesics|mesh-ancestor
83193937|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
84053271|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
84053272|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053273|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84053274|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84053275|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053276|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053277|NCT00743119|Hormones|hormones|mesh-ancestor
84053278|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053279|NCT02610010|Cisplatin|cisplatin|mesh-list
84053280|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053281|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
84053282|NCT02610088|Gliclazide|gliclazide|mesh-list
84053283|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84053284|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053285|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84053286|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053287|NCT02734407|Aflibercept|aflibercept|mesh-list
84053288|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84053289|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84053290|NCT02734407|Growth Substances|growth substances|mesh-ancestor
84053291|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053292|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
84053293|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053294|NCT02734173|Ritonavir|ritonavir|mesh-list
84053295|NCT02734173|Ribavirin|ribavirin|mesh-list
83194129|NCT03299257|Donepezil|donepezil|mesh-list
84053296|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84053297|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84053298|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
84053299|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053300|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053301|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84053302|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84053303|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
84053304|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053305|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83194272|NCT00702325|Budesonide|budesonide|mesh-list
84053306|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84053307|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
84053308|NCT05297422|Ketamine|ketamine|mesh-list
84053309|NCT05297422|Ropivacaine|ropivacaine|mesh-list
84053310|NCT05297422|Analgesics|analgesics|mesh-ancestor
84053311|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
84053312|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053313|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053314|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84053315|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84053316|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
84053317|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
84053318|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053319|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84053320|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84053321|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053322|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053323|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053324|NCT00813124|Fludarabine|fludarabine|mesh-list
84053325|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
84053326|NCT00813124|Azacitidine|azacitidine|mesh-list
84053327|NCT00813124|Busulfan|busulfan|mesh-list
84053328|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
84053329|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84053330|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053331|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84053332|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
84053333|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053334|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84053335|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
84053336|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053337|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053338|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
84053339|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84053340|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84053341|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84053342|NCT02728869|Vaccines|vaccines|mesh-list
84053343|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
84053344|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053345|NCT02594761|Trastuzumab|trastuzumab|mesh-list
84053346|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84053347|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053348|NCT02728947|Rotigotine|rotigotine|mesh-list
84053349|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
84053350|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
83194445|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
84053351|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053352|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053353|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053354|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84053355|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053356|NCT02733705|Fentanyl|fentanyl|mesh-list
84053357|NCT02733705|Propofol|propofol|mesh-list
84053358|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84053359|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053360|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053361|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84053362|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
84053363|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
84053364|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84053365|NCT02733705|Narcotics|narcotics|mesh-ancestor
84053366|NCT02733705|Analgesics|analgesics|mesh-ancestor
84053367|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
84053368|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053369|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84053370|NCT02597257|Lidocaine|lidocaine|mesh-list
84053371|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053372|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
83194720|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194789|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
84053373|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053374|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053375|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
84053376|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053377|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84053378|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84053379|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84053380|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053381|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053382|NCT02596555|Dabigatran|dabigatran|mesh-list
84053383|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
84053384|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84053385|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
84053386|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053387|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053388|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
84053389|NCT02733471|Lidocaine|lidocaine|mesh-list
84053390|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053391|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
84053392|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053393|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053394|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
84053395|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053396|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83195002|NCT03375593|Narcotics|narcotics|mesh-ancestor
84053397|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83293338|NCT02015195|Ethanol|ethanol|mesh-list
84053398|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84053399|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053400|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053401|NCT02733237|Oxytocin|oxytocin|mesh-list
84053402|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
84053403|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84053404|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053405|NCT04206813|Vaccines|vaccines|mesh-list
84053406|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
84053407|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053408|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
84053409|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053410|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
84053411|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053412|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053413|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
84053414|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053415|NCT00811720|Nalmefene|nalmefene|mesh-list
84053416|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84053417|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053418|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
84053419|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053420|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
84053421|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195126|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84053422|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053423|NCT00811642|Posaconazole|posaconazole|mesh-list
84053424|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
84053425|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053426|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84053427|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84053428|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84053429|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84053430|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84053431|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053432|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195186|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053433|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84053434|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
84053435|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053436|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053437|NCT02609152|Esmolol|esmolol|mesh-list
84053438|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83195250|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
84053439|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84053440|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84053441|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
84053442|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053443|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053444|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053445|NCT02733393|Lidocaine|lidocaine|mesh-list
84053446|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053447|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
84053448|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053449|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053450|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
84053451|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053452|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84053453|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84053454|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84053455|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053456|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053457|NCT00809926|Valsartan|valsartan|mesh-list
84053458|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84053459|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84053460|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84053461|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053462|NCT02728245|Dienogest|dienogest|mesh-list
84053463|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84053464|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
84053465|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195643|NCT03359057|Folic Acid|folic acid|mesh-list
83195691|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
83195765|NCT02458339|Methotrexate|methotrexate|mesh-list
84053466|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053467|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84053468|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84053469|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84053470|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84053471|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
84053472|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053473|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84053474|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053475|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84053476|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84053477|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84053478|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84053479|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053480|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
84053482|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83195979|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053483|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053484|NCT05753722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84053485|NCT05753722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053486|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
84053487|NCT02727621|Propofol|propofol|mesh-list
84053488|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84053489|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053490|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053491|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84053492|NCT02727621|Analgesics|analgesics|mesh-ancestor
84053493|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
84053494|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053495|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84053496|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84053497|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84053498|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
84053499|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053500|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053501|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84053502|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
84053503|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
84053504|NCT02608606|Tacrolimus|tacrolimus|mesh-list
84053505|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84053506|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
84053507|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053508|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84053509|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053510|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053511|NCT02608918|BMS-955176|bms-955176|mesh-list
84053512|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84053513|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84053514|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
84053515|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196175|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83196248|NCT02518295|Sulfalene|sulfalene|mesh-list
84053516|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84053517|NCT05755204|Cabotegravir|cabotegravir|mesh-list
84053518|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84053519|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84053520|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053521|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053522|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
84053523|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053524|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84053525|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84053526|NCT05755204|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84053527|NCT05755204|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84053528|NCT02727309|Apatinib|apatinib|mesh-list
84053529|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053530|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84053531|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053532|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053533|NCT05755750|Genipin|genipin|mesh-list
84053534|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84053535|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84053536|NCT02732067|Anesthetics|anesthetics|mesh-list
84053537|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053538|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053539|NCT02609932|Interferons|interferons|mesh-list
84053540|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
84053541|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053542|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
84053543|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053544|NCT02726919|Clobazam|clobazam|mesh-list
84053545|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
84053546|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84053547|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84053548|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053549|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053550|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84053551|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84053552|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
84053553|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
84053554|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053555|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053556|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84053557|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196364|NCT03467113|Cannabidiol|cannabidiol|mesh-list
84053558|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84053559|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053560|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053561|NCT05753566|Androgens|androgens|mesh-list
84053562|NCT05753566|Hormones|hormones|mesh-ancestor
84053563|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053564|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053565|NCT00590824|Interleukin-2|interleukin-2|mesh-list
84053566|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053567|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84053568|NCT00590824|Analgesics|analgesics|mesh-ancestor
84053569|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
84053570|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053571|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053572|NCT02720991|Misoprostol|misoprostol|mesh-list
84053573|NCT02720991|Mifepristone|mifepristone|mesh-list
84053574|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84053575|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
84053576|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84053577|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053578|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84053579|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84053580|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
84053581|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84053582|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84053583|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84053584|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84053585|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
84053586|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84053587|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84053588|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
84053589|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053590|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
84053591|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84053592|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84053593|NCT02720601|Capecitabine|capecitabine|mesh-list
84053594|NCT02720601|Irinotecan|irinotecan|mesh-list
84053595|NCT02720601|Camptothecin|camptothecin|mesh-list
84053596|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84053597|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
83196482|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84053598|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053599|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053600|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84053601|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84053602|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053603|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84053604|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
84053605|NCT00590590|Promethazine|promethazine|mesh-list
84053606|NCT00590590|Lidocaine|lidocaine|mesh-list
84053607|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053608|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
84053609|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053610|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196612|NCT03249025|Lidocaine|lidocaine|mesh-list
84053611|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
84053612|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053613|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84053614|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84053615|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84053616|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053617|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053618|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84053619|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84053620|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
84053621|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
83196672|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84053622|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84053623|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84053624|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
84053625|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
84053626|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053627|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84053628|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
84053629|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
84053630|NCT02720367|Gemcitabine|gemcitabine|mesh-list
84053631|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84053632|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
84053633|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053634|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053635|NCT02693769|Fluticasone|fluticasone|mesh-list
84053636|NCT02693769|Xhance|xhance|mesh-list
84053637|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
84053638|NCT02693769|Bromides|bromides|mesh-list
84053639|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
84053640|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84053641|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84053642|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
84053643|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053644|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053645|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84053646|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
84053647|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
84053648|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84053649|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84053650|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84053651|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84053652|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
84053653|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053654|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053655|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
84053656|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84053657|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84053658|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84053659|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
84053660|NCT05335941|Pemetrexed|pemetrexed|mesh-list
84053661|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053662|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053663|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053664|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83197122|NCT03237715|Protective Agents|protective agents|mesh-ancestor
84053665|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84053666|NCT02725359|Tizanidine|tizanidine|mesh-list
84053667|NCT02725359|Bupivacaine|bupivacaine|mesh-list
84053668|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053669|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
84053670|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053671|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053672|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
84053673|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053674|NCT02725359|Analgesics|analgesics|mesh-ancestor
84053675|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
84053676|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84053677|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84053678|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
84053679|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
84053680|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84053681|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84053682|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84053683|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
84053684|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053685|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053686|NCT00731731|Temozolomide|temozolomide|mesh-list
84053687|NCT00731731|Vorinostat|vorinostat|mesh-list
84053688|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84053689|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
84053690|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053691|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053692|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83197371|NCT03236233|PC-786|pc-786|mesh-list
84053693|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053694|NCT05755048|Trastuzumab|trastuzumab|mesh-list
84053695|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84053696|NCT05755048|Maytansine|maytansine|mesh-list
84053697|NCT05755048|Antibodies|antibodies|mesh-list
84053698|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84053699|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
84053700|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053701|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84053702|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053703|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84053704|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
84053705|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
84053706|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
84053707|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053708|NCT05755048|Immunotoxins|immunotoxins|mesh-ancestor
84053709|NCT05755048|Immunoconjugates|immunoconjugates|mesh-ancestor
84053710|NCT02719431|Warfarin|warfarin|mesh-list
84053711|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
84053712|NCT00806494|Fesoterodine|fesoterodine|mesh-list
84053713|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84053714|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84053715|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
84053716|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053717|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053718|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053719|NCT00806494|Urological Agents|urological agents|mesh-ancestor
84053720|NCT00806416|Vitamin D|vitamin d|mesh-list
84053721|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
84053722|NCT00806416|Alendronate|alendronate|mesh-list
84053723|NCT00806416|Vitamins|vitamins|mesh-ancestor
84053724|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
84053725|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053726|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84053727|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84053728|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84053729|NCT00811252|Vortioxetine|vortioxetine|mesh-list
84053730|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84053731|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84053732|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053733|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053734|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053735|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053736|NCT00811252|Analgesics|analgesics|mesh-ancestor
84053737|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
84053738|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053739|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
84053740|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84053741|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
84053742|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84053743|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84053744|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053745|NCT00811252|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84053746|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
84053747|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84053748|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84053749|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84053750|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84053751|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84053752|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
83197711|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
84053753|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053754|NCT00736957|Acetaminophen|acetaminophen|mesh-list
84053755|NCT00736957|Tramadol|tramadol|mesh-list
84053756|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84053757|NCT00736957|Analgesics|analgesics|mesh-ancestor
84053758|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
84053759|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053760|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053761|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
84053762|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84053763|NCT00736957|Narcotics|narcotics|mesh-ancestor
84053764|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053765|NCT05294523|Rocuronium|rocuronium|mesh-list
84053766|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84053767|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84053768|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84053769|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053770|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053772|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84053773|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053774|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84053775|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053776|NCT02718261|Pantoprazole|pantoprazole|mesh-list
84053777|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84053778|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84053779|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84053780|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053781|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053782|NCT00806260|Ethanol|ethanol|mesh-list
84053783|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84053784|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053785|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053786|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053787|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84053788|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
84053789|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84053790|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053791|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
84053792|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84053793|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84053794|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
84053795|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053796|NCT02723487|Bupivacaine|bupivacaine|mesh-list
84053797|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
84053798|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
84053799|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053800|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053801|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
84053802|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053803|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
84053804|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
84053805|NCT02717871|Levofloxacin|levofloxacin|mesh-list
84053806|NCT02717871|Ofloxacin|ofloxacin|mesh-list
84053807|NCT02717871|Gentamicins|gentamicins|mesh-list
84053808|NCT02717871|Cefazolin|cefazolin|mesh-list
84053809|NCT02717871|Tobramycin|tobramycin|mesh-list
84053810|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
84053811|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
84053812|NCT02717871|Besifloxacin|besifloxacin|mesh-list
84053813|NCT02717871|Prednisolone|prednisolone|mesh-list
84053814|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84053815|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
84053816|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84053817|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
84053818|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84053819|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84053820|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
84053821|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
84053822|NCT02717871|Mydriatics|mydriatics|mesh-list
84053823|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84053824|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
84053825|NCT02717871|Hormones|hormones|mesh-ancestor
84053826|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053827|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198168|NCT02493725|Eculizumab|eculizumab|mesh-list
83198230|NCT02493179|Analgesics|analgesics|mesh-ancestor
84053828|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84053829|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053830|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
84053831|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
84053832|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053833|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84053834|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84053835|NCT02717871|Protective Agents|protective agents|mesh-ancestor
84053836|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84053837|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053838|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84053839|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84053840|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053841|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053842|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84053843|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84053844|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84053845|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84053846|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83198371|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84053847|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84053848|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
84053849|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84053850|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84053851|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
84053852|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053853|NCT02723253|Raltitrexed|raltitrexed|mesh-list
84053854|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053855|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84053856|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
84053857|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053858|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84053859|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053860|NCT00730405|Albaconazole|albaconazole|mesh-list
84053861|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
84053862|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053863|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
84053864|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84053865|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053866|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
84053867|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053868|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
84053869|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
84053870|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84053871|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
84053872|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
84053873|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053874|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053875|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84053876|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
84053877|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84053878|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84053879|NCT00736645|Selenium|selenium|mesh-list
84053880|NCT00736645|Finasteride|finasteride|mesh-list
84053881|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84053882|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84053883|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053884|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053885|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
84053886|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053887|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053888|NCT00736645|Urological Agents|urological agents|mesh-ancestor
84053889|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
84053890|NCT00736645|Protective Agents|protective agents|mesh-ancestor
84053891|NCT00736645|Trace Elements|trace elements|mesh-ancestor
84053892|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
84053893|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
84053894|NCT02326311|Dasatinib|dasatinib|mesh-list
84053895|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053896|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84053897|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053898|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053899|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
84053900|NCT00736489|AZD-3199|azd-3199|mesh-list
84053901|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84053902|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
84053903|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053904|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053905|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84053906|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
84053907|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84053908|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83198693|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
84053909|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84053910|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
84053911|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053912|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053913|NCT02716233|Pegaspargase|pegaspargase|mesh-list
84053914|NCT02716233|Asparaginase|asparaginase|mesh-list
84053915|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053916|NCT01999569|Letrozole|letrozole|mesh-list
84053917|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053918|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84053919|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84053920|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053921|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053922|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84053923|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
84053924|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84053925|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053926|NCT04087915|Evolocumab|evolocumab|mesh-list
84053927|NCT04087915|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84053928|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84053929|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84053930|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
84053931|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053932|NCT04087915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84053933|NCT04087915|Protease Inhibitors|protease inhibitors|mesh-ancestor
84053934|NCT04087915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053935|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84053936|NCT02715687|Amiodarone|amiodarone|mesh-list
84053937|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84053938|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
84053939|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84053940|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84053941|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053942|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84053943|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84053944|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84053945|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053946|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84053947|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84053948|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84053949|NCT04068831|Avelumab|avelumab|mesh-list
84053950|NCT04068831|Talazoparib|talazoparib|mesh-list
84053951|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84053952|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053953|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84053954|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84053955|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053956|NCT02715531|Leucovorin|leucovorin|mesh-list
84053957|NCT02715531|Paclitaxel|paclitaxel|mesh-list
84053958|NCT02715531|Bevacizumab|bevacizumab|mesh-list
84053959|NCT02715531|Gemcitabine|gemcitabine|mesh-list
84053960|NCT02715531|Capecitabine|capecitabine|mesh-list
84053961|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
84053962|NCT02715531|Atezolizumab|atezolizumab|mesh-list
84053963|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84053964|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84053965|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
84053966|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
84053967|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
84053968|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053969|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84053970|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84053971|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84053972|NCT02715531|Growth Substances|growth substances|mesh-ancestor
84053973|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053974|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
84053975|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84053976|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
84053977|NCT02715531|Antidotes|antidotes|mesh-ancestor
84053978|NCT02715531|Protective Agents|protective agents|mesh-ancestor
84053979|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
84053980|NCT02715531|Vitamins|vitamins|mesh-ancestor
84053981|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
84053982|NCT02715531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84053983|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
84053984|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84053985|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84053986|NCT04037085|Ketamine|ketamine|mesh-list
84053987|NCT04037085|Analgesics|analgesics|mesh-ancestor
84053988|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
83199059|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
84053989|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84053990|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84053991|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84053992|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84053993|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
84053994|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
84053995|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84053996|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83293951|NCT01419184|Vancomycin|vancomycin|mesh-list
84053997|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84053998|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84053999|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054001|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054002|NCT00730171|Linaclotide|linaclotide|mesh-list
84054003|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84054004|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
84054005|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054006|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054007|NCT04787835|Anesthetics|anesthetics|mesh-list
84054008|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
84054009|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199267|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
84054010|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054011|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
84054012|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054013|NCT00730015|Linaclotide|linaclotide|mesh-list
84054014|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84054015|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
84054016|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054017|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054018|NCT00806026|Pregabalin|pregabalin|mesh-list
84054019|NCT00806026|Pramipexole|pramipexole|mesh-list
84054020|NCT00806026|Analgesics|analgesics|mesh-ancestor
84054021|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
84054022|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054023|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054024|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
84054025|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84054026|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84054027|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054028|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84054029|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84054030|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84054031|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054032|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84054033|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
84054034|NCT00806026|Protective Agents|protective agents|mesh-ancestor
84054035|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84054036|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84054037|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
84054038|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
84054039|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054040|NCT04227093|Acetazolamide|acetazolamide|mesh-list
84054041|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
84054042|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84054043|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054044|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054045|NCT04227093|Diuretics|diuretics|mesh-ancestor
84054046|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
84054047|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054048|NCT00805792|Donepezil|donepezil|mesh-list
84054049|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84054050|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054051|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054052|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
84054053|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054054|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054055|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
84054056|NCT04777929|Progesterone|progesterone|mesh-list
84054057|NCT04777929|Estrogens|estrogens|mesh-list
84054058|NCT04777929|Progestins|progestins|mesh-ancestor
84054059|NCT04777929|Hormones|hormones|mesh-ancestor
84054060|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054061|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054062|NCT00590044|Insulin|insulin|mesh-list
84054063|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83199654|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
84054064|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
84054065|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
84054066|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84054067|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054068|NCT02714361|Vitamin D|vitamin d|mesh-list
84054069|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
83294004|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
84054070|NCT02714361|Vitamins|vitamins|mesh-ancestor
84054071|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
84054072|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054073|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84054074|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84054075|NCT00248703|Docetaxel|docetaxel|mesh-list
84054076|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054077|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
84054078|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
84054079|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
84054080|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054081|NCT02713893|Econazole|econazole|mesh-list
84054082|NCT02713893|Benzydamine|benzydamine|mesh-list
84054083|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054084|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
84054085|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054086|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84054087|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84054088|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054089|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054090|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84054091|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
84054092|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054093|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054094|NCT00729937|Clindamycin|clindamycin|mesh-list
84054095|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
84054096|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
84054097|NCT00729937|Cephalexin|cephalexin|mesh-list
83199790|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
84054098|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84054099|NCT00729937|Trimethoprim|trimethoprim|mesh-list
84054100|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
84054101|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84054102|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054103|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84054104|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054105|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054106|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84054107|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
84054108|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84054109|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84054110|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84054111|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84054112|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84054113|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84054114|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
84054115|NCT00729859|Anastrozole|anastrozole|mesh-list
84054116|NCT00729859|Testosterone|testosterone|mesh-list
84054117|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
84054118|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
84054119|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84054120|NCT00729859|Acyline|acyline|mesh-list
84054121|NCT00729859|Androgens|androgens|mesh-ancestor
84054122|NCT00729859|Hormones|hormones|mesh-ancestor
84054123|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054124|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054125|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84054126|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054127|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
84054128|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84054129|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84054130|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054131|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054132|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84054133|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
84054134|NCT00810394|Sorafenib|sorafenib|mesh-list
84054135|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054136|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84054137|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054138|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054139|NCT00736333|Doxorubicin|doxorubicin|mesh-list
84054140|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84054141|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84054142|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054143|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84054144|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84054145|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054146|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054147|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84054149|NCT00736255|Nicotine|nicotine|mesh-list
84054150|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84054151|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
84054152|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054153|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054154|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84054155|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84054156|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
84054157|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054158|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054159|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84054160|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84054161|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83200170|NCT02484209|Metformin|metformin|mesh-list
84054162|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84054163|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
84054164|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
84054165|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84054166|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054167|NCT00808444|Vaccines|vaccines|mesh-list
84054168|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84054169|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
84054170|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054171|NCT00914134|Levodopa|levodopa|mesh-list
84054172|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84054173|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84054174|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
84054175|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054176|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054177|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054178|NCT05754736|Bevacizumab|bevacizumab|mesh-list
84054179|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84054180|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054181|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84054182|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84054183|NCT05754736|Growth Substances|growth substances|mesh-ancestor
83200234|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054184|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054185|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
84054186|NCT00742027|Panobinostat|panobinostat|mesh-list
84054187|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054188|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84054189|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054190|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054191|NCT02609698|Aspirin|aspirin|mesh-list
84054192|NCT02609698|Clopidogrel|clopidogrel|mesh-list
84054193|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84054194|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054195|NCT02609698|Analgesics|analgesics|mesh-ancestor
84054196|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
84054197|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054198|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054199|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054200|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054201|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84054202|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84054203|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054204|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84054205|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84054206|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054207|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
84054208|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84054209|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84054210|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84054211|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
84054212|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054213|NCT05750134|Pancrelipase|pancrelipase|mesh-list
84054214|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054215|NCT05749822|Fenofibrate|fenofibrate|mesh-list
84054216|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84054217|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
84054218|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054219|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84054220|NCT02713191|Fentanyl|fentanyl|mesh-list
84054221|NCT02713191|Midazolam|midazolam|mesh-list
84054222|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
84054223|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84054224|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054225|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054226|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054227|NCT02713191|Analgesics|analgesics|mesh-ancestor
84054228|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
84054229|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054230|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84054231|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84054232|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83200479|NCT02448199|Meloxicam|meloxicam|mesh-list
84054233|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
84054234|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054235|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054236|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84054237|NCT02713191|Narcotics|narcotics|mesh-ancestor
84054238|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84054239|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84054240|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
84054241|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
84054242|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84054243|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84054244|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84054245|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
84054246|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
84054247|NCT00611169|Tirofiban|tirofiban|mesh-list
84054248|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84054249|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84054250|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054251|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84054252|NCT05754502|Trastuzumab|trastuzumab|mesh-list
84054253|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84054254|NCT05754502|Maytansine|maytansine|mesh-list
84054255|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200608|NCT02447809|Aspirin|aspirin|mesh-list
84054256|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054257|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84054258|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
84054259|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
84054260|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
84054261|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054262|NCT05754502|Immunotoxins|immunotoxins|mesh-ancestor
84054263|NCT05754502|Immunoconjugates|immunoconjugates|mesh-ancestor
84054264|NCT05754502|Immunologic Factors|immunologic factors|mesh-ancestor
84054265|NCT05754502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054266|NCT02712957|Naproxen|naproxen|mesh-list
84054267|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84054268|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054269|NCT02712957|Analgesics|analgesics|mesh-ancestor
84054270|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
84054271|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054272|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054273|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200666|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
84054274|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054275|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
84054276|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84054277|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054278|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054279|NCT04226625|Propofol|propofol|mesh-list
84054280|NCT04226625|Desflurane|desflurane|mesh-list
84054281|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84054282|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054283|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054284|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84054285|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
84054286|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
84054287|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84054288|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
84054289|NCT02777619|Propofol|propofol|mesh-list
84054290|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84054291|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054292|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054293|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054294|NCT02777619|Analgesics|analgesics|mesh-ancestor
84054295|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
84054296|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054297|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84054298|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83200784|NCT02480543|Misoprostol|misoprostol|mesh-list
84054299|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84054300|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
84054301|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054302|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054303|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84054304|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
84054306|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
84054307|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84054308|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054309|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84054310|NCT00636831|Cefazolin|cefazolin|mesh-list
84054311|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054312|NCT04193631|Cannabidiol|cannabidiol|mesh-list
84054313|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
84054314|NCT04856631|Cetuximab|cetuximab|mesh-list
83200850|NCT03208465|Hormones|hormones|mesh-ancestor
84054315|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84054316|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054317|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
84054318|NCT00808210|Infliximab|infliximab|mesh-list
84054319|NCT00808210|Methotrexate|methotrexate|mesh-list
84054320|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
84054321|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84054322|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
84054323|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84054324|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054325|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84054326|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
84054327|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054328|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054329|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
84054330|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054331|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84054332|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84054333|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
84054334|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054335|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84054336|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054337|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
84054338|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
84054339|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054340|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054341|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
84054342|NCT00808210|Hormones|hormones|mesh-ancestor
84131346|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83201257|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
84054343|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054344|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84054345|NCT00808210|Protective Agents|protective agents|mesh-ancestor
84054346|NCT00808210|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84054347|NCT02777229|Tenofovir|tenofovir|mesh-list
84054348|NCT02777229|Lamivudine|lamivudine|mesh-list
84054349|NCT02777229|Efavirenz|efavirenz|mesh-list
84054350|NCT02777229|Dolutegravir|dolutegravir|mesh-list
84054351|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
84054352|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054353|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84054354|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84054355|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054356|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054357|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84054358|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84054359|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84054360|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84054361|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84054362|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83201331|NCT03652961|Abatacept|abatacept|mesh-list
84054363|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84054364|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84054365|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84054366|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84054367|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84054368|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
84054369|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054370|NCT00635037|Bupivacaine|bupivacaine|mesh-list
84054371|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
84054372|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
84054373|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054374|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054375|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
84054376|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131347|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84054377|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
84054378|NCT02777151|Atoltivimab|atoltivimab|mesh-list
84054379|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
84054380|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054381|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
84054382|NCT02777073|Liraglutide|liraglutide|mesh-list
84054383|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84054384|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054385|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84054386|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054387|NCT02777073|Incretins|incretins|mesh-ancestor
84054388|NCT02777073|Hormones|hormones|mesh-ancestor
84131348|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201469|NCT03309215|Nickel|nickel|mesh-list
84054389|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054390|NCT02711865|Antibodies|antibodies|mesh-list
84054391|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
84054392|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054393|NCT02711943|Levofloxacin|levofloxacin|mesh-list
84054394|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84054395|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054396|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84054397|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84054398|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84054399|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054400|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054401|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054402|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84054403|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84054404|NCT02776761|Vaccines|vaccines|mesh-list
84054405|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
84054406|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054407|NCT04848753|Paclitaxel|paclitaxel|mesh-list
84054408|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84054409|NCT04848753|Cisplatin|cisplatin|mesh-list
84054410|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83201547|NCT04442633|Miconazole|miconazole|mesh-list
83201560|NCT03312335|Aldesleukin|aldesleukin|mesh-list
84054411|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054412|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
84054413|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
84054414|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
84054415|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054416|NCT00736099|Pioglitazone|pioglitazone|mesh-list
84054417|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84054418|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054419|NCT04616547|Edetic Acid|edetic acid|mesh-list
84054420|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
84054421|NCT04616547|Antidotes|antidotes|mesh-ancestor
84054422|NCT04616547|Protective Agents|protective agents|mesh-ancestor
84054423|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054424|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
84054425|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
84054426|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054427|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84054428|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
83201634|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
84054429|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84054430|NCT02711241|Dipyrone|dipyrone|mesh-list
84054431|NCT02711241|Papaverine|papaverine|mesh-list
84054432|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84054433|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054434|NCT02711241|Analgesics|analgesics|mesh-ancestor
84054435|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
84054436|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054437|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054438|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054439|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054440|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
83201756|NCT02467127|Vitamin D|vitamin d|mesh-list
84054441|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84054442|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054443|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054444|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
84054445|NCT02711241|Urological Agents|urological agents|mesh-ancestor
84054446|NCT02711007|Apatinib|apatinib|mesh-list
84054447|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054448|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84054449|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054450|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054451|NCT02710539|Amlodipine|amlodipine|mesh-list
84054452|NCT02710539|Perindopril|perindopril|mesh-list
84054453|NCT02710539|Indapamide|indapamide|mesh-list
84054454|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84054455|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84054456|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84054457|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054458|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84054459|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054460|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
84054461|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84054462|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
84054463|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054464|NCT02710539|Diuretics|diuretics|mesh-ancestor
84054465|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
84054466|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84054467|NCT00735709|Vortioxetine|vortioxetine|mesh-list
84054468|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
84054469|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84054470|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84054471|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84054472|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054473|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054474|NCT00735709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84054475|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84054476|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84054477|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054478|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054479|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
84054480|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84054481|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84054482|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84054483|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84054484|NCT02776527|Apatinib|apatinib|mesh-list
84054485|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054486|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84054487|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054488|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054489|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
84054490|NCT00729157|Aflibercept|aflibercept|mesh-list
84054491|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
84054492|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84054493|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84054494|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84054495|NCT00729157|Growth Substances|growth substances|mesh-ancestor
84054496|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054497|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
84054498|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054499|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054500|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84054501|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
84054502|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
84054503|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054504|NCT02710305|Lidocaine|lidocaine|mesh-list
84054505|NCT02710305|Scopolamine|scopolamine|mesh-list
84054506|NCT02710305|Bromides|bromides|mesh-list
84054507|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84054508|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
84054509|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
84054510|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054511|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054512|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
84054513|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054514|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84054515|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84054516|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84054517|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84054518|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054519|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
84054520|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84054521|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
84054522|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
84054523|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054524|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
84054525|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84054526|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
84054527|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054528|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84054529|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
84054530|NCT02708511|Copper|copper|mesh-list
84054531|NCT02708511|Trace Elements|trace elements|mesh-ancestor
84054532|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
84054533|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054534|NCT00728689|Tecovirimat|tecovirimat|mesh-list
84054535|NCT00728689|Antiviral Agents|antiviral agents|mesh-ancestor
84054536|NCT00728689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054537|NCT02596243|Vaccines|vaccines|mesh-list
84054538|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
84054539|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054540|NCT02717091|Paclitaxel|paclitaxel|mesh-list
84054541|NCT02717091|Gemcitabine|gemcitabine|mesh-list
84054542|NCT02717091|Folfirinox|folfirinox|mesh-list
83202188|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
84054543|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84054544|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054545|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
84054546|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
84054547|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
84054548|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054549|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84054550|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
84054551|NCT03911973|Talazoparib|talazoparib|mesh-list
84054552|NCT03911973|Gedatolisib|gedatolisib|mesh-list
84054553|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84054554|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054555|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054556|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054557|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84054558|NCT00726895|Quinine|quinine|mesh-list
84054559|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
84054560|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84054561|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84054562|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054563|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84054564|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054565|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84054566|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054567|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054568|NCT00726895|Analgesics|analgesics|mesh-ancestor
84054569|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
84054570|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84054571|NCT02593201|Cefazolin|cefazolin|mesh-list
84054572|NCT02593201|Ceftazidime|ceftazidime|mesh-list
84054573|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84054574|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054575|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
84054576|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
84054577|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84054578|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054579|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054580|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054581|NCT02707809|Analgesics|analgesics|mesh-ancestor
84054582|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
84054583|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202309|NCT04489745|Androgens|androgens|mesh-list
84054584|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84054585|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84054586|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84054587|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
84054588|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054589|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054590|NCT00585325|Lidocaine|lidocaine|mesh-list
84054591|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
84054592|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
83294534|NCT01925612|Prednisone|prednisone|mesh-list
84054593|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054594|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054595|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
84054596|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054597|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84054598|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84054599|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84054600|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202506|NCT04872257|Vitamins|vitamins|mesh-ancestor
84054601|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054602|NCT02716857|Oxycodone|oxycodone|mesh-list
84054603|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84054604|NCT02716857|Narcotics|narcotics|mesh-ancestor
84054605|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054606|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054607|NCT02716857|Analgesics|analgesics|mesh-ancestor
84054608|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
84054609|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054610|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
84054611|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
84054612|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84054613|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054614|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84054615|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
84054616|NCT00917761|Entecavir|entecavir|mesh-list
84054617|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
84054618|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054619|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
84054620|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054621|NCT02709603|Scopolamine|scopolamine|mesh-list
84054622|NCT02709603|Bromides|bromides|mesh-list
84054623|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84054624|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
84054625|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84054626|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
84054627|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
84054628|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054629|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054630|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054631|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
84054632|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84054633|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
84054634|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054635|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054636|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84054637|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
84054638|NCT00611793|Bevacizumab|bevacizumab|mesh-list
84054639|NCT00611793|Vatalanib|vatalanib|mesh-list
84054640|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84054641|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054642|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84054643|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84054644|NCT00611793|Growth Substances|growth substances|mesh-ancestor
84054645|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054646|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
84054647|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84054648|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054649|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054650|NCT00611871|Propranolol|propranolol|mesh-list
84054651|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84054652|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84054653|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
84054654|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202633|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
84054655|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054656|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054657|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84054658|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84054659|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
84054660|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
84054661|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84054662|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
84054663|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054664|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
84054665|NCT02709525|Protective Agents|protective agents|mesh-ancestor
84054666|NCT05087589|Tofacitinib|tofacitinib|mesh-list
84054667|NCT05087589|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84054668|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84054669|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202669|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84054670|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054671|NCT00612651|Temozolomide|temozolomide|mesh-list
84054672|NCT00612651|Lonafarnib|lonafarnib|mesh-list
84054673|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84054674|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
84054675|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054676|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054677|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054678|NCT00918307|Varenicline|varenicline|mesh-list
84054679|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84054680|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84054681|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
84054682|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054683|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054684|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054685|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
84054686|NCT00741013|Protein C|protein c|mesh-list
84054687|NCT00741013|Lovastatin|lovastatin|mesh-list
84054688|NCT00741013|L 647318|l 647318|mesh-list
84054689|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
84054690|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84054691|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84054692|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
84054693|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054694|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84054695|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84054696|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054697|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
84054698|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84054699|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84054700|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054701|NCT04087759|Bedaquiline|bedaquiline|mesh-list
84054702|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
84054703|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
84054704|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84054705|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054706|NCT00740857|Ibuprofen|ibuprofen|mesh-list
84054707|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84054708|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054709|NCT00740857|Analgesics|analgesics|mesh-ancestor
84054710|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
84054711|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054712|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054713|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054714|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054715|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84054716|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054717|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054718|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
83203215|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
84054719|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84054720|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
84054721|NCT00808132|Estrogens|estrogens|mesh-list
84054722|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84054723|NCT00808132|Hormones|hormones|mesh-ancestor
84054724|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054725|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054726|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84054727|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84054728|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84054729|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
84054730|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84054731|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84054732|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84054733|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84054734|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84054735|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054736|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84054737|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84054738|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
84054739|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84054740|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
84054741|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84054742|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
84054743|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054744|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054745|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84054746|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
84054747|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054748|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054749|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84054750|NCT00914368|Clopidogrel|clopidogrel|mesh-list
84054751|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84054752|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84054753|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84054754|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84054755|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
84054756|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054757|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054758|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054759|NCT02607982|Paclitaxel|paclitaxel|mesh-list
84054760|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
84054761|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84054762|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203419|NCT03107507|Levetiracetam|levetiracetam|mesh-list
84054763|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
84054764|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
84054765|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
84054766|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054767|NCT02692989|Anesthetics|anesthetics|mesh-list
84054768|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054769|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054770|NCT04126473|Ivacaftor|ivacaftor|mesh-list
84054771|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84054772|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84054773|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054774|NCT03643276|Cytarabine|cytarabine|mesh-list
84054775|NCT03643276|Dexamethasone|dexamethasone|mesh-list
84054776|NCT03643276|Prednisone|prednisone|mesh-list
84054777|NCT03643276|Prednisolone|prednisolone|mesh-list
84054778|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
84054779|NCT03643276|Ifosfamide|ifosfamide|mesh-list
84054780|NCT03643276|Doxorubicin|doxorubicin|mesh-list
84054781|NCT03643276|Methotrexate|methotrexate|mesh-list
84054782|NCT03643276|Fludarabine|fludarabine|mesh-list
84054783|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
84054784|NCT03643276|Etoposide|etoposide|mesh-list
84054785|NCT03643276|Vincristine|vincristine|mesh-list
84054786|NCT03643276|Bortezomib|bortezomib|mesh-list
84054787|NCT03643276|Daunorubicin|daunorubicin|mesh-list
84054788|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
84054789|NCT03643276|Pegaspargase|pegaspargase|mesh-list
84054790|NCT03643276|Blinatumomab|blinatumomab|mesh-list
84054791|NCT03643276|Vindesine|vindesine|mesh-list
84054792|NCT03643276|Asparaginase|asparaginase|mesh-list
84054793|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84054794|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
84054795|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054796|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054797|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84054798|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
84054799|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054800|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054801|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84054802|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054803|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
84054804|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
84054805|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054806|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054807|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
84054808|NCT03643276|Hormones|hormones|mesh-ancestor
84054809|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054810|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84054811|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84054812|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84054813|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84054814|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054815|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84054816|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
84054817|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84054818|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83294751|NCT01915303|Cabergoline|cabergoline|mesh-list
84054819|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
84054820|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
84054821|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84054822|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84054823|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84054824|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
84054825|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054826|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
84054827|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
84054828|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
84054829|NCT04882293|Atorvastatin|atorvastatin|mesh-list
84054830|NCT04882293|Fenofibrate|fenofibrate|mesh-list
84054831|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84054832|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84054833|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
84054834|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054835|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84054836|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84054837|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054838|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
84054839|NCT02608060|Hematinics|hematinics|mesh-ancestor
84054840|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
84054841|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84054842|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84054843|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054844|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
84054845|NCT04085575|Coagulants|coagulants|mesh-ancestor
84054846|NCT00585169|Memantine|memantine|mesh-list
84054847|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84054848|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84054849|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
84054850|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054851|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054852|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054853|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84054854|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84054855|NCT00807742|Nicotine|nicotine|mesh-list
84054856|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84054857|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
84054858|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054859|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054860|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84054861|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84054862|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
84054863|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054864|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054865|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
84054866|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84054867|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054868|NCT05738434|Apatinib|apatinib|mesh-list
84054869|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054870|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84054871|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054872|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054873|NCT00803452|Azithromycin|azithromycin|mesh-list
84054874|NCT00803452|Doxycycline|doxycycline|mesh-list
84054875|NCT00803452|Minocycline|minocycline|mesh-list
84054876|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84054877|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054878|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
84054879|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84054880|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84054881|NCT04546113|Ropivacaine|ropivacaine|mesh-list
84054882|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
84054883|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
84054884|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84054885|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054886|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
84054887|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054888|NCT05737342|Red yeast rice|red yeast rice|mesh-list
84054889|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84054890|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84054891|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84054892|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
84054893|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054894|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294827|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
83204105|NCT03265223|Ropivacaine|ropivacaine|mesh-list
84054895|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84054896|NCT00914212|Sibutramine|sibutramine|mesh-list
84054897|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
84054898|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84054899|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
84054900|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84054901|NCT04456023|Tisagenlecleucel|tisagenlecleucel|mesh-list
84054902|NCT04456023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84054903|NCT04456023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054904|NCT04188483|Selenium|selenium|mesh-list
84054905|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
83204162|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054906|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054907|NCT04188483|Protective Agents|protective agents|mesh-ancestor
84054908|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054909|NCT04188483|Trace Elements|trace elements|mesh-ancestor
84054910|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
84054911|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84054912|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
84054913|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054914|NCT00717067|Ritonavir|ritonavir|mesh-list
84054915|NCT00717067|Saquinavir|saquinavir|mesh-list
84054916|NCT00717067|Maraviroc|maraviroc|mesh-list
84054917|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84054918|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84054919|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
84054920|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054921|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054922|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84054923|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84054924|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
84054925|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054926|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84054927|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84054928|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84054929|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84054930|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84054931|NCT05731960|Dexamethasone|dexamethasone|mesh-list
84054932|NCT05731960|Metoclopramide|metoclopramide|mesh-list
83204290|NCT04975971|Hormones|hormones|mesh-ancestor
84054933|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054934|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
84054935|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
84054936|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054937|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054938|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84054939|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
84054940|NCT05731960|Hormones|hormones|mesh-ancestor
84054941|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84054942|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84054943|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054944|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84054945|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84054946|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
84054947|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054948|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054949|NCT04393311|Urinastatin|urinastatin|mesh-list
84054950|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84054951|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84054952|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
84054953|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054954|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054955|NCT02607436|Aspirin|aspirin|mesh-list
84054956|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
84054957|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84054958|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84054959|NCT02607436|Analgesics|analgesics|mesh-ancestor
84054960|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
84054961|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054962|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054963|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84054964|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84054965|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84054966|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84054967|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054968|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84054969|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84054970|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204456|NCT04432155|Xenon|xenon|mesh-list
83204503|NCT04953741|Xhance|xhance|mesh-list
84054971|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
84054972|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84054973|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
84054974|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84054975|NCT02607592|Pemetrexed|pemetrexed|mesh-list
84054976|NCT02607592|Nedaplatin|nedaplatin|mesh-list
84054977|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054978|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84054979|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84054980|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84054981|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84054982|NCT04356339|Interferons|interferons|mesh-list
84054983|NCT04356339|Interferon-beta|interferon-beta|mesh-list
84054984|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
84054985|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84054986|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
84054987|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84054988|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
84054989|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054990|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84054991|NCT03511846|Capsaicin|capsaicin|mesh-list
84054992|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
84054993|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
84054994|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
84054995|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84054996|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84054997|NCT04331145|Ticagrelor|ticagrelor|mesh-list
84054998|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84054999|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84055000|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84055001|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84055002|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
84055003|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055004|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055005|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055006|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84055007|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055008|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055009|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84055010|NCT03460522|Immunotoxins|immunotoxins|mesh-ancestor
84055011|NCT03460522|Immunoconjugates|immunoconjugates|mesh-ancestor
84055012|NCT03460522|Immunologic Factors|immunologic factors|mesh-ancestor
84055013|NCT03460522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055014|NCT02605720|Piperaquine|piperaquine|mesh-list
84055015|NCT02605720|Artenimol|artenimol|mesh-list
84055016|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
83204582|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
84055017|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84055018|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84055019|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055020|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
84055021|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84055022|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
84055023|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055024|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
84055025|NCT04188561|Protective Agents|protective agents|mesh-ancestor
84055026|NCT00588952|Ketamine|ketamine|mesh-list
84055027|NCT00588952|Analgesics|analgesics|mesh-ancestor
84055028|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
84055029|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204644|NCT04961931|Empagliflozin|empagliflozin|mesh-list
84055030|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055031|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84055032|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84055033|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
84055034|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
84055035|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84055036|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84055037|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84055038|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055039|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055040|NCT04885257|Methylphenidate|methylphenidate|mesh-list
84055041|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84055042|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055043|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84055044|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84055045|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055046|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055047|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
84055048|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055050|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84055051|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204765|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055052|NCT03484923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055053|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055054|NCT00802360|Menotropins|menotropins|mesh-list
84055055|NCT00802360|Progesterone|progesterone|mesh-list
84055056|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84055057|NCT00802360|Ganirelix|ganirelix|mesh-list
84055058|NCT00802360|Progestins|progestins|mesh-ancestor
84055059|NCT00802360|Hormones|hormones|mesh-ancestor
84055060|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055061|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055062|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
84055063|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84055064|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
84055065|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055066|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84055067|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84055068|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055069|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055070|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84055071|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055072|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055073|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
84055074|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055075|NCT04811625|Aspirin|aspirin|mesh-list
84055076|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84055077|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84055078|NCT04811625|Analgesics|analgesics|mesh-ancestor
84055079|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
84055080|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055081|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055082|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055083|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204962|NCT04939857|Trimetazidine|trimetazidine|mesh-list
84055084|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84055085|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84055086|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055087|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84055088|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84055089|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055090|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
84055091|NCT02764593|Nivolumab|nivolumab|mesh-list
84055092|NCT02764593|Cetuximab|cetuximab|mesh-list
84055093|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055094|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055095|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84055096|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055097|NCT04028596|Acetaminophen|acetaminophen|mesh-list
84055098|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84055099|NCT04028596|Analgesics|analgesics|mesh-ancestor
84055100|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
84055101|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055102|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055103|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
84055104|NCT04594551|Vaccines|vaccines|mesh-list
84055105|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
84055106|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84055107|NCT04594551|Antibodies|antibodies|mesh-list
84055108|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
84055109|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055110|NCT02692599|Vaccines|vaccines|mesh-list
84055111|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
84055112|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055113|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84055114|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
84055115|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055116|NCT02606266|Valganciclovir|valganciclovir|mesh-list
84055117|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
84055118|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055119|NCT04115020|Naltrexone|naltrexone|mesh-list
84055120|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84055121|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84055122|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055124|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055125|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
84055126|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055127|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055128|NCT03292666|Warfarin|warfarin|mesh-list
84055129|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
84055130|NCT03292666|Dabigatran|dabigatran|mesh-list
84055131|NCT03292666|Apixaban|apixaban|mesh-list
84055132|NCT03292666|Anticoagulants|anticoagulants|mesh-list
84055133|NCT03292666|Edoxaban|edoxaban|mesh-list
84055134|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84055135|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
84055136|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84055137|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
84055138|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055139|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055140|NCT02707653|Misoprostol|misoprostol|mesh-list
84055141|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84055142|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
84055143|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055144|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055145|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84055146|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84055147|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
84055148|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84055149|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84055150|NCT03901131|Norethindrone|norethindrone|mesh-list
84055151|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
84055152|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
84055153|NCT03901131|Estradiol|estradiol|mesh-list
84055154|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84055155|NCT03901131|Estrogens|estrogens|mesh-ancestor
84055156|NCT03901131|Hormones|hormones|mesh-ancestor
84055157|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055158|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055159|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84055160|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
84055161|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055162|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84055163|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84055164|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84055165|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84055166|NCT02607202|Paclitaxel|paclitaxel|mesh-list
84055167|NCT02607202|Carboplatin|carboplatin|mesh-list
84055168|NCT02607202|Gemcitabine|gemcitabine|mesh-list
84055169|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84055170|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055171|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
84055172|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
84055173|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
84055174|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055175|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84055176|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
84055177|NCT03896685|Linezolid|linezolid|mesh-list
84055178|NCT03896685|Bedaquiline|bedaquiline|mesh-list
84055179|NCT03896685|Clofazimine|clofazimine|mesh-list
84055180|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84055181|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055182|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84055183|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055184|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055185|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
84055186|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055187|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
84055188|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84055189|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84055190|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84055191|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84055192|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055193|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84055194|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84055195|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84055196|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84055197|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
84055198|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205534|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055199|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055200|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84055201|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84055202|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
84055203|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84055204|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84055205|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
84055206|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
84055207|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055208|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
84055209|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055210|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
84055211|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055212|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055213|NCT03868839|Telmisartan|telmisartan|mesh-list
84055214|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84055215|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84055216|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84055217|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055218|NCT00589420|Docetaxel|docetaxel|mesh-list
84055219|NCT00589420|Sorafenib|sorafenib|mesh-list
84055220|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055221|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
84055222|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
84055223|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83205662|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84055224|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055225|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84055226|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055227|NCT04114630|Erenumab|erenumab|mesh-list
84055228|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
84055229|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055230|NCT04114630|Analgesics|analgesics|mesh-ancestor
84055231|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
84055232|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055233|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055234|NCT04112212|Vedolizumab|vedolizumab|mesh-list
84055235|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84055236|NCT00914524|Olmesartan|olmesartan|mesh-list
84055237|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84055238|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84055239|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84055240|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84055241|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055242|NCT03787095|Cemiplimab|cemiplimab|mesh-list
84055243|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055244|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055245|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
84055246|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84055247|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205788|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84055248|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055249|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84055250|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055251|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84055252|NCT00796978|Trastuzumab|trastuzumab|mesh-list
84055253|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055254|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055255|NCT03779295|Clindamycin|clindamycin|mesh-list
84055256|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
84055257|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
84055258|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84055259|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055260|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84055261|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055262|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055263|NCT00613665|Vaccines|vaccines|mesh-list
84055264|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
84055265|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055266|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
84055267|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055268|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055269|NCT03746769|Gastrins|gastrins|mesh-list
84055270|NCT03746769|Hormones|hormones|mesh-ancestor
83295193|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
84055271|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055272|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055274|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84055275|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055276|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055277|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84055278|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84055279|NCT00796822|Protective Agents|protective agents|mesh-ancestor
84055280|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055281|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
84055282|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84055283|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
84055284|NCT04007991|Ecopipam|ecopipam|mesh-list
84055285|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84055286|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84055287|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84055288|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055289|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84055290|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84055291|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
84055292|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055293|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055294|NCT03822507|Cinacalcet|cinacalcet|mesh-list
84055295|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84055296|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055297|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
84055298|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
84055299|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055300|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
84055301|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84055302|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84055303|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055304|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055305|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
84055306|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055307|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055308|NCT00614679|Tigecycline|tigecycline|mesh-list
84055309|NCT00614679|Heparin|heparin|mesh-list
84055310|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
84055311|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84055312|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84055313|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055314|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84055315|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055316|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84055317|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055318|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84055319|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84055320|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055321|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84055322|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055323|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
84055324|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84055325|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055326|NCT01024946|Everolimus|everolimus|mesh-list
84055327|NCT01024946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84055328|NCT01024946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84055329|NCT01024946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055330|NCT01024946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055331|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84055332|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
84055333|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055334|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055335|NCT00724867|Belimumab|belimumab|mesh-list
84055336|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84055337|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
84055338|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055339|NCT00627536|Mitogens|mitogens|mesh-list
84055340|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
83295268|NCT01895270|Isradipine|isradipine|mesh-list
84055341|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055342|NCT00724711|Tenofovir|tenofovir|mesh-list
84055343|NCT00724711|Lamivudine|lamivudine|mesh-list
84055344|NCT00724711|Emtricitabine|emtricitabine|mesh-list
84055345|NCT00724711|Abacavir|abacavir|mesh-list
84055346|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
84055347|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055348|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84055349|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84055350|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055351|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055352|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84055353|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84055354|NCT00721279|Pramipexole|pramipexole|mesh-list
84055355|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
84055356|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055357|NCT00721279|Protective Agents|protective agents|mesh-ancestor
84055358|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055359|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84055360|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84055361|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
84055362|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
84055363|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055364|NCT01030952|Acarbose|acarbose|mesh-list
84055365|NCT01030952|Nateglinide|nateglinide|mesh-list
84055366|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84055367|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055368|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055369|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84055370|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055371|NCT03611751|Apremilast|apremilast|mesh-list
84055372|NCT03611751|Deucravacitinib|deucravacitinib|mesh-list
84055373|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84055374|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84055375|NCT03611751|Analgesics|analgesics|mesh-ancestor
84055376|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
84055377|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055378|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055379|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055380|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84055381|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84055382|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84055383|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055384|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055385|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
84055386|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84055387|NCT00613743|Morphine|morphine|mesh-list
84055388|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84055389|NCT00613743|Narcotics|narcotics|mesh-ancestor
84055390|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84055391|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055392|NCT00613743|Analgesics|analgesics|mesh-ancestor
84055393|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
84055394|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055395|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
84055396|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84055397|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
84055398|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055399|NCT00614757|Expectorants|expectorants|mesh-ancestor
84055400|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
84055401|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84055402|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
84055403|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055404|NCT00614757|Protective Agents|protective agents|mesh-ancestor
84055405|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055406|NCT00614757|Antidotes|antidotes|mesh-ancestor
84055407|NCT02692365|Manganese|manganese|mesh-list
84055408|NCT02692365|Trace Elements|trace elements|mesh-ancestor
84055409|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
84055410|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055411|NCT03492099|Buprenorphine|buprenorphine|mesh-list
84055412|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84055413|NCT03492099|Narcotics|narcotics|mesh-ancestor
84055414|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84055415|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055416|NCT03492099|Analgesics|analgesics|mesh-ancestor
84055417|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
84055418|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055419|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84055420|NCT03481959|Methylphenidate|methylphenidate|mesh-list
84055421|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84055422|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055423|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84055424|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84055425|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055426|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055427|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
84055428|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055429|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84055430|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84055431|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84055432|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
84055433|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055434|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84055435|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84055436|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055437|NCT03462069|Empagliflozin|empagliflozin|mesh-list
84055438|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84055439|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84055440|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055441|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84055442|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055443|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84055445|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84055446|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
84055447|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055448|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055449|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84055450|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84055451|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84055452|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055453|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84055454|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84055455|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84055456|NCT03387657|Diuretics|diuretics|mesh-ancestor
84055457|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
84055458|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055459|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84055460|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055461|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055462|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84055463|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84055464|NCT00720499|Bromides|bromides|mesh-list
84055465|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
84055466|NCT00720499|Olodaterol|olodaterol|mesh-list
84055467|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84055468|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
84055469|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055470|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055471|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83206552|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
84055472|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
84055473|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
84055474|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84055475|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
84055476|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055477|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055478|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
84055479|NCT00724243|Infliximab|infliximab|mesh-list
84055480|NCT00724243|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84055481|NCT00724243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055482|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
84055483|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84055484|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84055485|NCT02590705|Lidocaine|lidocaine|mesh-list
84055486|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
84055488|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84055489|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206594|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84055490|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
84055491|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055492|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84055493|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84055494|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84055495|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055496|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055497|NCT00720343|Choline|choline|mesh-list
84055498|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
84055499|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84055500|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
84055501|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055502|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84055503|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84055504|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
84055505|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
84055506|NCT00720109|Leucovorin|leucovorin|mesh-list
84055507|NCT00720109|Folic Acid|folic acid|mesh-list
84055508|NCT00720109|Cytarabine|cytarabine|mesh-list
84055509|NCT00720109|Dexamethasone|dexamethasone|mesh-list
84055510|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
84055511|NCT00720109|Prednisone|prednisone|mesh-list
84055512|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
84055513|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84055514|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84055515|NCT00720109|Prednisolone|prednisolone|mesh-list
84055516|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
84055517|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
84055518|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84055519|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84055520|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84055521|NCT00720109|Cortisone|cortisone|mesh-list
84055522|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
84055523|NCT00720109|Ifosfamide|ifosfamide|mesh-list
84055524|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
84055525|NCT00720109|Methotrexate|methotrexate|mesh-list
84055526|NCT00720109|Etoposide|etoposide|mesh-list
84055527|NCT00720109|Vincristine|vincristine|mesh-list
84055528|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
84055529|NCT00720109|Daunorubicin|daunorubicin|mesh-list
84055530|NCT00720109|Asparaginase|asparaginase|mesh-list
84055531|NCT00720109|Dasatinib|dasatinib|mesh-list
84055532|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
84055533|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
84055534|NCT00720109|Pegaspargase|pegaspargase|mesh-list
84055535|NCT00720109|Lenograstim|lenograstim|mesh-list
84055536|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84055537|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
84055538|NCT00720109|BB 1101|bb 1101|mesh-list
84055539|NCT00720109|Calcium|calcium|mesh-list
84055540|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
84055541|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84055542|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
84055543|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055544|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84055545|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84055546|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
84055547|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055548|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055549|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84055550|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055551|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
84055552|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
84055553|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055554|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84055555|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
84055556|NCT00720109|Hormones|hormones|mesh-ancestor
84055557|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055558|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295495|NCT01865084|Tadalafil|tadalafil|mesh-list
84055559|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
84055560|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055561|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84055562|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84055563|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84055564|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
84055565|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055566|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84055568|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
84055569|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84055570|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84055571|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84055572|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84055573|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84055574|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
84055575|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055576|NCT00720109|Antidotes|antidotes|mesh-ancestor
84055577|NCT00720109|Protective Agents|protective agents|mesh-ancestor
84055578|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
84055579|NCT00720109|Vitamins|vitamins|mesh-ancestor
84055580|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
84055581|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84055582|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
84055583|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
84055584|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
84055585|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84055586|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84055587|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84055588|NCT00720109|Hematinics|hematinics|mesh-ancestor
84055589|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
84055590|NCT01705977|Belimumab|belimumab|mesh-list
84055591|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207257|NCT04860531|Lidocaine|lidocaine|mesh-list
84055592|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
84055593|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055594|NCT02590627|Lumefantrine|lumefantrine|mesh-list
84055595|NCT02590627|Artemether|artemether|mesh-list
84055596|NCT02590627|Piperaquine|piperaquine|mesh-list
84055597|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84055598|NCT02590627|Artenimol|artenimol|mesh-list
84055599|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
84055600|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84055601|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84055602|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055603|NCT01015118|Paclitaxel|paclitaxel|mesh-list
84055604|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84055605|NCT01015118|Carboplatin|carboplatin|mesh-list
84055606|NCT01015118|Nintedanib|nintedanib|mesh-list
84055607|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84055608|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055609|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
84055610|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
84055611|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
84055612|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055613|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84055614|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055615|NCT02415153|Pomalidomide|pomalidomide|mesh-list
84055616|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
84055617|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055618|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84055619|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84055620|NCT02415153|Growth Substances|growth substances|mesh-ancestor
84055621|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
84055622|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055623|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
84055624|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84055625|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84055626|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055627|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
84055628|NCT04111822|Coagulants|coagulants|mesh-ancestor
84055629|NCT00628160|Terlipressin|terlipressin|mesh-list
84055630|NCT00628160|Dopamine|dopamine|mesh-list
84055631|NCT00628160|Norepinephrine|norepinephrine|mesh-list
84055632|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
83207440|NCT04860219|Lactoferrin|lactoferrin|mesh-list
84055633|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84055634|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84055635|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055636|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055637|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055638|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
84055639|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
84055640|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055641|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84055643|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84055644|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
84055645|NCT00628160|Protective Agents|protective agents|mesh-ancestor
84055646|NCT02274285|Vaccines|vaccines|mesh-list
84055647|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
84055648|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055649|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
84055650|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84055651|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
84055652|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
83207508|NCT02606877|Analgesics|analgesics|mesh-ancestor
84055653|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
84055654|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055655|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055656|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84055657|NCT00614835|Gemcitabine|gemcitabine|mesh-list
84055658|NCT00614835|Docetaxel|docetaxel|mesh-list
84055659|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84055660|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
84055661|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055662|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055663|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
84055664|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
84055665|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
84055666|NCT00715429|Vitamin D|vitamin d|mesh-list
84055667|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
84055668|NCT00715429|Vitamins|vitamins|mesh-ancestor
84055669|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
84055670|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055671|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84055672|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84055673|NCT02606032|Metronidazole|metronidazole|mesh-list
84055674|NCT02606032|Doxycycline|doxycycline|mesh-list
84055675|NCT02606032|Terbinafine|terbinafine|mesh-list
84055676|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055677|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84055678|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84055679|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84055680|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
84055681|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
84055682|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055683|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055684|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84055685|NCT01743651|Baclofen|baclofen|mesh-list
84055686|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84055687|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055688|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84055689|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055690|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84055691|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
84055692|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
84055693|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055694|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055695|NCT00715117|Naltrexone|naltrexone|mesh-list
84055696|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84055697|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84055698|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055699|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
84055700|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055701|NCT00723229|Acyclovir|acyclovir|mesh-list
84055702|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
84055703|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055704|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
84055705|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84055706|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055707|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055708|NCT01030718|Dasatinib|dasatinib|mesh-list
84055709|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055710|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84055711|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055712|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055713|NCT00722761|Drospirenone|drospirenone|mesh-list
84055714|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84055715|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
84055716|NCT00722761|Estradiol|estradiol|mesh-list
84055717|NCT00722761|Estrogens|estrogens|mesh-ancestor
84055718|NCT00722761|Hormones|hormones|mesh-ancestor
84055719|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055720|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055721|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84055723|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055724|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84055725|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84055726|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84055727|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84055728|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
84055729|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84055730|NCT00722761|Diuretics|diuretics|mesh-ancestor
84055731|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
84055732|NCT00628238|Rituximab|rituximab|mesh-list
84055733|NCT00628238|Lenalidomide|lenalidomide|mesh-list
84055734|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055735|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055736|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
84055737|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055738|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84055739|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84055740|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84055741|NCT00628238|Growth Substances|growth substances|mesh-ancestor
84055742|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
84055743|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
84055744|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84055745|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
84055746|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055747|NCT01019486|Regadenoson|regadenoson|mesh-list
84055748|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
84055749|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84055750|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84055751|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
84055752|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
84055753|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055754|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055755|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055756|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84055757|NCT02803203|Bevacizumab|bevacizumab|mesh-list
84055758|NCT02803203|Osimertinib|osimertinib|mesh-list
84055759|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055760|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055761|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84055762|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84055763|NCT02803203|Growth Substances|growth substances|mesh-ancestor
84055764|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055765|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
84055766|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84055767|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207992|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055768|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055769|NCT00714493|Infliximab|infliximab|mesh-list
84055770|NCT00714493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84055771|NCT00714493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055772|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
84055773|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84055774|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84055775|NCT01013870|Atorvastatin|atorvastatin|mesh-list
84055776|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84055777|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84055778|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
84055779|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055780|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84055781|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84055782|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055783|NCT05020184|Cimetidine|cimetidine|mesh-list
84055784|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84055785|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84055786|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84055787|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
84055788|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
84055789|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055790|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055791|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055792|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84055793|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84055794|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055795|NCT00628316|Caffeine|caffeine|mesh-list
84055796|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84055797|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055798|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84055799|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055800|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208262|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
84055801|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84055802|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84055803|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
84055804|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055805|NCT01018862|Azelastine|azelastine|mesh-list
84055806|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84055807|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
84055808|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208327|NCT04807335|Sufentanil|sufentanil|mesh-list
83208383|NCT04352439|Aspirin|aspirin|mesh-list
83208449|NCT02597049|Dulaglutide|dulaglutide|mesh-list
84055809|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055810|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84055811|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
84055812|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84055813|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055814|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055815|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84055816|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84055817|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83208525|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
84055818|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
84055819|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
84055820|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055821|NCT01018394|Nicotine|nicotine|mesh-list
84055822|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84055823|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
84055824|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055825|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055826|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84055827|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84055828|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
84055829|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055830|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055831|NCT04301336|Zinc|zinc|mesh-list
84055832|NCT04301336|Folic Acid|folic acid|mesh-list
84055833|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
84055834|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
84055835|NCT04301336|Morphine|morphine|mesh-list
84055836|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
84055837|NCT04301336|Simvastatin|simvastatin|mesh-list
84055838|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84055839|NCT04301336|Narcotics|narcotics|mesh-ancestor
84055840|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84055841|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055842|NCT04301336|Analgesics|analgesics|mesh-ancestor
84055843|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
84055844|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055845|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83208594|NCT04808895|Aspirin|aspirin|mesh-list
84055846|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84055847|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
84055848|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055849|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84055850|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84055851|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055852|NCT04301336|Trace Elements|trace elements|mesh-ancestor
84055853|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
84055854|NCT04301336|Hematinics|hematinics|mesh-ancestor
84055855|NCT04301336|Vitamins|vitamins|mesh-ancestor
84055856|NCT04301336|Astringents|astringents|mesh-ancestor
84055857|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
84055858|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055859|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
84055860|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84055861|NCT00627848|Rivastigmine|rivastigmine|mesh-list
84055862|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84055863|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055864|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055865|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
84055866|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055867|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055869|NCT00627848|Protective Agents|protective agents|mesh-ancestor
84055870|NCT04299854|Dinoprostone|dinoprostone|mesh-list
84055871|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
84055872|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055873|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055874|NCT01017146|Tazarotene|tazarotene|mesh-list
84055875|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
84055876|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
84055877|NCT02872064|Verteporfin|verteporfin|mesh-list
84055878|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84055879|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
84055880|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
83208860|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
84055881|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
84055882|NCT04205240|Melphalan|melphalan|mesh-list
84055883|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
84055884|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
84055885|NCT04205240|Fludarabine|fludarabine|mesh-list
84055886|NCT04205240|Daratumumab|daratumumab|mesh-list
84055887|NCT04205240|Tacrolimus|tacrolimus|mesh-list
84055888|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84055889|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
84055890|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055891|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208909|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84055892|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84055893|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
84055894|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055895|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055896|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84055897|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84055898|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055899|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84055900|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84055901|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
84055902|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84055903|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84055904|NCT01010750|Amphetamine|amphetamine|mesh-list
84055905|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84055906|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84055907|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055908|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
84055909|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
84055910|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84055911|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
84055912|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055913|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055914|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
84055915|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84055916|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84055917|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055918|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84055919|NCT01012622|Methylphenidate|methylphenidate|mesh-list
84055920|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84055921|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055922|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84055923|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84055924|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84055925|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055926|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
84055927|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84055928|NCT00722371|Metformin|metformin|mesh-list
84055929|NCT00722371|Pioglitazone|pioglitazone|mesh-list
84055930|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84055931|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84055932|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055933|NCT00722371|Incretins|incretins|mesh-ancestor
84055934|NCT00722371|Hormones|hormones|mesh-ancestor
84055935|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055936|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84055937|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
84055938|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055939|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055940|NCT02871986|Estrogens|estrogens|mesh-list
84055941|NCT02871986|Hormones|hormones|mesh-ancestor
83295866|NCT01383928|Lenalidomide|lenalidomide|mesh-list
84055942|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055943|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055944|NCT00722137|Prednisone|prednisone|mesh-list
84055945|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
84055946|NCT00722137|Rituximab|rituximab|mesh-list
84055947|NCT00722137|Doxorubicin|doxorubicin|mesh-list
84055948|NCT00722137|Vincristine|vincristine|mesh-list
84055949|NCT00722137|Bortezomib|bortezomib|mesh-list
84055950|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84055951|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
84055952|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055953|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84055954|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84055955|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
83209242|NCT02152384|Insulin|insulin|mesh-list
84055956|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055957|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84055958|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84055959|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84055960|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84055961|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84055962|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84055963|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055964|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84055965|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
84055966|NCT00722137|Hormones|hormones|mesh-ancestor
84055967|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055968|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83209293|NCT04787289|Bevacizumab|bevacizumab|mesh-list
84055969|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84055970|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
84055971|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
84055972|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
84055973|NCT04114396|Antibodies|antibodies|mesh-list
84055974|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
84055975|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055976|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
84055977|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
84055978|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
84055979|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84055980|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84055981|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84055982|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84055983|NCT00796666|Urological Agents|urological agents|mesh-ancestor
84055984|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84055985|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84055986|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84055987|NCT00799708|Estradiol|estradiol|mesh-list
84055988|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84055989|NCT00799708|Estrogens|estrogens|mesh-ancestor
84055990|NCT00799708|Hormones|hormones|mesh-ancestor
84055991|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84055992|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84055993|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84055994|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
84055995|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84055996|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84055997|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
84055998|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
84055999|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
84056000|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84056001|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84056002|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056003|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056004|NCT00796510|Urological Agents|urological agents|mesh-ancestor
84056005|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84056006|NCT04111432|Vaccines|vaccines|mesh-list
84056007|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
84056008|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056009|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
84056010|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056011|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84056012|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056013|NCT00588640|Methadone|methadone|mesh-list
84056014|NCT00588640|D-methadone|d-methadone|mesh-list
84056015|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84056016|NCT00588640|Narcotics|narcotics|mesh-ancestor
83209613|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
84056017|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056018|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056019|NCT00588640|Analgesics|analgesics|mesh-ancestor
84056020|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
84056021|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056022|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
84056023|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209684|NCT02172040|Analgesics|analgesics|mesh-ancestor
84056024|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84056025|NCT01016912|Ribavirin|ribavirin|mesh-list
84056026|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84056027|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
84056028|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056029|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
84056030|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056031|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
84056032|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84056033|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056034|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056035|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84056036|NCT02604940|Analgesics|analgesics|mesh-ancestor
84056037|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
84056038|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056039|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84056040|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84056041|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84056042|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
84056043|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056044|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056045|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
84056046|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
84056047|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056048|NCT00802672|Ciclopirox|ciclopirox|mesh-list
84056049|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
84056050|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056051|NCT04113772|Nitisinone|nitisinone|mesh-list
84056052|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056053|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056054|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
84056055|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
84056056|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056057|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84056058|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056059|NCT04115800|Sirolimus|sirolimus|mesh-list
84056060|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056061|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056062|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84056063|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056064|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
84056065|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84056066|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
84056067|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056068|NCT04115410|Cisplatin|cisplatin|mesh-list
84056069|NCT04115410|Carboplatin|carboplatin|mesh-list
83209964|NCT02141620|Cocaine|cocaine|mesh-list
84056070|NCT04115410|Gemcitabine|gemcitabine|mesh-list
84056071|NCT04115410|Docetaxel|docetaxel|mesh-list
84056072|NCT04115410|Pemetrexed|pemetrexed|mesh-list
84056073|NCT04115410|Vinorelbine|vinorelbine|mesh-list
84056074|NCT04115410|Gefitinib|gefitinib|mesh-list
84056075|NCT04115410|Mitomycins|mitomycins|mesh-list
84056076|NCT04115410|Mitomycin|mitomycin|mesh-list
84056077|NCT04115410|Osimertinib|osimertinib|mesh-list
84056078|NCT04115410|Afatinib|afatinib|mesh-list
84056079|NCT04115410|Vinblastine|vinblastine|mesh-list
84056080|NCT04115410|Crizotinib|crizotinib|mesh-list
84056081|NCT04115410|Ceritinib|ceritinib|mesh-list
84056082|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
84056083|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84056084|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84056085|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
84056086|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056087|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
84056088|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
84056089|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
84056090|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056091|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84056092|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84056093|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84056094|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84056095|NCT04115410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84056096|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83210223|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
84056097|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
84056098|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84056099|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056100|NCT02604784|Cisplatin|cisplatin|mesh-list
84056101|NCT02604784|Doxorubicin|doxorubicin|mesh-list
84056102|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84056103|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
84056104|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056105|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84056106|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84056107|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84056108|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056109|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056110|NCT04110808|Phentolamine|phentolamine|mesh-list
84056111|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
84056112|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
84056113|NCT04110808|Anesthetics|anesthetics|mesh-list
84056114|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056115|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056116|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
84056117|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84056118|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84056119|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
84056120|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210285|NCT05128773|Tamoxifen|tamoxifen|mesh-list
84056121|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056122|NCT00714259|Fludarabine|fludarabine|mesh-list
84056123|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056124|NCT00796120|Doxorubicin|doxorubicin|mesh-list
84056125|NCT00796120|Ifosfamide|ifosfamide|mesh-list
84056126|NCT00796120|Trabectedin|trabectedin|mesh-list
84056127|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84056128|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056129|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84056130|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84056131|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056132|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056133|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84056134|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
84056135|NCT00795886|Sirolimus|sirolimus|mesh-list
84056136|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056137|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056138|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84056139|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056140|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
83210407|NCT02583477|Paclitaxel|paclitaxel|mesh-list
84056141|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84056142|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
84056143|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056144|NCT04110418|Terlipressin|terlipressin|mesh-list
84056145|NCT04110418|Methylene Blue|methylene blue|mesh-list
84056146|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056147|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056148|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056149|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84056150|NCT04110028|Niacinamide|niacinamide|mesh-list
84056151|NCT04110028|Niacin|niacin|mesh-list
84056152|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
84056153|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
84056154|NCT04110028|Vitamins|vitamins|mesh-ancestor
84056155|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
84056156|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056157|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84056158|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
84056159|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056160|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84056161|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
84056162|NCT02589457|Tenofovir|tenofovir|mesh-list
84056163|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
84056164|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056165|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84056166|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84056167|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056168|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296096|NCT05792540|Fluoxetine|fluoxetine|mesh-list
84056169|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84056170|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84056171|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
84056172|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84056173|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056174|NCT05310643|Nivolumab|nivolumab|mesh-list
84056175|NCT05310643|Ipilimumab|ipilimumab|mesh-list
83210598|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
84056176|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84056177|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056178|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84056179|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056180|NCT05257213|Heparin|heparin|mesh-list
84056181|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
84056182|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84056183|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84056184|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056185|NCT00918853|Pancrelipase|pancrelipase|mesh-list
84056186|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84056187|NCT01016600|Lenalidomide|lenalidomide|mesh-list
84056188|NCT01016600|Azacitidine|azacitidine|mesh-list
84056189|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
84056190|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056191|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84056192|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84056193|NCT01016600|Growth Substances|growth substances|mesh-ancestor
84056194|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
84056195|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056196|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84056197|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
84056198|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056199|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056200|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
84056201|NCT05175235|Nivolumab|nivolumab|mesh-list
84056202|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84056203|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056204|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84056205|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056206|NCT04298684|Metformin|metformin|mesh-list
84056207|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84056208|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84056209|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056210|NCT04298684|Incretins|incretins|mesh-ancestor
84056211|NCT04298684|Hormones|hormones|mesh-ancestor
84056212|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056213|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84056214|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
84056215|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056216|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056217|NCT04298372|Lenalidomide|lenalidomide|mesh-list
84056218|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
83210780|NCT03192293|Metformin|metformin|mesh-list
84056219|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056220|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84056221|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84056222|NCT04298372|Growth Substances|growth substances|mesh-ancestor
84056223|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
84056224|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056225|NCT01010204|Varenicline|varenicline|mesh-list
84056226|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84056227|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84056228|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
84056229|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056230|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056231|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056232|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
84056233|NCT00718549|Rituximab|rituximab|mesh-list
84056234|NCT00718549|Cladribine|cladribine|mesh-list
84056235|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84056236|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
83296164|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296165|NCT05746208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296166|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296167|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296168|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296169|NCT05742958|Morphine|morphine|mesh-list
83296170|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83296171|NCT05742958|Narcotics|narcotics|mesh-ancestor
84056237|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056238|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056239|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84056240|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
84056241|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056242|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056243|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84056244|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84056245|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
84056246|NCT00793624|Olodaterol|olodaterol|mesh-list
84056247|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84056248|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
84056249|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056250|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056251|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84056252|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
84056253|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84056254|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84056255|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84056256|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
84056257|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210880|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
84056258|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056259|NCT00919243|Prednisone|prednisone|mesh-list
84056260|NCT00919243|Allopurinol|allopurinol|mesh-list
84056261|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84056262|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
84056263|NCT00919243|Hormones|hormones|mesh-ancestor
84056264|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056265|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211087|NCT02440841|Itraconazole|itraconazole|mesh-list
84056266|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84056267|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056268|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
84056269|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056270|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056271|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
84056272|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056273|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84056274|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
84056275|NCT00919243|Protective Agents|protective agents|mesh-ancestor
84056276|NCT00794950|Sunitinib|sunitinib|mesh-list
84056277|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056278|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84056279|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84056280|NCT00794950|Growth Substances|growth substances|mesh-ancestor
84056281|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056282|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
84056283|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84056284|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056285|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056286|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
84056287|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
84056288|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
84056289|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056290|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
84056291|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84056292|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84056293|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
84056294|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056295|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056296|NCT00793546|Exemestane|exemestane|mesh-list
84056297|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056298|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84056299|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84056300|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056301|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056302|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84056303|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
84056304|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056305|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056306|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84056307|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84056308|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84056309|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056310|NCT00798694|Travoprost|travoprost|mesh-list
84056311|NCT00798694|Latanoprost|latanoprost|mesh-list
84056312|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84056313|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84056314|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056315|NCT00718315|Erythromycin|erythromycin|mesh-list
84056316|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
83211405|NCT02433587|Analgesics|analgesics|mesh-ancestor
84056317|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84056318|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
84056319|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
84056320|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84056321|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056322|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84056323|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056324|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056325|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056326|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056327|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84056328|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84056329|NCT00798304|Vaccines|vaccines|mesh-list
83211484|NCT02429921|Selenium|selenium|mesh-list
84056330|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
84056331|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056332|NCT04109872|Lenalidomide|lenalidomide|mesh-list
84056333|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
84056334|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056335|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84056336|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84056337|NCT04109872|Growth Substances|growth substances|mesh-ancestor
84056338|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
84056339|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056340|NCT00793780|Naltrexone|naltrexone|mesh-list
84056341|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84056342|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84056343|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056344|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
84056345|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056346|NCT04107220|Valsartan|valsartan|mesh-list
84056347|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83211604|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056348|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056349|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84056350|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84056351|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056352|NCT02591017|Ketamine|ketamine|mesh-list
84056353|NCT02591017|Morphine|morphine|mesh-list
84056354|NCT02591017|Chitosan|chitosan|mesh-list
84056355|NCT02591017|Analgesics|analgesics|mesh-ancestor
84056356|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
84056357|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211813|NCT02431013|Cilostazol|cilostazol|mesh-list
84056358|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056359|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84056360|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84056361|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
84056362|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
84056363|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056364|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84056365|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84056366|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211882|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
84056367|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056368|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84056369|NCT02591017|Narcotics|narcotics|mesh-ancestor
84056370|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84056371|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84056372|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
84056373|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84056374|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
84056375|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
84056376|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
84056377|NCT02591017|Coagulants|coagulants|mesh-ancestor
84056378|NCT02591095|Navitoclax|navitoclax|mesh-list
84056379|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056380|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
84056381|NCT02588755|Tegafur|tegafur|mesh-list
84056382|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84056383|NCT02588755|Estrogens|estrogens|mesh-ancestor
84056384|NCT02588755|Hormones|hormones|mesh-ancestor
84056385|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056386|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211951|NCT02426177|Labetalol|labetalol|mesh-list
84056387|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84056389|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84056390|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
84056391|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056392|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84056393|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
84056394|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056395|NCT02643303|Durvalumab|durvalumab|mesh-list
84056396|NCT02643303|Tremelimumab|tremelimumab|mesh-list
84056397|NCT02643303|Poly ICLC|poly iclc|mesh-list
84056398|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84056399|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056400|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
83212001|NCT02073682|Tinzaparin|tinzaparin|mesh-list
84056401|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
83212139|NCT01598506|Analgesics|analgesics|mesh-ancestor
84056402|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056403|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
84056404|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84056405|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84056406|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056407|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
84056408|NCT00615147|Coagulants|coagulants|mesh-ancestor
84056409|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84056410|NCT01029717|Minocycline|minocycline|mesh-list
84056411|NCT01029717|Rifampin|rifampin|mesh-list
84056412|NCT01029717|Heparin|heparin|mesh-list
84056413|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056414|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84056415|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
84056416|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
84056417|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84056418|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84056419|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056420|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
84056421|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84056422|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056423|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84056424|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84056425|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84056426|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84056427|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84056428|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84056429|NCT00790036|Everolimus|everolimus|mesh-list
84056430|NCT00790036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84056431|NCT00790036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84056432|NCT00790036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056433|NCT00790036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056434|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84056435|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
83212341|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84056436|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056437|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056438|NCT05563168|Diltiazem|diltiazem|mesh-list
84056439|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056440|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84056441|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84056442|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056443|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84056444|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056445|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
84056446|NCT00789958|Gemcitabine|gemcitabine|mesh-list
84056447|NCT00789958|Capecitabine|capecitabine|mesh-list
83212404|NCT02099110|Glimepiride|glimepiride|mesh-list
84056448|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84056449|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
84056450|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056451|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056452|NCT00789880|Vitamin D|vitamin d|mesh-list
84056453|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
84056454|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
84056455|NCT00789880|Vitamins|vitamins|mesh-list
84056456|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
84056457|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056458|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84056459|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84056460|NCT00915616|Melatonin|melatonin|mesh-list
84056461|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
84056462|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056463|NCT00915616|Protective Agents|protective agents|mesh-ancestor
84056464|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056465|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056466|NCT00914836|Betamethasone|betamethasone|mesh-list
84056467|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
84056468|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84056469|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
84056470|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
84056471|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84056472|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84056473|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
84056474|NCT00914836|Hormones|hormones|mesh-ancestor
84056475|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056476|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056477|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84056478|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
84056479|NCT04106752|Caffeine|caffeine|mesh-list
84056480|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83212520|NCT01623310|Xhance|xhance|mesh-list
84056481|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056482|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84056483|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056484|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056485|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84056486|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84056487|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
84056488|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056489|NCT00792298|Suvorexant|suvorexant|mesh-list
83212598|NCT02419859|Insulin|insulin|mesh-list
84056490|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84056491|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84056492|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056493|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056494|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84056495|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056496|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056497|NCT04108468|Golimumab|golimumab|mesh-list
84056498|NCT04108468|Methotrexate|methotrexate|mesh-list
84056499|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83212652|NCT02422199|Capecitabine|capecitabine|mesh-list
84056500|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
84056501|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84056502|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056503|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84056504|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
84056505|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056506|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056507|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
84056508|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056509|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84056510|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212715|NCT02415803|Clopidogrel|clopidogrel|mesh-list
84056511|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
84056512|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056513|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84056514|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84056515|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84056516|NCT02603068|Treprostinil|treprostinil|mesh-list
84056517|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056518|NCT00718081|Sufentanil|sufentanil|mesh-list
84056519|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84056520|NCT00718081|Narcotics|narcotics|mesh-ancestor
84056521|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056522|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056523|NCT00718081|Analgesics|analgesics|mesh-ancestor
84056524|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
83212778|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83212847|NCT02414399|Azithromycin|azithromycin|mesh-list
84056525|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056526|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84056527|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84056528|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
84056529|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
84056530|NCT00788710|Etoricoxib|etoricoxib|mesh-list
84056531|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84056532|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84056533|NCT00788710|Analgesics|analgesics|mesh-ancestor
84056534|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
84056535|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056536|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056537|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212918|NCT02414009|Leucovorin|leucovorin|mesh-list
84056538|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056539|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84056540|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84056541|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056542|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056543|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
84056544|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
84056545|NCT04083625|Carbetocin|carbetocin|mesh-list
84056546|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
84056547|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84056548|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056549|NCT00787930|Valproic Acid|valproic acid|mesh-list
84056550|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
84056551|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056552|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056553|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
84056554|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056555|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056556|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
84056557|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84056558|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056559|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84056560|NCT04106050|Lidocaine|lidocaine|mesh-list
84056561|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
84056562|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
84056563|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056564|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056565|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
83213044|NCT02412449|Glycine|glycine|mesh-list
84056566|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056567|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84056568|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84056569|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84056570|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84056571|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056572|NCT00588094|Rituximab|rituximab|mesh-list
84056573|NCT00588094|Carboplatin|carboplatin|mesh-list
84056574|NCT00588094|Etoposide|etoposide|mesh-list
84056575|NCT00588094|Ifosfamide|ifosfamide|mesh-list
83213176|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
84056576|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84056577|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056578|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
84056579|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056580|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056581|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84056582|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84056583|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84056584|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056585|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056586|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84056587|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
84056588|NCT05194735|Aldesleukin|aldesleukin|mesh-list
84056589|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056590|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84056591|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84056592|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
84056593|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056594|NCT03373383|Padsevonil|padsevonil|mesh-list
84056595|NCT03373383|Anticonvulsants|anticonvulsants|mesh-ancestor
84056596|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84056597|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
84056598|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056599|NCT00482157|Vitamin D|vitamin d|mesh-list
84056600|NCT00482157|Calcitriol|calcitriol|mesh-list
84056601|NCT00482157|Vitamins|vitamins|mesh-ancestor
84056602|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
84056603|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056604|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84056605|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84056606|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84056607|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84056608|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056609|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84056611|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
84056612|NCT02706015|Caffeine|caffeine|mesh-list
83213379|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
84056613|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84056614|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056615|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84056616|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056617|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056618|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84056619|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84056620|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
84056621|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056622|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84056623|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84056624|NCT02706015|Analgesics|analgesics|mesh-ancestor
84056625|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
84056626|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056627|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84056628|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056629|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
84056630|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84056631|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
84056632|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
84056633|NCT02707575|Ranibizumab|ranibizumab|mesh-list
84056634|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84056635|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84056636|NCT02707575|Growth Substances|growth substances|mesh-ancestor
84056637|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056638|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
84056639|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056640|NCT00919399|Tamoxifen|tamoxifen|mesh-list
84056641|NCT00919399|Exemestane|exemestane|mesh-list
84056642|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84056643|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
84056644|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056645|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056646|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84056647|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056648|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84056649|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84056650|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84056651|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84056652|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84056653|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056654|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056655|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84056656|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84056657|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056658|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84056659|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84056660|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84056661|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056662|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
84056663|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056664|NCT02588287|Tenofovir|tenofovir|mesh-list
84056665|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
84056666|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056667|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84056668|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84056669|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056670|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056671|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84056672|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84056673|NCT02707107|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
84056674|NCT02707107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056675|NCT02707107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056676|NCT02707263|Heparin|heparin|mesh-list
84056677|NCT02707263|Calcium heparin|calcium heparin|mesh-list
84056678|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
84056679|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84056680|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84056681|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056682|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84056683|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84056684|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84056685|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
84056686|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056687|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84056688|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84056689|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056690|NCT00615303|Simethicone|simethicone|mesh-list
84056691|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
84056692|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056693|NCT00615303|Emollients|emollients|mesh-ancestor
84056694|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
84056695|NCT00787150|Warfarin|warfarin|mesh-list
84056696|NCT00787150|Apixaban|apixaban|mesh-list
84056697|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
84056698|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84056699|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
84056700|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84056701|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
84056702|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056703|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056704|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84056705|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84056706|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056707|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
84056708|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84056709|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056710|NCT00786838|Trabectedin|trabectedin|mesh-list
84056711|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84056712|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
83213648|NCT05366283|Sargramostim|sargramostim|mesh-list
84056713|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056714|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056715|NCT02604004|Lamivudine|lamivudine|mesh-list
84056716|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84056717|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84056718|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056719|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213734|NCT02061280|Xhance|xhance|mesh-list
83213772|NCT04698850|Ranibizumab|ranibizumab|mesh-list
84056720|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
84056721|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056722|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84056723|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84056724|NCT05095207|Bicalutamide|bicalutamide|mesh-list
84056725|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
84056726|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
84056727|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056728|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056729|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056730|NCT03354039|Tamoxifen|tamoxifen|mesh-list
84056731|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84056732|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
84056733|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84056734|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056735|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84056736|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056737|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84056738|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84056739|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84056740|NCT04105426|Antioxidants|antioxidants|mesh-list
84056741|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056742|NCT04105426|Protective Agents|protective agents|mesh-ancestor
84056743|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056744|NCT02704923|Atropine|atropine|mesh-list
84056745|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84056746|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84056747|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84056748|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84056749|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84056750|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
84056751|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056752|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056753|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84056754|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
83296687|NCT05072093|Cabotegravir|cabotegravir|mesh-list
84056755|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
84056756|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
84056757|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84056758|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84056759|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
84056760|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056761|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213899|NCT02093026|Folic Acid|folic acid|mesh-list
84056762|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
84056763|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
84056764|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84056765|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84056766|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84056767|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84056768|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056769|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
84056770|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056771|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056772|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84056773|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056774|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84056775|NCT02704767|Apatinib|apatinib|mesh-list
84056776|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84056777|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056778|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84056779|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056780|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056781|NCT02587273|Fentanyl|fentanyl|mesh-list
84056782|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84056783|NCT02587273|Narcotics|narcotics|mesh-ancestor
84056784|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056785|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056786|NCT02587273|Analgesics|analgesics|mesh-ancestor
84056787|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
83214016|NCT02058628|Clindamycin|clindamycin|mesh-list
84056788|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056789|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84056790|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84056791|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
84056792|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
84056793|NCT02704299|Immunomodulating Agents|immunomodulating agents|mesh-list
84056794|NCT02704299|Immunologic Factors|immunologic factors|mesh-ancestor
84056795|NCT02704299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056796|NCT02587741|Metformin|metformin|mesh-list
84056797|NCT02587741|Acarbose|acarbose|mesh-list
84056798|NCT02587741|Gliclazide|gliclazide|mesh-list
84056799|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84056800|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84056801|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056802|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84056803|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056804|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056805|NCT02703363|Minocycline|minocycline|mesh-list
84056806|NCT02703363|Celecoxib|celecoxib|mesh-list
84056807|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84056808|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84056809|NCT02703363|Analgesics|analgesics|mesh-ancestor
84056810|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
84056811|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056812|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056813|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84056814|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056815|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84056816|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84056817|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056818|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056819|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056820|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056821|NCT05018221|Vitamins|vitamins|mesh-list
84056822|NCT05018221|Vitamin K|vitamin k|mesh-list
84056823|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
84056824|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
84056825|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
84056826|NCT05018221|Citric Acid|citric acid|mesh-list
84056827|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
84056828|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
84056829|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056830|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
83214281|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
84056831|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84056832|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
84056833|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
84056834|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056835|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84056836|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84056837|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
84056838|NCT05018221|Coagulants|coagulants|mesh-ancestor
84056839|NCT05018221|Antidotes|antidotes|mesh-ancestor
84056840|NCT05018221|Protective Agents|protective agents|mesh-ancestor
84056841|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
84056842|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
84056843|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056844|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056845|NCT05018221|Cathartics|cathartics|mesh-ancestor
84056846|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84056847|NCT00615381|Insulin|insulin|mesh-list
84056848|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84056849|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84056850|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056851|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
84056852|NCT00785980|Quinine|quinine|mesh-list
84056853|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056854|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056855|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84056856|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84056857|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056858|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056859|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056860|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84056861|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84056862|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
84056863|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84056864|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84056865|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84056866|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056867|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84056868|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056869|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84056870|NCT00785980|Analgesics|analgesics|mesh-ancestor
84056871|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
84056872|NCT04805073|Promethazine|promethazine|mesh-list
84056873|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
84056874|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
84056875|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
84056876|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84056877|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
84056878|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
84056879|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056880|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056881|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056882|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84056883|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84056884|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84056885|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056886|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
84056887|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
84056888|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
84056889|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056890|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
84056891|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
84056892|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84056893|NCT00915694|Nelfinavir|nelfinavir|mesh-list
84056894|NCT00915694|Temozolomide|temozolomide|mesh-list
84056895|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84056896|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
84056897|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056898|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056899|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84056900|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84056901|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
84056902|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056903|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84056904|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84056905|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
84056906|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296903|NCT04784715|Taxane|taxane|mesh-list
84056907|NCT02703051|Lenograstim|lenograstim|mesh-list
83214589|NCT03629925|Carboplatin|carboplatin|mesh-list
84056908|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84056909|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
84056910|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056911|NCT00785512|Nebivolol|nebivolol|mesh-list
84056912|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84056913|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
84056914|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84056915|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84056916|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84056917|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
84056918|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056919|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056920|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056921|NCT02702817|Naproxen|naproxen|mesh-list
84056922|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84056923|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84056924|NCT02702817|Analgesics|analgesics|mesh-ancestor
84056925|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
84056926|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056927|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056928|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84056929|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84056930|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
84056931|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84056932|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056933|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056934|NCT02702739|Ribavirin|ribavirin|mesh-list
84056935|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
84056936|NCT02702739|Simeprevir|simeprevir|mesh-list
84056937|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
84056938|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056939|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
84056940|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056941|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
84056942|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056943|NCT02602444|Ticagrelor|ticagrelor|mesh-list
83215061|NCT02697773|Tanezumab|tanezumab|mesh-list
84056944|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84056945|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84056946|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84056947|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84056948|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
84056949|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84056950|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056951|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056952|NCT02702661|Anesthetics|anesthetics|mesh-list
84056953|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
84056954|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
84056955|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056956|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056957|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
84056958|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056959|NCT05065021|Paclitaxel|paclitaxel|mesh-list
84056960|NCT05065021|Bevacizumab|bevacizumab|mesh-list
84056961|NCT05065021|Niraparib|niraparib|mesh-list
84056962|NCT05065021|Dostarlimab|dostarlimab|mesh-list
84056963|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84056964|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84056965|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
84056966|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
84056967|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83215193|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215262|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84056968|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84056969|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84056970|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84056971|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84056972|NCT05065021|Growth Substances|growth substances|mesh-ancestor
84056973|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056974|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
84056975|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84056976|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84056977|NCT02702349|Penicillins|penicillins|mesh-list
84056978|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84056979|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84056980|NCT04104334|Remifentanil|remifentanil|mesh-list
84056981|NCT04104334|Desflurane|desflurane|mesh-list
83296916|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
84056982|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
84056983|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84056984|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056985|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84056986|NCT04104334|Narcotics|narcotics|mesh-ancestor
84056987|NCT04104334|Analgesics|analgesics|mesh-ancestor
84056988|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
84056989|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84056990|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84056991|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
84056992|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84056993|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84056994|NCT02602600|Liraglutide|liraglutide|mesh-list
84056995|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84056996|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84056997|NCT02602600|Incretins|incretins|mesh-ancestor
84056998|NCT02602600|Hormones|hormones|mesh-ancestor
84056999|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84057000|NCT00615615|Levetiracetam|levetiracetam|mesh-list
84057001|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
84057002|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
84057003|NCT00784810|Acetaminophen|acetaminophen|mesh-list
84057004|NCT00784810|Oxycodone|oxycodone|mesh-list
84057005|NCT00784810|Codeine|codeine|mesh-list
84057006|NCT00784810|Naloxone|naloxone|mesh-list
84057007|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057008|NCT00784810|Analgesics|analgesics|mesh-ancestor
84057009|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
83215535|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
84057010|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057011|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057012|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
84057013|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84057014|NCT00784810|Narcotics|narcotics|mesh-ancestor
84057015|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057016|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84057017|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
84057018|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
84057019|NCT02603770|Lovastatin|lovastatin|mesh-list
84057020|NCT02603770|L 647318|l 647318|mesh-list
84057021|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
84057022|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84057023|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84057024|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
84057025|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057026|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84057027|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84057028|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057029|NCT04081909|Fentanyl|fentanyl|mesh-list
84057030|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
84057031|NCT04081909|Ketamine|ketamine|mesh-list
84057032|NCT04081909|Remifentanil|remifentanil|mesh-list
84057033|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84057034|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057035|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057036|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057037|NCT04081909|Analgesics|analgesics|mesh-ancestor
84057038|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
84057039|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057040|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84057041|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84057042|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84057043|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057044|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057045|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057046|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84057047|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84057048|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
84057049|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
84057050|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84057051|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83215781|NCT05127395|Acyclovir|acyclovir|mesh-list
84057052|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84057053|NCT04081909|Narcotics|narcotics|mesh-ancestor
84057054|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84057055|NCT03272217|Bevacizumab|bevacizumab|mesh-list
84057056|NCT03272217|Atezolizumab|atezolizumab|mesh-list
84057057|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84057058|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057059|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84057060|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84057061|NCT03272217|Growth Substances|growth substances|mesh-ancestor
84057062|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057063|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
84057064|NCT03272217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84057065|NCT03272217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057066|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84057067|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84057068|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057069|NCT00915382|Cisplatin|cisplatin|mesh-list
84057070|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057071|NCT05344443|Lemborexant|lemborexant|mesh-list
84057072|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84057073|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057074|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057075|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84057076|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84057077|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057078|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057079|NCT00919555|Pioglitazone|pioglitazone|mesh-list
84057080|NCT00919555|Tretinoin|tretinoin|mesh-list
84057081|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84057082|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057083|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057084|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
84057085|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
84057086|NCT02979093|Oxytocin|oxytocin|mesh-list
84057087|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
84057088|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84057089|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057090|NCT02588131|Durvalumab|durvalumab|mesh-list
84057091|NCT02588131|Tremelimumab|tremelimumab|mesh-list
84057092|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84057093|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057094|NCT04766983|Dimercaprol|dimercaprol|mesh-list
84057095|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
84057096|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
84057097|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057098|NCT04766437|Ticagrelor|ticagrelor|mesh-list
84057099|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84057100|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84057101|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84057102|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84057103|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84057104|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
84057105|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057106|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057107|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057108|NCT00776230|Vaccines|vaccines|mesh-list
84057109|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
84057110|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057111|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
84057112|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
84057113|NCT02586259|Budesonide|budesonide|mesh-list
84057114|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84057115|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84057116|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
84057117|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057118|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057119|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84057120|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
84057121|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
84057122|NCT02586259|Hormones|hormones|mesh-ancestor
84057123|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84057124|NCT00775606|Ritonavir|ritonavir|mesh-list
84057125|NCT00775606|Lopinavir|lopinavir|mesh-list
84057126|NCT00775606|Efavirenz|efavirenz|mesh-list
84057127|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84057128|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84057129|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
84057130|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057131|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057132|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84057133|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84057134|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
84057135|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057136|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84057137|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84057138|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84057139|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84057140|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84057141|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84057142|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84057143|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84057144|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84057145|NCT04761601|Paclitaxel|paclitaxel|mesh-list
84057146|NCT04761601|Gemcitabine|gemcitabine|mesh-list
84057147|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84057148|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057149|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
84057150|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
84057151|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
84057152|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057153|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84057154|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
84057155|NCT02960763|Aripiprazole|aripiprazole|mesh-list
84057156|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
84057157|NCT02960763|Bupropion|bupropion|mesh-list
84057158|NCT02960763|Nortriptyline|nortriptyline|mesh-list
84057159|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84057160|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
84057161|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84057162|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84057163|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84057164|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057165|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057166|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
84057167|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057168|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057169|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84057170|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84057171|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057172|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84057173|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84057174|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057175|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
84057176|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84057177|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84057178|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
84057179|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84057180|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84057181|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84057182|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84057183|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
84057184|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84057185|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84057186|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057187|NCT00775528|Pancrelipase|pancrelipase|mesh-list
84057188|NCT00775528|Pancreatin|pancreatin|mesh-list
84057189|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84057190|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84057191|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84057192|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84057193|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057194|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057195|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057196|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057197|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84057198|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
84057199|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84057200|NCT02701179|Lidocaine|lidocaine|mesh-list
84057201|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84057202|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
84057203|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
84057204|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057205|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057206|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
83297146|NCT04284787|Venetoclax|venetoclax|mesh-list
84057207|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057208|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84057209|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84057210|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84057211|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057212|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057213|NCT02586961|Betamethasone|betamethasone|mesh-list
84057214|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
84057215|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84057216|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
84057217|NCT02586961|Epinephrine|epinephrine|mesh-list
84057218|NCT02586961|Racepinephrine|racepinephrine|mesh-list
84057219|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84057220|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
84057221|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84057222|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
84057223|NCT02586961|Hormones|hormones|mesh-ancestor
84057224|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84057225|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057226|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84057227|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
84057228|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84057229|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84057230|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057231|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057232|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057233|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84057234|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84057235|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
84057236|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057237|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
84057238|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
84057239|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84057240|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84057241|NCT02700711|Methylphenidate|methylphenidate|mesh-list
84057242|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84057243|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057244|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84057245|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84057246|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057247|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057248|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
84057249|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216954|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
84057250|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84057251|NCT02700711|Analgesics|analgesics|mesh-ancestor
84057252|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
84057253|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057254|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
84057255|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84057256|NCT04215159|Gemcitabine|gemcitabine|mesh-list
83217017|NCT02372903|Hormones|hormones|mesh-ancestor
84057257|NCT04215159|Trastuzumab|trastuzumab|mesh-list
84057258|NCT04215159|Irinotecan|irinotecan|mesh-list
84057259|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84057260|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
84057261|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057262|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057263|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84057264|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84057265|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84057266|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057267|NCT00775450|Vaccines|vaccines|mesh-list
84057268|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
84057269|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057270|NCT02700477|Fenugreek seed meal|fenugreek seed meal|mesh-list
84057271|NCT02700477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84057272|NCT02700477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057273|NCT02699385|Domperidone|domperidone|mesh-list
84057274|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
84057275|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
84057276|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057277|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217375|NCT02769689|Prednisolone|prednisolone|mesh-list
84057278|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84057279|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83297216|NCT03980561|Varenicline|varenicline|mesh-list
84057280|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
84057281|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057282|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057283|NCT02700087|Famotidine|famotidine|mesh-list
84057284|NCT02700087|Ranitidine|ranitidine|mesh-list
84057285|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84057286|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84057287|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84057288|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84057289|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
84057290|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
84057291|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057292|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057293|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057294|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
84057295|NCT02586181|Vitamin D|vitamin d|mesh-list
84057296|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
84057297|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
84057298|NCT02586181|Vitamins|vitamins|mesh-list
84057299|NCT02586181|Folic Acid|folic acid|mesh-list
84057300|NCT02586181|Calcium|calcium|mesh-list
84057301|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
84057302|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057303|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84057304|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84057305|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
84057306|NCT02586181|Hematinics|hematinics|mesh-ancestor
84057307|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
84057308|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84057309|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057310|NCT00775138|Amikacin|amikacin|mesh-list
84057311|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84057312|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057313|NCT03236805|Ketamine|ketamine|mesh-list
84057314|NCT03236805|Morphine|morphine|mesh-list
84057315|NCT03236805|Analgesics|analgesics|mesh-ancestor
83217716|NCT02356445|Infliximab|infliximab|mesh-list
84057316|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
84057317|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057318|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057319|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84057320|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84057321|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
84057322|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
84057323|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057324|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84057325|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84057326|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057327|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057328|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84057329|NCT03236805|Narcotics|narcotics|mesh-ancestor
84057330|NCT02698995|Acetaminophen|acetaminophen|mesh-list
84057331|NCT02698995|Dexamethasone|dexamethasone|mesh-list
84057332|NCT02698995|Lidocaine|lidocaine|mesh-list
84057333|NCT02698995|Morphine|morphine|mesh-list
84057334|NCT02698995|Ropivacaine|ropivacaine|mesh-list
84057335|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84057336|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
84057337|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
84057338|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217916|NCT02350361|Endostatins|endostatins|mesh-list
84057339|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057340|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84057341|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
84057342|NCT02698995|Hormones|hormones|mesh-ancestor
84057343|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84057344|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84057345|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057346|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
84057347|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
84057348|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057349|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
84057350|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84057351|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84057352|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84057353|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83217973|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
84057354|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297303|NCT03914625|Hormones|hormones|mesh-ancestor
84057355|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84057357|NCT02698995|Analgesics|analgesics|mesh-ancestor
84057358|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057359|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
84057360|NCT00920101|Atorvastatin|atorvastatin|mesh-list
84057361|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84057362|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84057363|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
84057364|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057365|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84057366|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84057367|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057368|NCT00616785|Irinotecan|irinotecan|mesh-list
84057369|NCT00616785|Etoposide|etoposide|mesh-list
84057370|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057371|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84057372|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84057373|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057374|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057375|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84057376|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84057377|NCT00616005|Irinotecan|irinotecan|mesh-list
84057378|NCT00616005|Temozolomide|temozolomide|mesh-list
84057379|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84057380|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84057381|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057382|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057383|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057384|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84057385|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
84057386|NCT02698527|Lidocaine|lidocaine|mesh-list
84057387|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
84057388|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
84057389|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057390|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057391|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
84057392|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057393|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84057394|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84057395|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84057396|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057397|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057398|NCT04215237|Atorvastatin|atorvastatin|mesh-list
84057399|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84057400|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84057401|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
84057402|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057403|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84057404|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84057405|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218291|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
84057406|NCT02586649|Bromides|bromides|mesh-list
84057407|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
84057408|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
84057409|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84057410|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
84057411|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057412|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057413|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84057414|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
84057415|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
84057416|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
84057417|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057418|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057419|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
84057420|NCT04213833|Lidocaine|lidocaine|mesh-list
84057421|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
84057422|NCT04213833|Propofol|propofol|mesh-list
84057423|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
84057424|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
84057425|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057426|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057427|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
83218419|NCT02642315|Gabapentin|gabapentin|mesh-list
84057428|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057429|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84057430|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84057431|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84057432|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057433|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057434|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84057435|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057436|NCT04213833|Analgesics|analgesics|mesh-ancestor
84057437|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84057438|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84057439|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84057440|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057441|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057442|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84057443|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
84057444|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
84057445|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84057446|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057447|NCT00783796|Everolimus|everolimus|mesh-list
84057448|NCT00783796|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84057449|NCT00783796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057450|NCT00783796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057451|NCT00783796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057452|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84057453|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
84057454|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057455|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057456|NCT00637065|Bosentan|bosentan|mesh-list
84057457|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84057458|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84057459|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057460|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
84057461|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
84057462|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84057463|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84057464|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057465|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057466|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84057467|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84057468|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
84057469|NCT04947553|Bupropion|bupropion|mesh-list
84057470|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84057471|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
84057472|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84057473|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84057474|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84057475|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057476|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057477|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
84057478|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057479|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057480|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84057481|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84057482|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057483|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
84057484|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
84057485|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84057486|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84057487|NCT04079647|Immunomodulating Agents|immunomodulating agents|mesh-list
84057488|NCT04079647|Immunologic Factors|immunologic factors|mesh-ancestor
84057489|NCT04079647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057490|NCT00617253|Sunitinib|sunitinib|mesh-list
84057491|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218803|NCT02039999|Citric Acid|citric acid|mesh-list
84057492|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84057493|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84057494|NCT00617253|Growth Substances|growth substances|mesh-ancestor
84057495|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057496|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
84057497|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057498|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057499|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057500|NCT02585947|Tenofovir|tenofovir|mesh-list
84057501|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
84057502|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057503|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84057504|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84057505|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057506|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057508|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84057509|NCT02607891|Cannabidiol|cannabidiol|mesh-list
84057510|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
84057511|NCT02607813|Spartalizumab|spartalizumab|mesh-list
84057512|NCT02607813|Naporafenib|naporafenib|mesh-list
84057513|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84057514|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057515|NCT02607813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84057516|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057517|NCT02607813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057518|NCT02607813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057519|NCT04079725|Mitomycins|mitomycins|mesh-list
84057520|NCT04079725|Mitomycin|mitomycin|mesh-list
84057521|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84057522|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057523|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
84057524|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057525|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84057526|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057527|NCT00783718|Vedolizumab|vedolizumab|mesh-list
84057528|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84057529|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84057530|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057531|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84057532|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057533|NCT04213287|Analgesics|analgesics|mesh-ancestor
84057534|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
84057535|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057536|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84057537|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84057538|NCT02585791|Glycerol|glycerol|mesh-list
84057539|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84057540|NCT02585791|Protective Agents|protective agents|mesh-ancestor
84057541|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057542|NCT04913389|Acetazolamide|acetazolamide|mesh-list
84057543|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
84057544|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84057545|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057546|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057547|NCT04913389|Diuretics|diuretics|mesh-ancestor
84057548|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
84057549|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057550|NCT04904965|Propofol|propofol|mesh-list
84057551|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84057552|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219103|NCT02326727|Ropivacaine|ropivacaine|mesh-list
84057553|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057554|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84057555|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
84057556|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
84057557|NCT00617565|Insulin|insulin|mesh-list
84057558|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84057559|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
84057560|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
84057561|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84057562|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057563|NCT04079413|Insulin|insulin|mesh-list
84057564|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83219261|NCT04984733|Nivolumab|nivolumab|mesh-list
84057565|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
84057566|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
84057567|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84057568|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84057569|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057570|NCT00915460|Interferons|interferons|mesh-list
84057571|NCT00915460|Interferon-beta|interferon-beta|mesh-list
84057572|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
84057573|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057574|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
84057575|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057576|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
84057577|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057578|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84057579|NCT00617643|Nevirapine|nevirapine|mesh-list
84057580|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84057581|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84057582|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057583|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057584|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
84057585|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057586|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84057587|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84057588|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84057589|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84057590|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
84057591|NCT04566133|Trametinib|trametinib|mesh-list
84057592|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
84057593|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84057594|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84057595|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057596|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219372|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
84057597|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057598|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84057599|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057600|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057601|NCT02584075|Metformin|metformin|mesh-list
84057602|NCT02584075|Exenatide|exenatide|mesh-list
84057603|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84057604|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057605|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84057606|NCT02584075|Incretins|incretins|mesh-ancestor
84057607|NCT02584075|Hormones|hormones|mesh-ancestor
84057608|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84057609|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
84057610|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
84057611|NCT02585479|Pirarubicin|pirarubicin|mesh-list
84057612|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
84057613|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057614|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
84057615|NCT02585479|Coagulants|coagulants|mesh-ancestor
84057616|NCT00583453|Celecoxib|celecoxib|mesh-list
84057617|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84057618|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057619|NCT00583453|Analgesics|analgesics|mesh-ancestor
84057620|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
84057621|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057622|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057623|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84057624|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84057625|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84057626|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84057627|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057628|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057629|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
84057630|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
84057631|NCT02584231|Coagulants|coagulants|mesh-ancestor
84057632|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84057633|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
84057634|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057635|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
84057636|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84057637|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219557|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
84057638|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057639|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
84057640|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057641|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057642|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84057643|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
84057644|NCT02584153|Coagulants|coagulants|mesh-ancestor
84057645|NCT02585401|Aflibercept|aflibercept|mesh-list
84057646|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84057647|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84057648|NCT02585401|Growth Substances|growth substances|mesh-ancestor
84057649|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057650|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
84057651|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057652|NCT04874311|Doxorubicin|doxorubicin|mesh-list
84057653|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84057654|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057655|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84057656|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84057657|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057658|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057659|NCT04873453|Cannabidiol|cannabidiol|mesh-list
84057660|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
84057661|NCT04080349|Misoprostol|misoprostol|mesh-list
84057662|NCT04080349|Dinoprostone|dinoprostone|mesh-list
84057663|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84057664|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
83219671|NCT02421289|Efavirenz|efavirenz|mesh-list
84057665|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84057666|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057667|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84057668|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84057669|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
84057670|NCT02585011|Epinephrine|epinephrine|mesh-list
84057671|NCT02585011|Ropivacaine|ropivacaine|mesh-list
84057672|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
84057673|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
84057674|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057675|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057676|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
84057677|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057678|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84057679|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84057680|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057681|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057682|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057683|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84057684|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84057685|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
84057686|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84057687|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
84057688|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
84057689|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
84057690|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84057692|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84057693|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
84057694|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84057695|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057696|NCT02583451|Lemborexant|lemborexant|mesh-list
84057697|NCT02583451|Zopiclone|zopiclone|mesh-list
84057698|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84057699|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057700|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057701|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84057702|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84057703|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057704|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057705|NCT05435911|Propofol|propofol|mesh-list
84057706|NCT05435911|Flumazenil|flumazenil|mesh-list
84057707|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84057708|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057709|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057710|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84057711|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
84057712|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
84057713|NCT05435911|Antidotes|antidotes|mesh-ancestor
84057714|NCT05435911|Protective Agents|protective agents|mesh-ancestor
84057715|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
84057716|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
84057717|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057718|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057719|NCT04472299|Ropivacaine|ropivacaine|mesh-list
84057720|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
84057721|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
84057722|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057723|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057724|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
84057725|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057726|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84057727|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
84057728|NCT02583685|Ribavirin|ribavirin|mesh-list
84057729|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
84057730|NCT02583685|Simeprevir|simeprevir|mesh-list
84057731|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
84057732|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057733|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
84057734|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057736|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057737|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
84057738|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057739|NCT04606771|Osimertinib|osimertinib|mesh-list
84057740|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057741|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057742|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057743|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057744|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84057745|NCT04504123|Doxycycline|doxycycline|mesh-list
84057746|NCT04504123|Tetracycline|tetracycline|mesh-list
84057747|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057748|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
84057749|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84057750|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84057751|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84057752|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057753|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057754|NCT02584543|Vaccines|vaccines|mesh-list
84057755|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
84057756|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220038|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84057757|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
84057758|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
84057759|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84057760|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
84057761|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84057762|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057763|NCT04077853|Progestins|progestins|mesh-ancestor
84057764|NCT04077853|Hormones|hormones|mesh-ancestor
84057765|NCT04502407|Cisplatin|cisplatin|mesh-list
84057766|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057767|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84057768|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84057769|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
84057770|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84057771|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84057772|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057773|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
84057774|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057775|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057776|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84057777|NCT00583219|Protective Agents|protective agents|mesh-ancestor
84057778|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84057779|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
84057780|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84057781|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057782|NCT04501939|Venetoclax|venetoclax|mesh-list
84057783|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057784|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
84057785|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
84057786|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057787|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84057788|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84057789|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
84057790|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057791|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057792|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84057793|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
84057794|NCT04332211|Ephedrine|ephedrine|mesh-list
84057795|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84057796|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
83220210|NCT02415985|Lopinavir|lopinavir|mesh-list
84057797|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057798|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057799|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84057800|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
84057801|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
84057802|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84057803|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84057804|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
84057805|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057806|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220289|NCT03178123|Interferons|interferons|mesh-list
84057807|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057809|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
84057810|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057811|NCT02581501|Gemcitabine|gemcitabine|mesh-list
84057812|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84057813|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84057814|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
84057815|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057816|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057817|NCT01072175|Trametinib|trametinib|mesh-list
84057818|NCT01072175|Dabrafenib|dabrafenib|mesh-list
84057819|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057820|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057821|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057822|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057823|NCT04078711|Losartan|losartan|mesh-list
84057824|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84057825|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84057826|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84057827|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84057828|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057829|NCT05290129|Oxytocin|oxytocin|mesh-list
84057830|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
84057831|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84057832|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057833|NCT04304573|Calcium|calcium|mesh-list
84057834|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84057835|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057836|NCT04667117|Ofatumumab|ofatumumab|mesh-list
84057837|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057838|NCT04426669|Aldesleukin|aldesleukin|mesh-list
84057839|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
84057840|NCT04426669|Fludarabine|fludarabine|mesh-list
84057841|NCT04426669|Interleukin-2|interleukin-2|mesh-list
84057842|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84057843|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
84057844|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057845|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84057846|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84057847|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
84057848|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057849|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057850|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84057851|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83220537|NCT02419105|Vitamin D|vitamin d|mesh-list
84057852|NCT04426669|Analgesics|analgesics|mesh-ancestor
84057853|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
84057854|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057855|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84057856|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84057857|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
84057858|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057859|NCT02874989|Dasatinib|dasatinib|mesh-list
84057860|NCT02874989|Quercetin|quercetin|mesh-list
84057861|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057862|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057863|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057864|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057865|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
84057866|NCT02874989|Protective Agents|protective agents|mesh-ancestor
84057867|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057868|NCT01071317|Naproxen|naproxen|mesh-list
84057869|NCT01071317|Sumatriptan|sumatriptan|mesh-list
84057870|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84057871|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057872|NCT01071317|Analgesics|analgesics|mesh-ancestor
84057873|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
84057874|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057875|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057876|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84057877|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84057878|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
84057879|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84057880|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057881|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057882|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84057883|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84057884|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84057885|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
84057886|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057887|NCT00783094|Tadalafil|tadalafil|mesh-list
84057888|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
84057889|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84057890|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84057891|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057892|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057893|NCT00783094|Urological Agents|urological agents|mesh-ancestor
84057894|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
84057895|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
84057896|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84057897|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057898|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057899|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
84057900|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84057901|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057902|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057903|NCT02583217|Ketamine|ketamine|mesh-list
84057904|NCT02583217|Remifentanil|remifentanil|mesh-list
84057905|NCT02583217|Propofol|propofol|mesh-list
84057906|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84057907|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84057908|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057909|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84057910|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
84057911|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
84057912|NCT02583217|Analgesics|analgesics|mesh-ancestor
84057913|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
84057914|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057915|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84057916|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84057917|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84057918|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057919|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057920|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84057921|NCT02583217|Narcotics|narcotics|mesh-ancestor
84057922|NCT00774046|Cytarabine|cytarabine|mesh-list
84057923|NCT00774046|Etoposide|etoposide|mesh-list
84057924|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
84057925|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84057926|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057927|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84057928|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84057929|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057930|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057931|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84057932|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
84057933|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
84057934|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84057935|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84057936|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
84057937|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057938|NCT00774046|Analgesics|analgesics|mesh-ancestor
84057939|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
84057940|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057941|NCT01046903|Dalteparin|dalteparin|mesh-list
84057942|NCT01046903|Tinzaparin|tinzaparin|mesh-list
84057943|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84057944|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
84057945|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84057946|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84057947|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057948|NCT02581423|Capecitabine|capecitabine|mesh-list
84057949|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84057950|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
84057951|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057952|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057953|NCT04102072|Dobutamine|dobutamine|mesh-list
84057954|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84057955|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
83297887|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
84057956|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
84057957|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057958|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057959|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84057960|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84057961|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84057962|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057963|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057964|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057965|NCT04102072|Protective Agents|protective agents|mesh-ancestor
84057966|NCT02875457|Cisplatin|cisplatin|mesh-list
84057967|NCT02875457|Etoposide|etoposide|mesh-list
84057968|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
84057969|NCT02875457|Apatinib|apatinib|mesh-list
84057970|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84057971|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84057972|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84057973|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84057974|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057975|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057976|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84057977|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
84057978|NCT00773968|Hematinics|hematinics|mesh-ancestor
84057979|NCT04060381|Ibuprofen|ibuprofen|mesh-list
84057980|NCT04060381|Dopamine|dopamine|mesh-list
84057981|NCT04060381|Epinephrine|epinephrine|mesh-list
84057982|NCT04060381|Norepinephrine|norepinephrine|mesh-list
84057983|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84057984|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84057985|NCT04060381|Analgesics|analgesics|mesh-ancestor
84057986|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
84057987|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84057988|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84057989|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84057990|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84057991|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84057992|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84057993|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84057994|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84057995|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84057996|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
84057997|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84057998|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84057999|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84058000|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
84058001|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84058002|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
84058003|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
84058004|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
84058005|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84058006|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84058007|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
84058008|NCT04060381|Protective Agents|protective agents|mesh-ancestor
84058009|NCT00782626|Everolimus|everolimus|mesh-list
84058010|NCT00782626|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84058011|NCT00782626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058012|NCT00782626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221230|NCT01989208|Cathartics|cathartics|mesh-ancestor
84058013|NCT00782626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058014|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058015|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
84058016|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058017|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058018|NCT04076371|Olanzapine|olanzapine|mesh-list
84058019|NCT04076371|Risperidone|risperidone|mesh-list
84058020|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84058021|NCT04076371|Ziprasidone|ziprasidone|mesh-list
84058022|NCT04076371|Sertraline|sertraline|mesh-list
84058023|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84058024|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
84058025|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058026|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058027|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058028|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84058029|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84058030|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058031|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058032|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84058033|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
84058034|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
84058035|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
84058036|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058037|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058038|NCT04076371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84058039|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84058040|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84058041|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
84058042|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84058043|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84058044|NCT03977467|Atezolizumab|atezolizumab|mesh-list
84058045|NCT03977467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84058046|NCT03977467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058047|NCT03977467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058048|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058049|NCT01071083|Interferons|interferons|mesh-list
84058050|NCT01071083|Interferon-beta|interferon-beta|mesh-list
84058051|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
84058052|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
84058053|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
84058054|NCT01071083|Natalizumab|natalizumab|mesh-list
84058056|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058057|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
84058058|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058059|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058060|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
84058061|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
84058062|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058063|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058064|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058065|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
84058066|NCT01071083|Hormones|hormones|mesh-ancestor
84058067|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058068|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84058069|NCT01071083|Protective Agents|protective agents|mesh-ancestor
84058070|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
84058071|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84058072|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058073|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058074|NCT03973333|Atezolizumab|atezolizumab|mesh-list
84058075|NCT03973333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84058076|NCT03973333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058077|NCT03973333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058078|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058079|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84058080|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058081|NCT04078399|Interferons|interferons|mesh-list
84058082|NCT04078399|Azacitidine|azacitidine|mesh-list
84058083|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058084|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
84058085|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058086|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058087|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
84058088|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058089|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058090|NCT05189509|Plasminogen|plasminogen|mesh-list
84058091|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84058092|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84058093|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84058094|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058095|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84058096|NCT01010126|Sirolimus|sirolimus|mesh-list
84058097|NCT01010126|Bevacizumab|bevacizumab|mesh-list
84058098|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84058099|NCT01010126|Temsirolimus|temsirolimus|mesh-list
84058100|NCT01010126|MTOR Inhibitors|mtor inhibitors|mesh-list
84058101|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
84058102|NCT01010126|Antibodies|antibodies|mesh-list
84058103|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
84058104|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84058105|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
84058106|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058107|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84058108|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84058109|NCT01010126|Growth Substances|growth substances|mesh-ancestor
84058110|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058111|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
84058112|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
84058113|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84058114|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058115|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83221717|NCT05097365|Hematinics|hematinics|mesh-ancestor
83221794|NCT05102045|Memantine|memantine|mesh-list
84058116|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
84058117|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058118|NCT01010126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058119|NCT01010126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058120|NCT01010126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058121|NCT04076137|Decitabine|decitabine|mesh-list
84058122|NCT04076137|Antibodies|antibodies|mesh-list
84058123|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
84058124|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
84058125|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058126|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058127|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
84058128|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058129|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058130|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058131|NCT03879577|Tamoxifen|tamoxifen|mesh-list
84058132|NCT03879577|Docetaxel|docetaxel|mesh-list
84058133|NCT03879577|Trastuzumab|trastuzumab|mesh-list
84058134|NCT03879577|Letrozole|letrozole|mesh-list
84058135|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058136|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
84058137|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
84058138|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
84058139|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058140|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058141|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84058142|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84058143|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058144|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84058145|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
84058146|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058147|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058148|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84058149|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83222064|NCT02400385|Growth Substances|growth substances|mesh-ancestor
84058150|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84058151|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84058152|NCT03141177|Nivolumab|nivolumab|mesh-list
84058153|NCT03141177|Ipilimumab|ipilimumab|mesh-list
84058154|NCT03141177|Sunitinib|sunitinib|mesh-list
84058155|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058156|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058157|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83222130|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
84058158|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058159|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84058160|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84058161|NCT03141177|Growth Substances|growth substances|mesh-ancestor
84058162|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058163|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
84058164|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058165|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058166|NCT03862495|Azithromycin|azithromycin|mesh-list
84058167|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84058168|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058169|NCT00617799|Aldesleukin|aldesleukin|mesh-list
84058170|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058171|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83222262|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84058172|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84058173|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
84058174|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058175|NCT00617877|Losartan|losartan|mesh-list
84058176|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84058177|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84058178|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84058179|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84058180|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84058181|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058182|NCT00617877|Diuretics|diuretics|mesh-ancestor
84058183|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
84058184|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058185|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84058186|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84058187|NCT00617955|Aprotinin|aprotinin|mesh-list
84058188|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058189|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
84058190|NCT00617955|Coagulants|coagulants|mesh-ancestor
84058191|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84058192|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84058193|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
84058194|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058195|NCT03834883|Ibutilide|ibutilide|mesh-list
84058196|NCT03834883|Progesterone|progesterone|mesh-list
84058197|NCT03834883|Progestins|progestins|mesh-ancestor
84058198|NCT03834883|Hormones|hormones|mesh-ancestor
84058199|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058200|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058201|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84058202|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
84058203|NCT02582437|Narcotics|narcotics|mesh-ancestor
83222399|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058204|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058205|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058206|NCT02582437|Analgesics|analgesics|mesh-ancestor
84058207|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
84058208|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058209|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
84058210|NCT05674201|Remifentanil|remifentanil|mesh-list
84058211|NCT05674201|Propofol|propofol|mesh-list
84058212|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84058213|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058214|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058215|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84058216|NCT05674201|Analgesics|analgesics|mesh-ancestor
84058217|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
84058218|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058219|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84058220|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84058221|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84058222|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
84058223|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058224|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058225|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84058226|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
84058227|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
84058228|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84058229|NCT05674201|Narcotics|narcotics|mesh-ancestor
84058230|NCT01070303|Adalimumab|adalimumab|mesh-list
84058231|NCT01070303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84058232|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058233|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058234|NCT00618111|Granisetron|granisetron|mesh-list
84058235|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
84058236|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
84058237|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058238|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058239|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058240|NCT00618111|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84058241|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84058242|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
84058243|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058244|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058245|NCT01009814|Ritonavir|ritonavir|mesh-list
84058246|NCT01009814|Fostemsavir|fostemsavir|mesh-list
84058247|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84058248|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84058249|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
84058250|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058251|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058252|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84058253|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84058254|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
84058255|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058256|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84058257|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84058258|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83298194|NCT04565301|Dexamethasone|dexamethasone|mesh-list
84058259|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84058260|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
84058261|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
84058262|NCT03824587|Calcium|calcium|mesh-list
84058263|NCT03824587|Sevelamer|sevelamer|mesh-list
84058264|NCT03824587|Calcium acetate|calcium acetate|mesh-list
84058265|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84058266|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058267|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84058268|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
84058269|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
83222689|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84058270|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058271|NCT03824587|Antacids|antacids|mesh-ancestor
84058272|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058273|NCT00773734|Thalidomide|thalidomide|mesh-list
84058274|NCT00773734|Apremilast|apremilast|mesh-list
84058275|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84058276|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84058277|NCT00773734|Analgesics|analgesics|mesh-ancestor
84058278|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
83222766|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
84058279|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058280|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058281|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058282|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058283|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84058284|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84058285|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058286|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058287|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058288|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
84058289|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
84058290|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84058291|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058292|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83222831|NCT03169985|Ezetimibe|ezetimibe|mesh-list
84058293|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84058294|NCT00773734|Growth Substances|growth substances|mesh-ancestor
84058295|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
84058296|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058297|NCT04297202|Apatinib|apatinib|mesh-list
84058298|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058299|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058300|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058301|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058302|NCT02691897|Melatonin|melatonin|mesh-list
84058303|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
84058304|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058305|NCT02691897|Protective Agents|protective agents|mesh-ancestor
84058306|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058307|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058308|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
84058309|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058310|NCT01009580|Insulin|insulin|mesh-list
84058311|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84058312|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
84058313|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
84058314|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84058315|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
84058316|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83223127|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
84058317|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84058318|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058319|NCT01009346|Cisplatin|cisplatin|mesh-list
84058320|NCT01009346|Carboplatin|carboplatin|mesh-list
84058321|NCT01009346|Cetuximab|cetuximab|mesh-list
84058322|NCT01009346|Everolimus|everolimus|mesh-list
84058323|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058324|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058325|NCT01009346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84058326|NCT01009346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058327|NCT01009346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058328|NCT01009346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058329|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058330|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
84058331|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058332|NCT04101682|Bupivacaine|bupivacaine|mesh-list
83298262|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
84058333|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
84058334|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
84058335|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058336|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058337|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
84058338|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058339|NCT01001702|Aripiprazole|aripiprazole|mesh-list
84058340|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
84058341|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058342|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84058343|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84058344|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058345|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058346|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
84058347|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
84058348|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058349|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058350|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83223451|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
84058351|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84058352|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
84058353|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84058354|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84058355|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84058356|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84058357|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
84058358|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84058359|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058360|NCT00618345|Everolimus|everolimus|mesh-list
84058361|NCT00618345|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84058362|NCT00618345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058363|NCT00618345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058364|NCT00618345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058365|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058366|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
84058367|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058368|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058369|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
84058370|NCT02601898|Progesterone|progesterone|mesh-list
83223517|NCT02003638|Niacin|niacin|mesh-list
84058371|NCT02601898|Progestins|progestins|mesh-ancestor
84058372|NCT02601898|Hormones|hormones|mesh-ancestor
84058373|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058374|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058375|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
84058376|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058377|NCT02601898|Protective Agents|protective agents|mesh-ancestor
84058378|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
84058379|NCT02601898|Vitamins|vitamins|mesh-ancestor
84058380|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
84058381|NCT00618423|Ketamine|ketamine|mesh-list
84058382|NCT00618423|Analgesics|analgesics|mesh-ancestor
84058383|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
84058384|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058385|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058386|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84058387|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84058388|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
84058389|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
84058390|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058391|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84058392|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84058393|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058394|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058395|NCT04101760|Lenograstim|lenograstim|mesh-list
84058396|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84058397|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
84058398|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058399|NCT00616551|Octreotide|octreotide|mesh-list
84058400|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058401|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84058402|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058403|NCT04478942|Misoprostol|misoprostol|mesh-list
84058404|NCT04478942|Oxytocin|oxytocin|mesh-list
84058405|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
84058406|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84058407|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058408|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84058409|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
84058410|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84058411|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058412|NCT04214145|Phenylephrine|phenylephrine|mesh-list
84058413|NCT04214145|Vasopressins|vasopressins|mesh-list
84058414|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
84058415|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
84058416|NCT04214145|Norepinephrine|norepinephrine|mesh-list
84058417|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84058418|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
84058419|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
84058420|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058421|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058422|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
84058423|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84058424|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
84058425|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
84058426|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84058427|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84058428|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84058429|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
84058430|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058431|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058432|NCT04214145|Protective Agents|protective agents|mesh-ancestor
84058433|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
84058434|NCT04214145|Coagulants|coagulants|mesh-ancestor
84058435|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84058436|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
84058437|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
84058438|NCT04212429|Levofloxacin|levofloxacin|mesh-list
84058439|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84058440|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84058441|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84058442|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058443|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84058444|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84058445|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058446|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058447|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058448|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84058449|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84058450|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84058451|NCT01068665|Insulin|insulin|mesh-list
84058452|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84058453|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
84058454|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84058455|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058456|NCT00618501|Leucovorin|leucovorin|mesh-list
84058457|NCT00618501|Cytarabine|cytarabine|mesh-list
84058458|NCT00618501|Prednisolone|prednisolone|mesh-list
84058459|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
84058460|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84058461|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84058462|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84058463|NCT00618501|Methotrexate|methotrexate|mesh-list
84058464|NCT00618501|Etoposide|etoposide|mesh-list
84058465|NCT00618501|Vincristine|vincristine|mesh-list
84058466|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
84058467|NCT00618501|Daunorubicin|daunorubicin|mesh-list
84058468|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
84058469|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058470|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84058471|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
84058472|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84058473|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058474|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
84058475|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223860|NCT03115099|Hormones|hormones|mesh-ancestor
84058476|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058477|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
84058478|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058479|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84058480|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058481|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
84058482|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058483|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84058484|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84058485|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84058486|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84058487|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
84058488|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058489|NCT00618501|Antidotes|antidotes|mesh-ancestor
84058490|NCT00618501|Protective Agents|protective agents|mesh-ancestor
84058491|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
84058492|NCT00618501|Vitamins|vitamins|mesh-ancestor
84058493|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
84058494|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
84058495|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
84058496|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
84058497|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058498|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
84058499|NCT00618501|Hormones|hormones|mesh-ancestor
84058500|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058501|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84058502|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224062|NCT02506517|Afatinib|afatinib|mesh-list
84058503|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84058504|NCT00772954|Vaccines|vaccines|mesh-list
84058505|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
84058506|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058507|NCT05322681|Pregabalin|pregabalin|mesh-list
84058508|NCT05322681|Analgesics|analgesics|mesh-ancestor
84058509|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
84058510|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058511|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058512|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
84058513|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84058514|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84058515|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058516|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84058517|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84058518|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84058519|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058520|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058521|NCT05322603|Diclofenac|diclofenac|mesh-list
84058522|NCT05322603|Morphine|morphine|mesh-list
84058523|NCT05322603|Analgesics|analgesics|mesh-list
84058524|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
84058525|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84058526|NCT05322603|Narcotics|narcotics|mesh-ancestor
84058527|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058528|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058529|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
84058530|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058531|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84058532|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058533|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058534|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84058535|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058536|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058537|NCT00618579|Warfarin|warfarin|mesh-list
84058538|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
84058539|NCT00781768|Ondansetron|ondansetron|mesh-list
84058540|NCT00781768|Aprepitant|aprepitant|mesh-list
84058541|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
84058542|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
84058543|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058544|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224393|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
84058545|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058546|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
84058547|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
84058548|NCT00781768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84058549|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84058550|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
84058551|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058552|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058553|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84058554|NCT01005680|Gemcitabine|gemcitabine|mesh-list
84058555|NCT01005680|Pemetrexed|pemetrexed|mesh-list
84058556|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058557|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058558|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
84058559|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058560|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058561|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84058562|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84058563|NCT04101370|Bosentan|bosentan|mesh-list
84058564|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84058565|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84058566|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058567|NCT00618657|Paclitaxel|paclitaxel|mesh-list
84058568|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84058569|NCT00618657|Bevacizumab|bevacizumab|mesh-list
84058570|NCT00618657|Carboplatin|carboplatin|mesh-list
84058571|NCT00618657|Trastuzumab|trastuzumab|mesh-list
84058572|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84058573|NCT00618657|Antibodies|antibodies|mesh-list
84058574|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
84058575|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84058576|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84058577|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058578|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
84058579|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
84058580|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
84058581|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058582|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224895|NCT05900531|Incretins|incretins|mesh-ancestor
84058583|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84058584|NCT00618657|Growth Substances|growth substances|mesh-ancestor
84058585|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058586|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
84058587|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
84058588|NCT04188249|Golimumab|golimumab|mesh-list
84058589|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84058590|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058591|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058592|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
84058593|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058594|NCT01005602|Digoxin|digoxin|mesh-list
84058595|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84058596|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84058597|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058598|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058599|NCT01005602|Protective Agents|protective agents|mesh-ancestor
84058600|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058601|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84058602|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
84058603|NCT05490940|Coagulants|coagulants|mesh-ancestor
84058604|NCT04304261|Metformin|metformin|mesh-list
84058605|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
84058606|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84058607|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058608|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84058609|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058610|NCT04103398|Sorafenib|sorafenib|mesh-list
84058611|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
84058612|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058613|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058614|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058615|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058616|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84058617|NCT04103398|Estrogens|estrogens|mesh-ancestor
84058618|NCT04103398|Hormones|hormones|mesh-ancestor
84058619|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058620|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058621|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84058622|NCT00768430|Midazolam|midazolam|mesh-list
84058623|NCT00768430|Ketamine|ketamine|mesh-list
84058624|NCT00768430|Analgesics|analgesics|mesh-ancestor
84058625|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
84058626|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058627|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058628|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84058629|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84058630|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
84058631|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
84058632|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058633|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84058634|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84058635|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058636|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058637|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84058638|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84058639|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84058640|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84058641|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058642|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
84058643|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
84058644|NCT04101136|Atorvastatin|atorvastatin|mesh-list
84058645|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84058646|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84058647|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
84058648|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058649|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84058650|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84058651|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058652|NCT00618969|Busulfan|busulfan|mesh-list
84058653|NCT00618969|Melphalan|melphalan|mesh-list
84058654|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
84058655|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058656|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058657|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
84058658|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058659|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84058660|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058661|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84058662|NCT01064297|Lamotrigine|lamotrigine|mesh-list
84058663|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
84058664|NCT01064297|Valproic Acid|valproic acid|mesh-list
84058665|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84058666|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84058667|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058668|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84058669|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058670|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84058671|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84058672|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058673|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058674|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84058675|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058676|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
84058677|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058678|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
84058679|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
84058680|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
84058681|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
84058682|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84058683|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058684|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84058685|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84058686|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84058687|NCT00582907|Rilonacept|rilonacept|mesh-list
84058688|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058689|NCT01062113|Celecoxib|celecoxib|mesh-list
84058690|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84058691|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84058692|NCT01062113|Analgesics|analgesics|mesh-ancestor
84058693|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
84058694|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058695|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058696|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058697|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058698|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84058699|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84058700|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058701|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058702|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84058703|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83225312|NCT05886036|Deoxyglucose|deoxyglucose|mesh-list
84058704|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
84058705|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058706|NCT04075201|Vaccines|vaccines|mesh-list
84058707|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
84058708|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058709|NCT01038869|Azelaic acid|azelaic acid|mesh-list
84058710|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058711|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
84058712|NCT02580331|Metformin|metformin|mesh-list
84058713|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84058714|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058715|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84058716|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84058717|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84058718|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84058719|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058720|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058721|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058722|NCT00767806|Analgesics|analgesics|mesh-ancestor
84058723|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
84058724|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058725|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
84058726|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058727|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
84058729|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83225375|NCT05818618|Clobetasol|clobetasol|mesh-list
84058730|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
84058731|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058732|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
84058733|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058734|NCT02582203|Vancomycin|vancomycin|mesh-list
84058735|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
84058736|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84058737|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058738|NCT05035927|Psilocybin|psilocybin|mesh-list
84058739|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
84058740|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058741|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058742|NCT00771472|Vorinostat|vorinostat|mesh-list
84058743|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058744|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84058745|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058746|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058747|NCT00771316|Meropenem|meropenem|mesh-list
84058748|NCT00771316|Ertapenem|ertapenem|mesh-list
84058749|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84058750|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058751|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
84058752|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058753|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
84058754|NCT00770770|Hormones|hormones|mesh-ancestor
83225488|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
84058755|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058756|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058757|NCT00766636|Gemcitabine|gemcitabine|mesh-list
84058758|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84058759|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058760|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
84058761|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058762|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058763|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84058764|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058765|NCT04348045|Durvalumab|durvalumab|mesh-list
84058766|NCT04348045|Olaparib|olaparib|mesh-list
84058767|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058768|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058769|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84058770|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058771|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058772|NCT03337009|Naloxone|naloxone|mesh-list
84058773|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84058774|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058775|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
84058776|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058777|NCT02581969|Factor VIII|factor viii|mesh-list
84058778|NCT02581969|Coagulants|coagulants|mesh-ancestor
84058779|NCT00770692|Eszopiclone|eszopiclone|mesh-list
84058780|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84058781|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058782|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058783|NCT02816203|Hemostatics|hemostatics|mesh-list
84058784|NCT02816203|Coagulants|coagulants|mesh-ancestor
84058785|NCT04099732|Dabigatran|dabigatran|mesh-list
84058786|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84058787|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83298715|NCT01853072|Analgesics|analgesics|mesh-ancestor
84058788|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84058789|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
84058790|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058791|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84058792|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84058793|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058794|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
84058795|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84058796|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
84058797|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
84058798|NCT03183115|Lugol's solution|lugol's solution|mesh-list
84058799|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
84058800|NCT03183115|Coagulants|coagulants|mesh-ancestor
84058801|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
84058802|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
84058803|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058804|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
84058805|NCT02743819|Ipilimumab|ipilimumab|mesh-list
84058806|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058807|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058808|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84058809|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058810|NCT04074421|Rifaximin|rifaximin|mesh-list
84058811|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84058812|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058813|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058814|NCT02579707|Ivosidenib|ivosidenib|mesh-list
84058815|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058816|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058817|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058818|NCT02713009|Vitamin D|vitamin d|mesh-list
84058819|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
84058820|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
84058821|NCT02713009|Vitamins|vitamins|mesh-list
84058822|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
84058823|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058824|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84058825|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84058826|NCT03085225|Durvalumab|durvalumab|mesh-list
84058827|NCT03085225|Trabectedin|trabectedin|mesh-list
84058828|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058829|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058830|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84058831|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
84058832|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058833|NCT02705287|Vitamin D|vitamin d|mesh-list
84058834|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
84058835|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
84058836|NCT02705287|Vitamins|vitamins|mesh-list
84058837|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
84058838|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058839|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84058840|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84058841|NCT04295408|Ropivacaine|ropivacaine|mesh-list
84058842|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
84058843|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
84058844|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84058845|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058846|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
84058847|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058848|NCT02578537|Clopidogrel|clopidogrel|mesh-list
84058849|NCT02578537|Ticagrelor|ticagrelor|mesh-list
84058850|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84058851|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84058852|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84058853|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84058854|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
84058855|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058856|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058857|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058858|NCT03011671|Temozolomide|temozolomide|mesh-list
84058859|NCT03011671|Acetazolamide|acetazolamide|mesh-list
84058860|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84058861|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
83226261|NCT04088188|Cisplatin|cisplatin|mesh-list
84058862|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058863|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298782|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
84058864|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
84058865|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84058866|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058867|NCT03011671|Diuretics|diuretics|mesh-ancestor
84058868|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
84058869|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058870|NCT00628706|Dronabinol|dronabinol|mesh-list
84058871|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
84058872|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058873|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84058874|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84058875|NCT00628706|Analgesics|analgesics|mesh-ancestor
84058876|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
84058877|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058878|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84058879|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84058880|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058881|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058882|NCT00628706|Hormones|hormones|mesh-ancestor
84058883|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058884|NCT01001234|Rizatriptan|rizatriptan|mesh-list
84058885|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84058886|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
84058887|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84058888|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058889|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058890|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
84058891|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84058892|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058893|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
84058894|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058895|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058896|NCT02609503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84058897|NCT02609503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058898|NCT04073953|Primaquine|primaquine|mesh-list
84058899|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
84058900|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84058901|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84058902|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84058903|NCT02589691|Rocuronium|rocuronium|mesh-list
84058904|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84058905|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84058906|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83226449|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84058907|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058908|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058909|NCT01004432|Golimumab|golimumab|mesh-list
84058910|NCT01004432|Methotrexate|methotrexate|mesh-list
84058911|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84058912|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84058913|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
84058914|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84058915|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058916|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058917|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
84058918|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058919|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058920|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
84058921|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058922|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84058923|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058924|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
84058925|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058926|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84058927|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84058928|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058929|NCT02539537|Leucovorin|leucovorin|mesh-list
84058930|NCT02539537|Folic Acid|folic acid|mesh-list
84058931|NCT02539537|Gemcitabine|gemcitabine|mesh-list
84058932|NCT02539537|Fluorouracil|fluorouracil|mesh-list
84058933|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
84058934|NCT02539537|Irinotecan|irinotecan|mesh-list
84058935|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
84058936|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058937|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
84058938|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058939|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058940|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84058941|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84058942|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058943|NCT02539537|Antidotes|antidotes|mesh-ancestor
84058944|NCT02539537|Protective Agents|protective agents|mesh-ancestor
84058945|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058946|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
84058947|NCT02539537|Vitamins|vitamins|mesh-ancestor
84058948|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
84058949|NCT02539537|Hematinics|hematinics|mesh-ancestor
84058950|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84058951|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
84058952|NCT02576275|Rituximab|rituximab|mesh-list
84058953|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84058954|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058955|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058956|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
84058957|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058958|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058959|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84058960|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
84058961|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058962|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
84058963|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84058964|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84058965|NCT01000610|Prednisolone|prednisolone|mesh-list
84058966|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
84058967|NCT01000610|Rituximab|rituximab|mesh-list
84058968|NCT01000610|Methotrexate|methotrexate|mesh-list
84058969|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84058970|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
84058971|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84058972|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84058973|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
84058974|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84058975|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84058976|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84058977|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
84058978|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84058979|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84058980|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
84058981|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84058982|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
84058983|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84058984|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84058985|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226964|NCT01228331|Hormones|hormones|mesh-ancestor
84058986|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84058987|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84058988|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
84058989|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
84058990|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84058991|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84058992|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
84058993|NCT01000610|Hormones|hormones|mesh-ancestor
84058994|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84058995|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83227047|NCT03938831|Fentanyl|fentanyl|mesh-list
84058996|NCT01000610|Protective Agents|protective agents|mesh-ancestor
84058997|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84058998|NCT02523469|Nivolumab|nivolumab|mesh-list
84058999|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059000|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059001|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84059002|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059003|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
84059004|NCT00586924|Immunotoxins|immunotoxins|mesh-ancestor
84059005|NCT00586924|Immunoconjugates|immunoconjugates|mesh-ancestor
84059006|NCT00586924|Immunologic Factors|immunologic factors|mesh-ancestor
84059007|NCT00586924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059008|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059009|NCT04211961|Scopolamine|scopolamine|mesh-list
84059010|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84059011|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84059012|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
84059013|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
84059014|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059015|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059016|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059017|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
84059018|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84059019|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
83227286|NCT02642159|Niacin|niacin|mesh-list
83227306|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
84059020|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059021|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059022|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84059023|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
84059024|NCT01000376|Ketoconazole|ketoconazole|mesh-list
84059025|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
84059026|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059027|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84059028|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83227409|NCT03412591|Suvorexant|suvorexant|mesh-list
84059029|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059030|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059031|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84059032|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
84059033|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059034|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059035|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84059036|NCT01038635|Lenalidomide|lenalidomide|mesh-list
84059037|NCT01038635|Azacitidine|azacitidine|mesh-list
84059038|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
84059039|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059040|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84059041|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84059042|NCT01038635|Growth Substances|growth substances|mesh-ancestor
84059043|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
84059044|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059045|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84059046|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
84059047|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059048|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059049|NCT00619203|Acetaminophen|acetaminophen|mesh-list
84059050|NCT00619203|Glycerol|glycerol|mesh-list
84059051|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84059052|NCT00619203|Analgesics|analgesics|mesh-ancestor
84059053|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
84059054|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059055|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059056|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
84059057|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84059058|NCT00619203|Protective Agents|protective agents|mesh-ancestor
84059059|NCT04072471|Lesinurad|lesinurad|mesh-list
84059060|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
84059061|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059062|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
84059063|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84059064|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84059065|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059066|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84059067|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84059068|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84059069|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059070|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
84059071|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059072|NCT01812603|Nabiximols|nabiximols|mesh-list
84059073|NCT01812603|Analgesics|analgesics|mesh-ancestor
84059074|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
84059075|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059076|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059077|NCT04211805|Tenofovir|tenofovir|mesh-list
84059078|NCT04211805|Vaccines|vaccines|mesh-list
84059079|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
84059080|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059081|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
84059082|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059083|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84059084|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84059085|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059086|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059087|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84059088|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84059089|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
84059090|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
84059091|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84059092|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84059093|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059094|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227863|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059095|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059096|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059097|NCT00580801|Interferons|interferons|mesh-list
84059098|NCT00580801|Ribavirin|ribavirin|mesh-list
84059099|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
84059100|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
84059101|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84059102|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059103|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
84059104|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059105|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
84059106|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059107|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
84059108|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059109|NCT00619671|Rituximab|rituximab|mesh-list
84059110|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059111|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059112|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
84059113|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059114|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059115|NCT00628550|Vasopressins|vasopressins|mesh-list
84059116|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
84059117|NCT00628550|Epinephrine|epinephrine|mesh-list
84059118|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84059119|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84059120|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
84059121|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059122|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059123|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059124|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84059125|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84059126|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
84059127|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059128|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84059129|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
84059130|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
84059131|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
84059132|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84059133|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
84059134|NCT00628550|Coagulants|coagulants|mesh-ancestor
84059135|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84059136|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
84059137|NCT01059539|Cariprazine|cariprazine|mesh-list
84059138|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84059139|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84059140|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059141|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059142|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84059143|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
84059144|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84059145|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
84059146|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059147|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059148|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84059149|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
84059150|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
84059151|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84059152|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
84059153|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059154|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059155|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
84059156|NCT02576119|BMS-955176|bms-955176|mesh-list
84059157|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84059158|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059159|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84059160|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84059161|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059162|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059163|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059164|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83299083|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059165|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84059166|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
84059168|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059169|NCT04304144|Dexamethasone|dexamethasone|mesh-list
84059170|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
84059171|NCT04304144|Bortezomib|bortezomib|mesh-list
84059172|NCT04304144|Daratumumab|daratumumab|mesh-list
84059173|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059174|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
84059175|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059176|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059177|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84059178|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
84059179|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059180|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059181|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84059182|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059183|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
84059184|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
84059185|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059186|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059187|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
84059188|NCT04304144|Hormones|hormones|mesh-ancestor
84059189|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059190|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84059191|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
84059192|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84059193|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84059194|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
83228225|NCT05035277|Aspirin|aspirin|mesh-list
83228255|NCT02368561|Hylan|hylan|mesh-list
84059195|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059196|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84059197|NCT00770224|Prednisone|prednisone|mesh-list
84059198|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
84059199|NCT00770224|Rituximab|rituximab|mesh-list
84059200|NCT00770224|Doxorubicin|doxorubicin|mesh-list
84059201|NCT00770224|Vincristine|vincristine|mesh-list
84059202|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
84059203|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059204|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
84059205|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059206|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059207|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84059208|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
84059209|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059210|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059211|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84059212|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059213|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83228446|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228512|NCT02373943|Carotenoids|carotenoids|mesh-list
84059214|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84059215|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84059216|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059217|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059218|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
84059219|NCT00770224|Hormones|hormones|mesh-ancestor
84059220|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059221|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84059222|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84059223|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
84059224|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
84059225|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
84059226|NCT04594811|Nivolumab|nivolumab|mesh-list
84059227|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059228|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059229|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84059230|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059231|NCT02399215|Nintedanib|nintedanib|mesh-list
84059232|NCT02399215|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
84059233|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059234|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84059235|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059236|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059237|NCT02389465|Celecoxib|celecoxib|mesh-list
84059238|NCT02389465|Dexetimide|dexetimide|mesh-list
84059239|NCT02389465|Citalopram|citalopram|mesh-list
84059240|NCT02389465|Escitalopram|escitalopram|mesh-list
84059241|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84059242|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84059243|NCT02389465|Analgesics|analgesics|mesh-ancestor
84059244|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
84059245|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059246|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059247|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059248|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059249|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84059250|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83228943|NCT04499131|Progesterone|progesterone|mesh-list
84059251|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059252|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059253|NCT02389465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84059254|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84059255|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84059256|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059257|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
84059258|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84059259|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84059260|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
84059261|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
84059262|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84059263|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84059264|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
84059265|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84059266|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
84059267|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84059268|NCT01057589|Folic Acid|folic acid|mesh-list
84059269|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
84059270|NCT01057589|Hydroxocobalamin|hydroxocobalamin|mesh-list
84059271|NCT01057589|Pemetrexed|pemetrexed|mesh-list
84059272|NCT01057589|Cetuximab|cetuximab|mesh-list
84059273|NCT01057589|Vitamins|vitamins|mesh-ancestor
84059274|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
84059275|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059276|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059277|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059278|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059279|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84059280|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84059281|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059282|NCT01057589|Hematinics|hematinics|mesh-ancestor
84059283|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
84059284|NCT02575885|Nicotine|nicotine|mesh-list
84059285|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84059286|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
84059287|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059288|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059289|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84059290|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84059291|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
84059292|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059293|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059294|NCT02575729|Betamethasone|betamethasone|mesh-list
84059295|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
84059296|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059297|NCT02575729|Hormones|hormones|mesh-ancestor
83229283|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84059298|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059299|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059300|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84059301|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
84059302|NCT02575651|Fluzoparib|fluzoparib|mesh-list
84059303|NCT02575651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84059304|NCT02575651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059305|NCT02575651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059306|NCT02575651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059307|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
84059308|NCT01716117|Antacids|antacids|mesh-ancestor
84059309|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059310|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059311|NCT00579553|Progesterone|progesterone|mesh-list
83229426|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
84059312|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
84059313|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
84059314|NCT00579553|Progestins|progestins|mesh-ancestor
84059315|NCT00579553|Hormones|hormones|mesh-ancestor
84059316|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059317|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059319|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
84059320|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
84059321|NCT04209933|Bismuth|bismuth|mesh-list
84059322|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059323|NCT04209933|Antacids|antacids|mesh-ancestor
84059324|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059325|NCT04209933|Diuretics|diuretics|mesh-ancestor
84059326|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
84059327|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059328|NCT04209933|Expectorants|expectorants|mesh-ancestor
84059329|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
84059330|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84059331|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
84059332|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059333|NCT04209699|Deucravacitinib|deucravacitinib|mesh-list
84059334|NCT04209699|Famotidine|famotidine|mesh-list
84059335|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84059336|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059337|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84059338|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
84059339|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
84059340|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059341|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059342|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059343|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
84059344|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84059345|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059346|NCT00620295|Gemcitabine|gemcitabine|mesh-list
84059347|NCT00620295|Bortezomib|bortezomib|mesh-list
84059348|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84059349|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
84059350|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059351|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059352|NCT00581893|Phenytoin|phenytoin|mesh-list
84059353|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
84059354|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84059355|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84059356|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229907|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83230044|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059357|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059358|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84059359|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84059360|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
84059361|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059362|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059363|NCT04211103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84059364|NCT04211103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059365|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84059366|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059367|NCT02334865|Lenalidomide|lenalidomide|mesh-list
84059368|NCT02334865|Sargramostim|sargramostim|mesh-list
84059369|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84059370|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
84059371|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
84059372|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059373|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84059374|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84059375|NCT02334865|Growth Substances|growth substances|mesh-ancestor
84059376|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
84059377|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059378|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84059379|NCT04073719|Acetic Acid|acetic acid|mesh-list
84059380|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84059381|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059382|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
84059383|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84059384|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84059385|NCT00379431|Prednisolone|prednisolone|mesh-list
84059386|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
84059387|NCT00379431|Rituximab|rituximab|mesh-list
84059388|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84059389|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
84059390|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059391|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059392|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
84059393|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059394|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059395|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230241|NCT05007587|Vitamins|vitamins|mesh-ancestor
83230309|NCT05917340|Antipyretics|antipyretics|mesh-ancestor
84059396|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
83230394|NCT05916781|Hormones|hormones|mesh-ancestor
84059397|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
84059398|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059399|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059400|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
84059401|NCT00379431|Hormones|hormones|mesh-ancestor
84059402|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059403|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84059404|NCT00379431|Protective Agents|protective agents|mesh-ancestor
84059405|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84059406|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
84059407|NCT04954989|Hematinics|hematinics|mesh-ancestor
84059408|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
84059409|NCT03890289|Idelalisib|idelalisib|mesh-list
84059410|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059411|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059412|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059413|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059414|NCT00621699|Ezetimibe|ezetimibe|mesh-list
84059415|NCT00621699|Tacrolimus|tacrolimus|mesh-list
84059416|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059417|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
84059418|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059419|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84059420|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059421|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059422|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84059423|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84059424|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
84059425|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84059426|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83230656|NCT05915013|Sensory System Agents|sensory system agents|mesh-ancestor
84059427|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84059428|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
84059429|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059430|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059431|NCT00770146|Mipomersen|mipomersen|mesh-list
84059432|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84059433|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84059434|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
83230722|NCT05914662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84059435|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059436|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84059437|NCT00915850|Cisplatin|cisplatin|mesh-list
84059438|NCT00915850|Docetaxel|docetaxel|mesh-list
84059439|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059440|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
84059441|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
84059442|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
84059443|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059444|NCT04208763|Imipenem|imipenem|mesh-list
84059445|NCT04208763|Colistin|colistin|mesh-list
84059446|NCT04208763|Tigecycline|tigecycline|mesh-list
84059447|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84059448|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059449|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84059450|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059451|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059452|NCT00620919|Secretin|secretin|mesh-list
84059453|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059454|NCT00620919|Hormones|hormones|mesh-ancestor
84059455|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059456|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059457|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
84059458|NCT00916552|Hematinics|hematinics|mesh-ancestor
84059459|NCT03950037|Albendazole|albendazole|mesh-list
84059460|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
84059461|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84059462|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059463|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
84059464|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84059465|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84059466|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
84059467|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
84059468|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
84059469|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059470|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059472|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
84059473|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84059474|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
84059475|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
84059476|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
84059477|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059478|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059479|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
84059480|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059481|NCT00622011|Risperidone|risperidone|mesh-list
84059482|NCT00622011|Zotepine|zotepine|mesh-list
84059483|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84059484|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
84059485|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059486|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059487|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059488|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84059489|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84059490|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059491|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84059492|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84059493|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
84059494|NCT03936309|Lidocaine|lidocaine|mesh-list
84059495|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
84059496|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
84059497|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059498|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059499|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
84059500|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059501|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84059502|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84059503|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84059504|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84059505|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059506|NCT04208373|Itraconazole|itraconazole|mesh-list
84059507|NCT04208373|Etravirine|etravirine|mesh-list
84059508|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
84059509|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059510|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84059511|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84059512|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059513|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059514|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84059515|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
84059516|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059517|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059518|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84059519|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84059520|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84059521|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
84059522|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84059523|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
84059524|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84059525|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83231089|NCT05911308|Paclitaxel|paclitaxel|mesh-list
84059526|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84059527|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059528|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059529|NCT01056341|Propranolol|propranolol|mesh-list
84059530|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84059531|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84059532|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
83231152|NCT05910801|Lenalidomide|lenalidomide|mesh-list
84059533|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059534|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059535|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059536|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84059537|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84059538|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
84059539|NCT00999518|Tanezumab|tanezumab|mesh-list
84059540|NCT00999518|Analgesics|analgesics|mesh-ancestor
84059541|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
84059542|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059543|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059545|NCT00621387|Roxithromycin|roxithromycin|mesh-list
84059546|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84059547|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059548|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84059549|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84059550|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84059551|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059552|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059553|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059554|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84059555|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84059556|NCT02873273|Dexamethasone|dexamethasone|mesh-list
84059557|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059558|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
84059559|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
84059560|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231281|NCT05894239|Inavolisib|inavolisib|mesh-list
84059561|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059562|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059563|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
84059564|NCT02873273|Hormones|hormones|mesh-ancestor
84059565|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059566|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84059567|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059568|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
84059569|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059570|NCT01056263|Axitinib|axitinib|mesh-list
84059571|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059572|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84059573|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059574|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059575|NCT00637143|Cyclosporine|cyclosporine|mesh-list
84059576|NCT00637143|Tacrolimus|tacrolimus|mesh-list
84059577|NCT00637143|Cyclosporins|cyclosporins|mesh-list
84059578|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059579|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
84059580|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059581|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84059582|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059583|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059584|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
84059585|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059586|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
84059587|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059588|NCT01056107|Glucagon|glucagon|mesh-list
84059589|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84059590|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059591|NCT01056107|Hormones|hormones|mesh-ancestor
83231486|NCT05819619|Ibuprofen|ibuprofen|mesh-list
84059592|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059593|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059594|NCT01056107|Incretins|incretins|mesh-ancestor
84059595|NCT03548805|Mitomycins|mitomycins|mesh-list
84059596|NCT03548805|Mitomycin|mitomycin|mesh-list
84059597|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84059598|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059599|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
84059600|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059601|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84059602|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059603|NCT01003886|Doxazosin|doxazosin|mesh-list
84059604|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84059605|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84059606|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84059607|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84059608|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
84059609|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231625|NCT05748600|Pramipexole|pramipexole|mesh-list
84059610|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059611|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059612|NCT04138641|Cangrelor|cangrelor|mesh-list
84059613|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84059614|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84059615|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84059616|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84059617|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
84059618|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059619|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059620|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059621|NCT01003184|Exenatide|exenatide|mesh-list
84059622|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
84059623|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84059624|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059625|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84059626|NCT01003184|Incretins|incretins|mesh-ancestor
84059627|NCT01003184|Hormones|hormones|mesh-ancestor
84059628|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059629|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
84059630|NCT04314219|Methotrexate|methotrexate|mesh-list
84059631|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059632|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
84059633|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059634|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059635|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84059636|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
84059637|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059638|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059639|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84059640|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84059641|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
84059642|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84059643|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84059644|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
84059645|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
84059646|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059647|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84059648|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84059649|NCT02407119|Amoxicillin|amoxicillin|mesh-list
84059650|NCT02407119|Clarithromycin|clarithromycin|mesh-list
84059651|NCT02407119|Omeprazole|omeprazole|mesh-list
84059652|NCT02407119|Rabeprazole|rabeprazole|mesh-list
84059653|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84059654|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84059655|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059656|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84059657|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059658|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059659|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059660|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84059661|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84059662|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84059663|NCT01008410|Budesonide|budesonide|mesh-list
84059664|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059665|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84059666|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
84059667|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059668|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059669|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84059670|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
84059671|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
84059672|NCT01008410|Hormones|hormones|mesh-ancestor
84059673|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059674|NCT00627653|Fenofibrate|fenofibrate|mesh-list
84059675|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84059676|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
84059677|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059678|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84059679|NCT02347917|Pemetrexed|pemetrexed|mesh-list
84059680|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059681|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059682|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059683|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84059684|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84059685|NCT01972035|Valacyclovir|valacyclovir|mesh-list
84059686|NCT01972035|Valganciclovir|valganciclovir|mesh-list
84059687|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
84059688|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059689|NCT00622479|Sorafenib|sorafenib|mesh-list
84059690|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059691|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84059692|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059693|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059694|NCT01207011|Docetaxel|docetaxel|mesh-list
84059695|NCT01207011|Amrubicin|amrubicin|mesh-list
84059696|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059697|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
84059698|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
84059699|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
84059700|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059701|NCT05264805|Bupivacaine|bupivacaine|mesh-list
84059702|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
84059703|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
84059704|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059705|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059706|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
83232273|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059707|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059708|NCT05264493|Naloxone|naloxone|mesh-list
84059709|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84059710|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059711|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
84059712|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059713|NCT00612261|Triamcinolone|triamcinolone|mesh-list
84059714|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84059715|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83232339|NCT05543278|Amiodarone|amiodarone|mesh-list
84059716|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84059717|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059718|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
84059719|NCT00612261|Hormones|hormones|mesh-ancestor
84059720|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059721|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059722|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059723|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
84059724|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059725|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059726|NCT00636909|Cyclosporine|cyclosporine|mesh-list
84059727|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
84059728|NCT00636909|Methotrexate|methotrexate|mesh-list
84059729|NCT00636909|Fludarabine|fludarabine|mesh-list
84059730|NCT00636909|Cyclosporins|cyclosporins|mesh-list
84059731|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059732|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
84059733|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059734|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059735|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84059736|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
84059737|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059738|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059739|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84059740|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84059741|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
84059742|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84059743|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84059744|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
84059745|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
84059746|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059747|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84059748|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84059749|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
84059750|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059751|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84059752|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84059753|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84059754|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059755|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84059756|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84059757|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84059758|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84059759|NCT02697045|Aripiprazole|aripiprazole|mesh-list
84059760|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
84059761|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84059762|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84059763|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84059764|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059765|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059766|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
84059767|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
84059768|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059769|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059770|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84059771|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84059772|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
84059773|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84059774|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84059775|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84059776|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84059777|NCT01007942|Trastuzumab|trastuzumab|mesh-list
84059778|NCT01007942|Everolimus|everolimus|mesh-list
84059779|NCT01007942|Vinorelbine|vinorelbine|mesh-list
84059780|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059781|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059782|NCT01007942|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84059783|NCT01007942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84059784|NCT01007942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059785|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059786|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059787|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
84059788|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059789|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84059790|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
84059791|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
84059792|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
84059793|NCT05661669|Ketamine|ketamine|mesh-list
84059794|NCT05661669|Analgesics|analgesics|mesh-ancestor
84059795|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
83232617|NCT05417425|Lidocaine|lidocaine|mesh-list
84059796|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059797|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059798|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84059799|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84059800|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
84059801|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
84059802|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83232657|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059803|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84059804|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84059805|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059806|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059807|NCT01023035|Ribavirin|ribavirin|mesh-list
84059808|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84059809|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
84059810|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
84059811|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059812|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
84059813|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059814|NCT01023035|Hematinics|hematinics|mesh-ancestor
84059815|NCT01028651|Treprostinil|treprostinil|mesh-list
84059816|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84059817|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
83232785|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
84059818|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84059819|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84059820|NCT00627731|Prednisolone|prednisolone|mesh-list
84059821|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
84059822|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84059823|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
84059824|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059825|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
84059826|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
84059827|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059828|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059829|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059830|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
84059831|NCT00627731|Hormones|hormones|mesh-ancestor
84059832|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059833|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84059834|NCT00627731|Protective Agents|protective agents|mesh-ancestor
84059835|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84059836|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059837|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
84059838|NCT01028027|Tobramycin|tobramycin|mesh-list
84059839|NCT01028027|Dexamethasone|dexamethasone|mesh-list
84059840|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059841|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
84059842|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
84059843|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059844|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059845|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84059846|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
84059847|NCT01028027|Hormones|hormones|mesh-ancestor
84059848|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059849|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84059850|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059851|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84059852|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059853|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84059854|NCT01007552|Bevacizumab|bevacizumab|mesh-list
84059855|NCT01007552|Gemcitabine|gemcitabine|mesh-list
84059856|NCT01007552|Capecitabine|capecitabine|mesh-list
84059857|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84059858|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059859|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84059860|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84059861|NCT01007552|Growth Substances|growth substances|mesh-ancestor
84059862|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059863|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
84059864|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84059865|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
84059866|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059867|NCT02870036|Leucovorin|leucovorin|mesh-list
84059868|NCT02870036|Thalidomide|thalidomide|mesh-list
84059869|NCT02870036|Fluorouracil|fluorouracil|mesh-list
84059870|NCT02870036|Calcium|calcium|mesh-list
84059871|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
84059872|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84059873|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059874|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
83232994|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
84059875|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059876|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84059877|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059878|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84059879|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
84059880|NCT02870036|Antidotes|antidotes|mesh-ancestor
84059881|NCT02870036|Protective Agents|protective agents|mesh-ancestor
84059882|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
84059883|NCT02870036|Vitamins|vitamins|mesh-ancestor
84059884|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
84059885|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
84059886|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84059887|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84059888|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84059889|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84059890|NCT02870036|Growth Substances|growth substances|mesh-ancestor
84059891|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
84059892|NCT04296422|Ibuprofen|ibuprofen|mesh-list
84059893|NCT04296422|Diclofenac|diclofenac|mesh-list
84059894|NCT04296422|Naproxen|naproxen|mesh-list
84059895|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84059896|NCT04296422|Piroxicam|piroxicam|mesh-list
84059897|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
84059898|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
84059899|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84059900|NCT04296422|Analgesics|analgesics|mesh-ancestor
84059901|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
84059902|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059903|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059904|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059905|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84059906|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83233119|NCT05192200|Interferons|interferons|mesh-list
84059907|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059908|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059909|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
84059910|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84059911|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84059912|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
84059913|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
84059914|NCT00998738|Calcium|calcium|mesh-list
83299851|NCT03929224|Bacitracin|bacitracin|mesh-list
84059915|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84059916|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059917|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84059918|NCT00998738|Analgesics|analgesics|mesh-ancestor
84059919|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
84059920|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059921|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
84059922|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84059923|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83233252|NCT05131828|Metformin|metformin|mesh-list
84059924|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
84059925|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84059926|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84059927|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059928|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
84059929|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84059930|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84059931|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059932|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84059933|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059934|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059935|NCT04369664|Atorvastatin|atorvastatin|mesh-list
84059936|NCT04369664|Ezetimibe|ezetimibe|mesh-list
84059937|NCT04369664|Evolocumab|evolocumab|mesh-list
84059938|NCT04369664|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
84059939|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84059940|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84059941|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
84059942|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059943|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84059944|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84059945|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059946|NCT04369664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84059947|NCT04369664|Protease Inhibitors|protease inhibitors|mesh-ancestor
84059948|NCT04296578|Selenious Acid|selenious acid|mesh-list
84059949|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
84059950|NCT04296578|Prednisone|prednisone|mesh-list
83233619|NCT04987294|Rasburicase|rasburicase|mesh-list
83233704|NCT04913805|Niacin|niacin|mesh-list
84059951|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
84059952|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84059953|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
84059954|NCT04296578|Hormones|hormones|mesh-ancestor
84059955|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84059956|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059957|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84059958|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059959|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84059960|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84059961|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059962|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
84059963|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84059964|NCT04296578|Trace Elements|trace elements|mesh-ancestor
84059965|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
84059966|NCT00996944|Ropinirole|ropinirole|mesh-list
84059967|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84059968|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84059969|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
84059970|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
84059971|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059972|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059973|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059974|NCT01027949|Treprostinil|treprostinil|mesh-list
84059975|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84059976|NCT01038323|Milnacipran|milnacipran|mesh-list
84059977|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
84059978|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84059979|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84059980|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84059981|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84059982|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84059983|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059984|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84059985|NCT01038323|Analgesics|analgesics|mesh-ancestor
84059986|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
84059987|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84059988|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
84059989|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84059990|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
84059991|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84059992|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84059993|NCT04301375|Paclitaxel|paclitaxel|mesh-list
84059994|NCT04301375|Trastuzumab|trastuzumab|mesh-list
84059995|NCT04301375|Pertuzumab|pertuzumab|mesh-list
84059996|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84059997|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84059998|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
84059999|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
84060000|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
84060001|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233937|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84060002|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060003|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
84060004|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060005|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060006|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
84060007|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
84060008|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
84060009|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060010|NCT01025843|Candesartan|candesartan|mesh-list
84060011|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
84060012|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84060013|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84060014|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84060015|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060016|NCT02873351|Levodopa|levodopa|mesh-list
84060017|NCT02873351|Carbidopa|carbidopa|mesh-list
84060018|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84060019|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84060020|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84060021|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
84060022|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060023|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060024|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060025|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84060026|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060027|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84060028|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
84060029|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
84060030|NCT04299971|Methotrexate|methotrexate|mesh-list
84060031|NCT04299971|Tofacitinib|tofacitinib|mesh-list
84060032|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84060033|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
84060034|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060035|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060036|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84060037|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
84060038|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060039|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060040|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
84060041|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060042|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84060043|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060044|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
84060045|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84060046|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84060047|NCT04299971|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84060048|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060049|NCT01020305|Sirolimus|sirolimus|mesh-list
84060050|NCT01020305|Temsirolimus|temsirolimus|mesh-list
84060051|NCT01020305|MTOR Inhibitors|mtor inhibitors|mesh-list
84060052|NCT01020305|Bicalutamide|bicalutamide|mesh-list
84060053|NCT01020305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060054|NCT01020305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060055|NCT01020305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060056|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060057|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
84060058|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060059|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060060|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060061|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060062|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84060063|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
84060064|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
84060065|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
84060066|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060067|NCT00627575|Lamotrigine|lamotrigine|mesh-list
84060068|NCT00627575|Phenytoin|phenytoin|mesh-list
84060069|NCT00627575|Atorvastatin|atorvastatin|mesh-list
84060070|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84060071|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84060072|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
84060073|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060074|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84060075|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84060076|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060077|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
84060078|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84060079|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84060080|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84060081|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060082|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84060083|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84060084|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060085|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84060086|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84060087|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84060088|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84060089|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84060090|NCT00627809|Streptokinase|streptokinase|mesh-list
84060091|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84060092|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84060093|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060094|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84060095|NCT02872649|Warfarin|warfarin|mesh-list
84060096|NCT02872649|Dabigatran|dabigatran|mesh-list
84060097|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
84060098|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
84060099|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
84060100|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84060101|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
84060102|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060103|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060104|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84060105|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
84060106|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84060107|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84060108|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84060109|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
84060110|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060111|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060112|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84060113|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84060114|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84060115|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84060116|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060117|NCT01018511|Tamsulosin|tamsulosin|mesh-list
84060118|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
84060119|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84060120|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84060121|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84060122|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
84060123|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060124|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060125|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060126|NCT01018511|Urological Agents|urological agents|mesh-ancestor
84060127|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84060128|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84060129|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
84060130|NCT00996476|Simeprevir|simeprevir|mesh-list
84060131|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
84060132|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060133|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
84060134|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060135|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060136|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
84060137|NCT02269267|Dasatinib|dasatinib|mesh-list
83300067|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
84060138|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
84060139|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060140|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060141|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060142|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060143|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
84060144|NCT02269267|Protective Agents|protective agents|mesh-ancestor
84060145|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060146|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84060147|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84060148|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060149|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
84060150|NCT02575261|Immunomodulating Agents|immunomodulating agents|mesh-list
84060151|NCT02575261|Immunologic Factors|immunologic factors|mesh-ancestor
84060152|NCT02575261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060153|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
84060154|NCT01017731|Promethazine|promethazine|mesh-list
84060155|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
84060156|NCT01017731|Ramucirumab|ramucirumab|mesh-list
84060157|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060158|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060159|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84060160|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84060161|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060162|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060163|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060164|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060165|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84060166|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84060167|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060168|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
84060169|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
84060170|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
84060171|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060172|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
84060173|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
84060174|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84060175|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84060176|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
84060177|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
84060178|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060179|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84060180|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
84060181|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
84060182|NCT02575183|Varenicline|varenicline|mesh-list
83234703|NCT04394858|Olaparib|olaparib|mesh-list
84060183|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84060184|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84060185|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
84060186|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060187|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060188|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060189|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
84060190|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84060191|NCT00779584|Gemcitabine|gemcitabine|mesh-list
84060192|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84060193|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
84060194|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060195|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060196|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84060197|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
84060198|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84060199|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84060200|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84060201|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060202|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060203|NCT01385059|Axitinib|axitinib|mesh-list
84060204|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060205|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060206|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060207|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060208|NCT00769132|Niacin|niacin|mesh-list
84060209|NCT00769132|Niacinamide|niacinamide|mesh-list
84060210|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
84060211|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84060212|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
84060213|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060214|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84060215|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
84060216|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
84060218|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
84060219|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060220|NCT04070755|Minocycline|minocycline|mesh-list
84060221|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060222|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060223|NCT04100434|Evolocumab|evolocumab|mesh-list
84060224|NCT04100434|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84060225|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84060226|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84060227|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
84060228|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060229|NCT04100434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84060230|NCT04100434|Protease Inhibitors|protease inhibitors|mesh-ancestor
84060231|NCT04100434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060232|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84060233|NCT00991952|Irinotecan|irinotecan|mesh-list
84060234|NCT00991952|Alvocidib|alvocidib|mesh-list
84060235|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84060236|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84060237|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060238|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060239|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060240|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
84060241|NCT00991952|Growth Substances|growth substances|mesh-ancestor
84060242|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060243|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060244|NCT00779038|Fentanyl|fentanyl|mesh-list
84060245|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84060246|NCT00779038|Narcotics|narcotics|mesh-ancestor
84060247|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060248|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060249|NCT00779038|Analgesics|analgesics|mesh-ancestor
84060250|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
84060251|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060252|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84060253|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84060254|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
84060255|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
84060256|NCT04292990|Fentanyl|fentanyl|mesh-list
84060257|NCT04292990|Morphine|morphine|mesh-list
84060258|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84060259|NCT04292990|Narcotics|narcotics|mesh-ancestor
84060260|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060261|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060262|NCT04292990|Analgesics|analgesics|mesh-ancestor
84060263|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
84060264|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060265|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84060266|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84060267|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
84060268|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
84060269|NCT02868632|Durvalumab|durvalumab|mesh-list
84060270|NCT02868632|Tremelimumab|tremelimumab|mesh-list
84060271|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060272|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060273|NCT04021498|Simvastatin|simvastatin|mesh-list
84060274|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84060275|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84060276|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
84060277|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060278|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84060279|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84060280|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060281|NCT00994682|Pioglitazone|pioglitazone|mesh-list
84060282|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84060283|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060284|NCT00994448|Bupropion|bupropion|mesh-list
84060285|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84060286|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
84060287|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83235186|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
84060288|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84060289|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84060290|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84060291|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060292|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
84060293|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060294|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060295|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84060296|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84060297|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060298|NCT04292444|Oxytocin|oxytocin|mesh-list
84060299|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
84060300|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060301|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060302|NCT01017575|Ribavirin|ribavirin|mesh-list
84060303|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84060304|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
84060305|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060306|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
84060307|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060308|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84060309|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
84060310|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84060311|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060312|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84060313|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84060314|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84060315|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060316|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
84060317|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060318|NCT01253161|Pasireotide|pasireotide|mesh-list
84060319|NCT01253161|Hormones|hormones|mesh-ancestor
84060320|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060321|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060322|NCT00709423|Moxaverine|moxaverine|mesh-list
84060323|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
84060324|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
84060325|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060326|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060327|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84060328|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
84060329|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84060330|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060331|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060332|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84060333|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84060334|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84060335|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060336|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84060337|NCT02576665|Flucytosine|flucytosine|mesh-list
84060338|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
84060339|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060340|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
84060341|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060342|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
84060343|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060344|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
84060345|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84060346|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84060347|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060348|NCT00627965|Urological Agents|urological agents|mesh-ancestor
84060349|NCT02576353|Fentanyl|fentanyl|mesh-list
84060350|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84060351|NCT02576353|Narcotics|narcotics|mesh-ancestor
84060352|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060353|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060354|NCT02576353|Analgesics|analgesics|mesh-ancestor
84060355|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
84060356|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060357|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84060358|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84060359|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
84060360|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
84060361|NCT01016015|Sirolimus|sirolimus|mesh-list
84060362|NCT01016015|Temsirolimus|temsirolimus|mesh-list
84060363|NCT01016015|MTOR Inhibitors|mtor inhibitors|mesh-list
84060364|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84060365|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060366|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060367|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84060368|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060369|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
84060370|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060371|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
84060372|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060373|NCT01016015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060374|NCT01016015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060375|NCT01016015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060376|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
84060377|NCT00628043|Hematinics|hematinics|mesh-ancestor
84060378|NCT00709657|Bevacizumab|bevacizumab|mesh-list
84060379|NCT00709657|Ranibizumab|ranibizumab|mesh-list
84060380|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060381|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060382|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84060383|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84060384|NCT00709657|Growth Substances|growth substances|mesh-ancestor
84060385|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060386|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
84060387|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
84060389|NCT04073173|Narcotics|narcotics|mesh-ancestor
84060390|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83235749|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060391|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060392|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
84060393|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060394|NCT00628121|Cetrorelix|cetrorelix|mesh-list
84060395|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84060396|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
84060397|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060398|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060399|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
84060400|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060401|NCT00709969|Lumefantrine|lumefantrine|mesh-list
84060402|NCT00709969|Artemether|artemether|mesh-list
84060403|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84060404|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
84060405|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84060406|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83235818|NCT03860207|Antibodies|antibodies|mesh-list
84060407|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060408|NCT00710125|Doxorubicin|doxorubicin|mesh-list
84060409|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84060410|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060411|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84060412|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84060413|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060414|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060415|NCT02573701|Risperidone|risperidone|mesh-list
84060416|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
84060417|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84060418|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
84060419|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060420|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060421|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060422|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84060423|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060424|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84060425|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84060426|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
84060427|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
84060428|NCT01017029|Everolimus|everolimus|mesh-list
84060429|NCT01017029|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84060430|NCT01017029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060431|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060432|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060433|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060434|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
84060435|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060436|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060437|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84060438|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84060439|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
84060440|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060441|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060442|NCT00714649|Cetuximab|cetuximab|mesh-list
84060443|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060444|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060445|NCT00710359|Vitamins|vitamins|mesh-list
84060446|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
84060447|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
84060448|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
84060449|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
84060450|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060451|NCT00710359|Hematinics|hematinics|mesh-ancestor
84060452|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84060453|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84060454|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
84060455|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060456|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84060457|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84060458|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
84060459|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
84060460|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060461|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060462|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
84060463|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84060464|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060465|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236382|NCT03464097|Ozanimod|ozanimod|mesh-list
84060466|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84060467|NCT00710437|Analgesics|analgesics|mesh-ancestor
84060468|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
84060469|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060470|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84060471|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84060472|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84060473|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
84060474|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060475|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060476|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
84060477|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84060478|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
84060479|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060480|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060481|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84060482|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84060483|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84060484|NCT00714883|Sirolimus|sirolimus|mesh-list
84060485|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060486|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060487|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84060488|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060489|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
84060490|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060491|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
84060492|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060493|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
84060494|NCT00710827|Androgens|androgens|mesh-ancestor
84060495|NCT00710827|Hormones|hormones|mesh-ancestor
84060496|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060497|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236584|NCT03274258|Nivolumab|nivolumab|mesh-list
84060498|NCT01034657|Panobinostat|panobinostat|mesh-list
84060499|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
84060500|NCT01034657|Hematinics|hematinics|mesh-ancestor
84060501|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060502|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84060503|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060504|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060505|NCT01014767|Leucovorin|leucovorin|mesh-list
84060506|NCT01014767|Dactinomycin|dactinomycin|mesh-list
84060507|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
84060508|NCT01014767|Temozolomide|temozolomide|mesh-list
84060509|NCT01014767|Cisplatin|cisplatin|mesh-list
84060510|NCT01014767|Carboplatin|carboplatin|mesh-list
84060511|NCT01014767|Doxorubicin|doxorubicin|mesh-list
84060512|NCT01014767|Methotrexate|methotrexate|mesh-list
84060513|NCT01014767|Irinotecan|irinotecan|mesh-list
84060514|NCT01014767|Etoposide|etoposide|mesh-list
84060515|NCT01014767|Vincristine|vincristine|mesh-list
84060516|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060517|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
84060518|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060519|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84060520|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84060521|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
84060522|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060523|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060524|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84060525|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84060526|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84060527|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84060528|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060529|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84060530|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
84060531|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060532|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84060533|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
84060534|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
84060535|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84060536|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84060537|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84060538|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84060539|NCT01014767|Antidotes|antidotes|mesh-ancestor
84060540|NCT01014767|Protective Agents|protective agents|mesh-ancestor
84060541|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
84060542|NCT01014767|Vitamins|vitamins|mesh-ancestor
84060543|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
84060544|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
84060545|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
84060546|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
84060547|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060548|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060549|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84060550|NCT01014689|Lymecycline|lymecycline|mesh-list
84060551|NCT01014689|Adapalene|adapalene|mesh-list
84060552|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84060553|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84060554|NCT01014689|Analgesics|analgesics|mesh-ancestor
83237138|NCT02437136|Entinostat|entinostat|mesh-list
84060555|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
84060556|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060557|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060558|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060559|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84060560|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
84060561|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060562|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060563|NCT01014533|Gabapentin|gabapentin|mesh-list
84060564|NCT01014533|Analgesics|analgesics|mesh-ancestor
84060565|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
84060566|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060567|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060568|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
84060569|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84060570|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84060571|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060572|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84060573|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84060574|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84060575|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060576|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060577|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
84060578|NCT02013427|Naproxen|naproxen|mesh-list
84060579|NCT02013427|Omeprazole|omeprazole|mesh-list
84060580|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84060581|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84060582|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84060583|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060584|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060585|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84060586|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84060587|NCT02013427|Analgesics|analgesics|mesh-ancestor
84060588|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
84060589|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300514|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
84060590|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060591|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060592|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84060593|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
84060594|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84060595|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
84060596|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84060597|NCT01014143|Triclosan|triclosan|mesh-list
84060598|NCT01014143|Fluorides|fluorides|mesh-list
84060599|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
84060600|NCT01014143|Protective Agents|protective agents|mesh-ancestor
84060601|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060602|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84060603|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060604|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
84060605|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
84060606|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84060607|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84060608|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
83237461|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84060609|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060610|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84060611|NCT00714961|Clopidogrel|clopidogrel|mesh-list
84060612|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84060613|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84060614|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84060615|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84060616|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
84060617|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060618|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060619|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060620|NCT02574403|Eculizumab|eculizumab|mesh-list
84060621|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84060622|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060623|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
84060624|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060625|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
84060626|NCT01013753|Olodaterol|olodaterol|mesh-list
84060627|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84060628|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
84060629|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060630|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060631|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84060632|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
84060633|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84060634|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84060635|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84060636|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
84060637|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060638|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060639|NCT00715039|Lorazepam|lorazepam|mesh-list
84060640|NCT00715039|Paroxetine|paroxetine|mesh-list
84060641|NCT00715039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84060642|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84060643|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84060644|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060645|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060646|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
84060647|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060648|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84060649|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
84060650|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84060651|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84060652|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84060653|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060654|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
84060655|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
84060656|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
84060657|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060658|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84060659|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84060660|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060661|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84060662|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84060663|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
84060664|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
84060665|NCT00711295|Vaccines|vaccines|mesh-list
84060666|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
84060667|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060668|NCT02871869|Buformin|buformin|mesh-list
84060669|NCT02871869|Prednisone|prednisone|mesh-list
84060670|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
84060671|NCT02871869|Rituximab|rituximab|mesh-list
84060672|NCT02871869|Epirubicin|epirubicin|mesh-list
84060673|NCT02871869|Vindesine|vindesine|mesh-list
84060674|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060675|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
84060676|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060677|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84060678|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84060679|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
84060680|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060681|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060682|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84060683|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060684|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060685|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
84060686|NCT02871869|Hormones|hormones|mesh-ancestor
84060687|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060688|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84060689|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84060690|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84060691|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84060692|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060693|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84060694|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
84060695|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
84060696|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
84060697|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84060698|NCT01013597|Panobinostat|panobinostat|mesh-list
84060699|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060700|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84060701|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060702|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060704|NCT00715273|Niacinamide|niacinamide|mesh-list
84060705|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
84060706|NCT00715273|Atorvastatin|atorvastatin|mesh-list
84060707|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84060708|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84060709|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84060710|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
84060711|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060712|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83237810|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060713|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84060714|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060715|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
84060716|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
84060717|NCT00715273|Vitamins|vitamins|mesh-ancestor
84060718|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
84060719|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060720|NCT01013285|Bevacizumab|bevacizumab|mesh-list
84060721|NCT01013285|Temozolomide|temozolomide|mesh-list
84060722|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060723|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060724|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84060725|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84060726|NCT01013285|Growth Substances|growth substances|mesh-ancestor
84060727|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060728|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
84060729|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84060730|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
84060731|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060732|NCT00715351|Insulin|insulin|mesh-list
84060733|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84060734|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
84060735|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
84060736|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
84060737|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
84060738|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83237941|NCT00003129|Valrubicin|valrubicin|mesh-list
84060739|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300667|NCT04146298|Antibodies|antibodies|mesh-list
84060740|NCT04245085|Paclitaxel|paclitaxel|mesh-list
84060741|NCT04245085|Bevacizumab|bevacizumab|mesh-list
84060742|NCT04245085|Carboplatin|carboplatin|mesh-list
84060743|NCT04245085|Pemetrexed|pemetrexed|mesh-list
84060744|NCT04245085|Atezolizumab|atezolizumab|mesh-list
84060745|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84060746|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060747|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
84060748|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
84060749|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
84060750|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060751|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060752|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84060753|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84060754|NCT04245085|Growth Substances|growth substances|mesh-ancestor
84060755|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060756|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
84060757|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060758|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84060759|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84060760|NCT04245085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84060761|NCT00711841|Dexamethasone|dexamethasone|mesh-list
84060762|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
84060763|NCT00711841|BB 1101|bb 1101|mesh-list
84060764|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060765|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
84060766|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
84060767|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060768|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060769|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84060770|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
84060771|NCT00711841|Hormones|hormones|mesh-ancestor
84060772|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060773|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84060774|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060775|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
84060776|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060777|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060778|NCT00711919|Pitavastatin|pitavastatin|mesh-list
84060779|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84060780|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83238197|NCT02345239|Pantoprazole|pantoprazole|mesh-list
84060781|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84060782|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
84060783|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060784|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060785|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84060786|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
84060787|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
84060788|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84060789|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84060790|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060791|NCT00712465|Digoxin|digoxin|mesh-list
84060792|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84060793|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84060794|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060795|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060796|NCT00712465|Protective Agents|protective agents|mesh-ancestor
84060797|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060798|NCT00715975|Clobetasol|clobetasol|mesh-list
84060799|NCT00715975|Halobetasol|halobetasol|mesh-list
84060800|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060801|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
84060802|NCT00715975|Hormones|hormones|mesh-ancestor
84060803|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060804|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060805|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84060806|NCT02572687|Durvalumab|durvalumab|mesh-list
84060807|NCT02572687|Ramucirumab|ramucirumab|mesh-list
84060808|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060809|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060810|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84060811|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84060812|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84060813|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84060814|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83300737|NCT03154918|Etoposide|etoposide|mesh-list
84060815|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
84060816|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060817|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060818|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060819|NCT00603447|Dexamethasone|dexamethasone|mesh-list
84060820|NCT00603447|Lenalidomide|lenalidomide|mesh-list
84060821|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060822|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
84060823|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
84060824|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060825|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060826|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84060827|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
84060829|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060830|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84060831|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060832|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
84060833|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84060834|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84060835|NCT00603447|Growth Substances|growth substances|mesh-ancestor
84060836|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
84060837|NCT00718705|Josamycin|josamycin|mesh-list
84060838|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060839|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060840|NCT00639015|Phenylephrine|phenylephrine|mesh-list
84060841|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
84060842|NCT00639015|Norepinephrine|norepinephrine|mesh-list
84060843|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84060844|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
84060845|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
84060846|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060847|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060848|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
84060849|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84060850|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
84060851|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
84060852|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84060853|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84060854|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84060855|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
83238492|NCT02334007|Tinzaparin|tinzaparin|mesh-list
84060856|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84060857|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060858|NCT00639015|Protective Agents|protective agents|mesh-ancestor
84060859|NCT00712855|Sorafenib|sorafenib|mesh-list
84060860|NCT00712855|Mapatumumab|mapatumumab|mesh-list
84060861|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060862|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060863|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060864|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060865|NCT02537925|Celecoxib|celecoxib|mesh-list
84060866|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
84060867|NCT02537925|Nedaplatin|nedaplatin|mesh-list
84060868|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84060869|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84060870|NCT02537925|Analgesics|analgesics|mesh-ancestor
84060871|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
84060872|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060873|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060874|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060875|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84060876|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84060877|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060878|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238627|NCT02331511|Aspirin|aspirin|mesh-list
84060879|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060880|NCT00713011|Nifedipine|nifedipine|mesh-list
84060881|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84060882|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84060883|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060884|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84060885|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060886|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
83300818|NCT03154294|Paclitaxel|paclitaxel|mesh-list
84060887|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
84060888|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84060889|NCT04185675|Anesthetics|anesthetics|mesh-list
84060890|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060891|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060892|NCT04208061|Ritonavir|ritonavir|mesh-list
84060893|NCT04208061|Darunavir|darunavir|mesh-list
84060894|NCT04208061|Dabigatran|dabigatran|mesh-list
84060895|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84060896|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84060897|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
84060898|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060899|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060900|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84060901|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84060902|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
84060903|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84060904|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84060905|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84060906|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
84060907|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84060908|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
84060909|NCT00988208|Prednisone|prednisone|mesh-list
84060910|NCT00988208|Docetaxel|docetaxel|mesh-list
84060911|NCT00988208|Lenalidomide|lenalidomide|mesh-list
84060912|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060913|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
84060914|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
84060915|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
84060916|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060917|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060918|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
84060919|NCT00988208|Hormones|hormones|mesh-ancestor
84060920|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060921|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060922|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84060923|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
84060924|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84060925|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84060926|NCT00988208|Growth Substances|growth substances|mesh-ancestor
84060927|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
84060928|NCT00639249|SA 4503|sa 4503|mesh-list
84060929|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
84060930|NCT04185831|Everolimus|everolimus|mesh-list
84060931|NCT04185831|Atezolizumab|atezolizumab|mesh-list
84060932|NCT04185831|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84060933|NCT04185831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84060934|NCT04185831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060935|NCT04185831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060936|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84060937|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
84060938|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060939|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060940|NCT04185831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84060941|NCT04185831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060942|NCT02686983|Betamethasone|betamethasone|mesh-list
84060943|NCT02686983|Anesthetics|anesthetics|mesh-list
84060944|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
84060945|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84060946|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060947|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
83238948|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
84060948|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84060949|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84060950|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
84060951|NCT02686983|Hormones|hormones|mesh-ancestor
84060952|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060953|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84060954|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
84060955|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
84060956|NCT02686905|Vitamin D|vitamin d|mesh-list
84060957|NCT02686905|Vitamins|vitamins|mesh-list
84060958|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
84060959|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
84060960|NCT02686905|Calcium|calcium|mesh-list
84060961|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
84060962|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060963|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84060964|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84060965|NCT02686905|Hematinics|hematinics|mesh-ancestor
84060966|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
84060967|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
84060968|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060969|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
84060970|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84060971|NCT00990704|Protective Agents|protective agents|mesh-ancestor
84060972|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060973|NCT00639327|Irinotecan|irinotecan|mesh-list
84060974|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84060975|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84060976|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060977|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060978|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060979|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
84060980|NCT04089553|Durvalumab|durvalumab|mesh-list
84060981|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84060982|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060983|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
84060984|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84060985|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84060986|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84060987|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84060988|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
84060989|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84060990|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239052|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84060991|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84060992|NCT02686827|Vitamin D|vitamin d|mesh-list
84060993|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
84060994|NCT02686827|Vitamins|vitamins|mesh-ancestor
84060995|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
84060996|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84060997|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84060998|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84060999|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
84061000|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83239103|NCT02328079|Protective Agents|protective agents|mesh-ancestor
84061001|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061002|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
84061003|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061004|NCT00713167|Protective Agents|protective agents|mesh-ancestor
84061005|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061006|NCT00716521|Zolpidem|zolpidem|mesh-list
84061007|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84061008|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84061009|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061010|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061011|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84061012|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
84061013|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
84061014|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061015|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061016|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
84061017|NCT00993668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84061018|NCT00993668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84061019|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061020|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
84061021|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061022|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061023|NCT00778102|Leucovorin|leucovorin|mesh-list
84061024|NCT00778102|Bevacizumab|bevacizumab|mesh-list
84061025|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
84061026|NCT00778102|Irinotecan|irinotecan|mesh-list
84061027|NCT00778102|Fluorouracil|fluorouracil|mesh-list
84061028|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
84061029|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84061030|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061031|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84061032|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84061033|NCT00778102|Growth Substances|growth substances|mesh-ancestor
84061034|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061035|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
84061036|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84061037|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84061038|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300962|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239294|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061039|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061040|NCT00778102|Antidotes|antidotes|mesh-ancestor
84061041|NCT00778102|Protective Agents|protective agents|mesh-ancestor
84061042|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
84061043|NCT00778102|Vitamins|vitamins|mesh-ancestor
84061044|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
84061045|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
84061046|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84061047|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061048|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
84061049|NCT00713557|Tirofiban|tirofiban|mesh-list
84061050|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84061051|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84061052|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061053|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84061054|NCT00719095|Naltrexone|naltrexone|mesh-list
84061055|NCT00719095|Buprenorphine|buprenorphine|mesh-list
84061056|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84061057|NCT00719095|Narcotics|narcotics|mesh-ancestor
84061058|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061059|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061060|NCT00719095|Analgesics|analgesics|mesh-ancestor
84061061|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
84061062|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061063|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84061064|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84061065|NCT00916630|Pemetrexed|pemetrexed|mesh-list
84061066|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061067|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061068|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061069|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84061070|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84061071|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
84061072|NCT02572375|Codeine|codeine|mesh-list
84061073|NCT02572375|Guaifenesin|guaifenesin|mesh-list
84061074|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
84061075|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84061076|NCT02572375|Narcotics|narcotics|mesh-ancestor
83239483|NCT04892069|Insulin|insulin|mesh-list
84061077|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061078|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061079|NCT02572375|Analgesics|analgesics|mesh-ancestor
84061080|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
84061081|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061082|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
84061083|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
84061084|NCT02572375|Expectorants|expectorants|mesh-ancestor
84061085|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84061086|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84061087|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
84061088|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061089|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061090|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
83239549|NCT04985669|Prucalopride|prucalopride|mesh-list
84061091|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84061092|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
84061093|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
84061094|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
84061095|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84061096|NCT00716911|Ganciclovir|ganciclovir|mesh-list
84061097|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
84061098|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
84061099|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061100|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84061101|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061102|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061103|NCT00612495|Fluorouracil|fluorouracil|mesh-list
84061104|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
84061105|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
84061106|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061107|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84061108|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061109|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061110|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
84061111|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061112|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
84061113|NCT00719173|Aprepitant|aprepitant|mesh-list
84061114|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061115|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
84061116|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061117|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061118|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84061119|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
84061120|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061121|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061122|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84061123|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
84061124|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
84061125|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061126|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84061127|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84061128|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061129|NCT00756886|Atorvastatin|atorvastatin|mesh-list
84061130|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84061131|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84061132|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
84061133|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061134|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84061135|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84061136|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061137|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84061138|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84061139|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84061140|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
84061141|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061142|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061143|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84061144|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84061145|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
84061146|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061147|NCT02573935|Clarithromycin|clarithromycin|mesh-list
84061148|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84061149|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061150|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84061151|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061152|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061153|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84061154|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84061155|NCT00984620|Interferons|interferons|mesh-list
84061156|NCT00984620|Ribavirin|ribavirin|mesh-list
84061157|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
84061158|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061159|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
84061160|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061161|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
84061162|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061163|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
84061164|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061165|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
84061166|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
84061167|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84061168|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84061169|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061170|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84061171|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061172|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84061173|NCT00639483|Celecoxib|celecoxib|mesh-list
84061174|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84061175|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061176|NCT00639483|Analgesics|analgesics|mesh-ancestor
84061177|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
84061178|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061179|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061180|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84061181|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061182|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84061183|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84061184|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061185|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061186|NCT00777946|Amlodipine|amlodipine|mesh-list
84061187|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84061188|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83301107|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
84061189|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84061190|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061191|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84061192|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061193|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
84061195|NCT02686047|Hylan|hylan|mesh-list
84061196|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84061197|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
84061198|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061199|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
84061200|NCT02686047|Protective Agents|protective agents|mesh-ancestor
84061201|NCT00713947|Amoxicillin|amoxicillin|mesh-list
84061202|NCT00713947|Metronidazole|metronidazole|mesh-list
84061203|NCT00713947|Clarithromycin|clarithromycin|mesh-list
84061204|NCT00713947|Pantoprazole|pantoprazole|mesh-list
84061205|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84061206|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061207|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84061208|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84061209|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84061210|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061211|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061212|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84061213|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84061214|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84061215|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84061216|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84061217|NCT00990314|Epoprostenol|epoprostenol|mesh-list
84061218|NCT00990314|Beraprost|beraprost|mesh-list
84061219|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84061220|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
84061221|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84061222|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
84061223|NCT00909831|Sirolimus|sirolimus|mesh-list
84061224|NCT00909831|Temsirolimus|temsirolimus|mesh-list
84061225|NCT00909831|MTOR Inhibitors|mtor inhibitors|mesh-list
84061226|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
84061227|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84061228|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84061229|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061230|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061231|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061232|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061233|NCT00909831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84061234|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061235|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
84061236|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061237|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061238|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84061239|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84061240|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
84061241|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
84061242|NCT00717379|Prednisone|prednisone|mesh-list
84061243|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
84061244|NCT00717379|Tacrolimus|tacrolimus|mesh-list
84061245|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84061246|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
84061247|NCT00717379|Hormones|hormones|mesh-ancestor
83240148|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
84061248|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84061249|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061250|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84061251|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061252|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061253|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
84061254|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84061255|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061256|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061257|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84061258|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84061259|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
84061260|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84061261|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061262|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
84061263|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
84061264|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061265|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84061266|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84061267|NCT00717379|Protective Agents|protective agents|mesh-ancestor
84061268|NCT02867306|Methotrexate|methotrexate|mesh-list
83240202|NCT05090137|Diuretics|diuretics|mesh-list
84061269|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84061270|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
84061271|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84061272|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061273|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84061274|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
84061275|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061276|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061277|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
84061278|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061279|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84061280|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061281|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
84061282|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061283|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84061284|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
84061285|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84061286|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
84061287|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84061288|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061289|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84061290|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84061291|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84061292|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
84061293|NCT02685657|Docetaxel|docetaxel|mesh-list
84061294|NCT02685657|Doxorubicin|doxorubicin|mesh-list
84061295|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061296|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
84061297|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061298|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061299|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84061300|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
84061301|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061302|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061303|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84061304|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
84061305|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
84061306|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
84061307|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84061308|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84061309|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84061310|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061311|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
84061312|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84061313|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84061314|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061315|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
84061316|NCT04290884|Coagulants|coagulants|mesh-ancestor
84061317|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
84061318|NCT00719407|Hematinics|hematinics|mesh-ancestor
84061319|NCT00714025|Everolimus|everolimus|mesh-list
84061320|NCT00714025|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84061321|NCT00714025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84061322|NCT00714025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061323|NCT00714025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061324|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061325|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
84061326|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240435|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061327|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061328|NCT02685345|Firuglipel|firuglipel|mesh-list
84061329|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84061330|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061331|NCT02869100|Listerine|listerine|mesh-list
84061332|NCT02869100|Fluorides|fluorides|mesh-list
84061333|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
84061334|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
84061335|NCT02869100|Protective Agents|protective agents|mesh-ancestor
84061336|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061337|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84061338|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061339|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
84061340|NCT04096768|Ketamine|ketamine|mesh-list
83301257|NCT01565889|Ritonavir|ritonavir|mesh-list
84061341|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84061342|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061343|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061344|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061345|NCT04096768|Analgesics|analgesics|mesh-ancestor
84061346|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
84061347|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061348|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84061349|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84061350|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84061351|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
84061352|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240565|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
84061353|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061354|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84061355|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84061356|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
84061357|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
84061358|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84061359|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84061360|NCT00714103|Adenosine|adenosine|mesh-list
84061361|NCT00714103|Analgesics|analgesics|mesh-ancestor
84061362|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
84061363|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061364|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061365|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84061366|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
84061367|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84061368|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
84061369|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
84061370|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061371|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061372|NCT00993044|Bevacizumab|bevacizumab|mesh-list
84061373|NCT00993044|Irinotecan|irinotecan|mesh-list
84061374|NCT00993044|Vincristine|vincristine|mesh-list
84061375|NCT00993044|Temozolomide|temozolomide|mesh-list
84061376|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84061377|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061378|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84061379|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84061380|NCT00993044|Growth Substances|growth substances|mesh-ancestor
84061381|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061382|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
84061383|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84061384|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84061385|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061386|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061387|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84061388|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
84061389|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
84061390|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
84061391|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84061392|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
84061393|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
83240684|NCT02819479|Mannitol|mannitol|mesh-list
84061394|NCT00714181|Temozolomide|temozolomide|mesh-list
84061395|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84061396|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
84061397|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061398|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061399|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
84061400|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84061401|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84061402|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061403|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061404|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061405|NCT02600806|Azithromycin|azithromycin|mesh-list
84061406|NCT02600806|Levofloxacin|levofloxacin|mesh-list
84061407|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84061408|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061409|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84061410|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84061411|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84061412|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061413|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061414|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061415|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84061416|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84061417|NCT00639873|Doxycycline|doxycycline|mesh-list
84061418|NCT00639873|Artesunate|artesunate|mesh-list
84061419|NCT00639873|Quinine|quinine|mesh-list
84061420|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84061421|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061422|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
84061423|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84061424|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84061425|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061426|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
84061427|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
84061428|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84061429|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
84061430|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84061431|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061432|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84061433|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061434|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061435|NCT00639873|Analgesics|analgesics|mesh-ancestor
84061436|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
84061437|NCT04291118|Budesonide|budesonide|mesh-list
84061438|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84061439|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84061440|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
84061441|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061442|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061443|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84061444|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
84061445|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
84061446|NCT04291118|Hormones|hormones|mesh-ancestor
84061447|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84061448|NCT02868944|Sufentanil|sufentanil|mesh-list
84061449|NCT02868944|Morphine|morphine|mesh-list
84061450|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
84061451|NCT02868944|Anesthetics|anesthetics|mesh-list
84061452|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
84061453|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84061454|NCT02868944|Narcotics|narcotics|mesh-ancestor
84061455|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061456|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061457|NCT02868944|Analgesics|analgesics|mesh-ancestor
84061458|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
84061459|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061460|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84061461|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84061462|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
83241069|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
84061463|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84061464|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84061465|NCT00722839|Vaccines|vaccines|mesh-list
84061466|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
84061467|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061468|NCT04096690|Pegaspargase|pegaspargase|mesh-list
84061469|NCT04096690|Antibodies|antibodies|mesh-list
84061470|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84061471|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
84061472|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061473|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061474|NCT03565783|Cemiplimab|cemiplimab|mesh-list
84061475|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84061476|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061477|NCT00719797|Leucovorin|leucovorin|mesh-list
84061478|NCT00719797|Bevacizumab|bevacizumab|mesh-list
84061479|NCT00719797|Fluorouracil|fluorouracil|mesh-list
84061480|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
84061481|NCT00719797|Irinotecan|irinotecan|mesh-list
84061482|NCT00719797|Calcium|calcium|mesh-list
84061483|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
83241205|NCT03118037|Zaleplon|zaleplon|mesh-list
84061484|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84061485|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061486|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84061487|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84061488|NCT00719797|Growth Substances|growth substances|mesh-ancestor
84061489|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061490|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
84061491|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84061492|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
84061493|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061494|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84061495|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061496|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
84061497|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84061498|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84061499|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061500|NCT00719797|Antidotes|antidotes|mesh-ancestor
83241325|NCT04389775|Hormones|hormones|mesh-ancestor
84061501|NCT00719797|Protective Agents|protective agents|mesh-ancestor
84061502|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
84061503|NCT00719797|Vitamins|vitamins|mesh-ancestor
84061504|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
84061505|NCT00979628|Insulin|insulin|mesh-list
84061506|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84061507|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
84061508|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
84061509|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83241427|NCT03945721|Niraparib|niraparib|mesh-list
84061510|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061511|NCT00719875|Vorinostat|vorinostat|mesh-list
84061512|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84061513|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061514|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061515|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061516|NCT02685111|Lenograstim|lenograstim|mesh-list
84061517|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84061518|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
84061519|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061520|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84061521|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84061522|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061523|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84061524|NCT00717925|Immunotoxins|immunotoxins|mesh-ancestor
84061525|NCT00717925|Immunoconjugates|immunoconjugates|mesh-ancestor
84061526|NCT00717925|Immunologic Factors|immunologic factors|mesh-ancestor
84061527|NCT00717925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061528|NCT03258723|Metformin|metformin|mesh-list
84061529|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84061530|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061531|NCT00640029|Meloxicam|meloxicam|mesh-list
84061532|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84061533|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061534|NCT00640029|Analgesics|analgesics|mesh-ancestor
84061535|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
84061536|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061537|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061538|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84061539|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061540|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84061541|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84061542|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061543|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061544|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
84061545|NCT02684799|Omeprazole|omeprazole|mesh-list
84061546|NCT02684799|Famotidine|famotidine|mesh-list
84061547|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84061548|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84061549|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84061550|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061551|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061552|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84061553|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
84061554|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
84061555|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061556|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061557|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84061558|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84061559|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84061560|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
84061561|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061562|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
84061563|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061564|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061565|NCT00992108|Lidocaine|lidocaine|mesh-list
84061566|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
84061567|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
84061568|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241572|NCT05103397|Hormones|hormones|mesh-ancestor
84061569|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061570|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
84061571|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061572|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84061573|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84061574|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84061575|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84061576|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061577|NCT00752986|Fulvestrant|fulvestrant|mesh-list
84061578|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84061579|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061580|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84061581|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84061582|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
84061583|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84061584|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061585|NCT02684487|Vitamin D|vitamin d|mesh-list
84061586|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
84061587|NCT02684487|Vitamins|vitamins|mesh-ancestor
84061588|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
84061589|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061590|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84061591|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84061592|NCT02684409|Sumatriptan|sumatriptan|mesh-list
84061593|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84061594|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84061595|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84061596|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
84061597|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061598|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061599|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061600|NCT00762892|Tenofovir|tenofovir|mesh-list
84061601|NCT00762892|Emtricitabine|emtricitabine|mesh-list
84061602|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
84061603|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84061604|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84061605|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
84061606|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061607|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83241899|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84061608|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84061609|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061610|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061611|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84061612|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84061613|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84061614|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84061615|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84061616|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84061617|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
84061618|NCT04290572|Isotretinoin|isotretinoin|mesh-list
84061619|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
84061620|NCT04069429|Heparin|heparin|mesh-list
84061621|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
84061622|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84061623|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84061624|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061625|NCT00755716|Topiramate|topiramate|mesh-list
84061626|NCT00755716|Nicotine|nicotine|mesh-list
84061627|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84061628|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
84061629|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061630|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061631|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84061632|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83241964|NCT04210141|Antivenins|antivenins|mesh-list
84061633|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
84061634|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061635|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061636|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
84061637|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84061638|NCT00629252|Risperidone|risperidone|mesh-list
84061639|NCT00629252|Sertindole|sertindole|mesh-list
84061640|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84061641|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
83242078|NCT04965545|Copper|copper|mesh-list
84061642|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061643|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061644|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061645|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84061646|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84061647|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061648|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84061649|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84061650|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
84061651|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
84061652|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84061653|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061654|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061655|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
84061656|NCT04095754|Anesthetics|anesthetics|mesh-list
84061657|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061658|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061659|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84061660|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061661|NCT04095754|Analgesics|analgesics|mesh-ancestor
84061662|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
84061663|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061664|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84061665|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84061666|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84061667|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
84061668|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061669|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061670|NCT00720265|Tacrolimus|tacrolimus|mesh-list
84061671|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061672|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
84061673|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061674|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84061675|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061676|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061677|NCT02600650|Testosterone|testosterone|mesh-list
84061678|NCT02600650|Androgens|androgens|mesh-ancestor
84061679|NCT02600650|Hormones|hormones|mesh-ancestor
84061680|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84061681|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061682|NCT03084471|Durvalumab|durvalumab|mesh-list
84061683|NCT03084471|Tremelimumab|tremelimumab|mesh-list
84061684|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84061685|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84061686|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061687|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
84061688|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061689|NCT00718471|Heparin|heparin|mesh-list
84061690|NCT00718471|Enoxaparin|enoxaparin|mesh-list
84061691|NCT00718471|Calcium heparin|calcium heparin|mesh-list
84061692|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
84061693|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84061694|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83242276|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
84061695|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061696|NCT00723307|Metformin|metformin|mesh-list
84061697|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84061698|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061699|NCT00723385|Vitamin D|vitamin d|mesh-list
84061700|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
84061701|NCT00723385|Vitamins|vitamins|mesh-ancestor
84061702|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
84061703|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061704|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83242332|NCT04121299|Protective Agents|protective agents|mesh-ancestor
83242476|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
84061705|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84061706|NCT00754936|Escitalopram|escitalopram|mesh-list
84061707|NCT00754936|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84061708|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84061709|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84061710|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061711|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061712|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
84061713|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061714|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
84061715|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
84061716|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84061717|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061718|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301644|NCT04762966|Metformin|metformin|mesh-list
84061720|NCT02684019|Analgesics|analgesics|mesh-ancestor
84061721|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
84061722|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061723|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84061724|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84061725|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84061726|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
84061727|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061728|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061729|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
84061730|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84061731|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
84061732|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84061733|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84061734|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84061735|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
84061736|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84061737|NCT00720421|Lorazepam|lorazepam|mesh-list
84061738|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
84061739|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
84061740|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
84061741|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061742|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061743|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84061744|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84061745|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061746|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84061747|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84061748|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84061749|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
84061750|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
84061751|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061752|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061753|NCT02689713|Voriconazole|voriconazole|mesh-list
84061754|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
84061755|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061756|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84061757|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84061758|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061759|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061760|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84061761|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
84061762|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84061763|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061764|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84061765|NCT02601508|Rocuronium|rocuronium|mesh-list
84061766|NCT02601508|Atracurium|atracurium|mesh-list
84061767|NCT02601508|Cisatracurium|cisatracurium|mesh-list
84061768|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84061769|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84061770|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84061771|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061772|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061773|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84061774|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84061775|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
84061776|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061777|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061778|NCT02570581|Acetaminophen|acetaminophen|mesh-list
84061779|NCT02570581|Ramipril|ramipril|mesh-list
84061780|NCT02570581|Furosemide|furosemide|mesh-list
84061781|NCT02570581|Memantine|memantine|mesh-list
84061782|NCT02570581|Alprazolam|alprazolam|mesh-list
84061783|NCT02570581|Zopiclone|zopiclone|mesh-list
84061784|NCT02570581|Oxazepam|oxazepam|mesh-list
84061785|NCT02570581|Donepezil|donepezil|mesh-list
84061786|NCT02570581|Clopidogrel|clopidogrel|mesh-list
84061787|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84061788|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84061789|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84061790|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84061791|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
84061792|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301713|NCT01560507|Bupropion|bupropion|mesh-list
84061793|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061794|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061796|NCT02570581|Analgesics|analgesics|mesh-ancestor
84061797|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
84061798|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061799|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
84061800|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84061801|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061802|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
84061803|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
84061804|NCT02570581|Diuretics|diuretics|mesh-ancestor
84061805|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
84061806|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84061807|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84061808|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84061809|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84061810|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
84061811|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84061812|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84061813|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84061814|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
84061815|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84061816|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84061817|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061818|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84061819|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84061820|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84061821|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
84061822|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
84061823|NCT00640263|Ritonavir|ritonavir|mesh-list
84061824|NCT00640263|Lopinavir|lopinavir|mesh-list
84061825|NCT00640263|Lamivudine|lamivudine|mesh-list
84061826|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84061827|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84061828|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
83243437|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
83243490|NCT03520231|Calcium|calcium|mesh-list
84061829|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061830|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061831|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84061832|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84061833|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
84061834|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061835|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84061836|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84061837|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84061838|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84061839|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84061840|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
84061841|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84061842|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
84061843|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061844|NCT04019288|Durvalumab|durvalumab|mesh-list
84061845|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
84061846|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84061847|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
84061848|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84061849|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061850|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
84061851|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061852|NCT02865668|Metformin|metformin|mesh-list
84061853|NCT02865668|Canagliflozin|canagliflozin|mesh-list
84061854|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84061855|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061856|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84061857|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061858|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
84061859|NCT02867930|Ketamine|ketamine|mesh-list
84061860|NCT02867930|Propofol|propofol|mesh-list
84061861|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83301783|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061862|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061863|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061864|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061865|NCT02867930|Analgesics|analgesics|mesh-ancestor
84061866|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
84061867|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061868|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84061869|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84061871|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
84061872|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061873|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061874|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84061875|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
84061876|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
84061877|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84061878|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84061879|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84061880|NCT02570893|Paclitaxel|paclitaxel|mesh-list
84061881|NCT02570893|Carboplatin|carboplatin|mesh-list
84061882|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84061883|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84061884|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
84061885|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
84061886|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
84061887|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061888|NCT02538081|Risperidone|risperidone|mesh-list
84061889|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84061890|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
84061891|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061892|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061893|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061894|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84061895|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84061896|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84061897|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84061898|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84061899|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
84061900|NCT02570971|Mannitol|mannitol|mesh-list
84061901|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84061902|NCT02570971|Diuretics|diuretics|mesh-ancestor
84061903|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
84061904|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061905|NCT02866214|Febuxostat|febuxostat|mesh-list
84061906|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
84061907|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061908|NCT02866448|Aspirin|aspirin|mesh-list
84061909|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84061910|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061911|NCT02866448|Analgesics|analgesics|mesh-ancestor
84061912|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
84061913|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061914|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061915|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84061916|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84061917|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84061918|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84061919|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061920|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84061921|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84061922|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061923|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
84061924|NCT00578227|Vaccines|vaccines|mesh-list
84061925|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
84061926|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061927|NCT00720577|Pioglitazone|pioglitazone|mesh-list
84061928|NCT00720577|Losartan|losartan|mesh-list
84061929|NCT00720577|Simvastatin|simvastatin|mesh-list
84061930|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84061931|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84061932|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
84061933|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061934|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84061935|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84061936|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061937|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84061938|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061939|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84061940|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83301854|NCT03674242|Carboplatin|carboplatin|mesh-list
84061941|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84061942|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84061943|NCT05373277|Ticagrelor|ticagrelor|mesh-list
84061944|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84061945|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84061946|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84061947|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
84061948|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84061949|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84061950|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84061951|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84061952|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84061953|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84061954|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84061955|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83244300|NCT04881851|Folic Acid|folic acid|mesh-list
84061956|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
84061957|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84061958|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061959|NCT00724321|Iloprost|iloprost|mesh-list
84061960|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84061961|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
84061962|NCT00720811|Acetaminophen|acetaminophen|mesh-list
84061963|NCT00720811|Amoxicillin|amoxicillin|mesh-list
84061964|NCT00720811|Lumefantrine|lumefantrine|mesh-list
84061965|NCT00720811|Artemether|artemether|mesh-list
84061966|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84061967|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244429|NCT04878497|Warfarin|warfarin|mesh-list
84061968|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84061969|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84061970|NCT00720811|Analgesics|analgesics|mesh-ancestor
84061971|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
84061972|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84061973|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84061974|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
84061975|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
84061976|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84061977|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84061978|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
84061979|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84061980|NCT00577993|Interferons|interferons|mesh-list
84061981|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
84061982|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
84061983|NCT00577993|Dexamethasone|dexamethasone|mesh-list
84061984|NCT00577993|Prednisone|prednisone|mesh-list
84061985|NCT00577993|Prednisolone|prednisolone|mesh-list
84061986|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84061987|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
84061988|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84061989|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
84061990|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
84061991|NCT00577993|Rituximab|rituximab|mesh-list
84061992|NCT00577993|Doxorubicin|doxorubicin|mesh-list
84061993|NCT00577993|Fludarabine|fludarabine|mesh-list
84061994|NCT00577993|Etoposide|etoposide|mesh-list
84061995|NCT00577993|Vincristine|vincristine|mesh-list
84061996|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
84061997|NCT00577993|Bleomycin|bleomycin|mesh-list
84061998|NCT00577993|Procarbazine|procarbazine|mesh-list
84061999|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84062000|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
84062001|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83244493|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
84062002|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
84062003|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062004|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062005|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84062006|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
84062007|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062008|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062009|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84062010|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84062011|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062012|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
84062013|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
84062014|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062015|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062016|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
84062017|NCT00577993|Hormones|hormones|mesh-ancestor
84062018|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84062019|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84062020|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062021|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062022|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84062023|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84062024|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84062025|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
84062026|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062027|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
84062028|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
84062029|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
84062030|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84062031|NCT00577993|Protective Agents|protective agents|mesh-ancestor
84062032|NCT00577993|Analgesics|analgesics|mesh-ancestor
84062033|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
84062034|NCT00975806|Lenalidomide|lenalidomide|mesh-list
84062035|NCT00975806|Sunitinib|sunitinib|mesh-list
84062036|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
84062037|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062038|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84062039|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84062040|NCT00975806|Growth Substances|growth substances|mesh-ancestor
84062041|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
83244669|NCT04969237|Vitamin D|vitamin d|mesh-list
84062042|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062043|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84062044|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062045|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062046|NCT00721201|Mifepristone|mifepristone|mesh-list
84062047|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84062048|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
84062049|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062050|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062051|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84062052|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84062053|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84062054|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
84062055|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84062056|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84062057|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
84062058|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84062059|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
84062060|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84062061|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84062062|NCT02866370|Paclitaxel|paclitaxel|mesh-list
84062063|NCT02866370|Carboplatin|carboplatin|mesh-list
84062064|NCT02866370|Doxorubicin|doxorubicin|mesh-list
84062065|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84062066|NCT02866370|Topotecan|topotecan|mesh-list
84062067|NCT02866370|Nintedanib|nintedanib|mesh-list
84062068|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84062069|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062070|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
84062071|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
84062072|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
84062073|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062074|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062075|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84062076|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84062077|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062078|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84062079|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84062080|NCT00978068|Ritonavir|ritonavir|mesh-list
84062081|NCT00978068|Lopinavir|lopinavir|mesh-list
84062082|NCT00978068|Nevirapine|nevirapine|mesh-list
84062083|NCT00978068|Efavirenz|efavirenz|mesh-list
84062084|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
84062085|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84062086|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84062087|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
84062088|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062089|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062090|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84062091|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84062092|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
84062093|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062094|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84062095|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84062096|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84062097|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84062098|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84062099|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84062100|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84062101|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84062102|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
84062103|NCT00629642|Oxybutynin|oxybutynin|mesh-list
84062104|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84062105|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84062106|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
84062107|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062108|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062109|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062110|NCT00629642|Urological Agents|urological agents|mesh-ancestor
84062111|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
84062112|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
84062113|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062114|NCT02865356|Cyclosporine|cyclosporine|mesh-list
84062115|NCT02865356|Cyclosporins|cyclosporins|mesh-list
84062116|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062117|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062118|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062119|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
84062120|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062121|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
84062122|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062123|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
84062124|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062125|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84062126|NCT04287842|Sevoflurane|sevoflurane|mesh-list
84062127|NCT04287842|Desflurane|desflurane|mesh-list
84062128|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84062129|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84062130|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
84062131|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
84062132|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062133|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062134|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
84062135|NCT00721747|Docetaxel|docetaxel|mesh-list
84062136|NCT00721747|Doxorubicin|doxorubicin|mesh-list
84062137|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84062138|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062139|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
84062140|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062141|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062142|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84062143|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
84062144|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062145|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062146|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84062147|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
84062148|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
84062149|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
83245217|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062150|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062151|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84062152|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84062153|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062154|NCT00603525|Ofatumumab|ofatumumab|mesh-list
84062155|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062156|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84062157|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
84062158|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062159|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84062160|NCT02689401|Hematinics|hematinics|mesh-ancestor
84062161|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84062162|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84062163|NCT00640575|Triamcinolone|triamcinolone|mesh-list
84062164|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84062165|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84062166|NCT00640575|Lidocaine|lidocaine|mesh-list
84062167|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84062168|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
84062169|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
84062170|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062171|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062172|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
84062173|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062174|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84062175|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84062176|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84062177|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84062178|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062179|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062181|NCT00640575|Hormones|hormones|mesh-ancestor
84062182|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84062183|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062184|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
84062185|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062186|NCT04067791|Melatonin|melatonin|mesh-list
84062187|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
84062188|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062189|NCT04067791|Protective Agents|protective agents|mesh-ancestor
84062190|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062191|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062192|NCT00762034|Paclitaxel|paclitaxel|mesh-list
84062193|NCT00762034|Bevacizumab|bevacizumab|mesh-list
84062194|NCT00762034|Carboplatin|carboplatin|mesh-list
84062195|NCT00762034|Pemetrexed|pemetrexed|mesh-list
84062196|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83245419|NCT05244811|Progestins|progestins|mesh-list
84062197|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062198|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
84062199|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
84062200|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
84062201|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062202|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84062203|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84062204|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84062205|NCT00762034|Growth Substances|growth substances|mesh-ancestor
84062206|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062207|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
84062208|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062209|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84062210|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84062211|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
84062212|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84062213|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
84062214|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84062215|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
84062216|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062217|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062218|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
84062219|NCT04183881|Brodalumab|brodalumab|mesh-list
84062220|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
84062221|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
84062222|NCT04093648|Fludarabine|fludarabine|mesh-list
84062223|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062224|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
84062225|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062226|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062227|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84062228|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
84062229|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062230|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062231|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84062232|NCT04184115|Scopolamine|scopolamine|mesh-list
84062233|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83245584|NCT04843553|Niacin|niacin|mesh-list
84062234|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
84062235|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
84062236|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062237|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062238|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062239|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
84062240|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84062241|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
84062242|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062243|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302160|NCT01689519|Vemurafenib|vemurafenib|mesh-list
84062244|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84062245|NCT00722215|Nifedipine|nifedipine|mesh-list
84062246|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
84062247|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83245590|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84062248|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84062249|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062250|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84062251|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062252|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
84062253|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
84062254|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062255|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84062256|NCT00640809|Ibuprofen|ibuprofen|mesh-list
84062257|NCT00640809|Celecoxib|celecoxib|mesh-list
84062258|NCT00640809|Omeprazole|omeprazole|mesh-list
84062259|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84062260|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84062261|NCT00640809|Analgesics|analgesics|mesh-ancestor
84062262|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
84062263|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062264|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062265|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062266|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062267|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84062268|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062269|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062270|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84062271|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84062272|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062273|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84062274|NCT00754624|Insulin|insulin|mesh-list
84062275|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84062276|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062277|NCT05630209|Doxorubicin|doxorubicin|mesh-list
84062278|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062279|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062280|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84062281|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84062282|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062283|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062284|NCT00722293|Doxorubicin|doxorubicin|mesh-list
84062285|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84062286|NCT00722293|Epirubicin|epirubicin|mesh-list
84062287|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062288|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062289|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84062290|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84062291|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245778|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84062292|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062293|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
84062294|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84062295|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062296|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84062297|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062298|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
84062299|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
84062300|NCT02683005|Ledipasvir|ledipasvir|mesh-list
84062301|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
84062302|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062303|NCT03583957|Caffeine|caffeine|mesh-list
83245847|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062304|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84062305|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062306|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84062307|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062308|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062309|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84062310|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84062311|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
84062312|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062313|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
84062314|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
84062315|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84062316|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84062317|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
84062319|NCT02571283|Epinephrine|epinephrine|mesh-list
84062320|NCT02571283|Bupivacaine|bupivacaine|mesh-list
84062321|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
84062322|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
84062323|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062324|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062325|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
84062326|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062327|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062328|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
84062329|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84062330|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84062331|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
84062332|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062333|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84062334|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84062335|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84062336|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
84062337|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
84062338|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
84062339|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84062340|NCT02682693|Denosumab|denosumab|mesh-list
84062341|NCT02682693|Paclitaxel|paclitaxel|mesh-list
84062342|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
84062343|NCT02682693|Carboplatin|carboplatin|mesh-list
84062344|NCT02682693|Trastuzumab|trastuzumab|mesh-list
84062345|NCT02682693|Epirubicin|epirubicin|mesh-list
84062346|NCT02682693|Pertuzumab|pertuzumab|mesh-list
84062347|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84062348|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062349|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
84062350|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
84062351|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
84062352|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062353|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062354|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
84062355|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062356|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246244|NCT04822649|Adenosine|adenosine|mesh-list
84062357|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84062358|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
84062359|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84062360|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84062361|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062362|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84062363|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84062364|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062365|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84062366|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
84062367|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84062368|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84062369|NCT02571517|Prednisolone|prednisolone|mesh-list
84062370|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
84062371|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84062372|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
84062373|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
84062374|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062375|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
84062376|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
84062377|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062378|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246324|NCT05062681|Hormones|hormones|mesh-ancestor
84062379|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062380|NCT02571517|Hormones|hormones|mesh-ancestor
84062381|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84062382|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84062383|NCT02571517|Protective Agents|protective agents|mesh-ancestor
84062384|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84062385|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062386|NCT00586846|Doxorubicin|doxorubicin|mesh-list
84062387|NCT00586846|Methotrexate|methotrexate|mesh-list
84062388|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246440|NCT05035381|Fluorouracil|fluorouracil|mesh-list
84062389|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062390|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84062391|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83302318|NCT01558089|Etanercept|etanercept|mesh-list
84062392|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062393|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062394|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84062395|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
84062396|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062397|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062398|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84062399|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
84062400|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
84062401|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84062402|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062403|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
84062404|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062405|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84062406|NCT04144465|Phenylephrine|phenylephrine|mesh-list
84062407|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
84062408|NCT04144465|Norepinephrine|norepinephrine|mesh-list
84062409|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84062410|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
84062411|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
84062412|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062413|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062414|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
84062415|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84062416|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
84062417|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
84062418|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84062419|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84062420|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84062421|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
84062422|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062423|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062424|NCT04144465|Protective Agents|protective agents|mesh-ancestor
84062425|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
84062426|NCT00754390|Calcium|calcium|mesh-list
84062427|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84062428|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062429|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84062430|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
84062431|NCT04066621|Sulbactam|sulbactam|mesh-list
84062432|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84062433|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062434|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84062435|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062436|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062437|NCT00629564|Esomeprazole|esomeprazole|mesh-list
84062438|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84062439|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062440|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84062441|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062442|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062443|NCT02865824|Aspirin|aspirin|mesh-list
84062444|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84062445|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84062446|NCT02865824|Analgesics|analgesics|mesh-ancestor
84062447|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
84062448|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062449|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062450|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062451|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062452|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84062453|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84062454|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062455|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84062456|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84062457|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062458|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
84062459|NCT02570035|Mirabegron|mirabegron|mesh-list
84062460|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84062461|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83302384|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302385|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302386|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83302387|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302388|NCT03085030|Antioxidants|antioxidants|mesh-list
84062462|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84062463|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
84062464|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062465|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062466|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062467|NCT02570035|Urological Agents|urological agents|mesh-ancestor
84062468|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
84062469|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84062470|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062471|NCT04098796|Antibodies|antibodies|mesh-list
84062472|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
84062473|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062474|NCT00522145|XL647|xl647|mesh-list
84062475|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062476|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84062477|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062478|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062479|NCT00726973|Ranibizumab|ranibizumab|mesh-list
84062480|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84062481|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84062482|NCT00726973|Growth Substances|growth substances|mesh-ancestor
84062483|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062484|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
84062485|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062486|NCT02571361|Acetaminophen|acetaminophen|mesh-list
84062487|NCT02571361|Ibuprofen|ibuprofen|mesh-list
84062488|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84062489|NCT02571361|Analgesics|analgesics|mesh-ancestor
84062490|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
84062491|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062492|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062493|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
84062494|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83246898|NCT05027191|Desflurane|desflurane|mesh-list
83246934|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84062495|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062496|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062497|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84062498|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062499|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062500|NCT04290104|Ampicillin|ampicillin|mesh-list
84062501|NCT04290104|Sulbactam|sulbactam|mesh-list
84062502|NCT04290104|Sultamicillin|sultamicillin|mesh-list
84062503|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84062504|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062505|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84062506|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062507|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062508|NCT02571205|Testosterone|testosterone|mesh-list
84062509|NCT02571205|Androgens|androgens|mesh-ancestor
84062510|NCT02571205|Hormones|hormones|mesh-ancestor
84062511|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84062512|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062513|NCT04290026|Metoclopramide|metoclopramide|mesh-list
84062514|NCT04290026|Granisetron|granisetron|mesh-list
84062515|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
84062516|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
84062517|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062518|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062519|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062520|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84062521|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84062522|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
84062523|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062524|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247069|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84062525|NCT04290026|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84062526|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84062527|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
84062528|NCT00640887|Ritonavir|ritonavir|mesh-list
84062529|NCT00640887|Lopinavir|lopinavir|mesh-list
84062530|NCT00640887|Nevirapine|nevirapine|mesh-list
84062531|NCT00640887|Efavirenz|efavirenz|mesh-list
84062532|NCT00640887|Rifabutin|rifabutin|mesh-list
84062533|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84062534|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84062535|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
84062536|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062537|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062538|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84062539|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84062540|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
84062541|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062542|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84062543|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84062544|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84062545|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83247349|NCT02637037|Metformin|metformin|mesh-list
84062546|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84062547|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84062548|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84062549|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84062550|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84062551|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84062552|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84062553|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
84062554|NCT05615623|Doxorubicin|doxorubicin|mesh-list
84062555|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84062556|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062557|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83247420|NCT03081949|Selenium|selenium|mesh-list
84062558|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84062559|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062560|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062561|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
84062562|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
84062564|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
84062565|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062566|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
84062567|NCT00730093|Hematinics|hematinics|mesh-ancestor
83247554|NCT02522325|Cocaine|cocaine|mesh-list
84062568|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84062569|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84062570|NCT00727129|Estradiol|estradiol|mesh-list
84062571|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84062572|NCT00727129|Estrogens|estrogens|mesh-ancestor
84062573|NCT00727129|Hormones|hormones|mesh-ancestor
84062574|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84062575|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062576|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84062577|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
84062578|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062579|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84062580|NCT04183725|Oseltamivir|oseltamivir|mesh-list
84062581|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
84062582|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062583|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062584|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062585|NCT00730249|Methylphenidate|methylphenidate|mesh-list
84062586|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84062587|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062588|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84062589|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84062590|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84062591|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062592|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
84062593|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062594|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84062595|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84062596|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062597|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84062598|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062599|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062600|NCT01632657|Sumatriptan|sumatriptan|mesh-list
84062601|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84062602|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84062603|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84062604|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
84062605|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062606|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062607|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062608|NCT00727207|Everolimus|everolimus|mesh-list
84062609|NCT00727207|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83302545|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
84062610|NCT00727207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84062611|NCT00727207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062612|NCT00727207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062613|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062614|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
84062615|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062616|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062617|NCT02682459|Lisinopril|lisinopril|mesh-list
84062618|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84062619|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
84062620|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247796|NCT03073057|Charcoal|charcoal|mesh-list
84062621|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062622|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84062623|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84062624|NCT02682459|Protective Agents|protective agents|mesh-ancestor
84062625|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062626|NCT02620579|Propranolol|propranolol|mesh-list
84062627|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84062628|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84062629|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
84062630|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062631|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062632|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062633|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84062634|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84062635|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
84062636|NCT02682225|Ketamine|ketamine|mesh-list
84062637|NCT02682225|Esketamine|esketamine|mesh-list
84062638|NCT02682225|Analgesics|analgesics|mesh-ancestor
84062639|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
84062640|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062641|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062642|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84062643|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84062644|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
84062645|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
84062646|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062647|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84062648|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84062649|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062650|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062651|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
84062652|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84062653|NCT00365157|Halichondrin B|halichondrin b|mesh-list
84062654|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
83247925|NCT03072121|Trimetazidine|trimetazidine|mesh-list
84062655|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
84062656|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
84062657|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062658|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062659|NCT04066231|Erythromycin|erythromycin|mesh-list
84062660|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
84062661|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84062662|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
84062663|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
84062664|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84062665|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062666|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062667|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84062668|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062669|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062670|NCT04183491|Interferons|interferons|mesh-list
84062671|NCT04183491|Interferon-beta|interferon-beta|mesh-list
84062672|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
84062673|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062674|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
84062675|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062676|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
84062677|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062678|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84062679|NCT03702283|Penicillins|penicillins|mesh-list
84062680|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84062681|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062682|NCT00727753|Bevacizumab|bevacizumab|mesh-list
84062683|NCT00727753|Ranibizumab|ranibizumab|mesh-list
83302614|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
84062684|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84062685|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062686|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84062687|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84062688|NCT00727753|Growth Substances|growth substances|mesh-ancestor
84062689|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062690|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
84062691|NCT00727831|Leucovorin|leucovorin|mesh-list
84062692|NCT00727831|Methotrexate|methotrexate|mesh-list
84062693|NCT00727831|Calcium|calcium|mesh-list
84062694|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
84062695|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84062696|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062697|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84062698|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
84062699|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062700|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84062701|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
84062702|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062703|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062704|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
84062705|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062706|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84062707|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062708|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
84062709|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062710|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84062711|NCT00727831|Antidotes|antidotes|mesh-ancestor
84062712|NCT00727831|Protective Agents|protective agents|mesh-ancestor
84062713|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
84062714|NCT00727831|Vitamins|vitamins|mesh-ancestor
84062715|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
84062716|NCT00727987|Golimumab|golimumab|mesh-list
84062717|NCT00727987|Methotrexate|methotrexate|mesh-list
84062718|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84062719|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
84062720|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062721|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062722|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84062723|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
84062724|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062725|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062726|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
84062727|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062728|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84062729|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062730|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
84062731|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062732|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84062733|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84062734|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062735|NCT02681913|Adenosine|adenosine|mesh-list
84062736|NCT02681913|Analgesics|analgesics|mesh-ancestor
83248154|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
84062737|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
84062738|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062739|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062740|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84062741|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
84062742|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84062743|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
84062744|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
84062745|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062746|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062747|NCT02681679|Bromfenac|bromfenac|mesh-list
84062748|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84062749|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84062750|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84062751|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84062752|NCT02681679|Analgesics|analgesics|mesh-ancestor
83248284|NCT02595749|Oxytocin|oxytocin|mesh-list
84062753|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
84062754|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062755|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062756|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062757|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062758|NCT04183257|Vitamin D|vitamin d|mesh-list
84062759|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
84062760|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
84062761|NCT04183257|Vitamins|vitamins|mesh-list
84062762|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
84062763|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062764|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84062765|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84062766|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
84062767|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
84062768|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84062769|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84062770|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83248418|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
84062771|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84062772|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
84062773|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84062774|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
84062775|NCT00641589|Hematinics|hematinics|mesh-ancestor
84062776|NCT00734383|Propofol|propofol|mesh-list
84062777|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84062778|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062779|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062780|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84062781|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
84062782|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
84062783|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84062784|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
84062785|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062786|NCT02680977|Levodopa|levodopa|mesh-list
84062787|NCT02680977|Benserazide|benserazide|mesh-list
84062788|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84062789|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84062790|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
84062791|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84062792|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062793|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062794|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062795|NCT00734695|Vitamins|vitamins|mesh-list
84062796|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
84062797|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
84062798|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062799|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
84062800|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062801|NCT00734695|Protective Agents|protective agents|mesh-ancestor
84062802|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84062803|NCT00586690|Antibodies|antibodies|mesh-list
84062804|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
84062805|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84062806|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
84062807|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062808|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062809|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
84062810|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84062811|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
84062812|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062813|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
84062814|NCT00728611|Protective Agents|protective agents|mesh-ancestor
84062815|NCT05663775|Mesalamine|mesalamine|mesh-list
84062816|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84062817|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84062818|NCT05663775|Analgesics|analgesics|mesh-ancestor
84062819|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
84062820|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062821|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062822|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062823|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062824|NCT00909987|Bevacizumab|bevacizumab|mesh-list
84062825|NCT00909987|Capecitabine|capecitabine|mesh-list
84062826|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
84062827|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84062828|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062829|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84062830|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84062831|NCT00909987|Growth Substances|growth substances|mesh-ancestor
84062832|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062833|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
84062834|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84062835|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
84062836|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062837|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84062838|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
84062839|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062840|NCT00760474|Pregabalin|pregabalin|mesh-list
84062841|NCT00760474|Analgesics|analgesics|mesh-ancestor
84062842|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
84062843|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062844|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062845|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
84062846|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84062847|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84062848|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062849|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84062850|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84062851|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84062852|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062853|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84062854|NCT02843035|Venglustat|venglustat|mesh-list
84062855|NCT02843035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062856|NCT02843035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062857|NCT02680119|Esomeprazole|esomeprazole|mesh-list
84062858|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84062859|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84062860|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84062861|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062862|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062863|NCT00734773|Cytarabine|cytarabine|mesh-list
84062864|NCT00734773|Rituximab|rituximab|mesh-list
84062865|NCT00734773|Methotrexate|methotrexate|mesh-list
84062866|NCT00734773|Vincristine|vincristine|mesh-list
84062867|NCT00734773|Procarbazine|procarbazine|mesh-list
84062868|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
84062869|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84062870|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062871|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
84062872|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062873|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84062874|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84062875|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
84062876|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062877|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84062878|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
84062879|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062880|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
84062881|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062882|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84062883|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062884|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84062885|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
84062886|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248989|NCT01667081|Grazoprevir|grazoprevir|mesh-list
84062887|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84062888|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
84062889|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
84062890|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
84062891|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84062892|NCT04289090|Propofol|propofol|mesh-list
84062893|NCT04289090|Sevoflurane|sevoflurane|mesh-list
84062894|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84062895|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062896|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062897|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84062898|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
84062899|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
84062900|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84062901|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84062902|NCT00975416|Oxytocin|oxytocin|mesh-list
84062903|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
84062904|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062905|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062906|NCT02679963|Olaparib|olaparib|mesh-list
84062907|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84062908|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062909|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062910|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062911|NCT00760084|Decitabine|decitabine|mesh-list
84062912|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84062914|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062915|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062916|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062917|NCT00735241|Leucovorin|leucovorin|mesh-list
84062918|NCT00735241|Folic Acid|folic acid|mesh-list
84062919|NCT00735241|Bevacizumab|bevacizumab|mesh-list
84062920|NCT00735241|Fluorouracil|fluorouracil|mesh-list
84062921|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
84062922|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
84062923|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84062924|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062925|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84062926|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83249168|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
84062927|NCT00735241|Growth Substances|growth substances|mesh-ancestor
84062928|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062929|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
84062930|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
84062931|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062932|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84062933|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84062934|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
84062935|NCT00735241|Antidotes|antidotes|mesh-ancestor
84062936|NCT00735241|Protective Agents|protective agents|mesh-ancestor
84062937|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
84062938|NCT00735241|Vitamins|vitamins|mesh-ancestor
84062939|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
84062940|NCT00735241|Hematinics|hematinics|mesh-ancestor
84062941|NCT00729313|Lanreotide|lanreotide|mesh-list
84062942|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062943|NCT00641979|Budesonide|budesonide|mesh-list
84062944|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062945|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84062946|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
84062947|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062948|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062949|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84062950|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
84062951|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
84062952|NCT00641979|Hormones|hormones|mesh-ancestor
84062953|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84062954|NCT02679339|Lidocaine|lidocaine|mesh-list
84062955|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
84062956|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
84062957|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84062958|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84062959|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
84062960|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062961|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83249440|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
84062962|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84062963|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84062964|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84062965|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062966|NCT02679261|Atorvastatin|atorvastatin|mesh-list
84062967|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84062968|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84062969|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
84062970|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062971|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84062972|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84062973|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062974|NCT00752206|Saracatinib|saracatinib|mesh-list
83249508|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
84062975|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84062976|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84062977|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062978|NCT02678949|Fluticasone|fluticasone|mesh-list
84062979|NCT02678949|Xhance|xhance|mesh-list
84062980|NCT02678949|Albuterol|albuterol|mesh-list
84062981|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84062982|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84062983|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
84062984|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84062985|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302913|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
84062986|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84062987|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
84062988|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
84062989|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84062990|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
84062991|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84062992|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84062993|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84062994|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84062995|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
84062996|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249629|NCT05008809|Protective Agents|protective agents|mesh-ancestor
84062997|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84062999|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
84063000|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84063001|NCT00642135|Tropicamide|tropicamide|mesh-list
84063002|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84063003|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
84063004|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
84063005|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063006|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063007|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
84063008|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84063009|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
84063010|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
84063011|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84063012|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84063013|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84063014|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
84063015|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063016|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063017|NCT00642135|Protective Agents|protective agents|mesh-ancestor
84063018|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84063019|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84063020|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84063021|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
84063022|NCT00642291|Emtricitabine|emtricitabine|mesh-list
84063023|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
84063024|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063025|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84063026|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84063027|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063028|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063029|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84063030|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84063031|NCT02600260|Enoxaparin|enoxaparin|mesh-list
84063032|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
84063033|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
84063034|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84063035|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063036|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063037|NCT02537379|Ribavirin|ribavirin|mesh-list
84063038|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
84063039|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063040|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
84063041|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063042|NCT05442034|Mitogens|mitogens|mesh-list
84063043|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
84063044|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063045|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
84063046|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063047|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
84063048|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84063049|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84063050|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063051|NCT04179747|Urological Agents|urological agents|mesh-ancestor
84063052|NCT04204772|Charcoal|charcoal|mesh-list
84063053|NCT04204772|Antidotes|antidotes|mesh-ancestor
84063054|NCT04204772|Protective Agents|protective agents|mesh-ancestor
84063055|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063056|NCT02675205|Aspirin|aspirin|mesh-list
84063057|NCT02675205|Clopidogrel|clopidogrel|mesh-list
84063058|NCT02675205|Ticagrelor|ticagrelor|mesh-list
84063059|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063060|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063061|NCT02675205|Analgesics|analgesics|mesh-ancestor
84063062|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
83250083|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
84063063|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063064|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063065|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063066|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063067|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84063068|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063069|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063070|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84063071|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84063072|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063073|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
84063074|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84063075|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84063076|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84063077|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
84063078|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063079|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
84063080|NCT00753454|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84063081|NCT00753454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063082|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83250159|NCT02513823|Vitamins|vitamins|mesh-ancestor
84063083|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
84063084|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063085|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063086|NCT00643539|Azithromycin|azithromycin|mesh-list
84063087|NCT00643539|Amoxicillin|amoxicillin|mesh-list
84063088|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063089|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063090|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
84063091|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84063092|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84063093|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84063094|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063095|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063096|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84063097|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84063098|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063099|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063100|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063101|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84063102|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
84063103|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84063104|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063105|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84063106|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84063107|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84063108|NCT00910065|Aspirin|aspirin|mesh-list
84063109|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
84063110|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063111|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063112|NCT00910065|Analgesics|analgesics|mesh-ancestor
84063113|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
84063114|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063115|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063116|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063117|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063118|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84063119|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063120|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063121|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84063122|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84063123|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063124|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
84063125|NCT02601040|Vaccines|vaccines|mesh-list
84063126|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
84063127|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063128|NCT04179513|Methotrexate|methotrexate|mesh-list
84063129|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84063130|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
84063131|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84063132|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063133|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84063134|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
84063135|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063136|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063137|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
84063138|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063139|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84063140|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063141|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
84063142|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250277|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
84063143|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84063144|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
84063145|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84063146|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063147|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063148|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063149|NCT02675049|Analgesics|analgesics|mesh-ancestor
84063150|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
84063151|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063152|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84063153|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83250309|NCT03064243|Apatinib|apatinib|mesh-list
84063154|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84063155|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
84063156|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063157|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063158|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
84063159|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
84063161|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84063162|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250366|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
84063163|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063164|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063165|NCT02674737|Analgesics|analgesics|mesh-ancestor
84063166|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
84063167|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063168|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84063169|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84063170|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84063171|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
84063172|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063173|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063174|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84063175|NCT02674737|Narcotics|narcotics|mesh-ancestor
84063176|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063177|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063178|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063179|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84063180|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063181|NCT02674893|Liraglutide|liraglutide|mesh-list
84063182|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84063183|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063184|NCT02674893|Incretins|incretins|mesh-ancestor
84063185|NCT02674893|Hormones|hormones|mesh-ancestor
84063186|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063187|NCT02717455|Panobinostat|panobinostat|mesh-list
84063188|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063189|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84063190|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063191|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063192|NCT02674581|Fostemsavir|fostemsavir|mesh-list
84063193|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84063194|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84063195|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
84063196|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063197|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84063198|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84063199|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063200|NCT04065919|Epinephrine|epinephrine|mesh-list
84063201|NCT04065919|Bupivacaine|bupivacaine|mesh-list
84063202|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063203|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
84063204|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063205|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063206|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
84063207|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063208|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84063209|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84063210|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
84063211|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063212|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063213|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84063214|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84063215|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
84063216|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84063217|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
84063218|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
84063219|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
84063220|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84063221|NCT04065529|Zinc|zinc|mesh-list
84063222|NCT04065529|Trace Elements|trace elements|mesh-ancestor
84063223|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
84063224|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063225|NCT04179045|Sirolimus|sirolimus|mesh-list
84063226|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063227|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063228|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84063229|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063230|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
84063231|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063232|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
84063233|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063234|NCT00970268|Bromides|bromides|mesh-list
84063235|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
84063236|NCT02674113|Bupivacaine|bupivacaine|mesh-list
84063237|NCT02674113|Anesthetics|anesthetics|mesh-list
84063238|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063239|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250683|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
84063240|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063241|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
84063242|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063243|NCT00644085|Aspirin|aspirin|mesh-list
84063244|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063245|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063246|NCT00644085|Analgesics|analgesics|mesh-ancestor
84063247|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
84063248|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063249|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063250|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063251|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063252|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84063253|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063254|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063255|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84063256|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84063257|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063258|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
84063259|NCT00731575|Prednisolone|prednisolone|mesh-list
84063260|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84063261|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
84063262|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84063263|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
84063264|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84063265|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
84063266|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063267|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
84063268|NCT00731575|Hormones|hormones|mesh-ancestor
84063269|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250795|NCT05536193|Mitogens|mitogens|mesh-list
84063270|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063271|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84063272|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063273|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
84063274|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
84063275|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063276|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84063277|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84063278|NCT00731575|Protective Agents|protective agents|mesh-ancestor
84063279|NCT02674191|Clindamycin|clindamycin|mesh-list
84063280|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
84063281|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
84063282|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
84063283|NCT02674191|Mepivacaine|mepivacaine|mesh-list
84063284|NCT02674191|Benzocaine|benzocaine|mesh-list
84063285|NCT02674191|Povidone|povidone|mesh-list
84063286|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063287|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063288|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84063289|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063290|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063291|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
84063292|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
84063293|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83250859|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
84063294|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063295|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
84063296|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063297|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063298|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
84063299|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063300|NCT00736021|Escitalopram|escitalopram|mesh-list
84063301|NCT00736021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84063302|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84063303|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063304|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063305|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063306|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
84063307|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063308|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
84063309|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84063310|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063311|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063312|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
84063313|NCT04178655|Coagulants|coagulants|mesh-ancestor
84063314|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
84063315|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84063316|NCT00738517|Antibodies|antibodies|mesh-list
84063317|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
84063318|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063319|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84063320|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84063321|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063322|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063323|NCT00738595|Nicotine|nicotine|mesh-list
84063324|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84063325|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
84063326|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063327|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063328|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84063329|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84063330|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
84063331|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063332|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063333|NCT05273775|Vitamin K|vitamin k|mesh-list
84063334|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
84063335|NCT05273775|Digoxin|digoxin|mesh-list
84063336|NCT05273775|Midazolam|midazolam|mesh-list
84063337|NCT05273775|Omeprazole|omeprazole|mesh-list
84063338|NCT05273775|Warfarin|warfarin|mesh-list
84063339|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84063340|NCT05273775|Vitamins|vitamins|mesh-ancestor
84063341|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
84063342|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063343|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84063344|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84063345|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063346|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84063347|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84063348|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84063349|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84063350|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
84063351|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
84063352|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
84063353|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
84063354|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063355|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063356|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84063357|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84063358|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
84063359|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83251231|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
83251298|NCT04959253|Psilocybin|psilocybin|mesh-list
84063360|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84063361|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303297|NCT01908829|Mirabegron|mirabegron|mesh-list
84063362|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
84063363|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84063364|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84063365|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84063366|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84063367|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84063368|NCT05273775|Protective Agents|protective agents|mesh-ancestor
84063369|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84063370|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063371|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
84063372|NCT05273775|Coagulants|coagulants|mesh-ancestor
84063373|NCT02671851|Acetaminophen|acetaminophen|mesh-list
84063374|NCT02671851|Dipyrone|dipyrone|mesh-list
84063375|NCT02671851|Fentanyl|fentanyl|mesh-list
84063376|NCT02671851|Tramadol|tramadol|mesh-list
84063377|NCT02671851|Bupivacaine|bupivacaine|mesh-list
84063378|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063379|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
84063380|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063381|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063382|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
84063383|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063384|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84063385|NCT02671851|Narcotics|narcotics|mesh-ancestor
84063386|NCT02671851|Analgesics|analgesics|mesh-ancestor
84063387|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84063388|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84063389|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
84063390|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063391|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
84063392|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063393|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063394|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063395|NCT02135419|Fluorouracil|fluorouracil|mesh-list
84063396|NCT02135419|Imiquimod|imiquimod|mesh-list
84063397|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
84063398|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063399|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84063400|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063401|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063402|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
84063403|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063404|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84063405|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
84063406|NCT04177095|Sirolimus|sirolimus|mesh-list
84063407|NCT04177095|Prednisone|prednisone|mesh-list
84063408|NCT04177095|Everolimus|everolimus|mesh-list
84063409|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063410|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
84063411|NCT04177095|Hormones|hormones|mesh-ancestor
84063412|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063413|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063414|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84063415|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063416|NCT04177095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84063417|NCT04177095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84063418|NCT04177095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063419|NCT04177095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063420|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063421|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
84063422|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84063423|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063424|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063425|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
84063426|NCT02671695|Amlodipine|amlodipine|mesh-list
84063427|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84063428|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84063429|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063430|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063431|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84063432|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063433|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
84063434|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
84063435|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
84063436|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84063437|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84063438|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063439|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063440|NCT00644631|Urological Agents|urological agents|mesh-ancestor
84063441|NCT02671383|Lopinavir|lopinavir|mesh-list
84063442|NCT02671383|Darunavir|darunavir|mesh-list
84063443|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84063444|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84063445|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
84063446|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063447|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063448|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84063449|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84063450|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
84063451|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063452|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84063453|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84063454|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84063455|NCT00738751|Panobinostat|panobinostat|mesh-list
84063456|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84063457|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063458|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84063459|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063460|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063461|NCT05243823|Estradiol|estradiol|mesh-list
84063462|NCT05243823|Estrogens|estrogens|mesh-ancestor
84063463|NCT05243823|Hormones|hormones|mesh-ancestor
84063464|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063465|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063466|NCT00736801|Fluticasone|fluticasone|mesh-list
84063467|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84063468|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063469|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84063470|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
84063471|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063472|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063473|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84063474|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
84063475|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
84063476|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84063477|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84063478|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84063479|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84063480|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
84063481|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063482|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063483|NCT00738829|Rituximab|rituximab|mesh-list
84063484|NCT00738829|Fludarabine|fludarabine|mesh-list
84063485|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
84063486|NCT00738829|Lenalidomide|lenalidomide|mesh-list
84063487|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84063488|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063489|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
84063490|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063491|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063492|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84063493|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
84063494|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063495|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063496|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84063497|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84063498|NCT00738829|Growth Substances|growth substances|mesh-ancestor
84063499|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
84063500|NCT02671227|Bupivacaine|bupivacaine|mesh-list
84063501|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063502|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
84063503|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063504|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063505|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
84063506|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063507|NCT00644709|Atorvastatin|atorvastatin|mesh-list
84063508|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84063509|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84063510|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
84063511|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063512|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84063513|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84063514|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063516|NCT00738985|Ezetimibe|ezetimibe|mesh-list
84063517|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
84063518|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84063519|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84063520|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
84063521|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063522|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84063523|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84063524|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063525|NCT05216211|Bupivacaine|bupivacaine|mesh-list
84063526|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063527|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
84063528|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063529|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063530|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
84063531|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063532|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84063533|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84063534|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063535|NCT00732121|Incretins|incretins|mesh-ancestor
84063536|NCT00732121|Hormones|hormones|mesh-ancestor
84063537|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063538|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84063539|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
84063540|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063541|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063542|NCT02537223|Cisplatin|cisplatin|mesh-list
84063543|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063544|NCT02568943|Panobinostat|panobinostat|mesh-list
84063545|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063546|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84063547|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063548|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063549|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
84063550|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84063551|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84063552|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84063553|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063554|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84063555|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063556|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84063557|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063558|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063559|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
84063560|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84063561|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84063562|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84063563|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84063564|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063565|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063566|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
84063567|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063568|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063569|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84063570|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063571|NCT00737113|Hormones|hormones|mesh-list
84063572|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063573|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063574|NCT00737191|Olanzapine|olanzapine|mesh-list
84063575|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
84063576|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
84063577|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063578|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063579|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84063580|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84063581|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84063582|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063583|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84063584|NCT00737191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84063585|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84063586|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063587|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063588|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063589|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
84063590|NCT04175067|Antioxidants|antioxidants|mesh-list
84063591|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063592|NCT04175067|Protective Agents|protective agents|mesh-ancestor
84063593|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063594|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
84063595|NCT00758602|Tacrolimus|tacrolimus|mesh-list
84063596|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063597|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
84063598|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063599|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84063600|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063601|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063602|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84063603|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063604|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84063605|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
84063606|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063607|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063608|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
84063609|NCT02667561|Testosterone|testosterone|mesh-list
84063610|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
84063611|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
84063612|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84063613|NCT02667561|Androgens|androgens|mesh-ancestor
84063614|NCT02667561|Hormones|hormones|mesh-ancestor
84063615|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063616|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063617|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84063618|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063619|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
84063620|NCT00732511|Metoprolol|metoprolol|mesh-list
84063621|NCT00732511|Carvedilol|carvedilol|mesh-list
84063622|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84063623|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84063624|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
84063625|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
84063626|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063627|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063628|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84063629|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84063630|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84063631|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
84063632|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063633|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063634|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
84063635|NCT00732511|Protective Agents|protective agents|mesh-ancestor
84063636|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84063637|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063638|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84063639|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
84063640|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84063641|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84063642|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
84063643|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84063644|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
84063645|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063646|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063647|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84063648|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
84063649|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84063650|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
84063651|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063652|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063653|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84063654|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
84063655|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
84063656|NCT00739531|Protective Agents|protective agents|mesh-ancestor
84063657|NCT00739609|Tryptophan|tryptophan|mesh-list
84063658|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84063659|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
84063660|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84063661|NCT00645723|Colistin|colistin|mesh-list
84063662|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063663|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063664|NCT00711529|Gabapentin|gabapentin|mesh-list
84063665|NCT00711529|Analgesics|analgesics|mesh-ancestor
84063666|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
84063667|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063668|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063669|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
84063670|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84063671|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84063672|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063673|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84063674|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84063675|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84063676|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063677|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063678|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
84063679|NCT00732589|Lidocaine|lidocaine|mesh-list
84063680|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063681|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
84063682|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063683|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063684|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
84063685|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063686|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84063687|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84063688|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84063689|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063690|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063691|NCT04957485|Tecovirimat|tecovirimat|mesh-list
84063692|NCT04957485|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84063693|NCT04957485|Antiviral Agents|antiviral agents|mesh-ancestor
84063694|NCT04957485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063695|NCT00645879|Citric Acid|citric acid|mesh-list
84063696|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
84063697|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
84063698|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84063699|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
84063700|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
84063701|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063702|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
84063703|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84063704|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063705|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84063706|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
84063707|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84063708|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063709|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063710|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063711|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
84063712|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84063713|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84063714|NCT02666703|Prednisolone|prednisolone|mesh-list
84063715|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
84063716|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84063717|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
84063718|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063719|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
84063720|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
84063721|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063722|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063723|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84063724|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
84063725|NCT02666703|Hormones|hormones|mesh-ancestor
84063726|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063727|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84063728|NCT02666703|Protective Agents|protective agents|mesh-ancestor
84063729|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84063730|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063731|NCT05560009|Levodopa|levodopa|mesh-list
84063732|NCT05560009|Fluorides|fluorides|mesh-list
84063733|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
84063734|NCT05560009|Protective Agents|protective agents|mesh-ancestor
84063735|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063736|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
84063737|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063738|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063739|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84063740|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84063741|NCT04174131|Lidocaine|lidocaine|mesh-list
84063742|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
84063743|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
84063744|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
84063745|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063746|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063747|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
84063748|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063749|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84063750|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84063751|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84063752|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063753|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063754|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84063755|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
84063756|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
84063757|NCT04174131|Protective Agents|protective agents|mesh-ancestor
84063758|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
84063759|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84063760|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063761|NCT00646035|Vitamins|vitamins|mesh-ancestor
84063762|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
84063763|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84063764|NCT00646191|Adalimumab|adalimumab|mesh-list
84063765|NCT00646191|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84063766|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063767|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063768|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
84063769|NCT02666157|Apixaban|apixaban|mesh-list
84063770|NCT02666157|Dabigatran|dabigatran|mesh-list
84063771|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84063772|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
84063773|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84063774|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
84063775|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063776|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063777|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
84063778|NCT02666001|Fostemsavir|fostemsavir|mesh-list
84063779|NCT02666001|Buprenorphine|buprenorphine|mesh-list
84063780|NCT02666001|Methadone|methadone|mesh-list
84063781|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84063782|NCT02666001|Narcotics|narcotics|mesh-ancestor
84063783|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063784|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063785|NCT02666001|Analgesics|analgesics|mesh-ancestor
84063786|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
84063787|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063788|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84063789|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
84063790|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
84063791|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84063792|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84063793|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
84063794|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063795|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83251754|NCT04922047|Tislelizumab|tislelizumab|mesh-list
84063796|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84063797|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063798|NCT02665845|Mesalamine|mesalamine|mesh-list
84063799|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063800|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063801|NCT02665845|Analgesics|analgesics|mesh-ancestor
84063802|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
84063803|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063804|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063805|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063806|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063807|NCT00646425|Basiliximab|basiliximab|mesh-list
84063808|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063809|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
84063810|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303737|NCT04397770|Apatinib|apatinib|mesh-list
84063811|NCT04837209|Niraparib|niraparib|mesh-list
84063812|NCT04837209|Dostarlimab|dostarlimab|mesh-list
84063813|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84063814|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063815|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063816|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063817|NCT02665533|Dexamethasone|dexamethasone|mesh-list
84063818|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
84063819|NCT02665533|Diclofenac|diclofenac|mesh-list
84063820|NCT02665533|Codeine|codeine|mesh-list
84063821|NCT02665533|BB 1101|bb 1101|mesh-list
84063822|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063823|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
84063824|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
84063825|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063826|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063827|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84063828|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
84063829|NCT02665533|Hormones|hormones|mesh-ancestor
84063830|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84063831|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84063832|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063833|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
84063834|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063835|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063836|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063837|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063838|NCT02665533|Analgesics|analgesics|mesh-ancestor
84063839|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
84063840|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063841|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84063842|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84063843|NCT02665533|Narcotics|narcotics|mesh-ancestor
84063844|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063845|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
84063846|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
84063847|NCT00646503|Telbivudine|telbivudine|mesh-list
84063848|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
84063849|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063850|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84063851|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063852|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063853|NCT04173039|Antibodies|antibodies|mesh-list
84063854|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
84063855|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063856|NCT00646659|Carboplatin|carboplatin|mesh-list
84063857|NCT00646659|Docetaxel|docetaxel|mesh-list
84063858|NCT00646659|Fluorouracil|fluorouracil|mesh-list
84063859|NCT00646659|Cetuximab|cetuximab|mesh-list
84063860|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063861|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
84063862|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
84063863|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
84063864|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063865|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
83251761|NCT04406389|Argatroban|argatroban|mesh-list
84063866|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84063867|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063868|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
84063869|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063870|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84063871|NCT00648531|Balsalazide|balsalazide|mesh-list
84063872|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063873|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063874|NCT00648531|Analgesics|analgesics|mesh-ancestor
84063875|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
84063876|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063877|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063878|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063879|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063880|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84063881|NCT00648765|Anagrelide|anagrelide|mesh-list
84063882|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84063883|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84063884|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063885|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84063886|NCT00648843|Oxybutynin|oxybutynin|mesh-list
83303809|NCT02511106|Osimertinib|osimertinib|mesh-list
84063887|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
84063888|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
84063889|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063890|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063891|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84063892|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84063893|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
84063894|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063895|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063896|NCT00648843|Urological Agents|urological agents|mesh-ancestor
84063897|NCT02662959|Irinotecan|irinotecan|mesh-list
84063898|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84063899|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84063900|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063901|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063902|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063903|NCT02662647|Cytarabine|cytarabine|mesh-list
84063904|NCT02662647|Decitabine|decitabine|mesh-list
84063905|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
84063906|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84063907|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
84063908|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063909|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063910|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
84063911|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063912|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84063913|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
84063914|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063915|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063916|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84063917|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84063918|NCT02662725|Ipilimumab|ipilimumab|mesh-list
84063919|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84063920|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063921|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84063922|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063923|NCT00648921|Olanzapine|olanzapine|mesh-list
84063924|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
84063925|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
84063926|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063927|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063928|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84063929|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84063930|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84063931|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063932|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84063933|NCT00648921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84063934|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84063935|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84063936|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063937|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84063938|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
84063939|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
84063940|NCT02662491|Vitamin D|vitamin d|mesh-list
84063941|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
84063942|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
84063943|NCT02662491|Vitamins|vitamins|mesh-list
84063944|NCT02662491|Calcium|calcium|mesh-list
84063945|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
84063946|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063947|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84063948|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84063949|NCT00648999|Ritonavir|ritonavir|mesh-list
84063950|NCT00648999|Lopinavir|lopinavir|mesh-list
84063951|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84063952|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84063953|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
84063954|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063955|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063956|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84063957|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84063958|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
84063959|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063960|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84063961|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84063962|NCT02661711|Aflibercept|aflibercept|mesh-list
84063963|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84063964|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84063965|NCT02661711|Growth Substances|growth substances|mesh-ancestor
84063966|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063967|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
84063968|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063969|NCT02661789|Goserelin|goserelin|mesh-list
84063970|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84063971|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063972|NCT02661477|Interferons|interferons|mesh-list
84063973|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
84063974|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
84063975|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84063976|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
84063977|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063978|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
84063979|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063980|NCT00649077|Meloxicam|meloxicam|mesh-list
84063981|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84063982|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84063983|NCT00649077|Analgesics|analgesics|mesh-ancestor
84063984|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
84063985|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84063986|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84063987|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84063988|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84063989|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84063990|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84063991|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84063992|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84063993|NCT02656251|Ethanol|ethanol|mesh-list
84063994|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
84063995|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84063996|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84063997|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84063998|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84063999|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064000|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
84064001|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
84064002|NCT02656095|Heparin|heparin|mesh-list
84064003|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
84064004|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84064005|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84064006|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064007|NCT00649935|Azithromycin|azithromycin|mesh-list
84064008|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064009|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064010|NCT02655705|Cyclosporine|cyclosporine|mesh-list
84064011|NCT02655705|Methotrexate|methotrexate|mesh-list
84064012|NCT02655705|Cyclosporins|cyclosporins|mesh-list
84064013|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84064014|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
84064015|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84064016|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064017|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84064018|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
84064019|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064020|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064021|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
84064022|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064023|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84064024|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064025|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
84064026|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064027|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84064028|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
84064029|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064030|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84064031|NCT02655471|Zidovudine|zidovudine|mesh-list
84064032|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
84064033|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
84064034|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064035|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84064036|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84064037|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064038|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
84064039|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064040|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84064041|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84064042|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84064043|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84064044|NCT00650013|Midodrine|midodrine|mesh-list
84064045|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
84064046|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
84064047|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064048|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064049|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84064050|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84064051|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84064052|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84064053|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064054|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064055|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064056|NCT00712933|Belimumab|belimumab|mesh-list
84064057|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064058|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
84064059|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064060|NCT02654847|Norepinephrine|norepinephrine|mesh-list
84064061|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84064062|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84064063|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064064|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064065|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251780|NCT04930471|Metformin|metformin|mesh-list
84064066|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064067|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
84064068|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
84064069|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064070|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84064071|NCT02536209|Oxycodone|oxycodone|mesh-list
84064072|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84064073|NCT02536209|Narcotics|narcotics|mesh-ancestor
84064074|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84064075|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064076|NCT02536209|Analgesics|analgesics|mesh-ancestor
84064077|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
84064078|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064079|NCT00732745|Docetaxel|docetaxel|mesh-list
84064080|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
84064081|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064082|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
84064083|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
84064084|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
84064085|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064086|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
84064087|NCT00737815|Cathartics|cathartics|mesh-ancestor
84064088|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84064089|NCT02654379|Rituximab|rituximab|mesh-list
84064090|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84064091|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064092|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
84064093|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064094|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064095|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
84064096|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
84064097|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
84064098|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064099|NCT00712543|Lactulose|lactulose|mesh-list
84064100|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84064101|NCT00650169|Clopidogrel|clopidogrel|mesh-list
84064102|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84064103|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84064104|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84064105|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84064106|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
84064107|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064108|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064109|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064110|NCT04064125|Minocycline|minocycline|mesh-list
84064111|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064112|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064113|NCT00740389|Etravirine|etravirine|mesh-list
84064114|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84064115|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84064116|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064117|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064118|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
84064119|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064120|NCT00740467|Cyclosporine|cyclosporine|mesh-list
84064121|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
84064122|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
84064123|NCT00740467|Busulfan|busulfan|mesh-list
84064124|NCT00740467|Fludarabine|fludarabine|mesh-list
84064125|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
84064126|NCT00740467|Cyclosporins|cyclosporins|mesh-list
84064127|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84064128|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064129|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
84064130|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064131|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064132|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84064133|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
83251791|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064134|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064135|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064136|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84064137|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84064138|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
84064139|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064140|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
84064141|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064142|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
84064143|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84064144|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84064145|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84064146|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
84064147|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064148|NCT00740545|Enoxaparin|enoxaparin|mesh-list
84064149|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
84064150|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84064151|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84064152|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064153|NCT02653833|Tadalafil|tadalafil|mesh-list
84064154|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
84064155|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84064156|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84064157|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064158|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064159|NCT02653833|Urological Agents|urological agents|mesh-ancestor
84064160|NCT00733057|Minocycline|minocycline|mesh-list
84064161|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064162|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064163|NCT00737971|Triamcinolone|triamcinolone|mesh-list
84064164|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84064165|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84064166|NCT00737971|Bevacizumab|bevacizumab|mesh-list
84064167|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84064168|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84064169|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064170|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84064171|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84064172|NCT00737971|Growth Substances|growth substances|mesh-ancestor
84064173|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064174|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
84064175|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84064176|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
84064177|NCT00737971|Hormones|hormones|mesh-ancestor
84064178|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064179|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064180|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
84064181|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064182|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064183|NCT00650247|Sumatriptan|sumatriptan|mesh-list
84064184|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84064185|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84064186|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84064187|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
84064188|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064189|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064190|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064191|NCT02568709|Oxytocin|oxytocin|mesh-list
84064192|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
84064193|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84064194|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064195|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
84064196|NCT04316169|Letrozole|letrozole|mesh-list
84064197|NCT04316169|Fulvestrant|fulvestrant|mesh-list
84064198|NCT04316169|Anastrozole|anastrozole|mesh-list
84064199|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064200|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84064201|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84064202|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251799|NCT04940689|Analgesics|analgesics|mesh-ancestor
84064203|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064204|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84064205|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
84064206|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064207|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064208|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
84064209|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84064210|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84064211|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064212|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064213|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84064214|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84064215|NCT02653209|Pioglitazone|pioglitazone|mesh-list
84064216|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84064217|NCT02653209|Canagliflozin|canagliflozin|mesh-list
84064218|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84064219|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064220|NCT02653209|Incretins|incretins|mesh-ancestor
84064221|NCT02653209|Hormones|hormones|mesh-ancestor
84064222|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064223|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84064224|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064225|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064226|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064227|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84064228|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84064229|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
84064230|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84064231|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064232|NCT02653131|Incretins|incretins|mesh-ancestor
84064233|NCT02653131|Hormones|hormones|mesh-ancestor
84064234|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064235|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064236|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064237|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064238|NCT02652585|Naltrexone|naltrexone|mesh-list
84064239|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84064240|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84064241|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064242|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
84064243|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064244|NCT00741169|Rifampin|rifampin|mesh-list
84064245|NCT00741169|Simeprevir|simeprevir|mesh-list
84064246|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84064247|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
84064248|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064249|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064250|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
84064251|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84064252|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064253|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064254|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84064255|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84064256|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84064257|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84064258|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84064259|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84064260|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
84064261|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064262|NCT00741325|Plerixafor|plerixafor|mesh-list
84064264|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84064265|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
84064266|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064267|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84064268|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84064269|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
84064270|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064271|NCT02652741|Enalapril|enalapril|mesh-list
84064272|NCT02652741|Enalaprilat|enalaprilat|mesh-list
84064273|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84064274|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064275|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064276|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064277|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84064278|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
84064279|NCT02652507|Ketamine|ketamine|mesh-list
84064280|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84064281|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84064282|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064283|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84064284|NCT02652507|Analgesics|analgesics|mesh-ancestor
84064285|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
84064286|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064287|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84064288|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84064289|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84064290|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064291|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064292|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064293|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84064294|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84064295|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
84064296|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
84064297|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84064298|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84064299|NCT05742295|Vitamin K|vitamin k|mesh-list
84064300|NCT05742295|Vitamins|vitamins|mesh-ancestor
84064301|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
84064302|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064303|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84064304|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84064305|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064306|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
84064307|NCT05742295|Coagulants|coagulants|mesh-ancestor
84064308|NCT02652273|Abatacept|abatacept|mesh-list
84064309|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84064310|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064311|NCT02652273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84064312|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064313|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064314|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
84064315|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064316|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064317|NCT00650325|Sertraline|sertraline|mesh-list
84064318|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
84064319|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84064320|NCT00650325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84064321|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84064322|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84064323|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064324|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064325|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
84064326|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064327|NCT00650403|Paroxetine|paroxetine|mesh-list
84064328|NCT00650403|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84064329|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84064330|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84064331|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064332|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064333|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
84064334|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064335|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84064336|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
84064337|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84064338|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84064339|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84064340|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064341|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84064342|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84064343|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
84064344|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064345|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064346|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84064347|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
84064348|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84064349|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84064350|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84064351|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064352|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064353|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064354|NCT00920803|Resveratrol|resveratrol|mesh-list
84064355|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
84064356|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064357|NCT00920803|Protective Agents|protective agents|mesh-ancestor
84064358|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064359|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064360|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84064361|NCT04617535|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
84064362|NCT04617535|Antiviral Agents|antiviral agents|mesh-ancestor
84064363|NCT04617535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064364|NCT03912363|Insulin|insulin|mesh-list
84064365|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84064366|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064367|NCT05740969|Fluorouracil|fluorouracil|mesh-list
84064368|NCT05740969|Imiquimod|imiquimod|mesh-list
84064369|NCT05740969|Melatonin|melatonin|mesh-list
84064370|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
84064371|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064372|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84064373|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064374|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064375|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
84064376|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064377|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
84064378|NCT05740969|Protective Agents|protective agents|mesh-ancestor
84064379|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84064380|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84064381|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
84064382|NCT02568241|Interferons|interferons|mesh-list
84064383|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
84064384|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
84064385|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064386|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
84064387|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064388|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
84064389|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064390|NCT05551897|Itraconazole|itraconazole|mesh-list
84064391|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
84064392|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064393|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84064394|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84064395|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064396|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064397|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84064398|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
84064399|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064400|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064401|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84064402|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
84064403|NCT02647671|Calcium|calcium|mesh-list
84064404|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84064405|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064406|NCT02647671|Antacids|antacids|mesh-ancestor
84064407|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064408|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304335|NCT01929382|Interferons|interferons|mesh-list
84064410|NCT04578613|Chlorambucil|chlorambucil|mesh-list
84064411|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84064412|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064413|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
84064414|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064415|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064416|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84064417|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
84064418|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064419|NCT02647515|Ranibizumab|ranibizumab|mesh-list
84064420|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84064421|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84064422|NCT02647515|Growth Substances|growth substances|mesh-ancestor
84064423|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064424|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
84064425|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064426|NCT03818763|Factor VIII|factor viii|mesh-list
84064427|NCT03818763|Coagulants|coagulants|mesh-ancestor
84064428|NCT02647047|Acetaminophen|acetaminophen|mesh-list
84064429|NCT02647047|Ketorolac|ketorolac|mesh-list
84064430|NCT02647047|Sufentanil|sufentanil|mesh-list
84064431|NCT02647047|Ropivacaine|ropivacaine|mesh-list
84064432|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
84064433|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
84064434|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84064435|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064436|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
84064437|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064438|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84064439|NCT02647047|Analgesics|analgesics|mesh-ancestor
84064440|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
84064441|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84064442|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84064443|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064444|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84064445|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064446|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064447|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84064448|NCT02647047|Narcotics|narcotics|mesh-ancestor
84064449|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84064450|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84064451|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
84064452|NCT00651651|Budesonide|budesonide|mesh-list
84064453|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
84064454|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84064455|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84064456|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
84064457|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064458|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064459|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84064460|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
84064461|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
84064462|NCT00651651|Hormones|hormones|mesh-ancestor
84064463|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064464|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84064465|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84064466|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84064467|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064468|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064469|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064470|NCT00709111|Maraviroc|maraviroc|mesh-list
84064471|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84064472|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84064473|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064474|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84064475|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84064476|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
84064477|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064478|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84064479|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
84064480|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84064481|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84064482|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84064483|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84064484|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064485|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
84064486|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064487|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064488|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84064489|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064490|NCT02646735|Fulvestrant|fulvestrant|mesh-list
84064491|NCT02646735|Exemestane|exemestane|mesh-list
84064492|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84064493|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064494|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84064495|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84064496|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
84064497|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064498|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064499|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84064500|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84064501|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064502|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064503|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
84064504|NCT02646657|Vedolizumab|vedolizumab|mesh-list
84064505|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84064506|NCT00652041|Thalidomide|thalidomide|mesh-list
84064507|NCT00652041|Bortezomib|bortezomib|mesh-list
84064508|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064509|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064510|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
84064511|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064512|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
84064513|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064514|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064515|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84064516|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84064517|NCT00652041|Growth Substances|growth substances|mesh-ancestor
84064518|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
84064519|NCT02646111|Ribavirin|ribavirin|mesh-list
84064520|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
84064521|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064522|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
84064523|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064524|NCT00652119|Paclitaxel|paclitaxel|mesh-list
84064525|NCT00652119|Bevacizumab|bevacizumab|mesh-list
84064526|NCT00652119|Carboplatin|carboplatin|mesh-list
84064527|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84064528|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064529|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
84064530|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
84064531|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
84064532|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064533|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84064534|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84064535|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83251838|NCT03057145|Olaparib|olaparib|mesh-list
84064536|NCT00652119|Growth Substances|growth substances|mesh-ancestor
84064537|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064538|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
84064539|NCT05740657|Fentanyl|fentanyl|mesh-list
84064540|NCT05740657|Sufentanil|sufentanil|mesh-list
84064541|NCT05740657|Morphine|morphine|mesh-list
84064542|NCT05740657|Remifentanil|remifentanil|mesh-list
84064543|NCT05740657|Oxycodone|oxycodone|mesh-list
84064544|NCT05740657|Hydromorphone|hydromorphone|mesh-list
84064545|NCT05740657|Alfentanil|alfentanil|mesh-list
84064546|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83304482|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83304483|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83304484|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
84064547|NCT05740657|Narcotics|narcotics|mesh-ancestor
83304485|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304486|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304487|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83304488|NCT01904149|Tramadol|tramadol|mesh-list
83304489|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83304490|NCT01904149|Narcotics|narcotics|mesh-ancestor
84064548|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84064549|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064550|NCT05740657|Analgesics|analgesics|mesh-ancestor
84064551|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
84064552|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064553|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84064554|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84064555|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
84064557|NCT02646267|Warfarin|warfarin|mesh-list
84064558|NCT02646267|Dabigatran|dabigatran|mesh-list
84064559|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
84064560|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
84064561|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84064562|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064563|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064564|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064565|NCT02646189|Interferons|interferons|mesh-list
84064566|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
84064567|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
84064568|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84064569|NCT02646189|REP 2139|rep 2139|mesh-list
84064570|NCT02646189|Thymalfasin|thymalfasin|mesh-list
84064571|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064572|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
84064573|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064574|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
84064575|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064576|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84064577|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
84064578|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84064579|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84064580|NCT02645565|Prednisolone|prednisolone|mesh-list
84064581|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
84064582|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
84064583|NCT02645565|Azathioprine|azathioprine|mesh-list
84064584|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84064585|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
84064586|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064587|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
84064588|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064589|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064590|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84064591|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
84064592|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064593|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064594|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84064595|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84064596|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
84064597|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
84064598|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064599|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84064600|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
84064601|NCT02645565|Hormones|hormones|mesh-ancestor
84064602|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064603|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84064604|NCT02645565|Protective Agents|protective agents|mesh-ancestor
84064605|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84064606|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
84064607|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84064608|NCT00699907|Flutamide|flutamide|mesh-list
84064609|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
84064610|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
84064611|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064612|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064613|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84064614|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064615|NCT00599313|Sunitinib|sunitinib|mesh-list
84064616|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064617|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84064618|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84064619|NCT00599313|Growth Substances|growth substances|mesh-ancestor
84064620|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064621|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
84064622|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84064623|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064624|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064625|NCT03159897|Doxorubicin|doxorubicin|mesh-list
84064626|NCT03159897|Bleomycin|bleomycin|mesh-list
84064627|NCT03159897|Dacarbazine|dacarbazine|mesh-list
84064628|NCT03159897|Vinblastine|vinblastine|mesh-list
84064629|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84064630|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064631|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84064632|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84064633|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064634|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064635|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84064636|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
84064637|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84064638|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
84064639|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
84064640|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
84064641|NCT00708175|Pioglitazone|pioglitazone|mesh-list
84064642|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84064643|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064644|NCT05740345|Metformin|metformin|mesh-list
84064645|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84064646|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064647|NCT02641431|Ajmaline|ajmaline|mesh-list
84064648|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84064649|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84064650|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84064651|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84064652|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064653|NCT00733525|Fluoxetine|fluoxetine|mesh-list
84064654|NCT00733525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84064655|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84064656|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84064657|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064658|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064659|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
84064660|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064661|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83251853|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
84064662|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
84064663|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84064664|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84064665|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84064666|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064667|NCT02567149|Cidofovir|cidofovir|mesh-list
84064668|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
84064669|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064670|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064671|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064672|NCT00707239|Imipenem|imipenem|mesh-list
84064673|NCT00707239|Tigecycline|tigecycline|mesh-list
84064674|NCT00707239|Cilastatin|cilastatin|mesh-list
84064675|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064676|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064677|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84064678|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064679|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064680|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064681|NCT00968708|Alogliptin|alogliptin|mesh-list
84064682|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84064683|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064684|NCT00968708|Incretins|incretins|mesh-ancestor
84064685|NCT00968708|Hormones|hormones|mesh-ancestor
84064686|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064687|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84064688|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064689|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064690|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064691|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84064692|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
84064693|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064694|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
84064695|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064696|NCT04062565|Treprostinil|treprostinil|mesh-list
84064697|NCT04062565|Riociguat|riociguat|mesh-list
84064698|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84064699|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
84064700|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064701|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
84064702|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84064703|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
84064704|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
84064705|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84064706|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064707|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84064708|NCT00967694|Analgesics|analgesics|mesh-ancestor
84064709|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
84064710|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064711|NCT04288700|Timolol|timolol|mesh-list
84064712|NCT04288700|Propranolol|propranolol|mesh-list
84064713|NCT04288700|Captopril|captopril|mesh-list
84064714|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84064715|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84064716|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064717|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064718|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84064719|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84064720|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064721|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064722|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064723|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84064724|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84064725|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
84064726|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84064727|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
84064728|NCT02863406|Dimercaprol|dimercaprol|mesh-list
84064729|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
84064730|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
84064731|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064732|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
84064733|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064734|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064735|NCT00629720|Alfuzosin|alfuzosin|mesh-list
84064736|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84064737|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84064738|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84064739|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064740|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064741|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064742|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064743|NCT00629720|Urological Agents|urological agents|mesh-ancestor
84064744|NCT00967616|Leucovorin|leucovorin|mesh-list
84064745|NCT00967616|Fluorouracil|fluorouracil|mesh-list
84064746|NCT00967616|Irinotecan|irinotecan|mesh-list
84064747|NCT00967616|Efatutazone|efatutazone|mesh-list
84064748|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
84064749|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
84064750|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064751|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84064752|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064753|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064754|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
84064755|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064756|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84064757|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84064758|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064759|NCT00967616|Antidotes|antidotes|mesh-ancestor
84064760|NCT00967616|Protective Agents|protective agents|mesh-ancestor
84064761|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
84064762|NCT00967616|Vitamins|vitamins|mesh-ancestor
84064763|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
84064764|NCT04288232|Aflibercept|aflibercept|mesh-list
84064765|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84064766|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84064767|NCT04288232|Growth Substances|growth substances|mesh-ancestor
84064768|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064769|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
84064770|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304705|NCT03110926|Vitamins|vitamins|mesh-ancestor
83304706|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
83304707|NCT01928329|Exenatide|exenatide|mesh-list
83304708|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83304709|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304710|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83304711|NCT01928329|Incretins|incretins|mesh-ancestor
83304712|NCT01928329|Hormones|hormones|mesh-ancestor
83304713|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064771|NCT02864264|Interferons|interferons|mesh-list
84064772|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
84064773|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064774|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
84064775|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064776|NCT03107793|Ustekinumab|ustekinumab|mesh-list
84064777|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
84064778|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
84064779|NCT02640417|Vitamins|vitamins|mesh-ancestor
84064780|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
84064781|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064782|NCT02640495|Artesunate|artesunate|mesh-list
84064783|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
84064784|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84064785|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84064786|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064787|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064788|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
84064789|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
84064790|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84064791|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
84064792|NCT00653757|Leuprolide|leuprolide|mesh-list
84064793|NCT00653757|Goserelin|goserelin|mesh-list
84064794|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84064795|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
84064796|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84064797|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064798|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84064799|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064800|NCT00654225|Atorvastatin|atorvastatin|mesh-list
84064801|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84064802|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84064803|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84064804|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
84064805|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064806|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84064807|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84064808|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064809|NCT00974090|Glimepiride|glimepiride|mesh-list
84064810|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84064811|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84064812|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064813|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84064814|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
84064815|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84064816|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84064817|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84064818|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
84064819|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064820|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84064821|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84064822|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064823|NCT02639091|Pemetrexed|pemetrexed|mesh-list
84064824|NCT02639091|Anetumab ravtansine|anetumab ravtansine|mesh-list
84064825|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064826|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064827|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064828|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84064829|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84064830|NCT02639091|Immunoconjugates|immunoconjugates|mesh-ancestor
84064831|NCT02639091|Immunologic Factors|immunologic factors|mesh-ancestor
84064832|NCT02639091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064833|NCT00654459|Policosanol|policosanol|mesh-list
84064834|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84064835|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84064836|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
84064837|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304789|NCT01927588|Prednisone|prednisone|mesh-list
83304790|NCT01927588|Everolimus|everolimus|mesh-list
83304791|NCT01927588|Tacrolimus|tacrolimus|mesh-list
83304792|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84064838|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83304793|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
83304794|NCT01927588|Hormones|hormones|mesh-ancestor
83304795|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304796|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064839|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84064840|NCT00654537|Atorvastatin|atorvastatin|mesh-list
84064841|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84064842|NCT00654537|Simvastatin|simvastatin|mesh-list
84064843|NCT00654537|Pravastatin|pravastatin|mesh-list
84064844|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84064845|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84064846|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
84064847|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064848|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84064849|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84064850|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064851|NCT02638857|Epirubicin|epirubicin|mesh-list
84064852|NCT02638857|Mitomycins|mitomycins|mesh-list
84064853|NCT02638857|Mitomycin|mitomycin|mesh-list
84064854|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
84064855|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84064856|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064857|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84064858|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84064859|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251868|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
84064860|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064861|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
84064862|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84064863|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
84064864|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84064865|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84064866|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064867|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84064868|NCT02638545|Analgesics|analgesics|mesh-ancestor
84064869|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
84064870|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064871|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84064872|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84064873|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84064874|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064875|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064876|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064877|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
84064878|NCT02638233|Ledipasvir|ledipasvir|mesh-list
84064879|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
84064880|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064881|NCT04285268|Rituximab|rituximab|mesh-list
84064882|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84064883|NCT04285268|Bortezomib|bortezomib|mesh-list
84064884|NCT04285268|Venetoclax|venetoclax|mesh-list
84064885|NCT04285268|Antibodies|antibodies|mesh-list
84064886|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
84064887|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84064888|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
84064889|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064890|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064891|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064892|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84064893|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064894|NCT01842399|Resveratrol|resveratrol|mesh-list
84064895|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
84064896|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064897|NCT01842399|Protective Agents|protective agents|mesh-ancestor
84064898|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064899|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064900|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84064901|NCT00970502|Celecoxib|celecoxib|mesh-list
84064902|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84064903|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064904|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84064905|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064906|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064907|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84064908|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84064909|NCT00970502|Analgesics|analgesics|mesh-ancestor
84064910|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
84064911|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064912|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304857|NCT00981526|Olanzapine|olanzapine|mesh-list
84064913|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84064914|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84064915|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84064916|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84064917|NCT02635893|Cycloserine|cycloserine|mesh-list
84064918|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84064919|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84064920|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84064921|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
84064922|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84064923|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
84064924|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064925|NCT02567773|Itraconazole|itraconazole|mesh-list
84064926|NCT02567773|GSK2881078|gsk2881078|mesh-list
84064927|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
84064928|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251873|NCT04939675|Lamotrigine|lamotrigine|mesh-list
84064929|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84064930|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84064931|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064932|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064933|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84064934|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
84064935|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064936|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064937|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84064938|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
84064939|NCT02567773|Hormones|hormones|mesh-ancestor
84064940|NCT00967226|Prednisolone|prednisolone|mesh-list
84064941|NCT00967226|Propranolol|propranolol|mesh-list
84064942|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
84064943|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84064944|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
84064945|NCT00967226|Hormones|hormones|mesh-ancestor
84064946|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84064947|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064948|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84064949|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064950|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84064951|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84064952|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064953|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064954|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064955|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84064956|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84064957|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
84064958|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84064959|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84064960|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84064961|NCT00964886|Benztropine|benztropine|mesh-list
84064962|NCT00964886|Desipramine|desipramine|mesh-list
84064963|NCT00964886|Clomipramine|clomipramine|mesh-list
84064964|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84064965|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
84064966|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84064967|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064968|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064969|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84064970|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84064971|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84064972|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
84064973|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84064974|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84064975|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84064976|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84064977|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
84064978|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
84064979|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84064980|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84064981|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84064982|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
84064983|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84064984|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
84064985|NCT00964886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84064986|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
84064987|NCT02861222|Doxorubicin|doxorubicin|mesh-list
84064988|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83304937|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
84064989|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064990|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84064991|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84064992|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84064993|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84064994|NCT04062019|Aldesleukin|aldesleukin|mesh-list
84064995|NCT04062019|Interleukin-2|interleukin-2|mesh-list
84064996|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84064997|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84064998|NCT04062019|Analgesics|analgesics|mesh-ancestor
84064999|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
84065000|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065001|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065002|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84065003|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84065004|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
84065005|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065006|NCT04061863|Nivolumab|nivolumab|mesh-list
84065007|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065008|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065009|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84065010|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065011|NCT02861378|Phentolamine|phentolamine|mesh-list
84065012|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84065013|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84065014|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065015|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065016|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065017|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065018|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84065019|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
84065020|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84065021|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84065022|NCT00705757|Bimatoprost|bimatoprost|mesh-list
84065023|NCT00705757|Travoprost|travoprost|mesh-list
84065024|NCT00705757|Latanoprost|latanoprost|mesh-list
84065025|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84065026|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84065027|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84065028|NCT04284644|Propofol|propofol|mesh-list
84065029|NCT04284644|Sevoflurane|sevoflurane|mesh-list
84065030|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84065031|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065032|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065033|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84065034|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
84065035|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
84065036|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84065037|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84065038|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84065039|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
84065040|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065041|NCT04284722|Metformin|metformin|mesh-list
84065042|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065043|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065044|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
84065045|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
84065046|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84065047|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84065048|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065049|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065050|NCT04283240|Urological Agents|urological agents|mesh-ancestor
84065051|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
84065052|NCT03588884|Vitamin D|vitamin d|mesh-list
84065053|NCT03588884|Calcifediol|calcifediol|mesh-list
84065054|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84065055|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065056|NCT03588884|Vitamins|vitamins|mesh-ancestor
84065057|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
84065058|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84065059|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84065060|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84065061|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
84065062|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84065063|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
84065064|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84065065|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065066|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84065067|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84065068|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065070|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
84065071|NCT04283162|Calcium|calcium|mesh-list
84065072|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84065073|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065074|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84065075|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
84065076|NCT04283162|Coagulants|coagulants|mesh-ancestor
84065077|NCT00758524|Eplerenone|eplerenone|mesh-list
84065078|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84065079|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
84065080|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065081|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065082|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84065083|NCT00758524|Diuretics|diuretics|mesh-ancestor
84065084|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
84065085|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84065086|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
84065087|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84065088|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
84065089|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84065090|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065091|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84065092|NCT00757588|Insulin|insulin|mesh-list
84065093|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84065094|NCT00757588|Saxagliptin|saxagliptin|mesh-list
84065095|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065096|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065097|NCT00757588|Incretins|incretins|mesh-ancestor
84065098|NCT00757588|Hormones|hormones|mesh-ancestor
84065099|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065100|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84065101|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
84065102|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065103|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065104|NCT00917254|Enoxaparin|enoxaparin|mesh-list
84065105|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
84065106|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84065107|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84065108|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065109|NCT02599792|Ivacaftor|ivacaftor|mesh-list
84065110|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84065111|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84065112|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065113|NCT00705679|Tenofovir|tenofovir|mesh-list
84065114|NCT00705679|Emtricitabine|emtricitabine|mesh-list
84065115|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84065116|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
84065117|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065118|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84065119|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84065120|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065121|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065122|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84065123|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84065124|NCT04092868|Protamines|protamines|mesh-list
84065125|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
84065126|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065127|NCT04092868|Coagulants|coagulants|mesh-ancestor
84065128|NCT05695573|Cystatins|cystatins|mesh-list
84065129|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
84065130|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
84065131|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065132|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065133|NCT00916942|Lidocaine|lidocaine|mesh-list
84065134|NCT00916942|Prilocaine|prilocaine|mesh-list
84065135|NCT00916942|Capsaicin|capsaicin|mesh-list
84065136|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
84065137|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
84065138|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065139|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065140|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
84065141|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065142|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84065143|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84065144|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84065145|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84065146|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065147|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
84065148|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
84065149|NCT00751114|Metformin|metformin|mesh-list
84065150|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
84065151|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84065152|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065153|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065154|NCT00751114|Incretins|incretins|mesh-ancestor
84065155|NCT00751114|Hormones|hormones|mesh-ancestor
84065156|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065157|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84065158|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
84065159|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065160|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065161|NCT00960440|Tofacitinib|tofacitinib|mesh-list
84065162|NCT00960440|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84065163|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84065164|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065165|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065166|NCT04092478|Anesthetics|anesthetics|mesh-list
84065167|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065168|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065169|NCT02598466|Abatacept|abatacept|mesh-list
84065170|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84065171|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065172|NCT02598466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065173|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065174|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84065175|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
84065176|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065177|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065178|NCT04089592|Fentanyl|fentanyl|mesh-list
84065179|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
84065180|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84065181|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065182|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065183|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84065184|NCT04089592|Analgesics|analgesics|mesh-ancestor
84065185|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
84065186|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065187|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84065188|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84065189|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84065190|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065191|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065192|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065193|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84065194|NCT04089592|Narcotics|narcotics|mesh-ancestor
84065195|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84065196|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84065197|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
84065198|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
84065199|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
84065200|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065201|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84065202|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065203|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065204|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84065205|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84065206|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84065207|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84065208|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065209|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065210|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305160|NCT03824314|Fentanyl|fentanyl|mesh-list
84065212|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
84065213|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065214|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
84065215|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84065216|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
84065217|NCT00744328|Sertraline|sertraline|mesh-list
84065218|NCT00744328|Estradiol|estradiol|mesh-list
84065219|NCT00744328|Estrogens|estrogens|mesh-ancestor
84065220|NCT00744328|Hormones|hormones|mesh-ancestor
84065221|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065222|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065223|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
84065224|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84065225|NCT00744328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84065226|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84065227|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84065228|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065229|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065230|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
84065231|NCT04019782|Hylan|hylan|mesh-list
84065232|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
84065233|NCT04019782|Protective Agents|protective agents|mesh-ancestor
84065234|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065235|NCT02599480|Mirabegron|mirabegron|mesh-list
84065236|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84065237|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84065238|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84065239|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065240|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065241|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065242|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065243|NCT02599480|Urological Agents|urological agents|mesh-ancestor
84065244|NCT03245840|Budesonide|budesonide|mesh-list
84065245|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065246|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84065247|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
84065248|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065249|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065250|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84065251|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
84065252|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
84065253|NCT03245840|Hormones|hormones|mesh-ancestor
84065254|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065255|NCT04091698|Ubiquinone|ubiquinone|mesh-list
84065256|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
84065257|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
84065258|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065259|NCT04091698|Vitamins|vitamins|mesh-ancestor
84065260|NCT04281290|Bleomycin|bleomycin|mesh-list
84065261|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84065262|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065263|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
84065264|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84065265|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065266|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065267|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065268|NCT00959894|Tenofovir|tenofovir|mesh-list
84065269|NCT00959894|Emtricitabine|emtricitabine|mesh-list
83251901|NCT04938583|Growth Substances|growth substances|mesh-ancestor
84065270|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84065271|NCT00959894|Etravirine|etravirine|mesh-list
84065272|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
84065273|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065274|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84065275|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84065276|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065277|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065278|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84065279|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84065280|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
84065281|NCT02599168|Propofol|propofol|mesh-list
84065282|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84065283|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065284|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305240|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
84065285|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84065286|NCT02599168|Analgesics|analgesics|mesh-ancestor
84065287|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
84065288|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065289|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84065290|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84065291|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84065292|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065293|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065294|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065295|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84065296|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
84065297|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
84065298|NCT00746590|Tretazicar|tretazicar|mesh-list
84065299|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065300|NCT01032629|Canagliflozin|canagliflozin|mesh-list
84065301|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84065302|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065303|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065304|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065305|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84065306|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84065307|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84065308|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84065309|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84065310|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065311|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065312|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065313|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065314|NCT00749944|Varenicline|varenicline|mesh-list
84065315|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84065316|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84065317|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
84065318|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065319|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065320|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065321|NCT02597140|Lidocaine|lidocaine|mesh-list
84065322|NCT02597140|Propofol|propofol|mesh-list
84065323|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
84065324|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
84065325|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065326|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065327|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
84065328|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065329|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84065330|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84065331|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84065332|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84065333|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065334|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84065335|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84065336|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
84065337|NCT02598310|Paclitaxel|paclitaxel|mesh-list
84065338|NCT02598310|Trastuzumab|trastuzumab|mesh-list
84065339|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84065340|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065341|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
84065342|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
84065343|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
84065344|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065345|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065346|NCT04091074|Clopidogrel|clopidogrel|mesh-list
84065347|NCT04091074|Ticagrelor|ticagrelor|mesh-list
84065348|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84065349|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84065350|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84065351|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84065352|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
84065353|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065354|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065355|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065356|NCT00749398|Infliximab|infliximab|mesh-list
84065357|NCT00749398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84065358|NCT00749398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065359|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
84065360|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84065361|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065362|NCT01012973|Aflibercept|aflibercept|mesh-list
84065363|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84065364|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84065365|NCT01012973|Growth Substances|growth substances|mesh-ancestor
84065366|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065367|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
84065368|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065369|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
84065370|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
84065371|NCT03974464|Coagulants|coagulants|mesh-ancestor
84065372|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84065373|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84065374|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
84065375|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065376|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
84065377|NCT00742924|Leucovorin|leucovorin|mesh-list
84065378|NCT00742924|Cisplatin|cisplatin|mesh-list
84065379|NCT00742924|Doxorubicin|doxorubicin|mesh-list
84065380|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84065381|NCT00742924|Methotrexate|methotrexate|mesh-list
84065382|NCT00742924|Etoposide|etoposide|mesh-list
84065383|NCT00742924|Ifosfamide|ifosfamide|mesh-list
84065384|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
84065385|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
84065386|NCT00742924|Razoxane|razoxane|mesh-list
84065387|NCT00742924|Imidazole|imidazole|mesh-list
84065388|NCT00742924|Lenograstim|lenograstim|mesh-list
84065389|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
84065390|NCT00742924|Mesna|mesna|mesh-list
84065391|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065392|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84065393|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84065394|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84065395|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065396|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065397|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065398|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84065399|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
84065400|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84065401|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84065402|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
84065403|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
84065404|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84065405|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83251921|NCT04928365|Antibodies|antibodies|mesh-list
84065406|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
84065407|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065408|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84065409|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84065410|NCT00742924|Antidotes|antidotes|mesh-ancestor
84065411|NCT00742924|Protective Agents|protective agents|mesh-ancestor
84065412|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
84065413|NCT00742924|Vitamins|vitamins|mesh-ancestor
84065414|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
84065415|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84065416|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84065417|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
84065418|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84065419|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84065420|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
84065421|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
84065422|NCT02596984|Caspofungin|caspofungin|mesh-list
84065423|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
84065424|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065425|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065426|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065427|NCT00698815|Pemetrexed|pemetrexed|mesh-list
84065428|NCT00698815|Sunitinib|sunitinib|mesh-list
84065429|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065430|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065431|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065432|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84065433|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84065434|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84065435|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84065436|NCT00698815|Growth Substances|growth substances|mesh-ancestor
84065437|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065438|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
84065439|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84065440|NCT02599090|Temozolomide|temozolomide|mesh-list
84065441|NCT02599090|Sorafenib|sorafenib|mesh-list
84065442|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84065443|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
84065444|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065445|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065446|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84065447|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065448|NCT00745498|Bevacizumab|bevacizumab|mesh-list
84065449|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065450|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065451|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84065452|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84065453|NCT00745498|Growth Substances|growth substances|mesh-ancestor
84065454|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065455|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
84065456|NCT02596828|Sirolimus|sirolimus|mesh-list
84065457|NCT02596828|Irinotecan|irinotecan|mesh-list
84065458|NCT02596828|Temozolomide|temozolomide|mesh-list
84065459|NCT02596828|Dasatinib|dasatinib|mesh-list
84065460|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84065461|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84065462|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065463|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065464|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065465|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84065466|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
84065467|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84065468|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065469|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84065470|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
84065471|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84065472|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
84065473|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065474|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84065475|NCT03896815|INCB054329|incb054329|mesh-list
83251940|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
84065476|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065477|NCT02598856|Naloxone|naloxone|mesh-list
84065478|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84065479|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065480|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
84065481|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065482|NCT04827979|Daratumumab|daratumumab|mesh-list
84065483|NCT04827979|Abatacept|abatacept|mesh-list
84065484|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
84065485|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
84065486|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
84065487|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065488|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065489|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84065490|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065491|NCT04827979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065492|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84065493|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065494|NCT02597998|BI 409306|bi 409306|mesh-list
84065495|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84065496|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065497|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065498|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
84065499|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065500|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065501|NCT00576901|Bevacizumab|bevacizumab|mesh-list
84065502|NCT00576901|Docetaxel|docetaxel|mesh-list
84065503|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065504|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065505|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84065506|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84065507|NCT00576901|Growth Substances|growth substances|mesh-ancestor
84065508|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065509|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
84065510|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
84065511|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
84065512|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
84065513|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065514|NCT00699283|Brivaracetam|brivaracetam|mesh-list
84065515|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
84065516|NCT04062721|Immunomodulating Agents|immunomodulating agents|mesh-list
84065517|NCT04062721|Immunologic Factors|immunologic factors|mesh-ancestor
84065518|NCT04062721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065519|NCT01023815|Cyclosporine|cyclosporine|mesh-list
84065520|NCT01023815|Everolimus|everolimus|mesh-list
84065521|NCT01023815|Cyclosporins|cyclosporins|mesh-list
84065522|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065523|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065524|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84065525|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
84065526|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065527|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
84065528|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065529|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
84065530|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065531|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84065532|NCT01023815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84065533|NCT01023815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84065534|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065535|NCT02567383|Docetaxel|docetaxel|mesh-list
84065536|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065537|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
84065538|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
84065539|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
84065540|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065541|NCT01023659|Bupropion|bupropion|mesh-list
84065542|NCT01023659|Varenicline|varenicline|mesh-list
84065543|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84065544|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
84065545|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84065546|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84065547|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84065548|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84065549|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065550|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
84065551|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065552|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252243|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84065553|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84065554|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84065555|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065556|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84065557|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84065558|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
84065559|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
84065560|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84065561|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84065562|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065563|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
84065564|NCT00740116|Coagulants|coagulants|mesh-ancestor
84065565|NCT02567461|Aspirin|aspirin|mesh-list
84065566|NCT02567461|Edoxaban|edoxaban|mesh-list
84065567|NCT02567461|Clopidogrel|clopidogrel|mesh-list
84065568|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84065569|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84065570|NCT02567461|Analgesics|analgesics|mesh-ancestor
84065571|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
84065572|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065573|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065574|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065575|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065576|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84065577|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84065578|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065579|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84065580|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84065581|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065582|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
84065583|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84065584|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84065585|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84065586|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
84065587|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065588|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84065589|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
84065590|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84065591|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
84065592|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
84065593|NCT00698581|Brivaracetam|brivaracetam|mesh-list
84065594|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
84065595|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
84065596|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
84065597|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84065598|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84065599|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065600|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252493|NCT04906915|Ketamine|ketamine|mesh-list
84065601|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065602|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065603|NCT01023581|Metformin|metformin|mesh-list
84065604|NCT01023581|Alogliptin|alogliptin|mesh-list
84065605|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065606|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065607|NCT01023581|Incretins|incretins|mesh-ancestor
84065608|NCT01023581|Hormones|hormones|mesh-ancestor
84065609|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065610|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84065611|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
84065612|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065613|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065614|NCT05571787|Rabeprazole|rabeprazole|mesh-list
84065615|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84065616|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84065617|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84065618|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065619|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065620|NCT04063189|Clarithromycin|clarithromycin|mesh-list
84065621|NCT04063189|Dexamethasone|dexamethasone|mesh-list
84065622|NCT04063189|Lenalidomide|lenalidomide|mesh-list
84065623|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065624|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
84065625|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
84065626|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065627|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065628|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84065629|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
84065630|NCT04063189|Hormones|hormones|mesh-ancestor
83252769|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84065631|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065632|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84065633|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065634|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
84065635|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84065636|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84065637|NCT04063189|Growth Substances|growth substances|mesh-ancestor
84065638|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
84065639|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84065640|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065641|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84065642|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065643|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065644|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84065645|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84065646|NCT02567929|Propofol|propofol|mesh-list
84065647|NCT02567929|Sevoflurane|sevoflurane|mesh-list
84065648|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84065649|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065650|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065651|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84065652|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
84065653|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
84065654|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84065655|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84065656|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84065657|NCT05188417|Tirofiban|tirofiban|mesh-list
84065658|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84065659|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84065660|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065661|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84065662|NCT00962780|Vaccines|vaccines|mesh-list
84065663|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84065664|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
84065665|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065666|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84065667|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065668|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065669|NCT02567851|Immunotoxins|immunotoxins|mesh-ancestor
84065670|NCT02567851|Immunoconjugates|immunoconjugates|mesh-ancestor
84065671|NCT02567851|Immunologic Factors|immunologic factors|mesh-ancestor
84065672|NCT02567851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065673|NCT00739882|Antibodies|antibodies|mesh-list
84065674|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84065675|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
84065676|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065677|NCT00961220|Carmustine|carmustine|mesh-list
84065678|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
84065679|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84065680|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
84065681|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065682|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065683|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065684|NCT00734656|Ethanol|ethanol|mesh-list
84065685|NCT00734656|Dutasteride|dutasteride|mesh-list
84065686|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84065687|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065688|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065689|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065690|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84065691|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84065692|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065693|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065694|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
84065695|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065696|NCT04644289|Durvalumab|durvalumab|mesh-list
84065697|NCT04644289|Olaparib|olaparib|mesh-list
83253165|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
84065698|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065699|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065700|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84065701|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065702|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065703|NCT02565979|Resveratrol|resveratrol|mesh-list
84065704|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
84065705|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065706|NCT02565979|Protective Agents|protective agents|mesh-ancestor
84065707|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065708|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065709|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84065710|NCT04062175|Azithromycin|azithromycin|mesh-list
84065711|NCT04062175|Cephalosporins|cephalosporins|mesh-list
84065712|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84065713|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065714|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
84065715|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84065716|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84065717|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84065718|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065719|NCT04391569|Ganaxolone|ganaxolone|mesh-list
84065720|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
84065721|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065722|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065723|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065724|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
84065725|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
84065726|NCT05324917|Rituximab|rituximab|mesh-list
83253283|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065727|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065728|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065729|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
84065730|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065731|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065732|NCT00739648|Levofloxacin|levofloxacin|mesh-list
84065733|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84065734|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065735|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84065736|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84065737|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84065738|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065739|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065740|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065741|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84065742|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84065743|NCT01032239|Baclofen|baclofen|mesh-list
84065744|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84065745|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065746|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84065747|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065748|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84065749|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
84065750|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
84065751|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065752|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065753|NCT02871713|Morphine|morphine|mesh-list
84065754|NCT02871713|Ropivacaine|ropivacaine|mesh-list
84065755|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84065756|NCT02871713|Narcotics|narcotics|mesh-ancestor
84065757|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065758|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065759|NCT02871713|Analgesics|analgesics|mesh-ancestor
84065760|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
84065761|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065762|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
84065763|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
84065764|NCT04342975|Niacinamide|niacinamide|mesh-list
84065765|NCT04342975|Niacin|niacin|mesh-list
84065766|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
84065767|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
84065768|NCT04342975|Vitamins|vitamins|mesh-ancestor
84065769|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
84065770|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065771|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84065772|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
84065773|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065774|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84065775|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
84065776|NCT00734578|Guanfacine|guanfacine|mesh-list
84065777|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84065778|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84065779|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84065780|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84065781|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065782|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065783|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065784|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065785|NCT00637715|Alfuzosin|alfuzosin|mesh-list
84065786|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84065787|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84065788|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84065789|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065790|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065791|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065792|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065793|NCT00637715|Urological Agents|urological agents|mesh-ancestor
84065794|NCT02596282|Anesthetics|anesthetics|mesh-list
84065795|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065796|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065797|NCT04557085|Cenobamate|cenobamate|mesh-list
84065798|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
84065799|NCT02593708|Paclitaxel|paclitaxel|mesh-list
84065800|NCT02593708|Trastuzumab|trastuzumab|mesh-list
84065801|NCT02593708|Pertuzumab|pertuzumab|mesh-list
84065802|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84065803|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065804|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
84065805|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
84065806|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
84065807|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065808|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065809|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
84065810|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84065811|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
84065812|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065813|NCT00696787|Pregabalin|pregabalin|mesh-list
83305759|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
84065814|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84065815|NCT00696787|Analgesics|analgesics|mesh-ancestor
84065816|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
84065817|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065818|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065819|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
84065820|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84065821|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84065822|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065823|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84065824|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84065825|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83253676|NCT05048615|Itraconazole|itraconazole|mesh-list
84065826|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065827|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84065828|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84065829|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84065830|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065831|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
84065832|NCT01012037|Linagliptin|linagliptin|mesh-list
84065833|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065834|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065835|NCT01012037|Incretins|incretins|mesh-ancestor
84065837|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065838|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84065839|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
84065840|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065841|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065842|NCT00630110|Docetaxel|docetaxel|mesh-list
84065843|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065844|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
84065845|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
84065846|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
84065847|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065848|NCT00734032|Darapladib|darapladib|mesh-list
84065849|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
84065850|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065851|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065852|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
84065853|NCT04284098|Bupivacaine|bupivacaine|mesh-list
84065854|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
84065855|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
84065856|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065857|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065858|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
84065859|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065860|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84065861|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84065862|NCT04284098|Analgesics|analgesics|mesh-ancestor
84065863|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84065864|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84065865|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84065866|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065867|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065868|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065869|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
84065870|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84065871|NCT00733954|Clobetasol|clobetasol|mesh-list
84065872|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065873|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
84065874|NCT00733954|Hormones|hormones|mesh-ancestor
84065875|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065876|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065877|NCT02595268|Pitavastatin|pitavastatin|mesh-list
84065878|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84065879|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84065880|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84065881|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
83253845|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83253900|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84065882|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065883|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065884|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84065885|NCT00921505|Acetaminophen|acetaminophen|mesh-list
84065886|NCT00921505|Ibuprofen|ibuprofen|mesh-list
84065887|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84065888|NCT00921505|Analgesics|analgesics|mesh-ancestor
84065889|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
84065890|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065891|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065892|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
84065893|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84065894|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84065895|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84065896|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84065897|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065898|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065899|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
84065900|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84065901|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065902|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84065903|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
84065904|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065905|NCT04298021|Durvalumab|durvalumab|mesh-list
84065906|NCT04298021|Olaparib|olaparib|mesh-list
84065907|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84065908|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065909|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84065910|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065911|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065912|NCT02595190|Gabapentin|gabapentin|mesh-list
84065913|NCT02595190|Tramadol|tramadol|mesh-list
84065914|NCT02595190|Analgesics|analgesics|mesh-ancestor
84065915|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
84065916|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065917|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065918|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
84065919|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84065920|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84065921|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065922|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84065923|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84065924|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84065925|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065926|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065927|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
84065928|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84065929|NCT02595190|Narcotics|narcotics|mesh-ancestor
84065930|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84065931|NCT04061473|Empagliflozin|empagliflozin|mesh-list
84065932|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84065933|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065934|NCT04061473|Incretins|incretins|mesh-ancestor
84065935|NCT04061473|Hormones|hormones|mesh-ancestor
83254151|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065936|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065937|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84065938|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
84065939|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065940|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065941|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84065942|NCT04502693|Vaccines|vaccines|mesh-list
84065943|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
84065944|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065945|NCT00733408|Paclitaxel|paclitaxel|mesh-list
84065946|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84065947|NCT00733408|Bevacizumab|bevacizumab|mesh-list
84065948|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84065949|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84065950|NCT00733408|Antibodies|antibodies|mesh-list
84065951|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
84065952|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84065953|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84065954|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84065955|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
84065956|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
84065957|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
84065958|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065959|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84065960|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84065961|NCT00733408|Growth Substances|growth substances|mesh-ancestor
84065962|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065963|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
84065964|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
84065965|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84065966|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84065967|NCT04296383|Azithromycin|azithromycin|mesh-list
84065968|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84065969|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84065970|NCT00576823|Alfuzosin|alfuzosin|mesh-list
84065971|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84065972|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84065973|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84065974|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
84065975|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84065976|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84065977|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065978|NCT00576823|Urological Agents|urological agents|mesh-ancestor
84065979|NCT00732940|Belimumab|belimumab|mesh-list
84065980|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84065981|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
84065982|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065983|NCT00962390|Equol|equol|mesh-list
84065984|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
84065985|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84065986|NCT00962390|Estrogens|estrogens|mesh-ancestor
84065987|NCT00962390|Hormones|hormones|mesh-ancestor
84065988|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84065989|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065990|NCT00742807|Alfentanil|alfentanil|mesh-list
84065991|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84065992|NCT00742807|Narcotics|narcotics|mesh-ancestor
84065993|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84065994|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84065995|NCT00742807|Analgesics|analgesics|mesh-ancestor
84065996|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
84065997|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84065998|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84065999|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
84066000|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
84066001|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
84066002|NCT03221257|Pirfenidone|pirfenidone|mesh-list
84066003|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84066004|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254393|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84066005|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84066006|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
84066007|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84066008|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066009|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066010|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066011|NCT03221257|Analgesics|analgesics|mesh-ancestor
84066012|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
84066013|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066014|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066015|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84066016|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84066017|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066018|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066019|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84066020|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84066021|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84066022|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066023|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066024|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066025|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066026|NCT00960986|Analgesics|analgesics|mesh-ancestor
84066027|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
84066028|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066029|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
84066030|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84066031|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
84066032|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84066033|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066034|NCT00958880|Yohimbine|yohimbine|mesh-list
84066035|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
84066036|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
83254527|NCT04853797|Calcium|calcium|mesh-list
84066037|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066038|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066039|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84066040|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84066041|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84066042|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
84066043|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066044|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066045|NCT00958880|Urological Agents|urological agents|mesh-ancestor
84066046|NCT02595034|Clindamycin|clindamycin|mesh-list
84066047|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
84066048|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
84066049|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84066050|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84066051|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066052|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84066053|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066054|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066055|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
84066056|NCT00958724|Vinorelbine|vinorelbine|mesh-list
84066057|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066058|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066059|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066060|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066061|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066062|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066063|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84066064|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
84066065|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84066066|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84066067|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066068|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066069|NCT00738400|Urological Agents|urological agents|mesh-ancestor
84066070|NCT00958568|Olanzapine|olanzapine|mesh-list
84066071|NCT00958568|Fluoxetine|fluoxetine|mesh-list
84066072|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
84066073|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
84066074|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066075|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066076|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066077|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84066078|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84066079|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84066080|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84066081|NCT00958568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83254837|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
84066082|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84066083|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066084|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066085|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066086|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
84066087|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84066088|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
84066089|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84066090|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84066091|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066092|NCT00630500|Memantine|memantine|mesh-list
84066093|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84066094|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84066095|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
84066096|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066097|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066098|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254902|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066099|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84066100|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84066101|NCT02858804|Cytarabine|cytarabine|mesh-list
84066102|NCT02858804|Thalidomide|thalidomide|mesh-list
84066103|NCT02858804|Dexamethasone|dexamethasone|mesh-list
84066104|NCT02858804|Prednisone|prednisone|mesh-list
84066105|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
84066106|NCT02858804|Rituximab|rituximab|mesh-list
84066107|NCT02858804|Doxorubicin|doxorubicin|mesh-list
84066108|NCT02858804|Etoposide|etoposide|mesh-list
84066109|NCT02858804|Vincristine|vincristine|mesh-list
83306061|NCT04123288|ACT-709478|act-709478|mesh-list
83254957|NCT04822909|Thalidomide|thalidomide|mesh-list
84066111|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
84066112|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066113|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066114|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84066115|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
84066116|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066117|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066118|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84066119|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066120|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066121|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
84066122|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
84066123|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066124|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066125|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
84066126|NCT02858804|Hormones|hormones|mesh-ancestor
84066127|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066128|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84066129|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84066130|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84066131|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84066132|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066133|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066134|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84066135|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
84066136|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
84066137|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066138|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066139|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066140|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066141|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
84066142|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84066143|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84066144|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84066145|NCT02858804|Growth Substances|growth substances|mesh-ancestor
84066146|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
84066147|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
84066148|NCT00958256|Rituximab|rituximab|mesh-list
84066149|NCT00958256|Bortezomib|bortezomib|mesh-list
84066150|NCT00958256|Lenograstim|lenograstim|mesh-list
84066151|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066152|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
83255149|NCT05617729|Povidone|povidone|mesh-list
84066153|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066154|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066155|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84066156|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
84066157|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066158|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066159|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84066160|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066161|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84066162|NCT01006265|Ponesimod|ponesimod|mesh-list
84066163|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84066164|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066165|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066166|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
84066167|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066168|NCT02861690|Paclitaxel|paclitaxel|mesh-list
84066169|NCT02861690|Nedaplatin|nedaplatin|mesh-list
84066170|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066171|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066172|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066173|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066174|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066175|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066176|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
84066177|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84066178|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066179|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84066180|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066181|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
84066182|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84066183|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066185|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84066186|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066187|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84066188|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066189|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066190|NCT02858258|Rituximab|rituximab|mesh-list
84066191|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066192|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066193|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
84066194|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066195|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066196|NCT01008995|Ustekinumab|ustekinumab|mesh-list
84066197|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
84066198|NCT04295993|Norepinephrine|norepinephrine|mesh-list
84066199|NCT04295993|Methylene Blue|methylene blue|mesh-list
84066200|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84066201|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84066202|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
84066203|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066204|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066205|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066206|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
84066207|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
83255397|NCT04814485|Paclitaxel|paclitaxel|mesh-list
84066208|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066209|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84066210|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066211|NCT00743587|Naproxen|naproxen|mesh-list
84066212|NCT00743587|Oxycodone|oxycodone|mesh-list
84066213|NCT00743587|Tramadol|tramadol|mesh-list
84066214|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84066215|NCT00743587|Narcotics|narcotics|mesh-ancestor
84066216|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84066217|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066218|NCT00743587|Analgesics|analgesics|mesh-ancestor
84066219|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
84066220|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066221|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84066222|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84066223|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066224|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066225|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
84066226|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84066227|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066228|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066229|NCT00957944|Rotigotine|rotigotine|mesh-list
84066230|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
84066231|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
84066232|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066233|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066234|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066235|NCT02871323|Durvalumab|durvalumab|mesh-list
84066236|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
84066237|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84066238|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
84066239|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066240|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066241|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
84066242|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066243|NCT04296149|Octreotide|octreotide|mesh-list
84066244|NCT04296149|Edotreotide|edotreotide|mesh-list
84066245|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066246|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84066247|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066248|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84066249|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066250|NCT01005875|Sorafenib|sorafenib|mesh-list
84066251|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066252|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84066253|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066254|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066255|NCT02701088|Mitomycins|mitomycins|mesh-list
84066256|NCT02701088|Mitomycin|mitomycin|mesh-list
84066257|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84066258|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066259|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
84066260|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066261|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84066262|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066263|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
84066264|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84066265|NCT04279106|Listerine|listerine|mesh-list
84066266|NCT04279106|Fluorides|fluorides|mesh-list
84066267|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
84066268|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
84066269|NCT04279106|Protective Agents|protective agents|mesh-ancestor
84066270|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066271|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84066272|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066273|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
84066274|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
84066275|NCT00743743|Resveratrol|resveratrol|mesh-list
83255712|NCT03938389|Valsartan|valsartan|mesh-list
84066276|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
84066277|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066278|NCT00743743|Protective Agents|protective agents|mesh-ancestor
84066279|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066280|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066281|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84066282|NCT01005719|Omeprazole|omeprazole|mesh-list
84066283|NCT01005719|Lansoprazole|lansoprazole|mesh-list
84066284|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
84066285|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84066286|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066287|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84066288|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066289|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066290|NCT02856854|Cocaine|cocaine|mesh-list
84066291|NCT02856854|Oxazepam|oxazepam|mesh-list
84066292|NCT02856854|Metyrapone|metyrapone|mesh-list
84066293|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
84066294|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
84066295|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84066296|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066297|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
84066298|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066299|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84066300|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84066301|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84066302|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066303|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066304|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
84066305|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066306|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
84066307|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066308|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84066309|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84066310|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84066311|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84066312|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
84066313|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
84066314|NCT02857166|Antibodies|antibodies|mesh-list
84066315|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84066316|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
83255822|NCT04589611|Amobarbital|amobarbital|mesh-list
84066317|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066318|NCT02856932|Methamphetamine|methamphetamine|mesh-list
84066319|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84066320|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066321|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
84066322|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
84066323|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066324|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
84066325|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256029|NCT05347459|Canagliflozin|canagliflozin|mesh-list
84066326|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066327|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
84066328|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84066329|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84066330|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066331|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84066332|NCT02563951|Granisetron|granisetron|mesh-list
84066333|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
84066334|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
84066335|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066336|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066337|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066338|NCT02563951|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84066339|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84066340|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
84066341|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066342|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066343|NCT00953576|Ketoconazole|ketoconazole|mesh-list
84066344|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
84066345|NCT00953576|Lapatinib|lapatinib|mesh-list
84066346|NCT00953576|Dutasteride|dutasteride|mesh-list
84066347|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066348|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066349|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84066350|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066351|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066352|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
84066353|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066354|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84066355|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84066356|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84066357|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
84066358|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066359|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066360|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84066361|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84066362|NCT02100956|Oxytocin|oxytocin|mesh-list
84066363|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
84066364|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84066365|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066366|NCT02073968|Paclitaxel|paclitaxel|mesh-list
83256374|NCT05461261|Docetaxel|docetaxel|mesh-list
84066367|NCT02073968|Carboplatin|carboplatin|mesh-list
84066368|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84066369|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066370|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066371|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066372|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066373|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066374|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066375|NCT01005329|Paclitaxel|paclitaxel|mesh-list
84066376|NCT01005329|Bevacizumab|bevacizumab|mesh-list
84066377|NCT01005329|Cisplatin|cisplatin|mesh-list
84066378|NCT01005329|Carboplatin|carboplatin|mesh-list
84066379|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84066380|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84066381|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
84066382|NCT01005329|Antibodies|antibodies|mesh-list
84066383|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
84066384|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84066385|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
84066386|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066387|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066388|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066389|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066390|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066391|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066392|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84066393|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84066394|NCT01005329|Growth Substances|growth substances|mesh-ancestor
84066395|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066396|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
84066397|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
84066398|NCT00921349|Nadolol|nadolol|mesh-list
84066399|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84066400|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84066401|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
84066402|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066403|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066404|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066405|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84066406|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84066407|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
84066408|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
84066409|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066411|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066412|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84066413|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
84066414|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
84066415|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066416|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066417|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066418|NCT03048578|Liraglutide|liraglutide|mesh-list
84066419|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84066420|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066421|NCT03048578|Incretins|incretins|mesh-ancestor
84066422|NCT03048578|Hormones|hormones|mesh-ancestor
84066423|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066424|NCT02856776|Vitamin D|vitamin d|mesh-list
84066425|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
84066426|NCT02856776|Vitamins|vitamins|mesh-ancestor
84066427|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
84066428|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066429|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84066430|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84066431|NCT04296851|Niclosamide|niclosamide|mesh-list
84066432|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
84066433|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84066434|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
84066435|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84066436|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066437|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
84066438|NCT02858024|Dapivirine|dapivirine|mesh-list
84066439|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84066440|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84066441|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
84066442|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066443|NCT02857946|Linagliptin|linagliptin|mesh-list
84066444|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84066445|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066446|NCT02857946|Incretins|incretins|mesh-ancestor
84066447|NCT02857946|Hormones|hormones|mesh-ancestor
84066448|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256664|NCT02581345|Adalimumab|adalimumab|mesh-list
84066449|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84066450|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
84066451|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066452|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066453|NCT02857712|Axitinib|axitinib|mesh-list
84066454|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066455|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84066456|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066457|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066458|NCT00696241|Olmesartan|olmesartan|mesh-list
84066459|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84066460|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84066461|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84066462|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84066463|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84066464|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066465|NCT00630968|Levetiracetam|levetiracetam|mesh-list
84066466|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
84066467|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
84066468|NCT02513563|Paclitaxel|paclitaxel|mesh-list
84066469|NCT02513563|Carboplatin|carboplatin|mesh-list
84066470|NCT02513563|Adavosertib|adavosertib|mesh-list
84066471|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066472|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066473|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066474|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066475|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066476|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066477|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066478|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
84066479|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
84066480|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066481|NCT00689611|Bupropion|bupropion|mesh-list
84066482|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84066483|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
84066484|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84066485|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84066486|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84066487|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066488|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066489|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
84066490|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066491|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066492|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84066493|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84066494|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066495|NCT02563795|Fentanyl|fentanyl|mesh-list
84066496|NCT02563795|Bupivacaine|bupivacaine|mesh-list
84066497|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
84066498|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
83256797|NCT02576977|Pomalidomide|pomalidomide|mesh-list
84066499|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84066500|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066501|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
84066502|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066503|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84066504|NCT02563795|Narcotics|narcotics|mesh-ancestor
84066505|NCT02563795|Analgesics|analgesics|mesh-ancestor
84066506|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84066507|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84066508|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
84066509|NCT04281680|Octreotide|octreotide|mesh-list
84066510|NCT04281680|Pasireotide|pasireotide|mesh-list
84066511|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066512|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84066513|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066514|NCT04281680|Hormones|hormones|mesh-ancestor
84066515|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066516|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066517|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
84066518|NCT00744445|Hematinics|hematinics|mesh-ancestor
84066519|NCT02854748|Empagliflozin|empagliflozin|mesh-list
84066520|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84066521|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066522|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84066523|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066524|NCT03881917|Cystatins|cystatins|mesh-list
84066525|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
84066526|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
84066527|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066528|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066529|NCT00744679|Natalizumab|natalizumab|mesh-list
84066530|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
84066531|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066532|NCT04060459|Paclitaxel|paclitaxel|mesh-list
84066533|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066534|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066535|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066536|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066537|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066538|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066539|NCT01007435|Methotrexate|methotrexate|mesh-list
84066540|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84066541|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
84066542|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84066543|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066544|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84066545|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
84066546|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066547|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066548|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
84066549|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066550|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84066551|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066552|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
84066553|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066554|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84066555|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
84066556|NCT00948896|Piperaquine|piperaquine|mesh-list
84066557|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
84066558|NCT00948896|Trimethoprim|trimethoprim|mesh-list
84066559|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84066560|NCT00948896|Artenimol|artenimol|mesh-list
84066561|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84066563|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
84066564|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84066565|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84066566|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066567|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84066568|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066569|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066570|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84066571|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84066572|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84066573|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84066574|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84066575|NCT01004159|Irinotecan|irinotecan|mesh-list
84066576|NCT01004159|Cetuximab|cetuximab|mesh-list
84066577|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83257075|NCT05753189|Aceclidine|aceclidine|mesh-list
84066578|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84066579|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066580|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066581|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066582|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066583|NCT00948818|Linaclotide|linaclotide|mesh-list
84066584|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84066585|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
83257132|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
84066586|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066587|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066588|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84066589|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84066590|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84066591|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066592|NCT00948506|Cidofovir|cidofovir|mesh-list
84066593|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
84066594|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066595|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066596|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066597|NCT00689221|Temozolomide|temozolomide|mesh-list
84066598|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84066599|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
84066600|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066601|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066602|NCT04060771|Dexamethasone|dexamethasone|mesh-list
84066603|NCT04060771|Palonosetron|palonosetron|mesh-list
84066604|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066605|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
84066606|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
84066607|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066608|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066609|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066610|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
84066611|NCT04060771|Hormones|hormones|mesh-ancestor
84066612|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066613|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84066614|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066615|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84066616|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84066617|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
84066618|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066619|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066620|NCT00744913|Nicotine|nicotine|mesh-list
84066621|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84066622|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
83257251|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
84066623|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066624|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066625|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84066626|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84066627|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
84066628|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066629|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066630|NCT01875445|Inositol|inositol|mesh-list
84066631|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
84066632|NCT01875445|Vitamins|vitamins|mesh-ancestor
84066633|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
84066634|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066635|NCT00745069|Tapentadol|tapentadol|mesh-list
84066636|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84066637|NCT00745069|Narcotics|narcotics|mesh-ancestor
84066638|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84066639|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066640|NCT00745069|Analgesics|analgesics|mesh-ancestor
84066641|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
84066642|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066643|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84066644|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83257377|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
84066645|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066646|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066647|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
84066648|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066649|NCT00745147|Laxatives|laxatives|mesh-list
84066650|NCT00745147|Lactulose|lactulose|mesh-list
84066651|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84066652|NCT00688909|Letrozole|letrozole|mesh-list
84066653|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066654|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84066655|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84066656|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257443|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84066657|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066658|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84066659|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
84066660|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066661|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066662|NCT00948428|Imiquimod|imiquimod|mesh-list
84066663|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84066664|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
84066665|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066666|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066667|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
84066668|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
84066669|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84066670|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
84066671|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066672|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066673|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84066674|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
84066675|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84066676|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
84066677|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066678|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066679|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84066680|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
84066681|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
84066682|NCT00948194|Protective Agents|protective agents|mesh-ancestor
84066683|NCT00691483|Varenicline|varenicline|mesh-list
84066684|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84066685|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84066686|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
84066687|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066688|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066689|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066690|NCT00691093|Fesoterodine|fesoterodine|mesh-list
84066691|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84066692|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84066693|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
84066694|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066695|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066696|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066697|NCT00691093|Urological Agents|urological agents|mesh-ancestor
84066698|NCT03646825|Antioxidants|antioxidants|mesh-list
84066699|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066700|NCT03646825|Protective Agents|protective agents|mesh-ancestor
84066701|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066702|NCT00745225|Pioglitazone|pioglitazone|mesh-list
84066703|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84066704|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066705|NCT02856542|Betamethasone|betamethasone|mesh-list
84066706|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
84066707|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84066708|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
84066709|NCT02856542|Calcipotriene|calcipotriene|mesh-list
84066710|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84066711|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066712|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
84066713|NCT02856542|Hormones|hormones|mesh-ancestor
84066714|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066715|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257711|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
84066716|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84066717|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
84066718|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
84066719|NCT00688753|Everolimus|everolimus|mesh-list
84066720|NCT00688753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84066721|NCT00688753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84066722|NCT00688753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257776|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066723|NCT00688753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066724|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066725|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
84066726|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066727|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066728|NCT04204382|Levofloxacin|levofloxacin|mesh-list
84066729|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84066730|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066731|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84066732|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84066733|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84066734|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066735|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066736|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066737|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84066738|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84066739|NCT02856230|Paclitaxel|paclitaxel|mesh-list
84066740|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83257845|NCT03553004|Niraparib|niraparib|mesh-list
84066741|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066742|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066743|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066744|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066745|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066746|NCT00631124|Drospirenone|drospirenone|mesh-list
84066747|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84066748|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84066749|NCT00631124|Estradiol|estradiol|mesh-list
84066750|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84066751|NCT00631124|Estrogens|estrogens|mesh-ancestor
84066752|NCT00631124|Hormones|hormones|mesh-ancestor
84066753|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066754|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066755|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84066756|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
84066757|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83257902|NCT03250377|Brivaracetam|brivaracetam|mesh-list
84066758|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84066759|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84066760|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
84066761|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84066762|NCT00631124|Diuretics|diuretics|mesh-ancestor
84066763|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
84066764|NCT02855684|Insulin|insulin|mesh-list
84066765|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84066766|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
84066767|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84066768|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066769|NCT01667744|Citalopram|citalopram|mesh-list
84066770|NCT01667744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84066771|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84066772|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066773|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066774|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066775|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
84066776|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066777|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84066778|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
84066779|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84066780|NCT04274270|Endostar protein|endostar protein|mesh-list
84066781|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84066782|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84066783|NCT04274270|Growth Substances|growth substances|mesh-ancestor
84066784|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066785|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
84066786|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066787|NCT02855294|Drospirenone|drospirenone|mesh-list
84066788|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84066789|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
84066790|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84066791|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066792|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84066793|NCT02855294|Diuretics|diuretics|mesh-ancestor
84066794|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
84066795|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84066796|NCT00950690|Latanoprost|latanoprost|mesh-list
84066797|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84066798|NCT02855138|Isotretinoin|isotretinoin|mesh-list
84066799|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
84066800|NCT00694369|Acetaminophen|acetaminophen|mesh-list
84066802|NCT00694369|Etoricoxib|etoricoxib|mesh-list
84066803|NCT00694369|Codeine|codeine|mesh-list
84066804|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84066805|NCT00694369|Analgesics|analgesics|mesh-ancestor
84066806|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
84066807|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066808|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066809|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
84066810|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84066811|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066812|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066813|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84066814|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066815|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066816|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84066817|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84066818|NCT00694369|Narcotics|narcotics|mesh-ancestor
84066819|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84066820|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
84066821|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258141|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
84066822|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
84066823|NCT00745693|BQ 788|bq 788|mesh-list
84066824|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84066825|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84066826|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066827|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
84066828|NCT02563405|Doxazosin|doxazosin|mesh-list
84066829|NCT02563405|Nifedipine|nifedipine|mesh-list
84066830|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84066831|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066832|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066833|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84066834|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066835|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
84066836|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
84066837|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84066838|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84066839|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84066840|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84066841|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84066842|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
84066843|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066844|NCT03412747|Adalimumab|adalimumab|mesh-list
84066845|NCT03412747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84066846|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066847|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066848|NCT00513019|Lamotrigine|lamotrigine|mesh-list
83258332|NCT01610713|Nabiximols|nabiximols|mesh-list
84066849|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
84066850|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84066851|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84066852|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066853|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84066854|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306824|NCT02556424|Dexamethasone|dexamethasone|mesh-list
84066855|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84066856|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84066857|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84066858|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84066859|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84066860|NCT00053677|Naltrexone|naltrexone|mesh-list
84066861|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84066862|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84066863|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066864|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
84066865|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066866|NCT00954512|Leucovorin|leucovorin|mesh-list
84066867|NCT00954512|Folic Acid|folic acid|mesh-list
84066868|NCT00954512|Carboplatin|carboplatin|mesh-list
84066869|NCT00954512|Gemcitabine|gemcitabine|mesh-list
84066870|NCT00954512|Trastuzumab|trastuzumab|mesh-list
84066871|NCT00954512|Irinotecan|irinotecan|mesh-list
84066872|NCT00954512|Cetuximab|cetuximab|mesh-list
84066873|NCT00954512|Everolimus|everolimus|mesh-list
84066874|NCT00954512|Epirubicin|epirubicin|mesh-list
84066875|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
84066876|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066877|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258606|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066878|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84066879|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
84066880|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066881|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84066882|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84066883|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066884|NCT00954512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84066885|NCT00954512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84066886|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066887|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
84066888|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066889|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84066890|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84066891|NCT00954512|Antidotes|antidotes|mesh-ancestor
84066892|NCT00954512|Protective Agents|protective agents|mesh-ancestor
84066893|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
84066894|NCT00954512|Vitamins|vitamins|mesh-ancestor
84066895|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
84066896|NCT00954512|Hematinics|hematinics|mesh-ancestor
84066897|NCT00691015|Cytarabine|cytarabine|mesh-list
84066898|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
84066899|NCT00691015|Melphalan|melphalan|mesh-list
84066900|NCT00691015|Busulfan|busulfan|mesh-list
84066901|NCT00691015|Carmustine|carmustine|mesh-list
84066902|NCT00691015|Rituximab|rituximab|mesh-list
84066903|NCT00691015|Fludarabine|fludarabine|mesh-list
84066904|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
84066905|NCT00691015|Etoposide|etoposide|mesh-list
84066906|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
84066907|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84066908|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066909|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
84066910|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066911|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066912|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84066913|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
84066914|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066915|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066916|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84066917|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066918|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84066919|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
84066920|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84066921|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84066922|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84066923|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066924|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
84066925|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84066926|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
84066927|NCT00950300|Docetaxel|docetaxel|mesh-list
84066928|NCT00950300|Fluorouracil|fluorouracil|mesh-list
84066929|NCT00950300|Trastuzumab|trastuzumab|mesh-list
84066930|NCT00950300|Epirubicin|epirubicin|mesh-list
84066931|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066932|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
84066933|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066934|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066935|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84066936|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
84066937|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066938|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066939|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84066940|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
84066941|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
84066942|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
84066943|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
84066944|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84066945|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066946|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83259072|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
84066947|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84066948|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84066949|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066950|NCT00949988|Rituximab|rituximab|mesh-list
84066951|NCT00949988|Dasatinib|dasatinib|mesh-list
84066952|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84066953|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84066954|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
84066955|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066956|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84066957|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84066958|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066959|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066960|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
84066961|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84066962|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066963|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84066964|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
84066965|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066966|NCT02593474|Naltrexone|naltrexone|mesh-list
84066967|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83259135|NCT02559817|Linaclotide|linaclotide|mesh-list
84066968|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84066969|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066970|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
84066971|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066972|NCT00687193|Tofacitinib|tofacitinib|mesh-list
84066973|NCT00687193|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84066974|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84066975|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84066976|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066977|NCT00917878|Calcium|calcium|mesh-list
84066978|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84066979|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066980|NCT00730912|Loratadine|loratadine|mesh-list
84066981|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
84066982|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
84066983|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84066984|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84066985|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84066986|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
84066987|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
84066988|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84066989|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84066990|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066991|NCT00730756|Fluticasone|fluticasone|mesh-list
84066992|NCT00730756|Xhance|xhance|mesh-list
84066993|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84066994|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84066995|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
84066996|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84066997|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84066998|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84066999|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
83259336|NCT05494567|Tadalafil|tadalafil|mesh-list
84067000|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
84067001|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84067002|NCT00730132|Ezetimibe|ezetimibe|mesh-list
84067003|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84067004|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84067005|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
84067006|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067007|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84067008|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
84067009|NCT00737464|Hematinics|hematinics|mesh-ancestor
84067010|NCT00729586|Tamoxifen|tamoxifen|mesh-list
84067011|NCT00729586|Sirolimus|sirolimus|mesh-list
84067012|NCT00729586|Temsirolimus|temsirolimus|mesh-list
84067013|NCT00729586|Megestrol|megestrol|mesh-list
84067014|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
84067015|NCT00729586|MTOR Inhibitors|mtor inhibitors|mesh-list
84067016|NCT00729586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067017|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84067018|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067019|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84067020|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067021|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
84067022|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067023|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
84067024|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067025|NCT00729586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067026|NCT00729586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067027|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84067028|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
84067029|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067030|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067031|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84067032|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84067033|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84067034|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84067035|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84067036|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84067037|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
84067038|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84067039|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84067040|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84067041|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
84067042|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84067043|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84067044|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067045|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067046|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067047|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067048|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84067049|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84067050|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84067051|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
84067052|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067053|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84067054|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84067055|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067056|NCT02593162|Ribavirin|ribavirin|mesh-list
84067057|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
84067058|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067059|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
84067060|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067061|NCT00686959|Paclitaxel|paclitaxel|mesh-list
84067062|NCT00686959|Etoposide|etoposide|mesh-list
84067063|NCT00686959|Vinorelbine|vinorelbine|mesh-list
84067064|NCT00686959|Carboplatin|carboplatin|mesh-list
84067065|NCT00686959|Pemetrexed|pemetrexed|mesh-list
84067066|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84067067|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067068|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
84067069|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
84067070|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
84067071|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067072|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84067073|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84067074|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067075|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84067076|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84067077|NCT04088110|Trastuzumab|trastuzumab|mesh-list
84067078|NCT04088110|Letrozole|letrozole|mesh-list
84067079|NCT04088110|Anastrozole|anastrozole|mesh-list
84067080|NCT04088110|Exemestane|exemestane|mesh-list
84067081|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84067082|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067083|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067084|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84067085|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067086|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067087|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84067088|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
84067089|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259751|NCT02370615|Digoxin|digoxin|mesh-list
84067090|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067091|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067092|NCT04088266|Buprenorphine|buprenorphine|mesh-list
84067093|NCT04088266|Naloxone|naloxone|mesh-list
84067094|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84067095|NCT04088266|Narcotics|narcotics|mesh-ancestor
84067096|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067097|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067098|NCT04088266|Analgesics|analgesics|mesh-ancestor
84067099|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
84067100|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067101|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84067102|NCT05311579|Niraparib|niraparib|mesh-list
84067103|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83259818|NCT01646073|Adalimumab|adalimumab|mesh-list
84067104|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067105|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067106|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067107|NCT00602342|Terbinafine|terbinafine|mesh-list
84067108|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
84067109|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067110|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067111|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067112|NCT00602498|Clarithromycin|clarithromycin|mesh-list
84067113|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84067114|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067115|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84067116|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259877|NCT02304705|Urological Agents|urological agents|mesh-ancestor
84067117|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067118|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84067119|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84067120|NCT00749359|Paroxetine|paroxetine|mesh-list
84067121|NCT00749359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84067122|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83260014|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
84067123|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84067124|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067125|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067126|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
84067127|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067128|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84067129|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
84067130|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84067131|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84067132|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84067133|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067134|NCT00946088|Progesterone|progesterone|mesh-list
84067135|NCT00946088|Progestins|progestins|mesh-ancestor
84067136|NCT00946088|Hormones|hormones|mesh-ancestor
84067137|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067138|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067139|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
84067140|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84067141|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067142|NCT00736996|Pioglitazone|pioglitazone|mesh-list
84067143|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84067144|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067145|NCT00741949|Propofol|propofol|mesh-list
84067146|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84067147|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067148|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067149|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84067150|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
84067151|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
84067152|NCT01410344|Vidarabine|vidarabine|mesh-list
84067153|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
84067154|NCT01410344|Melphalan|melphalan|mesh-list
84067155|NCT01410344|Busulfan|busulfan|mesh-list
84067156|NCT01410344|Fludarabine|fludarabine|mesh-list
84067157|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
84067158|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067159|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
84067160|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067161|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84067162|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84067163|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
84067164|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067165|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067166|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84067167|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84067168|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
84067169|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
84067170|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067171|NCT02594410|Lercanidipine|lercanidipine|mesh-list
84067172|NCT02594410|Clopidogrel|clopidogrel|mesh-list
84067173|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84067174|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84067175|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84067176|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84067177|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
84067178|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067179|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067180|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067181|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84067182|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84067183|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84067184|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84067185|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84067186|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
84067187|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84067188|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84067189|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84067190|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067191|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067192|NCT00586066|Memantine|memantine|mesh-list
84067193|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84067194|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84067195|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
83260400|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
84067196|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067197|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067198|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067199|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84067200|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84067201|NCT00630890|Capecitabine|capecitabine|mesh-list
84067202|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84067203|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
84067204|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067205|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067206|NCT00728494|Ribavirin|ribavirin|mesh-list
83260530|NCT05488925|Analgesics|analgesics|mesh-ancestor
84067207|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84067208|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
84067209|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
84067210|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067211|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
84067212|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067213|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
84067214|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067215|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
84067216|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84067217|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067218|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067219|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84067220|NCT02854904|Analgesics|analgesics|mesh-ancestor
84067221|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
84067222|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067223|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83260611|NCT04051619|Oxytocin|oxytocin|mesh-list
84067224|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84067225|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84067226|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
84067227|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067228|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067229|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
84067230|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84067231|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
84067232|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83260668|NCT02558231|Selexipag|selexipag|mesh-list
84067233|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
84067234|NCT00941330|Docetaxel|docetaxel|mesh-list
84067235|NCT00941330|Exemestane|exemestane|mesh-list
84067236|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067237|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
84067238|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067239|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84067240|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84067241|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
84067242|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067243|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067244|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84067245|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
84067246|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
84067247|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
84067248|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84067249|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84067250|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067251|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84067252|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
84067253|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067254|NCT00736450|Prednisone|prednisone|mesh-list
84067255|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
84067256|NCT00736450|Rituximab|rituximab|mesh-list
84067257|NCT00736450|Doxorubicin|doxorubicin|mesh-list
84067258|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84067259|NCT00736450|Vincristine|vincristine|mesh-list
84067260|NCT00736450|Oblimersen|oblimersen|mesh-list
84067261|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067262|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
84067263|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067264|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84067265|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84067266|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
84067267|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067268|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067269|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84067270|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067271|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84067272|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84067273|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84067274|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067275|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84067276|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
84067277|NCT00736450|Hormones|hormones|mesh-ancestor
84067278|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067279|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067280|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84067281|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
84067282|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
84067283|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
84067284|NCT00686881|Interferons|interferons|mesh-list
84067285|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
84067286|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
84067287|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84067288|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067289|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
84067290|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067291|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
84067292|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260909|NCT02551055|Paclitaxel|paclitaxel|mesh-list
83260968|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261056|NCT02301975|Xhance|xhance|mesh-list
84067293|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84067294|NCT02857244|Modafinil|modafinil|mesh-list
84067295|NCT02857244|Donepezil|donepezil|mesh-list
84067296|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84067297|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84067298|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84067299|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067300|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067301|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067302|NCT02857244|Analgesics|analgesics|mesh-ancestor
84067303|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
84067304|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067305|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
84067306|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84067307|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
84067308|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84067309|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067310|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
84067311|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
84067312|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84067313|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84067314|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84067315|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84067316|NCT04273256|Inositol|inositol|mesh-list
84067317|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
84067318|NCT04273256|Vitamins|vitamins|mesh-ancestor
84067319|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
84067320|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067321|NCT00921661|Aflibercept|aflibercept|mesh-list
84067322|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84067323|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84067324|NCT00921661|Growth Substances|growth substances|mesh-ancestor
84067325|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067326|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
84067327|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067328|NCT05096468|Pregabalin|pregabalin|mesh-list
84067329|NCT05096468|Ketamine|ketamine|mesh-list
84067330|NCT05096468|Esketamine|esketamine|mesh-list
84067331|NCT05096468|Analgesics|analgesics|mesh-ancestor
84067332|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
84067333|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067334|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067335|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84067336|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84067337|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
84067338|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
84067339|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067340|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84067341|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84067342|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067343|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067344|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
84067345|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84067346|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84067347|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84067348|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84067349|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84067350|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84067351|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
84067352|NCT04088032|Durvalumab|durvalumab|mesh-list
84067353|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84067354|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067355|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067356|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84067357|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067358|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067359|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84067360|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
84067361|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067362|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067363|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
84067364|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
84067365|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067366|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067367|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067368|NCT00735904|Gemcitabine|gemcitabine|mesh-list
84067369|NCT00735904|Axitinib|axitinib|mesh-list
84067370|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067371|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84067372|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
84067373|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067374|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067375|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067376|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
84067377|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
84067378|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84067379|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84067380|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067381|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
84067382|NCT02561923|Coagulants|coagulants|mesh-ancestor
84067383|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84067384|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
84067385|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84067386|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
84067387|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067388|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
84067389|NCT00918190|Dexamethasone|dexamethasone|mesh-list
84067390|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
84067391|NCT00918190|Midazolam|midazolam|mesh-list
84067392|NCT00918190|Ondansetron|ondansetron|mesh-list
84067393|NCT00918190|BB 1101|bb 1101|mesh-list
84067394|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84067395|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
84067396|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
84067397|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067398|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067399|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84067400|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
84067401|NCT00918190|Hormones|hormones|mesh-ancestor
84067402|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067403|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067404|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067405|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
84067406|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067407|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067408|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84067409|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84067410|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067411|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84067412|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84067413|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84067414|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84067415|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
84067416|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
84067417|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
84067418|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
84067419|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067420|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
84067421|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
84067422|NCT00918190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84067423|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84067424|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
84067425|NCT02563327|Pyridoxine|pyridoxine|mesh-list
84067426|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
84067427|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
84067428|NCT02563327|Rifampin|rifampin|mesh-list
84067429|NCT02563327|Isoniazid|isoniazid|mesh-list
84067430|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
84067431|NCT02563327|Ethambutol|ethambutol|mesh-list
84067432|NCT02563327|Rifapentine|rifapentine|mesh-list
84067433|NCT02563327|Vitamins|vitamins|mesh-ancestor
84067434|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
84067435|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067436|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84067437|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067438|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84067439|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84067440|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067441|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067442|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067443|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
84067444|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84067445|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
84067446|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
84067447|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83261317|NCT05447065|Vitamin D|vitamin d|mesh-list
84067448|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84067449|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84067450|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84067451|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84067452|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84067453|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84067454|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84067455|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84067456|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
84067457|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84067458|NCT00918034|Talaporfin|talaporfin|mesh-list
84067459|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067460|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84067461|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
84067462|NCT02593942|Remifentanil|remifentanil|mesh-list
84067463|NCT02593942|Propofol|propofol|mesh-list
84067464|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84067465|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067466|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067467|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84067468|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
84067469|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
84067470|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84067471|NCT02593942|Narcotics|narcotics|mesh-ancestor
84067472|NCT02593942|Analgesics|analgesics|mesh-ancestor
84067473|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
84067474|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067475|NCT00742339|Octreotide|octreotide|mesh-list
84067476|NCT00742339|Terlipressin|terlipressin|mesh-list
84067477|NCT00742339|Midodrine|midodrine|mesh-list
84067478|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84067479|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067480|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067481|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
84067482|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
84067483|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067484|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067485|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84067486|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84067487|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84067488|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84067489|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
84067490|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067491|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067492|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84067493|NCT02592772|Menthol|menthol|mesh-list
84067494|NCT02592772|Nicotine|nicotine|mesh-list
84067495|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84067496|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
84067497|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067498|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067499|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84067500|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84067501|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
84067502|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067503|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067504|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
84067505|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
84067506|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
84067507|NCT00631202|Hematinics|hematinics|mesh-ancestor
84067508|NCT02851784|Immunomodulating Agents|immunomodulating agents|mesh-list
84067509|NCT02851784|Immunologic Factors|immunologic factors|mesh-ancestor
84067510|NCT02851784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067511|NCT00721630|Capecitabine|capecitabine|mesh-list
84067512|NCT00721630|Lapatinib|lapatinib|mesh-list
84067513|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84067514|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
84067515|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067516|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067517|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067518|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067519|NCT00686725|Temozolomide|temozolomide|mesh-list
84067520|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84067521|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
83261506|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84067522|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067523|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067524|NCT04055623|Aldesleukin|aldesleukin|mesh-list
84067525|NCT04055623|Interleukin-2|interleukin-2|mesh-list
84067526|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067527|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84067528|NCT04055623|Analgesics|analgesics|mesh-ancestor
84067529|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
84067530|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067531|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067532|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84067533|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84067534|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
84067535|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067536|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84067537|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84067538|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84067539|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
84067540|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067541|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84067542|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84067543|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067544|NCT00727246|Choline|choline|mesh-list
84067545|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
84067546|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
84067547|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84067548|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
84067549|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067550|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84067551|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84067552|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
84067553|NCT05381558|Triamcinolone|triamcinolone|mesh-list
84067554|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84067555|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
84067556|NCT05381558|Hormones|hormones|mesh-ancestor
84067557|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067558|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067559|NCT04055233|Biguanides|biguanides|mesh-list
84067560|NCT04055233|Polihexanide|polihexanide|mesh-list
84067561|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067562|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
83261572|NCT02481635|Paclitaxel|paclitaxel|mesh-list
84067563|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84067564|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067565|NCT04268966|Brincidofovir|brincidofovir|mesh-list
84067566|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
84067567|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067568|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
84067569|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84067570|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067571|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067572|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84067573|NCT04269278|Analgesics|analgesics|mesh-ancestor
84067574|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
84067575|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067576|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84067577|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84067578|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84067579|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
84067580|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067581|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067582|NCT02853578|Budesonide|budesonide|mesh-list
84067583|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84067584|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84067585|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
84067586|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067587|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067588|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84067589|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
84067590|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
84067591|NCT02853578|Hormones|hormones|mesh-ancestor
84067592|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067593|NCT02592694|Tenecteplase|tenecteplase|mesh-list
84067594|NCT02592694|Tirofiban|tirofiban|mesh-list
84067595|NCT02592694|Bivalirudin|bivalirudin|mesh-list
84067596|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84067597|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84067598|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067599|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
84067600|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84067601|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
84067602|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067603|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
84067604|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84067605|NCT02591836|Atorvastatin|atorvastatin|mesh-list
84067606|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84067607|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84067608|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
84067609|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067610|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84067611|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84067612|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067613|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
84067614|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84067615|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
84067616|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067617|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067618|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84067619|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
84067620|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84067621|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
84067622|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067623|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067624|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84067625|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
84067626|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
84067627|NCT02851472|Protective Agents|protective agents|mesh-ancestor
84067628|NCT00687973|Atenolol|atenolol|mesh-list
84067629|NCT00687973|Amlodipine|amlodipine|mesh-list
84067630|NCT00687973|Valsartan|valsartan|mesh-list
84067631|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84067632|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84067633|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84067634|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067635|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84067636|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067637|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
84067638|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84067639|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84067640|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84067641|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
84067642|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
84067643|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067644|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84067645|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84067646|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84067647|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
84067648|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067649|NCT00747097|Gemcitabine|gemcitabine|mesh-list
84067650|NCT00747097|Cetuximab|cetuximab|mesh-list
84067651|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84067652|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
84067653|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067654|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067655|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067656|NCT00747331|Fenoldopam|fenoldopam|mesh-list
84067657|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84067658|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
84067659|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
84067660|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
84067661|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067662|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067663|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067664|NCT00747409|Insulin|insulin|mesh-list
84067665|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84067666|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
84067667|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
84067668|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
84067669|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84067670|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
84067671|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
84067672|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
84067673|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84067674|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067675|NCT00752011|Carboplatin|carboplatin|mesh-list
84067676|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067677|NCT00721396|Vaccines|vaccines|mesh-list
84067678|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84067679|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
84067680|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067681|NCT00943826|Bevacizumab|bevacizumab|mesh-list
84067682|NCT00943826|Temozolomide|temozolomide|mesh-list
84067683|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067684|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067685|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84067686|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84067687|NCT00943826|Growth Substances|growth substances|mesh-ancestor
84067688|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067689|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
84067691|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
84067692|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067693|NCT04268888|Nivolumab|nivolumab|mesh-list
84067694|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
84067695|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067696|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067697|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84067698|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067699|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84067700|NCT04268888|Estrogens|estrogens|mesh-ancestor
84067701|NCT04268888|Hormones|hormones|mesh-ancestor
84067702|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067703|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067704|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067705|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84067706|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067707|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067708|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067709|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067710|NCT02851394|Tramadol|tramadol|mesh-list
84067711|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
84067712|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84067713|NCT02851394|Narcotics|narcotics|mesh-ancestor
84067714|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067715|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067716|NCT02851394|Analgesics|analgesics|mesh-ancestor
84067717|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
84067718|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067719|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
84067720|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
84067721|NCT00603434|Methylphenidate|methylphenidate|mesh-list
84067722|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84067723|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067724|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84067725|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84067726|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84067727|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067728|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
84067729|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067730|NCT01004003|Sorafenib|sorafenib|mesh-list
84067731|NCT01004003|Nintedanib|nintedanib|mesh-list
84067732|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067733|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067734|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067735|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067736|NCT00943670|Trastuzumab|trastuzumab|mesh-list
84067737|NCT00943670|Pertuzumab|pertuzumab|mesh-list
84067738|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84067739|NCT00943670|Maytansine|maytansine|mesh-list
84067740|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067741|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067742|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84067743|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
84067744|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
84067745|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
84067746|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067747|NCT00943670|Immunotoxins|immunotoxins|mesh-ancestor
84067748|NCT00943670|Immunoconjugates|immunoconjugates|mesh-ancestor
84067749|NCT00943670|Immunologic Factors|immunologic factors|mesh-ancestor
84067750|NCT00943670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067751|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
84067752|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067753|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067754|NCT02851004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84067755|NCT02851004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067756|NCT00938366|Cladribine|cladribine|mesh-list
84067757|NCT00938366|Pantoprazole|pantoprazole|mesh-list
84067758|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84067759|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84067760|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84067761|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307713|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84067762|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067763|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067764|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067765|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
84067766|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067767|NCT00943592|Melphalan|melphalan|mesh-list
84067768|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
84067769|NCT00943592|Clofarabine|clofarabine|mesh-list
84067770|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84067771|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
84067772|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067773|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067774|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84067775|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067776|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
84067777|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067778|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067779|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84067780|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
84067781|NCT00943124|Niacin|niacin|mesh-list
84067782|NCT00943124|Niacinamide|niacinamide|mesh-list
84067783|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
84067784|NCT00943124|Simvastatin|simvastatin|mesh-list
84067785|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84067786|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84067787|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
84067788|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067789|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84067790|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84067791|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067792|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
84067793|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
84067794|NCT00943124|Vitamins|vitamins|mesh-ancestor
84067795|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
84067796|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067797|NCT00492050|Valacyclovir|valacyclovir|mesh-list
84067798|NCT00492050|Rituximab|rituximab|mesh-list
84067799|NCT00492050|Bortezomib|bortezomib|mesh-list
84067800|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067801|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067802|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
84067803|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067804|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84067805|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
84067806|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067807|NCT00940316|Irinotecan|irinotecan|mesh-list
84067808|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84067809|NCT00940316|Panitumumab|panitumumab|mesh-list
84067810|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84067811|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83261969|NCT05321875|Candesartan|candesartan|mesh-list
84067812|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067813|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067814|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067815|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067816|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067817|NCT02850848|Entecavir|entecavir|mesh-list
84067818|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
84067819|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067820|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
84067821|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
84067822|NCT05381168|Calcium|calcium|mesh-list
84067823|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84067824|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067825|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84067826|NCT05381168|Antacids|antacids|mesh-ancestor
84067827|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067828|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84067829|NCT00726388|Diclofenac|diclofenac|mesh-list
84067830|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84067831|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84067832|NCT00726388|Analgesics|analgesics|mesh-ancestor
84067833|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
84067834|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067835|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262099|NCT05313997|Analgesics|analgesics|mesh-ancestor
84067836|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84067837|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84067838|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84067839|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067840|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067842|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84067843|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84067844|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84067845|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84067846|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
84067847|NCT00686335|Prednisone|prednisone|mesh-list
84067848|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84067849|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
84067850|NCT00686335|Hormones|hormones|mesh-ancestor
84067851|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067852|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067853|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067854|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067855|NCT00685945|Isosorbide|isosorbide|mesh-list
84067856|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84067857|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84067858|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
84067859|NCT00685945|Bradykinin|bradykinin|mesh-list
84067860|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
84067861|NCT00685945|Kininogens|kininogens|mesh-list
84067862|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
84067863|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84067864|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84067865|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067866|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067867|NCT00685945|Urological Agents|urological agents|mesh-ancestor
84067868|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84067869|NCT00685945|Diuretics|diuretics|mesh-ancestor
84067870|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
84067871|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067872|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84067873|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
84067874|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
84067875|NCT00747487|Idebenone|idebenone|mesh-list
84067876|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
84067877|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067878|NCT00747487|Protective Agents|protective agents|mesh-ancestor
84067879|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067880|NCT00750217|Buprenorphine|buprenorphine|mesh-list
84067881|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84067882|NCT00750217|Narcotics|narcotics|mesh-ancestor
84067883|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067884|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067885|NCT00750217|Analgesics|analgesics|mesh-ancestor
84067886|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
84067887|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067888|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84067889|NCT00687739|Leuprolide|leuprolide|mesh-list
84067890|NCT00687739|Estradiol|estradiol|mesh-list
84067891|NCT00687739|Estrogens|estrogens|mesh-ancestor
84067892|NCT00687739|Hormones|hormones|mesh-ancestor
84067893|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067894|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067895|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84067896|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84067897|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
84067898|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84067899|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067900|NCT00752401|Vitamin D|vitamin d|mesh-list
84067901|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
84067902|NCT00752401|Vitamins|vitamins|mesh-ancestor
84067903|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
84067904|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067905|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84067906|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84067907|NCT00750451|Heparin|heparin|mesh-list
84067908|NCT00750451|Enoxaparin|enoxaparin|mesh-list
84067909|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84067910|NCT00750451|Tinzaparin|tinzaparin|mesh-list
84067911|NCT00750451|Dalteparin|dalteparin|mesh-list
84067912|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
84067913|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
84067914|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84067915|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84067916|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067918|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84067919|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067920|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067921|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84067922|NCT00747721|Analgesics|analgesics|mesh-ancestor
84067923|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
84067924|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067925|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84067926|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84067927|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84067928|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
84067929|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84067930|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067931|NCT01006889|Exenatide|exenatide|mesh-list
84067932|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84067933|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067934|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84067935|NCT01006889|Incretins|incretins|mesh-ancestor
84067936|NCT01006889|Hormones|hormones|mesh-ancestor
84067937|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84067938|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
84067939|NCT02561767|Tacrolimus|tacrolimus|mesh-list
84067940|NCT02561767|Basiliximab|basiliximab|mesh-list
84067941|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067942|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
84067943|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067944|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84067945|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067946|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067947|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84067948|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067949|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84067950|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
84067951|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84067952|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84067953|NCT00747799|Fluorouracil|fluorouracil|mesh-list
84067954|NCT00747799|Sorafenib|sorafenib|mesh-list
84067955|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067956|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
84067957|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067958|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84067959|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84067960|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
84067961|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067962|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84067963|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067964|NCT04294823|Esomeprazole|esomeprazole|mesh-list
84067965|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84067966|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84067967|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84067968|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84067969|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067970|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84067971|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067972|NCT04294511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84067973|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84067974|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
84067975|NCT01001429|Propofol|propofol|mesh-list
84067976|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84067977|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84067978|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84067979|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84067980|NCT01001429|Analgesics|analgesics|mesh-ancestor
84067981|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
84067982|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84067983|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84067984|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84067985|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84067986|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
84067987|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307940|NCT04755322|Analgesics|analgesics|mesh-ancestor
84067988|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067989|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84067990|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
84067991|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
84067992|NCT01000961|Cysteamine|cysteamine|mesh-list
84067993|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
84067994|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84067995|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84067996|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84067997|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84067998|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84067999|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068000|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068001|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068002|NCT01000805|Analgesics|analgesics|mesh-ancestor
84068003|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
84068004|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068005|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
84068006|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84068007|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
84068008|NCT00684307|Vitamin K|vitamin k|mesh-list
84068009|NCT00684307|Warfarin|warfarin|mesh-list
84068010|NCT00684307|Vitamins|vitamins|mesh-ancestor
84068011|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
84068012|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068013|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
84068014|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84068015|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84068016|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068017|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
84068018|NCT00684307|Coagulants|coagulants|mesh-ancestor
84068019|NCT00683917|Leuprolide|leuprolide|mesh-list
84068020|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84068021|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
84068022|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84068023|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262439|NCT05225155|Enoxaparin|enoxaparin|mesh-list
84068024|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84068025|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068026|NCT00750529|Donepezil|donepezil|mesh-list
84068027|NCT00750529|Galantamine|galantamine|mesh-list
84068028|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84068029|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068030|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068031|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
84068032|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068033|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068034|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
84068035|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84068036|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
84068037|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068038|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
84068039|NCT00747877|Melphalan|melphalan|mesh-list
84068040|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84068041|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
84068042|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068043|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068044|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84068045|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
84068046|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068047|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068048|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84068049|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
84068050|NCT00750763|Cathartics|cathartics|mesh-ancestor
84068051|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068052|NCT00752479|Cyclosporine|cyclosporine|mesh-list
84068053|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
84068054|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
84068055|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84068056|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84068057|NCT00752479|Prednisolone|prednisolone|mesh-list
84068058|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
84068059|NCT00752479|Cyclosporins|cyclosporins|mesh-list
84068060|NCT00752479|Basiliximab|basiliximab|mesh-list
84068061|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
84068062|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84068063|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
84068064|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068065|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068066|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84068067|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
84068068|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068069|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
84068070|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068071|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
84068072|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068073|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84068074|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84068075|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068076|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84068077|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
84068078|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84068079|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068080|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
84068081|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
84068082|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068083|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068084|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
84068085|NCT00752479|Hormones|hormones|mesh-ancestor
84068086|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068087|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84068088|NCT00752479|Protective Agents|protective agents|mesh-ancestor
84068089|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84068090|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
84068091|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
84068092|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84068093|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84068094|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84068095|NCT00752635|Norgestimate|norgestimate|mesh-list
84068096|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84068097|NCT00752635|Estradiol|estradiol|mesh-list
84068098|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84068099|NCT00752635|Cyproterone|cyproterone|mesh-list
84068100|NCT00752635|Estrogens|estrogens|mesh-ancestor
84068101|NCT00752635|Hormones|hormones|mesh-ancestor
84068102|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068103|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068104|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84068105|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
84068106|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84068107|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84068108|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84068109|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84068110|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
84068111|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
84068112|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068113|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84068114|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84068115|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84068116|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068117|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84068118|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84068119|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262705|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068120|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068121|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84068122|NCT00750997|Dextrans|dextrans|mesh-list
84068123|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
84068124|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
84068125|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
84068126|NCT00748345|Caspofungin|caspofungin|mesh-list
84068127|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
84068128|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068129|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068130|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068131|NCT00752869|Dutasteride|dutasteride|mesh-list
84068132|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84068133|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84068134|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068135|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068136|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
84068137|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068138|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068139|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
84068140|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84068141|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84068142|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84068143|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
84068144|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068145|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84068146|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84068147|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068148|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068149|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84068150|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84068151|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
84068152|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
84068153|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84068154|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
84068155|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068156|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068157|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84068158|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
84068159|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84068160|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
84068161|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068162|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068163|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84068164|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
84068165|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
84068166|NCT00748423|Protective Agents|protective agents|mesh-ancestor
84068167|NCT00687271|Atorvastatin|atorvastatin|mesh-list
84068168|NCT00687271|Calcium|calcium|mesh-list
84068169|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84068170|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068171|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84068172|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84068173|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
84068174|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068175|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84068176|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84068177|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068178|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
84068179|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84068180|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068181|NCT02562625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84068182|NCT02562625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068183|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
84068184|NCT00752947|Metronidazole|metronidazole|mesh-list
84068185|NCT00752947|Levofloxacin|levofloxacin|mesh-list
84068186|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84068187|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068188|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84068189|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84068190|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068191|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068192|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068193|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84068194|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84068195|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84068196|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84068197|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84068198|NCT04614545|Phentermine|phentermine|mesh-list
84068199|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84068200|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068201|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
84068202|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84068203|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
84068204|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
84068205|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068206|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
84068207|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068208|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068209|NCT01031381|Bevacizumab|bevacizumab|mesh-list
84068210|NCT01031381|Everolimus|everolimus|mesh-list
84068211|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308181|NCT04776226|Citalopram|citalopram|mesh-list
84068212|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068213|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84068214|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84068215|NCT01031381|Growth Substances|growth substances|mesh-ancestor
84068216|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068217|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
84068218|NCT01031381|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84068219|NCT01031381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84068220|NCT01031381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068221|NCT01031381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068222|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84068223|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
84068224|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84068225|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
84068226|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068227|NCT00751699|Mesalamine|mesalamine|mesh-list
84068228|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84068229|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068230|NCT00751699|Analgesics|analgesics|mesh-ancestor
84068231|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
84068232|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068233|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068234|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068235|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068236|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
84068237|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
84068238|NCT00753103|Prednisolone|prednisolone|mesh-list
84068239|NCT00753103|Infliximab|infliximab|mesh-list
83262887|NCT02315625|Everolimus|everolimus|mesh-list
84068240|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
84068241|NCT00753103|Azathioprine|azathioprine|mesh-list
84068242|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84068243|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
84068244|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068245|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068246|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84068247|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
84068248|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068249|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068250|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84068251|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84068252|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84068253|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
84068254|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84068255|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068256|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068257|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068258|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
84068259|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
84068260|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068261|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068262|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
84068263|NCT00753103|Hormones|hormones|mesh-ancestor
84068264|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068265|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84068266|NCT00753103|Protective Agents|protective agents|mesh-ancestor
84068267|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84068268|NCT00753103|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84068269|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
84068270|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
84068271|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84068272|NCT00748891|Cediranib|cediranib|mesh-list
84068273|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068274|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84068275|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068276|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068277|NCT00685165|Primidone|primidone|mesh-list
84068278|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
84068279|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
84068280|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
84068281|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068282|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068283|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068284|NCT00749047|Pioglitazone|pioglitazone|mesh-list
84068285|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84068286|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068287|NCT05393713|Antibodies|antibodies|mesh-list
84068288|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84068289|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
84068290|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068291|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
84068292|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068293|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
84068294|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
84068295|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84068296|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068297|NCT00753493|Topiramate|topiramate|mesh-list
84068298|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
84068299|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84068300|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068301|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
84068302|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84068303|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84068304|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068305|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068306|NCT00753571|Protective Agents|protective agents|mesh-ancestor
84068307|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068308|NCT00753727|Sunitinib|sunitinib|mesh-list
84068309|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068310|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84068311|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84068312|NCT00753727|Growth Substances|growth substances|mesh-ancestor
84068313|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068314|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
84068315|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84068316|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068317|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068318|NCT00755989|Morphine|morphine|mesh-list
84068319|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84068320|NCT00755989|Narcotics|narcotics|mesh-ancestor
84068321|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068322|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068323|NCT00755989|Analgesics|analgesics|mesh-ancestor
84068324|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
84068325|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068326|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84068327|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
84068328|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068329|NCT05388877|Dabrafenib|dabrafenib|mesh-list
84068330|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068331|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84068332|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068333|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068334|NCT04053205|Paclitaxel|paclitaxel|mesh-list
84068335|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84068336|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068337|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
84068338|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
84068339|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
84068340|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068341|NCT02559973|Buprenorphine|buprenorphine|mesh-list
84068342|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84068343|NCT02559973|Naloxone|naloxone|mesh-list
84068344|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84068345|NCT02559973|Narcotics|narcotics|mesh-ancestor
84068346|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068347|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068348|NCT02559973|Analgesics|analgesics|mesh-ancestor
84068349|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
84068350|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068351|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84068352|NCT00753883|Simvastatin|simvastatin|mesh-list
84068353|NCT00753883|Ezetimibe|ezetimibe|mesh-list
84068354|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84068355|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84068356|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
84068357|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068358|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84068359|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84068360|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068361|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
84068362|NCT00720382|Azelastine|azelastine|mesh-list
83308316|NCT00820846|Vaccines|vaccines|mesh-list
84068363|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068364|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
84068365|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83263430|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84068366|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84068367|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
84068368|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068369|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068370|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84068371|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
84068372|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83263731|NCT01651039|Hormones|hormones|mesh-ancestor
84068373|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068374|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068375|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84068376|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84068377|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
84068378|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
84068379|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068380|NCT00754039|Fenofibrate|fenofibrate|mesh-list
84068381|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84068382|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84068383|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
83263939|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84068384|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068385|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84068386|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84068387|NCT02560909|Vaccines|vaccines|mesh-list
83264087|NCT01641939|Trastuzumab|trastuzumab|mesh-list
84068388|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
84068389|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068390|NCT02592226|Anesthetics|anesthetics|mesh-list
84068391|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068392|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068393|NCT02970448|Temozolomide|temozolomide|mesh-list
84068394|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84068395|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
84068396|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068397|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068398|NCT00756301|Lidocaine|lidocaine|mesh-list
83264532|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
84068399|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
84068400|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
84068401|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068402|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068403|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
84068404|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068405|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84068406|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84068407|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84068408|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264822|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84068409|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068410|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
84068411|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84068412|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068413|NCT00720226|Losartan|losartan|mesh-list
83264965|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
84068414|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84068415|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83265039|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84068416|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84068417|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84068418|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068419|NCT00725920|Topiramate|topiramate|mesh-list
84068420|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
84068421|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84068422|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068423|NCT00725842|Ribavirin|ribavirin|mesh-list
83265177|NCT02243631|Probenecid|probenecid|mesh-list
84068424|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
84068425|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84068426|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
84068427|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068428|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
83265472|NCT02469519|Dexamethasone|dexamethasone|mesh-list
84068429|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068430|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068431|NCT04051723|Dexamethasone|dexamethasone|mesh-list
84068432|NCT04051723|Ropivacaine|ropivacaine|mesh-list
83265620|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
84068433|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068434|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
84068435|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
83265695|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84068436|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068437|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068438|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068439|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
84068440|NCT04051723|Hormones|hormones|mesh-ancestor
83266072|NCT02375971|Ranibizumab|ranibizumab|mesh-list
84068441|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068442|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84068443|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068444|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
84068445|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
84068446|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068447|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
84068448|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
84068449|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
84068450|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84068451|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83266294|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
84068452|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83266357|NCT02372383|Azithromycin|azithromycin|mesh-list
84068453|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068454|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84068455|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84068456|NCT00756847|Paclitaxel|paclitaxel|mesh-list
84068457|NCT00756847|Carboplatin|carboplatin|mesh-list
84068458|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83266431|NCT01615198|Olmesartan|olmesartan|mesh-list
84068459|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068460|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
84068461|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
84068462|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
84068463|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068464|NCT04051567|Aspirin|aspirin|mesh-list
83266495|NCT02132637|Insulin|insulin|mesh-list
84068465|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84068466|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068467|NCT04051567|Analgesics|analgesics|mesh-ancestor
84068468|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
84068469|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068470|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068471|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068472|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068473|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84068474|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84068475|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068476|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84068477|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83266574|NCT02188719|Prednisone|prednisone|mesh-list
84068478|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068479|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
83266633|NCT02132247|Diclofenac|diclofenac|mesh-list
84068480|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
84068481|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84068482|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068483|NCT00757315|Triamcinolone|triamcinolone|mesh-list
84068484|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84068485|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84068486|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84068487|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068488|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
84068489|NCT00757315|Hormones|hormones|mesh-ancestor
84068490|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068491|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068492|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84068493|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
84068494|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068495|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068496|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
84068497|NCT00757393|Vitamin D|vitamin d|mesh-list
84068498|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
84068499|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
84068500|NCT00757393|Vitamins|vitamins|mesh-list
84068501|NCT00757393|Calcium|calcium|mesh-list
84068502|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
84068503|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068504|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84068505|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84068506|NCT00754351|Bevacizumab|bevacizumab|mesh-list
84068507|NCT00754351|Gemcitabine|gemcitabine|mesh-list
84068508|NCT00754351|Docetaxel|docetaxel|mesh-list
84068509|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267125|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
84068510|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308472|NCT04781686|Docetaxel|docetaxel|mesh-list
84068511|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84068512|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83267270|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
84068513|NCT00754351|Growth Substances|growth substances|mesh-ancestor
84068514|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068515|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
84068516|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84068517|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
84068518|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068519|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
84068520|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
84068521|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
84068523|NCT00754429|Amlodipine|amlodipine|mesh-list
84068524|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84068525|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84068526|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84068527|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068528|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84068529|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068530|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
84068531|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84068532|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84068533|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84068534|NCT00754507|Atorvastatin|atorvastatin|mesh-list
84068535|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84068536|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84068537|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84068538|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
83267498|NCT02118597|Interferons|interferons|mesh-list
84068539|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068540|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84068541|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84068542|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068543|NCT00725608|Buprenorphine|buprenorphine|mesh-list
84068544|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84068545|NCT00725608|Naloxone|naloxone|mesh-list
84068546|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84068547|NCT00725608|Narcotics|narcotics|mesh-ancestor
84068548|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267638|NCT02175771|Fluticasone|fluticasone|mesh-list
84068549|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068550|NCT00725608|Analgesics|analgesics|mesh-ancestor
84068551|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
84068552|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068553|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84068554|NCT00725452|Infliximab|infliximab|mesh-list
84068555|NCT00725452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84068556|NCT00725452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068557|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
84068558|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068559|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068560|NCT00725296|Infliximab|infliximab|mesh-list
84068561|NCT00725296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84068562|NCT00725296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068563|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
84068564|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068565|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068566|NCT00585052|Paclitaxel|paclitaxel|mesh-list
84068567|NCT00585052|Lovastatin|lovastatin|mesh-list
84068568|NCT00585052|L 647318|l 647318|mesh-list
84068569|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
84068570|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84068571|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068572|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
84068573|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
84068574|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
84068575|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068576|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84068577|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84068578|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
84068579|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84068580|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84068581|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068582|NCT00724282|Eszopiclone|eszopiclone|mesh-list
84068583|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84068584|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308547|NCT04779892|Infliximab|infliximab|mesh-list
84068585|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068586|NCT04086238|Decitabine|decitabine|mesh-list
84068587|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
84068588|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84068589|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
84068590|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068591|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068592|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068593|NCT00724126|Rifaximin|rifaximin|mesh-list
84068594|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84068595|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068596|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068597|NCT00723892|Ribavirin|ribavirin|mesh-list
84068598|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84068599|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
84068600|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
84068601|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068602|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
84068603|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068604|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
84068605|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068606|NCT04086940|Esmolol|esmolol|mesh-list
84068607|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84068608|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84068609|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84068610|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
84068611|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268613|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068612|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068613|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068614|NCT02590900|Acetaminophen|acetaminophen|mesh-list
84068615|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068616|NCT02590900|Analgesics|analgesics|mesh-ancestor
84068617|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
84068618|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068619|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068620|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
84068621|NCT02591914|Bevacizumab|bevacizumab|mesh-list
84068622|NCT02591914|Ranibizumab|ranibizumab|mesh-list
84068623|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84068624|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068625|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84068626|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84068627|NCT02591914|Growth Substances|growth substances|mesh-ancestor
84068628|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068629|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
84068630|NCT00723190|Clonidine|clonidine|mesh-list
84068631|NCT00723190|Analgesics|analgesics|mesh-ancestor
84068632|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
83308619|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308620|NCT00054028|Suramin|suramin|mesh-list
83308621|NCT00054028|Paclitaxel|paclitaxel|mesh-list
83308622|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83308623|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308624|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308625|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308626|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308627|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308628|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
83308629|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
83308630|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83308631|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308632|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83308633|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83308634|NCT00058240|Alvocidib|alvocidib|mesh-list
83308635|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308636|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
83308637|NCT00058240|Growth Substances|growth substances|mesh-ancestor
83308638|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308639|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308640|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308641|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308671|NCT03026907|Azathioprine|azathioprine|mesh-list
83308672|NCT03026907|Alitretinoin|alitretinoin|mesh-list
83308673|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308674|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308675|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
84068633|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068634|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068635|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84068636|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
84068637|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
84068638|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84068639|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84068640|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84068641|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
84068642|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068643|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068644|NCT00722800|Drospirenone|drospirenone|mesh-list
84068645|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83269186|NCT04939883|Carvedilol|carvedilol|mesh-list
84068646|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
84068647|NCT00722800|Estradiol|estradiol|mesh-list
84068648|NCT00722800|Estrogens|estrogens|mesh-ancestor
84068649|NCT00722800|Hormones|hormones|mesh-ancestor
84068650|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068651|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068652|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84068653|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
84068654|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84068655|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84068656|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84068657|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84068658|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84068659|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
84068660|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84068661|NCT00722800|Diuretics|diuretics|mesh-ancestor
84068662|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
84068663|NCT00741598|Galantamine|galantamine|mesh-list
84068664|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84068665|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068666|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068667|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
84068668|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068669|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068670|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84068671|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
84068672|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068673|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
84068674|NCT03947632|Chrysarobin|chrysarobin|mesh-list
84068675|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84068676|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068677|NCT03947632|Analgesics|analgesics|mesh-ancestor
84068678|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
84068679|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068680|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068681|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068682|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068683|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
84068684|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
84068685|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83269331|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
84068686|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068687|NCT04085770|Vitamins|vitamins|mesh-ancestor
84068688|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
84068689|NCT00741286|Aspirin|aspirin|mesh-list
84068690|NCT00741286|Cilostazol|cilostazol|mesh-list
84068691|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84068692|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068693|NCT00741286|Analgesics|analgesics|mesh-ancestor
84068694|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
84068695|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068696|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269395|NCT01644643|Ceftazidime|ceftazidime|mesh-list
84068697|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068698|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068699|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84068700|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84068701|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068702|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84068703|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84068704|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068705|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
84068706|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83308704|NCT00062764|Pioglitazone|pioglitazone|mesh-list
84068707|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
84068708|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84068709|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
84068710|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
84068711|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84068712|NCT00741286|Protective Agents|protective agents|mesh-ancestor
84068713|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84068714|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84068715|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84068716|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068717|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84068718|NCT00716092|Linagliptin|linagliptin|mesh-list
84068719|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84068720|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068721|NCT00716092|Incretins|incretins|mesh-ancestor
84068722|NCT00716092|Hormones|hormones|mesh-ancestor
84068723|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270049|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
84068724|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84068725|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
84068726|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270187|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84068727|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068728|NCT02590510|Methotrexate|methotrexate|mesh-list
84068729|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84068730|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
84068731|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83270341|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
84068732|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068733|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84068734|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
84068735|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068736|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068737|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
84068738|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068739|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83270697|NCT02331368|Melphalan|melphalan|mesh-list
84068740|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84068741|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
84068742|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068743|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84068744|NCT00919204|Axitinib|axitinib|mesh-list
84068745|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068746|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84068747|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068748|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068749|NCT00715624|Metformin|metformin|mesh-list
84068750|NCT00715624|Lixisenatide|lixisenatide|mesh-list
84068751|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271063|NCT01846624|Decitabine|decitabine|mesh-list
84068752|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068753|NCT00919282|Leucovorin|leucovorin|mesh-list
84068754|NCT00919282|Folic Acid|folic acid|mesh-list
84068755|NCT00919282|Gemcitabine|gemcitabine|mesh-list
84068756|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
84068757|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84068758|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
84068759|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068760|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271357|NCT02034513|Insulin|insulin|mesh-list
84068761|NCT00919282|Antidotes|antidotes|mesh-ancestor
84068762|NCT00919282|Protective Agents|protective agents|mesh-ancestor
84068763|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068764|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
84068765|NCT00919282|Vitamins|vitamins|mesh-ancestor
84068766|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
84068767|NCT00919282|Hematinics|hematinics|mesh-ancestor
84068768|NCT00679783|Olaparib|olaparib|mesh-list
84068769|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84068770|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068771|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068772|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068773|NCT05414305|Lidocaine|lidocaine|mesh-list
84068774|NCT05414305|Heparin|heparin|mesh-list
84068775|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
84068776|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
84068777|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068778|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271796|NCT01825876|Warfarin|warfarin|mesh-list
84068779|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
84068780|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068781|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83272014|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
83272085|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84068782|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84068783|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84068784|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84068785|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068786|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
84068787|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84068788|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84068789|NCT00757549|Cetuximab|cetuximab|mesh-list
84068790|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83272305|NCT01651403|Tenofovir|tenofovir|mesh-list
84068791|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068792|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84068793|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84068794|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068795|NCT00576199|Bevacizumab|bevacizumab|mesh-list
84068796|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84068797|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068798|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84068799|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84068800|NCT00576199|Growth Substances|growth substances|mesh-ancestor
84068801|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068802|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
84068803|NCT00754819|Colchicine|colchicine|mesh-list
84068804|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
84068805|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068806|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
84068807|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
84068808|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
84068809|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068810|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068811|NCT05684692|Siltuximab|siltuximab|mesh-list
84068812|NCT05684692|Erenumab|erenumab|mesh-list
84068813|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83272886|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068814|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
84068815|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068816|NCT05684692|Analgesics|analgesics|mesh-ancestor
83272964|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
83273029|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
84068817|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
84068818|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068819|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273110|NCT02011113|Hormones|hormones|mesh-ancestor
84068820|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
84068821|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068822|NCT02589652|Interferons|interferons|mesh-list
84068823|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
84068824|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
84068825|NCT02589652|Entecavir|entecavir|mesh-list
84068826|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83273321|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
83273390|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84068827|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068828|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
84068829|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068830|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
83273463|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
83273539|NCT01607476|Corticosterone|corticosterone|mesh-list
84068831|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068832|NCT00679627|Galantamine|galantamine|mesh-list
84068833|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84068834|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068835|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068836|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
84068837|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068838|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068839|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84068840|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
84068841|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068842|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
84068843|NCT00714688|Methylphenidate|methylphenidate|mesh-list
84068844|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84068845|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068846|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84068847|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83274047|NCT02006667|Trastuzumab|trastuzumab|mesh-list
83274126|NCT01981473|Infliximab|infliximab|mesh-list
84068848|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83274200|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
84068849|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068850|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
84068851|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068852|NCT05165212|Amoxicillin|amoxicillin|mesh-list
84068853|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83274350|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84068854|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84068855|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
83274498|NCT04832269|Hormones|hormones|mesh-ancestor
84068856|NCT04051099|Bupivacaine|bupivacaine|mesh-list
84068857|NCT04051099|Propofol|propofol|mesh-list
84068858|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
83274641|NCT01731886|Melphalan|melphalan|mesh-list
84068859|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
84068860|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274714|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068861|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068862|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
84068863|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068864|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84068865|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068866|NCT04051099|Analgesics|analgesics|mesh-ancestor
84068867|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84068868|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84068869|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84068870|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
84068871|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068872|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068873|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84068874|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
84068875|NCT01031069|Vaccines|vaccines|mesh-list
84068876|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
83274922|NCT05814302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83274999|NCT05813366|Vitamin B 6|vitamin b 6|mesh-list
84068877|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068878|NCT04084912|Dexamethasone|dexamethasone|mesh-list
83275074|NCT05813015|Docetaxel|docetaxel|mesh-list
84068879|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
84068880|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84068881|NCT04084912|BB 1101|bb 1101|mesh-list
83275149|NCT05757388|Acetaminophen|acetaminophen|mesh-list
83275225|NCT05690204|Colchicine|colchicine|mesh-list
84068882|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068883|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
84068884|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
84068885|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068886|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068887|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068888|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
84068889|NCT04084912|Hormones|hormones|mesh-ancestor
84068890|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84068891|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84068892|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068893|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
84068894|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068895|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068896|NCT00755053|Clotrimazole|clotrimazole|mesh-list
84068897|NCT00755053|Miconazole|miconazole|mesh-list
84068898|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84068899|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275654|NCT04529278|Incretins|incretins|mesh-ancestor
84068900|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
84068901|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84068902|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84068903|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068904|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068905|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84068906|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83275827|NCT04084951|Nivolumab|nivolumab|mesh-list
84068907|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275877|NCT04023227|Valsartan|valsartan|mesh-list
84068908|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068909|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84068910|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84068911|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
84068912|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84068913|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83276090|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84068914|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068915|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
84068916|NCT00755209|Coagulants|coagulants|mesh-ancestor
84068917|NCT02589340|Buspirone|buspirone|mesh-list
84068918|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84068919|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84068920|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068921|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068922|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84068923|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84068924|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
84068925|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276384|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
84068926|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068927|NCT00682435|Hydromorphone|hydromorphone|mesh-list
84068928|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84068929|NCT00682435|Narcotics|narcotics|mesh-ancestor
83308923|NCT00168298|Hormones|hormones|mesh-ancestor
84068930|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84068931|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068932|NCT00682435|Analgesics|analgesics|mesh-ancestor
84068933|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
84068934|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068935|NCT05340205|Misoprostol|misoprostol|mesh-list
84068936|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
84068937|NCT05340205|Oxytocin|oxytocin|mesh-list
84068938|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
84068939|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84068940|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068941|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84068942|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84068943|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068944|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
84068945|NCT05340205|Coagulants|coagulants|mesh-ancestor
83276533|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
84068946|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84068947|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
84068948|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84068949|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84068950|NCT00713830|Metformin|metformin|mesh-list
84068951|NCT00713830|Lixisenatide|lixisenatide|mesh-list
84068952|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84068953|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068954|NCT05291221|Lidocaine|lidocaine|mesh-list
84068955|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
84068956|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
84068957|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
84068958|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276749|NCT01774786|Pertuzumab|pertuzumab|mesh-list
84068959|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068960|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
84068961|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068962|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84068963|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84068964|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84068965|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84068966|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068967|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84068968|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068969|NCT05291221|Analgesics|analgesics|mesh-ancestor
84068970|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84068971|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84068972|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84068973|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
84068974|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84068975|NCT00755521|Etoricoxib|etoricoxib|mesh-list
84068976|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84068977|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84068978|NCT00755521|Analgesics|analgesics|mesh-ancestor
84068979|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
84068980|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84068981|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84068982|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84068983|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068984|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84068985|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83277675|NCT02230891|Carvedilol|carvedilol|mesh-list
84068986|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84068987|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068988|NCT00681187|Lanreotide|lanreotide|mesh-list
84068989|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84068990|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84068991|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
84068992|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84068993|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84068994|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84068995|NCT00680407|Silymarin|silymarin|mesh-list
84068996|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
83277963|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84068997|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84068998|NCT00680407|Protective Agents|protective agents|mesh-ancestor
84068999|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069000|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84069001|NCT04007809|Glucagon|glucagon|mesh-list
84069002|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069003|NCT04007809|Hormones|hormones|mesh-ancestor
83278107|NCT02203513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278183|NCT01644188|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84069004|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069005|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069006|NCT05170009|Oseltamivir|oseltamivir|mesh-list
84069008|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
84069009|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069010|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069011|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069012|NCT04083664|Hepcidins|hepcidins|mesh-list
84069013|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069014|NCT05202730|Anesthetics|anesthetics|mesh-list
84069015|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
84069016|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069017|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069018|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
84069019|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069020|NCT00677365|Levofloxacin|levofloxacin|mesh-list
84069021|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84069022|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069023|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84069024|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84069025|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84069026|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278393|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83278472|NCT02263547|Teriflunomide|teriflunomide|mesh-list
84069027|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069028|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069029|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84069030|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84069031|NCT05039944|Irinotecan|irinotecan|mesh-list
84069032|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84069033|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84069034|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069035|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069036|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069037|NCT05038462|Lactoferrin|lactoferrin|mesh-list
84069038|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069039|NCT03719131|Rituximab|rituximab|mesh-list
84069040|NCT03719131|Nivolumab|nivolumab|mesh-list
84069041|NCT03719131|Ipilimumab|ipilimumab|mesh-list
84069042|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84069043|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069044|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
84069045|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069046|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84069047|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84069048|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069049|NCT05190094|Letrozole|letrozole|mesh-list
84069050|NCT05190094|Palbociclib|palbociclib|mesh-list
84069051|NCT05190094|Anastrozole|anastrozole|mesh-list
84069052|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84069053|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069054|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84069055|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069056|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069057|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84069058|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
84069059|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069060|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279113|NCT04863716|Fentanyl|fentanyl|mesh-list
84069061|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84069062|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069063|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84069064|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
84069065|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84069066|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84069067|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
84069068|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069069|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84069070|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84069071|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069072|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84069073|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84069074|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069075|NCT00676663|Exemestane|exemestane|mesh-list
84069076|NCT00676663|Entinostat|entinostat|mesh-list
84069077|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069078|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84069079|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83309086|NCT01897012|Romidepsin|romidepsin|mesh-list
84069080|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069081|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069082|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84069083|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
84069084|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069085|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069086|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84069087|NCT02560207|Cefotaxime|cefotaxime|mesh-list
84069088|NCT02560207|Cefoxitin|cefoxitin|mesh-list
84069089|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84069090|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069091|NCT00678691|Modafinil|modafinil|mesh-list
84069092|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84069093|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069094|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84069095|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84069096|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84069097|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069098|NCT05003752|Goserelin|goserelin|mesh-list
84069099|NCT05003752|Androgens|androgens|mesh-list
83279609|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069100|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069101|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069102|NCT05003752|Hormones|hormones|mesh-ancestor
84069103|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279750|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
84069104|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069105|NCT04997980|Amiodarone|amiodarone|mesh-list
84069106|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84069107|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
84069108|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84069109|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84069110|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279962|NCT02159365|Dexamethasone|dexamethasone|mesh-list
84069111|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84069112|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84069113|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84069114|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069115|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84069116|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84069117|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84069118|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84069119|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84069120|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069121|NCT05683912|Aflibercept|aflibercept|mesh-list
84069122|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84069123|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84069124|NCT05683912|Growth Substances|growth substances|mesh-ancestor
84069125|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069126|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
84069127|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069128|NCT00679939|Metformin|metformin|mesh-list
84069129|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
84069130|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84069131|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069132|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
84069133|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84069134|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069135|NCT02587390|Simvastatin|simvastatin|mesh-list
84069136|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84069137|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84069138|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
83280391|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069139|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069140|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84069141|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84069142|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069143|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
84069144|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069145|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280539|NCT02154061|Vancomycin|vancomycin|mesh-list
84069146|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069147|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069148|NCT02588716|Terlipressin|terlipressin|mesh-list
84069149|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84069150|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84069151|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83309180|NCT00185692|Hormones|hormones|mesh-ancestor
84069152|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
84069153|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84069154|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069155|NCT00761449|Lenalidomide|lenalidomide|mesh-list
84069156|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
84069157|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069158|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83280825|NCT02180659|Analgesics|analgesics|mesh-ancestor
84069159|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84069160|NCT00761449|Growth Substances|growth substances|mesh-ancestor
84069161|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
84069162|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069163|NCT04968106|Doxorubicin|doxorubicin|mesh-list
84069164|NCT04968106|Ifosfamide|ifosfamide|mesh-list
84069165|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84069166|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069167|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84069168|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84069169|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069170|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069171|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84069172|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
84069173|NCT00919438|Diuretics|diuretics|mesh-list
84069174|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
84069175|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069176|NCT04082182|Immunomodulating Agents|immunomodulating agents|mesh-list
84069177|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
84069178|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069179|NCT00571519|Metformin|metformin|mesh-list
84069180|NCT00571519|Pioglitazone|pioglitazone|mesh-list
83281124|NCT02175277|Hematinics|hematinics|mesh-ancestor
84069181|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84069182|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069183|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84069184|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069185|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069186|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
84069187|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84069188|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
83281250|NCT02236988|Growth Substances|growth substances|mesh-ancestor
84069189|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84069190|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069191|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84069192|NCT04935034|Vitamin D|vitamin d|mesh-list
84069193|NCT04935034|Vitamins|vitamins|mesh-ancestor
84069194|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
84069195|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069196|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84069197|NCT04807816|Gemcitabine|gemcitabine|mesh-list
84069198|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069199|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
84069200|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069201|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069202|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84069203|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069204|NCT00921973|Vaccines|vaccines|mesh-list
84069205|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
84069206|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069207|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
84069208|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84069209|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
84069210|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069211|NCT00676195|Expectorants|expectorants|mesh-ancestor
84069212|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
84069213|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84069214|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
84069215|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069216|NCT00676195|Protective Agents|protective agents|mesh-ancestor
84069217|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069218|NCT00676195|Antidotes|antidotes|mesh-ancestor
84069219|NCT02558959|Capecitabine|capecitabine|mesh-list
84069220|NCT02558959|Irinotecan|irinotecan|mesh-list
84069221|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069222|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
84069223|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069224|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069225|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84069226|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84069227|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069228|NCT04049539|Cytarabine|cytarabine|mesh-list
84069229|NCT04049539|Daunorubicin|daunorubicin|mesh-list
84069230|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069231|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
84069232|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069233|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069234|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
84069235|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069236|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069237|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
84069238|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069239|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84069240|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83282042|NCT04373369|Atezolizumab|atezolizumab|mesh-list
84069241|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84069242|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069243|NCT04082962|Dexamethasone|dexamethasone|mesh-list
84069244|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069245|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
84069246|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
84069247|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069248|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069249|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069250|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
84069251|NCT04082962|Hormones|hormones|mesh-ancestor
84069252|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069253|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069254|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069255|NCT02471833|Telmisartan|telmisartan|mesh-list
84069256|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84069257|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84069258|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84069259|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069260|NCT04895410|Dexamethasone|dexamethasone|mesh-list
84069261|NCT04895410|Daratumumab|daratumumab|mesh-list
84069262|NCT04895410|Pomalidomide|pomalidomide|mesh-list
84069263|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069264|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
84069265|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
84069266|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069267|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069268|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069269|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
84069270|NCT04895410|Hormones|hormones|mesh-ancestor
84069271|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069272|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069273|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069274|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
84069275|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84069276|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84069277|NCT04895410|Growth Substances|growth substances|mesh-ancestor
84069278|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
84069279|NCT00675025|Donepezil|donepezil|mesh-list
84069280|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84069281|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282472|NCT01563172|Listerine|listerine|mesh-list
84069282|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069283|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
84069284|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069285|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069286|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
84069287|NCT00758407|Methylphenidate|methylphenidate|mesh-list
84069288|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84069289|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069290|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84069291|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84069292|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84069293|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069294|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
84069295|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069296|NCT04767061|Propranolol|propranolol|mesh-list
84069297|NCT04767061|Metoprolol|metoprolol|mesh-list
84069298|NCT04767061|Atenolol|atenolol|mesh-list
84069299|NCT04767061|Sotalol|sotalol|mesh-list
84069300|NCT04767061|Nadolol|nadolol|mesh-list
84069301|NCT04767061|Acebutolol|acebutolol|mesh-list
84069302|NCT04767061|Carvedilol|carvedilol|mesh-list
83309297|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
84069303|NCT04767061|Nebivolol|nebivolol|mesh-list
84069305|NCT04767061|Labetalol|labetalol|mesh-list
84069306|NCT04767061|Pindolol|pindolol|mesh-list
84069307|NCT04767061|Betaxolol|betaxolol|mesh-list
84069308|NCT04767061|Penbutolol|penbutolol|mesh-list
84069309|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84069310|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84069311|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
84069312|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069313|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069314|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282881|NCT02161562|Omalizumab|omalizumab|mesh-list
84069315|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84069316|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84069317|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
84069318|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
84069319|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
84069320|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069321|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84069322|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
84069323|NCT04767061|Protective Agents|protective agents|mesh-ancestor
84069324|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84069325|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84069326|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84069327|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84069328|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84069329|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84069330|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84069331|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84069332|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
84069333|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84069334|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
84069335|NCT05322577|Nivolumab|nivolumab|mesh-list
84069336|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
84069337|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84069338|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069339|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83283382|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
83283530|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
83283606|NCT01950741|Aflibercept|aflibercept|mesh-list
84069340|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069341|NCT00759421|Olanzapine|olanzapine|mesh-list
84069342|NCT00759421|Sertindole|sertindole|mesh-list
84069343|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
84069344|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
84069345|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283759|NCT01487200|FX006|fx006|mesh-list
83283827|NCT01948791|Rivastigmine|rivastigmine|mesh-list
84069346|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069347|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069348|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84069349|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84069350|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069351|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84069352|NCT00759421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84069353|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84069354|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84069355|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069356|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069357|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
84069358|NCT04869358|Ofatumumab|ofatumumab|mesh-list
84069359|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069360|NCT00762775|Vitamin D|vitamin d|mesh-list
84069361|NCT00762775|Calcium|calcium|mesh-list
84069362|NCT00762775|Vitamins|vitamins|mesh-ancestor
84069363|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
83284433|NCT02139644|Hormones|hormones|mesh-ancestor
84069364|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069365|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84069366|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84069367|NCT00763165|Triclosan|triclosan|mesh-list
84069368|NCT00763165|Fluorides|fluorides|mesh-list
84069369|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
84069370|NCT00763165|Protective Agents|protective agents|mesh-ancestor
84069371|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284715|NCT04732208|Mydriatics|mydriatics|mesh-list
84069372|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84069373|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069374|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84069375|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84069376|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
84069377|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069378|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84069379|NCT04049227|Letrozole|letrozole|mesh-list
84069380|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069381|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84069382|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84069383|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069384|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069385|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84069386|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
84069387|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069388|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069389|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84069390|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
84069391|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069392|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84069393|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
84069394|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84069395|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84069396|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
84069397|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069398|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
84069399|NCT00760045|Protective Agents|protective agents|mesh-ancestor
84069400|NCT00678379|Lidocaine|lidocaine|mesh-list
84069401|NCT00678379|Clonidine|clonidine|mesh-list
84069402|NCT00678379|Bupivacaine|bupivacaine|mesh-list
84069403|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
84069404|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
84069405|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069406|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069407|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
84069408|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069409|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83284986|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069410|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84069411|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84069412|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84069413|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069414|NCT00678379|Analgesics|analgesics|mesh-ancestor
84069415|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84069416|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
84069417|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
84069418|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84069419|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84069420|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84069421|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
84069422|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069423|NCT00760279|Azithromycin|azithromycin|mesh-list
84069424|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84069425|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069426|NCT00674323|Ranibizumab|ranibizumab|mesh-list
84069427|NCT00674323|Verteporfin|verteporfin|mesh-list
84069428|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84069429|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84069430|NCT00674323|Growth Substances|growth substances|mesh-ancestor
84069431|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069432|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
84069433|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069434|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84069435|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069436|NCT00763633|Vitamins|vitamins|mesh-list
84069437|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
84069438|NCT00763633|Pyridoxal|pyridoxal|mesh-list
84069439|NCT00763633|Pyridoxine|pyridoxine|mesh-list
84069440|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
84069441|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
84069442|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069443|NCT00763789|Remifentanil|remifentanil|mesh-list
84069444|NCT00763789|Anesthetics|anesthetics|mesh-list
84069445|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069446|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069447|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84069448|NCT00763789|Narcotics|narcotics|mesh-ancestor
84069449|NCT00763789|Analgesics|analgesics|mesh-ancestor
84069450|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
84069451|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069452|NCT04115956|Dexamethasone|dexamethasone|mesh-list
84069453|NCT04115956|Melphalan|melphalan|mesh-list
84069454|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069455|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
83309449|NCT00012298|Rituximab|rituximab|mesh-list
84069456|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
84069457|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285323|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
84069458|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069459|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069460|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
84069462|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069463|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069464|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285380|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
84069465|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84069466|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
84069467|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285450|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
84069468|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84069469|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069470|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
84069471|NCT04081480|Valacyclovir|valacyclovir|mesh-list
84069472|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
84069473|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069474|NCT00678301|Vaccines|vaccines|mesh-list
84069475|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
83285597|NCT02093390|Fluconazole|fluconazole|mesh-list
84069476|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069477|NCT02586454|Morphine|morphine|mesh-list
84069478|NCT02586454|Ropivacaine|ropivacaine|mesh-list
84069479|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84069480|NCT02586454|Narcotics|narcotics|mesh-ancestor
84069481|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069482|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069483|NCT02586454|Analgesics|analgesics|mesh-ancestor
84069484|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
84069485|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069486|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
84069487|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
84069488|NCT00939770|Crizotinib|crizotinib|mesh-list
84069489|NCT00939770|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
84069490|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84069491|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286203|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
84069492|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069493|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069494|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
84069495|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
84069496|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
84069497|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069498|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069499|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
84069500|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069501|NCT00939692|Topiramate|topiramate|mesh-list
84069502|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
84069503|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84069504|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069505|NCT00920608|Methotrexate|methotrexate|mesh-list
84069506|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83286491|NCT04724629|Colchicine|colchicine|mesh-list
84069507|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
84069508|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83286636|NCT01625377|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84069509|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069510|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069511|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
84069512|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069513|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069514|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069515|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069516|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84069517|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069518|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
84069519|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84069520|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84069521|NCT04674514|Dexamethasone|dexamethasone|mesh-list
84069522|NCT04674514|Lenalidomide|lenalidomide|mesh-list
84069523|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069524|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
84069525|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
84069526|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069527|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069528|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069529|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
84069530|NCT04674514|Hormones|hormones|mesh-ancestor
84069531|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069532|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069533|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069534|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
84069535|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84069536|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84069537|NCT04674514|Growth Substances|growth substances|mesh-ancestor
83287064|NCT01824693|Melphalan|melphalan|mesh-list
84069538|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
84069539|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
84069540|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84069541|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
84069542|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069543|NCT04081012|Expectorants|expectorants|mesh-ancestor
84069544|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
84069545|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84069546|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
84069547|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069548|NCT04081012|Protective Agents|protective agents|mesh-ancestor
84069549|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069550|NCT04081012|Antidotes|antidotes|mesh-ancestor
84069551|NCT04551040|Terazosin|terazosin|mesh-list
83287356|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069552|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84069553|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84069554|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84069555|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
84069556|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069557|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069558|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069559|NCT04551040|Urological Agents|urological agents|mesh-ancestor
84069560|NCT00942968|Dalteparin|dalteparin|mesh-list
84069561|NCT00942968|Tinzaparin|tinzaparin|mesh-list
84069562|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84069563|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
84069564|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84069565|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84069566|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069567|NCT00942734|Everolimus|everolimus|mesh-list
84069568|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84069569|NCT00942734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84069570|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84069571|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287775|NCT04701008|Analgesics|analgesics|mesh-ancestor
84069572|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069573|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069574|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
84069575|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069576|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069577|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
84069578|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84069579|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84069580|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84069581|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84069582|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069583|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
83288140|NCT05885646|Sulthiame|sulthiame|mesh-list
84069584|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069585|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069586|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84069587|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069588|NCT00919984|Paclitaxel|paclitaxel|mesh-list
84069589|NCT00919984|Carboplatin|carboplatin|mesh-list
84069590|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84069591|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069592|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288509|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
84069593|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
84069594|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288583|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
83288650|NCT05441410|Artesunate|artesunate|mesh-list
84069595|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069596|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
84069597|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
84069598|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069599|NCT00942422|Protective Agents|protective agents|mesh-ancestor
84069600|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069601|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84069602|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84069603|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069604|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84069605|NCT05380934|Methotrexate|methotrexate|mesh-list
84069606|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84069608|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84069609|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289294|NCT04224493|Growth Substances|growth substances|mesh-ancestor
84069610|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069611|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
84069612|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069613|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069614|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069615|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069616|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84069617|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069618|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
84069619|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84069620|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84069621|NCT00603824|PENTA|penta|mesh-list
84069622|NCT00603824|Lepirudin|lepirudin|mesh-list
84069623|NCT00603824|Fondaparinux|fondaparinux|mesh-list
84069624|NCT00603824|Argatroban|argatroban|mesh-list
84069625|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84069626|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
84069627|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84069628|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
83289813|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
84069629|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069630|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069631|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
84069632|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83290036|NCT03193190|Antidotes|antidotes|mesh-ancestor
84069633|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84069634|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84069635|NCT00677833|Azithromycin|azithromycin|mesh-list
84069636|NCT00677833|Chloroquine|chloroquine|mesh-list
84069637|NCT00677833|Lumefantrine|lumefantrine|mesh-list
84069638|NCT00677833|Artemether|artemether|mesh-list
84069639|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84069640|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83290177|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
84069641|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069642|NCT00677833|Amebicides|amebicides|mesh-ancestor
84069643|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84069644|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84069645|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
83290324|NCT01822899|Xhance|xhance|mesh-list
84069646|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84069647|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
84069648|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83290396|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
84069649|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84069650|NCT05086874|Protective Agents|protective agents|mesh-ancestor
84069651|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069652|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
84069653|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84069654|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290775|NCT01994720|Analgesics|analgesics|mesh-ancestor
84069655|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
84069656|NCT00942266|Leucovorin|leucovorin|mesh-list
84069657|NCT00942266|Fluorouracil|fluorouracil|mesh-list
84069658|NCT00942266|Vorinostat|vorinostat|mesh-list
84069659|NCT00942266|Calcium|calcium|mesh-list
84069660|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
83290908|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84069661|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84069662|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069663|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84069664|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
84069665|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069666|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069667|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291055|NCT01842633|Analgesics|analgesics|mesh-ancestor
84069668|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069669|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
84069670|NCT00942266|Antidotes|antidotes|mesh-ancestor
84069671|NCT00942266|Protective Agents|protective agents|mesh-ancestor
84069672|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
84069673|NCT00942266|Vitamins|vitamins|mesh-ancestor
84069674|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
84069675|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84069676|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069677|NCT05382182|Androgens|androgens|mesh-list
84069678|NCT05382182|Hormones|hormones|mesh-ancestor
84131349|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069679|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069680|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069681|NCT04727242|Gemcitabine|gemcitabine|mesh-list
84069682|NCT04727242|Dacarbazine|dacarbazine|mesh-list
84069683|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069684|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
84069685|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069686|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069687|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84069688|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
84069689|NCT04079374|Etanercept|etanercept|mesh-list
84069690|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84069691|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84069692|NCT04079374|Analgesics|analgesics|mesh-ancestor
83291731|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
84069693|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
84069694|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069695|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069696|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069697|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84069698|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069699|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069700|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
84069701|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
84069702|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84131350|NCT03462017|Urological Agents|urological agents|mesh-ancestor
84069703|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069704|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84069705|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069706|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84069707|NCT02583958|Laxatives|laxatives|mesh-ancestor
84069708|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069709|NCT00604058|Vaccines|vaccines|mesh-list
84069710|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
84069711|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069712|NCT02852798|Docetaxel|docetaxel|mesh-list
84069713|NCT02852798|Apatinib|apatinib|mesh-list
84069714|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069715|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
84069716|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
84069717|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
84069718|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069719|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84069720|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069721|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
84069722|NCT02586610|Capecitabine|capecitabine|mesh-list
84069723|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84069724|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069725|NCT02586610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84069726|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069727|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069728|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
84069729|NCT00604682|Apremilast|apremilast|mesh-list
84069730|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84069731|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83292691|NCT02020577|Cetuximab|cetuximab|mesh-list
84069732|NCT00604682|Analgesics|analgesics|mesh-ancestor
84069733|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
83292892|NCT04659044|Venetoclax|venetoclax|mesh-list
84069734|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069735|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069736|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069737|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84069738|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84069739|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84069740|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131351|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84069741|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293037|NCT01962974|Golimumab|golimumab|mesh-list
84069742|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
84069743|NCT00672841|Clotrimazole|clotrimazole|mesh-list
84069744|NCT00672841|Miconazole|miconazole|mesh-list
84069745|NCT00672841|Anidulafungin|anidulafungin|mesh-list
84069746|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131352|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
84069747|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84069748|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84069749|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84069750|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069751|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069752|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84069753|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
84069754|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069755|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069756|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84069757|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84069758|NCT00920296|Cabotegravir|cabotegravir|mesh-list
84069759|NCT00920296|Etravirine|etravirine|mesh-list
84069760|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83293688|NCT01993667|Diuretics|diuretics|mesh-ancestor
84069761|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84069762|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293763|NCT01906346|Cocaine|cocaine|mesh-list
84131353|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069763|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069764|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84069765|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84069766|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
84069767|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294060|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
84069768|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84069769|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84069770|NCT04080388|Diuretics|diuretics|mesh-list
84069771|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
84069772|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069773|NCT00765115|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
84069774|NCT00765115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84069775|NCT00765115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294211|NCT04053712|Glucagon|glucagon|mesh-list
84069776|NCT00765115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069777|NCT04080622|Selenium|selenium|mesh-list
84069778|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
84069779|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294349|NCT01900730|Valproic Acid|valproic acid|mesh-list
84069780|NCT04080622|Protective Agents|protective agents|mesh-ancestor
84069781|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069782|NCT04080622|Trace Elements|trace elements|mesh-ancestor
84069783|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
84069784|NCT04079140|Dinoprostone|dinoprostone|mesh-list
84069785|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
84069786|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84069787|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069788|NCT04707196|Fulvestrant|fulvestrant|mesh-list
84069789|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84069790|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84069791|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294635|NCT04661683|Charcoal|charcoal|mesh-list
84069792|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84069793|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84069794|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
84069795|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069796|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294773|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84069797|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84069798|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069799|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069800|NCT00673465|Metformin|metformin|mesh-list
84069801|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83294918|NCT01786707|Metformin|metformin|mesh-list
84069802|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069803|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
83295004|NCT01912963|Pertuzumab|pertuzumab|mesh-list
84069804|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84069805|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84069806|NCT00764413|Prednisolone|prednisolone|mesh-list
83295134|NCT04173416|Analgesics|analgesics|mesh-ancestor
84069807|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
84069808|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84069809|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
83295206|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295275|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
84069810|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069811|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
84069812|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
84069813|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069814|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295499|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069815|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069816|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
84069817|NCT00764413|Hormones|hormones|mesh-ancestor
84069818|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84069819|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84069820|NCT00764413|Protective Agents|protective agents|mesh-ancestor
83295718|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
84069821|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295795|NCT01885208|Hormones|hormones|mesh-ancestor
84069822|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069823|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
84069824|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069825|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069826|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84069827|NCT00583102|Cytarabine|cytarabine|mesh-list
84069828|NCT00583102|Lovastatin|lovastatin|mesh-list
84069829|NCT00583102|L 647318|l 647318|mesh-list
84069830|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
84069831|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84069832|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
84069833|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069834|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069835|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
84069836|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069837|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069838|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
84069839|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069840|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84069841|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84069842|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84069843|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84069844|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069845|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
84069846|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
84069847|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84069848|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84069849|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84069850|NCT00605930|Niacinamide|niacinamide|mesh-list
84069851|NCT00605930|Niacin|niacin|mesh-list
84069852|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
83296609|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
84069853|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
84069854|NCT00605930|Vitamins|vitamins|mesh-ancestor
84069855|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
84069856|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069857|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84069858|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
84069859|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069860|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83296758|NCT04978584|Hormones|hormones|mesh-ancestor
84069861|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
84069862|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
83296981|NCT04605861|Incretins|incretins|mesh-ancestor
84069863|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84069864|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069865|NCT00602186|Prazosin|prazosin|mesh-list
83297055|NCT04450173|Venetoclax|venetoclax|mesh-list
83297127|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84069866|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84069867|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84069868|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83297202|NCT04081545|Analgesics|analgesics|mesh-list
84069869|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84069870|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
84069871|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84069872|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069873|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069874|NCT04204304|Isotretinoin|isotretinoin|mesh-list
84069875|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
84069876|NCT05380778|Anesthetics|anesthetics|mesh-list
84069877|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069878|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069879|NCT02852720|Anesthetics|anesthetics|mesh-list
84069880|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
84069881|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069882|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069883|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
84069884|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
84069885|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069886|NCT05857631|Cisplatin|cisplatin|mesh-list
84069887|NCT05857631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069888|NCT05857306|Olvanil|olvanil|mesh-list
84069889|NCT05857306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84069890|NCT05857306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84069891|NCT05857306|Analgesics|analgesics|mesh-ancestor
84069892|NCT05857306|Sensory System Agents|sensory system agents|mesh-ancestor
84069893|NCT05857306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069894|NCT05857306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069895|NCT05857306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84069896|NCT05857306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84069897|NCT05857267|Timolol|timolol|mesh-list
84069898|NCT05857267|Dorzolamide|dorzolamide|mesh-list
84069899|NCT05857267|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83297624|NCT03118986|Olanzapine|olanzapine|mesh-list
84069900|NCT05857267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84069901|NCT05857267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84069902|NCT05857267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84069903|NCT05857267|Adrenergic Agents|adrenergic agents|mesh-ancestor
84069904|NCT05857267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131354|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069905|NCT05857267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069906|NCT05857267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069908|NCT05857267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83297778|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
84069909|NCT05857267|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83297847|NCT02553460|Vitamins|vitamins|mesh-ancestor
84069910|NCT05857267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069911|NCT05857202|Analgesics, Opioid|analgesics, opioid|mesh-list
84069912|NCT05857202|Analgesics|analgesics|mesh-list
84069913|NCT05857202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
84069914|NCT05857202|Narcotics|narcotics|mesh-ancestor
84069915|NCT05857202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069916|NCT05857202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069917|NCT05857202|Sensory System Agents|sensory system agents|mesh-ancestor
84069918|NCT05857202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069919|NCT05857085|Empagliflozin|empagliflozin|mesh-list
84069920|NCT05857085|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84069921|NCT05857085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069922|NCT05857085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84069923|NCT05857085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069924|NCT05857059|Misoprostol|misoprostol|mesh-list
84069925|NCT05857059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84069926|NCT05857059|Abortifacient Agents|abortifacient agents|mesh-ancestor
84069927|NCT05857059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84069928|NCT05857059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069929|NCT05857059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84069930|NCT05857059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84069931|NCT05857059|Oxytocics|oxytocics|mesh-ancestor
84069932|NCT05857046|Melatonin|melatonin|mesh-list
84069933|NCT05857046|Antioxidants|antioxidants|mesh-ancestor
84069934|NCT05857046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297924|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
84069935|NCT05857046|Protective Agents|protective agents|mesh-ancestor
84069936|NCT05857046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069937|NCT05857046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069938|NCT05856994|Tacrolimus|tacrolimus|mesh-list
84069939|NCT05856994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84069940|NCT05856994|Immunologic Factors|immunologic factors|mesh-ancestor
84069941|NCT05856994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069942|NCT05856994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84069943|NCT05856994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84069944|NCT05856994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069945|NCT05856695|Paclitaxel|paclitaxel|mesh-list
84069946|NCT05856695|Carboplatin|carboplatin|mesh-list
84069947|NCT05856695|Durvalumab|durvalumab|mesh-list
84131355|NCT00913419|Amitriptyline|amitriptyline|mesh-list
84069948|NCT05856695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84069949|NCT05856695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069950|NCT05856695|Tubulin Modulators|tubulin modulators|mesh-ancestor
84069951|NCT05856695|Antimitotic Agents|antimitotic agents|mesh-ancestor
84069952|NCT05856695|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131356|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
84069953|NCT05856695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069954|NCT05856695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84069955|NCT05856630|Goserelin|goserelin|mesh-list
84069956|NCT05856630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83298406|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
84069957|NCT05856630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069958|NCT05856578|Canagliflozin|canagliflozin|mesh-list
84069959|NCT05856578|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84069960|NCT05856578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84069961|NCT05856578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069962|NCT05856578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069963|NCT05856396|Vaccines|vaccines|mesh-list
84069964|NCT05856396|Immunologic Factors|immunologic factors|mesh-ancestor
84069965|NCT05856396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069966|NCT05856383|Vinorelbine|vinorelbine|mesh-list
84069967|NCT05856383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84069968|NCT05856383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84069969|NCT05856383|Tubulin Modulators|tubulin modulators|mesh-ancestor
84069970|NCT05856383|Antimitotic Agents|antimitotic agents|mesh-ancestor
84069971|NCT05856383|Mitosis Modulators|mitosis modulators|mesh-ancestor
84069972|NCT05856383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069973|NCT05856084|Vaccines|vaccines|mesh-list
84069974|NCT05856084|Immunologic Factors|immunologic factors|mesh-ancestor
83298909|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84069975|NCT05856084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069976|NCT05855876|Ketamine|ketamine|mesh-list
84069977|NCT05855876|Analgesics|analgesics|mesh-ancestor
84069978|NCT05855876|Sensory System Agents|sensory system agents|mesh-ancestor
83299136|NCT00217672|Bevacizumab|bevacizumab|mesh-list
84069979|NCT05855876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84069980|NCT05855876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069981|NCT05855876|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84069982|NCT05855876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84069983|NCT05855876|Anesthetics, General|anesthetics, general|mesh-ancestor
84069984|NCT05855876|Anesthetics|anesthetics|mesh-ancestor
84069985|NCT05855876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069986|NCT05855876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83299424|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84069987|NCT05855876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84069988|NCT05855876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299572|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
84069989|NCT05855876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84069990|NCT05852132|Temazepam|temazepam|mesh-list
84069991|NCT05852132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84069992|NCT05852132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84069993|NCT05852132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84069994|NCT05852132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84069995|NCT05852132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84069996|NCT05852132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84069997|NCT05852132|GABA Modulators|gaba modulators|mesh-ancestor
84069998|NCT05852132|GABA Agents|gaba agents|mesh-ancestor
84069999|NCT05852132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070000|NCT05852132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299863|NCT04146610|Antibodies|antibodies|mesh-list
84070001|NCT05851313|Vitamin D|vitamin d|mesh-list
84070002|NCT05851313|Vitamins|vitamins|mesh-ancestor
84070003|NCT05851313|Micronutrients|micronutrients|mesh-ancestor
84070004|NCT05851313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070005|NCT05851313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84070006|NCT05850611|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83300013|NCT05583058|Hormones|hormones|mesh-list
84070007|NCT05850611|Methylene Blue|methylene blue|mesh-list
84070008|NCT05850611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070009|NCT05850611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070010|NCT05850611|Hemostatics|hemostatics|mesh-ancestor
84070011|NCT05850611|Coagulants|coagulants|mesh-ancestor
84070012|NCT05844813|Doxorubicin|doxorubicin|mesh-list
84070013|NCT05844813|Ifosfamide|ifosfamide|mesh-list
84070014|NCT05844813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84070015|NCT05844813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070016|NCT05844813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84070017|NCT05844813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84070018|NCT05844813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070019|NCT05844813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070020|NCT05844813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84070021|NCT05844813|Alkylating Agents|alkylating agents|mesh-ancestor
84070022|NCT05812417|DA-8010|da-8010|mesh-list
83300450|NCT03020056|Antioxidants|antioxidants|mesh-list
84070023|NCT05812417|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84070024|NCT05812417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84070025|NCT05812417|Cholinergic Agents|cholinergic agents|mesh-ancestor
84070026|NCT05812417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070027|NCT05812417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070028|NCT05812417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070029|NCT05808881|Naloxone|naloxone|mesh-list
84070030|NCT05808881|Nalmefene|nalmefene|mesh-list
84070031|NCT05808881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84070032|NCT05808881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070033|NCT05808881|Sensory System Agents|sensory system agents|mesh-ancestor
83300740|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
84070034|NCT05808881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070035|NCT05790681|Insulin|insulin|mesh-list
84070036|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84070037|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070038|NCT05766540|Metformin|metformin|mesh-list
84070039|NCT05766540|Aripiprazole|aripiprazole|mesh-list
84070040|NCT05766540|Clozapine|clozapine|mesh-list
84070041|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83300814|NCT01676506|Growth Substances|growth substances|mesh-ancestor
84070042|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070043|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
84070044|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84070045|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84070046|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84070047|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070048|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
84070049|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
84070050|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070051|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301099|NCT01065532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83301170|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84070052|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84070053|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84070054|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
84070055|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83310047|NCT05815186|Sotorasib|sotorasib|mesh-list
84070056|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84070057|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84070058|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84070059|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
84070060|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
84070061|NCT05765084|Pemetrexed|pemetrexed|mesh-list
84070062|NCT05765084|Atezolizumab|atezolizumab|mesh-list
84070063|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301695|NCT01561755|Antibodies|antibodies|mesh-list
84070064|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070065|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070066|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84070067|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84070068|NCT05765084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070069|NCT05765084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070070|NCT05757167|Lumefantrine|lumefantrine|mesh-list
84070071|NCT05757167|Artemether|artemether|mesh-list
84070072|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84070073|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
84070074|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84070075|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84070076|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070077|NCT05751668|Paclitaxel|paclitaxel|mesh-list
84070078|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84070079|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301899|NCT03570814|Ivermectin|ivermectin|mesh-list
84070080|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
84070081|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
84070082|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83301972|NCT03559348|Leucovorin|leucovorin|mesh-list
84131357|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84070083|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070084|NCT05746806|Androgens|androgens|mesh-list
84070085|NCT05746806|Hormones|hormones|mesh-ancestor
84070086|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070087|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070088|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
84070089|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
84070090|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
84070091|NCT05733715|Lenvatinib|lenvatinib|mesh-list
84070092|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070093|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070094|NCT05733715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070095|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070096|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070097|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302650|NCT01610336|Gefitinib|gefitinib|mesh-list
84070098|NCT05733351|Docetaxel|docetaxel|mesh-list
84070099|NCT05733351|Antibodies|antibodies|mesh-list
84070100|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
84070101|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
84070102|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
84070103|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302798|NCT01842308|Melphalan|melphalan|mesh-list
84070104|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070105|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
84070106|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
84070107|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
83303020|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84070108|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070109|NCT05721755|Paclitaxel|paclitaxel|mesh-list
84070110|NCT05721755|Cisplatin|cisplatin|mesh-list
84070111|NCT05721755|Carboplatin|carboplatin|mesh-list
84070112|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
84070113|NCT05721755|Fluorouracil|fluorouracil|mesh-list
84070114|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83303166|NCT01363297|Immunotoxins|immunotoxins|mesh-ancestor
84070115|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84070116|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070117|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
84070118|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
84070119|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
84070120|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070121|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070122|NCT05721755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83303309|NCT01773122|Dapsone|dapsone|mesh-list
84070123|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
84070124|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070125|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070126|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
84070127|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070128|NCT05700422|Varenicline|varenicline|mesh-list
84070129|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84070130|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84070131|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
84070132|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070133|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070134|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070135|NCT05681481|Prednisone|prednisone|mesh-list
84070136|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070137|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
84070138|NCT05681481|Hormones|hormones|mesh-ancestor
83303595|NCT01769378|Glimepiride|glimepiride|mesh-list
84070139|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070140|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303814|NCT03180034|Vaccines|vaccines|mesh-list
84070141|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84070142|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070143|NCT05678647|Iron|iron|mesh-list
84070144|NCT05678647|Trace Elements|trace elements|mesh-ancestor
84070145|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
84070146|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070147|NCT05669664|Leuprolide|leuprolide|mesh-list
84070148|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
84070149|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84070150|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
84070151|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84070152|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070153|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84070154|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070155|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
84070156|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070157|NCT05641324|Dexamethasone|dexamethasone|mesh-list
84070158|NCT05641324|Lenalidomide|lenalidomide|mesh-list
84070159|NCT05641324|Daratumumab|daratumumab|mesh-list
84070160|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070161|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
84070162|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
84070163|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070164|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070165|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84070166|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
84070167|NCT05641324|Hormones|hormones|mesh-ancestor
83304158|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070168|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070169|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83304234|NCT01539837|Deferiprone|deferiprone|mesh-list
84070170|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070171|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
84070172|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83304306|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
84070173|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84070174|NCT05641324|Growth Substances|growth substances|mesh-ancestor
83304383|NCT01929031|Ibuprofen|ibuprofen|mesh-list
84070175|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
84070176|NCT05639907|Ethanol|ethanol|mesh-list
84070177|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84070178|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304449|NCT00986674|Cetuximab|cetuximab|mesh-list
84070179|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070180|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070181|NCT05625334|Aspirin|aspirin|mesh-list
84070182|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84070183|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84070184|NCT05625334|Analgesics|analgesics|mesh-ancestor
84070185|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
84070186|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070187|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070188|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070189|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070190|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84070191|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84070192|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070193|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84070194|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84070195|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070196|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
84070197|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
84070198|NCT05623319|Olaparib|olaparib|mesh-list
84070199|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070200|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070201|NCT05623319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070202|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070203|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84070204|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070205|NCT05615636|Lenalidomide|lenalidomide|mesh-list
84070206|NCT05615636|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
84070207|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
84070208|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070209|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84070210|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84070211|NCT05615636|Growth Substances|growth substances|mesh-ancestor
84070212|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
84070213|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070214|NCT05615636|Immunoconjugates|immunoconjugates|mesh-ancestor
84070215|NCT05614115|Empagliflozin|empagliflozin|mesh-list
84070216|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84070217|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070218|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305452|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84070219|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070220|NCT05604794|Ketamine|ketamine|mesh-list
84070221|NCT05604794|Analgesics|analgesics|mesh-ancestor
84070222|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
84070223|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070224|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305736|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84070225|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83305812|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
84070226|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84070227|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
84070228|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
84070229|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070230|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84070231|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84070232|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070233|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070234|NCT05589688|Acyclovir|acyclovir|mesh-list
83306032|NCT01884571|Hormones|hormones|mesh-ancestor
84070235|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
84070236|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070237|NCT05578092|Adagrasib|adagrasib|mesh-list
84070238|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070239|NCT05564598|Valganciclovir|valganciclovir|mesh-list
84070240|NCT05564598|Ganciclovir|ganciclovir|mesh-list
84070241|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
84070242|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070243|NCT05551936|Rituximab|rituximab|mesh-list
84070244|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84070245|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070246|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070247|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
84070248|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070249|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070250|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84070251|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
84070252|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070253|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84070254|NCT05485805|Naproxen|naproxen|mesh-list
83306547|NCT04847752|Dabigatran|dabigatran|mesh-list
84070255|NCT05485805|Caffeine|caffeine|mesh-list
84070256|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84070257|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070258|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84070259|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070260|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070261|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84070262|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84070263|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
84070264|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070265|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84070266|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84070267|NCT05485805|Analgesics|analgesics|mesh-ancestor
84070268|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
84070269|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070270|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070271|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070272|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
84070273|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84070274|NCT05450692|Docetaxel|docetaxel|mesh-list
84070275|NCT05450692|Durvalumab|durvalumab|mesh-list
84070276|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070277|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
84070278|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
84070279|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
84070280|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070281|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070282|NCT05419089|Cisplatin|cisplatin|mesh-list
84070283|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070284|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
84070285|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070286|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
84070287|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070288|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070289|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84070290|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
84070291|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070292|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070293|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84070294|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
84070295|NCT05400109|Fludarabine|fludarabine|mesh-list
84070296|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
84070297|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070298|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
84070299|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070300|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070301|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84070302|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
84070303|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070304|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070305|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84070306|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070307|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
84070308|NCT05366829|Tislelizumab|tislelizumab|mesh-list
84070309|NCT05366829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070310|NCT05366829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070311|NCT05356897|Trifluridine|trifluridine|mesh-list
84070312|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84070313|NCT05356897|Trastuzumab|trastuzumab|mesh-list
84070314|NCT05356897|Tucatinib|tucatinib|mesh-list
84070315|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
84070316|NCT05356897|Antibodies|antibodies|mesh-list
84070317|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
84070318|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84070319|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
84070320|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070321|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070322|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
84070323|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070324|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
84070325|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070326|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070327|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070328|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
84070329|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84070330|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070331|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070332|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84070333|NCT05305248|Analgesics|analgesics|mesh-ancestor
84070334|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
84070335|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070336|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84070337|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84070338|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84070339|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
84070340|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070341|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070342|NCT05296837|Doxycycline|doxycycline|mesh-list
84070343|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84070344|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070345|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
84070346|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84070347|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84070348|NCT05286996|Anesthetics|anesthetics|mesh-list
84070349|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
84070350|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070351|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070352|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
84070353|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070354|NCT05248984|Ketorolac|ketorolac|mesh-list
84070355|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84070356|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84070357|NCT05248984|Analgesics|analgesics|mesh-ancestor
84070358|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
84070359|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070360|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070361|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070362|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070363|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84070364|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070365|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070366|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
84070367|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
84070368|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070369|NCT05210166|Protective Agents|protective agents|mesh-ancestor
84070370|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306990|NCT02493322|Olmesartan|olmesartan|mesh-list
84070371|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84070372|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070373|NCT05183828|Letrozole|letrozole|mesh-list
84070374|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070375|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84070376|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84070377|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070378|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070379|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84070380|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
84070381|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070382|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070383|NCT05169593|Adalimumab|adalimumab|mesh-list
84070384|NCT05169593|Infliximab|infliximab|mesh-list
84070385|NCT05169593|Ustekinumab|ustekinumab|mesh-list
84070386|NCT05169593|Vedolizumab|vedolizumab|mesh-list
84070387|NCT05169593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84070388|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070389|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070390|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
84070391|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84070392|NCT05168163|Atezolizumab|atezolizumab|mesh-list
84070393|NCT05168163|Lenvatinib|lenvatinib|mesh-list
84070394|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84070395|NCT05168163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070396|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070397|NCT05168163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070398|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070399|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070400|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070401|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
84070402|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070403|NCT05158153|Furosemide|furosemide|mesh-list
84070404|NCT05158153|Diuretics|diuretics|mesh-ancestor
84070405|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
84070406|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070407|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84070408|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84070409|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070410|NCT05148234|Decitabine|decitabine|mesh-list
84070411|NCT05148234|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
84070412|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070413|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
84070414|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070415|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070416|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070417|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
84070418|NCT05147558|Lenvatinib|lenvatinib|mesh-list
84070419|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070420|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070421|NCT05147558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070422|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070423|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070424|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070425|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
84070426|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84070427|NCT05110001|Natamycin|natamycin|mesh-list
84070428|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
84070429|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84070430|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070431|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
84070432|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
84070433|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84070434|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84070435|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84070436|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070437|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070438|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070439|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
84070440|NCT05098366|Furosemide|furosemide|mesh-list
84070441|NCT05098366|Diuretics|diuretics|mesh-ancestor
84070442|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
84070443|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070444|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84070445|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84070446|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070447|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
84070448|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84070449|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
84070450|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070451|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
84070452|NCT05082480|Protective Agents|protective agents|mesh-ancestor
84070453|NCT05073250|Rituximab|rituximab|mesh-list
84070454|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070455|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070456|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
84070457|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070458|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070459|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
84070460|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070461|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
84070462|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070463|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
84070464|NCT05041270|Nalbuphine|nalbuphine|mesh-list
84070465|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84070466|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83307116|NCT02398240|Doxorubicin|doxorubicin|mesh-list
84070467|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070468|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84070469|NCT05041270|Analgesics|analgesics|mesh-ancestor
84070470|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
84070471|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070472|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84070473|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84070474|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84070475|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
84070476|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070477|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070478|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84070479|NCT05041270|Narcotics|narcotics|mesh-ancestor
84070480|NCT05039736|Nivolumab|nivolumab|mesh-list
84070481|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070482|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070483|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070484|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070485|NCT05010590|Denosumab|denosumab|mesh-list
84070486|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84070487|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070488|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
84070489|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84070490|NCT04983940|Testosterone|testosterone|mesh-list
84070491|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
84070492|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
84070493|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84070494|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070495|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
84070496|NCT04983940|Hormones|hormones|mesh-ancestor
84070497|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070498|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070499|NCT04983940|Androgens|androgens|mesh-ancestor
84070500|NCT04940637|Niraparib|niraparib|mesh-list
84070501|NCT04940637|Dostarlimab|dostarlimab|mesh-list
84070502|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84070503|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070504|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070505|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070506|NCT04939090|Megestrol|megestrol|mesh-list
84070507|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
84070508|NCT04939090|Olanzapine|olanzapine|mesh-list
84070509|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
84070510|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
84070511|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070512|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070513|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84070514|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84070515|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84070516|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070517|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84070518|NCT04939090|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84070519|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84070520|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84070521|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070522|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070523|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
84070524|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84070525|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84070526|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84070527|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
84070528|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84070529|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84070530|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84070531|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84070532|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070533|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
84070534|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84070535|NCT04911660|Empagliflozin|empagliflozin|mesh-list
84070536|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84070537|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070538|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84070539|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070540|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
84070541|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84070542|NCT04881682|Antibodies|antibodies|mesh-list
84070543|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
84070544|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070545|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84070546|NCT04839185|Hematinics|hematinics|mesh-ancestor
84070547|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84070548|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84070549|NCT04809220|Dulaglutide|dulaglutide|mesh-list
84070550|NCT04809220|Biguanides|biguanides|mesh-list
84070551|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
84070552|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
84070553|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84070554|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070555|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070556|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070557|NCT04806906|Azacitidine|azacitidine|mesh-list
84070558|NCT04806906|Cc-486|cc-486|mesh-list
84070559|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070560|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
84070561|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070562|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070563|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070564|NCT04803201|Prednisone|prednisone|mesh-list
84070565|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
84070566|NCT04803201|Doxorubicin|doxorubicin|mesh-list
84070567|NCT04803201|Etoposide|etoposide|mesh-list
84070568|NCT04803201|Vincristine|vincristine|mesh-list
84070569|NCT04803201|Azacitidine|azacitidine|mesh-list
84070570|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070571|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
84070572|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070573|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070574|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84070575|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
84070576|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070577|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070578|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84070579|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84070580|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84070581|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84070582|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070583|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070584|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
84070585|NCT04803201|Hormones|hormones|mesh-ancestor
84070586|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070587|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84070588|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84070589|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
84070590|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
84070591|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
84070592|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070593|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
84070594|NCT04752059|Trastuzumab|trastuzumab|mesh-list
84070595|NCT04752059|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
84070596|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070597|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070598|NCT04752059|Immunoconjugates|immunoconjugates|mesh-ancestor
84070599|NCT04752059|Immunologic Factors|immunologic factors|mesh-ancestor
84070600|NCT04752059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070601|NCT04750473|Edetic Acid|edetic acid|mesh-list
84070602|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84070603|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
84070604|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
84070605|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070606|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
84070607|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84070608|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84070609|NCT04745351|Remdesivir|remdesivir|mesh-list
84070610|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
84070611|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070612|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
84070613|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070614|NCT04735549|Hormones|hormones|mesh-list
84070615|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070616|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070617|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
84070618|NCT04710277|Narcotics|narcotics|mesh-ancestor
84070619|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070620|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070621|NCT04710277|Analgesics|analgesics|mesh-ancestor
84070622|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
84070623|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070624|NCT04665089|Erythromycin|erythromycin|mesh-list
84070625|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
84070626|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84070627|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
84070628|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84070629|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070630|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84070631|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84070632|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070633|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070634|NCT04626791|Cytarabine|cytarabine|mesh-list
84070635|NCT04626791|Prednisone|prednisone|mesh-list
84070636|NCT04626791|Cortisone|cortisone|mesh-list
84070637|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
84070638|NCT04626791|Rituximab|rituximab|mesh-list
84070639|NCT04626791|Doxorubicin|doxorubicin|mesh-list
84070640|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84070641|NCT04626791|Bortezomib|bortezomib|mesh-list
84070642|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
84070643|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84070644|NCT04626791|Antibodies|antibodies|mesh-list
84070645|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
84070646|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84070647|NCT04626791|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
84070648|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070649|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
84070650|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070651|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070652|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84070653|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
84070654|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070655|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070656|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84070657|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84070658|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84070659|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84070660|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070661|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070662|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
84070663|NCT04626791|Hormones|hormones|mesh-ancestor
84070664|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070665|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84070666|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070667|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
84070668|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
84070669|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070670|NCT04626791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070671|NCT04612790|Benralizumab|benralizumab|mesh-list
84070672|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84070673|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
84070674|NCT04591002|Osimertinib|osimertinib|mesh-list
84070675|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070676|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070677|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070678|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070679|NCT04576455|Fulvestrant|fulvestrant|mesh-list
84070680|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84070681|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84070682|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070683|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84070684|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84070685|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
84070686|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84070687|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070688|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84070689|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070690|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070691|NCT04544111|Trametinib|trametinib|mesh-list
84070692|NCT04544111|Dabrafenib|dabrafenib|mesh-list
84070693|NCT04544111|Spartalizumab|spartalizumab|mesh-list
84070694|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070695|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070696|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070697|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070698|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83307842|NCT04283656|Diuretics|diuretics|mesh-ancestor
84070699|NCT04544111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070700|NCT04498780|Valsartan|valsartan|mesh-list
83307903|NCT01547260|Lenalidomide|lenalidomide|mesh-list
84070701|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84070702|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84070703|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84070704|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84070705|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070706|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
84070707|NCT04493333|Psyllium|psyllium|mesh-list
84070708|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84070709|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84070710|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
84070711|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307980|NCT00410956|Dexamethasone|dexamethasone|mesh-list
84070712|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
84070713|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84070714|NCT04493333|Cathartics|cathartics|mesh-ancestor
84070715|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
83308120|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
84070716|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84070717|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
84070718|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070719|NCT04481048|Expectorants|expectorants|mesh-ancestor
84070720|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
84070721|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84070722|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
84070723|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070724|NCT04481048|Protective Agents|protective agents|mesh-ancestor
84070725|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070726|NCT04481048|Antidotes|antidotes|mesh-ancestor
84070727|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
84070728|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
84070729|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070730|NCT04403165|Norepinephrine|norepinephrine|mesh-list
84070731|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84070732|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84070733|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
84070734|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070735|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070736|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070737|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
84070738|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
84070739|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070740|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84070741|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
84070742|NCT04379596|Fluorouracil|fluorouracil|mesh-list
84070743|NCT04379596|Capecitabine|capecitabine|mesh-list
84070744|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
84070745|NCT04379596|Trastuzumab|trastuzumab|mesh-list
84070746|NCT04379596|Durvalumab|durvalumab|mesh-list
84070747|NCT04379596|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
84070748|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070749|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070750|NCT04379596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070751|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070752|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
84070753|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070754|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070755|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
84070756|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070757|NCT04379596|Immunoconjugates|immunoconjugates|mesh-ancestor
84070758|NCT04375631|Cytarabine|cytarabine|mesh-list
84070759|NCT04375631|Cyclosporine|cyclosporine|mesh-list
84070760|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
84070761|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
84070762|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
84070763|NCT04375631|Cladribine|cladribine|mesh-list
84070764|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
84070765|NCT04375631|Cyclosporins|cyclosporins|mesh-list
84070766|NCT04375631|Lenograstim|lenograstim|mesh-list
84070767|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070768|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
84070769|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070770|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070771|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84070772|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
84070773|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070774|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070775|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84070776|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070777|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
84070778|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
84070779|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070780|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84070781|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070782|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
84070783|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
84070784|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84070785|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84070786|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84070787|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
84070788|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84070789|NCT04375631|Analgesics|analgesics|mesh-ancestor
84070790|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
84070791|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070792|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84070793|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84070794|NCT04289779|Atezolizumab|atezolizumab|mesh-list
84070795|NCT04289779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070796|NCT04289779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070797|NCT04289779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070798|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070799|NCT04271202|Erenumab|erenumab|mesh-list
84131358|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
84070800|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
84070801|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070802|NCT04271202|Analgesics|analgesics|mesh-ancestor
84070803|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
84070804|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84070805|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070806|NCT04269213|Cytarabine|cytarabine|mesh-list
84070807|NCT04269213|Daunorubicin|daunorubicin|mesh-list
84070808|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84070809|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
84070810|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070811|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070812|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
84070813|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070814|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308267|NCT00878254|Leucovorin|leucovorin|mesh-list
84070815|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
83308395|NCT04781998|Incretins|incretins|mesh-ancestor
84070816|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070817|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84070818|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84070819|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84070820|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070821|NCT04228965|Varenicline|varenicline|mesh-list
84070822|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84070823|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84070824|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
84070825|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131359|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84070826|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070827|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308896|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070828|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84070829|NCT04197687|Trastuzumab|trastuzumab|mesh-list
84070830|NCT04197687|Pertuzumab|pertuzumab|mesh-list
84070831|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84070832|NCT04197687|Maytansine|maytansine|mesh-list
84070833|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
84070834|NCT04197687|Vaccines|vaccines|mesh-list
84070835|NCT04197687|Antibodies|antibodies|mesh-list
84070836|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
84070837|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84070838|NCT04197687|Sargramostim|sargramostim|mesh-list
83309033|NCT01499277|Vancomycin|vancomycin|mesh-list
84070839|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
84070840|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
84070841|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070842|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070843|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84070844|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
84070845|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
84070846|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
84070847|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070848|NCT04197687|Immunotoxins|immunotoxins|mesh-ancestor
84070849|NCT04153760|Aspirin|aspirin|mesh-list
83309405|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
84070850|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84070851|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84070852|NCT04153760|Analgesics|analgesics|mesh-ancestor
84070853|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
84070854|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309486|NCT00194116|Valproic Acid|valproic acid|mesh-list
84070855|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070856|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84070857|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84070858|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84070859|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84070860|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309843|NCT05820256|Sequestering Agents|sequestering agents|mesh-ancestor
84070861|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84070862|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84070863|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070864|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
84070865|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
83310057|NCT05814874|Selenium|selenium|mesh-list
84070866|NCT04130516|Antibodies|antibodies|mesh-list
84070867|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
83310134|NCT05814640|Lithium Carbonate|lithium carbonate|mesh-list
84070868|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070869|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070870|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070871|NCT04130516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070872|NCT04130516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070873|NCT03989778|Vitamin D|vitamin d|mesh-list
84070874|NCT03989778|Vitamins|vitamins|mesh-ancestor
84070875|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
84070876|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070877|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84070878|NCT03981614|Trifluridine|trifluridine|mesh-list
84070879|NCT03981614|Palbociclib|palbociclib|mesh-list
84070880|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070881|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070882|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310493|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310565|NCT05373680|Metformin|metformin|mesh-list
84070883|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070884|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
84070886|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070887|NCT03976063|Nifedipine|nifedipine|mesh-list
83311009|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84070888|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84070889|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311090|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
84070890|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070891|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84070892|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070893|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
84070894|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
83311313|NCT04117178|Memantine|memantine|mesh-list
84070895|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84070896|NCT03971253|Peficitinib|peficitinib|mesh-list
84070897|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070898|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070899|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070900|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
84070901|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070902|NCT03962855|Ifetroban|ifetroban|mesh-list
83311446|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
84070903|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84070904|NCT03959527|Azithromycin|azithromycin|mesh-list
84070905|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
84070906|NCT03959527|Zoliflodacin|zoliflodacin|mesh-list
84070907|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84070908|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070909|NCT03959527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84070910|NCT03959527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84070911|NCT03959527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311669|NCT03530124|Vaccines|vaccines|mesh-list
83311738|NCT03410030|Vitamins|vitamins|mesh-ancestor
84070912|NCT03959527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070913|NCT03959527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070914|NCT03955172|Everolimus|everolimus|mesh-list
84070915|NCT03955172|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84070916|NCT03955172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070917|NCT03955172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131360|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83312034|NCT02444429|Hormones|hormones|mesh-ancestor
84070918|NCT03955172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070919|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070920|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
83312119|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070921|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070922|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070923|NCT03947216|Pimavanserin|pimavanserin|mesh-list
84070924|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84070925|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84070926|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84070927|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83312266|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
84070928|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84070929|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312349|NCT00121186|Melphalan|melphalan|mesh-list
84070930|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84070931|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84070932|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84070933|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
84070934|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070935|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312558|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84070936|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84070937|NCT03889249|Tenecteplase|tenecteplase|mesh-list
84070938|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84070939|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84070940|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070941|NCT03844620|Trifluridine|trifluridine|mesh-list
84070942|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
84070943|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070944|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
84070945|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070946|NCT03841201|Nivolumab|nivolumab|mesh-list
84070947|NCT03841201|Lenvatinib|lenvatinib|mesh-list
84070948|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070949|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070950|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070951|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070952|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84070953|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070954|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84070955|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84070956|NCT03733535|Benralizumab|benralizumab|mesh-list
84070957|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83310941|NCT04792385|Diuretics|diuretics|mesh-ancestor
84070958|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
84070960|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84070961|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070962|NCT03728972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84070963|NCT03728972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070964|NCT03719092|Vitamins|vitamins|mesh-list
84070965|NCT03719092|Vitamin A|vitamin a|mesh-list
84070966|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
84070967|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
83313072|NCT01790542|Iron|iron|mesh-list
84070968|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070969|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
84070970|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070971|NCT03719092|Protective Agents|protective agents|mesh-ancestor
84070972|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83313136|NCT00287872|Thalidomide|thalidomide|mesh-list
84070973|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84070974|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
84070975|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84070976|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
84070977|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313205|NCT00291694|Analgesics|analgesics|mesh-ancestor
84070978|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84070979|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84070980|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
84070981|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84070982|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
84070983|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070984|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84070985|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84070986|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
84070987|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
84070988|NCT03661385|Protective Agents|protective agents|mesh-ancestor
84070989|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
84070990|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84070991|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
83313351|NCT00302068|Sertraline|sertraline|mesh-list
84070992|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84070993|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
84070994|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84070995|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84070996|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
84070997|NCT03617731|Dexamethasone|dexamethasone|mesh-list
84070998|NCT03617731|Lenalidomide|lenalidomide|mesh-list
84070999|NCT03617731|Bortezomib|bortezomib|mesh-list
84071000|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071001|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
84071002|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
84071003|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071004|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071005|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84071006|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
84071007|NCT03617731|Hormones|hormones|mesh-ancestor
84071008|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071009|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84071010|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071011|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
84071012|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84071013|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84071014|NCT03617731|Growth Substances|growth substances|mesh-ancestor
84071015|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
84071016|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
84071017|NCT03531736|Fludarabine|fludarabine|mesh-list
84071018|NCT03531736|Rituximab|rituximab|mesh-list
84071019|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84071020|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
84071021|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071022|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
83313840|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
84071023|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071024|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84071025|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84071026|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
84071027|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071028|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071029|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84071030|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071031|NCT03526874|Lidocaine|lidocaine|mesh-list
84071032|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
84071033|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
84071034|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071035|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071036|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
84071037|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071038|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84071039|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84071040|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84071041|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84071042|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071043|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
84071044|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
84071045|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314208|NCT01458639|Xenon|xenon|mesh-list
84071046|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
84071047|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84071048|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84071049|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071050|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
84071051|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
84071052|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071053|NCT03472560|Avelumab|avelumab|mesh-list
84071054|NCT03472560|Axitinib|axitinib|mesh-list
84071055|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071056|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071057|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071058|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071059|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071060|NCT03451799|Temozolomide|temozolomide|mesh-list
84071061|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84071062|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
83314633|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
84071063|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071064|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071065|NCT03439124|Cephalosporins|cephalosporins|mesh-list
84071066|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
84071067|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
84071068|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84071069|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071070|NCT03393741|Paclitaxel|paclitaxel|mesh-list
84071071|NCT03393741|Vinorelbine|vinorelbine|mesh-list
84071072|NCT03393741|Docetaxel|docetaxel|mesh-list
84071073|NCT03393741|Epothilones|epothilones|mesh-list
84071074|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
83314769|NCT00428584|Interferons|interferons|mesh-list
84071075|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84071076|NCT03393741|Taxane|taxane|mesh-list
84071077|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84071078|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071079|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
84071080|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
84071081|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
84071082|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071083|NCT03304093|Nivolumab|nivolumab|mesh-list
84071084|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071085|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314912|NCT00458848|Prednisone|prednisone|mesh-list
84071086|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84071087|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071088|NCT03279471|Sertraline|sertraline|mesh-list
84071089|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
84071090|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315065|NCT00381862|Antidotes|antidotes|mesh-ancestor
84071091|NCT03279471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84071092|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84071093|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315206|NCT00385216|Nicotine|nicotine|mesh-list
84131361|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071094|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071095|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071096|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
84071097|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071098|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
84071099|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071100|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071101|NCT03267888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84071102|NCT03267888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071103|NCT03263117|Anesthetics|anesthetics|mesh-list
83315719|NCT01433055|Minocycline|minocycline|mesh-list
84071104|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071105|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071106|NCT03232918|Oxytocin|oxytocin|mesh-list
84071107|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
84071108|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84071109|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071110|NCT03212989|Vorinostat|vorinostat|mesh-list
84071111|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071112|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84071113|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071114|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071115|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
84071116|NCT03199053|Saxagliptin|saxagliptin|mesh-list
84071117|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84071118|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071119|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84071120|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071121|NCT03199053|Incretins|incretins|mesh-ancestor
84071122|NCT03199053|Hormones|hormones|mesh-ancestor
84071123|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071124|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84071125|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071126|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316069|NCT01445535|Prednisone|prednisone|mesh-list
84071127|NCT03158688|Dexamethasone|dexamethasone|mesh-list
84071128|NCT03158688|Daratumumab|daratumumab|mesh-list
84071129|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071130|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
83316223|NCT00513526|Vaccines|vaccines|mesh-list
84071131|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
84071132|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071133|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316298|NCT00520468|Hematinics|hematinics|mesh-ancestor
84071134|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84071135|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
84071136|NCT03158688|Hormones|hormones|mesh-ancestor
84071137|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071138|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84071139|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071140|NCT03138733|Daptomycin|daptomycin|mesh-list
84071141|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
84071142|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
84071143|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84071144|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071145|NCT03137173|Vancomycin|vancomycin|mesh-list
84071146|NCT03137173|Aztreonam|aztreonam|mesh-list
84071147|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
84071148|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
84071149|NCT03137173|Cephalosporins|cephalosporins|mesh-list
84071150|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84071151|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071152|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
84071153|NCT03107988|Topotecan|topotecan|mesh-list
84071154|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071155|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
84071156|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071157|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84071158|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84071159|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
84071160|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071161|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071162|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84071163|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84071164|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071165|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071166|NCT03089957|Urinastatin|urinastatin|mesh-list
84071167|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84071168|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84071169|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071170|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071171|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071172|NCT03080883|Apixaban|apixaban|mesh-list
84071173|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84071174|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
84071175|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84071176|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071177|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071178|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071179|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
84071180|NCT03072147|Teriparatide|teriparatide|mesh-list
84071181|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84071182|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071183|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84071184|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
84071185|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071186|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071187|NCT02949219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84071188|NCT02949219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071189|NCT02838420|Crizotinib|crizotinib|mesh-list
84071190|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071191|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071192|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316988|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
84071193|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071194|NCT02835222|Cytarabine|cytarabine|mesh-list
84071195|NCT02835222|Daunorubicin|daunorubicin|mesh-list
84071196|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84071197|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
84071198|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071199|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071200|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
84071201|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317213|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
83317290|NCT01721486|Acetaminophen|acetaminophen|mesh-list
84071202|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071203|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
84071204|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071205|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84071206|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84071207|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071208|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071209|NCT02723513|Xenon|xenon|mesh-list
84071210|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84071211|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
84071212|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
84071213|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071214|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071215|NCT02706054|Meloxicam|meloxicam|mesh-list
84071216|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84071217|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071218|NCT02706054|Analgesics|analgesics|mesh-ancestor
84071219|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
83317728|NCT01855243|Insulin|insulin|mesh-list
84071220|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071221|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071222|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071223|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317811|NCT04199325|Uric Acid|uric acid|mesh-list
84071224|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84071225|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84071226|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071227|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071228|NCT02630641|Hormones|hormones|mesh-list
83317941|NCT04198623|Montelukast|montelukast|mesh-list
84131362|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84071229|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071230|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071231|NCT02600117|Tenofovir|tenofovir|mesh-list
84071232|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
84071233|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071234|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83318306|NCT01847443|Nicotine|nicotine|mesh-list
84071235|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84071236|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318528|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071237|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071238|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84071239|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84071240|NCT02599714|Fulvestrant|fulvestrant|mesh-list
84071241|NCT02599714|Palbociclib|palbociclib|mesh-list
84071242|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84071243|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071244|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84071245|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83318676|NCT05362942|Decitabine|decitabine|mesh-list
84071246|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
84071247|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071248|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071249|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071250|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071251|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071252|NCT02437318|Fulvestrant|fulvestrant|mesh-list
83318817|NCT02454322|Analgesics|analgesics|mesh-ancestor
84071253|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84071254|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318892|NCT00569530|Calfactant|calfactant|mesh-list
84071255|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84071256|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84071257|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
84131363|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071258|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071259|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071260|NCT02337634|Silymarin|silymarin|mesh-list
84071261|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
84071262|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071263|NCT02337634|Protective Agents|protective agents|mesh-ancestor
83319180|NCT00615472|Propofol|propofol|mesh-list
84071264|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071265|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
84071266|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071267|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071268|NCT02332668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84071269|NCT02332668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071270|NCT02288195|Capecitabine|capecitabine|mesh-list
84071271|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
84071272|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84071273|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
84071274|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071275|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071276|NCT02265874|Nicotine|nicotine|mesh-list
84071277|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84071278|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
84071279|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071280|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071281|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84071282|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84071283|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
84071284|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071285|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071286|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
84071287|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84071288|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84071289|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
84071290|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071291|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071292|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
84071293|NCT02168140|Protective Agents|protective agents|mesh-ancestor
84131364|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84071294|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071295|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
84071296|NCT02168140|Vitamins|vitamins|mesh-ancestor
84071297|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
84071298|NCT02087423|Durvalumab|durvalumab|mesh-list
84071299|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071300|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071301|NCT01996436|Verapamil|verapamil|mesh-list
84071302|NCT01996436|Nicardipine|nicardipine|mesh-list
84071303|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
84071304|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
84071305|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84071306|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84071307|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84071308|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320334|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071309|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320561|NCT01278004|Ethosuximide|ethosuximide|mesh-list
84071310|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071311|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84071312|NCT01845337|Capecitabine|capecitabine|mesh-list
84071313|NCT01845337|Tegafur|tegafur|mesh-list
84071314|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83320631|NCT01272856|Abatacept|abatacept|mesh-list
84071315|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
84071316|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071317|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071318|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84071319|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
84071320|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071321|NCT01613118|Irbesartan|irbesartan|mesh-list
84071322|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84071323|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83320841|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071324|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84071325|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071326|NCT00836537|Benazepril|benazepril|mesh-list
84071327|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84071328|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071329|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311314|NCT04117178|Donepezil|donepezil|mesh-list
84131365|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071330|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071331|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84071332|NCT00680901|Capecitabine|capecitabine|mesh-list
83321143|NCT02984865|Dsuvia|dsuvia|mesh-list
84071333|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
84071334|NCT00680901|Lapatinib|lapatinib|mesh-list
84071335|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84071336|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
84071337|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071338|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321212|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
84071339|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071340|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071341|NCT00572169|Thalidomide|thalidomide|mesh-list
83321324|NCT03580395|Paclitaxel|paclitaxel|mesh-list
84071342|NCT00572169|Dexamethasone|dexamethasone|mesh-list
84071343|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
84071344|NCT00572169|Cisplatin|cisplatin|mesh-list
84071345|NCT00572169|Doxorubicin|doxorubicin|mesh-list
84071346|NCT00572169|Etoposide|etoposide|mesh-list
84071347|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84071348|NCT00572169|Bortezomib|bortezomib|mesh-list
84071349|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071350|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
84071351|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071352|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84071353|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84071354|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
84071355|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071356|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071357|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84071358|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071359|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
84071360|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
84071361|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071362|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84071363|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
84071364|NCT00572169|Hormones|hormones|mesh-ancestor
83321714|NCT05701059|Analgesics|analgesics|mesh-ancestor
84071365|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071366|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84071367|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84071368|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84071369|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071370|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071371|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84071372|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
83322074|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
84071373|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84071374|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071375|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83322148|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
84071376|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84071377|NCT00572169|Growth Substances|growth substances|mesh-ancestor
83322220|NCT03805282|Lidocaine|lidocaine|mesh-list
84071378|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
84071379|NCT00505063|Vaccines|vaccines|mesh-list
84071380|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84071381|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
83322290|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
84071382|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322370|NCT00757822|Hormones|hormones|mesh-ancestor
84071383|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
84071384|NCT00941720|Busulfan|busulfan|mesh-list
84071385|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071386|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
83322582|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84071387|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071388|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84071389|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84071390|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
84071391|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071392|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071393|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84071394|NCT02583568|Bevacizumab|bevacizumab|mesh-list
83322658|NCT01784419|Ivacaftor|ivacaftor|mesh-list
84071395|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071396|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071397|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84071398|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84071399|NCT02583568|Growth Substances|growth substances|mesh-ancestor
84071400|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071401|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
83322879|NCT00790270|Ibuprofen|ibuprofen|mesh-list
84071402|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
84071403|NCT02852564|Diuretics|diuretics|mesh-ancestor
84071404|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
84071405|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071406|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071407|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071408|NCT05593042|Vaccines|vaccines|mesh-list
83323022|NCT01719380|Cetuximab|cetuximab|mesh-list
84071409|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
84071410|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071411|NCT05509816|Midazolam|midazolam|mesh-list
84071412|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84071413|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84071414|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071415|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071416|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83323163|NCT04520776|Meloxicam|meloxicam|mesh-list
84071417|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84071418|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84071419|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84071420|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
84071421|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
84071422|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
84071423|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
84071424|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071425|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071426|NCT04080310|Ezetimibe|ezetimibe|mesh-list
84071427|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
84071428|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84071429|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84071430|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
84071431|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071432|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84071433|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071434|NCT04078048|Vitamins|vitamins|mesh-list
84071435|NCT04078048|Vitamin E|vitamin e|mesh-list
84071436|NCT04078048|Antioxidants|antioxidants|mesh-list
84071437|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
84071438|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071439|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071440|NCT04078048|Protective Agents|protective agents|mesh-ancestor
84071441|NCT00673387|Pramlintide|pramlintide|mesh-list
84071442|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
84071443|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84071444|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071445|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
84071446|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84071447|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
84071448|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071449|NCT00933608|Memantine|memantine|mesh-list
84071450|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84071451|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84071452|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
84071453|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071454|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323646|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071455|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071456|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84071457|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84071458|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84071459|NCT02558023|Nicardipine|nicardipine|mesh-list
84071460|NCT02558023|Urapidil|urapidil|mesh-list
84071461|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84071462|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84071463|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131366|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071464|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071465|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84071466|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071467|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
84071468|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83324227|NCT00853840|Maraviroc|maraviroc|mesh-list
84071469|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
84071470|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071471|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84071472|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84131367|NCT00913419|Analgesics|analgesics|mesh-ancestor
84071473|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84071474|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83324457|NCT01857934|Melphalan|melphalan|mesh-list
84071475|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84071476|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84071477|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84071478|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311461|NCT03892785|Prednisone|prednisone|mesh-list
84131368|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
84071479|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071480|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
84071481|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071482|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071483|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
84071484|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84071485|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
83324810|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
83324881|NCT00820534|Penciclovir|penciclovir|mesh-list
84071486|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071487|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071488|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
84071489|NCT00574951|Imetelstat|imetelstat|mesh-list
83325025|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
84071490|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071491|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071492|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071493|NCT02584816|Vaccines|vaccines|mesh-list
84071494|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
84071495|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071496|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
84071497|NCT02584738|Prednisolone|prednisolone|mesh-list
84071498|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
84071499|NCT02584738|Bromides|bromides|mesh-list
84071500|NCT02584738|Albuterol|albuterol|mesh-list
84071501|NCT02584738|Ipratropium|ipratropium|mesh-list
84071502|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071503|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
84071504|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
84071505|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071506|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071507|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84071508|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
84071509|NCT02584738|Hormones|hormones|mesh-ancestor
84131369|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84071510|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071511|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84071512|NCT02584738|Protective Agents|protective agents|mesh-ancestor
84071513|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84071514|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071515|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
84071516|NCT02584738|Analgesics|analgesics|mesh-ancestor
84071517|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
84071518|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
84071519|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071520|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84071521|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84071522|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84071523|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071524|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84071525|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
84071526|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84071527|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84071528|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84071529|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
84071530|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84071531|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84071532|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83326512|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
84071533|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
84071534|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071535|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84071536|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
84071537|NCT00765271|Ritonavir|ritonavir|mesh-list
84071538|NCT00765271|Darunavir|darunavir|mesh-list
83326720|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
84071539|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
84071540|NCT00765271|Abacavir|abacavir|mesh-list
84071541|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84071542|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84071543|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071544|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071545|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071546|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84071547|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84071548|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
84071549|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071550|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83327164|NCT02241616|Entecavir|entecavir|mesh-list
84071551|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84071552|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84071553|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84071554|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84071555|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84071557|NCT04416568|Ipilimumab|ipilimumab|mesh-list
84071558|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071559|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327462|NCT01709318|Etonogestrel|etonogestrel|mesh-list
84071560|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84071561|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071562|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
84071563|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
84071564|NCT05269381|Sargramostim|sargramostim|mesh-list
84071565|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071566|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
84071567|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071568|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327740|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
84071569|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84071570|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
84131370|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84071571|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071572|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071573|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84071574|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328034|NCT03629223|Tepotinib|tepotinib|mesh-list
84071575|NCT05269381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84071576|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
83328183|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071577|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84071578|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071579|NCT02583022|Analgesics|analgesics|mesh-ancestor
84071580|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
83328258|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
84071581|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071582|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071583|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071584|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84071585|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
84071586|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83328482|NCT04356508|Nivolumab|nivolumab|mesh-list
84071587|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
83328549|NCT04368520|Vitamins|vitamins|mesh-list
84071588|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84071589|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071590|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071591|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
84071592|NCT00764725|Infliximab|infliximab|mesh-list
84071593|NCT00764725|Methotrexate|methotrexate|mesh-list
84071594|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84071595|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
83328854|NCT03542175|Rucaparib|rucaparib|mesh-list
84071596|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83328916|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
83328993|NCT01670409|Cisplatin|cisplatin|mesh-list
84071597|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071598|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84071599|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
84071600|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071601|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071602|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
84071603|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329068|NCT02404935|Cetuximab|cetuximab|mesh-list
83329131|NCT03032614|Veliparib|veliparib|mesh-list
84071604|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84071605|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071606|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
84071607|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329356|NCT00949234|Lopinavir|lopinavir|mesh-list
84071608|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84071609|NCT00764725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84071610|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071611|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84071612|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071613|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84071614|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071615|NCT00764725|Analgesics|analgesics|mesh-ancestor
84071616|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
84071617|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071618|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
84071619|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84071620|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329722|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071621|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
84071622|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071623|NCT04077892|Budesonide|budesonide|mesh-list
84071624|NCT04077892|Montelukast|montelukast|mesh-list
84071625|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071626|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84071627|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
84071628|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071629|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071630|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84071631|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
84071632|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
84071633|NCT04077892|Hormones|hormones|mesh-ancestor
84071634|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071635|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83330164|NCT05688345|Propofol|propofol|mesh-list
84071636|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
84071637|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83330303|NCT00417664|Propofol|propofol|mesh-list
84071638|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83330376|NCT01018420|Colchicine|colchicine|mesh-list
84071639|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071640|NCT00606242|Fluticasone|fluticasone|mesh-list
84071641|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071642|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84071643|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
84071644|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071645|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071646|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84071647|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
84071648|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
84071649|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84071650|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84071651|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84071652|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
84071653|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071654|NCT00770263|Sirolimus|sirolimus|mesh-list
84071655|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84071656|NCT00770263|Temsirolimus|temsirolimus|mesh-list
84071657|NCT00770263|MTOR Inhibitors|mtor inhibitors|mesh-list
84071658|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071659|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071660|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071661|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071662|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071663|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
83331405|NCT01051570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84071664|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071665|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84071666|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331556|NCT05225805|Lefamulin|lefamulin|mesh-list
84071667|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84071668|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
84071669|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
84071670|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071671|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071672|NCT02691026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331693|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
84071673|NCT02691026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071674|NCT05400148|Bupivacaine|bupivacaine|mesh-list
84071675|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
84071676|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
83331845|NCT03080974|Nivolumab|nivolumab|mesh-list
84071677|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071678|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071679|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
84071680|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071681|NCT00765427|Retinol acetate|retinol acetate|mesh-list
84071682|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84071683|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
83331977|NCT01120834|Azacitidine|azacitidine|mesh-list
84071684|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071685|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84071686|NCT00765427|Protective Agents|protective agents|mesh-ancestor
84071687|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071688|NCT02584582|Liraglutide|liraglutide|mesh-list
84071689|NCT02584582|Exenatide|exenatide|mesh-list
84071690|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83332050|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071691|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071692|NCT02584582|Incretins|incretins|mesh-ancestor
84071693|NCT02584582|Hormones|hormones|mesh-ancestor
84071694|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071695|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84071696|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84071697|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
84071698|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071699|NCT00765973|Topotecan|topotecan|mesh-list
84071700|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83332262|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071701|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071702|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071703|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071704|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071706|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84071707|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071708|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
84071709|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84071710|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84071711|NCT00770497|Pioglitazone|pioglitazone|mesh-list
84071712|NCT00770497|Ramipril|ramipril|mesh-list
84071713|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84071714|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071715|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84071716|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071717|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332617|NCT01163656|Cobalt|cobalt|mesh-list
83332698|NCT01133158|Dexamethasone|dexamethasone|mesh-list
84071718|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071719|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84071720|NCT02581696|Irsogladine|irsogladine|mesh-list
84071721|NCT02581696|Lafutidine|lafutidine|mesh-list
84071722|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071723|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84071724|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84071725|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84071726|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
84071727|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
84071728|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071729|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071730|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332866|NCT04397289|Heparin|heparin|mesh-list
84071731|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84071732|NCT02581696|Protective Agents|protective agents|mesh-ancestor
84071733|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84071734|NCT00607958|Ritonavir|ritonavir|mesh-list
84071735|NCT00607958|Tipranavir|tipranavir|mesh-list
84071736|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84071737|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84071738|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071739|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131371|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84071740|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071741|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84071742|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84071743|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
83333076|NCT05309460|Nifedipine|nifedipine|mesh-list
84071744|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071745|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84071746|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84071747|NCT00770575|Pioglitazone|pioglitazone|mesh-list
84071748|NCT00770575|Atorvastatin|atorvastatin|mesh-list
84071749|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84071750|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84071751|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
83333291|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
84071752|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071753|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84071754|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84071755|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071756|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84071757|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071758|NCT00770731|Sirolimus|sirolimus|mesh-list
84071759|NCT00770731|Bortezomib|bortezomib|mesh-list
84071760|NCT00770731|Topotecan|topotecan|mesh-list
84071761|NCT00770731|Temsirolimus|temsirolimus|mesh-list
84071762|NCT00770731|MTOR Inhibitors|mtor inhibitors|mesh-list
84071763|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071764|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84071765|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071766|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071767|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071768|NCT00770731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071769|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071770|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
84071771|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071772|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84071773|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071774|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84071775|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
84071776|NCT00775255|Clarithromycin|clarithromycin|mesh-list
84071777|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83333643|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
84071778|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071779|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84071780|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071781|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333723|NCT01200160|Niacin|niacin|mesh-list
84071782|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84071783|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84071784|NCT00606866|Sorafenib|sorafenib|mesh-list
84071785|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071786|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071787|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333865|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071788|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071789|NCT00766285|Vaccines|vaccines|mesh-list
84071790|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
84071791|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071792|NCT04265456|Acetaminophen|acetaminophen|mesh-list
84071793|NCT04265456|Pregabalin|pregabalin|mesh-list
84071794|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071795|NCT04265456|Analgesics|analgesics|mesh-ancestor
84071796|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
84071797|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071798|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071799|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
83334229|NCT03438240|Fentanyl|fentanyl|mesh-list
84071800|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
84071801|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84071802|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84071803|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071804|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84071805|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84071806|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84071807|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071808|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84071809|NCT04379518|Interferons|interferons|mesh-list
84071810|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
84071811|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
84071812|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
84071813|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071814|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
84071815|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071816|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
84071817|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071818|NCT04378426|Midazolam|midazolam|mesh-list
84071819|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
84071820|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84071821|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84071822|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071823|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071824|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84071825|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84071826|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84071827|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84071828|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
83335102|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
84071829|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
84071830|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
84071831|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
84071832|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335396|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071833|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071834|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84071835|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071836|NCT04378426|Analgesics|analgesics|mesh-ancestor
84071837|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
84071838|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071839|NCT02581462|Trastuzumab|trastuzumab|mesh-list
84071840|NCT02581462|Pertuzumab|pertuzumab|mesh-list
83335767|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
84071841|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84071842|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071843|NCT00668863|Leucovorin|leucovorin|mesh-list
84071844|NCT00668863|Fluorouracil|fluorouracil|mesh-list
84071845|NCT00668863|Irinotecan|irinotecan|mesh-list
84071846|NCT00668863|Sunitinib|sunitinib|mesh-list
84071847|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
83335994|NCT00985959|Bortezomib|bortezomib|mesh-list
84071848|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
83336063|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071849|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071850|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83336208|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
84071851|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071852|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84071853|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
84071854|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336427|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
84071855|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84071856|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071857|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071858|NCT00668863|Antidotes|antidotes|mesh-ancestor
84071859|NCT00668863|Protective Agents|protective agents|mesh-ancestor
84071860|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
84071862|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
84071863|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84071864|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84071865|NCT00668863|Growth Substances|growth substances|mesh-ancestor
83336803|NCT01962792|Dexamethasone|dexamethasone|mesh-list
84071866|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
84071867|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071868|NCT04077736|Aldesleukin|aldesleukin|mesh-list
84071869|NCT04077736|Interleukin-2|interleukin-2|mesh-list
84071870|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336942|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
84071871|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071872|NCT04077736|Analgesics|analgesics|mesh-ancestor
84071873|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
84071874|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071875|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071876|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84071877|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83337037|NCT01865747|Everolimus|everolimus|mesh-list
84071878|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
83337090|NCT01412710|Vitamin D|vitamin d|mesh-list
84071879|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071880|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84071881|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84071882|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071883|NCT00766441|Incretins|incretins|mesh-ancestor
84071884|NCT00766441|Hormones|hormones|mesh-ancestor
84071885|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071886|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84071887|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
84071888|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071889|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071890|NCT00771043|Natalizumab|natalizumab|mesh-list
84071891|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
84071892|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071893|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
84071894|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84071895|NCT04267250|Estradiol|estradiol|mesh-list
84071896|NCT04267250|PF-06700841|pf-06700841|mesh-list
84071897|NCT04267250|Estrogens|estrogens|mesh-ancestor
84071898|NCT04267250|Hormones|hormones|mesh-ancestor
83337683|NCT01611857|Vitamins|vitamins|mesh-ancestor
84071899|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071900|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071901|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84071902|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
84071903|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84071904|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83337895|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071905|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84071906|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84071907|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84071908|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84071909|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84071910|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071911|NCT00775489|Beclomethasone|beclomethasone|mesh-list
84071912|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338192|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
84071913|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
84071914|NCT00775489|Hormones|hormones|mesh-ancestor
84071915|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84071916|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071917|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84071918|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
84071919|NCT00771199|Fentanyl|fentanyl|mesh-list
84071920|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84071921|NCT00771199|Narcotics|narcotics|mesh-ancestor
84071922|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338481|NCT01451632|Irinotecan|irinotecan|mesh-list
84071923|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071924|NCT00771199|Analgesics|analgesics|mesh-ancestor
84071925|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
84071926|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071927|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84071928|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84071929|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
83338701|NCT02981212|Hormones|hormones|mesh-ancestor
84071930|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
84071931|NCT04264130|Artesunate|artesunate|mesh-list
84071932|NCT04264130|Lumefantrine|lumefantrine|mesh-list
83338805|NCT03389958|Copper|copper|mesh-list
84071933|NCT04264130|Artemether|artemether|mesh-list
84071934|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84071935|NCT04264130|Pyronaridine|pyronaridine|mesh-list
84071936|NCT04264130|Artefenomel|artefenomel|mesh-list
84071937|NCT04264130|Ferroquine|ferroquine|mesh-list
84071938|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
84071939|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84071940|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84071941|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84071942|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84071943|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
84071944|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
83338913|NCT01566838|Bupivacaine|bupivacaine|mesh-list
84071945|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84071946|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
84071947|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
84071948|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84071949|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84071950|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071951|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84071952|NCT02557867|Analgesics|analgesics|mesh-ancestor
84071953|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
84071954|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071955|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84071956|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84071957|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84071958|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
83338983|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
84071959|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339043|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84071960|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071961|NCT00605774|Epinephrine|epinephrine|mesh-list
84071962|NCT00605774|Racepinephrine|racepinephrine|mesh-list
84071963|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
84071964|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84071965|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84071966|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
84071967|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071968|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339263|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84071969|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071970|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84071971|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84071972|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
84071973|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84071974|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84071975|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
84071976|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
84071977|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
84071978|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84071979|NCT04264286|Esmolol|esmolol|mesh-list
84071980|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84071981|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84071982|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84071983|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
84071984|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84071985|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071986|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071987|NCT02582476|Bumetanide|bumetanide|mesh-list
84071988|NCT02582476|Diuretics|diuretics|mesh-ancestor
84071989|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
84071990|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071991|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84071992|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84071993|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84071994|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83339470|NCT01802879|Panobinostat|panobinostat|mesh-list
84071995|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84071996|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84071997|NCT04078204|Protective Agents|protective agents|mesh-ancestor
84071998|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84071999|NCT00668707|Melatonin|melatonin|mesh-list
84072000|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
84072001|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072002|NCT00668707|Protective Agents|protective agents|mesh-ancestor
84072003|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072004|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072005|NCT00766909|Cyclosporine|cyclosporine|mesh-list
84072006|NCT00766909|Tacrolimus|tacrolimus|mesh-list
84072007|NCT00766909|Cyclosporins|cyclosporins|mesh-list
83339674|NCT01530178|Incretins|incretins|mesh-ancestor
84072008|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84072009|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
84072010|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339832|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072011|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84072012|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339983|NCT01593592|Amoxicillin|amoxicillin|mesh-list
84072013|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072014|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
84072015|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072016|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
84072017|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072018|NCT00771433|Lenograstim|lenograstim|mesh-list
84072019|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84072020|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
84072021|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072022|NCT00668395|Efavirenz|efavirenz|mesh-list
84072023|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84072024|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84072025|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072026|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072027|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
84072028|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072029|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84072030|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84072031|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84072032|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84072033|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84072034|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84072035|NCT00668317|Omeprazole|omeprazole|mesh-list
84072036|NCT00668317|Ranitidine|ranitidine|mesh-list
84072037|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84072038|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84072039|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072040|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84072041|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072042|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072043|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84072044|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
84072045|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
84072046|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072047|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072048|NCT00775879|Sevoflurane|sevoflurane|mesh-list
84072049|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83341078|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072050|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84072051|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
84072052|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
84072053|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072054|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072055|NCT00767221|Budesonide|budesonide|mesh-list
84072056|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84072057|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84072058|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
84072059|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072060|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072061|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84072062|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
84072063|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
84072064|NCT00767221|Hormones|hormones|mesh-ancestor
84072065|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84072066|NCT04024072|Brinzolamide|brinzolamide|mesh-list
84072067|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84072068|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072069|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341741|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84072070|NCT00771511|Capsaicin|capsaicin|mesh-list
84072071|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
84072072|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
84072073|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
84072074|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341891|NCT02507232|Temozolomide|temozolomide|mesh-list
84072075|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072076|NCT00776113|Carvedilol|carvedilol|mesh-list
83312063|NCT02019875|Clarithromycin|clarithromycin|mesh-list
83312064|NCT02019875|Rifampin|rifampin|mesh-list
83312065|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312066|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341962|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
83312067|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83312068|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312088|NCT01907009|Melphalan|melphalan|mesh-list
84072077|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84072078|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84072080|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342182|NCT04499898|Carvedilol|carvedilol|mesh-list
84072081|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072082|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072083|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84072084|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
83342331|NCT02509806|Apatinib|apatinib|mesh-list
84072085|NCT00776113|Protective Agents|protective agents|mesh-ancestor
84072086|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84072087|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84072088|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84072089|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
84072090|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84072091|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84072092|NCT02580448|Seviteronel|seviteronel|mesh-list
84072093|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072094|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84072095|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072096|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072097|NCT04008238|Trabectedin|trabectedin|mesh-list
84072098|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84072099|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
84072100|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072101|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072102|NCT00672139|Bromides|bromides|mesh-list
84072103|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
84072104|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
84072105|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84072106|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072107|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
84072108|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072109|NCT02557789|Lefamulin|lefamulin|mesh-list
84072110|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84072111|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072112|NCT00771823|Maraviroc|maraviroc|mesh-list
84072113|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84072114|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84072115|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072116|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84072117|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84072118|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
84072119|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072120|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84072121|NCT04219540|Buprenorphine|buprenorphine|mesh-list
84072122|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84072123|NCT04219540|Narcotics|narcotics|mesh-ancestor
84072124|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072125|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072126|NCT04219540|Analgesics|analgesics|mesh-ancestor
83342741|NCT01709032|Deferasirox|deferasirox|mesh-list
84072127|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
83342814|NCT01670110|Pasireotide|pasireotide|mesh-list
84072128|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072129|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84072130|NCT03955042|Pemetrexed|pemetrexed|mesh-list
83342885|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
84072131|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072132|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342959|NCT01688596|Bupivacaine|bupivacaine|mesh-list
84072133|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072134|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84072135|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84072136|NCT00570739|Metformin|metformin|mesh-list
84072137|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84072138|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83343107|NCT02497326|Heparin|heparin|mesh-list
84072139|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072140|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84072141|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83343198|NCT03342300|Doxorubicin|doxorubicin|mesh-list
84072142|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
84072143|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072144|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84072145|NCT04076098|Minocycline|minocycline|mesh-list
84072146|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84072147|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072148|NCT00771979|Saracatinib|saracatinib|mesh-list
84072149|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072150|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072151|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072152|NCT00767689|Pyridoxine|pyridoxine|mesh-list
84072153|NCT00767689|Pyridoxal|pyridoxal|mesh-list
84072154|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
84072155|NCT00767689|Vitamins|vitamins|mesh-ancestor
84072156|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
84072157|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072158|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
84072159|NCT00772057|Propranolol|propranolol|mesh-list
84072160|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84072161|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84072162|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
84072163|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072164|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072165|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072166|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84072167|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84072168|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
84072169|NCT00776347|Donepezil|donepezil|mesh-list
84072170|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84072171|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072172|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072173|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
84072174|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072175|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072176|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
84072177|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
84072178|NCT00776425|Hematinics|hematinics|mesh-ancestor
84072179|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
84072180|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84072181|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84072182|NCT03913702|Prednisolone|prednisolone|mesh-list
84072183|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
84072184|NCT03913702|Ketorolac|ketorolac|mesh-list
84072185|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84072186|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84072187|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
84072188|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072189|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
84072190|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
84072191|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072192|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072193|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072194|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
84072195|NCT03913702|Hormones|hormones|mesh-ancestor
84072196|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84072197|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84072198|NCT03913702|Protective Agents|protective agents|mesh-ancestor
84072199|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84072200|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072201|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84072202|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84072203|NCT03913702|Analgesics|analgesics|mesh-ancestor
84072204|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
84072205|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072206|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84072207|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072208|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072209|NCT03909412|Dexamethasone|dexamethasone|mesh-list
84072210|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
84072211|NCT03909412|Lenograstim|lenograstim|mesh-list
84072212|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84072213|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
84072214|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072215|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072216|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84072217|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
84072218|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072219|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072220|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84072221|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072222|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
84072223|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
84072224|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072225|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072226|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
84072227|NCT03909412|Hormones|hormones|mesh-ancestor
84072228|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84072229|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84072230|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84072231|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
84072232|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344296|NCT03315312|Fluorides|fluorides|mesh-list
84072233|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
84072234|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84072235|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84072236|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072237|NCT00772135|Urological Agents|urological agents|mesh-ancestor
84072238|NCT00776503|Vorinostat|vorinostat|mesh-list
84072239|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072240|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84072241|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072242|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072243|NCT04075006|Ketamine|ketamine|mesh-list
84072244|NCT04075006|Analgesics|analgesics|mesh-ancestor
84072245|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
84072246|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072247|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072248|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84072249|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84072250|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
84072251|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
84072252|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072253|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84072254|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84072255|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072256|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072257|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
84072258|NCT04188106|Varenicline|varenicline|mesh-list
84072259|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84072260|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84072261|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
84072262|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072263|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072264|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072265|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
84072266|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
84072267|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84072268|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
84072269|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
84072270|NCT00669955|Amoxicillin|amoxicillin|mesh-list
84072271|NCT00669955|Metronidazole|metronidazole|mesh-list
84072272|NCT00669955|Clarithromycin|clarithromycin|mesh-list
84072273|NCT00669955|Tetracycline|tetracycline|mesh-list
83345086|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
84072274|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
84072275|NCT00669955|Omeprazole|omeprazole|mesh-list
84072276|NCT00669955|Bismuth|bismuth|mesh-list
84072277|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84072278|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072279|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84072280|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84072281|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84072282|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072283|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84072284|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072285|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072286|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84072287|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84072288|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84072289|NCT00669955|Antacids|antacids|mesh-ancestor
84072290|NCT00772291|Pregabalin|pregabalin|mesh-list
84072291|NCT00772291|Analgesics|analgesics|mesh-ancestor
84072292|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
84072293|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072294|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072295|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
84072296|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84072297|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84072298|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072299|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84072300|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84072301|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83312304|NCT00119392|Rituximab|rituximab|mesh-list
84072302|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072304|NCT03595150|Diclofenac|diclofenac|mesh-list
83345883|NCT02469012|Ribavirin|ribavirin|mesh-list
84072305|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84072306|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84072307|NCT03595150|Analgesics|analgesics|mesh-ancestor
84072308|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
84072309|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346022|NCT02467920|Incretins|incretins|mesh-ancestor
84072310|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072311|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072312|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072313|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84072314|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346168|NCT02722278|Testosterone|testosterone|mesh-list
84072315|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072316|NCT00768157|Lamivudine|lamivudine|mesh-list
84072317|NCT00768157|Entecavir|entecavir|mesh-list
84072318|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
84072319|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84072320|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83346248|NCT01993810|Paclitaxel|paclitaxel|mesh-list
84072321|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072322|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072323|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072324|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84072325|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84072326|NCT00671749|Clindamycin|clindamycin|mesh-list
84072327|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
84072328|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
84072329|NCT00671749|Adapalene|adapalene|mesh-list
84072330|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84072331|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84072332|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072333|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84072334|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072335|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072336|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
84072337|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84072338|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84072339|NCT00671749|Analgesics|analgesics|mesh-ancestor
84072340|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
84072341|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072342|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072343|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072344|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072345|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
84072346|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
84072347|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84072348|NCT04149106|Amodiaquine|amodiaquine|mesh-list
84072349|NCT04149106|Artenimol|artenimol|mesh-list
84072350|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
84072351|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84072352|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84072353|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072354|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84072355|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346802|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
84072356|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346876|NCT02996721|Vitamins|vitamins|mesh-ancestor
84072357|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84072358|NCT02580604|Calcium|calcium|mesh-list
84072359|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84072360|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072361|NCT00768391|Olaratumab|olaratumab|mesh-list
84072362|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072363|NCT00669877|Cytarabine|cytarabine|mesh-list
84072364|NCT00669877|Dexamethasone|dexamethasone|mesh-list
83347154|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
84072365|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
84072366|NCT00669877|Rituximab|rituximab|mesh-list
84072367|NCT00669877|Doxorubicin|doxorubicin|mesh-list
84072368|NCT00669877|Methotrexate|methotrexate|mesh-list
84072369|NCT00669877|Vincristine|vincristine|mesh-list
84072370|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84072371|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
84072372|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072373|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072374|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84072375|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
84072376|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072377|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072378|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83347520|NCT02916771|Dexamethasone|dexamethasone|mesh-list
84072379|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072380|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072382|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
83347664|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
84072383|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072384|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072385|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
84072386|NCT00669877|Hormones|hormones|mesh-ancestor
84072387|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84072388|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84072389|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84072390|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84072391|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84072392|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347809|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84072393|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84072394|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
84072395|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83347956|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
84072396|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84072397|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
84072398|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
84072399|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84072400|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84072401|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
83348099|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
84072402|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072403|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84072404|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
84072405|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
84072406|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
84072407|NCT00772681|Docetaxel|docetaxel|mesh-list
84072408|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072409|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348391|NCT05824832|BB 1101|bb 1101|mesh-list
84072410|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
84072411|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
84072412|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072413|NCT00772759|AZD-3199|azd-3199|mesh-list
84072414|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84072415|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84072416|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84072417|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
84072418|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348864|NCT05015439|Cannabidiol|cannabidiol|mesh-list
84072419|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072420|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072421|NCT03866668|Esomeprazole|esomeprazole|mesh-list
84072422|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83349079|NCT04578886|Guanfacine|guanfacine|mesh-list
84072423|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072424|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84072425|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349150|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84072426|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072427|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84072428|NCT00772837|Amoxicillin|amoxicillin|mesh-list
84072429|NCT00772837|Clarithromycin|clarithromycin|mesh-list
84072430|NCT00772837|Omeprazole|omeprazole|mesh-list
84072431|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072432|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84072433|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072434|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84072435|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349442|NCT02985957|Ipilimumab|ipilimumab|mesh-list
84072436|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072437|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84072438|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84072439|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84072440|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
83349588|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84072441|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072442|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072443|NCT00768859|Paclitaxel|paclitaxel|mesh-list
84072444|NCT00768859|Carboplatin|carboplatin|mesh-list
84072445|NCT00768859|Trastuzumab|trastuzumab|mesh-list
84072446|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84072447|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072448|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
84072449|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
84072450|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
83349883|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072451|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072452|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072453|NCT00768937|Sorafenib|sorafenib|mesh-list
83350105|NCT02282319|Analgesics|analgesics|mesh-ancestor
84072454|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072455|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84072456|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350258|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84072457|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072458|NCT04047745|Bupivacaine|bupivacaine|mesh-list
84072459|NCT04047745|Ropivacaine|ropivacaine|mesh-list
84072460|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
84072461|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
84072462|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072463|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350404|NCT01752023|Cisplatin|cisplatin|mesh-list
84072464|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
84072465|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072466|NCT00777439|Domperidone|domperidone|mesh-list
83350472|NCT02418195|Ketamine|ketamine|mesh-list
84072467|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072468|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
84072469|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
84072470|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350616|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
84072471|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072472|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072473|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83350771|NCT01722071|Oxytocin|oxytocin|mesh-list
84072474|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
84072475|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350918|NCT02292082|Hormones|hormones|mesh-ancestor
84072476|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84072477|NCT00769093|Hematinics|hematinics|mesh-ancestor
83350990|NCT03099382|Docetaxel|docetaxel|mesh-list
84072478|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84072479|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84072480|NCT00671437|Cetuximab|cetuximab|mesh-list
84072481|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072482|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072483|NCT00777517|Atorvastatin|atorvastatin|mesh-list
84072484|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84072485|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84072486|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
83351207|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072487|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072488|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84072489|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84072490|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072491|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
84072492|NCT00769171|Metronidazole|metronidazole|mesh-list
84072493|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
84072494|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84072495|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84072496|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072497|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84072498|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84072499|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072500|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072501|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072502|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84072503|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
84072504|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84072505|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072506|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84072507|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84072508|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83351727|NCT01173172|Boron|boron|mesh-list
84072509|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83351793|NCT03773484|Analgesics|analgesics|mesh-ancestor
84072510|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84072511|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
84072512|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84072513|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351945|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
83352021|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84072514|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84072515|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84072516|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072517|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072518|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072519|NCT00769405|Leucovorin|leucovorin|mesh-list
84072520|NCT00769405|Fluorouracil|fluorouracil|mesh-list
84072521|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
84072522|NCT00769405|Calcium|calcium|mesh-list
84072523|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
84072524|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84072525|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072526|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
84072527|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072528|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84072529|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352612|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072530|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84072531|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
83352685|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
84072533|NCT00769405|Protective Agents|protective agents|mesh-ancestor
84072534|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
84072535|NCT00769405|Vitamins|vitamins|mesh-ancestor
84072536|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
84072537|NCT02829502|Exenatide|exenatide|mesh-list
84072538|NCT02829502|Glucagon|glucagon|mesh-list
84072539|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84072540|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84072541|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072542|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84072543|NCT02829502|Incretins|incretins|mesh-ancestor
84072544|NCT02829502|Hormones|hormones|mesh-ancestor
84072545|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84072546|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072547|NCT02635191|Amoxicillin|amoxicillin|mesh-list
84072548|NCT02635191|Metronidazole|metronidazole|mesh-list
84072549|NCT02635191|Clarithromycin|clarithromycin|mesh-list
84072550|NCT02635191|Esomeprazole|esomeprazole|mesh-list
84072551|NCT02635191|Omeprazole|omeprazole|mesh-list
84072552|NCT02635191|Rabeprazole|rabeprazole|mesh-list
84072553|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84072554|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353275|NCT03260166|Niacin|niacin|mesh-list
84072555|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84072556|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84072557|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84072558|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353444|NCT00907101|Adapalene|adapalene|mesh-list
84072559|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83353493|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
84072560|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353645|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
83353831|NCT00789399|PENTA|penta|mesh-list
83353870|NCT01720043|Bortezomib|bortezomib|mesh-list
83353940|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072561|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072562|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84072563|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83354166|NCT03248076|Analgesics|analgesics|mesh-ancestor
84072564|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84072565|NCT00777673|Paclitaxel|paclitaxel|mesh-list
84072566|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
84072567|NCT00777673|Bevacizumab|bevacizumab|mesh-list
84072568|NCT00777673|Carboplatin|carboplatin|mesh-list
84072569|NCT00777673|Doxorubicin|doxorubicin|mesh-list
83354237|NCT03237312|Hormones|hormones|mesh-list
83354319|NCT03247296|Ribavirin|ribavirin|mesh-list
84072570|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84072571|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83354463|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072572|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072573|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
84072574|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
84072575|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83354677|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072576|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072577|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84072578|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
84072579|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072580|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072581|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84072582|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
83354898|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84072583|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83355065|NCT05003037|Pemetrexed|pemetrexed|mesh-list
84072584|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072585|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84072586|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84072587|NCT00777673|Growth Substances|growth substances|mesh-ancestor
83355193|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84072588|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
84072589|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84072590|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84072591|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84072592|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072593|NCT02579902|Vitamin D|vitamin d|mesh-list
84072594|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
84072595|NCT02579902|Vitamins|vitamins|mesh-ancestor
84072596|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
84072597|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355411|NCT03214302|Tenofovir|tenofovir|mesh-list
84072598|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84072599|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84072600|NCT02557087|Meperidine|meperidine|mesh-list
84072601|NCT02557087|Scopolamine|scopolamine|mesh-list
83312594|NCT01795898|Analgesics|analgesics|mesh-ancestor
84072602|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84072603|NCT02557087|Narcotics|narcotics|mesh-ancestor
84072604|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355697|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
84072605|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072606|NCT02557087|Analgesics|analgesics|mesh-ancestor
83355781|NCT02096679|Osimertinib|osimertinib|mesh-list
84072607|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
84072608|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072609|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84072610|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
84072611|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
84072612|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072613|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
84072614|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84072615|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
84072616|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072617|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072618|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84072619|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84072620|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
84072621|NCT02579590|Desogestrel|desogestrel|mesh-list
84072622|NCT02579590|Etonogestrel|etonogestrel|mesh-list
83356300|NCT05372380|Ezetimibe|ezetimibe|mesh-list
84072623|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83356358|NCT04484844|Listerine|listerine|mesh-list
84072624|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84072625|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84072626|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
84072627|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84072628|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072629|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84072630|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84072631|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84072632|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84072633|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072634|NCT02579590|Progestins|progestins|mesh-ancestor
84072635|NCT02579590|Hormones|hormones|mesh-ancestor
84072636|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84072637|NCT02634723|Factor VIII|factor viii|mesh-list
84072638|NCT02634723|Coagulants|coagulants|mesh-ancestor
83356644|NCT02449746|Antibodies|antibodies|mesh-list
83356809|NCT02446002|Lofexidine|lofexidine|mesh-list
84072639|NCT02634489|Tamsulosin|tamsulosin|mesh-list
84072640|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
84072641|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84072642|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83357174|NCT03196362|Pioglitazone|pioglitazone|mesh-list
84072643|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84072644|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
84072645|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072646|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072647|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072648|NCT02634489|Urological Agents|urological agents|mesh-ancestor
84072649|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84072650|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84072651|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
84072652|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
84072653|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
84072654|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84072655|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072656|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072657|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
84072658|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83357768|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84072659|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072660|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357926|NCT05292586|Hormones|hormones|mesh-ancestor
84072661|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84072662|NCT03920566|Dalteparin|dalteparin|mesh-list
84072663|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
83358065|NCT02437656|Metformin|metformin|mesh-list
84072664|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83358138|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
84072665|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84072666|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072667|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
84072668|NCT00582790|Interleukin-2|interleukin-2|mesh-list
83358288|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
84072669|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072670|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83358367|NCT00227019|Vitamins|vitamins|mesh-list
84072671|NCT00582790|Analgesics|analgesics|mesh-ancestor
84072672|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
83358510|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
84072673|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072674|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072675|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84072676|NCT00774007|Mesalamine|mesalamine|mesh-list
84072677|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84072678|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84072679|NCT00774007|Analgesics|analgesics|mesh-ancestor
84072680|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
84072681|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358803|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84072682|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072683|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83358887|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
84072684|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072685|NCT00769873|Heparin|heparin|mesh-list
84072686|NCT00769873|Enoxaparin|enoxaparin|mesh-list
84072687|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84072688|NCT00769873|Tinzaparin|tinzaparin|mesh-list
84072689|NCT00769873|Dalteparin|dalteparin|mesh-list
84072690|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
84072691|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84072692|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84072693|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072694|NCT00777985|Bosentan|bosentan|mesh-list
84072695|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83359319|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072696|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84072697|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072698|NCT00770107|Thiamine|thiamine|mesh-list
83359466|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
84072699|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
84072700|NCT00770107|Vitamins|vitamins|mesh-ancestor
83359700|NCT01697267|Rituximab|rituximab|mesh-list
84072701|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
84072702|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072703|NCT00774241|Bevacizumab|bevacizumab|mesh-list
84072704|NCT00774241|Docetaxel|docetaxel|mesh-list
83359834|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359985|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
83360081|NCT02517580|Vitamin K|vitamin k|mesh-list
84072705|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072706|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072707|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84072708|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84072709|NCT00774241|Growth Substances|growth substances|mesh-ancestor
84072710|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072711|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
84072712|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
84072713|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
84072714|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
84072715|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072716|NCT00774319|Cisplatin|cisplatin|mesh-list
84072717|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072718|NCT00881751|Bevacizumab|bevacizumab|mesh-list
84072719|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84072720|NCT00881751|Sorafenib|sorafenib|mesh-list
84072721|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072722|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072723|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84072724|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84072725|NCT00881751|Growth Substances|growth substances|mesh-ancestor
84072726|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072727|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
83360428|NCT02408328|Caffeine|caffeine|mesh-list
84072728|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83360652|NCT02407314|Aspirin|aspirin|mesh-list
84072729|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072730|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072731|NCT02634255|Fentanyl|fentanyl|mesh-list
84072732|NCT02634255|Propofol|propofol|mesh-list
84072733|NCT02634255|Rocuronium|rocuronium|mesh-list
83360863|NCT02974348|Acetaminophen|acetaminophen|mesh-list
84072734|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84072735|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072736|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072737|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84072738|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
84072739|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
84072740|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84072741|NCT02634255|Narcotics|narcotics|mesh-ancestor
84072742|NCT02634255|Analgesics|analgesics|mesh-ancestor
84072743|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
84072744|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072745|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84072746|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84072747|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84072748|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84072749|NCT02634021|Midazolam|midazolam|mesh-list
84072750|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
84072751|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84072752|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072753|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072754|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83312745|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
84072755|NCT02634021|Analgesics|analgesics|mesh-ancestor
84072756|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
84072757|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072758|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84072759|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84072760|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84072761|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
84072762|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072763|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072764|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84072765|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84072766|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84072767|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84072768|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84072769|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
84072771|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
84072772|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
84072773|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
84072774|NCT04161729|Analgesics|analgesics|mesh-ancestor
84072775|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
84072776|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072777|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072778|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
84072779|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072780|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84072781|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
84072782|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84072783|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362647|NCT04775550|Daratumumab|daratumumab|mesh-list
83362876|NCT01536535|Analgesics|analgesics|mesh-ancestor
84072784|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072785|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84072786|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
84072787|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84072788|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
84072789|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
84072790|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84072791|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84072792|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363165|NCT01534637|Gemcitabine|gemcitabine|mesh-list
84072793|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072794|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072795|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072796|NCT00934856|Docetaxel|docetaxel|mesh-list
84072797|NCT00934856|Trastuzumab|trastuzumab|mesh-list
84072798|NCT00934856|Pertuzumab|pertuzumab|mesh-list
84072799|NCT00934856|Maytansine|maytansine|mesh-list
84072800|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83363618|NCT01526057|Rituximab|rituximab|mesh-list
83363695|NCT00248547|Ondansetron|ondansetron|mesh-list
84072801|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072802|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
83363846|NCT01535053|Folic Acid|folic acid|mesh-list
84072803|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
84072804|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
84072805|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072806|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072807|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84072808|NCT00934856|Immunotoxins|immunotoxins|mesh-ancestor
84072809|NCT00934856|Immunoconjugates|immunoconjugates|mesh-ancestor
84072810|NCT00934856|Immunologic Factors|immunologic factors|mesh-ancestor
84072811|NCT00934856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072812|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84072813|NCT04265612|Laxatives|laxatives|mesh-ancestor
84072814|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072815|NCT00934700|Xenon|xenon|mesh-list
84072816|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84072817|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
84072818|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
84072819|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072820|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072821|NCT00669409|Tanezumab|tanezumab|mesh-list
84072822|NCT00669409|Analgesics|analgesics|mesh-ancestor
84072823|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
84072824|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072825|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072826|NCT00778141|Metformin|metformin|mesh-list
84072827|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84072828|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072829|NCT00774475|Clopidogrel|clopidogrel|mesh-list
83364115|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
84072830|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84072831|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83364272|NCT01529749|Losartan|losartan|mesh-list
83364337|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
84072833|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84072834|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
84072835|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84072836|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072837|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072838|NCT00669331|Mannitol|mannitol|mesh-list
84072839|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84072840|NCT00669331|Diuretics|diuretics|mesh-ancestor
84072841|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
84072842|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072843|NCT00778297|Vaccines|vaccines|mesh-list
84072844|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
84072845|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072846|NCT00779233|Zidovudine|zidovudine|mesh-list
84072847|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
84072848|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072849|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83364997|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072850|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84072851|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072852|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
84072853|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365144|NCT00345969|Androgens|androgens|mesh-ancestor
84072854|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84072855|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84072856|NCT00607178|Vaccines|vaccines|mesh-list
84072857|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
84072858|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072859|NCT02556463|Durvalumab|durvalumab|mesh-list
84072860|NCT02556463|MEDI9197|medi9197|mesh-list
84072861|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072862|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072863|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84072864|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
84072865|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365291|NCT02365272|Amikacin|amikacin|mesh-list
84072866|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84072867|NCT00779389|Dasatinib|dasatinib|mesh-list
84072868|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072869|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84072870|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365511|NCT05800275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072871|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072872|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84072873|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83365805|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
84072874|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84072875|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
84072876|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84072877|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072878|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84072879|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84072880|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84072881|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84072882|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84072883|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
84072884|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84072885|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84072886|NCT05153174|Sulforaphane|sulforaphane|mesh-list
83366025|NCT05108688|Sumatriptan|sumatriptan|mesh-list
83366099|NCT04905316|Durvalumab|durvalumab|mesh-list
84072887|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84072888|NCT05153174|Protective Agents|protective agents|mesh-ancestor
84072889|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072890|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072891|NCT00778765|Gabapentin|gabapentin|mesh-list
84072892|NCT00778765|Analgesics|analgesics|mesh-ancestor
84072893|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
84072894|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072895|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072896|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
84072897|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84072898|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84072899|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84072900|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84072901|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84072902|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84072903|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312896|NCT00242632|Memantine|memantine|mesh-list
83366608|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
84072904|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072906|NCT00779935|Infliximab|infliximab|mesh-list
83366679|NCT01997840|Dexamethasone|dexamethasone|mesh-list
84072907|NCT00779935|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84072908|NCT00779935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072909|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
84072910|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84072911|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072912|NCT00780013|Metformin|metformin|mesh-list
84072913|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84072914|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072915|NCT00667225|Cantharidin|cantharidin|mesh-list
84072916|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072917|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072918|NCT00780169|Sorafenib|sorafenib|mesh-list
84072919|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072920|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84072921|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072922|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072923|NCT00780325|Celecoxib|celecoxib|mesh-list
84072924|NCT00780325|Naproxen|naproxen|mesh-list
84072925|NCT00780325|Acetazolamide|acetazolamide|mesh-list
83366967|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
84072926|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84072927|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84072928|NCT00780325|Analgesics|analgesics|mesh-ancestor
84072929|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
84072930|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072931|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072932|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072933|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072934|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84072935|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84072936|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072937|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072938|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
84072939|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
84072940|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84072941|NCT00780325|Diuretics|diuretics|mesh-ancestor
84072942|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
84072943|NCT02556229|Aflibercept|aflibercept|mesh-list
84072944|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84072945|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84072946|NCT02556229|Growth Substances|growth substances|mesh-ancestor
84072947|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072948|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
84072949|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072950|NCT00929864|Adalimumab|adalimumab|mesh-list
84072951|NCT00929864|Abatacept|abatacept|mesh-list
84072952|NCT00929864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84072953|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84072954|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072955|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84072956|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072957|NCT00929864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072958|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072959|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84072960|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
83367388|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
84072961|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072962|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
84072963|NCT00597753|Hematinics|hematinics|mesh-ancestor
83367632|NCT01792557|Phenol|phenol|mesh-list
84072964|NCT04262804|Gemcitabine|gemcitabine|mesh-list
84072965|NCT04262804|Capecitabine|capecitabine|mesh-list
84072966|NCT04262804|Trastuzumab|trastuzumab|mesh-list
84072967|NCT04262804|Vinorelbine|vinorelbine|mesh-list
84072968|NCT04262804|Margetuximab|margetuximab|mesh-list
84072969|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84072970|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
84072971|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072972|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84072973|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84072974|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84072975|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83368052|NCT02349204|Zaleplon|zaleplon|mesh-list
83368127|NCT01569295|Rituximab|rituximab|mesh-list
84072976|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
84072977|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
84072978|NCT00665431|Celecoxib|celecoxib|mesh-list
84072979|NCT00665431|Antacids|antacids|mesh-list
84072980|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84072981|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84072983|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
84072984|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84072985|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84072986|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368351|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83368425|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
84072987|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84072988|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84072989|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84072990|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84072991|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84072992|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368640|NCT02330640|Ticagrelor|ticagrelor|mesh-list
84072993|NCT02633709|Itraconazole|itraconazole|mesh-list
84072994|NCT02633709|Risdiplam|risdiplam|mesh-list
84072995|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
84072996|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84072997|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84072998|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84072999|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368854|NCT03111420|Clopidogrel|clopidogrel|mesh-list
83368928|NCT03143946|Vitamins|vitamins|mesh-list
84073000|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073001|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84073002|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
84073003|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073004|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369168|NCT01794273|Ephedrine|ephedrine|mesh-list
83369229|NCT01794507|Bortezomib|bortezomib|mesh-list
84073005|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84073006|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84073007|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073008|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
84073009|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
84073010|NCT04264988|Protective Agents|protective agents|mesh-ancestor
84073011|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073012|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84073013|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
83369589|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
83369665|NCT01544491|Everolimus|everolimus|mesh-list
84073014|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84073015|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83369890|NCT01473953|Incretins|incretins|mesh-ancestor
84073016|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073017|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073018|NCT00657033|Urological Agents|urological agents|mesh-ancestor
84073019|NCT02633007|Levodopa|levodopa|mesh-list
84073020|NCT02633007|Carbidopa|carbidopa|mesh-list
84073021|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84073022|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84073023|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
84073024|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073025|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073026|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073027|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83370410|NCT01588184|Bevacizumab|bevacizumab|mesh-list
84073028|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073029|NCT01000727|Darapladib|darapladib|mesh-list
84073030|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
84073031|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073032|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073033|NCT00881205|Rivastigmine|rivastigmine|mesh-list
84073034|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84073035|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073036|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073037|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
84073038|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073039|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073040|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84073041|NCT00881205|Protective Agents|protective agents|mesh-ancestor
84073042|NCT00879879|Losartan|losartan|mesh-list
84073043|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84073044|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84073045|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84073046|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84073047|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073048|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
84073049|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
84073050|NCT00661999|Hematinics|hematinics|mesh-ancestor
84073051|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84073052|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073053|NCT04156815|Isotretinoin|isotretinoin|mesh-list
84073054|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
84073055|NCT04156425|Golimumab|golimumab|mesh-list
84073056|NCT04156425|Dexetimide|dexetimide|mesh-list
84073057|NCT04156425|Citalopram|citalopram|mesh-list
84073058|NCT04156425|Calcium|calcium|mesh-list
84073059|NCT04156425|Escitalopram|escitalopram|mesh-list
84073060|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84073061|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073062|NCT04156425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84073063|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84073064|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84073065|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073066|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073067|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
84073068|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84073069|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84073070|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
84073071|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
84073072|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073073|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84073074|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84073075|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
84073076|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84073077|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
84073078|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073079|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84073080|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073081|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84073082|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
84073083|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
84073084|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84073085|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073086|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84073087|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84073088|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073089|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073090|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073091|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84073092|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84073093|NCT00790075|Risperidone|risperidone|mesh-list
84073094|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84073095|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
84073096|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073097|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073098|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073099|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84073100|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073101|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073102|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073103|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84073104|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
84073105|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
84073106|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84073107|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073108|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84073109|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
84073110|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073111|NCT00780637|Bradykinin|bradykinin|mesh-list
84073112|NCT00780637|Kininogens|kininogens|mesh-list
84073113|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
84073114|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
84073115|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
84073116|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073117|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073118|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
84073119|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
84073120|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073121|NCT00790153|Insulin|insulin|mesh-list
84073122|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84073123|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073124|NCT02631603|Prednisolone|prednisolone|mesh-list
84073125|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073126|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
84073128|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073129|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073130|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84073131|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073132|NCT00790387|Heparin|heparin|mesh-list
84073133|NCT00790387|Enoxaparin|enoxaparin|mesh-list
84073134|NCT00790387|Calcium heparin|calcium heparin|mesh-list
84073135|NCT00790387|Tirofiban|tirofiban|mesh-list
84073136|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
84073137|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84073138|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84073139|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073140|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84073141|NCT04156035|Lamotrigine|lamotrigine|mesh-list
84073142|NCT04156035|Ketamine|ketamine|mesh-list
84073143|NCT04156035|Analgesics|analgesics|mesh-ancestor
84073144|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
84073145|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073146|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073147|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84073148|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84073149|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
84073150|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
84073151|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073152|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84073153|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84073154|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073155|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073156|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
84073157|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84073158|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84073159|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84073160|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84073161|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073162|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073163|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84073164|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
84073165|NCT00662337|Promethazine|promethazine|mesh-list
84073166|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84073167|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84073168|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073169|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073170|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
84073171|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
84073172|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
84073173|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073174|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
84073175|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
84073176|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84073177|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84073178|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
84073179|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
84073180|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073181|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073182|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84073183|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
84073184|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
84073185|NCT00665353|Pioglitazone|pioglitazone|mesh-list
84073186|NCT00665353|Ribavirin|ribavirin|mesh-list
84073187|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
84073188|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073189|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
84073190|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073191|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84073192|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073193|NCT00785395|Oxytocin|oxytocin|mesh-list
84073194|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
84073195|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84073196|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073197|NCT00662571|Acamprosate|acamprosate|mesh-list
84073198|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84073199|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
84073200|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073201|NCT00661635|Valdecoxib|valdecoxib|mesh-list
84073202|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84073204|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073205|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073206|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84073207|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84073208|NCT00661635|Analgesics|analgesics|mesh-ancestor
84073209|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
84073210|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073211|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073212|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073213|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073214|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84073215|NCT02555761|Alcaftadine|alcaftadine|mesh-list
84073216|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84073217|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84073218|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
84073219|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
84073220|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073221|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073222|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073223|NCT04155879|Colchicine|colchicine|mesh-list
84073224|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
84073225|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073226|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
84073227|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
84073228|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
84073229|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073230|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073231|NCT00662805|Fluticasone|fluticasone|mesh-list
84073232|NCT00662805|Xhance|xhance|mesh-list
84073233|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84073234|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073235|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84073236|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
84073237|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073238|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073239|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84073240|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
84073241|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
84073242|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84073243|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84073244|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84073245|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84073246|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
84073247|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073248|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073249|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
84073250|NCT00662883|Ketamine|ketamine|mesh-list
84073251|NCT00662883|Analgesics|analgesics|mesh-ancestor
84073252|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
84073253|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073254|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073255|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84073256|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84073257|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
84073258|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
84073259|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073260|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84073261|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84073262|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073263|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073264|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073265|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
84073266|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84073267|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
84073268|NCT00785473|Vitamin D|vitamin d|mesh-list
84073269|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
84073270|NCT00785473|Calcium|calcium|mesh-list
84073271|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84073272|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073273|NCT00785473|Vitamins|vitamins|mesh-ancestor
84073274|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
84073275|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84073276|NCT00785473|Antacids|antacids|mesh-ancestor
83313288|NCT00300430|Calcium|calcium|mesh-list
84073277|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073278|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84073279|NCT00785551|Quinine|quinine|mesh-list
84073280|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
84073281|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84073282|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84073283|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073284|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84073285|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073286|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84073287|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073288|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84073289|NCT00785551|Analgesics|analgesics|mesh-ancestor
84073290|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
84073291|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84073292|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84073293|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073294|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073295|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073296|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073297|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84073298|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84073299|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
84073300|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073301|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073302|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84073303|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84073304|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
84073305|NCT00663195|Furosemide|furosemide|mesh-list
84073306|NCT00663195|Spironolactone|spironolactone|mesh-list
84073307|NCT00663195|Diuretics|diuretics|mesh-ancestor
84073308|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
84073309|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073310|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84073311|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84073312|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073313|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84073314|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
84073315|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073316|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84073317|NCT00791011|Bortezomib|bortezomib|mesh-list
84073318|NCT00791011|Vorinostat|vorinostat|mesh-list
84073319|NCT00791011|Conatumumab|conatumumab|mesh-list
84073320|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073321|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84073322|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073323|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073324|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84073325|NCT00781105|Telbivudine|telbivudine|mesh-list
84073326|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
84073327|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073328|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84073329|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073330|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073331|NCT00785863|Ketorolac|ketorolac|mesh-list
84073332|NCT00785863|Parecoxib|parecoxib|mesh-list
84073333|NCT00785863|Remifentanil|remifentanil|mesh-list
84073334|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84073335|NCT00785863|Narcotics|narcotics|mesh-ancestor
84073336|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073337|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073338|NCT00785863|Analgesics|analgesics|mesh-ancestor
84073339|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
84073340|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073341|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84073342|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84073343|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073344|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073345|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84073346|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073347|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073348|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83313347|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073349|NCT00664105|Carboplatin|carboplatin|mesh-list
84073350|NCT00664105|Docetaxel|docetaxel|mesh-list
84073351|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073352|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
84073353|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
84073354|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
84073355|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073356|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84073357|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
84073358|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073359|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
84073360|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84073361|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073362|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073363|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84073364|NCT02555605|Analgesics|analgesics|mesh-ancestor
84073365|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
84073366|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073367|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84073368|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84073369|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84073370|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
84073371|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073372|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073373|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84073374|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84073375|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073376|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073377|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073378|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073379|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84073380|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84073381|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
84073382|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073383|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073384|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84073385|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84073386|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
84073387|NCT00663741|Sorafenib|sorafenib|mesh-list
84073388|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073389|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84073390|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073391|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073392|NCT00663897|Lansoprazole|lansoprazole|mesh-list
84073393|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
84073394|NCT00663897|Mosapride|mosapride|mesh-list
84073395|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84073396|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84073397|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84073398|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073399|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073400|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84073401|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
84073402|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073403|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073404|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84073405|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84073406|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
84073407|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073408|NCT04031859|Aspirin|aspirin|mesh-list
84073409|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84073410|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84073411|NCT04031859|Analgesics|analgesics|mesh-ancestor
84073412|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
84073413|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073414|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073415|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073416|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073417|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84073418|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84073419|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073420|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84073421|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84073422|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073423|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
84073424|NCT00664287|Niacin|niacin|mesh-list
84073425|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84073426|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
84073427|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073428|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84073429|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
84073430|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
84073431|NCT00664287|Vitamins|vitamins|mesh-ancestor
84073432|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
84073433|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073434|NCT00664599|Rituximab|rituximab|mesh-list
84073435|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84073436|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073437|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
84073438|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073439|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073440|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
84073441|NCT02631135|Remifentanil|remifentanil|mesh-list
84073442|NCT02631135|Propofol|propofol|mesh-list
84073443|NCT02631135|Rocuronium|rocuronium|mesh-list
84073444|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84073445|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073446|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073447|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84073448|NCT02631135|Analgesics|analgesics|mesh-ancestor
84073449|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
84073450|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073451|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84073452|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84073453|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84073454|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
84073455|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073456|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073457|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84073458|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
84073459|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
84073460|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84073461|NCT02631135|Narcotics|narcotics|mesh-ancestor
84073462|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84073463|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84073464|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84073465|NCT00664677|Masoprocol|masoprocol|mesh-list
84073466|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
84073467|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073468|NCT00664677|Protective Agents|protective agents|mesh-ancestor
84073469|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073470|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84073471|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073472|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84073473|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84073474|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84073475|NCT00664677|Analgesics|analgesics|mesh-ancestor
84073476|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
84073477|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073478|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073479|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073480|NCT00596817|Vortioxetine|vortioxetine|mesh-list
84073481|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
84073482|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073483|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84073484|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073485|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073486|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073487|NCT00596817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84073488|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84073489|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84073490|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073491|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073492|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
84073493|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84073494|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84073495|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84073496|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84073497|NCT01000649|Vasopressins|vasopressins|mesh-list
83313499|NCT05266690|Dextrans|dextrans|mesh-list
84073498|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
84073499|NCT01000649|Coagulants|coagulants|mesh-ancestor
84073500|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84073501|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84073502|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
84073503|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073504|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84073505|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
84073506|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84073507|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84073508|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073509|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073510|NCT00664833|Urological Agents|urological agents|mesh-ancestor
84073511|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
84073512|NCT00666835|Hematinics|hematinics|mesh-ancestor
84073513|NCT00879411|Telmisartan|telmisartan|mesh-list
84073514|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84073515|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84073516|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84073517|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073518|NCT00671151|Theophylline|theophylline|mesh-list
84073519|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84073520|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
84073521|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073522|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073523|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84073524|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
84073525|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84073526|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073527|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073528|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
84073529|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84073530|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84073531|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
84073532|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073533|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84073534|NCT00666757|Sertraline|sertraline|mesh-list
84073535|NCT00666757|Fluoxetine|fluoxetine|mesh-list
84073536|NCT00666757|Paroxetine|paroxetine|mesh-list
84073537|NCT00666757|Citalopram|citalopram|mesh-list
84073538|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84073539|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84073540|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84073541|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073542|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073543|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073544|NCT00666757|Analgesics|analgesics|mesh-ancestor
84073545|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
84073546|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073547|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
84073548|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073549|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
84073550|NCT00666757|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84073551|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
84073552|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84073553|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84073554|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84073555|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073556|NCT01000337|Propofol|propofol|mesh-list
84073557|NCT01000337|Sevoflurane|sevoflurane|mesh-list
84073558|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84073559|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073560|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073561|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84073562|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
84073563|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
84073564|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84073565|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84073566|NCT02869763|Ethanol|ethanol|mesh-list
84073567|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84073568|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073569|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073570|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313575|NCT01755416|Hormones|hormones|mesh-ancestor
84073571|NCT04153383|Milrinone|milrinone|mesh-list
84073572|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84073573|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84073574|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
84073575|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84073576|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84073577|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073578|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073579|NCT04153383|Protective Agents|protective agents|mesh-ancestor
84073580|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073581|NCT00671697|Decitabine|decitabine|mesh-list
84073582|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
84073583|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84073584|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
84073585|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073586|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073587|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073588|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
84073589|NCT00666679|Montelukast|montelukast|mesh-list
84073590|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84073591|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
84073592|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84073593|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
84073594|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073595|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073596|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84073597|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84073598|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073599|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073600|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
84073601|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84073602|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84073603|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84073604|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073605|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073606|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073607|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073608|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84073609|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84073610|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
84073611|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073612|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073613|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84073614|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84073615|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
84073616|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84073617|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
84073618|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84073619|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84073620|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073621|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073622|NCT00786253|Urological Agents|urological agents|mesh-ancestor
84073623|NCT00595413|Adalimumab|adalimumab|mesh-list
84073624|NCT00595413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84073625|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073626|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073627|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
84073628|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84073629|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073630|NCT00786331|Carboplatin|carboplatin|mesh-list
84073631|NCT00786331|Pemetrexed|pemetrexed|mesh-list
84073632|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073633|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073634|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073635|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84073636|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84073637|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84073638|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84073639|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073640|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073641|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073642|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073643|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84073644|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84073645|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
84073646|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073647|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073648|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84073649|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84073650|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
84073651|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
84073652|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84073653|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84073654|NCT00595335|Prednisolone|prednisolone|mesh-list
84073655|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
84073656|NCT00595335|Rituximab|rituximab|mesh-list
84073657|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84073658|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
84073659|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84073660|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073661|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
84073662|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073663|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84073664|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073665|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
84073666|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
84073667|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073668|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84073669|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
84073670|NCT00595335|Hormones|hormones|mesh-ancestor
84073671|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073672|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84073673|NCT00595335|Protective Agents|protective agents|mesh-ancestor
84073674|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84073675|NCT00781417|Vitamin D|vitamin d|mesh-list
84073676|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
84073677|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
84073678|NCT00781417|Vitamins|vitamins|mesh-list
84073679|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
84073680|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073681|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84073682|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84073683|NCT00672165|Antibodies|antibodies|mesh-list
84073684|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84073685|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
84073686|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073687|NCT04293809|Bupivacaine|bupivacaine|mesh-list
84073688|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
84073689|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
84073690|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073691|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073692|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
84073693|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073694|NCT00672399|Exenatide|exenatide|mesh-list
84073695|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
84073696|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84073697|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073698|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84073699|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84073700|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073701|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073702|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073703|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073704|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84073705|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84073706|NCT00672399|Incretins|incretins|mesh-ancestor
84073707|NCT00672399|Hormones|hormones|mesh-ancestor
84073708|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073709|NCT00661531|Anastrozole|anastrozole|mesh-list
84073710|NCT00661531|Estradiol|estradiol|mesh-list
84073711|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84073712|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073713|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84073714|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84073715|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073716|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073717|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84073718|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
84073719|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073720|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073721|NCT00661531|Estrogens|estrogens|mesh-ancestor
84073722|NCT00661531|Hormones|hormones|mesh-ancestor
84073723|NCT00998309|Azithromycin|azithromycin|mesh-list
84073724|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84073725|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073726|NCT02629575|Sirolimus|sirolimus|mesh-list
84073727|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84073728|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073729|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84073730|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073731|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
84073732|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84073733|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
84073734|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073735|NCT00781573|Clopidogrel|clopidogrel|mesh-list
84073736|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84073737|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84073738|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84073739|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84073740|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
84073741|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073742|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073743|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073744|NCT00671541|Gentamicins|gentamicins|mesh-list
84073745|NCT00671541|Bacitracin|bacitracin|mesh-list
84073746|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84073747|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073748|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84073749|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073750|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073751|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84073752|NCT04152681|Apatinib|apatinib|mesh-list
84073753|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073754|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84073755|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073756|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073757|NCT00999713|Calfactant|calfactant|mesh-list
84073758|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
84073759|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
84073760|NCT00672867|Adefovir|adefovir|mesh-list
84073761|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84073762|NCT00672867|Clevudine|clevudine|mesh-list
84073763|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
84073764|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073765|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84073766|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84073767|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073768|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073769|NCT00997373|Letrozole|letrozole|mesh-list
84073770|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073771|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84073772|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84073773|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073774|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073775|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84073776|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
84073777|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073778|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073779|NCT04152759|Golimumab|golimumab|mesh-list
84073780|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84073781|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073782|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84073783|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
84073784|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073785|NCT00792025|Sunitinib|sunitinib|mesh-list
84073786|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073787|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84073788|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84073789|NCT00792025|Growth Substances|growth substances|mesh-ancestor
84073790|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073791|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
84073792|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84073793|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313795|NCT01521117|Donepezil|donepezil|mesh-list
84073794|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073795|NCT02870231|Liraglutide|liraglutide|mesh-list
84073796|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84073797|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073798|NCT02870231|Incretins|incretins|mesh-ancestor
84073799|NCT02870231|Hormones|hormones|mesh-ancestor
84073800|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073801|NCT00782041|Leucovorin|leucovorin|mesh-list
84073802|NCT00782041|Folic Acid|folic acid|mesh-list
84073803|NCT00782041|Fluorouracil|fluorouracil|mesh-list
84073804|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
84073805|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
84073806|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
84073807|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073808|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84073809|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073810|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84073811|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
84073812|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073813|NCT00782041|Antidotes|antidotes|mesh-ancestor
84073814|NCT00782041|Protective Agents|protective agents|mesh-ancestor
84073815|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
84073816|NCT00782041|Vitamins|vitamins|mesh-ancestor
84073817|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
84073818|NCT00782041|Hematinics|hematinics|mesh-ancestor
84073819|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84073820|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073821|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84073822|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073823|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073824|NCT00792181|Midazolam|midazolam|mesh-list
84073825|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84073826|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84073827|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073828|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073829|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84073830|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84073831|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073832|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84073833|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
84073834|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
84073835|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
84073836|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
84073837|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073838|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073839|NCT00792337|Simvastatin|simvastatin|mesh-list
84073840|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84073841|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84073842|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
84073843|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073844|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84073845|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84073846|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073847|NCT00787111|Fluoxetine|fluoxetine|mesh-list
84073848|NCT00787111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84073849|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84073850|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84073851|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073852|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073853|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
84073854|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073855|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84073856|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
84073857|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073858|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84073859|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84073860|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073861|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
84073862|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84073863|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
84073864|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073865|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
84073866|NCT00782197|Protective Agents|protective agents|mesh-ancestor
84073867|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83313869|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84073868|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84073869|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84073870|NCT00996593|Iodine|iodine|mesh-list
84073871|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
84073872|NCT00996593|Antibodies|antibodies|mesh-list
84073873|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
84073874|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
84073875|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073876|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84073877|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073878|NCT00996593|Trace Elements|trace elements|mesh-ancestor
84073879|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
84073880|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073881|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
84073882|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84073883|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073884|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073885|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
84073886|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073887|NCT00787501|Fluoxetine|fluoxetine|mesh-list
84073888|NCT00787501|Sertraline|sertraline|mesh-list
84073889|NCT00787501|Escitalopram|escitalopram|mesh-list
84073890|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84073891|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84073892|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84073893|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073894|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073895|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
84073896|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073897|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84073898|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
84073899|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84073900|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84073901|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84073902|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073903|NCT00787657|Interferons|interferons|mesh-list
84073904|NCT00787657|Interferon-beta|interferon-beta|mesh-list
84073905|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
84073906|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073907|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
84073908|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073909|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
84073910|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073911|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84073912|NCT04264676|Metronidazole|metronidazole|mesh-list
84073913|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073914|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84073915|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84073916|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84073917|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
84073918|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
84073919|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
84073920|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84073921|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073922|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
84073923|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073924|NCT00637637|Ritonavir|ritonavir|mesh-list
84073925|NCT00637637|Indinavir|indinavir|mesh-list
84073926|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84073927|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84073928|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
84073929|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84073930|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073931|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84073932|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84073933|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
84073934|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073935|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84073936|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84073937|NCT00927758|Fluticasone|fluticasone|mesh-list
84073938|NCT00927758|Xhance|xhance|mesh-list
84073939|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84073940|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84073941|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84073942|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84073943|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
83313945|NCT04567407|Ropivacaine|ropivacaine|mesh-list
84073944|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84073945|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073946|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84073947|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
84073948|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
84073949|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84073950|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84073951|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84073952|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84073953|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
84073954|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84073955|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073956|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
84073957|NCT00927758|Hormones|hormones|mesh-ancestor
84073958|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073959|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
84073960|NCT00783523|Doxycycline|doxycycline|mesh-list
84073961|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84073962|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073963|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
84073964|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84073965|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84073966|NCT00783601|Montelukast|montelukast|mesh-list
84073967|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84073968|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
84073969|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84073970|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
84073971|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84073972|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073973|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84073974|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84073975|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073976|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
84073977|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84073978|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
84073979|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84073980|NCT00787813|Expectorants|expectorants|mesh-ancestor
84073981|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
84073982|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84073983|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
84073984|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073985|NCT00787813|Protective Agents|protective agents|mesh-ancestor
84073986|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84073987|NCT00787813|Antidotes|antidotes|mesh-ancestor
84073988|NCT04261634|Mitogens|mitogens|mesh-list
84073989|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
84073990|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84073991|NCT00787969|Sirolimus|sirolimus|mesh-list
84073992|NCT00787969|Rituximab|rituximab|mesh-list
84073993|NCT00787969|Temsirolimus|temsirolimus|mesh-list
84073994|NCT00787969|Cladribine|cladribine|mesh-list
84073995|NCT00787969|MTOR Inhibitors|mtor inhibitors|mesh-list
84073996|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84073997|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84073998|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
84073999|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074000|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84074001|NCT00787969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84074002|NCT00787969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074003|NCT00787969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074004|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84074005|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84074006|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074007|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84074008|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
84074009|NCT00609596|Dutasteride|dutasteride|mesh-list
84074010|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84074011|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84074012|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074013|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074014|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
84074015|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074016|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314028|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
84074017|NCT00608816|Epinephrine|epinephrine|mesh-list
84074018|NCT00608816|Racepinephrine|racepinephrine|mesh-list
84074019|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
84074020|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84074021|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84074022|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
84074023|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074024|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074025|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074026|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84074027|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074028|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
84074029|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074030|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074031|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074032|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
84074033|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
84074034|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84074035|NCT02535273|Lidocaine|lidocaine|mesh-list
84074036|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
84074037|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
84074038|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
84074039|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074040|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074041|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
84074042|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074043|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84074044|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84074045|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84074046|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84074047|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074048|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84074049|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84074050|NCT02535273|Analgesics|analgesics|mesh-ancestor
84074051|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84074052|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84074053|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84074054|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
84074055|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074056|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
84074057|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
84074058|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074059|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84074060|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84074061|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074062|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074063|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074064|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
84074065|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84074066|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
84074067|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074068|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
84074069|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074070|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074071|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074072|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074073|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84074074|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
84074075|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074076|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074077|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84074078|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
84074079|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
84074080|NCT04259684|Protective Agents|protective agents|mesh-ancestor
84074081|NCT00788515|Lormetazepam|lormetazepam|mesh-list
84074082|NCT00788515|Volinanserin|volinanserin|mesh-list
84074083|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84074084|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074085|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074086|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84074087|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
84074088|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074089|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074090|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
84074091|NCT04259606|Antacids|antacids|mesh-ancestor
84074092|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074093|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84074094|NCT00788749|Fluticasone|fluticasone|mesh-list
84074095|NCT00788749|Xhance|xhance|mesh-list
84074096|NCT00788749|Prednisolone|prednisolone|mesh-list
84074097|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84074098|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074099|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
84074100|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074101|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074102|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074103|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074104|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
84074105|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84074106|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
84074107|NCT00788749|Hormones|hormones|mesh-ancestor
84074108|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074109|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84074110|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074111|NCT00609752|Prednisolone|prednisolone|mesh-list
84074112|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84074113|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
84074114|NCT00609752|Hormones|hormones|mesh-ancestor
84074115|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074116|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074117|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84074118|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074119|NCT00662857|Insulin|insulin|mesh-list
84074120|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84074121|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84074122|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074123|NCT00878553|Zaleplon|zaleplon|mesh-list
84074124|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
84074125|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84074126|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074127|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074128|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
84074129|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
84074130|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074131|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074132|NCT05220020|Lenvatinib|lenvatinib|mesh-list
84074133|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074134|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84074135|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074136|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074137|NCT00789061|Lansoprazole|lansoprazole|mesh-list
84074138|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84074139|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84074140|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84074141|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074142|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074143|NCT00996437|Ranibizumab|ranibizumab|mesh-list
84074144|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84074145|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84074146|NCT00996437|Growth Substances|growth substances|mesh-ancestor
84074147|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074148|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
84074149|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074150|NCT02628951|Paclitaxel|paclitaxel|mesh-list
84074151|NCT02628951|Ramucirumab|ramucirumab|mesh-list
84074152|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074153|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074154|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074155|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
84074156|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074157|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074158|NCT00662311|Paclitaxel|paclitaxel|mesh-list
84074159|NCT00662311|Vorinostat|vorinostat|mesh-list
84074160|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074161|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074162|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074163|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314171|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
84074164|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074165|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074166|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84074167|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074168|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
84074169|NCT00929708|AZD-3199|azd-3199|mesh-list
84074170|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074171|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
84074172|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074173|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074174|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074175|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074176|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84074177|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84074178|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84074179|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
84074180|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074181|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074182|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84074183|NCT00996281|Olmesartan|olmesartan|mesh-list
84074184|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84074185|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
84074186|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84074187|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074188|NCT00996281|Diuretics|diuretics|mesh-ancestor
84074189|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
84074190|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074191|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84074192|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84074193|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074194|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84074195|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84074196|NCT04046653|Sulforaphane|sulforaphane|mesh-list
84074197|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84074198|NCT04046653|Protective Agents|protective agents|mesh-ancestor
84074199|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074200|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074201|NCT04293887|Interferons|interferons|mesh-list
84074202|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074203|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
84074204|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074205|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84074206|NCT00675207|Dorzolamide|dorzolamide|mesh-list
84074207|NCT00675207|Brinzolamide|brinzolamide|mesh-list
84074208|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074209|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84074210|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84074211|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84074212|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
84074213|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074214|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074215|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074216|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84074217|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074218|NCT00795223|Morphine|morphine|mesh-list
84074219|NCT00795223|Bupivacaine|bupivacaine|mesh-list
84074220|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
84074221|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
84074222|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074223|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074224|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
84074225|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074226|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84074227|NCT00795223|Narcotics|narcotics|mesh-ancestor
84074228|NCT00795223|Analgesics|analgesics|mesh-ancestor
84074229|NCT00795301|Capecitabine|capecitabine|mesh-list
84074230|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
84074231|NCT00795301|Cetuximab|cetuximab|mesh-list
84074232|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84074233|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
84074234|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074235|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074236|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84074237|NCT00675285|Montelukast|montelukast|mesh-list
84074238|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074239|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074240|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84074241|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
84074242|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074243|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074244|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84074245|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84074246|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074247|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
84074248|NCT00789763|Gemcitabine|gemcitabine|mesh-list
84074249|NCT00789763|Sorafenib|sorafenib|mesh-list
84074250|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84074251|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
84074252|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074253|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074254|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84074255|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074256|NCT02554357|Bupivacaine|bupivacaine|mesh-list
84074257|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
84074258|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
84074259|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074260|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074261|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
84074262|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074263|NCT00877929|Amlodipine|amlodipine|mesh-list
84074264|NCT00877929|Telmisartan|telmisartan|mesh-list
84074265|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074266|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84074267|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84074268|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074269|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84074270|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074271|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
84074272|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84074273|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84074274|NCT00795457|Poly I-C|poly i-c|mesh-list
84074275|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84074276|NCT00795457|Vaccines|vaccines|mesh-list
84074277|NCT00795457|Poly ICLC|poly iclc|mesh-list
84074278|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
84074279|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074280|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
84074281|NCT00795457|Laxatives|laxatives|mesh-ancestor
84074282|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84074283|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
84074284|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074285|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84074286|NCT00793195|SMOFlipid|smoflipid|mesh-list
84074287|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84074288|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84074289|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84074290|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
84074291|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84074292|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074293|NCT04979780|Heparin|heparin|mesh-list
84074294|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84074295|NCT04979780|Tinzaparin|tinzaparin|mesh-list
84074296|NCT04979780|Dalteparin|dalteparin|mesh-list
84074297|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
84074298|NCT04979780|Anticoagulants|anticoagulants|mesh-list
84074299|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84074300|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84074301|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074302|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84074303|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
84074304|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84074305|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
84074306|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074307|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
84074308|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074309|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84074310|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074311|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074312|NCT00795613|Doxorubicin|doxorubicin|mesh-list
84074313|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84074314|NCT00795613|Vincristine|vincristine|mesh-list
84074315|NCT00795613|Procarbazine|procarbazine|mesh-list
84074316|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84074317|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074318|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84074319|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84074320|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074321|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074322|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074323|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074324|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
84074325|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074326|NCT00800761|Deferiprone|deferiprone|mesh-list
84074327|NCT00800761|Deferoxamine|deferoxamine|mesh-list
84074328|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84074329|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
84074330|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
84074331|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074332|NCT00800761|Siderophores|siderophores|mesh-ancestor
84074333|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
84074334|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84074335|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074336|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84074337|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
84074338|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84074339|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074340|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074341|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074342|NCT00800917|Sirolimus|sirolimus|mesh-list
84074343|NCT00800917|Bevacizumab|bevacizumab|mesh-list
84074344|NCT00800917|Temsirolimus|temsirolimus|mesh-list
84074345|NCT00800917|MTOR Inhibitors|mtor inhibitors|mesh-list
84074346|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84074347|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074348|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84074349|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84074350|NCT00800917|Growth Substances|growth substances|mesh-ancestor
84074351|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074352|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
84074353|NCT00800917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84074354|NCT00800917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074355|NCT00800917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074356|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84074357|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
84074358|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84074359|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074360|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84074361|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
84074362|NCT05003102|Fentanyl|fentanyl|mesh-list
84074363|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
84074364|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84074365|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074366|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074367|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84074368|NCT05003102|Analgesics|analgesics|mesh-ancestor
84074369|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
84074370|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074371|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84074372|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84074373|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84074374|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
84074375|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074376|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074377|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84074378|NCT05003102|Narcotics|narcotics|mesh-ancestor
84074379|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84074380|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84074381|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
84074382|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
84074383|NCT00676377|Neostigmine|neostigmine|mesh-list
84074384|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84074385|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074386|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074387|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
84074388|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074389|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074390|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84074391|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
84074392|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074393|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
84074394|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84074395|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074396|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84074397|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84074398|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074399|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074400|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074401|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84074402|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84074403|NCT00676845|Olmesartan|olmesartan|mesh-list
84074404|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84074405|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074406|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84074407|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84074408|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074409|NCT04152057|Paclitaxel|paclitaxel|mesh-list
84074410|NCT04152057|Trastuzumab|trastuzumab|mesh-list
84074411|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074412|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074413|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074414|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
84074415|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074416|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074417|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84074418|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
84074419|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
84074420|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84074421|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84074422|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84074423|NCT00610142|Analgesics|analgesics|mesh-ancestor
84074424|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
84074425|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074426|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074427|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84074428|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
84074429|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84074430|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
84074431|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84074432|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074433|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074434|NCT04151823|Vitamin D|vitamin d|mesh-list
84074435|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
84074436|NCT04151823|Vitamins|vitamins|mesh-ancestor
84074437|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
84074438|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074439|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84074440|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84074441|NCT05199038|Octreotide|octreotide|mesh-list
84074442|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84074443|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84074444|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074445|NCT00660907|Metformin|metformin|mesh-list
84074446|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
84074447|NCT00660907|Glipizide|glipizide|mesh-list
84074448|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84074449|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074450|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84074451|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074452|NCT04992572|Lidocaine|lidocaine|mesh-list
84074453|NCT04992572|Propofol|propofol|mesh-list
84074454|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
84074455|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
84074456|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074457|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074458|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
84074459|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074460|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84074461|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84074462|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84074463|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84074464|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074465|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84074466|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84074467|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
84074468|NCT05083052|Propolis|propolis|mesh-list
84074469|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074470|NCT04031703|Paclitaxel|paclitaxel|mesh-list
84074471|NCT04031703|Docetaxel|docetaxel|mesh-list
84074472|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
84074473|NCT04031703|Carboplatin|carboplatin|mesh-list
84074474|NCT04031703|Fluorouracil|fluorouracil|mesh-list
84074475|NCT04031703|Epirubicin|epirubicin|mesh-list
84074476|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074477|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074478|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074479|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
84074480|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074481|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074482|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84074483|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
84074484|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074485|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84074486|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84074487|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
84074488|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84074489|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
84074490|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84074491|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84074492|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84074493|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84074494|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074495|NCT00795847|Losartan|losartan|mesh-list
84074496|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84074497|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84074498|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074499|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84074500|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84074501|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074502|NCT00795847|Diuretics|diuretics|mesh-ancestor
84074503|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
84074504|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074505|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84074506|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84074507|NCT00877773|Sirolimus|sirolimus|mesh-list
84074508|NCT00877773|Temsirolimus|temsirolimus|mesh-list
84074509|NCT00877773|MTOR Inhibitors|mtor inhibitors|mesh-list
84074510|NCT00877773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84074511|NCT00877773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074512|NCT00877773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074513|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84074514|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
84074515|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074516|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074517|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84074518|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074519|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84074520|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
84074521|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84074522|NCT00994643|Aldesleukin|aldesleukin|mesh-list
84074523|NCT00994643|Rituximab|rituximab|mesh-list
84074524|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84074525|NCT00994643|Interleukin-2|interleukin-2|mesh-list
84074526|NCT00994643|Antibodies|antibodies|mesh-list
84074527|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
84074528|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84074529|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
84074530|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074531|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074532|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84074533|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84074534|NCT00994643|Analgesics|analgesics|mesh-ancestor
84074535|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
84074536|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074537|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84074538|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84074539|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
84074540|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074541|NCT00912171|Budesonide|budesonide|mesh-list
84074542|NCT00912171|Montelukast|montelukast|mesh-list
84074543|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84074544|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074545|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
84074546|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074547|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074548|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074549|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074550|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
84074551|NCT00912171|Hormones|hormones|mesh-ancestor
84074552|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074553|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84074554|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
84074555|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84074556|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84074557|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074558|NCT00677391|Sibutramine|sibutramine|mesh-list
84074559|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
84074560|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84074561|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
84074562|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84074563|NCT00629057|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84074564|NCT00629057|Antiviral Agents|antiviral agents|mesh-ancestor
84074565|NCT00629057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074566|NCT00660829|Azelastine|azelastine|mesh-list
84074567|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074568|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
84074569|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074570|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074571|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074572|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074573|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84074574|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074575|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074576|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84074577|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84074578|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84074579|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
84074580|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
84074581|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074582|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
84074583|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84074584|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84074585|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
84074586|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074587|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84074588|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
84074589|NCT00629135|Metronidazole|metronidazole|mesh-list
84074590|NCT00629135|Tazobactam|tazobactam|mesh-list
84074591|NCT00629135|Piperacillin|piperacillin|mesh-list
84074592|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84074593|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84074594|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074595|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84074596|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84074597|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074598|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074599|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074600|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84074601|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84074602|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84074603|NCT00795925|Propiverine|propiverine|mesh-list
84074604|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
84074605|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
84074606|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074607|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074608|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84074609|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84074610|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
84074611|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074612|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074613|NCT00795925|Urological Agents|urological agents|mesh-ancestor
84074614|NCT04293419|Durvalumab|durvalumab|mesh-list
84074615|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84074616|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074617|NCT00793429|Prucalopride|prucalopride|mesh-list
84074618|NCT00793429|Laxatives|laxatives|mesh-ancestor
84074619|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84074620|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
84074621|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84074622|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
84074623|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074624|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074625|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074626|NCT00801151|Vinorelbine|vinorelbine|mesh-list
84074627|NCT00801151|Vorinostat|vorinostat|mesh-list
84074628|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074629|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074630|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074631|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
84074632|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074633|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074634|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84074635|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074636|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84074637|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84074638|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84074639|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074640|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074641|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84074642|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84074643|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84074644|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
84074645|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074646|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074647|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84074648|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84074649|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
84074650|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
84074651|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074652|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
84074653|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074654|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074655|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074656|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074657|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
84074658|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84074659|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
84074660|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074661|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074662|NCT00796159|Olmesartan|olmesartan|mesh-list
84074663|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84074664|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074665|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84074666|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84074667|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074668|NCT00993473|Insulin|insulin|mesh-list
84074669|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84074670|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
84074671|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
84074672|NCT00993473|Protamines|protamines|mesh-list
84074673|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84074674|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074675|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
84074676|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074677|NCT00993473|Coagulants|coagulants|mesh-ancestor
84074678|NCT00660595|Risperidone|risperidone|mesh-list
84074679|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84074680|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84074681|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
84074682|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074683|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074684|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074685|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84074686|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84074687|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074688|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84074689|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84074690|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
84074691|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
83314694|NCT00424840|Growth Substances|growth substances|mesh-ancestor
84074692|NCT00929240|Bevacizumab|bevacizumab|mesh-list
84074693|NCT00929240|Capecitabine|capecitabine|mesh-list
84074694|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84074695|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074696|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84074697|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84074698|NCT00929240|Growth Substances|growth substances|mesh-ancestor
84074699|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074700|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
84074701|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84074702|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
84074703|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074704|NCT00793663|Dexamethasone|dexamethasone|mesh-list
84074705|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
84074706|NCT00793663|Ondansetron|ondansetron|mesh-list
84074707|NCT00793663|Sevoflurane|sevoflurane|mesh-list
84074708|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84074709|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
84074710|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
84074711|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074712|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074713|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84074714|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
84074715|NCT00793663|Hormones|hormones|mesh-ancestor
84074716|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074717|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84074718|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074719|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84074720|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84074721|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
84074722|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
84074723|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074724|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
84074725|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
84074726|NCT00793663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84074727|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84074728|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
84074729|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074730|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074731|NCT04932980|Aflibercept|aflibercept|mesh-list
84074732|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84074733|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84074734|NCT04932980|Growth Substances|growth substances|mesh-ancestor
84074735|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074736|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
84074737|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074738|NCT02554045|Tadalafil|tadalafil|mesh-list
84074739|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
84074740|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84074741|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84074742|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074743|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074744|NCT02554045|Urological Agents|urological agents|mesh-ancestor
84074745|NCT05330390|Levetiracetam|levetiracetam|mesh-list
84074746|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
84074747|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
84074748|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
84074749|NCT00993317|Methotrexate|methotrexate|mesh-list
84074750|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84074751|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
84074752|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84074753|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074754|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84074755|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
84074756|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074757|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074758|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
84074759|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074760|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84074761|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84074762|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
84074763|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84074764|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84074765|NCT00993317|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84074766|NCT00993317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84074767|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84074768|NCT00801385|Sorafenib|sorafenib|mesh-list
84074769|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074770|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84074771|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074772|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074773|NCT00677001|R 306465|r 306465|mesh-list
84074774|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84074775|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074776|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074777|NCT00877071|Doxorubicin|doxorubicin|mesh-list
84074778|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84074779|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074780|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84074781|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84074782|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074783|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074784|NCT02868827|Vitamin D|vitamin d|mesh-list
84074785|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
84074786|NCT02868827|Vitamins|vitamins|mesh-ancestor
84074787|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
84074788|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074789|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84074790|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84074791|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
84074792|NCT00987389|Hormones|hormones|mesh-ancestor
84074793|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074794|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074795|NCT00929162|Paclitaxel|paclitaxel|mesh-list
84074796|NCT00929162|Carboplatin|carboplatin|mesh-list
84074797|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074798|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074799|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074800|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
84074801|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074802|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074803|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
84074804|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84074805|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
84074806|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074807|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074808|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84074809|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
84074810|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
84074811|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84074812|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
84074813|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074814|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074815|NCT00678483|Rimonabant|rimonabant|mesh-list
84074816|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84074817|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
84074818|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84074819|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074820|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074821|NCT00678483|Hormones|hormones|mesh-ancestor
84074822|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074823|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074824|NCT00610454|Levetiracetam|levetiracetam|mesh-list
84074825|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
84074826|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
84074827|NCT04151355|Atorvastatin|atorvastatin|mesh-list
84074828|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84074829|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84074830|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
84074831|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074832|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84074833|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84074834|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074835|NCT00609284|Carboplatin|carboplatin|mesh-list
84074836|NCT00609284|Cetuximab|cetuximab|mesh-list
84074837|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074838|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84074839|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
84074840|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074841|NCT00930722|Quinapril|quinapril|mesh-list
84074842|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84074843|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
84074844|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074845|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074846|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074847|NCT00610610|Paroxetine|paroxetine|mesh-list
84074848|NCT00610610|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84074849|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84074850|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84074851|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074852|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074853|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
84074854|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074855|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84074856|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
84074857|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84074858|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84074859|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84074860|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074861|NCT00912327|Cetuximab|cetuximab|mesh-list
84074862|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84074863|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074864|NCT04257812|Tazobactam|tazobactam|mesh-list
84074865|NCT04257812|Ceftolozane|ceftolozane|mesh-list
84074866|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
84074867|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84074868|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074869|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84074870|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074871|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074872|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84074873|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
84074874|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84074875|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
84074876|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074877|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
84074878|NCT02868749|Protective Agents|protective agents|mesh-ancestor
84074879|NCT00659581|Telmisartan|telmisartan|mesh-list
84074880|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074881|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84074882|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84074883|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074884|NCT00793741|Somatostatin|somatostatin|mesh-list
84074885|NCT00793741|Hormones|hormones|mesh-ancestor
84074886|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84074887|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074888|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84074889|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84074890|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84074891|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84074892|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074893|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84074894|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84074895|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84074896|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
84074897|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074898|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074899|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84074900|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84074901|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
84074902|NCT00991289|Interferons|interferons|mesh-list
84074903|NCT00991289|Ribavirin|ribavirin|mesh-list
84074904|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
84074905|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
84074906|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84074907|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
84074908|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074909|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
84074910|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074911|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
84074912|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074913|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
84074914|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074915|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84074916|NCT04046029|Heparin|heparin|mesh-list
84074917|NCT04046029|Bivalirudin|bivalirudin|mesh-list
84074918|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
84074919|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84074920|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84074921|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074922|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
84074923|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84074924|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
84074925|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074926|NCT00679653|Sibutramine|sibutramine|mesh-list
84074927|NCT00679653|Metoprolol|metoprolol|mesh-list
84074928|NCT00679653|Verapamil|verapamil|mesh-list
84074929|NCT00679653|Felodipine|felodipine|mesh-list
84074930|NCT00679653|Ramipril|ramipril|mesh-list
84074931|NCT00679653|Trandolapril|trandolapril|mesh-list
84074932|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84074933|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84074934|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
84074935|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
84074936|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84074937|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074938|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84074939|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84074940|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84074941|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
84074942|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84074943|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074944|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84074945|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
84074946|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84074947|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84074948|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84074949|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84074950|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
84074951|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
84074952|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84074953|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
84074954|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84074955|NCT00793897|Paclitaxel|paclitaxel|mesh-list
84074956|NCT00793897|Carboplatin|carboplatin|mesh-list
84074957|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84074958|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074959|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
84074960|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
84074961|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
84074962|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074963|NCT00793975|Ramucirumab|ramucirumab|mesh-list
84074964|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84074965|NCT00679965|Tavaborole|tavaborole|mesh-list
84074966|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
84074967|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074968|NCT00930644|Teduglutide|teduglutide|mesh-list
84074969|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84074970|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84074971|NCT00930644|Protective Agents|protective agents|mesh-ancestor
84074972|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074973|NCT02627469|Listerine|listerine|mesh-list
84074974|NCT02627469|Fluorides|fluorides|mesh-list
84074975|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
84074976|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
84074977|NCT02627469|Protective Agents|protective agents|mesh-ancestor
84074978|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074979|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84074980|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84074981|NCT00680277|Carotenoids|carotenoids|mesh-list
84074982|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
84074983|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074984|NCT00680277|Protective Agents|protective agents|mesh-ancestor
84074985|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074986|NCT00680355|Carotenoids|carotenoids|mesh-list
84074987|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
84074988|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84074989|NCT00680355|Protective Agents|protective agents|mesh-ancestor
84074990|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074991|NCT00801697|Vaccines|vaccines|mesh-list
84074992|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
84074993|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84074994|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
84074995|NCT00684489|Coal Tar|coal tar|mesh-list
84074996|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
84074997|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
84074998|NCT00990821|Midazolam|midazolam|mesh-list
84074999|NCT00990821|Aprepitant|aprepitant|mesh-list
84075000|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
84075001|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84075002|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84075003|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075004|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075005|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84075006|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84075007|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84075008|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84075009|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
84075010|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
84075011|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
84075012|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
84075013|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075014|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075015|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
84075016|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
84075017|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075018|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075019|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84075020|NCT00801853|Interleukin-4|interleukin-4|mesh-list
84075021|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84075022|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
84075023|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075024|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075025|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370494|NCT00536601|Melphalan|melphalan|mesh-list
84075026|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84075027|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84075028|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
84075029|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84075030|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075031|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84075032|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84075033|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84075034|NCT00658567|Pimavanserin|pimavanserin|mesh-list
84075035|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84075036|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84075037|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84075038|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84075039|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075040|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075041|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84075042|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84075043|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84075044|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
84075045|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075046|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075047|NCT00875433|Afatinib|afatinib|mesh-list
84075048|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075049|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84075050|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075051|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075052|NCT00684957|Hormones|hormones|mesh-list
84075053|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075054|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075055|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
84075056|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84075057|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84075058|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
84075059|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075060|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84075061|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84075062|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075063|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075064|NCT00685269|Eszopiclone|eszopiclone|mesh-list
84075065|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84075066|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075067|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075068|NCT00794209|Fentanyl|fentanyl|mesh-list
84075069|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84075070|NCT00794209|Narcotics|narcotics|mesh-ancestor
84075071|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075072|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075073|NCT00794209|Analgesics|analgesics|mesh-ancestor
84075074|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
84075075|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075076|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84075077|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84075078|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
84075079|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
84075080|NCT00985985|Nicotine|nicotine|mesh-list
84075081|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84075082|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
84075083|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075084|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075085|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84075086|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84075087|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
84075088|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075089|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075090|NCT00685347|Albuterol|albuterol|mesh-list
84075091|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84075092|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
84075093|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075094|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075095|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84075096|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
84075097|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
84075098|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84075099|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84075100|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84075101|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84075102|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
84075103|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075104|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075105|NCT00685425|Albuterol|albuterol|mesh-list
84075106|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84075107|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
84075108|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075109|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075110|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84075111|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
84075112|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
84075113|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84075114|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84075115|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84075116|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84075117|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
84075118|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075119|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075120|NCT04290455|Castor Oil|castor oil|mesh-list
84075121|NCT04290455|Cathartics|cathartics|mesh-ancestor
84075122|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075123|NCT00685503|Ranibizumab|ranibizumab|mesh-list
84075124|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84075125|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84075126|NCT00685503|Growth Substances|growth substances|mesh-ancestor
84075127|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075128|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
84075129|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075130|NCT00802009|Dexamethasone|dexamethasone|mesh-list
84075131|NCT00802009|Mepivacaine|mepivacaine|mesh-list
84075132|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075133|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
84075134|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
84075135|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075136|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075137|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075138|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
84075139|NCT00802009|Hormones|hormones|mesh-ancestor
84075140|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075141|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84075142|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075143|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
84075145|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075146|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
84075147|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
84075148|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84075149|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
84075150|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075151|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
84075152|NCT02868437|Protective Agents|protective agents|mesh-ancestor
84075153|NCT00802087|Acetaminophen|acetaminophen|mesh-list
84075154|NCT00802087|Hydrocodone|hydrocodone|mesh-list
84075155|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84075156|NCT00802087|Analgesics|analgesics|mesh-ancestor
84075157|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
84075158|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075159|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075160|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
84075161|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84075162|NCT00802087|Narcotics|narcotics|mesh-ancestor
84075163|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075164|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
84075165|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
84075166|NCT00923936|Bevacizumab|bevacizumab|mesh-list
84075167|NCT00923936|Doxorubicin|doxorubicin|mesh-list
84075168|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84075169|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075170|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075171|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84075172|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84075173|NCT00923936|Growth Substances|growth substances|mesh-ancestor
84075174|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075175|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
84075176|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84075177|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84075178|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84075179|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075180|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075181|NCT00797017|Fentanyl|fentanyl|mesh-list
84075182|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84075183|NCT00797017|Narcotics|narcotics|mesh-ancestor
84075184|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075185|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075186|NCT00797017|Analgesics|analgesics|mesh-ancestor
84075187|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
84075188|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075189|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84075190|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84075191|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
84075192|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
84075193|NCT05330000|Voriconazole|voriconazole|mesh-list
84075194|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
84075195|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075196|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84075197|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84075198|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075199|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075200|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84075201|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
84075202|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075203|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075204|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84075205|NCT00794443|Diphosphonates|diphosphonates|mesh-list
84075206|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84075207|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075208|NCT00924950|Calcitriol|calcitriol|mesh-list
84075209|NCT00924950|Betamethasone|betamethasone|mesh-list
84075210|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075211|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
84075212|NCT00924950|Hormones|hormones|mesh-ancestor
84075213|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075214|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075215|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84075216|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
83315230|NCT00470392|Hormones|hormones|mesh-ancestor
84075217|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84075218|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84075219|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84075220|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075221|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84075223|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
84075224|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84075225|NCT02626065|Nivolumab|nivolumab|mesh-list
84075226|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075227|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075228|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84075229|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075230|NCT00794755|Vitamin K|vitamin k|mesh-list
84075231|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
84075232|NCT00794755|Vitamins|vitamins|mesh-ancestor
84075233|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
84075234|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075235|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84075236|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84075237|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075238|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
84075239|NCT00794755|Coagulants|coagulants|mesh-ancestor
84075240|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
84075241|NCT00685971|Vitamin D|vitamin d|mesh-list
84075242|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84075243|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075244|NCT00685971|Vitamins|vitamins|mesh-ancestor
84075245|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
83370499|NCT00536601|Etoposide|etoposide|mesh-list
84075246|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84075247|NCT00802243|Leflunomide|leflunomide|mesh-list
84075248|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075249|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075250|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075251|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
84075252|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075253|NCT00988637|Calcitriol|calcitriol|mesh-list
84075254|NCT00988637|Clobetasol|clobetasol|mesh-list
84075255|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84075256|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075257|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84075258|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84075259|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075260|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84075261|NCT00988637|Vitamins|vitamins|mesh-ancestor
84075262|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
84075263|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84075264|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075265|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
84075266|NCT00988637|Hormones|hormones|mesh-ancestor
84075267|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075268|NCT00802321|Dutasteride|dutasteride|mesh-list
84075269|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84075270|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84075271|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075272|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075273|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
84075274|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075275|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075276|NCT00686361|Choline|choline|mesh-list
84075277|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
84075278|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84075279|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
84075280|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075281|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075282|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84075283|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
84075284|NCT00686439|Adalimumab|adalimumab|mesh-list
84075285|NCT00686439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84075286|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075287|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84075288|NCT04161755|Atezolizumab|atezolizumab|mesh-list
84075289|NCT04161755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83315305|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075290|NCT04161755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075291|NCT04161755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075292|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075294|NCT00797485|Bevacizumab|bevacizumab|mesh-list
84075295|NCT00797485|Fluorouracil|fluorouracil|mesh-list
84075296|NCT00797485|Capecitabine|capecitabine|mesh-list
84075297|NCT00797485|Irinotecan|irinotecan|mesh-list
84075298|NCT00797485|Calcium|calcium|mesh-list
84075299|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
84075300|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075301|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075302|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84075303|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84075304|NCT00797485|Growth Substances|growth substances|mesh-ancestor
84075305|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075306|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
84075307|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84075308|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
84075309|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075310|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84075311|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075312|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
84075313|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84075314|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84075315|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075316|NCT00797485|Antidotes|antidotes|mesh-ancestor
84075317|NCT00797485|Protective Agents|protective agents|mesh-ancestor
84075318|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
84075319|NCT00797485|Vitamins|vitamins|mesh-ancestor
84075320|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
84075321|NCT00686985|Carboplatin|carboplatin|mesh-list
84075322|NCT00686985|Docetaxel|docetaxel|mesh-list
84075323|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075324|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
84075325|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
84075326|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
84075327|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075328|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
84075329|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84075330|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075331|NCT02866955|Tamoxifen|tamoxifen|mesh-list
84075332|NCT02866955|Estramustine|estramustine|mesh-list
84075333|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84075334|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
84075335|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075336|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075337|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84075338|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075339|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84075340|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84075341|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84075342|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84075343|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
84075344|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075345|NCT02625753|Acetaminophen|acetaminophen|mesh-list
84075346|NCT02625753|Codeine|codeine|mesh-list
84075347|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84075348|NCT02625753|Analgesics|analgesics|mesh-ancestor
84075349|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
84075350|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075351|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075352|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
84075353|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84075354|NCT02625753|Narcotics|narcotics|mesh-ancestor
84075355|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075356|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
84075357|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
84075358|NCT04257656|Remdesivir|remdesivir|mesh-list
84075359|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
84075360|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075361|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
84075362|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075363|NCT05329844|Vildagliptin|vildagliptin|mesh-list
84075364|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83315372|NCT00453388|Cyclosporine|cyclosporine|mesh-list
84075365|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075366|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84075367|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
84075368|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075369|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075370|NCT00687999|Interferons|interferons|mesh-list
84075371|NCT00687999|Ribavirin|ribavirin|mesh-list
84075372|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
84075373|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075374|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
84075375|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075376|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
84075377|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075378|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
84075379|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075380|NCT00688077|Calcitonin|calcitonin|mesh-list
84075381|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
84075382|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
84075383|NCT00688077|Katacalcin|katacalcin|mesh-list
84075384|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84075385|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075386|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84075387|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
84075388|NCT00923156|Ramipril|ramipril|mesh-list
84075389|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84075390|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
84075391|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075392|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075393|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84075394|NCT00688857|Diazoxide|diazoxide|mesh-list
84075395|NCT00688857|Choline|choline|mesh-list
84075396|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
84075397|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84075398|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
84075399|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075400|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075401|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84075402|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
84075403|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84075404|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
84075405|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
84075406|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84075407|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075408|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
84075409|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
84075410|NCT00687843|Tegafur|tegafur|mesh-list
84075411|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84075412|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
84075413|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075414|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075415|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84075416|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
84075417|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075418|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84075419|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
84075420|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075421|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
84075422|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84075423|NCT00687843|Protective Agents|protective agents|mesh-ancestor
84075424|NCT00689169|Cytarabine|cytarabine|mesh-list
84075425|NCT00689169|Rituximab|rituximab|mesh-list
84075426|NCT00689169|Etoposide|etoposide|mesh-list
84075427|NCT00689169|Melphalan|melphalan|mesh-list
84075428|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075429|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075430|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
84075431|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075432|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84075433|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84075434|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84075435|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84075436|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075437|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075438|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84075439|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
84075440|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84075441|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075442|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84075443|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
84075444|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
84075445|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075446|NCT04203914|Empagliflozin|empagliflozin|mesh-list
84075447|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84075448|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075449|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84075450|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075451|NCT00874731|Sirolimus|sirolimus|mesh-list
84075452|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84075453|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075454|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84075455|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075456|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
84075457|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075458|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
84075459|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075460|NCT02625519|Hormones|hormones|mesh-list
84075461|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84075462|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075463|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075464|NCT00912483|Heparin|heparin|mesh-list
84075465|NCT00912483|Calcium heparin|calcium heparin|mesh-list
84075466|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
84075467|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84075468|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84075469|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075470|NCT04257032|Dabigatran|dabigatran|mesh-list
84075471|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84075472|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84075473|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84075474|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
84075475|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075476|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84075477|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84075478|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075479|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
84075480|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84075481|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
84075482|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
84075483|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84075484|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84075485|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
84075486|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84075487|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
84075488|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
84075489|NCT00924560|Estradiol|estradiol|mesh-list
84075490|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84075491|NCT00924560|Estrogens|estrogens|mesh-ancestor
84075492|NCT00924560|Hormones|hormones|mesh-ancestor
84075493|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84075494|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075495|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84075496|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84075497|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84075498|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84075499|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84075500|NCT00689559|Aripiprazole|aripiprazole|mesh-list
84075501|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
84075502|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84075503|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84075504|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84075505|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075506|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075507|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
84075508|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
84075509|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075510|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075511|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84075512|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84075513|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
84075514|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84075516|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84075517|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84075518|NCT00689637|Warfarin|warfarin|mesh-list
84075519|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
84075520|NCT00689715|Ethanol|ethanol|mesh-list
84075521|NCT00689715|Paclitaxel|paclitaxel|mesh-list
84075522|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84075523|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84075524|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075525|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
84075526|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
84075527|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
84075528|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075529|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84075530|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075531|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075532|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075533|NCT00689949|Folic Acid|folic acid|mesh-list
84075534|NCT00689949|Hematinics|hematinics|mesh-ancestor
84075535|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
84075536|NCT00689949|Vitamins|vitamins|mesh-ancestor
84075537|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
84075538|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075539|NCT04256642|Morphine|morphine|mesh-list
84075540|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84075541|NCT04256642|Narcotics|narcotics|mesh-ancestor
84075542|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075543|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075544|NCT04256642|Analgesics|analgesics|mesh-ancestor
84075545|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
84075546|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075547|NCT00611000|Folic Acid|folic acid|mesh-list
84075548|NCT00611000|Hematinics|hematinics|mesh-ancestor
84075549|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
84075550|NCT00611000|Vitamins|vitamins|mesh-ancestor
84075551|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
84075552|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075553|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
84075554|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84075555|NCT00690105|Fluticasone|fluticasone|mesh-list
84075556|NCT00690105|Tacrolimus|tacrolimus|mesh-list
84075557|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075558|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
84075559|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075560|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84075561|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075562|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075563|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075564|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84075565|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
84075566|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075567|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84075568|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
84075569|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
84075570|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84075571|NCT00694317|Zaleplon|zaleplon|mesh-list
84075572|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
84075573|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84075574|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075575|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075576|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
84075577|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
84075578|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075579|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075580|NCT04136613|Copper|copper|mesh-list
84075581|NCT04136613|Trace Elements|trace elements|mesh-ancestor
84075582|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
84075583|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075584|NCT00978731|Dasatinib|dasatinib|mesh-list
84075585|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075586|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84075587|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075588|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075589|NCT04136535|Carboplatin|carboplatin|mesh-list
84075590|NCT04136535|Pemetrexed|pemetrexed|mesh-list
84075591|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075592|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075593|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075594|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84075595|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84075596|NCT00694629|Rifampin|rifampin|mesh-list
84075597|NCT00694629|Rifapentine|rifapentine|mesh-list
84075598|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84075599|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
84075600|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84075601|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075602|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
84075603|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84075604|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075605|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075606|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84075607|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84075608|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84075609|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84075610|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84075611|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84075612|NCT00912639|Paclitaxel|paclitaxel|mesh-list
84075613|NCT00912639|genexol-PM|genexol-pm|mesh-list
84075614|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84075615|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075616|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
84075617|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
84075618|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
84075619|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075620|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
84075621|NCT02866409|Bupivacaine|bupivacaine|mesh-list
84075622|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
84075623|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
84075624|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075625|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075626|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
84075627|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075628|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84075629|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84075630|NCT02866409|Analgesics|analgesics|mesh-ancestor
84075631|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84075632|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84075633|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84075634|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
84075635|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075636|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075637|NCT05833984|Tislelizumab|tislelizumab|mesh-list
84075638|NCT05833984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075639|NCT05833984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075640|NCT05833919|Capecitabine|capecitabine|mesh-list
84075641|NCT05833919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84075642|NCT05833919|Antimetabolites|antimetabolites|mesh-ancestor
84075643|NCT05833919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075644|NCT05833919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075645|NCT05833867|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84075646|NCT05833867|Immunoconjugates|immunoconjugates|mesh-ancestor
84075647|NCT05833867|Immunologic Factors|immunologic factors|mesh-ancestor
84075648|NCT05833867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075649|NCT05833815|Everolimus|everolimus|mesh-list
84075650|NCT05833815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84075651|NCT05833815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84075652|NCT05833815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075653|NCT05833815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075654|NCT05833815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075655|NCT05833815|Immunologic Factors|immunologic factors|mesh-ancestor
84075656|NCT05833815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075657|NCT05833815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075658|NCT05833802|Antineoplastic Agents|antineoplastic agents|mesh-list
84075659|NCT05833763|Obinutuzumab|obinutuzumab|mesh-list
84075660|NCT05833763|Pirtobrutinib|pirtobrutinib|mesh-list
84075661|NCT05833763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075662|NCT05833763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075663|NCT05833763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315670|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83315675|NCT01450761|Carboplatin|carboplatin|mesh-list
84075664|NCT05833763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075665|NCT05833763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075666|NCT05833477|Epoetin Alfa|epoetin alfa|mesh-list
84075667|NCT05833477|Hematinics|hematinics|mesh-ancestor
84075668|NCT05833399|Carbamazepine|carbamazepine|mesh-list
84075669|NCT05833399|Amitriptyline|amitriptyline|mesh-list
84075670|NCT05833399|Olanzapine|olanzapine|mesh-list
84075671|NCT05833399|Chlorpromazine|chlorpromazine|mesh-list
84075672|NCT05833399|Risperidone|risperidone|mesh-list
84075673|NCT05833399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84075674|NCT05833399|Mirtazapine|mirtazapine|mesh-list
84075675|NCT05833399|Sertraline|sertraline|mesh-list
84075676|NCT05833399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84075677|NCT05833399|Serotonin Agents|serotonin agents|mesh-ancestor
84075678|NCT05833399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075679|NCT05833399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075680|NCT05833399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075681|NCT05833399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84075682|NCT05833399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84075683|NCT05833399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075684|NCT05833399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84075685|NCT05833399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84075686|NCT05833399|Dopamine Agents|dopamine agents|mesh-ancestor
84075687|NCT05833399|Antiemetics|antiemetics|mesh-ancestor
84075688|NCT05833399|Autonomic Agents|autonomic agents|mesh-ancestor
84075689|NCT05833399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075690|NCT05833399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075691|NCT05833399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84075692|NCT05833399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84075693|NCT05833399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84075694|NCT05833399|Antidepressive Agents|antidepressive agents|mesh-ancestor
84075695|NCT05833399|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84075696|NCT05833399|Histamine Antagonists|histamine antagonists|mesh-ancestor
84075697|NCT05833399|Histamine Agents|histamine agents|mesh-ancestor
84075698|NCT05833399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84075699|NCT05833399|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84075700|NCT05833399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84075701|NCT05833399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84075702|NCT05833399|Adrenergic Agents|adrenergic agents|mesh-ancestor
84075703|NCT05833399|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84075704|NCT05833399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84075705|NCT05833399|Anticonvulsants|anticonvulsants|mesh-ancestor
84075706|NCT05833399|Antimanic Agents|antimanic agents|mesh-ancestor
84075707|NCT05833399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84075708|NCT05833399|Analgesics|analgesics|mesh-ancestor
84075709|NCT05833399|Sensory System Agents|sensory system agents|mesh-ancestor
84075710|NCT05833399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84075711|NCT05833399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84075712|NCT05833399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84075713|NCT05833399|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84075714|NCT05833399|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84075715|NCT05832996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84075716|NCT05832996|Lubricant Eye Drops|lubricant eye drops|mesh-list
84075717|NCT05832996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84075718|NCT05832827|Paclitaxel|paclitaxel|mesh-list
84075719|NCT05832827|Carboplatin|carboplatin|mesh-list
84075720|NCT05832827|Pembrolizumab|pembrolizumab|mesh-list
84075721|NCT05832827|Lenvatinib|lenvatinib|mesh-list
84075722|NCT05832827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84075723|NCT05832827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075724|NCT05832827|Tubulin Modulators|tubulin modulators|mesh-ancestor
84075725|NCT05832827|Antimitotic Agents|antimitotic agents|mesh-ancestor
84075726|NCT05832827|Mitosis Modulators|mitosis modulators|mesh-ancestor
84075727|NCT05832827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075728|NCT05832827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075729|NCT05832827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84075730|NCT05832827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84075731|NCT05832827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075732|NCT05832749|Hyaluronic Acid|hyaluronic acid|mesh-list
84075733|NCT05832749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84075734|NCT05832749|Immunologic Factors|immunologic factors|mesh-ancestor
84075735|NCT05832749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075736|NCT05832749|Viscosupplements|viscosupplements|mesh-ancestor
84075737|NCT05832749|Protective Agents|protective agents|mesh-ancestor
84075738|NCT05832697|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84075739|NCT05832697|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84075740|NCT05832697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075741|NCT05832619|Serotonin|serotonin|mesh-list
84075742|NCT05832619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84075744|NCT05832619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075745|NCT05832619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075746|NCT05832619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075747|NCT05832580|Etidronic Acid|etidronic acid|mesh-list
84075748|NCT05832580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84075749|NCT05832580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075750|NCT05832515|Fludarabine|fludarabine|mesh-list
84075751|NCT05832515|Fludarabine phosphate|fludarabine phosphate|mesh-list
84075752|NCT05832515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075753|NCT05832515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84075754|NCT05832515|Antimetabolites|antimetabolites|mesh-ancestor
84075755|NCT05832515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075756|NCT05832515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075757|NCT05832515|Immunologic Factors|immunologic factors|mesh-ancestor
84075758|NCT05832515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075759|NCT05832489|Methylphenidate|methylphenidate|mesh-list
84075760|NCT05832489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84075761|NCT05832489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075762|NCT05832489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84075763|NCT05832489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84075764|NCT05832489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84075765|NCT05832489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075766|NCT05832489|Dopamine Agents|dopamine agents|mesh-ancestor
84075767|NCT05832489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84075768|NCT05832333|Vaccines|vaccines|mesh-list
84075769|NCT05832333|Immunologic Factors|immunologic factors|mesh-ancestor
84075770|NCT05832333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075771|NCT05832320|Etoposide|etoposide|mesh-list
84075772|NCT05832320|Daunorubicin|daunorubicin|mesh-list
84075773|NCT05832320|Tretinoin|tretinoin|mesh-list
84075774|NCT05832320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84075775|NCT05832320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075776|NCT05832320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84075777|NCT05832320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84075778|NCT05832320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075779|NCT05832320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075780|NCT05832320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84075781|NCT05832320|Keratolytic Agents|keratolytic agents|mesh-ancestor
84075782|NCT05832320|Dermatologic Agents|dermatologic agents|mesh-ancestor
84075783|NCT05832229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84075784|NCT05832229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84075785|NCT05832229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84075786|NCT05832229|Antimetabolites|antimetabolites|mesh-ancestor
84075787|NCT05832229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075788|NCT05832229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84075789|NCT05832229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84075790|NCT05832229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075791|NCT05832216|Daratumumab|daratumumab|mesh-list
84075792|NCT05832216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075793|NCT05832190|Biotin|biotin|mesh-list
84075794|NCT05832190|Vitamin B Complex|vitamin b complex|mesh-ancestor
84075795|NCT05832190|Vitamins|vitamins|mesh-ancestor
84075796|NCT05832190|Micronutrients|micronutrients|mesh-ancestor
84075797|NCT05832190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075798|NCT05832073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84075799|NCT05832073|Antibodies|antibodies|mesh-list
84075800|NCT05832073|Immunoglobulins|immunoglobulins|mesh-list
84075801|NCT05832073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84075802|NCT05832073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84075803|NCT05832073|Immunologic Factors|immunologic factors|mesh-ancestor
84075804|NCT05832073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075805|NCT05832073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075806|NCT05832034|Immunoglobulins|immunoglobulins|mesh-list
84075807|NCT05832034|Antibodies|antibodies|mesh-list
84075808|NCT05832034|gamma-Globulins|gamma-globulins|mesh-list
84075809|NCT05832034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84075810|NCT05832034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84075811|NCT05832034|Immunologic Factors|immunologic factors|mesh-ancestor
84075812|NCT05832034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075813|NCT05830539|Doxorubicin|doxorubicin|mesh-list
84075814|NCT05830539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84075815|NCT05830539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83315816|NCT00542620|Insulin|insulin|mesh-list
84075817|NCT05830539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84075818|NCT05830539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84075819|NCT05830539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075820|NCT05830539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075821|NCT05828940|Losartan|losartan|mesh-list
84075822|NCT05828940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84075823|NCT05828940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84075824|NCT05828940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84075825|NCT05828940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84075826|NCT05828940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075827|NCT05827055|Paclitaxel|paclitaxel|mesh-list
84075828|NCT05827055|Gemcitabine|gemcitabine|mesh-list
84075829|NCT05827055|Proglumide|proglumide|mesh-list
84075830|NCT05827055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84075831|NCT05827055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075832|NCT05827055|Tubulin Modulators|tubulin modulators|mesh-ancestor
84075833|NCT05827055|Antimitotic Agents|antimitotic agents|mesh-ancestor
84075834|NCT05827055|Mitosis Modulators|mitosis modulators|mesh-ancestor
84075835|NCT05827055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075836|NCT05827055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84075837|NCT05827055|Antimetabolites|antimetabolites|mesh-ancestor
84075838|NCT05827055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84075839|NCT05827055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075840|NCT05826275|Pembrolizumab|pembrolizumab|mesh-list
84075841|NCT05826275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075842|NCT05826275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075843|NCT05826275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84075844|NCT05826275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075845|NCT05818423|Benzocaine|benzocaine|mesh-list
84075846|NCT05818423|Anesthetics, Local|anesthetics, local|mesh-ancestor
84075847|NCT05818423|Anesthetics|anesthetics|mesh-ancestor
84075848|NCT05818423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84075849|NCT05818423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075850|NCT05818423|Sensory System Agents|sensory system agents|mesh-ancestor
84075851|NCT05818423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075852|NCT05816785|Cetuximab|cetuximab|mesh-list
84075853|NCT05816785|Imatinib Mesylate|imatinib mesylate|mesh-list
84075854|NCT05816785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84075855|NCT05816785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075856|NCT05816785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84075857|NCT05816785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075858|NCT05816785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075859|NCT05813912|Insulin|insulin|mesh-list
84075860|NCT05813912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84075861|NCT05813912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075862|NCT05807399|Moxifloxacin|moxifloxacin|mesh-list
84075863|NCT05807399|Rifampin|rifampin|mesh-list
84075864|NCT05807399|Isoniazid|isoniazid|mesh-list
84075865|NCT05807399|Pyrazinamide|pyrazinamide|mesh-list
84075866|NCT05807399|Bedaquiline|bedaquiline|mesh-list
84075867|NCT05807399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84075868|NCT05807399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075869|NCT05807399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84075870|NCT05807399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84075871|NCT05807399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075872|NCT05807399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075873|NCT05807399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075874|NCT05807399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84075875|NCT05807399|Antitubercular Agents|antitubercular agents|mesh-ancestor
84075876|NCT05807399|Leprostatic Agents|leprostatic agents|mesh-ancestor
84075877|NCT05807399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84075878|NCT05807399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84075879|NCT05807399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84075880|NCT05807399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84075881|NCT05807399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84075882|NCT05807399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84075883|NCT05807399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84075884|NCT05807399|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84075885|NCT05807399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84075886|NCT05807399|Antimetabolites|antimetabolites|mesh-ancestor
84075887|NCT05807399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83315889|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075888|NCT05798390|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
84075889|NCT05798390|Ezetimibe|ezetimibe|mesh-list
84075890|NCT05798390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84075891|NCT05798390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84075892|NCT05798390|Antimetabolites|antimetabolites|mesh-ancestor
84075893|NCT05798390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075894|NCT05798390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84075895|NCT05798390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075896|NCT05798390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84075897|NCT05798390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075898|NCT05796401|Leucovorin|leucovorin|mesh-list
84075899|NCT05796401|Folic Acid|folic acid|mesh-list
84075900|NCT05796401|Vitamin B 12|vitamin b 12|mesh-list
84075901|NCT05796401|Hydroxocobalamin|hydroxocobalamin|mesh-list
84075902|NCT05796401|Levoleucovorin|levoleucovorin|mesh-list
84075903|NCT05796401|Vitamins|vitamins|mesh-ancestor
84075904|NCT05796401|Micronutrients|micronutrients|mesh-ancestor
84075905|NCT05796401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075906|NCT05796401|Antidotes|antidotes|mesh-ancestor
84075907|NCT05796401|Protective Agents|protective agents|mesh-ancestor
84075908|NCT05796401|Vitamin B Complex|vitamin b complex|mesh-ancestor
84075909|NCT05796401|Hematinics|hematinics|mesh-ancestor
84075910|NCT05771402|Antibodies|antibodies|mesh-list
84075911|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
84075912|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075913|NCT05769816|Antibodies|antibodies|mesh-list
84075914|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
84075915|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075916|NCT05745142|Sunitinib|sunitinib|mesh-list
84075917|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075918|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84075919|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84075920|NCT05745142|Growth Substances|growth substances|mesh-ancestor
84075921|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075922|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
84075923|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84075924|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075925|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075926|NCT05737069|Ibuprofen|ibuprofen|mesh-list
84075927|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
84075928|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84075929|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84075930|NCT05737069|Analgesics|analgesics|mesh-ancestor
84075931|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
84075932|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075933|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075934|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075935|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84075936|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84075937|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075938|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075939|NCT05709483|Aspirin|aspirin|mesh-list
84075940|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84075941|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84075942|NCT05709483|Analgesics|analgesics|mesh-ancestor
84075943|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
84075944|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075945|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075946|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075947|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84075948|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84075949|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84075950|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075951|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84075952|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84075953|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075954|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
84075955|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
84075956|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84075957|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84075958|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075959|NCT05668091|Ritonavir|ritonavir|mesh-list
84075960|NCT05668091|Nirmatrelvir|nirmatrelvir|mesh-list
84075961|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84075962|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84075963|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
84075964|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075965|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075966|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84075967|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84075968|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
84075969|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075970|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84075971|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84075972|NCT05647057|Polygeline|polygeline|mesh-list
84075973|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
84075974|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
84075975|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84075976|NCT05646082|Dostarlimab|dostarlimab|mesh-list
84075977|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
84075978|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84075979|NCT05646082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84075980|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
84075981|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84075982|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
84075983|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075984|NCT05641363|Ketorolac|ketorolac|mesh-list
84075985|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84075986|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84075987|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84075988|NCT05641363|Analgesics|analgesics|mesh-ancestor
84075989|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
84075990|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84075991|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84075992|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84075993|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84075994|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84075995|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84075996|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84075997|NCT05639322|Ketamine|ketamine|mesh-list
84075998|NCT05639322|Analgesics|analgesics|mesh-ancestor
84075999|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
84076000|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076001|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076002|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84076003|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84076004|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
84076005|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
84076006|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076007|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84076008|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84076009|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076010|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076011|NCT05629702|Temozolomide|temozolomide|mesh-list
84076012|NCT05629702|Nabiximols|nabiximols|mesh-list
84076013|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84076014|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
84076015|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076016|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076017|NCT05629702|Analgesics|analgesics|mesh-ancestor
84076018|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
84076019|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076020|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076021|NCT05622201|Rituximab|rituximab|mesh-list
84076022|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076023|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076024|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
84076025|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076026|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076027|NCT05594615|Midazolam|midazolam|mesh-list
84076028|NCT05594615|Caffeine|caffeine|mesh-list
84076029|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84076030|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84076031|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84076032|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076033|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076034|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84076035|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84076036|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84076037|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84076038|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
84076039|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
84076040|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
84076041|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
84076042|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076043|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076044|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84076045|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84076046|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
84076047|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84076048|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84076049|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076050|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84076051|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84076052|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84076053|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84076054|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
84076055|NCT05594602|Itraconazole|itraconazole|mesh-list
84076056|NCT05594602|Quinidine|quinidine|mesh-list
84076057|NCT05594602|Carbamazepine|carbamazepine|mesh-list
84076058|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
84076059|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076060|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84076061|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84076062|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076063|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076064|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84076065|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
84076066|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076067|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076068|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84076069|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
84076070|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
84076071|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84076072|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076073|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84076074|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84076075|NCT05594602|Analgesics|analgesics|mesh-ancestor
84076076|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
84076077|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076078|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84076079|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84076080|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84076081|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84076082|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84076083|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84076084|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
84076085|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076086|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84076087|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
84076088|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84076089|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84076090|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84076091|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84076092|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
84076093|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84076094|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84076095|NCT05590260|Iron|iron|mesh-list
84076096|NCT05590260|Trace Elements|trace elements|mesh-ancestor
84076097|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
84076098|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076099|NCT05589844|Vaccines|vaccines|mesh-list
84076100|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
84076101|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076102|NCT05485519|Midazolam|midazolam|mesh-list
84076103|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
84076104|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84076105|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076106|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076107|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84076108|NCT05485519|Analgesics|analgesics|mesh-ancestor
84076109|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
84076110|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076111|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84076112|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84076113|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84076114|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
84076115|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076116|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076117|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84076118|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84076119|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84076120|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84076121|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84076122|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
84076123|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
84076124|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
84076125|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
84076126|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
84076127|NCT05411744|Pyridoxal|pyridoxal|mesh-list
84076128|NCT05411744|Pyridoxine|pyridoxine|mesh-list
84076129|NCT05411744|Isoniazid|isoniazid|mesh-list
84076130|NCT05411744|Rifapentine|rifapentine|mesh-list
84076131|NCT05411744|Vitamins|vitamins|mesh-ancestor
84076132|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
84076133|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076134|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
84076135|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
84076136|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84076137|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076138|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84076139|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84076140|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
84076141|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076142|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84076143|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84076144|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
84076145|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
84076146|NCT05400603|Irinotecan|irinotecan|mesh-list
84076147|NCT05400603|Temozolomide|temozolomide|mesh-list
84076148|NCT05400603|Dinutuximab|dinutuximab|mesh-list
84076149|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84076150|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84076151|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076152|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076153|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076154|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84076155|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
84076156|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84076157|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076158|NCT05378113|Lidocaine|lidocaine|mesh-list
84076159|NCT05378113|Ondansetron|ondansetron|mesh-list
84076160|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
84076161|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
84076162|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076163|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076164|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
84076165|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076166|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84076167|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84076168|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84076169|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84076170|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076171|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
84076172|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
84076173|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84076174|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
84076175|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
84076176|NCT05378113|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84076177|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84076178|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
84076179|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076180|NCT05359627|Polymyxins|polymyxins|mesh-list
84076181|NCT05359627|Polymyxin B|polymyxin b|mesh-list
84076182|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84076183|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076184|NCT05612490|Furosemide|furosemide|mesh-list
84076185|NCT05612490|Diuretics|diuretics|mesh-ancestor
84076186|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
84076187|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076188|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84076189|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316187|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
84076190|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076192|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
84076193|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076194|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84076195|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076196|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84076197|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076198|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84076199|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84076200|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
84076201|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076202|NCT05246293|Tofacitinib|tofacitinib|mesh-list
84076203|NCT05246293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84076204|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84076205|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076206|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076207|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
84076208|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
84076209|NCT05243147|Coagulants|coagulants|mesh-ancestor
84076210|NCT05212610|Vaccines|vaccines|mesh-list
84076211|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
84076212|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076213|NCT05207280|Terlipressin|terlipressin|mesh-list
84076214|NCT05207280|Norepinephrine|norepinephrine|mesh-list
84076215|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84076216|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84076217|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84076218|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84076219|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
84076220|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076221|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076222|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076223|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
84076224|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
84076225|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076226|NCT05174832|Paclitaxel|paclitaxel|mesh-list
84076227|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
84076228|NCT05174832|Olaparib|olaparib|mesh-list
84076229|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84076230|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076231|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
84076232|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
84076233|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
83370723|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
83370794|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84076234|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076235|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076236|NCT05174832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370872|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
84076237|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84076238|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076239|NCT05157672|Letrozole|letrozole|mesh-list
84076240|NCT05157672|Nicotine|nicotine|mesh-list
84076241|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84076242|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
84076243|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076244|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076245|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84076246|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84076247|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
84076248|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371017|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076249|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076250|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076251|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84076252|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83371090|NCT01457053|Torsemide|torsemide|mesh-list
84076253|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076254|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84076255|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
84076256|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076257|NCT05149378|Azacitidine|azacitidine|mesh-list
84076258|NCT05149378|Venetoclax|venetoclax|mesh-list
84076259|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84076260|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
84076261|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076262|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076263|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076264|NCT05134857|Zonisamide|zonisamide|mesh-list
84076265|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
84076266|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84076267|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84076268|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076269|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371445|NCT01468987|Insulin|insulin|mesh-list
84076270|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076271|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
84076272|NCT05114590|Lixisenatide|lixisenatide|mesh-list
84076273|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84076274|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076275|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84076276|NCT05108935|Buprenorphine|buprenorphine|mesh-list
84076277|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84076278|NCT05108935|Naloxone|naloxone|mesh-list
84076279|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84076280|NCT05108935|Narcotics|narcotics|mesh-ancestor
84076281|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076282|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076283|NCT05108935|Analgesics|analgesics|mesh-ancestor
84076284|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
84076285|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076286|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84076287|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84076288|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84076289|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371636|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076290|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076291|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
84076292|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076293|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84076294|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84076295|NCT05051527|Silymarin|silymarin|mesh-list
84076296|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
84076297|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076298|NCT05051527|Protective Agents|protective agents|mesh-ancestor
84076299|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076300|NCT05041062|Nivolumab|nivolumab|mesh-list
84076301|NCT05041062|Ipilimumab|ipilimumab|mesh-list
84076302|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076303|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076304|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83372005|NCT01491841|Pixantrone|pixantrone|mesh-list
84076305|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076306|NCT04939753|Sevoflurane|sevoflurane|mesh-list
84076307|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84076308|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84076309|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
84076310|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
83372148|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
84076311|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076312|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076313|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
84076314|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84076315|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84076316|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84076317|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
83372362|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076318|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076319|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076320|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076321|NCT04902885|Carboplatin|carboplatin|mesh-list
84076322|NCT04902885|Etoposide|etoposide|mesh-list
84076323|NCT04902885|Topotecan|topotecan|mesh-list
84076324|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076325|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84076326|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84076327|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84076328|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076329|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076330|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84076331|NCT04868058|Ropivacaine|ropivacaine|mesh-list
84076332|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
84076333|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
84076334|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076335|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076336|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
84076337|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076338|NCT04763759|Antibodies|antibodies|mesh-list
84076339|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84076341|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076342|NCT04628988|Prednisone|prednisone|mesh-list
84076343|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
83372872|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
84076344|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076345|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
84076346|NCT04628988|Hormones|hormones|mesh-ancestor
83373014|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076347|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076348|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076349|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076350|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076351|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076352|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076353|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84076354|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84076355|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076356|NCT04567615|Nivolumab|nivolumab|mesh-list
84076357|NCT04567615|Relatlimab|relatlimab|mesh-list
84076358|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076359|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076360|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84076361|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076362|NCT04526899|Cemiplimab|cemiplimab|mesh-list
84076363|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076364|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076365|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
84076366|NCT04525274|Ketamine|ketamine|mesh-list
84076367|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84076368|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076369|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076370|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84076371|NCT04525274|Analgesics|analgesics|mesh-ancestor
84076372|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
84076373|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076374|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84076375|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84076376|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84076377|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
84076378|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076379|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076380|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84076381|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84076382|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
84076383|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
84076384|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84076385|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84076386|NCT04507503|Futibatinib|futibatinib|mesh-list
84076387|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076388|NCT04503668|Dexamethasone|dexamethasone|mesh-list
84076389|NCT04503668|Ondansetron|ondansetron|mesh-list
84076390|NCT04503668|Olanzapine|olanzapine|mesh-list
84076391|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
84076392|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
84076393|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
84076394|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076395|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
84076396|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
84076397|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076398|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076399|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84076400|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
84076401|NCT04503668|Hormones|hormones|mesh-ancestor
84076402|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076403|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076404|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076405|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
84076406|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
84076407|NCT04503668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84076408|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84076409|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
84076410|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076411|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076412|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84076413|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84076414|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076415|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84076416|NCT04503668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84076417|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84076418|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84076419|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84076420|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
84076421|NCT04481113|Niraparib|niraparib|mesh-list
84076422|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84076423|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076424|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076425|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076426|NCT04472611|Colchicine|colchicine|mesh-list
84076427|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84076428|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84076429|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84076430|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
84076431|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076432|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84076433|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84076434|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076435|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
84076436|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076437|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
84076438|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
84076439|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
84076440|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076441|NCT04472598|Navitoclax|navitoclax|mesh-list
84076442|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076443|NCT04460885|Insulin|insulin|mesh-list
84076444|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84076445|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
84076446|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84076447|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076448|NCT04423718|Aflibercept|aflibercept|mesh-list
84076449|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84076450|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84076451|NCT04423718|Growth Substances|growth substances|mesh-ancestor
84076452|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076453|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
84076454|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076455|NCT04367233|Anesthetics|anesthetics|mesh-list
84076456|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076457|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076458|NCT04341350|Analgesics|analgesics|mesh-list
84076459|NCT04341350|Propofol|propofol|mesh-list
84076460|NCT04341350|Isoflurane|isoflurane|mesh-list
84076461|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84076462|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076463|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076464|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84076465|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
84076466|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
84076467|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
84076468|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076469|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84076470|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
84076471|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84076472|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84076473|NCT04233164|Prednisolone|prednisolone|mesh-list
84076474|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
84076475|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84076476|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
84076477|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076478|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
84076479|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
84076480|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076481|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076482|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84076483|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
84076484|NCT04233164|Hormones|hormones|mesh-ancestor
84076485|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076486|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84076487|NCT04233164|Protective Agents|protective agents|mesh-ancestor
83316505|NCT01392573|Insulin|insulin|mesh-list
84076488|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076489|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076490|NCT04193215|Vaccines|vaccines|mesh-list
84076491|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
84076492|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076493|NCT04125563|Capsaicin|capsaicin|mesh-list
84076494|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
84076495|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
84076496|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
84076497|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076498|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076499|NCT04101357|Carboplatin|carboplatin|mesh-list
84076500|NCT04101357|Etoposide|etoposide|mesh-list
84076501|NCT04101357|Atezolizumab|atezolizumab|mesh-list
84076502|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076503|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84076504|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84076505|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84076506|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076507|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076508|NCT04101357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84076509|NCT04101357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076510|NCT04078295|Nivolumab|nivolumab|mesh-list
84076511|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076512|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076513|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84076514|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076515|NCT04068597|Dexamethasone|dexamethasone|mesh-list
84076516|NCT04068597|Azacitidine|azacitidine|mesh-list
84076517|NCT04068597|Venetoclax|venetoclax|mesh-list
84076518|NCT04068597|Pomalidomide|pomalidomide|mesh-list
84076519|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076520|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
84076521|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
84076522|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076523|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076524|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84076525|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
84076526|NCT04068597|Hormones|hormones|mesh-ancestor
84076527|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076528|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076529|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076530|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84076531|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
84076532|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076533|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076534|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
84076535|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84076536|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84076537|NCT04068597|Growth Substances|growth substances|mesh-ancestor
84076538|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
84076539|NCT04004611|Mirikizumab|mirikizumab|mesh-list
84076540|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84076541|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84076542|NCT04004611|Analgesics|analgesics|mesh-ancestor
84076543|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
84076544|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076545|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076546|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076547|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076548|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84076549|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84076550|NCT03974828|Anesthetics|anesthetics|mesh-list
84076551|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076552|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076553|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
84076554|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
84076555|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076556|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
84076557|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84076558|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84076559|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076560|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076561|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84076562|NCT03953677|Analgesics|analgesics|mesh-ancestor
83316572|NCT01402947|Analgesics|analgesics|mesh-ancestor
84076563|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
84076564|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076565|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84076566|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84076567|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84076568|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
84076569|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84076570|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076571|NCT03937713|Eszopiclone|eszopiclone|mesh-list
84076572|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84076573|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076574|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076575|NCT03934216|Deucravacitinib|deucravacitinib|mesh-list
84076576|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
84076577|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84076578|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076579|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076580|NCT03925480|Azithromycin|azithromycin|mesh-list
84076581|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84076582|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076583|NCT03915769|Ozanimod|ozanimod|mesh-list
84076584|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84076585|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076586|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84076587|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
84076588|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076589|NCT03878069|Elapegademase|elapegademase|mesh-list
84076590|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
84076591|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076592|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076593|NCT03876873|Anesthetics|anesthetics|mesh-list
84076594|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076595|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076596|NCT03845517|PF-06700841|pf-06700841|mesh-list
84076597|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84076598|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076599|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076600|NCT03842696|Cyclosporine|cyclosporine|mesh-list
84076601|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
84076602|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
84076603|NCT03842696|Methotrexate|methotrexate|mesh-list
84076604|NCT03842696|Vorinostat|vorinostat|mesh-list
84076605|NCT03842696|Tacrolimus|tacrolimus|mesh-list
84076606|NCT03842696|Cyclosporins|cyclosporins|mesh-list
84076607|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84076608|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
84076609|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076610|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076611|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84076612|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
84076613|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076614|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076615|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84076616|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84076617|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
84076618|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84076619|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84076620|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
84076621|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
84076622|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076623|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84076624|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84076625|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84076626|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
84076627|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076628|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84076629|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84076630|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
84076631|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84076632|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84076633|NCT03832361|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
84076634|NCT03832361|Immunoconjugates|immunoconjugates|mesh-ancestor
84076635|NCT03832361|Immunologic Factors|immunologic factors|mesh-ancestor
84076636|NCT03832361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076637|NCT03789240|Rituximab|rituximab|mesh-list
84076638|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076639|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076640|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
84076641|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076642|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076643|NCT03779191|Bevacizumab|bevacizumab|mesh-list
84076644|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076645|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076646|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84076647|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84076648|NCT03779191|Growth Substances|growth substances|mesh-ancestor
84076649|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076650|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
84076651|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
84076652|NCT03762850|Irbesartan|irbesartan|mesh-list
84076653|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84076654|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076655|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84076656|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076657|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84076658|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84076659|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84076660|NCT03759288|Adalimumab|adalimumab|mesh-list
84076661|NCT03759288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84076662|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076663|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076664|NCT03601078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
84076665|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076666|NCT03601078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076667|NCT03591510|Cytarabine|cytarabine|mesh-list
84076668|NCT03591510|Fludarabine|fludarabine|mesh-list
84076669|NCT03591510|Etoposide|etoposide|mesh-list
84076670|NCT03591510|Daunorubicin|daunorubicin|mesh-list
84076671|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
84076672|NCT03591510|Idarubicin|idarubicin|mesh-list
84076673|NCT03591510|Midostaurin|midostaurin|mesh-list
84076674|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076675|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84076676|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
84076677|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076678|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84076679|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
84076680|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076681|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84076682|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84076683|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84076684|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076685|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
84076686|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076687|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84076688|NCT03591510|Analgesics|analgesics|mesh-ancestor
84076689|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
84076690|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076691|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84076692|NCT03479502|Doxycycline|doxycycline|mesh-list
84076693|NCT03479502|Prednisone|prednisone|mesh-list
84076694|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
84076695|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84076696|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84076697|NCT03479502|Prednisolone|prednisolone|mesh-list
84076698|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
84076699|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84076700|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
84076701|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076702|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
84076703|NCT03479502|Hormones|hormones|mesh-ancestor
84076704|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076705|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076706|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076707|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076708|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
84076709|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
84076710|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076711|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84076712|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84076713|NCT03479502|Protective Agents|protective agents|mesh-ancestor
84076714|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84076715|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076716|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
84076717|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84076718|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84076719|NCT03294460|Ethanol|ethanol|mesh-list
84076720|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84076721|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076722|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076723|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076724|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
84076725|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84076726|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076727|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076728|NCT03240016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84076729|NCT03240016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076730|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
84076731|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
84076732|NCT03067051|Verteporfin|verteporfin|mesh-list
84076733|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84076734|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
84076735|NCT03013998|Cytarabine|cytarabine|mesh-list
84076736|NCT03013998|Azacitidine|azacitidine|mesh-list
84076737|NCT03013998|Decitabine|decitabine|mesh-list
84076738|NCT03013998|Daunorubicin|daunorubicin|mesh-list
84076739|NCT03013998|Venetoclax|venetoclax|mesh-list
84076740|NCT03013998|AZD5991|azd5991|mesh-list
84076741|NCT03013998|Pevonedistat|pevonedistat|mesh-list
84076742|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84076743|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
84076744|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076745|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076746|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
84076747|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076748|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84076749|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
84076750|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076751|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076752|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84076753|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84076754|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84076755|NCT02996487|Vancomycin|vancomycin|mesh-list
84076756|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84076757|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076758|NCT02911142|Prednisone|prednisone|mesh-list
84076759|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
84076760|NCT02911142|Rituximab|rituximab|mesh-list
84076761|NCT02911142|Doxorubicin|doxorubicin|mesh-list
84076762|NCT02911142|Vincristine|vincristine|mesh-list
84076763|NCT02911142|Lenalidomide|lenalidomide|mesh-list
84076764|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84076765|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
84076766|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076767|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076768|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84076769|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
84076770|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076771|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076772|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84076773|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076774|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84076775|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84076776|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84076777|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076778|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076779|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
84076780|NCT02911142|Hormones|hormones|mesh-ancestor
84076781|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076782|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076783|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84076784|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
84076785|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
84076786|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316788|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
84076787|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84076788|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84076789|NCT02911142|Growth Substances|growth substances|mesh-ancestor
84076790|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
84076791|NCT02901067|Aspirin|aspirin|mesh-list
84076792|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84076793|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84076794|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84076795|NCT02901067|Analgesics|analgesics|mesh-ancestor
84076796|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
84076797|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076798|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076799|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076800|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076801|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84076802|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84076803|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076804|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84076805|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84076806|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076807|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
84076808|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84076809|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84076810|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
84076811|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84076812|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84076813|NCT02859896|Calcitriol|calcitriol|mesh-list
84076814|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
84076815|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84076816|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076817|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84076818|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84076819|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076820|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84076821|NCT02859896|Vitamins|vitamins|mesh-ancestor
84076822|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
84076823|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84076824|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84076825|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
84076826|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84076827|NCT02711670|Diuretics|diuretics|mesh-ancestor
84076828|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
84076829|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076830|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84076831|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84076832|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076833|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
84076834|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076835|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076836|NCT02658097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84076837|NCT02658097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076838|NCT02581527|Rifampin|rifampin|mesh-list
84076839|NCT02581527|Isoniazid|isoniazid|mesh-list
84076840|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
84076841|NCT02581527|Ethambutol|ethambutol|mesh-list
84076842|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84076843|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
84076844|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84076845|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84076846|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
84076847|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84076848|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076849|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076850|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84076851|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84076852|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84076853|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84076854|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84076855|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84076856|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84076857|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84076858|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
84076859|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84076860|NCT02558010|Morphine|morphine|mesh-list
84076861|NCT02558010|Methadone|methadone|mesh-list
84076862|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84076863|NCT02558010|Narcotics|narcotics|mesh-ancestor
84076864|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84076865|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076866|NCT02558010|Analgesics|analgesics|mesh-ancestor
84076867|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
84076868|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076869|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
84076870|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
84076871|NCT02496663|Osimertinib|osimertinib|mesh-list
84076872|NCT02496663|Necitumumab|necitumumab|mesh-list
84076873|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84076874|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076875|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076876|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84076877|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076878|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076879|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
84076880|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076882|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076883|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84076884|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076885|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076886|NCT02466074|Acetazolamide|acetazolamide|mesh-list
84076887|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
84076888|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84076889|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076890|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076891|NCT02466074|Diuretics|diuretics|mesh-ancestor
84076892|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
84076893|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076894|NCT02393794|Nivolumab|nivolumab|mesh-list
84076895|NCT02393794|Romidepsin|romidepsin|mesh-list
84076896|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84076897|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076898|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076899|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84076900|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076901|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84076902|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076903|NCT02319837|Leuprolide|leuprolide|mesh-list
84076904|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84076905|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
84076906|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84076907|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076908|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076909|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076910|NCT02159950|Vaccines|vaccines|mesh-list
84076911|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
84076912|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076913|NCT02152137|Paclitaxel|paclitaxel|mesh-list
84076914|NCT02152137|Efatutazone|efatutazone|mesh-list
84076915|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84076916|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076917|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
84076918|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
84076919|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
84076920|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076921|NCT02007512|Exemestane|exemestane|mesh-list
84076922|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076923|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84076924|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84076925|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076926|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076927|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84076928|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
84076929|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076930|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076931|NCT01971489|Cisplatin|cisplatin|mesh-list
84076932|NCT01971489|Gemcitabine|gemcitabine|mesh-list
84076933|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076934|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84076935|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
84076936|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076937|NCT01942135|Fulvestrant|fulvestrant|mesh-list
84076938|NCT01942135|Palbociclib|palbociclib|mesh-list
84076939|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076940|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076941|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84076942|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84076943|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
84076944|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076945|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076946|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84076947|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84076948|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076949|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
84076950|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84076951|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84076952|NCT01838174|Prednisolone|prednisolone|mesh-list
84076953|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
84076954|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84076955|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
84076956|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84076957|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
84076958|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
84076959|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84076960|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076961|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84076962|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
84076963|NCT01838174|Hormones|hormones|mesh-ancestor
84076964|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84076965|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84076966|NCT01838174|Protective Agents|protective agents|mesh-ancestor
84076967|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84076968|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076969|NCT01743131|Abatacept|abatacept|mesh-list
84076970|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84076971|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076972|NCT01743131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84076973|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076974|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84076975|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
84076976|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076977|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84076978|NCT01685814|Lenalidomide|lenalidomide|mesh-list
84076979|NCT01685814|Bortezomib|bortezomib|mesh-list
84076980|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
84076981|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84076982|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84076983|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84076984|NCT01685814|Growth Substances|growth substances|mesh-ancestor
84076985|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
84076986|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076987|NCT01147016|Paclitaxel|paclitaxel|mesh-list
84076988|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
84076989|NCT01147016|Doxorubicin|doxorubicin|mesh-list
84076990|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84076991|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84076992|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84076993|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
84076994|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
84076995|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
84076996|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84076997|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84076998|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
84076999|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077000|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077001|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84077002|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
84077003|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84077004|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84077005|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84077006|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84077007|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077008|NCT00967785|Plerixafor|plerixafor|mesh-list
84077009|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84077010|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84077011|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
84077012|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077013|NCT00539591|Interferons|interferons|mesh-list
84077014|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
84077015|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
84077016|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84077017|NCT00539591|Temozolomide|temozolomide|mesh-list
84077018|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077019|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
84077020|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077021|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84077022|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
84077023|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077024|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
84077025|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077026|NCT00200200|Bevacizumab|bevacizumab|mesh-list
84077027|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84077028|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077029|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84077030|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84077031|NCT00200200|Growth Substances|growth substances|mesh-ancestor
84077032|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077033|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
84077034|NCT00106587|Paclitaxel|paclitaxel|mesh-list
84077035|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84077036|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077037|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
84077038|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
84077039|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
84077040|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077041|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
84077042|NCT00097474|Melatonin|melatonin|mesh-list
84077043|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077044|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
84077045|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077046|NCT00097474|Protective Agents|protective agents|mesh-ancestor
84077047|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077048|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077049|NCT00694863|Cosyntropin|cosyntropin|mesh-list
84077050|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
84077051|NCT00694863|Hormones|hormones|mesh-ancestor
84077052|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077053|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077054|NCT00629213|Acarbose|acarbose|mesh-list
84077055|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84077056|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077057|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077058|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84077059|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077060|NCT00978341|Pregabalin|pregabalin|mesh-list
84077061|NCT00978341|Analgesics|analgesics|mesh-ancestor
84077062|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
84077063|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077064|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077065|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
84077066|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84077067|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84077068|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077069|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84077070|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84077071|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84077072|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077073|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84077074|NCT00695331|Misoprostol|misoprostol|mesh-list
84077075|NCT00695331|Oxytocin|oxytocin|mesh-list
84077076|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
84077077|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84077078|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077079|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84077080|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
84077081|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84077082|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84077083|NCT00695643|Mesalamine|mesalamine|mesh-list
84077084|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84077085|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077086|NCT00695643|Analgesics|analgesics|mesh-ancestor
83317091|NCT01396395|Vitamins|vitamins|mesh-ancestor
84077087|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
84077088|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077089|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077090|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077091|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077092|NCT02623881|Progesterone|progesterone|mesh-list
84077093|NCT02623881|Progestins|progestins|mesh-ancestor
84077094|NCT02623881|Hormones|hormones|mesh-ancestor
84077095|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077096|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077097|NCT04135833|Itraconazole|itraconazole|mesh-list
84077098|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
84077099|NCT04135833|Rifampin|rifampin|mesh-list
84077100|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
84077101|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077102|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84077103|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84077104|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077105|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077106|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84077107|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
84077108|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077109|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077110|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84077111|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84077112|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
84077113|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84077114|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
84077115|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84077116|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84077117|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84077118|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84077119|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84077120|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84077121|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84077122|NCT00696033|Diazepam|diazepam|mesh-list
84077123|NCT00696033|Lorazepam|lorazepam|mesh-list
84077124|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
84077125|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
84077126|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
84077127|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077128|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077129|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84077130|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84077131|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077132|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84077133|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84077134|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84077135|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
84077136|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
84077137|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077138|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077139|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84077140|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84077141|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84077142|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84077143|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
84077144|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
84077145|NCT02623569|Atenolol|atenolol|mesh-list
84077146|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84077147|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84077148|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
84077149|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
84077150|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077151|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077152|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84077153|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84077154|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84077155|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077156|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077157|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077158|NCT00977561|Cisplatin|cisplatin|mesh-list
84077159|NCT00977561|Carboplatin|carboplatin|mesh-list
84077160|NCT00977561|Etoposide|etoposide|mesh-list
84077161|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
84077162|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077163|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84077164|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84077165|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84077166|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077167|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077169|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
84077170|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
84077171|NCT04291313|Vitamins|vitamins|mesh-list
84077172|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
84077173|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077174|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84077175|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84077176|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84077177|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84077178|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
84077179|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077180|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84077181|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84077182|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84077183|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84077184|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
84077185|NCT04049669|Temozolomide|temozolomide|mesh-list
84077186|NCT04049669|Lomustine|lomustine|mesh-list
84077187|NCT04049669|Etoposide|etoposide|mesh-list
84077188|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84077189|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
84077190|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077191|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077192|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84077193|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
84077194|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077195|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077196|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84077197|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84077198|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84077199|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84077200|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077201|NCT00594165|Rotigotine|rotigotine|mesh-list
84077202|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
84077203|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
84077204|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077205|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077206|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077207|NCT00928070|Fesoterodine|fesoterodine|mesh-list
84077208|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84077209|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84077210|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
84077211|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077212|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077213|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077214|NCT00928070|Urological Agents|urological agents|mesh-ancestor
84077215|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
84077216|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84077217|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077218|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077219|NCT04001621|Capecitabine|capecitabine|mesh-list
84077220|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84077221|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
84077222|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077223|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077224|NCT00976937|Metformin|metformin|mesh-list
84077225|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84077226|NCT00976937|Lixisenatide|lixisenatide|mesh-list
84077227|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84077228|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077229|NCT00976937|Incretins|incretins|mesh-ancestor
84077230|NCT00976937|Hormones|hormones|mesh-ancestor
84077231|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077232|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84077233|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
84077234|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077235|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077236|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
84077237|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84077238|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84077240|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077241|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077242|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077243|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84077244|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84077245|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84077246|NCT04256252|Rituximab|rituximab|mesh-list
84077247|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84077248|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077249|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
84077250|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077251|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077252|NCT02622555|Mirabegron|mirabegron|mesh-list
84077253|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84077254|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84077255|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84077256|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077257|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077258|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077259|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077260|NCT02622555|Urological Agents|urological agents|mesh-ancestor
84077261|NCT05329454|Ibuprofen|ibuprofen|mesh-list
84077262|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84077263|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077264|NCT05329454|Analgesics|analgesics|mesh-ancestor
84077265|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
84077266|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077267|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077268|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077269|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077270|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84077271|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077272|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077273|NCT00629447|Tinzaparin|tinzaparin|mesh-list
84077274|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
84077275|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84077276|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84077277|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077278|NCT02622477|Pirfenidone|pirfenidone|mesh-list
84077279|NCT02622477|Analgesics|analgesics|mesh-ancestor
84077280|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
84077281|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077282|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077283|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84077284|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077285|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077286|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077287|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077288|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
84077289|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
84077290|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84077291|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
84077292|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077293|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077294|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84077295|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
84077296|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
84077297|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84077298|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
84077299|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077300|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077301|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84077302|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84077303|NCT04289675|Interferons|interferons|mesh-list
84077304|NCT04289675|Interferon-beta|interferon-beta|mesh-list
84077305|NCT04289675|Teriflunomide|teriflunomide|mesh-list
84077306|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83317320|NCT04007055|Ticagrelor|ticagrelor|mesh-list
84077307|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077308|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
84077309|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077310|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
84077311|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077312|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
84077313|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84077314|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84077315|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077316|NCT04289675|Analgesics|analgesics|mesh-ancestor
84077317|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
84077318|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077319|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077320|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077321|NCT00696579|Gemcitabine|gemcitabine|mesh-list
84077322|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84077323|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
84077324|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077325|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077326|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
84077327|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84077328|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
84077329|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077330|NCT02865629|Expectorants|expectorants|mesh-ancestor
84077331|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
84077332|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84077333|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
84077334|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077335|NCT02865629|Protective Agents|protective agents|mesh-ancestor
84077336|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077337|NCT02865629|Antidotes|antidotes|mesh-ancestor
84077338|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
84077339|NCT02867345|Interleukin-2|interleukin-2|mesh-list
84077340|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84077341|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
84077342|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077343|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077344|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84077345|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
84077346|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077347|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077348|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84077349|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077350|NCT02867345|Analgesics|analgesics|mesh-ancestor
84077351|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
84077352|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077353|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
84077354|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84077355|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
84077356|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077357|NCT00975689|Expectorants|expectorants|mesh-ancestor
84077358|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
84077359|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84077360|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
84077361|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077362|NCT00975689|Protective Agents|protective agents|mesh-ancestor
84077363|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077364|NCT00975689|Antidotes|antidotes|mesh-ancestor
84077365|NCT02621385|Midazolam|midazolam|mesh-list
84077366|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84077367|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84077368|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077369|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077370|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84077371|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84077372|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84077373|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84077374|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
84077375|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
84077376|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
84077377|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
84077378|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077379|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077380|NCT00922766|Dalteparin|dalteparin|mesh-list
84077381|NCT00922766|Tinzaparin|tinzaparin|mesh-list
83317391|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
84077382|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84077384|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84077385|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84077386|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077387|NCT04134897|Capecitabine|capecitabine|mesh-list
84077388|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
84077389|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84077390|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
84077391|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077392|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077393|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
84077394|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077395|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
84077396|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84077397|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84077398|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077399|NCT02620995|Urological Agents|urological agents|mesh-ancestor
84077400|NCT02620839|Cisplatin|cisplatin|mesh-list
84077401|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077402|NCT02620605|Cabergoline|cabergoline|mesh-list
84077403|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84077404|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84077405|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
84077406|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
84077407|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077408|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077409|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077410|NCT00976391|Insulin|insulin|mesh-list
84077411|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84077412|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
84077413|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
84077414|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
84077415|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84077416|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077417|NCT00976391|Incretins|incretins|mesh-ancestor
84077418|NCT00976391|Hormones|hormones|mesh-ancestor
84077419|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077420|NCT04252664|Remdesivir|remdesivir|mesh-list
84077421|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
84077422|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077423|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
84077424|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077425|NCT00696969|Amphotericin B|amphotericin b|mesh-list
84077426|NCT00696969|Paromomycin|paromomycin|mesh-list
84077427|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84077428|NCT00696969|Miltefosine|miltefosine|mesh-list
84077429|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
84077430|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
84077431|NCT00696969|Amebicides|amebicides|mesh-ancestor
84077432|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84077433|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84077434|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077435|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84077436|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
84077437|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077438|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84077439|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84077440|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
84077441|NCT04203680|Tryptophan|tryptophan|mesh-list
84077442|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84077443|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84077444|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
84077445|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84077446|NCT02620215|Dinoprostone|dinoprostone|mesh-list
84077447|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
84077448|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84077449|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077450|NCT02620293|Emollients|emollients|mesh-list
84077451|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
84077452|NCT02619981|Lidocaine|lidocaine|mesh-list
84077453|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
84077454|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
84077455|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077456|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077457|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
84077458|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077459|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84077460|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84077461|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84077462|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84077463|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077464|NCT02619669|Letrozole|letrozole|mesh-list
84077465|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077466|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84077467|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84077468|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077469|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077470|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84077471|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
84077472|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077473|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077474|NCT03965117|Norepinephrine|norepinephrine|mesh-list
84077475|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84077476|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84077477|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077478|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077479|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077480|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077481|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
84077482|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
84077483|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077484|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84077485|NCT00917462|Sorafenib|sorafenib|mesh-list
84077486|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077487|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84077488|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077489|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077490|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
84077491|NCT02619513|Ropivacaine|ropivacaine|mesh-list
84077492|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84077493|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077494|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077495|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077496|NCT02619513|Analgesics|analgesics|mesh-ancestor
84077497|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
84077498|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077499|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84077500|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84077501|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84077502|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077503|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077504|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077505|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
84077506|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
84077507|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84077508|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84077509|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077510|NCT03947255|Immunotoxins|immunotoxins|mesh-ancestor
84077511|NCT03947255|Immunoconjugates|immunoconjugates|mesh-ancestor
84077512|NCT03947255|Immunologic Factors|immunologic factors|mesh-ancestor
84077513|NCT03947255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077514|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
84077515|NCT02619747|Antacids|antacids|mesh-ancestor
84077516|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077517|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84077518|NCT00697125|Vaccines|vaccines|mesh-list
84077519|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
84077520|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077521|NCT04134273|Clindamycin|clindamycin|mesh-list
84077522|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
84077523|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
84077524|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84077525|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077526|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84077527|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077528|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077529|NCT04134117|Tisagenlecleucel|tisagenlecleucel|mesh-list
84077530|NCT04134117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317544|NCT01827163|Paclitaxel|paclitaxel|mesh-list
84077531|NCT04134117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077533|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84077534|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84077535|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077536|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
84077537|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077538|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
84077539|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84077540|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84077541|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077542|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
84077543|NCT03849443|Coagulants|coagulants|mesh-ancestor
84077544|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
84077545|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
84077546|NCT00697281|Growth Substances|growth substances|mesh-ancestor
84077547|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077548|NCT00979901|Loratadine|loratadine|mesh-list
84077549|NCT00979901|Montelukast|montelukast|mesh-list
84077550|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84077551|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
84077552|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84077553|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
84077554|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077555|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077556|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84077557|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84077558|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077559|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
84077560|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
84077561|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84077562|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84077563|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84077564|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
84077565|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
84077566|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077567|NCT02619201|Ondansetron|ondansetron|mesh-list
84077568|NCT02619201|Metoclopramide|metoclopramide|mesh-list
84077569|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
84077570|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
84077571|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077572|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077573|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84077574|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
84077575|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
84077576|NCT02619201|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84077577|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84077578|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
84077579|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077580|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077581|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84077582|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84077583|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
84077584|NCT00975611|Amantadine|amantadine|mesh-list
84077585|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84077586|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84077587|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
84077588|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077589|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
84077590|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077591|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077592|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077593|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077594|NCT00975611|Analgesics|analgesics|mesh-ancestor
84077595|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
84077596|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077597|NCT02865005|Dapsone|dapsone|mesh-list
84077598|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077599|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
84077600|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84077601|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84077602|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84077603|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077604|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077605|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
84077606|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84077607|NCT02862977|Ketoprofen|ketoprofen|mesh-list
84077608|NCT02862977|Amitriptyline|amitriptyline|mesh-list
84077609|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
84077610|NCT02862977|Caffeine|caffeine|mesh-list
84077611|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84077612|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077613|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84077614|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077615|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077616|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84077617|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84077618|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
84077619|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077620|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84077621|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077622|NCT02862977|Analgesics|analgesics|mesh-ancestor
84077623|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
84077624|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077625|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077626|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077627|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84077628|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84077629|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
84077630|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84077631|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84077632|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84077633|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84077634|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077635|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84077636|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84077637|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373201|NCT01534520|Lidocaine|lidocaine|mesh-list
84077638|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077639|NCT02864927|Vaccines|vaccines|mesh-list
84077640|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
84077641|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077642|NCT02618499|Oxytocin|oxytocin|mesh-list
84077643|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
84077644|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84077645|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077646|NCT04133961|Phenylephrine|phenylephrine|mesh-list
84077647|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
84077648|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84077649|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
84077650|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
84077651|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077652|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077653|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
84077654|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84077655|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
84077656|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
84077657|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84077658|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84077659|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84077660|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077661|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077662|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077663|NCT04133961|Protective Agents|protective agents|mesh-ancestor
84077664|NCT02618733|Clopidogrel|clopidogrel|mesh-list
84077665|NCT02618733|Ticagrelor|ticagrelor|mesh-list
84077666|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84077667|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84077668|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84077669|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84077670|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
84077671|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077672|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077673|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077674|NCT00970307|Vaccines|vaccines|mesh-list
84077675|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84077676|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
84077677|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077678|NCT00917384|Ramucirumab|ramucirumab|mesh-list
84077679|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317702|NCT01876381|Tolvaptan|tolvaptan|mesh-list
84077681|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
84077682|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
84077683|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077684|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077685|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
84077686|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077687|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84077688|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84077689|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84077690|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84077691|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077692|NCT00629681|Pregabalin|pregabalin|mesh-list
84077693|NCT00629681|Analgesics|analgesics|mesh-ancestor
84077694|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
84077695|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077696|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077697|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
84077698|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84077699|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84077700|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077701|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84077702|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84077703|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84077704|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077705|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84077706|NCT02617485|Prednisone|prednisone|mesh-list
84077707|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
84077708|NCT02617485|Rituximab|rituximab|mesh-list
84077709|NCT02617485|Doxorubicin|doxorubicin|mesh-list
84077710|NCT02617485|Vincristine|vincristine|mesh-list
84077711|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84077712|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
84077713|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077714|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077715|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84077716|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
84077717|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077718|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077719|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84077720|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84077721|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84077722|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84077723|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84077724|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077725|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077726|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
84077727|NCT02617485|Hormones|hormones|mesh-ancestor
84077728|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077729|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84077730|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84077731|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
84077732|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
84077733|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
84077734|NCT04289207|Danazol|danazol|mesh-list
84077735|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84077736|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
84077737|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077738|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077739|NCT02863835|Albuterol|albuterol|mesh-list
84077740|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84077741|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
84077742|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077743|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077744|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84077745|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
84077746|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
84077747|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84077748|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84077749|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84077750|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84077751|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077752|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077753|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077754|NCT00697437|Ketoconazole|ketoconazole|mesh-list
84077755|NCT00697437|Docetaxel|docetaxel|mesh-list
84077756|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077757|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
84077758|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
84077759|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
84077760|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077761|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
84077762|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077763|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84077764|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84077765|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077766|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84077767|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
84077768|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077769|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077770|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84077771|NCT04252274|Darunavir|darunavir|mesh-list
84077772|NCT04252274|Cobicistat|cobicistat|mesh-list
84077773|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
84077774|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84077775|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84077776|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
84077777|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077778|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077779|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84077780|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84077781|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
84077782|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373214|NCT00611325|Bortezomib|bortezomib|mesh-list
84077783|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84077784|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84077785|NCT00864513|Pemetrexed|pemetrexed|mesh-list
84077786|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077787|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077788|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077789|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84077790|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84077791|NCT04128891|Valsartan|valsartan|mesh-list
84077792|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84077793|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84077794|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84077795|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84077796|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077797|NCT04251962|Fentanyl|fentanyl|mesh-list
84077798|NCT04251962|Bupivacaine|bupivacaine|mesh-list
84077799|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
84077800|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
84077801|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077802|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077803|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
84077804|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077805|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84077806|NCT04251962|Narcotics|narcotics|mesh-ancestor
84077807|NCT04251962|Analgesics|analgesics|mesh-ancestor
84077808|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84077809|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84077810|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
84077811|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
84077812|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84077813|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077814|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84077815|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077816|NCT04250948|Capecitabine|capecitabine|mesh-list
84077817|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
84077818|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84077819|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
84077820|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077821|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077822|NCT05251766|Paclitaxel|paclitaxel|mesh-list
84077823|NCT05251766|Docetaxel|docetaxel|mesh-list
84077824|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84077825|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077826|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
84077827|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
84077828|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
84077829|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077830|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
84077831|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84077832|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077833|NCT00631514|Acetaminophen|acetaminophen|mesh-list
84077834|NCT00631514|Ibuprofen|ibuprofen|mesh-list
84077835|NCT00631514|Piroxicam|piroxicam|mesh-list
84077836|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077837|NCT00631514|Analgesics|analgesics|mesh-ancestor
84077838|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
84077839|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077840|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077841|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
84077842|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84077843|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84077844|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077845|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84077846|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077847|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077848|NCT04623944|Cytarabine|cytarabine|mesh-list
84077849|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
84077850|NCT04623944|Fludarabine|fludarabine|mesh-list
84077851|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84077852|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
84077853|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077854|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077855|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84077856|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
84077857|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077858|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077859|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84077860|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84077861|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
84077862|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
84077863|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077864|NCT05253014|Acetaminophen|acetaminophen|mesh-list
84077865|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84077866|NCT05253014|Analgesics|analgesics|mesh-ancestor
84077867|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
84077868|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077869|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077870|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
84077871|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
84077872|NCT00659425|Immunotoxins|immunotoxins|mesh-ancestor
84077873|NCT00659425|Immunoconjugates|immunoconjugates|mesh-ancestor
84077874|NCT00659425|Immunologic Factors|immunologic factors|mesh-ancestor
84077875|NCT00659425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077876|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077877|NCT00656851|Pioglitazone|pioglitazone|mesh-list
84077878|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84077879|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077880|NCT00803335|Estrogens|estrogens|mesh-list
84077881|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84077882|NCT00803335|Hormones|hormones|mesh-ancestor
84077883|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84077884|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077885|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
84077886|NCT00656617|Cytarabine|cytarabine|mesh-list
84077887|NCT00656617|Vorinostat|vorinostat|mesh-list
84077888|NCT00656617|Idarubicin|idarubicin|mesh-list
84077889|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84077890|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
84077891|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077892|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077893|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
84077894|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077895|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84077896|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
84077897|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077898|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84077899|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077900|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84077901|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84077902|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84077903|NCT00798343|Vaccines|vaccines|mesh-list
84077904|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
84077905|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077906|NCT00803725|Fentanyl|fentanyl|mesh-list
84077907|NCT00803725|Mepivacaine|mepivacaine|mesh-list
84077908|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84077909|NCT00803725|Narcotics|narcotics|mesh-ancestor
84077910|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84077911|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077912|NCT00803725|Analgesics|analgesics|mesh-ancestor
84077913|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
84077914|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077915|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84077916|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84077917|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
84077918|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
84077919|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
84077920|NCT00803803|Pilocarpine|pilocarpine|mesh-list
84077921|NCT00803803|Miotics|miotics|mesh-ancestor
84077922|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
84077923|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077924|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077925|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84077926|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84077927|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
84077928|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077929|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077930|NCT04775329|Rifaximin|rifaximin|mesh-list
84077931|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84077932|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077933|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84077934|NCT00659269|Vitamins|vitamins|mesh-list
84077935|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
84077936|NCT00659269|Hydroxocobalamin|hydroxocobalamin|mesh-list
84077937|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
84077938|NCT00659269|Pyridoxal|pyridoxal|mesh-list
84077939|NCT00659269|Pyridoxine|pyridoxine|mesh-list
84077940|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
84077941|NCT00659269|Vincristine|vincristine|mesh-list
84077942|NCT00659269|Vinorelbine|vinorelbine|mesh-list
84077943|NCT00659269|Docetaxel|docetaxel|mesh-list
84077944|NCT00659269|Cisplatin|cisplatin|mesh-list
84077945|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
84077946|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84077947|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077948|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
84077949|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
84077950|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
84077951|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077952|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
84077953|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077954|NCT00659269|Hematinics|hematinics|mesh-ancestor
84077955|NCT00922129|Cyclosporine|cyclosporine|mesh-list
84077956|NCT00922129|Sirolimus|sirolimus|mesh-list
84077957|NCT00922129|Temsirolimus|temsirolimus|mesh-list
84077958|NCT00922129|MTOR Inhibitors|mtor inhibitors|mesh-list
84077959|NCT00922129|Tacrolimus|tacrolimus|mesh-list
84077960|NCT00922129|Cyclosporins|cyclosporins|mesh-list
84077961|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84077962|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
84077963|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077964|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84077965|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84077966|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077967|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
84077968|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84077969|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
84077970|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84077971|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84077972|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84077973|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84077974|NCT00922129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84077975|NCT00806299|Loperamide|loperamide|mesh-list
83317994|NCT01822561|Diuretics|diuretics|mesh-ancestor
84077976|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
84077977|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84077978|NCT00804115|Timolol|timolol|mesh-list
84077979|NCT00804115|Latanoprost|latanoprost|mesh-list
84077980|NCT00804115|Pilocarpine|pilocarpine|mesh-list
84077981|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84077982|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84077983|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
84077984|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84077985|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84077986|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84077987|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84077988|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84077989|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84077990|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84077991|NCT00804115|Miotics|miotics|mesh-ancestor
84077992|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
84077993|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84077994|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84077995|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84077996|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
84077997|NCT02554123|Vitamin E|vitamin e|mesh-list
84077998|NCT02554123|Petrolatum|petrolatum|mesh-list
84077999|NCT02554123|Vitamins|vitamins|mesh-ancestor
84078000|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
84078001|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078002|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
84078003|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078004|NCT02554123|Protective Agents|protective agents|mesh-ancestor
84078005|NCT02554123|Emollients|emollients|mesh-ancestor
84078006|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
84078007|NCT00799045|Clopidogrel|clopidogrel|mesh-list
84078008|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84078009|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84078010|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84078011|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84078012|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
84078013|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078014|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078015|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078016|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
84078017|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84078018|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078019|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84078020|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
84078021|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84078022|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078023|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078024|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078025|NCT00804271|Memantine|memantine|mesh-list
84078026|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84078027|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84078028|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
84078029|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078030|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078031|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078032|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84078033|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84078034|NCT00799201|Naloxone|naloxone|mesh-list
84078035|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84078036|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078037|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
84078038|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078039|NCT00806611|Ethanol|ethanol|mesh-list
84078040|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84078041|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078042|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078043|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078044|NCT00799513|Lenalidomide|lenalidomide|mesh-list
84078045|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
84078046|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078047|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84078048|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84078049|NCT00799513|Growth Substances|growth substances|mesh-ancestor
84078050|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
84078051|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078052|NCT00806767|Fludarabine|fludarabine|mesh-list
84078053|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
84078054|NCT00806767|Busulfan|busulfan|mesh-list
84078055|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
84078056|NCT00806767|Antibodies|antibodies|mesh-list
84078057|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
84078058|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84078059|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84078060|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078061|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84078062|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
84078063|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078064|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078065|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
84078066|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078067|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
84078068|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84078069|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84078070|NCT00863655|Everolimus|everolimus|mesh-list
84078071|NCT00863655|Exemestane|exemestane|mesh-list
84078072|NCT00863655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84078073|NCT00863655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84078074|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078075|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078076|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078077|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
84078078|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078079|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078080|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84078081|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84078082|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84078083|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
84078084|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078085|NCT00806923|Bevacizumab|bevacizumab|mesh-list
84078086|NCT00806923|Gemcitabine|gemcitabine|mesh-list
84078087|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84078088|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078089|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84078090|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84078091|NCT00806923|Growth Substances|growth substances|mesh-ancestor
84078092|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078093|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
84078094|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84078095|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
84078096|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078097|NCT00698607|Sirolimus|sirolimus|mesh-list
84078098|NCT00698607|Everolimus|everolimus|mesh-list
84078099|NCT00698607|Clopidogrel|clopidogrel|mesh-list
84078100|NCT00698607|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84078101|NCT00698607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84078102|NCT00698607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078103|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078104|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078105|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
84078106|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078107|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078108|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84078109|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84078110|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84078111|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84078112|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
84078113|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078114|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84078115|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078116|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84078117|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
84078118|NCT04124757|Rocuronium|rocuronium|mesh-list
84078119|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84078120|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84078121|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84078122|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078123|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078124|NCT04123041|Nicotine|nicotine|mesh-list
84078125|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84078126|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
84078127|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078128|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078129|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84078130|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84078131|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
84078132|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318142|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078133|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078134|NCT00698763|Simendan|simendan|mesh-list
84078135|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84078136|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
84078137|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84078138|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84078139|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078140|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078141|NCT00698763|Protective Agents|protective agents|mesh-ancestor
84078142|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078143|NCT00804895|Cortivazol|cortivazol|mesh-list
84078144|NCT00804895|Verapamil|verapamil|mesh-list
84078145|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84078146|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84078147|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078148|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078149|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84078150|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078151|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
84078152|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078153|NCT00800137|Heparin|heparin|mesh-list
84078154|NCT00800137|Calcium heparin|calcium heparin|mesh-list
84078155|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84078156|NCT00800137|Tinzaparin|tinzaparin|mesh-list
84078157|NCT00800137|Dalteparin|dalteparin|mesh-list
84078158|NCT00800137|Warfarin|warfarin|mesh-list
84078159|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
84078160|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84078161|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84078162|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078163|NCT00807079|Carboplatin|carboplatin|mesh-list
84078164|NCT00807079|Topotecan|topotecan|mesh-list
84078165|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078166|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84078167|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84078168|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078169|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078170|NCT00800293|Betamethasone|betamethasone|mesh-list
84078171|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
84078172|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84078173|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
84078174|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84078175|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078176|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
84078177|NCT00800293|Hormones|hormones|mesh-ancestor
84078178|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078179|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078180|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84078181|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
84078182|NCT00658021|Exenatide|exenatide|mesh-list
84078183|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84078184|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078185|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84078186|NCT00658021|Incretins|incretins|mesh-ancestor
84078187|NCT00658021|Hormones|hormones|mesh-ancestor
84078188|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078189|NCT00920816|Sorafenib|sorafenib|mesh-list
84078190|NCT00920816|Axitinib|axitinib|mesh-list
84078191|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078192|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84078193|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078194|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078195|NCT00631592|Dolutegravir|dolutegravir|mesh-list
84078196|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84078197|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84078198|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078199|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078200|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84078201|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84078202|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
84078203|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078204|NCT05251610|Propranolol|propranolol|mesh-list
84078205|NCT05251610|Oxytocin|oxytocin|mesh-list
84078206|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
84078207|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84078208|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078209|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84078210|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84078211|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
84078212|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078213|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078214|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84078215|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84078216|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
84078217|NCT00657709|Vaccines|vaccines|mesh-list
84078218|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84078219|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
84078220|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078221|NCT00657553|Bortezomib|bortezomib|mesh-list
84078222|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078223|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
84078224|NCT04253912|Povidone|povidone|mesh-list
84078225|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
84078226|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
84078227|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84078228|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078229|NCT00800527|Diclofenac|diclofenac|mesh-list
84078230|NCT00800527|Gabapentin|gabapentin|mesh-list
84078231|NCT00800527|Analgesics|analgesics|mesh-ancestor
84078232|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
84078233|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078234|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078235|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
84078236|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84078237|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84078238|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078239|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84078240|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84078241|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84078242|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078243|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078244|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
84078245|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84078246|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078247|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078248|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078249|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84078250|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078251|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84078252|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84078253|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078254|NCT00862719|Incretins|incretins|mesh-ancestor
84078255|NCT00862719|Hormones|hormones|mesh-ancestor
84078256|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078257|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84078258|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
84078259|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078260|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078261|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
84078262|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078263|NCT00862641|Regadenoson|regadenoson|mesh-list
84078264|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84078265|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84078266|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
84078267|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
84078268|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078269|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078270|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078271|NCT04119921|Ketorolac|ketorolac|mesh-list
84078272|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84078273|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
84078274|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84078275|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078276|NCT04119921|Analgesics|analgesics|mesh-ancestor
84078277|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
84078278|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078279|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078280|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078281|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078282|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84078283|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078284|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078285|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84078286|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84078287|NCT00861471|Docetaxel|docetaxel|mesh-list
84078288|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
84078289|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078290|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
84078291|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
84078292|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
84078293|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078294|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84078295|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078296|NCT02613585|Permethrin|permethrin|mesh-list
84078297|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078298|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078299|NCT04119297|Heparinoids|heparinoids|mesh-list
84078300|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078301|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
84078302|NCT00699387|Benzonidazole|benzonidazole|mesh-list
84078303|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078304|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
84078305|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078306|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84078307|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84078308|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84078309|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078310|NCT00699465|Enoxaparin|enoxaparin|mesh-list
84078311|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
84078312|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
84078313|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84078314|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84078315|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078316|NCT00858117|Rituximab|rituximab|mesh-list
84078317|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
84078318|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84078319|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078320|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
84078321|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078322|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078323|NCT00700947|Metoprolol|metoprolol|mesh-list
84078324|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84078325|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84078326|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
84078327|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078328|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078329|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078330|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84078331|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84078332|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
84078333|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
84078334|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078335|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84078336|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84078337|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
84078338|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078339|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
84078340|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078341|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
84078342|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
84078343|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
84078344|NCT00805519|Chloroquine|chloroquine|mesh-list
84078345|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
84078346|NCT00805519|Prednisolone|prednisolone|mesh-list
84078347|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84078348|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
84078349|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84078350|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
84078351|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84078352|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
84078353|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078354|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
84078355|NCT00805519|Hormones|hormones|mesh-ancestor
84078356|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078357|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078358|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83318369|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078359|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078360|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
84078361|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
84078362|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078363|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84078364|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84078365|NCT00805519|Protective Agents|protective agents|mesh-ancestor
84078366|NCT00805519|Amebicides|amebicides|mesh-ancestor
84078367|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84078368|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84078369|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078370|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
84078371|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078372|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84078373|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078374|NCT00805519|Analgesics|analgesics|mesh-ancestor
84078375|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
84078376|NCT00805519|Filaricides|filaricides|mesh-ancestor
84078377|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
84078378|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
84078379|NCT00592683|Aripiprazole|aripiprazole|mesh-list
84078380|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
84078381|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84078382|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84078383|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84078384|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078385|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078386|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
84078387|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
84078388|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078389|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078390|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84078391|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84078392|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
84078393|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84078394|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84078395|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84078396|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84078397|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
84078398|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
84078399|NCT02613039|Estrogens|estrogens|mesh-list
84078400|NCT02613039|Progestins|progestins|mesh-list
84078401|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84078402|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078403|NCT02613039|Hormones|hormones|mesh-ancestor
84078404|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078405|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84078406|NCT00813475|Insulin|insulin|mesh-list
84078407|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84078408|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84078409|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078410|NCT00701259|Lansoprazole|lansoprazole|mesh-list
84078411|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
84078412|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84078413|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84078414|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84078415|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078416|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078417|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84078418|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84078419|NCT00701337|Estradiol|estradiol|mesh-list
84078420|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84078421|NCT00701337|Estrogens|estrogens|mesh-ancestor
84078422|NCT00701337|Hormones|hormones|mesh-ancestor
84078423|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078424|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078425|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84078426|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
84078427|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84078428|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84078429|NCT00654901|Vaccines|vaccines|mesh-list
84078430|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
84078431|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078432|NCT00701493|Topiramate|topiramate|mesh-list
84078433|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
84078434|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84078435|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078436|NCT04253678|Vortioxetine|vortioxetine|mesh-list
84078437|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
84078438|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84078439|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84078440|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84078441|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078442|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078443|NCT04253678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84078444|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84078445|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078446|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078447|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078448|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
84078449|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84078450|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84078451|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84078452|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84078453|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84078454|NCT00813631|Laxatives|laxatives|mesh-ancestor
84078455|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84078456|NCT02551861|Ribavirin|ribavirin|mesh-list
84078457|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
84078458|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
84078459|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078460|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
84078461|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078462|NCT00846495|Topiramate|topiramate|mesh-list
84078463|NCT00846495|Frovatriptan|frovatriptan|mesh-list
84078464|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
84078465|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84078466|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078467|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84078468|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
84078469|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078470|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078471|NCT00654745|Amlodipine|amlodipine|mesh-list
84078472|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84078473|NCT00654745|Olmesartan|olmesartan|mesh-list
84078474|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84078475|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84078476|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84078477|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078478|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078479|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84078480|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078481|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
84078482|NCT00654745|Diuretics|diuretics|mesh-ancestor
84078483|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
84078484|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84078485|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84078486|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84078487|NCT00809887|Micafungin|micafungin|mesh-list
84078488|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
84078489|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078490|NCT00846027|Paclitaxel|paclitaxel|mesh-list
84078491|NCT00846027|Bevacizumab|bevacizumab|mesh-list
84078492|NCT00846027|Gemcitabine|gemcitabine|mesh-list
84078493|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84078494|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078495|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
84078496|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
84078497|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
84078498|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078499|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84078500|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84078501|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84078502|NCT00846027|Growth Substances|growth substances|mesh-ancestor
84078503|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078504|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
84078505|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84078506|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
84078507|NCT00807625|Copper|copper|mesh-list
84078508|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84078509|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
84078510|NCT00807625|Trace Elements|trace elements|mesh-ancestor
84078511|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
84078512|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078513|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84078514|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
84078515|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84078516|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84078517|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84078518|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84078519|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078520|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84078521|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84078522|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84078523|NCT02551549|Rezafungin|rezafungin|mesh-list
84078524|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
84078525|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078526|NCT00810121|Ketoprofen|ketoprofen|mesh-list
84078527|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84078528|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078529|NCT00810121|Analgesics|analgesics|mesh-ancestor
84078530|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
84078531|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078532|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078533|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078534|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078535|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84078536|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078537|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078538|NCT00652327|Atorvastatin|atorvastatin|mesh-list
84078539|NCT00652327|Simvastatin|simvastatin|mesh-list
84078540|NCT00652327|Ezetimibe|ezetimibe|mesh-list
84078541|NCT00652327|Pravastatin|pravastatin|mesh-list
84078542|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
84078543|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84078544|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84078545|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
84078546|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078547|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84078548|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078549|NCT00814021|Sunitinib|sunitinib|mesh-list
84078550|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078551|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84078552|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84078553|NCT00814021|Growth Substances|growth substances|mesh-ancestor
84078554|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078555|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
84078556|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84078557|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078558|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078559|NCT00645853|Warfarin|warfarin|mesh-list
84078560|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
84078561|NCT00652093|Acetaminophen|acetaminophen|mesh-list
84078562|NCT00652093|Oxymorphone|oxymorphone|mesh-list
84078563|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
84078564|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
84078565|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
84078566|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078567|NCT00652093|Analgesics|analgesics|mesh-ancestor
84078568|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
84078569|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078570|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078571|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
84078572|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84078573|NCT00652093|Narcotics|narcotics|mesh-ancestor
84078574|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078575|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84078576|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
84078577|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
84078578|NCT00651937|Melphalan|melphalan|mesh-list
84078579|NCT00651937|Lenograstim|lenograstim|mesh-list
84078580|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84078581|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
84078582|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078583|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078584|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84078585|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318610|NCT00997906|Paclitaxel|paclitaxel|mesh-list
84078586|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
84078587|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078588|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84078589|NCT00654355|Tacrolimus|tacrolimus|mesh-list
84078590|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078591|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
84078592|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078593|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84078594|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078595|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078596|NCT00651313|Lidocaine|lidocaine|mesh-list
84078597|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
84078598|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
84078599|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078600|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078601|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
84078602|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078603|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84078604|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84078605|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84078606|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078607|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078608|NCT00808171|Lidocaine|lidocaine|mesh-list
84078609|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
84078610|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
84078611|NCT00808171|Prilocaine|prilocaine|mesh-list
84078612|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
84078613|NCT00808171|Anesthetics|anesthetics|mesh-list
84078614|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078615|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078616|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
84078617|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078618|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84078619|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84078620|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84078621|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078622|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078623|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84078624|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
84078625|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078626|NCT00808171|Analgesics|analgesics|mesh-ancestor
84078627|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
84078628|NCT04703257|Dipyrone|dipyrone|mesh-list
84078629|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84078630|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078631|NCT04703257|Analgesics|analgesics|mesh-ancestor
84078632|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
84078633|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078634|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078635|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078636|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078637|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
84078638|NCT00808327|Fentanyl|fentanyl|mesh-list
84078639|NCT00808327|Bupivacaine|bupivacaine|mesh-list
84078640|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
84078641|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
84078642|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078643|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078644|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
84078645|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078646|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84078647|NCT00808327|Narcotics|narcotics|mesh-ancestor
84078648|NCT00808327|Analgesics|analgesics|mesh-ancestor
84078649|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84078650|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84078651|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
84078652|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84078653|NCT00814723|Ezetimibe|ezetimibe|mesh-list
84078654|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84078655|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84078656|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
84078657|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078658|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84078659|NCT00845871|Deferasirox|deferasirox|mesh-list
84078660|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84078661|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
84078662|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
84078663|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078664|NCT02864849|Capecitabine|capecitabine|mesh-list
84078665|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
84078666|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84078667|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
84078668|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078669|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078670|NCT00701961|Artesunate|artesunate|mesh-list
84078671|NCT00701961|Mefloquine|mefloquine|mesh-list
84078672|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
84078673|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84078674|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84078675|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078676|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078677|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
84078678|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
84078679|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84078680|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
84078681|NCT04286711|Paclitaxel|paclitaxel|mesh-list
84078682|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84078683|NCT04286711|Apatinib|apatinib|mesh-list
84078684|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84078685|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078686|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
84078687|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
84078688|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
84078689|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078690|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84078691|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078692|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
84078693|NCT02863913|Interleukin-2|interleukin-2|mesh-list
84078694|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078695|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
84078696|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078697|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078698|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84078699|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
84078700|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078701|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078702|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84078703|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078704|NCT02863913|Analgesics|analgesics|mesh-ancestor
84078705|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
84078706|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078707|NCT02612649|Ramosetron|ramosetron|mesh-list
84078708|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
84078709|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
84078710|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078711|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078712|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84078713|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84078714|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
84078715|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078716|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078717|NCT04908800|Itraconazole|itraconazole|mesh-list
84078718|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
84078719|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078720|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84078721|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84078722|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078723|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078724|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84078725|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
84078726|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078727|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078728|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84078729|NCT00844857|Olanzapine|olanzapine|mesh-list
84078730|NCT00844857|Fluoxetine|fluoxetine|mesh-list
84078731|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
84078732|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
84078733|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078734|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078735|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84078736|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84078737|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84078738|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078739|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84078740|NCT00844857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84078741|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84078742|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078743|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078744|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078745|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
84078746|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84078747|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
84078748|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84078749|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84078750|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078751|NCT00702117|Flecainide|flecainide|mesh-list
84078752|NCT00702117|Procainamide|procainamide|mesh-list
84078753|NCT00702117|Ajmaline|ajmaline|mesh-list
84078754|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84078755|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84078756|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84078757|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078758|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078759|NCT00913107|Lamotrigine|lamotrigine|mesh-list
84078760|NCT00913107|Carbamazepine|carbamazepine|mesh-list
84078761|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
84078762|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84078763|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078764|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078765|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84078766|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078767|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84078768|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84078769|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078770|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84078771|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84078772|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
84078773|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078774|NCT00913107|Analgesics|analgesics|mesh-ancestor
84078775|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
84078776|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078777|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84078778|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84078779|NCT00569803|Abatacept|abatacept|mesh-list
84078780|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84078781|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078782|NCT00569803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84078783|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078784|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078785|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
84078786|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078787|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078788|NCT00920426|Cabotegravir|cabotegravir|mesh-list
84078789|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84078790|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84078791|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078792|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078793|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84078794|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84078795|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
84078796|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078797|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84078798|NCT04046185|Progesterone|progesterone|mesh-list
84078799|NCT04046185|Progestins|progestins|mesh-ancestor
84078800|NCT04046185|Hormones|hormones|mesh-ancestor
84078801|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078802|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078803|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078804|NCT04046185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84078805|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078806|NCT00810589|Insulin|insulin|mesh-list
84078807|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84078808|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
84078809|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
84078810|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84078811|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078812|NCT00810667|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
84078813|NCT00810667|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84078815|NCT00810667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078816|NCT00810667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078817|NCT00810667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078818|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
84078819|NCT04253132|Analgesics|analgesics|mesh-ancestor
84078820|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
84078821|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078822|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078823|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84078824|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078825|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84078826|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84078827|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84078828|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84078829|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078830|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84078831|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
84078832|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
84078833|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078834|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84078835|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
84078836|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078837|NCT00914966|Complement C1s|complement c1s|mesh-list
84078838|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
84078839|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
84078840|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
84078841|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078842|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84078843|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078844|NCT00815269|Sevoflurane|sevoflurane|mesh-list
84078845|NCT00815269|Desflurane|desflurane|mesh-list
84078846|NCT00815269|Isoflurane|isoflurane|mesh-list
84078847|NCT00815269|Halothane|halothane|mesh-list
84078848|NCT00815269|Enflurane|enflurane|mesh-list
84078849|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84078850|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84078851|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
84078852|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
84078853|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078854|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078855|NCT00914810|Vitamin D|vitamin d|mesh-list
84078856|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
84078857|NCT00914810|Vitamins|vitamins|mesh-ancestor
84078858|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
84078859|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078860|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84078861|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84078862|NCT00808717|Atorvastatin|atorvastatin|mesh-list
84078863|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84078864|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84078865|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
84078866|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078867|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84078868|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84078869|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078870|NCT00914732|Vaccines|vaccines|mesh-list
84078871|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
84078872|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078873|NCT00844545|Eculizumab|eculizumab|mesh-list
84078874|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84078875|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84078876|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
84078877|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078878|NCT00815503|Ropivacaine|ropivacaine|mesh-list
84078879|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
84078880|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
84078881|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078882|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078883|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
84078884|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078885|NCT00702819|Bevacizumab|bevacizumab|mesh-list
84078886|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84078887|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078888|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84078889|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84078890|NCT00702819|Growth Substances|growth substances|mesh-ancestor
84078891|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078892|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
84078893|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
84078894|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
84078895|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
84078896|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078897|NCT00842985|Dronabinol|dronabinol|mesh-list
84078898|NCT00842985|Modafinil|modafinil|mesh-list
84078899|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84078900|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078901|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84078902|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84078903|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84078904|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078905|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
84078906|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84078907|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84078908|NCT00842985|Analgesics|analgesics|mesh-ancestor
84078909|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
84078910|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078911|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84078912|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84078913|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84078914|NCT00842985|Hormones|hormones|mesh-ancestor
84078915|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078916|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
84078917|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84078918|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
84078919|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078920|NCT00808795|Expectorants|expectorants|mesh-ancestor
84078921|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
84078922|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84078923|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
84078924|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078925|NCT00808795|Protective Agents|protective agents|mesh-ancestor
84078926|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078927|NCT00808795|Antidotes|antidotes|mesh-ancestor
84078928|NCT00808951|Artesunate|artesunate|mesh-list
84078929|NCT00808951|Lumefantrine|lumefantrine|mesh-list
84078930|NCT00808951|Artemether|artemether|mesh-list
84078931|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84078932|NCT00808951|Amodiaquine|amodiaquine|mesh-list
84078933|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
84078934|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84078935|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84078936|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84078937|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078938|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
84078939|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
84078940|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84078941|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
84078942|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
84078943|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84078944|NCT00809029|Incretins|incretins|mesh-ancestor
84078945|NCT00809029|Hormones|hormones|mesh-ancestor
84078946|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078947|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078948|NCT00842829|Fentanyl|fentanyl|mesh-list
84078949|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84078950|NCT00842829|Narcotics|narcotics|mesh-ancestor
84078951|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84078952|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078953|NCT00842829|Analgesics|analgesics|mesh-ancestor
84078954|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
84078955|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84078956|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84078957|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84078958|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
84078959|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
84078961|NCT04045093|Dabigatran|dabigatran|mesh-list
84078962|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
84078963|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
84078964|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84078965|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
84078966|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84078967|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84078968|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
84078969|NCT00811291|Folic Acid|folic acid|mesh-list
84078970|NCT00811291|Calcium|calcium|mesh-list
84078971|NCT00811291|Vitamins|vitamins|mesh-ancestor
84078972|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
84078973|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078974|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84078975|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84078976|NCT00811291|Hematinics|hematinics|mesh-ancestor
84078977|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
84078978|NCT00811369|Fulvestrant|fulvestrant|mesh-list
84078979|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84078980|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078981|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84078982|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84078983|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
84078984|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84078985|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078986|NCT00842361|Insulin|insulin|mesh-list
84078987|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84078988|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
84078989|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
84078990|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84078991|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
84078992|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84078993|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84078994|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84078995|NCT00811447|Docetaxel|docetaxel|mesh-list
84078996|NCT00811447|Fluorouracil|fluorouracil|mesh-list
84078997|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84078998|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
84078999|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
84079000|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
84079001|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079002|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
84079003|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079004|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84079005|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
84079006|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079007|NCT00702975|Paclitaxel|paclitaxel|mesh-list
84079008|NCT00702975|Bevacizumab|bevacizumab|mesh-list
84079009|NCT00702975|Carboplatin|carboplatin|mesh-list
84079010|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84079011|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84079012|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079013|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
84079014|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
84079015|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
84079016|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079017|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84079018|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84079019|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84079020|NCT00702975|Growth Substances|growth substances|mesh-ancestor
84079021|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079022|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
84079023|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079024|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079025|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84079026|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84079027|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079028|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
84079029|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84079030|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319042|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319043|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319053|NCT00608062|Estradiol|estradiol|mesh-list
84079031|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079032|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84079033|NCT02612181|Analgesics|analgesics|mesh-ancestor
84079034|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
84079035|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079036|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84079037|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84079038|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84079039|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
84079040|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079041|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079042|NCT02612259|Tryptophan|tryptophan|mesh-list
84079043|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84079044|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
84079045|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079046|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84079047|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079048|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079049|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079050|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079051|NCT00642811|Aspirin|aspirin|mesh-list
84079052|NCT00642811|Clopidogrel|clopidogrel|mesh-list
84079053|NCT00642811|Ticagrelor|ticagrelor|mesh-list
84079054|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84079055|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84079056|NCT00642811|Analgesics|analgesics|mesh-ancestor
84079057|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
84079058|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079059|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079060|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84079061|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84079062|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84079063|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84079064|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079065|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84079066|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84079067|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079068|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
84079069|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84079070|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84079071|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84079072|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
84079073|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079074|NCT00838929|Vorinostat|vorinostat|mesh-list
84079075|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079076|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84079077|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079078|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079079|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84079080|NCT00811603|Cefazolin|cefazolin|mesh-list
84079081|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079082|NCT00811681|Pioglitazone|pioglitazone|mesh-list
84079083|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84079084|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079085|NCT00811759|Temozolomide|temozolomide|mesh-list
84079086|NCT00811759|Sorafenib|sorafenib|mesh-list
84079087|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84079088|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
84079089|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079090|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079091|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079092|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079093|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
84079094|NCT00815893|Propofol|propofol|mesh-list
84079095|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84079096|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079097|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079098|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84079099|NCT00815893|Analgesics|analgesics|mesh-ancestor
84079100|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
84079101|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079102|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84079103|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84079104|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84079105|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
84079106|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079107|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079108|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84079109|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
84079111|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
84079112|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
84079113|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373231|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079114|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079115|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079116|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84079117|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
84079118|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079119|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84079120|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079121|NCT04648891|Lidocaine|lidocaine|mesh-list
84079122|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079123|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
84079124|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079125|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079126|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
84079127|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079128|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84079129|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84079130|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84079131|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079132|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079133|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
84079134|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84079135|NCT00811837|Midazolam|midazolam|mesh-list
84079136|NCT00811837|Remifentanil|remifentanil|mesh-list
84079137|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84079138|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84079139|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079140|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079141|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84079142|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84079143|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079144|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84079145|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
84079146|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
84079147|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
84079148|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
84079149|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079150|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079151|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84079152|NCT00811837|Narcotics|narcotics|mesh-ancestor
84079153|NCT00811837|Analgesics|analgesics|mesh-ancestor
84079154|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
84079155|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079156|NCT00811915|Sirolimus|sirolimus|mesh-list
84079157|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84079158|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079159|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84079160|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079161|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
84079162|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84079163|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
84079164|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079165|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
84079166|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
84079167|NCT00816127|Coagulants|coagulants|mesh-ancestor
84079168|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84079169|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
84079170|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079171|NCT00916058|Melphalan|melphalan|mesh-list
84079172|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84079173|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84079174|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
84079175|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079176|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079177|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84079178|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84079179|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
84079180|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079181|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
84079182|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079183|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
84079184|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079185|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079186|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
84079187|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079188|NCT00912782|Vitamin D|vitamin d|mesh-list
84079189|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
84079190|NCT00912782|Vitamins|vitamins|mesh-ancestor
84079191|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
84079192|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079193|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84079194|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84079195|NCT04202978|Capecitabine|capecitabine|mesh-list
84079196|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
84079197|NCT04202978|Apatinib|apatinib|mesh-list
84079198|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079199|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
84079200|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079201|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079202|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079203|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079204|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
84079205|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84079206|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84079207|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84079208|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079209|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079210|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
84079211|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079212|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079213|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84079214|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079215|NCT04203368|Adenosine|adenosine|mesh-list
84079216|NCT04203368|Verapamil|verapamil|mesh-list
84079217|NCT04203368|Analgesics|analgesics|mesh-ancestor
84079218|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
84079219|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079220|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079221|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84079222|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
84079223|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84079224|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
84079225|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
84079226|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079227|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079228|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84079229|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079230|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84079231|NCT04133948|Nivolumab|nivolumab|mesh-list
84079232|NCT04133948|Ipilimumab|ipilimumab|mesh-list
84079233|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84079234|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079235|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84079236|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079237|NCT00911534|Rabeprazole|rabeprazole|mesh-list
84079238|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84079239|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84079240|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84079241|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079242|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079243|NCT00911300|Vitamin K|vitamin k|mesh-list
84079244|NCT00911300|Heparin|heparin|mesh-list
84079245|NCT00911300|Calcium heparin|calcium heparin|mesh-list
84079246|NCT00911300|PENTA|penta|mesh-list
84079247|NCT00911300|Fondaparinux|fondaparinux|mesh-list
84079248|NCT00911300|Vitamins|vitamins|mesh-ancestor
84079249|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
84079250|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079251|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
84079252|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84079253|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84079254|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319262|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84079255|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84079256|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
84079257|NCT00911300|Coagulants|coagulants|mesh-ancestor
84079258|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84079259|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
84079260|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84079261|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
84079262|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079263|NCT00911144|Vaccines|vaccines|mesh-list
84079264|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84079265|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
84079266|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079267|NCT04395248|Anesthetics|anesthetics|mesh-list
84079268|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079269|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079270|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
84079271|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84079272|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079273|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079274|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84079275|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079276|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84079277|NCT04276298|Metronidazole|metronidazole|mesh-list
84079278|NCT04276298|Lidocaine|lidocaine|mesh-list
84079279|NCT04276298|Diltiazem|diltiazem|mesh-list
84079280|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079281|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
84079282|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079283|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079284|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
84079285|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079286|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84079287|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84079288|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84079289|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079290|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079291|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079292|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84079293|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84079294|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84079295|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84079296|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84079297|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84079298|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
84079299|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
84079300|NCT04273880|Methylphenidate|methylphenidate|mesh-list
84079301|NCT04273880|Vitamins|vitamins|mesh-ancestor
84079302|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
84079303|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079304|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
84079305|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079306|NCT04273880|Protective Agents|protective agents|mesh-ancestor
84079307|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84079308|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84079309|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84079310|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079311|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
84079312|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079313|NCT00910988|Olanzapine|olanzapine|mesh-list
84079314|NCT00910988|Ziprasidone|ziprasidone|mesh-list
84079315|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
84079316|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
84079317|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079318|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079319|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84079320|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84079321|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84079322|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079323|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079324|NCT00910988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84079325|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84079326|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079327|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079328|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079330|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84079331|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84079332|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
84079333|NCT00644059|Vaccines|vaccines|mesh-list
84079334|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
84079335|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079336|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
84079337|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84079338|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079339|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84079340|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
84079341|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84079342|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079343|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079344|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079345|NCT00811993|Etoposide|etoposide|mesh-list
84079346|NCT00811993|Docetaxel|docetaxel|mesh-list
84079347|NCT00811993|Bevacizumab|bevacizumab|mesh-list
84079348|NCT00811993|Carboplatin|carboplatin|mesh-list
84079349|NCT00811993|Gemcitabine|gemcitabine|mesh-list
84079350|NCT00811993|Capecitabine|capecitabine|mesh-list
84079351|NCT00811993|Trastuzumab|trastuzumab|mesh-list
84079352|NCT00811993|Irinotecan|irinotecan|mesh-list
84079353|NCT00811993|Cetuximab|cetuximab|mesh-list
84079354|NCT00811993|Temozolomide|temozolomide|mesh-list
84079355|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84079356|NCT00811993|Sorafenib|sorafenib|mesh-list
84079357|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84079358|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079359|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
84079360|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
84079361|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
84079362|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079363|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84079364|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84079365|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84079366|NCT00811993|Growth Substances|growth substances|mesh-ancestor
84079367|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079368|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
84079369|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079370|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
84079371|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84079372|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84079373|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079374|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84079375|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84079376|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
84079377|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079378|NCT00817765|Ritonavir|ritonavir|mesh-list
84079379|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
84079380|NCT00817765|Posaconazole|posaconazole|mesh-list
84079381|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84079382|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84079383|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
84079384|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079385|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079386|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84079387|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84079388|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
84079389|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079390|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84079391|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84079392|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
84079393|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84079394|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84079395|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84079396|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84079397|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84079398|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
84079399|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84079400|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079401|NCT00816205|Nifedipine|nifedipine|mesh-list
84079402|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84079403|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079404|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079405|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84079406|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079407|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
84079408|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
84079409|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84079410|NCT00816283|Dasatinib|dasatinib|mesh-list
84079411|NCT00816283|Vorinostat|vorinostat|mesh-list
84079412|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079413|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079414|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079415|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079416|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84079417|NCT00910910|Lenalidomide|lenalidomide|mesh-list
84079418|NCT00910910|Chlorambucil|chlorambucil|mesh-list
84079419|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
84079420|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079421|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84079422|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84079423|NCT00910910|Growth Substances|growth substances|mesh-ancestor
84079424|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
84079425|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079426|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84079427|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
84079428|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079429|NCT04522544|Durvalumab|durvalumab|mesh-list
84079430|NCT04522544|Tremelimumab|tremelimumab|mesh-list
84079431|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84079432|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079433|NCT04384562|Methylphenidate|methylphenidate|mesh-list
84079434|NCT04384562|Reboxetine|reboxetine|mesh-list
84079435|NCT04384562|Nicotine|nicotine|mesh-list
84079436|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84079437|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
84079438|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079439|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079440|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84079441|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84079442|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
84079443|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079444|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079445|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84079446|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84079447|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84079448|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079449|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
84079450|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
84079451|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079452|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84079453|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
84079454|NCT04515134|Ubiquinone|ubiquinone|mesh-list
84079455|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
84079456|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
84079457|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079458|NCT04515134|Vitamins|vitamins|mesh-ancestor
84079459|NCT04238390|Meropenem|meropenem|mesh-list
84079460|NCT04238390|Tazobactam|tazobactam|mesh-list
84079461|NCT04238390|Ceftolozane|ceftolozane|mesh-list
84079462|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
84079463|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84079464|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079465|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84079466|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079467|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079468|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84079469|NCT04236830|Fluorides|fluorides|mesh-list
84079470|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
84079471|NCT04236830|Protective Agents|protective agents|mesh-ancestor
84079472|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079473|NCT04203212|Goserelin|goserelin|mesh-list
84079474|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84079475|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079476|NCT00637910|Docetaxel|docetaxel|mesh-list
84079477|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84079478|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079479|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
84079480|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
84079481|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
84079482|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079483|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079484|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079485|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
84079486|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84079487|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84079488|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84079489|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079490|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079491|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
84079492|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079493|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079494|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84079495|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079496|NCT04449536|Mesna|mesna|mesh-list
84079497|NCT04449536|Protective Agents|protective agents|mesh-ancestor
84079498|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079499|NCT03960554|Denosumab|denosumab|mesh-list
84079500|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84079501|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079502|NCT04084106|Amoxicillin|amoxicillin|mesh-list
84079503|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
84079504|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
84079505|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84079506|NCT04084106|Penicillin V|penicillin v|mesh-list
84079507|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84079508|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079509|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079510|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079511|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84079512|NCT02977052|Nivolumab|nivolumab|mesh-list
84079513|NCT02977052|Ipilimumab|ipilimumab|mesh-list
84079514|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84079515|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079516|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84079517|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079518|NCT02973542|Ethosuximide|ethosuximide|mesh-list
84079519|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
84079520|NCT02973386|Cisplatin|cisplatin|mesh-list
84079521|NCT02973386|Capecitabine|capecitabine|mesh-list
84079522|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079523|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079524|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
84079525|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079526|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
84079527|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84079528|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84079529|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
84079530|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079531|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079532|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079533|NCT00909428|Urological Agents|urological agents|mesh-ancestor
84079534|NCT03718130|Vaccines|vaccines|mesh-list
84079535|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
84079536|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079537|NCT00908960|Enoxaparin|enoxaparin|mesh-list
84079538|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
84079539|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84079540|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84079541|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079542|NCT05332106|Dienogest|dienogest|mesh-list
84079543|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84079544|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84079545|NCT05332106|Estradiol|estradiol|mesh-list
84079546|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84079547|NCT05332106|Nandrolone|nandrolone|mesh-list
84079548|NCT05332106|Estrogens|estrogens|mesh-ancestor
84079549|NCT05332106|Hormones|hormones|mesh-ancestor
84079550|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84079551|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079552|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84079553|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
84079554|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84079555|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84079556|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84079557|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84079558|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84079559|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
84079560|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83373238|NCT01534208|Clomiphene|clomiphene|mesh-list
84079561|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079562|NCT05332106|Androgens|androgens|mesh-ancestor
84079563|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
84079564|NCT05332028|Fentanyl|fentanyl|mesh-list
84079565|NCT05332028|Bupivacaine|bupivacaine|mesh-list
84079566|NCT05332028|Propofol|propofol|mesh-list
84079567|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079568|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
84079569|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079570|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079571|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
84079572|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079573|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84079574|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84079575|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
84079576|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84079577|NCT05332028|Narcotics|narcotics|mesh-ancestor
84079578|NCT05332028|Analgesics|analgesics|mesh-ancestor
84079579|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84079580|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
84079581|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84079582|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84079583|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84079584|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079585|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079586|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
84079587|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079588|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079589|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84079590|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079591|NCT00643201|Enoxaparin|enoxaparin|mesh-list
84079592|NCT00643201|Warfarin|warfarin|mesh-list
84079593|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
84079594|NCT00643201|Apixaban|apixaban|mesh-list
84079595|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
84079596|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84079597|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84079598|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079599|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84079600|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
84079601|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84079602|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
84079603|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079604|NCT00643123|Allopurinol|allopurinol|mesh-list
84079605|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
84079606|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079607|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079608|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
84079609|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84079610|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84079611|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
84079612|NCT00643123|Protective Agents|protective agents|mesh-ancestor
84079613|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079614|NCT00816673|Melatonin|melatonin|mesh-list
84079615|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
84079616|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079617|NCT00816673|Protective Agents|protective agents|mesh-ancestor
84079618|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079619|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079620|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84079621|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84079622|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84079623|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079624|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079625|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079626|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079627|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
84079628|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079629|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84079630|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84079631|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84079632|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079633|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079634|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079635|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079636|NCT00641719|Analgesics|analgesics|mesh-ancestor
84079637|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
84079638|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079639|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
84079640|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079641|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
84079642|NCT02863367|Gemcitabine|gemcitabine|mesh-list
84079643|NCT02863367|Apatinib|apatinib|mesh-list
84079644|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079645|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
84079646|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079647|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079648|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079649|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079650|NCT00648895|Metoprolol|metoprolol|mesh-list
84079651|NCT00648895|Nebivolol|nebivolol|mesh-list
84079652|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84079653|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84079654|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
84079655|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
84079656|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079657|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079658|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84079659|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84079660|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84079661|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
84079662|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079663|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079664|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
84079665|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84079666|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84079667|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84079668|NCT00975221|Cinacalcet|cinacalcet|mesh-list
84079669|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84079670|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079671|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
84079672|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
84079673|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84079674|NCT02863679|Tetracaine|tetracaine|mesh-list
84079675|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079676|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
84079677|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079678|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079679|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
84079680|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079681|NCT00906698|Vinorelbine|vinorelbine|mesh-list
84079682|NCT00906698|Afatinib|afatinib|mesh-list
84079683|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84079684|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079685|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
84079686|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
84079687|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
84079688|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079689|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079690|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079691|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84079692|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84079693|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
84079694|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079695|NCT03396926|Bevacizumab|bevacizumab|mesh-list
84079696|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84079697|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
84079698|NCT03396926|Capecitabine|capecitabine|mesh-list
84079699|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
84079700|NCT03396926|Antibodies|antibodies|mesh-list
84079701|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
84079702|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84079703|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
84079704|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079705|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83319711|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84079706|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84079707|NCT03396926|Growth Substances|growth substances|mesh-ancestor
84079708|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079709|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
84079710|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
84079711|NCT03396926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84079712|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079713|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079714|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
84079715|NCT00971945|Paclitaxel|paclitaxel|mesh-list
84079716|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84079717|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079718|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
84079719|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
84079720|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
84079721|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079722|NCT03672500|Epinephrine|epinephrine|mesh-list
84079723|NCT03672500|Bupivacaine|bupivacaine|mesh-list
84079724|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079725|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
84079726|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079727|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079728|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
84079729|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079730|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84079731|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84079732|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
84079733|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079734|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079735|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84079736|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84079737|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
84079738|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84079739|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
84079740|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
84079741|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
84079742|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84079743|NCT00971867|Paclitaxel|paclitaxel|mesh-list
84079744|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84079745|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079746|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
84079747|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
84079748|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
84079749|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079750|NCT00812851|Dronabinol|dronabinol|mesh-list
84079751|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
84079752|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079753|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079754|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84079755|NCT00812851|Analgesics|analgesics|mesh-ancestor
84079756|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
84079757|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079758|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84079759|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84079760|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079761|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079762|NCT00812851|Hormones|hormones|mesh-ancestor
84079763|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84079764|NCT00648037|Rituximab|rituximab|mesh-list
84079765|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84079766|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079767|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
84079768|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079769|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84079770|NCT00817375|Milnacipran|milnacipran|mesh-list
84079771|NCT00817375|Mirtazapine|mirtazapine|mesh-list
84079772|NCT00817375|Sertraline|sertraline|mesh-list
84079773|NCT00817375|Fluoxetine|fluoxetine|mesh-list
84079774|NCT00817375|Paroxetine|paroxetine|mesh-list
84079775|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84079776|NCT00817375|Nortriptyline|nortriptyline|mesh-list
84079777|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
84079778|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84079779|NCT00817375|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84079780|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84079781|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079782|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079783|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079784|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
84079785|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079786|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84079787|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84079788|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84079789|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079790|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84079791|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84079792|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
84079793|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
84079794|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84079795|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84079796|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079797|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84079798|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84079799|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84079800|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
84079801|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84079802|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84079803|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84079804|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84079805|NCT00817375|Analgesics|analgesics|mesh-ancestor
84079806|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
84079807|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079808|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84079809|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84079810|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84079811|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
84079812|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
84079813|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84079814|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84079815|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079816|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079817|NCT00818701|Urological Agents|urological agents|mesh-ancestor
84079818|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
84079819|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079820|NCT00813241|Celecoxib|celecoxib|mesh-list
84079821|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84079822|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84079823|NCT00813241|Analgesics|analgesics|mesh-ancestor
84079824|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
84079825|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079826|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079827|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84079828|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84079829|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84079830|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84079831|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079832|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079833|NCT00640393|Etanercept|etanercept|mesh-list
84079834|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84079835|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84079836|NCT00640393|Analgesics|analgesics|mesh-ancestor
84079837|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
84079838|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079839|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079840|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84079841|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84079842|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84079843|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84079844|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
84079845|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
84079846|NCT05315024|Imiquimod|imiquimod|mesh-list
84079847|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84079848|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
84079849|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079850|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079851|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
84079852|NCT00627445|Insulin|insulin|mesh-list
83319862|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
84079853|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84079854|NCT00627445|Metformin|metformin|mesh-list
84079855|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
84079856|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
84079857|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84079858|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
84079859|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84079860|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84079861|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079862|NCT02030990|Fluorometholone|fluorometholone|mesh-list
84079863|NCT02030990|Mitomycins|mitomycins|mesh-list
84079864|NCT02030990|Mitomycin|mitomycin|mesh-list
84079865|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84079866|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079867|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
84079868|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079869|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84079870|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079871|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84079872|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
84079873|NCT02030990|Hormones|hormones|mesh-ancestor
84079874|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84079875|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079876|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84079877|NCT00822055|Timolol|timolol|mesh-list
84079878|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84079879|NCT00822055|Dorzolamide|dorzolamide|mesh-list
84079880|NCT00822055|Maleic acid|maleic acid|mesh-list
84079881|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
84079882|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079883|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079884|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84079885|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84079886|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
84079887|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079888|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079889|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84079890|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84079891|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84079892|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84079893|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84079894|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84079895|NCT00822133|Lidocaine|lidocaine|mesh-list
84079896|NCT00822133|Ketamine|ketamine|mesh-list
84079897|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079898|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
84079899|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079900|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079901|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
84079902|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079903|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84079904|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84079905|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84079906|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079907|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079908|NCT00822133|Analgesics|analgesics|mesh-ancestor
84079909|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84079910|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84079911|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
84079912|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84079913|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84079914|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079915|NCT00822211|Vildagliptin|vildagliptin|mesh-list
84079916|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84079917|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079918|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84079919|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
84079920|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079921|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079922|NCT04018417|Amphotericin B|amphotericin b|mesh-list
84079923|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84079924|NCT04018417|Amebicides|amebicides|mesh-ancestor
84079925|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84079926|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84079927|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84079928|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84079929|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
84079930|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
84079931|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84079932|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84079933|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84079934|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079935|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079936|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
84079937|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84079938|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079939|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84079940|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079941|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
84079942|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
84079943|NCT00826657|Vitamins|vitamins|mesh-ancestor
84079944|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
84079945|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079946|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
84079947|NCT00826657|Hematinics|hematinics|mesh-ancestor
84079948|NCT02992964|Nivolumab|nivolumab|mesh-list
84079949|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84079950|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079951|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84079952|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079953|NCT03597776|Lidocaine|lidocaine|mesh-list
84079954|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
84079955|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
84079956|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84079957|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079958|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
84079959|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84079960|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84079961|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84079962|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84079963|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84079964|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079965|NCT00625183|Selenium|selenium|mesh-list
84079966|NCT00625183|Capecitabine|capecitabine|mesh-list
84079967|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
84079968|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84079969|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
84079970|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079971|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079972|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
84079973|NCT00625183|Protective Agents|protective agents|mesh-ancestor
84079974|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079975|NCT00625183|Trace Elements|trace elements|mesh-ancestor
84079976|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
84079977|NCT00826891|Topotecan|topotecan|mesh-list
84079978|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84079979|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84079980|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84079981|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079982|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079983|NCT00826969|Ciclesonide|ciclesonide|mesh-list
84079984|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
84079985|NCT00826969|Hormones|hormones|mesh-ancestor
84079986|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84079987|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84079988|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84079989|NCT03560882|Atorvastatin|atorvastatin|mesh-list
84079990|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84079991|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84079992|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
84079993|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84079994|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84079995|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84079996|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84079997|NCT04044547|Rotigotine|rotigotine|mesh-list
84079998|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
84079999|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
84080000|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080001|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080002|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080003|NCT05242874|Dexamethasone|dexamethasone|mesh-list
84080004|NCT05242874|Olanzapine|olanzapine|mesh-list
84080005|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
84080006|NCT05242874|Aprepitant|aprepitant|mesh-list
84080007|NCT05242874|Antiemetics|antiemetics|mesh-list
84080008|NCT05242874|Tropisetron|tropisetron|mesh-list
84080009|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080010|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
84080011|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080012|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080013|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080014|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
84080015|NCT05242874|Hormones|hormones|mesh-ancestor
84080016|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080017|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84080018|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080019|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080020|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84080021|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84080022|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080023|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84080024|NCT05242874|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84080025|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84080026|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080027|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080028|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
84080029|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84080030|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84080031|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84080032|NCT02768948|Losartan|losartan|mesh-list
84080033|NCT02768948|Telmisartan|telmisartan|mesh-list
84080034|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84080035|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84080036|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84080037|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84080038|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080039|NCT00640315|Riociguat|riociguat|mesh-list
84080040|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
84080041|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080042|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
84080043|NCT00904748|Citric Acid|citric acid|mesh-list
84080044|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
84080045|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
84080046|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84080047|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
84080048|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
84080049|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080050|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
84080051|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84080052|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84080053|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080054|NCT00904748|Urological Agents|urological agents|mesh-ancestor
84080055|NCT00574405|Insulin|insulin|mesh-list
84080056|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84080057|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
84080058|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
84080059|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
84080060|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
84080061|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
84080062|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080063|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080064|NCT00971243|Metformin|metformin|mesh-list
84080065|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080066|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080067|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84080068|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84080069|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84080070|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080071|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080072|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84080073|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080074|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080075|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
84080076|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080077|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84080078|NCT04400383|Antibodies|antibodies|mesh-list
84080079|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
84080080|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84080081|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
84080082|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080083|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080084|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
84080085|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
84080086|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84080087|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080088|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080089|NCT00568555|Naltrexone|naltrexone|mesh-list
84080090|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84080091|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84080092|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080093|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
84080094|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080095|NCT00819325|Pioglitazone|pioglitazone|mesh-list
84080096|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84080097|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080098|NCT00904670|Methylphenidate|methylphenidate|mesh-list
84080099|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84080100|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080101|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84080102|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84080103|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080104|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080105|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
84080106|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080107|NCT00827281|Cycloserine|cycloserine|mesh-list
84080108|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84080109|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080110|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84080111|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
84080112|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84080113|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
84080114|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080115|NCT00823381|Resveratrol|resveratrol|mesh-list
84080116|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
84080117|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080118|NCT00823381|Protective Agents|protective agents|mesh-ancestor
84080119|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080120|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080121|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84080122|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
84080123|NCT00638443|Promethazine|promethazine|mesh-list
84080124|NCT00638443|Pregabalin|pregabalin|mesh-list
84080125|NCT00638443|Analgesics|analgesics|mesh-ancestor
84080126|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
84080127|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080128|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080129|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
84080130|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84080131|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080132|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080133|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84080134|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84080135|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84080136|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080137|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84080138|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84080139|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84080140|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
84080141|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
84080142|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
84080143|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
84080144|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080145|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84080146|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
84080147|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
84080148|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080149|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84080150|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
84080151|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
84080152|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
84080154|NCT00568399|Protective Agents|protective agents|mesh-ancestor
84080155|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080156|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
84080157|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080158|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
84080159|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84080160|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080161|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
84080162|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
84080163|NCT00975143|Isotretinoin|isotretinoin|mesh-list
84080164|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
84080165|NCT04286087|Anesthetics|anesthetics|mesh-list
84080166|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080167|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080168|NCT04288349|Epinephrine|epinephrine|mesh-list
84080169|NCT04288349|Racepinephrine|racepinephrine|mesh-list
84080170|NCT04288349|Ropivacaine|ropivacaine|mesh-list
84080171|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
84080172|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
84080173|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
84080174|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080175|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080176|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
84080177|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080178|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84080179|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84080180|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
84080181|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080182|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080183|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84080184|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84080185|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
84080186|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84080187|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
84080188|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
84080189|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
84080190|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84080191|NCT03667313|Sirolimus|sirolimus|mesh-list
84080192|NCT03667313|Paclitaxel|paclitaxel|mesh-list
84080193|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84080194|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080195|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
84080196|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
84080197|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
84080198|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080199|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84080200|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080201|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84080202|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
84080203|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84080204|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
84080205|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080206|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84080207|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
84080208|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080209|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84080210|NCT04925531|Ampicillin|ampicillin|mesh-list
84080211|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080212|NCT00634933|Prednisone|prednisone|mesh-list
84080213|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
84080214|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84080215|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84080216|NCT00634933|Prednisolone|prednisolone|mesh-list
84080217|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
84080218|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84080219|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
84080220|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080221|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
84080222|NCT00634933|Hormones|hormones|mesh-ancestor
84080223|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080224|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320233|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
84080225|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84080226|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080227|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
84080228|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
84080229|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080230|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080231|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84080232|NCT00634933|Protective Agents|protective agents|mesh-ancestor
84080233|NCT00967499|Ondansetron|ondansetron|mesh-list
84080234|NCT00967499|Palonosetron|palonosetron|mesh-list
84080235|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
84080236|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
84080237|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080238|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080239|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080240|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
84080241|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
84080242|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84080243|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84080244|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
84080245|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080246|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080247|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84080248|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
84080249|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84080250|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
84080251|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
84080252|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84080253|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
84080254|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080255|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080256|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080257|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080258|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84080259|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
84080260|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080261|NCT00629837|Factor VIII|factor viii|mesh-list
84080262|NCT00629837|Coagulants|coagulants|mesh-ancestor
84080263|NCT00827671|Cetuximab|cetuximab|mesh-list
84080264|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84080265|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080266|NCT03643133|Mifamurtide|mifamurtide|mesh-list
84080267|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84080268|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
84080269|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080270|NCT00823849|Cilostazol|cilostazol|mesh-list
84080271|NCT00823849|Probucol|probucol|mesh-list
84080272|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84080273|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
84080274|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080275|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080276|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84080277|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
84080278|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84080279|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84080280|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080281|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84080282|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
84080283|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84080284|NCT00823849|Protective Agents|protective agents|mesh-ancestor
84080285|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84080286|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84080287|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080288|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84080289|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84080290|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
84080291|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84080292|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
84080293|NCT02550067|Copper|copper|mesh-list
84080294|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84080295|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
84080296|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
84080297|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84080298|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
84080299|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84080300|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080301|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84080302|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84080303|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84080304|NCT02550067|Trace Elements|trace elements|mesh-ancestor
84080305|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
84080306|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84080307|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84080308|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84080309|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080311|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080312|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84080313|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
84080314|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080315|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080316|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84080317|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
84080318|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
84080319|NCT02862509|Hormones|hormones|mesh-ancestor
84080320|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080321|NCT04285775|Chrysarobin|chrysarobin|mesh-list
84080322|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84080323|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080324|NCT04285775|Analgesics|analgesics|mesh-ancestor
84080325|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
84080326|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080327|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080328|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080329|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84080330|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84080331|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84080332|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84080333|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080334|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080335|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080336|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080337|NCT00965081|Analgesics|analgesics|mesh-ancestor
84080338|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
84080339|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080340|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
84080341|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84080342|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
84080343|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84080344|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84080345|NCT00961649|Brinzolamide|brinzolamide|mesh-list
84080346|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84080347|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84080348|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84080349|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84080350|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84080351|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
84080352|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080353|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080354|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080355|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84080356|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080357|NCT04267601|Anagliptin|anagliptin|mesh-list
84080358|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84080359|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
84080360|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080361|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080362|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080363|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080364|NCT02861261|Promethazine|promethazine|mesh-list
84080365|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
84080366|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
84080367|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
84080368|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84080369|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
84080370|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
84080371|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080372|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080373|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080374|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84080375|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84080376|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84080377|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080378|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
84080379|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
84080380|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
84080381|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080382|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
84080383|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
84080384|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080385|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
84080386|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84080387|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84080389|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84080390|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080391|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080392|NCT04283435|Estrogens|estrogens|mesh-ancestor
84080393|NCT04283435|Hormones|hormones|mesh-ancestor
84080394|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080395|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84080396|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
84080397|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84080398|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84080399|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
84080400|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84080401|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84080402|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080403|NCT04283435|Urological Agents|urological agents|mesh-ancestor
84080404|NCT04284761|Bicalutamide|bicalutamide|mesh-list
84080405|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
84080406|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
84080407|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080408|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080409|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080410|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
84080411|NCT00632125|Hematinics|hematinics|mesh-ancestor
84080412|NCT00903968|Plerixafor|plerixafor|mesh-list
84080413|NCT00903968|Dexamethasone|dexamethasone|mesh-list
84080414|NCT00903968|Bortezomib|bortezomib|mesh-list
84080415|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080416|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
84080417|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
84080418|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080419|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080420|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080421|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
84080422|NCT00903968|Hormones|hormones|mesh-ancestor
84080423|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080424|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84080425|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080426|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84080427|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84080428|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
84080429|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080430|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
84080431|NCT00632606|Metoclopramide|metoclopramide|mesh-list
84080432|NCT00632606|Analgesics|analgesics|mesh-ancestor
84080433|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
84080434|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080435|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080436|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
84080437|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080438|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84080439|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
84080440|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84080441|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080442|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080443|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84080444|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
84080445|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84080446|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
84080447|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
84080448|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080449|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84080450|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84080451|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
83320456|NCT00711490|Sirolimus|sirolimus|mesh-list
84080452|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080453|NCT00903344|Vitamin D|vitamin d|mesh-list
84080454|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
84080455|NCT00903344|Vitamins|vitamins|mesh-ancestor
84080456|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
84080457|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080458|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84080459|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84080460|NCT02847338|Amlodipine|amlodipine|mesh-list
84080461|NCT02847338|Lisinopril|lisinopril|mesh-list
84080462|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
84080463|NCT02847338|Amiloride|amiloride|mesh-list
84080464|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84080465|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84080466|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080467|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080468|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84080469|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080470|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
84080471|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84080472|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
84080473|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080474|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84080475|NCT02847338|Protective Agents|protective agents|mesh-ancestor
84080476|NCT02847338|Diuretics|diuretics|mesh-ancestor
84080477|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
84080478|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84080479|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
84080480|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84080481|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
84080482|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84080483|NCT02847104|Insulin|insulin|mesh-list
84080484|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84080485|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080486|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080487|NCT02849366|Immunomodulating Agents|immunomodulating agents|mesh-list
84080488|NCT02849366|Immunologic Factors|immunologic factors|mesh-ancestor
84080489|NCT02849366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080490|NCT02849132|Entecavir|entecavir|mesh-list
84080491|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
84080492|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080493|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
84080494|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84080495|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080496|NCT02848508|Metformin|metformin|mesh-list
84080497|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080498|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080499|NCT00902564|Escitalopram|escitalopram|mesh-list
84080500|NCT00902564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84080501|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84080502|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080503|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080504|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080505|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
84080506|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080507|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
84080508|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
84080509|NCT00626197|Azathioprine|azathioprine|mesh-list
84080510|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
84080511|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84080512|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
84080513|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080514|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84080515|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84080516|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
84080517|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080518|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080519|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84080520|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84080521|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84080522|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
84080523|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84080524|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080525|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080526|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
84080527|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84080529|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84080530|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080531|NCT00626275|Analgesics|analgesics|mesh-ancestor
84080532|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
84080533|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080534|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080535|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080536|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84080537|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
84080538|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84080539|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080540|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080541|NCT02847884|Infliximab|infliximab|mesh-list
84080542|NCT02847884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84080543|NCT02847884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080544|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
84080545|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080546|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84080547|NCT00623935|Fludarabine|fludarabine|mesh-list
84080548|NCT00623935|Busulfan|busulfan|mesh-list
84080549|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080550|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080551|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84080552|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
84080553|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080554|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
84080555|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84080556|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84080557|NCT00623779|Aspirin|aspirin|mesh-list
84080558|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84080559|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080560|NCT00623779|Analgesics|analgesics|mesh-ancestor
84080561|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
84080562|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080563|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080564|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080565|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84080566|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84080567|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84080568|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080569|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84080570|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84080571|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080572|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
84080573|NCT00828373|Lidocaine|lidocaine|mesh-list
84080574|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
84080575|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
84080576|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080577|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080578|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
84080579|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080580|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84080581|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84080582|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84080583|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080584|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080585|NCT00824239|Fentanyl|fentanyl|mesh-list
84080586|NCT00824239|Midazolam|midazolam|mesh-list
84080587|NCT00824239|Propofol|propofol|mesh-list
84080588|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84080589|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080590|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080591|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84080592|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
84080593|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
84080594|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84080595|NCT00824239|Narcotics|narcotics|mesh-ancestor
84080596|NCT00824239|Analgesics|analgesics|mesh-ancestor
84080597|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
84080598|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080599|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84080600|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84080601|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84080602|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84080603|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
84080604|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
84080605|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080606|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080607|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
84080608|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
84080609|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
84080610|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84080611|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84080612|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84080613|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
84080614|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080615|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080616|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84080617|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84080618|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
84080619|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080620|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080621|NCT04044703|Vancomycin|vancomycin|mesh-list
84080622|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84080623|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080624|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
84080625|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080626|NCT00824317|Methylphenidate|methylphenidate|mesh-list
84080627|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84080628|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080629|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84080630|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84080631|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080632|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080633|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
84080634|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080635|NCT02847806|Insulin|insulin|mesh-list
84080636|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84080637|NCT02847806|Estradiol|estradiol|mesh-list
84080638|NCT02847806|Testosterone|testosterone|mesh-list
84080639|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080640|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080641|NCT02847806|Estrogens|estrogens|mesh-ancestor
84080642|NCT02847806|Hormones|hormones|mesh-ancestor
84080643|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080644|NCT02847806|Androgens|androgens|mesh-ancestor
84080645|NCT00828529|Bedaquiline|bedaquiline|mesh-list
84080646|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
84080647|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84080648|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080649|NCT00632762|Amantadine|amantadine|mesh-list
84080650|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84080651|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84080652|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
84080653|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080654|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
84080655|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080656|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080657|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080658|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080659|NCT00632762|Analgesics|analgesics|mesh-ancestor
84080660|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
84080661|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080662|NCT01351766|Nicotine|nicotine|mesh-list
84080663|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84080664|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
84080665|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080666|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080667|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84080668|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84080669|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
84080670|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080671|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080672|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
84080673|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84080674|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080675|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080676|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080677|NCT02846090|Analgesics|analgesics|mesh-ancestor
84080678|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
84080679|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080680|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84080681|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84080682|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84080683|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
84080684|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080685|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080686|NCT00828763|Dolutegravir|dolutegravir|mesh-list
84080687|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84080688|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84080689|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080690|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080691|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84080692|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84080693|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
84080694|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080695|NCT00824707|Entecavir|entecavir|mesh-list
84080696|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
84080697|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080698|NCT00824785|Capecitabine|capecitabine|mesh-list
84080699|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
84080700|NCT00824785|Epirubicin|epirubicin|mesh-list
84080701|NCT00824785|Panitumumab|panitumumab|mesh-list
84080702|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84080703|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
84080704|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080705|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080706|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84080707|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84080708|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84080709|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080710|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84080711|NCT00824863|Ketoconazole|ketoconazole|mesh-list
84080712|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
84080713|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080714|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84080715|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84080716|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080717|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080718|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84080719|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
84080720|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080721|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080722|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84080723|NCT02844530|Epratuzumab|epratuzumab|mesh-list
84080724|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
84080725|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84080726|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080727|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
84080728|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
84080729|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080730|NCT00820417|Cetuximab|cetuximab|mesh-list
84080731|NCT00820417|Gefitinib|gefitinib|mesh-list
84080732|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84080733|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080734|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84080735|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080736|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080737|NCT04923620|Cetuximab|cetuximab|mesh-list
84080738|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84080739|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080740|NCT00828919|Axitinib|axitinib|mesh-list
84080741|NCT00828919|Crizotinib|crizotinib|mesh-list
84080742|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080743|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84080744|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080745|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080746|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84080747|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
84080748|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080749|NCT02548741|Metformin|metformin|mesh-list
84080750|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
84080751|NCT02548741|Calcium|calcium|mesh-list
84080752|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080753|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080754|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84080755|NCT02548741|Antacids|antacids|mesh-ancestor
84080756|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080757|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080758|NCT02845856|Cetuximab|cetuximab|mesh-list
84080759|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84080760|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080761|NCT00825019|Paroxetine|paroxetine|mesh-list
84080762|NCT00825019|Amibegron|amibegron|mesh-list
84080763|NCT00825019|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
84080764|NCT00825019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84080765|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84080766|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080767|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080768|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080769|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
84080770|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080771|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84080772|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
84080773|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84080774|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84080775|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84080776|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080777|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84080778|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84080779|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
84080780|NCT00825019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84080781|NCT00929006|Progesterone|progesterone|mesh-list
84080782|NCT00929006|Progestins|progestins|mesh-ancestor
84080783|NCT00929006|Hormones|hormones|mesh-ancestor
84080784|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080785|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080786|NCT00877214|Rituximab|rituximab|mesh-list
84080787|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84080788|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080789|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
84080790|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080791|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84080792|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
84080793|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84080794|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080795|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080796|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
84080797|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080798|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080799|NCT05242718|Palmidrol|palmidrol|mesh-list
84080800|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
84080801|NCT05242718|Curcumin|curcumin|mesh-list
84080802|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84080803|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84080804|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080805|NCT05242718|Analgesics|analgesics|mesh-ancestor
84080806|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
84080807|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080808|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080809|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080810|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84080811|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080812|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080813|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080814|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
84080815|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080816|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84080817|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84080818|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080819|NCT05242718|Hormones|hormones|mesh-ancestor
84080820|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080821|NCT05242718|Expectorants|expectorants|mesh-ancestor
84080822|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
84080823|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84080824|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
84080825|NCT05242718|Protective Agents|protective agents|mesh-ancestor
84080826|NCT05242718|Antidotes|antidotes|mesh-ancestor
84080827|NCT00045968|Immunomodulating Agents|immunomodulating agents|mesh-list
84080828|NCT00045968|Immunologic Factors|immunologic factors|mesh-ancestor
84080829|NCT00045968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080831|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
84080832|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080833|NCT02845778|Protective Agents|protective agents|mesh-ancestor
84080834|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080835|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080836|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84080837|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84080838|NCT05337332|Triamcinolone|triamcinolone|mesh-list
84080839|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84080840|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84080841|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84080842|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84080843|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
84080844|NCT05337332|Hormones|hormones|mesh-ancestor
84080845|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080846|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080847|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84080848|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
84080849|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080850|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080851|NCT00901394|Folic Acid|folic acid|mesh-list
84080852|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
84080853|NCT00901394|Hematinics|hematinics|mesh-ancestor
84080854|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
84080855|NCT00901394|Vitamins|vitamins|mesh-ancestor
84080856|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
84080857|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080858|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84080859|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
84080860|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
84080861|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84080862|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080863|NCT00901394|Analgesics|analgesics|mesh-ancestor
84080864|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
84080865|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080866|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
84080867|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84080868|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
84080869|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
84080870|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080871|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080872|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080873|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84080874|NCT05337254|Analgesics|analgesics|mesh-ancestor
84080875|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
84080876|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080877|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
84080878|NCT00896532|Denosumab|denosumab|mesh-list
84080879|NCT00896532|Alendronate|alendronate|mesh-list
84080880|NCT00896532|Teriparatide|teriparatide|mesh-list
84080881|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84080882|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84080883|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080884|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84080885|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
84080886|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
84080887|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080888|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84080889|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080890|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080891|NCT02843490|Ranibizumab|ranibizumab|mesh-list
84080892|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84080893|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84080894|NCT02843490|Growth Substances|growth substances|mesh-ancestor
84080895|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080896|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
84080897|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080898|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
84080899|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84080900|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84080902|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080903|NCT04201808|Tenofovir|tenofovir|mesh-list
84080904|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
84080905|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84080906|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84080907|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84080908|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080909|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080910|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84080911|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84080912|NCT01341600|Omeprazole|omeprazole|mesh-list
84080913|NCT01341600|Clopidogrel|clopidogrel|mesh-list
84080914|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84080915|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84080916|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84080917|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84080918|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
84080919|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080920|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080921|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080922|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84080923|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84080924|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84080925|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080926|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
84080927|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84080928|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84080929|NCT02845388|Estradiol|estradiol|mesh-list
84080930|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84080931|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080932|NCT02845388|Estrogens|estrogens|mesh-ancestor
84080933|NCT02845388|Hormones|hormones|mesh-ancestor
84080934|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84080935|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080936|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84080937|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
84080938|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84080939|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84080940|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
84080941|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84080942|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84080943|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84080944|NCT02845388|Urological Agents|urological agents|mesh-ancestor
84080945|NCT02845466|Becaplermin|becaplermin|mesh-list
84080946|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
84080947|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
84080948|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84080949|NCT02845466|Growth Substances|growth substances|mesh-ancestor
84080950|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080951|NCT04345796|Empagliflozin|empagliflozin|mesh-list
84080952|NCT04345796|Carvedilol|carvedilol|mesh-list
84080953|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84080954|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080955|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84080956|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080957|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84080958|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84080959|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
84080960|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080961|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84080962|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
84080963|NCT04345796|Protective Agents|protective agents|mesh-ancestor
84080964|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84080965|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080966|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84080967|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
84080968|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84080969|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84080970|NCT00623623|Enoxaparin|enoxaparin|mesh-list
84080971|NCT00623623|Tenecteplase|tenecteplase|mesh-list
84080972|NCT00623623|Clopidogrel|clopidogrel|mesh-list
84080973|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84080974|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84080975|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84080976|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84080977|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
84080978|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080979|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080980|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080981|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
84080982|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84080983|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84080985|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84080986|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080987|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84080988|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84080989|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84080990|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84080991|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84080992|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84080993|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84080994|NCT04224584|Analgesics|analgesics|mesh-ancestor
84080995|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
84080996|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84080997|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
84080998|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84080999|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
84081000|NCT02993198|Carvedilol|carvedilol|mesh-list
84081001|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84081002|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84081003|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
84081004|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081005|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081006|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081007|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84081008|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
84081009|NCT02993198|Protective Agents|protective agents|mesh-ancestor
84081010|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84081011|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081012|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84081013|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
84081014|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84081015|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84081016|NCT00829231|Sorafenib|sorafenib|mesh-list
84081017|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081018|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84081019|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081020|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081021|NCT00901628|Cefuroxime|cefuroxime|mesh-list
84081022|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
84081023|NCT00901628|Ketorolac|ketorolac|mesh-list
84081024|NCT00901628|Epinephrine|epinephrine|mesh-list
84081025|NCT00901628|Morphine|morphine|mesh-list
84081026|NCT00901628|Ropivacaine|ropivacaine|mesh-list
84081027|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84081028|NCT00901628|Narcotics|narcotics|mesh-ancestor
84081029|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081030|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081031|NCT00901628|Analgesics|analgesics|mesh-ancestor
84081032|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
84081033|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081034|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
84081035|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
84081036|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84081037|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84081038|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
84081039|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081040|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081041|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84081042|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84081043|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
84081044|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84081045|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
84081046|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
84081047|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
84081048|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84081049|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84081050|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081051|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84081052|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84081053|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84081054|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081055|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081056|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081057|NCT00623545|Exenatide|exenatide|mesh-list
84081058|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84081059|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081060|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84081061|NCT00623545|Incretins|incretins|mesh-ancestor
84081062|NCT00623545|Hormones|hormones|mesh-ancestor
84081063|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84081064|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
84081065|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84081066|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081067|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081068|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
84081069|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081070|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081071|NCT02839668|Acetaminophen|acetaminophen|mesh-list
84081072|NCT02839668|Lidocaine|lidocaine|mesh-list
84081073|NCT02839668|Atropine|atropine|mesh-list
84081074|NCT02839668|Tramadol|tramadol|mesh-list
84081075|NCT02839668|Sevoflurane|sevoflurane|mesh-list
84081076|NCT02839668|Neostigmine|neostigmine|mesh-list
84081077|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
84081078|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
84081079|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081080|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081081|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
84081082|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081083|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83373367|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84081084|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84081085|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84081086|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081087|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081088|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081089|NCT02839668|Analgesics|analgesics|mesh-ancestor
84081090|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
84081091|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84081092|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84081093|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
84081094|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84081095|NCT02839668|Narcotics|narcotics|mesh-ancestor
84081096|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84081097|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84081098|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
84081099|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84081100|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
84081101|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
84081102|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
84081103|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84081104|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84081105|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
84081106|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081107|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84081108|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081109|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84081110|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84081111|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
84081112|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081113|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84081114|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
84081115|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081116|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84081117|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
84081118|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081119|NCT02839356|Epinephrine|epinephrine|mesh-list
84081120|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84081121|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83373703|NCT02394795|Antidotes|antidotes|mesh-ancestor
84081122|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
84081123|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081124|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081125|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081126|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84081127|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84081128|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
83373844|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
84081129|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081130|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84081131|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
84081132|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
84081133|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
84081134|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84081135|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84081136|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081137|NCT02840526|Acetaminophen|acetaminophen|mesh-list
84081138|NCT02840526|Fentanyl|fentanyl|mesh-list
84081139|NCT02840526|Bupivacaine|bupivacaine|mesh-list
84081140|NCT02840526|Propofol|propofol|mesh-list
84081141|NCT02840526|Sevoflurane|sevoflurane|mesh-list
84081142|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
84081143|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
84081144|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081145|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081146|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
84081147|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081148|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84081149|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84081150|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
84081151|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84081152|NCT02840526|Narcotics|narcotics|mesh-ancestor
84081153|NCT02840526|Analgesics|analgesics|mesh-ancestor
84081154|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84081155|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081156|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
84081157|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84081158|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84081159|NCT02342444|Enoxaparin|enoxaparin|mesh-list
84081160|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
84081161|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
84081162|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84081163|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081164|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081165|NCT00825253|Insulin|insulin|mesh-list
84081166|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84081167|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
84081168|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
83374167|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
84081169|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84081170|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84081171|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081172|NCT00820885|Teduglutide|teduglutide|mesh-list
84081173|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374297|NCT00654069|Vitamins|vitamins|mesh-ancestor
83374358|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84081174|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84081175|NCT00820885|Protective Agents|protective agents|mesh-ancestor
83374432|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
84081176|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081177|NCT03845582|Vitamin A|vitamin a|mesh-list
84081178|NCT03845582|Retinol acetate|retinol acetate|mesh-list
84081179|NCT03845582|Vitamins|vitamins|mesh-ancestor
84081180|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
84081181|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081182|NCT03845582|Protective Agents|protective agents|mesh-ancestor
83374585|NCT01436071|Xhance|xhance|mesh-list
84081183|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83374652|NCT01419197|Trastuzumab|trastuzumab|mesh-list
84081184|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081185|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84081186|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
84081187|NCT00820963|Temozolomide|temozolomide|mesh-list
84081188|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84081189|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
84081190|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081191|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081192|NCT02834676|Ethanol|ethanol|mesh-list
84081193|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84081194|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375102|NCT04051957|Isosorbide|isosorbide|mesh-list
84081195|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081196|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081197|NCT00632840|Atorvastatin|atorvastatin|mesh-list
84081198|NCT00632840|Fenofibrate|fenofibrate|mesh-list
84081199|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83321214|NCT03586869|Antidotes|antidotes|mesh-ancestor
84081200|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84081201|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
84081202|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081203|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84081204|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84081205|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081206|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83375235|NCT01428583|Oxycodone|oxycodone|mesh-list
84081207|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84081208|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84081209|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84081210|NCT00829777|Naloxone|naloxone|mesh-list
84081211|NCT00829777|Lactulose|lactulose|mesh-list
84081212|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84081213|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081214|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
84081215|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081216|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84081217|NCT02834754|Vedolizumab|vedolizumab|mesh-list
84081218|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84081219|NCT02839122|Tadalafil|tadalafil|mesh-list
84081220|NCT02839122|Dutasteride|dutasteride|mesh-list
84081221|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
84081222|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84081223|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84081224|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081225|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081226|NCT02839122|Urological Agents|urological agents|mesh-ancestor
84081227|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84081228|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84081229|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
84081230|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84081231|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081232|NCT00633282|Pioglitazone|pioglitazone|mesh-list
84081233|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
84081234|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84081235|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081236|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
84081237|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
84081238|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
84081239|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081240|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081241|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
84081242|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375576|NCT02618148|Estrogens|estrogens|mesh-list
84081243|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84081244|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081245|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84081246|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375644|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
83375717|NCT01402063|Temozolomide|temozolomide|mesh-list
84081247|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081248|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
84081249|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84081250|NCT02838030|Aspirin|aspirin|mesh-list
84081251|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84081252|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081253|NCT02838030|Analgesics|analgesics|mesh-ancestor
84081254|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
84081255|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081256|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081257|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84081258|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375963|NCT05086848|Leucovorin|leucovorin|mesh-list
84081259|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84081260|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081261|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081262|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83376080|NCT00706719|Enclomiphene|enclomiphene|mesh-list
84081263|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83376154|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
84081264|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081265|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
84081266|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
84081267|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83376225|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
84081268|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081269|NCT04044079|Misoprostol|misoprostol|mesh-list
84081270|NCT04044079|Dinoprostone|dinoprostone|mesh-list
83376306|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
84081271|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84081272|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
83376377|NCT02995707|Thalidomide|thalidomide|mesh-list
84081273|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83321286|NCT03586089|Diazepam|diazepam|mesh-list
84081274|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081275|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84081276|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84081277|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
84081278|NCT00830323|Oseltamivir|oseltamivir|mesh-list
84081279|NCT00830323|Amantadine|amantadine|mesh-list
84081280|NCT00830323|Zanamivir|zanamivir|mesh-list
84081281|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
84081282|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081283|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081284|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081285|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84081286|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84081287|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
84081288|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081289|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376517|NCT00716079|Clonidine|clonidine|mesh-list
83376586|NCT01381549|Imipenem|imipenem|mesh-list
84081290|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081291|NCT00830323|Analgesics|analgesics|mesh-ancestor
84081292|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
84081293|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081294|NCT00830401|Doxycycline|doxycycline|mesh-list
84081295|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081296|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081297|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
84081298|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84081299|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84081300|NCT04249908|Maleic acid|maleic acid|mesh-list
84081301|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081302|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081303|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84081304|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84081305|NCT02837640|Levodopa|levodopa|mesh-list
84081306|NCT02837640|Carbidopa|carbidopa|mesh-list
84081307|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84081308|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84081309|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84081310|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
83376790|NCT05094492|Fluorides|fluorides|mesh-list
83376865|NCT05090592|Atropine|atropine|mesh-list
84081311|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081312|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081313|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081314|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84081315|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081316|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84081317|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
84081318|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
84081319|NCT02834286|Dexamethasone|dexamethasone|mesh-list
84081320|NCT02834286|Rituximab|rituximab|mesh-list
84081321|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081322|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081323|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
84081324|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081325|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84081326|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84081327|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
84081328|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
84081329|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081330|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84081331|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
84081332|NCT02834286|Hormones|hormones|mesh-ancestor
84081333|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84081334|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84081335|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
84081336|NCT02839044|Vitamin K|vitamin k|mesh-list
84081337|NCT02839044|Menaquinone 7|menaquinone 7|mesh-list
84081338|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84081339|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081340|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081341|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
84081342|NCT02839044|Coagulants|coagulants|mesh-ancestor
84081343|NCT02839044|Vitamins|vitamins|mesh-ancestor
84081344|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
84081345|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081346|NCT02833506|Sirolimus|sirolimus|mesh-list
84081347|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081348|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081349|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84081350|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081351|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
83377223|NCT01431287|Olodaterol|olodaterol|mesh-list
84081352|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84081353|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
84081354|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081355|NCT02838576|Estrogens|estrogens|mesh-list
84081356|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84081357|NCT02838576|Hormones|hormones|mesh-ancestor
84081358|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84081359|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081360|NCT00838539|Sirolimus|sirolimus|mesh-list
84081361|NCT00838539|Temsirolimus|temsirolimus|mesh-list
84081362|NCT00838539|MTOR Inhibitors|mtor inhibitors|mesh-list
84081363|NCT00838539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84081364|NCT00838539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081365|NCT00838539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081366|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84081367|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
84081368|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081369|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081370|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081371|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081372|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84081373|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
84081374|NCT02836548|Vorinostat|vorinostat|mesh-list
84081375|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84081376|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081377|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081378|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081379|NCT02836704|Metformin|metformin|mesh-list
84081380|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
84081381|NCT02836704|Acarbose|acarbose|mesh-list
84081382|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84081383|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081384|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84081385|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081386|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081387|NCT02833584|Acetaminophen|acetaminophen|mesh-list
84081388|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081389|NCT02833584|Analgesics|analgesics|mesh-ancestor
84081390|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
84081391|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081392|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081393|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
84081394|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84081395|NCT00837759|Lansoprazole|lansoprazole|mesh-list
84081396|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
84081397|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84081398|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081399|NCT00837759|Incretins|incretins|mesh-ancestor
84081400|NCT00837759|Hormones|hormones|mesh-ancestor
83377990|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83378055|NCT03832465|Levofloxacin|levofloxacin|mesh-list
84081401|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84081402|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84081403|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
84081404|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081405|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081406|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84081407|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84081408|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84081409|NCT00703365|Gemcitabine|gemcitabine|mesh-list
84081410|NCT00703365|Sorafenib|sorafenib|mesh-list
84081411|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84081412|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
84081413|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081414|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081415|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84081416|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081417|NCT05878899|Enoxaparin|enoxaparin|mesh-list
84081418|NCT05878899|Anticoagulants|anticoagulants|mesh-ancestor
84081419|NCT05878899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84081420|NCT05878899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081421|NCT05878899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081422|NCT05878717|Belimumab|belimumab|mesh-list
84081423|NCT05878717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84081424|NCT05878717|Immunologic Factors|immunologic factors|mesh-ancestor
84081425|NCT05878717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081426|NCT05878639|Lactulose|lactulose|mesh-list
84081427|NCT05878639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84081429|NCT05878574|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84081430|NCT05878574|Tinzaparin|tinzaparin|mesh-list
84081431|NCT05878574|Dalteparin|dalteparin|mesh-list
84081432|NCT05878574|Anticoagulants|anticoagulants|mesh-ancestor
84081433|NCT05878574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84081434|NCT05878574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081435|NCT05878574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081436|NCT05878561|Indapamide|indapamide|mesh-list
84081437|NCT05878561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84081438|NCT05878561|Diuretics|diuretics|mesh-ancestor
84081439|NCT05878561|Natriuretic Agents|natriuretic agents|mesh-ancestor
84081440|NCT05878561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081441|NCT05878561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84081442|NCT05878561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081443|NCT05878561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081444|NCT05878522|Moxifloxacin|moxifloxacin|mesh-list
84081445|NCT05878522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081446|NCT05878522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081447|NCT05878522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84081448|NCT05878522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84081449|NCT05878522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081450|NCT05878522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081451|NCT05878522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081452|NCT05878379|Iron|iron|mesh-list
84081453|NCT05878379|Trace Elements|trace elements|mesh-ancestor
84081454|NCT05878379|Micronutrients|micronutrients|mesh-ancestor
84081455|NCT05878379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081456|NCT05878353|Doxycycline|doxycycline|mesh-list
84081457|NCT05878353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081458|NCT05878353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081459|NCT05878353|Antimalarials|antimalarials|mesh-ancestor
84081460|NCT05878353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84081461|NCT05878353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84081462|NCT05878288|Cemiplimab|cemiplimab|mesh-list
83379370|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
84081463|NCT05878288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081464|NCT05878288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081465|NCT05878262|Ibuprofen|ibuprofen|mesh-list
84081466|NCT05878262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84081467|NCT05878262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081468|NCT05878262|Analgesics|analgesics|mesh-ancestor
84081469|NCT05878262|Sensory System Agents|sensory system agents|mesh-ancestor
83379505|NCT03580135|Propolis|propolis|mesh-list
84081470|NCT05878262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081471|NCT05878262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081472|NCT05878262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84081473|NCT05878262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84081474|NCT05878262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84081475|NCT05878262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83379579|NCT03586219|Analgesics|analgesics|mesh-ancestor
84081476|NCT05878262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081477|NCT05878249|Sodium Hypochlorite|sodium hypochlorite|mesh-list
84081478|NCT05878249|Eusol|eusol|mesh-list
84081479|NCT05878249|Edetic Acid|edetic acid|mesh-list
84081480|NCT05878249|Pentetic Acid|pentetic acid|mesh-list
84081481|NCT05878249|Disinfectants|disinfectants|mesh-ancestor
84081482|NCT05878249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081483|NCT05878249|Anticoagulants|anticoagulants|mesh-ancestor
84081484|NCT05878249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84081485|NCT05878249|Chelating Agents|chelating agents|mesh-ancestor
84081486|NCT05878249|Sequestering Agents|sequestering agents|mesh-ancestor
83379790|NCT05122338|Lidocaine|lidocaine|mesh-list
83379792|NCT05122338|Esketamine|esketamine|mesh-list
84081487|NCT05878249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081488|NCT05878249|Antidotes|antidotes|mesh-ancestor
84081489|NCT05878249|Protective Agents|protective agents|mesh-ancestor
83379868|NCT03156361|Insulin|insulin|mesh-list
84081490|NCT05878249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081491|NCT05878249|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84081492|NCT05878158|Simvastatin|simvastatin|mesh-list
84081493|NCT05878158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84081494|NCT05878158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84081495|NCT05878158|Antimetabolites|antimetabolites|mesh-ancestor
84081496|NCT05878158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081497|NCT05878158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84081498|NCT05878158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84081499|NCT05878158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081500|NCT05878028|Docetaxel|docetaxel|mesh-list
84081501|NCT05878028|Tislelizumab|tislelizumab|mesh-list
83380156|NCT03155035|Vitamin D|vitamin d|mesh-list
84081502|NCT05878028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081503|NCT05878028|Tubulin Modulators|tubulin modulators|mesh-ancestor
84081504|NCT05878028|Antimitotic Agents|antimitotic agents|mesh-ancestor
84081505|NCT05878028|Mitosis Modulators|mitosis modulators|mesh-ancestor
84081506|NCT05878028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081507|NCT05878028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081508|NCT05878015|Acetaminophen|acetaminophen|mesh-list
84081509|NCT05878015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081510|NCT05878015|Analgesics|analgesics|mesh-ancestor
83380449|NCT03243175|Apixaban|apixaban|mesh-list
84081511|NCT05878015|Sensory System Agents|sensory system agents|mesh-ancestor
84081512|NCT05878015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380527|NCT01923649|Lanreotide|lanreotide|mesh-list
84081513|NCT05878015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081514|NCT05878015|Antipyretics|antipyretics|mesh-ancestor
84081515|NCT05877911|Sodium sulfate|sodium sulfate|mesh-list
84081516|NCT05877911|Cathartics|cathartics|mesh-ancestor
84081517|NCT05877911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83380594|NCT01675999|Antidotes|antidotes|mesh-ancestor
84081518|NCT05877872|Immunomodulating Agents|immunomodulating agents|mesh-list
84081519|NCT05877872|Immunologic Factors|immunologic factors|mesh-ancestor
84081520|NCT05877872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081521|NCT05877846|Vitamin D|vitamin d|mesh-list
84081522|NCT05877846|Ergocalciferols|ergocalciferols|mesh-list
84081523|NCT05877846|Cholecalciferol|cholecalciferol|mesh-list
84081524|NCT05877846|Vitamins|vitamins|mesh-list
84081525|NCT05877846|Micronutrients|micronutrients|mesh-ancestor
84081526|NCT05877846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081527|NCT05877846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84081528|NCT05877846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84081529|NCT05877820|Lenvatinib|lenvatinib|mesh-list
84081530|NCT05877820|Tislelizumab|tislelizumab|mesh-list
84081531|NCT05877820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081532|NCT05877820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84081533|NCT05877820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081534|NCT05877820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081535|NCT05877820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081536|NCT05877807|Baclofen|baclofen|mesh-list
84081537|NCT05877807|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84081538|NCT05877807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081539|NCT05877807|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84081540|NCT05877807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83380961|NCT03637075|Insulin|insulin|mesh-list
84081541|NCT05877807|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84081542|NCT05877807|GABA Agonists|gaba agonists|mesh-ancestor
84081543|NCT05877807|GABA Agents|gaba agents|mesh-ancestor
84081544|NCT05877807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081545|NCT05877807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081546|NCT05877781|Palmidrol|palmidrol|mesh-list
84081547|NCT05877781|Analgesics|analgesics|mesh-ancestor
83381093|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
84081548|NCT05877781|Sensory System Agents|sensory system agents|mesh-ancestor
84081549|NCT05877781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081550|NCT05877781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081551|NCT05877781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84081552|NCT05877781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081553|NCT05877781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84081554|NCT05877781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84081555|NCT05877781|Antiviral Agents|antiviral agents|mesh-ancestor
83381313|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
84081556|NCT05877781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081557|NCT05877781|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84081558|NCT05877781|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84081559|NCT05877781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83381464|NCT01275183|Cisplatin|cisplatin|mesh-list
84081560|NCT05877781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081561|NCT05877781|Hormones|hormones|mesh-ancestor
84081562|NCT05877781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84081563|NCT05877690|Bupivacaine|bupivacaine|mesh-list
84081564|NCT05877690|Prilocaine|prilocaine|mesh-list
84081565|NCT05877690|Anesthetics, Local|anesthetics, local|mesh-ancestor
84081566|NCT05877690|Anesthetics|anesthetics|mesh-ancestor
84081567|NCT05877690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83381604|NCT00245037|Busulfan|busulfan|mesh-list
84081568|NCT05877690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081569|NCT05877690|Sensory System Agents|sensory system agents|mesh-ancestor
84081570|NCT05877690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081571|NCT05877638|Sulfadiazine|sulfadiazine|mesh-list
84081572|NCT05877638|Silver Sulfadiazine|silver sulfadiazine|mesh-list
84081573|NCT05877638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081574|NCT05877638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081575|NCT05877638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83381742|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
84081576|NCT05877638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84081577|NCT05877638|Coccidiostats|coccidiostats|mesh-ancestor
84081578|NCT05877638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84081579|NCT05877573|Capecitabine|capecitabine|mesh-list
84081580|NCT05877573|Oxaliplatin|oxaliplatin|mesh-list
84081581|NCT05877573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84081582|NCT05877573|Antimetabolites|antimetabolites|mesh-ancestor
84081583|NCT05877573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081584|NCT05877573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081585|NCT05877313|Nitric Oxide|nitric oxide|mesh-list
84081586|NCT05877313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84081587|NCT05877313|Autonomic Agents|autonomic agents|mesh-ancestor
84081588|NCT05877313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081589|NCT05877313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081590|NCT05877313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84081591|NCT05877313|Respiratory System Agents|respiratory system agents|mesh-ancestor
84081592|NCT05877313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84081593|NCT05877313|Antioxidants|antioxidants|mesh-ancestor
84081594|NCT05877313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081595|NCT05877313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081596|NCT05877313|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84081597|NCT05877313|Vasodilator Agents|vasodilator agents|mesh-ancestor
84081598|NCT05877313|Gasotransmitters|gasotransmitters|mesh-ancestor
84081599|NCT05877313|Protective Agents|protective agents|mesh-ancestor
84081600|NCT05877235|Quercetin|quercetin|mesh-list
84081601|NCT05877235|Antioxidants|antioxidants|mesh-ancestor
84081602|NCT05877235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83382105|NCT04846218|Progesterone|progesterone|mesh-list
84081603|NCT05877235|Protective Agents|protective agents|mesh-ancestor
84081604|NCT05877235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081605|NCT05877131|Ropivacaine|ropivacaine|mesh-list
84081606|NCT05877131|Levobupivacaine|levobupivacaine|mesh-list
84081607|NCT05877131|Anesthetics, Local|anesthetics, local|mesh-ancestor
84081608|NCT05877131|Anesthetics|anesthetics|mesh-ancestor
84081609|NCT05877131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081610|NCT05877131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081611|NCT05877131|Sensory System Agents|sensory system agents|mesh-ancestor
84081612|NCT05877131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081613|NCT05877079|Menthol|menthol|mesh-list
84081614|NCT05877079|Antipruritics|antipruritics|mesh-ancestor
84081615|NCT05877079|Dermatologic Agents|dermatologic agents|mesh-ancestor
84081616|NCT05877040|Rituximab|rituximab|mesh-list
84081617|NCT05877040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081618|NCT05877040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081619|NCT05877040|Immunologic Factors|immunologic factors|mesh-ancestor
83382302|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
84081620|NCT05877040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081621|NCT05877040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84081622|NCT05877001|Tislelizumab|tislelizumab|mesh-list
84081623|NCT05877001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081624|NCT05877001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081625|NCT05876949|Denosumab|denosumab|mesh-list
84081626|NCT05876949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84081627|NCT05876949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081628|NCT05876858|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84081629|NCT05876858|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84081630|NCT05876858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081631|NCT05873777|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84081632|NCT05873777|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84081633|NCT05873777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081634|NCT05859009|Propranolol|propranolol|mesh-list
84081635|NCT05859009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84081636|NCT05859009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84081637|NCT05859009|Adrenergic Agents|adrenergic agents|mesh-ancestor
83382729|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
84081638|NCT05859009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081639|NCT05859009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081640|NCT05859009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83382804|NCT00085423|Interleukin-2|interleukin-2|mesh-list
84081641|NCT05859009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84081642|NCT05859009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84081643|NCT05859009|Vasodilator Agents|vasodilator agents|mesh-ancestor
84081644|NCT05838560|Dasatinib|dasatinib|mesh-list
84081645|NCT05838560|Quercetin|quercetin|mesh-list
84081646|NCT05838560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081647|NCT05838560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84081648|NCT05838560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081649|NCT05838560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081650|NCT05838560|Antioxidants|antioxidants|mesh-ancestor
84081651|NCT05838560|Protective Agents|protective agents|mesh-ancestor
84081652|NCT05838560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081653|NCT05795309|Insulin|insulin|mesh-list
84081654|NCT05795309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84081655|NCT05795309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081656|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
84081657|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
84081658|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
84081659|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081660|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84081661|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
84081662|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081663|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081664|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84081665|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84081666|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081667|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
84081668|NCT05737121|Lidocaine|lidocaine|mesh-list
84081669|NCT05737121|Heparin|heparin|mesh-list
84081670|NCT05737121|Calcium heparin|calcium heparin|mesh-list
84081671|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
84081672|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
84081673|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081674|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081675|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
84081676|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081677|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84081678|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84081679|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84081680|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081681|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081682|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
84081683|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84081684|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081685|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
84081686|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081687|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081688|NCT05727904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84081689|NCT05727904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081690|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
84081691|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84081692|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081693|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84081694|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84081695|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081696|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081697|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
84081698|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081699|NCT05685602|Paclitaxel|paclitaxel|mesh-list
84081700|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84081701|NCT05685602|Gemcitabine|gemcitabine|mesh-list
83383599|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
84081702|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84081703|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081704|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
84081705|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
84081706|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
84081707|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081708|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84081709|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
84081710|NCT05683977|Durvalumab|durvalumab|mesh-list
84081711|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081712|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83383644|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84081713|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83383794|NCT01400243|Nicotine|nicotine|mesh-list
84081714|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
84081715|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
84081716|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081717|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
84081718|NCT05675579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84081719|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081720|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081721|NCT05675579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84081722|NCT05675579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081723|NCT05675579|Immunoconjugates|immunoconjugates|mesh-ancestor
84081724|NCT05675579|Immunologic Factors|immunologic factors|mesh-ancestor
84081725|NCT05675579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081726|NCT05663658|Morphine|morphine|mesh-list
84081727|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84081728|NCT05663658|Narcotics|narcotics|mesh-ancestor
83383997|NCT04401085|Antibodies|antibodies|mesh-list
84081729|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081730|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081731|NCT05663658|Analgesics|analgesics|mesh-ancestor
84081732|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
84081733|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081734|NCT05660135|Amlodipine|amlodipine|mesh-list
84081735|NCT05660135|Olmesartan|olmesartan|mesh-list
84081736|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84081737|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84081738|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84081739|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83384141|NCT03395899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081740|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081741|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081742|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84081743|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081744|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
84081745|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84081746|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84081747|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
84081748|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84081749|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84081750|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081751|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84081752|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83384352|NCT00812877|Calcium|calcium|mesh-list
84081753|NCT05653713|Lenograstim|lenograstim|mesh-list
84081754|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84081755|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
84081756|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081757|NCT05635929|Betaine|betaine|mesh-list
84081758|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83384487|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
84081759|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
84081760|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84081761|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
84081762|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081763|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83384705|NCT03300427|Valsartan|valsartan|mesh-list
84081764|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
84081765|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84081766|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
84081767|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081768|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84081769|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84081770|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
84081771|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081772|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081773|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84081774|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
84081775|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081776|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081777|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
84081778|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
84081779|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
84081780|NCT05597722|Amphetamine|amphetamine|mesh-list
84081781|NCT05597722|Adderall|adderall|mesh-list
84081782|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
84081783|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84081784|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081785|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
84081786|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
84081787|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081788|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
84081789|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081790|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081791|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
84081792|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84081793|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84081794|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84081795|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84081796|NCT05574101|Cemiplimab|cemiplimab|mesh-list
84081797|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081798|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081799|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
84081800|NCT05568550|Olaparib|olaparib|mesh-list
84081801|NCT05568550|Androgens|androgens|mesh-list
84081802|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081803|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081804|NCT05568550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83385116|NCT00831987|Vaccines|vaccines|mesh-list
84081805|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081806|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84081807|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081808|NCT05568550|Hormones|hormones|mesh-ancestor
84081809|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84081810|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081811|NCT05563220|Everolimus|everolimus|mesh-list
84081812|NCT05563220|Palbociclib|palbociclib|mesh-list
84081813|NCT05563220|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84081814|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84081815|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83385330|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84081816|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081817|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84081818|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
84081819|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081820|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081821|NCT05555667|Propofol|propofol|mesh-list
84081822|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84081823|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081824|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081825|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83385474|NCT03104010|Hormones|hormones|mesh-list
84081826|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
84081827|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
84081828|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
84081829|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081830|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081831|NCT05491226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84081832|NCT05491226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081833|NCT05474846|Melatonin|melatonin|mesh-list
84081834|NCT05474846|Methylphenidate|methylphenidate|mesh-list
84081835|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
84081836|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081837|NCT05474846|Protective Agents|protective agents|mesh-ancestor
84081838|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83385800|NCT04313166|Copper|copper|mesh-list
84081839|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081840|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84081841|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84081842|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83385831|NCT04133532|Metoprolol|metoprolol|mesh-list
84081843|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83385909|NCT03358875|Docetaxel|docetaxel|mesh-list
84081844|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
84081845|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84081846|NCT05462613|Aspirin|aspirin|mesh-list
84081847|NCT05462613|Bevacizumab|bevacizumab|mesh-list
84081848|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83385973|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84081849|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081850|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84081851|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84081852|NCT05462613|Growth Substances|growth substances|mesh-ancestor
84081853|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081854|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
84081855|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84081856|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84081857|NCT05462613|Analgesics|analgesics|mesh-ancestor
84081858|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
84081859|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081860|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84081861|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84081862|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84081863|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081864|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081865|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84081866|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84081867|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081868|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
84081869|NCT05411887|Olmesartan|olmesartan|mesh-list
84081870|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84081871|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84081872|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84081873|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84081874|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
84081875|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081877|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84081878|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081879|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84081880|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84081881|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84081882|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
84081883|NCT05398081|Cefuroxime|cefuroxime|mesh-list
84081884|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
84081885|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84081886|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081887|NCT05382299|Paclitaxel|paclitaxel|mesh-list
84081888|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84081889|NCT05382299|Carboplatin|carboplatin|mesh-list
84081890|NCT05382299|Gemcitabine|gemcitabine|mesh-list
84081891|NCT05382299|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84081892|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84081893|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081894|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
84081895|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
84081896|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
84081897|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081898|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84081899|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
84081900|NCT05382299|Immunoconjugates|immunoconjugates|mesh-ancestor
84081901|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
84081902|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081903|NCT05382286|Paclitaxel|paclitaxel|mesh-list
84081904|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84081905|NCT05382286|Carboplatin|carboplatin|mesh-list
84081906|NCT05382286|Gemcitabine|gemcitabine|mesh-list
84081907|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
84081908|NCT05382286|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84081909|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84081910|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081911|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
84081912|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
84081913|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
83386601|NCT03218709|Vitamins|vitamins|mesh-list
84081914|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081915|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84081916|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
84081917|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081918|NCT05382286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84081919|NCT05382286|Immunoconjugates|immunoconjugates|mesh-ancestor
84081920|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
84081921|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081922|NCT05372614|Trastuzumab|trastuzumab|mesh-list
84081923|NCT05372614|Camptothecin|camptothecin|mesh-list
84081924|NCT05372614|Maleic acid|maleic acid|mesh-list
84081925|NCT05372614|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
84081926|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
84081927|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081928|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081929|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84081930|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081931|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
84081932|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081933|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84081934|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84081935|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84081936|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
84081937|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
84081938|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081939|NCT05364008|Protective Agents|protective agents|mesh-ancestor
84081940|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081941|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84081942|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84081943|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081944|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84081945|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84081946|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84081947|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
84081948|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081949|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081950|NCT05357898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83386927|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84081951|NCT05357898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081952|NCT05318573|Gemcitabine|gemcitabine|mesh-list
84081953|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
84081954|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84081955|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
84081956|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081957|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081958|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081959|NCT05318573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84081960|NCT05307770|Melatonin|melatonin|mesh-list
84081961|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
83387142|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84081962|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081963|NCT05307770|Protective Agents|protective agents|mesh-ancestor
84081964|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081965|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081966|NCT05307458|Buprenorphine|buprenorphine|mesh-list
84081967|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84081968|NCT05307458|Naloxone|naloxone|mesh-list
84081969|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84081970|NCT05307458|Narcotics|narcotics|mesh-ancestor
84081971|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84081972|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84081973|NCT05307458|Analgesics|analgesics|mesh-ancestor
84081974|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
84081975|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84081976|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84081977|NCT05269355|Dacarbazine|dacarbazine|mesh-list
84081978|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84081979|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
84081980|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081981|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081982|NCT05267626|Aldesleukin|aldesleukin|mesh-list
84081983|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081984|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84081985|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84081986|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
84081987|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84081988|NCT05199662|Tenecteplase|tenecteplase|mesh-list
84081989|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84081990|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84081991|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081992|NCT05198934|Trifluridine|trifluridine|mesh-list
84081993|NCT05198934|Panitumumab|panitumumab|mesh-list
84081994|NCT05198934|Sotorasib|sotorasib|mesh-list
84081995|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84081996|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84081997|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
84081998|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84081999|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
84082000|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83387288|NCT05248633|Hormones|hormones|mesh-ancestor
84082001|NCT05198934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082002|NCT05123053|Amifampridine|amifampridine|mesh-list
84082003|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84082004|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082005|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082006|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84082007|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84082008|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082009|NCT05112601|Nivolumab|nivolumab|mesh-list
84082010|NCT05112601|Ipilimumab|ipilimumab|mesh-list
84082011|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082012|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082013|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082014|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082015|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84082016|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84082017|NCT05100862|Rituximab|rituximab|mesh-list
84082018|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
84082019|NCT05100862|Lenalidomide|lenalidomide|mesh-list
84082020|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
84082021|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082022|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082023|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
84082024|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082025|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082026|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84082027|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84082028|NCT05100862|Growth Substances|growth substances|mesh-ancestor
84082029|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
84082030|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082031|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082032|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082033|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
84082034|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082035|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082036|NCT05083481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082037|NCT05083481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082038|NCT05061550|Paclitaxel|paclitaxel|mesh-list
84082039|NCT05061550|Cisplatin|cisplatin|mesh-list
84082040|NCT05061550|Carboplatin|carboplatin|mesh-list
84082041|NCT05061550|Pemetrexed|pemetrexed|mesh-list
84082042|NCT05061550|Durvalumab|durvalumab|mesh-list
84082043|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082044|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082045|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082046|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082047|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082048|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082049|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082050|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84082051|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84082052|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082053|NCT05060744|Antacids|antacids|mesh-list
84082054|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
84082055|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082056|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082057|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
84082058|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84082059|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84082060|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84082061|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83387805|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
84082062|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082063|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
84082064|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84082065|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082066|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84082067|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082068|NCT05047939|Propofol|propofol|mesh-list
84082069|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83387876|NCT04377867|Abatacept|abatacept|mesh-list
84082070|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082071|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082072|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84082073|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
84082074|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
84082075|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84082076|NCT05041127|Cetuximab|cetuximab|mesh-list
84082077|NCT05041127|Antibodies|antibodies|mesh-list
84082078|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
84082079|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84082080|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
84082081|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082082|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082083|NCT05030298|Temozolomide|temozolomide|mesh-list
84082084|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082085|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
84082086|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082087|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082088|NCT04943900|Nivolumab|nivolumab|mesh-list
84082089|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082090|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082091|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082092|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082093|NCT04913675|Sotrovimab|sotrovimab|mesh-list
84082094|NCT04913675|Antiviral Agents|antiviral agents|mesh-ancestor
84082095|NCT04913675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082096|NCT04926285|Venetoclax|venetoclax|mesh-list
84082097|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
84082098|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082099|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082100|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84082101|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082102|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082103|NCT04858854|Sulforaphane|sulforaphane|mesh-list
84082104|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84082105|NCT04858854|Protective Agents|protective agents|mesh-ancestor
83388070|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
84082106|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082107|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082108|NCT04856566|Ethanol|ethanol|mesh-list
84082109|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84082110|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082111|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082112|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082113|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
84082114|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84082115|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082116|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082117|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84082118|NCT04798482|Analgesics|analgesics|mesh-ancestor
84082119|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
84082120|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082121|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84082122|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84082123|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84082124|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
84082125|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84082126|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082127|NCT04774250|Zonisamide|zonisamide|mesh-list
84082128|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
84082129|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84082130|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84082131|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082132|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84082133|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082134|NCT04768569|Zonisamide|zonisamide|mesh-list
84082135|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
84082136|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83388341|NCT00983515|Ritonavir|ritonavir|mesh-list
84082137|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84082138|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082139|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84082140|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082141|NCT04740671|Ranibizumab|ranibizumab|mesh-list
84082142|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84082143|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84082144|NCT04740671|Growth Substances|growth substances|mesh-ancestor
84082145|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082146|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
84082147|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082148|NCT04721132|Bevacizumab|bevacizumab|mesh-list
84082149|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84082150|NCT04721132|Atezolizumab|atezolizumab|mesh-list
84082151|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
84082152|NCT04721132|Antibodies|antibodies|mesh-list
84082153|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
84082154|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84082155|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
84082156|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082157|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84082158|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84082159|NCT04721132|Growth Substances|growth substances|mesh-ancestor
84082160|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082161|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
84082162|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
84082163|NCT04721132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082164|NCT04721132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082165|NCT04711837|Propofol|propofol|mesh-list
84082166|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84082167|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082168|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082169|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84082170|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
84082171|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
84082172|NCT04669457|Midazolam|midazolam|mesh-list
84082173|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
83322199|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
84082174|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83388521|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
84082175|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082176|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082177|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84082178|NCT04669457|Analgesics|analgesics|mesh-ancestor
84082179|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
84082180|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082181|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84082182|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84082183|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84082184|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
84082185|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84082186|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082187|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84082188|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84082189|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84082190|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84082191|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84082192|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
84082193|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
84082194|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
84082195|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
84082196|NCT04666649|Venetoclax|venetoclax|mesh-list
84082197|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082198|NCT04642365|Atezolizumab|atezolizumab|mesh-list
84082199|NCT04642365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082200|NCT04642365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082201|NCT04642365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082202|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082203|NCT04626635|Cemiplimab|cemiplimab|mesh-list
83388932|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84082204|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082205|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082206|NCT04537715|Itraconazole|itraconazole|mesh-list
84082207|NCT04537715|Rifampin|rifampin|mesh-list
84082208|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
84082209|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082210|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84082211|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84082212|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082213|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082214|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84082215|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
84082216|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082217|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082218|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84082219|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84082220|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
84082221|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83389308|NCT05017116|Entecavir|entecavir|mesh-list
84082222|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
84082223|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84082224|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83389370|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84082225|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84082226|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84082227|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84082228|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83389515|NCT00919503|Fludarabine|fludarabine|mesh-list
84082229|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84082230|NCT04532528|Dabigatran|dabigatran|mesh-list
84082231|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
84082232|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84082233|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
84082234|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082235|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082236|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
83421034|NCT01879085|Gemcitabine|gemcitabine|mesh-list
84082237|NCT04427956|Riboflavin|riboflavin|mesh-list
84082238|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
84082239|NCT04427956|Vitamins|vitamins|mesh-ancestor
84082240|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
84082241|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082242|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84082243|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
84082244|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
84082245|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84082246|NCT04427241|Protective Agents|protective agents|mesh-ancestor
84082247|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082249|NCT04385290|Cytarabine|cytarabine|mesh-list
84082250|NCT04385290|Daunorubicin|daunorubicin|mesh-list
84082251|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
84082252|NCT04385290|Midostaurin|midostaurin|mesh-list
84082253|NCT04385290|Staurosporine|staurosporine|mesh-list
84082254|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082255|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
84082256|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082257|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082258|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
84082259|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83421397|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082260|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082261|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
84082262|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082263|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83421477|NCT05340309|Atezolizumab|atezolizumab|mesh-list
84082264|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84082265|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84082266|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082267|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082268|NCT04385290|Immunotoxins|immunotoxins|mesh-ancestor
84082269|NCT04385290|Immunoconjugates|immunoconjugates|mesh-ancestor
84082270|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082271|NCT04324463|Aspirin|aspirin|mesh-list
84082272|NCT04324463|Interferons|interferons|mesh-list
84082273|NCT04324463|Interferon-beta|interferon-beta|mesh-list
84082274|NCT04324463|Colchicine|colchicine|mesh-list
84082275|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
84082276|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082277|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
84082278|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082279|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84082280|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84082281|NCT04324463|Analgesics|analgesics|mesh-ancestor
84082282|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
84082283|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082284|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082285|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082286|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082287|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84082288|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84082289|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83421967|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
84082290|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83422044|NCT00100841|Leucovorin|leucovorin|mesh-list
84082291|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84082292|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082293|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
84082294|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84082295|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
84082296|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84082297|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
84082298|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
84082299|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
84082300|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082301|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082302|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082303|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
84082304|NCT04315701|Cemiplimab|cemiplimab|mesh-list
84082305|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082306|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082307|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
84082308|NCT04305054|Lenvatinib|lenvatinib|mesh-list
84082309|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082310|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082311|NCT04305054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082312|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082313|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082314|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082315|NCT04256421|Carboplatin|carboplatin|mesh-list
84082316|NCT04256421|Etoposide|etoposide|mesh-list
84082317|NCT04256421|Atezolizumab|atezolizumab|mesh-list
84082318|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082319|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082320|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84082321|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84082322|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082323|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082324|NCT04256421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082325|NCT04256421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082326|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
84082327|NCT04240093|Narcotics|narcotics|mesh-ancestor
84082328|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082329|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082330|NCT04240093|Analgesics|analgesics|mesh-ancestor
84082331|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
84082332|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082333|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
84082334|NCT04213794|Cisplatin|cisplatin|mesh-list
84082335|NCT04213794|Doxorubicin|doxorubicin|mesh-list
84082336|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84082337|NCT04213794|Daunorubicin|daunorubicin|mesh-list
84082338|NCT04213794|Antidotes|antidotes|mesh-list
84082339|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082340|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84082341|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84082342|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84082343|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082344|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082345|NCT04213794|Protective Agents|protective agents|mesh-ancestor
84082346|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082347|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
84082348|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
84082349|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84082350|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082351|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
84082352|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
84082353|NCT04206319|Listerine|listerine|mesh-list
84082354|NCT04206319|Fluorides|fluorides|mesh-list
84082355|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
84082356|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
83422736|NCT05536596|Melatonin|melatonin|mesh-list
84082357|NCT04206319|Protective Agents|protective agents|mesh-ancestor
84082358|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082359|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84082360|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082361|NCT04157335|Benralizumab|benralizumab|mesh-list
84082362|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84082363|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
84082364|NCT04115774|Diphosphonates|diphosphonates|mesh-list
84082365|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84082366|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082367|NCT04083170|Vidarabine|vidarabine|mesh-list
84082368|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
84082369|NCT04083170|Thiotepa|thiotepa|mesh-list
84082370|NCT04083170|Fludarabine|fludarabine|mesh-list
84082371|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
84082372|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082373|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
83422966|NCT01748799|Hormones|hormones|mesh-ancestor
84082374|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082375|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082376|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082377|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
84082378|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082379|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082380|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84082381|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082382|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
84082383|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
84082384|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082385|NCT04025359|Dronabinol|dronabinol|mesh-list
84082386|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
84082387|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082388|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84082389|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84082390|NCT04025359|Analgesics|analgesics|mesh-ancestor
84082391|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
84082392|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082393|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84082394|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84082395|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84082396|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082397|NCT04025359|Hormones|hormones|mesh-ancestor
84082398|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082399|NCT04005716|Cisplatin|cisplatin|mesh-list
84082400|NCT04005716|Carboplatin|carboplatin|mesh-list
84082401|NCT04005716|Etoposide|etoposide|mesh-list
84082402|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
84082404|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082405|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082406|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84082407|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84082408|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082409|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082410|NCT04005716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082411|NCT03995628|Dexamethasone|dexamethasone|mesh-list
84082412|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082413|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
84082414|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
84082415|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082416|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082417|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082418|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
84082419|NCT03995628|Hormones|hormones|mesh-ancestor
84082420|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082421|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83423141|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
84082422|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082423|NCT03972280|Antibodies|antibodies|mesh-list
84082424|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84082425|NCT03972280|Lenograstim|lenograstim|mesh-list
84082426|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
84082427|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082428|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84082429|NCT03961568|Cenobamate|cenobamate|mesh-list
84082430|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
84082431|NCT03941886|Aspirin|aspirin|mesh-list
84082432|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84082433|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84082434|NCT03941886|Analgesics|analgesics|mesh-ancestor
84082435|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
83423214|NCT02094443|Ribavirin|ribavirin|mesh-list
84082436|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082437|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082438|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082439|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082440|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84082441|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84082442|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082443|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84082444|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84082445|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082446|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
84082447|NCT03921008|Paclitaxel|paclitaxel|mesh-list
84082448|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082449|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082450|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082451|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082452|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082453|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082454|NCT03845296|Rucaparib|rucaparib|mesh-list
84082455|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84082456|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082457|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082458|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082459|NCT03813108|Lumefantrine|lumefantrine|mesh-list
84082460|NCT03813108|Artemether|artemether|mesh-list
84082461|NCT03813108|Mefloquine|mefloquine|mesh-list
84082462|NCT03813108|Atovaquone|atovaquone|mesh-list
84082463|NCT03813108|Proguanil|proguanil|mesh-list
84082464|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
84082465|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84082466|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
84082467|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84082468|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84082469|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082470|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83423310|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84082471|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082472|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
84082473|NCT03718767|Nivolumab|nivolumab|mesh-list
84082474|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082475|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082476|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83322480|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
84082477|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082479|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082480|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082481|NCT03711032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082482|NCT03711032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082483|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
84082484|NCT03675737|Fluorouracil|fluorouracil|mesh-list
84082485|NCT03675737|Capecitabine|capecitabine|mesh-list
84082486|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
84082487|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082488|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082489|NCT03675737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082490|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082491|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
84082492|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082493|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082494|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
84082495|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082496|NCT03621748|Anesthetics|anesthetics|mesh-list
84082497|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082498|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082499|NCT03604991|Paclitaxel|paclitaxel|mesh-list
84082500|NCT03604991|Carboplatin|carboplatin|mesh-list
84082501|NCT03604991|Nivolumab|nivolumab|mesh-list
84082502|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84082503|NCT03604991|Ipilimumab|ipilimumab|mesh-list
84082504|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082505|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082506|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082507|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082508|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082509|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082510|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082511|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082512|NCT03586453|Osimertinib|osimertinib|mesh-list
84082513|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082514|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082515|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082516|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082517|NCT03576547|Dexamethasone|dexamethasone|mesh-list
84082518|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
84082519|NCT03576547|Rituximab|rituximab|mesh-list
84082520|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84082521|NCT03576547|Venetoclax|venetoclax|mesh-list
84082522|NCT03576547|Ponatinib|ponatinib|mesh-list
84082523|NCT03576547|Antibodies|antibodies|mesh-list
84082524|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
84082525|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84082526|NCT03576547|BB 1101|bb 1101|mesh-list
84082527|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
84082528|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082529|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082530|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082531|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83423554|NCT00186875|Cytarabine|cytarabine|mesh-list
84082532|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
84082533|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
84082534|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082535|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082536|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
84082537|NCT03576547|Hormones|hormones|mesh-ancestor
84082538|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082539|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082540|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
84082541|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082542|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082543|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082544|NCT03467373|Prednisone|prednisone|mesh-list
84082545|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
84082546|NCT03467373|Rituximab|rituximab|mesh-list
84082547|NCT03467373|Doxorubicin|doxorubicin|mesh-list
84082548|NCT03467373|Vincristine|vincristine|mesh-list
84082549|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
84082550|NCT03467373|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
84082551|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83322556|NCT00774202|Prednisone|prednisone|mesh-list
84082552|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
84082553|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082554|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082555|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082556|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
84082557|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082558|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082559|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84082560|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082561|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84082562|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84082563|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84082564|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082565|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082566|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
83423711|NCT01761747|Ponatinib|ponatinib|mesh-list
84082568|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082569|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082570|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082571|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082572|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082573|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082574|NCT03467373|Immunoconjugates|immunoconjugates|mesh-ancestor
84082575|NCT03440450|Gemcitabine|gemcitabine|mesh-list
84082576|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082577|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
84082578|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082579|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082580|NCT03425643|Gemcitabine|gemcitabine|mesh-list
84082581|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
84082582|NCT03425643|Pemetrexed|pemetrexed|mesh-list
84082583|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082584|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082585|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
84082586|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082587|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082588|NCT03425643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082589|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082590|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84082591|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84082592|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
84082593|NCT03417154|Nivolumab|nivolumab|mesh-list
84082594|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082595|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
84082596|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082597|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082598|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082599|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
84082600|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082601|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082602|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84082603|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082604|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082605|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
84082606|NCT03396315|Alendronate|alendronate|mesh-list
84082607|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84082608|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082609|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
84082610|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
84082611|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082612|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082613|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082614|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082615|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082616|NCT03245437|Oxytocin|oxytocin|mesh-list
84082617|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
84082618|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84082619|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082620|NCT03221036|Vedolizumab|vedolizumab|mesh-list
84082621|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082622|NCT03120624|Iodine|iodine|mesh-list
84082623|NCT03120624|Interferons|interferons|mesh-list
84082624|NCT03120624|Interferon-beta|interferon-beta|mesh-list
84082625|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
84082626|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
84082627|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082628|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
83424354|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
84082629|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082630|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
84082631|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082632|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84082633|NCT03120624|Trace Elements|trace elements|mesh-ancestor
84082634|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
84082635|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082636|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082637|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082638|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84082639|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
84082640|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
84082641|NCT03032783|Tacrolimus|tacrolimus|mesh-list
84082642|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082643|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
84082644|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082645|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082646|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082647|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
84082648|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082649|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082650|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84082651|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84082652|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082653|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84082654|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84082655|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
84082656|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84082657|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082658|NCT02978625|Nivolumab|nivolumab|mesh-list
84082659|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
84082660|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082661|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082662|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082663|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082664|NCT02971501|Bevacizumab|bevacizumab|mesh-list
83424478|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082665|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84082666|NCT02971501|Osimertinib|osimertinib|mesh-list
84082667|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
84082668|NCT02971501|Antibodies|antibodies|mesh-list
84082669|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
84082670|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84082671|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
84082672|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082673|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84082674|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84082675|NCT02971501|Growth Substances|growth substances|mesh-ancestor
84082676|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082677|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
84082678|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
84082679|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082680|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082681|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082682|NCT02784210|Prednisone|prednisone|mesh-list
84082683|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
84082684|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84082685|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84082686|NCT02784210|Prednisolone|prednisolone|mesh-list
84082687|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
84082688|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84082689|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
84082690|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082691|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
84082692|NCT02784210|Hormones|hormones|mesh-ancestor
84082693|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082694|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082695|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082696|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082697|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
84082698|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
84082699|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082700|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082701|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83322706|NCT05742568|Bismuth|bismuth|mesh-list
84082702|NCT02784210|Protective Agents|protective agents|mesh-ancestor
84082703|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
84082704|NCT02778685|Letrozole|letrozole|mesh-list
84082705|NCT02778685|Fulvestrant|fulvestrant|mesh-list
84082706|NCT02778685|Palbociclib|palbociclib|mesh-list
84082707|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83424724|NCT01830699|Triamcinolone|triamcinolone|mesh-list
84082708|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082709|NCT02778685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84082710|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082711|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84082712|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84082713|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424796|NCT02261727|Hormones|hormones|mesh-ancestor
84082714|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84082715|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
84082716|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082717|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082718|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082719|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84082720|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082721|NCT02740985|Docetaxel|docetaxel|mesh-list
84082722|NCT02740985|Durvalumab|durvalumab|mesh-list
84082723|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
84082724|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082725|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082726|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082727|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082728|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082729|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082730|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84082731|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83424978|NCT01794741|Xhance|xhance|mesh-list
84082732|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
84082733|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082734|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082735|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84082736|NCT02728531|Cytarabine|cytarabine|mesh-list
84082737|NCT02728531|Rituximab|rituximab|mesh-list
84082738|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83425068|NCT00287989|Paclitaxel|paclitaxel|mesh-list
84082739|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082740|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082741|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
84082742|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082743|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082744|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082745|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
84082746|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082747|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
84082748|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082749|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082750|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082751|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
84082752|NCT02723331|Paclitaxel|paclitaxel|mesh-list
84082753|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84082754|NCT02723331|Gemcitabine|gemcitabine|mesh-list
84082755|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84082756|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082757|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082758|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082759|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
84082760|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082761|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082762|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
84082763|NCT02593526|Bumetanide|bumetanide|mesh-list
84082764|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
84082765|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84082766|NCT02593526|Diuretics|diuretics|mesh-ancestor
84082767|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
84082768|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082769|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84082770|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84082771|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082772|NCT02484677|Docetaxel|docetaxel|mesh-list
84082773|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082774|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
84082775|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082777|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082778|NCT02476097|Esomeprazole|esomeprazole|mesh-list
84082779|NCT02476097|Omeprazole|omeprazole|mesh-list
84082780|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84082781|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082782|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84082783|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082784|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082785|NCT02456857|Bevacizumab|bevacizumab|mesh-list
84082786|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84082787|NCT02456857|Doxorubicin|doxorubicin|mesh-list
84082788|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84082789|NCT02456857|Everolimus|everolimus|mesh-list
84082790|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
84082791|NCT02456857|Antibodies|antibodies|mesh-list
84082792|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
84082793|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84082794|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
84082795|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082796|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84082797|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84082798|NCT02456857|Growth Substances|growth substances|mesh-ancestor
84082799|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082800|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
84082801|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
84082802|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84082803|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84082804|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84082805|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082806|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082807|NCT02456857|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83425754|NCT01790555|Diazepam|diazepam|mesh-list
84082808|NCT02456857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082809|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082810|NCT02343042|Clarithromycin|clarithromycin|mesh-list
84082811|NCT02343042|Dexamethasone|dexamethasone|mesh-list
84082812|NCT02343042|Lenalidomide|lenalidomide|mesh-list
84082813|NCT02343042|Bortezomib|bortezomib|mesh-list
84082814|NCT02343042|Daratumumab|daratumumab|mesh-list
84082815|NCT02343042|Pomalidomide|pomalidomide|mesh-list
84082816|NCT02343042|Ixazomib|ixazomib|mesh-list
84082817|NCT02343042|Elotuzumab|elotuzumab|mesh-list
84082818|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082819|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
84082820|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
84082821|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082822|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082823|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082824|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
84082825|NCT02343042|Hormones|hormones|mesh-ancestor
84082826|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082827|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082828|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082829|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
84082830|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84082831|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84082832|NCT02343042|Growth Substances|growth substances|mesh-ancestor
84082833|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
84082834|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84082835|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84082836|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84082837|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83426173|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
83426246|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
84082838|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082839|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84082840|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84082841|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
84082842|NCT02211755|Bortezomib|bortezomib|mesh-list
84082843|NCT02211755|Clofarabine|clofarabine|mesh-list
84082844|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082845|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84082846|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
84082847|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082848|NCT03946358|Atezolizumab|atezolizumab|mesh-list
84082849|NCT03946358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83426384|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84082850|NCT03946358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322853|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
84082851|NCT03946358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84082852|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082853|NCT02118584|Etrolizumab|etrolizumab|mesh-list
84082854|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84082855|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
84082856|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082857|NCT02115282|Exemestane|exemestane|mesh-list
84082858|NCT02115282|Goserelin|goserelin|mesh-list
84082859|NCT02115282|Entinostat|entinostat|mesh-list
84082860|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84082861|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082862|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84082863|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84082864|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082865|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082866|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84082867|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
84082868|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83426830|NCT00340379|Haloperidol|haloperidol|mesh-list
84082869|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426897|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082870|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082871|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
84082872|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082873|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
83426989|NCT05487456|Menthol|menthol|mesh-list
84082874|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082875|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84082876|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082877|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
84082878|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83427189|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
84082879|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082880|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84082881|NCT02106507|Everolimus|everolimus|mesh-list
84082882|NCT02106507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84082883|NCT02106507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84082884|NCT02106507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082885|NCT02106507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082886|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84082887|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
84082888|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082889|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082890|NCT02051218|Denosumab|denosumab|mesh-list
84082891|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84082892|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082893|NCT01950520|Topiramate|topiramate|mesh-list
84082894|NCT01950520|Phentermine|phentermine|mesh-list
84082895|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
84082896|NCT01950520|Propranolol|propranolol|mesh-list
84082897|NCT01950520|Pindolol|pindolol|mesh-list
84082898|NCT01950520|Naltrexone|naltrexone|mesh-list
84082899|NCT01950520|Caffeine|caffeine|mesh-list
84082900|NCT01950520|Dantrolene|dantrolene|mesh-list
84082901|NCT01950520|Mirabegron|mirabegron|mesh-list
84082902|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84082903|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84082904|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082905|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
84082906|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082907|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84082908|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84082909|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082910|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082911|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84082912|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84082913|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
84082914|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84082915|NCT01950520|Analgesics|analgesics|mesh-ancestor
84082916|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
84082917|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84082918|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84082919|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
84082920|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84082921|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84082922|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84082923|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
84082924|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84082925|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83427676|NCT00375973|Analgesics|analgesics|mesh-ancestor
84082926|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84082928|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84082929|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
84082930|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84082931|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83427820|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84082932|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84082933|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84082934|NCT01950520|Urological Agents|urological agents|mesh-ancestor
84082935|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
84082936|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84082937|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
84082938|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
84082939|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84082940|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
84082941|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84082942|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84082943|NCT01940094|Prednisone|prednisone|mesh-list
84082944|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
84082945|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082946|NCT01940094|Hormones|hormones|mesh-ancestor
84082947|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082948|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082949|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082950|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082951|NCT01905046|Metformin|metformin|mesh-list
84082952|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84082953|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082954|NCT01786265|Prednisone|prednisone|mesh-list
84082955|NCT01786265|Cortisone|cortisone|mesh-list
84082956|NCT01786265|Leuprolide|leuprolide|mesh-list
84082957|NCT01786265|Goserelin|goserelin|mesh-list
84082958|NCT01786265|Flutamide|flutamide|mesh-list
84082959|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
84082960|NCT01786265|Bicalutamide|bicalutamide|mesh-list
84082961|NCT01786265|Nilutamide|nilutamide|mesh-list
84082962|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84082963|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
84082964|NCT01786265|Hormones|hormones|mesh-ancestor
84082965|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84082966|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082967|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84082968|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082969|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83428243|NCT00400205|Fluorouracil|fluorouracil|mesh-list
84082970|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
84082971|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84082972|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84082973|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84082974|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428307|NCT00465595|Psilocybin|psilocybin|mesh-list
84082975|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
84082976|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84082977|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
84082978|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84082979|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84082980|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
83428517|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
84082981|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84082982|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082983|NCT01264315|Lenalidomide|lenalidomide|mesh-list
84082984|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
84082985|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082986|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84082987|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84082988|NCT01264315|Growth Substances|growth substances|mesh-ancestor
84082989|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
84082990|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84082991|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
84082992|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84082993|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
84082994|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84082995|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84082996|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84082997|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
84082998|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84082999|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83428838|NCT01381562|Meropenem|meropenem|mesh-list
84083000|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84083001|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
84083002|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083003|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083004|NCT00890149|Ondansetron|ondansetron|mesh-list
84083005|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
84083006|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
84083007|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083008|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083009|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84083010|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
84083011|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083012|NCT00890149|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84083013|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84083014|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
83428944|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84083015|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083016|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083017|NCT00716066|Cytarabine|cytarabine|mesh-list
84083018|NCT00716066|Prednisone|prednisone|mesh-list
84083019|NCT00716066|Cortisone|cortisone|mesh-list
84083020|NCT00716066|Etoposide|etoposide|mesh-list
84083021|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
84083022|NCT00716066|Melphalan|melphalan|mesh-list
84083023|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
84083024|NCT00716066|Carmustine|carmustine|mesh-list
84083025|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
84083026|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
84083027|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
84083028|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84083029|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083030|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
84083031|NCT00716066|Hormones|hormones|mesh-ancestor
83429221|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
84083032|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083033|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083034|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84083035|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083036|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84083037|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84083038|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84083039|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083040|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083041|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84083042|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
84083043|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
84083044|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083045|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083046|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
84083047|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84083048|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
84083049|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84083050|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
84083051|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083052|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
84083053|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
84083054|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
84083055|NCT00566098|Melphalan|melphalan|mesh-list
84083056|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84083057|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
84083058|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083059|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083060|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84083061|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083062|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
84083063|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083064|NCT00248287|Carboplatin|carboplatin|mesh-list
84083065|NCT00248287|Irinotecan|irinotecan|mesh-list
84083066|NCT00248287|Cetuximab|cetuximab|mesh-list
84083067|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083068|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84083069|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84083070|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083071|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083072|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84083073|NCT04249284|Deucravacitinib|deucravacitinib|mesh-list
84083074|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083075|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84083076|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083077|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083078|NCT04474938|Dexamethasone|dexamethasone|mesh-list
84083079|NCT04474938|Bortezomib|bortezomib|mesh-list
84083080|NCT04474938|Daratumumab|daratumumab|mesh-list
84083081|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083082|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
84083083|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
84083084|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083085|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083086|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84083087|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
84083088|NCT04474938|Hormones|hormones|mesh-ancestor
84083089|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083090|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84083091|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083092|NCT00837213|Doxycycline|doxycycline|mesh-list
84083093|NCT00837213|Clindamycin|clindamycin|mesh-list
84083094|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
84083095|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
84083096|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84083097|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84083098|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083099|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
84083100|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84083101|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84083102|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84083103|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083104|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083105|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083106|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
84083107|NCT02833038|Analgesics|analgesics|mesh-ancestor
84083108|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
84083109|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083110|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083111|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
84083112|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083113|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84083114|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
84083115|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84083116|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84083117|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083118|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84083119|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
84083120|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84083121|NCT00703755|Metformin|metformin|mesh-list
84083122|NCT00703755|Fenofibrate|fenofibrate|mesh-list
84083123|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84083124|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083125|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84083126|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
84083127|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083128|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84083129|NCT02838342|Interferons|interferons|mesh-list
84083130|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
84083131|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
84083132|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083133|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
84083134|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083135|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083136|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84083137|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
84083138|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083139|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083140|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84083141|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
84083142|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083143|NCT05333640|Sirolimus|sirolimus|mesh-list
84083144|NCT05333640|Paclitaxel|paclitaxel|mesh-list
84083145|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84083146|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083147|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
84083148|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
84083149|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
84083150|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083151|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84083152|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083153|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84083154|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
84083155|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083156|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
84083157|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083158|NCT02838264|Itraconazole|itraconazole|mesh-list
84083159|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
84083160|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083161|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84083162|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84083163|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083164|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083165|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84083166|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
84083167|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083168|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083169|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84083170|NCT00633438|Celecoxib|celecoxib|mesh-list
84083171|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84083172|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083173|NCT00633438|Analgesics|analgesics|mesh-ancestor
84083174|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
84083175|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083176|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083177|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083178|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083179|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84083180|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84083181|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083182|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083183|NCT02833116|Dexamethasone|dexamethasone|mesh-list
84083184|NCT02833116|Betamethasone|betamethasone|mesh-list
84083185|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083186|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
84083187|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
84083188|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083189|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083190|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84083191|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
84083192|NCT02833116|Hormones|hormones|mesh-ancestor
84083193|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083194|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84083195|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083196|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84083197|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
84083198|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
84083199|NCT00703989|Benphothiamine|benphothiamine|mesh-list
84083200|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
84083201|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083202|NCT00703989|Protective Agents|protective agents|mesh-ancestor
84083203|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083204|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
84083205|NCT00703989|Vitamins|vitamins|mesh-ancestor
84083206|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
84083207|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84083208|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
84083209|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
84083210|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
84083211|NCT05335460|Capecitabine|capecitabine|mesh-list
84083212|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
84083213|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84083214|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
84083215|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083216|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083217|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
84083218|NCT02836002|Piperaquine|piperaquine|mesh-list
84083219|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
84083220|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84083221|NCT02836002|Atovaquone|atovaquone|mesh-list
84083222|NCT02836002|Proguanil|proguanil|mesh-list
84083223|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
84083224|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
84083225|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84083226|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84083227|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083228|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84083229|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083230|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083231|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84083232|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
84083233|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
84083234|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84083235|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
84083236|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84083237|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84083238|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083239|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
84083240|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083241|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083242|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84083243|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
84083244|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
84083245|NCT02297516|Protective Agents|protective agents|mesh-ancestor
84083246|NCT02842580|Leucovorin|leucovorin|mesh-list
84083247|NCT02842580|Bevacizumab|bevacizumab|mesh-list
84083248|NCT02842580|Capecitabine|capecitabine|mesh-list
84083249|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
84083250|NCT02842580|Irinotecan|irinotecan|mesh-list
84083251|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
84083252|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84083253|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083254|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84083255|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84083256|NCT02842580|Growth Substances|growth substances|mesh-ancestor
84083257|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083258|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
84083259|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84083260|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
84083261|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083262|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84083263|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84083264|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083265|NCT02842580|Antidotes|antidotes|mesh-ancestor
84083266|NCT02842580|Protective Agents|protective agents|mesh-ancestor
84083267|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
84083268|NCT02842580|Vitamins|vitamins|mesh-ancestor
84083269|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
84083270|NCT00836277|Irinotecan|irinotecan|mesh-list
84083271|NCT00836277|Panitumumab|panitumumab|mesh-list
84083272|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84083273|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84083274|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083275|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083276|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083277|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84083278|NCT00831025|Immunomodulating Agents|immunomodulating agents|mesh-list
84083279|NCT00831025|Immunologic Factors|immunologic factors|mesh-ancestor
84083280|NCT00831025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083281|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
84083282|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
84083283|NCT00835731|Misoprostol|misoprostol|mesh-list
84083284|NCT00835731|Vitamins|vitamins|mesh-ancestor
84083285|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
84083286|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083287|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84083288|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
84083289|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84083290|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84083291|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84083292|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
84083293|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
84083294|NCT00835731|Hematinics|hematinics|mesh-ancestor
84083295|NCT03721406|Ropivacaine|ropivacaine|mesh-list
84083296|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
84083297|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
84083298|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083299|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083300|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
84083301|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083302|NCT00751166|Cetirizine|cetirizine|mesh-list
84083303|NCT00751166|Desloratadine|desloratadine|mesh-list
84083304|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84083305|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84083306|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84083307|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
84083308|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
84083309|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083310|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083311|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083312|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84083313|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
84083314|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84083315|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
84083316|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84083317|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84083318|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84083319|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083320|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083321|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
84083322|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083323|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083324|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84083325|NCT00704145|Paclitaxel|paclitaxel|mesh-list
84083326|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84083327|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083328|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
84083329|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
84083330|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
84083331|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083332|NCT03508232|Doxycycline|doxycycline|mesh-list
84083333|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84083334|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083335|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
84083336|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84083337|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84083338|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
84083339|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
84083340|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84083341|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083342|NCT00704301|Rivastigmine|rivastigmine|mesh-list
84083343|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84083344|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083345|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083346|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
84083347|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083348|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083349|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84083350|NCT00704301|Protective Agents|protective agents|mesh-ancestor
84083351|NCT00831103|Valacyclovir|valacyclovir|mesh-list
84083352|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
84083353|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083354|NCT00704444|Ezetimibe|ezetimibe|mesh-list
84083355|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84083356|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84083357|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
84083358|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083359|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84083360|NCT00704691|Lenalidomide|lenalidomide|mesh-list
84083361|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
84083362|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083363|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84083364|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84083365|NCT00704691|Growth Substances|growth substances|mesh-ancestor
84083366|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
84083367|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083368|NCT00704925|Amifampridine|amifampridine|mesh-list
84083369|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84083370|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083371|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083372|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84083373|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84083374|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083375|NCT00574249|Adalimumab|adalimumab|mesh-list
84083376|NCT00574249|Betamethasone|betamethasone|mesh-list
84083377|NCT00574249|Calcipotriene|calcipotriene|mesh-list
84083378|NCT00574249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84083379|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083380|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083381|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
84083382|NCT00574249|Hormones|hormones|mesh-ancestor
84083383|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083384|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083385|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84083386|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
84083387|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083388|NCT00891228|ST 1435|st 1435|mesh-list
84083389|NCT00891228|Testosterone|testosterone|mesh-list
84083390|NCT00891228|Androgens|androgens|mesh-ancestor
84083391|NCT00891228|Hormones|hormones|mesh-ancestor
84083392|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083393|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083394|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84083395|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
84083396|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84083397|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84083398|NCT00896168|Infliximab|infliximab|mesh-list
84083399|NCT00896168|Methotrexate|methotrexate|mesh-list
84083400|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84083401|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
84083402|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84083403|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083404|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84083405|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
84083406|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083407|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083408|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083409|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083410|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84083411|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083412|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
84083413|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083414|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84083415|NCT00896168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84083416|NCT00896168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083417|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84083418|NCT00833703|Clopidogrel|clopidogrel|mesh-list
84083419|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84083420|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84083421|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84083422|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84083423|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
84083424|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083425|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083426|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083427|NCT00833547|Eszopiclone|eszopiclone|mesh-list
84083428|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84083429|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083430|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083431|NCT00833469|Escitalopram|escitalopram|mesh-list
84083432|NCT00833469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84083433|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84083434|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84083435|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083436|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083437|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
84083438|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083439|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
84083440|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84083441|NCT02831478|Protective Agents|protective agents|mesh-ancestor
84083442|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083443|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083444|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
84083445|NCT00837655|Calcium|calcium|mesh-list
84083446|NCT00837655|Sevelamer|sevelamer|mesh-list
84083447|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84083448|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083449|NCT00837655|Antacids|antacids|mesh-ancestor
84083450|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083451|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84083452|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
84083453|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
84083454|NCT00843661|Ezetimibe|ezetimibe|mesh-list
84083455|NCT00843661|Pravastatin|pravastatin|mesh-list
84083456|NCT00843661|Fenofibrate|fenofibrate|mesh-list
84083457|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84083458|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84083459|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
84083460|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083461|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84083462|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84083463|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083464|NCT00832377|Timolol|timolol|mesh-list
84083465|NCT00832377|Dorzolamide|dorzolamide|mesh-list
84083466|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84083467|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84083468|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
84083469|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083470|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083471|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083472|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84083473|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84083474|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84083475|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083476|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84083477|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
84083478|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083479|NCT00705315|Bevacizumab|bevacizumab|mesh-list
84083480|NCT00705315|Docetaxel|docetaxel|mesh-list
84083481|NCT00705315|Epirubicin|epirubicin|mesh-list
84083482|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84083483|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083484|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84083485|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84083486|NCT00705315|Growth Substances|growth substances|mesh-ancestor
84083487|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083488|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
84083489|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
84083490|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
84083491|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
84083492|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083493|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84083494|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84083495|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84083496|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083497|NCT00892008|Pregabalin|pregabalin|mesh-list
84083498|NCT00892008|Analgesics|analgesics|mesh-ancestor
84083499|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
84083500|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083501|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083502|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
84083503|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84083504|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84083505|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083506|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84083507|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84083508|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84083509|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083510|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84083511|NCT00623233|Bevacizumab|bevacizumab|mesh-list
84083512|NCT00623233|Gemcitabine|gemcitabine|mesh-list
84083513|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84083514|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083515|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84083516|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84083517|NCT00623233|Growth Substances|growth substances|mesh-ancestor
84083518|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083519|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
84083520|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84083521|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
84083522|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083523|NCT00837889|Diuretics|diuretics|mesh-list
84083524|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
84083525|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083526|NCT02841488|Fentanyl|fentanyl|mesh-list
84083527|NCT02841488|Ropivacaine|ropivacaine|mesh-list
84083528|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
84083529|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
84083530|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083531|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083532|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
84083533|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083534|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84083535|NCT02841488|Narcotics|narcotics|mesh-ancestor
84083536|NCT02841488|Analgesics|analgesics|mesh-ancestor
84083537|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84083538|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84083539|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
84083540|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
84083541|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
84083542|NCT02832726|Vitamins|vitamins|mesh-ancestor
84083543|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
84083544|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083545|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
84083546|NCT02832726|Hematinics|hematinics|mesh-ancestor
84083547|NCT00202904|Ezetimibe|ezetimibe|mesh-list
84083548|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84083549|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84083550|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
84083551|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083552|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84083553|NCT02690870|Tamoxifen|tamoxifen|mesh-list
84083554|NCT02690870|Clomiphene|clomiphene|mesh-list
84083555|NCT02690870|Enclomiphene|enclomiphene|mesh-list
84083556|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
84083557|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84083558|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
84083559|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083560|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083561|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84083562|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083563|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84083564|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84083565|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84083566|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84083567|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
84083568|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84083569|NCT00844207|Azithromycin|azithromycin|mesh-list
84083570|NCT00844207|Chloroquine|chloroquine|mesh-list
84083571|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
84083572|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84083573|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083574|NCT00844207|Amebicides|amebicides|mesh-ancestor
84083575|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84083576|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84083577|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
84083578|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083579|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84083580|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083581|NCT00844207|Analgesics|analgesics|mesh-ancestor
84083582|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
84083583|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083584|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083585|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083586|NCT00844207|Filaricides|filaricides|mesh-ancestor
84083587|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
84083588|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
84083589|NCT02841722|Lenograstim|lenograstim|mesh-list
84083590|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84083591|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
84083592|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083593|NCT02548117|Finasteride|finasteride|mesh-list
84083594|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84083595|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84083596|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083597|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083598|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
84083599|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083600|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083601|NCT02548117|Urological Agents|urological agents|mesh-ancestor
84083602|NCT02841800|Phenobarbital|phenobarbital|mesh-list
84083603|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
84083604|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84083605|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083606|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083607|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84083608|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84083609|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083610|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083611|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
84083612|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
84083613|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84083614|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84083615|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84083616|NCT02832336|Caffeine|caffeine|mesh-list
84083617|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
84083618|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083619|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84083620|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083621|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84083622|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083623|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84083624|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84083625|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
84083626|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083627|NCT00621751|Carbamazepine|carbamazepine|mesh-list
84083628|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
84083629|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
84083630|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84083631|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083632|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083633|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84083634|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083635|NCT00621751|Analgesics|analgesics|mesh-ancestor
84083636|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
84083637|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083638|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84083639|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84083640|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083641|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84083642|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84083643|NCT02690792|Vitamin E|vitamin e|mesh-list
84083644|NCT02690792|Vitamins|vitamins|mesh-ancestor
84083645|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
84083646|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083647|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
84083648|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083649|NCT02690792|Protective Agents|protective agents|mesh-ancestor
84083650|NCT00831649|Natalizumab|natalizumab|mesh-list
84083651|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
84083652|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083653|NCT02841332|Misonidazole|misonidazole|mesh-list
84083654|NCT02841332|Bevacizumab|bevacizumab|mesh-list
84083655|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84083656|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083657|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84083658|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84083659|NCT02841332|Growth Substances|growth substances|mesh-ancestor
84083660|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083661|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
84083662|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84083663|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84083664|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083665|NCT00838357|Plerixafor|plerixafor|mesh-list
84083666|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84083667|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84083668|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
84083669|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083670|NCT00156104|Haloperidol|haloperidol|mesh-list
84083671|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
84083672|NCT00156104|Asenapine|asenapine|mesh-list
84083673|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
84083674|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
84083675|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083676|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083677|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84083678|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84083679|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84083680|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083681|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84083682|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84083683|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
84083684|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083685|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083686|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84083687|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84083688|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84083689|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84083690|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84083691|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083693|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083694|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083695|NCT00891930|Irinotecan|irinotecan|mesh-list
84083696|NCT00891930|Panitumumab|panitumumab|mesh-list
84083697|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84083698|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84083699|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083700|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083701|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083702|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84083703|NCT02831088|Salicylates|salicylates|mesh-list
84083704|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84083705|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083706|NCT02831088|Analgesics|analgesics|mesh-ancestor
84083707|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
84083708|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083709|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083710|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083711|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083712|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84083713|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083714|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083715|NCT02841176|Golimumab|golimumab|mesh-list
84083716|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84083717|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083718|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083719|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
84083720|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083721|NCT01615874|Prednisone|prednisone|mesh-list
84083722|NCT01615874|Prednisolone|prednisolone|mesh-list
84083723|NCT01615874|Montelukast|montelukast|mesh-list
84083724|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
84083725|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083726|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
84083727|NCT01615874|Hormones|hormones|mesh-ancestor
84083728|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083729|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083730|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84083731|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083732|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
84083733|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083734|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84083735|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
84083736|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84083737|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
84083738|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84083739|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84083740|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083741|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84083742|NCT00891462|Bromides|bromides|mesh-list
84083743|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
84083744|NCT04248348|Heparin|heparin|mesh-list
84083745|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84083746|NCT04248348|Tinzaparin|tinzaparin|mesh-list
84083747|NCT04248348|Dalteparin|dalteparin|mesh-list
84083748|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
84083749|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84083750|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84083751|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083752|NCT04245774|Bupivacaine|bupivacaine|mesh-list
84083753|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
84083754|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
84083755|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
84083756|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083757|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083758|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
84083759|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083760|NCT04247646|Melatonin|melatonin|mesh-list
84083761|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
84083762|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083763|NCT04247646|Protective Agents|protective agents|mesh-ancestor
84083764|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083765|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083766|NCT00900146|Metformin|metformin|mesh-list
84083767|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84083768|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083769|NCT00140972|Diclofenac|diclofenac|mesh-list
84083770|NCT00140972|Etoricoxib|etoricoxib|mesh-list
84083771|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84083772|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083773|NCT00140972|Analgesics|analgesics|mesh-ancestor
84083774|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
84083775|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083776|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083777|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083778|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083779|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84083780|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083781|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083782|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84083783|NCT02830932|Vaccines|vaccines|mesh-list
84083784|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
84083785|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083786|NCT00895310|Ketoconazole|ketoconazole|mesh-list
84083787|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
84083788|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083789|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
84083790|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083791|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84083792|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84083793|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083794|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083795|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84083796|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
84083797|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083798|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083799|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84083800|NCT04245618|Cisplatin|cisplatin|mesh-list
84083801|NCT04245618|Gemcitabine|gemcitabine|mesh-list
84083802|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083803|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84083804|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
84083805|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083806|NCT00092768|Celecoxib|celecoxib|mesh-list
84083807|NCT00092768|Etoricoxib|etoricoxib|mesh-list
84083808|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84083809|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083810|NCT00092768|Analgesics|analgesics|mesh-ancestor
84083811|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
84083812|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083813|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083814|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083815|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083816|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84083817|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84083818|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083819|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083820|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
84083821|NCT02831712|Trace Elements|trace elements|mesh-ancestor
84083822|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
84083823|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083824|NCT02843984|Lactoferrin|lactoferrin|mesh-list
84083825|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083826|NCT02840708|Sargramostim|sargramostim|mesh-list
84083827|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
84083828|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083829|NCT00817076|Desloratadine|desloratadine|mesh-list
84083830|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84083831|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
84083832|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083833|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083834|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083835|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84083836|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84083837|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
84083838|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
84083839|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
84083840|NCT02844062|Fludarabine|fludarabine|mesh-list
84083841|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083842|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
84083843|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083844|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083845|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84083846|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
84083847|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083848|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083849|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84083850|NCT02830230|Azithromycin|azithromycin|mesh-list
84083851|NCT02830230|Cefixime|cefixime|mesh-list
84083852|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84083853|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083854|NCT02840240|Gabapentin|gabapentin|mesh-list
84083855|NCT02840240|Analgesics|analgesics|mesh-ancestor
84083856|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
84083857|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083858|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083859|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
84083860|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84083861|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84083862|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083863|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84083864|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84083865|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84083866|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083867|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083868|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
84083869|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
84083870|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84083871|NCT00888654|Protective Agents|protective agents|mesh-ancestor
84083872|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083873|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083874|NCT03238430|Morphine|morphine|mesh-list
84083875|NCT03238430|Ropivacaine|ropivacaine|mesh-list
84083876|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84083877|NCT03238430|Narcotics|narcotics|mesh-ancestor
84083878|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083879|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083880|NCT03238430|Analgesics|analgesics|mesh-ancestor
84083881|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
84083882|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083883|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
84083884|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
84083885|NCT02829840|Azacitidine|azacitidine|mesh-list
84083886|NCT02829840|Ponatinib|ponatinib|mesh-list
84083887|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84083888|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
84083889|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083890|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083891|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083892|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84083893|NCT03223220|Midazolam|midazolam|mesh-list
84083894|NCT03223220|Ketamine|ketamine|mesh-list
84083895|NCT03223220|Analgesics|analgesics|mesh-ancestor
84083896|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
84083897|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083898|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083899|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84083900|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84083901|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
84083902|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
84083903|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84083904|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84083905|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84083906|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083907|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083908|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84083909|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84083910|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84083911|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84083912|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84083913|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
84083914|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
84083915|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84083916|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84083917|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083918|NCT02827890|Incretins|incretins|mesh-ancestor
84083919|NCT02827890|Hormones|hormones|mesh-ancestor
84083920|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84083921|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84083922|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
84083923|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083924|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083925|NCT04250792|Naltrexone|naltrexone|mesh-list
84083926|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84083927|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84083928|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083929|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
84083930|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083931|NCT02840162|Celecoxib|celecoxib|mesh-list
84083932|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
84083933|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84083934|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083935|NCT02840162|Analgesics|analgesics|mesh-ancestor
84083936|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
84083937|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083938|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083939|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083940|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083941|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84083942|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84083943|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083944|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083945|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84083946|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84083947|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
84083948|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84083949|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
84083950|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84083951|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083952|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84083953|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84083954|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84083955|NCT02827578|Tamsulosin|tamsulosin|mesh-list
84083956|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
84083957|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84083958|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84083959|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84083960|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
84083961|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84083962|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083963|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083964|NCT02827578|Urological Agents|urological agents|mesh-ancestor
84083965|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84083966|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84083967|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
84083968|NCT02829372|Antibodies|antibodies|mesh-list
84083969|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84083970|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
84083971|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
84083972|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083973|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
84083974|NCT00899678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84083975|NCT00899678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083976|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84083977|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
84083978|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083979|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083980|NCT00887484|Clindamycin|clindamycin|mesh-list
84083981|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
84083982|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
84083983|NCT00887484|Adapalene|adapalene|mesh-list
84083984|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84083985|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84083986|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84083987|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84083988|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84083989|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84083990|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
84083991|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84083992|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84083993|NCT00887484|Analgesics|analgesics|mesh-ancestor
84083994|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
84083995|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84083996|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84083997|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84083998|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84083999|NCT00794378|Cetirizine|cetirizine|mesh-list
84084000|NCT00794378|Desloratadine|desloratadine|mesh-list
84084001|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84084002|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84084003|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84084004|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
84084005|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
84084006|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084007|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084008|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084009|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84084010|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
84084011|NCT00789152|Levocetirizine|levocetirizine|mesh-list
84084012|NCT00789152|Desloratadine|desloratadine|mesh-list
84084013|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84084014|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84084015|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
84084016|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
84084017|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084018|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084019|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084020|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84084021|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
84084022|NCT00783458|Fluticasone|fluticasone|mesh-list
84084023|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
84084024|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084025|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84084026|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
84084027|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084028|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084029|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84084030|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
84084031|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084032|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84084033|NCT00620659|Modafinil|modafinil|mesh-list
84084034|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84084035|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084036|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84084037|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84084038|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84084039|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084040|NCT02829060|Gentamicins|gentamicins|mesh-list
84084041|NCT02829060|Ampicillin|ampicillin|mesh-list
84084042|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
84084043|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84084044|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084045|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84084046|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084047|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084048|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84084049|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84084050|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84084051|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84084052|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084053|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084054|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84084055|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84084056|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84084057|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
84084058|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084059|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084060|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84084061|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84084062|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
84084063|NCT00783146|Fexofenadine|fexofenadine|mesh-list
84084064|NCT00783146|Desloratadine|desloratadine|mesh-list
84084065|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84084066|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
84084067|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084068|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084069|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084070|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84084071|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84084072|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
84084073|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
84084074|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84084075|NCT00844675|Rabeprazole|rabeprazole|mesh-list
84084076|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84084077|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084078|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84084079|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084080|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084081|NCT02840006|Anesthetics|anesthetics|mesh-list
84084082|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084083|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084084|NCT02826252|Iloprost|iloprost|mesh-list
84084085|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84084086|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
84084087|NCT02839928|Ketamine|ketamine|mesh-list
84084088|NCT02839928|Analgesics|analgesics|mesh-list
84084089|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
84084090|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
84084091|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084092|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084093|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84084094|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84084095|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
84084096|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
84084097|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084098|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84084099|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84084100|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084101|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084102|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
84084103|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
84084104|NCT05018520|Prednisone|prednisone|mesh-list
84084105|NCT05018520|Rituximab|rituximab|mesh-list
84084106|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
84084107|NCT05018520|Vincristine|vincristine|mesh-list
84084108|NCT05018520|Doxorubicin|doxorubicin|mesh-list
84084109|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84084110|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084111|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
84084112|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084113|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084114|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84084115|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84084116|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
84084117|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084118|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84084119|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084120|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
84084121|NCT05018520|Hormones|hormones|mesh-ancestor
84084122|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084123|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84084124|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84084125|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
84084126|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
84084127|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
84084128|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84084129|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84084130|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84084131|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084132|NCT04321746|Ketamine|ketamine|mesh-list
84084133|NCT04321746|Analgesics|analgesics|mesh-ancestor
84084134|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
84084135|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084136|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084137|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84084138|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84084139|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
84084140|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
84084141|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084142|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84084143|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84084144|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084145|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084146|NCT02839694|Celecoxib|celecoxib|mesh-list
84084147|NCT02839694|Decitabine|decitabine|mesh-list
84084148|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
84084149|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84084150|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84084151|NCT02839694|Analgesics|analgesics|mesh-ancestor
84084152|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
84084153|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084154|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084155|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084156|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084157|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84084158|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84084159|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084160|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084161|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084162|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
84084163|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084164|NCT04243434|Prednisone|prednisone|mesh-list
84084165|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
84084166|NCT04243434|Doxorubicin|doxorubicin|mesh-list
84084167|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84084168|NCT04243434|Vincristine|vincristine|mesh-list
84084169|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84084170|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
84084171|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084172|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084173|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84084174|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
84084175|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084176|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084177|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84084178|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84084179|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84084180|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84084181|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084182|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084183|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
84084184|NCT04243434|Hormones|hormones|mesh-ancestor
84084185|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084186|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84084187|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84084188|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
84084189|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
84084190|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
84084191|NCT00832039|Selenious Acid|selenious acid|mesh-list
84084192|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
84084193|NCT00832039|Trace Elements|trace elements|mesh-ancestor
84084194|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
84084195|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084196|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
84084197|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84084198|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084199|NCT02826564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84084200|NCT02826564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084201|NCT02837978|Methotrexate|methotrexate|mesh-list
84084202|NCT02837978|Tacrolimus|tacrolimus|mesh-list
84084203|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84084204|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
84084205|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84084206|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084207|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084208|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
84084209|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084210|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084211|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084212|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084213|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84084214|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84084215|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
84084216|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084217|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84084218|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84084219|NCT00839059|Lenalidomide|lenalidomide|mesh-list
84084220|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
84084221|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084222|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84084223|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84084224|NCT00839059|Growth Substances|growth substances|mesh-ancestor
84084225|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
84084226|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084227|NCT02839538|Anesthetics|anesthetics|mesh-list
84084228|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084229|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084230|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84084231|NCT02826174|Anesthetics|anesthetics|mesh-list
84084232|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084233|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084234|NCT00621517|Bupropion|bupropion|mesh-list
84084235|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84084236|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
84084237|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84084238|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84084239|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84084240|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84084241|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084242|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
84084243|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084244|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084245|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84084246|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84084247|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084248|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
84084249|NCT02827266|Hematinics|hematinics|mesh-ancestor
84084250|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
84084251|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084252|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84084253|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084254|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084255|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
84084256|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84084257|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084258|NCT02826876|Ropivacaine|ropivacaine|mesh-list
84084259|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
84084260|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
84084261|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084262|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084263|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
84084264|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084265|NCT04244448|Emtricitabine|emtricitabine|mesh-list
84084266|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
84084267|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084268|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84084269|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84084270|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084271|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084272|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84084273|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84084274|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84084275|NCT02547025|Amoxicillin|amoxicillin|mesh-list
84084276|NCT02547025|Clarithromycin|clarithromycin|mesh-list
84084277|NCT02547025|Levofloxacin|levofloxacin|mesh-list
84084278|NCT02547025|Ofloxacin|ofloxacin|mesh-list
84084279|NCT02547025|Tetracycline|tetracycline|mesh-list
84084280|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84084281|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
84084282|NCT02547025|Rabeprazole|rabeprazole|mesh-list
84084283|NCT02547025|Bismuth|bismuth|mesh-list
84084284|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084285|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
84084286|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84084287|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084288|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084289|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84084290|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84084291|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84084292|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84084293|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84084294|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084295|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84084296|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84084297|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084298|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84084299|NCT02547025|Antacids|antacids|mesh-ancestor
84084300|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
84084301|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84084302|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84084303|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
84084304|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084305|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84084306|NCT05660382|Miconazole|miconazole|mesh-list
84084307|NCT05660382|Clotrimazole|clotrimazole|mesh-list
84084308|NCT05660382|Mineral Oil|mineral oil|mesh-list
84084309|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
84084310|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084311|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84084312|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84084313|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084314|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084315|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84084316|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
84084317|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084318|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084319|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84084320|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84084321|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84084322|NCT05660382|Emollients|emollients|mesh-ancestor
84084323|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084324|NCT00839371|Midazolam|midazolam|mesh-list
84084325|NCT00839371|Propofol|propofol|mesh-list
84084326|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84084327|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084328|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084329|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84084330|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
84084331|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
84084332|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84084333|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84084334|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84084335|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84084336|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
84084337|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
84084338|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084339|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084340|NCT02826408|Rabeprazole|rabeprazole|mesh-list
84084341|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84084342|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084343|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84084344|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084345|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084346|NCT00573937|Morphine|morphine|mesh-list
84084347|NCT00573937|Methadone|methadone|mesh-list
84084348|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84084349|NCT00573937|Narcotics|narcotics|mesh-ancestor
84084350|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084351|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084352|NCT00573937|Analgesics|analgesics|mesh-ancestor
84084353|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
84084354|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084355|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
84084356|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
84084357|NCT00845533|Piperaquine|piperaquine|mesh-list
84084358|NCT00845533|Artenimol|artenimol|mesh-list
84084359|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
84084360|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84084361|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84084362|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084363|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
84084364|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84084365|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84084366|NCT04958538|Methotrexate|methotrexate|mesh-list
84084367|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84084368|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
84084369|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84084370|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084371|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084372|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
84084373|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084374|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084375|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084376|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084377|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84084378|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84084379|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
84084380|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084381|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84084382|NCT02548195|Gemcitabine|gemcitabine|mesh-list
84084383|NCT02548195|Capecitabine|capecitabine|mesh-list
84084384|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
84084385|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084386|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
84084387|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084388|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084389|NCT00573859|Methylphenidate|methylphenidate|mesh-list
84084390|NCT00573859|Amphetamine|amphetamine|mesh-list
84084391|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84084392|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
84084393|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84084394|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84084395|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084396|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84084397|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84084398|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84084399|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084400|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
84084401|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084402|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84084403|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
84084404|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
84084405|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
84084406|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084407|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
84084408|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84084409|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
84084410|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84084411|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084412|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084413|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84084414|NCT00839605|Analgesics|analgesics|mesh-ancestor
84084415|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
84084416|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084417|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84084418|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84084419|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84084420|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
84084421|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084422|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084423|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
84084424|NCT00839683|Valsartan|valsartan|mesh-list
84084425|NCT00839683|Simvastatin|simvastatin|mesh-list
84084426|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84084427|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84084428|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
84084429|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084430|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84084431|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84084432|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084433|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84084434|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84084435|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084436|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84084437|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84084438|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84084439|NCT00839761|Iron|iron|mesh-list
84084440|NCT00839761|Trace Elements|trace elements|mesh-ancestor
84084441|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
84084442|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084443|NCT02825394|Ecarin|ecarin|mesh-list
84084444|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84084445|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84084446|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084447|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84084448|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84084449|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
84084450|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084451|NCT00845689|Adenosine|adenosine|mesh-list
84084452|NCT00845689|Analgesics|analgesics|mesh-ancestor
84084453|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
84084454|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084455|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084456|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84084457|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
84084458|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84084459|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
84084460|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
84084461|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084462|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084463|NCT05660694|Vitamin E|vitamin e|mesh-list
84084464|NCT05660694|Triamcinolone|triamcinolone|mesh-list
84084465|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
84084466|NCT05660694|Vitamins|vitamins|mesh-ancestor
84084467|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
84084468|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084469|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084470|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
84084471|NCT05660694|Hormones|hormones|mesh-ancestor
84084472|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084473|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084474|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084475|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
84084476|NCT05660694|Protective Agents|protective agents|mesh-ancestor
84084477|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84084478|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84084479|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84084480|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
84084481|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84084482|NCT05113368|Fulvestrant|fulvestrant|mesh-list
84084483|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84084484|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084485|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84084486|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84084487|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
84084488|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084489|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084490|NCT02824614|Erythritol|erythritol|mesh-list
84084491|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
84084492|NCT00840229|Triamcinolone|triamcinolone|mesh-list
84084493|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84084494|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84084495|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84084496|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084497|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
84084498|NCT00840229|Hormones|hormones|mesh-ancestor
84084499|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084500|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084501|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84084502|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
84084503|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084504|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084505|NCT00831441|Apixaban|apixaban|mesh-list
84084506|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84084507|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
84084508|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84084509|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
84084510|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084511|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084512|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
84084513|NCT00840385|Vidarabine|vidarabine|mesh-list
84084514|NCT00840385|Fludarabine|fludarabine|mesh-list
84084515|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
84084516|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084517|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084518|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
84084519|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084520|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84084521|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
84084522|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084523|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
84084524|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084525|NCT02824458|Apatinib|apatinib|mesh-list
84084526|NCT02824458|Gefitinib|gefitinib|mesh-list
84084527|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084528|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84084529|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084530|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084531|NCT00840931|Lenalidomide|lenalidomide|mesh-list
84084532|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
84084533|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084534|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84084535|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84084536|NCT00840931|Growth Substances|growth substances|mesh-ancestor
84084537|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
84084538|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084539|NCT05659992|Cytarabine|cytarabine|mesh-list
84084540|NCT05659992|Azacitidine|azacitidine|mesh-list
84084541|NCT05659992|Venetoclax|venetoclax|mesh-list
84084542|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084543|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
84084544|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084545|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084546|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
84084547|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084548|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84084549|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
84084550|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084551|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084552|NCT00834379|Pravastatin|pravastatin|mesh-list
84084553|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84084554|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84084555|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
84084556|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084557|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84084558|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84084559|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084560|NCT00834457|Ritonavir|ritonavir|mesh-list
84084561|NCT00834457|Lopinavir|lopinavir|mesh-list
84084562|NCT00834457|Zidovudine|zidovudine|mesh-list
84084563|NCT00834457|Lamivudine|lamivudine|mesh-list
84084564|NCT00834457|Abacavir|abacavir|mesh-list
84084565|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
84084566|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84084567|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84084568|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
84084569|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084570|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084571|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84084572|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84084573|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
84084574|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084575|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84084576|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84084577|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
84084578|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84084579|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84084580|NCT03851965|Plasminogen|plasminogen|mesh-list
84084581|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84084582|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84084583|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084585|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
84084586|NCT02611635|Dabigatran|dabigatran|mesh-list
84084587|NCT02611635|Apixaban|apixaban|mesh-list
84084588|NCT02611635|Edoxaban|edoxaban|mesh-list
84084589|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
84084590|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84084591|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
84084592|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84084593|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
84084594|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084595|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084596|NCT02824926|Ketoconazole|ketoconazole|mesh-list
84084597|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
84084598|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084599|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84084600|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84084601|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084602|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084603|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84084604|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
84084605|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084606|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084607|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84084608|NCT00705471|Infliximab|infliximab|mesh-list
84084609|NCT00705471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84084610|NCT00705471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084611|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084612|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084613|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084614|NCT00705549|Cisplatin|cisplatin|mesh-list
84084615|NCT00705549|Gemcitabine|gemcitabine|mesh-list
84084616|NCT00705549|Docetaxel|docetaxel|mesh-list
84084617|NCT00705549|Vinorelbine|vinorelbine|mesh-list
84084618|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084619|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084620|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
84084621|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084622|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
84084623|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
84084624|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
84084625|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84084626|NCT02824770|Tramadol|tramadol|mesh-list
84084627|NCT02824770|Bupivacaine|bupivacaine|mesh-list
84084628|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
84084629|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
84084630|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084631|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084632|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
84084633|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084634|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84084635|NCT02824770|Narcotics|narcotics|mesh-ancestor
84084636|NCT02824770|Analgesics|analgesics|mesh-ancestor
84084637|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84084638|NCT02824536|Antibodies|antibodies|mesh-list
84084639|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
84084640|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84084641|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
84084642|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084643|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084644|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
84084645|NCT00831129|Simvastatin|simvastatin|mesh-list
84084646|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84084647|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84084648|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
84084649|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084650|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84084651|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84084652|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084653|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84084654|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084655|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
84084656|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84084657|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
84084658|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084660|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084661|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
84084662|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084663|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
84084664|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84084665|NCT00637962|Protective Agents|protective agents|mesh-ancestor
84084666|NCT00913341|Alprazolam|alprazolam|mesh-list
84084667|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84084668|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084669|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084670|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84084671|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84084672|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84084673|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
84084674|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
84084675|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084676|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084677|NCT00620113|Vitamin D|vitamin d|mesh-list
84084678|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
84084679|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
84084680|NCT00620113|Calcium|calcium|mesh-list
84084681|NCT00620113|Vitamins|vitamins|mesh-ancestor
84084682|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
84084683|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084684|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84084685|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84084686|NCT00620113|Antacids|antacids|mesh-ancestor
84084687|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084688|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084689|NCT00830115|Pantoprazole|pantoprazole|mesh-list
84084690|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84084691|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084692|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84084693|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084694|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084695|NCT00633672|Esomeprazole|esomeprazole|mesh-list
84084696|NCT00633672|Ranitidine|ranitidine|mesh-list
84084697|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84084698|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84084699|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084700|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84084701|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084702|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084703|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84084704|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
84084705|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
84084706|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084707|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084708|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
84084709|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84084710|NCT02547103|Mupirocin|mupirocin|mesh-list
84084711|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84084712|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084713|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
84084714|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084715|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84084716|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84084717|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084718|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084719|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84084720|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84084721|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084722|NCT02822586|Immunotoxins|immunotoxins|mesh-ancestor
84084723|NCT02822586|Immunoconjugates|immunoconjugates|mesh-ancestor
84084724|NCT02822586|Immunologic Factors|immunologic factors|mesh-ancestor
84084725|NCT02822586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084726|NCT00848809|Vancomycin|vancomycin|mesh-list
84084727|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84084728|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84084729|NCT00834847|Pravastatin|pravastatin|mesh-list
84084730|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84084731|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84084732|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
84084733|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084734|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84084735|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84084736|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084737|NCT00841477|Vaccines|vaccines|mesh-list
84084738|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
84084739|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084740|NCT00834925|Diltiazem|diltiazem|mesh-list
84084741|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84084742|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84084743|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84084744|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084745|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84084746|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084747|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
84084748|NCT00841633|Norepinephrine|norepinephrine|mesh-list
84084749|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84084750|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84084751|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
84084752|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084753|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429373|NCT01395758|Docetaxel|docetaxel|mesh-list
84084754|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084755|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
84084756|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
84084757|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084758|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84084759|NCT02823912|Capsaicin|capsaicin|mesh-list
84084760|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
84084761|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
84084762|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084763|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
84084764|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084765|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084766|NCT02823912|Antacids|antacids|mesh-ancestor
84084767|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084768|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084769|NCT00841945|Prednisone|prednisone|mesh-list
84084770|NCT00841945|Rituximab|rituximab|mesh-list
84084771|NCT00841945|Doxorubicin|doxorubicin|mesh-list
84084772|NCT00841945|Vincristine|vincristine|mesh-list
84084773|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84084774|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084775|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
84084776|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084777|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084778|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84084779|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84084780|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84084781|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084782|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084783|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084784|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
84084785|NCT00841945|Hormones|hormones|mesh-ancestor
84084786|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084787|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84084788|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84084789|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
84084790|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
84084791|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
84084792|NCT02822196|Lidocaine|lidocaine|mesh-list
84084793|NCT02822196|Bupivacaine|bupivacaine|mesh-list
84084794|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
84084795|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
84084796|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084797|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084798|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
84084799|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084800|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84084801|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84084802|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84084803|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84084804|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084805|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
84084806|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84084807|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324784|NCT01714609|Sorafenib|sorafenib|mesh-list
84084809|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84084810|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84084811|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
84084812|NCT00849355|Rituximab|rituximab|mesh-list
84084813|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84084814|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084815|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
84084816|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084817|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084818|NCT00835393|Pantoprazole|pantoprazole|mesh-list
84084819|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84084820|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84084821|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84084822|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084823|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084824|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
84084825|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084826|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84084827|NCT02822742|Latanoprost|latanoprost|mesh-list
84084828|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84084829|NCT00835471|Docetaxel|docetaxel|mesh-list
84084830|NCT00835471|Pemetrexed|pemetrexed|mesh-list
84084831|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84084832|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084833|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
84084834|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
84084835|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
84084836|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084837|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084838|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84084839|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84084840|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84084841|NCT00849511|Melatonin|melatonin|mesh-list
84084842|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
84084843|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084844|NCT00849511|Protective Agents|protective agents|mesh-ancestor
84084845|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084846|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084847|NCT02546791|Dasatinib|dasatinib|mesh-list
84084848|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084849|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84084850|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084851|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084852|NCT00966875|Ixekizumab|ixekizumab|mesh-list
84084853|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
84084854|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
84084855|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84084856|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084857|NCT00835627|Sertraline|sertraline|mesh-list
84084858|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
84084859|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84084860|NCT00835627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84084861|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84084862|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84084863|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084864|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084865|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
84084866|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084867|NCT00842491|Cisplatin|cisplatin|mesh-list
84084868|NCT00842491|Capecitabine|capecitabine|mesh-list
84084869|NCT00842491|Endostar protein|endostar protein|mesh-list
84084870|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084871|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084872|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
84084873|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084874|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84084875|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84084876|NCT00842491|Growth Substances|growth substances|mesh-ancestor
84084877|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084878|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
84084879|NCT05659212|Lidocaine|lidocaine|mesh-list
84084880|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
84084881|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
83324860|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
84084882|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
84084883|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
84084884|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084885|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084886|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
84084887|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084888|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84084889|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84084890|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84084891|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84084892|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084893|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84084894|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84084895|NCT05659212|Analgesics|analgesics|mesh-ancestor
84084896|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84084897|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84084898|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84084899|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
84084900|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084901|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
84084902|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84084903|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84084904|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
84084905|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84084906|NCT00835939|Lidocaine|lidocaine|mesh-list
84084907|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
84084908|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
84084909|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084910|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084911|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
84084912|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084913|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84084914|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84084915|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84084916|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84084917|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084918|NCT05659368|Tirzepatide|tirzepatide|mesh-list
84084919|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84084920|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084921|NCT05659368|Incretins|incretins|mesh-ancestor
84084922|NCT05659368|Hormones|hormones|mesh-ancestor
84084923|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84084924|NCT00818649|Bortezomib|bortezomib|mesh-list
84084925|NCT00818649|Vorinostat|vorinostat|mesh-list
84084926|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084927|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84084928|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084929|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084930|NCT02861105|Enoxaparin|enoxaparin|mesh-list
84084931|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84084932|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
84084933|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84084934|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84084935|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084936|NCT02820558|Substance P|substance p|mesh-list
84084937|NCT02820558|Neurokinin A|neurokinin a|mesh-list
84084938|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084939|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084940|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084941|NCT00961571|Capecitabine|capecitabine|mesh-list
84084942|NCT00961571|Sunitinib|sunitinib|mesh-list
84084943|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84084944|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
84084945|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084946|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84084947|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84084948|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84084949|NCT00961571|Growth Substances|growth substances|mesh-ancestor
84084950|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084951|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
84084952|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84084953|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084954|NCT02820948|Vitamins|vitamins|mesh-list
84084955|NCT02820948|Vitamin E|vitamin e|mesh-list
84084956|NCT02820948|Tocopherols|tocopherols|mesh-list
84084958|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
84084959|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
84084960|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084961|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
84084962|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084963|NCT02820948|Protective Agents|protective agents|mesh-ancestor
84084964|NCT02860949|Ketorolac|ketorolac|mesh-list
84084965|NCT02860949|Epinephrine|epinephrine|mesh-list
84084966|NCT02860949|Morphine|morphine|mesh-list
84084967|NCT02860949|Bupivacaine|bupivacaine|mesh-list
84084968|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
84084969|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
84084970|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84084971|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84084972|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
84084973|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84084974|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84084975|NCT02860949|Narcotics|narcotics|mesh-ancestor
84084976|NCT02860949|Analgesics|analgesics|mesh-ancestor
84084977|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84084978|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84084979|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
84084980|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84084981|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84084982|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84084983|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84084984|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
84084985|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84084986|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
84084987|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
84084988|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
84084989|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84084990|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84084991|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84084992|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84084993|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84084994|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84084995|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84084996|NCT03248063|Cefazolin|cefazolin|mesh-list
84084997|NCT03248063|Cloxacillin|cloxacillin|mesh-list
84084998|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84084999|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085000|NCT00964223|Clindamycin|clindamycin|mesh-list
84085001|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
84085002|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
84085003|NCT00964223|Adapalene|adapalene|mesh-list
84085004|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
84085005|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84085006|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84085007|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085008|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84085009|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085010|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085011|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085012|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84085013|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84085014|NCT00964223|Analgesics|analgesics|mesh-ancestor
84085015|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
84085016|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085017|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085018|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085019|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085020|NCT00620815|Vaccines|vaccines|mesh-list
84085021|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
84085022|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
84085023|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085024|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84085025|NCT04238988|Paclitaxel|paclitaxel|mesh-list
84085026|NCT04238988|Carboplatin|carboplatin|mesh-list
84085027|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
84085028|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84085029|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085030|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
84085031|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
84085032|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085033|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085034|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84085035|NCT04238988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84085036|NCT04284215|Paclitaxel|paclitaxel|mesh-list
84085037|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84085038|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84085039|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085040|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
84085041|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
84085042|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085043|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085044|NCT02816970|Vildagliptin|vildagliptin|mesh-list
84085045|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84085046|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085047|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84085048|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
84085049|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085050|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085051|NCT03372941|Dalbavancin|dalbavancin|mesh-list
84085052|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84085053|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085054|NCT04238832|Nicotine|nicotine|mesh-list
84085055|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84085056|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
84085057|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085058|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085059|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84085060|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84085061|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
84085062|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085063|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085064|NCT04622904|Lidocaine|lidocaine|mesh-list
84085065|NCT04622904|Ketamine|ketamine|mesh-list
84085066|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085067|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
84085068|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085069|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085070|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
84085071|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085072|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84085073|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84085074|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84085075|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085076|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085077|NCT04622904|Analgesics|analgesics|mesh-ancestor
84085078|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84085079|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84085080|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
84085081|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84085082|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84085083|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085084|NCT00634062|Lamotrigine|lamotrigine|mesh-list
84085085|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
84085086|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84085087|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085088|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085089|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84085090|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085091|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84085092|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84085093|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085094|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84085095|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84085096|NCT00634140|Ezetimibe|ezetimibe|mesh-list
84085097|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84085098|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84085099|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
84085100|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085101|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84085102|NCT02819544|Ropivacaine|ropivacaine|mesh-list
84085103|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085104|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
84085105|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085106|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325084|NCT01928225|Vaccines|vaccines|mesh-list
84085107|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
84085108|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085109|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
84085110|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84085111|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085113|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085114|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
84085115|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085116|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085117|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
84085118|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085119|NCT04238208|Lidocaine|lidocaine|mesh-list
84085120|NCT04238208|Capsaicin|capsaicin|mesh-list
84085121|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085122|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
84085123|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085124|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085125|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
84085126|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085127|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84085128|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84085129|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84085130|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085131|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085132|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
84085133|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085134|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
84085135|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84085136|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085137|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84085138|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84085139|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085140|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085141|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085142|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84085143|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84085144|NCT02815722|Simvastatin|simvastatin|mesh-list
84085145|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84085146|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84085147|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
84085148|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085149|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84085150|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84085151|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085152|NCT02817750|Zolpidem|zolpidem|mesh-list
84085153|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84085154|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84085155|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085156|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085157|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84085158|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
84085159|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
84085160|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085161|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085162|NCT02815410|Levetiracetam|levetiracetam|mesh-list
84085163|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
84085164|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
84085165|NCT02814630|Omalizumab|omalizumab|mesh-list
84085166|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84085167|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84085168|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
84085169|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
84085170|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84085171|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085172|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085173|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84085174|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085175|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84085176|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
84085177|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84085178|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84085179|NCT04519476|Prednisolone|prednisolone|mesh-list
84085181|NCT04519476|Lenalidomide|lenalidomide|mesh-list
84085182|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84085183|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
84085184|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
84085185|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085186|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84085187|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84085188|NCT04519476|Growth Substances|growth substances|mesh-ancestor
84085189|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
84085190|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085191|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085192|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
84085193|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
84085194|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085195|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085196|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
84085197|NCT04519476|Hormones|hormones|mesh-ancestor
84085198|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085199|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84085200|NCT04519476|Protective Agents|protective agents|mesh-ancestor
84085201|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085202|NCT00961415|Bevacizumab|bevacizumab|mesh-list
84085203|NCT00961415|Pemetrexed|pemetrexed|mesh-list
84085204|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84085205|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085206|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84085207|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84085208|NCT00961415|Growth Substances|growth substances|mesh-ancestor
84085209|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085210|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
84085211|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085212|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085213|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84085214|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84085215|NCT00851227|Conivaptan|conivaptan|mesh-list
84085216|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84085217|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085218|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
84085219|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085220|NCT03365609|Bismuth|bismuth|mesh-list
84085221|NCT03365609|Antacids|antacids|mesh-ancestor
84085222|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085223|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085224|NCT05636904|Minoxidil|minoxidil|mesh-list
84085225|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84085226|NCT05636904|Dinoprost|dinoprost|mesh-list
84085227|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
84085228|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84085229|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
84085230|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84085231|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
84085232|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84085233|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085234|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
84085235|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
84085236|NCT00836485|Ketotifen|ketotifen|mesh-list
84085237|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
84085238|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84085239|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84085240|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84085241|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84085242|NCT00836485|Analgesics|analgesics|mesh-ancestor
84085243|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
84085244|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085245|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085246|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085247|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085248|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84085249|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84085250|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84085251|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
84085252|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
84085253|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325236|NCT01908101|Halichondrin B|halichondrin b|mesh-list
84085254|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085255|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
84085256|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085257|NCT00963599|Loratadine|loratadine|mesh-list
84085258|NCT00963599|Montelukast|montelukast|mesh-list
84085259|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84085260|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
84085261|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84085262|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
84085263|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085264|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085265|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84085266|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84085267|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085268|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
84085269|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085270|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84085271|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84085272|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84085273|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
84085274|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
84085275|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085276|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84085277|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085278|NCT05636592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84085279|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085280|NCT00851461|Goserelin|goserelin|mesh-list
84085281|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085282|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085283|NCT04205136|Spironolactone|spironolactone|mesh-list
84085284|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84085285|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
84085286|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085287|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085288|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84085289|NCT04205136|Diuretics|diuretics|mesh-ancestor
84085290|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
84085291|NCT02815332|Minocycline|minocycline|mesh-list
84085292|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84085293|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085294|NCT02811354|Osimertinib|osimertinib|mesh-list
84085295|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085296|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84085297|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085298|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085299|NCT02810808|Ranibizumab|ranibizumab|mesh-list
84085300|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84085301|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84085302|NCT02810808|Growth Substances|growth substances|mesh-ancestor
84085303|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085304|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
84085305|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085306|NCT00619801|Levocetirizine|levocetirizine|mesh-list
84085307|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84085308|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84085309|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
84085310|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
84085311|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085312|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085313|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085314|NCT02545777|Diclofenac|diclofenac|mesh-list
84085315|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84085316|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84085317|NCT02545777|Analgesics|analgesics|mesh-ancestor
84085318|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
84085319|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085320|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085321|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085322|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085323|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84085324|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085325|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085326|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84085327|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84085328|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085329|NCT00962741|Etanercept|etanercept|mesh-list
84085330|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84085331|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84085332|NCT00962741|Analgesics|analgesics|mesh-ancestor
84085333|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
84085334|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085335|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085336|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085337|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085338|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085339|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085340|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
84085341|NCT00851929|Ambrisentan|ambrisentan|mesh-list
84085342|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84085343|NCT02813382|Bupivacaine|bupivacaine|mesh-list
84085344|NCT02813382|Prilocaine|prilocaine|mesh-list
84085345|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
84085346|NCT02813382|Procaine|procaine|mesh-list
84085347|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085348|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
84085349|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085350|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085351|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
84085352|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085353|NCT00619645|Cyclosporine|cyclosporine|mesh-list
84085354|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
84085355|NCT00619645|Fludarabine|fludarabine|mesh-list
84085356|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
84085357|NCT00619645|Busulfan|busulfan|mesh-list
84085358|NCT00619645|Cyclosporins|cyclosporins|mesh-list
84085359|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085360|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84085361|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
84085362|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085363|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085364|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
84085365|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085366|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085367|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
84085368|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085369|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085370|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085371|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84085372|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84085373|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84085374|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
84085375|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84085376|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
84085377|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84085378|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84085379|NCT00852163|Busulfan|busulfan|mesh-list
84085380|NCT00852163|Clofarabine|clofarabine|mesh-list
84085381|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
84085382|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085383|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085384|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
84085385|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085386|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84085387|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085388|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84085389|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84085390|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
84085391|NCT00855517|Latanoprost|latanoprost|mesh-list
84085392|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84085393|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84085394|NCT02544919|SMOFlipid|smoflipid|mesh-list
84085395|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84085396|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84085397|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84085398|NCT00818259|Dexamethasone|dexamethasone|mesh-list
84085399|NCT00818259|Ondansetron|ondansetron|mesh-list
84085400|NCT00818259|Aprepitant|aprepitant|mesh-list
84085401|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
84085402|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085403|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
84085404|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
84085405|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085406|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085407|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085408|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
84085409|NCT00818259|Hormones|hormones|mesh-ancestor
84085410|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085411|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085412|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085413|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
84085414|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085415|NCT00818259|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84085416|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84085417|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
84085418|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085419|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085420|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84085421|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
84085422|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
84085423|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085424|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085425|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84085426|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84085427|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085428|NCT02809404|Everolimus|everolimus|mesh-list
84085429|NCT02809404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84085430|NCT02809404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84085431|NCT02809404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085432|NCT02809404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085433|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085434|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
84085435|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085436|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085437|NCT00619099|Decitabine|decitabine|mesh-list
84085438|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84085439|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
84085440|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085441|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085442|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085443|NCT02812992|Paclitaxel|paclitaxel|mesh-list
84085444|NCT02812992|Gemcitabine|gemcitabine|mesh-list
84085445|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84085446|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085447|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
84085448|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
84085449|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085450|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085451|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84085452|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
84085453|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84085454|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84085455|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84085456|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085457|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085458|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
84085459|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085460|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085461|NCT02812602|Lidocaine|lidocaine|mesh-list
84085462|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085463|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
84085464|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085465|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085466|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
84085467|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085468|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84085469|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84085470|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84085471|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085472|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085473|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
84085474|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84085475|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085476|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085477|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84085479|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
84085480|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085481|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84085482|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84085483|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84085484|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
84085485|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085486|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085487|NCT00962585|Equol|equol|mesh-list
84085488|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
84085489|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84085490|NCT00962585|Estrogens|estrogens|mesh-ancestor
84085491|NCT00962585|Hormones|hormones|mesh-ancestor
84085492|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085493|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085494|NCT00621985|Dexamethasone|dexamethasone|mesh-list
84085495|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
84085496|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085497|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
84085498|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
84085499|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085500|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085501|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085502|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
84085503|NCT00621985|Hormones|hormones|mesh-ancestor
84085504|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085505|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085506|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085507|NCT02812368|Clonidine|clonidine|mesh-list
84085508|NCT02812368|Analgesics|analgesics|mesh-ancestor
84085509|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
84085510|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085511|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085512|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84085513|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
84085514|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
84085515|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84085516|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84085517|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84085518|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
84085519|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085520|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085521|NCT03312257|Atropine|atropine|mesh-list
84085522|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84085523|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84085524|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84085525|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
84085526|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085527|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085528|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84085529|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
84085530|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
84085531|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
84085532|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84085533|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84085534|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
84085535|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085536|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085537|NCT00856687|Montelukast|montelukast|mesh-list
84085538|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84085539|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
84085540|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84085541|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
84085542|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085543|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085544|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84085545|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84085546|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085547|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
84085548|NCT02862665|Hematinics|hematinics|mesh-ancestor
84085549|NCT02807922|Zopiclone|zopiclone|mesh-list
84085550|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84085551|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085552|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085553|NCT00861367|Aspirin|aspirin|mesh-list
84085554|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84085555|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84085556|NCT00861367|Analgesics|analgesics|mesh-ancestor
84085557|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
84085558|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085559|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085560|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085561|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085562|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84085563|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84085564|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085565|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84085566|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84085567|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085568|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
84085569|NCT04285073|Paclitaxel|paclitaxel|mesh-list
84085570|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84085571|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085572|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
84085573|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
84085574|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085575|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085576|NCT00861445|Lacosamide|lacosamide|mesh-list
84085577|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
84085578|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84085579|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84085580|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085581|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085582|NCT04284059|Vitamin D|vitamin d|mesh-list
84085583|NCT04284059|Vitamins|vitamins|mesh-list
84085584|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
84085585|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085586|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84085587|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
84085588|NCT00852709|Clofarabine|clofarabine|mesh-list
84085589|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085590|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
84085591|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085592|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085593|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84085594|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
84085595|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085596|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085597|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84085598|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84085599|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
84085600|NCT00861523|Thiamine|thiamine|mesh-list
84085601|NCT00861523|Promethazine|promethazine|mesh-list
84085602|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
84085603|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
84085604|NCT00861523|Vitamins|vitamins|mesh-ancestor
84085605|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
84085606|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085607|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
84085608|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085609|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84085610|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
84085611|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
84085612|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085613|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085614|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84085615|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84085616|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84085617|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085618|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085619|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
84085620|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
84085621|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085622|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
84085623|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
84085624|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085625|NCT02811978|Dexamethasone|dexamethasone|mesh-list
84085626|NCT02811978|Bortezomib|bortezomib|mesh-list
84085627|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085628|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
84085629|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
84085630|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085631|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085632|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085633|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
84085634|NCT02811978|Hormones|hormones|mesh-ancestor
84085635|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085636|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085637|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085638|NCT00630149|Pemetrexed|pemetrexed|mesh-list
84085639|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085640|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085641|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085642|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84085643|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84085644|NCT04204577|Apatinib|apatinib|mesh-list
84085645|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085646|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84085647|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085648|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085649|NCT00852787|Digoxin|digoxin|mesh-list
84085650|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84085651|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84085652|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085653|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085654|NCT00852787|Protective Agents|protective agents|mesh-ancestor
84085655|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085656|NCT02545465|Riociguat|riociguat|mesh-list
84085657|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
84085658|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085659|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
84085660|NCT00961259|Fenofibrate|fenofibrate|mesh-list
84085661|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84085662|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84085663|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
84085664|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085665|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84085666|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
84085667|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84085668|NCT04283747|Antibodies|antibodies|mesh-list
84085669|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
84085670|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085671|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
84085672|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84085673|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085674|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085675|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84085676|NCT04111926|Analgesics|analgesics|mesh-ancestor
84085677|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
84085678|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085679|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84085680|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84085681|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84085682|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
84085683|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085684|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085685|NCT04041349|Mitogens|mitogens|mesh-list
84085686|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085687|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085688|NCT00961181|Paclitaxel|paclitaxel|mesh-list
84085689|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84085690|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085691|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
84085692|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
84085693|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085694|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085695|NCT02807610|Propofol|propofol|mesh-list
84085696|NCT02807610|Etomidate|etomidate|mesh-list
84085697|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84085698|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325680|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085699|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085700|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84085701|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
84085702|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
84085703|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
84085704|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
84085705|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84085706|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
84085707|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84085708|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84085709|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085710|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84085711|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085712|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085713|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84085714|NCT00857155|Clopidogrel|clopidogrel|mesh-list
84085715|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84085716|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84085717|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84085718|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84085719|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
84085720|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085721|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085722|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085723|NCT00817635|Eplerenone|eplerenone|mesh-list
84085724|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84085725|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
84085726|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085727|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085728|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84085729|NCT00817635|Diuretics|diuretics|mesh-ancestor
84085730|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
84085731|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84085732|NCT00853177|Lidocaine|lidocaine|mesh-list
84085733|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085734|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
84085735|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085736|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085737|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
84085738|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085739|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84085740|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84085741|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84085742|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085743|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085744|NCT00924079|Nalbuphine|nalbuphine|mesh-list
84085745|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84085746|NCT00924079|Narcotics|narcotics|mesh-ancestor
84085747|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085748|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085749|NCT00924079|Analgesics|analgesics|mesh-ancestor
84085750|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
84085751|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085752|NCT00817479|Dexamethasone|dexamethasone|mesh-list
84085753|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085754|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
84085755|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
84085756|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085757|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085758|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84085759|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
84085760|NCT00817479|Hormones|hormones|mesh-ancestor
84085761|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085762|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085763|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085764|NCT00853411|Prednisone|prednisone|mesh-list
84085765|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085766|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
84085767|NCT00853411|Hormones|hormones|mesh-ancestor
84085768|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085769|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085770|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085771|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085772|NCT04030533|Ustekinumab|ustekinumab|mesh-list
84085773|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84085774|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
84085775|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
84085776|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085777|NCT02807298|Lidocaine|lidocaine|mesh-list
84085778|NCT02807298|Epinephrine|epinephrine|mesh-list
84085779|NCT02807298|Carticaine|carticaine|mesh-list
84085780|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84085781|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84085782|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
84085783|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085784|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085785|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085786|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84085787|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84085788|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
84085789|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085790|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84085791|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
84085792|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
84085793|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
84085794|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84085795|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
84085796|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
84085797|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085798|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
84085799|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84085800|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84085801|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84085802|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085803|NCT04041427|Albendazole|albendazole|mesh-list
84085804|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
84085805|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84085806|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085807|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
84085808|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84085809|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84085810|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
84085811|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
84085812|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085813|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085814|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085815|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
84085816|NCT00961961|Fluoxetine|fluoxetine|mesh-list
84085817|NCT00961961|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84085818|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84085819|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84085820|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085821|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84085822|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
84085823|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085824|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84085825|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
84085826|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84085827|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84085828|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84085829|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085830|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
84085831|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84085832|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84085833|NCT02610933|Vitamin K|vitamin k|mesh-list
84085834|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
84085835|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
84085836|NCT02610933|Vitamins|vitamins|mesh-ancestor
84085837|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
84085838|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085839|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84085840|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
84085841|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84085842|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
84085843|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085844|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085845|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
84085846|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84085847|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84085848|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
84085849|NCT02610933|Coagulants|coagulants|mesh-ancestor
84085850|NCT04042441|Insulin|insulin|mesh-list
84085851|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
84085852|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84085853|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085854|NCT00817089|Naltrexone|naltrexone|mesh-list
84085855|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84085856|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84085857|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085858|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
84085859|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085860|NCT03296033|Enoxaparin|enoxaparin|mesh-list
84085861|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
84085862|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
84085863|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84085864|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84085865|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085866|NCT00857779|Immunomodulating Agents|immunomodulating agents|mesh-list
84085867|NCT00857779|Immunologic Factors|immunologic factors|mesh-ancestor
84085868|NCT00857779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085869|NCT05758389|Paclitaxel|paclitaxel|mesh-list
84085870|NCT05758389|Tislelizumab|tislelizumab|mesh-list
84085871|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84085872|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085873|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
84085874|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
84085875|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
84085876|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085877|NCT05758389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84085878|NCT00857935|Permethrin|permethrin|mesh-list
84085879|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085880|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085881|NCT00853879|Vitamins|vitamins|mesh-list
84085882|NCT00853879|Folic Acid|folic acid|mesh-list
84085883|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
84085884|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
84085885|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
84085886|NCT00853879|Pyridoxal|pyridoxal|mesh-list
84085887|NCT00853879|Pyridoxine|pyridoxine|mesh-list
84085888|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
84085889|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
84085890|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085891|NCT00853879|Hematinics|hematinics|mesh-ancestor
84085892|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
84085893|NCT04171843|Fludarabine|fludarabine|mesh-list
84085894|NCT04171843|Nirogacestat|nirogacestat|mesh-list
84085895|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085896|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
84085897|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085898|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84085899|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84085900|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
84085901|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085902|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085903|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84085904|NCT04171843|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84085905|NCT04171843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085906|NCT00815919|Prednisone|prednisone|mesh-list
84085907|NCT00815919|Bortezomib|bortezomib|mesh-list
84085908|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085909|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
84085910|NCT00815919|Hormones|hormones|mesh-ancestor
84085911|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085912|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085913|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84085914|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085915|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84085916|NCT02545153|Aprotinin|aprotinin|mesh-list
84085917|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
84085918|NCT02545153|Coagulants|coagulants|mesh-ancestor
84085919|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84085920|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84085921|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
84085922|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085923|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085924|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84085925|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84085926|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085927|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84085928|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84085929|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085930|NCT00854035|Incretins|incretins|mesh-ancestor
84085931|NCT00854035|Hormones|hormones|mesh-ancestor
84085932|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085933|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84085934|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
84085935|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085936|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085937|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
84085938|NCT00957905|Leucovorin|leucovorin|mesh-list
84085939|NCT00957905|Folic Acid|folic acid|mesh-list
84085940|NCT00957905|Fluorouracil|fluorouracil|mesh-list
84085941|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
84085942|NCT00957905|Alvocidib|alvocidib|mesh-list
84085943|NCT00957905|Calcium|calcium|mesh-list
84085944|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
84085945|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84085946|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085947|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84085948|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
84085949|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085950|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84085951|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085952|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085953|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
84085954|NCT00957905|Antidotes|antidotes|mesh-ancestor
84085955|NCT00957905|Protective Agents|protective agents|mesh-ancestor
84085956|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
84085957|NCT00957905|Vitamins|vitamins|mesh-ancestor
84085958|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
84085959|NCT00957905|Hematinics|hematinics|mesh-ancestor
84085960|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
84085961|NCT00957905|Growth Substances|growth substances|mesh-ancestor
84085962|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84085963|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085964|NCT02804646|Carboplatin|carboplatin|mesh-list
84085965|NCT02804646|Pemetrexed|pemetrexed|mesh-list
84085966|NCT02804646|Endostatins|endostatins|mesh-list
84085967|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84085968|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84085969|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085970|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84085971|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84085972|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84085973|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84085974|NCT02804646|Growth Substances|growth substances|mesh-ancestor
84085975|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085976|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
84085977|NCT02858297|Triamcinolone|triamcinolone|mesh-list
84085978|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84085979|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84085980|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84085981|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84085982|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
84085983|NCT02858297|Hormones|hormones|mesh-ancestor
84085984|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84085985|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84085986|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84085987|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
84085988|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429402|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84085989|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84085990|NCT00858325|Daptomycin|daptomycin|mesh-list
84085991|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84085992|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84085993|NCT02804490|Vitamin A|vitamin a|mesh-list
84085994|NCT02804490|Beta Carotene|beta carotene|mesh-list
84085995|NCT02804490|Provitamins|provitamins|mesh-list
84085996|NCT02804490|Carotenoids|carotenoids|mesh-list
84085997|NCT02804490|Vitamins|vitamins|mesh-ancestor
84085998|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
84085999|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325978|NCT04380220|Complement C3|complement c3|mesh-list
84086000|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
84086001|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086002|NCT02804490|Protective Agents|protective agents|mesh-ancestor
84086003|NCT00960323|Colchicine|colchicine|mesh-list
84086004|NCT00960323|Atorvastatin|atorvastatin|mesh-list
84086006|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84086007|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
84086008|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086009|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84086010|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84086011|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086012|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
84086013|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086014|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
84086015|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
84086016|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
84086017|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086018|NCT00617929|Rituximab|rituximab|mesh-list
84086019|NCT00617929|Clofarabine|clofarabine|mesh-list
84086020|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
84086021|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84086022|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84086023|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086024|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
84086025|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086026|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086027|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086028|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84086029|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
84086030|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086031|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
84086032|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086033|NCT02800590|Abp-700|abp-700|mesh-list
84086034|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84086035|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
84086036|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
84086037|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086038|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086039|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086040|NCT00815295|Cetuximab|cetuximab|mesh-list
84086041|NCT00815295|Sorafenib|sorafenib|mesh-list
84086042|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84086043|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086044|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84086045|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086046|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086047|NCT00630383|Histamine|histamine|mesh-list
84086048|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
84086049|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
84086050|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086051|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086052|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086053|NCT02806752|Triamcinolone|triamcinolone|mesh-list
84086054|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84086055|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84086056|NCT02806752|Ranibizumab|ranibizumab|mesh-list
84086057|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84086058|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84086059|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84086060|NCT02806752|Growth Substances|growth substances|mesh-ancestor
84086061|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429416|NCT01395524|Naloxegol|naloxegol|mesh-list
84086062|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
84086063|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086064|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086065|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
84086066|NCT02806752|Hormones|hormones|mesh-ancestor
84086067|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086068|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086069|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
84086070|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086071|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086072|NCT00854425|Asparaginase|asparaginase|mesh-list
84086073|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086074|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
84086075|NCT05757999|Analgesics|analgesics|mesh-ancestor
84086076|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
84086077|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086078|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086079|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
84086080|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086081|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84086082|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
84086083|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84086084|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086085|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086086|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84086087|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
84086088|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84086089|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84086090|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84086091|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84086092|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
84086093|NCT02544529|Laxatives|laxatives|mesh-ancestor
84086094|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086095|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84086096|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086097|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086098|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
84086099|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086100|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086101|NCT02544529|Miotics|miotics|mesh-ancestor
84086102|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
84086103|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086104|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84086105|NCT02806596|Sevoflurane|sevoflurane|mesh-list
84086106|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84086107|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84086108|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
84086109|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
84086110|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086111|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086112|NCT04282031|Letrozole|letrozole|mesh-list
84086113|NCT04282031|Fulvestrant|fulvestrant|mesh-list
84086114|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086115|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84086116|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84086117|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086118|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086119|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84086120|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
84086121|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086122|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086123|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84086124|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84086125|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84086126|NCT00854503|Simvastatin|simvastatin|mesh-list
84086127|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84086128|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83429421|NCT04338698|Azithromycin|azithromycin|mesh-list
84086129|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
84086130|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086131|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84086132|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84086133|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086134|NCT00858715|Aspirin|aspirin|mesh-list
84086135|NCT00858715|Clopidogrel|clopidogrel|mesh-list
84086136|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84086137|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84086138|NCT00858715|Analgesics|analgesics|mesh-ancestor
84086139|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
84086140|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086141|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086142|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086143|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086144|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84086145|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84086146|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086147|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84086148|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84086149|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086150|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
84086151|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84086152|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84086153|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84086154|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
84086155|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086156|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84086157|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
84086158|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086159|NCT00960869|Aspirin|aspirin|mesh-list
84086160|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84086161|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84086162|NCT00960869|Analgesics|analgesics|mesh-ancestor
84086163|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
84086164|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086165|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086166|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086167|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086168|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84086169|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84086170|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086171|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84086172|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84086173|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086174|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
84086175|NCT02799888|Cyclosporine|cyclosporine|mesh-list
84086176|NCT02799888|Maraviroc|maraviroc|mesh-list
84086177|NCT02799888|Methotrexate|methotrexate|mesh-list
84086178|NCT02799888|Tacrolimus|tacrolimus|mesh-list
84086179|NCT02799888|Cyclosporins|cyclosporins|mesh-list
84086180|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84086181|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
84086182|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84086183|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086184|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84086185|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
84086186|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086187|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086188|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
84086189|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086190|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84086191|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086192|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
84086193|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086194|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84086195|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84086196|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
84086197|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086198|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84086199|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84086200|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84086201|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84086202|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
84086203|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84086204|NCT00859105|Imiquimod|imiquimod|mesh-list
84086205|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84086206|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
84086207|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086208|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086209|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
84086210|NCT00859183|Sirolimus|sirolimus|mesh-list
84086211|NCT00859183|Temsirolimus|temsirolimus|mesh-list
84086212|NCT00859183|MTOR Inhibitors|mtor inhibitors|mesh-list
84086213|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84086214|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086215|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84086216|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086217|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
84086218|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086219|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
84086220|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086221|NCT00859183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84086222|NCT00859183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086223|NCT00859183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086224|NCT02803944|Azithromycin|azithromycin|mesh-list
84086225|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84086226|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086227|NCT02545231|Pitavastatin|pitavastatin|mesh-list
84086228|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84086229|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84086230|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84086231|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
84086232|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086233|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086234|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84086235|NCT02803788|Dexamethasone|dexamethasone|mesh-list
84086236|NCT02803788|Ondansetron|ondansetron|mesh-list
84086238|NCT02803788|Antiemetics|antiemetics|mesh-list
84086239|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086240|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
84086241|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086242|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086243|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086244|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
84086245|NCT02803788|Hormones|hormones|mesh-ancestor
84086246|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086247|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84086248|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086249|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
84086250|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
84086251|NCT02803788|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84086252|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84086253|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
84086254|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086255|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086256|NCT02610153|Vitamin K|vitamin k|mesh-list
84086257|NCT02610153|Vitamins|vitamins|mesh-ancestor
84086258|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
84086259|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086260|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84086261|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84086262|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086263|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
84086264|NCT02610153|Coagulants|coagulants|mesh-ancestor
84086265|NCT00862693|Calcitriol|calcitriol|mesh-list
84086266|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84086267|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086268|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84086269|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086270|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086271|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84086272|NCT00862693|Vitamins|vitamins|mesh-ancestor
84086273|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
84086274|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84086275|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
84086276|NCT05757063|Propofol|propofol|mesh-list
84086277|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84086278|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086279|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086280|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84086281|NCT05757063|Analgesics|analgesics|mesh-ancestor
84086282|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
84086283|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086284|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84086285|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84086286|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84086287|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
84086288|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086289|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086290|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84086291|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
84086292|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
84086293|NCT02799498|Etanercept|etanercept|mesh-list
84086294|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84086295|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84086296|NCT02799498|Analgesics|analgesics|mesh-ancestor
84086297|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
84086298|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086299|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086300|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086301|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086302|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086303|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086304|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
84086305|NCT00617851|Vaccines|vaccines|mesh-list
84086306|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
84086307|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086308|NCT02806440|Naltrexone|naltrexone|mesh-list
84086309|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84086310|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84086311|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086312|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
84086313|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086314|NCT00913809|Desipramine|desipramine|mesh-list
84086315|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84086316|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
84086317|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086318|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086319|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086320|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84086321|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84086322|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086323|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
84086324|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086325|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086326|NCT02806362|Ritonavir|ritonavir|mesh-list
84086327|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84086328|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84086329|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
84086330|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086331|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086332|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84086333|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84086334|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
84086335|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086336|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84086337|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84086338|NCT00855049|Acetaminophen|acetaminophen|mesh-list
84086339|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84086340|NCT00855049|Analgesics|analgesics|mesh-ancestor
84086341|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
84086342|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086343|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086344|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
84086345|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84086346|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84086347|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
84086348|NCT00812955|Simvastatin|simvastatin|mesh-list
84086349|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84086350|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84086351|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
84086352|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086353|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84086354|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84086355|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086356|NCT04235478|Triamcinolone|triamcinolone|mesh-list
84086357|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84086358|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086359|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
84086360|NCT04235478|Hormones|hormones|mesh-ancestor
84086361|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086362|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086363|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086364|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
84086365|NCT00619489|Vedolizumab|vedolizumab|mesh-list
84086366|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086367|NCT02806206|Prucalopride|prucalopride|mesh-list
84086368|NCT02806206|Laxatives|laxatives|mesh-ancestor
84086369|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086370|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
84086371|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84086372|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
84086373|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086374|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086375|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086376|NCT00855205|Rituximab|rituximab|mesh-list
84086377|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84086378|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086379|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
84086380|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086381|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086382|NCT00859807|Amodiaquine|amodiaquine|mesh-list
84086383|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
84086384|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84086385|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84086386|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086387|NCT00859885|Clopidogrel|clopidogrel|mesh-list
84086388|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086389|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086390|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84086391|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84086392|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84086393|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84086394|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
84086395|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086396|NCT02798874|Clopidogrel|clopidogrel|mesh-list
84086397|NCT02798874|Ticagrelor|ticagrelor|mesh-list
84086398|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84086399|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84086400|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84086401|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84086402|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
84086403|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086404|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086405|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086406|NCT02799264|Cabotegravir|cabotegravir|mesh-list
84086407|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84086408|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84086409|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086410|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086411|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84086412|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84086413|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
84086414|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086415|NCT00959699|Interferons|interferons|mesh-list
84086416|NCT00959699|Ribavirin|ribavirin|mesh-list
84086417|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
84086418|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
84086419|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84086420|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086421|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
84086422|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086423|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
84086424|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086425|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
84086426|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086427|NCT02806128|Kallikreins|kallikreins|mesh-list
84086428|NCT02806128|Coagulants|coagulants|mesh-ancestor
84086429|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
84086430|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
84086431|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84086432|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086433|NCT00860119|Alprazolam|alprazolam|mesh-list
84086434|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84086435|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086436|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086437|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84086438|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84086439|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086440|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
84086441|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
84086442|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086443|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086444|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
84086445|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84086446|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84086447|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84086448|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
84086449|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086450|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086451|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086452|NCT02805738|Tenofovir|tenofovir|mesh-list
83326430|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
84086453|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
84086454|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086455|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84086456|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84086457|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086458|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086459|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84086460|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84086462|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84086463|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086464|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84086465|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086466|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086467|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
84086468|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84086469|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086470|NCT02798406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84086471|NCT02798406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086472|NCT05550636|Midazolam|midazolam|mesh-list
84086473|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84086474|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84086475|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086476|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086477|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84086478|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84086479|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086480|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84086481|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
84086482|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
84086483|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
84086484|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
84086485|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086486|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086487|NCT02857829|Caffeine|caffeine|mesh-list
84086488|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84086489|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086490|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84086491|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086492|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086493|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84086494|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84086495|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
84086496|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086497|NCT00860275|Fluconazole|fluconazole|mesh-list
84086498|NCT00860275|Ketoconazole|ketoconazole|mesh-list
84086499|NCT00860275|BMS 708163|bms 708163|mesh-list
84086500|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
84086501|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086502|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84086503|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84086504|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086505|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086506|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84086507|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
84086508|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086509|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086510|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84086511|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84086512|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84086513|NCT00860275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84086514|NCT02798250|Insulin|insulin|mesh-list
84086515|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84086516|NCT02798250|Glucagon|glucagon|mesh-list
84086517|NCT02798250|Hormones|hormones|mesh-list
84086518|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84086519|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086520|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086521|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086522|NCT00865111|Bupropion|bupropion|mesh-list
84086523|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84086524|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
84086525|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086526|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84086527|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84086528|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086529|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086530|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
84086531|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086532|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086533|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84086534|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84086535|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086536|NCT02802696|Furosemide|furosemide|mesh-list
84086537|NCT02802696|Diuretics|diuretics|mesh-ancestor
84086538|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
84086539|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086540|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84086541|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086542|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086543|NCT00865267|Halobetasol|halobetasol|mesh-list
84086544|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84086545|NCT02798172|Metformin|metformin|mesh-list
84086546|NCT02798172|Alogliptin|alogliptin|mesh-list
84086547|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84086548|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086549|NCT02798172|Incretins|incretins|mesh-ancestor
84086550|NCT02798172|Hormones|hormones|mesh-ancestor
84086551|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086552|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84086553|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
84086554|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086555|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086556|NCT00865423|Gabapentin|gabapentin|mesh-list
84086557|NCT00865423|Analgesics|analgesics|mesh-ancestor
84086558|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
84086559|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086560|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086561|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
84086562|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84086563|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84086564|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086565|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086566|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84086567|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84086568|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086569|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086570|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
84086571|NCT00955721|Gemcitabine|gemcitabine|mesh-list
84086572|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
84086573|NCT00955721|Sorafenib|sorafenib|mesh-list
84086574|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84086575|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
84086576|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086577|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086578|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84086579|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086580|NCT02802540|Nabilone|nabilone|mesh-list
84086581|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
84086582|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
84086583|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086584|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086585|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086586|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84086587|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84086588|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086589|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086590|NCT00865501|Spironolactone|spironolactone|mesh-list
84086591|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84086592|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
84086593|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086594|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086595|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84086596|NCT00865501|Diuretics|diuretics|mesh-ancestor
84086597|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
84086598|NCT02797704|Aflibercept|aflibercept|mesh-list
84086599|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84086600|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84086601|NCT02797704|Growth Substances|growth substances|mesh-ancestor
84086602|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086603|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
84086604|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086605|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
84086606|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84086607|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84086608|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84086609|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086610|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086611|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
84086612|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086613|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086614|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84086615|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086616|NCT00863161|Lesogaberan|lesogaberan|mesh-list
84086617|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086618|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84086619|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
84086620|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
84086621|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086622|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086623|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086624|NCT00863239|Interferons|interferons|mesh-list
84086625|NCT00863239|Ribavirin|ribavirin|mesh-list
84086626|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
84086627|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
84086628|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84086629|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086630|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
84086631|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086632|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
84086633|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086634|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
84086635|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086636|NCT02802072|Aspirin|aspirin|mesh-list
84086637|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84086638|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84086639|NCT02802072|Analgesics|analgesics|mesh-ancestor
84086640|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
84086641|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086642|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086643|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086644|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086645|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84086646|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84086647|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086648|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84086649|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84086650|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086651|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
84086652|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
84086653|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84086654|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086655|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086656|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84086657|NCT04276883|Analgesics|analgesics|mesh-ancestor
84086658|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
84086659|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086660|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84086661|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84086662|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84086663|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
84086664|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086665|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086666|NCT00865657|Alprazolam|alprazolam|mesh-list
84086667|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84086668|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086669|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086670|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84086671|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84086672|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83326655|NCT01728922|Vitamins|vitamins|mesh-list
84086673|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
84086674|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
84086675|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086676|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086677|NCT00863395|Lidocaine|lidocaine|mesh-list
84086678|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
84086679|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
84086680|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086681|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086682|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
84086683|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086684|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84086685|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84086686|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84086687|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086688|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086689|NCT02939183|Dexamethasone|dexamethasone|mesh-list
84086690|NCT02939183|Pomalidomide|pomalidomide|mesh-list
84086691|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086692|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
84086693|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
84086694|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086695|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086696|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086697|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
84086698|NCT02939183|Hormones|hormones|mesh-ancestor
84086699|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086700|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84086701|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086702|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
84086703|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84086704|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84086705|NCT02939183|Growth Substances|growth substances|mesh-ancestor
84086706|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
84086707|NCT02801838|Morphine|morphine|mesh-list
84086708|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84086709|NCT02801838|Narcotics|narcotics|mesh-ancestor
84086710|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086711|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086712|NCT02801838|Analgesics|analgesics|mesh-ancestor
84086713|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
84086714|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086715|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84086716|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84086717|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086718|NCT02797860|Rocuronium|rocuronium|mesh-list
84086719|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84086720|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84086721|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84086722|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086723|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086724|NCT00860899|Clonidine|clonidine|mesh-list
84086725|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
84086726|NCT00860899|Analgesics|analgesics|mesh-ancestor
84086727|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
84086728|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086729|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086730|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84086731|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
84086732|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
84086733|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84086734|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84086735|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84086736|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
84086737|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086738|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086739|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
84086740|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
84086741|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086742|NCT02797782|Antibodies|antibodies|mesh-list
84086743|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
84086744|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086745|NCT00863629|Insulin|insulin|mesh-list
84086746|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84086747|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086748|NCT00860977|Valacyclovir|valacyclovir|mesh-list
84086749|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
84086750|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086751|NCT00865891|Nifedipine|nifedipine|mesh-list
84086752|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84086753|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086754|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086755|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84086756|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086757|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
84086758|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
84086759|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84086760|NCT02797236|Vaccines|vaccines|mesh-list
84086761|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
84086762|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086763|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
84086764|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84086765|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
84086766|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086767|NCT00863785|Expectorants|expectorants|mesh-ancestor
84086768|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
84086769|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84086770|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
84086771|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086772|NCT00863785|Protective Agents|protective agents|mesh-ancestor
84086773|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086774|NCT00863785|Antidotes|antidotes|mesh-ancestor
84086775|NCT02801526|Amlodipine|amlodipine|mesh-list
84086776|NCT02801526|Candesartan|candesartan|mesh-list
84086777|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84086778|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84086779|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086780|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086781|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84086782|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086783|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
84086784|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84086785|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84086786|NCT02805426|Misoprostol|misoprostol|mesh-list
84086787|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
84086788|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84086789|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84086790|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086791|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
84086792|NCT02805426|Coagulants|coagulants|mesh-ancestor
84086793|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84086794|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
84086795|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84086796|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086797|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84086798|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84086799|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
84086800|NCT02801292|Ketamine|ketamine|mesh-list
84086801|NCT02801292|Analgesics|analgesics|mesh-ancestor
84086802|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
84086803|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086804|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086805|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84086806|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84086807|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
84086808|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
84086809|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086810|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84086811|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84086812|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086813|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086814|NCT02544061|Interleukin-12|interleukin-12|mesh-list
84086815|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84086816|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
84086817|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086818|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84086819|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84086820|NCT02544061|Growth Substances|growth substances|mesh-ancestor
84086821|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
84086822|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086823|NCT00863863|Griseofulvin|griseofulvin|mesh-list
84086824|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
84086825|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086826|NCT03853044|Prednisone|prednisone|mesh-list
84086827|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
84086828|NCT03853044|Doxorubicin|doxorubicin|mesh-list
84086829|NCT03853044|Vincristine|vincristine|mesh-list
84086830|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086831|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
84086832|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086833|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84086834|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84086835|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
84086836|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086837|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086838|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84086839|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84086840|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84086841|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84086842|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086843|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84086844|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
84086845|NCT03853044|Hormones|hormones|mesh-ancestor
84086846|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086847|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84086848|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84086849|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
84086850|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
84086851|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
84086852|NCT00870337|Everolimus|everolimus|mesh-list
84086853|NCT00870337|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84086854|NCT00870337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84086855|NCT00870337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086856|NCT00870337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086857|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84086858|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
84086859|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086860|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84086861|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84086862|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84086863|NCT00866437|Estropipate|estropipate|mesh-list
84086864|NCT00866437|Estradiol|estradiol|mesh-list
84086865|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84086866|NCT00866437|Estrone|estrone|mesh-list
84086867|NCT00866437|Progesterone|progesterone|mesh-list
84086868|NCT00866437|Estrogens|estrogens|mesh-ancestor
84086869|NCT00866437|Hormones|hormones|mesh-ancestor
84086870|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086871|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086872|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84086873|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
84086874|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84086875|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84086876|NCT00866437|Progestins|progestins|mesh-ancestor
84086877|NCT00863941|Bupropion|bupropion|mesh-list
84086878|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84086879|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
84086880|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086881|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84086882|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84086883|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086884|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086885|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
84086886|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086887|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086888|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84086889|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84086890|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086891|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
84086892|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84086893|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84086894|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
84086895|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086896|NCT00866515|Ketoconazole|ketoconazole|mesh-list
84086897|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
84086898|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086899|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84086900|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84086901|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086902|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086903|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84086904|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
84086905|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84086906|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086907|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84086908|NCT02795754|Ritonavir|ritonavir|mesh-list
84086909|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
84086910|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84086911|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84086912|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
84086913|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086914|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086915|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84086916|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84086917|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
84086918|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086919|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84086920|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84086921|NCT00864019|Sertraline|sertraline|mesh-list
84086922|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
84086923|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086924|NCT00864019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84086925|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84086926|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086927|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086928|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086929|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
84086930|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086931|NCT00812487|Insulin|insulin|mesh-list
84086932|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84086933|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84086934|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086935|NCT04235868|Mitogens|mitogens|mesh-list
84086936|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
84086937|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086938|NCT02800902|Atorvastatin|atorvastatin|mesh-list
84086939|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84086940|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84086941|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84086942|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
84086943|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086944|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84086945|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84086946|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086947|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84086948|NCT00617461|Gabapentin|gabapentin|mesh-list
84086949|NCT00617461|Analgesics|analgesics|mesh-ancestor
84086950|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
84086951|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84086952|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086953|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
84086954|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84086955|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84086956|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086957|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84086958|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84086959|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84086960|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84086961|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086962|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
84086963|NCT00812331|Simeprevir|simeprevir|mesh-list
84086964|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
84086965|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086966|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
84086967|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086968|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086969|NCT04233996|Meropenem|meropenem|mesh-list
84086970|NCT04233996|Tazobactam|tazobactam|mesh-list
84086971|NCT04233996|Piperacillin|piperacillin|mesh-list
84086972|NCT04233996|Cefepime|cefepime|mesh-list
84086973|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84086974|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84086975|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84086976|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84086977|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84086978|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086979|NCT00812253|Insulin|insulin|mesh-list
84086980|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84086981|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84086982|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086983|NCT00870571|Amlodipine|amlodipine|mesh-list
84086984|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84086985|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84086986|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84086987|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84086988|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84086989|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086990|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
84086991|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84086992|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086993|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086994|NCT00616759|Propofol|propofol|mesh-list
84086995|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84086996|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84086997|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84086998|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84086999|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
84087000|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
84087001|NCT02610075|Adavosertib|adavosertib|mesh-list
84087002|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087003|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087004|NCT00866593|Dexetimide|dexetimide|mesh-list
84087005|NCT00866593|Citalopram|citalopram|mesh-list
84087006|NCT00866593|Escitalopram|escitalopram|mesh-list
84087007|NCT00866593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84087008|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84087009|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087010|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087011|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087012|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
84087013|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087014|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84087015|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84087016|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
84087017|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
84087018|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087019|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84087020|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84087021|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
84087022|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84087023|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
84087024|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087025|NCT02796378|Ubiquinone|ubiquinone|mesh-list
84087026|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
84087027|NCT02796378|Simvastatin|simvastatin|mesh-list
84087028|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84087029|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84087030|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
84087031|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087032|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84087033|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84087034|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087035|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
84087036|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087037|NCT02796378|Vitamins|vitamins|mesh-ancestor
84087038|NCT00864409|Ropivacaine|ropivacaine|mesh-list
84087039|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
84087040|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
84087041|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087042|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087043|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
84087044|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087045|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
84087046|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
84087048|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84087049|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087050|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087051|NCT00866983|Urological Agents|urological agents|mesh-ancestor
84087052|NCT05226013|Rasburicase|rasburicase|mesh-list
84087053|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
84087054|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087055|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
84087056|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84087057|NCT00870883|Deferoxamine|deferoxamine|mesh-list
84087058|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
84087059|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087060|NCT00870883|Expectorants|expectorants|mesh-ancestor
84087061|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
84087062|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84087063|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
84087064|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087065|NCT00870883|Protective Agents|protective agents|mesh-ancestor
84087066|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087067|NCT00870883|Antidotes|antidotes|mesh-ancestor
84087068|NCT00870883|Siderophores|siderophores|mesh-ancestor
84087069|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84087070|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
84087071|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
84087072|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
84087073|NCT00870961|Vitamin D|vitamin d|mesh-list
84087074|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84087075|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087076|NCT00870961|Vitamins|vitamins|mesh-ancestor
84087077|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
84087078|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84087079|NCT00811941|Nalmefene|nalmefene|mesh-list
84087080|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84087081|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087082|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
84087083|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087084|NCT00864565|Fentanyl|fentanyl|mesh-list
84087085|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84087086|NCT00864565|Narcotics|narcotics|mesh-ancestor
84087087|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087088|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087089|NCT00864565|Analgesics|analgesics|mesh-ancestor
84087090|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
84087091|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087092|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84087093|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84087094|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
84087095|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
84087096|NCT00864643|Atorvastatin|atorvastatin|mesh-list
84087097|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84087098|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84087099|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
84087100|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087101|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84087102|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84087103|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087104|NCT00871039|Midazolam|midazolam|mesh-list
84087105|NCT00871039|Propofol|propofol|mesh-list
84087106|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84087107|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087108|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087109|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84087110|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
84087111|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
84087112|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84087113|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84087114|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84087115|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087116|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
84087117|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
84087118|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087119|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087120|NCT00867061|ON 01910|on 01910|mesh-list
84087121|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087122|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84087123|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087124|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087125|NCT00864799|Misoprostol|misoprostol|mesh-list
84087126|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84087127|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
84087128|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84087129|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087130|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84087131|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84087132|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
84087133|NCT04234776|Ketamine|ketamine|mesh-list
84087134|NCT04234776|Aripiprazole|aripiprazole|mesh-list
84087135|NCT04234776|Escitalopram|escitalopram|mesh-list
84087136|NCT04234776|Analgesics|analgesics|mesh-ancestor
84087137|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
84087138|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087139|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087140|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84087141|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84087142|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
84087143|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
84087144|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087145|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84087146|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84087147|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087148|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087149|NCT04234776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84087150|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84087151|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087152|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
84087153|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
84087154|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087155|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84087156|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84087157|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
84087158|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
84087159|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84087160|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84087161|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84087162|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84087163|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84087164|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84087165|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84087166|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087167|NCT00871273|Capecitabine|capecitabine|mesh-list
84087168|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84087169|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
84087170|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087171|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087172|NCT00867295|Cefazolin|cefazolin|mesh-list
84087173|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087174|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087175|NCT02794506|Propolis|propolis|mesh-list
84087176|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087177|NCT04040491|Gemcitabine|gemcitabine|mesh-list
84087178|NCT04040491|Lenalidomide|lenalidomide|mesh-list
84087179|NCT04040491|Antibodies|antibodies|mesh-list
84087180|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
84087181|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
84087182|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087183|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84087184|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
84087185|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087186|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087187|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84087188|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84087189|NCT04040491|Growth Substances|growth substances|mesh-ancestor
84087190|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
84087191|NCT02794584|Sufentanil|sufentanil|mesh-list
84087192|NCT02794584|Dsuvia|dsuvia|mesh-list
84087193|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
84087194|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087195|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087196|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84087197|NCT02794584|Narcotics|narcotics|mesh-ancestor
84087198|NCT02794584|Analgesics|analgesics|mesh-ancestor
84087199|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
84087200|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087201|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84087202|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84087203|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
84087204|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84087205|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
84087206|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087207|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84087208|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84087209|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087210|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087211|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84087212|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84087213|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087214|NCT00871507|Incretins|incretins|mesh-ancestor
84087215|NCT00871507|Hormones|hormones|mesh-ancestor
84087216|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087217|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84087218|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
84087219|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087220|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087221|NCT00865033|Metformin|metformin|mesh-list
84087222|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84087223|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087224|NCT04234932|Latanoprost|latanoprost|mesh-list
84087225|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84087226|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84087227|NCT02789592|Clonazepam|clonazepam|mesh-list
84087228|NCT02789592|Melatonin|melatonin|mesh-list
84087229|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
84087230|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087231|NCT02789592|Protective Agents|protective agents|mesh-ancestor
84087232|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087233|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087234|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
84087235|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
84087236|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
84087237|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087238|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84087239|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84087240|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84087241|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
84087242|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087243|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087244|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087245|NCT00876421|Urological Agents|urological agents|mesh-ancestor
84087246|NCT00872131|Sertraline|sertraline|mesh-list
84087247|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
84087248|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087249|NCT00872131|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84087250|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84087251|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087252|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087253|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087254|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
84087255|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087256|NCT04233294|Decitabine|decitabine|mesh-list
84087257|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84087258|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
84087259|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087260|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087261|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087262|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
84087263|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087264|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087265|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84087266|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84087267|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087268|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087269|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087270|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84087271|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84087272|NCT00872365|Micronutrients|micronutrients|mesh-list
83327268|NCT01710020|Tofacitinib|tofacitinib|mesh-list
84087273|NCT00872365|Trace Elements|trace elements|mesh-list
84087274|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087275|NCT03637062|Progesterone|progesterone|mesh-list
84087276|NCT03637062|Progestins|progestins|mesh-ancestor
84087277|NCT03637062|Hormones|hormones|mesh-ancestor
84087278|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087279|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087280|NCT02793648|Vitamins|vitamins|mesh-list
84087281|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
84087282|NCT02793648|Vitamin E|vitamin e|mesh-list
84087283|NCT02793648|Tocopherols|tocopherols|mesh-list
84087284|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
84087285|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
84087286|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087287|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
84087288|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087289|NCT02793648|Protective Agents|protective agents|mesh-ancestor
84087290|NCT02789358|Adenosine|adenosine|mesh-list
84087291|NCT02789358|Analgesics|analgesics|mesh-ancestor
84087292|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
84087293|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087294|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087295|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84087296|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
84087297|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84087298|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
84087299|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
84087300|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087301|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087302|NCT03847506|Amlodipine|amlodipine|mesh-list
84087303|NCT03847506|Candesartan|candesartan|mesh-list
84087304|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
84087305|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84087306|NCT03847506|Ezetimibe|ezetimibe|mesh-list
84087307|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84087308|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84087309|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087310|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087311|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84087312|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087313|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
84087314|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84087315|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84087316|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
84087317|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84087318|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84087319|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087320|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84087321|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84087322|NCT00617305|Ambrisentan|ambrisentan|mesh-list
84087323|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
84087324|NCT00617305|Tadalafil|tadalafil|mesh-list
84087325|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
84087326|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84087327|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84087328|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087329|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087330|NCT00617305|Urological Agents|urological agents|mesh-ancestor
84087331|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84087332|NCT02792712|Clopidogrel|clopidogrel|mesh-list
84087333|NCT02792712|Ticagrelor|ticagrelor|mesh-list
84087334|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84087335|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84087336|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84087337|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84087338|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
84087339|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087340|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087341|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087342|NCT02789202|Fluorides|fluorides|mesh-list
84087343|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
84087344|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
84087345|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
84087346|NCT02789202|Protective Agents|protective agents|mesh-ancestor
84087347|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087348|NCT00811395|Interferons|interferons|mesh-list
84087349|NCT00811395|Interferon-beta|interferon-beta|mesh-list
84087350|NCT00811395|Teriflunomide|teriflunomide|mesh-list
84087351|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
84087352|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
84087353|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
84087354|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087355|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
84087356|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087357|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84087358|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
84087359|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087360|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087361|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087362|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84087363|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84087364|NCT00811395|Analgesics|analgesics|mesh-ancestor
84087365|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
84087366|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087367|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84087368|NCT02792946|Ambroxol|ambroxol|mesh-list
84087369|NCT02792946|Expectorants|expectorants|mesh-ancestor
84087370|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
84087371|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
84087372|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84087373|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087374|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087375|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84087376|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84087377|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087378|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087379|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087380|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84087381|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
84087382|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84087383|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087384|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84087385|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84087386|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84087387|NCT05079789|Amiloride|amiloride|mesh-list
84087388|NCT05079789|Furosemide|furosemide|mesh-list
84087389|NCT05079789|Diuretics|diuretics|mesh-ancestor
84087390|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
84087391|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087392|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84087393|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087394|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087395|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
84087396|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84087397|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
84087398|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84087399|NCT02787798|Valsartan|valsartan|mesh-list
84087400|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84087401|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84087402|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84087403|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84087404|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087405|NCT02609997|Dexamethasone|dexamethasone|mesh-list
84087406|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
84087407|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84087408|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
84087409|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
84087410|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087411|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087412|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84087413|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
84087414|NCT02609997|Hormones|hormones|mesh-ancestor
84087415|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087416|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84087417|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087418|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
84087419|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
83327415|NCT02242864|Telmisartan|telmisartan|mesh-list
84087420|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087421|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
84087422|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
84087423|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087424|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087425|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
84087426|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
84087427|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
84087428|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087429|NCT04114500|Estradiol|estradiol|mesh-list
84087430|NCT04114500|Progesterone|progesterone|mesh-list
84087431|NCT04114500|Estrogens|estrogens|mesh-ancestor
84087432|NCT04114500|Hormones|hormones|mesh-ancestor
84087433|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087434|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087435|NCT04114500|Progestins|progestins|mesh-ancestor
84087436|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
84087437|NCT05755659|Aprepitant|aprepitant|mesh-list
84087438|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
84087439|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
84087440|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087441|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087442|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84087443|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84087444|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087445|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087446|NCT00913887|Diclofenac|diclofenac|mesh-list
84087447|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84087448|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84087449|NCT00913887|Analgesics|analgesics|mesh-ancestor
84087450|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
84087451|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087452|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087453|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84087454|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087455|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84087456|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087457|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087458|NCT02792400|Empagliflozin|empagliflozin|mesh-list
84087459|NCT02792400|Linagliptin|linagliptin|mesh-list
84087460|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84087461|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087462|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84087463|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087464|NCT02792400|Incretins|incretins|mesh-ancestor
84087465|NCT02792400|Hormones|hormones|mesh-ancestor
84087466|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087467|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84087468|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
84087469|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087470|NCT04040023|Vitamins|vitamins|mesh-list
84087471|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
84087472|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087473|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
84087474|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
84087475|NCT05017155|Mexiletine|mexiletine|mesh-list
84087476|NCT05017155|Lamotrigine|lamotrigine|mesh-list
84087477|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
84087478|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84087479|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087480|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087481|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84087482|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087483|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84087484|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84087485|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087486|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087487|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84087488|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84087489|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84087490|NCT05162131|Ticagrelor|ticagrelor|mesh-list
84087491|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84087492|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84087493|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84087494|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84087495|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
84087496|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087497|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087498|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087499|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
84087500|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84087501|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
84087502|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84087503|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087504|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84087505|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84087506|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84087508|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
84087509|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84087510|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84087511|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087512|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087513|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087514|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84087515|NCT00876889|Protective Agents|protective agents|mesh-ancestor
84087516|NCT00868465|Lumefantrine|lumefantrine|mesh-list
84087517|NCT00868465|Artemether|artemether|mesh-list
84087518|NCT00868465|Piperaquine|piperaquine|mesh-list
84087519|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84087520|NCT00868465|Artenimol|artenimol|mesh-list
84087521|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
84087522|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84087523|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84087524|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087525|NCT02689986|Rituximab|rituximab|mesh-list
84087526|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84087527|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84087528|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087529|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
84087530|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087531|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087532|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84087533|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
84087534|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087535|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
84087536|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
84087537|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
84087538|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
84087539|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84087540|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
84087541|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087542|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84087543|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087544|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84087545|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087546|NCT00877123|Vitamin D|vitamin d|mesh-list
84087547|NCT00877123|Vitamins|vitamins|mesh-ancestor
84087548|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
84087549|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087550|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84087551|NCT00873223|Liraglutide|liraglutide|mesh-list
84087552|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
84087553|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84087554|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087555|NCT00873223|Incretins|incretins|mesh-ancestor
84087556|NCT00873223|Hormones|hormones|mesh-ancestor
84087557|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087558|NCT00873379|Melatonin|melatonin|mesh-list
84087559|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
84087560|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087561|NCT00873379|Protective Agents|protective agents|mesh-ancestor
84087562|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087563|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087564|NCT00868855|Bradykinin|bradykinin|mesh-list
84087565|NCT00868855|Kininogens|kininogens|mesh-list
84087566|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
84087567|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
84087568|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
84087569|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087570|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087571|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
84087572|NCT00615901|Fluorouracil|fluorouracil|mesh-list
84087573|NCT00615901|Methotrexate|methotrexate|mesh-list
84087574|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087575|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
84087576|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087577|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087578|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84087579|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
84087580|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087581|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087582|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84087583|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
84087584|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84087585|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84087586|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
84087587|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84087588|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
84087589|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087590|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84087591|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84087592|NCT00616603|Dexamethasone|dexamethasone|mesh-list
84087593|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
84087594|NCT00616603|Ropivacaine|ropivacaine|mesh-list
84087595|NCT00616603|BB 1101|bb 1101|mesh-list
84087596|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84087597|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
84087598|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
84087599|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087600|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087601|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84087602|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
84087603|NCT00616603|Hormones|hormones|mesh-ancestor
84087604|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087605|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84087606|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087607|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
84087608|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087609|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087610|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
84087611|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
84087612|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087613|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
84087614|NCT00873535|Varenicline|varenicline|mesh-list
84087615|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84087616|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84087617|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
84087618|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087619|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087620|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087621|NCT02790996|Vancomycin|vancomycin|mesh-list
84087622|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087623|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087624|NCT00810693|Riociguat|riociguat|mesh-list
84087625|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
84087626|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087627|NCT02790840|Omeprazole|omeprazole|mesh-list
84087628|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84087629|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84087630|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84087631|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087632|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087633|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
84087634|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84087635|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087636|NCT02362997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84087637|NCT02362997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087638|NCT02790684|Firuglipel|firuglipel|mesh-list
84087639|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84087640|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087641|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
84087642|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087643|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
84087644|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
84087645|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
84087646|NCT02790450|Benzbromarone|benzbromarone|mesh-list
84087647|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
84087648|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
84087649|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087650|NCT02790528|Atorvastatin|atorvastatin|mesh-list
84087651|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84087652|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84087653|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
84087654|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087655|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84087656|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84087657|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087658|NCT00953615|Thalidomide|thalidomide|mesh-list
84087659|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087660|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
84087661|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087662|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
84087663|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087664|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087665|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84087666|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84087667|NCT00953615|Growth Substances|growth substances|mesh-ancestor
84087668|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
84087669|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087670|NCT00873769|Loxapine|loxapine|mesh-list
84087671|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84087672|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84087673|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087674|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087675|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087676|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84087677|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
84087678|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087679|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087680|NCT02785614|Trazodone|trazodone|mesh-list
84087681|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84087682|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84087683|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087684|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087685|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087686|NCT02785614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84087687|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84087688|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087689|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087690|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087691|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
84087692|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84087693|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
84087694|NCT02787018|Dexamethasone|dexamethasone|mesh-list
84087695|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
84087696|NCT02787018|Ropivacaine|ropivacaine|mesh-list
84087697|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84087698|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
84087699|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
84087700|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087701|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087702|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84087703|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
84087704|NCT02787018|Hormones|hormones|mesh-ancestor
84087705|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84087706|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84087707|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087708|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84087709|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087710|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84087711|NCT02787018|Analgesics|analgesics|mesh-ancestor
84087712|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
84087713|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84087714|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84087715|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84087716|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
84087717|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087718|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087719|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
84087720|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
84087721|NCT00873925|Vitamin D|vitamin d|mesh-list
84087722|NCT00873925|Vitamins|vitamins|mesh-ancestor
84087723|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
84087724|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087725|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84087726|NCT03870529|Vitamins|vitamins|mesh-list
84087727|NCT03870529|Vitamin A|vitamin a|mesh-list
84087728|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
84087729|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
84087730|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
84087731|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087732|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
84087733|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087734|NCT03870529|Protective Agents|protective agents|mesh-ancestor
84087735|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84087736|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087737|NCT03412266|Cytarabine|cytarabine|mesh-list
84087738|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
84087739|NCT03412266|Busulfan|busulfan|mesh-list
84087740|NCT03412266|Semustine|semustine|mesh-list
84087741|NCT03412266|Fludarabine|fludarabine|mesh-list
84087742|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84087743|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087744|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
84087745|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087746|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087747|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84087748|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
84087749|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087750|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087751|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84087752|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84087753|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
84087754|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
84087755|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087756|NCT00877591|Ritonavir|ritonavir|mesh-list
84087757|NCT00877591|Darunavir|darunavir|mesh-list
84087758|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
84087759|NCT00877591|Rifampin|rifampin|mesh-list
84087760|NCT00877591|Rifabutin|rifabutin|mesh-list
84087761|NCT00877591|Buprenorphine|buprenorphine|mesh-list
84087762|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84087763|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84087764|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
84087765|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087766|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087767|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84087768|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84087769|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
84087770|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087771|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84087772|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84087773|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84087774|NCT00877591|Narcotics|narcotics|mesh-ancestor
84087775|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087776|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087777|NCT00877591|Analgesics|analgesics|mesh-ancestor
84087778|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
84087779|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087780|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84087781|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84087782|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
84087783|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087784|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
84087785|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84087786|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84087787|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84087788|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84087789|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84087790|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83327785|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
84087791|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84087792|NCT04200222|Vanadium|vanadium|mesh-list
84087793|NCT04200222|Trace Elements|trace elements|mesh-ancestor
84087794|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
84087795|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087796|NCT00874003|Mirtazapine|mirtazapine|mesh-list
84087797|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
84087798|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84087799|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84087800|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
84087801|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
84087802|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087803|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087804|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087805|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84087806|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84087807|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087808|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84087809|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84087810|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84087811|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
84087812|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84087813|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84087814|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
84087815|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84087816|NCT04915365|Acetazolamide|acetazolamide|mesh-list
84087817|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
84087818|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84087819|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087820|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087821|NCT04915365|Diuretics|diuretics|mesh-ancestor
84087822|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
84087823|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087824|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
84087825|NCT02785146|Leucovorin|leucovorin|mesh-list
84087826|NCT02785146|Fluorouracil|fluorouracil|mesh-list
84087827|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
84087828|NCT02785146|Calcium|calcium|mesh-list
84087829|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
84087830|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84087831|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087832|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84087833|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
83429438|NCT00464711|Escitalopram|escitalopram|mesh-list
84087834|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087835|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84087836|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087837|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087838|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
84087839|NCT02785146|Antidotes|antidotes|mesh-ancestor
84087840|NCT02785146|Protective Agents|protective agents|mesh-ancestor
84087841|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
84087842|NCT02785146|Vitamins|vitamins|mesh-ancestor
84087843|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
84087844|NCT00913965|Atenolol|atenolol|mesh-list
84087845|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84087846|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84087847|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
84087848|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
84087849|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087850|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087851|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84087852|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84087853|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84087854|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
84087855|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087856|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087857|NCT05753865|Paclitaxel|paclitaxel|mesh-list
84087858|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84087859|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087860|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
84087861|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
84087862|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
84087863|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087864|NCT00869869|Melatonin|melatonin|mesh-list
84087865|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
84087866|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087867|NCT00869869|Protective Agents|protective agents|mesh-ancestor
84087868|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087869|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84087870|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84087871|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84087872|NCT00874315|Cyclosporine|cyclosporine|mesh-list
84087873|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
84087874|NCT00874315|Fludarabine|fludarabine|mesh-list
84087875|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
84087876|NCT00874315|Busulfan|busulfan|mesh-list
84087877|NCT00874315|Tacrolimus|tacrolimus|mesh-list
84087878|NCT00874315|Cyclosporins|cyclosporins|mesh-list
84087879|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
84087880|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84087881|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087882|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84087883|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
84087884|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087885|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087886|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
84087887|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087888|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84087889|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087890|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
84087891|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84087892|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
84087893|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087894|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84087895|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84087896|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
84087897|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84087898|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
84087899|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84087900|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84087901|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
84087902|NCT00874393|Dopamine|dopamine|mesh-list
84087903|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84087904|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84087905|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
84087906|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
84087907|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087908|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087909|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
84087910|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087911|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087912|NCT00874393|Protective Agents|protective agents|mesh-ancestor
84087913|NCT04199364|Poractant alfa|poractant alfa|mesh-list
84087914|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
84087915|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
84087916|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84087917|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84087918|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087919|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
84087920|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84087921|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087922|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
84087923|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84087924|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84087925|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84087926|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087927|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087928|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
84087929|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84087930|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087931|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84087932|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087933|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
84087934|NCT02784054|Melphalan|melphalan|mesh-list
84087935|NCT02784054|Thiotepa|thiotepa|mesh-list
84087936|NCT02784054|Carboplatin|carboplatin|mesh-list
84087937|NCT02784054|Etoposide|etoposide|mesh-list
84087938|NCT02784054|Bleomycin|bleomycin|mesh-list
84087939|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087940|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
84087941|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087942|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087943|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84087944|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
83327938|NCT02244190|Ritonavir|ritonavir|mesh-list
84087945|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087946|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087947|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84087948|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84087949|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84087950|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84087951|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84087952|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84087954|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
84087955|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
84087956|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087957|NCT04038853|Vitamin D|vitamin d|mesh-list
84087958|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
84087959|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
84087960|NCT04038853|Calcitriol|calcitriol|mesh-list
84087961|NCT04038853|Vitamins|vitamins|mesh-ancestor
84087962|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
84087963|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087964|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84087965|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84087966|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84087967|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84087968|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087969|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84087970|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
84087971|NCT02066220|Lomustine|lomustine|mesh-list
84087972|NCT02066220|Cisplatin|cisplatin|mesh-list
84087973|NCT02066220|Carboplatin|carboplatin|mesh-list
84087974|NCT02066220|Vincristine|vincristine|mesh-list
84087975|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84087976|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
84087977|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087978|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84087979|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84087980|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
84087981|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84087982|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84087983|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84087984|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84087985|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
84087986|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
84087987|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
84087988|NCT00573391|Thalidomide|thalidomide|mesh-list
84087989|NCT00573391|Dexamethasone|dexamethasone|mesh-list
84087990|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
84087991|NCT00573391|Melphalan|melphalan|mesh-list
84087992|NCT00573391|Bortezomib|bortezomib|mesh-list
84087993|NCT00573391|BB 1101|bb 1101|mesh-list
84087994|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84087995|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
84087996|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
84087997|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84087998|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84087999|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088000|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
84088001|NCT00573391|Hormones|hormones|mesh-ancestor
84088002|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088003|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84088004|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088005|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
84088006|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088007|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088008|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84088009|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
84088010|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84088011|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84088012|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
84088013|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
84088014|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088015|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088016|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84088017|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84088018|NCT00573391|Growth Substances|growth substances|mesh-ancestor
84088019|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
84088020|NCT00590967|Cisplatin|cisplatin|mesh-list
84088021|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088022|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
84088023|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
84088024|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088025|NCT00878371|Morphine|morphine|mesh-list
84088026|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84088027|NCT00878371|Narcotics|narcotics|mesh-ancestor
84088028|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088029|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088030|NCT00878371|Analgesics|analgesics|mesh-ancestor
84088031|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
84088032|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088033|NCT04054635|Fluorides|fluorides|mesh-list
84088034|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
84088035|NCT04054635|Protective Agents|protective agents|mesh-ancestor
84088036|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088037|NCT00923299|Trastuzumab|trastuzumab|mesh-list
84088038|NCT00923299|Cetuximab|cetuximab|mesh-list
84088039|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84088040|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088041|NCT05753397|Ropivacaine|ropivacaine|mesh-list
84088042|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
84088043|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
84088044|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088045|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088046|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
84088047|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088048|NCT00875173|Selenium|selenium|mesh-list
84088049|NCT00875173|Antioxidants|antioxidants|mesh-list
84088050|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088051|NCT00875173|Protective Agents|protective agents|mesh-ancestor
84088052|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088053|NCT00875173|Trace Elements|trace elements|mesh-ancestor
84088054|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
84088055|NCT04029831|Ketamine|ketamine|mesh-list
84088056|NCT04029831|Propofol|propofol|mesh-list
84088057|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84088058|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088059|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088060|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84088061|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
84088062|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
84088063|NCT04029831|Analgesics|analgesics|mesh-ancestor
84088064|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
84088065|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088066|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84088067|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84088068|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84088069|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088070|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088071|NCT00878449|Etoposide|etoposide|mesh-list
84088072|NCT00878449|Navitoclax|navitoclax|mesh-list
84088073|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088074|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84088075|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84088076|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088077|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088078|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088079|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
84088080|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84088081|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
84088082|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088083|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088084|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088085|NCT00875875|Rifaximin|rifaximin|mesh-list
84088086|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088087|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088088|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088089|NCT01716312|Omalizumab|omalizumab|mesh-list
84088090|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84088091|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84088092|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
84088093|NCT00880243|Cytarabine|cytarabine|mesh-list
84088094|NCT00880243|Etoposide|etoposide|mesh-list
84088095|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
84088096|NCT00880243|Daunorubicin|daunorubicin|mesh-list
84088097|NCT00880243|Molgramostim|molgramostim|mesh-list
84088098|NCT00880243|Sargramostim|sargramostim|mesh-list
84088099|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83328086|NCT03615105|Melphalan|melphalan|mesh-list
84088101|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84088102|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088103|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088104|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088105|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84088106|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
84088107|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
84088108|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088109|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84088110|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
84088111|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088112|NCT00880243|Analgesics|analgesics|mesh-ancestor
84088113|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
84088114|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088115|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84088116|NCT02783586|Bupivacaine|bupivacaine|mesh-list
84088117|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
84088118|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
84088119|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088120|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088121|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
84088122|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088123|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84088124|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84088125|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84088126|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088127|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088128|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84088129|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84088130|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84088131|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
84088132|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088133|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088134|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84088135|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84088136|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
84088137|NCT00880321|Dabrafenib|dabrafenib|mesh-list
84088138|NCT00880321|Midazolam|midazolam|mesh-list
84088139|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84088140|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84088141|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088142|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088143|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84088144|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84088145|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84088146|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84088147|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
84088148|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
84088149|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
84088150|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
84088151|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088152|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088153|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088154|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84088155|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088156|NCT02608437|Ipilimumab|ipilimumab|mesh-list
84088157|NCT02608437|Guadecitabine|guadecitabine|mesh-list
84088158|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84088159|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088160|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84088161|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088162|NCT05753007|Cannabidiol|cannabidiol|mesh-list
84088163|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
84088164|NCT04230330|Dexamethasone|dexamethasone|mesh-list
84088165|NCT04230330|Gemcitabine|gemcitabine|mesh-list
84088166|NCT04230330|Nivolumab|nivolumab|mesh-list
84088167|NCT04230330|Asparaginase|asparaginase|mesh-list
84088168|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84088169|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
84088170|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
84088171|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088172|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088173|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088174|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
84088175|NCT04230330|Hormones|hormones|mesh-ancestor
84088176|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088177|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84088178|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088179|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84088180|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
84088181|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088182|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84088183|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84088184|NCT02785068|Leucovorin|leucovorin|mesh-list
84088185|NCT02785068|Fluorouracil|fluorouracil|mesh-list
84088186|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
84088187|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088188|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84088189|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088190|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84088191|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
84088192|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088193|NCT02785068|Antidotes|antidotes|mesh-ancestor
84088194|NCT02785068|Protective Agents|protective agents|mesh-ancestor
84088195|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
84088196|NCT02785068|Vitamins|vitamins|mesh-ancestor
84088197|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
84088198|NCT05752929|Insulin|insulin|mesh-list
84088199|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84088200|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84088201|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088202|NCT00880477|Edetic Acid|edetic acid|mesh-list
84088203|NCT00880477|Vaccines|vaccines|mesh-list
84088204|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
84088205|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
84088206|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088207|NCT00880477|Antidotes|antidotes|mesh-ancestor
84088208|NCT00880477|Protective Agents|protective agents|mesh-ancestor
84088209|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
84088210|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
84088211|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088212|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84088213|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
84088214|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84088215|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
84088216|NCT05293938|Cathartics|cathartics|mesh-ancestor
84088217|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088218|NCT00882739|Clopidogrel|clopidogrel|mesh-list
84088219|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84088220|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84088221|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84088222|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84088223|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
84088224|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088225|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088226|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088227|NCT02783040|Digoxin|digoxin|mesh-list
84088228|NCT02783040|Midazolam|midazolam|mesh-list
84088229|NCT02783040|BI 425809|bi 425809|mesh-list
84088230|NCT02783040|Omeprazole|omeprazole|mesh-list
84088231|NCT02783040|Warfarin|warfarin|mesh-list
84088232|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84088233|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84088234|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088235|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088236|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84088237|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84088238|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84088239|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84088240|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
84088241|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
84088242|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
84088243|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
84088244|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088245|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088246|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
83328234|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
84088247|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84088248|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088249|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84088250|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088251|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84088252|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84088253|NCT02783040|Protective Agents|protective agents|mesh-ancestor
84088254|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
84088255|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
84088256|NCT02512926|Etoposide|etoposide|mesh-list
84088257|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84088258|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
84088259|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088260|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088261|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84088262|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
84088263|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088264|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088265|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84088266|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84088267|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84088268|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088269|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088270|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84088271|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84088272|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84088273|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088274|NCT05275686|Fluticasone|fluticasone|mesh-list
84088275|NCT05275686|Xhance|xhance|mesh-list
84088276|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84088277|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84088278|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
84088279|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088280|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088281|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84088282|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
84088283|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
84088284|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84088285|NCT01503606|Clarithromycin|clarithromycin|mesh-list
84088286|NCT01503606|Cefazolin|cefazolin|mesh-list
84088287|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088288|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088289|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84088290|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088291|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088292|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84088293|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84088294|NCT00882973|genexol-PM|genexol-pm|mesh-list
84088295|NCT00882973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088296|NCT00882973|Tubulin Modulators|tubulin modulators|mesh-ancestor
84088297|NCT00882973|Antimitotic Agents|antimitotic agents|mesh-ancestor
84088298|NCT00882973|Mitosis Modulators|mitosis modulators|mesh-ancestor
84088299|NCT00882973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088300|NCT00805935|Leuprolide|leuprolide|mesh-list
84088301|NCT00805935|Menotropins|menotropins|mesh-list
84088302|NCT00805935|Progesterone|progesterone|mesh-list
84088303|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84088304|NCT00805935|Progestins|progestins|mesh-ancestor
84088305|NCT00805935|Hormones|hormones|mesh-ancestor
84088306|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088307|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088308|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84088309|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
84088310|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84088311|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84088312|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088313|NCT00878917|Dorzolamide|dorzolamide|mesh-list
84088314|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84088315|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84088316|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84088317|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84088318|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088319|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088320|NCT00638118|Fexofenadine|fexofenadine|mesh-list
84088321|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84088322|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84088323|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84088324|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
84088325|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
84088326|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088327|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088328|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088329|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84088330|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84088331|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088332|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
84088333|NCT00590031|Irinotecan|irinotecan|mesh-list
84088334|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088335|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84088336|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088337|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088338|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088339|NCT02783196|Liraglutide|liraglutide|mesh-list
84088340|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84088341|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088342|NCT02783196|Incretins|incretins|mesh-ancestor
84088343|NCT02783196|Hormones|hormones|mesh-ancestor
84088344|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088345|NCT05188170|Niclosamide|niclosamide|mesh-list
84088346|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
84088347|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84088348|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
84088349|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84088350|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088351|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
84088352|NCT02782338|Diclofenac|diclofenac|mesh-list
84088353|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84088354|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84088355|NCT02782338|Analgesics|analgesics|mesh-ancestor
84088356|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
84088357|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088358|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088359|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84088360|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088361|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84088362|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088363|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088364|NCT02782260|Dipyridamole|dipyridamole|mesh-list
84088365|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84088366|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088367|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088368|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84088369|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
84088370|NCT05031936|Ropivacaine|ropivacaine|mesh-list
84088371|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
84088372|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
84088373|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088374|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088375|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
84088376|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088377|NCT03577704|Paclitaxel|paclitaxel|mesh-list
84088378|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84088379|NCT03577704|Cisplatin|cisplatin|mesh-list
84088380|NCT03577704|Carboplatin|carboplatin|mesh-list
84088381|NCT03577704|Gemcitabine|gemcitabine|mesh-list
84088382|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
84088383|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84088384|NCT03577704|Antibodies|antibodies|mesh-list
84088385|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
84088386|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84088387|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84088388|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088389|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
84088390|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
84088391|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
84088392|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088393|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
84088394|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088395|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84088396|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
84088397|NCT05176626|Phentermine|phentermine|mesh-list
84088398|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84088399|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088400|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
84088401|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83328432|NCT01696214|Xhance|xhance|mesh-list
84088402|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
84088403|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
84088404|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088405|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
84088406|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088407|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088408|NCT05030766|Nicotine|nicotine|mesh-list
84088409|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84088410|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
84088411|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088412|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088413|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84088414|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84088415|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
84088416|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088417|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088418|NCT00615199|Tofacitinib|tofacitinib|mesh-list
84088419|NCT00615199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84088420|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84088421|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088422|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088423|NCT05328024|Immunomodulating Agents|immunomodulating agents|mesh-list
84088424|NCT05328024|Immunologic Factors|immunologic factors|mesh-ancestor
84088425|NCT05328024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088426|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84088427|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84088428|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
84088429|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088430|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088431|NCT00880867|Poly ICLC|poly iclc|mesh-list
84088432|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
84088433|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
84088434|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088435|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84088436|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84088437|NCT02782182|Leucovorin|leucovorin|mesh-list
84088438|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
84088439|NCT02782182|Irinotecan|irinotecan|mesh-list
84088440|NCT02782182|Folfirinox|folfirinox|mesh-list
84088441|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088442|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84088443|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088444|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088445|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088446|NCT02782182|Antidotes|antidotes|mesh-ancestor
84088447|NCT02782182|Protective Agents|protective agents|mesh-ancestor
84088448|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088449|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
84088450|NCT02782182|Vitamins|vitamins|mesh-ancestor
84088451|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
84088452|NCT02780778|Docetaxel|docetaxel|mesh-list
84088453|NCT02780778|Apatinib|apatinib|mesh-list
84088454|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088455|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
84088456|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
84088457|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
84088458|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088459|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84088460|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088461|NCT00881101|Paclitaxel|paclitaxel|mesh-list
84088462|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84088463|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088464|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
84088465|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
84088466|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
84088467|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088468|NCT00883909|Dutasteride|dutasteride|mesh-list
84088469|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84088470|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84088471|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088472|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088473|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
84088474|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088475|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328467|NCT01696214|Hormones|hormones|mesh-ancestor
84088476|NCT00634686|Vitamin D|vitamin d|mesh-list
84088478|NCT00634686|Vitamins|vitamins|mesh-ancestor
84088479|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
84088480|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088481|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84088482|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84088483|NCT05340192|Octreotide|octreotide|mesh-list
84088484|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088485|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84088486|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088487|NCT03955861|Adalimumab|adalimumab|mesh-list
84088488|NCT03955861|Golimumab|golimumab|mesh-list
84088489|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
84088490|NCT03955861|Etanercept|etanercept|mesh-list
84088491|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84088492|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84088493|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088494|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84088495|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84088496|NCT03955861|Analgesics|analgesics|mesh-ancestor
84088497|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
84088498|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088499|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088500|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088501|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84088502|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
84088503|NCT00881179|Clarithromycin|clarithromycin|mesh-list
84088504|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088505|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088506|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84088507|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088508|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088509|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84088510|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84088511|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
84088512|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84088513|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088514|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088515|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84088516|NCT02781246|Analgesics|analgesics|mesh-ancestor
84088517|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
84088518|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088519|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84088520|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84088521|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84088522|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
84088523|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088524|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088525|NCT00613951|Insulin|insulin|mesh-list
84088526|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84088527|NCT00613951|Metformin|metformin|mesh-list
84088528|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
84088529|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
84088530|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84088531|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
84088532|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84088533|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088534|NCT00881413|Esomeprazole|esomeprazole|mesh-list
84088535|NCT00881413|Pantoprazole|pantoprazole|mesh-list
84088536|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84088537|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088538|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84088539|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088540|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088541|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84088542|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84088543|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088544|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
84088545|NCT00958841|Pasireotide|pasireotide|mesh-list
84088546|NCT00958841|Hormones|hormones|mesh-ancestor
84088547|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088548|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328534|NCT01696058|Olodaterol|olodaterol|mesh-list
84088549|NCT02937116|Cisplatin|cisplatin|mesh-list
84088550|NCT02937116|Gemcitabine|gemcitabine|mesh-list
84088551|NCT02937116|Capecitabine|capecitabine|mesh-list
84088552|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
84088553|NCT02937116|Irinotecan|irinotecan|mesh-list
84088554|NCT02937116|Etoposide|etoposide|mesh-list
84088555|NCT02937116|Pemetrexed|pemetrexed|mesh-list
84088556|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088557|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84088558|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
84088559|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088560|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84088561|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088562|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088563|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84088564|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84088565|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84088566|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84088567|NCT03927105|Nivolumab|nivolumab|mesh-list
84088568|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84088569|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088570|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84088571|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088572|NCT00613327|Oxybutynin|oxybutynin|mesh-list
84088573|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
84088574|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
84088575|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088576|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088577|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84088578|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84088579|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
84088580|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088581|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088582|NCT00613327|Urological Agents|urological agents|mesh-ancestor
84088583|NCT04273997|Metronidazole|metronidazole|mesh-list
84088584|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088585|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088586|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84088587|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84088588|NCT05339802|Linezolid|linezolid|mesh-list
84088589|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088590|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088591|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84088592|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088593|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088594|NCT04649203|Riboflavin|riboflavin|mesh-list
84088595|NCT04649203|Niacinamide|niacinamide|mesh-list
84088596|NCT04649203|Niacin|niacin|mesh-list
84088597|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
84088598|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
84088599|NCT04649203|Vitamins|vitamins|mesh-ancestor
84088600|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
84088601|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088602|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84088603|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
84088604|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84088605|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
84088606|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088607|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84088608|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
84088609|NCT00881725|Metformin|metformin|mesh-list
84088610|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84088611|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088612|NCT05086224|Lidocaine|lidocaine|mesh-list
84088613|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
84088614|NCT05086224|Anesthetics|anesthetics|mesh-list
84088615|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088616|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088617|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
84088618|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088619|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84088620|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84088621|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84088622|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84088623|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088624|NCT00954941|Ondansetron|ondansetron|mesh-list
83328601|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
84088625|NCT00954941|Aprepitant|aprepitant|mesh-list
84088626|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
84088627|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
84088628|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088629|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088630|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088631|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
84088632|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
84088633|NCT00954941|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84088634|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84088635|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
84088636|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088637|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088638|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84088639|NCT05339646|Ritonavir|ritonavir|mesh-list
84088640|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84088641|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84088642|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
84088643|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088644|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088645|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84088646|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84088647|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
84088648|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088649|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84088650|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84088651|NCT00630695|Lanreotide|lanreotide|mesh-list
84088652|NCT00630695|Somatostatin|somatostatin|mesh-list
84088653|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088654|NCT00630695|Hormones|hormones|mesh-ancestor
84088655|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088656|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088657|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84088658|NCT00954707|Aspirin|aspirin|mesh-list
84088659|NCT00954707|Clopidogrel|clopidogrel|mesh-list
84088660|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84088661|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84088662|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84088663|NCT00954707|Analgesics|analgesics|mesh-ancestor
84088664|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
84088665|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088666|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088667|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84088668|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088669|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84088670|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84088671|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088672|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84088673|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84088674|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088675|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
84088676|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84088677|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84088678|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84088679|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
84088680|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088681|NCT00630851|Donepezil|donepezil|mesh-list
84088682|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84088683|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088684|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088685|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
84088686|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088687|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088688|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
84088689|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
84088690|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088691|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84088692|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088693|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088694|NCT05156892|Tamoxifen|tamoxifen|mesh-list
84088695|NCT05156892|Itraconazole|itraconazole|mesh-list
84088696|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84088697|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
84088698|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088699|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088700|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84088701|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088702|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84088703|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84088704|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84088705|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
84088706|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088707|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84088708|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84088709|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088710|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088711|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84088712|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84088713|NCT03894345|Prazosin|prazosin|mesh-list
84088714|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84088715|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84088716|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84088717|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84088718|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
84088719|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088720|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088721|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088722|NCT02859077|Carboplatin|carboplatin|mesh-list
84088723|NCT02859077|Gemcitabine|gemcitabine|mesh-list
84088724|NCT02859077|Pemetrexed|pemetrexed|mesh-list
84088725|NCT02859077|Gefitinib|gefitinib|mesh-list
84088726|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088727|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84088728|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
84088729|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088730|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088731|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84088732|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84088733|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84088734|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84088735|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
84088736|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84088737|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84088738|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84088739|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088740|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088741|NCT03851835|Ondansetron|ondansetron|mesh-list
84088742|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
84088743|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
84088744|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088745|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088746|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088747|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
84088748|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
84088749|NCT03851835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84088750|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84088751|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
84088752|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088753|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088754|NCT00879385|Decitabine|decitabine|mesh-list
84088755|NCT00879385|Panitumumab|panitumumab|mesh-list
84088756|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84088757|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
84088758|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088759|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088760|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088761|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84088762|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
84088763|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088764|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088765|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84088766|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088767|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088768|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088769|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088770|NCT00953225|Vitamin D|vitamin d|mesh-list
84088771|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
84088772|NCT00953225|Vitamins|vitamins|mesh-ancestor
84088773|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
83328754|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
84088774|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088775|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84088776|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84088777|NCT03819231|Oxytocin|oxytocin|mesh-list
84088778|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
84088779|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84088780|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088781|NCT00613015|Guanfacine|guanfacine|mesh-list
84088782|NCT00613015|Modafinil|modafinil|mesh-list
84088783|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84088784|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088785|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84088786|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84088787|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84088788|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088789|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84088790|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84088791|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84088792|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84088793|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
84088794|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088795|NCT02779608|Docetaxel|docetaxel|mesh-list
84088796|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088797|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
84088798|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
84088799|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
84088800|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088801|NCT02543671|Vitamin D|vitamin d|mesh-list
84088802|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
84088803|NCT02543671|Vitamins|vitamins|mesh-ancestor
84088804|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
84088805|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088806|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84088807|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84088808|NCT02838992|Cyclosporine|cyclosporine|mesh-list
84088809|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
84088810|NCT02838992|Cyclosporins|cyclosporins|mesh-list
84088811|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
84088812|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84088813|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
84088814|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088815|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088816|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84088817|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
84088818|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088819|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088820|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84088821|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088822|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
84088823|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088824|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
84088825|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84088826|NCT00879541|Factor VIII|factor viii|mesh-list
84088827|NCT00879541|Coagulants|coagulants|mesh-ancestor
84088828|NCT00884299|Antioxidants|antioxidants|mesh-list
84088829|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088830|NCT00884299|Protective Agents|protective agents|mesh-ancestor
84088831|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088832|NCT02843126|Trastuzumab|trastuzumab|mesh-list
84088833|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84088834|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088835|NCT04201652|Anesthetics|anesthetics|mesh-list
84088836|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
84088837|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088838|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088839|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
84088840|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088841|NCT05338476|Midazolam|midazolam|mesh-list
84088842|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84088843|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84088844|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088845|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088846|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84088847|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84088848|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84088849|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84088850|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
84088851|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
84088852|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
84088853|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
84088854|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088855|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088856|NCT02838758|Lidocaine|lidocaine|mesh-list
84088857|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
84088858|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
84088859|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088860|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088861|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
84088862|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088863|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84088864|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84088865|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84088866|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84088867|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088868|NCT00803595|Oseltamivir|oseltamivir|mesh-list
84088869|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
84088870|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088871|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088872|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088873|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
84088874|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84088875|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088876|NCT02843204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84088877|NCT02843204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088878|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
84088879|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84088880|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088881|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
84088882|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
84088883|NCT04227990|Docetaxel|docetaxel|mesh-list
84088884|NCT04227990|Doxorubicin|doxorubicin|mesh-list
84088885|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84088886|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
84088887|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088888|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088889|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84088890|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
84088891|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088892|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088893|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84088894|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
84088895|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
84088896|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
84088897|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84088898|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84088899|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088900|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088901|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
84088902|NCT02606409|Propofol|propofol|mesh-list
84088903|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84088904|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84088905|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088906|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84088907|NCT02606409|Analgesics|analgesics|mesh-ancestor
84088908|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
84088909|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088910|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84088911|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84088912|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84088913|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
84088914|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088915|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088916|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84088917|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
84088918|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
84088919|NCT00611767|Thiopental|thiopental|mesh-list
84088920|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
84088921|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84088922|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328902|NCT02084511|Analgesics|analgesics|mesh-ancestor
84088923|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088924|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84088925|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
84088926|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
84088927|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
84088928|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
84088929|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088930|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088931|NCT04967508|Ustekinumab|ustekinumab|mesh-list
84088932|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
84088933|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84088934|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84088935|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84088936|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84088937|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088938|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088939|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088940|NCT00803361|Analgesics|analgesics|mesh-ancestor
84088941|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
84088942|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088943|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
84088944|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84088945|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
84088946|NCT02837198|Dotinurad|dotinurad|mesh-list
84088947|NCT02837198|FYX-051|fyx-051|mesh-list
84088948|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
84088949|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
84088950|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088951|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088952|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088953|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84088954|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84088955|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84088956|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84088957|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088958|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
84088959|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84088960|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088961|NCT04038307|Acetaminophen|acetaminophen|mesh-list
84088962|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84088963|NCT04038307|Analgesics|analgesics|mesh-ancestor
84088964|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
84088965|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84088966|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088967|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
84088968|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
84088969|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84088970|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088971|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84088972|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84088973|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088974|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088975|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84088976|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
84088977|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
84088978|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
84088979|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84088980|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84088981|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088982|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84088983|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088984|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84088985|NCT02842814|Hormones|hormones|mesh-ancestor
84088986|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84088987|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84088988|NCT00882193|Ribavirin|ribavirin|mesh-list
84088989|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84088990|NCT00882193|Betaine|betaine|mesh-list
84088991|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
84088992|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84088993|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
84088994|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84088995|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84088996|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
84088997|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84088998|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84088999|NCT02778360|Methylphenidate|methylphenidate|mesh-list
84089000|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84089001|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089002|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84089003|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84089004|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84089005|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089006|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
84089007|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089008|NCT00953147|Ciclesonide|ciclesonide|mesh-list
84089009|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
84089010|NCT00953147|Hormones|hormones|mesh-ancestor
84089011|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089012|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089013|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84089014|NCT05333744|Prednisone|prednisone|mesh-list
84089015|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089016|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
84089017|NCT05333744|Hormones|hormones|mesh-ancestor
84089018|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089019|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089020|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089021|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089022|NCT04250246|Nivolumab|nivolumab|mesh-list
84089023|NCT04250246|Ipilimumab|ipilimumab|mesh-list
84089024|NCT04250246|Guadecitabine|guadecitabine|mesh-list
84089025|NCT04250246|Azacitidine|azacitidine|mesh-list
84089026|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84089027|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089028|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84089029|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089030|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089031|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
84089032|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089033|NCT04273529|Thalidomide|thalidomide|mesh-list
84089034|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089035|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
84089036|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089037|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
84089038|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84089039|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089040|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84089041|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84089042|NCT04273529|Growth Substances|growth substances|mesh-ancestor
84089043|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
84089044|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089045|NCT02858843|Ivacaftor|ivacaftor|mesh-list
84089046|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84089047|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84089048|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089049|NCT02779530|Diclofenac|diclofenac|mesh-list
84089050|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84089051|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089052|NCT02779530|Analgesics|analgesics|mesh-ancestor
84089053|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
84089054|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089055|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089056|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089057|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089058|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84089059|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089060|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089061|NCT00952523|Adapalene|adapalene|mesh-list
84089062|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
84089063|NCT00952523|Tretinoin|tretinoin|mesh-list
84089064|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84089065|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
84089066|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84089067|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089068|NCT00952523|Analgesics|analgesics|mesh-ancestor
84089069|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
84089070|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089071|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089072|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089073|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089074|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089075|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
84089076|NCT04249154|Leuprolide|leuprolide|mesh-list
84089077|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84089078|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
84089079|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84089080|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089081|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089082|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089083|NCT02857361|Ketamine|ketamine|mesh-list
84089084|NCT02857361|Analgesics|analgesics|mesh-ancestor
84089085|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
84089086|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089087|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089088|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84089089|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84089090|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
84089091|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
84089092|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089093|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84089094|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84089095|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089096|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089097|NCT02778126|Prexasertib|prexasertib|mesh-list
84089098|NCT02778126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84089099|NCT02778126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089100|NCT02778126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089101|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
84089102|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84089103|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089104|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84089105|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089106|NCT02232737|Nicotine|nicotine|mesh-list
84089107|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84089108|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
84089109|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089110|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089111|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84089112|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84089113|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
84089114|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089115|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089116|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84089117|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089118|NCT02777814|Entecavir|entecavir|mesh-list
84089119|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
84089120|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089121|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
84089122|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84089123|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089124|NCT02778906|Abatacept|abatacept|mesh-list
84089125|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84089126|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089127|NCT02778906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84089128|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089129|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089130|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
84089131|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089132|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089133|NCT00630929|Ibuprofen|ibuprofen|mesh-list
84089134|NCT00630929|Celecoxib|celecoxib|mesh-list
84089135|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84089136|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089137|NCT00630929|Analgesics|analgesics|mesh-ancestor
84089138|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
84089139|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089140|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089141|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089142|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089143|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84089144|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089145|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089146|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84089148|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089149|NCT02834546|Sorafenib|sorafenib|mesh-list
84089150|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089151|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84089152|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089153|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089154|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84089155|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84089156|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
84089157|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089158|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84089159|NCT04227912|Anesthetics|anesthetics|mesh-list
84089160|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
84089161|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089162|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089163|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
84089164|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089165|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84089166|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089167|NCT04227912|Analgesics|analgesics|mesh-ancestor
84089168|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089169|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089170|NCT02854787|Phenylephrine|phenylephrine|mesh-list
84089171|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
84089172|NCT02854787|Norepinephrine|norepinephrine|mesh-list
84089173|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84089174|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
84089175|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
84089176|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089177|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089178|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
84089179|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84089180|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
84089181|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
84089182|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84089183|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84089184|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84089185|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
84089186|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089187|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089188|NCT02854787|Protective Agents|protective agents|mesh-ancestor
84089189|NCT02778828|Linezolid|linezolid|mesh-list
84089190|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84089191|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089192|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84089193|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089194|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089195|NCT02777736|Methotrexate|methotrexate|mesh-list
84089196|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84089197|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
84089198|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84089199|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089200|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089201|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
84089202|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089203|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089204|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
84089205|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089206|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84089207|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089208|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
84089209|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089210|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84089211|NCT02836184|Niacin|niacin|mesh-list
84089212|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
84089213|NCT02836184|Niacinamide|niacinamide|mesh-list
84089214|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
84089215|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089216|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84089217|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
84089218|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089219|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84089220|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
84089221|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
84089222|NCT02836184|Vitamins|vitamins|mesh-ancestor
84089223|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
84089224|NCT02836184|Antacids|antacids|mesh-ancestor
84089225|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84089226|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
84089227|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84089228|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089229|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089230|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089231|NCT04824144|Analgesics|analgesics|mesh-ancestor
84089232|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
84089233|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089234|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84089235|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84089236|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84089237|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
84089238|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089239|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089240|NCT02775474|Fentanyl|fentanyl|mesh-list
84089241|NCT02775474|Methadone|methadone|mesh-list
84089242|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84089243|NCT02775474|Narcotics|narcotics|mesh-ancestor
84089244|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089245|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089246|NCT02775474|Analgesics|analgesics|mesh-ancestor
84089247|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
84089248|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089249|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84089250|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84089251|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
84089252|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
84089253|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
84089254|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
84089255|NCT05158686|Paclitaxel|paclitaxel|mesh-list
84089256|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84089257|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089258|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
84089259|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
84089260|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
84089261|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089262|NCT02835794|Azacitidine|azacitidine|mesh-list
84089263|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
84089264|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089265|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
84089266|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089267|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089268|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089269|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84089270|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84089271|NCT02836028|Temozolomide|temozolomide|mesh-list
84089272|NCT02836028|Talazoparib|talazoparib|mesh-list
84089273|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84089274|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
84089275|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089276|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089277|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84089278|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089279|NCT01778946|Nicotine|nicotine|mesh-list
84089280|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84089281|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
84089282|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089283|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089284|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84089285|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84089286|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
84089287|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089288|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089289|NCT04227210|Vaccines|vaccines|mesh-list
84089290|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
84089291|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089292|NCT02833766|Doxorubicin|doxorubicin|mesh-list
84089293|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84089294|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089295|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83329280|NCT00945256|Nitroprusside|nitroprusside|mesh-list
84089296|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84089297|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089298|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089299|NCT04813380|Immunomodulating Agents|immunomodulating agents|mesh-list
84089300|NCT04813380|Immunologic Factors|immunologic factors|mesh-ancestor
84089301|NCT04813380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089302|NCT04951362|Ivermectin|ivermectin|mesh-list
84089303|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84089304|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089305|NCT02833610|Denosumab|denosumab|mesh-list
84089306|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84089307|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089308|NCT04225728|Iron|iron|mesh-list
84089309|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84089310|NCT04225728|Teferrol|teferrol|mesh-list
84089311|NCT04225728|Trace Elements|trace elements|mesh-ancestor
84089312|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
84089313|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089314|NCT04225728|Hematinics|hematinics|mesh-ancestor
84089315|NCT02835716|Ustekinumab|ustekinumab|mesh-list
84089316|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
84089317|NCT04247984|Bevacizumab|bevacizumab|mesh-list
84089318|NCT04247984|Fluorouracil|fluorouracil|mesh-list
84089319|NCT04247984|Capecitabine|capecitabine|mesh-list
84089320|NCT04247984|Irinotecan|irinotecan|mesh-list
84089321|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84089322|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089323|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84089324|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84089325|NCT04247984|Growth Substances|growth substances|mesh-ancestor
84089326|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089327|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
84089328|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
84089329|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089330|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089331|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089332|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
84089333|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84089334|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84089335|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089336|NCT00948389|Dasatinib|dasatinib|mesh-list
84089337|NCT00948389|Lomustine|lomustine|mesh-list
84089338|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089339|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84089340|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089341|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089342|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84089343|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
84089344|NCT02775318|Bupivacaine|bupivacaine|mesh-list
84089345|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
84089346|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
84089347|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089348|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089349|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
84089350|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089351|NCT00948155|Varenicline|varenicline|mesh-list
84089352|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84089353|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84089354|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
84089355|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089356|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089357|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089358|NCT02776956|Atorvastatin|atorvastatin|mesh-list
84089359|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84089360|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84089361|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
84089362|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089363|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84089364|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84089365|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089366|NCT04910178|Empagliflozin|empagliflozin|mesh-list
84089367|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
84089368|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
84089369|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84089370|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089371|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84089372|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089373|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84089374|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089375|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84089376|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84089377|NCT04910178|Protective Agents|protective agents|mesh-ancestor
84089378|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
84089379|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84089380|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
84089381|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84089382|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84089383|NCT02778594|Levodopa|levodopa|mesh-list
84089384|NCT02778594|Benserazide|benserazide|mesh-list
84089385|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84089386|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84089387|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
84089388|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089389|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089390|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089391|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089392|NCT02775006|Docetaxel|docetaxel|mesh-list
84089393|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84089394|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089395|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
84089396|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
84089397|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
84089398|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089399|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84089400|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089401|NCT04851834|Cisplatin|cisplatin|mesh-list
84089402|NCT04851834|Carboplatin|carboplatin|mesh-list
84089403|NCT04851834|Temozolomide|temozolomide|mesh-list
84089404|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089405|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84089406|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
84089407|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089408|NCT01880567|Rituximab|rituximab|mesh-list
84089409|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84089410|NCT01880567|Antibodies|antibodies|mesh-list
84089411|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
84089412|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84089413|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
84089414|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089415|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089416|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089417|NCT02776722|Tagatose|tagatose|mesh-list
84089418|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84089419|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
84089420|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
84089421|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089422|NCT02776878|Dasatinib|dasatinib|mesh-list
84089423|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089424|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84089425|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089426|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089427|NCT02772822|Rituximab|rituximab|mesh-list
84089428|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84089429|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089430|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
84089431|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089432|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089433|NCT00635076|Alprazolam|alprazolam|mesh-list
84089434|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84089435|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089436|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089437|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84089438|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84089439|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84089440|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
84089441|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
84089442|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089443|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089444|NCT02772744|Ribavirin|ribavirin|mesh-list
84089445|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
84089446|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
84089447|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089448|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
84089449|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089450|NCT02774382|Vancomycin|vancomycin|mesh-list
84089451|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84089452|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089453|NCT02774460|Amlodipine|amlodipine|mesh-list
84089454|NCT02774460|Candesartan|candesartan|mesh-list
84089455|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
84089456|NCT02774460|Lisinopril|lisinopril|mesh-list
84089457|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84089458|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84089459|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84089460|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089461|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84089462|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089463|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
84089464|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84089465|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84089466|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84089467|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
84089468|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089469|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84089470|NCT02774460|Protective Agents|protective agents|mesh-ancestor
84089471|NCT02772354|Metoprolol|metoprolol|mesh-list
84089472|NCT02772354|Verapamil|verapamil|mesh-list
84089473|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84089474|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84089475|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
84089476|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
84089477|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089478|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089479|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84089480|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84089481|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84089482|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
84089483|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089484|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089485|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84089486|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84089487|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84089488|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
84089489|NCT00611455|Ofatumumab|ofatumumab|mesh-list
84089490|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089491|NCT02767752|Gemcitabine|gemcitabine|mesh-list
84089492|NCT02767752|Capecitabine|capecitabine|mesh-list
84089493|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089494|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
84089495|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089496|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089497|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84089498|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
84089499|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089500|NCT02835404|Nedaplatin|nedaplatin|mesh-list
84089501|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089502|NCT00885781|SMOFlipid|smoflipid|mesh-list
84089503|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84089504|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84089505|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84089506|NCT02767674|Prednisone|prednisone|mesh-list
84089507|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
84089508|NCT02767674|Rituximab|rituximab|mesh-list
84089509|NCT02767674|Gemcitabine|gemcitabine|mesh-list
84089510|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
84089511|NCT02767674|Epirubicin|epirubicin|mesh-list
84089512|NCT02767674|Vindesine|vindesine|mesh-list
84089513|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089514|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
84089515|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089516|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089517|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84089518|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
84089519|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089520|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089521|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84089522|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84089523|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089524|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
84089525|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089527|NCT02767674|Hormones|hormones|mesh-ancestor
84089528|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089529|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089530|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84089531|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84089532|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84089533|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089534|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84089535|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
84089536|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
84089537|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
84089538|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
84089539|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84089540|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089541|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089542|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089543|NCT02833688|Analgesics|analgesics|mesh-ancestor
84089544|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
84089545|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089546|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84089547|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84089548|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84089549|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
84089550|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089551|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089552|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
84089553|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84089554|NCT00947531|Protective Agents|protective agents|mesh-ancestor
84089555|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089556|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
84089557|NCT00612313|Fluoxetine|fluoxetine|mesh-list
84089558|NCT00612313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84089559|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84089560|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84089561|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089562|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089563|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
84089564|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089565|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84089566|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
84089567|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84089568|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84089569|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84089570|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089571|NCT00890552|Dexamethasone|dexamethasone|mesh-list
84089572|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
84089573|NCT00890552|Lenalidomide|lenalidomide|mesh-list
84089574|NCT00890552|Melphalan|melphalan|mesh-list
84089575|NCT00890552|BB 1101|bb 1101|mesh-list
84089576|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089577|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
84089578|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
84089579|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089580|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089581|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84089582|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
84089583|NCT00890552|Hormones|hormones|mesh-ancestor
84089584|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089585|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089586|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089587|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
84089588|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089589|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089590|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
84089591|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84089592|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84089593|NCT00890552|Growth Substances|growth substances|mesh-ancestor
84089594|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
84089595|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84089596|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
84089597|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84089598|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089599|NCT02856503|Vitamin D|vitamin d|mesh-list
84089600|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
84089601|NCT02856503|Vitamins|vitamins|mesh-ancestor
84089602|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
84089603|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089604|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84089605|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84089606|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
84089607|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84089608|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089609|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
84089610|NCT02542813|Oxytocin|oxytocin|mesh-list
84089611|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
84089612|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84089613|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089614|NCT02772120|Progesterone|progesterone|mesh-list
84089615|NCT02772120|Progestins|progestins|mesh-ancestor
84089616|NCT02772120|Hormones|hormones|mesh-ancestor
84089617|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089618|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089619|NCT04248608|Morphine|morphine|mesh-list
84089620|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84089621|NCT04248608|Narcotics|narcotics|mesh-ancestor
84089622|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089623|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089624|NCT04248608|Analgesics|analgesics|mesh-ancestor
84089625|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
84089626|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089627|NCT04783194|Dexamethasone|dexamethasone|mesh-list
84089628|NCT04783194|Bupivacaine|bupivacaine|mesh-list
84089629|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089630|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
84089631|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
84089632|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089633|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089634|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84089635|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
84089636|NCT04783194|Hormones|hormones|mesh-ancestor
84089637|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089638|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089639|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089640|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
84089641|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
84089642|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089643|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
84089644|NCT02854241|Liver Extracts|liver extracts|mesh-list
84089645|NCT02854241|Hematinics|hematinics|mesh-ancestor
84089646|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
84089647|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84089648|NCT02835170|Antibodies|antibodies|mesh-list
84089649|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
84089650|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089651|NCT00946985|Risperidone|risperidone|mesh-list
84089652|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84089653|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84089654|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
84089655|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089656|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089657|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089658|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84089659|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84089660|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089661|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84089662|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84089663|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
84089664|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84089665|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84089666|NCT00611923|Flutamide|flutamide|mesh-list
84089667|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
84089668|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
84089669|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089670|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089671|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089672|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089673|NCT04246502|Capecitabine|capecitabine|mesh-list
84089674|NCT04246502|Trastuzumab|trastuzumab|mesh-list
84089675|NCT04246502|Pertuzumab|pertuzumab|mesh-list
84089676|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089677|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
84089678|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089679|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089680|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84089681|NCT02767362|Atorvastatin|atorvastatin|mesh-list
84089682|NCT02767362|Ezetimibe|ezetimibe|mesh-list
84089683|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84089684|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84089685|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
84089686|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089687|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84089688|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84089689|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089690|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
84089691|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84089692|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089693|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84089694|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84089695|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089696|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089697|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089698|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84089699|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84089700|NCT02541643|Elotuzumab|elotuzumab|mesh-list
84089701|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089702|NCT02696694|Progesterone|progesterone|mesh-list
84089703|NCT02696694|Progestins|progestins|mesh-ancestor
84089704|NCT02696694|Hormones|hormones|mesh-ancestor
84089705|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089706|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089707|NCT04038073|Antibodies|antibodies|mesh-list
84089708|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
84089709|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
84089710|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089711|NCT04739592|Vitamin D|vitamin d|mesh-list
84089712|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
84089713|NCT04739592|Alendronate|alendronate|mesh-list
84089714|NCT04739592|Vitamins|vitamins|mesh-ancestor
84089715|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
84089716|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089717|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84089718|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84089719|NCT00633386|Celecoxib|celecoxib|mesh-list
84089720|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84089721|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089722|NCT00633386|Analgesics|analgesics|mesh-ancestor
84089723|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
84089724|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089725|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089726|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089727|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089728|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84089729|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84089730|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089731|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089732|NCT02771418|Anesthetics|anesthetics|mesh-list
84089733|NCT02771418|Propofol|propofol|mesh-list
84089734|NCT02771418|Sevoflurane|sevoflurane|mesh-list
84089735|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089736|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089737|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84089738|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84089739|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
84089740|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84089741|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84089742|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84089743|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
84089744|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84089745|NCT00888901|Prednisolone|prednisolone|mesh-list
84089746|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
84089747|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84089748|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
84089749|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329741|NCT03020680|Ubiquinone|ubiquinone|mesh-list
84089751|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
84089752|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089753|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089754|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84089755|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
84089756|NCT00888901|Hormones|hormones|mesh-ancestor
84089757|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089758|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84089759|NCT00888901|Protective Agents|protective agents|mesh-ancestor
84089760|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089761|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089762|NCT00803049|Teriflunomide|teriflunomide|mesh-list
84089763|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84089764|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089765|NCT00803049|Analgesics|analgesics|mesh-ancestor
84089766|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
84089767|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089768|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089769|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089770|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089771|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089772|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
84089773|NCT00884767|Leucovorin|leucovorin|mesh-list
84089774|NCT00884767|Fluorouracil|fluorouracil|mesh-list
84089775|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
84089776|NCT00884767|Calcium|calcium|mesh-list
84089777|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
84089778|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84089779|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089780|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
84089781|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089782|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089783|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089784|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84089785|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
84089786|NCT00884767|Antidotes|antidotes|mesh-ancestor
84089787|NCT00884767|Protective Agents|protective agents|mesh-ancestor
84089788|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
84089789|NCT00884767|Vitamins|vitamins|mesh-ancestor
84089790|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
84089791|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84089792|NCT00890084|Telmisartan|telmisartan|mesh-list
84089793|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
84089794|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84089795|NCT00890084|Diuretics|diuretics|mesh-ancestor
84089796|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
84089797|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089798|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84089799|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84089800|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089801|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84089802|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84089803|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84089804|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089805|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84089806|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089807|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089808|NCT02773602|Dexamethasone|dexamethasone|mesh-list
84089809|NCT02773602|Clonidine|clonidine|mesh-list
84089810|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089811|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
84089812|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
84089813|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089814|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089815|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84089816|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
84089817|NCT02773602|Hormones|hormones|mesh-ancestor
84089818|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84089819|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84089820|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089821|NCT02773602|Analgesics|analgesics|mesh-ancestor
84089822|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
84089823|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83329818|NCT02981836|Vaccines|vaccines|mesh-list
84089824|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
84089825|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84089826|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84089827|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84089828|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
84089829|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089830|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089832|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84089833|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84089834|NCT02770950|Analgesics|analgesics|mesh-ancestor
84089835|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
84089836|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089837|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089838|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089839|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089840|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
84089841|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
84089842|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84089843|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84089844|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089845|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089846|NCT00889057|Sorafenib|sorafenib|mesh-list
84089847|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089848|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84089849|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089850|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089851|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
84089852|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
84089853|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84089854|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84089855|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089856|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089857|NCT05684289|Urological Agents|urological agents|mesh-ancestor
84089858|NCT02829008|Bevacizumab|bevacizumab|mesh-list
84089859|NCT02829008|Pemetrexed|pemetrexed|mesh-list
84089860|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84089861|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089862|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84089863|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84089864|NCT02829008|Growth Substances|growth substances|mesh-ancestor
84089865|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089866|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
84089867|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089868|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089869|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84089870|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84089871|NCT05683821|Nicotine|nicotine|mesh-list
84089872|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84089873|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
84089874|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089875|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089876|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84089877|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84089878|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
84089879|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089880|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089881|NCT00889135|Droxidopa|droxidopa|mesh-list
84089882|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84089883|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84089884|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84089885|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
84089886|NCT00889213|Coagulants|coagulants|mesh-ancestor
84089887|NCT00382200|Decitabine|decitabine|mesh-list
84089888|NCT00382200|Tretinoin|tretinoin|mesh-list
84089889|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089890|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
84089891|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089892|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089893|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089894|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
84089895|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
84089896|NCT02696928|Lumefantrine|lumefantrine|mesh-list
84089897|NCT02696928|Primaquine|primaquine|mesh-list
84089898|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
84089899|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84089900|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84089901|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089902|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
84089903|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
84089904|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84089905|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84089906|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84089907|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84089908|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089909|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089910|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089911|NCT00889369|Analgesics|analgesics|mesh-ancestor
84089912|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
84089913|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089914|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
84089915|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84089916|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
84089917|NCT02766192|Ketamine|ketamine|mesh-list
84089918|NCT02766192|Analgesics|analgesics|mesh-ancestor
84089919|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
84089920|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089921|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089922|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84089923|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84089924|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
84089925|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
84089926|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089927|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84089928|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84089929|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089930|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089931|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
84089932|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84089933|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
84089934|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089935|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
84089936|NCT05278897|Protective Agents|protective agents|mesh-ancestor
84089937|NCT00889525|Cabergoline|cabergoline|mesh-list
84089938|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84089939|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84089940|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
84089941|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
84089942|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84089943|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089944|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089945|NCT02770794|Infliximab|infliximab|mesh-list
84089946|NCT02770794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84089947|NCT02770794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84089948|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
84089949|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84089950|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84089951|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
84089952|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84089953|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84089954|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
84089955|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
84089956|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089957|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089958|NCT02766270|Temozolomide|temozolomide|mesh-list
84089959|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84089960|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
84089961|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089962|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089963|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84089964|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
84089965|NCT02766348|Gemcitabine|gemcitabine|mesh-list
84089966|NCT02766348|Cisplatin|cisplatin|mesh-list
84089967|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84089968|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
84089969|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089970|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84089971|NCT00608569|Ritonavir|ritonavir|mesh-list
84089972|NCT00608569|Lopinavir|lopinavir|mesh-list
83329957|NCT00960622|Tenofovir|tenofovir|mesh-list
84089973|NCT00608569|Tenofovir|tenofovir|mesh-list
84089974|NCT00608569|Emtricitabine|emtricitabine|mesh-list
84089975|NCT00608569|Zidovudine|zidovudine|mesh-list
84089976|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84089977|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84089978|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84089979|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
84089980|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84089981|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84089982|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84089983|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84089984|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
84089985|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84089986|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84089987|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84089988|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84089989|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84089990|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
84089991|NCT04699422|Pirinitramide|pirinitramide|mesh-list
84089992|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84089993|NCT04699422|Narcotics|narcotics|mesh-ancestor
84089994|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84089995|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84089996|NCT04699422|Analgesics|analgesics|mesh-ancestor
84089997|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
84089998|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84089999|NCT02828384|Psyllium|psyllium|mesh-list
84090000|NCT02828384|Cathartics|cathartics|mesh-ancestor
84090001|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090002|NCT00886717|Paclitaxel|paclitaxel|mesh-list
84090003|NCT00886717|genexol-PM|genexol-pm|mesh-list
84090004|NCT00886717|Carboplatin|carboplatin|mesh-list
84090005|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84090006|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090007|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
84090008|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
84090009|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
84090010|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090011|NCT00889837|Loxapine|loxapine|mesh-list
84090012|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84090013|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84090014|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090015|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090016|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84090017|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84090018|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
84090019|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090020|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090021|NCT02770404|Nafithromycin|nafithromycin|mesh-list
84090022|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090023|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090024|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84090025|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090026|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090027|NCT00886873|Mifepristone|mifepristone|mesh-list
84090028|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84090029|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
84090030|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84090031|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090032|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84090033|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84090034|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84090035|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
84090036|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84090037|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84090038|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
84090039|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090040|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
84090041|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84090042|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84090043|NCT04243850|Empagliflozin|empagliflozin|mesh-list
84090044|NCT04243850|Caffeine|caffeine|mesh-list
84090045|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84090046|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090047|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84090048|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090049|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090050|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84090051|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84090052|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
84090053|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090054|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84090055|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84090056|NCT00892801|Everolimus|everolimus|mesh-list
84090057|NCT00892801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84090058|NCT00892801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84090059|NCT00892801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090060|NCT00892801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090061|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090062|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
84090063|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090064|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090065|NCT04222842|Vorolanib|vorolanib|mesh-list
84090066|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84090067|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090068|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090069|NCT00633542|Interferons|interferons|mesh-list
84090070|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
84090071|NCT00633542|Thalidomide|thalidomide|mesh-list
84090072|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090073|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
84090074|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090075|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
84090076|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090077|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090078|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
84090079|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090080|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84090081|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84090082|NCT00633542|Growth Substances|growth substances|mesh-ancestor
84090083|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
84090084|NCT02766036|Propolis|propolis|mesh-list
84090085|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090086|NCT00610675|Mirtazapine|mirtazapine|mesh-list
84090087|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
84090088|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84090089|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84090090|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
84090091|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
84090092|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090093|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090094|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090095|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84090096|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84090097|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090098|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84090099|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84090100|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84090101|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
84090102|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84090103|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84090104|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
84090105|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84090106|NCT02828228|Vitamin D|vitamin d|mesh-list
84090107|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
84090108|NCT02828228|Vitamins|vitamins|mesh-ancestor
84090109|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
84090110|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090111|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84090112|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84090113|NCT02769936|Cycloserine|cycloserine|mesh-list
84090114|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84090115|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090116|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84090117|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
84090118|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090119|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
84090120|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090121|NCT00887029|Timolol|timolol|mesh-list
84090122|NCT00887029|Travoprost|travoprost|mesh-list
84090123|NCT00887029|Latanoprost|latanoprost|mesh-list
84090124|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84090125|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84090126|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84090127|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
84090128|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090129|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090130|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090131|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84090132|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84090133|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84090134|NCT00635310|Liver Extracts|liver extracts|mesh-list
84090135|NCT00635310|Hematinics|hematinics|mesh-ancestor
84090136|NCT02762448|Asunaprevir|asunaprevir|mesh-list
84090137|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
84090138|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090139|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090140|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
84090141|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84090142|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090143|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84090144|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
84090145|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090146|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090147|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090148|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090149|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
84090150|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
84090151|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
84090152|NCT00887107|Sorafenib|sorafenib|mesh-list
84090153|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090154|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84090155|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090156|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090157|NCT00802737|Ofatumumab|ofatumumab|mesh-list
84090158|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090159|NCT02769390|Clonidine|clonidine|mesh-list
84090160|NCT02769390|Diazepam|diazepam|mesh-list
84090161|NCT02769390|Analgesics|analgesics|mesh-ancestor
84090162|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
84090163|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090164|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090165|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84090166|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
84090167|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
84090168|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84090169|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84090170|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84090171|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
84090172|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090173|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090174|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84090175|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
84090176|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
84090177|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090178|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84090179|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090180|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84090181|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84090182|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84090183|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84090184|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84090185|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84090186|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
84090187|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
84090188|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
84090189|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
84090190|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
84090191|NCT00890539|Miotics|miotics|mesh-ancestor
84090192|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
84090193|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090194|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090195|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84090196|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
84090197|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
83330186|NCT04401345|Bromides|bromides|mesh-list
84090198|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84090200|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
84090201|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090202|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090203|NCT00887263|Budesonide|budesonide|mesh-list
84090204|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090205|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84090206|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
84090207|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090208|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090209|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84090210|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
84090211|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
84090212|NCT00887263|Hormones|hormones|mesh-ancestor
84090213|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090214|NCT00415233|Hormones|hormones|mesh-list
84090215|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090216|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090217|NCT00914667|Warfarin|warfarin|mesh-list
84090218|NCT00914667|Fesoterodine|fesoterodine|mesh-list
84090219|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
84090220|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84090221|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84090222|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
84090223|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090224|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090225|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090226|NCT00914667|Urological Agents|urological agents|mesh-ancestor
84090227|NCT00887978|Treprostinil|treprostinil|mesh-list
84090228|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84090229|NCT00608023|Tesamorelin|tesamorelin|mesh-list
84090230|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
84090231|NCT00608023|Growth Substances|growth substances|mesh-ancestor
84090232|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090233|NCT00608023|Hormones|hormones|mesh-ancestor
84090234|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090235|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
84090236|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
84090237|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
84090238|NCT02765022|Hormones|hormones|mesh-ancestor
84090239|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090240|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090241|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090242|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090243|NCT04224636|Bevacizumab|bevacizumab|mesh-list
84090244|NCT04224636|Atezolizumab|atezolizumab|mesh-list
84090245|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84090246|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090247|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84090248|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84090249|NCT04224636|Growth Substances|growth substances|mesh-ancestor
84090250|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090251|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
84090252|NCT04224636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84090253|NCT04224636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090254|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84090255|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84090256|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84090257|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84090258|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090259|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090260|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090261|NCT00607789|Analgesics|analgesics|mesh-ancestor
84090262|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
84090263|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090264|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
84090265|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84090266|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
84090267|NCT02761512|Lansoprazole|lansoprazole|mesh-list
84090268|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
84090269|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84090270|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090272|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090273|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090274|NCT00893269|Zolpidem|zolpidem|mesh-list
84090275|NCT00893269|Eszopiclone|eszopiclone|mesh-list
84090276|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84090277|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84090278|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090279|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090280|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84090281|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
84090282|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
84090283|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090284|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090285|NCT05672667|Oxytocin|oxytocin|mesh-list
84090286|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
84090287|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84090288|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090289|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
84090290|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84090291|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090292|NCT00887822|Bevacizumab|bevacizumab|mesh-list
84090293|NCT00887822|Capecitabine|capecitabine|mesh-list
84090294|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84090295|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090296|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84090297|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84090298|NCT00887822|Growth Substances|growth substances|mesh-ancestor
84090299|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090300|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
84090301|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84090302|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
84090303|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090304|NCT04222920|Adalimumab|adalimumab|mesh-list
84090305|NCT04222920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84090306|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090307|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84090308|NCT04115163|Paclitaxel|paclitaxel|mesh-list
84090309|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84090310|NCT04115163|Gemcitabine|gemcitabine|mesh-list
84090311|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84090312|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090313|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
84090314|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
84090315|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
84090316|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090317|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84090318|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
84090319|NCT02542111|Dexamethasone|dexamethasone|mesh-list
84090320|NCT02542111|Gemcitabine|gemcitabine|mesh-list
84090321|NCT02542111|Bortezomib|bortezomib|mesh-list
84090322|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090323|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
84090324|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
84090325|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090326|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090327|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090328|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
84090329|NCT02542111|Hormones|hormones|mesh-ancestor
84090330|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090331|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84090332|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090333|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84090334|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
84090335|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090336|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
84090337|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84090338|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090339|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090340|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84090341|NCT02768688|Analgesics|analgesics|mesh-ancestor
84090342|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
84090343|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090344|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84090345|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84090347|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
84090348|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090349|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090350|NCT00891163|Lidocaine|lidocaine|mesh-list
84090351|NCT00891163|Tetracaine|tetracaine|mesh-list
84090352|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
84090353|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
84090354|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090355|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090356|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
84090357|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090358|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84090359|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84090360|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84090361|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84090362|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090363|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
84090364|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84090365|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
84090366|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090367|NCT00893425|Ramipril|ramipril|mesh-list
84090368|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84090369|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
84090370|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090371|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090372|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84090373|NCT00951665|Paclitaxel|paclitaxel|mesh-list
84090374|NCT00951665|Maytansine|maytansine|mesh-list
84090375|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84090376|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84090377|NCT00951665|Trastuzumab|trastuzumab|mesh-list
84090378|NCT00951665|Pertuzumab|pertuzumab|mesh-list
84090379|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84090380|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090381|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
84090382|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
84090383|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
84090384|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090385|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84090386|NCT00951665|Immunotoxins|immunotoxins|mesh-ancestor
84090387|NCT00951665|Immunoconjugates|immunoconjugates|mesh-ancestor
84090388|NCT00951665|Immunologic Factors|immunologic factors|mesh-ancestor
84090389|NCT00951665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090390|NCT02769078|Warfarin|warfarin|mesh-list
84090391|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
84090392|NCT02769078|Dabigatran|dabigatran|mesh-list
84090393|NCT02769078|Apixaban|apixaban|mesh-list
84090394|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
84090395|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84090396|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
84090397|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84090398|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
84090399|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090400|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090401|NCT04036201|Bupivacaine|bupivacaine|mesh-list
84090402|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
84090403|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
84090404|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
84090405|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090406|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090407|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
84090408|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090409|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84090410|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
84090411|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
84090412|NCT04036201|Protective Agents|protective agents|mesh-ancestor
84090413|NCT00801099|Amoxicillin|amoxicillin|mesh-list
84090414|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84090415|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
84090416|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
84090417|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090418|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090419|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84090420|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090421|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090422|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
84090423|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84090424|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090425|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090426|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84090427|NCT02768610|Analgesics|analgesics|mesh-ancestor
84090428|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
84090429|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090430|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84090431|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84090432|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84090433|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
84090434|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090435|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090436|NCT02764710|Amoxicillin|amoxicillin|mesh-list
84090437|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
84090438|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
84090439|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84090440|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090441|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090442|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84090443|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090444|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090445|NCT00923169|Mitogens|mitogens|mesh-list
84090446|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
84090447|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090448|NCT02541019|Ondansetron|ondansetron|mesh-list
84090449|NCT02541019|Palonosetron|palonosetron|mesh-list
84090450|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
84090451|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
84090452|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090453|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090454|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090455|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
84090456|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
84090457|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84090458|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84090459|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
84090460|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090461|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090462|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84090463|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
84090464|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84090465|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84090466|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84090467|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090468|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090469|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
84090470|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090471|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84090472|NCT04114383|Protective Agents|protective agents|mesh-ancestor
84090473|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090474|NCT04114461|Tofacitinib|tofacitinib|mesh-list
84090475|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090476|NCT04114461|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84090477|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84090478|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090479|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84090480|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090481|NCT02768376|Fentanyl|fentanyl|mesh-list
84090482|NCT02768376|Bupivacaine|bupivacaine|mesh-list
84090483|NCT02768376|Anesthetics|anesthetics|mesh-list
84090484|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
84090485|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090486|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090487|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
84090488|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090489|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84090490|NCT02768376|Narcotics|narcotics|mesh-ancestor
84090491|NCT02768376|Analgesics|analgesics|mesh-ancestor
84090492|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84090493|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84090494|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
84090495|NCT02696460|Lidocaine|lidocaine|mesh-list
84090497|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
84090498|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
84090499|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
84090500|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090501|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090502|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
84090503|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090504|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84090505|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84090506|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84090507|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84090508|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090509|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
84090510|NCT00888043|Bevacizumab|bevacizumab|mesh-list
84090511|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84090512|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090513|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84090514|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84090515|NCT00888043|Growth Substances|growth substances|mesh-ancestor
84090516|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090517|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
84090518|NCT02768220|Empagliflozin|empagliflozin|mesh-list
84090519|NCT02768220|Linagliptin|linagliptin|mesh-list
84090520|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84090521|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090522|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84090523|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090524|NCT02768220|Incretins|incretins|mesh-ancestor
84090525|NCT02768220|Hormones|hormones|mesh-ancestor
84090526|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090527|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84090528|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
84090529|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090530|NCT02760888|Diclofenac|diclofenac|mesh-list
84090531|NCT02760888|Tramadol|tramadol|mesh-list
84090532|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84090533|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84090534|NCT02760888|Analgesics|analgesics|mesh-ancestor
84090535|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
84090536|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090537|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090538|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090539|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84090540|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84090541|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090542|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090543|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84090544|NCT02760888|Narcotics|narcotics|mesh-ancestor
84090545|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090546|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
84090547|NCT00799617|Testosterone|testosterone|mesh-list
84090548|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
84090549|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
84090550|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84090551|NCT00799617|Androgens|androgens|mesh-ancestor
84090552|NCT00799617|Hormones|hormones|mesh-ancestor
84090553|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090554|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090555|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84090556|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090557|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
84090558|NCT00607087|Insulin|insulin|mesh-list
84090559|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84090560|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
84090561|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
84090562|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
84090563|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84090564|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090565|NCT00610363|Rilonacept|rilonacept|mesh-list
84090566|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090567|NCT00887588|Valsartan|valsartan|mesh-list
84090568|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84090569|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84090570|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84090572|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090573|NCT00799383|Vitamin D|vitamin d|mesh-list
84090574|NCT00799383|Calcium|calcium|mesh-list
84090575|NCT00799383|Vitamins|vitamins|mesh-ancestor
84090576|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
84090577|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090578|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84090579|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84090580|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
84090581|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090582|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090583|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
84090584|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090585|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090586|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
84090587|NCT04114149|Narcotics|narcotics|mesh-ancestor
84090588|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090589|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090590|NCT04114149|Analgesics|analgesics|mesh-ancestor
84090591|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
84090592|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090593|NCT00891397|Pregabalin|pregabalin|mesh-list
84090594|NCT00891397|Analgesics|analgesics|mesh-ancestor
84090595|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
84090596|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090597|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090598|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
84090599|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84090600|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84090601|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090602|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84090603|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84090604|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84090605|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090606|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84090607|NCT02767596|Lixisenatide|lixisenatide|mesh-list
84090608|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84090609|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090610|NCT02826902|Remifentanil|remifentanil|mesh-list
84090611|NCT02826902|Propofol|propofol|mesh-list
84090612|NCT02826902|Desflurane|desflurane|mesh-list
84090613|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84090614|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090615|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090616|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84090617|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
84090618|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
84090619|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84090620|NCT02826902|Narcotics|narcotics|mesh-ancestor
84090621|NCT02826902|Analgesics|analgesics|mesh-ancestor
84090622|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
84090623|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090624|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84090625|NCT00798759|Travoprost|travoprost|mesh-list
84090626|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84090627|NCT00798759|Latanoprost|latanoprost|mesh-list
84090628|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84090629|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84090630|NCT00891475|Interferons|interferons|mesh-list
84090631|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
84090632|NCT00891475|Sunitinib|sunitinib|mesh-list
84090633|NCT00891475|Maleic acid|maleic acid|mesh-list
84090634|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090635|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
84090636|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090637|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
84090638|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090639|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84090640|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84090641|NCT00891475|Growth Substances|growth substances|mesh-ancestor
84090642|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
84090643|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84090644|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330628|NCT05066997|BB 1101|bb 1101|mesh-list
84090645|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090646|NCT00887432|Vitamin D|vitamin d|mesh-list
84090647|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
84090648|NCT00887432|Vitamins|vitamins|mesh-ancestor
84090649|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
84090650|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090651|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84090652|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84090653|NCT04222686|Losartan|losartan|mesh-list
84090654|NCT04222686|Perindopril|perindopril|mesh-list
84090655|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84090656|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84090657|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84090658|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84090659|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090660|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84090661|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
84090662|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090663|NCT04113915|Cyclosporine|cyclosporine|mesh-list
84090664|NCT04113915|Dexamethasone|dexamethasone|mesh-list
84090665|NCT04113915|Cyclosporins|cyclosporins|mesh-list
84090666|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090667|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
84090668|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090669|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84090670|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090671|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
84090672|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
84090673|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090674|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090675|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
84090676|NCT04113915|Hormones|hormones|mesh-ancestor
84090677|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090678|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84090679|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090680|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090681|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090682|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
84090683|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090684|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
84090685|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84090686|NCT03590821|Aspirin|aspirin|mesh-list
84090687|NCT03590821|Celecoxib|celecoxib|mesh-list
84090688|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84090689|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84090690|NCT03590821|Analgesics|analgesics|mesh-ancestor
84090691|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
84090692|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090693|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090694|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090695|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84090696|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84090697|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84090698|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090699|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84090700|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84090701|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090702|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
84090703|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84090704|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
84090705|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84090706|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84090707|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
84090708|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090709|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090710|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84090711|NCT02758470|Acetazolamide|acetazolamide|mesh-list
84090712|NCT02758470|Methazolamide|methazolamide|mesh-list
84090713|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
84090714|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84090715|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090716|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090717|NCT02758470|Diuretics|diuretics|mesh-ancestor
84090718|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
84090719|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090720|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
84090721|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84090722|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84090723|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090724|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
84090725|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
84090726|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
84090727|NCT02764008|Bupivacaine|bupivacaine|mesh-list
84090728|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
84090729|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
84090730|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090731|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090732|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
84090733|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090734|NCT00798603|Bevacizumab|bevacizumab|mesh-list
84090735|NCT00798603|Carboplatin|carboplatin|mesh-list
84090736|NCT00798603|Pemetrexed|pemetrexed|mesh-list
84090737|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84090738|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090739|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84090740|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84090741|NCT00798603|Growth Substances|growth substances|mesh-ancestor
84090742|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090743|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
84090744|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090745|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090746|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84090747|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84090748|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
84090749|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84090750|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84090751|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84090752|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84090753|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090754|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
84090755|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090756|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090757|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84090758|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090759|NCT00887354|Vitamin D|vitamin d|mesh-list
84090760|NCT00887354|Teriparatide|teriparatide|mesh-list
84090761|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
84090762|NCT00887354|Calcium|calcium|mesh-list
84090763|NCT00887354|Vitamins|vitamins|mesh-ancestor
84090764|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
84090765|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090766|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84090767|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84090768|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84090769|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84090770|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090771|NCT00951041|Vaccines|vaccines|mesh-list
84090772|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
84090773|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090774|NCT02832596|Norepinephrine|norepinephrine|mesh-list
84090775|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84090776|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84090777|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
84090778|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090779|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090780|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090781|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
84090782|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
84090783|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090784|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84090785|NCT02760420|Amoxicillin|amoxicillin|mesh-list
84090786|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090787|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090788|NCT04612530|Nivolumab|nivolumab|mesh-list
84090789|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84090790|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090791|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84090792|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090793|NCT00945815|Cytarabine|cytarabine|mesh-list
84090794|NCT00945815|Clofarabine|clofarabine|mesh-list
84090795|NCT00945815|Epratuzumab|epratuzumab|mesh-list
84090796|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84090797|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
84090798|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090799|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090800|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
84090801|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090802|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090803|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
84090804|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090805|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84090806|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
84090807|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84090808|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090809|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090810|NCT00798369|Triamcinolone|triamcinolone|mesh-list
84090811|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84090812|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84090813|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84090814|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84090815|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090816|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
84090817|NCT00798369|Hormones|hormones|mesh-ancestor
84090818|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090819|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090820|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090821|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
84090822|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090823|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090824|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
84090825|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84090826|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090827|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
84090828|NCT02760342|Metformin|metformin|mesh-list
84090829|NCT02760342|Peficitinib|peficitinib|mesh-list
84090830|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84090831|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090832|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090833|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090834|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090835|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
84090836|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
84090837|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
84090838|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84090839|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84090840|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84090841|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090842|NCT00894283|Enoxaparin|enoxaparin|mesh-list
84090843|NCT00894283|PENTA|penta|mesh-list
84090844|NCT00894283|Fondaparinux|fondaparinux|mesh-list
84090845|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
84090846|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84090847|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84090848|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090849|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84090850|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
84090851|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84090852|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
84090853|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090854|NCT00895609|Neostigmine|neostigmine|mesh-list
84090855|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84090856|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090857|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090858|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
84090859|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090860|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090861|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84090862|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
84090863|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090864|NCT00894439|Piperacillin|piperacillin|mesh-list
84090865|NCT00894439|BLI-489|bli-489|mesh-list
84090866|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84090867|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090868|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84090869|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090870|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090871|NCT04035889|Melatonin|melatonin|mesh-list
84090872|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
84090873|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090874|NCT04035889|Protective Agents|protective agents|mesh-ancestor
84090875|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090876|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84090877|NCT00895687|Bortezomib|bortezomib|mesh-list
84090878|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84090879|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090880|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84090881|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090882|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090883|NCT00798135|Itraconazole|itraconazole|mesh-list
84090884|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
84090885|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84090886|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84090887|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84090888|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090889|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090890|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84090891|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
84090892|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090893|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090894|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84090895|NCT02762838|Folic Acid|folic acid|mesh-list
84090896|NCT02762838|Infliximab|infliximab|mesh-list
84090897|NCT02762838|Methotrexate|methotrexate|mesh-list
84090898|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84090899|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
84090900|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84090901|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090902|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84090903|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
84090904|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090905|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090906|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
84090907|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090908|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84090909|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090910|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
84090911|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84090912|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84090913|NCT02762838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84090914|NCT02762838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090915|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090916|NCT02762838|Hematinics|hematinics|mesh-ancestor
84090917|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
84090918|NCT02762838|Vitamins|vitamins|mesh-ancestor
84090919|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
84090920|NCT02753166|Dexamethasone|dexamethasone|mesh-list
84090921|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84090922|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
84090923|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
84090924|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090925|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090926|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090927|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
84090928|NCT02753166|Hormones|hormones|mesh-ancestor
84090929|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090930|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84090931|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090932|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
84090933|NCT02753088|Mannitol|mannitol|mesh-list
84090934|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
84090935|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84090936|NCT02753088|Diuretics|diuretics|mesh-ancestor
84090937|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
84090938|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090939|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84090940|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
84090941|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84090942|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84090943|NCT02757534|Domperidone|domperidone|mesh-list
84090945|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
84090946|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090947|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090948|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090949|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84090950|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
84090951|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090952|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090953|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84090954|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84090955|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
84090956|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090957|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090958|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84090959|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
84090960|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84090961|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84090962|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84090963|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
84090964|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84090965|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090966|NCT00797823|Insulin|insulin|mesh-list
84090967|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84090968|NCT00797823|Glucagon|glucagon|mesh-list
84090969|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84090970|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090971|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090972|NCT00797823|Hormones|hormones|mesh-ancestor
84090973|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090974|NCT02757144|Esomeprazole|esomeprazole|mesh-list
84090975|NCT02757144|Fexuprazan|fexuprazan|mesh-list
84090976|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84090977|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84090978|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84090979|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090980|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090981|NCT04568616|Letrozole|letrozole|mesh-list
84090982|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84090983|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84090984|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84090985|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84090986|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84090987|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84090988|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
84090989|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84090990|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090991|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
84090992|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84090993|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
84090994|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84090995|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84090996|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84090997|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
84090998|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
84090999|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84091000|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
84091001|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091002|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091003|NCT00608881|Ubiquinone|ubiquinone|mesh-list
84091004|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
84091005|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
84091006|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091007|NCT00608881|Vitamins|vitamins|mesh-ancestor
84091008|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
84091009|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84091010|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091011|NCT04221906|Betamethasone|betamethasone|mesh-list
84091012|NCT04221906|Calcipotriene|calcipotriene|mesh-list
84091013|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84091014|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091015|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
84091016|NCT04221906|Hormones|hormones|mesh-ancestor
84091017|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84091018|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091019|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84091020|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
84091022|NCT00945191|Paclitaxel|paclitaxel|mesh-list
84091023|NCT00945191|Carboplatin|carboplatin|mesh-list
84091024|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84091025|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091026|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
84091027|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
84091028|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
84091029|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091030|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
84091031|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
84091032|NCT01082393|Tacrolimus|tacrolimus|mesh-list
84091033|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091034|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
84091035|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091036|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84091037|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091038|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091039|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091040|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
84091041|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84091042|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091043|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091044|NCT01082393|Analgesics|analgesics|mesh-ancestor
84091045|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
84091046|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091047|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091048|NCT02757066|Melatonin|melatonin|mesh-list
84091049|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
84091050|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091051|NCT02757066|Protective Agents|protective agents|mesh-ancestor
84091052|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091053|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091054|NCT00894673|Heparin|heparin|mesh-list
84091055|NCT00894673|Calcium heparin|calcium heparin|mesh-list
84091056|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
84091057|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84091058|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84091059|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091060|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84091061|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84091062|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84091063|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091064|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091065|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84091066|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84091067|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84091068|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
84091069|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091070|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091071|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84091072|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84091073|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
84091074|NCT02752308|Atropine|atropine|mesh-list
84091075|NCT02752308|Epinephrine|epinephrine|mesh-list
84091076|NCT02752308|Fentanyl|fentanyl|mesh-list
84091077|NCT02752308|Bupivacaine|bupivacaine|mesh-list
84091078|NCT02752308|Neostigmine|neostigmine|mesh-list
84091079|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
84091080|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
84091081|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091082|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091083|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
84091084|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091085|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84091086|NCT02752308|Narcotics|narcotics|mesh-ancestor
84091087|NCT02752308|Analgesics|analgesics|mesh-ancestor
84091088|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84091089|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84091090|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
84091091|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84091092|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84091093|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
84091094|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091095|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091096|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84091097|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84091098|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
84091099|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84091100|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
84091101|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
84091102|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
84091103|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84091104|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84091105|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
84091106|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84091107|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84091108|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
84091109|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84091110|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091111|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84091112|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
84091113|NCT00894751|Propofol|propofol|mesh-list
84091114|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84091115|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091116|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091117|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091118|NCT00894751|Analgesics|analgesics|mesh-ancestor
84091119|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
84091120|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091121|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84091122|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84091123|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84091124|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
84091125|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091126|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091127|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84091128|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
84091129|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
84091130|NCT00896077|Lisofylline|lisofylline|mesh-list
84091131|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84091132|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
84091133|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091134|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091135|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091136|NCT00896077|Analgesics|analgesics|mesh-ancestor
84091137|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
84091138|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091139|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091140|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091141|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091142|NCT00792909|Vaccines|vaccines|mesh-list
84091143|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84091144|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
84091145|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091146|NCT00896155|Tamoxifen|tamoxifen|mesh-list
84091147|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84091148|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
84091149|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84091150|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091151|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84091152|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091153|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84091154|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84091155|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84091156|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
84091157|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
84091158|NCT02751996|Tenofovir|tenofovir|mesh-list
84091159|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
84091160|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091161|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84091162|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84091163|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091164|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091165|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84091166|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84091167|NCT00944645|Niacin|niacin|mesh-list
84091168|NCT00944645|Niacinamide|niacinamide|mesh-list
84091170|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84091171|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
84091172|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091173|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84091174|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
84091175|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
84091176|NCT00944645|Vitamins|vitamins|mesh-ancestor
84091177|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
84091178|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091179|NCT02751918|Doxorubicin|doxorubicin|mesh-list
84091180|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84091181|NCT02751918|Maytansine|maytansine|mesh-list
84091182|NCT02751918|Anetumab ravtansine|anetumab ravtansine|mesh-list
84091183|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84091184|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091185|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84091186|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84091187|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091188|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091189|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84091190|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
84091191|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
84091192|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
84091193|NCT02751918|Immunoconjugates|immunoconjugates|mesh-ancestor
84091194|NCT02751918|Immunologic Factors|immunologic factors|mesh-ancestor
84091195|NCT02751918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091196|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
84091197|NCT00901069|Rituximab|rituximab|mesh-list
84091198|NCT00901069|Vincristine|vincristine|mesh-list
84091199|NCT00901069|Azacitidine|azacitidine|mesh-list
84091200|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091201|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
84091202|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091203|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091204|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84091205|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
84091206|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091207|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091208|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84091209|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84091210|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84091211|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
84091212|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
84091213|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
84091214|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091215|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
84091216|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091217|NCT02853539|Denosumab|denosumab|mesh-list
84091218|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84091219|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091220|NCT02751840|Caffeine|caffeine|mesh-list
84091221|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84091222|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091223|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84091224|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091225|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091226|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84091227|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84091228|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
84091229|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091230|NCT00894829|Heparin|heparin|mesh-list
84091231|NCT00894829|Calcium heparin|calcium heparin|mesh-list
84091232|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
84091233|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84091234|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84091235|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091236|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84091237|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
84091238|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091239|NCT00606229|Aripiprazole|aripiprazole|mesh-list
84091240|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
84091241|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84091242|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84091243|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84091244|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091245|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091246|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
84091247|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
84091248|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091249|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091250|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84091251|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84091252|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
84091253|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84091254|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84091255|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84091256|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84091257|NCT02756598|Sufentanil|sufentanil|mesh-list
84091258|NCT02756598|Dsuvia|dsuvia|mesh-list
84091259|NCT02756598|Propofol|propofol|mesh-list
84091260|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84091261|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091262|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091263|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84091264|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
84091265|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
84091266|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84091267|NCT02756598|Narcotics|narcotics|mesh-ancestor
84091268|NCT02756598|Analgesics|analgesics|mesh-ancestor
84091269|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
84091270|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091271|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84091272|NCT00950651|Tramadol|tramadol|mesh-list
84091273|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84091274|NCT00950651|Narcotics|narcotics|mesh-ancestor
84091275|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091276|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091277|NCT00950651|Analgesics|analgesics|mesh-ancestor
84091278|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
84091279|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091280|NCT00901147|Bortezomib|bortezomib|mesh-list
84091281|NCT00901147|Panobinostat|panobinostat|mesh-list
84091282|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091283|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84091284|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091285|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091286|NCT04268537|Antibodies|antibodies|mesh-list
84091287|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
84091288|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
84091289|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091290|NCT02756130|Carboplatin|carboplatin|mesh-list
84091291|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091292|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84091293|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84091294|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84091295|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84091296|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091297|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091298|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84091299|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84091300|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091301|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
84091302|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091303|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
84091304|NCT00605293|Hematinics|hematinics|mesh-ancestor
84091305|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84091306|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84091307|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
84091308|NCT05594589|Lemborexant|lemborexant|mesh-list
84091309|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84091310|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091311|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091312|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84091313|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84091314|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091315|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091316|NCT00602303|Torsemide|torsemide|mesh-list
84091317|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84091318|NCT00602303|Diuretics|diuretics|mesh-ancestor
84091319|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
84091320|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091321|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84091322|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84091323|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091325|NCT00631085|Vitamin E|vitamin e|mesh-list
84091326|NCT00631085|Tocotrienols|tocotrienols|mesh-list
84091327|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
84091328|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
84091329|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
84091330|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091331|NCT00631085|Protective Agents|protective agents|mesh-ancestor
84091332|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091333|NCT00631085|Vitamins|vitamins|mesh-ancestor
84091334|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
84091335|NCT04269863|Aspirin|aspirin|mesh-list
84091336|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091337|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091338|NCT04269863|Analgesics|analgesics|mesh-ancestor
84091339|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
84091340|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091341|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091342|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091343|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091344|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84091345|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84091346|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091347|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84091348|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84091349|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091350|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
84091351|NCT00901381|Lenograstim|lenograstim|mesh-list
84091352|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84091353|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
84091354|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091355|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
84091356|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
84091357|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84091358|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091359|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091360|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
84091361|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84091362|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091363|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091364|NCT02751528|Vaccines|vaccines|mesh-list
84091365|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
84091366|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091367|NCT00901537|Azacitidine|azacitidine|mesh-list
84091368|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091369|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091370|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
84091371|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091372|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091373|NCT00894985|Heparin|heparin|mesh-list
84091374|NCT00894985|Calcium heparin|calcium heparin|mesh-list
84091375|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
84091376|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84091377|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84091378|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091379|NCT04585152|Rituximab|rituximab|mesh-list
84091380|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84091381|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091382|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
84091383|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091384|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091385|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84091386|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091387|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
84091388|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84091389|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83429487|NCT00535925|Clonidine|clonidine|mesh-list
84091390|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091391|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
84091392|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331375|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091393|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091394|NCT02751294|Tafenoquine|tafenoquine|mesh-list
84091395|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
84091396|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84091397|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84091398|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091399|NCT00901615|Lenalidomide|lenalidomide|mesh-list
84091400|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
84091401|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091402|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84091403|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84091404|NCT00901615|Growth Substances|growth substances|mesh-ancestor
84091405|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
84091406|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091407|NCT00949325|Sirolimus|sirolimus|mesh-list
84091408|NCT00949325|Doxorubicin|doxorubicin|mesh-list
84091409|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84091410|NCT00949325|Temsirolimus|temsirolimus|mesh-list
84091411|NCT00949325|MTOR Inhibitors|mtor inhibitors|mesh-list
84091412|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84091413|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091414|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84091415|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84091416|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091417|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091418|NCT00949325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84091419|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091420|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
84091421|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091422|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84091423|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091424|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
84091425|NCT02853071|Estramustine|estramustine|mesh-list
84091426|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84091427|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
84091428|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091429|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091430|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84091431|NCT02603757|Vitamin D|vitamin d|mesh-list
84091432|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
84091433|NCT02603757|Vitamins|vitamins|mesh-ancestor
84091434|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
84091435|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091436|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84091437|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84091438|NCT02758782|Celecoxib|celecoxib|mesh-list
84091439|NCT02758782|Golimumab|golimumab|mesh-list
84091440|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091441|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091442|NCT02758782|Analgesics|analgesics|mesh-ancestor
84091443|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
84091444|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091445|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091446|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091447|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091448|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84091449|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84091450|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091451|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091452|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84091453|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091454|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
84091455|NCT04221672|Terlipressin|terlipressin|mesh-list
84091456|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84091457|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84091458|NCT00895297|Dasatinib|dasatinib|mesh-list
84091459|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091460|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84091461|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091462|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091463|NCT00943319|Fludarabine|fludarabine|mesh-list
84091464|NCT00943319|Busulfan|busulfan|mesh-list
84091465|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
84091466|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091467|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091468|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091469|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
84091470|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091471|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
84091472|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84091473|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84091474|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84091475|NCT02603991|Levetiracetam|levetiracetam|mesh-list
84091476|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
84091477|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
84091478|NCT02540785|Levofloxacin|levofloxacin|mesh-list
84091479|NCT02540785|Ofloxacin|ofloxacin|mesh-list
84091480|NCT02540785|Tobramycin|tobramycin|mesh-list
84091481|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
84091482|NCT02540785|Dexamethasone|dexamethasone|mesh-list
84091483|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
84091484|NCT02540785|BB 1101|bb 1101|mesh-list
84091485|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
84091486|NCT02540785|Dipivefrin|dipivefrin|mesh-list
84091487|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091488|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
84091489|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
84091490|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091491|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091492|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84091493|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
84091494|NCT02540785|Hormones|hormones|mesh-ancestor
84091495|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84091496|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84091497|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091498|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
84091499|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091500|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091501|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84091502|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091503|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84091504|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84091505|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84091506|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84091507|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84091508|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84091509|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
84091510|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
84091511|NCT02540785|Protective Agents|protective agents|mesh-ancestor
84091512|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84091513|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
84091514|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091515|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84091516|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84091517|NCT04243278|Aspirin|aspirin|mesh-list
84091518|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091519|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091520|NCT04243278|Analgesics|analgesics|mesh-ancestor
84091521|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
84091522|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091523|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091524|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091525|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091526|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84091527|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84091528|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091529|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84091530|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84091531|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091532|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
84091533|NCT00915369|Paclitaxel|paclitaxel|mesh-list
84091534|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84091535|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091536|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
84091537|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
84091538|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
84091539|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091540|NCT00901849|Sirolimus|sirolimus|mesh-list
84091541|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84091542|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84091543|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091544|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84091545|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091546|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
84091547|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091548|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
84091549|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091550|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84091551|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091552|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091553|NCT04243122|Aspirin|aspirin|mesh-list
84091554|NCT04243122|Apixaban|apixaban|mesh-list
84091555|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091556|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091557|NCT04243122|Analgesics|analgesics|mesh-ancestor
84091558|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
84091559|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091560|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091561|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091562|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091563|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84091564|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84091565|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091566|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84091567|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84091568|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091569|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
84091570|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84091571|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
84091572|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84091573|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
84091574|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
84091575|NCT04268927|Letrozole|letrozole|mesh-list
84091576|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
84091577|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
84091578|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091579|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84091580|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84091581|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091582|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091583|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84091584|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
84091585|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84091586|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091587|NCT04268927|Hormones|hormones|mesh-ancestor
84091588|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
84091589|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84091590|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84091591|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091592|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
84091593|NCT05429580|Coagulants|coagulants|mesh-ancestor
84091594|NCT00790647|Bortezomib|bortezomib|mesh-list
84091595|NCT00790647|Melphalan|melphalan|mesh-list
84091596|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
84091597|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091598|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091599|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84091600|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
84091601|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091602|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84091603|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091604|NCT00286013|Gemcitabine|gemcitabine|mesh-list
84091605|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
84091606|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091607|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
84091608|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091609|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091610|NCT02754882|Paclitaxel|paclitaxel|mesh-list
84091611|NCT02754882|Bevacizumab|bevacizumab|mesh-list
84091612|NCT02754882|Carboplatin|carboplatin|mesh-list
84091613|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84091614|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091615|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
84091616|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
83331599|NCT04333407|Atorvastatin|atorvastatin|mesh-list
84091617|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
84091618|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091619|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84091620|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84091621|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84091622|NCT02754882|Growth Substances|growth substances|mesh-ancestor
84091623|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091624|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
84091625|NCT00790569|Nicotine|nicotine|mesh-list
84091626|NCT00790569|Varenicline|varenicline|mesh-list
84091627|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84091628|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
84091629|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091630|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091631|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84091632|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84091633|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
84091634|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091635|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091636|NCT00939029|Nicotine|nicotine|mesh-list
84091637|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84091638|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
84091639|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091640|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091641|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84091642|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84091643|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
84091644|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091645|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091646|NCT00602615|Torsemide|torsemide|mesh-list
84091647|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84091648|NCT00602615|Diuretics|diuretics|mesh-ancestor
84091649|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
84091650|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091651|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84091652|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84091653|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091654|NCT00604253|Insulin|insulin|mesh-list
84091655|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84091656|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
84091657|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
84091658|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
84091659|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
84091660|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84091661|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091662|NCT02754960|Thalidomide|thalidomide|mesh-list
84091663|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091664|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
84091665|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091666|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
84091667|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84091668|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091669|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84091670|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84091671|NCT02754960|Growth Substances|growth substances|mesh-ancestor
84091672|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
84091673|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091674|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
84091675|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84091676|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091677|NCT02540239|Simethicone|simethicone|mesh-list
84091678|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
84091679|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091680|NCT02540239|Emollients|emollients|mesh-ancestor
84091681|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
84091682|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
84091683|NCT02540395|Prednisolone|prednisolone|mesh-list
84091684|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84091685|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
84091686|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84091687|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
84091688|NCT02540395|Tacrolimus|tacrolimus|mesh-list
84091689|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84091690|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
84091691|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091692|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
84091693|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091694|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84091695|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091696|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091697|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84091698|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091699|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84091700|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
84091701|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84091702|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091703|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091704|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
84091705|NCT02540395|Hormones|hormones|mesh-ancestor
84091706|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84091707|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84091708|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
84091709|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
84091710|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091711|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84091712|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84091713|NCT02540395|Protective Agents|protective agents|mesh-ancestor
84091714|NCT05565729|Levocetirizine|levocetirizine|mesh-list
84091715|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84091716|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84091717|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
84091718|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
84091719|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091720|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091721|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091722|NCT04547166|Bevacizumab|bevacizumab|mesh-list
84091723|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84091724|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091725|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84091726|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84091727|NCT04547166|Growth Substances|growth substances|mesh-ancestor
84091728|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091729|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
84091730|NCT00602693|Sirolimus|sirolimus|mesh-list
84091731|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
84091732|NCT00602693|Fludarabine|fludarabine|mesh-list
84091733|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
84091734|NCT00602693|Allopurinol|allopurinol|mesh-list
84091735|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091736|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
84091737|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091738|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091739|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84091740|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
84091741|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091742|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091743|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84091744|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091745|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
84091746|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84091747|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091748|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84091749|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
84091750|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091751|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
84091752|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84091753|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
84091754|NCT00602693|Protective Agents|protective agents|mesh-ancestor
84091755|NCT00902395|Midazolam|midazolam|mesh-list
84091756|NCT00902395|Ketamine|ketamine|mesh-list
84091757|NCT00902395|Analgesics|analgesics|mesh-ancestor
84091758|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
84091759|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091760|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091761|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84091762|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84091763|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
84091764|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
84091765|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091766|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84091767|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84091768|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091769|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091770|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84091771|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84091772|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84091773|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84091774|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84091775|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
84091776|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
84091777|NCT04213404|Spartalizumab|spartalizumab|mesh-list
84091778|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84091779|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091780|NCT04213404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84091781|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091782|NCT00604409|Capecitabine|capecitabine|mesh-list
84091783|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091784|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
84091785|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091786|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091787|NCT00905905|Simvastatin|simvastatin|mesh-list
84091788|NCT00905905|Ezetimibe|ezetimibe|mesh-list
84091789|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
84091790|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84091791|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84091792|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
84091793|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091794|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84091795|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84091796|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091797|NCT00902473|Topiramate|topiramate|mesh-list
84091798|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
84091799|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84091800|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091801|NCT05177484|Ferric maltol|ferric maltol|mesh-list
84091802|NCT05177484|Hematinics|hematinics|mesh-ancestor
84091803|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
84091804|NCT04104789|Tetracaine|tetracaine|mesh-list
84091805|NCT04104789|Carticaine|carticaine|mesh-list
84091806|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
84091807|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
84091808|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091809|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091810|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
84091811|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091812|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84091813|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84091814|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
84091815|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091816|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091817|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
84091818|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
84091819|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
84091820|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84091821|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
84091822|NCT00938717|Linaclotide|linaclotide|mesh-list
84091823|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84091824|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
84091825|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091826|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84091827|NCT00905983|Gemcitabine|gemcitabine|mesh-list
84091828|NCT00905983|Docetaxel|docetaxel|mesh-list
84091829|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091830|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
84091831|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091832|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091833|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
84091834|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
84091835|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
84091836|NCT00906061|Gemcitabine|gemcitabine|mesh-list
84091837|NCT00906061|Docetaxel|docetaxel|mesh-list
84091838|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091839|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
84091840|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091841|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091842|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
84091843|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
84091844|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
84091845|NCT02602509|Rifampin|rifampin|mesh-list
84091846|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
84091847|NCT02602509|Celecoxib|celecoxib|mesh-list
84091848|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091849|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091850|NCT02602509|Analgesics|analgesics|mesh-ancestor
84091851|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
84091852|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091853|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091854|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091855|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091856|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84091857|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84091858|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091859|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091860|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84091861|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
84091862|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84091863|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84091864|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
84091865|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84091866|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84091867|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84091868|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84091869|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84091870|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84091871|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84091872|NCT02852837|Daratumumab|daratumumab|mesh-list
84091873|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091874|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
84091875|NCT00897871|Carboplatin|carboplatin|mesh-list
84091876|NCT00897871|Etoposide|etoposide|mesh-list
84091877|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
84091878|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091879|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
84091880|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091881|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091882|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84091883|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
84091884|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091885|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091886|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84091887|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84091888|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84091889|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84091890|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091891|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
84091892|NCT00902707|Guaifenesin|guaifenesin|mesh-list
84091893|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
84091894|NCT00902707|Expectorants|expectorants|mesh-ancestor
84091895|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
84091896|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84091897|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84091898|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
84091899|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091900|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091901|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091902|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
84091903|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84091904|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
84091905|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
84091906|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091907|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
84091908|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84091909|NCT00906139|Fentanyl|fentanyl|mesh-list
84091910|NCT00906139|Midazolam|midazolam|mesh-list
84091911|NCT00906139|Propofol|propofol|mesh-list
84091912|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84091913|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84091914|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091915|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84091916|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
84091917|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
84091918|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84091919|NCT00906139|Narcotics|narcotics|mesh-ancestor
84091920|NCT00906139|Analgesics|analgesics|mesh-ancestor
84091921|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
84091922|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091923|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84091924|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84091925|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84091926|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84091927|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
84091928|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
84091929|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091930|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091931|NCT00906295|Chrysarobin|chrysarobin|mesh-list
84091932|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84091933|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84091934|NCT00906295|Analgesics|analgesics|mesh-ancestor
84091935|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
84091936|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84091937|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091938|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84091939|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84091940|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
84091941|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84091942|NCT02754102|Protective Agents|protective agents|mesh-ancestor
84091943|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091944|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
84091945|NCT00134303|Metformin|metformin|mesh-list
84091946|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84091947|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091948|NCT00902941|Rasagiline|rasagiline|mesh-list
84091949|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84091950|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091951|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091952|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84091953|NCT00902941|Protective Agents|protective agents|mesh-ancestor
84091954|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091955|NCT02754258|Methylphenidate|methylphenidate|mesh-list
84091956|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84091957|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091958|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84091959|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84091960|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84091961|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091962|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
84091963|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091964|NCT04267991|Tacrolimus|tacrolimus|mesh-list
84091965|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84091966|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
84091967|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091968|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84091969|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84091970|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091971|NCT02852681|Drospirenone|drospirenone|mesh-list
84091972|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84091973|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
84091974|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84091975|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091976|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84091977|NCT02852681|Diuretics|diuretics|mesh-ancestor
84091978|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
84091979|NCT02754180|Gemcitabine|gemcitabine|mesh-list
84091980|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84091981|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
84091982|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091983|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84091984|NCT00602849|Sertraline|sertraline|mesh-list
84091985|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
84091986|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84091987|NCT00602849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84091988|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84091989|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84091990|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091991|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84091992|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
84091993|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84091994|NCT00906451|Simvastatin|simvastatin|mesh-list
84091995|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84091996|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84091997|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
84091998|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84091999|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84092000|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84092001|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092002|NCT00898417|Paclitaxel|paclitaxel|mesh-list
84092003|NCT00898417|Bevacizumab|bevacizumab|mesh-list
84092004|NCT00898417|Carboplatin|carboplatin|mesh-list
84092005|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84092006|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092007|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
84092008|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
84092009|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
84092010|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092011|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092012|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84092013|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84092014|NCT00898417|Growth Substances|growth substances|mesh-ancestor
84092015|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092016|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
84092017|NCT05381363|Interferons|interferons|mesh-list
84092018|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092019|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
84092020|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092021|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
84092022|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
84092023|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84092024|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092025|NCT00783705|Inositol|inositol|mesh-list
84092026|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
84092027|NCT00783705|Vitamins|vitamins|mesh-ancestor
84092028|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
84092029|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092030|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84092031|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84092032|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84092033|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092034|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092035|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
84092036|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092037|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84092038|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84092039|NCT04103697|Capecitabine|capecitabine|mesh-list
84092040|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
84092041|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84092042|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
84092043|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092044|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092045|NCT00898573|Lapatinib|lapatinib|mesh-list
84092046|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092047|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84092048|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092049|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092050|NCT04321668|Hylan|hylan|mesh-list
84092051|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
84092052|NCT04321668|Protective Agents|protective agents|mesh-ancestor
84092053|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092054|NCT02851745|Linagliptin|linagliptin|mesh-list
84092055|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84092056|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092057|NCT02851745|Incretins|incretins|mesh-ancestor
84092058|NCT02851745|Hormones|hormones|mesh-ancestor
84092059|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092060|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84092061|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
84092062|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092063|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092064|NCT02602197|Acetaminophen|acetaminophen|mesh-list
84092065|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84092066|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092067|NCT02602197|Analgesics|analgesics|mesh-ancestor
84092068|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
84092069|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092070|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092071|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
84092072|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84092073|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092074|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092075|NCT02753712|Fluticasone|fluticasone|mesh-list
84092076|NCT02753712|Xhance|xhance|mesh-list
84092077|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
84092078|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092079|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84092080|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
84092081|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092082|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092083|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84092084|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
84092085|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
84092086|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84092087|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84092088|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84092089|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84092090|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
84092091|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092092|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092093|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
84092094|NCT04220892|Pemetrexed|pemetrexed|mesh-list
84092095|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092096|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092097|NCT04220892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84092098|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092099|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092100|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84092101|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84092102|NCT02696148|Liraglutide|liraglutide|mesh-list
84092103|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84092104|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092105|NCT02696148|Incretins|incretins|mesh-ancestor
84092106|NCT02696148|Hormones|hormones|mesh-ancestor
84092107|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092108|NCT00887198|Prednisone|prednisone|mesh-list
84092109|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
84092110|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092111|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
84092112|NCT00887198|Hormones|hormones|mesh-ancestor
84092113|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092114|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092115|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84092116|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092117|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84092118|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092119|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092120|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
84092121|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84092122|NCT04342585|Progesterone|progesterone|mesh-list
84092123|NCT04342585|Progestins|progestins|mesh-ancestor
84092124|NCT04342585|Hormones|hormones|mesh-ancestor
84092125|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092126|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092127|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84092128|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092129|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092130|NCT00782067|Midostaurin|midostaurin|mesh-list
84092131|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092132|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84092133|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092134|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092135|NCT05520723|Loperamide|loperamide|mesh-list
84092136|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
84092137|NCT05520723|Lenograstim|lenograstim|mesh-list
84092138|NCT05520723|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84092139|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84092140|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
84092141|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092142|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092143|NCT05520723|Immunoconjugates|immunoconjugates|mesh-ancestor
84092144|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
84092145|NCT02826746|Analgesics|analgesics|mesh-ancestor
84092146|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
84092147|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092148|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092149|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
84092150|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092151|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84092152|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
84092153|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84092154|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092155|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092156|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84092157|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
84092158|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84092159|NCT02750904|Nicotine|nicotine|mesh-list
84092160|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84092161|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
84092162|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092163|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092164|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84092165|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84092166|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
84092167|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092168|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092169|NCT02831972|Itraconazole|itraconazole|mesh-list
84092170|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
84092171|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092172|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84092173|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84092174|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092175|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092176|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84092177|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
84092178|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092179|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092180|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84092181|NCT02695758|Bupivacaine|bupivacaine|mesh-list
84092182|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
84092183|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
84092184|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092185|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092186|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
84092187|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092188|NCT00605215|Interferons|interferons|mesh-list
84092189|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
84092190|NCT00605215|Interferon-beta|interferon-beta|mesh-list
84092191|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092192|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
84092193|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092194|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84092195|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
84092196|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092197|NCT02827682|Anesthetics|anesthetics|mesh-list
84092198|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092199|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092200|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
84092201|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
84092202|NCT04244708|Temozolomide|temozolomide|mesh-list
84092203|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84092204|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
84092205|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092206|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092207|NCT02750748|Naltrexone|naltrexone|mesh-list
84092208|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84092209|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84092210|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092211|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
84092212|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092213|NCT00604279|Risperidone|risperidone|mesh-list
84092214|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84092215|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84092216|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
84092217|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092218|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092219|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092220|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84092221|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84092222|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092223|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84092224|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84092225|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
84092226|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84092227|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84092228|NCT00635856|Gefitinib|gefitinib|mesh-list
84092229|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092230|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84092231|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092232|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092233|NCT00906685|Bevacizumab|bevacizumab|mesh-list
84092234|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092235|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092236|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84092237|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84092238|NCT00906685|Growth Substances|growth substances|mesh-ancestor
84092239|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092240|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
84092241|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
84092242|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84092243|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84092244|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092245|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84092246|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84092247|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092248|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092249|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092250|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84092251|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
84092252|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84092253|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092254|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84092255|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84092256|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84092257|NCT02695212|Apremilast|apremilast|mesh-list
84092258|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84092259|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092260|NCT02695212|Analgesics|analgesics|mesh-ancestor
84092261|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
84092262|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092263|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092264|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092265|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092266|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84092267|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84092268|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092269|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092270|NCT05381207|Fluticasone|fluticasone|mesh-list
84092271|NCT05381207|Xhance|xhance|mesh-list
84092272|NCT05381207|Montelukast|montelukast|mesh-list
84092273|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092274|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84092275|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
84092276|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092277|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092278|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84092279|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
84092280|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
84092281|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84092282|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84092283|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
84092284|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092285|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84092286|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84092287|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092288|NCT02750670|Dexamethasone|dexamethasone|mesh-list
84092289|NCT02750670|Gemcitabine|gemcitabine|mesh-list
84092290|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
84092291|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092292|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
84092293|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
84092294|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092295|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092296|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092297|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
84092298|NCT02750670|Hormones|hormones|mesh-ancestor
84092299|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092300|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84092301|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092302|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84092303|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
84092304|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092305|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092306|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84092307|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84092308|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
84092309|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092310|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092311|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84092312|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
84092313|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84092314|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84092315|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84092316|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
84092317|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092318|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092319|NCT05122208|Famotidine|famotidine|mesh-list
84092320|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84092321|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092322|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84092323|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
84092324|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
84092325|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092326|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092327|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092328|NCT00781911|Octreotide|octreotide|mesh-list
84092329|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092330|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84092331|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092332|NCT00605917|Sertraline|sertraline|mesh-list
84092333|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
84092334|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84092335|NCT00605917|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84092336|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84092337|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092338|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092339|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092340|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
84092341|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092342|NCT04919096|Aflibercept|aflibercept|mesh-list
84092343|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84092344|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84092345|NCT04919096|Growth Substances|growth substances|mesh-ancestor
84092346|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092347|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
84092348|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092349|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84092350|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84092351|NCT00781599|Varenicline|varenicline|mesh-list
84092352|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84092353|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84092354|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
84092355|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092356|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092357|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092358|NCT00904111|Lidocaine|lidocaine|mesh-list
84092359|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
84092360|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
84092361|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092362|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092363|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
84092364|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092365|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84092366|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84092367|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84092368|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092369|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092370|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
84092371|NCT03240211|Decitabine|decitabine|mesh-list
84092372|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092373|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092374|NCT03240211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84092375|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092376|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84092377|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
84092378|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092379|NCT04278144|Nivolumab|nivolumab|mesh-list
84092380|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092381|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092382|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84092383|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092384|NCT00899197|Tamoxifen|tamoxifen|mesh-list
84092385|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84092386|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
84092387|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092388|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092389|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84092390|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092391|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84092392|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84092393|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84092394|NCT00603083|Ketorolac|ketorolac|mesh-list
84092395|NCT00603083|Ropivacaine|ropivacaine|mesh-list
84092396|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
84092397|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
84092398|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092399|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092400|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
84092401|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092402|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84092403|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092404|NCT00603083|Analgesics|analgesics|mesh-ancestor
84092405|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092406|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092407|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84092408|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092409|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092410|NCT05379257|Furosemide|furosemide|mesh-list
84092411|NCT05379257|Diuretics|diuretics|mesh-ancestor
84092412|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
84092413|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092414|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84092415|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092416|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092417|NCT04241744|Vancomycin|vancomycin|mesh-list
84092418|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84092419|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092420|NCT02824094|Crizotinib|crizotinib|mesh-list
84092421|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092422|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84092423|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092424|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092425|NCT00899587|Enalapril|enalapril|mesh-list
84092426|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84092427|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
84092428|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092429|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092430|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84092431|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84092432|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83332411|NCT01041274|Citalopram|citalopram|mesh-list
84092433|NCT02824406|Acetazolamide|acetazolamide|mesh-list
84092434|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
84092435|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84092436|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092437|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092438|NCT02824406|Diuretics|diuretics|mesh-ancestor
84092439|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
84092440|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092441|NCT04267679|Cannabidiol|cannabidiol|mesh-list
84092442|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
84092443|NCT04951388|Somatomedin B|somatomedin b|mesh-list
84092444|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84092445|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84092446|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
84092447|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092448|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092449|NCT04242914|Midazolam|midazolam|mesh-list
84092450|NCT04242914|Ketamine|ketamine|mesh-list
84092451|NCT04242914|Analgesics|analgesics|mesh-ancestor
84092452|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
84092453|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092454|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092455|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84092456|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84092457|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
84092458|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
84092459|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092460|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84092461|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84092462|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092463|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092464|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84092465|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84092466|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84092467|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84092468|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84092469|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
84092470|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
84092471|NCT00780273|Cimetidine|cimetidine|mesh-list
84092472|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84092473|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092474|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84092475|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
84092476|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
84092477|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092478|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092479|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092480|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84092481|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84092482|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092483|NCT02827136|Lidocaine|lidocaine|mesh-list
84092484|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
84092485|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
84092486|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092487|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092488|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
84092489|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092490|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84092491|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84092492|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84092493|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092494|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092495|NCT04102995|Pregnanolone|pregnanolone|mesh-list
84092496|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
84092497|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092498|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092499|NCT00899821|Aldesleukin|aldesleukin|mesh-list
84092500|NCT00899821|Interleukin-12|interleukin-12|mesh-list
84092501|NCT00899821|Sargramostim|sargramostim|mesh-list
84092502|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
84092503|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092504|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092505|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84092506|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84092507|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
84092508|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092509|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84092510|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84092511|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84092512|NCT00899821|Growth Substances|growth substances|mesh-ancestor
84092513|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
84092515|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092516|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092517|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
84092518|NCT04163406|Trace Elements|trace elements|mesh-ancestor
84092519|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
84092520|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092521|NCT04218552|Amlodipine|amlodipine|mesh-list
84092522|NCT04218552|Telmisartan|telmisartan|mesh-list
84092523|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84092524|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84092525|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092526|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092527|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84092528|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092529|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
84092530|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84092531|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84092532|NCT00904657|Sunitinib|sunitinib|mesh-list
84092533|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092534|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84092535|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84092536|NCT00904657|Growth Substances|growth substances|mesh-ancestor
84092537|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092538|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
84092539|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84092540|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092541|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092542|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
84092543|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
84092544|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092545|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84092546|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092547|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092548|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
84092549|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84092550|NCT02823626|Spironolactone|spironolactone|mesh-list
84092551|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84092552|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
84092553|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092554|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092555|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84092556|NCT02823626|Diuretics|diuretics|mesh-ancestor
84092557|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
84092558|NCT00779259|Quinine|quinine|mesh-list
84092559|NCT00779259|Theophylline|theophylline|mesh-list
84092560|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84092561|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
84092562|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092563|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092564|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84092565|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
84092566|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84092567|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092568|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092569|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
84092570|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84092571|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84092572|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
84092573|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092574|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
84092575|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84092576|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84092577|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092578|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84092579|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84092580|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092581|NCT00779259|Analgesics|analgesics|mesh-ancestor
84092582|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
84092583|NCT02746380|Adalimumab|adalimumab|mesh-list
84092584|NCT02746380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84092585|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092586|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092587|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
84092588|NCT02745990|Hematinics|hematinics|mesh-ancestor
84092589|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84092590|NCT00915915|Gestodene|gestodene|mesh-list
84092591|NCT00915915|Femovan|femovan|mesh-list
84092592|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84092593|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84092594|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84092595|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
84092596|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84092597|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092598|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84092599|NCT00915915|Estrogens|estrogens|mesh-ancestor
84092600|NCT00915915|Hormones|hormones|mesh-ancestor
84092601|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092602|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84092603|NCT00915915|Progestins|progestins|mesh-ancestor
84092604|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84092605|NCT02538367|Prucalopride|prucalopride|mesh-list
84092606|NCT02538367|YH12852|yh12852|mesh-list
84092607|NCT02538367|Laxatives|laxatives|mesh-ancestor
84092608|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092609|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
84092610|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84092611|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
84092612|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092613|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092614|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092615|NCT00900445|Prednisone|prednisone|mesh-list
84092616|NCT00900445|Prednisolone|prednisolone|mesh-list
84092617|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84092618|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
84092619|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84092620|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
84092621|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
84092622|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84092623|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84092624|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84092625|NCT00900445|Cortisone|cortisone|mesh-list
84092626|NCT00900445|Vincristine|vincristine|mesh-list
84092627|NCT00900445|Daunorubicin|daunorubicin|mesh-list
84092628|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84092629|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
84092630|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092631|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
84092632|NCT00900445|Hormones|hormones|mesh-ancestor
84092633|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092634|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092635|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84092636|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092637|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84092638|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
84092639|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
84092640|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
84092641|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092642|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
84092643|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
84092644|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092645|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092646|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84092647|NCT00900445|Protective Agents|protective agents|mesh-ancestor
84092648|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84092649|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84092650|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84092651|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092652|NCT03994419|Anesthetics|anesthetics|mesh-list
84092653|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092654|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092655|NCT00936065|Etanercept|etanercept|mesh-list
84092656|NCT00936065|Acitretin|acitretin|mesh-list
84092657|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84092658|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092659|NCT00936065|Analgesics|analgesics|mesh-ancestor
84092660|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
84092661|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092662|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092663|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092664|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092665|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092666|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84092667|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
84092668|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
84092669|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
84092670|NCT04241276|Paclitaxel|paclitaxel|mesh-list
84092671|NCT04241276|Gemcitabine|gemcitabine|mesh-list
84092672|NCT04241276|Tretinoin|tretinoin|mesh-list
84092673|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84092674|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092675|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
84092676|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
84092677|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
84092678|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092679|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84092680|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
84092681|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
84092682|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
84092683|NCT00905047|Leucovorin|leucovorin|mesh-list
84092684|NCT00905047|Folic Acid|folic acid|mesh-list
84092685|NCT00905047|Tegafur|tegafur|mesh-list
84092686|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
84092687|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84092688|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
84092689|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092690|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092691|NCT00905047|Antidotes|antidotes|mesh-ancestor
84092692|NCT00905047|Protective Agents|protective agents|mesh-ancestor
84092693|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092694|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
84092695|NCT00905047|Vitamins|vitamins|mesh-ancestor
84092696|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
84092697|NCT00905047|Hematinics|hematinics|mesh-ancestor
84092698|NCT04102449|Apremilast|apremilast|mesh-list
84092699|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84092700|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092701|NCT04102449|Analgesics|analgesics|mesh-ancestor
84092702|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
84092703|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092704|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092705|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092706|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092707|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84092708|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84092709|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092710|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092711|NCT02823236|Triamcinolone|triamcinolone|mesh-list
84092712|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84092713|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84092714|NCT02823236|Pirfenidone|pirfenidone|mesh-list
84092715|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84092716|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092717|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
84092718|NCT02823236|Hormones|hormones|mesh-ancestor
84092719|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092720|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092721|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332711|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83332712|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
83332713|NCT01133158|Hormones|hormones|mesh-ancestor
83332714|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332715|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332716|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83332717|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
83332718|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332719|NCT01133158|Analgesics|analgesics|mesh-ancestor
83332720|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
83332721|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84092722|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
84092723|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092724|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092725|NCT02823236|Analgesics|analgesics|mesh-ancestor
84092726|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
84092727|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092728|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84092729|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092730|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092731|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092732|NCT00633698|Niacin|niacin|mesh-list
84092733|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
84092734|NCT00633698|Niacinamide|niacinamide|mesh-list
84092735|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84092736|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
84092737|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092738|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84092739|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
84092740|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
84092741|NCT00633698|Vitamins|vitamins|mesh-ancestor
84092742|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
84092743|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092744|NCT02825342|Citalopram|citalopram|mesh-list
84092745|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84092746|NCT02825342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84092747|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84092748|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092749|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092750|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092751|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
84092752|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092753|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84092754|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
84092755|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84092756|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092757|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
84092758|NCT02749890|Lixisenatide|lixisenatide|mesh-list
84092759|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84092760|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092761|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
84092762|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84092763|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84092764|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092765|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84092766|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092767|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84092768|NCT04242758|Diuretics|diuretics|mesh-ancestor
84092769|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
84092770|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84092771|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092772|NCT02745912|Metformin|metformin|mesh-list
84092773|NCT02745912|Naltrexone|naltrexone|mesh-list
84092774|NCT02745912|Bupropion|bupropion|mesh-list
84092775|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84092776|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092777|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84092778|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84092779|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
84092780|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092781|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84092782|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
84092783|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84092784|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84092785|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84092786|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092787|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092788|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
84092789|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092790|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84092791|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84092792|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092793|NCT02825186|Dexamethasone|dexamethasone|mesh-list
83332788|NCT05376228|Vancomycin|vancomycin|mesh-list
83332789|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83332790|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332791|NCT05164848|Afatinib|afatinib|mesh-list
83332796|NCT05164770|Prednisone|prednisone|mesh-list
84092794|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092796|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
84092797|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092798|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092799|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092800|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
84092801|NCT02825186|Hormones|hormones|mesh-ancestor
84092802|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092803|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84092804|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092805|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84092806|NCT00604825|Estrogens|estrogens|mesh-ancestor
84092807|NCT00604825|Hormones|hormones|mesh-ancestor
84092808|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092809|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092810|NCT04239560|Boron|boron|mesh-list
84092811|NCT04239560|Trace Elements|trace elements|mesh-ancestor
84092812|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
84092813|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092814|NCT04218162|Lasmiditan|lasmiditan|mesh-list
84092815|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84092816|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
84092817|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092818|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092819|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092820|NCT00606125|Sorafenib|sorafenib|mesh-list
84092821|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092822|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84092823|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092824|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092825|NCT04242212|Misoprostol|misoprostol|mesh-list
84092826|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84092827|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
84092828|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84092829|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092830|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84092831|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092832|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
84092833|NCT02851433|Anesthetics|anesthetics|mesh-list
84092834|NCT02851433|Propofol|propofol|mesh-list
84092835|NCT02851433|Sevoflurane|sevoflurane|mesh-list
84092836|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092837|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092838|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84092839|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84092840|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
84092841|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84092842|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84092843|NCT05629806|Metformin|metformin|mesh-list
84092844|NCT05629806|Pioglitazone|pioglitazone|mesh-list
84092845|NCT05629806|Acarbose|acarbose|mesh-list
84092846|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84092847|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092848|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84092849|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092850|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092851|NCT02745756|Vaccines|vaccines|mesh-list
84092852|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
84092853|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092854|NCT04242368|Fluticasone|fluticasone|mesh-list
84092855|NCT04242368|Xhance|xhance|mesh-list
84092856|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092857|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84092858|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
84092859|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092860|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092861|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84092862|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
84092863|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
84092864|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84092865|NCT04217148|Dexamethasone|dexamethasone|mesh-list
84092866|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
84092867|NCT04217148|Tretinoin|tretinoin|mesh-list
84092868|NCT04217148|BB 1101|bb 1101|mesh-list
84092869|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092870|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
84092871|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
84092872|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092873|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092874|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092875|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
84092876|NCT04217148|Hormones|hormones|mesh-ancestor
84092877|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092878|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84092879|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092880|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
84092881|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092882|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092883|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
84092884|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
84092885|NCT00900913|Ropivacaine|ropivacaine|mesh-list
84092886|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
84092887|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
84092888|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84092889|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092890|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
84092891|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092892|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
84092893|NCT04216836|Antacids|antacids|mesh-ancestor
84092894|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092895|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84092896|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
84092897|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
84092898|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84092899|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
84092900|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092901|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84092902|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092903|NCT04034173|Leucovorin|leucovorin|mesh-list
84092904|NCT04034173|Folic Acid|folic acid|mesh-list
84092905|NCT04034173|Irinotecan|irinotecan|mesh-list
84092906|NCT04034173|Panitumumab|panitumumab|mesh-list
84092907|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
84092908|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84092909|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84092910|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092911|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092912|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092913|NCT04034173|Antidotes|antidotes|mesh-ancestor
84092914|NCT04034173|Protective Agents|protective agents|mesh-ancestor
84092915|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092916|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
84092917|NCT04034173|Vitamins|vitamins|mesh-ancestor
84092918|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
84092919|NCT04034173|Hematinics|hematinics|mesh-ancestor
84092920|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092921|NCT00606203|Milnacipran|milnacipran|mesh-list
84092922|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
84092923|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84092924|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84092925|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092926|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092927|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092928|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092929|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84092930|NCT00606203|Analgesics|analgesics|mesh-ancestor
84092931|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
84092932|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84092933|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
84092934|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84092935|NCT02539849|Adalimumab|adalimumab|mesh-list
84092936|NCT02539849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84092937|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092938|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84092939|NCT02749578|Atorvastatin|atorvastatin|mesh-list
84092940|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84092941|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84092942|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
84092943|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092944|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84092945|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84092946|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092948|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84092949|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84092950|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84092951|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84092952|NCT05378867|Growth Substances|growth substances|mesh-ancestor
84092953|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092954|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
84092955|NCT02749656|Desoximetasone|desoximetasone|mesh-list
84092956|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84092957|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
84092958|NCT02749656|Hormones|hormones|mesh-ancestor
84092959|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84092960|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092961|NCT00603317|Amoxicillin|amoxicillin|mesh-list
84092962|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
84092963|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
84092964|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84092965|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84092966|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84092967|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84092968|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092969|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84092970|NCT02745522|Oxytocin|oxytocin|mesh-list
84092971|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
84092972|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84092973|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092974|NCT02824718|Teriparatide|teriparatide|mesh-list
84092975|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
84092976|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
84092977|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
84092978|NCT02824718|Diuretics|diuretics|mesh-list
84092979|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
84092980|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84092981|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092982|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84092983|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
84092984|NCT02824718|Vitamins|vitamins|mesh-ancestor
84092985|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
84092986|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092987|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092988|NCT05378711|Fluoxetine|fluoxetine|mesh-list
84092989|NCT05378711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84092990|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84092991|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84092992|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84092993|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84092994|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
84092995|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84092996|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84092997|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
84092998|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84092999|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84093000|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84093001|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093002|NCT00777153|Cediranib|cediranib|mesh-list
84093003|NCT00777153|Lomustine|lomustine|mesh-list
84093004|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093005|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84093006|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093007|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093008|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84093009|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
84093010|NCT02821520|Verteporfin|verteporfin|mesh-list
84093011|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84093012|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
84093013|NCT00604955|Paromomycin|paromomycin|mesh-list
84093014|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093015|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093016|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84093017|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84093018|NCT04266509|Rifampin|rifampin|mesh-list
84093019|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84093020|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
84093021|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093022|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093023|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
84093024|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84093025|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093026|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093027|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84093028|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84093029|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84093030|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84093031|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84093032|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84093033|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84093034|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84093035|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093036|NCT02824874|Incretins|incretins|mesh-ancestor
84093037|NCT02824874|Hormones|hormones|mesh-ancestor
84093038|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093039|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84093040|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
84093041|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093042|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093043|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
84093044|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84093045|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
84093046|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093047|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
84093048|NCT04204265|Protective Agents|protective agents|mesh-ancestor
84093049|NCT04267913|Dexamethasone|dexamethasone|mesh-list
84093050|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
84093051|NCT04267913|Docetaxel|docetaxel|mesh-list
84093052|NCT04267913|Ramucirumab|ramucirumab|mesh-list
84093053|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84093054|NCT04267913|Antibodies|antibodies|mesh-list
84093055|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
84093056|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84093057|NCT04267913|Lexatumumab|lexatumumab|mesh-list
84093058|NCT04267913|BB 1101|bb 1101|mesh-list
84093059|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
84093060|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093061|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093062|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
84093063|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
84093064|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093065|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84093066|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
84093067|NCT04267913|Hormones|hormones|mesh-ancestor
84093068|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093069|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093070|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093071|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
84093072|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093073|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093074|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
84093075|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
84093076|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
84093077|NCT04216758|Paclitaxel|paclitaxel|mesh-list
84093078|NCT04216758|Gemcitabine|gemcitabine|mesh-list
84093079|NCT04216758|Tegafur|tegafur|mesh-list
84093080|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84093081|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093082|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
84093083|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
84093084|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
84093085|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093086|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093087|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
84093088|NCT00606437|Fludarabine|fludarabine|mesh-list
84093089|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093090|NCT02538211|Vaccines|vaccines|mesh-list
84093091|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84093092|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
84093093|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093094|NCT02821676|Anesthetics|anesthetics|mesh-list
83333095|NCT01093690|Metoclopramide|metoclopramide|mesh-list
84093095|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093096|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093097|NCT02745054|Anticoagulants|anticoagulants|mesh-list
84093098|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
84093099|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
84093100|NCT00908089|Prednisolone|prednisolone|mesh-list
84093101|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84093102|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
84093103|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84093104|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
84093105|NCT00908089|Infliximab|infliximab|mesh-list
84093106|NCT00908089|Naltrexone|naltrexone|mesh-list
84093107|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84093108|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
84093109|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093110|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
84093111|NCT00908089|Hormones|hormones|mesh-ancestor
84093112|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093113|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093114|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093115|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093116|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
84093117|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
84093118|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093119|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84093120|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84093121|NCT00908089|Protective Agents|protective agents|mesh-ancestor
84093122|NCT00908089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84093123|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
84093124|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093125|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093126|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84093127|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84093128|NCT00908089|Analgesics|analgesics|mesh-ancestor
84093129|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
84093130|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84093131|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84093132|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
84093133|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84093134|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84093135|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093136|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093137|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84093138|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84093139|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093140|NCT05378555|Ketamine|ketamine|mesh-list
84093141|NCT05378555|Analgesics|analgesics|mesh-ancestor
84093142|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
84093143|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093144|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093145|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84093146|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84093147|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
84093148|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
84093149|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093150|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84093151|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84093152|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093153|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093154|NCT03553446|Sevoflurane|sevoflurane|mesh-list
84093155|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84093156|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84093157|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
84093158|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
84093159|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093160|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093161|NCT00908167|Cytarabine|cytarabine|mesh-list
84093162|NCT00908167|Clofarabine|clofarabine|mesh-list
84093163|NCT00908167|Sorafenib|sorafenib|mesh-list
84093164|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093165|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
84093166|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093167|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093168|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
84093169|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093170|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093171|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
84093172|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093173|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84093175|NCT02821052|Insulin|insulin|mesh-list
84093176|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
84093177|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84093178|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093179|NCT05659628|Tislelizumab|tislelizumab|mesh-list
84093180|NCT05659628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84093181|NCT05659628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093182|NCT00606515|Paclitaxel|paclitaxel|mesh-list
84093183|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84093184|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84093185|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093186|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
84093187|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
84093188|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
84093189|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093190|NCT00908323|Vaccines|vaccines|mesh-list
84093191|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
84093192|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093193|NCT02749032|Metformin|metformin|mesh-list
84093194|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84093195|NCT02749032|Vildagliptin|vildagliptin|mesh-list
84093196|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84093197|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093198|NCT02749032|Incretins|incretins|mesh-ancestor
84093199|NCT02749032|Hormones|hormones|mesh-ancestor
84093200|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093201|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84093202|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
84093203|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093204|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093205|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
84093206|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84093207|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84093208|NCT00908713|Prednisolone|prednisolone|mesh-list
84093209|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
84093210|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84093211|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
84093212|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093213|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
84093214|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
84093215|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093216|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093217|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84093218|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
84093219|NCT00908713|Hormones|hormones|mesh-ancestor
84093220|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093221|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84093222|NCT00908713|Protective Agents|protective agents|mesh-ancestor
84093223|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093224|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093225|NCT00908869|Interferons|interferons|mesh-list
84093226|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
84093227|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
84093228|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
84093229|NCT00908869|Vinorelbine|vinorelbine|mesh-list
84093230|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093231|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
84093232|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093233|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093234|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84093235|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
84093236|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093237|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093238|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84093239|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
84093240|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093241|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84093242|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
84093243|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
84093244|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
84093245|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
84093246|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
84093247|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84093248|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093249|NCT03465774|Doxycycline|doxycycline|mesh-list
84093250|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093251|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093252|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
84093253|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84093254|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84093255|NCT04240496|Clozapine|clozapine|mesh-list
84093256|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84093257|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
84093258|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093259|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093260|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093261|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84093262|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84093263|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093264|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84093265|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
84093266|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
84093267|NCT03450018|Gemcitabine|gemcitabine|mesh-list
84093268|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093269|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
84093270|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093271|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093272|NCT00909337|Bosentan|bosentan|mesh-list
84093273|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84093274|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84093275|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093276|NCT00909571|Tacrolimus|tacrolimus|mesh-list
84093277|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093278|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
84093279|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093280|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84093281|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093282|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093283|NCT04015375|Dapsone|dapsone|mesh-list
84093284|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093285|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
84093286|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84093287|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84093288|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84093289|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093290|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093291|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
84093292|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093293|NCT04239794|Propofol|propofol|mesh-list
84093294|NCT04239794|Sevoflurane|sevoflurane|mesh-list
84093295|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84093296|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093297|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093298|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84093299|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
84093300|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
84093301|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84093302|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84093303|NCT02850887|Anesthetics|anesthetics|mesh-list
84093304|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093305|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093306|NCT00931645|Cytarabine|cytarabine|mesh-list
84093307|NCT00931645|Dexamethasone|dexamethasone|mesh-list
84093308|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
84093309|NCT00931645|Cisplatin|cisplatin|mesh-list
84093310|NCT00931645|Fludarabine|fludarabine|mesh-list
84093311|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093312|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
84093313|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093314|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093315|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84093316|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
84093317|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093318|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093319|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84093320|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333322|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
84093321|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
84093322|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
84093323|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093324|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84093325|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
84093327|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093328|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093329|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093330|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
84093331|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
84093332|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093333|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
84093334|NCT05658692|Dexamethasone|dexamethasone|mesh-list
84093335|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
84093336|NCT05658692|Simendan|simendan|mesh-list
84093337|NCT05658692|Dopamine|dopamine|mesh-list
84093338|NCT05658692|Isoproterenol|isoproterenol|mesh-list
84093339|NCT05658692|Olprinone|olprinone|mesh-list
84093340|NCT05658692|Epinephrine|epinephrine|mesh-list
84093341|NCT05658692|Norepinephrine|norepinephrine|mesh-list
84093342|NCT05658692|Metaraminol|metaraminol|mesh-list
84093343|NCT05658692|Midazolam|midazolam|mesh-list
84093344|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
84093345|NCT05658692|Bromides|bromides|mesh-list
84093346|NCT05658692|Propofol|propofol|mesh-list
84093347|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84093348|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84093349|NCT05658692|Simvastatin|simvastatin|mesh-list
84093350|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
84093351|NCT05658692|Succinylcholine|succinylcholine|mesh-list
84093352|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
84093353|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093354|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
84093355|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
84093356|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093357|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093358|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84093359|NCT05658692|Hormones|hormones|mesh-ancestor
84093360|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093361|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093362|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093363|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093364|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093365|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093366|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84093367|NCT05658692|Analgesics|analgesics|mesh-ancestor
84093368|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
84093369|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84093370|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84093371|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84093372|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
84093373|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093374|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84093375|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
84093376|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
84093377|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84093378|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84093379|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84093380|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84093381|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
84093382|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
84093383|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84093384|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84093385|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
84093386|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84093387|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84093388|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84093389|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84093390|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84093391|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
84093392|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
84093393|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
84093394|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84093395|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
84093396|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84093397|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
84093398|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84093399|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84093400|NCT05658692|Protective Agents|protective agents|mesh-ancestor
84093401|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
84093402|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
84093403|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84093404|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84093405|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84093406|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84093407|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84093408|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
84093409|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84093410|NCT02744508|Dexamethasone|dexamethasone|mesh-list
84093411|NCT02744508|Palonosetron|palonosetron|mesh-list
84093412|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093413|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
84093414|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
84093415|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093416|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093417|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84093418|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
84093419|NCT02744508|Hormones|hormones|mesh-ancestor
84093420|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093421|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093422|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093423|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84093424|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84093425|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
84093426|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093427|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093428|NCT00927511|Fulvestrant|fulvestrant|mesh-list
84093429|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093430|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093431|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84093432|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84093433|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
84093434|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093435|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093436|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
84093437|NCT04637594|Nivolumab|nivolumab|mesh-list
84093438|NCT04637594|Atezolizumab|atezolizumab|mesh-list
84093439|NCT04637594|Durvalumab|durvalumab|mesh-list
84093440|NCT04637594|Avelumab|avelumab|mesh-list
84093441|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84093442|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093443|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84093444|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093445|NCT03211338|Progesterone|progesterone|mesh-list
84093446|NCT03211338|Mitogens|mitogens|mesh-list
84093447|NCT03211338|Progestins|progestins|mesh-ancestor
84093448|NCT03211338|Hormones|hormones|mesh-ancestor
84093449|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093450|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093451|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
84093452|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093453|NCT00936611|Panobinostat|panobinostat|mesh-list
84093454|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093455|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84093456|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093457|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093458|NCT02744196|Methotrexate|methotrexate|mesh-list
84093459|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093460|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
84093461|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093462|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093463|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84093464|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
84093465|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84093466|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093467|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
84093468|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093469|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
84093470|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093471|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84093472|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093473|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84093474|NCT02139852|Capsaicin|capsaicin|mesh-list
84093475|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
84093476|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
84093477|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
84093478|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093479|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093480|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
84093482|NCT05379647|Fludarabine|fludarabine|mesh-list
84093483|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093484|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
84093485|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093486|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093487|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84093488|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
84093489|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093490|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093491|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84093492|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84093493|NCT02748330|Aspirin|aspirin|mesh-list
84093494|NCT02748330|Clopidogrel|clopidogrel|mesh-list
84093495|NCT02748330|Ticagrelor|ticagrelor|mesh-list
84093496|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84093497|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84093498|NCT02748330|Analgesics|analgesics|mesh-ancestor
84093499|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
84093500|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093501|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093502|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093503|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093504|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84093505|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84093506|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093507|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84093508|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84093509|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093510|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
84093511|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84093512|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84093513|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84093514|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
84093515|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093516|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
84093517|NCT05379569|Fludarabine|fludarabine|mesh-list
84093518|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093519|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
84093520|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093521|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093522|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84093523|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
84093524|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093525|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093526|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84093527|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
84093528|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84093529|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
84093530|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093531|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
84093532|NCT02818556|Protective Agents|protective agents|mesh-ancestor
84093533|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84093534|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093535|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84093536|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093537|NCT04627142|Irinotecan|irinotecan|mesh-list
84093538|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84093539|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84093540|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093541|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093542|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093543|NCT00936221|Dacarbazine|dacarbazine|mesh-list
84093544|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84093545|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
84093546|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093547|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093548|NCT00776919|Clindamycin|clindamycin|mesh-list
84093549|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
84093550|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
84093551|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84093552|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093553|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093554|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84093555|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093556|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093557|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
84093558|NCT05657678|Vitamin D|vitamin d|mesh-list
84093559|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
84093560|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
84093561|NCT05657678|Vitamins|vitamins|mesh-list
84093562|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
84093563|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093564|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84093565|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84093566|NCT02747940|Pregabalin|pregabalin|mesh-list
84093567|NCT02747940|Flunarizine|flunarizine|mesh-list
84093568|NCT02747940|Analgesics|analgesics|mesh-ancestor
84093569|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
84093570|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093571|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093572|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
84093573|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84093574|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093575|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093576|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84093577|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84093578|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84093579|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093580|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84093581|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84093582|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
84093583|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
84093584|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093585|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
84093586|NCT04238702|Empagliflozin|empagliflozin|mesh-list
84093587|NCT04238702|Losartan|losartan|mesh-list
84093588|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84093589|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84093590|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84093591|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84093592|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093593|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84093594|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84093595|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093596|NCT00603785|Omalizumab|omalizumab|mesh-list
84093597|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84093598|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84093599|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
84093600|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
84093601|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84093602|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
84093603|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093604|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093605|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84093606|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
84093607|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84093608|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84093609|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84093610|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
84093611|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093612|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093613|NCT05382923|Melatonin|melatonin|mesh-list
84093614|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
84093615|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093616|NCT05382923|Protective Agents|protective agents|mesh-ancestor
84093617|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093618|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093619|NCT02743572|Iron|iron|mesh-list
84093620|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84093621|NCT02743572|Trace Elements|trace elements|mesh-ancestor
84093622|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
84093623|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093624|NCT02743572|Hematinics|hematinics|mesh-ancestor
84093625|NCT00775593|Sirolimus|sirolimus|mesh-list
84093626|NCT00775593|Temsirolimus|temsirolimus|mesh-list
84093627|NCT00775593|MTOR Inhibitors|mtor inhibitors|mesh-list
84093628|NCT00775593|Clofarabine|clofarabine|mesh-list
84093629|NCT00775593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84093630|NCT00775593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093631|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093632|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093633|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
84093634|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093635|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093636|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093637|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093638|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84093639|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
84093640|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093641|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
84093642|NCT00606983|Tamsulosin|tamsulosin|mesh-list
84093643|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84093644|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84093645|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84093646|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
84093647|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093648|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093649|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093650|NCT00606983|Urological Agents|urological agents|mesh-ancestor
84093651|NCT02817932|Ranolazine|ranolazine|mesh-list
84093652|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84093653|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093654|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093655|NCT02743260|Metformin|metformin|mesh-list
84093656|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84093657|NCT02743260|Adefovir|adefovir|mesh-list
84093658|NCT02743260|Digoxin|digoxin|mesh-list
84093659|NCT02743260|Pitavastatin|pitavastatin|mesh-list
84093660|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84093661|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093662|NCT02743260|Incretins|incretins|mesh-ancestor
84093663|NCT02743260|Hormones|hormones|mesh-ancestor
84093664|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093665|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84093666|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
84093667|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093668|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093669|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84093670|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84093671|NCT02743260|Protective Agents|protective agents|mesh-ancestor
84093672|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
84093673|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093674|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84093675|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84093676|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84093677|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84093678|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84093679|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
84093680|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84093681|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
84093682|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093683|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
84093684|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093685|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093686|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84093687|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
84093688|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093689|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093690|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84093691|NCT02819648|Prednisolone|prednisolone|mesh-list
84093692|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
84093693|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093694|NCT02819648|Hormones|hormones|mesh-ancestor
84093695|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093696|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093697|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093698|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333689|NCT01106950|Fludarabine|fludarabine|mesh-list
84093699|NCT00934661|Morphine|morphine|mesh-list
84093700|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84093701|NCT00934661|Narcotics|narcotics|mesh-ancestor
84093702|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093703|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093704|NCT00934661|Analgesics|analgesics|mesh-ancestor
84093705|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
84093706|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093707|NCT02743182|Interferons|interferons|mesh-list
84093708|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
84093709|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
84093710|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84093711|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093712|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
84093713|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093714|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
84093715|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093716|NCT00775437|Adalimumab|adalimumab|mesh-list
84093717|NCT00775437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84093718|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093719|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093720|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
84093721|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84093722|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093723|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
84093724|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84093725|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093726|NCT02819414|Acetaminophen|acetaminophen|mesh-list
84093727|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84093728|NCT02819414|Analgesics|analgesics|mesh-ancestor
84093729|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
84093730|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093731|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093732|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
84093733|NCT02743104|Lidocaine|lidocaine|mesh-list
84093734|NCT02743104|Atropine|atropine|mesh-list
84093735|NCT02743104|Midazolam|midazolam|mesh-list
84093736|NCT02743104|Ketamine|ketamine|mesh-list
84093737|NCT02743104|Propofol|propofol|mesh-list
84093738|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
84093739|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
84093740|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093741|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093742|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
84093743|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093744|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84093745|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84093746|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84093747|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093748|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093749|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84093750|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84093751|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
84093752|NCT02743104|Analgesics|analgesics|mesh-ancestor
84093753|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84093754|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84093755|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84093756|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093757|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84093758|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84093759|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84093760|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84093761|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
84093762|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
84093763|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84093764|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
84093765|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84093766|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
84093767|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
84093768|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
84093769|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84093770|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84093771|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
84093772|NCT00775203|Trazodone|trazodone|mesh-list
84093773|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84093774|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84093775|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093776|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093777|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84093778|NCT00775203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84093779|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84093780|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093781|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093782|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093783|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
84093784|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84093785|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
84093786|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84093787|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
84093788|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093789|NCT00607217|Vaccines|vaccines|mesh-list
84093790|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
84093791|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093793|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84093794|NCT02747316|Trace Elements|trace elements|mesh-ancestor
84093795|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
84093796|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093797|NCT05648708|Bupivacaine|bupivacaine|mesh-list
84093798|NCT05648708|Prilocaine|prilocaine|mesh-list
84093799|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
84093800|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
84093801|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093802|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093803|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
84093804|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093805|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
84093806|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093807|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093808|NCT00636246|Sertraline|sertraline|mesh-list
84093809|NCT00636246|Reboxetine|reboxetine|mesh-list
84093810|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
84093811|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84093812|NCT00636246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84093813|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84093814|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093815|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093816|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093817|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
84093818|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093819|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84093820|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
84093821|NCT02819570|Ampicillin|ampicillin|mesh-list
84093822|NCT02819570|Cefuroxime|cefuroxime|mesh-list
84093823|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
84093824|NCT02819570|Roxithromycin|roxithromycin|mesh-list
84093825|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093826|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093827|NCT04239170|Gemcitabine|gemcitabine|mesh-list
84093828|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
84093829|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093830|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
84093831|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093832|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093833|NCT04480190|Gemcitabine|gemcitabine|mesh-list
84093834|NCT04480190|Fluorouracil|fluorouracil|mesh-list
84093835|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093836|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093837|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
84093838|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093839|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093840|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
84093841|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093842|NCT02741856|Paclitaxel|paclitaxel|mesh-list
84093843|NCT02741856|Carboplatin|carboplatin|mesh-list
84093844|NCT02741856|Capecitabine|capecitabine|mesh-list
84093845|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84093846|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093847|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
84093848|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
84093849|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
84093850|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093851|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093852|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
84093854|NCT02741232|Epinephrine|epinephrine|mesh-list
84093855|NCT02741232|Racepinephrine|racepinephrine|mesh-list
84093856|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
84093857|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
84093858|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
84093859|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093860|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093861|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
84093862|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093863|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84093864|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84093865|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84093866|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093867|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093868|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84093869|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84093870|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
84093871|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093872|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84093873|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84093874|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
84093875|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84093876|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
84093877|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
84093878|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
84093879|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84093880|NCT04237922|Clopidogrel|clopidogrel|mesh-list
84093881|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84093882|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84093883|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84093884|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84093885|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84093886|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
84093887|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093888|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093889|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093890|NCT04239014|Olaparib|olaparib|mesh-list
84093891|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84093892|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093893|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093894|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093895|NCT00568321|Tanezumab|tanezumab|mesh-list
84093896|NCT00568321|Analgesics|analgesics|mesh-ancestor
84093897|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
84093898|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093899|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093900|NCT02742480|Dabigatran|dabigatran|mesh-list
84093901|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
84093902|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
84093903|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84093904|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
84093905|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093906|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093907|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
84093908|NCT00774345|Lenalidomide|lenalidomide|mesh-list
84093909|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
84093910|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093911|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84093912|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84093913|NCT00774345|Growth Substances|growth substances|mesh-ancestor
84093914|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
84093915|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093916|NCT02819102|Berotralstat|berotralstat|mesh-list
84093917|NCT02819102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84093918|NCT02819102|Protease Inhibitors|protease inhibitors|mesh-ancestor
84093919|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093920|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093921|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
84093922|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093923|NCT02819180|Vaccines|vaccines|mesh-list
84093924|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
84093925|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093926|NCT04661930|Fenofibrate|fenofibrate|mesh-list
84093927|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84093928|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
84093929|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093930|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84093931|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
84093932|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84093933|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84093934|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84093935|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093936|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093937|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
84093938|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84093939|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093940|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84093941|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093942|NCT02601963|Minocycline|minocycline|mesh-list
84093943|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84093944|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84093945|NCT00927979|Ropivacaine|ropivacaine|mesh-list
84093946|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
84093947|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
84093948|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093949|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093950|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
84093951|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093952|NCT00931957|Prednisolone|prednisolone|mesh-list
84093953|NCT00931957|Etanercept|etanercept|mesh-list
84093954|NCT00931957|Methotrexate|methotrexate|mesh-list
84093955|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84093956|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
84093957|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84093958|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093959|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84093960|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
84093961|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093962|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84093963|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
84093964|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84093965|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84093966|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84093967|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
84093968|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84093969|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84093970|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84093971|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
84093972|NCT00931957|Hormones|hormones|mesh-ancestor
84093973|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84093974|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84093975|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093976|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84093977|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84093978|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84093979|NCT00931957|Analgesics|analgesics|mesh-ancestor
84093980|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
84093981|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
84093982|NCT02731950|Bupivacaine|bupivacaine|mesh-list
84093983|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
84093984|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
84093985|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84093986|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84093987|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
84093988|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84093989|NCT02731950|Analgesics|analgesics|mesh-ancestor
84093990|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84093991|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
84093992|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84093993|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84093994|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84093995|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84093996|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
84093997|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84093998|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
84093999|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84094000|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83333989|NCT03707028|Paclitaxel|paclitaxel|mesh-list
84094001|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84094002|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094003|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094004|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
84094005|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094006|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094007|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84094008|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094009|NCT00928213|Heparin|heparin|mesh-list
84094010|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84094011|NCT00928213|Tinzaparin|tinzaparin|mesh-list
84094012|NCT00928213|Dalteparin|dalteparin|mesh-list
84094013|NCT00928213|Progesterone|progesterone|mesh-list
84094014|NCT00928213|Hormones|hormones|mesh-ancestor
84094015|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094016|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094017|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
84094018|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84094019|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84094020|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094021|NCT00928213|Progestins|progestins|mesh-ancestor
84094022|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84094023|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094024|NCT02736240|Vaccines|vaccines|mesh-list
84094025|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84094026|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
84094027|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094028|NCT02741154|Letrozole|letrozole|mesh-list
84094029|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84094030|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094031|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84094032|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84094033|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094034|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094035|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84094036|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094037|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094038|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094039|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
84094040|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84094041|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
84094042|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094043|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84094044|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84094045|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
84094046|NCT04287816|Antithrombins|antithrombins|mesh-list
84094047|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84094048|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
84094049|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094050|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094051|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
84094052|NCT04313790|Heparin|heparin|mesh-list
84094053|NCT04313790|Calcium heparin|calcium heparin|mesh-list
84094054|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
84094055|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84094056|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84094057|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094058|NCT02735928|Doxorubicin|doxorubicin|mesh-list
84094059|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094060|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84094061|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84094062|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84094063|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094064|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094065|NCT02731560|Rituximab|rituximab|mesh-list
84094066|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094067|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094068|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
84094069|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094070|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094071|NCT00773097|Poly ICLC|poly iclc|mesh-list
84094072|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
84094073|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
84094074|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094075|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
84094076|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094077|NCT02814110|Lenograstim|lenograstim|mesh-list
84094078|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84094079|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
84094080|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094081|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
84094082|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094083|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84094084|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094085|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094086|NCT04264481|Lidocaine|lidocaine|mesh-list
84094087|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
84094088|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
84094089|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094090|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094091|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
84094092|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094093|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84094094|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84094095|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84094096|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094097|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094098|NCT05303909|Gentamicins|gentamicins|mesh-list
84094099|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094100|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094101|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84094102|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094103|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094104|NCT04306692|Inositol|inositol|mesh-list
84094105|NCT04306692|Clomiphene|clomiphene|mesh-list
84094106|NCT04306692|Enclomiphene|enclomiphene|mesh-list
84094107|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
84094108|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84094109|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094110|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094111|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094112|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84094113|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
84094114|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094115|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84094116|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84094117|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
84094118|NCT04306692|Vitamins|vitamins|mesh-ancestor
84094119|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
84094120|NCT00772941|Varenicline|varenicline|mesh-list
84094121|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84094122|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84094123|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
84094124|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094125|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094126|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094127|NCT02735694|Cycloserine|cycloserine|mesh-list
84094128|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84094129|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094130|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84094131|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
84094132|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094133|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
84094134|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094135|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
84094136|NCT04717375|Cetuximab|cetuximab|mesh-list
84094137|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094138|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094139|NCT04717375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84094140|NCT04717375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094141|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
84094142|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84094143|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094144|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094145|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84094146|NCT04237532|Analgesics|analgesics|mesh-ancestor
84094147|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
84094148|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094149|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84094150|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84094151|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84094152|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
84094153|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094154|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094155|NCT02731092|Lactoferrin|lactoferrin|mesh-list
84094156|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094157|NCT00928837|Naproxen|naproxen|mesh-list
84094158|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84094159|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84094160|NCT00928837|Analgesics|analgesics|mesh-ancestor
84094161|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
84094162|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094163|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094164|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094165|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094166|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
84094167|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84094168|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094169|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094170|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
84094171|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84094172|NCT00925093|Vancomycin|vancomycin|mesh-list
84094173|NCT00925093|Linezolid|linezolid|mesh-list
84094174|NCT00925093|Teicoplanin|teicoplanin|mesh-list
84094175|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094176|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094177|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84094178|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094179|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094180|NCT01562977|Rituximab|rituximab|mesh-list
84094181|NCT01562977|Gemcitabine|gemcitabine|mesh-list
84094182|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
84094183|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094184|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094185|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
84094186|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094187|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094188|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84094189|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
84094190|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094191|NCT00607685|Fluorouracil|fluorouracil|mesh-list
84094192|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
84094193|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
84094194|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094195|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84094196|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094197|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84094198|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
84094199|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094200|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84094201|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
84094202|NCT00607685|Protective Agents|protective agents|mesh-ancestor
84094203|NCT05450718|Buprenorphine|buprenorphine|mesh-list
84094204|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84094205|NCT05450718|Naloxone|naloxone|mesh-list
84094206|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84094207|NCT05450718|Narcotics|narcotics|mesh-ancestor
84094208|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094209|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094210|NCT05450718|Analgesics|analgesics|mesh-ancestor
84094211|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
84094212|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094213|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84094214|NCT04265027|Opicapone|opicapone|mesh-list
84094215|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84094216|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094217|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094218|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84094219|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84094220|NCT00607763|Micafungin|micafungin|mesh-list
84094221|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
84094222|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094223|NCT00928915|Thrombin|thrombin|mesh-list
84094224|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
84094225|NCT00928915|Coagulants|coagulants|mesh-ancestor
84094226|NCT02814500|Amlodipine|amlodipine|mesh-list
84094228|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84094229|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84094230|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094231|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094232|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84094233|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094234|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
84094235|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84094236|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84094237|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
84094238|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84094239|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84094240|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094241|NCT00939341|Budesonide|budesonide|mesh-list
84094242|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
84094243|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84094244|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094245|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84094246|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
84094247|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094248|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094249|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84094250|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
84094251|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
84094252|NCT00939341|Hormones|hormones|mesh-ancestor
84094253|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094254|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84094255|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84094256|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84094257|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
84094258|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094259|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094260|NCT00925327|Riboflavin|riboflavin|mesh-list
84094261|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
84094262|NCT00925327|Vitamins|vitamins|mesh-ancestor
84094263|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
84094264|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094265|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84094266|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
84094267|NCT04237376|Tenofovir|tenofovir|mesh-list
84094268|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
84094269|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094270|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84094271|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84094272|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094273|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094274|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84094275|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84094276|NCT04015687|Lamotrigine|lamotrigine|mesh-list
84094277|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
84094278|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84094279|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094280|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094281|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84094282|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094283|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84094284|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84094285|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094286|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84094287|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84094288|NCT02739906|Insulin|insulin|mesh-list
84094289|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84094290|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
84094291|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84094292|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094293|NCT02739672|Amlodipine|amlodipine|mesh-list
84094294|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84094295|NCT02739672|Telmisartan|telmisartan|mesh-list
84094296|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
84094297|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84094298|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84094299|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094300|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094301|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84094302|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094304|NCT02739672|Diuretics|diuretics|mesh-ancestor
84094305|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
84094306|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84094307|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84094308|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84094309|NCT00932971|Tenofovir|tenofovir|mesh-list
84094310|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84094311|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
84094312|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
84094313|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
84094314|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
84094315|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094316|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84094317|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84094318|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094319|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094320|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84094321|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84094322|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
84094323|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094324|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094325|NCT05382143|Atosiban|atosiban|mesh-list
84094326|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094327|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094328|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094329|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
84094330|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094331|NCT00933049|Amoxicillin|amoxicillin|mesh-list
84094332|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84094333|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094334|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094335|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84094336|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
84094337|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84094338|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84094339|NCT05788458|Bupivacaine|bupivacaine|mesh-list
84094340|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
84094341|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
84094342|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094343|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094344|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
84094345|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094346|NCT05788393|Lidocaine|lidocaine|mesh-list
84094347|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
84094348|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
84094349|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
84094350|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094351|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094352|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
84094353|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094354|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84094355|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84094356|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84094357|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094358|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094359|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84094360|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84094361|NCT05788393|Analgesics|analgesics|mesh-ancestor
84094362|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84094363|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84094364|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84094365|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
84094366|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094367|NCT05788159|Lacosamide|lacosamide|mesh-list
84094368|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
84094369|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84094370|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84094371|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334365|NCT03444636|Fentanyl|fentanyl|mesh-list
84094372|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094373|NCT05788094|Chloroquine|chloroquine|mesh-list
84094374|NCT05788094|Piperaquine|piperaquine|mesh-list
84094375|NCT05788094|Artenimol|artenimol|mesh-list
84094376|NCT05788094|Tafenoquine|tafenoquine|mesh-list
84094377|NCT05788094|Amebicides|amebicides|mesh-ancestor
84094378|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84094379|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84094380|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094381|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
84094382|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094383|NCT05787925|Vitamin E|vitamin e|mesh-list
84094384|NCT05787925|Vitamins|vitamins|mesh-ancestor
84094385|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
84094386|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094387|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
84094388|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094389|NCT05787925|Protective Agents|protective agents|mesh-ancestor
84094390|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
84094391|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84094392|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
84094393|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094394|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
84094395|NCT05787912|Protective Agents|protective agents|mesh-ancestor
84094396|NCT05787808|Vitamin D|vitamin d|mesh-list
84094397|NCT05787808|Vitamins|vitamins|mesh-ancestor
84094398|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
84094399|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094400|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84094401|NCT05787743|Tocotrienols|tocotrienols|mesh-list
84094402|NCT05787743|Vitamin E|vitamin e|mesh-list
84094403|NCT05787743|Tocopherols|tocopherols|mesh-list
84094404|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
84094405|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094406|NCT05787743|Protective Agents|protective agents|mesh-ancestor
84094407|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094408|NCT05787743|Vitamins|vitamins|mesh-ancestor
84094409|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
84094410|NCT05787574|Dexamethasone|dexamethasone|mesh-list
84094411|NCT05787574|Fludarabine|fludarabine|mesh-list
84094412|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094413|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
84094414|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
84094415|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094416|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094417|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84094418|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
84094419|NCT05787574|Hormones|hormones|mesh-ancestor
84094420|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094421|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84094422|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094423|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
84094424|NCT05787535|Fludarabine|fludarabine|mesh-list
84094425|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84094426|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
84094427|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094428|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094429|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84094430|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
84094431|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094432|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094433|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84094434|NCT05787509|Progesterone|progesterone|mesh-list
84094435|NCT05787509|Progestins|progestins|mesh-ancestor
84094436|NCT05787509|Hormones|hormones|mesh-ancestor
84094437|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094438|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094439|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84094440|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84094441|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84094442|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
84094443|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094444|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84094445|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84094446|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334445|NCT01282138|Dextrans|dextrans|mesh-list
84094447|NCT05786950|Bromides|bromides|mesh-list
84094448|NCT05786950|Albuterol|albuterol|mesh-list
84094449|NCT05786950|Ipratropium|ipratropium|mesh-list
84094450|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
84094451|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84094452|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
84094453|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094454|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094455|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84094456|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
84094457|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
84094458|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094459|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84094460|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84094461|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84094462|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
84094463|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094464|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094465|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84094466|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
84094468|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
84094469|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
84094470|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094471|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
84094472|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094473|NCT05786885|Protective Agents|protective agents|mesh-ancestor
84094474|NCT05786859|Rifaximin|rifaximin|mesh-list
84094475|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094476|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094477|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84094478|NCT05786768|Rituximab|rituximab|mesh-list
84094479|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
84094480|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094481|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094482|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
84094483|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094484|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094485|NCT05786638|Immunomodulating Agents|immunomodulating agents|mesh-list
84094486|NCT05786638|Immunologic Factors|immunologic factors|mesh-ancestor
84094487|NCT05786638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094488|NCT05785897|Sirolimus|sirolimus|mesh-list
84094489|NCT05785897|Ticagrelor|ticagrelor|mesh-list
84094490|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84094491|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094492|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094493|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84094494|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094495|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094496|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84094497|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094498|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
84094499|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84094500|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
84094501|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84094502|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84094503|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84094504|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
84094505|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094506|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
84094507|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094508|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
84094509|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094510|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094511|NCT05784688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84094512|NCT05784688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094513|NCT05776459|Prednisolone|prednisolone|mesh-list
84094514|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094515|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
84094516|NCT05776459|Hormones|hormones|mesh-ancestor
84094517|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094518|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094519|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84094520|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094521|NCT05764044|Gemcitabine|gemcitabine|mesh-list
84094522|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334516|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094523|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84094524|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
84094525|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094526|NCT05739136|Norethindrone|norethindrone|mesh-list
84094527|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
84094528|NCT05739136|Estradiol|estradiol|mesh-list
84094529|NCT05739136|Relugolix|relugolix|mesh-list
84094530|NCT05739136|Estrogens|estrogens|mesh-ancestor
84094531|NCT05739136|Hormones|hormones|mesh-ancestor
84094532|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094533|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094534|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84094535|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
84094536|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094537|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84094538|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84094539|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84094540|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84094541|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
84094542|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094543|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
84094544|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
84094545|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84094546|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094547|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094548|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094549|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84094550|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094551|NCT05716295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094552|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094553|NCT05715216|Nivolumab|nivolumab|mesh-list
84094554|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094555|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094556|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84094557|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094558|NCT05708625|Doxycycline|doxycycline|mesh-list
84094559|NCT05708625|Voriconazole|voriconazole|mesh-list
84094560|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
84094561|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094562|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094563|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
84094564|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84094565|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84094566|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
84094567|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84094568|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84094569|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094570|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094571|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84094572|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094573|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094574|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094575|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84094576|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
84094577|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84094578|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
84094579|NCT05706844|Anesthetics|anesthetics|mesh-list
84094580|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094581|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094582|NCT05702827|Meloxicam|meloxicam|mesh-list
84094583|NCT05702827|Bupivacaine|bupivacaine|mesh-list
84094584|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
84094585|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
84094586|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094587|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094588|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
84094589|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094590|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84094591|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84094592|NCT05702827|Analgesics|analgesics|mesh-ancestor
84094593|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094594|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094595|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84094596|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84094597|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094598|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094600|NCT05685628|Antidotes|antidotes|mesh-ancestor
84094601|NCT05685628|Protective Agents|protective agents|mesh-ancestor
84094602|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094603|NCT05673889|Dabigatran|dabigatran|mesh-list
84094604|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
84094605|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84094606|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
84094607|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094608|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094609|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
84094610|NCT05654298|Sumatriptan|sumatriptan|mesh-list
84094611|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84094612|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84094613|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84094614|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
84094615|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094616|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094617|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094618|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
84094619|NCT05649293|Pyridoxal|pyridoxal|mesh-list
84094620|NCT05649293|Pyridoxine|pyridoxine|mesh-list
84094621|NCT05649293|Vitamins|vitamins|mesh-ancestor
84094622|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
84094623|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094624|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
84094625|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84094626|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84094627|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094628|NCT05639972|Aldesleukin|aldesleukin|mesh-list
84094629|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094630|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84094631|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84094632|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
84094633|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094634|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
84094635|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
84094636|NCT05622318|Tacrolimus|tacrolimus|mesh-list
84094637|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84094638|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
84094639|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094640|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094641|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84094642|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
84094643|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094644|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094645|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84094646|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84094647|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094648|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84094649|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84094650|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
84094651|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094652|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094653|NCT05618613|Onapristone|onapristone|mesh-list
84094654|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094655|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84094656|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
84094657|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094658|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094659|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094660|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094661|NCT05617963|Durvalumab|durvalumab|mesh-list
84094662|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094663|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094664|NCT05604560|Tislelizumab|tislelizumab|mesh-list
84094665|NCT05604560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094666|NCT05604560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094667|NCT05587036|Rifaximin|rifaximin|mesh-list
84094668|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094669|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094670|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84094671|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
84094672|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84094673|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094674|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84094675|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094677|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094678|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094679|NCT05561543|Peppermint oil|peppermint oil|mesh-list
84094680|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
84094681|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
84094682|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094683|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094684|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84094685|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
84094686|NCT05535309|Sulbactam|sulbactam|mesh-list
84094687|NCT05535309|Cefoperazone|cefoperazone|mesh-list
84094688|NCT05535309|Sulperazone|sulperazone|mesh-list
84094689|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094690|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094691|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84094692|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094693|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094694|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84094695|NCT05506046|Nicotine|nicotine|mesh-list
84094696|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84094697|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
84094698|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094699|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094700|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84094701|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84094702|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
84094703|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094704|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094705|NCT05503875|Adalimumab|adalimumab|mesh-list
84094706|NCT05503875|Methotrexate|methotrexate|mesh-list
84094707|NCT05503875|Ixekizumab|ixekizumab|mesh-list
84094708|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
84094709|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84094710|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
84094711|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094712|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094713|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84094714|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
84094715|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094716|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094717|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
84094718|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094719|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84094720|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84094721|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
84094722|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094723|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84094724|NCT05503875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84094725|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094726|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84094727|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
84094728|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84094729|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
84094730|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84094731|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
84094732|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094733|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094734|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
84094735|NCT05477823|Androgens|androgens|mesh-list
84094736|NCT05477823|Hormones|hormones|mesh-ancestor
84094737|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094738|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094739|NCT05452512|Vitamin D|vitamin d|mesh-list
84094740|NCT05452512|Vitamins|vitamins|mesh-list
84094741|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
84094742|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094743|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84094744|NCT05432089|Oxytocin|oxytocin|mesh-list
84094745|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
83334737|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
84094746|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094747|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094748|NCT05430399|Docetaxel|docetaxel|mesh-list
84094749|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094750|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
84094751|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
84094752|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
84094753|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094754|NCT05428826|Prednisone|prednisone|mesh-list
84094755|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094756|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
84094757|NCT05428826|Hormones|hormones|mesh-ancestor
84094758|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094759|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094760|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84094761|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094762|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
84094763|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84094764|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84094765|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094766|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
84094767|NCT05427513|Coagulants|coagulants|mesh-ancestor
84094768|NCT05411718|Aspirin|aspirin|mesh-list
84094769|NCT05411718|Naproxen|naproxen|mesh-list
84094770|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84094771|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84094772|NCT05411718|Analgesics|analgesics|mesh-ancestor
84094773|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
84094774|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094775|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094776|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094777|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094778|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84094779|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84094780|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094781|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84094782|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84094783|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094784|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
84094785|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
84094786|NCT05403723|Carboplatin|carboplatin|mesh-list
84094787|NCT05403723|Etoposide|etoposide|mesh-list
84094788|NCT05403723|Durvalumab|durvalumab|mesh-list
84094789|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094790|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84094791|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84094792|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84094793|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094794|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094795|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094796|NCT05386095|Bupivacaine|bupivacaine|mesh-list
84094797|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
84094798|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
84094799|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094800|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094801|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
84094802|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094803|NCT05360264|Decitabine|decitabine|mesh-list
84094804|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84094805|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
84094806|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094807|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094808|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094809|NCT05357482|Sirolimus|sirolimus|mesh-list
84094810|NCT05357482|Plerixafor|plerixafor|mesh-list
84094811|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
84094812|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
84094813|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
84094814|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094815|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094816|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094817|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84094818|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094819|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
84094820|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84094821|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094822|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094823|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094824|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
84094825|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84094826|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84094827|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84094828|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
84094829|NCT05323812|Edaravone|edaravone|mesh-list
84094830|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84094831|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
84094832|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094833|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84094834|NCT05323812|Protective Agents|protective agents|mesh-ancestor
84094835|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094836|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
84094837|NCT05321524|Cathartics|cathartics|mesh-ancestor
84094838|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84094839|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
84094840|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094841|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094842|NCT05286060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84094843|NCT05286060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094844|NCT05280496|Metformin|metformin|mesh-list
84094845|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84094846|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094847|NCT05280457|Nivolumab|nivolumab|mesh-list
84094848|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094849|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094850|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84094851|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094852|NCT05279937|Lidocaine|lidocaine|mesh-list
84094853|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84094854|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
84094855|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
84094856|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84094857|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094858|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
84094859|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094860|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84094861|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84094862|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84094863|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094864|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094865|NCT05247268|Letrozole|letrozole|mesh-list
84094866|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84094867|NCT05247268|Megestrol|megestrol|mesh-list
84094868|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
84094869|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
84094870|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094871|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84094872|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84094873|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094874|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094875|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84094876|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094877|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094878|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094879|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84094880|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84094881|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84094882|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
84094883|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84094884|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84094885|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84094886|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84094887|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84094888|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
84094889|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84094890|NCT05239546|Dostarlimab|dostarlimab|mesh-list
84094891|NCT05239546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094892|NCT05211804|Ranibizumab|ranibizumab|mesh-list
84094893|NCT05211804|Aflibercept|aflibercept|mesh-list
83334891|NCT04892940|Analgesics|analgesics|mesh-list
84094894|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094895|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84094896|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84094898|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094899|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
84094900|NCT05136560|Dexamethasone|dexamethasone|mesh-list
84094901|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
84094902|NCT05136560|BB 1101|bb 1101|mesh-list
84094903|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84094904|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
84094905|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
84094906|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84094907|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094908|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84094909|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
84094910|NCT05136560|Hormones|hormones|mesh-ancestor
84094911|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094912|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84094913|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094914|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
84094915|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094916|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094917|NCT05125016|Cemiplimab|cemiplimab|mesh-list
84094918|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094919|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094920|NCT05084586|Epirubicin|epirubicin|mesh-list
84094921|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84094922|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84094923|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094924|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84094925|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84094926|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094927|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094928|NCT05077085|Vancomycin|vancomycin|mesh-list
84094929|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094930|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094931|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
84094932|NCT05059626|Simvastatin|simvastatin|mesh-list
84094933|NCT05059626|Estrogens|estrogens|mesh-list
84094934|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84094935|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84094936|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
84094937|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094938|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84094939|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84094940|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094941|NCT05059626|Hormones|hormones|mesh-ancestor
84094942|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84094943|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094944|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84094945|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84094946|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
84094947|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84094948|NCT05035407|Aldesleukin|aldesleukin|mesh-list
84094949|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
84094950|NCT05035407|Fludarabine|fludarabine|mesh-list
84094951|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84094952|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
84094953|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094954|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84094955|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84094956|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
84094957|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094958|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094959|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84094960|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84094961|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84094962|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
84094963|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094964|NCT04975958|Atezolizumab|atezolizumab|mesh-list
84094965|NCT04975958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84094966|NCT04975958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334961|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094967|NCT04975958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84094968|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094969|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84094970|NCT04973930|Escitalopram|escitalopram|mesh-list
84094971|NCT04973930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84094972|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84094973|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84094974|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094975|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84094976|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
84094977|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094978|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84094979|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
84094980|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84094981|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84094982|NCT04972942|Daratumumab|daratumumab|mesh-list
84094983|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84094984|NCT04930744|Metformin|metformin|mesh-list
84094985|NCT04930744|Rifampin|rifampin|mesh-list
84094986|NCT04930744|Isoniazid|isoniazid|mesh-list
84094987|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
84094988|NCT04930744|Ethambutol|ethambutol|mesh-list
84094989|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84094990|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84094991|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84094992|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
84094993|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84094994|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84094995|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
84094996|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84094997|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84094998|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84094999|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84095000|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84095001|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84095002|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84095003|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84095004|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84095005|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84095006|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84095007|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
84095008|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84095009|NCT04884763|Erenumab|erenumab|mesh-list
84095010|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
84095011|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095012|NCT04884763|Analgesics|analgesics|mesh-ancestor
84095013|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
84095014|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095015|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095016|NCT04877093|Clonidine|clonidine|mesh-list
84095017|NCT04877093|Analgesics|analgesics|mesh-ancestor
84095018|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
84095019|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095020|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095021|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84095022|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
84095023|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
84095024|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84095025|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84095026|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84095027|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095028|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095029|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095030|NCT04866017|Durvalumab|durvalumab|mesh-list
84095031|NCT04866017|Tislelizumab|tislelizumab|mesh-list
84095032|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095033|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095034|NCT04850911|Ketamine|ketamine|mesh-list
84095035|NCT04850911|Analgesics|analgesics|mesh-ancestor
84095036|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
84095037|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095038|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095039|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84095040|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84095041|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
84095042|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
84095043|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84095044|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84095045|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84095046|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095047|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095048|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
84095049|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84095050|NCT04828694|Naltrexone|naltrexone|mesh-list
84095051|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84095052|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84095053|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095054|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
84095055|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095056|NCT04827056|Ethanol|ethanol|mesh-list
84095057|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
84095058|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84095059|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84095060|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095061|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095062|NCT04827056|Analgesics|analgesics|mesh-ancestor
84095063|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
84095064|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095065|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84095066|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84095067|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84095068|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095069|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095070|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095071|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84095072|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095073|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
84095074|NCT04807127|Durvalumab|durvalumab|mesh-list
84095075|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84095076|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095077|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095078|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095079|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
84095080|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84095081|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095082|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095083|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095084|NCT04759664|LUT014|lut014|mesh-list
84095085|NCT04759664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095086|NCT04759664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095087|NCT04759664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095088|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
84095089|NCT04746924|Tislelizumab|tislelizumab|mesh-list
84095090|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095091|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095092|NCT04746924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095093|NCT04746924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095094|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
84095095|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84095096|NCT04674813|Fludarabine|fludarabine|mesh-list
84095097|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095098|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
84095099|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095100|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095101|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095102|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
84095103|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095104|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095105|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84095106|NCT04642404|Cannabidiol|cannabidiol|mesh-list
84095107|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
84095108|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84095109|NCT04642352|Bupivacaine|bupivacaine|mesh-list
84095110|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
84095111|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
84095112|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335133|NCT01925547|Curcumin|curcumin|mesh-list
84095113|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095115|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095116|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095117|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
84095118|NCT04642352|Hormones|hormones|mesh-ancestor
84095119|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095120|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095121|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
84095122|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
84095123|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84095124|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
84095125|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095126|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84095127|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84095128|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84095129|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095130|NCT04598477|Prednisone|prednisone|mesh-list
84095131|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095132|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
84095133|NCT04598477|Hormones|hormones|mesh-ancestor
84095134|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095135|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095136|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84095137|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095138|NCT04594408|Epinephrine|epinephrine|mesh-list
84095139|NCT04594408|Racepinephrine|racepinephrine|mesh-list
84095140|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
84095141|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
84095142|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84095143|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84095144|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095145|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
84095146|NCT04594408|Coagulants|coagulants|mesh-ancestor
84095147|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84095148|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84095149|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095150|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095151|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095152|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84095153|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84095154|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
84095155|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095156|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84095157|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
84095158|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
84095159|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
84095160|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84095161|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
84095162|NCT04557215|Rifaximin|rifaximin|mesh-list
84095163|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84095164|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
84095165|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095166|NCT04557215|Expectorants|expectorants|mesh-ancestor
84095167|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
84095168|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84095169|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
84095170|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095171|NCT04557215|Protective Agents|protective agents|mesh-ancestor
84095172|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095173|NCT04557215|Antidotes|antidotes|mesh-ancestor
84095174|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095175|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84095176|NCT04498117|Paclitaxel|paclitaxel|mesh-list
84095177|NCT04498117|Carboplatin|carboplatin|mesh-list
84095178|NCT04498117|Oregovomab|oregovomab|mesh-list
84095179|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84095180|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095181|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095182|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095183|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095184|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095185|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095186|NCT04468230|Nicotine|nicotine|mesh-list
84095187|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84095188|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
84095189|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095190|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095192|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84095193|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
84095194|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095195|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095196|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
84095197|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095198|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095199|NCT04432857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095200|NCT04432857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095201|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84095202|NCT04423627|Clonidine|clonidine|mesh-list
84095203|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84095204|NCT04423627|Diuretics|diuretics|mesh-ancestor
84095205|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
84095206|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095207|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84095208|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84095209|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095210|NCT04423627|Analgesics|analgesics|mesh-ancestor
84095211|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
84095212|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095213|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
84095214|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
84095215|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84095216|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84095217|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84095218|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095219|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095220|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84095221|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84095222|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84095223|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84095224|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095225|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095226|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095227|NCT04395001|Analgesics|analgesics|mesh-ancestor
84095228|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
84095229|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095230|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
84095231|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84095232|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
84095233|NCT04391764|Naltrexone|naltrexone|mesh-list
84095234|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84095235|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84095236|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095237|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
84095238|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095239|NCT04339062|Sirolimus|sirolimus|mesh-list
84095240|NCT04339062|Prednisone|prednisone|mesh-list
84095241|NCT04339062|Everolimus|everolimus|mesh-list
84095242|NCT04339062|Cemiplimab|cemiplimab|mesh-list
84095243|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095244|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
84095245|NCT04339062|Hormones|hormones|mesh-ancestor
84095246|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095247|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095248|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84095249|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095250|NCT04339062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84095251|NCT04339062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095252|NCT04339062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095253|NCT04339062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095254|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095255|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
84095256|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095257|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095258|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84095259|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
84095260|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095261|NCT04318080|Tislelizumab|tislelizumab|mesh-list
84095262|NCT04318080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095263|NCT04318080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095265|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84095266|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
84095267|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
84095268|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84095269|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095270|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095271|NCT04305158|Analgesics|analgesics|mesh-ancestor
84095272|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
84095273|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095274|NCT04303195|Metopimazine|metopimazine|mesh-list
84095275|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
84095276|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
84095277|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095278|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095279|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84095280|NCT04300192|Vaccines|vaccines|mesh-list
84095281|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
84095282|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095283|NCT04292470|Amitriptyline|amitriptyline|mesh-list
84095284|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84095285|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
84095286|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84095287|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095288|NCT04292470|Analgesics|analgesics|mesh-ancestor
84095289|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
84095290|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095291|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095292|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84095293|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84095294|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84095295|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095296|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095297|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095298|NCT04208334|Curcumin|curcumin|mesh-list
84095299|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84095300|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095301|NCT04208334|Analgesics|analgesics|mesh-ancestor
84095302|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
84095303|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095304|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095305|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095306|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095307|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095308|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095309|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095310|NCT04158141|Cisplatin|cisplatin|mesh-list
84095311|NCT04158141|Carboplatin|carboplatin|mesh-list
84095312|NCT04158141|Pemetrexed|pemetrexed|mesh-list
84095313|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095314|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095315|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095316|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84095317|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84095318|NCT04080284|Niraparib|niraparib|mesh-list
84095319|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84095320|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095321|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095322|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095323|NCT04074967|Nivolumab|nivolumab|mesh-list
84095324|NCT04074967|Ipilimumab|ipilimumab|mesh-list
84095325|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095326|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095327|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095328|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095329|NCT04073797|Colchicine|colchicine|mesh-list
84095330|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
84095331|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095332|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095333|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095334|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095335|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095337|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
84095338|NCT04060017|Leucovorin|leucovorin|mesh-list
84095339|NCT04060017|Calcium|calcium|mesh-list
84095340|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
84095341|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84095342|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095343|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84095344|NCT04060017|Antidotes|antidotes|mesh-ancestor
84095345|NCT04060017|Protective Agents|protective agents|mesh-ancestor
84095346|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
84095347|NCT04060017|Vitamins|vitamins|mesh-ancestor
84095348|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
84095349|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
84095350|NCT04052334|Fludarabine|fludarabine|mesh-list
84095351|NCT04052334|Interleukin-2|interleukin-2|mesh-list
84095352|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095353|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
84095354|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095355|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095356|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095357|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
84095358|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095359|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095360|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84095361|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095362|NCT04052334|Analgesics|analgesics|mesh-ancestor
84095363|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
84095364|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095365|NCT04046549|Abatacept|abatacept|mesh-list
84095366|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095367|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095368|NCT04046549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095369|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095370|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095371|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
84095372|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095373|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095374|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
84095375|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
84095376|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095377|NCT04042935|Protective Agents|protective agents|mesh-ancestor
84095378|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095379|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
84095380|NCT04042935|Vitamins|vitamins|mesh-ancestor
84095381|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
84095382|NCT04027309|Midostaurin|midostaurin|mesh-list
84095383|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095384|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095385|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095386|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095387|NCT03988933|Rifampin|rifampin|mesh-list
84095388|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84095389|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
84095390|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095391|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095392|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
84095393|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84095394|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095395|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095396|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84095397|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84095398|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84095399|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84095400|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84095401|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84095402|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
84095403|NCT03958565|Denosumab|denosumab|mesh-list
84095404|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84095405|NCT03958565|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
84095406|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84095407|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095408|NCT03958565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095409|NCT03958565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095410|NCT03958565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095411|NCT03947385|Crizotinib|crizotinib|mesh-list
84095412|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095413|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095414|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095415|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095416|NCT03910452|Sirolimus|sirolimus|mesh-list
84095417|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
84095418|NCT03910452|Busulfan|busulfan|mesh-list
84095419|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
84095420|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095421|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
84095422|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095423|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095424|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095425|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
84095426|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095427|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095428|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84095429|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095430|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095431|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84095432|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
84095433|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095434|NCT03785925|Nivolumab|nivolumab|mesh-list
84095435|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095436|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095437|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095438|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095439|NCT03752398|Ipilimumab|ipilimumab|mesh-list
84095440|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095441|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095442|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095443|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095444|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
84095445|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
84095446|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095447|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095448|NCT03734692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095449|NCT03734692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095450|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
84095451|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095452|NCT03700476|Gemcitabine|gemcitabine|mesh-list
84095453|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095454|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84095455|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
84095456|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095457|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
84095458|NCT03644667|Prednisone|prednisone|mesh-list
84095459|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
84095460|NCT03644667|Tacrolimus|tacrolimus|mesh-list
84095461|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
84095462|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095463|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
84095464|NCT03644667|Hormones|hormones|mesh-ancestor
84095465|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095466|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095467|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84095468|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095469|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095470|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
84095471|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095472|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095473|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84095474|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84095475|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
84095476|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095477|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095478|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
84095479|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
84095480|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095481|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84095482|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83335482|NCT04072770|Caseins|caseins|mesh-list
84095483|NCT03644667|Protective Agents|protective agents|mesh-ancestor
84095484|NCT03638141|Durvalumab|durvalumab|mesh-list
84095485|NCT03638141|Ipilimumab|ipilimumab|mesh-list
84095486|NCT03638141|Tremelimumab|tremelimumab|mesh-list
84095487|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84095488|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095489|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095490|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
84095491|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095492|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095493|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095494|NCT03330106|Paclitaxel|paclitaxel|mesh-list
84095495|NCT03330106|Docetaxel|docetaxel|mesh-list
84095496|NCT03330106|Carboplatin|carboplatin|mesh-list
84095497|NCT03330106|Pevonedistat|pevonedistat|mesh-list
84095498|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84095499|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095500|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095501|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095502|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095503|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095504|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095505|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
84095506|NCT03239145|Trebananib|trebananib|mesh-list
84095507|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095508|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095509|NCT03239145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095510|NCT03239145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095511|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84095512|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84095513|NCT03239145|Growth Substances|growth substances|mesh-ancestor
84095514|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095515|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
84095516|NCT03164564|Tenofovir|tenofovir|mesh-list
84095517|NCT03164564|Emtricitabine|emtricitabine|mesh-list
84095518|NCT03164564|Cabotegravir|cabotegravir|mesh-list
84095519|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
84095520|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095521|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84095522|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84095523|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095524|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095525|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84095526|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84095527|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84095528|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84095529|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
84095530|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
84095531|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095532|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
84095533|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095534|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095535|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095536|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
84095537|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095538|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095539|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84095540|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095541|NCT03153410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095542|NCT03113422|Venetoclax|venetoclax|mesh-list
84095543|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095544|NCT03070886|Docetaxel|docetaxel|mesh-list
84095545|NCT03070886|Leuprolide|leuprolide|mesh-list
84095546|NCT03070886|Goserelin|goserelin|mesh-list
84095547|NCT03070886|Bicalutamide|bicalutamide|mesh-list
84095548|NCT03070886|Flutamide|flutamide|mesh-list
84095549|NCT03070886|Nilutamide|nilutamide|mesh-list
84095550|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095551|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095552|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095553|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095554|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095555|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84095556|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
84095557|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84095558|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095559|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84095560|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
84095561|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
84095562|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095563|NCT02987257|Cyclosporine|cyclosporine|mesh-list
84095564|NCT02987257|Etanercept|etanercept|mesh-list
84095565|NCT02987257|Cyclosporins|cyclosporins|mesh-list
84095566|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095567|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095568|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095569|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
84095570|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095571|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
84095572|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095573|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
84095574|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095575|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84095576|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84095577|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095578|NCT02987257|Analgesics|analgesics|mesh-ancestor
84095579|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
84095580|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095581|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095582|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84095583|NCT02913274|Paclitaxel|paclitaxel|mesh-list
84095584|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84095585|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095586|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095587|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095588|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095589|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095590|NCT02896335|Palbociclib|palbociclib|mesh-list
84095591|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095592|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095593|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095594|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095595|NCT02821754|Durvalumab|durvalumab|mesh-list
84095596|NCT02821754|Tremelimumab|tremelimumab|mesh-list
84095597|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095598|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095599|NCT02781883|Decitabine|decitabine|mesh-list
84095600|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84095601|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
84095602|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095603|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095604|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095605|NCT02772003|Interleukin-12|interleukin-12|mesh-list
84095606|NCT02772003|Vaccines|vaccines|mesh-list
84095607|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
84095608|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095609|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84095610|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84095611|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84095612|NCT02772003|Growth Substances|growth substances|mesh-ancestor
84095613|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
84095614|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095615|NCT02684162|Guadecitabine|guadecitabine|mesh-list
84095616|NCT02684162|Azacitidine|azacitidine|mesh-list
84095617|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095618|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84095619|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
84095620|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095621|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095622|NCT02619682|Lenalidomide|lenalidomide|mesh-list
84095623|NCT02619682|Ixazomib|ixazomib|mesh-list
84095624|NCT02619682|Glycine|glycine|mesh-list
84095625|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
84095626|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095627|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84095628|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84095629|NCT02619682|Growth Substances|growth substances|mesh-ancestor
84095630|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
84095631|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095632|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095633|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
84095634|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095635|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
84095636|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095638|NCT02617589|Temozolomide|temozolomide|mesh-list
84095639|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095640|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095641|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095642|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095643|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095644|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
84095645|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
84095646|NCT02540707|Mirabegron|mirabegron|mesh-list
84095647|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84095648|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84095649|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
84095650|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095651|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095652|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095653|NCT02540707|Urological Agents|urological agents|mesh-ancestor
84095654|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84095655|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84095656|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84095657|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095658|NCT02531932|Carboplatin|carboplatin|mesh-list
84095659|NCT02531932|Everolimus|everolimus|mesh-list
84095660|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095661|NCT02531932|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84095662|NCT02531932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095663|NCT02531932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095664|NCT02531932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095665|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095666|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
84095667|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095668|NCT02506959|Gemcitabine|gemcitabine|mesh-list
84095669|NCT02506959|Melphalan|melphalan|mesh-list
84095670|NCT02506959|Busulfan|busulfan|mesh-list
84095671|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
84095672|NCT02506959|Panobinostat|panobinostat|mesh-list
84095673|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
84095674|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84095675|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
84095676|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095677|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095678|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095679|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
84095680|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84095681|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095682|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
84095683|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095684|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84095685|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095686|NCT02504346|Osimertinib|osimertinib|mesh-list
84095687|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095688|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095689|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095690|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095691|NCT02345265|Olaparib|olaparib|mesh-list
84095692|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84095693|NCT02345265|Cediranib|cediranib|mesh-list
84095694|NCT02345265|Maleic acid|maleic acid|mesh-list
84095695|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095696|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095697|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095698|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095699|NCT02340169|Desoximetasone|desoximetasone|mesh-list
84095700|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095701|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
84095702|NCT02340169|Hormones|hormones|mesh-ancestor
84095703|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095704|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095705|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
84095706|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095707|NCT02317874|Paclitaxel|paclitaxel|mesh-list
84095708|NCT02317874|Carboplatin|carboplatin|mesh-list
84095709|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84095710|NCT02317874|Talazoparib|talazoparib|mesh-list
83335717|NCT03422796|Cilostazol|cilostazol|mesh-list
84095711|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84095712|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095713|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095714|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095715|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095716|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095717|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84095718|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095719|NCT02257528|Nivolumab|nivolumab|mesh-list
84095720|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84095721|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095722|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84095723|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095724|NCT02179086|Temozolomide|temozolomide|mesh-list
84095725|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095726|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
84095727|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095728|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095729|NCT02160015|Rituximab|rituximab|mesh-list
84095730|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84095731|NCT02160015|Lenalidomide|lenalidomide|mesh-list
84095732|NCT02160015|Antibodies|antibodies|mesh-list
84095733|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
84095734|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84095735|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
84095736|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095737|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095738|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095739|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84095740|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84095741|NCT02160015|Growth Substances|growth substances|mesh-ancestor
84095742|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
84095743|NCT01899326|Desipramine|desipramine|mesh-list
84095744|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095745|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84095746|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
84095747|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84095748|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095749|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095750|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84095751|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84095752|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84095753|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095754|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095755|NCT01856192|Prednisone|prednisone|mesh-list
84095756|NCT01856192|Cortisone|cortisone|mesh-list
84095757|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
84095758|NCT01856192|Rituximab|rituximab|mesh-list
84095759|NCT01856192|Doxorubicin|doxorubicin|mesh-list
84095760|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84095761|NCT01856192|Vincristine|vincristine|mesh-list
84095762|NCT01856192|Lenalidomide|lenalidomide|mesh-list
83429523|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
84095763|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84095764|NCT01856192|Antibodies|antibodies|mesh-list
84095765|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
84095766|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84095767|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095768|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
84095769|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095770|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095771|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095772|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
84095773|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095774|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095775|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84095776|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84095777|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84095778|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84095779|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095780|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095781|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
84095782|NCT01856192|Hormones|hormones|mesh-ancestor
84095783|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095784|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84095785|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84095787|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095788|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095789|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84095790|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84095791|NCT01856192|Growth Substances|growth substances|mesh-ancestor
84095792|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
84095793|NCT01849146|Temozolomide|temozolomide|mesh-list
84095794|NCT01849146|Adavosertib|adavosertib|mesh-list
84095795|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84095796|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
84095797|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095798|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095799|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095800|NCT01572480|Dexamethasone|dexamethasone|mesh-list
84095801|NCT01572480|Lenalidomide|lenalidomide|mesh-list
84095802|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095803|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
84095804|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
84095805|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095806|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095807|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84095808|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
84095809|NCT01572480|Hormones|hormones|mesh-ancestor
84095810|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095811|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84095812|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095813|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
84095814|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84095815|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84095816|NCT01572480|Growth Substances|growth substances|mesh-ancestor
84095817|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
84095818|NCT01515137|Sulindac|sulindac|mesh-list
84095819|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84095820|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095821|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095822|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095823|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095824|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84095825|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095826|NCT01515137|Analgesics|analgesics|mesh-ancestor
84095827|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
84095828|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095829|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095830|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84095831|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84095832|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84095833|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
84095834|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095835|NCT01375829|Sirolimus|sirolimus|mesh-list
84095836|NCT01375829|Temsirolimus|temsirolimus|mesh-list
84095837|NCT01375829|Epothilone B|epothilone b|mesh-list
84095838|NCT01375829|MTOR Inhibitors|mtor inhibitors|mesh-list
84095839|NCT01375829|Epothilones|epothilones|mesh-list
84095840|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095841|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095842|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84095843|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095844|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
84095845|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095846|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
84095847|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095848|NCT01375829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095849|NCT01375829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095850|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095851|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095852|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095853|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
84095854|NCT01126190|Docetaxel|docetaxel|mesh-list
84095855|NCT01126190|Doxorubicin|doxorubicin|mesh-list
84095856|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095857|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
84095858|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
84095859|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
83335872|NCT03427086|Biotin|biotin|mesh-list
84095860|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095861|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84095862|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84095863|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84095864|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095865|NCT00472654|Vitamin D|vitamin d|mesh-list
84095866|NCT00472654|Vitamins|vitamins|mesh-ancestor
84095867|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
84095868|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095869|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84095870|NCT00323037|Carvedilol|carvedilol|mesh-list
84095871|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84095872|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84095873|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095874|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095875|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095876|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095877|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84095878|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
84095879|NCT00323037|Protective Agents|protective agents|mesh-ancestor
84095880|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84095881|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84095882|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84095883|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
84095884|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84095885|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84095886|NCT00128297|Pamidronate|pamidronate|mesh-list
84095887|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84095888|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095889|NCT00939185|Azithromycin|azithromycin|mesh-list
84095890|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095891|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095892|NCT02808104|Mazindol|mazindol|mesh-list
84095893|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84095894|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095895|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84095896|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84095897|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84095898|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095899|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
84095900|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095901|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84095902|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
84095903|NCT05165771|Tofacitinib|tofacitinib|mesh-list
84095904|NCT05165771|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84095905|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84095906|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095907|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095908|NCT02730624|Tazobactam|tazobactam|mesh-list
84095909|NCT02730624|Piperacillin|piperacillin|mesh-list
84095910|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84095911|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84095912|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095913|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84095914|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095915|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095916|NCT02807870|Methylphenidate|methylphenidate|mesh-list
84095917|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84095918|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095919|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84095920|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84095921|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84095922|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095923|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
84095924|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095925|NCT00925873|Vidarabine|vidarabine|mesh-list
84095926|NCT00925873|Fludarabine|fludarabine|mesh-list
84095927|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
84095928|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095929|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84095930|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
84095931|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335942|NCT03421314|Selenium|selenium|mesh-list
84095932|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84095933|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
84095934|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095935|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
84095936|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095938|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84095939|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
84095940|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095941|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095942|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84095943|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
84095944|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84095945|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095946|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095947|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84095948|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84095949|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84095950|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
84095951|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
84095952|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84095953|NCT00925951|Acetaminophen|acetaminophen|mesh-list
84095954|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84095955|NCT00925951|Analgesics|analgesics|mesh-ancestor
84095956|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
84095957|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095958|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095959|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
84095960|NCT00933205|Tipranavir|tipranavir|mesh-list
84095961|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84095962|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84095963|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
84095964|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84095965|NCT02813486|Vaccines|vaccines|mesh-list
84095966|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
84095967|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095968|NCT02739516|Letrozole|letrozole|mesh-list
84095969|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84095970|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84095971|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84095972|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84095973|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84095974|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84095975|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84095976|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
84095977|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84095978|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095979|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84095980|NCT00933283|Methadone|methadone|mesh-list
84095981|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84095982|NCT00933283|Narcotics|narcotics|mesh-ancestor
84095983|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84095984|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095985|NCT00933283|Analgesics|analgesics|mesh-ancestor
84095986|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
84095987|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095988|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
84095989|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
84095990|NCT02813018|Ropivacaine|ropivacaine|mesh-list
84095991|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
84095992|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
84095993|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84095994|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84095995|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
84095996|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84095997|NCT04253964|Paclitaxel|paclitaxel|mesh-list
84095998|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84095999|NCT04253964|Carboplatin|carboplatin|mesh-list
84096000|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
84096001|NCT04253964|Pemetrexed|pemetrexed|mesh-list
84096002|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84096003|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096004|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
84096005|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
84096006|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
84096007|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096008|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096009|NCT04253964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84096010|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096011|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84096012|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84096013|NCT02810132|Metformin|metformin|mesh-list
84096014|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84096015|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096016|NCT02734524|Carboplatin|carboplatin|mesh-list
84096017|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096018|NCT04173962|Midazolam|midazolam|mesh-list
84096019|NCT04173962|Ketamine|ketamine|mesh-list
84096020|NCT04173962|Analgesics|analgesics|mesh-ancestor
84096021|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
84096022|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096023|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096024|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84096025|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84096026|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
84096027|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
84096028|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096029|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84096030|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84096031|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096032|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096033|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84096034|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84096035|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84096036|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84096037|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84096038|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
84096039|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
84096040|NCT00772005|Modafinil|modafinil|mesh-list
84096041|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84096042|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096043|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84096044|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84096045|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84096046|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096047|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84096048|NCT03333408|Clindamycin|clindamycin|mesh-list
84096049|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
84096050|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
84096051|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84096052|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096053|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84096054|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096055|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096056|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84096057|NCT04262999|Levetiracetam|levetiracetam|mesh-list
84096058|NCT04262999|Valproic Acid|valproic acid|mesh-list
84096059|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
84096060|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
84096061|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096062|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096063|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
84096064|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096065|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096066|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
84096067|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84096068|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096069|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84096070|NCT05582174|Esomeprazole|esomeprazole|mesh-list
84096071|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84096072|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84096073|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84096074|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096075|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096076|NCT00926107|Sirolimus|sirolimus|mesh-list
84096077|NCT00926107|Temsirolimus|temsirolimus|mesh-list
84096078|NCT00926107|MTOR Inhibitors|mtor inhibitors|mesh-list
84096079|NCT00926107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84096080|NCT00926107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336089|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
84096081|NCT00926107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096082|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096083|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
84096084|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096085|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096086|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84096087|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096088|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84096089|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
84096091|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84096092|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096093|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84096094|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096095|NCT02812940|Everolimus|everolimus|mesh-list
84096096|NCT02812940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84096097|NCT02812940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84096098|NCT02812940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096099|NCT02812940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096100|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096101|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
84096102|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096103|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096104|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84096105|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84096106|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84096107|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84096108|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096109|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096110|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096111|NCT00933439|Analgesics|analgesics|mesh-ancestor
84096112|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
84096113|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096114|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
84096115|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84096116|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
84096117|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
84096118|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
84096119|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84096120|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096121|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096122|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
84096123|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84096124|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096125|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096126|NCT02809742|Ropivacaine|ropivacaine|mesh-list
84096127|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
84096128|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
84096129|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096130|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096131|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
84096132|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096133|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
84096134|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84096135|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
84096136|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096137|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096138|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84096139|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
84096140|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84096141|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84096142|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84096143|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
84096144|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096145|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096146|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
84096147|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096148|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096149|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
84096150|NCT00933517|Docetaxel|docetaxel|mesh-list
84096151|NCT00933517|Panitumumab|panitumumab|mesh-list
84096152|NCT00933517|Epirubicin|epirubicin|mesh-list
84096153|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096154|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
84096155|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096156|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84096157|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84096158|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
84096159|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096160|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096161|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84096162|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
84096163|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
84096164|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
84096165|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096166|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84096167|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84096168|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84096169|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096170|NCT00926341|Pioglitazone|pioglitazone|mesh-list
84096171|NCT00926341|Telmisartan|telmisartan|mesh-list
84096172|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84096173|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096174|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84096175|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84096176|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84096177|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096178|NCT00926419|Vaccines|vaccines|mesh-list
84096179|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
84096180|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096181|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
84096182|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84096183|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096184|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096185|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84096186|NCT00608231|Analgesics|analgesics|mesh-ancestor
84096187|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
84096188|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096189|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84096190|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84096191|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84096192|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
84096193|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096194|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096195|NCT02739204|Celecoxib|celecoxib|mesh-list
84096196|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84096197|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84096198|NCT02739204|Analgesics|analgesics|mesh-ancestor
84096199|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
84096200|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096201|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096202|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84096203|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84096204|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84096205|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84096206|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096207|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096208|NCT00927485|Curcumin|curcumin|mesh-list
84096209|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84096210|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84096211|NCT00927485|Analgesics|analgesics|mesh-ancestor
84096212|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
84096213|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096214|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096215|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84096216|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84096217|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096218|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096219|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096220|NCT00926653|Escitalopram|escitalopram|mesh-list
84096221|NCT00926653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84096222|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84096223|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84096224|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096225|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096226|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
84096227|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096228|NCT02733822|Naloxone|naloxone|mesh-list
84096229|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84096230|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096231|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
84096232|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096233|NCT00930241|Tacrolimus|tacrolimus|mesh-list
84096234|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096235|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
84096236|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096237|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84096238|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096239|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096240|NCT04260269|Trifluridine|trifluridine|mesh-list
84096241|NCT04260269|Fluorouracil|fluorouracil|mesh-list
84096242|NCT04260269|Capecitabine|capecitabine|mesh-list
84096243|NCT04260269|Tegafur|tegafur|mesh-list
84096244|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
84096245|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096246|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84096247|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096248|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096249|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
84096250|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096251|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
84096252|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096253|NCT02738970|Trastuzumab|trastuzumab|mesh-list
84096254|NCT02738970|Pertuzumab|pertuzumab|mesh-list
84096255|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096256|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096257|NCT00926731|Cytarabine|cytarabine|mesh-list
84096258|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84096259|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
84096260|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096261|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096262|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
84096263|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096264|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096265|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
84096266|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096267|NCT00926809|Amoxicillin|amoxicillin|mesh-list
84096268|NCT00926809|Clarithromycin|clarithromycin|mesh-list
84096269|NCT00926809|Lansoprazole|lansoprazole|mesh-list
84096270|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
84096271|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84096272|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84096273|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096274|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84096275|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096276|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096277|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84096278|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84096279|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84096280|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84096281|NCT02805920|Bupivacaine|bupivacaine|mesh-list
84096282|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
84096283|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
84096284|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096285|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096286|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
84096287|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096288|NCT04262765|Amlodipine|amlodipine|mesh-list
84096289|NCT04262765|Ramipril|ramipril|mesh-list
84096290|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
84096291|NCT04262765|Atorvastatin|atorvastatin|mesh-list
84096292|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84096293|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84096294|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
84096295|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096296|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84096297|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84096298|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096299|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84096300|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84096301|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84096302|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84096303|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096304|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
84096305|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84096306|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
84096307|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
84096308|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84096309|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84096310|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84096311|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84096312|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096313|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
84096314|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096315|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096316|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84096317|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096319|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84096320|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096321|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096322|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84096323|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
84096324|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
84096325|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84096326|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84096327|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096328|NCT02729064|Insulin|insulin|mesh-list
84096329|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84096330|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84096331|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096332|NCT00609401|Sorafenib|sorafenib|mesh-list
84096333|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096334|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84096335|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096336|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096337|NCT02805842|Tacrolimus|tacrolimus|mesh-list
84096338|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096339|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
84096340|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096341|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84096342|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096343|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096344|NCT00926965|Olanzapine|olanzapine|mesh-list
84096345|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
84096346|NCT00926965|Amisulpride|amisulpride|mesh-list
84096347|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
84096348|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
84096349|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096350|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096351|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84096352|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84096353|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096354|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84096355|NCT00926965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84096356|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84096357|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84096358|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096359|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096360|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
84096361|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84096362|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
84096363|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84096364|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
84096365|NCT04260113|Apatinib|apatinib|mesh-list
84096366|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096367|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84096368|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096369|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096370|NCT02738658|Everolimus|everolimus|mesh-list
84096371|NCT02738658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84096372|NCT02738658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84096373|NCT02738658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096374|NCT02738658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096375|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096376|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
84096377|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096378|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096380|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84096381|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84096382|NCT02733510|Prednisolone|prednisolone|mesh-list
84096383|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
84096384|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84096385|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
84096386|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84096387|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
84096388|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
84096389|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096390|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096391|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84096392|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
84096393|NCT02733510|Hormones|hormones|mesh-ancestor
84096394|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096395|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84096396|NCT02733510|Protective Agents|protective agents|mesh-ancestor
84096397|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84096398|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096399|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
84096400|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84096401|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096402|NCT00933985|Doxorubicin|doxorubicin|mesh-list
84096403|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84096404|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
84096405|NCT00933985|Vincristine|vincristine|mesh-list
84096406|NCT00933985|Razoxane|razoxane|mesh-list
84096407|NCT00933985|Obatoclax|obatoclax|mesh-list
84096408|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84096409|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096410|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84096411|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84096412|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096413|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096414|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84096415|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
84096416|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
84096417|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
84096418|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84096419|NCT00933985|Protective Agents|protective agents|mesh-ancestor
84096420|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096421|NCT02812394|Levodopa|levodopa|mesh-list
84096422|NCT02812394|Carbidopa|carbidopa|mesh-list
84096423|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84096424|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84096425|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84096426|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
84096427|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096428|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096429|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096430|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84096431|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096432|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84096433|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
84096434|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
84096435|NCT00930475|Carboplatin|carboplatin|mesh-list
84096436|NCT00930475|Everolimus|everolimus|mesh-list
84096437|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096438|NCT00930475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84096439|NCT00930475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84096440|NCT00930475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096441|NCT00930475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096442|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096443|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
84096444|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096445|NCT05623592|Methotrexate|methotrexate|mesh-list
84096446|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84096447|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
84096448|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84096449|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096450|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84096452|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096453|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096454|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
84096455|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096456|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84096457|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096458|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
84096459|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84096460|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84096461|NCT02728518|Amikacin|amikacin|mesh-list
84096462|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84096463|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096464|NCT00634400|Candesartan|candesartan|mesh-list
84096465|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84096466|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84096467|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84096468|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096469|NCT04262375|Durvalumab|durvalumab|mesh-list
84096470|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096471|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096472|NCT00936793|Ritonavir|ritonavir|mesh-list
84096473|NCT00936793|Darunavir|darunavir|mesh-list
84096474|NCT00936793|Beclomethasone|beclomethasone|mesh-list
84096475|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84096476|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84096477|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
84096478|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096479|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096480|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84096481|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84096482|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
84096483|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096484|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84096485|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84096486|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84096487|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
84096488|NCT00936793|Hormones|hormones|mesh-ancestor
84096489|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096490|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096491|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84096492|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
84096493|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
84096494|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84096495|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84096496|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
84096497|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096498|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096499|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096500|NCT02805452|Urological Agents|urological agents|mesh-ancestor
84096501|NCT00937027|Aminopterin|aminopterin|mesh-list
84096502|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84096503|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096504|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096505|NCT02738502|Ritonavir|ritonavir|mesh-list
84096506|NCT02738502|Darunavir|darunavir|mesh-list
84096507|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84096508|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84096509|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
84096510|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096511|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096512|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84096513|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84096514|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
84096515|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096516|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84096517|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84096518|NCT04261907|Ritonavir|ritonavir|mesh-list
84096519|NCT04261907|Lopinavir|lopinavir|mesh-list
84096520|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84096521|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84096522|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
84096523|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096524|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096525|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84096526|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84096527|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
84096528|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096529|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84096530|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84096531|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
84096532|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84096533|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84096534|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84096535|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84096536|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096537|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
84096538|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096539|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096540|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84096541|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096542|NCT02738346|Carboplatin|carboplatin|mesh-list
84096544|NCT02738346|Topotecan|topotecan|mesh-list
84096545|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096546|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84096547|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84096548|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84096549|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096550|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096551|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84096552|NCT00932165|Exemestane|exemestane|mesh-list
84096553|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096554|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84096555|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84096556|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096557|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096558|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84096559|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
84096560|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096561|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096562|NCT00937183|Vaccines|vaccines|mesh-list
84096563|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
84096564|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096565|NCT00937261|Risperidone|risperidone|mesh-list
84096566|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84096567|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84096568|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
84096569|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096570|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096571|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096572|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84096573|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84096574|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096575|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84096576|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84096577|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
84096578|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84096579|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84096580|NCT05906459|Antibodies|antibodies|mesh-list
84096581|NCT05906459|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
84096582|NCT05906459|Immunologic Factors|immunologic factors|mesh-ancestor
84096583|NCT05906459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096584|NCT05906433|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84096585|NCT05906433|Triamcinolone|triamcinolone|mesh-list
84096586|NCT05906433|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84096587|NCT05906433|Bupivacaine|bupivacaine|mesh-list
84096588|NCT05906433|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84096589|NCT05906433|Anesthetics, Local|anesthetics, local|mesh-ancestor
84096590|NCT05906433|Anesthetics|anesthetics|mesh-ancestor
84096591|NCT05906433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096592|NCT05906433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096593|NCT05906433|Sensory System Agents|sensory system agents|mesh-ancestor
84096594|NCT05906433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096595|NCT05906433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84096596|NCT05906433|Glucocorticoids|glucocorticoids|mesh-ancestor
84096597|NCT05906433|Hormones|hormones|mesh-ancestor
84096598|NCT05906433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096599|NCT05906433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84096600|NCT05906433|Immunologic Factors|immunologic factors|mesh-ancestor
84096601|NCT05906433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096602|NCT05906433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096603|NCT05906225|Anesthetics|anesthetics|mesh-list
84096604|NCT05906225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096605|NCT05906225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096607|NCT05906199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84096608|NCT05906199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84096609|NCT05906199|Analgesics|analgesics|mesh-ancestor
84096610|NCT05906199|Sensory System Agents|sensory system agents|mesh-ancestor
84096611|NCT05906199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096612|NCT05906199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096613|NCT05906199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84096614|NCT05906199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84096615|NCT05906199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84096616|NCT05906199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84096617|NCT05906199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096618|NCT05906199|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84096619|NCT05906199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84096620|NCT05906199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096621|NCT05906199|Antipyretics|antipyretics|mesh-ancestor
84096622|NCT05905965|Empagliflozin|empagliflozin|mesh-list
84096623|NCT05905965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84096624|NCT05905965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096625|NCT05905965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84096626|NCT05905965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096627|NCT05905913|Meropenem|meropenem|mesh-list
84096628|NCT05905913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84096629|NCT05905913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096630|NCT05905887|Paclitaxel|paclitaxel|mesh-list
84096631|NCT05905887|Apatinib|apatinib|mesh-list
84096632|NCT05905887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84096633|NCT05905887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096634|NCT05905887|Tubulin Modulators|tubulin modulators|mesh-ancestor
84096635|NCT05905887|Antimitotic Agents|antimitotic agents|mesh-ancestor
84096636|NCT05905887|Mitosis Modulators|mitosis modulators|mesh-ancestor
84096637|NCT05905887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096638|NCT05905887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84096639|NCT05905887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096640|NCT05905757|Tramadol|tramadol|mesh-list
84096641|NCT05905757|Dexmedetomidine|dexmedetomidine|mesh-list
84096642|NCT05905757|Bupivacaine|bupivacaine|mesh-list
84096643|NCT05905757|Anesthetics, Local|anesthetics, local|mesh-ancestor
84096644|NCT05905757|Anesthetics|anesthetics|mesh-ancestor
84096645|NCT05905757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096646|NCT05905757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096647|NCT05905757|Sensory System Agents|sensory system agents|mesh-ancestor
84096648|NCT05905757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096649|NCT05905757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84096650|NCT05905757|Narcotics|narcotics|mesh-ancestor
84096651|NCT05905757|Analgesics|analgesics|mesh-ancestor
84096652|NCT05905757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84096653|NCT05905757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84096654|NCT05905757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84096655|NCT05905757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84096656|NCT05905757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84096657|NCT05905757|Adrenergic Agents|adrenergic agents|mesh-ancestor
84096658|NCT05905757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096659|NCT05905757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096660|NCT05905653|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84096661|NCT05905653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84096662|NCT05905484|Moxifloxacin|moxifloxacin|mesh-list
84096663|NCT05905484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84096664|NCT05905484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096665|NCT05905484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84096666|NCT05905484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84096667|NCT05905484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096668|NCT05905484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096669|NCT05905484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096670|NCT05905419|Analgesics, Opioid|analgesics, opioid|mesh-list
84096671|NCT05905419|Narcotics|narcotics|mesh-ancestor
84096672|NCT05905419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096673|NCT05905419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096674|NCT05905419|Analgesics|analgesics|mesh-ancestor
84096675|NCT05905419|Sensory System Agents|sensory system agents|mesh-ancestor
84096676|NCT05905419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096677|NCT05905367|Fentanyl|fentanyl|mesh-list
84096678|NCT05905367|Morphine|morphine|mesh-list
84096679|NCT05905367|Methadone|methadone|mesh-list
84096680|NCT05905367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84096681|NCT05905367|Narcotics|narcotics|mesh-ancestor
83429559|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84096682|NCT05905367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096683|NCT05905367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096684|NCT05905367|Analgesics|analgesics|mesh-ancestor
84096685|NCT05905367|Sensory System Agents|sensory system agents|mesh-ancestor
84096686|NCT05905367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096687|NCT05905367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84096688|NCT05905367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84096689|NCT05905367|Anesthetics, General|anesthetics, general|mesh-ancestor
84096690|NCT05905367|Anesthetics|anesthetics|mesh-ancestor
84096691|NCT05905367|Antitussive Agents|antitussive agents|mesh-ancestor
84096692|NCT05905367|Respiratory System Agents|respiratory system agents|mesh-ancestor
84096693|NCT05905341|Fulvestrant|fulvestrant|mesh-list
84096694|NCT05905341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84096695|NCT05905341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096696|NCT05905341|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84096697|NCT05905341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84096698|NCT05905341|Hormone Antagonists|hormone antagonists|mesh-ancestor
84096699|NCT05905341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096700|NCT05905341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096701|NCT05905315|Paclitaxel|paclitaxel|mesh-list
84096702|NCT05905315|Carboplatin|carboplatin|mesh-list
84096703|NCT05905315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84096704|NCT05905315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096705|NCT05905315|Tubulin Modulators|tubulin modulators|mesh-ancestor
84096706|NCT05905315|Antimitotic Agents|antimitotic agents|mesh-ancestor
84096707|NCT05905315|Mitosis Modulators|mitosis modulators|mesh-ancestor
84096708|NCT05905315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096709|NCT05905185|Vitamin E|vitamin e|mesh-list
84096710|NCT05905185|Tocopherols|tocopherols|mesh-list
84096711|NCT05905185|Tocotrienols|tocotrienols|mesh-list
84096712|NCT05905185|Vitamins|vitamins|mesh-ancestor
84096713|NCT05905185|Micronutrients|micronutrients|mesh-ancestor
84096714|NCT05905185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096715|NCT05905185|Antioxidants|antioxidants|mesh-ancestor
84096716|NCT05905185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096717|NCT05905185|Protective Agents|protective agents|mesh-ancestor
84096718|NCT05905055|Cefepime|cefepime|mesh-list
84096719|NCT05905055|Aztreonam|aztreonam|mesh-list
84096720|NCT05905055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84096721|NCT05905055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096722|NCT05904912|Bupivacaine|bupivacaine|mesh-list
84096723|NCT05904912|Anesthetics, Local|anesthetics, local|mesh-ancestor
84096724|NCT05904912|Anesthetics|anesthetics|mesh-ancestor
84096725|NCT05904912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096726|NCT05904912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096727|NCT05904912|Sensory System Agents|sensory system agents|mesh-ancestor
84096728|NCT05904912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096729|NCT05904886|Bevacizumab|bevacizumab|mesh-list
84096730|NCT05904886|Atezolizumab|atezolizumab|mesh-list
84096731|NCT05904886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096732|NCT05904886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096733|NCT05904886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84096734|NCT05904886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84096735|NCT05904886|Growth Substances|growth substances|mesh-ancestor
84096736|NCT05904886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096737|NCT05904886|Growth Inhibitors|growth inhibitors|mesh-ancestor
84096738|NCT05904886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84096739|NCT05904886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096740|NCT05904808|Metolazone|metolazone|mesh-list
84096741|NCT05904808|Furosemide|furosemide|mesh-list
84096742|NCT05904808|Acetazolamide|acetazolamide|mesh-list
84096743|NCT05904808|Magnesium citrate|magnesium citrate|mesh-list
84096744|NCT05904808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096745|NCT05904808|Diuretics|diuretics|mesh-ancestor
84096746|NCT05904808|Natriuretic Agents|natriuretic agents|mesh-ancestor
84096747|NCT05904808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096748|NCT05904808|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84096749|NCT05904808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84096750|NCT05904808|Anticonvulsants|anticonvulsants|mesh-ancestor
84096751|NCT05904808|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84096752|NCT05904808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096753|NCT05904808|Cathartics|cathartics|mesh-ancestor
84096754|NCT05904808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84096755|NCT05904808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84096756|NCT05904808|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84096757|NCT05898841|Tenofovir|tenofovir|mesh-list
84096758|NCT05898841|Emtricitabine|emtricitabine|mesh-list
84096759|NCT05898841|Dolutegravir|dolutegravir|mesh-list
84096760|NCT05898841|Rilpivirine|rilpivirine|mesh-list
84096761|NCT05898841|Antiviral Agents|antiviral agents|mesh-ancestor
84096762|NCT05898841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096763|NCT05898841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84096764|NCT05898841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84096765|NCT05898841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096766|NCT05898841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096767|NCT05898841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84096768|NCT05898841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84096769|NCT05898841|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84096770|NCT05898841|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84096771|NCT05896384|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84096772|NCT05896384|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
84096773|NCT05896384|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84096774|NCT05896384|Contraceptive Agents|contraceptive agents|mesh-ancestor
84096775|NCT05896384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84096776|NCT05896384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096777|NCT05896384|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84096778|NCT05896384|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84096779|NCT05896384|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84096780|NCT05896384|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84096781|NCT05896384|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84096782|NCT05896384|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
84096783|NCT05896384|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84096784|NCT05896384|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84096785|NCT05893069|Oxandrolone|oxandrolone|mesh-list
84096786|NCT05893069|Androgens|androgens|mesh-ancestor
84096787|NCT05893069|Hormones|hormones|mesh-ancestor
84096788|NCT05893069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096789|NCT05893069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096790|NCT05893069|Anabolic Agents|anabolic agents|mesh-ancestor
84096791|NCT05887492|Pembrolizumab|pembrolizumab|mesh-list
84096792|NCT05887492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096793|NCT05887492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096794|NCT05887492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84096795|NCT05887492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096796|NCT05882877|KHK4083|khk4083|mesh-list
84096797|NCT05882877|Dermatologic Agents|dermatologic agents|mesh-ancestor
84096798|NCT05881811|Probenecid|probenecid|mesh-list
84096799|NCT05881811|Cimetidine|cimetidine|mesh-list
84096800|NCT05881811|Uricosuric Agents|uricosuric agents|mesh-ancestor
84096801|NCT05881811|Gout Suppressants|gout suppressants|mesh-ancestor
84096802|NCT05881811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84096803|NCT05881811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84096804|NCT05881811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84096805|NCT05881811|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84096806|NCT05881811|Histamine Antagonists|histamine antagonists|mesh-ancestor
84096807|NCT05881811|Histamine Agents|histamine agents|mesh-ancestor
84096808|NCT05881811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096809|NCT05881811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096810|NCT05881811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096811|NCT05881811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84096812|NCT05881811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84096813|NCT05881811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096814|NCT05867654|Amoxicillin|amoxicillin|mesh-list
84096815|NCT05867654|Levofloxacin|levofloxacin|mesh-list
84096816|NCT05867654|Clindamycin|clindamycin|mesh-list
84096817|NCT05867654|Clindamycin palmitate|clindamycin palmitate|mesh-list
84096818|NCT05867654|Clindamycin phosphate|clindamycin phosphate|mesh-list
84096819|NCT05867654|Clavulanic Acid|clavulanic acid|mesh-list
84096820|NCT05867654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84096821|NCT05867654|Ampicillin|ampicillin|mesh-list
84096822|NCT05867654|Sulbactam|sulbactam|mesh-list
84096823|NCT05867654|Sultamicillin|sultamicillin|mesh-list
84096824|NCT05867654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84096825|NCT05867654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096826|NCT05867654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84096827|NCT05867654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84096828|NCT05867654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84096829|NCT05867654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096830|NCT05867654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096831|NCT05867654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096832|NCT05867654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84096833|NCT05867654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84096834|NCT05867654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84096835|NCT05867654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84096836|NCT05846750|Lenalidomide|lenalidomide|mesh-list
84096837|NCT05846750|Obinutuzumab|obinutuzumab|mesh-list
84096838|NCT05846750|Immunologic Factors|immunologic factors|mesh-ancestor
84096839|NCT05846750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096840|NCT05846750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84096841|NCT05846750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84096842|NCT05846750|Growth Substances|growth substances|mesh-ancestor
84096843|NCT05846750|Growth Inhibitors|growth inhibitors|mesh-ancestor
84096844|NCT05846750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096845|NCT05846750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096847|NCT05843565|Trace Elements|trace elements|mesh-ancestor
84096848|NCT05843565|Micronutrients|micronutrients|mesh-ancestor
84096849|NCT05843565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096850|NCT05838703|Bromides|bromides|mesh-list
84096851|NCT05838703|Tiotropium Bromide|tiotropium bromide|mesh-list
84096852|NCT05838703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84096853|NCT05838703|Autonomic Agents|autonomic agents|mesh-ancestor
84096854|NCT05838703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096855|NCT05838703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096856|NCT05838703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84096857|NCT05838703|Respiratory System Agents|respiratory system agents|mesh-ancestor
84096858|NCT05838703|Parasympatholytics|parasympatholytics|mesh-ancestor
84096859|NCT05838703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84096860|NCT05838703|Cholinergic Agents|cholinergic agents|mesh-ancestor
84096861|NCT05838703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096862|NCT05838703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096863|NCT05838703|Anticonvulsants|anticonvulsants|mesh-ancestor
84096864|NCT05831683|Anesthetics|anesthetics|mesh-list
84096865|NCT05831683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096866|NCT05831683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096867|NCT05831358|Myeloma Proteins|myeloma proteins|mesh-list
84096868|NCT05831358|Paraproteins|paraproteins|mesh-list
84096869|NCT05831358|Immunologic Factors|immunologic factors|mesh-ancestor
84096870|NCT05831358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096871|NCT05825924|Nicotine|nicotine|mesh-list
84096872|NCT05825924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84096873|NCT05825924|Autonomic Agents|autonomic agents|mesh-ancestor
84096874|NCT05825924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096875|NCT05825924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096876|NCT05825924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84096877|NCT05825924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84096878|NCT05825924|Cholinergic Agents|cholinergic agents|mesh-ancestor
84096879|NCT05825924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84096880|NCT05825924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096881|NCT05807048|Daratumumab|daratumumab|mesh-list
84096882|NCT05807048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096883|NCT05796089|Carboplatin|carboplatin|mesh-list
84096884|NCT05796089|Etoposide|etoposide|mesh-list
84096885|NCT05796089|Etoposide phosphate|etoposide phosphate|mesh-list
84096886|NCT05796089|Durvalumab|durvalumab|mesh-list
84096887|NCT05796089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096888|NCT05796089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84096889|NCT05796089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84096890|NCT05796089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84096891|NCT05796089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096892|NCT05796089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096893|NCT05796089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84096894|NCT05789992|Remifentanil|remifentanil|mesh-list
84096895|NCT05789992|Propofol|propofol|mesh-list
84096896|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84096897|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84096898|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096899|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84096900|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
84096901|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
84096902|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84096903|NCT05789992|Narcotics|narcotics|mesh-ancestor
84096904|NCT05789992|Analgesics|analgesics|mesh-ancestor
84096905|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
84096906|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096907|NCT05774951|Tamoxifen|tamoxifen|mesh-list
84096908|NCT05774951|Letrozole|letrozole|mesh-list
84096909|NCT05774951|Anastrozole|anastrozole|mesh-list
84096910|NCT05774951|Exemestane|exemestane|mesh-list
84096911|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096912|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84096913|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84096914|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096915|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096916|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84096917|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
84096918|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096919|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096920|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84096921|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84096922|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84096923|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84096924|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
84096925|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84096926|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84096927|NCT05765266|Prednisolone|prednisolone|mesh-list
84096928|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
84096929|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84096930|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
84096931|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84096932|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
84096933|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
84096934|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84096935|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096936|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84096937|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
84096938|NCT05765266|Hormones|hormones|mesh-ancestor
84096939|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096940|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84096941|NCT05765266|Protective Agents|protective agents|mesh-ancestor
84096942|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84096943|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096944|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
84096945|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
84096946|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84096947|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84096948|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
84096949|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096950|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84096951|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84096952|NCT05727176|Futibatinib|futibatinib|mesh-list
84096953|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096954|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84096955|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
84096956|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096957|NCT05712941|Letrozole|letrozole|mesh-list
84096958|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84096959|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84096960|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84096961|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096962|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096963|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84096964|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
84096965|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84096966|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096967|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
84096968|NCT05701501|Vitamins|vitamins|mesh-ancestor
84096969|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
84096970|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096971|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
84096972|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
84096973|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84096974|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
84096975|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84096976|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096977|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84096978|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84096979|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84096980|NCT05681273|Empagliflozin|empagliflozin|mesh-list
84096981|NCT05681273|Valsartan|valsartan|mesh-list
84096982|NCT05681273|Atorvastatin|atorvastatin|mesh-list
84096983|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84096984|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84096985|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
84096986|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84096987|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84096988|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84096989|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84096990|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84096991|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84096992|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84096993|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84096994|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84096995|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84096996|NCT05660850|Mannitol|mannitol|mesh-list
84096997|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84096998|NCT05660850|Diuretics|diuretics|mesh-ancestor
84096999|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
84097000|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097001|NCT05656911|Zabedosertib|zabedosertib|mesh-list
84097002|NCT05656911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84097003|NCT05656911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097004|NCT05656911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097005|NCT05656742|Vitamin D|vitamin d|mesh-list
84097006|NCT05656742|Vitamins|vitamins|mesh-ancestor
84097007|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
84097008|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097009|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84097010|NCT05643560|Factor VIII|factor viii|mesh-list
84097011|NCT05643560|Coagulants|coagulants|mesh-ancestor
84097012|NCT05639647|Aztreonam|aztreonam|mesh-list
84097013|NCT05639647|Avibactam|avibactam|mesh-list
84097014|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097015|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097016|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84097017|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097018|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097019|NCT05592223|Rifampin|rifampin|mesh-list
84097020|NCT05592223|Isoniazid|isoniazid|mesh-list
84097021|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
84097022|NCT05592223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84097023|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
84097024|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097025|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097026|NCT05592223|Leprostatic Agents|leprostatic agents|mesh-ancestor
84097027|NCT05592223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84097028|NCT05592223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097029|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097030|NCT05592223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84097031|NCT05592223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84097032|NCT05592223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84097033|NCT05592223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84097034|NCT05592223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84097035|NCT05592223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84097036|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84097037|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84097038|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
84097039|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84097040|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84097041|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
84097042|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097043|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84097044|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
84097045|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097046|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84097047|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
84097048|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097049|NCT05562947|Ranibizumab|ranibizumab|mesh-list
84097050|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84097051|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84097052|NCT05562947|Growth Substances|growth substances|mesh-ancestor
84097053|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097054|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
84097055|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097056|NCT05549505|Anastrozole|anastrozole|mesh-list
84097057|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097058|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097059|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84097060|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84097061|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097062|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097063|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84097064|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
84097065|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097066|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097067|NCT05538767|Albendazole|albendazole|mesh-list
84097068|NCT05538767|Emodepside|emodepside|mesh-list
84097069|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
84097070|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84097071|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097072|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
84097073|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84097074|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84097075|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
84097076|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
84097077|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
84097078|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097079|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097080|NCT05524168|Gemcitabine|gemcitabine|mesh-list
84097081|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097082|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84097083|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
84097084|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097085|NCT05488847|Acetaminophen|acetaminophen|mesh-list
84097086|NCT05488847|Dexamethasone|dexamethasone|mesh-list
84097087|NCT05488847|Ibuprofen|ibuprofen|mesh-list
84097088|NCT05488847|Celecoxib|celecoxib|mesh-list
84097089|NCT05488847|Ketorolac|ketorolac|mesh-list
84097090|NCT05488847|Pregabalin|pregabalin|mesh-list
84097091|NCT05488847|Epinephrine|epinephrine|mesh-list
84097092|NCT05488847|Oxycodone|oxycodone|mesh-list
84097093|NCT05488847|Tramadol|tramadol|mesh-list
84097094|NCT05488847|Tizanidine|tizanidine|mesh-list
84097095|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
84097096|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097097|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
84097098|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
84097099|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097100|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097101|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097102|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
84097103|NCT05488847|Hormones|hormones|mesh-ancestor
84097104|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097105|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097106|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097107|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84097108|NCT05488847|Analgesics|analgesics|mesh-ancestor
84097109|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
84097110|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
84097111|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84097112|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097113|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84097114|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097115|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097116|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
84097117|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84097118|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84097119|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84097120|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84097121|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84097122|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84097123|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84097124|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84097125|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84097126|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
84097127|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097128|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84097129|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84097130|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84097131|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
84097132|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
84097133|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
84097134|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84097135|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84097136|NCT05488847|Narcotics|narcotics|mesh-ancestor
84097137|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84097138|NCT05488847|Antacids|antacids|mesh-ancestor
84097139|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84097140|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84097141|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
84097142|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84097143|NCT05487599|Sirolimus|sirolimus|mesh-list
84097144|NCT05487599|Prednisone|prednisone|mesh-list
84097145|NCT05487599|Methylprednisolone|methylprednisolone|mesh-list
84097146|NCT05487599|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84097147|NCT05487599|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84097148|NCT05487599|Prednisolone|prednisolone|mesh-list
84097149|NCT05487599|Prednisolone acetate|prednisolone acetate|mesh-list
84097150|NCT05487599|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84097151|NCT05487599|Prednisolone phosphate|prednisolone phosphate|mesh-list
84097152|NCT05487599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097153|NCT05487599|Glucocorticoids|glucocorticoids|mesh-ancestor
84097154|NCT05487599|Hormones|hormones|mesh-ancestor
84097155|NCT05487599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097156|NCT05487599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097157|NCT05487599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097158|NCT05487599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097159|NCT05487599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097160|NCT05487599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097161|NCT05487599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84097162|NCT05487599|Antifungal Agents|antifungal agents|mesh-ancestor
84097163|NCT05487599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097164|NCT05487599|Immunologic Factors|immunologic factors|mesh-ancestor
84097165|NCT05487599|Antiemetics|antiemetics|mesh-ancestor
84097166|NCT05487599|Autonomic Agents|autonomic agents|mesh-ancestor
84097167|NCT05487599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097168|NCT05487599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097169|NCT05487599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84097170|NCT05487599|Protective Agents|protective agents|mesh-ancestor
84097171|NCT05487235|Atezolizumab|atezolizumab|mesh-list
84097172|NCT05487235|Omeprazole|omeprazole|mesh-list
84097173|NCT05487235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097174|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097175|NCT05487235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097176|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097177|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84097178|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097179|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84097180|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097181|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84097182|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
84097183|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097184|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84097185|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
84097186|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84097187|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
84097188|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84097189|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097190|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84097191|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097192|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097193|NCT05432804|Temozolomide|temozolomide|mesh-list
84097194|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84097195|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
84097196|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097197|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097198|NCT05431582|Bevacizumab|bevacizumab|mesh-list
84097199|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
84097200|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83337211|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
84097201|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097202|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84097203|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84097204|NCT05431582|Growth Substances|growth substances|mesh-ancestor
83429577|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84097205|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097206|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
84097207|NCT05431582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097208|NCT05431582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097209|NCT05425420|Methadone|methadone|mesh-list
84097210|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84097211|NCT05425420|Narcotics|narcotics|mesh-ancestor
84097212|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84097213|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097214|NCT05425420|Analgesics|analgesics|mesh-ancestor
84097215|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
84097216|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097217|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
84097218|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
84097219|NCT05418556|Aspirin|aspirin|mesh-list
84097220|NCT05418556|Clopidogrel|clopidogrel|mesh-list
84097221|NCT05418556|Ticagrelor|ticagrelor|mesh-list
84097222|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84097223|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84097224|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84097225|NCT05418556|Analgesics|analgesics|mesh-ancestor
84097226|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
84097227|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097228|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097229|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097230|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097231|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84097232|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84097233|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097234|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84097235|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84097236|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097237|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
84097238|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84097239|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84097240|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84097241|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
84097242|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097243|NCT05413122|Nicotine|nicotine|mesh-list
84097244|NCT05413122|Varenicline|varenicline|mesh-list
84097245|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84097246|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
84097247|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097248|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097249|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84097250|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84097251|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
84097252|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097253|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097254|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84097255|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
84097256|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097257|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
84097258|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
84097259|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
84097260|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097261|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097262|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84097263|NCT05407662|Diuretics|diuretics|mesh-ancestor
84097264|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
84097265|NCT05407662|Hormones|hormones|mesh-ancestor
84097266|NCT05384756|Sirolimus|sirolimus|mesh-list
84097267|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84097268|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
84097269|NCT05384756|Antibodies|antibodies|mesh-list
84097270|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
84097271|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84097272|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
84097273|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097274|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097275|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83337289|NCT01831817|Listerine|listerine|mesh-list
84097276|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097277|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84097278|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
84097279|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097280|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
84097281|NCT05364424|Rituximab|rituximab|mesh-list
84097282|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
84097283|NCT05364424|Carboplatin|carboplatin|mesh-list
84097284|NCT05364424|Etoposide|etoposide|mesh-list
84097285|NCT05364424|Ifosfamide|ifosfamide|mesh-list
84097286|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097287|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097288|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
84097289|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097290|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097291|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84097292|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84097293|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84097294|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097295|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097296|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84097297|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
84097298|NCT05362760|Fulvestrant|fulvestrant|mesh-list
84097299|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84097300|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097301|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097302|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84097303|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84097304|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
84097305|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097306|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097307|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84097308|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097309|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097310|NCT05355701|Cetuximab|cetuximab|mesh-list
84097311|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097312|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097313|NCT05349188|Melatonin|melatonin|mesh-list
84097314|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
84097315|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097316|NCT05349188|Protective Agents|protective agents|mesh-ancestor
84097317|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097318|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84097319|NCT05331027|Sevoflurane|sevoflurane|mesh-list
84097320|NCT05331027|Desflurane|desflurane|mesh-list
84097321|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84097322|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84097323|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
84097324|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
84097325|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84097326|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097327|NCT05330429|Leucovorin|leucovorin|mesh-list
84097328|NCT05330429|Bevacizumab|bevacizumab|mesh-list
84097329|NCT05330429|Magrolimab|magrolimab|mesh-list
84097330|NCT05330429|Fluorouracil|fluorouracil|mesh-list
84097331|NCT05330429|Irinotecan|irinotecan|mesh-list
84097332|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097333|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097334|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84097335|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84097336|NCT05330429|Growth Substances|growth substances|mesh-ancestor
84097337|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097338|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
84097339|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
84097340|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097341|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84097342|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097343|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
84097344|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84097345|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84097346|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097347|NCT05330429|Antidotes|antidotes|mesh-ancestor
84097348|NCT05330429|Protective Agents|protective agents|mesh-ancestor
84097349|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
84097350|NCT05330429|Vitamins|vitamins|mesh-ancestor
84097351|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
84097353|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
84097354|NCT05311176|Ramucirumab|ramucirumab|mesh-list
84097355|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84097356|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097357|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
84097358|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
84097359|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
84097360|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097361|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097362|NCT05311176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097363|NCT05299242|Adalimumab|adalimumab|mesh-list
84097364|NCT05299242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84097365|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097366|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097367|NCT05299125|Pemetrexed|pemetrexed|mesh-list
84097368|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
84097369|NCT05299125|Lazertinib|lazertinib|mesh-list
84097370|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097371|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097372|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097373|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84097374|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84097375|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84097376|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097377|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
84097378|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84097379|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
84097380|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097381|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
84097382|NCT05290727|Protective Agents|protective agents|mesh-ancestor
84097383|NCT05282706|Peppermint oil|peppermint oil|mesh-list
84097384|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
84097385|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
84097386|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097387|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097388|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097389|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
84097390|NCT05262764|Empagliflozin|empagliflozin|mesh-list
84097391|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84097392|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097393|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84097394|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097395|NCT05261399|Carboplatin|carboplatin|mesh-list
84097396|NCT05261399|Pemetrexed|pemetrexed|mesh-list
84097397|NCT05261399|Osimertinib|osimertinib|mesh-list
84097398|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097399|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097400|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097401|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84097402|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84097403|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84097404|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
84097405|NCT05232825|Promethazine|promethazine|mesh-list
84097406|NCT05232825|Dexamethasone|dexamethasone|mesh-list
84097407|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
84097408|NCT05232825|Desloratadine|desloratadine|mesh-list
84097409|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
84097410|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097411|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
84097412|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
84097413|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097414|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097415|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097416|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
84097417|NCT05232825|Hormones|hormones|mesh-ancestor
84097418|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097419|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097420|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097421|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84097422|NCT05232825|Protective Agents|protective agents|mesh-ancestor
84097423|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84097424|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84097425|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84097426|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
84097427|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
84097428|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
84097429|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84097430|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
84097431|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
84097432|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097433|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097434|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84097435|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
84097436|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
84097437|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
84097438|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84097439|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
84097440|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84097441|NCT05222984|Decitabine|decitabine|mesh-list
84097442|NCT05222984|Venetoclax|venetoclax|mesh-list
84097443|NCT05222984|Navitoclax|navitoclax|mesh-list
84097444|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84097445|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
84097446|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097447|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097448|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097449|NCT05221840|Durvalumab|durvalumab|mesh-list
84097450|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097451|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097452|NCT05177848|Nicotine|nicotine|mesh-list
84097453|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84097454|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
84097455|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097456|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097457|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84097458|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84097459|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
84097460|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097461|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097462|NCT05169008|Vaccines|vaccines|mesh-list
84097463|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
84097464|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097465|NCT05159453|Insulin|insulin|mesh-list
84097466|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84097467|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84097468|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097469|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
84097470|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097471|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097472|NCT05155254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097473|NCT05155254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097474|NCT05147662|Factor VIII|factor viii|mesh-list
84097475|NCT05147662|Coagulants|coagulants|mesh-ancestor
84097476|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
84097477|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
84097478|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
84097479|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097480|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84097481|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097482|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097483|NCT05120349|Osimertinib|osimertinib|mesh-list
84097484|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097485|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84097486|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097487|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097488|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
84097489|NCT05096195|Vitamin D|vitamin d|mesh-list
84097490|NCT05096195|Denosumab|denosumab|mesh-list
84097491|NCT05096195|Calcium|calcium|mesh-list
84097492|NCT05096195|Vitamins|vitamins|mesh-ancestor
84097493|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
84097494|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097495|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84097496|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84097497|NCT05067933|Vaccines|vaccines|mesh-list
84097498|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
84097499|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097500|NCT05067634|Cenobamate|cenobamate|mesh-list
84097501|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
84097502|NCT05059860|Insulin|insulin|mesh-list
84097503|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84097504|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097505|NCT05037929|Astegolimab|astegolimab|mesh-list
84097506|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84097507|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097508|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
84097509|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097510|NCT05022524|Acetic Acid|acetic acid|mesh-list
84097511|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097512|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097513|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
84097514|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
84097515|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097516|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
84097517|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
84097518|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097519|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
84097520|NCT04959175|Sirolimus|sirolimus|mesh-list
84097521|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
84097522|NCT04959175|Fludarabine|fludarabine|mesh-list
84097523|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097524|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
84097525|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097526|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097527|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84097528|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
84097529|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097530|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097531|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84097532|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84097533|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84097534|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
84097535|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097536|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097537|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097538|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
84097539|NCT04958785|Paclitaxel|paclitaxel|mesh-list
84097540|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84097541|NCT04958785|Magrolimab|magrolimab|mesh-list
84097542|NCT04958785|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84097543|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84097544|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097545|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
84097546|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
84097547|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
84097548|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097549|NCT04958785|Immunoconjugates|immunoconjugates|mesh-ancestor
84097550|NCT04958785|Immunologic Factors|immunologic factors|mesh-ancestor
84097551|NCT04958785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097552|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097553|NCT04938830|Palivizumab|palivizumab|mesh-list
84097554|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
84097555|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097556|NCT04853251|Ranibizumab|ranibizumab|mesh-list
84097557|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84097558|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84097559|NCT04853251|Growth Substances|growth substances|mesh-ancestor
84097560|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097561|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
84097562|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097563|NCT04852068|Vaccines|vaccines|mesh-list
84097564|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
84097565|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097566|NCT04839042|Cloricromen|cloricromen|mesh-list
84097567|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84097568|NCT04835441|ALPN-101|alpn-101|mesh-list
84097569|NCT04835441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097570|NCT04835441|Immunologic Factors|immunologic factors|mesh-ancestor
84097571|NCT04835441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097572|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
84097573|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097574|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097575|NCT04825223|Vaccines|vaccines|mesh-list
84097576|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
84097577|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097578|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
84097579|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84097580|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097581|NCT04799275|Prednisone|prednisone|mesh-list
84097582|NCT04799275|Cortisone|cortisone|mesh-list
84097583|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
84097584|NCT04799275|Rituximab|rituximab|mesh-list
84097585|NCT04799275|Doxorubicin|doxorubicin|mesh-list
84097586|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84097587|NCT04799275|Vincristine|vincristine|mesh-list
84097588|NCT04799275|Azacitidine|azacitidine|mesh-list
84097589|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84097590|NCT04799275|Antibodies|antibodies|mesh-list
84097591|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
84097592|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84097593|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097594|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
84097595|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097596|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097597|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84097598|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
84097599|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097600|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097601|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84097602|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84097603|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84097604|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84097605|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097606|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097607|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
84097608|NCT04799275|Hormones|hormones|mesh-ancestor
84097609|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097610|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097611|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84097612|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
84097613|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
84097614|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
84097615|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84097616|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
84097617|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
84097618|NCT04789096|Trastuzumab|trastuzumab|mesh-list
84097619|NCT04789096|Capecitabine|capecitabine|mesh-list
84097620|NCT04789096|Tucatinib|tucatinib|mesh-list
84097621|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097622|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097623|NCT04789096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097624|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097625|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84097626|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
84097627|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84097628|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097629|NCT04774094|Ceftazidime|ceftazidime|mesh-list
84097630|NCT04774094|Avibactam|avibactam|mesh-list
84097631|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
84097632|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097633|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097634|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84097635|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097636|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097637|NCT04761822|Vaccines|vaccines|mesh-list
84097638|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
84097639|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097640|NCT04754399|Cannabidiol|cannabidiol|mesh-list
84097641|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
84097642|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84097643|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84097644|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097645|NCT04708470|Entinostat|entinostat|mesh-list
84097646|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097647|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84097648|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097649|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097650|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
84097651|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097652|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
84097653|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097654|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097655|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84097656|NCT04702893|Nintedanib|nintedanib|mesh-list
84097657|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097658|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84097659|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097660|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097661|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84097662|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84097663|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84097664|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097665|NCT04667234|Sotorasib|sotorasib|mesh-list
84097666|NCT04667234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097667|NCT04667234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097668|NCT04667234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097669|NCT04667234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097670|NCT04665037|Posaconazole|posaconazole|mesh-list
84097671|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
84097672|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097673|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84097674|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84097675|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84097676|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84097677|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84097678|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097679|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097680|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84097681|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
84097682|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097683|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097684|NCT04657289|Ranibizumab|ranibizumab|mesh-list
84097685|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84097686|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84097687|NCT04657289|Growth Substances|growth substances|mesh-ancestor
84097688|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097689|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
84097690|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097691|NCT04639466|Vaccines|vaccines|mesh-list
84097692|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
84097693|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097694|NCT04609046|Rituximab|rituximab|mesh-list
84097695|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84097696|NCT04609046|Nivolumab|nivolumab|mesh-list
84097697|NCT04609046|Methotrexate|methotrexate|mesh-list
84097698|NCT04609046|Lenalidomide|lenalidomide|mesh-list
84097699|NCT04609046|Antibodies|antibodies|mesh-list
84097700|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
84097701|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84097702|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
84097703|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097704|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097705|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097706|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097707|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097708|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84097709|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
84097710|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84097711|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84097712|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
84097713|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
84097714|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097715|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84097716|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097717|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84097718|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84097719|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84097720|NCT04609046|Growth Substances|growth substances|mesh-ancestor
84097721|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
84097722|NCT04603807|Crizotinib|crizotinib|mesh-list
84097723|NCT04603807|Entrectinib|entrectinib|mesh-list
84097724|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097725|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84097726|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097727|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097728|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
84097729|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
84097730|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
84097731|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
84097732|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097733|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
84097734|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
84097735|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097736|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097737|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097738|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
84097739|NCT04548999|Hormones|hormones|mesh-ancestor
84097740|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097741|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84097742|NCT04548999|Protective Agents|protective agents|mesh-ancestor
84097743|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
84097744|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
84097745|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097746|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097747|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
84097748|NCT04548661|Povidone|povidone|mesh-list
84097749|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
84097750|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
84097751|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84097752|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097753|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
84097754|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
84097755|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
84097756|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
84097757|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097758|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
84097759|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
84097760|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097761|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097762|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097763|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
84097764|NCT04544436|Hormones|hormones|mesh-ancestor
84097765|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097766|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84097767|NCT04544436|Protective Agents|protective agents|mesh-ancestor
84097768|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
84097769|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
84097770|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097771|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097772|NCT04537156|Vaccines|vaccines|mesh-list
84097773|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
84097774|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097775|NCT04536298|Vitamin D|vitamin d|mesh-list
84097776|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
84097777|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
84097778|NCT04536298|Vitamins|vitamins|mesh-list
84097779|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
84097780|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097781|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84097782|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84097783|NCT04509674|Empagliflozin|empagliflozin|mesh-list
84097784|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84097785|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097786|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84097787|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097788|NCT04472429|Paclitaxel|paclitaxel|mesh-list
84097789|NCT04472429|Carboplatin|carboplatin|mesh-list
84097790|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84097791|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097792|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
84097793|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
84097794|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
84097795|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097796|NCT04465318|Nicotine|nicotine|mesh-list
84097797|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84097798|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
84097799|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097800|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097801|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84097802|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84097803|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
84097804|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097805|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097806|NCT04462523|Prednisolone|prednisolone|mesh-list
84097807|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097808|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
84097809|NCT04462523|Hormones|hormones|mesh-ancestor
84097810|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097811|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097812|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097813|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097814|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
84097815|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84097816|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84097817|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
84097818|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84097819|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097820|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097821|NCT04437108|Urological Agents|urological agents|mesh-ancestor
84097822|NCT04401761|Aspirin|aspirin|mesh-list
84097823|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
84097824|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84097825|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84097826|NCT04401761|Analgesics|analgesics|mesh-ancestor
84097827|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
84097828|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097829|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097830|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097831|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097832|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84097833|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84097834|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097835|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84097836|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84097837|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097838|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
84097839|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84097840|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
84097841|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84097842|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
84097843|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
84097844|NCT04395079|Durvalumab|durvalumab|mesh-list
84097845|NCT04395079|Ipilimumab|ipilimumab|mesh-list
84097846|NCT04395079|Tremelimumab|tremelimumab|mesh-list
84097847|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
84097848|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84097849|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
84097850|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097851|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097852|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
84097853|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097854|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097855|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097856|NCT04391309|Remdesivir|remdesivir|mesh-list
84097857|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
84097858|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097859|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
84097860|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097861|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
84097862|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84097863|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
84097864|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097865|NCT04381897|Expectorants|expectorants|mesh-ancestor
84097866|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
84097867|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84097868|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
84097869|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097870|NCT04381897|Protective Agents|protective agents|mesh-ancestor
84097871|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097872|NCT04381897|Antidotes|antidotes|mesh-ancestor
84097873|NCT04356690|Etoposide|etoposide|mesh-list
84097874|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84097875|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097876|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84097877|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84097878|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097879|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097880|NCT04353661|Azithromycin|azithromycin|mesh-list
84097881|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097882|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097883|NCT04352205|Thalidomide|thalidomide|mesh-list
84097884|NCT04352205|Dexamethasone|dexamethasone|mesh-list
84097885|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
84097886|NCT04352205|Lenalidomide|lenalidomide|mesh-list
84097887|NCT04352205|Bortezomib|bortezomib|mesh-list
84097888|NCT04352205|Daratumumab|daratumumab|mesh-list
84097889|NCT04352205|Ichthammol|ichthammol|mesh-list
84097890|NCT04352205|BB 1101|bb 1101|mesh-list
84097891|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097892|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
84097893|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
84097894|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097895|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097896|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097897|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
84097898|NCT04352205|Hormones|hormones|mesh-ancestor
84097899|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097900|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097901|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097902|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
84097903|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097904|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097905|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
84097906|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84097907|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84097908|NCT04352205|Growth Substances|growth substances|mesh-ancestor
84097909|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
84097910|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84097911|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
84097912|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097913|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097914|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
84097915|NCT04339140|Zafirlukast|zafirlukast|mesh-list
84097916|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84097917|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
84097918|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84097919|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
84097920|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097921|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097922|NCT04337827|Rituximab|rituximab|mesh-list
84097923|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
84097924|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097925|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097926|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
84097927|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097928|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097929|NCT04308785|Atezolizumab|atezolizumab|mesh-list
84097930|NCT04308785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097931|NCT04308785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097932|NCT04308785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097933|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097934|NCT04279847|INCB057643|incb057643|mesh-list
84097935|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097936|NCT04266301|Azacitidine|azacitidine|mesh-list
84097937|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84097938|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
84097939|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097940|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097941|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097942|NCT04263922|Valsartan|valsartan|mesh-list
84097943|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84097944|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84097945|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84097946|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097947|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
84097948|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097949|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097950|NCT04251117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097951|NCT04251117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097952|NCT04249622|Rifaximin|rifaximin|mesh-list
84097953|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84097954|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84097955|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097956|NCT04246047|Dexamethasone|dexamethasone|mesh-list
84097957|NCT04246047|Bortezomib|bortezomib|mesh-list
84097958|NCT04246047|Daratumumab|daratumumab|mesh-list
84097959|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097960|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
84097961|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
84097962|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097963|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097964|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84097965|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
84097966|NCT04246047|Hormones|hormones|mesh-ancestor
84097967|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84097968|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84097969|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097970|NCT04222062|Carmustine|carmustine|mesh-list
84097971|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84097972|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
84097973|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097974|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097975|NCT04221529|Atezolizumab|atezolizumab|mesh-list
84097976|NCT04221529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84097977|NCT04221529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097978|NCT04221529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84097979|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84097980|NCT04219774|Aspirin|aspirin|mesh-list
84097981|NCT04219774|Clopidogrel|clopidogrel|mesh-list
84097982|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84097983|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84097984|NCT04219774|Analgesics|analgesics|mesh-ancestor
84097985|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
84097986|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84097987|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84097988|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84097989|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84097990|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84097991|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84097992|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84097993|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84097994|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84097995|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84097996|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
84097997|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84097998|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84097999|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84098000|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
84098001|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098002|NCT04218539|Psilocybin|psilocybin|mesh-list
84098003|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
84098004|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098005|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84098006|NCT04195139|Nivolumab|nivolumab|mesh-list
84098007|NCT04195139|Temozolomide|temozolomide|mesh-list
84098008|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098009|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098010|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098011|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098012|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098013|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
84098014|NCT04174352|Tamoxifen|tamoxifen|mesh-list
84098015|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84098016|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
84098017|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098018|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098019|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098020|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098021|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84098022|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84098023|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84098024|NCT04150289|Panobinostat|panobinostat|mesh-list
84098025|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098026|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84098027|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098028|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098029|NCT04136756|Rituximab|rituximab|mesh-list
84098030|NCT04136756|Daratumumab|daratumumab|mesh-list
84098031|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098032|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098033|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
84098034|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098035|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098036|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
84098037|NCT04123366|Olaparib|olaparib|mesh-list
84098038|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098039|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098040|NCT04123366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098041|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098042|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84098043|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098044|NCT04092270|Doxorubicin|doxorubicin|mesh-list
84098045|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84098046|NCT04092270|Peposertib|peposertib|mesh-list
84098047|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84098048|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098049|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84098050|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098051|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098052|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098053|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098054|NCT04091386|Factor VIII|factor viii|mesh-list
84098055|NCT04091386|Coagulants|coagulants|mesh-ancestor
84098056|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
84098057|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
84098058|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098059|NCT04056624|Carotenoids|carotenoids|mesh-list
84098060|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
84098061|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098062|NCT04056624|Protective Agents|protective agents|mesh-ancestor
84098063|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098064|NCT04052880|Dexamethasone|dexamethasone|mesh-list
84098065|NCT04052880|Lenalidomide|lenalidomide|mesh-list
84098066|NCT04052880|Bortezomib|bortezomib|mesh-list
84098067|NCT04052880|Daratumumab|daratumumab|mesh-list
84098068|NCT04052880|Ixazomib|ixazomib|mesh-list
84098069|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098070|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
84098071|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
84098072|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098073|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098074|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84098075|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
84098076|NCT04052880|Hormones|hormones|mesh-ancestor
84098077|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098078|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098079|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098080|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
84098081|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098082|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098083|NCT04052880|Growth Substances|growth substances|mesh-ancestor
84098084|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098085|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
84098086|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098087|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098088|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
84098089|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
84098090|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098091|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84098092|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84098093|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84098094|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84098095|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84098096|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84098097|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84098098|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
84098099|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098100|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098101|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098102|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
84098103|NCT03969446|Decitabine|decitabine|mesh-list
84098104|NCT03969446|Venetoclax|venetoclax|mesh-list
84098105|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098106|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098107|NCT03969446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098108|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338121|NCT01544998|Tadalafil|tadalafil|mesh-list
84098109|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84098110|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
84098111|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098112|NCT03933631|Ofloxacin|ofloxacin|mesh-list
84098113|NCT03933631|Prednisolone|prednisolone|mesh-list
84098114|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
84098115|NCT03933631|Pilocarpine|pilocarpine|mesh-list
84098116|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098117|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
84098118|NCT03933631|Hormones|hormones|mesh-ancestor
84098119|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098120|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098121|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098122|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098123|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
84098124|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098125|NCT03933631|Miotics|miotics|mesh-ancestor
84098126|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84098127|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84098128|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
84098129|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098130|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098131|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84098132|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098133|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84098134|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84098135|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098136|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098137|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84098138|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84098139|NCT03927690|Ranibizumab|ranibizumab|mesh-list
84098140|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098141|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098142|NCT03927690|Growth Substances|growth substances|mesh-ancestor
84098143|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098144|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098145|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098146|NCT03900715|Luspatercept|luspatercept|mesh-list
84098147|NCT03900715|Hematinics|hematinics|mesh-ancestor
84098148|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84098149|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
84098150|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098151|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
84098152|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098153|NCT03858231|Acetaminophen|acetaminophen|mesh-list
84098154|NCT03858231|Ibuprofen|ibuprofen|mesh-list
84098155|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84098156|NCT03858231|Analgesics|analgesics|mesh-ancestor
84098157|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
84098158|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098159|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098160|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
84098161|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84098162|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098163|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098164|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84098165|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098166|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098167|NCT03856515|Nicotine|nicotine|mesh-list
84098168|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84098169|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
84098170|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098171|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098172|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84098173|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84098174|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
84098175|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098176|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098177|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
84098178|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84098179|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
84098180|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
84098181|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84098182|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098183|NCT03850782|Bimatoprost|bimatoprost|mesh-list
84098184|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84098186|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098187|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098188|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098189|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098190|NCT03806985|Psilocybin|psilocybin|mesh-list
84098191|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
84098192|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098193|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84098194|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
84098195|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098196|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
84098197|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098198|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098199|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84098200|NCT03761173|Anticoagulants|anticoagulants|mesh-list
84098201|NCT03742414|Fluticasone|fluticasone|mesh-list
84098202|NCT03742414|Xhance|xhance|mesh-list
84098203|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098204|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84098205|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
84098206|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098207|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098208|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84098209|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
84098210|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
84098211|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84098212|NCT03728556|Antibodies|antibodies|mesh-list
84098213|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84098214|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
84098215|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098216|NCT03677141|Prednisone|prednisone|mesh-list
84098217|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
84098218|NCT03677141|Doxorubicin|doxorubicin|mesh-list
84098219|NCT03677141|Vincristine|vincristine|mesh-list
84098220|NCT03677141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
84098221|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098222|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
84098223|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098224|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098225|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098226|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
84098227|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098228|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098229|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84098230|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84098231|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84098232|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098233|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098234|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098235|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
84098236|NCT03677141|Hormones|hormones|mesh-ancestor
84098237|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098238|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098239|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098240|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098241|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098242|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098243|NCT03677141|Immunoconjugates|immunoconjugates|mesh-ancestor
84098244|NCT03634228|Cytarabine|cytarabine|mesh-list
84098245|NCT03634228|Venetoclax|venetoclax|mesh-list
84098246|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84098247|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
83429597|NCT00210626|Hematinics|hematinics|mesh-ancestor
84098248|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098249|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098250|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
84098251|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098252|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098253|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
84098254|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098255|NCT03612973|Insulin|insulin|mesh-list
84098256|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84098257|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098258|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
84098259|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098260|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098261|NCT03603223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098262|NCT03603223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098263|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
84098264|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
84098265|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098266|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
84098267|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
84098268|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098269|NCT03587142|Buspirone|buspirone|mesh-list
84098270|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84098271|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84098272|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84098273|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098274|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84098275|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84098276|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
84098277|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098278|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098279|NCT03559647|Atezolizumab|atezolizumab|mesh-list
84098280|NCT03559647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098281|NCT03559647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098282|NCT03559647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098283|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098284|NCT03535688|Cycloserine|cycloserine|mesh-list
84098285|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84098286|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098287|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84098288|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
84098289|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84098290|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
84098291|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098292|NCT03532139|Enoxaparin|enoxaparin|mesh-list
84098293|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
84098294|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84098295|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84098296|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84098297|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
84098298|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098299|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84098300|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84098301|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098302|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
84098303|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84098304|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84098305|NCT03509584|Nivolumab|nivolumab|mesh-list
84098306|NCT03509584|Ipilimumab|ipilimumab|mesh-list
84098307|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098308|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098309|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098310|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098311|NCT03493945|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84098312|NCT03493945|Antiviral Agents|antiviral agents|mesh-ancestor
84098313|NCT03493945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098314|NCT03493854|Paclitaxel|paclitaxel|mesh-list
84098315|NCT03493854|Docetaxel|docetaxel|mesh-list
84098316|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
84098317|NCT03493854|Doxorubicin|doxorubicin|mesh-list
84098318|NCT03493854|Trastuzumab|trastuzumab|mesh-list
84098319|NCT03493854|Pertuzumab|pertuzumab|mesh-list
84098320|NCT03493854|Hormones|hormones|mesh-list
84098321|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098322|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098323|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098324|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098325|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098326|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098327|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098328|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
84098329|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098330|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098331|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098332|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
84098333|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83338344|NCT02520180|Everolimus|everolimus|mesh-list
84098334|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84098335|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84098336|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098337|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098338|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098339|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098340|NCT03448042|Trastuzumab|trastuzumab|mesh-list
84098341|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098342|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098343|NCT03440567|Rituximab|rituximab|mesh-list
84098344|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84098345|NCT03440567|Avelumab|avelumab|mesh-list
84098346|NCT03440567|Carboplatin|carboplatin|mesh-list
84098347|NCT03440567|Etoposide|etoposide|mesh-list
84098348|NCT03440567|Ifosfamide|ifosfamide|mesh-list
84098349|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
84098350|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
84098351|NCT03440567|Antibodies|antibodies|mesh-list
84098352|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
84098353|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84098354|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
84098355|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
84098356|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098357|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098358|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098359|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098360|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84098361|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098362|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098363|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098364|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098365|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
84098366|NCT03390686|Paclitaxel|paclitaxel|mesh-list
84098367|NCT03390686|Bevacizumab|bevacizumab|mesh-list
84098368|NCT03390686|Carboplatin|carboplatin|mesh-list
84098369|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098370|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098371|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098372|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098373|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098374|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098375|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098376|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098377|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098378|NCT03390686|Growth Substances|growth substances|mesh-ancestor
84098379|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098380|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098381|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
84098382|NCT03384277|Rituximab|rituximab|mesh-list
84098383|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098384|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
84098385|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098386|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098387|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098388|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
84098389|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098390|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098391|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84098392|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098393|NCT03370367|Tretinoin|tretinoin|mesh-list
84098394|NCT03370367|Isotretinoin|isotretinoin|mesh-list
84098395|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098396|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
84098397|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
84098398|NCT03341689|Psilocybin|psilocybin|mesh-list
84098399|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
84098400|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098401|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84098402|NCT03324425|Simvastatin|simvastatin|mesh-list
84098403|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84098404|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84098405|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
83338418|NCT03390738|Nivolumab|nivolumab|mesh-list
84098406|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098407|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84098408|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84098409|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098411|NCT03317457|Durvalumab|durvalumab|mesh-list
84098412|NCT03317457|Tremelimumab|tremelimumab|mesh-list
84098413|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84098414|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098415|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84098416|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098417|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098418|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098419|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098420|NCT03267836|Avelumab|avelumab|mesh-list
84098421|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098422|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098423|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
84098424|NCT03197506|Temozolomide|temozolomide|mesh-list
84098425|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098426|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098427|NCT03197506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098428|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098429|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098430|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
84098431|NCT03188705|Aspirin|aspirin|mesh-list
84098432|NCT03188705|Clopidogrel|clopidogrel|mesh-list
84098433|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84098434|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84098435|NCT03188705|Analgesics|analgesics|mesh-ancestor
84098436|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
84098437|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098438|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098439|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098440|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098441|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84098442|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84098443|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098444|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84098445|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84098446|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098447|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
84098448|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84098449|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84098450|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84098451|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
84098452|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098453|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
84098454|NCT03113487|Vaccines|vaccines|mesh-list
84098455|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
84098456|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098457|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098458|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098459|NCT03113487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098460|NCT03113487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098461|NCT03072238|Prednisone|prednisone|mesh-list
84098462|NCT03072238|Prednisolone|prednisolone|mesh-list
84098463|NCT03072238|Ipatasertib|ipatasertib|mesh-list
84098464|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098465|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
84098466|NCT03072238|Hormones|hormones|mesh-ancestor
84098467|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098468|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098469|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098470|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098471|NCT03072238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098472|NCT03072238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098473|NCT03072238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098474|NCT03032484|Bevacizumab|bevacizumab|mesh-list
84098475|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098476|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098477|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098478|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098479|NCT03032484|Growth Substances|growth substances|mesh-ancestor
84098480|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098481|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098482|NCT03003546|Paclitaxel|paclitaxel|mesh-list
84098483|NCT03003546|Rituximab|rituximab|mesh-list
84098485|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098486|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098487|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098488|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098489|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098490|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098491|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098492|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
84098493|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098494|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098495|NCT02996825|Gemcitabine|gemcitabine|mesh-list
84098496|NCT02996825|Maytansine|maytansine|mesh-list
84098497|NCT02996825|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
84098498|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84098499|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
84098500|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098501|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098502|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098503|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098504|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098505|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098506|NCT02996825|Immunoconjugates|immunoconjugates|mesh-ancestor
84098507|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
84098508|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098509|NCT02981173|Psilocybin|psilocybin|mesh-list
84098510|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
84098511|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098512|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84098513|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84098514|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
84098515|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098516|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
84098517|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098518|NCT02955394|Fulvestrant|fulvestrant|mesh-list
84098519|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098520|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098521|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84098522|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84098523|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
84098524|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098525|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098526|NCT02864953|Glyburide|glyburide|mesh-list
84098527|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84098528|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098529|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84098530|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098531|NCT02768532|Vedolizumab|vedolizumab|mesh-list
84098532|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84098533|NCT02710851|Vaccines|vaccines|mesh-list
84098534|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
84098535|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098536|NCT02675829|Trastuzumab|trastuzumab|mesh-list
84098537|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84098538|NCT02675829|Maytansine|maytansine|mesh-list
84098539|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098540|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098541|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098542|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098543|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098544|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098545|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098546|NCT02675829|Immunotoxins|immunotoxins|mesh-ancestor
84098547|NCT02675829|Immunoconjugates|immunoconjugates|mesh-ancestor
84098548|NCT02675829|Immunologic Factors|immunologic factors|mesh-ancestor
84098549|NCT02675829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098550|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84098551|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098552|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098553|NCT02588651|Immunotoxins|immunotoxins|mesh-ancestor
84098554|NCT02588651|Immunoconjugates|immunoconjugates|mesh-ancestor
84098555|NCT02588651|Immunologic Factors|immunologic factors|mesh-ancestor
84098556|NCT02588651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098557|NCT02554851|Mitogens|mitogens|mesh-list
84098558|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098559|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098560|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84098561|NCT02520141|Ramucirumab|ramucirumab|mesh-list
84098562|NCT02520141|Antibodies|antibodies|mesh-list
84098563|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
84098564|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84098565|NCT02520141|Lexatumumab|lexatumumab|mesh-list
84098566|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
84098567|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098568|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098569|NCT02513875|Vitamin D|vitamin d|mesh-list
84098570|NCT02513875|Vitamins|vitamins|mesh-ancestor
84098571|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
84098572|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098573|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84098574|NCT02513394|Palbociclib|palbociclib|mesh-list
84098575|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098576|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098577|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098578|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098579|NCT02329847|Nivolumab|nivolumab|mesh-list
84098580|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098581|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098582|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098583|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098584|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
84098585|NCT02287428|Temozolomide|temozolomide|mesh-list
84098586|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098587|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098588|NCT02287428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098589|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098590|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098591|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
84098592|NCT02286687|Talazoparib|talazoparib|mesh-list
84098593|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84098594|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098595|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098596|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098597|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84098598|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
84098599|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098600|NCT02192359|Irinotecan|irinotecan|mesh-list
84098601|NCT02192359|Camptothecin|camptothecin|mesh-list
84098602|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84098603|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098604|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098605|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098606|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098607|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098608|NCT02169310|Raclopride|raclopride|mesh-list
84098609|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84098610|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84098611|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84098612|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098613|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84098614|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84098615|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
84098616|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098617|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098618|NCT02145143|Vemurafenib|vemurafenib|mesh-list
84098619|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098620|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098621|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098622|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098623|NCT02133196|Aldesleukin|aldesleukin|mesh-list
84098624|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
84098625|NCT02133196|Fludarabine|fludarabine|mesh-list
84098626|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098627|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
84098628|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098629|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098630|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83338636|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098631|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
84098632|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098633|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098634|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84098635|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84098636|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84098637|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
84098638|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098639|NCT02119468|Dexamethasone|dexamethasone|mesh-list
84098640|NCT02119468|Pomalidomide|pomalidomide|mesh-list
84098642|NCT02119468|Glycine|glycine|mesh-list
84098643|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
84098644|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098645|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
84098646|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
84098647|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098648|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098649|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84098650|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
84098651|NCT02119468|Hormones|hormones|mesh-ancestor
84098652|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098653|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098654|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098655|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098656|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
84098657|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098658|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098659|NCT02119468|Growth Substances|growth substances|mesh-ancestor
84098660|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098661|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
84098662|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098663|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
84098664|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098665|NCT02017717|Bevacizumab|bevacizumab|mesh-list
84098666|NCT02017717|Nivolumab|nivolumab|mesh-list
84098667|NCT02017717|Ipilimumab|ipilimumab|mesh-list
84098668|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098669|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098670|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098671|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098672|NCT02017717|Growth Substances|growth substances|mesh-ancestor
84098673|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098674|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098675|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098676|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098677|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84098678|NCT01935921|Cetuximab|cetuximab|mesh-list
84098679|NCT01935921|Ipilimumab|ipilimumab|mesh-list
84098680|NCT01935921|Antibodies|antibodies|mesh-list
84098681|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
84098682|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84098683|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
84098684|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098685|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098686|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098687|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098688|NCT01863550|Dexamethasone|dexamethasone|mesh-list
84098689|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
84098690|NCT01863550|Lenalidomide|lenalidomide|mesh-list
84098691|NCT01863550|Bortezomib|bortezomib|mesh-list
84098692|NCT01863550|Ichthammol|ichthammol|mesh-list
84098693|NCT01863550|BB 1101|bb 1101|mesh-list
84098694|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098695|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
84098696|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
84098697|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098698|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098699|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84098700|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
84098701|NCT01863550|Hormones|hormones|mesh-ancestor
84098702|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098703|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098704|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098705|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
84098706|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098707|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098708|NCT01863550|Growth Substances|growth substances|mesh-ancestor
84098710|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
84098711|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098712|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098713|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
84098714|NCT01824836|Anastrozole|anastrozole|mesh-list
84098715|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098716|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098717|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84098718|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84098719|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098720|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098721|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84098722|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
84098723|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098724|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098725|NCT01810913|Cisplatin|cisplatin|mesh-list
84098726|NCT01810913|Docetaxel|docetaxel|mesh-list
84098727|NCT01810913|Cetuximab|cetuximab|mesh-list
84098728|NCT01810913|Atezolizumab|atezolizumab|mesh-list
84098729|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84098730|NCT01810913|Antibodies|antibodies|mesh-list
84098731|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
84098732|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84098733|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
84098734|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098735|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098736|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098737|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098738|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098739|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098740|NCT01810913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84098741|NCT01552434|Sirolimus|sirolimus|mesh-list
84098742|NCT01552434|Bevacizumab|bevacizumab|mesh-list
84098743|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84098744|NCT01552434|Cetuximab|cetuximab|mesh-list
84098745|NCT01552434|Temsirolimus|temsirolimus|mesh-list
84098746|NCT01552434|MTOR Inhibitors|mtor inhibitors|mesh-list
84098747|NCT01552434|Valproic Acid|valproic acid|mesh-list
84098748|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
84098749|NCT01552434|Antibodies|antibodies|mesh-list
84098750|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
84098751|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84098752|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
84098753|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098754|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098755|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098756|NCT01552434|Growth Substances|growth substances|mesh-ancestor
84098757|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098758|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098759|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
84098760|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84098761|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098762|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84098763|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
84098764|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098765|NCT01552434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098766|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098767|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098768|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
84098769|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
84098770|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84098771|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
84098772|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84098773|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84098774|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84098775|NCT01415752|Rituximab|rituximab|mesh-list
84098776|NCT01415752|Lenalidomide|lenalidomide|mesh-list
84098777|NCT01415752|Bortezomib|bortezomib|mesh-list
84098778|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84098779|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098780|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098781|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
84098782|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338784|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84098783|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098784|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098785|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098786|NCT01415752|Growth Substances|growth substances|mesh-ancestor
84098787|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098788|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098789|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
84098790|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098791|NCT01164228|Gemcitabine|gemcitabine|mesh-list
84098793|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84098794|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
84098795|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098796|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098797|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098798|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098799|NCT01164228|Growth Substances|growth substances|mesh-ancestor
84098800|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098801|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098802|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098803|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098804|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
84098805|NCT00950846|Busulfan|busulfan|mesh-list
84098806|NCT00950846|Fludarabine|fludarabine|mesh-list
84098807|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098808|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
84098809|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098810|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098811|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098812|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
84098813|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098814|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098815|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84098816|NCT00923013|Rituximab|rituximab|mesh-list
84098817|NCT00923013|Cladribine|cladribine|mesh-list
84098818|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098819|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098820|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
84098821|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098822|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098823|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098824|NCT00641030|Melphalan|melphalan|mesh-list
84098825|NCT00641030|Clofarabine|clofarabine|mesh-list
84098826|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098827|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
84098828|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098829|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098830|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84098831|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098832|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
84098833|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098834|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84098835|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
84098836|NCT00554515|Aldesleukin|aldesleukin|mesh-list
84098837|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098838|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84098839|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84098840|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
84098841|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098842|NCT00329043|Sunitinib|sunitinib|mesh-list
84098843|NCT00329043|Leuprolide|leuprolide|mesh-list
84098844|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098845|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098846|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098847|NCT00329043|Growth Substances|growth substances|mesh-ancestor
84098848|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098849|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098850|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098851|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098852|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098853|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84098854|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
84098855|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84098856|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098857|NCT00209586|Fospropofol|fospropofol|mesh-list
84098858|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84098859|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84098860|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098861|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
84098862|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098863|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098864|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098865|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84098866|NCT00082797|Leucovorin|leucovorin|mesh-list
84098867|NCT00082797|Methotrexate|methotrexate|mesh-list
84098868|NCT00082797|Calcium|calcium|mesh-list
84098869|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
84098870|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84098871|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098872|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84098873|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
84098874|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84098875|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84098876|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
84098877|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098878|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098879|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
84098880|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098881|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84098882|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098883|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
84098884|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098885|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84098886|NCT00082797|Antidotes|antidotes|mesh-ancestor
84098887|NCT00082797|Protective Agents|protective agents|mesh-ancestor
84098888|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
84098889|NCT00082797|Vitamins|vitamins|mesh-ancestor
84098890|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
84098891|NCT00060398|Dexamethasone|dexamethasone|mesh-list
84098892|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
84098893|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098894|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
84098895|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
84098896|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098897|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098898|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84098899|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
84098900|NCT00060398|Hormones|hormones|mesh-ancestor
84098901|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84098902|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84098903|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098904|NCT00060398|Hematinics|hematinics|mesh-ancestor
84098905|NCT00054561|Vitamin E|vitamin e|mesh-list
84098906|NCT00054561|Interferons|interferons|mesh-list
84098907|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
84098908|NCT00054561|Isotretinoin|isotretinoin|mesh-list
84098909|NCT00054561|Vitamins|vitamins|mesh-ancestor
84098910|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
84098911|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098912|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098913|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
84098914|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098915|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
84098916|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
84098917|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098918|NCT00054561|Protective Agents|protective agents|mesh-ancestor
84098919|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
84098920|NCT00049517|Cytarabine|cytarabine|mesh-list
84098921|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
84098922|NCT00049517|Busulfan|busulfan|mesh-list
84098923|NCT00049517|Daunorubicin|daunorubicin|mesh-list
84098924|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
84098925|NCT00049517|Sargramostim|sargramostim|mesh-list
84098926|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84098927|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
84098928|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098929|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098930|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84098931|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
84098932|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098933|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098934|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84098935|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83338936|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
84098936|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
84098937|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
84098938|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098939|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84098940|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84098941|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84098942|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098943|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098944|NCT00049517|Immunotoxins|immunotoxins|mesh-ancestor
84098945|NCT00049517|Immunoconjugates|immunoconjugates|mesh-ancestor
84098946|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
84098947|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098948|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84098949|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098950|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098951|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
84098952|NCT00041314|Carboplatin|carboplatin|mesh-list
84098953|NCT00041314|Gemcitabine|gemcitabine|mesh-list
84098954|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098955|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84098956|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
84098957|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098958|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84098959|NCT00041314|Protective Agents|protective agents|mesh-ancestor
84098960|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098961|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84098962|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84098963|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84098964|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84098965|NCT00041314|Analgesics|analgesics|mesh-ancestor
84098966|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
84098967|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84098968|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098969|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84098970|NCT00028990|Paclitaxel|paclitaxel|mesh-list
84098971|NCT00028990|Bevacizumab|bevacizumab|mesh-list
84098972|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84098973|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098974|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098975|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098976|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098977|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84098978|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84098979|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84098980|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84098981|NCT00028990|Growth Substances|growth substances|mesh-ancestor
84098982|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84098983|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
84098984|NCT00027859|Ketoconazole|ketoconazole|mesh-list
84098985|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
84098986|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84098987|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84098988|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84098989|NCT00027859|Docetaxel|docetaxel|mesh-list
84098990|NCT00027859|Estramustine|estramustine|mesh-list
84098991|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84098992|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
84098993|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
84098994|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
84098995|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429609|NCT03595514|Hormones|hormones|mesh-ancestor
84098996|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84098997|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
84098998|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84098999|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84099000|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84099001|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099002|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84099003|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
84099004|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099005|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099006|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84099007|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84099008|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
84099009|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099010|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83339009|NCT05173584|Albuterol|albuterol|mesh-list
84099012|NCT00026286|Estrogens|estrogens|mesh-list
84099013|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84099014|NCT00026286|Hormones|hormones|mesh-ancestor
84099015|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099016|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099017|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84099018|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84099019|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84099020|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
84099021|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84099022|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84099023|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84099024|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84099025|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099026|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099027|NCT00014118|Paclitaxel|paclitaxel|mesh-list
84099028|NCT00014118|Carboplatin|carboplatin|mesh-list
84099029|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099030|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099031|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099032|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099033|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099034|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099035|NCT00006004|Paclitaxel|paclitaxel|mesh-list
84099036|NCT00006004|Carboplatin|carboplatin|mesh-list
84099037|NCT00006004|Gemcitabine|gemcitabine|mesh-list
84099038|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099039|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099040|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099041|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099042|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099043|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099044|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84099045|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
84099046|NCT00004860|Leucovorin|leucovorin|mesh-list
84099047|NCT00004860|Tegafur|tegafur|mesh-list
84099048|NCT00004860|Calcium|calcium|mesh-list
84099049|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
84099050|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84099051|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099052|NCT00004860|Antidotes|antidotes|mesh-ancestor
84099053|NCT00004860|Protective Agents|protective agents|mesh-ancestor
84099054|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
84099055|NCT00004860|Vitamins|vitamins|mesh-ancestor
84099056|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
84099057|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84099058|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
84099059|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099060|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099061|NCT00003864|Carboplatin|carboplatin|mesh-list
84099062|NCT00003864|Docetaxel|docetaxel|mesh-list
84099063|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099064|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099065|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099066|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099067|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099068|NCT00003810|Gemcitabine|gemcitabine|mesh-list
84099069|NCT00003810|Docetaxel|docetaxel|mesh-list
84099070|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84099071|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
84099072|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099073|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099074|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099075|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099076|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099077|NCT00003701|Paclitaxel|paclitaxel|mesh-list
84099078|NCT00003701|Vinblastine|vinblastine|mesh-list
84099079|NCT00003701|Carboplatin|carboplatin|mesh-list
84099080|NCT00003701|Doxorubicin|doxorubicin|mesh-list
84099081|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84099082|NCT00003701|Methotrexate|methotrexate|mesh-list
84099083|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099084|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099085|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099086|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099087|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099088|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099089|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84099090|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84099091|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84099092|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099093|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84099094|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
84099095|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84099096|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099097|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84099098|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
84099099|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
84099100|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84099101|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84099102|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
84099103|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099104|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84099105|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
84099106|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099107|NCT00003614|Paclitaxel|paclitaxel|mesh-list
84099108|NCT00003614|Estramustine|estramustine|mesh-list
84099109|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099110|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099111|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099112|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099113|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099114|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099115|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84099116|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
84099117|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099118|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
84099119|NCT00003519|Docetaxel|docetaxel|mesh-list
84099120|NCT00003519|Doxorubicin|doxorubicin|mesh-list
84099121|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84099122|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84099123|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
84099124|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099125|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099126|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84099127|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
84099128|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099129|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099130|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84099131|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099132|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099133|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099134|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84099135|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84099136|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84099137|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099138|NCT00003283|Prednisone|prednisone|mesh-list
84099139|NCT00003283|Octreotide|octreotide|mesh-list
84099140|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099141|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
84099142|NCT00003283|Hormones|hormones|mesh-ancestor
84099143|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099144|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099145|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099146|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099147|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84099148|NCT00003235|Paclitaxel|paclitaxel|mesh-list
84099149|NCT00003235|Carboplatin|carboplatin|mesh-list
84099150|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099151|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099152|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099153|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099154|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099155|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099156|NCT00003206|Paclitaxel|paclitaxel|mesh-list
84099157|NCT00003206|Carboplatin|carboplatin|mesh-list
84099158|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099159|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099160|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099161|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099162|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099163|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099165|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099166|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099167|NCT00003008|Ritonavir|ritonavir|mesh-list
84099168|NCT00003008|Nelfinavir|nelfinavir|mesh-list
84099169|NCT00003008|Indinavir|indinavir|mesh-list
84099170|NCT00003008|Saquinavir|saquinavir|mesh-list
84099171|NCT00003008|Paclitaxel|paclitaxel|mesh-list
84099172|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099173|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099174|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099175|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099176|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099177|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099178|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84099179|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84099180|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
84099181|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099182|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84099183|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84099184|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
84099185|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099186|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84099187|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84099188|NCT00002996|Flecainide|flecainide|mesh-list
84099189|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84099190|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84099191|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84099192|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099193|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099194|NCT00002878|Dexamethasone|dexamethasone|mesh-list
84099195|NCT00002878|Doxorubicin|doxorubicin|mesh-list
84099196|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84099197|NCT00002878|Vincristine|vincristine|mesh-list
84099198|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099199|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
84099200|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
84099201|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099202|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099203|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84099204|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
84099205|NCT00002878|Hormones|hormones|mesh-ancestor
84099206|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099207|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099208|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099209|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84099210|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84099211|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84099212|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099213|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099214|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099215|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099216|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099217|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099218|NCT00002632|Paclitaxel|paclitaxel|mesh-list
84099219|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099220|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099221|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099222|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099223|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099224|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099225|NCT00002520|Nicotine|nicotine|mesh-list
84099226|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84099227|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
84099228|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099229|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099230|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84099231|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84099232|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
84099233|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099234|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099235|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
84099236|NCT00001230|Filaricides|filaricides|mesh-ancestor
84099237|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
84099238|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
84099239|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84099240|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099241|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84099242|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099243|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099244|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84099245|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84099246|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84099247|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099248|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099249|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099250|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099251|NCT00609557|Analgesics|analgesics|mesh-ancestor
84099252|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
84099253|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099254|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
84099255|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84099256|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
84099257|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
84099258|NCT05122481|Vitamins|vitamins|mesh-ancestor
84099259|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
84099260|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099261|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
84099262|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099263|NCT05122481|Protective Agents|protective agents|mesh-ancestor
84099264|NCT00937417|Docetaxel|docetaxel|mesh-list
84099265|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099266|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099267|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099268|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099269|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099270|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84099271|NCT02728440|Menotropins|menotropins|mesh-list
84099272|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84099273|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099274|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84099275|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
84099276|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
84099277|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
84099278|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
84099279|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84099280|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84099281|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099282|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099283|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099284|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099285|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
84099286|NCT00930865|Bumetanide|bumetanide|mesh-list
84099287|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84099288|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099289|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099290|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099291|NCT00930865|Diuretics|diuretics|mesh-ancestor
84099292|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
84099293|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84099294|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099295|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84099296|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
84099297|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84099298|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
84099299|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84099300|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099301|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84099302|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099303|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099304|NCT00934531|Donepezil|donepezil|mesh-list
84099305|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84099306|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099307|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099308|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
84099309|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099310|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099311|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
84099312|NCT00931021|Nicotine|nicotine|mesh-list
84099313|NCT00931021|Varenicline|varenicline|mesh-list
84099314|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84099315|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
84099316|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099317|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099318|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84099319|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84099320|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
84099321|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099322|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099323|NCT00937807|Sevoflurane|sevoflurane|mesh-list
84099324|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84099325|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84099326|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
84099327|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
84099328|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099329|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099330|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
84099331|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84099332|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84099333|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84099334|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099335|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099336|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
84099337|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099338|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099339|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84099340|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099341|NCT02808728|Bupivacaine|bupivacaine|mesh-list
84099342|NCT02808728|Ropivacaine|ropivacaine|mesh-list
84099343|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
84099344|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
84099345|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099346|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099347|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
84099348|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099349|NCT05331053|Atorvastatin|atorvastatin|mesh-list
84099350|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84099351|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84099352|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
84099353|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099354|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84099355|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84099356|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099357|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84099358|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84099359|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84099360|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099361|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099362|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
84099363|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099364|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84099365|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84099366|NCT02808650|Prexasertib|prexasertib|mesh-list
84099367|NCT02808650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84099368|NCT02808650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099369|NCT02808650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099370|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
84099371|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84099372|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
84099373|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099374|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099375|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84099376|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
84099377|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84099378|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
84099379|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099380|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099381|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84099382|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
84099383|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
84099384|NCT04996667|Protective Agents|protective agents|mesh-ancestor
84099386|NCT00929669|Hormones|hormones|mesh-ancestor
84099387|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099388|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099389|NCT02804360|Dexamethasone|dexamethasone|mesh-list
84099390|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
84099391|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099392|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
84099393|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
84099394|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099395|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099396|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84099397|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
84099398|NCT02804360|Hormones|hormones|mesh-ancestor
84099399|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099400|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099401|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099402|NCT02727738|Selenium|selenium|mesh-list
84099403|NCT02727738|Methimazole|methimazole|mesh-list
84099404|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
84099405|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099406|NCT02727738|Protective Agents|protective agents|mesh-ancestor
84099407|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099408|NCT02727738|Trace Elements|trace elements|mesh-ancestor
84099409|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
84099410|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
84099411|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
84099412|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099413|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84099414|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
84099415|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
84099416|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84099417|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099418|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84099419|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84099420|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84099421|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099422|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099423|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84099424|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84099425|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84099426|NCT02811692|Aflibercept|aflibercept|mesh-list
84099427|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84099428|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84099429|NCT02811692|Growth Substances|growth substances|mesh-ancestor
84099430|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099431|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
84099432|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099433|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
84099434|NCT04004078|Clotrimazole|clotrimazole|mesh-list
84099435|NCT04004078|Miconazole|miconazole|mesh-list
84099436|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099437|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84099438|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83429614|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
84099439|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84099440|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099441|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099442|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84099443|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
84099444|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099445|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099446|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84099447|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84099448|NCT02732262|Oxycodone|oxycodone|mesh-list
84099449|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84099450|NCT02732262|Narcotics|narcotics|mesh-ancestor
84099451|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099452|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099453|NCT02732262|Analgesics|analgesics|mesh-ancestor
84099454|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
84099455|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099456|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84099457|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
84099458|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84099459|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84099460|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84099461|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099462|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099463|NCT02737254|Oxytocin|oxytocin|mesh-list
84099464|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
84099465|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84099466|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099467|NCT00938197|Amlodipine|amlodipine|mesh-list
84099468|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84099469|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84099470|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099471|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099472|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84099473|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099474|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
84099475|NCT02727504|Dobutamine|dobutamine|mesh-list
84099476|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84099477|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
84099478|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
84099479|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099480|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099481|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84099482|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84099483|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84099484|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
84099485|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099486|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099487|NCT02727504|Protective Agents|protective agents|mesh-ancestor
84099488|NCT02727348|Anesthetics|anesthetics|mesh-list
84099489|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099490|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099491|NCT02804126|Acetaminophen|acetaminophen|mesh-list
84099492|NCT02804126|Dipyrone|dipyrone|mesh-list
84099493|NCT02804126|Ketoprofen|ketoprofen|mesh-list
84099494|NCT02804126|Morphine|morphine|mesh-list
84099495|NCT02804126|Bupivacaine|bupivacaine|mesh-list
84099496|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
84099497|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
84099498|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099499|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099500|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
84099501|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099502|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84099503|NCT02804126|Narcotics|narcotics|mesh-ancestor
84099504|NCT02804126|Analgesics|analgesics|mesh-ancestor
84099505|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84099506|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
84099507|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84099508|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099509|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099510|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84099511|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099512|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099513|NCT04013815|Ropivacaine|ropivacaine|mesh-list
84099514|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
84099515|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
84099516|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099517|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099518|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
84099519|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099520|NCT00610103|Apomorphine|apomorphine|mesh-list
84099521|NCT00610103|Emetics|emetics|mesh-ancestor
84099522|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099523|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
84099524|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099525|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84099526|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
84099527|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
84099528|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099529|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099530|NCT05624190|Plasminogen|plasminogen|mesh-list
84099531|NCT05624190|Tenecteplase|tenecteplase|mesh-list
84099532|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84099533|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84099534|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84099535|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099536|NCT00938353|Beclomethasone|beclomethasone|mesh-list
84099537|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099538|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
84099539|NCT00938353|Hormones|hormones|mesh-ancestor
84099540|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099541|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099542|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84099543|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
84099544|NCT04259333|Acetaminophen|acetaminophen|mesh-list
84099545|NCT04259333|Celecoxib|celecoxib|mesh-list
84099546|NCT04259333|Codeine|codeine|mesh-list
84099547|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84099548|NCT04259333|Analgesics|analgesics|mesh-ancestor
84099549|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
84099550|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099551|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099552|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
84099553|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84099554|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099555|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099556|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84099557|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84099558|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099559|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099560|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84099561|NCT04259333|Narcotics|narcotics|mesh-ancestor
84099562|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099563|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
84099564|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
84099565|NCT02721420|Piperaquine|piperaquine|mesh-list
84099566|NCT02721420|Artenimol|artenimol|mesh-list
84099567|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
84099568|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84099569|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84099570|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099571|NCT00608699|Niacin|niacin|mesh-list
84099572|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84099573|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
84099574|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099575|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84099576|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
84099577|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
84099578|NCT00608699|Vitamins|vitamins|mesh-ancestor
84099579|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
84099580|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099581|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
84099582|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099583|NCT02726490|Metformin|metformin|mesh-list
84099584|NCT02726490|Glyburide|glyburide|mesh-list
84099585|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099586|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099587|NCT02726646|Doxycycline|doxycycline|mesh-list
84099588|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84099589|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099590|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
84099591|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84099592|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84099593|NCT02803892|Vildagliptin|vildagliptin|mesh-list
84099594|NCT02803892|Sirolimus|sirolimus|mesh-list
84099595|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84099596|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099597|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84099598|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099599|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
84099600|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84099601|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
84099602|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099603|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099604|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099605|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099606|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84099607|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
83339614|NCT03374280|Cisplatin|cisplatin|mesh-list
84099608|NCT02803502|Thrombin|thrombin|mesh-list
84099609|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
84099610|NCT02803502|Coagulants|coagulants|mesh-ancestor
84099611|NCT02721186|Piperaquine|piperaquine|mesh-list
84099612|NCT02721186|Primaquine|primaquine|mesh-list
84099613|NCT02721186|Artenimol|artenimol|mesh-list
84099614|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
84099615|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84099616|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84099617|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099618|NCT02716428|Ribavirin|ribavirin|mesh-list
84099619|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
84099620|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099621|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
84099622|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099623|NCT05511428|Daratumumab|daratumumab|mesh-list
84099624|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84099625|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099626|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
84099627|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099628|NCT00931463|Ritonavir|ritonavir|mesh-list
84099629|NCT00931463|Lopinavir|lopinavir|mesh-list
84099630|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
84099631|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84099632|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84099633|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
84099634|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099635|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099636|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84099637|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84099638|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
84099639|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099640|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84099641|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84099642|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84099643|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84099644|NCT03974594|Trifluridine|trifluridine|mesh-list
84099645|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
84099646|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099647|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
84099648|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099649|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
84099650|NCT03964688|Vitamins|vitamins|mesh-ancestor
84099651|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
84099652|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099653|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
84099654|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099655|NCT03964688|Protective Agents|protective agents|mesh-ancestor
84099656|NCT00929201|Metformin|metformin|mesh-list
84099657|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84099658|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099659|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099660|NCT00929201|Incretins|incretins|mesh-ancestor
84099661|NCT00929201|Hormones|hormones|mesh-ancestor
84099662|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099663|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84099664|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
84099665|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099666|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099667|NCT02800772|Acetic Acid|acetic acid|mesh-list
84099668|NCT02800772|Retinol acetate|retinol acetate|mesh-list
84099669|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84099670|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099671|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84099672|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
84099673|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099674|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84099675|NCT02800772|Protective Agents|protective agents|mesh-ancestor
84099676|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099677|NCT02773212|Amphetamine|amphetamine|mesh-list
84099678|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
84099679|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84099680|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099681|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
84099682|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
84099683|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099684|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
84099685|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099686|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099687|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
84099688|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84099689|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84099690|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099691|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84099692|NCT00610493|Sirolimus|sirolimus|mesh-list
84099693|NCT00610493|Bevacizumab|bevacizumab|mesh-list
84099694|NCT00610493|Temsirolimus|temsirolimus|mesh-list
84099695|NCT00610493|MTOR Inhibitors|mtor inhibitors|mesh-list
84099696|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84099697|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099698|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84099699|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84099700|NCT00610493|Growth Substances|growth substances|mesh-ancestor
84099701|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099702|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
84099703|NCT00610493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84099704|NCT00610493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099705|NCT00610493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099706|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84099707|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
84099708|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84099709|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099710|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84099711|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
84099712|NCT02716272|Nivolumab|nivolumab|mesh-list
84099713|NCT02716272|Ipilimumab|ipilimumab|mesh-list
84099714|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84099715|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099716|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84099717|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099718|NCT02720406|Ketamine|ketamine|mesh-list
84099719|NCT02720406|Analgesics|analgesics|mesh-ancestor
84099720|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
84099721|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099722|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099723|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84099724|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84099725|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
84099726|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
84099727|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099728|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84099729|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84099730|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099731|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099732|NCT05504876|Midazolam|midazolam|mesh-list
84099733|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84099734|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84099735|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099736|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099737|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84099738|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84099739|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84099740|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84099741|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
84099742|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
84099743|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
84099744|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
84099745|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099746|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099747|NCT02802722|Vitamin D|vitamin d|mesh-list
84099748|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
84099749|NCT02802722|Vitamins|vitamins|mesh-ancestor
84099750|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
84099751|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099752|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84099753|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84099754|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83339749|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
83339750|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83339751|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83339752|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83339753|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83339754|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339755|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83339763|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
84099755|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099756|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099757|NCT02802644|Incretins|incretins|mesh-ancestor
84099758|NCT02802644|Hormones|hormones|mesh-ancestor
84099759|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099760|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84099761|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
84099762|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099763|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099764|NCT02744976|Metformin|metformin|mesh-list
84099765|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099766|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099767|NCT00928889|Acarbose|acarbose|mesh-list
84099768|NCT00928889|Nateglinide|nateglinide|mesh-list
84099769|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84099770|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099771|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099772|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099773|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099774|NCT02725398|Scopolamine|scopolamine|mesh-list
84099775|NCT02725398|Bromides|bromides|mesh-list
84099776|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84099777|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
84099778|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84099779|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
84099780|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
84099781|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099782|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099783|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84099784|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
84099785|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84099786|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
84099787|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099788|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099789|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84099790|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
84099791|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
84099792|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099793|NCT02795546|Alendronate|alendronate|mesh-list
84099794|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84099795|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099796|NCT03978091|Ceftazidime|ceftazidime|mesh-list
84099797|NCT03978091|Avibactam|avibactam|mesh-list
84099798|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
84099799|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84099800|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099801|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84099802|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099803|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099804|NCT00610571|Temozolomide|temozolomide|mesh-list
84099805|NCT00610571|Topotecan|topotecan|mesh-list
84099806|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84099807|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
84099808|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099809|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099810|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84099811|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84099812|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099813|NCT02725242|Budesonide|budesonide|mesh-list
84099814|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
84099815|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099816|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84099817|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
84099818|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099819|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099820|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84099821|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
84099822|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
84099823|NCT02725242|Hormones|hormones|mesh-ancestor
84099824|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099825|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84099826|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84099827|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84099828|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
84099829|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099830|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099831|NCT00564733|Paclitaxel|paclitaxel|mesh-list
84099832|NCT00564733|Docetaxel|docetaxel|mesh-list
84099833|NCT00564733|Carboplatin|carboplatin|mesh-list
84099834|NCT00564733|Gemcitabine|gemcitabine|mesh-list
84099835|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84099836|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84099837|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099838|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
84099839|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
84099840|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
84099841|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099842|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84099843|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
84099844|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84099845|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
84099846|NCT02725164|Sevoflurane|sevoflurane|mesh-list
84099847|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84099848|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84099849|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
84099850|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
84099851|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099852|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099853|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84099854|NCT02725164|Analgesics|analgesics|mesh-ancestor
84099855|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
84099856|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099857|NCT02800694|Fentanyl|fentanyl|mesh-list
84099858|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84099859|NCT02800694|Narcotics|narcotics|mesh-ancestor
84099860|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099861|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099862|NCT02800694|Analgesics|analgesics|mesh-ancestor
84099863|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
84099864|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099865|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84099866|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84099867|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
84099868|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
84099869|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
84099870|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84099871|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
84099872|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099873|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099874|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84099875|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
84099876|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84099877|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84099878|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84099879|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
84099880|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099881|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099882|NCT00938509|Ibuprofen|ibuprofen|mesh-list
84099883|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84099884|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84099885|NCT00938509|Analgesics|analgesics|mesh-ancestor
84099886|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
84099887|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099888|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099889|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099890|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099891|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84099892|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099893|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099894|NCT02724618|Curcumin|curcumin|mesh-list
84099895|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84099896|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84099897|NCT02724618|Analgesics|analgesics|mesh-ancestor
84099898|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
84099899|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099900|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099901|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84099902|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099903|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339900|NCT01536886|Hormones|hormones|mesh-ancestor
84099904|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84099905|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099906|NCT02801786|Tamoxifen|tamoxifen|mesh-list
84099907|NCT02801786|Lidocaine|lidocaine|mesh-list
84099908|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
84099909|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
84099910|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099911|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099912|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
84099913|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099914|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84099915|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84099916|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84099917|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099918|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099919|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84099920|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
84099921|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84099922|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84099923|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099924|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84099925|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84099926|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84099927|NCT04258553|Antioxidants|antioxidants|mesh-list
84099928|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099929|NCT04258553|Protective Agents|protective agents|mesh-ancestor
84099930|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099931|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84099932|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84099933|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84099934|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84099935|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099936|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
84099937|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84099938|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099939|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
84099940|NCT02719392|Minocycline|minocycline|mesh-list
84099941|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84099942|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
84099943|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84099944|NCT02719392|Expectorants|expectorants|mesh-ancestor
84099945|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
84099946|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84099947|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
84099948|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099949|NCT02719392|Protective Agents|protective agents|mesh-ancestor
84099950|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099951|NCT02719392|Antidotes|antidotes|mesh-ancestor
84099952|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84099953|NCT02802098|Bevacizumab|bevacizumab|mesh-list
84099954|NCT02802098|Durvalumab|durvalumab|mesh-list
84099955|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84099956|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099957|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84099958|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84099959|NCT02802098|Growth Substances|growth substances|mesh-ancestor
84099960|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099961|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
84099962|NCT00938821|Morphine|morphine|mesh-list
84099963|NCT00938821|Bupivacaine|bupivacaine|mesh-list
84099964|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
84099965|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
84099966|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84099967|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099968|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
84099969|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84099970|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84099971|NCT00938821|Narcotics|narcotics|mesh-ancestor
84099972|NCT00938821|Analgesics|analgesics|mesh-ancestor
84099973|NCT04013581|Empagliflozin|empagliflozin|mesh-list
84099974|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84099975|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84099976|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84099977|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099978|NCT02715960|Vitamin A|vitamin a|mesh-list
84099979|NCT02715960|Tretinoin|tretinoin|mesh-list
84099980|NCT02715960|Acitretin|acitretin|mesh-list
84099981|NCT02715960|Vitamins|vitamins|mesh-ancestor
84099982|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
84099983|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099984|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099985|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
84099986|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
84099987|NCT03983018|Rituximab|rituximab|mesh-list
84099988|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84099989|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84099990|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
84099991|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099992|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84099993|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
84099994|NCT02794922|Vitamins|vitamins|mesh-ancestor
84099995|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
84099996|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84099997|NCT00935467|Saxagliptin|saxagliptin|mesh-list
84099998|NCT00935467|Incretins|incretins|mesh-ancestor
84099999|NCT00935467|Hormones|hormones|mesh-ancestor
84100000|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100001|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100002|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84100003|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100004|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100005|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100006|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100007|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84100008|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84100009|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
84100010|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100011|NCT04235816|Azithromycin|azithromycin|mesh-list
84100012|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84100013|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100014|NCT00936013|Oseltamivir|oseltamivir|mesh-list
84100015|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
84100016|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100017|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100018|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100019|NCT00936091|Vitamin A|vitamin a|mesh-list
84100020|NCT00936091|Vitamins|vitamins|mesh-ancestor
84100021|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
84100022|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100023|NCT00563797|Mecamylamine|mecamylamine|mesh-list
84100024|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84100025|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
84100026|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
84100027|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100028|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100029|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84100030|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84100031|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100032|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100033|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100034|NCT01192698|Interferons|interferons|mesh-list
84100035|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100036|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
84100037|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100038|NCT04014361|Itraconazole|itraconazole|mesh-list
84100039|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
84100040|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100041|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84100042|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84100043|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100044|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100045|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84100046|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
84100047|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100048|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100049|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84100050|NCT00771927|Lacosamide|lacosamide|mesh-list
84100051|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
84100052|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84100053|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83340057|NCT01595854|Dabigatran|dabigatran|mesh-list
84100054|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84100055|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100056|NCT02715492|Enoxaparin|enoxaparin|mesh-list
84100057|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
84100058|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84100059|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84100060|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100061|NCT03940196|Paclitaxel|paclitaxel|mesh-list
84100062|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84100063|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84100064|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100065|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
84100066|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
84100067|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
84100068|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100069|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
84100070|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100071|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100072|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100073|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100074|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100075|NCT02724150|Omeprazole|omeprazole|mesh-list
84100076|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84100077|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100078|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84100079|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100080|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100081|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84100082|NCT04042740|Ribavirin|ribavirin|mesh-list
84100083|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
84100084|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100085|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
84100086|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100087|NCT02715336|Leuprolide|leuprolide|mesh-list
84100088|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84100089|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
84100090|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84100091|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100092|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84100093|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100094|NCT02794610|Tacrolimus|tacrolimus|mesh-list
84100095|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84100096|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
84100097|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100098|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84100099|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100100|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100101|NCT02799758|Pitavastatin|pitavastatin|mesh-list
84100102|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84100103|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84100104|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84100105|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
84100106|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100107|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100108|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84100109|NCT00938899|Simeprevir|simeprevir|mesh-list
84100110|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
84100111|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100112|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100113|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100114|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100115|NCT03259165|Diuretics|diuretics|mesh-list
84100116|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
84100117|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
84100118|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100119|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84100120|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100121|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84100122|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84100123|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100124|NCT00939133|Tretinoin|tretinoin|mesh-list
84100125|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100126|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
83340130|NCT01900002|Sorafenib|sorafenib|mesh-list
84100127|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
84100128|NCT02799446|Reslizumab|reslizumab|mesh-list
84100129|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84100130|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
84100131|NCT00564889|Dexamethasone|dexamethasone|mesh-list
84100132|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
84100133|NCT00564889|Lenalidomide|lenalidomide|mesh-list
84100134|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84100135|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
84100136|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100137|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84100138|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84100139|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
84100140|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100141|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100142|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84100143|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100144|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
84100145|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
84100146|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100147|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100148|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
84100149|NCT00564889|Hormones|hormones|mesh-ancestor
84100150|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100151|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84100152|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84100153|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84100154|NCT00564889|Growth Substances|growth substances|mesh-ancestor
84100155|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
84100156|NCT02790164|Rocuronium|rocuronium|mesh-list
84100157|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84100158|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84100159|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84100160|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100161|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100162|NCT00939757|Mirabegron|mirabegron|mesh-list
84100163|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84100164|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84100165|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84100166|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100167|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100168|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100169|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100170|NCT00939757|Urological Agents|urological agents|mesh-ancestor
84100171|NCT05415644|Metformin|metformin|mesh-list
84100172|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100173|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100174|NCT00939835|Dexetimide|dexetimide|mesh-list
84100175|NCT00939835|Citalopram|citalopram|mesh-list
84100176|NCT00939835|Escitalopram|escitalopram|mesh-list
84100177|NCT00939835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84100178|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84100179|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84100180|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100181|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100182|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
84100183|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100184|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84100185|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
84100186|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84100187|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84100188|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84100189|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
84100190|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
84100191|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100192|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84100193|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84100194|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100195|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
84100196|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
84100197|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100198|NCT02690012|Cathartics|cathartics|mesh-ancestor
84100199|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100200|NCT02690012|Antacids|antacids|mesh-ancestor
84100201|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
84100202|NCT02793986|Propofol|propofol|mesh-list
84100203|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84100204|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100205|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100206|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100208|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
84100209|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100210|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84100211|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84100212|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84100213|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100214|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100215|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100216|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84100217|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
84100218|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
84100219|NCT00940069|Pemetrexed|pemetrexed|mesh-list
84100220|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100221|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100222|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100223|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84100224|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84100225|NCT00940303|Leucovorin|leucovorin|mesh-list
84100226|NCT00940303|Bevacizumab|bevacizumab|mesh-list
84100227|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
84100228|NCT00940303|Irinotecan|irinotecan|mesh-list
84100229|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84100230|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100231|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84100232|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84100233|NCT00940303|Growth Substances|growth substances|mesh-ancestor
84100234|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100235|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
84100236|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84100237|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84100238|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100239|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100240|NCT00940303|Antidotes|antidotes|mesh-ancestor
84100241|NCT00940303|Protective Agents|protective agents|mesh-ancestor
84100242|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
84100243|NCT00940303|Vitamins|vitamins|mesh-ancestor
84100244|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
84100245|NCT02794220|Nicotine|nicotine|mesh-list
84100246|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84100247|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
84100248|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100249|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100250|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84100251|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84100252|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100253|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100254|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100255|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
84100256|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84100257|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84100258|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
84100259|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100260|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84100261|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84100262|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100263|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100264|NCT04405999|Bromhexine|bromhexine|mesh-list
84100265|NCT04405999|Expectorants|expectorants|mesh-ancestor
84100266|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
84100267|NCT02793908|Progesterone|progesterone|mesh-list
84100268|NCT02793908|Progestins|progestins|mesh-ancestor
84100269|NCT02793908|Hormones|hormones|mesh-ancestor
84100270|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100271|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100272|NCT02789930|Anesthetics|anesthetics|mesh-list
84100273|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100274|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100275|NCT00560833|Mirtazapine|mirtazapine|mesh-list
84100276|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100277|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
84100278|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84100279|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84100280|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
84100281|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
84100282|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100283|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100284|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84100285|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84100286|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100287|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84100288|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84100289|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84100290|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100291|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84100292|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84100293|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
84100294|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84100295|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
84100296|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84100297|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100298|NCT00941161|Metformin|metformin|mesh-list
84100299|NCT00941161|Glimepiride|glimepiride|mesh-list
84100300|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100301|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100302|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84100303|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84100304|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
84100305|NCT00944515|Azithromycin|azithromycin|mesh-list
84100306|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84100307|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100308|NCT00771654|Phentermine|phentermine|mesh-list
84100309|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84100310|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100311|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
84100312|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84100313|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
84100314|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
84100315|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100316|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100317|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100318|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100319|NCT00941239|Metformin|metformin|mesh-list
84100320|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100321|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100322|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
84100323|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
84100324|NCT04235426|Diclofenac|diclofenac|mesh-list
84100325|NCT04235426|Vitamins|vitamins|mesh-ancestor
84100326|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
84100327|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100328|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84100329|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100330|NCT04235426|Analgesics|analgesics|mesh-ancestor
84100331|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
84100332|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100333|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100334|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84100335|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84100336|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100337|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100338|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
84100339|NCT04235426|Hematinics|hematinics|mesh-ancestor
84100340|NCT02793440|Cortivazol|cortivazol|mesh-list
84100341|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100342|NCT02723838|Gemcitabine|gemcitabine|mesh-list
84100343|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100344|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84100345|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
84100346|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100347|NCT02789150|Norepinephrine|norepinephrine|mesh-list
84100348|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84100349|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84100350|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100351|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100352|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100353|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100354|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
84100355|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
84100356|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100357|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84100358|NCT02715024|Tamsulosin|tamsulosin|mesh-list
84100359|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
84100360|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84100361|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84100362|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84100363|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100364|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100365|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100366|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100367|NCT02715024|Urological Agents|urological agents|mesh-ancestor
84100368|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84100369|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84100370|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100371|NCT02798744|Empagliflozin|empagliflozin|mesh-list
84100372|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84100373|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100374|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100375|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100376|NCT00925769|Bevacizumab|bevacizumab|mesh-list
84100377|NCT00925769|Capecitabine|capecitabine|mesh-list
84100378|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84100379|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84100380|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100381|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84100382|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84100383|NCT00925769|Growth Substances|growth substances|mesh-ancestor
84100384|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100385|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
84100386|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84100387|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
84100388|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100389|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84100390|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100391|NCT00770913|Rabeprazole|rabeprazole|mesh-list
84100392|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84100393|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100394|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84100395|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100396|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100397|NCT00562861|Lamotrigine|lamotrigine|mesh-list
84100398|NCT00562861|Carbamazepine|carbamazepine|mesh-list
84100399|NCT00562861|Valproic Acid|valproic acid|mesh-list
84100400|NCT00562861|Citalopram|citalopram|mesh-list
84100401|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
84100402|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84100403|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84100404|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100405|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84100406|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100407|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84100408|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84100409|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100410|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84100411|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84100412|NCT00562861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84100413|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84100414|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100415|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
84100416|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84100417|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
84100418|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100419|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100420|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
84100421|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
84100422|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100423|NCT00562861|Analgesics|analgesics|mesh-ancestor
84100424|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
83340426|NCT04398706|Vaccines|vaccines|mesh-list
84100425|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84100426|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84100427|NCT02723448|Aclarubicin|aclarubicin|mesh-list
84100428|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
84100429|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84100430|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100431|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84100432|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84100433|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100434|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100435|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84100436|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
84100437|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100438|NCT02798510|Gemcitabine|gemcitabine|mesh-list
84100439|NCT02798510|Capecitabine|capecitabine|mesh-list
84100440|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84100441|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
84100442|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100443|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100444|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84100445|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100446|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
84100447|NCT00941473|Hormones|hormones|mesh-ancestor
84100448|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100449|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100450|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84100451|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
84100452|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
84100453|NCT04258475|Calcium|calcium|mesh-list
84100454|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84100455|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100456|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84100457|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84100458|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
84100459|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100460|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84100461|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84100462|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100463|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100464|NCT03944954|Dronabinol|dronabinol|mesh-list
84100465|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
84100466|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100467|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84100468|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100469|NCT03944954|Analgesics|analgesics|mesh-ancestor
84100470|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
84100471|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100472|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84100473|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84100474|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100475|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100476|NCT03944954|Hormones|hormones|mesh-ancestor
84100477|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100478|NCT00609011|Temozolomide|temozolomide|mesh-list
84100479|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84100480|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
84100481|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100482|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100483|NCT00770679|Atorvastatin|atorvastatin|mesh-list
84100484|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84100485|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84100486|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
84100487|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100488|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84100489|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84100490|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100491|NCT04042116|Nivolumab|nivolumab|mesh-list
84100492|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84100493|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100494|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84100495|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100496|NCT04260581|Amantadine|amantadine|mesh-list
84100497|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84100498|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84100499|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
83340503|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
84100500|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100501|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
84100502|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100503|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100504|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100505|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100506|NCT04260581|Analgesics|analgesics|mesh-ancestor
84100507|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
84100508|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100509|NCT00770367|Pioglitazone|pioglitazone|mesh-list
84100510|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100511|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100512|NCT00941785|Amodiaquine|amodiaquine|mesh-list
84100513|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
84100514|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84100515|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84100516|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100517|NCT05502081|Remdesivir|remdesivir|mesh-list
84100518|NCT05502081|Favipiravir|favipiravir|mesh-list
84100519|NCT05502081|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
84100520|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
84100521|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100522|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
84100523|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100524|NCT02793050|Trabectedin|trabectedin|mesh-list
84100525|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84100526|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
84100527|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100528|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100529|NCT00944905|MDX-1203|mdx-1203|mesh-list
84100530|NCT00944905|Immunoconjugates|immunoconjugates|mesh-ancestor
84100531|NCT00944905|Immunologic Factors|immunologic factors|mesh-ancestor
84100532|NCT00944905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100533|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
84100534|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84100535|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
84100536|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100537|NCT04964843|Expectorants|expectorants|mesh-ancestor
84100538|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
84100539|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84100540|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
83429624|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100541|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100542|NCT04964843|Protective Agents|protective agents|mesh-ancestor
84100543|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100544|NCT04964843|Antidotes|antidotes|mesh-ancestor
84100545|NCT00942253|Dopamine|dopamine|mesh-list
84100546|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
84100547|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84100548|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
84100549|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
84100550|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100551|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100552|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
84100553|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100554|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100555|NCT00942253|Protective Agents|protective agents|mesh-ancestor
84100556|NCT02792816|Artesunate|artesunate|mesh-list
84100557|NCT02792816|Artemether|artemether|mesh-list
84100558|NCT02792816|Piperaquine|piperaquine|mesh-list
84100559|NCT02792816|Artenimol|artenimol|mesh-list
84100560|NCT02792816|Mefloquine|mefloquine|mesh-list
84100561|NCT02792816|Antimalarials|antimalarials|mesh-list
84100562|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84100563|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84100564|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100565|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100566|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
84100567|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
84100568|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84100569|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
84100570|NCT00940381|Sirolimus|sirolimus|mesh-list
84100571|NCT00940381|Cetuximab|cetuximab|mesh-list
84100572|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84100573|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100574|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84100575|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100576|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84100577|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
84100578|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84100579|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
84100580|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100581|NCT00637988|Aspirin|aspirin|mesh-list
84100582|NCT00637988|Rofecoxib|rofecoxib|mesh-list
84100583|NCT00637988|Esomeprazole|esomeprazole|mesh-list
84100584|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84100585|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100586|NCT00637988|Analgesics|analgesics|mesh-ancestor
84100587|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
84100588|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100589|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100590|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100591|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84100592|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84100593|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84100594|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100595|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84100596|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84100597|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100598|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
84100599|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84100600|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100601|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84100602|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84100603|NCT04258163|Gemcitabine|gemcitabine|mesh-list
84100604|NCT04258163|Capecitabine|capecitabine|mesh-list
84100605|NCT04258163|Doxorubicin|doxorubicin|mesh-list
84100606|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84100607|NCT04258163|Letrozole|letrozole|mesh-list
84100608|NCT04258163|Fulvestrant|fulvestrant|mesh-list
84100609|NCT04258163|Anastrozole|anastrozole|mesh-list
84100610|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84100611|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
84100612|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100613|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100614|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84100615|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84100616|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84100617|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100618|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84100619|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84100620|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84100621|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
84100622|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100623|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100624|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84100625|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84100626|NCT00942487|Nebivolol|nebivolol|mesh-list
84100627|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84100628|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
84100629|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84100630|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84100631|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84100632|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
84100633|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100634|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100635|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100636|NCT00611039|Ritonavir|ritonavir|mesh-list
84100637|NCT00611039|Darunavir|darunavir|mesh-list
84100638|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84100639|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84100640|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100641|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100642|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100643|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84100644|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84100645|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
84100646|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100647|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84100648|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84100649|NCT00942565|Acetaminophen|acetaminophen|mesh-list
84100650|NCT00942565|Tramadol|tramadol|mesh-list
84100651|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100652|NCT00942565|Analgesics|analgesics|mesh-ancestor
84100653|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
84100654|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100655|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100656|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
84100657|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84100658|NCT00942565|Narcotics|narcotics|mesh-ancestor
84100659|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100660|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
84100661|NCT00945373|Calcium|calcium|mesh-list
84100662|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84100663|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100664|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
84100665|NCT00945373|Coagulants|coagulants|mesh-ancestor
84100666|NCT04100655|Molgramostim|molgramostim|mesh-list
84100667|NCT04100655|Estradiol|estradiol|mesh-list
84100668|NCT04100655|Sargramostim|sargramostim|mesh-list
84100669|NCT04100655|Estrogens|estrogens|mesh-ancestor
84100670|NCT04100655|Hormones|hormones|mesh-ancestor
84100671|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100672|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100673|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
84100674|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100675|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
84100676|NCT00556933|Sirolimus|sirolimus|mesh-list
84100677|NCT00556933|Tacrolimus|tacrolimus|mesh-list
84100678|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
84100679|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84100680|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84100681|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
84100682|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100683|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84100684|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100685|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100686|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84100687|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100688|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84100689|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
84100690|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84100691|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100692|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
84100693|NCT02792426|Nicotine|nicotine|mesh-list
84100694|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84100695|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
84100696|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100697|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100698|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84100699|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84100700|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100701|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100702|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100703|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
84100704|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84100705|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84100706|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84100707|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84100708|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84100709|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100710|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100711|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100712|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100713|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84100714|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100715|NCT02792036|Carboplatin|carboplatin|mesh-list
84100716|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100717|NCT02797340|Metformin|metformin|mesh-list
84100718|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100719|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100720|NCT00928187|Ritonavir|ritonavir|mesh-list
84100721|NCT00928187|Lopinavir|lopinavir|mesh-list
84100722|NCT00928187|Darunavir|darunavir|mesh-list
84100723|NCT00928187|Tenofovir|tenofovir|mesh-list
84100724|NCT00928187|Emtricitabine|emtricitabine|mesh-list
84100725|NCT00928187|Abacavir|abacavir|mesh-list
84100726|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84100727|NCT00928187|Didanosine|didanosine|mesh-list
84100728|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84100729|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84100730|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100731|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100732|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100733|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84100734|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84100735|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
84100736|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100737|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84100738|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84100739|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84100740|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84100741|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
84100742|NCT04235270|Tadalafil|tadalafil|mesh-list
84100743|NCT04235270|Macitentan|macitentan|mesh-list
84100744|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
84100745|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84100746|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84100747|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100748|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100749|NCT04235270|Urological Agents|urological agents|mesh-ancestor
84100750|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
84100751|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84100752|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
84100753|NCT04256525|Aspirin|aspirin|mesh-list
84100754|NCT04256525|Heparin|heparin|mesh-list
84100755|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
84100756|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84100757|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100758|NCT04256525|Analgesics|analgesics|mesh-ancestor
84100759|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
84100760|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100761|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100762|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100763|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84100764|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84100765|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84100766|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100767|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84100768|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84100769|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100770|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
84100771|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
84100772|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84100773|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
84100774|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84100775|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100776|NCT02791958|Ramipril|ramipril|mesh-list
84100777|NCT02791958|Atorvastatin|atorvastatin|mesh-list
84100778|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84100779|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84100780|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
84100781|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100782|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84100783|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84100784|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100785|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84100786|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100787|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84100788|NCT02601651|Lidocaine|lidocaine|mesh-list
84100789|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
84100790|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
84100791|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100792|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100793|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
84100794|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100795|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84100796|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84100797|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84100798|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84100799|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100800|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
84100801|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100802|NCT00945919|Oxymorphone|oxymorphone|mesh-list
84100803|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84100804|NCT00945919|Narcotics|narcotics|mesh-ancestor
84100805|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100806|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100807|NCT00945919|Analgesics|analgesics|mesh-ancestor
84100808|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
84100809|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100810|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84100811|NCT00945997|Misoprostol|misoprostol|mesh-list
84100812|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84100813|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
84100814|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84100815|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100816|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84100817|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100818|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
84100819|NCT00943345|Indomethacin|indomethacin|mesh-list
84100820|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84100821|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84100822|NCT00943345|Analgesics|analgesics|mesh-ancestor
84100823|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
84100824|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100825|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100826|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100827|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84100828|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
84100829|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
84100830|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84100831|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84100832|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100833|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100834|NCT02797028|Allopurinol|allopurinol|mesh-list
84100835|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
84100836|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100837|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100838|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
84100839|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84100840|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84100841|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
84100842|NCT02797028|Protective Agents|protective agents|mesh-ancestor
84100843|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100844|NCT00916461|Minocycline|minocycline|mesh-list
84100845|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84100846|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100847|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
84100848|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100849|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
84100850|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84100851|NCT04260035|Protective Agents|protective agents|mesh-ancestor
84100852|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100853|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84100854|NCT00768651|Pantoprazole|pantoprazole|mesh-list
84100855|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100856|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100857|NCT00768651|Incretins|incretins|mesh-ancestor
84100858|NCT00768651|Hormones|hormones|mesh-ancestor
84100859|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100860|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84100861|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100862|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100863|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100864|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84100865|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100866|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84100867|NCT05378750|Diuretics|diuretics|mesh-list
84100868|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
84100869|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100870|NCT00943501|Liraglutide|liraglutide|mesh-list
84100871|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84100872|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100873|NCT00943501|Incretins|incretins|mesh-ancestor
84100874|NCT00943501|Hormones|hormones|mesh-ancestor
84100875|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100876|NCT04258241|Bupivacaine|bupivacaine|mesh-list
84100877|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
84100878|NCT04258241|Anesthetics|anesthetics|mesh-list
84100879|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84100880|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100881|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100882|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
84100883|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100885|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84100886|NCT02796794|Protective Agents|protective agents|mesh-ancestor
84100887|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100888|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100889|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84100890|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100891|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100892|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
84100893|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84100894|NCT02796794|Estrogens|estrogens|mesh-ancestor
84100895|NCT02796794|Hormones|hormones|mesh-ancestor
84100896|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100897|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
84100898|NCT04097613|Budesonide|budesonide|mesh-list
84100899|NCT04097613|Povidone|povidone|mesh-list
84100900|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84100901|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84100902|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
84100903|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100904|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100905|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84100906|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
84100907|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
84100908|NCT04097613|Hormones|hormones|mesh-ancestor
84100909|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84100910|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
84100911|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
84100912|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84100913|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100914|NCT00946387|Ondansetron|ondansetron|mesh-list
84100915|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
84100916|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
84100917|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84100918|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100919|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84100920|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
84100921|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
84100922|NCT00946387|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84100923|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84100924|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
84100925|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100926|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100927|NCT00916695|Everolimus|everolimus|mesh-list
84100928|NCT00916695|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84100929|NCT00916695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84100930|NCT00916695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100931|NCT00916695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100932|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84100933|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
84100934|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100935|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84100936|NCT00946465|Ramipril|ramipril|mesh-list
84100937|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84100938|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100939|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100940|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100941|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84100942|NCT00756717|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
84100943|NCT00756717|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84100944|NCT00756717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100945|NCT00756717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100946|NCT00946621|Ramipril|ramipril|mesh-list
84100947|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84100948|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
84100949|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100950|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100951|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84100952|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
84100953|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84100954|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100955|NCT04235894|Propofol|propofol|mesh-list
84100956|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84100957|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84100958|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100959|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84100960|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
84100961|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
84100963|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
84100964|NCT04096599|Protective Agents|protective agents|mesh-ancestor
84100965|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100966|NCT00923351|Vaccines|vaccines|mesh-list
84100967|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
84100968|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100969|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
84100970|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84100971|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
84100972|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100973|NCT02788292|Expectorants|expectorants|mesh-ancestor
84100974|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
84100975|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84100976|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
84100977|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100978|NCT02788292|Protective Agents|protective agents|mesh-ancestor
84100979|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100980|NCT02788292|Antidotes|antidotes|mesh-ancestor
84100981|NCT00944359|Zinc|zinc|mesh-list
84100982|NCT00944359|Trace Elements|trace elements|mesh-ancestor
84100983|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
84100984|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100985|NCT02791256|Ribavirin|ribavirin|mesh-list
84100986|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84100987|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
84100988|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100989|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
84100990|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84100991|NCT04258007|Neostigmine|neostigmine|mesh-list
84100992|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84100993|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84100994|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84100995|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
84100996|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84100997|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84100998|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84100999|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
84101000|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101001|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84101002|NCT02787824|Hematinics|hematinics|mesh-ancestor
84101003|NCT02796950|Acipimox|acipimox|mesh-list
84101004|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84101005|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
84101006|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101007|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84101008|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
84101009|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
84101010|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101011|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101012|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101013|NCT00950209|Heparin|heparin|mesh-list
84101014|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
84101015|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84101016|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84101017|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101018|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
84101019|NCT05370326|Narcotics|narcotics|mesh-ancestor
84101020|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101021|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101022|NCT05370326|Analgesics|analgesics|mesh-ancestor
84101023|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
84101024|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101025|NCT00947323|Simvastatin|simvastatin|mesh-list
84101026|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84101027|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84101028|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
84101029|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101030|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84101031|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84101032|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101033|NCT04236050|Rocuronium|rocuronium|mesh-list
84101034|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84101035|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84101036|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84101037|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101038|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101039|NCT02790632|Nimodipine|nimodipine|mesh-list
84101040|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84101041|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84101042|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101043|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101044|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84101045|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101046|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
84101047|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
84101048|NCT03633110|Nivolumab|nivolumab|mesh-list
84101049|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84101050|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101051|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84101052|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101053|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84101054|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84101055|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101056|NCT02788058|Gefitinib|gefitinib|mesh-list
84101057|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101058|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84101059|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101060|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101061|NCT04200092|Granisetron|granisetron|mesh-list
84101062|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
84101063|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
84101064|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101065|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101066|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101067|NCT04200092|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84101068|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84101069|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
84101070|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101071|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101072|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
84101073|NCT00754065|Dienogest|dienogest|mesh-list
84101074|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84101075|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84101076|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84101077|NCT00754065|Estradiol|estradiol|mesh-list
84101078|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84101079|NCT00754065|Estrogens|estrogens|mesh-ancestor
84101080|NCT00754065|Hormones|hormones|mesh-ancestor
84101081|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101082|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101083|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84101084|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
84101085|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84101086|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84101087|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84101088|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84101089|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84101090|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
84101091|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84101092|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101093|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84101094|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84101095|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101096|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84101097|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84101098|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101099|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101100|NCT02787746|Donepezil|donepezil|mesh-list
84101101|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84101102|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101103|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341107|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
84101104|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
84101105|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101106|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101107|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
84101108|NCT03254654|Apatinib|apatinib|mesh-list
84101109|NCT03254654|Vinorelbine|vinorelbine|mesh-list
84101110|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101111|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84101112|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101113|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101114|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84101115|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
84101116|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
84101117|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
84101118|NCT02785718|Hemostatics|hemostatics|mesh-list
84101119|NCT02785718|Coagulants|coagulants|mesh-ancestor
84101120|NCT04094805|Calcitriol|calcitriol|mesh-list
84101121|NCT04094805|Dexamethasone|dexamethasone|mesh-list
84101122|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101123|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
84101124|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
84101125|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101126|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101127|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101128|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
84101129|NCT04094805|Hormones|hormones|mesh-ancestor
84101130|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101131|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84101132|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101133|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84101134|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84101135|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101136|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101137|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84101138|NCT04094805|Vitamins|vitamins|mesh-ancestor
84101139|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
84101140|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84101141|NCT04094727|Lumefantrine|lumefantrine|mesh-list
84101142|NCT04094727|Artemether|artemether|mesh-list
84101143|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84101144|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
84101145|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84101146|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84101147|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101148|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
84101149|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84101150|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84101151|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84101152|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101153|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101154|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
84101155|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101156|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101157|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84101158|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101159|NCT02786732|Ustekinumab|ustekinumab|mesh-list
84101160|NCT02786732|Brodalumab|brodalumab|mesh-list
84101161|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84101162|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
84101163|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
84101164|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101165|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
84101166|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101167|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
84101168|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101169|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101170|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84101171|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
84101172|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101173|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101174|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84101175|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
84101176|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84101177|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84101178|NCT03110822|Prednisolone|prednisolone|mesh-list
83341178|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101179|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
84101180|NCT03110822|Lenalidomide|lenalidomide|mesh-list
84101181|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84101182|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
84101183|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
84101184|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101185|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84101186|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84101187|NCT03110822|Growth Substances|growth substances|mesh-ancestor
84101188|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
84101189|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101190|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101191|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
84101192|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
84101193|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101194|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101195|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
84101196|NCT03110822|Hormones|hormones|mesh-ancestor
84101197|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101198|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84101199|NCT03110822|Protective Agents|protective agents|mesh-ancestor
84101200|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84101201|NCT02787356|Lidocaine|lidocaine|mesh-list
84101202|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
84101203|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
84101204|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101205|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101206|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
84101207|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101208|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84101209|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84101210|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84101211|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101212|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101213|NCT02787278|Otaplimastat|otaplimastat|mesh-list
84101214|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84101215|NCT02787278|Protective Agents|protective agents|mesh-ancestor
84101216|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101217|NCT03083678|Afatinib|afatinib|mesh-list
84101218|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101219|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84101220|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101221|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101222|NCT04232150|Midazolam|midazolam|mesh-list
84101223|NCT04232150|Anesthetics|anesthetics|mesh-list
84101224|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101225|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101226|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84101227|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84101228|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84101229|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84101230|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101231|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84101232|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
84101233|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
84101234|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
84101235|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101236|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101237|NCT04197752|Anesthetics|anesthetics|mesh-list
84101238|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101239|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101240|NCT02336750|Aprepitant|aprepitant|mesh-list
84101241|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
84101242|NCT02336750|Mirtazapine|mirtazapine|mesh-list
84101243|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
84101244|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
84101245|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101246|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101247|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101248|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84101249|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101250|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101251|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
84101252|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101253|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84101254|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
84101255|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
84101256|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84101257|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84101258|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101259|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84101260|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84101261|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84101262|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
84101263|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84101264|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84101265|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
84101266|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84101267|NCT02784392|Metoclopramide|metoclopramide|mesh-list
84101268|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
84101269|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
84101270|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101271|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101272|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101273|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84101274|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84101275|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
84101276|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101277|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101278|NCT00634556|Levodopa|levodopa|mesh-list
84101279|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
84101280|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84101281|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84101282|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
84101283|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101284|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101285|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101286|NCT02784080|Isoantibodies|isoantibodies|mesh-list
84101287|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
84101288|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101289|NCT02784860|Lidocaine|lidocaine|mesh-list
84101290|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
84101291|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
84101292|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101293|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101294|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
84101295|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101296|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84101297|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84101298|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84101299|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101300|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101301|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
84101302|NCT02783924|Vitamin D|vitamin d|mesh-list
84101303|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84101304|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101305|NCT02783924|Vitamins|vitamins|mesh-ancestor
84101306|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
84101307|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84101308|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
84101309|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84101310|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101311|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101312|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84101313|NCT02783846|Analgesics|analgesics|mesh-ancestor
84101314|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
84101315|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101316|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84101317|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84101318|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84101319|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
84101320|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101321|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101322|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
84101323|NCT02783378|Antacids|antacids|mesh-ancestor
84101324|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101325|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101326|NCT05237726|Heparin|heparin|mesh-list
84101327|NCT05237726|Enoxaparin|enoxaparin|mesh-list
84101328|NCT05237726|Calcium heparin|calcium heparin|mesh-list
84101329|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
84101330|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
84101331|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84101332|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84101333|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101334|NCT02783144|Dexamethasone|dexamethasone|mesh-list
84101335|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
84101336|NCT02783144|BB 1101|bb 1101|mesh-list
84101337|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101338|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
84101339|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
84101340|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101341|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101342|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101343|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
84101344|NCT02783144|Hormones|hormones|mesh-ancestor
84101345|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101346|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84101347|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101348|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
84101349|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101350|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101351|NCT05260320|Anesthetics|anesthetics|mesh-list
84101352|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101353|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101354|NCT02783222|Paclitaxel|paclitaxel|mesh-list
84101355|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84101356|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101357|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
84101358|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
84101359|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
84101360|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101361|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
84101362|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84101363|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84101364|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84101365|NCT02689856|Lidocaine|lidocaine|mesh-list
84101366|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
84101367|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
84101368|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101369|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101370|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
84101371|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101372|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84101373|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84101374|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84101375|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101376|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101377|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101378|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84101379|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84101380|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84101381|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84101382|NCT05206448|Letrozole|letrozole|mesh-list
84101383|NCT05206448|Clomiphene|clomiphene|mesh-list
84101384|NCT05206448|Enclomiphene|enclomiphene|mesh-list
84101385|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
84101386|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101387|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101388|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84101389|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84101390|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101391|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84101392|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
84101393|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101394|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101395|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84101396|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
84101397|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84101398|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84101399|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84101400|NCT02722746|Epinephrine|epinephrine|mesh-list
84101401|NCT02722746|Ropivacaine|ropivacaine|mesh-list
84101402|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
84101403|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
84101404|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101405|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101406|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
84101407|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101408|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84101409|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84101410|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
84101411|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101412|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101413|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84101414|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84101415|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
84101416|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84101417|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
84101418|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
84101419|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
84101420|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84101421|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
84101422|NCT02784626|Propofol|propofol|mesh-list
84101423|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84101424|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101425|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101426|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84101427|NCT02784626|Analgesics|analgesics|mesh-ancestor
84101428|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
84101429|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101430|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84101431|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84101432|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84101433|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
84101434|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101435|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101436|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84101437|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
84101438|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
84101439|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
84101440|NCT02782754|Carboplatin|carboplatin|mesh-list
84101441|NCT02782754|Etoposide|etoposide|mesh-list
84101442|NCT02782754|Bleomycin|bleomycin|mesh-list
84101443|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101444|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
84101445|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101446|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101447|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84101448|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
84101449|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101450|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101451|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84101452|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84101453|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84101454|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84101455|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101456|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84101457|NCT05341076|Oxytocin|oxytocin|mesh-list
84101458|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
84101459|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84101460|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101461|NCT05133518|Midazolam|midazolam|mesh-list
84101462|NCT05133518|Ketamine|ketamine|mesh-list
84101463|NCT05133518|Analgesics|analgesics|mesh-ancestor
84101464|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
84101465|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101466|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101467|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84101468|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84101469|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
84101470|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
84101471|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101472|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83341488|NCT05584644|Palbociclib|palbociclib|mesh-list
84101473|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84101474|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101475|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101477|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84101478|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84101479|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84101480|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101481|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
84101482|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
84101483|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84101484|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
84101485|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101486|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
84101487|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84101488|NCT02714166|Protective Agents|protective agents|mesh-ancestor
84101489|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101490|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
84101491|NCT04231682|Denosumab|denosumab|mesh-list
84101492|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84101493|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101494|NCT02722356|Oxytocin|oxytocin|mesh-list
84101495|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
84101496|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84101497|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101498|NCT00753675|Gemcitabine|gemcitabine|mesh-list
84101499|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84101500|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
84101501|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101502|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101503|NCT05131178|Bupivacaine|bupivacaine|mesh-list
84101504|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
84101505|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
84101506|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101507|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101508|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
84101509|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101510|NCT02546934|Cisplatin|cisplatin|mesh-list
84101511|NCT02546934|Gemcitabine|gemcitabine|mesh-list
84101512|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101513|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84101514|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
84101515|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101516|NCT00586521|Factor VIII|factor viii|mesh-list
84101517|NCT00586521|Coagulants|coagulants|mesh-ancestor
84101518|NCT02782286|Ketorolac|ketorolac|mesh-list
84101519|NCT02782286|Morphine|morphine|mesh-list
84101520|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84101521|NCT02782286|Narcotics|narcotics|mesh-ancestor
84101522|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101523|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101524|NCT02782286|Analgesics|analgesics|mesh-ancestor
84101525|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
84101526|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101527|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84101528|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84101529|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101530|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101531|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84101532|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101533|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101534|NCT04231448|Prednisone|prednisone|mesh-list
84101535|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
84101536|NCT04231448|Rituximab|rituximab|mesh-list
84101537|NCT04231448|Doxorubicin|doxorubicin|mesh-list
84101538|NCT04231448|Vincristine|vincristine|mesh-list
84101539|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101540|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
84101541|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101542|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101543|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84101544|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
84101545|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101546|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101547|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84101548|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84101549|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83341558|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
84101550|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84101551|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84101552|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101553|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101554|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
84101555|NCT04231448|Hormones|hormones|mesh-ancestor
84101556|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101557|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84101558|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84101559|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
84101560|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
84101561|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
84101562|NCT02600247|Acetaminophen|acetaminophen|mesh-list
84101563|NCT02600247|Celecoxib|celecoxib|mesh-list
84101564|NCT02600247|Pregabalin|pregabalin|mesh-list
84101565|NCT02600247|Oxycodone|oxycodone|mesh-list
84101566|NCT02600247|Tramadol|tramadol|mesh-list
84101567|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84101568|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84101569|NCT02600247|Analgesics|analgesics|mesh-ancestor
84101570|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
84101571|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101572|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101573|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
84101574|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
84101575|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84101576|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101577|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101578|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84101579|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84101580|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84101581|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101582|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101583|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84101584|NCT02600247|Narcotics|narcotics|mesh-ancestor
84101585|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84101586|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101587|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101588|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84101589|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84101590|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101591|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84101592|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84101593|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101594|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
84101595|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
84101596|NCT05453253|Vaccines|vaccines|mesh-list
84101597|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
84101598|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101599|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84101600|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101601|NCT02717052|Ketamine|ketamine|mesh-list
84101602|NCT02717052|Esketamine|esketamine|mesh-list
84101603|NCT02717052|Analgesics|analgesics|mesh-ancestor
84101604|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
84101605|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101606|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101607|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84101608|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84101609|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
84101610|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
84101611|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101612|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84101613|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84101614|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101615|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101616|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
84101617|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101618|NCT05342558|Fluticasone|fluticasone|mesh-list
84101619|NCT05342558|Xhance|xhance|mesh-list
84101620|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101621|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84101622|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
84101623|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341635|NCT01606852|Analgesics|analgesics|mesh-ancestor
84101624|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101625|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84101626|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
84101627|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
84101628|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84101629|NCT00923273|Folic Acid|folic acid|mesh-list
84101630|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
84101631|NCT00923273|Hydroxocobalamin|hydroxocobalamin|mesh-list
84101632|NCT00923273|Sirolimus|sirolimus|mesh-list
84101633|NCT00923273|Dexamethasone|dexamethasone|mesh-list
84101634|NCT00923273|Pemetrexed|pemetrexed|mesh-list
84101635|NCT00923273|Vitamins|vitamins|mesh-ancestor
84101636|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
84101637|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101638|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101639|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
84101640|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
84101641|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101642|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101643|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
84101644|NCT00923273|Hormones|hormones|mesh-ancestor
84101645|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101646|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84101647|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101648|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101649|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101650|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84101651|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84101652|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84101653|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101654|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84101655|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
84101656|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101657|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
84101658|NCT00923273|Hematinics|hematinics|mesh-ancestor
84101659|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
84101660|NCT04231370|Lenalidomide|lenalidomide|mesh-list
84101661|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
84101662|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101663|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84101664|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84101665|NCT04231370|Growth Substances|growth substances|mesh-ancestor
84101666|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
84101667|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101668|NCT05340530|Meropenem|meropenem|mesh-list
84101669|NCT05340530|Avibactam|avibactam|mesh-list
84101670|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84101671|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101672|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84101673|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101674|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101675|NCT00634712|Candesartan|candesartan|mesh-list
84101676|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84101677|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84101678|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84101679|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101680|NCT00923195|Aldesleukin|aldesleukin|mesh-list
84101681|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
84101682|NCT00923195|Fludarabine|fludarabine|mesh-list
84101683|NCT00923195|Interleukin-2|interleukin-2|mesh-list
84101684|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84101685|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101686|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
84101687|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101688|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101689|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84101690|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
84101691|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101692|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101693|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84101694|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84101695|NCT00923195|Analgesics|analgesics|mesh-ancestor
84101696|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
84101697|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101698|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84101699|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84101700|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
84101701|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101702|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84101704|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84101705|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101706|NCT02721888|Incretins|incretins|mesh-ancestor
84101707|NCT02721888|Hormones|hormones|mesh-ancestor
84101708|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101709|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
84101710|NCT04256057|Analgesics|analgesics|mesh-ancestor
84101711|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
84101712|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101713|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101714|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
84101715|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101716|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84101717|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
84101718|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84101719|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101720|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101721|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84101722|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
84101723|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84101724|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
84101725|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
84101726|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
84101727|NCT02714010|Gefitinib|gefitinib|mesh-list
84101728|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101729|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84101730|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101731|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101732|NCT00917241|Dexamethasone|dexamethasone|mesh-list
84101733|NCT00917241|Methimazole|methimazole|mesh-list
84101734|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84101735|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
84101736|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
84101737|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101738|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101739|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84101740|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
84101741|NCT00917241|Hormones|hormones|mesh-ancestor
84101742|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101743|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84101744|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101745|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
84101746|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
84101747|NCT00919061|Gemcitabine|gemcitabine|mesh-list
84101748|NCT00919061|Sorafenib|sorafenib|mesh-list
84101749|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101750|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84101751|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
84101752|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101753|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84101754|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101755|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
84101756|NCT05106296|Etoposide|etoposide|mesh-list
84101757|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101758|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
84101759|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101760|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101761|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84101762|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
84101763|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101764|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101765|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84101766|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84101767|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84101768|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84101769|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101770|NCT02598687|Paclitaxel|paclitaxel|mesh-list
84101771|NCT02598687|Carboplatin|carboplatin|mesh-list
84101772|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84101773|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101774|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
84101775|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
84101776|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
84101777|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101778|NCT05338190|Rituximab|rituximab|mesh-list
84101779|NCT05338190|Belimumab|belimumab|mesh-list
84101780|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84101781|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101782|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
84101783|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101784|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84101785|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101786|NCT04908605|Melatonin|melatonin|mesh-list
84101787|NCT04908605|Mirtazapine|mirtazapine|mesh-list
84101788|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
84101789|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101790|NCT04908605|Protective Agents|protective agents|mesh-ancestor
84101791|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101792|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101793|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
84101794|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101795|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84101796|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
84101797|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
84101798|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101799|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84101800|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84101801|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84101802|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84101803|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84101804|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
84101805|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84101806|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84101807|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
84101808|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84101809|NCT02782208|Acipimox|acipimox|mesh-list
84101810|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84101811|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
84101812|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101813|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84101814|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
84101815|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84101816|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101817|NCT00611286|Sirolimus|sirolimus|mesh-list
84101818|NCT00611286|Paclitaxel|paclitaxel|mesh-list
84101819|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84101820|NCT00611286|Everolimus|everolimus|mesh-list
84101821|NCT00611286|Clopidogrel|clopidogrel|mesh-list
84101822|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
84101823|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84101824|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101825|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
84101826|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
84101827|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
84101828|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101829|NCT00611286|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84101830|NCT00611286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84101831|NCT00611286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101832|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84101833|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
84101834|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101835|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84101836|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84101837|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84101838|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
84101839|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101840|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84101841|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101842|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84101843|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
84101844|NCT04257851|Sumatriptan|sumatriptan|mesh-list
84101845|NCT04257851|Theophylline|theophylline|mesh-list
84101846|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84101847|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84101848|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84101849|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
84101850|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101851|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101852|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101853|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84101855|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101856|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84101857|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
84101858|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84101859|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101860|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
84101861|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84101862|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84101863|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
84101864|NCT02780102|Methylphenidate|methylphenidate|mesh-list
84101865|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84101866|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101867|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84101868|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84101869|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101870|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101871|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
84101872|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101873|NCT04197050|Valsartan|valsartan|mesh-list
84101874|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84101875|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84101876|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84101877|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84101878|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101879|NCT04090047|Itraconazole|itraconazole|mesh-list
84101880|NCT04090047|PF-06700841|pf-06700841|mesh-list
84101881|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
84101882|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84101883|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84101884|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84101885|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84101886|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101887|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84101888|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
84101889|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101890|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101891|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84101892|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84101893|NCT02782052|Bromides|bromides|mesh-list
84101894|NCT02782052|Albuterol|albuterol|mesh-list
84101895|NCT02782052|Ipratropium|ipratropium|mesh-list
84101896|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
84101897|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84101898|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
84101899|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101900|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101901|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84101902|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
84101903|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
84101904|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84101905|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84101906|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84101907|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84101908|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
84101909|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101910|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101911|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84101912|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
84101913|NCT02708628|Heparin|heparin|mesh-list
84101914|NCT02708628|Allantoin|allantoin|mesh-list
84101915|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
84101916|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84101917|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84101918|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101919|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
84101920|NCT00746733|Amphetamine|amphetamine|mesh-list
84101921|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84101922|NCT00746733|Adderall|adderall|mesh-list
84101923|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84101924|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101925|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
84101926|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
84101927|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101928|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
84101929|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101930|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101931|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
84101932|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84101933|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84101934|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101935|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84101936|NCT00636870|Fexofenadine|fexofenadine|mesh-list
84101937|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84101938|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84101939|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84101940|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
84101941|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
84101942|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101943|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101944|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101945|NCT00634790|Alprazolam|alprazolam|mesh-list
84101946|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84101947|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101948|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101949|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84101950|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84101951|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101952|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
84101953|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
84101954|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101955|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101956|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
84101957|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101958|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
84101959|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
84101960|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84101961|NCT00917397|Sertraline|sertraline|mesh-list
84101962|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
84101963|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84101964|NCT00917397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84101965|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84101966|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84101967|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101968|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84101969|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
84101970|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101971|NCT02708160|Fluorides|fluorides|mesh-list
84101972|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
84101973|NCT02708160|Protective Agents|protective agents|mesh-ancestor
84101974|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101975|NCT04257461|Capecitabine|capecitabine|mesh-list
84101976|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
84101977|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84101978|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
84101979|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84101980|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101981|NCT02712528|Sufentanil|sufentanil|mesh-list
84101982|NCT02712528|Remifentanil|remifentanil|mesh-list
84101983|NCT02712528|Sevoflurane|sevoflurane|mesh-list
84101984|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84101985|NCT02712528|Narcotics|narcotics|mesh-ancestor
84101986|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84101987|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84101988|NCT02712528|Analgesics|analgesics|mesh-ancestor
84101989|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
84101990|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84101991|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84101992|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84101993|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
84101994|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
84101995|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84101996|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84101997|NCT04089657|Apatinib|apatinib|mesh-list
84101998|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84101999|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84102000|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102001|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102002|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
84102003|NCT02713074|Povidone|povidone|mesh-list
84102004|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
84102005|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
84102006|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84102007|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102008|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
84102009|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84102010|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84102011|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
84102012|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102013|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102014|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102015|NCT00745875|Pemetrexed|pemetrexed|mesh-list
84102016|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102017|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102018|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102019|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84102020|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84102021|NCT04089813|Metformin|metformin|mesh-list
84102022|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84102023|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102024|NCT00555217|Losartan|losartan|mesh-list
84102025|NCT00555217|Lisinopril|lisinopril|mesh-list
84102026|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84102027|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83429638|NCT03595046|Dexamethasone|dexamethasone|mesh-list
84102028|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84102029|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84102030|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102031|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84102032|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
84102033|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102034|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84102035|NCT00555217|Protective Agents|protective agents|mesh-ancestor
84102036|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102037|NCT02711904|Remifentanil|remifentanil|mesh-list
84102038|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84102039|NCT02711904|Narcotics|narcotics|mesh-ancestor
84102040|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102041|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102042|NCT02711904|Analgesics|analgesics|mesh-ancestor
84102043|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
84102044|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102045|NCT05326490|Metformin|metformin|mesh-list
84102046|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84102047|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102048|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
84102049|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84102050|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
84102051|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102052|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
84102053|NCT02693808|Protective Agents|protective agents|mesh-ancestor
84102054|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
84102055|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84102056|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84102057|NCT02711982|Prednisolone|prednisolone|mesh-list
84102058|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
84102059|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84102060|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
84102061|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102062|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
84102063|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
84102064|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102065|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102066|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102067|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
84102068|NCT02711982|Hormones|hormones|mesh-ancestor
84102069|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84102070|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84102071|NCT02711982|Protective Agents|protective agents|mesh-ancestor
84102072|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84102074|NCT00745095|Neostigmine|neostigmine|mesh-list
84102075|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84102076|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102077|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102078|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
84102079|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102080|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102081|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84102082|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
84102083|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102084|NCT05181462|Carboplatin|carboplatin|mesh-list
84102085|NCT05181462|Gemcitabine|gemcitabine|mesh-list
84102086|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102087|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84102088|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
84102089|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102090|NCT00612612|Rituximab|rituximab|mesh-list
84102091|NCT00612612|Fludarabine|fludarabine|mesh-list
84102092|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
84102093|NCT00612612|Obatoclax|obatoclax|mesh-list
84102094|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84102095|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102096|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
84102097|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102098|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102099|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84102100|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
84102101|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102102|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102103|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102104|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84102105|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84102106|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102107|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84102108|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84102109|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84102110|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84102111|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102112|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102113|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102114|NCT00940693|Analgesics|analgesics|mesh-ancestor
84102115|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
84102116|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102117|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
84102118|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84102119|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
84102120|NCT02598063|Lamivudine|lamivudine|mesh-list
84102121|NCT02598063|Adefovir|adefovir|mesh-list
84102122|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84102123|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84102124|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84102125|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84102126|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102127|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102128|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
84102129|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102130|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84102131|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84102132|NCT02707458|Probucol|probucol|mesh-list
84102133|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84102134|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84102135|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
84102136|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102137|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84102138|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
84102139|NCT02707458|Protective Agents|protective agents|mesh-ancestor
84102140|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102141|NCT00950677|Exenatide|exenatide|mesh-list
84102142|NCT00950677|Pramlintide|pramlintide|mesh-list
84102143|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84102144|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102145|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84102146|NCT00950677|Incretins|incretins|mesh-ancestor
84102147|NCT00950677|Hormones|hormones|mesh-ancestor
84102148|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84102149|NCT05174598|Calcitriol|calcitriol|mesh-list
84102150|NCT05174598|Calcipotriene|calcipotriene|mesh-list
84102151|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
84102152|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84102153|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102154|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84102155|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84102156|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102157|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84102158|NCT05174598|Vitamins|vitamins|mesh-ancestor
84102159|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
84102160|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84102161|NCT05341856|Isosorbide|isosorbide|mesh-list
84102162|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84102163|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84102164|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84102165|NCT05341856|Diuretics|diuretics|mesh-ancestor
84102166|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
84102167|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102168|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
84102169|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84102170|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102171|NCT00951223|Interferons|interferons|mesh-list
84102172|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
84102173|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102174|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
84102175|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102176|NCT02711592|Analgesics|analgesics|mesh-list
84102177|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
84102178|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102179|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102180|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
84102181|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84102182|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
84102183|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
84102184|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102185|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102186|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84102187|NCT00948103|Analgesics|analgesics|mesh-ancestor
84102188|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
84102189|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102190|NCT02012114|Cysteamine|cysteamine|mesh-list
84102191|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
84102192|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102193|NCT05301205|Gabapentin|gabapentin|mesh-list
84102194|NCT05301205|Analgesics|analgesics|mesh-ancestor
84102195|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
84102196|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102197|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102198|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
84102199|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84102200|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84102201|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102202|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84102203|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84102204|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84102205|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102206|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102207|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
84102208|NCT02707224|Candesartan|candesartan|mesh-list
84102209|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
84102210|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84102211|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84102212|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84102213|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
84102214|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102215|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84102216|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84102217|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102218|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84102219|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84102220|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84102221|NCT04229264|Apixaban|apixaban|mesh-list
84102222|NCT04229264|Clopidogrel|clopidogrel|mesh-list
84102223|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84102224|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84102225|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84102226|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84102227|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
84102228|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102229|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102230|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102231|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84102232|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
84102233|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84102234|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
84102235|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102236|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
84102237|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
84102238|NCT02597829|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84102239|NCT02597829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102240|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102241|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
84102242|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102243|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102245|NCT02711202|Infliximab|infliximab|mesh-list
84102246|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
84102247|NCT02711202|Tacrolimus|tacrolimus|mesh-list
84102248|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102249|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
84102250|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102251|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84102252|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102253|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102254|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102255|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102256|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84102257|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102258|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
84102259|NCT02711202|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84102260|NCT02711202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102261|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
84102262|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102263|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102264|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84102265|NCT04227938|ALPN-101|alpn-101|mesh-list
84102266|NCT04227938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102267|NCT04227938|Immunologic Factors|immunologic factors|mesh-ancestor
84102268|NCT04227938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102269|NCT02711358|Indomethacin|indomethacin|mesh-list
84102270|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84102271|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84102272|NCT02711358|Analgesics|analgesics|mesh-ancestor
84102273|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
84102274|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102275|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102276|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102277|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102278|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
84102279|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
84102280|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84102281|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84102282|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102283|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102284|NCT04962152|Nalbuphine|nalbuphine|mesh-list
84102285|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84102286|NCT04962152|Narcotics|narcotics|mesh-ancestor
84102287|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102288|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102289|NCT04962152|Analgesics|analgesics|mesh-ancestor
84102290|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
84102291|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102292|NCT00744627|Vortioxetine|vortioxetine|mesh-list
84102293|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
84102294|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84102295|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84102296|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84102297|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102298|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102299|NCT00744627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84102300|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84102301|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84102302|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102303|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102304|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
84102305|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84102306|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84102307|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84102308|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84102310|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
84102311|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102312|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
84102313|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
84102314|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84102315|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84102316|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84102317|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102318|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84102319|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84102320|NCT02711280|Propofol|propofol|mesh-list
84102321|NCT02711280|Sevoflurane|sevoflurane|mesh-list
84102322|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84102323|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102324|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102325|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84102326|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
84102327|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
84102328|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84102329|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84102330|NCT00948493|Insulin|insulin|mesh-list
84102331|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84102332|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84102333|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102334|NCT00952003|Bevacizumab|bevacizumab|mesh-list
84102335|NCT00952003|Docetaxel|docetaxel|mesh-list
84102336|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
84102337|NCT00952003|Irinotecan|irinotecan|mesh-list
84102338|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84102339|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102340|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84102341|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84102342|NCT00952003|Growth Substances|growth substances|mesh-ancestor
84102343|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102344|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
84102345|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
84102346|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
84102347|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
84102348|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102349|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84102350|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84102351|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102352|NCT00612144|Metformin|metformin|mesh-list
84102353|NCT00612144|Glimepiride|glimepiride|mesh-list
84102354|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84102355|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102356|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84102357|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102358|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
84102359|NCT02597361|Irbesartan|irbesartan|mesh-list
84102360|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84102361|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84102362|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84102363|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102364|NCT00562627|Ketorolac|ketorolac|mesh-list
84102365|NCT00562627|Epinephrine|epinephrine|mesh-list
84102366|NCT00562627|Racepinephrine|racepinephrine|mesh-list
84102367|NCT00562627|Fentanyl|fentanyl|mesh-list
84102368|NCT00562627|Morphine|morphine|mesh-list
84102369|NCT00562627|Bupivacaine|bupivacaine|mesh-list
84102370|NCT00562627|Ropivacaine|ropivacaine|mesh-list
84102371|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
84102372|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
84102373|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
84102374|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102375|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102376|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
84102377|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102378|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84102380|NCT00562627|Analgesics|analgesics|mesh-ancestor
84102381|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84102382|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84102383|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
84102384|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84102385|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84102386|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
84102387|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102388|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102389|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84102390|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84102391|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
84102392|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84102393|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
84102394|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
84102395|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
84102396|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84102397|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84102398|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84102399|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102400|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102401|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84102402|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102403|NCT02597283|Sirolimus|sirolimus|mesh-list
84102404|NCT02597283|Temsirolimus|temsirolimus|mesh-list
84102405|NCT02597283|MTOR Inhibitors|mtor inhibitors|mesh-list
84102406|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102407|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102408|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84102409|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102410|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
84102411|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102412|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
84102413|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102414|NCT02597283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84102415|NCT02597283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102416|NCT02597283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102417|NCT00948649|Varenicline|varenicline|mesh-list
84102418|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84102419|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84102420|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
84102421|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102422|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102423|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102424|NCT00952159|Tramadol|tramadol|mesh-list
84102425|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
84102426|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84102427|NCT00952159|Narcotics|narcotics|mesh-ancestor
84102428|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102429|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102430|NCT00952159|Analgesics|analgesics|mesh-ancestor
84102431|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
84102432|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102433|NCT00948727|Cyclosporine|cyclosporine|mesh-list
84102434|NCT00948727|Cyclosporins|cyclosporins|mesh-list
84102435|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102436|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102437|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102438|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
84102439|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102440|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
84102441|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102442|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
84102443|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102444|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84102445|NCT02778776|Metformin|metformin|mesh-list
84102446|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84102447|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102448|NCT00948805|Goserelin|goserelin|mesh-list
84102449|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84102450|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84102451|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102452|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84102453|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102455|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84102456|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102457|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
84102458|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
84102459|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
84102460|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102461|NCT02780882|Pasireotide|pasireotide|mesh-list
84102462|NCT02780882|Hormones|hormones|mesh-ancestor
84102463|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84102464|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102465|NCT02710266|Gabexate|gabexate|mesh-list
84102466|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
84102467|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84102468|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
84102469|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102470|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102471|NCT00562159|Fluticasone|fluticasone|mesh-list
84102472|NCT00562159|Xhance|xhance|mesh-list
84102473|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
84102474|NCT00562159|Loratadine|loratadine|mesh-list
84102475|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
84102476|NCT00562159|Prednisone|prednisone|mesh-list
84102477|NCT00562159|Albuterol|albuterol|mesh-list
84102478|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102479|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
84102480|NCT00562159|Hormones|hormones|mesh-ancestor
84102481|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84102482|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102483|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84102484|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102485|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84102486|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
84102487|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102488|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84102489|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
84102490|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
84102491|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84102492|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
84102493|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84102494|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84102495|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84102496|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84102497|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
84102498|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102499|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102500|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
84102501|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84102502|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84102503|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
84102504|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
84102505|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84102506|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84102507|NCT00562159|Analgesics|analgesics|mesh-ancestor
84102508|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
84102509|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102510|NCT02710110|Capsaicin|capsaicin|mesh-list
84102511|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
84102512|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
84102513|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
84102514|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102515|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102516|NCT00952627|Pycnogenols|pycnogenols|mesh-list
84102517|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84102518|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
84102519|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102520|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
84102521|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102522|NCT00952627|Protective Agents|protective agents|mesh-ancestor
84102523|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84102524|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84102525|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84102526|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84102527|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84102528|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102529|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102530|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102531|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84102532|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
84102533|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84102534|NCT04848714|Antivenins|antivenins|mesh-list
84102535|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
84102536|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102537|NCT00952861|Doxycycline|doxycycline|mesh-list
84102538|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102539|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102540|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
84102541|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84102542|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84102543|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
84102544|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102545|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84102546|NCT04889066|Durvalumab|durvalumab|mesh-list
84102547|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84102548|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102549|NCT04223778|Islatravir|islatravir|mesh-list
84102550|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
84102551|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102552|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102553|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102554|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84102555|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84102556|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84102557|NCT05109416|Bupivacaine|bupivacaine|mesh-list
84102558|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
84102559|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
84102560|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102561|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102562|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
84102563|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102564|NCT04074564|Apatinib|apatinib|mesh-list
84102565|NCT04074564|Antibodies|antibodies|mesh-list
84102566|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
84102567|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102568|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102569|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84102570|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102571|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102572|NCT02778308|Gemcitabine|gemcitabine|mesh-list
84102573|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102574|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84102575|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
84102576|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102577|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
84102578|NCT02776202|Sirolimus|sirolimus|mesh-list
84102579|NCT02776202|Fludarabine|fludarabine|mesh-list
84102580|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
84102581|NCT02776202|Melphalan|melphalan|mesh-list
84102582|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102583|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84102584|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
84102585|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102586|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102587|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
84102588|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102589|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84102590|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84102591|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
84102592|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102593|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102594|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102595|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
84102596|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84102597|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
83342611|NCT03343002|Narcotics|narcotics|mesh-ancestor
84102598|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84102600|NCT00921557|Alendronate|alendronate|mesh-list
84102601|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
84102602|NCT00921557|Calcium|calcium|mesh-list
84102603|NCT00921557|Vitamins|vitamins|mesh-ancestor
84102604|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
84102605|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102606|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84102607|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84102608|NCT00921557|Antacids|antacids|mesh-ancestor
84102609|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102610|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102611|NCT00611754|Fluorouracil|fluorouracil|mesh-list
84102612|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
84102613|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
84102614|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102615|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84102616|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102617|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102618|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
84102619|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102620|NCT00550615|Dasatinib|dasatinib|mesh-list
84102621|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102622|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84102623|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102624|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102625|NCT02709720|Cisplatin|cisplatin|mesh-list
84102626|NCT02709720|Vinorelbine|vinorelbine|mesh-list
84102627|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102628|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84102629|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
84102630|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
84102631|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
84102632|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102633|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
84102634|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
84102635|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102636|NCT02779634|Vitamins|vitamins|mesh-ancestor
84102637|NCT04255589|Ethanol|ethanol|mesh-list
84102638|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84102639|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102640|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102641|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102642|NCT00744471|Tanezumab|tanezumab|mesh-list
84102643|NCT00744471|Analgesics|analgesics|mesh-ancestor
84102644|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
84102645|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102646|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102647|NCT02776436|Dexamethasone|dexamethasone|mesh-list
84102648|NCT02776436|Prednisone|prednisone|mesh-list
84102649|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102650|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
84102651|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
84102652|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102653|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102654|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102655|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
84102656|NCT02776436|Hormones|hormones|mesh-ancestor
84102657|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84102658|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84102659|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102660|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84102661|NCT02775968|Azithromycin|azithromycin|mesh-list
84102662|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
84102663|NCT02775968|Erythromycin|erythromycin|mesh-list
84102664|NCT02775968|Cephalosporins|cephalosporins|mesh-list
84102665|NCT02775968|Cefamandole|cefamandole|mesh-list
84102666|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102667|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102668|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84102669|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102670|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102671|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
84102672|NCT02775734|Clomiphene|clomiphene|mesh-list
84102673|NCT02775734|Enclomiphene|enclomiphene|mesh-list
84102674|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
84102675|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84102676|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102677|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84102678|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
84102679|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84102680|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102681|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84102682|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
84102683|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84102684|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84102685|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84102686|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
84102687|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102688|NCT02775734|Expectorants|expectorants|mesh-ancestor
84102689|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
84102690|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84102691|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
84102692|NCT02775734|Protective Agents|protective agents|mesh-ancestor
84102693|NCT02775734|Antidotes|antidotes|mesh-ancestor
84102694|NCT02772926|Benphothiamine|benphothiamine|mesh-list
84102695|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84102696|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
84102697|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102698|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
84102699|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
84102700|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102701|NCT02709564|Misoprostol|misoprostol|mesh-list
84102702|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84102703|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
84102704|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84102705|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102706|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84102707|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102708|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
84102709|NCT04688814|Morphine|morphine|mesh-list
84102710|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84102711|NCT04688814|Narcotics|narcotics|mesh-ancestor
84102712|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102713|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102714|NCT04688814|Analgesics|analgesics|mesh-ancestor
84102715|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
84102716|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102717|NCT00744237|Metoprolol|metoprolol|mesh-list
84102718|NCT00744237|Nebivolol|nebivolol|mesh-list
84102719|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84102720|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84102721|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
84102722|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
84102723|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102724|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102725|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84102726|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84102727|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84102728|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
84102729|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102730|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102731|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
84102732|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84102733|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84102734|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84102735|NCT04821284|Leucovorin|leucovorin|mesh-list
84102736|NCT04821284|Paclitaxel|paclitaxel|mesh-list
84102737|NCT04821284|Gemcitabine|gemcitabine|mesh-list
84102738|NCT04821284|Fluorouracil|fluorouracil|mesh-list
84102739|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
84102740|NCT04821284|Irinotecan|irinotecan|mesh-list
84102741|NCT04821284|Calcium|calcium|mesh-list
84102742|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
84102743|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84102744|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102745|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
84102746|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
84102747|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
84102748|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102749|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84102750|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
84102751|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84102752|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102753|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102754|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
84102755|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84102756|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84102757|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102759|NCT04821284|Protective Agents|protective agents|mesh-ancestor
84102760|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
84102761|NCT04821284|Vitamins|vitamins|mesh-ancestor
84102762|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
84102763|NCT05260554|Fosfomycin|fosfomycin|mesh-list
84102764|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102765|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102766|NCT04089345|Ustekinumab|ustekinumab|mesh-list
84102767|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
84102768|NCT02693574|Amoxicillin|amoxicillin|mesh-list
84102769|NCT02693574|Clarithromycin|clarithromycin|mesh-list
84102770|NCT02693574|Levofloxacin|levofloxacin|mesh-list
84102771|NCT02693574|Esomeprazole|esomeprazole|mesh-list
84102772|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102773|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102774|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84102775|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102776|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84102777|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102778|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102779|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84102780|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84102781|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84102782|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84102783|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84102784|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84102785|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102786|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84102787|NCT04179266|Ketamine|ketamine|mesh-list
84102788|NCT04179266|Analgesics|analgesics|mesh-ancestor
84102789|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
84102790|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102791|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102792|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84102793|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84102794|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
84102795|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
84102796|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102797|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84102798|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84102799|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102800|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102801|NCT00743145|Naltrexone|naltrexone|mesh-list
84102802|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84102803|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84102804|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102805|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
84102806|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102807|NCT04875728|Cefazolin|cefazolin|mesh-list
84102808|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102809|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102810|NCT00611910|Sirolimus|sirolimus|mesh-list
84102811|NCT00611910|Paclitaxel|paclitaxel|mesh-list
84102812|NCT00611910|Temsirolimus|temsirolimus|mesh-list
84102813|NCT00611910|MTOR Inhibitors|mtor inhibitors|mesh-list
84102814|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84102815|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102816|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
84102817|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
84102818|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
84102819|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102820|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102821|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102822|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84102823|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
84102824|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102825|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
84102826|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102827|NCT00611910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84102829|NCT00920855|Bortezomib|bortezomib|mesh-list
84102830|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84102831|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102832|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84102833|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
84102834|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102835|NCT04251845|Melatonin|melatonin|mesh-list
84102836|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
84102837|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102838|NCT04251845|Protective Agents|protective agents|mesh-ancestor
84102839|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102840|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102841|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
84102842|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
84102843|NCT05207358|Rituximab|rituximab|mesh-list
84102844|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84102845|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
84102846|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102847|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102848|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84102849|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
84102850|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102851|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102852|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84102853|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84102854|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84102855|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84102856|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
84102857|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84102858|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84102859|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102860|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84102861|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102862|NCT05387031|Ustekinumab|ustekinumab|mesh-list
84102863|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
84102864|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
84102865|NCT04570644|Ibuprofen|ibuprofen|mesh-list
84102866|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84102867|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84102868|NCT04570644|Analgesics|analgesics|mesh-ancestor
84102869|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
84102870|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102871|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102872|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84102873|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84102874|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84102875|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102876|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102877|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
84102878|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
84102879|NCT04570644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84102880|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84102881|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
84102882|NCT02775110|Natalizumab|natalizumab|mesh-list
84102883|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
84102884|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102885|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
84102886|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
84102887|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102888|NCT02775266|Protective Agents|protective agents|mesh-ancestor
84102889|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102890|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
84102891|NCT02775266|Vitamins|vitamins|mesh-ancestor
84102892|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
84102893|NCT01524926|Crizotinib|crizotinib|mesh-list
84102894|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102895|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84102896|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84102897|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102898|NCT03738228|Cisplatin|cisplatin|mesh-list
84102899|NCT03738228|Atezolizumab|atezolizumab|mesh-list
84102900|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84102901|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102902|NCT03738228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84102903|NCT03738228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102904|NCT03738228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84102905|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
84102906|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102907|NCT04756232|Mecamylamine|mecamylamine|mesh-list
84102908|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84102909|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
84102910|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
84102911|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102912|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102913|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84102914|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84102915|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
84102916|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102917|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102918|NCT02774876|Insulin|insulin|mesh-list
84102919|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84102920|NCT02774876|Hormones|hormones|mesh-list
84102921|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84102922|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102923|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84102924|NCT04225364|Paclitaxel|paclitaxel|mesh-list
84102925|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84102926|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84102927|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84102928|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
84102929|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
84102930|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
84102931|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102932|NCT02771834|Vitamin D|vitamin d|mesh-list
84102933|NCT02771834|Vitamins|vitamins|mesh-ancestor
84102934|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
84102935|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102936|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84102937|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84102938|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84102939|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
84102940|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102941|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84102942|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84102943|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
84102944|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
84102945|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102946|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102947|NCT00613470|Citalopram|citalopram|mesh-list
84102948|NCT00613470|Escitalopram|escitalopram|mesh-list
84102949|NCT00613470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84102950|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84102951|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84102952|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102953|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84102954|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
84102955|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102956|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84102957|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
84102958|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84102959|NCT02771912|Propofol|propofol|mesh-list
84102960|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84102961|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84102962|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102963|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102964|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84102965|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
84102966|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
84102967|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84102968|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84102969|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84102970|NCT00741819|Treprostinil|treprostinil|mesh-list
84102971|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84102972|NCT04457466|Mitogens|mitogens|mesh-list
84102973|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
84102974|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102975|NCT04954742|Riociguat|riociguat|mesh-list
83342990|NCT02495220|Analgesics|analgesics|mesh-ancestor
84102976|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
84102977|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84102978|NCT04193696|Immunomodulating Agents|immunomodulating agents|mesh-list
84102979|NCT04193696|Immunologic Factors|immunologic factors|mesh-ancestor
84102980|NCT04193696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102982|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84102983|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
84102984|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
84102985|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102986|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102987|NCT04181385|Bromocriptine|bromocriptine|mesh-list
84102988|NCT04181385|Olanzapine|olanzapine|mesh-list
84102989|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
84102990|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
84102991|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84102992|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84102993|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84102994|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84102995|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84102996|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84102997|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84102998|NCT04181385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84102999|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84103000|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84103001|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103002|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103003|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
84103004|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84103005|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84103006|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
84103007|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103008|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
84103009|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
84103010|NCT00924443|Clofarabine|clofarabine|mesh-list
84103011|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84103012|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
84103013|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103014|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103015|NCT02677155|Rituximab|rituximab|mesh-list
84103016|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
84103017|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84103018|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103019|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
84103020|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103021|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103022|NCT02677155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84103023|NCT02677155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103024|NCT02537691|Theophylline|theophylline|mesh-list
84103025|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84103026|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
84103027|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103028|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103029|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84103030|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
84103031|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84103032|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103033|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103034|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
84103035|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84103036|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84103037|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
84103038|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103039|NCT04225052|Varenicline|varenicline|mesh-list
84103040|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84103041|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84103042|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
84103043|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103044|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103045|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103046|NCT04255121|Lidocaine|lidocaine|mesh-list
84103047|NCT04255121|Epinephrine|epinephrine|mesh-list
84103048|NCT04255121|Racepinephrine|racepinephrine|mesh-list
84103049|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
84103050|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103051|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
84103052|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103053|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103054|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
84103055|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103056|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84103057|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84103058|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84103059|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84103060|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103061|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84103062|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84103063|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
84103064|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103065|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84103066|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84103067|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
84103068|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84103069|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
84103070|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
84103071|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
84103072|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84103073|NCT03521232|Niclosamide|niclosamide|mesh-list
84103074|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
84103075|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84103076|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
84103077|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84103078|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103079|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
84103080|NCT00924287|Aldesleukin|aldesleukin|mesh-list
84103081|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
84103082|NCT00924287|Fludarabine|fludarabine|mesh-list
84103083|NCT00924287|Interleukin-2|interleukin-2|mesh-list
84103084|NCT00924287|Mesna|mesna|mesh-list
84103085|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103086|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
84103087|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103088|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103089|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84103090|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
84103091|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103092|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103093|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84103094|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103095|NCT00924287|Analgesics|analgesics|mesh-ancestor
84103096|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
84103097|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103098|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84103099|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84103100|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
84103101|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103102|NCT00924287|Protective Agents|protective agents|mesh-ancestor
84103103|NCT02696954|Lumefantrine|lumefantrine|mesh-list
84103104|NCT02696954|Artemether|artemether|mesh-list
84103105|NCT02696954|Primaquine|primaquine|mesh-list
84103106|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84103107|NCT02696954|Amodiaquine|amodiaquine|mesh-list
84103108|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
84103109|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84103110|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84103111|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103112|NCT02677077|Natalizumab|natalizumab|mesh-list
84103113|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
84103114|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103115|NCT02771600|Anesthetics|anesthetics|mesh-list
84103116|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
84103117|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103118|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103119|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
84103120|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103121|NCT02773316|Morphine|morphine|mesh-list
84103122|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84103123|NCT02773316|Narcotics|narcotics|mesh-ancestor
84103124|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103125|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103126|NCT02773316|Analgesics|analgesics|mesh-ancestor
84103127|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
84103128|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103129|NCT00642681|Insulin|insulin|mesh-list
84103130|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84103131|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103132|NCT02773550|Prednisone|prednisone|mesh-list
84103133|NCT02773550|Bortezomib|bortezomib|mesh-list
84103134|NCT02773550|Melphalan|melphalan|mesh-list
84103135|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103136|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
84103137|NCT02773550|Hormones|hormones|mesh-ancestor
84103138|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103139|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103140|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84103141|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103142|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84103143|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
84103144|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103145|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84103146|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103147|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
84103148|NCT02773472|Morphine|morphine|mesh-list
84103149|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84103150|NCT02773472|Narcotics|narcotics|mesh-ancestor
84103151|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103152|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103153|NCT02773472|Analgesics|analgesics|mesh-ancestor
84103154|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
84103155|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103156|NCT00637871|Tamoxifen|tamoxifen|mesh-list
84103157|NCT00637871|Bicalutamide|bicalutamide|mesh-list
84103158|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84103159|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
84103160|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103161|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103162|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84103163|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103164|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84103165|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84103166|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84103167|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
84103168|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84103169|NCT00635258|Ganirelix|ganirelix|mesh-list
84103170|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103171|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103172|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
84103173|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84103174|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
84103175|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84103176|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84103177|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84103178|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103179|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
84103180|NCT00642837|Acetaminophen|acetaminophen|mesh-list
84103181|NCT00642837|Tramadol|tramadol|mesh-list
84103182|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103183|NCT00642837|Analgesics|analgesics|mesh-ancestor
84103184|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
84103185|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103186|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103187|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
84103188|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84103189|NCT00642837|Narcotics|narcotics|mesh-ancestor
84103190|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103191|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84103192|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84103193|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84103194|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103195|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103196|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
84103197|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103198|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84103199|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84103200|NCT02676609|Insulin|insulin|mesh-list
84103201|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84103202|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103203|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
84103204|NCT00642915|Glimepiride|glimepiride|mesh-list
84103205|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84103206|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103207|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84103208|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103209|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
84103210|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
84103211|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84103212|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
84103213|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103214|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103215|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84103216|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
84103217|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
84103218|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84103219|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
84103220|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103221|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103222|NCT02696720|Lidocaine|lidocaine|mesh-list
84103223|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103224|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
84103225|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103226|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103227|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
83429652|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103228|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103229|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84103230|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84103231|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84103232|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84103233|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103234|NCT00643071|Tacrolimus|tacrolimus|mesh-list
84103235|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103236|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
84103237|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103238|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84103239|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103240|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103241|NCT03728634|Vitamin A|vitamin a|mesh-list
84103242|NCT03728634|Vitamins|vitamins|mesh-ancestor
84103243|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
84103244|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103245|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84103246|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84103247|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84103248|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
84103249|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103250|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84103251|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84103252|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103253|NCT04353414|Bupivacaine|bupivacaine|mesh-list
84103254|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103255|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
84103256|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103257|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103258|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
84103259|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103260|NCT00643149|Amoxicillin|amoxicillin|mesh-list
84103261|NCT00643149|Azithromycin|azithromycin|mesh-list
84103262|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103263|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103264|NCT05141682|Azacitidine|azacitidine|mesh-list
84103265|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84103266|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
84103267|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103268|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103269|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103270|NCT00643227|Azithromycin|azithromycin|mesh-list
84103271|NCT00643227|Clarithromycin|clarithromycin|mesh-list
84103272|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103273|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103274|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84103275|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343291|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
84103276|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103277|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84103278|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84103279|NCT00613392|Antioxidants|antioxidants|mesh-list
84103280|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103281|NCT00613392|Protective Agents|protective agents|mesh-ancestor
84103282|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103283|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
84103284|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84103285|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
84103286|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84103287|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
84103288|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103289|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103290|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
84103291|NCT02762864|Clopidogrel|clopidogrel|mesh-list
84103292|NCT02762864|Ticagrelor|ticagrelor|mesh-list
84103293|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103294|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103295|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84103296|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84103297|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84103298|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84103299|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
84103300|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103301|NCT02767154|Mannitol|mannitol|mesh-list
84103302|NCT02767154|Dextrans|dextrans|mesh-list
84103303|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84103304|NCT02767154|Diuretics|diuretics|mesh-ancestor
84103305|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
84103306|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103307|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
84103308|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
84103309|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
84103310|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84103311|NCT02767232|Plasminogen|plasminogen|mesh-list
84103312|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84103313|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84103314|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103315|NCT02767076|Anesthetics|anesthetics|mesh-list
84103316|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103317|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103318|NCT02766764|Hormones|hormones|mesh-list
84103319|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103320|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103321|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
84103322|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84103323|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103324|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103325|NCT02770508|Ritonavir|ritonavir|mesh-list
84103326|NCT02770508|Darunavir|darunavir|mesh-list
84103327|NCT02770508|Tenofovir|tenofovir|mesh-list
84103328|NCT02770508|Lamivudine|lamivudine|mesh-list
84103329|NCT02770508|Emtricitabine|emtricitabine|mesh-list
84103330|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84103331|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84103332|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
84103333|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103334|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103335|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84103336|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84103337|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
84103338|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103339|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84103340|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84103341|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84103342|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84103343|NCT02762942|Misoprostol|misoprostol|mesh-list
84103344|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84103345|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
84103346|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84103347|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103348|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83343362|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84103349|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84103350|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
84103351|NCT02770430|Infliximab|infliximab|mesh-list
84103352|NCT02770430|Basiliximab|basiliximab|mesh-list
84103353|NCT02770430|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84103354|NCT02770430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103355|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
84103356|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84103357|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103358|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103359|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
84103360|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103361|NCT00918203|Paclitaxel|paclitaxel|mesh-list
84103362|NCT00918203|Carboplatin|carboplatin|mesh-list
84103363|NCT00918203|Olaratumab|olaratumab|mesh-list
84103364|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84103365|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103366|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
84103367|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
84103368|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
84103369|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103370|NCT00644319|Ibuprofen|ibuprofen|mesh-list
84103371|NCT00644319|Morphine|morphine|mesh-list
84103372|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84103373|NCT00644319|Narcotics|narcotics|mesh-ancestor
84103374|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103375|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103376|NCT00644319|Analgesics|analgesics|mesh-ancestor
84103377|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
84103378|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103379|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84103380|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103381|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103382|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103383|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84103384|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103385|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103386|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
84103387|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84103388|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84103389|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103390|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
84103391|NCT04224116|Coagulants|coagulants|mesh-ancestor
84103392|NCT02672709|Apixaban|apixaban|mesh-list
84103393|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84103394|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
84103395|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84103396|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
84103397|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103398|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103399|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
84103400|NCT02770274|Aspirin|aspirin|mesh-list
84103401|NCT02770274|Cilostazol|cilostazol|mesh-list
84103402|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84103403|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103404|NCT02770274|Analgesics|analgesics|mesh-ancestor
84103405|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
84103406|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103407|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103408|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103409|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103410|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84103411|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84103412|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103413|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84103414|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84103415|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103416|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
84103417|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84103418|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
84103419|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84103420|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
84103421|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
84103422|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84103423|NCT02770274|Protective Agents|protective agents|mesh-ancestor
84103424|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84103425|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84103427|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84103428|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84103429|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
84103430|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103431|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84103432|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84103433|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103434|NCT04657562|Tacrolimus|tacrolimus|mesh-list
84103435|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103436|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
84103437|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103438|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84103439|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103440|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103441|NCT05252117|Carticaine|carticaine|mesh-list
84103442|NCT05252117|Mepivacaine|mepivacaine|mesh-list
84103443|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103444|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
84103445|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103446|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103447|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
84103448|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103449|NCT04224350|Tacrolimus|tacrolimus|mesh-list
84103450|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103451|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
84103452|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103453|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84103454|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103455|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103456|NCT02770716|Terlipressin|terlipressin|mesh-list
84103457|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84103458|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84103459|NCT04846829|Citalopram|citalopram|mesh-list
84103460|NCT04846829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84103461|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84103462|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84103463|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103464|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103465|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
84103466|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103467|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84103468|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
84103469|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84103470|NCT02672241|Temozolomide|temozolomide|mesh-list
84103471|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
84103472|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84103473|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
84103474|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103475|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103476|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84103477|NCT04177875|Paclitaxel|paclitaxel|mesh-list
84103478|NCT04177875|Docetaxel|docetaxel|mesh-list
84103479|NCT04177875|Cisplatin|cisplatin|mesh-list
84103480|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84103481|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84103482|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103483|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
84103484|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
84103485|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
84103486|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103487|NCT00917579|Atorvastatin|atorvastatin|mesh-list
84103488|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84103489|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84103490|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
84103491|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103492|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84103493|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84103494|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103495|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84103496|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84103497|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83343509|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103498|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84103499|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103500|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
84103501|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103502|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103504|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103505|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
84103506|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
84103507|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
84103508|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103509|NCT04177641|Antioxidants|antioxidants|mesh-list
84103510|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103511|NCT04177641|Protective Agents|protective agents|mesh-ancestor
84103512|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103513|NCT04178109|Acetaminophen|acetaminophen|mesh-list
84103514|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84103515|NCT04178109|Tramadol|tramadol|mesh-list
84103516|NCT04178109|Ropivacaine|ropivacaine|mesh-list
84103517|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
84103518|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103519|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
84103520|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103521|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103522|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
84103523|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103524|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103525|NCT04178109|Analgesics|analgesics|mesh-ancestor
84103526|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
84103527|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84103528|NCT04178109|Narcotics|narcotics|mesh-ancestor
84103529|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84103530|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103531|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103532|NCT00644475|Candesartan|candesartan|mesh-list
84103533|NCT00644475|Imidapril|imidapril|mesh-list
84103534|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84103535|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84103536|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84103537|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103538|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84103539|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
84103540|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103541|NCT04177719|Oxytocin|oxytocin|mesh-list
84103542|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
84103543|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84103544|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103545|NCT00644553|Amoxicillin|amoxicillin|mesh-list
84103546|NCT00644553|Clarithromycin|clarithromycin|mesh-list
84103547|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
84103548|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84103549|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103550|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103551|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84103552|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103553|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103554|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84103555|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84103556|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84103557|NCT02762474|Paclitaxel|paclitaxel|mesh-list
84103558|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84103559|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103560|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
84103561|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
84103562|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
84103563|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103564|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
84103565|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84103566|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84103567|NCT00915473|Prednisolone|prednisolone|mesh-list
84103568|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
84103569|NCT00915473|Lidocaine|lidocaine|mesh-list
84103570|NCT00915473|Bupivacaine|bupivacaine|mesh-list
84103571|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84103572|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
84103573|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103574|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
84103575|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103576|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103577|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
84103578|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103579|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84103580|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84103581|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84103582|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84103583|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103584|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103585|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
84103586|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
84103587|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84103588|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
84103589|NCT00915473|Hormones|hormones|mesh-ancestor
84103590|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103591|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84103592|NCT00915473|Protective Agents|protective agents|mesh-ancestor
84103593|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84103594|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103595|NCT04691726|Dipyrone|dipyrone|mesh-list
84103596|NCT04691726|Lidocaine|lidocaine|mesh-list
84103597|NCT04691726|Morphine|morphine|mesh-list
84103598|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103599|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
84103600|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103601|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103602|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
84103603|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103604|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84103605|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84103606|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84103607|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84103608|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103609|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84103610|NCT04691726|Narcotics|narcotics|mesh-ancestor
84103611|NCT04691726|Analgesics|analgesics|mesh-ancestor
84103612|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84103613|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103614|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103615|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103616|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
84103617|NCT00614328|Naltrexone|naltrexone|mesh-list
84103618|NCT00614328|Baclofen|baclofen|mesh-list
84103619|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84103620|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84103621|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103622|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
84103623|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103624|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84103625|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84103626|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84103627|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
84103628|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
84103629|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103630|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103631|NCT04177173|Methotrexate|methotrexate|mesh-list
84103632|NCT04177173|Simvastatin|simvastatin|mesh-list
84103633|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84103634|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
84103635|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84103636|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103637|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84103638|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
84103639|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103640|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103641|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
84103642|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103643|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84103644|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103645|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
84103646|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343658|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
84103647|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84103648|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84103649|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84103650|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84103651|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84103652|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84103653|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84103654|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
84103655|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84103656|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
84103657|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84103658|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103659|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84103660|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84103661|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103662|NCT03651804|Acetaminophen|acetaminophen|mesh-list
84103663|NCT03651804|Diphosphonates|diphosphonates|mesh-list
84103664|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84103665|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84103666|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103667|NCT03651804|Analgesics|analgesics|mesh-ancestor
84103668|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
84103669|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103670|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103671|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
84103672|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84103673|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103674|NCT00917267|Exenatide|exenatide|mesh-list
84103675|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84103676|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103677|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84103678|NCT00917267|Incretins|incretins|mesh-ancestor
84103679|NCT00917267|Hormones|hormones|mesh-ancestor
84103680|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103681|NCT02670759|Bupivacaine|bupivacaine|mesh-list
84103682|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103683|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
84103684|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103685|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103686|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
84103687|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103688|NCT00644943|Amoxicillin|amoxicillin|mesh-list
84103689|NCT00644943|Cefdinir|cefdinir|mesh-list
84103690|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103691|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103692|NCT02762006|Durvalumab|durvalumab|mesh-list
84103693|NCT02762006|Tremelimumab|tremelimumab|mesh-list
84103694|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84103695|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103696|NCT02769884|Pancrelipase|pancrelipase|mesh-list
84103697|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84103698|NCT05213507|Amikacin|amikacin|mesh-list
84103699|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103700|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103701|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84103702|NCT04253873|Temozolomide|temozolomide|mesh-list
84103703|NCT04253873|Apatinib|apatinib|mesh-list
84103704|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84103705|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
84103706|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103707|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103708|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84103709|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103710|NCT05147727|Fluconazole|fluconazole|mesh-list
84103711|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
84103712|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103713|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84103714|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84103715|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103716|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103717|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84103718|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
84103719|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103720|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103721|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84103722|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84103723|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
84103724|NCT02765594|Valsartan|valsartan|mesh-list
84103725|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84103726|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84103727|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84103728|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103729|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
84103730|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84103731|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84103732|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103733|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103734|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103735|NCT00920699|Ubiquinone|ubiquinone|mesh-list
84103736|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
84103737|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
84103738|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103739|NCT00920699|Vitamins|vitamins|mesh-ancestor
84103740|NCT02670135|Triclosan|triclosan|mesh-list
84103741|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84103742|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103743|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84103744|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84103745|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
84103746|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103747|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84103748|NCT02769494|Riboflavin|riboflavin|mesh-list
84103749|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
84103750|NCT02769494|Mesalamine|mesalamine|mesh-list
84103751|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
84103752|NCT02769494|Vitamins|vitamins|mesh-ancestor
84103753|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
84103754|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103755|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84103756|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
84103757|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84103758|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103759|NCT02769494|Analgesics|analgesics|mesh-ancestor
84103760|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
84103761|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103762|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103763|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103764|NCT02769572|Diclofenac|diclofenac|mesh-list
84103765|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84103766|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84103767|NCT02769572|Analgesics|analgesics|mesh-ancestor
84103768|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
84103769|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103770|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103771|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103772|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103773|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84103774|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103775|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103776|NCT02669589|Heparin|heparin|mesh-list
84103777|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
84103778|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103779|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84103780|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84103781|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
84103782|NCT02765204|Saxagliptin|saxagliptin|mesh-list
84103783|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84103784|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103785|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84103786|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103787|NCT02765204|Incretins|incretins|mesh-ancestor
84103788|NCT02765204|Hormones|hormones|mesh-ancestor
84103789|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103790|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84103791|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
84103792|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103793|NCT03342456|Amoxicillin|amoxicillin|mesh-list
84103794|NCT03342456|Doxycycline|doxycycline|mesh-list
84103795|NCT03342456|Furazolidone|furazolidone|mesh-list
84103796|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
84103797|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103798|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103799|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103800|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
84103801|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84103802|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84103803|NCT03342456|Diuretics|diuretics|mesh-ancestor
84103804|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
84103805|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103806|NCT03342456|Expectorants|expectorants|mesh-ancestor
84103807|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
84103808|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84103809|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84103810|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84103811|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84103812|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103813|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84103814|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
84103815|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84103816|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
84103817|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103818|NCT02769104|Docetaxel|docetaxel|mesh-list
84103819|NCT02769104|Letrozole|letrozole|mesh-list
84103820|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84103821|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103822|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
84103823|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
84103824|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
84103825|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103826|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84103827|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103828|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84103829|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
84103830|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103831|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103832|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
84103833|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84103834|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103835|NCT00645255|Sibutramine|sibutramine|mesh-list
84103836|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
84103837|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84103838|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
84103839|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84103840|NCT04679012|Prednisone|prednisone|mesh-list
84103841|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
84103842|NCT04679012|Rituximab|rituximab|mesh-list
84103843|NCT04679012|Doxorubicin|doxorubicin|mesh-list
84103844|NCT04679012|Etoposide|etoposide|mesh-list
84103845|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84103846|NCT04679012|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
84103847|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103848|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
84103849|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103850|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103851|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84103852|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
84103853|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103854|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103855|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84103856|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84103857|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84103858|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84103859|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84103860|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103861|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84103862|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
84103863|NCT04679012|Hormones|hormones|mesh-ancestor
84103864|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103865|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84103866|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84103867|NCT04679012|Immunoconjugates|immunoconjugates|mesh-ancestor
84103868|NCT00910455|SRX246|srx246|mesh-list
84103869|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84103870|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103871|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
83343882|NCT03320538|Rabeprazole|rabeprazole|mesh-list
84103872|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103873|NCT02765126|Vaccines|vaccines|mesh-list
84103874|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
84103875|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103876|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84103877|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84103878|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103879|NCT00916721|Propranolol|propranolol|mesh-list
84103880|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84103881|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84103882|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
84103883|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103884|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103885|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103886|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84103887|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84103888|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
84103889|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
84103890|NCT00613782|Testosterone|testosterone|mesh-list
84103891|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
84103892|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
83429660|NCT00217022|Budesonide|budesonide|mesh-list
84103893|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84103894|NCT00613782|Androgens|androgens|mesh-ancestor
84103895|NCT00613782|Hormones|hormones|mesh-ancestor
84103896|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103897|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103898|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84103899|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103900|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
84103901|NCT02764736|Atorvastatin|atorvastatin|mesh-list
84103902|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84103903|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84103904|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
84103905|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103906|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84103907|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84103908|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103909|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
84103910|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84103911|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103912|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84103913|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
84103914|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103915|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103916|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103917|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103918|NCT00646815|Hormones|hormones|mesh-list
84103919|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84103920|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103921|NCT00915005|Paclitaxel|paclitaxel|mesh-list
84103922|NCT00915005|Carboplatin|carboplatin|mesh-list
84103923|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84103924|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103925|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
84103926|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
84103927|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
84103928|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103929|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
84103930|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84103931|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103932|NCT02696642|Maytansine|maytansine|mesh-list
84103933|NCT02696642|Anetumab ravtansine|anetumab ravtansine|mesh-list
84103934|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84103935|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103936|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
84103937|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
84103938|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
84103939|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103940|NCT02696642|Immunoconjugates|immunoconjugates|mesh-ancestor
84103941|NCT02696642|Immunologic Factors|immunologic factors|mesh-ancestor
84103942|NCT02696642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103943|NCT00647049|Cytarabine|cytarabine|mesh-list
84103944|NCT00647049|Rituximab|rituximab|mesh-list
84103945|NCT00647049|Methotrexate|methotrexate|mesh-list
84103946|NCT00647049|Thiotepa|thiotepa|mesh-list
84103947|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84103948|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103949|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
84103950|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103951|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84103952|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84103953|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
84103954|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84103955|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84103956|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
84103957|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103958|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
84103959|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84103960|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84103961|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84103962|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84103963|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
84103964|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84103965|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84103966|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
84103967|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84103968|NCT02696330|Enoxaparin|enoxaparin|mesh-list
84103969|NCT02696330|Clopidogrel|clopidogrel|mesh-list
84103970|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84103971|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84103972|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84103973|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84103974|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
84103975|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84103976|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103977|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103978|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
84103979|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84103980|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84103981|NCT04172727|Bupivacaine|bupivacaine|mesh-list
84103982|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
84103983|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
84103984|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103985|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103986|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
84103987|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84103988|NCT04648319|Nivolumab|nivolumab|mesh-list
84103989|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84103990|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84103991|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84103992|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84103993|NCT00647127|Fentanyl|fentanyl|mesh-list
84103994|NCT00647127|Buprenorphine|buprenorphine|mesh-list
84103995|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84103996|NCT00647127|Narcotics|narcotics|mesh-ancestor
84103997|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84103998|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84103999|NCT00647127|Analgesics|analgesics|mesh-ancestor
84104000|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
84104001|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104002|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84104003|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84104004|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
84104005|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
84104006|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84104007|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84104008|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84104009|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104010|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104011|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
84104012|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104013|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104014|NCT04750070|Dopamine|dopamine|mesh-list
84104015|NCT04750070|Epinephrine|epinephrine|mesh-list
84104016|NCT04750070|Racepinephrine|racepinephrine|mesh-list
84104017|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
84104018|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84104019|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84104020|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
83344032|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84104021|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104022|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104023|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104025|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84104026|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
84104027|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104028|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84104029|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
84104030|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
84104031|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
84104032|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84104033|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84104034|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
84104035|NCT04750070|Protective Agents|protective agents|mesh-ancestor
84104036|NCT02763722|Emollients|emollients|mesh-list
84104037|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
84104038|NCT01143246|Terlipressin|terlipressin|mesh-list
84104039|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84104040|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84104041|NCT00647673|Verapamil|verapamil|mesh-list
84104042|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84104043|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84104044|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104045|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104046|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84104047|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104048|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
84104049|NCT00561925|Nevirapine|nevirapine|mesh-list
84104050|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84104051|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84104052|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104053|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104054|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
84104055|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104056|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84104057|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84104058|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84104059|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84104060|NCT02760992|Baclofen|baclofen|mesh-list
84104061|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84104062|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104063|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84104064|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104065|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84104066|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
84104067|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
84104068|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104069|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104070|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
84104071|NCT04172259|Docetaxel|docetaxel|mesh-list
84104072|NCT04172259|Doxorubicin|doxorubicin|mesh-list
84104073|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84104074|NCT04172259|Trastuzumab|trastuzumab|mesh-list
84104075|NCT04172259|Epirubicin|epirubicin|mesh-list
84104076|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84104077|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
84104078|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104079|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104080|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84104081|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
84104082|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104083|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104084|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84104085|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
84104086|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
84104087|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
84104088|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84104089|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84104090|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84104091|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104092|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104093|NCT00647751|Lamotrigine|lamotrigine|mesh-list
84104094|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
84104095|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83344107|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84104096|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104097|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104098|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84104099|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104100|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84104101|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84104102|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104103|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84104104|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84104105|NCT02536989|Omeprazole|omeprazole|mesh-list
84104106|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84104107|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104108|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84104109|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104110|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104111|NCT00647829|Valdecoxib|valdecoxib|mesh-list
84104112|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84104113|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84104114|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104115|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104116|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84104117|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84104118|NCT00647829|Analgesics|analgesics|mesh-ancestor
84104119|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
84104120|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104121|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104122|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104123|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104124|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
84104125|NCT02517918|Sirolimus|sirolimus|mesh-list
84104126|NCT02517918|Methotrexate|methotrexate|mesh-list
84104127|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84104128|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
84104129|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104130|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104131|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84104132|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
84104133|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104134|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104135|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
84104136|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104137|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84104138|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84104139|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
84104140|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104141|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84104142|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84104143|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104144|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84104145|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
84104146|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84104147|NCT00647907|Voriconazole|voriconazole|mesh-list
84104148|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
84104149|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104150|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84104151|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84104152|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104153|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104154|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84104155|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
84104156|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104157|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104158|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84104159|NCT04017546|Venetoclax|venetoclax|mesh-list
84104160|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104161|NCT04171791|Venetoclax|venetoclax|mesh-list
84104162|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104163|NCT04003818|Teicoplanin|teicoplanin|mesh-list
84104164|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84104165|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104166|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
84104167|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104168|NCT00949663|Incretins|incretins|mesh-ancestor
84104170|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104171|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104172|NCT00647985|Fexofenadine|fexofenadine|mesh-list
84104173|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84104174|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84104175|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84104176|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
84104177|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
84104178|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104179|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104180|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104181|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
84104182|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
84104183|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
84104184|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104185|NCT02664051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84104186|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104187|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84104188|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
84104189|NCT00648063|Letrozole|letrozole|mesh-list
84104190|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104191|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84104192|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84104193|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104194|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104195|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84104196|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
84104197|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104198|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104199|NCT00648141|Celecoxib|celecoxib|mesh-list
84104200|NCT00648141|Diclofenac|diclofenac|mesh-list
84104201|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84104202|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84104203|NCT00648141|Analgesics|analgesics|mesh-ancestor
84104204|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
84104205|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104206|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104207|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104208|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104209|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84104210|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84104211|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104212|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104213|NCT00953641|Misoprostol|misoprostol|mesh-list
84104214|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84104215|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
84104216|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104217|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104218|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84104219|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104220|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
84104221|NCT02763098|Remifentanil|remifentanil|mesh-list
84104222|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84104223|NCT02763098|Narcotics|narcotics|mesh-ancestor
84104224|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104225|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104226|NCT02763098|Analgesics|analgesics|mesh-ancestor
84104227|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
84104228|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104229|NCT00648219|Olmesartan|olmesartan|mesh-list
84104230|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84104231|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84104232|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84104233|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84104234|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104235|NCT00648297|Nadolol|nadolol|mesh-list
84104236|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
84104237|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84104238|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84104239|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
84104240|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104241|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104242|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104243|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84104244|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84104245|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
84104246|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
84104247|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104248|NCT00648297|Diuretics|diuretics|mesh-ancestor
84104249|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
84104250|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84104251|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104252|NCT00648453|Clopidogrel|clopidogrel|mesh-list
84104253|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84104254|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84104255|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84104256|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84104257|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
84104258|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104259|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104260|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104261|NCT00549445|Azithromycin|azithromycin|mesh-list
84104262|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84104263|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104264|NCT00637026|Gefitinib|gefitinib|mesh-list
84104265|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104266|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84104267|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104268|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104269|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
84104270|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84104271|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104272|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84104273|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84104274|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104275|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104276|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104277|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84104278|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84104279|NCT02758340|Misoprostol|misoprostol|mesh-list
84104280|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84104281|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
84104282|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104283|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104284|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84104285|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104286|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
84104287|NCT02768168|Dezocine|dezocine|mesh-list
84104288|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84104289|NCT02768168|Narcotics|narcotics|mesh-ancestor
84104290|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104291|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104292|NCT02768168|Analgesics|analgesics|mesh-ancestor
84104293|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
84104294|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104295|NCT03739554|Venetoclax|venetoclax|mesh-list
84104296|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104297|NCT02659683|Esomeprazole|esomeprazole|mesh-list
84104298|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84104299|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104300|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84104301|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104302|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104303|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
84104304|NCT04701476|Tirapazamine|tirapazamine|mesh-list
84104305|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104306|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104307|NCT04701476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84104308|NCT04701476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104309|NCT05343702|Rocuronium|rocuronium|mesh-list
84104310|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84104311|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84104312|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84104313|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104314|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104315|NCT02659761|Lamivudine|lamivudine|mesh-list
84104317|NCT02659761|Dolutegravir|dolutegravir|mesh-list
84104318|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84104319|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84104320|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104321|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104322|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
84104323|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104324|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84104325|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84104326|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84104327|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84104329|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
84104330|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84104331|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
84104332|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104333|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104334|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84104335|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84104336|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84104337|NCT05343546|Trace Elements|trace elements|mesh-ancestor
84104338|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
84104339|NCT02659917|Methamphetamine|methamphetamine|mesh-list
84104340|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84104341|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104342|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
84104343|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
84104344|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104345|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
84104346|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104347|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104348|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
84104349|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84104350|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84104351|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104352|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84104353|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84104354|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104355|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104356|NCT04500236|Anesthetics|anesthetics|mesh-list
84104357|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104358|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104359|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84104360|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
84104361|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84104362|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84104363|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104364|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
84104365|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84104366|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84104367|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104368|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84104369|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84104370|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104371|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104372|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104373|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84104374|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
84104375|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104376|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104377|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84104378|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84104379|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84104380|NCT00649233|Metoprolol|metoprolol|mesh-list
84104381|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84104382|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84104383|NCT00649233|Diuretics|diuretics|mesh-ancestor
84104384|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
84104385|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104386|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84104387|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344406|NCT03315000|Xhance|xhance|mesh-list
84104388|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104389|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84104390|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
84104391|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
84104392|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104393|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84104394|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84104395|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84104396|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
84104397|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104398|NCT00954811|Progesterone|progesterone|mesh-list
84104399|NCT00954811|Progestins|progestins|mesh-ancestor
84104401|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104402|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104403|NCT00954889|Tamsulosin|tamsulosin|mesh-list
84104404|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84104405|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84104406|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84104407|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
84104408|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104409|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104410|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104411|NCT00954889|Urological Agents|urological agents|mesh-ancestor
84104412|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
84104413|NCT03666000|Fludarabine|fludarabine|mesh-list
84104414|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84104415|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
84104416|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104417|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104418|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84104419|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
84104420|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104421|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104422|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84104423|NCT02692248|Dexamethasone|dexamethasone|mesh-list
84104424|NCT02692248|Rituximab|rituximab|mesh-list
84104425|NCT02692248|Gemcitabine|gemcitabine|mesh-list
84104426|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
84104427|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104428|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104429|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
84104430|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104431|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104432|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104433|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
84104434|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
84104435|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104436|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104437|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
84104438|NCT02692248|Hormones|hormones|mesh-ancestor
84104439|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104440|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84104441|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84104442|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
84104443|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104444|NCT04477772|Antibodies|antibodies|mesh-list
84104445|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84104446|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
84104447|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104448|NCT02851290|Anesthetics|anesthetics|mesh-list
84104449|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104450|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104451|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84104452|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84104453|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104454|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104455|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84104456|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104457|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104458|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
84104459|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344483|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
84104460|NCT00955045|Istradefylline|istradefylline|mesh-list
84104461|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
84104462|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84104463|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84104464|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
84104465|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104466|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104467|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104468|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
84104469|NCT00601107|Vitamins|vitamins|mesh-ancestor
84104470|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
84104471|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104472|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84104473|NCT00957385|Lenalidomide|lenalidomide|mesh-list
84104474|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
84104475|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104476|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84104477|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84104478|NCT00957385|Growth Substances|growth substances|mesh-ancestor
84104479|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
84104480|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104481|NCT04169841|Durvalumab|durvalumab|mesh-list
84104482|NCT04169841|Olaparib|olaparib|mesh-list
84104483|NCT04169841|Tremelimumab|tremelimumab|mesh-list
84104484|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104485|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104486|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84104487|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104488|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104489|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
84104490|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84104491|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104492|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84104493|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104494|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104495|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104496|NCT02462538|Immunotoxins|immunotoxins|mesh-ancestor
84104497|NCT02462538|Immunoconjugates|immunoconjugates|mesh-ancestor
84104498|NCT02462538|Immunologic Factors|immunologic factors|mesh-ancestor
84104499|NCT02462538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104500|NCT02752646|Ketorolac|ketorolac|mesh-list
84104501|NCT02752646|Nepafenac|nepafenac|mesh-list
84104502|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84104503|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84104504|NCT02752646|Analgesics|analgesics|mesh-ancestor
84104505|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
84104506|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104507|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104508|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104509|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104510|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84104511|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104512|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104513|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
84104514|NCT04169919|Povidone|povidone|mesh-list
84104515|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
84104516|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
84104517|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84104518|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104519|NCT02757248|Romidepsin|romidepsin|mesh-list
84104520|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84104521|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104522|NCT02757248|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84104523|NCT02757248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104524|NCT02757248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104525|NCT00649311|Losartan|losartan|mesh-list
84104526|NCT00649311|Eplerenone|eplerenone|mesh-list
84104527|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84104528|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84104529|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84104530|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84104531|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104532|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84104533|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
84104534|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104535|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104536|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84104538|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
84104539|NCT02704494|Losartan|losartan|mesh-list
84104540|NCT02704494|Resveratrol|resveratrol|mesh-list
84104541|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84104542|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84104543|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84104544|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84104545|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104546|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
84104547|NCT02704494|Protective Agents|protective agents|mesh-ancestor
84104548|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104549|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104550|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84104551|NCT00649467|Topiramate|topiramate|mesh-list
84104552|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
84104553|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84104554|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104555|NCT00649545|Adalimumab|adalimumab|mesh-list
84104556|NCT00649545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84104557|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104558|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104559|NCT04169763|Nelfinavir|nelfinavir|mesh-list
84104560|NCT04169763|Cisplatin|cisplatin|mesh-list
84104561|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104562|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84104563|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84104564|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
84104565|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104566|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104567|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84104568|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84104569|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
84104570|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104571|NCT00635414|Esomeprazole|esomeprazole|mesh-list
84104572|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84104573|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104574|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84104575|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104576|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104577|NCT02658435|Tafenoquine|tafenoquine|mesh-list
84104578|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
84104579|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84104580|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84104581|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104582|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
84104583|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
84104584|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
84104585|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84104586|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
84104587|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104588|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104589|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84104590|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
84104591|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104592|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104593|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84104594|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104595|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
84104596|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84104597|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84104598|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104599|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104600|NCT02759666|Fluzoparib|fluzoparib|mesh-list
84104601|NCT02759666|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84104602|NCT02759666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104603|NCT02759666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104604|NCT02759666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104605|NCT02752724|Ketamine|ketamine|mesh-list
84104606|NCT02752724|Methohexital|methohexital|mesh-list
84104607|NCT02752724|Analgesics|analgesics|mesh-ancestor
84104608|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
84104609|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104610|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104611|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84104612|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84104613|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
84104615|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104616|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84104617|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84104618|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104619|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104620|NCT00649623|Olmesartan|olmesartan|mesh-list
84104621|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84104622|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84104623|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84104624|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84104625|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104626|NCT02756312|Anesthetics|anesthetics|mesh-list
84104627|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104628|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104629|NCT02657187|Rocuronium|rocuronium|mesh-list
84104630|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84104631|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84104632|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84104633|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104634|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104635|NCT00649779|Albuterol|albuterol|mesh-list
84104636|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84104637|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
84104638|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104639|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104640|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84104641|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
84104642|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
84104643|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104644|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84104645|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84104646|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84104647|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
84104648|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104649|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104650|NCT00615186|Temozolomide|temozolomide|mesh-list
84104651|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84104652|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
84104653|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104654|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104655|NCT00616044|Anesthetics|anesthetics|mesh-list
84104656|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104657|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104658|NCT02536911|Eliglustat|eliglustat|mesh-list
84104659|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104660|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104661|NCT04221152|Empagliflozin|empagliflozin|mesh-list
84104662|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84104663|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104664|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84104665|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104666|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84104667|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104668|NCT02759510|Phenylephrine|phenylephrine|mesh-list
84104669|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
84104670|NCT02759510|Norepinephrine|norepinephrine|mesh-list
84104671|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84104672|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
84104673|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
84104674|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104675|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104676|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
84104677|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84104678|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
84104679|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
84104680|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84104681|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84104682|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84104683|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
84104684|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104685|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104686|NCT02759510|Protective Agents|protective agents|mesh-ancestor
84104687|NCT04220528|Capecitabine|capecitabine|mesh-list
84104688|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84104689|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
84104690|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104691|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104692|NCT02759042|Leronlimab|leronlimab|mesh-list
84104693|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84104694|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84104695|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104696|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84104697|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84104698|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
84104699|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104700|NCT02755532|Bupivacaine|bupivacaine|mesh-list
84104701|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
84104702|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
84104703|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104704|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104705|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
84104706|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104707|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
84104708|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84104709|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
84104710|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104711|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
84104712|NCT02755376|Protective Agents|protective agents|mesh-ancestor
84104713|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
84104714|NCT02752334|Bupivacaine|bupivacaine|mesh-list
84104715|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
84104716|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
84104717|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104718|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104719|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
84104720|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104721|NCT02752334|Analgesics|analgesics|mesh-ancestor
84104722|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84104723|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
84104724|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84104725|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104726|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104727|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84104728|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
84104729|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84104730|NCT02755298|Acetazolamide|acetazolamide|mesh-list
84104731|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
84104732|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84104733|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104734|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104735|NCT02755298|Diuretics|diuretics|mesh-ancestor
84104736|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
84104737|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104738|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84104739|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84104740|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
84104741|NCT02759198|Celecoxib|celecoxib|mesh-list
84104742|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84104743|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84104744|NCT02759198|Analgesics|analgesics|mesh-ancestor
84104745|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
84104746|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104747|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104748|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104749|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84104750|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84104751|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84104752|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104753|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104754|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
84104755|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
84104756|NCT02755064|Erythromycin|erythromycin|mesh-list
84104757|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
84104758|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84104759|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
84104760|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
84104761|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84104762|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104763|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104764|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84104765|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104766|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104767|NCT02705976|Warfarin|warfarin|mesh-list
84104768|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
84104769|NCT02752412|Insulin|insulin|mesh-list
84104770|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84104771|NCT02752412|Metformin|metformin|mesh-list
84104772|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
84104773|NCT02752412|Lixisenatide|lixisenatide|mesh-list
84104774|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84104775|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104776|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
84104777|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104778|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104779|NCT02705820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84104780|NCT02705820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104781|NCT02703090|Remifentanil|remifentanil|mesh-list
84104782|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84104783|NCT02703090|Narcotics|narcotics|mesh-ancestor
84104784|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104785|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104786|NCT02703090|Analgesics|analgesics|mesh-ancestor
84104787|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
84104788|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104789|NCT02754362|Bevacizumab|bevacizumab|mesh-list
84104790|NCT02754362|Poly ICLC|poly iclc|mesh-list
84104791|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
84104792|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
84104793|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104794|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104795|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84104796|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84104797|NCT02754362|Growth Substances|growth substances|mesh-ancestor
84104798|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104799|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
84104800|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
84104801|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
84104802|NCT03373188|Nivolumab|nivolumab|mesh-list
84104803|NCT03373188|Ipilimumab|ipilimumab|mesh-list
84104804|NCT03373188|Antibodies|antibodies|mesh-list
84104805|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84104806|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
84104807|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104808|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104809|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104810|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84104811|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104812|NCT02698098|Methadone|methadone|mesh-list
84104813|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84104814|NCT02698098|Narcotics|narcotics|mesh-ancestor
84104815|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104816|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104817|NCT02698098|Analgesics|analgesics|mesh-ancestor
84104818|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
84104819|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104820|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
84104821|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
84104822|NCT04220996|Vortioxetine|vortioxetine|mesh-list
84104823|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
84104824|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84104825|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84104826|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84104827|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104828|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104829|NCT04220996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84104830|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84104831|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104832|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104833|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104834|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
84104835|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84104836|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84104837|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84104838|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84104839|NCT02702700|Verteporfin|verteporfin|mesh-list
84104840|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84104841|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
84104842|NCT02702622|Provitamins|provitamins|mesh-list
84104843|NCT02702622|Beta Carotene|beta carotene|mesh-list
84104844|NCT02702622|Vitamins|vitamins|mesh-ancestor
84104845|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
84104846|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104847|NCT04214808|Dutasteride|dutasteride|mesh-list
84104848|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84104849|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84104850|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104851|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104852|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
84104853|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104854|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104855|NCT02702778|Prednisone|prednisone|mesh-list
84104856|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104857|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
84104858|NCT02702778|Hormones|hormones|mesh-ancestor
84104859|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104860|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104861|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84104862|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104863|NCT02753738|Escitalopram|escitalopram|mesh-list
84104864|NCT02753738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84104865|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84104866|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104867|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104868|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104869|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
84104870|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104871|NCT02751632|Fluoxetine|fluoxetine|mesh-list
84104872|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
84104873|NCT02751632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84104874|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84104875|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104876|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104877|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104878|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
84104879|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104880|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84104881|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84104882|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84104883|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84104884|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104885|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84104886|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84104887|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104888|NCT02751476|Disinfectants|disinfectants|mesh-list
84104889|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104890|NCT02705664|Amorolfine|amorolfine|mesh-list
84104891|NCT02705664|Bifonazole|bifonazole|mesh-list
84104892|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
84104893|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104894|NCT02753426|Doxycycline|doxycycline|mesh-list
84104895|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84104896|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104897|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
84104898|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84104899|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84104900|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
84104901|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84104902|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104903|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84104904|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344935|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
84104905|NCT02702076|Apomorphine|apomorphine|mesh-list
84104906|NCT02702076|Emetics|emetics|mesh-ancestor
84104907|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104908|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
84104909|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104910|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104911|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
84104912|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
84104913|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104914|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104915|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
84104916|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84104917|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104918|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84104919|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104920|NCT02753114|Ketamine|ketamine|mesh-list
84104921|NCT02753114|Analgesics|analgesics|mesh-ancestor
84104922|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
84104923|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104924|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104925|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84104926|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84104927|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
84104928|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
84104929|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104930|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84104931|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84104932|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104933|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104934|NCT03288324|Tofacitinib|tofacitinib|mesh-list
84104935|NCT03288324|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84104936|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84104937|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84104938|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104939|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
84104940|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84104941|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84104942|NCT05324748|Prednisolone|prednisolone|mesh-list
84104943|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
84104944|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84104945|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
84104946|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84104947|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
84104948|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
84104949|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104950|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104951|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104952|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
84104953|NCT05324748|Hormones|hormones|mesh-ancestor
84104954|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84104955|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84104956|NCT05324748|Protective Agents|protective agents|mesh-ancestor
84104957|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84104958|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104959|NCT02705274|Bevacizumab|bevacizumab|mesh-list
84104960|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84104961|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84104962|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84104963|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84104964|NCT02705274|Growth Substances|growth substances|mesh-ancestor
84104965|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104966|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
84104967|NCT00914849|Plerixafor|plerixafor|mesh-list
84104968|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84104969|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84104970|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
84104971|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84104972|NCT02704962|Olanzapine|olanzapine|mesh-list
84104973|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
84104974|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
84104975|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104976|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104977|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84104978|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84104979|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84104980|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84104981|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84104982|NCT02704962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84104983|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84104984|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104985|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104986|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84104987|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
84104988|NCT00631943|Pregabalin|pregabalin|mesh-list
84104989|NCT00631943|Analgesics|analgesics|mesh-ancestor
84104990|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
84104991|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84104992|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84104993|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
84104994|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84104995|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84104996|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84104997|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84104998|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84104999|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84105000|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105001|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84105002|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84105003|NCT05429684|Capecitabine|capecitabine|mesh-list
84105004|NCT05429684|Trastuzumab|trastuzumab|mesh-list
84105005|NCT05429684|Everolimus|everolimus|mesh-list
84105006|NCT05429684|Letrozole|letrozole|mesh-list
84105007|NCT05429684|Palbociclib|palbociclib|mesh-list
84105008|NCT05429684|Pertuzumab|pertuzumab|mesh-list
84105009|NCT05429684|Antibodies|antibodies|mesh-list
84105010|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84105011|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105012|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105013|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105014|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105015|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105016|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
84105017|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105018|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84105019|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
84105020|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105021|NCT05429684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84105022|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105023|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105024|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84105025|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84105026|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84105027|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84105028|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
84105029|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84105030|NCT05429684|Immunotoxins|immunotoxins|mesh-ancestor
84105031|NCT05429684|Immunoconjugates|immunoconjugates|mesh-ancestor
84105032|NCT05324592|Aflibercept|aflibercept|mesh-list
84105033|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84105034|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84105035|NCT05324592|Growth Substances|growth substances|mesh-ancestor
84105036|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105037|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
84105038|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105039|NCT04433858|Psilocybin|psilocybin|mesh-list
84105040|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
84105041|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105042|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84105043|NCT02750696|Acetaminophen|acetaminophen|mesh-list
84105044|NCT02750696|Tramadol|tramadol|mesh-list
84105045|NCT02750696|Codeine|codeine|mesh-list
84105046|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84105047|NCT02750696|Analgesics|analgesics|mesh-ancestor
84105048|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
84105049|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105050|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105051|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
84105052|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84105053|NCT02750696|Narcotics|narcotics|mesh-ancestor
83345091|NCT01783912|Nicotine|nicotine|mesh-list
84105054|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105055|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
84105057|NCT02695550|Conteltinib|conteltinib|mesh-list
84105058|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105059|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105060|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105061|NCT00912743|Olaparib|olaparib|mesh-list
84105062|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84105063|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105064|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105065|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105066|NCT04432610|Nebivolol|nebivolol|mesh-list
84105067|NCT04432610|Bisoprolol|bisoprolol|mesh-list
84105068|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84105069|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
84105070|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84105071|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84105072|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84105073|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
84105074|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105075|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105076|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105077|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
84105078|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
84105079|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105080|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84105081|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84105082|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84105083|NCT04643093|Ezetimibe|ezetimibe|mesh-list
84105084|NCT04643093|Pitavastatin|pitavastatin|mesh-list
84105085|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84105086|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84105087|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
84105088|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105089|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84105090|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84105091|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105092|NCT00914459|Factor VIII|factor viii|mesh-list
84105093|NCT00914459|Coagulants|coagulants|mesh-ancestor
84105094|NCT02701608|Levofloxacin|levofloxacin|mesh-list
84105095|NCT02701608|Rifampin|rifampin|mesh-list
84105096|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
84105097|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84105098|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105099|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84105100|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105101|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105102|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105103|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105104|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105105|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84105106|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84105107|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84105108|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
84105109|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
84105110|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84105111|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84105112|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84105113|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84105114|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84105115|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84105116|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84105117|NCT00635960|Hormones|hormones|mesh-list
84105118|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84105119|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105120|NCT05429294|Paclitaxel|paclitaxel|mesh-list
84105121|NCT05429294|Trastuzumab|trastuzumab|mesh-list
84105122|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105123|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105124|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105125|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105126|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105127|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105128|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105130|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84105131|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105132|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
84105133|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105134|NCT00912509|Riboflavin|riboflavin|mesh-list
84105135|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
84105136|NCT00912509|Vitamins|vitamins|mesh-ancestor
84105137|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
84105138|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105139|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84105140|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
84105141|NCT02873598|Paclitaxel|paclitaxel|mesh-list
84105142|NCT02873598|Gemcitabine|gemcitabine|mesh-list
84105143|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84105144|NCT02873598|Folfirinox|folfirinox|mesh-list
84105145|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105146|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105147|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105148|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105149|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105150|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105151|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84105152|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
84105153|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84105154|NCT02749994|Ezetimibe|ezetimibe|mesh-list
84105155|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84105156|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84105157|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
84105158|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105159|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84105160|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84105161|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105162|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
84105163|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84105164|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105165|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105166|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84105167|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84105168|NCT04417049|Protective Agents|protective agents|mesh-ancestor
84105169|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105170|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
84105171|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84105172|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
84105173|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
84105174|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
84105175|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84105176|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105177|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105178|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
84105179|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84105180|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105181|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105182|NCT05323422|Ketamine|ketamine|mesh-list
84105183|NCT05323422|Analgesics|analgesics|mesh-ancestor
84105184|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
84105185|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105186|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105187|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84105188|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84105189|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
84105190|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
84105191|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105192|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84105193|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84105194|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105195|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105196|NCT02700906|Lidocaine|lidocaine|mesh-list
84105197|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
84105198|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
84105199|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105200|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345228|NCT01878526|Domperidone|domperidone|mesh-list
84105201|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
84105202|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105204|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84105205|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84105206|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105207|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105208|NCT00636038|Beta Carotene|beta carotene|mesh-list
84105209|NCT00636038|Carotenoids|carotenoids|mesh-list
84105210|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
84105211|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105212|NCT00636038|Protective Agents|protective agents|mesh-ancestor
84105213|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105214|NCT00636038|Provitamins|provitamins|mesh-ancestor
84105215|NCT00636038|Vitamins|vitamins|mesh-ancestor
84105216|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
84105217|NCT04723004|Bevacizumab|bevacizumab|mesh-list
84105218|NCT04723004|Sorafenib|sorafenib|mesh-list
84105219|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105220|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105221|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84105222|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84105223|NCT04723004|Growth Substances|growth substances|mesh-ancestor
84105224|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105225|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
84105226|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105227|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105228|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105229|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
84105230|NCT04213716|Calcium|calcium|mesh-list
84105231|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84105232|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105233|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84105234|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
84105235|NCT04218890|Thromboplastin|thromboplastin|mesh-list
84105236|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84105237|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84105238|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105239|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
84105240|NCT04218890|Coagulants|coagulants|mesh-ancestor
84105241|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
84105242|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84105243|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
84105244|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105245|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84105246|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
84105247|NCT00636116|Antivenins|antivenins|mesh-list
84105248|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
84105249|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105250|NCT04772196|Vitamin D|vitamin d|mesh-list
84105251|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
84105252|NCT04772196|Vitamins|vitamins|mesh-ancestor
84105253|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
84105254|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105255|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84105256|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84105257|NCT05428670|Rituximab|rituximab|mesh-list
84105258|NCT05428670|Lenalidomide|lenalidomide|mesh-list
84105259|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
84105260|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105261|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105262|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
84105263|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105264|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84105265|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84105266|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84105267|NCT05428670|Growth Substances|growth substances|mesh-ancestor
84105268|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
84105269|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105270|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105271|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105272|NCT00635726|Cisplatin|cisplatin|mesh-list
84105273|NCT00635726|Gemcitabine|gemcitabine|mesh-list
84105274|NCT00635726|Doxorubicin|doxorubicin|mesh-list
84105275|NCT00635726|Methotrexate|methotrexate|mesh-list
84105276|NCT00635726|Vinblastine|vinblastine|mesh-list
84105277|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105278|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84105279|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
84105280|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105281|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84105282|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105283|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105284|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105285|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84105286|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
84105287|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84105288|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105289|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
84105290|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84105291|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84105292|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
84105293|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84105294|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84105295|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105296|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105297|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105298|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105299|NCT02749292|Rituximab|rituximab|mesh-list
84105300|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105301|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105302|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
84105303|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105304|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84105305|NCT04219982|Scopolamine|scopolamine|mesh-list
84105306|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84105307|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84105308|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
84105309|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
84105310|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105311|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105312|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84105313|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
84105314|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84105315|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
84105316|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105317|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105318|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84105319|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
84105320|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
84105321|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
84105322|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
84105323|NCT04216706|Sympatholytics|sympatholytics|mesh-list
84105324|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84105325|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105326|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105327|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105328|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
84105329|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105330|NCT00913835|Doxorubicin|doxorubicin|mesh-list
84105331|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84105332|NCT00913835|Olaratumab|olaratumab|mesh-list
84105333|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84105334|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105335|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105336|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105337|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105338|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105339|NCT05322720|Paclitaxel|paclitaxel|mesh-list
84105340|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84105341|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105342|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105343|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105344|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105345|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105346|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105347|NCT04213170|Bevacizumab|bevacizumab|mesh-list
84105348|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105349|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105350|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83345375|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
84105351|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84105352|NCT04213170|Growth Substances|growth substances|mesh-ancestor
84105353|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105354|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
84105355|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
84105356|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84105357|NCT05322564|Narcotics|narcotics|mesh-ancestor
84105358|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105359|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105360|NCT05322564|Analgesics|analgesics|mesh-ancestor
84105361|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
84105362|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105363|NCT02749136|Gemcitabine|gemcitabine|mesh-list
84105364|NCT02749136|Folfirinox|folfirinox|mesh-list
84105365|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84105366|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
84105367|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105368|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105369|NCT00631631|Mifamurtide|mifamurtide|mesh-list
84105370|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84105371|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
84105372|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105373|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
84105374|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
84105375|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84105376|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105377|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105378|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
84105379|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84105380|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105381|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105382|NCT04238741|Anesthetics|anesthetics|mesh-list
84105383|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105384|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105385|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
84105386|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84105387|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84105388|NCT04218500|Niacinamide|niacinamide|mesh-list
84105389|NCT04218500|Niacin|niacin|mesh-list
84105390|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
84105391|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
84105392|NCT04218500|Vitamins|vitamins|mesh-ancestor
84105393|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
84105394|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105395|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84105396|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
84105397|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105398|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84105399|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
84105400|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
84105401|NCT04264208|Bombesin|bombesin|mesh-list
84105402|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84105403|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105404|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105405|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105406|NCT05412056|Metformin|metformin|mesh-list
84105407|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84105408|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105409|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
84105410|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105411|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105412|NCT04453046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84105413|NCT04453046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105414|NCT04216628|Oxytocin|oxytocin|mesh-list
84105415|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
84105416|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84105417|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105418|NCT04217096|Paclitaxel|paclitaxel|mesh-list
84105419|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105420|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105421|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105422|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105423|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105424|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105425|NCT05411978|Ubiquinone|ubiquinone|mesh-list
84105426|NCT05411978|Idebenone|idebenone|mesh-list
84105427|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
84105428|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105429|NCT05411978|Protective Agents|protective agents|mesh-ancestor
84105430|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105431|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
84105432|NCT00617370|Paclitaxel|paclitaxel|mesh-list
84105433|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
84105434|NCT00617370|Epirubicin|epirubicin|mesh-list
84105435|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105436|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105437|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105438|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105439|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105440|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105441|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84105442|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
84105443|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105444|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84105445|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84105446|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
84105447|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84105448|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84105449|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105450|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105451|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105452|NCT02699658|Levofloxacin|levofloxacin|mesh-list
84105453|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84105454|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105455|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84105456|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105457|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105458|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105459|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105460|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105461|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84105462|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84105463|NCT04218734|Metformin|metformin|mesh-list
84105464|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84105465|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105466|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84105467|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84105468|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
84105469|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105470|NCT04496063|Ustekinumab|ustekinumab|mesh-list
84105471|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
84105472|NCT04032626|Lenalidomide|lenalidomide|mesh-list
84105473|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
84105474|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105475|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84105476|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84105477|NCT04032626|Growth Substances|growth substances|mesh-ancestor
84105478|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
84105479|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105480|NCT04214106|Thiamine|thiamine|mesh-list
84105481|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
84105482|NCT04214106|Vitamins|vitamins|mesh-ancestor
84105483|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
84105484|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105485|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84105486|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105487|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84105488|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
84105489|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105490|NCT02695862|Terlipressin|terlipressin|mesh-list
84105491|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84105492|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84105493|NCT00617448|Anesthetics|anesthetics|mesh-list
84105494|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105495|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105496|NCT04308863|Chitosan|chitosan|mesh-list
84105497|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105498|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84105499|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84105500|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
84105501|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84105502|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
84105503|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
84105504|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
84105505|NCT04308863|Coagulants|coagulants|mesh-ancestor
84105506|NCT00615810|Efavirenz|efavirenz|mesh-list
84105507|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84105508|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84105509|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84105510|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105511|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105512|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
84105513|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105514|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84105515|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84105516|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84105517|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84105518|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84105519|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84105520|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84105521|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84105522|NCT03355157|Tamoxifen|tamoxifen|mesh-list
84105523|NCT03355157|Paclitaxel|paclitaxel|mesh-list
84105524|NCT03355157|Vinorelbine|vinorelbine|mesh-list
84105525|NCT03355157|Capecitabine|capecitabine|mesh-list
84105526|NCT03355157|Letrozole|letrozole|mesh-list
84105527|NCT03355157|Epirubicin|epirubicin|mesh-list
84105528|NCT03355157|Fulvestrant|fulvestrant|mesh-list
84105529|NCT03355157|Palbociclib|palbociclib|mesh-list
84105530|NCT03355157|Exemestane|exemestane|mesh-list
84105531|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105532|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105533|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105534|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105535|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105536|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105537|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84105538|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
84105539|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84105540|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84105541|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105542|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84105543|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
84105544|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84105545|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105546|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84105547|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105548|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105549|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84105550|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84105551|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84105552|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84105553|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84105554|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105555|NCT04215432|Propolis|propolis|mesh-list
84105556|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105557|NCT02747342|Fluzoparib|fluzoparib|mesh-list
84105558|NCT02747342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84105559|NCT02747342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105560|NCT02747342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105561|NCT02747342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105562|NCT03324035|Tramadol|tramadol|mesh-list
84105563|NCT03324035|Amitriptyline|amitriptyline|mesh-list
84105564|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84105565|NCT03324035|Narcotics|narcotics|mesh-ancestor
84105566|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105567|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105568|NCT03324035|Analgesics|analgesics|mesh-ancestor
84105569|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
84105570|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105571|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84105572|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
84105573|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84105574|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84105575|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84105576|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84105577|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105578|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105579|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
84105580|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105582|NCT00616746|Nicotine|nicotine|mesh-list
84105583|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84105584|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
84105585|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429680|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84105586|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105587|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84105588|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84105589|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
84105590|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105591|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105592|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84105593|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105594|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105595|NCT00777582|Olaparib|olaparib|mesh-list
84105596|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84105597|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105598|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105599|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105600|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
84105601|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105602|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105603|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105604|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105605|NCT05271578|Nicotine|nicotine|mesh-list
84105606|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84105607|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
84105608|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105609|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105610|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84105611|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84105612|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
84105613|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105614|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105615|NCT04203485|Paclitaxel|paclitaxel|mesh-list
84105616|NCT04203485|Carboplatin|carboplatin|mesh-list
84105617|NCT04203485|Pemetrexed|pemetrexed|mesh-list
84105618|NCT04203485|Apatinib|apatinib|mesh-list
84105619|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105620|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105621|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105622|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105623|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105624|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105625|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105626|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84105627|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84105628|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105629|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
84105630|NCT03851627|Testosterone|testosterone|mesh-list
84105631|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
84105632|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
84105633|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84105634|NCT03851627|Androgens|androgens|mesh-ancestor
84105635|NCT03851627|Hormones|hormones|mesh-ancestor
84105636|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84105637|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105638|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84105639|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105640|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
84105641|NCT03116126|Guanfacine|guanfacine|mesh-list
84105642|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84105643|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84105644|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84105645|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84105646|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
84105647|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105648|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105649|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105650|NCT02983682|Lidocaine|lidocaine|mesh-list
84105651|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
84105652|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
84105653|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105654|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105655|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
84105656|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105657|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84105658|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84105659|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84105660|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105661|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105662|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
84105663|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
84105664|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84105665|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84105666|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105667|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105668|NCT04217798|Etoposide|etoposide|mesh-list
84105669|NCT04217798|Niraparib|niraparib|mesh-list
84105670|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105671|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105672|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105673|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105674|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105675|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105676|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84105677|NCT02742038|Fluorides|fluorides|mesh-list
84105678|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
84105679|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
84105680|NCT02742038|Protective Agents|protective agents|mesh-ancestor
84105681|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105682|NCT02022098|Cisplatin|cisplatin|mesh-list
84105683|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105684|NCT02746250|Amitriptyline|amitriptyline|mesh-list
84105685|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
84105686|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
84105687|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84105688|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84105689|NCT02746250|Analgesics|analgesics|mesh-ancestor
84105690|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
84105691|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105692|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105693|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84105694|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84105695|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105696|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105697|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
84105698|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105699|NCT02741960|Metformin|metformin|mesh-list
84105700|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84105701|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105702|NCT00910091|Megestrol|megestrol|mesh-list
84105703|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
84105704|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84105705|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84105706|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84105707|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
84105708|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84105709|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105710|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84105711|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84105712|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84105713|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105714|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
84105715|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84105716|NCT04216550|Apatinib|apatinib|mesh-list
84105717|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105718|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105719|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105720|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105721|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
84105722|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84105723|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
84105724|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84105726|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83429686|NCT00490009|Promethazine|promethazine|mesh-list
84105727|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105728|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
84105729|NCT00909857|Dienogest|dienogest|mesh-list
84105730|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84105731|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84105732|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
84105733|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84105734|NCT00909857|Estradiol|estradiol|mesh-list
84105735|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84105736|NCT00909857|Estrogens|estrogens|mesh-ancestor
84105737|NCT00909857|Hormones|hormones|mesh-ancestor
84105738|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84105739|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105740|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84105741|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
84105742|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84105743|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84105744|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84105745|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84105746|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84105747|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84105748|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
84105749|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84105750|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105751|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
84105752|NCT00911807|Donepezil|donepezil|mesh-list
84105753|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84105754|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105755|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105756|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
84105757|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105758|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105759|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
84105760|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84105761|NCT00911807|Protective Agents|protective agents|mesh-ancestor
84105762|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84105763|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84105764|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105765|NCT04117451|Propolis|propolis|mesh-list
84105766|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105767|NCT03690089|Atropine|atropine|mesh-list
84105768|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84105769|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84105770|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84105771|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
84105772|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105773|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105774|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84105775|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
84105776|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
84105777|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
84105778|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84105779|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84105780|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
84105781|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105782|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105783|NCT03812588|Escitalopram|escitalopram|mesh-list
84105784|NCT03812588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84105785|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84105786|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105787|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105788|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105789|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
84105790|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105791|NCT02387099|Everolimus|everolimus|mesh-list
84105792|NCT02387099|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84105793|NCT02387099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105794|NCT02387099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105795|NCT02387099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105796|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84105797|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
84105798|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105799|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105800|NCT02745860|Selexipag|selexipag|mesh-list
84105801|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84105802|NCT04788641|Cyclosporine|cyclosporine|mesh-list
84105803|NCT04788641|Tacrolimus|tacrolimus|mesh-list
84105804|NCT04788641|Cyclosporins|cyclosporins|mesh-list
84105805|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84105806|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
84105807|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105808|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84105809|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105810|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105811|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
84105812|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105813|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
84105814|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84105815|NCT04331288|Ethanol|ethanol|mesh-list
84105816|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84105817|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105818|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105819|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105820|NCT02745470|Lixisenatide|lixisenatide|mesh-list
84105821|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84105822|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105823|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84105824|NCT02741414|Amoxicillin|amoxicillin|mesh-list
84105825|NCT02741414|Metronidazole|metronidazole|mesh-list
84105826|NCT02741414|Clarithromycin|clarithromycin|mesh-list
84105827|NCT02741414|Levofloxacin|levofloxacin|mesh-list
84105828|NCT02741414|Tetracycline|tetracycline|mesh-list
84105829|NCT02741414|Furazolidone|furazolidone|mesh-list
84105830|NCT02741414|Esomeprazole|esomeprazole|mesh-list
84105831|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105832|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84105833|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84105834|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84105835|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84105836|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84105837|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105838|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105839|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84105840|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84105841|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84105842|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84105843|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84105844|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84105845|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105846|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84105847|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84105848|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84105849|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84105850|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
84105851|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84105852|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105853|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
84105854|NCT05629598|Hematinics|hematinics|mesh-ancestor
84105855|NCT02744690|Mitomycins|mitomycins|mesh-list
84105856|NCT02744690|Mitomycin|mitomycin|mesh-list
84105857|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84105858|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105859|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
84105860|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105861|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84105862|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105863|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
84105864|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105865|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105866|NCT02736266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84105867|NCT02736266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105868|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84105869|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84105870|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84105871|NCT02736032|Estradiol|estradiol|mesh-list
84105872|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84105873|NCT02736032|Progesterone|progesterone|mesh-list
84105874|NCT02736032|Estrogens|estrogens|mesh-ancestor
84105875|NCT02736032|Hormones|hormones|mesh-ancestor
84105876|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84105877|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105878|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84105879|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
84105880|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84105881|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84105882|NCT02736032|Progestins|progestins|mesh-ancestor
84105883|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
84105884|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84105885|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105886|NCT02744768|Dasatinib|dasatinib|mesh-list
84105887|NCT02744768|Blinatumomab|blinatumomab|mesh-list
84105888|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105889|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105890|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105891|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105892|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
84105893|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84105894|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
84105895|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105896|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105897|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84105898|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
84105899|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84105900|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84105901|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84105902|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
84105903|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84105904|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105905|NCT04096391|Analgesics|analgesics|mesh-list
84105906|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
84105907|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84105908|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105909|NCT02744378|Clobetasol|clobetasol|mesh-list
84105910|NCT02744378|Tacrolimus|tacrolimus|mesh-list
84105911|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84105912|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
84105913|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105914|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84105915|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105916|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105917|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84105918|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
84105919|NCT02744378|Hormones|hormones|mesh-ancestor
84105920|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84105921|NCT04318730|Apatinib|apatinib|mesh-list
84105922|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105923|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84105924|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84105925|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105926|NCT00632333|Fluorouracil|fluorouracil|mesh-list
84105927|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105928|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
84105929|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105930|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84105931|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84105932|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
84105933|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105934|NCT02744456|Losartan|losartan|mesh-list
84105935|NCT02744456|Amlodipine|amlodipine|mesh-list
84105936|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84105937|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84105938|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84105939|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84105940|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105941|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84105942|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105943|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
84105944|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84105945|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84105946|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84105947|NCT02744456|Diuretics|diuretics|mesh-ancestor
84105948|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
84105949|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84105950|NCT02744222|Interferons|interferons|mesh-list
84105951|NCT02744222|Interferon-beta|interferon-beta|mesh-list
84105952|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
84105953|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105954|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
84105955|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105956|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
84105957|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105958|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84105959|NCT02741024|Artesunate|artesunate|mesh-list
84105960|NCT02741024|Lumefantrine|lumefantrine|mesh-list
84105961|NCT02741024|Artemether|artemether|mesh-list
84105962|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84105963|NCT02741024|Amodiaquine|amodiaquine|mesh-list
84105964|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
84105965|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84105966|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84105967|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105968|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105969|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
84105970|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
84105971|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84105972|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
84105973|NCT02735876|Rituximab|rituximab|mesh-list
84105974|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
84105975|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84105976|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105977|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
84105978|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105979|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84105980|NCT00910871|Bedaquiline|bedaquiline|mesh-list
84105981|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
84105982|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84105983|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84105984|NCT04230707|Melatonin|melatonin|mesh-list
84105985|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
84105986|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105987|NCT04230707|Protective Agents|protective agents|mesh-ancestor
84105988|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84105989|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84105990|NCT03943667|Paclitaxel|paclitaxel|mesh-list
84105991|NCT03943667|Gemcitabine|gemcitabine|mesh-list
84105992|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84105993|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84105994|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
84105995|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
84105996|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
84105997|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84105998|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84105999|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
84106000|NCT02735798|Trastuzumab|trastuzumab|mesh-list
84106001|NCT02735798|Gancotamab|gancotamab|mesh-list
84106002|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84106003|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106004|NCT02735798|Immunoconjugates|immunoconjugates|mesh-ancestor
84106005|NCT02735798|Immunologic Factors|immunologic factors|mesh-ancestor
84106006|NCT02735798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106007|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
84106008|NCT03760718|Procaine|procaine|mesh-list
84106009|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
84106010|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
84106011|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106012|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106013|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
84106014|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106015|NCT05590286|Amoxicillin|amoxicillin|mesh-list
84106016|NCT05590286|Esomeprazole|esomeprazole|mesh-list
84106017|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106018|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106019|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84106020|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106021|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84106022|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106023|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106024|NCT05580029|Triamcinolone|triamcinolone|mesh-list
84106025|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106026|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
84106027|NCT05580029|Hormones|hormones|mesh-ancestor
84106028|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106029|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106030|NCT03724994|Paclitaxel|paclitaxel|mesh-list
84106031|NCT03724994|Gemcitabine|gemcitabine|mesh-list
84106032|NCT03724994|Fluorouracil|fluorouracil|mesh-list
84106033|NCT03724994|Folfirinox|folfirinox|mesh-list
84106034|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84106035|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106036|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
84106037|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
84106038|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
84106039|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106040|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84106041|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
84106042|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106043|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
84106044|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106045|NCT02735330|Ethanol|ethanol|mesh-list
84106046|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84106047|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106048|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106049|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106050|NCT02631941|Budesonide|budesonide|mesh-list
84106051|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
84106052|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84106053|NCT02631941|Charcoal|charcoal|mesh-list
84106054|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106055|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84106056|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
84106057|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106058|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106059|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84106060|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
84106061|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
84106062|NCT02631941|Hormones|hormones|mesh-ancestor
84106063|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106064|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84106065|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84106066|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84106067|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
84106068|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106069|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106070|NCT02631941|Antidotes|antidotes|mesh-ancestor
84106071|NCT02631941|Protective Agents|protective agents|mesh-ancestor
84106072|NCT02690987|Exenatide|exenatide|mesh-list
84106073|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106074|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106075|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84106076|NCT02690987|Incretins|incretins|mesh-ancestor
84106077|NCT02690987|Hormones|hormones|mesh-ancestor
84106078|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106079|NCT02740166|Propranolol|propranolol|mesh-list
84106080|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84106081|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84106082|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
84106083|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106084|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106085|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106086|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84106087|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84106088|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
84106089|NCT02735018|Epinephrine|epinephrine|mesh-list
84106090|NCT02735018|Racepinephrine|racepinephrine|mesh-list
84106091|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
84106092|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84106093|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84106094|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
84106095|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106096|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106097|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106098|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84106099|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84106100|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
84106101|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106102|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84106103|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
84106104|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
84106105|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
84106106|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84106107|NCT00908375|Pregabalin|pregabalin|mesh-list
84106108|NCT00908375|Analgesics|analgesics|mesh-ancestor
84106109|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
84106110|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106111|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106112|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
84106113|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84106114|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84106115|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106116|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84106117|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84106118|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84106119|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106120|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84106121|NCT04247867|Psyllium|psyllium|mesh-list
84106122|NCT04247867|Cathartics|cathartics|mesh-ancestor
84106123|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106124|NCT02731664|Glucagon|glucagon|mesh-list
84106125|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84106126|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106127|NCT02731664|Hormones|hormones|mesh-ancestor
84106128|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106129|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106130|NCT02731664|Incretins|incretins|mesh-ancestor
84106131|NCT02543255|Prednisone|prednisone|mesh-list
84106132|NCT02543255|Leuprolide|leuprolide|mesh-list
84106133|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
84106134|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106135|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
84106136|NCT02543255|Hormones|hormones|mesh-ancestor
84106137|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106138|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106139|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84106140|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106141|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84106142|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
84106143|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84106144|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84106145|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106146|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106147|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
84106148|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84106149|NCT02695004|Donepezil|donepezil|mesh-list
84106150|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84106151|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106152|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106153|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
84106154|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106155|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106156|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
84106157|NCT00909389|Simvastatin|simvastatin|mesh-list
84106158|NCT00909389|Ezetimibe|ezetimibe|mesh-list
84106159|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
84106160|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84106161|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84106162|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
84106163|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106164|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84106165|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84106166|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106167|NCT00910715|Doxycycline|doxycycline|mesh-list
84106168|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106169|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106170|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
84106171|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84106172|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84106173|NCT02731430|Morphine|morphine|mesh-list
84106174|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84106175|NCT02731430|Narcotics|narcotics|mesh-ancestor
83346202|NCT04490694|Lenvatinib|lenvatinib|mesh-list
84106176|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106177|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106179|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
84106180|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106181|NCT04232969|Exenatide|exenatide|mesh-list
84106182|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106183|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106184|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84106185|NCT04232969|Incretins|incretins|mesh-ancestor
84106186|NCT04232969|Hormones|hormones|mesh-ancestor
84106187|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106188|NCT03364868|Insulin|insulin|mesh-list
84106189|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106190|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106191|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
84106192|NCT03695510|Afatinib|afatinib|mesh-list
84106193|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84106194|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106195|NCT03695510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84106196|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106197|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84106198|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106199|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
84106200|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
84106201|NCT02731040|Diphosphonates|diphosphonates|mesh-list
84106202|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
84106203|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84106204|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106205|NCT02734160|Durvalumab|durvalumab|mesh-list
84106206|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84106207|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106208|NCT02730572|Methylphenidate|methylphenidate|mesh-list
84106209|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84106210|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106211|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84106212|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84106213|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84106214|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106215|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
84106216|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106217|NCT04225988|Tacrolimus|tacrolimus|mesh-list
84106218|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106219|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
84106220|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106221|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84106222|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106223|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106224|NCT02730026|Ketoprofen|ketoprofen|mesh-list
84106225|NCT02730026|Omeprazole|omeprazole|mesh-list
84106226|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84106227|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106228|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84106229|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106230|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106231|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84106232|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84106233|NCT02730026|Analgesics|analgesics|mesh-ancestor
84106234|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
84106235|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106236|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106237|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106238|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84106239|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84106240|NCT02738918|Abatacept|abatacept|mesh-list
84106241|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84106242|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106243|NCT02738918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84106244|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106245|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106246|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
84106247|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106248|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84106249|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
84106250|NCT03195374|Narcotics|narcotics|mesh-ancestor
84106251|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106252|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106253|NCT03195374|Analgesics|analgesics|mesh-ancestor
84106254|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
84106255|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106256|NCT02739386|Ipilimumab|ipilimumab|mesh-list
84106257|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84106258|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106259|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84106260|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106261|NCT00636428|Midazolam|midazolam|mesh-list
84106262|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84106263|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84106264|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106265|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106266|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84106267|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84106268|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84106269|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84106270|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
84106271|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
84106272|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
84106273|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
84106274|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106275|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106276|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84106277|NCT02729870|Laxatives|laxatives|mesh-ancestor
84106278|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106279|NCT05628662|Insulin|insulin|mesh-list
84106280|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106281|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106282|NCT02694848|Aspirin|aspirin|mesh-list
84106283|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84106284|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84106285|NCT02694848|Analgesics|analgesics|mesh-ancestor
84106286|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
84106287|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106288|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106289|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106290|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84106291|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84106292|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84106293|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106294|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84106295|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84106296|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106297|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
84106298|NCT02729324|Protective Agents|protective agents|mesh-list
84106299|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
84106300|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106301|NCT02733458|Dexamethasone|dexamethasone|mesh-list
84106302|NCT02733458|Gemcitabine|gemcitabine|mesh-list
84106303|NCT02733458|Etoposide|etoposide|mesh-list
84106304|NCT02733458|Pegaspargase|pegaspargase|mesh-list
84106305|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106306|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
84106307|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
84106308|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106309|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106310|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106311|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
84106312|NCT02733458|Hormones|hormones|mesh-ancestor
84106313|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106314|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84106315|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106316|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106317|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106318|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84106319|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
84106320|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84106321|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84106322|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84106323|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
84106324|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84106325|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106326|NCT03658772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84106327|NCT03658772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106328|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84106329|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
84106330|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84106331|NCT02728856|Protective Agents|protective agents|mesh-ancestor
84106332|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106333|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
84106334|NCT02728934|Infliximab|infliximab|mesh-list
84106335|NCT02728934|Golimumab|golimumab|mesh-list
84106336|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84106337|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106338|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
84106339|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106340|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84106341|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106342|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
84106343|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106344|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
84106345|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
84106346|NCT04179500|Bedaquiline|bedaquiline|mesh-list
84106347|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106348|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106349|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84106350|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84106351|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106352|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106353|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106354|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
84106355|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
84106356|NCT02728700|Sirolimus|sirolimus|mesh-list
84106357|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84106358|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106359|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84106360|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
84106361|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106362|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106363|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106364|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106365|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
84106366|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106367|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
84106368|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106369|NCT02728622|Tamoxifen|tamoxifen|mesh-list
84106370|NCT02728622|Paclitaxel|paclitaxel|mesh-list
84106371|NCT02728622|Doxorubicin|doxorubicin|mesh-list
84106372|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84106373|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84106374|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106375|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
84106376|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
84106377|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
84106378|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106379|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84106380|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84106381|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84106382|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106383|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84106384|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
84106385|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106386|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106387|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84106388|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84106389|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84106390|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84106391|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
84106392|NCT02728466|Procyanidin|procyanidin|mesh-list
84106393|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
84106394|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106395|NCT02728466|Protective Agents|protective agents|mesh-ancestor
84106396|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106397|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84106398|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84106399|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106400|NCT02733380|Thalidomide|thalidomide|mesh-list
84106401|NCT02733380|Dexamethasone|dexamethasone|mesh-list
84106402|NCT02733380|Doxorubicin|doxorubicin|mesh-list
84106403|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84106404|NCT02733380|Vinorelbine|vinorelbine|mesh-list
84106405|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
84106406|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106407|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
84106408|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
84106409|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106410|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106411|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106412|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
84106413|NCT02733380|Hormones|hormones|mesh-ancestor
84106414|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106415|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84106416|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106417|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84106418|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84106419|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84106420|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106421|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106422|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84106423|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
84106424|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
84106425|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
84106426|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106427|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
84106428|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
84106429|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106430|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106431|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84106432|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84106433|NCT02733380|Growth Substances|growth substances|mesh-ancestor
84106434|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
84106435|NCT02733380|Analgesics|analgesics|mesh-ancestor
84106436|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
84106437|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
84106438|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
84106439|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84106440|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
84106441|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106442|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84106443|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84106444|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84106445|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106446|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106447|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
84106448|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
84106449|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
84106450|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106451|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106452|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
84106453|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106454|NCT00636584|Nitroprusside|nitroprusside|mesh-list
84106455|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84106456|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
84106457|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84106458|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106459|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
84106460|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84106461|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84106462|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
84106463|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106464|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106465|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106466|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
84106467|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
84106468|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106469|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
84106470|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84106471|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
84106472|NCT02732522|Misoprostol|misoprostol|mesh-list
84106473|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84106474|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
84106475|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84106476|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106477|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84106478|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106479|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
84106480|NCT02732678|Propranolol|propranolol|mesh-list
84106481|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84106482|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84106483|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
84106484|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106485|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106486|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106487|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84106488|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84106489|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
84106490|NCT02727608|Eculizumab|eculizumab|mesh-list
84106491|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84106492|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106493|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
84106494|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106495|NCT02727296|Propofol|propofol|mesh-list
84106496|NCT02727296|Sevoflurane|sevoflurane|mesh-list
84106497|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84106498|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106499|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106500|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84106501|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
84106502|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
84106503|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84106504|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84106505|NCT02732132|Fentanyl|fentanyl|mesh-list
84106506|NCT02732132|Midazolam|midazolam|mesh-list
84106507|NCT02732132|Ketamine|ketamine|mesh-list
84106508|NCT02732132|Propofol|propofol|mesh-list
84106509|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84106510|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106511|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106512|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84106513|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
84106514|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
84106515|NCT02732132|Analgesics|analgesics|mesh-ancestor
84106516|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
84106517|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106518|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84106519|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84106520|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84106521|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106522|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106523|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84106524|NCT02732132|Narcotics|narcotics|mesh-ancestor
84106525|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84106526|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84106527|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84106528|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84106529|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
84106530|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
84106531|NCT02737202|Saracatinib|saracatinib|mesh-list
84106532|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106533|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106534|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106535|NCT02721368|Lidocaine|lidocaine|mesh-list
84106536|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
84106537|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
84106538|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106539|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106540|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
84106541|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106542|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84106543|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84106544|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84106545|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84106546|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106547|NCT02737124|Acetaminophen|acetaminophen|mesh-list
84106548|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84106549|NCT02737124|Analgesics|analgesics|mesh-ancestor
84106550|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
84106551|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106552|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106553|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
84106554|NCT02721290|Ropivacaine|ropivacaine|mesh-list
84106555|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
84106556|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
84106557|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106558|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106559|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
84106560|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106561|NCT02720978|Oxytocin|oxytocin|mesh-list
84106562|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
84106563|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84106564|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106565|NCT02726984|Listerine|listerine|mesh-list
84106566|NCT02726984|Fluorides|fluorides|mesh-list
84106567|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
84106568|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
84106569|NCT02726984|Protective Agents|protective agents|mesh-ancestor
84106570|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106571|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84106572|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106573|NCT02726828|Ketamine|ketamine|mesh-list
84106574|NCT02726828|Morphine|morphine|mesh-list
84106575|NCT02726828|Analgesics|analgesics|mesh-ancestor
84106576|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
84106577|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106578|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106579|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84106580|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84106581|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
84106582|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
84106583|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106584|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84106585|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84106586|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106587|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106588|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84106589|NCT02726828|Narcotics|narcotics|mesh-ancestor
84106590|NCT02799134|Dexamethasone|dexamethasone|mesh-list
84106591|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106592|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106593|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
84106594|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
84106595|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106596|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106597|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
84106598|NCT02799134|Hormones|hormones|mesh-ancestor
84106599|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106600|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84106601|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106602|NCT02720822|Morphine|morphine|mesh-list
84106603|NCT02720822|Laxatives|laxatives|mesh-list
84106604|NCT02720822|Cathartics|cathartics|mesh-list
84106605|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84106606|NCT02720822|Narcotics|narcotics|mesh-ancestor
84106607|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106608|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106609|NCT02720822|Analgesics|analgesics|mesh-ancestor
84106610|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
84106611|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106612|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106613|NCT02757872|Vitamin D|vitamin d|mesh-list
84106614|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
84106615|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
84106616|NCT02757872|Vitamins|vitamins|mesh-list
84106617|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
84106618|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106619|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84106620|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84106621|NCT02746796|Capecitabine|capecitabine|mesh-list
84106622|NCT02746796|Tegafur|tegafur|mesh-list
84106623|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
84106624|NCT02746796|Nivolumab|nivolumab|mesh-list
84106625|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84106626|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
84106627|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106628|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106629|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84106630|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84106631|NCT04167176|Lidocaine|lidocaine|mesh-list
84106632|NCT04167176|Bupivacaine|bupivacaine|mesh-list
84106633|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
84106634|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
84106635|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106636|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106637|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
84106638|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106639|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84106640|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84106641|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84106642|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84106643|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106644|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
84106645|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
84106646|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106647|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
84106648|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
84106649|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106650|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
84106651|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106652|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106653|NCT02726126|Fentanyl|fentanyl|mesh-list
84106654|NCT02726126|Melatonin|melatonin|mesh-list
84106655|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84106656|NCT02726126|Narcotics|narcotics|mesh-ancestor
84106657|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106658|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106659|NCT02726126|Analgesics|analgesics|mesh-ancestor
84106660|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
84106661|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106662|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84106663|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84106664|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
84106665|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
84106666|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
84106667|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106668|NCT02726126|Protective Agents|protective agents|mesh-ancestor
84106669|NCT02694458|Vancomycin|vancomycin|mesh-list
84106670|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106671|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106672|NCT02719808|Tenofovir|tenofovir|mesh-list
84106673|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
84106674|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106675|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84106676|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84106677|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106678|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106679|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84106680|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84106681|NCT02719418|Tinzaparin|tinzaparin|mesh-list
84106682|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84106683|NCT02719418|Dalteparin|dalteparin|mesh-list
83430138|NCT00506155|Cisplatin|cisplatin|mesh-list
84106684|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
84106685|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84106686|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84106687|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106688|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
84106689|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
84106690|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84106691|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106692|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106693|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
84106694|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84106695|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106696|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106697|NCT02725736|Nifedipine|nifedipine|mesh-list
84106698|NCT02725736|Atosiban|atosiban|mesh-list
84106699|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84106700|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84106701|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106702|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84106703|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346732|NCT01775501|Vitamins|vitamins|mesh-ancestor
84106704|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
84106705|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
84106706|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84106707|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
84106708|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106709|NCT02716142|Misoprostol|misoprostol|mesh-list
84106710|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84106711|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
84106712|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84106713|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106714|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84106715|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106716|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
84106717|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
84106718|NCT03015974|Prednisone|prednisone|mesh-list
84106719|NCT03015974|Prednisolone|prednisolone|mesh-list
84106720|NCT03015974|Deflazacort|deflazacort|mesh-list
84106721|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
84106722|NCT03015974|Dipyridamole|dipyridamole|mesh-list
84106723|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
84106724|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
84106725|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106726|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
84106727|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106728|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84106729|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84106730|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
84106731|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106732|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106733|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84106734|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84106735|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
84106736|NCT03015974|Hormones|hormones|mesh-ancestor
84106737|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106738|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84106739|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84106740|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84106741|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
84106742|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106743|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106744|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106745|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
84106746|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84106747|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84106748|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
84106749|NCT02718950|Liraglutide|liraglutide|mesh-list
84106750|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106751|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106752|NCT02718950|Incretins|incretins|mesh-ancestor
84106753|NCT02718950|Hormones|hormones|mesh-ancestor
84106754|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106755|NCT02725502|Linagliptin|linagliptin|mesh-list
84106756|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106757|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106758|NCT02725502|Incretins|incretins|mesh-ancestor
84106759|NCT02725502|Hormones|hormones|mesh-ancestor
84106760|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106761|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84106762|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
84106763|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106764|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106765|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
84106766|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106767|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
84106768|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106769|NCT04153136|Valsartan|valsartan|mesh-list
84106770|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84106771|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84106772|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84106773|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84106774|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106775|NCT01959464|Progesterone|progesterone|mesh-list
84106776|NCT01959464|Progestins|progestins|mesh-ancestor
84106777|NCT01959464|Hormones|hormones|mesh-ancestor
84106778|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106779|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106780|NCT02718482|Gemcitabine|gemcitabine|mesh-list
84106781|NCT02718482|Docetaxel|docetaxel|mesh-list
84106782|NCT02718482|Ifosfamide|ifosfamide|mesh-list
84106783|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
84106784|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84106785|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
84106786|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106787|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106788|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
84106789|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
84106790|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
84106791|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84106792|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
84106793|NCT01921166|Leuprolide|leuprolide|mesh-list
84106794|NCT01921166|Clomiphene|clomiphene|mesh-list
84106795|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84106796|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
84106797|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84106798|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106799|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84106800|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106801|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84106802|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
84106803|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106804|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84106805|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84106806|NCT05087030|Denosumab|denosumab|mesh-list
84106807|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84106808|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106809|NCT02717858|Liraglutide|liraglutide|mesh-list
84106810|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106811|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106812|NCT02717858|Incretins|incretins|mesh-ancestor
84106813|NCT02717858|Hormones|hormones|mesh-ancestor
84106814|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106815|NCT02725112|Pregabalin|pregabalin|mesh-list
84106816|NCT02725112|Analgesics|analgesics|mesh-ancestor
84106817|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
84106818|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106819|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106820|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
84106821|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84106822|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84106823|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106824|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84106825|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84106826|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84106827|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106828|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84106829|NCT02724332|Sirolimus|sirolimus|mesh-list
84106830|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106831|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106832|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84106833|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106834|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
84106835|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106836|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
84106837|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106838|NCT02717780|Fentanyl|fentanyl|mesh-list
84106839|NCT02717780|Remifentanil|remifentanil|mesh-list
84106840|NCT02717780|Sevoflurane|sevoflurane|mesh-list
84106841|NCT02717780|Desflurane|desflurane|mesh-list
84106842|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84106843|NCT02717780|Narcotics|narcotics|mesh-ancestor
84106844|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106845|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106846|NCT02717780|Analgesics|analgesics|mesh-ancestor
84106847|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
84106848|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106849|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84106850|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83346881|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
84106851|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
84106852|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
84106853|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84106854|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84106855|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
84106856|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84106857|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84106858|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106859|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84106860|NCT02724098|Analgesics|analgesics|mesh-ancestor
84106861|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
84106862|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106863|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84106864|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84106865|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84106866|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
84106867|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106868|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106869|NCT02723942|Immunomodulating Agents|immunomodulating agents|mesh-list
84106870|NCT02723942|Immunologic Factors|immunologic factors|mesh-ancestor
84106871|NCT02723942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106872|NCT04138316|Candesartan|candesartan|mesh-list
84106873|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84106874|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84106875|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84106876|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106877|NCT05291390|Pyronaridine|pyronaridine|mesh-list
84106878|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
84106879|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84106880|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84106881|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106882|NCT04189484|Evolocumab|evolocumab|mesh-list
84106883|NCT04189484|Alirocumab|alirocumab|mesh-list
84106884|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84106885|NCT04189484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84106886|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84106887|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84106888|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
84106889|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106890|NCT04189484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84106891|NCT04189484|Protease Inhibitors|protease inhibitors|mesh-ancestor
84106892|NCT04189484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106893|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84106894|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
84106895|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106896|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
84106897|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84106898|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106899|NCT02716766|Capecitabine|capecitabine|mesh-list
84106900|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
84106901|NCT02716766|Sorafenib|sorafenib|mesh-list
83429714|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84106902|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84106903|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
84106904|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106905|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106906|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84106907|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106908|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
84106909|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84106910|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106911|NCT02694224|Paclitaxel|paclitaxel|mesh-list
84106912|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
84106913|NCT02694224|Epirubicin|epirubicin|mesh-list
84106914|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84106915|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106916|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
84106917|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
84106918|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
84106919|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106920|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84106921|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
84106922|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106923|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84106924|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84106925|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
84106926|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84106927|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84106928|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84106929|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84106930|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106932|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84106933|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84106934|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106935|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106936|NCT00782288|Protective Agents|protective agents|mesh-ancestor
84106937|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106938|NCT04189094|Etoposide|etoposide|mesh-list
84106939|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84106940|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84106941|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84106942|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84106943|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106944|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106945|NCT02712944|Testosterone|testosterone|mesh-list
84106946|NCT02712944|Androgens|androgens|mesh-ancestor
84106947|NCT02712944|Hormones|hormones|mesh-ancestor
84106948|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84106949|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106950|NCT02712866|Vedolizumab|vedolizumab|mesh-list
84106951|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84106952|NCT00600483|Gentamicins|gentamicins|mesh-list
84106953|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84106954|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84106955|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84106956|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84106957|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106958|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
84106959|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
84106960|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106961|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
84106962|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106963|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106964|NCT00649857|Cetirizine|cetirizine|mesh-list
84106965|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84106966|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84106967|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84106968|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
84106969|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
84106970|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106971|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106972|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106973|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
84106974|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
84106975|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106976|NCT00764270|Protective Agents|protective agents|mesh-ancestor
84106977|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106978|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
84106979|NCT00764270|Vitamins|vitamins|mesh-ancestor
84106980|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
84106981|NCT00650481|Oxybutynin|oxybutynin|mesh-list
84106982|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
83347028|NCT01933984|Fenoterol|fenoterol|mesh-list
83347029|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83347030|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
83347031|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347032|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
83347033|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347034|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347035|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83347036|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
83347037|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
83347038|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83347039|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83347040|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83347041|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83347042|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347043|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347044|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347045|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
83347046|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
84106983|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
84106984|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84106985|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106986|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84106987|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84106988|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
84106989|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84106990|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84106991|NCT00650481|Urological Agents|urological agents|mesh-ancestor
84106992|NCT02712476|Furosemide|furosemide|mesh-list
84106993|NCT02712476|Mannitol|mannitol|mesh-list
84106994|NCT02712476|Diuretics|diuretics|mesh-ancestor
84106995|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
84106996|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84106997|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84106998|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84106999|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107000|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84107001|NCT02722538|Gemcitabine|gemcitabine|mesh-list
84107002|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107003|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
84107004|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107005|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107006|NCT02651727|Paclitaxel|paclitaxel|mesh-list
84107007|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84107008|NCT02651727|Gemcitabine|gemcitabine|mesh-list
84107009|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84107010|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107011|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
84107012|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
84107013|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
84107014|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107015|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107016|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
84107017|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
84107018|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84107019|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84107020|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107021|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
84107022|NCT02650791|Coagulants|coagulants|mesh-ancestor
84107023|NCT04035668|Remibrutinib|remibrutinib|mesh-list
84107024|NCT04035668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84107025|NCT04035668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107026|NCT04035668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107027|NCT02650713|Atezolizumab|atezolizumab|mesh-list
84107028|NCT02650713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83429719|NCT00490009|Coagulants|coagulants|mesh-ancestor
84107029|NCT02650713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107030|NCT02650713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84107031|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107032|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
84107033|NCT02650635|Lenograstim|lenograstim|mesh-list
84107034|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107035|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
84107036|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107037|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107038|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84107039|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
84107040|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107041|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107042|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84107043|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84107044|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
84107045|NCT00650637|Lamivudine|lamivudine|mesh-list
84107046|NCT00650637|Zidovudine|zidovudine|mesh-list
84107047|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
84107048|NCT00650637|Nelfinavir|nelfinavir|mesh-list
84107049|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
84107050|NCT00650637|Loperamide|loperamide|mesh-list
83347112|NCT01902004|Memantine|memantine|mesh-list
83347113|NCT01902004|Escitalopram|escitalopram|mesh-list
83347114|NCT01902004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83347115|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83347116|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83347117|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107051|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
84107052|NCT00650637|Calcium|calcium|mesh-list
84107053|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84107054|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107055|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84107056|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84107057|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84107058|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107059|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107060|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
84107061|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107062|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84107063|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84107064|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
84107065|NCT00650637|Antacids|antacids|mesh-ancestor
84107066|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107067|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84107068|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84107069|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
84107070|NCT02650479|Exenatide|exenatide|mesh-list
84107071|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
84107072|NCT02650479|Palonosetron|palonosetron|mesh-list
84107073|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84107074|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107075|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84107076|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84107077|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107078|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107079|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107080|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107081|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107082|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84107083|NCT02650479|Incretins|incretins|mesh-ancestor
84107084|NCT02650479|Hormones|hormones|mesh-ancestor
84107085|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84107086|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
84107087|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
84107088|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107089|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107090|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84107091|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84107092|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
84107093|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107094|NCT02722772|Etanercept|etanercept|mesh-list
84107095|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84107096|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107097|NCT02722772|Analgesics|analgesics|mesh-ancestor
84107098|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
84107099|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107100|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107101|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107102|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107103|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107104|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107105|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
84107106|NCT02650245|Lactulose|lactulose|mesh-list
84107107|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107108|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84107109|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84107110|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84107111|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107112|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107113|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84107114|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84107115|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84107116|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
84107117|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107118|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107119|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84107120|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84107121|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
84107122|NCT00910767|Insulin|insulin|mesh-list
84107123|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107124|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107125|NCT02722694|Methotrexate|methotrexate|mesh-list
84107126|NCT02722694|Abatacept|abatacept|mesh-list
84107127|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84107128|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
84107129|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84107130|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107131|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107132|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
84107133|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107134|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107135|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
84107136|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107137|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84107138|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107139|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
84107140|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107141|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84107142|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84107143|NCT02722694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84107144|NCT00650871|Casopitant|casopitant|mesh-list
84107145|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
84107146|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
84107147|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107148|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107149|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107150|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84107151|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107152|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107153|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84107154|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84107155|NCT02649465|Glimepiride|glimepiride|mesh-list
84107156|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
84107157|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84107158|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107159|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107160|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107161|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
84107162|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84107163|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107164|NCT00651105|Vildagliptin|vildagliptin|mesh-list
84107165|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107166|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107167|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84107168|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
84107169|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107170|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107171|NCT02694146|Hylan|hylan|mesh-list
84107172|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
84107173|NCT02694146|Protective Agents|protective agents|mesh-ancestor
84107174|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107175|NCT04167267|Fexuprazan|fexuprazan|mesh-list
84107176|NCT04167267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107177|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
84107178|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84107179|NCT02649075|Antibodies|antibodies|mesh-list
84107180|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
84107181|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107182|NCT02644785|Protamines|protamines|mesh-list
84107183|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
84107184|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107185|NCT02644785|Coagulants|coagulants|mesh-ancestor
84107186|NCT02644707|Selenium|selenium|mesh-list
84107187|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
84107188|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107189|NCT02644707|Protective Agents|protective agents|mesh-ancestor
84107190|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107191|NCT02644707|Trace Elements|trace elements|mesh-ancestor
84107192|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
84107193|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
84107194|NCT02711228|Antibodies|antibodies|mesh-list
84107195|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
84107196|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84107197|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84107198|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
84107199|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107200|NCT02644863|Paclitaxel|paclitaxel|mesh-list
84107201|NCT02644863|Cisplatin|cisplatin|mesh-list
84107202|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84107203|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107204|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
84107205|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
84107206|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
84107207|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107208|NCT03524235|Rituximab|rituximab|mesh-list
84107209|NCT03524235|Fludarabine|fludarabine|mesh-list
84107210|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84107211|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84107212|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107213|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
84107214|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107215|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107216|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107217|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84107218|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
84107219|NCT00302744|Niacin|niacin|mesh-list
84107220|NCT00302744|Psilocybin|psilocybin|mesh-list
84107221|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84107222|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
84107223|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107224|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84107225|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
84107226|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
84107227|NCT00302744|Vitamins|vitamins|mesh-ancestor
84107228|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
84107229|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107230|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
84107231|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84107232|NCT02644629|Ketamine|ketamine|mesh-list
84107233|NCT02644629|Analgesics|analgesics|mesh-ancestor
84107234|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
84107235|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107236|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107237|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84107238|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84107239|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
84107240|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
84107241|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83429721|NCT03769532|Azacitidine|azacitidine|mesh-list
84107242|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84107243|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84107244|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107245|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107246|NCT00652665|Leflunomide|leflunomide|mesh-list
84107247|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107248|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107249|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107250|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
84107251|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107252|NCT02644551|Ciclopirox|ciclopirox|mesh-list
84107253|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
84107254|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107255|NCT02644395|Amlodipine|amlodipine|mesh-list
84107256|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
84107257|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84107258|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84107259|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107260|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107261|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84107262|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107263|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
84107264|NCT02644395|Diuretics|diuretics|mesh-ancestor
84107265|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
84107266|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84107267|NCT04166565|Dexamethasone|dexamethasone|mesh-list
84107268|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
84107269|NCT04166565|Bortezomib|bortezomib|mesh-list
84107270|NCT04166565|Daratumumab|daratumumab|mesh-list
84107271|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107272|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
84107273|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107274|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107275|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83347335|NCT02987218|Propofol|propofol|mesh-list
84107276|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
84107277|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107278|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107279|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84107280|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107281|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
84107282|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
84107283|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107284|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107285|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
84107286|NCT04166565|Hormones|hormones|mesh-ancestor
84107287|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84107288|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84107289|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
84107290|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84107291|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84107292|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107293|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
84107294|NCT02644473|Coagulants|coagulants|mesh-ancestor
84107295|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84107296|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
84107297|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107298|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
84107299|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107300|NCT04005872|Calcium|calcium|mesh-list
84107301|NCT04005872|Fluorides|fluorides|mesh-list
84107302|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84107303|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107304|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
84107305|NCT04005872|Protective Agents|protective agents|mesh-ancestor
84107306|NCT00652821|Tramadol|tramadol|mesh-list
84107307|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84107308|NCT00652821|Narcotics|narcotics|mesh-ancestor
84107309|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107310|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107311|NCT00652821|Analgesics|analgesics|mesh-ancestor
84107312|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
84107313|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107314|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
84107315|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84107316|NCT02535975|Metformin|metformin|mesh-list
84107317|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107318|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107319|NCT02714036|Ibudilast|ibudilast|mesh-list
84107320|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84107321|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
84107322|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107323|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107324|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84107325|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
84107326|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84107327|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107328|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107329|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84107330|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
84107331|NCT02710448|Metformin|metformin|mesh-list
84107332|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107333|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107334|NCT04602026|Coal Tar|coal tar|mesh-list
84107335|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
84107336|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
84107337|NCT04166253|Vitamin D|vitamin d|mesh-list
84107338|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
84107339|NCT04166253|Vitamins|vitamins|mesh-ancestor
84107340|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
84107341|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107342|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84107343|NCT00653055|Cabergoline|cabergoline|mesh-list
84107344|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84107345|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84107346|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
84107347|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
84107348|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107349|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107350|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347409|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
84107351|NCT02643147|Furosemide|furosemide|mesh-list
84107352|NCT02643147|Diuretics|diuretics|mesh-list
84107353|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
84107354|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
84107355|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107356|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107357|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107358|NCT02642913|Sorafenib|sorafenib|mesh-list
84107359|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107360|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84107361|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107362|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107363|NCT04165629|Aspirin|aspirin|mesh-list
84107364|NCT04165629|Clopidogrel|clopidogrel|mesh-list
84107365|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84107366|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107367|NCT04165629|Analgesics|analgesics|mesh-ancestor
84107368|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
84107369|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107370|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107371|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107372|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107373|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84107374|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84107375|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107376|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84107377|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84107378|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107379|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
84107380|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84107381|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84107382|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84107383|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
84107384|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107385|NCT02642523|Insulin|insulin|mesh-list
84107386|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84107387|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84107388|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107389|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107390|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
84107391|NCT02713802|Propofol|propofol|mesh-list
84107392|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84107393|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107394|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107395|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84107396|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
84107397|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
84107398|NCT02642601|Indomethacin|indomethacin|mesh-list
84107399|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84107400|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107401|NCT02642601|Analgesics|analgesics|mesh-ancestor
84107402|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
84107403|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107404|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107405|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107406|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107407|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
84107408|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
84107409|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84107410|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84107411|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107412|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107413|NCT02709902|Adapalene|adapalene|mesh-list
84107414|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
84107415|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84107416|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
84107417|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84107418|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107419|NCT02709902|Analgesics|analgesics|mesh-ancestor
84107420|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
84107421|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107422|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107423|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107424|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347486|NCT03823989|Mitomycins|mitomycins|mesh-list
84107425|NCT02710604|Tenofovir|tenofovir|mesh-list
84107426|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
84107427|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
84107428|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107429|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84107430|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84107431|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107432|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107433|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84107434|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84107435|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
84107436|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84107437|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84107438|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107439|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
84107440|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
84107441|NCT02642367|Rocuronium|rocuronium|mesh-list
84107442|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84107443|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84107444|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84107445|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107446|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107447|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84107448|NCT00653445|Ezetimibe|ezetimibe|mesh-list
84107449|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84107450|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84107451|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
84107452|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107453|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84107454|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84107455|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107456|NCT02641899|Acetaminophen|acetaminophen|mesh-list
84107457|NCT02641899|Exenatide|exenatide|mesh-list
84107458|NCT02641899|Digoxin|digoxin|mesh-list
84107459|NCT02641899|Lisinopril|lisinopril|mesh-list
84107460|NCT02641899|Warfarin|warfarin|mesh-list
84107461|NCT02641899|Atorvastatin|atorvastatin|mesh-list
84107462|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84107463|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84107464|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
84107465|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107466|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84107467|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84107468|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107469|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107470|NCT02641899|Analgesics|analgesics|mesh-ancestor
84107471|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
84107472|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107473|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107474|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
84107475|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
84107476|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84107477|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84107478|NCT02641899|Protective Agents|protective agents|mesh-ancestor
84107479|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84107480|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
84107481|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84107482|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107483|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84107484|NCT02641899|Incretins|incretins|mesh-ancestor
84107485|NCT02641899|Hormones|hormones|mesh-ancestor
84107486|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84107487|NCT02641821|Nifedipine|nifedipine|mesh-list
84107488|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84107489|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107490|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107491|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84107492|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107493|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
84107494|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
84107495|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84107496|NCT01320345|Fenofibrate|fenofibrate|mesh-list
84107497|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84107498|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
84107499|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107500|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84107502|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107503|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
84107504|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107505|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107506|NCT04164459|Latanoprost|latanoprost|mesh-list
84107507|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84107508|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84107509|NCT04164693|Heparin|heparin|mesh-list
84107510|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84107511|NCT04164693|Tinzaparin|tinzaparin|mesh-list
84107512|NCT04164693|Dalteparin|dalteparin|mesh-list
84107513|NCT04164693|Warfarin|warfarin|mesh-list
84107514|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
84107515|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84107516|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84107517|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107518|NCT00655785|Gemcitabine|gemcitabine|mesh-list
84107519|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107520|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
84107521|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107522|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107523|NCT00885495|Ritonavir|ritonavir|mesh-list
84107524|NCT00885495|Darunavir|darunavir|mesh-list
84107525|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84107526|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84107527|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84107528|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
84107529|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107530|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107531|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84107532|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84107533|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
84107534|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107535|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84107536|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84107537|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84107538|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84107539|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
84107540|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84107541|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84107542|NCT02637375|Paclitaxel|paclitaxel|mesh-list
84107543|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
84107544|NCT02637375|Doxorubicin|doxorubicin|mesh-list
84107545|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84107546|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107547|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
84107548|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
84107549|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
84107550|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107551|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107552|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
84107553|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107554|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107555|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84107556|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
84107557|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84107558|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84107559|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84107560|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84107561|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107562|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
84107563|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107564|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84107565|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107566|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107567|NCT00885105|Vaccines|vaccines|mesh-list
84107568|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
84107569|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107570|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
84107571|NCT02709668|Vitamins|vitamins|mesh-ancestor
84107572|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
84107573|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107574|NCT04188782|Sevoflurane|sevoflurane|mesh-list
84107575|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84107576|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84107577|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
84107578|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
84107579|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107580|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107581|NCT02709590|Diclofenac|diclofenac|mesh-list
84107582|NCT02709590|Lidocaine|lidocaine|mesh-list
84107583|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
84107584|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
84107585|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107586|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107587|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
84107588|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107589|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84107590|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84107591|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84107592|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107593|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107594|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84107595|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107596|NCT02709590|Analgesics|analgesics|mesh-ancestor
84107597|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107598|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107599|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84107600|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107601|NCT02707874|Ropivacaine|ropivacaine|mesh-list
84107602|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
84107603|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
84107604|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107605|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107606|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
84107607|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107608|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
84107609|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84107610|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107611|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107612|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107613|NCT02709200|Analgesics|analgesics|mesh-ancestor
84107614|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
84107615|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107616|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84107617|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84107618|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84107619|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
84107620|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107621|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107622|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84107623|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84107624|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84107625|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107626|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107627|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
84107628|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107629|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107630|NCT02707328|Paclitaxel|paclitaxel|mesh-list
84107631|NCT02707328|Gemcitabine|gemcitabine|mesh-list
84107632|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84107633|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107634|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
84107635|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
84107636|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
84107637|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107638|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107639|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
84107640|NCT00612638|Irinotecan|irinotecan|mesh-list
84107641|NCT00612638|Temozolomide|temozolomide|mesh-list
84107642|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
84107643|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84107644|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84107645|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107646|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107647|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107648|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84107649|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
84107650|NCT05151848|Adalimumab|adalimumab|mesh-list
84107651|NCT05151848|Tofacitinib|tofacitinib|mesh-list
84107652|NCT05151848|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84107653|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107654|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107655|NCT05151848|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84107656|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84107657|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107658|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107659|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
84107660|NCT05134688|Analgesics|analgesics|mesh-ancestor
84107661|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
84107662|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107663|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107664|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
84107665|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107666|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84107667|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
84107668|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84107669|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107670|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107671|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84107672|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
84107673|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84107674|NCT02693288|Anesthetics|anesthetics|mesh-list
84107675|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107676|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107677|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
84107678|NCT02693210|Rituximab|rituximab|mesh-list
84107679|NCT02693210|Methotrexate|methotrexate|mesh-list
84107680|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107681|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
84107682|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107683|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107684|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84107685|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
84107686|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107687|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107688|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84107689|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84107690|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84107691|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
84107692|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84107693|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107694|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
84107695|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
84107696|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107697|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84107698|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84107699|NCT05029466|Psilocybin|psilocybin|mesh-list
84107700|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
84107701|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107702|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84107703|NCT05024006|Interferons|interferons|mesh-list
84107704|NCT05024006|Ritonavir|ritonavir|mesh-list
84107705|NCT05024006|Lopinavir|lopinavir|mesh-list
84107706|NCT05024006|Interferon-beta|interferon-beta|mesh-list
84107707|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
84107708|NCT05024006|Remdesivir|remdesivir|mesh-list
84107709|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
84107710|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
84107711|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107712|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
84107713|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107714|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84107715|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84107716|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
84107717|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107718|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107719|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84107720|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84107721|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84107722|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84107723|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
84107724|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84107725|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84107726|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107727|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
84107728|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107729|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84107730|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
84107732|NCT02707250|Bupivacaine|bupivacaine|mesh-list
84107733|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
84107734|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
84107735|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107736|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107737|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
84107738|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107739|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84107740|NCT02707250|Narcotics|narcotics|mesh-ancestor
84107741|NCT02707250|Analgesics|analgesics|mesh-ancestor
84107742|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84107743|NCT03781544|Acetaminophen|acetaminophen|mesh-list
84107744|NCT03781544|Diclofenac|diclofenac|mesh-list
84107745|NCT03781544|Tramadol|tramadol|mesh-list
84107746|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107747|NCT03781544|Analgesics|analgesics|mesh-ancestor
84107748|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
84107749|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107750|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107751|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
84107752|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84107753|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107754|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107755|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84107756|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107757|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107758|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84107759|NCT03781544|Narcotics|narcotics|mesh-ancestor
83429736|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
84107760|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107761|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
84107762|NCT02707094|Immunomodulating Agents|immunomodulating agents|mesh-list
84107763|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107764|NCT02707016|Sevoflurane|sevoflurane|mesh-list
84107765|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84107766|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84107767|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
84107768|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
84107769|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107770|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107771|NCT02706704|Adalimumab|adalimumab|mesh-list
84107772|NCT02706704|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84107773|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107774|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107775|NCT04956146|Carboplatin|carboplatin|mesh-list
84107776|NCT04956146|Pemetrexed|pemetrexed|mesh-list
84107777|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107778|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107779|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107780|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84107781|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84107782|NCT00612794|Exenatide|exenatide|mesh-list
84107783|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107784|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107785|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84107786|NCT00612794|Incretins|incretins|mesh-ancestor
84107787|NCT00612794|Hormones|hormones|mesh-ancestor
84107788|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84107789|NCT03773276|Norepinephrine|norepinephrine|mesh-list
84107790|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84107791|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84107792|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
84107793|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107794|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107795|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107796|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
84107797|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
84107798|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107799|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84107800|NCT02706860|Atorvastatin|atorvastatin|mesh-list
83347868|NCT01453881|Hormones|hormones|mesh-ancestor
84107801|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84107802|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84107803|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
84107804|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107805|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84107806|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84107807|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107808|NCT02706470|Cyclosporine|cyclosporine|mesh-list
84107809|NCT02706470|Cyclosporins|cyclosporins|mesh-list
84107810|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
84107811|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107812|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107813|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84107814|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
84107815|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107816|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
84107817|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107818|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
84107819|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107820|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84107821|NCT02706470|Progestins|progestins|mesh-ancestor
84107822|NCT02706470|Hormones|hormones|mesh-ancestor
84107823|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84107824|NCT03769766|Curcumin|curcumin|mesh-list
84107825|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84107826|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84107827|NCT03769766|Analgesics|analgesics|mesh-ancestor
84107828|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
84107829|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107830|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107831|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107832|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107833|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107834|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107835|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107836|NCT03764540|Prednisone|prednisone|mesh-list
84107837|NCT03764540|Docetaxel|docetaxel|mesh-list
84107838|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107839|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
84107840|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
84107841|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
84107842|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107843|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107844|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
84107845|NCT03764540|Hormones|hormones|mesh-ancestor
84107846|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84107847|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107848|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84107849|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
84107850|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
84107851|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107852|NCT02706236|Pancrelipase|pancrelipase|mesh-list
84107853|NCT02706236|Pancreatin|pancreatin|mesh-list
84107854|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107855|NCT00613496|Irbesartan|irbesartan|mesh-list
84107856|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84107857|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84107858|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84107859|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107860|NCT04789928|Gentamicins|gentamicins|mesh-list
84107861|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84107862|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107863|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84107864|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107865|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107866|NCT00612950|Glucagon|glucagon|mesh-list
84107867|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
84107868|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84107869|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107870|NCT00612950|Hormones|hormones|mesh-ancestor
84107871|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84107872|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107873|NCT00612950|Incretins|incretins|mesh-ancestor
84107874|NCT00884793|Ritonavir|ritonavir|mesh-list
84107875|NCT00884793|Lopinavir|lopinavir|mesh-list
84107876|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84107878|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
84107879|NCT00884793|Efavirenz|efavirenz|mesh-list
84107880|NCT00884793|Etravirine|etravirine|mesh-list
84107881|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84107882|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84107883|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
84107884|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107885|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107886|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84107887|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84107888|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
84107889|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107890|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84107891|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84107892|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84107893|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84107894|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84107895|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84107896|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84107897|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84107898|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84107899|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84107900|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84107901|NCT00656331|Amlodipine|amlodipine|mesh-list
84107902|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84107903|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84107904|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107905|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107906|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84107907|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107908|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
84107909|NCT02636829|Calcium|calcium|mesh-list
84107910|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84107911|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107912|NCT00884325|Levocetirizine|levocetirizine|mesh-list
84107913|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84107914|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84107915|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
84107916|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
84107917|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107918|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107919|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107920|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84107921|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
84107922|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107923|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
84107924|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
84107925|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84107926|NCT04705844|Adalimumab|adalimumab|mesh-list
84107927|NCT04705844|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84107928|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84107929|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84107930|NCT00636896|Olanzapine|olanzapine|mesh-list
84107931|NCT00636896|Modafinil|modafinil|mesh-list
84107932|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
84107933|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
84107934|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107935|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107936|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84107937|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84107938|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84107939|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107940|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84107941|NCT00636896|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84107942|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84107943|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107944|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107945|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84107946|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
84107947|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84107948|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84107949|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84107950|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84107952|NCT04470674|Pemetrexed|pemetrexed|mesh-list
84107953|NCT04470674|Durvalumab|durvalumab|mesh-list
84107954|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107955|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107956|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107957|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84107958|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84107959|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84107960|NCT00883779|Carboplatin|carboplatin|mesh-list
84107961|NCT00883779|Gemcitabine|gemcitabine|mesh-list
84107962|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84107963|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84107964|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84107965|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
84107966|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107967|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84107968|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107969|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
84107970|NCT05263778|Ezetimibe|ezetimibe|mesh-list
84107971|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84107972|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84107973|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
84107974|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107975|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84107976|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84107977|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84107978|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107979|NCT02693444|Lidocaine|lidocaine|mesh-list
84107980|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
84107981|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
84107982|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107983|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107984|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
84107985|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84107986|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84107987|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84107988|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84107989|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84107990|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84107991|NCT04162743|Trazodone|trazodone|mesh-list
84107992|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84107993|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84107994|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84107995|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84107996|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84107997|NCT04162743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84107998|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84107999|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108000|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108001|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108002|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
84108003|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84108004|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
84108005|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
84108006|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108007|NCT04302896|Tenofovir|tenofovir|mesh-list
84108008|NCT04302896|Lamivudine|lamivudine|mesh-list
84108009|NCT04302896|Emtricitabine|emtricitabine|mesh-list
84108010|NCT04302896|Dolutegravir|dolutegravir|mesh-list
84108011|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84108012|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
84108013|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108014|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84108015|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84108016|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108017|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108018|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84108019|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83348122|NCT01455909|Exenatide|exenatide|mesh-list
84108020|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84108021|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84108022|NCT00656643|Sirolimus|sirolimus|mesh-list
84108023|NCT00656643|Temsirolimus|temsirolimus|mesh-list
84108024|NCT00656643|MTOR Inhibitors|mtor inhibitors|mesh-list
84108025|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84108026|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108027|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84108028|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108029|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
84108030|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108031|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
84108032|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108033|NCT00656643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84108034|NCT00656643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108035|NCT00656643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108036|NCT04291820|Anesthetics|anesthetics|mesh-list
84108037|NCT04291820|Sevoflurane|sevoflurane|mesh-list
84108038|NCT04291820|Desflurane|desflurane|mesh-list
84108039|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108040|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108041|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84108042|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84108043|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
83429748|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
84108044|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84108045|NCT03712202|Nivolumab|nivolumab|mesh-list
84108046|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84108047|NCT03712202|Doxorubicin|doxorubicin|mesh-list
84108048|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84108049|NCT03712202|Daunorubicin|daunorubicin|mesh-list
84108050|NCT03712202|Bleomycin|bleomycin|mesh-list
84108051|NCT03712202|Dacarbazine|dacarbazine|mesh-list
84108052|NCT03712202|Vinblastine|vinblastine|mesh-list
84108053|NCT03712202|Antibodies|antibodies|mesh-list
84108054|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
84108055|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84108056|NCT03712202|Imidazole|imidazole|mesh-list
84108057|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
84108058|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
84108059|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108060|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108061|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84108062|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84108063|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84108064|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108065|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108066|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84108067|NCT03712202|Immunotoxins|immunotoxins|mesh-ancestor
84108068|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84108069|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
84108070|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84108071|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108072|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108073|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108074|NCT02635971|Gemcitabine|gemcitabine|mesh-list
84108075|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
84108076|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84108077|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
84108078|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108079|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108080|NCT00657423|Cisplatin|cisplatin|mesh-list
84108081|NCT00657423|Docetaxel|docetaxel|mesh-list
84108082|NCT00657423|Endostar protein|endostar protein|mesh-list
84108083|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108084|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108085|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108086|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108087|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108088|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84108089|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84108090|NCT00657423|Growth Substances|growth substances|mesh-ancestor
84108091|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108092|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
84108093|NCT00911235|Fluconazole|fluconazole|mesh-list
84108094|NCT00911235|Fesoterodine|fesoterodine|mesh-list
84108095|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
84108096|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108097|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84108098|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84108099|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108100|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108101|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84108102|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
84108103|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108104|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108105|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84108106|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84108107|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84108108|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84108109|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
84108110|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108111|NCT00911235|Urological Agents|urological agents|mesh-ancestor
84108112|NCT00636974|Anesthetics|anesthetics|mesh-list
84108113|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108114|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108115|NCT02535351|Sunitinib|sunitinib|mesh-list
84108116|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108117|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84108118|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84108119|NCT02535351|Growth Substances|growth substances|mesh-ancestor
84108120|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108121|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
84108122|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84108123|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108124|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108125|NCT00613964|Diuretics|diuretics|mesh-list
84108126|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
84108127|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
84108128|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108129|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108130|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108131|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
84108132|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84108133|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108134|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108135|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84108136|NCT05342870|Analgesics|analgesics|mesh-ancestor
84108137|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
84108138|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108139|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84108140|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84108141|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84108142|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
84108143|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108144|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108145|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84108146|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84108147|NCT05342792|Capecitabine|capecitabine|mesh-list
84108148|NCT05342792|Tislelizumab|tislelizumab|mesh-list
84108149|NCT05342792|Antibodies|antibodies|mesh-list
84108150|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
84108151|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108152|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84108153|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
84108154|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108155|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108156|NCT05342792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108157|NCT00657891|Omalizumab|omalizumab|mesh-list
84108158|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84108159|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84108160|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
84108161|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
84108162|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84108163|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108164|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108165|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
84108166|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108167|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108168|NCT04159077|Tamsulosin|tamsulosin|mesh-list
83348247|NCT05826990|Cefepime|cefepime|mesh-list
84108169|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84108170|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84108171|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84108172|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
84108173|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108174|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108175|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108176|NCT04159077|Urological Agents|urological agents|mesh-ancestor
84108177|NCT02690480|Fulvestrant|fulvestrant|mesh-list
84108178|NCT02690480|Palbociclib|palbociclib|mesh-list
84108179|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84108180|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108181|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84108182|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84108183|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
84108184|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108185|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108186|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84108187|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108188|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108189|NCT00658593|Gemcitabine|gemcitabine|mesh-list
84108190|NCT00658593|Capecitabine|capecitabine|mesh-list
84108191|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84108192|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
84108193|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108194|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108195|NCT00880269|Panobinostat|panobinostat|mesh-list
84108196|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108197|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84108198|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108199|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108200|NCT00880191|Dexamethasone|dexamethasone|mesh-list
84108201|NCT00880191|Gabapentin|gabapentin|mesh-list
84108202|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108203|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
84108204|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
84108205|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108206|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108207|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108208|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
84108209|NCT00880191|Hormones|hormones|mesh-ancestor
84108210|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108211|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84108212|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108213|NCT00880191|Analgesics|analgesics|mesh-ancestor
84108214|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
84108215|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
84108216|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84108217|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84108218|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108219|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84108220|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84108221|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84108222|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108223|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108224|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
84108225|NCT00659451|Losartan|losartan|mesh-list
84108226|NCT00659451|Amlodipine|amlodipine|mesh-list
84108227|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84108228|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84108229|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108230|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108231|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84108232|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108233|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108234|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84108235|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84108236|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84108237|NCT00911313|Metformin|metformin|mesh-list
84108238|NCT00911313|Letrozole|letrozole|mesh-list
84108239|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84108240|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108241|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108242|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84108243|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84108244|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108245|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108246|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84108247|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
84108248|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108249|NCT00659685|Ondansetron|ondansetron|mesh-list
84108250|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
84108251|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
84108252|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108253|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108254|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108255|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
84108256|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
84108257|NCT00659685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84108258|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84108259|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
84108260|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108261|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108262|NCT00659841|Ciclesonide|ciclesonide|mesh-list
84108263|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
84108264|NCT00659841|Hormones|hormones|mesh-ancestor
84108265|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108266|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108267|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84108268|NCT00659919|Trazodone|trazodone|mesh-list
84108269|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84108270|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84108271|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108272|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108273|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84108274|NCT00659919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84108275|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84108276|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108277|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108278|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108279|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
84108280|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84108281|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
84108282|NCT00659997|Albendazole|albendazole|mesh-list
84108283|NCT00659997|Levamisole|levamisole|mesh-list
84108284|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
84108285|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84108286|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108287|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
84108288|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84108289|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84108290|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108291|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108292|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108293|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108294|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108295|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84108296|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
84108297|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108298|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
84108299|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84108300|NCT00660153|Tivozanib|tivozanib|mesh-list
84108301|NCT00660153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84108302|NCT00660153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108303|NCT00660153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108304|NCT00660231|Gemcitabine|gemcitabine|mesh-list
84108305|NCT00660231|Bexarotene|bexarotene|mesh-list
84108306|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84108307|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
84108308|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108309|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108310|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
84108311|NCT00597519|Fludarabine|fludarabine|mesh-list
84108312|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108313|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
84108314|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108315|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84108316|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84108318|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108319|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108320|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84108321|NCT00660621|Bevacizumab|bevacizumab|mesh-list
84108322|NCT00660621|Temozolomide|temozolomide|mesh-list
84108323|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108324|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108325|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84108326|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84108327|NCT00660621|Growth Substances|growth substances|mesh-ancestor
84108328|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108329|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
84108330|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84108331|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
84108332|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108333|NCT02632305|Paclitaxel|paclitaxel|mesh-list
84108334|NCT02632305|Gemcitabine|gemcitabine|mesh-list
84108335|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84108336|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108337|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108338|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108339|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108340|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108341|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84108342|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
84108343|NCT02631993|Furocoumarins|furocoumarins|mesh-list
84108344|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
84108345|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84108346|NCT00660855|Parecoxib|parecoxib|mesh-list
84108347|NCT00660855|Valdecoxib|valdecoxib|mesh-list
84108348|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84108349|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84108350|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108351|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108352|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84108353|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84108354|NCT00660855|Analgesics|analgesics|mesh-ancestor
84108355|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
84108356|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108357|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108358|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108359|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84108360|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84108361|NCT00660933|Hematinics|hematinics|mesh-ancestor
84108362|NCT02632071|Paclitaxel|paclitaxel|mesh-list
84108363|NCT02632071|Ricolinostat|ricolinostat|mesh-list
84108364|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84108365|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108366|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108367|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108368|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108369|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108370|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84108371|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108372|NCT00879333|Everolimus|everolimus|mesh-list
84108373|NCT00879333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84108374|NCT00879333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84108375|NCT00879333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108376|NCT00879333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108377|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108378|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
84108379|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108380|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108381|NCT02630823|Paclitaxel|paclitaxel|mesh-list
84108382|NCT02630823|Carboplatin|carboplatin|mesh-list
84108383|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
84108384|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84108385|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108386|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108387|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108388|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108389|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108390|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108391|NCT02630823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84108392|NCT02630511|Mannitol|mannitol|mesh-list
84108393|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
84108394|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84108395|NCT02630511|Diuretics|diuretics|mesh-ancestor
84108396|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
84108397|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108398|NCT02630511|Miotics|miotics|mesh-ancestor
84108399|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
84108400|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108401|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84108402|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
84108403|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
84108404|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84108405|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84108406|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
84108407|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108408|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108409|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
84108410|NCT00666159|Tacrolimus|tacrolimus|mesh-list
84108411|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108412|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
84108413|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108414|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84108415|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108416|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108417|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84108418|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84108419|NCT00666159|Analgesics|analgesics|mesh-ancestor
84108420|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
84108421|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108422|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108423|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84108424|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
84108425|NCT00666393|Fentanyl|fentanyl|mesh-list
84108426|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84108427|NCT00666393|Narcotics|narcotics|mesh-ancestor
84108428|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108429|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108430|NCT00666393|Analgesics|analgesics|mesh-ancestor
84108431|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
84108432|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108433|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84108434|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84108435|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
84108436|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
84108437|NCT00666627|Alendronate|alendronate|mesh-list
84108438|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
84108439|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
84108440|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84108441|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108442|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84108443|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108444|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108445|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84108446|NCT00666783|Palonosetron|palonosetron|mesh-list
84108447|NCT00666783|Granisetron|granisetron|mesh-list
84108448|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
84108449|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
84108450|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108451|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108452|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108453|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84108454|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84108455|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
84108456|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108457|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108458|NCT00666939|Gabapentin|gabapentin|mesh-list
84108459|NCT00666939|Analgesics|analgesics|mesh-ancestor
84108460|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
84108461|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108462|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108463|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
84108464|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84108465|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84108466|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108467|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84108468|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84108469|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84108470|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108471|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108472|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
84108473|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84108474|NCT00667407|Albuterol|albuterol|mesh-list
84108475|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84108476|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
84108477|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108478|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108479|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84108480|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
84108481|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
84108482|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84108483|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84108484|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84108485|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84108486|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
84108487|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108488|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108489|NCT00667485|Sirolimus|sirolimus|mesh-list
84108490|NCT00667485|Bevacizumab|bevacizumab|mesh-list
84108491|NCT00667485|Temsirolimus|temsirolimus|mesh-list
84108492|NCT00667485|MTOR Inhibitors|mtor inhibitors|mesh-list
84108493|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108494|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108495|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84108496|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84108497|NCT00667485|Growth Substances|growth substances|mesh-ancestor
84108498|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108499|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
84108500|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84108501|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108502|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84108503|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
84108504|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108505|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
84108506|NCT00667485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84108507|NCT00667485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108508|NCT00667485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108509|NCT00667641|Paclitaxel|paclitaxel|mesh-list
84108510|NCT00667641|Bortezomib|bortezomib|mesh-list
84108511|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84108512|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108513|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108514|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108515|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108516|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108517|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84108518|NCT00667797|Albuterol|albuterol|mesh-list
84108519|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84108520|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
84108521|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108522|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108523|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84108524|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
84108525|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
84108526|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84108527|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84108528|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84108529|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84108530|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
84108531|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108532|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108533|NCT03481556|Dexamethasone|dexamethasone|mesh-list
84108534|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
84108535|NCT03481556|Bortezomib|bortezomib|mesh-list
84108536|NCT03481556|Melphalan|melphalan|mesh-list
84108537|NCT03481556|Daratumumab|daratumumab|mesh-list
84108538|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108539|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
83348629|NCT05487859|Acarbose|acarbose|mesh-list
84108540|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
84108541|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108542|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108543|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108544|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
84108545|NCT03481556|Hormones|hormones|mesh-ancestor
84108546|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108547|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84108548|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108549|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84108550|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
84108551|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108552|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84108553|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108554|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
84108555|NCT00668031|Aprotinin|aprotinin|mesh-list
84108556|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
84108557|NCT00668031|Coagulants|coagulants|mesh-ancestor
84108558|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84108559|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84108560|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
84108561|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108562|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108563|NCT03480776|Aspirin|aspirin|mesh-list
84108564|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84108565|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84108566|NCT03480776|Analgesics|analgesics|mesh-ancestor
84108567|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
84108568|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108569|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108570|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108571|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84108572|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84108573|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84108574|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108575|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84108576|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84108577|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108578|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
84108579|NCT00668109|Tadalafil|tadalafil|mesh-list
84108580|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84108581|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108582|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84108583|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84108584|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108585|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108586|NCT00668109|Urological Agents|urological agents|mesh-ancestor
84108587|NCT00668343|Simvastatin|simvastatin|mesh-list
84108588|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84108589|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84108590|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
84108591|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108592|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84108593|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84108594|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108595|NCT04717700|Dexamethasone|dexamethasone|mesh-list
84108596|NCT04717700|Lenalidomide|lenalidomide|mesh-list
84108597|NCT04717700|Bortezomib|bortezomib|mesh-list
84108598|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108599|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
84108600|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
84108601|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108602|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108603|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108604|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
84108605|NCT04717700|Hormones|hormones|mesh-ancestor
84108606|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108607|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84108608|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108609|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
84108610|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84108611|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84108612|NCT04717700|Growth Substances|growth substances|mesh-ancestor
83348689|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108613|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
84108614|NCT02630277|Aflibercept|aflibercept|mesh-list
84108615|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84108616|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84108617|NCT02630277|Growth Substances|growth substances|mesh-ancestor
84108618|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108619|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
84108620|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108621|NCT00668499|Pemetrexed|pemetrexed|mesh-list
84108622|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108623|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108624|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108625|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84108626|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84108627|NCT05201846|Insulin|insulin|mesh-list
84108628|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84108629|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84108630|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108631|NCT00668967|Verapamil|verapamil|mesh-list
84108632|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84108633|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84108634|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108635|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108636|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84108637|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108638|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108639|NCT03583658|Ambroxol|ambroxol|mesh-list
84108640|NCT03583658|Expectorants|expectorants|mesh-ancestor
84108641|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
84108642|NCT03555968|Dronabinol|dronabinol|mesh-list
84108643|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
84108644|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108645|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84108646|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84108647|NCT03555968|Analgesics|analgesics|mesh-ancestor
84108648|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
84108649|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108650|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84108651|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84108652|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108653|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108654|NCT03555968|Hormones|hormones|mesh-ancestor
84108655|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108656|NCT04593680|Tenofovir|tenofovir|mesh-list
84108657|NCT04593680|Emtricitabine|emtricitabine|mesh-list
84108658|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
84108659|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108660|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84108661|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84108662|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108663|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108664|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84108665|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84108666|NCT00669435|Losartan|losartan|mesh-list
84108667|NCT00669435|Amlodipine|amlodipine|mesh-list
84108668|NCT00669435|Simvastatin|simvastatin|mesh-list
84108669|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84108670|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84108671|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108672|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108673|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84108674|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108675|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108676|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84108677|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84108678|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
83348762|NCT05171062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348763|NCT05161637|Bupivacaine|bupivacaine|mesh-list
83348764|NCT05161637|Ropivacaine|ropivacaine|mesh-list
83348765|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
83348766|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
83348767|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348768|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348769|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
83348770|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108679|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84108680|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84108681|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108682|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84108683|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84108684|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84108685|NCT00669591|Bavituximab|bavituximab|mesh-list
84108686|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108687|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108688|NCT00669747|Carboplatin|carboplatin|mesh-list
84108689|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108690|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84108691|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84108692|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84108693|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
84108694|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108695|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84108696|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
84108697|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84108698|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108699|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84108700|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84108701|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108702|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108703|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108704|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84108705|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84108706|NCT00670293|Raclopride|raclopride|mesh-list
84108707|NCT00670293|Methylphenidate|methylphenidate|mesh-list
84108708|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84108709|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108710|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84108711|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84108712|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108713|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108714|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
84108715|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108716|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84108717|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84108718|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108719|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84108720|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84108721|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
84108722|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84108723|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108724|NCT00670761|Misoprostol|misoprostol|mesh-list
84108725|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84108726|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
84108727|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84108728|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108729|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84108730|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108731|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
84108732|NCT00680433|Ketamine|ketamine|mesh-list
84108733|NCT00680433|Analgesics|analgesics|mesh-ancestor
84108734|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
84108735|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108736|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108737|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84108738|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84108739|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
84108740|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
84108741|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108742|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84108743|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84108744|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108745|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108746|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
84108747|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84108748|NCT03322280|Estrogens|estrogens|mesh-ancestor
84108749|NCT03322280|Hormones|hormones|mesh-ancestor
84108750|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348839|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
84108751|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108752|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84108753|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108754|NCT04150965|Thalidomide|thalidomide|mesh-list
84108755|NCT04150965|Dexamethasone|dexamethasone|mesh-list
84108756|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
84108757|NCT04150965|Pomalidomide|pomalidomide|mesh-list
84108758|NCT04150965|Elotuzumab|elotuzumab|mesh-list
84108759|NCT04150965|Relatlimab|relatlimab|mesh-list
84108760|NCT04150965|BB 1101|bb 1101|mesh-list
84108761|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108762|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
84108763|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
84108764|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108765|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108766|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108767|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
84108768|NCT04150965|Hormones|hormones|mesh-ancestor
84108769|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108770|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84108771|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108772|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
84108773|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108774|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108775|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
84108776|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84108777|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84108778|NCT04150965|Growth Substances|growth substances|mesh-ancestor
84108779|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
84108780|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108781|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
84108782|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84108783|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108784|NCT04150965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108785|NCT04150965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84108786|NCT04150575|Paclitaxel|paclitaxel|mesh-list
84108787|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84108788|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84108789|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108790|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108791|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108792|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108793|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108794|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
84108795|NCT05345132|Nifedipine|nifedipine|mesh-list
84108796|NCT05345132|Analgesics|analgesics|mesh-ancestor
84108797|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
84108798|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108799|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108800|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
84108801|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108802|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84108803|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
84108804|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84108805|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108806|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108807|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84108808|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
84108809|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84108810|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108811|NCT04349306|Rasburicase|rasburicase|mesh-list
84108812|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
84108813|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84108814|NCT00614588|Anesthetics|anesthetics|mesh-list
84108815|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108816|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108817|NCT03421652|Nivolumab|nivolumab|mesh-list
84108818|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108819|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108820|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84108821|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108822|NCT02699840|Vaccines|vaccines|mesh-list
84108823|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
84108824|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108825|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
83348943|NCT04775680|Antibodies|antibodies|mesh-list
84108827|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
84108828|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108829|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108830|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84108831|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
84108832|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84108833|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
84108834|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108835|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108836|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84108837|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108838|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
84108839|NCT00613808|Protective Agents|protective agents|mesh-ancestor
84108840|NCT05344742|Paclitaxel|paclitaxel|mesh-list
84108841|NCT05344742|Capecitabine|capecitabine|mesh-list
84108842|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
84108843|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84108844|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108845|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
84108846|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
84108847|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
84108848|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108849|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84108850|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
84108851|NCT05344742|Analgesics|analgesics|mesh-ancestor
84108852|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
84108853|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108854|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108855|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84108856|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84108857|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108858|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
84108859|NCT02046434|Glycerol|glycerol|mesh-list
84108860|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84108861|NCT02046434|Protective Agents|protective agents|mesh-ancestor
84108862|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108863|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108864|NCT03930446|Ethanol|ethanol|mesh-list
84108865|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84108866|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108867|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108868|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108869|NCT00614666|Nikkomycin|nikkomycin|mesh-list
84108870|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
84108871|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84108872|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108873|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108874|NCT03794336|Aspirin|aspirin|mesh-list
84108875|NCT03794336|Metformin|metformin|mesh-list
84108876|NCT03794336|Alogliptin|alogliptin|mesh-list
84108877|NCT03794336|Acarbose|acarbose|mesh-list
84108878|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84108879|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108880|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84108881|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84108882|NCT03794336|Analgesics|analgesics|mesh-ancestor
84108883|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
84108884|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108885|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84108886|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84108887|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84108888|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84108889|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108890|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84108891|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84108892|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108893|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
84108894|NCT03794336|Incretins|incretins|mesh-ancestor
84108895|NCT03794336|Hormones|hormones|mesh-ancestor
84108896|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84108897|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84108898|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
84108899|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84108900|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
84108901|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108902|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108903|NCT03687554|Venglustat|venglustat|mesh-list
84108904|NCT03687554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108905|NCT03687554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108906|NCT03681158|Valproic Acid|valproic acid|mesh-list
84108907|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
84108908|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108909|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108910|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
84108911|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108912|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108913|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
84108914|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84108915|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108916|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84108917|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
84108918|NCT05343806|Nifedipine|nifedipine|mesh-list
84108919|NCT05343806|Analgesics|analgesics|mesh-ancestor
84108920|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
84108921|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108922|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108923|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
84108924|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108925|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84108926|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
84108927|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84108928|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84108929|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108930|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84108931|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
84108932|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84108933|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
84108934|NCT05343728|Hemostatics|hemostatics|mesh-list
84108935|NCT05343728|Coagulants|coagulants|mesh-ancestor
84108936|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
84108937|NCT00436748|Hematinics|hematinics|mesh-ancestor
84108938|NCT02704598|Warfarin|warfarin|mesh-list
84108939|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
84108940|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
84108941|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84108942|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
84108943|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84108944|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
84108945|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108946|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108947|NCT03342404|Luspatercept|luspatercept|mesh-list
84108948|NCT03342404|Hematinics|hematinics|mesh-ancestor
84108949|NCT03094052|Trastuzumab|trastuzumab|mesh-list
84108950|NCT03094052|Atropine|atropine|mesh-list
84108951|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
84108952|NCT03094052|Loperamide|loperamide|mesh-list
84108953|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
84108954|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
84108955|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84108956|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108957|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84108958|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84108959|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84108960|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
84108961|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84108962|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108963|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84108964|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
84108965|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
84108966|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
84108967|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84108968|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84108969|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
84108970|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84108971|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108972|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84108973|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84108974|NCT03094052|Narcotics|narcotics|mesh-ancestor
84108975|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84108976|NCT03094052|Analgesics|analgesics|mesh-ancestor
84108977|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
84108978|NCT05343338|Sivelestat|sivelestat|mesh-list
84108979|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84108980|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
84108981|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84108982|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108983|NCT02704520|Leucovorin|leucovorin|mesh-list
84108984|NCT02704520|Folic Acid|folic acid|mesh-list
84108985|NCT02704520|Fluorouracil|fluorouracil|mesh-list
84108986|NCT02704520|Capecitabine|capecitabine|mesh-list
84108987|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
84108988|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
84108989|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84108990|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
84108991|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84108992|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84108993|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84108994|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84108995|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
84108996|NCT02704520|Antidotes|antidotes|mesh-ancestor
84108997|NCT02704520|Protective Agents|protective agents|mesh-ancestor
84108998|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
84108999|NCT02704520|Vitamins|vitamins|mesh-ancestor
84109000|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
84109001|NCT02704520|Hematinics|hematinics|mesh-ancestor
84109002|NCT02704052|Enoxaparin|enoxaparin|mesh-list
84109003|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
84109004|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
84109005|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84109006|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84109007|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109008|NCT02703896|Esomeprazole|esomeprazole|mesh-list
84109009|NCT02703896|Omeprazole|omeprazole|mesh-list
84109010|NCT02703896|Pantoprazole|pantoprazole|mesh-list
84109011|NCT02703896|Lansoprazole|lansoprazole|mesh-list
84109012|NCT02703896|Famotidine|famotidine|mesh-list
84109013|NCT02703896|Ranitidine|ranitidine|mesh-list
84109014|NCT02703896|Cimetidine|cimetidine|mesh-list
84109015|NCT02703896|Nizatidine|nizatidine|mesh-list
84109016|NCT02703896|Lafutidine|lafutidine|mesh-list
84109017|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84109018|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109019|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84109020|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109021|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109022|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84109023|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
84109024|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
84109025|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109026|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109027|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84109028|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84109029|NCT02737436|Oxytocin|oxytocin|mesh-list
84109030|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
84109031|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84109032|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109033|NCT03552692|Venetoclax|venetoclax|mesh-list
84109034|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109035|NCT00614978|Temozolomide|temozolomide|mesh-list
84109036|NCT00614978|Lapatinib|lapatinib|mesh-list
84109037|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84109038|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
84109039|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109040|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109041|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84109042|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109043|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84109044|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84109045|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109046|NCT02703740|Lidocaine|lidocaine|mesh-list
84109047|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
84109048|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
84109049|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
84109050|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109051|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109052|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
84109053|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109054|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84109055|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84109056|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84109057|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109058|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109059|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84109060|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
84109061|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
84109062|NCT02703740|Protective Agents|protective agents|mesh-ancestor
84109063|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
84109064|NCT00615368|Hematinics|hematinics|mesh-ancestor
84109065|NCT00615446|Gemcitabine|gemcitabine|mesh-list
84109066|NCT00615446|Sunitinib|sunitinib|mesh-list
84109067|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84109068|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
84109069|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429760|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
84109070|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109071|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84109072|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84109073|NCT00615446|Growth Substances|growth substances|mesh-ancestor
84109074|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109075|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
84109076|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84109077|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109078|NCT02703272|Dexamethasone|dexamethasone|mesh-list
84109079|NCT02703272|Rituximab|rituximab|mesh-list
84109080|NCT02703272|Carboplatin|carboplatin|mesh-list
84109081|NCT02703272|Etoposide|etoposide|mesh-list
84109082|NCT02703272|Vincristine|vincristine|mesh-list
84109083|NCT02703272|Ifosfamide|ifosfamide|mesh-list
84109084|NCT02703272|Idarubicin|idarubicin|mesh-list
84109085|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84109086|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109087|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
84109088|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109089|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109090|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109091|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
84109092|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
84109093|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109094|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109095|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
84109096|NCT02703272|Hormones|hormones|mesh-ancestor
84109097|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109098|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84109099|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84109100|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84109101|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84109102|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109103|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109104|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
84109105|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
84109106|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
84109107|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84109108|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
84109109|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84109110|NCT02703194|Prednisone|prednisone|mesh-list
84109111|NCT02703194|Prednisolone|prednisolone|mesh-list
84109112|NCT02703194|Leflunomide|leflunomide|mesh-list
84109113|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109114|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
84109115|NCT02703194|Hormones|hormones|mesh-ancestor
84109116|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109117|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109118|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84109119|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109120|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109121|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109122|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109123|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
84109124|NCT02402660|Vitamin A|vitamin a|mesh-list
84109125|NCT02402660|Retinol acetate|retinol acetate|mesh-list
84109126|NCT02402660|Vitamins|vitamins|mesh-ancestor
84109127|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
84109128|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109129|NCT02402660|Protective Agents|protective agents|mesh-ancestor
83349209|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
84109130|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84109131|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109132|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84109133|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
84109134|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
84109135|NCT02702960|Prednisone|prednisone|mesh-list
84109136|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
84109137|NCT02702960|Fludarabine|fludarabine|mesh-list
84109138|NCT02702960|Tacrolimus|tacrolimus|mesh-list
84109139|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84109140|NCT02702960|Mesna|mesna|mesh-list
84109141|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109142|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
84109143|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109144|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109145|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84109146|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
84109147|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109148|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109149|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84109150|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109151|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
84109152|NCT02702960|Hormones|hormones|mesh-ancestor
84109153|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109154|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84109155|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84109156|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109157|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84109158|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84109159|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
84109160|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84109161|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109162|NCT02702960|Protective Agents|protective agents|mesh-ancestor
84109163|NCT02699528|Methylphenidate|methylphenidate|mesh-list
84109164|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84109165|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109166|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84109167|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84109168|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109169|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109170|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
84109171|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109172|NCT04215770|Penicillins|penicillins|mesh-list
84109173|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84109174|NCT04215770|Penicillin G|penicillin g|mesh-list
84109175|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
84109176|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
84109177|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84109178|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109179|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84109180|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109181|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109182|NCT02702882|Fenugreek seed meal|fenugreek seed meal|mesh-list
84109183|NCT02702882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109184|NCT02702882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109185|NCT02699138|Trazodone|trazodone|mesh-list
84109186|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84109187|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84109188|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109189|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109190|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84109191|NCT02699138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84109192|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84109193|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109194|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109195|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109196|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
84109197|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84109198|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
84109199|NCT04215536|Empagliflozin|empagliflozin|mesh-list
84109200|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
84109201|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84109202|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109203|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109204|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109205|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
84109206|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109207|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
84109208|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84109209|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84109210|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109211|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84109212|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84109213|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
84109214|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109215|NCT01831076|Tamoxifen|tamoxifen|mesh-list
84109216|NCT01831076|Exemestane|exemestane|mesh-list
84109217|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84109218|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
84109219|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109220|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109221|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84109222|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109223|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84109224|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84109225|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84109226|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84109227|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84109228|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109229|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109230|NCT02698982|Anesthetics|anesthetics|mesh-list
84109231|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109232|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109233|NCT00615524|Exemestane|exemestane|mesh-list
84109234|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109235|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84109236|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84109237|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109238|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109239|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84109240|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
84109241|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109242|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109243|NCT00908141|Sargramostim|sargramostim|mesh-list
84109244|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
84109245|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109246|NCT01246310|Inositol|inositol|mesh-list
84109247|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
84109248|NCT01246310|Vitamins|vitamins|mesh-ancestor
84109249|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
84109250|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109251|NCT01773707|Abatacept|abatacept|mesh-list
84109252|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84109253|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109254|NCT01773707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84109255|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109256|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109257|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
84109258|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109259|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109260|NCT00700076|Ketamine|ketamine|mesh-list
84109261|NCT00700076|Analgesics|analgesics|mesh-ancestor
84109262|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
84109263|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109264|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109265|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84109266|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84109267|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
84109268|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
84109269|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109270|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84109271|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84109272|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109273|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109274|NCT02698514|Sevoflurane|sevoflurane|mesh-list
84109275|NCT02698514|Desflurane|desflurane|mesh-list
84109276|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84109277|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84109278|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
83349361|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84109279|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
84109280|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109281|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109282|NCT02706158|Vitamin D|vitamin d|mesh-list
84109283|NCT02706158|Calcium|calcium|mesh-list
84109284|NCT02706158|Vitamins|vitamins|mesh-ancestor
84109285|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
84109286|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109287|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84109288|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84109289|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
84109290|NCT03739853|Adalimumab|adalimumab|mesh-list
84109291|NCT03739853|Methotrexate|methotrexate|mesh-list
84109292|NCT03739853|Leflunomide|leflunomide|mesh-list
84109293|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84109294|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
84109295|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84109296|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109297|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84109298|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
84109299|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109300|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109301|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
84109302|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109303|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84109304|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109305|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
84109306|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109307|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84109308|NCT03739853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84109309|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109310|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109311|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84109312|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109313|NCT03739853|Analgesics|analgesics|mesh-ancestor
84109314|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
84109315|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109316|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109317|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
84109318|NCT00615602|Docetaxel|docetaxel|mesh-list
84109319|NCT00615602|Trastuzumab|trastuzumab|mesh-list
84109320|NCT00615602|Epirubicin|epirubicin|mesh-list
84109321|NCT00615602|Fluorouracil|fluorouracil|mesh-list
84109322|NCT00615602|Lenograstim|lenograstim|mesh-list
84109323|NCT00615602|Mitogens|mitogens|mesh-list
84109324|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109325|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
84109326|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109327|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109328|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84109329|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
84109330|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109331|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109332|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84109333|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
84109334|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
84109335|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
84109336|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84109337|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84109338|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84109339|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84109340|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109341|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
84109342|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84109343|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84109344|NCT02698748|Chloroquine|chloroquine|mesh-list
84109345|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
84109346|NCT02698748|Amebicides|amebicides|mesh-ancestor
84109347|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84109348|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84109349|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109350|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
84109351|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109352|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84109353|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109354|NCT02698748|Analgesics|analgesics|mesh-ancestor
84109355|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
84109356|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109357|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109358|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109359|NCT02698748|Filaricides|filaricides|mesh-ancestor
84109360|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
84109361|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
84109362|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84109363|NCT04214990|Aspirin|aspirin|mesh-list
84109364|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84109365|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109366|NCT04214990|Analgesics|analgesics|mesh-ancestor
84109367|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
84109368|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109369|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109370|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109371|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109372|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84109373|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84109374|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109375|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84109376|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84109377|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109378|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
84109379|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
84109380|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
84109381|NCT00615212|Midazolam|midazolam|mesh-list
84109382|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84109383|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84109384|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109385|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109386|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84109387|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84109388|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84109389|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84109390|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
84109391|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
84109392|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
84109393|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
84109394|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109395|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109396|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109397|NCT00615212|Analgesics|analgesics|mesh-ancestor
84109398|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
84109399|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109400|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84109401|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109402|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109403|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109404|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84109405|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109406|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
84109407|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84109408|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
84109409|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
84109410|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109411|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109412|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109413|NCT02701478|Analgesics|analgesics|mesh-ancestor
84109414|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
84109415|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109416|NCT03314363|Trace Elements|trace elements|mesh-list
84109417|NCT03314363|Micronutrients|micronutrients|mesh-list
84109418|NCT03314363|Citric Acid|citric acid|mesh-list
84109419|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
84109420|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109421|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
84109422|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84109423|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
84109424|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
84109425|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109426|NCT00906347|Misoprostol|misoprostol|mesh-list
84109427|NCT00906347|Oxytocin|oxytocin|mesh-list
84109428|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
84109429|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84109430|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109431|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84109432|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
84109434|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109435|NCT02705768|Carbamazepine|carbamazepine|mesh-list
84109436|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
84109437|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
84109438|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
84109439|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84109440|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109441|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109442|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84109443|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109444|NCT02705768|Analgesics|analgesics|mesh-ancestor
84109445|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
84109446|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109447|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84109448|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109449|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109450|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84109451|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84109452|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84109453|NCT00616070|Difluprednate|difluprednate|mesh-list
84109454|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
84109455|NCT00616070|Hormones|hormones|mesh-ancestor
84109456|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109457|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109458|NCT03153527|Prednisone|prednisone|mesh-list
84109459|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109460|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
84109461|NCT03153527|Hormones|hormones|mesh-ancestor
84109462|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109463|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109464|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84109465|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109466|NCT02705534|Ribavirin|ribavirin|mesh-list
84109467|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
84109468|NCT02705534|Ledipasvir|ledipasvir|mesh-list
84109469|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
84109470|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109471|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
84109472|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109473|NCT02701166|Bezafibrate|bezafibrate|mesh-list
84109474|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84109475|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
84109476|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109477|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84109478|NCT03141203|Romidepsin|romidepsin|mesh-list
84109479|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84109480|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109481|NCT03141203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84109482|NCT03141203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109483|NCT03141203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109484|NCT05320991|Ketamine|ketamine|mesh-list
84109485|NCT05320991|Analgesics|analgesics|mesh-ancestor
84109486|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
84109487|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109488|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109489|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84109490|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84109491|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
84109492|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
84109493|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109494|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84109495|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84109496|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109497|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109498|NCT04215614|Lidocaine|lidocaine|mesh-list
84109499|NCT04215614|Bupivacaine|bupivacaine|mesh-list
84109500|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
84109501|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
84109502|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109503|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109504|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
84109505|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109506|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84109507|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84109508|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84109509|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109510|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109511|NCT00906035|Aspirin|aspirin|mesh-list
84109512|NCT00906035|Dipyridamole|dipyridamole|mesh-list
84109513|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84109514|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109515|NCT00906035|Analgesics|analgesics|mesh-ancestor
84109516|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
84109517|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109518|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109519|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109520|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109521|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84109522|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84109523|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109524|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84109525|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84109526|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109527|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
84109528|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84109529|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
84109530|NCT02698280|Bevacizumab|bevacizumab|mesh-list
84109531|NCT02698280|Nimustine|nimustine|mesh-list
84109532|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84109533|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109534|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84109535|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84109536|NCT02698280|Growth Substances|growth substances|mesh-ancestor
84109537|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109538|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
84109539|NCT03087773|Empagliflozin|empagliflozin|mesh-list
84109540|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84109541|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109542|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109543|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109544|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
84109545|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109546|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84109547|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
84109548|NCT05333159|Empagliflozin|empagliflozin|mesh-list
84109549|NCT05333159|Canagliflozin|canagliflozin|mesh-list
84109550|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
84109551|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109552|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109553|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109554|NCT02698124|Decitabine|decitabine|mesh-list
84109555|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84109556|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
84109557|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109558|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109559|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109560|NCT00905489|Nevirapine|nevirapine|mesh-list
84109561|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84109562|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84109563|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109564|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109565|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
84109566|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109567|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84109568|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84109569|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84109570|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84109571|NCT02705378|Naloxegol|naloxegol|mesh-list
84109572|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84109573|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109574|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
84109575|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109576|NCT03059147|Nivolumab|nivolumab|mesh-list
84109577|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84109578|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109579|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84109580|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109581|NCT03356834|Tenofovir|tenofovir|mesh-list
84109582|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
84109583|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109584|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84109585|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84109586|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109587|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109588|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84109589|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84109590|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
84109591|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
84109592|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84109593|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109594|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84109595|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109596|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109597|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84109598|NCT02704754|Suvorexant|suvorexant|mesh-list
84109599|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84109600|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84109601|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109602|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109603|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84109604|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109605|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109606|NCT05182658|Empagliflozin|empagliflozin|mesh-list
84109607|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84109608|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109609|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109610|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109611|NCT04214054|Calcium|calcium|mesh-list
84109612|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84109613|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109614|NCT02909036|Melphalan|melphalan|mesh-list
84109615|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84109616|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
84109617|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109618|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109619|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84109620|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109621|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
84109622|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109623|NCT04213898|Paclitaxel|paclitaxel|mesh-list
84109624|NCT04213898|Epirubicin|epirubicin|mesh-list
84109625|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84109626|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84109627|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109628|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
84109629|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
84109630|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
84109631|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109632|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84109633|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84109634|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84109635|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109636|NCT03170882|Dexamethasone|dexamethasone|mesh-list
84109637|NCT03170882|Pomalidomide|pomalidomide|mesh-list
84109638|NCT03170882|Ixazomib|ixazomib|mesh-list
84109639|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109640|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
84109641|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
84109642|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109643|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109644|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109645|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
84109646|NCT03170882|Hormones|hormones|mesh-ancestor
84109647|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109648|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84109649|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109650|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
84109651|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84109652|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84109653|NCT03170882|Growth Substances|growth substances|mesh-ancestor
84109654|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
84109655|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
84109656|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109657|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109658|NCT00616850|Lidocaine|lidocaine|mesh-list
84109659|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
84109660|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
84109661|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109662|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109663|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
84109664|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109665|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84109666|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84109667|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84109668|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109669|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109670|NCT00618644|Ranibizumab|ranibizumab|mesh-list
84109671|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84109672|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84109673|NCT00618644|Growth Substances|growth substances|mesh-ancestor
84109674|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109675|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
84109676|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109677|NCT05324774|Aflibercept|aflibercept|mesh-list
84109678|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84109679|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84109680|NCT05324774|Growth Substances|growth substances|mesh-ancestor
84109681|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109682|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
84109683|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109684|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
84109685|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84109686|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84109687|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84109688|NCT05324618|Tacrolimus|tacrolimus|mesh-list
84109689|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109690|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
84109691|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109692|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84109693|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109694|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109695|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109696|NCT03654989|Treprostinil|treprostinil|mesh-list
84109697|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84109698|NCT05300594|Vitamins|vitamins|mesh-list
84109699|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
84109700|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109701|NCT00907517|Cytarabine|cytarabine|mesh-list
84109702|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84109703|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
84109704|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109705|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109706|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
84109707|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109708|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109709|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
84109710|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109711|NCT03043547|Leucovorin|leucovorin|mesh-list
84109712|NCT03043547|Antidotes|antidotes|mesh-ancestor
84109713|NCT03043547|Protective Agents|protective agents|mesh-ancestor
84109714|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109715|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
84109716|NCT03043547|Vitamins|vitamins|mesh-ancestor
84109717|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
84109718|NCT00905255|Lixisenatide|lixisenatide|mesh-list
84109719|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109720|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109721|NCT00905021|Sunitinib|sunitinib|mesh-list
84109722|NCT00905021|Exemestane|exemestane|mesh-list
84109723|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109724|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84109725|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84109726|NCT00905021|Growth Substances|growth substances|mesh-ancestor
84109727|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109728|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
84109729|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84109730|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109731|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109732|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84109733|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84109734|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84109735|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
84109736|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109738|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84109739|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109740|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84109741|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109742|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
84109743|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84109744|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84109745|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84109746|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109747|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109748|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
84109749|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109750|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109751|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84109752|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109753|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84109754|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109755|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
84109756|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84109757|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109758|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
84109759|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
84109760|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109761|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109762|NCT00632645|Olanzapine|olanzapine|mesh-list
84109763|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
84109764|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
84109765|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
84109766|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
84109767|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109768|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109769|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109770|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84109771|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84109772|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109773|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84109774|NCT00632645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84109775|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84109776|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109777|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109778|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109779|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
84109780|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84109781|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
84109782|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84109783|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
84109784|NCT02849873|Tazarotene|tazarotene|mesh-list
84109785|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
84109786|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
84109787|NCT02304809|Vemurafenib|vemurafenib|mesh-list
84109788|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109789|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84109790|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109791|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109792|NCT02849483|Ramosetron|ramosetron|mesh-list
84109793|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
84109794|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
84109795|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109796|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109797|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109798|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84109799|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
84109800|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109801|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109802|NCT02432274|Etoposide|etoposide|mesh-list
84109803|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
84109804|NCT02432274|Ifosfamide|ifosfamide|mesh-list
84109805|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
84109806|NCT02432274|Lenvatinib|lenvatinib|mesh-list
84109807|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84109808|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109809|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84109810|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84109811|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109812|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109813|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84109814|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
84109815|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84109816|NCT04500665|Colchicine|colchicine|mesh-list
84109817|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
84109818|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109819|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
84109820|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
84109821|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
84109822|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109823|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109824|NCT05116007|Carboplatin|carboplatin|mesh-list
84109825|NCT05116007|Etoposide|etoposide|mesh-list
84109826|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109827|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84109828|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84109829|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84109830|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109831|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109832|NCT02849327|Immunomodulating Agents|immunomodulating agents|mesh-list
84109833|NCT02849327|Immunologic Factors|immunologic factors|mesh-ancestor
84109834|NCT02849327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109835|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84109836|NCT00618696|Antibodies|antibodies|mesh-list
84109837|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
84109838|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84109839|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
84109840|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109841|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109842|NCT00618852|Furosemide|furosemide|mesh-list
84109843|NCT00618852|Diuretics|diuretics|mesh-ancestor
84109844|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
84109845|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109846|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84109847|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109848|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109849|NCT02073474|Nabiximols|nabiximols|mesh-list
84109850|NCT02073474|Analgesics|analgesics|mesh-ancestor
84109851|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
84109852|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109853|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109854|NCT00637104|Chromium|chromium|mesh-list
84109855|NCT00637104|Trace Elements|trace elements|mesh-ancestor
84109856|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
84109857|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109858|NCT00617760|Vaccines|vaccines|mesh-list
84109859|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84109860|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
84109861|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109862|NCT00620490|Ropivacaine|ropivacaine|mesh-list
84109863|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
84109864|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
84109865|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84109866|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109867|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
84109868|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109869|NCT04212078|Levofloxacin|levofloxacin|mesh-list
84109870|NCT04212078|Cefuroxime|cefuroxime|mesh-list
84109871|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
84109872|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84109873|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109874|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84109875|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84109876|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84109877|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109878|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109879|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109880|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84109881|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84109882|NCT01898520|Nabiximols|nabiximols|mesh-list
84109883|NCT01898520|Analgesics|analgesics|mesh-ancestor
84109884|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
84109885|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109886|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109888|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
84109889|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84109890|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
84109891|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109892|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84109893|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
84109894|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
84109895|NCT00903617|Vitamins|vitamins|mesh-ancestor
84109896|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
84109897|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109898|NCT02848937|Citric Acid|citric acid|mesh-list
84109899|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
84109900|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
84109901|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84109902|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
84109903|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
84109904|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109905|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84109906|NCT00343824|Laxatives|laxatives|mesh-ancestor
84109907|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84109908|NCT02849015|Immunomodulating Agents|immunomodulating agents|mesh-list
84109909|NCT02849015|Immunologic Factors|immunologic factors|mesh-ancestor
84109910|NCT02849015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109911|NCT01428089|Progesterone|progesterone|mesh-list
84109912|NCT01428089|Progestins|progestins|mesh-ancestor
84109913|NCT01428089|Hormones|hormones|mesh-ancestor
84109914|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109915|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109916|NCT04212000|Ketoconazole|ketoconazole|mesh-list
84109917|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
84109918|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84109919|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84109920|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84109921|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109922|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109923|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84109924|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
84109925|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84109926|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109927|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84109928|NCT00619398|Tacrolimus|tacrolimus|mesh-list
84109929|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84109930|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
84109931|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109932|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84109933|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109934|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109935|NCT00620646|Aspirin|aspirin|mesh-list
84109936|NCT00620646|Cilostazol|cilostazol|mesh-list
84109937|NCT00620646|Clopidogrel|clopidogrel|mesh-list
84109938|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84109939|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84109940|NCT00620646|Analgesics|analgesics|mesh-ancestor
84109941|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
84109942|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109943|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109944|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84109945|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84109946|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84109947|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84109948|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109949|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84109950|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84109951|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109952|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
84109953|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84109954|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84109955|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84109956|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
84109957|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109958|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84109959|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
84109960|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84109961|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
84109962|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
84109963|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84109964|NCT00620646|Protective Agents|protective agents|mesh-ancestor
84109965|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84109966|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84109967|NCT00810017|Trastuzumab|trastuzumab|mesh-list
84109968|NCT00810017|Etoposide|etoposide|mesh-list
84109969|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84109970|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84109971|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84109972|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84109973|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84109974|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109975|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109976|NCT00620724|Nifedipine|nifedipine|mesh-list
84109977|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84109978|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84109979|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109980|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84109981|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109982|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
84109983|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
84109984|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84109985|NCT04209426|Tacrine|tacrine|mesh-list
84109986|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84109987|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84109988|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84109989|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
84109990|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84109991|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84109992|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84109993|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
84109994|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84109995|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
84109996|NCT00620802|Clopidogrel|clopidogrel|mesh-list
84109997|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84109998|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84109999|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84110000|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84110001|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
84110002|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110003|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110004|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110005|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
84110006|NCT02848157|Ropivacaine|ropivacaine|mesh-list
84110007|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84110008|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110009|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110010|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110011|NCT02848157|Analgesics|analgesics|mesh-ancestor
84110012|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
84110013|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110014|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84110015|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84110016|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84110017|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
84110018|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110019|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110020|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
84110021|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
83350119|NCT02278965|Metformin|metformin|mesh-list
84110022|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
84110023|NCT04211844|Ledipasvir|ledipasvir|mesh-list
84110024|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
84110025|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110026|NCT00619710|Meropenem|meropenem|mesh-list
84110027|NCT00619710|Imipenem|imipenem|mesh-list
84110028|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
84110029|NCT00619710|Cilastatin|cilastatin|mesh-list
84110030|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110031|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110032|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
84110033|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110034|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110035|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
84110036|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110037|NCT04019015|Thrombin|thrombin|mesh-list
84110038|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
84110039|NCT04019015|Coagulants|coagulants|mesh-ancestor
84110040|NCT02846909|Progesterone|progesterone|mesh-list
84110041|NCT02846909|Progestins|progestins|mesh-ancestor
84110042|NCT02846909|Hormones|hormones|mesh-ancestor
84110043|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110044|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110045|NCT00632723|Gefitinib|gefitinib|mesh-list
84110046|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110047|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84110048|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110049|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110050|NCT02847143|Oxytocin|oxytocin|mesh-list
84110051|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
84110052|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84110053|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110054|NCT02847455|Rabeprazole|rabeprazole|mesh-list
84110055|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84110056|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84110057|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84110058|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110059|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110060|NCT03897335|Aminophylline|aminophylline|mesh-list
84110061|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84110062|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
84110063|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110064|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110065|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84110066|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
84110067|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84110068|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84110069|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110070|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110071|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84110072|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84110073|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
84110074|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110075|NCT03897335|Protective Agents|protective agents|mesh-ancestor
84110076|NCT01617096|Dapivirine|dapivirine|mesh-list
84110077|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84110078|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84110079|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
84110080|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110081|NCT00619944|Ritonavir|ritonavir|mesh-list
84110082|NCT00619944|Lopinavir|lopinavir|mesh-list
84110083|NCT00619944|Lumefantrine|lumefantrine|mesh-list
84110084|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84110085|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84110086|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84110087|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
84110088|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110089|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110090|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84110091|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84110092|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
84110093|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110094|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84110095|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84110096|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
84110097|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84110098|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84110099|NCT00621036|Methotrexate|methotrexate|mesh-list
84110101|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
84110102|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84110103|NCT00621036|Antibodies|antibodies|mesh-list
84110104|NCT00621036|Sargramostim|sargramostim|mesh-list
84110105|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
84110106|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84110107|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
84110108|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84110109|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110110|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84110111|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
84110112|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110113|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110114|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
84110115|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110116|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84110117|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84110118|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
84110119|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110120|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84110121|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84110122|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
84110123|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84110124|NCT02846831|Insulin|insulin|mesh-list
84110125|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84110126|NCT02846831|Hormones|hormones|mesh-list
84110127|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84110128|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110129|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110130|NCT01497509|Epinephrine|epinephrine|mesh-list
84110131|NCT01497509|Racepinephrine|racepinephrine|mesh-list
84110132|NCT01497509|Fentanyl|fentanyl|mesh-list
84110133|NCT01497509|Bupivacaine|bupivacaine|mesh-list
84110134|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
84110135|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
84110136|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
84110137|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110138|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110139|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
84110140|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110141|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84110142|NCT01497509|Narcotics|narcotics|mesh-ancestor
84110143|NCT01497509|Analgesics|analgesics|mesh-ancestor
84110144|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84110145|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84110146|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
84110147|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84110148|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84110149|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
84110150|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110151|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110152|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84110153|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84110154|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
84110155|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84110156|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
84110157|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
84110158|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
84110159|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84110160|NCT02844881|Apatinib|apatinib|mesh-list
84110161|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110162|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84110163|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110164|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110165|NCT02846519|Rifampin|rifampin|mesh-list
84110166|NCT02846519|Esketamine|esketamine|mesh-list
84110167|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84110168|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
84110169|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110170|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110171|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
84110172|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84110173|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110174|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110175|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84110177|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84110178|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84110179|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84110180|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84110181|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
84110182|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84110183|NCT00618228|Balsalazide|balsalazide|mesh-list
84110184|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110185|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110186|NCT00618228|Analgesics|analgesics|mesh-ancestor
84110187|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
84110188|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110189|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110190|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110191|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110192|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84110193|NCT03711305|Carboplatin|carboplatin|mesh-list
84110194|NCT03711305|Etoposide|etoposide|mesh-list
84110195|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110196|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84110197|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84110198|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84110199|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110200|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110201|NCT00618384|Sorafenib|sorafenib|mesh-list
84110202|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110203|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84110204|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110205|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110206|NCT03608657|Apremilast|apremilast|mesh-list
84110207|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110208|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110209|NCT03608657|Analgesics|analgesics|mesh-ancestor
84110210|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
84110211|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110212|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110213|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110214|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110215|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84110216|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84110217|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110218|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110219|NCT05000658|Dexamethasone|dexamethasone|mesh-list
84110220|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84110221|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110222|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
84110223|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
84110224|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110225|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110226|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84110227|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
84110228|NCT05000658|Hormones|hormones|mesh-ancestor
84110229|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110230|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84110231|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110232|NCT02844803|Metformin|metformin|mesh-list
84110233|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84110234|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110235|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
84110236|NCT04211298|Propofol|propofol|mesh-list
84110237|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84110238|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110239|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110240|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110241|NCT04211298|Analgesics|analgesics|mesh-ancestor
84110242|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
84110243|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110244|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84110245|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84110246|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84110247|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
84110248|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110249|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110250|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84110251|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
84110252|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
84110253|NCT04212702|Everolimus|everolimus|mesh-list
84110254|NCT04212702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84110255|NCT04212702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84110256|NCT04212702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110257|NCT04212702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110258|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84110259|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
84110260|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110261|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110262|NCT02691780|Sorafenib|sorafenib|mesh-list
84110263|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110264|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84110265|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110266|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110267|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
84110268|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84110269|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110270|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110271|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110272|NCT02845661|Analgesics|analgesics|mesh-ancestor
84110273|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
84110274|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110275|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84110276|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84110277|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84110278|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
84110279|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110280|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110281|NCT02844335|Immunomodulating Agents|immunomodulating agents|mesh-list
84110282|NCT02844335|Immunologic Factors|immunologic factors|mesh-ancestor
84110283|NCT02844335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110284|NCT00880074|Alovudine|alovudine|mesh-list
84110285|NCT00880074|Antiviral Agents|antiviral agents|mesh-ancestor
84110286|NCT00880074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110287|NCT04375787|Atorvastatin|atorvastatin|mesh-list
84110288|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84110289|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84110290|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
84110291|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110292|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84110293|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84110294|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110295|NCT00825630|Esomeprazole|esomeprazole|mesh-list
84110296|NCT00825630|Pantoprazole|pantoprazole|mesh-list
84110297|NCT00825630|Lansoprazole|lansoprazole|mesh-list
84110298|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
84110299|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84110300|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84110301|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84110302|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110303|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110304|NCT00620100|Docetaxel|docetaxel|mesh-list
84110305|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110306|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
84110307|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
84110308|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
84110309|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110310|NCT02845349|Vortioxetine|vortioxetine|mesh-list
84110311|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
84110312|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84110313|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84110314|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84110315|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110316|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110317|NCT02845349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84110318|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84110319|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84110320|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110321|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110322|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
84110323|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84110324|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84110325|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84110326|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84110327|NCT03852251|Capecitabine|capecitabine|mesh-list
84110328|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
84110329|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84110330|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
84110331|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110332|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110333|NCT00620178|Losartan|losartan|mesh-list
84110334|NCT00620178|Candesartan|candesartan|mesh-list
84110335|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
84110336|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84110337|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83429829|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84110338|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84110339|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84110340|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110341|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
84110342|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84110343|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84110344|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110345|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
84110346|NCT04349982|Coagulants|coagulants|mesh-ancestor
84110347|NCT04315350|Prednisolone|prednisolone|mesh-list
84110348|NCT04315350|Curcumin|curcumin|mesh-list
84110349|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110350|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
84110351|NCT04315350|Hormones|hormones|mesh-ancestor
84110352|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110353|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110354|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84110355|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110356|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110357|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110358|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110359|NCT04315350|Analgesics|analgesics|mesh-ancestor
84110360|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
84110361|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110362|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110363|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110364|NCT04288206|Cefazolin|cefazolin|mesh-list
84110365|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110366|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110367|NCT04958772|Lenograstim|lenograstim|mesh-list
84110368|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84110369|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
84110370|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110371|NCT02771249|Pyridoxine|pyridoxine|mesh-list
84110372|NCT02771249|Isoniazid|isoniazid|mesh-list
84110373|NCT02771249|Darunavir|darunavir|mesh-list
84110374|NCT02771249|Cobicistat|cobicistat|mesh-list
84110375|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
84110376|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
84110377|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110378|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110379|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84110380|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84110381|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
84110382|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110383|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84110384|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84110385|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84110386|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
84110387|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110388|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84110389|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84110390|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
84110391|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84110392|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84110393|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
84110394|NCT02771249|Vitamins|vitamins|mesh-ancestor
84110395|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
84110396|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110397|NCT04208958|Vancomycin|vancomycin|mesh-list
84110398|NCT04208958|Nivolumab|nivolumab|mesh-list
84110399|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84110400|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110401|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84110402|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110403|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110404|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110405|NCT04048278|Lidocaine|lidocaine|mesh-list
84110406|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
84110407|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
84110408|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110409|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110410|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
84110411|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110412|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84110413|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84110414|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84110415|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84110416|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110417|NCT02697318|Timolol|timolol|mesh-list
84110418|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84110419|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84110420|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110421|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84110422|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84110423|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
84110424|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110425|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110426|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84110427|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84110428|NCT05242133|Interferons|interferons|mesh-list
84110429|NCT05242133|Interferon-beta|interferon-beta|mesh-list
84110430|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
84110431|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110432|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
84110433|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110434|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
84110435|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110436|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84110437|NCT00621816|Nitroprusside|nitroprusside|mesh-list
84110438|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84110439|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
84110440|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84110441|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110442|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
84110443|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110444|NCT04186026|Glucagon|glucagon|mesh-list
84110445|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84110446|NCT04186026|Incretins|incretins|mesh-ancestor
84110447|NCT04186026|Hormones|hormones|mesh-ancestor
84110448|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110449|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110450|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84110451|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
84110452|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84110453|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
84110454|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110455|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110456|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84110457|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
84110458|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
84110459|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84110460|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
84110461|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110462|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110463|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84110464|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110465|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
84110466|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84110467|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110468|NCT00650819|Simvastatin|simvastatin|mesh-list
84110469|NCT00650819|Ezetimibe|ezetimibe|mesh-list
84110470|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84110471|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84110472|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
84110473|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110474|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84110475|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84110477|NCT05662410|Aflibercept|aflibercept|mesh-list
84110478|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84110479|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84110480|NCT05662410|Growth Substances|growth substances|mesh-ancestor
84110481|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110482|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
84110483|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110484|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84110485|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84110486|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110487|NCT02689362|Incretins|incretins|mesh-ancestor
84110488|NCT02689362|Hormones|hormones|mesh-ancestor
84110489|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110490|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84110491|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
84110492|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110493|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110494|NCT02687256|Heparin|heparin|mesh-list
84110495|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
84110496|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84110497|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84110498|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110499|NCT00622206|Ritonavir|ritonavir|mesh-list
84110500|NCT00622206|Saquinavir|saquinavir|mesh-list
84110501|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84110502|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84110503|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
84110504|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110505|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110506|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84110507|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84110508|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
84110509|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110510|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84110511|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84110512|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
84110513|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84110514|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84110515|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110516|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
84110517|NCT03582293|Coagulants|coagulants|mesh-ancestor
84110518|NCT03574337|Neostigmine|neostigmine|mesh-list
84110519|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84110520|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110521|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110522|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
84110523|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110524|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110525|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84110526|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
84110527|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110528|NCT02689596|Oxytocin|oxytocin|mesh-list
84110529|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
84110530|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84110531|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110532|NCT04574856|Temozolomide|temozolomide|mesh-list
84110533|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84110534|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
84110535|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110536|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110537|NCT00423995|Loratadine|loratadine|mesh-list
84110538|NCT00423995|Montelukast|montelukast|mesh-list
84110539|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84110540|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
84110541|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84110542|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
84110543|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110544|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110545|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84110546|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84110547|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429849|NCT05632328|Paclitaxel|paclitaxel|mesh-list
84110548|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
84110549|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
84110550|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84110551|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84110552|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84110553|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
84110554|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
84110555|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110557|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110558|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110559|NCT00380627|Analgesics|analgesics|mesh-ancestor
84110560|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
84110561|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110562|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110563|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110564|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110565|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84110566|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84110567|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110568|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110569|NCT00212771|Olanzapine|olanzapine|mesh-list
84110570|NCT00212771|Asenapine|asenapine|mesh-list
84110571|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
84110572|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
84110573|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110574|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110575|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84110576|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84110577|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84110578|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110579|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84110580|NCT00212771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84110581|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84110582|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84110583|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110584|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110585|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
84110586|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84110587|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84110588|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84110589|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110590|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110591|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
84110592|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110593|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84110594|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84110595|NCT03829722|Paclitaxel|paclitaxel|mesh-list
84110596|NCT03829722|Carboplatin|carboplatin|mesh-list
84110597|NCT03829722|Nivolumab|nivolumab|mesh-list
84110598|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84110599|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110600|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
84110601|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
84110602|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
84110603|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110604|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84110605|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84110606|NCT03822312|Tobramycin|tobramycin|mesh-list
84110607|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110608|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110609|NCT02687178|Canrenone|canrenone|mesh-list
84110610|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84110611|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
84110612|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110613|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110614|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84110615|NCT02687178|Diuretics|diuretics|mesh-ancestor
84110616|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
84110617|NCT03711318|Buprenorphine|buprenorphine|mesh-list
83350725|NCT01724021|Hormones|hormones|mesh-ancestor
84110618|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84110620|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84110621|NCT03711318|Narcotics|narcotics|mesh-ancestor
84110622|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110623|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110624|NCT03711318|Analgesics|analgesics|mesh-ancestor
84110625|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
84110626|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110627|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84110628|NCT03535116|Ketorolac|ketorolac|mesh-list
84110629|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110630|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110631|NCT03535116|Analgesics|analgesics|mesh-ancestor
84110632|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
84110633|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110634|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110635|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110636|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110637|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84110638|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110639|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110640|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
84110641|NCT03704298|Fludarabine|fludarabine|mesh-list
84110642|NCT03704298|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
84110643|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84110644|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
84110645|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110646|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110647|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84110648|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
84110649|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110650|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110651|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84110652|NCT03704298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84110653|NCT02687100|Beclomethasone|beclomethasone|mesh-list
84110654|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110655|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
84110656|NCT02687100|Hormones|hormones|mesh-ancestor
84110657|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110658|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110659|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84110660|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
84110661|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
84110662|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110663|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
84110664|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110665|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110666|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84110667|NCT02153645|Amantadine|amantadine|mesh-list
84110668|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84110669|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84110670|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
84110671|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110672|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
84110673|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110674|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110675|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110676|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110677|NCT02153645|Analgesics|analgesics|mesh-ancestor
84110678|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
84110679|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110680|NCT02688738|Doxycycline|doxycycline|mesh-list
84110681|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110682|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110683|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
84110684|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84110685|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84110686|NCT00639366|Trastuzumab|trastuzumab|mesh-list
84110687|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84110688|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110689|NCT02686788|Tarenflurbil|tarenflurbil|mesh-list
84110690|NCT02686788|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84110691|NCT02686788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110692|NCT02686788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110694|NCT02686710|Sevoflurane|sevoflurane|mesh-list
84110695|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84110696|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110697|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110698|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84110699|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
84110700|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
84110701|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84110702|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84110703|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84110704|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
84110705|NCT01773083|Heparin|heparin|mesh-list
84110706|NCT01773083|Calcium heparin|calcium heparin|mesh-list
84110707|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
84110708|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84110709|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84110710|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110711|NCT02354898|Sorafenib|sorafenib|mesh-list
84110712|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110713|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84110714|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110715|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110716|NCT00110435|Atorvastatin|atorvastatin|mesh-list
84110717|NCT00110435|Simvastatin|simvastatin|mesh-list
84110718|NCT00110435|Ezetimibe|ezetimibe|mesh-list
84110719|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84110720|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84110721|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
84110722|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110723|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84110724|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84110725|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110726|NCT00093899|Simvastatin|simvastatin|mesh-list
84110727|NCT00093899|Ezetimibe|ezetimibe|mesh-list
84110728|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84110729|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84110730|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
84110731|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110732|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84110733|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84110734|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110735|NCT00092807|Ezetimibe|ezetimibe|mesh-list
84110736|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84110737|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84110738|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
84110739|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110740|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84110741|NCT00092729|Naproxen|naproxen|mesh-list
84110742|NCT00092729|Etoricoxib|etoricoxib|mesh-list
84110743|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110744|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110745|NCT00092729|Analgesics|analgesics|mesh-ancestor
84110746|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
84110747|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110748|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110749|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110750|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110751|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
84110752|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84110753|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110754|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110755|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84110756|NCT02686476|Empagliflozin|empagliflozin|mesh-list
84110757|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84110758|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110759|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84110760|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110761|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
84110762|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84110763|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110764|NCT00616382|Indomethacin|indomethacin|mesh-list
84110765|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
83350870|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
84110766|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84110767|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110768|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110769|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84110770|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84110771|NCT00616382|Protective Agents|protective agents|mesh-ancestor
84110772|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110773|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
84110774|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84110775|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
84110776|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110777|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110778|NCT00616382|Analgesics|analgesics|mesh-ancestor
84110779|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
84110780|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110781|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110782|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110783|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
84110784|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
84110785|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84110786|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84110787|NCT01864746|Palbociclib|palbociclib|mesh-list
84110788|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110789|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84110790|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110791|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110792|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
84110793|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84110794|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
84110795|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84110796|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
84110797|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110798|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110799|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
84110800|NCT04212650|Losartan|losartan|mesh-list
84110801|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84110802|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84110803|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84110804|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84110805|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110806|NCT02574728|Sirolimus|sirolimus|mesh-list
84110807|NCT02574728|Celecoxib|celecoxib|mesh-list
84110808|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
84110809|NCT02574728|Etoposide|etoposide|mesh-list
84110810|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84110811|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
84110812|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110813|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110814|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84110815|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
84110816|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110817|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110818|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84110819|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84110820|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84110821|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84110822|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110823|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84110824|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110825|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84110826|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
84110827|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110828|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110829|NCT02574728|Analgesics|analgesics|mesh-ancestor
84110830|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
84110831|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110832|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110833|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84110834|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84110835|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
84110836|NCT00617474|Hematinics|hematinics|mesh-ancestor
84110837|NCT00619034|Diclofenac|diclofenac|mesh-list
84110838|NCT00619034|Dorzolamide|dorzolamide|mesh-list
84110839|NCT00619034|Latanoprost|latanoprost|mesh-list
83350946|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84110840|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84110841|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84110842|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84110844|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
84110845|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110846|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110847|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110848|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110849|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84110850|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110851|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110852|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84110853|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84110854|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84110855|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84110856|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84110857|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84110858|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110859|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110860|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84110861|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84110862|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84110863|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84110864|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
84110865|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110866|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110867|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84110868|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84110869|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
84110870|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84110871|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84110872|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
84110873|NCT00638742|Latanoprost|latanoprost|mesh-list
84110874|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84110875|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84110876|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84110877|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84110878|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84110879|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110880|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110881|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
84110882|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110883|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84110884|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84110885|NCT02686242|Anesthetics|anesthetics|mesh-list
84110886|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84110887|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110888|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
84110889|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110890|NCT00639522|Paclitaxel|paclitaxel|mesh-list
84110891|NCT00639522|Capecitabine|capecitabine|mesh-list
84110892|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84110893|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110894|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
84110895|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
84110896|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
84110897|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110898|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84110899|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
84110900|NCT00411138|Paclitaxel|paclitaxel|mesh-list
84110901|NCT00411138|Carboplatin|carboplatin|mesh-list
84110902|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84110903|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110904|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
84110905|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
84110906|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
84110907|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110908|NCT02686086|Albuterol|albuterol|mesh-list
84110909|NCT02686086|Ipratropium|ipratropium|mesh-list
84110910|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84110911|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
84110912|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110913|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110914|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84110915|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
84110917|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84110918|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84110919|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84110920|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84110921|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
84110922|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84110923|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110924|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84110925|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
84110926|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
84110927|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84110928|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
84110929|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110930|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
84110931|NCT03460158|Protective Agents|protective agents|mesh-ancestor
84110932|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
84110933|NCT02697630|Entinostat|entinostat|mesh-list
84110934|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84110935|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110936|NCT02697630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84110937|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110938|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84110939|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110940|NCT02685852|Exenatide|exenatide|mesh-list
84110941|NCT02685852|Acarbose|acarbose|mesh-list
84110942|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84110943|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110944|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84110945|NCT02685852|Incretins|incretins|mesh-ancestor
84110946|NCT02685852|Hormones|hormones|mesh-ancestor
84110947|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84110948|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84110949|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110950|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110951|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
84110952|NCT02697162|Octenidine|octenidine|mesh-list
84110953|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110954|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84110955|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84110956|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84110957|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
84110958|NCT00622674|Cetuximab|cetuximab|mesh-list
84110959|NCT00622674|Bortezomib|bortezomib|mesh-list
84110960|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84110961|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84110962|NCT02687724|Golimumab|golimumab|mesh-list
84110963|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84110964|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84110965|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84110966|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
84110967|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110968|NCT02685774|Metformin|metformin|mesh-list
84110969|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84110970|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110971|NCT00638976|Eptifibatide|eptifibatide|mesh-list
84110972|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84110973|NCT05661708|Chitosan|chitosan|mesh-list
84110974|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84110975|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84110976|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
84110977|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110978|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84110979|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
84110980|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
84110981|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
84110982|NCT05661708|Coagulants|coagulants|mesh-ancestor
84110983|NCT00639756|Allopurinol|allopurinol|mesh-list
84110984|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
84110985|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84110986|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84110987|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
84110988|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84110989|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84110991|NCT00639756|Protective Agents|protective agents|mesh-ancestor
84110992|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110993|NCT00622752|Nicotine|nicotine|mesh-list
84110994|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84110995|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
84110996|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84110997|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84110998|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84110999|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84111000|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
84111001|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111002|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111003|NCT03451578|alpha-MSH|alpha-msh|mesh-list
84111004|NCT03451578|Hormones|hormones|mesh-ancestor
84111005|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111006|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111007|NCT02686008|Olaparib|olaparib|mesh-list
84111008|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84111009|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111010|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111011|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111012|NCT02685618|Iloprost|iloprost|mesh-list
84111013|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84111014|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
84111015|NCT00602472|Linagliptin|linagliptin|mesh-list
84111016|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84111017|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111018|NCT00602472|Incretins|incretins|mesh-ancestor
84111019|NCT00602472|Hormones|hormones|mesh-ancestor
84111020|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111021|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84111022|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
84111023|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111024|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111025|NCT03384654|Cytarabine|cytarabine|mesh-list
84111026|NCT03384654|Prednisone|prednisone|mesh-list
84111027|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
84111028|NCT03384654|Doxorubicin|doxorubicin|mesh-list
84111029|NCT03384654|Methotrexate|methotrexate|mesh-list
84111030|NCT03384654|Vincristine|vincristine|mesh-list
84111031|NCT03384654|Asparaginase|asparaginase|mesh-list
84111032|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
84111033|NCT03384654|Daratumumab|daratumumab|mesh-list
84111034|NCT03384654|Pegaspargase|pegaspargase|mesh-list
84111035|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84111036|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
84111037|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111038|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111039|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84111040|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
84111041|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111042|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111043|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84111044|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84111045|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84111046|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84111047|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111048|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111049|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
84111050|NCT03384654|Hormones|hormones|mesh-ancestor
84111051|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111052|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84111053|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84111054|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
84111055|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84111056|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84111057|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
84111058|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
84111059|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84111060|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84111061|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
84111062|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111063|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84111064|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
84111065|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
84111066|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
84111067|NCT02685462|Digoxin|digoxin|mesh-list
84111068|NCT02685462|Caffeine|caffeine|mesh-list
84111069|NCT02685462|Atorvastatin|atorvastatin|mesh-list
84111070|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84111071|NCT02685462|Simvastatin|simvastatin|mesh-list
84111072|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84111073|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84111074|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
84111075|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111076|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84111077|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84111078|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111079|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84111080|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111081|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84111082|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84111083|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84111084|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
84111085|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111086|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84111087|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84111088|NCT02685462|Protective Agents|protective agents|mesh-ancestor
84111089|NCT02685306|Paclitaxel|paclitaxel|mesh-list
84111090|NCT02685306|Taxane|taxane|mesh-list
84111091|NCT02685306|Bavituximab|bavituximab|mesh-list
84111092|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84111093|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111094|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
84111095|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
84111096|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
84111097|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111098|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84111099|NCT02680938|Oxytocin|oxytocin|mesh-list
84111100|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
84111101|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84111102|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111103|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84111104|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84111105|NCT05663892|Estradiol|estradiol|mesh-list
84111106|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84111107|NCT05663892|Estrogens|estrogens|mesh-ancestor
84111108|NCT05663892|Hormones|hormones|mesh-ancestor
84111109|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111110|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111111|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84111112|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
84111113|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84111114|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84111115|NCT02685228|Gemcitabine|gemcitabine|mesh-list
84111116|NCT02685228|Decitabine|decitabine|mesh-list
84111117|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84111118|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
84111119|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111120|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111121|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111122|NCT00616460|Bivalirudin|bivalirudin|mesh-list
84111123|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
84111124|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84111125|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
84111126|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111127|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111128|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
84111129|NCT00616538|Fluticasone|fluticasone|mesh-list
84111130|NCT00616538|Xhance|xhance|mesh-list
84111131|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111132|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84111133|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
84111134|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111135|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111136|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84111137|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
84111138|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
84111139|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84111140|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
84111141|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84111142|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84111143|NCT02680548|Prednisolone|prednisolone|mesh-list
84111144|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
84111145|NCT02680548|Bupivacaine|bupivacaine|mesh-list
84111146|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84111147|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
84111148|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
84111149|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
84111150|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111151|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111152|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
84111153|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111154|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111155|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
84111156|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
84111157|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111158|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
84111159|NCT02680548|Hormones|hormones|mesh-ancestor
84111160|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111161|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84111162|NCT02680548|Protective Agents|protective agents|mesh-ancestor
84111163|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84111164|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111165|NCT05663736|Glimepiride|glimepiride|mesh-list
84111166|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84111167|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84111168|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111169|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84111170|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
84111171|NCT02685150|Omeprazole|omeprazole|mesh-list
84111172|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84111173|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84111174|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111175|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111176|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111177|NCT02682186|Ropivacaine|ropivacaine|mesh-list
84111178|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
84111179|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
84111180|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111181|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111182|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
84111183|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111184|NCT00619268|Interferons|interferons|mesh-list
84111185|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
84111186|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
84111187|NCT00619268|Sirolimus|sirolimus|mesh-list
84111188|NCT00619268|Bevacizumab|bevacizumab|mesh-list
84111189|NCT00619268|Sunitinib|sunitinib|mesh-list
84111190|NCT00619268|Temsirolimus|temsirolimus|mesh-list
84111191|NCT00619268|MTOR Inhibitors|mtor inhibitors|mesh-list
84111192|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84111193|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111194|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84111195|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84111196|NCT00619268|Growth Substances|growth substances|mesh-ancestor
84111197|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111198|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
84111199|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
84111200|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111201|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
84111202|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84111203|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111204|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111205|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84111206|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84111207|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84111208|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
84111209|NCT00619346|Pafuramidine|pafuramidine|mesh-list
84111210|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84111211|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84111212|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84111213|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111214|NCT04182828|Lidocaine|lidocaine|mesh-list
84111215|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
84111216|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
84111217|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111218|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111219|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
84111220|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111221|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84111222|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84111223|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84111224|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84111225|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111227|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84111228|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111229|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111230|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111231|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84111232|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84111233|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84111234|NCT00641004|Esomeprazole|esomeprazole|mesh-list
84111235|NCT00641004|Rebamipide|rebamipide|mesh-list
84111236|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84111237|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111238|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84111239|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111240|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111241|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
84111242|NCT00641004|Protective Agents|protective agents|mesh-ancestor
84111243|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111244|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
84111245|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84111246|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111247|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84111248|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84111249|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111250|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111251|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111252|NCT01009788|Temozolomide|temozolomide|mesh-list
84111253|NCT01009788|Veliparib|veliparib|mesh-list
84111254|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84111255|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
84111256|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111257|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111258|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84111259|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111260|NCT04183608|Adalimumab|adalimumab|mesh-list
84111261|NCT04183608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84111262|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111263|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111264|NCT00641082|Adefovir|adefovir|mesh-list
84111265|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84111266|NCT00641082|Clevudine|clevudine|mesh-list
84111267|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
84111268|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111269|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84111270|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84111271|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111272|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111273|NCT00641160|Vinorelbine|vinorelbine|mesh-list
84111274|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84111275|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111276|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
84111277|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
84111278|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
84111279|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111280|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
84111281|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84111282|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
84111283|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111284|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
84111285|NCT02679924|Protective Agents|protective agents|mesh-ancestor
84111286|NCT00618176|Lamivudine|lamivudine|mesh-list
84111287|NCT00618176|Zidovudine|zidovudine|mesh-list
84111288|NCT00618176|Nevirapine|nevirapine|mesh-list
84111289|NCT00618176|Stavudine|stavudine|mesh-list
84111290|NCT00618176|Didanosine|didanosine|mesh-list
84111291|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84111292|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84111293|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111294|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111296|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111297|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84111298|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84111299|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
84111300|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84111301|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84111302|NCT04211558|Ozanimod|ozanimod|mesh-list
84111303|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84111304|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111305|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84111306|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
84111307|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111308|NCT05048498|Azacitidine|azacitidine|mesh-list
84111309|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84111310|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
84111311|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111312|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111313|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111314|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84111315|NCT00901901|Sorafenib|sorafenib|mesh-list
84111316|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111317|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84111318|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111319|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111320|NCT00618254|Granisetron|granisetron|mesh-list
84111321|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
84111322|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
84111323|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111324|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111325|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111326|NCT00618254|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84111327|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84111328|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
84111329|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111330|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111331|NCT04184466|Insulin|insulin|mesh-list
84111332|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84111333|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
84111334|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
84111335|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84111336|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84111337|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111338|NCT03620201|Atezolizumab|atezolizumab|mesh-list
84111339|NCT03620201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84111340|NCT03620201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111341|NCT03620201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84111342|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111343|NCT04201769|Dexamethasone|dexamethasone|mesh-list
84111344|NCT04201769|Palonosetron|palonosetron|mesh-list
84111345|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111346|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
84111347|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
84111348|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111349|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111350|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111351|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
84111352|NCT04201769|Hormones|hormones|mesh-ancestor
84111353|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111354|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84111355|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111356|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84111357|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84111358|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
84111359|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111360|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111361|NCT05336825|Lidocaine|lidocaine|mesh-list
84111362|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
84111363|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
84111364|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111365|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351479|NCT04491084|Antibodies|antibodies|mesh-list
84111366|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
84111367|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111368|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84111369|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84111370|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84111371|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84111372|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111373|NCT04748783|Listerine|listerine|mesh-list
84111374|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
84111375|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84111376|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84111377|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
84111378|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
84111379|NCT04748783|Protective Agents|protective agents|mesh-ancestor
84111380|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111381|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84111382|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111383|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
84111384|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
84111385|NCT02777580|Tenecteplase|tenecteplase|mesh-list
84111386|NCT02777580|Clopidogrel|clopidogrel|mesh-list
84111387|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84111388|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84111389|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84111390|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84111391|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
84111392|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111393|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111394|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111395|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84111396|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84111397|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
84111398|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84111399|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111400|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111401|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84111402|NCT04628663|Analgesics|analgesics|mesh-ancestor
84111403|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
84111404|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111405|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84111406|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84111407|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84111408|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
84111409|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111410|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111411|NCT05663268|Infliximab|infliximab|mesh-list
84111412|NCT05663268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84111413|NCT05663268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111414|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
84111415|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111416|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111417|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
84111418|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84111419|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84111420|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
84111421|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111422|NCT00642096|Metoprolol|metoprolol|mesh-list
84111423|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84111424|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84111425|NCT00642096|Diuretics|diuretics|mesh-ancestor
84111426|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
84111427|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111428|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84111429|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84111430|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111431|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84111432|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
84111433|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
84111434|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111435|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84111436|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84111437|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84111438|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
84111439|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111440|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84111441|NCT02679456|Fluconazole|fluconazole|mesh-list
84111442|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
84111443|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
84111444|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111445|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84111446|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84111447|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111448|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111449|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84111450|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
84111451|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111452|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111453|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84111454|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84111455|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
84111456|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
84111457|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84111458|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84111459|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111460|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111461|NCT00640458|Urological Agents|urological agents|mesh-ancestor
84111462|NCT00909948|Fludarabine|fludarabine|mesh-list
84111463|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111464|NCT02681562|Olaparib|olaparib|mesh-list
84111465|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84111466|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111467|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111468|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111469|NCT00633035|Esomeprazole|esomeprazole|mesh-list
84111470|NCT00633035|Famotidine|famotidine|mesh-list
84111471|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84111472|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111473|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84111474|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111475|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111476|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84111477|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
84111478|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
84111479|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111480|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111481|NCT02511132|Gemcitabine|gemcitabine|mesh-list
84111482|NCT02511132|Docetaxel|docetaxel|mesh-list
84111483|NCT02511132|Irinotecan|irinotecan|mesh-list
84111484|NCT02511132|Temozolomide|temozolomide|mesh-list
84111485|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84111486|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
84111487|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111488|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111489|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
84111490|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
84111491|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
84111492|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84111493|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84111494|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111495|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84111496|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
84111497|NCT02678520|Goserelin|goserelin|mesh-list
84111498|NCT02678520|Bicalutamide|bicalutamide|mesh-list
84111499|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111500|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111501|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84111502|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111503|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
84111504|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
84111505|NCT00642252|Fluorides|fluorides|mesh-list
84111506|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
84111507|NCT00642252|Protective Agents|protective agents|mesh-ancestor
84111508|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111509|NCT00642330|Ibuprofen|ibuprofen|mesh-list
84111510|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84111511|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84111512|NCT00642330|Analgesics|analgesics|mesh-ancestor
84111513|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
83351628|NCT02307916|Mitogens|mitogens|mesh-list
84111515|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111516|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111517|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111518|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84111519|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111520|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111521|NCT02681796|Bupivacaine|bupivacaine|mesh-list
84111522|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
84111523|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
84111524|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111525|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111526|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
84111527|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111528|NCT02842931|Prednisone|prednisone|mesh-list
84111529|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
84111530|NCT02842931|Doxorubicin|doxorubicin|mesh-list
84111531|NCT02842931|Etoposide|etoposide|mesh-list
84111532|NCT02842931|Vincristine|vincristine|mesh-list
84111533|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84111534|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
84111535|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111536|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111537|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84111538|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
84111539|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111540|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111541|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84111542|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84111543|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84111544|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84111545|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111546|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84111547|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111548|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
84111549|NCT02842931|Hormones|hormones|mesh-ancestor
84111550|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111551|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84111552|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
84111553|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
84111554|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
84111555|NCT04183296|Propofol|propofol|mesh-list
84111556|NCT04183296|Sevoflurane|sevoflurane|mesh-list
84111557|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84111558|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111559|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111560|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84111561|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
84111562|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
84111563|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84111564|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84111565|NCT00642408|Micronutrients|micronutrients|mesh-list
84111566|NCT00642408|Trace Elements|trace elements|mesh-list
84111567|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111568|NCT02678598|Micafungin|micafungin|mesh-list
84111569|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
84111570|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111571|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
84111572|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84111573|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111574|NCT02359019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84111575|NCT02359019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111576|NCT02678364|Vitamin D|vitamin d|mesh-list
84111577|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
84111578|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
84111579|NCT02678364|Calcifediol|calcifediol|mesh-list
84111580|NCT02678364|Vitamins|vitamins|mesh-ancestor
84111581|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
84111582|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111583|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84111584|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84111585|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
84111586|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84111587|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83351705|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84111588|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111590|NCT02678208|Coagulants|coagulants|mesh-ancestor
84111591|NCT05551182|Nicergoline|nicergoline|mesh-list
84111592|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84111593|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84111594|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
84111595|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111596|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111597|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111598|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
84111599|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
84111600|NCT02677584|Caffeine|caffeine|mesh-list
84111601|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
84111602|NCT02677584|Citric Acid|citric acid|mesh-list
84111603|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
84111604|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
84111605|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84111606|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
84111607|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
84111608|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111609|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84111610|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111611|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84111612|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111613|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84111614|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84111615|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
84111616|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111617|NCT05662956|Azacitidine|azacitidine|mesh-list
84111618|NCT05662956|Venetoclax|venetoclax|mesh-list
84111619|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84111620|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
84111621|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111622|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111623|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111624|NCT02838173|Ropivacaine|ropivacaine|mesh-list
84111625|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
84111626|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
84111627|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111628|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111629|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
84111630|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111631|NCT00641472|Budesonide|budesonide|mesh-list
84111632|NCT00641472|Montelukast|montelukast|mesh-list
84111633|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111634|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84111635|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
84111636|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111637|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111638|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84111639|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
84111640|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
84111641|NCT00641472|Hormones|hormones|mesh-ancestor
84111642|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111643|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84111644|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
84111645|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84111646|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84111647|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111648|NCT00896051|Ritonavir|ritonavir|mesh-list
84111649|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84111650|NCT00896051|Tenofovir|tenofovir|mesh-list
84111651|NCT00896051|Etravirine|etravirine|mesh-list
84111652|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
84111653|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84111654|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84111655|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
84111656|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111657|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111658|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84111659|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84111660|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
84111661|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111662|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84111663|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84111664|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84111665|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84111666|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84111668|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84111669|NCT02673606|Estrogens|estrogens|mesh-ancestor
84111670|NCT02673606|Hormones|hormones|mesh-ancestor
84111671|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111672|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111673|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84111674|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
84111675|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84111676|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84111677|NCT02675400|Methylphenidate|methylphenidate|mesh-list
84111678|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84111679|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84111680|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111681|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84111682|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84111683|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84111684|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111685|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
84111686|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111687|NCT05501886|Fulvestrant|fulvestrant|mesh-list
84111688|NCT05501886|Palbociclib|palbociclib|mesh-list
84111689|NCT05501886|Gedatolisib|gedatolisib|mesh-list
84111690|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84111691|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111692|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84111693|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84111694|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
84111695|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111696|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111697|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84111698|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111699|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111700|NCT00894647|Imiquimod|imiquimod|mesh-list
84111701|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84111702|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
84111703|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111704|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111705|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
84111706|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
84111707|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84111708|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111709|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84111710|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84111711|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111712|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111713|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111714|NCT02841839|Fluorides|fluorides|mesh-list
84111715|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
84111716|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
84111717|NCT02841839|Protective Agents|protective agents|mesh-ancestor
84111718|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111719|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
84111720|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84111721|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
84111722|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111723|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111724|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84111725|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
84111726|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84111727|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
84111728|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111729|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111730|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84111731|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
84111732|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
84111733|NCT04179942|Protective Agents|protective agents|mesh-ancestor
84111734|NCT04250831|Chromium|chromium|mesh-list
83351854|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84111735|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
84111736|NCT04250831|Trace Elements|trace elements|mesh-ancestor
84111737|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
84111738|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111739|NCT04250831|Cathartics|cathartics|mesh-ancestor
84111740|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111741|NCT00633191|Immunomodulating Agents|immunomodulating agents|mesh-list
84111742|NCT00633191|Immunologic Factors|immunologic factors|mesh-ancestor
84111743|NCT00633191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111744|NCT00643500|Levetiracetam|levetiracetam|mesh-list
84111745|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
84111746|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
84111747|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
84111748|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84111749|NCT00633269|Olaparib|olaparib|mesh-list
84111750|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84111751|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111752|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111753|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111754|NCT04181346|Pregabalin|pregabalin|mesh-list
84111755|NCT04181346|Analgesics|analgesics|mesh-ancestor
84111756|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
84111757|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111758|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111759|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
84111760|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84111761|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84111762|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111763|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84111764|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84111765|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84111766|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111767|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84111768|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84111769|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84111770|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111771|NCT00642798|Incretins|incretins|mesh-ancestor
84111772|NCT00642798|Hormones|hormones|mesh-ancestor
84111773|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84111774|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84111775|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
84111776|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111777|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111778|NCT05364996|Dimercaprol|dimercaprol|mesh-list
84111779|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
84111780|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
84111781|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111782|NCT00643734|Azithromycin|azithromycin|mesh-list
84111783|NCT00643734|Levofloxacin|levofloxacin|mesh-list
84111784|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84111785|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111786|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84111787|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84111788|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84111789|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111790|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111791|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111792|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84111793|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84111794|NCT02674308|Vedolizumab|vedolizumab|mesh-list
84111795|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111796|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
84111797|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84111798|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84111799|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111800|NCT04178850|Folic Acid|folic acid|mesh-list
84111801|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
84111802|NCT04178850|Infliximab|infliximab|mesh-list
84111803|NCT04178850|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84111804|NCT04178850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111805|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
84111806|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111807|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111808|NCT04178850|Hematinics|hematinics|mesh-ancestor
84111809|NCT04178850|Vitamins|vitamins|mesh-ancestor
83351940|NCT03294252|Vitamins|vitamins|mesh-ancestor
84111810|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
84111811|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111812|NCT02676336|Iodine|iodine|mesh-list
84111813|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
84111814|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84111815|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111816|NCT02676336|Trace Elements|trace elements|mesh-ancestor
84111817|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
84111818|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111819|NCT02672358|Trametinib|trametinib|mesh-list
84111820|NCT02672358|Dabrafenib|dabrafenib|mesh-list
84111821|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111822|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84111823|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111824|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111825|NCT02675868|Phenylephrine|phenylephrine|mesh-list
84111826|NCT02675868|Vasopressins|vasopressins|mesh-list
84111827|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
84111828|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
84111829|NCT02675868|Norepinephrine|norepinephrine|mesh-list
84111830|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84111831|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
84111832|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
84111833|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111834|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111835|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
84111836|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84111837|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
84111838|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
84111839|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84111840|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84111841|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84111842|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
84111843|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111844|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111845|NCT02675868|Protective Agents|protective agents|mesh-ancestor
84111846|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
84111847|NCT02675868|Coagulants|coagulants|mesh-ancestor
84111848|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84111849|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
84111850|NCT05279742|Valsartan|valsartan|mesh-list
84111851|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84111852|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84111853|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84111854|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84111855|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111856|NCT02673840|Ketotifen|ketotifen|mesh-list
84111857|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
84111858|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
84111859|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84111860|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
84111861|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
84111862|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111863|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111864|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111865|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84111866|NCT00644124|Aflibercept|aflibercept|mesh-list
84111867|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84111868|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84111869|NCT00644124|Growth Substances|growth substances|mesh-ancestor
84111870|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111871|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
84111872|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111873|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
84111874|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
84111875|NCT02670954|Tramadol|tramadol|mesh-list
84111876|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84111877|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111878|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111879|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84111880|NCT02670954|Analgesics|analgesics|mesh-ancestor
84111881|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
84111882|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111883|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84111884|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84111885|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83352011|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
84111886|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
84111887|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111888|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111889|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84111890|NCT02670954|Narcotics|narcotics|mesh-ancestor
84111891|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84111892|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84111893|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84111894|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84111895|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111896|NCT00644904|Vitamin D|vitamin d|mesh-list
84111897|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
84111898|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
84111899|NCT00644904|Vitamins|vitamins|mesh-list
84111900|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
84111901|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111902|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84111903|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84111904|NCT02670564|Busulfan|busulfan|mesh-list
84111905|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
84111906|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111907|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84111908|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
84111909|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111910|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84111911|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84111912|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84111913|NCT02672202|Pregabalin|pregabalin|mesh-list
84111914|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84111915|NCT02672202|Analgesics|analgesics|mesh-ancestor
84111916|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
84111917|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111918|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111919|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
84111920|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84111921|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84111922|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111923|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84111924|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84111925|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84111926|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111927|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84111928|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84111929|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84111930|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111931|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
84111932|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
84111933|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
84111934|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84111935|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
84111936|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
84111937|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84111938|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111939|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84111940|NCT02671578|Analgesics|analgesics|mesh-ancestor
84111941|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
84111942|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84111943|NCT00644982|Sertraline|sertraline|mesh-list
84111944|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84111945|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
84111946|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84111947|NCT00644982|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84111948|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84111949|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84111950|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111951|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84111952|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
84111953|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111954|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84111955|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84111956|NCT02670642|Esomeprazole|esomeprazole|mesh-list
84111957|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83352084|NCT02008942|Analgesics|analgesics|mesh-ancestor
84111958|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84111959|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84111960|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111961|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111962|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84111963|NCT02670018|Metformin|metformin|mesh-list
84111964|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84111965|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111966|NCT02670096|Acetazolamide|acetazolamide|mesh-list
84111967|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
84111968|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84111969|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111970|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111971|NCT02670096|Diuretics|diuretics|mesh-ancestor
84111972|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
84111973|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111974|NCT00645060|Antibodies|antibodies|mesh-list
84111975|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84111976|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
84111977|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84111978|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84111979|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84111980|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84111981|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
84111982|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111983|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84111984|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84111985|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111986|NCT00644670|Atorvastatin|atorvastatin|mesh-list
84111987|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84111988|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84111989|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
84111990|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84111991|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84111992|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84111993|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84111994|NCT02669706|Pentamidine|pentamidine|mesh-list
84111995|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
84111996|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84111997|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84111998|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84111999|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84112000|NCT00645138|Anesthetics|anesthetics|mesh-list
84112001|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112002|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112003|NCT00895895|Donepezil|donepezil|mesh-list
84112004|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84112005|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112006|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112007|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
84112008|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112009|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112010|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
84112011|NCT00644748|Gabapentin|gabapentin|mesh-list
84112012|NCT00644748|Analgesics|analgesics|mesh-ancestor
84112013|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
84112014|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112015|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112016|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
84112017|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84112018|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112019|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112020|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112021|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84112022|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84112023|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112024|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112025|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
84112026|NCT00910416|Remifentanil|remifentanil|mesh-list
84112027|NCT00910416|Propofol|propofol|mesh-list
84112028|NCT00910416|Sevoflurane|sevoflurane|mesh-list
84112029|NCT00910416|Atracurium|atracurium|mesh-list
84112030|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84112031|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112032|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112033|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84112034|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
84112035|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
84112036|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84112037|NCT00910416|Narcotics|narcotics|mesh-ancestor
84112038|NCT00910416|Analgesics|analgesics|mesh-ancestor
84112039|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
84112040|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112041|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84112042|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84112043|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84112044|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84112045|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84112046|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84112047|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84112048|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
84112049|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112050|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112051|NCT02669238|Etonogestrel|etonogestrel|mesh-list
84112052|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84112053|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
84112054|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84112055|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112056|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84112057|NCT02669004|Morphine|morphine|mesh-list
84112058|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84112059|NCT02669004|Narcotics|narcotics|mesh-ancestor
84112060|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112061|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112062|NCT02669004|Analgesics|analgesics|mesh-ancestor
84112063|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
84112064|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112065|NCT00895661|Rituximab|rituximab|mesh-list
84112066|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112067|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112068|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
84112069|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112070|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112071|NCT00645294|Adefovir|adefovir|mesh-list
84112072|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84112073|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
84112074|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112075|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84112076|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84112077|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112078|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112079|NCT02837003|Aspirin|aspirin|mesh-list
84112080|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84112081|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84112082|NCT02837003|Analgesics|analgesics|mesh-ancestor
84112083|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
84112084|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112085|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112086|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112087|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112088|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84112089|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84112090|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112091|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84112092|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84112093|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112094|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
84112095|NCT02668926|Amphetamine|amphetamine|mesh-list
84112096|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84112097|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
84112098|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84112099|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112100|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
84112101|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
84112102|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112103|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
84112104|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112105|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112106|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
83352235|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
84112107|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84112108|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84112109|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112110|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84112112|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84112113|NCT02668536|Protective Agents|protective agents|mesh-ancestor
84112114|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112115|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
84112116|NCT00645372|Risperidone|risperidone|mesh-list
84112117|NCT00645372|Ziprasidone|ziprasidone|mesh-list
84112118|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84112119|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
84112120|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112121|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112122|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112123|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84112124|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112125|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112126|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112127|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84112128|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
84112129|NCT00645918|Clopidogrel|clopidogrel|mesh-list
84112130|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84112131|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84112132|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84112133|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84112134|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
84112135|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112136|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112137|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112138|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
84112139|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
84112140|NCT00646854|Doxorubicin|doxorubicin|mesh-list
84112141|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84112142|NCT00646854|Vincristine|vincristine|mesh-list
84112143|NCT00646854|Lenograstim|lenograstim|mesh-list
84112144|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112145|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
84112146|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112147|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112148|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84112149|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
84112150|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112151|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112152|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84112153|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84112154|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112155|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84112156|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84112157|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84112158|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112159|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84112160|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
84112161|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
84112162|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
84112163|NCT04173858|Naloxegol|naloxegol|mesh-list
84112164|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84112165|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112166|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
84112167|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112168|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
84112169|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84112170|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112171|NCT00646932|Vitamins|vitamins|mesh-ancestor
84112172|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
84112173|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84112174|NCT00646152|Poly ICLC|poly iclc|mesh-list
84112175|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
84112176|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
83429872|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
84112177|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112178|NCT00647166|Azathioprine|azathioprine|mesh-list
84112179|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
84112180|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112182|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112183|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112184|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
84112185|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112186|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112187|NCT00647244|Tenofovir|tenofovir|mesh-list
84112188|NCT00647244|Abacavir|abacavir|mesh-list
84112189|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
84112190|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112191|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84112192|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84112193|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112194|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112195|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84112196|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84112197|NCT00895583|Sirolimus|sirolimus|mesh-list
84112198|NCT00895583|Tacrolimus|tacrolimus|mesh-list
84112199|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112200|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
84112201|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112202|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84112203|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112204|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112205|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112206|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112207|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84112208|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112209|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
84112210|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
84112211|NCT04174872|Midazolam|midazolam|mesh-list
84112212|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
84112213|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84112214|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112215|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112216|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84112217|NCT04174872|Analgesics|analgesics|mesh-ancestor
84112218|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
84112219|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112220|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84112221|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84112222|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84112223|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
84112224|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112225|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112226|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84112227|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84112228|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112229|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112230|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84112231|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
84112232|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
84112233|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
84112234|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
84112235|NCT02841137|Progesterone|progesterone|mesh-list
84112236|NCT02841137|Progestins|progestins|mesh-ancestor
84112237|NCT02841137|Hormones|hormones|mesh-ancestor
84112238|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112239|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112240|NCT00645606|Rituximab|rituximab|mesh-list
84112241|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112242|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112243|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
84112244|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112245|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112246|NCT02836847|Trastuzumab|trastuzumab|mesh-list
84112247|NCT02836847|Cetuximab|cetuximab|mesh-list
84112248|NCT02836847|Everolimus|everolimus|mesh-list
84112249|NCT02836847|Sorafenib|sorafenib|mesh-list
84112250|NCT02836847|Lapatinib|lapatinib|mesh-list
84112251|NCT02836847|Gefitinib|gefitinib|mesh-list
84112252|NCT02836847|Crizotinib|crizotinib|mesh-list
84112253|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112254|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112255|NCT02836847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84112256|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84112257|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112258|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112259|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112260|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
84112261|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112262|NCT02666040|Anesthetics|anesthetics|mesh-list
84112263|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112264|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112265|NCT00894413|Tadalafil|tadalafil|mesh-list
84112266|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
84112267|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84112268|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84112269|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112270|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112271|NCT00894413|Urological Agents|urological agents|mesh-ancestor
84112272|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
84112273|NCT04250519|Eusol|eusol|mesh-list
84112274|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
84112275|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112276|NCT04172220|Midazolam|midazolam|mesh-list
84112277|NCT04172220|Anesthetics|anesthetics|mesh-list
84112278|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112279|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112280|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84112281|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84112282|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84112283|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112284|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112285|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84112286|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
84112287|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
84112288|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
84112289|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112290|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112291|NCT02665806|Fluticasone|fluticasone|mesh-list
84112292|NCT02665806|Ciclesonide|ciclesonide|mesh-list
84112293|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112294|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84112295|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
84112296|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112297|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112298|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84112299|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
84112300|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
84112301|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84112302|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
84112303|NCT02665806|Hormones|hormones|mesh-ancestor
84112304|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112305|NCT00646386|Adalimumab|adalimumab|mesh-list
84112306|NCT00646386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84112307|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112308|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112309|NCT00647634|Alprazolam|alprazolam|mesh-list
84112310|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84112311|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112312|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112313|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84112314|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112315|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112316|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
84112317|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
84112318|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112319|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112320|NCT04172064|Dobutamine|dobutamine|mesh-list
84112321|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84112322|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
84112323|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
84112324|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112325|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112326|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84112327|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84112328|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84112329|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
84112330|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112331|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112332|NCT04172064|Protective Agents|protective agents|mesh-ancestor
84112333|NCT00647712|Valproic Acid|valproic acid|mesh-list
84112335|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112336|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112337|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
84112338|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112339|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112340|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
84112341|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112342|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112343|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112344|NCT04173390|Pregabalin|pregabalin|mesh-list
84112345|NCT04173390|Analgesics|analgesics|mesh-ancestor
84112346|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
84112347|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112348|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112349|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
84112350|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84112351|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112352|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112353|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84112354|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84112355|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112356|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112357|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112358|NCT04895202|Siponimod|siponimod|mesh-list
84112359|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
84112360|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112361|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112362|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
84112363|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112364|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
84112365|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112366|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112367|NCT02665650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84112368|NCT02665650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112369|NCT00647868|Testosterone|testosterone|mesh-list
84112370|NCT00647868|Androgens|androgens|mesh-ancestor
84112371|NCT00647868|Hormones|hormones|mesh-ancestor
84112372|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112373|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112374|NCT00647946|Tenofovir|tenofovir|mesh-list
84112375|NCT00647946|Abacavir|abacavir|mesh-list
84112376|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
84112377|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112378|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84112379|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84112380|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112381|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112382|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84112383|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84112384|NCT00648024|Anagrelide|anagrelide|mesh-list
84112385|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84112386|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84112387|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112388|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84112389|NCT02665416|Bevacizumab|bevacizumab|mesh-list
84112390|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112391|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112392|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84112393|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84112394|NCT02665416|Growth Substances|growth substances|mesh-ancestor
84112395|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112396|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
84112397|NCT00646620|Fluticasone|fluticasone|mesh-list
84112398|NCT00646620|Budesonide|budesonide|mesh-list
84112399|NCT00646620|Albuterol|albuterol|mesh-list
84112400|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
84112401|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84112402|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83429874|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
84112403|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84112404|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112405|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84112406|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
84112407|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112408|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112410|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
84112411|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
84112412|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84112413|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
84112414|NCT00646620|Hormones|hormones|mesh-ancestor
84112415|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112416|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84112417|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84112418|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84112419|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
84112420|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112421|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112422|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
84112423|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84112424|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
84112425|NCT00648180|Doxycycline|doxycycline|mesh-list
84112426|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112427|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112428|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
84112429|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84112430|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84112431|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84112432|NCT02664168|Laxatives|laxatives|mesh-ancestor
84112433|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112434|NCT00648492|Metformin|metformin|mesh-list
84112435|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84112436|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112437|NCT00648570|Dexetimide|dexetimide|mesh-list
84112438|NCT00648570|Citalopram|citalopram|mesh-list
84112439|NCT00648570|Escitalopram|escitalopram|mesh-list
84112440|NCT00648570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84112441|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84112442|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112443|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112444|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112445|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
84112446|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112447|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84112448|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84112449|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
84112450|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
84112451|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112452|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84112453|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84112454|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
84112455|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84112456|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
84112457|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112458|NCT00648258|Naproxen|naproxen|mesh-list
84112459|NCT00648258|Valdecoxib|valdecoxib|mesh-list
84112460|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84112461|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84112462|NCT00648258|Analgesics|analgesics|mesh-ancestor
84112463|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
84112464|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112465|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112466|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112467|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112468|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
84112469|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84112470|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112471|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112472|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84112473|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
84112474|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
84112475|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429878|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112476|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84112477|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112478|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112479|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
84112480|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112481|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84112482|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112483|NCT04650984|Doxorubicin|doxorubicin|mesh-list
84112484|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84112485|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112486|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84112487|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84112488|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112489|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112490|NCT00648414|Fentanyl|fentanyl|mesh-list
84112491|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84112492|NCT00648414|Narcotics|narcotics|mesh-ancestor
84112493|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112494|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112495|NCT00648414|Analgesics|analgesics|mesh-ancestor
84112496|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
84112497|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112498|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84112499|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84112500|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
84112501|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
84112502|NCT02663700|Artesunate|artesunate|mesh-list
84112503|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
84112504|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84112505|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84112506|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112507|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112508|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
84112509|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
84112510|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84112511|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
84112512|NCT00648726|Azithromycin|azithromycin|mesh-list
84112513|NCT00648726|Erythromycin|erythromycin|mesh-list
84112514|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
84112515|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84112516|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
84112517|NCT00648726|Cefuroxime|cefuroxime|mesh-list
84112518|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
84112519|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112520|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112521|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112522|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84112523|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112524|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112525|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
84112526|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
84112527|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112528|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112529|NCT00648804|Ondansetron|ondansetron|mesh-list
84112530|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
84112531|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
84112532|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112533|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112534|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112535|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
84112536|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
84112537|NCT00648804|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84112538|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84112539|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
84112540|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112541|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112542|NCT02664012|Menthol|menthol|mesh-list
84112543|NCT02664012|Nicotine|nicotine|mesh-list
84112544|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84112545|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
84112546|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112547|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112548|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84112549|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84112550|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
84112551|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112552|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112553|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
84112554|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
84112555|NCT00895037|Factor VIII|factor viii|mesh-list
84112556|NCT00895037|Coagulants|coagulants|mesh-ancestor
84112557|NCT04170504|Methotrexate|methotrexate|mesh-list
84112558|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84112559|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
84112560|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84112561|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112562|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84112563|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
84112564|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112565|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112566|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
84112567|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112568|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84112569|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112570|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
84112571|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112572|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84112574|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84112575|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112576|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84112577|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112578|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112579|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84112580|NCT00633347|Cetrorelix|cetrorelix|mesh-list
84112581|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
84112582|NCT00633347|Hormones|hormones|mesh-ancestor
84112583|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112584|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112585|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84112586|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
84112587|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84112588|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
84112589|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
84112590|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84112591|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
84112592|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84112593|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84112594|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112595|NCT02838719|Dexamethasone|dexamethasone|mesh-list
84112596|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
84112597|NCT02838719|BB 1101|bb 1101|mesh-list
84112598|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112599|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
84112600|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
84112601|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112602|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112603|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112604|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
84112605|NCT02838719|Hormones|hormones|mesh-ancestor
84112606|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112607|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84112608|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112609|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
84112610|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112611|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112612|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84112613|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84112614|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112615|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84112616|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84112617|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112618|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112619|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
84112620|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112621|NCT00649194|Rabeprazole|rabeprazole|mesh-list
84112622|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84112623|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112624|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84112625|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112626|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112627|NCT02659254|Sirolimus|sirolimus|mesh-list
84112628|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112629|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112630|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84112631|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112632|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
84112633|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112634|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
84112635|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112636|NCT02658864|Lafutidine|lafutidine|mesh-list
84112637|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84112638|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112639|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84112640|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
84112641|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
84112642|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112643|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112644|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112645|NCT02835833|Bevacizumab|bevacizumab|mesh-list
84112646|NCT02835833|Nintedanib|nintedanib|mesh-list
84112647|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112648|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112649|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84112650|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84112651|NCT02835833|Growth Substances|growth substances|mesh-ancestor
84112652|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112653|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
84112654|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84112655|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112656|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112657|NCT04171284|Docetaxel|docetaxel|mesh-list
84112658|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112659|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
84112660|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
84112661|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
84112662|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112663|NCT02838329|Ropivacaine|ropivacaine|mesh-list
84112664|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
84112665|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
84112666|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112667|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112668|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
84112669|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112670|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
84112671|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84112672|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84112673|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84112674|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112675|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112676|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
84112677|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112678|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112679|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84112680|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112681|NCT02835521|Triamcinolone|triamcinolone|mesh-list
84112682|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84112683|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84112684|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84112685|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112686|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
84112687|NCT02835521|Hormones|hormones|mesh-ancestor
84112688|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112689|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112690|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112691|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
84112692|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112693|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112694|NCT00649272|Oxybutynin|oxybutynin|mesh-list
84112695|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
84112696|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
84112697|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112698|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112699|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84112700|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84112701|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
84112702|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112703|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112704|NCT00649272|Urological Agents|urological agents|mesh-ancestor
84112705|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
84112706|NCT02666898|Fludarabine|fludarabine|mesh-list
84112707|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
84112708|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112709|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
84112710|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112711|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112712|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84112713|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
84112714|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112715|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112716|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84112717|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112718|NCT00633425|Glimepiride|glimepiride|mesh-list
84112719|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84112720|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84112721|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112722|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112723|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
84112724|NCT02840279|BPN14770|bpn14770|mesh-list
84112725|NCT02840279|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84112726|NCT02840279|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84112727|NCT02840279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112728|NCT02840279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112729|NCT00648960|Clarithromycin|clarithromycin|mesh-list
84112730|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112731|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112732|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84112733|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112734|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112735|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84112736|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84112737|NCT04437329|Cisplatin|cisplatin|mesh-list
84112738|NCT04437329|Docetaxel|docetaxel|mesh-list
84112739|NCT04437329|Fluorouracil|fluorouracil|mesh-list
84112740|NCT04437329|Nedaplatin|nedaplatin|mesh-list
84112741|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112742|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
84112743|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
84112744|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
84112745|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112746|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
84112747|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84112748|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84112749|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
84112750|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112751|NCT02834507|Levodopa|levodopa|mesh-list
84112752|NCT02834507|Carbidopa|carbidopa|mesh-list
84112753|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84112754|NCT02834507|Entacapone|entacapone|mesh-list
84112755|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84112756|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84112757|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
84112758|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112759|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112760|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112761|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84112762|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112763|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84112764|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
84112765|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
84112766|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
84112767|NCT02831543|Mosapride|mosapride|mesh-list
84112768|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112769|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84112770|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84112771|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
84112772|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112773|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112774|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
84112775|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
84112776|NCT02667054|Anesthetics|anesthetics|mesh-list
84112777|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
84112778|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112779|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352926|NCT02456454|Valproic Acid|valproic acid|mesh-list
84112780|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
84112781|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112782|NCT02662296|Idelalisib|idelalisib|mesh-list
84112783|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112784|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112785|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112786|NCT02662374|Nystatin|nystatin|mesh-list
84112787|NCT02662374|Calcium|calcium|mesh-list
84112788|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84112789|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112790|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112791|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112792|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
84112793|NCT02662374|Ionophores|ionophores|mesh-ancestor
84112794|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112795|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112796|NCT05334251|Anesthetics|anesthetics|mesh-list
84112797|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112798|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112799|NCT00649350|Metformin|metformin|mesh-list
84112800|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84112801|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112802|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
84112803|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84112804|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112805|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112806|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84112807|NCT00649038|Benazepril|benazepril|mesh-list
84112808|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84112809|NCT00649038|Diuretics|diuretics|mesh-ancestor
84112810|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
84112811|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112812|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84112813|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112814|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112815|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84112816|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
84112817|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112818|NCT04169256|Bupivacaine|bupivacaine|mesh-list
84112819|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
84112820|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
84112821|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112822|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112823|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
84112824|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112825|NCT02658396|Bortezomib|bortezomib|mesh-list
84112826|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112827|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
84112828|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112829|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112830|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84112831|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84112832|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112833|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112834|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112835|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84112836|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84112837|NCT00894803|Eptifibatide|eptifibatide|mesh-list
84112838|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84112839|NCT00601458|Naproxen|naproxen|mesh-list
84112840|NCT00601458|Pregabalin|pregabalin|mesh-list
84112841|NCT00601458|Analgesics|analgesics|mesh-ancestor
84112842|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
84112843|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112844|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112845|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
84112846|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84112847|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112848|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112849|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84112850|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84112851|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84112852|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112853|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112854|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84112856|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84112857|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84112858|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
84112859|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84112860|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112861|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
84112862|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84112863|NCT02660736|Incretins|incretins|mesh-ancestor
84112864|NCT02660736|Hormones|hormones|mesh-ancestor
84112865|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112866|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112867|NCT00649584|Gemcitabine|gemcitabine|mesh-list
84112868|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84112869|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84112870|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
84112871|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112872|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112873|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112874|NCT00649584|Immunotoxins|immunotoxins|mesh-ancestor
84112875|NCT00649584|Immunoconjugates|immunoconjugates|mesh-ancestor
84112876|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
84112877|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112878|NCT02141282|Venetoclax|venetoclax|mesh-list
84112879|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112880|NCT02657616|Vitamin K|vitamin k|mesh-list
84112881|NCT02657616|Anticoagulants|anticoagulants|mesh-list
84112882|NCT02657616|Vitamins|vitamins|mesh-ancestor
84112883|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
84112884|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112885|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84112886|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84112887|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112888|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
84112889|NCT02657616|Coagulants|coagulants|mesh-ancestor
84112890|NCT05288777|Capecitabine|capecitabine|mesh-list
84112891|NCT05288777|Trastuzumab|trastuzumab|mesh-list
84112892|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84112893|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84112894|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
84112895|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112896|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112897|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112898|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
84112899|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
84112900|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
84112901|NCT05288777|Immunotoxins|immunotoxins|mesh-ancestor
84112902|NCT05288777|Immunoconjugates|immunoconjugates|mesh-ancestor
84112903|NCT05288777|Immunologic Factors|immunologic factors|mesh-ancestor
84112904|NCT05288777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112905|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
84112906|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
84112907|NCT02657694|Ledipasvir|ledipasvir|mesh-list
84112908|NCT02657694|Velpatasvir|velpatasvir|mesh-list
84112909|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
84112910|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112911|NCT02657460|Cisplatin|cisplatin|mesh-list
84112912|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112913|NCT00649896|Estradiol|estradiol|mesh-list
84112914|NCT00649896|Estrogens|estrogens|mesh-ancestor
84112915|NCT00649896|Hormones|hormones|mesh-ancestor
84112916|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84112917|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112918|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
84112919|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112920|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112921|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84112922|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84112923|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84112924|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112925|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112926|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84112927|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84112928|NCT04188158|Capecitabine|capecitabine|mesh-list
84112929|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
83353128|NCT03261024|Nickel|nickel|mesh-list
84112930|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84112931|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
84112932|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112933|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112934|NCT02831231|Xanomeline|xanomeline|mesh-list
84112935|NCT02831231|Trospium chloride|trospium chloride|mesh-list
84112936|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
84112937|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
84112938|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112939|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112940|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84112941|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84112942|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
84112943|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112944|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112945|NCT02831231|Urological Agents|urological agents|mesh-ancestor
84112946|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84112947|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84112948|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84112949|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84112950|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
84112951|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84112952|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84112953|NCT05234606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84112954|NCT05234606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112955|NCT00649740|Topiramate|topiramate|mesh-list
84112956|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
84112957|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84112958|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112959|NCT04209920|Chromium|chromium|mesh-list
84112960|NCT04209920|Nickel|nickel|mesh-list
84112961|NCT04209920|Trace Elements|trace elements|mesh-ancestor
84112962|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
84112963|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112964|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
84112965|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84112966|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84112967|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112968|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84112969|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112970|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84112971|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
84112972|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84112973|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84112974|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112975|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84112976|NCT02660658|Analgesics|analgesics|mesh-ancestor
84112977|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
84112978|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84112979|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84112980|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84112981|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84112982|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
84112983|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84112984|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84112985|NCT02660502|Insulin|insulin|mesh-list
84112986|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84112987|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
84112988|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84112989|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84112990|NCT02660346|Vancomycin|vancomycin|mesh-list
84112991|NCT02660346|Daptomycin|daptomycin|mesh-list
84112992|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
84112993|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84112994|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84112995|NCT00620438|Efavirenz|efavirenz|mesh-list
84112996|NCT00620438|Nevirapine|nevirapine|mesh-list
84112997|NCT00620438|Rifampin|rifampin|mesh-list
84112998|NCT00620438|Lumefantrine|lumefantrine|mesh-list
84112999|NCT00620438|Artemether|artemether|mesh-list
84113000|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84113001|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83353136|NCT04777383|Acetylcholine|acetylcholine|mesh-list
84113002|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84113003|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113004|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113006|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113007|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84113008|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84113009|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84113010|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84113011|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84113012|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84113013|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84113014|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
84113015|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84113016|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
84113017|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84113018|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84113019|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84113020|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84113021|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84113022|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
84113023|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84113024|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84113025|NCT00891839|Rituximab|rituximab|mesh-list
84113026|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84113027|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84113028|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113029|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
84113030|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113031|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113032|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84113033|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
84113034|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113035|NCT00600756|Risperidone|risperidone|mesh-list
84113036|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84113037|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84113038|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
84113039|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113040|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113041|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113042|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84113043|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84113044|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113045|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84113046|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84113047|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
84113048|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
84113049|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
84113050|NCT02657148|Etonogestrel|etonogestrel|mesh-list
84113051|NCT02657148|Desogestrel|desogestrel|mesh-list
84113052|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84113053|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113054|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84113055|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84113056|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84113057|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84113058|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84113059|NCT02657148|Progestins|progestins|mesh-ancestor
84113060|NCT02657148|Hormones|hormones|mesh-ancestor
84113061|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113062|NCT04247087|Vitamin K|vitamin k|mesh-list
84113063|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
84113064|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84113065|NCT04247087|Vitamins|vitamins|mesh-ancestor
84113066|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
84113067|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113068|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84113069|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84113070|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113071|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
84113072|NCT04247087|Coagulants|coagulants|mesh-ancestor
84113073|NCT00649116|Metoprolol|metoprolol|mesh-list
84113074|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84113075|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84113076|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
84113077|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
83353209|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113078|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113079|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113080|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84113081|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84113082|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84113083|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
84113084|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113085|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113086|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
84113087|NCT04459416|Narcotics|narcotics|mesh-ancestor
84113088|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113089|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113090|NCT04459416|Analgesics|analgesics|mesh-ancestor
84113091|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
84113092|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113093|NCT02652234|Endostar protein|endostar protein|mesh-list
84113094|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84113095|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84113096|NCT02652234|Growth Substances|growth substances|mesh-ancestor
84113097|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113098|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
84113099|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113100|NCT04211012|Paclitaxel|paclitaxel|mesh-list
84113101|NCT04211012|Cisplatin|cisplatin|mesh-list
84113102|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84113103|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113104|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
84113105|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
84113106|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
84113107|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113108|NCT00649974|Valacyclovir|valacyclovir|mesh-list
84113109|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
84113110|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113111|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84113112|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113113|NCT00620594|Dactolisib|dactolisib|mesh-list
84113114|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113115|NCT02655822|Atezolizumab|atezolizumab|mesh-list
84113116|NCT02655822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84113117|NCT02655822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113118|NCT02655822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84113119|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113120|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84113121|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84113122|NCT00650442|Estradiol|estradiol|mesh-list
84113123|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84113124|NCT00650442|Estrogens|estrogens|mesh-ancestor
84113125|NCT00650442|Hormones|hormones|mesh-ancestor
84113126|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113127|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113128|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84113129|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
84113130|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84113131|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84113132|NCT00890825|Docetaxel|docetaxel|mesh-list
84113133|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113134|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
84113135|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
84113136|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
84113137|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113138|NCT04760132|Vaccines|vaccines|mesh-list
84113139|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
84113140|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113141|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
84113142|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84113143|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113144|NCT00649818|Lorazepam|lorazepam|mesh-list
84113145|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
84113146|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
84113147|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
84113148|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113149|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113150|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113151|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84113152|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113153|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84113154|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84113155|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84113156|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
84113157|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
84113158|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113159|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113160|NCT04246697|Acetaminophen|acetaminophen|mesh-list
84113161|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84113162|NCT04246697|Morphine|morphine|mesh-list
84113163|NCT04246697|Oxycodone|oxycodone|mesh-list
84113164|NCT04246697|Gabapentin|gabapentin|mesh-list
84113165|NCT04246697|Bupivacaine|bupivacaine|mesh-list
84113166|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
84113167|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
84113168|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113169|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113170|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
84113171|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113172|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84113173|NCT04246697|Narcotics|narcotics|mesh-ancestor
84113174|NCT04246697|Analgesics|analgesics|mesh-ancestor
84113175|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
84113176|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84113177|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84113178|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84113179|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84113180|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84113181|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113182|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113183|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
84113184|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113185|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
84113186|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84113187|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113188|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113189|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84113190|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113191|NCT02830139|Capecitabine|capecitabine|mesh-list
84113192|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
84113193|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113194|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84113195|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
84113196|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113197|NCT02833025|Thrombin|thrombin|mesh-list
84113198|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
84113199|NCT02833025|Coagulants|coagulants|mesh-ancestor
84113200|NCT02651610|Paclitaxel|paclitaxel|mesh-list
84113201|NCT02651610|Docetaxel|docetaxel|mesh-list
84113202|NCT02651610|Taxane|taxane|mesh-list
84113203|NCT02651610|Bavituximab|bavituximab|mesh-list
84113204|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84113205|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113206|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
84113207|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
84113208|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
84113209|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113210|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84113211|NCT04208594|Propranolol|propranolol|mesh-list
84113212|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84113213|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84113214|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
84113215|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113216|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113217|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113218|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84113219|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84113220|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
84113221|NCT04733144|Dexamethasone|dexamethasone|mesh-list
84113222|NCT04733144|Prednisolone|prednisolone|mesh-list
84113223|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113224|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
84113225|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
84113226|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113227|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113228|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113229|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
83353361|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
84113230|NCT04733144|Hormones|hormones|mesh-ancestor
84113231|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113232|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84113234|NCT04724720|Famotidine|famotidine|mesh-list
84113235|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84113236|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113237|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84113238|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
84113239|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
84113240|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113241|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113242|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113243|NCT02833103|Pinaverium|pinaverium|mesh-list
84113244|NCT02833103|Bromides|bromides|mesh-list
84113245|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
84113246|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84113247|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113248|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113249|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84113250|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113251|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
84113252|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
84113253|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113254|NCT02648490|Acetaminophen|acetaminophen|mesh-list
84113255|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
84113256|NCT02648490|Promethazine|promethazine|mesh-list
84113257|NCT02648490|Dexamethasone|dexamethasone|mesh-list
84113258|NCT02648490|Ondansetron|ondansetron|mesh-list
84113259|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113260|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
84113261|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
84113262|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113263|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113264|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113265|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
84113266|NCT02648490|Hormones|hormones|mesh-ancestor
84113267|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113268|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84113269|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113270|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113271|NCT02648490|Analgesics|analgesics|mesh-ancestor
84113272|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
84113273|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
84113274|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
84113275|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
84113276|NCT02648490|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84113277|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84113278|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
84113279|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113280|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113281|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84113282|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84113283|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113284|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
84113285|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
84113286|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84113287|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
84113288|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
84113289|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84113290|NCT04965272|Cariprazine|cariprazine|mesh-list
84113291|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84113292|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84113293|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430146|NCT00506155|Growth Substances|growth substances|mesh-ancestor
84113294|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113295|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84113296|NCT02648412|Ketamine|ketamine|mesh-list
84113297|NCT02648412|Analgesics|analgesics|mesh-ancestor
84113298|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
84113299|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113300|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113301|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84113302|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84113303|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
84113304|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
84113305|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113306|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84113307|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84113308|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113309|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113310|NCT00650520|Bromocriptine|bromocriptine|mesh-list
84113311|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84113312|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84113313|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
84113314|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113315|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113316|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
84113317|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
84113318|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113319|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113320|NCT04244981|Thrombin|thrombin|mesh-list
84113321|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
84113322|NCT04244981|Coagulants|coagulants|mesh-ancestor
84113323|NCT00621218|Tretinoin|tretinoin|mesh-list
84113324|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113325|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
84113326|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
84113327|NCT02655276|Glycine|glycine|mesh-list
84113328|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
84113329|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113330|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113331|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113332|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
84113333|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84113334|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
84113335|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84113336|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
84113337|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113338|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113339|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
84113340|NCT00651300|Parecoxib|parecoxib|mesh-list
84113341|NCT00651300|Valdecoxib|valdecoxib|mesh-list
84113342|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84113343|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84113344|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113345|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113346|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84113347|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113348|NCT00651300|Analgesics|analgesics|mesh-ancestor
84113349|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
84113350|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113351|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113352|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113353|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113354|NCT02828033|Rilonacept|rilonacept|mesh-list
84113355|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113356|NCT00621998|Olanzapine|olanzapine|mesh-list
84113357|NCT00621998|Risperidone|risperidone|mesh-list
84113358|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84113359|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
84113360|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113361|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113362|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113363|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84113364|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84113365|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113366|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84113367|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84113368|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
84113369|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
84113370|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
84113371|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113372|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113373|NCT00621998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84113374|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84113375|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113376|NCT02655198|Fenfluramine|fenfluramine|mesh-list
84113377|NCT02655198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84113378|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83353510|NCT04754763|Propolis|propolis|mesh-list
84113379|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113380|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113381|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113382|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
84113383|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113384|NCT00650052|Zonisamide|zonisamide|mesh-list
84113385|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
84113386|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84113387|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113388|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113389|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84113390|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113391|NCT00891527|Bevacizumab|bevacizumab|mesh-list
84113392|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
84113393|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84113394|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113395|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84113396|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84113397|NCT00891527|Growth Substances|growth substances|mesh-ancestor
84113398|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113399|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
84113400|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84113401|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113402|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113403|NCT03861078|Nicotine|nicotine|mesh-list
84113404|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84113405|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
84113406|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113407|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113408|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84113409|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84113410|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
84113411|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113412|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113413|NCT03845166|Atezolizumab|atezolizumab|mesh-list
84113414|NCT03845166|Avelumab|avelumab|mesh-list
84113415|NCT03845166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84113416|NCT03845166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113417|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84113418|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113419|NCT02829359|Entecavir|entecavir|mesh-list
84113420|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
84113421|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113422|NCT02650752|Capecitabine|capecitabine|mesh-list
84113423|NCT02650752|Lapatinib|lapatinib|mesh-list
84113424|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84113425|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
84113426|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113427|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113428|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84113429|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113430|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
84113431|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84113432|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84113433|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
84113434|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84113435|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113436|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113437|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
84113438|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113439|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113440|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84113441|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
84113442|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
84113443|NCT02832713|Protective Agents|protective agents|mesh-ancestor
84113444|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84113445|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113446|NCT02832635|Temozolomide|temozolomide|mesh-list
84113447|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84113448|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
84113449|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113450|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113451|NCT00650598|Diclofenac|diclofenac|mesh-list
84113452|NCT00650598|Valdecoxib|valdecoxib|mesh-list
84113453|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84113454|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113455|NCT00650598|Analgesics|analgesics|mesh-ancestor
84113456|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
84113457|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113458|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113459|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113460|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113461|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84113462|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113463|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113464|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84113465|NCT00620204|Atorvastatin|atorvastatin|mesh-list
84113466|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84113467|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84113468|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
84113469|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113470|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84113471|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84113472|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113473|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84113474|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113475|NCT02650596|Liraglutide|liraglutide|mesh-list
84113476|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84113477|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113478|NCT02650596|Incretins|incretins|mesh-ancestor
84113479|NCT02650596|Hormones|hormones|mesh-ancestor
84113480|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113481|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84113482|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113483|NCT02832089|Carvedilol|carvedilol|mesh-list
84113484|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84113485|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84113486|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
84113487|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113488|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113489|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113490|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84113491|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
84113492|NCT02832089|Protective Agents|protective agents|mesh-ancestor
84113493|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84113494|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113495|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84113496|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
84113497|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84113498|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84113499|NCT04247633|Palbociclib|palbociclib|mesh-list
84113500|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113501|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84113502|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113503|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113504|NCT00891371|Lanreotide|lanreotide|mesh-list
84113505|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113506|NCT04324229|Liraglutide|liraglutide|mesh-list
84113507|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84113508|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113509|NCT04324229|Incretins|incretins|mesh-ancestor
84113510|NCT04324229|Hormones|hormones|mesh-ancestor
84113511|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113512|NCT04430894|Dexamethasone|dexamethasone|mesh-list
84113513|NCT04430894|Lenalidomide|lenalidomide|mesh-list
84113514|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113515|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
84113516|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
84113517|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113518|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113519|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113520|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
84113521|NCT04430894|Hormones|hormones|mesh-ancestor
84113522|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113523|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84113524|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113525|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
84113526|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84113527|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84113528|NCT04430894|Growth Substances|growth substances|mesh-ancestor
84113529|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
84113530|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
84113531|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84113532|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
84113533|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113534|NCT02829281|Triamcinolone|triamcinolone|mesh-list
84113535|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84113536|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84113537|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
84113538|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84113539|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84113540|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84113541|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84113542|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113543|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113544|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
84113545|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113546|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113547|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113548|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
84113549|NCT02829281|Hormones|hormones|mesh-ancestor
84113550|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113551|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84113552|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
84113553|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113554|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84113555|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113556|NCT04210544|Caseins|caseins|mesh-list
84113557|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
84113558|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
84113559|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113560|NCT04168944|Lenvatinib|lenvatinib|mesh-list
84113561|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
84113562|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113563|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84113564|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113565|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113566|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
84113567|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113568|NCT02697032|Bicalutamide|bicalutamide|mesh-list
84113569|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
84113570|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
84113571|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113572|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113573|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113574|NCT04409834|Heparin|heparin|mesh-list
84113575|NCT04409834|Calcium heparin|calcium heparin|mesh-list
84113576|NCT04409834|Enoxaparin|enoxaparin|mesh-list
84113577|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
84113578|NCT04409834|Clopidogrel|clopidogrel|mesh-list
84113579|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84113580|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84113581|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84113582|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84113583|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
84113584|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113585|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113586|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113587|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
84113588|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84113589|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84113590|NCT02647632|Ribavirin|ribavirin|mesh-list
84113591|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
84113592|NCT02647632|Grazoprevir|grazoprevir|mesh-list
84113593|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
84113594|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
84113595|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113596|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
84113597|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113598|NCT00621452|Aldesleukin|aldesleukin|mesh-list
84113599|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
84113600|NCT00621452|Interleukin-2|interleukin-2|mesh-list
84113601|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84113602|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
84113603|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113604|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113605|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84113606|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
84113607|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113608|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113609|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84113610|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113611|NCT00621452|Analgesics|analgesics|mesh-ancestor
84113612|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
84113613|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113614|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84113615|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84113616|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
84113617|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113618|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
84113619|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
84113620|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84113621|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84113622|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113623|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113624|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113625|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113626|NCT00651612|Timolol|timolol|mesh-list
84113627|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84113628|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84113629|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84113630|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84113631|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84113632|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
84113633|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113634|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113635|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113636|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84113637|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84113638|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84113639|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84113640|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84113641|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84113642|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84113643|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
84113644|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113645|NCT02831933|Valacyclovir|valacyclovir|mesh-list
84113646|NCT02831933|Nivolumab|nivolumab|mesh-list
84113647|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84113648|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113649|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84113650|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113651|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
84113652|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113653|NCT02650206|Liraglutide|liraglutide|mesh-list
84113654|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84113655|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113656|NCT02650206|Incretins|incretins|mesh-ancestor
84113657|NCT02650206|Hormones|hormones|mesh-ancestor
84113658|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113659|NCT05368766|Diuretics|diuretics|mesh-list
84113660|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
84113661|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113662|NCT00891293|Fenofibrate|fenofibrate|mesh-list
84113663|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84113664|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
84113665|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113666|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84113667|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
84113668|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84113669|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
84113670|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113671|NCT00889421|Apremilast|apremilast|mesh-list
84113672|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84113673|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113674|NCT00889421|Analgesics|analgesics|mesh-ancestor
84113675|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
84113676|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113677|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113678|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113679|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113680|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84113681|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84113682|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113683|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113684|NCT02827643|Vitamin D|vitamin d|mesh-list
84113685|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
84113686|NCT02827643|Lamivudine|lamivudine|mesh-list
84113687|NCT02827643|Calcium|calcium|mesh-list
84113688|NCT02827643|Vitamins|vitamins|mesh-ancestor
84113689|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
84113690|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113691|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84113692|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84113693|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84113694|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84113695|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113696|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113697|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
84113698|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113699|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84113700|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84113701|NCT02646774|Micafungin|micafungin|mesh-list
84113702|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
84113703|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113704|NCT02647086|Metoprolol|metoprolol|mesh-list
84113705|NCT02647086|Midazolam|midazolam|mesh-list
84113706|NCT02647086|Caffeine|caffeine|mesh-list
84113707|NCT02647086|Omeprazole|omeprazole|mesh-list
84113708|NCT02647086|Warfarin|warfarin|mesh-list
84113709|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84113710|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84113711|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113712|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113713|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84113714|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84113715|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84113716|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84113717|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
84113718|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
84113719|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
84113720|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
84113721|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113722|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113723|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
84113724|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84113725|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84113726|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113727|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84113728|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84113729|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
84113730|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84113731|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113732|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84113733|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84113734|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84113735|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
84113736|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
84113737|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113738|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84113739|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84113740|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84113741|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
84113742|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
84113743|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84113744|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84113745|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84113746|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113747|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113748|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
84113749|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113750|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113751|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83353896|NCT04772781|Ibuprofen|ibuprofen|mesh-list
84113752|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113753|NCT00651768|Budesonide|budesonide|mesh-list
84113754|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
84113755|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84113756|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113757|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84113759|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113760|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113761|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84113762|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
84113763|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
84113764|NCT00651768|Hormones|hormones|mesh-ancestor
84113765|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113766|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84113767|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84113768|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84113769|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
84113770|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113771|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113772|NCT05660525|Nicotine|nicotine|mesh-list
84113773|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84113774|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
84113775|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113776|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113777|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84113778|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84113779|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
84113780|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113781|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113782|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84113783|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
84113784|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84113785|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113786|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84113787|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
84113788|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84113789|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84113790|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84113791|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84113792|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84113793|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
84113794|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84113795|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84113796|NCT04167306|Bupropion|bupropion|mesh-list
84113797|NCT04167306|Varenicline|varenicline|mesh-list
84113798|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84113799|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
84113800|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84113801|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84113802|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84113803|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113804|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113805|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
84113806|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113807|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113808|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84113809|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84113810|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113811|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84113812|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84113813|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
84113814|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
84113815|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84113816|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84113817|NCT04244591|Prednisolone|prednisolone|mesh-list
84113818|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
84113819|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84113820|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
84113821|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113822|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
84113823|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
84113824|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113825|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113826|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113827|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
84113828|NCT04244591|Hormones|hormones|mesh-ancestor
84113829|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113830|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84113831|NCT04244591|Protective Agents|protective agents|mesh-ancestor
84113832|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84113833|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113834|NCT02649582|Temozolomide|temozolomide|mesh-list
84113835|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84113836|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
84113837|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113838|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113839|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
84113840|NCT04167696|Fludarabine|fludarabine|mesh-list
84113841|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
84113842|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84113843|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
84113844|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113845|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113846|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84113847|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
84113848|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113849|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113850|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84113851|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84113852|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
84113853|NCT02827487|Celecoxib|celecoxib|mesh-list
84113854|NCT02827487|Tramadol|tramadol|mesh-list
84113855|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84113856|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113857|NCT02827487|Analgesics|analgesics|mesh-ancestor
84113858|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
84113859|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113860|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113861|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113862|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113863|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84113864|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84113865|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113866|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113867|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84113868|NCT02827487|Narcotics|narcotics|mesh-ancestor
84113869|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84113870|NCT04098666|Metformin|metformin|mesh-list
84113871|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84113872|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113873|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
84113874|NCT02649504|Dexamethasone|dexamethasone|mesh-list
84113875|NCT02649504|Rituximab|rituximab|mesh-list
84113876|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84113877|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113878|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
84113879|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113880|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113881|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113882|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
84113883|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
84113884|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113885|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113886|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
84113887|NCT02649504|Hormones|hormones|mesh-ancestor
84113888|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113889|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84113890|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84113891|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84113892|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
84113893|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84113894|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113895|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113896|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113897|NCT03703856|Memantine|memantine|mesh-list
84113898|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84113899|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84113900|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
84113901|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113902|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113903|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113904|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84113905|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84113907|NCT00650910|Digoxin|digoxin|mesh-list
84113908|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84113909|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84113910|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113911|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113912|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84113913|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84113914|NCT00650910|Protective Agents|protective agents|mesh-ancestor
84113915|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113916|NCT02654730|Piperaquine|piperaquine|mesh-list
84113917|NCT02654730|Primaquine|primaquine|mesh-list
84113918|NCT02654730|Artenimol|artenimol|mesh-list
84113919|NCT02654730|Artemisinins|artemisinins|mesh-list
84113920|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
84113921|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84113922|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84113923|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84113924|NCT00888329|Aprepitant|aprepitant|mesh-list
84113925|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
84113926|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
84113927|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113928|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113929|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84113930|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84113931|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84113932|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113933|NCT00652002|Budesonide|budesonide|mesh-list
84113934|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
84113935|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113936|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84113937|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
84113938|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113939|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113940|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84113941|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
84113942|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
84113943|NCT00652002|Hormones|hormones|mesh-ancestor
84113944|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84113945|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84113946|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84113947|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84113948|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
84113949|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430149|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84113950|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113951|NCT02646540|Metolazone|metolazone|mesh-list
84113952|NCT02646540|Furosemide|furosemide|mesh-list
84113953|NCT02646540|Tolvaptan|tolvaptan|mesh-list
84113954|NCT02646540|Diuretics|diuretics|mesh-list
84113955|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
84113956|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113957|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84113958|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84113959|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113960|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84113961|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84113962|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84113963|NCT00651066|Ritonavir|ritonavir|mesh-list
84113964|NCT00651066|Lopinavir|lopinavir|mesh-list
84113965|NCT00651066|Rifabutin|rifabutin|mesh-list
84113966|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84113967|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84113968|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
84113969|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113970|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113971|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84113972|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84113973|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
84113974|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354141|NCT03238092|Estradiol|estradiol|mesh-list
84113975|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84113976|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84113977|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84113978|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84113979|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
84113980|NCT02646072|Ketorolac|ketorolac|mesh-list
84113981|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84113982|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84113983|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84113984|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84113985|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84113986|NCT02646072|Analgesics|analgesics|mesh-ancestor
84113987|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
84113988|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84113989|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84113990|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84113991|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84113992|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84113993|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84113994|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113995|NCT02654106|Temozolomide|temozolomide|mesh-list
84113996|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84113997|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
84113998|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84113999|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114000|NCT04243733|Pemetrexed|pemetrexed|mesh-list
84114001|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114002|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114003|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114004|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84114005|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84114006|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
84114007|NCT03434366|Ketamine|ketamine|mesh-list
84114008|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114009|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114010|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114011|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114012|NCT03434366|Analgesics|analgesics|mesh-ancestor
84114013|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
84114014|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114015|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84114016|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114017|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114018|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114019|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114020|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114021|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84114022|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84114023|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
84114024|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
84114025|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84114026|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84114027|NCT04167228|Ceftazidime|ceftazidime|mesh-list
84114028|NCT04167228|Avibactam|avibactam|mesh-list
84114029|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
84114030|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114031|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114032|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84114033|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114034|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114035|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
84114036|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114037|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
84114038|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84114039|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
84114040|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84114041|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114042|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84114043|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114044|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
84114045|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114046|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114047|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114048|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114049|NCT02648958|Analgesics|analgesics|mesh-ancestor
84114050|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
84114051|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114052|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84114053|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114054|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114055|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114056|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114057|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114059|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114060|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114061|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114062|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84114063|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84114064|NCT04243811|Anesthetics|anesthetics|mesh-list
84114065|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114066|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114067|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
84114068|NCT00638300|Calcium|calcium|mesh-list
84114069|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84114070|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114071|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84114072|NCT00887315|Cisplatin|cisplatin|mesh-list
84114073|NCT00887315|Docetaxel|docetaxel|mesh-list
84114074|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114075|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
84114076|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
84114077|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
84114078|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114079|NCT02645994|Anesthetics|anesthetics|mesh-list
84114080|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114081|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114082|NCT03014648|Atezolizumab|atezolizumab|mesh-list
84114083|NCT03014648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84114084|NCT03014648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114085|NCT03014648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84114086|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114087|NCT02645058|Analgesics|analgesics|mesh-list
84114088|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114089|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
84114090|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114091|NCT02644980|Anesthetics|anesthetics|mesh-list
84114092|NCT02644980|Propofol|propofol|mesh-list
84114093|NCT02644980|Etomidate|etomidate|mesh-list
84114094|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114095|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114096|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114097|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84114098|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
84114099|NCT04187456|Midazolam|midazolam|mesh-list
84114100|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84114101|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114102|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114103|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114104|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84114105|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114106|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114107|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84114108|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
84114109|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
84114110|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
84114111|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
84114112|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114113|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114114|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84114115|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
84114116|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
84114117|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114118|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114119|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114120|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114121|NCT02687204|Enoxaparin|enoxaparin|mesh-list
84114122|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
84114123|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
84114124|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84114125|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84114126|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114127|NCT00650208|Lamotrigine|lamotrigine|mesh-list
84114128|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
84114129|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84114130|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114131|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114132|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84114133|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114134|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84114135|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114136|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114137|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114138|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84114139|NCT02645370|Topiramate|topiramate|mesh-list
84114140|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
84114141|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84114142|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114143|NCT00652392|Budesonide|budesonide|mesh-list
84114144|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
84114145|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114146|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84114147|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
84114148|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114149|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114150|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84114151|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
84114152|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
84114153|NCT00652392|Hormones|hormones|mesh-ancestor
84114154|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114155|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84114156|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84114157|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114158|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114159|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114160|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114161|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
84114162|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114163|NCT02653638|Indomethacin|indomethacin|mesh-list
84114164|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84114165|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114166|NCT02653638|Analgesics|analgesics|mesh-ancestor
84114167|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
84114168|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114169|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114170|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114171|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114172|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
84114173|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
84114174|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84114175|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84114176|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114177|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114178|NCT02644590|Melatonin|melatonin|mesh-list
84114179|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
84114180|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114181|NCT02644590|Protective Agents|protective agents|mesh-ancestor
84114182|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114183|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114184|NCT00910806|Nevirapine|nevirapine|mesh-list
84114185|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84114186|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84114187|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114188|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114189|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
84114190|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114191|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84114192|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84114193|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84114194|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84114195|NCT00652704|Doxycycline|doxycycline|mesh-list
84114196|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114197|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114198|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
84114199|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84114200|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84114201|NCT00652782|Rolofylline|rolofylline|mesh-list
84114202|NCT00652782|Diuretics|diuretics|mesh-ancestor
84114203|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
84114204|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114205|NCT00653562|Zolpidem|zolpidem|mesh-list
84114206|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84114207|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114208|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114209|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114210|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84114211|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
84114212|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
84114213|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114214|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114215|NCT00887159|Cisplatin|cisplatin|mesh-list
84114216|NCT00887159|Etoposide|etoposide|mesh-list
84114217|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
84114218|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
84114219|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84114220|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114221|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84114222|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84114223|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84114224|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114225|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114226|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
84114227|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
84114228|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
84114229|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
84114230|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
84114231|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
84114232|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114233|NCT00650286|Modafinil|modafinil|mesh-list
84114234|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84114235|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114236|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84114237|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84114238|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84114239|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114240|NCT02640846|Simendan|simendan|mesh-list
84114241|NCT02640846|Milrinone|milrinone|mesh-list
84114242|NCT02640846|Norepinephrine|norepinephrine|mesh-list
84114243|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114244|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114245|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114246|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114247|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114248|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114249|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
84114250|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
84114251|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114252|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84114253|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84114254|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
84114255|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84114256|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84114257|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114258|NCT02640846|Protective Agents|protective agents|mesh-ancestor
84114259|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84114260|NCT02644044|Methotrexate|methotrexate|mesh-list
84114261|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84114262|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
84114263|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84114264|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114265|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84114266|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
84114267|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114268|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114269|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
84114270|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114271|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84114272|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84114273|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
84114274|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114275|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84114276|NCT00652860|Doxorubicin|doxorubicin|mesh-list
84114277|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84114279|NCT00652860|Molgramostim|molgramostim|mesh-list
84114280|NCT00652860|Mitomycins|mitomycins|mesh-list
84114281|NCT00652860|Mitomycin|mitomycin|mesh-list
84114282|NCT00652860|Sargramostim|sargramostim|mesh-list
84114283|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114284|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84114285|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84114286|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84114287|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114288|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114289|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84114290|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
84114291|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
84114292|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114293|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84114294|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
84114295|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114296|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114297|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114298|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114299|NCT02536014|Analgesics|analgesics|mesh-ancestor
84114300|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
84114301|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114302|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84114303|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114304|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114305|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114306|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114307|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114308|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
84114309|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
84114310|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
84114311|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114312|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114313|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84114314|NCT02653014|Diuretics|diuretics|mesh-ancestor
84114315|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
84114316|NCT02653014|Hormones|hormones|mesh-ancestor
84114317|NCT00886613|Vaccines|vaccines|mesh-list
84114318|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
84114319|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114320|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84114321|NCT00653016|Norelgestromin|norelgestromin|mesh-list
84114322|NCT00653016|Estradiol|estradiol|mesh-list
84114323|NCT00653016|Estrogens|estrogens|mesh-ancestor
84114324|NCT00653016|Hormones|hormones|mesh-ancestor
84114325|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114326|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114327|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84114328|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
84114329|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84114330|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84114331|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84114332|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84114333|NCT00886379|Vitamin D|vitamin d|mesh-list
84114334|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
84114335|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
84114336|NCT00886379|Vitamins|vitamins|mesh-list
84114337|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
84114338|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114339|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84114340|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84114341|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
84114342|NCT00633581|Vitamins|vitamins|mesh-ancestor
84114343|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
84114344|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114345|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
84114346|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114347|NCT00633581|Protective Agents|protective agents|mesh-ancestor
84114348|NCT02825147|Dexamethasone|dexamethasone|mesh-list
84114349|NCT02825147|Methotrexate|methotrexate|mesh-list
84114350|NCT02825147|Etoposide|etoposide|mesh-list
84114351|NCT02825147|Pegaspargase|pegaspargase|mesh-list
84114352|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114353|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
84114354|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
84114355|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114356|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114357|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114358|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
84114359|NCT02825147|Hormones|hormones|mesh-ancestor
84114360|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114361|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84114362|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114363|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84114364|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
84114365|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84114366|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84114367|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
84114368|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114369|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
84114370|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114371|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84114372|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84114373|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
84114374|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114375|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84114376|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84114377|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84114378|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84114379|NCT02825225|Anesthetics|anesthetics|mesh-list
84114380|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114381|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114382|NCT00637949|Rofecoxib|rofecoxib|mesh-list
84114383|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
84114384|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84114385|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84114386|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114387|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114388|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84114389|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114390|NCT00637949|Analgesics|analgesics|mesh-ancestor
84114391|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
84114392|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114393|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114394|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114395|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114396|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84114397|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
84114398|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84114399|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
84114400|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84114401|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114402|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84114403|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84114404|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114405|NCT00599196|Rotigotine|rotigotine|mesh-list
84114406|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
84114407|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
84114408|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114409|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114410|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114411|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
84114412|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84114413|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114414|NCT04201145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84114415|NCT04201145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114416|NCT02824601|Calcium|calcium|mesh-list
84114417|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83354557|NCT02359006|Minocycline|minocycline|mesh-list
84114418|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114419|NCT02643732|Methylphenidate|methylphenidate|mesh-list
84114420|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84114421|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114422|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84114423|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84114424|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114425|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114426|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
84114427|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114428|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
84114429|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114430|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114431|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114432|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114433|NCT04876937|Analgesics|analgesics|mesh-ancestor
84114434|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
84114435|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114436|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84114437|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114438|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114439|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114440|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114441|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114442|NCT04165590|Immunomodulating Agents|immunomodulating agents|mesh-list
84114443|NCT04165590|Immunologic Factors|immunologic factors|mesh-ancestor
84114444|NCT04165590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114445|NCT05660993|Nivolumab|nivolumab|mesh-list
84114446|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84114447|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114448|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84114449|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114450|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
84114451|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84114452|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
84114453|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
84114454|NCT04241705|Lumefantrine|lumefantrine|mesh-list
84114455|NCT04241705|Artemether|artemether|mesh-list
84114456|NCT04241705|Primaquine|primaquine|mesh-list
84114457|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84114458|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
84114459|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84114460|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84114461|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114462|NCT04243109|Dexamethasone|dexamethasone|mesh-list
84114463|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
84114464|NCT04243109|Pomalidomide|pomalidomide|mesh-list
84114465|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84114466|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
84114467|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114468|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114469|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84114470|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
84114471|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114472|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114473|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84114474|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114475|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
84114476|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
84114477|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114478|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114479|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
84114480|NCT04243109|Hormones|hormones|mesh-ancestor
84114481|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114482|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84114483|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84114484|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84114485|NCT04243109|Growth Substances|growth substances|mesh-ancestor
84114486|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
84114487|NCT04861181|Niraparib|niraparib|mesh-list
84114488|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84114489|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114490|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114491|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114493|NCT00603512|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84114494|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84114495|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114496|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114497|NCT04167774|Paclitaxel|paclitaxel|mesh-list
84114498|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84114499|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84114500|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114501|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
84114502|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
84114503|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
84114504|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114505|NCT02640300|Clozapine|clozapine|mesh-list
84114506|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84114507|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
84114508|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114509|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114510|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114511|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84114512|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114513|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114514|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114515|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
84114516|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
84114517|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
84114518|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84114519|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
84114520|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114521|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
84114522|NCT02640144|Protective Agents|protective agents|mesh-ancestor
84114523|NCT02643186|Misoprostol|misoprostol|mesh-list
84114524|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84114525|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
84114526|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84114527|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114528|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84114529|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114530|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
84114531|NCT02652312|Diclofenac|diclofenac|mesh-list
84114532|NCT02652312|Fentanyl|fentanyl|mesh-list
84114533|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
84114534|NCT02652312|Ondansetron|ondansetron|mesh-list
84114535|NCT02652312|Propofol|propofol|mesh-list
84114536|NCT02652312|Desflurane|desflurane|mesh-list
84114537|NCT02652312|Atracurium|atracurium|mesh-list
84114538|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114539|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114540|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114541|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114542|NCT02652312|Analgesics|analgesics|mesh-ancestor
84114543|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
84114544|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114545|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84114546|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114547|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114548|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114549|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114550|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114551|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84114552|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
84114553|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
84114554|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84114555|NCT02652312|Narcotics|narcotics|mesh-ancestor
84114556|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84114557|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
84114558|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
84114559|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114560|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
84114561|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
84114562|NCT02652312|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84114563|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84114564|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
84114565|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84114566|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114567|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114568|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84114569|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114570|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84114571|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84114572|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84114573|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84114574|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84114575|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84114576|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
84114578|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84114579|NCT04165512|Bupivacaine|bupivacaine|mesh-list
84114580|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
84114581|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
84114582|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114583|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114584|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
84114585|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114586|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114587|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
84114588|NCT04165512|Hormones|hormones|mesh-ancestor
84114589|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114590|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84114591|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
84114592|NCT02642874|Methocarbamol|methocarbamol|mesh-list
84114593|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
84114594|NCT02642874|Calcium|calcium|mesh-list
84114595|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84114596|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114597|NCT02642874|Antacids|antacids|mesh-ancestor
84114598|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114599|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114600|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84114601|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84114602|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114603|NCT00653874|Bilirubin|bilirubin|mesh-list
84114604|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
84114605|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114606|NCT00653874|Protective Agents|protective agents|mesh-ancestor
84114607|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114608|NCT04224701|Vaccines|vaccines|mesh-list
84114609|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
84114610|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114611|NCT00653952|Paclitaxel|paclitaxel|mesh-list
84114612|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84114613|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114614|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
84114615|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
84114616|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
84114617|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114618|NCT00650364|Midodrine|midodrine|mesh-list
84114619|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
84114620|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
84114621|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114622|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114623|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84114624|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84114625|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114626|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114627|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114628|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114629|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114630|NCT04909697|Sivelestat|sivelestat|mesh-list
84114631|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84114632|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
84114633|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114634|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114635|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
84114636|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
84114637|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114638|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114639|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84114640|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84114641|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354791|NCT03228108|Fosfomycin|fosfomycin|mesh-list
84114642|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114643|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114644|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84114645|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84114646|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
84114647|NCT00654108|Protective Agents|protective agents|mesh-ancestor
84114648|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114649|NCT00654108|Vitamins|vitamins|mesh-ancestor
84114650|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
84114651|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
84114652|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84114653|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
84114654|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114655|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
84114656|NCT04165902|Protective Agents|protective agents|mesh-ancestor
84114657|NCT02639598|Topiramate|topiramate|mesh-list
84114658|NCT02639598|Flunarizine|flunarizine|mesh-list
84114659|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
84114660|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84114661|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114662|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84114663|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114664|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114665|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84114666|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84114667|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
84114668|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
84114669|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114670|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
84114671|NCT04907279|Aripiprazole|aripiprazole|mesh-list
84114672|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
84114673|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114674|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84114675|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114676|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114677|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114678|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
84114679|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
84114680|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114681|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114682|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84114683|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84114684|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
84114685|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84114686|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84114687|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84114688|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84114689|NCT02642718|Ketorolac|ketorolac|mesh-list
84114690|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84114691|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84114692|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114693|NCT02642718|Analgesics|analgesics|mesh-ancestor
84114694|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
84114695|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114696|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114697|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114698|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114699|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84114700|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114701|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114702|NCT02642484|Gabapentin|gabapentin|mesh-list
84114703|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
84114704|NCT02642484|Calcium|calcium|mesh-list
84114705|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84114706|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114707|NCT02642484|Analgesics|analgesics|mesh-ancestor
84114708|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
84114709|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114710|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
84114711|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84114712|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114713|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114714|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114715|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83354862|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
84114716|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84114717|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114718|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114719|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
84114721|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114722|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
84114723|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84114724|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114725|NCT04185350|Exenatide|exenatide|mesh-list
84114726|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84114727|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114728|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84114729|NCT04185350|Incretins|incretins|mesh-ancestor
84114730|NCT04185350|Hormones|hormones|mesh-ancestor
84114731|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114732|NCT00653172|Streptogramin A|streptogramin a|mesh-list
84114733|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114734|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114735|NCT02639520|Fosfomycin|fosfomycin|mesh-list
84114736|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114737|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114738|NCT02822729|Timolol|timolol|mesh-list
84114739|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84114740|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84114741|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84114742|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84114743|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114744|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114745|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114746|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114747|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84114748|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84114749|NCT02642250|Metronidazole|metronidazole|mesh-list
84114750|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114751|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114752|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84114753|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84114754|NCT00653250|Celecoxib|celecoxib|mesh-list
84114755|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84114756|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114757|NCT00653250|Analgesics|analgesics|mesh-ancestor
84114758|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
84114759|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114760|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114761|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114762|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114763|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84114764|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84114765|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114766|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114767|NCT00638534|Telithromycin|telithromycin|mesh-list
84114768|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114769|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114770|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84114771|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84114772|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84114773|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114774|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114775|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84114776|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114777|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114778|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
84114779|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114780|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
84114781|NCT02638896|Celecoxib|celecoxib|mesh-list
84114782|NCT02638896|Etanercept|etanercept|mesh-list
84114783|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84114784|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114785|NCT02638896|Analgesics|analgesics|mesh-ancestor
84114786|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
84114787|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114788|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114789|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114790|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114791|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84114792|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84114794|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114795|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114796|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84114797|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
84114798|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114799|NCT04240223|Brilacidin|brilacidin|mesh-list
84114800|NCT04240223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114801|NCT00653406|Risperidone|risperidone|mesh-list
84114802|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84114803|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
84114804|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114805|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114806|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114807|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84114808|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114809|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114810|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114811|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84114812|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
84114813|NCT00638612|Valacyclovir|valacyclovir|mesh-list
84114814|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
84114815|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114816|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
84114817|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84114818|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114819|NCT04239755|Doxycycline|doxycycline|mesh-list
84114820|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84114821|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84114822|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
84114823|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84114824|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84114825|NCT04185194|Lidocaine|lidocaine|mesh-list
84114826|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
84114827|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
84114828|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114829|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114830|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
84114831|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114832|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84114833|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84114834|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84114835|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114836|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114837|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
84114838|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84114839|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84114840|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84114841|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114842|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114843|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
84114844|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114845|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114846|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84114847|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114848|NCT04239833|Gefitinib|gefitinib|mesh-list
84114849|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114850|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84114851|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114852|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114853|NCT03513770|Ketorolac|ketorolac|mesh-list
84114854|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84114855|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84114856|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114857|NCT03513770|Analgesics|analgesics|mesh-ancestor
84114858|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
84114859|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114860|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114861|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114862|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84114863|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84114864|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114865|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114866|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
84114867|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
84114868|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114869|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84114870|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114871|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
84114872|NCT02823977|Ketamine|ketamine|mesh-list
84114873|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114874|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114875|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114876|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114877|NCT02823977|Analgesics|analgesics|mesh-ancestor
84114878|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
84114879|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114880|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84114881|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114882|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114883|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114884|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114885|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114886|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84114887|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84114888|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
84114889|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
84114890|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84114891|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84114892|NCT00680511|Methamphetamine|methamphetamine|mesh-list
84114893|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84114894|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114895|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
84114896|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
84114897|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114898|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
84114899|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114900|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114901|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114902|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84114903|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84114904|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114905|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84114906|NCT00654576|Olanzapine|olanzapine|mesh-list
84114907|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
84114908|NCT00654576|Risperidone|risperidone|mesh-list
84114909|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84114910|NCT00654576|Clozapine|clozapine|mesh-list
84114911|NCT00654576|Sulpiride|sulpiride|mesh-list
84114912|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84114913|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
84114914|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114915|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114916|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114917|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84114918|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84114919|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114920|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84114921|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84114922|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
84114923|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
84114924|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
84114925|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114926|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84114927|NCT00654576|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84114928|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84114929|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84114930|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
84114931|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
84114932|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
84114933|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84114934|NCT00622622|Gemcitabine|gemcitabine|mesh-list
84114935|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84114936|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
84114937|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355083|NCT02374060|Hormones|hormones|mesh-ancestor
84114938|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114939|NCT00598650|Donepezil|donepezil|mesh-list
84114940|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84114941|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114942|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114943|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
84114944|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114945|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114946|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
84114947|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84114948|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84114949|NCT04150731|Estradiol|estradiol|mesh-list
84114950|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84114951|NCT04150731|Estrogens|estrogens|mesh-ancestor
84114952|NCT04150731|Hormones|hormones|mesh-ancestor
84114953|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114954|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114955|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84114956|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
84114957|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84114958|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84114959|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
84114960|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84114961|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84114962|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114963|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84114964|NCT02641938|Analgesics|analgesics|mesh-ancestor
84114965|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
84114966|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84114967|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84114968|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84114969|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84114970|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
84114971|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84114972|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114973|NCT04249076|Clobetasol|clobetasol|mesh-list
84114974|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84114975|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
84114976|NCT04249076|Hormones|hormones|mesh-ancestor
84114977|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84114978|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114979|NCT00681135|Olaflur|olaflur|mesh-list
84114980|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
84114981|NCT00681135|Protective Agents|protective agents|mesh-ancestor
84114982|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114983|NCT02821559|Bevacizumab|bevacizumab|mesh-list
84114984|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
84114985|NCT02821559|Raltitrexed|raltitrexed|mesh-list
84114986|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84114987|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84114988|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84114989|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84114990|NCT02821559|Growth Substances|growth substances|mesh-ancestor
84114991|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84114992|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
84114993|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84114994|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
84114995|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84114996|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84114997|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84114998|NCT00681213|Sirolimus|sirolimus|mesh-list
84114999|NCT00681213|Temsirolimus|temsirolimus|mesh-list
84115000|NCT00681213|MTOR Inhibitors|mtor inhibitors|mesh-list
84115001|NCT00681213|Tacrolimus|tacrolimus|mesh-list
84115002|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115003|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
84115004|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115005|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84115006|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115007|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115008|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84115009|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115010|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84115011|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115012|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
84115013|NCT00681213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84115014|NCT02638506|Fentanyl|fentanyl|mesh-list
84115015|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84115016|NCT02638506|Narcotics|narcotics|mesh-ancestor
84115017|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115018|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115019|NCT02638506|Analgesics|analgesics|mesh-ancestor
84115020|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
84115021|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115022|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84115023|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84115024|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
84115025|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
84115026|NCT04745975|Paclitaxel|paclitaxel|mesh-list
84115027|NCT04745975|Vinorelbine|vinorelbine|mesh-list
84115028|NCT04745975|Gemcitabine|gemcitabine|mesh-list
84115029|NCT04745975|Capecitabine|capecitabine|mesh-list
84115030|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84115031|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115032|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
84115033|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
84115034|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
84115035|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115036|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84115037|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
84115038|NCT04150107|Insulin|insulin|mesh-list
84115039|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84115040|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84115041|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115042|NCT02638428|Cytarabine|cytarabine|mesh-list
84115043|NCT02638428|Carboplatin|carboplatin|mesh-list
84115044|NCT02638428|Trastuzumab|trastuzumab|mesh-list
84115045|NCT02638428|Fludarabine|fludarabine|mesh-list
84115046|NCT02638428|Etoposide|etoposide|mesh-list
84115047|NCT02638428|Everolimus|everolimus|mesh-list
84115048|NCT02638428|Sorafenib|sorafenib|mesh-list
84115049|NCT02638428|Dasatinib|dasatinib|mesh-list
84115050|NCT02638428|Ifosfamide|ifosfamide|mesh-list
84115051|NCT02638428|Axitinib|axitinib|mesh-list
84115052|NCT02638428|Vemurafenib|vemurafenib|mesh-list
84115053|NCT02638428|Crizotinib|crizotinib|mesh-list
84115054|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115055|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115056|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84115057|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
84115058|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115059|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115060|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
84115061|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115062|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84115063|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115064|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115065|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115066|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
84115067|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115068|NCT02638428|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84115069|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84115070|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84115071|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
84115072|NCT01003964|Cisplatin|cisplatin|mesh-list
84115073|NCT01003964|Gemcitabine|gemcitabine|mesh-list
84115074|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115075|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84115076|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
84115077|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115078|NCT02823743|Aspirin|aspirin|mesh-list
84115079|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84115080|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115081|NCT02823743|Analgesics|analgesics|mesh-ancestor
84115082|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
84115083|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115084|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115085|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115086|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115087|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83355234|NCT02043652|Chloroquine|chloroquine|mesh-list
84115088|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84115089|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115090|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84115091|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84115092|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115094|NCT00654888|Mitomycins|mitomycins|mesh-list
84115095|NCT00654888|Mitomycin|mitomycin|mesh-list
84115096|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84115097|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115098|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
84115099|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115100|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84115101|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115102|NCT05299203|Verapamil|verapamil|mesh-list
84115103|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84115104|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84115105|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115106|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115107|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84115108|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115109|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
84115110|NCT02638584|Rabeprazole|rabeprazole|mesh-list
84115111|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84115112|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84115113|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84115114|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115115|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115116|NCT04208516|Dexamethasone|dexamethasone|mesh-list
84115117|NCT04208516|Lidocaine|lidocaine|mesh-list
84115118|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
84115119|NCT04208516|Ropivacaine|ropivacaine|mesh-list
84115120|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115121|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
84115122|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
84115123|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115124|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115125|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84115126|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
84115127|NCT04208516|Hormones|hormones|mesh-ancestor
84115128|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115129|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84115130|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115131|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
84115132|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
84115133|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115134|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
84115135|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84115136|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84115137|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84115138|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115139|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115140|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84115141|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115142|NCT04208516|Analgesics|analgesics|mesh-ancestor
84115143|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84115144|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84115145|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84115146|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115147|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115148|NCT02821169|Ropivacaine|ropivacaine|mesh-list
84115149|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
84115150|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
84115151|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115152|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115153|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
84115154|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115155|NCT02820935|Itraconazole|itraconazole|mesh-list
84115156|NCT02820935|Rifampin|rifampin|mesh-list
84115157|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
84115158|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115159|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84115160|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84115161|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115162|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115163|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84115164|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
84115165|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115166|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115167|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84115168|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84115169|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
84115170|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84115171|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
84115172|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84115173|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84115174|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84115175|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84115176|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84115177|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84115178|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84115179|NCT02626845|Rituximab|rituximab|mesh-list
84115180|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115181|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115182|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
84115183|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115184|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115185|NCT02821247|Aflibercept|aflibercept|mesh-list
84115186|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84115187|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84115188|NCT02821247|Growth Substances|growth substances|mesh-ancestor
84115189|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115190|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
84115191|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115192|NCT00681525|Atorvastatin|atorvastatin|mesh-list
84115193|NCT00681525|Ezetimibe|ezetimibe|mesh-list
84115194|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
84115195|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84115196|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84115197|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
84115198|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115199|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84115200|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84115201|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115202|NCT00681603|Bevacizumab|bevacizumab|mesh-list
84115203|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115204|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115205|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84115206|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84115207|NCT00681603|Growth Substances|growth substances|mesh-ancestor
84115208|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115209|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
84115210|NCT04239443|Apatinib|apatinib|mesh-list
84115211|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84115212|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115213|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84115214|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115215|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115216|NCT04239443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115217|NCT04200599|Oxytocin|oxytocin|mesh-list
84115218|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
84115219|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84115220|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115221|NCT02820077|Hemostatics|hemostatics|mesh-list
84115222|NCT02820077|Coagulants|coagulants|mesh-ancestor
84115223|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
84115224|NCT00681993|Carboplatin|carboplatin|mesh-list
84115225|NCT00681993|Docetaxel|docetaxel|mesh-list
84115226|NCT00681993|Trastuzumab|trastuzumab|mesh-list
84115227|NCT00681993|Doxorubicin|doxorubicin|mesh-list
84115228|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84115229|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115230|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
84115231|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115232|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115233|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84115234|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
84115235|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115236|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115237|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84115238|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
84115239|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
84115240|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
84115241|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115242|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84115243|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115244|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115245|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115246|NCT02819999|Etoposide|etoposide|mesh-list
84115247|NCT02819999|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
84115248|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115249|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84115250|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115251|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115252|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115253|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115254|NCT02819999|Immunoconjugates|immunoconjugates|mesh-ancestor
84115255|NCT02819999|Immunologic Factors|immunologic factors|mesh-ancestor
84115256|NCT02819999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115257|NCT04173494|Danazol|danazol|mesh-list
84115258|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
84115259|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84115260|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
84115261|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115262|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115263|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84115264|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115265|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115266|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83429921|NCT02982889|Bupivacaine|bupivacaine|mesh-list
84115267|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84115268|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84115269|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115270|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115271|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115272|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115273|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
84115274|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84115275|NCT00875979|Trastuzumab|trastuzumab|mesh-list
84115276|NCT00875979|Pertuzumab|pertuzumab|mesh-list
84115277|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84115278|NCT00875979|Maytansine|maytansine|mesh-list
84115279|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115280|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115281|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84115282|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
84115283|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
84115284|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
84115285|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115286|NCT00875979|Immunotoxins|immunotoxins|mesh-ancestor
84115287|NCT00875979|Immunoconjugates|immunoconjugates|mesh-ancestor
84115288|NCT00875979|Immunologic Factors|immunologic factors|mesh-ancestor
84115289|NCT00875979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115290|NCT02818751|Escitalopram|escitalopram|mesh-list
84115291|NCT02818751|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84115292|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84115293|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115294|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115295|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115296|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
84115297|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115298|NCT04238975|Vaccines|vaccines|mesh-list
84115299|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
84115300|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115301|NCT00602420|Naproxen|naproxen|mesh-list
84115302|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84115303|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115304|NCT00602420|Analgesics|analgesics|mesh-ancestor
84115305|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
84115306|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115307|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115308|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115309|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115310|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
84115311|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84115312|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115313|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115314|NCT04635605|Methylene Blue|methylene blue|mesh-list
84115315|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115316|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115317|NCT02688374|Nicotine|nicotine|mesh-list
84115318|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84115319|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
84115320|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115321|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115322|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84115323|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84115324|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
84115325|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115326|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115327|NCT02819375|Ketamine|ketamine|mesh-list
84115328|NCT02819375|Remifentanil|remifentanil|mesh-list
84115329|NCT02819375|Propofol|propofol|mesh-list
84115330|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84115331|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115332|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115333|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84115334|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
84115335|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
84115336|NCT02819375|Analgesics|analgesics|mesh-ancestor
84115337|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
84115338|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115339|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84115340|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84115341|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84115342|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115343|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115344|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84115345|NCT02819375|Narcotics|narcotics|mesh-ancestor
84115346|NCT02818985|Dexamethasone|dexamethasone|mesh-list
84115347|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
84115348|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115349|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
84115350|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
84115351|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115352|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115353|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84115354|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
84115355|NCT02818985|Hormones|hormones|mesh-ancestor
84115356|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115357|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84115358|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115359|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84115360|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115361|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115362|NCT02818985|Analgesics|analgesics|mesh-ancestor
84115363|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
84115364|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84115365|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84115366|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84115367|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115368|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115369|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115370|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
84115371|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115372|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115373|NCT03362060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84115374|NCT03362060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115375|NCT02815787|Glyburide|glyburide|mesh-list
84115376|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84115377|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115378|NCT00639938|Nevirapine|nevirapine|mesh-list
84115379|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
84115380|NCT00639938|Antibodies|antibodies|mesh-list
84115381|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
84115382|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84115383|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84115384|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
84115385|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115386|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84115387|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84115388|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115389|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115390|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
84115391|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115392|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84115393|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84115394|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84115395|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84115396|NCT02815319|Dexamethasone|dexamethasone|mesh-list
84115397|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115398|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
84115399|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
84115400|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115401|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115402|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84115403|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
84115404|NCT02815319|Hormones|hormones|mesh-ancestor
84115405|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115406|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84115407|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115408|NCT02815475|Curcumin|curcumin|mesh-list
84115409|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84115410|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115411|NCT02815475|Analgesics|analgesics|mesh-ancestor
84115412|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
84115413|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115414|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115415|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115416|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115417|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115418|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115419|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115420|NCT00640796|Aldesleukin|aldesleukin|mesh-list
84115421|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
84115422|NCT00640796|Fludarabine|fludarabine|mesh-list
84115423|NCT00640796|Interleukin-2|interleukin-2|mesh-list
84115424|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115425|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
84115426|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115427|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115428|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84115429|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
84115430|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115431|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115432|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84115433|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115434|NCT00640796|Analgesics|analgesics|mesh-ancestor
84115435|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
84115436|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115437|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84115438|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84115439|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
84115440|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115441|NCT02687984|Risperidone|risperidone|mesh-list
84115442|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84115443|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
84115444|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115445|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115446|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115447|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84115448|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84115449|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115450|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84115451|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84115452|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
84115453|NCT05657873|Immunomodulating Agents|immunomodulating agents|mesh-list
84115454|NCT05657873|Immunologic Factors|immunologic factors|mesh-ancestor
84115455|NCT05657873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115456|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84115457|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84115458|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
83355602|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84115459|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115460|NCT02684786|Lidocaine|lidocaine|mesh-list
84115461|NCT02684786|Reserpine|reserpine|mesh-list
84115462|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
84115463|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
84115464|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115465|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115466|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
84115467|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115468|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84115469|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84115470|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83429930|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
84115471|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115472|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115473|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84115474|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84115475|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84115476|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84115477|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84115478|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84115479|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115480|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115481|NCT02683070|Tramadol|tramadol|mesh-list
84115482|NCT02683070|Ropivacaine|ropivacaine|mesh-list
84115483|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
84115484|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
84115485|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115486|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115487|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
84115488|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115489|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84115490|NCT02683070|Narcotics|narcotics|mesh-ancestor
84115491|NCT02683070|Analgesics|analgesics|mesh-ancestor
84115492|NCT02685176|Charcoal|charcoal|mesh-list
84115493|NCT02685176|Antidotes|antidotes|mesh-ancestor
84115494|NCT02685176|Protective Agents|protective agents|mesh-ancestor
84115495|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115496|NCT05664074|Ketorolac|ketorolac|mesh-list
84115497|NCT05664074|Indomethacin|indomethacin|mesh-list
84115498|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84115499|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115500|NCT05664074|Analgesics|analgesics|mesh-ancestor
84115501|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
84115502|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115503|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115504|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115505|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115506|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84115507|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115508|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115509|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
84115510|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
84115511|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84115512|NCT00634205|Doxorubicin|doxorubicin|mesh-list
84115513|NCT00634205|Valproic Acid|valproic acid|mesh-list
84115514|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84115515|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115516|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115517|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115518|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115519|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115520|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
84115521|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
84115522|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115523|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115524|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
84115525|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84115526|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115527|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84115528|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
84115529|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84115530|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115531|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115532|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115533|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115534|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115535|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115536|NCT02818049|Dimercaprol|dimercaprol|mesh-list
84115537|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
84115538|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
84115539|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115540|NCT02684708|Prednisone|prednisone|mesh-list
84115541|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
84115542|NCT02684708|Dacarbazine|dacarbazine|mesh-list
84115543|NCT02684708|Vincristine|vincristine|mesh-list
84115544|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115545|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
84115546|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115547|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115548|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84115549|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
84115550|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115551|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115552|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84115553|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115554|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
84115555|NCT02684708|Hormones|hormones|mesh-ancestor
84115556|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115557|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84115558|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84115559|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
84115560|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
84115561|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
84115562|NCT02817503|Folic Acid|folic acid|mesh-list
84115563|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
84115564|NCT02817503|Amlodipine|amlodipine|mesh-list
84115565|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84115566|NCT02817503|Enalapril|enalapril|mesh-list
84115567|NCT02817503|Enalaprilat|enalaprilat|mesh-list
84115568|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84115569|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84115570|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115571|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115572|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84115573|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115574|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
84115575|NCT02817503|Diuretics|diuretics|mesh-ancestor
84115576|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
84115577|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84115578|NCT02817503|Hematinics|hematinics|mesh-ancestor
84115579|NCT02817503|Vitamins|vitamins|mesh-ancestor
84115580|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
84115581|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84115582|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
84115583|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115584|NCT02814461|Axitinib|axitinib|mesh-list
84115585|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115586|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84115587|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115588|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115589|NCT00875667|Fludarabine|fludarabine|mesh-list
84115590|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
84115591|NCT00875667|Lenalidomide|lenalidomide|mesh-list
84115592|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115593|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84115594|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
84115595|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115596|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115597|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
84115598|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115599|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84115600|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84115601|NCT00875667|Growth Substances|growth substances|mesh-ancestor
84115602|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
84115603|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84115604|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84115605|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115606|NCT02811341|Scopolamine|scopolamine|mesh-list
84115607|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84115608|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84115609|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
84115610|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
84115611|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115612|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115613|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84115614|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
84115615|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84115616|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
84115617|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115618|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115619|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84115620|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
84115621|NCT00682383|Docetaxel|docetaxel|mesh-list
84115622|NCT00682383|Etoposide|etoposide|mesh-list
84115623|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115624|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
84115625|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
84115626|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
84115627|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115628|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84115629|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115630|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115631|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115632|NCT04237493|Insulin|insulin|mesh-list
84115633|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84115634|NCT04237493|Metformin|metformin|mesh-list
84115635|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
84115636|NCT04237493|Glimepiride|glimepiride|mesh-list
84115637|NCT04237493|Vildagliptin|vildagliptin|mesh-list
84115638|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84115639|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115640|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84115641|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115642|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
84115643|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84115644|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
84115645|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115646|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115647|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
84115648|NCT00683319|Carboplatin|carboplatin|mesh-list
84115649|NCT00683319|Methotrexate|methotrexate|mesh-list
84115650|NCT00683319|Vincristine|vincristine|mesh-list
84115651|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115652|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
84115653|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115654|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115655|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84115656|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
84115657|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115658|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115659|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84115660|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84115661|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
84115662|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84115663|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84115664|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
84115665|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
84115666|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115667|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84115668|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84115669|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84115670|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
84115671|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
84115672|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
84115673|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
84115674|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84115675|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84115676|NCT02810483|Topiramate|topiramate|mesh-list
84115677|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
84115678|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84115679|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115680|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
84115681|NCT00683865|Ofloxacin|ofloxacin|mesh-list
84115682|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84115683|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84115684|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115685|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115686|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115687|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115688|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115689|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115690|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84115691|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
84115692|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84115693|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115694|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84115695|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84115696|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84115697|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84115698|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84115699|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84115700|NCT02813369|Naloxegol|naloxegol|mesh-list
84115701|NCT02813369|Laxatives|laxatives|mesh-list
84115702|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84115703|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115704|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
84115705|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115706|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84115707|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
84115708|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
84115709|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84115710|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115711|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115712|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
84115713|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84115714|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115715|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115716|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
84115717|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84115718|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84115719|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84115720|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115721|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115722|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
84115723|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115724|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115725|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84115726|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115727|NCT02809781|Etanercept|etanercept|mesh-list
84115728|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84115729|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115730|NCT02809781|Analgesics|analgesics|mesh-ancestor
84115731|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
84115732|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115733|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115734|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115735|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115736|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84115737|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115738|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
84115739|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
84115740|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84115741|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115742|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115743|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115744|NCT02809937|Analgesics|analgesics|mesh-ancestor
84115745|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
84115746|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115747|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84115748|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84115749|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84115750|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115751|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115752|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115753|NCT02812979|Albuterol|albuterol|mesh-list
84115754|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84115755|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
84115756|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115757|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115758|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84115759|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
84115760|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
84115761|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84115762|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84115763|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84115764|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84115765|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115766|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115767|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115768|NCT02809469|Apixaban|apixaban|mesh-list
84115769|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84115770|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
84115771|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84115772|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
84115773|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115774|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115775|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
84115776|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
84115777|NCT02809079|Prednisone|prednisone|mesh-list
84115778|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115779|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
84115780|NCT02809079|Hormones|hormones|mesh-ancestor
84115781|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115782|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115783|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84115784|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115785|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84115786|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84115787|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
84115788|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84115789|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115790|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115791|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115792|NCT02812199|Lidocaine|lidocaine|mesh-list
84115793|NCT02812199|Epinephrine|epinephrine|mesh-list
84115794|NCT02812199|Racepinephrine|racepinephrine|mesh-list
84115795|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
84115796|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
84115797|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
84115798|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115799|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115800|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
84115801|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115802|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84115803|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84115804|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84115805|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115806|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115807|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84115808|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84115809|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115810|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115811|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84115812|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84115813|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
84115814|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84115815|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
84115816|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
84115817|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
84115818|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84115819|NCT02812043|Amorolfine|amorolfine|mesh-list
84115820|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
84115821|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115822|NCT02808767|Ticagrelor|ticagrelor|mesh-list
84115823|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84115824|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84115825|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84115826|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84115827|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84115828|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
84115829|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115830|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115831|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115832|NCT02812355|Heparin|heparin|mesh-list
84115833|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
84115834|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84115835|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84115836|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115837|NCT02811731|Amlodipine|amlodipine|mesh-list
84115838|NCT02811731|Candesartan|candesartan|mesh-list
84115839|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84115840|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84115841|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115842|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115843|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84115844|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115845|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
84115846|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84115847|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84115848|NCT02811809|Leuprolide|leuprolide|mesh-list
84115849|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84115850|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
84115851|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84115852|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115853|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84115854|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115855|NCT05569421|Budesonide|budesonide|mesh-list
84115856|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
84115857|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115858|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84115859|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
84115860|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115861|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115862|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84115863|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
84115864|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
84115865|NCT05569421|Hormones|hormones|mesh-ancestor
84115866|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115867|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84115868|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84115869|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84115870|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115871|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115872|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115873|NCT02808611|Propranolol|propranolol|mesh-list
84115874|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84115875|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84115876|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115877|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115878|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115879|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115880|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84115881|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84115882|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
84115883|NCT02808533|Topiramate|topiramate|mesh-list
84115884|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
84115885|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84115886|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115887|NCT02811497|Azacitidine|azacitidine|mesh-list
84115888|NCT02811497|Durvalumab|durvalumab|mesh-list
84115889|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84115890|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
84115891|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115892|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115893|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115894|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84115895|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84115896|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84115897|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84115898|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115899|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115900|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
84115901|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115902|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115903|NCT02807909|Itraconazole|itraconazole|mesh-list
84115904|NCT02807909|Diltiazem|diltiazem|mesh-list
84115905|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
84115906|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115907|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84115908|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84115909|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115910|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115911|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84115912|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
84115913|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84115914|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115915|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84115916|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84115917|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84115918|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84115919|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84115920|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
84115921|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
84115922|NCT02808065|Tacrolimus|tacrolimus|mesh-list
84115923|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84115924|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
84115925|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115926|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84115927|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115928|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115929|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84115930|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115931|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84115932|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
84115933|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84115934|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115935|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84115936|NCT00602030|Entinostat|entinostat|mesh-list
84115937|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115938|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84115939|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115940|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115941|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84115942|NCT02804711|Vaccines|vaccines|mesh-list
84115943|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
84115944|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115945|NCT00640094|Melatonin|melatonin|mesh-list
84115946|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
84115947|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115948|NCT00640094|Protective Agents|protective agents|mesh-ancestor
84115949|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115950|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84115951|NCT04183634|Rotigotine|rotigotine|mesh-list
84115952|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
84115953|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
84115954|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84115955|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115956|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115957|NCT02804633|Acetaminophen|acetaminophen|mesh-list
84115958|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115959|NCT02804633|Analgesics|analgesics|mesh-ancestor
84115960|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
84115961|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115962|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115963|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
84115964|NCT02807441|Aspirin|aspirin|mesh-list
84115965|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84115966|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84115967|NCT02807441|Analgesics|analgesics|mesh-ancestor
84115968|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
84115969|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84115970|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115971|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84115972|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84115973|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84115974|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84115975|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115976|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84115977|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84115978|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115979|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
84115980|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
83356124|NCT04943848|Iodine|iodine|mesh-list
83356125|NCT04943848|Vaccines|vaccines|mesh-list
84115981|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
84115982|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84115983|NCT02682680|Ezetimibe|ezetimibe|mesh-list
84115984|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84115985|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84115986|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84115987|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
84115988|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115989|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84115990|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
84115991|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84115992|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84115993|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84115994|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84115995|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84115996|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84115997|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84115998|NCT02682758|Xenon|xenon|mesh-list
84115999|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84116000|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
84116001|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
84116002|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116003|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116004|NCT02682524|Aceclofenac|aceclofenac|mesh-list
84116005|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84116006|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116007|NCT02682524|Analgesics|analgesics|mesh-ancestor
84116008|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
84116009|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116010|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116011|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116012|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116013|NCT04183556|Naproxen|naproxen|mesh-list
84116014|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84116015|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84116016|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116017|NCT04183556|Analgesics|analgesics|mesh-ancestor
84116018|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
84116019|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116020|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116021|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116022|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
84116023|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84116024|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116025|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116026|NCT00640952|Acamprosate|acamprosate|mesh-list
84116027|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84116028|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
84116029|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84116030|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116031|NCT02807051|Clarithromycin|clarithromycin|mesh-list
84116032|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84116033|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116034|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84116035|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116036|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116037|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84116038|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84116039|NCT02684084|Dexamethasone|dexamethasone|mesh-list
84116040|NCT02684084|Ranibizumab|ranibizumab|mesh-list
84116041|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116042|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
84116043|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
84116044|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116045|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116046|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116047|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
84116048|NCT02684084|Hormones|hormones|mesh-ancestor
84116049|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116050|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116051|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116052|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84116053|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84116054|NCT02684084|Growth Substances|growth substances|mesh-ancestor
84116055|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
84116056|NCT02684318|Olaparib|olaparib|mesh-list
84116057|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84116058|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116059|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116060|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116061|NCT02806817|Bevacizumab|bevacizumab|mesh-list
84116062|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116063|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116064|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84116065|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84116066|NCT02806817|Growth Substances|growth substances|mesh-ancestor
84116067|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116068|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
84116069|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84116070|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84116071|NCT04182854|Diuretics|diuretics|mesh-ancestor
84116072|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
84116073|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116074|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84116075|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84116076|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116077|NCT02680808|Olorofim|olorofim|mesh-list
84116078|NCT02680808|Midazolam|midazolam|mesh-list
84116079|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84116080|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84116081|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116082|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116083|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84116084|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84116085|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84116086|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84116087|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
84116088|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
84116089|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
84116090|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
84116091|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116092|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116093|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
84116094|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116095|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
84116096|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84116097|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84116098|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
84116099|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
84116100|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116101|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116102|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
84116103|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116104|NCT04004819|Rituximab|rituximab|mesh-list
84116105|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116106|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116107|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
84116108|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116109|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116110|NCT00641654|Interferons|interferons|mesh-list
84116111|NCT00641654|Ribavirin|ribavirin|mesh-list
84116112|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
84116113|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
84116114|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84116115|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116116|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
84116117|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116118|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
84116119|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116120|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
84116121|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116122|NCT02826434|Durvalumab|durvalumab|mesh-list
84116123|NCT02826434|Poly ICLC|poly iclc|mesh-list
84116124|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116125|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116126|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
84116127|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
84116128|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116129|NCT00549601|Rivastigmine|rivastigmine|mesh-list
84116130|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84116131|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116132|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116133|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
84116134|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116135|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116136|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84116137|NCT00549601|Protective Agents|protective agents|mesh-ancestor
84116138|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
84116139|NCT02806349|Cathartics|cathartics|mesh-ancestor
84116140|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116141|NCT04184492|Insulin|insulin|mesh-list
84116142|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84116143|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
84116144|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
84116145|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84116146|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
84116147|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84116148|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
84116149|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84116150|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116151|NCT02806115|Acetic Acid|acetic acid|mesh-list
84116152|NCT02806115|Retinol acetate|retinol acetate|mesh-list
84116153|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84116154|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116155|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84116156|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
84116157|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116158|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84116159|NCT02806115|Protective Agents|protective agents|mesh-ancestor
84116160|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116161|NCT02682134|Dexamethasone|dexamethasone|mesh-list
84116162|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
84116163|NCT02682134|Lidocaine|lidocaine|mesh-list
84116164|NCT02682134|BB 1101|bb 1101|mesh-list
84116165|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116166|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
84116167|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
84116168|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116169|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116170|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116171|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
84116172|NCT02682134|Hormones|hormones|mesh-ancestor
84116173|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116174|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116175|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116176|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
84116177|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116178|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116179|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
84116180|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
84116181|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116182|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
84116183|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84116184|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84116185|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84116186|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84116187|NCT04236323|Remifentanil|remifentanil|mesh-list
84116188|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84116189|NCT04236323|Narcotics|narcotics|mesh-ancestor
84116190|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116191|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116192|NCT04236323|Analgesics|analgesics|mesh-ancestor
84116193|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
84116194|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116195|NCT04206163|Edotreotide|edotreotide|mesh-list
84116196|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84116197|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116198|NCT00909974|Micronutrients|micronutrients|mesh-list
84116199|NCT00909974|Trace Elements|trace elements|mesh-list
84116200|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116201|NCT05300347|Adenosine|adenosine|mesh-list
84116202|NCT05300347|Analgesics|analgesics|mesh-ancestor
84116203|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
83356351|NCT00421642|Adalimumab|adalimumab|mesh-list
84116204|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116205|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116206|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84116208|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84116209|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
84116210|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
84116211|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116212|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116213|NCT04011241|Itraconazole|itraconazole|mesh-list
84116214|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
84116215|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116216|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84116217|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84116218|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116219|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116220|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84116221|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
84116222|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116223|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116224|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84116225|NCT00956059|Prednisone|prednisone|mesh-list
84116226|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116227|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
84116228|NCT00956059|Hormones|hormones|mesh-ancestor
84116229|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116230|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116231|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116232|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116233|NCT04010929|Pemetrexed|pemetrexed|mesh-list
84116234|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116235|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116236|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116237|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84116238|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84116239|NCT00956215|Aprepitant|aprepitant|mesh-list
84116240|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
84116241|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
84116242|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
84116243|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116244|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116245|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116246|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84116247|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116248|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116249|NCT00640640|Bevacizumab|bevacizumab|mesh-list
84116250|NCT00640640|Ranibizumab|ranibizumab|mesh-list
84116251|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116252|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116253|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84116254|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84116255|NCT00640640|Growth Substances|growth substances|mesh-ancestor
84116256|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116257|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
84116258|NCT03973177|Phenol|phenol|mesh-list
84116259|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
84116260|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84116261|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84116262|NCT03973177|Prednisolone|prednisolone|mesh-list
84116263|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
84116264|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84116265|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
84116266|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116267|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
84116268|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
84116269|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116270|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116271|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116272|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
84116273|NCT03973177|Hormones|hormones|mesh-ancestor
84116274|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116275|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84116276|NCT03973177|Protective Agents|protective agents|mesh-ancestor
84116277|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116278|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116279|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84116280|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116281|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
84116282|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
84116283|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84116284|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
84116285|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84116286|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116287|NCT00961909|Metformin|metformin|mesh-list
84116288|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84116289|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116290|NCT04115189|Sunitinib|sunitinib|mesh-list
84116291|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116292|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84116293|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84116294|NCT04115189|Growth Substances|growth substances|mesh-ancestor
84116295|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116296|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
84116297|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84116298|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116299|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116300|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
84116301|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84116302|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116303|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
84116304|NCT02678234|Acetaminophen|acetaminophen|mesh-list
84116305|NCT02678234|Phenylephrine|phenylephrine|mesh-list
84116306|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
84116307|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116308|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116309|NCT02678234|Analgesics|analgesics|mesh-ancestor
84116310|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
84116311|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116312|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
84116313|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116314|NCT02678234|Protective Agents|protective agents|mesh-ancestor
84116315|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84116316|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
84116317|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
84116318|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
84116319|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84116320|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
84116321|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
84116322|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84116323|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84116324|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84116325|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
84116326|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116327|NCT00601640|Eflornithine|eflornithine|mesh-list
84116328|NCT00601640|Diclofenac|diclofenac|mesh-list
84116329|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84116330|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116331|NCT00601640|Analgesics|analgesics|mesh-ancestor
84116332|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
84116333|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116334|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116335|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116336|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116337|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84116338|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116339|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116340|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116341|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84116342|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84116343|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84116344|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116345|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
84116346|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
84116347|NCT02805725|Trabectedin|trabectedin|mesh-list
84116348|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84116349|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
84116350|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116351|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116352|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84116353|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
84116354|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116355|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116356|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84116357|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
84116358|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84116360|NCT03549715|Tremelimumab|tremelimumab|mesh-list
84116361|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116362|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116363|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
84116364|NCT02803385|Anesthetics|anesthetics|mesh-list
84116365|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
84116366|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116367|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116368|NCT02803385|Narcotics|narcotics|mesh-ancestor
84116369|NCT02803385|Analgesics|analgesics|mesh-ancestor
84116370|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
84116371|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116372|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84116373|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84116374|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116375|NCT00642434|Metoprolol|metoprolol|mesh-list
84116376|NCT00642434|Carvedilol|carvedilol|mesh-list
84116377|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84116378|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84116379|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
84116380|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
84116381|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116382|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116383|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84116384|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84116385|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84116386|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
84116387|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116388|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116389|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
84116390|NCT00642434|Protective Agents|protective agents|mesh-ancestor
84116391|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84116392|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84116393|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84116394|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
84116395|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84116396|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84116397|NCT05352373|Calcium|calcium|mesh-list
84116398|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84116399|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116400|NCT02677532|Acetaminophen|acetaminophen|mesh-list
84116401|NCT02677532|Sufentanil|sufentanil|mesh-list
84116402|NCT02677532|Morphine|morphine|mesh-list
84116403|NCT02677532|Dsuvia|dsuvia|mesh-list
84116404|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
84116405|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84116406|NCT02677532|Narcotics|narcotics|mesh-ancestor
84116407|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116408|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116409|NCT02677532|Analgesics|analgesics|mesh-ancestor
84116410|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
84116411|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116412|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116413|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
84116414|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84116415|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84116416|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
84116417|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
84116418|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
84116419|NCT00641810|Caffeine|caffeine|mesh-list
84116420|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84116421|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116422|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84116423|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116424|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116425|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84116426|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84116427|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
84116428|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116429|NCT02802995|Thrombin|thrombin|mesh-list
84116430|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
83356604|NCT05156632|Vaccines|vaccines|mesh-list
84116431|NCT02802995|Coagulants|coagulants|mesh-ancestor
84116432|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84116434|NCT00910052|Coagulants|coagulants|mesh-ancestor
84116435|NCT02677376|Listerine|listerine|mesh-list
84116436|NCT02677376|Fluorides|fluorides|mesh-list
84116437|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
84116438|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
84116439|NCT02677376|Protective Agents|protective agents|mesh-ancestor
84116440|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116441|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84116442|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116443|NCT02800889|Pixantrone|pixantrone|mesh-list
84116444|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84116445|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84116446|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116447|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116448|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116449|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
84116450|NCT02803073|Testosterone|testosterone|mesh-list
84116451|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
84116452|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
84116453|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84116454|NCT02803073|Androgens|androgens|mesh-ancestor
84116455|NCT02803073|Hormones|hormones|mesh-ancestor
84116456|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116457|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116458|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116459|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116460|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
84116461|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
84116462|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84116463|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
84116464|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116465|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116466|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84116467|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
84116468|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84116469|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
84116470|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116471|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116472|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84116473|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
84116474|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
84116475|NCT00922532|Protective Agents|protective agents|mesh-ancestor
84116476|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
84116477|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116478|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116479|NCT05662904|Immunotoxins|immunotoxins|mesh-ancestor
84116480|NCT05662904|Immunoconjugates|immunoconjugates|mesh-ancestor
84116481|NCT05662904|Immunologic Factors|immunologic factors|mesh-ancestor
84116482|NCT05662904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116483|NCT00642512|Dronabinol|dronabinol|mesh-list
84116484|NCT00642512|Ondansetron|ondansetron|mesh-list
84116485|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
84116486|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
84116487|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116488|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116489|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116490|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
84116491|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
84116492|NCT00642512|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84116493|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84116494|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
84116495|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116496|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116497|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
84116498|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84116499|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116500|NCT00642512|Analgesics|analgesics|mesh-ancestor
84116501|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
84116502|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84116503|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84116504|NCT00642512|Hormones|hormones|mesh-ancestor
84116505|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116506|NCT02802683|Phenylephrine|phenylephrine|mesh-list
84116507|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
84116508|NCT02802683|Bupivacaine|bupivacaine|mesh-list
84116510|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
84116511|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
84116512|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116513|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116514|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
84116515|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116516|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84116517|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
84116518|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
84116519|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
84116520|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84116521|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
84116522|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
84116523|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84116524|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84116525|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84116526|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
84116527|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116528|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116529|NCT02802683|Protective Agents|protective agents|mesh-ancestor
84116530|NCT00641264|Omeprazole|omeprazole|mesh-list
84116531|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84116532|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116533|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84116534|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116535|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116536|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
84116537|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84116538|NCT05484167|Testosterone|testosterone|mesh-list
84116539|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
84116540|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
84116541|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116542|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116543|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
84116544|NCT05484167|Hormones|hormones|mesh-ancestor
84116545|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116546|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116547|NCT05484167|Androgens|androgens|mesh-ancestor
84116548|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84116549|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
84116550|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116551|NCT04180982|Febuxostat|febuxostat|mesh-list
84116552|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
84116553|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116554|NCT02802605|Bemiparin|bemiparin|mesh-list
84116555|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
84116556|NCT02800265|Sulforaphane|sulforaphane|mesh-list
84116557|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84116558|NCT02800265|Protective Agents|protective agents|mesh-ancestor
84116559|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116560|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116561|NCT02676986|Exemestane|exemestane|mesh-list
84116562|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116563|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84116564|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84116565|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116566|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116567|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84116568|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
84116569|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116570|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116571|NCT02802215|Folic Acid|folic acid|mesh-list
84116572|NCT02802215|Metformin|metformin|mesh-list
84116573|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84116574|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116575|NCT02802215|Hematinics|hematinics|mesh-ancestor
84116576|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
84116577|NCT02802215|Vitamins|vitamins|mesh-ancestor
84116578|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
84116579|NCT02799797|Sufentanil|sufentanil|mesh-list
84116580|NCT02799797|Dsuvia|dsuvia|mesh-list
84116581|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84116582|NCT02799797|Narcotics|narcotics|mesh-ancestor
84116583|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116584|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116585|NCT02799797|Analgesics|analgesics|mesh-ancestor
84116586|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
84116587|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116588|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84116589|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84116591|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
84116592|NCT05663372|Eplerenone|eplerenone|mesh-list
84116593|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84116594|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
84116595|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116596|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116597|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84116598|NCT05663372|Diuretics|diuretics|mesh-ancestor
84116599|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
84116600|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84116601|NCT02802137|Timolol|timolol|mesh-list
84116602|NCT02802137|Dorzolamide|dorzolamide|mesh-list
84116603|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84116604|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84116605|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
84116606|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116607|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116608|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116609|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84116610|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84116611|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84116612|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116613|NCT04033562|Lidocaine|lidocaine|mesh-list
84116614|NCT04033562|Bupivacaine|bupivacaine|mesh-list
84116615|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
84116616|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
84116617|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116618|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116619|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
84116620|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116621|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84116622|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84116623|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84116624|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84116625|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116626|NCT04032834|Budesonide|budesonide|mesh-list
84116627|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116628|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84116629|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
84116630|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116631|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116632|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84116633|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
84116634|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
84116635|NCT04032834|Hormones|hormones|mesh-ancestor
84116636|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116637|NCT02817191|Tobramycin|tobramycin|mesh-list
84116638|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
84116639|NCT02817191|Dexamethasone|dexamethasone|mesh-list
84116640|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
84116641|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84116642|NCT02817191|BB 1101|bb 1101|mesh-list
84116643|NCT02817191|Dipivefrin|dipivefrin|mesh-list
84116644|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116645|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
84116646|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
84116647|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116648|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116649|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116650|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
84116651|NCT02817191|Hormones|hormones|mesh-ancestor
84116652|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116653|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116654|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116655|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
84116656|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116657|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116658|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84116659|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84116660|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116661|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84116662|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
84116663|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116664|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
84116665|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116666|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116667|NCT02636010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84116668|NCT02636010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116669|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
84116670|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
84116671|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84116672|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84116673|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116674|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
84116675|NCT05474027|Coagulants|coagulants|mesh-ancestor
84116676|NCT00642824|Bevacizumab|bevacizumab|mesh-list
84116677|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116678|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116679|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84116680|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84116681|NCT00642824|Growth Substances|growth substances|mesh-ancestor
84116682|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116683|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
84116684|NCT02679014|Petesicatib|petesicatib|mesh-list
84116685|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116686|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116687|NCT02801357|Lofexidine|lofexidine|mesh-list
84116688|NCT02801357|Buprenorphine|buprenorphine|mesh-list
84116689|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84116690|NCT02801357|Narcotics|narcotics|mesh-ancestor
84116691|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116692|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116693|NCT02801357|Analgesics|analgesics|mesh-ancestor
84116694|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
84116695|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116696|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84116697|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84116698|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84116699|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84116700|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84116701|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
84116702|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116703|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116704|NCT02676674|Vitamin D|vitamin d|mesh-list
84116705|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
84116706|NCT02676674|Vitamins|vitamins|mesh-ancestor
84116707|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
84116708|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116709|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84116710|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84116711|NCT00962299|Beclomethasone|beclomethasone|mesh-list
84116712|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116713|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
84116714|NCT00962299|Hormones|hormones|mesh-ancestor
84116715|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116716|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116717|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84116718|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
84116719|NCT02679092|Misoprostol|misoprostol|mesh-list
84116720|NCT02679092|Mifepristone|mifepristone|mesh-list
84116721|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84116722|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
84116723|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84116724|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116725|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84116726|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116727|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
84116728|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84116729|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84116730|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84116731|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84116732|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
84116733|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83356883|NCT05039476|Vitamin A|vitamin a|mesh-list
84116734|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84116735|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
84116736|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116737|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
84116738|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84116739|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84116740|NCT04183088|Tislelizumab|tislelizumab|mesh-list
84116741|NCT04183088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116742|NCT04183088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116743|NCT00642122|Budesonide|budesonide|mesh-list
84116744|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116745|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84116746|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
84116747|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116748|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116749|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84116750|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
84116751|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
84116752|NCT00642122|Hormones|hormones|mesh-ancestor
84116753|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116754|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
84116755|NCT00546871|Antibodies|antibodies|mesh-list
84116756|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
84116757|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84116758|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84116759|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
84116760|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116761|NCT02817113|Fluorouracil|fluorouracil|mesh-list
84116762|NCT02817113|Cetuximab|cetuximab|mesh-list
84116763|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
84116764|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116765|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84116766|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116767|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84116768|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
84116769|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116770|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116771|NCT02801201|Midazolam|midazolam|mesh-list
84116772|NCT02801201|Bupivacaine|bupivacaine|mesh-list
84116773|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
84116774|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
84116775|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116776|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116777|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
84116778|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116779|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84116780|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84116781|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84116782|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84116783|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84116784|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84116785|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
84116786|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
84116787|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
84116788|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116789|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116790|NCT04182932|Vaccines|vaccines|mesh-list
84116791|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
84116792|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116793|NCT03951805|Insulin|insulin|mesh-list
84116794|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84116795|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
84116796|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84116797|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116798|NCT02681198|Lofexidine|lofexidine|mesh-list
84116799|NCT02681198|Paroxetine|paroxetine|mesh-list
84116800|NCT02681198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83429963|NCT00501631|Naltrexone|naltrexone|mesh-list
84116801|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84116802|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84116803|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116804|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84116805|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
84116806|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116807|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84116808|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
84116809|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84116810|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84116811|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84116812|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116813|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84116814|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84116815|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
84116816|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116817|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84116818|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84116819|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84116820|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
84116821|NCT05597306|Venetoclax|venetoclax|mesh-list
84116822|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116823|NCT00962533|Telbivudine|telbivudine|mesh-list
84116824|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
84116825|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116826|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84116827|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116828|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116829|NCT00642980|Clindamycin|clindamycin|mesh-list
84116830|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
84116831|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
84116832|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84116833|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116834|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84116835|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116836|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116837|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
84116838|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116839|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
84116840|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84116841|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84116842|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116843|NCT02798159|Urological Agents|urological agents|mesh-ancestor
84116844|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
84116845|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116846|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116847|NCT00962767|Immunotoxins|immunotoxins|mesh-ancestor
84116848|NCT00962767|Immunoconjugates|immunoconjugates|mesh-ancestor
84116849|NCT00962767|Immunologic Factors|immunologic factors|mesh-ancestor
84116850|NCT00962767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116851|NCT02678780|Lenvatinib|lenvatinib|mesh-list
84116852|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116853|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84116854|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116855|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116856|NCT00963001|Treprostinil|treprostinil|mesh-list
84116857|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84116858|NCT00643136|Pregabalin|pregabalin|mesh-list
84116859|NCT00643136|Analgesics|analgesics|mesh-ancestor
84116860|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
84116861|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116862|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116863|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
84116864|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84116865|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84116866|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116867|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84116868|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84116869|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84116870|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116871|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84116872|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
84116873|NCT01563367|Hematinics|hematinics|mesh-ancestor
84116874|NCT00963313|Adalimumab|adalimumab|mesh-list
84116875|NCT00963313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84116876|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116877|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116878|NCT02797145|Digoxin|digoxin|mesh-list
84116879|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84116880|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84116881|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116882|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116883|NCT02797145|Protective Agents|protective agents|mesh-ancestor
84116884|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116885|NCT02690129|Progesterone|progesterone|mesh-list
84116886|NCT02690129|Progestins|progestins|mesh-ancestor
84116887|NCT02690129|Hormones|hormones|mesh-ancestor
84116888|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116889|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116890|NCT00883116|Paclitaxel|paclitaxel|mesh-list
84116891|NCT00883116|Doxorubicin|doxorubicin|mesh-list
84116892|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84116893|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84116894|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116895|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
84116896|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
84116897|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
84116898|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116899|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84116900|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84116901|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84116902|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116903|NCT02139397|Eflornithine|eflornithine|mesh-list
84116904|NCT02139397|Bortezomib|bortezomib|mesh-list
84116905|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116906|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84116907|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84116908|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84116909|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116910|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
84116911|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116912|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116913|NCT02795429|Spartalizumab|spartalizumab|mesh-list
84116914|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84116915|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116916|NCT02795429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116917|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116918|NCT00643292|Amoxicillin|amoxicillin|mesh-list
84116919|NCT00643292|Azithromycin|azithromycin|mesh-list
84116920|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
84116921|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
84116922|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84116923|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84116924|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84116925|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84116926|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116927|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116928|NCT02797067|Indomethacin|indomethacin|mesh-list
84116929|NCT02797067|Glycerol|glycerol|mesh-list
84116930|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84116931|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116932|NCT02797067|Analgesics|analgesics|mesh-ancestor
84116933|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
84116934|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116935|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116936|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116937|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116938|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
84116939|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
84116940|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84116941|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84116942|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116943|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116944|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84116945|NCT02797067|Protective Agents|protective agents|mesh-ancestor
84116946|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
84116947|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84116948|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116949|NCT00963703|Rituximab|rituximab|mesh-list
84116950|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84116951|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116952|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
84116953|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116954|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116955|NCT00655122|Dalteparin|dalteparin|mesh-list
84116956|NCT00655122|Tinzaparin|tinzaparin|mesh-list
84116957|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84116958|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
83357110|NCT01704755|Ribavirin|ribavirin|mesh-list
84116959|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84116960|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84116961|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116962|NCT02638116|Omeprazole|omeprazole|mesh-list
84116963|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84116964|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84116965|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84116966|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84116967|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84116968|NCT04164264|Propofol|propofol|mesh-list
84116969|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84116970|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84116971|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116972|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84116973|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
84116974|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
84116975|NCT02795039|Fulvestrant|fulvestrant|mesh-list
84116976|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84116977|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84116978|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84116979|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84116980|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
84116981|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84116982|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116983|NCT02796833|SMOFlipid|smoflipid|mesh-list
84116984|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84116985|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84116986|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84116987|NCT04009603|Metformin|metformin|mesh-list
84116988|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84116989|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116990|NCT02635230|Aspirin|aspirin|mesh-list
84116991|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84116992|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84116993|NCT02635230|Analgesics|analgesics|mesh-ancestor
84116994|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
84116995|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84116996|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84116997|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84116998|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84116999|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84117000|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84117001|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117002|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84117003|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84117004|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117005|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
84117006|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
84117007|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
84117008|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
84117009|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84117010|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
84117011|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84117012|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
84117013|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84117014|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117015|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84117016|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84117017|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117018|NCT04009525|Cyclosporine|cyclosporine|mesh-list
84117019|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
84117020|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
84117021|NCT04009525|Busulfan|busulfan|mesh-list
84117022|NCT04009525|Methotrexate|methotrexate|mesh-list
84117023|NCT04009525|Fludarabine|fludarabine|mesh-list
84117024|NCT04009525|Tacrolimus|tacrolimus|mesh-list
84117025|NCT04009525|Cyclosporins|cyclosporins|mesh-list
84117026|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
84117027|NCT04009525|Basiliximab|basiliximab|mesh-list
84117028|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84117029|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
84117030|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117031|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117032|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83357184|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117033|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
84117034|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117035|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117036|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84117037|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84117038|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
84117039|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84117040|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117041|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
84117042|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117043|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117044|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84117045|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84117046|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84117047|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
84117048|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117049|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84117050|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84117051|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
84117052|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84117053|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
84117054|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84117055|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
84117056|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117057|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117058|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84117059|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
84117060|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84117061|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
84117062|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117063|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117064|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84117065|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
84117066|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
84117067|NCT04032366|Protective Agents|protective agents|mesh-ancestor
84117068|NCT02537600|Vemurafenib|vemurafenib|mesh-list
84117069|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117070|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84117071|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117072|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117073|NCT00684099|Docetaxel|docetaxel|mesh-list
84117074|NCT00684099|Pemetrexed|pemetrexed|mesh-list
84117075|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117076|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
84117077|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
84117078|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
84117079|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117080|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117081|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84117082|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84117083|NCT04159896|Nivolumab|nivolumab|mesh-list
84117084|NCT04159896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
84117085|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84117086|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117087|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84117088|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117089|NCT04159896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84117090|NCT04159896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117091|NCT02635074|Cytarabine|cytarabine|mesh-list
84117092|NCT02635074|Idarubicin|idarubicin|mesh-list
84117093|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117094|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
84117095|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117096|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117097|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
84117098|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117099|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84117100|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
84117101|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117102|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84117103|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117104|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117105|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117106|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
84117107|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84117108|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117109|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117110|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117111|NCT02537366|Analgesics|analgesics|mesh-ancestor
84117112|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
84117113|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117114|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84117115|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84117116|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84117117|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
84117118|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117119|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117120|NCT00690417|Vitamin D|vitamin d|mesh-list
84117121|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
84117122|NCT00690417|Vitamins|vitamins|mesh-ancestor
84117123|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
84117124|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117125|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84117126|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84117127|NCT05434559|Insulin|insulin|mesh-list
84117128|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117129|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117130|NCT00546637|Fesoterodine|fesoterodine|mesh-list
84117131|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84117132|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84117133|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
84117134|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117135|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117136|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117137|NCT00546637|Urological Agents|urological agents|mesh-ancestor
84117138|NCT00690885|Interferons|interferons|mesh-list
84117139|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
84117140|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
84117141|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
84117142|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117143|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
84117144|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117145|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
84117146|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117147|NCT04138719|Paclitaxel|paclitaxel|mesh-list
84117148|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84117149|NCT04138719|Carboplatin|carboplatin|mesh-list
84117150|NCT04138719|Epirubicin|epirubicin|mesh-list
84117151|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84117152|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117153|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
84117154|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
84117155|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
84117156|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117157|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84117158|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117159|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117160|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117161|NCT02790203|Celecoxib|celecoxib|mesh-list
84117162|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84117163|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117164|NCT02790203|Analgesics|analgesics|mesh-ancestor
84117165|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
84117166|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117167|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117168|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117169|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117170|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84117171|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84117172|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117173|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117174|NCT02816567|Sufentanil|sufentanil|mesh-list
84117175|NCT02816567|Propofol|propofol|mesh-list
84117176|NCT02816567|Cisatracurium|cisatracurium|mesh-list
84117177|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84117178|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117179|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117180|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84117181|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
84117182|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
84117183|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84117185|NCT02816567|Analgesics|analgesics|mesh-ancestor
84117186|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
84117187|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117188|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84117189|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84117190|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84117191|NCT00657774|Prednisone|prednisone|mesh-list
84117192|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117193|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
84117194|NCT00657774|Hormones|hormones|mesh-ancestor
84117195|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117196|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117197|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84117198|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117199|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
84117200|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
84117201|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117202|NCT02789969|Fentanyl|fentanyl|mesh-list
84117203|NCT02789969|Hydromorphone|hydromorphone|mesh-list
84117204|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84117205|NCT02789969|Narcotics|narcotics|mesh-ancestor
84117206|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117207|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117208|NCT02789969|Analgesics|analgesics|mesh-ancestor
84117209|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
84117210|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117211|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84117212|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84117213|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
84117214|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
84117215|NCT00657852|Pamidronate|pamidronate|mesh-list
84117216|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84117217|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117218|NCT00691275|Ondansetron|ondansetron|mesh-list
84117219|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
84117220|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
84117221|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117222|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117223|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84117224|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
84117225|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117226|NCT00691275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84117227|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84117228|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
84117229|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117230|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117231|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
84117232|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117233|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117234|NCT00655512|Clobetasol|clobetasol|mesh-list
84117235|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
84117236|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117237|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
84117238|NCT00655512|Hormones|hormones|mesh-ancestor
84117239|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117240|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117241|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84117242|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117243|NCT00655512|Analgesics|analgesics|mesh-ancestor
84117244|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
84117245|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117246|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117247|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117248|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84117249|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
84117250|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84117251|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117252|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117253|NCT00644306|Thalidomide|thalidomide|mesh-list
84117254|NCT00644306|Prednisone|prednisone|mesh-list
84117255|NCT00644306|Melphalan|melphalan|mesh-list
84117256|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117257|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
84117258|NCT00644306|Hormones|hormones|mesh-ancestor
84117259|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117260|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117261|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84117263|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84117264|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
84117265|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117266|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84117267|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84117268|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
84117269|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
84117270|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84117271|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117272|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84117273|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84117274|NCT00644306|Growth Substances|growth substances|mesh-ancestor
84117275|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
84117276|NCT02634528|Insulin|insulin|mesh-list
84117277|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84117278|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
84117279|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
84117280|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
84117281|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117282|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117283|NCT02816411|Caseins|caseins|mesh-list
84117284|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
84117285|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
84117286|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117287|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
84117288|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84117289|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
84117290|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84117291|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84117292|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117293|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117294|NCT00655590|Urological Agents|urological agents|mesh-ancestor
84117295|NCT02794025|Esmolol|esmolol|mesh-list
84117296|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84117297|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84117298|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84117299|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
84117300|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117301|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117302|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117303|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
84117304|NCT00546481|Hematinics|hematinics|mesh-ancestor
84117305|NCT02789813|Valproic Acid|valproic acid|mesh-list
84117306|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
84117307|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117308|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117309|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
84117310|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117311|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117312|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
84117313|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84117314|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117315|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84117316|NCT02632578|Vaccines|vaccines|mesh-list
84117317|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
84117318|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117319|NCT04138251|Empagliflozin|empagliflozin|mesh-list
84117320|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84117321|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117322|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117323|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117324|NCT00964171|Efavirenz|efavirenz|mesh-list
84117325|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84117326|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84117327|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117328|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117329|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
84117330|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117331|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84117332|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84117333|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84117334|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84117335|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84117336|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84117337|NCT04016246|Propofol|propofol|mesh-list
84117338|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84117339|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117340|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117341|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84117342|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
84117343|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
84117344|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84117345|NCT04178876|Ethanol|ethanol|mesh-list
84117346|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84117347|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117348|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117349|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117350|NCT02789579|Levofloxacin|levofloxacin|mesh-list
84117351|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
84117352|NCT02789579|Cefuroxime|cefuroxime|mesh-list
84117353|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
84117354|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84117355|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117356|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84117357|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117358|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117359|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117360|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117361|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117362|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84117363|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84117364|NCT04233203|Insulin|insulin|mesh-list
84117365|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84117366|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117367|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117368|NCT00959101|Metformin|metformin|mesh-list
84117369|NCT00959101|Repaglinide|repaglinide|mesh-list
84117370|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117371|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117372|NCT04233359|Anesthetics|anesthetics|mesh-list
84117373|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
84117374|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117375|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117376|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
84117377|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117378|NCT00964327|Darunavir|darunavir|mesh-list
84117379|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84117380|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84117381|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
84117382|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117383|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117384|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84117385|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84117386|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
84117387|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117388|NCT05252546|Loperamide|loperamide|mesh-list
84117389|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
84117390|NCT05252546|Bentonite|bentonite|mesh-list
84117391|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84117392|NCT05252546|Antidotes|antidotes|mesh-ancestor
84117393|NCT05252546|Protective Agents|protective agents|mesh-ancestor
84117394|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117395|NCT00644384|Acitretin|acitretin|mesh-list
84117396|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
84117397|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117398|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
84117399|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84117400|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84117401|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
84117402|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
84117403|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117404|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117405|NCT02815865|Oxytocin|oxytocin|mesh-list
84117406|NCT02815865|Dinoprostone|dinoprostone|mesh-list
84117407|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
84117408|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84117409|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117410|NCT02673866|Pregabalin|pregabalin|mesh-list
84117411|NCT02673866|DS-1971a|ds-1971a|mesh-list
84117412|NCT02673866|Analgesics|analgesics|mesh-ancestor
84117413|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
84117414|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117415|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117416|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
84117417|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84117418|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84117419|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117420|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84117421|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84117422|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84117423|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117424|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84117425|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84117426|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84117427|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84117428|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
84117429|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84117430|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117431|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
84117432|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117433|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117434|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117435|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117436|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117437|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84117438|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84117439|NCT02793323|Anesthetics|anesthetics|mesh-list
84117440|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117441|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117442|NCT00964639|Ropivacaine|ropivacaine|mesh-list
84117443|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
84117444|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
84117445|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117446|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117447|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
84117448|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117449|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84117450|NCT00880620|Carbidopa|carbidopa|mesh-list
84117451|NCT00880620|Levodopa|levodopa|mesh-list
84117452|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84117453|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
84117454|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117455|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84117456|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84117457|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
84117458|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
84117459|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117460|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117461|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84117462|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117463|NCT00959335|Bicalutamide|bicalutamide|mesh-list
84117464|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
84117465|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
84117466|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117467|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117468|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117469|NCT00644618|Gemcitabine|gemcitabine|mesh-list
84117470|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117471|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
84117472|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117473|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117474|NCT03967847|Ketorolac|ketorolac|mesh-list
84117475|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84117476|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117477|NCT03967847|Analgesics|analgesics|mesh-ancestor
84117478|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
84117479|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117480|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117481|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117482|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117483|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84117484|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117485|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117486|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
84117487|NCT04175990|Progestins|progestins|mesh-ancestor
84117488|NCT04175990|Hormones|hormones|mesh-ancestor
84117489|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117490|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117491|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84117492|NCT00959569|Esmolol|esmolol|mesh-list
84117493|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84117494|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
84117495|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117496|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117497|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117498|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84117499|NCT00881868|Clobetasol|clobetasol|mesh-list
84117500|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117501|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
84117502|NCT00881868|Hormones|hormones|mesh-ancestor
84117503|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117504|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117505|NCT04176068|Calcium|calcium|mesh-list
84117506|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84117507|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117508|NCT00959725|Infliximab|infliximab|mesh-list
84117509|NCT00959725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84117510|NCT00959725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117511|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117512|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84117513|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117514|NCT02789189|Gemcitabine|gemcitabine|mesh-list
84117515|NCT02789189|Nedaplatin|nedaplatin|mesh-list
84117516|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117517|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
84117518|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117519|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117520|NCT04234607|Carboplatin|carboplatin|mesh-list
84117521|NCT04234607|Etoposide|etoposide|mesh-list
84117522|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117523|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84117524|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117525|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117526|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117527|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117528|NCT03955471|Niraparib|niraparib|mesh-list
84117529|NCT03955471|Dostarlimab|dostarlimab|mesh-list
84117530|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84117531|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117532|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117533|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117534|NCT02637726|Remifentanil|remifentanil|mesh-list
84117535|NCT02637726|Propofol|propofol|mesh-list
84117536|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84117537|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117538|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117539|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84117540|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
84117541|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
84117542|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84117543|NCT02637726|Narcotics|narcotics|mesh-ancestor
84117544|NCT02637726|Analgesics|analgesics|mesh-ancestor
84117545|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
84117546|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117547|NCT04161768|Norfloxacin|norfloxacin|mesh-list
84117548|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84117549|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117550|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117551|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117552|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117553|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117554|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117555|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84117556|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84117557|NCT05300282|Gemcitabine|gemcitabine|mesh-list
84117558|NCT05300282|Atezolizumab|atezolizumab|mesh-list
84117559|NCT05300282|Vinorelbine|vinorelbine|mesh-list
84117560|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84117561|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117562|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
84117563|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117564|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117565|NCT05300282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84117566|NCT05300282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84117567|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84117568|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
84117569|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
84117570|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
84117571|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84117572|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
84117573|NCT02793011|Dexamethasone|dexamethasone|mesh-list
84117574|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117575|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
84117576|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
84117577|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117578|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117579|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84117580|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
84117581|NCT02793011|Hormones|hormones|mesh-ancestor
84117582|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117583|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84117584|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117585|NCT00965107|Thiopental|thiopental|mesh-list
84117586|NCT00965107|Propofol|propofol|mesh-list
84117587|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84117588|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117589|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117590|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84117591|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
84117592|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
84117593|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
84117594|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
84117595|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
84117596|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117597|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117598|NCT02788877|Aflibercept|aflibercept|mesh-list
84117599|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84117600|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84117601|NCT02788877|Growth Substances|growth substances|mesh-ancestor
84117602|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117603|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
84117604|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117605|NCT00959881|Donepezil|donepezil|mesh-list
84117606|NCT00959881|Begacestat|begacestat|mesh-list
84117607|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84117608|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117609|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117610|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
84117611|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117612|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117613|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
84117614|NCT00959881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84117615|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
84117616|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117617|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117618|NCT03651011|Aflibercept|aflibercept|mesh-list
84117619|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84117620|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84117621|NCT03651011|Growth Substances|growth substances|mesh-ancestor
84117622|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117623|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
84117624|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117625|NCT00880542|Sorafenib|sorafenib|mesh-list
84117626|NCT00880542|Ifosfamide|ifosfamide|mesh-list
84117627|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117628|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84117629|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117630|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117631|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84117632|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
84117633|NCT00960037|Vitamin D|vitamin d|mesh-list
84117634|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
84117635|NCT00960037|Vitamins|vitamins|mesh-ancestor
84117636|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
84117637|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117638|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84117639|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84117640|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84117641|NCT04161690|Ropivacaine|ropivacaine|mesh-list
84117642|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
84117643|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
84117644|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117645|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117646|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
84117647|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117648|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84117649|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117650|NCT04161690|Analgesics|analgesics|mesh-ancestor
84117651|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117652|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117653|NCT00885534|Temozolomide|temozolomide|mesh-list
84117654|NCT00885534|Vinblastine|vinblastine|mesh-list
84117655|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117656|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84117657|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
84117658|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117659|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84117660|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
84117661|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
84117662|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
84117663|NCT05277038|Clonidine|clonidine|mesh-list
84117664|NCT05277038|Zopiclone|zopiclone|mesh-list
84117665|NCT05277038|Analgesics|analgesics|mesh-ancestor
84117666|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
84117667|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117668|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117669|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84117670|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
84117671|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
84117672|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84117673|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84117674|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84117675|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
84117676|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117677|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117678|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84117679|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117680|NCT00960349|Cisplatin|cisplatin|mesh-list
84117681|NCT00960349|Capecitabine|capecitabine|mesh-list
84117682|NCT00960349|Cediranib|cediranib|mesh-list
84117683|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117684|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117685|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
84117686|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117687|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84117688|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117689|NCT05375903|Imiquimod|imiquimod|mesh-list
84117690|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84117691|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84117692|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
84117693|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117694|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117695|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
84117696|NCT02670434|Pitavastatin|pitavastatin|mesh-list
84117697|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84117698|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84117699|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84117700|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
84117701|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117702|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117703|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84117704|NCT00965653|Folic Acid|folic acid|mesh-list
84117705|NCT00965653|Methotrexate|methotrexate|mesh-list
84117706|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84117707|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
83357859|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117708|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84117709|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117710|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117711|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
84117712|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117713|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117714|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117715|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117716|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84117717|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84117718|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
84117719|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117720|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84117721|NCT00965653|Hematinics|hematinics|mesh-ancestor
84117722|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
84117723|NCT00965653|Vitamins|vitamins|mesh-ancestor
84117724|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
84117725|NCT00644696|Cefixime|cefixime|mesh-list
84117726|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
84117727|NCT00644696|Irinotecan|irinotecan|mesh-list
84117728|NCT00644696|Bortezomib|bortezomib|mesh-list
84117729|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84117730|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117731|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117732|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117733|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117734|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84117735|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117736|NCT00960739|Topotecan|topotecan|mesh-list
84117737|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
84117738|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84117739|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117740|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117741|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117742|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117743|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84117744|NCT00659022|Bevacizumab|bevacizumab|mesh-list
84117745|NCT00659022|Capecitabine|capecitabine|mesh-list
84117746|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
84117747|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84117748|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117749|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84117750|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84117751|NCT00659022|Growth Substances|growth substances|mesh-ancestor
84117752|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117753|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
84117754|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117755|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
84117756|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117757|NCT02788643|Dimercaprol|dimercaprol|mesh-list
84117758|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
84117759|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
84117760|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117761|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
84117762|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84117763|NCT04175522|Antibodies|antibodies|mesh-list
84117764|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
84117765|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
84117766|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117767|NCT00960817|Aspirin|aspirin|mesh-list
84117768|NCT00960817|Dipyridamole|dipyridamole|mesh-list
84117769|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84117770|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117771|NCT00960817|Analgesics|analgesics|mesh-ancestor
84117772|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
84117773|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117774|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117775|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117776|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117777|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84117778|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84117779|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117780|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84117781|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84117782|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117783|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
84117784|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84117785|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
84117786|NCT00965809|Dronabinol|dronabinol|mesh-list
84117787|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
84117788|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117789|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84117790|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117791|NCT00965809|Analgesics|analgesics|mesh-ancestor
84117792|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
84117793|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117794|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84117795|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84117796|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117797|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117798|NCT00965809|Hormones|hormones|mesh-ancestor
84117799|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117800|NCT00885378|Metformin|metformin|mesh-list
84117801|NCT00885378|Saxagliptin|saxagliptin|mesh-list
84117802|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117803|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117804|NCT00885378|Incretins|incretins|mesh-ancestor
84117805|NCT00885378|Hormones|hormones|mesh-ancestor
84117806|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117807|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84117808|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
84117809|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117810|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117811|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
84117812|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84117813|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
84117814|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
84117815|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117816|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117817|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117818|NCT04095494|Analgesics|analgesics|mesh-ancestor
84117819|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
84117820|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117821|NCT02537210|Mesalamine|mesalamine|mesh-list
84117822|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84117823|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117824|NCT02537210|Analgesics|analgesics|mesh-ancestor
84117825|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
84117826|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117827|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117828|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117829|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117830|NCT01563289|Ibuprofen|ibuprofen|mesh-list
84117831|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84117832|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84117833|NCT01563289|Analgesics|analgesics|mesh-ancestor
84117834|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
84117835|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117836|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117837|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117838|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117839|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84117840|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117841|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117842|NCT00960973|Menatetrenone|menatetrenone|mesh-list
84117843|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
84117844|NCT00960973|Coagulants|coagulants|mesh-ancestor
84117845|NCT04099849|Zinc|zinc|mesh-list
84117846|NCT04099849|Trace Elements|trace elements|mesh-ancestor
84117847|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
84117848|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117849|NCT00659100|Gabapentin|gabapentin|mesh-list
84117850|NCT00659100|Analgesics|analgesics|mesh-ancestor
84117851|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
84117852|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117853|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117854|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
84117855|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84117856|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84117857|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117858|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84117859|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84117860|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84117861|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117862|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117863|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
84117864|NCT00659178|Doxorubicin|doxorubicin|mesh-list
84117865|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84117866|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84117867|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117868|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117869|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117870|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117871|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117872|NCT02792621|Acipimox|acipimox|mesh-list
84117873|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84117874|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
84117875|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117876|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84117877|NCT04009759|Ketamine|ketamine|mesh-list
84117878|NCT04009759|Morphine|morphine|mesh-list
84117879|NCT04009759|Analgesics|analgesics|mesh-ancestor
84117880|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
84117881|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84117882|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117883|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84117884|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84117885|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
84117886|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
84117887|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84117888|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84117889|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84117890|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117891|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117892|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84117893|NCT04009759|Narcotics|narcotics|mesh-ancestor
84117894|NCT00645086|Clarithromycin|clarithromycin|mesh-list
84117895|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84117896|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117897|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84117898|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117899|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117900|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84117901|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84117902|NCT05238649|Vaccines|vaccines|mesh-list
84117903|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
84117904|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117905|NCT02792153|Estradiol|estradiol|mesh-list
84117906|NCT02792153|Estrogens|estrogens|mesh-ancestor
84117907|NCT02792153|Hormones|hormones|mesh-ancestor
84117908|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117909|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117910|NCT00644540|Vaccines|vaccines|mesh-list
84117911|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
84117912|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117913|NCT02669732|Firuglipel|firuglipel|mesh-list
84117914|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84117915|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117916|NCT05003245|Ranibizumab|ranibizumab|mesh-list
84117917|NCT05003245|Antibodies|antibodies|mesh-list
84117918|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84117919|NCT05003245|Mitogens|mitogens|mesh-list
84117920|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
84117921|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
84117922|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117923|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
84117924|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117925|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84117926|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84117927|NCT05003245|Growth Substances|growth substances|mesh-ancestor
84117928|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
84117929|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117930|NCT05367089|Fluconazole|fluconazole|mesh-list
84117931|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
84117932|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117933|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84117934|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84117935|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117936|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117937|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84117938|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
84117939|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84117940|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117941|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84117942|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84117943|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
84117944|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84117945|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84117946|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84117947|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84117948|NCT02791919|Cytarabine|cytarabine|mesh-list
84117949|NCT02791919|Fludarabine|fludarabine|mesh-list
84117950|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
84117951|NCT02791919|Lenograstim|lenograstim|mesh-list
84117952|NCT02791919|Adavosertib|adavosertib|mesh-list
84117953|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117954|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117955|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
84117956|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117957|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84117958|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
84117959|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117960|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
84117961|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117962|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84117963|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117964|NCT00966121|Propranolol|propranolol|mesh-list
84117965|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84117966|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84117967|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
84117968|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84117969|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117970|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117971|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84117972|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84117973|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
84117974|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
84117975|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84117976|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84117977|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84117978|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84117979|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117980|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117981|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117982|NCT00659412|Methotrexate|methotrexate|mesh-list
84117983|NCT00659412|Alefacept|alefacept|mesh-list
84117984|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84117985|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
84117986|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84117987|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84117988|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84117989|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
84117990|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84117991|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84117992|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
84117993|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84117994|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84117995|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84117996|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
84117997|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84117998|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84117999|NCT04176224|Edaravone|edaravone|mesh-list
84118000|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84118001|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
84118002|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118003|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84118004|NCT04176224|Protective Agents|protective agents|mesh-ancestor
84118005|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118006|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
84118007|NCT04158102|Bupivacaine|bupivacaine|mesh-list
83358165|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
84118008|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
84118009|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
84118010|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118011|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118012|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
84118013|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118014|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84118015|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
84118016|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118017|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84118018|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84118019|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118020|NCT00961363|Incretins|incretins|mesh-ancestor
84118021|NCT00961363|Hormones|hormones|mesh-ancestor
84118022|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118023|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84118024|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
84118025|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118026|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118027|NCT02633202|Cisplatin|cisplatin|mesh-list
84118028|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118029|NCT00645242|Fluconazole|fluconazole|mesh-list
84118030|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
84118031|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118032|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84118033|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84118034|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118035|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118036|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84118037|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
84118038|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118039|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118040|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84118041|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84118042|NCT00659568|Metformin|metformin|mesh-list
84118043|NCT00659568|Sirolimus|sirolimus|mesh-list
84118044|NCT00659568|Temsirolimus|temsirolimus|mesh-list
84118045|NCT00659568|MTOR Inhibitors|mtor inhibitors|mesh-list
84118046|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84118047|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118048|NCT00659568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84118049|NCT00659568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118050|NCT00659568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118051|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118052|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
84118053|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118054|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84118055|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118056|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84118057|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
84118058|NCT00961753|Ibuprofen|ibuprofen|mesh-list
84118059|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84118060|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84118061|NCT00961753|Analgesics|analgesics|mesh-ancestor
84118062|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
84118063|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118064|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118065|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118066|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118067|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84118068|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118069|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118070|NCT04232813|Estradiol|estradiol|mesh-list
84118071|NCT04232813|Estrogens|estrogens|mesh-ancestor
84118072|NCT04232813|Hormones|hormones|mesh-ancestor
84118073|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118074|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118075|NCT00659958|Zonisamide|zonisamide|mesh-list
84118076|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
84118077|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84118078|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118079|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118080|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84118081|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118083|NCT00644774|Cefdinir|cefdinir|mesh-list
84118084|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84118085|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118086|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
84118087|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84118088|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118089|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
84118090|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84118091|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
84118092|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118093|NCT00910442|Expectorants|expectorants|mesh-ancestor
84118094|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
84118095|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84118096|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
84118097|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118098|NCT00910442|Protective Agents|protective agents|mesh-ancestor
84118099|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118100|NCT00910442|Antidotes|antidotes|mesh-ancestor
84118101|NCT00660036|Etoposide|etoposide|mesh-list
84118102|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
84118103|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
84118104|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84118105|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118106|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84118107|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84118108|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118109|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118110|NCT00660036|Analgesics|analgesics|mesh-ancestor
84118111|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
84118112|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118113|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118114|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84118115|NCT00660036|Immunotoxins|immunotoxins|mesh-ancestor
84118116|NCT00660036|Immunoconjugates|immunoconjugates|mesh-ancestor
84118117|NCT00660036|Immunologic Factors|immunologic factors|mesh-ancestor
84118118|NCT02791373|Gemcitabine|gemcitabine|mesh-list
84118119|NCT02791373|Vinorelbine|vinorelbine|mesh-list
84118120|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118121|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
84118122|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118123|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118124|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84118125|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
84118126|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
84118127|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
84118128|NCT03102047|Durvalumab|durvalumab|mesh-list
84118129|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84118130|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118131|NCT00966745|Milrinone|milrinone|mesh-list
84118132|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84118133|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84118134|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
84118135|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84118136|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84118137|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118138|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118139|NCT00966745|Protective Agents|protective agents|mesh-ancestor
84118140|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118141|NCT02669030|Suvorexant|suvorexant|mesh-list
84118142|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84118143|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84118144|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118145|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118146|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84118147|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118148|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118149|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84118150|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84118151|NCT02668796|Estradiol|estradiol|mesh-list
84118152|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84118153|NCT02668796|Estrogens|estrogens|mesh-ancestor
84118154|NCT02668796|Hormones|hormones|mesh-ancestor
84118155|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118156|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118157|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84118158|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
84118159|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84118160|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84118161|NCT00645320|Ziprasidone|ziprasidone|mesh-list
84118162|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84118163|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
84118164|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118165|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118166|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118167|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84118168|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84118169|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118170|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84118171|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84118172|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
84118173|NCT03938857|Fentanyl|fentanyl|mesh-list
84118174|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
84118175|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84118176|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118177|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118178|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84118179|NCT03938857|Analgesics|analgesics|mesh-ancestor
84118180|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
84118181|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118182|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84118183|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84118184|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84118185|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
84118186|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118187|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118188|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84118189|NCT03938857|Narcotics|narcotics|mesh-ancestor
84118190|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84118191|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84118192|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
84118193|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
84118194|NCT04160598|Fentanyl|fentanyl|mesh-list
84118195|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84118196|NCT04160598|Narcotics|narcotics|mesh-ancestor
84118197|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118198|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118199|NCT04160598|Analgesics|analgesics|mesh-ancestor
84118200|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
84118201|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118202|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84118203|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84118204|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
84118205|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
84118206|NCT00967837|Insulin|insulin|mesh-list
84118207|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84118208|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84118209|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118210|NCT02668016|Atorvastatin|atorvastatin|mesh-list
84118211|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
84118212|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84118213|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84118214|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
84118215|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118216|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84118217|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118218|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
84118219|NCT03012971|Morphine|morphine|mesh-list
84118220|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84118221|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118222|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118223|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84118224|NCT03012971|Analgesics|analgesics|mesh-ancestor
84118225|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
84118226|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118227|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84118228|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84118229|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84118230|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
84118231|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118232|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118233|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84118234|NCT03012971|Narcotics|narcotics|mesh-ancestor
84118235|NCT00966901|Nicotine|nicotine|mesh-list
84118236|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84118237|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
84118238|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118239|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118240|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84118241|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84118242|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
84118243|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118244|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118245|NCT02668172|Pasireotide|pasireotide|mesh-list
84118246|NCT02668172|Hormones|hormones|mesh-ancestor
84118247|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118248|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118249|NCT00660270|Interferons|interferons|mesh-list
84118250|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
84118251|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
84118252|NCT00660270|Gemcitabine|gemcitabine|mesh-list
84118253|NCT00660270|Fluorouracil|fluorouracil|mesh-list
84118254|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118255|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118256|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
84118257|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118258|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118259|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
84118260|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118261|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
84118262|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118263|NCT04032132|Curcumin|curcumin|mesh-list
84118264|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84118265|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84118266|NCT04032132|Analgesics|analgesics|mesh-ancestor
84118267|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
84118268|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118269|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118270|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118271|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118272|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118273|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118274|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118275|NCT00967057|Dexamethasone|dexamethasone|mesh-list
84118276|NCT00967057|Methotrexate|methotrexate|mesh-list
84118277|NCT00967057|Vincristine|vincristine|mesh-list
84118278|NCT00967057|Asparaginase|asparaginase|mesh-list
84118279|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
84118280|NCT00967057|Idarubicin|idarubicin|mesh-list
84118281|NCT00967057|Pegaspargase|pegaspargase|mesh-list
84118282|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118283|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
84118284|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
84118285|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118286|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118287|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84118288|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
84118289|NCT00967057|Hormones|hormones|mesh-ancestor
84118290|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118291|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84118292|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118293|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84118294|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
84118295|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84118296|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118297|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
84118298|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118299|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
84118300|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118301|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84118302|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118303|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
83358467|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
84118304|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118305|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84118306|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84118307|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
84118308|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
84118309|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
84118310|NCT00967057|Analgesics|analgesics|mesh-ancestor
84118311|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
84118312|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84118313|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84118314|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84118315|NCT02633514|Etoposide|etoposide|mesh-list
84118316|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118317|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84118318|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84118319|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84118320|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118321|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118322|NCT00656214|Lycopene|lycopene|mesh-list
84118323|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118324|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
84118325|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118326|NCT00656214|Protective Agents|protective agents|mesh-ancestor
84118327|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118328|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84118329|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84118330|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118331|NCT02790671|Firuglipel|firuglipel|mesh-list
84118332|NCT02790671|Itraconazole|itraconazole|mesh-list
84118333|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
84118334|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118335|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84118336|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84118337|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118338|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118339|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84118340|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
84118341|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118342|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118343|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84118344|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84118345|NCT02668094|Lidocaine|lidocaine|mesh-list
84118346|NCT02668094|Pregabalin|pregabalin|mesh-list
84118347|NCT02668094|Propofol|propofol|mesh-list
84118348|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
84118349|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
84118350|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118351|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118352|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
84118353|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118354|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84118355|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84118356|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84118357|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118358|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118359|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84118360|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84118361|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
84118362|NCT02668094|Analgesics|analgesics|mesh-ancestor
84118363|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
84118364|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84118365|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84118366|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84118367|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84118368|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84118369|NCT00967135|Pregabalin|pregabalin|mesh-list
84118370|NCT00967135|Analgesics|analgesics|mesh-ancestor
84118371|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
84118372|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118373|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118374|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
84118375|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84118376|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118377|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118378|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84118379|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84118380|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84118381|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118382|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84118383|NCT02666768|Interferons|interferons|mesh-list
84118384|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
84118385|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118386|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
84118387|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118388|NCT00967213|Ranibizumab|ranibizumab|mesh-list
84118389|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84118390|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84118391|NCT00967213|Growth Substances|growth substances|mesh-ancestor
84118392|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118393|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
84118394|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118395|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
84118396|NCT04160676|Thiamine|thiamine|mesh-list
84118397|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
84118398|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118399|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
84118400|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118401|NCT04160676|Protective Agents|protective agents|mesh-ancestor
84118402|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118403|NCT04160676|Vitamins|vitamins|mesh-ancestor
84118404|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
84118405|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
84118406|NCT00660426|Gemcitabine|gemcitabine|mesh-list
84118407|NCT00660426|Capecitabine|capecitabine|mesh-list
84118408|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
84118409|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118410|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
84118411|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118412|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118413|NCT00967291|Ifosfamide|ifosfamide|mesh-list
84118414|NCT00967291|Mitomycins|mitomycins|mesh-list
84118415|NCT00967291|Mitomycin|mitomycin|mesh-list
84118416|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84118417|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
84118418|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118419|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118420|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84118421|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84118422|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118423|NCT00645398|Pregabalin|pregabalin|mesh-list
84118424|NCT00645398|Analgesics|analgesics|mesh-ancestor
84118425|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
84118426|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118427|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118428|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
84118429|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84118430|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118431|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118432|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84118433|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84118434|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84118435|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118436|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84118437|NCT00884832|Clonidine|clonidine|mesh-list
84118438|NCT00884832|Analgesics|analgesics|mesh-ancestor
84118439|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
84118440|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118441|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118442|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84118443|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
84118444|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
84118445|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84118446|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84118447|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84118448|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
84118449|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118450|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118451|NCT00660582|Leucovorin|leucovorin|mesh-list
84118452|NCT00660582|Folic Acid|folic acid|mesh-list
84118453|NCT00660582|Fluorouracil|fluorouracil|mesh-list
84118454|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
84118455|NCT00660582|Cetuximab|cetuximab|mesh-list
84118456|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
84118457|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
84118458|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118459|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118460|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118461|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118462|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
84118463|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118464|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84118465|NCT00660582|Antidotes|antidotes|mesh-ancestor
84118466|NCT00660582|Protective Agents|protective agents|mesh-ancestor
84118467|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
84118468|NCT00660582|Vitamins|vitamins|mesh-ancestor
84118469|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
84118470|NCT00660582|Hematinics|hematinics|mesh-ancestor
84118471|NCT00646802|Progesterone|progesterone|mesh-list
84118472|NCT00646802|Progestins|progestins|mesh-ancestor
84118473|NCT00646802|Hormones|hormones|mesh-ancestor
84118474|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118475|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118476|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84118477|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
84118478|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
84118479|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
84118480|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84118481|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
84118482|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118483|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118484|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118485|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118486|NCT00657228|Heparin|heparin|mesh-list
84118487|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
84118488|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84118489|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84118490|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118491|NCT02666534|Lidocaine|lidocaine|mesh-list
84118492|NCT02666534|Prilocaine|prilocaine|mesh-list
84118493|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
84118494|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84118495|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
84118496|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
84118497|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
84118498|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118499|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118500|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
84118501|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118502|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84118503|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84118504|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84118505|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118506|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118507|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84118508|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
84118509|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
84118510|NCT02787473|Docetaxel|docetaxel|mesh-list
84118511|NCT02787473|Pemetrexed|pemetrexed|mesh-list
84118512|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118513|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
84118514|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
84118515|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
84118516|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118517|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118518|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84118519|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84118520|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
84118521|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118522|NCT00967603|Sunitinib|sunitinib|mesh-list
84118523|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118524|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84118525|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84118526|NCT00967603|Growth Substances|growth substances|mesh-ancestor
84118527|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118528|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
84118529|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84118530|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118531|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118532|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
83358691|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
84118533|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84118534|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84118535|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118536|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
84118537|NCT00657384|Coagulants|coagulants|mesh-ancestor
84118538|NCT00973453|Immunomodulating Agents|immunomodulating agents|mesh-list
84118539|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
84118540|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118541|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84118542|NCT00646880|Propiverine|propiverine|mesh-list
84118543|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84118544|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84118545|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
84118546|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118547|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118548|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118549|NCT00646880|Urological Agents|urological agents|mesh-ancestor
84118550|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
84118551|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
84118552|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118553|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
84118554|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
84118555|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84118556|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
84118557|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118558|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118559|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118560|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
84118561|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118562|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118563|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84118564|NCT00968461|Protective Agents|protective agents|mesh-ancestor
84118565|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118566|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118567|NCT04157010|Methotrexate|methotrexate|mesh-list
84118568|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84118569|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
84118570|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84118571|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118572|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118573|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
84118574|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118575|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118576|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
84118577|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118578|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84118579|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118580|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
84118581|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118582|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84118583|NCT02632032|Insulin|insulin|mesh-list
84118584|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84118585|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84118586|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118587|NCT00973609|Folic Acid|folic acid|mesh-list
84118588|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
84118589|NCT00973609|Bevacizumab|bevacizumab|mesh-list
84118590|NCT00973609|Fluorouracil|fluorouracil|mesh-list
84118591|NCT00973609|Capecitabine|capecitabine|mesh-list
84118592|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84118593|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118594|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84118595|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84118596|NCT00973609|Growth Substances|growth substances|mesh-ancestor
84118597|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118598|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
84118599|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
84118600|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118601|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118602|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118603|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
84118604|NCT00973609|Hematinics|hematinics|mesh-ancestor
84118605|NCT00973609|Vitamins|vitamins|mesh-ancestor
84118606|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
84118607|NCT02537054|Aflibercept|aflibercept|mesh-list
84118608|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84118609|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84118610|NCT02537054|Growth Substances|growth substances|mesh-ancestor
84118611|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118612|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
84118613|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118614|NCT00973687|Dexamethasone|dexamethasone|mesh-list
84118615|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118616|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
84118617|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
84118618|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118619|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118620|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84118621|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
84118622|NCT00973687|Hormones|hormones|mesh-ancestor
84118623|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118624|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84118625|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118626|NCT02785757|Thrombin|thrombin|mesh-list
84118627|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
84118628|NCT02785757|Coagulants|coagulants|mesh-ancestor
84118629|NCT00645554|Galantamine|galantamine|mesh-list
84118630|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84118631|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118632|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118633|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
84118634|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118635|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118636|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84118637|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
84118638|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118639|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
84118640|NCT02785601|Trazodone|trazodone|mesh-list
84118641|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84118642|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84118643|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118644|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118645|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84118646|NCT02785601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84118647|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84118648|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118649|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118650|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118651|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
84118652|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84118653|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
84118654|NCT05299567|Azithromycin|azithromycin|mesh-list
84118655|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84118656|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118657|NCT00660894|Leucovorin|leucovorin|mesh-list
84118658|NCT00660894|Tegafur|tegafur|mesh-list
84118659|NCT00660894|Calcium|calcium|mesh-list
84118660|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
84118661|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84118662|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118663|NCT00660894|Antidotes|antidotes|mesh-ancestor
84118664|NCT00660894|Protective Agents|protective agents|mesh-ancestor
84118665|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
84118666|NCT00660894|Vitamins|vitamins|mesh-ancestor
84118667|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
84118668|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118669|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
84118670|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118671|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118672|NCT00660972|Tenofovir|tenofovir|mesh-list
84118673|NCT00660972|Emtricitabine|emtricitabine|mesh-list
84118674|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
84118675|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84118676|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
84118677|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118678|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84118679|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84118680|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118681|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118682|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84118683|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83358866|NCT00118209|Prednisone|prednisone|mesh-list
84118684|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84118685|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84118686|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
84118687|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84118688|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84118689|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
84118690|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118691|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118692|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118693|NCT02667470|Urological Agents|urological agents|mesh-ancestor
84118694|NCT05327699|Ketamine|ketamine|mesh-list
84118695|NCT05327699|Analgesics|analgesics|mesh-ancestor
84118696|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
84118697|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118698|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118699|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84118700|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84118701|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
84118702|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
84118703|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118704|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84118705|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84118706|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118707|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118708|NCT04157478|Temozolomide|temozolomide|mesh-list
84118709|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84118710|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
84118711|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118712|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118713|NCT00647192|Eplerenone|eplerenone|mesh-list
84118714|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84118715|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
84118716|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118717|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118718|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84118719|NCT00647192|Diuretics|diuretics|mesh-ancestor
84118720|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
84118721|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84118722|NCT00661206|Clopidogrel|clopidogrel|mesh-list
84118723|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84118724|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84118725|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84118726|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84118727|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
84118728|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118729|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118730|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118731|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
84118732|NCT05276960|Vitamin D|vitamin d|mesh-list
84118733|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84118734|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118735|NCT05276960|Vitamins|vitamins|mesh-ancestor
84118736|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
84118737|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84118738|NCT02787317|Heparin|heparin|mesh-list
84118739|NCT02787317|Bivalirudin|bivalirudin|mesh-list
84118740|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
84118741|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84118742|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84118743|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118744|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
84118745|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84118746|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
84118747|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118748|NCT00645632|Doxorubicin|doxorubicin|mesh-list
84118749|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84118750|NCT00645632|Methotrexate|methotrexate|mesh-list
84118751|NCT00645632|Ifosfamide|ifosfamide|mesh-list
84118752|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118753|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84118754|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84118755|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84118756|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118757|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118758|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84118759|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
84118760|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84118761|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118762|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118763|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
84118764|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
84118765|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84118766|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118767|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
84118768|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118769|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84118770|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84118771|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
84118773|NCT04156464|Phenobarbital|phenobarbital|mesh-list
84118774|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
84118775|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
84118776|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
84118777|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118778|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118779|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84118780|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84118781|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118782|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84118783|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84118784|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84118785|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
84118786|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
84118787|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118788|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118789|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84118790|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84118791|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84118792|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84118793|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84118794|NCT02607215|Vinorelbine|vinorelbine|mesh-list
84118795|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84118796|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118797|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
84118798|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
84118799|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
84118800|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118801|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
84118802|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84118803|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118804|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118805|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
84118806|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118807|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118808|NCT00968929|Streptokinase|streptokinase|mesh-list
84118809|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84118810|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84118811|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118812|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84118813|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
84118814|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84118815|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84118816|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118817|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118818|NCT00661596|Urological Agents|urological agents|mesh-ancestor
84118819|NCT00969085|Curcumin|curcumin|mesh-list
84118820|NCT00969085|Turmeric extract|turmeric extract|mesh-list
84118821|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84118822|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84118823|NCT00969085|Analgesics|analgesics|mesh-ancestor
84118824|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
84118825|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118826|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118827|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118828|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118829|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118830|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118831|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118832|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
84118833|NCT00969085|Protective Agents|protective agents|mesh-ancestor
84118835|NCT00974155|Citalopram|citalopram|mesh-list
84118836|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84118837|NCT00974155|Escitalopram|escitalopram|mesh-list
84118838|NCT00974155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84118839|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84118840|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118841|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118842|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118843|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
84118844|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118845|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84118846|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84118847|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
84118848|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
84118849|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118850|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84118851|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84118852|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
84118853|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84118854|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
84118855|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84118856|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84118857|NCT00879996|Buprenorphine|buprenorphine|mesh-list
84118858|NCT00879996|Methadone|methadone|mesh-list
84118859|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84118860|NCT00879996|Naloxone|naloxone|mesh-list
84118861|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84118862|NCT00879996|Narcotics|narcotics|mesh-ancestor
84118863|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84118864|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118865|NCT00879996|Analgesics|analgesics|mesh-ancestor
84118866|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
84118867|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118868|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84118869|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
84118870|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
84118871|NCT00969163|Testosterone|testosterone|mesh-list
84118872|NCT00969163|Androgens|androgens|mesh-ancestor
84118873|NCT00969163|Hormones|hormones|mesh-ancestor
84118874|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118875|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118876|NCT00873093|Leucovorin|leucovorin|mesh-list
84118877|NCT00873093|Cytarabine|cytarabine|mesh-list
84118878|NCT00873093|Prednisone|prednisone|mesh-list
84118879|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
84118880|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84118881|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84118882|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84118883|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
84118884|NCT00873093|Doxorubicin|doxorubicin|mesh-list
84118885|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84118886|NCT00873093|Methotrexate|methotrexate|mesh-list
84118887|NCT00873093|Etoposide|etoposide|mesh-list
84118888|NCT00873093|Vincristine|vincristine|mesh-list
84118889|NCT00873093|Bortezomib|bortezomib|mesh-list
84118890|NCT00873093|Asparaginase|asparaginase|mesh-list
84118891|NCT00873093|Pegaspargase|pegaspargase|mesh-list
84118892|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
84118893|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
84118894|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84118895|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
84118896|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118897|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84118898|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84118899|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
84118900|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118901|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118902|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84118903|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84118904|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84118905|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84118906|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84118907|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84118908|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
84118909|NCT00873093|Hormones|hormones|mesh-ancestor
84118910|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84118911|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84118912|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84118913|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
84118914|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84118915|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118916|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
84118917|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
84118918|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84118919|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84118920|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84118921|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
84118922|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84118923|NCT00873093|Antidotes|antidotes|mesh-ancestor
84118924|NCT00873093|Protective Agents|protective agents|mesh-ancestor
84118925|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
84118926|NCT00873093|Vitamins|vitamins|mesh-ancestor
84118927|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
84118928|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
84118929|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
84118930|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
84118931|NCT00969319|Factor VIII|factor viii|mesh-list
84118932|NCT00969319|Coagulants|coagulants|mesh-ancestor
84118933|NCT02784899|Iloprost|iloprost|mesh-list
84118934|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84118935|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
84118936|NCT00974389|Bevacizumab|bevacizumab|mesh-list
84118937|NCT00974389|Tegafur|tegafur|mesh-list
84118938|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84118939|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118940|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84118941|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84118942|NCT00974389|Growth Substances|growth substances|mesh-ancestor
84118943|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118944|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
84118945|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118946|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
84118947|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118948|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
84118949|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84118950|NCT00969397|Growth Substances|growth substances|mesh-ancestor
84118951|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118952|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
84118953|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118954|NCT02783885|Immunomodulating Agents|immunomodulating agents|mesh-list
84118955|NCT02783885|Immunologic Factors|immunologic factors|mesh-ancestor
84118956|NCT02783885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118957|NCT00647660|Nadolol|nadolol|mesh-list
84118958|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
84118959|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84118960|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84118961|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
84118962|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118963|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118964|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84118965|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84118966|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84118967|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
84118968|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
84118969|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118970|NCT00647660|Diuretics|diuretics|mesh-ancestor
84118971|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
84118972|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84118973|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84118974|NCT00634595|Paclitaxel|paclitaxel|mesh-list
84118975|NCT00634595|Cisplatin|cisplatin|mesh-list
84118976|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84118977|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118978|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
84118979|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
84118980|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
84118981|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118982|NCT00647738|Baclofen|baclofen|mesh-list
84118983|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84118985|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84118986|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84118987|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84118988|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
84118989|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
84118990|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84118991|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118992|NCT04008511|Capecitabine|capecitabine|mesh-list
84118993|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
84118994|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84118995|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
84118996|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84118997|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84118998|NCT00979537|Nisoldipine|nisoldipine|mesh-list
84118999|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84119000|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84119001|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119002|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119003|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84119004|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119005|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
84119006|NCT00692055|Naproxen|naproxen|mesh-list
84119007|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84119008|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119009|NCT00692055|Analgesics|analgesics|mesh-ancestor
84119010|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
84119011|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119012|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119013|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119014|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119015|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
84119016|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84119017|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119018|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119019|NCT04033250|Bisacodyl|bisacodyl|mesh-list
84119020|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
84119021|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
84119022|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
84119023|NCT04033250|Citric Acid|citric acid|mesh-list
84119024|NCT04033250|Cathartics|cathartics|mesh-ancestor
84119025|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119026|NCT04033250|Laxatives|laxatives|mesh-ancestor
84119027|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
84119028|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84119029|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
84119030|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
84119031|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119032|NCT04033250|Antacids|antacids|mesh-ancestor
84119033|NCT02624973|Tamoxifen|tamoxifen|mesh-list
84119034|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
84119035|NCT02624973|Docetaxel|docetaxel|mesh-list
84119036|NCT02624973|Trastuzumab|trastuzumab|mesh-list
84119037|NCT02624973|Letrozole|letrozole|mesh-list
84119038|NCT02624973|Epirubicin|epirubicin|mesh-list
84119039|NCT02624973|Olaparib|olaparib|mesh-list
84119040|NCT02624973|Palbociclib|palbociclib|mesh-list
84119041|NCT02624973|Pertuzumab|pertuzumab|mesh-list
84119042|NCT02624973|Goserelin|goserelin|mesh-list
84119043|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84119044|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
84119045|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119046|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119047|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84119048|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
84119049|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119050|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119051|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84119052|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
84119053|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
84119054|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
84119055|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84119056|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84119057|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84119058|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119059|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84119060|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
84119061|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119062|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84119063|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84119064|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84119065|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84119066|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84119067|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84119068|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84119069|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84119070|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119071|NCT00647816|Propranolol|propranolol|mesh-list
84119072|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84119073|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84119074|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119075|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119076|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119077|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119078|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84119079|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84119080|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
84119081|NCT05182931|Trametinib|trametinib|mesh-list
84119082|NCT05182931|Dabrafenib|dabrafenib|mesh-list
84119083|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119084|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119085|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119086|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119087|NCT00647894|Alprazolam|alprazolam|mesh-list
84119088|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84119089|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119090|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119091|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119092|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119093|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119094|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
84119095|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
84119096|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119097|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119098|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
84119099|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
84119100|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84119101|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84119102|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119103|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119104|NCT02782559|Urological Agents|urological agents|mesh-ancestor
84119105|NCT00647972|Olanzapine|olanzapine|mesh-list
84119106|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
84119107|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
84119108|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119109|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119110|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119111|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84119112|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119113|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119114|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119115|NCT00647972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84119116|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84119117|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119118|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119119|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119120|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
84119121|NCT02782403|Axitinib|axitinib|mesh-list
84119122|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119123|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119124|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119125|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119126|NCT00646178|Adalimumab|adalimumab|mesh-list
84119127|NCT00646178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84119128|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119129|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119130|NCT02624817|Glyburide|glyburide|mesh-list
84119131|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119132|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119133|NCT02664116|Diclofenac|diclofenac|mesh-list
84119135|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84119136|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84119137|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119138|NCT02664116|Analgesics|analgesics|mesh-ancestor
84119139|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
84119140|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119141|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119142|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119143|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119144|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84119145|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119146|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119147|NCT00692601|Capsaicin|capsaicin|mesh-list
84119148|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
84119149|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
84119150|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
84119151|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119152|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119153|NCT02785055|Hydromorphone|hydromorphone|mesh-list
84119154|NCT02785055|Bupivacaine|bupivacaine|mesh-list
84119155|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
84119156|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
84119157|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119158|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119159|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
84119160|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119161|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84119162|NCT02785055|Narcotics|narcotics|mesh-ancestor
84119163|NCT02785055|Analgesics|analgesics|mesh-ancestor
84119164|NCT02624661|Glycerol|glycerol|mesh-list
84119165|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84119166|NCT02624661|Protective Agents|protective agents|mesh-ancestor
84119167|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119168|NCT00648050|Verapamil|verapamil|mesh-list
84119169|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84119170|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84119171|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119172|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119173|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84119174|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119175|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
84119176|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
84119177|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84119178|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119179|NCT02624505|Albuterol|albuterol|mesh-list
84119180|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84119181|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
84119182|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119183|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119184|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84119185|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
84119186|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
84119187|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84119188|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84119189|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84119190|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84119191|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119192|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119193|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119194|NCT00969631|Metformin|metformin|mesh-list
84119195|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119196|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119197|NCT02782481|Levodopa|levodopa|mesh-list
84119198|NCT02782481|Carbidopa|carbidopa|mesh-list
84119199|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84119200|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84119201|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84119202|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
84119203|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119204|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119205|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119206|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84119207|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119208|NCT00648128|Clarithromycin|clarithromycin|mesh-list
84119209|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84119210|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119211|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84119212|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119213|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119214|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84119215|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84119217|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84119218|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
84119219|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119220|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84119221|NCT05342597|Protective Agents|protective agents|mesh-ancestor
84119222|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119223|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84119224|NCT02784821|Gentamicins|gentamicins|mesh-list
84119225|NCT02784821|Ampicillin|ampicillin|mesh-list
84119226|NCT02784821|Cefotaxime|cefotaxime|mesh-list
84119227|NCT02784821|Cefoxitin|cefoxitin|mesh-list
84119228|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84119229|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119230|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
84119231|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84119232|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119233|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119234|NCT00693069|Clopidogrel|clopidogrel|mesh-list
84119235|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84119236|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84119237|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84119238|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84119239|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
84119240|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119241|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119242|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119243|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
84119244|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84119245|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119246|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84119247|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84119248|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
84119249|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119250|NCT00974935|Antacids|antacids|mesh-ancestor
84119251|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119252|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119253|NCT00665808|Insulin|insulin|mesh-list
84119254|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84119255|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
84119256|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
84119257|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
84119258|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
84119259|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119260|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119261|NCT04230083|Dienogest|dienogest|mesh-list
84119262|NCT04230083|Nandrolone|nandrolone|mesh-list
84119263|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84119264|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
84119265|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84119266|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83429974|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119267|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84119268|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84119269|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84119270|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84119271|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
84119272|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119273|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84119274|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119275|NCT04230083|Androgens|androgens|mesh-ancestor
84119276|NCT04230083|Hormones|hormones|mesh-ancestor
84119277|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
84119278|NCT00645866|Docetaxel|docetaxel|mesh-list
84119279|NCT00645866|Capecitabine|capecitabine|mesh-list
84119280|NCT00645866|Epirubicin|epirubicin|mesh-list
84119281|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119282|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
84119283|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
84119284|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
84119285|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119286|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84119287|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
84119288|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84119289|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84119290|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84119291|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119292|NCT05221151|Pregabalin|pregabalin|mesh-list
84119293|NCT05221151|Ondansetron|ondansetron|mesh-list
84119294|NCT05221151|Melatonin|melatonin|mesh-list
84119295|NCT05221151|Analgesics|analgesics|mesh-ancestor
84119296|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
84119297|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119298|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119299|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
84119300|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84119301|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119302|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119303|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84119304|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119305|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119306|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119307|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119308|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
84119309|NCT05221151|Protective Agents|protective agents|mesh-ancestor
84119310|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
84119311|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
84119312|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119313|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
84119314|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
84119315|NCT05221151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84119316|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84119317|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
84119318|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119319|NCT04008043|Acetaminophen|acetaminophen|mesh-list
84119320|NCT04008043|Dexamethasone|dexamethasone|mesh-list
84119321|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
84119322|NCT04008043|Hydrocodone|hydrocodone|mesh-list
84119323|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119324|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
84119325|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
84119326|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119327|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119328|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119329|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
84119330|NCT04008043|Hormones|hormones|mesh-ancestor
84119331|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119332|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84119333|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119334|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119335|NCT04008043|Analgesics|analgesics|mesh-ancestor
84119336|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
84119337|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
84119338|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84119339|NCT04008043|Narcotics|narcotics|mesh-ancestor
84119340|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119341|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
84119342|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
84119343|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84119344|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119345|NCT02783183|Pregabalin|pregabalin|mesh-list
84119346|NCT02783183|Analgesics|analgesics|mesh-ancestor
84119347|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
84119348|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119349|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119350|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
84119351|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84119352|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119353|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119354|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84119355|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119356|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119357|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119358|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119359|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
84119361|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
84119362|NCT00693381|Tacrolimus|tacrolimus|mesh-list
84119363|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119364|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
84119365|NCT00693381|Hormones|hormones|mesh-ancestor
84119366|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119367|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119368|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84119369|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119370|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84119371|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
84119372|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84119373|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119374|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119375|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84119376|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84119377|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
84119378|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84119379|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119380|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
84119381|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
84119382|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119383|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119384|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84119385|NCT00693381|Protective Agents|protective agents|mesh-ancestor
84119386|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
84119387|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
84119388|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119389|NCT00693615|Vaccines|vaccines|mesh-list
84119390|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
84119391|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119392|NCT02663960|Citric Acid|citric acid|mesh-list
84119393|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
84119394|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
84119395|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84119396|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
84119397|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
84119398|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119399|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
84119400|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119401|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119402|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84119403|NCT00693849|Sertraline|sertraline|mesh-list
84119404|NCT00693849|Escitalopram|escitalopram|mesh-list
84119405|NCT00693849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84119406|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84119407|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119408|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119409|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119410|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
84119411|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119412|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84119413|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
84119414|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119415|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84119416|NCT00693927|Fludarabine|fludarabine|mesh-list
84119417|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119418|NCT00648362|Glimepiride|glimepiride|mesh-list
84119419|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84119420|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119421|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119422|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84119423|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
84119424|NCT00648440|Midodrine|midodrine|mesh-list
84119425|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
84119426|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
84119427|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119428|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119429|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84119430|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84119431|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84119432|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84119433|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119434|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119435|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119436|NCT00694005|Sirolimus|sirolimus|mesh-list
84119437|NCT00694005|Paclitaxel|paclitaxel|mesh-list
84119438|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84119439|NCT00694005|Everolimus|everolimus|mesh-list
84119440|NCT00694005|Temsirolimus|temsirolimus|mesh-list
84119441|NCT00694005|MTOR Inhibitors|mtor inhibitors|mesh-list
84119442|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84119443|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119444|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
84119445|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
84119446|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
84119447|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119448|NCT00694005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119449|NCT00694005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119450|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84119451|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
84119452|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119453|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84119454|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119455|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84119456|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
84119457|NCT00975325|Yohimbine|yohimbine|mesh-list
84119458|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
84119459|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
84119460|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119461|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119462|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84119463|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84119464|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84119465|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119466|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119467|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119468|NCT00975325|Urological Agents|urological agents|mesh-ancestor
84119469|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84119470|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119471|NCT00648518|Metformin|metformin|mesh-list
84119472|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119473|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119474|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
84119475|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
84119476|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84119477|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84119478|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119479|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119480|NCT00648596|Urological Agents|urological agents|mesh-ancestor
84119481|NCT03921151|Mirtazapine|mirtazapine|mesh-list
84119482|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
84119483|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119484|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84119485|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
84119486|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
84119487|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119488|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119489|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119490|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119491|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119492|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119493|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84119494|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84119495|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84119496|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119497|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84119498|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84119499|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
84119500|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84119501|NCT04570436|Diazepam|diazepam|mesh-list
84119502|NCT04570436|Gabapentin|gabapentin|mesh-list
84119503|NCT04570436|Analgesics|analgesics|mesh-ancestor
84119504|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
84119505|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119506|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119507|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
84119508|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119509|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119510|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119511|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119512|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84119513|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84119514|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119515|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119516|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
84119517|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84119518|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
84119519|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
84119520|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119521|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84119522|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84119523|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84119524|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84119525|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
84119526|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
84119527|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
84119528|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
84119529|NCT05195645|Abatacept|abatacept|mesh-list
84119530|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84119531|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119532|NCT05195645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84119533|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119534|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84119535|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
84119536|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119537|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119538|NCT04171388|Micronutrients|micronutrients|mesh-list
84119539|NCT04171388|Trace Elements|trace elements|mesh-list
84119540|NCT04171388|Azithromycin|azithromycin|mesh-list
84119541|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84119542|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119543|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119544|NCT00970411|Tivozanib|tivozanib|mesh-list
84119545|NCT00970411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119546|NCT00970411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119547|NCT00970411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119548|NCT05341193|Bevacizumab|bevacizumab|mesh-list
84119549|NCT05341193|Gemcitabine|gemcitabine|mesh-list
84119550|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84119551|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119552|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84119553|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84119554|NCT05341193|Growth Substances|growth substances|mesh-ancestor
84119555|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119556|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
84119557|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84119558|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
84119559|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119560|NCT04229459|Nivolumab|nivolumab|mesh-list
84119561|NCT04229459|Cetuximab|cetuximab|mesh-list
84119562|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119563|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84119564|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84119565|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119566|NCT00980239|Bevacizumab|bevacizumab|mesh-list
84119567|NCT00980239|Cetuximab|cetuximab|mesh-list
84119568|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
84119569|NCT00980239|Irinotecan|irinotecan|mesh-list
84119570|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84119571|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119572|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84119573|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84119574|NCT00980239|Growth Substances|growth substances|mesh-ancestor
84119575|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119576|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
84119577|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84119578|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84119579|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119580|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119581|NCT02665832|Amlodipine|amlodipine|mesh-list
84119582|NCT02665832|Olmesartan|olmesartan|mesh-list
84119583|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84119584|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84119585|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84119586|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119587|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119588|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84119589|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119590|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
84119591|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84119592|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84119593|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
84119594|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84119595|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84119596|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119597|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84119598|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84119599|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
84119601|NCT02781467|Interleukin-2|interleukin-2|mesh-list
84119602|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84119603|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
84119604|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119605|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119606|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84119607|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
84119608|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119609|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119610|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84119611|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119612|NCT02781467|Analgesics|analgesics|mesh-ancestor
84119613|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
84119614|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119615|NCT00648830|Clarithromycin|clarithromycin|mesh-list
84119616|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84119617|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119618|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84119619|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119620|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119621|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84119622|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84119623|NCT00970567|Insulin|insulin|mesh-list
84119624|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119625|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119626|NCT05341817|Letrozole|letrozole|mesh-list
84119627|NCT05341817|Mifepristone|mifepristone|mesh-list
84119628|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119629|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84119630|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84119631|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119632|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119633|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84119634|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
84119635|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119636|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119637|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84119638|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
84119639|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84119640|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84119641|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84119642|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84119643|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
84119644|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84119645|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84119646|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
84119647|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84119648|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84119649|NCT02663570|Melatonin|melatonin|mesh-list
84119650|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
84119651|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119652|NCT02663570|Protective Agents|protective agents|mesh-ancestor
84119653|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119654|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119655|NCT00980473|Timolol|timolol|mesh-list
84119656|NCT00980473|Travoprost|travoprost|mesh-list
84119657|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84119658|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84119659|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119660|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119661|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119662|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119663|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84119664|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84119666|NCT02784743|Albendazole|albendazole|mesh-list
84119667|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84119668|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119669|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
84119670|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
84119671|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84119672|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84119673|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
84119674|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
84119675|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
84119676|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119677|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119678|NCT05341583|Ensartinib|ensartinib|mesh-list
84119679|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119680|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119681|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119682|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119683|NCT00980551|Carboplatin|carboplatin|mesh-list
84119684|NCT00980551|Vincristine|vincristine|mesh-list
84119685|NCT00980551|Topotecan|topotecan|mesh-list
84119686|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119687|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84119688|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
84119689|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
84119690|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
84119691|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119692|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84119693|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84119694|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119695|NCT02660060|Pramipexole|pramipexole|mesh-list
84119696|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
84119697|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119698|NCT02660060|Protective Agents|protective agents|mesh-ancestor
84119699|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119700|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84119701|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84119702|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
84119703|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
84119704|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119705|NCT04008979|Aspirin|aspirin|mesh-list
84119706|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84119707|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119708|NCT04008979|Analgesics|analgesics|mesh-ancestor
84119709|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
84119710|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119711|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119712|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119713|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119714|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84119715|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84119716|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119717|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84119718|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84119719|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119720|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
84119721|NCT05263583|Bromides|bromides|mesh-list
84119722|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
84119723|NCT00970879|Mefloquine|mefloquine|mesh-list
84119724|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84119725|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
84119726|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84119727|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84119728|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119729|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84119730|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84119731|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
84119732|NCT05340803|Midazolam|midazolam|mesh-list
84119733|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
84119734|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84119735|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119736|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119737|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119739|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
84119740|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119741|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84119742|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84119743|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84119744|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119745|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119746|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119747|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84119748|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119749|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119750|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119751|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84119752|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
84119753|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
84119754|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
84119755|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
84119756|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84119757|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
84119758|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84119759|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119760|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84119761|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
84119762|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84119763|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
84119764|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84119765|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119766|NCT02663258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84119767|NCT02663258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119768|NCT04033172|Fulvestrant|fulvestrant|mesh-list
84119769|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84119770|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119771|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84119772|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84119773|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
84119774|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119775|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119776|NCT00980707|Fluticasone|fluticasone|mesh-list
84119777|NCT00980707|Xhance|xhance|mesh-list
84119778|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119779|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84119780|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
84119781|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119782|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119783|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84119784|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
84119785|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
84119786|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84119787|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
84119788|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84119789|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119790|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119791|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119792|NCT05340725|Analgesics|analgesics|mesh-ancestor
84119793|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
84119794|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119795|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84119796|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84119797|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84119798|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
84119799|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119800|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119801|NCT00970957|Bevacizumab|bevacizumab|mesh-list
84119802|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84119803|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119804|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84119805|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84119806|NCT00970957|Growth Substances|growth substances|mesh-ancestor
84119807|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119808|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
84119809|NCT00976105|Zolpidem|zolpidem|mesh-list
84119810|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84119811|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84119812|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119813|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119814|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84119815|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
84119816|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
84119817|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119818|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119819|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84119820|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119821|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119822|NCT00976261|Incretins|incretins|mesh-ancestor
84119823|NCT00976261|Hormones|hormones|mesh-ancestor
84119824|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119825|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84119826|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
84119827|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119828|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119829|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
84119830|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
84119831|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119832|NCT00976651|Menotropins|menotropins|mesh-list
84119833|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84119834|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
84119835|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84119836|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119837|NCT00971581|Ketoprofen|ketoprofen|mesh-list
84119838|NCT00971581|Omeprazole|omeprazole|mesh-list
84119839|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84119840|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119841|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84119842|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119843|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119844|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84119845|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84119846|NCT00971581|Analgesics|analgesics|mesh-ancestor
84119847|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
84119848|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119849|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119850|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119851|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84119852|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84119853|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84119854|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119855|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119856|NCT00971659|Insulin|insulin|mesh-list
84119857|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84119858|NCT00971659|Metformin|metformin|mesh-list
84119859|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
84119860|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84119861|NCT00971659|Exenatide|exenatide|mesh-list
84119862|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84119863|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119864|NCT00971659|Incretins|incretins|mesh-ancestor
84119865|NCT00971659|Hormones|hormones|mesh-ancestor
84119866|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119867|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84119868|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
84119869|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119870|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119871|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84119872|NCT00648986|Tazarotene|tazarotene|mesh-list
84119873|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
84119874|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
84119875|NCT00971815|Dexetimide|dexetimide|mesh-list
84119876|NCT00971815|Citalopram|citalopram|mesh-list
84119877|NCT00971815|Escitalopram|escitalopram|mesh-list
84119878|NCT00971815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84119879|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84119880|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119881|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119882|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119883|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
84119884|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119885|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84119886|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84119887|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
84119888|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
84119889|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119890|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84119891|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84119892|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
84119893|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84119894|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
84119895|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119896|NCT00981487|Ondansetron|ondansetron|mesh-list
84119897|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
84119898|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
84119899|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119900|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119901|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119902|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
84119903|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
84119904|NCT00981487|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84119905|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84119906|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
84119907|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119908|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119909|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84119910|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84119911|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119912|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
84119913|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84119914|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84119915|NCT00971893|Prednisolone|prednisolone|mesh-list
84119916|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
84119917|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84119918|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
84119919|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84119920|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
84119921|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
84119922|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119923|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119924|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119925|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
84119926|NCT00971893|Hormones|hormones|mesh-ancestor
84119927|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84119928|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84119929|NCT00971893|Protective Agents|protective agents|mesh-ancestor
84119930|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84119931|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119932|NCT02665208|Nicotine|nicotine|mesh-list
84119933|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84119934|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
84119935|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84119936|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119937|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84119938|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84119939|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
84119940|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119941|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119942|NCT00977353|Citalopram|citalopram|mesh-list
84119943|NCT00977353|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84119944|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84119945|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84119946|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119947|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119948|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
84119949|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119950|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84119951|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
84119952|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119953|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84119954|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119955|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119956|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119957|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119958|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
84119959|NCT04170530|Irinotecan|irinotecan|mesh-list
84119960|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119961|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84119962|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84119963|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119964|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119965|NCT02617017|Buspirone|buspirone|mesh-list
84119966|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84119967|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84119968|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84119969|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119970|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84119971|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84119972|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
84119973|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84119974|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119975|NCT02616861|Praliciguat|praliciguat|mesh-list
84119976|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84119977|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
84119978|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119979|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84119980|NCT00981721|Cediranib|cediranib|mesh-list
84119981|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119982|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119983|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119984|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119985|NCT04133337|Apatinib|apatinib|mesh-list
84119986|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84119987|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84119988|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84119989|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84119990|NCT04133259|Tenofovir|tenofovir|mesh-list
84119991|NCT04133259|Entecavir|entecavir|mesh-list
84119992|NCT04133259|Antibodies|antibodies|mesh-list
84119993|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84119994|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
84119995|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84119996|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
84119997|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84119998|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84119999|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84120000|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120001|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120002|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84120003|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84120004|NCT02616315|Naltrexone|naltrexone|mesh-list
84120005|NCT02616315|Bupropion|bupropion|mesh-list
84120006|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84120007|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84120008|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120009|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
84120010|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120011|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84120012|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
84120013|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83429977|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84120014|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84120015|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84120016|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120017|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120018|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
84120019|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120020|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84120021|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84120022|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120023|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
84120024|NCT02779283|Leucovorin|leucovorin|mesh-list
84120025|NCT02779283|Folic Acid|folic acid|mesh-list
84120026|NCT02779283|Cytarabine|cytarabine|mesh-list
84120027|NCT02779283|Dexamethasone|dexamethasone|mesh-list
84120028|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
84120029|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84120030|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84120031|NCT02779283|Prednisolone|prednisolone|mesh-list
84120032|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
84120033|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
84120034|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
84120035|NCT02779283|Rituximab|rituximab|mesh-list
84120036|NCT02779283|Doxorubicin|doxorubicin|mesh-list
84120037|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84120038|NCT02779283|Methotrexate|methotrexate|mesh-list
84120039|NCT02779283|Vincristine|vincristine|mesh-list
84120040|NCT02779283|Sorafenib|sorafenib|mesh-list
84120041|NCT02779283|Sunitinib|sunitinib|mesh-list
84120042|NCT02779283|Dasatinib|dasatinib|mesh-list
84120043|NCT02779283|Idarubicin|idarubicin|mesh-list
84120044|NCT02779283|Ponatinib|ponatinib|mesh-list
84120045|NCT02779283|Idelalisib|idelalisib|mesh-list
84120046|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84120047|NCT02779283|Antibodies|antibodies|mesh-list
84120048|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
84120049|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84120050|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84120051|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
84120052|NCT02779283|BB 1101|bb 1101|mesh-list
84120053|NCT02779283|Calcium|calcium|mesh-list
84120054|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
84120055|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120056|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
84120057|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120058|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120059|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84120060|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
84120061|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120062|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120063|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84120064|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84120065|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
84120066|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
84120067|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120068|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84120069|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
84120070|NCT02779283|Hormones|hormones|mesh-ancestor
84120071|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120072|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84120073|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84120074|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120075|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120076|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120077|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84120078|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84120079|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84120080|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
84120081|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120082|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84120083|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
84120084|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
84120085|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84120086|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84120087|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
84120088|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120089|NCT02779283|Antidotes|antidotes|mesh-ancestor
84120090|NCT02779283|Protective Agents|protective agents|mesh-ancestor
84120091|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
84120092|NCT02779283|Vitamins|vitamins|mesh-ancestor
84120093|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
84120094|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84120095|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
84120096|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
84120097|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
84120098|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84120099|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84120100|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84120101|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84120102|NCT02779283|Growth Substances|growth substances|mesh-ancestor
83360272|NCT02410746|Narcotics|narcotics|mesh-ancestor
84120103|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
84120104|NCT02779283|Hematinics|hematinics|mesh-ancestor
84120105|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
84120106|NCT02616003|Liraglutide|liraglutide|mesh-list
84120107|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120108|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120109|NCT02616003|Incretins|incretins|mesh-ancestor
84120110|NCT02616003|Hormones|hormones|mesh-ancestor
84120111|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120112|NCT02661152|Nimorazole|nimorazole|mesh-list
84120113|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84120114|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84120115|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84120116|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120117|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
84120118|NCT00697671|Etoposide|etoposide|mesh-list
84120119|NCT00697671|Interleukin-2|interleukin-2|mesh-list
84120120|NCT00697671|Clofarabine|clofarabine|mesh-list
84120121|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120122|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
84120123|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120124|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120125|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84120126|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
84120127|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120128|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120129|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84120130|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84120131|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120132|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120133|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120134|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84120135|NCT00697671|Analgesics|analgesics|mesh-ancestor
84120136|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
84120137|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120138|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84120139|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
84120140|NCT03922945|Topiramate|topiramate|mesh-list
84120141|NCT03922945|Phentermine|phentermine|mesh-list
84120142|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
84120143|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120144|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120145|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84120146|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
84120147|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84120148|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
84120149|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
84120150|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120151|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
84120152|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120153|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120154|NCT04973345|Terbutaline|terbutaline|mesh-list
84120155|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84120156|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
84120157|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120158|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120159|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84120160|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
84120161|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
84120162|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
84120163|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120164|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84120165|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84120166|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84120167|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
84120168|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120169|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120170|NCT05236985|Oxytocin|oxytocin|mesh-list
84120171|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
84120172|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120173|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120174|NCT03922477|Atezolizumab|atezolizumab|mesh-list
84120175|NCT03922477|Magrolimab|magrolimab|mesh-list
84120176|NCT03922477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84120177|NCT03922477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120178|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120179|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120180|NCT00978211|Octreotide|octreotide|mesh-list
84120181|NCT00978211|Somatostatin|somatostatin|mesh-list
84120182|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84120183|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84120184|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360346|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
84120185|NCT00978211|Hormones|hormones|mesh-ancestor
84120186|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120187|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120188|NCT00867165|Ezetimibe|ezetimibe|mesh-list
84120189|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84120190|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84120191|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
84120192|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120193|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84120194|NCT00981955|Caffeine|caffeine|mesh-list
84120195|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84120196|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120197|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84120198|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120199|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120200|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84120201|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84120202|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
84120203|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120204|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84120205|NCT00972829|Ezetimibe|ezetimibe|mesh-list
84120206|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84120207|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84120208|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
84120209|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120210|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84120211|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84120212|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120213|NCT05037617|Oxytocin|oxytocin|mesh-list
84120214|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
84120215|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120216|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120217|NCT00972907|Nifedipine|nifedipine|mesh-list
84120218|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84120219|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120220|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120221|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84120222|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120223|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
84120224|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
84120225|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120226|NCT04008433|Lidocaine|lidocaine|mesh-list
84120227|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
84120228|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
84120229|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120230|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120231|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
84120232|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120233|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84120234|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84120235|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84120236|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120237|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120238|NCT04132479|Amoxicillin|amoxicillin|mesh-list
84120239|NCT04132479|Clarithromycin|clarithromycin|mesh-list
84120240|NCT04132479|Tinidazole|tinidazole|mesh-list
84120241|NCT04132479|Rabeprazole|rabeprazole|mesh-list
84120242|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84120243|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120244|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84120245|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120246|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120247|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84120248|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84120249|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84120250|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84120251|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84120252|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
84120253|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84120254|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84120255|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84120256|NCT00972985|Lorazepam|lorazepam|mesh-list
84120257|NCT00972985|Methylphenidate|methylphenidate|mesh-list
84120258|NCT00972985|Modafinil|modafinil|mesh-list
84120259|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84120260|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120261|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84120262|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84120263|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120264|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120265|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
84120266|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120267|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84120268|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84120269|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84120270|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
84120271|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
84120272|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
84120273|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120274|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84120275|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84120276|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120277|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84120278|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84120279|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84120280|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
84120281|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
84120282|NCT00867087|Rituximab|rituximab|mesh-list
84120283|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84120284|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120285|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120286|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
84120287|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120288|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120289|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84120290|NCT00867087|Immunotoxins|immunotoxins|mesh-ancestor
84120291|NCT00867087|Immunoconjugates|immunoconjugates|mesh-ancestor
84120292|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84120293|NCT02778425|Somatostatin|somatostatin|mesh-list
84120294|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84120295|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
84120296|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120297|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120298|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120299|NCT02778425|Hormones|hormones|mesh-ancestor
84120300|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120301|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
84120302|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84120303|NCT04228757|Estrogens|estrogens|mesh-ancestor
84120304|NCT04228757|Hormones|hormones|mesh-ancestor
84120305|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120306|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120307|NCT04227431|Insulin|insulin|mesh-list
84120308|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120309|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120310|NCT04227041|Capecitabine|capecitabine|mesh-list
84120311|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84120312|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
83429980|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
84120313|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120314|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120315|NCT05074823|Ketamine|ketamine|mesh-list
84120316|NCT05074823|Analgesics|analgesics|mesh-ancestor
84120317|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
84120318|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120319|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120320|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84120321|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84120322|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
84120323|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
84120324|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120325|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84120326|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84120327|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120328|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120329|NCT04226963|Ketamine|ketamine|mesh-list
84120330|NCT04226963|Analgesics|analgesics|mesh-ancestor
84120331|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
84120332|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120333|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120334|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84120335|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84120336|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
84120337|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
84120338|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120339|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84120340|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84120341|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120342|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120343|NCT00545233|Pioglitazone|pioglitazone|mesh-list
84120344|NCT00545233|Ribavirin|ribavirin|mesh-list
84120345|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84120346|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
84120347|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120348|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
84120349|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120350|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120351|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120352|NCT02393248|Gemcitabine|gemcitabine|mesh-list
84120353|NCT02393248|Docetaxel|docetaxel|mesh-list
84120354|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
84120355|NCT02393248|Trastuzumab|trastuzumab|mesh-list
84120356|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120357|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84120358|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
84120359|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120360|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
84120361|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
84120362|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
84120363|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120364|NCT02393248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84120365|NCT00601484|Tanezumab|tanezumab|mesh-list
84120366|NCT00601484|Analgesics|analgesics|mesh-ancestor
84120367|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
84120368|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120369|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120370|NCT04228601|Fluzoparib|fluzoparib|mesh-list
84120371|NCT04228601|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84120372|NCT04228601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120373|NCT04228601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120374|NCT04228601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120375|NCT00978601|Analgesics|analgesics|mesh-list
84120376|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
84120377|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120378|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120379|NCT00883896|Fezakinumab|fezakinumab|mesh-list
84120380|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
84120381|NCT02778191|Carboplatin|carboplatin|mesh-list
84120382|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120383|NCT05170685|Nivolumab|nivolumab|mesh-list
84120384|NCT05170685|Relatlimab|relatlimab|mesh-list
84120385|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120386|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120387|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84120388|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120389|NCT02778893|Thalidomide|thalidomide|mesh-list
84120390|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120391|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
84120392|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120393|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
84120394|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84120395|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120396|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84120397|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84120398|NCT02778893|Growth Substances|growth substances|mesh-ancestor
84120399|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
84120400|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120401|NCT03920293|Ravulizumab|ravulizumab|mesh-list
84120402|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84120403|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120404|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
84120405|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120406|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84120407|NCT02671864|Incretins|incretins|mesh-list
84120408|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120409|NCT02671864|Hormones|hormones|mesh-ancestor
84120410|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120411|NCT00867009|Pemetrexed|pemetrexed|mesh-list
84120412|NCT00867009|Cetuximab|cetuximab|mesh-list
84120413|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120414|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120415|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120416|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84120417|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84120418|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120419|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
84120420|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84120421|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84120422|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84120423|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84120424|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120425|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120426|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120427|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120428|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120429|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120430|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84120431|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
84120432|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120433|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120434|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84120435|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84120436|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84120437|NCT02660840|Flupenthixol|flupenthixol|mesh-list
84120438|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
84120439|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84120440|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84120441|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120442|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120443|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84120444|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84120445|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
84120446|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120447|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120448|NCT02777801|Entecavir|entecavir|mesh-list
84120449|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
84120450|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120451|NCT00649064|Ziprasidone|ziprasidone|mesh-list
84120452|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84120453|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
84120454|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120455|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120456|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120457|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84120458|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84120459|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120460|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84120461|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84120462|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
84120463|NCT04132713|Capecitabine|capecitabine|mesh-list
84120464|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84120465|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
84120466|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120467|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120468|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
84120469|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84120470|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120471|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120472|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84120473|NCT04007341|Analgesics|analgesics|mesh-ancestor
84120474|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
84120475|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120476|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84120477|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84120478|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84120479|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
84120480|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120481|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120483|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84120484|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84120485|NCT02656082|Analgesics|analgesics|mesh-ancestor
84120486|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
84120487|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120488|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120489|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84120490|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120491|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84120492|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120493|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
84120494|NCT04132635|Mitogens|mitogens|mesh-list
84120495|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
84120496|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120497|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
84120498|NCT03335488|Glycerol|glycerol|mesh-list
84120499|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84120500|NCT03335488|Protective Agents|protective agents|mesh-ancestor
84120501|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120502|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120503|NCT02623504|Carbamazepine|carbamazepine|mesh-list
84120504|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
84120505|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
84120506|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84120507|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120508|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120509|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84120510|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84120511|NCT02623504|Analgesics|analgesics|mesh-ancestor
84120512|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
84120513|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120514|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84120515|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120516|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120517|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84120518|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84120519|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
84120520|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84120521|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
84120522|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120523|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
84120524|NCT02777723|Protective Agents|protective agents|mesh-ancestor
84120525|NCT00601250|Linagliptin|linagliptin|mesh-list
84120526|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120527|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120528|NCT00601250|Incretins|incretins|mesh-ancestor
84120529|NCT00601250|Hormones|hormones|mesh-ancestor
84120530|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120531|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84120532|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
84120533|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120534|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120535|NCT04226885|Fentanyl|fentanyl|mesh-list
84120536|NCT04226885|Midazolam|midazolam|mesh-list
84120537|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
84120538|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84120539|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120540|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120541|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84120542|NCT04226885|Analgesics|analgesics|mesh-ancestor
84120543|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
84120544|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120545|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84120546|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84120547|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84120548|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
84120549|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120550|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120551|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84120552|NCT04226885|Narcotics|narcotics|mesh-ancestor
84120553|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84120554|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84120555|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
84120556|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
84120557|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84120558|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84120559|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84120560|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
84120561|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
84120562|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
84120563|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
84120564|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84120565|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84120566|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120567|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120568|NCT02777411|Vaccines|vaccines|mesh-list
84120569|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
84120570|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120571|NCT02777489|Perindopril|perindopril|mesh-list
84120572|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84120573|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
84120574|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120575|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120576|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84120577|NCT02660762|Cytarabine|cytarabine|mesh-list
84120578|NCT02660762|Dexamethasone|dexamethasone|mesh-list
84120579|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
84120580|NCT02660762|Prednisone|prednisone|mesh-list
84120581|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
84120582|NCT02660762|Methotrexate|methotrexate|mesh-list
84120583|NCT02660762|Etoposide|etoposide|mesh-list
84120584|NCT02660762|Vincristine|vincristine|mesh-list
84120585|NCT02660762|Daunorubicin|daunorubicin|mesh-list
84120586|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
84120587|NCT02660762|Pegaspargase|pegaspargase|mesh-list
84120588|NCT02660762|Thioguanine|thioguanine|mesh-list
84120589|NCT02660762|BB 1101|bb 1101|mesh-list
84120590|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120591|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
84120592|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120593|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120594|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84120595|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
84120596|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120597|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120598|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84120599|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84120600|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
84120601|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
84120602|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120603|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84120604|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
84120605|NCT02660762|Hormones|hormones|mesh-ancestor
84120606|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120607|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84120608|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
84120609|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120610|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84120611|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
84120612|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120613|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84120614|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
84120615|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
84120616|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84120617|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84120618|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84120619|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120620|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120621|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
84120622|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120623|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
84120624|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
84120625|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
84120626|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84120627|NCT02660684|Cyclosporine|cyclosporine|mesh-list
84120628|NCT02660684|Methotrexate|methotrexate|mesh-list
84120629|NCT02660684|Tacrolimus|tacrolimus|mesh-list
84120630|NCT02660684|Cyclosporins|cyclosporins|mesh-list
84120631|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84120632|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
84120633|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120634|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120635|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84120636|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
84120637|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120638|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120639|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
84120640|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120641|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84120642|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120643|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
84120644|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120645|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84120646|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84120647|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
84120648|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120649|NCT00982891|Morphine|morphine|mesh-list
84120650|NCT00982891|Hydromorphone|hydromorphone|mesh-list
84120651|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84120652|NCT00982891|Narcotics|narcotics|mesh-ancestor
84120653|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120654|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120655|NCT00982891|Analgesics|analgesics|mesh-ancestor
84120656|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
84120657|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120658|NCT02615223|Bicalutamide|bicalutamide|mesh-list
84120659|NCT02615223|Hormones|hormones|mesh-list
84120660|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
84120661|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84120662|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120663|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
84120664|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
84120665|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120666|NCT04132557|Methylphenidate|methylphenidate|mesh-list
84120667|NCT04132557|Amphetamine|amphetamine|mesh-list
84120668|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84120669|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
84120670|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84120671|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84120672|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120673|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84120674|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84120675|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120676|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120677|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
84120678|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120679|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84120680|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
84120681|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
84120682|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
84120683|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120684|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
84120685|NCT00978913|Vaccines|vaccines|mesh-list
84120686|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
84120687|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120688|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120689|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120690|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84120691|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
84120692|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120693|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120694|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84120695|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
84120696|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120697|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120698|NCT04227509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84120699|NCT04227509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120700|NCT02778659|Zolpidem|zolpidem|mesh-list
84120701|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84120702|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84120703|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120704|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120705|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84120706|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
84120707|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
84120708|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120709|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120710|NCT04072900|Imiquimod|imiquimod|mesh-list
84120711|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84120712|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
84120713|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120714|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120715|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
84120716|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84120717|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84120718|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
84120719|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120720|NCT00984763|Antacids|antacids|mesh-ancestor
84120721|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120722|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84120723|NCT02578108|Lidocaine|lidocaine|mesh-list
84120724|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
84120725|NCT02578108|Anesthetics|anesthetics|mesh-list
84120726|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120727|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120728|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
84120729|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120730|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84120731|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84120732|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84120733|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120734|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120735|NCT02776163|Docetaxel|docetaxel|mesh-list
84120736|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120737|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
84120738|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
84120739|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
84120740|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120741|NCT05325346|Argatroban|argatroban|mesh-list
84120742|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
84120743|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84120744|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
84120745|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120746|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120747|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
84120748|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84120749|NCT00984997|Etoposide|etoposide|mesh-list
84120750|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120751|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84120752|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120753|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120754|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120755|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120756|NCT00973219|Interferons|interferons|mesh-list
84120757|NCT00973219|Tenofovir|tenofovir|mesh-list
84120758|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
84120759|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
84120760|NCT00973219|Adefovir|adefovir|mesh-list
84120761|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84120762|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84120763|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120764|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
84120765|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120766|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84120767|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84120768|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120769|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120770|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84120771|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84120772|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
84120773|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120774|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
84120775|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84120776|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120777|NCT04973891|Metformin|metformin|mesh-list
84120778|NCT04973891|Canagliflozin|canagliflozin|mesh-list
84120779|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120780|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120781|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84120782|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120784|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
84120785|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120786|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
84120787|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
84120788|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
84120789|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120790|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120791|NCT00983125|Clonidine|clonidine|mesh-list
84120792|NCT00983125|Analgesics|analgesics|mesh-ancestor
84120793|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
84120794|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120795|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120796|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84120797|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
84120798|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
84120799|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84120800|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84120801|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84120802|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
84120803|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120804|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120805|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
84120806|NCT00988039|Lopinavir|lopinavir|mesh-list
84120807|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84120808|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84120809|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
84120810|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120811|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84120812|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84120813|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120814|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120815|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84120816|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84120817|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
84120818|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84120819|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84120820|NCT04855513|Metformin|metformin|mesh-list
84120821|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120822|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120823|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
84120824|NCT02775773|Oxytocin|oxytocin|mesh-list
84120825|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
84120826|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120827|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120828|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84120829|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84120830|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120831|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
84120832|NCT02775773|Coagulants|coagulants|mesh-ancestor
84120833|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84120834|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
84120835|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84120836|NCT00988195|Doxorubicin|doxorubicin|mesh-list
84120837|NCT00988195|BCT-100|bct-100|mesh-list
84120838|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84120839|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120840|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120841|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120842|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120843|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120844|NCT00634985|Eletriptan|eletriptan|mesh-list
84120845|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84120846|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
84120847|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120848|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120849|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120850|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
84120851|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84120852|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84120853|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
84120854|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120855|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361029|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
84120856|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120857|NCT00985387|Urological Agents|urological agents|mesh-ancestor
84120858|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
84120859|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84120860|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
84120861|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120862|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
84120863|NCT02776943|Protective Agents|protective agents|mesh-ancestor
84120864|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
84120865|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
84120866|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84120867|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84120868|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120869|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120870|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120871|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120872|NCT04654351|Icatibant|icatibant|mesh-list
84120873|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84120874|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84120875|NCT04654351|Analgesics|analgesics|mesh-ancestor
84120876|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
84120877|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120878|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120879|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84120880|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84120881|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
84120882|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
84120883|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120884|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84120885|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84120886|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
84120887|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
84120888|NCT00582556|Leuprolide|leuprolide|mesh-list
84120889|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84120890|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120891|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84120892|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
84120893|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84120894|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84120895|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120896|NCT02776397|Vitamin E|vitamin e|mesh-list
84120897|NCT02776397|Tocopherols|tocopherols|mesh-list
84120898|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
84120899|NCT02776397|Vitamins|vitamins|mesh-ancestor
84120900|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
84120901|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120902|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
84120903|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120904|NCT02776397|Protective Agents|protective agents|mesh-ancestor
84120905|NCT00985777|Vitamin E|vitamin e|mesh-list
84120906|NCT00985777|Tocopherols|tocopherols|mesh-list
84120907|NCT00985777|Tocotrienols|tocotrienols|mesh-list
84120908|NCT00985777|Vitamins|vitamins|mesh-ancestor
84120909|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
84120910|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120911|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
84120912|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120913|NCT00985777|Protective Agents|protective agents|mesh-ancestor
84120914|NCT01563601|Carboplatin|carboplatin|mesh-list
84120915|NCT01563601|Etoposide|etoposide|mesh-list
84120916|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
84120917|NCT01563601|Obatoclax|obatoclax|mesh-list
84120918|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120919|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84120920|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120921|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120922|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120923|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120924|NCT00988507|Artesunate|artesunate|mesh-list
84120925|NCT00988507|Ferroquine|ferroquine|mesh-list
84120926|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
84120927|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84120928|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83361108|NCT02395068|Irinotecan|irinotecan|mesh-list
84120929|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84120930|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120931|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
84120932|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
84120933|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84120934|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
84120935|NCT00985855|Etoposide|etoposide|mesh-list
84120936|NCT00985855|Cetuximab|cetuximab|mesh-list
84120937|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84120938|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84120939|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84120940|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84120941|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120942|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120943|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84120944|NCT04226105|Insulin|insulin|mesh-list
84120945|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84120946|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
84120947|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
84120948|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84120949|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84120950|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84120951|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120952|NCT02776865|Lidocaine|lidocaine|mesh-list
84120953|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
84120954|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
84120955|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120956|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120957|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
84120958|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84120959|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84120960|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84120961|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84120962|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120963|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120964|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84120965|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
84120966|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120967|NCT00542269|Amlodipine|amlodipine|mesh-list
84120968|NCT00542269|Ramipril|ramipril|mesh-list
84120969|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84120970|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84120971|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84120972|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120973|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84120974|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120975|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
84120976|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84120977|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
84120978|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84120979|NCT02579434|Midazolam|midazolam|mesh-list
84120980|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84120981|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84120982|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84120983|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84120984|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84120985|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84120986|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84120987|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84120988|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
84120989|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
84120990|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
84120991|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
84120992|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84120993|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84120994|NCT00542191|Paclitaxel|paclitaxel|mesh-list
84120995|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
84120996|NCT00542191|Carboplatin|carboplatin|mesh-list
84120997|NCT00542191|Doxorubicin|doxorubicin|mesh-list
84120998|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84120999|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121000|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
84121001|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
84121002|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
84121003|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121004|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121005|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
84121006|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361178|NCT05745714|Cytarabine|cytarabine|mesh-list
84121007|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121008|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84121009|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
84121010|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84121011|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84121012|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84121013|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84121014|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121016|NCT00600938|Deferoxamine|deferoxamine|mesh-list
84121017|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84121018|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
84121019|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
84121020|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121021|NCT00600938|Siderophores|siderophores|mesh-ancestor
84121022|NCT03061474|Niacinamide|niacinamide|mesh-list
84121023|NCT03061474|Niacin|niacin|mesh-list
84121024|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
84121025|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
84121026|NCT03061474|Vitamins|vitamins|mesh-ancestor
84121027|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
84121028|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121029|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84121030|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
84121031|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121032|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84121033|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
84121034|NCT00988663|Memantine|memantine|mesh-list
84121035|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84121036|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84121037|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
84121038|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121039|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121040|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121041|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84121042|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84121043|NCT04072198|Leucovorin|leucovorin|mesh-list
84121044|NCT04072198|Bevacizumab|bevacizumab|mesh-list
84121045|NCT04072198|Nivolumab|nivolumab|mesh-list
84121046|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
84121047|NCT04072198|Irinotecan|irinotecan|mesh-list
84121048|NCT04072198|Fluorouracil|fluorouracil|mesh-list
84121049|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121050|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121051|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84121052|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84121053|NCT04072198|Growth Substances|growth substances|mesh-ancestor
84121054|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121055|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
84121056|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84121057|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121058|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84121059|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84121060|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121061|NCT04072198|Antidotes|antidotes|mesh-ancestor
84121062|NCT04072198|Protective Agents|protective agents|mesh-ancestor
84121063|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
84121064|NCT04072198|Vitamins|vitamins|mesh-ancestor
84121065|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
84121066|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
84121067|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84121068|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121069|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
84121070|NCT02772419|Benralizumab|benralizumab|mesh-list
84121071|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84121072|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
84121073|NCT00543439|Factor VIII|factor viii|mesh-list
84121074|NCT00543439|Coagulants|coagulants|mesh-ancestor
84121075|NCT02772497|Aflibercept|aflibercept|mesh-list
84121076|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84121077|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84121078|NCT02772497|Growth Substances|growth substances|mesh-ancestor
84121079|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121080|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
84121081|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121082|NCT00582166|Rituximab|rituximab|mesh-list
84121083|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84121084|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121085|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121086|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
84121087|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121088|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121090|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84121091|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84121092|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84121093|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
84121094|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121095|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121096|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121097|NCT02775539|Urological Agents|urological agents|mesh-ancestor
84121098|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
84121099|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
84121100|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121101|NCT04666961|Tamoxifen|tamoxifen|mesh-list
84121102|NCT04666961|Anastrozole|anastrozole|mesh-list
84121103|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84121104|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
84121105|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121106|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121107|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84121108|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121109|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84121110|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84121111|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84121112|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84121113|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84121114|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121115|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121116|NCT04006639|Analgesics|analgesics|mesh-list
84121117|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
84121118|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121119|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121120|NCT00601172|Dexamethasone|dexamethasone|mesh-list
84121121|NCT00601172|Ondansetron|ondansetron|mesh-list
84121122|NCT00601172|Casopitant|casopitant|mesh-list
84121123|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121124|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
84121125|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
84121126|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121127|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121128|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84121129|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
84121130|NCT00601172|Hormones|hormones|mesh-ancestor
84121131|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121132|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84121133|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121134|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
84121135|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
84121136|NCT00601172|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84121137|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84121138|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
84121139|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121140|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121141|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84121142|NCT02772107|Temozolomide|temozolomide|mesh-list
84121143|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84121144|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
84121145|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121146|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121147|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84121148|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
84121149|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84121150|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84121151|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84121152|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121153|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121154|NCT00988897|Leucovorin|leucovorin|mesh-list
84121155|NCT00988897|Bevacizumab|bevacizumab|mesh-list
84121156|NCT00988897|Fluorouracil|fluorouracil|mesh-list
84121157|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
84121158|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121159|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121160|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84121161|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84121162|NCT00988897|Growth Substances|growth substances|mesh-ancestor
84121163|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121164|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
84121165|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
84121166|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121167|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84121168|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121169|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
84121170|NCT00988897|Antidotes|antidotes|mesh-ancestor
84121171|NCT00988897|Protective Agents|protective agents|mesh-ancestor
84121172|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
84121174|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
84121175|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
84121176|NCT02775227|Pasireotide|pasireotide|mesh-list
84121177|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121178|NCT02775227|Hormones|hormones|mesh-ancestor
84121179|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121180|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121181|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
84121182|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121183|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121184|NCT02875132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84121185|NCT02875132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121186|NCT00984217|Panitumumab|panitumumab|mesh-list
84121187|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121188|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121189|NCT00989053|Escitalopram|escitalopram|mesh-list
84121190|NCT00989053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84121191|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84121192|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84121193|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121194|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121195|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
84121196|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121197|NCT04614493|Temozolomide|temozolomide|mesh-list
84121198|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84121199|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
84121200|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121201|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121202|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
84121203|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121204|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121205|NCT02841748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84121206|NCT02841748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121207|NCT04033094|Morphine|morphine|mesh-list
84121208|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84121209|NCT04033094|Narcotics|narcotics|mesh-ancestor
84121210|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121211|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121212|NCT04033094|Analgesics|analgesics|mesh-ancestor
84121213|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
84121214|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121215|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
84121216|NCT04073758|Remifentanil|remifentanil|mesh-list
84121217|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84121218|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121219|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121220|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121221|NCT04073758|Analgesics|analgesics|mesh-ancestor
84121222|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
84121223|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121224|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84121225|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84121226|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84121227|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
84121228|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121229|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121230|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84121231|NCT04073758|Narcotics|narcotics|mesh-ancestor
84121232|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
84121233|NCT02660606|Narcotics|narcotics|mesh-ancestor
84121234|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121235|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121236|NCT02660606|Analgesics|analgesics|mesh-ancestor
84121237|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
84121238|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121239|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
84121240|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84121241|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
84121242|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121243|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121244|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84121245|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
84121246|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84121247|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
84121248|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121249|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121250|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84121251|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
84121252|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
84121253|NCT00582010|Protective Agents|protective agents|mesh-ancestor
84121254|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
84121255|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84121256|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84121257|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84121258|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84121259|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121260|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
84121261|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121262|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121263|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84121264|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121265|NCT00649922|Adalimumab|adalimumab|mesh-list
84121266|NCT00649922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84121267|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121268|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121269|NCT00986557|Ganciclovir|ganciclovir|mesh-list
84121270|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
84121271|NCT00986557|Foscarnet|foscarnet|mesh-list
84121272|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
84121273|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
84121274|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121275|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121276|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
84121277|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121278|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84121279|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121280|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121281|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84121282|NCT00910754|Prednisone|prednisone|mesh-list
84121283|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
84121284|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121285|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
84121286|NCT00910754|Hormones|hormones|mesh-ancestor
84121287|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121288|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121289|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84121290|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121291|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84121292|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121293|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121294|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
84121295|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84121296|NCT00649376|Fexofenadine|fexofenadine|mesh-list
84121297|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84121298|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84121299|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84121300|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
84121301|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
84121302|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121303|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121304|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121305|NCT02340676|Interleukin-2|interleukin-2|mesh-list
84121306|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121307|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121308|NCT02340676|Analgesics|analgesics|mesh-ancestor
84121309|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
84121310|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121311|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121312|NCT00649454|Metformin|metformin|mesh-list
84121313|NCT00649454|Glipizide|glipizide|mesh-list
84121314|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84121315|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121316|NCT03920215|Varenicline|varenicline|mesh-list
84121317|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84121318|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84121319|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
84121320|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121321|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121322|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121323|NCT02655770|Liraglutide|liraglutide|mesh-list
84121324|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84121325|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121326|NCT02655770|Incretins|incretins|mesh-ancestor
84121327|NCT02655770|Hormones|hormones|mesh-ancestor
84121328|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121329|NCT00986713|Amphotericin B|amphotericin b|mesh-list
84121330|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84121331|NCT00986713|Amebicides|amebicides|mesh-ancestor
84121332|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84121333|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84121334|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121335|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84121336|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
84121337|NCT02651870|Amlodipine|amlodipine|mesh-list
84121338|NCT02651870|Candesartan|candesartan|mesh-list
84121339|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84121340|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84121341|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84121342|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121343|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84121344|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121345|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
84121346|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84121347|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84121348|NCT02766803|Resveratrol|resveratrol|mesh-list
84121349|NCT02766803|Simvastatin|simvastatin|mesh-list
84121350|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84121351|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84121352|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
84121353|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121354|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83429990|NCT03591536|Protective Agents|protective agents|mesh-ancestor
84121355|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84121356|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121357|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
84121358|NCT02766803|Protective Agents|protective agents|mesh-ancestor
84121359|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121360|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84121361|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
84121362|NCT00650468|Prednisone|prednisone|mesh-list
84121363|NCT00650468|Tacrolimus|tacrolimus|mesh-list
84121364|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121365|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
84121366|NCT00650468|Hormones|hormones|mesh-ancestor
84121367|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121368|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121369|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84121370|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121371|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121372|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
84121373|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84121374|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121375|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121376|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84121377|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84121378|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
84121379|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84121380|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121381|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
84121382|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121383|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84121384|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121385|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121387|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
84121388|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
84121389|NCT04006483|Protective Agents|protective agents|mesh-ancestor
84121390|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121391|NCT02651792|Meperidine|meperidine|mesh-list
84121392|NCT02651792|Ketamine|ketamine|mesh-list
84121393|NCT02651792|Propofol|propofol|mesh-list
84121394|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84121395|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121396|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121397|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84121398|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
84121399|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
84121400|NCT02651792|Analgesics|analgesics|mesh-ancestor
84121401|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
84121402|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121403|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84121404|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84121405|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84121406|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121407|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121408|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84121409|NCT02651792|Narcotics|narcotics|mesh-ancestor
84121410|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84121411|NCT04754815|Paclitaxel|paclitaxel|mesh-list
84121412|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84121413|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
84121414|NCT04754815|Pemetrexed|pemetrexed|mesh-list
84121415|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84121416|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121417|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
84121418|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
84121419|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
84121420|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121421|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121422|NCT04754815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84121423|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121424|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84121425|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84121426|NCT00649532|Ondansetron|ondansetron|mesh-list
84121427|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
84121428|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
84121429|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121430|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121431|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84121432|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
84121433|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
84121434|NCT00649532|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84121435|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84121436|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
84121437|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121438|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121439|NCT02655614|Midazolam|midazolam|mesh-list
84121440|NCT02655614|Caffeine|caffeine|mesh-list
84121441|NCT02655614|Rabeprazole|rabeprazole|mesh-list
84121442|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84121443|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84121444|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121445|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121446|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84121447|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84121448|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84121449|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84121450|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
84121451|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
84121452|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
84121453|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
84121454|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121455|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121456|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84121457|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84121458|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121459|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84121460|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84121461|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
84121462|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84121463|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84121464|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84121465|NCT02772029|Apatinib|apatinib|mesh-list
84121466|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121467|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84121468|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121469|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121470|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
84121471|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
84121472|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84121473|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84121474|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121475|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121476|NCT02766725|Urological Agents|urological agents|mesh-ancestor
84121477|NCT02658422|Montelukast|montelukast|mesh-list
84121478|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84121479|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
84121480|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84121481|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
84121482|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121483|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121484|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84121485|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84121486|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121487|NCT02771795|Trastuzumab|trastuzumab|mesh-list
84121488|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121489|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121490|NCT02655536|Bevacizumab|bevacizumab|mesh-list
84121491|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84121492|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121493|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121494|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84121495|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84121496|NCT02655536|Growth Substances|growth substances|mesh-ancestor
84121497|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121498|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
84121499|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84121500|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121501|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121502|NCT02766647|Lenograstim|lenograstim|mesh-list
84121503|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84121504|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
84121505|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121506|NCT02651636|Folic Acid|folic acid|mesh-list
84121507|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
84121508|NCT02651636|Inositol|inositol|mesh-list
84121509|NCT02651636|Hematinics|hematinics|mesh-ancestor
84121510|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
84121511|NCT02651636|Vitamins|vitamins|mesh-ancestor
84121512|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
84121513|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121514|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
84121515|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121516|NCT02651636|Protective Agents|protective agents|mesh-ancestor
84121517|NCT02774993|Doxycycline|doxycycline|mesh-list
84121518|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84121519|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121520|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
84121521|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84121522|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84121523|NCT02774837|Tenofovir|tenofovir|mesh-list
84121524|NCT02774837|Telbivudine|telbivudine|mesh-list
84121525|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
84121526|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121527|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84121528|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84121529|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121530|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121531|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84121532|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84121533|NCT02658188|Gabapentin|gabapentin|mesh-list
84121534|NCT02658188|Analgesics|analgesics|mesh-ancestor
84121535|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
84121536|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121537|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121538|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
84121539|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84121540|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84121541|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121542|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84121543|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84121544|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84121545|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121546|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121547|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
84121548|NCT02771717|Budesonide|budesonide|mesh-list
84121549|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121550|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84121551|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
84121552|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121553|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121554|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84121555|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
84121556|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
84121557|NCT02771717|Hormones|hormones|mesh-ancestor
84121558|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121559|NCT02655380|Ketamine|ketamine|mesh-list
84121560|NCT02655380|Remifentanil|remifentanil|mesh-list
84121561|NCT02655380|Analgesics|analgesics|mesh-ancestor
84121562|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
84121563|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121564|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121565|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84121566|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84121567|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
84121568|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
84121569|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121570|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84121571|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84121572|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121573|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121574|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84121575|NCT02655380|Narcotics|narcotics|mesh-ancestor
84121576|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
84121577|NCT00580840|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84121578|NCT00580840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121579|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121580|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
84121581|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121582|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121583|NCT00987103|Tacrolimus|tacrolimus|mesh-list
84121584|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121585|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
84121586|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121587|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84121588|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121589|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121590|NCT02655458|Lenalidomide|lenalidomide|mesh-list
84121591|NCT02655458|Elotuzumab|elotuzumab|mesh-list
84121592|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
84121593|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121594|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84121595|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84121596|NCT02655458|Growth Substances|growth substances|mesh-ancestor
84121597|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
84121598|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121599|NCT04006093|Apixaban|apixaban|mesh-list
84121600|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84121601|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
84121602|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84121603|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
84121604|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121605|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121606|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
84121607|NCT02766257|Anesthetics|anesthetics|mesh-list
84121608|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121609|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121610|NCT04005469|Treprostinil|treprostinil|mesh-list
84121611|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84121612|NCT02651324|Ketamine|ketamine|mesh-list
84121613|NCT02651324|Analgesics|analgesics|mesh-ancestor
84121614|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
84121615|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121616|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121617|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84121618|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84121619|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
84121620|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
84121621|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121622|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84121623|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84121624|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121625|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121626|NCT00662220|Ribavirin|ribavirin|mesh-list
84121627|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84121628|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
84121629|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
84121630|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121631|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
84121632|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121633|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
84121634|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121635|NCT02575924|Imidacloprid|imidacloprid|mesh-list
84121636|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
84121637|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121638|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121639|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121640|NCT02651168|Aflibercept|aflibercept|mesh-list
84121641|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84121642|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84121643|NCT02651168|Growth Substances|growth substances|mesh-ancestor
84121644|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121645|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
84121646|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121647|NCT04073602|Trastuzumab|trastuzumab|mesh-list
84121648|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121649|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121650|NCT00650000|Modafinil|modafinil|mesh-list
84121651|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84121652|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121653|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84121654|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84121655|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84121656|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121657|NCT02630862|Aspirin|aspirin|mesh-list
84121658|NCT02630862|Dipyridamole|dipyridamole|mesh-list
84121659|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84121660|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121661|NCT02630862|Analgesics|analgesics|mesh-ancestor
84121662|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
84121663|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121664|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121665|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121666|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121667|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84121668|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84121669|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121670|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84121671|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84121672|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121673|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
84121674|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84121675|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
84121676|NCT02536430|Ketorolac|ketorolac|mesh-list
84121677|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84121678|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84121679|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121680|NCT02536430|Analgesics|analgesics|mesh-ancestor
84121681|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
84121682|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121683|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121684|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121685|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121686|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84121687|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121688|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121689|NCT02631174|Antithrombins|antithrombins|mesh-list
84121690|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
84121691|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84121692|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
84121693|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121694|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121695|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
84121696|NCT04686929|Abatacept|abatacept|mesh-list
84121697|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84121698|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121699|NCT04686929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121700|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121701|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121702|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
84121703|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121704|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121705|NCT02765633|Cangrelor|cangrelor|mesh-list
84121706|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84121707|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84121708|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84121709|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84121710|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
84121711|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121712|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121713|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121714|NCT00581776|Dexamethasone|dexamethasone|mesh-list
84121715|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
84121716|NCT00581776|Rituximab|rituximab|mesh-list
84121717|NCT00581776|Doxorubicin|doxorubicin|mesh-list
84121718|NCT00581776|Vincristine|vincristine|mesh-list
84121719|NCT00581776|Bortezomib|bortezomib|mesh-list
84121720|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121721|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
84121722|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121723|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121724|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84121725|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
84121726|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121727|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121728|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84121729|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84121730|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121731|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
84121732|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
84121733|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121734|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84121735|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
84121736|NCT00581776|Hormones|hormones|mesh-ancestor
84121737|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121738|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84121739|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84121740|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84121741|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84121742|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121743|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84121744|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
84121745|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
84121746|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
84121747|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84121748|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84121749|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
84121750|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84121751|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84121752|NCT00662454|Estradiol|estradiol|mesh-list
84121753|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84121754|NCT00662454|Estrogens|estrogens|mesh-ancestor
83362626|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
84121755|NCT00662454|Hormones|hormones|mesh-ancestor
84121756|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121757|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121758|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84121759|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
84121760|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84121761|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84121762|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84121763|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84121764|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84121765|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84121766|NCT04156152|Listerine|listerine|mesh-list
84121767|NCT04156152|Fluorides|fluorides|mesh-list
84121768|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
84121769|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
84121770|NCT04156152|Protective Agents|protective agents|mesh-ancestor
84121771|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121772|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84121773|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121774|NCT00662610|Naproxen|naproxen|mesh-list
84121775|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
84121776|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84121777|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121778|NCT00662610|Analgesics|analgesics|mesh-ancestor
84121779|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
84121780|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121781|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121782|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121783|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121784|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
84121785|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84121786|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121787|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121788|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84121789|NCT04225325|Dolutegravir|dolutegravir|mesh-list
84121790|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84121791|NCT04225325|Emtricitabine|emtricitabine|mesh-list
84121792|NCT04225325|Darunavir|darunavir|mesh-list
84121793|NCT04225325|Cobicistat|cobicistat|mesh-list
84121794|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84121795|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84121796|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121797|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121798|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84121799|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84121800|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
84121801|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121802|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84121803|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84121804|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84121805|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84121806|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
84121807|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84121808|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84121809|NCT00649610|Diclofenac|diclofenac|mesh-list
84121810|NCT00649610|Valdecoxib|valdecoxib|mesh-list
84121811|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84121812|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121813|NCT00649610|Analgesics|analgesics|mesh-ancestor
84121814|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
84121815|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121816|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121817|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121818|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121819|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84121820|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121821|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121822|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84121823|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84121824|NCT02655146|Progesterone|progesterone|mesh-list
84121825|NCT02655146|Estradiol|estradiol|mesh-list
84121826|NCT02655146|Progestins|progestins|mesh-ancestor
84121827|NCT02655146|Hormones|hormones|mesh-ancestor
84121828|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84121829|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121830|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
84121831|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84121832|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
84121833|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84121834|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84121835|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84121836|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121837|NCT02655146|Estrogens|estrogens|mesh-ancestor
84121838|NCT02774525|Ethanol|ethanol|mesh-list
84121839|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84121840|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121841|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121842|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121843|NCT04167566|Artemisinins|artemisinins|mesh-list
84121844|NCT04167566|Artemisinin|artemisinin|mesh-list
84121845|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
84121846|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84121847|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84121848|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121849|NCT00650624|Valdecoxib|valdecoxib|mesh-list
84121850|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84121851|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84121852|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121853|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121854|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84121855|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121856|NCT00650624|Analgesics|analgesics|mesh-ancestor
84121857|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
84121858|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121859|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121860|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121861|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121862|NCT00666354|Methotrexate|methotrexate|mesh-list
84121863|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84121864|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
84121865|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84121866|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121867|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84121868|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
84121869|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83429998|NCT00501943|Riluzole|riluzole|mesh-list
84121870|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121871|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
84121872|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121873|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84121874|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121875|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
84121876|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121877|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84121878|NCT02774291|Aldesleukin|aldesleukin|mesh-list
84121879|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
84121880|NCT02774291|Fludarabine|fludarabine|mesh-list
84121881|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
84121882|NCT02774291|Interleukin-2|interleukin-2|mesh-list
84121883|NCT02774291|Lenograstim|lenograstim|mesh-list
84121884|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84121885|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
84121886|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121887|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121888|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84121889|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
84121890|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121891|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121892|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84121893|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84121894|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
84121895|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84121896|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121897|NCT02774291|Analgesics|analgesics|mesh-ancestor
84121898|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
84121899|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121900|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84121901|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84121902|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
84121903|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362781|NCT01583179|Buprenorphine|buprenorphine|mesh-list
84121904|NCT02536352|Vitamins|vitamins|mesh-list
84121905|NCT02536352|Fluorides|fluorides|mesh-list
84121906|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
84121907|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121908|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
84121909|NCT02536352|Protective Agents|protective agents|mesh-ancestor
84121910|NCT02773979|Chloroquine|chloroquine|mesh-list
84121911|NCT02773979|Amebicides|amebicides|mesh-ancestor
84121912|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84121913|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84121914|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121915|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
84121916|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121917|NCT00662844|Vitamin D|vitamin d|mesh-list
84121918|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
84121919|NCT00662844|Vitamins|vitamins|mesh-ancestor
84121920|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
84121921|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121922|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84121923|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84121924|NCT02650544|Mirtazapine|mirtazapine|mesh-list
84121925|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
84121926|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84121927|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84121928|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
84121929|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
84121930|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84121931|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121932|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121933|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84121934|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84121935|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121936|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84121937|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84121938|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84121939|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
84121940|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84121941|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84121942|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
84121943|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84121944|NCT02650388|Chrysarobin|chrysarobin|mesh-list
83430001|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84121945|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84121946|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121947|NCT02650388|Analgesics|analgesics|mesh-ancestor
84121948|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
84121949|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121950|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121951|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84121952|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84121953|NCT00883740|Pregabalin|pregabalin|mesh-list
84121954|NCT00883740|Analgesics|analgesics|mesh-ancestor
84121955|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
84121956|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121957|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121958|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
84121959|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84121960|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84121961|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121962|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84121963|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84121964|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84121965|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121966|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84121967|NCT04183712|Gemcitabine|gemcitabine|mesh-list
84121968|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
84121969|NCT04183712|Afatinib|afatinib|mesh-list
84121970|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84121971|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
84121972|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84121973|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84121974|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84121975|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84121976|NCT02773199|Bupivacaine|bupivacaine|mesh-list
84121977|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
84121978|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
84121979|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121980|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121981|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
84121982|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121983|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
84121984|NCT02654834|Anesthetics|anesthetics|mesh-list
84121985|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121986|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121987|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84121988|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
84121989|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84121990|NCT02654834|Analgesics|analgesics|mesh-ancestor
84121991|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
84121992|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84121993|NCT00656526|Lidocaine|lidocaine|mesh-list
84121994|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
84121995|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
84121996|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84121997|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84121998|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
84121999|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122000|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84122001|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84122002|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84122003|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122004|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122005|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84122006|NCT02765009|Furosemide|furosemide|mesh-list
84122007|NCT02765009|Bumetanide|bumetanide|mesh-list
84122008|NCT02765009|Diuretics|diuretics|mesh-list
84122009|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84122010|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
84122011|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122012|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84122013|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122014|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122015|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84122016|NCT02649920|Dinoprostone|dinoprostone|mesh-list
84122017|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
84122018|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84122019|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122020|NCT00649688|Metoprolol|metoprolol|mesh-list
84122021|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84122022|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84122023|NCT00649688|Diuretics|diuretics|mesh-ancestor
84122024|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
84122025|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122026|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84122027|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122028|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122029|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84122030|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
84122031|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
84122032|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122033|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84122034|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84122035|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84122036|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
84122037|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122038|NCT00667056|Tacrolimus|tacrolimus|mesh-list
84122039|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84122040|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
84122041|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122042|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84122043|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122044|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122045|NCT02764619|Spironolactone|spironolactone|mesh-list
84122046|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84122047|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
84122048|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122049|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122050|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84122051|NCT02764619|Diuretics|diuretics|mesh-ancestor
84122052|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
84122053|NCT04032210|Zinc|zinc|mesh-list
84122054|NCT04032210|Fluorides|fluorides|mesh-list
84122055|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
84122056|NCT04032210|Protective Agents|protective agents|mesh-ancestor
84122057|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122058|NCT04032210|Trace Elements|trace elements|mesh-ancestor
84122059|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
84122060|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
84122061|NCT04223219|Fentanyl|fentanyl|mesh-list
84122062|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
84122063|NCT04223219|Ketamine|ketamine|mesh-list
84122064|NCT04223219|Propofol|propofol|mesh-list
84122065|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84122066|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122067|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122068|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84122069|NCT04223219|Analgesics|analgesics|mesh-ancestor
84122070|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
84122071|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122072|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84122073|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84122074|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84122075|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
84122076|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122077|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122078|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84122079|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
84122080|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
84122081|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84122082|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84122083|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84122084|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84122085|NCT04223219|Narcotics|narcotics|mesh-ancestor
84122086|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84122087|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84122088|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
84122089|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84122090|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122091|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84122092|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
84122093|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84122094|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
84122095|NCT02631252|Etoposide|etoposide|mesh-list
84122096|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
84122097|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84122098|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122099|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84122100|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84122101|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122102|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122103|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
84122104|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84122105|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84122106|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122107|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122108|NCT02631252|Analgesics|analgesics|mesh-ancestor
84122109|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
84122110|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122111|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122112|NCT02631408|Vancomycin|vancomycin|mesh-list
84122113|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84122114|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122115|NCT02630394|Azithromycin|azithromycin|mesh-list
84122116|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84122117|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122118|NCT04629443|Azacitidine|azacitidine|mesh-list
84122119|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84122120|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
84122121|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122122|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122123|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122124|NCT02771405|Ribavirin|ribavirin|mesh-list
84122125|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
84122126|NCT02771405|Simeprevir|simeprevir|mesh-list
84122127|NCT02771405|Ledipasvir|ledipasvir|mesh-list
84122128|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
84122129|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122130|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
84122131|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122132|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
84122133|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122134|NCT00667758|Cetrorelix|cetrorelix|mesh-list
84122135|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84122136|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
84122137|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84122138|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122139|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
84122140|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122141|NCT00542815|Sevelamer|sevelamer|mesh-list
84122142|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
84122143|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
84122144|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122145|NCT02762591|Pimavanserin|pimavanserin|mesh-list
84122146|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84122147|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84122148|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84122149|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84122150|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122151|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122152|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84122153|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84122154|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84122155|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
84122156|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122157|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122158|NCT02696369|Lidocaine|lidocaine|mesh-list
84122159|NCT02696369|Epinephrine|epinephrine|mesh-list
84122160|NCT02696369|Racepinephrine|racepinephrine|mesh-list
84122161|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
84122162|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
84122163|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
84122164|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122165|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122166|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
84122167|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122168|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84122169|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84122170|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84122171|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122172|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122173|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84122174|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84122175|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
84122176|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122177|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84122178|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84122179|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
84122180|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84122181|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
84122182|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
84122183|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
84122184|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84122185|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84122186|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122187|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122188|NCT02636088|Cetuximab|cetuximab|mesh-list
84122189|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84122190|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122191|NCT02630160|Epinephrine|epinephrine|mesh-list
84122192|NCT02630160|Bupivacaine|bupivacaine|mesh-list
84122193|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
84122194|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
84122195|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122196|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122197|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
84122198|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122199|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84122200|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84122201|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
84122202|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122203|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122204|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84122205|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84122206|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
84122207|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84122208|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
84122209|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
84122210|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
84122211|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84122212|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
84122213|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84122214|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84122215|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122216|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84122217|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84122218|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122219|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122220|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122221|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84122222|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
84122223|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84122224|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122225|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84122226|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84122227|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84122228|NCT00542425|Teriparatide|teriparatide|mesh-list
84122229|NCT00542425|Abaloparatide|abaloparatide|mesh-list
84122230|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
84122231|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84122232|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122233|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84122234|NCT00668538|Miconazole|miconazole|mesh-list
84122235|NCT00668538|Clotrimazole|clotrimazole|mesh-list
84122236|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
84122237|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122238|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84122239|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84122240|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122241|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122242|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84122243|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
84122244|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122245|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122246|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84122247|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84122248|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84122249|NCT00668616|Paclitaxel|paclitaxel|mesh-list
84122250|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84122251|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
84122252|NCT00668616|Epirubicin|epirubicin|mesh-list
84122253|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84122254|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122255|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
84122256|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
84122257|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
84122258|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122259|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84122260|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
84122261|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122262|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122263|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84122264|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
84122265|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84122266|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84122267|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84122268|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84122269|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122270|NCT02763761|Prednisone|prednisone|mesh-list
84122271|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
84122272|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84122273|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84122274|NCT02763761|Prednisolone|prednisolone|mesh-list
84122275|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
84122276|NCT02763761|Infliximab|infliximab|mesh-list
84122277|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84122278|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
84122279|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122280|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
84122281|NCT02763761|Hormones|hormones|mesh-ancestor
84122282|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122283|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122284|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84122285|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122286|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
84122287|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
84122288|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122289|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84122290|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84122291|NCT02763761|Protective Agents|protective agents|mesh-ancestor
84122292|NCT02763761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84122293|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
84122294|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122295|NCT04155918|Allopurinol|allopurinol|mesh-list
84122296|NCT04155918|Febuxostat|febuxostat|mesh-list
84122297|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
84122298|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122299|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122300|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
84122301|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122302|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84122303|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
84122304|NCT04155918|Protective Agents|protective agents|mesh-ancestor
84122305|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122306|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84122307|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84122308|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
84122309|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122310|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84122311|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84122312|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
84122313|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
84122314|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122315|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122316|NCT00541099|Bevacizumab|bevacizumab|mesh-list
84122317|NCT00541099|Docetaxel|docetaxel|mesh-list
84122318|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84122319|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122320|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84122321|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84122322|NCT00541099|Growth Substances|growth substances|mesh-ancestor
84122323|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122324|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
84122325|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
84122326|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
84122327|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
84122328|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122329|NCT00580606|Glycerol|glycerol|mesh-list
84122330|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84122331|NCT00580606|Protective Agents|protective agents|mesh-ancestor
84122332|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122333|NCT02575768|Adenosine|adenosine|mesh-list
84122334|NCT02575768|Analgesics|analgesics|mesh-ancestor
84122335|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
84122336|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122337|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122338|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84122339|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
84122340|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84122341|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
84122342|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
84122343|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122344|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122345|NCT00987493|Rituximab|rituximab|mesh-list
84122346|NCT00987493|Lenalidomide|lenalidomide|mesh-list
84122347|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84122348|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84122349|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122350|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
84122351|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122352|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122353|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84122354|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84122355|NCT00987493|Growth Substances|growth substances|mesh-ancestor
84122356|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
84122357|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84122358|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
84122359|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122361|NCT02579356|Atorvastatin|atorvastatin|mesh-list
84122362|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84122363|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84122364|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
84122365|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122366|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84122367|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84122368|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122369|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84122370|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84122371|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84122372|NCT03914170|Cetuximab|cetuximab|mesh-list
84122373|NCT03914170|Folfirinox|folfirinox|mesh-list
84122374|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84122375|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122376|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
84122377|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84122378|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122379|NCT02577250|Ketamine|ketamine|mesh-list
84122380|NCT02577250|Analgesics|analgesics|mesh-ancestor
84122381|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
84122382|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122383|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122384|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84122385|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84122386|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
84122387|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
84122388|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122389|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84122390|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84122391|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122392|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122393|NCT00668850|Insulin|insulin|mesh-list
84122394|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84122395|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84122396|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122397|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
84122398|NCT02762123|Digoxin|digoxin|mesh-list
84122399|NCT02762123|Midazolam|midazolam|mesh-list
84122400|NCT02762123|Omeprazole|omeprazole|mesh-list
84122401|NCT02762123|Montelukast|montelukast|mesh-list
84122402|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84122403|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84122404|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122405|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122406|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84122407|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84122408|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84122409|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84122410|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
84122411|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
84122412|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
84122413|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
84122414|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122415|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122416|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84122417|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84122418|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84122419|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122420|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84122421|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
84122422|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84122423|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
84122424|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122425|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84122426|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84122427|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84122428|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84122429|NCT02762123|Protective Agents|protective agents|mesh-ancestor
84122430|NCT02762123|Analgesics|analgesics|mesh-ancestor
84122431|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
84122432|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122433|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84122434|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84122435|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122436|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122437|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84122438|NCT04153734|Paclitaxel|paclitaxel|mesh-list
84122439|NCT04153734|Carboplatin|carboplatin|mesh-list
84122440|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
84122441|NCT04153734|Pemetrexed|pemetrexed|mesh-list
84122442|NCT04153734|Cisplatin|cisplatin|mesh-list
84122443|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84122444|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122445|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
84122446|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
84122447|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
84122448|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122449|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84122450|NCT04153734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84122451|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122452|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84122453|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84122454|NCT04073680|Canagliflozin|canagliflozin|mesh-list
84122455|NCT04073680|Serabelisib|serabelisib|mesh-list
84122456|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84122457|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122458|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84122459|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122460|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122461|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
84122462|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84122463|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
84122464|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122465|NCT02761577|Expectorants|expectorants|mesh-ancestor
84122466|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
84122467|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84122468|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
84122469|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122470|NCT02761577|Protective Agents|protective agents|mesh-ancestor
84122471|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122472|NCT02761577|Antidotes|antidotes|mesh-ancestor
84122473|NCT00579982|Lamotrigine|lamotrigine|mesh-list
84122474|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
84122475|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84122476|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122477|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122478|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84122479|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122480|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84122481|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84122482|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122483|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84122484|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84122485|NCT00596466|Pregabalin|pregabalin|mesh-list
84122486|NCT00596466|Analgesics|analgesics|mesh-ancestor
84122487|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
84122488|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122489|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122490|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
84122491|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84122492|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122493|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122494|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84122495|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84122496|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84122497|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122498|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84122499|NCT02763059|Acetaminophen|acetaminophen|mesh-list
84122500|NCT02763059|Dexamethasone|dexamethasone|mesh-list
84122501|NCT02763059|Ibuprofen|ibuprofen|mesh-list
84122502|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122503|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
84122504|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
84122505|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122506|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122507|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84122508|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
84122510|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122511|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84122512|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122513|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84122514|NCT02763059|Analgesics|analgesics|mesh-ancestor
84122515|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
84122516|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
84122517|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84122518|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122519|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84122520|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122521|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122522|NCT04222517|Hemostatics|hemostatics|mesh-list
84122523|NCT04222517|Coagulants|coagulants|mesh-ancestor
84122524|NCT00671112|Everolimus|everolimus|mesh-list
84122525|NCT00671112|Bortezomib|bortezomib|mesh-list
84122526|NCT00671112|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84122527|NCT00671112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84122528|NCT00671112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122529|NCT00671112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122530|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84122531|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
84122532|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122533|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122534|NCT04857385|Hemostatics|hemostatics|mesh-list
84122535|NCT04857385|Coagulants|coagulants|mesh-ancestor
84122536|NCT00664014|Tolvaptan|tolvaptan|mesh-list
84122537|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84122538|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122539|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
84122540|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122541|NCT02696915|Fentanyl|fentanyl|mesh-list
84122542|NCT02696915|Bupivacaine|bupivacaine|mesh-list
84122543|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
84122544|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
84122545|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122546|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122547|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
84122548|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122549|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84122550|NCT02696915|Narcotics|narcotics|mesh-ancestor
84122551|NCT02696915|Analgesics|analgesics|mesh-ancestor
84122552|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84122553|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84122554|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
84122555|NCT00911664|Vitamin D|vitamin d|mesh-list
84122556|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
84122557|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
84122558|NCT00911664|Vitamins|vitamins|mesh-list
84122559|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
84122560|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122561|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84122562|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84122563|NCT04821817|Rocuronium|rocuronium|mesh-list
84122564|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84122565|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84122566|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84122567|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122568|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122569|NCT00664170|Docetaxel|docetaxel|mesh-list
84122570|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122571|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
84122572|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
84122573|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
84122574|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122575|NCT02758067|Risperidone|risperidone|mesh-list
84122576|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
84122577|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84122578|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
84122579|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122580|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122581|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122582|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84122583|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84122584|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122585|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84122586|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84122587|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
84122588|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
84122589|NCT00664248|Clindamycin|clindamycin|mesh-list
84122590|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
84122591|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
84122592|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
84122593|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84122594|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122595|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84122596|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122597|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122598|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
84122599|NCT00579670|Ziprasidone|ziprasidone|mesh-list
84122600|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84122601|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
84122602|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122603|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122604|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122605|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84122606|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84122607|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122608|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84122609|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84122610|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
84122611|NCT00669786|Menotropins|menotropins|mesh-list
84122612|NCT00669786|Hormones|hormones|mesh-list
84122613|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84122614|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122615|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122616|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84122617|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
84122618|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84122619|NCT02760953|Epirubicin|epirubicin|mesh-list
84122620|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84122621|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122622|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84122623|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84122624|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122625|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122626|NCT02630004|Melatonin|melatonin|mesh-list
84122627|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
84122628|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122629|NCT02630004|Protective Agents|protective agents|mesh-ancestor
84122630|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122631|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122632|NCT00129922|Paclitaxel|paclitaxel|mesh-list
84122633|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
84122634|NCT00129922|Fluorouracil|fluorouracil|mesh-list
84122635|NCT00129922|Epirubicin|epirubicin|mesh-list
84122636|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84122637|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122638|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
84122639|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
84122640|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
84122641|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122642|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84122643|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
84122644|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122645|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122646|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84122647|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
84122648|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84122649|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
84122650|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84122651|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84122652|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84122653|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84122654|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122655|NCT03909295|Valsartan|valsartan|mesh-list
84122656|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84122657|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84122658|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84122659|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84122660|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122661|NCT04153968|Retinol acetate|retinol acetate|mesh-list
84122662|NCT04153968|Protective Agents|protective agents|mesh-ancestor
84122663|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122664|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84122665|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
84122666|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84122667|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122668|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
84122669|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84122670|NCT00671424|Furosemide|furosemide|mesh-list
84122671|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84122672|NCT00671424|Diuretics|diuretics|mesh-ancestor
84122673|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
84122674|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122675|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84122676|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122677|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122678|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84122679|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84122680|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84122681|NCT00599924|Leucovorin|leucovorin|mesh-list
84122682|NCT00599924|Sunitinib|sunitinib|mesh-list
84122683|NCT00599924|Fluorouracil|fluorouracil|mesh-list
84122684|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
84122685|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122686|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84122687|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84122688|NCT00599924|Growth Substances|growth substances|mesh-ancestor
84122689|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122690|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
84122691|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84122692|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122693|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122694|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
84122695|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84122696|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84122697|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
84122698|NCT00599924|Antidotes|antidotes|mesh-ancestor
84122699|NCT00599924|Protective Agents|protective agents|mesh-ancestor
84122700|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
84122701|NCT00599924|Vitamins|vitamins|mesh-ancestor
84122702|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
84122703|NCT02757209|Fluticasone|fluticasone|mesh-list
84122704|NCT02757209|Xhance|xhance|mesh-list
84122705|NCT02757209|Budesonide|budesonide|mesh-list
84122706|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
84122707|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84122708|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84122709|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122710|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84122711|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
84122712|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122713|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122714|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84122715|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
84122716|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
84122717|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84122718|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
84122719|NCT02757209|Hormones|hormones|mesh-ancestor
84122720|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122721|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84122722|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84122723|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84122724|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
84122725|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122726|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122727|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
84122728|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122729|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
84122730|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84122731|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122732|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84122733|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84122734|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122735|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122736|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122737|NCT05338801|Menthol|menthol|mesh-list
84122738|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
84122739|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
84122740|NCT02757287|Desogestrel|desogestrel|mesh-list
84122741|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84122742|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84122743|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84122744|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
84122745|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84122746|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122747|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84122748|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84122749|NCT02757287|Progestins|progestins|mesh-ancestor
84122750|NCT02757287|Hormones|hormones|mesh-ancestor
84122751|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122752|NCT02649686|Trastuzumab|trastuzumab|mesh-list
84122753|NCT02649686|Durvalumab|durvalumab|mesh-list
84122754|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84122755|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122756|NCT02757365|Aspirin|aspirin|mesh-list
84122757|NCT02757365|Levofloxacin|levofloxacin|mesh-list
84122758|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84122759|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84122760|NCT02757365|Analgesics|analgesics|mesh-ancestor
84122761|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
84122762|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122763|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122764|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122765|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122766|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84122767|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84122768|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122769|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84122770|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84122771|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122772|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
84122773|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84122774|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122775|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84122776|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84122777|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84122778|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122779|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84122780|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84122781|NCT02649530|LGK974|lgk974|mesh-list
84122782|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122783|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122784|NCT02575534|Procainamide|procainamide|mesh-list
84122785|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84122786|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84122787|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84122788|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122789|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122790|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
84122791|NCT02757443|Anesthetics|anesthetics|mesh-list
84122792|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122793|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122794|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84122795|NCT02757443|Protective Agents|protective agents|mesh-ancestor
84122796|NCT04071262|Prednisolone|prednisolone|mesh-list
84122797|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
84122798|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122799|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
84122800|NCT04071262|Hormones|hormones|mesh-ancestor
84122801|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122802|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122803|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84122804|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122805|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83363694|NCT00248547|Dexamethasone|dexamethasone|mesh-list
84122806|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122807|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122808|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
84122809|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84122810|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
84122811|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84122812|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
84122813|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122814|NCT04154982|Expectorants|expectorants|mesh-ancestor
84122815|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
84122816|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84122817|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
84122818|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122819|NCT04154982|Protective Agents|protective agents|mesh-ancestor
84122820|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122821|NCT04154982|Antidotes|antidotes|mesh-ancestor
84122822|NCT04154748|Omeprazole|omeprazole|mesh-list
84122823|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84122824|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84122825|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84122826|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122827|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122828|NCT02657096|Hybenx|hybenx|mesh-list
84122829|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
84122830|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
84122831|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122832|NCT02536742|Fulvestrant|fulvestrant|mesh-list
84122833|NCT02536742|Palbociclib|palbociclib|mesh-list
84122834|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84122835|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122836|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84122837|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84122838|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
84122839|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122840|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122841|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84122842|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122843|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122844|NCT00670410|Fludarabine|fludarabine|mesh-list
84122845|NCT00670410|Busulfan|busulfan|mesh-list
84122846|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
84122847|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122848|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122849|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84122850|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
84122851|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122852|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
84122853|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84122854|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84122855|NCT02756663|Dexamethasone|dexamethasone|mesh-list
84122856|NCT02756663|Panobinostat|panobinostat|mesh-list
84122857|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122858|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
84122859|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
84122860|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122861|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122862|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84122863|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
84122864|NCT02756663|Hormones|hormones|mesh-ancestor
84122865|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122866|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84122867|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122868|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84122869|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122870|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122871|NCT02654678|Enalapril|enalapril|mesh-list
84122872|NCT02654678|Enalaprilat|enalaprilat|mesh-list
84122873|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84122874|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
84122875|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122876|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122877|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84122878|NCT05288023|Azithromycin|azithromycin|mesh-list
84122879|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84122880|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122881|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84122882|NCT00670566|Irbesartan|irbesartan|mesh-list
84122883|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84122884|NCT00670566|Diuretics|diuretics|mesh-ancestor
84122885|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
84122886|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122887|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84122888|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84122889|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122890|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84122891|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84122892|NCT02629848|Paclitaxel|paclitaxel|mesh-list
84122893|NCT02629848|Carboplatin|carboplatin|mesh-list
84122894|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
84122895|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84122896|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122897|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
84122898|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
84122899|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
84122900|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122901|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84122902|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122903|NCT03912337|Erenumab|erenumab|mesh-list
84122904|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
84122905|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122906|NCT03912337|Analgesics|analgesics|mesh-ancestor
84122907|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
84122908|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122909|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122910|NCT00650156|Adalimumab|adalimumab|mesh-list
84122911|NCT00650156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84122912|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122913|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84122914|NCT02576782|Dexamethasone|dexamethasone|mesh-list
84122915|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
84122916|NCT02576782|Bupivacaine|bupivacaine|mesh-list
84122917|NCT02576782|BB 1101|bb 1101|mesh-list
84122918|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84122919|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
84122920|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
84122921|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84122922|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122923|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84122924|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
84122925|NCT02576782|Hormones|hormones|mesh-ancestor
84122926|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84122927|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84122928|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122929|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
84122930|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122931|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122932|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
84122933|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
84122934|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122935|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
84122936|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84122937|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84122938|NCT02577094|Fludarabine|fludarabine|mesh-list
84122939|NCT02577094|Busulfan|busulfan|mesh-list
84122940|NCT02577094|Epratuzumab|epratuzumab|mesh-list
84122941|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
84122942|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122943|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122944|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84122945|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
84122946|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122947|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
84122948|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84122949|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84122950|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84122951|NCT00649844|Ziprasidone|ziprasidone|mesh-list
84122952|NCT00649844|Clozapine|clozapine|mesh-list
84122953|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84122954|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
83363845|NCT01535053|Leucovorin|leucovorin|mesh-list
84122955|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84122956|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122957|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122958|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84122959|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84122960|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122961|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84122962|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84122963|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
84122964|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
84122965|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
84122966|NCT03912259|Emollients|emollients|mesh-list
84122967|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
84122968|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
84122969|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
84122970|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84122971|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84122972|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122973|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
84122974|NCT02656472|Coagulants|coagulants|mesh-ancestor
84122975|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84122976|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
84122977|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84122978|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84122979|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84122980|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122981|NCT00665340|Urological Agents|urological agents|mesh-ancestor
84122982|NCT00665418|Sevoflurane|sevoflurane|mesh-list
84122983|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84122984|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84122985|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
84122986|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
84122987|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84122988|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84122989|NCT04058990|Paclitaxel|paclitaxel|mesh-list
84122990|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84122991|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84122992|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84122993|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
84122994|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
84122995|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
84122996|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84122997|NCT00595920|Vaccines|vaccines|mesh-list
84122998|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
84122999|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123000|NCT02654288|Gemcitabine|gemcitabine|mesh-list
84123001|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84123002|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
84123003|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123004|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123005|NCT02649140|Acetic Acid|acetic acid|mesh-list
84123006|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123007|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123008|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84123009|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
84123010|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84123011|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84123012|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123013|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123014|NCT00665496|Urological Agents|urological agents|mesh-ancestor
84123015|NCT02653898|Artesunate|artesunate|mesh-list
84123016|NCT02653898|Piperaquine|piperaquine|mesh-list
84123017|NCT02653898|Primaquine|primaquine|mesh-list
84123018|NCT02653898|Artenimol|artenimol|mesh-list
84123019|NCT02653898|Mefloquine|mefloquine|mesh-list
84123020|NCT02653898|Permethrin|permethrin|mesh-list
84123021|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
84123022|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84123023|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84123024|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123025|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123026|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
84123027|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
84123028|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83363911|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
84123029|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
84123030|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123031|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123033|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84123034|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
84123035|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123036|NCT02629536|Expectorants|expectorants|mesh-ancestor
84123037|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
84123038|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84123039|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
84123040|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123041|NCT02629536|Protective Agents|protective agents|mesh-ancestor
84123042|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123043|NCT02629536|Antidotes|antidotes|mesh-ancestor
84123044|NCT04071106|Betamethasone|betamethasone|mesh-list
84123045|NCT04071106|Calcipotriene|calcipotriene|mesh-list
84123046|NCT04071106|Petrolatum|petrolatum|mesh-list
84123047|NCT04071106|Turmeric extract|turmeric extract|mesh-list
84123048|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123049|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
84123050|NCT04071106|Hormones|hormones|mesh-ancestor
84123051|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123052|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123053|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84123054|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
84123055|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
84123056|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
84123057|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123058|NCT04071106|Protective Agents|protective agents|mesh-ancestor
84123059|NCT04071106|Emollients|emollients|mesh-ancestor
84123060|NCT00670722|Insulin|insulin|mesh-list
84123061|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84123062|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
84123063|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
84123064|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84123065|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
84123066|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
84123067|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84123068|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84123069|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123070|NCT02648906|Choline|choline|mesh-list
84123071|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
84123072|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84123073|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
84123074|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123075|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84123076|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84123077|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
84123078|NCT00670878|Gemcitabine|gemcitabine|mesh-list
84123079|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84123080|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
84123081|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123082|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123083|NCT02760095|Vitamin A|vitamin a|mesh-list
84123084|NCT02760095|Acetic Acid|acetic acid|mesh-list
84123085|NCT02760095|Retinol acetate|retinol acetate|mesh-list
84123086|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
84123087|NCT02760095|Vitamins|vitamins|mesh-ancestor
84123088|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
84123089|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123090|NCT02760095|Protective Agents|protective agents|mesh-ancestor
84123091|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84123092|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123093|NCT02760095|Astringents|astringents|mesh-ancestor
84123094|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
84123095|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84123096|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
84123097|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123098|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123099|NCT04418167|Dabrafenib|dabrafenib|mesh-list
84123100|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123101|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84123102|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123103|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123104|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
84123105|NCT02576626|Albuterol|albuterol|mesh-list
84123106|NCT02576626|Ipratropium|ipratropium|mesh-list
84123107|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84123108|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
84123109|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123110|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123111|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84123112|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
84123113|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
84123114|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84123115|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84123116|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84123117|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84123118|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
84123119|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123120|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123121|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84123122|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84123123|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84123124|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
84123125|NCT00877890|Exenatide|exenatide|mesh-list
84123126|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84123127|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123128|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84123129|NCT00877890|Incretins|incretins|mesh-ancestor
84123130|NCT00877890|Hormones|hormones|mesh-ancestor
84123131|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123132|NCT02648672|BPN14770|bpn14770|mesh-list
84123133|NCT02648672|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84123134|NCT02648672|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84123135|NCT02648672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123136|NCT02648672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123137|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
84123138|NCT04221971|Fludarabine|fludarabine|mesh-list
84123139|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123140|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
84123141|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123142|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123143|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84123144|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
84123145|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123146|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123147|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84123148|NCT02644694|Dexamethasone|dexamethasone|mesh-list
84123149|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84123150|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84123151|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123152|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
84123153|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
84123154|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123155|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123156|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84123157|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
84123158|NCT02644694|Hormones|hormones|mesh-ancestor
84123159|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123160|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84123161|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123162|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84123163|NCT02653742|Ketorolac|ketorolac|mesh-list
84123164|NCT02653742|Fentanyl|fentanyl|mesh-list
84123165|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84123166|NCT02653742|Narcotics|narcotics|mesh-ancestor
84123167|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123168|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123169|NCT02653742|Analgesics|analgesics|mesh-ancestor
84123170|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
84123171|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123172|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84123173|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84123174|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
84123175|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
84123176|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84123177|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84123178|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123179|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123180|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84123181|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123182|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123183|NCT02755259|Acetazolamide|acetazolamide|mesh-list
84123184|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
84123185|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84123186|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123187|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123188|NCT02755259|Diuretics|diuretics|mesh-ancestor
84123189|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
84123190|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123192|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123193|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123194|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84123195|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123196|NCT00680394|Misoprostol|misoprostol|mesh-list
84123197|NCT00680394|Mifepristone|mifepristone|mesh-list
84123198|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84123199|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
84123200|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84123201|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123202|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84123203|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84123204|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
84123205|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84123206|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84123207|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84123208|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84123209|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
84123210|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84123211|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84123212|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
84123213|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123214|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
84123215|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84123216|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84123217|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
84123218|NCT04724044|Clarithromycin|clarithromycin|mesh-list
84123219|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
84123220|NCT04724044|Lactams|lactams|mesh-list
84123221|NCT04724044|beta-Lactams|beta-lactams|mesh-list
84123222|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84123223|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123224|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123225|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84123226|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84123227|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123228|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123229|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123230|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84123231|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
84123232|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84123233|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123234|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84123235|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84123236|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84123237|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84123238|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84123239|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84123240|NCT02768519|OTS167|ots167|mesh-list
84123241|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84123242|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123243|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123244|NCT03530696|Palbociclib|palbociclib|mesh-list
84123245|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123246|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84123247|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123248|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123249|NCT00671814|Linezolid|linezolid|mesh-list
84123250|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123251|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123252|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84123253|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123254|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123255|NCT02627430|Talazoparib|talazoparib|mesh-list
84123256|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84123258|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123259|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123260|NCT02759393|Lansoprazole|lansoprazole|mesh-list
84123261|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
84123262|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84123263|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84123264|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84123265|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123266|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123267|NCT02576548|MEDI4276|medi4276|mesh-list
84123268|NCT02576548|Immunoconjugates|immunoconjugates|mesh-ancestor
84123269|NCT02576548|Immunologic Factors|immunologic factors|mesh-ancestor
84123270|NCT02576548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123271|NCT02758925|Cytarabine|cytarabine|mesh-list
84123272|NCT02758925|Rituximab|rituximab|mesh-list
84123273|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84123274|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123275|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123276|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
84123277|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123278|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123279|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84123280|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
84123281|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123282|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
84123283|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123284|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123285|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84123286|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
84123287|NCT00676260|Pioglitazone|pioglitazone|mesh-list
84123288|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84123289|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123290|NCT00652652|Furosemide|furosemide|mesh-list
84123291|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84123292|NCT00652652|Diuretics|diuretics|mesh-ancestor
84123293|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
84123294|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123295|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84123296|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123297|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123298|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
84123299|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84123300|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123301|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84123302|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84123303|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123304|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123305|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
84123306|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123307|NCT02644616|Torsemide|torsemide|mesh-list
84123308|NCT02644616|Tolvaptan|tolvaptan|mesh-list
84123309|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84123310|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123311|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
84123312|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123313|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84123314|NCT02644616|Diuretics|diuretics|mesh-ancestor
84123315|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84123316|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123317|NCT02648048|Pirfenidone|pirfenidone|mesh-list
84123318|NCT02648048|Analgesics|analgesics|mesh-ancestor
84123319|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
84123320|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123321|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123322|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84123323|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84123324|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123325|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123326|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123327|NCT00676416|Propofol|propofol|mesh-list
84123328|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83364211|NCT02391636|Oxytocin|oxytocin|mesh-list
84123329|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123330|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123331|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84123332|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
84123333|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
84123334|NCT00651326|Docetaxel|docetaxel|mesh-list
84123335|NCT00651326|Leuprolide|leuprolide|mesh-list
84123336|NCT00651326|Goserelin|goserelin|mesh-list
84123337|NCT00651326|Bicalutamide|bicalutamide|mesh-list
84123338|NCT00651326|Flutamide|flutamide|mesh-list
84123339|NCT00651326|Buserelin|buserelin|mesh-list
84123340|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123341|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
84123342|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
84123343|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
84123344|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123345|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84123346|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
84123347|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84123348|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123349|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84123350|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
84123351|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
84123352|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123353|NCT04150536|Lidocaine|lidocaine|mesh-list
84123354|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
84123355|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
84123356|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123357|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123358|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
84123359|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123360|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84123361|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84123362|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84123363|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123364|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123365|NCT05167123|Calcium|calcium|mesh-list
84123366|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84123367|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123368|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84123369|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
84123370|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123371|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
84123372|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
84123373|NCT02576314|Ledipasvir|ledipasvir|mesh-list
84123374|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
84123375|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123376|NCT00650234|Metformin|metformin|mesh-list
84123377|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84123378|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123379|NCT00680940|Paclitaxel|paclitaxel|mesh-list
84123380|NCT00680940|Cisplatin|cisplatin|mesh-list
84123381|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84123382|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123383|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
84123384|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
84123385|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
84123386|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123387|NCT03472885|Eculizumab|eculizumab|mesh-list
84123388|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84123389|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123390|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
84123391|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123392|NCT02644304|Cabergoline|cabergoline|mesh-list
84123393|NCT02644304|Clomiphene|clomiphene|mesh-list
84123394|NCT02644304|Enclomiphene|enclomiphene|mesh-list
84123395|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
84123396|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123397|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84123398|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
84123399|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123400|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123401|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84123402|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
84123403|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84123404|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84123405|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84123406|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84123407|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84123408|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
84123409|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
84123410|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123412|NCT00681174|Morphine|morphine|mesh-list
84123413|NCT00681174|Remifentanil|remifentanil|mesh-list
84123414|NCT00681174|Oxycodone|oxycodone|mesh-list
84123415|NCT00681174|Propofol|propofol|mesh-list
84123416|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84123417|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123418|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123419|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84123420|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
84123421|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
84123422|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84123423|NCT00681174|Narcotics|narcotics|mesh-ancestor
84123424|NCT00681174|Analgesics|analgesics|mesh-ancestor
84123425|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
84123426|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123427|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84123428|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
84123429|NCT02758769|Abatacept|abatacept|mesh-list
84123430|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84123431|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123432|NCT02758769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123433|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123434|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123435|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
84123436|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123437|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123438|NCT04150146|Rebamipide|rebamipide|mesh-list
83430012|NCT03598634|Riboflavin|riboflavin|mesh-list
84123439|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84123440|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84123441|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
84123442|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123443|NCT04150146|Protective Agents|protective agents|mesh-ancestor
84123444|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123445|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123446|NCT00652730|Buspirone|buspirone|mesh-list
84123447|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84123448|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84123449|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123450|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123451|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84123452|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84123453|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
84123454|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123455|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123456|NCT00652808|Naproxen|naproxen|mesh-list
84123457|NCT00652808|Valdecoxib|valdecoxib|mesh-list
84123458|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84123459|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84123460|NCT00652808|Analgesics|analgesics|mesh-ancestor
84123461|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
84123462|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123463|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123464|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123465|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123466|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
84123467|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84123468|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123469|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123470|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84123471|NCT00635531|Alprazolam|alprazolam|mesh-list
84123472|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84123473|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123474|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123475|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84123476|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84123477|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84123478|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
84123479|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
84123480|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364359|NCT01528345|Fulvestrant|fulvestrant|mesh-list
84123481|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123482|NCT02535156|Risperidone|risperidone|mesh-list
84123483|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84123484|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
84123485|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123486|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123487|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123488|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84123489|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84123490|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123491|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84123492|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84123493|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
84123494|NCT03417895|Apatinib|apatinib|mesh-list
84123495|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123496|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84123497|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123498|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123499|NCT05299164|Rituximab|rituximab|mesh-list
84123500|NCT05299164|Gemcitabine|gemcitabine|mesh-list
84123501|NCT05299164|Vinorelbine|vinorelbine|mesh-list
84123502|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
84123503|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123504|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123505|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
84123506|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123507|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123508|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84123509|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
84123510|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430013|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
84123511|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84123512|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
84123513|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
84123514|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
84123515|NCT05299164|Analgesics|analgesics|mesh-ancestor
84123516|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
84123517|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123518|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84123519|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84123520|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123521|NCT01563835|Fentanyl|fentanyl|mesh-list
84123522|NCT01563835|Bupivacaine|bupivacaine|mesh-list
84123523|NCT01563835|Citric Acid|citric acid|mesh-list
84123524|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
84123525|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
84123526|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
84123527|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123528|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123529|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
84123530|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123531|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84123532|NCT01563835|Narcotics|narcotics|mesh-ancestor
84123533|NCT01563835|Analgesics|analgesics|mesh-ancestor
84123534|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84123535|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84123536|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
84123537|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
84123538|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84123539|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
84123540|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
84123541|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123542|NCT02768207|Vemurafenib|vemurafenib|mesh-list
84123543|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123544|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84123545|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123546|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123547|NCT02653196|Cyclosporine|cyclosporine|mesh-list
84123548|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
84123549|NCT02653196|Fludarabine|fludarabine|mesh-list
84123550|NCT02653196|Etoposide|etoposide|mesh-list
84123551|NCT02653196|Melphalan|melphalan|mesh-list
84123552|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
84123553|NCT02653196|Thiotepa|thiotepa|mesh-list
84123554|NCT02653196|Tacrolimus|tacrolimus|mesh-list
84123555|NCT02653196|Cyclosporins|cyclosporins|mesh-list
84123556|NCT02653196|Mitogens|mitogens|mesh-list
84123557|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123558|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123559|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123560|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
84123561|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123562|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84123563|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84123564|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84123565|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123566|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84123567|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
84123568|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123569|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
84123570|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123571|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84123572|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84123573|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
84123574|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123575|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84123576|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
84123577|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84123578|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
84123579|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123580|NCT05135845|Spartalizumab|spartalizumab|mesh-list
84123581|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84123582|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123583|NCT05135845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123584|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123585|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
84123586|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123587|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123588|NCT00677118|Cisplatin|cisplatin|mesh-list
84123589|NCT00677118|Fluorouracil|fluorouracil|mesh-list
84123590|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123591|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
84123592|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123593|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84123594|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123595|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
84123596|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123597|NCT02644226|Sevoflurane|sevoflurane|mesh-list
84123598|NCT02644226|Desflurane|desflurane|mesh-list
84123599|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84123600|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84123601|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
84123602|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
84123603|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123604|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123605|NCT02753855|Telavancin|telavancin|mesh-list
84123606|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123607|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123608|NCT02758691|Insulin|insulin|mesh-list
84123609|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84123610|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123611|NCT00714376|Docetaxel|docetaxel|mesh-list
84123612|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123613|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
84123614|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
84123615|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
84123616|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123617|NCT04068766|Bupivacaine|bupivacaine|mesh-list
84123618|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
84123619|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
84123620|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123621|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123622|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
84123623|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123624|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
84123625|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84123626|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123627|NCT04725695|Lidocaine|lidocaine|mesh-list
84123628|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
84123629|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
84123630|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123631|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123632|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
84123633|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123634|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84123635|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84123636|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84123637|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123638|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123639|NCT04151472|Ubiquinone|ubiquinone|mesh-list
84123640|NCT04151472|Idebenone|idebenone|mesh-list
84123641|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
84123642|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123643|NCT04151472|Protective Agents|protective agents|mesh-ancestor
84123644|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123645|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
84123646|NCT04070794|Metformin|metformin|mesh-list
84123647|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84123648|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123649|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
84123650|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84123651|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84123652|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123653|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
84123654|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
84123655|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
84123656|NCT00677664|Mannitol|mannitol|mesh-list
84123657|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
84123658|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84123659|NCT00677664|Diuretics|diuretics|mesh-ancestor
84123660|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
84123661|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123662|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84123663|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
84123664|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123665|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123666|NCT02572492|Dexamethasone|dexamethasone|mesh-list
84123667|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
84123668|NCT02572492|Melphalan|melphalan|mesh-list
84123669|NCT02572492|BB 1101|bb 1101|mesh-list
84123670|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123671|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
84123672|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
84123673|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123674|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123675|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84123676|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
84123677|NCT02572492|Hormones|hormones|mesh-ancestor
84123678|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123679|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84123680|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123681|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
84123682|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123683|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123684|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84123685|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
84123686|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84123687|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123688|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
84123689|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
84123690|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84123691|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123692|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
84123693|NCT00672282|Bicalutamide|bicalutamide|mesh-list
84123694|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
84123695|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
84123696|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123697|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123698|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123699|NCT02753309|Sirolimus|sirolimus|mesh-list
84123700|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123701|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123702|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84123703|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123704|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
84123705|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84123706|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
84123707|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123708|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
84123709|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84123710|NCT04147728|Growth Substances|growth substances|mesh-ancestor
84123711|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123712|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
84123713|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123714|NCT04544189|Fulvestrant|fulvestrant|mesh-list
84123715|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84123716|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123717|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84123718|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84123719|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
84123720|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123721|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123722|NCT04330690|Artesunate|artesunate|mesh-list
84123723|NCT04330690|Dexamethasone|dexamethasone|mesh-list
84123724|NCT04330690|Infliximab|infliximab|mesh-list
84123725|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
84123726|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123727|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
84123728|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
84123729|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123730|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123731|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84123732|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
84123733|NCT04330690|Hormones|hormones|mesh-ancestor
84123734|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123735|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84123736|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123737|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84123738|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123739|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123740|NCT04330690|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84123741|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
84123742|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123743|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
84123744|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84123745|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84123746|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123747|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
84123748|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
84123749|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84123750|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
84123751|NCT03083041|Apatinib|apatinib|mesh-list
84123752|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123753|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84123754|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123755|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123756|NCT00672360|Folic Acid|folic acid|mesh-list
84123757|NCT00672360|Hematinics|hematinics|mesh-ancestor
84123758|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
84123759|NCT00672360|Vitamins|vitamins|mesh-ancestor
84123760|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
84123761|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123762|NCT02628522|Lidocaine|lidocaine|mesh-list
84123763|NCT02628522|Epinephrine|epinephrine|mesh-list
84123764|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
84123765|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
84123766|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123767|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123768|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
84123769|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123770|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84123771|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84123772|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84123773|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123774|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123775|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84123776|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84123777|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
84123778|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123779|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84123780|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84123781|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
84123782|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84123783|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
84123784|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
84123785|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
84123786|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84123787|NCT02572336|Plasminogen|plasminogen|mesh-list
84123788|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84123789|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84123790|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84123791|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123793|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
84123794|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
84123795|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123796|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123797|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
84123798|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123799|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84123800|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84123801|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84123802|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123803|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123804|NCT04067011|Doxycycline|doxycycline|mesh-list
84123805|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
84123806|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123807|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123808|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
84123809|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84123810|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84123811|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84123812|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84123813|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123814|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123815|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123816|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84123817|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84123818|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
84123819|NCT04044859|Nivolumab|nivolumab|mesh-list
84123820|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123821|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123822|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84123823|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123824|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
84123825|NCT00719056|Lactams|lactams|mesh-list
84123826|NCT00719056|Cephalosporins|cephalosporins|mesh-list
84123827|NCT00719056|Teicoplanin|teicoplanin|mesh-list
84123828|NCT00719056|beta-Lactams|beta-lactams|mesh-list
84123829|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84123830|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123831|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84123832|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84123833|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123834|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123835|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123836|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84123837|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84123838|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84123839|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84123840|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
84123841|NCT03475004|Bevacizumab|bevacizumab|mesh-list
84123842|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
84123843|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123844|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123845|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84123846|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84123847|NCT03475004|Growth Substances|growth substances|mesh-ancestor
84123848|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123849|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
84123850|NCT03475004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84123851|NCT03475004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123852|NCT02695745|Celecoxib|celecoxib|mesh-list
84123853|NCT02695745|Capsaicin|capsaicin|mesh-list
84123854|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84123855|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84123856|NCT02695745|Analgesics|analgesics|mesh-ancestor
84123857|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
84123858|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364735|NCT00291135|Letrozole|letrozole|mesh-list
84123859|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123860|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123861|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84123862|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84123863|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84123864|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84123865|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123866|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
84123867|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
84123868|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84123869|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
84123870|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84123871|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84123872|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84123873|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123874|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123875|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123876|NCT00990067|Analgesics|analgesics|mesh-ancestor
84123877|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
84123878|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123879|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
84123880|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84123881|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
84123882|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
84123883|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
84123884|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84123885|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
84123886|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
84123887|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84123888|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
84123889|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123890|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
84123891|NCT00719290|Protective Agents|protective agents|mesh-ancestor
84123892|NCT00635921|Ziprasidone|ziprasidone|mesh-list
84123893|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84123894|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
84123895|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123896|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123897|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123898|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84123899|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84123900|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123901|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84123902|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84123903|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
84123904|NCT04166006|Interleukin-2|interleukin-2|mesh-list
84123905|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123906|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84123907|NCT04166006|Analgesics|analgesics|mesh-ancestor
84123908|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
84123909|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123910|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123912|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
84123913|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123914|NCT00710086|Remifentanil|remifentanil|mesh-list
84123915|NCT00710086|Hydromorphone|hydromorphone|mesh-list
84123916|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84123917|NCT00710086|Narcotics|narcotics|mesh-ancestor
84123918|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84123919|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123920|NCT00710086|Analgesics|analgesics|mesh-ancestor
84123921|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
84123922|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123923|NCT00652886|Oxandrolone|oxandrolone|mesh-list
84123924|NCT00652886|Androgens|androgens|mesh-ancestor
84123925|NCT00652886|Hormones|hormones|mesh-ancestor
84123926|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123927|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123928|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
84123929|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
84123930|NCT00539305|Testosterone|testosterone|mesh-list
84123931|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
84123932|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
84123933|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84123934|NCT00539305|Androgens|androgens|mesh-ancestor
84123935|NCT00539305|Hormones|hormones|mesh-ancestor
84123936|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123937|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123938|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84123939|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123940|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
84123941|NCT02643914|Nicotine|nicotine|mesh-list
84123942|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84123943|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
84123944|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84123945|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123946|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84123947|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84123948|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
84123949|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84123950|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123951|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
84123952|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84123953|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123954|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84123955|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84123956|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
84123957|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84123958|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
84123959|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84123960|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84123961|NCT04808999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84123962|NCT04808999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84123963|NCT00990223|Eplerenone|eplerenone|mesh-list
84123964|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84123965|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
84123966|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123967|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123968|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84123969|NCT00990223|Diuretics|diuretics|mesh-ancestor
84123970|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
84123971|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84123972|NCT00715780|Insulin|insulin|mesh-list
84123973|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84123974|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
84123975|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
84123976|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84123977|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
84123978|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
84123979|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
84123980|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
84123981|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
84123982|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84123983|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123984|NCT02652884|Betamethasone|betamethasone|mesh-list
84123985|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
84123986|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84123987|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
84123988|NCT02652884|Hormones|hormones|mesh-ancestor
84123989|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84123990|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123991|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84123992|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
84123993|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84123994|NCT00990301|Moexipril|moexipril|mesh-list
84123995|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84123996|NCT00990301|Diuretics|diuretics|mesh-ancestor
84123997|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
84123998|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84123999|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84124000|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124001|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124002|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84124003|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
84124004|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124005|NCT00715858|Doxycycline|doxycycline|mesh-list
84124006|NCT00715858|Rifampin|rifampin|mesh-list
84124007|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84124008|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124010|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84124011|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84124012|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84124013|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
84124014|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
84124015|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84124016|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124017|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124018|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84124019|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84124020|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84124021|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84124022|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84124023|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84124024|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
84124025|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84124026|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124027|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
84124028|NCT04696445|Morphine|morphine|mesh-list
84124029|NCT04696445|Oxycodone|oxycodone|mesh-list
84124030|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124031|NCT04696445|Narcotics|narcotics|mesh-ancestor
84124032|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124033|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124034|NCT04696445|Analgesics|analgesics|mesh-ancestor
84124035|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
84124036|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124037|NCT05360953|Clonidine|clonidine|mesh-list
84124038|NCT05360953|Doxazosin|doxazosin|mesh-list
84124039|NCT05360953|Analgesics|analgesics|mesh-ancestor
84124040|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
84124041|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124042|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124043|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124044|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
84124045|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
84124046|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84124047|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84124048|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84124049|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124050|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124051|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124052|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84124053|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84124054|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84124055|NCT02647424|Letrozole|letrozole|mesh-list
84124056|NCT02647424|Clomiphene|clomiphene|mesh-list
84124057|NCT02647424|Enclomiphene|enclomiphene|mesh-list
84124058|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
84124059|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124060|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84124061|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84124062|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124063|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124064|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84124065|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
84124066|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124067|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124068|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84124069|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
84124070|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84124071|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84124072|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84124073|NCT02574754|Warfarin|warfarin|mesh-list
84124074|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
84124075|NCT00719602|Ritonavir|ritonavir|mesh-list
84124076|NCT00719602|Lopinavir|lopinavir|mesh-list
84124077|NCT00719602|Lamivudine|lamivudine|mesh-list
84124078|NCT00719602|Zidovudine|zidovudine|mesh-list
84124079|NCT00719602|Nevirapine|nevirapine|mesh-list
84124080|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84124081|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84124082|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
84124083|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124084|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124085|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84124086|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84124087|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
84124088|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124089|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84124090|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84124091|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84124092|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84124093|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
84124094|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84124095|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84124096|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84124097|NCT02652650|Norethindrone|norethindrone|mesh-list
84124098|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
84124099|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84124100|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84124101|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84124102|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
84124103|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84124104|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124105|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84124106|NCT02652650|Estrogens|estrogens|mesh-ancestor
84124107|NCT02652650|Hormones|hormones|mesh-ancestor
83430018|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
84124108|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124109|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84124110|NCT02643602|Theophylline|theophylline|mesh-list
84124111|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84124112|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
84124113|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124114|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124115|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84124116|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
84124117|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84124118|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124119|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124120|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
84124121|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84124122|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84124123|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
84124124|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124125|NCT00710320|Anesthetics|anesthetics|mesh-list
84124126|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124127|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124128|NCT00716170|Glucagon|glucagon|mesh-list
84124129|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
84124130|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84124131|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84124132|NCT00716170|Hormones|hormones|mesh-ancestor
84124133|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124134|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124135|NCT00716170|Incretins|incretins|mesh-ancestor
84124136|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
84124137|NCT02652806|Hematinics|hematinics|mesh-ancestor
84124138|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
84124139|NCT04529135|Remifentanil|remifentanil|mesh-list
84124140|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84124141|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124142|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124143|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124144|NCT04529135|Analgesics|analgesics|mesh-ancestor
84124145|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
84124146|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124147|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84124148|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84124149|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84124150|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124151|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124152|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124153|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124154|NCT04529135|Narcotics|narcotics|mesh-ancestor
84124155|NCT02647190|Asparaginase|asparaginase|mesh-list
84124156|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365041|NCT00343083|Paclitaxel|paclitaxel|mesh-list
84124157|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84124158|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
84124159|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124161|NCT04165850|Celecoxib|celecoxib|mesh-list
84124162|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84124163|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124164|NCT04165850|Analgesics|analgesics|mesh-ancestor
84124165|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
84124166|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124167|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124168|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124169|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124170|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84124171|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84124172|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124173|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124174|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84124175|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124176|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84124177|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84124178|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124179|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84124180|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84124181|NCT00719758|Beraprost|beraprost|mesh-list
84124182|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84124183|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
84124184|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
84124185|NCT02647268|Oxytocin|oxytocin|mesh-list
84124186|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
84124187|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84124188|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124189|NCT02647268|Analgesics|analgesics|mesh-ancestor
84124190|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
84124191|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124192|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
84124193|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124194|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84124195|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
84124196|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84124197|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124198|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124199|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84124200|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
84124201|NCT04218149|Bupivacaine|bupivacaine|mesh-list
84124202|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
84124203|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
84124204|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124205|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124206|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
84124207|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124208|NCT04032860|Tenofovir|tenofovir|mesh-list
84124209|NCT04032860|Entecavir|entecavir|mesh-list
84124210|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
84124211|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124212|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84124213|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84124214|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124215|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124216|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84124217|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84124218|NCT00716248|Bucillamine|bucillamine|mesh-list
84124219|NCT00716248|Methotrexate|methotrexate|mesh-list
84124220|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84124221|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
84124222|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84124223|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124224|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84124225|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
84124226|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124227|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124228|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
84124229|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124230|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84124231|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84124232|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
84124233|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124234|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84124235|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84124236|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124237|NCT00716248|Analgesics|analgesics|mesh-ancestor
84124238|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
84124239|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124240|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124241|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
84124242|NCT00716248|Protective Agents|protective agents|mesh-ancestor
84124243|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
84124244|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84124245|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
84124246|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84124247|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
84124248|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124249|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124250|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
84124251|NCT02642900|Nystatin|nystatin|mesh-list
84124252|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84124253|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124254|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
84124255|NCT02642900|Ionophores|ionophores|mesh-ancestor
84124256|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124257|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124258|NCT02652728|Enalapril|enalapril|mesh-list
84124259|NCT02652728|Enalaprilat|enalaprilat|mesh-list
84124260|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84124261|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
84124262|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124263|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124264|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124265|NCT00720148|Bortezomib|bortezomib|mesh-list
84124266|NCT00720148|Sunitinib|sunitinib|mesh-list
84124267|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124268|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84124269|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84124270|NCT00720148|Growth Substances|growth substances|mesh-ancestor
84124271|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124272|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
84124273|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84124274|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124275|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124276|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
84124277|NCT00710788|Calcium|calcium|mesh-list
84124278|NCT00710788|Sevelamer|sevelamer|mesh-list
84124279|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84124280|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124281|NCT00710788|Antacids|antacids|mesh-ancestor
84124282|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124283|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84124284|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
84124285|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
84124286|NCT03530189|Insulin|insulin|mesh-list
84124287|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84124288|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124289|NCT02646800|Micafungin|micafungin|mesh-list
84124290|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
84124291|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124292|NCT02749409|Parecoxib|parecoxib|mesh-list
84124293|NCT02749409|Morphine|morphine|mesh-list
84124294|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124295|NCT02749409|Narcotics|narcotics|mesh-ancestor
84124296|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124297|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124298|NCT02749409|Analgesics|analgesics|mesh-ancestor
84124299|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
84124300|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124301|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84124302|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84124303|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124304|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124305|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84124306|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124307|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124308|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124309|NCT03454529|Simvastatin|simvastatin|mesh-list
84124310|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84124311|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84124312|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
84124313|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124314|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84124315|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84124316|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124317|NCT03449459|Amikacin|amikacin|mesh-list
84124318|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84124319|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124320|NCT00653120|Propranolol|propranolol|mesh-list
84124321|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84124322|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84124323|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124324|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124325|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124326|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124327|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84124328|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124329|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
84124330|NCT00678132|Gemcitabine|gemcitabine|mesh-list
84124331|NCT00678132|Olaparib|olaparib|mesh-list
84124332|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124333|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84124334|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
84124335|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124336|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84124337|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124338|NCT02789345|Osimertinib|osimertinib|mesh-list
84124339|NCT02789345|Ramucirumab|ramucirumab|mesh-list
84124340|NCT02789345|Necitumumab|necitumumab|mesh-list
84124341|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124342|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84124343|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124344|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124345|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84124346|NCT02772965|Methotrexate|methotrexate|mesh-list
84124347|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84124348|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
84124349|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84124350|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124351|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84124352|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
84124353|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124354|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124355|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
84124356|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124357|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84124358|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84124359|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
84124360|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124361|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84124362|NCT00681720|Flumazenil|flumazenil|mesh-list
84124363|NCT00681720|Antidotes|antidotes|mesh-ancestor
84124364|NCT00681720|Protective Agents|protective agents|mesh-ancestor
84124365|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124366|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
84124367|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
84124368|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124369|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124370|NCT00650312|Metformin|metformin|mesh-list
84124371|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84124372|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124373|NCT00538681|Pemetrexed|pemetrexed|mesh-list
84124374|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124375|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124376|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124377|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84124378|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84124379|NCT00650390|Adalimumab|adalimumab|mesh-list
84124380|NCT00650390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83365255|NCT02037126|Psilocybin|psilocybin|mesh-list
84124381|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124382|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124383|NCT00681876|Bevacizumab|bevacizumab|mesh-list
84124384|NCT00681876|Cetuximab|cetuximab|mesh-list
84124385|NCT00681876|Irinotecan|irinotecan|mesh-list
84124386|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84124387|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124388|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84124389|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84124390|NCT00681876|Growth Substances|growth substances|mesh-ancestor
84124391|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124392|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
84124393|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84124394|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84124395|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124396|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124397|NCT02226367|Prazosin|prazosin|mesh-list
84124398|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124399|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84124400|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84124401|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84124402|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124403|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124404|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124405|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124406|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84124407|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
84124408|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124409|NCT02159989|Aflibercept|aflibercept|mesh-list
84124410|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
84124411|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84124412|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84124413|NCT02159989|Growth Substances|growth substances|mesh-ancestor
84124414|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124415|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
84124416|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124417|NCT02628132|Paclitaxel|paclitaxel|mesh-list
84124418|NCT02628132|Durvalumab|durvalumab|mesh-list
84124419|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84124420|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124421|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
84124422|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
84124423|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
84124424|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124425|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84124426|NCT02695355|Methylphenidate|methylphenidate|mesh-list
84124427|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84124428|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124429|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84124430|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84124431|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124432|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124433|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
84124434|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124435|NCT02573038|Aflibercept|aflibercept|mesh-list
84124436|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84124437|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84124438|NCT02573038|Growth Substances|growth substances|mesh-ancestor
84124439|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124440|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
84124441|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124442|NCT02159755|Palbociclib|palbociclib|mesh-list
84124443|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124444|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84124445|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124446|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124447|NCT01822015|Cytarabine|cytarabine|mesh-list
84124448|NCT01822015|Sirolimus|sirolimus|mesh-list
84124449|NCT01822015|Idarubicin|idarubicin|mesh-list
84124450|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84124451|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
84124452|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124453|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124454|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
84124455|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124456|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84124457|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
84124458|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124459|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84124460|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84124461|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
84124462|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124463|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84124464|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84124466|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84124467|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84124468|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124469|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
84124470|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84124471|NCT00720304|Docetaxel|docetaxel|mesh-list
84124472|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84124473|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124474|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
84124475|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
84124476|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
84124477|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124478|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84124479|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124480|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
84124481|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
84124482|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
84124483|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124484|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124485|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
84124486|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124487|NCT00990691|Desipramine|desipramine|mesh-list
84124488|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84124489|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
84124490|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84124491|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124492|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124493|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84124494|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84124495|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124496|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124497|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124498|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124499|NCT00678522|Atorvastatin|atorvastatin|mesh-list
84124500|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84124501|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84124502|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
84124503|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124504|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84124505|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84124506|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124507|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
84124508|NCT04391855|Tramadol|tramadol|mesh-list
84124509|NCT04391855|Ropivacaine|ropivacaine|mesh-list
84124510|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84124511|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124512|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124513|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124514|NCT04391855|Analgesics|analgesics|mesh-ancestor
84124515|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
84124516|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124517|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84124518|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84124519|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84124520|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124521|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124522|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124523|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
84124524|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
84124525|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124526|NCT04391855|Narcotics|narcotics|mesh-ancestor
84124527|NCT00716950|Losartan|losartan|mesh-list
84124528|NCT00716950|Valsartan|valsartan|mesh-list
84124529|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124530|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84124531|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84124532|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124533|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84124534|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84124535|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
84124536|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84124537|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
84124538|NCT00678756|Ketoconazole|ketoconazole|mesh-list
84124539|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
84124540|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124541|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84124542|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84124543|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124544|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124545|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84124546|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
84124547|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124548|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124549|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84124550|NCT02748395|Triamcinolone|triamcinolone|mesh-list
84124551|NCT02748395|Lidocaine|lidocaine|mesh-list
84124552|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
84124553|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
84124554|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124555|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124556|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
84124557|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124558|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84124559|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84124560|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84124561|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124562|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124563|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124564|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
84124565|NCT02748395|Hormones|hormones|mesh-ancestor
84124566|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124567|NCT02629224|Gabapentin|gabapentin|mesh-list
84124568|NCT02629224|Analgesics|analgesics|mesh-ancestor
84124569|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
84124570|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124571|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124572|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
84124573|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84124574|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84124575|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124576|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84124577|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84124578|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84124579|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124580|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124581|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
84124582|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
84124583|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84124584|NCT00711256|Protective Agents|protective agents|mesh-ancestor
84124585|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124586|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
84124587|NCT04069234|Clopidogrel|clopidogrel|mesh-list
84124588|NCT04069234|Ticagrelor|ticagrelor|mesh-list
84124589|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84124590|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84124591|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84124592|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84124593|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
84124594|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124595|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124596|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124755|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124756|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124757|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365481|NCT05800366|Protective Agents|protective agents|mesh-ancestor
84124759|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
84124760|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
84124761|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84124762|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
84148834|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148835|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148836|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
84148837|NCT04135313|Capecitabine|capecitabine|mesh-list
84148838|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
84148839|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148840|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
84148841|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148842|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148843|NCT00692159|Pemetrexed|pemetrexed|mesh-list
84148844|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148845|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148846|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148847|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84148848|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84148849|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
84148850|NCT00692315|Vitamins|vitamins|mesh-ancestor
84148851|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
84148852|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148853|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
84148854|NCT02623049|Anticoagulants|anticoagulants|mesh-list
84148855|NCT02608944|Adenosine|adenosine|mesh-list
84148856|NCT02608944|Regadenoson|regadenoson|mesh-list
84148857|NCT02608944|Analgesics|analgesics|mesh-ancestor
84148858|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
84148859|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148860|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148861|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84148862|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
84148863|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84148864|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
84148865|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
84148866|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148867|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148868|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84148869|NCT00913614|SR 46349B|sr 46349b|mesh-list
84148870|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84148871|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84148872|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148873|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84148874|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84148875|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
84148876|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148877|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148878|NCT00664534|Insulin|insulin|mesh-list
84148879|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84148880|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
84148881|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
84148882|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84148883|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148884|NCT00913848|Valproic Acid|valproic acid|mesh-list
84148885|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
84148886|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148887|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148888|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
84148889|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148890|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148891|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
84148892|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148893|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148894|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148895|NCT02620163|Amlodipine|amlodipine|mesh-list
84148896|NCT02620163|Telmisartan|telmisartan|mesh-list
84148897|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
84148898|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
84148899|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84148900|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84148901|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84148902|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365557|NCT05799924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84124763|NCT03874715|Insulin|insulin|mesh-list
84124764|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84124765|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
84124766|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
84124767|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
84124768|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84124769|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84124770|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124771|NCT00679458|Buprenorphine|buprenorphine|mesh-list
84124772|NCT00679458|Naloxone|naloxone|mesh-list
84124773|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124774|NCT00679458|Narcotics|narcotics|mesh-ancestor
84124775|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124776|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124777|NCT00679458|Analgesics|analgesics|mesh-ancestor
84124778|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
84124779|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124780|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84124781|NCT04216511|Autoantibodies|autoantibodies|mesh-list
84124782|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
84124783|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124784|NCT02747537|Irinotecan|irinotecan|mesh-list
84124785|NCT02747537|Sorafenib|sorafenib|mesh-list
84124786|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84124787|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84124788|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124789|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124790|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124791|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84124792|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
84124793|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
84124794|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84124795|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124796|NCT02747381|Vitamins|vitamins|mesh-ancestor
84124797|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
84124798|NCT00673218|Omalizumab|omalizumab|mesh-list
84124799|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84124800|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84124801|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
84124802|NCT00673296|Bevacizumab|bevacizumab|mesh-list
84124803|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84124804|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124805|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84124806|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84124807|NCT00673296|Growth Substances|growth substances|mesh-ancestor
84124808|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124809|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
84124810|NCT04216355|Azacitidine|azacitidine|mesh-list
84124811|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84124812|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
84124813|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124814|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124815|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124816|NCT00683124|Losartan|losartan|mesh-list
84124817|NCT00683124|Nebivolol|nebivolol|mesh-list
84124818|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84124819|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84124820|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84124821|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84124822|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124823|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
84124824|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84124825|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84124826|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84124827|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
84124828|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124829|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124830|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
84124831|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84124832|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124833|NCT00683202|Aspirin|aspirin|mesh-list
84124834|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84124835|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124836|NCT00683202|Analgesics|analgesics|mesh-ancestor
84124837|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
84124838|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124839|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124840|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124841|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124842|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84124843|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84124844|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124845|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84124846|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84124847|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124849|NCT00679536|Fludarabine|fludarabine|mesh-list
84124850|NCT00679536|Busulfan|busulfan|mesh-list
84124851|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
84124852|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124853|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124854|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84124855|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
84124856|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124857|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
84124858|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84124859|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84124860|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
84124861|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84124862|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124863|NCT00537979|Vitamins|vitamins|mesh-ancestor
84124864|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
84124865|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84124866|NCT00679614|Acetaminophen|acetaminophen|mesh-list
84124867|NCT00679614|Tramadol|tramadol|mesh-list
84124868|NCT00679614|Naloxone|naloxone|mesh-list
84124869|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84124870|NCT00679614|Analgesics|analgesics|mesh-ancestor
84124871|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
84124872|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124873|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124874|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
84124875|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124876|NCT00679614|Narcotics|narcotics|mesh-ancestor
84124877|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124878|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84124879|NCT02744417|Bupropion|bupropion|mesh-list
84124880|NCT02744417|Nicotine|nicotine|mesh-list
84124881|NCT02744417|Varenicline|varenicline|mesh-list
84124882|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84124883|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
84124884|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124885|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124886|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84124887|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84124888|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
84124889|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124890|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124891|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84124892|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
84124893|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84124894|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84124895|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84124896|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84124897|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
84124898|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84124899|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84124900|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124901|NCT02629146|Fentanyl|fentanyl|mesh-list
84124902|NCT02629146|Midazolam|midazolam|mesh-list
84124903|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84124904|NCT02629146|Narcotics|narcotics|mesh-ancestor
84124905|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124906|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124907|NCT02629146|Analgesics|analgesics|mesh-ancestor
84124908|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
84124909|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124910|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84124911|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84124912|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
84124913|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
84124914|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84124915|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84124916|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84124917|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84124918|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
84124919|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
84124920|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124921|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124922|NCT02744339|Riociguat|riociguat|mesh-list
84124923|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
84124924|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124925|NCT00991159|Bococizumab|bococizumab|mesh-list
84124926|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84124927|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84124928|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
84124929|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124930|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84124931|NCT00679770|Tavaborole|tavaborole|mesh-list
84124932|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
84124933|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124934|NCT02744495|Betamethasone|betamethasone|mesh-list
84124935|NCT02744495|Droperidol|droperidol|mesh-list
84124936|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84124937|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
84124938|NCT02744495|Hormones|hormones|mesh-ancestor
84124939|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84124940|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124941|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84124942|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
84124943|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84124944|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
84124945|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
84124946|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84124947|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84124948|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84124949|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84124950|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124951|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84124952|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84124953|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84124954|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
84124955|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124956|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124957|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84124958|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84124959|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
84124960|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124961|NCT00683436|Adipiplon|adipiplon|mesh-list
84124962|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124963|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124964|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
84124965|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
84124966|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84124967|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124968|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84124969|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84124970|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84124971|NCT00989443|Cidofovir|cidofovir|mesh-list
84124972|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
84124973|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84124974|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84124975|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124976|NCT00683514|Cisplatin|cisplatin|mesh-list
84124977|NCT00683514|Vinorelbine|vinorelbine|mesh-list
84124978|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124979|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84124980|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
84124981|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
84124982|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
84124983|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124984|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
84124985|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84124986|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
84124987|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124988|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84124989|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84124990|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
84124991|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84124992|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84124993|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84124994|NCT05629325|Buspirone|buspirone|mesh-list
84124995|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84124996|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84124997|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84124998|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84124999|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84125000|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84125001|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
84125002|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125003|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125004|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
84125005|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84125006|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
84125007|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125008|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
84125009|NCT02629380|Protective Agents|protective agents|mesh-ancestor
84125010|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
84125011|NCT02743247|Tacrolimus|tacrolimus|mesh-list
84125012|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125013|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
84125014|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125015|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84125016|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125017|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125018|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84125019|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125020|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84125021|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
84125022|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84125023|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125024|NCT00680160|Tavaborole|tavaborole|mesh-list
84125025|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
84125026|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125027|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
84125028|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84125029|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125030|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
84125031|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84125032|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
84125033|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84125034|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
84125035|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125036|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125037|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
84125038|NCT00537823|Leucovorin|leucovorin|mesh-list
84125039|NCT00537823|Bevacizumab|bevacizumab|mesh-list
84125040|NCT00537823|Cetuximab|cetuximab|mesh-list
84125041|NCT00537823|Fluorouracil|fluorouracil|mesh-list
84125042|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
84125043|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84125044|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125045|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84125046|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84125047|NCT00537823|Growth Substances|growth substances|mesh-ancestor
84125048|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125049|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
84125050|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
84125051|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125052|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84125053|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125054|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
84125055|NCT00537823|Antidotes|antidotes|mesh-ancestor
84125056|NCT00537823|Protective Agents|protective agents|mesh-ancestor
84125057|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
84125058|NCT00537823|Vitamins|vitamins|mesh-ancestor
84125059|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
84125060|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
84125061|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
84125062|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125063|NCT04139928|Cathartics|cathartics|mesh-ancestor
83365852|NCT05633381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125064|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125065|NCT04139928|Antacids|antacids|mesh-ancestor
84125066|NCT05589025|Eugenol|eugenol|mesh-list
84125067|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
84125068|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
84125069|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
84125070|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84125071|NCT05589025|Protective Agents|protective agents|mesh-ancestor
84125072|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125073|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125075|NCT02742233|Incretins|incretins|mesh-ancestor
84125076|NCT02742233|Hormones|hormones|mesh-ancestor
84125077|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125078|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125079|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84125080|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
84125081|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125082|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125083|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84125084|NCT00673608|Deferasirox|deferasirox|mesh-list
84125085|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84125086|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
84125087|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
84125088|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125089|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
84125090|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
84125091|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84125092|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84125093|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125094|NCT02742467|Amlodipine|amlodipine|mesh-list
84125095|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84125096|NCT02742467|Perindopril|perindopril|mesh-list
84125097|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84125098|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84125099|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84125100|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125101|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84125102|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125103|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
84125104|NCT02742467|Diuretics|diuretics|mesh-ancestor
84125105|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
84125106|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84125107|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84125108|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
84125109|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125110|NCT00684216|Tamoxifen|tamoxifen|mesh-list
84125111|NCT00684216|Capecitabine|capecitabine|mesh-list
84125112|NCT00684216|Letrozole|letrozole|mesh-list
84125113|NCT00684216|Anastrozole|anastrozole|mesh-list
84125114|NCT00684216|Exemestane|exemestane|mesh-list
84125115|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84125116|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
84125117|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125118|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125119|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84125120|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84125121|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125122|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84125123|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
84125124|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125125|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125126|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84125127|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84125128|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84125129|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84125130|NCT00684450|Protamines|protamines|mesh-list
84125131|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
84125132|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125133|NCT00684450|Coagulants|coagulants|mesh-ancestor
84125134|NCT00684528|Metformin|metformin|mesh-list
84125135|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84125136|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125137|NCT00684606|Oxytocin|oxytocin|mesh-list
84125138|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
84125139|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84125140|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125141|NCT00684372|Leflunomide|leflunomide|mesh-list
84125142|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125143|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125144|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125145|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
84125146|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125147|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
84125148|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84125149|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125150|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
84125151|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84125152|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125153|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84125154|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84125155|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
84125156|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125157|NCT00991627|Atropine|atropine|mesh-list
84125158|NCT00991627|Ephedrine|ephedrine|mesh-list
84125159|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
84125160|NCT00991627|Morphine|morphine|mesh-list
84125161|NCT00991627|Bupivacaine|bupivacaine|mesh-list
84125162|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
84125163|NCT00991627|Anesthetics|anesthetics|mesh-list
84125164|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125165|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125166|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
84125167|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125168|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84125169|NCT00991627|Narcotics|narcotics|mesh-ancestor
84125170|NCT00991627|Analgesics|analgesics|mesh-ancestor
84125171|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84125172|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84125173|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84125174|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
84125175|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84125176|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125177|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
84125178|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
84125179|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84125180|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84125181|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
84125182|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125183|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125184|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84125185|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
84125186|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84125187|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
84125188|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
84125189|NCT03562871|Carboplatin|carboplatin|mesh-list
84125190|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
84125191|NCT03562871|Pemetrexed|pemetrexed|mesh-list
84125192|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125193|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84125194|NCT03562871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84125195|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125196|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125197|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84125198|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84125199|NCT00690222|Mydriatics|mydriatics|mesh-list
84125200|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
84125201|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125202|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125203|NCT02736071|Celecoxib|celecoxib|mesh-list
84125204|NCT02736071|Tramadol|tramadol|mesh-list
84125205|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84125206|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84125207|NCT02736071|Analgesics|analgesics|mesh-ancestor
84125208|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
84125209|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125210|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125211|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125212|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84125213|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84125214|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84125215|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125216|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125217|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84125218|NCT02736071|Narcotics|narcotics|mesh-ancestor
84125219|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125220|NCT00690300|Docetaxel|docetaxel|mesh-list
84125221|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
84125222|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125223|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125224|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125225|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125226|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125227|NCT02741219|Sufentanil|sufentanil|mesh-list
84125228|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
84125230|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84125231|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125232|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125233|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84125234|NCT02741219|Analgesics|analgesics|mesh-ancestor
84125235|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
84125236|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125237|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84125238|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84125239|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84125240|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
84125241|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125242|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125243|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84125244|NCT02741219|Narcotics|narcotics|mesh-ancestor
84125245|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84125246|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84125247|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
84125248|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
84125249|NCT00690534|Insulin|insulin|mesh-list
84125250|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84125251|NCT00690534|Nitroprusside|nitroprusside|mesh-list
84125252|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84125253|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125254|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84125255|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
84125256|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84125257|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125258|NCT00991705|Atorvastatin|atorvastatin|mesh-list
84125259|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84125260|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84125261|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
84125262|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125263|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84125264|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84125265|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125266|NCT02735837|Doxycycline|doxycycline|mesh-list
84125267|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84125268|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125269|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
84125270|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84125271|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84125272|NCT02625558|Riociguat|riociguat|mesh-list
84125273|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
84125274|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125275|NCT00685230|Antivenins|antivenins|mesh-list
84125276|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
84125277|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125278|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
84125279|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125280|NCT00991783|Digoxin|digoxin|mesh-list
84125281|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84125282|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84125283|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125284|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125285|NCT00991783|Protective Agents|protective agents|mesh-ancestor
84125286|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125287|NCT00690768|Bevacizumab|bevacizumab|mesh-list
84125288|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84125289|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125290|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84125291|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84125292|NCT00690768|Growth Substances|growth substances|mesh-ancestor
84125293|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125294|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
84125295|NCT00690846|Adalimumab|adalimumab|mesh-list
84125296|NCT00690846|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84125297|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125298|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84125299|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
84125300|NCT04683679|Olaparib|olaparib|mesh-list
84125301|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84125302|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125303|NCT04683679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84125304|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125305|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84125306|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125307|NCT00685464|Abciximab|abciximab|mesh-list
84125308|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
84125309|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84125310|NCT02740829|Glucagon|glucagon|mesh-list
84125311|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125312|NCT02740829|Hormones|hormones|mesh-ancestor
84125313|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125314|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125315|NCT00685542|Diacerein|diacerein|mesh-list
84125316|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125317|NCT02741063|Oxytocin|oxytocin|mesh-list
84125318|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
84125319|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84125320|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125321|NCT04138836|Itraconazole|itraconazole|mesh-list
84125322|NCT04138836|Midazolam|midazolam|mesh-list
84125323|NCT04138836|Esomeprazole|esomeprazole|mesh-list
84125324|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84125325|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84125326|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125327|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125328|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84125329|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84125330|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84125331|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84125332|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
84125333|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
84125334|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
84125335|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
84125336|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125337|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125338|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84125339|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125340|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84125341|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125342|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
84125343|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125344|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84125345|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84125346|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84125347|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
84125348|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125349|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84125350|NCT00922584|Sorafenib|sorafenib|mesh-list
84125351|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125352|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125353|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125354|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125355|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
84125356|NCT02735603|Naltrexone|naltrexone|mesh-list
84125357|NCT02735603|Bupropion|bupropion|mesh-list
84125358|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84125359|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125360|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84125361|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84125362|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125363|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125364|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125365|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125366|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84125367|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83366153|NCT04653337|Serotonin|serotonin|mesh-list
84125368|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
84125369|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125370|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84125371|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
84125372|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84125373|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84125374|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84125375|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84125376|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
84125377|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125378|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84125379|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84125380|NCT00685776|Anacetrapib|anacetrapib|mesh-list
84125381|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84125382|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84125383|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
84125384|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125385|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84125386|NCT00685854|Ranibizumab|ranibizumab|mesh-list
84125387|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84125388|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84125389|NCT00685854|Growth Substances|growth substances|mesh-ancestor
84125390|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125391|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
84125392|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125393|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
84125394|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
84125395|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84125396|NCT04003207|Hormones|hormones|mesh-list
84125397|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125398|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125399|NCT04582435|Insulin|insulin|mesh-list
84125400|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84125401|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125402|NCT05295355|Bromides|bromides|mesh-list
84125403|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
84125404|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84125405|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
84125406|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125407|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125408|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84125409|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125410|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
84125411|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84125412|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
84125413|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125414|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125415|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
84125416|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
84125417|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84125418|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
84125419|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
84125420|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125421|NCT01564303|Expectorants|expectorants|mesh-ancestor
84125422|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125423|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84125424|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
84125425|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125426|NCT01564303|Protective Agents|protective agents|mesh-ancestor
84125427|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125428|NCT01564303|Antidotes|antidotes|mesh-ancestor
84125429|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84125430|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125431|NCT00674232|Misoprostol|misoprostol|mesh-list
84125432|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84125433|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
84125434|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84125435|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125436|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84125437|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125438|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
84125439|NCT00674310|Ropinirole|ropinirole|mesh-list
84125440|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84125441|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84125442|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
83366223|NCT04442581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84125444|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125445|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125446|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125447|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
84125448|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84125449|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84125450|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
84125451|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125452|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84125453|NCT05265247|Esomeprazole|esomeprazole|mesh-list
84125454|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84125455|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125456|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84125457|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125458|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125459|NCT03823300|Aflibercept|aflibercept|mesh-list
84125460|NCT03823300|Faricimab|faricimab|mesh-list
84125461|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84125462|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84125463|NCT03823300|Growth Substances|growth substances|mesh-ancestor
84125464|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125465|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
84125466|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125467|NCT00537745|Naltrexone|naltrexone|mesh-list
84125468|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84125469|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84125470|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125471|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
84125472|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125473|NCT00686322|Paclitaxel|paclitaxel|mesh-list
84125474|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84125475|NCT00686322|Cisplatin|cisplatin|mesh-list
84125476|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84125477|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125478|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125479|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125480|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125481|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125482|NCT02734511|Propofol|propofol|mesh-list
84125483|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84125484|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125485|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125486|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84125487|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
84125488|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
84125489|NCT04003441|Fexuprazan|fexuprazan|mesh-list
84125490|NCT04003441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125491|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84125492|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
84125493|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125494|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84125495|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84125496|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125497|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
84125498|NCT02739815|Coagulants|coagulants|mesh-ancestor
84125499|NCT00720616|Insulin|insulin|mesh-list
84125500|NCT00720616|Hormones|hormones|mesh-list
84125501|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84125502|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125503|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125504|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
84125505|NCT00720772|Antidotes|antidotes|mesh-ancestor
84125506|NCT00720772|Protective Agents|protective agents|mesh-ancestor
84125507|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125508|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
84125509|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125510|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
84125511|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84125512|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125513|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
84125514|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
84125515|NCT00720850|Lenalidomide|lenalidomide|mesh-list
84125516|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
84125517|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125518|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84125519|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84125520|NCT00720850|Growth Substances|growth substances|mesh-ancestor
84125521|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
84125522|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125523|NCT03785158|Melatonin|melatonin|mesh-list
84125524|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
84125525|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125526|NCT03785158|Protective Agents|protective agents|mesh-ancestor
84125527|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125528|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125529|NCT05116891|Leucovorin|leucovorin|mesh-list
84125530|NCT05116891|Cisplatin|cisplatin|mesh-list
84125531|NCT05116891|Gemcitabine|gemcitabine|mesh-list
84125532|NCT05116891|Docetaxel|docetaxel|mesh-list
84125533|NCT05116891|Fluorouracil|fluorouracil|mesh-list
84125534|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
84125535|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125536|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84125537|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
84125538|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125539|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125540|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125541|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125542|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125543|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
84125544|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125545|NCT05116891|Antidotes|antidotes|mesh-ancestor
84125546|NCT05116891|Protective Agents|protective agents|mesh-ancestor
84125547|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
84125548|NCT05116891|Vitamins|vitamins|mesh-ancestor
84125549|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
84125550|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84125551|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84125552|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
84125553|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125554|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125555|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125556|NCT02733809|Sorafenib|sorafenib|mesh-list
84125557|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125558|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125559|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125560|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125561|NCT00717340|Paclitaxel|paclitaxel|mesh-list
84125562|NCT00717340|Tivozanib|tivozanib|mesh-list
84125563|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84125564|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125565|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125566|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125567|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125568|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125569|NCT00717340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125570|NCT00717340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125571|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84125572|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84125573|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125574|NCT00874848|Paclitaxel|paclitaxel|mesh-list
84125575|NCT00874848|Carboplatin|carboplatin|mesh-list
84125576|NCT00874848|Cetuximab|cetuximab|mesh-list
84125577|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84125578|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84125579|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125580|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125581|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125582|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125583|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125584|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84125585|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
84125586|NCT00691236|Doxorubicin|doxorubicin|mesh-list
84125587|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84125588|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125589|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84125590|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84125591|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125592|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125593|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84125594|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125595|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
84125596|NCT04137978|Diuretics|diuretics|mesh-ancestor
84125597|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
84125598|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125599|NCT04137978|Expectorants|expectorants|mesh-ancestor
84125600|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125601|NCT05408065|Triamcinolone|triamcinolone|mesh-list
84125602|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84125603|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84125604|NCT05408065|Cortisone|cortisone|mesh-list
84125605|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
84125606|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84125607|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125608|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
84125609|NCT05408065|Hormones|hormones|mesh-ancestor
84125610|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125611|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125612|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125613|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
84125614|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125615|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125616|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84125617|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
84125618|NCT05408065|Protective Agents|protective agents|mesh-ancestor
84125619|NCT00691392|Linezolid|linezolid|mesh-list
84125620|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84125621|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125622|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84125623|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125624|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125625|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84125626|NCT02625168|Afatinib|afatinib|mesh-list
84125627|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125628|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125629|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125630|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125631|NCT00717730|Vitamins|vitamins|mesh-list
84125632|NCT00717730|Folic Acid|folic acid|mesh-list
84125633|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
84125634|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
84125635|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
84125636|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
84125637|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125638|NCT00717730|Hematinics|hematinics|mesh-ancestor
84125639|NCT00691470|Warfarin|warfarin|mesh-list
84125640|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
84125641|NCT05407597|Icatibant|icatibant|mesh-list
84125642|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84125643|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84125644|NCT05407597|Analgesics|analgesics|mesh-ancestor
84125645|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
84125646|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125647|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125648|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125649|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84125650|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
84125651|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
84125652|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125653|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84125654|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125655|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
84125656|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
84125657|NCT05407207|Immunomodulating Agents|immunomodulating agents|mesh-list
84125658|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125659|NCT05493995|Paclitaxel|paclitaxel|mesh-list
84125660|NCT05493995|Gemcitabine|gemcitabine|mesh-list
84125661|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84125662|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125663|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125664|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125665|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125666|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125667|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84125668|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
84125669|NCT00717808|Tranilast|tranilast|mesh-list
84125670|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
84125671|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84125672|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84125673|NCT00717808|Analgesics|analgesics|mesh-ancestor
84125674|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
84125675|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125676|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125677|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125678|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84125679|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84125680|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84125681|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125682|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84125683|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84125684|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
84125685|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
84125686|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125687|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84125688|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84125689|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
84125690|NCT02738177|Isosorbide|isosorbide|mesh-list
84125691|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84125692|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84125693|NCT02738177|Misoprostol|misoprostol|mesh-list
84125694|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84125695|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
84125696|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84125697|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125698|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84125699|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125700|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
84125701|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84125702|NCT02738177|Diuretics|diuretics|mesh-ancestor
84125703|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
84125704|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
84125705|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84125706|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125707|NCT04043806|Ivacaftor|ivacaftor|mesh-list
84125708|NCT04043806|Elexacaftor|elexacaftor|mesh-list
84125709|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84125710|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84125711|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125712|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84125713|NCT02737943|Analgesics|analgesics|mesh-list
84125714|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125715|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
84125716|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125717|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125718|NCT05290753|Erythromycin|erythromycin|mesh-list
84125719|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84125720|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125721|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125722|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84125723|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125724|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125725|NCT02737709|Paclitaxel|paclitaxel|mesh-list
84125726|NCT02737709|Carboplatin|carboplatin|mesh-list
84125727|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84125728|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125729|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125730|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125731|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125732|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125733|NCT02572960|Vitamin D|vitamin d|mesh-list
84125734|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
84125735|NCT02572960|Valsartan|valsartan|mesh-list
84125736|NCT02572960|Vitamins|vitamins|mesh-ancestor
84125737|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
84125738|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125739|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84125740|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84125741|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84125742|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84125743|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84125744|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125745|NCT04001959|Fluorides|fluorides|mesh-list
84125746|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
84125747|NCT04001959|Protective Agents|protective agents|mesh-ancestor
84125748|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125750|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84125751|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125752|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84125753|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
84125754|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125755|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125756|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84125757|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84125758|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125759|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84125760|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84125761|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84125762|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
84125763|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125764|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84125765|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84125766|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125767|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84125768|NCT00721552|Prednisolone|prednisolone|mesh-list
84125769|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84125770|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
84125771|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84125772|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
84125773|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84125774|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
84125775|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125776|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
84125777|NCT00721552|Hormones|hormones|mesh-ancestor
84125778|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125779|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125780|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84125781|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125782|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
84125783|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
84125784|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125785|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125786|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84125787|NCT00721552|Protective Agents|protective agents|mesh-ancestor
84125788|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84125789|NCT00721552|Incretins|incretins|mesh-ancestor
84125790|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84125791|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
84125792|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125793|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125794|NCT04069078|Scopolamine|scopolamine|mesh-list
84125795|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84125796|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84125797|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
84125798|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
84125799|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125800|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125801|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125802|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
84125803|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84125804|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
84125805|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125806|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125807|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84125808|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
84125809|NCT02732249|Metronidazole|metronidazole|mesh-list
84125810|NCT02732249|Clarithromycin|clarithromycin|mesh-list
84125811|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
84125812|NCT02732249|Esomeprazole|esomeprazole|mesh-list
84125813|NCT02732249|Bismuth|bismuth|mesh-list
84125814|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125815|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125816|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84125817|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84125818|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84125819|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84125820|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125821|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84125822|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125823|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84125824|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84125825|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84125826|NCT02732249|Antacids|antacids|mesh-ancestor
84125827|NCT02732249|Diuretics|diuretics|mesh-ancestor
84125828|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
84125829|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125830|NCT02732249|Expectorants|expectorants|mesh-ancestor
84125831|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125832|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
84125833|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
84125834|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
84125835|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84125836|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84125837|NCT02732093|Lidocaine|lidocaine|mesh-list
84125838|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
84125839|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
84125840|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125841|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125842|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
84125843|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125844|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84125845|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84125846|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84125847|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84125848|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125849|NCT00718276|Vitamin D|vitamin d|mesh-list
84125850|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
84125851|NCT00718276|Vitamins|vitamins|mesh-ancestor
84125852|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
84125853|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125854|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84125855|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84125856|NCT00718354|Cisplatin|cisplatin|mesh-list
84125857|NCT00718354|Carboplatin|carboplatin|mesh-list
84125858|NCT00718354|Fluorouracil|fluorouracil|mesh-list
84125859|NCT00718354|Capecitabine|capecitabine|mesh-list
84125860|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
84125861|NCT00718354|Epirubicin|epirubicin|mesh-list
84125862|NCT00718354|Enoxaparin|enoxaparin|mesh-list
84125863|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125864|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
84125865|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125866|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84125867|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125868|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
84125869|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125870|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84125871|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84125872|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84125873|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125874|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
84125875|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84125876|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84125877|NCT00536809|Capecitabine|capecitabine|mesh-list
84125878|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
84125879|NCT00536809|Lapatinib|lapatinib|mesh-list
84125880|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84125881|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
84125882|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125883|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125884|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125885|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125886|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
84125887|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
84125888|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125889|NCT04067986|Apatinib|apatinib|mesh-list
84125890|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125891|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125892|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125893|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125894|NCT00536731|Budesonide|budesonide|mesh-list
84125895|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84125896|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83366683|NCT01997840|BB 1101|bb 1101|mesh-list
84125897|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
84125898|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84125899|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84125900|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
84125901|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125902|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125903|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
84125905|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84125906|NCT02571712|Timolol|timolol|mesh-list
84125907|NCT02571712|Bimatoprost|bimatoprost|mesh-list
84125908|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84125909|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84125910|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
84125911|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125912|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125913|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125914|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84125915|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84125916|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
84125917|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84125918|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84125919|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125920|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84125921|NCT02730845|Analgesics|analgesics|mesh-ancestor
84125922|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
84125923|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84125924|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84125925|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84125926|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84125927|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
84125928|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84125929|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125930|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84125931|NCT02730689|Ezetimibe|ezetimibe|mesh-list
84125932|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84125933|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84125934|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
84125935|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125936|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84125937|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84125938|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125939|NCT03579316|Olaparib|olaparib|mesh-list
84125940|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84125941|NCT03579316|Adavosertib|adavosertib|mesh-list
84125942|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125943|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125944|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125945|NCT02730533|Esomeprazole|esomeprazole|mesh-list
84125946|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84125947|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84125948|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84125949|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125950|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125951|NCT00536575|Bortezomib|bortezomib|mesh-list
84125952|NCT00536575|Sorafenib|sorafenib|mesh-list
84125953|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125954|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125955|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125956|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125957|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
84125958|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84125959|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
84125960|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125961|NCT03214250|Paclitaxel|paclitaxel|mesh-list
84125962|NCT03214250|Gemcitabine|gemcitabine|mesh-list
84125963|NCT03214250|Nivolumab|nivolumab|mesh-list
84125964|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84125965|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125966|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
84125967|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
84125968|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
84125969|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366770|NCT01497275|Rituximab|rituximab|mesh-list
84125970|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84125971|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
84125972|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84125973|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84125974|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
84125975|NCT00722098|Vaccines|vaccines|mesh-list
84125976|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
84125977|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125978|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125979|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84125980|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84125981|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
84125982|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125983|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125984|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84125985|NCT04186871|Abatacept|abatacept|mesh-list
84125986|NCT04186871|Branebrutinib|branebrutinib|mesh-list
84125987|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83430035|NCT03590912|Prednisolone|prednisolone|mesh-list
84125988|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84125989|NCT04186871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84125990|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84125991|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84125992|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
84125993|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84125994|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84125995|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84125996|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84125997|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
84125998|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
84125999|NCT00992095|Buprenorphine|buprenorphine|mesh-list
84126000|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84126001|NCT00992095|Narcotics|narcotics|mesh-ancestor
84126002|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126003|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126004|NCT00992095|Analgesics|analgesics|mesh-ancestor
84126005|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
84126006|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126007|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84126008|NCT00653354|Valdecoxib|valdecoxib|mesh-list
84126009|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84126010|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84126011|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126012|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126013|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84126014|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126015|NCT00653354|Analgesics|analgesics|mesh-ancestor
84126016|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
84126017|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126018|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126019|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126020|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126021|NCT00712504|Docetaxel|docetaxel|mesh-list
84126022|NCT00712504|Sunitinib|sunitinib|mesh-list
84126023|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126024|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
84126025|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
84126026|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
84126027|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126028|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84126029|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84126030|NCT00712504|Growth Substances|growth substances|mesh-ancestor
84126031|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126032|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
84126033|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84126034|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126035|NCT00653510|Insulin|insulin|mesh-list
84126036|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84126037|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84126038|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126039|NCT02694653|Acetaminophen|acetaminophen|mesh-list
84126040|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126041|NCT02694653|Analgesics|analgesics|mesh-ancestor
84126042|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
84126043|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126044|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126045|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
84126046|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
84126047|NCT00722956|Atorvastatin|atorvastatin|mesh-list
84126048|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84126049|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84126050|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
84126051|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126052|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84126053|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84126054|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126055|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84126056|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84126057|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84126058|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
84126059|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126060|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
84126061|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126062|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126063|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126064|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84126065|NCT02729285|Ketorolac|ketorolac|mesh-list
84126066|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84126067|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84126068|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126069|NCT02729285|Analgesics|analgesics|mesh-ancestor
84126070|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
84126071|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126072|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126073|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126074|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126075|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84126076|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126077|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126078|NCT00722176|Risperidone|risperidone|mesh-list
84126079|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84126080|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
84126081|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126082|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126083|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126084|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84126085|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84126086|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126087|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84126088|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84126089|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
84126090|NCT02729441|Ramipril|ramipril|mesh-list
84126091|NCT02729441|Perindopril|perindopril|mesh-list
84126092|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84126093|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
84126094|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126095|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126096|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84126097|NCT04181333|Trastuzumab|trastuzumab|mesh-list
84126098|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84126099|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126100|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
84126101|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84126102|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126103|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126104|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84126105|NCT00636545|Oblimersen|oblimersen|mesh-list
84126106|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126107|NCT00722488|Pevonedistat|pevonedistat|mesh-list
84126108|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126109|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126110|NCT00652106|Timolol|timolol|mesh-list
84126111|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84126112|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84126113|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84126114|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84126115|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84126116|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
84126117|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126118|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126119|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126120|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84126121|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84126122|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84126123|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84126124|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84126125|NCT00723268|Prednisolone|prednisolone|mesh-list
84126126|NCT00723268|Colchicine|colchicine|mesh-list
84126127|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126128|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
84126129|NCT00723268|Hormones|hormones|mesh-ancestor
84126130|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126131|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126132|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126133|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126134|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
84126135|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126136|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
84126137|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
84126138|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
84126139|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126140|NCT00874770|Ribavirin|ribavirin|mesh-list
84126141|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84126142|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
84126143|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126144|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
84126145|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126146|NCT00536263|Interferons|interferons|mesh-list
84126147|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
84126148|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
84126149|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84126150|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126151|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
84126152|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126153|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
84126154|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126155|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
84126156|NCT00578344|Busulfan|busulfan|mesh-list
84126157|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
84126158|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84126159|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
84126160|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126161|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126162|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84126163|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
84126164|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126165|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126166|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84126167|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84126168|NCT00653588|Atorvastatin|atorvastatin|mesh-list
84126169|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84126170|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84126171|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84126172|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
84126173|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126174|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84126175|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84126176|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126177|NCT00723346|Asparaginase|asparaginase|mesh-list
84126178|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126179|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
84126180|NCT02571400|Analgesics|analgesics|mesh-list
84126181|NCT02571400|Narcotics|narcotics|mesh-ancestor
84126182|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126183|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126184|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
84126185|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126186|NCT02641652|Sertraline|sertraline|mesh-list
84126187|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
84126188|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84126189|NCT02641652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84126190|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83366978|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
84126191|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84126192|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126193|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126194|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
84126195|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126196|NCT02626104|Lactoferrin|lactoferrin|mesh-list
84126197|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126198|NCT02571166|Valacyclovir|valacyclovir|mesh-list
84126199|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
84126200|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126201|NCT00686478|Interferons|interferons|mesh-list
84126202|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
84126203|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
84126204|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126205|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
84126206|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126207|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
84126208|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126209|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
84126210|NCT00723424|Digoxin|digoxin|mesh-list
84126211|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84126212|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84126213|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126214|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126215|NCT00723424|Protective Agents|protective agents|mesh-ancestor
84126216|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126217|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84126218|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84126219|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84126220|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
84126221|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126222|NCT02641340|Fentanyl|fentanyl|mesh-list
84126223|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84126224|NCT02641340|Narcotics|narcotics|mesh-ancestor
84126225|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126226|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126227|NCT02641340|Analgesics|analgesics|mesh-ancestor
84126228|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
84126229|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126230|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84126231|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84126232|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
84126233|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
84126234|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
84126235|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84126236|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84126237|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126238|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
84126239|NCT02625948|Coagulants|coagulants|mesh-ancestor
84126240|NCT02571556|Dexamethasone|dexamethasone|mesh-list
84126241|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84126242|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84126243|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126244|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
84126245|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
84126246|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126247|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126248|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126249|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
84126250|NCT02571556|Hormones|hormones|mesh-ancestor
84126251|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126252|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126253|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126254|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84126255|NCT03635749|Atorvastatin|atorvastatin|mesh-list
84126256|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
84126257|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126258|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126259|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84126260|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84126261|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
84126262|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84126263|NCT03752216|Niraparib|niraparib|mesh-list
84126264|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84126265|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367045|NCT00310791|Hormones|hormones|mesh-list
84126266|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126267|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126268|NCT00691548|Cetuximab|cetuximab|mesh-list
84126269|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84126270|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126271|NCT00712738|Nifedipine|nifedipine|mesh-list
84126272|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84126273|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84126274|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126275|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84126276|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126277|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
84126278|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
84126279|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84126280|NCT00686556|Cyclosporine|cyclosporine|mesh-list
84126281|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
84126282|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
84126283|NCT00686556|Fludarabine|fludarabine|mesh-list
84126284|NCT00686556|Cyclosporins|cyclosporins|mesh-list
84126285|NCT00686556|Lenograstim|lenograstim|mesh-list
84126286|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84126287|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
84126288|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126289|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126290|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84126291|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
84126292|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126293|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126294|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84126295|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126296|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
84126297|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126298|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
84126299|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84126300|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84126301|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84126302|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
84126303|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84126304|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84126305|NCT04070482|Tenofovir|tenofovir|mesh-list
84126306|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
84126307|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126308|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84126309|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84126310|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126311|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126312|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84126313|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84126314|NCT04166786|Ethanol|ethanol|mesh-list
84126315|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
84126316|NCT04166786|Petrolatum|petrolatum|mesh-list
84126317|NCT04166786|Testosterone|testosterone|mesh-list
84126318|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
84126319|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
84126320|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84126321|NCT04166786|Androgens|androgens|mesh-ancestor
84126322|NCT04166786|Hormones|hormones|mesh-ancestor
84126323|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126324|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126325|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126326|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126327|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
84126328|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84126329|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126330|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126331|NCT04166786|Emollients|emollients|mesh-ancestor
84126332|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
84126333|NCT02727647|Factor VIII|factor viii|mesh-list
84126334|NCT02727647|Coagulants|coagulants|mesh-ancestor
84126335|NCT00723502|Amoxicillin|amoxicillin|mesh-list
84126336|NCT00723502|Finafloxacin|finafloxacin|mesh-list
84126337|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
84126338|NCT00723502|Esomeprazole|esomeprazole|mesh-list
84126339|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84126340|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126341|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84126342|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126343|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84126344|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126345|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126346|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84126347|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84126348|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84126349|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126350|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84126351|NCT02727881|Squalamine|squalamine|mesh-list
84126352|NCT02727881|Ranibizumab|ranibizumab|mesh-list
84126353|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84126354|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84126355|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84126356|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84126357|NCT02727881|Growth Substances|growth substances|mesh-ancestor
84126358|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126359|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
84126360|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126361|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84126362|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126363|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84126364|NCT02727881|Protective Agents|protective agents|mesh-ancestor
84126365|NCT01564381|Resveratrol|resveratrol|mesh-list
84126366|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
84126367|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126368|NCT01564381|Protective Agents|protective agents|mesh-ancestor
84126369|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126370|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126371|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84126372|NCT04164524|Gentamicins|gentamicins|mesh-list
84126373|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84126374|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126375|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84126376|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126377|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126378|NCT00723658|Cytarabine|cytarabine|mesh-list
84126379|NCT00723658|Thalidomide|thalidomide|mesh-list
84126380|NCT00723658|Dexamethasone|dexamethasone|mesh-list
84126381|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
84126382|NCT00723658|Melphalan|melphalan|mesh-list
84126383|NCT00723658|Carmustine|carmustine|mesh-list
84126384|NCT00723658|Rituximab|rituximab|mesh-list
84126385|NCT00723658|Doxorubicin|doxorubicin|mesh-list
84126386|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84126387|NCT00723658|Etoposide|etoposide|mesh-list
84126388|NCT00723658|Bortezomib|bortezomib|mesh-list
84126389|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84126390|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
84126391|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126392|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126393|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84126394|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
84126395|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126396|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126397|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84126398|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84126399|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126400|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
84126401|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
84126402|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126403|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126404|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
84126405|NCT00723658|Hormones|hormones|mesh-ancestor
84126406|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126407|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126408|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84126409|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84126410|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84126411|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126412|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84126413|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84126414|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
84126415|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
84126416|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126417|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
84126418|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84126419|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84126420|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84126421|NCT00723658|Growth Substances|growth substances|mesh-ancestor
84126422|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
84126423|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
84126424|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126425|NCT02638142|Furosemide|furosemide|mesh-list
84126426|NCT02638142|Diuretics|diuretics|mesh-ancestor
84126427|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
84126428|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126429|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84126430|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84126431|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126432|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
84126433|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
84126434|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
84126435|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84126436|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84126437|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126438|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126439|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126440|NCT03562195|Albuterol|albuterol|mesh-list
84126441|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84126442|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
84126443|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126444|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126445|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84126446|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
84126447|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
84126448|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84126449|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84126450|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84126451|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84126452|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
84126453|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126454|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126455|NCT00686868|Ofatumumab|ofatumumab|mesh-list
84126456|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126457|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
84126458|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84126459|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126460|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84126461|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84126462|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126463|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126464|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126465|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84126466|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84126467|NCT02645864|Irinotecan|irinotecan|mesh-list
84126468|NCT02645864|Apatinib|apatinib|mesh-list
84126469|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84126470|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84126471|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126472|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126473|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126474|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84126475|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
84126476|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84126477|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126478|NCT02574130|Amikacin|amikacin|mesh-list
84126479|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84126480|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126481|NCT00652184|Valacyclovir|valacyclovir|mesh-list
84126482|NCT00652184|Sorivudine|sorivudine|mesh-list
84126483|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
84126484|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126485|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126486|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126487|NCT02726867|Lacosamide|lacosamide|mesh-list
84126488|NCT02726867|Ketamine|ketamine|mesh-list
84126489|NCT02726867|Levetiracetam|levetiracetam|mesh-list
84126490|NCT02726867|Phenobarbital|phenobarbital|mesh-list
84126491|NCT02726867|Analgesics|analgesics|mesh-ancestor
84126492|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
84126493|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126495|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84126496|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84126497|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
84126498|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
84126499|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126500|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84126501|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84126502|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126503|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126504|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
84126505|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
84126506|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84126507|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84126508|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84126509|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84126510|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
84126511|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
84126512|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84126513|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84126514|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84126515|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84126516|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
84126517|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84126518|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84126519|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84126520|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126521|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126522|NCT00873366|Tamoxifen|tamoxifen|mesh-list
84126523|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
84126524|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126525|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84126526|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
84126527|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126528|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126529|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126530|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126531|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84126532|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84126533|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84126534|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
84126535|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
84126536|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84126537|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84126538|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126539|NCT00712894|Verapamil|verapamil|mesh-list
84126540|NCT00712894|Diltiazem|diltiazem|mesh-list
84126541|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
84126542|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
84126543|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84126544|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84126545|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84126546|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126547|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84126548|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126549|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84126550|NCT04164368|Lenalidomide|lenalidomide|mesh-list
84126551|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
84126552|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126553|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84126554|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84126555|NCT04164368|Growth Substances|growth substances|mesh-ancestor
84126556|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
84126557|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126558|NCT02726555|Atorvastatin|atorvastatin|mesh-list
84126559|NCT02726555|Red yeast rice|red yeast rice|mesh-list
84126560|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84126561|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84126562|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
84126563|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126564|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83367339|NCT01522651|Ranolazine|ranolazine|mesh-list
84126565|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84126566|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126567|NCT00536107|Docetaxel|docetaxel|mesh-list
84126568|NCT00536107|Gefitinib|gefitinib|mesh-list
84126569|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126570|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
84126571|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
84126572|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
84126573|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126574|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84126575|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126576|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
84126577|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84126578|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
84126579|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126580|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126581|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84126582|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
84126583|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126584|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126585|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84126586|NCT00724360|Trastuzumab|trastuzumab|mesh-list
84126587|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84126588|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126589|NCT02637830|Fluorides|fluorides|mesh-list
84126590|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
84126591|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
84126592|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
84126593|NCT02637830|Protective Agents|protective agents|mesh-ancestor
84126594|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126595|NCT00687258|Vitamin E|vitamin e|mesh-list
84126596|NCT00687258|Vitamins|vitamins|mesh-ancestor
84126597|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
84126598|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126599|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
84126600|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126601|NCT00687258|Protective Agents|protective agents|mesh-ancestor
84126602|NCT04001569|Paclitaxel|paclitaxel|mesh-list
84126603|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84126604|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126605|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
84126606|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
84126607|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
84126608|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126609|NCT00692016|Naproxen|naproxen|mesh-list
84126610|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84126611|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126612|NCT00692016|Analgesics|analgesics|mesh-ancestor
84126613|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
84126614|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126615|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126616|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126617|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126618|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
84126619|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84126620|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126621|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126622|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
84126623|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84126624|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126625|NCT02733107|Etoposide|etoposide|mesh-list
84126626|NCT02733107|Apatinib|apatinib|mesh-list
84126627|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84126628|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126629|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84126630|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84126631|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126632|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126633|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84126634|NCT00675012|Capecitabine|capecitabine|mesh-list
84126635|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
84126636|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84126637|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
84126638|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126639|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126640|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84126641|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
84126642|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84126643|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84126644|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126645|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126646|NCT00652262|Urological Agents|urological agents|mesh-ancestor
84126647|NCT02640794|Aspirin|aspirin|mesh-list
84126648|NCT02640794|Clopidogrel|clopidogrel|mesh-list
84126649|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84126650|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126651|NCT02640794|Analgesics|analgesics|mesh-ancestor
84126652|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
84126653|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126654|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126655|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126656|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126657|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84126658|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84126659|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126660|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84126661|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84126662|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126663|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
84126664|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84126665|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84126666|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84126667|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
84126668|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126669|NCT00724672|Adalimumab|adalimumab|mesh-list
84126670|NCT00724672|Infliximab|infliximab|mesh-list
84126671|NCT00724672|Etanercept|etanercept|mesh-list
84126672|NCT00724672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84126673|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126674|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126675|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
84126676|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126677|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84126678|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126679|NCT00724672|Analgesics|analgesics|mesh-ancestor
84126680|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
84126681|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126682|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126683|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84126684|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
84126685|NCT02624856|Dexamethasone|dexamethasone|mesh-list
84126686|NCT02624856|Bupivacaine|bupivacaine|mesh-list
84126687|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126688|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
84126689|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
84126690|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126691|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126692|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126693|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
84126694|NCT02624856|Hormones|hormones|mesh-ancestor
84126695|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126696|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126697|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126698|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
84126699|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
84126700|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126701|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
84126702|NCT02646020|Loratadine|loratadine|mesh-list
84126703|NCT02646020|Aprepitant|aprepitant|mesh-list
84126704|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
84126705|NCT02646020|Desloratadine|desloratadine|mesh-list
84126706|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
84126707|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
84126708|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126709|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126710|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126711|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84126712|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126713|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126714|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84126715|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
84126716|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84126717|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84126718|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
84126719|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
84126720|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
84126721|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
84126722|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84126723|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84126724|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
84126725|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
84126726|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126727|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84126728|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84126729|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126730|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84126731|NCT00992797|Vitamin D|vitamin d|mesh-list
84126732|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
84126733|NCT00992797|Vitamins|vitamins|mesh-ancestor
84126734|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
84126735|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126736|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84126737|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84126738|NCT02725541|Trastuzumab|trastuzumab|mesh-list
84126739|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84126740|NCT02725541|Maytansine|maytansine|mesh-list
84126741|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84126742|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126743|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84126744|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
84126745|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
84126746|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
84126747|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126748|NCT02725541|Immunotoxins|immunotoxins|mesh-ancestor
84126749|NCT02725541|Immunoconjugates|immunoconjugates|mesh-ancestor
84126750|NCT02725541|Immunologic Factors|immunologic factors|mesh-ancestor
84126751|NCT02725541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126752|NCT00911066|Azacitidine|azacitidine|mesh-list
84126753|NCT00911066|Pevonedistat|pevonedistat|mesh-list
84126754|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84126755|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
84126756|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126757|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126758|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126759|NCT02733341|Ticagrelor|ticagrelor|mesh-list
84126760|NCT02733341|Cangrelor|cangrelor|mesh-list
84126761|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84126762|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84126763|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84126764|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84126765|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
84126766|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126767|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126768|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126769|NCT00692172|Alefacept|alefacept|mesh-list
84126770|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
84126771|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
84126772|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126773|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84126774|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84126775|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84126776|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
84126777|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126778|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84126779|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84126780|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
84126781|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
84126782|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84126783|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84126784|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84126785|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
84126786|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84126787|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126788|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84126789|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84126790|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84126791|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126792|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126793|NCT03675139|Progestins|progestins|mesh-ancestor
84126794|NCT03675139|Hormones|hormones|mesh-ancestor
84126795|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126796|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
84126797|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84126798|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84126799|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126800|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
84126801|NCT02645552|Coagulants|coagulants|mesh-ancestor
84126802|NCT00692328|Levodopa|levodopa|mesh-list
84126803|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84126804|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84126805|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
84126806|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126807|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126808|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126809|NCT03415828|Ethanol|ethanol|mesh-list
84126810|NCT03415828|Prednisolone|prednisolone|mesh-list
84126811|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84126812|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
84126813|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84126814|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
84126815|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84126816|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
84126817|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126818|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
84126819|NCT03415828|Hormones|hormones|mesh-ancestor
84126820|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126821|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126822|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126823|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126824|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
84126825|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
84126826|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126827|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126828|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84126829|NCT03415828|Protective Agents|protective agents|mesh-ancestor
84126830|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84126831|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126832|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126833|NCT00687648|Prednisolone|prednisolone|mesh-list
84126834|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
84126835|NCT00687648|Methotrexate|methotrexate|mesh-list
84126836|NCT00687648|Letrozole|letrozole|mesh-list
84126837|NCT00687648|Anastrozole|anastrozole|mesh-list
84126838|NCT00687648|Exemestane|exemestane|mesh-list
84126839|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84126840|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
84126841|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126842|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126843|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84126844|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
84126845|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126846|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126847|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84126848|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84126849|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
84126850|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84126851|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84126852|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
84126853|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
84126854|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126855|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84126856|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84126857|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126858|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
84126859|NCT00687648|Hormones|hormones|mesh-ancestor
84126860|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126861|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126862|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84126863|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84126864|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84126865|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
83367650|NCT02352168|Hormones|hormones|mesh-ancestor
84126866|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
84126867|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
84126868|NCT00725218|Analgesics|analgesics|mesh-ancestor
84126869|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
84126870|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126871|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126872|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84126873|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126874|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126875|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126876|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84126877|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126878|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126879|NCT02732795|Morphine|morphine|mesh-list
84126880|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84126881|NCT02732795|Narcotics|narcotics|mesh-ancestor
84126882|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126883|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126884|NCT02732795|Analgesics|analgesics|mesh-ancestor
84126885|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
84126886|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126887|NCT05373004|Empagliflozin|empagliflozin|mesh-list
84126888|NCT05373004|Enalapril|enalapril|mesh-list
84126889|NCT05373004|Enalaprilat|enalaprilat|mesh-list
84126890|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84126891|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126892|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84126893|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126894|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84126895|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84126896|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
84126897|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84126898|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84126899|NCT00655616|Montelukast|montelukast|mesh-list
84126900|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84126901|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
84126902|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126903|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126904|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84126905|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
84126906|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84126907|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84126908|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84126909|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
84126910|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84126911|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126912|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84126913|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
84126914|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126915|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84126916|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84126917|NCT00713440|Acetaminophen|acetaminophen|mesh-list
84126918|NCT00713440|Prednisolone|prednisolone|mesh-list
84126919|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84126920|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
84126921|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84126922|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
84126923|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84126924|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
84126925|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126926|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
84126927|NCT00713440|Hormones|hormones|mesh-ancestor
84126928|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126929|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126930|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126931|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126932|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
84126933|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
84126934|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126935|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126936|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84126937|NCT00713440|Protective Agents|protective agents|mesh-ancestor
84126938|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84126939|NCT00713440|Analgesics|analgesics|mesh-ancestor
84126940|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
84126941|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
84126943|NCT00993109|Nifedipine|nifedipine|mesh-list
84126944|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84126945|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84126946|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84126947|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84126948|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84126949|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84126950|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84126951|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126952|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
84126953|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
84126954|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84126955|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
84126956|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
84126957|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
84126958|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84126959|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126960|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
84126961|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126962|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
84126963|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
84126964|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
84126965|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126966|NCT00675246|Betamethasone|betamethasone|mesh-list
84126967|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
84126968|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126969|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
84126970|NCT00675246|Hormones|hormones|mesh-ancestor
84126971|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126972|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126973|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84126974|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
84126975|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84126976|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
84126977|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126978|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84126979|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84126980|NCT02732405|Grazoprevir|grazoprevir|mesh-list
84126981|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
84126982|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84126983|NCT04001725|Metformin|metformin|mesh-list
84126984|NCT04001725|Dexamethasone|dexamethasone|mesh-list
84126985|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84126986|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
84126987|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
84126988|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84126989|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84126990|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84126991|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
84126992|NCT04001725|Hormones|hormones|mesh-ancestor
84126993|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84126994|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84126995|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84126996|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84126997|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84126998|NCT00713674|Mupirocin|mupirocin|mesh-list
84126999|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127000|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84127001|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127002|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127003|NCT00885482|Ritonavir|ritonavir|mesh-list
84127004|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84127005|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84127006|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84127007|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
84127008|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127009|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127010|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84127011|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84127012|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
84127013|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127014|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84127015|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84127016|NCT04139226|CC-11050|cc-11050|mesh-list
84127017|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84127018|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84127019|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127020|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127021|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
84127022|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
84127023|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127024|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
83430045|NCT03590912|Hormones|hormones|mesh-ancestor
84127025|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127026|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127027|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84127028|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
84127029|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127030|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127031|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84127032|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127033|NCT05366062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84127034|NCT02645240|Heparin|heparin|mesh-list
84127035|NCT02645240|Calcium heparin|calcium heparin|mesh-list
84127036|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84127037|NCT02645240|Tinzaparin|tinzaparin|mesh-list
84127038|NCT02645240|Dalteparin|dalteparin|mesh-list
84127039|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
84127040|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84127041|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84127042|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127043|NCT00688194|Letrozole|letrozole|mesh-list
84127044|NCT00688194|Fulvestrant|fulvestrant|mesh-list
84127045|NCT00688194|Lapatinib|lapatinib|mesh-list
84127046|NCT00688194|Anastrozole|anastrozole|mesh-list
84127047|NCT00688194|Exemestane|exemestane|mesh-list
84127048|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127049|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84127050|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84127051|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127052|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127053|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84127054|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
84127055|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127056|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127057|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84127058|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84127059|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84127060|NCT00653744|Atorvastatin|atorvastatin|mesh-list
84127061|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84127062|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84127063|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84127064|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
84127065|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127066|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84127067|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84127068|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127069|NCT03322267|Cisplatin|cisplatin|mesh-list
84127070|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
84127071|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127072|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127073|NCT03322267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84127074|NCT03322267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127075|NCT00652496|Bimatoprost|bimatoprost|mesh-list
84127076|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84127077|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84127078|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84127079|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
84127080|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84127081|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127082|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84127083|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84127084|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127085|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127086|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127087|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84127088|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84127089|NCT00993343|Cyclosporine|cyclosporine|mesh-list
84127090|NCT00993343|Sirolimus|sirolimus|mesh-list
84127091|NCT00993343|Methotrexate|methotrexate|mesh-list
84127092|NCT00993343|Tacrolimus|tacrolimus|mesh-list
84127093|NCT00993343|Cyclosporins|cyclosporins|mesh-list
84127094|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84127095|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
84127096|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84127097|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127098|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84127099|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
84127100|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127101|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127102|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
84127103|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127104|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84127105|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127106|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
84127107|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127108|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84127109|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84127110|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
84127111|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127112|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84127113|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84127114|NCT02974049|Ivermectin|ivermectin|mesh-list
84127115|NCT02974049|Albendazole|albendazole|mesh-list
84127116|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
84127117|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84127118|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127119|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
84127120|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
84127121|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84127122|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84127123|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127124|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127125|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127126|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127127|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127128|NCT02974049|Filaricides|filaricides|mesh-ancestor
84127129|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
84127130|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84127131|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127132|NCT02637284|BPC 157|bpc 157|mesh-list
84127133|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84127134|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84127135|NCT04138992|Bevacizumab|bevacizumab|mesh-list
84127136|NCT04138992|Cisplatin|cisplatin|mesh-list
84127137|NCT04138992|Docetaxel|docetaxel|mesh-list
84127138|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127139|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127140|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84127141|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84127142|NCT04138992|Growth Substances|growth substances|mesh-ancestor
84127143|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127144|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
84127145|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127146|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127147|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127148|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127149|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84127150|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
84127151|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127152|NCT04137588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127153|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127154|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84127155|NCT04137588|Growth Substances|growth substances|mesh-ancestor
84127156|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127157|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
84127158|NCT02721329|Acetaminophen|acetaminophen|mesh-list
84127159|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84127160|NCT02721329|Analgesics|analgesics|mesh-ancestor
84127161|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
84127162|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127163|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127164|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
84127165|NCT02637128|Artesunate|artesunate|mesh-list
84127166|NCT02637128|Lumefantrine|lumefantrine|mesh-list
84127167|NCT02637128|Artemether|artemether|mesh-list
84127168|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84127169|NCT02637128|Amodiaquine|amodiaquine|mesh-list
84127170|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
84127171|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84127172|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84127173|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127174|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127175|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
84127176|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
84127177|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84127178|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
84127179|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
84127180|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84127181|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84127182|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127183|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
84127184|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
84127185|NCT00585247|Imiquimod|imiquimod|mesh-list
84127186|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84127187|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
84127188|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127189|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127190|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
84127191|NCT04002349|Budesonide|budesonide|mesh-list
84127192|NCT04002349|Levocabastine|levocabastine|mesh-list
84127193|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127194|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84127195|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
84127196|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127197|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127198|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84127199|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
84127200|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
84127201|NCT04002349|Hormones|hormones|mesh-ancestor
84127202|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127203|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84127204|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84127205|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
84127206|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
84127207|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127208|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127209|NCT00688428|Aspirin|aspirin|mesh-list
84127210|NCT00688428|Esomeprazole|esomeprazole|mesh-list
84127211|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84127212|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84127213|NCT00688428|Analgesics|analgesics|mesh-ancestor
84127214|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
84127215|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127216|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127217|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127218|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127219|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84127220|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84127221|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127222|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84127223|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84127224|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127225|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
84127226|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84127227|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84127228|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84127229|NCT02724761|Epinephrine|epinephrine|mesh-list
84127230|NCT02724761|Racepinephrine|racepinephrine|mesh-list
84127231|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
84127232|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84127233|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84127234|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
84127235|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127236|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127237|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127238|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84127239|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84127240|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
84127241|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127242|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84127243|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
84127244|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
84127245|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
84127246|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84127247|NCT04350190|Apatinib|apatinib|mesh-list
84127248|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127249|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84127250|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127251|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127252|NCT02721173|Clindamycin|clindamycin|mesh-list
84127253|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
84127254|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
84127255|NCT02721173|Adapalene|adapalene|mesh-list
84127256|NCT02721173|Tazarotene|tazarotene|mesh-list
84127257|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84127258|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127259|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84127260|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127261|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127262|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84127263|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84127264|NCT02721173|Analgesics|analgesics|mesh-ancestor
84127265|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
84127266|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127267|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127268|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127269|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127270|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
84127271|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
84127272|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
84127273|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
84127274|NCT00713986|Protective Agents|protective agents|mesh-ancestor
84127275|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127276|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
84127277|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84127278|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84127279|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127280|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84127281|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127282|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127283|NCT04137432|Oxytocin|oxytocin|mesh-list
84127284|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
84127285|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84127286|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127287|NCT00885170|Vitamin D|vitamin d|mesh-list
84127288|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
84127289|NCT00885170|Calcium|calcium|mesh-list
84127290|NCT00885170|Vitamins|vitamins|mesh-ancestor
84127291|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
84127292|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127293|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84127294|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84127295|NCT05342467|Dinoprostone|dinoprostone|mesh-list
84127296|NCT05342467|Gemeprost|gemeprost|mesh-list
84127297|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
84127298|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84127299|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127300|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84127301|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
84127302|NCT02720783|Econazole|econazole|mesh-list
84127303|NCT02720783|Benzydamine|benzydamine|mesh-list
84127304|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127305|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
84127306|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127307|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84127308|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84127309|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127310|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127311|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84127312|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
84127313|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127314|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127315|NCT00714064|Edetic Acid|edetic acid|mesh-list
84127316|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84127317|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
84127318|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
84127319|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127320|NCT00714064|Antidotes|antidotes|mesh-ancestor
84127321|NCT00714064|Protective Agents|protective agents|mesh-ancestor
84127322|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
84127323|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
84127324|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127325|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84127326|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
84127327|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84127328|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
84127329|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84127330|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127331|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127332|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84127333|NCT02720705|Analgesics|analgesics|mesh-ancestor
84127334|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
84127335|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127336|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84127337|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84127338|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84127339|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
84127340|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127341|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127342|NCT02720471|Anesthetics|anesthetics|mesh-list
84127343|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
84127344|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127345|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127346|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
84127347|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127348|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84127349|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
84127350|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84127351|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84127352|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84127353|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127354|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127355|NCT00656006|Ribavirin|ribavirin|mesh-list
84127356|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
84127357|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127358|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
84127359|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127360|NCT00688896|Pravastatin|pravastatin|mesh-list
84127361|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
84127362|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84127363|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84127364|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
84127365|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127366|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84127367|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84127368|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127369|NCT02724293|Pregabalin|pregabalin|mesh-list
84127370|NCT02724293|Analgesics|analgesics|mesh-ancestor
84127371|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
84127372|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127373|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127374|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
84127375|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84127376|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84127377|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127378|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84127379|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84127380|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84127381|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127382|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84127383|NCT05092828|Morphine|morphine|mesh-list
84127384|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84127385|NCT05092828|Narcotics|narcotics|mesh-ancestor
84127386|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127387|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127388|NCT05092828|Analgesics|analgesics|mesh-ancestor
84127389|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
84127390|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127391|NCT04137198|Sufentanil|sufentanil|mesh-list
84127392|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84127393|NCT04137198|Narcotics|narcotics|mesh-ancestor
84127394|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127395|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127396|NCT04137198|Analgesics|analgesics|mesh-ancestor
84127397|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
84127398|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127399|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84127400|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84127401|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
84127402|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
84127403|NCT00995293|Docetaxel|docetaxel|mesh-list
84127404|NCT00995293|Fluorouracil|fluorouracil|mesh-list
84127405|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127406|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127407|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127408|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127409|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127410|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
84127411|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84127412|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127413|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
84127414|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127415|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
84127416|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
84127417|NCT00692952|Nonoxynol|nonoxynol|mesh-list
84127418|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84127419|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127420|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84127421|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127422|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
84127423|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
84127424|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84127425|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84127426|NCT02639858|Docetaxel|docetaxel|mesh-list
84127427|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127428|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127429|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127430|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127431|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127432|NCT00689208|Atropine|atropine|mesh-list
84127433|NCT00689208|Physostigmine|physostigmine|mesh-list
84127434|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84127435|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84127436|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84127437|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
84127438|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127439|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127440|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84127441|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
84127442|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
84127443|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
84127444|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84127445|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84127446|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
84127447|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127448|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127449|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84127450|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127451|NCT00689208|Miotics|miotics|mesh-ancestor
84127452|NCT00726466|Ranibizumab|ranibizumab|mesh-list
84127453|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84127454|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84127455|NCT00726466|Growth Substances|growth substances|mesh-ancestor
84127456|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127457|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
84127458|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127459|NCT02694263|Pioglitazone|pioglitazone|mesh-list
84127460|NCT02694263|Glimepiride|glimepiride|mesh-list
84127461|NCT02694263|Canagliflozin|canagliflozin|mesh-list
84127462|NCT02694263|Repaglinide|repaglinide|mesh-list
84127463|NCT02694263|Gliclazide|gliclazide|mesh-list
84127464|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84127465|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127466|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84127467|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127468|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
84127469|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84127470|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127471|NCT04139070|Bleomycin|bleomycin|mesh-list
84127472|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84127473|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127474|NCT00693030|Sirolimus|sirolimus|mesh-list
84127475|NCT00693030|Paclitaxel|paclitaxel|mesh-list
84127476|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84127477|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127478|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127479|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127480|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127481|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127482|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84127483|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127484|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84127485|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
84127486|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127487|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
84127488|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127489|NCT00653822|Alefacept|alefacept|mesh-list
84127490|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
84127491|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
84127492|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127493|NCT04137276|Vitamins|vitamins|mesh-list
84127494|NCT04137276|Thiamine|thiamine|mesh-list
84127495|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
84127496|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
84127497|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127498|NCT02723981|Vitamins|vitamins|mesh-list
84127499|NCT02723981|Vitamin K|vitamin k|mesh-list
84127500|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
84127501|NCT02723981|Dabigatran|dabigatran|mesh-list
84127502|NCT02723981|Anticoagulants|anticoagulants|mesh-list
84127503|NCT02723981|Clopidogrel|clopidogrel|mesh-list
84127504|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
84127505|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127506|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84127507|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84127508|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84127509|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84127510|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
84127511|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127512|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127513|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84127514|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
84127515|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84127516|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
84127517|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127518|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84127519|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84127520|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
84127521|NCT02723981|Coagulants|coagulants|mesh-ancestor
84127522|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
84127523|NCT00912444|Docetaxel|docetaxel|mesh-list
84127524|NCT00912444|Doxorubicin|doxorubicin|mesh-list
84127525|NCT00912444|Epirubicin|epirubicin|mesh-list
84127526|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127527|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
84127528|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127529|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127530|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84127531|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
84127532|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127533|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127534|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84127535|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127536|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127537|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127538|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84127539|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84127540|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84127541|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127542|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
84127543|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127544|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84127545|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127546|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127547|NCT00726700|Prednisone|prednisone|mesh-list
84127548|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
84127549|NCT00726700|Rituximab|rituximab|mesh-list
84127550|NCT00726700|Doxorubicin|doxorubicin|mesh-list
84127551|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84127552|NCT00726700|Vincristine|vincristine|mesh-list
84127553|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127554|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
84127555|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127556|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127557|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84127558|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
84127559|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127560|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127561|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84127562|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127563|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84127564|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84127565|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84127566|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127567|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127568|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
84127569|NCT00726700|Hormones|hormones|mesh-ancestor
84127570|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127571|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84127572|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84127573|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127574|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127575|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127576|NCT02723903|Fluoxetine|fluoxetine|mesh-list
84127577|NCT02723903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84127578|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84127579|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84127580|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127581|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127582|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
84127583|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127584|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84127585|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
84127586|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84127587|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84127588|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84127589|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127590|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
84127591|NCT00675714|Itraconazole|itraconazole|mesh-list
84127592|NCT00675714|Fluconazole|fluconazole|mesh-list
84127593|NCT00675714|Ketoconazole|ketoconazole|mesh-list
84127594|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
84127595|NCT00675714|Propranolol|propranolol|mesh-list
84127596|NCT00675714|Metoprolol|metoprolol|mesh-list
84127597|NCT00675714|Hormones|hormones|mesh-list
84127598|NCT00675714|Testosterone|testosterone|mesh-list
84127599|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
84127600|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
84127601|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84127602|NCT00675714|Oxandrolone|oxandrolone|mesh-list
84127603|NCT00675714|Nandrolone|nandrolone|mesh-list
84127604|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
84127605|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127606|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127607|NCT00675714|Androgens|androgens|mesh-ancestor
84127608|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84127609|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127610|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
84127611|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
84127612|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127613|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84127614|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84127615|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127616|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127617|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84127618|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
84127619|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84127620|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84127621|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84127622|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
84127623|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127624|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84127625|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84127626|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
84127627|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
84127628|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
84127629|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127630|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84127631|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84127632|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84127633|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84127634|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84127635|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84127636|NCT00729976|Ibuprofen|ibuprofen|mesh-list
84127637|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84127638|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84127639|NCT00729976|Analgesics|analgesics|mesh-ancestor
84127640|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
84127641|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127642|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127643|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127644|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127645|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84127646|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127647|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127648|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
84127649|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
84127650|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
84127651|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84127652|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127653|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84127654|NCT02451553|Capecitabine|capecitabine|mesh-list
84127655|NCT02451553|Afatinib|afatinib|mesh-list
84127656|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84127657|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
84127658|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127659|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127660|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84127661|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127662|NCT02636816|Carbetocin|carbetocin|mesh-list
84127663|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
84127664|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84127665|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127666|NCT00730054|Clonidine|clonidine|mesh-list
84127667|NCT00730054|Remifentanil|remifentanil|mesh-list
84127668|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84127669|NCT00730054|Narcotics|narcotics|mesh-ancestor
84127670|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127671|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127672|NCT00730054|Analgesics|analgesics|mesh-ancestor
84127673|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
84127674|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127675|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84127676|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
84127677|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
84127678|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84127679|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84127680|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84127681|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
84127682|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127683|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127684|NCT00866619|Vaccines|vaccines|mesh-list
84127685|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
84127686|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127687|NCT00693108|Testosterone|testosterone|mesh-list
84127688|NCT00693108|Androgens|androgens|mesh-ancestor
84127689|NCT00693108|Hormones|hormones|mesh-ancestor
84127690|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127691|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127692|NCT00884390|Factor VIII|factor viii|mesh-list
84127693|NCT00884390|Coagulants|coagulants|mesh-ancestor
84127694|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
84127695|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84127696|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
84127697|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127698|NCT02723669|Expectorants|expectorants|mesh-ancestor
84127699|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
84127700|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84127701|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
84127702|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127703|NCT02723669|Protective Agents|protective agents|mesh-ancestor
84127704|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127705|NCT02723669|Antidotes|antidotes|mesh-ancestor
84127706|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84127707|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
84127708|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127709|NCT00689442|Atorvastatin|atorvastatin|mesh-list
84127710|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
84127711|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84127712|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84127713|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
84127714|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127715|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84127716|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84127717|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127718|NCT02625636|Glucagon|glucagon|mesh-list
84127719|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84127720|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84127721|NCT02625636|Hormones|hormones|mesh-ancestor
84127722|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127723|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127724|NCT02625636|Incretins|incretins|mesh-ancestor
84127725|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
84127726|NCT03012100|Vaccines|vaccines|mesh-list
84127727|NCT03012100|Sargramostim|sargramostim|mesh-list
84127728|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
84127729|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127730|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127731|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127732|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84127733|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
84127734|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127735|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127736|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84127737|NCT02379247|Paclitaxel|paclitaxel|mesh-list
84127738|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84127739|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127740|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127741|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127742|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127743|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127744|NCT00689520|Vitamin K|vitamin k|mesh-list
84127745|NCT00689520|Tinzaparin|tinzaparin|mesh-list
84127746|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84127747|NCT00689520|Dalteparin|dalteparin|mesh-list
84127748|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
84127749|NCT00689520|Vitamins|vitamins|mesh-ancestor
84127750|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
84127751|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127752|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84127753|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84127754|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127755|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
84127756|NCT00689520|Coagulants|coagulants|mesh-ancestor
84127757|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
84127758|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84127759|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84127760|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84127761|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84127762|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
84127763|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127764|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127765|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127766|NCT02723279|Urological Agents|urological agents|mesh-ancestor
84127767|NCT02615301|Vitamin D|vitamin d|mesh-list
84127768|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
84127769|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
84127770|NCT02615301|Vitamins|vitamins|mesh-list
84127771|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
84127772|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127773|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84127774|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84127775|NCT02570230|Ketamine|ketamine|mesh-list
84127776|NCT02570230|Analgesics|analgesics|mesh-ancestor
84127777|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
84127778|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127779|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127780|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84127781|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84127782|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
84127783|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
84127784|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127785|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84127786|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84127787|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127788|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127789|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
84127790|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
84127791|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127792|NCT02718911|Durvalumab|durvalumab|mesh-list
84127793|NCT02718911|Tremelimumab|tremelimumab|mesh-list
84127794|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127795|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127796|NCT00697905|Carboplatin|carboplatin|mesh-list
84127797|NCT00697905|Gemcitabine|gemcitabine|mesh-list
84127798|NCT00697905|Fluorouracil|fluorouracil|mesh-list
84127799|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127800|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84127801|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
84127802|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127803|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127804|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
84127805|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127806|NCT02718755|Cytarabine|cytarabine|mesh-list
84127807|NCT02718755|Fludarabine|fludarabine|mesh-list
84127808|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
84127809|NCT02718755|Asparaginase|asparaginase|mesh-list
84127810|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127811|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84127812|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
84127813|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127814|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127815|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
84127816|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127817|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
84127818|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127819|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
84127820|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84127821|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127822|NCT00730288|Vaccines|vaccines|mesh-list
84127823|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
84127824|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127825|NCT00872898|Memantine|memantine|mesh-list
84127826|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84127827|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84127828|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
84127829|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127830|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127831|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127832|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84127833|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84127834|NCT02723435|Midostaurin|midostaurin|mesh-list
84127835|NCT02723435|Staurosporine|staurosporine|mesh-list
84127836|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127837|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84127838|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127839|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127840|NCT02718677|Factor VIII|factor viii|mesh-list
84127841|NCT02718677|Coagulants|coagulants|mesh-ancestor
84127842|NCT04132011|Morphine|morphine|mesh-list
84127843|NCT04132011|Oxycodone|oxycodone|mesh-list
84127844|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
84127845|NCT04132011|Hydromorphone|hydromorphone|mesh-list
84127846|NCT04132011|Narcotics|narcotics|mesh-ancestor
84127847|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84127848|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127849|NCT04132011|Analgesics|analgesics|mesh-ancestor
84127850|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
84127851|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127852|NCT00693576|Simvastatin|simvastatin|mesh-list
84127853|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84127854|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84127855|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
84127856|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127857|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84127858|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84127859|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127860|NCT04116047|Durvalumab|durvalumab|mesh-list
84127861|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127862|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127863|NCT00693732|Escitalopram|escitalopram|mesh-list
84127864|NCT00693732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84127865|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84127866|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84127867|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127868|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127869|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
84127870|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127871|NCT00689598|Spironolactone|spironolactone|mesh-list
84127872|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84127873|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
84127874|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84127875|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127876|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84127877|NCT00689598|Diuretics|diuretics|mesh-ancestor
84127878|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
84127879|NCT04163354|Listerine|listerine|mesh-list
84127880|NCT04163354|Fluorides|fluorides|mesh-list
84127881|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
84127882|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
84127883|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
84127884|NCT04163354|Protective Agents|protective agents|mesh-ancestor
84127885|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127886|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84127887|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127888|NCT04131621|Nivolumab|nivolumab|mesh-list
84127889|NCT04131621|Ipilimumab|ipilimumab|mesh-list
84127890|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127891|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127892|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84127893|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127894|NCT00689832|Fluticasone|fluticasone|mesh-list
84127895|NCT00689832|Tacrolimus|tacrolimus|mesh-list
84127896|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127897|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
84127898|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127899|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84127900|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127901|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127902|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127903|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84127904|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
84127905|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127906|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84127907|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
84127908|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
84127909|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84127910|NCT02718521|Isosorbide|isosorbide|mesh-list
84127911|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84127912|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84127913|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84127914|NCT02718521|Diuretics|diuretics|mesh-ancestor
84127915|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
84127916|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127917|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
84127918|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84127919|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127920|NCT02718599|Terlipressin|terlipressin|mesh-list
84127921|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84127922|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84127923|NCT00693966|Vaccines|vaccines|mesh-list
84127924|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
84127925|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127926|NCT00694044|Varenicline|varenicline|mesh-list
84127927|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84127928|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84127929|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
84127930|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84127931|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127932|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127933|NCT02722811|Etanercept|etanercept|mesh-list
84127934|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84127935|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84127936|NCT02722811|Analgesics|analgesics|mesh-ancestor
84127937|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
84127938|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84127939|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127940|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84127941|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127942|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84127943|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127944|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
84127945|NCT04136886|Cisplatin|cisplatin|mesh-list
84127946|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127947|NCT04103645|Vactosertib|vactosertib|mesh-list
84127948|NCT04103645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84127949|NCT04103645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127950|NCT04103645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127951|NCT00534313|Abatacept|abatacept|mesh-list
84127952|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84127953|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127954|NCT00534313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127955|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127956|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127957|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
84127958|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127959|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84127960|NCT00694200|Bevacizumab|bevacizumab|mesh-list
84127961|NCT00694200|Vinorelbine|vinorelbine|mesh-list
84127962|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84127963|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127964|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84127965|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84127966|NCT00694200|Growth Substances|growth substances|mesh-ancestor
84127967|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127968|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
84127969|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84127970|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
84127971|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
84127972|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
84127973|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127974|NCT02722733|Cytarabine|cytarabine|mesh-list
84127975|NCT02722733|Lenograstim|lenograstim|mesh-list
84127976|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84127977|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
84127978|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84127979|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84127980|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
84127981|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127982|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84127983|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
84127984|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127985|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84127986|NCT02722421|Efavirenz|efavirenz|mesh-list
84127987|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
84127988|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84127989|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84127990|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84127991|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84127992|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
84127993|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84127994|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84127995|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84127996|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84127997|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84127998|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84127999|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84128000|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84128001|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
84128002|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84128003|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128004|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84128005|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84128006|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84128007|NCT02617290|Clopidogrel|clopidogrel|mesh-list
84128008|NCT02617290|Ticagrelor|ticagrelor|mesh-list
84128009|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84128010|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84128011|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84128012|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84128013|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
84128014|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128015|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128016|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128017|NCT02717819|Vitamin D|vitamin d|mesh-list
84128018|NCT02717819|Vitamins|vitamins|mesh-ancestor
84128019|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
84128020|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128021|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84128022|NCT02007655|Apixaban|apixaban|mesh-list
84128023|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84128024|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
84128025|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84128026|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
84128027|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128028|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128029|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
84128030|NCT02611960|Gemcitabine|gemcitabine|mesh-list
84128031|NCT02611960|Capecitabine|capecitabine|mesh-list
84128032|NCT02611960|Docetaxel|docetaxel|mesh-list
84128033|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
84128034|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128035|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
84128036|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128037|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128038|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128039|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128040|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128041|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128042|NCT02611960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84128043|NCT05298462|Antibodies|antibodies|mesh-list
84128044|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
84128045|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128046|NCT00730366|Chloroquine|chloroquine|mesh-list
84128047|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
84128048|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
84128049|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84128050|NCT00730366|Amebicides|amebicides|mesh-ancestor
84128051|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84128052|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84128053|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128054|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
84128055|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128056|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84128057|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128058|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128059|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84128060|NCT02722343|Tenofovir|tenofovir|mesh-list
84128061|NCT02722343|Emtricitabine|emtricitabine|mesh-list
84128062|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84128063|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
84128064|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128065|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84128066|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84128067|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128068|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128069|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84128070|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84128071|NCT00694590|Plerixafor|plerixafor|mesh-list
84128072|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84128073|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84128074|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
84128075|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128076|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
84128077|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128078|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128079|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128080|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84128081|NCT03903406|Dexamethasone|dexamethasone|mesh-list
84128082|NCT03903406|Lenalidomide|lenalidomide|mesh-list
84128083|NCT03903406|Ixazomib|ixazomib|mesh-list
84128084|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128085|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
84128086|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
84128087|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128088|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128089|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128090|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
84128091|NCT03903406|Hormones|hormones|mesh-ancestor
84128092|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128093|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84128094|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128095|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
84128096|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84128097|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84128098|NCT03903406|Growth Substances|growth substances|mesh-ancestor
84128099|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
84128100|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
84128101|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128102|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128103|NCT00594204|Varenicline|varenicline|mesh-list
84128104|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84128105|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84128106|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
84128107|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128108|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128109|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128110|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
84128111|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128112|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
84128113|NCT00999271|Hormones|hormones|mesh-list
84128114|NCT00999271|Incretins|incretins|mesh-list
84128115|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128116|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128117|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128118|NCT02716961|Gemcitabine|gemcitabine|mesh-list
84128119|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128120|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128121|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
84128122|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128123|NCT02704156|Gemcitabine|gemcitabine|mesh-list
84128124|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
84128125|NCT02704156|Trametinib|trametinib|mesh-list
84128126|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128127|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
84128128|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128129|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128130|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128131|NCT02704156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84128132|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84128133|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128134|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
84128135|NCT00912678|Tacrolimus|tacrolimus|mesh-list
84128136|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128137|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
84128138|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128139|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84128140|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128141|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128142|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84128143|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128144|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84128145|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
84128146|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84128147|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128148|NCT00995839|Terlipressin|terlipressin|mesh-list
84128149|NCT00995839|Vasopressins|vasopressins|mesh-list
84128150|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
84128151|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
84128152|NCT00995839|Coagulants|coagulants|mesh-ancestor
84128153|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84128154|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84128155|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
84128156|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128157|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84128158|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
84128159|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
84128160|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128161|NCT00994513|Protective Agents|protective agents|mesh-ancestor
84128162|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128163|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
84128164|NCT00994513|Vitamins|vitamins|mesh-ancestor
84128165|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
84128166|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
84128167|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84128168|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128169|NCT00995917|Vitamin K|vitamin k|mesh-list
84128170|NCT00995917|Vitamins|vitamins|mesh-ancestor
84128171|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
84128172|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128173|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84128174|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84128175|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128176|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
84128177|NCT00995917|Coagulants|coagulants|mesh-ancestor
84128178|NCT02616822|Resveratrol|resveratrol|mesh-list
84128179|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
84128180|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128181|NCT02616822|Protective Agents|protective agents|mesh-ancestor
84128182|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128183|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128184|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84128185|NCT00912756|Cilostazol|cilostazol|mesh-list
84128186|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84128187|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
84128188|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128189|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128190|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84128191|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
84128192|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84128193|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84128194|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128195|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84128196|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
84128197|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84128198|NCT00912756|Protective Agents|protective agents|mesh-ancestor
84128199|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84128200|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84128201|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128202|NCT04426240|Cyclosporine|cyclosporine|mesh-list
84128203|NCT04426240|Cyclosporins|cyclosporins|mesh-list
84128204|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128205|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128206|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128207|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
84128208|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128209|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
84128210|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128211|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
84128212|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128213|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84128214|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
84128215|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84128216|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128217|NCT00999349|Silymarin|silymarin|mesh-list
84128218|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
84128219|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128220|NCT00999349|Protective Agents|protective agents|mesh-ancestor
84128221|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128222|NCT02621112|Imiquimod|imiquimod|mesh-list
84128223|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84128224|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
84128225|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128226|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128227|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
84128228|NCT04000789|Vitamins|vitamins|mesh-list
84128229|NCT04000789|Vitamin E|vitamin e|mesh-list
84128230|NCT04000789|Vitamin A|vitamin a|mesh-list
84128231|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
84128232|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
84128233|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128234|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
84128235|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128236|NCT04000789|Protective Agents|protective agents|mesh-ancestor
84128237|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84128238|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
84128239|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
84128240|NCT00697554|Vaccines|vaccines|mesh-list
84128241|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
84128242|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128243|NCT00731068|Mitogens|mitogens|mesh-list
84128244|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128245|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128246|NCT00866307|Cytarabine|cytarabine|mesh-list
84128247|NCT00866307|Dexamethasone|dexamethasone|mesh-list
84128248|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
84128249|NCT00866307|Prednisone|prednisone|mesh-list
84128250|NCT00866307|Cortisone|cortisone|mesh-list
84128251|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
84128252|NCT00866307|Doxorubicin|doxorubicin|mesh-list
84128253|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84128254|NCT00866307|Methotrexate|methotrexate|mesh-list
84128255|NCT00866307|Vincristine|vincristine|mesh-list
84128256|NCT00866307|Daunorubicin|daunorubicin|mesh-list
84128257|NCT00866307|Asparaginase|asparaginase|mesh-list
84128258|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
84128259|NCT00866307|Pegaspargase|pegaspargase|mesh-list
84128260|NCT00866307|Thioguanine|thioguanine|mesh-list
84128261|NCT00866307|BB 1101|bb 1101|mesh-list
84128262|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
84128263|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128264|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
84128265|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128266|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128267|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84128268|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
84128269|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128270|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128271|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84128272|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128273|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
84128274|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
84128275|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128276|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128277|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
84128278|NCT00866307|Hormones|hormones|mesh-ancestor
84128279|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128280|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84128281|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
84128282|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128283|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84128284|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84128285|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84128286|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84128287|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
84128288|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84128289|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128290|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
84128291|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
84128292|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84128293|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84128294|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
84128295|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128296|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84128297|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128298|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128299|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128300|NCT00731146|Anesthetics|anesthetics|mesh-list
84128301|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128302|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369078|NCT01488487|Everolimus|everolimus|mesh-list
84128303|NCT02716415|Menthol|menthol|mesh-list
84128304|NCT02716415|Petrolatum|petrolatum|mesh-list
84128305|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
84128306|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
84128307|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
84128308|NCT02716415|Emollients|emollients|mesh-ancestor
84128309|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
84128310|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84128311|NCT02716415|Protective Agents|protective agents|mesh-ancestor
84128312|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128313|NCT02616354|Imipenem|imipenem|mesh-list
84128314|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84128315|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128316|NCT00731224|Rivastigmine|rivastigmine|mesh-list
84128317|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84128318|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128319|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128320|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
84128321|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128322|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128323|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84128324|NCT00731224|Protective Agents|protective agents|mesh-ancestor
84128325|NCT00531427|Buprenorphine|buprenorphine|mesh-list
84128326|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84128327|NCT00531427|Narcotics|narcotics|mesh-ancestor
84128328|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128329|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128330|NCT00531427|Analgesics|analgesics|mesh-ancestor
84128331|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
84128332|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128333|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84128334|NCT00731302|Aspirin|aspirin|mesh-list
84128335|NCT00731302|Meloxicam|meloxicam|mesh-list
84128336|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84128337|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84128338|NCT00731302|Analgesics|analgesics|mesh-ancestor
84128339|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
84128340|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128341|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128342|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128343|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128344|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84128345|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84128346|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128347|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84128348|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84128349|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128350|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
84128351|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84128352|NCT00871728|Itraconazole|itraconazole|mesh-list
84128353|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
84128354|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128355|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84128356|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84128357|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128358|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128359|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84128360|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
84128361|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128362|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128363|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84128364|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84128365|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128366|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
84128367|NCT00999427|Povidone|povidone|mesh-list
84128368|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
84128369|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
84128370|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84128371|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128372|NCT04189211|Trastuzumab|trastuzumab|mesh-list
84128373|NCT04189211|Maytansine|maytansine|mesh-list
84128374|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128375|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128376|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84128377|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128378|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128379|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128380|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128381|NCT00364780|XL647|xl647|mesh-list
83369160|NCT00411411|Hormones|hormones|mesh-ancestor
84128382|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128383|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84128384|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128385|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128386|NCT00868998|Gemcitabine|gemcitabine|mesh-list
84128387|NCT00868998|Capecitabine|capecitabine|mesh-list
84128388|NCT00868998|Docetaxel|docetaxel|mesh-list
84128389|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128390|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
84128391|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128392|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128393|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128394|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128395|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128396|NCT00996151|Testosterone|testosterone|mesh-list
84128397|NCT00996151|Androgens|androgens|mesh-ancestor
84128398|NCT00996151|Hormones|hormones|mesh-ancestor
84128399|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128400|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128401|NCT04131231|Aldesleukin|aldesleukin|mesh-list
84128402|NCT04131231|Methotrexate|methotrexate|mesh-list
84128403|NCT04131231|Interleukin-2|interleukin-2|mesh-list
84128404|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84128405|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
84128406|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84128407|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128408|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128409|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
84128410|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128411|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128412|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
84128413|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128414|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84128415|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128416|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
84128417|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128418|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84128419|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84128420|NCT04131231|Analgesics|analgesics|mesh-ancestor
84128421|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
84128422|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128423|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84128424|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84128425|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
84128426|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128427|NCT02716259|Fluorides|fluorides|mesh-list
84128428|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
84128429|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
84128430|NCT02716259|Protective Agents|protective agents|mesh-ancestor
84128431|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128432|NCT00996229|Resveratrol|resveratrol|mesh-list
84128433|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
83430076|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
84128434|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128435|NCT00996229|Protective Agents|protective agents|mesh-ancestor
84128436|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128437|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128438|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84128439|NCT02712671|Interferons|interferons|mesh-list
84128440|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
84128441|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128442|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
84128443|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128444|NCT02614833|Paclitaxel|paclitaxel|mesh-list
84128445|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84128446|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128447|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128448|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128449|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128450|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128451|NCT05260957|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
84128452|NCT05260957|Immunoconjugates|immunoconjugates|mesh-ancestor
84128453|NCT05260957|Immunologic Factors|immunologic factors|mesh-ancestor
84128454|NCT05260957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128455|NCT00999505|Amantadine|amantadine|mesh-list
84128456|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84128457|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84128458|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
84128459|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128461|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128462|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128463|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128464|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84128465|NCT00999505|Analgesics|analgesics|mesh-ancestor
84128466|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
84128467|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128468|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
84128469|NCT00996385|Bortezomib|bortezomib|mesh-list
84128470|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128471|NCT00533845|Bupivacaine|bupivacaine|mesh-list
84128472|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
84128473|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
84128474|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128475|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128476|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
84128477|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128478|NCT02752763|Dextrans|dextrans|mesh-list
84128479|NCT02752763|Povidone|povidone|mesh-list
84128480|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84128481|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
84128482|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84128483|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
84128484|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
84128485|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
84128486|NCT00857649|Memantine|memantine|mesh-list
84128487|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84128488|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84128489|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
84128490|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128491|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128492|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128493|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84128494|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84128495|NCT02752841|Vitamin D|vitamin d|mesh-list
84128496|NCT02752841|Vitamins|vitamins|mesh-ancestor
84128497|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
84128498|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128499|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84128500|NCT03971669|Vaccines|vaccines|mesh-list
84128501|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
84128502|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128503|NCT02715869|Sevoflurane|sevoflurane|mesh-list
84128504|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84128505|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84128506|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
84128507|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
84128508|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128509|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128510|NCT00532441|Docetaxel|docetaxel|mesh-list
84128511|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84128512|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128513|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128514|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128515|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128516|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128517|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84128518|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128519|NCT00999739|Vaccines|vaccines|mesh-list
84128520|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84128521|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
84128522|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128523|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
84128524|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84128525|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84128526|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128527|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
84128528|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84128529|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
84128530|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
84128531|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
84128532|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
84128533|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84128534|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84128535|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128536|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128537|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128538|NCT00857259|Everolimus|everolimus|mesh-list
84128539|NCT00857259|Ranibizumab|ranibizumab|mesh-list
84128540|NCT00857259|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84128541|NCT00857259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84128542|NCT00857259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128543|NCT00857259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128544|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128545|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
84128546|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128547|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128548|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84128549|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84128550|NCT00857259|Growth Substances|growth substances|mesh-ancestor
84128551|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
84128552|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84128553|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128554|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128555|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84128556|NCT00868608|Immunotoxins|immunotoxins|mesh-ancestor
84128557|NCT00868608|Immunoconjugates|immunoconjugates|mesh-ancestor
84128558|NCT00868608|Immunologic Factors|immunologic factors|mesh-ancestor
84128559|NCT00868608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128560|NCT04000633|Lidocaine|lidocaine|mesh-list
84128561|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
84128562|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
84128563|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128564|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128565|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
84128566|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128567|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84128568|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84128569|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84128570|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84128571|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128572|NCT00994825|Simendan|simendan|mesh-list
84128573|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84128574|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
84128575|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84128576|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84128577|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128578|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128579|NCT00994825|Protective Agents|protective agents|mesh-ancestor
84128580|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128581|NCT02752529|Tacrolimus|tacrolimus|mesh-list
84128582|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128583|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
84128584|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128585|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84128586|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128587|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128588|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
84128589|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
84128590|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84128591|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
84128592|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128593|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128594|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128595|NCT02620800|Leucovorin|leucovorin|mesh-list
84128596|NCT02620800|Paclitaxel|paclitaxel|mesh-list
84128597|NCT02620800|Bevacizumab|bevacizumab|mesh-list
84128598|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
84128599|NCT02620800|Calcium|calcium|mesh-list
84128600|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
84128601|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84128602|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128603|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128604|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128605|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128606|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128607|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128608|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84128609|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84128610|NCT02620800|Growth Substances|growth substances|mesh-ancestor
84128611|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128612|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
84128613|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84128614|NCT02620800|Antidotes|antidotes|mesh-ancestor
84128615|NCT02620800|Protective Agents|protective agents|mesh-ancestor
84128616|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
84128617|NCT02620800|Vitamins|vitamins|mesh-ancestor
84128618|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
84128619|NCT04135014|Midazolam|midazolam|mesh-list
84128620|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
84128621|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84128622|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128623|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128624|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84128625|NCT04135014|Analgesics|analgesics|mesh-ancestor
84128626|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
84128627|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128628|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84128629|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84128630|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84128631|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
84128632|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128633|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128634|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84128635|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84128636|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84128637|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84128638|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84128639|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
84128640|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
84128641|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
84128642|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
84128643|NCT00996697|Budesonide|budesonide|mesh-list
84128644|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
84128645|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
84128646|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84128647|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128648|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84128649|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
84128650|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128651|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128652|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84128653|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
84128654|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
84128655|NCT00996697|Hormones|hormones|mesh-ancestor
84128656|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128657|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84128658|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84128659|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84128660|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
84128661|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128662|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128663|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
84128664|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84128665|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
84128666|NCT00999973|Mitomycins|mitomycins|mesh-list
84128667|NCT00999973|Mitomycin|mitomycin|mesh-list
84128668|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84128669|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128670|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
84128671|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128672|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84128673|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128674|NCT02715947|Methotrexate|methotrexate|mesh-list
84128675|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84128676|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
84128677|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84128678|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128679|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128680|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
84128681|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369452|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
84128682|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128683|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
84128684|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128686|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128687|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
84128688|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128689|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84128690|NCT00856323|Tenofovir|tenofovir|mesh-list
84128691|NCT00856323|Emtricitabine|emtricitabine|mesh-list
84128692|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84128693|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
84128694|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128695|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84128696|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84128697|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128698|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128699|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84128700|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84128701|NCT00856245|Rituximab|rituximab|mesh-list
84128702|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128703|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128704|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
84128705|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128706|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128707|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
84128708|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84128709|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128710|NCT00994903|Simvastatin|simvastatin|mesh-list
84128711|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84128712|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84128713|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
84128714|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128715|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84128716|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84128717|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128718|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
84128719|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
84128720|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84128721|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84128722|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128723|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84128724|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128725|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84128726|NCT00997009|Paclitaxel|paclitaxel|mesh-list
84128727|NCT00997009|Carboplatin|carboplatin|mesh-list
84128728|NCT00997009|Cetuximab|cetuximab|mesh-list
84128729|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84128730|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128731|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
84128732|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
84128733|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
84128734|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128735|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128736|NCT02712125|Isosorbide|isosorbide|mesh-list
84128737|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84128738|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84128739|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84128740|NCT02712125|Diuretics|diuretics|mesh-ancestor
84128741|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
84128742|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128743|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
84128744|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84128745|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128746|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
84128747|NCT00994981|Analgesics|analgesics|mesh-ancestor
84128748|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
84128749|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128750|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128751|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
84128752|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128753|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84128754|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
84128755|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84128756|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369519|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128757|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128758|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84128759|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
84128760|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84128762|NCT02715479|BMS-955176|bms-955176|mesh-list
84128763|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84128764|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84128765|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128766|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128767|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84128768|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84128769|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
84128770|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128771|NCT01000441|Adalimumab|adalimumab|mesh-list
84128772|NCT01000441|Infliximab|infliximab|mesh-list
84128773|NCT01000441|Etanercept|etanercept|mesh-list
84128774|NCT01000441|Rituximab|rituximab|mesh-list
84128775|NCT01000441|Abatacept|abatacept|mesh-list
84128776|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128777|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128778|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
84128779|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128780|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128781|NCT01000441|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84128782|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128783|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
84128784|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128785|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84128786|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84128787|NCT01000441|Analgesics|analgesics|mesh-ancestor
84128788|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
84128789|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128790|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128791|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84128792|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128793|NCT00997087|Flumazenil|flumazenil|mesh-list
84128794|NCT00997087|Antidotes|antidotes|mesh-ancestor
84128795|NCT00997087|Protective Agents|protective agents|mesh-ancestor
84128796|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128797|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
84128798|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
84128799|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128800|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128801|NCT01000597|Fluticasone|fluticasone|mesh-list
84128802|NCT01000597|Xhance|xhance|mesh-list
84128803|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128804|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84128805|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
84128806|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128807|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128808|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84128809|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
84128810|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
84128811|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84128812|NCT02751593|Dexamethasone|dexamethasone|mesh-list
84128813|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128814|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
84128815|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
84128816|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128817|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128818|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128819|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
84128820|NCT02751593|Hormones|hormones|mesh-ancestor
84128821|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128822|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84128823|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128824|NCT00997399|Panobinostat|panobinostat|mesh-list
84128825|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128826|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84128827|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128828|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128829|NCT00997477|Budesonide|budesonide|mesh-list
83369595|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84128830|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
84128831|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128832|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84128833|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
84128834|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128835|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128836|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84128837|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
84128838|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
84128839|NCT00997477|Hormones|hormones|mesh-ancestor
84128840|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128841|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84128842|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84128843|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84128844|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
84128845|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128846|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128847|NCT01000831|Vaccines|vaccines|mesh-list
84128848|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
84128849|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128850|NCT05170789|Dexamethasone|dexamethasone|mesh-list
84128851|NCT05170789|Elotuzumab|elotuzumab|mesh-list
84128852|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128853|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
84128854|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
84128855|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128856|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128857|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128858|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
84128859|NCT05170789|Hormones|hormones|mesh-ancestor
84128860|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128861|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84128862|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128863|NCT02693951|Cefotiam|cefotiam|mesh-list
84128864|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84128865|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128866|NCT00997711|Sirolimus|sirolimus|mesh-list
84128867|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84128868|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128869|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84128870|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128871|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
84128872|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84128873|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
84128874|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128875|NCT01001143|Decitabine|decitabine|mesh-list
84128876|NCT01001143|Bexarotene|bexarotene|mesh-list
84128877|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84128878|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
84128879|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128880|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128881|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128882|NCT02715167|Budesonide|budesonide|mesh-list
84128883|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128884|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84128885|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
84128886|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128887|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128888|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84128889|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
84128890|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
84128891|NCT02715167|Hormones|hormones|mesh-ancestor
84128892|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128893|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
84128894|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84128895|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84128896|NCT02620566|Bupivacaine|bupivacaine|mesh-list
84128897|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
84128898|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
84128899|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84128900|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128901|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
84128902|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128903|NCT00855465|Riociguat|riociguat|mesh-list
84128904|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
84128905|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128906|NCT02714699|Diclofenac|diclofenac|mesh-list
83369674|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
84128907|NCT02714699|Scopolamine|scopolamine|mesh-list
84128909|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84128910|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84128911|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84128912|NCT02714699|Analgesics|analgesics|mesh-ancestor
84128913|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
84128914|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128915|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128916|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128917|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128918|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84128919|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128920|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128921|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
84128922|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84128923|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
84128924|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
84128925|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128926|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
84128927|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84128928|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
84128929|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128930|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84128931|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
84128932|NCT01004419|Fulvestrant|fulvestrant|mesh-list
84128933|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84128934|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128935|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84128936|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84128937|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
84128938|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84128939|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128940|NCT02714855|Apixaban|apixaban|mesh-list
84128941|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84128942|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
84128943|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84128944|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
84128945|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128946|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128947|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
84128948|NCT02712203|Vaccines|vaccines|mesh-list
84128949|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
84128950|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128951|NCT00696930|Edotreotide|edotreotide|mesh-list
84128952|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84128953|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128954|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
84128955|NCT00598442|Hematinics|hematinics|mesh-ancestor
84128956|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
84128957|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
84128958|NCT02714543|Antioxidants|antioxidants|mesh-list
84128959|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128960|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84128961|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
84128962|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128963|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
84128964|NCT02714543|Protective Agents|protective agents|mesh-ancestor
84128965|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128966|NCT02714231|Diclofenac|diclofenac|mesh-list
84128967|NCT02714231|Scopolamine|scopolamine|mesh-list
84128968|NCT02714231|Bromides|bromides|mesh-list
84128969|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84128970|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84128971|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84128972|NCT02714231|Analgesics|analgesics|mesh-ancestor
84128973|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
84128974|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84128975|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84128976|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84128977|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84128978|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84128979|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84128980|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84128981|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
84128982|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84128983|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
84128984|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
84128985|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84128986|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
84128987|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84128988|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
84128989|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84128990|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84128991|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
84128992|NCT00855309|Acyclovir|acyclovir|mesh-list
84128993|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
84128994|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84128995|NCT00532129|Rituximab|rituximab|mesh-list
84128996|NCT00532129|Chlorambucil|chlorambucil|mesh-list
84128997|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84128998|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84128999|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
84129000|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129001|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129002|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84129003|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
84129004|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129005|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84129006|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84129007|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129008|NCT04163588|Metolazone|metolazone|mesh-list
84129009|NCT04163588|Diuretics|diuretics|mesh-list
84129010|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
84129011|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
84129012|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129013|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129014|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129015|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84129016|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84129017|NCT05167513|Metformin|metformin|mesh-list
84129018|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84129019|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84129020|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129021|NCT05167513|Incretins|incretins|mesh-ancestor
84129022|NCT05167513|Hormones|hormones|mesh-ancestor
84129023|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129024|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84129025|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
84129026|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129027|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129028|NCT00654056|Insulin|insulin|mesh-list
84129029|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84129030|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84129031|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129032|NCT00854373|Hormones|hormones|mesh-list
84129033|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84129034|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129035|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129036|NCT00611507|Fluorouracil|fluorouracil|mesh-list
84129037|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
84129038|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
84129039|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129040|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84129041|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129042|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84129043|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
84129044|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129045|NCT01001845|Vitamin E|vitamin e|mesh-list
84129046|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
84129047|NCT01001845|Tocopherols|tocopherols|mesh-list
84129048|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
84129049|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129050|NCT01001845|Protective Agents|protective agents|mesh-ancestor
84129051|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129052|NCT01001845|Vitamins|vitamins|mesh-ancestor
84129053|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
84129054|NCT02635334|Montelukast|montelukast|mesh-list
84129055|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84129056|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
83369819|NCT00445263|Tirofiban|tirofiban|mesh-list
84129057|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84129059|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129060|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129061|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84129062|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84129063|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129064|NCT00853905|Triamcinolone|triamcinolone|mesh-list
84129065|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84129066|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84129067|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84129068|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84129069|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129070|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
84129071|NCT00853905|Hormones|hormones|mesh-ancestor
84129072|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129073|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129074|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84129075|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
84129076|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129077|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129078|NCT00998101|Carboplatin|carboplatin|mesh-list
84129079|NCT00998101|Cetuximab|cetuximab|mesh-list
84129080|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129081|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84129082|NCT04234217|Niacin|niacin|mesh-list
84129083|NCT04234217|Niacinamide|niacinamide|mesh-list
84129084|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
84129085|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84129086|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
84129087|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129088|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84129089|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
84129090|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
84129091|NCT04234217|Vitamins|vitamins|mesh-ancestor
84129092|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
84129093|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129094|NCT01002079|Rifampin|rifampin|mesh-list
84129095|NCT01002079|BMS 708163|bms 708163|mesh-list
84129096|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84129097|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
84129098|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84129099|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129100|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
84129101|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84129102|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129103|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129104|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84129105|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84129106|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84129107|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84129108|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84129109|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84129110|NCT01002079|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84129111|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
84129112|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84129113|NCT05429567|Fentanyl|fentanyl|mesh-list
84129114|NCT05429567|Bupivacaine|bupivacaine|mesh-list
84129115|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
84129116|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
84129117|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129118|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129119|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
84129120|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129121|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84129122|NCT05429567|Narcotics|narcotics|mesh-ancestor
84129123|NCT05429567|Analgesics|analgesics|mesh-ancestor
84129124|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84129125|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84129126|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
84129127|NCT00868296|Pantoprazole|pantoprazole|mesh-list
84129128|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84129129|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129130|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84129131|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129132|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129133|NCT01002157|Vitamin K|vitamin k|mesh-list
84129134|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
84129135|NCT01002157|Menaquinone 7|menaquinone 7|mesh-list
84129136|NCT01002157|Vitamins|vitamins|mesh-ancestor
84129137|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
84129138|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129139|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84129140|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84129141|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129142|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
84129143|NCT01002157|Coagulants|coagulants|mesh-ancestor
84129144|NCT01004497|Cytarabine|cytarabine|mesh-list
84129145|NCT01004497|Dexamethasone|dexamethasone|mesh-list
84129146|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
84129147|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
84129148|NCT01004497|Vincristine|vincristine|mesh-list
84129149|NCT01004497|Daunorubicin|daunorubicin|mesh-list
84129150|NCT01004497|Dasatinib|dasatinib|mesh-list
84129151|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
84129152|NCT01004497|BB 1101|bb 1101|mesh-list
84129153|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84129154|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
84129155|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129156|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129157|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84129158|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
84129159|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129160|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129161|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84129162|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129163|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
84129164|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
84129165|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129166|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129167|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
84129168|NCT01004497|Hormones|hormones|mesh-ancestor
84129169|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129170|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84129171|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
84129172|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129173|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84129174|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
84129175|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
84129176|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129177|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84129178|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
84129179|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
84129180|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
84129181|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84129182|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84129183|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84129184|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129185|NCT01004497|Analgesics|analgesics|mesh-ancestor
84129186|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
84129187|NCT02713841|Insulin|insulin|mesh-list
84129188|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84129189|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
84129190|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84129191|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129192|NCT01004575|Cobalt|cobalt|mesh-list
84129193|NCT01004575|Chromium|chromium|mesh-list
84129194|NCT01004575|Trace Elements|trace elements|mesh-ancestor
84129195|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
84129196|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129197|NCT02615730|Paclitaxel|paclitaxel|mesh-list
84129198|NCT02615730|GSK2636771|gsk2636771|mesh-list
84129199|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84129200|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129201|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
84129202|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
84129203|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
84129204|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129205|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129206|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129207|NCT02711891|Loperamide|loperamide|mesh-list
84129208|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
84129209|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129210|NCT02615496|Aflibercept|aflibercept|mesh-list
84129211|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84129212|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84129213|NCT02615496|Growth Substances|growth substances|mesh-ancestor
84129214|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129215|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
84129216|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129217|NCT02714075|Zinc|zinc|mesh-list
84129218|NCT02714075|Iron|iron|mesh-list
84129219|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
84129220|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
84129221|NCT02714075|Citric Acid|citric acid|mesh-list
84129222|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
84129223|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
84129224|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84129225|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
84129226|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
84129227|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129228|NCT02714075|Trace Elements|trace elements|mesh-ancestor
84129229|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
84129230|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129231|NCT02714075|Astringents|astringents|mesh-ancestor
84129232|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
84129233|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
84129234|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84129235|NCT02714075|Protective Agents|protective agents|mesh-ancestor
84129236|NCT02636426|Sorafenib|sorafenib|mesh-list
84129237|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129238|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129239|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129240|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129241|NCT02713763|Sunitinib|sunitinib|mesh-list
84129242|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129243|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84129244|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84129245|NCT02713763|Growth Substances|growth substances|mesh-ancestor
84129246|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129247|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
84129248|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129249|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129250|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129251|NCT00867360|Mifepristone|mifepristone|mesh-list
84129252|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84129253|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
84129254|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84129255|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129256|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84129257|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84129258|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84129259|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
84129260|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84129261|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84129262|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
84129263|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129264|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
84129265|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84129266|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84129267|NCT00656552|Escitalopram|escitalopram|mesh-list
84129268|NCT00656552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84129269|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84129270|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129271|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129272|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129273|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
84129274|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129275|NCT01004809|Dutasteride|dutasteride|mesh-list
84129276|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84129277|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84129278|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129279|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129280|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
84129281|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129282|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129283|NCT00883688|Bevacizumab|bevacizumab|mesh-list
84129284|NCT00883688|Lapatinib|lapatinib|mesh-list
84129285|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84129286|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129287|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84129288|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84129289|NCT00883688|Growth Substances|growth substances|mesh-ancestor
84129290|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129291|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
84129292|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129293|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129294|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129295|NCT04191863|Valproic Acid|valproic acid|mesh-list
84129296|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
84129297|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129298|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129299|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
84129300|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129301|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129302|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
84129303|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84129304|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129305|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84129306|NCT02636348|Vitamin D|vitamin d|mesh-list
84129307|NCT02636348|Calcium|calcium|mesh-list
84129308|NCT02636348|Vitamins|vitamins|mesh-ancestor
84129309|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
84129310|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129311|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84129312|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84129313|NCT04219865|Edaravone|edaravone|mesh-list
84129314|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84129315|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
84129316|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129317|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84129318|NCT04219865|Protective Agents|protective agents|mesh-ancestor
84129319|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129320|NCT01002703|Prednisone|prednisone|mesh-list
84129321|NCT01002703|Lenalidomide|lenalidomide|mesh-list
84129322|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84129323|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129324|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
84129325|NCT01002703|Hormones|hormones|mesh-ancestor
84129326|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129327|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129328|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84129329|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129330|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
84129331|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84129332|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84129333|NCT01002703|Growth Substances|growth substances|mesh-ancestor
84129334|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
84129335|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84129336|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
84129337|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129338|NCT02639234|Nivolumab|nivolumab|mesh-list
84129339|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84129340|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129341|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84129342|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129343|NCT00654290|Propranolol|propranolol|mesh-list
84129344|NCT00654290|Amiodarone|amiodarone|mesh-list
84129345|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84129346|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84129347|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
84129348|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129349|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129350|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129351|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84129352|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84129353|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
84129354|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84129355|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129356|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84129357|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84129358|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370125|NCT01478113|Adderall|adderall|mesh-list
84129359|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129360|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84129361|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84129362|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84129363|NCT02713139|Metronidazole|metronidazole|mesh-list
84129364|NCT02713139|Clotrimazole|clotrimazole|mesh-list
84129365|NCT02713139|Miconazole|miconazole|mesh-list
84129366|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129367|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84129368|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84129369|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84129370|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84129371|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
84129372|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84129373|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84129374|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129375|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129376|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84129377|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
84129378|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129379|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129380|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84129381|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84129382|NCT01005121|Colchicine|colchicine|mesh-list
84129383|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
84129384|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129385|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
84129386|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
84129387|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
84129388|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129389|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129390|NCT02711579|Celecoxib|celecoxib|mesh-list
84129391|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84129392|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84129393|NCT02711579|Analgesics|analgesics|mesh-ancestor
84129394|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
84129395|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129396|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129397|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129398|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129399|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84129400|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84129401|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129402|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129403|NCT00611195|Remifentanil|remifentanil|mesh-list
84129404|NCT00611195|Propofol|propofol|mesh-list
84129405|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84129406|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129407|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129408|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84129409|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
84129410|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
84129411|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84129412|NCT00611195|Narcotics|narcotics|mesh-ancestor
84129413|NCT00611195|Analgesics|analgesics|mesh-ancestor
84129414|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
84129415|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129416|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
84129417|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
84129418|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
84129419|NCT01008709|Hormones|hormones|mesh-ancestor
84129420|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129421|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129422|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129423|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129424|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84129425|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
84129426|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84129427|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
84129428|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129429|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
84129430|NCT04117893|Protective Agents|protective agents|mesh-ancestor
84129431|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84129432|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84129433|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129434|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129435|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129436|NCT04117893|Analgesics|analgesics|mesh-ancestor
84129437|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
84129438|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129439|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
84129440|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84129441|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
84129442|NCT02615574|Interferons|interferons|mesh-list
84129443|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
84129445|NCT02615574|Vaccines|vaccines|mesh-list
84129446|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
84129447|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129448|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129449|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
84129450|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129451|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84129452|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84129453|NCT02615574|Analgesics|analgesics|mesh-ancestor
84129454|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
84129455|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129456|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129457|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129458|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84129459|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84129460|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129461|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129462|NCT02708693|Triamcinolone|triamcinolone|mesh-list
84129463|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84129464|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84129465|NCT02708693|Lidocaine|lidocaine|mesh-list
84129466|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84129467|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
84129468|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
84129469|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129470|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129471|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
84129472|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129473|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84129474|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84129475|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84129476|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129477|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129478|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129479|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
84129480|NCT02708693|Hormones|hormones|mesh-ancestor
84129481|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129482|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84129483|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
84129484|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129485|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84129486|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84129487|NCT02638922|Trisequens|trisequens|mesh-list
84129488|NCT02638922|Norethindrone|norethindrone|mesh-list
84129489|NCT02638922|Estradiol|estradiol|mesh-list
84129490|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84129491|NCT02638922|Estrogens|estrogens|mesh-ancestor
84129492|NCT02638922|Hormones|hormones|mesh-ancestor
84129493|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129494|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129495|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84129496|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
84129497|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84129498|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84129499|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84129500|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84129501|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84129502|NCT01005199|Everolimus|everolimus|mesh-list
84129503|NCT01005199|Sorafenib|sorafenib|mesh-list
84129504|NCT01005199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84129505|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129506|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129507|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129508|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84129509|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
84129510|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129511|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129512|NCT02711189|Oxytocin|oxytocin|mesh-list
84129513|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
84129514|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84129515|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129516|NCT02635802|Lidocaine|lidocaine|mesh-list
84129517|NCT02635802|Midazolam|midazolam|mesh-list
84129518|NCT02635802|Remifentanil|remifentanil|mesh-list
84129519|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
84129520|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
84129521|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129522|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129523|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
84129524|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129525|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84129526|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84129527|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84129528|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129529|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129530|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84129531|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84129532|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84129533|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84129534|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84129535|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84129536|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
84129537|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
84129538|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
84129539|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129540|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84129541|NCT02635802|Narcotics|narcotics|mesh-ancestor
84129542|NCT02635802|Analgesics|analgesics|mesh-ancestor
84129543|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84129544|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
84129545|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129546|NCT00657410|Dexamethasone|dexamethasone|mesh-list
84129547|NCT00657410|Prednisone|prednisone|mesh-list
84129548|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129549|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
84129550|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
84129551|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129552|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129553|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129554|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
84129555|NCT00657410|Hormones|hormones|mesh-ancestor
84129556|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129557|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84129558|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129559|NCT01009021|Diclofenac|diclofenac|mesh-list
84129560|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84129561|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84129562|NCT01009021|Analgesics|analgesics|mesh-ancestor
84129563|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
84129564|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129565|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129566|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129567|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129568|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84129569|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129570|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129571|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
84129572|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84129573|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129574|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129575|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84129576|NCT01005433|Analgesics|analgesics|mesh-ancestor
84129577|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
84129578|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129579|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84129580|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84129581|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84129582|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
84129583|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129584|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129585|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84129586|NCT00654446|Simvastatin|simvastatin|mesh-list
84129587|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84129588|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84129589|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
84129590|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129591|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84129592|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84129593|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129594|NCT01003483|Orlistat|orlistat|mesh-list
84129595|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129596|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129597|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84129598|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84129599|NCT00592839|Estrogens|estrogens|mesh-list
84129600|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84129601|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
84129602|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
84129603|NCT00592839|Hormones|hormones|mesh-ancestor
84129604|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129605|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129606|NCT01009177|Bosentan|bosentan|mesh-list
84129607|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84129608|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84129609|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129610|NCT00598832|Adapalene|adapalene|mesh-list
84129611|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84129612|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84129613|NCT00598832|Analgesics|analgesics|mesh-ancestor
84129614|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
84129615|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129616|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129617|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129618|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129619|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
84129620|NCT01003561|Anesthetics|anesthetics|mesh-list
84129621|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129622|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129623|NCT02711267|Acyclovir|acyclovir|mesh-list
84129624|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
84129625|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129626|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
84129627|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84129628|NCT04459871|Thrombin|thrombin|mesh-list
84129629|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
84129630|NCT04459871|Coagulants|coagulants|mesh-ancestor
84129631|NCT02708459|Morphine|morphine|mesh-list
84129632|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84129633|NCT02708459|Narcotics|narcotics|mesh-ancestor
84129634|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129635|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129636|NCT02708459|Analgesics|analgesics|mesh-ancestor
84129637|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
84129638|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129639|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
84129640|NCT01005979|Rituximab|rituximab|mesh-list
84129641|NCT01005979|Lenalidomide|lenalidomide|mesh-list
84129642|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84129643|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
84129644|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129645|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129646|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84129647|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
84129648|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129649|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129650|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84129651|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84129652|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84129653|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84129654|NCT01005979|Growth Substances|growth substances|mesh-ancestor
84129655|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
84129656|NCT00913029|Timolol|timolol|mesh-list
84129657|NCT00913029|Latanoprost|latanoprost|mesh-list
84129658|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84129659|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84129660|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
84129661|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129662|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129663|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129664|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84129665|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84129666|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84129667|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84129668|NCT01006057|Insulin|insulin|mesh-list
84129669|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84129670|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
84129671|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84129672|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129673|NCT00853125|Sunitinib|sunitinib|mesh-list
84129674|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129675|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84129676|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84129677|NCT00853125|Growth Substances|growth substances|mesh-ancestor
84129678|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129679|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
84129680|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129681|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129682|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129683|NCT02707913|Amlodipine|amlodipine|mesh-list
84129684|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84129685|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84129686|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129687|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129688|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84129689|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129690|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
84129691|NCT02710877|Sufentanil|sufentanil|mesh-list
84129692|NCT02710877|Dsuvia|dsuvia|mesh-list
84129693|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
84129694|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84129695|NCT02710877|Narcotics|narcotics|mesh-ancestor
84129696|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129697|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129698|NCT02710877|Analgesics|analgesics|mesh-ancestor
84129699|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
84129700|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129701|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84129702|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84129703|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
84129704|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
84129705|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
84129706|NCT00530023|Insulin|insulin|mesh-list
84129707|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84129708|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129709|NCT02707445|Clopidogrel|clopidogrel|mesh-list
84129710|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84129711|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84129712|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84129713|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84129714|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
84129715|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129716|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129717|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129718|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
84129719|NCT03999775|Vitamin D|vitamin d|mesh-list
84129720|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
84129721|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
84129722|NCT03999775|Vitamins|vitamins|mesh-list
84129723|NCT03999775|Calcium|calcium|mesh-list
84129724|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
84129725|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129726|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84129727|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84129728|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84129729|NCT02706977|Carbidopa|carbidopa|mesh-list
84129730|NCT02706977|Levodopa|levodopa|mesh-list
84129731|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84129732|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
84129733|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129734|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84129735|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84129736|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
84129737|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
84129738|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129739|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129740|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84129741|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129742|NCT02707211|Antibodies|antibodies|mesh-list
84129743|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
84129744|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
84129745|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129746|NCT01006525|Zolpidem|zolpidem|mesh-list
84129747|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84129748|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84129749|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129750|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129751|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84129752|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
84129753|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
84129754|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129755|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129756|NCT01006681|Vaccines|vaccines|mesh-list
84129757|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
84129758|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
84129759|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129760|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84129761|NCT05733403|Norepinephrine|norepinephrine|mesh-list
84129762|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84129763|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84129764|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
84129765|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129766|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129767|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129768|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
84129769|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
84129770|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129771|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84129772|NCT03893903|Avelumab|avelumab|mesh-list
84129773|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84129774|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129775|NCT02706509|Tramadol|tramadol|mesh-list
84129776|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129777|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129778|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84129779|NCT02706509|Narcotics|narcotics|mesh-ancestor
84129780|NCT02706509|Analgesics|analgesics|mesh-ancestor
84129781|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
84129782|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129783|NCT02710409|Vaccines|vaccines|mesh-list
84129784|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
84129785|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129786|NCT00529087|Bromides|bromides|mesh-list
84129787|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
84129788|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
84129789|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84129790|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129791|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
84129792|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129793|NCT04318210|Tenofovir|tenofovir|mesh-list
84129794|NCT04318210|Emtricitabine|emtricitabine|mesh-list
84129795|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
84129796|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129797|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84129798|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84129799|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129800|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129801|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84129802|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84129803|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84129804|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
84129805|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129806|NCT00870870|Carboplatin|carboplatin|mesh-list
83370572|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
84129807|NCT00870870|Gemcitabine|gemcitabine|mesh-list
84129808|NCT00870870|Cetuximab|cetuximab|mesh-list
84129809|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84129810|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129811|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84129812|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
84129813|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129814|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84129815|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
84129816|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129817|NCT04120636|Celecoxib|celecoxib|mesh-list
84129818|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84129819|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84129820|NCT04120636|Analgesics|analgesics|mesh-ancestor
84129821|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
84129822|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129823|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129824|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84129825|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129826|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84129827|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84129828|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129829|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129830|NCT00731926|Vitamins|vitamins|mesh-list
84129831|NCT00731926|Vitamin E|vitamin e|mesh-list
84129832|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
84129833|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129834|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
84129835|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129836|NCT00731926|Protective Agents|protective agents|mesh-ancestor
84129837|NCT00732082|Gemcitabine|gemcitabine|mesh-list
84129838|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84129839|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
84129840|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129841|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129842|NCT00611741|Furosemide|furosemide|mesh-list
84129843|NCT00611741|Diuretics|diuretics|mesh-ancestor
84129844|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
84129845|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129846|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84129847|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129848|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129849|NCT02022982|Palbociclib|palbociclib|mesh-list
84129850|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129851|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129852|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129853|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129854|NCT04134468|Gemcitabine|gemcitabine|mesh-list
84129855|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84129856|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84129857|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
84129858|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129859|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129860|NCT02709863|Propofol|propofol|mesh-list
84129861|NCT02709863|Sevoflurane|sevoflurane|mesh-list
84129862|NCT02709863|Desflurane|desflurane|mesh-list
84129863|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84129864|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129865|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129866|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84129867|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
84129868|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
84129869|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84129870|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84129871|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
84129872|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84129873|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129874|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84129875|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129876|NCT02619786|Colistin|colistin|mesh-list
84129877|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84129878|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129879|NCT00697086|Dronedarone|dronedarone|mesh-list
84129880|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84129881|NCT04066660|Fucoidan|fucoidan|mesh-list
84129882|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84129883|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129884|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
84129885|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129886|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
84129887|NCT00697164|Hematinics|hematinics|mesh-ancestor
84129888|NCT00694980|Etrolizumab|etrolizumab|mesh-list
84129889|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129890|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
84129891|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129892|NCT00612755|Ribavirin|ribavirin|mesh-list
84129893|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84129894|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
84129895|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129896|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
84129897|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129898|NCT04132674|Tenofovir|tenofovir|mesh-list
84129899|NCT04132674|Emtricitabine|emtricitabine|mesh-list
84129900|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84129901|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
84129902|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129903|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84129904|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84129905|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129906|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129907|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84129908|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84129909|NCT00612287|Buprenorphine|buprenorphine|mesh-list
84129910|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84129911|NCT00612287|Narcotics|narcotics|mesh-ancestor
84129912|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84129913|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129914|NCT00612287|Analgesics|analgesics|mesh-ancestor
84129915|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
84129916|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129917|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84129918|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
84129919|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
84129920|NCT00732784|Calcium|calcium|mesh-list
84129921|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84129922|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129923|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129924|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84129925|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84129926|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129927|NCT00732784|Antacids|antacids|mesh-ancestor
84129928|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129929|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84129930|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
84129931|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84129932|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
84129933|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129934|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
84129935|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
84129936|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84129937|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129938|NCT02947126|Antidotes|antidotes|mesh-ancestor
84129939|NCT02947126|Protective Agents|protective agents|mesh-ancestor
84129940|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129941|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
84129942|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
84129943|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84129944|NCT04492553|Testosterone|testosterone|mesh-list
84129945|NCT04492553|Androgens|androgens|mesh-ancestor
84129946|NCT04492553|Hormones|hormones|mesh-ancestor
84129947|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129948|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129949|NCT00871494|Azithromycin|azithromycin|mesh-list
84129950|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84129951|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129952|NCT01007539|Choline|choline|mesh-list
84129953|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
84129954|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
84129955|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84129956|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
84129957|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129958|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84129959|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84129960|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
84129962|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84129963|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129964|NCT04137185|Hormones|hormones|mesh-list
84129965|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84129966|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129967|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
84129968|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84129969|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129970|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84129971|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84129972|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84129973|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84129974|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129975|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84129976|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129977|NCT00529789|Analgesics|analgesics|mesh-ancestor
84129978|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
84129979|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84129980|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
84129981|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84129982|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
84129983|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84129984|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84129985|NCT00611819|Interferons|interferons|mesh-list
84129986|NCT00611819|Ribavirin|ribavirin|mesh-list
84129987|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84129988|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
84129989|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84129990|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
84129991|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84129992|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
84129993|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84129994|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
84129995|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129996|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
84129997|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84129998|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84129999|NCT02619162|Letrozole|letrozole|mesh-list
84130000|NCT02619162|Nintedanib|nintedanib|mesh-list
84130001|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130002|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84130003|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84130004|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130005|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130006|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84130007|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
84130008|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130009|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130010|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84130011|NCT04018690|Triamcinolone|triamcinolone|mesh-list
84130012|NCT04018690|Ropivacaine|ropivacaine|mesh-list
84130013|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
84130014|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
84130015|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130016|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130017|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
84130018|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130019|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130020|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
84130021|NCT04018690|Hormones|hormones|mesh-ancestor
84130022|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130023|NCT00697866|Vaccines|vaccines|mesh-list
84130024|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
84130025|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130026|NCT00733564|Lidocaine|lidocaine|mesh-list
84130027|NCT00733564|Propofol|propofol|mesh-list
84130028|NCT00733564|Sevoflurane|sevoflurane|mesh-list
84130029|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
84130030|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
84130031|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130032|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130033|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
83370818|NCT01458535|Ritonavir|ritonavir|mesh-list
84130034|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130035|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84130036|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84130037|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84130038|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84130039|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130040|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84130041|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84130042|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
84130043|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84130044|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84130045|NCT00727870|Glycerol|glycerol|mesh-list
84130046|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84130047|NCT00727870|Protective Agents|protective agents|mesh-ancestor
84130048|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130049|NCT01007695|Valproic Acid|valproic acid|mesh-list
84130050|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
84130051|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130052|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130053|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
84130054|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130055|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130056|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
84130057|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84130058|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130059|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84130060|NCT02709473|Remifentanil|remifentanil|mesh-list
84130061|NCT02709473|Propofol|propofol|mesh-list
84130062|NCT02709473|Rocuronium|rocuronium|mesh-list
84130063|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84130064|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130065|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130066|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84130067|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
84130068|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
84130069|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84130070|NCT02709473|Narcotics|narcotics|mesh-ancestor
84130071|NCT02709473|Analgesics|analgesics|mesh-ancestor
84130072|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
84130073|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130074|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84130075|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84130076|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84130077|NCT00866658|Lixisenatide|lixisenatide|mesh-list
84130078|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84130079|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130080|NCT04942067|Dexamethasone|dexamethasone|mesh-list
84130081|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
84130082|NCT04942067|Lenalidomide|lenalidomide|mesh-list
84130083|NCT04942067|Daratumumab|daratumumab|mesh-list
84130084|NCT04942067|Pomalidomide|pomalidomide|mesh-list
84130085|NCT04942067|BB 1101|bb 1101|mesh-list
84130086|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130087|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
84130088|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
84130089|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130090|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130091|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130092|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
84130093|NCT04942067|Hormones|hormones|mesh-ancestor
84130094|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130095|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130096|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130097|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
84130098|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130099|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130100|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
84130101|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130102|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130103|NCT04942067|Growth Substances|growth substances|mesh-ancestor
84130104|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130105|NCT01007773|Fentanyl|fentanyl|mesh-list
84130106|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
84130107|NCT01007773|Propofol|propofol|mesh-list
84130108|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83370876|NCT01460381|Quinidine|quinidine|mesh-list
84130109|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130110|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130111|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84130112|NCT01007773|Analgesics|analgesics|mesh-ancestor
84130113|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
84130114|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130115|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84130116|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84130117|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84130118|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
84130119|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130120|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130121|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84130122|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
84130123|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
84130124|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84130125|NCT01007773|Narcotics|narcotics|mesh-ancestor
84130126|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84130127|NCT02615340|Melatonin|melatonin|mesh-list
84130128|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
84130129|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130130|NCT02615340|Protective Agents|protective agents|mesh-ancestor
84130131|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130132|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130133|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
84130134|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130135|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
84130136|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130137|NCT04899791|Protective Agents|protective agents|mesh-ancestor
84130138|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130139|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84130140|NCT02615106|Endostar protein|endostar protein|mesh-list
84130141|NCT02615106|Endostatins|endostatins|mesh-list
84130142|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130143|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130144|NCT02615106|Growth Substances|growth substances|mesh-ancestor
84130145|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130146|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130147|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130148|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
84130149|NCT04930237|Bisacodyl|bisacodyl|mesh-list
84130150|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
84130151|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
84130152|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
84130153|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
84130154|NCT04930237|Calcium|calcium|mesh-list
84130155|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84130156|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130157|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130158|NCT04930237|Cathartics|cathartics|mesh-ancestor
84130159|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130160|NCT04930237|Laxatives|laxatives|mesh-ancestor
84130161|NCT04930237|Antacids|antacids|mesh-ancestor
84130162|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84130163|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
84130164|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130165|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
84130166|NCT02615262|Dexamethasone|dexamethasone|mesh-list
84130167|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130168|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
84130169|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
84130170|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130171|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130172|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130173|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
84130174|NCT02615262|Hormones|hormones|mesh-ancestor
84130175|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130176|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130177|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130178|NCT00733720|Naltrexone|naltrexone|mesh-list
84130179|NCT00733720|Buprenorphine|buprenorphine|mesh-list
84130180|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84130181|NCT00733720|Naloxone|naloxone|mesh-list
84130182|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84130183|NCT00733720|Narcotics|narcotics|mesh-ancestor
84130184|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130185|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130187|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
84130188|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130189|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84130190|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84130191|NCT04134312|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84130192|NCT04134312|Antiviral Agents|antiviral agents|mesh-ancestor
84130193|NCT04134312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130194|NCT05732389|Nivolumab|nivolumab|mesh-list
84130195|NCT05732389|Ipilimumab|ipilimumab|mesh-list
84130196|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84130197|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130198|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84130199|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130200|NCT02624388|Genistein|genistein|mesh-list
84130201|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84130202|NCT02624388|Protective Agents|protective agents|mesh-ancestor
84130203|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130204|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130205|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84130206|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130207|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130208|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
84130209|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84130210|NCT02624388|Estrogens|estrogens|mesh-ancestor
84130211|NCT02624388|Hormones|hormones|mesh-ancestor
84130212|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130213|NCT00727948|Aspirin|aspirin|mesh-list
84130214|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84130215|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84130216|NCT00727948|Analgesics|analgesics|mesh-ancestor
84130217|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
84130218|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130219|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130220|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130221|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84130222|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84130223|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84130224|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130225|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84130226|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84130227|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130228|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
84130229|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84130230|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
84130231|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84130232|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
84130233|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84130234|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130235|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84130236|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130237|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130238|NCT05580016|Plasminogen|plasminogen|mesh-list
84130239|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84130240|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84130241|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130242|NCT05730673|Leronlimab|leronlimab|mesh-list
84130243|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84130244|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84130245|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130246|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84130247|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84130248|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
84130249|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130250|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
84130251|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84130252|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
84130253|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130254|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130255|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84130256|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
84130257|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84130258|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
84130259|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130260|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130261|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84130262|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
84130264|NCT04134078|Protective Agents|protective agents|mesh-ancestor
84130265|NCT03871829|Dexamethasone|dexamethasone|mesh-list
84130266|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
84130267|NCT03871829|BB 1101|bb 1101|mesh-list
84130268|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130269|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
84130270|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
84130271|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130272|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130273|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130274|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
84130275|NCT03871829|Hormones|hormones|mesh-ancestor
84130276|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130277|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130278|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130279|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
84130280|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130281|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130282|NCT00738556|Sirolimus|sirolimus|mesh-list
84130283|NCT00738556|Paclitaxel|paclitaxel|mesh-list
84130284|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84130285|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130286|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
84130287|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
84130288|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
84130289|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130290|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84130291|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130292|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84130293|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
84130294|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84130295|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
84130296|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130297|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
84130298|NCT00597584|Hematinics|hematinics|mesh-ancestor
84130299|NCT00529633|Thalidomide|thalidomide|mesh-list
84130300|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84130301|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
84130302|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130303|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
84130304|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84130305|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130306|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130307|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130308|NCT00529633|Growth Substances|growth substances|mesh-ancestor
84130309|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130310|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130311|NCT01366144|Paclitaxel|paclitaxel|mesh-list
84130312|NCT01366144|Carboplatin|carboplatin|mesh-list
84130313|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84130314|NCT01366144|Veliparib|veliparib|mesh-list
84130315|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84130316|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130317|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
84130318|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
84130319|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
84130320|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130321|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84130322|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130323|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84130324|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
84130325|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130326|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84130327|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84130328|NCT00657488|Thalidomide|thalidomide|mesh-list
84130329|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84130330|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
84130331|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371100|NCT04082767|Midazolam|midazolam|mesh-list
84130332|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
84130333|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84130334|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130335|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130336|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130337|NCT00657488|Growth Substances|growth substances|mesh-ancestor
84130338|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130339|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130340|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84130341|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84130342|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84130343|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84130344|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130345|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
84130346|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130347|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130348|NCT00712270|Risperidone|risperidone|mesh-list
84130349|NCT00712270|Aripiprazole|aripiprazole|mesh-list
84130350|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84130351|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
84130352|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130353|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130354|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130355|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84130356|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84130357|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130358|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84130359|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84130360|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
84130361|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
84130362|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
84130363|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84130364|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84130365|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84130366|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84130367|NCT03860597|Memantine|memantine|mesh-list
84130368|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84130369|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84130370|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
84130371|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130372|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130373|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130374|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84130375|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84130376|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
84130377|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
84130378|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84130379|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
84130380|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130381|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130382|NCT00695604|Fluticasone|fluticasone|mesh-list
84130383|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130384|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84130385|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
84130386|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130387|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130388|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84130389|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
84130390|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
84130391|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84130392|NCT00654524|Vitamin D|vitamin d|mesh-list
84130393|NCT00654524|Goserelin|goserelin|mesh-list
84130394|NCT00654524|Hormones|hormones|mesh-list
84130395|NCT00654524|Vitamins|vitamins|mesh-ancestor
84130396|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
84130397|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130398|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84130399|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130400|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130401|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130402|NCT05260619|Lenalidomide|lenalidomide|mesh-list
84130403|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
84130404|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130405|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130406|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130407|NCT05260619|Growth Substances|growth substances|mesh-ancestor
84130409|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130410|NCT00695682|Infliximab|infliximab|mesh-list
84130411|NCT00695682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84130412|NCT00695682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130413|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
84130414|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130415|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84130416|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84130417|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84130418|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130419|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
84130420|NCT03828773|Fluconazole|fluconazole|mesh-list
84130421|NCT03828773|Posaconazole|posaconazole|mesh-list
84130422|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
84130423|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130424|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84130425|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84130426|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130427|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130428|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84130429|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
84130430|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130431|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130432|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84130433|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84130434|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84130435|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84130436|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84130437|NCT00530257|Methylphenidate|methylphenidate|mesh-list
84130438|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84130439|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130440|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84130441|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84130442|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84130443|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130444|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
84130445|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130446|NCT00738868|Cetuximab|cetuximab|mesh-list
84130447|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84130448|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130449|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84130450|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
84130451|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84130452|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84130453|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130454|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130455|NCT00657644|Urological Agents|urological agents|mesh-ancestor
84130456|NCT00869778|Vaccines|vaccines|mesh-list
84130457|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
84130458|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130459|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
84130460|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84130461|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84130462|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84130463|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
84130464|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130465|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130466|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130467|NCT04162028|Ketamine|ketamine|mesh-list
84130468|NCT04162028|Analgesics|analgesics|mesh-ancestor
84130469|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
84130470|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130471|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130472|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84130473|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84130474|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
84130475|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
84130476|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130477|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84130478|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84130479|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130480|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130481|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
84130482|NCT00656786|Vitamin K|vitamin k|mesh-list
84130483|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84130484|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84130485|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130486|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
84130487|NCT00656786|Coagulants|coagulants|mesh-ancestor
84130488|NCT00656786|Vitamins|vitamins|mesh-ancestor
84130489|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
84130490|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130491|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
84130492|NCT01008631|Antidotes|antidotes|mesh-ancestor
84130493|NCT01008631|Protective Agents|protective agents|mesh-ancestor
84130494|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130495|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
84130496|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130497|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
84130498|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84130499|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130500|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
84130501|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
84130502|NCT00734890|Bevacizumab|bevacizumab|mesh-list
84130503|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84130504|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130505|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130506|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130507|NCT00734890|Growth Substances|growth substances|mesh-ancestor
84130508|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130509|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130510|NCT05325190|Granisetron|granisetron|mesh-list
84130511|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
84130512|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
84130513|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130514|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130515|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130516|NCT05325190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84130517|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84130518|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
84130519|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130520|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130521|NCT02624310|Droxidopa|droxidopa|mesh-list
84130522|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84130523|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84130524|NCT00612521|Adenosine|adenosine|mesh-list
84130525|NCT00612521|Analgesics|analgesics|mesh-ancestor
84130526|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
84130527|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130528|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130529|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84130530|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
84130531|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84130532|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
84130533|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
84130534|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130535|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130536|NCT00735124|Gabapentin|gabapentin|mesh-list
84130537|NCT00735124|Analgesics|analgesics|mesh-ancestor
84130538|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
84130539|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130540|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130541|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
84130542|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84130543|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84130544|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130545|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84130546|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84130547|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84130548|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130549|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130550|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
84130551|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
83371320|NCT01458275|Hormones|hormones|mesh-ancestor
84130552|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84130553|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84130554|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84130555|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84130556|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130557|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
84130558|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130559|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130560|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84130561|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130562|NCT04246541|Acetaminophen|acetaminophen|mesh-list
84130564|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
84130565|NCT04246541|Oxycodone|oxycodone|mesh-list
84130566|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84130567|NCT04246541|Analgesics|analgesics|mesh-ancestor
84130568|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
84130569|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130570|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130571|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
84130572|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84130573|NCT04246541|Narcotics|narcotics|mesh-ancestor
84130574|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130575|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84130576|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130577|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84130578|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84130579|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130580|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130581|NCT05153395|Insulin|insulin|mesh-list
84130582|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84130583|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84130584|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130585|NCT04902859|Clonidine|clonidine|mesh-list
84130586|NCT04902859|Analgesics|analgesics|mesh-ancestor
84130587|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
84130588|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130589|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130590|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84130591|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
84130592|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
84130593|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84130594|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84130595|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84130596|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
84130597|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430093|NCT00504751|Ifosfamide|ifosfamide|mesh-list
84130598|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130599|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84130600|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84130601|NCT04180943|Bupivacaine|bupivacaine|mesh-list
84130602|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
84130603|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
84130604|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130605|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130606|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
84130607|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130608|NCT05011357|Phenylephrine|phenylephrine|mesh-list
84130609|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
84130610|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84130611|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
84130612|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
84130613|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130614|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130615|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
84130616|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84130617|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
84130618|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
84130619|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84130620|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84130621|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84130622|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
84130623|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130624|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130625|NCT05011357|Protective Agents|protective agents|mesh-ancestor
84130626|NCT00711880|Nabiximols|nabiximols|mesh-list
84130627|NCT00711880|Analgesics|analgesics|mesh-ancestor
84130628|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
84130629|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130630|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130631|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
84130632|NCT02693483|Povidone|povidone|mesh-list
84130633|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
84130634|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
84130635|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84130636|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130637|NCT04873063|Beclomethasone|beclomethasone|mesh-list
84130638|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130639|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
84130640|NCT04873063|Hormones|hormones|mesh-ancestor
84130641|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130642|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130643|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84130644|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
84130645|NCT00739414|Panobinostat|panobinostat|mesh-list
84130646|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130647|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84130648|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130649|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130650|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
84130651|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
84130652|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84130653|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130654|NCT00735280|Heparin|heparin|mesh-list
84130655|NCT00735280|Calcium heparin|calcium heparin|mesh-list
84130656|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
84130657|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84130658|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84130659|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130660|NCT00612989|Temozolomide|temozolomide|mesh-list
84130661|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
84130662|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84130663|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
84130664|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130665|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130666|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130667|NCT04929067|Immunomodulating Agents|immunomodulating agents|mesh-list
84130668|NCT04929067|Immunologic Factors|immunologic factors|mesh-ancestor
84130669|NCT04929067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130670|NCT05215405|Venetoclax|venetoclax|mesh-list
84130671|NCT05215405|Navitoclax|navitoclax|mesh-list
84130672|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130673|NCT00613067|Escitalopram|escitalopram|mesh-list
84130674|NCT00613067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84130675|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84130676|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84130677|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130678|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130679|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
84130680|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130681|NCT04649489|Bevacizumab|bevacizumab|mesh-list
84130682|NCT04649489|Atezolizumab|atezolizumab|mesh-list
84130683|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84130684|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84130685|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130686|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130687|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130688|NCT04649489|Growth Substances|growth substances|mesh-ancestor
84130689|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130690|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130691|NCT04649489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84130692|NCT04649489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130693|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
84130694|NCT00613145|Capecitabine|capecitabine|mesh-list
84130695|NCT00613145|Sorafenib|sorafenib|mesh-list
84130696|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84130697|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
84130698|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130699|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130700|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84130701|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130702|NCT04570085|Caffeine|caffeine|mesh-list
84130703|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84130704|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130705|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84130706|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130707|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130708|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84130709|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84130710|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
84130711|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130712|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84130713|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
84130714|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84130715|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
84130716|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130717|NCT00529399|Antacids|antacids|mesh-ancestor
84130718|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130719|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130720|NCT05268419|Ethanol|ethanol|mesh-list
84130721|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84130722|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130723|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130724|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130725|NCT00852969|Niacin|niacin|mesh-list
84130726|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84130727|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
84130728|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130729|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84130730|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
84130731|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
84130732|NCT00852969|Vitamins|vitamins|mesh-ancestor
84130733|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
84130734|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130735|NCT00613457|Cytarabine|cytarabine|mesh-list
84130736|NCT00613457|Dexamethasone|dexamethasone|mesh-list
84130737|NCT00613457|Prednisone|prednisone|mesh-list
84130738|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
84130739|NCT00613457|Ifosfamide|ifosfamide|mesh-list
84130740|NCT00613457|Doxorubicin|doxorubicin|mesh-list
84130741|NCT00613457|Methotrexate|methotrexate|mesh-list
84130742|NCT00613457|Etoposide|etoposide|mesh-list
84130743|NCT00613457|Vincristine|vincristine|mesh-list
84130744|NCT00613457|Daunorubicin|daunorubicin|mesh-list
84130745|NCT00613457|Asparaginase|asparaginase|mesh-list
84130746|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
84130747|NCT00613457|Thioguanine|thioguanine|mesh-list
84130748|NCT00613457|Vindesine|vindesine|mesh-list
84130749|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84130750|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
84130751|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130752|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84130753|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84130754|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
84130755|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130756|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130757|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84130758|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130759|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
84130760|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
84130761|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130762|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130763|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
84130764|NCT00613457|Hormones|hormones|mesh-ancestor
84130765|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130766|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130767|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84130768|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84130769|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84130770|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130771|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84130772|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
84130773|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84130774|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84130775|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
84130776|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
84130777|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83371548|NCT01468207|Adalimumab|adalimumab|mesh-list
84130778|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84130779|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84130780|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
84130781|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130782|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
84130783|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
84130784|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
84130785|NCT04131582|Metformin|metformin|mesh-list
84130786|NCT04131582|Empagliflozin|empagliflozin|mesh-list
84130787|NCT04131582|Linagliptin|linagliptin|mesh-list
84130788|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84130789|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130790|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84130791|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130792|NCT04131582|Incretins|incretins|mesh-ancestor
84130793|NCT04131582|Hormones|hormones|mesh-ancestor
84130794|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130795|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84130796|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
84130797|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130798|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84130799|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
84130800|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84130801|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84130802|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84130803|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130804|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130805|NCT00695994|Carboplatin|carboplatin|mesh-list
84130806|NCT00695994|Gemcitabine|gemcitabine|mesh-list
84130807|NCT00695994|Docetaxel|docetaxel|mesh-list
84130808|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130809|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84130810|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
84130811|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130812|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
84130813|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
84130814|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
84130815|NCT00711802|Daptomycin|daptomycin|mesh-list
84130816|NCT00711802|Cloxacillin|cloxacillin|mesh-list
84130817|NCT00711802|Oxacillin|oxacillin|mesh-list
84130818|NCT00711802|Nafcillin|nafcillin|mesh-list
84130819|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84130820|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130821|NCT00851877|Paclitaxel|paclitaxel|mesh-list
84130822|NCT00851877|Cetuximab|cetuximab|mesh-list
84130823|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84130824|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130825|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
84130826|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
84130827|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
84130828|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130829|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84130830|NCT00613223|Etoposide|etoposide|mesh-list
84130831|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
84130832|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84130833|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130834|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84130835|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84130836|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130837|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130838|NCT00882908|Ribavirin|ribavirin|mesh-list
84130839|NCT00882908|Simeprevir|simeprevir|mesh-list
84130840|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
84130841|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130842|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
84130843|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130844|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
84130845|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130846|NCT03580967|Vortioxetine|vortioxetine|mesh-list
84130847|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
84130848|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84130849|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84130850|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84130851|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130852|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130853|NCT03580967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84130854|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84130855|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84130856|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130857|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130858|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
84130859|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84130860|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84130861|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84130862|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84130864|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84130865|NCT00851799|Darunavir|darunavir|mesh-list
84130866|NCT00851799|Tenofovir|tenofovir|mesh-list
84130867|NCT00851799|Emtricitabine|emtricitabine|mesh-list
84130868|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
84130869|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84130870|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84130871|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84130872|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
84130873|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130874|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130875|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84130876|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84130877|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
84130878|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130879|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84130880|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84130881|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84130882|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84130883|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84130884|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84130885|NCT00853047|Octreotide|octreotide|mesh-list
84130886|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130887|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130888|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130889|NCT00501826|Cytarabine|cytarabine|mesh-list
84130890|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
84130891|NCT00501826|Dexamethasone|dexamethasone|mesh-list
84130892|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
84130893|NCT00501826|Prednisone|prednisone|mesh-list
84130894|NCT00501826|Cortisone|cortisone|mesh-list
84130895|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
84130896|NCT00501826|Doxorubicin|doxorubicin|mesh-list
84130897|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84130898|NCT00501826|Methotrexate|methotrexate|mesh-list
84130899|NCT00501826|Vincristine|vincristine|mesh-list
84130900|NCT00501826|Venetoclax|venetoclax|mesh-list
84130901|NCT00501826|Asparaginase|asparaginase|mesh-list
84130902|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
84130903|NCT00501826|Pegaspargase|pegaspargase|mesh-list
84130904|NCT00501826|BB 1101|bb 1101|mesh-list
84130905|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84130906|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
84130907|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130908|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84130909|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84130910|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
84130911|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130912|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130913|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84130914|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84130915|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
84130916|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
84130917|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130918|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84130919|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
84130920|NCT00501826|Hormones|hormones|mesh-ancestor
84130921|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84130922|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84130923|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
84130924|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130925|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84130926|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84130927|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84130928|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84130929|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
84130930|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84130931|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84130932|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
84130933|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
84130934|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84130935|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84130936|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
84130937|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84130938|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84130939|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
84130940|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
84130941|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
84130942|NCT04117191|Tryptophan|tryptophan|mesh-list
84130943|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84130944|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
84130945|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84130946|NCT00520975|Paclitaxel|paclitaxel|mesh-list
84130947|NCT00520975|Bevacizumab|bevacizumab|mesh-list
84130948|NCT00520975|Carboplatin|carboplatin|mesh-list
84130949|NCT00520975|Trastuzumab|trastuzumab|mesh-list
84130950|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84130951|NCT00520975|Antibodies|antibodies|mesh-list
84130952|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
84130953|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84130954|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84130955|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130956|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
84130957|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
84130958|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
84130959|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130960|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84130961|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84130962|NCT00520975|Growth Substances|growth substances|mesh-ancestor
84130963|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130964|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
84130965|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
84130966|NCT00614159|Ketamine|ketamine|mesh-list
84130967|NCT00614159|Propofol|propofol|mesh-list
84130968|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84130969|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84130970|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130971|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84130972|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
84130973|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
84130974|NCT00614159|Analgesics|analgesics|mesh-ancestor
84130975|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
84130976|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84130977|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84130978|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84130979|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84130980|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84130981|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130982|NCT05042531|Azacitidine|azacitidine|mesh-list
84130983|NCT05042531|Dasatinib|dasatinib|mesh-list
84130984|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84130985|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
84130986|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84130987|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84130988|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84130989|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84130990|NCT00851721|Factor VIII|factor viii|mesh-list
84130991|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
84130992|NCT00851721|Coagulants|coagulants|mesh-ancestor
84130993|NCT04071119|Oxytocin|oxytocin|mesh-list
84130994|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
84130995|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84130996|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84130997|NCT02634476|Ethanol|ethanol|mesh-list
84130998|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84130999|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131000|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131001|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131002|NCT04385303|Lorecivivint|lorecivivint|mesh-list
84131003|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131004|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84131005|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84131006|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84131007|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
84131008|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131009|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84131010|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84131011|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131012|NCT00740194|Estradiol|estradiol|mesh-list
84131013|NCT00740194|Estrogens|estrogens|mesh-ancestor
84131014|NCT00740194|Hormones|hormones|mesh-ancestor
84131015|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131016|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131017|NCT04159142|Paclitaxel|paclitaxel|mesh-list
84131018|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84131019|NCT04159142|Carboplatin|carboplatin|mesh-list
84131020|NCT04159142|Capecitabine|capecitabine|mesh-list
84131021|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84131022|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131023|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
84131024|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
84131025|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131026|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131027|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84131028|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
84131029|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84131030|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131031|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84131032|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84131033|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131034|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131035|NCT00654680|Urological Agents|urological agents|mesh-ancestor
84131036|NCT00520741|Lacosamide|lacosamide|mesh-list
84131037|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
84131038|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84131039|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84131040|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131041|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131042|NCT03682289|Durvalumab|durvalumab|mesh-list
84131043|NCT03682289|Olaparib|olaparib|mesh-list
84131044|NCT03682289|Adenosine|adenosine|mesh-list
84131045|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84131046|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131047|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131048|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
84131049|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131050|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84131051|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131052|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131053|NCT03682289|Analgesics|analgesics|mesh-ancestor
84131054|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
84131055|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131056|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84131057|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131058|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84131059|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
84131060|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
84131061|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131062|NCT00729118|Lenalidomide|lenalidomide|mesh-list
84131063|NCT00729118|Vorinostat|vorinostat|mesh-list
84131064|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
84131065|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131066|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84131067|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84131068|NCT00729118|Growth Substances|growth substances|mesh-ancestor
84131069|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
84131070|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131071|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84131072|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131073|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131074|NCT04064632|Darunavir|darunavir|mesh-list
84131075|NCT04064632|Cobicistat|cobicistat|mesh-list
84131076|NCT04064632|Rilpivirine|rilpivirine|mesh-list
84131077|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
84131078|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84131079|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84131080|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
84131081|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131082|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131083|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84131084|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84131085|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
83371889|NCT01556438|Bortezomib|bortezomib|mesh-list
84131086|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131087|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84131088|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84131089|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84131090|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84131091|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
84131092|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84131093|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
84131094|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84131095|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84131096|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84131097|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131098|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131099|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
84131100|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
84131101|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131102|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84131103|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84131104|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
84131105|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131106|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131107|NCT00882362|Aripiprazole|aripiprazole|mesh-list
84131108|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
84131109|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84131110|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84131111|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84131112|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131113|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131114|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
84131115|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
84131116|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131117|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416193|NCT01517243|Sunitinib|sunitinib|mesh-list
84131118|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84131119|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84131120|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
84131121|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84131122|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84131123|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84131124|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84131125|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
84131126|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84131127|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84131128|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
84131129|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131130|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84131131|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84131132|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131133|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131134|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84131135|NCT00636935|Clindamycin|clindamycin|mesh-list
84131136|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
84131137|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
84131138|NCT00636935|Dapsone|dapsone|mesh-list
84131139|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84131140|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84131141|NCT00636935|Primaquine|primaquine|mesh-list
84131142|NCT00636935|Trimethoprim|trimethoprim|mesh-list
84131143|NCT00636935|Atovaquone|atovaquone|mesh-list
84131144|NCT00636935|Pentamidine|pentamidine|mesh-list
84131145|NCT00636935|Prednisone|prednisone|mesh-list
84131146|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131147|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
84131148|NCT00636935|Hormones|hormones|mesh-ancestor
84131149|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131150|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131151|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84131152|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131153|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131154|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
84131155|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84131156|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131157|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131158|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
83371921|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
84131159|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84131160|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84131161|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84131162|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84131163|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84131164|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84131165|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84131166|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
84131167|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
84131168|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84131169|NCT00654758|Paclitaxel|paclitaxel|mesh-list
84131170|NCT00654758|Carboplatin|carboplatin|mesh-list
84131171|NCT00654758|Volociximab|volociximab|mesh-list
84131172|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84131173|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84131174|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131175|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
84131176|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
84131177|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131178|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131179|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84131180|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84131181|NCT00654758|Growth Substances|growth substances|mesh-ancestor
84131182|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131183|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
84131184|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
84131185|NCT00656864|Pioglitazone|pioglitazone|mesh-list
84131186|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131187|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131188|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
84131189|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84131190|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131191|NCT00613613|Fenofibrate|fenofibrate|mesh-list
84131192|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84131193|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
84131194|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131195|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84131196|NCT04298099|Ropivacaine|ropivacaine|mesh-list
84131197|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
84131198|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
84131199|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131200|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131201|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
84131202|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131203|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84131204|NCT00850395|Maraviroc|maraviroc|mesh-list
84131205|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84131206|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84131207|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131208|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84131209|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84131210|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
84131211|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131212|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84131213|NCT04188431|Dexamethasone|dexamethasone|mesh-list
84131214|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131215|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
84131216|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
84131217|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131218|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131219|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84131220|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
84131221|NCT04188431|Hormones|hormones|mesh-ancestor
84131222|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131223|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84131224|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131225|NCT03630809|Vaccines|vaccines|mesh-list
84131226|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
84131227|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131228|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
84131229|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
84131230|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84131231|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131232|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131233|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84131234|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131235|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84131237|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84131238|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
84131239|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131240|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131241|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84131242|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
84131243|NCT00512707|Testosterone|testosterone|mesh-list
84131244|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131245|NCT00512707|Androgens|androgens|mesh-ancestor
84131246|NCT00512707|Hormones|hormones|mesh-ancestor
84131247|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131248|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131249|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131250|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84131251|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84131252|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131253|NCT00512707|Urological Agents|urological agents|mesh-ancestor
84131254|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84131255|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
84131256|NCT03471767|Bupropion|bupropion|mesh-list
84131257|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84131258|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
84131259|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84131260|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84131261|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84131262|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131263|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131264|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
84131265|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131266|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131267|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84131268|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84131269|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131270|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
84131271|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
84131272|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84131273|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84131274|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84131275|NCT00849693|Fluoxetine|fluoxetine|mesh-list
84131276|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84131277|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84131278|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131279|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131280|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131281|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131282|NCT00849693|Analgesics|analgesics|mesh-ancestor
84131283|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
84131284|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131285|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
84131286|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84131287|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
84131288|NCT00849693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84131289|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
84131290|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84131291|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84131292|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84131293|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131294|NCT00736606|Simvastatin|simvastatin|mesh-list
84131295|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84131296|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84131297|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
84131298|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131299|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84131300|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84131301|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131302|NCT00527605|Dutasteride|dutasteride|mesh-list
84131303|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84131304|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83372078|NCT01448707|Ritonavir|ritonavir|mesh-list
84131305|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131306|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131307|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
84131308|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131309|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131310|NCT04865939|Gemcitabine|gemcitabine|mesh-list
84131311|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84131312|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
84131313|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131314|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131315|NCT00741052|Azithromycin|azithromycin|mesh-list
84131316|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
84131317|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84131318|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131319|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84131320|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84131321|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131322|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131323|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131324|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84131325|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84131326|NCT04116411|Valganciclovir|valganciclovir|mesh-list
84131327|NCT04116411|Temozolomide|temozolomide|mesh-list
84131328|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84131329|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
84131330|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131331|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131332|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
84131333|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131334|NCT00706953|Doxorubicin|doxorubicin|mesh-list
84131335|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84131336|NCT00706953|Bortezomib|bortezomib|mesh-list
84131372|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131373|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
84131374|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131375|NCT00711412|Capecitabine|capecitabine|mesh-list
84131376|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
84131377|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84131378|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
84131379|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131380|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131381|NCT01840007|Metformin|metformin|mesh-list
84131382|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131383|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131384|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
84131385|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131386|NCT03746951|Ropivacaine|ropivacaine|mesh-list
84131387|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
84131388|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
84131389|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131390|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131391|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
84131392|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131393|NCT00577408|Naltrexone|naltrexone|mesh-list
84131394|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84131395|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84131396|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131397|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
84131398|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131399|NCT03391193|Vaccines|vaccines|mesh-list
84131400|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
84131401|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131402|NCT00741364|Vitamin D|vitamin d|mesh-list
84131403|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
84131404|NCT00741364|Vitamins|vitamins|mesh-ancestor
84131405|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
84131406|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131407|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84131408|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84131409|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84131410|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84131411|NCT03332303|Estradiol|estradiol|mesh-list
84131412|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84131413|NCT03332303|Estrogens|estrogens|mesh-ancestor
84131414|NCT03332303|Hormones|hormones|mesh-ancestor
84131415|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131416|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131417|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84131418|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
84131419|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84131420|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84131421|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84131422|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
84131423|NCT00614471|Entecavir|entecavir|mesh-list
84131424|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
84131425|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131426|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
84131427|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131428|NCT05742256|Sufentanil|sufentanil|mesh-list
84131429|NCT05742256|Oxycodone|oxycodone|mesh-list
84131430|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84131431|NCT05742256|Narcotics|narcotics|mesh-ancestor
84131432|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131433|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131434|NCT05742256|Analgesics|analgesics|mesh-ancestor
84131435|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
84131436|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131437|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84131438|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84131439|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
84131440|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
84131441|NCT00828009|Paclitaxel|paclitaxel|mesh-list
84131442|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
84131443|NCT00828009|Bevacizumab|bevacizumab|mesh-list
84131444|NCT00828009|Carboplatin|carboplatin|mesh-list
84131445|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84131446|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131447|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
84131448|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
84131449|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131450|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131451|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84131452|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
84131453|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131454|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84131455|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84131456|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
84131457|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84131458|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131459|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84131460|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84131461|NCT00828009|Growth Substances|growth substances|mesh-ancestor
84131462|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
84131463|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84131465|NCT00713596|Coagulants|coagulants|mesh-ancestor
84131466|NCT00729664|Atezolizumab|atezolizumab|mesh-list
84131467|NCT00729664|BMS-936559|bms-936559|mesh-list
84131468|NCT00729664|Antibodies|antibodies|mesh-list
84131469|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
84131470|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84131471|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
84131472|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131473|NCT00729664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84131474|NCT00729664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131475|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131476|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131477|NCT04229615|Apatinib|apatinib|mesh-list
84131478|NCT04229615|Fluzoparib|fluzoparib|mesh-list
84131479|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131480|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84131481|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131482|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131483|NCT04229615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84131484|NCT00881894|Rotigotine|rotigotine|mesh-list
84131485|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
84131486|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
84131487|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131488|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131489|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131490|NCT02638376|Riboflavin|riboflavin|mesh-list
84131491|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84131492|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84131493|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
84131494|NCT02638376|Vitamins|vitamins|mesh-ancestor
84131495|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
84131496|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131497|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84131498|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
84131499|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
84131500|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84131501|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84131502|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131503|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
84131504|NCT00827931|Coagulants|coagulants|mesh-ancestor
84131505|NCT04158674|Simendan|simendan|mesh-list
84131506|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84131507|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131508|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84131509|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84131510|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131511|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131512|NCT04158674|Protective Agents|protective agents|mesh-ancestor
84131513|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131514|NCT00526669|Capecitabine|capecitabine|mesh-list
84131515|NCT00526669|Lapatinib|lapatinib|mesh-list
84131516|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84131517|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
84131518|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131519|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131520|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84131521|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131522|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
84131523|NCT03640949|Vasopressins|vasopressins|mesh-list
84131524|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
84131525|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131526|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
84131527|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
84131528|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131529|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131530|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84131531|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
84131532|NCT03640949|Hormones|hormones|mesh-ancestor
84131533|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131534|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84131535|NCT03640949|Protective Agents|protective agents|mesh-ancestor
84131536|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
84131537|NCT03640949|Coagulants|coagulants|mesh-ancestor
84131538|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84131539|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84131540|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
84131541|NCT00827775|Carvedilol|carvedilol|mesh-list
84131542|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84131543|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84131544|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
84131545|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131546|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131547|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131548|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84131549|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
84131550|NCT00827775|Protective Agents|protective agents|mesh-ancestor
84131551|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84131552|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131553|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84131554|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131555|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84131556|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84131557|NCT02544308|Dexamethasone|dexamethasone|mesh-list
84131558|NCT02544308|Lenalidomide|lenalidomide|mesh-list
84131559|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131560|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
84131561|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
84131562|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131563|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131564|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84131565|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
84131566|NCT02544308|Hormones|hormones|mesh-ancestor
84131567|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131568|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84131569|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131570|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
84131571|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84131572|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84131573|NCT02544308|Growth Substances|growth substances|mesh-ancestor
84131574|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
84131575|NCT00707187|Tadalafil|tadalafil|mesh-list
84131576|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131577|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84131578|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84131579|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131580|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131581|NCT00707187|Urological Agents|urological agents|mesh-ancestor
84131582|NCT03998761|Progesterone|progesterone|mesh-list
84131583|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
84131584|NCT03998761|Progestins|progestins|mesh-ancestor
84131585|NCT03998761|Hormones|hormones|mesh-ancestor
84131586|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131587|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131588|NCT00658580|Etoposide|etoposide|mesh-list
84131589|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
84131590|NCT00658580|Epirubicin|epirubicin|mesh-list
84131591|NCT00658580|Ifosfamide|ifosfamide|mesh-list
84131592|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131593|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84131594|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84131595|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84131596|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131597|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131598|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84131599|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84131600|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
84131601|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84131602|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131603|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84131604|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131605|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131606|NCT03435107|Durvalumab|durvalumab|mesh-list
84131607|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131609|NCT03612791|Atezolizumab|atezolizumab|mesh-list
84131610|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131611|NCT03612791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84131612|NCT03612791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131613|NCT03612791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131614|NCT00827541|Tigecycline|tigecycline|mesh-list
84131615|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84131616|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131617|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84131618|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131619|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131620|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
84131621|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84131622|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84131623|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131624|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
84131625|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
84131626|NCT03916601|Insulin|insulin|mesh-list
84131627|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84131628|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
84131629|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
84131630|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84131631|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131632|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131633|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84131634|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84131635|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84131636|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131637|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131638|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84131639|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84131640|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84131641|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
84131642|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131643|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131644|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84131645|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84131646|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
84131647|NCT00707421|Fluorometholone|fluorometholone|mesh-list
84131648|NCT00707421|Ketorolac|ketorolac|mesh-list
84131649|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84131650|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84131651|NCT00707421|Analgesics|analgesics|mesh-ancestor
84131652|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
84131653|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131654|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131655|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131656|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84131657|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84131658|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131659|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131660|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
84131661|NCT00707421|Hormones|hormones|mesh-ancestor
84131662|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131663|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84131664|NCT03570437|Paclitaxel|paclitaxel|mesh-list
84131665|NCT03570437|Olaparib|olaparib|mesh-list
84131666|NCT03570437|Cediranib|cediranib|mesh-list
84131667|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84131668|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131669|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
84131670|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
84131671|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131672|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131673|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84131674|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131675|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84131676|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84131677|NCT00826449|Dasatinib|dasatinib|mesh-list
84131678|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131679|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84131680|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372454|NCT02130063|Iron|iron|mesh-list
84131681|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131683|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84131684|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84131685|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84131686|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84131687|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131688|NCT00825825|Citalopram|citalopram|mesh-list
84131689|NCT00825825|Escitalopram|escitalopram|mesh-list
84131690|NCT00825825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84131691|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84131692|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131693|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131694|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131695|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
84131696|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131697|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84131698|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
84131699|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84131700|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
84131701|NCT03802487|Charcoal|charcoal|mesh-list
84131702|NCT03802487|Antidotes|antidotes|mesh-ancestor
84131703|NCT03802487|Protective Agents|protective agents|mesh-ancestor
84131704|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131705|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84131706|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131707|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131708|NCT00880334|Docetaxel|docetaxel|mesh-list
84131709|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131710|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
84131711|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
84131712|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131713|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131714|NCT01033565|Melatonin|melatonin|mesh-list
84131715|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
84131716|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131717|NCT01033565|Protective Agents|protective agents|mesh-ancestor
84131718|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131719|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131720|NCT00658892|Antibodies|antibodies|mesh-list
84131721|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
84131722|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131723|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84131724|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131725|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84131726|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84131727|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131728|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131729|NCT00654914|Urological Agents|urological agents|mesh-ancestor
84131730|NCT00865566|Vaccines|vaccines|mesh-list
84131731|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
84131732|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131733|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
84131734|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131735|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131736|NCT00659048|Ciclesonide|ciclesonide|mesh-list
84131737|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
84131738|NCT00659048|Hormones|hormones|mesh-ancestor
84131739|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131740|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131741|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84131742|NCT02623920|Rituximab|rituximab|mesh-list
84131743|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84131744|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84131745|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131746|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131747|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
84131748|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131749|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84131750|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84131751|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
84131752|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131753|NCT02623920|Immunotoxins|immunotoxins|mesh-ancestor
84131754|NCT02623920|Immunoconjugates|immunoconjugates|mesh-ancestor
84131755|NCT00525499|Androgens|androgens|mesh-list
84131756|NCT00525499|Hormones|hormones|mesh-ancestor
84131757|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131758|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131759|NCT04576546|Inositol|inositol|mesh-list
84131760|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
84131761|NCT04576546|Vitamins|vitamins|mesh-ancestor
84131762|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
84131763|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131764|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
84131765|NCT02617680|Desflurane|desflurane|mesh-list
84131766|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84131767|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
84131768|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131769|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131770|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84131771|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
84131772|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84131773|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
84131774|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131775|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131776|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84131777|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
84131778|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
84131779|NCT02617680|Protective Agents|protective agents|mesh-ancestor
84131780|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84131781|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
84131782|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
84131783|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131784|NCT02568280|Insulin|insulin|mesh-list
84131785|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84131786|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
84131787|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
84131788|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84131789|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131790|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131791|NCT00525265|Tolvaptan|tolvaptan|mesh-list
84131792|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84131793|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131794|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
84131795|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131796|NCT04158830|Aspirin|aspirin|mesh-list
84131797|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84131798|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84131799|NCT04158830|Analgesics|analgesics|mesh-ancestor
84131800|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
84131801|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131802|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131803|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84131804|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84131805|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84131806|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84131807|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131808|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84131809|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84131810|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131811|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
84131812|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
84131813|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
84131814|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84131815|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131816|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131817|NCT02617758|Fentanyl|fentanyl|mesh-list
84131818|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84131819|NCT02617758|Narcotics|narcotics|mesh-ancestor
84131820|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131821|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131822|NCT02617758|Analgesics|analgesics|mesh-ancestor
84131823|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
84131824|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131825|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83372626|NCT01572038|Paclitaxel|paclitaxel|mesh-list
84131826|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84131827|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
84131828|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
84131829|NCT00737542|Lidocaine|lidocaine|mesh-list
84131830|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
84131831|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
84131832|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84131833|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131834|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
84131835|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131836|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84131837|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84131838|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84131839|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131840|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131841|NCT00865098|Cetuximab|cetuximab|mesh-list
84131842|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131843|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131844|NCT00880100|Pancrelipase|pancrelipase|mesh-list
84131845|NCT00880100|Pancreatin|pancreatin|mesh-list
84131846|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84131847|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
84131848|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
84131849|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84131850|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131851|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131852|NCT00659594|Ciclesonide|ciclesonide|mesh-list
84131853|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
84131854|NCT00659594|Hormones|hormones|mesh-ancestor
84131855|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131856|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131857|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84131858|NCT05541016|Cisplatin|cisplatin|mesh-list
84131859|NCT05541016|Docetaxel|docetaxel|mesh-list
84131860|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131861|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
84131862|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
84131863|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
84131864|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131865|NCT04158050|Omalizumab|omalizumab|mesh-list
84131866|NCT04158050|Antibodies|antibodies|mesh-list
84131867|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
84131868|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131869|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84131870|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84131871|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
84131872|NCT00659750|Ciclesonide|ciclesonide|mesh-list
84131873|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
84131874|NCT00659750|Hormones|hormones|mesh-ancestor
84131875|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84131876|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131877|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84131878|NCT00697476|Topotecan|topotecan|mesh-list
84131879|NCT00697476|Vorinostat|vorinostat|mesh-list
84131880|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84131881|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84131882|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131883|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131884|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131885|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84131886|NCT00660062|Dexetimide|dexetimide|mesh-list
84131887|NCT00660062|Citalopram|citalopram|mesh-list
84131888|NCT00660062|Nortriptyline|nortriptyline|mesh-list
84131889|NCT00660062|Escitalopram|escitalopram|mesh-list
84131890|NCT00660062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84131891|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84131892|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131893|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131894|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84131895|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
84131896|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131897|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84131898|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84131899|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
84131900|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
84131901|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84131902|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84131903|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84131905|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84131906|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
84131907|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84131908|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84131909|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84131910|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
84131911|NCT04063540|Amiloride|amiloride|mesh-list
84131912|NCT04063540|Diuretics|diuretics|mesh-ancestor
84131913|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
84131914|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131915|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
84131916|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84131917|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131918|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131919|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
84131920|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84131921|NCT04161560|Cetuximab|cetuximab|mesh-list
84131922|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84131923|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131924|NCT00518011|Gemcitabine|gemcitabine|mesh-list
84131925|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84131926|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84131927|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
84131928|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131929|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131930|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84131931|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131932|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
84131933|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
84131934|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84131935|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131936|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131937|NCT02633930|Amoxicillin|amoxicillin|mesh-list
84131938|NCT02633930|Clarithromycin|clarithromycin|mesh-list
84131939|NCT02633930|Lansoprazole|lansoprazole|mesh-list
84131940|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
84131941|NCT02633930|Bismuth|bismuth|mesh-list
84131942|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84131943|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131944|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84131945|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131946|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131947|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84131948|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84131949|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84131950|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84131951|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84131952|NCT02633930|Antacids|antacids|mesh-ancestor
84131953|NCT00698334|Rifampin|rifampin|mesh-list
84131954|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
84131955|NCT00698334|Ethambutol|ethambutol|mesh-list
84131956|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84131957|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
84131958|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84131959|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84131960|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
84131961|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84131962|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84131963|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131964|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84131965|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84131966|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84131967|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84131968|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84131969|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84131970|NCT04161482|Furosemide|furosemide|mesh-list
84131971|NCT04161482|Diuretics|diuretics|mesh-ancestor
84131972|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
84131973|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131974|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84131975|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84131976|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131978|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84131979|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131980|NCT02633696|Silybin|silybin|mesh-list
84131981|NCT02633696|Silymarin|silymarin|mesh-list
84131982|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
84131983|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84131984|NCT02633696|Protective Agents|protective agents|mesh-ancestor
84131985|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131986|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84131987|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131988|NCT02633852|Aflibercept|aflibercept|mesh-list
84131989|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84131990|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84131991|NCT02633852|Growth Substances|growth substances|mesh-ancestor
84131992|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84131993|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
84131994|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84131995|NCT02633774|Propafenone|propafenone|mesh-list
84131996|NCT02633774|Apixaban|apixaban|mesh-list
84131997|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84131998|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
84131999|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84132000|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
84132001|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132002|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132003|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
84132004|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84132005|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84132006|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84132007|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132008|NCT02633618|Neurotropin|neurotropin|mesh-list
84132009|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84132010|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
84132011|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132012|NCT02633618|Analgesics|analgesics|mesh-ancestor
84132013|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
84132014|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132015|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
84132016|NCT00865020|Telmisartan|telmisartan|mesh-list
84132017|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84132018|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84132019|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84132020|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132021|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
84132022|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132023|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
84132024|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84132025|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84132026|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132027|NCT00517933|Urological Agents|urological agents|mesh-ancestor
84132028|NCT02633384|Sorbitol|sorbitol|mesh-list
84132029|NCT02633384|SMOFlipid|smoflipid|mesh-list
84132030|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84132031|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84132032|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84132033|NCT02633384|Cathartics|cathartics|mesh-ancestor
84132034|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84132035|NCT02633462|Inositol|inositol|mesh-list
84132036|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
84132037|NCT02633462|Vitamins|vitamins|mesh-ancestor
84132038|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
84132039|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132040|NCT02638064|Surgiflo|surgiflo|mesh-list
84132041|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
84132042|NCT02638064|Coagulants|coagulants|mesh-ancestor
84132043|NCT04119336|Dexamethasone|dexamethasone|mesh-list
84132044|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
84132045|NCT04119336|Nivolumab|nivolumab|mesh-list
84132046|NCT04119336|Ixazomib|ixazomib|mesh-list
83372823|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
84132047|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132048|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
84132049|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132050|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132051|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132052|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
84132053|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132054|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132055|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84132056|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132058|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
84132059|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132060|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84132061|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
84132062|NCT04119336|Hormones|hormones|mesh-ancestor
84132063|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132064|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84132065|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132066|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84132067|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
84132068|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132069|NCT00655148|Vaccines|vaccines|mesh-list
84132070|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
84132071|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132072|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84132073|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84132074|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
84132075|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132076|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132077|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84132078|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
84132079|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
84132080|NCT00857766|Hormones|hormones|mesh-ancestor
84132081|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132082|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
84132083|NCT04161404|Metformin|metformin|mesh-list
84132084|NCT04161404|Andrographolide|andrographolide|mesh-list
84132085|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132086|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132087|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132088|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84132089|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84132090|NCT04161404|Analgesics|analgesics|mesh-ancestor
84132091|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
84132092|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132093|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132094|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84132095|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84132096|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132097|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
84132098|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84132099|NCT00517699|Cytarabine|cytarabine|mesh-list
84132100|NCT00517699|Rituximab|rituximab|mesh-list
84132101|NCT00517699|Methotrexate|methotrexate|mesh-list
84132102|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132103|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132104|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
84132105|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132106|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132107|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84132108|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
84132109|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84132110|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132111|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
84132112|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132113|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
84132114|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132115|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84132116|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132117|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84132118|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
84132119|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132120|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
84132121|NCT03096275|Hormones|hormones|mesh-ancestor
84132122|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132123|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132124|NCT04161014|Nintedanib|nintedanib|mesh-list
84132125|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132126|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84132127|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132128|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132130|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
84132131|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84132132|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84132133|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84132134|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
84132135|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132136|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84132137|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84132138|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132139|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84132140|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84132141|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84132142|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
84132143|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84132144|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132145|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84132146|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84132147|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84132148|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132149|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
84132150|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84132151|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
84132152|NCT00699504|Cangrelor|cangrelor|mesh-list
84132153|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84132154|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132155|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84132156|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84132157|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132158|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132159|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132160|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132161|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84132162|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84132163|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84132164|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84132165|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
84132166|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132167|NCT02997605|Prednisone|prednisone|mesh-list
84132168|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
84132169|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
84132170|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132171|NCT02997605|Hormones|hormones|mesh-ancestor
84132172|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132173|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132174|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84132175|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132176|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
84132177|NCT03767543|Lixisenatide|lixisenatide|mesh-list
84132178|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132179|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132180|NCT00857454|Testosterone|testosterone|mesh-list
84132181|NCT00857454|Androgens|androgens|mesh-ancestor
84132182|NCT00857454|Hormones|hormones|mesh-ancestor
84132183|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132184|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132185|NCT00660140|Carboplatin|carboplatin|mesh-list
84132186|NCT00660140|Gemcitabine|gemcitabine|mesh-list
84132187|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132188|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132189|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
84132190|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132191|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
84132192|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132193|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132194|NCT00525031|Interferons|interferons|mesh-list
84132195|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
84132196|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
84132197|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84132198|NCT00525031|Temozolomide|temozolomide|mesh-list
84132199|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132200|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
84132201|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132202|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132203|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
84132204|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132205|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
84132206|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132207|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
84132208|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
84132209|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
84132210|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132211|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132212|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84132213|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84132214|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
84132215|NCT00857220|Eszopiclone|eszopiclone|mesh-list
84132216|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84132217|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132218|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132219|NCT00524173|Tenofovir|tenofovir|mesh-list
84132220|NCT00524173|Emtricitabine|emtricitabine|mesh-list
84132221|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
84132222|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132223|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84132224|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84132225|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132226|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132227|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84132228|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84132229|NCT02704481|Misoprostol|misoprostol|mesh-list
84132230|NCT02704481|Mifepristone|mifepristone|mesh-list
84132231|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84132232|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
84132233|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84132234|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132235|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84132236|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84132237|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
84132238|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84132239|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84132240|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84132241|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84132242|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
84132243|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84132244|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84132245|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
84132246|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132247|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
84132248|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84132249|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84132250|NCT02614482|Fesoterodine|fesoterodine|mesh-list
84132251|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84132252|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84132253|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
84132254|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132255|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132256|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132257|NCT02614482|Urological Agents|urological agents|mesh-ancestor
84132258|NCT04713709|Naloxone|naloxone|mesh-list
84132259|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84132260|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132261|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
84132262|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132263|NCT00879710|Simvastatin|simvastatin|mesh-list
84132264|NCT00879710|Ezetimibe|ezetimibe|mesh-list
84132265|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84132266|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84132267|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
84132268|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132269|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84132270|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84132271|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373042|NCT04417569|Estrogens|estrogens|mesh-ancestor
84132272|NCT02703857|Cefoxitin|cefoxitin|mesh-list
84132273|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84132274|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132275|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
84132276|NCT02623062|Antacids|antacids|mesh-ancestor
84132277|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132278|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84132279|NCT00597506|Bevacizumab|bevacizumab|mesh-list
84132280|NCT00597506|Everolimus|everolimus|mesh-list
84132281|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132282|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132283|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132284|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132285|NCT00597506|Growth Substances|growth substances|mesh-ancestor
84132286|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132287|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132288|NCT00597506|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84132289|NCT00597506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84132290|NCT00597506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132291|NCT00597506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132292|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132293|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
84132294|NCT03393611|Cytarabine|cytarabine|mesh-list
84132295|NCT03393611|Fludarabine|fludarabine|mesh-list
84132296|NCT03393611|Melphalan|melphalan|mesh-list
84132297|NCT03393611|Daunorubicin|daunorubicin|mesh-list
84132298|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
84132299|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132300|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132301|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
84132302|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132303|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132304|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
84132305|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132306|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
84132307|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132308|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132309|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
84132310|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84132311|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84132312|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84132313|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84132314|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132315|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
84132316|NCT04032548|Propolis|propolis|mesh-list
84132317|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84132318|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132319|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
84132320|NCT04032236|Caffeine|caffeine|mesh-list
84132321|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84132322|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132323|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84132324|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132325|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132326|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84132327|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84132328|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
84132329|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132330|NCT02313389|Rituximab|rituximab|mesh-list
84132331|NCT02313389|Methotrexate|methotrexate|mesh-list
84132332|NCT02313389|Temozolomide|temozolomide|mesh-list
84132333|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132334|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132335|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
84132336|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132337|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132338|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84132339|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
84132340|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84132341|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132342|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
84132343|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132344|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
84132345|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132346|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84132348|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84132349|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132350|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
84132351|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84132352|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
84132353|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132354|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
84132355|NCT02632916|Denosumab|denosumab|mesh-list
84132356|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84132357|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132358|NCT00881504|Bevacizumab|bevacizumab|mesh-list
84132359|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132360|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132361|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132362|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132363|NCT00881504|Growth Substances|growth substances|mesh-ancestor
84132364|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132365|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132366|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84132367|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84132368|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84132369|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
84132370|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132371|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84132372|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84132373|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132374|NCT02131493|Gemcitabine|gemcitabine|mesh-list
84132375|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132376|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
84132377|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132378|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132379|NCT02096159|Trimethoprim|trimethoprim|mesh-list
84132380|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84132381|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
84132382|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84132383|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132384|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
84132385|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84132386|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84132387|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84132388|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132389|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132390|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84132391|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84132392|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84132393|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84132394|NCT02632136|Bupivacaine|bupivacaine|mesh-list
84132395|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
84132396|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
84132397|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132398|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132399|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
84132400|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132401|NCT00660920|Ponatinib|ponatinib|mesh-list
84132402|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132403|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84132404|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132405|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132406|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
84132407|NCT01936831|Pyridoxal|pyridoxal|mesh-list
84132408|NCT01936831|Pyridoxine|pyridoxine|mesh-list
84132409|NCT01936831|Isoniazid|isoniazid|mesh-list
84132410|NCT01936831|Vitamins|vitamins|mesh-ancestor
84132411|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
84132412|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132413|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
84132414|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
84132415|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84132416|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132417|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84132418|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84132419|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
83373195|NCT01569464|Rotigotine|rotigotine|mesh-list
84132420|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132421|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84132422|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
84132423|NCT00615173|Azathioprine|azathioprine|mesh-list
84132424|NCT00615173|Tacrolimus|tacrolimus|mesh-list
84132425|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132426|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
84132427|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132428|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132429|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132430|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
84132431|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132432|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132433|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84132434|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84132435|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132436|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
84132437|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132438|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84132439|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
84132440|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84132441|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84132442|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132443|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132444|NCT00660998|Urological Agents|urological agents|mesh-ancestor
84132445|NCT00657254|Sorafenib|sorafenib|mesh-list
84132446|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132447|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84132448|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132449|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132450|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
84132451|NCT01455389|Promethazine|promethazine|mesh-list
84132452|NCT01455389|Dexamethasone|dexamethasone|mesh-list
84132453|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84132454|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132455|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
84132456|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
84132457|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132458|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132459|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84132460|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
84132461|NCT01455389|Hormones|hormones|mesh-ancestor
84132462|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132463|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84132464|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132465|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84132466|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132467|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132468|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84132469|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84132470|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132471|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
84132472|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
84132473|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
84132474|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84132475|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
84132476|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
84132477|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132478|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84132479|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
84132480|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
84132481|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84132482|NCT00661076|Adefovir|adefovir|mesh-list
84132483|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
84132484|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
84132485|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132486|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84132487|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84132488|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132489|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132490|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
84132491|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84132492|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84132493|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
84132494|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84132495|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84132496|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132497|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132498|NCT00661700|Urological Agents|urological agents|mesh-ancestor
84132499|NCT00613769|Metronidazole|metronidazole|mesh-list
84132500|NCT00613769|Trimethoprim|trimethoprim|mesh-list
84132501|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
84132503|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
84132504|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84132505|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132506|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84132507|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84132508|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84132509|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84132510|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
84132511|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84132512|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132513|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132514|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84132515|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84132516|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84132517|NCT00661154|Bevacizumab|bevacizumab|mesh-list
84132518|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132519|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132520|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132521|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132522|NCT00661154|Growth Substances|growth substances|mesh-ancestor
84132523|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132524|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132525|NCT00523705|Escitalopram|escitalopram|mesh-list
84132526|NCT00523705|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84132527|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84132528|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132529|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132530|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132531|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
84132532|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132533|NCT00193427|Carboplatin|carboplatin|mesh-list
84132534|NCT00193427|Gemcitabine|gemcitabine|mesh-list
84132535|NCT00193427|Docetaxel|docetaxel|mesh-list
84132536|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132537|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132538|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
84132539|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132540|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
84132541|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
84132542|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
84132543|NCT00665678|Paroxetine|paroxetine|mesh-list
84132544|NCT00665678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84132545|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84132546|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132547|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132548|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132549|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
84132550|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132551|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84132552|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
84132553|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84132554|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84132555|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84132556|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132557|NCT05345327|Metformin|metformin|mesh-list
84132558|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
84132559|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132560|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132561|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84132562|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132563|NCT00523549|Amlodipine|amlodipine|mesh-list
84132564|NCT00523549|Valsartan|valsartan|mesh-list
84132565|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84132566|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83373345|NCT01547390|Analgesics|analgesics|mesh-ancestor
84132567|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132568|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132569|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84132570|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132572|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84132573|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84132574|NCT04215653|Rabeprazole|rabeprazole|mesh-list
84132575|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84132576|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84132577|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84132578|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132579|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132580|NCT02706119|Insulin|insulin|mesh-list
84132581|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84132582|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
84132583|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132584|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132585|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
84132586|NCT02631668|Hematinics|hematinics|mesh-ancestor
84132587|NCT00665756|Mitomycins|mitomycins|mesh-list
84132588|NCT00665756|Mitomycin|mitomycin|mesh-list
84132589|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84132590|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132591|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
84132592|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132593|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84132594|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132595|NCT00661856|Genistein|genistein|mesh-list
84132596|NCT00661856|Daidzein|daidzein|mesh-list
84132597|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84132598|NCT00661856|Protective Agents|protective agents|mesh-ancestor
84132599|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132600|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132601|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84132602|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132603|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132604|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
84132605|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84132606|NCT00661856|Estrogens|estrogens|mesh-ancestor
84132607|NCT00661856|Hormones|hormones|mesh-ancestor
84132608|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132609|NCT04215731|Leucovorin|leucovorin|mesh-list
84132610|NCT04215731|Bevacizumab|bevacizumab|mesh-list
84132611|NCT04215731|Fluorouracil|fluorouracil|mesh-list
84132612|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
84132613|NCT04215731|Irinotecan|irinotecan|mesh-list
84132614|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
84132615|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132616|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132617|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132618|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132619|NCT04215731|Growth Substances|growth substances|mesh-ancestor
84132620|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132621|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132622|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
84132623|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132624|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132625|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132626|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
84132627|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84132628|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84132629|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132630|NCT04215731|Antidotes|antidotes|mesh-ancestor
84132631|NCT04215731|Protective Agents|protective agents|mesh-ancestor
84132632|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
84132633|NCT04215731|Vitamins|vitamins|mesh-ancestor
84132634|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
84132635|NCT00665834|Atorvastatin|atorvastatin|mesh-list
84132636|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84132637|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84132638|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84132639|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
84132640|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373420|NCT03571191|Denosumab|denosumab|mesh-list
84132641|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84132642|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84132643|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132644|NCT02704013|Oxybutynin|oxybutynin|mesh-list
84132645|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
84132646|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
84132647|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132648|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132649|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84132650|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84132651|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
84132652|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132653|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132654|NCT02704013|Urological Agents|urological agents|mesh-ancestor
84132655|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
84132656|NCT00665990|Bevacizumab|bevacizumab|mesh-list
84132657|NCT00665990|Sorafenib|sorafenib|mesh-list
84132658|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132659|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
84132660|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132661|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132662|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132663|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
84132664|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132665|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132666|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84132667|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132668|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132669|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132670|NCT00665990|Growth Substances|growth substances|mesh-ancestor
84132671|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132672|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84132673|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132674|NCT00666068|Hormones|hormones|mesh-list
84132675|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
84132676|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
84132677|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132678|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132679|NCT00700102|Bevacizumab|bevacizumab|mesh-list
84132680|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132681|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132682|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132683|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132684|NCT00700102|Growth Substances|growth substances|mesh-ancestor
84132685|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132686|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132687|NCT02705729|Methamphetamine|methamphetamine|mesh-list
84132688|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84132689|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132690|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
84132691|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
84132692|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132693|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
84132694|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132695|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132696|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
84132697|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84132698|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84132699|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132700|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84132701|NCT02705573|Mannitol|mannitol|mesh-list
84132702|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84132703|NCT02705573|Diuretics|diuretics|mesh-ancestor
84132704|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
84132705|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132706|NCT00613847|Trastuzumab|trastuzumab|mesh-list
84132707|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
84132708|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132709|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132710|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132711|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
84132712|NCT00516295|Bevacizumab|bevacizumab|mesh-list
84132713|NCT00516295|Vincristine|vincristine|mesh-list
84132714|NCT00516295|Topotecan|topotecan|mesh-list
84132715|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84132716|NCT00516295|Antibodies|antibodies|mesh-list
84132717|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
84132718|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84132719|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132720|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
84132721|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132722|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132723|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132724|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
84132725|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132726|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132727|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84132728|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132729|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132730|NCT00516295|Growth Substances|growth substances|mesh-ancestor
84132731|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132732|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84132733|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
84132734|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
84132735|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
84132736|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84132737|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84132738|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132739|NCT03362099|Bupropion|bupropion|mesh-list
84132740|NCT03362099|Varenicline|varenicline|mesh-list
84132741|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84132742|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
84132743|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84132744|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84132745|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84132746|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132747|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132748|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
84132749|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132750|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132751|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84132752|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84132753|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132754|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84132755|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84132756|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
84132757|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
84132758|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132759|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
84132760|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84132761|NCT02705651|Somatostatin|somatostatin|mesh-list
84132762|NCT02705651|Hormones|hormones|mesh-ancestor
84132763|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132764|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132765|NCT00738088|Gliclazide|gliclazide|mesh-list
84132766|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132767|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132768|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
84132769|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84132770|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
84132771|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
84132772|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132773|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132774|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84132775|NCT02703233|Analgesics|analgesics|mesh-ancestor
84132776|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
84132777|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132778|NCT04152941|Olaparib|olaparib|mesh-list
84132779|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84132780|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132781|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132782|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132783|NCT04062760|Diuretics|diuretics|mesh-list
84132784|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
84132785|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132787|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84132788|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
84132789|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
84132790|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132791|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132792|NCT00516139|Lamotrigine|lamotrigine|mesh-list
84132793|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
84132794|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84132795|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132796|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132797|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84132798|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132799|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84132800|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84132801|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132802|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84132803|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84132804|NCT02704715|Anesthetics|anesthetics|mesh-list
84132805|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132806|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132807|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
84132808|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84132809|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84132810|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
84132811|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84132812|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84132813|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84132814|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132815|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132816|NCT00615875|Naproxen|naproxen|mesh-list
84132817|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84132818|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84132819|NCT00615875|Analgesics|analgesics|mesh-ancestor
84132820|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
84132821|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132822|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132823|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132824|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132825|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
84132826|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84132827|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132828|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132829|NCT02630888|Memantine|memantine|mesh-list
84132830|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84132831|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84132832|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
84132833|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132834|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132835|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132836|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84132837|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84132838|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
84132839|NCT00666302|Tacrolimus|tacrolimus|mesh-list
84132840|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132841|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
84132842|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132843|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84132844|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132845|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132846|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84132847|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84132848|NCT00666302|Analgesics|analgesics|mesh-ancestor
84132849|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
84132850|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132851|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132852|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132853|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
84132854|NCT00671372|Bevacizumab|bevacizumab|mesh-list
84132855|NCT00671372|Cetuximab|cetuximab|mesh-list
84132856|NCT00671372|Irinotecan|irinotecan|mesh-list
84132857|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132858|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132859|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132860|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132861|NCT00671372|Growth Substances|growth substances|mesh-ancestor
84132862|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132863|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
83373646|NCT00627861|Metoprolol|metoprolol|mesh-list
84132864|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84132865|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84132866|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132867|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132869|NCT00856986|Liraglutide|liraglutide|mesh-list
84132870|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
84132871|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84132872|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132873|NCT00856986|Incretins|incretins|mesh-ancestor
84132874|NCT00856986|Hormones|hormones|mesh-ancestor
84132875|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84132876|NCT00666692|Paclitaxel|paclitaxel|mesh-list
84132877|NCT00666692|Bevacizumab|bevacizumab|mesh-list
84132878|NCT00666692|Carboplatin|carboplatin|mesh-list
84132879|NCT00666692|Volociximab|volociximab|mesh-list
84132880|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84132881|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84132882|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132883|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
84132884|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
84132885|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
84132886|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132887|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132888|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84132889|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84132890|NCT00666692|Growth Substances|growth substances|mesh-ancestor
84132891|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132892|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
84132893|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
84132894|NCT00707746|Mipomersen|mipomersen|mesh-list
84132895|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84132896|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84132897|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
84132898|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132899|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84132900|NCT00666770|Gabapentin|gabapentin|mesh-list
84132901|NCT00666770|Analgesics|analgesics|mesh-ancestor
84132902|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
84132903|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132904|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132905|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
84132906|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84132907|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84132908|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132909|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84132910|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84132911|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84132912|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132913|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132914|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
84132915|NCT04188353|Mannitol|mannitol|mesh-list
84132916|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84132917|NCT04188353|Diuretics|diuretics|mesh-ancestor
84132918|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
84132919|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132920|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
84132921|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
84132922|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132923|NCT02630420|Cetuximab|cetuximab|mesh-list
84132924|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84132925|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132926|NCT00667082|Vorinostat|vorinostat|mesh-list
84132927|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84132928|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
84132929|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132930|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132931|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132932|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
84132933|NCT05343299|Lidocaine|lidocaine|mesh-list
84132934|NCT05343299|Ropivacaine|ropivacaine|mesh-list
84132935|NCT05343299|Anesthetics|anesthetics|mesh-list
84132936|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
84132937|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84132938|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132939|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
84132940|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132941|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84132942|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84132943|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84132944|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84132945|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132946|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
84132947|NCT00667160|Tacrolimus|tacrolimus|mesh-list
84132948|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132949|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
84132950|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132951|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84132952|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132953|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132954|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84132955|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84132956|NCT00667160|Analgesics|analgesics|mesh-ancestor
84132957|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
84132958|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84132959|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84132960|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84132961|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
84132962|NCT02701673|Pyridoxine|pyridoxine|mesh-list
84132963|NCT02701673|Gemcitabine|gemcitabine|mesh-list
84132964|NCT02701673|Azacitidine|azacitidine|mesh-list
84132965|NCT02701673|Melphalan|melphalan|mesh-list
84132966|NCT02701673|Busulfan|busulfan|mesh-list
84132967|NCT02701673|Belinostat|belinostat|mesh-list
84132968|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84132969|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
84132970|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132971|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132972|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132973|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84132974|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
84132975|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84132976|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84132977|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
84132978|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132979|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
84132980|NCT02701673|Vitamins|vitamins|mesh-ancestor
84132981|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
84132982|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84132983|NCT00522379|Rotigotine|rotigotine|mesh-list
84132984|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
84132985|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
84132986|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84132987|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132988|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84132989|NCT00856830|Carboplatin|carboplatin|mesh-list
84132990|NCT00856830|Irinotecan|irinotecan|mesh-list
84132991|NCT00856830|Etoposide|etoposide|mesh-list
84132992|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84132993|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84132994|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84132995|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84132996|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84132997|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84132998|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84132999|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84133000|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84133001|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
84133002|NCT02614404|Piperaquine|piperaquine|mesh-list
84133003|NCT02614404|Artenimol|artenimol|mesh-list
84133004|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
84133005|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133006|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84133007|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133008|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133009|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
84133010|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84133011|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84133012|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373787|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133013|NCT00522301|Sorafenib|sorafenib|mesh-list
84133014|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133015|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84133016|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133017|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133018|NCT00662636|Dasatinib|dasatinib|mesh-list
84133019|NCT00662636|Lapatinib|lapatinib|mesh-list
84133020|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133021|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84133022|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133023|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133024|NCT05726344|Lactulose|lactulose|mesh-list
84133025|NCT05726344|Bisacodyl|bisacodyl|mesh-list
84133026|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
84133027|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84133028|NCT05726344|Cathartics|cathartics|mesh-ancestor
84133029|NCT05726344|Laxatives|laxatives|mesh-ancestor
84133030|NCT00506389|Mirtazapine|mirtazapine|mesh-list
84133031|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
84133032|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133033|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84133034|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
84133035|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
84133036|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133037|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133038|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133039|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84133040|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84133041|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133042|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84133043|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84133044|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84133045|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
84133046|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84133047|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84133048|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
84133049|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84133050|NCT00667472|Ranibizumab|ranibizumab|mesh-list
84133051|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84133052|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84133053|NCT00667472|Growth Substances|growth substances|mesh-ancestor
84133054|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133055|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
84133056|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133057|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
84133058|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84133059|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133060|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133061|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84133062|NCT05705128|Analgesics|analgesics|mesh-ancestor
84133063|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
84133064|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133065|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84133066|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84133067|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84133068|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
84133069|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133070|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133071|NCT00662714|Insulin|insulin|mesh-list
84133072|NCT00662714|Repaglinide|repaglinide|mesh-list
84133073|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84133074|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
84133075|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84133076|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133077|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84133078|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
84133079|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84133080|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84133081|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133082|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133083|NCT00668018|Urological Agents|urological agents|mesh-ancestor
84133084|NCT00871338|Vaccines|vaccines|mesh-list
84133085|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84133086|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
84133087|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133088|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
84133089|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84133090|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
84133091|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133092|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
84133093|NCT04130100|Protective Agents|protective agents|mesh-ancestor
84133094|NCT00597116|Vinorelbine|vinorelbine|mesh-list
84133095|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133096|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133097|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133098|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133099|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133100|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133101|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84133102|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
84133103|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84133104|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84133105|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133106|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133107|NCT00668096|Urological Agents|urological agents|mesh-ancestor
84133108|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
84133109|NCT03252587|Deucravacitinib|deucravacitinib|mesh-list
84133110|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
84133111|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84133112|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133113|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133114|NCT02630264|Paclitaxel|paclitaxel|mesh-list
84133115|NCT02630264|Endostatins|endostatins|mesh-list
84133116|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133117|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133118|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133119|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133120|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133121|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133122|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84133123|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84133124|NCT02630264|Growth Substances|growth substances|mesh-ancestor
84133125|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133126|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
84133127|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
84133128|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
84133129|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
84133130|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
84133131|NCT00668330|Calcium|calcium|mesh-list
84133132|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84133133|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133134|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84133135|NCT00668330|Vitamins|vitamins|mesh-ancestor
84133136|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
84133137|NCT01012687|Perindopril|perindopril|mesh-list
84133138|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84133139|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
84133140|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133141|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133142|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84133143|NCT00662948|Rituximab|rituximab|mesh-list
84133144|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84133145|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133146|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
84133147|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133148|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133149|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
84133150|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84133151|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
84133152|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84133153|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
84133154|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133155|NCT00672464|Metformin|metformin|mesh-list
84133156|NCT00672464|Olanzapine|olanzapine|mesh-list
84133157|NCT00672464|Simvastatin|simvastatin|mesh-list
84133158|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84133159|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133160|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84133161|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83373937|NCT00638937|Saracatinib|saracatinib|mesh-list
84133162|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
84133163|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133164|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84133165|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84133166|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133167|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
84133168|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
84133169|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133170|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84133171|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84133172|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84133173|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133174|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133175|NCT00672464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84133176|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84133177|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84133178|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133179|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
84133180|NCT02701595|Amoxicillin|amoxicillin|mesh-list
84133181|NCT02701595|Vancomycin|vancomycin|mesh-list
84133182|NCT02701595|Gentamicins|gentamicins|mesh-list
84133183|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
84133184|NCT02701595|Penicillins|penicillins|mesh-list
84133185|NCT02701595|Penicillin G|penicillin g|mesh-list
84133186|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
84133187|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
84133188|NCT02701595|Netilmicin|netilmicin|mesh-list
84133189|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133190|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133191|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84133192|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133193|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133194|NCT00668642|Dutasteride|dutasteride|mesh-list
84133195|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84133196|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84133197|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133198|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133199|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
84133200|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84133201|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133202|NCT02698553|Bupropion|bupropion|mesh-list
84133203|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84133204|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
84133205|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133206|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84133207|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84133208|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84133209|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133210|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
84133211|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133212|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133213|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84133214|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84133215|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133216|NCT00663182|Entecavir|entecavir|mesh-list
84133217|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
84133218|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133219|NCT00616031|Paclitaxel|paclitaxel|mesh-list
84133220|NCT00616031|Carboplatin|carboplatin|mesh-list
84133221|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
84133222|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133223|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133224|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133225|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133226|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133227|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133228|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
84133229|NCT04213937|Paclitaxel|paclitaxel|mesh-list
84133230|NCT04213937|Topotecan|topotecan|mesh-list
84133231|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133232|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133233|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133234|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133235|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133236|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133237|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84133238|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83374012|NCT01570751|Insulin|insulin|mesh-list
84133239|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133240|NCT02701517|Cyclosporine|cyclosporine|mesh-list
84133241|NCT02701517|Methotrexate|methotrexate|mesh-list
84133242|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
84133243|NCT02701517|Cyclosporins|cyclosporins|mesh-list
84133244|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84133245|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
84133246|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84133247|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133248|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84133249|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
84133250|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133251|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133252|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
84133253|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133254|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84133255|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133256|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
84133257|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133258|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84133259|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
84133260|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133261|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84133262|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84133263|NCT02630108|Epirubicin|epirubicin|mesh-list
84133264|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
84133265|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84133266|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133267|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84133268|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84133269|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133270|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133271|NCT00505921|Cytarabine|cytarabine|mesh-list
84133272|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
84133273|NCT00505921|Melphalan|melphalan|mesh-list
84133274|NCT00505921|Carmustine|carmustine|mesh-list
84133275|NCT00505921|Fludarabine|fludarabine|mesh-list
84133276|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
84133277|NCT00505921|Etoposide|etoposide|mesh-list
84133278|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
84133279|NCT00505921|Molgramostim|molgramostim|mesh-list
84133280|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
84133281|NCT00505921|Sargramostim|sargramostim|mesh-list
84133282|NCT00505921|Lenograstim|lenograstim|mesh-list
84133283|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133284|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
83430212|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84133285|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133286|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133287|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84133288|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
84133289|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133290|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133291|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84133292|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84133293|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
84133294|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
84133295|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133296|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133297|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84133298|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84133299|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133300|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84133301|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84133302|NCT04729205|Mitomycins|mitomycins|mesh-list
84133303|NCT04729205|Mitomycin|mitomycin|mesh-list
84133304|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84133305|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133306|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
84133307|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133308|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84133309|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133310|NCT00669344|Rivastigmine|rivastigmine|mesh-list
84133311|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83374039|NCT02141451|Rituximab|rituximab|mesh-list
84133312|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133313|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133314|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
84133315|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133316|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133317|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84133318|NCT00669344|Protective Agents|protective agents|mesh-ancestor
84133319|NCT02701127|Niacinamide|niacinamide|mesh-list
84133321|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
84133322|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
84133323|NCT02701127|Vitamins|vitamins|mesh-ancestor
84133324|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
84133325|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133326|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84133327|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
84133328|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133329|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84133330|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
84133331|NCT02700893|Atropine|atropine|mesh-list
84133332|NCT02700893|Sufentanil|sufentanil|mesh-list
84133333|NCT02700893|Propofol|propofol|mesh-list
84133334|NCT02700893|Atracurium|atracurium|mesh-list
84133335|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84133336|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133337|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133338|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84133339|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
84133340|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
84133341|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84133342|NCT02700893|Narcotics|narcotics|mesh-ancestor
84133343|NCT02700893|Analgesics|analgesics|mesh-ancestor
84133344|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
84133345|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133346|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84133347|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84133348|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84133349|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
84133350|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84133351|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
84133352|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
84133353|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
84133354|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84133355|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84133356|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
84133357|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133358|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133359|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84133360|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84133361|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84133362|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84133363|NCT04213781|Sufentanil|sufentanil|mesh-list
84133364|NCT04213781|Propofol|propofol|mesh-list
84133365|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84133366|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133367|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133368|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84133369|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
84133370|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
84133371|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84133372|NCT04213781|Narcotics|narcotics|mesh-ancestor
84133373|NCT04213781|Analgesics|analgesics|mesh-ancestor
84133374|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
84133375|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133376|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84133377|NCT00505687|Rotigotine|rotigotine|mesh-list
84133378|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
84133379|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
84133380|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133381|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133382|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133383|NCT00669656|Vitamin D|vitamin d|mesh-list
84133384|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
84133385|NCT00669656|Vitamins|vitamins|mesh-list
84133386|NCT00669656|Vitamin E|vitamin e|mesh-list
84133387|NCT00669656|Tocopherols|tocopherols|mesh-list
84133388|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
84133389|NCT00669656|Selenium|selenium|mesh-list
84133390|NCT00669656|Lycopene|lycopene|mesh-list
84133391|NCT00669656|Daidzein|daidzein|mesh-list
84133392|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
84133393|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133394|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84133395|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84133396|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
84133397|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133398|NCT00669656|Protective Agents|protective agents|mesh-ancestor
84133399|NCT00669656|Trace Elements|trace elements|mesh-ancestor
84133400|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84133401|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84133402|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84133403|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133404|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
84133405|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84133406|NCT00669656|Estrogens|estrogens|mesh-ancestor
84133408|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84133409|NCT00672776|Paroxetine|paroxetine|mesh-list
84133410|NCT00672776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84133411|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84133412|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84133413|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133414|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133415|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
84133416|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133417|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84133418|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
84133419|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133420|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84133421|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84133422|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133423|NCT00616187|Interferons|interferons|mesh-list
84133424|NCT00616187|Interferon-beta|interferon-beta|mesh-list
84133425|NCT00616187|Atorvastatin|atorvastatin|mesh-list
84133426|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133427|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
84133428|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133429|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84133430|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84133431|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
84133432|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133433|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84133434|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84133435|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133436|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
83430216|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84133437|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133438|NCT00663338|Rotigotine|rotigotine|mesh-list
84133439|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
84133440|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
84133441|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133442|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133443|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133444|NCT02992015|Gemcitabine|gemcitabine|mesh-list
84133445|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84133446|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
84133447|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133448|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133449|NCT01009567|Cabergoline|cabergoline|mesh-list
84133450|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84133451|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84133452|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
84133453|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
84133454|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133455|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133456|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133457|NCT00669812|Cytarabine|cytarabine|mesh-list
84133458|NCT00669812|Prednisolone|prednisolone|mesh-list
84133459|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
84133460|NCT00669812|Melphalan|melphalan|mesh-list
84133461|NCT00669812|Ifosfamide|ifosfamide|mesh-list
84133462|NCT00669812|Carmustine|carmustine|mesh-list
84133463|NCT00669812|Doxorubicin|doxorubicin|mesh-list
84133464|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84133465|NCT00669812|Methotrexate|methotrexate|mesh-list
84133466|NCT00669812|Etoposide|etoposide|mesh-list
84133467|NCT00669812|Vincristine|vincristine|mesh-list
84133468|NCT00669812|Epirubicin|epirubicin|mesh-list
83374188|NCT00680823|Ropivacaine|ropivacaine|mesh-list
84133469|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133471|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133472|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133473|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84133474|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
84133475|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133476|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133477|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84133478|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84133479|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84133480|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84133481|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133482|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84133483|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
84133484|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84133485|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84133486|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
84133487|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
84133488|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84133489|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84133490|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133491|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
84133492|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133493|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133494|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133495|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133496|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84133497|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
84133498|NCT00669812|Hormones|hormones|mesh-ancestor
84133499|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84133500|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84133501|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84133502|NCT02697851|Cobicistat|cobicistat|mesh-list
84133503|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
84133504|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84133505|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
84133506|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
84133507|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84133508|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
84133509|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84133510|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133511|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84133512|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84133513|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84133514|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84133515|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84133516|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
84133517|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133518|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133519|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84133520|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84133521|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
84133522|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133523|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84133524|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84133525|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84133526|NCT02697851|Estrogens|estrogens|mesh-ancestor
84133527|NCT02697851|Hormones|hormones|mesh-ancestor
84133528|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84133529|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84133530|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
84133531|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84133532|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84133533|NCT01012843|Amoxicillin|amoxicillin|mesh-list
84133534|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
84133535|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
84133536|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84133537|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133538|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133539|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84133540|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374280|NCT00654069|Niacin|niacin|mesh-list
84133541|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133542|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
84133543|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
84133544|NCT00669890|Busulfan|busulfan|mesh-list
84133545|NCT00669890|Methotrexate|methotrexate|mesh-list
84133546|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
84133547|NCT00669890|Tacrolimus|tacrolimus|mesh-list
84133548|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
84133549|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133550|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
84133551|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133552|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133553|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84133554|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
84133555|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133556|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133557|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84133558|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84133559|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
84133560|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84133561|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84133562|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
84133563|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
84133564|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133565|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84133566|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84133567|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84133568|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84133569|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84133570|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
84133571|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133572|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133573|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84133574|NCT00669890|Immunotoxins|immunotoxins|mesh-ancestor
84133575|NCT00669890|Immunoconjugates|immunoconjugates|mesh-ancestor
84133576|NCT02697929|Neostigmine|neostigmine|mesh-list
84133577|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84133578|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133579|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133580|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
84133581|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133582|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133583|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84133584|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
84133585|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133586|NCT00505375|Abatacept|abatacept|mesh-list
84133587|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84133588|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133589|NCT00505375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84133590|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133591|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133592|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
84133593|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133594|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133595|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
84133596|NCT02700347|Allopurinol|allopurinol|mesh-list
84133597|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
84133598|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133599|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133600|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
84133601|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133602|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84133603|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
84133604|NCT02700347|Protective Agents|protective agents|mesh-ancestor
84133605|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133606|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
84133607|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133608|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133609|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
84133610|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84133611|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133612|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84133613|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
84133614|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83374338|NCT01418209|Progesterone|progesterone|mesh-list
84133615|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133616|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133617|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133618|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84133619|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
84133620|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133621|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84133622|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84133623|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133624|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133625|NCT00673088|Ropinirole|ropinirole|mesh-list
84133626|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84133627|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84133628|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
84133629|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
84133630|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133631|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133632|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133633|NCT00504829|Atorvastatin|atorvastatin|mesh-list
84133634|NCT00504829|Fenofibrate|fenofibrate|mesh-list
84133635|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84133636|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84133637|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
84133638|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133639|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84133640|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84133641|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133642|NCT02701205|Etanercept|etanercept|mesh-list
84133643|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84133644|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84133645|NCT02701205|Analgesics|analgesics|mesh-ancestor
84133646|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
84133647|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133648|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133649|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84133650|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133651|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84133652|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133653|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
84133654|NCT00670436|Paclitaxel|paclitaxel|mesh-list
84133655|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84133656|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133657|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133658|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133659|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133660|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133661|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133662|NCT02699879|Pirfenidone|pirfenidone|mesh-list
84133663|NCT02699879|Analgesics|analgesics|mesh-ancestor
84133664|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
84133665|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133666|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133667|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84133668|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84133669|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84133670|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133671|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133672|NCT02699723|Itraconazole|itraconazole|mesh-list
84133673|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
84133674|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
84133675|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133676|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84133677|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84133678|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133679|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133680|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84133681|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
84133682|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84133683|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133684|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84133685|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133686|NCT02699645|Amlodipine|amlodipine|mesh-list
84133687|NCT02699645|Telmisartan|telmisartan|mesh-list
84133688|NCT02699645|Indapamide|indapamide|mesh-list
84133689|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84133690|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84133691|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84133692|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133693|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84133694|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133695|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
84133696|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84133697|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84133698|NCT02699645|Diuretics|diuretics|mesh-ancestor
84133699|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
84133700|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84133701|NCT04152434|Erenumab|erenumab|mesh-list
84133702|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
84133703|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133704|NCT04152434|Analgesics|analgesics|mesh-ancestor
84133705|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
84133706|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133707|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133708|NCT00615797|Penicillins|penicillins|mesh-list
84133709|NCT00615797|Penicillin V|penicillin v|mesh-list
84133710|NCT00615797|Haloperidol|haloperidol|mesh-list
84133711|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
84133712|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
84133713|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84133714|NCT00615797|Antibodies|antibodies|mesh-list
84133715|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
84133716|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84133717|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
84133718|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133719|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
84133720|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
84133721|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133722|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84133723|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84133724|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84133725|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133726|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133727|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84133728|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
84133729|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133730|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133731|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84133732|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133733|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133734|NCT00705016|Fluorouracil|fluorouracil|mesh-list
84133735|NCT00705016|Cetuximab|cetuximab|mesh-list
84133736|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133737|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
84133738|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133739|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84133740|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133741|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
84133742|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133743|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84133744|NCT00595868|Varenicline|varenicline|mesh-list
84133745|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84133746|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84133747|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
84133748|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133749|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133750|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133751|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
84133752|NCT02699801|Propofol|propofol|mesh-list
84133753|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84133754|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133755|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133756|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84133757|NCT02699801|Analgesics|analgesics|mesh-ancestor
84133758|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
84133759|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133760|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84133761|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84133762|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83374487|NCT01436305|Hormones|hormones|mesh-ancestor
84133763|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
84133764|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133765|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133766|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84133767|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
84133768|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
84133769|NCT02727907|Interferons|interferons|mesh-list
84133770|NCT02727907|Interferon-beta|interferon-beta|mesh-list
84133771|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
84133772|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133773|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
84133774|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133775|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
84133776|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133777|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84133778|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84133779|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
84133780|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84133781|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84133782|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133783|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133784|NCT00663728|Urological Agents|urological agents|mesh-ancestor
84133785|NCT01009801|Doxorubicin|doxorubicin|mesh-list
84133787|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84133788|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133789|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84133790|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84133791|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133792|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133793|NCT01009801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84133794|NCT01009801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84133795|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133796|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
84133797|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133798|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84133799|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84133800|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84133801|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84133802|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133803|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133804|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133805|NCT00617045|Analgesics|analgesics|mesh-ancestor
84133806|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
84133807|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133808|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
84133809|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133810|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
84133811|NCT02629718|Paclitaxel|paclitaxel|mesh-list
84133812|NCT02629718|Carboplatin|carboplatin|mesh-list
84133813|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133814|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133815|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133816|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133817|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133818|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133819|NCT01009879|Etanercept|etanercept|mesh-list
84133820|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84133821|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84133822|NCT01009879|Analgesics|analgesics|mesh-ancestor
84133823|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
84133824|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84133825|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133826|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84133827|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84133828|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84133829|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133830|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
84133831|NCT01009957|Everolimus|everolimus|mesh-list
84133832|NCT01009957|MTOR Inhibitors|mtor inhibitors|mesh-list
84133833|NCT01009957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84133834|NCT01009957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133835|NCT01009957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133836|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84133837|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
84133838|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133839|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133840|NCT04062370|Ranibizumab|ranibizumab|mesh-list
84133841|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84133842|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84133843|NCT04062370|Growth Substances|growth substances|mesh-ancestor
84133844|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133845|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
84133846|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133847|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
84133848|NCT01015183|Astringents|astringents|mesh-ancestor
84133849|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133850|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
84133851|NCT00856284|Metformin|metformin|mesh-list
84133852|NCT00856284|Alogliptin|alogliptin|mesh-list
84133853|NCT00856284|Glipizide|glipizide|mesh-list
84133854|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84133855|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133856|NCT00856284|Incretins|incretins|mesh-ancestor
84133857|NCT00856284|Hormones|hormones|mesh-ancestor
84133858|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84133859|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84133860|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
84133861|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133862|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133863|NCT00510289|Sorafenib|sorafenib|mesh-list
84133864|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133865|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84133866|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133867|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133868|NCT01013155|Perindopril|perindopril|mesh-list
84133869|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84133870|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
84133871|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133872|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133873|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84133874|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
84133875|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133876|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133877|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84133878|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84133879|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133880|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133881|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133882|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84133883|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84133884|NCT01015339|Paclitaxel|paclitaxel|mesh-list
84133885|NCT01015339|Capecitabine|capecitabine|mesh-list
84133886|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84133887|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84133888|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
84133889|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
84133890|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
84133891|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133892|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84133893|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
84133894|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84133895|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
84133896|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133897|NCT02622906|Pasireotide|pasireotide|mesh-list
84133898|NCT02622906|Hormones|hormones|mesh-ancestor
84133899|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84133900|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133901|NCT00673556|Alefacept|alefacept|mesh-list
84133902|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
84133903|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
84133904|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133905|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84133906|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
84133907|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84133908|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84133909|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84133910|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84133911|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133913|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84133914|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
84133915|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
84133916|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133917|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133918|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84133919|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133920|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133921|NCT04061824|Olmesartan|olmesartan|mesh-list
84133922|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
84133923|NCT04061824|Giapreza|giapreza|mesh-list
84133924|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84133925|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
84133926|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
84133927|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84133928|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84133929|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
84133930|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133931|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84133932|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84133933|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133934|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84133935|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84133936|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84133937|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84133938|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
84133939|NCT04212533|Vitamin D|vitamin d|mesh-list
84133940|NCT04212533|Vitamins|vitamins|mesh-ancestor
84133941|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
84133942|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133943|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84133944|NCT04155554|Tenofovir|tenofovir|mesh-list
84133945|NCT04155554|Lamivudine|lamivudine|mesh-list
84133946|NCT04155554|Emtricitabine|emtricitabine|mesh-list
84133947|NCT04155554|Dolutegravir|dolutegravir|mesh-list
84133948|NCT04155554|Abacavir|abacavir|mesh-list
84133949|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
84133950|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
84133951|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133952|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84133953|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84133954|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133955|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133956|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84133957|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84133958|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84133959|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84133960|NCT00663884|Voglibose|voglibose|mesh-list
84133961|NCT00663884|Mitiglinide|mitiglinide|mesh-list
84133962|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84133963|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133964|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84133965|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133966|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133967|NCT00856206|Rilonacept|rilonacept|mesh-list
84133968|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84133969|NCT03997279|Amoxicillin|amoxicillin|mesh-list
84133970|NCT03997279|Metronidazole|metronidazole|mesh-list
84133971|NCT03997279|Clarithromycin|clarithromycin|mesh-list
84133972|NCT03997279|Rabeprazole|rabeprazole|mesh-list
84133973|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84133974|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84133975|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84133976|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84133977|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84133978|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133979|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133980|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84133981|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84133982|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84133983|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84133984|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84133985|NCT00920998|Z 338|z 338|mesh-list
84133986|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84133987|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84133988|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84133990|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84133991|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133992|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84133993|NCT00593112|Methylphenidate|methylphenidate|mesh-list
84133994|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84133995|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84133996|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84133997|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84133998|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84133999|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134000|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
84134001|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134002|NCT05323565|Dexamethasone|dexamethasone|mesh-list
84134003|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
84134004|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134005|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
84134006|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
84134007|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134008|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134009|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134010|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
84134011|NCT05323565|Hormones|hormones|mesh-ancestor
84134012|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134013|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84134014|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134015|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134016|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84134017|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134018|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134019|NCT05323565|Analgesics|analgesics|mesh-ancestor
84134020|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
84134021|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84134022|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84134023|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84134024|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
84134025|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134026|NCT01015495|Ranibizumab|ranibizumab|mesh-list
84134027|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84134028|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84134029|NCT01015495|Growth Substances|growth substances|mesh-ancestor
84134030|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134031|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
84134032|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134033|NCT00676286|Choline|choline|mesh-list
84134034|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
84134035|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84134036|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
84134037|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134038|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134039|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84134040|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
84134041|NCT00699894|Ondansetron|ondansetron|mesh-list
84134042|NCT00699894|Aprepitant|aprepitant|mesh-list
84134043|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
84134044|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
84134045|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134046|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134047|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134048|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
84134049|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
84134050|NCT00699894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84134051|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84134052|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
84134053|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134054|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134055|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84134056|NCT00664196|Hormones|hormones|mesh-list
84134057|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134058|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134059|NCT00616499|Gefitinib|gefitinib|mesh-list
84134060|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134061|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84134062|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134063|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134064|NCT05317936|Venetoclax|venetoclax|mesh-list
84134065|NCT05317936|Pirtobrutinib|pirtobrutinib|mesh-list
84134066|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134067|NCT05317936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84134068|NCT05317936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134069|NCT05317936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134070|NCT02614248|Protective Agents|protective agents|mesh-list
84134071|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134072|NCT00491179|Interferons|interferons|mesh-list
84134073|NCT00491179|Ribavirin|ribavirin|mesh-list
84134074|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
84134075|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
84134076|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84134077|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134078|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
84134079|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134080|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
84134081|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134082|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
84134083|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134084|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
84134085|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
84134086|NCT04502095|Levofloxacin|levofloxacin|mesh-list
84134087|NCT04502095|Ofloxacin|ofloxacin|mesh-list
84134088|NCT04502095|Trimethoprim|trimethoprim|mesh-list
84134089|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84134090|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
84134091|NCT04502095|Clindamycin|clindamycin|mesh-list
84134092|NCT04502095|Ertapenem|ertapenem|mesh-list
84134093|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
84134094|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84134095|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134096|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84134097|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84134098|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84134099|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134100|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134101|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134102|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84134103|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84134104|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84134105|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
84134106|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84134107|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84134108|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84134109|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84134110|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84134111|NCT00674102|Vadimezan|vadimezan|mesh-list
84134112|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134113|NCT00503581|Megestrol|megestrol|mesh-list
84134114|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
84134115|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84134116|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84134117|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84134118|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
84134119|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134120|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134121|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84134122|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84134123|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84134124|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134125|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
84134126|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84134127|NCT00677144|Capecitabine|capecitabine|mesh-list
84134128|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
84134129|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84134130|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
84134131|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134132|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134133|NCT00703534|Lesogaberan|lesogaberan|mesh-list
84134134|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134135|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84134136|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
84134137|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
84134138|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134139|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134140|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134141|NCT00503425|Rituximab|rituximab|mesh-list
84134142|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84134143|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134144|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
84134145|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134146|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134147|NCT00863772|Tanezumab|tanezumab|mesh-list
84134148|NCT00863772|Analgesics|analgesics|mesh-ancestor
84134149|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
84134150|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134151|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134152|NCT01010425|Hormones|hormones|mesh-list
84134153|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134154|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134155|NCT04914676|Cytarabine|cytarabine|mesh-list
84134156|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84134157|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
84134158|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134159|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134160|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
84134161|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134162|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134163|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
84134164|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134165|NCT00677300|Ritonavir|ritonavir|mesh-list
84134166|NCT00677300|Darunavir|darunavir|mesh-list
84134167|NCT00677300|Tenofovir|tenofovir|mesh-list
84134168|NCT00677300|Emtricitabine|emtricitabine|mesh-list
84134169|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
84134170|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84134171|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84134172|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
84134173|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134174|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134175|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84134176|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84134177|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
84134178|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134179|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84134180|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84134181|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84134182|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84134183|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84134184|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84134185|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84134186|NCT02628392|Firuglipel|firuglipel|mesh-list
84134187|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134188|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134189|NCT02628392|Incretins|incretins|mesh-ancestor
84134190|NCT02628392|Hormones|hormones|mesh-ancestor
84134191|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134192|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84134193|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
84134194|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134195|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134196|NCT00664586|Masoprocol|masoprocol|mesh-list
84134197|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
84134198|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134199|NCT00664586|Protective Agents|protective agents|mesh-ancestor
84134200|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134201|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84134202|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134203|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84134204|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84134205|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134206|NCT00664586|Analgesics|analgesics|mesh-ancestor
84134207|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
84134208|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134209|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134210|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134211|NCT00502801|Doripenem|doripenem|mesh-list
84134212|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84134213|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134215|NCT04154852|Adalimumab|adalimumab|mesh-list
84134216|NCT04154852|Methotrexate|methotrexate|mesh-list
84134217|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84134218|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
84134219|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134220|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134221|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84134222|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
84134223|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134224|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134225|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
84134226|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134227|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84134228|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134229|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
84134230|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134231|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84134232|NCT04154852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84134233|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134234|NCT04154852|Hematinics|hematinics|mesh-ancestor
84134235|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
84134236|NCT04154852|Vitamins|vitamins|mesh-ancestor
84134237|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
84134238|NCT00921154|Ivermectin|ivermectin|mesh-list
84134239|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84134240|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134241|NCT01015651|Remifentanil|remifentanil|mesh-list
84134242|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84134243|NCT01015651|Narcotics|narcotics|mesh-ancestor
84134244|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134245|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134246|NCT01015651|Analgesics|analgesics|mesh-ancestor
84134247|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
84134248|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134249|NCT00674414|Trastuzumab|trastuzumab|mesh-list
84134250|NCT00674414|Everolimus|everolimus|mesh-list
84134251|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84134252|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134253|NCT00674414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84134254|NCT00674414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84134255|NCT00674414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134256|NCT00674414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134257|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134258|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
84134259|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134260|NCT05570422|Cisplatin|cisplatin|mesh-list
84134261|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134262|NCT05272930|Dienogest|dienogest|mesh-list
84134263|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84134264|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
84134265|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134266|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134267|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84134268|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84134269|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84134270|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84134271|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
84134272|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134273|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84134274|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134275|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84134276|NCT00855894|Pertuzumab|pertuzumab|mesh-list
84134277|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134278|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84134279|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134280|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134281|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84134282|NCT02566096|Morphine|morphine|mesh-list
84134283|NCT02566096|Bupivacaine|bupivacaine|mesh-list
84134284|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
84134285|NCT02566096|Anesthetics|anesthetics|mesh-list
84134286|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375015|NCT01412879|Hormones|hormones|mesh-ancestor
84134287|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134288|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
84134289|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134290|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84134291|NCT02566096|Narcotics|narcotics|mesh-ancestor
84134292|NCT02566096|Analgesics|analgesics|mesh-ancestor
84134293|NCT04482244|Cannabidiol|cannabidiol|mesh-list
84134294|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
84134295|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84134296|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84134297|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
84134298|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
84134299|NCT02628860|Hematinics|hematinics|mesh-ancestor
84134300|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
84134301|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134302|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134303|NCT00855738|Topiramate|topiramate|mesh-list
84134304|NCT00855738|Pregabalin|pregabalin|mesh-list
84134305|NCT00855738|Lamotrigine|lamotrigine|mesh-list
84134306|NCT00855738|Zonisamide|zonisamide|mesh-list
84134307|NCT00855738|Gabapentin|gabapentin|mesh-list
84134308|NCT00855738|Levetiracetam|levetiracetam|mesh-list
84134309|NCT00855738|Tiagabine|tiagabine|mesh-list
84134310|NCT00855738|Analgesics|analgesics|mesh-ancestor
84134311|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
84134312|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134313|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134314|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
84134315|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84134316|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84134317|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134318|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84134319|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84134320|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84134321|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134322|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84134323|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84134324|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84134325|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134326|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
84134327|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134328|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
84134329|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84134330|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84134331|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
84134332|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84134333|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
84134334|NCT02628002|Regadenoson|regadenoson|mesh-list
84134335|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84134336|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84134337|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
84134338|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
84134339|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134340|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134341|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134342|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84134343|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
84134344|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84134345|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84134346|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134347|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134348|NCT00665054|Urological Agents|urological agents|mesh-ancestor
84134349|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
84134350|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
84134351|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134352|NCT02622672|Vitamins|vitamins|mesh-ancestor
84134353|NCT04152356|Sorafenib|sorafenib|mesh-list
84134354|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134355|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84134356|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134357|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134358|NCT04271956|Tislelizumab|tislelizumab|mesh-list
84134359|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
84134360|NCT04271956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84134361|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134362|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84134363|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134364|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134365|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
84134366|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84134367|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
84134368|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
84134369|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134370|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134371|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134372|NCT05255146|Analgesics|analgesics|mesh-ancestor
84134373|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
84134374|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134375|NCT02628080|Atovaquone|atovaquone|mesh-list
84134376|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134377|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
84134378|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84134379|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84134380|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134381|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134382|NCT00678236|Gentamicins|gentamicins|mesh-list
84134383|NCT00678236|Cimetidine|cimetidine|mesh-list
84134384|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84134385|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134386|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84134387|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
84134388|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
84134389|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134390|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134391|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134392|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84134393|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84134394|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134395|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84134396|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134397|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84134398|NCT00678314|Ropivacaine|ropivacaine|mesh-list
84134399|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
84134400|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
84134401|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134402|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134403|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
84134404|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134405|NCT02566720|Amantadine|amantadine|mesh-list
84134406|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84134407|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84134408|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
84134409|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134410|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
84134411|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134412|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134413|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134414|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134415|NCT02566720|Analgesics|analgesics|mesh-ancestor
84134416|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
84134417|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134418|NCT00675194|Capecitabine|capecitabine|mesh-list
84134419|NCT00675194|Irinotecan|irinotecan|mesh-list
84134420|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134421|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84134422|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
84134423|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134424|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84134425|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84134426|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134427|NCT00665522|Fentanyl|fentanyl|mesh-list
84134428|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84134429|NCT00665522|Narcotics|narcotics|mesh-ancestor
84134430|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134431|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134432|NCT00665522|Analgesics|analgesics|mesh-ancestor
84134433|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
84134434|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134435|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84134436|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84134437|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
84134438|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
84134439|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
84134440|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134442|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134443|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
84134444|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
84134445|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
84134446|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134447|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84134448|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
84134449|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84134450|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84134451|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134452|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134453|NCT00678704|Urological Agents|urological agents|mesh-ancestor
84134454|NCT00678782|Etanercept|etanercept|mesh-list
84134455|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84134456|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134457|NCT00678782|Analgesics|analgesics|mesh-ancestor
84134458|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
84134459|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134460|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134461|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134462|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134463|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134464|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134465|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
84134466|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
84134467|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84134468|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134469|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134470|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134471|NCT04061200|Empagliflozin|empagliflozin|mesh-list
84134472|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84134473|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134474|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134475|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134476|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
84134477|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84134478|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134479|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84134480|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134481|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134482|NCT02565862|Metformin|metformin|mesh-list
84134483|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134484|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134485|NCT04060888|Ustekinumab|ustekinumab|mesh-list
84134486|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
84134487|NCT00879398|Fesoterodine|fesoterodine|mesh-list
84134488|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84134489|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84134490|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
84134491|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134492|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134493|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134494|NCT00879398|Urological Agents|urological agents|mesh-ancestor
84134495|NCT00679250|Cetirizine|cetirizine|mesh-list
84134496|NCT00679250|Levocetirizine|levocetirizine|mesh-list
84134497|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84134498|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84134499|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
84134500|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
84134501|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134502|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134503|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134504|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84134505|NCT00696436|Valsartan|valsartan|mesh-list
84134506|NCT00696436|Olmesartan|olmesartan|mesh-list
84134507|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84134508|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84134509|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84134510|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84134511|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134512|NCT00878072|Famciclovir|famciclovir|mesh-list
84134513|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
84134514|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134515|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84134516|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134517|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134518|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
84134519|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134520|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134521|NCT03045341|Naltrexone|naltrexone|mesh-list
84134522|NCT03045341|Bupropion|bupropion|mesh-list
84134523|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84134524|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84134525|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134526|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
84134527|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134528|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84134529|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
84134530|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84134531|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84134532|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84134533|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84134534|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134535|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
84134536|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134537|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84134538|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84134539|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134540|NCT00679484|Candesartan|candesartan|mesh-list
84134541|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
84134542|NCT00679484|Olmesartan|olmesartan|mesh-list
84134543|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84134544|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84134545|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84134546|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84134547|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134548|NCT00679640|Candesartan|candesartan|mesh-list
84134549|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84134550|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84134551|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84134552|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134553|NCT00921388|Varenicline|varenicline|mesh-list
84134554|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84134555|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84134556|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
84134557|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134558|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134559|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134560|NCT04212065|Buprenorphine|buprenorphine|mesh-list
84134561|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84134562|NCT04212065|Narcotics|narcotics|mesh-ancestor
84134563|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134564|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134565|NCT04212065|Analgesics|analgesics|mesh-ancestor
84134566|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
84134567|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134568|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84134569|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
84134570|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84134571|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84134572|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
84134573|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84134574|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84134575|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134576|NCT00617513|Prucalopride|prucalopride|mesh-list
84134577|NCT00617513|Laxatives|laxatives|mesh-ancestor
84134578|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134579|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
84134580|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84134581|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
84134582|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134583|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134584|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134585|NCT02627222|Vitamin A|vitamin a|mesh-list
84134586|NCT02627222|Provitamins|provitamins|mesh-list
84134587|NCT02627222|Vitamins|vitamins|mesh-ancestor
84134588|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
84134589|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134590|NCT00684476|Immunomodulating Agents|immunomodulating agents|mesh-list
84134591|NCT00684476|Immunologic Factors|immunologic factors|mesh-ancestor
84134592|NCT00684476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134593|NCT00594854|Diclofenac|diclofenac|mesh-list
84134594|NCT00594854|Arthrotec|arthrotec|mesh-list
84134595|NCT00594854|Misoprostol|misoprostol|mesh-list
84134596|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84134597|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
84134598|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134599|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134600|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84134601|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134602|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
84134603|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84134604|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134605|NCT00594854|Analgesics|analgesics|mesh-ancestor
84134606|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
84134607|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134608|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134609|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134610|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84134611|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134612|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134613|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84134614|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84134615|NCT00684632|Fentanyl|fentanyl|mesh-list
84134616|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84134617|NCT00684632|Narcotics|narcotics|mesh-ancestor
84134618|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134619|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134620|NCT00684632|Analgesics|analgesics|mesh-ancestor
84134621|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
84134622|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134623|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84134624|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84134625|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
84134626|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
84134627|NCT00855582|Tadalafil|tadalafil|mesh-list
84134628|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
84134629|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84134630|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84134631|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134632|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134633|NCT00855582|Urological Agents|urological agents|mesh-ancestor
84134634|NCT00619541|Fluorouracil|fluorouracil|mesh-list
84134635|NCT00619541|Sorafenib|sorafenib|mesh-list
84134636|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
84134637|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134638|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84134639|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134640|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134641|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
84134642|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134643|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84134644|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134645|NCT00680498|Ranibizumab|ranibizumab|mesh-list
84134646|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84134647|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84134648|NCT00680498|Growth Substances|growth substances|mesh-ancestor
84134649|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134650|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
84134651|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134652|NCT00684866|Albuterol|albuterol|mesh-list
84134653|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84134654|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
84134655|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134656|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134657|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84134658|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
84134659|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
84134660|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134661|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84134662|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84134663|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84134664|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
84134665|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134666|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134668|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
84134669|NCT00619697|Insulin|insulin|mesh-list
84134670|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84134671|NCT00619697|Metformin|metformin|mesh-list
84134672|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
84134673|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
84134674|NCT00619697|Glimepiride|glimepiride|mesh-list
84134675|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
84134676|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84134677|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134678|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134679|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84134680|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134681|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
84134682|NCT00680654|Riociguat|riociguat|mesh-list
84134683|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
84134684|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134685|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84134686|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84134687|NCT00680732|Folic Acid|folic acid|mesh-list
84134688|NCT00680732|Micronutrients|micronutrients|mesh-list
84134689|NCT00680732|Trace Elements|trace elements|mesh-list
84134690|NCT00680732|Chloroquine|chloroquine|mesh-list
84134691|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
84134692|NCT00680732|Hematinics|hematinics|mesh-ancestor
84134693|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
84134694|NCT00680732|Vitamins|vitamins|mesh-ancestor
84134695|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134696|NCT00680732|Amebicides|amebicides|mesh-ancestor
84134697|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84134698|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84134699|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134700|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
84134701|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134702|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84134703|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134704|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134705|NCT00698932|Saxagliptin|saxagliptin|mesh-list
84134706|NCT00698932|Incretins|incretins|mesh-ancestor
84134707|NCT00698932|Hormones|hormones|mesh-ancestor
84134708|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134709|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134710|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84134711|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
84134712|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134713|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134714|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84134715|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
84134716|NCT02566252|Albuterol|albuterol|mesh-list
84134717|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
84134718|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84134719|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
84134720|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134721|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134722|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84134723|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
84134724|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
84134725|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134726|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84134727|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84134728|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84134729|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
84134730|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134731|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134732|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
84134733|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
84134734|NCT02566252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84134735|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134736|NCT00823719|Ofatumumab|ofatumumab|mesh-list
84134737|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84134738|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134739|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
84134740|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134741|NCT03953170|Teduglutide|teduglutide|mesh-list
84134742|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134743|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84134744|NCT03953170|Protective Agents|protective agents|mesh-ancestor
84134745|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134746|NCT00708591|Sirolimus|sirolimus|mesh-list
84134747|NCT00708591|Ketoconazole|ketoconazole|mesh-list
84134748|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84134749|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134750|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84134751|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134752|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
84134753|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134754|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
84134755|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134756|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134757|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134758|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84134759|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84134760|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84134761|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
84134762|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134763|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84134764|NCT04595266|Leucovorin|leucovorin|mesh-list
84134765|NCT04595266|Bevacizumab|bevacizumab|mesh-list
84134766|NCT04595266|Fluorouracil|fluorouracil|mesh-list
84134767|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
84134768|NCT04595266|Irinotecan|irinotecan|mesh-list
84134769|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84134770|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134771|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84134772|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84134773|NCT04595266|Growth Substances|growth substances|mesh-ancestor
84134774|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134775|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
84134776|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
84134777|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134778|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84134779|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134780|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
84134781|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84134782|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84134783|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134784|NCT04595266|Antidotes|antidotes|mesh-ancestor
84134785|NCT04595266|Protective Agents|protective agents|mesh-ancestor
84134786|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
84134787|NCT04595266|Vitamins|vitamins|mesh-ancestor
84134788|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
84134789|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
84134790|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84134791|NCT00708747|Antibodies|antibodies|mesh-list
84134792|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
84134793|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134794|NCT00685022|Albuterol|albuterol|mesh-list
84134795|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84134796|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
84134797|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134798|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134799|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84134800|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
84134801|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
84134802|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134803|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84134804|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84134805|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84134806|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
84134807|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134808|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134809|NCT03787264|Venetoclax|venetoclax|mesh-list
84134810|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84134811|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
84134812|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
83375542|NCT01431521|Pioglitazone|pioglitazone|mesh-list
84134813|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134814|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84134815|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
84134816|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134817|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84134819|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
84134820|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134821|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
84134822|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84134823|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84134824|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
84134825|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134826|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134827|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134828|NCT00685100|Triamcinolone|triamcinolone|mesh-list
84134829|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134830|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
84134831|NCT00685100|Hormones|hormones|mesh-ancestor
84134832|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134833|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134834|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
84134835|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84134836|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134837|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84134838|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84134839|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134840|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134841|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134842|NCT00637091|Irinotecan|irinotecan|mesh-list
84134843|NCT00637091|Cetuximab|cetuximab|mesh-list
84134844|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84134845|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84134846|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134847|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134848|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134849|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84134850|NCT04213391|Sulforaphane|sulforaphane|mesh-list
84134851|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84134852|NCT04213391|Protective Agents|protective agents|mesh-ancestor
84134853|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134854|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134855|NCT00709137|Amiloride|amiloride|mesh-list
84134856|NCT00709137|Spironolactone|spironolactone|mesh-list
84134857|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84134858|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
84134859|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134860|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134861|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84134862|NCT00709137|Diuretics|diuretics|mesh-ancestor
84134863|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
84134864|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
84134865|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84134866|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84134867|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134868|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
84134869|NCT04150172|Rebamipide|rebamipide|mesh-list
84134870|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84134871|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134872|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
84134873|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134874|NCT04150172|Protective Agents|protective agents|mesh-ancestor
84134875|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134876|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134877|NCT02325011|Fluconazole|fluconazole|mesh-list
84134878|NCT02325011|Nabiximols|nabiximols|mesh-list
84134879|NCT02325011|Dronabinol|dronabinol|mesh-list
84134880|NCT02325011|Cannabidiol|cannabidiol|mesh-list
84134881|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
84134882|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134883|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84134884|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84134885|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134886|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134887|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84134888|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
84134889|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134890|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134891|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84134892|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84134893|NCT02325011|Analgesics|analgesics|mesh-ancestor
84134894|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
84134895|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134896|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
84134897|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
84134898|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84134899|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134900|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84134901|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84134902|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134903|NCT02325011|Hormones|hormones|mesh-ancestor
84134904|NCT00577096|Thalidomide|thalidomide|mesh-list
84134905|NCT00577096|Dexamethasone|dexamethasone|mesh-list
84134906|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
84134907|NCT00577096|Melphalan|melphalan|mesh-list
84134908|NCT00577096|Cisplatin|cisplatin|mesh-list
84134909|NCT00577096|Doxorubicin|doxorubicin|mesh-list
84134910|NCT00577096|Etoposide|etoposide|mesh-list
84134911|NCT00577096|Vincristine|vincristine|mesh-list
84134912|NCT00577096|Heparin|heparin|mesh-list
84134913|NCT00577096|Calcium heparin|calcium heparin|mesh-list
84134914|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84134915|NCT00577096|Tinzaparin|tinzaparin|mesh-list
84134916|NCT00577096|Dalteparin|dalteparin|mesh-list
84134917|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
84134918|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84134919|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
84134920|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134921|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134922|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84134923|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
84134924|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134925|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84134926|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84134927|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134928|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
84134929|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
84134930|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134931|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84134932|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
84134933|NCT00577096|Hormones|hormones|mesh-ancestor
84134934|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84134935|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84134936|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134937|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84134938|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84134939|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84134940|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84134941|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
84134942|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
84134943|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
84134944|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
84134945|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84134946|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84134947|NCT00577096|Hematinics|hematinics|mesh-ancestor
84134948|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
84134949|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84134950|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84134951|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84134952|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84134953|NCT00577096|Growth Substances|growth substances|mesh-ancestor
84134954|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
84134955|NCT02625506|Tramadol|tramadol|mesh-list
84134956|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
84134957|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84134958|NCT02625506|Narcotics|narcotics|mesh-ancestor
84134959|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84134960|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134961|NCT02625506|Analgesics|analgesics|mesh-ancestor
84134962|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
84134963|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134964|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
84134965|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
84134966|NCT04209959|Nifekalant|nifekalant|mesh-list
84134967|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84134968|NCT04209803|Minoxidil|minoxidil|mesh-list
84134969|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84134970|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
84134971|NCT02567032|Oxytocin|oxytocin|mesh-list
84134972|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
84134973|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84134974|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134975|NCT00618059|Pilocarpine|pilocarpine|mesh-list
84134976|NCT00618059|Miotics|miotics|mesh-ancestor
84134977|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
84134978|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134979|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134980|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84134981|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84134982|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
84134983|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84134984|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134985|NCT00863304|Naproxen|naproxen|mesh-list
84134986|NCT00863304|Tanezumab|tanezumab|mesh-list
84134987|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84134988|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84134989|NCT00863304|Analgesics|analgesics|mesh-ancestor
84134990|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
84134991|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84134992|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84134993|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84134994|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84134995|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
84134996|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84134997|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84134998|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84134999|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
84135000|NCT00695110|Testosterone|testosterone|mesh-list
84135001|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
84135002|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
84135003|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84135004|NCT00695110|Androgens|androgens|mesh-ancestor
84135005|NCT00695110|Hormones|hormones|mesh-ancestor
84135006|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135007|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135008|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84135009|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135010|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
84135011|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
84135012|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84135013|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135014|NCT03374332|Immunotoxins|immunotoxins|mesh-ancestor
84135015|NCT03374332|Immunoconjugates|immunoconjugates|mesh-ancestor
84135016|NCT03374332|Immunologic Factors|immunologic factors|mesh-ancestor
84135017|NCT03374332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135018|NCT03264352|Amlodipine|amlodipine|mesh-list
84135019|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84135020|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84135021|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84135022|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135023|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84135024|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135025|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
84135026|NCT04897919|Lumefantrine|lumefantrine|mesh-list
84135027|NCT04897919|Artemether|artemether|mesh-list
84135028|NCT04897919|Piperaquine|piperaquine|mesh-list
84135029|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84135030|NCT04897919|Artenimol|artenimol|mesh-list
84135031|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
84135032|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84135033|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84135034|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135035|NCT00594386|Rotigotine|rotigotine|mesh-list
84135036|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
84135037|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
84135038|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135039|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135040|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135041|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84135042|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
84135043|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84135044|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84135045|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84135046|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84135047|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135048|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
84135049|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135050|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135051|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84135052|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135053|NCT03466450|Temozolomide|temozolomide|mesh-list
84135054|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84135055|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
84135056|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135057|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135058|NCT00690560|Prednisone|prednisone|mesh-list
84135059|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
84135060|NCT00690560|Rituximab|rituximab|mesh-list
84135061|NCT00690560|Doxorubicin|doxorubicin|mesh-list
84135062|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84135063|NCT00690560|Vincristine|vincristine|mesh-list
84135064|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135065|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
84135066|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135067|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135068|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84135069|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
84135070|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135071|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135072|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84135073|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84135074|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84135075|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84135076|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84135077|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135078|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135079|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
84135080|NCT00690560|Hormones|hormones|mesh-ancestor
84135081|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135082|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84135083|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84135084|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135085|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135086|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135087|NCT00742690|Terlipressin|terlipressin|mesh-list
84135088|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84135089|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84135090|NCT00742768|Vitamins|vitamins|mesh-list
84135091|NCT00742768|Vitamin K|vitamin k|mesh-list
84135092|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
84135093|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
84135094|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135095|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84135096|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84135097|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135098|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
84135099|NCT00742768|Coagulants|coagulants|mesh-ancestor
84135100|NCT00862992|Cariprazine|cariprazine|mesh-list
84135101|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84135102|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84135103|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135104|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135105|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135106|NCT02565316|Sertraline|sertraline|mesh-list
84135107|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
84135108|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135109|NCT02565316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84135110|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84135111|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84135112|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135113|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135114|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
84135115|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135116|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84135117|NCT00742846|Triamcinolone|triamcinolone|mesh-list
84135118|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84135120|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84135121|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
84135122|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
84135123|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135124|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135125|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
84135126|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135127|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84135128|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84135129|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84135130|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84135131|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135132|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135133|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
84135134|NCT00742846|Hormones|hormones|mesh-ancestor
84135135|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135136|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135137|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
84135138|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135139|NCT00690872|Carboplatin|carboplatin|mesh-list
84135140|NCT00690872|Gemcitabine|gemcitabine|mesh-list
84135141|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135142|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84135143|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
84135144|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135145|NCT00694096|Sunitinib|sunitinib|mesh-list
84135146|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135147|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84135148|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84135149|NCT00694096|Growth Substances|growth substances|mesh-ancestor
84135150|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135151|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
84135152|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84135153|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135154|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135155|NCT04808531|Oxycodone|oxycodone|mesh-list
84135156|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84135157|NCT04808531|Narcotics|narcotics|mesh-ancestor
84135158|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135159|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135160|NCT04808531|Analgesics|analgesics|mesh-ancestor
84135161|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
84135162|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135163|NCT00690950|Dutasteride|dutasteride|mesh-list
84135164|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84135165|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84135166|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135167|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135168|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
84135169|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135170|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135171|NCT02622126|Atropine|atropine|mesh-list
84135172|NCT02622126|Ephedrine|ephedrine|mesh-list
84135173|NCT02622126|Morphine|morphine|mesh-list
84135174|NCT02622126|Bupivacaine|bupivacaine|mesh-list
84135175|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
84135176|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
84135177|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135178|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135179|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
84135180|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135181|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84135182|NCT02622126|Narcotics|narcotics|mesh-ancestor
84135183|NCT02622126|Analgesics|analgesics|mesh-ancestor
84135184|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84135185|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84135186|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84135187|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
84135188|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84135189|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
84135190|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
84135191|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
83375914|NCT05087706|Leuprolide|leuprolide|mesh-list
84135192|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84135193|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84135194|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
84135195|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135196|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135197|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84135198|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
84135199|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84135200|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
84135201|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
84135202|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84135203|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135204|NCT00685568|Celecoxib|celecoxib|mesh-list
84135205|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84135206|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84135207|NCT00685568|Analgesics|analgesics|mesh-ancestor
84135208|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
84135209|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135210|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135211|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135212|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135213|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84135214|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84135215|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135216|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135217|NCT02626208|ST 1435|st 1435|mesh-list
84135218|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
84135219|NCT02626208|Estradiol|estradiol|mesh-list
84135220|NCT02626208|Estrogens|estrogens|mesh-ancestor
84135221|NCT02626208|Hormones|hormones|mesh-ancestor
84135222|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135223|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135224|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84135225|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84135226|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84135227|NCT04210739|Betamethasone|betamethasone|mesh-list
84135228|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
84135229|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84135230|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
84135231|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84135232|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
84135233|NCT04210739|Hormones|hormones|mesh-ancestor
84135234|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135235|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135236|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135237|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84135238|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
84135239|NCT00696540|Albuterol|albuterol|mesh-list
84135240|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84135241|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
84135242|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135243|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135244|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84135245|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
84135246|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
84135247|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84135248|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84135249|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84135250|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84135251|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
84135252|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135253|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135254|NCT04212845|Dexamethasone|dexamethasone|mesh-list
84135255|NCT04212845|Bupivacaine|bupivacaine|mesh-list
84135256|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135257|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
84135258|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
84135259|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135260|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135261|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84135262|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
84135263|NCT04212845|Hormones|hormones|mesh-ancestor
84135264|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135265|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84135266|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135267|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
84135269|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135270|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
84135271|NCT00620165|Levetiracetam|levetiracetam|mesh-list
84135272|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
84135273|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
84135274|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
84135275|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
84135276|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84135277|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135278|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
84135279|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135280|NCT00685958|Enoxaparin|enoxaparin|mesh-list
84135281|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
84135282|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84135283|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84135284|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135285|NCT04138472|Lidocaine|lidocaine|mesh-list
84135286|NCT04138472|Fentanyl|fentanyl|mesh-list
84135287|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
84135288|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
84135289|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
84135290|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135291|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135292|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
84135293|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135294|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84135295|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84135296|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84135297|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84135298|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135299|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84135300|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84135301|NCT04138472|Analgesics|analgesics|mesh-ancestor
84135302|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84135303|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84135304|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84135305|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
84135306|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135307|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84135308|NCT04138472|Narcotics|narcotics|mesh-ancestor
84135309|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84135310|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84135311|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
84135312|NCT00620789|Dexetimide|dexetimide|mesh-list
84135313|NCT00620789|Citalopram|citalopram|mesh-list
84135314|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
84135315|NCT00620789|Escitalopram|escitalopram|mesh-list
84135316|NCT00620789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84135317|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84135318|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84135319|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135320|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135321|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
84135322|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135323|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84135324|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84135325|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
84135326|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
84135327|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135328|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84135329|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84135330|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
84135331|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84135332|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135333|NCT00691184|Terbinafine|terbinafine|mesh-list
84135334|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
84135335|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135336|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135337|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135338|NCT00854100|Cariprazine|cariprazine|mesh-list
84135339|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
84135340|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135341|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84135342|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84135343|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135344|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135345|NCT00691262|Tacrolimus|tacrolimus|mesh-list
84135346|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135347|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
84135348|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135349|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84135350|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135351|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135352|NCT00620867|Ibuprofen|ibuprofen|mesh-list
84135353|NCT00620867|Celecoxib|celecoxib|mesh-list
84135354|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84135355|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84135356|NCT00620867|Analgesics|analgesics|mesh-ancestor
84135357|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
84135358|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135359|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135360|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135361|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135362|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84135363|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135364|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135365|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84135366|NCT04271917|Acetaminophen|acetaminophen|mesh-list
84135367|NCT04271917|Ibuprofen|ibuprofen|mesh-list
84135368|NCT04271917|Cannabidiol|cannabidiol|mesh-list
84135369|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84135370|NCT04271917|Analgesics|analgesics|mesh-ancestor
84135371|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
84135372|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135373|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135374|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
84135375|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84135376|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135377|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135378|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84135379|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135380|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135381|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
84135382|NCT04122222|Vaccines|vaccines|mesh-list
84135383|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
84135384|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135385|NCT00686114|Paclitaxel|paclitaxel|mesh-list
84135386|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84135387|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84135388|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135389|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135390|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135391|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135392|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135393|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84135394|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135395|NCT01015729|Esomeprazole|esomeprazole|mesh-list
84135396|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135397|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135398|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84135399|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84135400|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84135401|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
84135402|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84135403|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
84135404|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84135405|NCT00698724|Prednisolone|prednisolone|mesh-list
84135406|NCT00698724|Bromfenac|bromfenac|mesh-list
84135407|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84135408|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
84135409|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135410|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
84135411|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
84135412|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135413|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135414|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84135415|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
84135416|NCT00698724|Hormones|hormones|mesh-ancestor
84135417|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135418|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84135419|NCT00698724|Protective Agents|protective agents|mesh-ancestor
84135420|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84135421|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135422|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84135423|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84135424|NCT00698724|Analgesics|analgesics|mesh-ancestor
84135425|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
84135426|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135427|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
84135429|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84135430|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135431|NCT00686192|Antacids|antacids|mesh-ancestor
84135432|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135433|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84135434|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
84135435|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84135436|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84135437|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135438|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
84135439|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
84135440|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
84135441|NCT00922610|Hematinics|hematinics|mesh-ancestor
84135442|NCT04117698|Ethambutol|ethambutol|mesh-list
84135443|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
84135444|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84135445|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135446|NCT04118322|Peppermint oil|peppermint oil|mesh-list
84135447|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
84135448|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
84135449|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135450|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135451|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84135452|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
84135453|NCT00698802|Insulin|insulin|mesh-list
84135454|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84135455|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84135456|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135457|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84135458|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
84135459|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135460|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84135461|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84135462|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135463|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135464|NCT02621970|Cisplatin|cisplatin|mesh-list
84135465|NCT02621970|Docetaxel|docetaxel|mesh-list
84135466|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135467|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135468|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135469|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135470|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135471|NCT00820755|Cetuximab|cetuximab|mesh-list
84135472|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84135473|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135474|NCT00700128|Frovatriptan|frovatriptan|mesh-list
84135475|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84135476|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
84135477|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135478|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135479|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135480|NCT04662515|Warfarin|warfarin|mesh-list
84135481|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
84135482|NCT04662515|Dabigatran|dabigatran|mesh-list
84135483|NCT04662515|Apixaban|apixaban|mesh-list
84135484|NCT04662515|Edoxaban|edoxaban|mesh-list
84135485|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
84135486|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84135487|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
84135488|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84135489|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
84135490|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135491|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135492|NCT04660097|Etoposide|etoposide|mesh-list
84135493|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
84135494|NCT04660097|Durvalumab|durvalumab|mesh-list
84135495|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84135496|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84135497|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135498|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84135499|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84135500|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135501|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135502|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84135503|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
84135504|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135506|NCT00621101|Temsirolimus|temsirolimus|mesh-list
84135507|NCT00621101|MTOR Inhibitors|mtor inhibitors|mesh-list
84135508|NCT00621101|Ezetimibe|ezetimibe|mesh-list
84135509|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84135510|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135511|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84135512|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135513|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
84135514|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135515|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
84135516|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135517|NCT00621101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84135518|NCT00621101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135519|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135520|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84135521|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84135522|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
84135523|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84135524|NCT00709215|Cordycepin|cordycepin|mesh-list
84135525|NCT00709215|Pentostatin|pentostatin|mesh-list
84135526|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135527|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
84135528|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135529|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135530|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
84135531|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135532|NCT00699036|Metformin|metformin|mesh-list
84135533|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
84135534|NCT00699036|Losartan|losartan|mesh-list
84135535|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84135536|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135537|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84135538|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84135539|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84135540|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84135541|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135542|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84135543|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
84135544|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135545|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135546|NCT00913497|Insulin|insulin|mesh-list
84135547|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84135548|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
84135549|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
84135550|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84135551|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135552|NCT00819741|Metformin|metformin|mesh-list
84135553|NCT00819741|Repaglinide|repaglinide|mesh-list
84135554|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84135555|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135556|NCT04208555|Terconazole|terconazole|mesh-list
84135557|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
84135558|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135559|NCT00621725|Cediranib|cediranib|mesh-list
84135560|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135561|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84135562|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135563|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135564|NCT00862134|Docetaxel|docetaxel|mesh-list
84135565|NCT00862134|Lenograstim|lenograstim|mesh-list
84135566|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135567|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135568|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135569|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135570|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135571|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84135572|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
84135573|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135574|NCT00700284|Dapivirine|dapivirine|mesh-list
84135575|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84135576|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84135577|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
84135578|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135579|NCT00618527|Interferons|interferons|mesh-list
84135580|NCT00618527|Interferon-beta|interferon-beta|mesh-list
84135581|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
84135582|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
84135583|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135584|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
84135585|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135586|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84135587|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84135588|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
84135589|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84135590|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135591|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135592|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
84135593|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135594|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84135595|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84135596|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84135597|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84135598|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84135599|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
84135600|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84135601|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135602|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
84135603|NCT04115982|Vitamin D|vitamin d|mesh-list
84135604|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84135605|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135606|NCT04115982|Vitamins|vitamins|mesh-ancestor
84135607|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
84135608|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84135609|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
84135610|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84135611|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84135612|NCT01010581|Folic Acid|folic acid|mesh-list
84135613|NCT01010581|Methotrexate|methotrexate|mesh-list
84135614|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84135615|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
84135616|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84135617|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135618|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84135619|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
84135620|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135621|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135622|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
84135623|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135624|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84135625|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135626|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
84135627|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135628|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84135629|NCT01010581|Hematinics|hematinics|mesh-ancestor
84135630|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
84135631|NCT01010581|Vitamins|vitamins|mesh-ancestor
84135632|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
84135633|NCT04382885|Cariprazine|cariprazine|mesh-list
84135634|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84135635|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84135636|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135637|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135638|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135639|NCT04208945|Colistin|colistin|mesh-list
84135640|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84135641|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135642|NCT01016041|Paclitaxel|paclitaxel|mesh-list
84135643|NCT01016041|Everolimus|everolimus|mesh-list
84135644|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84135645|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135646|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135647|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135648|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135649|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135650|NCT01016041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84135651|NCT01016041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84135652|NCT01016041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135653|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135654|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
84135655|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135657|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
84135658|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84135659|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84135660|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135661|NCT02696837|Rocuronium|rocuronium|mesh-list
84135662|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84135663|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84135664|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84135665|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135666|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135667|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
84135668|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84135669|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
84135670|NCT00490555|Testosterone|testosterone|mesh-list
84135671|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
84135672|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
84135673|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84135674|NCT00490555|Dutasteride|dutasteride|mesh-list
84135675|NCT00490555|Androgens|androgens|mesh-ancestor
84135676|NCT00490555|Hormones|hormones|mesh-ancestor
84135677|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135678|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135679|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84135680|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135681|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
84135682|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84135683|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84135684|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135685|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135686|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
84135687|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84135688|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84135689|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84135690|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
84135691|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84135692|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84135693|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84135694|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84135695|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
84135696|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84135697|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84135698|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135699|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84135700|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84135701|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135702|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135703|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135704|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84135705|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
84135706|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84135707|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135708|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84135709|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84135710|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84135711|NCT00049595|Prednisone|prednisone|mesh-list
84135712|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
84135713|NCT00049595|Dacarbazine|dacarbazine|mesh-list
84135714|NCT00049595|Doxorubicin|doxorubicin|mesh-list
84135715|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84135716|NCT00049595|Etoposide|etoposide|mesh-list
84135717|NCT00049595|Vincristine|vincristine|mesh-list
84135718|NCT00049595|Bleomycin|bleomycin|mesh-list
84135719|NCT00049595|Vinblastine|vinblastine|mesh-list
84135720|NCT00049595|Procarbazine|procarbazine|mesh-list
84135721|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135722|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
84135723|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135724|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135725|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84135726|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
84135727|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135728|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135729|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84135730|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84135731|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84135732|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84135733|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135734|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135735|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
84135736|NCT00049595|Hormones|hormones|mesh-ancestor
84135737|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135738|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84135739|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84135740|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135741|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135742|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135743|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84135744|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
84135745|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135746|NCT03854227|Docetaxel|docetaxel|mesh-list
84135747|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135748|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135749|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135750|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135751|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135752|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
84135753|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84135754|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135755|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135756|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135757|NCT02626754|Sunitinib|sunitinib|mesh-list
84135758|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135759|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84135760|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84135761|NCT02626754|Growth Substances|growth substances|mesh-ancestor
84135762|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135763|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
84135764|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84135765|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135766|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135767|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
84135768|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84135769|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135770|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135771|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84135772|NCT00691886|Analgesics|analgesics|mesh-ancestor
84135773|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
84135774|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135775|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84135776|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84135777|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84135778|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
84135779|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135780|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135781|NCT04138004|Lubiprostone|lubiprostone|mesh-list
84135782|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84135783|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84135784|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135785|NCT00621491|Warfarin|warfarin|mesh-list
84135786|NCT00621491|Anticoagulants|anticoagulants|mesh-list
84135787|NCT00622349|Cisplatin|cisplatin|mesh-list
84135788|NCT00622349|Gemcitabine|gemcitabine|mesh-list
84135789|NCT00622349|Docetaxel|docetaxel|mesh-list
84135790|NCT00622349|Ifosfamide|ifosfamide|mesh-list
84135791|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
84135792|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135793|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84135794|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
84135795|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376516|NCT00716079|Metoprolol|metoprolol|mesh-list
84135796|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135797|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135798|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135799|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84135800|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
84135801|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
84135802|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84135803|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84135804|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
84135805|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135806|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84135807|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
84135808|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84135809|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84135810|NCT05368181|Prednisolone|prednisolone|mesh-list
84135811|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
84135812|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84135813|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
84135814|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84135815|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
84135816|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
84135817|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135818|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135819|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84135820|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
84135821|NCT05368181|Hormones|hormones|mesh-ancestor
84135822|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135823|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84135824|NCT05368181|Protective Agents|protective agents|mesh-ancestor
84135825|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84135826|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135827|NCT05662163|Anesthetics|anesthetics|mesh-list
84135828|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135829|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135830|NCT02666105|Exemestane|exemestane|mesh-list
84135831|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135832|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84135833|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84135834|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135835|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135836|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84135837|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
84135838|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84135839|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135840|NCT04138238|Sirolimus|sirolimus|mesh-list
84135841|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84135842|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135843|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84135844|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135845|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
84135846|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135847|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
84135848|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135849|NCT00622817|Epinephrine|epinephrine|mesh-list
84135850|NCT00622817|Xylometazoline|xylometazoline|mesh-list
84135851|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84135852|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84135853|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
84135854|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135855|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135856|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135857|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84135858|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84135859|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
84135860|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135861|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84135862|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
84135863|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
84135864|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
84135865|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84135866|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
84135867|NCT02432417|Chloroquine|chloroquine|mesh-list
84135868|NCT02432417|Amebicides|amebicides|mesh-ancestor
84135869|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84135870|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84135871|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84135872|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
84135873|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135874|NCT00692120|Vitamin D|vitamin d|mesh-list
84135875|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
84135876|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
84135877|NCT00692120|Vitamins|vitamins|mesh-list
84135878|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
84135879|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135880|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84135881|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84135882|NCT00819585|Colchicine|colchicine|mesh-list
84135883|NCT00819585|Allopurinol|allopurinol|mesh-list
84135884|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84135885|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
84135886|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84135887|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
84135888|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
84135889|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
84135890|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135891|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135892|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
84135893|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135894|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84135895|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
84135896|NCT00819585|Protective Agents|protective agents|mesh-ancestor
84135897|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135898|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
84135899|NCT00687206|Valsartan|valsartan|mesh-list
84135900|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84135901|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84135902|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84135903|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135904|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
84135905|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84135906|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135907|NCT02358395|Sorafenib|sorafenib|mesh-list
84135908|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135909|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84135910|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135911|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135912|NCT00692354|Tosedostat|tosedostat|mesh-list
84135913|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135914|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135915|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
84135916|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
84135917|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135918|NCT03928847|Protective Agents|protective agents|mesh-ancestor
84135919|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135920|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84135921|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84135922|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135923|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84135924|NCT02624726|Leucovorin|leucovorin|mesh-list
84135925|NCT02624726|Fluorouracil|fluorouracil|mesh-list
84135926|NCT02624726|Irinotecan|irinotecan|mesh-list
84135927|NCT02624726|Aflibercept|aflibercept|mesh-list
84135928|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
84135929|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
84135930|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135931|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84135932|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84135933|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84135934|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
84135935|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135936|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84135937|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84135938|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135939|NCT02624726|Antidotes|antidotes|mesh-ancestor
84135940|NCT02624726|Protective Agents|protective agents|mesh-ancestor
84135941|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
84135942|NCT02624726|Vitamins|vitamins|mesh-ancestor
84135943|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
84135944|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84135945|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84135946|NCT02624726|Growth Substances|growth substances|mesh-ancestor
84135947|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
84135948|NCT00681746|Flumazenil|flumazenil|mesh-list
84135949|NCT00681746|Antidotes|antidotes|mesh-ancestor
84135950|NCT00681746|Protective Agents|protective agents|mesh-ancestor
84135951|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135952|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
84135954|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135955|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135956|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84135957|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
84135958|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135959|NCT00819039|Ondansetron|ondansetron|mesh-list
84135960|NCT00819039|Aprepitant|aprepitant|mesh-list
84135961|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
84135962|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
84135963|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84135964|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135965|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84135966|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
84135967|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
84135968|NCT00819039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84135969|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84135970|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
84135971|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135972|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135973|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84135974|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
84135975|NCT00692510|Midazolam|midazolam|mesh-list
84135976|NCT00692510|Caffeine|caffeine|mesh-list
84135977|NCT00692510|Bupropion|bupropion|mesh-list
84135978|NCT00692510|Omeprazole|omeprazole|mesh-list
84135979|NCT00692510|Bilirubin|bilirubin|mesh-list
84135980|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84135981|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84135982|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84135983|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84135984|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84135985|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84135986|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84135987|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84135988|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
84135989|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
84135990|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
84135991|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
84135992|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84135993|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84135994|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84135995|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84135996|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84135997|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84135998|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84135999|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
84136000|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84136001|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84136002|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84136003|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84136004|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
84136005|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84136006|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84136007|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136008|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
84136009|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84136010|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84136011|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84136012|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
84136013|NCT00692510|Protective Agents|protective agents|mesh-ancestor
84136014|NCT00500539|Omalizumab|omalizumab|mesh-list
84136015|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84136016|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84136017|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
84136018|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
84136019|NCT00687518|Hematinics|hematinics|mesh-ancestor
84136020|NCT02303795|Warfarin|warfarin|mesh-list
84136021|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
84136022|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
84136023|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84136024|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
84136025|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83376746|NCT02999295|Nivolumab|nivolumab|mesh-list
84136027|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136028|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136029|NCT04187417|Tetracaine|tetracaine|mesh-list
84136030|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
84136031|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
84136032|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136033|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136034|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
84136035|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136036|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84136037|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
84136038|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84136039|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84136040|NCT00818883|Diuretics|diuretics|mesh-ancestor
84136041|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
84136042|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136043|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84136044|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136045|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136046|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84136047|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84136048|NCT01014481|Tenofovir|tenofovir|mesh-list
84136049|NCT01014481|Lamivudine|lamivudine|mesh-list
84136050|NCT01014481|Efavirenz|efavirenz|mesh-list
84136051|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
84136052|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136053|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84136054|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84136055|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136056|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136057|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84136058|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84136059|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84136060|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84136061|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84136062|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84136063|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84136064|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84136065|NCT02167763|Copper|copper|mesh-list
84136066|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
84136067|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84136068|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136069|NCT02167763|Trace Elements|trace elements|mesh-ancestor
84136070|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
84136071|NCT00508027|Simvastatin|simvastatin|mesh-list
84136072|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84136073|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84136074|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
84136075|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136076|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84136077|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84136078|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136079|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84136080|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84136081|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84136082|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136083|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136084|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84136085|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84136086|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84136087|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84136088|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
84136089|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136090|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136091|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84136092|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84136093|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
84136094|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84136095|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84136096|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
84136097|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84136098|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84136099|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136100|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84136101|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84136102|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136103|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136104|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
84136105|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136106|NCT00681902|Lidocaine|lidocaine|mesh-list
84136107|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
84136108|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
84136109|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136110|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136111|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
84136112|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136113|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84136114|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84136115|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84136116|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136117|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136118|NCT04185857|Olmesartan|olmesartan|mesh-list
84136119|NCT04185857|Canrenone|canrenone|mesh-list
84136120|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84136121|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84136122|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84136123|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136124|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84136125|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
84136126|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136127|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136128|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84136129|NCT04185857|Diuretics|diuretics|mesh-ancestor
84136130|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
84136131|NCT01016509|Insulin|insulin|mesh-list
84136132|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84136133|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84136134|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136135|NCT00639119|Ropinirole|ropinirole|mesh-list
84136136|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84136137|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84136138|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
84136139|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
84136140|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136141|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136142|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136143|NCT01010893|Vaccines|vaccines|mesh-list
84136144|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
84136145|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136146|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84136147|NCT01011127|Pravastatin|pravastatin|mesh-list
84136148|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84136149|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84136150|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
84136151|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136152|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84136153|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84136154|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136155|NCT00912548|Tamoxifen|tamoxifen|mesh-list
84136156|NCT00912548|Goserelin|goserelin|mesh-list
84136157|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84136158|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
84136159|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136160|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136161|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84136162|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136163|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84136164|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84136165|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84136166|NCT01016665|Anastrozole|anastrozole|mesh-list
84136167|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84136168|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376900|NCT00725751|Ribavirin|ribavirin|mesh-list
84136169|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84136170|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84136171|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136172|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136173|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84136174|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
84136175|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136176|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136177|NCT00681980|Valproic Acid|valproic acid|mesh-list
84136178|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
84136179|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136180|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136181|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
84136182|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136183|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136184|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
84136185|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84136186|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136187|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84136188|NCT00692900|Docetaxel|docetaxel|mesh-list
84136189|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
84136190|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136191|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
84136192|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
84136193|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
84136194|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136195|NCT03800381|Rifampin|rifampin|mesh-list
84136196|NCT03800381|Isoniazid|isoniazid|mesh-list
84136197|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
84136198|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84136199|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
84136200|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84136201|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136202|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
84136203|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84136204|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136205|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136206|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84136207|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84136208|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84136209|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84136210|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84136211|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84136212|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84136213|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84136214|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
84136215|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84136216|NCT00489853|Budesonide|budesonide|mesh-list
84136217|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
84136218|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136219|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84136220|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
84136221|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136222|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136223|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84136224|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
84136225|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
84136226|NCT00489853|Hormones|hormones|mesh-ancestor
84136227|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136228|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84136229|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84136230|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84136231|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
84136232|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136233|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136234|NCT00682136|Ropivacaine|ropivacaine|mesh-list
84136235|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
84136236|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
84136237|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136238|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136239|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
84136240|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136241|NCT00693056|beta-Lactams|beta-lactams|mesh-list
83376984|NCT05001360|Nivolumab|nivolumab|mesh-list
84136242|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84136243|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136245|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136246|NCT04145336|Indomethacin|indomethacin|mesh-list
84136247|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84136248|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84136249|NCT04145336|Analgesics|analgesics|mesh-ancestor
84136250|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
84136251|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136252|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136253|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136254|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84136255|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
84136256|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
84136257|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84136258|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84136259|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136260|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136261|NCT00499681|Letrozole|letrozole|mesh-list
84136262|NCT00499681|Lapatinib|lapatinib|mesh-list
84136263|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136264|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84136265|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84136266|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136267|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136268|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84136269|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
84136270|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136271|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136272|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84136273|NCT02687009|Niclosamide|niclosamide|mesh-list
84136274|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
84136275|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84136276|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
84136277|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84136278|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136279|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
84136280|NCT00693212|Methylphenidate|methylphenidate|mesh-list
84136281|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84136282|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136283|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84136284|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84136285|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136286|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136287|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
84136288|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136289|NCT00688298|Imidacloprid|imidacloprid|mesh-list
84136290|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
84136291|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136292|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136293|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136294|NCT00499603|Paclitaxel|paclitaxel|mesh-list
84136295|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
84136296|NCT00499603|Fluorouracil|fluorouracil|mesh-list
84136297|NCT00499603|Epirubicin|epirubicin|mesh-list
84136298|NCT00499603|Everolimus|everolimus|mesh-list
84136299|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84136300|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136301|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
84136302|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
84136303|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
84136304|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136305|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136306|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
84136307|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136308|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84136309|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84136310|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
84136311|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84136312|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
84136313|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84136314|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84136315|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84136316|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84136317|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136318|NCT00499603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84136319|NCT00499603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84136320|NCT01946711|Budesonide|budesonide|mesh-list
84136321|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136322|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84136323|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
84136324|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136325|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136326|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84136327|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
84136328|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
84136329|NCT01946711|Hormones|hormones|mesh-ancestor
84136330|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136331|NCT00693446|Sirolimus|sirolimus|mesh-list
84136332|NCT00693446|Tacrolimus|tacrolimus|mesh-list
84136333|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136334|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
84136335|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136336|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84136337|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136338|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136339|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84136340|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136341|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84136342|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136343|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
84136344|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
84136345|NCT00693524|Prednisone|prednisone|mesh-list
84136346|NCT00693524|Tacrolimus|tacrolimus|mesh-list
84136347|NCT00693524|Daclizumab|daclizumab|mesh-list
84136348|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136349|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
84136350|NCT00693524|Hormones|hormones|mesh-ancestor
84136351|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136352|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136353|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84136354|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136355|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136356|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
84136357|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84136358|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136359|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136360|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84136361|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84136362|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
84136363|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84136364|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136365|NCT00693602|Asparaginase|asparaginase|mesh-list
84136366|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136367|NCT00682214|Vitamin D|vitamin d|mesh-list
84136368|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
84136369|NCT00682214|Vitamins|vitamins|mesh-ancestor
84136370|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
84136371|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136372|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84136373|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84136374|NCT04137380|Mirikizumab|mirikizumab|mesh-list
84136375|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84136376|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84136377|NCT04137380|Analgesics|analgesics|mesh-ancestor
84136378|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
84136379|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136380|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136381|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136382|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84136383|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84136384|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84136385|NCT00693680|Imipramine|imipramine|mesh-list
84136386|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84136387|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
84136388|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84136389|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84136390|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84136391|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136392|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136393|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
84136394|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136395|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136396|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
84136397|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84136398|NCT00682292|Daclizumab|daclizumab|mesh-list
84136399|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
84136400|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136401|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136402|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84136403|NCT00810069|Escitalopram|escitalopram|mesh-list
84136404|NCT00810069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84136405|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84136406|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136407|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136408|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136409|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
84136410|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136411|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136412|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
84136413|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84136414|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84136415|NCT00810069|Analgesics|analgesics|mesh-ancestor
84136416|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
84136417|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
84136418|NCT00693758|Adenosine|adenosine|mesh-list
84136419|NCT00693758|Analgesics|analgesics|mesh-ancestor
84136420|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
84136421|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136422|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136423|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84136424|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
84136425|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84136426|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
84136427|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
84136428|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136429|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136430|NCT02625740|Paclitaxel|paclitaxel|mesh-list
84136431|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84136432|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136433|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
84136434|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
84136435|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
84136436|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136437|NCT00688922|Pravastatin|pravastatin|mesh-list
84136438|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84136439|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84136440|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
84136441|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136442|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84136443|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84136444|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136445|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84136446|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84136447|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136448|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136449|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84136450|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136451|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136452|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
84136453|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136454|NCT02626364|Crenolanib|crenolanib|mesh-list
84136455|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136456|NCT00694460|Vaccines|vaccines|mesh-list
84136457|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
84136458|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136459|NCT04776525|Doxorubicin|doxorubicin|mesh-list
84136460|NCT04776525|Ifosfamide|ifosfamide|mesh-list
84136461|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84136462|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136463|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84136464|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84136465|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136466|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136467|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84136468|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
84136469|NCT00689000|Tosedostat|tosedostat|mesh-list
84136470|NCT00689000|Glycine|glycine|mesh-list
84136471|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136472|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136473|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
84136474|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136475|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136476|NCT00489541|Paclitaxel|paclitaxel|mesh-list
84136477|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84136478|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136479|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
84136480|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
84136481|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
84136482|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136483|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
84136484|NCT00689156|Docetaxel|docetaxel|mesh-list
84136485|NCT00689156|Epirubicin|epirubicin|mesh-list
84136486|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136487|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
84136488|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136489|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84136490|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84136491|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
84136492|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136493|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136494|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84136495|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
84136496|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
84136497|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
84136498|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84136499|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84136500|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84136501|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136502|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
84136503|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
84136504|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84136505|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136506|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136507|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
84136508|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84136509|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136510|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136511|NCT01016821|Oxycodone|oxycodone|mesh-list
84136512|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84136513|NCT01016821|Narcotics|narcotics|mesh-ancestor
84136514|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136515|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136516|NCT01016821|Analgesics|analgesics|mesh-ancestor
84136517|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
84136518|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136519|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
84136520|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
84136521|NCT01011205|Tacrolimus|tacrolimus|mesh-list
84136522|NCT01011205|Basiliximab|basiliximab|mesh-list
84136523|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136524|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
84136525|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136526|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84136527|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136528|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136529|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84136530|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136531|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84136532|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
84136533|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84136534|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136535|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136536|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
84136537|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
84136538|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136539|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84136540|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
84136541|NCT01011205|Hormones|hormones|mesh-ancestor
84136542|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136543|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84136544|NCT01011205|Protective Agents|protective agents|mesh-ancestor
84136545|NCT00809835|Galantamine|galantamine|mesh-list
84136546|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84136547|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136548|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136549|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
84136550|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136551|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136552|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84136553|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
84136554|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136555|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
84136557|NCT01014559|Naloxone|naloxone|mesh-list
84136558|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84136559|NCT01014559|Narcotics|narcotics|mesh-ancestor
84136560|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136561|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136562|NCT01014559|Analgesics|analgesics|mesh-ancestor
84136563|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
84136564|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136565|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84136566|NCT00853242|Sevelamer|sevelamer|mesh-list
84136567|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
84136568|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
84136569|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136570|NCT02609061|Alendronate|alendronate|mesh-list
84136571|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84136572|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136573|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
84136574|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
84136575|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136576|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
84136577|NCT00694694|Azithromycin|azithromycin|mesh-list
84136578|NCT00694694|Artesunate|artesunate|mesh-list
84136579|NCT00694694|Lumefantrine|lumefantrine|mesh-list
84136580|NCT00694694|Artemether|artemether|mesh-list
84136581|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84136582|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84136583|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136584|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
84136585|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84136586|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84136587|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136588|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
84136589|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
84136590|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84136591|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
84136592|NCT00700362|Insulin|insulin|mesh-list
84136593|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84136594|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136595|NCT04136600|Antibodies|antibodies|mesh-list
84136596|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
84136597|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136598|NCT00809757|Albuterol|albuterol|mesh-list
84136599|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84136600|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
84136601|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136602|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136603|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84136604|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
84136605|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
84136606|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84136607|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84136608|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84136609|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84136610|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
84136611|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136612|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136613|NCT00594464|Rotigotine|rotigotine|mesh-list
84136614|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
84136615|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
84136616|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136617|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136618|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136619|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
84136620|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84136621|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84136622|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84136623|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84136624|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136625|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
84136626|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136627|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136628|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84136629|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136630|NCT05326269|Terbutaline|terbutaline|mesh-list
84136631|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84136632|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
84136633|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136634|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136635|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84136636|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
84136637|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
84136638|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
84136639|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84136640|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84136641|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84136642|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84136643|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
84136644|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136645|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136646|NCT02624570|Midostaurin|midostaurin|mesh-list
84136647|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136648|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84136649|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136650|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136651|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
84136652|NCT04665453|Melatonin|melatonin|mesh-list
84136653|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84136654|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136655|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136656|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84136657|NCT04665453|Analgesics|analgesics|mesh-ancestor
84136658|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
84136659|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136660|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84136661|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84136662|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84136663|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
84136664|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136665|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136666|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
84136667|NCT04665453|Protective Agents|protective agents|mesh-ancestor
84136668|NCT00695240|Bupivacaine|bupivacaine|mesh-list
84136669|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
84136670|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
84136671|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136672|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136673|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
84136674|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136675|NCT00689702|Capecitabine|capecitabine|mesh-list
84136676|NCT00689702|Cetuximab|cetuximab|mesh-list
84136677|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84136678|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
84136679|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136680|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136681|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84136682|NCT00689780|Midazolam|midazolam|mesh-list
84136683|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84136684|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84136685|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136686|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136687|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84136688|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84136689|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84136690|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84136691|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
84136692|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
84136693|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
84136694|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
84136695|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136696|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136697|NCT00689858|Cilostazol|cilostazol|mesh-list
84136698|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84136699|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
84136700|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136701|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136702|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84136703|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
84136704|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84136705|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84136706|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136707|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84136708|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
84136709|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84136710|NCT00689858|Protective Agents|protective agents|mesh-ancestor
84136711|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84136712|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84136713|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136714|NCT00695630|Flumazenil|flumazenil|mesh-list
84136715|NCT00695630|Antidotes|antidotes|mesh-ancestor
84136716|NCT00695630|Protective Agents|protective agents|mesh-ancestor
84136717|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136718|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
84136719|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
84136720|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136721|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136722|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84136723|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84136724|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84136725|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136726|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136727|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84136728|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84136729|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84136730|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84136731|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
84136732|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136733|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136734|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84136735|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84136736|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
84136737|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84136738|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84136739|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
84136740|NCT00690014|Probenecid|probenecid|mesh-list
84136741|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
84136742|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
84136743|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84136744|NCT00683306|Gefitinib|gefitinib|mesh-list
84136745|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136746|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84136747|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136748|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136749|NCT01475123|Nicorandil|nicorandil|mesh-list
84136750|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84136751|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84136752|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
84136753|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
84136754|NCT01475123|Vitamins|vitamins|mesh-ancestor
84136755|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
84136756|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136757|NCT04135898|Bevacizumab|bevacizumab|mesh-list
84136758|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84136759|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136760|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84136761|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84136762|NCT04135898|Growth Substances|growth substances|mesh-ancestor
84136763|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136764|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
84136765|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
84136766|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
84136767|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136768|NCT00912392|Carboplatin|carboplatin|mesh-list
84136769|NCT00912392|Etoposide|etoposide|mesh-list
84136770|NCT00912392|Endostar protein|endostar protein|mesh-list
84136771|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136772|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84136773|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84136774|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84136775|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136776|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136777|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84136778|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84136779|NCT00912392|Growth Substances|growth substances|mesh-ancestor
84136780|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136781|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
84136782|NCT00690170|Ketamine|ketamine|mesh-list
84136783|NCT00690170|Nicotine|nicotine|mesh-list
84136784|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84136785|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
84136786|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84136787|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136788|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84136789|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84136790|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
84136791|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136792|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136793|NCT00690170|Analgesics|analgesics|mesh-ancestor
84136794|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
84136795|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84136796|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84136797|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
84136798|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
84136799|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84136800|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84136801|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84136802|NCT00689624|Leucovorin|leucovorin|mesh-list
84136803|NCT00689624|Fluorouracil|fluorouracil|mesh-list
84136804|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
84136805|NCT00689624|Irinotecan|irinotecan|mesh-list
84136806|NCT00689624|Cetuximab|cetuximab|mesh-list
84136807|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
84136808|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136809|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84136810|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136811|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136812|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
84136813|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136814|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84136815|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84136816|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136817|NCT00689624|Antidotes|antidotes|mesh-ancestor
84136818|NCT00689624|Protective Agents|protective agents|mesh-ancestor
84136819|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
84136820|NCT00689624|Vitamins|vitamins|mesh-ancestor
84136821|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
84136822|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84136823|NCT00696098|Butyric Acid|butyric acid|mesh-list
84136824|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
84136825|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
84136826|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136827|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136828|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136829|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
84136830|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84136831|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136832|NCT00684164|Conivaptan|conivaptan|mesh-list
84136833|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84136834|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136835|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
84136836|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136837|NCT04135508|Adalimumab|adalimumab|mesh-list
84136838|NCT04135508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84136839|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84136840|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84136841|NCT02622854|Insulin|insulin|mesh-list
84136842|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84136843|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136844|NCT02616770|Perflubron|perflubron|mesh-list
84136845|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84136847|NCT00499369|Bevacizumab|bevacizumab|mesh-list
84136848|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84136849|NCT00499369|Cetuximab|cetuximab|mesh-list
84136850|NCT00499369|Fluorouracil|fluorouracil|mesh-list
84136851|NCT00499369|Irinotecan|irinotecan|mesh-list
84136852|NCT00499369|Antibodies|antibodies|mesh-list
84136853|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
84136854|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84136855|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
84136856|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136857|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84136858|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84136859|NCT00499369|Growth Substances|growth substances|mesh-ancestor
84136860|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136861|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
84136862|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
84136863|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
84136864|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136865|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84136866|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136867|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84136868|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84136869|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136870|NCT00499369|Antidotes|antidotes|mesh-ancestor
84136871|NCT00499369|Protective Agents|protective agents|mesh-ancestor
84136872|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
84136873|NCT00499369|Vitamins|vitamins|mesh-ancestor
84136874|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
84136875|NCT02616692|Sorafenib|sorafenib|mesh-list
84136876|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136877|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84136878|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136879|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136880|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
84136881|NCT01014637|Clotrimazole|clotrimazole|mesh-list
84136882|NCT01014637|Miconazole|miconazole|mesh-list
84136883|NCT01014637|Amorolfine|amorolfine|mesh-list
84136884|NCT01014637|Ciclopirox|ciclopirox|mesh-list
84136885|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
84136886|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136887|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84136888|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84136889|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84136890|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136891|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136892|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84136893|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
84136894|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136895|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136896|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84136897|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84136898|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
84136899|NCT00696566|Rifampin|rifampin|mesh-list
84136900|NCT00696566|Clopidogrel|clopidogrel|mesh-list
84136901|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84136902|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84136903|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84136904|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84136905|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
84136906|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84136907|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136908|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136909|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84136910|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
84136911|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84136912|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136913|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
84136914|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84136915|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136916|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84136917|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84136918|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84136919|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84136920|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84136921|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84136922|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
84136923|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84136924|NCT01017133|Fluorides|fluorides|mesh-list
84136925|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84136926|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136927|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
84136928|NCT01017133|Protective Agents|protective agents|mesh-ancestor
84136929|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136930|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
84136931|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
84136932|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136933|NCT00869258|Gemcitabine|gemcitabine|mesh-list
84136934|NCT00869258|Capecitabine|capecitabine|mesh-list
84136935|NCT00869258|Docetaxel|docetaxel|mesh-list
84136936|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84136937|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
84136938|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136939|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136940|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
84136941|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
84136942|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
84136943|NCT00696644|Teriparatide|teriparatide|mesh-list
84136944|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84136945|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136946|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84136947|NCT01017367|Antibodies|antibodies|mesh-list
84136948|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
84136949|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136950|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84136951|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84136952|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84136953|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
84136954|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136955|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136956|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84136957|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84136958|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
84136959|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84136960|NCT00696956|Paclitaxel|paclitaxel|mesh-list
84136961|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84136962|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136963|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
84136964|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
84136965|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
84136966|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136967|NCT02616848|Everolimus|everolimus|mesh-list
84136968|NCT02616848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84136969|NCT02616848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84136970|NCT02616848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136971|NCT02616848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136972|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84136973|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
84136974|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136975|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136976|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84136977|NCT02620124|Hormones|hormones|mesh-list
84136978|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136979|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136980|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
84136981|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84136982|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
84136983|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84136984|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84136985|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84136986|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84136987|NCT04134650|Metformin|metformin|mesh-list
84136988|NCT04134650|Linagliptin|linagliptin|mesh-list
84136989|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84136990|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84136991|NCT04134650|Incretins|incretins|mesh-ancestor
84136992|NCT04134650|Hormones|hormones|mesh-ancestor
84136993|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84136994|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84136995|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
84136996|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84136997|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84136998|NCT00488683|Vaccines|vaccines|mesh-list
84136999|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
84137000|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137001|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
84137002|NCT02563288|Esmolol|esmolol|mesh-list
84137003|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
84137004|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
84137005|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
84137006|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
84137007|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84137008|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137009|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137010|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137011|NCT02563288|Analgesics|analgesics|mesh-ancestor
84137012|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
84137013|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137014|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84137015|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137016|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137017|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84137018|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84137019|NCT00711269|Risperidone|risperidone|mesh-list
84137020|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84137021|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84137022|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
84137023|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137024|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137025|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137026|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84137027|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84137028|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137029|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84137030|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84137031|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
84137032|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84137033|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84137034|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84137035|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
84137036|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84137037|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84137038|NCT01014793|Cabergoline|cabergoline|mesh-list
84137039|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84137040|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84137041|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
84137042|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
84137043|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137044|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137045|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137046|NCT00286169|Amrubicin|amrubicin|mesh-list
84137047|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137048|NCT00693472|Propranolol|propranolol|mesh-list
84137049|NCT00693472|Haloperidol|haloperidol|mesh-list
84137050|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
84137051|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
84137052|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
84137053|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
84137054|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137055|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137056|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137057|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84137058|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84137059|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137060|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84137061|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84137062|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
84137063|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137064|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137065|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84137066|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
83377799|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
84137067|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84137068|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84137069|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
84137070|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84137071|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84137072|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
84137074|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84137075|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84137076|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84137077|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137078|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84137079|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137080|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
84137081|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84137082|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84137083|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137084|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
84137085|NCT00746746|Interferons|interferons|mesh-list
84137086|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
84137087|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
84137088|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84137089|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137090|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
84137091|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137092|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
84137093|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137094|NCT00498355|Ranibizumab|ranibizumab|mesh-list
84137095|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84137096|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84137097|NCT00498355|Growth Substances|growth substances|mesh-ancestor
84137098|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137099|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
84137100|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137101|NCT04539223|Evolocumab|evolocumab|mesh-list
84137102|NCT04539223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
84137103|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84137104|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84137105|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
84137106|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137107|NCT04539223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84137108|NCT04539223|Protease Inhibitors|protease inhibitors|mesh-ancestor
84137109|NCT04539223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137110|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84137111|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
84137112|NCT01011751|Leuprolide|leuprolide|mesh-list
84137113|NCT01011751|Flutamide|flutamide|mesh-list
84137114|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
84137115|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84137116|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
84137117|NCT01011751|Cyproterone|cyproterone|mesh-list
84137118|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84137119|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84137120|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84137121|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137122|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137123|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137124|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84137125|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
84137126|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84137127|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84137128|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84137129|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84137130|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
84137131|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84137132|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84137133|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84137134|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84137135|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84137136|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137137|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84137138|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
84137139|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
84137140|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
84137141|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137142|NCT03672695|Venetoclax|venetoclax|mesh-list
84137143|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137144|NCT02686619|Cyclosporine|cyclosporine|mesh-list
84137145|NCT02686619|Sirolimus|sirolimus|mesh-list
84137146|NCT02686619|Prednisolone|prednisolone|mesh-list
84137147|NCT02686619|Cyclosporins|cyclosporins|mesh-list
84137148|NCT02686619|Daclizumab|daclizumab|mesh-list
84137149|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137150|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137151|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137152|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
84137153|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137154|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
84137155|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137156|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
84137157|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137158|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84137159|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84137160|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84137161|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137162|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137163|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
84137164|NCT02686619|Hormones|hormones|mesh-ancestor
84137165|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137166|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84137167|NCT00688636|Infliximab|infliximab|mesh-list
84137168|NCT00688636|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84137169|NCT00688636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137170|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
84137171|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137172|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137173|NCT00870740|Daclizumab|daclizumab|mesh-list
84137174|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137175|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
84137176|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137177|NCT02686853|Amphotericin B|amphotericin b|mesh-list
84137178|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84137179|NCT02686853|Amebicides|amebicides|mesh-ancestor
84137180|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84137181|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84137182|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137183|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84137184|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
84137185|NCT01017679|Gefitinib|gefitinib|mesh-list
84137186|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137187|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84137188|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137189|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137190|NCT04130672|Hemostatics|hemostatics|mesh-list
84137191|NCT04130672|Coagulants|coagulants|mesh-ancestor
84137192|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
84137193|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84137194|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137195|NCT02685449|Insulin|insulin|mesh-list
84137196|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84137197|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
84137198|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
84137199|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
84137200|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84137201|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137202|NCT00697034|Capsaicin|capsaicin|mesh-list
84137203|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
84137204|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
84137205|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
84137206|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137207|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137208|NCT00506779|Paclitaxel|paclitaxel|mesh-list
84137209|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
84137210|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84137211|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137212|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
84137213|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
84137214|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
84137215|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137216|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84137217|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137218|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
84137219|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84137220|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
84137222|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137223|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137224|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137225|NCT04185233|Analgesics|analgesics|mesh-ancestor
84137226|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
84137227|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137228|NCT04185077|Heparin|heparin|mesh-list
84137229|NCT04185077|Calcium heparin|calcium heparin|mesh-list
84137230|NCT04185077|Bivalirudin|bivalirudin|mesh-list
84137231|NCT04185077|Antithrombins|antithrombins|mesh-list
84137232|NCT04185077|Thrombin|thrombin|mesh-list
84137233|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
84137234|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84137235|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84137236|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137237|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
84137238|NCT04185077|Coagulants|coagulants|mesh-ancestor
84137239|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84137240|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
84137241|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137242|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
84137243|NCT02686385|Prednisolone|prednisolone|mesh-list
84137244|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84137245|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137246|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
84137247|NCT02686385|Hormones|hormones|mesh-ancestor
84137248|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137249|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137250|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84137251|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137252|NCT02686385|Protective Agents|protective agents|mesh-ancestor
84137253|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
84137254|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137255|NCT02686385|Expectorants|expectorants|mesh-ancestor
84137256|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
84137257|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84137258|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
84137259|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137260|NCT02686385|Antidotes|antidotes|mesh-ancestor
84137261|NCT02686151|Dexamethasone|dexamethasone|mesh-list
84137262|NCT02686151|Letrozole|letrozole|mesh-list
84137263|NCT02686151|Polygeline|polygeline|mesh-list
84137264|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137265|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
84137266|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
84137267|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137268|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137269|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137270|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
84137271|NCT02686151|Hormones|hormones|mesh-ancestor
84137272|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137273|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84137274|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137275|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84137276|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84137277|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137278|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137279|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84137280|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
84137281|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
84137282|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
84137283|NCT00868790|Metformin|metformin|mesh-list
84137284|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84137285|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137286|NCT00496483|Tacrolimus|tacrolimus|mesh-list
84137287|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137288|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
84137289|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137290|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84137291|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137292|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137293|NCT02614352|Candesartan|candesartan|mesh-list
84137294|NCT02614352|Atorvastatin|atorvastatin|mesh-list
83378018|NCT04199143|Analgesics|analgesics|mesh-ancestor
84137295|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84137296|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84137297|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
84137298|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137299|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84137300|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84137301|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137302|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84137303|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84137304|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84137305|NCT01018225|Darifenacin|darifenacin|mesh-list
84137306|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84137307|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84137308|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
84137309|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137310|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137311|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137312|NCT01018225|Urological Agents|urological agents|mesh-ancestor
84137313|NCT03528551|Factor VIII|factor viii|mesh-list
84137314|NCT03528551|Coagulants|coagulants|mesh-ancestor
84137315|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
84137316|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137317|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137318|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
84137319|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
84137320|NCT01012063|Hematinics|hematinics|mesh-ancestor
84137321|NCT03242915|Carboplatin|carboplatin|mesh-list
84137322|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
84137323|NCT03242915|Pemetrexed|pemetrexed|mesh-list
84137324|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137325|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84137326|NCT03242915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84137327|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137328|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137329|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84137330|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84137331|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84137332|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
84137333|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137334|NCT02685059|Paclitaxel|paclitaxel|mesh-list
84137335|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
84137336|NCT02685059|Durvalumab|durvalumab|mesh-list
84137337|NCT02685059|Epirubicin|epirubicin|mesh-list
84137338|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84137339|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137340|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
84137341|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
84137342|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
84137343|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137344|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137345|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
84137346|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137347|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137348|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84137349|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
84137350|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84137351|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84137352|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84137353|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84137354|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84137355|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137356|NCT00603239|Exenatide|exenatide|mesh-list
84137357|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84137358|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137359|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84137360|NCT00603239|Incretins|incretins|mesh-ancestor
84137361|NCT00603239|Hormones|hormones|mesh-ancestor
84137362|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137363|NCT00699114|Acetaminophen|acetaminophen|mesh-list
84137364|NCT00699114|Ibuprofen|ibuprofen|mesh-list
84137365|NCT00699114|Codeine|codeine|mesh-list
84137366|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137367|NCT00699114|Analgesics|analgesics|mesh-ancestor
84137368|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
84137369|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137370|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137371|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
84137372|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137373|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137374|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137375|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84137376|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137377|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137378|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84137379|NCT00699114|Narcotics|narcotics|mesh-ancestor
84137380|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137381|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
84137382|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
84137383|NCT00639587|Cetirizine|cetirizine|mesh-list
84137384|NCT00639587|Ketotifen|ketotifen|mesh-list
84137385|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84137386|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84137387|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84137388|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
84137389|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
84137390|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137391|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137392|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137393|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
84137394|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
84137395|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
84137396|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
84137397|NCT00852540|Linezolid|linezolid|mesh-list
84137398|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84137399|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137400|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84137401|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137402|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137403|NCT00701220|Atorvastatin|atorvastatin|mesh-list
84137404|NCT00701220|Calcium|calcium|mesh-list
84137405|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84137406|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137407|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84137408|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84137409|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
84137410|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137411|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84137412|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84137413|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137414|NCT00701298|Interferons|interferons|mesh-list
84137415|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
84137416|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
84137417|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84137418|NCT00701298|Decitabine|decitabine|mesh-list
84137419|NCT00701298|Azacitidine|azacitidine|mesh-list
84137420|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137421|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
84137422|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137423|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
84137424|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137425|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84137426|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
84137427|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137428|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137429|NCT00860574|Methotrexate|methotrexate|mesh-list
84137430|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
84137431|NCT00860574|Fludarabine|fludarabine|mesh-list
84137432|NCT00860574|Treosulfan|treosulfan|mesh-list
84137433|NCT00860574|Tacrolimus|tacrolimus|mesh-list
84137434|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84137435|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
84137436|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84137437|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137438|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84137439|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
84137440|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137441|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137442|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
84137443|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137444|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84137445|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137446|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
84137447|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137448|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84137449|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84137450|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84137451|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
84137452|NCT00496015|Acetaminophen|acetaminophen|mesh-list
84137453|NCT00496015|Vaccines|vaccines|mesh-list
84137454|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84137455|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
84137456|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137457|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137458|NCT00496015|Analgesics|analgesics|mesh-ancestor
84137459|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
84137460|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137461|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
84137462|NCT01018381|Ethanol|ethanol|mesh-list
84137463|NCT01018381|Entecavir|entecavir|mesh-list
84137464|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84137465|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137466|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137467|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137468|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
84137469|NCT00487825|Methotrexate|methotrexate|mesh-list
84137470|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84137471|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
84137472|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84137473|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137474|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84137475|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
84137476|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137477|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137478|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
84137479|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137480|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84137481|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137482|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
84137483|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137484|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84137485|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84137486|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
84137487|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137488|NCT01012141|Docetaxel|docetaxel|mesh-list
84137489|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137490|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
84137491|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
84137492|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
84137493|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137494|NCT00487435|Tapentadol|tapentadol|mesh-list
84137495|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84137496|NCT00487435|Narcotics|narcotics|mesh-ancestor
84137497|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137498|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137499|NCT00487435|Analgesics|analgesics|mesh-ancestor
84137500|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
84137501|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137502|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84137503|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84137504|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84137505|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137506|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
84137507|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137508|NCT00495625|Sunitinib|sunitinib|mesh-list
84137509|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137510|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84137511|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84137512|NCT00495625|Growth Substances|growth substances|mesh-ancestor
84137513|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137514|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
84137515|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84137516|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137517|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137518|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
84137519|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84137520|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84137521|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84137522|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137523|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84137524|NCT00847626|Diuretics|diuretics|mesh-ancestor
84137525|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
84137526|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137527|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84137528|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84137529|NCT04115904|Ibuprofen|ibuprofen|mesh-list
84137530|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137531|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137532|NCT04115904|Analgesics|analgesics|mesh-ancestor
84137533|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
84137534|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137535|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137536|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137537|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137538|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84137539|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137540|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137541|NCT05297994|Vaccines|vaccines|mesh-list
84137542|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
84137543|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137544|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
84137545|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
84137546|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137547|NCT00860262|Amlodipine|amlodipine|mesh-list
84137548|NCT00860262|Telmisartan|telmisartan|mesh-list
84137549|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
84137550|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84137551|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84137552|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84137553|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137554|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84137555|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137556|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
84137557|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84137558|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84137559|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
84137560|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84137561|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137562|NCT00860028|Varenicline|varenicline|mesh-list
84137563|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84137564|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84137565|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
84137566|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137567|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137568|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137569|NCT00701532|Modafinil|modafinil|mesh-list
84137570|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84137571|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137572|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84137573|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84137574|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84137575|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137576|NCT00846768|Olodaterol|olodaterol|mesh-list
84137577|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84137578|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
84137579|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137580|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137581|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84137582|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
84137583|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84137584|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84137585|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84137586|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84137587|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137588|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137589|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137590|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
84137591|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84137592|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84137593|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84137594|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84137595|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137596|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137597|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84137598|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84137599|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84137601|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137602|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137603|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84137604|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84137605|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
84137606|NCT00699426|Esomeprazole|esomeprazole|mesh-list
84137607|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84137608|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137609|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84137610|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137611|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137612|NCT00593606|Rotigotine|rotigotine|mesh-list
84137613|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
84137614|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
84137615|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137616|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137617|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137618|NCT02614118|Acetaminophen|acetaminophen|mesh-list
84137619|NCT02614118|Ketorolac|ketorolac|mesh-list
84137620|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84137621|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137622|NCT02614118|Analgesics|analgesics|mesh-ancestor
84137623|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
84137624|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137625|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137626|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
84137627|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137628|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137629|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137630|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84137631|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137632|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137633|NCT04134416|Donepezil|donepezil|mesh-list
84137634|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84137635|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137636|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137637|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
84137638|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137639|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137640|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
84137641|NCT04134182|Nivolumab|nivolumab|mesh-list
84137642|NCT04134182|Ipilimumab|ipilimumab|mesh-list
84137643|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84137644|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137645|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84137646|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137647|NCT00870584|Omalizumab|omalizumab|mesh-list
84137648|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84137649|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84137650|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
84137651|NCT02614508|Ofatumumab|ofatumumab|mesh-list
84137652|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84137653|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137654|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
84137655|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137656|NCT02616068|Loxoprofen|loxoprofen|mesh-list
84137657|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137658|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137659|NCT02616068|Analgesics|analgesics|mesh-ancestor
84137660|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
84137661|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137662|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137663|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137664|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137665|NCT04127084|Empagliflozin|empagliflozin|mesh-list
84137666|NCT04127084|Canagliflozin|canagliflozin|mesh-list
84137667|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84137668|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137669|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84137670|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137671|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84137672|NCT00870194|Exenatide|exenatide|mesh-list
84137673|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84137674|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137675|NCT00870194|Incretins|incretins|mesh-ancestor
84137676|NCT00870194|Hormones|hormones|mesh-ancestor
84137677|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137678|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84137679|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
84137680|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137681|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137682|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84137683|NCT00690430|Octreotide|octreotide|mesh-list
84137684|NCT00690430|Pasireotide|pasireotide|mesh-list
84137685|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137686|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84137687|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137688|NCT00690430|Hormones|hormones|mesh-ancestor
84137689|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137690|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137691|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84137692|NCT04126304|Azithromycin|azithromycin|mesh-list
84137693|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137694|NCT02563054|Fluorouracil|fluorouracil|mesh-list
84137695|NCT02563054|Capecitabine|capecitabine|mesh-list
84137696|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137697|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
84137698|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137699|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84137700|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137701|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
84137702|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137703|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
84137704|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84137705|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84137706|NCT00743470|Ritonavir|ritonavir|mesh-list
84137707|NCT00743470|Lopinavir|lopinavir|mesh-list
84137708|NCT00743470|Rifabutin|rifabutin|mesh-list
84137709|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84137710|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84137711|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
84137712|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137713|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137714|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84137715|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84137716|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
84137717|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137718|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84137719|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84137720|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84137721|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84137722|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
84137723|NCT00688324|Acamprosate|acamprosate|mesh-list
84137724|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84137725|NCT02619578|Remifentanil|remifentanil|mesh-list
84137726|NCT02619578|Propofol|propofol|mesh-list
84137727|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
84137728|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84137729|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137730|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137731|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84137732|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
84137733|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
84137734|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84137735|NCT02619578|Narcotics|narcotics|mesh-ancestor
84137736|NCT02619578|Analgesics|analgesics|mesh-ancestor
84137737|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
84137738|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137739|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84137740|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84137741|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84137742|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84137743|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84137744|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
84137745|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137746|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137747|NCT02615912|Castor Oil|castor oil|mesh-list
84137748|NCT02615912|Cathartics|cathartics|mesh-ancestor
84137749|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137750|NCT04123652|Lidocaine|lidocaine|mesh-list
84137751|NCT04123652|Ketamine|ketamine|mesh-list
84137752|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
84137753|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
84137754|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137755|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137756|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
84137757|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137758|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84137759|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84137760|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84137761|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84137762|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137763|NCT04123652|Analgesics|analgesics|mesh-ancestor
84137764|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84137765|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84137766|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
84137767|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84137768|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84137769|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137770|NCT00862940|Memantine|memantine|mesh-list
84137771|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84137772|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84137773|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
84137774|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137775|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137776|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137777|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84137778|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84137779|NCT04122716|Liraglutide|liraglutide|mesh-list
84137780|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84137781|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137782|NCT04122716|Incretins|incretins|mesh-ancestor
84137783|NCT04122716|Hormones|hormones|mesh-ancestor
84137784|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137785|NCT00868166|Riluzole|riluzole|mesh-list
84137786|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
84137787|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84137788|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84137789|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137790|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137791|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137792|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84137793|NCT00868166|Protective Agents|protective agents|mesh-ancestor
84137794|NCT00858780|Etanercept|etanercept|mesh-list
84137795|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137796|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137797|NCT00858780|Analgesics|analgesics|mesh-ancestor
84137798|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
84137799|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137800|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137801|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137802|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137803|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84137804|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137805|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
84137806|NCT02619266|Megestrol|megestrol|mesh-list
84137807|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
84137808|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84137809|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84137810|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84137811|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
84137812|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84137813|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137814|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84137815|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84137816|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84137817|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137818|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
84137819|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84137820|NCT00699062|Montelukast|montelukast|mesh-list
84137821|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84137822|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
84137823|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84137824|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
84137825|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137826|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137827|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84137828|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84137829|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137830|NCT02619032|Fentanyl|fentanyl|mesh-list
84137831|NCT02619032|Remifentanil|remifentanil|mesh-list
84137832|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84137833|NCT02619032|Narcotics|narcotics|mesh-ancestor
84137834|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137835|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137836|NCT02619032|Analgesics|analgesics|mesh-ancestor
84137837|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
84137838|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137839|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84137840|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84137841|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
84137842|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
84137843|NCT00858234|Bortezomib|bortezomib|mesh-list
84137844|NCT00858234|Vorinostat|vorinostat|mesh-list
84137845|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137846|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84137847|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137848|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137849|NCT00697814|Clomiphene|clomiphene|mesh-list
84137850|NCT00697814|Enclomiphene|enclomiphene|mesh-list
84137851|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
84137852|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84137853|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
84137854|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84137855|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137856|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84137857|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
84137858|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84137859|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84137860|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84137861|NCT00862082|Sorafenib|sorafenib|mesh-list
84137862|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
84137863|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137864|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84137865|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137866|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137867|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84137868|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
84137869|NCT00849186|Sunitinib|sunitinib|mesh-list
84137870|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137871|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84137872|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84137873|NCT00849186|Growth Substances|growth substances|mesh-ancestor
84137874|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137875|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
84137876|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84137877|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137878|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137879|NCT00692770|Sorafenib|sorafenib|mesh-list
84137880|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137881|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84137882|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137883|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137884|NCT00867308|Lenalidomide|lenalidomide|mesh-list
84137885|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
84137886|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137887|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84137888|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84137889|NCT00867308|Growth Substances|growth substances|mesh-ancestor
84137890|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
84137891|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137892|NCT02618876|Nalbuphine|nalbuphine|mesh-list
84137893|NCT02618876|Bupivacaine|bupivacaine|mesh-list
84137894|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
84137895|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
84137896|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84137897|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137898|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
84137899|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137900|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84137901|NCT02618876|Narcotics|narcotics|mesh-ancestor
84137902|NCT02618876|Analgesics|analgesics|mesh-ancestor
84137904|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137905|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137906|NCT04119752|Analgesics|analgesics|mesh-ancestor
84137907|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
84137908|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137909|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137910|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137911|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137912|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137913|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137914|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137915|NCT00866918|Vitamins|vitamins|mesh-list
84137916|NCT00866918|Vitamin A|vitamin a|mesh-list
84137917|NCT00866918|Cytarabine|cytarabine|mesh-list
84137918|NCT00866918|Methotrexate|methotrexate|mesh-list
84137919|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
84137920|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
84137921|NCT00866918|Idarubicin|idarubicin|mesh-list
84137922|NCT00866918|Tretinoin|tretinoin|mesh-list
84137923|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
84137924|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
84137925|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
84137926|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137927|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84137928|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
84137929|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84137930|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84137931|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
84137932|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137933|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84137934|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
84137935|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137936|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84137937|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84137938|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
84137939|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137940|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84137941|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
84137942|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137943|NCT00866918|Analgesics|analgesics|mesh-ancestor
84137944|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
84137945|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137946|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84137947|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84137948|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84137949|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
84137950|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
84137951|NCT00866918|Protective Agents|protective agents|mesh-ancestor
84137952|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84137953|NCT00861692|Argatroban|argatroban|mesh-list
84137954|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
84137955|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84137956|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
84137957|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137958|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137959|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
84137960|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84137961|NCT03131765|Poly I-C|poly i-c|mesh-list
84137962|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
84137963|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84137964|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
84137965|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
84137966|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137967|NCT02689037|Aspirin|aspirin|mesh-list
84137968|NCT02689037|Clopidogrel|clopidogrel|mesh-list
84137969|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137970|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137971|NCT02689037|Analgesics|analgesics|mesh-ancestor
84137972|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
84137973|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137974|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137975|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137976|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137977|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84137978|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84137979|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84137980|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84137981|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84137982|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84137983|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
84137984|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84137985|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84137986|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84137987|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
84137988|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84137989|NCT04184921|Aspirin|aspirin|mesh-list
84137990|NCT04184921|Osimertinib|osimertinib|mesh-list
84137991|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84137992|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84137993|NCT04184921|Analgesics|analgesics|mesh-ancestor
84137994|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
84137995|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84137996|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84137997|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84137998|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84137999|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84138000|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84138001|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138002|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84138003|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84138004|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138005|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
84138006|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138007|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138008|NCT00602927|Varenicline|varenicline|mesh-list
84138009|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84138010|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84138011|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
84138012|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138013|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138014|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138015|NCT00639743|Tenecteplase|tenecteplase|mesh-list
84138016|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84138017|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84138018|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138019|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
84138020|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84138021|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138022|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138023|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84138024|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84138025|NCT04186559|Protective Agents|protective agents|mesh-ancestor
84138026|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138027|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
84138028|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84138029|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
84138030|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
84138031|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84138032|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
84138033|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84138034|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138035|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138036|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
84138037|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84138038|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138039|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138040|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84138041|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84138042|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84138043|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138044|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84138045|NCT02688803|Paclitaxel|paclitaxel|mesh-list
84138046|NCT02688803|Docetaxel|docetaxel|mesh-list
84138047|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84138048|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
84138049|NCT02688803|Doxorubicin|doxorubicin|mesh-list
84138050|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84138051|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84138052|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138053|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
84138054|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
84138055|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
84138056|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138057|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84138058|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
84138059|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138060|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138061|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84138062|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
84138063|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84138064|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84138065|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84138066|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84138067|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138068|NCT02684669|Naloxone|naloxone|mesh-list
84138069|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84138070|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138071|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
84138072|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138073|NCT02976935|Xenon|xenon|mesh-list
84138074|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84138075|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
84138076|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
84138077|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138078|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138079|NCT00861614|Ipilimumab|ipilimumab|mesh-list
84138080|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84138081|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138082|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84138083|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138084|NCT00861380|Vaccines|vaccines|mesh-list
84138085|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84138086|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
84138087|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138088|NCT00495391|Ribavirin|ribavirin|mesh-list
84138089|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84138090|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
84138091|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
84138092|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138093|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
84138094|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138095|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84138096|NCT04378621|Adalimumab|adalimumab|mesh-list
84138097|NCT04378621|Infliximab|infliximab|mesh-list
84138098|NCT04378621|Golimumab|golimumab|mesh-list
84138099|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
84138100|NCT04378621|Etanercept|etanercept|mesh-list
84138101|NCT04378621|Tofacitinib|tofacitinib|mesh-list
84138102|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
84138103|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84138104|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138105|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138106|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
84138107|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84138108|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84138109|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138110|NCT04378621|Analgesics|analgesics|mesh-ancestor
84138111|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
84138112|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138113|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138114|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84138115|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
84138116|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138117|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138118|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138119|NCT00869960|Ritonavir|ritonavir|mesh-list
83378862|NCT04148599|Analgesics|analgesics|mesh-ancestor
84138120|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84138121|NCT00869960|Tenofovir|tenofovir|mesh-list
84138122|NCT00869960|Emtricitabine|emtricitabine|mesh-list
84138123|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84138124|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84138125|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
84138126|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138127|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138128|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84138129|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84138130|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
84138131|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138132|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84138133|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84138134|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84138135|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84138136|NCT02618564|Sennosides|sennosides|mesh-list
84138137|NCT02618564|Laxatives|laxatives|mesh-ancestor
84138138|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84138139|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
84138140|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84138141|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84138142|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138143|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
84138144|NCT02615366|Coagulants|coagulants|mesh-ancestor
84138145|NCT00699296|Panobinostat|panobinostat|mesh-list
84138146|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138147|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84138148|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138149|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138150|NCT04119674|Temozolomide|temozolomide|mesh-list
84138151|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84138152|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
84138153|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138154|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138155|NCT00494299|Sorafenib|sorafenib|mesh-list
84138156|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138157|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138158|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138159|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138160|NCT05298176|Carboplatin|carboplatin|mesh-list
84138161|NCT05298176|Pemetrexed|pemetrexed|mesh-list
84138162|NCT05298176|Osimertinib|osimertinib|mesh-list
84138163|NCT05298176|Afatinib|afatinib|mesh-list
84138164|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138165|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138166|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138167|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84138168|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84138169|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138170|NCT02615288|Vitamin D|vitamin d|mesh-list
84138171|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
84138172|NCT02615288|Vitamins|vitamins|mesh-ancestor
84138173|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
84138174|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138175|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84138176|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84138177|NCT02618096|Oxytocin|oxytocin|mesh-list
84138178|NCT02618096|Dinoprostone|dinoprostone|mesh-list
84138179|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
84138180|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84138181|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138182|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
84138183|NCT04134026|Hematinics|hematinics|mesh-ancestor
84138184|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
84138185|NCT02963831|Durvalumab|durvalumab|mesh-list
84138186|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84138187|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
84138188|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138189|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138190|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84138191|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
84138192|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138193|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138194|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84138195|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84138196|NCT00859898|Metformin|metformin|mesh-list
84138197|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
84138198|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84138199|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138200|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84138201|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138203|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84138204|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138205|NCT02684123|Analgesics|analgesics|mesh-ancestor
84138206|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
84138207|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138208|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138209|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138210|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138211|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84138212|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84138213|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138214|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138215|NCT00638729|Clonidine|clonidine|mesh-list
84138216|NCT00638729|Midazolam|midazolam|mesh-list
84138217|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84138218|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84138219|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138220|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138221|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84138222|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84138223|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84138224|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84138225|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
84138226|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
84138227|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
84138228|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
84138229|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138230|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138231|NCT00638729|Analgesics|analgesics|mesh-ancestor
84138232|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
84138233|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138234|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84138235|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
84138236|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
84138237|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84138238|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84138239|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84138240|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
84138241|NCT00697892|Ritonavir|ritonavir|mesh-list
84138242|NCT00697892|Lopinavir|lopinavir|mesh-list
84138243|NCT00697892|Efavirenz|efavirenz|mesh-list
84138244|NCT00697892|Lumefantrine|lumefantrine|mesh-list
84138245|NCT00697892|Artemether|artemether|mesh-list
84138246|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84138247|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84138248|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84138249|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
84138250|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138251|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138252|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84138253|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84138254|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
84138255|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138256|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84138257|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84138258|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84138259|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84138260|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84138261|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84138262|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84138263|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84138264|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84138265|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
84138266|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84138267|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84138268|NCT00699452|Candesartan|candesartan|mesh-list
84138269|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84138270|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83379023|NCT03896737|Bortezomib|bortezomib|mesh-list
84138271|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84138272|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138273|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
84138275|NCT02683733|Mesalamine|mesalamine|mesh-list
84138276|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84138277|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138278|NCT02683733|Analgesics|analgesics|mesh-ancestor
84138279|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
84138280|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138281|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138282|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138283|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138284|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138285|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138286|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138287|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
84138288|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84138289|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138290|NCT02683655|Apatinib|apatinib|mesh-list
84138291|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138292|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138293|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138294|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138295|NCT00494221|Leucovorin|leucovorin|mesh-list
84138296|NCT00494221|Fluorouracil|fluorouracil|mesh-list
84138297|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
84138298|NCT00494221|Cediranib|cediranib|mesh-list
84138299|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
84138300|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
84138301|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138302|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84138303|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138304|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84138305|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
84138306|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138307|NCT00494221|Antidotes|antidotes|mesh-ancestor
84138308|NCT00494221|Protective Agents|protective agents|mesh-ancestor
84138309|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
84138310|NCT00494221|Vitamins|vitamins|mesh-ancestor
84138311|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
84138312|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138313|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138314|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
84138315|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84138316|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138317|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138318|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138319|NCT00909935|Analgesics|analgesics|mesh-ancestor
84138320|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
84138321|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138322|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84138323|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84138324|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84138325|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
84138326|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138327|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138328|NCT00857948|Ivermectin|ivermectin|mesh-list
84138329|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84138330|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138331|NCT02688491|Sunitinib|sunitinib|mesh-list
84138332|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138333|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84138334|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84138335|NCT02688491|Growth Substances|growth substances|mesh-ancestor
84138336|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138337|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
84138338|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138339|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138340|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138341|NCT00857792|Regadenoson|regadenoson|mesh-list
84138342|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84138343|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84138344|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
84138345|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
84138346|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138347|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138348|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138349|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
84138350|NCT02613494|Scopolamine|scopolamine|mesh-list
84138351|NCT02613494|Bromides|bromides|mesh-list
84138352|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84138353|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
84138354|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84138355|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84138356|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84138357|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
84138358|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138359|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138360|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138361|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
84138362|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
84138363|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138364|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84138365|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
84138366|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
84138367|NCT00699530|Cabergoline|cabergoline|mesh-list
84138368|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84138369|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84138370|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
84138371|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
84138372|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138373|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138374|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138375|NCT02617862|Anesthetics|anesthetics|mesh-list
84138376|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138377|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138378|NCT00601835|Vaccines|vaccines|mesh-list
84138379|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
84138380|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138381|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84138382|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84138383|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84138384|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138385|NCT00697502|Capecitabine|capecitabine|mesh-list
84138386|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84138387|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
84138388|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138389|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138390|NCT00857246|Irinotecan|irinotecan|mesh-list
84138391|NCT00857246|Cetuximab|cetuximab|mesh-list
84138392|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138393|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84138394|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84138395|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138396|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138397|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84138398|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
84138399|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
84138400|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84138401|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138402|NCT00640679|Clopidogrel|clopidogrel|mesh-list
84138403|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84138404|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84138405|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84138406|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84138407|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
84138408|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138409|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138410|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138411|NCT02682953|Plerixafor|plerixafor|mesh-list
84138412|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84138413|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84138414|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
84138415|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138416|NCT02683031|Ionophores|ionophores|mesh-list
84138417|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84138418|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138419|NCT04184141|Alprazolam|alprazolam|mesh-list
84138420|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
84138421|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84138422|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138423|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138424|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84138425|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84138426|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84138427|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
84138428|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
84138429|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138430|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138431|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
84138432|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
84138433|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84138434|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
84138435|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
84138436|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84138437|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
84138438|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84138439|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138440|NCT00640991|Insulin|insulin|mesh-list
84138441|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
84138442|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
84138443|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84138444|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138445|NCT00638807|Celecoxib|celecoxib|mesh-list
84138446|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84138447|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138448|NCT00638807|Analgesics|analgesics|mesh-ancestor
84138449|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
84138450|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138451|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138452|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138453|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138454|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84138455|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84138456|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138457|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138458|NCT00856856|Everolimus|everolimus|mesh-list
84138459|NCT00856856|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84138460|NCT00856856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138461|NCT00856856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138462|NCT00856856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138463|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84138464|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
84138465|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138466|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138467|NCT00782327|Losartan|losartan|mesh-list
84138468|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84138469|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84138470|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84138471|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84138472|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138473|NCT00559091|Ribavirin|ribavirin|mesh-list
84138474|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
84138475|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138476|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
84138477|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138478|NCT02682017|Fucoidan|fucoidan|mesh-list
84138479|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84138480|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84138481|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
84138482|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138483|NCT04076579|Olaparib|olaparib|mesh-list
84138484|NCT04076579|Trabectedin|trabectedin|mesh-list
84138485|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84138486|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138487|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138488|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138489|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84138490|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
84138491|NCT00603473|Gabapentin|gabapentin|mesh-list
84138492|NCT00603473|Analgesics|analgesics|mesh-ancestor
84138493|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
84138494|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138495|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138496|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
84138497|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84138498|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84138499|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138500|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84138501|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84138502|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84138503|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138504|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138505|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
84138506|NCT02688023|Leucovorin|leucovorin|mesh-list
84138507|NCT02688023|Fluorouracil|fluorouracil|mesh-list
84138508|NCT02688023|Capecitabine|capecitabine|mesh-list
84138509|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
84138510|NCT02688023|Irinotecan|irinotecan|mesh-list
84138511|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
84138512|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138513|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84138514|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138515|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84138516|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
84138517|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138518|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84138519|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84138520|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138521|NCT02688023|Antidotes|antidotes|mesh-ancestor
84138522|NCT02688023|Protective Agents|protective agents|mesh-ancestor
84138523|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
84138524|NCT02688023|Vitamins|vitamins|mesh-ancestor
84138525|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
84138526|NCT00910013|Ropivacaine|ropivacaine|mesh-list
84138527|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
84138528|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
84138529|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138530|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138531|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
84138532|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138533|NCT04182191|Tenoxicam|tenoxicam|mesh-list
84138534|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84138535|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138536|NCT04182191|Analgesics|analgesics|mesh-ancestor
84138537|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
84138538|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138539|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138540|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138541|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138542|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84138543|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138544|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138545|NCT02680379|Minocycline|minocycline|mesh-list
84138546|NCT02680379|Lovastatin|lovastatin|mesh-list
84138547|NCT02680379|L 647318|l 647318|mesh-list
84138548|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
84138549|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84138550|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138551|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84138552|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84138553|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
84138554|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138555|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84138556|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84138557|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138558|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
84138559|NCT03996421|Trace Elements|trace elements|mesh-ancestor
84138560|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
84138561|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138562|NCT00641693|Budesonide|budesonide|mesh-list
84138563|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138564|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84138565|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
84138566|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138567|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138568|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84138569|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
84138570|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
84138571|NCT00641693|Hormones|hormones|mesh-ancestor
84138572|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84138573|NCT04183361|Cortisone|cortisone|mesh-list
84138575|NCT02503774|Durvalumab|durvalumab|mesh-list
84138576|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84138577|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138578|NCT02687867|Vitamin K|vitamin k|mesh-list
84138579|NCT02687867|Dabigatran|dabigatran|mesh-list
84138580|NCT02687867|Vitamins|vitamins|mesh-ancestor
84138581|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
84138582|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138583|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
84138584|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84138585|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
84138586|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138587|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138588|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
84138589|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84138590|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84138591|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
84138592|NCT02687867|Coagulants|coagulants|mesh-ancestor
84138593|NCT02681783|Aflibercept|aflibercept|mesh-list
84138594|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84138595|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84138596|NCT02681783|Growth Substances|growth substances|mesh-ancestor
84138597|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138598|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
84138599|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138600|NCT00486811|Oxycodone|oxycodone|mesh-list
84138601|NCT00486811|Tapentadol|tapentadol|mesh-list
84138602|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84138603|NCT00486811|Narcotics|narcotics|mesh-ancestor
84138604|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138605|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138606|NCT00486811|Analgesics|analgesics|mesh-ancestor
84138607|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
84138608|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138609|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84138610|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84138611|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84138612|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138613|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
84138614|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138615|NCT00921700|Acetaminophen|acetaminophen|mesh-list
84138616|NCT00921700|Ibuprofen|ibuprofen|mesh-list
84138617|NCT00921700|Codeine|codeine|mesh-list
84138618|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138619|NCT00921700|Analgesics|analgesics|mesh-ancestor
84138620|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
84138621|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138622|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138623|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
84138624|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84138625|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138626|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138627|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84138628|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138629|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138630|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84138631|NCT00921700|Narcotics|narcotics|mesh-ancestor
84138632|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138633|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
84138634|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
84138635|NCT02678195|Amoxicillin|amoxicillin|mesh-list
84138636|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84138637|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138638|NCT03996577|Lidocaine|lidocaine|mesh-list
84138639|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
84138640|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
84138641|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138642|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138643|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
84138644|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138645|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84138646|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83379382|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
84138647|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84138648|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84138649|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138650|NCT02681705|Temozolomide|temozolomide|mesh-list
84138651|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84138652|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
84138653|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138654|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138655|NCT00921622|Vitamin D|vitamin d|mesh-list
84138656|NCT00921622|Vitamins|vitamins|mesh-list
84138657|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
84138658|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138659|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84138660|NCT02681471|Mannitol|mannitol|mesh-list
84138661|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84138662|NCT02681471|Diuretics|diuretics|mesh-ancestor
84138663|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
84138664|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138665|NCT00642395|Bortezomib|bortezomib|mesh-list
84138666|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138667|NCT01018615|Silymarin|silymarin|mesh-list
84138668|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
84138669|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138670|NCT01018615|Protective Agents|protective agents|mesh-ancestor
84138671|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138672|NCT00743782|Hormones|hormones|mesh-list
84138673|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
84138674|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84138675|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138676|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84138677|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
84138678|NCT02678117|Pregabalin|pregabalin|mesh-list
84138679|NCT02678117|Analgesics|analgesics|mesh-ancestor
84138680|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
84138681|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138682|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138683|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
84138684|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84138685|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84138686|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138687|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84138688|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84138689|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84138690|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138691|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84138692|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
84138693|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84138694|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
84138695|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84138696|NCT01018849|Vitamin D|vitamin d|mesh-list
84138697|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
84138698|NCT01018849|Vitamins|vitamins|mesh-ancestor
84138699|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
84138700|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138701|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84138702|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84138703|NCT04102319|Hepcidins|hepcidins|mesh-list
84138704|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138705|NCT00743860|Darapladib|darapladib|mesh-list
84138706|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
84138707|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138708|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138709|NCT00747526|Rabeprazole|rabeprazole|mesh-list
84138710|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84138711|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84138712|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84138713|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138714|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138715|NCT00747604|Mecasermin|mecasermin|mesh-list
84138716|NCT00747604|Growth Substances|growth substances|mesh-ancestor
84138717|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138718|NCT02151604|Xenon|xenon|mesh-list
84138719|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84138720|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
84138721|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
84138722|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138723|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138724|NCT00466921|Lenalidomide|lenalidomide|mesh-list
84138725|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
84138726|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138727|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84138728|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84138729|NCT00466921|Growth Substances|growth substances|mesh-ancestor
84138730|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
84138731|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138732|NCT00601523|Pramipexole|pramipexole|mesh-list
84138733|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
84138734|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138735|NCT00601523|Protective Agents|protective agents|mesh-ancestor
84138736|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138737|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84138738|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84138739|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
84138740|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
84138741|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138742|NCT00466687|Bevacizumab|bevacizumab|mesh-list
84138743|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84138744|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84138745|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138746|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84138747|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84138748|NCT00466687|Growth Substances|growth substances|mesh-ancestor
84138749|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138750|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
84138751|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138752|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138753|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138754|NCT01522768|Paclitaxel|paclitaxel|mesh-list
84138755|NCT01522768|Afatinib|afatinib|mesh-list
84138756|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84138757|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138758|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
84138759|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
84138760|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
84138761|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138762|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84138763|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138764|NCT01759459|Lidocaine|lidocaine|mesh-list
84138765|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
84138766|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
84138767|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138768|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138769|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
84138770|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138771|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84138772|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84138773|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84138774|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84138775|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138776|NCT02562742|Ribavirin|ribavirin|mesh-list
84138777|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
84138778|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138779|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
84138780|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138781|NCT00744016|Mesalamine|mesalamine|mesh-list
84138782|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84138783|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84138784|NCT00744016|Analgesics|analgesics|mesh-ancestor
84138785|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
84138786|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138787|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138788|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138789|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138790|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
84138791|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84138792|NCT04182737|Antibodies|antibodies|mesh-list
84138793|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
84138794|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
84138795|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
84138796|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138797|NCT04181645|Paclitaxel|paclitaxel|mesh-list
84138798|NCT04181645|Gemcitabine|gemcitabine|mesh-list
84138799|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84138800|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138801|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
84138802|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
84138803|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
84138804|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138805|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84138806|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
84138807|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
84138808|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
84138809|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
84138810|NCT02679833|Vitamins|vitamins|mesh-ancestor
84138811|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
84138812|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138813|NCT02679833|Hematinics|hematinics|mesh-ancestor
84138814|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
84138815|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84138816|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
84138817|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84138818|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138819|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138820|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
84138821|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84138822|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138823|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138824|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84138825|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84138826|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84138827|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138828|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84138829|NCT02677571|Morphine|morphine|mesh-list
84138830|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
84138831|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84138832|NCT02677571|Narcotics|narcotics|mesh-ancestor
84138833|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138834|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138835|NCT02677571|Analgesics|analgesics|mesh-ancestor
84138836|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
84138837|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138838|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
84138839|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
84138840|NCT04181567|Agomelatine|agomelatine|mesh-list
84138841|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84138842|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138843|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138844|NCT05664191|Simendan|simendan|mesh-list
84138845|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84138846|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
84138847|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84138848|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84138849|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138850|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138851|NCT05664191|Protective Agents|protective agents|mesh-ancestor
84138852|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138853|NCT02676011|Atropine|atropine|mesh-list
84138854|NCT02676011|Succinylcholine|succinylcholine|mesh-list
84138855|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84138856|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84138857|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84138858|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
84138859|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138860|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138861|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84138862|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
84138863|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
84138864|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
84138865|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84138866|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84138867|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
84138868|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138869|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138870|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
84138871|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84138872|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84138873|NCT05662943|Aflibercept|aflibercept|mesh-list
84138874|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84138875|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84138876|NCT05662943|Growth Substances|growth substances|mesh-ancestor
84138877|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138878|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
84138879|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138880|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84138881|NCT05663255|Azithromycin|azithromycin|mesh-list
84138882|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84138884|NCT02678975|Temozolomide|temozolomide|mesh-list
84138885|NCT02678975|Lomustine|lomustine|mesh-list
84138886|NCT02678975|Disulfiram|disulfiram|mesh-list
84138887|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
84138888|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84138889|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138890|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138891|NCT02678975|Trace Elements|trace elements|mesh-ancestor
84138892|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
83430263|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84138893|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138894|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84138895|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
84138896|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138897|NCT02677415|Anesthetics|anesthetics|mesh-list
84138898|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
84138899|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84138900|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138901|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
84138902|NCT00454051|Omalizumab|omalizumab|mesh-list
84138903|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84138904|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84138905|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
84138906|NCT04181489|Prednisolone|prednisolone|mesh-list
84138907|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
84138908|NCT04181489|Rituximab|rituximab|mesh-list
84138909|NCT04181489|Doxorubicin|doxorubicin|mesh-list
84138910|NCT04181489|Vincristine|vincristine|mesh-list
84138911|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84138912|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
84138913|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138914|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84138915|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84138916|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
84138917|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138918|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138919|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84138920|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84138921|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84138922|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84138923|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84138924|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138925|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84138926|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
84138927|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
84138928|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
84138929|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138930|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
84138931|NCT04181489|Hormones|hormones|mesh-ancestor
84138932|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84138933|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84138934|NCT02537561|Cisplatin|cisplatin|mesh-list
84138935|NCT02537561|Gemcitabine|gemcitabine|mesh-list
84138936|NCT02537561|Talazoparib|talazoparib|mesh-list
84138937|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138938|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84138939|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
84138940|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138941|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84138942|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138943|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
84138944|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84138945|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
84138946|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138947|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138948|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84138949|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
84138950|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
84138951|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84138953|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84138954|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138955|NCT02679131|Belinostat|belinostat|mesh-list
84138956|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138957|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84138958|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84138959|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138960|NCT00484939|Bevacizumab|bevacizumab|mesh-list
84138961|NCT00484939|Capecitabine|capecitabine|mesh-list
84138962|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84138963|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138964|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84138965|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84138966|NCT00484939|Growth Substances|growth substances|mesh-ancestor
84138967|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138968|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
84138969|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84138970|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
84138971|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138972|NCT00642161|Budesonide|budesonide|mesh-list
84138973|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84138974|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84138975|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
84138976|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84138977|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84138978|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84138979|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
84138980|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
84138981|NCT00642161|Hormones|hormones|mesh-ancestor
84138982|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84138983|NCT05663177|Vinorelbine|vinorelbine|mesh-list
84138984|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84138985|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84138986|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
84138987|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
84138988|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
84138989|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138990|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
84138991|NCT00642551|Vitamin K|vitamin k|mesh-list
84138992|NCT00642551|Menaquinone 7|menaquinone 7|mesh-list
84138993|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84138994|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84138995|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84138996|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
84138997|NCT00642551|Coagulants|coagulants|mesh-ancestor
84138998|NCT00642551|Vitamins|vitamins|mesh-ancestor
84138999|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
84139000|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139001|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84139002|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84139003|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139004|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84139005|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84139006|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139007|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139008|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
84139009|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139010|NCT00643409|Azithromycin|azithromycin|mesh-list
84139011|NCT00643409|Levofloxacin|levofloxacin|mesh-list
84139012|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139013|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139014|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84139015|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84139016|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84139017|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139018|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139019|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139020|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84139021|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84139022|NCT04180007|Apatinib|apatinib|mesh-list
84139023|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139024|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84139025|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139026|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139027|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84139028|NCT02675309|Simvastatin|simvastatin|mesh-list
84139029|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84139030|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84139031|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
84139032|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139033|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84139034|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84139035|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139036|NCT01025245|Remifentanil|remifentanil|mesh-list
84139037|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84139038|NCT01025245|Narcotics|narcotics|mesh-ancestor
84139039|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139040|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139041|NCT01025245|Analgesics|analgesics|mesh-ancestor
84139042|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
84139043|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139044|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84139045|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84139046|NCT02677259|Estradiol|estradiol|mesh-list
84139047|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84139048|NCT02677259|Progesterone|progesterone|mesh-list
84139049|NCT02677259|Estrogens|estrogens|mesh-ancestor
84139050|NCT02677259|Hormones|hormones|mesh-ancestor
84139051|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139052|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139053|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84139054|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
84139055|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84139056|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84139057|NCT02677259|Progestins|progestins|mesh-ancestor
84139058|NCT02675387|Lidocaine|lidocaine|mesh-list
84139059|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
84139060|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
84139061|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139062|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139063|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
84139064|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139065|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84139066|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84139067|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84139068|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139069|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139070|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
84139071|NCT02678507|Narcotics|narcotics|mesh-ancestor
84139072|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139073|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139074|NCT02678507|Analgesics|analgesics|mesh-ancestor
84139075|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
84139076|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139077|NCT00464737|Rotigotine|rotigotine|mesh-list
84139078|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
84139079|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
84139080|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139081|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139082|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139083|NCT02678585|Lidocaine|lidocaine|mesh-list
84139084|NCT02678585|Nalbuphine|nalbuphine|mesh-list
84139085|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
84139086|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
84139087|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139088|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139089|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
84139090|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139091|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84139092|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84139093|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84139094|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139095|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139096|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84139097|NCT02678585|Narcotics|narcotics|mesh-ancestor
84139098|NCT02678585|Analgesics|analgesics|mesh-ancestor
84139099|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
84139100|NCT00453349|Metronidazole|metronidazole|mesh-list
84139101|NCT00453349|Levofloxacin|levofloxacin|mesh-list
84139102|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84139103|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139104|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139105|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84139106|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84139107|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139108|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139109|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139110|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84139111|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
84139112|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84139113|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139114|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84139115|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84139116|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84139117|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84139118|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84139119|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84139120|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84139121|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84139122|NCT02675153|Sirolimus|sirolimus|mesh-list
84139123|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139124|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139125|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84139126|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139127|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
84139128|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84139129|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
84139130|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139131|NCT04179617|Nicotine|nicotine|mesh-list
84139132|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84139133|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
84139134|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139135|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139136|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84139137|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84139138|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
84139139|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139140|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139141|NCT00464269|Brivaracetam|brivaracetam|mesh-list
84139142|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
84139143|NCT00642863|Vitamin D|vitamin d|mesh-list
84139144|NCT00642863|Vitamins|vitamins|mesh-list
84139145|NCT00642863|Vitamin A|vitamin a|mesh-list
84139146|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
84139147|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
84139148|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139149|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
84139150|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139151|NCT00642863|Protective Agents|protective agents|mesh-ancestor
84139152|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84139153|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139154|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84139155|NCT02674997|Factor VIII|factor viii|mesh-list
84139156|NCT02674997|Coagulants|coagulants|mesh-ancestor
84139157|NCT04178291|Erythritol|erythritol|mesh-list
84139158|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
84139159|NCT05372315|Dexamethasone|dexamethasone|mesh-list
84139160|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
84139161|NCT05372315|BB 1101|bb 1101|mesh-list
84139162|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84139163|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
84139164|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
84139165|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139166|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139167|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84139168|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
84139169|NCT05372315|Hormones|hormones|mesh-ancestor
84139170|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139171|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84139172|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139173|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
84139174|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139175|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139176|NCT00643643|Maraviroc|maraviroc|mesh-list
84139177|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84139178|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84139179|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139180|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84139181|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84139182|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
84139183|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139184|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84139185|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
84139186|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84139187|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139188|NCT02676869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84139189|NCT02676869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139190|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
84139191|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84139192|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84139193|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84139194|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139195|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139196|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
84139197|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139198|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139199|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84139200|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139201|NCT05584319|Empagliflozin|empagliflozin|mesh-list
84139202|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84139203|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139204|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84139205|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139206|NCT02676323|Leucovorin|leucovorin|mesh-list
84139207|NCT02676323|Cytarabine|cytarabine|mesh-list
84139208|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
84139209|NCT02676323|Methotrexate|methotrexate|mesh-list
84139210|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
84139211|NCT02676323|Fludarabine|fludarabine|mesh-list
84139212|NCT02676323|Panobinostat|panobinostat|mesh-list
84139213|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
84139214|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139215|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84139216|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
84139217|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84139218|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84139219|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
84139220|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139221|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139222|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
84139223|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139224|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84139225|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84139226|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
84139227|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84139228|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84139229|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
84139230|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139231|NCT02676323|Antidotes|antidotes|mesh-ancestor
84139232|NCT02676323|Protective Agents|protective agents|mesh-ancestor
84139233|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
84139234|NCT02676323|Vitamins|vitamins|mesh-ancestor
84139235|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
84139236|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84139237|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84139238|NCT00643799|Celecoxib|celecoxib|mesh-list
84139239|NCT00643799|Naproxen|naproxen|mesh-list
84139240|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84139241|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84139242|NCT00643799|Analgesics|analgesics|mesh-ancestor
84139243|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
84139244|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139245|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139246|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84139247|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84139248|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84139249|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84139250|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139251|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139252|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
84139253|NCT05348213|Decitabine|decitabine|mesh-list
84139254|NCT05348213|Pomalidomide|pomalidomide|mesh-list
84139255|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
84139256|NCT05348213|Tofacitinib|tofacitinib|mesh-list
84139257|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84139258|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
84139259|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139260|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139261|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139262|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
84139263|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139264|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84139265|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84139266|NCT05348213|Growth Substances|growth substances|mesh-ancestor
84139267|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
84139268|NCT05348213|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84139269|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84139270|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
84139271|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139272|NCT02674295|Esketamine|esketamine|mesh-list
84139273|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
84139274|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84139275|NCT04179071|Famotidine|famotidine|mesh-list
84139276|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84139277|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84139278|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84139279|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
84139280|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
84139281|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139282|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139283|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139284|NCT02674139|Copper|copper|mesh-list
84139285|NCT02674139|Trace Elements|trace elements|mesh-ancestor
84139286|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
84139287|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139288|NCT00644033|Frovatriptan|frovatriptan|mesh-list
84139289|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84139290|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
84139291|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139292|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139293|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139294|NCT00484315|Paclitaxel|paclitaxel|mesh-list
84139295|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84139296|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84139297|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139298|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
84139299|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
84139300|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
84139301|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139302|NCT01019083|Zinc|zinc|mesh-list
84139303|NCT01019083|Albendazole|albendazole|mesh-list
84139304|NCT01019083|Secnidazole|secnidazole|mesh-list
84139305|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
84139306|NCT01019083|Trace Elements|trace elements|mesh-ancestor
84139307|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
84139308|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139309|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
84139310|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84139311|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139312|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
84139313|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84139314|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84139315|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
84139316|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
84139317|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
84139318|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139319|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139320|NCT01019083|Astringents|astringents|mesh-ancestor
84139321|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
84139322|NCT00463801|Daptomycin|daptomycin|mesh-list
84139323|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139324|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139325|NCT02672345|Sevoflurane|sevoflurane|mesh-list
84139326|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84139327|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84139328|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
84139329|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
84139330|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139331|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139332|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
84139333|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84139334|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139335|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139336|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84139337|NCT02537249|Analgesics|analgesics|mesh-ancestor
84139338|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
84139339|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139340|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84139341|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84139342|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84139343|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
84139344|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139345|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139346|NCT00644111|Hydromorphone|hydromorphone|mesh-list
84139347|NCT00644111|Bupivacaine|bupivacaine|mesh-list
84139348|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
84139349|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
84139350|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139351|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139352|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
84139353|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139354|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84139355|NCT00644111|Narcotics|narcotics|mesh-ancestor
84139356|NCT00644111|Analgesics|analgesics|mesh-ancestor
84139357|NCT00644891|Amoxicillin|amoxicillin|mesh-list
84139359|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139360|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139361|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
84139362|NCT05203445|Olaparib|olaparib|mesh-list
84139363|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84139364|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139365|NCT05203445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84139366|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139367|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84139368|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139369|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84139370|NCT04178057|Antibodies|antibodies|mesh-list
84139371|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
84139372|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84139373|NCT04178057|Mitogens|mitogens|mesh-list
84139374|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
84139375|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
84139376|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139377|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139378|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
84139379|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139380|NCT04178057|Growth Substances|growth substances|mesh-ancestor
84139381|NCT04177043|Antibodies|antibodies|mesh-list
84139382|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
84139383|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
84139384|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139385|NCT02670785|Estradiol|estradiol|mesh-list
84139386|NCT02670785|Estrogens|estrogens|mesh-ancestor
84139387|NCT02670785|Hormones|hormones|mesh-ancestor
84139388|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139389|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139390|NCT02670317|Prednisone|prednisone|mesh-list
84139391|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
84139392|NCT02670317|Doxorubicin|doxorubicin|mesh-list
84139393|NCT02670317|Vincristine|vincristine|mesh-list
84139394|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
84139395|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84139396|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
84139397|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139398|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84139399|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84139400|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
84139401|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139402|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139403|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84139404|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84139405|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84139406|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84139407|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139408|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84139409|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
84139410|NCT02670317|Hormones|hormones|mesh-ancestor
84139411|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139412|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84139413|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84139414|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
84139415|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
84139416|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
84139417|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84139418|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
84139419|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84139420|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
84139421|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139422|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
84139423|NCT02671565|Protective Agents|protective agents|mesh-ancestor
84139424|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
84139425|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84139426|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
84139427|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84139428|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
84139429|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139430|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139431|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
84139432|NCT04175171|Trastuzumab|trastuzumab|mesh-list
84139433|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84139434|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139435|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
84139436|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139437|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139438|NCT00645125|Amoxicillin|amoxicillin|mesh-list
84139439|NCT00645125|Cefdinir|cefdinir|mesh-list
84139440|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139441|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139442|NCT02669459|Imiquimod|imiquimod|mesh-list
84139443|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84139444|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
84139445|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139446|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139447|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
84139448|NCT04176887|Phenytoin|phenytoin|mesh-list
84139449|NCT04176887|Levetiracetam|levetiracetam|mesh-list
84139450|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
84139451|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
84139452|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84139453|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84139454|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139455|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139456|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84139457|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84139458|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84139459|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139460|NCT00645203|Cefdinir|cefdinir|mesh-list
84139461|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139462|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139463|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
84139464|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84139465|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84139466|NCT02669303|Prednisolone|prednisolone|mesh-list
84139467|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
84139468|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84139469|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
84139470|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84139471|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
84139472|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
84139473|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139474|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139475|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84139476|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
84139477|NCT02669303|Hormones|hormones|mesh-ancestor
84139478|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139479|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84139480|NCT02669303|Protective Agents|protective agents|mesh-ancestor
84139481|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84139482|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139483|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84139484|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84139485|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84139486|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
84139487|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139488|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139489|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139490|NCT00645281|Urological Agents|urological agents|mesh-ancestor
84139492|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139493|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139494|NCT00645437|Levofloxacin|levofloxacin|mesh-list
84139495|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84139496|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139497|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139498|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84139499|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84139500|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139501|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139502|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139503|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84139504|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84139505|NCT02537171|Apatinib|apatinib|mesh-list
84139506|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139507|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84139508|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139509|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139510|NCT00645515|Risperidone|risperidone|mesh-list
84139511|NCT00645515|Ziprasidone|ziprasidone|mesh-list
84139512|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84139513|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
84139514|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139515|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139516|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139517|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84139518|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84139519|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139520|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84139521|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84139522|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
84139523|NCT00644735|Esomeprazole|esomeprazole|mesh-list
84139524|NCT00644735|Lansoprazole|lansoprazole|mesh-list
84139525|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
84139526|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84139527|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84139528|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84139529|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139530|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139531|NCT02667743|Paclitaxel|paclitaxel|mesh-list
84139532|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84139533|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84139534|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139535|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
84139536|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
84139537|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
84139538|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139539|NCT02666651|Tolvaptan|tolvaptan|mesh-list
84139540|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84139541|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139542|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
84139543|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139544|NCT02671175|Piperaquine|piperaquine|mesh-list
84139545|NCT02671175|Artenimol|artenimol|mesh-list
84139546|NCT02671175|Artemisinins|artemisinins|mesh-list
84139547|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
84139548|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84139549|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84139550|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139551|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84139552|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84139553|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84139554|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
84139555|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139556|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84139557|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84139558|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139559|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
84139561|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139562|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139563|NCT02667197|Analgesics|analgesics|mesh-ancestor
84139564|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
84139565|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139566|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
84139567|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
84139568|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84139569|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
84139570|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139571|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139572|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84139573|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
84139574|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84139575|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84139576|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84139577|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
84139578|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139579|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139580|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
84139581|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84139582|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
84139583|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84139584|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
84139585|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
84139586|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139587|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139588|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84139589|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84139590|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
84139591|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139592|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139593|NCT00646841|Doxazosin|doxazosin|mesh-list
84139594|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84139595|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84139596|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84139597|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84139598|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
84139599|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139600|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139601|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139602|NCT04786067|Abatacept|abatacept|mesh-list
84139603|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84139604|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139605|NCT04786067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84139606|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139607|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84139608|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
84139609|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139610|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84139611|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
84139612|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139613|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139614|NCT00484159|Lidocaine|lidocaine|mesh-list
84139615|NCT00484159|Bupivacaine|bupivacaine|mesh-list
84139616|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
84139617|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
84139618|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139619|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139620|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
84139621|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139622|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84139623|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84139624|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84139625|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139626|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139628|NCT02666417|Trace Elements|trace elements|mesh-ancestor
84139629|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
84139630|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139631|NCT00910637|Gestodene|gestodene|mesh-list
84139632|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84139633|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84139634|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84139635|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
84139636|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84139637|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139638|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84139639|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84139640|NCT00910637|Progestins|progestins|mesh-ancestor
84139641|NCT00910637|Hormones|hormones|mesh-ancestor
84139642|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139643|NCT00462865|Bevacizumab|bevacizumab|mesh-list
84139644|NCT00462865|Gemcitabine|gemcitabine|mesh-list
84139645|NCT00462865|Capecitabine|capecitabine|mesh-list
84139646|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84139647|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139648|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84139649|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84139650|NCT00462865|Growth Substances|growth substances|mesh-ancestor
84139651|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139652|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
84139653|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84139654|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
84139655|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139656|NCT02667353|Anesthetics|anesthetics|mesh-list
84139657|NCT02667353|Etomidate|etomidate|mesh-list
84139658|NCT02667353|Succinylcholine|succinylcholine|mesh-list
84139659|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139660|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139661|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84139662|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84139663|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
84139664|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
84139665|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84139666|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84139667|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139668|NCT00462709|Complement C1s|complement c1s|mesh-list
84139669|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
84139670|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
84139671|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
84139672|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139673|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84139674|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84139675|NCT02664857|Vitamin D|vitamin d|mesh-list
84139676|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
84139677|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
84139678|NCT02664857|Vitamins|vitamins|mesh-list
84139679|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
84139680|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139681|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84139682|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84139683|NCT02665871|Vaccines|vaccines|mesh-list
84139684|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
84139685|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139686|NCT00647543|Atorvastatin|atorvastatin|mesh-list
84139687|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84139688|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84139689|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
84139690|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139691|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84139692|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84139693|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139694|NCT00647621|Phenytoin|phenytoin|mesh-list
84139695|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
84139696|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84139697|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84139698|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139699|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139700|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84139701|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84139702|NCT00461305|Drospirenone|drospirenone|mesh-list
84139703|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84139704|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
84139705|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139706|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139707|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84139708|NCT00461305|Diuretics|diuretics|mesh-ancestor
84139709|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
84139710|NCT01022671|Belotecan|belotecan|mesh-list
84139711|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84139712|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84139713|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139714|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139715|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139716|NCT01022749|Vaccines|vaccines|mesh-list
84139717|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
84139718|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139719|NCT00645905|Adalimumab|adalimumab|mesh-list
84139720|NCT00645905|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84139721|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84139722|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84139723|NCT00647777|Olanzapine|olanzapine|mesh-list
84139724|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
84139725|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
84139726|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139727|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139728|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84139729|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84139730|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84139731|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139732|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84139733|NCT00647777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84139734|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84139735|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139736|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139737|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139738|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
84139739|NCT04173611|Bupivacaine|bupivacaine|mesh-list
84139740|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
84139741|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
84139742|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139743|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139744|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
84139745|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139746|NCT02665637|Trastuzumab|trastuzumab|mesh-list
84139747|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84139748|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139749|NCT04733183|Dacarbazine|dacarbazine|mesh-list
84139750|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84139751|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
84139752|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139753|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139754|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84139755|NCT00648011|Quinapril|quinapril|mesh-list
84139756|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84139757|NCT00648011|Diuretics|diuretics|mesh-ancestor
84139758|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
84139759|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139760|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84139761|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139762|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139763|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84139764|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
84139765|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139766|NCT00646529|Budesonide|budesonide|mesh-list
84139767|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
84139768|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84139769|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84139770|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84139771|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
84139772|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139773|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139774|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84139775|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
84139776|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
84139777|NCT00646529|Hormones|hormones|mesh-ancestor
84139778|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139779|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84139780|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84139781|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84139782|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
84139783|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139784|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139785|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
84139786|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84139787|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139788|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
84139789|NCT00646607|Leucovorin|leucovorin|mesh-list
84139790|NCT00646607|Fluorouracil|fluorouracil|mesh-list
84139791|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
84139792|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
84139793|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
84139794|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139795|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84139796|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139797|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84139798|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
84139799|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139800|NCT00646607|Antidotes|antidotes|mesh-ancestor
84139801|NCT00646607|Protective Agents|protective agents|mesh-ancestor
84139802|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
84139803|NCT00646607|Vitamins|vitamins|mesh-ancestor
84139804|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
84139805|NCT00856544|Tofacitinib|tofacitinib|mesh-list
84139806|NCT00856544|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84139807|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84139808|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139809|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139810|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84139811|NCT00648323|Doxazosin|doxazosin|mesh-list
84139812|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84139813|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84139814|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84139815|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84139816|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
84139817|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139818|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139819|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139820|NCT00856388|Fludarabine|fludarabine|mesh-list
84139821|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
84139822|NCT00856388|Melphalan|melphalan|mesh-list
84139823|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
84139824|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84139825|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
84139826|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139827|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84139828|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
84139829|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139830|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84139831|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
84139832|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139833|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84139834|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
84139835|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84139836|NCT00648401|Verapamil|verapamil|mesh-list
84139837|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84139838|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84139839|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139840|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139841|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84139842|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139843|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
84139844|NCT02663999|Diazepam|diazepam|mesh-list
84139845|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84139846|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
84139847|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
84139848|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
84139849|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139850|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139851|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84139852|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84139853|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139854|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84139855|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84139856|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84139857|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84139858|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84139859|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84139860|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
84139861|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
84139862|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
84139863|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
84139864|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139865|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139866|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
84139867|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
84139868|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84139869|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139870|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139871|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
84139872|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84139873|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139874|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139875|NCT04171739|Itraconazole|itraconazole|mesh-list
84139876|NCT04171739|Olorofim|olorofim|mesh-list
84139877|NCT04171739|Rifampin|rifampin|mesh-list
84139878|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
84139879|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139880|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84139881|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84139882|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139883|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139884|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84139885|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
84139886|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139887|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139888|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84139889|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84139890|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
84139891|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84139892|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
84139893|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84139894|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84139895|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84139896|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84139897|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84139898|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84139899|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84139900|NCT02656121|Vitamin D|vitamin d|mesh-list
84139901|NCT02656121|Clomiphene|clomiphene|mesh-list
84139902|NCT02656121|Vitamins|vitamins|mesh-ancestor
84139903|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
84139904|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139905|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84139906|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84139907|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
84139908|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139909|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84139910|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
84139911|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84139912|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84139913|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84139914|NCT00648713|Terbinafine|terbinafine|mesh-list
84139915|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
84139916|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84139917|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139918|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139919|NCT00649883|Vaccines|vaccines|mesh-list
84139920|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
84139921|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139923|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84139924|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84139925|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139926|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139927|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
84139928|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84139929|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139930|NCT00648791|Urological Agents|urological agents|mesh-ancestor
84139931|NCT00649181|Metolazone|metolazone|mesh-list
84139932|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84139933|NCT00649181|Diuretics|diuretics|mesh-ancestor
84139934|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
84139935|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139936|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84139937|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139938|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139939|NCT02655965|Clonidine|clonidine|mesh-list
84139940|NCT02655965|Ropivacaine|ropivacaine|mesh-list
84139941|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
84139942|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
84139943|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139944|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139945|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
84139946|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139947|NCT02655965|Analgesics|analgesics|mesh-ancestor
84139948|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84139949|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
84139950|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
84139951|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84139952|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84139953|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84139954|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
84139955|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139956|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139957|NCT04170179|Lenvatinib|lenvatinib|mesh-list
84139958|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139959|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84139960|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84139961|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139962|NCT02659085|Ketamine|ketamine|mesh-list
84139963|NCT02659085|Analgesics|analgesics|mesh-ancestor
84139964|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
84139965|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84139966|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139967|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84139968|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84139969|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
84139970|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
84139971|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139972|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84139973|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84139974|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139975|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139976|NCT04171193|Isoflurane|isoflurane|mesh-list
84139977|NCT04171193|Sertraline|sertraline|mesh-list
84139978|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
84139979|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84139980|NCT04171193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84139981|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84139982|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84139983|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84139984|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84139985|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
84139986|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139987|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84139988|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
84139989|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
84139990|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84139991|NCT02663141|Bevacizumab|bevacizumab|mesh-list
84139992|NCT02663141|Losartan|losartan|mesh-list
84139993|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83380737|NCT03661411|Clopidogrel|clopidogrel|mesh-list
84139994|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84139995|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84139996|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84139997|NCT02663141|Growth Substances|growth substances|mesh-ancestor
84139998|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84139999|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
84140000|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84140001|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84140002|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84140003|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84140004|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140005|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
84140006|NCT04171349|Carticaine|carticaine|mesh-list
84140007|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84140008|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140009|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140010|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140011|NCT04171349|Analgesics|analgesics|mesh-ancestor
84140012|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
84140013|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140014|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84140015|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84140016|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84140017|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
84140018|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140019|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140020|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140021|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
84140022|NCT00650039|Valdecoxib|valdecoxib|mesh-list
84140023|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84140024|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84140025|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140026|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140027|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140028|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140029|NCT00650039|Analgesics|analgesics|mesh-ancestor
84140030|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
84140031|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140032|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140033|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140034|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140035|NCT00649259|Oxybutynin|oxybutynin|mesh-list
84140036|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
84140037|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
84140038|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140039|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140040|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84140041|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84140042|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
84140043|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140044|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140045|NCT00649259|Urological Agents|urological agents|mesh-ancestor
84140046|NCT04401059|Gefitinib|gefitinib|mesh-list
84140047|NCT04401059|Osimertinib|osimertinib|mesh-list
84140048|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140049|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84140050|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140051|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140052|NCT02658773|Lidocaine|lidocaine|mesh-list
84140053|NCT02658773|Prilocaine|prilocaine|mesh-list
84140054|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
84140055|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140056|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
84140057|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140058|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140059|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
84140060|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140061|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84140062|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84140063|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84140064|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140065|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140066|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
84140068|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140069|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140070|NCT04169945|Erythritol|erythritol|mesh-list
84140071|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
84140072|NCT04169867|Nivolumab|nivolumab|mesh-list
84140073|NCT04169867|Ipilimumab|ipilimumab|mesh-list
84140074|NCT04169867|Atezolizumab|atezolizumab|mesh-list
84140075|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140076|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140077|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84140078|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140079|NCT02655029|Amlodipine|amlodipine|mesh-list
84140080|NCT02655029|Perindopril|perindopril|mesh-list
84140081|NCT02655029|Indapamide|indapamide|mesh-list
84140082|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84140083|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84140084|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140085|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140086|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84140087|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140088|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
84140089|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84140090|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
84140091|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140092|NCT02655029|Diuretics|diuretics|mesh-ancestor
84140093|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
84140094|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84140095|NCT02536859|Insulin|insulin|mesh-list
84140096|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84140097|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
84140098|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140099|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140100|NCT02536937|Eliglustat|eliglustat|mesh-list
84140101|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140102|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140103|NCT02654561|Heparin|heparin|mesh-list
84140104|NCT02654561|Calcium heparin|calcium heparin|mesh-list
84140105|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
84140106|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84140107|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84140108|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140109|NCT02654405|Butyric Acid|butyric acid|mesh-list
84140110|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
84140111|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
84140112|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140113|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140114|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140115|NCT00649415|Valdecoxib|valdecoxib|mesh-list
84140116|NCT00649415|Piroxicam|piroxicam|mesh-list
84140117|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84140118|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84140119|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140120|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140121|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140122|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140123|NCT00649415|Analgesics|analgesics|mesh-ancestor
84140124|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
84140125|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140126|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140127|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140128|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140129|NCT00650117|Fentanyl|fentanyl|mesh-list
84140130|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84140131|NCT00650117|Narcotics|narcotics|mesh-ancestor
84140132|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140133|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140134|NCT00650117|Analgesics|analgesics|mesh-ancestor
84140135|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
84140136|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140137|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84140138|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84140139|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
84140140|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
84140141|NCT00648947|Clopidogrel|clopidogrel|mesh-list
84140142|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84140143|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84140144|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84140145|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84140146|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
84140147|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140148|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140149|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140150|NCT00649493|Rabeprazole|rabeprazole|mesh-list
84140151|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84140152|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84140153|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84140154|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140155|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140156|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
84140157|NCT02654093|Vitamin D|vitamin d|mesh-list
84140158|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
84140159|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84140160|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140161|NCT02654093|Vitamins|vitamins|mesh-ancestor
84140162|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
84140163|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84140164|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84140165|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
84140166|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140167|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84140168|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84140169|NCT04168619|Methotrexate|methotrexate|mesh-list
84140170|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84140171|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
84140172|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84140173|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140174|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140175|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
84140176|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140177|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140178|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
84140179|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140180|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84140181|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140182|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
84140183|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140184|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84140185|NCT02654171|Ziresovir|ziresovir|mesh-list
84140186|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
84140187|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140188|NCT00650195|Metolazone|metolazone|mesh-list
84140189|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84140190|NCT00650195|Diuretics|diuretics|mesh-ancestor
84140191|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
84140192|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140193|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84140194|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140195|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140196|NCT04170959|Metformin|metformin|mesh-list
84140197|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140198|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140199|NCT00848354|Etanercept|etanercept|mesh-list
84140200|NCT00848354|Methotrexate|methotrexate|mesh-list
84140201|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84140202|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
84140203|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84140204|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140205|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140206|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
84140207|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140208|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140209|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
84140210|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140211|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84140212|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140213|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
84140214|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140215|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84140216|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140217|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140218|NCT00848354|Analgesics|analgesics|mesh-ancestor
84140219|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
84140220|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140221|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140222|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84140223|NCT00600821|Paclitaxel|paclitaxel|mesh-list
84140224|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84140225|NCT00600821|Bevacizumab|bevacizumab|mesh-list
84140226|NCT00600821|Carboplatin|carboplatin|mesh-list
84140227|NCT00600821|Axitinib|axitinib|mesh-list
84140228|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84140229|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140230|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
84140231|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
84140232|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
84140233|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140234|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140235|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84140236|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84140237|NCT00600821|Growth Substances|growth substances|mesh-ancestor
84140238|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140239|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
84140240|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84140241|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140242|NCT00699764|Vaccines|vaccines|mesh-list
84140243|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
84140244|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140245|NCT02653703|Ethanol|ethanol|mesh-list
84140246|NCT02653703|Menthol|menthol|mesh-list
84140247|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84140248|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140249|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140250|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140251|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
84140252|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
84140253|NCT00649571|Doxycycline|doxycycline|mesh-list
84140254|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84140255|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140256|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
84140257|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84140258|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84140259|NCT02662283|Acteoside|acteoside|mesh-list
84140260|NCT02662283|Prednisolone|prednisolone|mesh-list
84140261|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140262|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
84140263|NCT02662283|Hormones|hormones|mesh-ancestor
84140264|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140265|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140266|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84140267|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140268|NCT02662283|Protective Agents|protective agents|mesh-ancestor
84140269|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140270|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84140271|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
84140272|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140273|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
84140274|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
84140275|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140276|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
84140277|NCT02657603|Lidocaine|lidocaine|mesh-list
84140278|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140279|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
84140280|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140281|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140282|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
84140283|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140284|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84140285|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84140286|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84140287|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140288|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140289|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83381047|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
84140290|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
84140291|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
84140292|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140293|NCT00649649|Quinapril|quinapril|mesh-list
84140294|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84140295|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
84140296|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140297|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140298|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84140299|NCT02657291|Ropivacaine|ropivacaine|mesh-list
84140300|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140301|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
84140302|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140303|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140304|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
84140305|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140306|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
84140307|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
84140308|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84140309|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84140310|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140311|NCT02661893|Rifampin|rifampin|mesh-list
84140312|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84140313|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
84140314|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84140315|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140316|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
84140317|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84140318|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140319|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140320|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84140321|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84140322|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84140323|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84140324|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84140325|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84140326|NCT00855920|Indomethacin|indomethacin|mesh-list
84140327|NCT00855920|Rilonacept|rilonacept|mesh-list
84140328|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140329|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140330|NCT00855920|Analgesics|analgesics|mesh-ancestor
84140331|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
84140332|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140333|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140334|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140335|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140336|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
84140337|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
84140338|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84140339|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84140340|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140341|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140342|NCT02657213|Insulin|insulin|mesh-list
84140343|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84140344|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140345|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140346|NCT00649727|Oxybutynin|oxybutynin|mesh-list
84140347|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
84140348|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
84140349|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140350|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140351|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84140352|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84140353|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
84140354|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140355|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140356|NCT00649727|Urological Agents|urological agents|mesh-ancestor
84140357|NCT00650273|Azithromycin|azithromycin|mesh-list
84140358|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84140359|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140360|NCT00698126|Insulin|insulin|mesh-list
84140361|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84140362|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
84140363|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
84140364|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140365|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140366|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
84140367|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
84140368|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140369|NCT02656901|Anesthetics|anesthetics|mesh-list
84140370|NCT02656901|Sevoflurane|sevoflurane|mesh-list
84140371|NCT02656901|Desflurane|desflurane|mesh-list
84140372|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140373|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140374|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84140375|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84140376|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
84140377|NCT00847886|Methotrexate|methotrexate|mesh-list
84140378|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84140379|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
84140380|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84140381|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140382|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140383|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
84140384|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140385|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140386|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
84140387|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140388|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84140389|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140390|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
84140391|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140392|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84140393|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
84140394|NCT00847808|Lansoprazole|lansoprazole|mesh-list
84140395|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84140396|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84140397|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84140398|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140399|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140400|NCT02656979|Latanoprost|latanoprost|mesh-list
84140401|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84140402|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84140403|NCT04017455|Bevacizumab|bevacizumab|mesh-list
84140404|NCT04017455|Atezolizumab|atezolizumab|mesh-list
84140405|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140406|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140407|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84140408|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84140409|NCT04017455|Growth Substances|growth substances|mesh-ancestor
84140410|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140411|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
84140412|NCT04017455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84140413|NCT04017455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140414|NCT05298020|Paclitaxel|paclitaxel|mesh-list
84140415|NCT05298020|Gemcitabine|gemcitabine|mesh-list
84140416|NCT05298020|Endostar protein|endostar protein|mesh-list
84140417|NCT05298020|Endostatins|endostatins|mesh-list
84140418|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84140419|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140420|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
84140421|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
84140422|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
84140423|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140424|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140425|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
84140426|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140427|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84140428|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84140429|NCT05298020|Growth Substances|growth substances|mesh-ancestor
84140430|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
84140431|NCT04170647|Plasminogen|plasminogen|mesh-list
84140432|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84140433|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84140434|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140435|NCT02661347|Risperidone|risperidone|mesh-list
84140436|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84140437|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
84140438|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140439|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140440|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140442|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84140443|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140444|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84140445|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84140446|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
84140447|NCT00649805|Verapamil|verapamil|mesh-list
84140448|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84140449|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84140450|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140451|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140452|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84140453|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140454|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
84140455|NCT02656589|Capecitabine|capecitabine|mesh-list
84140456|NCT02656589|Trastuzumab|trastuzumab|mesh-list
84140457|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140458|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
84140459|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140460|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140461|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140462|NCT00600353|Dexamethasone|dexamethasone|mesh-list
84140463|NCT00600353|Aprepitant|aprepitant|mesh-list
84140464|NCT00600353|Palonosetron|palonosetron|mesh-list
84140465|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140466|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
84140467|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
84140468|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140469|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140470|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84140471|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
84140472|NCT00600353|Hormones|hormones|mesh-ancestor
84140473|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140474|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84140475|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140476|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84140477|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140478|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140479|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84140480|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84140481|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
84140482|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
84140483|NCT02661191|Vitamin D|vitamin d|mesh-list
84140484|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84140485|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140486|NCT02661191|Vitamins|vitamins|mesh-ancestor
84140487|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
84140488|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84140489|NCT00691210|Niacinamide|niacinamide|mesh-list
84140490|NCT00691210|Niacin|niacin|mesh-list
84140491|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
84140492|NCT00691210|Etoposide|etoposide|mesh-list
84140493|NCT00691210|Vorinostat|vorinostat|mesh-list
84140494|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84140495|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140496|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84140497|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84140498|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140499|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140500|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84140501|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
84140502|NCT00691210|Vitamins|vitamins|mesh-ancestor
84140503|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
84140504|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140505|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84140506|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
84140507|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84140508|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
84140509|NCT02652065|Acetylcholine|acetylcholine|mesh-list
84140510|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
84140511|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84140512|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
84140513|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140514|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140515|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140516|NCT00650429|Ziprasidone|ziprasidone|mesh-list
84140517|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84140518|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
84140519|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140520|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140521|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140522|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84140523|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84140524|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140525|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84140526|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84140527|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
84140528|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
84140529|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140530|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140531|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84140532|NCT00691132|Protective Agents|protective agents|mesh-ancestor
84140533|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140534|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140535|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
84140536|NCT02651753|Atorvastatin|atorvastatin|mesh-list
84140537|NCT02651753|Fenofibrate|fenofibrate|mesh-list
84140538|NCT02651753|Calcium|calcium|mesh-list
84140539|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84140540|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140541|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84140542|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84140543|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84140544|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
84140545|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140546|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84140547|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84140548|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140549|NCT00855218|Sorafenib|sorafenib|mesh-list
84140550|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140551|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84140552|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140553|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140554|NCT00748150|Vaccines|vaccines|mesh-list
84140555|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
84140556|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140557|NCT02651519|Ropivacaine|ropivacaine|mesh-list
84140558|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140559|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
84140560|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140561|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140562|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
84140563|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140564|NCT02651441|Gemcitabine|gemcitabine|mesh-list
84140565|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140566|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140567|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
84140568|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140569|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
84140570|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84140571|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
84140572|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140573|NCT01063348|Expectorants|expectorants|mesh-ancestor
84140574|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
84140575|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84140576|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
84140577|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140578|NCT01063348|Protective Agents|protective agents|mesh-ancestor
84140579|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140580|NCT01063348|Antidotes|antidotes|mesh-ancestor
84140581|NCT00855062|Minocycline|minocycline|mesh-list
84140582|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84140583|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140584|NCT00744250|Pancrelipase|pancrelipase|mesh-list
84140585|NCT00744250|Pancreatin|pancreatin|mesh-list
84140586|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84140587|NCT02651207|Lidocaine|lidocaine|mesh-list
84140588|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
84140589|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
84140590|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140591|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
84140592|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140593|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140594|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
84140595|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140596|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84140597|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84140598|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84140599|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140600|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140601|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84140602|NCT02564536|Decitabine|decitabine|mesh-list
84140603|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140604|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
84140605|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140606|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140607|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140608|NCT00600119|Naloxegol|naloxegol|mesh-list
84140609|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84140610|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140611|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
84140612|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140613|NCT00866294|Paroxetine|paroxetine|mesh-list
84140614|NCT00866294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84140615|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84140616|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140617|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140618|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140619|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
84140620|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140621|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84140622|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
84140623|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84140624|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84140625|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84140626|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140627|NCT02660255|Cannabidiol|cannabidiol|mesh-list
84140628|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
84140629|NCT00649103|Quinapril|quinapril|mesh-list
84140630|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84140631|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
84140632|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140633|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140634|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84140635|NCT02660177|Dipyrone|dipyrone|mesh-list
84140636|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140637|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140638|NCT02660177|Analgesics|analgesics|mesh-ancestor
84140639|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
84140640|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140641|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140642|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140643|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140644|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
84140645|NCT00701246|Folic Acid|folic acid|mesh-list
84140646|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
84140647|NCT00701246|Hematinics|hematinics|mesh-ancestor
84140648|NCT00701246|Vitamins|vitamins|mesh-ancestor
84140649|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
84140650|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140651|NCT02648711|Leucovorin|leucovorin|mesh-list
84140652|NCT02648711|Bevacizumab|bevacizumab|mesh-list
84140653|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
84140654|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140655|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140656|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84140657|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84140658|NCT02648711|Growth Substances|growth substances|mesh-ancestor
84140659|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140660|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
84140661|NCT02648711|Antidotes|antidotes|mesh-ancestor
84140662|NCT02648711|Protective Agents|protective agents|mesh-ancestor
84140663|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
84140664|NCT02648711|Vitamins|vitamins|mesh-ancestor
83381417|NCT00005803|Melphalan|melphalan|mesh-list
84140665|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
84140666|NCT00854360|Beclomethasone|beclomethasone|mesh-list
84140667|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140668|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
84140669|NCT00854360|Hormones|hormones|mesh-ancestor
84140670|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140671|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140672|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84140673|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
84140674|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
84140675|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84140676|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140677|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84140678|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84140679|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140680|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140681|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140682|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84140683|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84140684|NCT02648633|Nivolumab|nivolumab|mesh-list
84140685|NCT02648633|Valproic Acid|valproic acid|mesh-list
84140686|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140687|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140688|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84140689|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140690|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
84140691|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140692|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
84140693|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140694|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140695|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
84140696|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84140697|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140698|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84140699|NCT00853970|Bromfenac|bromfenac|mesh-list
84140700|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84140701|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84140702|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140703|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140704|NCT00853970|Analgesics|analgesics|mesh-ancestor
84140705|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
84140706|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140707|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140708|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140709|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140710|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84140711|NCT00651287|Quinapril|quinapril|mesh-list
84140712|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84140713|NCT00651287|Diuretics|diuretics|mesh-ancestor
84140714|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
84140715|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140716|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84140717|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140718|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140719|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84140720|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
84140721|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140722|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84140723|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140724|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140725|NCT02650427|Incretins|incretins|mesh-ancestor
84140726|NCT02650427|Hormones|hormones|mesh-ancestor
84140727|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140728|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84140729|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
84140730|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140731|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140732|NCT02644811|Anesthetics|anesthetics|mesh-list
84140733|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140734|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140735|NCT00651443|Galiximab|galiximab|mesh-list
84140736|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140737|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140738|NCT00650897|Escitalopram|escitalopram|mesh-list
84140739|NCT00650897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84140740|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84140741|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140742|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140743|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140744|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
84140745|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140747|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
84140748|NCT02644499|Prednisolone|prednisolone|mesh-list
84140749|NCT02644499|Methotrexate|methotrexate|mesh-list
84140750|NCT02644499|Leflunomide|leflunomide|mesh-list
84140751|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
84140752|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84140753|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
84140754|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84140755|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140756|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84140757|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
84140758|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140759|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140760|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
84140761|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140762|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84140763|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140764|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
84140765|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140766|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84140767|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140768|NCT02644499|Hormones|hormones|mesh-ancestor
84140769|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140770|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84140771|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
84140772|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84140773|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84140774|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140775|NCT02644499|Hematinics|hematinics|mesh-ancestor
84140776|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
84140777|NCT02644499|Vitamins|vitamins|mesh-ancestor
84140778|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
84140779|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
84140780|NCT00652691|Carboplatin|carboplatin|mesh-list
84140781|NCT00652691|Topotecan|topotecan|mesh-list
84140782|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140783|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
84140784|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140785|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140786|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84140787|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
84140788|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140789|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140790|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84140791|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84140792|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84140793|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140794|NCT02649179|Ropivacaine|ropivacaine|mesh-list
84140795|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140796|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
84140797|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140798|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140799|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
84140800|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140801|NCT02644577|Metformin|metformin|mesh-list
84140802|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140803|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140804|NCT02644421|Lidocaine|lidocaine|mesh-list
84140805|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140806|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
84140807|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140808|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140809|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
84140810|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140811|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84140812|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84140813|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84140814|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84140815|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140816|NCT00651599|Drospirenone|drospirenone|mesh-list
84140818|NCT00651599|Estrogens|estrogens|mesh-ancestor
84140819|NCT00651599|Hormones|hormones|mesh-ancestor
84140820|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140821|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140822|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84140823|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
84140824|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84140825|NCT00651599|Diuretics|diuretics|mesh-ancestor
84140826|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
84140827|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84140828|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
84140829|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84140830|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
84140831|NCT02536391|Ipatasertib|ipatasertib|mesh-list
84140832|NCT02536391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140833|NCT02536391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84140834|NCT02536391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140835|NCT02536391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140836|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84140837|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84140838|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
84140839|NCT00651131|Daptomycin|daptomycin|mesh-list
84140840|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84140841|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140842|NCT04167137|Atezolizumab|atezolizumab|mesh-list
84140843|NCT04167137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84140844|NCT04167137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140845|NCT04167137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140846|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140847|NCT02649413|Prednisone|prednisone|mesh-list
84140848|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140849|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
84140850|NCT02649413|Hormones|hormones|mesh-ancestor
84140851|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84140852|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140853|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84140854|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140855|NCT02643563|Epinephrine|epinephrine|mesh-list
84140856|NCT02643563|Bupivacaine|bupivacaine|mesh-list
84140857|NCT02643563|Ropivacaine|ropivacaine|mesh-list
84140858|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
84140859|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
84140860|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140861|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140862|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
84140863|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140864|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84140865|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84140866|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
84140867|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140868|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140869|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84140870|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84140871|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
84140872|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84140873|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
84140874|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
84140875|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
84140876|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84140877|NCT00651209|Tenofovir|tenofovir|mesh-list
84140878|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
84140879|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140880|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84140881|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84140882|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140883|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140884|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84140885|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84140886|NCT00652925|Celecoxib|celecoxib|mesh-list
84140887|NCT00652925|Naproxen|naproxen|mesh-list
84140888|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140889|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140890|NCT00652925|Analgesics|analgesics|mesh-ancestor
84140891|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
84140892|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140893|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140894|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140895|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140896|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84140897|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84140898|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140899|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140900|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
84140901|NCT00653003|Leflunomide|leflunomide|mesh-list
84140902|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140903|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140904|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140905|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
84140906|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140907|NCT02643719|Topiramate|topiramate|mesh-list
84140908|NCT02643719|Naproxen|naproxen|mesh-list
84140909|NCT02643719|Sumatriptan|sumatriptan|mesh-list
84140910|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140911|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140912|NCT02643719|Analgesics|analgesics|mesh-ancestor
84140913|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
84140914|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140915|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140916|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140917|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140918|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
84140919|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84140920|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140921|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140922|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
84140923|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140924|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84140925|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84140926|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84140927|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
84140928|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140929|NCT02649101|Thalidomide|thalidomide|mesh-list
84140930|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84140931|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
84140932|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140933|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
84140934|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84140935|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84140936|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84140937|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84140938|NCT02649101|Growth Substances|growth substances|mesh-ancestor
84140939|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
84140940|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140941|NCT00700154|Insulin|insulin|mesh-list
84140942|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84140943|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
84140944|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140945|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140946|NCT00651911|Rasburicase|rasburicase|mesh-list
84140947|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
84140948|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140949|NCT02643407|Docetaxel|docetaxel|mesh-list
84140950|NCT02643407|Nedaplatin|nedaplatin|mesh-list
84140951|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140952|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
84140953|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
84140954|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
84140955|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140956|NCT02643329|Gliclazide|gliclazide|mesh-list
84140957|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84140958|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140959|NCT03245489|Aspirin|aspirin|mesh-list
84140960|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
84140961|NCT03245489|Clopidogrel|clopidogrel|mesh-list
84140962|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84140963|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84140964|NCT03245489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83381729|NCT00762177|Triclosan|triclosan|mesh-list
84140965|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140966|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84140967|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140968|NCT03245489|Analgesics|analgesics|mesh-ancestor
84140969|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
84140970|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140971|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140972|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84140973|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84140974|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84140975|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84140976|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84140977|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84140978|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84140979|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
84140980|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84140981|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84140982|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84140983|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
84140984|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140985|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
84140986|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84140987|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84140988|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84140989|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84140990|NCT02643017|Analgesics|analgesics|mesh-ancestor
84140991|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
84140992|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84140993|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84140994|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84140995|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84140996|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
84140997|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84140998|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84140999|NCT02643173|Anesthetics|anesthetics|mesh-list
84141000|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
84141001|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141002|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141003|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
84141004|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
84141005|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84141006|NCT02646137|Estrogens|estrogens|mesh-ancestor
84141007|NCT02646137|Hormones|hormones|mesh-ancestor
84141008|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141009|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141010|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84141011|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141012|NCT00653549|Torsemide|torsemide|mesh-list
84141013|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84141014|NCT00653549|Diuretics|diuretics|mesh-ancestor
84141015|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
84141016|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141017|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84141018|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84141019|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141020|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
84141021|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
84141022|NCT02642861|Calcium|calcium|mesh-list
84141023|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84141024|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141025|NCT02642861|Antacids|antacids|mesh-ancestor
84141026|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141027|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141028|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84141029|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
84141030|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141031|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84141032|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84141033|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141034|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84141035|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141036|NCT02641457|Ranibizumab|ranibizumab|mesh-list
83381805|NCT02403193|Spartalizumab|spartalizumab|mesh-list
84141038|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141039|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141040|NCT02641457|Growth Substances|growth substances|mesh-ancestor
84141041|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141042|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141043|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141044|NCT02642939|Mifepristone|mifepristone|mesh-list
84141045|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84141046|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
84141047|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84141048|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141049|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84141050|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84141051|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84141052|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
84141053|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84141054|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84141055|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
84141056|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141057|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
84141058|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84141059|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84141060|NCT02641301|Morphine|morphine|mesh-list
84141061|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84141062|NCT02641301|Narcotics|narcotics|mesh-ancestor
84141063|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141064|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141065|NCT02641301|Analgesics|analgesics|mesh-ancestor
84141066|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
84141067|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141068|NCT03679949|Oxycodone|oxycodone|mesh-list
84141069|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84141070|NCT03679949|Narcotics|narcotics|mesh-ancestor
84141071|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141072|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141073|NCT03679949|Analgesics|analgesics|mesh-ancestor
84141074|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
84141075|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141076|NCT02640989|Vaccines|vaccines|mesh-list
84141077|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
84141078|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141079|NCT02645747|Aflibercept|aflibercept|mesh-list
84141080|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141081|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141082|NCT02645747|Growth Substances|growth substances|mesh-ancestor
84141083|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141084|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141085|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141086|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
84141087|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84141088|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141089|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
84141090|NCT00653315|Tramadol|tramadol|mesh-list
84141091|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84141092|NCT00653315|Narcotics|narcotics|mesh-ancestor
84141093|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141094|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141095|NCT00653315|Analgesics|analgesics|mesh-ancestor
84141096|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
84141097|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141098|NCT02640833|Venetoclax|venetoclax|mesh-list
84141099|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141100|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
84141101|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
84141102|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141103|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84141104|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141105|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141106|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84141107|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84141108|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141109|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141110|NCT02645903|Morphine|morphine|mesh-list
84141111|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141113|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84141114|NCT02645903|Narcotics|narcotics|mesh-ancestor
84141115|NCT02645903|Analgesics|analgesics|mesh-ancestor
84141116|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
84141117|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141118|NCT02645981|Sorafenib|sorafenib|mesh-list
84141119|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141120|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84141121|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141122|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141123|NCT02535767|Primaquine|primaquine|mesh-list
84141124|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
84141125|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84141126|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84141127|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141128|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
84141129|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141130|NCT02640365|Leucovorin|leucovorin|mesh-list
84141131|NCT02640365|Bevacizumab|bevacizumab|mesh-list
84141132|NCT02640365|Irinotecan|irinotecan|mesh-list
84141133|NCT02640365|Camptothecin|camptothecin|mesh-list
84141134|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84141135|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141136|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141137|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141138|NCT02640365|Growth Substances|growth substances|mesh-ancestor
84141139|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141140|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141141|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84141142|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84141143|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141144|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141145|NCT02640365|Antidotes|antidotes|mesh-ancestor
84141146|NCT02640365|Protective Agents|protective agents|mesh-ancestor
84141147|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
84141148|NCT02640365|Vitamins|vitamins|mesh-ancestor
84141149|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
84141150|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84141151|NCT02642003|Lenograstim|lenograstim|mesh-list
84141152|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84141153|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
84141154|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141155|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
84141156|NCT02641847|Gemcitabine|gemcitabine|mesh-list
84141157|NCT02641847|Docetaxel|docetaxel|mesh-list
84141158|NCT02641847|Doxorubicin|doxorubicin|mesh-list
84141159|NCT02641847|Epirubicin|epirubicin|mesh-list
84141160|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141161|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
84141162|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141163|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141164|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84141165|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
84141166|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141167|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141168|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84141169|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84141170|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
84141171|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
84141172|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
84141173|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
84141174|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84141175|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84141176|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84141177|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141178|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
84141179|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141180|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
84141181|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84141182|NCT00652379|Octreotide|octreotide|mesh-list
84141183|NCT00652379|Lanreotide|lanreotide|mesh-list
84141184|NCT00652379|Somatostatin|somatostatin|mesh-list
83381947|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84141185|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141186|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84141187|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141188|NCT00652379|Hormones|hormones|mesh-ancestor
84141189|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141190|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141191|NCT04164797|Endostar protein|endostar protein|mesh-list
84141192|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141193|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141194|NCT04164797|Growth Substances|growth substances|mesh-ancestor
84141195|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141196|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141197|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141198|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
84141199|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
84141200|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84141201|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84141202|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141203|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141204|NCT00654017|Urological Agents|urological agents|mesh-ancestor
84141205|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
84141206|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84141207|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84141208|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141209|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
84141210|NCT02639819|Coagulants|coagulants|mesh-ancestor
84141211|NCT02639741|Vitamins|vitamins|mesh-list
84141212|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
84141213|NCT02639741|Melatonin|melatonin|mesh-list
84141214|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
84141215|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141216|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
84141217|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141218|NCT02639741|Protective Agents|protective agents|mesh-ancestor
84141219|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141220|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
84141221|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84141222|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
84141223|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141224|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84141225|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141226|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84141227|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141228|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84141229|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141230|NCT01149083|Carboplatin|carboplatin|mesh-list
84141231|NCT01149083|Veliparib|veliparib|mesh-list
84141232|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141233|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84141234|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141235|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141236|NCT00654173|Atorvastatin|atorvastatin|mesh-list
84141237|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84141238|NCT00654173|Simvastatin|simvastatin|mesh-list
84141239|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84141240|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84141241|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
84141242|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141243|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84141244|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84141245|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141246|NCT02645279|Midazolam|midazolam|mesh-list
84141247|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84141248|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84141249|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141250|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141251|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84141252|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84141253|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141254|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84141255|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
84141256|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
84141257|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
84141258|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
84141259|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141260|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141261|NCT04164329|Anesthetics|anesthetics|mesh-list
84141262|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
84141263|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141264|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141265|NCT02639039|Cortisone|cortisone|mesh-list
84141266|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141267|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84141268|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84141269|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84141270|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
84141271|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141272|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84141273|NCT02562664|Metformin|metformin|mesh-list
84141274|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83430280|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141275|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141276|NCT00654407|Atorvastatin|atorvastatin|mesh-list
84141277|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84141278|NCT00654407|Simvastatin|simvastatin|mesh-list
84141279|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84141280|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84141281|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
84141282|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141283|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84141284|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84141285|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141286|NCT00691054|Paclitaxel|paclitaxel|mesh-list
84141287|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84141288|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84141289|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141290|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
84141291|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
84141292|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
84141293|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141294|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84141295|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84141296|NCT00744406|Sertraline|sertraline|mesh-list
84141297|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84141298|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
84141299|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141300|NCT00744406|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84141301|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84141302|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84141303|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141304|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141305|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
84141306|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141307|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84141308|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84141309|NCT00690820|Pancrelipase|pancrelipase|mesh-list
84141310|NCT00690820|Pancreatin|pancreatin|mesh-list
84141311|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141312|NCT02562508|Vaccines|vaccines|mesh-list
84141313|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
84141314|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141315|NCT00689338|Fluconazole|fluconazole|mesh-list
84141316|NCT00689338|Voriconazole|voriconazole|mesh-list
84141317|NCT00689338|Anidulafungin|anidulafungin|mesh-list
84141318|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
84141319|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141320|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84141321|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84141322|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141323|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141324|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84141325|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
84141326|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141327|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141328|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84141329|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84141330|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84141331|NCT00686998|Olanzapine|olanzapine|mesh-list
84141332|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
84141333|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
84141334|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141335|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141336|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141337|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84141338|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84141339|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141340|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141341|NCT00686998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84141342|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84141343|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84141344|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141345|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141347|NCT00744640|Gemcitabine|gemcitabine|mesh-list
84141348|NCT00744640|Capecitabine|capecitabine|mesh-list
84141349|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
84141350|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84141351|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
84141352|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141353|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141354|NCT00848718|Paclitaxel|paclitaxel|mesh-list
84141355|NCT00848718|Docetaxel|docetaxel|mesh-list
84141356|NCT00848718|Carboplatin|carboplatin|mesh-list
84141357|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84141358|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84141359|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141360|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
84141361|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
84141362|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
84141363|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141364|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84141365|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141366|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
84141367|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84141368|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141369|NCT00883337|Interferons|interferons|mesh-list
84141370|NCT00883337|Interferon-beta|interferon-beta|mesh-list
84141371|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
84141372|NCT00883337|Teriflunomide|teriflunomide|mesh-list
84141373|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141374|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
84141375|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141376|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84141377|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84141378|NCT00883337|Analgesics|analgesics|mesh-ancestor
84141379|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
84141380|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141381|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141382|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141383|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141384|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141385|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
84141386|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84141387|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
84141388|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141389|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84141390|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141391|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141392|NCT00654485|Atorvastatin|atorvastatin|mesh-list
84141393|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84141394|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84141395|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84141396|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
84141397|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141398|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84141399|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84141400|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141401|NCT00837876|Sorafenib|sorafenib|mesh-list
84141402|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141403|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84141404|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141405|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141406|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
84141407|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
84141408|NCT00655421|Coagulants|coagulants|mesh-ancestor
84141409|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
84141410|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141411|NCT00707070|Acitretin|acitretin|mesh-list
83382171|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141412|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84141413|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
84141414|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141415|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
84141416|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
84141417|NCT00686920|Rifaximin|rifaximin|mesh-list
84141418|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84141419|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141420|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141421|NCT02562118|Letrozole|letrozole|mesh-list
84141422|NCT02562118|Lenvatinib|lenvatinib|mesh-list
84141423|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141424|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84141425|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84141426|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141427|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141428|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84141429|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
84141430|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141431|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141432|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84141433|NCT00744718|Bevacizumab|bevacizumab|mesh-list
84141434|NCT00744718|Carboplatin|carboplatin|mesh-list
84141435|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84141436|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141437|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141438|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141439|NCT00744718|Growth Substances|growth substances|mesh-ancestor
84141440|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141441|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141442|NCT00741910|Semapimod|semapimod|mesh-list
84141443|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84141444|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84141445|NCT00741910|Analgesics|analgesics|mesh-ancestor
84141446|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
84141447|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141448|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141449|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141450|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141451|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141452|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
84141453|NCT00845832|Rituximab|rituximab|mesh-list
84141454|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84141455|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141456|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
84141457|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141458|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141459|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
84141460|NCT00703482|Ubiquinone|ubiquinone|mesh-list
84141461|NCT00703482|Fenofibrate|fenofibrate|mesh-list
84141462|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84141463|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
84141464|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141465|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84141466|NCT00703482|Vitamins|vitamins|mesh-ancestor
84141467|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
84141468|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141469|NCT00885755|Capecitabine|capecitabine|mesh-list
84141470|NCT00885755|Trastuzumab|trastuzumab|mesh-list
84141471|NCT00885755|Taxane|taxane|mesh-list
84141472|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84141473|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
84141474|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141475|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141476|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84141477|NCT00749710|Clopidogrel|clopidogrel|mesh-list
84141478|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84141479|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84141480|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84141481|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84141482|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
84141483|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141484|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141485|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141486|NCT00749866|Gentamicins|gentamicins|mesh-list
84141487|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84141488|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141489|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84141490|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141491|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141492|NCT04058236|Polygeline|polygeline|mesh-list
84141493|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
84141494|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
84141495|NCT00742066|Felodipine|felodipine|mesh-list
84141496|NCT00742066|Irbesartan|irbesartan|mesh-list
84141497|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84141498|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84141499|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84141500|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141501|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84141502|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84141503|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84141504|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84141505|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141506|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
84141507|NCT00742144|Ofatumumab|ofatumumab|mesh-list
84141508|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141509|NCT00845676|Interferons|interferons|mesh-list
84141510|NCT00845676|Ribavirin|ribavirin|mesh-list
84141511|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
84141512|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
84141513|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84141514|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141515|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
84141516|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141517|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
84141518|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141519|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
84141520|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141521|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
84141522|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141523|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
84141524|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141525|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141526|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84141527|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
84141528|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141529|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141530|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84141531|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
84141532|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84141533|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141534|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84141535|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84141536|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84141537|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84141538|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
84141539|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141540|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84141541|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84141542|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141543|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84141544|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84141545|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84141546|NCT00655655|Everolimus|everolimus|mesh-list
84141547|NCT00655655|Vatalanib|vatalanib|mesh-list
84141548|NCT00655655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84141549|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84141550|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141551|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141552|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141553|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
84141554|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141555|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141556|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
84141557|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141558|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141559|NCT05483400|Atezolizumab|atezolizumab|mesh-list
84141560|NCT05483400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84141561|NCT05483400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141562|NCT05483400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84141563|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141564|NCT00837330|Ranibizumab|ranibizumab|mesh-list
84141565|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141566|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141567|NCT00837330|Growth Substances|growth substances|mesh-ancestor
84141568|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141569|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141570|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141572|NCT00703638|Sorafenib|sorafenib|mesh-list
84141573|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141574|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141575|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141576|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84141577|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84141578|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84141579|NCT02581943|Paclitaxel|paclitaxel|mesh-list
84141580|NCT02581943|Carboplatin|carboplatin|mesh-list
84141581|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
84141582|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84141583|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84141584|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141585|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
84141586|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
84141587|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
84141588|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141589|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84141590|NCT02581943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84141591|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
84141592|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84141593|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
84141594|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141595|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
84141596|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141597|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84141598|NCT00885365|Tobramycin|tobramycin|mesh-list
84141599|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84141600|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141601|NCT00827112|Ritonavir|ritonavir|mesh-list
84141602|NCT00827112|Lopinavir|lopinavir|mesh-list
84141603|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84141604|NCT00827112|Darunavir|darunavir|mesh-list
84141605|NCT00827112|Tenofovir|tenofovir|mesh-list
84141606|NCT00827112|Emtricitabine|emtricitabine|mesh-list
84141607|NCT00827112|Maraviroc|maraviroc|mesh-list
84141608|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84141609|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84141610|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
84141611|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141612|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141613|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84141614|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84141615|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
84141616|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141617|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84141618|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84141619|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84141620|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84141621|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84141622|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84141623|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84141624|NCT00689104|Mirabegron|mirabegron|mesh-list
84141625|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84141626|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84141627|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84141628|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84141629|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
84141630|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141631|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141632|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141633|NCT00689104|Urological Agents|urological agents|mesh-ancestor
84141634|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83382397|NCT00088153|Progesterone|progesterone|mesh-list
84141635|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84141636|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
84141637|NCT02118467|Phenylephrine|phenylephrine|mesh-list
84141638|NCT02118467|Vasopressins|vasopressins|mesh-list
84141639|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
84141640|NCT02118467|Epinephrine|epinephrine|mesh-list
84141641|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
84141642|NCT02118467|Norepinephrine|norepinephrine|mesh-list
84141644|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84141645|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84141646|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
84141647|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141648|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141649|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141650|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84141651|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84141652|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
84141653|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141654|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84141655|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
84141656|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
84141657|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
84141658|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84141659|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84141660|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
84141661|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84141662|NCT02118467|Protective Agents|protective agents|mesh-ancestor
84141663|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
84141664|NCT02118467|Coagulants|coagulants|mesh-ancestor
84141665|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84141666|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
84141667|NCT00702156|Bisoprolol|bisoprolol|mesh-list
84141668|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84141669|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
84141670|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
84141671|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141672|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141673|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84141674|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84141675|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84141676|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
84141677|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141678|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141679|NCT02638415|Carvedilol|carvedilol|mesh-list
84141680|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84141681|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84141682|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
84141683|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141684|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141685|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141686|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84141687|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
84141688|NCT02638415|Protective Agents|protective agents|mesh-ancestor
84141689|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84141690|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84141691|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84141692|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
84141693|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84141694|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84141695|NCT00703872|Interferons|interferons|mesh-list
84141696|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141697|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
84141698|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141699|NCT00689026|Lubiprostone|lubiprostone|mesh-list
84141700|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
84141701|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84141702|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141703|NCT00598559|Acetaminophen|acetaminophen|mesh-list
84141704|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84141705|NCT00598559|Analgesics|analgesics|mesh-ancestor
84141706|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
84141707|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141708|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141709|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
84141710|NCT00686686|Infliximab|infliximab|mesh-list
84141711|NCT00686686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84141712|NCT00686686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141713|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
84141714|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141715|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141716|NCT02637167|Rifaximin|rifaximin|mesh-list
84141717|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84141718|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141719|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141720|NCT04057300|Aspirin|aspirin|mesh-list
84141721|NCT04057300|Clopidogrel|clopidogrel|mesh-list
84141722|NCT04057300|Ticagrelor|ticagrelor|mesh-list
84141723|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84141724|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84141725|NCT04057300|Analgesics|analgesics|mesh-ancestor
84141726|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
84141727|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141728|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141729|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141730|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141731|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84141732|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84141733|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141734|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84141735|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84141736|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141737|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
84141738|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84141739|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84141740|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84141741|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
84141742|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141743|NCT00655967|Acamprosate|acamprosate|mesh-list
84141744|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84141745|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
84141746|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84141747|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141748|NCT00655109|Fluticasone|fluticasone|mesh-list
84141749|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
84141750|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
84141751|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141752|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84141753|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
84141754|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141755|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141756|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84141757|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
84141758|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
84141759|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84141760|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84141761|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84141762|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84141763|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84141764|NCT00655109|Analgesics|analgesics|mesh-ancestor
84141765|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
84141766|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141767|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84141768|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84141769|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
84141770|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
84141771|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141772|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141773|NCT02632877|Pirfenidone|pirfenidone|mesh-list
84141774|NCT02632877|Ketanserin|ketanserin|mesh-list
84141775|NCT02632877|Analgesics|analgesics|mesh-ancestor
84141776|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
84141777|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141778|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141779|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84141780|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84141781|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141782|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141783|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141784|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84141785|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84141786|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84141787|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
84141788|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141789|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141790|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
84141791|NCT00656123|Molgramostim|molgramostim|mesh-list
84141792|NCT00656123|Sargramostim|sargramostim|mesh-list
84141793|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
84141794|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141795|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141796|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141797|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84141798|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
84141799|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141800|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141801|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84141802|NCT04163471|Hemostatics|hemostatics|mesh-list
84141803|NCT04163471|Coagulants|coagulants|mesh-ancestor
84141804|NCT00657449|Valdecoxib|valdecoxib|mesh-list
84141805|NCT00657449|Rofecoxib|rofecoxib|mesh-list
84141806|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84141807|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84141808|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141809|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141810|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84141811|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84141812|NCT00657449|Analgesics|analgesics|mesh-ancestor
84141813|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
84141814|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141815|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141816|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141817|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141818|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
84141819|NCT04160195|Fludarabine|fludarabine|mesh-list
84141820|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141821|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
84141822|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141823|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141824|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84141825|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
84141826|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141827|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141828|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84141829|NCT00911261|Oxymorphone|oxymorphone|mesh-list
84141830|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84141831|NCT00911261|Narcotics|narcotics|mesh-ancestor
84141832|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141833|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141834|NCT00911261|Analgesics|analgesics|mesh-ancestor
84141835|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
84141836|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141837|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84141838|NCT00686374|Adalimumab|adalimumab|mesh-list
84141839|NCT00686374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84141840|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84141841|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84141842|NCT00750178|Vorinostat|vorinostat|mesh-list
84141843|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141844|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84141845|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141846|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141847|NCT00750334|Clofarabine|clofarabine|mesh-list
84141848|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84141849|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
84141850|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141851|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141852|NCT00745186|Glucagon|glucagon|mesh-list
84141853|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141854|NCT00745186|Hormones|hormones|mesh-ancestor
84141855|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141856|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141857|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
84141858|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84141859|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
84141860|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141861|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
84141862|NCT00750724|Protective Agents|protective agents|mesh-ancestor
84141863|NCT00752518|Bortezomib|bortezomib|mesh-list
84141864|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141865|NCT00752596|Azimilide|azimilide|mesh-list
84141866|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84141867|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84141868|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84141869|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141870|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84141871|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141872|NCT00750802|Lorazepam|lorazepam|mesh-list
84141873|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
84141874|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
84141875|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
84141876|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84141877|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141878|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141879|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84141880|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141881|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84141882|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84141883|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141884|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
84141885|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
84141886|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84141887|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141888|NCT00751270|Valacyclovir|valacyclovir|mesh-list
84141889|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
84141890|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141891|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84141892|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
84141893|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84141894|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84141895|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84141896|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84141897|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141898|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
84141899|NCT00576628|Hematinics|hematinics|mesh-ancestor
84141900|NCT00683878|Pioglitazone|pioglitazone|mesh-list
84141901|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
84141902|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
84141903|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84141904|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141905|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84141906|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141907|NCT00884741|Bevacizumab|bevacizumab|mesh-list
84141908|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84141909|NCT00884741|Temozolomide|temozolomide|mesh-list
84141910|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
84141911|NCT00884741|Antibodies|antibodies|mesh-list
84141912|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
84141913|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84141914|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
84141915|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141916|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141917|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141918|NCT00884741|Growth Substances|growth substances|mesh-ancestor
84141919|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141920|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141921|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
84141922|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84141923|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
84141924|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141925|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84141926|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84141927|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84141928|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
84141929|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141930|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84141931|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84141932|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141933|NCT00598481|Busulfan|busulfan|mesh-list
84141934|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
84141935|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141936|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84141937|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
84141938|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141939|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84141940|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141941|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84141942|NCT04159649|Letrozole|letrozole|mesh-list
84141943|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141944|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84141945|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84141946|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141947|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141948|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84141949|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
84141950|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141951|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141952|NCT00880763|Interferons|interferons|mesh-list
84141953|NCT00880763|Ribavirin|ribavirin|mesh-list
84141954|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141955|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
84141956|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141957|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
84141958|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141959|NCT00884273|Goserelin|goserelin|mesh-list
84141960|NCT00884273|Bicalutamide|bicalutamide|mesh-list
84141961|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84141962|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141963|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
84141964|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
84141965|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84141966|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141967|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
84141968|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84141969|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84141970|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141971|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84141972|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84141973|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
84141974|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141975|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84141976|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
84141977|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84141978|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84141979|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141980|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141981|NCT00657839|Urological Agents|urological agents|mesh-ancestor
84141982|NCT00884117|Oseltamivir|oseltamivir|mesh-list
84141983|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
84141984|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84141985|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84141986|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84141987|NCT04159181|Lactulose|lactulose|mesh-list
84141988|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
84141989|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84141990|NCT04159181|Cathartics|cathartics|mesh-ancestor
84141991|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
84141992|NCT00884039|Anecortave|anecortave|mesh-list
84141993|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84141994|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84141995|NCT00884039|Growth Substances|growth substances|mesh-ancestor
84141996|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84141997|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
84141998|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84141999|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84142000|NCT00657995|Pancrelipase|pancrelipase|mesh-list
84142001|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84142002|NCT02632565|Lidocaine|lidocaine|mesh-list
84142003|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
84142004|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
84142005|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142006|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142007|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
84142008|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142009|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84142010|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84142011|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84142012|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83382764|NCT00787761|Busulfan|busulfan|mesh-list
84142013|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142014|NCT04158947|Trastuzumab|trastuzumab|mesh-list
84142015|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84142016|NCT04158947|Afatinib|afatinib|mesh-list
84142017|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142018|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142019|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142020|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142021|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142022|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
84142023|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
84142024|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
84142025|NCT04158947|Immunotoxins|immunotoxins|mesh-ancestor
84142026|NCT04158947|Immunoconjugates|immunoconjugates|mesh-ancestor
84142027|NCT04158947|Immunologic Factors|immunologic factors|mesh-ancestor
84142028|NCT04158947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142029|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
84142030|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
84142031|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142032|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
84142033|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142034|NCT04163237|Sorafenib|sorafenib|mesh-list
84142035|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142036|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142037|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142038|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142039|NCT00880685|Memantine|memantine|mesh-list
84142040|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84142041|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84142042|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
84142043|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142044|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142045|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142046|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84142047|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84142048|NCT02612298|Metoprolol|metoprolol|mesh-list
84142049|NCT02612298|Arotinolol|arotinolol|mesh-list
84142050|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84142051|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84142052|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
84142053|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
84142054|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142055|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142056|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84142057|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84142058|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84142059|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
84142060|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142061|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142062|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84142063|NCT00880607|Morphine|morphine|mesh-list
84142064|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84142065|NCT00880607|Narcotics|narcotics|mesh-ancestor
84142066|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142067|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142068|NCT00880607|Analgesics|analgesics|mesh-ancestor
84142069|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
84142070|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142071|NCT00656435|Bevacizumab|bevacizumab|mesh-list
84142072|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142073|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142074|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84142075|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84142076|NCT00656435|Growth Substances|growth substances|mesh-ancestor
84142077|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142078|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
84142079|NCT02636231|Endostatins|endostatins|mesh-list
84142080|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84142081|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84142082|NCT02636231|Growth Substances|growth substances|mesh-ancestor
84142083|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142084|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
84142085|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142086|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84142087|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84142088|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84142090|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142091|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84142092|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84142093|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142094|NCT00656591|Methotrexate|methotrexate|mesh-list
84142095|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84142096|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
84142097|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84142098|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142099|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142100|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
84142101|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142102|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142103|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
84142104|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142105|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84142106|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142107|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
84142108|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84142109|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84142110|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84142111|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84142112|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84142113|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84142114|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142115|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142116|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142117|NCT00658931|Analgesics|analgesics|mesh-ancestor
84142118|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
84142119|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142120|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
84142121|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84142122|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
84142123|NCT00834912|Tramadol|tramadol|mesh-list
84142124|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84142125|NCT00834912|Narcotics|narcotics|mesh-ancestor
84142126|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142127|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142128|NCT00834912|Analgesics|analgesics|mesh-ancestor
84142129|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
84142130|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142131|NCT02535689|Tofacitinib|tofacitinib|mesh-list
84142132|NCT02535689|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84142133|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142134|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142135|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142136|NCT02632331|Gabapentin|gabapentin|mesh-list
84142137|NCT02632331|Analgesics|analgesics|mesh-ancestor
84142138|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
84142139|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142140|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142141|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
84142142|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84142143|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84142144|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142145|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84142146|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84142147|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84142148|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142149|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142150|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
84142151|NCT04162535|Lidocaine|lidocaine|mesh-list
84142152|NCT04162535|Propofol|propofol|mesh-list
84142153|NCT04162535|Anesthetics|anesthetics|mesh-list
84142154|NCT04162535|Sevoflurane|sevoflurane|mesh-list
84142155|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
84142156|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
84142157|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142158|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142159|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
84142160|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142161|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84142162|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84142163|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84142164|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84142165|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142166|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84142167|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
84142168|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84142169|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84142170|NCT02632019|Gemcitabine|gemcitabine|mesh-list
84142171|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142172|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
84142173|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142174|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142175|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84142176|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
84142177|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
84142178|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84142179|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84142180|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84142181|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142182|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142183|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142184|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142185|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
84142186|NCT04158713|Piperaquine|piperaquine|mesh-list
84142188|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
84142189|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84142190|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84142191|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142192|NCT00659321|Nicotine|nicotine|mesh-list
84142193|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84142194|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
84142195|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142196|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142197|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84142198|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84142199|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
84142200|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142201|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142202|NCT00659399|PENTA|penta|mesh-list
84142203|NCT00659399|Fondaparinux|fondaparinux|mesh-list
84142204|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84142205|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
84142206|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84142207|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
84142208|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142209|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142210|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
84142211|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84142212|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84142213|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
84142214|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84142215|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142216|NCT00911339|Atorvastatin|atorvastatin|mesh-list
84142217|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84142218|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84142219|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
84142220|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142221|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84142222|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84142223|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142224|NCT05863195|Leucovorin|leucovorin|mesh-list
84142225|NCT05863195|Bevacizumab|bevacizumab|mesh-list
84142226|NCT05863195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84142227|NCT05863195|Cetuximab|cetuximab|mesh-list
84142228|NCT05863195|Panitumumab|panitumumab|mesh-list
84142229|NCT05863195|Fluorouracil|fluorouracil|mesh-list
84142230|NCT05863195|Oxaliplatin|oxaliplatin|mesh-list
84142231|NCT05863195|Irinotecan|irinotecan|mesh-list
84142232|NCT05863195|Floxuridine|floxuridine|mesh-list
84142233|NCT05863195|Endothelial Growth Factors|endothelial growth factors|mesh-list
84142234|NCT05863195|Antibodies|antibodies|mesh-list
84142235|NCT05863195|Immunoglobulins|immunoglobulins|mesh-list
84142236|NCT05863195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83382991|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
84142237|NCT05863195|Immunoglobulin G|immunoglobulin g|mesh-list
84142238|NCT05863195|Deoxyuridine|deoxyuridine|mesh-list
84142239|NCT05863195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142240|NCT05863195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84142241|NCT05863195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84142242|NCT05863195|Growth Substances|growth substances|mesh-ancestor
84142243|NCT05863195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142244|NCT05863195|Growth Inhibitors|growth inhibitors|mesh-ancestor
84142245|NCT05863195|Immunologic Factors|immunologic factors|mesh-ancestor
84142246|NCT05863195|Antimetabolites|antimetabolites|mesh-ancestor
84142247|NCT05863195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142248|NCT05863195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142249|NCT05863195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142250|NCT05863195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84142251|NCT05863195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84142252|NCT05863195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142253|NCT05863195|Antidotes|antidotes|mesh-ancestor
84142254|NCT05863195|Protective Agents|protective agents|mesh-ancestor
84142255|NCT05863195|Vitamin B Complex|vitamin b complex|mesh-ancestor
84142256|NCT05863195|Vitamins|vitamins|mesh-ancestor
84142257|NCT05863195|Micronutrients|micronutrients|mesh-ancestor
84142258|NCT05863104|Glycopyrrolate|glycopyrrolate|mesh-list
84142259|NCT05863104|Bromides|bromides|mesh-list
84142260|NCT05863104|Anticonvulsants|anticonvulsants|mesh-ancestor
84142261|NCT05863104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84142262|NCT05863104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84142263|NCT05863104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84142264|NCT05863104|Cholinergic Agents|cholinergic agents|mesh-ancestor
84142265|NCT05863104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142266|NCT05863104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142267|NCT05863104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142268|NCT05863052|Immunomodulating Agents|immunomodulating agents|mesh-list
84142269|NCT05863052|Immunologic Factors|immunologic factors|mesh-ancestor
84142270|NCT05863052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142271|NCT05862792|Bupivacaine|bupivacaine|mesh-list
84142272|NCT05862792|Anesthetics, Local|anesthetics, local|mesh-ancestor
84142273|NCT05862792|Anesthetics|anesthetics|mesh-ancestor
84142274|NCT05862792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142275|NCT05862792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142276|NCT05862792|Sensory System Agents|sensory system agents|mesh-ancestor
84142277|NCT05862792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142278|NCT05862753|Etomidate|etomidate|mesh-list
84142279|NCT05862753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84142280|NCT05862753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142281|NCT05862753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142282|NCT05862753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84142283|NCT05862753|Anesthetics, General|anesthetics, general|mesh-ancestor
84142284|NCT05862753|Anesthetics|anesthetics|mesh-ancestor
84142285|NCT05862714|Itraconazole|itraconazole|mesh-list
84142286|NCT05862714|Fluconazole|fluconazole|mesh-list
84142287|NCT05862714|Antifungal Agents|antifungal agents|mesh-ancestor
84142288|NCT05862714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142289|NCT05862714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84142290|NCT05862714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84142291|NCT05862714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142292|NCT05862714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142293|NCT05862714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84142294|NCT05862714|Hormone Antagonists|hormone antagonists|mesh-ancestor
84142295|NCT05862714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84142296|NCT05862714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142297|NCT05862714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84142298|NCT05862714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84142299|NCT05862714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84142300|NCT05862701|Permethrin|permethrin|mesh-list
84142301|NCT05862701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142302|NCT05862701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142303|NCT05862688|Anti-Infective Agents|anti-infective agents|mesh-list
84142304|NCT05862688|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84142305|NCT05862519|Testosterone|testosterone|mesh-list
84142306|NCT05862519|Androgens|androgens|mesh-ancestor
84142307|NCT05862519|Hormones|hormones|mesh-ancestor
84142308|NCT05862519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84142309|NCT05862519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142310|NCT05862428|Misoprostol|misoprostol|mesh-list
84142311|NCT05862428|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84142312|NCT05862428|Abortifacient Agents|abortifacient agents|mesh-ancestor
84142313|NCT05862428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84142314|NCT05862428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142315|NCT05862428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84142316|NCT05862428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84142317|NCT05862428|Oxytocics|oxytocics|mesh-ancestor
84142318|NCT05862402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84142319|NCT05862402|Gentamicins|gentamicins|mesh-list
84142320|NCT05862402|Meropenem|meropenem|mesh-list
84142321|NCT05862402|Imipenem|imipenem|mesh-list
84142322|NCT05862402|Amikacin|amikacin|mesh-list
84142323|NCT05862402|Colistin|colistin|mesh-list
84142324|NCT05862402|Ceftazidime|ceftazidime|mesh-list
84142325|NCT05862402|Tigecycline|tigecycline|mesh-list
84142326|NCT05862402|Avibactam|avibactam|mesh-list
84142327|NCT05862402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84142328|NCT05862402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142329|NCT05862402|Antitubercular Agents|antitubercular agents|mesh-ancestor
84142330|NCT05862402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84142331|NCT05862402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142332|NCT05862402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142333|NCT05862402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84142334|NCT05862220|Fibrin fragment D|fibrin fragment d|mesh-list
84142335|NCT05862220|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84142336|NCT05862220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84142337|NCT05862220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142338|NCT05862220|Hemostatics|hemostatics|mesh-ancestor
84142339|NCT05862220|Coagulants|coagulants|mesh-ancestor
84142340|NCT05862194|Lazertinib|lazertinib|mesh-list
84142341|NCT05862194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142342|NCT05862194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142343|NCT05862194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142344|NCT05862168|Paclitaxel|paclitaxel|mesh-list
84142345|NCT05862168|Fluorouracil|fluorouracil|mesh-list
84142346|NCT05862168|Tislelizumab|tislelizumab|mesh-list
84142347|NCT05862168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84142348|NCT05862168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142349|NCT05862168|Tubulin Modulators|tubulin modulators|mesh-ancestor
84142350|NCT05862168|Antimitotic Agents|antimitotic agents|mesh-ancestor
84142351|NCT05862168|Mitosis Modulators|mitosis modulators|mesh-ancestor
84142352|NCT05862168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142353|NCT05862168|Antimetabolites|antimetabolites|mesh-ancestor
84142354|NCT05862168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142355|NCT05862168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142356|NCT05862168|Immunologic Factors|immunologic factors|mesh-ancestor
84142357|NCT05862168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142358|NCT05862168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142359|NCT05862064|Paclitaxel|paclitaxel|mesh-list
84142360|NCT05862064|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84142361|NCT05862064|Cyclophosphamide|cyclophosphamide|mesh-list
84142362|NCT05862064|Epirubicin|epirubicin|mesh-list
84142363|NCT05862064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84142364|NCT05862064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142365|NCT05862064|Tubulin Modulators|tubulin modulators|mesh-ancestor
84142366|NCT05862064|Antimitotic Agents|antimitotic agents|mesh-ancestor
84142367|NCT05862064|Mitosis Modulators|mitosis modulators|mesh-ancestor
84142368|NCT05862064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142369|NCT05862064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142370|NCT05862064|Immunologic Factors|immunologic factors|mesh-ancestor
84142371|NCT05862064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142372|NCT05862064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84142373|NCT05862064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84142374|NCT05862064|Alkylating Agents|alkylating agents|mesh-ancestor
84142375|NCT05862064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84142376|NCT05862064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84142377|NCT05862064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84142378|NCT05862064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84142379|NCT05862064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142380|NCT05861921|Lithium Carbonate|lithium carbonate|mesh-list
84142381|NCT05861921|Antidepressive Agents|antidepressive agents|mesh-ancestor
84142382|NCT05861921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84142383|NCT05861921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142384|NCT05861921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142385|NCT05861921|Antimanic Agents|antimanic agents|mesh-ancestor
84142386|NCT05861921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84142387|NCT05861921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142388|NCT05861921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142389|NCT05861791|Ketorolac|ketorolac|mesh-list
84142390|NCT05861791|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
84142391|NCT05861791|Fentanyl|fentanyl|mesh-list
84142392|NCT05861791|Nefopam|nefopam|mesh-list
84142393|NCT05861791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84142394|NCT05861791|Narcotics|narcotics|mesh-ancestor
84142395|NCT05861791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142396|NCT05861791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142397|NCT05861791|Analgesics|analgesics|mesh-ancestor
84142398|NCT05861791|Sensory System Agents|sensory system agents|mesh-ancestor
84142399|NCT05861791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142400|NCT05861791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84142401|NCT05861791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84142402|NCT05861791|Anesthetics, General|anesthetics, general|mesh-ancestor
84142403|NCT05861791|Anesthetics|anesthetics|mesh-ancestor
84142404|NCT05861791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84142405|NCT05861791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84142406|NCT05861791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84142407|NCT05861791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84142408|NCT05861791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84142409|NCT05861791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142410|NCT05861791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142411|NCT05861713|Dimenhydrinate|dimenhydrinate|mesh-list
84142412|NCT05861713|Antiemetics|antiemetics|mesh-ancestor
84142413|NCT05861713|Autonomic Agents|autonomic agents|mesh-ancestor
84142414|NCT05861713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142415|NCT05861713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142416|NCT05861713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84142417|NCT05861713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84142418|NCT05861713|Histamine Antagonists|histamine antagonists|mesh-ancestor
84142419|NCT05861713|Histamine Agents|histamine agents|mesh-ancestor
84142420|NCT05861713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142421|NCT05861713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142422|NCT05861687|Amoxicillin|amoxicillin|mesh-list
84142423|NCT05861687|Clarithromycin|clarithromycin|mesh-list
84142424|NCT05861687|Esomeprazole|esomeprazole|mesh-list
84142425|NCT05861687|Lansoprazole|lansoprazole|mesh-list
84142426|NCT05861687|Dexlansoprazole|dexlansoprazole|mesh-list
84142427|NCT05861687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84142428|NCT05861687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142429|NCT05861687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84142430|NCT05861687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84142431|NCT05861687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84142432|NCT05861687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142433|NCT05861687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142434|NCT05861687|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84142435|NCT05861687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84142436|NCT05861687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84142437|NCT05861648|Folic Acid|folic acid|mesh-list
84142438|NCT05861648|Hematinics|hematinics|mesh-ancestor
84142439|NCT05861648|Vitamin B Complex|vitamin b complex|mesh-ancestor
84142440|NCT05861648|Vitamins|vitamins|mesh-ancestor
84142441|NCT05861648|Micronutrients|micronutrients|mesh-ancestor
84142442|NCT05861648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142443|NCT05861635|Tislelizumab|tislelizumab|mesh-list
84142444|NCT05861635|Disitamab vedotin|disitamab vedotin|mesh-list
84142445|NCT05861635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142446|NCT05861635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142447|NCT05861635|Immunoconjugates|immunoconjugates|mesh-ancestor
84142448|NCT05861635|Immunologic Factors|immunologic factors|mesh-ancestor
84142449|NCT05861635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142450|NCT05861609|Analgesics|analgesics|mesh-list
84142451|NCT05861609|Sensory System Agents|sensory system agents|mesh-ancestor
84142452|NCT05861609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142453|NCT05861609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142454|NCT05857384|Acetazolamide|acetazolamide|mesh-list
84142455|NCT05857384|Dronabinol|dronabinol|mesh-list
84142456|NCT05857384|Anticonvulsants|anticonvulsants|mesh-ancestor
84142457|NCT05857384|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84142458|NCT05857384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142459|NCT05857384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142460|NCT05857384|Diuretics|diuretics|mesh-ancestor
84142461|NCT05857384|Natriuretic Agents|natriuretic agents|mesh-ancestor
84142462|NCT05857384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142463|NCT05857384|Hallucinogens|hallucinogens|mesh-ancestor
84142464|NCT05857384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84142465|NCT05857384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84142466|NCT05857384|Analgesics|analgesics|mesh-ancestor
84142467|NCT05857384|Sensory System Agents|sensory system agents|mesh-ancestor
84142468|NCT05857384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142469|NCT05857384|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84142470|NCT05857384|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84142471|NCT05857384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142472|NCT05857384|Hormones|hormones|mesh-ancestor
84142473|NCT05857384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84142474|NCT05827978|Vaccines|vaccines|mesh-list
84142475|NCT05827978|Immunologic Factors|immunologic factors|mesh-ancestor
84142476|NCT05827978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142477|NCT05817461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84142478|NCT05773326|Sirolimus|sirolimus|mesh-list
84142479|NCT05773326|Temsirolimus|temsirolimus|mesh-list
84142480|NCT05773326|MTOR Inhibitors|mtor inhibitors|mesh-list
84142481|NCT05773326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142482|NCT05773326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142483|NCT05773326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142484|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142485|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
84142486|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142487|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142488|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84142489|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142490|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84142491|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
84142492|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
84142493|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84142494|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84142495|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84142496|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84142497|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142498|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
84142499|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142500|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142501|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84142502|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142503|NCT05750745|Fluorides|fluorides|mesh-list
84142504|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
84142505|NCT05750745|Protective Agents|protective agents|mesh-ancestor
84142506|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142507|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
84142508|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142509|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142510|NCT05746897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84142511|NCT05746897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142512|NCT05725382|Remifentanil|remifentanil|mesh-list
84142513|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84142514|NCT05725382|Narcotics|narcotics|mesh-ancestor
84142515|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142516|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142517|NCT05725382|Analgesics|analgesics|mesh-ancestor
84142518|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
84142519|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142520|NCT05718297|Durvalumab|durvalumab|mesh-list
84142521|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142522|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142523|NCT05710406|Cetuximab|cetuximab|mesh-list
84142524|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142525|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142526|NCT05704543|Buprenorphine|buprenorphine|mesh-list
84142527|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84142528|NCT05704543|Narcotics|narcotics|mesh-ancestor
84142529|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142530|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142531|NCT05704543|Analgesics|analgesics|mesh-ancestor
84142532|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
84142533|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142534|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84142535|NCT05686564|Choline|choline|mesh-list
84142536|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
84142537|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84142538|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
84142539|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142540|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84142541|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84142542|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
84142543|NCT05672355|Vaccines|vaccines|mesh-list
84142544|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
84142545|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142546|NCT05671900|Gemcitabine|gemcitabine|mesh-list
84142547|NCT05671900|Docetaxel|docetaxel|mesh-list
84142548|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142549|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
84142550|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142551|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142552|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
84142553|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
84142554|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
84142555|NCT05645432|Pregnanolone|pregnanolone|mesh-list
84142556|NCT05645432|Brexanolone|brexanolone|mesh-list
84142557|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
84142558|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142559|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142560|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
84142561|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142562|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142563|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
84142564|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
84142565|NCT05618301|Natalizumab|natalizumab|mesh-list
84142566|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
84142567|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142568|NCT05610163|Leucovorin|leucovorin|mesh-list
84142569|NCT05610163|Fluorouracil|fluorouracil|mesh-list
84142570|NCT05610163|Capecitabine|capecitabine|mesh-list
84142571|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
84142572|NCT05610163|Irinotecan|irinotecan|mesh-list
84142573|NCT05610163|Calcium|calcium|mesh-list
84142574|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
84142575|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84142576|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142577|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
84142578|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142579|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142580|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142581|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142582|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
84142583|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84142584|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84142585|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142586|NCT05610163|Antidotes|antidotes|mesh-ancestor
84142587|NCT05610163|Protective Agents|protective agents|mesh-ancestor
84142588|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
84142589|NCT05610163|Vitamins|vitamins|mesh-ancestor
84142590|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
84142591|NCT05594147|Sorafenib|sorafenib|mesh-list
84142592|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142593|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142594|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142595|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142596|NCT05546554|Suvorexant|suvorexant|mesh-list
84142597|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84142598|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84142599|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142600|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142601|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
84142602|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142603|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142604|NCT05540574|Zolpidem|zolpidem|mesh-list
84142605|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84142606|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84142607|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142608|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142609|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84142610|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
84142611|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
84142612|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142613|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142614|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
84142615|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
84142616|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142617|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
84142618|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84142619|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142620|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
84142621|NCT05501678|Promethazine|promethazine|mesh-list
84142622|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84142623|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84142624|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142625|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142626|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
84142627|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
84142628|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
84142629|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142630|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
84142631|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
84142632|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84142633|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84142634|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
84142635|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
84142636|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142637|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142638|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84142639|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
84142640|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
84142641|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
84142642|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84142643|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84142644|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142645|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
84142646|NCT05489185|Coagulants|coagulants|mesh-ancestor
84142647|NCT05487586|Ceftazidime|ceftazidime|mesh-list
84142648|NCT05487586|Avibactam|avibactam|mesh-list
84142649|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
84142650|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84142651|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142652|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84142653|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142654|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142655|NCT05465304|Azithromycin|azithromycin|mesh-list
84142656|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84142657|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142658|NCT05458024|Vitamin D|vitamin d|mesh-list
84142659|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
84142660|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
84142661|NCT05458024|Vitamins|vitamins|mesh-list
84142662|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
84142663|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142664|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84142665|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84142666|NCT05456685|Carboplatin|carboplatin|mesh-list
84142667|NCT05456685|Maytansine|maytansine|mesh-list
84142668|NCT05456685|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
84142669|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142670|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84142671|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
84142672|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
84142673|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
84142674|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142675|NCT05456685|Immunoconjugates|immunoconjugates|mesh-ancestor
84142676|NCT05456685|Immunologic Factors|immunologic factors|mesh-ancestor
84142677|NCT05456685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142678|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
84142679|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84142680|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142681|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84142682|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142683|NCT05370313|Nicotine|nicotine|mesh-list
84142684|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84142685|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
84142686|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142687|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142688|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84142689|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84142690|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
84142691|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142692|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142693|NCT05368623|Mydriatics|mydriatics|mesh-list
84142694|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
84142695|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142696|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142698|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
84142699|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142700|NCT05329766|Leucovorin|leucovorin|mesh-list
84142701|NCT05329766|Fluorouracil|fluorouracil|mesh-list
84142702|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
84142703|NCT05329766|Quemliclustat|quemliclustat|mesh-list
84142704|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
84142705|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142706|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142707|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142708|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142709|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
84142710|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142711|NCT05329766|Antidotes|antidotes|mesh-ancestor
84142712|NCT05329766|Protective Agents|protective agents|mesh-ancestor
84142713|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
84142714|NCT05329766|Vitamins|vitamins|mesh-ancestor
84142715|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
84142716|NCT05329766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84142717|NCT05329766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142718|NCT05324449|Cannabidiol|cannabidiol|mesh-list
84142719|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
84142720|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
84142721|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84142722|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
84142723|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142724|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
84142725|NCT05316233|Protective Agents|protective agents|mesh-ancestor
84142726|NCT05304871|Cefazolin|cefazolin|mesh-list
84142727|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84142728|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142729|NCT05281406|Carboplatin|carboplatin|mesh-list
84142730|NCT05281406|Pemetrexed|pemetrexed|mesh-list
84142731|NCT05281406|Osimertinib|osimertinib|mesh-list
84142732|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142733|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142734|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142735|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84142736|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84142737|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142738|NCT05265299|Aspirin|aspirin|mesh-list
84142739|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84142740|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84142741|NCT05265299|Analgesics|analgesics|mesh-ancestor
84142742|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
84142743|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142744|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142745|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84142746|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84142747|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84142748|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84142749|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142750|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84142751|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84142752|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142753|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
84142754|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
84142755|NCT05255666|Irinotecan|irinotecan|mesh-list
84142756|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142757|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142758|NCT05255666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84142759|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142760|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84142761|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84142762|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142763|NCT05246514|Trastuzumab|trastuzumab|mesh-list
84142764|NCT05246514|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
84142765|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142766|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142767|NCT05246514|Immunoconjugates|immunoconjugates|mesh-ancestor
83383525|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
84142768|NCT05246514|Immunologic Factors|immunologic factors|mesh-ancestor
84142769|NCT05246514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142770|NCT05233722|Sirolimus|sirolimus|mesh-list
84142771|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142772|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84142773|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142774|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84142775|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142776|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
84142777|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142778|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
84142779|NCT05221892|Thiamine|thiamine|mesh-list
84142780|NCT05221892|Pyridoxine|pyridoxine|mesh-list
84142781|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
84142782|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
84142783|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
84142784|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142785|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
84142786|NCT05221892|Vitamins|vitamins|mesh-ancestor
84142787|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
84142788|NCT05221892|Hematinics|hematinics|mesh-ancestor
84142789|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
84142790|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142791|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142792|NCT05183035|Cytarabine|cytarabine|mesh-list
84142793|NCT05183035|Fludarabine|fludarabine|mesh-list
84142794|NCT05183035|Azacitidine|azacitidine|mesh-list
84142795|NCT05183035|Venetoclax|venetoclax|mesh-list
84142796|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
84142797|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142798|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142799|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
84142800|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142801|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142802|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
84142803|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142804|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
84142805|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142806|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142807|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142808|NCT05183035|Immunotoxins|immunotoxins|mesh-ancestor
84142809|NCT05183035|Immunoconjugates|immunoconjugates|mesh-ancestor
84142810|NCT05161338|Estradiol|estradiol|mesh-list
84142811|NCT05161338|Progesterone|progesterone|mesh-list
84142812|NCT05161338|Estrogens|estrogens|mesh-ancestor
84142813|NCT05161338|Hormones|hormones|mesh-ancestor
84142814|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84142815|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142816|NCT05161338|Progestins|progestins|mesh-ancestor
84142817|NCT05147805|Treprostinil|treprostinil|mesh-list
84142818|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84142819|NCT05108428|Capecitabine|capecitabine|mesh-list
84142820|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142821|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
84142822|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142823|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142824|NCT05045794|Liver Extracts|liver extracts|mesh-list
84142825|NCT05045794|Hematinics|hematinics|mesh-ancestor
84142826|NCT05044936|Cannabidiol|cannabidiol|mesh-list
84142827|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
84142828|NCT05036408|Coal Tar|coal tar|mesh-list
84142829|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
84142830|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
84142831|NCT05033743|Secnidazole|secnidazole|mesh-list
84142832|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84142833|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84142834|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142835|NCT05021900|Tenalisib|tenalisib|mesh-list
84142836|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
84142837|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142838|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142839|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
84142840|NCT05014646|Leflunomide|leflunomide|mesh-list
84142841|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142842|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142843|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84142844|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
84142845|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142846|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84142847|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84142848|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
84142849|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84142850|NCT04995029|Buprenorphine|buprenorphine|mesh-list
84142851|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84142852|NCT04995029|Narcotics|narcotics|mesh-ancestor
84142853|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142854|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142855|NCT04995029|Analgesics|analgesics|mesh-ancestor
84142856|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
84142857|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142858|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84142859|NCT04979806|Meropenem|meropenem|mesh-list
84142860|NCT04979806|Cefepime|cefepime|mesh-list
84142861|NCT04979806|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
84142862|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84142863|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142864|NCT04971954|Nicotine|nicotine|mesh-list
84142865|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84142866|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
84142867|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142868|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142869|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84142870|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84142871|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
84142872|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142873|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142874|NCT04951206|Clobetasol|clobetasol|mesh-list
84142875|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84142876|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
84142877|NCT04951206|Hormones|hormones|mesh-ancestor
84142878|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84142879|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142880|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
84142881|NCT04942340|Caffeine|caffeine|mesh-list
84142882|NCT04942340|Atipamezole|atipamezole|mesh-list
84142883|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84142884|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142885|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142886|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84142887|NCT04942340|Analgesics|analgesics|mesh-ancestor
84142888|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
84142889|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142890|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84142891|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84142892|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84142893|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
84142894|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142895|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142896|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84142897|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84142898|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142899|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84142900|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84142901|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
84142902|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84142903|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84142904|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84142905|NCT04925479|Niacinamide|niacinamide|mesh-list
84142906|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
84142907|NCT04925479|Vitamins|vitamins|mesh-ancestor
84142908|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
84142909|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142910|NCT04905654|Cromakalim|cromakalim|mesh-list
84142911|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84142912|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84142913|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
84142914|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84142915|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142916|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84142917|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
84142918|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
84142919|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
84142920|NCT04870034|Palbociclib|palbociclib|mesh-list
84142921|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142922|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84142923|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142924|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142925|NCT04857398|Insulin|insulin|mesh-list
84142926|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84142927|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142928|NCT04826432|Pasireotide|pasireotide|mesh-list
84142929|NCT04826432|Hormones|hormones|mesh-ancestor
84142930|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84142931|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142932|NCT04812548|Azacitidine|azacitidine|mesh-list
84142933|NCT04812548|Venetoclax|venetoclax|mesh-list
84142934|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84142935|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
84142936|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142937|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142938|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142939|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84142940|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84142941|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142942|NCT04698525|Valproic Acid|valproic acid|mesh-list
84142943|NCT04698525|Memantine|memantine|mesh-list
84142944|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84142945|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84142946|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
84142947|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84142948|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142949|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142950|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84142951|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84142952|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
84142953|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142954|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
84142955|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
84142956|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84142957|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84142958|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84142959|NCT04667104|Tenofovir|tenofovir|mesh-list
84142960|NCT04667104|Entecavir|entecavir|mesh-list
84142961|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84142962|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
84142963|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84142964|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84142965|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84142966|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142967|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142968|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84142969|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84142970|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
84142971|NCT04666740|Olaparib|olaparib|mesh-list
84142972|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142973|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142974|NCT04666740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84142975|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142976|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84142977|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84142978|NCT04660812|Bevacizumab|bevacizumab|mesh-list
84142979|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142980|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142981|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84142982|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84142983|NCT04660812|Growth Substances|growth substances|mesh-ancestor
84142984|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142985|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
84142986|NCT04659369|Nivolumab|nivolumab|mesh-list
84142987|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84142988|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84142989|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84142990|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84142991|NCT04651439|Lenograstim|lenograstim|mesh-list
84142992|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84142993|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
84142994|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142995|NCT04635774|Insulin|insulin|mesh-list
84142996|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84142997|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84142998|NCT04634799|Plasminogen|plasminogen|mesh-list
84142999|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
84143000|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
83383745|NCT01421303|Etanercept|etanercept|mesh-list
84143001|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84143002|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84143003|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143004|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84143005|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
84143006|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143007|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
84143008|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
84143009|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143010|NCT04603365|Temozolomide|temozolomide|mesh-list
84143011|NCT04603365|Pamiparib|pamiparib|mesh-list
84143012|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84143013|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84143014|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
84143015|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143016|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143017|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143018|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
84143019|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
84143020|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84143021|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84143022|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
84143023|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143024|NCT04560660|Midazolam|midazolam|mesh-list
84143025|NCT04560660|Ketamine|ketamine|mesh-list
84143026|NCT04560660|Analgesics|analgesics|mesh-ancestor
84143027|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
84143028|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143029|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143030|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84143031|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84143032|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
84143033|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
84143034|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143035|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84143036|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84143037|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143038|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143039|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84143040|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84143041|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84143042|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84143043|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143044|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
84143045|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
84143046|NCT04556526|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84143047|NCT04556526|Antiviral Agents|antiviral agents|mesh-ancestor
84143048|NCT04556526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143049|NCT04517435|Prednisone|prednisone|mesh-list
84143050|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
84143051|NCT04517435|Rituximab|rituximab|mesh-list
84143052|NCT04517435|Doxorubicin|doxorubicin|mesh-list
84143053|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84143054|NCT04517435|Vincristine|vincristine|mesh-list
84143055|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84143056|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
84143057|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143058|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143059|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84143060|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
84143061|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143062|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143063|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84143064|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143065|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84143066|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84143067|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84143068|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143069|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143070|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
84143071|NCT04517435|Hormones|hormones|mesh-ancestor
84143072|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143073|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143074|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84143075|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
84143076|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
84143077|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
84143078|NCT04478617|Metronidazole|metronidazole|mesh-list
84143079|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143080|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84143081|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84143082|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84143083|NCT04439357|Trametinib|trametinib|mesh-list
84143084|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
84143085|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143086|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84143087|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143088|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143089|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84143090|NCT04439357|Protective Agents|protective agents|mesh-ancestor
84143091|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143092|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84143093|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
84143094|NCT04439318|Trametinib|trametinib|mesh-list
84143095|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
84143096|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143097|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84143098|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143099|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143100|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
84143101|NCT04439318|Protective Agents|protective agents|mesh-ancestor
84143102|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143103|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84143104|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
84143105|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
84143106|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84143107|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84143108|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
84143109|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143110|NCT04424966|Infigratinib|infigratinib|mesh-list
84143111|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143112|NCT04344873|Abatacept|abatacept|mesh-list
84143113|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143114|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143115|NCT04344873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143116|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143117|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84143118|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
84143119|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143120|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143121|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
84143122|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143123|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143124|NCT04340258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143125|NCT04340258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143126|NCT04301271|Simvastatin|simvastatin|mesh-list
84143127|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84143128|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84143129|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
84143130|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143131|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84143132|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84143133|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143134|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
84143135|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84143136|NCT04285567|Rituximab|rituximab|mesh-list
84143137|NCT04285567|Fludarabine|fludarabine|mesh-list
84143138|NCT04285567|Venetoclax|venetoclax|mesh-list
84143139|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
84143140|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84143141|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
84143142|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143143|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143144|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84143145|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
84143146|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143147|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143148|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84143149|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148903|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84143150|NCT04228783|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
84143151|NCT04228783|Antiviral Agents|antiviral agents|mesh-ancestor
84143152|NCT04228783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143153|NCT04188119|Aspirin|aspirin|mesh-list
84143154|NCT04188119|Avelumab|avelumab|mesh-list
84143155|NCT04188119|Lansoprazole|lansoprazole|mesh-list
84143156|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
84143157|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84143158|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84143159|NCT04188119|Analgesics|analgesics|mesh-ancestor
84143160|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
84143161|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143162|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143163|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143164|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143165|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84143166|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84143167|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143168|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84143169|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84143170|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143171|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
84143172|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143173|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143174|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84143175|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84143176|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84143177|NCT04174170|Sertraline|sertraline|mesh-list
84143178|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
84143179|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
84143180|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143181|NCT04174170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84143182|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84143183|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84143184|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143185|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143186|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
84143187|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143188|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
84143189|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
84143190|NCT04142658|Warfarin|warfarin|mesh-list
84143191|NCT04142658|Apixaban|apixaban|mesh-list
84143192|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
84143193|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84143194|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
84143195|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84143196|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
84143197|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143198|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143199|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
84143200|NCT04138394|Vitamins|vitamins|mesh-ancestor
84143201|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
84143202|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143203|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
84143204|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143205|NCT04138394|Protective Agents|protective agents|mesh-ancestor
84143206|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
84143207|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
84143208|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143209|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84143210|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143211|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143212|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84143213|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
84143214|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143215|NCT04126070|Docetaxel|docetaxel|mesh-list
84143216|NCT04126070|Nivolumab|nivolumab|mesh-list
84143217|NCT04126070|Leuprolide|leuprolide|mesh-list
84143218|NCT04126070|Goserelin|goserelin|mesh-list
84143219|NCT04126070|Androgens|androgens|mesh-list
84143220|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143221|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
84143222|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
84143223|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
84143224|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143225|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143226|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143227|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84143229|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84143230|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143231|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143232|NCT04126070|Hormones|hormones|mesh-ancestor
84143233|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143234|NCT04124614|Sertraline|sertraline|mesh-list
84143235|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
84143236|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
84143237|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143238|NCT04124614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84143239|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84143240|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84143241|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143242|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143243|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
84143244|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143245|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
84143246|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
84143247|NCT04095442|Benzocaine|benzocaine|mesh-list
84143248|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
84143249|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
84143250|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143251|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143252|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
84143253|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143254|NCT04082780|Rifamycins|rifamycins|mesh-list
84143255|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
84143256|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84143257|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143258|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143259|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
84143260|NCT04027946|LMB-100|lmb-100|mesh-list
84143261|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143262|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143263|NCT04027946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143264|NCT04027946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143265|NCT04027946|Immunoconjugates|immunoconjugates|mesh-ancestor
84143266|NCT04027946|Immunologic Factors|immunologic factors|mesh-ancestor
84143267|NCT04027946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143268|NCT03994627|Olaratumab|olaratumab|mesh-list
84143269|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143270|NCT03977363|Anticoagulants|anticoagulants|mesh-list
84143271|NCT03950674|Folic Acid|folic acid|mesh-list
84143272|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
84143273|NCT03950674|Hydroxocobalamin|hydroxocobalamin|mesh-list
84143274|NCT03950674|Dexamethasone|dexamethasone|mesh-list
84143275|NCT03950674|Carboplatin|carboplatin|mesh-list
84143276|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
84143277|NCT03950674|Pemetrexed|pemetrexed|mesh-list
84143278|NCT03950674|Vitamins|vitamins|mesh-ancestor
84143279|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
84143280|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143281|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143282|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
84143283|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
84143284|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143285|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84143286|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
84143287|NCT03950674|Hormones|hormones|mesh-ancestor
84143288|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143289|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143290|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143291|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143292|NCT03950674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143293|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143294|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143295|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84143296|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84143297|NCT03950674|Hematinics|hematinics|mesh-ancestor
84143298|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
84143299|NCT03911661|Warfarin|warfarin|mesh-list
84143300|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
84143301|NCT03909477|Xenon|xenon|mesh-list
84143302|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84143303|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
84143304|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
84143305|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143306|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143307|NCT03874052|Venetoclax|venetoclax|mesh-list
84143308|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
84143309|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143310|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84143311|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143312|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143313|NCT03851159|Mannitol|mannitol|mesh-list
84143314|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84143315|NCT03851159|Diuretics|diuretics|mesh-ancestor
84143316|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
84143317|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143318|NCT04491877|Vaccines|vaccines|mesh-list
84143319|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
84143320|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143321|NCT03829410|Bevacizumab|bevacizumab|mesh-list
84143322|NCT03829410|Onvansertib|onvansertib|mesh-list
84143323|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143324|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143325|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84143326|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84143327|NCT03829410|Growth Substances|growth substances|mesh-ancestor
84143328|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143329|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
84143330|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84143331|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143332|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143333|NCT03793478|Cytarabine|cytarabine|mesh-list
84143334|NCT03793478|Fludarabine|fludarabine|mesh-list
84143335|NCT03793478|Etoposide|etoposide|mesh-list
84143336|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143337|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84143338|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
84143339|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143340|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84143341|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
84143342|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143343|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84143344|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84143345|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84143346|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143347|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
84143348|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143349|NCT03711604|Tenalisib|tenalisib|mesh-list
84143350|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
84143351|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143352|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143353|NCT03708627|Bimatoprost|bimatoprost|mesh-list
84143354|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84143355|NCT03702621|Bupivacaine|bupivacaine|mesh-list
84143356|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
84143357|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
84143358|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143359|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143360|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
84143361|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143362|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84143363|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84143364|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143365|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
84143366|NCT03684876|Diuretics|diuretics|mesh-list
84143367|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
84143368|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143369|NCT03655665|Ofloxacin|ofloxacin|mesh-list
84143370|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84143371|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143372|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84143373|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84143374|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83384117|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
84143375|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143376|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143377|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143378|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84143379|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84143380|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
84143381|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84143382|NCT03604627|Calcium|calcium|mesh-list
84143383|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84143384|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143385|NCT03600701|Atezolizumab|atezolizumab|mesh-list
84143386|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84143387|NCT03600701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143388|NCT03600701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143389|NCT03600701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143390|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143391|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
84143392|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143393|NCT03593317|Spironolactone|spironolactone|mesh-list
84143394|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84143395|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
84143396|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143397|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143398|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84143399|NCT03593317|Diuretics|diuretics|mesh-ancestor
84143400|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
84143401|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
84143402|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84143403|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143404|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143405|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84143406|NCT03522688|Analgesics|analgesics|mesh-ancestor
84143407|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
84143408|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143409|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84143410|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84143411|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84143412|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
84143413|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143414|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143415|NCT03516656|Heparin|heparin|mesh-list
84143416|NCT03516656|Calcium heparin|calcium heparin|mesh-list
84143417|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
84143418|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84143419|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84143420|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143421|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
84143422|NCT03479268|Pevonedistat|pevonedistat|mesh-list
84143423|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143424|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
84143425|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84143426|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84143427|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84143428|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84143429|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143430|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
84143431|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143432|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143433|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84143434|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143435|NCT03437421|Vitamin D|vitamin d|mesh-list
84143436|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
84143437|NCT03437421|Vitamins|vitamins|mesh-ancestor
84143438|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
84143439|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143440|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84143441|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84143442|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
84143443|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84143444|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143445|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84143446|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143447|NCT03414034|Prednisone|prednisone|mesh-list
84143448|NCT03414034|Onvansertib|onvansertib|mesh-list
84143449|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143450|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
84143451|NCT03414034|Hormones|hormones|mesh-ancestor
84143452|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143453|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143454|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143455|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143456|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84143457|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143458|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143459|NCT03361436|Halichondrin B|halichondrin b|mesh-list
84143460|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
84143461|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
84143462|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
84143463|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143464|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143465|NCT03284866|Vaccines|vaccines|mesh-list
84143466|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
84143467|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143468|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
84143469|NCT03260894|Sunitinib|sunitinib|mesh-list
84143470|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143471|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143472|NCT03260894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143473|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143474|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84143475|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84143476|NCT03260894|Growth Substances|growth substances|mesh-ancestor
84143477|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143478|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
84143479|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84143480|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143481|NCT03245008|Fasinumab|fasinumab|mesh-list
84143482|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84143483|NCT03245008|Analgesics|analgesics|mesh-ancestor
84143484|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
84143485|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143486|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143487|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
84143488|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84143489|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143490|NCT03203473|Nivolumab|nivolumab|mesh-list
84143491|NCT03203473|Ipilimumab|ipilimumab|mesh-list
84143492|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143493|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143494|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143495|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143496|NCT03191786|Gemcitabine|gemcitabine|mesh-list
84143497|NCT03191786|Atezolizumab|atezolizumab|mesh-list
84143498|NCT03191786|Vinorelbine|vinorelbine|mesh-list
84143499|NCT03191786|Antibodies|antibodies|mesh-list
84143500|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84143501|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
84143502|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143503|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84143504|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
84143505|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143506|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143507|NCT03191786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143508|NCT03191786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143509|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84143510|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
84143511|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
84143512|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
84143513|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
84143514|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
84143515|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143516|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143517|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143518|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
84143519|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84143520|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143521|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143522|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
84143523|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
84143524|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84143525|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84143526|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143527|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143528|NCT03142568|Urological Agents|urological agents|mesh-ancestor
84143529|NCT03115567|Triamcinolone|triamcinolone|mesh-list
84143530|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143531|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
84143533|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143534|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143535|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
84143536|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143537|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143538|NCT03051659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143539|NCT03051659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143540|NCT02982902|Immunomodulating Agents|immunomodulating agents|mesh-list
84143541|NCT02982902|Immunologic Factors|immunologic factors|mesh-ancestor
84143542|NCT02982902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143543|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
84143544|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143545|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143546|NCT02971761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143547|NCT02971761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143548|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
84143549|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143550|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143551|NCT02964559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143552|NCT02964559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143553|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84143554|NCT02893293|Hematinics|hematinics|mesh-ancestor
84143555|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84143556|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84143557|NCT02860000|Fulvestrant|fulvestrant|mesh-list
84143558|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143559|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143560|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84143561|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84143562|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
84143563|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143564|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143565|NCT02724878|Bevacizumab|bevacizumab|mesh-list
84143566|NCT02724878|Atezolizumab|atezolizumab|mesh-list
84143567|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143568|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143569|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84143570|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84143571|NCT02724878|Growth Substances|growth substances|mesh-ancestor
84143572|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143573|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
84143574|NCT02724878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143575|NCT02724878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143576|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84143577|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84143578|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
84143579|NCT02672475|Paclitaxel|paclitaxel|mesh-list
84143580|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84143581|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84143582|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143583|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
84143584|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
84143585|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
84143586|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143587|NCT02578680|Folic Acid|folic acid|mesh-list
84143588|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
84143589|NCT02578680|Hydroxocobalamin|hydroxocobalamin|mesh-list
84143590|NCT02578680|Dexamethasone|dexamethasone|mesh-list
84143591|NCT02578680|Carboplatin|carboplatin|mesh-list
84143592|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
84143593|NCT02578680|Pemetrexed|pemetrexed|mesh-list
84143594|NCT02578680|Vitamins|vitamins|mesh-ancestor
84143595|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
84143596|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143597|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83384340|NCT04311411|Hormones|hormones|mesh-ancestor
84143599|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
84143600|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143601|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84143602|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
84143603|NCT02578680|Hormones|hormones|mesh-ancestor
84143604|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143605|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143606|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143607|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143608|NCT02578680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84143609|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143610|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143611|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84143612|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84143613|NCT02578680|Hematinics|hematinics|mesh-ancestor
84143614|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
84143615|NCT02385266|Cycloserine|cycloserine|mesh-list
84143616|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84143617|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143618|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84143619|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
84143620|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84143621|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
84143622|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143623|NCT02351765|Cisplatin|cisplatin|mesh-list
84143624|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143625|NCT02251431|Exenatide|exenatide|mesh-list
84143626|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84143627|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143628|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84143629|NCT02251431|Incretins|incretins|mesh-ancestor
84143630|NCT02251431|Hormones|hormones|mesh-ancestor
84143631|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143632|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84143633|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84143634|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
84143635|NCT02105766|Sirolimus|sirolimus|mesh-list
84143636|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
84143637|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
84143638|NCT02105766|Pentostatin|pentostatin|mesh-list
84143639|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84143640|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
84143641|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143642|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143643|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84143644|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
84143645|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143646|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143647|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84143648|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84143649|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143650|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84143651|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
84143652|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143653|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143654|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
84143655|NCT02000089|Secretin|secretin|mesh-list
84143656|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84143657|NCT02000089|Hormones|hormones|mesh-ancestor
84143658|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143659|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143660|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
84143661|NCT01494441|Calcium|calcium|mesh-list
84143662|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84143663|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143664|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84143665|NCT01367002|Paclitaxel|paclitaxel|mesh-list
84143666|NCT01367002|Carboplatin|carboplatin|mesh-list
84143667|NCT01367002|Trastuzumab|trastuzumab|mesh-list
84143668|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84143669|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143670|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
84143671|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
84143672|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
84143673|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143674|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84143676|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84143677|NCT00858273|Antioxidants|antioxidants|mesh-list
84143678|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84143679|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143680|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143681|NCT00858273|Protective Agents|protective agents|mesh-ancestor
84143682|NCT04158167|Oxytocin|oxytocin|mesh-list
84143683|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
84143684|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84143685|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143686|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84143687|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84143688|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84143689|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84143690|NCT02635607|Ganirelix|ganirelix|mesh-list
84143691|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
84143692|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84143693|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
84143694|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84143695|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143696|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84143697|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143698|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143699|NCT02635607|Hormones|hormones|mesh-ancestor
84143700|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143701|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
84143702|NCT00660257|Vaccines|vaccines|mesh-list
84143703|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
84143704|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143705|NCT00844428|Eculizumab|eculizumab|mesh-list
84143706|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84143707|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84143708|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
84143709|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143710|NCT00660335|Secretin|secretin|mesh-list
84143711|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84143712|NCT00660335|Hormones|hormones|mesh-ancestor
84143713|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143714|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143715|NCT00707772|Ribavirin|ribavirin|mesh-list
84143716|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84143717|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
84143718|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
84143719|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143720|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
84143721|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143722|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
84143723|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143724|NCT00834834|Fluoxetine|fluoxetine|mesh-list
84143725|NCT00834834|Citalopram|citalopram|mesh-list
84143726|NCT00834834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84143727|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84143728|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84143729|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143730|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143731|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
84143732|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143733|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84143734|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
84143735|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143736|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84143737|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84143738|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143739|NCT00834366|Tramadol|tramadol|mesh-list
84143740|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84143741|NCT00834366|Narcotics|narcotics|mesh-ancestor
84143742|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143743|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143744|NCT00834366|Analgesics|analgesics|mesh-ancestor
84143745|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
84143746|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143747|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
84143748|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84143749|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143750|NCT00660647|Adalimumab|adalimumab|mesh-list
84143751|NCT00660647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84143752|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143753|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143754|NCT04156451|Furosemide|furosemide|mesh-list
84143755|NCT04156451|Diuretics|diuretics|mesh-ancestor
84143756|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
84143757|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143758|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84143759|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84143760|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143761|NCT00660725|Gemcitabine|gemcitabine|mesh-list
84143762|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
84143763|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84143764|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
84143765|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143766|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143767|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84143768|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84143769|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84143770|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84143771|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143772|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143773|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143774|NCT00844194|Analgesics|analgesics|mesh-ancestor
84143775|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
84143776|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143777|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
84143778|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143779|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
84143780|NCT00660803|Fulvestrant|fulvestrant|mesh-list
84143781|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84143782|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143783|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84143784|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84143785|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
84143786|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143787|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143788|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84143789|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
84143790|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84143791|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84143792|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143793|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143794|NCT00661115|Urological Agents|urological agents|mesh-ancestor
84143795|NCT04157699|Tenofovir|tenofovir|mesh-list
84143796|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
84143797|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143798|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84143799|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84143800|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143801|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143802|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84143803|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84143804|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
84143805|NCT00665717|Pravastatin|pravastatin|mesh-list
84143806|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84143807|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84143808|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
84143809|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143810|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84143811|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84143812|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143813|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143814|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84143815|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84143816|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
84143817|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84143818|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84143819|NCT02611596|Ranolazine|ranolazine|mesh-list
84143820|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84143821|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84143822|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143823|NCT00661349|Ritonavir|ritonavir|mesh-list
84143824|NCT00661349|Lopinavir|lopinavir|mesh-list
84143825|NCT00661349|Nevirapine|nevirapine|mesh-list
84143826|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84143827|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84143828|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
84143829|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143830|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143831|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84143832|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84143833|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
84143834|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143835|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84143836|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84143837|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84143838|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84143839|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84143840|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84143841|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84143842|NCT00665873|Amoxicillin|amoxicillin|mesh-list
84143843|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
84143844|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
84143845|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84143846|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143847|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
84143848|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143849|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143850|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84143851|NCT00707850|Ribavirin|ribavirin|mesh-list
84143852|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84143853|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
84143854|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
84143855|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143856|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
84143857|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143858|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
84143859|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143860|NCT00665951|Ritonavir|ritonavir|mesh-list
84143861|NCT00665951|Lopinavir|lopinavir|mesh-list
84143862|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84143863|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84143864|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
84143865|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143866|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143867|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84143868|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84143869|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
84143870|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143871|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84143872|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84143873|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84143874|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84143875|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
84143876|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143877|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84143878|NCT00878969|Valsartan|valsartan|mesh-list
84143879|NCT00878969|Ramipril|ramipril|mesh-list
84143880|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
84143881|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84143882|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84143883|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84143884|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143885|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
84143886|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143887|NCT00843492|PENTA|penta|mesh-list
84143888|NCT00843492|Nadroparin|nadroparin|mesh-list
84143889|NCT00843492|Fondaparinux|fondaparinux|mesh-list
84143890|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84143891|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
84143892|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84143893|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
84143894|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143895|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143896|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
84143897|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84143898|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84143899|NCT00666107|Vaccines|vaccines|mesh-list
84143900|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
84143901|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143902|NCT00666185|Fluconazole|fluconazole|mesh-list
84143903|NCT00666185|Micafungin|micafungin|mesh-list
84143904|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
84143905|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143906|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84143907|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84143908|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143909|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143910|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84143911|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
84143912|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143913|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143914|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84143915|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84143916|NCT00913224|Diclofenac|diclofenac|mesh-list
84143917|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84143918|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84143919|NCT00913224|Analgesics|analgesics|mesh-ancestor
84143920|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
84143921|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143922|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143923|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143924|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84143925|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84143926|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143927|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143928|NCT00666341|Immunomodulating Agents|immunomodulating agents|mesh-list
84143929|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
84143930|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143931|NCT00661973|Budesonide|budesonide|mesh-list
84143932|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84143933|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84143934|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
84143935|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143936|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143937|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84143938|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
84143939|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
84143940|NCT00661973|Hormones|hormones|mesh-ancestor
84143941|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84143942|NCT00666575|Gabapentin|gabapentin|mesh-list
84143943|NCT00666575|Analgesics|analgesics|mesh-ancestor
84143944|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
84143945|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143946|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143947|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
84143948|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84143949|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84143950|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143951|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143952|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84143953|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84143954|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143955|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143956|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
84143957|NCT00666653|Pramipexole|pramipexole|mesh-list
84143958|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
84143959|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143960|NCT00666653|Protective Agents|protective agents|mesh-ancestor
84143961|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143962|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84143963|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84143964|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
84143965|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
84143966|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84143967|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
84143968|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
84143969|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84143970|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
84143971|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84143972|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84143973|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84143974|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84143975|NCT00666809|Urological Agents|urological agents|mesh-ancestor
84143977|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84143978|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84143979|NCT00667043|Fentanyl|fentanyl|mesh-list
84143980|NCT00667043|Midazolam|midazolam|mesh-list
84143981|NCT00667043|Remifentanil|remifentanil|mesh-list
84143982|NCT00667043|Propofol|propofol|mesh-list
84143983|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84143984|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84143985|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84143986|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84143987|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
84143988|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
84143989|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84143990|NCT00667043|Narcotics|narcotics|mesh-ancestor
84143991|NCT00667043|Analgesics|analgesics|mesh-ancestor
84143992|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
84143993|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84143994|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84143995|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84143996|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84143997|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84143998|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
84143999|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
84144000|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144001|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144002|NCT02631473|Ritonavir|ritonavir|mesh-list
84144003|NCT02631473|Lopinavir|lopinavir|mesh-list
84144004|NCT02631473|Efavirenz|efavirenz|mesh-list
84144005|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84144006|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84144007|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
84144008|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144009|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144010|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84144011|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84144012|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
84144013|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144014|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84144015|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84144016|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84144017|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84144018|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84144019|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84144020|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84144021|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84144022|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84144023|NCT00825162|Vaccines|vaccines|mesh-list
84144024|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
84144025|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144026|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84144027|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
84144028|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84144029|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84144030|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144031|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144032|NCT00662441|Urological Agents|urological agents|mesh-ancestor
84144033|NCT00911573|Vancomycin|vancomycin|mesh-list
84144034|NCT00911573|Clindamycin|clindamycin|mesh-list
84144035|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
84144036|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
84144037|NCT00911573|Tigecycline|tigecycline|mesh-list
84144038|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144039|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144040|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84144041|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144042|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144043|NCT00667433|Tenofovir|tenofovir|mesh-list
84144044|NCT00667433|Emtricitabine|emtricitabine|mesh-list
84144045|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
84144046|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84144047|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
84144048|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144049|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84144050|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84144051|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144052|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144053|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84144054|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84144055|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84144056|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84144057|NCT00662519|Lenograstim|lenograstim|mesh-list
84144058|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84144059|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
84144060|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144061|NCT00667901|Riluzole|riluzole|mesh-list
84144062|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
84144063|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84144064|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84144065|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144066|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144067|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144068|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84144069|NCT00667901|Protective Agents|protective agents|mesh-ancestor
84144070|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84144071|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
84144072|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84144073|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84144074|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144075|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144076|NCT00667979|Urological Agents|urological agents|mesh-ancestor
84144077|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84144078|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
84144079|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84144080|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84144081|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144082|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144083|NCT00668057|Urological Agents|urological agents|mesh-ancestor
84144084|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84144085|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
84144086|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84144087|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84144088|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144089|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144090|NCT00668135|Urological Agents|urological agents|mesh-ancestor
84144091|NCT02630303|Coal Tar|coal tar|mesh-list
84144092|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
84144093|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
84144094|NCT04155983|Ropivacaine|ropivacaine|mesh-list
84144095|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
84144096|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
84144097|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144098|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144099|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
84144100|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144101|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84144102|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84144103|NCT00668603|Estradiol|estradiol|mesh-list
84144104|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84144105|NCT00668603|Estrogens|estrogens|mesh-ancestor
84144106|NCT00668603|Hormones|hormones|mesh-ancestor
84144107|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84144108|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144109|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84144110|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
84144111|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84144112|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84144113|NCT00662987|Amoxicillin|amoxicillin|mesh-list
84144114|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144115|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144116|NCT00668759|Amiodarone|amiodarone|mesh-list
84144117|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84144118|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
84144119|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84144120|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144121|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144122|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84144123|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84144124|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84144125|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144126|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84144127|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84144128|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84144129|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84144130|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84144131|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84144132|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144133|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144134|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84144135|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84144136|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84144137|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
84144138|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144139|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144140|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84144141|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84144142|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
84144143|NCT00663221|Vitamin D|vitamin d|mesh-list
84144144|NCT00663221|Calcium|calcium|mesh-list
84144145|NCT00663221|Vitamins|vitamins|mesh-ancestor
84144146|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
84144147|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144148|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84144149|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84144150|NCT00824850|Vaccines|vaccines|mesh-list
84144151|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84144152|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
84144153|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144154|NCT00596687|Insulin|insulin|mesh-list
84144155|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84144156|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
84144157|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
84144158|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84144159|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144160|NCT02631239|Dexamethasone|dexamethasone|mesh-list
84144161|NCT02631239|Methotrexate|methotrexate|mesh-list
84144162|NCT02631239|Etoposide|etoposide|mesh-list
84144163|NCT02631239|Pegaspargase|pegaspargase|mesh-list
84144164|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84144165|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
84144166|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
84144167|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144168|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144169|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84144170|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
84144171|NCT02631239|Hormones|hormones|mesh-ancestor
84144172|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84144173|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84144174|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144175|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84144176|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
84144177|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84144178|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84144179|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
84144180|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144181|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
84144182|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144183|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84144184|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84144185|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
84144186|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144187|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84144188|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84144189|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84144190|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84144191|NCT00663377|Losartan|losartan|mesh-list
84144192|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84144193|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84144194|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84144195|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84144196|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144197|NCT00669149|Aspirin|aspirin|mesh-list
84144198|NCT00669149|Heparin|heparin|mesh-list
84144199|NCT00669149|Enoxaparin|enoxaparin|mesh-list
84144200|NCT00669149|Bivalirudin|bivalirudin|mesh-list
84144201|NCT00669149|Clopidogrel|clopidogrel|mesh-list
84144202|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84144203|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84144204|NCT00669149|Analgesics|analgesics|mesh-ancestor
84144205|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
84144206|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144207|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144208|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84144209|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144210|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84144211|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84144212|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144213|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84144214|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84144215|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144216|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
84144217|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84144218|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84144219|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84144220|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
84144221|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144222|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
84144223|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
84144224|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84144225|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
84144226|NCT00663455|Cyclosporine|cyclosporine|mesh-list
84144227|NCT00663455|Cyclosporins|cyclosporins|mesh-list
84144228|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144229|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144230|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84144231|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
84144232|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144233|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
84144234|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144235|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
84144236|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144237|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84144238|NCT00669695|Atorvastatin|atorvastatin|mesh-list
84144239|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84144240|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84144241|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
84144242|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144243|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84144244|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84144245|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144246|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84144247|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144248|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84144249|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144250|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144251|NCT00669773|Docetaxel|docetaxel|mesh-list
84144252|NCT00669773|Doxorubicin|doxorubicin|mesh-list
84144253|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84144254|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144255|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
84144256|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
84144257|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
84144258|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144259|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84144260|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84144261|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84144262|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144263|NCT00824616|Insulin|insulin|mesh-list
84144264|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84144265|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144266|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84144267|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
84144268|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84144269|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84144270|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144271|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144272|NCT00663845|Urological Agents|urological agents|mesh-ancestor
84144274|NCT00708240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84144275|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84144276|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144277|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144278|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144279|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
84144280|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144281|NCT04155515|Ribavirin|ribavirin|mesh-list
84144282|NCT04155515|Yimitasvir|yimitasvir|mesh-list
84144283|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
84144284|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144285|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
84144286|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144287|NCT00664001|Antioxidants|antioxidants|mesh-list
84144288|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144289|NCT00664001|Protective Agents|protective agents|mesh-ancestor
84144290|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144291|NCT00824382|Olodaterol|olodaterol|mesh-list
84144292|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84144293|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
84144294|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144295|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144296|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84144297|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
84144298|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
84144299|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84144300|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
84144301|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84144302|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144303|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84144304|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84144305|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84144306|NCT00708318|Fentanyl|fentanyl|mesh-list
84144307|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84144308|NCT00708318|Narcotics|narcotics|mesh-ancestor
84144309|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144310|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144311|NCT00708318|Analgesics|analgesics|mesh-ancestor
84144312|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
84144313|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144314|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84144315|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84144316|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
84144317|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
84144318|NCT00670475|Piroxicam|piroxicam|mesh-list
84144319|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84144320|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84144321|NCT00670475|Analgesics|analgesics|mesh-ancestor
84144322|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
84144323|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144324|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144325|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84144326|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144327|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84144328|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144329|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144330|NCT04154033|Naltrexone|naltrexone|mesh-list
84144331|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84144332|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84144333|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144334|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
84144335|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144336|NCT05530356|Dextrans|dextrans|mesh-list
84144337|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
84144338|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
84144339|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
84144340|NCT00664313|Linezolid|linezolid|mesh-list
83385143|NCT01397201|Xhance|xhance|mesh-list
84144342|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144343|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84144344|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144345|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144346|NCT00670553|Panobinostat|panobinostat|mesh-list
84144347|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144348|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84144349|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144350|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144351|NCT00833040|Sufentanil|sufentanil|mesh-list
84144352|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84144353|NCT00833040|Narcotics|narcotics|mesh-ancestor
84144354|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144355|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144356|NCT00833040|Analgesics|analgesics|mesh-ancestor
84144357|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
84144358|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144359|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84144360|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84144361|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
84144362|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
84144363|NCT02629835|Dexamethasone|dexamethasone|mesh-list
84144364|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
84144365|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84144366|NCT02629835|BB 1101|bb 1101|mesh-list
84144367|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84144368|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
84144369|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
84144370|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144371|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144372|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84144373|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
84144374|NCT02629835|Hormones|hormones|mesh-ancestor
84144375|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84144376|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84144377|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144378|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
84144379|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144380|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144381|NCT00664469|Atorvastatin|atorvastatin|mesh-list
84144382|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84144383|NCT00664469|Simvastatin|simvastatin|mesh-list
84144384|NCT00664469|Ezetimibe|ezetimibe|mesh-list
84144385|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84144386|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84144387|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
84144388|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144389|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84144390|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84144391|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144392|NCT00843024|Naproxen|naproxen|mesh-list
84144393|NCT00843024|Sumatriptan|sumatriptan|mesh-list
84144394|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84144395|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84144396|NCT00843024|Analgesics|analgesics|mesh-ancestor
84144397|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
84144398|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144399|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144400|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84144401|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144402|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
84144403|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84144404|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144405|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144406|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84144407|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84144408|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84144409|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
84144410|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144411|NCT04154813|Topiramate|topiramate|mesh-list
84144412|NCT04154813|Fluoxetine|fluoxetine|mesh-list
84144413|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
84144414|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84144415|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144416|NCT04154813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84144417|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84144418|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144419|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144420|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144421|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
84144422|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84144423|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
84144424|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84144425|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84144426|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84144427|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144428|NCT00664703|Methylphenidate|methylphenidate|mesh-list
84144429|NCT00664703|Lobeline|lobeline|mesh-list
84144430|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84144431|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144432|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84144433|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84144434|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144435|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144436|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
84144437|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144438|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84144439|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
84144440|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144441|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84144442|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84144443|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
84144444|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
84144445|NCT00670787|Losartan|losartan|mesh-list
84144446|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84144447|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84144448|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84144449|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84144450|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84144451|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144452|NCT00670787|Diuretics|diuretics|mesh-ancestor
84144453|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
84144454|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144455|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84144456|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144457|NCT00664781|Rucaparib|rucaparib|mesh-list
84144458|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84144459|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144460|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144461|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144462|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
84144463|NCT00832650|Fesoterodine|fesoterodine|mesh-list
84144464|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84144465|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84144466|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
84144467|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144468|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144469|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144470|NCT00832650|Urological Agents|urological agents|mesh-ancestor
84144471|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
84144472|NCT04153487|Vitamins|vitamins|mesh-ancestor
84144473|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
84144474|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144475|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
84144476|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144477|NCT04153487|Protective Agents|protective agents|mesh-ancestor
84144478|NCT00708396|Escitalopram|escitalopram|mesh-list
84144479|NCT00708396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84144480|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84144481|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144482|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144483|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144484|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
84144485|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144486|NCT00665093|Insulin|insulin|mesh-list
84144487|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84144488|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
84144489|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
84144490|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
84144491|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84144492|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84144493|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144494|NCT00595517|Esomeprazole|esomeprazole|mesh-list
84144495|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84144496|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84144497|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84144498|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144499|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144501|NCT00911651|Albuterol|albuterol|mesh-list
84144502|NCT00911651|Ipratropium|ipratropium|mesh-list
84144503|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
84144504|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84144505|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
84144506|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144507|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144508|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84144509|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
84144510|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
84144511|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84144512|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84144513|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84144514|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84144515|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
84144516|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144517|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144518|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84144519|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
84144520|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
84144521|NCT00665327|Levofloxacin|levofloxacin|mesh-list
84144522|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84144523|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144524|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144525|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84144526|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84144527|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144528|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144529|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144530|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84144531|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
84144532|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84144533|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144534|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84144535|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84144536|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84144537|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84144538|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84144539|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84144540|NCT00823836|Ropinirole|ropinirole|mesh-list
84144541|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84144542|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84144543|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
84144544|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
84144545|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144546|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144547|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144548|NCT04154735|Rifaximin|rifaximin|mesh-list
84144549|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
84144550|NCT04154735|Fludarabine|fludarabine|mesh-list
84144551|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
84144552|NCT04154735|Tacrolimus|tacrolimus|mesh-list
84144553|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84144554|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
84144555|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144556|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144557|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84144558|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
84144559|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144560|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144561|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84144562|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84144563|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144564|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84144565|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144566|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144567|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84144568|NCT00705042|Etanercept|etanercept|mesh-list
84144569|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84144570|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84144571|NCT00705042|Analgesics|analgesics|mesh-ancestor
84144572|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
84144573|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144574|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144575|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84144576|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144577|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84144578|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84144579|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
84144580|NCT00879437|Bevacizumab|bevacizumab|mesh-list
84144581|NCT00879437|Valproic Acid|valproic acid|mesh-list
84144582|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84144583|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144584|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84144585|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84144586|NCT00879437|Growth Substances|growth substances|mesh-ancestor
84144587|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144588|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
84144589|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
84144590|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144591|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144592|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
84144593|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144594|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
84144595|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84144596|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144597|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84144598|NCT00665639|Caspofungin|caspofungin|mesh-list
84144599|NCT00665639|Micafungin|micafungin|mesh-list
84144600|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
84144601|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144602|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144603|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144604|NCT04153253|Aflibercept|aflibercept|mesh-list
84144605|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84144606|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84144607|NCT04153253|Growth Substances|growth substances|mesh-ancestor
84144608|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144609|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
84144610|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144611|NCT00671645|Bevacizumab|bevacizumab|mesh-list
84144612|NCT00671645|Capecitabine|capecitabine|mesh-list
84144613|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84144614|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144615|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84144616|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84144617|NCT00671645|Growth Substances|growth substances|mesh-ancestor
84144618|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144619|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
84144620|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84144621|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
84144622|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144623|NCT02629523|Afatinib|afatinib|mesh-list
84144624|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144625|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84144626|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144627|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144628|NCT00671801|Irinotecan|irinotecan|mesh-list
84144629|NCT00671801|Lenalidomide|lenalidomide|mesh-list
84144630|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84144631|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84144632|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144633|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144634|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144635|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
84144636|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144637|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84144638|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84144639|NCT00671801|Growth Substances|growth substances|mesh-ancestor
84144640|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
84144641|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
84144642|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84144643|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
84144644|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144645|NCT00676559|Ranibizumab|ranibizumab|mesh-list
84144646|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84144647|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84144648|NCT00676559|Growth Substances|growth substances|mesh-ancestor
84144649|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144650|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
84144651|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144652|NCT00672113|Nifedipine|nifedipine|mesh-list
84144653|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84144654|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144655|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144656|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84144657|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144658|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
84144659|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
84144660|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84144661|NCT00676637|Timolol|timolol|mesh-list
84144662|NCT00676637|Travoprost|travoprost|mesh-list
84144663|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84144664|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84144665|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84144666|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84144667|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
84144668|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144669|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144670|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144671|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84144672|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84144673|NCT00672347|Clonidine|clonidine|mesh-list
84144674|NCT00672347|Morphine|morphine|mesh-list
84144675|NCT00672347|Bupivacaine|bupivacaine|mesh-list
84144676|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
84144677|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
84144678|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144679|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144680|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
84144681|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144682|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84144683|NCT00672347|Narcotics|narcotics|mesh-ancestor
84144684|NCT00672347|Analgesics|analgesics|mesh-ancestor
84144685|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84144686|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
84144687|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
84144688|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84144689|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84144690|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84144691|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
84144692|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144693|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144694|NCT00676871|Blinatumomab|blinatumomab|mesh-list
84144695|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144696|NCT00677027|Lentinan|lentinan|mesh-list
84144697|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84144698|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
84144699|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144700|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144701|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
84144702|NCT00595127|Fludarabine|fludarabine|mesh-list
84144703|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84144704|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
84144705|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144706|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84144707|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84144708|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
84144709|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144710|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144711|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84144712|NCT00672659|Dexetimide|dexetimide|mesh-list
84144713|NCT00672659|Pipamperone|pipamperone|mesh-list
84144714|NCT00672659|Citalopram|citalopram|mesh-list
84144715|NCT00672659|Escitalopram|escitalopram|mesh-list
84144716|NCT00672659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84144717|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84144718|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144719|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144720|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144721|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
84144722|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144723|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84144724|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
84144725|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84144726|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84144727|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84144728|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
84144729|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
84144730|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144731|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84144732|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84144733|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
84144734|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84144735|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84144736|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84144737|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144738|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84144739|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84144740|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144741|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84144742|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84144743|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144744|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144745|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
84144746|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144747|NCT00677261|Anesthetics|anesthetics|mesh-list
84144748|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
84144749|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144750|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144751|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
84144752|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144753|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
84144754|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84144755|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84144756|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144757|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
84144758|NCT00912119|Coagulants|coagulants|mesh-ancestor
84144759|NCT00677339|Vitamin D|vitamin d|mesh-list
84144760|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
84144761|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
84144762|NCT00677339|Vitamins|vitamins|mesh-list
84144763|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
84144764|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144765|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84144766|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84144767|NCT00672971|Permethrin|permethrin|mesh-list
84144768|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144769|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144770|NCT00673205|Bicalutamide|bicalutamide|mesh-list
84144771|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
84144772|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
84144773|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84144774|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144775|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144776|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84144777|NCT00677729|Albuterol|albuterol|mesh-list
84144778|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84144779|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
84144780|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144781|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144782|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84144783|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
84144784|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
84144785|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83385537|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
84144786|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84144787|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84144788|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84144789|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
84144790|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144791|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144792|NCT02628197|Vitamin D|vitamin d|mesh-list
84144793|NCT02628197|Calcium|calcium|mesh-list
84144794|NCT02628197|Vitamins|vitamins|mesh-ancestor
84144795|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
84144796|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144797|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84144798|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84144799|NCT00673829|Interleukin-2|interleukin-2|mesh-list
84144800|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144801|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84144802|NCT00673829|Analgesics|analgesics|mesh-ancestor
84144803|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
84144804|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144805|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144806|NCT04152629|Methylphenidate|methylphenidate|mesh-list
84144807|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84144808|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84144809|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144810|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84144811|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84144812|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144813|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144814|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
84144815|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144816|NCT02535299|Metformin|metformin|mesh-list
84144817|NCT02535299|Liraglutide|liraglutide|mesh-list
84144818|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84144819|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144820|NCT02535299|Incretins|incretins|mesh-ancestor
84144821|NCT02535299|Hormones|hormones|mesh-ancestor
84144822|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84144823|NCT00674063|Alefacept|alefacept|mesh-list
84144824|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
84144825|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
84144826|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144827|NCT04151459|Metformin|metformin|mesh-list
84144828|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84144829|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144830|NCT00674141|Dexamethasone|dexamethasone|mesh-list
84144831|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84144832|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
84144833|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
84144834|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144835|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144836|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84144837|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
84144838|NCT00674141|Hormones|hormones|mesh-ancestor
84144839|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84144840|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84144841|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144842|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84144843|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
84144844|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144845|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84144846|NCT02627807|Cisplatin|cisplatin|mesh-list
84144847|NCT02627807|Gemcitabine|gemcitabine|mesh-list
84144848|NCT02627807|Docetaxel|docetaxel|mesh-list
84144849|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144850|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84144851|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
84144852|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144853|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
84144854|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
84144855|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
84144856|NCT00678431|Resveratrol|resveratrol|mesh-list
84144857|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
84144858|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144859|NCT00678431|Protective Agents|protective agents|mesh-ancestor
84144860|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144861|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144862|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84144863|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84144864|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84144865|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
84144866|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144868|NCT00674687|Analgesics|analgesics|mesh-ancestor
84144869|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
84144870|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144871|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144872|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
84144873|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84144874|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84144875|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84144876|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84144877|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84144878|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84144879|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144880|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144881|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
84144882|NCT00656747|Amoxicillin|amoxicillin|mesh-list
84144883|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
84144884|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
84144885|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
84144886|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84144887|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84144888|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144889|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144890|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84144891|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84144892|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144893|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144894|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144895|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84144896|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
84144897|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84144898|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144899|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84144900|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84144901|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84144902|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84144903|NCT00678743|Simvastatin|simvastatin|mesh-list
84144904|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84144905|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84144906|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
84144907|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144908|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84144909|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84144910|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144911|NCT04152317|Misoprostol|misoprostol|mesh-list
84144912|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84144913|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
84144914|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84144915|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144916|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84144917|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84144918|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
84144919|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
84144920|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
84144921|NCT02628665|Trioxsalen|trioxsalen|mesh-list
84144922|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
84144923|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144924|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
84144925|NCT00678977|Gemcitabine|gemcitabine|mesh-list
84144926|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144927|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84144928|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
84144929|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144930|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84144931|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84144932|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144933|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83385686|NCT00876915|Tinzaparin|tinzaparin|mesh-list
84144934|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
84144935|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84144936|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84144938|NCT00674999|Nystatin|nystatin|mesh-list
84144939|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84144940|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144941|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144942|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
84144943|NCT00674999|Ionophores|ionophores|mesh-ancestor
84144944|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84144945|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144946|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
84144947|NCT00882713|Hematinics|hematinics|mesh-ancestor
84144948|NCT04151381|Aminophylline|aminophylline|mesh-list
84144949|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84144950|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
84144951|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84144952|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144953|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84144954|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
84144955|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84144956|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84144957|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144958|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144959|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84144960|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84144961|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
84144962|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84144963|NCT04151381|Protective Agents|protective agents|mesh-ancestor
84144964|NCT00809133|Paclitaxel|paclitaxel|mesh-list
84144965|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84144966|NCT00809133|Bevacizumab|bevacizumab|mesh-list
84144967|NCT00809133|Carboplatin|carboplatin|mesh-list
84144968|NCT00809133|Afatinib|afatinib|mesh-list
84144969|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84144970|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144971|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
84144972|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
84144973|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
84144974|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144975|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84144976|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84144977|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84144978|NCT00809133|Growth Substances|growth substances|mesh-ancestor
84144979|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84144980|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
84144981|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84144982|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144983|NCT00912275|Vinorelbine|vinorelbine|mesh-list
84144984|NCT00912275|Lapatinib|lapatinib|mesh-list
84144985|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84144986|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84144987|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
84144988|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
84144989|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
84144990|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84144991|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84144992|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84144993|NCT00882557|Daptomycin|daptomycin|mesh-list
84144994|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84144995|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84144996|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
84144997|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
84144998|NCT02627573|Busulfan|busulfan|mesh-list
84144999|NCT02627573|Fludarabine|fludarabine|mesh-list
84145000|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
84145001|NCT02627573|Tacrolimus|tacrolimus|mesh-list
84145002|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
84145003|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145004|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
84145005|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145006|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145007|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145008|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
84145009|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83385763|NCT03214731|Artesunate|artesunate|mesh-list
84145010|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145011|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84145012|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145013|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
84145014|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84145015|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145016|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84145017|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84145018|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
84145019|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145020|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145022|NCT00675545|Docetaxel|docetaxel|mesh-list
84145023|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145024|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145025|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145026|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145027|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145028|NCT00679523|Tavaborole|tavaborole|mesh-list
84145029|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84145030|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
84145031|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145032|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
84145033|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145034|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145035|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145036|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145037|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145038|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145039|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145040|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
84145041|NCT00808899|Doxorubicin|doxorubicin|mesh-list
84145042|NCT00808899|Irinotecan|irinotecan|mesh-list
84145043|NCT00808899|Etoposide|etoposide|mesh-list
84145044|NCT00808899|Topotecan|topotecan|mesh-list
84145045|NCT00808899|Temsirolimus|temsirolimus|mesh-list
84145046|NCT00808899|Tretinoin|tretinoin|mesh-list
84145047|NCT00808899|Isotretinoin|isotretinoin|mesh-list
84145048|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145049|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
84145050|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145051|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145052|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145053|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
84145054|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145055|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145056|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84145057|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84145058|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145059|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145060|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145061|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84145062|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145063|NCT00808899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84145064|NCT00808899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145065|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
84145066|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
84145067|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
84145068|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84145069|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145070|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145071|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145072|NCT00808665|Analgesics|analgesics|mesh-ancestor
84145073|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
84145074|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145075|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84145076|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84145077|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84145078|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
84145079|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145080|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145081|NCT00808509|Adalimumab|adalimumab|mesh-list
84145082|NCT00808509|Methotrexate|methotrexate|mesh-list
84145083|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84145084|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
84145085|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84145086|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145087|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145088|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
84145089|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145090|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145091|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
84145092|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145093|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84145094|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145095|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
84145096|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145097|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84145098|NCT00808509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84145099|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145100|NCT04444869|Cisplatin|cisplatin|mesh-list
84145101|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145102|NCT04276857|Leucovorin|leucovorin|mesh-list
84145103|NCT04276857|Paclitaxel|paclitaxel|mesh-list
84145104|NCT04276857|Gemcitabine|gemcitabine|mesh-list
84145105|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
84145106|NCT04276857|Irinotecan|irinotecan|mesh-list
84145107|NCT04276857|Folfirinox|folfirinox|mesh-list
84145108|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145109|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145110|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145111|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145112|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145113|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145114|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145115|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
84145116|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84145117|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145118|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145119|NCT04276857|Antidotes|antidotes|mesh-ancestor
84145120|NCT04276857|Protective Agents|protective agents|mesh-ancestor
84145121|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145122|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
84145123|NCT04276857|Vitamins|vitamins|mesh-ancestor
84145124|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
84145125|NCT00807573|Paclitaxel|paclitaxel|mesh-list
84145126|NCT00807573|Bevacizumab|bevacizumab|mesh-list
84145127|NCT00807573|Pemetrexed|pemetrexed|mesh-list
84145128|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145129|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145130|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145131|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145132|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145133|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145134|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145135|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84145136|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84145137|NCT00807573|Growth Substances|growth substances|mesh-ancestor
84145138|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145139|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
84145140|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145141|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84145142|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84145143|NCT00842712|Cisplatin|cisplatin|mesh-list
84145144|NCT00842712|Gemcitabine|gemcitabine|mesh-list
84145145|NCT00842712|Cetuximab|cetuximab|mesh-list
84145146|NCT00842712|Vinorelbine|vinorelbine|mesh-list
84145147|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145148|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145149|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
84145150|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145151|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145152|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145153|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145154|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145155|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145156|NCT00705120|Cyclosporine|cyclosporine|mesh-list
84145157|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
84145158|NCT00705120|Busulfan|busulfan|mesh-list
84145159|NCT00705120|Cyclosporins|cyclosporins|mesh-list
84145160|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145161|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
84145162|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145163|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145164|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145165|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
84145166|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145167|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145168|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84145169|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145170|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
84145171|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145172|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
84145173|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84145174|NCT00842244|Capecitabine|capecitabine|mesh-list
84145175|NCT00842244|Axitinib|axitinib|mesh-list
84145176|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145177|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145178|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
84145179|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145180|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145181|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145182|NCT00832416|Tramadol|tramadol|mesh-list
84145183|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84145184|NCT00832416|Narcotics|narcotics|mesh-ancestor
84145185|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145186|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145187|NCT00832416|Analgesics|analgesics|mesh-ancestor
84145188|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
84145189|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145190|NCT00705198|Temozolomide|temozolomide|mesh-list
84145191|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145192|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
84145193|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145194|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145195|NCT00702936|Telmisartan|telmisartan|mesh-list
84145196|NCT00702936|Ramipril|ramipril|mesh-list
84145197|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84145198|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84145199|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84145200|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145201|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84145202|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
84145203|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145204|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84145205|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84145206|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84145207|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145208|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145209|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145210|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145211|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
84145212|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84145213|NCT00683644|Zinc|zinc|mesh-list
84145214|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
84145215|NCT00683644|Trace Elements|trace elements|mesh-ancestor
84145216|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
84145217|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145218|NCT00683644|Astringents|astringents|mesh-ancestor
84145219|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
84145220|NCT00753064|Prazosin|prazosin|mesh-list
84145221|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84145222|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84145223|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84145224|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84145225|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
84145226|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145227|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145228|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145229|NCT00751738|Azimilide|azimilide|mesh-list
84145230|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84145231|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84145232|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145233|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145234|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84145235|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145236|NCT04060264|Eculizumab|eculizumab|mesh-list
84145237|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84145238|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145239|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
84145240|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145241|NCT00684814|Zolpidem|zolpidem|mesh-list
84145242|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84145243|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84145244|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145245|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145246|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84145247|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
84145248|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
84145249|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145250|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145251|NCT00576472|Methylphenidate|methylphenidate|mesh-list
84145252|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84145253|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145254|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84145255|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84145256|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145257|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145258|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
84145259|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145260|NCT00823212|Aspirin|aspirin|mesh-list
84145261|NCT00823212|Ticlopidine|ticlopidine|mesh-list
84145262|NCT00823212|Clopidogrel|clopidogrel|mesh-list
84145263|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84145264|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145265|NCT00823212|Analgesics|analgesics|mesh-ancestor
84145266|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
84145267|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145268|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145269|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145270|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145271|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84145272|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84145273|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145274|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84145275|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84145276|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145277|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
84145278|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84145279|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84145280|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84145281|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
84145282|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145283|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84145284|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84145285|NCT02561494|Nefopam|nefopam|mesh-list
84145286|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145287|NCT02561494|Analgesics|analgesics|mesh-ancestor
84145288|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
84145289|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145290|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145291|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
84145292|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84145293|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
84145294|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
84145295|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
84145296|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145297|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
84145298|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
84145299|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84145300|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145301|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145302|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84145303|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145304|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84145305|NCT00755950|Silymarin|silymarin|mesh-list
84145306|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
84145307|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145308|NCT00755950|Protective Agents|protective agents|mesh-ancestor
84145309|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145310|NCT00705354|Bacitracin|bacitracin|mesh-list
84145311|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84145312|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145313|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145314|NCT00575380|Azithromycin|azithromycin|mesh-list
84145315|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
84145316|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84145317|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84145318|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84145319|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145320|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145321|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145322|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145323|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145324|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145325|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145326|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84145327|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
84145328|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84145329|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145330|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84145331|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84145332|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84145333|NCT00840996|Lidocaine|lidocaine|mesh-list
84145334|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
84145335|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
84145336|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145337|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145338|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
84145339|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145340|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84145341|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84145342|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84145343|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145344|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145345|NCT00756184|Travoprost|travoprost|mesh-list
84145346|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84145347|NCT00756340|Bevacizumab|bevacizumab|mesh-list
84145348|NCT00756340|Everolimus|everolimus|mesh-list
84145349|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145350|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145351|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84145352|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84145353|NCT00756340|Growth Substances|growth substances|mesh-ancestor
84145354|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145355|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
84145356|NCT00756340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84145357|NCT00756340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145358|NCT00756340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145359|NCT00756340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145360|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145361|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
84145362|NCT00705510|Cyclosporine|cyclosporine|mesh-list
84145363|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84145364|NCT00705510|Cyclosporins|cyclosporins|mesh-list
84145365|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145366|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145367|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145368|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
84145369|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145370|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
84145371|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145372|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
84145373|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145374|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84145375|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84145376|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84145377|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
84145378|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145379|NCT00680836|Rifaximin|rifaximin|mesh-list
84145380|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145381|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145382|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84145383|NCT05428306|Acetaminophen|acetaminophen|mesh-list
84145384|NCT05428306|Ibuprofen|ibuprofen|mesh-list
84145385|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145386|NCT05428306|Analgesics|analgesics|mesh-ancestor
84145387|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
84145388|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145389|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145390|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
84145391|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84145392|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145393|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145394|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84145395|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145396|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145397|NCT05424796|Hemostatics|hemostatics|mesh-list
84145398|NCT05424796|Coagulants|coagulants|mesh-ancestor
84145399|NCT00757198|Remifentanil|remifentanil|mesh-list
84145400|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84145401|NCT00757198|Narcotics|narcotics|mesh-ancestor
84145402|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145403|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145404|NCT00757198|Analgesics|analgesics|mesh-ancestor
84145405|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
84145406|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145407|NCT00679432|Budesonide|budesonide|mesh-list
84145408|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145409|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84145410|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
84145411|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145412|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145413|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84145414|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
84145415|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
84145416|NCT00679432|Hormones|hormones|mesh-ancestor
84145417|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145418|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
84145419|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84145420|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84145421|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145422|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
84145423|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
84145424|NCT04050826|Lidocaine|lidocaine|mesh-list
84145425|NCT04050826|Prilocaine|prilocaine|mesh-list
84145426|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
84145427|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
84145428|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145429|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145430|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
84145431|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145432|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84145433|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84145434|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84145435|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145436|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145437|NCT00757978|Memantine|memantine|mesh-list
84145438|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84145439|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84145440|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
84145441|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145442|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145443|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145444|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84145445|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84145446|NCT00754702|Vinorelbine|vinorelbine|mesh-list
84145447|NCT00754702|Lapatinib|lapatinib|mesh-list
84145448|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145449|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145450|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145451|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145452|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145453|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145454|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145455|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145456|NCT00754780|Pirfenidone|pirfenidone|mesh-list
84145457|NCT00754780|Analgesics|analgesics|mesh-ancestor
84145458|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
84145459|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145460|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145461|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84145462|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145463|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145464|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145465|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145466|NCT00822900|Progesterone|progesterone|mesh-list
84145467|NCT00822900|Progestins|progestins|mesh-ancestor
84145468|NCT00822900|Hormones|hormones|mesh-ancestor
84145469|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145470|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145471|NCT00682786|Fluorouracil|fluorouracil|mesh-list
84145472|NCT00682786|Irinotecan|irinotecan|mesh-list
84145473|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
84145474|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145475|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145476|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145477|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145478|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
84145479|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145480|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84145481|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145482|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145483|NCT00840450|Paclitaxel|paclitaxel|mesh-list
84145484|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84145485|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
84145486|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145487|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145488|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145489|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145490|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145491|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145492|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145493|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145494|NCT00754858|Belotecan|belotecan|mesh-list
84145495|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145496|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84145497|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145498|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145499|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145500|NCT00755014|Ethanol|ethanol|mesh-list
84145501|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84145502|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145503|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145504|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145505|NCT00705588|Tadalafil|tadalafil|mesh-list
84145506|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84145507|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
84145508|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84145509|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84145510|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145511|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145512|NCT00705588|Urological Agents|urological agents|mesh-ancestor
84145513|NCT00755170|Bevacizumab|bevacizumab|mesh-list
84145514|NCT00755170|Vinorelbine|vinorelbine|mesh-list
84145515|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145516|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145517|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84145518|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84145519|NCT00755170|Growth Substances|growth substances|mesh-ancestor
84145520|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145521|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
84145522|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145523|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145524|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145525|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145526|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145527|NCT00705822|Prednisone|prednisone|mesh-list
84145528|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
84145529|NCT00705822|Docetaxel|docetaxel|mesh-list
84145530|NCT00705822|Estramustine|estramustine|mesh-list
84145531|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145532|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
83386289|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
84145533|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145534|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145535|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145536|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145537|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
84145538|NCT00705822|Hormones|hormones|mesh-ancestor
84145539|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145540|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145541|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84145542|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145543|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
84145544|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
84145545|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145546|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145547|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145548|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145549|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145550|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145551|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145552|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84145553|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84145554|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84145555|NCT00703170|Sirolimus|sirolimus|mesh-list
84145556|NCT00703170|Doxorubicin|doxorubicin|mesh-list
84145557|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84145558|NCT00703170|Temsirolimus|temsirolimus|mesh-list
84145559|NCT00703170|MTOR Inhibitors|mtor inhibitors|mesh-list
84145560|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84145561|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145562|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145563|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145564|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145565|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145566|NCT00703170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145567|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145568|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
84145569|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145570|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145571|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145572|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
84145573|NCT05370040|Vaccines|vaccines|mesh-list
84145574|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
84145575|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145576|NCT05354674|Bevacizumab|bevacizumab|mesh-list
84145577|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145578|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145579|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84145580|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84145581|NCT05354674|Growth Substances|growth substances|mesh-ancestor
84145582|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145583|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
84145584|NCT00758134|Trastuzumab|trastuzumab|mesh-list
84145585|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145586|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145587|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
84145588|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145589|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145590|NCT02560636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84145591|NCT02560636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145592|NCT00758212|Vaccines|vaccines|mesh-list
84145593|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
84145594|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145595|NCT00679042|Exenatide|exenatide|mesh-list
84145596|NCT00679042|Sirolimus|sirolimus|mesh-list
84145597|NCT00679042|Etanercept|etanercept|mesh-list
84145598|NCT00679042|Tacrolimus|tacrolimus|mesh-list
84145599|NCT00679042|Basiliximab|basiliximab|mesh-list
84145600|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145601|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
84145602|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145603|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84145604|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145605|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145606|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145607|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145608|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84145609|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145610|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
84145611|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84145612|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145613|NCT00679042|Analgesics|analgesics|mesh-ancestor
84145614|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
84145615|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145616|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145617|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145618|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84145619|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84145620|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84145621|NCT00679042|Incretins|incretins|mesh-ancestor
84145622|NCT00679042|Hormones|hormones|mesh-ancestor
84145623|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145624|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84145625|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
84145626|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84145627|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84145628|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145629|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145630|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84145631|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145632|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145633|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
84145634|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145635|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
84145636|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
84145637|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84145638|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
84145639|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145640|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145641|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84145642|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
84145643|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84145644|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84145645|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84145646|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
84145647|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145648|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145649|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
84145650|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84145651|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
84145652|NCT00758368|Apomorphine|apomorphine|mesh-list
84145653|NCT00758368|Emetics|emetics|mesh-ancestor
84145654|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145655|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
84145656|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145657|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84145658|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
84145659|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
84145660|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145661|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145662|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
84145663|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84145664|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145665|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145666|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145667|NCT05435560|Analgesics|analgesics|mesh-ancestor
84145668|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
84145669|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145670|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84145671|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84145672|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84145673|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
84145674|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145675|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145676|NCT00680992|Denosumab|denosumab|mesh-list
84145677|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
84145678|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
84145679|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
84145680|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145681|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84145682|NCT02559154|Thalidomide|thalidomide|mesh-list
84145683|NCT02559154|Dexamethasone|dexamethasone|mesh-list
84145684|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
84145685|NCT02559154|Doxorubicin|doxorubicin|mesh-list
84145686|NCT02559154|Bortezomib|bortezomib|mesh-list
84145687|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145688|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
84145689|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145690|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145691|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145692|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
84145693|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145694|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145695|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84145696|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145697|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
84145698|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
84145699|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145700|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84145701|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
84145702|NCT02559154|Hormones|hormones|mesh-ancestor
84145703|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145704|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84145705|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84145706|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145707|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145708|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145709|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
84145710|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145711|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145712|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84145713|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84145714|NCT02559154|Growth Substances|growth substances|mesh-ancestor
84145715|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
84145716|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
84145717|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
84145718|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145719|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145720|NCT05747469|Lidocaine|lidocaine|mesh-list
84145721|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
84145722|NCT05747469|Anesthetics|anesthetics|mesh-list
84145723|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145724|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145725|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
84145726|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145727|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84145728|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84145729|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84145730|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84145731|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145732|NCT00804843|Niacin|niacin|mesh-list
84145733|NCT00804843|Atorvastatin|atorvastatin|mesh-list
84145734|NCT00804843|Simvastatin|simvastatin|mesh-list
84145735|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84145736|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84145737|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
84145738|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145739|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84145740|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84145741|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145742|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
84145743|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
84145744|NCT00804843|Vitamins|vitamins|mesh-ancestor
84145745|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
84145746|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145747|NCT00822120|Prednisone|prednisone|mesh-list
84145748|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
84145749|NCT00822120|Dacarbazine|dacarbazine|mesh-list
84145750|NCT00822120|Doxorubicin|doxorubicin|mesh-list
84145751|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84145752|NCT00822120|Etoposide|etoposide|mesh-list
84145753|NCT00822120|Vincristine|vincristine|mesh-list
84145754|NCT00822120|Bleomycin|bleomycin|mesh-list
84145755|NCT00822120|Vinblastine|vinblastine|mesh-list
84145756|NCT00822120|Procarbazine|procarbazine|mesh-list
84145757|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145758|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
84145759|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145760|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145761|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145762|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
84145763|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145764|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145765|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84145766|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84145767|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145768|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84145769|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145770|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145771|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
84145773|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145774|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84145775|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84145776|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
84145777|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
84145778|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
84145779|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
84145780|NCT00804687|Ephedrine|ephedrine|mesh-list
84145781|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84145782|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
84145783|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145784|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145785|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84145786|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
84145787|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
84145788|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84145789|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84145790|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
84145791|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
84145792|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145793|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145794|NCT00678652|Vaccines|vaccines|mesh-list
84145795|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
84145796|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145797|NCT02607657|Eplerenone|eplerenone|mesh-list
84145798|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84145799|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
84145800|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145801|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145802|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84145803|NCT02607657|Diuretics|diuretics|mesh-ancestor
84145804|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
84145805|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84145806|NCT00574912|Insulin|insulin|mesh-list
84145807|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84145808|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
84145809|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84145810|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145811|NCT00922896|Gemcitabine|gemcitabine|mesh-list
84145812|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84145813|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145814|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145815|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
84145816|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145817|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145818|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145819|NCT00761020|Mefloquine|mefloquine|mesh-list
84145820|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
84145821|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84145822|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84145823|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145824|NCT00804141|Bromides|bromides|mesh-list
84145825|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
84145826|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
84145827|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84145828|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145829|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
84145830|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145831|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
84145832|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145833|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145834|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145835|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145836|NCT02607579|Ropivacaine|ropivacaine|mesh-list
84145837|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
84145838|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
84145839|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84145840|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145841|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
84145842|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145843|NCT03539367|Acetazolamide|acetazolamide|mesh-list
84145844|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
84145845|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84145846|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145847|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145848|NCT03539367|Diuretics|diuretics|mesh-ancestor
84145849|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
84145850|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145851|NCT03416361|Vitamin D|vitamin d|mesh-list
84145852|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
84145853|NCT03416361|Vitamins|vitamins|mesh-ancestor
84145854|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
84145855|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145856|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84145857|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84145858|NCT00761254|Domperidone|domperidone|mesh-list
84145859|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
84145860|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
84145861|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145862|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145863|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84145864|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84145865|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
84145866|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84145867|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145868|NCT00761332|Teriparatide|teriparatide|mesh-list
84145869|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
84145870|NCT00761332|Diphosphonates|diphosphonates|mesh-list
84145871|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84145872|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145873|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84145874|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84145875|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
84145876|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145877|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84145878|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84145879|NCT04741438|Nivolumab|nivolumab|mesh-list
84145880|NCT04741438|Ipilimumab|ipilimumab|mesh-list
84145881|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145882|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145883|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84145884|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145885|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84145886|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
84145887|NCT03321201|Coagulants|coagulants|mesh-ancestor
84145888|NCT02612220|Hemostatics|hemostatics|mesh-list
84145889|NCT02612220|Coagulants|coagulants|mesh-ancestor
84145890|NCT04627246|Vaccines|vaccines|mesh-list
84145891|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
84145892|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145893|NCT00761644|Sirolimus|sirolimus|mesh-list
84145894|NCT00761644|Bevacizumab|bevacizumab|mesh-list
84145895|NCT00761644|Doxorubicin|doxorubicin|mesh-list
84145896|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84145897|NCT00761644|Temsirolimus|temsirolimus|mesh-list
84145898|NCT00761644|MTOR Inhibitors|mtor inhibitors|mesh-list
84145899|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145900|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145901|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84145902|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84145903|NCT00761644|Growth Substances|growth substances|mesh-ancestor
84145904|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145905|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
84145906|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84145907|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84145908|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83386669|NCT01384877|Lidocaine|lidocaine|mesh-list
84145909|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145910|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145911|NCT00761644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84145912|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145913|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
84145914|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84145915|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84145916|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
84145918|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84145919|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
84145920|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84145921|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
84145922|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145923|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145924|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84145925|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84145926|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145927|NCT03168256|Apremilast|apremilast|mesh-list
84145928|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84145929|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84145930|NCT03168256|Analgesics|analgesics|mesh-ancestor
84145931|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
84145932|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84145933|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145934|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145935|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84145936|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84145937|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84145938|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145939|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145940|NCT00761722|Azacitidine|azacitidine|mesh-list
84145941|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84145942|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
84145943|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145944|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145945|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145946|NCT04507906|Nivolumab|nivolumab|mesh-list
84145947|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145948|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145949|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84145950|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145951|NCT00762190|Insulin|insulin|mesh-list
84145952|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84145953|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84145954|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145955|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
84145956|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84145957|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145958|NCT00762658|Betamethasone|betamethasone|mesh-list
84145959|NCT00762658|Tacrolimus|tacrolimus|mesh-list
84145960|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84145961|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145962|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
84145963|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145964|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84145965|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145966|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145967|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84145968|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
84145969|NCT00762658|Hormones|hormones|mesh-ancestor
84145970|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84145971|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84145972|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
84145973|NCT02558452|Tacrolimus|tacrolimus|mesh-list
84145974|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84145975|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
84145976|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145977|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84145978|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84145979|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145980|NCT00762736|Pioglitazone|pioglitazone|mesh-list
84145981|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84145982|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84145983|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84145984|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84145985|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84145986|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145988|NCT02915224|Chlorambucil|chlorambucil|mesh-list
84145989|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145990|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145991|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84145992|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
84145993|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84145994|NCT02870920|Durvalumab|durvalumab|mesh-list
84145995|NCT02870920|Tremelimumab|tremelimumab|mesh-list
84145996|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84145997|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84145998|NCT02813824|Aspirin|aspirin|mesh-list
84145999|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
84146000|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84146001|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146002|NCT02813824|Analgesics|analgesics|mesh-ancestor
84146003|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
84146004|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146005|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146006|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146007|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146008|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84146009|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84146010|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146011|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84146012|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84146013|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146014|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
84146015|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84146016|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146017|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146018|NCT00673894|Incretins|incretins|mesh-ancestor
84146019|NCT00673894|Hormones|hormones|mesh-ancestor
84146020|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146021|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84146022|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
84146023|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146024|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146025|NCT00763204|Betamethasone|betamethasone|mesh-list
84146026|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84146027|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146028|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
84146029|NCT00763204|Hormones|hormones|mesh-ancestor
84146030|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146031|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146032|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84146033|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
84146034|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
84146035|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146036|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146037|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146038|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
84146039|NCT02558218|Hormones|hormones|mesh-ancestor
84146040|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146041|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146042|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84146043|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84146044|NCT00763438|Sertindole|sertindole|mesh-list
84146045|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84146046|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84146047|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146048|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146049|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146050|NCT01737502|Sirolimus|sirolimus|mesh-list
84146051|NCT01737502|Auranofin|auranofin|mesh-list
84146052|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83386820|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
84146053|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146054|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84146055|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146056|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
84146057|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146058|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
84146059|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146060|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146061|NCT02559232|Anticoagulants|anticoagulants|mesh-list
84146062|NCT00673816|Sunitinib|sunitinib|mesh-list
84146063|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146064|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84146065|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84146066|NCT00673816|Growth Substances|growth substances|mesh-ancestor
84146067|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146068|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
84146069|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84146070|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146071|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146072|NCT00763906|Norepinephrine|norepinephrine|mesh-list
84146073|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84146074|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84146075|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
84146076|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146077|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146078|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146079|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
84146080|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
84146081|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146082|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84146083|NCT00764062|Amoxicillin|amoxicillin|mesh-list
84146084|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146085|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146086|NCT00758914|Vitamin E|vitamin e|mesh-list
84146087|NCT00758914|Vitamins|vitamins|mesh-ancestor
84146088|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
84146089|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146090|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
84146091|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146092|NCT00758914|Protective Agents|protective agents|mesh-ancestor
84146093|NCT00759070|Ritonavir|ritonavir|mesh-list
84146094|NCT00759070|Lopinavir|lopinavir|mesh-list
84146095|NCT00759070|Tenofovir|tenofovir|mesh-list
84146096|NCT00759070|Emtricitabine|emtricitabine|mesh-list
84146097|NCT00759070|Efavirenz|efavirenz|mesh-list
84146098|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84146099|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84146100|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
84146101|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146102|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146103|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84146104|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84146105|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
84146106|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146107|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84146108|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84146109|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84146110|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84146111|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84146112|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84146113|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84146114|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84146115|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84146116|NCT00764140|Mitogens|mitogens|mesh-list
84146117|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
84146118|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146119|NCT00672958|Vortioxetine|vortioxetine|mesh-list
84146120|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
84146121|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146122|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84146123|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84146124|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430305|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146125|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146126|NCT00672958|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84146127|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84146128|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84146129|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146130|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146131|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
84146132|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84146133|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84146134|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84146135|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84146136|NCT00764374|Z 338|z 338|mesh-list
84146137|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84146138|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146139|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146140|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
84146141|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146142|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146143|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84146144|NCT00759226|Leucovorin|leucovorin|mesh-list
84146145|NCT00759226|Folic Acid|folic acid|mesh-list
84146146|NCT00759226|Cisplatin|cisplatin|mesh-list
84146147|NCT00759226|Gemcitabine|gemcitabine|mesh-list
84146148|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
84146149|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146150|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146151|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
84146152|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146153|NCT00759226|Antidotes|antidotes|mesh-ancestor
84146154|NCT00759226|Protective Agents|protective agents|mesh-ancestor
84146155|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146156|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
84146157|NCT00759226|Vitamins|vitamins|mesh-ancestor
84146158|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
84146159|NCT00759226|Hematinics|hematinics|mesh-ancestor
84146160|NCT00672646|Naproxen|naproxen|mesh-list
84146161|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84146162|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146163|NCT00672646|Analgesics|analgesics|mesh-ancestor
84146164|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
84146165|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146166|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146167|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146168|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146169|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
84146170|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84146171|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146172|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146173|NCT00759460|Olanzapine|olanzapine|mesh-list
84146174|NCT00759460|Sertindole|sertindole|mesh-list
84146175|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
84146176|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
84146177|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146178|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146179|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84146180|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84146181|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84146182|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146183|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146184|NCT00759460|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84146185|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84146186|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84146187|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146188|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146189|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
84146190|NCT00765154|Ritonavir|ritonavir|mesh-list
84146191|NCT00765154|Darunavir|darunavir|mesh-list
84146192|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84146193|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84146194|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
84146195|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146196|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146197|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84146198|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84146199|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
84146200|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146201|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84146202|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84146203|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83386967|NCT03258385|Vitamins|vitamins|mesh-ancestor
84146204|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
84146205|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146206|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84146207|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84146208|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146209|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146210|NCT00770302|Saxagliptin|saxagliptin|mesh-list
84146211|NCT00770302|Incretins|incretins|mesh-ancestor
84146213|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146214|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146215|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84146216|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
84146217|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146218|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146219|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146220|NCT02557984|Naltrexone|naltrexone|mesh-list
84146221|NCT02557984|Amisulpride|amisulpride|mesh-list
84146222|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84146223|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84146224|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146225|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
84146226|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146227|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84146228|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84146229|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146230|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146231|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84146232|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
84146233|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146234|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146235|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84146236|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
84146237|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84146238|NCT00759928|Sorafenib|sorafenib|mesh-list
84146239|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146240|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84146241|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146242|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146243|NCT00670930|Omalizumab|omalizumab|mesh-list
84146244|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84146245|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84146246|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
84146247|NCT00770536|Doxorubicin|doxorubicin|mesh-list
84146248|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84146249|NCT00770536|Topotecan|topotecan|mesh-list
84146250|NCT00770536|Trebananib|trebananib|mesh-list
84146251|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84146252|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146253|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84146254|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84146255|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146256|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146257|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84146258|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84146259|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84146260|NCT00770536|Growth Substances|growth substances|mesh-ancestor
84146261|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146262|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
84146263|NCT00771004|Pioglitazone|pioglitazone|mesh-list
84146264|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146265|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146266|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
84146267|NCT00674362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84146268|NCT00674362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146269|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146270|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
84146271|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146272|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146273|NCT00820950|Betamethasone|betamethasone|mesh-list
84146274|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
84146275|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84146276|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
84146277|NCT00820950|Calcipotriene|calcipotriene|mesh-list
84146278|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84146279|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146280|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
84146282|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146283|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146284|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84146285|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
84146286|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
84146287|NCT00765934|Lidocaine|lidocaine|mesh-list
84146288|NCT00765934|Tetracaine|tetracaine|mesh-list
84146289|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
84146290|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
84146291|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146292|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146293|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
84146294|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146295|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84146296|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84146297|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84146298|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84146299|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146300|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
84146301|NCT04049344|Decitabine|decitabine|mesh-list
84146302|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146303|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146304|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
84146305|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146306|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146307|NCT00670306|Cetrorelix|cetrorelix|mesh-list
84146308|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84146309|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
84146310|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146311|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146312|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
84146313|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146314|NCT00709254|Fentanyl|fentanyl|mesh-list
84146315|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84146316|NCT00709254|Narcotics|narcotics|mesh-ancestor
84146317|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146318|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146319|NCT00709254|Analgesics|analgesics|mesh-ancestor
84146320|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
84146321|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146322|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84146323|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84146324|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
84146325|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
84146326|NCT00760318|Levetiracetam|levetiracetam|mesh-list
84146327|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
84146328|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
84146329|NCT00591630|Cytarabine|cytarabine|mesh-list
84146330|NCT00591630|Rituximab|rituximab|mesh-list
84146331|NCT00591630|Etoposide|etoposide|mesh-list
84146332|NCT00591630|Melphalan|melphalan|mesh-list
84146333|NCT00591630|Carmustine|carmustine|mesh-list
84146334|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84146335|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146336|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
84146337|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146338|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146339|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84146340|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84146341|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84146342|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146343|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146344|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146345|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
84146346|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
84146347|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146348|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146349|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84146350|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
83387115|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
84146351|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84146352|NCT00771394|Tamsulosin|tamsulosin|mesh-list
84146353|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
84146354|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84146355|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84146356|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84146357|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
84146358|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146359|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146360|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146361|NCT00771394|Urological Agents|urological agents|mesh-ancestor
84146362|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84146363|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84146364|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
84146365|NCT00670228|Insulin|insulin|mesh-list
84146366|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84146367|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
84146368|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
84146369|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146370|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146371|NCT00766246|Bevacizumab|bevacizumab|mesh-list
84146372|NCT00766246|Carboplatin|carboplatin|mesh-list
84146373|NCT00766246|Docetaxel|docetaxel|mesh-list
84146374|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84146375|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146376|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84146377|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84146378|NCT00766246|Growth Substances|growth substances|mesh-ancestor
84146379|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146380|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
84146381|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
84146382|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
84146383|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
84146384|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146385|NCT00766402|Acetaminophen|acetaminophen|mesh-list
84146386|NCT00766402|Diclofenac|diclofenac|mesh-list
84146387|NCT00766402|Tramadol|tramadol|mesh-list
84146388|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146389|NCT00766402|Analgesics|analgesics|mesh-ancestor
84146390|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
84146391|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146392|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146393|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
84146394|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84146395|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146396|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146397|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84146398|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146399|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146400|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84146401|NCT00766402|Narcotics|narcotics|mesh-ancestor
84146402|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146403|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
84146404|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146405|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146406|NCT00760864|Methotrexate|methotrexate|mesh-list
84146407|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84146408|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
84146409|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146410|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146411|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146412|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
84146413|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146414|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146415|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
84146416|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146417|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84146418|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146419|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
84146420|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146421|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84146422|NCT00766480|Fluorouracil|fluorouracil|mesh-list
84146423|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146424|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
84146425|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146426|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146427|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146428|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
84146429|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146430|NCT00772174|Metformin|metformin|mesh-list
84146431|NCT00772174|Pioglitazone|pioglitazone|mesh-list
84146432|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146433|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146434|NCT00772564|Atorvastatin|atorvastatin|mesh-list
84146435|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84146436|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84146437|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
84146438|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146439|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84146440|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84146441|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146442|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84146443|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84146444|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84146445|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84146446|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146447|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146448|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146449|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84146450|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
84146451|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146452|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
84146453|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84146454|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84146455|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
84146456|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146457|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84146458|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84146459|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146460|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146461|NCT00775294|Maraviroc|maraviroc|mesh-list
84146462|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84146463|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84146464|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146465|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84146466|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84146467|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
84146468|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146469|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84146470|NCT00772798|Paclitaxel|paclitaxel|mesh-list
84146471|NCT00772798|Carboplatin|carboplatin|mesh-list
84146472|NCT00772798|Vorinostat|vorinostat|mesh-list
84146473|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84146474|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146475|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
84146476|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
84146477|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
84146478|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146479|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84146480|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146481|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
84146482|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84146483|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84146484|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84146485|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
84146486|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146487|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146488|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146489|NCT00775372|Clarithromycin|clarithromycin|mesh-list
84146490|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146491|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146492|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84146493|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146494|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146495|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84146496|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84146497|NCT00668746|Minocycline|minocycline|mesh-list
84146498|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146499|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146500|NCT04047940|Metformin|metformin|mesh-list
84146501|NCT04047940|Valsartan|valsartan|mesh-list
84146502|NCT04047940|Atorvastatin|atorvastatin|mesh-list
84146503|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146504|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146505|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84146506|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84146507|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
84146508|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146509|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84146510|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84146511|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146512|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84146513|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84146514|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84146515|NCT00773188|Bevacizumab|bevacizumab|mesh-list
84146516|NCT00773188|Vinorelbine|vinorelbine|mesh-list
84146517|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84146518|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146519|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84146520|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84146521|NCT00773188|Growth Substances|growth substances|mesh-ancestor
84146522|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146523|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
84146524|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84146525|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
84146526|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
84146527|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
84146528|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146529|NCT00767260|Insulin|insulin|mesh-list
84146530|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146531|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146532|NCT00767494|Travoprost|travoprost|mesh-list
84146533|NCT00767494|Brinzolamide|brinzolamide|mesh-list
84146534|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84146535|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84146536|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146537|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146538|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
84146539|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84146540|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
84146541|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146542|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146543|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84146544|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
84146545|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84146546|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
84146547|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146548|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146549|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84146550|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
84146551|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
84146552|NCT00773578|Protective Agents|protective agents|mesh-ancestor
84146553|NCT00775762|Aspirin|aspirin|mesh-list
84146554|NCT00775762|Clopidogrel|clopidogrel|mesh-list
84146555|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84146556|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146557|NCT00775762|Analgesics|analgesics|mesh-ancestor
84146558|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
84146559|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146560|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146561|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146562|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146563|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84146564|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84146565|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146566|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84146567|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84146568|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146569|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
84146570|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84146571|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84146572|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84146573|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
84146574|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83387338|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146576|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84146577|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84146578|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84146579|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146580|NCT00775918|Doxycycline|doxycycline|mesh-list
84146581|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146582|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146583|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
84146584|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84146585|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84146586|NCT00878189|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
84146587|NCT00878189|Nirogacestat|nirogacestat|mesh-list
84146588|NCT00878189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146589|NCT00878189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146590|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
84146591|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
84146592|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84146593|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84146594|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146595|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146596|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146597|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
84146598|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
84146599|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146600|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146601|NCT00773812|Mecamylamine|mecamylamine|mesh-list
84146602|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84146603|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
84146604|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
84146605|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146606|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146607|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84146608|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84146609|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
84146610|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146611|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146612|NCT00767728|Mesalamine|mesalamine|mesh-list
84146613|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84146614|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146615|NCT00767728|Analgesics|analgesics|mesh-ancestor
84146616|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
84146617|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146618|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146619|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146620|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146621|NCT00776074|Leuprolide|leuprolide|mesh-list
84146622|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84146623|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
84146624|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146625|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146626|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84146627|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146628|NCT02628587|Clopidogrel|clopidogrel|mesh-list
84146629|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84146630|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84146631|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84146632|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84146633|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
84146634|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146635|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146636|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146637|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
84146638|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84146639|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
83430309|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146640|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146641|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146642|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84146643|NCT00668200|Vitamin D|vitamin d|mesh-list
84146644|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
84146645|NCT00668200|Calcium|calcium|mesh-list
84146646|NCT00668200|Vitamins|vitamins|mesh-ancestor
84146647|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
83387416|NCT01721655|Diuretics|diuretics|mesh-ancestor
84146648|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146649|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84146650|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84146651|NCT00679601|Tavaborole|tavaborole|mesh-list
84146652|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
84146653|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146654|NCT00675779|Atorvastatin|atorvastatin|mesh-list
84146655|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
84146656|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
84146657|NCT00675779|Dacuronium|dacuronium|mesh-list
84146658|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84146659|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84146660|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
84146661|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146662|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84146663|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84146664|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146665|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146666|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146667|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84146668|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84146669|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84146670|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84146671|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146672|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
84146673|NCT00774280|Busulfan|busulfan|mesh-list
84146674|NCT00774280|Fludarabine|fludarabine|mesh-list
84146675|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146676|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
84146677|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146678|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146679|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84146680|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
84146681|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146682|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146683|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84146684|NCT04151147|Mitogens|mitogens|mesh-list
84146685|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
84146686|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146687|NCT00774358|Aldesleukin|aldesleukin|mesh-list
84146688|NCT00774358|Interleukin-2|interleukin-2|mesh-list
84146689|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146690|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146691|NCT00774358|Analgesics|analgesics|mesh-ancestor
84146692|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
84146693|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146694|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146695|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84146696|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84146697|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
84146698|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146699|NCT02627417|Dapsone|dapsone|mesh-list
84146700|NCT02627417|Prednisone|prednisone|mesh-list
84146701|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146702|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
84146703|NCT02627417|Hormones|hormones|mesh-ancestor
84146704|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146705|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146706|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84146707|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146708|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146709|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
84146710|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84146711|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84146712|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84146713|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146714|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146715|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
84146716|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146717|NCT00679679|Metformin|metformin|mesh-list
84146718|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146719|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146720|NCT00838578|Irinotecan|irinotecan|mesh-list
84146721|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84146722|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84146723|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146724|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146725|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146726|NCT02634515|Insulin|insulin|mesh-list
84146727|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84146728|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146729|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146730|NCT00705900|Calcipotriene|calcipotriene|mesh-list
84146731|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
84146732|NCT00679835|Daptomycin|daptomycin|mesh-list
84146733|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146734|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146735|NCT00774904|Losartan|losartan|mesh-list
84146736|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84146737|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84146738|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84146739|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84146740|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146741|NCT00829296|Metoprolol|metoprolol|mesh-list
84146742|NCT00829296|Nebivolol|nebivolol|mesh-list
84146743|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84146744|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84146745|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
84146746|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
84146747|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146748|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146749|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84146750|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84146751|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84146752|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
84146753|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146754|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146755|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
84146756|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84146757|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84146758|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84146759|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
84146760|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
84146761|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146762|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146763|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146764|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146765|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
84146766|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146767|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84146768|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146769|NCT00881621|Capecitabine|capecitabine|mesh-list
84146770|NCT00881621|Lapatinib|lapatinib|mesh-list
84146771|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146772|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
84146773|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146774|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146775|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84146776|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146777|NCT02634281|Varenicline|varenicline|mesh-list
84146778|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84146779|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84146780|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
84146781|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146782|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146783|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146784|NCT00818766|Vancomycin|vancomycin|mesh-list
84146785|NCT00818766|Cefazolin|cefazolin|mesh-list
84146786|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146787|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146788|NCT00779350|Sertraline|sertraline|mesh-list
84146789|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
84146790|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84146791|NCT00779350|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84146792|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84146793|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84146794|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146795|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146796|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
84146797|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146798|NCT00705978|Pancreatin|pancreatin|mesh-list
84146799|NCT00705978|Pancrelipase|pancrelipase|mesh-list
84146800|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84146801|NCT02556970|Acetaminophen|acetaminophen|mesh-list
84146802|NCT02556970|Diclofenac|diclofenac|mesh-list
84146803|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
84146804|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146805|NCT02556970|Analgesics|analgesics|mesh-ancestor
84146806|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
84146807|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146808|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146809|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
84146810|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84146811|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146812|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146813|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84146814|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146815|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146816|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
84146817|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
84146818|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146819|NCT00594815|Leucovorin|leucovorin|mesh-list
84146820|NCT00594815|Cytarabine|cytarabine|mesh-list
84146821|NCT00594815|Rituximab|rituximab|mesh-list
84146822|NCT00594815|Methotrexate|methotrexate|mesh-list
84146823|NCT00594815|Vincristine|vincristine|mesh-list
84146824|NCT00594815|Procarbazine|procarbazine|mesh-list
84146825|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84146826|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146827|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
84146828|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146829|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146830|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84146831|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
84146832|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146833|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84146834|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
84146835|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146836|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
84146837|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146838|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84146839|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146840|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84146841|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
84146842|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146843|NCT00594815|Antidotes|antidotes|mesh-ancestor
84146844|NCT00594815|Protective Agents|protective agents|mesh-ancestor
84146845|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
84146846|NCT00594815|Vitamins|vitamins|mesh-ancestor
84146847|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
84146848|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84146849|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
84146850|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
84146851|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
84146852|NCT00776542|Minocycline|minocycline|mesh-list
84146853|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146854|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146855|NCT00776620|Glimepiride|glimepiride|mesh-list
84146856|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84146857|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146858|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146859|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84146860|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
84146861|NCT00776698|Bevacizumab|bevacizumab|mesh-list
84146862|NCT00776698|Etoposide|etoposide|mesh-list
84146863|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84146864|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146865|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84146866|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84146867|NCT00776698|Growth Substances|growth substances|mesh-ancestor
84146868|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146869|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
84146870|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84146871|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84146872|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84146873|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146874|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146875|NCT00820248|Panitumumab|panitumumab|mesh-list
84146876|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146877|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84146879|NCT04150757|Analgesics|analgesics|mesh-ancestor
84146880|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
84146881|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146882|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146883|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84146884|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84146885|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
84146886|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
84146887|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84146888|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84146889|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84146890|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146891|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146892|NCT04150367|Rifampin|rifampin|mesh-list
84146893|NCT04150367|Isoniazid|isoniazid|mesh-list
84146894|NCT04150367|Ethambutol|ethambutol|mesh-list
84146895|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84146896|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84146897|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
84146898|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84146899|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84146900|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
84146901|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84146902|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146903|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146904|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84146905|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84146906|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84146907|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84146908|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84146909|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84146910|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84146911|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84146912|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
84146913|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84146914|NCT02634203|Riociguat|riociguat|mesh-list
84146915|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
84146916|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146917|NCT00681005|Rabeprazole|rabeprazole|mesh-list
84146918|NCT00681005|Pantoprazole|pantoprazole|mesh-list
84146919|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84146920|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84146921|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84146922|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146923|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146924|NCT02633969|Indomethacin|indomethacin|mesh-list
84146925|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84146926|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84146927|NCT02633969|Analgesics|analgesics|mesh-ancestor
84146928|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
84146929|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146930|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146931|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84146932|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84146933|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
84146934|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
84146935|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146936|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84146937|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146938|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146939|NCT00684827|Albuterol|albuterol|mesh-list
84146940|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84146941|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
84146942|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84146943|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146944|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84146945|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
84146946|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
84146947|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146948|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84146949|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84146950|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84146951|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
84146952|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84146953|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146955|NCT00820170|Dasatinib|dasatinib|mesh-list
84146956|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84146957|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146958|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
84146959|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
84146960|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
84146961|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84146962|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84146963|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84146964|NCT02627027|Metformin|metformin|mesh-list
84146965|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84146966|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146967|NCT00709332|Folic Acid|folic acid|mesh-list
84146968|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84146969|NCT00709332|Norgestimate|norgestimate|mesh-list
84146970|NCT00709332|Estradiol|estradiol|mesh-list
84146971|NCT00709332|Estrogens|estrogens|mesh-ancestor
84146972|NCT00709332|Hormones|hormones|mesh-ancestor
84146973|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146974|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146975|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84146976|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
84146977|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146978|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84146979|NCT00709332|Hematinics|hematinics|mesh-ancestor
84146980|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
84146981|NCT00709332|Vitamins|vitamins|mesh-ancestor
84146982|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
84146983|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84146984|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84146985|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84146986|NCT00684905|Leuprolide|leuprolide|mesh-list
84146987|NCT00684905|Bicalutamide|bicalutamide|mesh-list
84146988|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84146989|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
84146990|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84146991|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84146992|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84146993|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84146994|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
84146995|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
84146996|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84146997|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
84146998|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
84146999|NCT00685061|Daclizumab|daclizumab|mesh-list
84147000|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
84147001|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147002|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147003|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84147004|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147005|NCT02633813|Naftifine|naftifine|mesh-list
84147006|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
84147007|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147008|NCT00818454|Albuterol|albuterol|mesh-list
84147009|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84147010|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
84147011|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147012|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147013|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84147014|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
84147015|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
84147016|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84147017|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84147018|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84147019|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84147020|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
84147021|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147022|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147023|NCT02626247|Vitamin A|vitamin a|mesh-list
84147024|NCT02626247|Vitamins|vitamins|mesh-ancestor
84147025|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
84147026|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147027|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
84147028|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147029|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147030|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84147031|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84147032|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147033|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147034|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147035|NCT00828984|Laxatives|laxatives|mesh-list
84147036|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
84147037|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147038|NCT00819390|Chloroquine|chloroquine|mesh-list
84147039|NCT00819390|Amebicides|amebicides|mesh-ancestor
84147040|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84147041|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84147042|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147043|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
84147044|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147045|NCT00876395|Paclitaxel|paclitaxel|mesh-list
84147046|NCT00876395|Trastuzumab|trastuzumab|mesh-list
84147047|NCT00876395|Everolimus|everolimus|mesh-list
84147048|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84147049|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147050|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
84147051|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
84147052|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
84147053|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147054|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84147055|NCT00876395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84147056|NCT00876395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84147057|NCT00876395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147058|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147059|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
84147060|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147061|NCT05758662|Listerine|listerine|mesh-list
84147062|NCT05758662|Fluorides|fluorides|mesh-list
84147063|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
84147064|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
84147065|NCT05758662|Protective Agents|protective agents|mesh-ancestor
84147066|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147067|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84147068|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147069|NCT02633657|Gabapentin|gabapentin|mesh-list
84147070|NCT02633657|Analgesics|analgesics|mesh-ancestor
84147071|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
84147072|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147073|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147074|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
84147075|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84147076|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84147077|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147078|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84147079|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84147080|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84147081|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147082|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147083|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
84147084|NCT02626169|Clopidogrel|clopidogrel|mesh-list
84147085|NCT02626169|Ticagrelor|ticagrelor|mesh-list
84147086|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84147087|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84147088|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84147089|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84147090|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
84147091|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147092|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147093|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147094|NCT04139915|Dactolisib|dactolisib|mesh-list
84147095|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147096|NCT04148183|Metformin|metformin|mesh-list
84147097|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
84147098|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83387867|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147099|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147100|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84147101|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84147102|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84147103|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
84147104|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147105|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84147106|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84147107|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147108|NCT02633579|Erythromycin|erythromycin|mesh-list
84147109|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
84147110|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
84147111|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
84147112|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
84147113|NCT02633579|Atropine|atropine|mesh-list
84147114|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84147115|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84147116|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84147117|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
84147118|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147119|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147120|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84147121|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
84147122|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
84147123|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
84147124|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84147125|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84147126|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
84147127|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147128|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147129|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147130|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147131|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147132|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84147133|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147134|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
84147135|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84147136|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
84147137|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147138|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147139|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84147140|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
84147141|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84147142|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84147143|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84147144|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
84147145|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147146|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147147|NCT00685607|Simethicone|simethicone|mesh-list
84147148|NCT00685607|Loperamide|loperamide|mesh-list
84147149|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
84147150|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147151|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
84147152|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147153|NCT00685607|Emollients|emollients|mesh-ancestor
84147154|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147155|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
84147156|NCT00657059|Prednisone|prednisone|mesh-list
84147157|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
84147158|NCT00657059|Irbesartan|irbesartan|mesh-list
84147159|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147160|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
84147161|NCT00657059|Hormones|hormones|mesh-ancestor
84147162|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147163|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147164|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84147165|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147166|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84147167|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84147168|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
84147169|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147170|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147171|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147172|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147173|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
84147174|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
84147175|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83387942|NCT00988117|Rivastigmine|rivastigmine|mesh-list
84147176|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147177|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84147178|NCT00657059|Protective Agents|protective agents|mesh-ancestor
84147179|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84147180|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84147181|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84147182|NCT00667732|Exenatide|exenatide|mesh-list
84147183|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84147184|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147185|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84147186|NCT00667732|Incretins|incretins|mesh-ancestor
84147187|NCT00667732|Hormones|hormones|mesh-ancestor
84147188|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147189|NCT04161209|Citalopram|citalopram|mesh-list
84147190|NCT04161209|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84147191|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84147192|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84147193|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147194|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147195|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
84147196|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147197|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84147198|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
84147199|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84147200|NCT04161053|Rifaximin|rifaximin|mesh-list
84147201|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
84147202|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147203|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147204|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147205|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84147206|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84147207|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
84147208|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84147209|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84147210|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
84147211|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147212|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147213|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84147214|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
84147215|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84147216|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84147217|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84147218|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
84147219|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147220|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147221|NCT00681785|Dalteparin|dalteparin|mesh-list
84147222|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84147223|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
84147224|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84147225|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84147226|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147227|NCT00671788|Dasatinib|dasatinib|mesh-list
84147228|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147229|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84147230|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147231|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147232|NCT02626481|Dexamethasone|dexamethasone|mesh-list
84147233|NCT02626481|Daratumumab|daratumumab|mesh-list
84147234|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147235|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
84147236|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
84147237|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147238|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147239|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147240|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
84147241|NCT02626481|Hormones|hormones|mesh-ancestor
84147242|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147243|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84147244|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147245|NCT00777166|Oxytocin|oxytocin|mesh-list
84147246|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
84147247|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84147248|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147249|NCT00681941|Sevelamer|sevelamer|mesh-list
84147250|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
84147252|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147253|NCT00657137|Capecitabine|capecitabine|mesh-list
84147254|NCT00657137|Lapatinib|lapatinib|mesh-list
84147255|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84147256|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
84147257|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147258|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147259|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84147260|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147261|NCT00777244|Mitotane|mitotane|mesh-list
84147262|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84147263|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147264|NCT04160897|Tenofovir|tenofovir|mesh-list
84147265|NCT04160897|Entecavir|entecavir|mesh-list
84147266|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
84147267|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147268|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84147269|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84147270|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147271|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147272|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84147273|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84147274|NCT00777322|Riboflavin|riboflavin|mesh-list
84147275|NCT00777322|Dextrans|dextrans|mesh-list
84147276|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
84147277|NCT00777322|Vitamins|vitamins|mesh-ancestor
84147278|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
84147279|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147280|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84147281|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147282|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
84147283|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
84147284|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
84147285|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
84147286|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
84147287|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84147288|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84147289|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147290|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147291|NCT00682019|Urological Agents|urological agents|mesh-ancestor
84147292|NCT00779896|Tazarotene|tazarotene|mesh-list
84147293|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147294|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
84147295|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84147296|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84147297|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84147298|NCT02556268|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
84147299|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
84147300|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
84147301|NCT02556268|Riociguat|riociguat|mesh-list
84147302|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
84147303|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
84147304|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147305|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
84147306|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147307|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84147308|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84147309|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147310|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84147311|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84147312|NCT00875615|Carboplatin|carboplatin|mesh-list
84147313|NCT00875615|Sorafenib|sorafenib|mesh-list
84147314|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147315|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84147316|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147317|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147318|NCT02626559|Bupivacaine|bupivacaine|mesh-list
84147319|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
84147320|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
84147321|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147322|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147323|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
84147324|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147325|NCT00768508|Naltrexone|naltrexone|mesh-list
84147326|NCT00768508|Ondansetron|ondansetron|mesh-list
84147327|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84147328|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84147329|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147330|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
84147331|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147332|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
84147333|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
84147334|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147335|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
84147336|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147337|NCT00768508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84147338|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84147339|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
84147340|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147341|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147342|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
84147343|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84147344|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84147345|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84147346|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147347|NCT00777478|Sunitinib|sunitinib|mesh-list
84147348|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147349|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84147350|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84147351|NCT00777478|Growth Substances|growth substances|mesh-ancestor
84147352|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147353|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
84147354|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84147355|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147356|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147357|NCT00780598|Tosedostat|tosedostat|mesh-list
84147358|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147359|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147360|NCT00780754|Dutasteride|dutasteride|mesh-list
84147361|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84147362|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84147363|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147364|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147365|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
84147366|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147367|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147368|NCT00780832|Caffeine|caffeine|mesh-list
84147369|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
84147370|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84147371|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147372|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84147373|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147374|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147375|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84147376|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84147377|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
84147378|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147379|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
84147380|NCT00597701|Lorazepam|lorazepam|mesh-list
84147381|NCT00597701|Baclofen|baclofen|mesh-list
84147382|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84147383|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147384|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84147385|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147386|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84147387|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
84147388|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
84147389|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147390|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147391|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
84147392|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
84147393|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
84147394|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147395|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84147396|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147397|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84147398|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84147399|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84147400|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
84147401|NCT02556658|Anesthetics|anesthetics|mesh-list
84147402|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147403|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147404|NCT00682721|Valacyclovir|valacyclovir|mesh-list
84147405|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
84147406|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147407|NCT02556814|Dexamethasone|dexamethasone|mesh-list
84147408|NCT02556814|Caffeic acid|caffeic acid|mesh-list
84147409|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147410|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
84147411|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
84147412|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147413|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147414|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147415|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
84147416|NCT02556814|Hormones|hormones|mesh-ancestor
84147417|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147418|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84147419|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147420|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
84147421|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147422|NCT02556814|Protective Agents|protective agents|mesh-ancestor
84147423|NCT00682955|Zinc|zinc|mesh-list
84147424|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
84147425|NCT00682955|Trace Elements|trace elements|mesh-ancestor
84147426|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
84147427|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147428|NCT00682955|Astringents|astringents|mesh-ancestor
84147429|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147430|NCT00686621|Posaconazole|posaconazole|mesh-list
84147431|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
84147432|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147433|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84147434|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84147435|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84147436|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84147437|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84147438|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147439|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147440|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84147441|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
84147442|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147443|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147444|NCT00683111|Esomeprazole|esomeprazole|mesh-list
84147445|NCT00683111|Famotidine|famotidine|mesh-list
84147446|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84147447|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147448|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84147449|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147450|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147451|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84147452|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
84147453|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
84147454|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147455|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147456|NCT04138901|Ropivacaine|ropivacaine|mesh-list
84147457|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
84147458|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
84147459|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147460|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147461|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
84147462|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147463|NCT00922649|Insulin|insulin|mesh-list
84147464|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84147465|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147466|NCT04142411|Insulin|insulin|mesh-list
84147467|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84147468|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
84147469|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84147470|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147471|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84147472|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
84147473|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
84147474|NCT04142411|Protective Agents|protective agents|mesh-ancestor
84147475|NCT00683189|Warfarin|warfarin|mesh-list
84147476|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
84147477|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
84147478|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147479|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147480|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84147481|NCT00667576|Protective Agents|protective agents|mesh-ancestor
84147482|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147483|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84147484|NCT04141787|Cefazolin|cefazolin|mesh-list
84147485|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
84147486|NCT04141787|Daptomycin|daptomycin|mesh-list
84147487|NCT04141787|Cloxacillin|cloxacillin|mesh-list
84147488|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147489|NCT02557594|Tenofovir|tenofovir|mesh-list
84147490|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
84147491|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147492|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84147493|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84147494|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147495|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147496|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84147497|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84147498|NCT00687011|Dexamethasone|dexamethasone|mesh-list
84147499|NCT00687011|Palonosetron|palonosetron|mesh-list
84147500|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147501|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
84147502|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
84147503|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147504|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147505|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147506|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
84147507|NCT00687011|Hormones|hormones|mesh-ancestor
84147508|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147509|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84147510|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147511|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84147512|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84147513|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
84147514|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147515|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147516|NCT00683267|Capsaicin|capsaicin|mesh-list
84147517|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
84147518|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147519|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
84147520|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147521|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147522|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
84147523|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147524|NCT00687245|Esomeprazole|esomeprazole|mesh-list
84147525|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84147526|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147527|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84147528|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147529|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147530|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84147531|NCT00690521|Metolazone|metolazone|mesh-list
84147532|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84147533|NCT00690521|Diuretics|diuretics|mesh-ancestor
84147534|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
84147535|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147536|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84147537|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84147538|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147539|NCT00666718|Insulin|insulin|mesh-list
84147540|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84147541|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
84147542|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
84147543|NCT00666718|Protamines|protamines|mesh-list
84147544|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84147545|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147546|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
83388317|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147547|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147548|NCT00666718|Coagulants|coagulants|mesh-ancestor
84147549|NCT00683735|Metformin|metformin|mesh-list
84147550|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84147551|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84147552|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147553|NCT00683735|Incretins|incretins|mesh-ancestor
84147555|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147556|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84147557|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
84147558|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147559|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147560|NCT04139681|Menthol|menthol|mesh-list
84147561|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
84147562|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
84147563|NCT04047394|Rasburicase|rasburicase|mesh-list
84147564|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
84147565|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147566|NCT02625779|Valproic Acid|valproic acid|mesh-list
84147567|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
84147568|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147569|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147570|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
84147571|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147572|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147573|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
84147574|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84147575|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147576|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84147577|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
84147578|NCT00667420|Epirubicin|epirubicin|mesh-list
84147579|NCT00667420|Panitumumab|panitumumab|mesh-list
84147580|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147581|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147582|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84147583|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84147584|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84147585|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147586|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84147587|NCT04141319|Ketorolac|ketorolac|mesh-list
84147588|NCT04141319|Epinephrine|epinephrine|mesh-list
84147589|NCT04141319|Ropivacaine|ropivacaine|mesh-list
84147590|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
84147591|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
84147592|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147593|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147594|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
84147595|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147596|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84147597|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84147598|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
84147599|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147600|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147601|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84147602|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84147603|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
84147604|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84147605|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
84147606|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
84147607|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
84147608|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84147609|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84147610|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84147611|NCT04141319|Analgesics|analgesics|mesh-ancestor
84147612|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147613|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147614|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84147615|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147616|NCT00683891|Clozapine|clozapine|mesh-list
84147617|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84147618|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
84147619|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147620|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147621|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147622|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84147623|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84147624|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147625|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83388395|NCT00981799|Etoposide|etoposide|mesh-list
84147626|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
84147627|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
84147628|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
84147629|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84147630|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147631|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84147632|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
84147633|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147634|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147635|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147636|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147637|NCT00778024|Fluoxetine|fluoxetine|mesh-list
84147638|NCT00778024|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84147639|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84147640|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84147641|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147642|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147643|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
84147644|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147645|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84147646|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
84147647|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84147648|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84147649|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84147650|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147651|NCT00853658|Enalapril|enalapril|mesh-list
84147652|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84147653|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
84147654|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147655|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147656|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84147657|NCT00690677|Panobinostat|panobinostat|mesh-list
84147658|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147659|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84147660|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147661|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147662|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
84147663|NCT00781300|Dexamethasone|dexamethasone|mesh-list
84147664|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147665|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
84147666|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
84147667|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147668|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147669|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84147670|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
84147671|NCT00781300|Hormones|hormones|mesh-ancestor
84147672|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147673|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84147674|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147675|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84147676|NCT00781378|Plasminogen|plasminogen|mesh-list
84147677|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84147678|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84147679|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84147680|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147681|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
84147682|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147683|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
84147684|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
84147685|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147686|NCT00666562|Protective Agents|protective agents|mesh-ancestor
84147687|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147688|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84147689|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84147690|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147691|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84147692|NCT00769054|Ropivacaine|ropivacaine|mesh-list
84147693|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
84147694|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
84147695|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147696|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147697|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
84147698|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147699|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
84147700|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147701|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
84147702|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147703|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147704|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84147705|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
84147706|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147707|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147708|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84147709|NCT00666328|Clevidipine|clevidipine|mesh-list
84147710|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84147711|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84147712|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147713|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84147714|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147715|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84147716|NCT00778180|Furosemide|furosemide|mesh-list
84147717|NCT00778180|Diuretics|diuretics|mesh-ancestor
84147718|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
84147719|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147720|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84147721|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84147722|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147723|NCT00769210|Simvastatin|simvastatin|mesh-list
84147724|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84147725|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84147726|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
84147727|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147728|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84147729|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84147730|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147731|NCT00690911|Adalimumab|adalimumab|mesh-list
84147732|NCT00690911|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84147733|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147734|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147735|NCT00781846|Sirolimus|sirolimus|mesh-list
84147736|NCT00781846|Bevacizumab|bevacizumab|mesh-list
84147737|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84147738|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147739|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84147740|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84147741|NCT00781846|Growth Substances|growth substances|mesh-ancestor
84147742|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147743|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
84147744|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147745|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147746|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84147747|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
84147748|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147749|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
84147750|NCT00853580|Lovastatin|lovastatin|mesh-list
84147751|NCT00853580|L 647318|l 647318|mesh-list
84147752|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
84147753|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84147754|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84147755|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
84147756|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147757|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84147758|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84147759|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147760|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
84147761|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
83430315|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147762|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84147763|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147764|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147765|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84147766|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84147767|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147768|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147769|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147770|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84147771|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
84147772|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84147773|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147774|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84147775|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84147776|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84147777|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84147778|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84147779|NCT00778414|Amoxicillin|amoxicillin|mesh-list
84147780|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
84147781|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
84147782|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84147783|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147784|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147785|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147786|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147787|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84147788|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
84147789|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
84147790|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
84147791|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147792|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
84147793|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147794|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
84147795|NCT00769288|Growth Substances|growth substances|mesh-ancestor
84147796|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147797|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
84147798|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84147799|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147800|NCT00688805|Propranolol|propranolol|mesh-list
84147801|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84147802|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84147803|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
84147804|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84147805|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147806|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147807|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84147808|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84147809|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
84147810|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
84147811|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
84147812|NCT04136639|Fluorides|fluorides|mesh-list
84147813|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
84147814|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
84147815|NCT04136639|Protective Agents|protective agents|mesh-ancestor
84147816|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147817|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147818|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84147819|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147820|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
84147821|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147822|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84147823|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84147824|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
84147825|NCT02613026|Docetaxel|docetaxel|mesh-list
84147826|NCT02613026|Pirarubicin|pirarubicin|mesh-list
84147827|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147828|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
84147829|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147830|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147831|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84147832|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
84147833|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147834|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147835|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84147836|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
84147837|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
84147838|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
84147839|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84147840|NCT00778726|Benazepril|benazepril|mesh-list
84147841|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84147842|NCT00778726|Diuretics|diuretics|mesh-ancestor
84147843|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
84147844|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147845|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84147846|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84147847|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147848|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84147849|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
84147850|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147851|NCT00688883|Fludarabine|fludarabine|mesh-list
84147852|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
84147853|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147854|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84147855|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
84147856|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147857|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147858|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
84147859|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147860|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
84147861|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84147862|NCT00769522|Rituximab|rituximab|mesh-list
84147863|NCT00769522|Fludarabine|fludarabine|mesh-list
84147864|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147865|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
84147866|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147867|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147868|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84147869|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
84147870|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147871|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147872|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84147873|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84147874|NCT00688961|Aspirin|aspirin|mesh-list
84147875|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84147876|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84147877|NCT00688961|Analgesics|analgesics|mesh-ancestor
84147878|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
84147879|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147880|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147881|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147882|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147883|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84147884|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84147885|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147886|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84147887|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84147888|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147889|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
84147890|NCT00782470|Factor VIII|factor viii|mesh-list
84147891|NCT00782470|Coagulants|coagulants|mesh-ancestor
84147892|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
84147893|NCT00865280|Linezolid|linezolid|mesh-list
84147894|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147895|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147896|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84147897|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84147898|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147899|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147900|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147901|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84147902|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84147903|NCT00782548|Morphine|morphine|mesh-list
84147904|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84147905|NCT00782548|Narcotics|narcotics|mesh-ancestor
84147906|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147907|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147908|NCT00782548|Analgesics|analgesics|mesh-ancestor
84147909|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
84147910|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147911|NCT00689195|Curcumin|curcumin|mesh-list
84147912|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84147913|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84147914|NCT00689195|Analgesics|analgesics|mesh-ancestor
84147915|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
84147916|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147917|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147918|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84147919|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84147920|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147921|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147922|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147923|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84147924|NCT00865124|Spironolactone|spironolactone|mesh-list
84147925|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84147926|NCT00865124|Diuretics|diuretics|mesh-ancestor
84147927|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
84147928|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147929|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84147930|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84147931|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147932|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84147933|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
84147934|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147935|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84147936|NCT00691067|Mifepristone|mifepristone|mesh-list
84147937|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84147938|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
84147939|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84147940|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147941|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84147942|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84147943|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84147944|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
84147945|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84147946|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84147947|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
84147948|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147949|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
84147950|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84147951|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84147952|NCT00691145|Tacrolimus|tacrolimus|mesh-list
84147953|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84147954|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
84147955|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147956|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84147957|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147958|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147959|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
84147960|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
84147961|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84147962|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
84147963|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147964|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147965|NCT00694967|Progestins|progestins|mesh-ancestor
84147966|NCT00694967|Hormones|hormones|mesh-ancestor
84147967|NCT00695045|Morphine|morphine|mesh-list
84147968|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84147969|NCT00695045|Narcotics|narcotics|mesh-ancestor
84147970|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84147971|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147972|NCT00695045|Analgesics|analgesics|mesh-ancestor
84147973|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
84147974|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84147975|NCT02624453|Fluconazole|fluconazole|mesh-list
84147976|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84147977|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
84147978|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84147979|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84147980|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84147981|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84147982|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84147983|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84147984|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
84147985|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84147986|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147987|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84147988|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84147989|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
84147990|NCT00819234|Pramlintide|pramlintide|mesh-list
84147991|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83388760|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84147992|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84147993|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
84147994|NCT00695201|Irinotecan|irinotecan|mesh-list
84147995|NCT00695201|Floxuridine|floxuridine|mesh-list
84147996|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84147997|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84147998|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84147999|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148000|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148001|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148002|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
84148003|NCT00689585|Ethosuximide|ethosuximide|mesh-list
84148004|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
84148005|NCT00667342|Bevacizumab|bevacizumab|mesh-list
84148006|NCT00667342|Doxorubicin|doxorubicin|mesh-list
84148007|NCT00667342|Methotrexate|methotrexate|mesh-list
84148008|NCT00667342|Etoposide|etoposide|mesh-list
84148009|NCT00667342|Ifosfamide|ifosfamide|mesh-list
84148010|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148011|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148012|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148013|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148014|NCT00667342|Growth Substances|growth substances|mesh-ancestor
84148015|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148016|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148017|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84148018|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84148019|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84148020|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148021|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148022|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84148023|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
84148024|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84148025|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148026|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
84148027|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
84148028|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84148029|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84148030|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
84148031|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148032|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84148033|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84148034|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84148035|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
84148036|NCT00783016|Morphine|morphine|mesh-list
84148037|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84148038|NCT00783016|Narcotics|narcotics|mesh-ancestor
84148039|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148040|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148041|NCT00783016|Analgesics|analgesics|mesh-ancestor
84148042|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
84148043|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148044|NCT00769990|Genistein|genistein|mesh-list
84148045|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84148046|NCT00769990|Protective Agents|protective agents|mesh-ancestor
84148047|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148048|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148049|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148050|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148051|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148052|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
84148053|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84148054|NCT00769990|Estrogens|estrogens|mesh-ancestor
84148055|NCT00769990|Hormones|hormones|mesh-ancestor
84148056|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148057|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
84148058|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84148059|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84148060|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
84148061|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148062|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84148063|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84148064|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148065|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83388836|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148066|NCT02555800|Cidofovir|cidofovir|mesh-list
84148068|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148069|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148070|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148071|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148072|NCT02555800|Growth Substances|growth substances|mesh-ancestor
84148073|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148074|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148075|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
84148076|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148077|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148078|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148079|NCT00783172|Gemcitabine|gemcitabine|mesh-list
84148080|NCT00783172|Mitogens|mitogens|mesh-list
84148081|NCT00783172|Enkephalins|enkephalins|mesh-list
84148082|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148083|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
84148084|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148085|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148086|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148087|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
84148088|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148089|NCT00783250|Albuterol|albuterol|mesh-list
84148090|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
84148091|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84148092|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
84148093|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148094|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148095|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84148096|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
84148097|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
84148098|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84148099|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
84148100|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148101|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148102|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
84148103|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84148104|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84148105|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84148106|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84148107|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
84148108|NCT02555644|Cetuximab|cetuximab|mesh-list
84148109|NCT02555644|Prexasertib|prexasertib|mesh-list
84148110|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148111|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148112|NCT02555644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148113|NCT02555644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148114|NCT02555644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148115|NCT00871403|Pemetrexed|pemetrexed|mesh-list
84148116|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148117|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148118|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148119|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84148120|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84148121|NCT00691379|Paclitaxel|paclitaxel|mesh-list
84148122|NCT00691379|Bevacizumab|bevacizumab|mesh-list
84148123|NCT00691379|Carboplatin|carboplatin|mesh-list
84148124|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84148125|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148126|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
84148127|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
84148128|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
84148129|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148130|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148131|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148132|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148133|NCT00691379|Growth Substances|growth substances|mesh-ancestor
84148134|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148135|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148136|NCT02624531|Cisplatin|cisplatin|mesh-list
84148137|NCT02624531|Taxane|taxane|mesh-list
84148138|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148139|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
84148140|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84148141|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
84148142|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148143|NCT04136015|Dasatinib|dasatinib|mesh-list
84148144|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148145|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148146|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148147|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148148|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
84148149|NCT02624063|Simeprevir|simeprevir|mesh-list
84148150|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
84148151|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148152|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
84148153|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148154|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148155|NCT05298683|Acetaminophen|acetaminophen|mesh-list
84148156|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
84148157|NCT05298683|Promethazine|promethazine|mesh-list
84148158|NCT05298683|Dexamethasone|dexamethasone|mesh-list
84148159|NCT05298683|Pomalidomide|pomalidomide|mesh-list
84148160|NCT05298683|Ranitidine|ranitidine|mesh-list
84148161|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84148162|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148163|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
84148164|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
84148165|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148166|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148167|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84148168|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
84148169|NCT05298683|Hormones|hormones|mesh-ancestor
84148170|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148171|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84148172|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148173|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84148174|NCT05298683|Analgesics|analgesics|mesh-ancestor
84148175|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
84148176|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
84148177|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
84148178|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148179|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148180|NCT05298683|Growth Substances|growth substances|mesh-ancestor
84148181|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148182|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84148183|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84148184|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148185|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
84148186|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
84148187|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84148188|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
84148189|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
84148190|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148191|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148192|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84148193|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
84148194|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
84148195|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84148196|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84148197|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
84148198|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
84148199|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84148200|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84148201|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148202|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148203|NCT00853112|Urological Agents|urological agents|mesh-ancestor
84148204|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
84148205|NCT02624141|Hematinics|hematinics|mesh-ancestor
84148206|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
84148207|NCT00691613|Hematinics|hematinics|mesh-ancestor
84148208|NCT00460603|Bevacizumab|bevacizumab|mesh-list
84148209|NCT00460603|Axitinib|axitinib|mesh-list
84148210|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148211|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148212|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148213|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148214|NCT00460603|Growth Substances|growth substances|mesh-ancestor
84148215|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148216|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148217|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148218|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148904|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148219|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148220|NCT00696059|Adalimumab|adalimumab|mesh-list
84148221|NCT00696059|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84148222|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148223|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148224|NCT00700466|Metoprolol|metoprolol|mesh-list
84148225|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84148226|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84148227|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84148228|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
84148229|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
84148230|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148231|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148232|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84148233|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84148234|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
84148235|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148236|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148237|NCT00700544|Norethandrolone|norethandrolone|mesh-list
84148238|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
84148239|NCT00700544|Hormones|hormones|mesh-ancestor
84148240|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148241|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148242|NCT02612792|Atorvastatin|atorvastatin|mesh-list
84148243|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84148244|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84148245|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
84148246|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148247|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84148248|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84148249|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148250|NCT00662038|Pirfenidone|pirfenidone|mesh-list
84148251|NCT00662038|Analgesics|analgesics|mesh-ancestor
84148252|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
84148253|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148254|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148255|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84148256|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84148257|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148258|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148259|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148260|NCT00701792|Liver Extracts|liver extracts|mesh-list
84148261|NCT00701792|Hematinics|hematinics|mesh-ancestor
84148262|NCT00784498|Midazolam|midazolam|mesh-list
84148263|NCT00784498|Ketamine|ketamine|mesh-list
84148264|NCT00784498|Propofol|propofol|mesh-list
84148265|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84148266|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148267|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148268|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84148269|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
84148270|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
84148271|NCT00784498|Analgesics|analgesics|mesh-ancestor
84148272|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
84148273|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148274|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84148275|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84148276|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84148277|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148278|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148279|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84148280|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84148281|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148282|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148283|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
84148284|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
84148285|NCT01022983|Simendan|simendan|mesh-list
84148286|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84148287|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
84148288|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84148289|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84148290|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148291|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148292|NCT01022983|Protective Agents|protective agents|mesh-ancestor
83389067|NCT04377321|Colchicine|colchicine|mesh-list
84148293|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148294|NCT00912860|Interferons|interferons|mesh-list
84148295|NCT00912860|Interferon-beta|interferon-beta|mesh-list
84148296|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
84148297|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148298|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
84148299|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148300|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
84148301|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148302|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84148303|NCT02623673|Dexamethasone|dexamethasone|mesh-list
84148304|NCT02623673|Bevacizumab|bevacizumab|mesh-list
84148305|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148306|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148307|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148308|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148309|NCT02623673|Growth Substances|growth substances|mesh-ancestor
84148310|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148311|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148312|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148313|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
84148314|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
84148315|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148316|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84148317|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
84148318|NCT02623673|Hormones|hormones|mesh-ancestor
84148319|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148320|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84148321|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
84148322|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148323|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
84148324|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84148325|NCT00459979|Sunitinib|sunitinib|mesh-list
84148326|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148327|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148328|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148329|NCT00459979|Growth Substances|growth substances|mesh-ancestor
84148330|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148331|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148332|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148333|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148334|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148335|NCT00783484|Maraviroc|maraviroc|mesh-list
84148336|NCT00783484|Darunavir|darunavir|mesh-list
84148337|NCT00783484|Midazolam|midazolam|mesh-list
84148338|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84148339|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84148340|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148341|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148342|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84148343|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148344|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148345|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84148346|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
84148347|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
84148348|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
84148349|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
84148350|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148351|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148352|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84148353|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84148354|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84148355|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84148356|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
84148357|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148358|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84148359|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84148360|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84148361|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
84148362|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148363|NCT00828672|Bevacizumab|bevacizumab|mesh-list
84148364|NCT00828672|Capecitabine|capecitabine|mesh-list
84148365|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
84148366|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148367|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148368|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148369|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148370|NCT00828672|Growth Substances|growth substances|mesh-ancestor
84148371|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148372|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148373|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148374|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
84148375|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148376|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84148377|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84148378|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148379|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148380|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84148381|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
84148382|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148383|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148385|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84148386|NCT00873119|Carboplatin|carboplatin|mesh-list
84148387|NCT00873119|Belinostat|belinostat|mesh-list
84148388|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84148389|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148390|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
84148391|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
84148392|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
84148393|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148394|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84148395|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148396|NCT00661726|Decitabine|decitabine|mesh-list
84148397|NCT00661726|Azacitidine|azacitidine|mesh-list
84148398|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148399|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
84148400|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148401|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148402|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148403|NCT00706680|Cyclosporine|cyclosporine|mesh-list
84148404|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
84148405|NCT00706680|Prednisone|prednisone|mesh-list
84148406|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84148407|NCT00706680|Cyclosporins|cyclosporins|mesh-list
84148408|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
84148409|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148410|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
84148411|NCT00706680|Hormones|hormones|mesh-ancestor
84148412|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148413|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148414|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84148415|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148416|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148417|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148418|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84148419|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
84148420|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
84148421|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148422|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
84148423|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148424|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84148425|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84148426|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84148427|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
84148428|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84148429|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84148430|NCT00706680|Protective Agents|protective agents|mesh-ancestor
84148431|NCT02624999|Cisplatin|cisplatin|mesh-list
84148432|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148433|NCT02612480|Aspirin|aspirin|mesh-list
84148434|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
84148435|NCT02612480|Clopidogrel|clopidogrel|mesh-list
84148436|NCT02612480|Ticagrelor|ticagrelor|mesh-list
84148437|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84148438|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84148439|NCT02612480|Analgesics|analgesics|mesh-ancestor
84148440|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
84148441|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148442|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148443|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148444|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148445|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84148446|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84148447|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148448|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84148449|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84148450|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148451|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
84148452|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84148453|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84148454|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84148455|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
84148456|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148457|NCT00784966|Etanercept|etanercept|mesh-list
84148458|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84148459|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84148460|NCT00784966|Analgesics|analgesics|mesh-ancestor
84148461|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
84148462|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148463|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148464|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148465|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148466|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84148467|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84148468|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
84148469|NCT02623595|Molgramostim|molgramostim|mesh-list
84148470|NCT02623595|Sargramostim|sargramostim|mesh-list
84148471|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
84148472|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148473|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148474|NCT00665392|Docetaxel|docetaxel|mesh-list
84148475|NCT00665392|Fluorouracil|fluorouracil|mesh-list
84148476|NCT00665392|Cetuximab|cetuximab|mesh-list
84148477|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148478|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
84148479|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
84148480|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
84148481|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148482|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
84148483|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148484|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84148485|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
84148486|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148487|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148488|NCT00851630|Lamivudine|lamivudine|mesh-list
84148489|NCT00851630|Zidovudine|zidovudine|mesh-list
84148490|NCT00851630|Abacavir|abacavir|mesh-list
84148491|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84148492|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84148493|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148494|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148495|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
84148496|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148497|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84148498|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84148499|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
84148500|NCT05298761|Lidocaine|lidocaine|mesh-list
84148501|NCT05298761|Nalbuphine|nalbuphine|mesh-list
84148502|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84148503|NCT05298761|Narcotics|narcotics|mesh-ancestor
84148504|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148505|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148506|NCT05298761|Analgesics|analgesics|mesh-ancestor
84148507|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
84148508|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148509|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
84148510|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
84148511|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84148512|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84148513|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84148514|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84148515|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148516|NCT00459667|Interferons|interferons|mesh-list
84148517|NCT00459667|Interferon-beta|interferon-beta|mesh-list
84148518|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
84148519|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148520|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
84148905|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
84148521|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148522|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
84148523|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148524|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84148525|NCT02621255|Bupivacaine|bupivacaine|mesh-list
84148526|NCT02621255|Anesthetics|anesthetics|mesh-list
84148527|NCT02621255|Sevoflurane|sevoflurane|mesh-list
84148528|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
84148529|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148530|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148531|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
84148532|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148533|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84148534|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84148535|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
84148536|NCT00828204|Interferons|interferons|mesh-list
84148537|NCT00828204|Interferon-beta|interferon-beta|mesh-list
84148538|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
84148539|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148540|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
84148541|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148542|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
84148543|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148544|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84148545|NCT00696215|Rasagiline|rasagiline|mesh-list
84148546|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84148547|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148548|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148549|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84148550|NCT00696215|Protective Agents|protective agents|mesh-ancestor
84148551|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148552|NCT00784186|Misoprostol|misoprostol|mesh-list
84148553|NCT00784186|Mifepristone|mifepristone|mesh-list
84148554|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84148555|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
84148556|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84148557|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148558|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84148559|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84148560|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
84148561|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84148562|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84148563|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84148564|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84148565|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
84148566|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84148567|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84148568|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
84148569|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148570|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
84148571|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84148572|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84148573|NCT00851552|Rituximab|rituximab|mesh-list
84148574|NCT00851552|Doxorubicin|doxorubicin|mesh-list
84148575|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84148576|NCT00851552|Bortezomib|bortezomib|mesh-list
84148577|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148578|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148579|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
84148580|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148581|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148582|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84148583|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84148584|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84148585|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148586|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148587|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
84148588|NCT00785122|Molgramostim|molgramostim|mesh-list
84148589|NCT00785122|Imiquimod|imiquimod|mesh-list
84148590|NCT00785122|Sargramostim|sargramostim|mesh-list
84148591|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84148592|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
84148593|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148594|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148595|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84148596|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
84148597|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148598|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148599|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84148600|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84148601|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
84148602|NCT04116554|Bupivacaine|bupivacaine|mesh-list
84148603|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
84148604|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
84148605|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148606|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148607|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
84148608|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148609|NCT00700856|Pioglitazone|pioglitazone|mesh-list
84148610|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84148611|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148612|NCT00790114|Midazolam|midazolam|mesh-list
84148613|NCT00790114|Caffeine|caffeine|mesh-list
84148614|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84148615|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84148616|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148617|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148618|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84148619|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148620|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148621|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84148622|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
84148623|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
84148624|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
84148625|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
84148626|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148627|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148628|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84148629|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84148630|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148631|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84148632|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84148633|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
84148634|NCT01023139|Sibutramine|sibutramine|mesh-list
84148635|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
84148636|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148637|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
84148638|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84148639|NCT00459043|Docetaxel|docetaxel|mesh-list
84148640|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148641|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
84148642|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
84148643|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
84148644|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148645|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
84148646|NCT00795262|Quinapril|quinapril|mesh-list
84148647|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
84148648|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148649|NCT00795262|Protective Agents|protective agents|mesh-ancestor
84148650|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148651|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
84148652|NCT00795262|Vitamins|vitamins|mesh-ancestor
84148653|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
84148654|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84148655|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
84148656|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148657|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84148658|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
84148659|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84148660|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84148661|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
84148662|NCT00817206|Tacrolimus|tacrolimus|mesh-list
84148663|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84148664|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
84148665|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148666|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84148667|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148668|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148669|NCT02611518|Metformin|metformin|mesh-list
84148670|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84148671|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84148672|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148673|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84148674|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84148675|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
84148676|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148677|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84148678|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84148679|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148680|NCT01023607|Atorvastatin|atorvastatin|mesh-list
84148681|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84148682|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84148683|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84148684|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
84148685|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148686|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84148687|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84148688|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148689|NCT00665002|Sargramostim|sargramostim|mesh-list
84148690|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
84148691|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
84148692|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148693|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84148694|NCT00660010|Leuprolide|leuprolide|mesh-list
84148695|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84148696|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
84148697|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84148698|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148699|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84148700|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148701|NCT04015908|Acetaminophen|acetaminophen|mesh-list
84148702|NCT04015908|Celecoxib|celecoxib|mesh-list
84148703|NCT04015908|Pregabalin|pregabalin|mesh-list
84148704|NCT04015908|Oxycodone|oxycodone|mesh-list
84148705|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84148706|NCT04015908|Analgesics|analgesics|mesh-ancestor
84148707|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
84148708|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148709|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148710|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
84148711|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
84148712|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84148713|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84148714|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148715|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84148716|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84148717|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148718|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148719|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148720|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84148721|NCT04015908|Narcotics|narcotics|mesh-ancestor
84148722|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84148723|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148724|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148725|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84148726|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84148727|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148728|NCT00790816|Lapatinib|lapatinib|mesh-list
84148729|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
84148730|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148731|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148732|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148733|NCT00873041|Deferasirox|deferasirox|mesh-list
84148734|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
84148735|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
84148736|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
84148737|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148738|NCT00795496|Histamine|histamine|mesh-list
84148739|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
84148740|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
84148741|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148742|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148743|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148744|NCT00795574|Infliximab|infliximab|mesh-list
84148745|NCT00795574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84148746|NCT00795574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84148747|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
84148748|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84148749|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148750|NCT00785434|Escitalopram|escitalopram|mesh-list
84148751|NCT00785434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84148752|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84148753|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84148754|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148755|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148756|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
84148757|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148758|NCT00790894|Epothilones|epothilones|mesh-list
84148759|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
84148760|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
84148761|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
84148762|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148763|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148764|NCT02623127|Sunitinib|sunitinib|mesh-list
84148765|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148766|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84148767|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84148768|NCT02623127|Growth Substances|growth substances|mesh-ancestor
84148769|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148770|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
84148771|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148772|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148773|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148774|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
84148775|NCT05263492|Lenvatinib|lenvatinib|mesh-list
84148776|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148777|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148778|NCT05263492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84148779|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148780|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84148781|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84148782|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
84148783|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84148784|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
84148785|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148786|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
84148787|NCT04134611|Protective Agents|protective agents|mesh-ancestor
84148788|NCT02620631|Morphine|morphine|mesh-list
84148789|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84148790|NCT02620631|Narcotics|narcotics|mesh-ancestor
84148791|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148792|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148793|NCT02620631|Analgesics|analgesics|mesh-ancestor
84148794|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
84148795|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148796|NCT04030572|Clonidine|clonidine|mesh-list
84148797|NCT04030572|Analgesics|analgesics|mesh-ancestor
84148798|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
84148799|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148800|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148801|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84148802|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
84148803|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
84148804|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84148805|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84148806|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84148807|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
84148808|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148809|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148810|NCT00795808|Metformin|metformin|mesh-list
84148811|NCT00795808|Clomiphene|clomiphene|mesh-list
84148812|NCT00795808|Enclomiphene|enclomiphene|mesh-list
84148813|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
84148814|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84148815|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148816|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84148817|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
84148818|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84148819|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84148820|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
84148821|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84148822|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84148823|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84148906|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84148907|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84148908|NCT02620163|Diuretics|diuretics|mesh-ancestor
84148909|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
84148910|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84148911|NCT05758116|Tislelizumab|tislelizumab|mesh-list
84148912|NCT05758116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148913|NCT05758116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148914|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
84148915|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84148916|NCT00570310|Pregabalin|pregabalin|mesh-list
84148917|NCT00570310|Analgesics|analgesics|mesh-ancestor
84148918|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
84148919|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84148920|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148921|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
84148922|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84148923|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84148924|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148925|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84148926|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84148927|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148928|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148929|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148930|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
84148931|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
84148932|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84148933|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84148934|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148935|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
84148936|NCT00664066|Hematinics|hematinics|mesh-ancestor
84148937|NCT04676958|Vitamin K|vitamin k|mesh-list
84148938|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
84148939|NCT04676958|Vitamins|vitamins|mesh-ancestor
84148940|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
84148941|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148942|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84148943|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84148944|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148945|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
84148946|NCT04676958|Coagulants|coagulants|mesh-ancestor
84148947|NCT02619929|Vinorelbine|vinorelbine|mesh-list
84148948|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84148949|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148950|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
84148951|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
84148952|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
84148953|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148954|NCT00796198|Latanoprost|latanoprost|mesh-list
84148955|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84148956|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84148957|NCT02622503|Rituximab|rituximab|mesh-list
84148958|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84148959|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148960|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
84148961|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148962|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84148963|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84148964|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
84148965|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148966|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84148967|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84148968|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148969|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148970|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148971|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148972|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84148973|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84148974|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
84148975|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148976|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148977|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83420980|NCT00115297|Montelukast|montelukast|mesh-list
84148978|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84148979|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
84148980|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84148981|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84148982|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84148983|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84148984|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84148985|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84148986|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84148987|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84148989|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84148990|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148991|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84148992|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84148993|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
84148994|NCT00786058|Fluorouracil|fluorouracil|mesh-list
84148995|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
84148996|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84148997|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84148998|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84148999|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149000|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
84149001|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149002|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
84149003|NCT00871169|Irinotecan|irinotecan|mesh-list
84149004|NCT00871169|Cetuximab|cetuximab|mesh-list
84149005|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149006|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84149007|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84149008|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149009|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149010|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84149011|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84149012|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84149013|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84149014|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149015|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149016|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84149017|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84149018|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84149019|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
84149020|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149021|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149022|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84149023|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84149024|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
84149025|NCT00814632|Apremilast|apremilast|mesh-list
84149026|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149027|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149028|NCT00814632|Analgesics|analgesics|mesh-ancestor
84149029|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
84149030|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149031|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149032|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149033|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149034|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84149035|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84149036|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149037|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149038|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84149039|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84149040|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84149041|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
84149042|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149043|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84149044|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84149045|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149046|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
84149047|NCT02620007|Rifaximin|rifaximin|mesh-list
84149048|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84149049|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149050|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84149051|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84149052|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149053|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149054|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149055|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84149056|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84149057|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84149058|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
84149059|NCT02554942|Hematinics|hematinics|mesh-ancestor
84149060|NCT02619773|Mupirocin|mupirocin|mesh-list
84149061|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84149062|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149063|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84149064|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149065|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149066|NCT02555488|Methylene Blue|methylene blue|mesh-list
84149067|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149068|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149069|NCT02554864|Lidocaine|lidocaine|mesh-list
84149070|NCT02554864|Ropivacaine|ropivacaine|mesh-list
84149071|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
84149072|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
84149073|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149074|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149075|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
84149076|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149077|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84149078|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84149079|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84149080|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84149081|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149082|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
84149083|NCT00851318|Methotrexate|methotrexate|mesh-list
84149084|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84149085|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
84149086|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84149087|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149088|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84149089|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
84149090|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149091|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149092|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
84149093|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149094|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84149095|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149096|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
84149097|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149098|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84149099|NCT00851318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84149100|NCT00851318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149101|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
84149102|NCT00786370|Propofol|propofol|mesh-list
84149103|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84149104|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149105|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149106|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149107|NCT00786370|Analgesics|analgesics|mesh-ancestor
84149108|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
84149109|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149110|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84149111|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84149112|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84149113|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
84149114|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149115|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149116|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84149117|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
84149118|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
84149119|NCT00796900|Dantrolene|dantrolene|mesh-list
84149120|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84149121|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149122|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84149123|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149124|NCT00791830|Irbesartan|irbesartan|mesh-list
84149125|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84149126|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84149127|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84149128|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149129|NCT00786448|Darifenacin|darifenacin|mesh-list
84149130|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84149131|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84149132|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
84149133|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149134|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149135|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149136|NCT00786448|Urological Agents|urological agents|mesh-ancestor
84149137|NCT04137653|Paclitaxel|paclitaxel|mesh-list
84149138|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84149139|NCT04137653|Carboplatin|carboplatin|mesh-list
84149140|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84149141|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149142|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
84149143|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
84149144|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
84149145|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149146|NCT00797056|Aspirin|aspirin|mesh-list
84149147|NCT00797056|Clopidogrel|clopidogrel|mesh-list
84149148|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149149|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149150|NCT00797056|Analgesics|analgesics|mesh-ancestor
84149151|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
84149152|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149153|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149154|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149155|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149156|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84149157|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84149158|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149159|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84149160|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84149161|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149162|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
84149163|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84149164|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84149165|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84149166|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
84149167|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149168|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
84149169|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
84149170|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
84149171|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84149172|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84149173|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149174|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149175|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149176|NCT00697151|Aspirin|aspirin|mesh-list
84149177|NCT00697151|Warfarin|warfarin|mesh-list
84149178|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149179|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149180|NCT00697151|Analgesics|analgesics|mesh-ancestor
84149181|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
84149182|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149183|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149184|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149185|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149186|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84149187|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84149188|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149189|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84149190|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84149191|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149192|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
84149193|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
84149194|NCT02621957|Pravastatin|pravastatin|mesh-list
84149195|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84149196|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84149197|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
84149198|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149199|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84149200|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84149201|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149202|NCT00851084|Leucovorin|leucovorin|mesh-list
84149203|NCT00851084|Folic Acid|folic acid|mesh-list
84149204|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
84149205|NCT00851084|Aflibercept|aflibercept|mesh-list
84149206|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
84149207|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149208|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84149209|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84149210|NCT00851084|Growth Substances|growth substances|mesh-ancestor
84149211|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149212|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
84149213|NCT00851084|Antidotes|antidotes|mesh-ancestor
84149214|NCT00851084|Protective Agents|protective agents|mesh-ancestor
84149215|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
84149216|NCT00851084|Vitamins|vitamins|mesh-ancestor
84149217|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
84149218|NCT00851084|Hematinics|hematinics|mesh-ancestor
84149219|NCT02617199|Fentanyl|fentanyl|mesh-list
84149220|NCT02617199|Analgesics|analgesics|mesh-list
84149221|NCT02617199|Ropivacaine|ropivacaine|mesh-list
84149222|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
84149223|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149224|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149225|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
84149226|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
84149227|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149228|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84149229|NCT02617199|Narcotics|narcotics|mesh-ancestor
84149230|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84149231|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84149232|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
84149233|NCT00845858|Metoclopramide|metoclopramide|mesh-list
84149234|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
84149235|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
84149236|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149237|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149238|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84149239|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84149240|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84149241|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
84149242|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149243|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149244|NCT02619149|Tazobactam|tazobactam|mesh-list
84149245|NCT02619149|Piperacillin|piperacillin|mesh-list
84149246|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84149247|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84149248|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149249|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84149250|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149251|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149252|NCT04134065|Vitamin D|vitamin d|mesh-list
84149253|NCT04134065|Vitamins|vitamins|mesh-ancestor
84149254|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
84149255|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149256|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84149257|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
84149258|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84149259|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84149260|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149261|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
84149262|NCT02616731|Coagulants|coagulants|mesh-ancestor
84149263|NCT00850460|Atorvastatin|atorvastatin|mesh-list
84149264|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84149265|NCT00850460|Simvastatin|simvastatin|mesh-list
84149266|NCT00850460|Pravastatin|pravastatin|mesh-list
84149267|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84149268|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84149269|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
84149270|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149271|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83421280|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
84149272|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84149273|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149274|NCT00661492|Cetuximab|cetuximab|mesh-list
84149275|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
84149276|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84149277|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149278|NCT00661492|Analgesics|analgesics|mesh-ancestor
84149279|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
84149280|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149281|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149282|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84149283|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84149284|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149285|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149286|NCT00693251|Sirolimus|sirolimus|mesh-list
84149287|NCT00693251|Paclitaxel|paclitaxel|mesh-list
84149288|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84149289|NCT00693251|Everolimus|everolimus|mesh-list
84149290|NCT00693251|Temsirolimus|temsirolimus|mesh-list
84149291|NCT00693251|MTOR Inhibitors|mtor inhibitors|mesh-list
84149292|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84149293|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149294|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
84149295|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
84149296|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
84149297|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149298|NCT00693251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84149299|NCT00693251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149300|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149301|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
84149302|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149303|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84149304|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149305|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84149306|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
84149307|NCT00792376|Diclofenac|diclofenac|mesh-list
84149308|NCT00792376|Etoricoxib|etoricoxib|mesh-list
84149309|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149310|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149311|NCT00792376|Analgesics|analgesics|mesh-ancestor
84149312|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
84149313|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149314|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149315|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149316|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149317|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84149318|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149319|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149320|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84149321|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84149322|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84149323|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84149324|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149325|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149326|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84149327|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84149328|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84149329|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
84149330|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149331|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149332|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84149333|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84149334|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
84149335|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
84149336|NCT00814320|Antibodies|antibodies|mesh-list
84149337|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
84149338|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84149339|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84149340|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
84149341|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
84149342|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149343|NCT00869999|Rituximab|rituximab|mesh-list
84149344|NCT00869999|Everolimus|everolimus|mesh-list
84149345|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84149346|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149347|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
84149348|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149349|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149350|NCT00869999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84149351|NCT00869999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83421355|NCT01681095|Tryptophan|tryptophan|mesh-list
84149352|NCT00869999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149353|NCT00869999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149354|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149356|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149357|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
84149358|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
84149359|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149360|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149361|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84149362|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
84149363|NCT04030988|Hormones|hormones|mesh-ancestor
84149364|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149365|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84149366|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149367|NCT00703352|Eplerenone|eplerenone|mesh-list
84149368|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84149369|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
84149370|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149371|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149372|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84149373|NCT00703352|Diuretics|diuretics|mesh-ancestor
84149374|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
84149375|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84149376|NCT00703430|Memantine|memantine|mesh-list
84149377|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84149378|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84149379|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
84149380|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149381|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149382|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149383|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84149384|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84149385|NCT00797836|Interferons|interferons|mesh-list
84149386|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149387|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
84149388|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149389|NCT00693407|Capsaicin|capsaicin|mesh-list
84149390|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
84149391|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
84149392|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
84149393|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149394|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149395|NCT02618603|Triamcinolone|triamcinolone|mesh-list
84149396|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84149397|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84149398|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
84149399|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84149400|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84149401|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84149402|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84149403|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84149404|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149405|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
84149406|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149407|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149408|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149409|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
84149410|NCT02618603|Hormones|hormones|mesh-ancestor
84149411|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149412|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149413|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
84149414|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149415|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84149416|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149417|NCT02616497|Aspirin|aspirin|mesh-list
84149418|NCT02616497|Triflusal|triflusal|mesh-list
84149419|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149420|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149421|NCT02616497|Analgesics|analgesics|mesh-ancestor
84149422|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
84149423|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149424|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149425|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149426|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149427|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84149428|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84149429|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149430|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84149431|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84149432|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149433|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
84149434|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84149435|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149436|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84149437|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149438|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149439|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
84149440|NCT05755854|Fludarabine|fludarabine|mesh-list
84149441|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
84149442|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149443|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
84149444|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149445|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149446|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84149447|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
84149448|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149449|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149450|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84149451|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84149452|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
84149453|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
84149454|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149455|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84149456|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149457|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149458|NCT04669002|Olaparib|olaparib|mesh-list
84149459|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84149460|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149461|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149462|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149463|NCT02616419|Lidocaine|lidocaine|mesh-list
84149464|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
84149465|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
84149466|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149467|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149468|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
84149469|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149470|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84149471|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84149472|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84149473|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430326|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149474|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149475|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
84149476|NCT00798070|Fluorouracil|fluorouracil|mesh-list
84149477|NCT00798070|Docetaxel|docetaxel|mesh-list
84149478|NCT00798070|Epirubicin|epirubicin|mesh-list
84149479|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149480|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
84149481|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149482|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149483|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84149484|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
84149485|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149486|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149487|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84149488|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
84149489|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84149490|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
84149491|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
84149492|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
84149493|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84149494|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84149495|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84149496|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149497|NCT00809328|Azithromycin|azithromycin|mesh-list
84149498|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84149499|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149500|NCT00798148|Carboplatin|carboplatin|mesh-list
84149501|NCT00798148|Etoposide|etoposide|mesh-list
84149502|NCT00798148|Melphalan|melphalan|mesh-list
84149503|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149504|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84149505|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84149506|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84149507|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149508|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149509|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84149510|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
84149511|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84149512|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149513|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
84149514|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149515|NCT00787462|Pregabalin|pregabalin|mesh-list
84149516|NCT00787462|Analgesics|analgesics|mesh-ancestor
84149517|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
84149518|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149519|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149520|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
84149521|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84149522|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84149523|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149524|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84149525|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84149526|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84149527|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149528|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84149529|NCT00792766|Everolimus|everolimus|mesh-list
84149530|NCT00792766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84149531|NCT00792766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84149532|NCT00792766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149533|NCT00792766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149534|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149535|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
84149536|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149537|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149538|NCT00798460|Lamivudine|lamivudine|mesh-list
84149539|NCT00798460|Adefovir|adefovir|mesh-list
84149540|NCT00798460|Clevudine|clevudine|mesh-list
84149541|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84149542|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84149543|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149544|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149545|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
84149546|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149547|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84149548|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84149549|NCT02615873|Levodopa|levodopa|mesh-list
84149550|NCT02615873|Carbidopa|carbidopa|mesh-list
84149551|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84149552|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84149553|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84149554|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
84149555|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149556|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149557|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149558|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84149559|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149560|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84149561|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
84149562|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
84149563|NCT00814164|Daunorubicin|daunorubicin|mesh-list
84149564|NCT00814164|Clofarabine|clofarabine|mesh-list
84149565|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84149566|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149567|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84149568|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84149569|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149570|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149571|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84149572|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
84149573|NCT02609334|Pemirolast|pemirolast|mesh-list
84149574|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
84149575|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
84149576|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149577|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149578|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149580|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84149581|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
84149582|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
84149583|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149584|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149585|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
84149586|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149587|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149588|NCT00659230|Protective Agents|protective agents|mesh-ancestor
84149589|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
84149590|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84149591|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
84149592|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149593|NCT00809094|Expectorants|expectorants|mesh-ancestor
84149594|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
84149595|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84149596|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
84149597|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149598|NCT00809094|Protective Agents|protective agents|mesh-ancestor
84149599|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149600|NCT00809094|Antidotes|antidotes|mesh-ancestor
84149601|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84149602|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
84149603|NCT02615639|Entecavir|entecavir|mesh-list
84149604|NCT02615639|Telbivudine|telbivudine|mesh-list
84149605|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
84149606|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
84149607|NCT02615639|Vaccines|vaccines|mesh-list
84149608|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
84149609|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149610|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
84149611|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149612|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84149613|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149614|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149615|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149616|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
84149617|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84149618|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84149619|NCT00798616|Prednisolone|prednisolone|mesh-list
84149620|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
84149621|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84149622|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
84149623|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149624|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
84149625|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
84149626|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149627|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149628|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84149629|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
84149630|NCT00798616|Hormones|hormones|mesh-ancestor
84149631|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149632|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84149633|NCT00798616|Protective Agents|protective agents|mesh-ancestor
84149634|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84149635|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149636|NCT02618057|Levofloxacin|levofloxacin|mesh-list
84149637|NCT02618057|Prednisolone|prednisolone|mesh-list
84149638|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149639|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
84149640|NCT02618057|Hormones|hormones|mesh-ancestor
84149641|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149642|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149643|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84149644|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149645|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84149646|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149647|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84149648|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84149649|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84149650|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149651|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149652|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84149653|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84149654|NCT04137029|Bromides|bromides|mesh-list
84149655|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
84149656|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
84149657|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84149658|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
84149659|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149660|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149661|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84149662|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
84149663|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84149664|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84149665|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84149666|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
84149667|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149668|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149669|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
84149670|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84149671|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
84149672|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
84149673|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
84149674|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84149675|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84149676|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
84149677|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149678|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84149679|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84149680|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149681|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149682|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84149683|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149684|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84149685|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149686|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149687|NCT00798772|Micronutrients|micronutrients|mesh-list
84149688|NCT00798772|Trace Elements|trace elements|mesh-list
84149689|NCT00798772|Antioxidants|antioxidants|mesh-list
84149690|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149691|NCT00798772|Protective Agents|protective agents|mesh-ancestor
84149692|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149693|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84149694|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84149695|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
84149696|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149697|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149698|NCT00788164|Imiquimod|imiquimod|mesh-list
84149699|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84149700|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
84149701|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149702|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149703|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
84149704|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
84149705|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
84149706|NCT02615561|Vitamins|vitamins|mesh-ancestor
84149707|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
84149708|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149709|NCT00793234|Enoxaparin|enoxaparin|mesh-list
84149710|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
84149711|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84149712|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84149713|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149714|NCT00697775|Vaccines|vaccines|mesh-list
84149715|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
84149716|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149717|NCT04133051|Bupivacaine|bupivacaine|mesh-list
84149718|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
84149719|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
84149720|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149721|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149722|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
84149723|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149724|NCT00788242|Insulin|insulin|mesh-list
84149725|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84149726|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149728|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149729|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149730|NCT04031027|Analgesics|analgesics|mesh-ancestor
84149731|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
84149732|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149733|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149734|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149735|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149736|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
84149737|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84149738|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149739|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149740|NCT02609802|Sevoflurane|sevoflurane|mesh-list
84149741|NCT02609802|Desflurane|desflurane|mesh-list
84149742|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84149743|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84149744|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
84149745|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
84149746|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149747|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149748|NCT02609646|Vancomycin|vancomycin|mesh-list
84149749|NCT02609646|Meropenem|meropenem|mesh-list
84149750|NCT02609646|Linezolid|linezolid|mesh-list
84149751|NCT02609646|Tazobactam|tazobactam|mesh-list
84149752|NCT02609646|Piperacillin|piperacillin|mesh-list
84149753|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84149754|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84149755|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149756|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84149757|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149758|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149759|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84149760|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
84149761|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84149762|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
84149763|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149764|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
84149765|NCT02610504|Protective Agents|protective agents|mesh-ancestor
84149766|NCT04132583|Diclofenac|diclofenac|mesh-list
84149767|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149768|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149769|NCT04132583|Analgesics|analgesics|mesh-ancestor
84149770|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
84149771|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149772|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149773|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149774|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149775|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84149776|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149777|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149778|NCT05754762|Remifentanil|remifentanil|mesh-list
84149779|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84149780|NCT05754762|Narcotics|narcotics|mesh-ancestor
84149781|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149782|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149783|NCT05754762|Analgesics|analgesics|mesh-ancestor
84149784|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
84149785|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149786|NCT05326152|Immunomodulating Agents|immunomodulating agents|mesh-list
84149787|NCT05326152|Immunologic Factors|immunologic factors|mesh-ancestor
84149788|NCT05326152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149789|NCT05757648|Anesthetics|anesthetics|mesh-list
84149790|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149791|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149792|NCT00914004|Desipramine|desipramine|mesh-list
84149793|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84149794|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
84149795|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84149796|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149797|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149798|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84149799|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84149800|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84149801|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
84149802|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149803|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149804|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
84149805|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149806|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84149807|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149808|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149810|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
84149811|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149812|NCT04030260|Antibodies|antibodies|mesh-list
84149813|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
84149814|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
84149815|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149816|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
84149817|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84149818|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84149819|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149820|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
84149821|NCT00697385|Coagulants|coagulants|mesh-ancestor
84149822|NCT00451555|Fulvestrant|fulvestrant|mesh-list
84149823|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84149824|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149825|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84149826|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84149827|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
84149828|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149829|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149830|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
84149831|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84149832|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
84149833|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84149834|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149835|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
84149836|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
84149837|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
84149838|NCT05754684|Aldesleukin|aldesleukin|mesh-list
84149839|NCT05754684|Interleukin-2|interleukin-2|mesh-list
84149840|NCT05754684|Molgramostim|molgramostim|mesh-list
84149841|NCT05754684|Dinutuximab|dinutuximab|mesh-list
84149842|NCT05754684|Spironolactone|spironolactone|mesh-list
84149843|NCT05754684|Sargramostim|sargramostim|mesh-list
84149844|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149845|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149846|NCT05754684|Analgesics|analgesics|mesh-ancestor
84149847|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
84149848|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149849|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149850|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
84149851|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84149852|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84149853|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
84149854|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84149855|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84149856|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
84149857|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149858|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84149859|NCT05754684|Diuretics|diuretics|mesh-ancestor
84149860|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
84149861|NCT00694187|Zaleplon|zaleplon|mesh-list
84149862|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
84149863|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84149864|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149865|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149866|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
84149867|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
84149868|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149869|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149870|NCT02617121|Gabapentin|gabapentin|mesh-list
84149871|NCT02617121|Ramosetron|ramosetron|mesh-list
84149872|NCT02617121|Analgesics|analgesics|mesh-ancestor
84149873|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
84149874|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149875|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149876|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
84149877|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84149878|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84149879|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149880|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84149881|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84149882|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84149883|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149884|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149885|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
84149886|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
84149887|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
84149888|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84149889|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84149890|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
84149891|NCT02609490|Olmesartan|olmesartan|mesh-list
84149892|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84149893|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84149894|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84149895|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84149896|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84149897|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149898|NCT02610348|Vaccines|vaccines|mesh-list
84149899|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84149900|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
84149901|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149902|NCT05757336|Paclitaxel|paclitaxel|mesh-list
84149903|NCT05757336|Bevacizumab|bevacizumab|mesh-list
84149904|NCT05757336|Gemcitabine|gemcitabine|mesh-list
84149905|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84149906|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149907|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
84149908|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
84149909|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
84149910|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149911|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84149912|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84149913|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84149914|NCT05757336|Growth Substances|growth substances|mesh-ancestor
84149915|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149916|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
84149917|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84149918|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
84149919|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84149920|NCT00871871|Isosorbide|isosorbide|mesh-list
84149921|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
84149922|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
84149923|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84149924|NCT00871871|Diuretics|diuretics|mesh-ancestor
84149925|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
84149926|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149927|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84149928|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84149929|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149930|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84149931|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
84149932|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84149933|NCT02608788|Ketorolac|ketorolac|mesh-list
84149934|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84149935|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84149936|NCT02608788|Analgesics|analgesics|mesh-ancestor
84149937|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
84149938|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149939|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149940|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149941|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84149942|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84149943|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149944|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149945|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
84149946|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84149947|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
84149948|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84149949|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149950|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84149952|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84149953|NCT04961190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84149954|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84149955|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84149956|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149957|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84149958|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
84149959|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149960|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84149961|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
84149962|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84149963|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84149964|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84149965|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84149966|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84149967|NCT00849680|Vaccines|vaccines|mesh-list
84149968|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
84149969|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149970|NCT00866723|Bevacizumab|bevacizumab|mesh-list
84149971|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84149972|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84149973|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84149974|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84149975|NCT00866723|Growth Substances|growth substances|mesh-ancestor
84149976|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149977|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
84149978|NCT02613455|Triamcinolone|triamcinolone|mesh-list
84149979|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84149980|NCT02613455|Lidocaine|lidocaine|mesh-list
84149981|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
84149982|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
84149983|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84149984|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84149985|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
84149986|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84149987|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84149988|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84149989|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84149990|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84149991|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84149992|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84149993|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
84149994|NCT02613455|Hormones|hormones|mesh-ancestor
84149995|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84149996|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84149997|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
84149998|NCT00703586|Maraviroc|maraviroc|mesh-list
84149999|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84150000|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84150001|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150002|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84150003|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84150004|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
84150005|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150006|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84150007|NCT04130399|Folfirinox|folfirinox|mesh-list
84150008|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150009|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
84150010|NCT00849056|Incretins|incretins|mesh-ancestor
84150011|NCT00849056|Hormones|hormones|mesh-ancestor
84150012|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150013|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150014|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84150015|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
84150016|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84150017|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84150018|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84150019|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150020|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150021|NCT00706862|Lactoferrin|lactoferrin|mesh-list
84150022|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
83422025|NCT02098993|Heparin|heparin|mesh-list
84150023|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150024|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150025|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84150026|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84150027|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84150028|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
84150029|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150030|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84150031|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84150032|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150033|NCT00837434|Adalimumab|adalimumab|mesh-list
84150034|NCT00837434|Etanercept|etanercept|mesh-list
84150035|NCT00837434|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84150036|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150037|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150038|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84150039|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84150040|NCT00837434|Analgesics|analgesics|mesh-ancestor
84150041|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
84150042|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150043|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150044|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150045|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150046|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
84150047|NCT00703742|Escitalopram|escitalopram|mesh-list
84150048|NCT00703742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84150049|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84150050|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150051|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150052|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150053|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
84150054|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150055|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84150056|NCT00702182|Vinorelbine|vinorelbine|mesh-list
84150057|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150058|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84150059|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150060|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150061|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84150062|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
84150063|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
84150064|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
84150065|NCT00702260|Ramipril|ramipril|mesh-list
84150066|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84150067|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
84150068|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150069|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150070|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84150071|NCT00702416|Acetaminophen|acetaminophen|mesh-list
84150072|NCT00702416|Fentanyl|fentanyl|mesh-list
84150073|NCT00702416|Morphine|morphine|mesh-list
84150074|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
84150075|NCT00702416|Narcotics|narcotics|mesh-list
84150076|NCT00702416|Analgesics|analgesics|mesh-list
84150077|NCT00702416|Anesthetics|anesthetics|mesh-list
84150078|NCT00702416|Ropivacaine|ropivacaine|mesh-list
84150079|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
84150080|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150081|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150082|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
84150083|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150084|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84150085|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84150086|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
84150087|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84150088|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
84150089|NCT00827918|Olanzapine|olanzapine|mesh-list
84150090|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
84150091|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
84150092|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150093|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150094|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150095|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84150096|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84150097|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83422112|NCT05708235|Inavolisib|inavolisib|mesh-list
84150098|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84150099|NCT00827918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84150100|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84150101|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150102|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150103|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150104|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
84150105|NCT00813150|Dexamethasone|dexamethasone|mesh-list
84150106|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
84150107|NCT00813150|Bortezomib|bortezomib|mesh-list
84150108|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150109|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
84150110|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150111|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150112|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84150113|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
84150114|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150115|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150116|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84150117|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150118|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
84150119|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
84150120|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150121|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150122|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
84150123|NCT00813150|Hormones|hormones|mesh-ancestor
84150124|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150125|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84150126|NCT00807846|Celecoxib|celecoxib|mesh-list
84150127|NCT00807846|Naproxen|naproxen|mesh-list
84150128|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84150129|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84150130|NCT00807846|Analgesics|analgesics|mesh-ancestor
84150131|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
84150132|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150133|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150134|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150135|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150136|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84150137|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84150138|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150139|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150140|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
84150141|NCT00810108|Ritonavir|ritonavir|mesh-list
84150142|NCT00810108|Lopinavir|lopinavir|mesh-list
84150143|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84150144|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84150145|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
84150146|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150147|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150148|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84150149|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84150150|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
84150151|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150152|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84150153|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84150154|NCT00827606|Atorvastatin|atorvastatin|mesh-list
84150155|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84150156|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84150157|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
84150158|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150159|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84150160|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84150161|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150162|NCT04016220|Budesonide|budesonide|mesh-list
84150163|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150164|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84150165|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
84150166|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150167|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150168|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84150169|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
84150170|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
83422176|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150171|NCT04016220|Hormones|hormones|mesh-ancestor
84150172|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150173|NCT00663052|Etanercept|etanercept|mesh-list
84150174|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84150175|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84150176|NCT00663052|Analgesics|analgesics|mesh-ancestor
84150177|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
84150178|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150179|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150180|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150181|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150182|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150183|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150184|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
84150185|NCT05599880|Bortezomib|bortezomib|mesh-list
84150186|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150187|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84150188|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150189|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84150190|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150191|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150192|NCT00826748|Beclomethasone|beclomethasone|mesh-list
84150193|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150194|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
84150195|NCT00826748|Hormones|hormones|mesh-ancestor
84150196|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150197|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150198|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84150199|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
84150200|NCT00922844|Sevoflurane|sevoflurane|mesh-list
84150201|NCT00922844|Isoflurane|isoflurane|mesh-list
84150202|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84150203|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84150204|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
84150205|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
84150206|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150207|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150208|NCT00707330|Clarithromycin|clarithromycin|mesh-list
84150209|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150210|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150211|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84150212|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150213|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150214|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84150215|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84150216|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
84150217|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150218|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84150219|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150220|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150221|NCT00788320|Vitamin D|vitamin d|mesh-list
84150222|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
84150223|NCT00788320|Vitamins|vitamins|mesh-ancestor
84150224|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
84150225|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150226|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84150227|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84150228|NCT00807144|Tacrolimus|tacrolimus|mesh-list
84150229|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150230|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
84150231|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150232|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84150233|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150234|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150235|NCT00799240|Cisplatin|cisplatin|mesh-list
84150236|NCT00799240|Pemetrexed|pemetrexed|mesh-list
84150237|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84150238|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150239|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150240|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150241|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84150242|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84150243|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
84150244|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150246|NCT00591006|Phenytoin|phenytoin|mesh-list
84150247|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150248|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
84150249|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84150250|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84150251|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150252|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150253|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84150254|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84150255|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84150256|NCT00844844|Eculizumab|eculizumab|mesh-list
84150257|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84150258|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150259|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
84150260|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150261|NCT05748054|Fluorides|fluorides|mesh-list
84150262|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
84150263|NCT05748054|Protective Agents|protective agents|mesh-ancestor
84150264|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150265|NCT00702572|Paclitaxel|paclitaxel|mesh-list
84150266|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84150267|NCT00702572|Bevacizumab|bevacizumab|mesh-list
84150268|NCT00702572|Carboplatin|carboplatin|mesh-list
84150269|NCT00702572|Vorinostat|vorinostat|mesh-list
84150270|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84150271|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150272|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
84150273|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
84150274|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
84150275|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150276|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150277|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84150278|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84150279|NCT00702572|Growth Substances|growth substances|mesh-ancestor
84150280|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150281|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
84150282|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84150283|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150284|NCT00793468|Nicotine|nicotine|mesh-list
84150285|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84150286|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
84150287|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150288|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150289|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84150290|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84150291|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
84150292|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150293|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150294|NCT00836810|Prednisone|prednisone|mesh-list
84150295|NCT00836810|Prednisolone|prednisolone|mesh-list
84150296|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150297|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
84150298|NCT00836810|Hormones|hormones|mesh-ancestor
84150299|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150300|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150301|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84150302|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150303|NCT00658684|Fesoterodine|fesoterodine|mesh-list
84150304|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84150305|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84150306|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
84150307|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150308|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150309|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150310|NCT00658684|Urological Agents|urological agents|mesh-ancestor
84150311|NCT00660400|Azacitidine|azacitidine|mesh-list
84150312|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84150313|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
84150314|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150315|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150316|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150317|NCT00826514|Tanezumab|tanezumab|mesh-list
84150318|NCT00826514|Analgesics|analgesics|mesh-ancestor
84150319|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
84150320|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150321|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150322|NCT00800566|Clofarabine|clofarabine|mesh-list
84150323|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84150324|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
84150325|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150326|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150327|NCT00793858|Ciclesonide|ciclesonide|mesh-list
84150328|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
84150329|NCT00793858|Hormones|hormones|mesh-ancestor
84150330|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150331|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150332|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84150333|NCT00800722|Sirolimus|sirolimus|mesh-list
84150334|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150335|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150336|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84150337|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150338|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
84150339|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150340|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
84150341|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150342|NCT00826280|Caffeine|caffeine|mesh-list
84150343|NCT00826280|Regadenoson|regadenoson|mesh-list
84150344|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84150345|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150346|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84150347|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150348|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150349|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84150350|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84150351|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
84150352|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150353|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84150354|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84150355|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
84150356|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84150357|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84150358|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84150359|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
84150360|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150361|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84150362|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84150363|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150364|NCT00703898|Nevirapine|nevirapine|mesh-list
84150365|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84150366|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84150367|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150368|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150369|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
84150370|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150371|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84150372|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84150373|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84150374|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84150375|NCT04030442|Morphine|morphine|mesh-list
84150376|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84150377|NCT04030442|Narcotics|narcotics|mesh-ancestor
84150378|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150379|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150380|NCT04030442|Analgesics|analgesics|mesh-ancestor
84150381|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
84150382|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150383|NCT00801034|Calcium|calcium|mesh-list
84150384|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84150385|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150386|NCT04130477|Nickel|nickel|mesh-list
84150387|NCT04130477|Trace Elements|trace elements|mesh-ancestor
84150388|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
84150389|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150390|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
84150391|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84150392|NCT00702728|Furosemide|furosemide|mesh-list
84150393|NCT00702728|Diuretics|diuretics|mesh-ancestor
84150394|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
84150395|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150396|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84150397|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150398|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150399|NCT04132115|Vancomycin|vancomycin|mesh-list
84150400|NCT04132115|Gentamicins|gentamicins|mesh-list
84150401|NCT04132115|Meropenem|meropenem|mesh-list
84150402|NCT04132115|Linezolid|linezolid|mesh-list
84150403|NCT04132115|Tazobactam|tazobactam|mesh-list
84150404|NCT04132115|Piperacillin|piperacillin|mesh-list
84150405|NCT04132115|Daptomycin|daptomycin|mesh-list
84150406|NCT04132115|Amikacin|amikacin|mesh-list
84150407|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84150408|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
84150409|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
84150410|NCT04132115|Acyclovir|acyclovir|mesh-list
84150411|NCT04132115|Ganciclovir|ganciclovir|mesh-list
84150412|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150413|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150414|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84150415|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150416|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150417|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84150418|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
84150419|NCT00801268|Emodin|emodin|mesh-list
84150420|NCT00801268|Cathartics|cathartics|mesh-ancestor
84150421|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150422|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84150423|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150424|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150425|NCT02614937|Squalamine|squalamine|mesh-list
84150426|NCT02614937|Ranibizumab|ranibizumab|mesh-list
84150427|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84150428|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84150429|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84150430|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84150431|NCT02614937|Growth Substances|growth substances|mesh-ancestor
84150432|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150433|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
84150434|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150435|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150436|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150437|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84150438|NCT02614937|Protective Agents|protective agents|mesh-ancestor
84150439|NCT00707642|Vaccines|vaccines|mesh-list
84150440|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
84150441|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150442|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
84150443|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84150444|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150445|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150446|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84150447|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84150448|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150449|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150450|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150451|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84150452|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
84150453|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84150454|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150455|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84150456|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84150457|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84150458|NCT00789646|Lidocaine|lidocaine|mesh-list
84150459|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
84150460|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
84150461|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150462|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150463|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
84150464|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150465|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84150466|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84150467|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84150468|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150469|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150470|NCT00856973|Eszopiclone|eszopiclone|mesh-list
84150471|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84150472|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150473|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150474|NCT00794638|Rituximab|rituximab|mesh-list
84150475|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84150476|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150477|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150478|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
84150479|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150480|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150481|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84150482|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
84150483|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150484|NCT00801580|Doxorubicin|doxorubicin|mesh-list
84150485|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84150486|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84150487|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150488|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84150489|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84150490|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150491|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150492|NCT04951492|Olaparib|olaparib|mesh-list
84150493|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
84150494|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150495|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150496|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150497|NCT00805194|Docetaxel|docetaxel|mesh-list
84150498|NCT00805194|Nintedanib|nintedanib|mesh-list
84150499|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150500|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
84150501|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
84150502|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
84150503|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150504|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84150505|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150506|NCT00657046|Droxidopa|droxidopa|mesh-list
84150507|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84150508|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84150509|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84150510|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
84150511|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150512|NCT00801736|Paclitaxel|paclitaxel|mesh-list
84150513|NCT00801736|Cisplatin|cisplatin|mesh-list
84150514|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84150515|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150516|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
84150517|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
84150518|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
84150519|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150520|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
84150521|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84150522|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84150523|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150524|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
84150525|NCT02606994|Lidocaine|lidocaine|mesh-list
84150526|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
84150527|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
84150528|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150529|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150530|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
84150531|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150532|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84150533|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84150534|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84150535|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150536|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150537|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84150538|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84150539|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
84150540|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
84150541|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150542|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83422561|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
84150543|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
84150544|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
84150545|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150546|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84150547|NCT00844376|Atorvastatin|atorvastatin|mesh-list
84150548|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84150549|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84150550|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
84150551|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150552|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84150553|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84150554|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150555|NCT04046302|Dinoprostone|dinoprostone|mesh-list
84150556|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
84150557|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84150558|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150559|NCT00914394|Phenylephrine|phenylephrine|mesh-list
84150560|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
84150561|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
84150562|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84150563|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
84150564|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
84150565|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150566|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150567|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
84150568|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84150569|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
84150570|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
84150571|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84150572|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84150573|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84150574|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
84150575|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150576|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150577|NCT00914394|Protective Agents|protective agents|mesh-ancestor
84150578|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150579|NCT04045678|Rotigotine|rotigotine|mesh-list
84150580|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
84150581|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
84150582|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150583|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150584|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150585|NCT00658606|Alefacept|alefacept|mesh-list
84150586|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
84150587|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
84150588|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150589|NCT00795106|Capsaicin|capsaicin|mesh-list
84150590|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
84150591|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
84150592|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
84150593|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150594|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150595|NCT00589290|Belinostat|belinostat|mesh-list
84150596|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150597|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84150598|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150599|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150600|NCT00802048|Ropivacaine|ropivacaine|mesh-list
84150601|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
84150602|NCT00802048|Anesthetics|anesthetics|mesh-list
84150603|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150604|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150605|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
84150606|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150607|NCT00809536|Metformin|metformin|mesh-list
84150608|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84150609|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150610|NCT00809692|Histamine|histamine|mesh-list
84150611|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
84150612|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
84150613|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
84150614|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150615|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150616|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150617|NCT00843284|Pregabalin|pregabalin|mesh-list
84150618|NCT00843284|Analgesics|analgesics|mesh-ancestor
84150619|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
84150620|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150621|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150622|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
84150623|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84150624|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150625|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150626|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84150627|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84150628|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84150629|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150630|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84150631|NCT00802282|Psilocybin|psilocybin|mesh-list
84150632|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
84150633|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150634|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84150635|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
84150636|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84150637|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150638|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84150639|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
84150640|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150641|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150642|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150643|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150644|NCT00825812|Atropine|atropine|mesh-list
84150645|NCT00825812|Neostigmine|neostigmine|mesh-list
84150646|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84150647|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84150648|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84150649|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
84150650|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150651|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150652|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84150653|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
84150654|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
84150655|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
84150656|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84150657|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84150658|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
84150659|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430338|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
84150660|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150661|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84150662|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150663|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84150664|NCT00802594|Pafuramidine|pafuramidine|mesh-list
84150665|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84150666|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84150667|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84150668|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150669|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
84150670|NCT00707876|Hematinics|hematinics|mesh-ancestor
84150671|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84150672|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84150673|NCT02606448|Bupivacaine|bupivacaine|mesh-list
84150674|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
84150675|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
84150676|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150677|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150678|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
84150679|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150680|NCT00802828|Famotidine|famotidine|mesh-list
84150681|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84150682|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150683|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84150684|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
84150685|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
84150686|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150687|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150688|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150689|NCT00802906|Bevacizumab|bevacizumab|mesh-list
84150690|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150691|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150692|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84150693|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84150694|NCT00802906|Growth Substances|growth substances|mesh-ancestor
84150695|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150696|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
84150697|NCT00803218|Fluticasone|fluticasone|mesh-list
84150698|NCT00803218|Xhance|xhance|mesh-list
84150699|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150700|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84150701|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
84150702|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150703|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150704|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84150705|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
84150706|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
84150707|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84150708|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
84150709|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84150710|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84150711|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150712|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
84150713|NCT00824564|Coagulants|coagulants|mesh-ancestor
84150714|NCT00803374|Ipilimumab|ipilimumab|mesh-list
84150715|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84150716|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150717|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150718|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84150719|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150720|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
84150721|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150722|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
84150723|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
84150724|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150725|NCT00803530|Protective Agents|protective agents|mesh-ancestor
84150726|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150727|NCT00803530|Vitamins|vitamins|mesh-ancestor
84150728|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
84150729|NCT00803764|Naproxen|naproxen|mesh-list
84150730|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84150731|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84150732|NCT00803764|Analgesics|analgesics|mesh-ancestor
84150733|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
84150734|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150735|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150736|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150737|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150738|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
84150739|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84150740|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150741|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150742|NCT00704366|Saracatinib|saracatinib|mesh-list
84150743|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150744|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150745|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150746|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84150747|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84150748|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84150749|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84150750|NCT00803842|Doxycycline|doxycycline|mesh-list
84150751|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150752|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150753|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
84150754|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84150755|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84150756|NCT00658528|Esomeprazole|esomeprazole|mesh-list
84150757|NCT00658528|Rabeprazole|rabeprazole|mesh-list
84150758|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84150759|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150760|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84150761|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150762|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150763|NCT02864394|Docetaxel|docetaxel|mesh-list
84150764|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
84150765|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150766|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
84150767|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
84150768|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
83422772|NCT04790175|Tolvaptan|tolvaptan|mesh-list
84150769|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150770|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150771|NCT02864394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84150772|NCT00856583|Risperidone|risperidone|mesh-list
84150773|NCT00856583|Sertindole|sertindole|mesh-list
84150774|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84150775|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
84150776|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150777|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150778|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150779|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84150780|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84150781|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150782|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84150783|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84150784|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
84150785|NCT00803244|Immunomodulating Agents|immunomodulating agents|mesh-list
84150786|NCT00803244|Immunologic Factors|immunologic factors|mesh-ancestor
84150787|NCT00803244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150788|NCT05753280|Vitamin D|vitamin d|mesh-list
84150789|NCT05753280|Vitamins|vitamins|mesh-ancestor
84150790|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
84150791|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150792|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84150793|NCT00824408|Pemetrexed|pemetrexed|mesh-list
84150794|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150795|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150796|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150797|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84150798|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84150799|NCT02611700|Paclitaxel|paclitaxel|mesh-list
84150800|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84150801|NCT02611700|Cisplatin|cisplatin|mesh-list
84150802|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
84150803|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84150804|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150805|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
84150806|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
84150807|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
84150808|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150809|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150810|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84150811|NCT00708344|Irbesartan|irbesartan|mesh-list
84150812|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84150813|NCT00708344|Diuretics|diuretics|mesh-ancestor
84150814|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
84150815|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150816|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84150817|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150818|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150819|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84150820|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84150821|NCT00866333|Entinostat|entinostat|mesh-list
84150822|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150823|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84150824|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150825|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150826|NCT00834080|Naltrexone|naltrexone|mesh-list
84150827|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84150828|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84150829|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150830|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
84150831|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150832|NCT00823472|Ganirelix|ganirelix|mesh-list
84150833|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
84150834|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150835|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150836|NCT04118699|Rifaximin|rifaximin|mesh-list
84150837|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84150838|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150839|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84150840|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
84150841|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84150842|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84150843|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84150844|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
84150845|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150846|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150847|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150848|NCT04130087|Selegiline|selegiline|mesh-list
84150849|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
84150850|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84150851|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84150852|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84150853|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
84150854|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150855|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150856|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84150857|NCT04130087|Protective Agents|protective agents|mesh-ancestor
84150858|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150859|NCT00652366|Gemcitabine|gemcitabine|mesh-list
84150860|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84150861|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84150862|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
84150863|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150864|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150865|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84150866|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150867|NCT00841568|Tolvaptan|tolvaptan|mesh-list
84150868|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84150869|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150870|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
84150871|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150872|NCT00855959|Budesonide|budesonide|mesh-list
84150873|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150874|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84150875|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
84150876|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150877|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150878|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84150879|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
84150880|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
84150881|NCT00855959|Hormones|hormones|mesh-ancestor
84150882|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150883|NCT00704600|Nelfinavir|nelfinavir|mesh-list
84150884|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84150885|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84150886|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
84150887|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150888|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150889|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84150890|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84150891|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
84150892|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150893|NCT00699881|Cetuximab|cetuximab|mesh-list
84150894|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150895|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150896|NCT00708578|Metformin|metformin|mesh-list
84150897|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
84150898|NCT00708578|Glimepiride|glimepiride|mesh-list
84150899|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84150900|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150901|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84150902|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150903|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
84150904|NCT00704678|Sevelamer|sevelamer|mesh-list
84150905|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
84150906|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
84150907|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150908|NCT00708656|Mesalamine|mesalamine|mesh-list
84150909|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84150910|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84150911|NCT00708656|Analgesics|analgesics|mesh-ancestor
84150912|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
84150913|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150914|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150915|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84150916|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150917|NCT00913328|Montelukast|montelukast|mesh-list
84150918|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84150919|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
84150920|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84150921|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
84150922|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84150923|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150924|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84150925|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84150926|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150927|NCT00804310|Lapatinib|lapatinib|mesh-list
84150928|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150929|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84150930|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150931|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150932|NCT04118777|Ropivacaine|ropivacaine|mesh-list
84150933|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
84150934|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
84150935|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84150936|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150937|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
84150938|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150939|NCT00708812|Paclitaxel|paclitaxel|mesh-list
84150940|NCT00708812|Carboplatin|carboplatin|mesh-list
84150941|NCT00708812|Endostar protein|endostar protein|mesh-list
84150942|NCT00708812|Endostatins|endostatins|mesh-list
84150943|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84150944|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150945|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
84150946|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
84150947|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
84150948|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150949|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84150950|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84150951|NCT00708812|Growth Substances|growth substances|mesh-ancestor
84150952|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150953|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
84150954|NCT04127747|Rituximab|rituximab|mesh-list
84150955|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84150956|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150957|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
84150958|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150959|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84150960|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
84150961|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84150962|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84150963|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84150964|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84150965|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150966|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
84150967|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84150968|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150969|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84150970|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84150971|NCT00822770|Plerixafor|plerixafor|mesh-list
84150972|NCT00822770|Fludarabine|fludarabine|mesh-list
84150973|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
84150974|NCT00822770|Busulfan|busulfan|mesh-list
84150975|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
84150976|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84150977|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84150978|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84150979|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
84150980|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150981|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84150982|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
84150983|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84150984|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
84150985|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150986|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
84150987|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84150988|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84150989|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84150990|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84150991|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84150992|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83423004|NCT05687448|Warfarin|warfarin|mesh-list
84150993|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84150994|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84150995|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84150996|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84150997|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
84150998|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84150999|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84151000|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84151001|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
84151002|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84151003|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151004|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84151005|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
84151006|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84151007|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84151008|NCT02607111|Dalteparin|dalteparin|mesh-list
84151009|NCT02607111|Tinzaparin|tinzaparin|mesh-list
84151010|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84151011|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
84151012|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84151013|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84151014|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151015|NCT00703196|Folic Acid|folic acid|mesh-list
84151016|NCT00703196|Hematinics|hematinics|mesh-ancestor
84151017|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
84151018|NCT00703196|Vitamins|vitamins|mesh-ancestor
84151019|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
84151020|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151021|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
84151022|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84151023|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
84151024|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151025|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151026|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
84151027|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151028|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
84151029|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
84151030|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84151031|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84151032|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151033|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151034|NCT00914277|Urological Agents|urological agents|mesh-ancestor
84151035|NCT00704756|Ribavirin|ribavirin|mesh-list
84151036|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84151037|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
84151038|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
84151039|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151040|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
84151041|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151042|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
84151043|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151044|NCT00806442|Borage oil|borage oil|mesh-list
84151045|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151046|NCT02608242|Amlodipine|amlodipine|mesh-list
84151047|NCT02608242|Telmisartan|telmisartan|mesh-list
84151048|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
84151049|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84151050|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84151051|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84151052|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84151053|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151054|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84151055|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151056|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
84151057|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84151058|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84151059|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
84151060|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84151061|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84151062|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151063|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84151064|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84151065|NCT02607696|Zolpidem|zolpidem|mesh-list
84151066|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83423076|NCT01438424|Lamivudine|lamivudine|mesh-list
84151067|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84151068|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151069|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151070|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84151071|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
84151072|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
84151073|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151074|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151075|NCT00839852|Cariprazine|cariprazine|mesh-list
84151076|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84151077|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84151078|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151079|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151080|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84151081|NCT02604849|Gentamicins|gentamicins|mesh-list
84151082|NCT02604849|Neomycin|neomycin|mesh-list
84151083|NCT02604849|Streptomycin|streptomycin|mesh-list
84151084|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84151085|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151086|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84151087|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151088|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151089|NCT00709046|Pantoprazole|pantoprazole|mesh-list
84151090|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84151091|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151092|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84151093|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151094|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151095|NCT00820898|Gemcitabine|gemcitabine|mesh-list
84151096|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84151097|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
84151098|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151099|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151100|NCT00865709|Leucovorin|leucovorin|mesh-list
84151101|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
84151102|NCT00865709|Fluorouracil|fluorouracil|mesh-list
84151103|NCT00865709|Sorafenib|sorafenib|mesh-list
84151104|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
84151105|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151106|NCT00865709|Antidotes|antidotes|mesh-ancestor
84151107|NCT00865709|Protective Agents|protective agents|mesh-ancestor
84151108|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151109|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
84151110|NCT00865709|Vitamins|vitamins|mesh-ancestor
84151111|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
84151112|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
84151113|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151114|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84151115|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84151116|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
84151117|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84151118|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151119|NCT00839306|Rabeprazole|rabeprazole|mesh-list
84151120|NCT00839306|Ranitidine|ranitidine|mesh-list
84151121|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84151122|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84151123|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151124|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84151125|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151126|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151127|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84151128|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
84151129|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
84151130|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151131|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151132|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84151133|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84151134|NCT00839072|Trazodone|trazodone|mesh-list
84151135|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84151136|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84151137|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151138|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151139|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84151140|NCT00839072|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84151141|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84151142|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84151143|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151144|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151145|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
84151146|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84151147|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
84151148|NCT00704990|Vitamins|vitamins|mesh-list
84151149|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
84151150|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
84151151|NCT00704990|Pyridoxal|pyridoxal|mesh-list
84151152|NCT00704990|Pyridoxine|pyridoxine|mesh-list
84151153|NCT00704990|Zinc|zinc|mesh-list
84151154|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
84151155|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
84151156|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151157|NCT00704990|Trace Elements|trace elements|mesh-ancestor
84151158|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
84151159|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151160|NCT00704990|Protective Agents|protective agents|mesh-ancestor
84151161|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
84151162|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151163|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151164|NCT03553836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84151165|NCT03553836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151166|NCT02607774|Midazolam|midazolam|mesh-list
84151167|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84151168|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84151169|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151170|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151171|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84151172|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84151173|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84151174|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84151175|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
84151176|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
84151177|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
84151178|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
84151179|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151180|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151181|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
84151182|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
84151183|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84151184|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151185|NCT00838916|Incretins|incretins|mesh-ancestor
84151186|NCT00838916|Hormones|hormones|mesh-ancestor
84151187|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151188|NCT00838682|Omeprazole|omeprazole|mesh-list
84151189|NCT00838682|Rabeprazole|rabeprazole|mesh-list
84151190|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84151191|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151192|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84151193|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151194|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151195|NCT00913484|Disulfiram|disulfiram|mesh-list
84151196|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84151197|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
84151198|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151199|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151200|NCT00803712|Vitamin D|vitamin d|mesh-list
84151201|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
84151202|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
84151203|NCT00803712|Vitamins|vitamins|mesh-list
84151204|NCT00803712|Cinacalcet|cinacalcet|mesh-list
84151205|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
84151206|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151207|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84151208|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84151209|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
84151210|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
84151211|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151212|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
84151213|NCT00803634|Diltiazem|diltiazem|mesh-list
84151214|NCT00803634|Nitroprusside|nitroprusside|mesh-list
84151215|NCT00803634|Nicardipine|nicardipine|mesh-list
84151216|NCT00803634|Clevidipine|clevidipine|mesh-list
84151217|NCT00803634|Isosorbide|isosorbide|mesh-list
84151218|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83423217|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
84151219|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
84151220|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
84151221|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84151222|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84151223|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151224|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84151225|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151226|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84151227|NCT00803634|Diuretics|diuretics|mesh-ancestor
84151228|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
84151229|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
84151230|NCT00838526|Rabeprazole|rabeprazole|mesh-list
84151231|NCT00838526|Ranitidine|ranitidine|mesh-list
84151232|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84151233|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84151234|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151235|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84151236|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151237|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151238|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84151239|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
84151240|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
84151241|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151242|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151243|NCT00914472|Heparin|heparin|mesh-list
84151244|NCT00914472|Calcium heparin|calcium heparin|mesh-list
84151245|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
84151246|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84151247|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84151248|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151249|NCT02611466|Naproxen|naproxen|mesh-list
84151250|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84151251|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151252|NCT02611466|Analgesics|analgesics|mesh-ancestor
84151253|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
84151254|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151255|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151256|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151257|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151258|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
84151259|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84151260|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151261|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151262|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
84151263|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
84151264|NCT02610920|Iron|iron|mesh-list
84151265|NCT02610920|Trace Elements|trace elements|mesh-ancestor
84151266|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
84151267|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151268|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84151269|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84151270|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84151271|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
84151272|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151273|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84151274|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84151275|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151276|NCT00818168|Infliximab|infliximab|mesh-list
84151277|NCT00818168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84151278|NCT00818168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151279|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
84151280|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151281|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151282|NCT02607540|Cisplatin|cisplatin|mesh-list
84151283|NCT02607540|Fluorouracil|fluorouracil|mesh-list
84151284|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151285|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
84151286|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151287|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84151288|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84151289|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
84151290|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151291|NCT00705692|Levamisole|levamisole|mesh-list
84151292|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84151293|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
84151294|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151295|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
84151296|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
84151297|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84151298|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151299|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151300|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
84151301|NCT00705770|Anecortave|anecortave|mesh-list
84151302|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84151303|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84151304|NCT00705770|Growth Substances|growth substances|mesh-ancestor
84151305|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151306|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
84151307|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151308|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151309|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
84151310|NCT00796653|Olodaterol|olodaterol|mesh-list
84151311|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84151312|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
84151313|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151314|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151315|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84151316|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
84151317|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84151318|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84151319|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84151320|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
84151321|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151322|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151323|NCT00806286|Paclitaxel|paclitaxel|mesh-list
84151324|NCT00806286|Carboplatin|carboplatin|mesh-list
84151325|NCT00806286|Efatutazone|efatutazone|mesh-list
84151326|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84151327|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151328|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
84151329|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
84151330|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
84151331|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151332|NCT03537924|Acetazolamide|acetazolamide|mesh-list
84151333|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
84151334|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84151335|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151336|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151337|NCT03537924|Diuretics|diuretics|mesh-ancestor
84151338|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
84151339|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151340|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
84151341|NCT00590538|Genistein|genistein|mesh-list
84151342|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151343|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84151344|NCT00590538|Protective Agents|protective agents|mesh-ancestor
84151345|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151346|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84151347|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151348|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151349|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
84151350|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84151351|NCT00590538|Estrogens|estrogens|mesh-ancestor
84151352|NCT00590538|Hormones|hormones|mesh-ancestor
84151353|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151354|NCT02608320|Fentanyl|fentanyl|mesh-list
84151355|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84151356|NCT02608320|Narcotics|narcotics|mesh-ancestor
84151357|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151358|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151359|NCT02608320|Analgesics|analgesics|mesh-ancestor
84151360|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
84151361|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151362|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84151363|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84151364|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
84151365|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
84151366|NCT01731444|Phenylephrine|phenylephrine|mesh-list
84151367|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
84151368|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84151369|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
84151370|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
84151371|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151372|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151373|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
84151374|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84151375|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
84151376|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
84151377|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84151378|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84151379|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84151380|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
84151381|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151382|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151383|NCT01731444|Protective Agents|protective agents|mesh-ancestor
84151384|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
84151385|NCT02608164|Vitamin D|vitamin d|mesh-list
84151386|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
84151387|NCT02608164|Vitamins|vitamins|mesh-ancestor
84151388|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
84151389|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151390|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84151391|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84151392|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
84151393|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
84151394|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
84151395|NCT04110873|Ubiquinone|ubiquinone|mesh-list
84151396|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
84151397|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151398|NCT02604615|Capecitabine|capecitabine|mesh-list
84151399|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
84151400|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84151401|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
84151402|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151403|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151404|NCT00796107|Letrozole|letrozole|mesh-list
84151405|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151406|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84151407|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84151408|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151409|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151410|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84151411|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
84151412|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151413|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151414|NCT00805740|Caspofungin|caspofungin|mesh-list
84151415|NCT00805740|Anidulafungin|anidulafungin|mesh-list
84151416|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
84151417|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151418|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151419|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151420|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
84151421|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84151422|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
84151423|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151424|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
84151425|NCT05613075|Protective Agents|protective agents|mesh-ancestor
84151426|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84151427|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
84151428|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84151429|NCT01227876|Prednisolone|prednisolone|mesh-list
84151430|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
84151431|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84151432|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
84151433|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151434|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
84151435|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
84151436|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151437|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151438|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151439|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
84151440|NCT01227876|Hormones|hormones|mesh-ancestor
84151441|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151442|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84151443|NCT01227876|Protective Agents|protective agents|mesh-ancestor
84151444|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84151445|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151446|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
84151447|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84151448|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151449|NCT05297292|Ranibizumab|ranibizumab|mesh-list
84151450|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84151451|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84151452|NCT05297292|Growth Substances|growth substances|mesh-ancestor
84151453|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151454|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
84151455|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151456|NCT02604459|Fentanyl|fentanyl|mesh-list
84151457|NCT02604459|Anesthetics|anesthetics|mesh-list
84151458|NCT02604459|Propofol|propofol|mesh-list
84151459|NCT02604459|Sevoflurane|sevoflurane|mesh-list
84151460|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151461|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151462|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84151463|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84151464|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
84151465|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84151466|NCT02604459|Narcotics|narcotics|mesh-ancestor
84151467|NCT02604459|Analgesics|analgesics|mesh-ancestor
84151468|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
84151469|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151470|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84151471|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84151472|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84151473|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
84151474|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84151475|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
84151476|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
84151477|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151478|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151479|NCT02607072|Aspirin|aspirin|mesh-list
84151480|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84151481|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151482|NCT02607072|Analgesics|analgesics|mesh-ancestor
84151483|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
84151484|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151485|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151486|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151487|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151488|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84151489|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84151490|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151491|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84151492|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84151493|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151494|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
84151495|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84151496|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151497|NCT04110093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151498|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151499|NCT03161652|Ranibizumab|ranibizumab|mesh-list
84151500|NCT03161652|Dopamine|dopamine|mesh-list
84151501|NCT03161652|Sulpiride|sulpiride|mesh-list
84151502|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84151503|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84151504|NCT03161652|Growth Substances|growth substances|mesh-ancestor
84151505|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151506|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
84151507|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151508|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84151509|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
84151510|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
84151511|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151512|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
84151513|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151514|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151515|NCT03161652|Protective Agents|protective agents|mesh-ancestor
84151516|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84151517|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84151518|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151519|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84151520|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84151521|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84151522|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
84151523|NCT00588237|Paclitaxel|paclitaxel|mesh-list
84151524|NCT00588237|Bevacizumab|bevacizumab|mesh-list
84151525|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84151526|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151527|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
84151528|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
84151529|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
84151530|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151531|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151532|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84151533|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84151534|NCT00588237|Growth Substances|growth substances|mesh-ancestor
84151535|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151536|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
84151537|NCT02605746|Ceritinib|ceritinib|mesh-list
84151538|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151539|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84151540|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151541|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151542|NCT04109859|Methylene Blue|methylene blue|mesh-list
84151543|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151544|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151545|NCT00790023|Ciclesonide|ciclesonide|mesh-list
84151546|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
84151547|NCT00790023|Hormones|hormones|mesh-ancestor
84151548|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151549|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151550|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84151551|NCT00588822|Rituximab|rituximab|mesh-list
84151552|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151553|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151554|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
84151555|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151556|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151557|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
84151558|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151559|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151560|NCT05563467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84151561|NCT05563467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151562|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84151563|NCT00589914|Risperidone|risperidone|mesh-list
84151564|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84151565|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84151566|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151567|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151568|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84151569|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84151570|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84151571|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
84151572|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151573|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151574|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84151575|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84151576|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
84151577|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
84151578|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84151579|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151580|NCT00789555|Analgesics|analgesics|mesh-ancestor
84151581|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
84151582|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151583|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151584|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151585|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151586|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84151587|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84151588|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84151589|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
84151590|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
84151591|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151592|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151593|NCT03770455|Avelumab|avelumab|mesh-list
84151594|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151595|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151596|NCT01026337|Sunitinib|sunitinib|mesh-list
84151597|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83423593|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
84151598|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84151599|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84151600|NCT01026337|Growth Substances|growth substances|mesh-ancestor
84151601|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151602|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
84151603|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84151604|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151605|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151607|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
84151608|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84151609|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151610|NCT03746275|Analgesics|analgesics|mesh-ancestor
84151611|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
84151612|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151613|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151614|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151615|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151616|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84151617|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84151618|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151619|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84151620|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84151621|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151622|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
84151623|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84151624|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
84151625|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84151626|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
84151627|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
84151628|NCT01026415|Rifampin|rifampin|mesh-list
84151629|NCT01026415|Ketoconazole|ketoconazole|mesh-list
84151630|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84151631|NCT01026415|Midazolam|midazolam|mesh-list
84151632|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84151633|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84151634|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84151635|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151636|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151637|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84151638|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84151639|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84151640|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84151641|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
84151642|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
84151643|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
84151644|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
84151645|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151646|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151647|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84151648|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
84151649|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84151650|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151651|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
84151652|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84151653|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151654|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84151655|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84151656|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84151657|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84151658|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84151659|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84151660|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151661|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151662|NCT01026415|Immunotoxins|immunotoxins|mesh-ancestor
84151663|NCT01026415|Immunoconjugates|immunoconjugates|mesh-ancestor
84151664|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
84151665|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
84151666|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84151667|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84151668|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84151669|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
84151670|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83423680|NCT02989701|Plerixafor|plerixafor|mesh-list
84151671|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84151672|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84151673|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
84151674|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151675|NCT02604966|Artesunate|artesunate|mesh-list
84151676|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
84151677|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84151678|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84151679|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151680|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151681|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
84151682|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
84151683|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84151684|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
84151685|NCT00914160|Diclofenac|diclofenac|mesh-list
84151686|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84151687|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151688|NCT00914160|Analgesics|analgesics|mesh-ancestor
84151689|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
84151690|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151691|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151692|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151693|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151694|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84151695|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151696|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151697|NCT00450619|Metronidazole|metronidazole|mesh-list
84151698|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
84151699|NCT00450619|Vaccines|vaccines|mesh-list
84151700|NCT00450619|Sargramostim|sargramostim|mesh-list
84151701|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
84151702|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151703|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151704|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84151705|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84151706|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84151707|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151708|NCT00450619|Analgesics|analgesics|mesh-ancestor
84151709|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
84151710|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151711|NCT00802074|Ritonavir|ritonavir|mesh-list
84151712|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
84151713|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
84151714|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84151715|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84151716|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
84151717|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151718|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151719|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84151720|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84151721|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
84151722|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151723|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84151724|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84151725|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84151726|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84151727|NCT04112394|Anesthetics|anesthetics|mesh-list
84151728|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
84151729|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151730|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151731|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
84151732|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151733|NCT00450385|Prednisone|prednisone|mesh-list
84151734|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
84151735|NCT00450385|Rituximab|rituximab|mesh-list
84151736|NCT00450385|Doxorubicin|doxorubicin|mesh-list
84151737|NCT00450385|Vincristine|vincristine|mesh-list
84151738|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84151739|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
84151740|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151741|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151742|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84151743|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
84151744|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151745|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151746|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84151747|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84151749|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84151750|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84151751|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151752|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151753|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
84151754|NCT00450385|Hormones|hormones|mesh-ancestor
84151755|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151756|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84151757|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84151758|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
84151759|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
84151760|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
84151761|NCT00588354|Triamcinolone|triamcinolone|mesh-list
84151762|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84151763|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84151764|NCT00588354|Lidocaine|lidocaine|mesh-list
84151765|NCT00588354|Clonidine|clonidine|mesh-list
84151766|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84151767|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
84151768|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
84151769|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151770|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151771|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
84151772|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151773|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84151774|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84151775|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84151776|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84151777|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151778|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151779|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
84151780|NCT00588354|Hormones|hormones|mesh-ancestor
84151781|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151782|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84151783|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
84151784|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151785|NCT00588354|Analgesics|analgesics|mesh-ancestor
84151786|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84151787|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
84151788|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
84151789|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84151790|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84151791|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84151792|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
84151793|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151794|NCT00449761|Panobinostat|panobinostat|mesh-list
84151795|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151796|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84151797|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151798|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151799|NCT00800982|Etanercept|etanercept|mesh-list
84151800|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84151801|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151802|NCT00800982|Analgesics|analgesics|mesh-ancestor
84151803|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
84151804|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151805|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151806|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151807|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151808|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151809|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84151810|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
84151811|NCT01019395|Daptomycin|daptomycin|mesh-list
84151812|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84151813|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151814|NCT00830960|Clopidogrel|clopidogrel|mesh-list
84151815|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84151816|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84151817|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84151818|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84151819|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84151820|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
84151821|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151822|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151823|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151825|NCT01026961|Dimethindene|dimethindene|mesh-list
84151826|NCT01026961|Phenylephrine|phenylephrine|mesh-list
84151827|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
84151828|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151829|NCT01026961|Analgesics|analgesics|mesh-ancestor
84151830|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
84151831|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151832|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151833|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
84151834|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151835|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84151836|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
84151837|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
84151838|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
84151839|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84151840|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
84151841|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
84151842|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84151843|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84151844|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84151845|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
84151846|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151847|NCT01026961|Protective Agents|protective agents|mesh-ancestor
84151848|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
84151849|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
84151850|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84151851|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
84151852|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
84151853|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84151854|NCT01566253|Acetaminophen|acetaminophen|mesh-list
84151855|NCT01566253|Ketoprofen|ketoprofen|mesh-list
84151856|NCT01566253|Morphine|morphine|mesh-list
84151857|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84151858|NCT01566253|Narcotics|narcotics|mesh-ancestor
84151859|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151860|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151861|NCT01566253|Analgesics|analgesics|mesh-ancestor
84151862|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
84151863|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151864|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84151865|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
84151866|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84151867|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151868|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151869|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84151870|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151871|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151872|NCT03849313|Adalimumab|adalimumab|mesh-list
84151873|NCT03849313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84151874|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151875|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84151876|NCT04111614|Tofacitinib|tofacitinib|mesh-list
84151877|NCT04111614|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84151878|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84151879|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151880|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151881|NCT01023919|Sirolimus|sirolimus|mesh-list
84151882|NCT01023919|Paclitaxel|paclitaxel|mesh-list
84151883|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84151884|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151885|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
84151886|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
84151887|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
84151888|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151889|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84151890|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151891|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84151892|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
84151893|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84151894|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
84151895|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151896|NCT04028622|Anesthetics|anesthetics|mesh-list
84151897|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151898|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151900|NCT00830804|Darunavir|darunavir|mesh-list
84151901|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
84151902|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84151903|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84151904|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
84151905|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151906|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151907|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84151908|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84151909|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
84151910|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151911|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84151912|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84151913|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84151914|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84151915|NCT00789477|Aflibercept|aflibercept|mesh-list
84151916|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84151917|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84151918|NCT00789477|Growth Substances|growth substances|mesh-ancestor
84151919|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151920|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
84151921|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151922|NCT01024075|Dexamethasone|dexamethasone|mesh-list
84151923|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84151924|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
84151925|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
84151926|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84151927|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151928|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84151929|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
84151930|NCT01024075|Hormones|hormones|mesh-ancestor
84151931|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151932|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84151933|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151934|NCT05756348|Protective Agents|protective agents|mesh-list
84151935|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151936|NCT00913874|Valproic Acid|valproic acid|mesh-list
84151937|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
84151938|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151939|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151940|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
84151941|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151942|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151943|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
84151944|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84151945|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84151946|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84151947|NCT00796614|Tamsulosin|tamsulosin|mesh-list
84151948|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84151949|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84151950|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84151951|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
84151952|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151953|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151954|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151955|NCT00796614|Urological Agents|urological agents|mesh-ancestor
84151956|NCT02603445|Idelalisib|idelalisib|mesh-list
84151957|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151958|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151959|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151960|NCT02603679|Tamoxifen|tamoxifen|mesh-list
84151961|NCT02603679|Paclitaxel|paclitaxel|mesh-list
84151962|NCT02603679|Letrozole|letrozole|mesh-list
84151963|NCT02603679|Palbociclib|palbociclib|mesh-list
84151964|NCT02603679|Anastrozole|anastrozole|mesh-list
84151965|NCT02603679|Exemestane|exemestane|mesh-list
84151966|NCT02603679|Goserelin|goserelin|mesh-list
84151967|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84151968|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84151969|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84151970|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
84151971|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
84151972|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
84151973|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151975|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151976|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84151977|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
84151978|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84151979|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151980|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84151981|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84151982|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84151983|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84151984|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84151985|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
84151986|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
84151987|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84151988|NCT02605434|Levodopa|levodopa|mesh-list
84151989|NCT02605434|Carbidopa|carbidopa|mesh-list
84151990|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84151991|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84151992|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84151993|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
84151994|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84151995|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84151996|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84151997|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84151998|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84151999|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84152000|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
84152001|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
84152002|NCT00863681|Riociguat|riociguat|mesh-list
84152003|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
84152004|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152005|NCT05758298|Nicotine|nicotine|mesh-list
84152006|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84152007|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
84152008|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152009|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152010|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84152011|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84152012|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
84152013|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152014|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152015|NCT00789321|Amlodipine|amlodipine|mesh-list
84152016|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84152017|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84152018|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152019|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152020|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84152021|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152022|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
84152023|NCT00811928|Fluconazole|fluconazole|mesh-list
84152024|NCT00811928|Posaconazole|posaconazole|mesh-list
84152025|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
84152026|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152027|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84152028|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84152029|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152030|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152031|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84152032|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
84152033|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152034|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152035|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84152036|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84152037|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84152038|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84152039|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84152040|NCT00448669|Tenofovir|tenofovir|mesh-list
84152041|NCT00448669|Emtricitabine|emtricitabine|mesh-list
84152042|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
84152043|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152044|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83424043|NCT01815333|Hematinics|hematinics|mesh-ancestor
84152045|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84152046|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152047|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152048|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84152049|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84152050|NCT00591734|Bevacizumab|bevacizumab|mesh-list
84152051|NCT00591734|Everolimus|everolimus|mesh-list
84152052|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152053|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152054|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84152055|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84152056|NCT00591734|Growth Substances|growth substances|mesh-ancestor
84152057|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152058|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
84152059|NCT00591734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84152060|NCT00591734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84152061|NCT00591734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152062|NCT00591734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152063|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152064|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
84152065|NCT00848549|Carbamazepine|carbamazepine|mesh-list
84152066|NCT00848549|Zonisamide|zonisamide|mesh-list
84152067|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
84152068|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
84152069|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84152070|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152071|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152072|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84152073|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152074|NCT00848549|Analgesics|analgesics|mesh-ancestor
84152075|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
84152076|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152077|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84152078|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152079|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152080|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84152081|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84152082|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84152083|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84152084|NCT00788151|Vaccines|vaccines|mesh-list
84152085|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84152086|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
84152087|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152088|NCT04116359|Cisplatin|cisplatin|mesh-list
84152089|NCT04116359|Etoposide|etoposide|mesh-list
84152090|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
84152091|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
84152092|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152093|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84152094|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84152095|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84152096|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152097|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152098|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
84152099|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152100|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
84152101|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
84152102|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
84152103|NCT04118153|Abatacept|abatacept|mesh-list
84152104|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84152105|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152106|NCT04118153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152107|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152108|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152109|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
84152110|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152111|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152112|NCT00848393|Fentanyl|fentanyl|mesh-list
84152113|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
84152114|NCT00848393|Citric Acid|citric acid|mesh-list
84152115|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
84152116|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84152117|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152118|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152119|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152120|NCT00848393|Analgesics|analgesics|mesh-ancestor
84152121|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
84152122|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152123|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84152124|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84152125|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84152126|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
84152127|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152128|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152129|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84152130|NCT00848393|Narcotics|narcotics|mesh-ancestor
84152131|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84152132|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84152133|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
84152134|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
84152135|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
84152136|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
84152137|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
84152138|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
84152139|NCT00815516|Amphotericin B|amphotericin b|mesh-list
84152140|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
84152141|NCT00815516|Micafungin|micafungin|mesh-list
84152142|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
84152143|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
84152144|NCT00815516|Amebicides|amebicides|mesh-ancestor
84152145|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84152146|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84152147|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152148|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84152149|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
84152150|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84152151|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84152152|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84152153|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
84152154|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152155|NCT00787917|Omalizumab|omalizumab|mesh-list
84152156|NCT00787917|Itraconazole|itraconazole|mesh-list
84152157|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
84152158|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152159|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84152160|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84152161|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152162|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152163|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84152164|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
84152165|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152166|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152167|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84152168|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84152169|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84152170|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
84152171|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
84152172|NCT05758064|Progestins|progestins|mesh-ancestor
84152173|NCT05758064|Hormones|hormones|mesh-ancestor
84152174|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152175|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152176|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84152177|NCT00829244|Hormones|hormones|mesh-ancestor
84152178|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152179|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152180|NCT00787605|Amlodipine|amlodipine|mesh-list
84152181|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84152182|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84152183|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84152184|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152185|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152186|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84152187|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152188|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
84152189|NCT00787605|Diuretics|diuretics|mesh-ancestor
84152190|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
84152191|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84152192|NCT00448591|Bevacizumab|bevacizumab|mesh-list
84152193|NCT00448591|Taxane|taxane|mesh-list
84152194|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152195|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152196|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84152197|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84152198|NCT00448591|Growth Substances|growth substances|mesh-ancestor
84152199|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152200|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
84152201|NCT00787527|Prednisone|prednisone|mesh-list
84152202|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
84152203|NCT00787527|Doxorubicin|doxorubicin|mesh-list
84152204|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84152205|NCT00787527|Vincristine|vincristine|mesh-list
84152206|NCT00787527|Vorinostat|vorinostat|mesh-list
84152207|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152208|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
84152209|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152210|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152211|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84152212|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
84152213|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152214|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152215|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84152216|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84152217|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84152218|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84152219|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152220|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152221|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
84152222|NCT00787527|Hormones|hormones|mesh-ancestor
84152223|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152224|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84152225|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84152226|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
84152227|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
84152228|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
84152229|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84152230|NCT00804388|Vitamin E|vitamin e|mesh-list
84152231|NCT00804388|Vitamins|vitamins|mesh-ancestor
84152232|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
84152233|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152234|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
84152235|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152236|NCT00804388|Protective Agents|protective agents|mesh-ancestor
84152237|NCT00806962|Vaccines|vaccines|mesh-list
84152238|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
84152239|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152240|NCT02553226|Oxytocin|oxytocin|mesh-list
84152241|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
84152242|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84152243|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152244|NCT00810316|Clonazepam|clonazepam|mesh-list
84152245|NCT00810316|Alprazolam|alprazolam|mesh-list
84152246|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84152247|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152248|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152249|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84152250|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84152251|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84152252|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
84152253|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
84152254|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152255|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152256|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
84152257|NCT00448435|Fluticasone|fluticasone|mesh-list
84152258|NCT00448435|Xhance|xhance|mesh-list
84152259|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84152260|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84152261|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152262|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84152263|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
84152264|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152265|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152266|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84152267|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
84152268|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83424270|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152269|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84152270|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84152271|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84152272|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84152273|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
84152274|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152275|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152276|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
84152277|NCT00448435|Hormones|hormones|mesh-ancestor
84152278|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152279|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
84152280|NCT00804622|Tenofovir|tenofovir|mesh-list
84152281|NCT00804622|Telbivudine|telbivudine|mesh-list
84152282|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
84152283|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152284|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84152285|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84152286|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152287|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152288|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84152289|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84152290|NCT02603055|Vaccines|vaccines|mesh-list
84152291|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
84152292|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152293|NCT02602743|Ketamine|ketamine|mesh-list
84152294|NCT02602743|Remifentanil|remifentanil|mesh-list
84152295|NCT02602743|Propofol|propofol|mesh-list
84152296|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84152297|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152298|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152299|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84152300|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
84152301|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
84152302|NCT02602743|Analgesics|analgesics|mesh-ancestor
84152303|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
84152304|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152305|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84152306|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84152307|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84152308|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152309|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152310|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84152311|NCT02602743|Narcotics|narcotics|mesh-ancestor
84152312|NCT00807118|Fesoterodine|fesoterodine|mesh-list
84152313|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84152314|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84152315|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
84152316|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152317|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152318|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152319|NCT00807118|Urological Agents|urological agents|mesh-ancestor
84152320|NCT00448279|Trastuzumab|trastuzumab|mesh-list
84152321|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152322|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152323|NCT00804856|Cytarabine|cytarabine|mesh-list
84152324|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84152325|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
84152326|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152327|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152328|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
84152329|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152330|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152331|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
84152332|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152333|NCT00810706|Exemestane|exemestane|mesh-list
84152334|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152335|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84152336|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84152337|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152338|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152339|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84152340|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
84152341|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152342|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152343|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
84152344|NCT00807196|Rituximab|rituximab|mesh-list
84152345|NCT00807196|Fludarabine|fludarabine|mesh-list
84152346|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152347|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
84152348|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152349|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152350|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84152351|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
84152352|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152353|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152354|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84152355|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152356|NCT00448123|Tamsulosin|tamsulosin|mesh-list
84152357|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84152358|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84152359|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84152360|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
84152361|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152362|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152363|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152364|NCT00448123|Urological Agents|urological agents|mesh-ancestor
84152365|NCT00804934|Ranibizumab|ranibizumab|mesh-list
84152366|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84152367|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84152368|NCT00804934|Growth Substances|growth substances|mesh-ancestor
84152369|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152370|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
84152371|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152372|NCT00805012|Docetaxel|docetaxel|mesh-list
84152373|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152374|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
84152375|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
84152376|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83430350|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
84152377|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152378|NCT00447499|Lanreotide|lanreotide|mesh-list
84152379|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152380|NCT00805090|Itraconazole|itraconazole|mesh-list
84152381|NCT00805090|Diclofenac|diclofenac|mesh-list
84152382|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84152383|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152384|NCT00805090|Analgesics|analgesics|mesh-ancestor
84152385|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
84152386|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152387|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152388|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152389|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152390|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84152391|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152392|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152393|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
84152394|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152395|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84152396|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84152397|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84152398|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
84152399|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152400|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84152401|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
84152402|NCT00810862|Lactitol|lactitol|mesh-list
84152403|NCT00810862|Cathartics|cathartics|mesh-ancestor
84152404|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84152405|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84152406|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152407|NCT00810862|Analgesics|analgesics|mesh-ancestor
84152408|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
84152409|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152410|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152411|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152412|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152413|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152414|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152415|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
84152416|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84152417|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152418|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152419|NCT00800436|Trastuzumab|trastuzumab|mesh-list
84152420|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152421|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152422|NCT00810940|Mannitol|mannitol|mesh-list
84152423|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84152424|NCT00810940|Diuretics|diuretics|mesh-ancestor
84152425|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
84152426|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152427|NCT00655564|Alefacept|alefacept|mesh-list
84152428|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152429|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
84152430|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152431|NCT00447421|Pemetrexed|pemetrexed|mesh-list
84152432|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152433|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152434|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152435|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84152436|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84152437|NCT00651118|Fluticasone|fluticasone|mesh-list
84152438|NCT00651118|Xhance|xhance|mesh-list
84152439|NCT00651118|Azelastine|azelastine|mesh-list
84152440|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152441|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84152442|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
84152443|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152444|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152445|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84152446|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
84152447|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152448|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84152449|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84152450|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152451|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152452|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84152453|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84152454|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
84152455|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
84152456|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152457|NCT00447265|Etanercept|etanercept|mesh-list
84152458|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84152459|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152460|NCT00447265|Analgesics|analgesics|mesh-ancestor
84152461|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
84152462|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152463|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152464|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152465|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152466|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84152467|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152468|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
84152469|NCT03641755|Olaparib|olaparib|mesh-list
84152470|NCT03641755|Sapacitabine|sapacitabine|mesh-list
84152471|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84152472|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152473|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152474|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152475|NCT00657358|Lidocaine|lidocaine|mesh-list
84152476|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
84152477|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
84152478|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152479|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152480|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
84152481|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152482|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84152483|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84152484|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84152485|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152486|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152487|NCT00457639|Cholic Acids|cholic acids|mesh-list
84152488|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84152489|NCT00800202|Paclitaxel|paclitaxel|mesh-list
84152490|NCT00800202|Bevacizumab|bevacizumab|mesh-list
84152491|NCT00800202|Carboplatin|carboplatin|mesh-list
83424493|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84152492|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84152493|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84152494|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152495|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
84152496|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
84152497|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
84152498|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152499|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152500|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84152501|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84152502|NCT00800202|Growth Substances|growth substances|mesh-ancestor
84152503|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152504|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
84152505|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84152506|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152507|NCT00811096|Chloroquine|chloroquine|mesh-list
84152509|NCT00811096|Amebicides|amebicides|mesh-ancestor
84152510|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84152511|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84152512|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152513|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
84152514|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152515|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
84152516|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152517|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84152518|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
84152519|NCT05146804|Sulforaphane|sulforaphane|mesh-list
84152520|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84152521|NCT05146804|Protective Agents|protective agents|mesh-ancestor
84152522|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152523|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152524|NCT00655486|Lacosamide|lacosamide|mesh-list
84152525|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
84152526|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84152527|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84152528|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152529|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152530|NCT04111302|Dezocine|dezocine|mesh-list
84152531|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84152532|NCT04111302|Narcotics|narcotics|mesh-ancestor
84152533|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152534|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152535|NCT04111302|Analgesics|analgesics|mesh-ancestor
84152536|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
84152537|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152538|NCT04111848|Ketamine|ketamine|mesh-list
84152539|NCT04111848|Analgesics|analgesics|mesh-ancestor
84152540|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
84152541|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152542|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152543|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84152544|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84152545|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
84152546|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
84152547|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152548|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84152549|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84152550|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152551|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152552|NCT00457015|Ecallantide|ecallantide|mesh-list
84152553|NCT00457015|Analgesics|analgesics|mesh-ancestor
84152554|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
84152555|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152556|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152557|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84152558|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152559|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152560|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152561|NCT00654940|Pregabalin|pregabalin|mesh-list
84152562|NCT00654940|Analgesics|analgesics|mesh-ancestor
84152563|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
84152564|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152565|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152566|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
83424569|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
84152567|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84152568|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152569|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152570|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84152571|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84152572|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84152573|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152574|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84152575|NCT00588666|Bevacizumab|bevacizumab|mesh-list
84152576|NCT00588666|Carboplatin|carboplatin|mesh-list
84152577|NCT00588666|Gemcitabine|gemcitabine|mesh-list
84152578|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152579|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152580|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84152581|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84152582|NCT00588666|Growth Substances|growth substances|mesh-ancestor
84152583|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152584|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
84152585|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84152586|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
84152587|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152588|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
84152589|NCT00805558|Metronidazole|metronidazole|mesh-list
84152590|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
84152591|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84152592|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84152593|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152594|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84152595|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84152596|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152597|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152598|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152599|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84152600|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
84152601|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84152602|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152603|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84152604|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84152605|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84152606|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84152607|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84152608|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84152609|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84152610|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
84152611|NCT01019785|Vitamin D|vitamin d|mesh-list
84152612|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84152613|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152614|NCT01019785|Vitamins|vitamins|mesh-ancestor
84152615|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
84152616|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84152617|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
84152618|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84152619|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152620|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152621|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
84152622|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152623|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152624|NCT01024543|Phenylephrine|phenylephrine|mesh-list
84152625|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
84152626|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
84152627|NCT01024543|Giapreza|giapreza|mesh-list
84152628|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
84152629|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84152630|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
84152631|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
84152632|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152633|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152634|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
84152635|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84152636|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
84152637|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
84152638|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84152639|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84152640|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84152641|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
84152642|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152643|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152644|NCT01024543|Protective Agents|protective agents|mesh-ancestor
84152645|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84152646|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
84152647|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152648|NCT00811330|Atorvastatin|atorvastatin|mesh-list
84152649|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84152650|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84152651|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
84152652|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152653|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84152654|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84152655|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152657|NCT00811408|Carboplatin|carboplatin|mesh-list
84152658|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152659|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
84152660|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152661|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152662|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152663|NCT00446797|Celecoxib|celecoxib|mesh-list
84152664|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84152665|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152666|NCT00446797|Analgesics|analgesics|mesh-ancestor
84152667|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
84152668|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152669|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152670|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152671|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152672|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84152673|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84152674|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152675|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152676|NCT00855335|Ritonavir|ritonavir|mesh-list
84152677|NCT00855335|Darunavir|darunavir|mesh-list
84152678|NCT00855335|Cobicistat|cobicistat|mesh-list
84152679|NCT00855335|Rilpivirine|rilpivirine|mesh-list
84152680|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
84152681|NCT00855335|Etravirine|etravirine|mesh-list
84152682|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84152683|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84152684|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
84152685|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152686|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152687|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84152688|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84152689|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
84152690|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152691|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84152692|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84152693|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84152694|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84152695|NCT00811486|Spironolactone|spironolactone|mesh-list
84152696|NCT00811486|Conivaptan|conivaptan|mesh-list
84152697|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84152698|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
84152699|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152700|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152701|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84152702|NCT00811486|Diuretics|diuretics|mesh-ancestor
84152703|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
84152704|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
84152705|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152706|NCT04114188|Prednisolone|prednisolone|mesh-list
84152707|NCT04114188|Infliximab|infliximab|mesh-list
84152708|NCT04114188|Tacrolimus|tacrolimus|mesh-list
84152709|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
84152710|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84152711|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
84152712|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84152713|NCT04114188|Antibodies|antibodies|mesh-list
84152714|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152715|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
83424712|NCT00274781|Immunoconjugates|immunoconjugates|mesh-ancestor
84152716|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152717|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84152718|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152719|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152720|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152721|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
84152722|NCT04114188|Hormones|hormones|mesh-ancestor
84152723|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152724|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84152725|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152726|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84152727|NCT04114188|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84152728|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152729|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152730|NCT00811876|Leuprolide|leuprolide|mesh-list
84152731|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84152732|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
84152733|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84152734|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152735|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84152736|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152737|NCT00915252|Cytarabine|cytarabine|mesh-list
84152738|NCT00915252|Azacitidine|azacitidine|mesh-list
84152739|NCT00915252|Daunorubicin|daunorubicin|mesh-list
84152740|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84152741|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
84152742|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152743|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152744|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
84152745|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152746|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152747|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
84152748|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152749|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152750|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84152751|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84152752|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84152753|NCT00593489|Insulin|insulin|mesh-list
84152754|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84152755|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152756|NCT00446641|Cilostazol|cilostazol|mesh-list
84152757|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84152758|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
84152759|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152760|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152761|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84152762|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
84152763|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84152764|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84152765|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152766|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84152767|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
84152768|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84152769|NCT00446641|Protective Agents|protective agents|mesh-ancestor
84152770|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84152771|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84152772|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152773|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
84152774|NCT00646282|Vitamins|vitamins|mesh-ancestor
84152775|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
84152776|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152777|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84152778|NCT00792636|Naproxen|naproxen|mesh-list
84152779|NCT00792636|Sumatriptan|sumatriptan|mesh-list
84152780|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84152781|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84152782|NCT00792636|Analgesics|analgesics|mesh-ancestor
84152783|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
84152784|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152785|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152786|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152787|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152788|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
84152789|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84152790|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152791|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152792|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84152793|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84152794|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84152795|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
84152796|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152797|NCT00446563|Losartan|losartan|mesh-list
84152798|NCT00446563|Amlodipine|amlodipine|mesh-list
84152799|NCT00446563|Valsartan|valsartan|mesh-list
84152800|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84152801|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84152802|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84152803|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152804|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152805|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84152806|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152807|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
84152808|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84152809|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84152810|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84152811|NCT00446563|Diuretics|diuretics|mesh-ancestor
84152812|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
84152813|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84152814|NCT00650806|Canagliflozin|canagliflozin|mesh-list
84152815|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84152816|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152817|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84152818|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152819|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84152820|NCT00863057|Methadone|methadone|mesh-list
84152821|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84152822|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84152823|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152824|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152825|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152826|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152827|NCT00863057|Analgesics|analgesics|mesh-ancestor
84152828|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
84152829|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152830|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
84152831|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84152832|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
84152833|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84152834|NCT00863057|Narcotics|narcotics|mesh-ancestor
84152835|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152836|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
84152837|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
84152838|NCT00814216|Fluticasone|fluticasone|mesh-list
84152839|NCT00814216|Xhance|xhance|mesh-list
84152840|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152841|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84152842|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
84152843|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152844|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152845|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84152846|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
84152847|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152848|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84152849|NCT00829166|Capecitabine|capecitabine|mesh-list
84152850|NCT00829166|Trastuzumab|trastuzumab|mesh-list
84152851|NCT00829166|Lapatinib|lapatinib|mesh-list
84152852|NCT00829166|Maytansine|maytansine|mesh-list
84152853|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
84152854|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84152855|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
84152856|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152857|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152858|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152859|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84152860|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152861|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84152862|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
84152863|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
83424867|NCT01790685|Hormones|hormones|mesh-ancestor
84152864|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
84152865|NCT00829166|Immunotoxins|immunotoxins|mesh-ancestor
84152866|NCT00829166|Immunoconjugates|immunoconjugates|mesh-ancestor
84152867|NCT00829166|Immunologic Factors|immunologic factors|mesh-ancestor
84152868|NCT00829166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152869|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
84152870|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84152871|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152872|NCT00650104|Ropinirole|ropinirole|mesh-list
84152873|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84152874|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84152875|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
84152876|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
84152877|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84152878|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152879|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152880|NCT00808054|Lidocaine|lidocaine|mesh-list
84152881|NCT00808054|Prilocaine|prilocaine|mesh-list
84152882|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
84152883|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
84152884|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152885|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152886|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
84152887|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152888|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84152889|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84152890|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84152891|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84152892|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152893|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
84152894|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
84152895|NCT00814528|Imiquimod|imiquimod|mesh-list
84152896|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84152897|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
84152898|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152899|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152900|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
84152901|NCT00814606|Ribavirin|ribavirin|mesh-list
84152902|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84152903|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
84152904|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152905|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
84152906|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152907|NCT00814762|Vaccines|vaccines|mesh-list
84152908|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
84152909|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152910|NCT00654238|Sorafenib|sorafenib|mesh-list
84152911|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152912|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84152913|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152914|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152915|NCT00862979|Cyclosporine|cyclosporine|mesh-list
84152916|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
84152917|NCT00862979|Everolimus|everolimus|mesh-list
84152918|NCT00862979|Tacrolimus|tacrolimus|mesh-list
84152919|NCT00862979|Cyclosporins|cyclosporins|mesh-list
84152920|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84152921|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
84152922|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152923|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84152924|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152925|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152926|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
84152927|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152928|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152929|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152930|NCT00862979|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84152931|NCT00862979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84152932|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152933|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84152934|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84152935|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
84152936|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84152937|NCT02605356|Dexamethasone|dexamethasone|mesh-list
84152938|NCT02605356|Bortezomib|bortezomib|mesh-list
84152939|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
84152940|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84152941|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
84152942|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
84152943|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152944|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152945|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84152946|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
84152947|NCT02605356|Hormones|hormones|mesh-ancestor
84152948|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152949|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84152950|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152951|NCT00812266|Carboplatin|carboplatin|mesh-list
84152952|NCT00812266|Etoposide|etoposide|mesh-list
84152953|NCT00812266|Topotecan|topotecan|mesh-list
84152954|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152955|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84152956|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84152957|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84152958|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152959|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152960|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84152961|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84152962|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84152963|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
84152964|NCT04113954|Prilocaine|prilocaine|mesh-list
84152965|NCT04113954|Mepivacaine|mepivacaine|mesh-list
84152966|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
84152967|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
84152968|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84152969|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152970|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
84152971|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84152972|NCT00812344|Ketoconazole|ketoconazole|mesh-list
84152973|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
84152974|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152975|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84152976|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84152977|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152978|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152979|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84152980|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
84152981|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84152982|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152983|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84152984|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
84152985|NCT00446251|Rituximab|rituximab|mesh-list
84152986|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84152987|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84152988|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
84152989|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84152990|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84152991|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84152992|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84152993|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
84152994|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84152995|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84152996|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84152997|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84152998|NCT00812422|Ibuprofen|ibuprofen|mesh-list
84152999|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84153000|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84153001|NCT00812422|Analgesics|analgesics|mesh-ancestor
84153002|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
84153003|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153004|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153005|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153006|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153007|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84153008|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153009|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153010|NCT04110834|Itraconazole|itraconazole|mesh-list
84153011|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
84153012|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
84153013|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153014|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84153015|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84153016|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153017|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153018|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84153019|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
84153020|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153021|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153022|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84153023|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
84153024|NCT00812578|Vitamin D|vitamin d|mesh-list
84153025|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84153026|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153027|NCT00812578|Vitamins|vitamins|mesh-ancestor
84153028|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
84153029|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84153030|NCT00796224|Azithromycin|azithromycin|mesh-list
84153031|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84153032|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153033|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
84153034|NCT00808366|Clotrimazole|clotrimazole|mesh-list
84153035|NCT00808366|Miconazole|miconazole|mesh-list
84153036|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
84153037|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153038|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84153039|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84153040|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84153041|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153042|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153043|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84153044|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
84153045|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153046|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153047|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84153048|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84153049|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153050|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
84153051|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84153052|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153053|NCT02551276|Albuterol|albuterol|mesh-list
84153054|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84153055|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
84153056|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153057|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153058|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84153059|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
84153060|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
84153061|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84153062|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84153063|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84153064|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84153065|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
84153066|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153067|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153068|NCT00848081|Tadalafil|tadalafil|mesh-list
84153069|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
84153070|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84153071|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84153072|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153073|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153074|NCT00848081|Urological Agents|urological agents|mesh-ancestor
84153075|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
84153076|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153077|NCT04111380|Paclitaxel|paclitaxel|mesh-list
84153078|NCT04111380|Cisplatin|cisplatin|mesh-list
84153079|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84153080|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153081|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
84153082|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
84153083|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
84153084|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153085|NCT04117919|Triamcinolone|triamcinolone|mesh-list
84153086|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84153087|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84153088|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
84153089|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
84153090|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
84153091|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
84153092|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84153093|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153094|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
84153095|NCT04117919|Hormones|hormones|mesh-ancestor
84153096|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153097|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153098|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153099|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
84153100|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153101|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153102|NCT00701285|Pravastatin|pravastatin|mesh-list
84153103|NCT00701285|Pitavastatin|pitavastatin|mesh-list
84153104|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84153105|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84153106|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
84153107|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153108|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84153109|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84153110|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153111|NCT02604498|Nemonoxacin|nemonoxacin|mesh-list
84153112|NCT02604498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84153113|NCT02604498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153114|NCT00700037|Atorvastatin|atorvastatin|mesh-list
84153115|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84153116|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84153117|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
84153118|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153119|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84153120|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84153121|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153122|NCT00815542|Dinoprostone|dinoprostone|mesh-list
84153123|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
84153124|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84153125|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153126|NCT00791778|Sorafenib|sorafenib|mesh-list
84153127|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153128|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84153129|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153130|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153131|NCT02604576|Bromopride|bromopride|mesh-list
84153132|NCT02604576|Metoclopramide|metoclopramide|mesh-list
84153133|NCT02604576|Simethicone|simethicone|mesh-list
84153134|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
84153135|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153136|NCT02604576|Emollients|emollients|mesh-ancestor
84153137|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153138|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
84153139|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
84153140|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153141|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153142|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84153143|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84153144|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
84153145|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153146|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84153147|NCT04110132|Bupivacaine|bupivacaine|mesh-list
84153148|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
84153149|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
84153150|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153151|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153152|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
84153153|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153154|NCT00795600|Insulin|insulin|mesh-list
84153155|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84153156|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
84153157|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
84153158|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
84153159|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
84153160|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84153161|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153162|NCT00795132|Cyclosporine|cyclosporine|mesh-list
83425163|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
84153163|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
84153164|NCT00795132|Fludarabine|fludarabine|mesh-list
84153165|NCT00795132|Busulfan|busulfan|mesh-list
84153166|NCT00795132|Cyclosporins|cyclosporins|mesh-list
84153167|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
84153168|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84153169|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153170|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153171|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153172|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
84153173|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153174|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153175|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
84153176|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153177|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153178|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153179|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84153180|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84153181|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84153182|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
84153183|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84153184|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
84153185|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84153186|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84153187|NCT02604420|Eculizumab|eculizumab|mesh-list
84153188|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84153189|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153190|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
84153191|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153192|NCT04110210|Morphine|morphine|mesh-list
84153193|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84153194|NCT04110210|Narcotics|narcotics|mesh-ancestor
84153195|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153196|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153197|NCT04110210|Analgesics|analgesics|mesh-ancestor
84153198|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
84153199|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153200|NCT00647296|Pramipexole|pramipexole|mesh-list
84153201|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
84153202|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153203|NCT00647296|Protective Agents|protective agents|mesh-ancestor
84153204|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153205|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84153206|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84153207|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
84153208|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
84153209|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153210|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84153211|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
84153212|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153213|NCT00646906|Aspirin|aspirin|mesh-list
84153214|NCT00646906|Acetaminophen|acetaminophen|mesh-list
84153215|NCT00646906|Ibuprofen|ibuprofen|mesh-list
84153216|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84153217|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84153218|NCT00646906|Analgesics|analgesics|mesh-ancestor
84153219|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
84153220|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153221|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153222|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153223|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153224|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84153225|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84153226|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153227|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84153228|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84153229|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153230|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
84153231|NCT00813436|Oxytocin|oxytocin|mesh-list
84153232|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
84153233|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84153234|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153235|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84153236|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84153237|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84153238|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
84153239|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153240|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84153241|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84153242|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153243|NCT00815854|Folic Acid|folic acid|mesh-list
84153244|NCT00815854|Hematinics|hematinics|mesh-ancestor
84153245|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
84153246|NCT00815854|Vitamins|vitamins|mesh-ancestor
84153247|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
84153248|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153249|NCT00817648|Risperidone|risperidone|mesh-list
84153250|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84153251|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84153252|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
84153253|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153254|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153255|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153256|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84153257|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84153258|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153259|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84153260|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84153261|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
84153262|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
84153263|NCT00829010|Vaccines|vaccines|mesh-list
84153264|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84153265|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
84153266|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153267|NCT00644332|Ranolazine|ranolazine|mesh-list
84153268|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84153269|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153270|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153271|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
84153272|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
84153273|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84153274|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84153275|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153276|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153277|NCT00808912|Urological Agents|urological agents|mesh-ancestor
84153278|NCT02551042|Factor VIII|factor viii|mesh-list
84153279|NCT02551042|Coagulants|coagulants|mesh-ancestor
84153280|NCT00445939|Adalimumab|adalimumab|mesh-list
84153281|NCT00445939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84153282|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153283|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153284|NCT00816244|Atorvastatin|atorvastatin|mesh-list
84153285|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84153286|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84153287|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
84153288|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153289|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84153290|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84153291|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153292|NCT00817960|Methylphenidate|methylphenidate|mesh-list
84153293|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84153294|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153295|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84153296|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84153297|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153298|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153299|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
84153300|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153301|NCT00818038|Natalizumab|natalizumab|mesh-list
84153302|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
84153303|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153304|NCT00482053|Acetaminophen|acetaminophen|mesh-list
84153305|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
84153306|NCT00482053|Promethazine|promethazine|mesh-list
84153307|NCT00482053|Cyclosporine|cyclosporine|mesh-list
84153308|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
84153309|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
84153310|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84153311|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
84153312|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
84153313|NCT00482053|Carmustine|carmustine|mesh-list
84153314|NCT00482053|Rituximab|rituximab|mesh-list
84153315|NCT00482053|Etoposide|etoposide|mesh-list
84153316|NCT00482053|Cyclosporins|cyclosporins|mesh-list
84153317|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84153318|NCT00482053|Lenograstim|lenograstim|mesh-list
84153319|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153320|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
84153321|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153322|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153323|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84153324|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
84153325|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153326|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153327|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84153328|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84153329|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84153330|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84153331|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84153332|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153333|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84153334|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
84153335|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153336|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153337|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84153338|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84153339|NCT00482053|Analgesics|analgesics|mesh-ancestor
84153340|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
84153341|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153342|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
84153343|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84153344|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84153345|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
84153346|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84153347|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153348|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
84153349|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
84153350|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84153351|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
84153352|NCT00482053|Hormones|hormones|mesh-ancestor
84153353|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153354|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84153355|NCT00482053|Protective Agents|protective agents|mesh-ancestor
84153356|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84153357|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84153358|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84153359|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153360|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
84153361|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
84153362|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84153363|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
84153364|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
84153365|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153366|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84153367|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
84153368|NCT00455923|Fluticasone|fluticasone|mesh-list
84153369|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
84153370|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84153371|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
84153372|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153373|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153374|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84153375|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
84153376|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
84153377|NCT00455923|Hormones|hormones|mesh-ancestor
84153378|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153379|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
84153380|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153381|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153382|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84153383|NCT00642616|Insulin|insulin|mesh-list
84153384|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84153385|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153386|NCT00809068|Tibolone|tibolone|mesh-list
84153387|NCT00809068|Fenofibrate|fenofibrate|mesh-list
84153388|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84153389|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
84153390|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153391|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84153392|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
84153393|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
84153394|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153395|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153396|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84153397|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84153398|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153399|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84153400|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
84153401|NCT00809068|Hormones|hormones|mesh-ancestor
84153402|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84153403|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84153404|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
84153405|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
84153406|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84153407|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84153408|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153409|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153410|NCT01027117|Urological Agents|urological agents|mesh-ancestor
84153411|NCT03995563|Dexamethasone|dexamethasone|mesh-list
84153412|NCT03995563|Ropivacaine|ropivacaine|mesh-list
84153413|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153414|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
84153415|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
84153416|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153417|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153418|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84153419|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
84153420|NCT03995563|Hormones|hormones|mesh-ancestor
84153421|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153422|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84153423|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153424|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
84153425|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
84153426|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153427|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
84153428|NCT00445003|Triamcinolone|triamcinolone|mesh-list
84153429|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84153430|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84153431|NCT00445003|Ranibizumab|ranibizumab|mesh-list
84153432|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84153433|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84153434|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84153435|NCT00445003|Growth Substances|growth substances|mesh-ancestor
84153436|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153437|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
84153438|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153439|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153440|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
84153441|NCT00445003|Hormones|hormones|mesh-ancestor
84153442|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153443|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153444|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
84153445|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153446|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153447|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84153448|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84153449|NCT00642460|Methotrexate|methotrexate|mesh-list
84153450|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84153451|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
84153452|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84153453|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153454|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84153455|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
84153456|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153457|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153458|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153459|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153460|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84153461|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153462|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
84153463|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153464|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84153465|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83425467|NCT00299221|Tacrolimus|tacrolimus|mesh-list
84153466|NCT00642460|Analgesics|analgesics|mesh-ancestor
84153467|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
84153468|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153469|NCT00814658|Nimodipine|nimodipine|mesh-list
84153470|NCT00814658|Galantamine|galantamine|mesh-list
84153471|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84153472|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153473|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153474|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
84153475|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153476|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153477|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84153478|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
84153479|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153480|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
84153481|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84153482|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84153483|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153484|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84153485|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
84153486|NCT00816634|Paclitaxel|paclitaxel|mesh-list
84153487|NCT00816634|Capecitabine|capecitabine|mesh-list
84153488|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84153489|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153490|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
84153491|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
84153492|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
84153493|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153494|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84153495|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
84153496|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
84153497|NCT00642304|Hematinics|hematinics|mesh-ancestor
84153498|NCT00814580|Oxycodone|oxycodone|mesh-list
84153499|NCT00814580|Tapentadol|tapentadol|mesh-list
84153500|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84153501|NCT00814580|Narcotics|narcotics|mesh-ancestor
84153502|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153503|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153504|NCT00814580|Analgesics|analgesics|mesh-ancestor
84153505|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
84153506|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153507|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84153508|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84153509|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153510|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153511|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
84153512|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153513|NCT00643162|Escitalopram|escitalopram|mesh-list
84153514|NCT00643162|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84153515|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84153516|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153517|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153518|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153519|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
84153520|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153521|NCT00814502|Zolpidem|zolpidem|mesh-list
84153522|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84153523|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84153524|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153525|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153526|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84153527|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
84153528|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
84153529|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153530|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153531|NCT00653224|Levocetirizine|levocetirizine|mesh-list
84153532|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84153533|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84153534|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
84153535|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
84153536|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153537|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153538|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153539|NCT00444925|Fesoterodine|fesoterodine|mesh-list
84153540|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84153541|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84153542|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84153543|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
84153544|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153545|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153546|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153547|NCT00444925|Urological Agents|urological agents|mesh-ancestor
84153548|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
84153549|NCT00641056|Exenatide|exenatide|mesh-list
84153550|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84153551|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153552|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84153553|NCT00641056|Incretins|incretins|mesh-ancestor
84153554|NCT00641056|Hormones|hormones|mesh-ancestor
84153555|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153556|NCT00569374|Modafinil|modafinil|mesh-list
84153557|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84153558|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153559|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84153560|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84153561|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84153562|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153563|NCT00828464|Clobetasol|clobetasol|mesh-list
84153564|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153565|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
84153566|NCT00828464|Hormones|hormones|mesh-ancestor
84153567|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153568|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153569|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
84153570|NCT00816712|Testosterone|testosterone|mesh-list
84153571|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
84153572|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
84153573|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
84153574|NCT00816712|Androgens|androgens|mesh-ancestor
84153575|NCT00816712|Hormones|hormones|mesh-ancestor
84153576|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153577|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153578|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84153579|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153580|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
84153581|NCT00818194|Cyclosporine|cyclosporine|mesh-list
84153582|NCT00818194|Tacrolimus|tacrolimus|mesh-list
84153583|NCT00818194|Cyclosporins|cyclosporins|mesh-list
84153584|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153585|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
84153586|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153587|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84153588|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153589|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153590|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
84153591|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153592|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153593|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153594|NCT02610686|Chloroquine|chloroquine|mesh-list
84153595|NCT02610686|Amebicides|amebicides|mesh-ancestor
84153596|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84153597|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84153598|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153599|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
84153600|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153601|NCT00816790|Tazobactam|tazobactam|mesh-list
84153602|NCT00816790|Piperacillin|piperacillin|mesh-list
84153603|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84153604|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84153605|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153606|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84153607|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153608|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153609|NCT00818350|Sunitinib|sunitinib|mesh-list
84153610|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153611|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84153612|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84153613|NCT00818350|Growth Substances|growth substances|mesh-ancestor
84153614|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153615|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
84153616|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84153617|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153618|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153619|NCT00810602|Vorinostat|vorinostat|mesh-list
84153620|NCT00810602|Tacrolimus|tacrolimus|mesh-list
84153621|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153622|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
84153623|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153624|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84153625|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153626|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153627|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153628|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84153629|NCT00816868|Capecitabine|capecitabine|mesh-list
84153630|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84153631|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84153632|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
84153633|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153634|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153635|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84153636|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153637|NCT05500586|Glucagon|glucagon|mesh-list
84153638|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84153639|NCT05500586|Hormones|hormones|mesh-ancestor
84153640|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84153641|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153642|NCT00791700|Maraviroc|maraviroc|mesh-list
84153643|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84153644|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84153645|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153646|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84153647|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84153648|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
84153649|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153650|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84153651|NCT00628108|Levocetirizine|levocetirizine|mesh-list
84153652|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84153653|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84153654|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
84153655|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
84153656|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153657|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153658|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153659|NCT00821392|Febuxostat|febuxostat|mesh-list
84153660|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
84153661|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153662|NCT00591578|Valsartan|valsartan|mesh-list
84153663|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84153664|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84153665|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84153666|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84153667|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153668|NCT00797862|Amlodipine|amlodipine|mesh-list
84153669|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84153670|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84153671|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84153672|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153673|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153674|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84153675|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153676|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
84153677|NCT00797862|Diuretics|diuretics|mesh-ancestor
84153678|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
84153679|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84153680|NCT00817258|Cisplatin|cisplatin|mesh-list
84153681|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153682|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
84153683|NCT00794820|Rituximab|rituximab|mesh-list
84153684|NCT00794820|Fludarabine|fludarabine|mesh-list
84153685|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
84153686|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153687|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
84153688|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153689|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153690|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84153691|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
84153692|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153693|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153694|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84153695|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84153696|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84153697|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
84153698|NCT00455533|Paclitaxel|paclitaxel|mesh-list
84153699|NCT00455533|Epothilones|epothilones|mesh-list
84153700|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
84153701|NCT00455533|Doxorubicin|doxorubicin|mesh-list
84153702|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84153703|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153704|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
84153705|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
84153706|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
84153707|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153708|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153709|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
84153710|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153711|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153712|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84153713|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
84153714|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84153715|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84153716|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84153717|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84153718|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153719|NCT00818584|Micafungin|micafungin|mesh-list
84153720|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
84153721|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153722|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
84153723|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153724|NCT00923000|Morphine|morphine|mesh-list
84153725|NCT00923000|Nalbuphine|nalbuphine|mesh-list
84153726|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84153727|NCT00923000|Narcotics|narcotics|mesh-ancestor
84153728|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153729|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153730|NCT00923000|Analgesics|analgesics|mesh-ancestor
84153731|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
84153732|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153733|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
84153734|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153735|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
84153736|NCT00642850|Hematinics|hematinics|mesh-ancestor
84153737|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84153738|NCT00913952|Clomipramine|clomipramine|mesh-list
84153739|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84153740|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
84153741|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84153742|NCT00913952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84153743|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84153744|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153745|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153746|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153747|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
84153748|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153749|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
84153750|NCT04581382|Nivolumab|nivolumab|mesh-list
84153751|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84153752|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153753|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84153754|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153755|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
84153756|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84153757|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84153758|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153759|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
84153760|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
84153761|NCT03840811|Cefixime|cefixime|mesh-list
84153762|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84153763|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153764|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84153765|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84153766|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153767|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153768|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153769|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84153770|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84153772|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
84153773|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
84153774|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153775|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153776|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84153777|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84153778|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84153779|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153780|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84153781|NCT00640510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84153782|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84153783|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153784|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153785|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153786|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
84153787|NCT00913718|Fluoxetine|fluoxetine|mesh-list
84153788|NCT00913718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84153789|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84153790|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153791|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153792|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153793|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
84153794|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153795|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84153796|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
84153797|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84153798|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84153799|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84153800|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153801|NCT00813800|Varenicline|varenicline|mesh-list
84153802|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84153803|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84153804|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
84153805|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153806|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153807|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153808|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
84153809|NCT00627016|Lansoprazole|lansoprazole|mesh-list
84153810|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84153811|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84153812|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84153813|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153814|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153815|NCT00794664|Mipomersen|mipomersen|mesh-list
84153816|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84153817|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84153818|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
84153819|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153820|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84153821|NCT00444535|Bevacizumab|bevacizumab|mesh-list
84153822|NCT00444535|Lapatinib|lapatinib|mesh-list
84153823|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84153824|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153825|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84153826|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84153827|NCT00444535|Growth Substances|growth substances|mesh-ancestor
84153828|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153829|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
84153830|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84153831|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153832|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153833|NCT04110288|Paclitaxel|paclitaxel|mesh-list
84153834|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84153835|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153836|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
84153837|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
84153838|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
84153839|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153840|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
84153841|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84153842|NCT00826306|Protective Agents|protective agents|mesh-ancestor
84153843|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153844|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153845|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
84153846|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
84153847|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153848|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84153849|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84153850|NCT00821782|Azithromycin|azithromycin|mesh-list
84153851|NCT00821782|Levofloxacin|levofloxacin|mesh-list
84153852|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84153853|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153854|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84153855|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84153856|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84153857|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153858|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153859|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153860|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84153861|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84153862|NCT00847613|Tofacitinib|tofacitinib|mesh-list
84153863|NCT00847613|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84153864|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84153865|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153866|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153867|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
84153868|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84153869|NCT00807092|Insulin|insulin|mesh-list
84153870|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84153871|NCT00807092|Metformin|metformin|mesh-list
84153872|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
84153873|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
84153874|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84153875|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84153876|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153877|NCT04112550|Acetaminophen|acetaminophen|mesh-list
84153878|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
84153879|NCT04112550|Oxycodone|oxycodone|mesh-list
84153880|NCT04112550|Methadone|methadone|mesh-list
84153881|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84153882|NCT04112550|Analgesics|analgesics|mesh-ancestor
84153883|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
84153884|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153885|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153886|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
84153887|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84153888|NCT04112550|Narcotics|narcotics|mesh-ancestor
84153889|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153890|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
84153891|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
84153892|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84153893|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153894|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153895|NCT00640042|Morphine|morphine|mesh-list
84153896|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84153897|NCT00640042|Narcotics|narcotics|mesh-ancestor
84153898|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153899|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153900|NCT00640042|Analgesics|analgesics|mesh-ancestor
84153901|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
84153902|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153903|NCT00807014|Adapalene|adapalene|mesh-list
84153904|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84153905|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84153906|NCT00807014|Analgesics|analgesics|mesh-ancestor
84153907|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
84153908|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153909|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153910|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153911|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153912|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
84153913|NCT00794040|Methylphenidate|methylphenidate|mesh-list
84153915|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84153916|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153917|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84153918|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84153919|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153920|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153921|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
84153922|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153923|NCT00794040|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84153924|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
84153925|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84153926|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
84153927|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84153928|NCT04109742|Curcumin|curcumin|mesh-list
84153929|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84153930|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84153931|NCT04109742|Analgesics|analgesics|mesh-ancestor
84153932|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
84153933|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153934|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153935|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153936|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153937|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153938|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84153939|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153940|NCT00813488|Fentanyl|fentanyl|mesh-list
84153941|NCT00813488|Oxycodone|oxycodone|mesh-list
84153942|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84153943|NCT00813488|Narcotics|narcotics|mesh-ancestor
84153944|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84153945|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153946|NCT00813488|Analgesics|analgesics|mesh-ancestor
84153947|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
84153948|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153949|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84153950|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84153951|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
84153952|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
84153953|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84153954|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84153955|NCT00797316|Diuretics|diuretics|mesh-ancestor
84153956|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
84153957|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153958|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84153959|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84153960|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153961|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84153962|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84153963|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84153964|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
84153965|NCT05753696|Losartan|losartan|mesh-list
84153966|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84153967|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84153968|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84153969|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84153970|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84153971|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153972|NCT04107480|Dopamine|dopamine|mesh-list
84153973|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
84153974|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84153975|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
84153976|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
84153977|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153978|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153979|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
84153980|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84153981|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153982|NCT04107480|Protective Agents|protective agents|mesh-ancestor
84153983|NCT00915408|Dexamethasone|dexamethasone|mesh-list
84153984|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
84153985|NCT00915408|Lenalidomide|lenalidomide|mesh-list
84153986|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84153987|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
84153988|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84153989|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84153990|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84153991|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
84153992|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84153993|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84153994|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84153995|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84153996|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
84153997|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
84153998|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84153999|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154000|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
84154001|NCT00915408|Hormones|hormones|mesh-ancestor
84154002|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154003|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84154004|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84154005|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84154006|NCT00915408|Growth Substances|growth substances|mesh-ancestor
84154007|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
84154008|NCT05573724|Itraconazole|itraconazole|mesh-list
84154009|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
84154010|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154011|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84154012|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84154013|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154014|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154015|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84154016|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
84154017|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154018|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154019|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84154020|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
84154021|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154022|NCT00791076|Hormones|hormones|mesh-ancestor
84154023|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154024|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154025|NCT02610062|AGS67E|ags67e|mesh-list
84154026|NCT02610062|Immunoconjugates|immunoconjugates|mesh-ancestor
84154027|NCT02610062|Immunologic Factors|immunologic factors|mesh-ancestor
84154028|NCT02610062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154029|NCT00625378|Sorafenib|sorafenib|mesh-list
84154030|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154031|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84154032|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154033|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154034|NCT00806624|Warfarin|warfarin|mesh-list
84154035|NCT00806624|Edoxaban|edoxaban|mesh-list
84154036|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
84154037|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84154038|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
84154039|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84154040|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
84154041|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154042|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154043|NCT00624832|Omalizumab|omalizumab|mesh-list
84154044|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84154045|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84154046|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
84154047|NCT05753150|Primaquine|primaquine|mesh-list
84154048|NCT05753150|Tafenoquine|tafenoquine|mesh-list
84154049|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
84154050|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84154051|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84154052|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154053|NCT00826852|Carboplatin|carboplatin|mesh-list
84154054|NCT00826852|Docetaxel|docetaxel|mesh-list
84154055|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154056|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
84154057|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
84154058|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
84154059|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154060|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
84154061|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
84154062|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154063|NCT00826930|Protective Agents|protective agents|mesh-ancestor
84154064|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154065|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84154066|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154067|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
84154068|NCT00913796|Diuretics|diuretics|mesh-ancestor
84154069|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
84154070|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154071|NCT00913796|Expectorants|expectorants|mesh-ancestor
84154072|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
84154074|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84154075|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84154076|NCT04029428|Octreotide|octreotide|mesh-list
84154077|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
84154078|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84154079|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154080|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154081|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84154082|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154083|NCT00819520|Ivermectin|ivermectin|mesh-list
84154084|NCT00819520|Malathion|malathion|mesh-list
84154085|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84154086|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430360|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84154087|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84154088|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154089|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154090|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
84154091|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154092|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154093|NCT00631696|Pregabalin|pregabalin|mesh-list
84154094|NCT00631696|Analgesics|analgesics|mesh-ancestor
84154095|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
84154096|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154097|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154098|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
84154099|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84154100|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84154101|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154102|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84154103|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84154104|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84154105|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154106|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84154107|NCT02608112|Methotrexate|methotrexate|mesh-list
84154108|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84154109|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
84154110|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84154111|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154112|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84154113|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
84154114|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154115|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154116|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
84154117|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154118|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84154119|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154120|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
84154121|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154122|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84154123|NCT04375384|Cetuximab|cetuximab|mesh-list
84154124|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154125|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154126|NCT02549326|Vitamin D|vitamin d|mesh-list
84154127|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
84154128|NCT02549326|Vitamins|vitamins|mesh-ancestor
84154129|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
84154130|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154131|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84154132|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84154133|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
84154134|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84154135|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
84154136|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154137|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154138|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84154139|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
84154140|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84154141|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
84154142|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154143|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154144|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84154145|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
84154146|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
84154147|NCT00819676|Protective Agents|protective agents|mesh-ancestor
84154148|NCT00827320|Levetiracetam|levetiracetam|mesh-list
84154149|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
84154150|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
84154151|NCT00819754|Bevacizumab|bevacizumab|mesh-list
84154152|NCT00819754|Capecitabine|capecitabine|mesh-list
84154153|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
84154154|NCT00819754|Irinotecan|irinotecan|mesh-list
84154155|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154156|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154157|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84154158|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84154159|NCT00819754|Growth Substances|growth substances|mesh-ancestor
84154160|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154161|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
84154162|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84154163|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
84154164|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154165|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84154166|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84154167|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154168|NCT00819988|Pregabalin|pregabalin|mesh-list
84154169|NCT00819988|Analgesics|analgesics|mesh-ancestor
84154170|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
84154171|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154172|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154173|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
84154174|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84154175|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84154176|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154177|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84154178|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84154179|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84154180|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154181|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84154182|NCT00827554|Nadroparin|nadroparin|mesh-list
84154183|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
84154184|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84154185|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84154186|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154187|NCT00847145|Vaccines|vaccines|mesh-list
84154188|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
84154189|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154190|NCT00701597|Bosentan|bosentan|mesh-list
84154191|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84154192|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84154193|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154194|NCT00700193|Vaccines|vaccines|mesh-list
84154195|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
84154196|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154197|NCT00846521|Acarbose|acarbose|mesh-list
84154198|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84154199|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154200|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154201|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84154202|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154203|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84154204|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84154205|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84154206|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84154207|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84154208|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
84154209|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154210|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154211|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154212|NCT00862823|Tenofovir|tenofovir|mesh-list
84154213|NCT00862823|Emtricitabine|emtricitabine|mesh-list
84154214|NCT00862823|Efavirenz|efavirenz|mesh-list
84154215|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
84154216|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154217|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84154218|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84154219|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154220|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154221|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84154222|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84154223|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84154224|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84154225|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84154226|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84154227|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84154228|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84154229|NCT00790842|Dexamethasone|dexamethasone|mesh-list
84154230|NCT00790842|Lenalidomide|lenalidomide|mesh-list
84154231|NCT00790842|Heparin|heparin|mesh-list
84154232|NCT00790842|Calcium heparin|calcium heparin|mesh-list
84154233|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84154234|NCT00790842|Tinzaparin|tinzaparin|mesh-list
84154235|NCT00790842|Dalteparin|dalteparin|mesh-list
84154236|NCT00790842|Anticoagulants|anticoagulants|mesh-list
84154237|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154238|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
84154239|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
84154240|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154241|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154242|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154243|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
84154244|NCT00790842|Hormones|hormones|mesh-ancestor
84154245|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154246|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84154247|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154248|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84154249|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84154250|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154251|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
84154252|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84154253|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84154254|NCT00790842|Growth Substances|growth substances|mesh-ancestor
84154255|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
84154256|NCT04104204|Morphine|morphine|mesh-list
84154257|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84154258|NCT04104204|Narcotics|narcotics|mesh-ancestor
84154259|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154260|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154261|NCT04104204|Analgesics|analgesics|mesh-ancestor
84154262|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
84154263|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154264|NCT05572476|Carboplatin|carboplatin|mesh-list
84154265|NCT05572476|Etoposide|etoposide|mesh-list
84154266|NCT05572476|Durvalumab|durvalumab|mesh-list
84154267|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154268|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84154269|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84154270|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84154271|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154272|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154273|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154274|NCT00574288|Dexamethasone|dexamethasone|mesh-list
84154275|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
84154276|NCT00574288|Daratumumab|daratumumab|mesh-list
84154277|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84154278|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154279|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
84154280|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
84154281|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154282|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154283|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154284|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
84154285|NCT00574288|Hormones|hormones|mesh-ancestor
84154286|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154287|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84154288|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154289|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84154290|NCT00574288|Protective Agents|protective agents|mesh-ancestor
84154291|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
84154292|NCT00790452|Aspirin|aspirin|mesh-list
84154293|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84154294|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84154295|NCT00790452|Analgesics|analgesics|mesh-ancestor
84154296|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
84154297|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154298|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154299|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154300|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154301|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84154302|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84154303|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154304|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84154305|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84154306|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154307|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
84154308|NCT00823030|Lidocaine|lidocaine|mesh-list
84154309|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
84154310|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
84154311|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154312|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154313|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
84154314|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154315|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84154316|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84154317|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84154318|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84154319|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154320|NCT00823186|Paclitaxel|paclitaxel|mesh-list
84154321|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84154322|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154323|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
84154324|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
84154325|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
84154326|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154327|NCT00626392|Aspirin|aspirin|mesh-list
84154329|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84154330|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84154331|NCT00626392|Analgesics|analgesics|mesh-ancestor
84154332|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
84154333|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154334|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154335|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154336|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154337|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84154338|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84154339|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154340|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84154341|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84154342|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154343|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
84154344|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84154345|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
84154346|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84154347|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
84154348|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
84154349|NCT00626392|Vitamins|vitamins|mesh-ancestor
84154350|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
84154351|NCT00820690|Paclitaxel|paclitaxel|mesh-list
84154352|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
84154353|NCT00820690|Doxorubicin|doxorubicin|mesh-list
84154354|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84154355|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154356|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
84154357|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
84154358|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
84154359|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154360|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154361|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
84154362|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426363|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154363|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154364|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84154365|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
84154366|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84154367|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84154368|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84154369|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84154370|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154371|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84154372|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154374|NCT00624052|Telmisartan|telmisartan|mesh-list
84154375|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84154376|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84154377|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84154378|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154379|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84154380|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154381|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
84154382|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84154383|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84154384|NCT00821080|Sirolimus|sirolimus|mesh-list
84154385|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84154386|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154387|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84154388|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154389|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
84154390|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154391|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
84154392|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154393|NCT04044430|Nivolumab|nivolumab|mesh-list
84154394|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154395|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154396|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84154397|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154398|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84154399|NCT00821158|Antioxidants|antioxidants|mesh-list
84154400|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154401|NCT00821158|Protective Agents|protective agents|mesh-ancestor
84154402|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154403|NCT00828646|BMS 708163|bms 708163|mesh-list
84154404|NCT00828646|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84154405|NCT00828646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154406|NCT00828646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154407|NCT02548936|Simvastatin|simvastatin|mesh-list
84154408|NCT02548936|Ezetimibe|ezetimibe|mesh-list
84154409|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
84154410|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84154411|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84154412|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
84154413|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154414|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84154415|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84154416|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154417|NCT00828802|Lenalidomide|lenalidomide|mesh-list
84154418|NCT00828802|Decitabine|decitabine|mesh-list
84154419|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
84154420|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154421|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84154422|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84154423|NCT00828802|Growth Substances|growth substances|mesh-ancestor
84154424|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
84154425|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154426|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84154427|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
84154428|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154429|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154430|NCT00785577|Pregabalin|pregabalin|mesh-list
84154431|NCT00785577|Analgesics|analgesics|mesh-ancestor
84154432|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
84154433|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154434|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83426445|NCT00322465|Tinidazole|tinidazole|mesh-list
84154435|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
84154436|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84154437|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84154438|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154439|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84154440|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84154441|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84154442|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154443|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84154444|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
84154445|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84154446|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
84154447|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154448|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
84154449|NCT00830830|Protective Agents|protective agents|mesh-ancestor
84154450|NCT00828958|Risperidone|risperidone|mesh-list
84154451|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84154452|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
84154453|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154454|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154455|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154456|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84154457|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84154458|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154459|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84154460|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84154461|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
84154462|NCT02548780|Doxorubicin|doxorubicin|mesh-list
84154463|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84154464|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154465|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84154466|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84154467|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154468|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154469|NCT04105023|Genistein|genistein|mesh-list
84154470|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84154471|NCT04105023|Protective Agents|protective agents|mesh-ancestor
84154472|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154473|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154474|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84154475|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154476|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154477|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
84154478|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
84154479|NCT04105023|Estrogens|estrogens|mesh-ancestor
84154480|NCT04105023|Hormones|hormones|mesh-ancestor
84154481|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154482|NCT04104867|Domperidone|domperidone|mesh-list
84154483|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
84154484|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
84154485|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154486|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154487|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154488|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84154489|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
84154490|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154491|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154492|NCT00789828|Everolimus|everolimus|mesh-list
84154493|NCT00789828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84154494|NCT00789828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84154495|NCT00789828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154496|NCT00789828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154497|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154498|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
84154499|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154500|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154501|NCT02550262|Fentanyl|fentanyl|mesh-list
84154502|NCT02550262|Bupivacaine|bupivacaine|mesh-list
84154503|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
84154504|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
84154505|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154506|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154507|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
84154508|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83426517|NCT02107339|Methadone|methadone|mesh-list
84154509|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84154510|NCT02550262|Narcotics|narcotics|mesh-ancestor
84154511|NCT02550262|Analgesics|analgesics|mesh-ancestor
84154512|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84154513|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84154514|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
84154515|NCT02550418|Budesonide|budesonide|mesh-list
84154516|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154517|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84154518|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
84154519|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154520|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154521|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84154522|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
84154523|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
84154524|NCT02550418|Hormones|hormones|mesh-ancestor
84154525|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154526|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84154527|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84154528|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84154529|NCT00829114|Estradiol|estradiol|mesh-list
84154530|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84154531|NCT00829114|Estrogens|estrogens|mesh-ancestor
84154532|NCT00829114|Hormones|hormones|mesh-ancestor
84154533|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154534|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154535|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84154536|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
84154537|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84154538|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84154539|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84154540|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84154541|NCT00790296|Hormones|hormones|mesh-list
84154542|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
84154543|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154544|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154545|NCT00829192|Afamelanotide|afamelanotide|mesh-list
84154546|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
84154547|NCT00623194|Insulin|insulin|mesh-list
84154548|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84154549|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
84154550|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
84154551|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84154552|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154553|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84154554|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
84154555|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
84154556|NCT02548468|Fludarabine|fludarabine|mesh-list
84154557|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
84154558|NCT02548468|Tacrolimus|tacrolimus|mesh-list
84154559|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154560|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
84154561|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154562|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154563|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84154564|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
84154565|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154566|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154567|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84154568|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84154569|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
84154570|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154571|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84154572|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154573|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84154574|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84154575|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
84154576|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84154577|NCT00829660|Acarbose|acarbose|mesh-list
84154578|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84154579|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154580|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154581|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84154582|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154583|NCT00915564|Simeprevir|simeprevir|mesh-list
84154584|NCT00915564|Methadone|methadone|mesh-list
83426602|NCT02009449|Vitamins|vitamins|mesh-ancestor
84154585|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84154586|NCT00915564|Narcotics|narcotics|mesh-ancestor
84154587|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154588|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154589|NCT00915564|Analgesics|analgesics|mesh-ancestor
84154590|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
84154591|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154592|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
84154593|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
84154594|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
84154595|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154596|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
84154597|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154598|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154599|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
84154600|NCT02603406|Hematinics|hematinics|mesh-ancestor
84154601|NCT04106700|Apixaban|apixaban|mesh-list
84154602|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84154603|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
84154604|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84154605|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
84154606|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154607|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154608|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
84154609|NCT00831376|Albuterol|albuterol|mesh-list
84154610|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84154611|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
84154612|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154613|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154614|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84154615|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
84154616|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
84154617|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84154618|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84154619|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84154620|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84154621|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
84154622|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154623|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154624|NCT02602470|Metronidazole|metronidazole|mesh-list
84154625|NCT02602470|Azelaic acid|azelaic acid|mesh-list
84154626|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84154627|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154628|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84154629|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84154630|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84154631|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84154632|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84154633|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84154634|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84154635|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
84154636|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154637|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154638|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154639|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154640|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
84154641|NCT00824200|Tamsulosin|tamsulosin|mesh-list
84154642|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
84154643|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
84154644|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
84154645|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84154646|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154647|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154648|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154649|NCT00824200|Urological Agents|urological agents|mesh-ancestor
84154650|NCT00829894|Risperidone|risperidone|mesh-list
84154651|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84154652|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
84154653|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154654|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154655|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154656|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84154657|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84154658|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154659|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84154660|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84154661|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
84154662|NCT00622726|Bevacizumab|bevacizumab|mesh-list
84154663|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154664|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154665|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84154666|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84154667|NCT00622726|Growth Substances|growth substances|mesh-ancestor
84154668|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154669|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
84154670|NCT00830050|Naproxen|naproxen|mesh-list
84154671|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84154672|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84154673|NCT00830050|Analgesics|analgesics|mesh-ancestor
84154674|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
84154675|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154676|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154677|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154678|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154679|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
84154680|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84154681|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154682|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154683|NCT00623428|Ribavirin|ribavirin|mesh-list
84154684|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84154685|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
84154686|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154687|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
84154688|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154689|NCT00824668|Insulin|insulin|mesh-list
84154690|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84154691|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
84154692|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
84154693|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
84154694|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84154695|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
84154696|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84154697|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154698|NCT00832234|Dexamethasone|dexamethasone|mesh-list
84154699|NCT00832234|Rituximab|rituximab|mesh-list
84154700|NCT00832234|Bortezomib|bortezomib|mesh-list
84154701|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154702|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154703|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
84154704|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154705|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154706|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154707|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
84154708|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
84154709|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154710|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154711|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
84154712|NCT00832234|Hormones|hormones|mesh-ancestor
84154713|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154714|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84154715|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
84154716|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
84154717|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154718|NCT05036980|Protective Agents|protective agents|mesh-ancestor
84154719|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154720|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84154721|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154722|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
84154723|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
84154724|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84154725|NCT00837850|Protective Agents|protective agents|mesh-ancestor
84154726|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154727|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84154728|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84154729|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84154730|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154731|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84154732|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84154733|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
83426742|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154734|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154735|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154736|NCT04102566|Ibuprofen|ibuprofen|mesh-list
84154737|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84154738|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84154739|NCT04102566|Analgesics|analgesics|mesh-ancestor
84154740|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
84154741|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154742|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154743|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154744|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154745|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84154746|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154747|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154748|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
84154749|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
84154750|NCT04102176|Protective Agents|protective agents|mesh-ancestor
84154751|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154752|NCT00783432|Azelastine|azelastine|mesh-list
84154753|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84154754|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
84154755|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154756|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154757|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84154758|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
84154759|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84154760|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154761|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154762|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84154763|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84154764|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84154765|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
84154766|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
84154767|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154768|NCT00789360|Loxapine|loxapine|mesh-list
84154769|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84154770|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84154771|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154772|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154773|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84154774|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84154775|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
84154776|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154777|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154778|NCT05526924|Fluorouracil|fluorouracil|mesh-list
84154779|NCT05526924|Tislelizumab|tislelizumab|mesh-list
84154780|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
84154781|NCT05526924|Pamiparib|pamiparib|mesh-list
84154782|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
84154783|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154784|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84154785|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154786|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154787|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
84154788|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154789|NCT05526924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154790|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
84154791|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154792|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84154793|NCT05526924|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84154794|NCT00782418|Exenatide|exenatide|mesh-list
84154795|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84154796|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154797|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84154798|NCT00782418|Incretins|incretins|mesh-ancestor
84154799|NCT00782418|Hormones|hormones|mesh-ancestor
84154800|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154801|NCT00782340|Droxidopa|droxidopa|mesh-list
84154802|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84154803|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84154804|NCT00774852|Prednisone|prednisone|mesh-list
84154805|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
84154806|NCT00774852|Abatacept|abatacept|mesh-list
84154807|NCT00774852|Azathioprine|azathioprine|mesh-list
84154808|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154809|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
84154810|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154811|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154812|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84154813|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
84154814|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154815|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154816|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84154817|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154818|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
84154819|NCT00774852|Hormones|hormones|mesh-ancestor
84154820|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154821|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84154822|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84154823|NCT00774852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84154824|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
84154825|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84154826|NCT00774306|Phenytoin|phenytoin|mesh-list
84154827|NCT00774306|Levetiracetam|levetiracetam|mesh-list
84154828|NCT00774306|Valproic Acid|valproic acid|mesh-list
84154829|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
84154830|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
84154831|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154832|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154833|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
84154834|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154835|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154836|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
84154837|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84154838|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154839|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84154840|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84154841|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84154842|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84154843|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84154844|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84154845|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
84154846|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84154847|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
84154848|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154849|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
84154850|NCT04105920|Protective Agents|protective agents|mesh-ancestor
84154851|NCT04105764|Bromides|bromides|mesh-list
84154852|NCT04105764|Rocuronium|rocuronium|mesh-list
84154853|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
84154854|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
84154855|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84154856|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84154857|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154858|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154859|NCT00781326|Nimodipine|nimodipine|mesh-list
84154860|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84154861|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84154862|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84154863|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154864|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84154865|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154866|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
84154867|NCT00773838|Dexamethasone|dexamethasone|mesh-list
84154868|NCT00773838|Bortezomib|bortezomib|mesh-list
84154869|NCT00773838|Vorinostat|vorinostat|mesh-list
84154870|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154871|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
84154872|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
84154873|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154874|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154875|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154876|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
84154877|NCT00773838|Hormones|hormones|mesh-ancestor
84154878|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84154879|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84154880|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154881|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84154882|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154883|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154884|NCT00787644|Pioglitazone|pioglitazone|mesh-list
84154885|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84154886|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154887|NCT02602002|Remifentanil|remifentanil|mesh-list
84154888|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84154889|NCT02602002|Narcotics|narcotics|mesh-ancestor
84154890|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154891|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154892|NCT02602002|Analgesics|analgesics|mesh-ancestor
84154893|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
84154894|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154895|NCT00787566|Granisetron|granisetron|mesh-list
84154896|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
84154897|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
84154898|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154899|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154900|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154901|NCT00787566|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83430368|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
84154902|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84154903|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
84154904|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154905|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154906|NCT02602938|Aspirin|aspirin|mesh-list
84154907|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84154908|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84154909|NCT02602938|Analgesics|analgesics|mesh-ancestor
84154910|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
84154911|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154912|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154913|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84154914|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154915|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84154916|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84154917|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154918|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84154919|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84154920|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154921|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
84154922|NCT00787254|Lansoprazole|lansoprazole|mesh-list
84154923|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
84154924|NCT00787254|Gefarnate|gefarnate|mesh-list
84154925|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84154926|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84154927|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84154928|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154929|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154930|NCT00922402|Insulin|insulin|mesh-list
84154931|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84154932|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154933|NCT02550028|Levetiracetam|levetiracetam|mesh-list
84154934|NCT02550028|Phenobarbital|phenobarbital|mesh-list
84154935|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
84154936|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
84154937|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84154938|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154939|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154940|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84154941|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84154942|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84154943|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154944|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
84154945|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
84154946|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84154947|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84154948|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84154949|NCT04105374|Flucytosine|flucytosine|mesh-list
84154950|NCT04105374|Temozolomide|temozolomide|mesh-list
84154951|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84154952|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
84154953|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154954|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154955|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
84154956|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154957|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
84154958|NCT04102878|Anesthetics|anesthetics|mesh-list
83426967|NCT00360685|Tacrolimus|tacrolimus|mesh-list
84154959|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
84154960|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84154961|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154962|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
84154963|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154964|NCT00838240|Cytarabine|cytarabine|mesh-list
84154965|NCT00838240|Clofarabine|clofarabine|mesh-list
84154966|NCT00838240|Idarubicin|idarubicin|mesh-list
84154967|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84154968|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
84154969|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154970|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84154971|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
84154972|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154973|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154974|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
84154975|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154976|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84154977|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84154978|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84154979|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154980|NCT00773292|Cyclosporine|cyclosporine|mesh-list
84154981|NCT00773292|Cyclosporins|cyclosporins|mesh-list
84154982|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84154983|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84154984|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84154985|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
84154986|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154987|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
84154988|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84154989|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
84154990|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84154991|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84154992|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
84154993|NCT00838396|Baclofen|baclofen|mesh-list
84154994|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84154995|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84154996|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84154997|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84154998|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
84154999|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
84155000|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
84155001|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155002|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155003|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
84155004|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155005|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155006|NCT00833326|Docetaxel|docetaxel|mesh-list
84155007|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
84155008|NCT00833326|Mitogens|mitogens|mesh-list
84155009|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155010|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
84155011|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
84155012|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155013|NCT00833404|Nicotine|nicotine|mesh-list
84155014|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84155015|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
84155016|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155017|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155018|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84155019|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84155020|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
84155021|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155022|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155023|NCT00621322|Vaccines|vaccines|mesh-list
84155024|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
84155025|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155026|NCT00839488|Pantoprazole|pantoprazole|mesh-list
84155027|NCT00839488|Famotidine|famotidine|mesh-list
84155028|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84155029|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155030|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84155031|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155032|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155033|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83427049|NCT00403117|Naltrexone|naltrexone|mesh-list
84155034|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
84155035|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
84155036|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155037|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155038|NCT00834184|Nikkomycin|nikkomycin|mesh-list
84155039|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
84155040|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155041|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155042|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155043|NCT00834262|Insulin|insulin|mesh-list
84155044|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84155045|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
84155046|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
84155047|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
84155048|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
84155049|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84155050|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84155051|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155052|NCT00853385|Adalimumab|adalimumab|mesh-list
84155053|NCT00853385|Tofacitinib|tofacitinib|mesh-list
84155054|NCT00853385|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84155055|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155056|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155057|NCT00853385|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84155058|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155059|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155060|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155061|NCT00622336|Lenalidomide|lenalidomide|mesh-list
84155062|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
84155063|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155064|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84155065|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84155066|NCT00622336|Growth Substances|growth substances|mesh-ancestor
84155067|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
84155068|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155069|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84155070|NCT00846365|Olmesartan|olmesartan|mesh-list
84155071|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84155072|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
84155073|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84155074|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84155075|NCT00846365|Diuretics|diuretics|mesh-ancestor
84155076|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
84155077|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155078|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84155079|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155080|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155081|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84155082|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84155083|NCT00834730|Ketamine|ketamine|mesh-list
84155084|NCT00834730|Analgesics|analgesics|mesh-ancestor
84155085|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
84155086|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155087|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155088|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84155089|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84155090|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
84155091|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
84155092|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155093|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84155094|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84155095|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155096|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155097|NCT02601924|Anesthetics|anesthetics|mesh-list
84155098|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
84155099|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155100|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155101|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
84155102|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155103|NCT00840112|Vitamin E|vitamin e|mesh-list
84155104|NCT00840112|Tocopherols|tocopherols|mesh-list
84155105|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
84155106|NCT00840112|Vitamins|vitamins|mesh-ancestor
84155107|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
84155108|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155109|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
84155110|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155111|NCT00840112|Protective Agents|protective agents|mesh-ancestor
84155113|NCT04101474|Analgesics|analgesics|mesh-ancestor
84155114|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
84155115|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155116|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155117|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84155118|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84155119|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
84155120|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
84155121|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155122|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84155123|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84155124|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155125|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155126|NCT04101708|Amoxicillin|amoxicillin|mesh-list
84155127|NCT04101708|Clarithromycin|clarithromycin|mesh-list
84155128|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
84155129|NCT04101708|Lansoprazole|lansoprazole|mesh-list
84155130|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
84155131|NCT04101708|Bismuth|bismuth|mesh-list
84155132|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155133|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155134|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84155135|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155136|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155137|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84155138|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84155139|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84155140|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155141|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84155142|NCT04101708|Antacids|antacids|mesh-ancestor
84155143|NCT00779142|Methotrexate|methotrexate|mesh-list
84155144|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84155145|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
84155146|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84155147|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155148|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84155149|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
84155150|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155151|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155152|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
84155153|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155154|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84155155|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155156|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
84155157|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155158|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84155159|NCT00840346|Panobinostat|panobinostat|mesh-list
84155160|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155161|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84155162|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155163|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155164|NCT04105140|Oxytocin|oxytocin|mesh-list
84155165|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
84155166|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84155167|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155168|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
84155169|NCT00840580|Levofloxacin|levofloxacin|mesh-list
84155170|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84155171|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84155172|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84155173|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155174|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155175|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84155176|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84155177|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155178|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155179|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83427192|NCT04523961|Lidocaine|lidocaine|mesh-list
83427193|NCT04523961|Tetracaine|tetracaine|mesh-list
84155180|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84155181|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
84155182|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84155183|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155184|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84155185|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84155186|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84155187|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84155188|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84155189|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84155190|NCT00773136|Bimatoprost|bimatoprost|mesh-list
84155191|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84155192|NCT02602860|Levetiracetam|levetiracetam|mesh-list
84155193|NCT02602860|Brivaracetam|brivaracetam|mesh-list
84155194|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
84155195|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
84155196|NCT00825058|Paroxetine|paroxetine|mesh-list
84155197|NCT00825058|Amibegron|amibegron|mesh-list
84155198|NCT00825058|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
84155199|NCT00825058|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84155200|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84155201|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155202|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155203|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155204|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
84155205|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155206|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84155207|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
84155208|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84155209|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84155210|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84155211|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155212|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84155213|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84155214|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
84155215|NCT00825058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
84155216|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
84155217|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84155218|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155219|NCT00835744|Clomiphene|clomiphene|mesh-list
84155220|NCT00835744|Enclomiphene|enclomiphene|mesh-list
84155221|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
84155222|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84155223|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
84155224|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155225|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155226|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84155227|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
84155228|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84155229|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84155230|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84155231|NCT00778830|Cetuximab|cetuximab|mesh-list
84155232|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84155233|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155234|NCT00772668|Prednisone|prednisone|mesh-list
84155235|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
84155236|NCT00772668|Rituximab|rituximab|mesh-list
84155237|NCT00772668|Bortezomib|bortezomib|mesh-list
84155238|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155239|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
84155240|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155241|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155242|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84155243|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
84155244|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155245|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155246|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84155247|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84155248|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155249|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
84155250|NCT00772668|Hormones|hormones|mesh-ancestor
84155251|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155252|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84155253|NCT00786474|Dalteparin|dalteparin|mesh-list
84155254|NCT00786474|Tinzaparin|tinzaparin|mesh-list
84155255|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84155256|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
84155258|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84155259|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155260|NCT00784875|Zolpidem|zolpidem|mesh-list
84155261|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84155262|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84155263|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155264|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155265|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84155266|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
84155267|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
84155268|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155269|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155270|NCT00701909|Ketamine|ketamine|mesh-list
84155271|NCT00701909|Morphine|morphine|mesh-list
84155272|NCT00701909|Analgesics|analgesics|mesh-ancestor
84155273|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
84155274|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155275|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155276|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84155277|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84155278|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
84155279|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
84155280|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155281|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84155282|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84155283|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155284|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155285|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84155286|NCT00701909|Narcotics|narcotics|mesh-ancestor
84155287|NCT00699023|Simvastatin|simvastatin|mesh-list
84155288|NCT00699023|Ezetimibe|ezetimibe|mesh-list
84155289|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84155290|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84155291|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
84155292|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155293|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84155294|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84155295|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155296|NCT00853229|Pregabalin|pregabalin|mesh-list
84155297|NCT00853229|Analgesics|analgesics|mesh-ancestor
84155298|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
84155299|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155300|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155301|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
84155302|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84155303|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155304|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155305|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84155306|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84155307|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84155308|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155309|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84155310|NCT00853073|Bevacizumab|bevacizumab|mesh-list
84155311|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84155312|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155313|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84155314|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84155315|NCT00853073|Growth Substances|growth substances|mesh-ancestor
84155316|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155317|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
84155318|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
84155319|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84155320|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155321|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155322|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
84155323|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155324|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155325|NCT04120337|Lidocaine|lidocaine|mesh-list
84155326|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
84155327|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
84155328|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155329|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155330|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
84155331|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155332|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84155333|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84155334|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84155335|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155336|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155337|NCT00592319|Celecoxib|celecoxib|mesh-list
84155338|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84155339|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84155340|NCT00592319|Analgesics|analgesics|mesh-ancestor
84155341|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
84155342|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155343|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155344|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155345|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155346|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84155347|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84155348|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155349|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155350|NCT00862121|Mesalamine|mesalamine|mesh-list
84155351|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84155352|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84155353|NCT00862121|Analgesics|analgesics|mesh-ancestor
84155354|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
84155355|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155356|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155357|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155358|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155359|NCT00784719|Cyclosporine|cyclosporine|mesh-list
84155360|NCT00784719|Cyclosporins|cyclosporins|mesh-list
84155361|NCT00784719|Tofacitinib|tofacitinib|mesh-list
84155362|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155363|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155364|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155365|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
84155366|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155367|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
84155368|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155369|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
84155370|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155371|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84155372|NCT00784719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84155373|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155374|NCT00852917|Tramadol|tramadol|mesh-list
84155375|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84155376|NCT00852917|Narcotics|narcotics|mesh-ancestor
84155377|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155378|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155379|NCT00852917|Analgesics|analgesics|mesh-ancestor
84155380|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
84155381|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155382|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84155383|NCT00700583|Terazosin|terazosin|mesh-list
84155384|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84155385|NCT00700583|Diuretics|diuretics|mesh-ancestor
84155386|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
84155387|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155388|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84155389|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155390|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155391|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84155392|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84155393|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84155394|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
84155395|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155396|NCT00700583|Urological Agents|urological agents|mesh-ancestor
84155397|NCT00913055|Octreotide|octreotide|mesh-list
84155398|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155399|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84155400|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155401|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84155402|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84155403|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155404|NCT00845429|Vaccines|vaccines|mesh-list
84155405|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
84155406|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155407|NCT00844883|Sorafenib|sorafenib|mesh-list
84155408|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155409|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155410|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155411|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155412|NCT00851903|Metformin|metformin|mesh-list
84155413|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
84155414|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84155415|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84155416|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155417|NCT00851903|Incretins|incretins|mesh-ancestor
84155418|NCT00851903|Hormones|hormones|mesh-ancestor
84155419|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155420|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84155421|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
84155422|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155423|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155424|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
84155425|NCT00587457|Immunotoxins|immunotoxins|mesh-ancestor
84155426|NCT00587457|Immunoconjugates|immunoconjugates|mesh-ancestor
84155427|NCT00587457|Immunologic Factors|immunologic factors|mesh-ancestor
84155428|NCT00587457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155429|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155430|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
84155431|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84155432|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155433|NCT04099563|Abrocitinib|abrocitinib|mesh-list
84155434|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155435|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155436|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155437|NCT00767325|Methotrexate|methotrexate|mesh-list
84155438|NCT00767325|Abatacept|abatacept|mesh-list
84155439|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84155440|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
84155441|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84155442|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155443|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84155444|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
84155445|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155446|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155447|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
84155448|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155449|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84155450|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155451|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
84155452|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155453|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84155454|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84155455|NCT00767325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84155456|NCT00851591|Psyllium|psyllium|mesh-list
84155457|NCT00851591|Cathartics|cathartics|mesh-ancestor
84155458|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155459|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
84155460|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84155461|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155462|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155463|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84155464|NCT02612363|Analgesics|analgesics|mesh-ancestor
84155465|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
84155466|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155467|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84155468|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84155469|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84155470|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
84155471|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155472|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155473|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
84155474|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
84155475|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
84155476|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84155477|NCT00912899|Noscapine|noscapine|mesh-list
84155478|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
84155479|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
84155480|NCT00700895|Warfarin|warfarin|mesh-list
84155481|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
84155482|NCT00861341|Aspirin|aspirin|mesh-list
84155483|NCT00861341|Pioglitazone|pioglitazone|mesh-list
84155484|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84155485|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84155486|NCT00861341|Analgesics|analgesics|mesh-ancestor
84155487|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
84155488|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155489|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155490|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155491|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155492|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84155493|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84155494|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155495|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84155496|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84155497|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155498|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
84155499|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84155500|NCT00766467|Modafinil|modafinil|mesh-list
84155501|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84155502|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155503|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84155504|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84155505|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84155506|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155507|NCT00850499|Rituximab|rituximab|mesh-list
84155508|NCT00850499|Fludarabine|fludarabine|mesh-list
84155509|NCT00850499|Bortezomib|bortezomib|mesh-list
84155510|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84155511|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155512|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
84155513|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155514|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155515|NCT00844805|Infliximab|infliximab|mesh-list
84155516|NCT00844805|Naproxen|naproxen|mesh-list
84155517|NCT00844805|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84155518|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155519|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
84155520|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155521|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155522|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84155523|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84155524|NCT00844805|Analgesics|analgesics|mesh-ancestor
84155525|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
84155526|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155527|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155528|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
84155529|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84155530|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155531|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155532|NCT00765999|Linaclotide|linaclotide|mesh-list
84155533|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84155534|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
84155535|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155536|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155537|NCT04099407|Pirfenidone|pirfenidone|mesh-list
84155538|NCT04099407|Analgesics|analgesics|mesh-ancestor
84155539|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
84155540|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155541|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155542|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84155543|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84155544|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155545|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155546|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155547|NCT00765063|Dalteparin|dalteparin|mesh-list
84155548|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
84155549|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84155550|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84155551|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155552|NCT00764751|Calcipotriene|calcipotriene|mesh-list
84155553|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
84155554|NCT00764517|Rituximab|rituximab|mesh-list
84155555|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84155556|NCT00764517|Vorinostat|vorinostat|mesh-list
84155557|NCT00764517|Cladribine|cladribine|mesh-list
84155558|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
84155559|NCT00764517|Antibodies|antibodies|mesh-list
84155560|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
84155561|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84155562|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
84155563|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155564|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155565|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155566|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84155567|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155568|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155569|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155570|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84155571|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
84155572|NCT00764361|Doxycycline|doxycycline|mesh-list
84155573|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155574|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155575|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
84155576|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84155577|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84155578|NCT00763971|Methylphenidate|methylphenidate|mesh-list
84155579|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84155580|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84155581|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155582|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84155583|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84155584|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155585|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155586|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
84155587|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155588|NCT00763815|Metformin|metformin|mesh-list
84155589|NCT00763815|Pioglitazone|pioglitazone|mesh-list
84155590|NCT00763815|Lixisenatide|lixisenatide|mesh-list
84155591|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84155592|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155593|NCT00763269|Silicon|silicon|mesh-list
84155594|NCT00763269|Triclosan|triclosan|mesh-list
84155595|NCT00763269|Fluorides|fluorides|mesh-list
84155596|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
84155597|NCT00763269|Protective Agents|protective agents|mesh-ancestor
84155598|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155599|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84155600|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155601|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84155602|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84155603|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
84155604|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155605|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84155606|NCT00763269|Trace Elements|trace elements|mesh-ancestor
84155607|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
84155608|NCT00763035|Dobutamine|dobutamine|mesh-list
84155609|NCT00763035|Regadenoson|regadenoson|mesh-list
84155610|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84155611|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
84155612|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
84155613|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155614|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155615|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84155616|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84155617|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84155618|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
84155619|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155620|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155621|NCT00763035|Protective Agents|protective agents|mesh-ancestor
84155622|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
84155623|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84155624|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
84155625|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
84155626|NCT00844649|Paclitaxel|paclitaxel|mesh-list
84155627|NCT00844649|Gemcitabine|gemcitabine|mesh-list
84155628|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84155629|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84155630|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155631|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
84155632|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
84155633|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
84155634|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155635|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84155636|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
84155637|NCT04098861|Timolol|timolol|mesh-list
84155638|NCT04098861|Latanoprost|latanoprost|mesh-list
84155639|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84155640|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84155641|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
84155642|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155643|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155644|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155645|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84155646|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84155647|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84155648|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84155649|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
84155650|NCT00850343|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84155651|NCT00850343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155652|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155653|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
84155654|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155655|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155656|NCT00849875|Dacarbazine|dacarbazine|mesh-list
84155657|NCT00849875|Imidazole|imidazole|mesh-list
84155658|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84155659|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
84155660|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155661|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155662|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155663|NCT00844415|Dabigatran|dabigatran|mesh-list
84155664|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
84155665|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84155666|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
84155667|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155668|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155669|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
84155670|NCT00843635|Tadalafil|tadalafil|mesh-list
84155671|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
84155672|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84155673|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84155674|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155675|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155676|NCT00843635|Urological Agents|urological agents|mesh-ancestor
84155677|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
84155678|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
84155679|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84155680|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84155681|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155682|NCT04116827|Tamoxifen|tamoxifen|mesh-list
84155683|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84155684|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
84155685|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155686|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155687|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84155688|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155689|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84155690|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84155691|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84155692|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
84155693|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84155694|NCT00849017|Incretins|incretins|mesh-ancestor
84155695|NCT00849017|Hormones|hormones|mesh-ancestor
84155696|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155697|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155698|NCT00842309|Cycloserine|cycloserine|mesh-list
84155699|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84155700|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155701|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84155702|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
84155703|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155704|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
84155705|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155707|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155708|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
84155709|NCT00842153|Hormones|hormones|mesh-ancestor
84155710|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155711|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155712|NCT00762411|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
84155713|NCT00762411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
84155714|NCT00762411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155715|NCT00762411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155716|NCT00841763|Vaccines|vaccines|mesh-list
84155717|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
84155718|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155719|NCT05603429|Antioxidants|antioxidants|mesh-list
84155720|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155721|NCT05603429|Protective Agents|protective agents|mesh-ancestor
84155722|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155723|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84155724|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
84155725|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155726|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
84155727|NCT02602704|Calcium|calcium|mesh-list
84155728|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84155729|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155730|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84155731|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84155732|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
84155733|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155734|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84155735|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
84155736|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
84155737|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
84155738|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
84155739|NCT00703313|Levofloxacin|levofloxacin|mesh-list
84155740|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
84155741|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84155742|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84155743|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84155744|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155745|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155746|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84155747|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84155748|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155749|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155750|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155751|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84155752|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
84155753|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84155754|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155755|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84155756|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84155757|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84155758|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84155759|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84155760|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84155761|NCT00703079|Octreotide|octreotide|mesh-list
84155762|NCT00703079|Lanreotide|lanreotide|mesh-list
84155763|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155764|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84155765|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155766|NCT00840827|Cyclosporine|cyclosporine|mesh-list
84155767|NCT00840827|Lenalidomide|lenalidomide|mesh-list
84155768|NCT00840827|Cyclosporins|cyclosporins|mesh-list
84155769|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155770|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155771|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155772|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
84155773|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155774|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
84155775|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155776|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
84155777|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155778|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84155779|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84155780|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84155781|NCT00840827|Growth Substances|growth substances|mesh-ancestor
84155782|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
84155783|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155785|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84155786|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155787|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84155788|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155789|NCT02612207|Bilirubin|bilirubin|mesh-list
84155790|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
84155791|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155792|NCT02612207|Protective Agents|protective agents|mesh-ancestor
84155793|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155794|NCT00859937|Dasatinib|dasatinib|mesh-list
84155795|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155796|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155797|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155798|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155799|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84155800|NCT04030715|Bismuth|bismuth|mesh-list
84155801|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155802|NCT04030715|Antacids|antacids|mesh-ancestor
84155803|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155804|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84155805|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84155806|NCT00592007|Fulvestrant|fulvestrant|mesh-list
84155807|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155808|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155809|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155810|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155811|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84155812|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84155813|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84155814|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
84155815|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155816|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155817|NCT00591851|Paclitaxel|paclitaxel|mesh-list
84155818|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
84155819|NCT00591851|Doxorubicin|doxorubicin|mesh-list
84155820|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84155821|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84155822|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155823|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
84155824|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
84155825|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
84155826|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155827|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155828|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
84155829|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155830|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155831|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84155832|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
84155833|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84155834|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84155835|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84155836|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84155837|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155838|NCT00839423|Vortioxetine|vortioxetine|mesh-list
84155839|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84155840|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84155841|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84155842|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84155843|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155844|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155845|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155846|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84155847|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
84155848|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84155849|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84155850|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84155851|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155852|NCT00839423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84155853|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
84155854|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84155855|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84155856|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84155857|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84155858|NCT00859469|Gemcitabine|gemcitabine|mesh-list
84155859|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
84155860|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84155861|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
84155862|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155863|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155864|NCT00703625|Sirolimus|sirolimus|mesh-list
84155865|NCT00703625|Docetaxel|docetaxel|mesh-list
84155866|NCT00703625|Temsirolimus|temsirolimus|mesh-list
84155867|NCT00703625|MTOR Inhibitors|mtor inhibitors|mesh-list
84155868|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155869|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
84155870|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
84155871|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
84155872|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155873|NCT00703625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155874|NCT00703625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155875|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155876|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
84155877|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155878|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155879|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155880|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84155881|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
84155882|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84155883|NCT00703703|Darifenacin|darifenacin|mesh-list
84155884|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84155885|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84155886|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
84155887|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84155888|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155889|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155890|NCT00703703|Urological Agents|urological agents|mesh-ancestor
84155891|NCT00859313|Sufentanil|sufentanil|mesh-list
84155892|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84155893|NCT00859313|Narcotics|narcotics|mesh-ancestor
84155894|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84155895|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155896|NCT00859313|Analgesics|analgesics|mesh-ancestor
84155897|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
84155898|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155899|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84155900|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84155901|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
84155902|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
84155903|NCT02611973|Aspirin|aspirin|mesh-list
84155904|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
84155905|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84155906|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84155907|NCT02611973|Analgesics|analgesics|mesh-ancestor
84155908|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
84155909|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155910|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155911|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84155912|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84155913|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84155914|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84155915|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155916|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84155917|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84155918|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155919|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
84155920|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155921|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
83427941|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
84155922|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84155923|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
84155924|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84155925|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
84155926|NCT00836927|Sirolimus|sirolimus|mesh-list
84155927|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84155928|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155929|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84155930|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155931|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
84155932|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84155933|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
84155934|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155935|NCT00703235|Bevacizumab|bevacizumab|mesh-list
84155936|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84155937|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155938|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84155939|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84155940|NCT00703235|Growth Substances|growth substances|mesh-ancestor
84155941|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155942|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
84155943|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84155944|NCT00771030|Brodalumab|brodalumab|mesh-list
84155945|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
84155946|NCT00768300|Ambrisentan|ambrisentan|mesh-list
84155947|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84155948|NCT00768222|Triclosan|triclosan|mesh-list
84155949|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84155950|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155951|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84155952|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84155953|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
84155954|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155955|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84155956|NCT00768144|Sunitinib|sunitinib|mesh-list
84155957|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155958|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84155959|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84155960|NCT00768144|Growth Substances|growth substances|mesh-ancestor
84155961|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155962|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
84155963|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155964|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155965|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155966|NCT00784836|Interferons|interferons|mesh-list
84155967|NCT00784836|Interferon-beta|interferon-beta|mesh-list
84155968|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
84155969|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155970|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
84155971|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84155972|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
84155973|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155974|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84155975|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
84155976|NCT04104984|Progesterone|progesterone|mesh-list
84155977|NCT04104984|Progestins|progestins|mesh-ancestor
84155978|NCT04104984|Hormones|hormones|mesh-ancestor
84155979|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155980|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155981|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84155982|NCT00767520|Dasatinib|dasatinib|mesh-list
84155983|NCT00767520|Exemestane|exemestane|mesh-list
84155984|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84155985|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84155986|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84155987|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84155988|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84155989|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84155990|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84155991|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
84155992|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84155993|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155994|NCT00858845|Clonidine|clonidine|mesh-list
84155995|NCT00858845|Analgesics|analgesics|mesh-ancestor
84155996|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
84155997|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84155998|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84155999|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84156000|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
84156001|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
84156002|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84156003|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84156004|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84156005|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
84156006|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156007|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156008|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
84156009|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84156010|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
84156011|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156012|NCT00770562|Dexamethasone|dexamethasone|mesh-list
84156013|NCT00770562|Rituximab|rituximab|mesh-list
84156014|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156015|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156016|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
84156017|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156018|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156019|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156020|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
84156021|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
84156022|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156023|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156024|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
84156025|NCT00770562|Hormones|hormones|mesh-ancestor
84156026|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156027|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84156028|NCT00836693|Tadalafil|tadalafil|mesh-list
84156029|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
84156030|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84156031|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84156032|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156033|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156034|NCT00836693|Urological Agents|urological agents|mesh-ancestor
84156035|NCT00770484|Propranolol|propranolol|mesh-list
84156036|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84156037|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84156038|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
84156039|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156040|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156041|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156042|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84156043|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84156044|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
84156045|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84156046|NCT00835679|Cetuximab|cetuximab|mesh-list
84156047|NCT00835679|Dasatinib|dasatinib|mesh-list
84156048|NCT00835679|Antibodies|antibodies|mesh-list
84156049|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
84156050|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84156051|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
84156052|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156053|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156054|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84156055|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156056|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156057|NCT00766506|Fentanyl|fentanyl|mesh-list
84156058|NCT00766506|Morphine|morphine|mesh-list
84156059|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84156060|NCT00766506|Narcotics|narcotics|mesh-ancestor
84156061|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156062|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156063|NCT00766506|Analgesics|analgesics|mesh-ancestor
84156064|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
84156065|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156066|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84156067|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84156068|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
84156069|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
84156070|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
84156071|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84156072|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83428126|NCT00456625|Vaccines|vaccines|mesh-list
84156073|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156074|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84156075|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84156076|NCT00770328|Protective Agents|protective agents|mesh-ancestor
84156077|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156078|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
84156079|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84156080|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
84156081|NCT05500092|Cisplatin|cisplatin|mesh-list
84156082|NCT05500092|Gemcitabine|gemcitabine|mesh-list
84156083|NCT05500092|Docetaxel|docetaxel|mesh-list
84156084|NCT05500092|Nivolumab|nivolumab|mesh-list
84156085|NCT05500092|Pemetrexed|pemetrexed|mesh-list
84156086|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156087|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84156088|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
84156089|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156090|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
84156091|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
84156092|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
84156093|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156094|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84156095|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156096|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84156097|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156098|NCT00916500|Cisplatin|cisplatin|mesh-list
84156099|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156100|NCT03110094|Adalimumab|adalimumab|mesh-list
84156101|NCT03110094|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84156102|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156103|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156104|NCT02600988|Vitamin D|vitamin d|mesh-list
84156105|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
84156106|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
84156107|NCT02600988|Vitamins|vitamins|mesh-list
84156108|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
84156109|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156110|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84156111|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84156112|NCT04097574|Menthol|menthol|mesh-list
84156113|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
84156114|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
84156115|NCT00766038|Hormones|hormones|mesh-list
82949480|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156116|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156117|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156118|NCT00765882|Linaclotide|linaclotide|mesh-list
84156119|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
84156120|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
84156121|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156122|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156123|NCT00913367|Insulin|insulin|mesh-list
84156124|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84156125|NCT00913367|Metformin|metformin|mesh-list
84156126|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
84156127|NCT00913367|Glimepiride|glimepiride|mesh-list
84156128|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84156129|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156130|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84156131|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84156132|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
84156133|NCT00828113|Varenicline|varenicline|mesh-list
84156134|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84156135|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84156136|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
84156137|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156138|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156139|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156140|NCT00707135|Sirolimus|sirolimus|mesh-list
84156141|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84156142|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156143|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84156144|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156145|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
84156146|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84156147|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
84156148|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156149|NCT00769704|Molgramostim|molgramostim|mesh-list
84156150|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
84156151|NCT00769704|Sargramostim|sargramostim|mesh-list
84156152|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
84156153|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156154|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156155|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156156|NCT00818753|Heparin|heparin|mesh-list
84156157|NCT00818753|Calcium heparin|calcium heparin|mesh-list
84156158|NCT00818753|Dabigatran|dabigatran|mesh-list
84156159|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
84156160|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84156161|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84156162|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156163|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
84156164|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84156165|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
84156166|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156167|NCT00704249|Nevirapine|nevirapine|mesh-list
84156168|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84156169|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156170|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156171|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156172|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
84156173|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156174|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84156175|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84156176|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84156177|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84156178|NCT00765726|Factor VIII|factor viii|mesh-list
84156179|NCT00765726|Coagulants|coagulants|mesh-ancestor
84156180|NCT04100226|Vitamin D|vitamin d|mesh-list
84156181|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
84156182|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
84156183|NCT04100226|Vitamins|vitamins|mesh-ancestor
84156184|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
84156185|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156186|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84156187|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84156188|NCT04100226|Antacids|antacids|mesh-ancestor
84156189|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156190|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156191|NCT00765336|Minocycline|minocycline|mesh-list
84156192|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84156193|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156194|NCT00818519|Drospirenone|drospirenone|mesh-list
84156195|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84156196|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
84156197|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156198|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156199|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84156200|NCT00818519|Diuretics|diuretics|mesh-ancestor
84156201|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
84156202|NCT00827567|Everolimus|everolimus|mesh-list
84156203|NCT00827567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84156204|NCT00827567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84156205|NCT00827567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156206|NCT00827567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156207|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84156208|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
84156209|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156210|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156211|NCT00765102|Bortezomib|bortezomib|mesh-list
84156212|NCT00765102|Romidepsin|romidepsin|mesh-list
84156213|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156214|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84156215|NCT00765102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84156216|NCT00765102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156217|NCT00765102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156218|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84156219|NCT00809354|Tanezumab|tanezumab|mesh-list
84156220|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84156221|NCT00809354|Analgesics|analgesics|mesh-ancestor
84156222|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
84156223|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156224|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156225|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83428242|NCT00400205|Docetaxel|docetaxel|mesh-list
84156226|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156228|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84156229|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
84156230|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84156231|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84156232|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
84156233|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156234|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84156235|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84156236|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156237|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156238|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84156239|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84156240|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156241|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84156242|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84156243|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156244|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156245|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
84156246|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156247|NCT05752916|Clopidogrel|clopidogrel|mesh-list
84156248|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
84156249|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156250|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156251|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84156252|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83430422|NCT00216476|Risperidone|risperidone|mesh-list
84156253|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84156254|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
84156255|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156256|NCT03990896|Talazoparib|talazoparib|mesh-list
84156257|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84156258|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156259|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156260|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156261|NCT00756444|Panitumumab|panitumumab|mesh-list
84156262|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156263|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156264|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
84156265|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84156266|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156267|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84156268|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84156269|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156270|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156271|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
84156272|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156273|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
84156274|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156275|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84156276|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84156277|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156278|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156279|NCT00764478|Asenapine|asenapine|mesh-list
84156280|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84156281|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84156282|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156283|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156284|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84156285|NCT00805766|Infliximab|infliximab|mesh-list
84156286|NCT00805766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84156287|NCT00805766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156288|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
84156289|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156290|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156291|NCT00764322|Tamoxifen|tamoxifen|mesh-list
84156292|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84156293|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
84156294|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156295|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428301|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84156296|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84156297|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156298|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84156299|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84156300|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84156302|NCT03908060|Methadone|methadone|mesh-list
84156303|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84156304|NCT03908060|Narcotics|narcotics|mesh-ancestor
84156305|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156306|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156307|NCT03908060|Analgesics|analgesics|mesh-ancestor
84156308|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
84156309|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156310|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
84156311|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
84156312|NCT00752856|Ritonavir|ritonavir|mesh-list
84156313|NCT00752856|Lopinavir|lopinavir|mesh-list
84156314|NCT00752856|Tenofovir|tenofovir|mesh-list
84156315|NCT00752856|Emtricitabine|emtricitabine|mesh-list
84156316|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
84156317|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84156318|NCT00752856|Efavirenz|efavirenz|mesh-list
84156319|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84156320|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84156321|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
84156322|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156323|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156324|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84156325|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84156326|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
84156327|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156328|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84156329|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84156330|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84156331|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156332|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84156333|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
84156334|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84156335|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84156336|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84156337|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84156338|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84156339|NCT00805142|Tapentadol|tapentadol|mesh-list
84156340|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84156341|NCT00805142|Narcotics|narcotics|mesh-ancestor
84156342|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156343|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156344|NCT00805142|Analgesics|analgesics|mesh-ancestor
84156345|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
84156346|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156347|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84156348|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84156349|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156350|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156351|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
84156352|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156353|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84156354|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
84156355|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156356|NCT03684980|Leucovorin|leucovorin|mesh-list
84156357|NCT03684980|Rituximab|rituximab|mesh-list
84156358|NCT03684980|Methotrexate|methotrexate|mesh-list
84156359|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156360|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156361|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
84156362|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156363|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156364|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84156365|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
84156366|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84156367|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84156368|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
84156369|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156371|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156372|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84156373|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84156374|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156375|NCT03684980|Antidotes|antidotes|mesh-ancestor
84156376|NCT03684980|Protective Agents|protective agents|mesh-ancestor
84156377|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
84156378|NCT03684980|Vitamins|vitamins|mesh-ancestor
84156379|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
84156380|NCT00761319|Travoprost|travoprost|mesh-list
84156381|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84156382|NCT00761319|Latanoprost|latanoprost|mesh-list
84156383|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84156384|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84156385|NCT00704639|Carboplatin|carboplatin|mesh-list
84156386|NCT00704639|Cetuximab|cetuximab|mesh-list
84156387|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156388|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156389|NCT00826943|Cetirizine|cetirizine|mesh-list
84156390|NCT00826943|Levocetirizine|levocetirizine|mesh-list
84156391|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84156392|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84156393|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84156394|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
84156395|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
84156396|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156397|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156398|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156399|NCT00707369|Amoxicillin|amoxicillin|mesh-list
84156400|NCT00707369|Metronidazole|metronidazole|mesh-list
84156401|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84156402|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156403|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84156404|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84156405|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84156406|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84156407|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156408|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84156409|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156410|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156411|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
84156412|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156413|NCT00704951|Posaconazole|posaconazole|mesh-list
84156414|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
84156415|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156416|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84156417|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84156418|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84156419|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84156420|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84156421|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156422|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156423|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84156424|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
84156425|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156426|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156427|NCT00759915|Morphine|morphine|mesh-list
84156428|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84156429|NCT00759915|Narcotics|narcotics|mesh-ancestor
84156430|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156431|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156432|NCT00759915|Analgesics|analgesics|mesh-ancestor
84156433|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
84156434|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156435|NCT00759759|Morphine|morphine|mesh-list
84156436|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84156437|NCT00759759|Narcotics|narcotics|mesh-ancestor
84156438|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156439|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156440|NCT00759759|Analgesics|analgesics|mesh-ancestor
84156441|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
84156442|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156443|NCT00759681|Thrombin|thrombin|mesh-list
83428456|NCT00405353|Testosterone|testosterone|mesh-list
84156444|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
84156445|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
84156446|NCT00759681|Coagulants|coagulants|mesh-ancestor
84156447|NCT00826241|Temozolomide|temozolomide|mesh-list
84156448|NCT00826241|Lapatinib|lapatinib|mesh-list
84156449|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84156450|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
84156451|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156452|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156453|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84156454|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156455|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
84156456|NCT04097847|Tocopherols|tocopherols|mesh-list
84156457|NCT04097847|Vitamin E|vitamin e|mesh-list
84156458|NCT04097847|Tocotrienols|tocotrienols|mesh-list
84156459|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
84156460|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
84156461|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84156462|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156463|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156464|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84156465|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84156466|NCT04097847|Protective Agents|protective agents|mesh-ancestor
84156467|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156468|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
84156469|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84156470|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
84156471|NCT04097847|Vitamins|vitamins|mesh-ancestor
84156472|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
84156473|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84156474|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
84156475|NCT00762372|Sevoflurane|sevoflurane|mesh-list
84156476|NCT00762372|Desflurane|desflurane|mesh-list
84156477|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84156478|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84156479|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
84156480|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
84156481|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156482|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156483|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84156484|NCT00762372|Analgesics|analgesics|mesh-ancestor
84156485|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
84156486|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156487|NCT00833261|Paclitaxel|paclitaxel|mesh-list
84156488|NCT00833261|Cetuximab|cetuximab|mesh-list
84156489|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84156490|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156491|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
84156492|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
84156493|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
84156494|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156495|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156496|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84156497|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84156498|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156499|NCT00833027|Incretins|incretins|mesh-ancestor
84156500|NCT00833027|Hormones|hormones|mesh-ancestor
84156501|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156502|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84156503|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
84156504|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156505|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156506|NCT00752622|Infliximab|infliximab|mesh-list
84156507|NCT00752622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84156508|NCT00752622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156509|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
84156510|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156511|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156512|NCT00754650|Bevacizumab|bevacizumab|mesh-list
84156513|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84156514|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156515|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84156516|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84156517|NCT00754650|Growth Substances|growth substances|mesh-ancestor
84156518|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83428526|NCT01383356|Incretins|incretins|mesh-ancestor
84156519|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
84156520|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84156521|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156522|NCT00825305|Vaccines|vaccines|mesh-list
84156523|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
84156524|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156525|NCT00754572|Methotrexate|methotrexate|mesh-list
84156526|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84156527|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
84156528|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84156529|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156530|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84156531|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
84156532|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156533|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156534|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
84156535|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156536|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84156537|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84156538|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
84156539|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156540|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156541|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
84156542|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430433|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84156543|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84156544|NCT04095312|Pancrelipase|pancrelipase|mesh-list
84156545|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156546|NCT04095390|Capecitabine|capecitabine|mesh-list
84156547|NCT04095390|Letrozole|letrozole|mesh-list
84156548|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84156549|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
84156550|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156551|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156552|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84156553|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84156554|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156555|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84156556|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
84156557|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156558|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156559|NCT00754338|Dipivefrin|dipivefrin|mesh-list
84156560|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84156561|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
84156562|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156563|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156564|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156565|NCT00708149|Lansoprazole|lansoprazole|mesh-list
84156566|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
84156567|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84156568|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156569|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84156570|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156571|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156572|NCT04016051|Clarithromycin|clarithromycin|mesh-list
84156573|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84156574|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156575|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84156576|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156577|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156578|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84156579|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84156580|NCT00761514|Adalimumab|adalimumab|mesh-list
84156581|NCT00761514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84156582|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156583|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156584|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
84156585|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84156586|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156587|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84156588|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156589|NCT00758043|Ribavirin|ribavirin|mesh-list
84156590|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84156591|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
84156592|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83428605|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
84156594|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156595|NCT00831701|Tamsulosin|tamsulosin|mesh-list
84156596|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84156597|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84156598|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84156599|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
84156600|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156601|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156602|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156603|NCT00831701|Urological Agents|urological agents|mesh-ancestor
84156604|NCT00705419|Tenofovir|tenofovir|mesh-list
84156605|NCT00705419|Emtricitabine|emtricitabine|mesh-list
84156606|NCT00705419|Maleic acid|maleic acid|mesh-list
84156607|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
84156608|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156609|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84156610|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156611|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156612|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156613|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84156614|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84156615|NCT05425355|Acetaminophen|acetaminophen|mesh-list
84156616|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84156617|NCT05425355|Analgesics|analgesics|mesh-ancestor
84156618|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
84156619|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156620|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156621|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
84156622|NCT04093713|Nordefrin|nordefrin|mesh-list
84156623|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84156624|NCT00831311|Vaccines|vaccines|mesh-list
84156625|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
84156626|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156627|NCT00831233|Goserelin|goserelin|mesh-list
84156628|NCT00831233|Bicalutamide|bicalutamide|mesh-list
84156629|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84156630|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156631|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
84156632|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
84156633|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156634|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156635|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
84156636|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84156637|NCT05438277|Triamcinolone|triamcinolone|mesh-list
84156638|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84156639|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84156640|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84156641|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156642|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
84156643|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
84156644|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156645|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156646|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84156647|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
84156648|NCT05438277|Hormones|hormones|mesh-ancestor
84156649|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156650|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84156651|NCT05438277|Protective Agents|protective agents|mesh-ancestor
84156652|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84156653|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
84156654|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156655|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156656|NCT00761280|Temozolomide|temozolomide|mesh-list
84156657|NCT00761280|Carmustine|carmustine|mesh-list
84156658|NCT00761280|Lomustine|lomustine|mesh-list
84156659|NCT00761280|Trabedersen|trabedersen|mesh-list
84156660|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84156661|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
84156662|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156663|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156664|NCT00916890|Fentanyl|fentanyl|mesh-list
84156665|NCT00916890|Morphine|morphine|mesh-list
84156666|NCT00916890|Oxycodone|oxycodone|mesh-list
84156667|NCT00916890|Buprenorphine|buprenorphine|mesh-list
84156668|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84156669|NCT00916890|Narcotics|narcotics|mesh-ancestor
84156670|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156671|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156672|NCT00916890|Analgesics|analgesics|mesh-ancestor
84156673|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
84156674|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156675|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84156676|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84156677|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
84156678|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
84156679|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84156680|NCT02599701|Gabapentin|gabapentin|mesh-list
84156681|NCT02599701|Analgesics|analgesics|mesh-ancestor
84156682|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
84156683|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156684|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156685|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
84156686|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84156687|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84156688|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156689|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84156690|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83430442|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
84156691|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84156692|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156693|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156694|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
84156695|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84156696|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84156697|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84156698|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156699|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156700|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156701|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156702|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
84156703|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84156704|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
84156705|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84156706|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
84156707|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156708|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84156709|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84156710|NCT00760266|Diuretics|diuretics|mesh-ancestor
84156711|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
84156712|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156713|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84156714|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156715|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156716|NCT00753714|Gemcitabine|gemcitabine|mesh-list
84156717|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84156718|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
84156719|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156720|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156721|NCT00759954|Morphine|morphine|mesh-list
84156722|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84156723|NCT00759954|Narcotics|narcotics|mesh-ancestor
84156724|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156725|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156726|NCT00759954|Analgesics|analgesics|mesh-ancestor
84156727|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
84156728|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156729|NCT00804908|Temozolomide|temozolomide|mesh-list
84156730|NCT00804908|Veliparib|veliparib|mesh-list
84156731|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84156732|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
84156733|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156734|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156735|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84156736|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156737|NCT02608034|Itraconazole|itraconazole|mesh-list
84156738|NCT02608034|Rifampin|rifampin|mesh-list
84156739|NCT02608034|Vemurafenib|vemurafenib|mesh-list
84156740|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
84156741|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156742|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83428749|NCT05365178|Fulvestrant|fulvestrant|mesh-list
84156743|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84156744|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156745|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156746|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84156747|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
84156748|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156749|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156750|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84156751|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84156752|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
84156753|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84156754|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
84156755|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156756|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
84156757|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84156758|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
84156759|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
84156760|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
84156761|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84156762|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156763|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84156764|NCT00589784|Sunitinib|sunitinib|mesh-list
84156765|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
84156766|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156767|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84156768|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84156769|NCT00589784|Growth Substances|growth substances|mesh-ancestor
84156770|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156771|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
84156772|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84156773|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156774|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156775|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84156776|NCT05750264|Ibuprofen|ibuprofen|mesh-list
84156777|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84156778|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84156779|NCT05750264|Analgesics|analgesics|mesh-ancestor
84156780|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
84156781|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156782|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156783|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156784|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156785|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84156786|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156787|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156788|NCT05742854|Oxytocin|oxytocin|mesh-list
84156789|NCT05742854|Carbetocin|carbetocin|mesh-list
84156790|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
84156791|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84156792|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156793|NCT00823979|Etravirine|etravirine|mesh-list
84156794|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84156795|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84156796|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156797|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156798|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
84156799|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156800|NCT04094766|Immunomodulating Agents|immunomodulating agents|mesh-list
84156801|NCT04094766|Immunologic Factors|immunologic factors|mesh-ancestor
84156802|NCT04094766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156803|NCT02606864|Nifurtimox|nifurtimox|mesh-list
84156804|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84156805|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84156806|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84156807|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156808|NCT00823901|Clindamycin|clindamycin|mesh-list
84156809|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
84156810|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
84156811|NCT00823901|Tretinoin|tretinoin|mesh-list
84156812|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84156813|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156814|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84156815|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156816|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156817|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156818|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
84156819|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
84156820|NCT00823823|Calpastatin|calpastatin|mesh-list
84156821|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
84156822|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
84156823|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156824|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156825|NCT02926898|Fenfluramine|fenfluramine|mesh-list
84156826|NCT02926898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84156827|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84156828|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156829|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156830|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156831|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
84156832|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156833|NCT00759564|Lactams|lactams|mesh-list
84156834|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84156835|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156836|NCT00816023|Ecallantide|ecallantide|mesh-list
84156837|NCT00816023|Analgesics|analgesics|mesh-ancestor
84156838|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
84156839|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156840|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156841|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84156842|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84156843|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156844|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156845|NCT00815633|Alefacept|alefacept|mesh-list
84156846|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
84156847|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
84156848|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156850|NCT02610881|Trace Elements|trace elements|mesh-list
84156851|NCT02610881|Folic Acid|folic acid|mesh-list
84156852|NCT02610881|Micronutrients|micronutrients|mesh-list
84156853|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156854|NCT02610881|Hematinics|hematinics|mesh-ancestor
84156855|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
84156856|NCT02610881|Vitamins|vitamins|mesh-ancestor
84156857|NCT00830765|Progesterone|progesterone|mesh-list
84156858|NCT00830765|Progestins|progestins|mesh-ancestor
84156859|NCT00830765|Hormones|hormones|mesh-ancestor
84156860|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156861|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156862|NCT04093206|Vitamins|vitamins|mesh-list
84156863|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
84156864|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
84156865|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156866|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
84156867|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156868|NCT04093206|Protective Agents|protective agents|mesh-ancestor
84156869|NCT00830375|Memantine|memantine|mesh-list
84156870|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84156871|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84156872|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
84156873|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156874|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156875|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156876|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84156877|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84156878|NCT00708539|Progesterone|progesterone|mesh-list
84156879|NCT00708539|Progestins|progestins|mesh-ancestor
84156880|NCT00708539|Hormones|hormones|mesh-ancestor
84156881|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84156882|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156883|NCT00914420|Trapidil|trapidil|mesh-list
84156884|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84156885|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156886|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156887|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83428901|NCT01380782|Nintedanib|nintedanib|mesh-list
84156888|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
84156889|NCT04094532|Bupivacaine|bupivacaine|mesh-list
84156890|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
84156891|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
84156892|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156893|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156894|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
84156895|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156897|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84156898|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84156899|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156900|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156901|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156902|NCT05758259|Vitamin D|vitamin d|mesh-list
84156903|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
84156904|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
84156905|NCT05758259|Vitamins|vitamins|mesh-list
84156906|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
84156907|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156908|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84156909|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84156910|NCT00803738|Terconazole|terconazole|mesh-list
84156911|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
84156912|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156913|NCT00591266|Amlodipine|amlodipine|mesh-list
84156914|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84156915|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84156916|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84156917|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156918|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156919|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84156920|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156921|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
84156922|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84156923|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84156924|NCT04093050|Vasopressins|vasopressins|mesh-list
84156925|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
84156926|NCT04093050|Coagulants|coagulants|mesh-ancestor
84156927|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84156928|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84156929|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
84156930|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156931|NCT00758394|Listerine|listerine|mesh-list
84156932|NCT00758394|Triclosan|triclosan|mesh-list
84156933|NCT00758394|Fluorides|fluorides|mesh-list
84156934|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
84156935|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
84156936|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
84156937|NCT00758394|Protective Agents|protective agents|mesh-ancestor
84156938|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156939|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84156940|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84156941|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84156942|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84156943|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
84156944|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156945|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84156946|NCT04450394|Insulin|insulin|mesh-list
84156947|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84156948|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156949|NCT00758160|Methylphenidate|methylphenidate|mesh-list
84156950|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84156951|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156952|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84156953|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84156954|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84156955|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156956|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
84156957|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156958|NCT02606552|Aspirin|aspirin|mesh-list
84156959|NCT02606552|Clopidogrel|clopidogrel|mesh-list
84156960|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84156961|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84156962|NCT02606552|Analgesics|analgesics|mesh-ancestor
84156963|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
84156964|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84156965|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156966|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84156967|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84156968|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84156969|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84156970|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156971|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84156972|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84156973|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156974|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
84156975|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84156976|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84156977|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84156978|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
84156979|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156980|NCT02852486|Pioglitazone|pioglitazone|mesh-list
84156981|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
84156982|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84156983|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156984|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84156985|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84156986|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156987|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156988|NCT02608736|Valproic Acid|valproic acid|mesh-list
84156989|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
84156990|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84156991|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84156992|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
84156993|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84156994|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84156995|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
84156996|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84156997|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84156998|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84156999|NCT02607410|Insulin|insulin|mesh-list
84157000|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84157001|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84157002|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
84157003|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
84157004|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
84157005|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
84157006|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
84157007|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84157008|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157009|NCT02607410|Incretins|incretins|mesh-ancestor
84157010|NCT02607410|Hormones|hormones|mesh-ancestor
84157011|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157012|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
84157013|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157014|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157015|NCT05693090|Osimertinib|osimertinib|mesh-list
84157016|NCT05693090|Tipifarnib|tipifarnib|mesh-list
84157017|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157018|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157019|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157020|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157021|NCT00751296|Lenalidomide|lenalidomide|mesh-list
84157022|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
84157023|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157024|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84157025|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84157026|NCT00751296|Growth Substances|growth substances|mesh-ancestor
84157027|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
84157028|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157029|NCT04093518|Estradiol|estradiol|mesh-list
84157030|NCT04093518|Estrogens|estrogens|mesh-ancestor
84157031|NCT04093518|Hormones|hormones|mesh-ancestor
84157032|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157033|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157034|NCT02606084|Esketamine|esketamine|mesh-list
84157035|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
84157036|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157037|NCT02607488|Lidocaine|lidocaine|mesh-list
84157038|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
84157039|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
84157040|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157041|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157042|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
84157043|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157044|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84157045|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84157046|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84157047|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157048|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157049|NCT00914498|Lidocaine|lidocaine|mesh-list
84157050|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
84157051|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
84157052|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157053|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157054|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
84157055|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157056|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84157057|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84157058|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84157059|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157060|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157061|NCT00751881|Teriflunomide|teriflunomide|mesh-list
84157062|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157063|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157064|NCT00751881|Analgesics|analgesics|mesh-ancestor
84157065|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
84157066|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157067|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157068|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157069|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157070|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84157071|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
84157072|NCT02386826|Bevacizumab|bevacizumab|mesh-list
84157073|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84157074|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157075|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84157076|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84157077|NCT02386826|Growth Substances|growth substances|mesh-ancestor
84157078|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157079|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
84157080|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
84157081|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84157082|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157083|NCT02599779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84157084|NCT02599779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157085|NCT02597556|Albendazole|albendazole|mesh-list
84157086|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
84157087|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84157088|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157089|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
84157090|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
84157091|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84157092|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
84157093|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
84157094|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
84157095|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157096|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157097|NCT02599857|Bisoprolol|bisoprolol|mesh-list
84157098|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84157099|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
84157100|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
84157101|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157102|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157103|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84157104|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84157105|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84157106|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
84157107|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157108|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157109|NCT05406726|Palmidrol|palmidrol|mesh-list
84157110|NCT05406726|Analgesics|analgesics|mesh-ancestor
84157111|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
84157112|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83429116|NCT00422201|Mifepristone|mifepristone|mesh-list
84157113|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157114|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157115|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157116|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157117|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157118|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
84157119|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157120|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84157121|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84157122|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157123|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157124|NCT05406726|Hormones|hormones|mesh-ancestor
84157125|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157126|NCT02599623|Anesthetics|anesthetics|mesh-list
84157127|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157128|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157129|NCT02597400|Metformin|metformin|mesh-list
84157130|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84157131|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157132|NCT00830063|Naproxen|naproxen|mesh-list
84157133|NCT00830063|Tanezumab|tanezumab|mesh-list
84157134|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157135|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157136|NCT00830063|Analgesics|analgesics|mesh-ancestor
84157137|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
84157138|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157139|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157140|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157141|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157142|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
84157143|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84157144|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157145|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157146|NCT04092621|Amiodarone|amiodarone|mesh-list
84157147|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84157148|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
84157149|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84157150|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157151|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157152|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84157153|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84157154|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84157155|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157156|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84157157|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84157158|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84157159|NCT00751101|Nicotine|nicotine|mesh-list
84157160|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84157161|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
84157162|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157163|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157164|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84157165|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84157166|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
84157167|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157168|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157169|NCT04092309|Valsartan|valsartan|mesh-list
84157170|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84157171|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
84157172|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84157173|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84157174|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84157175|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157176|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
84157177|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157178|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
84157179|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
84157180|NCT02598414|Protective Agents|protective agents|mesh-ancestor
84157181|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157182|NCT04020003|Simendan|simendan|mesh-list
84157183|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84157184|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
83429188|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84157185|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
84157186|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84157187|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157188|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157189|NCT04020003|Protective Agents|protective agents|mesh-ancestor
84157190|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157192|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157193|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157194|NCT03977142|Analgesics|analgesics|mesh-ancestor
84157195|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
84157196|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157197|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157198|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157199|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157200|NCT00751023|Modafinil|modafinil|mesh-list
84157201|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84157202|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157203|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84157204|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84157205|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84157206|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157207|NCT00917592|Amoxicillin|amoxicillin|mesh-list
84157208|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
84157209|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
84157210|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84157211|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157212|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157213|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157214|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84157215|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
84157216|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84157217|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84157218|NCT04091412|Protective Agents|protective agents|mesh-ancestor
84157219|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157220|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84157221|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84157222|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84157223|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
84157224|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157225|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157226|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157227|NCT02599311|Urological Agents|urological agents|mesh-ancestor
84157228|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
84157229|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84157230|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84157231|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84157232|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157233|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84157234|NCT00591773|Diuretics|diuretics|mesh-ancestor
84157235|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
84157236|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157237|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84157238|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157239|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
84157240|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84157241|NCT00750867|Antibodies|antibodies|mesh-list
84157242|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
84157243|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84157244|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
84157245|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157246|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
84157247|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
84157248|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157249|NCT04091763|Polidocanol|polidocanol|mesh-list
84157250|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
84157251|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84157252|NCT00829829|Rilonacept|rilonacept|mesh-list
84157253|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157254|NCT00829439|Levodopa|levodopa|mesh-list
84157255|NCT00829439|Carbidopa|carbidopa|mesh-list
84157256|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84157257|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84157258|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
84157259|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157260|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157261|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157262|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84157263|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157264|NCT02599077|Dienogest|dienogest|mesh-list
84157265|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
84157266|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84157267|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
84157268|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84157269|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157270|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84157271|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84157272|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84157273|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84157274|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84157275|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
84157276|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157277|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84157278|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157279|NCT00829283|Orlistat|orlistat|mesh-list
84157280|NCT00829283|Sibutramine|sibutramine|mesh-list
84157281|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157282|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157283|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84157284|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84157285|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
84157286|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157287|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
84157288|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
84157289|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84157290|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157291|NCT00706277|Fentanyl|fentanyl|mesh-list
84157292|NCT00706277|Remifentanil|remifentanil|mesh-list
84157293|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
84157294|NCT00706277|Propofol|propofol|mesh-list
84157295|NCT00706277|Sevoflurane|sevoflurane|mesh-list
84157296|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84157297|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157298|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157299|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84157300|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
84157301|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
84157302|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84157303|NCT00706277|Narcotics|narcotics|mesh-ancestor
84157304|NCT00706277|Analgesics|analgesics|mesh-ancestor
84157305|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
84157306|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157307|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84157308|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84157309|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84157310|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157311|NCT00749463|Nicotine|nicotine|mesh-list
84157312|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84157313|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
84157314|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157315|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157316|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84157317|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84157318|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
84157319|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157320|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157321|NCT00821327|Gemcitabine|gemcitabine|mesh-list
84157322|NCT00821327|Sunitinib|sunitinib|mesh-list
84157323|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157324|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84157325|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
84157326|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157327|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84157328|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84157329|NCT00821327|Growth Substances|growth substances|mesh-ancestor
84157330|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157331|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
84157332|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157333|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157334|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84157335|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
84157336|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157337|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84157338|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84157339|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
84157340|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157341|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157342|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84157343|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
84157344|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84157345|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84157346|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84157347|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
84157348|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157349|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157350|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
84157351|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
84157352|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157353|NCT02611505|Esketamine|esketamine|mesh-list
84157354|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
84157355|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157356|NCT00743652|Vaccines|vaccines|mesh-list
84157357|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84157358|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
84157359|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157360|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
84157361|NCT00748215|Loperamide|loperamide|mesh-list
84157362|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
84157363|NCT00748215|Calcium|calcium|mesh-list
84157364|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84157365|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157366|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157367|NCT00917163|Sirolimus|sirolimus|mesh-list
84157368|NCT00917163|Everolimus|everolimus|mesh-list
84157369|NCT00917163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84157370|NCT00917163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157371|NCT00917163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157372|NCT00917163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157373|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84157374|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
84157375|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157376|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157377|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84157378|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157379|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84157380|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
84157381|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84157382|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157383|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157384|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157385|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157386|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
84157387|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84157388|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84157389|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
84157390|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157391|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84157392|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84157393|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157394|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157395|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
84157396|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84157397|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157398|NCT04091178|Vitamin D|vitamin d|mesh-list
84157399|NCT04091178|Vitamins|vitamins|mesh-ancestor
84157400|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
84157401|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157402|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84157403|NCT00917358|Interferons|interferons|mesh-list
84157404|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
84157405|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
84157406|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84157407|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157408|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
84157409|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157410|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
84157411|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157412|NCT00743340|Emtricitabine|emtricitabine|mesh-list
84157413|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
84157414|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157415|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84157416|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84157417|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157418|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157419|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84157420|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84157421|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84157422|NCT00749190|Empagliflozin|empagliflozin|mesh-list
84157423|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84157424|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157425|NCT00749190|Incretins|incretins|mesh-ancestor
84157426|NCT00749190|Hormones|hormones|mesh-ancestor
84157427|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157428|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84157429|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
84157430|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157431|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157432|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84157433|NCT00748566|Ziprasidone|ziprasidone|mesh-list
84157434|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84157435|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
84157436|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157437|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157438|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157439|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84157440|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84157441|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157442|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157443|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84157444|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
84157445|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
84157446|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
84157447|NCT02597166|Ledipasvir|ledipasvir|mesh-list
84157448|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
84157449|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157450|NCT00743106|Fenoldopam|fenoldopam|mesh-list
84157451|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84157452|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
84157453|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
84157454|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
84157455|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157456|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157457|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157458|NCT02597322|Axitinib|axitinib|mesh-list
84157459|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157460|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157461|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157462|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157463|NCT00738699|Paclitaxel|paclitaxel|mesh-list
84157464|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84157465|NCT00738699|Farletuzumab|farletuzumab|mesh-list
84157466|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84157467|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157468|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
84157469|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
84157470|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
84157471|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157472|NCT00814307|Tofacitinib|tofacitinib|mesh-list
84157473|NCT00814307|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84157474|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157475|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157476|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157477|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
84157478|NCT02596776|Propranolol|propranolol|mesh-list
84157479|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84157480|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84157481|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
84157482|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157483|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157484|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157485|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84157486|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84157487|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
84157488|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157489|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84157490|NCT02596776|Protective Agents|protective agents|mesh-ancestor
84157491|NCT00748098|Gabapentin|gabapentin|mesh-list
84157492|NCT00748098|Analgesics|analgesics|mesh-ancestor
84157493|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
84157494|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157495|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157496|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
84157497|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84157498|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84157499|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157500|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157501|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84157502|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84157503|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157504|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157505|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
84157506|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84157507|NCT00813995|Metformin|metformin|mesh-list
84157508|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84157509|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157510|NCT00813995|Incretins|incretins|mesh-ancestor
84157511|NCT00813995|Hormones|hormones|mesh-ancestor
84157512|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157513|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84157514|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
84157515|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157516|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157517|NCT00737529|Lenalidomide|lenalidomide|mesh-list
84157518|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
84157519|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157520|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84157521|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84157522|NCT00737529|Growth Substances|growth substances|mesh-ancestor
84157523|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
84157524|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157525|NCT00813917|Varenicline|varenicline|mesh-list
84157526|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84157527|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84157528|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
84157529|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157530|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157531|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157532|NCT02598102|Diclofenac|diclofenac|mesh-list
84157533|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157534|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157535|NCT02598102|Analgesics|analgesics|mesh-ancestor
84157536|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
84157537|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157538|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157539|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157540|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157541|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84157542|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157543|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157544|NCT02610647|Anesthetics|anesthetics|mesh-list
84157545|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157546|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157547|NCT02595918|Nivolumab|nivolumab|mesh-list
84157548|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84157549|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157550|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84157551|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157552|NCT02595840|Pemetrexed|pemetrexed|mesh-list
84157553|NCT02595840|Afatinib|afatinib|mesh-list
84157554|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157555|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157556|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157557|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84157558|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84157559|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157560|NCT02594241|Prednisolone|prednisolone|mesh-list
84157561|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84157562|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
84157563|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84157564|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
84157565|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84157566|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
84157567|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157568|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
84157569|NCT02594241|Hormones|hormones|mesh-ancestor
84157570|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157571|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157572|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84157573|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157574|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
84157575|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
84157576|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157577|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157578|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84157579|NCT02594241|Protective Agents|protective agents|mesh-ancestor
84157580|NCT00585975|Bromfenac|bromfenac|mesh-list
84157581|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84157582|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84157583|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157584|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157585|NCT00585975|Analgesics|analgesics|mesh-ancestor
84157586|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
84157587|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157588|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157589|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157590|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157591|NCT00918021|Olanzapine|olanzapine|mesh-list
84157592|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
84157593|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
84157594|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157595|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157596|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157597|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84157598|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84157599|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157600|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157601|NCT00918021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84157602|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84157603|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157604|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157605|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157606|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
84157607|NCT00585585|Betahistine|betahistine|mesh-list
84157608|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
84157609|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
84157610|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
84157611|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157612|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157613|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157614|NCT02593695|Fluoxetine|fluoxetine|mesh-list
84157615|NCT02593695|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84157616|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84157617|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157618|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157619|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157620|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
84157621|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157622|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84157623|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
84157624|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157625|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84157626|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84157627|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157628|NCT00734097|Esomeprazole|esomeprazole|mesh-list
84157629|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84157630|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157631|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84157632|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157633|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157635|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84157636|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84157637|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84157638|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157639|NCT04088175|Menthol|menthol|mesh-list
84157640|NCT04088175|Nicotine|nicotine|mesh-list
84157641|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84157642|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
84157643|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157644|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157645|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84157646|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84157647|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
84157648|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157649|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157650|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
84157651|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
84157652|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
84157653|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157654|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
84157655|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84157656|NCT05756621|Topiramate|topiramate|mesh-list
84157657|NCT05756621|Lacosamide|lacosamide|mesh-list
84157658|NCT05756621|Phenytoin|phenytoin|mesh-list
84157659|NCT05756621|Midazolam|midazolam|mesh-list
84157660|NCT05756621|Ketamine|ketamine|mesh-list
84157661|NCT05756621|Levetiracetam|levetiracetam|mesh-list
84157662|NCT05756621|Thiopental|thiopental|mesh-list
84157663|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
84157664|NCT05756621|Propofol|propofol|mesh-list
84157665|NCT05756621|Anesthetics|anesthetics|mesh-list
84157666|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84157667|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157668|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157669|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84157670|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
84157671|NCT05756621|Analgesics|analgesics|mesh-ancestor
84157672|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
84157673|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157674|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84157675|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84157676|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84157677|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157678|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157679|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84157680|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84157681|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84157682|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157683|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
84157684|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
84157685|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84157686|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
84157687|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84157688|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84157689|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157690|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84157691|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84157692|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
84157693|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157694|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
84157695|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84157696|NCT00732303|Pemetrexed|pemetrexed|mesh-list
84157697|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157698|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157699|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157700|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84157701|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84157702|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84157703|NCT00732069|Valsartan|valsartan|mesh-list
84157704|NCT00732069|Ramipril|ramipril|mesh-list
84157705|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84157706|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84157707|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84157708|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157709|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84157710|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
84157711|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157712|NCT02593383|Clindamycin|clindamycin|mesh-list
84157713|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
84157714|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
84157715|NCT02593383|Adapalene|adapalene|mesh-list
84157716|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84157717|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157718|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84157719|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157720|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157721|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157722|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84157723|NCT02593383|Analgesics|analgesics|mesh-ancestor
84157724|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
84157725|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157726|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157727|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157728|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157729|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
84157730|NCT00731679|Rifaximin|rifaximin|mesh-list
84157731|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84157732|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157733|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157734|NCT02609087|Propofol|propofol|mesh-list
84157735|NCT02609087|Sevoflurane|sevoflurane|mesh-list
84157736|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84157737|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157738|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157739|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84157740|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
84157741|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
84157742|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84157743|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84157744|NCT00731133|Disulfiram|disulfiram|mesh-list
84157745|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84157746|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
84157747|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157748|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157749|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84157750|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84157751|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157752|NCT00730275|Incretins|incretins|mesh-ancestor
84157753|NCT00730275|Hormones|hormones|mesh-ancestor
84157754|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157755|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84157756|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
84157757|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157758|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157759|NCT04793711|Decanoic acid|decanoic acid|mesh-list
84157760|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
84157761|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157762|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
84157763|NCT00729651|Vitamin D|vitamin d|mesh-list
84157764|NCT00729651|Alendronate|alendronate|mesh-list
84157765|NCT00729651|Calcium|calcium|mesh-list
84157766|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84157767|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157768|NCT00729651|Vitamins|vitamins|mesh-ancestor
84157769|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
84157770|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84157771|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
84157772|NCT00729183|Vitamin D|vitamin d|mesh-list
84157773|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
84157774|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
84157775|NCT00729183|Calcium|calcium|mesh-list
84157776|NCT00729183|Vitamins|vitamins|mesh-ancestor
84157777|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
84157778|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157779|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84157780|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84157781|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157782|NCT00729183|Antacids|antacids|mesh-ancestor
84157783|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157784|NCT00811733|Ofatumumab|ofatumumab|mesh-list
84157785|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157786|NCT00728949|Tamoxifen|tamoxifen|mesh-list
84157787|NCT00728949|Letrozole|letrozole|mesh-list
84157788|NCT00728949|Fulvestrant|fulvestrant|mesh-list
84157789|NCT00728949|Anastrozole|anastrozole|mesh-list
84157790|NCT00728949|Exemestane|exemestane|mesh-list
84157791|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84157792|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157793|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84157794|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84157795|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157796|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157797|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84157798|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
84157799|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157800|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157801|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84157802|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84157803|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84157804|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84157805|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84157806|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
84157807|NCT00918177|Levodopa|levodopa|mesh-list
84157808|NCT00918177|Carbidopa|carbidopa|mesh-list
84157809|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84157810|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84157811|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84157812|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
84157813|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157814|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157815|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157816|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84157817|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157818|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84157819|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
84157820|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
84157821|NCT00728481|Budesonide|budesonide|mesh-list
84157822|NCT00728481|Esomeprazole|esomeprazole|mesh-list
84157823|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84157824|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84157825|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
84157826|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157827|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157828|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84157829|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
84157830|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
84157831|NCT00728481|Hormones|hormones|mesh-ancestor
84157832|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157833|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84157834|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157835|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84157836|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157837|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157838|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
84157839|NCT02593227|Vaccines|vaccines|mesh-list
84157840|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
84157841|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157842|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84157843|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84157844|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84157845|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
84157846|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157847|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157848|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84157849|NCT04030481|Anesthetics|anesthetics|mesh-list
84157850|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157851|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157852|NCT02592915|Clonidine|clonidine|mesh-list
84157853|NCT02592915|Anesthetics|anesthetics|mesh-list
84157854|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157855|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157856|NCT02592915|Analgesics|analgesics|mesh-ancestor
84157857|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
84157858|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157859|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83429873|NCT00466817|Valganciclovir|valganciclovir|mesh-list
84157860|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
84157861|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
84157862|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84157863|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84157864|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84157865|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
84157866|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157867|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157868|NCT00727311|Ribavirin|ribavirin|mesh-list
84157869|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84157870|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
84157871|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
84157872|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157873|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
84157874|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157875|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
84157876|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157877|NCT00726999|Morphine|morphine|mesh-list
84157878|NCT00726999|Gabapentin|gabapentin|mesh-list
84157879|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84157880|NCT00726999|Narcotics|narcotics|mesh-ancestor
84157881|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84157882|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157883|NCT00726999|Analgesics|analgesics|mesh-ancestor
84157884|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
84157885|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157886|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
84157887|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84157888|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84157889|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157890|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84157891|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84157892|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157893|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157894|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
84157895|NCT00585351|Ranitidine|ranitidine|mesh-list
84157896|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
84157897|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84157898|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84157899|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
84157900|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
84157901|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
84157902|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157903|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157904|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157905|NCT00726609|Posaconazole|posaconazole|mesh-list
84157906|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
84157907|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84157908|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84157909|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84157910|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84157911|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84157912|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84157913|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157914|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157915|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84157916|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
84157917|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84157918|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157919|NCT00808028|Vaccines|vaccines|mesh-list
84157920|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
84157921|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157922|NCT03466346|Fluoxetine|fluoxetine|mesh-list
84157923|NCT03466346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84157924|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84157925|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157926|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157927|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157928|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
84157929|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157930|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84157931|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
84157932|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83429949|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84157933|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84157934|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84157935|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157936|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
84157937|NCT05754242|Vitamins|vitamins|mesh-ancestor
84157938|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
84157939|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157940|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
84157941|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157942|NCT05754242|Protective Agents|protective agents|mesh-ancestor
84157943|NCT00809783|Tanezumab|tanezumab|mesh-list
84157944|NCT00809783|Analgesics|analgesics|mesh-ancestor
84157945|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
84157946|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157947|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157948|NCT05675462|Lenvatinib|lenvatinib|mesh-list
84157949|NCT05675462|Tislelizumab|tislelizumab|mesh-list
84157950|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157951|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84157952|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84157953|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157954|NCT05675462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84157955|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
84157956|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84157957|NCT02608658|Antibodies|antibodies|mesh-list
84157958|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
84157959|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157960|NCT00807248|Gaboxadol|gaboxadol|mesh-list
84157961|NCT00807248|Dexetimide|dexetimide|mesh-list
84157962|NCT00807248|Citalopram|citalopram|mesh-list
84157963|NCT00807248|Escitalopram|escitalopram|mesh-list
84157964|NCT00807248|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84157965|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84157966|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84157967|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157968|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84157969|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
84157970|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84157971|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84157972|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84157973|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
84157974|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
84157975|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84157976|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84157977|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84157978|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
84157979|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84157980|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
84157981|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84157982|NCT00807248|Analgesics|analgesics|mesh-ancestor
84157983|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
84157984|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
84157985|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
84157986|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
84157987|NCT02607332|Paclitaxel|paclitaxel|mesh-list
84157988|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84157989|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84157990|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
84157991|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
84157992|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
84157993|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157994|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84157995|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84157996|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84157997|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
84157998|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84157999|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158000|NCT05297669|Analgesics|analgesics|mesh-ancestor
84158001|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
84158002|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158003|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158004|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158005|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158006|NCT00589628|Infliximab|infliximab|mesh-list
84158007|NCT00589628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83430026|NCT03024476|Olmesartan|olmesartan|mesh-list
84158008|NCT00589628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158009|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
84158010|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158011|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158012|NCT05754983|Immunomodulating Agents|immunomodulating agents|mesh-list
84158013|NCT05754983|Immunologic Factors|immunologic factors|mesh-ancestor
84158014|NCT05754983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158016|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
84158017|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158018|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
84158019|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84158020|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
84158021|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158022|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158023|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84158024|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
84158025|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84158026|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84158027|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84158028|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158029|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158030|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158031|NCT02605772|Metformin|metformin|mesh-list
84158032|NCT02605772|Saxagliptin|saxagliptin|mesh-list
84158033|NCT02605772|Acarbose|acarbose|mesh-list
84158034|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84158035|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158036|NCT02605772|Incretins|incretins|mesh-ancestor
84158037|NCT02605772|Hormones|hormones|mesh-ancestor
84158038|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158039|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84158040|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
84158041|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158042|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158043|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
84158044|NCT04115462|Morphine|morphine|mesh-list
84158045|NCT04115462|Histamine|histamine|mesh-list
84158046|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
84158047|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84158048|NCT04115462|Narcotics|narcotics|mesh-ancestor
84158049|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158050|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158051|NCT04115462|Analgesics|analgesics|mesh-ancestor
84158052|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
84158053|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158054|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
84158055|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
84158056|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158057|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158058|NCT02605460|Plerixafor|plerixafor|mesh-list
84158059|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
84158060|NCT02605460|Busulfan|busulfan|mesh-list
84158061|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84158062|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
84158063|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158064|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158065|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84158066|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
84158067|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158068|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158069|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84158070|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84158071|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84158072|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
84158073|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158074|NCT00797108|Amoxicillin|amoxicillin|mesh-list
84158075|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
84158076|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
84158077|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
84158078|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84158079|NCT00797108|Lactams|lactams|mesh-list
84158080|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84158081|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158082|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84158083|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158084|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158085|NCT00742560|Dexamethasone|dexamethasone|mesh-list
84158086|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
84158087|NCT00742560|Lenalidomide|lenalidomide|mesh-list
84158088|NCT00742560|Elotuzumab|elotuzumab|mesh-list
84158089|NCT00742560|BB 1101|bb 1101|mesh-list
84158090|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158091|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
84158092|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
84158093|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158094|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158095|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158096|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
84158097|NCT00742560|Hormones|hormones|mesh-ancestor
84158098|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158099|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84158100|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158101|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
84158102|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158103|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158104|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
84158105|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84158106|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84158107|NCT00742560|Growth Substances|growth substances|mesh-ancestor
84158108|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
84158109|NCT02604914|Levodopa|levodopa|mesh-list
84158110|NCT02604914|Carbidopa|carbidopa|mesh-list
84158111|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84158112|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84158113|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84158114|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
84158115|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158116|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158117|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158118|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84158119|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158120|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84158121|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
84158122|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
84158123|NCT00796718|Capecitabine|capecitabine|mesh-list
84158124|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84158125|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
84158126|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158127|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158128|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
84158129|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84158130|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84158131|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
84158132|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158133|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84158134|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84158135|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158136|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158137|NCT04025840|Dexamethasone|dexamethasone|mesh-list
84158138|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
84158139|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158140|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
84158141|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
84158142|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158143|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158144|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158145|NCT04025840|Hormones|hormones|mesh-ancestor
84158146|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158147|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84158148|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158149|NCT00589472|Vorinostat|vorinostat|mesh-list
84158150|NCT00589472|Leuprolide|leuprolide|mesh-list
84158151|NCT00589472|Goserelin|goserelin|mesh-list
84158152|NCT00589472|Bicalutamide|bicalutamide|mesh-list
84158153|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158154|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84158155|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158156|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158157|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84158158|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
83430176|NCT00506857|Fludarabine|fludarabine|mesh-list
84158159|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84158160|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158161|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84158162|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
84158163|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
84158164|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158165|NCT02608931|Dronabinol|dronabinol|mesh-list
84158166|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
84158167|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158168|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84158169|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158170|NCT02608931|Analgesics|analgesics|mesh-ancestor
84158171|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
84158172|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158173|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84158174|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84158175|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158176|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158177|NCT02608931|Hormones|hormones|mesh-ancestor
84158178|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158179|NCT00744978|Varenicline|varenicline|mesh-list
84158180|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84158181|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84158182|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
84158183|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158184|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158185|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158186|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
84158187|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84158188|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
84158189|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158190|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
84158191|NCT02595606|Protective Agents|protective agents|mesh-ancestor
84158192|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
84158193|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
84158194|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84158195|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84158196|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
84158197|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158198|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158199|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158200|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158201|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84158202|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158203|NCT04570475|Vitamin D|vitamin d|mesh-list
84158204|NCT04570475|Vitamins|vitamins|mesh-ancestor
84158205|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
84158206|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158207|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84158208|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84158209|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84158210|NCT00739596|Amlodipine|amlodipine|mesh-list
84158211|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84158212|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84158213|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84158214|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84158215|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158216|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84158217|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158218|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
84158219|NCT00739596|Diuretics|diuretics|mesh-ancestor
84158220|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
84158221|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84158222|NCT00742326|Pioglitazone|pioglitazone|mesh-list
84158223|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84158224|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158225|NCT02597868|Capecitabine|capecitabine|mesh-list
84158226|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84158227|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
84158228|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158229|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158230|NCT00811187|Lidocaine|lidocaine|mesh-list
84158231|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
84158232|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
84158233|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158234|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158235|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
84158236|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158237|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84158238|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84158239|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84158240|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84158241|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158242|NCT00917748|Docetaxel|docetaxel|mesh-list
84158243|NCT00917748|Modafinil|modafinil|mesh-list
84158244|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158245|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
84158246|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
84158247|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
84158248|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158249|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84158250|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158251|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84158252|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84158253|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84158254|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
84158255|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84158256|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158257|NCT00591149|Docetaxel|docetaxel|mesh-list
84158258|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
84158259|NCT00591149|Cetuximab|cetuximab|mesh-list
84158260|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158261|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
84158262|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
84158263|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
84158264|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158265|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84158266|NCT00735072|Maraviroc|maraviroc|mesh-list
84158267|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84158268|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84158269|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158270|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84158271|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84158272|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
84158273|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158274|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84158275|NCT00793598|Brincidofovir|brincidofovir|mesh-list
84158276|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
84158277|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158278|NCT04115072|Praziquantel|praziquantel|mesh-list
84158279|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
84158280|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84158281|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158282|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
84158283|NCT00796562|Busulfan|busulfan|mesh-list
84158284|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84158285|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
84158286|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158287|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158288|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84158289|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
84158290|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158291|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158292|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84158293|NCT00801632|Prednisone|prednisone|mesh-list
84158294|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
84158295|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
84158296|NCT00801632|Rituximab|rituximab|mesh-list
84158297|NCT00801632|Tacrolimus|tacrolimus|mesh-list
84158298|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84158299|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
84158300|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158301|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158302|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84158303|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
84158304|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158305|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158306|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84158307|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84158308|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158309|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
84158310|NCT00801632|Hormones|hormones|mesh-ancestor
84158311|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158312|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84158313|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84158314|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158315|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
84158316|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
84158317|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158318|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158319|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84158320|NCT00801632|Protective Agents|protective agents|mesh-ancestor
84158321|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
84158322|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84158323|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84158324|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
84158325|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158326|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158327|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84158328|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
84158329|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84158330|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
84158331|NCT04111484|Protective Agents|protective agents|mesh-ancestor
84158332|NCT04111328|Sufentanil|sufentanil|mesh-list
84158333|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
84158334|NCT04111328|Dsuvia|dsuvia|mesh-list
84158335|NCT04111328|Hydromorphone|hydromorphone|mesh-list
84158336|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84158337|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158338|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158339|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158340|NCT04111328|Analgesics|analgesics|mesh-ancestor
84158341|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
84158342|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158343|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84158344|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84158345|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84158346|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158347|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158348|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158349|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84158350|NCT04111328|Narcotics|narcotics|mesh-ancestor
84158351|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84158352|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84158353|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
84158354|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
84158355|NCT00806819|Folic Acid|folic acid|mesh-list
84158356|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
84158357|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
84158358|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
84158359|NCT00806819|Dexamethasone|dexamethasone|mesh-list
84158360|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
84158361|NCT00806819|Pemetrexed|pemetrexed|mesh-list
84158362|NCT00806819|Nintedanib|nintedanib|mesh-list
84158363|NCT00806819|BB 1101|bb 1101|mesh-list
84158364|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158365|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
84158366|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
84158367|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158368|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158369|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158370|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
84158371|NCT00806819|Hormones|hormones|mesh-ancestor
84158372|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158373|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84158374|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158375|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
84158376|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158377|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158378|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84158379|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84158380|NCT00806819|Hematinics|hematinics|mesh-ancestor
84158381|NCT00806819|Vitamins|vitamins|mesh-ancestor
84158382|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
84158383|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84158384|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
84158385|NCT04109534|Miotics|miotics|mesh-ancestor
84158386|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
84158387|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158388|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158389|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84158390|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
84158391|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
84158392|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84158393|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84158394|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
84158395|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158396|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158397|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
84158398|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84158399|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84158400|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158401|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
84158402|NCT05326139|Coagulants|coagulants|mesh-ancestor
84158403|NCT02605694|Prednisone|prednisone|mesh-list
84158404|NCT02605694|Rituximab|rituximab|mesh-list
84158405|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84158406|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158407|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
84158408|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158409|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158410|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158411|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
84158412|NCT02605694|Hormones|hormones|mesh-ancestor
84158413|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158414|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84158415|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
84158416|NCT02604134|Fluorides|fluorides|mesh-list
84158417|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
84158418|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
84158419|NCT02604134|Protective Agents|protective agents|mesh-ancestor
84158420|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158421|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84158422|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158423|NCT00800540|Timolol|timolol|mesh-list
84158424|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84158425|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84158426|NCT00800540|Brinzolamide|brinzolamide|mesh-list
84158427|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84158428|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84158429|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84158430|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158431|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158432|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158433|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158434|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84158435|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84158436|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84158437|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84158438|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84158439|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
84158440|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158441|NCT00796328|Phenylephrine|phenylephrine|mesh-list
84158442|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
84158443|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84158444|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
84158445|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
84158446|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158447|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158448|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
84158449|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84158450|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
84158451|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
84158452|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84158453|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84158454|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84158455|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158456|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158457|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158458|NCT00796328|Protective Agents|protective agents|mesh-ancestor
84158459|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
84158460|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84158461|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84158462|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158463|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
84158464|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
84158465|NCT04110860|Voriconazole|voriconazole|mesh-list
84158466|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
84158467|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158468|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84158469|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84158470|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158471|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158472|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84158473|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
84158474|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158475|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158476|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84158477|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
84158478|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84158479|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158480|NCT04114526|Nicotine|nicotine|mesh-list
84158481|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84158482|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
84158483|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158484|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158485|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84158486|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84158487|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
84158488|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158489|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158490|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
84158491|NCT00915200|Silybin|silybin|mesh-list
84158492|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84158493|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
84158494|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158495|NCT00915200|Expectorants|expectorants|mesh-ancestor
84158496|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
84158497|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84158498|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
84158499|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158500|NCT00915200|Protective Agents|protective agents|mesh-ancestor
84158501|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158502|NCT00915200|Antidotes|antidotes|mesh-ancestor
84158503|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84158504|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158505|NCT00588146|Interferons|interferons|mesh-list
84158506|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
84158507|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
84158508|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84158509|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158510|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
84158511|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158512|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
84158513|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158514|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84158515|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
84158516|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158517|NCT00799058|Dapivirine|dapivirine|mesh-list
84158518|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84158519|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84158520|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
84158521|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158522|NCT00725985|Cladribine|cladribine|mesh-list
84158523|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158524|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84158525|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
84158526|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158527|NCT00793910|Gabapentin|gabapentin|mesh-list
84158528|NCT00793910|Analgesics|analgesics|mesh-ancestor
84158529|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
84158530|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158531|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158532|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
84158533|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84158534|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84158535|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158536|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83430547|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84158537|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84158538|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84158539|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158540|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158541|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
84158543|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84158544|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158545|NCT05589818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84158546|NCT05589818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158547|NCT01019941|Docetaxel|docetaxel|mesh-list
84158548|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158549|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
84158550|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
84158551|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
84158552|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158553|NCT04113668|Diflunisal|diflunisal|mesh-list
84158554|NCT04113668|Deucravacitinib|deucravacitinib|mesh-list
84158555|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
84158556|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84158557|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158558|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158559|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84158560|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158561|NCT04113668|Analgesics|analgesics|mesh-ancestor
84158562|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
84158563|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158564|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158565|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158566|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158567|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84158568|NCT00444145|Lansoprazole|lansoprazole|mesh-list
84158569|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84158570|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158571|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84158572|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158573|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158574|NCT04107896|Tamsulosin|tamsulosin|mesh-list
84158575|NCT04107896|Silodosin|silodosin|mesh-list
84158576|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84158577|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84158578|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84158579|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158580|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158581|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158582|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158583|NCT04107896|Urological Agents|urological agents|mesh-ancestor
84158584|NCT01024777|Vitamin D|vitamin d|mesh-list
84158585|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
84158586|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
84158587|NCT01024777|Vitamins|vitamins|mesh-list
84158588|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
84158589|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158590|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84158591|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84158592|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84158593|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
84158594|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
84158595|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
84158596|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84158597|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84158598|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84158599|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158600|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158601|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158602|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158603|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
84158604|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84158605|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84158606|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84158607|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158608|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84158609|NCT00725205|Ribavirin|ribavirin|mesh-list
84158610|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84158612|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
84158613|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158614|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
84158615|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158616|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
84158617|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158618|NCT00443755|Metformin|metformin|mesh-list
84158619|NCT00443755|Pioglitazone|pioglitazone|mesh-list
84158620|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84158621|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158622|NCT04107740|TA 0910|ta 0910|mesh-list
84158623|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
84158624|NCT00724971|Rituximab|rituximab|mesh-list
84158625|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
84158626|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84158627|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158628|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
84158629|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158630|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158631|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84158632|NCT00724971|Immunotoxins|immunotoxins|mesh-ancestor
84158633|NCT00724971|Immunoconjugates|immunoconjugates|mesh-ancestor
84158634|NCT00443599|Insulin|insulin|mesh-list
84158635|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84158636|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84158637|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158638|NCT04107428|Somatostatin|somatostatin|mesh-list
84158639|NCT04107428|Hormones|hormones|mesh-ancestor
84158640|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158641|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158642|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
84158643|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84158644|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158645|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158646|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158647|NCT00455143|Analgesics|analgesics|mesh-ancestor
84158648|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
84158649|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158650|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84158651|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84158652|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84158653|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158654|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158655|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158656|NCT00724893|Interferons|interferons|mesh-list
84158657|NCT00724893|Ribavirin|ribavirin|mesh-list
84158658|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
84158659|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
84158660|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84158661|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158662|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
84158663|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158664|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
84158665|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158666|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
84158667|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158668|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84158669|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
84158670|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
84158671|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84158672|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84158673|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84158674|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158675|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158676|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
84158677|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84158678|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84158679|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158680|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158681|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158682|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84158683|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84158684|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
84158685|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84158686|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84158687|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
84158689|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84158690|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84158691|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84158692|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
84158693|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158694|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158695|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158696|NCT00798590|Glucagon|glucagon|mesh-list
84158697|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
84158698|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158699|NCT00798590|Hormones|hormones|mesh-ancestor
84158700|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158701|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158702|NCT00798590|Incretins|incretins|mesh-ancestor
84158703|NCT00481195|Modafinil|modafinil|mesh-list
84158704|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84158705|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158706|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84158707|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84158708|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84158709|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158710|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
84158711|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158712|NCT01027429|Amoxicillin|amoxicillin|mesh-list
84158713|NCT01027429|Gentamicins|gentamicins|mesh-list
84158714|NCT01027429|Penicillins|penicillins|mesh-list
84158715|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
84158716|NCT01027429|Penicillin G|penicillin g|mesh-list
84158717|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
84158718|NCT01027429|Procaine|procaine|mesh-list
84158719|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84158720|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158721|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84158722|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158723|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158724|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
84158725|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
84158726|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158727|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158728|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
84158729|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158730|NCT01020253|Alendronate|alendronate|mesh-list
84158731|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
84158732|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
84158733|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84158734|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158735|NCT01020253|Vitamins|vitamins|mesh-ancestor
84158736|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
84158737|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
84158738|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158739|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
84158740|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84158741|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84158742|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158743|NCT00454207|Urological Agents|urological agents|mesh-ancestor
84158744|NCT01020331|Memantine|memantine|mesh-list
84158745|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84158746|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84158747|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
84158748|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158749|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158750|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158751|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84158752|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84158753|NCT00738894|Dipyridamole|dipyridamole|mesh-list
84158754|NCT00738894|Clopidogrel|clopidogrel|mesh-list
84158755|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158756|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158757|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84158758|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158759|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84158760|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84158761|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84158762|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
84158763|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158764|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84158765|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
84158767|NCT00734994|Mitomycin|mitomycin|mesh-list
84158768|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84158769|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158770|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
84158771|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158772|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84158773|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158774|NCT02593734|Olanzapine|olanzapine|mesh-list
84158775|NCT02593734|Risperidone|risperidone|mesh-list
84158776|NCT02593734|Fluoxetine|fluoxetine|mesh-list
84158777|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84158778|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
84158779|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158780|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158781|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158782|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84158783|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84158784|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158785|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84158786|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84158787|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
84158788|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
84158789|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
84158790|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158791|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158792|NCT02593734|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84158793|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84158794|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84158795|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84158796|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
84158797|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84158798|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84158799|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158800|NCT00798434|Fesoterodine|fesoterodine|mesh-list
84158801|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84158802|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84158803|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
84158804|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158805|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158806|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158807|NCT00798434|Urological Agents|urological agents|mesh-ancestor
84158808|NCT04106804|Abatacept|abatacept|mesh-list
84158809|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84158810|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158811|NCT04106804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84158812|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158813|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84158814|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
84158815|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158816|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158817|NCT00791648|Atorvastatin|atorvastatin|mesh-list
84158818|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84158819|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84158820|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
84158821|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158822|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84158823|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84158824|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158825|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
84158826|NCT05366595|Astringents|astringents|mesh-ancestor
84158827|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158828|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
84158829|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84158830|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
84158831|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158832|NCT04017338|Ezetimibe|ezetimibe|mesh-list
84158833|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84158834|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84158835|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
84158836|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158837|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84158838|NCT04106726|Ivermectin|ivermectin|mesh-list
84158839|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84158840|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158841|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
84158842|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84158843|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158844|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158845|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84158846|NCT00723957|Paclitaxel|paclitaxel|mesh-list
84158847|NCT00723957|Carboplatin|carboplatin|mesh-list
84158848|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84158849|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158850|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
84158851|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
84158852|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
84158853|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158854|NCT02603822|Indomethacin|indomethacin|mesh-list
84158855|NCT02603822|Mannitol|mannitol|mesh-list
84158856|NCT02603822|Lactulose|lactulose|mesh-list
84158857|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84158858|NCT02603822|Diuretics|diuretics|mesh-ancestor
84158859|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
84158860|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158861|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84158862|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158863|NCT02603822|Analgesics|analgesics|mesh-ancestor
84158864|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
84158865|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158866|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158867|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158868|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
84158869|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
84158870|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84158871|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84158872|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158873|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158874|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84158875|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
84158876|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
84158877|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158878|NCT00723801|Losartan|losartan|mesh-list
84158879|NCT00723801|Atenolol|atenolol|mesh-list
84158880|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84158881|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84158882|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84158883|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84158884|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158885|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
84158886|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
84158887|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158888|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158889|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84158890|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84158891|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84158892|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158893|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158894|NCT00797966|Fluoxetine|fluoxetine|mesh-list
84158895|NCT00797966|Paroxetine|paroxetine|mesh-list
84158896|NCT00797966|Sertraline|sertraline|mesh-list
84158897|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84158898|NCT00797966|Escitalopram|escitalopram|mesh-list
84158899|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
84158900|NCT00797966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84158901|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84158902|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84158903|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158904|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158905|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
84158906|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158907|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84158908|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
84158909|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84158910|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84158911|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84158912|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158913|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84158914|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
84158915|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
84158916|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
84158917|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84158918|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84158919|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158920|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158921|NCT05361837|Analgesics|analgesics|mesh-ancestor
84158922|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
84158923|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158924|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84158925|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84158926|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84158927|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
84158928|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84158929|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158930|NCT00723255|Sirolimus|sirolimus|mesh-list
84158931|NCT00723255|Bevacizumab|bevacizumab|mesh-list
84158932|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84158933|NCT00723255|Temsirolimus|temsirolimus|mesh-list
84158934|NCT00723255|MTOR Inhibitors|mtor inhibitors|mesh-list
84158935|NCT00723255|Antibodies|antibodies|mesh-list
84158936|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
84158937|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84158938|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84158939|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84158940|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84158941|NCT00723255|Growth Substances|growth substances|mesh-ancestor
84158942|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158943|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
84158944|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
84158945|NCT00723255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84158946|NCT00723255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158947|NCT00723255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158948|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84158949|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84158950|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84158951|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84158952|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
84158953|NCT00791258|Amlodipine|amlodipine|mesh-list
84158954|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84158955|NCT00791258|Olmesartan|olmesartan|mesh-list
84158956|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
84158957|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84158958|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84158959|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84158960|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158961|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84158962|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158963|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
84158964|NCT00791258|Diuretics|diuretics|mesh-ancestor
84158965|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
84158966|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84158967|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84158968|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84158969|NCT00808067|Dabigatran|dabigatran|mesh-list
84158970|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
84158971|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84158972|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
84158973|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158974|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158975|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
84158976|NCT00723021|Zileuton|zileuton|mesh-list
84158977|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84158978|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158979|NCT00723021|Analgesics|analgesics|mesh-ancestor
84158980|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
84158981|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158982|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431004|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84158983|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84158984|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84158985|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84158986|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84158987|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84158988|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
84158989|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
84158990|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84158991|NCT04087317|Acetaminophen|acetaminophen|mesh-list
84158992|NCT04087317|Ibuprofen|ibuprofen|mesh-list
84158993|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84158994|NCT04087317|Analgesics|analgesics|mesh-ancestor
84158995|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
84158996|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84158997|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84158998|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
84158999|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84159000|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84159001|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84159002|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84159003|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159004|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159005|NCT04309409|Nivolumab|nivolumab|mesh-list
84159006|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84159007|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159008|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84159009|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159010|NCT04086537|Hepcidins|hepcidins|mesh-list
84159011|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159012|NCT02608619|Choline|choline|mesh-list
84159013|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
84159014|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84159015|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
84159016|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159017|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84159018|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84159019|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
84159020|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84159021|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159022|NCT05754203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84159023|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159024|NCT02591667|Bevacizumab|bevacizumab|mesh-list
84159025|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84159026|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159027|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84159028|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84159029|NCT02591667|Growth Substances|growth substances|mesh-ancestor
84159030|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159031|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
84159032|NCT00807599|Dexamethasone|dexamethasone|mesh-list
84159033|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
84159034|NCT00807599|Lenalidomide|lenalidomide|mesh-list
84159035|NCT00807599|Melphalan|melphalan|mesh-list
84159036|NCT00807599|BB 1101|bb 1101|mesh-list
84159037|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84159038|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
84159039|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
84159040|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159041|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159042|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84159043|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
84159044|NCT00807599|Hormones|hormones|mesh-ancestor
84159045|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159046|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84159047|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159048|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
84159049|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159050|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159051|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
84159052|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84159053|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84159054|NCT00807599|Growth Substances|growth substances|mesh-ancestor
84159055|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
84159056|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84159057|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
84159058|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84159059|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84159060|NCT00788372|Fentanyl|fentanyl|mesh-list
84159061|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84159062|NCT00788372|Narcotics|narcotics|mesh-ancestor
84159063|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159064|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159065|NCT00788372|Analgesics|analgesics|mesh-ancestor
84159066|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
84159067|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159068|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84159069|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84159070|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
84159071|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
84159072|NCT00738582|Pemetrexed|pemetrexed|mesh-list
84159073|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159074|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159075|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159076|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84159077|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84159078|NCT05753657|Pioglitazone|pioglitazone|mesh-list
84159079|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84159080|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159081|NCT00720759|Cycloserine|cycloserine|mesh-list
84159082|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84159083|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159084|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84159085|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
84159086|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84159087|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
84159088|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159089|NCT00918411|Ramosetron|ramosetron|mesh-list
84159090|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
84159091|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
84159092|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159093|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159094|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84159095|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84159096|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
84159097|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159098|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159099|NCT00810407|Rifabutin|rifabutin|mesh-list
84159100|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84159101|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159102|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84159103|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
84159104|NCT00720057|Naproxen|naproxen|mesh-list
84159105|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84159106|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84159107|NCT00720057|Analgesics|analgesics|mesh-ancestor
84159108|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
84159109|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159110|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159111|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84159112|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84159113|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
84159114|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84159115|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159116|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159117|NCT00790868|Cycloserine|cycloserine|mesh-list
84159118|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84159119|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159120|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84159121|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
84159122|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84159123|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
84159124|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159125|NCT00719901|Bortezomib|bortezomib|mesh-list
84159126|NCT00719901|Obatoclax|obatoclax|mesh-list
84159127|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159128|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159129|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159130|NCT02603276|Red yeast rice|red yeast rice|mesh-list
84159131|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84159132|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84159133|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84159134|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
84159135|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159136|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159137|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84159138|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
84159139|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
84159140|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159141|NCT00807365|Hormones|hormones|mesh-list
84159142|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
84159143|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159144|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159145|NCT02609711|Candesartan|candesartan|mesh-list
84159146|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
84159147|NCT02609711|Atorvastatin|atorvastatin|mesh-list
84159148|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84159149|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84159150|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
84159151|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159152|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84159153|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84159154|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159155|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84159156|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84159157|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84159158|NCT04016207|Guanfacine|guanfacine|mesh-list
84159159|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84159160|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84159161|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84159162|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84159163|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159164|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159165|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159166|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159167|NCT04030091|Insulin|insulin|mesh-list
84159168|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84159169|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
84159170|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84159171|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159172|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
84159173|NCT00734604|Tadalafil|tadalafil|mesh-list
84159174|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159175|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
84159176|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84159177|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84159178|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159179|NCT00734604|Urological Agents|urological agents|mesh-ancestor
84159180|NCT00590681|Bevacizumab|bevacizumab|mesh-list
84159181|NCT00590681|Temozolomide|temozolomide|mesh-list
84159182|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84159183|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159184|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84159185|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84159186|NCT00590681|Growth Substances|growth substances|mesh-ancestor
84159187|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159188|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
84159189|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84159190|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
84159191|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159192|NCT00727272|Quinine|quinine|mesh-list
84159193|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
84159194|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84159195|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84159196|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159197|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84159198|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159199|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84159200|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159201|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84159202|NCT00727272|Analgesics|analgesics|mesh-ancestor
84159203|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
84159204|NCT02609477|Phentermine|phentermine|mesh-list
84159205|NCT02609477|Istradefylline|istradefylline|mesh-list
84159206|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84159207|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159208|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
84159209|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84159210|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
84159211|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
84159212|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159213|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159214|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159215|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159216|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
84159217|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84159218|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84159219|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
84159220|NCT02592720|Tenecteplase|tenecteplase|mesh-list
84159221|NCT02592720|Tirofiban|tirofiban|mesh-list
84159222|NCT02592720|Bivalirudin|bivalirudin|mesh-list
84159223|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84159224|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84159225|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159226|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
84159227|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84159228|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
84159229|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159230|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
84159231|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84159232|NCT02608073|Capecitabine|capecitabine|mesh-list
84159233|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159234|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84159235|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
84159236|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159237|NCT04041791|Amoxicillin|amoxicillin|mesh-list
84159238|NCT04041791|Gentamicins|gentamicins|mesh-list
84159239|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
84159240|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
84159241|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
84159242|NCT04041791|Penicillins|penicillins|mesh-list
84159243|NCT04041791|Ampicillin|ampicillin|mesh-list
84159244|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84159245|NCT04041791|Penicillin G|penicillin g|mesh-list
84159246|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
84159247|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
84159248|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84159249|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159250|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84159251|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159252|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159253|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84159254|NCT02605226|Bicalutamide|bicalutamide|mesh-list
84159255|NCT02605226|Hormones|hormones|mesh-list
84159256|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
84159257|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159258|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159259|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
84159260|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
84159261|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159262|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
84159263|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84159264|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159265|NCT04088448|Metformin|metformin|mesh-list
84159266|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84159267|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159268|NCT00806351|Caspofungin|caspofungin|mesh-list
84159269|NCT00806351|Anidulafungin|anidulafungin|mesh-list
84159270|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
84159271|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159272|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159273|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159274|NCT03995251|Testosterone|testosterone|mesh-list
84159275|NCT03995251|Androgens|androgens|mesh-ancestor
84159276|NCT03995251|Hormones|hormones|mesh-ancestor
84159277|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159278|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159279|NCT01031017|Progesterone|progesterone|mesh-list
83431309|NCT03840200|Rucaparib|rucaparib|mesh-list
84159280|NCT01031017|Progestins|progestins|mesh-ancestor
84159281|NCT01031017|Hormones|hormones|mesh-ancestor
84159282|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159283|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159284|NCT03742531|Oxytocin|oxytocin|mesh-list
84159285|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
84159286|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84159287|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159288|NCT05738135|Aminophylline|aminophylline|mesh-list
84159289|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159290|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
84159291|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159292|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159293|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159294|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159295|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84159296|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84159297|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159298|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159299|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84159300|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84159301|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
84159302|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159303|NCT05738135|Protective Agents|protective agents|mesh-ancestor
84159304|NCT00733902|Tanezumab|tanezumab|mesh-list
84159305|NCT00733902|Analgesics|analgesics|mesh-ancestor
84159306|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
84159307|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159308|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159309|NCT05737355|Red yeast rice|red yeast rice|mesh-list
84159310|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84159311|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84159312|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84159313|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
84159314|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159315|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159316|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84159317|NCT03540017|Cisplatin|cisplatin|mesh-list
84159318|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159319|NCT02606981|Vitamins|vitamins|mesh-list
84159320|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
84159321|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
84159322|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159323|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
84159324|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159325|NCT02606981|Protective Agents|protective agents|mesh-ancestor
84159326|NCT00914888|Metronidazole|metronidazole|mesh-list
84159327|NCT00914888|Clarithromycin|clarithromycin|mesh-list
84159328|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
84159329|NCT00914888|Tigecycline|tigecycline|mesh-list
84159330|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159331|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84159332|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84159333|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84159334|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84159335|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159336|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159337|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84159338|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84159339|NCT02603198|Epinephrine|epinephrine|mesh-list
84159340|NCT02603198|Nordefrin|nordefrin|mesh-list
84159341|NCT02603198|Anesthetics|anesthetics|mesh-list
84159342|NCT02603198|Mepivacaine|mepivacaine|mesh-list
84159343|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159344|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159345|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84159346|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84159347|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159348|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159349|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159350|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84159351|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159352|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
84159353|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159354|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159355|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159356|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
83431377|NCT04149938|Lidocaine|lidocaine|mesh-list
84159357|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
84159358|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84159359|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
84159360|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
84159361|NCT00719043|Vaccines|vaccines|mesh-list
84159362|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
84159363|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159364|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
84159365|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84159366|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
84159367|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84159368|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
84159369|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159370|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159371|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
84159372|NCT00718887|Entecavir|entecavir|mesh-list
84159373|NCT00718887|Adefovir|adefovir|mesh-list
84159374|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
84159375|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159376|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84159377|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84159378|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159379|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159380|NCT00786188|Paroxetine|paroxetine|mesh-list
84159381|NCT00786188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84159382|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84159383|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84159384|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159385|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159386|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
84159387|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159388|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84159389|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
84159390|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84159391|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84159392|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84159393|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159394|NCT00733824|Plerixafor|plerixafor|mesh-list
84159395|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84159396|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84159397|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
84159398|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159399|NCT00718809|Saracatinib|saracatinib|mesh-list
84159400|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159401|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159402|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159403|NCT00585039|Albuterol|albuterol|mesh-list
84159404|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159405|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
84159406|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159407|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159408|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159409|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159410|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
84159411|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84159412|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84159413|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84159414|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84159415|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159416|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159417|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159418|NCT04085913|Lidocaine|lidocaine|mesh-list
84159419|NCT04085913|Epinephrine|epinephrine|mesh-list
84159420|NCT04085913|Racepinephrine|racepinephrine|mesh-list
84159421|NCT04085913|Bupivacaine|bupivacaine|mesh-list
84159422|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
84159423|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
84159424|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
84159425|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159426|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159427|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
84159428|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159429|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84159430|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84159431|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84159432|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84159433|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159434|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84159435|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84159436|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159437|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159438|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84159439|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159440|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
84159441|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159442|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159444|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
84159445|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84159446|NCT00806195|Vaccines|vaccines|mesh-list
84159447|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84159448|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
84159449|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159450|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84159451|NCT03462329|Doxycycline|doxycycline|mesh-list
84159452|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159453|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
84159454|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84159455|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84159456|NCT05728151|Epinephrine|epinephrine|mesh-list
84159457|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
84159458|NCT05728151|Carticaine|carticaine|mesh-list
84159459|NCT05728151|Mepivacaine|mepivacaine|mesh-list
84159460|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84159461|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84159462|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159463|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159464|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159465|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159466|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84159467|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159468|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
84159469|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159470|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159471|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159472|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
84159473|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
84159474|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84159475|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
84159476|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
84159477|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159478|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
84159479|NCT00733746|Gemcitabine|gemcitabine|mesh-list
84159480|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84159481|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84159482|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
84159483|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159484|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159485|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84159486|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159487|NCT03422705|Lisinopril|lisinopril|mesh-list
84159488|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84159489|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
84159490|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159491|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159492|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84159493|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84159494|NCT03422705|Protective Agents|protective agents|mesh-ancestor
84159495|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159496|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
84159497|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
84159498|NCT02607293|Hormones|hormones|mesh-ancestor
84159499|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159500|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159501|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
84159502|NCT02607371|Apixaban|apixaban|mesh-list
84159503|NCT02607371|Edoxaban|edoxaban|mesh-list
84159504|NCT02607371|Dabigatran|dabigatran|mesh-list
84159505|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84159506|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
84159507|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84159508|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
84159509|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159510|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159512|NCT04085757|Dinoprostone|dinoprostone|mesh-list
84159513|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
84159514|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84159515|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159516|NCT00727194|Eculizumab|eculizumab|mesh-list
84159517|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84159518|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84159519|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
84159520|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159521|NCT00717093|Varenicline|varenicline|mesh-list
84159522|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84159523|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84159524|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
84159525|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159526|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159527|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159528|NCT00716859|Timolol|timolol|mesh-list
84159529|NCT00716859|Latanoprost|latanoprost|mesh-list
84159530|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84159531|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84159532|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159533|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159534|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159535|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159536|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84159537|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84159538|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
84159539|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84159540|NCT00590135|Atorvastatin|atorvastatin|mesh-list
84159541|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84159542|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84159543|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
84159544|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159545|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84159546|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84159547|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159548|NCT00589667|Gemcitabine|gemcitabine|mesh-list
84159549|NCT00589667|Pemetrexed|pemetrexed|mesh-list
84159550|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84159551|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
84159552|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159553|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159554|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159555|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84159556|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84159557|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
84159558|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84159559|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84159560|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159561|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159562|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
84159563|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159564|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84159565|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84159566|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
84159567|NCT05752799|Anesthetics|anesthetics|mesh-list
84159568|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159569|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159570|NCT05752799|Narcotics|narcotics|mesh-ancestor
84159571|NCT05752799|Analgesics|analgesics|mesh-ancestor
84159572|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
84159573|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159574|NCT00737100|Bromides|bromides|mesh-list
84159575|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
84159576|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159577|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
84159578|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159579|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159580|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83431599|NCT00487721|Silymarin|silymarin|mesh-list
84159581|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159583|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84159584|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
84159585|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159586|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159587|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
84159588|NCT00732498|Cytarabine|cytarabine|mesh-list
84159589|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
84159590|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84159591|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84159592|NCT00732498|Prednisolone|prednisolone|mesh-list
84159593|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
84159594|NCT00732498|Rituximab|rituximab|mesh-list
84159595|NCT00732498|Etoposide|etoposide|mesh-list
84159596|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84159597|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84159598|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
84159599|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84159600|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159601|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
84159602|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159603|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84159604|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84159605|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84159606|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84159607|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159608|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159609|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84159610|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
84159611|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
84159612|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159613|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84159614|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84159615|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
84159616|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
84159617|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159618|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84159619|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
84159620|NCT00732498|Hormones|hormones|mesh-ancestor
84159621|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159622|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84159623|NCT00732498|Protective Agents|protective agents|mesh-ancestor
84159624|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84159625|NCT00790400|Everolimus|everolimus|mesh-list
84159626|NCT00790400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84159627|NCT00790400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84159628|NCT00790400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159629|NCT00790400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159630|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84159631|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
84159632|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159633|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159634|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84159635|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84159636|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84159637|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159638|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159639|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84159640|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84159641|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84159642|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
84159643|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159644|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159645|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84159646|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84159647|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
84159648|NCT02602652|Vaccines|vaccines|mesh-list
84159649|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
84159650|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159651|NCT02593500|Budesonide|budesonide|mesh-list
84159652|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84159653|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159654|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
83431676|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159655|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159656|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159657|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159658|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159660|NCT02593500|Hormones|hormones|mesh-ancestor
84159661|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159662|NCT02594358|Caffeine|caffeine|mesh-list
84159663|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84159664|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159665|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84159666|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159667|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159668|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84159669|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84159670|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
84159671|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159672|NCT00785486|Quinine|quinine|mesh-list
84159673|NCT00785486|Midazolam|midazolam|mesh-list
84159674|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84159675|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84159676|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159677|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159678|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84159679|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84159680|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84159681|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84159682|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
84159683|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
84159684|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
84159685|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
84159686|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159687|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159688|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
84159689|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84159690|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84159691|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159692|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84159693|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84159694|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159695|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84159696|NCT00785486|Analgesics|analgesics|mesh-ancestor
84159697|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
84159698|NCT00917904|Dapivirine|dapivirine|mesh-list
84159699|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84159700|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84159701|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
84159702|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159703|NCT00589979|Lidocaine|lidocaine|mesh-list
84159704|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
84159705|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
84159706|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159707|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159708|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
84159709|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159710|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84159711|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84159712|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84159713|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84159714|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159715|NCT02590653|Atorvastatin|atorvastatin|mesh-list
84159716|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84159717|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84159718|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
84159719|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159720|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84159721|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84159722|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159723|NCT00915746|Ketoconazole|ketoconazole|mesh-list
84159724|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
84159725|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159726|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84159727|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84159728|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159729|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159730|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84159731|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
84159732|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159733|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159734|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84159735|NCT00736944|Cisplatin|cisplatin|mesh-list
84159736|NCT00736944|Cetuximab|cetuximab|mesh-list
84159737|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84159738|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159739|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84159740|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
84159741|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84159742|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159743|NCT04084977|Antibodies|antibodies|mesh-list
84159744|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
84159745|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159746|NCT04107194|Amoxicillin|amoxicillin|mesh-list
84159747|NCT04107194|Metronidazole|metronidazole|mesh-list
84159748|NCT04107194|Clarithromycin|clarithromycin|mesh-list
84159749|NCT04107194|Levofloxacin|levofloxacin|mesh-list
84159750|NCT04107194|Tetracycline|tetracycline|mesh-list
84159751|NCT04107194|Rifabutin|rifabutin|mesh-list
84159752|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
84159753|NCT04107194|Pantoprazole|pantoprazole|mesh-list
84159754|NCT04107194|Bismuth|bismuth|mesh-list
84159755|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84159756|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159757|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84159758|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84159759|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84159760|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159761|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159762|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84159763|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84159764|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84159765|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84159766|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84159767|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159768|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84159769|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84159770|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84159771|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84159772|NCT04107194|Antacids|antacids|mesh-ancestor
84159773|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84159774|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
84159775|NCT02590263|Temozolomide|temozolomide|mesh-list
84159776|NCT02590263|ABT-414|abt-414|mesh-list
84159777|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84159778|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
84159779|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159780|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159781|NCT02590263|Immunoconjugates|immunoconjugates|mesh-ancestor
84159782|NCT02590263|Immunologic Factors|immunologic factors|mesh-ancestor
84159783|NCT02590263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159784|NCT00736476|Vaccines|vaccines|mesh-list
84159785|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
84159786|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159787|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
84159788|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84159789|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159790|NCT04019496|Calcitonin|calcitonin|mesh-list
84159791|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
84159792|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
84159793|NCT04019496|Antibodies|antibodies|mesh-list
84159794|NCT04019496|Katacalcin|katacalcin|mesh-list
84159795|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
84159796|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159797|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84159798|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84159799|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
84159800|NCT05717153|Eflornithine|eflornithine|mesh-list
84159801|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159802|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
84159803|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84159804|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84159805|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159806|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
84159807|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159808|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159809|NCT00918489|Vorinostat|vorinostat|mesh-list
84159810|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159811|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84159812|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159813|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159814|NCT05690087|Lidocaine|lidocaine|mesh-list
84159815|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
84159816|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
84159817|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159818|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159819|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
84159820|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159821|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84159822|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84159823|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84159824|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84159825|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159826|NCT02604992|Dronabinol|dronabinol|mesh-list
84159827|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
84159828|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159829|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84159830|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84159831|NCT02604992|Analgesics|analgesics|mesh-ancestor
84159832|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
84159833|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159834|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
84159835|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
84159836|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159837|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159838|NCT02604992|Hormones|hormones|mesh-ancestor
84159839|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159840|NCT03899597|Oxytocin|oxytocin|mesh-list
84159841|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
84159842|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84159843|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159844|NCT00714285|Vaccines|vaccines|mesh-list
84159845|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
84159846|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159847|NCT02823665|Atropine|atropine|mesh-list
84159848|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84159849|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84159850|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159851|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
84159852|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159853|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159854|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159855|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159856|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
84159857|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
84159858|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84159859|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84159860|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
84159861|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159862|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159863|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
84159864|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159865|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
84159866|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159867|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159868|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159869|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159870|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
84159871|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84159872|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
84159873|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159874|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159875|NCT04015557|Acetaminophen|acetaminophen|mesh-list
84159876|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
84159877|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84159878|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84159879|NCT04015557|Analgesics|analgesics|mesh-ancestor
84159880|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
84159881|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159882|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159884|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
84159885|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159886|NCT04015557|Expectorants|expectorants|mesh-ancestor
84159887|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159888|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84159889|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
84159890|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159891|NCT04015557|Protective Agents|protective agents|mesh-ancestor
84159892|NCT04015557|Antidotes|antidotes|mesh-ancestor
84159893|NCT00784784|Zanamivir|zanamivir|mesh-list
84159894|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
84159895|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159896|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159897|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159898|NCT00587288|Reslizumab|reslizumab|mesh-list
84159899|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159900|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159901|NCT00800735|Interferons|interferons|mesh-list
84159902|NCT00800735|Ribavirin|ribavirin|mesh-list
84159903|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
84159904|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
84159905|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84159906|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159907|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
84159908|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84159909|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
84159910|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159911|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
84159912|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159913|NCT05324163|Celecoxib|celecoxib|mesh-list
84159914|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84159915|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84159916|NCT05324163|Analgesics|analgesics|mesh-ancestor
84159917|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
84159918|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159919|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159920|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84159921|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84159922|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84159923|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84159924|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159925|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159926|NCT00730158|Irinotecan|irinotecan|mesh-list
84159927|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84159928|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84159929|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84159930|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159931|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84159932|NCT04114643|Thrombin|thrombin|mesh-list
84159933|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
84159934|NCT04114643|Coagulants|coagulants|mesh-ancestor
84159935|NCT02989662|Mifepristone|mifepristone|mesh-list
84159936|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
84159937|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
84159938|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84159939|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159940|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84159941|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84159942|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84159943|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
84159944|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
84159945|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
84159946|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
84159947|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84159948|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
84159949|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84159950|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
84159951|NCT00784550|Fluticasone|fluticasone|mesh-list
84159952|NCT00784550|Xhance|xhance|mesh-list
84159953|NCT00784550|Bromides|bromides|mesh-list
84159954|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
84159955|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84159956|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84159957|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84159958|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
84159959|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159960|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159961|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84159962|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
84159963|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
84159964|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84159965|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
84159966|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84159967|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
84159968|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84159969|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159970|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84159971|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84159972|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84159973|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
84159974|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
84159975|NCT00729690|Pregabalin|pregabalin|mesh-list
84159976|NCT00729690|Analgesics|analgesics|mesh-ancestor
84159977|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
84159978|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159979|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159980|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
84159981|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84159982|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84159983|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84159984|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84159985|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84159986|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84159987|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159988|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84159989|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
84159990|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84159991|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84159992|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84159993|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84159994|NCT04027829|Analgesics|analgesics|mesh-ancestor
84159995|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
84159996|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84159997|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84159998|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84159999|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84160000|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
84160001|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160002|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160003|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84160004|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84160005|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84160006|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160007|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160008|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84160009|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84160010|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84160011|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
84160012|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160013|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160014|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84160015|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84160016|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
84160017|NCT00729612|Paclitaxel|paclitaxel|mesh-list
84160018|NCT00729612|Carboplatin|carboplatin|mesh-list
84160019|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84160020|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84160021|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160022|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
84160023|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
84160024|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
84160025|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160026|NCT05684913|Hemostatics|hemostatics|mesh-list
84160027|NCT05684913|Coagulants|coagulants|mesh-ancestor
84160028|NCT00585546|Clenbuterol|clenbuterol|mesh-list
84160029|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84160030|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84160031|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
84160032|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160033|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160034|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160035|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160036|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
84160037|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160038|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160039|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160040|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
84160041|NCT00768248|Ropivacaine|ropivacaine|mesh-list
84160042|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
84160043|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
84160044|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160045|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160046|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
84160047|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160048|NCT02589717|Atezolizumab|atezolizumab|mesh-list
84160049|NCT02589717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84160050|NCT02589717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160051|NCT02589717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84160052|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160053|NCT02602028|Colchicine|colchicine|mesh-list
84160054|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
84160055|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84160056|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
84160057|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
84160058|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
84160059|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160060|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160061|NCT04103684|Dexamethasone|dexamethasone|mesh-list
84160062|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
84160063|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84160064|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84160065|NCT04103684|Prednisolone|prednisolone|mesh-list
84160066|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
84160067|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84160068|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
84160069|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160070|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
84160071|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
84160072|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160073|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160074|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84160075|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
84160076|NCT04103684|Hormones|hormones|mesh-ancestor
84160077|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160078|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84160079|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160080|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84160081|NCT04103684|Protective Agents|protective agents|mesh-ancestor
84160082|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84160083|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84160084|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160085|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
84160086|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84160087|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84160088|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
84160089|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84160090|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160091|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84160092|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84160093|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84160094|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84160095|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160096|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84160097|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84160098|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160099|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160100|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160101|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
84160102|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84160103|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
84160104|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160106|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84160107|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
84160108|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84160109|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160110|NCT00439309|Thrombin|thrombin|mesh-list
84160111|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
84160112|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
84160113|NCT00439309|Coagulants|coagulants|mesh-ancestor
84160114|NCT00479167|Bortezomib|bortezomib|mesh-list
84160115|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
84160116|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160117|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
84160118|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84160119|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
84160120|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
84160121|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84160122|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160123|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
84160124|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160125|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160126|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84160127|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160128|NCT00725010|Temozolomide|temozolomide|mesh-list
84160129|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84160130|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
84160131|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160132|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160133|NCT05216055|Dexamethasone|dexamethasone|mesh-list
84160134|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
84160135|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
84160136|NCT05216055|Bupivacaine|bupivacaine|mesh-list
84160137|NCT05216055|Ropivacaine|ropivacaine|mesh-list
84160138|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
84160139|NCT05216055|BB 1101|bb 1101|mesh-list
84160140|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160141|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
84160142|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
84160143|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160144|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160145|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84160146|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
84160147|NCT05216055|Hormones|hormones|mesh-ancestor
84160148|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160149|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84160150|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160151|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
84160152|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
84160153|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160154|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
84160155|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84160156|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84160157|NCT05216055|Analgesics|analgesics|mesh-ancestor
84160158|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84160159|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84160160|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84160161|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
84160162|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160163|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160164|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
84160165|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160166|NCT00767000|Metformin|metformin|mesh-list
84160167|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
84160168|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84160169|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160170|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
84160171|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160172|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160173|NCT00724932|Atropine|atropine|mesh-list
84160174|NCT00724932|Bromides|bromides|mesh-list
84160175|NCT00724932|Rocuronium|rocuronium|mesh-list
84160176|NCT00724932|Neostigmine|neostigmine|mesh-list
84160177|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
84160178|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84160179|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84160180|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84160181|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160182|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160183|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84160184|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84160185|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160186|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
84160187|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160188|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160189|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
84160190|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
84160191|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84160192|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84160193|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
84160194|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160195|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160196|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84160197|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160198|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84160199|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
84160200|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84160201|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160202|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160203|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84160204|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
84160205|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160206|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160207|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84160208|NCT04083807|Thrombin|thrombin|mesh-list
84160209|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
84160210|NCT04083807|Coagulants|coagulants|mesh-ancestor
84160211|NCT05163483|Bevacizumab|bevacizumab|mesh-list
84160212|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84160213|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84160214|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160215|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84160216|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84160217|NCT05163483|Growth Substances|growth substances|mesh-ancestor
84160218|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160219|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
84160220|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160221|NCT00766142|Leucovorin|leucovorin|mesh-list
84160222|NCT00766142|Fluorouracil|fluorouracil|mesh-list
84160223|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
84160224|NCT00766142|Cetuximab|cetuximab|mesh-list
84160225|NCT00766142|Calcium|calcium|mesh-list
84160226|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
84160227|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84160228|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160229|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
84160230|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160231|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84160232|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160233|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84160234|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
84160235|NCT00766142|Antidotes|antidotes|mesh-ancestor
84160236|NCT00766142|Protective Agents|protective agents|mesh-ancestor
84160237|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
84160238|NCT00766142|Vitamins|vitamins|mesh-ancestor
84160239|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
84160240|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84160241|NCT00916526|Mannitol|mannitol|mesh-list
84160242|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84160243|NCT00916526|Diuretics|diuretics|mesh-ancestor
84160244|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
84160245|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160246|NCT00724854|Ribavirin|ribavirin|mesh-list
84160247|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84160248|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
84160249|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
84160250|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160251|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
84160252|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160253|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
84160254|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160255|NCT04083651|Bromides|bromides|mesh-list
84160256|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
84160257|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
84160259|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160260|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
84160261|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160262|NCT00728988|Atorvastatin|atorvastatin|mesh-list
84160263|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84160264|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84160265|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
84160266|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160267|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84160268|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84160269|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160270|NCT05133531|Ravulizumab|ravulizumab|mesh-list
84160271|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84160272|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84160273|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
84160274|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160275|NCT04087746|Ranibizumab|ranibizumab|mesh-list
84160276|NCT04087746|Aflibercept|aflibercept|mesh-list
84160277|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84160278|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84160279|NCT04087746|Growth Substances|growth substances|mesh-ancestor
84160280|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160281|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
84160282|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160283|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84160284|NCT04083417|Penicillins|penicillins|mesh-list
84160285|NCT04083417|Penicillin V|penicillin v|mesh-list
84160286|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160287|NCT02588937|Entecavir|entecavir|mesh-list
84160288|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
84160289|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160290|NCT04083105|Midazolam|midazolam|mesh-list
84160291|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
84160292|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84160293|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84160294|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160295|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160296|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84160297|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84160298|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84160299|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84160300|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
84160301|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
84160302|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
84160303|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
84160304|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160305|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160306|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84160307|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84160308|NCT04083105|Analgesics|analgesics|mesh-ancestor
84160309|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
84160310|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160311|NCT00735696|Paclitaxel|paclitaxel|mesh-list
84160312|NCT00735696|Carboplatin|carboplatin|mesh-list
84160313|NCT00735696|Ramucirumab|ramucirumab|mesh-list
84160314|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84160315|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160316|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
84160317|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
84160318|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
84160319|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160320|NCT02593968|Interferons|interferons|mesh-list
83430636|NCT00521989|Hormones|hormones|mesh-ancestor
84160321|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160322|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
84160323|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160324|NCT02588547|Granisetron|granisetron|mesh-list
84160325|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
84160326|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
84160327|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160328|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160329|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84160330|NCT02588547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84160331|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84160332|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
83432355|NCT00499109|Carboplatin|carboplatin|mesh-list
84160333|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160334|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160335|NCT00478231|Maraviroc|maraviroc|mesh-list
84160336|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84160337|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84160338|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160339|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84160340|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84160341|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
84160342|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160343|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84160344|NCT00474175|Benzocaine|benzocaine|mesh-list
84160345|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
84160346|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
84160347|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160348|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160349|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
84160350|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160351|NCT03002389|Fluticasone|fluticasone|mesh-list
84160352|NCT03002389|Xhance|xhance|mesh-list
84160353|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160354|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160355|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
84160356|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160357|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160358|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160359|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160360|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
84160361|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84160362|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
84160363|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
84160364|NCT04082949|Coagulants|coagulants|mesh-ancestor
84160365|NCT01020643|Propofol|propofol|mesh-list
84160366|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84160367|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160368|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160369|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84160370|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
84160371|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
84160372|NCT03537391|Fluorides|fluorides|mesh-list
84160373|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
84160374|NCT03537391|Protective Agents|protective agents|mesh-ancestor
84160375|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160376|NCT04082715|Celecoxib|celecoxib|mesh-list
84160377|NCT04082715|Levodopa|levodopa|mesh-list
84160378|NCT04082715|Carbidopa|carbidopa|mesh-list
84160379|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
84160380|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84160381|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84160382|NCT04082715|Analgesics|analgesics|mesh-ancestor
84160383|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
84160384|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160385|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160386|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160387|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84160388|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84160389|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84160390|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160391|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160392|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84160393|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84160394|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
84160395|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160396|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
84160397|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84160398|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
84160399|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
84160400|NCT00443209|Rizatriptan|rizatriptan|mesh-list
84160401|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84160402|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
84160403|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160404|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160405|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160406|NCT02588235|Atorvastatin|atorvastatin|mesh-list
84160407|NCT02588235|Ezetimibe|ezetimibe|mesh-list
84160408|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84160409|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84160410|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
84160411|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160413|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84160414|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160415|NCT01020955|Mecasermin|mecasermin|mesh-list
84160416|NCT01020955|Growth Substances|growth substances|mesh-ancestor
84160417|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160418|NCT04082793|Diclofenac|diclofenac|mesh-list
84160419|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84160420|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84160421|NCT04082793|Analgesics|analgesics|mesh-ancestor
84160422|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
84160423|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160424|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160425|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160426|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84160427|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84160428|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160429|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160430|NCT00439231|Lenalidomide|lenalidomide|mesh-list
84160431|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
84160432|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160433|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84160434|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84160435|NCT00439231|Growth Substances|growth substances|mesh-ancestor
84160436|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
84160437|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160438|NCT00783692|Vedolizumab|vedolizumab|mesh-list
84160439|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84160440|NCT04992273|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
84160441|NCT04992273|Antiviral Agents|antiviral agents|mesh-ancestor
84160442|NCT04992273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160443|NCT00783224|Fluticasone|fluticasone|mesh-list
84160444|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
84160445|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160446|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160447|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
84160448|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160449|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160450|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160451|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160452|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
84160453|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84160454|NCT04102124|Fluzoparib|fluzoparib|mesh-list
84160455|NCT04102124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84160456|NCT04102124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160457|NCT04102124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160458|NCT04102124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160459|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84160460|NCT04082559|Metronidazole|metronidazole|mesh-list
84160461|NCT04082559|Doxycycline|doxycycline|mesh-list
84160462|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
84160463|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
84160464|NCT04082559|Complement Factor H|complement factor h|mesh-list
84160465|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160466|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
84160467|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84160468|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84160469|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
84160470|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84160471|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84160472|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160473|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160474|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160475|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84160476|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84160477|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
84160478|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84160479|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
84160480|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160481|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
84160482|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84160483|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83432499|NCT00499655|Celecoxib|celecoxib|mesh-list
84160484|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160485|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
84160486|NCT02587845|Coagulants|coagulants|mesh-ancestor
84160488|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
84160489|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84160490|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84160491|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84160492|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160493|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84160494|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160495|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
84160496|NCT00765674|Diuretics|diuretics|mesh-ancestor
84160497|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
84160498|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84160499|NCT00586898|Ketoconazole|ketoconazole|mesh-list
84160500|NCT00586898|Bicalutamide|bicalutamide|mesh-list
84160501|NCT00586898|Testosterone|testosterone|mesh-list
84160502|NCT00586898|Estrogens|estrogens|mesh-list
84160503|NCT00586898|Androgens|androgens|mesh-ancestor
84160504|NCT00586898|Hormones|hormones|mesh-ancestor
84160505|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160506|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160507|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160508|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
84160509|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160510|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84160511|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84160512|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160513|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160514|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84160515|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
84160516|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84160517|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
84160518|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
84160519|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84160520|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160521|NCT02587455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84160522|NCT02587455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160523|NCT04099238|Warfarin|warfarin|mesh-list
84160524|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
84160525|NCT04099238|Dabigatran|dabigatran|mesh-list
84160526|NCT04099238|Apixaban|apixaban|mesh-list
84160527|NCT04099238|Anticoagulants|anticoagulants|mesh-list
84160528|NCT04099238|Edoxaban|edoxaban|mesh-list
84160529|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
84160530|NCT04099238|Phenindione|phenindione|mesh-list
84160531|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84160532|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
84160533|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84160534|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
84160535|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160536|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160537|NCT04932135|Hormones|hormones|mesh-list
82949481|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84160538|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160539|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160540|NCT04101812|Doxorubicin|doxorubicin|mesh-list
84160541|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84160542|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84160543|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160544|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84160545|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84160546|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160547|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160548|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
84160549|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84160550|NCT04923867|Estradiol|estradiol|mesh-list
84160551|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
84160552|NCT04923867|Estrogens|estrogens|mesh-ancestor
84160553|NCT04923867|Hormones|hormones|mesh-ancestor
84160554|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160555|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160556|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84160557|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
84160558|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84160559|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84160560|NCT02587533|Dopamine|dopamine|mesh-list
84160561|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84160562|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
84160563|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
84160564|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160565|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160566|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
84160567|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160568|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160569|NCT02587533|Protective Agents|protective agents|mesh-ancestor
84160570|NCT04847661|Mefloquine|mefloquine|mesh-list
84160571|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
84160572|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84160573|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84160574|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160575|NCT00919815|Cyclosporine|cyclosporine|mesh-list
84160576|NCT00919815|Prednisolone|prednisolone|mesh-list
84160577|NCT00919815|Cyclosporins|cyclosporins|mesh-list
84160578|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160579|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160580|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84160581|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
84160582|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160583|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
84160584|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160585|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
84160586|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84160587|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84160588|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160589|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
84160590|NCT00919815|Hormones|hormones|mesh-ancestor
84160591|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160592|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84160593|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160594|NCT00796991|Paclitaxel|paclitaxel|mesh-list
84160595|NCT00796991|Carboplatin|carboplatin|mesh-list
84160596|NCT00796991|Ipilimumab|ipilimumab|mesh-list
84160597|NCT00796991|Dacarbazine|dacarbazine|mesh-list
84160598|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84160599|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160600|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
84160601|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
84160602|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
84160603|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160604|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84160605|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84160606|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84160607|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
84160608|NCT04112147|Ubiquinone|ubiquinone|mesh-list
84160609|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
84160610|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160611|NCT00914771|Vaccines|vaccines|mesh-list
84160612|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
84160613|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160614|NCT02586987|Durvalumab|durvalumab|mesh-list
84160615|NCT02586987|Tremelimumab|tremelimumab|mesh-list
84160616|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84160617|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160618|NCT02586753|Paclitaxel|paclitaxel|mesh-list
84160619|NCT02586753|Cisplatin|cisplatin|mesh-list
84160620|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84160621|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160622|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
84160623|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
84160624|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
84160625|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160626|NCT00799487|Methylphenidate|methylphenidate|mesh-list
84160627|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84160628|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160629|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84160630|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84160631|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84160632|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160633|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
84160634|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160635|NCT00799409|Methylphenidate|methylphenidate|mesh-list
84160636|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84160637|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160638|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84160639|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84160640|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84160641|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160642|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
84160643|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160644|NCT00782210|Olodaterol|olodaterol|mesh-list
84160645|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160646|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
84160647|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160648|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160649|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160650|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160651|NCT01558115|Denosumab|denosumab|mesh-list
84160652|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84160653|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160654|NCT02605265|Capecitabine|capecitabine|mesh-list
84160655|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
84160656|NCT02605265|Irinotecan|irinotecan|mesh-list
84160657|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84160658|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
84160659|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160660|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160661|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84160662|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84160663|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160664|NCT04101500|Aminophylline|aminophylline|mesh-list
84160665|NCT04101500|Bromides|bromides|mesh-list
84160666|NCT04101500|Ipratropium|ipratropium|mesh-list
84160667|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
84160668|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160669|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
84160670|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160671|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160672|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160673|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160674|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84160675|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
84160676|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160677|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160678|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84160679|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84160680|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160681|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
84160682|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84160683|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
84160684|NCT04101500|Protective Agents|protective agents|mesh-ancestor
84160685|NCT02586441|Bromides|bromides|mesh-list
84160686|NCT02586441|Propofol|propofol|mesh-list
84160687|NCT02586441|Rocuronium|rocuronium|mesh-list
84160688|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84160689|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160690|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160691|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84160692|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
84160693|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
84160694|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
84160695|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84160696|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84160697|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84160698|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160699|NCT02586363|Entecavir|entecavir|mesh-list
84160700|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
84160701|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160702|NCT02586129|Metformin|metformin|mesh-list
84160703|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
84160704|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84160705|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160706|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84160707|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84160708|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
84160709|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160710|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84160711|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84160712|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160713|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
84160714|NCT04081077|Linezolid|linezolid|mesh-list
84160715|NCT04081077|Bedaquiline|bedaquiline|mesh-list
84160716|NCT04081077|Clofazimine|clofazimine|mesh-list
84160717|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84160718|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160719|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84160720|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84160721|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160722|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160723|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160724|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84160725|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
84160726|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160727|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
84160728|NCT04669665|Ketamine|ketamine|mesh-list
84160729|NCT04669665|Analgesics|analgesics|mesh-ancestor
84160730|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
84160731|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160732|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160733|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84160734|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84160735|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
84160736|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
84160737|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160738|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84160739|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84160740|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160741|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160742|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
84160743|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
84160744|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84160745|NCT02586051|Antibodies|antibodies|mesh-list
84160746|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
84160747|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84160748|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
84160749|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160750|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84160751|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160752|NCT00763958|Buprenorphine|buprenorphine|mesh-list
84160753|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84160754|NCT00763958|Narcotics|narcotics|mesh-ancestor
84160755|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160756|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160757|NCT00763958|Analgesics|analgesics|mesh-ancestor
84160758|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
84160759|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160760|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84160761|NCT04101578|Cyclosporine|cyclosporine|mesh-list
84160762|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
84160763|NCT04101578|Prednisone|prednisone|mesh-list
84160764|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
84160765|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
84160766|NCT04101578|Methotrexate|methotrexate|mesh-list
84160767|NCT04101578|Azathioprine|azathioprine|mesh-list
84160768|NCT04101578|Bromides|bromides|mesh-list
84160769|NCT04101578|Tacrolimus|tacrolimus|mesh-list
84160770|NCT04101578|Cyclosporins|cyclosporins|mesh-list
84160771|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
84160772|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
84160773|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84160774|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
84160775|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84160776|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
84160777|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
84160778|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160779|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84160780|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84160781|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
84160782|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160783|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160784|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84160785|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84160786|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
84160787|NCT04101578|Hormones|hormones|mesh-ancestor
84160788|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160789|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84160790|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84160791|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
84160792|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84160793|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84160794|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
84160795|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
84160796|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160797|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84160798|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84160799|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84160800|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
84160801|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160802|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84160803|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84160804|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
84160805|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84160807|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
84160808|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160809|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84160810|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84160811|NCT04101578|Protective Agents|protective agents|mesh-ancestor
84160812|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
84160813|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84160814|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
84160815|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160816|NCT00763256|Triclosan|triclosan|mesh-list
84160817|NCT00763256|Fluorides|fluorides|mesh-list
84160818|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
84160819|NCT00763256|Protective Agents|protective agents|mesh-ancestor
84160820|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160821|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84160822|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160823|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
84160824|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84160825|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
84160826|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160827|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84160828|NCT02585973|Cisplatin|cisplatin|mesh-list
84160829|NCT02585973|Adavosertib|adavosertib|mesh-list
84160830|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160831|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160832|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160833|NCT00920283|Cobalt|cobalt|mesh-list
84160834|NCT00920283|Trace Elements|trace elements|mesh-ancestor
84160835|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
84160836|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160837|NCT00583947|Albuterol|albuterol|mesh-list
84160838|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
84160839|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160840|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
84160841|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160842|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160843|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160844|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160845|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
84160846|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84160847|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84160848|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84160849|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84160850|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
84160851|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160852|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160853|NCT00772928|Vaccines|vaccines|mesh-list
84160854|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84160855|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
84160856|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160857|NCT00762164|Simvastatin|simvastatin|mesh-list
84160858|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
84160859|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84160860|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84160861|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
83432877|NCT00619723|Choline|choline|mesh-list
84160862|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160863|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84160864|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84160865|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160866|NCT00761774|Brivaracetam|brivaracetam|mesh-list
84160867|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
84160868|NCT04080375|Dinoprostone|dinoprostone|mesh-list
84160869|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
84160870|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84160871|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160872|NCT00781274|Ribavirin|ribavirin|mesh-list
84160873|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84160874|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
84160875|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160876|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
84160877|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160878|NCT05520177|Ranibizumab|ranibizumab|mesh-list
84160879|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84160880|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84160881|NCT05520177|Growth Substances|growth substances|mesh-ancestor
84160882|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160883|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
84160884|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160885|NCT00780416|Ribavirin|ribavirin|mesh-list
84160886|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84160887|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
84160888|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
84160889|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160890|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
84160891|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160892|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
84160893|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160894|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
84160895|NCT02584881|Narcotics|narcotics|mesh-ancestor
84160896|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160897|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160898|NCT02584881|Analgesics|analgesics|mesh-ancestor
84160899|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
84160900|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160901|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84160902|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
84160903|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160904|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84160905|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84160906|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84160907|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160908|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160909|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84160910|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84160911|NCT00761306|Vortioxetine|vortioxetine|mesh-list
84160912|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
84160913|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84160914|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84160915|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84160916|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160917|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160918|NCT00761306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84160919|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84160920|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84160921|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160922|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160923|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
84160924|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84160925|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84160926|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84160927|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84160928|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
84160929|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84160930|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
84160931|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160932|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160933|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84160934|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160935|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
84160936|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84160937|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
84160938|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84160939|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160940|NCT04079517|Tamoxifen|tamoxifen|mesh-list
84160941|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84160942|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
84160943|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84160944|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160945|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84160946|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84160947|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84160948|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84160949|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84160950|NCT00761150|Acetaminophen|acetaminophen|mesh-list
84160951|NCT00761150|Hydrocodone|hydrocodone|mesh-list
84160952|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84160953|NCT00761150|Analgesics|analgesics|mesh-ancestor
84160954|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
84160955|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160956|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160957|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
84160958|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84160959|NCT00761150|Narcotics|narcotics|mesh-ancestor
84160960|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160961|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
84160962|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
84160963|NCT00583557|Belimumab|belimumab|mesh-list
84160964|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84160965|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
84160966|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160967|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
84160968|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84160969|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
84160970|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160971|NCT00760838|Azithromycin|azithromycin|mesh-list
84160972|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84160973|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84160974|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
84160975|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84160976|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
84160977|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84160978|NCT02584335|Lidocaine|lidocaine|mesh-list
84160979|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84160980|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
84160981|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
84160982|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84160983|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160984|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
84160985|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160986|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84160987|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84160988|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84160989|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84160990|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84160991|NCT00437281|Pregabalin|pregabalin|mesh-list
84160992|NCT00437281|Analgesics|analgesics|mesh-ancestor
84160993|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
84160994|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84160995|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84160996|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
84160997|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84160998|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84160999|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161000|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84161001|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84161002|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84161003|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161004|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84161005|NCT04544007|Poly ICLC|poly iclc|mesh-list
84161006|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
84161007|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
84161008|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161009|NCT05468073|Aldesleukin|aldesleukin|mesh-list
84161010|NCT05468073|Interleukin-2|interleukin-2|mesh-list
84161011|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161012|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161013|NCT05468073|Analgesics|analgesics|mesh-ancestor
84161014|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
84161015|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161016|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161017|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84161018|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84161019|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
84161020|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161022|NCT05674695|Cyclosporine|cyclosporine|mesh-list
84161023|NCT05674695|Methotrexate|methotrexate|mesh-list
84161024|NCT05674695|Upadacitinib|upadacitinib|mesh-list
84161025|NCT05674695|Cyclosporins|cyclosporins|mesh-list
84161026|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84161027|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
84161028|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161029|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161030|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84161031|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
84161032|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161033|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161034|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
84161035|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161036|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84161037|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161038|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
84161039|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161040|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84161041|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
84161042|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161043|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84161044|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84161045|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84161046|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
84161047|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84161048|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84161049|NCT02596269|Nefopam|nefopam|mesh-list
84161050|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161051|NCT02596269|Analgesics|analgesics|mesh-ancestor
84161052|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
84161053|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161054|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161055|NCT00741039|Vaccines|vaccines|mesh-list
84161056|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84161057|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
84161058|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161059|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
84161060|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84161061|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161062|NCT04454229|Penicillins|penicillins|mesh-list
84161063|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161064|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161065|NCT04078659|Lidocaine|lidocaine|mesh-list
84161066|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
84161067|NCT04078659|Fentanyl|fentanyl|mesh-list
84161068|NCT04078659|Propofol|propofol|mesh-list
84161069|NCT04078659|Atracurium|atracurium|mesh-list
84161070|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
84161071|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
84161072|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161073|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161074|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
84161075|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161076|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84161077|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84161078|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84161079|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161080|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161081|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84161082|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84161083|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
84161084|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84161085|NCT04078659|Narcotics|narcotics|mesh-ancestor
84161086|NCT04078659|Analgesics|analgesics|mesh-ancestor
84161087|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84161089|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84161090|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84161091|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
84161092|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161093|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84161094|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84161095|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84161096|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
84161097|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84161098|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
84161099|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161100|NCT02583243|Buprenorphine|buprenorphine|mesh-list
84161101|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84161102|NCT02583243|Narcotics|narcotics|mesh-ancestor
84161103|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161104|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161105|NCT02583243|Analgesics|analgesics|mesh-ancestor
84161106|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
84161107|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161108|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84161109|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
84161110|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84161111|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84161112|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161113|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161114|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161115|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161116|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
84161117|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84161118|NCT00760214|Ramipril|ramipril|mesh-list
84161119|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
84161120|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84161121|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
84161122|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161123|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161124|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84161125|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84161126|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84161127|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
84161128|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
84161129|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161130|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161131|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84161132|NCT04078425|Diuretics|diuretics|mesh-ancestor
84161133|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
84161134|NCT00638391|Anastrozole|anastrozole|mesh-list
84161135|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84161136|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161137|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84161138|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84161139|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161140|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161141|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84161142|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
84161143|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161144|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161145|NCT02583633|Nifedipine|nifedipine|mesh-list
84161146|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
84161147|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84161148|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161149|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161150|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84161151|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161152|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
84161153|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
84161154|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161155|NCT04487067|Bevacizumab|bevacizumab|mesh-list
84161156|NCT04487067|Atezolizumab|atezolizumab|mesh-list
84161157|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84161158|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161159|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84161160|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84161161|NCT04487067|Growth Substances|growth substances|mesh-ancestor
84161162|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161163|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
84161164|NCT04487067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84161165|NCT04487067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161166|NCT05353257|Carboplatin|carboplatin|mesh-list
84161167|NCT05353257|Etoposide|etoposide|mesh-list
84161168|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161169|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84161170|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84161171|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84161172|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161173|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161174|NCT02582307|Acetaminophen|acetaminophen|mesh-list
84161175|NCT02582307|Scopolamine|scopolamine|mesh-list
84161176|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
84161177|NCT02582307|Analgesics|analgesics|mesh-list
84161178|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84161179|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
84161180|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949482|NCT01178047|Protective Agents|protective agents|mesh-ancestor
84161181|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161182|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
84161183|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84161184|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
84161185|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
84161186|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161187|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
84161188|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84161189|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
84161190|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161191|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161192|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84161193|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
84161194|NCT02689245|Tenofovir|tenofovir|mesh-list
84161195|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
84161196|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161197|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84161198|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84161199|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161200|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161201|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84161202|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84161203|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
84161204|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161205|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84161206|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161207|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161208|NCT00772148|Tacrolimus|tacrolimus|mesh-list
84161209|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161210|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
84161211|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161212|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84161213|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161214|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161215|NCT02689089|Rifapentine|rifapentine|mesh-list
84161216|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84161217|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
84161218|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161219|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161220|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
84161221|NCT00759902|Morphine|morphine|mesh-list
84161222|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84161223|NCT00759902|Narcotics|narcotics|mesh-ancestor
84161224|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161225|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161226|NCT00759902|Analgesics|analgesics|mesh-ancestor
84161227|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
84161228|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161229|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
84161230|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
84161231|NCT04077957|Etanercept|etanercept|mesh-list
84161232|NCT04077957|Methotrexate|methotrexate|mesh-list
84161233|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84161234|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
84161235|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161236|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161237|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84161238|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
84161239|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161240|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161241|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
84161242|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161243|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84161244|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161245|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
84161246|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161247|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84161248|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
84161249|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84161250|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84161251|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161252|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84161253|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161254|NCT04077957|Analgesics|analgesics|mesh-ancestor
84161255|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
84161256|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161257|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161258|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161259|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
84161260|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161261|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84161262|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
84161263|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
84161264|NCT04102670|Protective Agents|protective agents|mesh-ancestor
84161265|NCT04114097|Betamethasone|betamethasone|mesh-list
84161266|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
84161267|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
84161268|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
84161269|NCT04114097|Tacrolimus|tacrolimus|mesh-list
84161270|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
84161271|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161272|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
84161273|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161274|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84161275|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161276|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161277|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161278|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
84161279|NCT04114097|Hormones|hormones|mesh-ancestor
84161280|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161281|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84161282|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
84161283|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84161284|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84161285|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161286|NCT04323189|Incretins|incretins|mesh-ancestor
84161287|NCT04323189|Hormones|hormones|mesh-ancestor
84161288|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161289|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84161290|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
84161291|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161292|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161293|NCT00772070|Vaccines|vaccines|mesh-list
84161294|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
84161295|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161296|NCT00796757|Interferons|interferons|mesh-list
84161297|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
84161298|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
84161299|NCT00796757|Bevacizumab|bevacizumab|mesh-list
84161300|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84161301|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161302|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84161303|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84161304|NCT00796757|Growth Substances|growth substances|mesh-ancestor
84161305|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161306|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83433321|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161307|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
84161308|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161309|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
84161311|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84161312|NCT00759356|Narcotics|narcotics|mesh-ancestor
84161313|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161314|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161315|NCT00759356|Analgesics|analgesics|mesh-ancestor
84161316|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
84161317|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161318|NCT05637515|Adalimumab|adalimumab|mesh-list
84161319|NCT05637515|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84161320|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161321|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161322|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
84161323|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84161324|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161325|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161326|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83430684|NCT04028804|Fluorides|fluorides|mesh-list
84161327|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161328|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161329|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
84161330|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161331|NCT04102592|Permethrin|permethrin|mesh-list
84161332|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161333|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161334|NCT04113551|Guanfacine|guanfacine|mesh-list
84161335|NCT04113551|Methylphenidate|methylphenidate|mesh-list
84161336|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84161337|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84161338|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84161339|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161340|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161341|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
84161342|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161343|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161344|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84161345|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84161346|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
84161347|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84161348|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84161349|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84161350|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84161351|NCT00798317|Plasminogen|plasminogen|mesh-list
84161352|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84161353|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84161354|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161355|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
84161356|NCT00077285|Ifosfamide|ifosfamide|mesh-list
84161357|NCT00077285|Carboplatin|carboplatin|mesh-list
84161358|NCT00077285|Doxorubicin|doxorubicin|mesh-list
84161359|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84161360|NCT00077285|Irinotecan|irinotecan|mesh-list
84161361|NCT00077285|Etoposide|etoposide|mesh-list
84161362|NCT00077285|Vincristine|vincristine|mesh-list
84161363|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
84161364|NCT00077285|Razoxane|razoxane|mesh-list
84161365|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161366|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
84161367|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161368|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161369|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84161370|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
84161371|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161372|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161373|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84161374|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84161375|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84161376|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84161377|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161378|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84161379|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84161380|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
84161381|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
84161382|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
84161383|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84161384|NCT00077285|Protective Agents|protective agents|mesh-ancestor
84161385|NCT00771914|Aspirin|aspirin|mesh-list
84161386|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84161387|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161388|NCT00771914|Analgesics|analgesics|mesh-ancestor
84161389|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
84161390|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161391|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161392|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161393|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161394|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84161395|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84161396|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161397|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84161398|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84161399|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161400|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
84161401|NCT04307511|Aspirin|aspirin|mesh-list
84161402|NCT04307511|Ticagrelor|ticagrelor|mesh-list
84161403|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84161404|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161405|NCT04307511|Analgesics|analgesics|mesh-ancestor
84161406|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
84161407|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161408|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161409|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161410|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161411|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84161412|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84161413|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161414|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84161415|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84161416|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161417|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
84161418|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
84161419|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84161420|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84161421|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
84161422|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161423|NCT00779324|Amantadine|amantadine|mesh-list
84161424|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84161425|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84161426|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
84161427|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161428|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
84161429|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161430|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161431|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161432|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161433|NCT00779324|Analgesics|analgesics|mesh-ancestor
84161434|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
84161435|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161436|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
84161437|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
84161438|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84161439|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161440|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
84161441|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
84161442|NCT02581761|Misoprostol|misoprostol|mesh-list
84161443|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84161444|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
84161445|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161446|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161447|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84161448|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161449|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
84161450|NCT00771758|Oxycodone|oxycodone|mesh-list
84161451|NCT00771758|Tapentadol|tapentadol|mesh-list
84161452|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84161453|NCT00771758|Narcotics|narcotics|mesh-ancestor
84161454|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161455|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161456|NCT00771758|Analgesics|analgesics|mesh-ancestor
84161457|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
84161458|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161459|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84161460|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84161461|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161462|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161463|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
84161464|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161465|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
84161466|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84161467|NCT02581371|Protective Agents|protective agents|mesh-ancestor
84161468|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161469|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
84161470|NCT02688465|Apomorphine|apomorphine|mesh-list
84161471|NCT02688465|Emetics|emetics|mesh-ancestor
84161472|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161473|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
84161474|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161475|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161476|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
84161477|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
84161478|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161479|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161480|NCT00758498|Modafinil|modafinil|mesh-list
84161481|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84161482|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161483|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84161484|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84161485|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84161486|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161487|NCT00798161|Metformin|metformin|mesh-list
84161488|NCT00798161|Linagliptin|linagliptin|mesh-list
84161489|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84161490|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161491|NCT00798161|Incretins|incretins|mesh-ancestor
84161492|NCT00798161|Hormones|hormones|mesh-ancestor
84161493|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161494|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84161495|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
84161496|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161497|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161498|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
84161499|NCT02581683|Ropivacaine|ropivacaine|mesh-list
84161500|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
84161501|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
84161502|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161503|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161504|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
84161505|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161506|NCT02581683|Analgesics|analgesics|mesh-ancestor
84161507|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84161508|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
84161509|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84161510|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161511|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161512|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84161513|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
84161514|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161515|NCT04170855|Furosemide|furosemide|mesh-list
84161516|NCT04170855|Diuretics|diuretics|mesh-ancestor
84161517|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
84161518|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161519|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
84161520|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161521|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161522|NCT04076709|Anesthetics|anesthetics|mesh-list
84161523|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161524|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161525|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
84161526|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84161527|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84161528|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161529|NCT04115423|Adalimumab|adalimumab|mesh-list
83433548|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
84161530|NCT04115423|Infliximab|infliximab|mesh-list
84161531|NCT04115423|Golimumab|golimumab|mesh-list
84161532|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
84161533|NCT04115423|Etanercept|etanercept|mesh-list
84161534|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161535|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161536|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
84161537|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161538|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84161539|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161540|NCT04115423|Analgesics|analgesics|mesh-ancestor
84161541|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
84161542|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161543|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161544|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161545|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
84161546|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
84161547|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
84161548|NCT04113005|Coagulants|coagulants|mesh-ancestor
84161549|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
84161550|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
84161551|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161552|NCT00588341|Temozolomide|temozolomide|mesh-list
84161553|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84161554|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
84161555|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161556|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161557|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84161558|NCT00914693|Gestodene|gestodene|mesh-list
84161559|NCT00914693|Femovan|femovan|mesh-list
84161560|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84161561|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84161562|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84161563|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
84161564|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161565|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161566|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84161567|NCT00914693|Estrogens|estrogens|mesh-ancestor
84161568|NCT00914693|Hormones|hormones|mesh-ancestor
84161569|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161570|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84161571|NCT00914693|Progestins|progestins|mesh-ancestor
84161572|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84161573|NCT00915083|Amrubicin|amrubicin|mesh-list
84161574|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161575|NCT00802529|Gentamicins|gentamicins|mesh-list
84161576|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
84161577|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84161578|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84161579|NCT00802529|Prednisolone|prednisolone|mesh-list
84161580|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
84161581|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84161582|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
84161583|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161584|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
84161585|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
84161586|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161587|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161588|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161589|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
84161590|NCT00802529|Hormones|hormones|mesh-ancestor
84161591|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161592|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84161593|NCT00802529|Protective Agents|protective agents|mesh-ancestor
84161594|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84161595|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161596|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161597|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161598|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84161599|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161600|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161601|NCT02605811|Temozolomide|temozolomide|mesh-list
84161602|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84161603|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
84161604|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161605|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161606|NCT00758264|Vaccines|vaccines|mesh-list
84161607|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84161608|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
84161609|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161610|NCT05670743|Fluorides|fluorides|mesh-list
84161611|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
84161612|NCT05670743|Protective Agents|protective agents|mesh-ancestor
84161613|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161614|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
84161615|NCT04027517|Hematinics|hematinics|mesh-ancestor
84161616|NCT00588731|Cannabidiol|cannabidiol|mesh-list
84161617|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
84161618|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
84161619|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
84161620|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161621|NCT05629949|Docetaxel|docetaxel|mesh-list
84161622|NCT05629949|Trastuzumab|trastuzumab|mesh-list
84161623|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161624|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
84161625|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
84161626|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
84161627|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161628|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84161629|NCT05628233|Azasetron|azasetron|mesh-list
84161630|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
84161631|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
84161632|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161633|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161634|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161635|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84161636|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
84161637|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161638|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161639|NCT04109261|Palbociclib|palbociclib|mesh-list
84161640|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161641|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84161642|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161643|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161644|NCT04109339|Oxytocin|oxytocin|mesh-list
84161645|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
84161646|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161647|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161648|NCT00757172|Docetaxel|docetaxel|mesh-list
84161649|NCT00757172|Panitumumab|panitumumab|mesh-list
84161650|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161651|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
84161652|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
84161653|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
84161654|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161655|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84161656|NCT00797225|Leuprolide|leuprolide|mesh-list
84161657|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
84161658|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
84161659|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161660|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161661|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84161662|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161663|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
84161664|NCT05277285|Antidotes|antidotes|mesh-ancestor
84161665|NCT05277285|Protective Agents|protective agents|mesh-ancestor
84161666|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161667|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
84161668|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161669|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
84161670|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161671|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161672|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
84161673|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
84161674|NCT04110665|Acetaminophen|acetaminophen|mesh-list
84161675|NCT04110665|Morphine|morphine|mesh-list
84161676|NCT04110665|Oxycodone|oxycodone|mesh-list
84161677|NCT04110665|Tramadol|tramadol|mesh-list
84161678|NCT04110665|Nefopam|nefopam|mesh-list
84161679|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83433701|NCT05061524|Omalizumab|omalizumab|mesh-list
84161680|NCT04110665|Narcotics|narcotics|mesh-ancestor
84161681|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161682|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161683|NCT04110665|Analgesics|analgesics|mesh-ancestor
84161685|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161686|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161687|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
84161688|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
84161689|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
84161690|NCT00638859|Telithromycin|telithromycin|mesh-list
84161691|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161692|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161693|NCT02537847|Ertapenem|ertapenem|mesh-list
84161694|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
84161695|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
83430695|NCT02985554|Nivolumab|nivolumab|mesh-list
84161696|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161697|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161698|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84161699|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161700|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161701|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84161702|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84161703|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161704|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84161705|NCT04033029|Tazobactam|tazobactam|mesh-list
84161706|NCT04033029|Piperacillin|piperacillin|mesh-list
84161707|NCT04033029|Daptomycin|daptomycin|mesh-list
84161708|NCT04033029|Ceftazidime|ceftazidime|mesh-list
84161709|NCT04033029|Cefepime|cefepime|mesh-list
84161710|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84161711|NCT04033029|Ceftolozane|ceftolozane|mesh-list
84161712|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161713|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84161714|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161715|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161716|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
84161717|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84161718|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161719|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161720|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84161721|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
84161722|NCT02687841|Protective Agents|protective agents|mesh-ancestor
84161723|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161724|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
84161725|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84161726|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
84161727|NCT00778622|Metformin|metformin|mesh-list
84161728|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84161729|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161730|NCT00777920|Ambrisentan|ambrisentan|mesh-list
84161731|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84161732|NCT04236141|Rituximab|rituximab|mesh-list
84161733|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84161734|NCT04236141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
84161735|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84161736|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161737|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
84161738|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161739|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161740|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84161741|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
84161742|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161743|NCT04236141|Immunoconjugates|immunoconjugates|mesh-ancestor
84161744|NCT04097444|Leucovorin|leucovorin|mesh-list
84161745|NCT04097444|Bevacizumab|bevacizumab|mesh-list
84161746|NCT04097444|Fluorouracil|fluorouracil|mesh-list
84161747|NCT04097444|Capecitabine|capecitabine|mesh-list
84161748|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
84161749|NCT04097444|Irinotecan|irinotecan|mesh-list
84161750|NCT04097444|Calcium|calcium|mesh-list
84161751|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
84161752|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84161753|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161754|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84161755|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84161756|NCT04097444|Growth Substances|growth substances|mesh-ancestor
84161757|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161758|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
84161759|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84161760|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
84161761|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161762|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84161763|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83430700|NCT05560165|Listerine|listerine|mesh-list
84161764|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
84161765|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84161766|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84161767|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161768|NCT04097444|Antidotes|antidotes|mesh-ancestor
84161769|NCT04097444|Protective Agents|protective agents|mesh-ancestor
84161770|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
84161771|NCT04097444|Vitamins|vitamins|mesh-ancestor
84161772|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
84161773|NCT04097288|Dexetimide|dexetimide|mesh-list
84161774|NCT04097288|Citalopram|citalopram|mesh-list
84161775|NCT04097288|Reboxetine|reboxetine|mesh-list
84161776|NCT04097288|Escitalopram|escitalopram|mesh-list
84161777|NCT04097288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84161778|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84161779|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161780|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161781|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161782|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
84161783|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161784|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84161785|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
84161786|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84161787|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84161788|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84161789|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
84161790|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
84161791|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161792|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84161793|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84161794|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
84161795|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84161796|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
84161797|NCT04219449|Protein C|protein c|mesh-list
84161798|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
84161799|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84161800|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84161801|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161802|NCT04209855|Paclitaxel|paclitaxel|mesh-list
84161803|NCT04209855|Maytansine|maytansine|mesh-list
84161804|NCT04209855|Doxorubicin|doxorubicin|mesh-list
84161805|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84161806|NCT04209855|Topotecan|topotecan|mesh-list
84161807|NCT04209855|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
84161808|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84161809|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161810|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
84161811|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
84161812|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
84161813|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161814|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84161815|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84161816|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84161817|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430704|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
84161818|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84161819|NCT04209855|Immunoconjugates|immunoconjugates|mesh-ancestor
84161820|NCT04209855|Immunologic Factors|immunologic factors|mesh-ancestor
84161821|NCT04209855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161822|NCT00756938|Losartan|losartan|mesh-list
84161823|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84161824|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84161825|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84161826|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84161827|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161828|NCT04076865|Lidocaine|lidocaine|mesh-list
84161829|NCT04076865|Histamine|histamine|mesh-list
84161830|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
84161831|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
84161832|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161833|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161834|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
84161835|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161836|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84161837|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84161838|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84161839|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84161840|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161841|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
84161842|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
84161843|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161844|NCT00770588|Gefitinib|gefitinib|mesh-list
84161845|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161846|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84161847|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161848|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161849|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
84161850|NCT02604719|Ethamsylate|ethamsylate|mesh-list
84161851|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84161852|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84161853|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161854|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
84161855|NCT02604719|Coagulants|coagulants|mesh-ancestor
84161856|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
84161857|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
84161858|NCT02604797|Sufentanil|sufentanil|mesh-list
84161859|NCT02604797|Dsuvia|dsuvia|mesh-list
84161860|NCT02604797|Nalbuphine|nalbuphine|mesh-list
84161861|NCT02604797|Ramosetron|ramosetron|mesh-list
84161862|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84161863|NCT02604797|Narcotics|narcotics|mesh-ancestor
84161864|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161865|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161866|NCT02604797|Analgesics|analgesics|mesh-ancestor
84161867|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
84161868|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84161869|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84161870|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84161871|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
84161872|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
84161873|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84161874|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84161875|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84161876|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161877|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84161878|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161879|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161880|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
84161881|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
84161882|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161883|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84161884|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
84161885|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161886|NCT00777608|Donepezil|donepezil|mesh-list
84161887|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84161888|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161889|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161890|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
84161891|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161892|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161893|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
84161894|NCT00792935|Metformin|metformin|mesh-list
84161895|NCT00792935|Glimepiride|glimepiride|mesh-list
84161896|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84161897|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161898|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84161899|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161900|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
84161901|NCT03904563|Bevacizumab|bevacizumab|mesh-list
84161902|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84161903|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161904|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84161905|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84161906|NCT03904563|Growth Substances|growth substances|mesh-ancestor
84161907|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161908|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
84161909|NCT00770510|Zolpidem|zolpidem|mesh-list
84161910|NCT00770510|Eszopiclone|eszopiclone|mesh-list
84161911|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
84161912|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84161913|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84161914|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161915|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84161916|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
84161917|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
84161918|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84161919|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161920|NCT04077255|Paclitaxel|paclitaxel|mesh-list
84161921|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84161922|NCT04077255|Antibodies|antibodies|mesh-list
84161923|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84161924|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161925|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
84161926|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
84161927|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
84161928|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161929|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
84161930|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161931|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
84161932|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84161933|NCT00770432|Laxatives|laxatives|mesh-ancestor
84161934|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161935|NCT00792701|Gemcitabine|gemcitabine|mesh-list
84161936|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161937|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84161938|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
84161939|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161940|NCT03772353|Letrozole|letrozole|mesh-list
84161941|NCT03772353|Fulvestrant|fulvestrant|mesh-list
84161942|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161943|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84161944|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84161945|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161946|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161947|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84161948|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
84161949|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84161950|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161951|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84161952|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84161953|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
84161954|NCT05559983|Vaccines|vaccines|mesh-list
84161955|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
84161956|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161957|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84161958|NCT05559983|Antacids|antacids|mesh-ancestor
84161959|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161960|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84161961|NCT03765567|Vancomycin|vancomycin|mesh-list
84161962|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161963|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161964|NCT00777296|Amikacin|amikacin|mesh-list
84161965|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84161966|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84161967|NCT00756470|Paclitaxel|paclitaxel|mesh-list
84161968|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
84161969|NCT00756470|Fluorouracil|fluorouracil|mesh-list
84161970|NCT00756470|Epirubicin|epirubicin|mesh-list
84161971|NCT00756470|Lapatinib|lapatinib|mesh-list
84161972|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84161973|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161974|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
84161975|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
84161976|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
84161977|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84161978|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84161979|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
84161980|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161981|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84161982|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84161983|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
84161984|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84161985|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
84161986|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84161987|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84161988|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84161989|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84161990|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161991|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84161992|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
84161993|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84161994|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84161995|NCT00727506|Afatinib|afatinib|mesh-list
84161996|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84161997|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84161998|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84161999|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162000|NCT00789815|Midazolam|midazolam|mesh-list
84162001|NCT00789815|Propofol|propofol|mesh-list
84162002|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84162003|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162004|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162005|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84162006|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
84162007|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
84162008|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84162009|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84162010|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84162011|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84162012|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
84162013|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
84162014|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162015|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162016|NCT00721578|Voriconazole|voriconazole|mesh-list
84162017|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
84162018|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162019|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84162020|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84162021|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162022|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162023|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84162024|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
84162025|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162026|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162027|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84162028|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
84162029|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84162030|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84162031|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
84162032|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162033|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84162034|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
84162035|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162036|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162037|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84162038|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84162039|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162040|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162041|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162042|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
84162043|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
84162044|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162045|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162046|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
84162047|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84162048|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162049|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84162050|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
84162051|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162052|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162053|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162054|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162055|NCT05600387|Empagliflozin|empagliflozin|mesh-list
84162056|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84162057|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162058|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84162059|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162060|NCT00721110|Lidocaine|lidocaine|mesh-list
84162061|NCT00721110|Ketamine|ketamine|mesh-list
83434080|NCT01670084|Vitamins|vitamins|mesh-ancestor
84162062|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
84162063|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
84162064|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162065|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162066|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
84162067|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162068|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84162069|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84162070|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84162071|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84162072|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162073|NCT00721110|Analgesics|analgesics|mesh-ancestor
84162074|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
84162075|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84162076|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
84162077|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84162078|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84162079|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162080|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
84162081|NCT05073237|Estrogens|estrogens|mesh-list
84162082|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
84162083|NCT05073237|Hormones|hormones|mesh-ancestor
84162084|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162085|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162086|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84162087|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84162088|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
84162089|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84162090|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
84162091|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
84162092|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
84162093|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84162094|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162095|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
84162096|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162097|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84162098|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84162099|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162100|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162101|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162102|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84162103|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
84162104|NCT00791999|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84162105|NCT00791999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162106|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162107|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
84162108|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162109|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162110|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
84162111|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84162112|NCT04033263|Fluorides|fluorides|mesh-list
84162113|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
84162114|NCT04033263|Protective Agents|protective agents|mesh-ancestor
84162115|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162116|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
84162117|NCT04075227|Dexamethasone|dexamethasone|mesh-list
84162118|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162119|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
84162120|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
84162121|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162122|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162123|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162124|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
84162125|NCT04075227|Hormones|hormones|mesh-ancestor
84162126|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162127|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84162128|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162129|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84162130|NCT00585078|Capecitabine|capecitabine|mesh-list
84162131|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
84162132|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162133|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
84162134|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162135|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162136|NCT00720876|Rituximab|rituximab|mesh-list
84162137|NCT00720876|Vorinostat|vorinostat|mesh-list
84162138|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162139|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162140|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
84162141|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162142|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162143|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84162144|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162145|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162146|NCT00789581|Paclitaxel|paclitaxel|mesh-list
84162147|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
84162148|NCT00789581|Doxorubicin|doxorubicin|mesh-list
84162149|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84162150|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84162151|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162152|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
84162153|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
84162154|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
84162155|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162156|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162157|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
84162158|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162159|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162160|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84162161|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
84162162|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84162163|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84162164|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84162165|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84162166|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162167|NCT00717756|Lenalidomide|lenalidomide|mesh-list
84162168|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
84162169|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162170|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84162171|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84162172|NCT00717756|Growth Substances|growth substances|mesh-ancestor
84162173|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
84162174|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162175|NCT04111289|Tirofiban|tirofiban|mesh-list
84162176|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84162177|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84162178|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162179|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84162180|NCT04108637|Penicillins|penicillins|mesh-list
84162181|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162182|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162183|NCT05674539|Vidarabine|vidarabine|mesh-list
84162184|NCT05674539|Fludarabine|fludarabine|mesh-list
84162185|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
84162186|NCT05674539|Melphalan|melphalan|mesh-list
84162187|NCT05674539|Busulfan|busulfan|mesh-list
84162188|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162189|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162190|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
84162191|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162192|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162193|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
84162194|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162195|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
84162196|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162197|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84162198|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
84162199|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84162200|NCT00717522|Pomalidomide|pomalidomide|mesh-list
84162201|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
84162202|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162203|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84162204|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84162205|NCT00717522|Growth Substances|growth substances|mesh-ancestor
84162206|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
84162207|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162208|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
84162209|NCT00791921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84162210|NCT00791921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162211|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162212|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
84162213|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162214|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162215|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
84162216|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162217|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84162218|NCT03475953|Avelumab|avelumab|mesh-list
84162219|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84162220|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162221|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162222|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
84162223|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162224|NCT00582933|Vidarabine|vidarabine|mesh-list
84162225|NCT00582933|Fludarabine|fludarabine|mesh-list
84162226|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
84162227|NCT00582933|Melphalan|melphalan|mesh-list
84162228|NCT00582933|Busulfan|busulfan|mesh-list
84162229|NCT00582933|Lenograstim|lenograstim|mesh-list
84162230|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162231|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162232|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
84162233|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162234|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162235|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
84162236|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162237|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
84162238|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162239|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84162240|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
84162241|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84162242|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84162243|NCT00791765|Etanercept|etanercept|mesh-list
84162244|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84162245|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84162246|NCT00791765|Analgesics|analgesics|mesh-ancestor
84162247|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
84162248|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162249|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162250|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162251|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162252|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162253|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162254|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
84162255|NCT03648021|Acetaminophen|acetaminophen|mesh-list
84162256|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84162257|NCT03648021|Analgesics|analgesics|mesh-ancestor
84162258|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
84162259|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162260|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162261|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
84162262|NCT00789191|Metformin|metformin|mesh-list
84162263|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84162264|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
84162265|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84162266|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162267|NCT00789191|Incretins|incretins|mesh-ancestor
84162268|NCT00789191|Hormones|hormones|mesh-ancestor
84162269|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162270|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84162271|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
84162272|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162273|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162274|NCT02603315|Mitogens|mitogens|mesh-list
84162275|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
84162276|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
84162277|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162278|NCT02603315|Growth Substances|growth substances|mesh-ancestor
84162279|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162280|NCT00789035|Metformin|metformin|mesh-list
84162281|NCT00789035|Empagliflozin|empagliflozin|mesh-list
84162282|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84162283|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162284|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84162285|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162286|NCT04108013|Paclitaxel|paclitaxel|mesh-list
83434312|NCT04763876|Ketorolac|ketorolac|mesh-list
84162288|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84162289|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162290|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
84162291|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
84162292|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
84162293|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162294|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
84162295|NCT04105985|Tetracaine|tetracaine|mesh-list
84162296|NCT04105985|Carticaine|carticaine|mesh-list
84162297|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
84162298|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
84162299|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162300|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162301|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
84162302|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162303|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84162304|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84162305|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
84162306|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162307|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162308|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
84162309|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
84162310|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
84162311|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84162312|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
84162313|NCT04074213|Clozapine|clozapine|mesh-list
84162314|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84162315|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
84162316|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162317|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162318|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162319|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84162320|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84162321|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162322|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84162323|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
84162324|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
84162325|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84162326|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84162327|NCT04110587|Analgesics|analgesics|mesh-list
84162328|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
84162329|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162330|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84162331|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
84162332|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162333|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
84162334|NCT04110587|Protective Agents|protective agents|mesh-ancestor
84162335|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
84162336|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162337|NCT03616587|Everolimus|everolimus|mesh-list
84162338|NCT03616587|Palbociclib|palbociclib|mesh-list
84162339|NCT03616587|Anastrozole|anastrozole|mesh-list
84162340|NCT03616587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84162341|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84162342|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162343|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162344|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162345|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
84162346|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162347|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162348|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84162349|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84162350|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84162351|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84162352|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
84162353|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162354|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
84162355|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162356|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162357|NCT02658279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84162358|NCT02658279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162359|NCT03534453|Olaparib|olaparib|mesh-list
84162360|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84162361|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162362|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162363|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162364|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
84162365|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84162366|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162367|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
84162368|NCT02579733|Azathioprine|azathioprine|mesh-list
84162369|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
84162370|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162371|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162372|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162373|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162374|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
84162375|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162376|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162377|NCT03326193|Bevacizumab|bevacizumab|mesh-list
84162378|NCT03326193|Niraparib|niraparib|mesh-list
84162379|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162380|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162381|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84162382|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84162383|NCT03326193|Growth Substances|growth substances|mesh-ancestor
84162384|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162385|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
84162386|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84162387|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162388|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162389|NCT02517099|Azithromycin|azithromycin|mesh-list
84162390|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84162391|NCT02517099|Beclomethasone|beclomethasone|mesh-list
84162392|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162393|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162394|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84162395|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162396|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162397|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162398|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
84162399|NCT02517099|Hormones|hormones|mesh-ancestor
84162400|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162401|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162402|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84162403|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
84162404|NCT02478099|Atezolizumab|atezolizumab|mesh-list
84162405|NCT02478099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84162406|NCT02478099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162407|NCT02478099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162408|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162409|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
84162410|NCT02473263|Tazobactam|tazobactam|mesh-list
84162411|NCT02473263|Piperacillin|piperacillin|mesh-list
84162412|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
84162413|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
84162414|NCT02473263|Norepinephrine|norepinephrine|mesh-list
84162415|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162416|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84162417|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84162418|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
84162419|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162420|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162421|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162422|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
84162423|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
84162424|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162425|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84162426|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162427|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162428|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84162429|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162430|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
84162431|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
84162432|NCT03249831|Pentostatin|pentostatin|mesh-list
84162433|NCT03249831|Tacrolimus|tacrolimus|mesh-list
84162434|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
84162435|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
84162436|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162437|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
84162438|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430778|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
84162439|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162440|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84162441|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
84162442|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162443|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162444|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84162445|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84162446|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162447|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84162448|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84162449|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
84162450|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162451|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162452|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
84162453|NCT03222609|Navitoclax|navitoclax|mesh-list
84162454|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162455|NCT00437203|Gemcitabine|gemcitabine|mesh-list
84162456|NCT00437203|PF 00477736|pf 00477736|mesh-list
84162457|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162458|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
84162459|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162460|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162461|NCT00437203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84162462|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162463|NCT02419287|Crizotinib|crizotinib|mesh-list
84162464|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162465|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84162466|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162467|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162468|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
84162469|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
84162470|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84162471|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84162472|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162473|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162474|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162475|NCT00437125|Analgesics|analgesics|mesh-ancestor
84162476|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
84162477|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162478|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
84162479|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84162480|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
84162481|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
84162482|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
84162483|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
84162484|NCT01028287|Hormones|hormones|mesh-ancestor
84162485|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162486|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162487|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162488|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162489|NCT01028443|Cyclosporine|cyclosporine|mesh-list
84162490|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
84162491|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162492|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
84162493|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162494|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162495|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162496|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
84162497|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162498|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162499|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84162500|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
84162501|NCT03116997|Neostigmine|neostigmine|mesh-list
84162502|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84162503|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162504|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162505|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
84162506|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162507|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162508|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84162509|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
84162510|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162511|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84162512|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84162513|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84162515|NCT02600780|Febuxostat|febuxostat|mesh-list
84162516|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
84162517|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162518|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162519|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
84162520|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162521|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84162522|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
84162523|NCT02600780|Protective Agents|protective agents|mesh-ancestor
84162524|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162525|NCT00582309|Insulin|insulin|mesh-list
84162526|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84162527|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84162528|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162529|NCT00443053|PENTA|penta|mesh-list
84162530|NCT00443053|Fondaparinux|fondaparinux|mesh-list
84162531|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84162532|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
84162533|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84162534|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
84162535|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162536|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162537|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
84162538|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84162539|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84162540|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
84162541|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
84162542|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
84162543|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84162544|NCT00720798|Analgesics|analgesics|mesh-ancestor
84162545|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
84162546|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162547|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162548|NCT01816971|Dexamethasone|dexamethasone|mesh-list
84162549|NCT01816971|Lenalidomide|lenalidomide|mesh-list
84162550|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162551|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
84162552|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
84162553|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162554|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162555|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162556|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
84162557|NCT01816971|Hormones|hormones|mesh-ancestor
84162558|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162559|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84162560|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162561|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
84162562|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84162563|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84162564|NCT01816971|Growth Substances|growth substances|mesh-ancestor
84162565|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
84162566|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
84162567|NCT01021267|Urological Agents|urological agents|mesh-ancestor
84162568|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
84162569|NCT00717366|Hematinics|hematinics|mesh-ancestor
84162570|NCT02939989|Ribavirin|ribavirin|mesh-list
84162571|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
84162572|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
84162573|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162574|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
84162575|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162576|NCT04096742|Tretinoin|tretinoin|mesh-list
84162577|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162578|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
84162579|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
84162580|NCT04085640|Ropivacaine|ropivacaine|mesh-list
84162581|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
84162582|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
84162583|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162584|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162585|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
84162586|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162587|NCT01031719|Vaccines|vaccines|mesh-list
84162589|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162590|NCT00723606|Haloperidol|haloperidol|mesh-list
84162591|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
84162592|NCT00723606|Ziprasidone|ziprasidone|mesh-list
84162593|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
84162594|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
84162595|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162596|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162597|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162598|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84162599|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84162600|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162601|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84162602|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84162603|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
84162604|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162605|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162606|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84162607|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84162608|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
84162609|NCT01021501|Nifedipine|nifedipine|mesh-list
84162610|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84162611|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84162612|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162613|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84162614|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162615|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
84162616|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
84162617|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84162618|NCT01021579|Metformin|metformin|mesh-list
84162619|NCT01021579|Simvastatin|simvastatin|mesh-list
84162620|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84162621|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162622|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84162623|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84162624|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
84162625|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162626|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84162627|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84162628|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162629|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84162630|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84162631|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162632|NCT01021735|Adalimumab|adalimumab|mesh-list
84162633|NCT01021735|Etanercept|etanercept|mesh-list
84162634|NCT01021735|Rituximab|rituximab|mesh-list
84162635|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162636|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162637|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
84162638|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162639|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162640|NCT01021735|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84162641|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162642|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84162643|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84162644|NCT01021735|Analgesics|analgesics|mesh-ancestor
84162645|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
84162646|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162647|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162648|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162649|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
84162650|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162651|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
84162652|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84162653|NCT00436501|Docetaxel|docetaxel|mesh-list
84162654|NCT00436501|Aflibercept|aflibercept|mesh-list
84162655|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
84162656|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162657|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
84162658|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
84162659|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
82949483|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162660|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162661|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83434684|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162662|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84162663|NCT00436501|Growth Substances|growth substances|mesh-ancestor
84162664|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162665|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
84162666|NCT00755846|Alogliptin|alogliptin|mesh-list
84162667|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84162668|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162669|NCT00755846|Incretins|incretins|mesh-ancestor
84162670|NCT00755846|Hormones|hormones|mesh-ancestor
84162671|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162672|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84162673|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
84162674|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162675|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162676|NCT03850093|Bisoprolol|bisoprolol|mesh-list
84162677|NCT03850093|Gabapentin|gabapentin|mesh-list
84162678|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162679|NCT03850093|Analgesics|analgesics|mesh-ancestor
84162680|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
84162681|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162682|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
84162683|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84162684|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84162685|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162686|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84162687|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84162688|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84162689|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162690|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162691|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
84162692|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84162693|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
84162694|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
84162695|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84162696|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84162697|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84162698|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
84162699|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
84162700|NCT00442117|Budesonide|budesonide|mesh-list
84162701|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162702|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84162703|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
84162704|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162705|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162706|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84162707|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
84162708|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
84162709|NCT00442117|Hormones|hormones|mesh-ancestor
84162710|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162711|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
84162712|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84162713|NCT00752726|Orlistat|orlistat|mesh-list
84162714|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162715|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162716|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84162717|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84162718|NCT04072497|Vaccines|vaccines|mesh-list
84162719|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
84162720|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162721|NCT04072263|Interferons|interferons|mesh-list
84162722|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
84162723|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
84162724|NCT04072263|Paclitaxel|paclitaxel|mesh-list
84162725|NCT04072263|Carboplatin|carboplatin|mesh-list
84162726|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84162727|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162728|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
84162729|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
84162730|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
84162731|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162732|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
84162733|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162734|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
84162735|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162736|NCT00441727|Esomeprazole|esomeprazole|mesh-list
84162737|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84162738|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162739|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84162740|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162741|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162742|NCT00770120|Everolimus|everolimus|mesh-list
84162743|NCT00770120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84162744|NCT00770120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84162745|NCT00770120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162746|NCT00770120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162747|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162748|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
84162749|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162750|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162751|NCT03996655|Neostigmine|neostigmine|mesh-list
84162752|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84162753|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162754|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162755|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
84162756|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162757|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162758|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84162759|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
84162760|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162761|NCT01032109|Bevacizumab|bevacizumab|mesh-list
84162762|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162763|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162764|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84162765|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84162766|NCT01032109|Growth Substances|growth substances|mesh-ancestor
84162767|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162768|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
84162769|NCT04100330|Cytarabine|cytarabine|mesh-list
84162770|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162771|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
84162772|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162773|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162774|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
84162775|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162776|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162777|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
84162778|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162779|NCT00436345|Remifentanil|remifentanil|mesh-list
84162780|NCT00436345|Propofol|propofol|mesh-list
84162781|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84162782|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162783|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162784|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84162785|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
84162786|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
84162787|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84162788|NCT00436345|Narcotics|narcotics|mesh-ancestor
84162789|NCT00436345|Analgesics|analgesics|mesh-ancestor
84162790|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
84162791|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162792|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
84162793|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84162794|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84162795|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
84162796|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162797|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162798|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84162799|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84162800|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
84162801|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162802|NCT01032187|Amphotericin B|amphotericin b|mesh-list
84162803|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82949484|NCT01101113|Cinacalcet|cinacalcet|mesh-list
84162804|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
84162805|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
84162806|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
84162807|NCT01032187|Amebicides|amebicides|mesh-ancestor
84162808|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84162809|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84162810|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162811|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84162812|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
84162813|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84162814|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162815|NCT00769184|Clobetasol|clobetasol|mesh-list
84162816|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84162817|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
84162818|NCT00769184|Hormones|hormones|mesh-ancestor
84162819|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84162820|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162821|NCT00768560|Nifedipine|nifedipine|mesh-list
84162822|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84162823|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84162824|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162825|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84162826|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162827|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
84162828|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
84162829|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84162830|NCT00468559|Esomeprazole|esomeprazole|mesh-list
84162831|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84162832|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162833|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84162834|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162835|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162836|NCT00754442|Teriparatide|teriparatide|mesh-list
84162837|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84162838|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162839|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84162840|NCT00754052|Donepezil|donepezil|mesh-list
84162841|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84162842|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162843|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162844|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
84162845|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162846|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162847|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
84162848|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
84162849|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
84162850|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84162851|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84162852|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84162853|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162854|NCT05430152|Naltrexone|naltrexone|mesh-list
84162855|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84162856|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84162857|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162858|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
84162859|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162860|NCT02927067|Valganciclovir|valganciclovir|mesh-list
84162861|NCT02927067|Maribavir|maribavir|mesh-list
84162862|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
84162863|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162864|NCT02600468|Abatacept|abatacept|mesh-list
84162865|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84162866|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162867|NCT02600468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162868|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162869|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162870|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
84162871|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162872|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162873|NCT02598596|Azathioprine|azathioprine|mesh-list
84162874|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
84162875|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162876|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162877|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162878|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84162879|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
84162880|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162881|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84162882|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84162883|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84162884|NCT01771107|Doxorubicin|doxorubicin|mesh-list
84162885|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84162886|NCT01771107|Dacarbazine|dacarbazine|mesh-list
84162887|NCT01771107|Vinblastine|vinblastine|mesh-list
84162888|NCT01771107|Antibodies|antibodies|mesh-list
84162889|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
84162890|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84162891|NCT01771107|Imidazole|imidazole|mesh-list
84162892|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
84162893|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
84162894|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162895|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162896|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84162897|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84162898|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84162899|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162900|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162901|NCT01771107|Immunotoxins|immunotoxins|mesh-ancestor
84162902|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84162903|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
84162904|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84162905|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
84162906|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
84162907|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
84162908|NCT00586508|Bevacizumab|bevacizumab|mesh-list
84162909|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
84162910|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162911|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162912|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84162913|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84162914|NCT00586508|Growth Substances|growth substances|mesh-ancestor
84162915|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162916|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
84162917|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
84162918|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162919|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
84162920|NCT00581919|Vitamins|vitamins|mesh-ancestor
84162921|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
84162922|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
84162923|NCT00723528|Ustekinumab|ustekinumab|mesh-list
84162924|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
84162925|NCT02892123|Paclitaxel|paclitaxel|mesh-list
84162926|NCT02892123|Vinorelbine|vinorelbine|mesh-list
84162927|NCT02892123|Capecitabine|capecitabine|mesh-list
84162928|NCT02892123|Tucatinib|tucatinib|mesh-list
84162929|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84162930|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162931|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
84162932|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
84162933|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
84162934|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162935|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84162936|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
84162937|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84162938|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162939|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84162940|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
84162941|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84162942|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
84162943|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84162944|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162945|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84162946|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84162947|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162948|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83430797|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162949|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84162950|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
84162951|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84162952|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
84162953|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162954|NCT00916760|Antacids|antacids|mesh-ancestor
84162955|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162956|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84162957|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
84162958|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84162959|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84162960|NCT05442554|Immunotoxins|immunotoxins|mesh-ancestor
84162961|NCT05442554|Immunoconjugates|immunoconjugates|mesh-ancestor
84162962|NCT05442554|Immunologic Factors|immunologic factors|mesh-ancestor
84162963|NCT05442554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162964|NCT00723450|Lamotrigine|lamotrigine|mesh-list
84162965|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
84162966|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84162967|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84162968|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162969|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84162970|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162971|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84162972|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84162973|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84162974|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84162975|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84162976|NCT02599532|Apixaban|apixaban|mesh-list
84162977|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84162978|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
84162979|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84162980|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
84162981|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84162982|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162983|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
84162984|NCT04085094|Pilocarpine|pilocarpine|mesh-list
84162985|NCT04085094|Miotics|miotics|mesh-ancestor
84162986|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
84162987|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84162988|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84162989|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84162990|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84162991|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
84162992|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84162993|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84162994|NCT00751400|Naproxen|naproxen|mesh-list
84162995|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84162996|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84162997|NCT00751400|Analgesics|analgesics|mesh-ancestor
84162998|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
84162999|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163000|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163001|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163002|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163003|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
84163004|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84163005|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163006|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163007|NCT05420948|Paclitaxel|paclitaxel|mesh-list
84163008|NCT05420948|Carboplatin|carboplatin|mesh-list
84163009|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
84163010|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163011|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163012|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163013|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163014|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163015|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163016|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163017|NCT05420948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84163018|NCT00585312|Celecoxib|celecoxib|mesh-list
84163019|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84163020|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84163021|NCT00585312|Analgesics|analgesics|mesh-ancestor
84163022|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
84163023|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163024|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163025|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163026|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163027|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84163028|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84163029|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163030|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163031|NCT00753506|Artemisinins|artemisinins|mesh-list
84163032|NCT00753506|Artemisinin|artemisinin|mesh-list
84163033|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
84163034|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84163035|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84163036|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163037|NCT00720096|Doxorubicin|doxorubicin|mesh-list
84163038|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83435061|NCT00705133|Treprostinil|treprostinil|mesh-list
84163040|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84163041|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163042|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84163043|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84163044|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163045|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163046|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84163047|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
84163048|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
84163049|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163050|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163051|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163052|NCT02577783|Dexamethasone|dexamethasone|mesh-list
84163053|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
84163054|NCT02577783|Doxorubicin|doxorubicin|mesh-list
84163055|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84163056|NCT02577783|BB 1101|bb 1101|mesh-list
84163057|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163058|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
84163059|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
84163060|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163061|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163062|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163063|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
84163064|NCT02577783|Hormones|hormones|mesh-ancestor
84163065|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163066|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84163067|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163068|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
84163069|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163070|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163071|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84163072|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84163073|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84163074|NCT00918450|Navitoclax|navitoclax|mesh-list
84163075|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163076|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
84163077|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84163078|NCT02591628|Diuretics|diuretics|mesh-ancestor
84163079|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
84163080|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163081|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
84163082|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163083|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163084|NCT04090112|Lidocaine|lidocaine|mesh-list
84163085|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
84163086|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
84163087|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163088|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163089|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
84163090|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430803|NCT04021862|Antibodies|antibodies|mesh-list
84163091|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84163092|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84163093|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84163094|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163095|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163096|NCT00747344|Ustekinumab|ustekinumab|mesh-list
84163097|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
84163098|NCT00580983|Paclitaxel|paclitaxel|mesh-list
84163099|NCT00580983|Carboplatin|carboplatin|mesh-list
84163100|NCT00580983|Fluorouracil|fluorouracil|mesh-list
84163101|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163102|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163103|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163104|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163105|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163106|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163107|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
84163108|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84163109|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84163110|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
84163111|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83435138|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84163112|NCT02576223|Ropivacaine|ropivacaine|mesh-list
84163113|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
84163114|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
84163115|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163116|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163117|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
84163118|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163119|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
84163120|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163121|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
84163122|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
84163123|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163124|NCT02577393|Protective Agents|protective agents|mesh-ancestor
84163125|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163126|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
84163127|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
84163128|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163129|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84163130|NCT00753896|Exenatide|exenatide|mesh-list
84163131|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84163132|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163133|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84163134|NCT00753896|Incretins|incretins|mesh-ancestor
84163135|NCT00753896|Hormones|hormones|mesh-ancestor
84163136|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163137|NCT02597114|Insulin|insulin|mesh-list
84163138|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84163139|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84163140|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163141|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
84163142|NCT00716976|Antidotes|antidotes|mesh-ancestor
84163143|NCT00716976|Protective Agents|protective agents|mesh-ancestor
84163144|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163145|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
84163146|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163147|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
84163148|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84163149|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163150|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
84163151|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
84163152|NCT00743444|Lesogaberan|lesogaberan|mesh-list
84163153|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163154|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
84163155|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
84163156|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
84163157|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163158|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430807|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
84163159|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163160|NCT00743366|Riboflavin|riboflavin|mesh-list
84163161|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84163162|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
84163163|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84163164|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84163165|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84163166|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163167|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163168|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
84163169|NCT00743366|Vitamins|vitamins|mesh-ancestor
84163170|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
84163171|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84163172|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
84163173|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
84163174|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
84163175|NCT01760655|Busulfan|busulfan|mesh-list
84163176|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
84163177|NCT01760655|Fludarabine|fludarabine|mesh-list
84163178|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
84163179|NCT01760655|Tacrolimus|tacrolimus|mesh-list
84163180|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84163181|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
84163182|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163183|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163184|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83435224|NCT03591770|Vaccines|vaccines|mesh-list
84163185|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
84163186|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163187|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163188|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84163189|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84163190|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
84163191|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163192|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84163193|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163194|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84163195|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84163196|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
84163197|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84163198|NCT00743288|Melphalan|melphalan|mesh-list
84163199|NCT00743288|Panobinostat|panobinostat|mesh-list
84163200|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84163201|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
84163202|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163203|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163204|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84163205|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84163206|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
84163207|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163208|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
84163209|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163210|NCT02579187|Anesthetics|anesthetics|mesh-list
84163211|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163212|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163213|NCT02598440|Alendronate|alendronate|mesh-list
84163214|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
84163215|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84163216|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163217|NCT00750308|Ramipril|ramipril|mesh-list
84163218|NCT00750308|Tadalafil|tadalafil|mesh-list
84163219|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
84163220|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84163221|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84163222|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163223|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163224|NCT00750308|Urological Agents|urological agents|mesh-ancestor
84163225|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84163226|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
84163227|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84163228|NCT05392790|Calcium|calcium|mesh-list
84163229|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84163230|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163231|NCT02597036|Zansecimab|zansecimab|mesh-list
84163232|NCT02597036|Paclitaxel|paclitaxel|mesh-list
84163233|NCT02597036|Ramucirumab|ramucirumab|mesh-list
84163234|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163235|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163236|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163237|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163238|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163239|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163240|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
84163241|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163242|NCT04071639|Ubiquinone|ubiquinone|mesh-list
84163243|NCT04071639|Haloperidol|haloperidol|mesh-list
84163244|NCT04071639|Risperidone|risperidone|mesh-list
84163245|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
84163246|NCT04071639|Sertraline|sertraline|mesh-list
84163247|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
84163248|NCT04071639|Idebenone|idebenone|mesh-list
84163249|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84163250|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
84163251|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163252|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163253|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163254|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84163255|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84163256|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163257|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84163258|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84163259|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
84163260|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
84163261|NCT04071639|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84163262|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84163263|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163264|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
84163265|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
84163266|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163267|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163268|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84163269|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
84163270|NCT04071639|Protective Agents|protective agents|mesh-ancestor
84163271|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
84163272|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84163273|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163274|NCT04089176|Oxytocin|oxytocin|mesh-list
84163275|NCT04089176|Carbetocin|carbetocin|mesh-list
84163276|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
84163277|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84163278|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163279|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
84163280|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84163281|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163282|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84163283|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163284|NCT00749684|Interferons|interferons|mesh-list
84163285|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163286|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
84163287|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163288|NCT02575755|Azithromycin|azithromycin|mesh-list
84163289|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
84163290|NCT02575755|Piperaquine|piperaquine|mesh-list
84163291|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
84163292|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
84163293|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84163294|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163295|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
84163296|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84163297|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84163298|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84163299|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163300|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163301|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84163302|NCT00746798|Vaccines|vaccines|mesh-list
84163303|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
84163304|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163305|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
84163306|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84163307|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84163308|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163309|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163310|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163311|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163312|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163313|NCT01298193|Phenothiazine|phenothiazine|mesh-list
84163314|NCT01298193|Droperidol|droperidol|mesh-list
84163315|NCT01298193|Haloperidol|haloperidol|mesh-list
84163316|NCT01298193|Aprepitant|aprepitant|mesh-list
84163317|NCT01298193|Metoclopramide|metoclopramide|mesh-list
84163318|NCT01298193|Domperidone|domperidone|mesh-list
84163319|NCT01298193|Alizapride|alizapride|mesh-list
84163320|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
84163321|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
84163322|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
84163323|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163324|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163325|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163326|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84163327|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163328|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163329|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84163330|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84163331|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163332|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84163333|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84163334|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
84163335|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84163336|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84163337|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84163338|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84163339|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
84163340|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84163341|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84163342|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163343|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
84163344|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163345|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
84163346|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
84163347|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84163348|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163349|NCT02590536|Urological Agents|urological agents|mesh-ancestor
84163350|NCT00719862|Azelastine|azelastine|mesh-list
84163351|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84163352|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
84163353|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163354|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163355|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84163356|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
84163357|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84163358|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163359|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163360|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84163361|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84163362|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84163363|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
84163364|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
84163365|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163366|NCT02578953|Dutasteride|dutasteride|mesh-list
84163367|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
84163368|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84163369|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163370|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163371|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
84163372|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163373|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163374|NCT02578719|Bupivacaine|bupivacaine|mesh-list
84163375|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
84163376|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
84163377|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163378|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163379|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
84163380|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163381|NCT00742508|Carvedilol|carvedilol|mesh-list
84163382|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84163383|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84163384|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163385|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163386|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163387|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163388|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84163389|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
84163390|NCT00742508|Protective Agents|protective agents|mesh-ancestor
84163391|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84163392|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163393|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84163394|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
84163395|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84163396|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84163397|NCT02590614|Vitamin D|vitamin d|mesh-list
84163398|NCT02590614|Vitamins|vitamins|mesh-ancestor
84163399|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
84163400|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163401|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84163402|NCT02575443|Rocuronium|rocuronium|mesh-list
84163403|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
84163404|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84163405|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84163406|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163407|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163408|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
84163409|NCT05382650|Antibodies|antibodies|mesh-list
84163410|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
84163411|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84163412|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84163413|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
84163414|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163415|NCT02596334|Lamivudine|lamivudine|mesh-list
84163417|NCT02596334|Dolutegravir|dolutegravir|mesh-list
84163418|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84163419|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84163420|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163421|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163422|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
84163423|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163424|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84163425|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84163426|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84163427|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84163428|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
84163429|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
84163430|NCT00719706|Vitamins|vitamins|mesh-ancestor
84163431|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
84163432|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163433|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
84163434|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
84163435|NCT02575521|Propofol|propofol|mesh-list
84163436|NCT02575521|Sevoflurane|sevoflurane|mesh-list
84163437|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84163438|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163439|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163440|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84163441|NCT02575521|Analgesics|analgesics|mesh-ancestor
84163442|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
84163443|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163444|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84163445|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84163446|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84163447|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163448|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163449|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163450|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84163451|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
84163452|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
84163453|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84163454|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
84163455|NCT02576457|BMS-936559|bms-936559|mesh-list
84163456|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163457|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163458|NCT05276102|Emollients|emollients|mesh-list
84163459|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
84163460|NCT02596100|Betrixaban|betrixaban|mesh-list
84163461|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84163462|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
84163463|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84163464|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
84163465|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163466|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163467|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
84163468|NCT01192971|Apatinib|apatinib|mesh-list
84163469|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163470|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84163471|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163472|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163473|NCT00719472|Antipyretics|antipyretics|mesh-list
84163474|NCT00719472|Prednisone|prednisone|mesh-list
84163475|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
84163476|NCT00719472|Rituximab|rituximab|mesh-list
84163477|NCT00719472|Doxorubicin|doxorubicin|mesh-list
84163478|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84163479|NCT00719472|Vincristine|vincristine|mesh-list
84163480|NCT00719472|Analgesics|analgesics|mesh-list
84163481|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
84163482|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
84163483|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84163484|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
84163485|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163486|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163487|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84163488|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
84163489|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163490|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163491|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84163492|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163493|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84163494|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84163495|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84163496|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163497|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163498|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
84163499|NCT00719472|Hormones|hormones|mesh-ancestor
84163500|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163501|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84163502|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163503|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163504|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163505|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163506|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
84163507|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163508|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
84163509|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163510|NCT00579501|Dexamethasone|dexamethasone|mesh-list
84163511|NCT00579501|Trabectedin|trabectedin|mesh-list
84163512|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163513|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
84163514|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
84163515|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163516|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163517|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163518|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
84163519|NCT00579501|Hormones|hormones|mesh-ancestor
84163520|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163521|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84163522|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163523|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84163524|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
84163525|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163526|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
84163527|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84163528|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163529|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84163530|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84163531|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163532|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163533|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163534|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84163535|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84163536|NCT02576301|Cytarabine|cytarabine|mesh-list
84163537|NCT02576301|Combretastatin|combretastatin|mesh-list
84163538|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84163539|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
84163540|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163541|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163542|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
84163543|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163544|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84163545|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
84163546|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163547|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163548|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163549|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163550|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163551|NCT04086186|Bupivacaine|bupivacaine|mesh-list
84163552|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
84163553|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
84163554|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163555|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163556|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
84163557|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163558|NCT00741338|Cyclosporine|cyclosporine|mesh-list
84163559|NCT00741338|Azathioprine|azathioprine|mesh-list
84163560|NCT00741338|Cyclosporins|cyclosporins|mesh-list
84163561|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163562|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163563|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84163564|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
84163565|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163566|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
84163567|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163568|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
84163569|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163570|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84163571|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
84163572|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84163573|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163574|NCT02598830|Vitamin D|vitamin d|mesh-list
84163575|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
84163576|NCT02598830|Vitamins|vitamins|mesh-ancestor
84163577|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
84163578|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163579|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84163580|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84163581|NCT02578251|Acetaminophen|acetaminophen|mesh-list
84163582|NCT02578251|Meperidine|meperidine|mesh-list
84163583|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84163584|NCT02578251|Analgesics|analgesics|mesh-ancestor
84163585|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
84163586|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163587|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163588|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
84163589|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84163590|NCT02578251|Narcotics|narcotics|mesh-ancestor
84163591|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163592|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84163593|NCT05285358|Paclitaxel|paclitaxel|mesh-list
84163594|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84163595|NCT05285358|Cisplatin|cisplatin|mesh-list
84163596|NCT05285358|Gemcitabine|gemcitabine|mesh-list
84163597|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163598|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163599|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163600|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163601|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163602|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163603|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84163604|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
84163605|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
84163606|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
84163607|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84163608|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
84163609|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163610|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163611|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84163612|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
84163613|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84163614|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84163615|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84163616|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163617|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163618|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163619|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163620|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
84163621|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84163622|NCT02590224|Glycine|glycine|mesh-list
84163623|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
84163624|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163625|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163626|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163627|NCT00709449|Papaverine|papaverine|mesh-list
84163628|NCT00709449|Moxaverine|moxaverine|mesh-list
84163629|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
84163630|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
84163631|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163632|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163633|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84163634|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163635|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163636|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
84163637|NCT00709449|Urological Agents|urological agents|mesh-ancestor
84163638|NCT00746252|Risperidone|risperidone|mesh-list
84163639|NCT00746252|Aripiprazole|aripiprazole|mesh-list
84163640|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84163641|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
84163642|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163643|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163644|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163645|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84163646|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84163647|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163648|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84163649|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84163650|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
84163651|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
84163652|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
84163653|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84163654|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84163655|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84163656|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84163657|NCT02574975|Budesonide|budesonide|mesh-list
84163658|NCT02574975|Adenosine|adenosine|mesh-list
84163659|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
84163660|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
84163661|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163662|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84163663|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
84163664|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163665|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163666|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84163667|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
84163668|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
84163669|NCT02574975|Hormones|hormones|mesh-ancestor
84163670|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163671|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84163672|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84163673|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84163674|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163675|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163676|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163677|NCT02574975|Analgesics|analgesics|mesh-ancestor
84163678|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
84163679|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84163680|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
84163681|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
84163682|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
84163683|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
84163684|NCT02574975|Miotics|miotics|mesh-ancestor
84163685|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
84163686|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
84163687|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
84163688|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84163689|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
84163690|NCT00718770|Bexarotene|bexarotene|mesh-list
84163691|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163692|NCT04084158|Paclitaxel|paclitaxel|mesh-list
84163693|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84163694|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163695|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163696|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163697|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163698|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163699|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163700|NCT00714519|Castor Oil|castor oil|mesh-list
84163701|NCT00714519|Cathartics|cathartics|mesh-ancestor
84163702|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163703|NCT00714948|Gemcitabine|gemcitabine|mesh-list
84163704|NCT00714948|Sorafenib|sorafenib|mesh-list
84163705|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163706|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84163707|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
84163708|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163709|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84163710|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163711|NCT00714714|Adapalene|adapalene|mesh-list
84163712|NCT00714714|Tretinoin|tretinoin|mesh-list
84163713|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84163714|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84163715|NCT00714714|Analgesics|analgesics|mesh-ancestor
84163716|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
84163717|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83435733|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84163718|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163719|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163720|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163721|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
84163722|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163723|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
84163725|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163726|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163727|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84163728|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163729|NCT00578877|Nonoxynol|nonoxynol|mesh-list
84163730|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
84163731|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
84163732|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163733|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84163734|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
84163735|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84163736|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
84163737|NCT02573727|Terlipressin|terlipressin|mesh-list
84163738|NCT02573727|Epinephrine|epinephrine|mesh-list
84163739|NCT02573727|Racepinephrine|racepinephrine|mesh-list
84163740|NCT02573727|Norepinephrine|norepinephrine|mesh-list
84163741|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
84163742|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84163743|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84163744|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163745|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163746|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163747|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163748|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84163749|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84163750|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
84163751|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163752|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84163753|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
84163754|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
84163755|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
84163756|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84163757|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84163758|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
84163759|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
84163760|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
84163761|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84163762|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163763|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
84163764|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
84163765|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163766|NCT00918528|Mitomycins|mitomycins|mesh-list
84163767|NCT00918528|Mitomycin|mitomycin|mesh-list
84163768|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84163769|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163770|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
84163771|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163772|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84163773|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163774|NCT00468481|Drospirenone|drospirenone|mesh-list
84163775|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84163776|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
84163777|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84163778|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84163779|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84163780|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
84163781|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84163782|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163783|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84163784|NCT00468481|Estrogens|estrogens|mesh-ancestor
84163785|NCT00468481|Hormones|hormones|mesh-ancestor
84163786|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163787|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84163788|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
84163789|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84163790|NCT00468481|Diuretics|diuretics|mesh-ancestor
84163791|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
84163792|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
84163793|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84163794|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163795|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
84163796|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163797|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
84163798|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163800|NCT03949153|Ipilimumab|ipilimumab|mesh-list
84163801|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163802|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430851|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
84163803|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84163804|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163805|NCT00709917|Repaglinide|repaglinide|mesh-list
84163806|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84163807|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163808|NCT02574741|Aripiprazole|aripiprazole|mesh-list
84163809|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
84163810|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84163811|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
84163812|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84163813|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163814|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163815|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
84163816|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
84163817|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163818|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163819|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84163820|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84163821|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
84163822|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84163823|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84163824|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84163825|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84163826|NCT00468169|Cetuximab|cetuximab|mesh-list
84163827|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
84163828|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163829|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163830|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
84163831|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163832|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163833|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84163834|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
84163835|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84163836|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163837|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163838|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163839|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163840|NCT02589444|Vitamin D|vitamin d|mesh-list
84163841|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
84163842|NCT02589444|Vitamins|vitamins|mesh-ancestor
84163843|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
84163844|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163845|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84163846|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84163847|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84163848|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163849|NCT05325684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163850|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163851|NCT00435487|Heparin|heparin|mesh-list
84163852|NCT00435487|Calcium heparin|calcium heparin|mesh-list
84163853|NCT00435487|Dalteparin|dalteparin|mesh-list
84163854|NCT00435487|Tinzaparin|tinzaparin|mesh-list
84163855|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
84163856|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
84163857|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84163858|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84163859|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163860|NCT02589678|Vaccines|vaccines|mesh-list
84163861|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
84163862|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163863|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
84163864|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
84163865|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84163866|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
84163867|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84163868|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163869|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84163870|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84163871|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163872|NCT02591004|Nifedipine|nifedipine|mesh-list
84163873|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84163874|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163875|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163876|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84163877|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163878|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
84163879|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
84163880|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84163881|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
84163882|NCT05310786|Narcotics|narcotics|mesh-ancestor
84163883|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84163884|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163885|NCT05310786|Analgesics|analgesics|mesh-ancestor
84163886|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
84163887|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163888|NCT04085562|Amlodipine|amlodipine|mesh-list
84163889|NCT04085562|Bisoprolol|bisoprolol|mesh-list
84163890|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84163891|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84163892|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163893|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163894|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84163895|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163896|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
84163897|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
84163898|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
84163899|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163900|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
84163901|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
84163902|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84163903|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
84163904|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163905|NCT05048238|Tofacitinib|tofacitinib|mesh-list
84163906|NCT05048238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
84163907|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84163908|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163909|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163910|NCT05683626|Adalimumab|adalimumab|mesh-list
84163911|NCT05683626|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84163912|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163913|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163914|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84163915|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84163916|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163917|NCT05168202|Azacitidine|azacitidine|mesh-list
84163918|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84163919|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
84163920|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163921|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163922|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163923|NCT02588196|Dexamethasone|dexamethasone|mesh-list
84163924|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
84163925|NCT02588196|BB 1101|bb 1101|mesh-list
84163926|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84163927|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
84163928|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
84163929|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163930|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163931|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84163932|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
84163933|NCT02588196|Hormones|hormones|mesh-ancestor
84163934|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84163935|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84163936|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163937|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
84163938|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163939|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163940|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83435963|NCT00566813|Incretins|incretins|mesh-ancestor
84163942|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84163943|NCT00579345|Vaccines|vaccines|mesh-list
84163944|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
84163945|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163946|NCT00715377|Benztropine|benztropine|mesh-list
84163947|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
84163948|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84163949|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
84163950|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
84163951|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84163952|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163953|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84163954|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84163955|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
84163956|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84163957|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163958|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84163959|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84163960|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84163961|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
84163962|NCT05023980|Rituximab|rituximab|mesh-list
84163963|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
84163964|NCT05023980|Pirtobrutinib|pirtobrutinib|mesh-list
84163965|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163966|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163967|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
84163968|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84163969|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84163970|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84163971|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
84163972|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163973|NCT05023980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84163974|NCT05023980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84163975|NCT00715455|Heparin|heparin|mesh-list
84163976|NCT00715455|Calcium heparin|calcium heparin|mesh-list
84163977|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
84163978|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84163979|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84163980|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163981|NCT02574663|Leucovorin|leucovorin|mesh-list
84163982|NCT02574663|Folic Acid|folic acid|mesh-list
84163983|NCT02574663|Paclitaxel|paclitaxel|mesh-list
84163984|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84163985|NCT02574663|Bevacizumab|bevacizumab|mesh-list
84163986|NCT02574663|Gemcitabine|gemcitabine|mesh-list
84163987|NCT02574663|Fluorouracil|fluorouracil|mesh-list
84163988|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
84163989|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
84163990|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84163991|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84163992|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
84163993|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
84163994|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
84163995|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84163996|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84163997|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84163998|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84163999|NCT02574663|Growth Substances|growth substances|mesh-ancestor
84164000|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164001|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
84164002|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164003|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
84164004|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164005|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
84164006|NCT02574663|Antidotes|antidotes|mesh-ancestor
84164007|NCT02574663|Protective Agents|protective agents|mesh-ancestor
84164008|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
84164009|NCT02574663|Vitamins|vitamins|mesh-ancestor
84164010|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
84164011|NCT02574663|Hematinics|hematinics|mesh-ancestor
84164012|NCT04069845|Doxorubicin|doxorubicin|mesh-list
84164013|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
84164014|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84164015|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83436029|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84164016|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84164017|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84164018|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164019|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164020|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84164021|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
84164022|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164024|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164025|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164026|NCT00919542|Cyclosporine|cyclosporine|mesh-list
84164027|NCT00919542|Prednisolone|prednisolone|mesh-list
84164028|NCT00919542|Cyclosporins|cyclosporins|mesh-list
84164029|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164030|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164031|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164032|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
84164033|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164034|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
84164035|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164036|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164037|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164038|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84164039|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164040|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
84164041|NCT00919542|Hormones|hormones|mesh-ancestor
84164042|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164043|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84164044|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164045|NCT04240626|Acetaminophen|acetaminophen|mesh-list
84164046|NCT04240626|Scopolamine|scopolamine|mesh-list
84164047|NCT04240626|Oxycodone|oxycodone|mesh-list
84164048|NCT04240626|Gabapentin|gabapentin|mesh-list
84164049|NCT04240626|Hydromorphone|hydromorphone|mesh-list
84164050|NCT04240626|Hydrocodone|hydrocodone|mesh-list
84164051|NCT04240626|Bupivacaine|bupivacaine|mesh-list
84164052|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
84164053|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
84164054|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84164055|NCT04240626|Analgesics|analgesics|mesh-ancestor
84164056|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
84164057|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164058|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164059|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
84164060|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84164061|NCT04240626|Narcotics|narcotics|mesh-ancestor
84164062|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164063|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
84164064|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84164065|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84164066|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84164067|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84164068|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84164069|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164070|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164071|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
84164072|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
84164073|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
84164074|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
84164075|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
84164076|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84164077|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
84164078|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
84164079|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84164080|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
84164081|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84164082|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
84164083|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84164084|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
84164085|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
84164086|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
84164087|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84164088|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84164089|NCT00719121|Adapalene|adapalene|mesh-list
84164090|NCT00719121|R 115866|r 115866|mesh-list
84164091|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84164092|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84164093|NCT00719121|Analgesics|analgesics|mesh-ancestor
84164094|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
84164095|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164096|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164097|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164098|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164099|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164100|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84164101|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164102|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164103|NCT00719199|Cetuximab|cetuximab|mesh-list
84164104|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164105|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164106|NCT02589288|Ropivacaine|ropivacaine|mesh-list
84164107|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
84164108|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
84164109|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164110|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164111|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
84164112|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164113|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
84164114|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
84164115|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
84164116|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164117|NCT00716001|Expectorants|expectorants|mesh-ancestor
84164118|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
84164119|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84164120|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
84164121|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164122|NCT00716001|Protective Agents|protective agents|mesh-ancestor
84164123|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164124|NCT00716001|Antidotes|antidotes|mesh-ancestor
84164125|NCT05136846|Paclitaxel|paclitaxel|mesh-list
84164126|NCT05136846|Carboplatin|carboplatin|mesh-list
84164127|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84164128|NCT05136846|Durvalumab|durvalumab|mesh-list
84164129|NCT05136846|Papaverine|papaverine|mesh-list
84164130|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
84164131|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84164132|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
84164133|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84164134|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164135|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
84164136|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
84164137|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
84164138|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164139|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164140|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
84164141|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164142|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
84164143|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164144|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
84164145|NCT05136846|Urological Agents|urological agents|mesh-ancestor
84164146|NCT00710229|Bevacizumab|bevacizumab|mesh-list
84164147|NCT00710229|Ranibizumab|ranibizumab|mesh-list
84164148|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164149|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164150|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84164151|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84164152|NCT00710229|Growth Substances|growth substances|mesh-ancestor
84164153|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164154|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
84164155|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
84164156|NCT00710619|Coagulants|coagulants|mesh-ancestor
84164157|NCT05192460|Vaccines|vaccines|mesh-list
84164158|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
84164159|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164160|NCT00719433|Armin|armin|mesh-list
84164161|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
84164162|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164163|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164164|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
84164165|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164166|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164167|NCT04068519|Tislelizumab|tislelizumab|mesh-list
84164168|NCT04068519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164169|NCT04068519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164170|NCT04978272|Piperaquine|piperaquine|mesh-list
84164171|NCT04978272|Artenimol|artenimol|mesh-list
84164172|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
84164173|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84164174|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84164175|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164176|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
84164177|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84164178|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164179|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164180|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84164181|NCT04973124|Analgesics|analgesics|mesh-ancestor
84164182|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
84164183|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164184|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84164185|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84164186|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84164187|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
84164188|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164189|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164190|NCT04971720|Valsartan|valsartan|mesh-list
84164191|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
84164192|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84164193|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84164194|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84164195|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164196|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
84164197|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164198|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164199|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84164200|NCT00719745|Tacrolimus|tacrolimus|mesh-list
84164201|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164202|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
84164203|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164204|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84164205|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164206|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164207|NCT02587416|Atorvastatin|atorvastatin|mesh-list
84164208|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84164209|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84164210|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
84164211|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164212|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84164213|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84164214|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164215|NCT00719823|Maraviroc|maraviroc|mesh-list
84164216|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
84164217|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
84164218|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164219|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84164220|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84164221|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
84164222|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164223|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
84164224|NCT00919776|Cyclosporine|cyclosporine|mesh-list
84164225|NCT00919776|Prednisolone|prednisolone|mesh-list
84164226|NCT00919776|Cyclosporins|cyclosporins|mesh-list
84164227|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164228|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164229|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164230|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
84164231|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164232|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
84164233|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164234|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164235|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164236|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84164237|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164238|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
84164239|NCT00919776|Hormones|hormones|mesh-ancestor
84164240|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164241|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84164242|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164243|NCT00720135|Rituximab|rituximab|mesh-list
84164244|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84164245|NCT00720135|Interleukin-2|interleukin-2|mesh-list
84164247|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
84164248|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84164249|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
84164250|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164251|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164252|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164253|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84164254|NCT00720135|Analgesics|analgesics|mesh-ancestor
84164255|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
84164256|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164257|NCT02588118|Propofol|propofol|mesh-list
84164258|NCT02588118|Cisatracurium|cisatracurium|mesh-list
84164259|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84164260|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164261|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164262|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84164263|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
84164264|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
84164265|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
84164266|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84164267|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164268|NCT00716391|Cisplatin|cisplatin|mesh-list
84164269|NCT00716391|Cetuximab|cetuximab|mesh-list
84164270|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164271|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164272|NCT00716469|Talaporfin|talaporfin|mesh-list
84164273|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164274|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84164275|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164276|NCT04082598|Amoxicillin|amoxicillin|mesh-list
84164277|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
84164278|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
84164279|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84164280|NCT04082598|Lactoferrin|lactoferrin|mesh-list
84164281|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164282|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164283|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84164284|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164285|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164286|NCT03895203|Adalimumab|adalimumab|mesh-list
84164287|NCT03895203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84164288|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164289|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164290|NCT04958226|Midazolam|midazolam|mesh-list
84164291|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84164292|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84164293|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164294|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164295|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84164296|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84164297|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84164298|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84164299|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
84164300|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
84164301|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
84164302|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
84164303|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164304|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164305|NCT00716547|Celecoxib|celecoxib|mesh-list
84164306|NCT00716547|Ketoprofen|ketoprofen|mesh-list
84164307|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84164308|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84164309|NCT00716547|Analgesics|analgesics|mesh-ancestor
84164310|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
84164311|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164312|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164313|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164314|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164315|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84164316|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84164317|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164318|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164319|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
84164320|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
84164321|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
83430862|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
84164322|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
84164323|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
84164324|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164325|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
84164326|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164327|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164328|NCT00720291|Metronidazole|metronidazole|mesh-list
84164329|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164330|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164331|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84164332|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84164333|NCT00578643|Cyclosporine|cyclosporine|mesh-list
84164334|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
84164335|NCT00578643|Busulfan|busulfan|mesh-list
84164336|NCT00578643|Fludarabine|fludarabine|mesh-list
84164337|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
84164338|NCT00578643|Cyclosporins|cyclosporins|mesh-list
84164339|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164340|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
84164341|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164342|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164343|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84164344|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
84164345|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164346|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164347|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84164348|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164349|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
84164350|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164351|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164352|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84164353|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164354|NCT04082286|Antibodies|antibodies|mesh-list
84164355|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84164356|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
84164357|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164358|NCT00720447|Cytarabine|cytarabine|mesh-list
84164359|NCT00720447|Etoposide|etoposide|mesh-list
84164360|NCT00720447|Melphalan|melphalan|mesh-list
84164361|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
84164362|NCT00720447|Carmustine|carmustine|mesh-list
84164363|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84164364|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164365|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84164366|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84164367|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164368|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164369|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164370|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
84164371|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
84164372|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164373|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164374|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
84164375|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164376|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84164377|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
84164378|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84164379|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164380|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
84164381|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84164382|NCT04828824|Norgestimate|norgestimate|mesh-list
84164383|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84164384|NCT04828824|Estradiol|estradiol|mesh-list
84164385|NCT04828824|Estrogens|estrogens|mesh-ancestor
84164386|NCT04828824|Hormones|hormones|mesh-ancestor
84164387|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164388|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164389|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84164390|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
84164391|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84164392|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84164393|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84164394|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84164395|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84164396|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164397|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164398|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84164399|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84164400|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164401|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164402|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164403|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84164404|NCT00578565|Rituximab|rituximab|mesh-list
84164405|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164406|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164407|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
84164408|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164409|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164410|NCT02572089|Naloxone|naloxone|mesh-list
84164411|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84164412|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164413|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
84164414|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164415|NCT02588742|Melatonin|melatonin|mesh-list
84164416|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
84164417|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164418|NCT02588742|Protective Agents|protective agents|mesh-ancestor
84164419|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164420|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164421|NCT00720603|Plerixafor|plerixafor|mesh-list
84164422|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84164423|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84164424|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
84164425|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164426|NCT04936854|Sirolimus|sirolimus|mesh-list
84164427|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
84164428|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
84164429|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
84164430|NCT04936854|Prednisolone|prednisolone|mesh-list
84164431|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
84164432|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
84164433|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
84164434|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164435|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164436|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84164437|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164438|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
84164439|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164440|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
84164441|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164442|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164443|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
84164444|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
84164445|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164446|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84164447|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
84164448|NCT04936854|Hormones|hormones|mesh-ancestor
84164449|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164450|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84164451|NCT04936854|Protective Agents|protective agents|mesh-ancestor
84164452|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84164453|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
84164454|NCT00711789|Giapreza|giapreza|mesh-list
84164455|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
84164456|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84164457|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84164458|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
84164459|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164460|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164461|NCT00741260|Capecitabine|capecitabine|mesh-list
84164462|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164463|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
84164464|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164465|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164466|NCT02587260|Clopidogrel|clopidogrel|mesh-list
84164467|NCT02587260|Ticagrelor|ticagrelor|mesh-list
84164468|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
84164469|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84164470|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83436485|NCT01950039|Betaine|betaine|mesh-list
84164471|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
84164472|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
84164473|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
84164474|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164475|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164476|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164477|NCT02596256|Docetaxel|docetaxel|mesh-list
84164478|NCT02596256|Apatinib|apatinib|mesh-list
84164479|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164480|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
84164481|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
84164482|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
84164483|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164484|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84164485|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164486|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
84164487|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
84164488|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84164489|NCT00717561|Amoxicillin|amoxicillin|mesh-list
84164490|NCT00717561|Azithromycin|azithromycin|mesh-list
84164491|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
84164492|NCT00717561|Clarithromycin|clarithromycin|mesh-list
84164493|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
84164494|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
84164495|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
84164496|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
84164497|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84164498|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164499|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164500|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84164501|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84164502|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164503|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164504|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164505|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84164506|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
84164507|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84164508|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164509|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84164510|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84164511|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84164512|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84164513|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84164514|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84164515|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84164516|NCT00720915|Anticoagulants|anticoagulants|mesh-list
84164517|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
84164518|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
84164519|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84164520|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164521|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
84164522|NCT00720915|Coagulants|coagulants|mesh-ancestor
84164523|NCT00712101|Abciximab|abciximab|mesh-list
84164524|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
84164525|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84164526|NCT00712257|Heparin|heparin|mesh-list
84164527|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
84164528|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84164529|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84164530|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164531|NCT00740792|Fluticasone|fluticasone|mesh-list
84164532|NCT00740792|Xhance|xhance|mesh-list
84164533|NCT00740792|Azelastine|azelastine|mesh-list
84164534|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164535|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84164536|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
84164537|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164538|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164539|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84164540|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
84164541|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164542|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84164543|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
84164544|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164545|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164546|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
84164547|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84164548|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
84164549|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
84164550|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164551|NCT00721305|Lovastatin|lovastatin|mesh-list
84164552|NCT00721305|L 647318|l 647318|mesh-list
84164553|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
84164554|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84164555|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84164556|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
84164557|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164558|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84164559|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84164560|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164561|NCT00717951|Capecitabine|capecitabine|mesh-list
84164562|NCT00717951|Docetaxel|docetaxel|mesh-list
84164563|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164564|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164565|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
84164566|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164567|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
84164568|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
84164569|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
84164570|NCT02572947|Dolutegravir|dolutegravir|mesh-list
84164571|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
84164572|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
84164573|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164574|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164575|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84164576|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84164577|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
84164578|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164579|NCT00712491|Sirolimus|sirolimus|mesh-list
84164580|NCT00712491|Temsirolimus|temsirolimus|mesh-list
84164581|NCT00712491|MTOR Inhibitors|mtor inhibitors|mesh-list
84164582|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164583|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164584|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84164585|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164586|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
84164587|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164588|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
84164589|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164590|NCT00712491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84164591|NCT00712491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164592|NCT00712491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164593|NCT04083066|Cytarabine|cytarabine|mesh-list
84164594|NCT04083066|Dexamethasone|dexamethasone|mesh-list
84164595|NCT04083066|Rituximab|rituximab|mesh-list
84164596|NCT04083066|Methotrexate|methotrexate|mesh-list
84164597|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164598|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164599|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
84164600|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164601|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164602|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164603|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
84164604|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
84164605|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164606|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84164607|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
84164608|NCT04083066|Hormones|hormones|mesh-ancestor
84164609|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164610|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84164611|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84164612|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
84164613|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84164614|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164615|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
83430867|NCT00551707|Protective Agents|protective agents|mesh-ancestor
84164616|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164617|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164618|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164619|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84164620|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164621|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84164622|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
84164623|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164624|NCT05683782|Chitosan|chitosan|mesh-list
84164626|NCT05683782|Hematinics|hematinics|mesh-ancestor
84164627|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84164628|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84164629|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
84164630|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164631|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84164632|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
84164633|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
84164634|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
84164635|NCT05683782|Coagulants|coagulants|mesh-ancestor
84164636|NCT00740714|Vitamins|vitamins|mesh-list
84164637|NCT00740714|Vitamin E|vitamin e|mesh-list
84164638|NCT00740714|Tocopherols|tocopherols|mesh-list
84164639|NCT00740714|Tocotrienols|tocotrienols|mesh-list
84164640|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
84164641|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
84164642|NCT00740714|Ubiquinone|ubiquinone|mesh-list
84164643|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
84164644|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164645|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
84164646|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164647|NCT00740714|Protective Agents|protective agents|mesh-ancestor
84164648|NCT00721773|Valsartan|valsartan|mesh-list
84164649|NCT00721773|Benazepril|benazepril|mesh-list
84164650|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84164651|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84164652|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84164653|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164654|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84164655|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
84164656|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164657|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
84164658|NCT05676684|Spironolactone|spironolactone|mesh-list
84164659|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
84164660|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164661|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84164662|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164663|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
84164664|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
84164665|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164666|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
84164667|NCT05676684|Diuretics|diuretics|mesh-ancestor
84164668|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
84164669|NCT04070469|Amoxicillin|amoxicillin|mesh-list
84164670|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164671|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164672|NCT00712647|Beta Carotene|beta carotene|mesh-list
84164673|NCT00712647|Vitamin A|vitamin a|mesh-list
84164674|NCT00712647|Carotenoids|carotenoids|mesh-list
84164675|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
84164676|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164677|NCT00712647|Protective Agents|protective agents|mesh-ancestor
84164678|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164679|NCT00712647|Provitamins|provitamins|mesh-ancestor
84164680|NCT00712647|Vitamins|vitamins|mesh-ancestor
84164681|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
84164682|NCT00788957|Panitumumab|panitumumab|mesh-list
84164683|NCT00788957|Rilotumumab|rilotumumab|mesh-list
84164684|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164685|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164686|NCT04067817|Phenylephrine|phenylephrine|mesh-list
84164687|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
84164688|NCT04067817|Norepinephrine|norepinephrine|mesh-list
84164689|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
84164690|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84164691|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
84164692|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
83430872|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
84164693|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164694|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164695|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
84164696|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
84164697|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
84164698|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
84164699|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84164700|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84164701|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
84164702|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164703|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164704|NCT04067817|Protective Agents|protective agents|mesh-ancestor
84164705|NCT00740636|Temozolomide|temozolomide|mesh-list
84164706|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84164707|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
84164708|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164709|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164710|NCT02603159|Capecitabine|capecitabine|mesh-list
84164711|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164712|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
84164713|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164714|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164715|NCT02595554|Paclitaxel|paclitaxel|mesh-list
84164716|NCT02595554|Cisplatin|cisplatin|mesh-list
84164717|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84164718|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164719|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
84164720|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
84164721|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
84164722|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164723|NCT04069065|Tacrolimus|tacrolimus|mesh-list
84164724|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164725|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
84164726|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164727|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84164728|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164729|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164730|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
84164731|NCT04070391|Pyridoxal|pyridoxal|mesh-list
84164732|NCT04070391|Pyridoxine|pyridoxine|mesh-list
84164733|NCT04070391|Vitamins|vitamins|mesh-ancestor
84164734|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
84164735|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164736|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
84164737|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
84164738|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84164739|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164740|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
84164741|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84164742|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84164743|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
84164744|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164745|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164746|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164747|NCT00795509|Urological Agents|urological agents|mesh-ancestor
84164748|NCT02603003|Pemetrexed|pemetrexed|mesh-list
84164749|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164750|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164751|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164752|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84164753|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84164754|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84164755|NCT02603081|Ebselen|ebselen|mesh-list
84164756|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84164757|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84164758|NCT02603081|Analgesics|analgesics|mesh-ancestor
84164759|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
84164760|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164761|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164762|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164763|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164764|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84164765|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84164766|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
84164767|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164768|NCT02603081|Protective Agents|protective agents|mesh-ancestor
84164769|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84164770|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164771|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
84164772|NCT00787787|Capecitabine|capecitabine|mesh-list
84164773|NCT00787787|Sunitinib|sunitinib|mesh-list
84164774|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164775|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
84164776|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83436783|NCT00749749|Bupivacaine|bupivacaine|mesh-list
84164777|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164778|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84164779|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84164780|NCT00787787|Growth Substances|growth substances|mesh-ancestor
84164781|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164782|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
84164783|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84164784|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164785|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
84164786|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
84164787|NCT00722475|Antibodies|antibodies|mesh-list
84164788|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
84164789|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
84164790|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
84164791|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164792|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
84164793|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84164794|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84164795|NCT05549297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
84164796|NCT05549297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164797|NCT00915239|Pantoprazole|pantoprazole|mesh-list
84164798|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84164799|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84164800|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84164801|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164802|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164803|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
84164804|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164805|NCT00722631|Pioglitazone|pioglitazone|mesh-list
84164806|NCT00722631|Glimepiride|glimepiride|mesh-list
84164807|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84164808|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164809|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84164810|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84164811|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
84164812|NCT02604095|Melatonin|melatonin|mesh-list
84164813|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
84164814|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164815|NCT02604095|Protective Agents|protective agents|mesh-ancestor
84164816|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164817|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164818|NCT02571543|Ibuprofen|ibuprofen|mesh-list
84164819|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84164820|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84164821|NCT02571543|Analgesics|analgesics|mesh-ancestor
84164822|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
84164823|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164824|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164825|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84164826|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84164827|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84164828|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164829|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164830|NCT04107779|Menthol|menthol|mesh-list
84164831|NCT04107779|Nicotine|nicotine|mesh-list
84164832|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
84164833|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
84164834|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164835|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164836|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84164837|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84164838|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
84164839|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164840|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164841|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
84164842|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
84164843|NCT04067505|Nadroparin|nadroparin|mesh-list
84164844|NCT04067505|Warfarin|warfarin|mesh-list
84164845|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
84164846|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
84164847|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84164848|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
84164849|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84164850|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
84164851|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164852|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164853|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84164854|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84164855|NCT00794963|Metformin|metformin|mesh-list
84164856|NCT00794963|Orlistat|orlistat|mesh-list
84164857|NCT00794963|Irbesartan|irbesartan|mesh-list
84164858|NCT00794963|Fenofibrate|fenofibrate|mesh-list
84164859|NCT00794963|Pravastatin|pravastatin|mesh-list
84164860|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84164861|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164862|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84164863|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
84164864|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164865|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84164866|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84164867|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84164868|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164869|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84164870|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84164871|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84164872|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84164873|NCT00713271|AZD-3199|azd-3199|mesh-list
84164874|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84164875|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84164876|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84164877|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
84164878|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164879|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164880|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164881|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
84164882|NCT00722709|Ropivacaine|ropivacaine|mesh-list
84164883|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
84164884|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
84164885|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164886|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164887|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
84164888|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164889|NCT04105205|Apramycin|apramycin|mesh-list
84164890|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164891|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164892|NCT00794573|Varenicline|varenicline|mesh-list
84164893|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
84164894|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
84164895|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
84164896|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164897|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164898|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164899|NCT05061654|Tazobactam|tazobactam|mesh-list
84164900|NCT05061654|Ceftolozane|ceftolozane|mesh-list
84164901|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
84164902|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84164903|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164904|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
84164905|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164906|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164907|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84164908|NCT04070079|Tenofovir|tenofovir|mesh-list
84164909|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
84164910|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164911|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84164912|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84164913|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164914|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164915|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84164916|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84164917|NCT00739934|Voriconazole|voriconazole|mesh-list
84164918|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
84164919|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84164920|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84164921|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84164922|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164923|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164924|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84164925|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
84164926|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84164927|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164928|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84164929|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
84164930|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84164931|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
84164932|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164934|NCT02586636|Omeprazole|omeprazole|mesh-list
84164935|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84164936|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164937|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84164938|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84164939|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84164940|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164941|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164942|NCT00713739|Prazosin|prazosin|mesh-list
84164943|NCT00713739|Doxazosin|doxazosin|mesh-list
84164944|NCT00713739|Nifedipine|nifedipine|mesh-list
84164945|NCT00713739|Alfuzosin|alfuzosin|mesh-list
84164946|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84164947|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84164948|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164949|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84164950|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164951|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
84164952|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
84164953|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84164954|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84164955|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
84164956|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
84164957|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
84164958|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
84164959|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164960|NCT00713739|Urological Agents|urological agents|mesh-ancestor
84164961|NCT02595476|Remifentanil|remifentanil|mesh-list
84164962|NCT02595476|Propofol|propofol|mesh-list
84164963|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84164964|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84164965|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164966|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84164967|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
84164968|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
84164969|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84164970|NCT02595476|Narcotics|narcotics|mesh-ancestor
84164971|NCT02595476|Analgesics|analgesics|mesh-ancestor
84164972|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
84164973|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84164974|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
84164975|NCT02586402|Hematinics|hematinics|mesh-ancestor
84164976|NCT00734630|Losartan|losartan|mesh-list
84164977|NCT00734630|Lisinopril|lisinopril|mesh-list
84164978|NCT00734630|Nebivolol|nebivolol|mesh-list
84164979|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84164980|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84164981|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
84164982|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
84164983|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84164984|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
84164985|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
84164986|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84164987|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
84164988|NCT00734630|Protective Agents|protective agents|mesh-ancestor
84164989|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84164990|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
84164991|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
84164992|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84164993|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84164994|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
84164995|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84164996|NCT05636514|Decitabine|decitabine|mesh-list
84164997|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84164998|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
84164999|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165000|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165001|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165002|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
84165003|NCT02586246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84165004|NCT02586246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165005|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84165006|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
84165007|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165008|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165009|NCT00920244|Atropine|atropine|mesh-list
84165010|NCT00920244|Amiodarone|amiodarone|mesh-list
84165011|NCT00920244|Epinephrine|epinephrine|mesh-list
84165012|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84165013|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84165014|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
84165015|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165016|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165017|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165018|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84165019|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84165020|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
84165021|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165022|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84165023|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
84165024|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
84165025|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
84165026|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84165027|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84165028|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84165029|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
84165030|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84165031|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84165032|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
84165033|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
84165034|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84165035|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84165036|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84165037|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84165038|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84165039|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165040|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84165041|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84165042|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84165043|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
84165044|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
84165045|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165046|NCT00723879|Ribavirin|ribavirin|mesh-list
84165047|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
84165048|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
83430889|NCT00445211|Heparin|heparin|mesh-list
84165049|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165050|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
84165051|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165052|NCT03907605|Hormones|hormones|mesh-list
84165053|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165054|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165055|NCT00435409|Capecitabine|capecitabine|mesh-list
84165056|NCT00435409|Sunitinib|sunitinib|mesh-list
84165057|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84165058|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
84165059|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165060|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165061|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84165062|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84165063|NCT00435409|Growth Substances|growth substances|mesh-ancestor
84165064|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165065|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
84165066|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165067|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165068|NCT00724035|Fentanyl|fentanyl|mesh-list
84165069|NCT00724035|Midazolam|midazolam|mesh-list
84165070|NCT00724035|Analgesics|analgesics|mesh-list
84165071|NCT00724035|Anesthetics|anesthetics|mesh-list
84165072|NCT00724035|Ropivacaine|ropivacaine|mesh-list
84165073|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
84165074|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165075|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165076|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
83437094|NCT00578903|Methotrexate|methotrexate|mesh-list
84165077|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165078|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84165080|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84165081|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84165082|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
84165083|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84165084|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84165085|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84165086|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84165087|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
84165088|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
84165089|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165090|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165091|NCT04126824|Triamcinolone|triamcinolone|mesh-list
84165092|NCT04126824|Bupivacaine|bupivacaine|mesh-list
84165093|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
84165094|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
84165095|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165096|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165097|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
84165098|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165099|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165100|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
84165101|NCT04126824|Hormones|hormones|mesh-ancestor
84165102|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165103|NCT00724113|Lidocaine|lidocaine|mesh-list
84165104|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
84165105|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
84165106|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165107|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165108|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
84165109|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165110|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84165111|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84165112|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84165113|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84165114|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165115|NCT04070001|Ibuprofen|ibuprofen|mesh-list
84165116|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84165117|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84165118|NCT04070001|Analgesics|analgesics|mesh-ancestor
84165119|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
84165120|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165121|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165122|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165123|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165124|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84165125|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165126|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165127|NCT00435019|Insulin|insulin|mesh-list
84165128|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84165129|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
84165130|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
84165131|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
84165132|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
84165133|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
84165134|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84165135|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165136|NCT00724581|Amiodarone|amiodarone|mesh-list
84165137|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84165138|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
84165139|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
84165140|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84165141|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165142|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84165143|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84165144|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84165145|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165146|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
84165147|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84165148|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84165149|NCT02570841|Capsaicin|capsaicin|mesh-list
84165150|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
84165151|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
84165152|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
84165153|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165154|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165155|NCT00577863|Teriparatide|teriparatide|mesh-list
84165156|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84165157|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165158|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84165159|NCT04956627|Itraconazole|itraconazole|mesh-list
84165160|NCT04956627|Phenytoin|phenytoin|mesh-list
84165161|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
84165162|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
84165163|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165164|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
84165165|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84165166|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165167|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165168|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84165169|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
84165170|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165171|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165172|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84165173|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
84165174|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84165175|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84165176|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84165177|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84165178|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84165179|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84165180|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
84165181|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84165182|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
84165183|NCT00920088|Ritonavir|ritonavir|mesh-list
84165184|NCT00920088|Lopinavir|lopinavir|mesh-list
84165185|NCT00920088|Darunavir|darunavir|mesh-list
84165186|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
84165187|NCT00920088|Midazolam|midazolam|mesh-list
84165188|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
84165189|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
84165190|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84165191|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165192|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165193|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84165194|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84165195|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84165196|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
84165197|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
84165198|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
84165199|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
84165200|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
84165201|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165202|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165203|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
84165204|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
84165205|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
84165206|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165207|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84165208|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84165209|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
84165210|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165211|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
84165212|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84165213|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
84165214|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
84165215|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84165216|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84165217|NCT00920088|Analgesics|analgesics|mesh-ancestor
84165218|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
84165219|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165220|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84165221|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84165222|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165223|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83437229|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165224|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84165225|NCT04018833|Ranibizumab|ranibizumab|mesh-list
84165226|NCT04018833|Aflibercept|aflibercept|mesh-list
84165227|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
84165228|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84165229|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84165230|NCT04018833|Growth Substances|growth substances|mesh-ancestor
84165231|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165232|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
84165233|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165234|NCT04066803|Folic Acid|folic acid|mesh-list
84165235|NCT04066803|Hematinics|hematinics|mesh-ancestor
84165236|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
84165237|NCT04066803|Vitamins|vitamins|mesh-ancestor
84165238|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
84165239|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165240|NCT04921371|Listerine|listerine|mesh-list
84165241|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84165242|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165243|NCT00725439|R 115866|r 115866|mesh-list
84165244|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84165245|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165246|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165247|NCT03205761|Olaparib|olaparib|mesh-list
84165248|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84165249|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165250|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165251|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165252|NCT00725517|Icodextrin|icodextrin|mesh-list
84165253|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
84165254|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
84165255|NCT04066881|Vaccines|vaccines|mesh-list
84165256|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
84165257|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165258|NCT04620291|UB-421|ub-421|mesh-list
84165259|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84165260|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
84165261|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165262|NCT04657068|Gemcitabine|gemcitabine|mesh-list
84165263|NCT04657068|Irinotecan|irinotecan|mesh-list
84165264|NCT04657068|Camptothecin|camptothecin|mesh-list
84165265|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84165266|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
83430897|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
84165267|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165268|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165269|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84165270|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84165271|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165272|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84165273|NCT00794417|Pemetrexed|pemetrexed|mesh-list
84165274|NCT00794417|Aflibercept|aflibercept|mesh-list
84165275|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165276|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165277|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165278|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84165279|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84165280|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84165281|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84165282|NCT00794417|Growth Substances|growth substances|mesh-ancestor
84165283|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165284|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
84165285|NCT04483206|Melphalan|melphalan|mesh-list
84165286|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84165287|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
84165288|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165289|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165290|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84165291|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84165292|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
84165293|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165294|NCT00725829|Simvastatin|simvastatin|mesh-list
83437305|NCT01929759|Elvitegravir|elvitegravir|mesh-list
84165295|NCT00725829|Ezetimibe|ezetimibe|mesh-list
84165296|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84165297|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84165298|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
84165299|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165300|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84165301|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84165302|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165303|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
84165304|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84165305|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165306|NCT02583438|Saxagliptin|saxagliptin|mesh-list
84165307|NCT02583438|Incretins|incretins|mesh-ancestor
84165308|NCT02583438|Hormones|hormones|mesh-ancestor
84165309|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165310|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165311|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84165312|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
84165313|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165314|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165315|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84165316|NCT02603861|Modafinil|modafinil|mesh-list
84165317|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
84165318|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165319|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
84165320|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
84165321|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84165322|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165323|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
84165324|NCT02569905|Parecoxib|parecoxib|mesh-list
84165325|NCT02569905|Analgesics|analgesics|mesh-ancestor
84165326|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
84165327|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165328|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165329|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84165330|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84165331|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165332|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165333|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84165334|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165335|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165336|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84165337|NCT02603783|Capsaicin|capsaicin|mesh-list
84165338|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
84165339|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
84165340|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
84165341|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165342|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165343|NCT04110275|Plasminogen|plasminogen|mesh-list
84165344|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
84165345|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84165346|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84165347|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165348|NCT04250883|Iodine|iodine|mesh-list
84165349|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
84165350|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165351|NCT04250883|Trace Elements|trace elements|mesh-ancestor
84165352|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
84165353|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165354|NCT04469634|Antibodies|antibodies|mesh-list
84165355|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
84165356|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165357|NCT04209543|Progesterone|progesterone|mesh-list
84165358|NCT04209543|Progestins|progestins|mesh-ancestor
84165359|NCT04209543|Hormones|hormones|mesh-ancestor
84165360|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165361|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165362|NCT04465500|Androgens|androgens|mesh-list
84165363|NCT04465500|Hormones|hormones|mesh-ancestor
84165364|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165365|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165366|NCT04080726|Esomeprazole|esomeprazole|mesh-list
84165367|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84165368|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165369|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84165370|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165371|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165372|NCT04639986|Gemcitabine|gemcitabine|mesh-list
84165373|NCT04639986|Capecitabine|capecitabine|mesh-list
84165374|NCT04639986|Vinorelbine|vinorelbine|mesh-list
84165375|NCT04639986|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
84165376|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84165377|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
84165378|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165379|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165380|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84165381|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
84165382|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
84165383|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
84165384|NCT04639986|Immunoconjugates|immunoconjugates|mesh-ancestor
84165385|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
84165386|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165387|NCT04126317|Aflibercept|aflibercept|mesh-list
84165388|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84165389|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84165390|NCT04126317|Growth Substances|growth substances|mesh-ancestor
84165391|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165392|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
84165393|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165394|NCT02583516|Vemurafenib|vemurafenib|mesh-list
84165395|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165396|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165397|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165398|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165399|NCT00790907|Heparin|heparin|mesh-list
84165400|NCT00790907|PENTA|penta|mesh-list
84165401|NCT00790907|Fondaparinux|fondaparinux|mesh-list
84165402|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
84165403|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83430907|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
84165404|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84165405|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165406|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
84165407|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
84165408|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
84165409|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
84165410|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165411|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
84165412|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
84165413|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
84165414|NCT04066179|Prednisolone|prednisolone|mesh-list
84165415|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165416|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
84165417|NCT04066179|Hormones|hormones|mesh-ancestor
84165418|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165419|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165420|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84165421|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165422|NCT04110119|Diclofenac|diclofenac|mesh-list
84165423|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84165424|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84165425|NCT04110119|Analgesics|analgesics|mesh-ancestor
84165426|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
84165427|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165428|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165429|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165430|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165431|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84165432|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165433|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165434|NCT00726687|Capecitabine|capecitabine|mesh-list
84165435|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84165436|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
84165437|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165438|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165439|NCT00727077|Interferons|interferons|mesh-list
84165440|NCT00727077|Ribavirin|ribavirin|mesh-list
84165441|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
84165442|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
84165443|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165444|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
84165445|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165446|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
84165447|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165448|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
84165449|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165450|NCT02585388|Letrozole|letrozole|mesh-list
84165451|NCT02585388|Vinorelbine|vinorelbine|mesh-list
84165452|NCT02585388|Anastrozole|anastrozole|mesh-list
84165453|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165454|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84165455|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84165456|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165457|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165458|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84165459|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
84165460|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165461|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165462|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84165463|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
84165464|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
84165465|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
84165466|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84165467|NCT04080336|Misoprostol|misoprostol|mesh-list
84165468|NCT04080336|Dinoprostone|dinoprostone|mesh-list
84165469|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84165470|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
84165471|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84165472|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165473|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84165474|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165475|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
84165476|NCT00793871|Sunitinib|sunitinib|mesh-list
84165477|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165478|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84165479|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84165480|NCT00793871|Growth Substances|growth substances|mesh-ancestor
84165481|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165482|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
84165483|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165484|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165485|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165486|NCT05466474|Tislelizumab|tislelizumab|mesh-list
84165487|NCT05466474|Dacarbazine|dacarbazine|mesh-list
84165488|NCT05466474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84165489|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165490|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84165491|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
84165492|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165493|NCT00727233|Sorafenib|sorafenib|mesh-list
84165494|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165495|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165496|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165497|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165498|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
84165499|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
84165500|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165501|NCT04066257|Metronidazole|metronidazole|mesh-list
84165502|NCT04066257|Tetracycline|tetracycline|mesh-list
84165503|NCT04066257|Bismuth|bismuth|mesh-list
84165504|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165505|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84165506|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84165507|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84165508|NCT04066257|Antacids|antacids|mesh-ancestor
84165509|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165510|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165511|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
84165512|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165513|NCT03655821|Pemetrexed|pemetrexed|mesh-list
84165514|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165515|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165516|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165517|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84165518|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84165519|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
84165520|NCT04524702|Paclitaxel|paclitaxel|mesh-list
84165521|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84165522|NCT04524702|Gemcitabine|gemcitabine|mesh-list
84165523|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84165524|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165525|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
84165526|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
84165527|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
84165528|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165529|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84165530|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
84165531|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
84165532|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
84165533|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
84165534|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165535|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165536|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165538|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84165539|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
84165540|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165541|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165542|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84165543|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
84165544|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
84165545|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84165546|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84165547|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84165548|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84165549|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
84165550|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165551|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165552|NCT00727545|Chelating Agents|chelating agents|mesh-list
84165553|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
84165554|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165555|NCT02582892|Vitamin D|vitamin d|mesh-list
84165556|NCT02582892|Vitamins|vitamins|mesh-ancestor
84165557|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
84165558|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165559|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84165560|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
84165561|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
84165562|NCT00730509|Vitamins|vitamins|mesh-ancestor
84165563|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
84165564|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165565|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
84165566|NCT00730509|Hematinics|hematinics|mesh-ancestor
84165567|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
84165568|NCT02582736|Haloperidol|haloperidol|mesh-list
84165569|NCT02582736|Pimozide|pimozide|mesh-list
84165570|NCT02582736|Olanzapine|olanzapine|mesh-list
84165571|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
84165572|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
84165573|NCT02582736|Risperidone|risperidone|mesh-list
84165574|NCT02582736|Aripiprazole|aripiprazole|mesh-list
84165575|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
84165576|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
84165577|NCT02582736|Ziprasidone|ziprasidone|mesh-list
84165578|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
84165579|NCT02582736|Clozapine|clozapine|mesh-list
84165580|NCT02582736|Loxapine|loxapine|mesh-list
84165581|NCT02582736|Perphenazine|perphenazine|mesh-list
84165582|NCT02582736|Fluphenazine|fluphenazine|mesh-list
84165583|NCT02582736|Flupenthixol|flupenthixol|mesh-list
84165584|NCT02582736|Thioridazine|thioridazine|mesh-list
84165585|NCT02582736|Clopenthixol|clopenthixol|mesh-list
84165586|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
84165587|NCT02582736|Fluspirilene|fluspirilene|mesh-list
84165588|NCT02582736|Thiothixene|thiothixene|mesh-list
84165589|NCT02582736|Mesoridazine|mesoridazine|mesh-list
84165590|NCT02582736|Chlormezanone|chlormezanone|mesh-list
84165591|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
84165592|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84165593|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
84165594|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165595|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165596|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165597|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84165598|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165599|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84165600|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
84165601|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
84165602|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
84165603|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
84165604|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165605|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165606|NCT02582736|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
84165607|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84165608|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84165609|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
84165610|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
84165611|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
84165612|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84165613|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
84165614|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
84165615|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
84165616|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
84165617|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
84165618|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
84165619|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
84165620|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84165621|NCT02582736|Analgesics|analgesics|mesh-ancestor
84165622|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
84165623|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
84165624|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
84165625|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84165626|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
84165627|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
84165628|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84165629|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165630|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84165631|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84165632|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165633|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165634|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165635|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84165636|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
84165637|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84165638|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165639|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
84165640|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84165641|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84165642|NCT00735345|Docetaxel|docetaxel|mesh-list
84165643|NCT00735345|Cetuximab|cetuximab|mesh-list
84165644|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165645|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
84165646|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
84165647|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
84165648|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165649|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84165650|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
84165651|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84165652|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165653|NCT00727935|Lidocaine|lidocaine|mesh-list
84165654|NCT00727935|Ropivacaine|ropivacaine|mesh-list
84165655|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
84165656|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
84165657|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165658|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165659|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
84165660|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165661|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84165662|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
84165663|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
84165664|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84165665|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165666|NCT00728013|Atorvastatin|atorvastatin|mesh-list
84165667|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
84165668|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
84165669|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
84165670|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165671|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
84165672|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
84165673|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165674|NCT00577707|Pemetrexed|pemetrexed|mesh-list
84165675|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84165676|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165677|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437677|NCT05445921|Mepivacaine|mepivacaine|mesh-list
84165678|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165679|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84165680|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84165681|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165682|NCT00730821|Nintedanib|nintedanib|mesh-list
84165683|NCT00730821|Afatinib|afatinib|mesh-list
84165684|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165685|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165686|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165687|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165688|NCT00728559|Bupivacaine|bupivacaine|mesh-list
84165689|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
84165690|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
84165691|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165692|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165693|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
84165694|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165695|NCT00735813|Heparin|heparin|mesh-list
84165696|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
84165697|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84165698|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84165699|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165700|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
84165701|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
84165702|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
84165703|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
84165704|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165705|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165706|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165707|NCT04064619|Urological Agents|urological agents|mesh-ancestor
84165708|NCT00730977|Mannitol|mannitol|mesh-list
84165709|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
84165710|NCT00730977|Diuretics|diuretics|mesh-ancestor
84165711|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
84165712|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165713|NCT00728715|Budesonide|budesonide|mesh-list
84165714|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
84165715|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165716|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84165717|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
84165718|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165719|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165720|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84165721|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
84165722|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
84165723|NCT00728715|Hormones|hormones|mesh-ancestor
84165724|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165725|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84165726|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84165727|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84165728|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
84165729|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165730|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165731|NCT00731289|Triamcinolone|triamcinolone|mesh-list
84165732|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
84165733|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
84165734|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
84165735|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
84165736|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165737|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
84165738|NCT00731289|Hormones|hormones|mesh-ancestor
84165739|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165740|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165741|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84165742|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
84165743|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165744|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165745|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84165746|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
84165747|NCT00731289|Protective Agents|protective agents|mesh-ancestor
84165748|NCT00736515|Insulin|insulin|mesh-list
84165749|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
84165750|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
84165751|NCT00736515|Gliclazide|gliclazide|mesh-list
84165752|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84165753|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165754|NCT00045201|Irinotecan|irinotecan|mesh-list
84165755|NCT00045201|Camptothecin|camptothecin|mesh-list
84165756|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
84165757|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
84165758|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84165759|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165760|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165761|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165762|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165763|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84165764|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
84165765|NCT00731367|Laxatives|laxatives|mesh-ancestor
84165766|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165767|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
84165768|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83430922|NCT00552409|Vitamins|vitamins|mesh-ancestor
84165769|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165770|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84165771|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
84165772|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165773|NCT05601531|Calcitriol|calcitriol|mesh-list
84165774|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84165775|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165776|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
84165777|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84165778|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165779|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84165780|NCT05601531|Vitamins|vitamins|mesh-ancestor
84165781|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
84165782|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84165783|NCT02569125|Everolimus|everolimus|mesh-list
84165784|NCT02569125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
84165785|NCT02569125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
84165786|NCT02569125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165787|NCT02569125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165788|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84165789|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
84165790|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165791|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165792|NCT00731601|Pantoprazole|pantoprazole|mesh-list
84165793|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84165794|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165795|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
84165796|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165797|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165798|NCT00736905|Rilpivirine|rilpivirine|mesh-list
84165799|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
84165800|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84165801|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165802|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165803|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
84165804|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165805|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
84165806|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
84165807|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
84165808|NCT00736983|Adalimumab|adalimumab|mesh-list
84165809|NCT00736983|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
84165810|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165811|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165812|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84165813|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84165814|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84165815|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84165816|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165817|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165818|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165819|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
84165820|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84165821|NCT00729339|Mosapride|mosapride|mesh-list
84165822|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165823|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
84165824|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
84165825|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165826|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165827|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165828|NCT00737139|Epinephrine|epinephrine|mesh-list
84165829|NCT00737139|Bupivacaine|bupivacaine|mesh-list
84165830|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84165831|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84165832|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
84165833|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165834|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165835|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165836|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84165837|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84165838|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
84165839|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165840|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84165841|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
84165842|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
84165843|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
84165844|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
84165845|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
84165846|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
84165847|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165848|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
84165849|NCT00732147|Pramlintide|pramlintide|mesh-list
84165850|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84165851|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165852|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
84165853|NCT02569515|Hematinics|hematinics|mesh-ancestor
84165854|NCT00737373|Leucovorin|leucovorin|mesh-list
84165855|NCT00737373|Folic Acid|folic acid|mesh-list
84165856|NCT00737373|Docetaxel|docetaxel|mesh-list
84165857|NCT00737373|Fluorouracil|fluorouracil|mesh-list
84165858|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
84165859|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
84165860|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165861|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
84165862|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
84165863|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
84165864|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165865|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
84165866|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84165867|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84165868|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
84165869|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165870|NCT00737373|Antidotes|antidotes|mesh-ancestor
84165871|NCT00737373|Protective Agents|protective agents|mesh-ancestor
84165872|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
84165873|NCT00737373|Vitamins|vitamins|mesh-ancestor
84165874|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
84165875|NCT00737373|Hematinics|hematinics|mesh-ancestor
84165876|NCT00729495|Celecoxib|celecoxib|mesh-list
84165877|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84165878|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84165879|NCT00729495|Analgesics|analgesics|mesh-ancestor
84165880|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
84165881|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165882|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165883|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165884|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165885|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84165886|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84165887|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165888|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165889|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
84165890|NCT00737685|Fludarabine|fludarabine|mesh-list
84165891|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
84165892|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84165893|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
84165894|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165895|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165896|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84165897|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
84165898|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165899|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165900|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84165901|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
84165902|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84165903|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
84165904|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165905|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165906|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84165907|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
84165908|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
84165909|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
84165910|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165911|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84165912|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
84165913|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
84165914|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
84165915|NCT00732537|Protective Agents|protective agents|mesh-ancestor
84165916|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
84165917|NCT00732693|Norethindrone|norethindrone|mesh-list
84165918|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
84165919|NCT00732693|Estradiol|estradiol|mesh-list
84165920|NCT00732693|Progesterone|progesterone|mesh-list
84165921|NCT00732693|Estrogens|estrogens|mesh-ancestor
84165922|NCT00732693|Hormones|hormones|mesh-ancestor
84165923|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165924|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165925|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
84165926|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
84165927|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84165928|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
84165929|NCT00732693|Progestins|progestins|mesh-ancestor
84165930|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
84165931|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
84165932|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
84165933|NCT00729963|Sibutramine|sibutramine|mesh-list
84165934|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
84165935|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84165936|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
84165937|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84165938|NCT00737997|Morphine|morphine|mesh-list
84165939|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84165940|NCT00737997|Narcotics|narcotics|mesh-ancestor
84165941|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165942|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165943|NCT00737997|Analgesics|analgesics|mesh-ancestor
84165944|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
84165945|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165946|NCT00732927|Aspirin|aspirin|mesh-list
84165947|NCT00732927|Parnaparin|parnaparin|mesh-list
84165948|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84165949|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84165950|NCT00732927|Analgesics|analgesics|mesh-ancestor
84165951|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
84165952|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165953|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165954|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165955|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84165956|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
84165957|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
84165958|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84165959|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
84165960|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84165961|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84165962|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
84165963|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
84165964|NCT00733083|Dexamethasone|dexamethasone|mesh-list
84165965|NCT00733083|Morphine|morphine|mesh-list
84165966|NCT00733083|Oxycodone|oxycodone|mesh-list
84165967|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165968|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
84165969|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
84165970|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165971|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84165972|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84165973|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
84165974|NCT00733083|Hormones|hormones|mesh-ancestor
84165975|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84165976|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84165977|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84165978|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84165979|NCT00733083|Narcotics|narcotics|mesh-ancestor
84165980|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84165981|NCT00733083|Analgesics|analgesics|mesh-ancestor
84165982|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
84165983|NCT00712335|Fluticasone|fluticasone|mesh-list
84165984|NCT00712335|Xhance|xhance|mesh-list
84165985|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
84165986|NCT00712335|Montelukast|montelukast|mesh-list
84165987|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
84165988|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84165989|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84165990|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
84165991|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84165992|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430927|NCT03830918|Niraparib|niraparib|mesh-list
84165993|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84165994|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
84165995|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
84165996|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
84165997|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
84165998|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
84165999|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84166000|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
84166001|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84166002|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166003|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
84166004|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166005|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
84166006|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
84166007|NCT00738621|Dexamethasone|dexamethasone|mesh-list
84166008|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
84166009|NCT00738621|Ondansetron|ondansetron|mesh-list
84166010|NCT00738621|Aprepitant|aprepitant|mesh-list
84166011|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
84166012|NCT00738621|BB 1101|bb 1101|mesh-list
84166013|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84166014|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
84166015|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
84166016|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166017|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166018|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84166019|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
84166020|NCT00738621|Hormones|hormones|mesh-ancestor
84166021|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166022|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84166023|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166024|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
84166025|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166026|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166027|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
84166028|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
84166029|NCT00738621|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
84166030|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
84166031|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
84166032|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84166033|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
84166034|NCT00733239|Cycloserine|cycloserine|mesh-list
84166035|NCT00733239|Verapamil|verapamil|mesh-list
84166036|NCT00733239|Diltiazem|diltiazem|mesh-list
84166037|NCT00733239|Isradipine|isradipine|mesh-list
84166038|NCT00733239|Nifedipine|nifedipine|mesh-list
84166039|NCT00733239|Gabapentin|gabapentin|mesh-list
84166040|NCT00733239|Naloxone|naloxone|mesh-list
84166041|NCT00733239|Analgesics|analgesics|mesh-ancestor
84166042|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
84166043|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166044|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166045|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
84166046|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84166047|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84166048|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84166049|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84166050|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
84166051|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
84166052|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84166053|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166054|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
84166055|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84166056|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84166057|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84166058|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84166059|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
84166060|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
84166061|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84166062|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
84166063|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84166064|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84166065|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
84166066|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84166067|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
84166068|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
84166069|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84166070|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
84166071|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84166072|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166073|NCT04065165|Lanreotide|lanreotide|mesh-list
84166074|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166075|NCT00577629|Cytarabine|cytarabine|mesh-list
84166076|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
84166077|NCT00577629|Rituximab|rituximab|mesh-list
84166078|NCT00577629|Doxorubicin|doxorubicin|mesh-list
84166079|NCT00577629|Etoposide|etoposide|mesh-list
84166080|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84166081|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
84166082|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166083|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84166084|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84166085|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
84166086|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166087|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166088|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84166089|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84166090|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84166091|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
84166092|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
84166093|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166094|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84166095|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84166096|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
84166097|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
84166098|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84166099|NCT00733317|Budesonide|budesonide|mesh-list
84166100|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84166101|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84166102|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
84166103|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166104|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166105|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84166106|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
84166107|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
84166108|NCT00733317|Hormones|hormones|mesh-ancestor
84166109|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166110|NCT02568735|Etoricoxib|etoricoxib|mesh-list
84166111|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
84166112|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84166113|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84166114|NCT02568735|Analgesics|analgesics|mesh-ancestor
84166115|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
84166116|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166117|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166118|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84166119|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84166120|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
84166121|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
84166122|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166123|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166124|NCT00733473|Budesonide|budesonide|mesh-list
84166125|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84166126|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
84166127|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
84166128|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166129|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166130|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
84166131|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
84166132|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
84166133|NCT00733473|Hormones|hormones|mesh-ancestor
84166134|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166135|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
84166136|NCT00710385|Buprenorphine|buprenorphine|mesh-list
84166137|NCT00710385|Heroin|heroin|mesh-list
84166138|NCT00710385|Naloxone|naloxone|mesh-list
84166139|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84166140|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166141|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
84166142|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166143|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
84166144|NCT00710385|Narcotics|narcotics|mesh-ancestor
84166145|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84166146|NCT00710385|Analgesics|analgesics|mesh-ancestor
84166147|NCT04063527|Paclitaxel|paclitaxel|mesh-list
84166148|NCT04063527|Carboplatin|carboplatin|mesh-list
84166149|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84166150|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166151|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
84166152|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
84166153|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
84166154|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166155|NCT00738777|Tamoxifen|tamoxifen|mesh-list
84166156|NCT00738777|Fulvestrant|fulvestrant|mesh-list
84166157|NCT00738777|Anastrozole|anastrozole|mesh-list
84166158|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84166159|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
84166160|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166161|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166162|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
84166163|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166164|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
84166165|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
84166166|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
84166167|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
84166168|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84166169|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84166170|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166171|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166172|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
84166173|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84166174|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166175|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
84166176|NCT04063449|Endostar protein|endostar protein|mesh-list
84166177|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166178|NCT04063449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
84166179|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166180|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84166181|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84166182|NCT04063449|Growth Substances|growth substances|mesh-ancestor
84166183|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166184|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
84166185|NCT00700011|Clofarabine|clofarabine|mesh-list
84166186|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84166187|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
84166188|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166189|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166190|NCT05512767|Capecitabine|capecitabine|mesh-list
84166191|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84166192|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
84166193|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166194|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166195|NCT02567955|Vaccines|vaccines|mesh-list
84166196|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
84166197|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166198|NCT02568423|Mirikizumab|mirikizumab|mesh-list
84166199|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84166200|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84166201|NCT02568423|Analgesics|analgesics|mesh-ancestor
84166202|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
84166203|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166204|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166205|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84166206|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83438201|NCT00674219|Memantine|memantine|mesh-list
84166207|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
84166208|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
84166210|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
84166211|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
84166212|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166213|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
84166214|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
84166215|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84166216|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
84166217|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
84166218|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84166219|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166220|NCT00707031|Metformin|metformin|mesh-list
84166221|NCT00707031|Exenatide|exenatide|mesh-list
84166222|NCT00707031|Lixisenatide|lixisenatide|mesh-list
84166223|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84166224|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166225|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
84166226|NCT00707031|Incretins|incretins|mesh-ancestor
84166227|NCT00707031|Hormones|hormones|mesh-ancestor
84166228|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166229|NCT00711477|Naltrexone|naltrexone|mesh-list
84166230|NCT00711477|Bupropion|bupropion|mesh-list
84166231|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
84166232|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
84166233|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166234|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
84166235|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166236|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
84166237|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
84166238|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
84166239|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
84166240|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
84166241|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84166242|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166243|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
84166244|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84166245|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
84166246|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
84166247|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166248|NCT00734474|Metformin|metformin|mesh-list
84166249|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
84166250|NCT00734474|Dulaglutide|dulaglutide|mesh-list
84166251|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
84166252|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166253|NCT00734474|Incretins|incretins|mesh-ancestor
84166254|NCT00734474|Hormones|hormones|mesh-ancestor
84166255|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166256|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
84166257|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
84166258|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166259|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166260|NCT00583362|Belimumab|belimumab|mesh-list
84166261|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84166262|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
84166263|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166264|NCT00577473|Mesalamine|mesalamine|mesh-list
84166265|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84166266|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84166267|NCT00577473|Analgesics|analgesics|mesh-ancestor
84166268|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
84166269|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166270|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166271|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84166272|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84166273|NCT00740103|Semapimod|semapimod|mesh-list
84166274|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
84166275|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
84166276|NCT00740103|Analgesics|analgesics|mesh-ancestor
84166277|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
84166278|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
84166279|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438270|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166280|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
84166281|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84166282|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84166283|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
84166284|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
84166285|NCT02583828|Letrozole|letrozole|mesh-list
84166286|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84166287|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
84166288|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166289|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84166290|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84166291|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
84166292|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166293|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166294|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84166295|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
84166296|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
84166297|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166298|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
84166299|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
84166300|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
84166301|NCT02568111|Interferons|interferons|mesh-list
84166302|NCT02568111|Interferon-beta|interferon-beta|mesh-list
84166303|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
84166304|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
84166305|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166306|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
84166307|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84166308|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
84166309|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166310|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
84166311|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
84166312|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
84166313|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
84166314|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
84166315|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84166316|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166317|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
84166318|NCT05711667|Acetic Acid|acetic acid|mesh-list
84166319|NCT05711667|Letermovir|letermovir|mesh-list
84166320|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84166321|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84166322|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166323|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166324|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166325|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
84166326|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
84166327|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
84166328|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
84166329|NCT04384692|Melphalan|melphalan|mesh-list
84166330|NCT04384692|Busulfan|busulfan|mesh-list
84166331|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
84166332|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
84166333|NCT04384692|Methotrexate|methotrexate|mesh-list
84166334|NCT04384692|Fludarabine|fludarabine|mesh-list
84166335|NCT04384692|Tacrolimus|tacrolimus|mesh-list
84166336|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
84166337|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
84166338|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166339|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
84166340|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
84166341|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
84166342|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166343|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166344|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
84166345|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
84166346|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
84166347|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
84166348|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
84166349|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
84166350|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
84166351|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
84166352|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
84166353|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
84166354|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
84166355|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
84166356|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
84166357|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
84166358|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
84166359|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
84166360|NCT00785291|Paclitaxel|paclitaxel|mesh-list
84166361|NCT00785291|Epothilones|epothilones|mesh-list
84166362|NCT00785291|Epothilone B|epothilone b|mesh-list
84166363|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
84166364|NCT00785291|Bevacizumab|bevacizumab|mesh-list
84166365|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
84166366|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
84166367|NCT00785291|Antibodies|antibodies|mesh-list
84166368|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
84166369|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
84166370|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
84166371|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
84166372|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
84166373|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
84166374|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
84166375|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
84166376|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166377|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
84166378|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
84166379|NCT00785291|Growth Substances|growth substances|mesh-ancestor
84166380|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166381|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
84166382|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
84166383|NCT00740259|Flunarizine|flunarizine|mesh-list
84166384|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
84166385|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
84166386|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
84166387|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
84166388|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
84166389|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
84166390|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
84166391|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
84166392|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
84166393|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
84166394|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
83438650|NCT03298802|Diuretics|diuretics|mesh-ancestor
83438723|NCT03286634|Hormones|hormones|mesh-ancestor
83438872|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
83439168|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83439385|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83439837|NCT00659633|Lidocaine|lidocaine|mesh-list
83440507|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440585|NCT00706121|Vitamins|vitamins|mesh-list
83440659|NCT03809455|Narcotics|narcotics|mesh-ancestor
83441113|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83441882|NCT00743717|Cobalt|cobalt|mesh-list
83441952|NCT01272947|Diclofenac|diclofenac|mesh-list
83442007|NCT04387097|Remifentanil|remifentanil|mesh-list
83442084|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
83442328|NCT01276379|Vitamins|vitamins|mesh-ancestor
83442692|NCT00248651|Escitalopram|escitalopram|mesh-list
83442993|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
83443520|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
83443818|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
83444947|NCT03782103|Ethanol|ethanol|mesh-list
83445021|NCT05268237|Hormones|hormones|mesh-ancestor
83445171|NCT00807209|Analgesics|analgesics|mesh-ancestor
83446139|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
83446760|NCT03352843|Primaquine|primaquine|mesh-list
82858513|NCT05842044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82858514|NCT05842044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858515|NCT05842044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858516|NCT05842044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82858517|NCT05842044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858518|NCT05842044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858519|NCT05842044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82858520|NCT05842044|Narcotics|narcotics|mesh-ancestor
82858521|NCT05842044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858522|NCT05841992|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82858523|NCT05841992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82858524|NCT05841992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858525|NCT05841849|Aprepitant|aprepitant|mesh-list
82858526|NCT05841849|Fosaprepitant|fosaprepitant|mesh-list
82858527|NCT05841849|Palonosetron|palonosetron|mesh-list
82858528|NCT05841849|Antiemetics|antiemetics|mesh-ancestor
82858529|NCT05841849|Autonomic Agents|autonomic agents|mesh-ancestor
82858530|NCT05841849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858531|NCT05841849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858532|NCT05841849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858533|NCT05841849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82858534|NCT05841849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858535|NCT05841849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858536|NCT05841849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82858537|NCT05841849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82858538|NCT05841849|Serotonin Agents|serotonin agents|mesh-ancestor
82858539|NCT05841771|Azacitidine|azacitidine|mesh-list
82858540|NCT05841771|Decitabine|decitabine|mesh-list
82858541|NCT05841771|Venetoclax|venetoclax|mesh-list
82858542|NCT05841771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82858543|NCT05841771|Antimetabolites|antimetabolites|mesh-ancestor
82858544|NCT05841771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858545|NCT05841771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858546|NCT05841771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858547|NCT05841758|Hydroxychloroquine|hydroxychloroquine|mesh-list
82858548|NCT05841758|Antimalarials|antimalarials|mesh-ancestor
82858549|NCT05841758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82858550|NCT05841758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82858551|NCT05841758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858552|NCT05841758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858553|NCT05841758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858554|NCT05841758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858555|NCT05841654|Antihypertensive Agents|antihypertensive agents|mesh-list
82858556|NCT05841654|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82858557|NCT05841654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82858558|NCT05841654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82858559|NCT05841654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858560|NCT05841641|Hemostatics|hemostatics|mesh-list
82858561|NCT05841641|Coagulants|coagulants|mesh-ancestor
82858562|NCT05841589|Chlorhexidine|chlorhexidine|mesh-list
82858563|NCT05841589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82858564|NCT05841589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858565|NCT05841589|Disinfectants|disinfectants|mesh-ancestor
82858566|NCT05841472|Carboplatin|carboplatin|mesh-list
82858568|NCT05841472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858569|NCT05841472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858570|NCT05841472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858571|NCT05841472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82858572|NCT05841472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82858573|NCT05841446|Apixaban|apixaban|mesh-list
82858574|NCT05841446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82858575|NCT05841446|Antithrombins|antithrombins|mesh-ancestor
82858576|NCT05841446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82858577|NCT05841446|Protease Inhibitors|protease inhibitors|mesh-ancestor
82858578|NCT05841446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858579|NCT05841446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858580|NCT05841446|Anticoagulants|anticoagulants|mesh-ancestor
83447593|NCT01838395|Cytarabine|cytarabine|mesh-list
83449048|NCT00884897|Oxytocin|oxytocin|mesh-list
83449477|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
83450082|NCT01832129|Vitamins|vitamins|mesh-list
83450233|NCT03219983|Bupivacaine|bupivacaine|mesh-list
83452196|NCT02933320|Rituximab|rituximab|mesh-list
83452253|NCT02822950|Avibactam|avibactam|mesh-list
83452482|NCT00935311|Oxycodone|oxycodone|mesh-list
83452699|NCT01908465|Ebastine|ebastine|mesh-list
82858582|NCT05841420|Gemcitabine|gemcitabine|mesh-list
83452916|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454124|NCT01015807|Clonidine|clonidine|mesh-list
83454422|NCT05017545|Abatacept|abatacept|mesh-list
83430954|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
82858583|NCT05841420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83455392|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
83456074|NCT03316378|Ropivacaine|ropivacaine|mesh-list
83456249|NCT03460990|VX-659|vx-659|mesh-list
83456296|NCT01921010|Vitamins|vitamins|mesh-ancestor
82858584|NCT05841420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83457100|NCT03378076|FX006|fx006|mesh-list
83457113|NCT03520348|Vitamins|vitamins|mesh-ancestor
82858585|NCT05841420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83457274|NCT04356677|Ribavirin|ribavirin|mesh-list
82858586|NCT05841420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83457798|NCT01130077|Poly ICLC|poly iclc|mesh-list
83458466|NCT01009619|Azithromycin|azithromycin|mesh-list
83458700|NCT04343092|Ivermectin|ivermectin|mesh-list
83458849|NCT01012661|Lidocaine|lidocaine|mesh-list
82858587|NCT05841420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83459144|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
83459219|NCT03802864|Bupivacaine|bupivacaine|mesh-list
83459291|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83459362|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
83459745|NCT04552808|Yimitasvir|yimitasvir|mesh-list
83460576|NCT01222195|Growth Substances|growth substances|mesh-ancestor
83460802|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
83460952|NCT03821168|Growth Substances|growth substances|mesh-ancestor
83461089|NCT02564796|Iron|iron|mesh-list
83461101|NCT05563350|Omeprazole|omeprazole|mesh-list
83461935|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
83462009|NCT02994576|Atezolizumab|atezolizumab|mesh-list
83462083|NCT02558400|Latanoprost|latanoprost|mesh-list
83462164|NCT01891526|Tretinoin|tretinoin|mesh-list
83462236|NCT04280406|Azithromycin|azithromycin|mesh-list
83463068|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
83463285|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
83463735|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
83463886|NCT00020722|Ifosfamide|ifosfamide|mesh-list
83463960|NCT00000856|Ganciclovir|ganciclovir|mesh-list
83464189|NCT03252600|Dexamethasone|dexamethasone|mesh-list
83464262|NCT02744612|Immunotoxins|immunotoxins|mesh-ancestor
83464643|NCT01226719|Vitamins|vitamins|mesh-ancestor
83464726|NCT02548962|Hormones|hormones|mesh-ancestor
83464803|NCT00000292|Cocaine|cocaine|mesh-list
83464943|NCT00001996|Atovaquone|atovaquone|mesh-list
83465164|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83465240|NCT00002038|Fluconazole|fluconazole|mesh-list
83465389|NCT00380770|Lamivudine|lamivudine|mesh-list
83465536|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
83465917|NCT00000634|Nevirapine|nevirapine|mesh-list
83466218|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
83466674|NCT01938248|Apixaban|apixaban|mesh-list
83466903|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83467441|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
83467665|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
83467905|NCT05276219|Furosemide|furosemide|mesh-list
83467974|NCT04868708|Paclitaxel|paclitaxel|mesh-list
83468501|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83469637|NCT00002890|Lintuzumab|lintuzumab|mesh-list
83470023|NCT04778072|Iron|iron|mesh-list
83470238|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
83470390|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83470843|NCT00002812|Cytarabine|cytarabine|mesh-list
83471079|NCT04773236|Lidocaine|lidocaine|mesh-list
83471141|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
83471522|NCT00083720|Cetuximab|cetuximab|mesh-list
83471988|NCT00004048|Antibodies|antibodies|mesh-list
83472120|NCT00003796|Irofulven|irofulven|mesh-list
83472279|NCT00003874|Antibodies|antibodies|mesh-list
83472498|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
83472577|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
83472655|NCT05774691|Heparin|heparin|mesh-list
83473111|NCT04500158|Lidocaine|lidocaine|mesh-list
83473184|NCT03941964|Decitabine|decitabine|mesh-list
83473556|NCT00198978|Hormones|hormones|mesh-ancestor
83473637|NCT00004150|Antidotes|antidotes|mesh-ancestor
83474466|NCT00004450|Interferons|interferons|mesh-list
83474547|NCT00004486|Fluoxetine|fluoxetine|mesh-list
83474604|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
83474680|NCT00004582|Ritonavir|ritonavir|mesh-list
83475740|NCT01319851|Alefacept|alefacept|mesh-list
83475890|NCT01323517|Dactinomycin|dactinomycin|mesh-list
83476783|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83477454|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
83477831|NCT00248534|Hormones|hormones|mesh-ancestor
83478122|NCT02106494|Dexamethasone|dexamethasone|mesh-list
83478644|NCT01792700|Esomeprazole|esomeprazole|mesh-list
83478944|NCT05902208|Antiviral Agents|antiviral agents|mesh-list
83479994|NCT04668144|Cangrelor|cangrelor|mesh-list
83480292|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
83480822|NCT02903381|Dexamethasone|dexamethasone|mesh-list
83481201|NCT05287100|Midodrine|midodrine|mesh-list
83481342|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83481868|NCT05290662|Fludarabine|fludarabine|mesh-list
83482014|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
83483669|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
83483747|NCT05122884|Milrinone|milrinone|mesh-list
83483901|NCT00526292|Fludarabine|fludarabine|mesh-list
83484188|NCT04986852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83484275|NCT03236792|Hormones|hormones|mesh-ancestor
83484412|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
83484562|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83485980|NCT04707625|Aflibercept|aflibercept|mesh-list
83486055|NCT04451863|Analgesics|analgesics|mesh-ancestor
83486501|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
83486729|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
83487323|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
83487399|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
83487471|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
83487624|NCT00731198|Analgesics|analgesics|mesh-ancestor
83487695|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
83487932|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
83487994|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83488072|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
83488226|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83488447|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83481951|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83488970|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83489121|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
83489345|NCT01342523|Nicotine|nicotine|mesh-list
83489567|NCT01354145|Analgesics|analgesics|mesh-ancestor
83490193|NCT01365611|Xhance|xhance|mesh-list
83490246|NCT00815360|Ranibizumab|ranibizumab|mesh-list
83490627|NCT00862784|Leucovorin|leucovorin|mesh-list
83491409|NCT03247088|Busulfan|busulfan|mesh-list
83491600|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
83492653|NCT01839812|Hormones|hormones|mesh-ancestor
83482030|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493477|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83493637|NCT01591733|Irinotecan|irinotecan|mesh-list
83494743|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494818|NCT02459964|Analgesics|analgesics|mesh-ancestor
83495270|NCT04942470|Propolis|propolis|mesh-list
83495490|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83495641|NCT03875144|Cisplatin|cisplatin|mesh-list
83495791|NCT03031808|Lidocaine|lidocaine|mesh-list
83495959|NCT04353362|Ofloxacin|ofloxacin|mesh-list
83496014|NCT03033368|Rilpivirine|rilpivirine|mesh-list
83496234|NCT02457546|Coagulants|coagulants|mesh-ancestor
83496311|NCT01685411|Lenograstim|lenograstim|mesh-list
83496911|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83497135|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
83497361|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482031|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482032|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83498714|NCT02571153|Ketamine|ketamine|mesh-list
83499018|NCT03010202|Dexamethasone|dexamethasone|mesh-list
83482034|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482035|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83499453|NCT05857982|Dexamethasone|dexamethasone|mesh-list
83499533|NCT05735717|Rituximab|rituximab|mesh-list
83482036|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
83482037|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
83482038|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
83482039|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
83500210|NCT04086745|Adalimumab|adalimumab|mesh-list
83500582|NCT02620865|Hematinics|hematinics|mesh-ancestor
83500711|NCT01499953|PENTA|penta|mesh-list
83500824|NCT05220813|Lidocaine|lidocaine|mesh-list
83502161|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
83502235|NCT01250834|Dulaglutide|dulaglutide|mesh-list
83502603|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
83502684|NCT01322048|Analgesics|analgesics|mesh-ancestor
83503134|NCT01785095|Hormones|hormones|mesh-list
83504177|NCT01416584|Analgesics|analgesics|mesh-ancestor
83504504|NCT02724033|Hormones|hormones|mesh-ancestor
83504711|NCT05679479|Meplazumab|meplazumab|mesh-list
83505236|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83505386|NCT02833233|Ipilimumab|ipilimumab|mesh-list
83505461|NCT05451147|Metformin|metformin|mesh-list
83482040|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505981|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506354|NCT01556594|Glucagon|glucagon|mesh-list
83506724|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83507025|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
83507103|NCT00373581|Cocaine|cocaine|mesh-list
83507493|NCT03207945|Alirocumab|alirocumab|mesh-list
83507848|NCT01595282|Analgesics|analgesics|mesh-ancestor
83508307|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83508974|NCT02071394|Xenon|xenon|mesh-list
83509140|NCT03111381|Analgesics|analgesics|mesh-ancestor
83509214|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83430957|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
83509517|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83510190|NCT02288273|Hormones|hormones|mesh-ancestor
83510281|NCT05316935|Estrogens|estrogens|mesh-ancestor
83510339|NCT05710874|Protective Agents|protective agents|mesh-ancestor
83510490|NCT01619774|Dabrafenib|dabrafenib|mesh-list
83510639|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
83510711|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83510792|NCT04316871|Morphine|morphine|mesh-list
83510936|NCT01658241|Panobinostat|panobinostat|mesh-list
83511230|NCT01685684|Analgesics|analgesics|mesh-ancestor
83512123|NCT01717742|Plasminogen|plasminogen|mesh-list
83512266|NCT02406443|Hormones|hormones|mesh-ancestor
83512423|NCT02354339|Antacids|antacids|mesh-ancestor
83512563|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83512710|NCT02366663|Rituximab|rituximab|mesh-list
83513233|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
83513688|NCT03521505|Analgesics|analgesics|mesh-ancestor
83513762|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
83514585|NCT03936387|Ropivacaine|ropivacaine|mesh-list
83515491|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83515941|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
83516014|NCT01908062|Naltrexone|naltrexone|mesh-list
83516164|NCT00803283|Narcotics|narcotics|mesh-ancestor
83517517|NCT00001785|Interferons|interferons|mesh-list
83518044|NCT00001101|Doxycycline|doxycycline|mesh-list
83518132|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
83518879|NCT00002205|Abacavir|abacavir|mesh-list
83519103|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
83482117|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82858588|NCT05841420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858589|NCT05841420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82858590|NCT05841420|Antimetabolites|antimetabolites|mesh-ancestor
82858591|NCT05841394|Esomeprazole|esomeprazole|mesh-list
82858592|NCT05841394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82858593|NCT05841394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858594|NCT05841394|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82858595|NCT05841394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482118|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
83519928|NCT05806307|Mydriatics|mydriatics|mesh-ancestor
83520159|NCT05604300|Vitamin E|vitamin e|mesh-list
83520534|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
83521066|NCT04401995|Nivolumab|nivolumab|mesh-list
83521295|NCT00002715|Hormones|hormones|mesh-ancestor
83521360|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83522192|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
83522564|NCT05066607|Dexamethasone|dexamethasone|mesh-list
83522631|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
83523088|NCT02288156|Capsaicin|capsaicin|mesh-list
83523233|NCT00421811|Melphalan|melphalan|mesh-list
83523307|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
83523450|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83523605|NCT04173507|Avelumab|avelumab|mesh-list
83482119|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83524576|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83524654|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
83524959|NCT01746043|Minocycline|minocycline|mesh-list
83525031|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83525100|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
83525171|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
83482195|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482196|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527348|NCT04741295|Heparin|heparin|mesh-list
83527499|NCT02279641|Allopurinol|allopurinol|mesh-list
83527579|NCT00550459|Tolvaptan|tolvaptan|mesh-list
83527649|NCT01930747|Narcotics|narcotics|mesh-ancestor
83482197|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83528401|NCT02712047|Fluticasone|fluticasone|mesh-list
83482198|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83482199|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
83529970|NCT05598619|Protective Agents|protective agents|mesh-ancestor
83530196|NCT04396873|11C-PS13|11c-ps13|mesh-list
83530576|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
83530886|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
83531031|NCT01962961|Antidotes|antidotes|mesh-ancestor
83531325|NCT02017327|Bimatoprost|bimatoprost|mesh-list
83531636|NCT02344238|Riboflavin|riboflavin|mesh-list
83531767|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83532067|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532436|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83532507|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532584|NCT02062801|Ephedrine|ephedrine|mesh-list
83532734|NCT00375557|Valproic Acid|valproic acid|mesh-list
83533171|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
83533244|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83533468|NCT03308669|Topiramate|topiramate|mesh-list
83533779|NCT03216356|Cycloserine|cycloserine|mesh-list
83534452|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
83534828|NCT00003243|Aldesleukin|aldesleukin|mesh-list
83535281|NCT00360386|Clopidogrel|clopidogrel|mesh-list
83536179|NCT05898646|Daratumumab|daratumumab|mesh-list
83536402|NCT05832892|Mitosis Modulators|mitosis modulators|mesh-ancestor
83536555|NCT05797246|Bevacizumab|bevacizumab|mesh-list
83536640|NCT05770102|Atezolizumab|atezolizumab|mesh-list
83537077|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
83537222|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83537378|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
83537676|NCT05453903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83538883|NCT04868773|Trifluridine|trifluridine|mesh-list
83539337|NCT04599855|Esketamine|esketamine|mesh-list
83539413|NCT04551521|Trastuzumab|trastuzumab|mesh-list
83539636|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83540393|NCT04034095|Bicalutamide|bicalutamide|mesh-list
83540471|NCT03974217|Decitabine|decitabine|mesh-list
83540850|NCT03723551|Afabicin|afabicin|mesh-list
83540930|NCT03631784|Paclitaxel|paclitaxel|mesh-list
83541137|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83541305|NCT03092817|Dexamethasone|dexamethasone|mesh-list
83542049|NCT00551928|Prednisone|prednisone|mesh-list
83542186|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
82858596|NCT05841394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858598|NCT05841381|Trastuzumab|trastuzumab|mesh-list
82858599|NCT05841381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82858600|NCT05841381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858601|NCT05841381|Tubulin Modulators|tubulin modulators|mesh-ancestor
82858602|NCT05841381|Antimitotic Agents|antimitotic agents|mesh-ancestor
82858603|NCT05841381|Mitosis Modulators|mitosis modulators|mesh-ancestor
82858604|NCT05841381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858605|NCT05841381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858606|NCT05841303|Ascorbic Acid|ascorbic acid|mesh-list
82858607|NCT05841303|Antioxidants|antioxidants|mesh-ancestor
82858608|NCT05841303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858609|NCT05841303|Protective Agents|protective agents|mesh-ancestor
82858610|NCT05841303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858611|NCT05841303|Vitamins|vitamins|mesh-ancestor
82858612|NCT05841303|Micronutrients|micronutrients|mesh-ancestor
82858613|NCT05841290|Anesthetics|anesthetics|mesh-list
82858614|NCT05841290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858615|NCT05841290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858616|NCT05841251|Phenylephrine|phenylephrine|mesh-list
82858617|NCT05841251|Oxymetazoline|oxymetazoline|mesh-list
82858618|NCT05841251|Tranexamic Acid|tranexamic acid|mesh-list
82858619|NCT05841251|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82858620|NCT05841251|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82858621|NCT05841251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858622|NCT05841251|Hemostatics|hemostatics|mesh-ancestor
82858623|NCT05841251|Coagulants|coagulants|mesh-ancestor
82858624|NCT05841251|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82858625|NCT05841251|Mydriatics|mydriatics|mesh-ancestor
82858626|NCT05841251|Autonomic Agents|autonomic agents|mesh-ancestor
82858627|NCT05841251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858628|NCT05841251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858629|NCT05841251|Sympathomimetics|sympathomimetics|mesh-ancestor
82858630|NCT05841251|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82858631|NCT05841251|Nasal Decongestants|nasal decongestants|mesh-ancestor
82858632|NCT05841251|Respiratory System Agents|respiratory system agents|mesh-ancestor
82858633|NCT05841251|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82858634|NCT05841251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82858635|NCT05841251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82858636|NCT05841251|Adrenergic Agents|adrenergic agents|mesh-ancestor
82858637|NCT05841251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858638|NCT05841251|Protective Agents|protective agents|mesh-ancestor
82858640|NCT05841147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82858641|NCT05841147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82858642|NCT05841147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858643|NCT05841147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82858644|NCT05841121|Dexamethasone|dexamethasone|mesh-list
82858645|NCT05841121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858646|NCT05841121|Antiemetics|antiemetics|mesh-ancestor
82858647|NCT05841121|Autonomic Agents|autonomic agents|mesh-ancestor
82858648|NCT05841121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858649|NCT05841121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858650|NCT05841121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007711|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83007712|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83007713|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
83007714|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007715|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007716|NCT05431075|Amoxicillin|amoxicillin|mesh-list
83007717|NCT05431075|Tetracycline|tetracycline|mesh-list
83007718|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
83007719|NCT05431075|Esomeprazole|esomeprazole|mesh-list
83007720|NCT05431075|Bismuth|bismuth|mesh-list
83007721|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007722|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83007723|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007724|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83007725|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007726|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83007727|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007728|NCT05431075|Antacids|antacids|mesh-ancestor
83007729|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83007730|NCT05431075|Diuretics|diuretics|mesh-ancestor
83007731|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
83007732|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007733|NCT05431075|Expectorants|expectorants|mesh-ancestor
83007734|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
83007735|NCT03636659|Amphotericin B|amphotericin b|mesh-list
83007736|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83007737|NCT03636659|Amebicides|amebicides|mesh-ancestor
83007738|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83007739|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83007740|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007741|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83007742|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
83007743|NCT04892173|Cetuximab|cetuximab|mesh-list
83007744|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007745|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007746|NCT03198767|Licogliflozin|licogliflozin|mesh-list
83007747|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
83007748|NCT03198767|Psyllium|psyllium|mesh-list
83007749|NCT03198767|Calcium|calcium|mesh-list
83007750|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83007751|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007752|NCT03198767|Antacids|antacids|mesh-ancestor
83007753|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007754|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007755|NCT03198767|Cathartics|cathartics|mesh-ancestor
83007756|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83007757|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83007758|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
83007759|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
83007760|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83007761|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
83007762|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007763|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007764|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83007765|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
83007766|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83007767|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83007768|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83007769|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
83007770|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007771|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007772|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83007773|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83007774|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83007775|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
83007776|NCT01331785|Midodrine|midodrine|mesh-list
83007777|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
83007778|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
83430974|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83007779|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007780|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007781|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83007782|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83007783|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83007784|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83007785|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83007786|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007787|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007788|NCT01382589|Afamelanotide|afamelanotide|mesh-list
83007789|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007790|NCT03671759|Caffeine|caffeine|mesh-list
83007791|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83007792|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007793|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83007794|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007795|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007796|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83007797|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83007798|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
83007799|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007800|NCT01384227|Proflavine|proflavine|mesh-list
83007801|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83007802|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007803|NCT01382511|Simvastatin|simvastatin|mesh-list
83007804|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83007805|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83007806|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
83007807|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007808|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83007809|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83007810|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007811|NCT03684447|Propofol|propofol|mesh-list
83007812|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83007813|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007814|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007815|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83007816|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
83007817|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
83007818|NCT04505059|Anesthetics|anesthetics|mesh-list
83007819|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007820|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007821|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83007822|NCT04217135|Hydralazine|hydralazine|mesh-list
83007823|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83007824|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
83007825|NCT01337401|Cediranib|cediranib|mesh-list
83007826|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007827|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83007828|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007829|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007830|NCT04178603|Insulin|insulin|mesh-list
83007831|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83007832|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007833|NCT01333891|Nitroprusside|nitroprusside|mesh-list
83007834|NCT01333891|Phenylephrine|phenylephrine|mesh-list
83007835|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
83007836|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83007837|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
83007838|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
83007839|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007840|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007841|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
83007842|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83007843|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
83007844|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
83007845|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83007846|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83007847|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83007848|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83007849|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430975|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83007850|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007851|NCT01333891|Protective Agents|protective agents|mesh-ancestor
83007852|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83007853|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
83007854|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83007855|NCT04853875|Amoxicillin|amoxicillin|mesh-list
83007856|NCT04853875|Metronidazole|metronidazole|mesh-list
83007857|NCT04853875|Clarithromycin|clarithromycin|mesh-list
83007858|NCT04853875|Tetracycline|tetracycline|mesh-list
83007859|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83007860|NCT04853875|Bismuth|bismuth|mesh-list
83007861|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83007862|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007863|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83007864|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83007865|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83007866|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007867|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007868|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83007869|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83007870|NCT04853875|Antacids|antacids|mesh-ancestor
83007871|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007872|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83007873|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83007874|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83007875|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007876|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
83007877|NCT03196505|Bupivacaine|bupivacaine|mesh-list
83007878|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
83007879|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
83007880|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007881|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007882|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
83007883|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007884|NCT01334047|Vaccines|vaccines|mesh-list
83007885|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
83007886|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007887|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
83007888|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83007889|NCT03196349|Warfarin|warfarin|mesh-list
83007890|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
83007891|NCT03196349|Apixaban|apixaban|mesh-list
83007892|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
83007893|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83007894|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
83007895|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83007896|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
83007897|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007898|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007899|NCT01331941|Paclitaxel|paclitaxel|mesh-list
83007900|NCT01331941|Trebananib|trebananib|mesh-list
83007901|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83007902|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007903|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
83007904|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
83007905|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83007906|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007907|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83007908|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83007909|NCT01331941|Growth Substances|growth substances|mesh-ancestor
83007910|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007911|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
83007912|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
83007913|NCT02886715|Tazarotene|tazarotene|mesh-list
83007914|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007915|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
83007916|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
83007917|NCT02886715|Vitamins|vitamins|mesh-ancestor
83007918|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
83007919|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007920|NCT01337791|Telbivudine|telbivudine|mesh-list
83007921|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
83007922|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007923|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83007924|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007925|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007926|NCT01334203|Ranolazine|ranolazine|mesh-list
83007927|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83007928|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83007929|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007930|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
83007931|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007932|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007933|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83007934|NCT01569165|Fluorides|fluorides|mesh-list
83007935|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
83007936|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
83007937|NCT01569165|Protective Agents|protective agents|mesh-ancestor
83007938|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007939|NCT04259749|Menthol|menthol|mesh-list
83007940|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
83007941|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007942|NCT02535091|Cenobamate|cenobamate|mesh-list
83007943|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
83007944|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83007945|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83007946|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83007947|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
83007948|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007949|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83007950|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83007951|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007952|NCT01382199|Lactoferrin|lactoferrin|mesh-list
83007953|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007954|NCT01381497|Naproxen|naproxen|mesh-list
83007955|NCT01381497|Sumatriptan|sumatriptan|mesh-list
83007956|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83007957|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83007958|NCT01381497|Analgesics|analgesics|mesh-ancestor
83007959|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
83007960|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007961|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007962|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007963|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007964|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
83007965|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83007966|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007967|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007968|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83007969|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83007970|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83431007|NCT05533567|Sufentanil|sufentanil|mesh-list
83007971|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
83007972|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007973|NCT04221997|Sertraline|sertraline|mesh-list
83007974|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
83007975|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83007976|NCT04221997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83007977|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83007978|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83007979|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007980|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007981|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
83007982|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007983|NCT03635827|Xenon|xenon|mesh-list
83007984|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83007985|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
83007986|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
83007987|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007988|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007989|NCT01338103|Rituximab|rituximab|mesh-list
83007990|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007991|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007992|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
83007993|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007994|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007995|NCT03369665|Cladribine|cladribine|mesh-list
83007996|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007997|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83007998|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
83007999|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008000|NCT03621761|Modafinil|modafinil|mesh-list
83008001|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83008002|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008003|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83008004|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83008005|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83008006|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008007|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
83008008|NCT03318861|Fludarabine|fludarabine|mesh-list
83008009|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008010|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
83008011|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008012|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008013|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83008014|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
83008015|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068775|NCT02086227|Glucagon|glucagon|mesh-list
83008017|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83008018|NCT03084315|Nicotine|nicotine|mesh-list
83008019|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83008020|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
83008021|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008022|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008023|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83008024|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83008025|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
83008026|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008027|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008028|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
83008029|NCT03187301|Apomorphine|apomorphine|mesh-list
83008030|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83008031|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008032|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83008033|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83008034|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008035|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008036|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008037|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008038|NCT03187301|Emetics|emetics|mesh-ancestor
83008039|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
83008040|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008041|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008042|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
83008043|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
83008044|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008045|NCT01381185|Aspirin|aspirin|mesh-list
83008046|NCT01381185|Clopidogrel|clopidogrel|mesh-list
83008047|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83008048|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83008049|NCT01381185|Analgesics|analgesics|mesh-ancestor
83008050|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
83008051|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008052|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008053|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008054|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008055|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83008056|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83008057|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008058|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83008059|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83008060|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008061|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
83008062|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83008063|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83008064|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83008065|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
83008066|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008067|NCT02946047|Ixazomib|ixazomib|mesh-list
83008068|NCT02946047|Glycine|glycine|mesh-list
83008069|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008070|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83008071|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008072|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008073|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
83008074|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008075|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008076|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
83008077|NCT05421897|Temozolomide|temozolomide|mesh-list
83008078|NCT05421897|Irinotecan|irinotecan|mesh-list
83008079|NCT05421897|Topotecan|topotecan|mesh-list
83008080|NCT05421897|Dinutuximab|dinutuximab|mesh-list
83008081|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008082|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
83008083|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008084|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008085|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83008086|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
83008087|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008088|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008089|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83008090|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83008092|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008093|NCT03077919|Ropivacaine|ropivacaine|mesh-list
83008094|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
83008095|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
83008096|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008097|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008098|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
83008099|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008100|NCT01380951|Telbivudine|telbivudine|mesh-list
83008101|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
83008102|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008103|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83008104|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008105|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008106|NCT01377597|Ranibizumab|ranibizumab|mesh-list
83008107|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83008108|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83008109|NCT01377597|Growth Substances|growth substances|mesh-ancestor
83008110|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008111|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
83008112|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008113|NCT03287375|Cisplatin|cisplatin|mesh-list
83008114|NCT03287375|Doxorubicin|doxorubicin|mesh-list
83008115|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
83008116|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008117|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83008118|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83008119|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83008120|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008121|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008122|NCT03881059|Ustekinumab|ustekinumab|mesh-list
83008123|NCT03881059|Deucravacitinib|deucravacitinib|mesh-list
83008124|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
83008125|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83008126|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008127|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008128|NCT01338337|Azacitidine|azacitidine|mesh-list
83008129|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83008130|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
83008131|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008132|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008133|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008134|NCT03083847|Chloroquine|chloroquine|mesh-list
83008135|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83008136|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
83008137|NCT03083847|Amebicides|amebicides|mesh-ancestor
83008138|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83008139|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83008140|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008141|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
83008142|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008143|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83008144|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83008145|NCT03083847|Analgesics|analgesics|mesh-ancestor
83008146|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
83008147|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008148|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008149|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008150|NCT03083847|Filaricides|filaricides|mesh-ancestor
83008151|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
83008152|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
83008153|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83008154|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008155|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008156|NCT03082677|Ixazomib|ixazomib|mesh-list
83008157|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008158|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
83008159|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008160|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008161|NCT03136055|Paclitaxel|paclitaxel|mesh-list
83008162|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
83008163|NCT03136055|Irinotecan|irinotecan|mesh-list
83008164|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83008165|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008166|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
83008167|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
83008168|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83008169|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008170|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008171|NCT03136055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83008172|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83008173|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83008174|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008175|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
83008176|NCT03221309|Narcotics|narcotics|mesh-ancestor
83008177|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008178|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008179|NCT03221309|Analgesics|analgesics|mesh-ancestor
83008180|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
83008181|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008182|NCT05353829|Methotrexate|methotrexate|mesh-list
83008183|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83008184|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
83008185|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83008186|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008187|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83008188|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
83008189|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008190|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008191|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
83008192|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008193|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83008194|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008195|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
83008196|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008197|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83008199|NCT03426657|Tremelimumab|tremelimumab|mesh-list
83008200|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008201|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008202|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
83008203|NCT02858180|Ledipasvir|ledipasvir|mesh-list
83008204|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
83008205|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008206|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83008207|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83008208|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008209|NCT03609086|Melatonin|melatonin|mesh-list
83008210|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
83008211|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008212|NCT03609086|Protective Agents|protective agents|mesh-ancestor
83008213|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008214|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008215|NCT00730717|Adalimumab|adalimumab|mesh-list
83008216|NCT00730717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83008217|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008218|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008219|NCT01332409|Fluticasone|fluticasone|mesh-list
83008220|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83008221|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83008222|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008223|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83008224|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
83008225|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008226|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008227|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83008228|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
83008229|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
83008230|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83008231|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83008232|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83008233|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83008234|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
83008235|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008236|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008237|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
83008238|NCT01332409|Hormones|hormones|mesh-ancestor
83008239|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008240|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
83008241|NCT03181451|Ferric maltol|ferric maltol|mesh-list
83008242|NCT03181451|Hematinics|hematinics|mesh-ancestor
83008243|NCT03495973|Ustekinumab|ustekinumab|mesh-list
83008244|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
83008245|NCT00480805|Losartan|losartan|mesh-list
83008246|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83008247|NCT00480805|Ramipril|ramipril|mesh-list
83008248|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83008249|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83008250|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83008251|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83008252|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008253|NCT00480805|Diuretics|diuretics|mesh-ancestor
83008254|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
83008255|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008256|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83008257|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83008258|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83008259|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
83008260|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008261|NCT00406783|Desloratadine|desloratadine|mesh-list
83008262|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83008263|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
83008264|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008265|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008266|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008267|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83008268|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83008269|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
83008270|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
83008271|NCT03179891|Diazepam|diazepam|mesh-list
83008272|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83008273|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
83008274|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
83008275|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
83008276|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008277|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008278|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008279|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83008280|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008281|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83008282|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83008283|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83008284|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83008285|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83008286|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83008287|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
83008288|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
83008289|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
83008290|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
83008291|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008292|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008293|NCT01334671|Atorvastatin|atorvastatin|mesh-list
83008294|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83008295|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83008296|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
83008297|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008298|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83008299|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83008300|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008301|NCT01332565|Dolutegravir|dolutegravir|mesh-list
83008302|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83008303|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83008304|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008305|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008306|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83008307|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83008308|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
83008309|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008310|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83008311|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83008312|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008313|NCT02736227|Everolimus|everolimus|mesh-list
83008314|NCT02736227|Tacrolimus|tacrolimus|mesh-list
83008315|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008316|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
83008318|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83008319|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008320|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008321|NCT02736227|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83008322|NCT02736227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83008323|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008324|NCT01334905|Mirabegron|mirabegron|mesh-list
83008325|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83008326|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83008327|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83008328|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
83008329|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008330|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008331|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008332|NCT01334905|Urological Agents|urological agents|mesh-ancestor
83008333|NCT01335139|Immunomodulating Agents|immunomodulating agents|mesh-list
83008334|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
83008335|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008336|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
83008337|NCT05030129|Pyridoxal|pyridoxal|mesh-list
83008338|NCT05030129|Pyridoxine|pyridoxine|mesh-list
83008339|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
83008340|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83008341|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
83008342|NCT05030129|Vitamins|vitamins|mesh-ancestor
83008343|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
83008344|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008345|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
83008346|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83008347|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
83008348|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83008349|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83008350|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83008351|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
83008352|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008353|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008354|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
83008355|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
83008356|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
83008357|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
83008358|NCT03260023|Avelumab|avelumab|mesh-list
83008359|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008360|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008361|NCT01339039|Plerixafor|plerixafor|mesh-list
83008362|NCT01339039|Bevacizumab|bevacizumab|mesh-list
83008363|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008364|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008365|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83008366|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83008367|NCT01339039|Growth Substances|growth substances|mesh-ancestor
83008368|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008369|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83008370|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83008371|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83008372|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
83008373|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008374|NCT03176459|Bupivacaine|bupivacaine|mesh-list
83008375|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
83008376|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
83008377|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008378|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008379|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
83008380|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008381|NCT01332955|Ribavirin|ribavirin|mesh-list
83008382|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83008383|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
83008384|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008385|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
83008386|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008387|NCT05224895|Anesthetics|anesthetics|mesh-list
83008388|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008389|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008390|NCT01335373|Metronidazole|metronidazole|mesh-list
83008391|NCT01335373|Miconazole|miconazole|mesh-list
83008392|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008393|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83008394|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83008395|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83008396|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
83008397|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83008398|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83008399|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008400|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008401|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83008402|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
83008403|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008404|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008405|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83008406|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83008408|NCT01333267|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
83008409|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
83008410|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
83008411|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
83008412|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
83008413|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008414|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008415|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83008416|NCT01333267|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
83008417|NCT01335529|Interferons|interferons|mesh-list
83008418|NCT01335529|Ribavirin|ribavirin|mesh-list
83008419|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
83008420|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
83008421|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83008422|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008423|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
83008424|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008425|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
83008426|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008427|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
83008428|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008429|NCT00308347|Losartan|losartan|mesh-list
83008430|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83008431|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83008432|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83008433|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83008434|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008435|NCT02186834|Dexamethasone|dexamethasone|mesh-list
83008436|NCT02186834|Doxorubicin|doxorubicin|mesh-list
83008437|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83008438|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008439|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
83008440|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
83008441|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008442|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008443|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008444|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
83008445|NCT02186834|Hormones|hormones|mesh-ancestor
83008446|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008447|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83008448|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008449|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83008450|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83008451|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83008452|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008453|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008454|NCT04335890|Vaccines|vaccines|mesh-list
83008455|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
83008456|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008457|NCT01379157|Imipenem|imipenem|mesh-list
83008458|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83008459|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008460|NCT01538966|Octreotide|octreotide|mesh-list
83008461|NCT01538966|Lanreotide|lanreotide|mesh-list
83008462|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008463|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83008464|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008465|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
83008466|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83008467|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83008468|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008469|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008470|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83008471|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83008472|NCT01377285|Protective Agents|protective agents|mesh-ancestor
83008473|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008474|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
83008475|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83008476|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
83008477|NCT02905266|Nivolumab|nivolumab|mesh-list
83008478|NCT02905266|Ipilimumab|ipilimumab|mesh-list
83008479|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008480|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008481|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83008482|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008483|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
83008484|NCT01380717|Calcium|calcium|mesh-list
83008485|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83008486|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83008487|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83008488|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008489|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83008490|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
83008491|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008492|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008493|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
83008494|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008495|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83008496|NCT03080493|Acetaminophen|acetaminophen|mesh-list
83008497|NCT03080493|Ibuprofen|ibuprofen|mesh-list
83008498|NCT03080493|Gabapentin|gabapentin|mesh-list
83008499|NCT03080493|Codeine|codeine|mesh-list
83008500|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83008501|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83008502|NCT03080493|Analgesics|analgesics|mesh-ancestor
83008503|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
83008504|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008505|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008506|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
83008507|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83008508|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008509|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008510|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83008511|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008512|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008513|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
83008514|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83008515|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83008516|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008517|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83008518|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83008519|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83008520|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008521|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
83008522|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83008523|NCT03080493|Narcotics|narcotics|mesh-ancestor
83008524|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
83008525|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
83008526|NCT03080493|Laxatives|laxatives|mesh-ancestor
83008527|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008528|NCT02906007|Bedaquiline|bedaquiline|mesh-list
83008529|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
83008530|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83008531|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008532|NCT01339910|Vidarabine|vidarabine|mesh-list
83008533|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
83008534|NCT01339910|Melphalan|melphalan|mesh-list
83008535|NCT01339910|Busulfan|busulfan|mesh-list
83008536|NCT01339910|Fludarabine|fludarabine|mesh-list
83008537|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
83008538|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008539|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
83008540|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008541|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008542|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83008543|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
83008544|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008545|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008546|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83008547|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83008549|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
83008550|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008551|NCT02647827|Metformin|metformin|mesh-list
83008552|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83008553|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008554|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
83431033|NCT04026464|Ibuprofen|ibuprofen|mesh-list
83008555|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83008556|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
83008557|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008558|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008559|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83008560|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
83008561|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83008562|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
83008563|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008564|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008565|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83008566|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
83008567|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
83008568|NCT03655392|Protective Agents|protective agents|mesh-ancestor
83008569|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
83008570|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008571|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
83008572|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008573|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008574|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83008575|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
83008576|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008577|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008578|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83008579|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
83008580|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008581|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
83008582|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008583|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008584|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83008585|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
83008586|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008587|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008588|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83008589|NCT04203290|Bupivacaine|bupivacaine|mesh-list
83008590|NCT04203290|Sevoflurane|sevoflurane|mesh-list
83008591|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83008592|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
83008593|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008594|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008595|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
83008596|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008597|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83008598|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83008599|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
83008600|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83008601|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
83008602|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008603|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
83008604|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008605|NCT03654612|Apatinib|apatinib|mesh-list
83008606|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008607|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83008608|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008609|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008610|NCT01066104|Omalizumab|omalizumab|mesh-list
83008611|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83008612|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83008613|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83008614|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
83008615|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
83008616|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008617|NCT02736968|Auranofin|auranofin|mesh-list
83008618|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008619|NCT03608306|Methamphetamine|methamphetamine|mesh-list
83008620|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83008621|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008622|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
83008623|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
83008624|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008625|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
83008626|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431035|NCT04026464|Analgesics|analgesics|mesh-ancestor
83008627|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008628|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83008629|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83008630|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83008631|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83008632|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83008633|NCT03654144|Dienogest|dienogest|mesh-list
83008634|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
83008635|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
83008636|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83008637|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83008638|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008639|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83008640|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83008641|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83008642|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83008643|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
83008644|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008645|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83008646|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008647|NCT02591615|Paclitaxel|paclitaxel|mesh-list
83008648|NCT02591615|Carboplatin|carboplatin|mesh-list
83008649|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
83008650|NCT02591615|Pemetrexed|pemetrexed|mesh-list
83008651|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83008652|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008653|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83008654|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83008655|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83008656|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008657|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008658|NCT02591615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83008659|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008660|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83008661|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83008662|NCT03077607|Itraconazole|itraconazole|mesh-list
83008663|NCT03077607|Rifampin|rifampin|mesh-list
83008664|NCT03077607|Talazoparib|talazoparib|mesh-list
83008665|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
83008666|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008667|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83008668|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83008669|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008670|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008671|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83008672|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
83008673|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008674|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008675|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83008676|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83008677|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
83008678|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83008679|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
83008680|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83008681|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83008682|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83008683|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83008684|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83008685|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83008686|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83008687|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83008688|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008689|NCT04215588|Hemostatics|hemostatics|mesh-list
83008690|NCT04215588|Coagulants|coagulants|mesh-ancestor
83361567|NCT02651272|Macitentan|macitentan|mesh-list
83008692|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008693|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008694|NCT03217175|Glucagon|glucagon|mesh-list
83008695|NCT03217175|Pancrelipase|pancrelipase|mesh-list
83008696|NCT03217175|Pancreatin|pancreatin|mesh-list
83008697|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008698|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008699|NCT03217175|Hormones|hormones|mesh-ancestor
83008700|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008701|NCT01379079|Aspirin|aspirin|mesh-list
83008702|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
83008703|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
83008704|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
83008705|NCT01379079|Calcium|calcium|mesh-list
83008706|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83008707|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008708|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83008709|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83008710|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83008711|NCT01379079|Analgesics|analgesics|mesh-ancestor
83008712|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
83008713|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008714|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008715|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008716|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83008717|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83008718|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008719|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83008720|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83008721|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008722|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
83008723|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
83008724|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008725|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008726|NCT01379001|Scopolamine|scopolamine|mesh-list
83008727|NCT01379001|Donepezil|donepezil|mesh-list
83008728|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83008729|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83008730|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008731|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008732|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83008733|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008734|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008735|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
83008736|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83008737|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
83008738|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
83008739|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008740|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008741|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
83008742|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83008743|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83008744|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
83008745|NCT03172325|Folic Acid|folic acid|mesh-list
83008746|NCT03172325|Prednisolone|prednisolone|mesh-list
83008747|NCT03172325|Adalimumab|adalimumab|mesh-list
83008748|NCT03172325|Methotrexate|methotrexate|mesh-list
83008749|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83008750|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
83008751|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83008752|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008753|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83008754|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
83008755|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008756|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008757|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
83008758|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008759|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83008760|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008761|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
83008762|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83008763|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83008764|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008765|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
83008766|NCT03172325|Hormones|hormones|mesh-ancestor
83008767|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83008768|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83008769|NCT03172325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83008770|NCT03172325|Hematinics|hematinics|mesh-ancestor
83008771|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
83008772|NCT03172325|Vitamins|vitamins|mesh-ancestor
83008773|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
83008774|NCT03653520|Diazepam|diazepam|mesh-list
83008775|NCT03653520|Tramadol|tramadol|mesh-list
83008776|NCT03653520|Ondansetron|ondansetron|mesh-list
83008777|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
83008778|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
83008779|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008780|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008781|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008782|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
83008783|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
83008784|NCT03653520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83008785|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83008786|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
83008787|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008788|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008789|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83008790|NCT03653520|Narcotics|narcotics|mesh-ancestor
83008791|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008792|NCT03653520|Analgesics|analgesics|mesh-ancestor
83008793|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
83008794|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83008795|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
83008796|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83008797|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83008798|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83008799|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83008800|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83008801|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83008802|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83008803|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
83008804|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
83008805|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
83008806|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
83008807|NCT01208090|Ponesimod|ponesimod|mesh-list
83008808|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83008809|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008810|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008811|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
83008812|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008813|NCT01380483|Doxycycline|doxycycline|mesh-list
83008814|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83008815|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008816|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
83008817|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83008818|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83008819|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
83008820|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83008821|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83008822|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
83008823|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008824|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008825|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008826|NCT01378845|Bosentan|bosentan|mesh-list
83008827|NCT01378845|Alprostadil|alprostadil|mesh-list
83008828|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83008829|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83008830|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008831|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83008832|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
83008833|NCT01378845|Urological Agents|urological agents|mesh-ancestor
83008834|NCT04884399|Ranibizumab|ranibizumab|mesh-list
83008835|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83008836|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83008837|NCT04884399|Growth Substances|growth substances|mesh-ancestor
83008838|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008839|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
83008840|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008841|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
83008842|NCT03264404|Azacitidine|azacitidine|mesh-list
83008843|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008844|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008845|NCT03264404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83008846|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008847|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83008848|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
83008849|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008851|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
83008852|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008853|NCT03607916|Morphine|morphine|mesh-list
83008854|NCT03607916|Prilocaine|prilocaine|mesh-list
83008855|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83008856|NCT03607916|Narcotics|narcotics|mesh-ancestor
83008857|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008858|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008859|NCT03607916|Analgesics|analgesics|mesh-ancestor
83008860|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
83008861|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008862|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
83008863|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
83008864|NCT01141712|Cytarabine|cytarabine|mesh-list
83008865|NCT01141712|Etoposide|etoposide|mesh-list
83008866|NCT01141712|Melphalan|melphalan|mesh-list
83008867|NCT01141712|Carmustine|carmustine|mesh-list
83008868|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83008869|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008870|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83008871|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83008872|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008873|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008874|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83008875|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
83008876|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
83008877|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008878|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83008879|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
83008880|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008881|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83008882|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
83008883|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83008884|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
83008885|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83008886|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
83008887|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008888|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
83008889|NCT02034890|Protective Agents|protective agents|mesh-ancestor
83008890|NCT02015351|Bevacizumab|bevacizumab|mesh-list
83008891|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008892|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008893|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83008894|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83008895|NCT02015351|Growth Substances|growth substances|mesh-ancestor
83008896|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008897|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
83008898|NCT03604796|Acetaminophen|acetaminophen|mesh-list
83008899|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83008900|NCT03604796|Analgesics|analgesics|mesh-ancestor
83008901|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
83008902|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008903|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008904|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
83008905|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
83008906|NCT02237534|Calcium|calcium|mesh-list
83008907|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83008908|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008909|NCT02237534|Antacids|antacids|mesh-ancestor
83008910|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008911|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83008912|NCT03606902|Fentanyl|fentanyl|mesh-list
83008913|NCT03606902|Bupivacaine|bupivacaine|mesh-list
83008914|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
83008915|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
83008916|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83008917|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008918|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
83008919|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008920|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83008921|NCT03606902|Narcotics|narcotics|mesh-ancestor
83008922|NCT03606902|Analgesics|analgesics|mesh-ancestor
83008923|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83008924|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83008925|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
83008926|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
83008927|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008928|NCT03606824|Pitavastatin|pitavastatin|mesh-list
83008929|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83008930|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83008931|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83008932|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
83008933|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008934|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008935|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83008937|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
83008938|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008939|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83008940|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83008941|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008942|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008943|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83008944|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83008945|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
83008946|NCT01064622|Gemcitabine|gemcitabine|mesh-list
83008947|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83008948|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
83008949|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008950|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008951|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83008952|NCT01063764|Levetiracetam|levetiracetam|mesh-list
83008953|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
83008954|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
83008955|NCT04053972|Lenvatinib|lenvatinib|mesh-list
83008956|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008957|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83008958|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83008959|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008960|NCT01380249|Bromides|bromides|mesh-list
83008961|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
83008962|NCT04054518|Durvalumab|durvalumab|mesh-list
83008963|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83008964|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008965|NCT03652896|Liver Extracts|liver extracts|mesh-list
83008966|NCT03652896|Hematinics|hematinics|mesh-ancestor
83008967|NCT04565847|Albuterol|albuterol|mesh-list
83008968|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83008969|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
83008970|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83008971|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83008972|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83008973|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
83008974|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
83008975|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83008976|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83008977|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83008978|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83008979|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
83008980|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83008981|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83008982|NCT03075891|Doxycycline|doxycycline|mesh-list
83008983|NCT03075891|Ivermectin|ivermectin|mesh-list
83008984|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83008985|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83008986|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
83008987|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83008988|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83008989|NCT02013167|Blinatumomab|blinatumomab|mesh-list
83008990|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008991|NCT01378533|Paclitaxel|paclitaxel|mesh-list
83008992|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
83008993|NCT01378533|Carboplatin|carboplatin|mesh-list
83008994|NCT01378533|Epirubicin|epirubicin|mesh-list
83008995|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83008996|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83008997|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
83008998|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
83008999|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009000|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009001|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009002|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
83009003|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009004|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83009005|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83009006|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
83009007|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83009008|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83009009|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83009010|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83009011|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009012|NCT02630199|Paclitaxel|paclitaxel|mesh-list
83009013|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009014|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009015|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009016|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009017|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009018|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009019|NCT02588781|Pemetrexed|pemetrexed|mesh-list
83009020|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009021|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009022|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009023|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83009024|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83009025|NCT01063062|Methotrexate|methotrexate|mesh-list
83009026|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83009027|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
83009028|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83009029|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009030|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009031|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
83009032|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009033|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009034|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009035|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009036|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83009037|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009038|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
83009039|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83431079|NCT00475319|Protective Agents|protective agents|mesh-ancestor
83009040|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83009041|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
83009042|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
83009043|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009044|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83009045|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83009046|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
83009047|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
83009048|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009049|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009050|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009051|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83009052|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
83009053|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83009054|NCT04483115|Tadalafil|tadalafil|mesh-list
83009055|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
83009056|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83009057|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83009058|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009059|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009060|NCT04483115|Urological Agents|urological agents|mesh-ancestor
83009061|NCT04054362|Paclitaxel|paclitaxel|mesh-list
83009062|NCT04054362|Gemcitabine|gemcitabine|mesh-list
83009063|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83009064|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009065|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009066|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009067|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009068|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009069|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009070|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009071|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
83009072|NCT04467281|Daratumumab|daratumumab|mesh-list
83009073|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009074|NCT01378143|Pentamidine|pentamidine|mesh-list
83009075|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
83009076|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009077|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83009078|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83009079|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83009080|NCT02973048|Bupivacaine|bupivacaine|mesh-list
83009081|NCT02973048|Prilocaine|prilocaine|mesh-list
83009082|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
83009083|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
83009084|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009085|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009086|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
83009087|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009088|NCT03342027|Bupropion|bupropion|mesh-list
83009089|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83009090|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
83009091|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83009092|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83009093|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83009094|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009095|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009096|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
83009097|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009098|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009099|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83009100|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83009101|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009102|NCT04054206|Ibudilast|ibudilast|mesh-list
83009103|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83009104|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
83009105|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009106|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009107|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83009108|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009109|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83009110|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009111|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009112|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83009113|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
83009114|NCT03603938|Losartan|losartan|mesh-list
83009115|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83009116|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83009117|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83009118|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83009119|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009120|NCT03652116|Meperidine|meperidine|mesh-list
83009121|NCT03652116|Bupivacaine|bupivacaine|mesh-list
83009122|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
83009123|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
83009124|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009125|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009126|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
83009127|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009128|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83009129|NCT03652116|Narcotics|narcotics|mesh-ancestor
83009130|NCT03652116|Analgesics|analgesics|mesh-ancestor
83009131|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83009132|NCT04428671|Cemiplimab|cemiplimab|mesh-list
83009133|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83009134|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009135|NCT02232087|Fluticasone|fluticasone|mesh-list
83009136|NCT02232087|Xhance|xhance|mesh-list
83009137|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83009138|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83009139|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83009140|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83009141|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
83009142|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009143|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009144|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83009145|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009146|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009147|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83361568|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83009148|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83009149|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83009150|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83009151|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
83009152|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009153|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009154|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
83009156|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009157|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
83009158|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
83009159|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83009160|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83009161|NCT01380015|Analgesics|analgesics|mesh-ancestor
83009162|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
83009163|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009164|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009165|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83009166|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83009167|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
83009168|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009169|NCT01380015|Protective Agents|protective agents|mesh-ancestor
83009170|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83009171|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83009172|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
83009173|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009174|NCT03603626|Pregabalin|pregabalin|mesh-list
83009175|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009176|NCT03603626|Analgesics|analgesics|mesh-ancestor
83009177|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
83009178|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009179|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
83009180|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83009181|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009182|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009183|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83009184|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83009185|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83009186|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009187|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83009188|NCT01765218|Topiramate|topiramate|mesh-list
83009189|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
83009190|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83009191|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009192|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
83009193|NCT02972502|Promethazine|promethazine|mesh-list
83009194|NCT02972502|Haloperidol|haloperidol|mesh-list
83009195|NCT02972502|Metoclopramide|metoclopramide|mesh-list
83009196|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
83009197|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83009198|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83009199|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009200|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009201|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
83009202|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
83009203|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
83009204|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009205|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
83009206|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
83009207|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83009208|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83009209|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
83009210|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
83009211|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009212|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009213|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83009214|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
83009215|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009216|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83009217|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83009218|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83009219|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83009220|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
83009221|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83009222|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83009224|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009225|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83009226|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009227|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009228|NCT03163667|Everolimus|everolimus|mesh-list
83009229|NCT03163667|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83009230|NCT03163667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83009231|NCT03163667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009232|NCT03163667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009233|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009234|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
83009235|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009236|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009237|NCT03603548|Tacrolimus|tacrolimus|mesh-list
83009238|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009239|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
83009240|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009241|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83009242|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009243|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009244|NCT03954782|Nintedanib|nintedanib|mesh-list
83009245|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009246|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83009247|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009248|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009249|NCT03651726|Palmidrol|palmidrol|mesh-list
83009250|NCT03651726|Dronabinol|dronabinol|mesh-list
83009251|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
83009252|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009253|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83009254|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83009255|NCT03651726|Analgesics|analgesics|mesh-ancestor
83009256|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
83009257|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009258|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83009259|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83009260|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009261|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009262|NCT03651726|Hormones|hormones|mesh-ancestor
83009263|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009264|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83009265|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83009266|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83009267|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
83009268|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009269|NCT00107250|Paclitaxel|paclitaxel|mesh-list
83009270|NCT00107250|Carboplatin|carboplatin|mesh-list
83009271|NCT00107250|Capecitabine|capecitabine|mesh-list
83009272|NCT00107250|Cediranib|cediranib|mesh-list
83009273|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009274|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009275|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009276|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009277|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009278|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009279|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009280|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
83009281|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009282|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83009283|NCT03167411|Exenatide|exenatide|mesh-list
83009284|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
83009285|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83009286|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009287|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83009288|NCT03167411|Incretins|incretins|mesh-ancestor
83009289|NCT03167411|Hormones|hormones|mesh-ancestor
83009290|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009291|NCT02237768|Dirithromycin|dirithromycin|mesh-list
83009292|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83009293|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009294|NCT05461833|Octylonium|octylonium|mesh-list
83009295|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83009296|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009297|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009298|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83009299|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009300|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83009301|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
83009302|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
83009303|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009304|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83009305|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83009306|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
83009307|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009308|NCT01560585|Isotretinoin|isotretinoin|mesh-list
83009309|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009310|NCT01376427|Dexamethasone|dexamethasone|mesh-list
83009311|NCT01376427|Methotrexate|methotrexate|mesh-list
83009312|NCT01376427|Vincristine|vincristine|mesh-list
83009313|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83009314|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
83009315|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
83009316|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009317|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009318|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83009319|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
83009320|NCT01376427|Hormones|hormones|mesh-ancestor
83009321|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009322|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83009323|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009324|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83009325|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
83009326|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83009327|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009328|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
83009329|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009330|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009331|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009332|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83009333|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009334|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
83009335|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83009336|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83009337|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009338|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009339|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009340|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009341|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83009342|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009343|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009344|NCT05462535|Losartan|losartan|mesh-list
83009345|NCT05462535|Amlodipine|amlodipine|mesh-list
83009346|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
83009347|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83009348|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83009349|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009350|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009351|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83009352|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009353|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
83009354|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83009355|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83009356|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83009357|NCT05462535|Diuretics|diuretics|mesh-ancestor
83009358|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
83009359|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83009360|NCT05764317|Amlodipine|amlodipine|mesh-list
83009361|NCT05764317|Perindopril|perindopril|mesh-list
83009362|NCT05764317|Atorvastatin|atorvastatin|mesh-list
83009363|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83009364|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83009365|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
83009366|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009367|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83009368|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83009369|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009370|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83009371|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83009372|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009373|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83009374|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009375|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
83009376|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83009377|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
83009378|NCT05461365|Insulin|insulin|mesh-list
83009379|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83009380|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83009381|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009382|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83009383|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009384|NCT02317991|Paclitaxel|paclitaxel|mesh-list
83009385|NCT02317991|Ramucirumab|ramucirumab|mesh-list
83009386|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009387|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009388|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009389|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009390|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009391|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009392|NCT03602690|Ritonavir|ritonavir|mesh-list
83009393|NCT03602690|Darunavir|darunavir|mesh-list
83009394|NCT03602690|Dolutegravir|dolutegravir|mesh-list
83009395|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83009396|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83009397|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
83009398|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009399|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009400|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83009401|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83009402|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
83009403|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009404|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83009405|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83009406|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83009407|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83009408|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83009409|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009410|NCT02978495|Paclitaxel|paclitaxel|mesh-list
83009411|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
83009412|NCT02978495|Carboplatin|carboplatin|mesh-list
83009413|NCT02978495|Doxorubicin|doxorubicin|mesh-list
83009414|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009415|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009416|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009417|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009418|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009419|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009420|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009421|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
83009422|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009423|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83009424|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83009425|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
83009426|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83009427|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83009428|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83009429|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83009430|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009431|NCT02237690|Doxorubicin|doxorubicin|mesh-list
83009432|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83009433|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83009434|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009435|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83009436|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83009437|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009438|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009439|NCT04788017|Ziresovir|ziresovir|mesh-list
83009440|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
83009441|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009442|NCT03600974|Domperidone|domperidone|mesh-list
83009443|NCT03600974|Citalopram|citalopram|mesh-list
83009444|NCT03600974|Esomeprazole|esomeprazole|mesh-list
83009445|NCT03600974|Omeprazole|omeprazole|mesh-list
83009447|NCT03600974|Pantoprazole|pantoprazole|mesh-list
83009448|NCT03600974|Lansoprazole|lansoprazole|mesh-list
83009449|NCT03600974|Mosapride|mosapride|mesh-list
83009450|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83009451|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83009452|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83009453|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83009454|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009455|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009456|NCT03600974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83009457|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83009458|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009459|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
83009460|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009461|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83009462|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
83009463|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83009464|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
83009465|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009466|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
83009467|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83009468|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
83009469|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83009470|NCT03075267|Budesonide|budesonide|mesh-list
83009471|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
83009472|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
83009473|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83009474|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83009475|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
83009476|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009477|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009478|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83009479|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009480|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
83009481|NCT03075267|Hormones|hormones|mesh-ancestor
83009482|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009483|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83009484|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83009485|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83009486|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
83009487|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009488|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009489|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83009490|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83009491|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83009492|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
83009493|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
83009494|NCT03600506|Sympatholytics|sympatholytics|mesh-list
83009495|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83009496|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009497|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009498|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83009499|NCT03600506|Analgesics|analgesics|mesh-ancestor
83009500|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
83009501|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009502|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83009503|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83009504|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83009505|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
83009506|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009507|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009508|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
83009509|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
83009510|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83009511|NCT03074331|Velpatasvir|velpatasvir|mesh-list
83009512|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
83009513|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009514|NCT02237924|Endostar protein|endostar protein|mesh-list
83009515|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83009516|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83009517|NCT02237924|Growth Substances|growth substances|mesh-ancestor
83009518|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009519|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
83009520|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361569|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83009521|NCT03825302|Mannitol|mannitol|mesh-list
83009522|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
83009523|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83009524|NCT03825302|Diuretics|diuretics|mesh-ancestor
83009525|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
83009526|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009527|NCT03825302|Miotics|miotics|mesh-ancestor
83009528|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
83009529|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009530|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83009531|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83009532|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009533|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83009534|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83009535|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
83009536|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009537|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009538|NCT02238392|Adenosine|adenosine|mesh-list
83009539|NCT02238392|Analgesics|analgesics|mesh-ancestor
83009540|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
83009541|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009542|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009543|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83009544|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
83009545|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83009546|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
83009547|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
83009548|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009549|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009550|NCT02260193|Glycine|glycine|mesh-list
83009551|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
83009552|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009553|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009554|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009555|NCT02849678|Lidocaine|lidocaine|mesh-list
83009556|NCT02849678|Ropivacaine|ropivacaine|mesh-list
83009557|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
83009558|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
83009559|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009560|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009561|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
83009562|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009563|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83009564|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83009565|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83009566|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009567|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009568|NCT04295577|Niraparib|niraparib|mesh-list
83009569|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83009570|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009571|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009572|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009573|NCT02238158|Ipratropium|ipratropium|mesh-list
83009574|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83009575|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
83009576|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009577|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009578|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83009579|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009580|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83009581|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83009582|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009583|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009584|NCT02238314|Ritonavir|ritonavir|mesh-list
83009585|NCT02238314|Tipranavir|tipranavir|mesh-list
83009586|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83009587|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83009588|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83009589|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
83009590|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009591|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009592|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83009593|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83009594|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
83009595|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009596|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83009597|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83009598|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83009599|NCT02238470|Warfarin|warfarin|mesh-list
83009600|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
83009601|NCT02238470|Dabigatran|dabigatran|mesh-list
83009602|NCT02238470|Apixaban|apixaban|mesh-list
83009603|NCT02238470|Anticoagulants|anticoagulants|mesh-list
83009604|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83009605|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
83009606|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83009607|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
83009608|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009609|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009610|NCT03586934|Acetaminophen|acetaminophen|mesh-list
83009611|NCT03586934|Celecoxib|celecoxib|mesh-list
83009612|NCT03586934|Ketorolac|ketorolac|mesh-list
83009613|NCT03586934|Meloxicam|meloxicam|mesh-list
83009614|NCT03586934|Morphine|morphine|mesh-list
83009615|NCT03586934|Oxycodone|oxycodone|mesh-list
83009616|NCT03586934|Tramadol|tramadol|mesh-list
83009617|NCT03586934|Hydrocodone|hydrocodone|mesh-list
83009618|NCT03586934|Ropivacaine|ropivacaine|mesh-list
83009619|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83009620|NCT03586934|Narcotics|narcotics|mesh-ancestor
83009621|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009622|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009623|NCT03586934|Analgesics|analgesics|mesh-ancestor
83009624|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
83009625|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009626|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
83009627|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
83009628|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83009629|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
83009630|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83009631|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83009632|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83009633|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83009634|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83009635|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009636|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009637|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
83009638|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009639|NCT03586154|Ketamine|ketamine|mesh-list
83009640|NCT03586154|Bupivacaine|bupivacaine|mesh-list
83009641|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
83009642|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
83009643|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009644|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009645|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
83009646|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009647|NCT03586154|Analgesics|analgesics|mesh-ancestor
83009648|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83009649|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83009650|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
83009651|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83009652|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83009653|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009654|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009655|NCT03629847|Everolimus|everolimus|mesh-list
83009656|NCT03629847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83009657|NCT03629847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83009658|NCT03629847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009659|NCT03629847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009660|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009661|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
83009662|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009663|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009664|NCT01314833|Paclitaxel|paclitaxel|mesh-list
83009665|NCT01314833|Docetaxel|docetaxel|mesh-list
83009666|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
83009667|NCT01314833|Fluorouracil|fluorouracil|mesh-list
83009668|NCT01314833|Epirubicin|epirubicin|mesh-list
83009669|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009670|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009671|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009672|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009673|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83068776|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83009674|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009675|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009676|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
83009677|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009678|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83009679|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83009680|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
83009681|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83009682|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
83009683|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009684|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83009685|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83009686|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83009687|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009689|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009690|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
83009691|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009692|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009693|NCT02737826|Buprenorphine|buprenorphine|mesh-list
83009694|NCT02737826|Gabapentin|gabapentin|mesh-list
83009695|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83009696|NCT02737826|Narcotics|narcotics|mesh-ancestor
83009697|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009698|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009699|NCT02737826|Analgesics|analgesics|mesh-ancestor
83009700|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
83009701|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009702|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83009703|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
83009704|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83009705|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83009706|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83009707|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83009708|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83009709|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009710|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009711|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
83009712|NCT03367715|Nivolumab|nivolumab|mesh-list
83009713|NCT03367715|Ipilimumab|ipilimumab|mesh-list
83009714|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83009715|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009716|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83009717|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009718|NCT04064931|Niacin|niacin|mesh-list
83009719|NCT04064931|Vitamins|vitamins|mesh-ancestor
83009720|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
83009721|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009722|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83009723|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
83009724|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009725|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83009726|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83009727|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
83009728|NCT03577652|Ticagrelor|ticagrelor|mesh-list
83009729|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83009730|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83009731|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83009732|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83009733|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
83009734|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431135|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83009735|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009736|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009737|NCT03620513|Lidocaine|lidocaine|mesh-list
83009738|NCT03620513|Phenylephrine|phenylephrine|mesh-list
83009739|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
83009740|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
83009741|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
83009742|NCT03620513|Ephedrine|ephedrine|mesh-list
83009743|NCT03620513|Anesthetics|anesthetics|mesh-list
83009744|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
83009745|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009746|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009747|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
83009748|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009749|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83009750|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83009751|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83009752|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009753|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009754|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83009755|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83009756|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
83009757|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009758|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
83009759|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
83009760|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83009761|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009762|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83009763|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
83009764|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83009765|NCT03620513|Protective Agents|protective agents|mesh-ancestor
83009766|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83009767|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83009768|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83009769|NCT03585062|Paclitaxel|paclitaxel|mesh-list
83009770|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83009771|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009772|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83009773|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83009774|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83009775|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009776|NCT03584360|Calcitriol|calcitriol|mesh-list
83009777|NCT03584360|Betamethasone|betamethasone|mesh-list
83009778|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
83009779|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83009780|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
83009781|NCT03584360|Calcipotriene|calcipotriene|mesh-list
83009782|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83009783|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83009784|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
83009785|NCT03584360|Hormones|hormones|mesh-ancestor
83009786|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009787|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009788|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83009789|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
83009790|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009791|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83009792|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83009793|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009794|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009795|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83009796|NCT03584360|Vitamins|vitamins|mesh-ancestor
83009797|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
83009798|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83009799|NCT05763771|Nicotine|nicotine|mesh-list
83009800|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83009801|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
83009802|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009803|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009804|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83009805|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83009806|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
83009807|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009808|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009809|NCT03579758|Gemcitabine|gemcitabine|mesh-list
83009810|NCT03579758|Capecitabine|capecitabine|mesh-list
83009811|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009812|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009813|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
83009814|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009815|NCT03577574|Anesthetics|anesthetics|mesh-list
83009816|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009817|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009818|NCT01130519|Bevacizumab|bevacizumab|mesh-list
83009819|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83009820|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83009821|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009822|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83009823|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83009824|NCT01130519|Growth Substances|growth substances|mesh-ancestor
83009825|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009826|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
83009827|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83009828|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009829|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009830|NCT01330901|Ustekinumab|ustekinumab|mesh-list
83009831|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
83009833|NCT02428647|Trace Elements|trace elements|mesh-ancestor
83009834|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
83009835|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009836|NCT01071395|Amantadine|amantadine|mesh-list
83009837|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83009838|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83009839|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
83009840|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009841|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
83009842|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009843|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009844|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009845|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83009846|NCT01071395|Analgesics|analgesics|mesh-ancestor
83009847|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
83009848|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009849|NCT00335816|Leucovorin|leucovorin|mesh-list
83009850|NCT00335816|Fluorouracil|fluorouracil|mesh-list
83009851|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
83009852|NCT00335816|Calcium|calcium|mesh-list
83009853|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
83009854|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83009855|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009856|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
83009857|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009858|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83009859|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009860|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009861|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
83009862|NCT00335816|Antidotes|antidotes|mesh-ancestor
83009863|NCT00335816|Protective Agents|protective agents|mesh-ancestor
83009864|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
83009865|NCT00335816|Vitamins|vitamins|mesh-ancestor
83009866|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
83009867|NCT03577496|Peppermint oil|peppermint oil|mesh-list
83009868|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
83009869|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
83009870|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009871|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009872|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83009873|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
83009874|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
83009875|NCT03582878|Sirolimus|sirolimus|mesh-list
83009876|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83009877|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009878|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83009879|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
83009880|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83009881|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009882|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009883|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009884|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
83009885|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009886|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
83009887|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009888|NCT05763693|Azithromycin|azithromycin|mesh-list
83009889|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83009890|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009891|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
83009892|NCT02238704|Iron|iron|mesh-list
83009893|NCT02238704|Folic Acid|folic acid|mesh-list
83009894|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
83009895|NCT02238704|Calcium|calcium|mesh-list
83009896|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83009897|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858651|NCT05841121|Glucocorticoids|glucocorticoids|mesh-ancestor
83009898|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83009899|NCT02238704|Trace Elements|trace elements|mesh-ancestor
83009900|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
83009901|NCT02238704|Hematinics|hematinics|mesh-ancestor
83009902|NCT02238704|Vitamins|vitamins|mesh-ancestor
83009903|NCT01331135|Sirolimus|sirolimus|mesh-list
83009904|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83009905|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009906|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83009907|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009908|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
83009909|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83009910|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
83009911|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009912|NCT03577184|Metformin|metformin|mesh-list
83009913|NCT03577184|Vildagliptin|vildagliptin|mesh-list
83009914|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83009915|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009916|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83009917|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
83009918|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009919|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009920|NCT02849171|Choline|choline|mesh-list
83009921|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
83009922|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83009923|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
83009924|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009925|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83009926|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83009927|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
83009928|NCT02238860|Tenofovir|tenofovir|mesh-list
83009929|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
83009930|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83009931|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83009932|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83009933|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009934|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009935|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83009936|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83009937|NCT01333709|Folfirinox|folfirinox|mesh-list
83009938|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009939|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
83009940|NCT04869137|Lenvatinib|lenvatinib|mesh-list
83009941|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83009942|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009943|NCT04869137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83009944|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009945|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83009946|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009947|NCT00364637|Anesthetics|anesthetics|mesh-list
83009948|NCT00364637|Sevoflurane|sevoflurane|mesh-list
83009949|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83009950|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009951|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83009952|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83009953|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
83009954|NCT00493961|Hormones|hormones|mesh-list
83431147|NCT04192292|Incretins|incretins|mesh-ancestor
83009955|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009956|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009957|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83009958|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83009959|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83009960|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83009961|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009962|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009963|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009964|NCT02903238|Analgesics|analgesics|mesh-ancestor
83009965|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
83009966|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83009967|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
83009968|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83009969|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
83009970|NCT01329809|Molgramostim|molgramostim|mesh-list
83009971|NCT01329809|Sargramostim|sargramostim|mesh-list
83009972|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
83009973|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009975|NCT02847260|Treprostinil|treprostinil|mesh-list
83009976|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83009977|NCT01331447|Exemestane|exemestane|mesh-list
83009978|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009979|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83009980|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83009981|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009982|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009983|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83009984|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
83009985|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83009986|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83009987|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
83009988|NCT02968563|Idelalisib|idelalisib|mesh-list
83009989|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83009990|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83009991|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83009992|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83009993|NCT01329887|Ketanserin|ketanserin|mesh-list
83009994|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83009995|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83009996|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83009997|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
83009998|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83009999|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010000|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010001|NCT01334099|Tremelimumab|tremelimumab|mesh-list
83010002|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010003|NCT01331525|Ipilimumab|ipilimumab|mesh-list
83010004|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83010005|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010006|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83010007|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010008|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83010009|NCT01334177|Cetuximab|cetuximab|mesh-list
83010010|NCT01334177|Antibodies|antibodies|mesh-list
83010011|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
83010012|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83010013|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
83010014|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010015|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010016|NCT04098393|Fludarabine|fludarabine|mesh-list
83010017|NCT04098393|Melphalan|melphalan|mesh-list
83010018|NCT04098393|Busulfan|busulfan|mesh-list
83010019|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83010020|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010021|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010022|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010023|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
83010024|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010025|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83010026|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
83010027|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83010028|NCT03649230|Palonosetron|palonosetron|mesh-list
83010029|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
83010030|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
83010031|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010032|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010033|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010034|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83010035|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83010036|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
83010037|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010038|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010039|NCT05762523|Vaccines|vaccines|mesh-list
83010040|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
83010041|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010042|NCT02796261|Eflornithine|eflornithine|mesh-list
83010043|NCT02796261|Lomustine|lomustine|mesh-list
83010044|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83010045|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
83010046|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010047|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010048|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83010049|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83010050|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83010051|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010052|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83010053|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010055|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
83010056|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
83010057|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010058|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010059|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
83010060|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010061|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83010062|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83010063|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83010064|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83010065|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010066|NCT04079712|Nivolumab|nivolumab|mesh-list
83010067|NCT04079712|Ipilimumab|ipilimumab|mesh-list
83010068|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83010069|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010070|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83010071|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010072|NCT02586675|Tamoxifen|tamoxifen|mesh-list
83010073|NCT02586675|Goserelin|goserelin|mesh-list
83010074|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83010075|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
83010076|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010077|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010078|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83010079|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010080|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83010081|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83010082|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83010083|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
83010084|NCT03648528|Vitamin D|vitamin d|mesh-list
83010085|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83010086|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010087|NCT03648528|Vitamins|vitamins|mesh-ancestor
83010088|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
83010089|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83010090|NCT03161405|Itraconazole|itraconazole|mesh-list
83010091|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010092|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010093|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
83010094|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010095|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83010096|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83010097|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83010098|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
83010099|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010100|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010101|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83010102|NCT01813929|Metformin|metformin|mesh-list
83010103|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83010104|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010105|NCT01502085|Dexamethasone|dexamethasone|mesh-list
83010106|NCT01502085|Vorinostat|vorinostat|mesh-list
83010107|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010108|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
83010109|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
83010110|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010111|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010112|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010113|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
83010114|NCT01502085|Hormones|hormones|mesh-ancestor
83010115|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010116|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83010117|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010118|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83010119|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858652|NCT05841121|Hormones|hormones|mesh-ancestor
83010120|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010122|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83010123|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010124|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83010125|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010126|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010127|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83010128|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83010129|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
83010130|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010131|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83010132|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83010133|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010134|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010135|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83010136|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83010137|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010138|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
83010139|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010140|NCT02901054|Ondansetron|ondansetron|mesh-list
83010141|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
83010142|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
83010143|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010144|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010145|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010146|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
83010147|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
83010148|NCT02901054|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83010149|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83010150|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
83010151|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010152|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010154|NCT03647670|Abrocitinib|abrocitinib|mesh-list
83010155|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83010156|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83010157|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010158|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010159|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83010160|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83010161|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83010162|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83010163|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
83010164|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
83010165|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
83010166|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
83010167|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010168|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010169|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83010170|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010171|NCT02966340|Prazosin|prazosin|mesh-list
83010172|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83010173|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83010174|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83010175|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83010176|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
83010177|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010178|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010179|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010180|NCT05284734|Anesthetics|anesthetics|mesh-list
83010181|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010182|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010183|NCT05170893|Ubiquinone|ubiquinone|mesh-list
83010184|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
83010185|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
83010186|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010187|NCT05170893|Vitamins|vitamins|mesh-ancestor
83010188|NCT05761041|Listerine|listerine|mesh-list
83010189|NCT05761041|Fluorides|fluorides|mesh-list
83010190|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
83010191|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
83010192|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
83010193|NCT05761041|Protective Agents|protective agents|mesh-ancestor
83010194|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010195|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83010196|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010197|NCT03629379|Ustekinumab|ustekinumab|mesh-list
83010198|NCT03629379|Vedolizumab|vedolizumab|mesh-list
83010199|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
83010200|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010201|NCT05055999|Atezolizumab|atezolizumab|mesh-list
83010202|NCT05055999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83010203|NCT05055999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010204|NCT05055999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83010205|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010206|NCT05205837|Letrozole|letrozole|mesh-list
83010207|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010208|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83010209|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83010210|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010211|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010212|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83010213|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
83010214|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010215|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010216|NCT05205603|Infliximab|infliximab|mesh-list
83010217|NCT05205603|Mesalamine|mesalamine|mesh-list
83010218|NCT05205603|Vedolizumab|vedolizumab|mesh-list
83010219|NCT05205603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83010220|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010221|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83010222|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010223|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010224|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83010225|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83010226|NCT05205603|Analgesics|analgesics|mesh-ancestor
83010227|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
83010228|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010229|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010230|NCT03578900|Citric Acid|citric acid|mesh-list
83010231|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
83010232|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
83010233|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83010234|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
83010235|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
83010236|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010237|NCT02550002|Aflibercept|aflibercept|mesh-list
83010238|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83010239|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83010240|NCT02550002|Growth Substances|growth substances|mesh-ancestor
83010241|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010242|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
83010243|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010244|NCT03574376|Bupivacaine|bupivacaine|mesh-list
83010245|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
83010246|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
83010247|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010248|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010249|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
83010250|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010251|NCT03576794|Prednisolone|prednisolone|mesh-list
83010252|NCT03576794|Leflunomide|leflunomide|mesh-list
83010253|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010254|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
83010255|NCT03576794|Hormones|hormones|mesh-ancestor
83010256|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010257|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010258|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83010259|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010260|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010261|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010262|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010263|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
83010264|NCT03578822|Aspirin|aspirin|mesh-list
83010265|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83010266|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83010267|NCT03578822|Analgesics|analgesics|mesh-ancestor
83010268|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
83010269|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010270|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010271|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010272|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010273|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83010274|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83010275|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010276|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83010277|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83010278|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010279|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
83010280|NCT03576638|Levodopa|levodopa|mesh-list
83010281|NCT03576638|Carbidopa|carbidopa|mesh-list
83010282|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83010283|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83010284|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83010285|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
83010286|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010287|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010288|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010289|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83010290|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010291|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83010292|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
83010293|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
83010294|NCT04284657|Citric Acid|citric acid|mesh-list
83010295|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
83010296|NCT04284657|Pravastatin|pravastatin|mesh-list
83010297|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
83010298|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83010299|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
83010300|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
83010301|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010302|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83010303|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83010304|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
83010305|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83010306|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83010307|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010308|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83010309|NCT01569945|Clomiphene|clomiphene|mesh-list
83010310|NCT01569945|Menotropins|menotropins|mesh-list
83010311|NCT01569945|Estradiol|estradiol|mesh-list
83010312|NCT01569945|Estrogens|estrogens|mesh-ancestor
83010313|NCT01569945|Hormones|hormones|mesh-ancestor
83010314|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010315|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010316|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83010317|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
83010318|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83010319|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83010320|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83010321|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83010322|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83010323|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
83010324|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83010325|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
83010326|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83010327|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83010328|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
83010329|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83010330|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010331|NCT03574220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83010332|NCT03574220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010333|NCT04876677|Beclomethasone|beclomethasone|mesh-list
83010334|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
83010335|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
83010336|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83010337|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
83010338|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010339|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010340|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83010341|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
83010342|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83010343|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83010344|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83010345|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
83010346|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010347|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010348|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010350|NCT04876677|Hormones|hormones|mesh-ancestor
83010351|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010352|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83010353|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83010354|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83010355|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
83010356|NCT03578432|Everolimus|everolimus|mesh-list
83010357|NCT03578432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83010358|NCT03578432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83010359|NCT03578432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010360|NCT03578432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010361|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010362|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
83010363|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010364|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010365|NCT03578354|Atenolol|atenolol|mesh-list
83010366|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
83010367|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83010368|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83010369|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
83010370|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
83010371|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010372|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010373|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83010374|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83010375|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83010376|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
83010377|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010378|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010379|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83010380|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83010381|NCT05204979|Misoprostol|misoprostol|mesh-list
83010382|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83010383|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
83010384|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83010385|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010386|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83010387|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010388|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
83010389|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83010390|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010391|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83010392|NCT02239952|Sunitinib|sunitinib|mesh-list
83010393|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010394|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83010395|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010396|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010397|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83010398|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83010399|NCT02239952|Growth Substances|growth substances|mesh-ancestor
83010400|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010401|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
83010402|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83010403|NCT03647280|Epirubicin|epirubicin|mesh-list
83010404|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010405|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010406|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83010407|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83010408|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83010409|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010410|NCT03578042|Losartan|losartan|mesh-list
83010411|NCT03578042|Amlodipine|amlodipine|mesh-list
83010412|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83010413|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83010414|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83010415|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83010416|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010417|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83010418|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010419|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
83010420|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83010421|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83010422|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83010424|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
83010425|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83010426|NCT03646500|Remifentanil|remifentanil|mesh-list
83010427|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83010428|NCT03646500|Narcotics|narcotics|mesh-ancestor
83010429|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010430|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010431|NCT03646500|Analgesics|analgesics|mesh-ancestor
83010432|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
83010433|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010435|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83010436|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83010437|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010438|NCT03574064|Hormones|hormones|mesh-ancestor
83010439|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010440|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010441|NCT03574064|Incretins|incretins|mesh-ancestor
83010442|NCT03573986|Bevacizumab|bevacizumab|mesh-list
83010443|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83010444|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010445|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83010446|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83010447|NCT03573986|Growth Substances|growth substances|mesh-ancestor
83010448|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010449|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
83010450|NCT03959592|Carotenoids|carotenoids|mesh-list
83010451|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
83010452|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431165|NCT00476645|Fulvestrant|fulvestrant|mesh-list
83010453|NCT03959592|Protective Agents|protective agents|mesh-ancestor
83010454|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010455|NCT04087395|Lidocaine|lidocaine|mesh-list
83010456|NCT04087395|Anesthetics|anesthetics|mesh-list
83010457|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
83010458|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010459|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010460|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
83010461|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010462|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83010463|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83010464|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83010465|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83010466|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010467|NCT03573596|Dasatinib|dasatinib|mesh-list
83010468|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010469|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83010470|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010471|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010472|NCT03621618|Dobutamine|dobutamine|mesh-list
83010473|NCT03621618|Norepinephrine|norepinephrine|mesh-list
83010474|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83010475|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83010476|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
83010477|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010478|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010479|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010480|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
83010481|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
83010482|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010483|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83010484|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83010485|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83010486|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83010487|NCT03621618|Protective Agents|protective agents|mesh-ancestor
83010488|NCT03944304|Paclitaxel|paclitaxel|mesh-list
83010489|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83010490|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010492|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
83010493|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
83010494|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010495|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
83010496|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83010497|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83010498|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
83010499|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010500|NCT04671615|Palbociclib|palbociclib|mesh-list
83010501|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010502|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83010503|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010504|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010505|NCT03645876|Capecitabine|capecitabine|mesh-list
83010506|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
83010507|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83010508|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
83010509|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010510|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010512|NCT02899728|Carboplatin|carboplatin|mesh-list
83010513|NCT02899728|Etoposide|etoposide|mesh-list
83010514|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
83010515|NCT02899728|Olaparib|olaparib|mesh-list
83010516|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
83010517|NCT02899728|Cediranib|cediranib|mesh-list
83010518|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83010519|NCT02899728|Maleic acid|maleic acid|mesh-list
83010520|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010521|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83010522|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83010523|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83010524|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010525|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010526|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
83010527|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
83010528|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
83010529|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
83010530|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
83010531|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83010532|NCT03646266|Bromides|bromides|mesh-list
83010533|NCT03646266|Rocuronium|rocuronium|mesh-list
83010534|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
83010535|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83010536|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83010537|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83010538|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010539|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010540|NCT04052178|Capsaicin|capsaicin|mesh-list
83010541|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
83010542|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
83010543|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
83010544|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010545|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010546|NCT03645642|Midodrine|midodrine|mesh-list
83010547|NCT03645642|Diuretics|diuretics|mesh-list
83010548|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
83010549|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010550|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
83010551|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
83010552|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010553|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83010554|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83010555|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83010556|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83010557|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83010558|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010559|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010560|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83010561|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
83010562|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010563|NCT03768492|Caffeine|caffeine|mesh-list
83010564|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83010565|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010566|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83010567|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010568|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010569|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83010570|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83010571|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
83010572|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010573|NCT01345188|Ranolazine|ranolazine|mesh-list
83010574|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83010575|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83010576|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010577|NCT03852459|Ibuprofen|ibuprofen|mesh-list
83010578|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83010579|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83010580|NCT03852459|Analgesics|analgesics|mesh-ancestor
83010581|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
83010582|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010583|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010584|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010585|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010586|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83010587|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010588|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010589|NCT03580902|Buprenorphine|buprenorphine|mesh-list
83010590|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83010591|NCT03580902|Naloxone|naloxone|mesh-list
83010592|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83010593|NCT03580902|Narcotics|narcotics|mesh-ancestor
83010594|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010595|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010596|NCT03580902|Analgesics|analgesics|mesh-ancestor
83010597|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
83010598|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010599|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83010600|NCT02896296|Buprenorphine|buprenorphine|mesh-list
83010601|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83010602|NCT02896296|Narcotics|narcotics|mesh-ancestor
83010603|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010604|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010605|NCT02896296|Analgesics|analgesics|mesh-ancestor
83010606|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
83010607|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010608|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83010609|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
83010610|NCT03644706|Diuretics|diuretics|mesh-ancestor
83010611|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
83010612|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010613|NCT03644706|Expectorants|expectorants|mesh-ancestor
83010614|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
83010615|NCT03740919|Insulin|insulin|mesh-list
83010616|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83010617|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
83010618|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
83010619|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83010620|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010621|NCT01335685|Prednisone|prednisone|mesh-list
83010622|NCT01335685|Melphalan|melphalan|mesh-list
83010623|NCT01335685|Ixazomib|ixazomib|mesh-list
83010624|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010625|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
83010626|NCT01335685|Hormones|hormones|mesh-ancestor
83010627|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010628|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010629|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83010630|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010631|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83010632|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
83010633|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010634|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83010635|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010636|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
83010637|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
83010638|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010639|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
83010640|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83010641|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010642|NCT04462965|Temozolomide|temozolomide|mesh-list
83010643|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83010644|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
83010645|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010646|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010647|NCT01339663|Aldesleukin|aldesleukin|mesh-list
83010648|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
83010649|NCT01339663|Interleukin-2|interleukin-2|mesh-list
83010650|NCT01339663|Vaccines|vaccines|mesh-list
83010651|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
83010652|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010653|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010654|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010655|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83010656|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
83010657|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010658|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010659|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83010660|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83010661|NCT01339663|Analgesics|analgesics|mesh-ancestor
83010662|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
83010663|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010664|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83010665|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83010666|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
83010667|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010668|NCT00092599|Ezetimibe|ezetimibe|mesh-list
83010669|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83010670|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83010671|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
83010672|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010673|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83010674|NCT03737565|Tryptophan|tryptophan|mesh-list
83010675|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83010676|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
83010677|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83010678|NCT02889133|Iron|iron|mesh-list
83010679|NCT02889133|Dextrans|dextrans|mesh-list
83010680|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
83010681|NCT02889133|Trace Elements|trace elements|mesh-ancestor
83010682|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
83010683|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010684|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
83010685|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
83010686|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
83010687|NCT02889133|Hematinics|hematinics|mesh-ancestor
83010688|NCT01333423|Roscovitine|roscovitine|mesh-list
83010689|NCT01333423|Doxorubicin|doxorubicin|mesh-list
83010690|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83010691|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83010692|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010693|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83010694|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83010695|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010696|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010697|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
83010698|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010699|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83010700|NCT00092209|Losartan|losartan|mesh-list
83010701|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83010702|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83010703|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83010704|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83010705|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83010706|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010707|NCT00092209|Diuretics|diuretics|mesh-ancestor
83010708|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
83010709|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010710|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83010711|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83010712|NCT01339741|Vitamin D|vitamin d|mesh-list
83010713|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
83010714|NCT01339741|Vitamins|vitamins|mesh-ancestor
83010715|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
83010716|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010717|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83010718|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83010719|NCT00003777|Fluorouracil|fluorouracil|mesh-list
83010720|NCT00003777|Amifostine|amifostine|mesh-list
83010721|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010722|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
83010723|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010724|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83010725|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010726|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
83010727|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010728|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83010729|NCT00003777|Protective Agents|protective agents|mesh-ancestor
83010731|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
83010732|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
83010733|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83010734|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
83010735|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010736|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010737|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
83010738|NCT02963922|Liraglutide|liraglutide|mesh-list
83010739|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83010740|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010741|NCT02963922|Incretins|incretins|mesh-ancestor
83010742|NCT02963922|Hormones|hormones|mesh-ancestor
83010743|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010744|NCT00090181|Diclofenac|diclofenac|mesh-list
83010745|NCT00090181|Etoricoxib|etoricoxib|mesh-list
83010746|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83010747|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83010748|NCT00090181|Analgesics|analgesics|mesh-ancestor
83010749|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
83010750|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010751|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010752|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010753|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010754|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83010755|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010756|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010757|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83010758|NCT03619785|Acetaminophen|acetaminophen|mesh-list
83010759|NCT03619785|Ibuprofen|ibuprofen|mesh-list
83010760|NCT03619785|Ketorolac|ketorolac|mesh-list
83010761|NCT03619785|Fentanyl|fentanyl|mesh-list
83010762|NCT03619785|Ketamine|ketamine|mesh-list
83010763|NCT03619785|Morphine|morphine|mesh-list
83010764|NCT03619785|Gabapentin|gabapentin|mesh-list
83010765|NCT03619785|Hydromorphone|hydromorphone|mesh-list
83010766|NCT03619785|Hydrocodone|hydrocodone|mesh-list
83010767|NCT03619785|Bupivacaine|bupivacaine|mesh-list
83010768|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
83010769|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
83010770|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010771|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010772|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
83010773|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010774|NCT03619785|Analgesics|analgesics|mesh-ancestor
83010775|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83010776|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83010777|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
83010778|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83010779|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83010780|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010781|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010782|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83010783|NCT03619785|Narcotics|narcotics|mesh-ancestor
83010784|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83010785|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83010786|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
83010787|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83010788|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010789|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010790|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83010791|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010792|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
83010793|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83010794|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83010795|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83010796|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
83010797|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
83010798|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
83010800|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010801|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
83010802|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010803|NCT05184517|Cyclosporine|cyclosporine|mesh-list
83010804|NCT05184517|Cyclosporins|cyclosporins|mesh-list
83010805|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010806|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010807|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010808|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
83010809|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010810|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
83010811|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010812|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
83010813|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010814|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83010815|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
83010816|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83010817|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83010818|NCT02962284|Prednisolone|prednisolone|mesh-list
83010819|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
83010820|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
83010821|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83010822|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
83010823|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010824|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
83010825|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
83010826|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010827|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010828|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010829|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
83010830|NCT02962284|Hormones|hormones|mesh-ancestor
83010831|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010832|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83010833|NCT02962284|Protective Agents|protective agents|mesh-ancestor
83010834|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83010835|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010836|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83010837|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010838|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010839|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
83010840|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83010841|NCT03642600|Folic Acid|folic acid|mesh-list
83010842|NCT03642600|Inositol|inositol|mesh-list
83010843|NCT03642600|Liraglutide|liraglutide|mesh-list
83010844|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83010845|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010846|NCT03642600|Incretins|incretins|mesh-ancestor
83010847|NCT03642600|Hormones|hormones|mesh-ancestor
83010848|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010849|NCT03642600|Hematinics|hematinics|mesh-ancestor
83010850|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
83010851|NCT03642600|Vitamins|vitamins|mesh-ancestor
83010852|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
83010853|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
83010854|NCT01069692|Hematinics|hematinics|mesh-ancestor
83010855|NCT05183178|Ticagrelor|ticagrelor|mesh-list
83010856|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83010857|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83010858|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83010859|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83010860|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83010861|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
83010862|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010863|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010864|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010865|NCT03161093|Naproxen|naproxen|mesh-list
83010866|NCT03161093|Fasinumab|fasinumab|mesh-list
83010867|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83010868|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83010869|NCT03161093|Analgesics|analgesics|mesh-ancestor
83010870|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
83010871|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010872|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010873|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010874|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010875|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
83010876|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83010877|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361570|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010878|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010879|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
83010880|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83010881|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
83010882|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010883|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010884|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83010885|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
83010886|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83010887|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
83010888|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010889|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010890|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83010891|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
83010892|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
83010893|NCT03573284|Protective Agents|protective agents|mesh-ancestor
83010894|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
83010895|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010896|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010898|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010899|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
83010900|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010901|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83010902|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010903|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010904|NCT03573050|Rivastigmine|rivastigmine|mesh-list
83010905|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83010906|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010907|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010908|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
83010909|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010910|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010911|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83010912|NCT03573050|Protective Agents|protective agents|mesh-ancestor
83010913|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
83010914|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83010915|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83010916|NCT02847494|Dexamethasone|dexamethasone|mesh-list
83010917|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
83010918|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83010919|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83010920|NCT02847494|Prednisolone|prednisolone|mesh-list
83010921|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
83010922|NCT02847494|Metoclopramide|metoclopramide|mesh-list
83010923|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83010924|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
83010925|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83010926|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
83010927|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
83010928|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010929|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010930|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83010931|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
83010932|NCT02847494|Hormones|hormones|mesh-ancestor
83010933|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83010934|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83010935|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010936|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83010937|NCT02847494|Protective Agents|protective agents|mesh-ancestor
83010938|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83010939|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83010940|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
83010941|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010942|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010943|NCT02554253|Ketamine|ketamine|mesh-list
83010944|NCT02554253|Propofol|propofol|mesh-list
83010945|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83010946|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83010947|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010948|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83010949|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
83010950|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
83010951|NCT02554253|Analgesics|analgesics|mesh-ancestor
83010952|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
83010953|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83010954|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83010955|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83010956|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83010957|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010958|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010959|NCT02239484|Tadalafil|tadalafil|mesh-list
83010960|NCT02239484|Tamsulosin|tamsulosin|mesh-list
83010961|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
83010962|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83010963|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83010964|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010965|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010966|NCT02239484|Urological Agents|urological agents|mesh-ancestor
83010967|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83010968|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83010969|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83010970|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
83010971|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83010972|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010973|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
83010974|NCT03575234|Nivolumab|nivolumab|mesh-list
83010975|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83010976|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
83010977|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83010978|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83010979|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83010980|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
83010981|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010982|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010983|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83010984|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83010985|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83010986|NCT04508855|Heparin|heparin|mesh-list
83010987|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83010988|NCT04508855|Tinzaparin|tinzaparin|mesh-list
83010989|NCT04508855|Dalteparin|dalteparin|mesh-list
83010990|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
83010991|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83010992|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83010993|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010994|NCT03575078|Olaparib|olaparib|mesh-list
83010995|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83010996|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83010997|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83010998|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83010999|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
83011000|NCT03157583|Glycerol|glycerol|mesh-list
83011001|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83011002|NCT03157583|Protective Agents|protective agents|mesh-ancestor
83011003|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011004|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011005|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83011006|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
83011007|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83011008|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83011009|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011010|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
83011011|NCT03570710|Coagulants|coagulants|mesh-ancestor
83011012|NCT01337765|Dactolisib|dactolisib|mesh-list
83011013|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011014|NCT01307033|Losartan|losartan|mesh-list
83011015|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83011016|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83011017|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83011018|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83011019|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011020|NCT04475705|Propofol|propofol|mesh-list
83011021|NCT04475705|Sevoflurane|sevoflurane|mesh-list
83011022|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83011023|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011024|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011025|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83011026|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
83011028|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83011029|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83011030|NCT03158311|Fluticasone|fluticasone|mesh-list
83011031|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
83011032|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83011033|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011034|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83011035|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
83011036|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011037|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011038|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83011039|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83011040|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011041|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83011042|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
83011043|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83011044|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
83011045|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011046|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011047|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83011048|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83011049|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83011050|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
83011051|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83011052|NCT02244866|Hormones|hormones|mesh-ancestor
83011053|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011054|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011055|NCT01334567|Tenofovir|tenofovir|mesh-list
83011056|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
83011057|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011058|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83011059|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83011060|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011061|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011062|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83011063|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83011064|NCT04398329|Bupivacaine|bupivacaine|mesh-list
83011065|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83011066|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
83011067|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011068|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011069|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
83011070|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011071|NCT00449111|Losartan|losartan|mesh-list
83011072|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83011073|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83011074|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83011075|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83011076|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011077|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
83011078|NCT03568916|Apixaban|apixaban|mesh-list
83011079|NCT03568916|Dabigatran|dabigatran|mesh-list
83011080|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83011081|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
83011082|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83011083|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
83011084|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011085|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011086|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
83011087|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
83011088|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
83011089|NCT01334645|Coagulants|coagulants|mesh-ancestor
83011090|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83011091|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83011092|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
83011093|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011094|NCT03571490|Ropivacaine|ropivacaine|mesh-list
83011095|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
83011096|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
83011097|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011098|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011099|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
83011100|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011101|NCT01331993|Naproxen|naproxen|mesh-list
83011102|NCT01331993|Esomeprazole|esomeprazole|mesh-list
83011103|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83011104|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83011105|NCT01331993|Analgesics|analgesics|mesh-ancestor
83011106|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
83011107|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011108|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011109|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011110|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011111|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
83011112|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83011113|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011114|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011115|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83011116|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83011117|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83011118|NCT01338077|Omeprazole|omeprazole|mesh-list
83011119|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83011120|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83011121|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83011122|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011123|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011124|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
83011125|NCT03570320|Narcotics|narcotics|mesh-ancestor
83011126|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011127|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011128|NCT03570320|Analgesics|analgesics|mesh-ancestor
83011129|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
83011130|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011131|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
83011132|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83011133|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011134|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011135|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83011136|NCT04266665|Analgesics|analgesics|mesh-ancestor
83011137|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
83011138|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011139|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83011140|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83011141|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83011142|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
83011143|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011144|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011145|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
83011146|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83011147|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83011148|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011149|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
83011150|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011151|NCT01338311|Albuterol|albuterol|mesh-list
83011152|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83011153|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
83011154|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011155|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011156|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83011157|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83011158|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
83011159|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83011160|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83011161|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83011162|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83011163|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
83011164|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011165|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011166|NCT01334879|Ranibizumab|ranibizumab|mesh-list
83011167|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83011168|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83011169|NCT01334879|Growth Substances|growth substances|mesh-ancestor
83011170|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011171|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
83011172|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011173|NCT01315795|Lanreotide|lanreotide|mesh-list
83011174|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011175|NCT03570164|Sevoflurane|sevoflurane|mesh-list
83011176|NCT03570164|Desflurane|desflurane|mesh-list
83011177|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83011178|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83011179|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
83011181|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011182|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011183|NCT01315951|Petrolatum|petrolatum|mesh-list
83011184|NCT01315951|Emollients|emollients|mesh-ancestor
83011185|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011186|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
83011187|NCT05184049|Epalrestat|epalrestat|mesh-list
83011188|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
83011189|NCT05184049|Vitamins|vitamins|mesh-ancestor
83011190|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
83011191|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011192|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011193|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011194|NCT01336543|Cisplatin|cisplatin|mesh-list
83011195|NCT01336543|Gemcitabine|gemcitabine|mesh-list
83011196|NCT01336543|Etoposide|etoposide|mesh-list
83011197|NCT01336543|Pemetrexed|pemetrexed|mesh-list
83011198|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011199|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83011200|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
83011201|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011202|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83011203|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83011204|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83011205|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011206|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83011207|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83011208|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83011209|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
83011210|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011211|NCT01336621|Ezogabine|ezogabine|mesh-list
83011212|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
83011213|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83011214|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011215|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
83011216|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
83011217|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83011218|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
83011219|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011220|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011221|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83011222|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83011223|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83011224|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83011225|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83011226|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
83011227|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011228|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011229|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011230|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011231|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83011232|NCT01340521|Clomiphene|clomiphene|mesh-list
83011233|NCT01340521|Enclomiphene|enclomiphene|mesh-list
83011234|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
83011235|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83011236|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
83011237|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011238|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011239|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83011240|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
83011241|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83011242|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83011243|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83011244|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83011245|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
83011246|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011247|NCT01340599|Protective Agents|protective agents|mesh-ancestor
83011248|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011249|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83011250|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83011251|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011252|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83011253|NCT01335035|Deferasirox|deferasirox|mesh-list
83011254|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83011255|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
83011256|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
83011257|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011258|NCT01340677|Canagliflozin|canagliflozin|mesh-list
83011259|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83011260|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011261|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83011262|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011263|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
83011264|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83011265|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83011266|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
83011267|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011268|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83011269|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
83011270|NCT01340833|Dabrafenib|dabrafenib|mesh-list
83011271|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011272|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83011273|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011274|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011275|NCT01332383|Naratriptan|naratriptan|mesh-list
83011276|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83011277|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83011278|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83011279|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
83011280|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011281|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011282|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011283|NCT01342237|Carboplatin|carboplatin|mesh-list
83011284|NCT01342237|Etoposide|etoposide|mesh-list
83011285|NCT01342237|Melphalan|melphalan|mesh-list
83011286|NCT01342237|Topotecan|topotecan|mesh-list
83011287|NCT01342237|Thiotepa|thiotepa|mesh-list
83011288|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011289|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83011290|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83011291|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83011292|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011293|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011294|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83011295|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
83011296|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83011297|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83011298|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
83011299|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011300|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83011301|NCT01337323|Fluticasone|fluticasone|mesh-list
83011302|NCT01337323|Xhance|xhance|mesh-list
83011303|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011304|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83011305|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
83011306|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011307|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011308|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83011309|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83011310|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011311|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83011312|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
83011313|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
83011314|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
83011315|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011316|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
83011317|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83011318|NCT04830943|Protective Agents|protective agents|mesh-ancestor
83011319|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011320|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
83011321|NCT04429321|Nivolumab|nivolumab|mesh-list
83011322|NCT04429321|Ipilimumab|ipilimumab|mesh-list
83011323|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011324|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011325|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83011326|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011328|NCT03067610|Cisplatin|cisplatin|mesh-list
83011329|NCT03067610|Carboplatin|carboplatin|mesh-list
83011330|NCT03067610|Cetuximab|cetuximab|mesh-list
83011331|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83011332|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011333|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83011334|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83011335|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83011336|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011337|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011338|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
83011339|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
83011340|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83011341|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
83011342|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011343|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011344|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83011345|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
83011346|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83011347|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83011348|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83011349|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83011350|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011351|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011352|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011353|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011354|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83011355|NCT05182957|Lenalidomide|lenalidomide|mesh-list
83011356|NCT05182957|Azacitidine|azacitidine|mesh-list
83011357|NCT05182957|Antibodies|antibodies|mesh-list
83011358|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
83011359|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83011360|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
83011361|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011362|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83011363|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83011364|NCT05182957|Growth Substances|growth substances|mesh-ancestor
83011365|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
83011366|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011367|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83011368|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
83011369|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011370|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011371|NCT00092651|Simvastatin|simvastatin|mesh-list
83011372|NCT00092651|Ezetimibe|ezetimibe|mesh-list
83011373|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83011374|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83011375|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83011376|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
83011377|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011378|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83011379|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83011380|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011381|NCT04889599|Docetaxel|docetaxel|mesh-list
83011382|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011383|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83011384|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83011385|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83011386|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011387|NCT01342627|Sorafenib|sorafenib|mesh-list
83011388|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011389|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83011390|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011391|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011392|NCT03160703|Fluorides|fluorides|mesh-list
83011393|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
83011394|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
83011395|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
83011396|NCT03160703|Protective Agents|protective agents|mesh-ancestor
83011397|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011398|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
83011399|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
83011400|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83011401|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83011402|NCT01332617|Prednisolone|prednisolone|mesh-list
83361571|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83011403|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
83011404|NCT01332617|Diclofenac|diclofenac|mesh-list
83011405|NCT01332617|Bortezomib|bortezomib|mesh-list
83011406|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83011407|NCT01332617|Simvastatin|simvastatin|mesh-list
83011408|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83011409|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
83011410|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011411|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011412|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
83011413|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
83011414|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011415|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011416|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83011417|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
83011418|NCT01332617|Hormones|hormones|mesh-ancestor
83011419|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011420|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83011421|NCT01332617|Protective Agents|protective agents|mesh-ancestor
83011422|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83011423|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83011424|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83011425|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
83011426|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011427|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83011428|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83011429|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011430|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83011431|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83011432|NCT01332617|Analgesics|analgesics|mesh-ancestor
83011433|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
83011434|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011435|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83011436|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83011437|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
83011438|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83011439|NCT03569696|Nivolumab|nivolumab|mesh-list
83011440|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011441|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011442|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83011443|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011444|NCT00092573|Ezetimibe|ezetimibe|mesh-list
83011445|NCT00092573|Fenofibrate|fenofibrate|mesh-list
83011446|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83011447|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83011448|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
83011449|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011450|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83011451|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83011452|NCT01342939|Incretins|incretins|mesh-list
83011453|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83011454|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011455|NCT01342939|Hormones|hormones|mesh-ancestor
83011456|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011457|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83011458|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
83011459|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011460|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011461|NCT03569540|Glyburide|glyburide|mesh-list
83011462|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83011463|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011464|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
83011465|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83011466|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83011467|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011468|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
83011469|NCT05708690|Coagulants|coagulants|mesh-ancestor
83011470|NCT04851821|Quercetin|quercetin|mesh-list
83011471|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
83011472|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011473|NCT04851821|Protective Agents|protective agents|mesh-ancestor
83011474|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011475|NCT03379727|Midostaurin|midostaurin|mesh-list
83011476|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011477|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83361572|NCT01582061|Pasireotide|pasireotide|mesh-list
83011478|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011479|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011480|NCT02247128|Aspirin|aspirin|mesh-list
83011481|NCT02247128|Clopidogrel|clopidogrel|mesh-list
83011482|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83011483|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83011484|NCT02247128|Analgesics|analgesics|mesh-ancestor
83011485|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
83011486|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011487|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011488|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011489|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011490|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83011491|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83011492|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011493|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83011494|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83011495|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011496|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
83011497|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83011498|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83011499|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83011500|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
83011501|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011502|NCT01339481|Abatacept|abatacept|mesh-list
83011503|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83011504|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011505|NCT01339481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011506|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011507|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83011508|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
83011509|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011510|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011511|NCT01344031|Fulvestrant|fulvestrant|mesh-list
83011512|NCT01344031|Anastrozole|anastrozole|mesh-list
83011513|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83011514|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011515|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83011516|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83011517|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
83011518|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011519|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011520|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83011521|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83011522|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011523|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011524|NCT01332929|Bevacizumab|bevacizumab|mesh-list
83011525|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011526|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011527|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83011528|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83011529|NCT01332929|Growth Substances|growth substances|mesh-ancestor
83011530|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011531|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
83011532|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
83011533|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011534|NCT02247986|Methylphenidate|methylphenidate|mesh-list
83011535|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83011536|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011537|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83011538|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83011539|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83011540|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011541|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
83011542|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011543|NCT03567434|Ethanol|ethanol|mesh-list
83011544|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83011545|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011546|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011547|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361573|NCT01582061|Hormones|hormones|mesh-ancestor
83011550|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011551|NCT05708534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011552|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011553|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83011554|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
83011555|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011556|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011557|NCT03000374|Leucovorin|leucovorin|mesh-list
83011558|NCT03000374|Fluorouracil|fluorouracil|mesh-list
83011559|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
83011560|NCT03000374|Panitumumab|panitumumab|mesh-list
83011561|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
83011562|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011563|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83011564|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011565|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83011566|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
83011567|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011568|NCT03000374|Antidotes|antidotes|mesh-ancestor
83011569|NCT03000374|Protective Agents|protective agents|mesh-ancestor
83011570|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
83011571|NCT03000374|Vitamins|vitamins|mesh-ancestor
83011572|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
83011573|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011574|NCT03566576|Docetaxel|docetaxel|mesh-list
83011575|NCT03566576|Pemetrexed|pemetrexed|mesh-list
83011576|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011577|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83011578|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83011579|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83011580|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011581|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011582|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83011583|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83011584|NCT04377997|Heparin|heparin|mesh-list
83011585|NCT04377997|Calcium heparin|calcium heparin|mesh-list
83011586|NCT04377997|Enoxaparin|enoxaparin|mesh-list
83011587|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83011588|NCT04377997|Tinzaparin|tinzaparin|mesh-list
83011589|NCT04377997|Dalteparin|dalteparin|mesh-list
83011590|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
83011591|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83011592|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83011593|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011594|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
83011595|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011596|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011597|NCT04758949|Nivolumab|nivolumab|mesh-list
83011598|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011599|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011600|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83011601|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011602|NCT03566030|Tenofovir|tenofovir|mesh-list
83011603|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
83011604|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011605|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83011606|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83011607|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011608|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011609|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83011610|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83011611|NCT01333085|Paclitaxel|paclitaxel|mesh-list
83011612|NCT01333085|Carboplatin|carboplatin|mesh-list
83011613|NCT01333085|Everolimus|everolimus|mesh-list
83011614|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83011615|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011616|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
83011617|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
83011618|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
83011619|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011620|NCT01333085|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83011621|NCT01333085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83011622|NCT01333085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011623|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83011624|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
83011625|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011626|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83011627|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83011628|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
83011629|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011630|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011631|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83011632|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83011633|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83011634|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83011635|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83011636|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83011637|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011638|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011639|NCT04734535|Thrombin|thrombin|mesh-list
83011640|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83011641|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
83011642|NCT04734535|Coagulants|coagulants|mesh-ancestor
83011643|NCT03565406|Nivolumab|nivolumab|mesh-list
83011644|NCT03565406|Ipilimumab|ipilimumab|mesh-list
83011645|NCT03565406|Mocetinostat|mocetinostat|mesh-list
83011646|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83011647|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011648|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83011649|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011650|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83011651|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011652|NCT04734379|Fasudil|fasudil|mesh-list
83011653|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83011654|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83011655|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011656|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83011657|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011658|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
83011659|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83011660|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011661|NCT01339871|Vorinostat|vorinostat|mesh-list
83011662|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011663|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83011664|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011665|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011666|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
83011667|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83011668|NCT03564704|Cytarabine|cytarabine|mesh-list
83011669|NCT03564704|Dexamethasone|dexamethasone|mesh-list
83011670|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
83011671|NCT03564704|Methotrexate|methotrexate|mesh-list
83011672|NCT03564704|Etoposide|etoposide|mesh-list
83011673|NCT03564704|Vincristine|vincristine|mesh-list
83011674|NCT03564704|Doxorubicin|doxorubicin|mesh-list
83011675|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
83011676|NCT03564704|Idarubicin|idarubicin|mesh-list
83011677|NCT03564704|Pegaspargase|pegaspargase|mesh-list
83011678|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83011679|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
83011680|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011681|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011682|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83011683|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
83011684|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011685|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011686|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83011687|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011688|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
83011689|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
83011690|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011691|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83011692|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
83011693|NCT03564704|Hormones|hormones|mesh-ancestor
83011694|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011695|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83011696|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83011697|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
83011698|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83011699|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83011700|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
83361574|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011701|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011702|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011703|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83011704|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83011705|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83011706|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83011707|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83011708|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
83011709|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011710|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
83011711|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
83011712|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83011713|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83011714|NCT03564548|Morphine|morphine|mesh-list
83011715|NCT03564548|Oxycodone|oxycodone|mesh-list
83011716|NCT03564548|Hydromorphone|hydromorphone|mesh-list
83011717|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83011718|NCT03564548|Narcotics|narcotics|mesh-ancestor
83011719|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011720|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011721|NCT03564548|Analgesics|analgesics|mesh-ancestor
83011722|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
83011723|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011724|NCT05353010|Tacrolimus|tacrolimus|mesh-list
83011725|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83011726|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
83011727|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011728|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83011729|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011730|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011731|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83011732|NCT05352854|Pilocarpine|pilocarpine|mesh-list
83011733|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83011734|NCT05352854|Miotics|miotics|mesh-ancestor
83011735|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
83011736|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011737|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011738|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83011739|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83011740|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
83011741|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011742|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011743|NCT01841177|Milrinone|milrinone|mesh-list
83011744|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83011745|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83011746|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
83011747|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83011748|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83011749|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011750|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011751|NCT01841177|Protective Agents|protective agents|mesh-ancestor
83011752|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011753|NCT02838134|Rocuronium|rocuronium|mesh-list
83011754|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83011755|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83011756|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83011757|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011758|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011759|NCT03150589|Ranibizumab|ranibizumab|mesh-list
83011760|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83011761|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83011762|NCT03150589|Growth Substances|growth substances|mesh-ancestor
83011763|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011764|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
83011765|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011766|NCT05708300|Vaccines|vaccines|mesh-list
83011767|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
83011768|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011769|NCT05340452|Clarithromycin|clarithromycin|mesh-list
83011770|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83011771|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011772|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83011773|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011774|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011775|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83011776|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83011778|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
83011779|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
83011780|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011781|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011782|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
83011783|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011784|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83011785|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83011786|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83011787|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83011788|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011789|NCT02836652|Aspirin|aspirin|mesh-list
83011790|NCT02836652|Warfarin|warfarin|mesh-list
83011791|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83011792|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83011793|NCT02836652|Analgesics|analgesics|mesh-ancestor
83011794|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
83011795|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011796|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011797|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011798|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011799|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83011800|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83011801|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011802|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83011803|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83011804|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011805|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
83011806|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
83011807|NCT02836496|Prednisone|prednisone|mesh-list
83011808|NCT02836496|Prednisolone|prednisolone|mesh-list
83011809|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011810|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
83011811|NCT02836496|Hormones|hormones|mesh-ancestor
83011812|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83011813|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011814|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83011815|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011816|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
83011817|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83011818|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011819|NCT05250661|Propolis|propolis|mesh-list
83011820|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011821|NCT04044781|BPN14770|bpn14770|mesh-list
83011822|NCT04044781|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83011823|NCT04044781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83011824|NCT04044781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011825|NCT04044781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011826|NCT01345279|Paclitaxel|paclitaxel|mesh-list
83011827|NCT01345279|Topotecan|topotecan|mesh-list
83011828|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83011829|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011830|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
83011831|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
83011832|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
83011833|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011834|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83011835|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83011836|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011837|NCT02833844|Evolocumab|evolocumab|mesh-list
83011838|NCT02833844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83011839|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83011840|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83011841|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
83011842|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011843|NCT02833844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83011844|NCT02833844|Protease Inhibitors|protease inhibitors|mesh-ancestor
83011845|NCT02833844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011846|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83011847|NCT01345357|Gemcitabine|gemcitabine|mesh-list
83011848|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011849|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83011850|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
83011851|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011852|NCT01333631|Valproic Acid|valproic acid|mesh-list
83011853|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
83011854|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011855|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011856|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
83011857|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011858|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011859|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
83011860|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83011861|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011862|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83011863|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
83011864|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83011865|NCT04611763|Analgesics|analgesics|mesh-ancestor
83011866|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
83011867|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011868|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011869|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83011870|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83011871|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011872|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011873|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83011874|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011875|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011876|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
83011877|NCT01341782|Calcitriol|calcitriol|mesh-list
83011878|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
83011879|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83011880|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011881|NCT01341782|Vitamins|vitamins|mesh-ancestor
83011882|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
83011883|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83011884|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011885|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011886|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83011887|NCT01341782|Protective Agents|protective agents|mesh-ancestor
83011888|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83011889|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83011890|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011891|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83011892|NCT02607319|Bemiparin|bemiparin|mesh-list
83011893|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
83011894|NCT02250157|Irinotecan|irinotecan|mesh-list
83011895|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83011896|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83011897|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011898|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011899|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011900|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
83011901|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83011902|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
83011903|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011904|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
83011905|NCT03564158|Meropenem|meropenem|mesh-list
83011906|NCT03564158|Vaborbactam|vaborbactam|mesh-list
83011907|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83011908|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83011909|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83011910|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83011911|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011912|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011913|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011914|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83011915|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
83011916|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83011917|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83011918|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83011919|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83011920|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011921|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
83011922|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83011923|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011924|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83011925|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011927|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
83011928|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
83011929|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83011930|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011931|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
83011932|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011933|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83011934|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83011935|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83011936|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83011937|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011938|NCT00871351|Atorvastatin|atorvastatin|mesh-list
83011939|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83011940|NCT00871351|Ezetimibe|ezetimibe|mesh-list
83011941|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83011942|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83011943|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
83011944|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011945|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83011946|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83011947|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011948|NCT04920331|Erenumab|erenumab|mesh-list
83011949|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83011950|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011951|NCT04920331|Analgesics|analgesics|mesh-ancestor
83011952|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
83011953|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011954|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011955|NCT02745080|Adalimumab|adalimumab|mesh-list
83011956|NCT02745080|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83011957|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011958|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011959|NCT01346137|Meloxicam|meloxicam|mesh-list
83011960|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83011961|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83011962|NCT01346137|Analgesics|analgesics|mesh-ancestor
83011963|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
83011964|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83011965|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011966|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011967|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83011968|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83011969|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83011970|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011971|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011972|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
83011973|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83011974|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
83011975|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83011976|NCT00442897|Atorvastatin|atorvastatin|mesh-list
83011977|NCT00442897|Simvastatin|simvastatin|mesh-list
83011978|NCT00442897|Ezetimibe|ezetimibe|mesh-list
83011979|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83011980|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83011981|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
83011982|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011983|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83431225|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83011984|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83011985|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83011986|NCT01346215|Heparin|heparin|mesh-list
83011987|NCT01346215|Calcium heparin|calcium heparin|mesh-list
83011988|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
83011989|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83011990|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83011991|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011992|NCT02834390|Cytarabine|cytarabine|mesh-list
83011993|NCT02834390|Daunorubicin|daunorubicin|mesh-list
83011994|NCT02834390|Idarubicin|idarubicin|mesh-list
83011995|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83011996|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
83011997|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83011998|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83011999|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
83012000|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012001|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83012002|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
83012003|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012004|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83012005|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83012006|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83012007|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012009|NCT01317433|Cetuximab|cetuximab|mesh-list
83012010|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012011|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012012|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012013|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012014|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
83012015|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83012016|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83012017|NCT01317511|Caseins|caseins|mesh-list
83012018|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
83012019|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
83012020|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012021|NCT01356602|Triamcinolone|triamcinolone|mesh-list
83012022|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83012023|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83012024|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83012025|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83012026|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012027|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
83012028|NCT01356602|Hormones|hormones|mesh-ancestor
83012029|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012030|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012031|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83012032|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
83012033|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012034|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012035|NCT01347853|Ketorolac|ketorolac|mesh-list
83012036|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83012037|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83012038|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83012039|NCT01347853|Analgesics|analgesics|mesh-ancestor
83012040|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
83012041|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012042|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012043|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012044|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012045|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83012046|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012047|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012048|NCT01346917|Lidocaine|lidocaine|mesh-list
83012049|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
83012050|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
83012051|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012052|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012053|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
83012054|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012055|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83012056|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83012057|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83012058|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83012059|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012060|NCT01348009|Cisplatin|cisplatin|mesh-list
83012061|NCT01348009|Capecitabine|capecitabine|mesh-list
83012062|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012063|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83012064|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
83012065|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012066|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
83012067|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012068|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83012069|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012070|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012071|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
83012072|NCT01348243|Lidocaine|lidocaine|mesh-list
83361575|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012073|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
83012074|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
83012075|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012076|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012077|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
83012078|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012079|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83012080|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83012081|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83012082|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83012083|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012084|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83012085|NCT01348321|Levamisole|levamisole|mesh-list
83012086|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83012087|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
83012088|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012089|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
83012090|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
83012091|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83012092|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012093|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012094|NCT03772951|Clozapine|clozapine|mesh-list
83012095|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83012096|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
83012097|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012098|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012099|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012100|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83012101|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83012102|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012103|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83012104|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
83012105|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
83012106|NCT01343329|Propranolol|propranolol|mesh-list
83012107|NCT01343329|Esmolol|esmolol|mesh-list
83012108|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83012109|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83012110|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
83012111|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012112|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012113|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012114|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83012115|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83012116|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
83012117|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83012118|NCT01317589|Fentanyl|fentanyl|mesh-list
83012119|NCT01317589|Methadone|methadone|mesh-list
83012120|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83012121|NCT01317589|Narcotics|narcotics|mesh-ancestor
83012122|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012123|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012124|NCT01317589|Analgesics|analgesics|mesh-ancestor
83012125|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
83012126|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012127|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83012128|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83012129|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
83012130|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
83012131|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
83012132|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
83012133|NCT02825420|Trabectedin|trabectedin|mesh-list
83012134|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83012135|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
83012136|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012137|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012138|NCT02829944|Ketorolac|ketorolac|mesh-list
83012139|NCT02829944|Ropivacaine|ropivacaine|mesh-list
83012140|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
83012141|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
83012142|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012143|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012144|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
83012145|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012146|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83012147|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83012148|NCT02829944|Analgesics|analgesics|mesh-ancestor
83012149|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012150|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012151|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83012152|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012153|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012154|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
83012155|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012156|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012157|NCT04014530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83012158|NCT04014530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012159|NCT03563534|Fluorides|fluorides|mesh-list
83012160|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
83012161|NCT03563534|Protective Agents|protective agents|mesh-ancestor
83012162|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012163|NCT03563144|Leucovorin|leucovorin|mesh-list
83012164|NCT03563144|Paclitaxel|paclitaxel|mesh-list
83012165|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
83012166|NCT03563144|Bevacizumab|bevacizumab|mesh-list
83012167|NCT03563144|Gemcitabine|gemcitabine|mesh-list
83012168|NCT03563144|Fluorouracil|fluorouracil|mesh-list
83012169|NCT03563144|Capecitabine|capecitabine|mesh-list
83012170|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
83012171|NCT03563144|Avelumab|avelumab|mesh-list
83012172|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83012173|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012174|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
83012175|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
83012176|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
83012177|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012178|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83012179|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
83012180|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012181|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012182|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83012183|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
83012184|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83012185|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012186|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83012187|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83012188|NCT03563144|Growth Substances|growth substances|mesh-ancestor
83012189|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83012190|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83012191|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
83012192|NCT03563144|Antidotes|antidotes|mesh-ancestor
83012193|NCT03563144|Protective Agents|protective agents|mesh-ancestor
83012194|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
83012195|NCT03563144|Vitamins|vitamins|mesh-ancestor
83012196|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
83012197|NCT01338818|Methylphenidate|methylphenidate|mesh-list
83012198|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83012199|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012200|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83012201|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83012202|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83012203|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012204|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
83012205|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012206|NCT05310110|Lidocaine|lidocaine|mesh-list
83012207|NCT05310110|Propofol|propofol|mesh-list
83012208|NCT05310110|Cisatracurium|cisatracurium|mesh-list
83012209|NCT05310110|Atracurium|atracurium|mesh-list
83012210|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
83012211|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
83012212|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012213|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012214|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
83012215|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012216|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83012217|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83012218|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83012219|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83012220|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012221|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83361576|NCT01693523|Minocycline|minocycline|mesh-list
83012222|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83012223|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
83012224|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83012225|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83012226|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83012227|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83012228|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83012229|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
83012230|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012231|NCT02823470|Ivacaftor|ivacaftor|mesh-list
83012232|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83012233|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83012234|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012235|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
83012236|NCT04697576|Nivolumab|nivolumab|mesh-list
83012237|NCT04697576|Ipilimumab|ipilimumab|mesh-list
83012238|NCT04697576|Vaccines|vaccines|mesh-list
83012239|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
83012240|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012241|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012242|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012243|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83012244|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012245|NCT03562754|Heparin|heparin|mesh-list
83012246|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
83012247|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012248|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83012249|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83012250|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
83012251|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
83012252|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
83012253|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012254|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012255|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
83012256|NCT01371656|Levofloxacin|levofloxacin|mesh-list
83012257|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83012258|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012259|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012260|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83012261|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83012262|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012263|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012264|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012265|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83012266|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83012267|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83012268|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83012269|NCT01354964|Vitamin D|vitamin d|mesh-list
83012270|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
83012271|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
83012272|NCT01354964|Vitamins|vitamins|mesh-list
83012273|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
83012274|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012275|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83012276|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83012277|NCT02259998|Dipyridamole|dipyridamole|mesh-list
83012278|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83012279|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012280|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012281|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83012282|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
83012283|NCT02035904|Morphine|morphine|mesh-list
83012284|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
83012285|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83012286|NCT02035904|Narcotics|narcotics|mesh-ancestor
83012287|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012288|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012289|NCT02035904|Analgesics|analgesics|mesh-ancestor
83012290|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
83012291|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012292|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
83012293|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
83012294|NCT04110080|Anesthetics|anesthetics|mesh-list
83012295|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012296|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012297|NCT02035982|Rivastigmine|rivastigmine|mesh-list
83012298|NCT02035982|Donepezil|donepezil|mesh-list
83012299|NCT02035982|Galantamine|galantamine|mesh-list
83012300|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83012301|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012302|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012303|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
83012304|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012305|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012306|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
83012307|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83012308|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
83012309|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012310|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83012311|NCT02035982|Protective Agents|protective agents|mesh-ancestor
83012312|NCT05707832|Amphotericin B|amphotericin b|mesh-list
83012313|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83012314|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
83012315|NCT05707832|Amebicides|amebicides|mesh-ancestor
83012316|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83012317|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83012318|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012319|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012320|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
83012321|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83012322|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
83012323|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012324|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012325|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83012326|NCT05707832|Protective Agents|protective agents|mesh-ancestor
83012327|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012328|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012329|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
83012330|NCT02822222|Cathartics|cathartics|mesh-ancestor
83012331|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83012332|NCT02821910|Metformin|metformin|mesh-list
83012333|NCT02821910|Empagliflozin|empagliflozin|mesh-list
83012334|NCT02821910|Linagliptin|linagliptin|mesh-list
83012335|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012336|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012337|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83012338|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012339|NCT02821910|Incretins|incretins|mesh-ancestor
83012340|NCT02821910|Hormones|hormones|mesh-ancestor
83012341|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012342|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83012343|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
83012344|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012345|NCT03819452|Vitamin D|vitamin d|mesh-list
83012346|NCT03819452|Vitamins|vitamins|mesh-ancestor
83012347|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
83012348|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012349|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83012350|NCT03138655|Vedolizumab|vedolizumab|mesh-list
83012351|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83012352|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
83012353|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83012354|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012355|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83012356|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
83012357|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012358|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012359|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012360|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012361|NCT04412785|Cyclosporine|cyclosporine|mesh-list
83012362|NCT04412785|Cyclosporins|cyclosporins|mesh-list
83012363|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012364|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012365|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83012366|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
83012367|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012368|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
83012369|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012370|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83012371|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012372|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83012373|NCT01352611|Baclofen|baclofen|mesh-list
83012374|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83012375|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012376|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83012377|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012378|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83012379|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
83012380|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
83012381|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012382|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012383|NCT02819804|Nivolumab|nivolumab|mesh-list
83012384|NCT02819804|Dasatinib|dasatinib|mesh-list
83012385|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012386|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012387|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83012388|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012389|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83012390|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012391|NCT02819726|Rituximab|rituximab|mesh-list
83012392|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012393|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012394|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
83012395|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012396|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012397|NCT02816138|Nicotine|nicotine|mesh-list
83012398|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83012399|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
83012400|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012401|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012402|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83012403|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83012404|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
83012405|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012406|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012407|NCT02036060|Prednisone|prednisone|mesh-list
83012408|NCT02036060|Docetaxel|docetaxel|mesh-list
83012409|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012410|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
83012411|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
83012412|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
83012413|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012414|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012415|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
83012416|NCT02036060|Hormones|hormones|mesh-ancestor
83012417|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012418|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012419|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83012420|NCT02036372|Insulin|insulin|mesh-list
83012421|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83012422|NCT02036372|Liraglutide|liraglutide|mesh-list
83012423|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012424|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012425|NCT02036372|Incretins|incretins|mesh-ancestor
83012426|NCT02036372|Hormones|hormones|mesh-ancestor
83012427|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012428|NCT02036528|Doxycycline|doxycycline|mesh-list
83012429|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
83012430|NCT02036528|Gentamicins|gentamicins|mesh-list
83012431|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012432|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012433|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
83012434|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83012435|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83012436|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83012437|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83012438|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012439|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012440|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012441|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83012442|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83012443|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83012444|NCT02880865|Vaccines|vaccines|mesh-list
83012445|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
83012446|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012447|NCT03635125|Metoprolol|metoprolol|mesh-list
83012448|NCT03635125|Nebivolol|nebivolol|mesh-list
83012449|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83012450|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83012451|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
83012452|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
83012453|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012454|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012455|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83012456|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83012457|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83012458|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83012459|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012460|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012461|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
83012462|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83012463|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83012464|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83012465|NCT01854385|Sumatriptan|sumatriptan|mesh-list
83012466|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83012467|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83012468|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83012469|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
83012470|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012471|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012472|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012473|NCT02047838|Hormones|hormones|mesh-list
83012474|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83012475|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012476|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012477|NCT01318681|Fluticasone|fluticasone|mesh-list
83012478|NCT01318681|Xhance|xhance|mesh-list
83012479|NCT01318681|Cetirizine|cetirizine|mesh-list
83012480|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012481|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83012482|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
83012483|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012484|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012485|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83012486|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
83012487|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
83012488|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83012489|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83012490|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83012491|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
83012492|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
83012493|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012494|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012495|NCT03604159|Buprenorphine|buprenorphine|mesh-list
83012496|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83012497|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83012498|NCT03604159|Narcotics|narcotics|mesh-ancestor
83012499|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012500|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012501|NCT03604159|Analgesics|analgesics|mesh-ancestor
83012502|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
83012503|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012504|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83012505|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83012506|NCT01353235|Prednisolone|prednisolone|mesh-list
83012507|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012508|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
83012509|NCT01353235|Hormones|hormones|mesh-ancestor
83012510|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012511|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012512|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83012513|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012514|NCT02048228|Clopidogrel|clopidogrel|mesh-list
83012515|NCT02048228|Ticagrelor|ticagrelor|mesh-list
83012516|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83012517|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83012518|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83012519|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83012520|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
83012521|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012522|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012523|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012525|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
83012526|NCT03046927|Vitamins|vitamins|mesh-ancestor
83012527|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
83012528|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012529|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83012530|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83012531|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
83012532|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83012533|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
83012534|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012535|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012536|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83012537|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
83012538|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83012539|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83012540|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83012541|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
83012542|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012543|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012544|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
83012545|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
83012546|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012547|NCT02048384|Metformin|metformin|mesh-list
83012548|NCT02048384|Sirolimus|sirolimus|mesh-list
83012549|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012550|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012551|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012552|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012553|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83012554|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012555|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
83012556|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83012557|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
83012558|NCT01353391|Metformin|metformin|mesh-list
83012559|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012560|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012561|NCT01349335|Tolvaptan|tolvaptan|mesh-list
83012562|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83012563|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012564|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
83012565|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012566|NCT03009487|Amlodipine|amlodipine|mesh-list
83012567|NCT03009487|Olmesartan|olmesartan|mesh-list
83012568|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83012569|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
83012570|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83012571|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83012572|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83012573|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83012574|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012575|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83012576|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012577|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83012578|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83012579|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83012580|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
83012581|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83012582|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83012583|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012584|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83012585|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83012586|NCT02048540|Bevacizumab|bevacizumab|mesh-list
83012587|NCT02048540|Docetaxel|docetaxel|mesh-list
83012588|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
83012589|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012590|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012591|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83012592|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83012593|NCT02048540|Growth Substances|growth substances|mesh-ancestor
83012594|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012595|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
83012596|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
83012597|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
83012598|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
83012599|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012600|NCT01353469|Insulin|insulin|mesh-list
83012601|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83012602|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012603|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012604|NCT03562130|Teduglutide|teduglutide|mesh-list
83012605|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83012606|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83012607|NCT03562130|Protective Agents|protective agents|mesh-ancestor
83012608|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012609|NCT02050178|Paclitaxel|paclitaxel|mesh-list
83012610|NCT02050178|Gemcitabine|gemcitabine|mesh-list
83012611|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83012612|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012613|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
83012614|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
83012615|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
83012616|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012617|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83012618|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
83012619|NCT02048852|Menthol|menthol|mesh-list
83012620|NCT02048852|Nicotine|nicotine|mesh-list
83012621|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83012622|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
83012623|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012624|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012625|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83012626|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83012627|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
83012628|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012629|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012630|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
83012631|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83012632|NCT02048930|Budesonide|budesonide|mesh-list
83012633|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012634|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83012635|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
83012636|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012637|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012638|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83012639|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
83012640|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
83012641|NCT02048930|Hormones|hormones|mesh-ancestor
83012642|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012643|NCT02049320|Remifentanil|remifentanil|mesh-list
83012644|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83012645|NCT02049320|Narcotics|narcotics|mesh-ancestor
83012646|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012647|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012648|NCT02049320|Analgesics|analgesics|mesh-ancestor
83012649|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
83012650|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012651|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
83012652|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83012653|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012654|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
83012655|NCT02050802|Macitentan|macitentan|mesh-list
83012656|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012657|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012658|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83012659|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83012660|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012661|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012662|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012663|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83012664|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83012665|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83012666|NCT02051738|Mebendazole|mebendazole|mesh-list
83012667|NCT02051738|Piperazine|piperazine|mesh-list
83012668|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
83012669|NCT02051738|DMP 777|dmp 777|mesh-list
83012670|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
83012671|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
83012672|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83012673|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012674|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
83012675|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
83012676|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
83012677|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012678|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012679|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012680|NCT02050958|Ibuprofen|ibuprofen|mesh-list
83012681|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83012682|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83012683|NCT02050958|Analgesics|analgesics|mesh-ancestor
83012684|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
83012685|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012686|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012687|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012688|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012689|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83012690|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012691|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012692|NCT02037464|Capsaicin|capsaicin|mesh-list
83012693|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
83012694|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83012695|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
83012696|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012697|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012698|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
83012699|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012700|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012701|NCT02051894|Dobutamine|dobutamine|mesh-list
83012702|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83012703|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
83012704|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
83012705|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012706|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012707|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83012708|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83012709|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83012710|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
83012711|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012712|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012713|NCT02051894|Protective Agents|protective agents|mesh-ancestor
83012714|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83012715|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
83012716|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012717|NCT01357681|Protective Agents|protective agents|mesh-ancestor
83012718|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012719|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83012720|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83012721|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012722|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83012723|NCT01543633|Propofol|propofol|mesh-list
83012724|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83012725|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012726|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012727|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83012728|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
83012729|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
83012730|NCT03561740|Capecitabine|capecitabine|mesh-list
83012731|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83012732|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
83012733|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012734|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012735|NCT01357759|Gimsilumab|gimsilumab|mesh-list
83012736|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012737|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
83012738|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012739|NCT02052128|Onapristone|onapristone|mesh-list
83012740|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012741|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83012742|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
83012743|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83012744|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012745|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
83012746|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012747|NCT01349413|Esomeprazole|esomeprazole|mesh-list
83361577|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012748|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83012749|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83012750|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83012751|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012752|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012754|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
83012755|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012756|NCT02806232|Praziquantel|praziquantel|mesh-list
83012757|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
83012758|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83012759|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012760|NCT02908087|Liraglutide|liraglutide|mesh-list
83012761|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012762|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012763|NCT02908087|Incretins|incretins|mesh-ancestor
83012764|NCT02908087|Hormones|hormones|mesh-ancestor
83012765|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012766|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
83012767|NCT02053766|Propofol|propofol|mesh-list
83012768|NCT02053766|Sevoflurane|sevoflurane|mesh-list
83012769|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83012770|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012771|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012772|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83012773|NCT02053766|Analgesics|analgesics|mesh-ancestor
83012774|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
83012775|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012776|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83012777|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83012778|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83012779|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
83012780|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012781|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012782|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83012783|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
83012784|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
83012785|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83012786|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83012787|NCT02053922|Misoprostol|misoprostol|mesh-list
83012788|NCT02053922|Oxytocin|oxytocin|mesh-list
83012789|NCT02053922|Carbetocin|carbetocin|mesh-list
83012790|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83012791|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
83012792|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83012793|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012794|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83012795|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83012796|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
83012797|NCT02054000|Tirofiban|tirofiban|mesh-list
83012798|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83012799|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83012800|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012801|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83012802|NCT02054078|Bevacizumab|bevacizumab|mesh-list
83012803|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83012804|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012805|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83012806|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83012807|NCT02054078|Growth Substances|growth substances|mesh-ancestor
83012808|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012809|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
83012810|NCT00392327|Vitamin A|vitamin a|mesh-list
83012811|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
83012812|NCT00392327|Cisplatin|cisplatin|mesh-list
83012813|NCT00392327|Carboplatin|carboplatin|mesh-list
83012814|NCT00392327|Vincristine|vincristine|mesh-list
83012815|NCT00392327|Tretinoin|tretinoin|mesh-list
83012816|NCT00392327|Isotretinoin|isotretinoin|mesh-list
83012817|NCT00392327|Lenograstim|lenograstim|mesh-list
83012818|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83012819|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
83012820|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012821|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012822|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83012823|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
83012824|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012825|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012826|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83012827|NCT00392327|Vitamins|vitamins|mesh-ancestor
83012828|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
83012829|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83012830|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83012831|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
83012832|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
83012833|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
83012834|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
83012835|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
83012836|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
83012837|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83012838|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83012839|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83012840|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83012841|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012842|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83012843|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83012844|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012845|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83012846|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012847|NCT01336595|Cobalt|cobalt|mesh-list
83012848|NCT01336595|Triamcinolone|triamcinolone|mesh-list
83012849|NCT01336595|Trace Elements|trace elements|mesh-ancestor
83012850|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
83012851|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012852|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012853|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
83012854|NCT01336595|Hormones|hormones|mesh-ancestor
83012855|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012856|NCT01336751|Insulin|insulin|mesh-list
83012857|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83012858|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
83012859|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
83012860|NCT01336751|Protamines|protamines|mesh-list
83012861|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83012862|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012863|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
83012864|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012865|NCT01336751|Coagulants|coagulants|mesh-ancestor
83012866|NCT01336829|Rilpivirine|rilpivirine|mesh-list
83012867|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83012868|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83012869|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012870|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012871|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
83012872|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012873|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83012874|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83012875|NCT02960490|Quetmolimab|quetmolimab|mesh-list
83012876|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012877|NCT05184179|Olmesartan|olmesartan|mesh-list
83012878|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83012879|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83012880|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83012881|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83012882|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
83012883|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012884|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83012885|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83012886|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012887|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83012888|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83012889|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83012890|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83012891|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
83012892|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012893|NCT01065012|Udenafil|udenafil|mesh-list
83012894|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83012895|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83012896|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012897|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012898|NCT01315691|Amikacin|amikacin|mesh-list
83012899|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012900|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012903|NCT05654090|Sulperazone|sulperazone|mesh-list
83012904|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83012905|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012906|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83012907|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012908|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012909|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83012910|NCT02054468|Remifentanil|remifentanil|mesh-list
83012911|NCT02054468|Propofol|propofol|mesh-list
83012912|NCT02054468|Rocuronium|rocuronium|mesh-list
83012913|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83012914|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83012915|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012916|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83012917|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
83012918|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
83012919|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83012920|NCT02054468|Narcotics|narcotics|mesh-ancestor
83012921|NCT02054468|Analgesics|analgesics|mesh-ancestor
83012922|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
83012923|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012924|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83012925|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83012926|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83012927|NCT03640650|Triamcinolone|triamcinolone|mesh-list
83012928|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83012929|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83012930|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83012931|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83012932|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83012933|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83012934|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
83012935|NCT03640650|Hormones|hormones|mesh-ancestor
83012936|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012937|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012938|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83012939|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
83012940|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012941|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012942|NCT05183555|Edotreotide|edotreotide|mesh-list
83012943|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83012944|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012945|NCT02052908|Naproxen|naproxen|mesh-list
83012946|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83012947|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83012948|NCT02052908|Analgesics|analgesics|mesh-ancestor
83012949|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
83012950|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83012951|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012952|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012953|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83012954|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
83012955|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83012956|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012957|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012958|NCT01336985|Irinotecan|irinotecan|mesh-list
83012959|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83012960|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83012961|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83012962|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012963|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012964|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83012965|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
83012966|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
83012967|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012968|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
83012969|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012970|NCT03635411|Niacinamide|niacinamide|mesh-list
83012971|NCT03635411|Niacin|niacin|mesh-list
83012972|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
83012973|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
83012974|NCT03635411|Vitamins|vitamins|mesh-ancestor
83012975|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
83012976|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012977|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83012978|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
83012979|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83012980|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83012981|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
83012982|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83012983|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83012984|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
83012985|NCT02748512|Hormones|hormones|mesh-ancestor
83012986|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83012987|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83012988|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
83012989|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
83012990|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
83012991|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012992|NCT02053142|Acyclovir|acyclovir|mesh-list
83012993|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
83012994|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83012995|NCT01316549|Fludarabine|fludarabine|mesh-list
83012996|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83012997|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83012998|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
83012999|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013000|NCT01341743|Entecavir|entecavir|mesh-list
83013001|NCT01341743|Adefovir|adefovir|mesh-list
83013002|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83013003|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
83013004|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013005|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83013006|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83013007|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013008|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013009|NCT01341275|Vaccines|vaccines|mesh-list
83013010|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
83013011|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013012|NCT01353937|Plerixafor|plerixafor|mesh-list
83013013|NCT01353937|Becaplermin|becaplermin|mesh-list
83013014|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83013015|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83013016|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
83013017|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013018|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
83013019|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83013020|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83013021|NCT01353937|Growth Substances|growth substances|mesh-ancestor
83013022|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013023|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83013024|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83013025|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
83013026|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013027|NCT02053298|Timolol|timolol|mesh-list
83013028|NCT02053298|Dorzolamide|dorzolamide|mesh-list
83013029|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83013030|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83013031|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
83013032|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013033|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013034|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013035|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83013036|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83013037|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83013038|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013039|NCT02054936|Warfarin|warfarin|mesh-list
83013040|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
83013041|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
83013042|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83013043|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
83013044|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83013045|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
83013046|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013047|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013048|NCT04782791|Nivolumab|nivolumab|mesh-list
83013049|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013050|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013051|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83013052|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013053|NCT01341353|Amiodarone|amiodarone|mesh-list
83013054|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
83013055|NCT01341353|Calcium|calcium|mesh-list
83013056|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83013057|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013058|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83013059|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
83013060|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83013061|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013062|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013063|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83013064|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83013065|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83013066|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013067|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83013068|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83013069|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83013070|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
83013071|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83013072|NCT02056184|Adalimumab|adalimumab|mesh-list
83013073|NCT02056184|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83013074|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013075|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013076|NCT02800928|Aticaprant|aticaprant|mesh-list
83013077|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83013078|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013079|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
83013080|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013081|NCT02056418|Prednisone|prednisone|mesh-list
83013082|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
83013083|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013084|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
83013085|NCT02056418|Hormones|hormones|mesh-ancestor
83013086|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013087|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013088|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83013089|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013090|NCT02055014|Liraglutide|liraglutide|mesh-list
83013091|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83013092|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013093|NCT02055014|Incretins|incretins|mesh-ancestor
83013094|NCT02055014|Hormones|hormones|mesh-ancestor
83013095|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013096|NCT02055170|Finasteride|finasteride|mesh-list
83013097|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83013098|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83013099|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013100|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013101|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
83013102|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013103|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013104|NCT02055170|Urological Agents|urological agents|mesh-ancestor
83013105|NCT04490993|Epirubicin|epirubicin|mesh-list
83013106|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83013107|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013108|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83013109|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83013110|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013111|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013112|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
83013113|NCT02055482|Hematinics|hematinics|mesh-ancestor
83013114|NCT02059460|Terlipressin|terlipressin|mesh-list
83013115|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83013116|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83013117|NCT02055716|Sulforaphane|sulforaphane|mesh-list
83013118|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83013119|NCT02055716|Protective Agents|protective agents|mesh-ancestor
83013120|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013121|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013122|NCT04739735|Anesthetics|anesthetics|mesh-list
83013123|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013124|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013125|NCT02059616|Amlodipine|amlodipine|mesh-list
83361578|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013126|NCT02059616|Candesartan|candesartan|mesh-list
83013127|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
83013128|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83013129|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83013130|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013131|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013132|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83013133|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013134|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
83013135|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83013136|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83013137|NCT04356209|Pravastatin|pravastatin|mesh-list
83013138|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83013139|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83013140|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
83013141|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013142|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83013143|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83013144|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013145|NCT02059694|Lidocaine|lidocaine|mesh-list
83013146|NCT02059694|Epinephrine|epinephrine|mesh-list
83013147|NCT02059694|Racepinephrine|racepinephrine|mesh-list
83013148|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
83013149|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
83013150|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
83013151|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013152|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013153|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
83013154|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013155|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83013156|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83013157|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83013158|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013159|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013160|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83013161|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83013162|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
83013163|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013164|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83013165|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83013166|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
83013167|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83013168|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
83013169|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
83013170|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
83013171|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83013172|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83013173|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
83013174|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013175|NCT02056730|Calcium|calcium|mesh-list
83013176|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83013177|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013178|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
83013179|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83013180|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013181|NCT01337219|Tobramycin|tobramycin|mesh-list
83013182|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83013183|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013184|NCT03560804|Olmesartan|olmesartan|mesh-list
83013185|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
83013186|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83013187|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83013188|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83013189|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013190|NCT03560804|Diuretics|diuretics|mesh-ancestor
83013191|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
83013192|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013193|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83013194|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013195|NCT03150719|Ivacaftor|ivacaftor|mesh-list
83013196|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83013197|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013198|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013199|NCT02059772|Ranibizumab|ranibizumab|mesh-list
83361579|NCT03924323|Escitalopram|escitalopram|mesh-list
83013200|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83013201|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83013202|NCT02059772|Growth Substances|growth substances|mesh-ancestor
83013203|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013204|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
83013205|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013206|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83013207|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83013208|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013209|NCT01344083|Analgesics|analgesics|mesh-ancestor
83013210|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
83013211|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013212|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013213|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013214|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013215|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83013216|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83013217|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83013218|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
83013219|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
83013220|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013221|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013222|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
83013223|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83013224|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
83013225|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013226|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013227|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83013228|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
83013229|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013230|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013231|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83013232|NCT00982111|Pemetrexed|pemetrexed|mesh-list
83013233|NCT00982111|Necitumumab|necitumumab|mesh-list
83013234|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013235|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013236|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013237|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83013238|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83013239|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013240|NCT02957682|Alirocumab|alirocumab|mesh-list
83013241|NCT02957682|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83013242|NCT02957682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83013243|NCT02957682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83013244|NCT02957682|Antimetabolites|antimetabolites|mesh-ancestor
83013245|NCT02957682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013246|NCT02957682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83013247|NCT02957682|Protease Inhibitors|protease inhibitors|mesh-ancestor
83013248|NCT02957682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013249|NCT02957682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83013250|NCT03057951|Empagliflozin|empagliflozin|mesh-list
83013251|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83013252|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013253|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83013254|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013255|NCT02060318|Infliximab|infliximab|mesh-list
83013256|NCT02060318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83013257|NCT02060318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013258|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83013259|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013260|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013261|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
83013262|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83013263|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83013264|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
83013265|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013266|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013267|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013268|NCT01318837|Urological Agents|urological agents|mesh-ancestor
83013269|NCT01350037|Remifentanil|remifentanil|mesh-list
83013270|NCT01350037|Alfentanil|alfentanil|mesh-list
83013271|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83013272|NCT01350037|Narcotics|narcotics|mesh-ancestor
83013273|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013274|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013275|NCT01350037|Analgesics|analgesics|mesh-ancestor
83013276|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
83013277|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013278|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83013279|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
83013280|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
83013281|NCT02060006|Meloxicam|meloxicam|mesh-list
83013282|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83013283|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83013284|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013285|NCT02060006|Analgesics|analgesics|mesh-ancestor
83013286|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
83013287|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013288|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013289|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013290|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013291|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83013292|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013293|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013294|NCT03620435|Atezolizumab|atezolizumab|mesh-list
83013295|NCT03620435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83013296|NCT03620435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013297|NCT03620435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013298|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013299|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
83013300|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
83013301|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013302|NCT04686773|Vaccines|vaccines|mesh-list
83431338|NCT00450983|Thiotepa|thiotepa|mesh-list
83013303|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
83013304|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013305|NCT02956278|Allopurinol|allopurinol|mesh-list
83013306|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
83013307|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013308|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013309|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
83013310|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013311|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83013312|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
83013313|NCT02956278|Protective Agents|protective agents|mesh-ancestor
83013314|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013315|NCT02060396|Aspirin|aspirin|mesh-list
83013316|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83013317|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013318|NCT02060396|Analgesics|analgesics|mesh-ancestor
83013319|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
83013320|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013321|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013322|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013323|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013324|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83013325|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83013326|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013327|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83013328|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83013329|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013330|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
83013331|NCT01358071|Doxorubicin|doxorubicin|mesh-list
83013332|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83013333|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83013334|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013335|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83013336|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83013337|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013338|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013339|NCT02058212|Vitamin E|vitamin e|mesh-list
83013340|NCT02058212|Selenium|selenium|mesh-list
83013341|NCT02058212|Vitamins|vitamins|mesh-ancestor
83013342|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
83013343|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013344|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
83013345|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013346|NCT02058212|Protective Agents|protective agents|mesh-ancestor
83013347|NCT02058212|Trace Elements|trace elements|mesh-ancestor
83013348|NCT02058446|Amlodipine|amlodipine|mesh-list
83013349|NCT02058446|Valsartan|valsartan|mesh-list
83013350|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83013351|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83013352|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83013353|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013354|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013355|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83013356|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013357|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
83013358|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83013359|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83013360|NCT02842827|Tretinoin|tretinoin|mesh-list
83013361|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013362|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
83013363|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83013364|NCT01354405|Lanreotide|lanreotide|mesh-list
83013365|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013366|NCT03363035|Enoxaparin|enoxaparin|mesh-list
83013367|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
83013368|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83013369|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
83013370|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83013371|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
83013372|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013373|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013374|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
83013375|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83013376|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83013377|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
83013378|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
83013379|NCT02582775|Busulfan|busulfan|mesh-list
83013380|NCT02582775|Fludarabine|fludarabine|mesh-list
83013381|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
83013382|NCT02582775|Tacrolimus|tacrolimus|mesh-list
83013383|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
83013384|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83013385|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83013386|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
83013387|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013388|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013389|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83013390|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
83013391|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013392|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013393|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83013394|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83013395|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
83013396|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013397|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83013398|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013399|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83013400|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83013401|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
83013402|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83013403|NCT02060552|Diacerein|diacerein|mesh-list
83013404|NCT02060552|Colchicine|colchicine|mesh-list
83013405|NCT02060552|Febuxostat|febuxostat|mesh-list
83013406|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
83013407|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013408|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
83013409|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
83013410|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
83013411|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013412|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013413|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013414|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
83013415|NCT05384574|Vitamin D|vitamin d|mesh-list
83013416|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83013417|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013418|NCT05384574|Vitamins|vitamins|mesh-ancestor
83013419|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
83013420|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83013421|NCT04355585|Colchicine|colchicine|mesh-list
83013422|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
83013423|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013424|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83013425|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83013426|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83013427|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013428|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013429|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83013430|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013431|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83013432|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013433|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013434|NCT04653389|Immunomodulating Agents|immunomodulating agents|mesh-list
83013435|NCT04653389|Immunologic Factors|immunologic factors|mesh-ancestor
83013436|NCT04653389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013437|NCT01344395|Ketorolac|ketorolac|mesh-list
83013438|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83013439|NCT01344395|Ropivacaine|ropivacaine|mesh-list
83013440|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
83013441|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
83013442|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013443|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013444|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
83013445|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013446|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83013447|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013448|NCT01344395|Analgesics|analgesics|mesh-ancestor
83013449|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013450|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013451|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83013452|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013453|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013454|NCT02291445|Peppermint oil|peppermint oil|mesh-list
83013455|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
83013456|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
83013457|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013458|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013459|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013460|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
83013461|NCT02062112|Laxatives|laxatives|mesh-list
83013462|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013463|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
83013464|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
83013465|NCT01342289|Fludarabine|fludarabine|mesh-list
83013466|NCT01342289|Tacrolimus|tacrolimus|mesh-list
83013467|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83013468|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
83013469|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013470|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013471|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83013472|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
83013473|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013474|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013475|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83013476|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83013477|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013478|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83013479|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83013480|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
83013481|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83013482|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013483|NCT02062190|Resveratrol|resveratrol|mesh-list
83013484|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
83013485|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013486|NCT02062190|Protective Agents|protective agents|mesh-ancestor
83013487|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013488|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013489|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83013490|NCT05601752|Nivolumab|nivolumab|mesh-list
83013491|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013492|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013493|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83013494|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013495|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
83013496|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83013497|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83013498|NCT01354483|Prednisolone|prednisolone|mesh-list
83013499|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
83013500|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
83362123|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013501|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83013503|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013504|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
83013505|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
83013506|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013507|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013508|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013509|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
83013510|NCT01354483|Hormones|hormones|mesh-ancestor
83013511|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013512|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83013513|NCT01354483|Protective Agents|protective agents|mesh-ancestor
83013514|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83013515|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013516|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
83013517|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83013518|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013519|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013520|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
83013521|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83013522|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013523|NCT03618264|Dexamethasone|dexamethasone|mesh-list
83013524|NCT03618264|Ropivacaine|ropivacaine|mesh-list
83013525|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013526|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
83013527|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
83013528|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013529|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013530|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013531|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
83013532|NCT03618264|Hormones|hormones|mesh-ancestor
83013533|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013534|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83013535|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013536|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
83013537|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
83013538|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013539|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
83013540|NCT03617016|Domperidone|domperidone|mesh-list
83013541|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
83013542|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
83013543|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013544|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013545|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013546|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83013547|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
83013548|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013549|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013550|NCT02060786|Clopidogrel|clopidogrel|mesh-list
83013551|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83013552|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83013553|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83013554|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83013555|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
83013556|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013557|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013558|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013559|NCT03153137|Macitentan|macitentan|mesh-list
83013560|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83013561|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83013562|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013563|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83013564|NCT03617484|Bortezomib|bortezomib|mesh-list
83013565|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013566|NCT01344473|Caseins|caseins|mesh-list
83013567|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
83013568|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
83013569|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013570|NCT03618108|Azithromycin|azithromycin|mesh-list
83013571|NCT03618108|Doxycycline|doxycycline|mesh-list
83013572|NCT03618108|Rifabutin|rifabutin|mesh-list
83013573|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83013575|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
83013576|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83013577|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83013578|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83013579|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
83013580|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83013581|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83013582|NCT02236728|Pramipexole|pramipexole|mesh-list
83013583|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
83013584|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013585|NCT02236728|Protective Agents|protective agents|mesh-ancestor
83013586|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013587|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83013588|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83013589|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
83013590|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
83013591|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013592|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83013593|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
83013594|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013595|NCT01342679|Dasatinib|dasatinib|mesh-list
83013596|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013597|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83013598|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013599|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013600|NCT01342835|Propofol|propofol|mesh-list
83013601|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83013602|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013603|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013604|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83013605|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
83013606|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
83013607|NCT01344863|Trastuzumab|trastuzumab|mesh-list
83013608|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013609|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013610|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
83013611|NCT03139279|Propofol|propofol|mesh-list
83013612|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83013613|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013614|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013615|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013616|NCT03139279|Analgesics|analgesics|mesh-ancestor
83013617|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
83013618|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013619|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83013620|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83013621|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83013622|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
83013623|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013624|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013625|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83013626|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
83013627|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
83013628|NCT02562599|Raltitrexed|raltitrexed|mesh-list
83013629|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013630|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83013631|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
83013632|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013633|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83013634|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013635|NCT03311958|Nivolumab|nivolumab|mesh-list
83013636|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013637|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013638|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83013639|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013640|NCT02225405|Cisplatin|cisplatin|mesh-list
83013641|NCT02225405|Docetaxel|docetaxel|mesh-list
83013642|NCT02225405|Nintedanib|nintedanib|mesh-list
83013643|NCT02225405|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83013644|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013645|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
83013646|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
83013647|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
83013648|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013650|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013651|NCT01370642|Ribavirin|ribavirin|mesh-list
83013652|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
83013653|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013654|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
83013655|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013656|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
83013657|NCT03138967|Bromides|bromides|mesh-list
83013658|NCT03138967|Rocuronium|rocuronium|mesh-list
83013659|NCT03138967|Neostigmine|neostigmine|mesh-list
83013660|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
83013661|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83013662|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83013663|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83013664|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013665|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013666|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83013667|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013668|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013669|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
83013670|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013671|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83013672|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
83013673|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83013674|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83013675|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83013676|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
83013677|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
83013678|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013679|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
83013680|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013681|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013682|NCT01358383|Naproxen|naproxen|mesh-list
83013683|NCT01358383|Esomeprazole|esomeprazole|mesh-list
83013684|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83013685|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013686|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83013687|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013688|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013689|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83013690|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013691|NCT01358383|Analgesics|analgesics|mesh-ancestor
83013692|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
83013693|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013694|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013695|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013696|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013697|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
83013698|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83013699|NCT03560336|Liraglutide|liraglutide|mesh-list
83013700|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83013701|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013702|NCT03560336|Incretins|incretins|mesh-ancestor
83013703|NCT03560336|Hormones|hormones|mesh-ancestor
83013704|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013705|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
83013706|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83013707|NCT03615768|Clindamycin|clindamycin|mesh-list
83013708|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
83013709|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
83013710|NCT03615768|Adapalene|adapalene|mesh-list
83013711|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83013712|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013713|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83013714|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013715|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013716|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83013717|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013718|NCT03615768|Analgesics|analgesics|mesh-ancestor
83013719|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
83013720|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013721|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013722|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013723|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013724|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
83013726|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362124|NCT01685801|Ivacaftor|ivacaftor|mesh-list
83013727|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013728|NCT03793400|Bevacizumab|bevacizumab|mesh-list
83013729|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013730|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013731|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83013732|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83013733|NCT03793400|Growth Substances|growth substances|mesh-ancestor
83013734|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013735|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
83013736|NCT01318369|Diazepam|diazepam|mesh-list
83013737|NCT01318369|Dronabinol|dronabinol|mesh-list
83013738|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
83013739|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013740|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83013741|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83013742|NCT01318369|Analgesics|analgesics|mesh-ancestor
83013743|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
83013744|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013745|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83013746|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83431349|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013747|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013748|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013749|NCT01318369|Hormones|hormones|mesh-ancestor
83013750|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013751|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83013752|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
83013753|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
83013754|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
83013755|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013756|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83013757|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013758|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83013759|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83013760|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83013761|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83013762|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83013763|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
83013764|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
83013765|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
83013766|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
83013767|NCT03479684|Warfarin|warfarin|mesh-list
83013768|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
83013769|NCT03614052|Tamsulosin|tamsulosin|mesh-list
83013770|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83013771|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83013772|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83013773|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
83013774|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013775|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013776|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013777|NCT03614052|Urological Agents|urological agents|mesh-ancestor
83013778|NCT02062892|Sirolimus|sirolimus|mesh-list
83013779|NCT02062892|Everolimus|everolimus|mesh-list
83013780|NCT02062892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83013781|NCT02062892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83013782|NCT02062892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013783|NCT02062892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013784|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83013785|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
83013786|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013787|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013788|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83013789|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013790|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83013791|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
83013792|NCT02063360|Ritonavir|ritonavir|mesh-list
83013793|NCT02063360|Darunavir|darunavir|mesh-list
83013794|NCT02063360|Fostemsavir|fostemsavir|mesh-list
83013795|NCT02063360|Etravirine|etravirine|mesh-list
83013796|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83013797|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83013798|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
83013799|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013800|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013801|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83013802|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83013803|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
83013805|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83013806|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83013807|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83013808|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83013809|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83013810|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83013811|NCT03614832|Clopidogrel|clopidogrel|mesh-list
83013813|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83013814|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83013815|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83013816|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83013817|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
83013818|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013819|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013820|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013821|NCT05210595|Clopidogrel|clopidogrel|mesh-list
83013822|NCT05210595|Ticagrelor|ticagrelor|mesh-list
83431352|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
83013823|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83013824|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83013825|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83013826|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83013827|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
83013828|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013829|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013830|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013831|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
83013832|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83013833|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
83013834|NCT02061800|Melphalan|melphalan|mesh-list
83013835|NCT02061800|Busulfan|busulfan|mesh-list
83013836|NCT02061800|Thiotepa|thiotepa|mesh-list
83013837|NCT02061800|Fludarabine|fludarabine|mesh-list
83013838|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
83013839|NCT02061800|Tacrolimus|tacrolimus|mesh-list
83013840|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83013841|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
83013842|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013843|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83013844|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83013845|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
83013846|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013847|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013848|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83013849|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83013850|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013851|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013852|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
83013853|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
83013854|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013855|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83013856|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
83013857|NCT02061800|Hormones|hormones|mesh-ancestor
83013858|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013859|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83013860|NCT02061800|Protective Agents|protective agents|mesh-ancestor
83013861|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83013862|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83013863|NCT01350817|Docetaxel|docetaxel|mesh-list
83013864|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83013865|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013866|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
83013867|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
83013868|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
83013869|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013870|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83013871|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013872|NCT01986075|Amphetamine|amphetamine|mesh-list
83013873|NCT01986075|Adderall|adderall|mesh-list
83013874|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83013875|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013876|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
83013877|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
83013878|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013879|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
83013880|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013881|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013882|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
83013883|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83013884|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83013885|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013886|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83013888|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013889|NCT00394355|Fluticasone|fluticasone|mesh-list
83013890|NCT00394355|Xhance|xhance|mesh-list
83013891|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
83013892|NCT00394355|Montelukast|montelukast|mesh-list
83013893|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83013894|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83013895|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
83013896|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83013897|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013898|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83013899|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
83013900|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83013901|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83013902|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83013903|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
83013904|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83013905|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83013906|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83013907|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013908|NCT02797808|Sertraline|sertraline|mesh-list
83013909|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
83013910|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83013911|NCT02797808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83013912|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83013913|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83013914|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013915|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83013916|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
83013917|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013918|NCT02796560|Travoprost|travoprost|mesh-list
83013919|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83013920|NCT01316081|Vitamins|vitamins|mesh-list
83013921|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
83013922|NCT01316081|Vitamin E|vitamin e|mesh-list
83013923|NCT01316081|Tocopherols|tocopherols|mesh-list
83013924|NCT01316081|Tocotrienols|tocotrienols|mesh-list
83013925|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
83013926|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
83013927|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013928|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
83013929|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013930|NCT01316081|Protective Agents|protective agents|mesh-ancestor
83013931|NCT00958737|Leucovorin|leucovorin|mesh-list
83013932|NCT00958737|Fluorouracil|fluorouracil|mesh-list
83013933|NCT00958737|Capecitabine|capecitabine|mesh-list
83013934|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
83013935|NCT00958737|Calcium|calcium|mesh-list
83013936|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
83013937|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83013938|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013939|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
83013940|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013941|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83013942|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013943|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83013944|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
83013945|NCT00958737|Antidotes|antidotes|mesh-ancestor
83013946|NCT00958737|Protective Agents|protective agents|mesh-ancestor
83013947|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
83013948|NCT00958737|Vitamins|vitamins|mesh-ancestor
83013949|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
83013950|NCT02062034|Vitamins|vitamins|mesh-list
83013951|NCT02062034|Vitamin E|vitamin e|mesh-list
83013953|NCT02062034|Ubiquinone|ubiquinone|mesh-list
83013954|NCT02062034|Antioxidants|antioxidants|mesh-list
83013955|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
83013956|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013957|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013958|NCT02062034|Protective Agents|protective agents|mesh-ancestor
83013959|NCT00344487|Ritonavir|ritonavir|mesh-list
83013960|NCT00344487|Lopinavir|lopinavir|mesh-list
83013961|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83013962|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83013963|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
83013964|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013965|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013966|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83013967|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83013968|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
83013969|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013970|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83013971|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83013972|NCT03789968|Tenofovir|tenofovir|mesh-list
83013973|NCT03789968|Emtricitabine|emtricitabine|mesh-list
83013974|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83013975|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
83013976|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013977|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83013978|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83013979|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013980|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013981|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83013982|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83013983|NCT05089643|Capecitabine|capecitabine|mesh-list
83013984|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83013985|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
83013986|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013987|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83013988|NCT02871492|Acyclovir|acyclovir|mesh-list
83013989|NCT02871492|Pritelivir|pritelivir|mesh-list
83013990|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
83013991|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83013992|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83013993|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83013994|NCT03613974|Lidocaine|lidocaine|mesh-list
83013995|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
83013996|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
83013997|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83013998|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83013999|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
83014000|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014001|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83014002|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83014003|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83014004|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83014005|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014006|NCT01343225|Ritonavir|ritonavir|mesh-list
83014007|NCT01343225|Darunavir|darunavir|mesh-list
83014008|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
83014009|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83014010|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83014011|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83014012|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
83014013|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014014|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014015|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83014016|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83014017|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
83014018|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014019|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83014020|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83014021|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83014022|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83014023|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83014024|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83014025|NCT05208879|Carotenoids|carotenoids|mesh-list
83014026|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
83014027|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014028|NCT05208879|Protective Agents|protective agents|mesh-ancestor
83014029|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014031|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
83014032|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014033|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83014034|NCT01370408|Dexamethasone|dexamethasone|mesh-list
83014035|NCT01370408|Ondansetron|ondansetron|mesh-list
83014036|NCT01370408|Palonosetron|palonosetron|mesh-list
83014037|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014038|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
83014039|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
83014040|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014041|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014042|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83014043|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
83014044|NCT01370408|Hormones|hormones|mesh-ancestor
83014045|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014046|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014047|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014048|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
83014049|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
83014050|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83014051|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83014052|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
83014053|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014054|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014055|NCT04769388|Carboplatin|carboplatin|mesh-list
83014056|NCT04769388|Pemetrexed|pemetrexed|mesh-list
83014057|NCT04769388|Osimertinib|osimertinib|mesh-list
83014058|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014059|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014060|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014061|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83014062|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83014063|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83014064|NCT03294109|Bupivacaine|bupivacaine|mesh-list
83014065|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
83014066|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
83014067|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014068|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014069|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
83014070|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014071|NCT01345643|Chrysarobin|chrysarobin|mesh-list
83014072|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83014073|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014074|NCT01345643|Analgesics|analgesics|mesh-ancestor
83014075|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
83014076|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014077|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014078|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014079|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83014080|NCT02065466|Paclitaxel|paclitaxel|mesh-list
83014081|NCT02065466|Bevacizumab|bevacizumab|mesh-list
83014082|NCT02065466|Temozolomide|temozolomide|mesh-list
83014083|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83014084|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014085|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
83014086|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
83014087|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
83014088|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014089|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014090|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83014091|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83014092|NCT02065466|Growth Substances|growth substances|mesh-ancestor
83014093|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014094|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
83014095|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83014096|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
83014097|NCT03446040|Nivolumab|nivolumab|mesh-list
83014098|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014099|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014100|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83014101|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014102|NCT05208801|Morphine|morphine|mesh-list
83014103|NCT05208801|Bupivacaine|bupivacaine|mesh-list
83014104|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
83014105|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
83014106|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014107|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014108|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
83014109|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014110|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83014111|NCT05208801|Narcotics|narcotics|mesh-ancestor
83014112|NCT05208801|Analgesics|analgesics|mesh-ancestor
83014113|NCT02064140|Rocuronium|rocuronium|mesh-list
83014114|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83014115|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83014116|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83014117|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014118|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014119|NCT05190627|Loratadine|loratadine|mesh-list
83014120|NCT05190627|Sirolimus|sirolimus|mesh-list
83014121|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83014122|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014123|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83014124|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014125|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
83014126|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83014127|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
83014128|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014129|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014130|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
83014131|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
83014132|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83014133|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83014134|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83014135|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
83014136|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
83014137|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014138|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
83014139|NCT01343303|Naproxen|naproxen|mesh-list
83014140|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83014141|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014142|NCT01343303|Analgesics|analgesics|mesh-ancestor
83014143|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
83014144|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014145|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014146|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014147|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83014148|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
83014149|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83014150|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014151|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014152|NCT01343381|Heparin|heparin|mesh-list
83014153|NCT01343381|Calcium heparin|calcium heparin|mesh-list
83014154|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
83014155|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83014156|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83014157|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014158|NCT03620149|Denosumab|denosumab|mesh-list
83014159|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83014160|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014161|NCT02064374|Metformin|metformin|mesh-list
83014162|NCT02064374|Dolutegravir|dolutegravir|mesh-list
83014163|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83014164|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014165|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83014166|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83014167|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014168|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014169|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83014170|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83014171|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
83014172|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014173|NCT01355263|Vitamin A|vitamin a|mesh-list
83014174|NCT01355263|Vitamins|vitamins|mesh-ancestor
83014175|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
83014176|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014177|NCT03613428|Prednisone|prednisone|mesh-list
83362125|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83014179|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014180|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
83014181|NCT03613428|Hormones|hormones|mesh-ancestor
83014182|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014183|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014184|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014185|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014186|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83014187|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83014188|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83014189|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83014190|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014191|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
83014192|NCT02064530|Bupivacaine|bupivacaine|mesh-list
83014193|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
83014194|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
83014195|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014196|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014197|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
83014198|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014199|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83014200|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014201|NCT02064530|Analgesics|analgesics|mesh-ancestor
83014202|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83014203|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83014204|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83014205|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
83014206|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014207|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014208|NCT04519437|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83014209|NCT04519437|Antiviral Agents|antiviral agents|mesh-ancestor
83014210|NCT04519437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014211|NCT01359085|Pregabalin|pregabalin|mesh-list
83014212|NCT01359085|Analgesics|analgesics|mesh-ancestor
83014213|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
83014214|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014215|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014216|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
83014217|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83014218|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83014219|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014220|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83014221|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83014222|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83014223|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014224|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83014225|NCT04322357|Prednisone|prednisone|mesh-list
83014226|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
83014227|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014228|NCT04322357|Hormones|hormones|mesh-ancestor
83014229|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014230|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014231|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014232|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014233|NCT01351285|Remifentanil|remifentanil|mesh-list
83014234|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83014235|NCT01351285|Narcotics|narcotics|mesh-ancestor
83014236|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014237|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014238|NCT01351285|Analgesics|analgesics|mesh-ancestor
83014239|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
83014240|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014241|NCT02032290|Clopidogrel|clopidogrel|mesh-list
83014242|NCT02032290|Ticagrelor|ticagrelor|mesh-list
83014243|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83014244|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83014245|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83014246|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83014247|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
83014248|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014249|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014250|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014251|NCT03379428|Trastuzumab|trastuzumab|mesh-list
83014252|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361580|NCT03924323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83014253|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014254|NCT03628131|Carboplatin|carboplatin|mesh-list
83014255|NCT03628131|Etoposide|etoposide|mesh-list
83014256|NCT03628131|Ifosfamide|ifosfamide|mesh-list
83014257|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014258|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83014259|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83014260|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83014261|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014262|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014263|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83014264|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
83014265|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83014266|NCT03560024|Growth Substances|growth substances|mesh-ancestor
83014267|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014268|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
83014269|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014270|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014271|NCT05095857|Ketamine|ketamine|mesh-list
83014272|NCT05095857|Esketamine|esketamine|mesh-list
83014273|NCT05095857|Analgesics|analgesics|mesh-ancestor
83014274|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
83014275|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014276|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014277|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83014278|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83014279|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
83014280|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
83014281|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014282|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83014283|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83014284|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431410|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014285|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014286|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
83014287|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83014288|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83014289|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83014290|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83014291|NCT03612492|Lidocaine|lidocaine|mesh-list
83014292|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
83014293|NCT03612492|Anesthetics|anesthetics|mesh-list
83014294|NCT03612492|Esmolol|esmolol|mesh-list
83014295|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014296|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014297|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
83014298|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014299|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83014300|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83014301|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83014302|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83014303|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014304|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83014305|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83014306|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
83014307|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014308|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83014309|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
83014310|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83014311|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83014312|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83014313|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
83014314|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83014315|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014316|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83014317|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83014318|NCT03730337|Nivolumab|nivolumab|mesh-list
83014319|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014320|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014321|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83014322|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014324|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
83014325|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014326|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
83014327|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
83014328|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
83014329|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014331|NCT02793128|Mitomycin|mitomycin|mesh-list
83014332|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83014333|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014334|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
83014335|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014336|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83014337|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014338|NCT03612180|Metoprolol|metoprolol|mesh-list
83014339|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83014340|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83014341|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
83014342|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
83014343|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014344|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014345|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83014346|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83014347|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83014348|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
83014349|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014350|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014351|NCT04400799|Enoxaparin|enoxaparin|mesh-list
83014352|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
83014353|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83014354|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83014355|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014356|NCT01359241|Insulin|insulin|mesh-list
83014357|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83014358|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014359|NCT02068196|Ipilimumab|ipilimumab|mesh-list
83014360|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014361|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014362|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83014363|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014364|NCT03142451|Minocycline|minocycline|mesh-list
83014365|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83014366|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014367|NCT04065789|Dexamethasone|dexamethasone|mesh-list
83014368|NCT04065789|Lenalidomide|lenalidomide|mesh-list
83014369|NCT04065789|Daratumumab|daratumumab|mesh-list
83014370|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014371|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
83014372|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
83014373|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014374|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014375|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83014376|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
83014377|NCT04065789|Hormones|hormones|mesh-ancestor
83014378|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014379|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014380|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014381|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
83014382|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83014383|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83014384|NCT04065789|Growth Substances|growth substances|mesh-ancestor
83014385|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
83014386|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
83014387|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
83014388|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014389|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
83014390|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014391|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014392|NCT02064842|Ritonavir|ritonavir|mesh-list
83014393|NCT02064842|Simeprevir|simeprevir|mesh-list
83014394|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83014395|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83014396|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
83014397|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014398|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014399|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83014400|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83014401|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
83014402|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014403|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83014404|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83014405|NCT04192266|Estradiol|estradiol|mesh-list
83014406|NCT04192266|Estrogens|estrogens|mesh-ancestor
83014407|NCT04192266|Hormones|hormones|mesh-ancestor
83014408|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014409|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014410|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
83014411|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83014412|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014413|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014414|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83014415|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83014416|NCT01359397|Bevacizumab|bevacizumab|mesh-list
83014417|NCT01359397|Trastuzumab|trastuzumab|mesh-list
83014418|NCT01359397|Docetaxel|docetaxel|mesh-list
83014419|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
83014420|NCT01359397|Capecitabine|capecitabine|mesh-list
83014421|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83431429|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
83014422|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014423|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83014424|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83014425|NCT01359397|Growth Substances|growth substances|mesh-ancestor
83014426|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014427|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
83014428|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
83014429|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
83014430|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
83014431|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014432|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83014433|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
83014434|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83014435|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83014436|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83014437|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
83014438|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014439|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014440|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014441|NCT05250245|Urological Agents|urological agents|mesh-ancestor
83014442|NCT01347983|Methotrexate|methotrexate|mesh-list
83014443|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83014444|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
83014445|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83014446|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014447|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83014448|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
83014449|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014450|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014451|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
83014452|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014453|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83014454|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83014455|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
83014456|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83014457|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83014458|NCT05249933|Benzocaine|benzocaine|mesh-list
83014459|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
83014460|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
83014461|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014462|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014463|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
83014464|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014465|NCT02032836|Iloprost|iloprost|mesh-list
83014466|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83014467|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
83014468|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
83014470|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
83014471|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014472|NCT02465593|Fluorouracil|fluorouracil|mesh-list
83014473|NCT02465593|Capecitabine|capecitabine|mesh-list
83014474|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
83014475|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014476|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83014477|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014478|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83014479|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
83014480|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014481|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83014482|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014483|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
83014484|NCT02424019|Hormones|hormones|mesh-ancestor
83014485|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014486|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014487|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
83014488|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014489|NCT03611244|Benzocaine|benzocaine|mesh-list
83014490|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
83014491|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
83014492|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014493|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014494|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
83014495|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014496|NCT01359709|Nicotine|nicotine|mesh-list
83014497|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83014498|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
83014499|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014500|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014501|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83014502|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83014503|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
83014504|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014505|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014506|NCT02826486|Leucovorin|leucovorin|mesh-list
83014507|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
83014508|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014509|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014510|NCT02826486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83014511|NCT02826486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014512|NCT02826486|Antidotes|antidotes|mesh-ancestor
83014513|NCT02826486|Protective Agents|protective agents|mesh-ancestor
83014514|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014515|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
83014516|NCT02826486|Vitamins|vitamins|mesh-ancestor
83014517|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
83014518|NCT02825940|Gemcitabine|gemcitabine|mesh-list
83014519|NCT02825940|Atezolizumab|atezolizumab|mesh-list
83014520|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014521|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83014522|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
83014523|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014524|NCT02825940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83014525|NCT02825940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014526|NCT02304991|Glycerol|glycerol|mesh-list
83014527|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83014528|NCT02304991|Protective Agents|protective agents|mesh-ancestor
83014529|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014530|NCT02069132|Warfarin|warfarin|mesh-list
83014531|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
83014532|NCT01352065|Bosentan|bosentan|mesh-list
83014533|NCT01352065|Ambrisentan|ambrisentan|mesh-list
83014534|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83014535|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83014536|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014537|NCT01356043|Niacin|niacin|mesh-list
83014538|NCT01356043|Amlodipine|amlodipine|mesh-list
83014539|NCT01356043|Telmisartan|telmisartan|mesh-list
83014540|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83014541|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83014542|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83014543|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014544|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83014545|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014546|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
83014547|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83014548|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83014549|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83014550|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
83014551|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83014552|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
83014554|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
83014555|NCT02065388|Warfarin|warfarin|mesh-list
83014556|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
83014557|NCT01317563|Vitamin A|vitamin a|mesh-list
83014558|NCT01317563|Selenium|selenium|mesh-list
83014559|NCT01317563|Vitamins|vitamins|mesh-ancestor
83014560|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
83014561|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014562|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
83014563|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014564|NCT01317563|Protective Agents|protective agents|mesh-ancestor
83014565|NCT01317563|Trace Elements|trace elements|mesh-ancestor
83014566|NCT02067338|Morphine|morphine|mesh-list
83014567|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
83014568|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83014569|NCT02067338|Narcotics|narcotics|mesh-ancestor
83014570|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014571|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014572|NCT02067338|Analgesics|analgesics|mesh-ancestor
83014573|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
83014574|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014575|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
83014576|NCT02067338|Coagulants|coagulants|mesh-ancestor
83014577|NCT01352143|Thrombin|thrombin|mesh-list
83014578|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
83014579|NCT01352143|Coagulants|coagulants|mesh-ancestor
83014580|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
83014581|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
83014582|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
83014583|NCT05188495|Trastuzumab|trastuzumab|mesh-list
83014584|NCT05188495|Pertuzumab|pertuzumab|mesh-list
83014585|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014586|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014587|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
83014588|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014589|NCT01356121|Midazolam|midazolam|mesh-list
83014590|NCT01356121|Propofol|propofol|mesh-list
83014591|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83014592|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014593|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014594|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83014595|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
83014596|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
83014597|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83014598|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83014599|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83014600|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83014601|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
83014602|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
83014603|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014604|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014605|NCT01336608|Fluticasone|fluticasone|mesh-list
83014606|NCT01336608|Xhance|xhance|mesh-list
83014607|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014608|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83014609|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
83014610|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014611|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014612|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83014613|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
83014614|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
83014615|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83014616|NCT03628521|Carboplatin|carboplatin|mesh-list
83014617|NCT03628521|Gemcitabine|gemcitabine|mesh-list
83014618|NCT03628521|Pemetrexed|pemetrexed|mesh-list
83014619|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83014620|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014621|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83014622|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
83014623|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014624|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014625|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83014626|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83014627|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83014628|NCT05697003|Fluticasone|fluticasone|mesh-list
83014629|NCT05697003|Xhance|xhance|mesh-list
83014630|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83014631|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83014632|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014633|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83014634|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
83014635|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014636|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014637|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83014638|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
83014639|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
83014640|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83014641|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83014642|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83014643|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83014644|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
83014645|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014646|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014647|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
83014648|NCT05697003|Hormones|hormones|mesh-ancestor
83014649|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014650|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
83014651|NCT02069522|Carotenoids|carotenoids|mesh-list
83014652|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
83014653|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014654|NCT02069522|Protective Agents|protective agents|mesh-ancestor
83014655|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014656|NCT01361425|Methyldopa|methyldopa|mesh-list
83014657|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83014658|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
83014659|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
83014660|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014661|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014662|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83014663|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83014664|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83014665|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
83014666|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014667|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014668|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83014669|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83014670|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83014671|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
83014672|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014673|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014674|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014675|NCT01356355|Urological Agents|urological agents|mesh-ancestor
83014676|NCT01356433|Vitamins|vitamins|mesh-list
83014677|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
83014678|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
83014679|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014680|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
83014681|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014682|NCT01356433|Protective Agents|protective agents|mesh-ancestor
83014683|NCT03691727|Tirofiban|tirofiban|mesh-list
83014684|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83014685|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83014686|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014687|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83014688|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83014689|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
83014690|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83014691|NCT01356511|Dexamethasone|dexamethasone|mesh-list
83014692|NCT01356511|Prednisone|prednisone|mesh-list
83014693|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014694|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
83014695|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
83014696|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014697|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014698|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83014699|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
83014700|NCT01356511|Hormones|hormones|mesh-ancestor
83014701|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014702|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014703|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361581|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83361582|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83014704|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
83014705|NCT02069990|Vitamin D|vitamin d|mesh-list
83014706|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83014707|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014708|NCT02069990|Vitamins|vitamins|mesh-ancestor
83014709|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
83014710|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83014711|NCT05076409|Fluconazole|fluconazole|mesh-list
83014712|NCT05076409|BI 425809|bi 425809|mesh-list
83014713|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
83014714|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014715|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83014716|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83014717|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83431440|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014718|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014719|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83014720|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
83014721|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014722|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014723|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83014724|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83014725|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
83014726|NCT02076386|Dolutegravir|dolutegravir|mesh-list
83014727|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83014728|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83014729|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014730|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014731|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83014732|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83014733|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
83014734|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014735|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
83014736|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83014737|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014738|NCT02072330|Amlodipine|amlodipine|mesh-list
83014739|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83014740|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83014741|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83014742|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83014743|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83014744|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014745|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83014746|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014747|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
83014748|NCT02072330|Diuretics|diuretics|mesh-ancestor
83014749|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
83014750|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83014751|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83014752|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83014753|NCT02072408|Aflibercept|aflibercept|mesh-list
83014754|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83014755|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83014756|NCT02072408|Growth Substances|growth substances|mesh-ancestor
83014757|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014758|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
83014759|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014760|NCT02070458|Cytarabine|cytarabine|mesh-list
83014761|NCT02070458|Etoposide|etoposide|mesh-list
83014762|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
83014763|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
83014764|NCT02070458|Ixazomib|ixazomib|mesh-list
83014765|NCT02070458|Glycine|glycine|mesh-list
83014766|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83014767|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83014768|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014769|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83014770|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83014771|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014772|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014773|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83014774|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
83014775|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
83014776|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014777|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83014778|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
83014779|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014780|NCT02070458|Analgesics|analgesics|mesh-ancestor
83014781|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
83014782|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014783|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
83014784|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
83014785|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014786|NCT03131479|Licogliflozin|licogliflozin|mesh-list
83431446|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
83014787|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83014788|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014789|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83014790|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014791|NCT04984369|Cetuximab|cetuximab|mesh-list
83014792|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014793|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014794|NCT02077010|Milrinone|milrinone|mesh-list
83014795|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83014796|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83014797|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
83014798|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83014799|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83014800|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014801|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014802|NCT02077010|Protective Agents|protective agents|mesh-ancestor
83014803|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014804|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
83014805|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83014806|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
83014807|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014808|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
83014809|NCT01319461|Protective Agents|protective agents|mesh-ancestor
83014810|NCT02072720|Bevacizumab|bevacizumab|mesh-list
83014811|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014812|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014813|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83014814|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83014815|NCT02072720|Growth Substances|growth substances|mesh-ancestor
83014816|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014817|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
83014818|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
83014819|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83014820|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
83014821|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
83014822|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014823|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014824|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014825|NCT01356745|Analgesics|analgesics|mesh-ancestor
83014826|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
83014827|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014828|NCT02072798|Cefuroxime|cefuroxime|mesh-list
83014829|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
83014830|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83014831|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014832|NCT04943549|Bupivacaine|bupivacaine|mesh-list
83014833|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
83014834|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
83014835|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014836|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014837|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
83014838|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014839|NCT04252105|Antioxidants|antioxidants|mesh-list
83014840|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014841|NCT04252105|Protective Agents|protective agents|mesh-ancestor
83014842|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014843|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
83014844|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
83014845|NCT02077322|Coagulants|coagulants|mesh-ancestor
83014846|NCT02077400|Cefazolin|cefazolin|mesh-list
83014847|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83014848|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014849|NCT02077478|Remifentanil|remifentanil|mesh-list
83014850|NCT02077478|Propofol|propofol|mesh-list
83014851|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83014852|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014853|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014854|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83014855|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
83014856|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
83014857|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83014858|NCT02077478|Narcotics|narcotics|mesh-ancestor
83014859|NCT02077478|Analgesics|analgesics|mesh-ancestor
83431449|NCT00452387|Prednisone|prednisone|mesh-list
83014860|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
83014861|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014862|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
83014863|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
83014864|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83014865|NCT02077556|Prednisolone|prednisolone|mesh-list
83014866|NCT02077556|Everolimus|everolimus|mesh-list
83014867|NCT02077556|Tacrolimus|tacrolimus|mesh-list
83014868|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83014869|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
83014870|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014871|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83014872|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014873|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014874|NCT02077556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83014875|NCT02077556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83014876|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014877|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83014878|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83014879|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
83014880|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83014881|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83014882|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014883|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
83014884|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
83014885|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014886|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83014887|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
83014888|NCT02077556|Hormones|hormones|mesh-ancestor
83014889|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014890|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83014891|NCT02077556|Protective Agents|protective agents|mesh-ancestor
83014892|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014893|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
83014894|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83014895|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83014896|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014897|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
83014898|NCT02930941|Coagulants|coagulants|mesh-ancestor
83014899|NCT02077634|Prednisone|prednisone|mesh-list
83014900|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
83014901|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014902|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
83014903|NCT02077634|Hormones|hormones|mesh-ancestor
83482200|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014904|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014905|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014906|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014907|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014908|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83014909|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014910|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014911|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
83014912|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83014913|NCT01365403|Carbamazepine|carbamazepine|mesh-list
83014914|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
83014915|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
83014916|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83014917|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014918|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014919|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83014920|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014921|NCT01365403|Analgesics|analgesics|mesh-ancestor
83014922|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
83014923|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014924|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83014925|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83361583|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014926|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014927|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83014928|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83014930|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
83014931|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83014932|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014933|NCT01362361|Nintedanib|nintedanib|mesh-list
83014934|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014935|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83014936|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014937|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014938|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
83014939|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83014940|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014941|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014942|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014943|NCT02077712|Analgesics|analgesics|mesh-ancestor
83014944|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
83014945|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014946|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83014947|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83014948|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83014949|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
83014950|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83014951|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014952|NCT02073734|Dexamethasone|dexamethasone|mesh-list
83014953|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014954|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
83014955|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
83014956|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014957|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014958|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83014959|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
83014960|NCT02073734|Hormones|hormones|mesh-ancestor
83014961|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83014962|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83014963|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014964|NCT02071004|Aspirin|aspirin|mesh-list
83014965|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83014966|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014967|NCT02071004|Analgesics|analgesics|mesh-ancestor
83014968|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
83014969|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014970|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014971|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83014972|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83014973|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83014974|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83014975|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014976|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83014977|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83014978|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83014979|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
83014980|NCT02071160|Melatonin|melatonin|mesh-list
83014981|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
83014982|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014983|NCT02071160|Protective Agents|protective agents|mesh-ancestor
83014984|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014985|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83014986|NCT03131713|Acetaminophen|acetaminophen|mesh-list
83014987|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83014988|NCT03131713|Analgesics|analgesics|mesh-ancestor
83014989|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
83014990|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83014991|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83014992|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
83014993|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
83014994|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83014995|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83014996|NCT03514121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83014997|NCT03514121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83014998|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
83014999|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
83015000|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
83460171|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015001|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83015002|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015003|NCT02930005|Analgesics|analgesics|mesh-ancestor
83015004|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
83015005|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015006|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015007|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015008|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83015009|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83015010|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015011|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015012|NCT01349387|Metformin|metformin|mesh-list
83015013|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015014|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015015|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
83015016|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
83015017|NCT01361269|Clindamycin|clindamycin|mesh-list
83015018|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
83015019|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
83015020|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
83015021|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83015022|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015023|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83015024|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015025|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015026|NCT01353209|Letrozole|letrozole|mesh-list
83015027|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015028|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83015029|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83015030|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015031|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015032|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83015033|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
83015034|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015035|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015036|NCT03637491|Avelumab|avelumab|mesh-list
83015037|NCT03637491|Talazoparib|talazoparib|mesh-list
83015038|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015039|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015040|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83015041|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015042|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015043|NCT01363063|Ketorolac|ketorolac|mesh-list
83015044|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83015045|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83015046|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015047|NCT01363063|Analgesics|analgesics|mesh-ancestor
83015048|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
83015049|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015050|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015051|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015052|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83015053|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83015054|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015055|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015056|NCT04550455|Cladribine|cladribine|mesh-list
83015057|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015058|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83015059|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
83015060|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015061|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83015062|NCT01349699|Deferasirox|deferasirox|mesh-list
83015063|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83015064|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
83015065|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
83015066|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015067|NCT01349699|Hematinics|hematinics|mesh-ancestor
83015068|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83015069|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83015070|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83015071|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015072|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015073|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015074|NCT03628443|Mitogens|mitogens|mesh-list
83015075|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
83015076|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015077|NCT01365871|Anesthetics|anesthetics|mesh-list
83015078|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015079|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015080|NCT01349777|Clopidogrel|clopidogrel|mesh-list
83015081|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83015082|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83015083|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83015084|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83015085|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
83015086|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015087|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015088|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015089|NCT03446157|Cetuximab|cetuximab|mesh-list
83015090|NCT03446157|Palbociclib|palbociclib|mesh-list
83015091|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015092|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015093|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83015094|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015095|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015096|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
83015097|NCT04700007|Promethazine|promethazine|mesh-list
83015098|NCT04700007|Morphine|morphine|mesh-list
83015099|NCT04700007|Capsaicin|capsaicin|mesh-list
83015100|NCT04700007|Histamine|histamine|mesh-list
83015101|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
83015102|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83015103|NCT04700007|Narcotics|narcotics|mesh-ancestor
83015104|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015105|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015106|NCT04700007|Analgesics|analgesics|mesh-ancestor
83015107|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
83015108|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015109|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
83015110|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83015111|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83015112|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83015113|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83015114|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
83015115|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
83015116|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
83015117|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015118|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83015119|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
83015120|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015121|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015122|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83015123|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
83015124|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
83015125|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015126|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015128|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83015129|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015130|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
83015131|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015132|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
83015133|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015134|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
83015135|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83015136|NCT02961881|Blinatumomab|blinatumomab|mesh-list
83015137|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015138|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83015139|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83015140|NCT01350089|Ethanol|ethanol|mesh-list
83015141|NCT01350089|Caffeine|caffeine|mesh-list
83015142|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83015143|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015144|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015145|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015146|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83015147|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83015148|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015149|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015150|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83015151|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83015152|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
83015153|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015154|NCT03137303|Albuterol|albuterol|mesh-list
83015155|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83015156|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
83015157|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015158|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015159|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83015160|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
83015161|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
83015162|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83015163|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83015164|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83015165|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83015166|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
83015167|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015168|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015169|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83015170|NCT03296553|Valganciclovir|valganciclovir|mesh-list
83015171|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
83015172|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015173|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
83015174|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83015175|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015176|NCT01370707|Metformin|metformin|mesh-list
83015177|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015178|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015179|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83015180|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015181|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
83015182|NCT01363609|Liraglutide|liraglutide|mesh-list
83015183|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015184|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015185|NCT01363609|Incretins|incretins|mesh-ancestor
83015186|NCT01363609|Hormones|hormones|mesh-ancestor
83015187|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015188|NCT03060447|Vesatolimod|vesatolimod|mesh-list
83015189|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
83015190|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015191|NCT04623567|Metformin|metformin|mesh-list
83015192|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015193|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015194|NCT01712789|Dexamethasone|dexamethasone|mesh-list
83015195|NCT01712789|Pomalidomide|pomalidomide|mesh-list
83015196|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015197|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
83015198|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
83015199|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015200|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015201|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015202|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
83015203|NCT01712789|Hormones|hormones|mesh-ancestor
83431472|NCT00452543|Acamprosate|acamprosate|mesh-list
83015204|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015205|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83015206|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015207|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
83015208|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83015209|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83015210|NCT01712789|Growth Substances|growth substances|mesh-ancestor
83015211|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
83015212|NCT01350323|Bevacizumab|bevacizumab|mesh-list
83015213|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015214|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015215|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83015216|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83015217|NCT01350323|Growth Substances|growth substances|mesh-ancestor
83015218|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015219|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
83015220|NCT03074318|Avelumab|avelumab|mesh-list
83015221|NCT03074318|Trabectedin|trabectedin|mesh-list
83015222|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83015223|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015224|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015225|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83015226|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
83015227|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015228|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
83015229|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015231|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
83015232|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83015233|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83015234|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015235|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
83015236|NCT02071316|Coagulants|coagulants|mesh-ancestor
83015237|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83015238|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015239|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83015240|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015241|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83015242|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83015243|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015244|NCT02074280|Rifaximin|rifaximin|mesh-list
83015245|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83015246|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015247|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015248|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83015249|NCT02077946|Liraglutide|liraglutide|mesh-list
83015250|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015251|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015252|NCT02077946|Incretins|incretins|mesh-ancestor
83015253|NCT02077946|Hormones|hormones|mesh-ancestor
83015254|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015255|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83015256|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
83015257|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015258|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015259|NCT03559790|Tenofovir|tenofovir|mesh-list
83015260|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
83015261|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015262|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83015263|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83015264|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015265|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015266|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83015267|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83015268|NCT02079974|Pravastatin|pravastatin|mesh-list
83015269|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83015270|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83015271|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
83015272|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015273|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83015274|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83015275|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015276|NCT01353755|Immunomodulating Agents|immunomodulating agents|mesh-list
83015277|NCT01353755|Immunologic Factors|immunologic factors|mesh-ancestor
83015278|NCT01353755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015279|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83015280|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
83015281|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015282|NCT01317953|Protective Agents|protective agents|mesh-ancestor
83015283|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015284|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83015285|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83015286|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015287|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83015288|NCT02078336|Atropine|atropine|mesh-list
83015289|NCT02078336|Midazolam|midazolam|mesh-list
83015290|NCT02078336|Droperidol|droperidol|mesh-list
83015291|NCT02078336|Lorazepam|lorazepam|mesh-list
83015292|NCT02078336|Biperiden|biperiden|mesh-list
83015293|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83015294|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83015295|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015296|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015297|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83015298|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83015299|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83015300|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83015301|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
83015302|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
83015303|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
83015304|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
83015305|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015306|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015307|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83015308|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83015309|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
83015310|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015311|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83015312|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
83015313|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
83015314|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
83015315|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83015316|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83015317|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
83015318|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
83015319|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
83015320|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015321|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83015322|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83015323|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83015324|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83015325|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83015326|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
83015327|NCT01353833|Aldesleukin|aldesleukin|mesh-list
83015328|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015329|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83015330|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83015331|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
83015332|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015334|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015335|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015336|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83015337|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015338|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
83015339|NCT01350713|Povidone|povidone|mesh-list
83015340|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
83015341|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
83015342|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83015343|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015344|NCT02075294|Entecavir|entecavir|mesh-list
83015345|NCT02075294|Adefovir|adefovir|mesh-list
83015346|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83015347|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
83015348|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015349|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83015350|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83015351|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015352|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015353|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83015355|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83015356|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83015357|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83015358|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015359|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015360|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83015361|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83015362|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83015363|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015364|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015365|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83015366|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83015367|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83015368|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
83015369|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015370|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015371|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83015372|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83015373|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
83015374|NCT02078648|Poly I-C|poly i-c|mesh-list
83015375|NCT02078648|Bevacizumab|bevacizumab|mesh-list
83015376|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83015377|NCT02078648|Poly ICLC|poly iclc|mesh-list
83015378|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015379|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015380|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83015381|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83015382|NCT02078648|Growth Substances|growth substances|mesh-ancestor
83015383|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015384|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
83015385|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
83015386|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
83015387|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
83015388|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015389|NCT02078648|Laxatives|laxatives|mesh-ancestor
83015390|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015392|NCT01358045|Diclofenac|diclofenac|mesh-list
83015393|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83015394|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015395|NCT01358045|Analgesics|analgesics|mesh-ancestor
83015396|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
83015397|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015398|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015399|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015400|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83015401|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83015402|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015403|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015404|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83015405|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83015406|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83015407|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83015408|NCT01358045|Vitamins|vitamins|mesh-ancestor
83015409|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
83015410|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83015411|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
83015412|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83015413|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
83015414|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015415|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015416|NCT01357811|Digoxin|digoxin|mesh-list
83015417|NCT01357811|Eliglustat|eliglustat|mesh-list
83015418|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83015419|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83015420|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015421|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015422|NCT01357811|Protective Agents|protective agents|mesh-ancestor
83015423|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015424|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
83015425|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
83015426|NCT04300985|Anesthetics|anesthetics|mesh-list
83015427|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015428|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015429|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83015430|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015431|NCT04300985|Analgesics|analgesics|mesh-ancestor
83015432|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
83015433|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015434|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83015435|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83015436|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83015437|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
83015438|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015439|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015440|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83015441|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
83015442|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83015443|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83015444|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83015445|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
83015446|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83015447|NCT02079194|Aspirin|aspirin|mesh-list
83015448|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83015449|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015450|NCT02079194|Analgesics|analgesics|mesh-ancestor
83015451|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
83015452|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015453|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015454|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015455|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83015456|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83015457|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83015458|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015459|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83015460|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83015461|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015462|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
83015463|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
83015464|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83015465|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
83015466|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015467|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015468|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83015469|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
83015470|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83015471|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
83015472|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015473|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015474|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83015475|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
83015476|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
83015477|NCT01351493|Protective Agents|protective agents|mesh-ancestor
83015478|NCT01318187|Acetaminophen|acetaminophen|mesh-list
83015479|NCT01318187|Morphine|morphine|mesh-list
83015480|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83015481|NCT01318187|Narcotics|narcotics|mesh-ancestor
83015482|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015483|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015484|NCT01318187|Analgesics|analgesics|mesh-ancestor
83015485|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
83015486|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015487|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015488|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
83015489|NCT01358435|Insulin|insulin|mesh-list
83015490|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83015491|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
83015492|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
83015493|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
83015494|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015495|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015496|NCT01318265|Ketoconazole|ketoconazole|mesh-list
83015497|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
83015498|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015499|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83015500|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83015501|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015502|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015503|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83015504|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
83015505|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015506|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015507|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83015508|NCT01354457|Epratuzumab|epratuzumab|mesh-list
83015509|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015510|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015511|NCT02079350|Polygeline|polygeline|mesh-list
83015512|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
83015513|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
83015514|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
83015515|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83015516|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
83015517|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83015518|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83015519|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015520|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83015521|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015522|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83015523|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015524|NCT03060980|Empagliflozin|empagliflozin|mesh-list
83015525|NCT03060980|Glimepiride|glimepiride|mesh-list
83015526|NCT03060980|Exenatide|exenatide|mesh-list
83015527|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83015528|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015529|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015530|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015531|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83015532|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83015533|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
83015534|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83015535|NCT03060980|Incretins|incretins|mesh-ancestor
83015536|NCT03060980|Hormones|hormones|mesh-ancestor
83015537|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015538|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
83015539|NCT01358591|Calcium|calcium|mesh-list
83015540|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83015541|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015542|NCT01358591|Antacids|antacids|mesh-ancestor
83015543|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015544|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015545|NCT02081144|Nicotine|nicotine|mesh-list
83015546|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83015547|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
83015548|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015549|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015550|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83015551|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83015552|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
83015553|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015554|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015555|NCT02083328|Mannitol|mannitol|mesh-list
83015556|NCT02083328|Caffeine|caffeine|mesh-list
83015557|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83015558|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015559|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83015560|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015561|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015562|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83015563|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83015564|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
83015565|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015566|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83015567|NCT02083328|Diuretics|diuretics|mesh-ancestor
83015568|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
83015569|NCT02079506|Candesartan|candesartan|mesh-list
83015570|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83015571|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83015572|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83015573|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
83015574|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015575|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83015576|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83015577|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015578|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83015579|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83015580|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83015582|NCT02940548|Nifedipine|nifedipine|mesh-list
83015583|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83015584|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83015585|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83015586|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015587|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83015588|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015589|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
83015590|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
83015591|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83015592|NCT01366183|Paclitaxel|paclitaxel|mesh-list
83015593|NCT01366183|Carboplatin|carboplatin|mesh-list
83015594|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83015595|NCT01366183|Lenograstim|lenograstim|mesh-list
83015596|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83015597|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015598|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83015599|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83015600|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83015601|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015602|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83015603|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
83015604|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015605|NCT03134183|Misoprostol|misoprostol|mesh-list
83015606|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83015607|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
83015608|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83015609|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015610|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83015611|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015612|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
83015613|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
83015614|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015615|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015616|NCT02083484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83015617|NCT02083484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015618|NCT01354613|Amlodipine|amlodipine|mesh-list
83015619|NCT01354613|Dobutamine|dobutamine|mesh-list
83015620|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83015621|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83015622|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83015623|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015624|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83015625|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015626|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
83015627|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83015628|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
83015629|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
83015630|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015631|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83015632|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83015633|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83015634|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
83015635|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015636|NCT01354613|Protective Agents|protective agents|mesh-ancestor
83015637|NCT02083640|Palbociclib|palbociclib|mesh-list
83015638|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015639|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83015640|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015641|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015642|NCT01352039|Heparin|heparin|mesh-list
83015643|NCT01352039|Calcium heparin|calcium heparin|mesh-list
83015644|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
83015645|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83015646|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83015647|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015648|NCT04419337|Metformin|metformin|mesh-list
83015649|NCT04419337|Pioglitazone|pioglitazone|mesh-list
83015650|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83015651|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015652|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015653|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015655|NCT01359059|Analgesics|analgesics|mesh-ancestor
83015656|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
83015657|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015658|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015659|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
83015660|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83015661|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83015662|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015663|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83015664|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83015665|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83015666|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015667|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83015668|NCT05189093|Antibodies|antibodies|mesh-list
83015669|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83015670|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
83015671|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015672|NCT01371331|Tacrolimus|tacrolimus|mesh-list
83015673|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83015674|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
83015675|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015676|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83361584|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015677|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015678|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015679|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
83015680|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83015681|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015682|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
83015683|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015684|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
83015685|NCT03133793|Vitamins|vitamins|mesh-ancestor
83015686|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
83015687|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015688|NCT03133481|Ropivacaine|ropivacaine|mesh-list
83015689|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
83015690|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
83015691|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015692|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015693|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
83015694|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015695|NCT01366651|Doripenem|doripenem|mesh-list
83015696|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83015697|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015698|NCT05124509|Vaccines|vaccines|mesh-list
83015699|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
83015700|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015701|NCT02864316|Nivolumab|nivolumab|mesh-list
83015702|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015703|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015704|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83015705|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015706|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
83015707|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83015708|NCT01361399|Aspirin|aspirin|mesh-list
83015709|NCT01361399|Lidocaine|lidocaine|mesh-list
83015710|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
83015711|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
83015712|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015713|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015714|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
83015715|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015716|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83015717|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83015718|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83015719|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83015720|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015721|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83015722|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015723|NCT01361399|Analgesics|analgesics|mesh-ancestor
83015724|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015725|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83015726|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83015727|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83015728|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83015729|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83015730|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015732|NCT02862600|Perhexiline|perhexiline|mesh-list
83015733|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83015734|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83015735|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015736|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83015737|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015738|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
83015739|NCT01354925|Insulin|insulin|mesh-list
83015740|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015741|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015742|NCT03556345|Trastuzumab|trastuzumab|mesh-list
83015743|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015744|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015745|NCT03610230|Iron|iron|mesh-list
83015746|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83015747|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83015748|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
83015749|NCT03610230|Trace Elements|trace elements|mesh-ancestor
83015750|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
83015751|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015752|NCT03610230|Hematinics|hematinics|mesh-ancestor
83361585|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
83015753|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
83015754|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83015755|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015756|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015758|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015759|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015760|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015761|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83015762|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83015763|NCT02033538|Paclitaxel|paclitaxel|mesh-list
83015764|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83015765|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83015766|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015767|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
83015768|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
83015769|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
83015770|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015771|NCT02792192|Atezolizumab|atezolizumab|mesh-list
83015772|NCT02792192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83015773|NCT02792192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015774|NCT02792192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015775|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015776|NCT03609996|Ranibizumab|ranibizumab|mesh-list
83015777|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83015778|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83015779|NCT03609996|Growth Substances|growth substances|mesh-ancestor
83015780|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015781|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
83015782|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015783|NCT02088008|Valsartan|valsartan|mesh-list
83015784|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83015785|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83015786|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83015787|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015788|NCT01361789|Dexamethasone|dexamethasone|mesh-list
83015789|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
83015790|NCT01361789|Etoricoxib|etoricoxib|mesh-list
83015791|NCT01361789|Parecoxib|parecoxib|mesh-list
83015792|NCT01361789|Valdecoxib|valdecoxib|mesh-list
83015793|NCT01361789|BB 1101|bb 1101|mesh-list
83015794|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015795|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
83015796|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
83015797|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015798|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015799|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83015801|NCT01361789|Hormones|hormones|mesh-ancestor
83015802|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015803|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83015804|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015805|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
83015806|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015807|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015808|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83015809|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83015810|NCT01361789|Analgesics|analgesics|mesh-ancestor
83015811|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
83015812|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83015813|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83015814|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83015815|NCT02964507|Fulvestrant|fulvestrant|mesh-list
83015816|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83015817|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015818|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83015819|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83015820|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83015821|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015822|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015823|NCT02083874|Cannabidiol|cannabidiol|mesh-list
83015824|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
83015825|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
83015826|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83015827|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015828|NCT05188781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83015829|NCT05188781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015830|NCT03634735|Thiamine|thiamine|mesh-list
83015831|NCT03634735|Vitamins|vitamins|mesh-ancestor
83015832|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
83015833|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015834|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
83015835|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83015836|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
83015837|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83015838|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83015839|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015840|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
83015841|NCT02084342|Coagulants|coagulants|mesh-ancestor
83015842|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83015843|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
83015844|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015845|NCT01371487|Trametinib|trametinib|mesh-list
83015846|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015847|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83015848|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015849|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015850|NCT02084420|Pantoprazole|pantoprazole|mesh-list
83015851|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83015852|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83431506|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
83015853|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83015854|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015855|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015856|NCT01367431|Xanthohumol|xanthohumol|mesh-list
83015857|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015858|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83015859|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83015860|NCT01367431|Growth Substances|growth substances|mesh-ancestor
83015861|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015862|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
83015863|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
83015864|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83015865|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015866|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
83015867|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015868|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
83015869|NCT01364701|Tadalafil|tadalafil|mesh-list
83015870|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
83015871|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83015872|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83015873|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015874|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015875|NCT01364701|Urological Agents|urological agents|mesh-ancestor
83015876|NCT02440464|Fludarabine|fludarabine|mesh-list
83015877|NCT02440464|Bortezomib|bortezomib|mesh-list
83015878|NCT02440464|Melphalan|melphalan|mesh-list
83015879|NCT02440464|Ixazomib|ixazomib|mesh-list
83015880|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015881|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015882|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83015883|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
83015884|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015885|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83015886|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
83015887|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83015888|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
83015889|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015890|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
83015891|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83015892|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015893|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
83015894|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015895|NCT02088398|Ricolinostat|ricolinostat|mesh-list
83015896|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015897|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83015898|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015899|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015900|NCT02084576|Ketorolac|ketorolac|mesh-list
83015901|NCT02084576|Nepafenac|nepafenac|mesh-list
83015902|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83015904|NCT02084576|Analgesics|analgesics|mesh-ancestor
83015905|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
83015906|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015907|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015908|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83015909|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83015910|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83015911|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015912|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015913|NCT03131453|Umibecestat|umibecestat|mesh-list
83015914|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015915|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015916|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
83015917|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
83015918|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
83015919|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015920|NCT02084654|Exenatide|exenatide|mesh-list
83015921|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83015922|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015923|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83015924|NCT02084654|Incretins|incretins|mesh-ancestor
83015925|NCT02084654|Hormones|hormones|mesh-ancestor
83015926|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015927|NCT01367743|Epinephrine|epinephrine|mesh-list
83015928|NCT01367743|Norepinephrine|norepinephrine|mesh-list
83015929|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83015930|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83015931|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83015932|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
83015933|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015934|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015935|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015936|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83015937|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83015938|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
83015939|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015940|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83015941|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
83015942|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
83015943|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
83015944|NCT02084732|Sorafenib|sorafenib|mesh-list
83015945|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83015946|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83015947|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83015948|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015949|NCT02780401|Vaccines|vaccines|mesh-list
83015950|NCT02780401|Sargramostim|sargramostim|mesh-list
83015951|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
83015952|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015953|NCT02533232|Minocycline|minocycline|mesh-list
83015954|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83015955|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015956|NCT02673151|Edetic Acid|edetic acid|mesh-list
83015957|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83015958|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
83015959|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
83015960|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015961|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
83015962|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83015963|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83015964|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83015965|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
83015966|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83015967|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83015968|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015969|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83015970|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83015971|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
83015972|NCT05042947|Hormones|hormones|mesh-ancestor
83015973|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83015974|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015975|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83015976|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83015977|NCT02082236|Sufentanil|sufentanil|mesh-list
83015978|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83015979|NCT02082236|Narcotics|narcotics|mesh-ancestor
83015980|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83015981|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015982|NCT02082236|Analgesics|analgesics|mesh-ancestor
83015983|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
83015984|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83015985|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83015986|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83015987|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
83015988|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
83015989|NCT03557996|Listerine|listerine|mesh-list
83015990|NCT03557996|Fluorides|fluorides|mesh-list
83015991|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
83015992|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
83015993|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
83015994|NCT03557996|Protective Agents|protective agents|mesh-ancestor
83015995|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83015996|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83015997|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83015998|NCT02296801|Letrozole|letrozole|mesh-list
83015999|NCT02296801|Palbociclib|palbociclib|mesh-list
83016000|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016001|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83016002|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83016003|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016004|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016005|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83016006|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
83016007|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016008|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016009|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83016010|NCT02859324|Nivolumab|nivolumab|mesh-list
83016011|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83016012|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016013|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83016014|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016015|NCT02085590|Vaccines|vaccines|mesh-list
83016016|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
83016017|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
83016018|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016019|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83016020|NCT02143063|Cocaine|cocaine|mesh-list
83016021|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016022|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
83016023|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016024|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016025|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
83016026|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016027|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83016028|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83016029|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83016030|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83016031|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016032|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
83016033|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016034|NCT02088866|Lidocaine|lidocaine|mesh-list
83016035|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016036|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
83016037|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016038|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016039|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
83016040|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016041|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83016042|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83016043|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83016044|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83016045|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016046|NCT02859246|Guaifenesin|guaifenesin|mesh-list
83016047|NCT02859246|Expectorants|expectorants|mesh-ancestor
83016048|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
83016049|NCT02088944|Infliximab|infliximab|mesh-list
83016050|NCT02088944|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83016051|NCT02088944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016053|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016054|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83016055|NCT02073097|Acyclovir|acyclovir|mesh-list
83016056|NCT02073097|Prednisone|prednisone|mesh-list
83016057|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
83016058|NCT02073097|Rituximab|rituximab|mesh-list
83016059|NCT02073097|Doxorubicin|doxorubicin|mesh-list
83016060|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83016061|NCT02073097|Vincristine|vincristine|mesh-list
83016062|NCT02073097|Lenograstim|lenograstim|mesh-list
83016063|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83016064|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
83016065|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016066|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83016067|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83016068|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
83016069|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016070|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016071|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83016072|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83016073|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83016074|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83016075|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83016076|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016077|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016078|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
83016079|NCT02073097|Hormones|hormones|mesh-ancestor
83016080|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016081|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83016082|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83016083|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
83016084|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
83016085|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
83016086|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83016087|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
83016088|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016089|NCT02921997|Vaccines|vaccines|mesh-list
83016090|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
83016091|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016092|NCT02791490|Metformin|metformin|mesh-list
83016093|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83016094|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83016095|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016096|NCT02791490|Incretins|incretins|mesh-ancestor
83016097|NCT02791490|Hormones|hormones|mesh-ancestor
83016098|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016099|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83016100|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
83016101|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016102|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016103|NCT04635631|Talazoparib|talazoparib|mesh-list
83016104|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83016105|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016106|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016107|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016108|NCT02085824|Enoxaparin|enoxaparin|mesh-list
83016109|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
83016110|NCT02085824|Dabigatran|dabigatran|mesh-list
83016111|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83016112|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
83016113|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83016114|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
83016115|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016116|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016117|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
83016118|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83016119|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83016120|NCT01368445|Azelastine|azelastine|mesh-list
83016121|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83016122|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
83016123|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016124|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016125|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83016126|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
83016127|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83016129|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016130|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83016131|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83016132|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83016133|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
83016134|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
83016135|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016136|NCT02085902|Ropivacaine|ropivacaine|mesh-list
83016137|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016138|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
83016139|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016140|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016141|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
83016142|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016143|NCT01368757|Lenalidomide|lenalidomide|mesh-list
83016144|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
83016145|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016146|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83431515|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83016147|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83016148|NCT01368757|Growth Substances|growth substances|mesh-ancestor
83016149|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83016150|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016151|NCT02086292|Lidocaine|lidocaine|mesh-list
83016152|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016153|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
83016154|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016155|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016156|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
83016157|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016158|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83016159|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83016160|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83016161|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83016162|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016163|NCT02425644|Teriflunomide|teriflunomide|mesh-list
83016164|NCT02425644|Ponesimod|ponesimod|mesh-list
83016165|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83016166|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83016167|NCT02425644|Analgesics|analgesics|mesh-ancestor
83016168|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
83016169|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016170|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016171|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016172|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83016173|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83016174|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
83016175|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83016176|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016177|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
83016178|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83016179|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
83016180|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83016181|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
83016182|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016183|NCT02086526|Metformin|metformin|mesh-list
83016184|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83016185|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016186|NCT04180995|Axitinib|axitinib|mesh-list
83016187|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016188|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83016189|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016190|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016191|NCT02089178|Remifentanil|remifentanil|mesh-list
83016192|NCT02089178|Anesthetics|anesthetics|mesh-list
83016193|NCT02089178|Propofol|propofol|mesh-list
83016194|NCT02089178|Sevoflurane|sevoflurane|mesh-list
83016195|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016196|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016197|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83016198|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83016199|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
83016200|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83016201|NCT02089178|Narcotics|narcotics|mesh-ancestor
83016202|NCT02089178|Analgesics|analgesics|mesh-ancestor
83016203|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
83016204|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016205|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83016206|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83016207|NCT02089256|Liraglutide|liraglutide|mesh-list
83016208|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83016209|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016210|NCT02089256|Incretins|incretins|mesh-ancestor
83016211|NCT02089256|Hormones|hormones|mesh-ancestor
83016212|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016213|NCT02861664|Fluorides|fluorides|mesh-list
83016214|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
83016215|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
83016216|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
83016217|NCT02861664|Protective Agents|protective agents|mesh-ancestor
83016218|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016219|NCT02086838|Dextrans|dextrans|mesh-list
83016220|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
83016221|NCT02086838|Hematinics|hematinics|mesh-list
83016222|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
83016223|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
83016224|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
83016225|NCT03978039|Immunomodulating Agents|immunomodulating agents|mesh-list
83016226|NCT03978039|Immunologic Factors|immunologic factors|mesh-ancestor
83016227|NCT03978039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016228|NCT02236962|Pioglitazone|pioglitazone|mesh-list
83016229|NCT02236962|Ephedrine|ephedrine|mesh-list
83016230|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83016231|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016232|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83016233|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
83016234|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
83016235|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016236|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83016237|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
83016238|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016239|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016240|NCT04431375|Tenofovir|tenofovir|mesh-list
83016241|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
83016242|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016243|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83016244|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83016245|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016246|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016247|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83016248|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83016249|NCT02086994|Misoprostol|misoprostol|mesh-list
83016250|NCT02086994|Carbetocin|carbetocin|mesh-list
83016251|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83016252|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
83016253|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83016254|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016255|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83016256|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016257|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
83016258|NCT05664711|Bupivacaine|bupivacaine|mesh-list
83016259|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016260|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
83016261|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016262|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016263|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
83016264|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016265|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83016266|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83016267|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016268|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83016269|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016270|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016271|NCT03284853|Latanoprost|latanoprost|mesh-list
83016272|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83016273|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83016274|NCT02087384|Vaccines|vaccines|mesh-list
83016275|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
83016276|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016277|NCT02087462|Vitamins|vitamins|mesh-list
83016278|NCT02087462|Thiamine|thiamine|mesh-list
83016279|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
83016281|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
83016282|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016283|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83016284|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83016285|NCT02087462|Analgesics|analgesics|mesh-ancestor
83016286|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
83016287|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016288|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016289|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83016290|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83016291|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016292|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016293|NCT02087540|Telmisartan|telmisartan|mesh-list
83016294|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83016295|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83016296|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83016297|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
83016298|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016299|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83016300|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83016301|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016302|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83016303|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83016304|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83016305|NCT03055221|Treprostinil|treprostinil|mesh-list
83016306|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83016307|NCT03206463|Dronabinol|dronabinol|mesh-list
83016308|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
83016309|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016310|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83016311|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83016312|NCT03206463|Analgesics|analgesics|mesh-ancestor
83016313|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
83016314|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016315|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83016316|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83016317|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016318|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016319|NCT03206463|Hormones|hormones|mesh-ancestor
83016320|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016321|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
83016322|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83016323|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
83016324|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016325|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
83016326|NCT02091674|Protective Agents|protective agents|mesh-ancestor
83016327|NCT01218555|Lenalidomide|lenalidomide|mesh-list
83016328|NCT01218555|Everolimus|everolimus|mesh-list
83016329|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
83016330|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016331|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83016332|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83016333|NCT01218555|Growth Substances|growth substances|mesh-ancestor
83016334|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
83016335|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016337|NCT01218555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83016338|NCT01218555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016339|NCT01218555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016340|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83016341|NCT02091830|Acetaminophen|acetaminophen|mesh-list
83016342|NCT02091830|Cortisone|cortisone|mesh-list
83016343|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83016344|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83016345|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83016346|NCT02091830|Analgesics|analgesics|mesh-ancestor
83016347|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
83016348|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016349|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016350|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
83016351|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83016352|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
83016353|NCT01111305|Reslizumab|reslizumab|mesh-list
83016354|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83016355|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
83016356|NCT01111305|Filaricides|filaricides|mesh-ancestor
83016357|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
83016358|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
83016359|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83016360|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016361|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83016362|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016363|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016364|NCT03752307|Prednisone|prednisone|mesh-list
83016365|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
83016366|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
83016367|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016368|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
83016369|NCT03752307|Hormones|hormones|mesh-ancestor
83016370|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016371|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016372|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83016373|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016374|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
83016375|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
83016376|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016377|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016378|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83016379|NCT03752307|Protective Agents|protective agents|mesh-ancestor
83016380|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83016381|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83016382|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
83016383|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016384|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016385|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
83016386|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
83016387|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
83016388|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83016389|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83016390|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83016391|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016392|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016393|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83016394|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83016395|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016396|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016397|NCT02091908|Lactitol|lactitol|mesh-list
83016398|NCT02091908|Vaccines|vaccines|mesh-list
83016399|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
83016400|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016401|NCT02091908|Cathartics|cathartics|mesh-ancestor
83016402|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016403|NCT03627897|Bupivacaine|bupivacaine|mesh-list
83016404|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016405|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
83016406|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016407|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016408|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
83016409|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016411|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016412|NCT03125941|Dexamethasone|dexamethasone|mesh-list
83016413|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016414|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
83016415|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
83016416|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016417|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016418|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016419|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
83016420|NCT03125941|Hormones|hormones|mesh-ancestor
83016421|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016422|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83016423|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016424|NCT02092142|Vaccines|vaccines|mesh-list
83016425|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
83016426|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016427|NCT02095886|BMS-955176|bms-955176|mesh-list
83016428|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83016429|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83016430|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
83016431|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016432|NCT01372579|Carboplatin|carboplatin|mesh-list
83016433|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016434|NCT02090036|Lumefantrine|lumefantrine|mesh-list
83016435|NCT02090036|Artemether|artemether|mesh-list
83016436|NCT02090036|Primaquine|primaquine|mesh-list
83016437|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83016438|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
83016439|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83016440|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83016441|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016442|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83016443|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83016444|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016445|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
83016446|NCT02092376|Vitamin D|vitamin d|mesh-list
83016447|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83016448|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016449|NCT02092376|Vitamins|vitamins|mesh-ancestor
83016450|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
83016451|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83016452|NCT05452928|Valacyclovir|valacyclovir|mesh-list
83016453|NCT05452928|Acyclovir|acyclovir|mesh-list
83016454|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
83016455|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016456|NCT03125395|Ivacaftor|ivacaftor|mesh-list
83016457|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83016458|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83016459|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016460|NCT01369303|Tenofovir|tenofovir|mesh-list
83016461|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
83016462|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016463|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83016464|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83016465|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016466|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016467|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83016468|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83016469|NCT02092532|Aflibercept|aflibercept|mesh-list
83016470|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83016471|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83016472|NCT02092532|Growth Substances|growth substances|mesh-ancestor
83016473|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016474|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
83016475|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016476|NCT02092766|Artesunate|artesunate|mesh-list
83016477|NCT02092766|Quinine|quinine|mesh-list
83016478|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
83016479|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83016480|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83016481|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016482|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016483|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
83016484|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
83016485|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83016486|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
83016487|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83016488|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016489|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83016490|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016491|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83016492|NCT02092766|Analgesics|analgesics|mesh-ancestor
83016493|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
83016494|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83016495|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
83016496|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83016497|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
83016498|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016499|NCT02721069|Diazepam|diazepam|mesh-list
83016500|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83016501|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
83016502|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
83016503|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
83016504|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016505|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016506|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016507|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83016508|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016510|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83016511|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83016512|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83016513|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83016514|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83016515|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
83016516|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
83016517|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
83016518|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
83016519|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016520|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016521|NCT02093000|Bevacizumab|bevacizumab|mesh-list
83016522|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83016523|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016524|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83016525|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83016526|NCT02093000|Growth Substances|growth substances|mesh-ancestor
83016527|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016528|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
83016529|NCT00261807|Daptomycin|daptomycin|mesh-list
83016530|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83016531|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016532|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
83016533|NCT02090504|Oxazepam|oxazepam|mesh-list
83016534|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83016535|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83016536|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
83016537|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
83016538|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016539|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016540|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83016541|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83016542|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83016543|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83016544|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
83016545|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
83016546|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016547|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016548|NCT01567059|Cytarabine|cytarabine|mesh-list
83016549|NCT01567059|Decitabine|decitabine|mesh-list
83016550|NCT01567059|Azacitidine|azacitidine|mesh-list
83016551|NCT01567059|Tosedostat|tosedostat|mesh-list
83016552|NCT01567059|Glycine|glycine|mesh-list
83016553|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83016554|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
83016555|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016556|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016557|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
83016558|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016559|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83016560|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
83016561|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016562|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016563|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
83016564|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016565|NCT02090738|Amoxicillin|amoxicillin|mesh-list
83016566|NCT02090738|Clarithromycin|clarithromycin|mesh-list
83016567|NCT02090738|Acetazolamide|acetazolamide|mesh-list
83016568|NCT02090738|Esomeprazole|esomeprazole|mesh-list
83016569|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83016570|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016571|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83016572|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016573|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83016574|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016575|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016576|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83016577|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83016578|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83016579|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
83016580|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83016581|NCT02090738|Diuretics|diuretics|mesh-ancestor
83016582|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
83016583|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016584|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
83016585|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83361586|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016586|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83016587|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83016588|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016589|NCT03441555|Venetoclax|venetoclax|mesh-list
83016590|NCT03441555|Alvocidib|alvocidib|mesh-list
83016591|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016592|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
83016593|NCT03441555|Growth Substances|growth substances|mesh-ancestor
83016594|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016595|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83016596|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016597|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016598|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83016599|NCT03346239|Escitalopram|escitalopram|mesh-list
83016600|NCT03346239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83016601|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83016602|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83016603|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016604|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016605|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
83016606|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016607|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
83016608|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83016609|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016610|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016611|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83016612|NCT05218161|Analgesics|analgesics|mesh-ancestor
83016613|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
83016614|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016615|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83016616|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83016617|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83016618|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83016619|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016620|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016621|NCT02861586|Vaccines|vaccines|mesh-list
83016622|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
83016623|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016624|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83016625|NCT02099240|Amoxicillin|amoxicillin|mesh-list
83016626|NCT02099240|Azithromycin|azithromycin|mesh-list
83016627|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
83016628|NCT02099240|Vancomycin|vancomycin|mesh-list
83016629|NCT02099240|Clarithromycin|clarithromycin|mesh-list
83016630|NCT02099240|Doxycycline|doxycycline|mesh-list
83016631|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
83016632|NCT02099240|Levofloxacin|levofloxacin|mesh-list
83016633|NCT02099240|Ofloxacin|ofloxacin|mesh-list
83016634|NCT02099240|Minocycline|minocycline|mesh-list
83016635|NCT02099240|Rifampin|rifampin|mesh-list
83016636|NCT02099240|Clindamycin|clindamycin|mesh-list
83016637|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
83016638|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
83016639|NCT02099240|Gentamicins|gentamicins|mesh-list
83016640|NCT02099240|Isoniazid|isoniazid|mesh-list
83016641|NCT02099240|Meropenem|meropenem|mesh-list
83016642|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
83016643|NCT02099240|Linezolid|linezolid|mesh-list
83016644|NCT02099240|Tazobactam|tazobactam|mesh-list
83016645|NCT02099240|Cycloserine|cycloserine|mesh-list
83016646|NCT02099240|Piperacillin|piperacillin|mesh-list
83016647|NCT02099240|Metronidazole|metronidazole|mesh-list
83016648|NCT02099240|Penicillins|penicillins|mesh-list
83016649|NCT02099240|Imipenem|imipenem|mesh-list
83016650|NCT02099240|Amikacin|amikacin|mesh-list
83016651|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
83016652|NCT02099240|Erythromycin|erythromycin|mesh-list
83016653|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
83016654|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83016655|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
83016656|NCT02099240|Colistin|colistin|mesh-list
83016657|NCT02099240|Ceftazidime|ceftazidime|mesh-list
83016658|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83016659|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
83016660|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
83016661|NCT02099240|Rifabutin|rifabutin|mesh-list
83016662|NCT02099240|Ampicillin|ampicillin|mesh-list
83016663|NCT02099240|Mupirocin|mupirocin|mesh-list
83016664|NCT02099240|Rifapentine|rifapentine|mesh-list
83016665|NCT02099240|Cefuroxime|cefuroxime|mesh-list
83016666|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
83016667|NCT02099240|Fosfomycin|fosfomycin|mesh-list
83016668|NCT02099240|Cefepime|cefepime|mesh-list
83016669|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83016670|NCT02099240|Paromomycin|paromomycin|mesh-list
83016671|NCT02099240|Aztreonam|aztreonam|mesh-list
83016672|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
83016673|NCT02099240|Polymyxins|polymyxins|mesh-list
83016674|NCT02099240|Neomycin|neomycin|mesh-list
83016675|NCT02099240|Bacitracin|bacitracin|mesh-list
83016676|NCT02099240|Cefotaxime|cefotaxime|mesh-list
83016677|NCT02099240|Cefoxitin|cefoxitin|mesh-list
83016678|NCT02099240|Sulbactam|sulbactam|mesh-list
83016679|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
83016680|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
83016681|NCT02099240|Cefixime|cefixime|mesh-list
83016682|NCT02099240|Polymyxin B|polymyxin b|mesh-list
83016683|NCT02099240|Cefdinir|cefdinir|mesh-list
83016684|NCT02099240|Penicillin G|penicillin g|mesh-list
83016685|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83016686|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
83016687|NCT02099240|Norfloxacin|norfloxacin|mesh-list
83016688|NCT02099240|Cloxacillin|cloxacillin|mesh-list
83016689|NCT02099240|Cefprozil|cefprozil|mesh-list
83016690|NCT02099240|Cephalosporins|cephalosporins|mesh-list
83016691|NCT02099240|Oxacillin|oxacillin|mesh-list
83016692|NCT02099240|Nafcillin|nafcillin|mesh-list
83016693|NCT02099240|Streptomycin|streptomycin|mesh-list
83016694|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
83016695|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
83016696|NCT02099240|Ticarcillin|ticarcillin|mesh-list
83016697|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
83016698|NCT02099240|Sultamicillin|sultamicillin|mesh-list
83016699|NCT02099240|Penicillin V|penicillin v|mesh-list
83016700|NCT02099240|Cefoperazone|cefoperazone|mesh-list
83016701|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
83016702|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
83016703|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
83016704|NCT02099240|Ethionamide|ethionamide|mesh-list
83016705|NCT02099240|Kanamycin|kanamycin|mesh-list
83016706|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83016707|NCT02099240|Ceftibuten|ceftibuten|mesh-list
83016708|NCT02099240|Lincomycin|lincomycin|mesh-list
83016709|NCT02099240|Dirithromycin|dirithromycin|mesh-list
83016710|NCT02099240|Cefotetan|cefotetan|mesh-list
83016711|NCT02099240|Demeclocycline|demeclocycline|mesh-list
83016712|NCT02099240|Tobramycin|tobramycin|mesh-list
83016713|NCT02099240|Mafenide|mafenide|mesh-list
83016714|NCT02099240|Cefaclor|cefaclor|mesh-list
83016715|NCT02099240|Capreomycin|capreomycin|mesh-list
83016716|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
83016717|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
83016718|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
83016719|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
83016720|NCT02099240|Netilmicin|netilmicin|mesh-list
83016721|NCT02099240|Enoxacin|enoxacin|mesh-list
83016722|NCT02099240|Novobiocin|novobiocin|mesh-list
83016723|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
83016724|NCT02099240|Virginiamycin|virginiamycin|mesh-list
83016725|NCT02099240|Methicillin|methicillin|mesh-list
83016726|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
83016727|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83016728|NCT02099240|Spectinomycin|spectinomycin|mesh-list
83016729|NCT02099240|Dalfopristin|dalfopristin|mesh-list
83016730|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
83016731|NCT02099240|Tetracycline|tetracycline|mesh-list
83016732|NCT02099240|Methacycline|methacycline|mesh-list
83016733|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
83016734|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
83016735|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
83016736|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
83016737|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
83016738|NCT02099240|Loracarbef|loracarbef|mesh-list
83016739|NCT02099240|Cefmetazole|cefmetazole|mesh-list
83016740|NCT02099240|Cefonicid|cefonicid|mesh-list
83016741|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
83016742|NCT02099240|Cefamandole|cefamandole|mesh-list
83016743|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
83016744|NCT02099240|Mezlocillin|mezlocillin|mesh-list
83016745|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
83016746|NCT02099240|Carbenicillin|carbenicillin|mesh-list
83016747|NCT02099240|Bacampicillin|bacampicillin|mesh-list
83016748|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83016749|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
83016750|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
83016751|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83016752|NCT02099240|Methenamine|methenamine|mesh-list
83016753|NCT02099240|Sulperazone|sulperazone|mesh-list
83016754|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
83016755|NCT02099240|Cinoxacin|cinoxacin|mesh-list
83016756|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
83016757|NCT02099240|Trimethoprim|trimethoprim|mesh-list
83016758|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
83361588|NCT01581281|Amitriptyline|amitriptyline|mesh-list
83016759|NCT02099240|Procaine|procaine|mesh-list
83016760|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83016761|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83016762|NCT02099240|Cilastatin|cilastatin|mesh-list
83016763|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016764|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
83016765|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83016766|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83016767|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016768|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016769|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016770|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83016771|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
83016772|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83016773|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016774|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83016775|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83016776|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83016777|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83016778|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83016779|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83016780|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
83016781|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83016782|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83016783|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83016784|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83016785|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
83016786|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83016787|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83016788|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83016789|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83016790|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83016791|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83016792|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83016793|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83016794|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83016795|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
83016796|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83016797|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83016798|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016799|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83016800|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83016801|NCT02099240|Analgesics|analgesics|mesh-ancestor
83016802|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
83016803|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016804|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83016805|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83016806|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83016807|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83016808|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83016809|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83016810|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
83016811|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
83016812|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
83016813|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016814|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83016815|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83016816|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83016817|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83016818|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
83016819|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83016820|NCT02245230|Trimethaphan|trimethaphan|mesh-list
83016821|NCT02245230|Phenylephrine|phenylephrine|mesh-list
83016822|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
83016823|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
83016824|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83016825|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
83016826|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
83016827|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016828|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016829|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
83016830|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83016831|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
83361589|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
83016832|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
83016833|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83016834|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83016835|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83016836|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
83016837|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016838|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016839|NCT02245230|Protective Agents|protective agents|mesh-ancestor
83016840|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83016841|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
83016842|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83016843|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83016844|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83016845|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83016846|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
83016847|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
83016848|NCT05215743|Antioxidants|antioxidants|mesh-list
83016849|NCT05215743|Deferoxamine|deferoxamine|mesh-list
83016850|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
83016851|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016852|NCT05215743|Expectorants|expectorants|mesh-ancestor
83016853|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
83016854|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83016855|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016856|NCT05215743|Protective Agents|protective agents|mesh-ancestor
83016857|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016858|NCT05215743|Siderophores|siderophores|mesh-ancestor
83016859|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83016860|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
83016861|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
83016862|NCT02099396|Gemcitabine|gemcitabine|mesh-list
83016863|NCT02099396|Docetaxel|docetaxel|mesh-list
83016864|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83016865|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
83016866|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016867|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016868|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
83016869|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
83016870|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
83016871|NCT05215665|Lenvatinib|lenvatinib|mesh-list
83016872|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016873|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83016874|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016875|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016876|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
83016877|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83016878|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83016879|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
83016880|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83016881|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83016882|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83016883|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016884|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016885|NCT05217069|Leucovorin|leucovorin|mesh-list
83016886|NCT05217069|Folic Acid|folic acid|mesh-list
83016887|NCT05217069|Irinotecan|irinotecan|mesh-list
83016888|NCT05217069|Cetuximab|cetuximab|mesh-list
83016889|NCT05217069|Avelumab|avelumab|mesh-list
83016890|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
83016891|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83016892|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83016893|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016894|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016895|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016896|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83016897|NCT05217069|Antidotes|antidotes|mesh-ancestor
83016898|NCT05217069|Protective Agents|protective agents|mesh-ancestor
83016899|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016900|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
83016901|NCT05217069|Vitamins|vitamins|mesh-ancestor
83016902|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
83016903|NCT05217069|Hematinics|hematinics|mesh-ancestor
83016904|NCT02065635|Propofol|propofol|mesh-list
83016905|NCT02065635|Sevoflurane|sevoflurane|mesh-list
83016906|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83016907|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016908|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016909|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83016910|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
83016911|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
83016912|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83016913|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83016914|NCT03628053|Blinatumomab|blinatumomab|mesh-list
83016915|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83016916|NCT03628053|Tisagenlecleucel|tisagenlecleucel|mesh-list
83016917|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016918|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83016919|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83016920|NCT03628053|Immunotoxins|immunotoxins|mesh-ancestor
83016921|NCT03628053|Immunoconjugates|immunoconjugates|mesh-ancestor
83016922|NCT03628053|Immunologic Factors|immunologic factors|mesh-ancestor
83016923|NCT03628053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016924|NCT02100176|Dopamine|dopamine|mesh-list
83016925|NCT02100176|Rotigotine|rotigotine|mesh-list
83016926|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
83016927|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
83016928|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016929|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016930|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016931|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83016932|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
83016933|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
83016934|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016935|NCT02100176|Protective Agents|protective agents|mesh-ancestor
83016936|NCT02250482|Factor VIII|factor viii|mesh-list
83016937|NCT02250482|Coagulants|coagulants|mesh-ancestor
83016938|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83016939|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83016940|NCT05189145|Hormones|hormones|mesh-list
83016941|NCT05189145|Estradiol|estradiol|mesh-list
83016942|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83016943|NCT05189145|Progesterone|progesterone|mesh-list
83016944|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
83016945|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83016946|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016947|NCT05189145|Estrogens|estrogens|mesh-ancestor
83016948|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83016949|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
83016950|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83016951|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83016952|NCT05189145|Progestins|progestins|mesh-ancestor
83016953|NCT04967079|Trametinib|trametinib|mesh-list
83016954|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83016955|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83016956|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016957|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016958|NCT03556592|Metoprolol|metoprolol|mesh-list
83016959|NCT03556592|Midazolam|midazolam|mesh-list
83016960|NCT03556592|Caffeine|caffeine|mesh-list
83016961|NCT03556592|Omeprazole|omeprazole|mesh-list
83016962|NCT03556592|Warfarin|warfarin|mesh-list
83016963|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83016964|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83016965|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83016966|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83016967|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83016969|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83016970|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83016971|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
83016972|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
83016973|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
83016974|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
83016975|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83016976|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83016977|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
83016978|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83016979|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83016980|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83016981|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83016982|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83016983|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
83361590|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83016984|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83016985|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83016986|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83016987|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83016988|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83016989|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
83016990|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
83016991|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83016992|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83016993|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83016994|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83016995|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
83016996|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
83016997|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83016998|NCT04964193|Cyproterone|cyproterone|mesh-list
83016999|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83017000|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83017001|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83017002|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83017003|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
83017004|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83017005|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017006|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83017007|NCT04964193|Estrogens|estrogens|mesh-ancestor
83017008|NCT04964193|Hormones|hormones|mesh-ancestor
83017009|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017010|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
83017011|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83017012|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017013|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83017014|NCT02100488|Insulin|insulin|mesh-list
83017015|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83017016|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83017017|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017018|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
83017019|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83017020|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017021|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83017022|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
83017023|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83017024|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017025|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017026|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017027|NCT04865497|Vaccines|vaccines|mesh-list
83017028|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
83017029|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017030|NCT05665725|Siltuximab|siltuximab|mesh-list
83017031|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83017032|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017033|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
83017034|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017035|NCT02098148|Xenon|xenon|mesh-list
83017036|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83017037|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
83017038|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
83017039|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017040|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017041|NCT05168527|Paclitaxel|paclitaxel|mesh-list
83017042|NCT05168527|Gemcitabine|gemcitabine|mesh-list
83017043|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83017044|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017045|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
83017046|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
83017047|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
83017048|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017049|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83017050|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
83017051|NCT02098460|Cilostazol|cilostazol|mesh-list
83017052|NCT02098460|Atorvastatin|atorvastatin|mesh-list
83017053|NCT02098460|Probucol|probucol|mesh-list
83017054|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83017055|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83017056|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
83017057|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017058|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83017059|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83017060|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017061|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83017062|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
83017063|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017064|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017065|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83017066|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
83017067|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83017068|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83017069|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83017070|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
83017071|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83017072|NCT02098460|Protective Agents|protective agents|mesh-ancestor
83017073|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83017074|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83017075|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
83017076|NCT02095574|Venetoclax|venetoclax|mesh-list
83017077|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017078|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83017079|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017080|NCT02095730|Vitamins|vitamins|mesh-list
83017081|NCT02095730|Riboflavin|riboflavin|mesh-list
83017082|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
83017083|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
83017084|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017085|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83017086|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
83017087|NCT02102438|Paclitaxel|paclitaxel|mesh-list
83017088|NCT02102438|Carboplatin|carboplatin|mesh-list
83017089|NCT02102438|Trastuzumab|trastuzumab|mesh-list
83017090|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83017091|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017092|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
83017093|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
83017094|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
83017095|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017096|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017097|NCT02098616|Asunaprevir|asunaprevir|mesh-list
83017098|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017099|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017100|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017101|NCT02102516|Ketorolac|ketorolac|mesh-list
83017102|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83017103|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83017104|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017105|NCT02102516|Analgesics|analgesics|mesh-ancestor
83017106|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
83017107|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017108|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017109|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017110|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017111|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83017112|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017113|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017114|NCT02106182|Silodosin|silodosin|mesh-list
83017115|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83017116|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83017117|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83017118|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
83017119|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017120|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017121|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017122|NCT02106182|Urological Agents|urological agents|mesh-ancestor
83017123|NCT01369693|Lobeline|lobeline|mesh-list
83017124|NCT01369693|Nicotine|nicotine|mesh-list
83017125|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83017126|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
83017127|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017128|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017129|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83017130|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83017131|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
83017132|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017133|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017134|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
83017135|NCT02102594|Bortezomib|bortezomib|mesh-list
83017136|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017137|NCT02102672|Trimetazidine|trimetazidine|mesh-list
83017138|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
83017139|NCT02106338|REP 3123|rep 3123|mesh-list
83017140|NCT02106338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83017141|NCT02106338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017142|NCT03121261|Clonidine|clonidine|mesh-list
83017143|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
83017144|NCT03121261|Analgesics|analgesics|mesh-ancestor
83017145|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
83017146|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017147|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017148|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83017149|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
83017150|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
83017151|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83017152|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83017153|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83017154|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83017155|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017156|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017157|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
83017158|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
83017159|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017160|NCT04249323|Prednisone|prednisone|mesh-list
83017161|NCT04249323|Cortisone|cortisone|mesh-list
83017162|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017163|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
83017164|NCT04249323|Hormones|hormones|mesh-ancestor
83017165|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017166|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017167|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017168|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017169|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83017170|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83017171|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017172|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017173|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83017174|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
83017175|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017176|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017177|NCT02102828|Aspirin|aspirin|mesh-list
83017178|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83017179|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017180|NCT02102828|Analgesics|analgesics|mesh-ancestor
83017181|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
83017182|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017183|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017184|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017185|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017186|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83017187|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83017188|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017189|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83017190|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83017191|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017192|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
83017193|NCT01372423|Lubiprostone|lubiprostone|mesh-list
83017194|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83017195|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83017196|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017197|NCT04218357|Probenecid|probenecid|mesh-list
83017198|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
83017199|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
83017200|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017201|NCT02106650|Leucovorin|leucovorin|mesh-list
83017202|NCT02106650|Folic Acid|folic acid|mesh-list
83017203|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
83017204|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
83017205|NCT02106650|Vitamins|vitamins|mesh-ancestor
83017206|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
83017207|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017208|NCT02106650|Antidotes|antidotes|mesh-ancestor
83017209|NCT02106650|Protective Agents|protective agents|mesh-ancestor
83017210|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
83017211|NCT02106650|Hematinics|hematinics|mesh-ancestor
83017212|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83017213|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017214|NCT01376011|Quercetin|quercetin|mesh-list
83017215|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
83017216|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017217|NCT01376011|Protective Agents|protective agents|mesh-ancestor
83017218|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017219|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
83017220|NCT04033107|Metformin|metformin|mesh-list
83017221|NCT04033107|Vitamins|vitamins|mesh-ancestor
83017222|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
83017223|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017224|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83017225|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
83017226|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017227|NCT04033107|Protective Agents|protective agents|mesh-ancestor
83017228|NCT02106806|Zinc|zinc|mesh-list
83017229|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
83017230|NCT02106806|Trace Elements|trace elements|mesh-ancestor
83017231|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
83017232|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017233|NCT02106806|Astringents|astringents|mesh-ancestor
83017234|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
83017235|NCT02966119|Aspirin|aspirin|mesh-list
83017236|NCT02966119|Clopidogrel|clopidogrel|mesh-list
83017237|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83017238|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017239|NCT02966119|Analgesics|analgesics|mesh-ancestor
83017240|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
83017241|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017242|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017243|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017244|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017245|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83017246|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83017247|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017248|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83017249|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83017250|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017251|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
83017252|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83017253|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83017254|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83017255|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
83017256|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017257|NCT02101892|Amitriptyline|amitriptyline|mesh-list
83017258|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83017259|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
83017260|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83017261|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017262|NCT02101892|Analgesics|analgesics|mesh-ancestor
83017263|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
83017264|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017265|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017266|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83017267|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83017268|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83017269|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017270|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
83017271|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017273|NCT03634111|Ropivacaine|ropivacaine|mesh-list
83017274|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83017275|NCT03634111|Narcotics|narcotics|mesh-ancestor
83017276|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017277|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017278|NCT03634111|Analgesics|analgesics|mesh-ancestor
83017279|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
83017280|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017281|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
83017282|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
83017283|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83017284|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83017285|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83017286|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017287|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017288|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017289|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83017290|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83017291|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
83017292|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017293|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
83017294|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83017295|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
83017296|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83017297|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017298|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83017299|NCT02250794|Insulin|insulin|mesh-list
83017300|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83017301|NCT02250794|Metformin|metformin|mesh-list
83017302|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
83017303|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83017304|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
83017305|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83017306|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017307|NCT02250794|Incretins|incretins|mesh-ancestor
83017308|NCT02250794|Hormones|hormones|mesh-ancestor
83017309|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017310|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83017311|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017312|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017313|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017314|NCT02103374|Terbutaline|terbutaline|mesh-list
83017315|NCT02103374|Ipratropium|ipratropium|mesh-list
83017316|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83017317|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
83017318|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017319|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017320|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83017321|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
83017322|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83017323|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
83017324|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017325|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017326|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
83017327|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
83017328|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83017329|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83017330|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83017331|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83017332|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
83017333|NCT03555188|Ondansetron|ondansetron|mesh-list
83017334|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
83017335|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
83017336|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017337|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017338|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017339|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
83017340|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83017341|NCT03555188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83017342|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83017343|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
83017344|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017345|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017346|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
83017347|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83017348|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017349|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
83017350|NCT03117361|Dexamethasone|dexamethasone|mesh-list
83017351|NCT03117361|Bortezomib|bortezomib|mesh-list
83017352|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017353|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
83017354|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
83017355|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017356|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017357|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017358|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
83017359|NCT03117361|Hormones|hormones|mesh-ancestor
83017360|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017361|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017362|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017363|NCT03053427|Gabapentin|gabapentin|mesh-list
83017364|NCT03053427|Analgesics|analgesics|mesh-ancestor
83017365|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
83017366|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017367|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361591|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361592|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83361593|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
83361594|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83361595|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83361596|NCT01581281|Analgesics|analgesics|mesh-ancestor
83361597|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
83361598|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017368|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
83017369|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83017370|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83017371|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017372|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83017373|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83017374|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83017375|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017376|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017377|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
83017378|NCT02107118|Complement Factor H|complement factor h|mesh-list
83017379|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83017380|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83017381|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
83017382|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017383|NCT05081089|Lumefantrine|lumefantrine|mesh-list
83017384|NCT05081089|Artemether|artemether|mesh-list
83017385|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
83017386|NCT05081089|Primaquine|primaquine|mesh-list
83017387|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
83017388|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83017389|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83017390|NCT05081089|Amodiaquine|amodiaquine|mesh-list
83017391|NCT05081089|Tafenoquine|tafenoquine|mesh-list
83017392|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
83017393|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83017394|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83017395|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017396|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83017397|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017398|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017399|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83017400|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83017401|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017402|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017403|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83017404|NCT03554408|Antibodies|antibodies|mesh-list
83017405|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
83017406|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83017407|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
83017408|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017409|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017410|NCT02103686|Pregabalin|pregabalin|mesh-list
83017411|NCT02103686|Analgesics|analgesics|mesh-ancestor
83017412|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
83017413|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017414|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017416|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83017417|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83017418|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017419|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83017420|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83017421|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83017422|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017423|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83017424|NCT02110082|Cetuximab|cetuximab|mesh-list
83017425|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017426|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017427|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83017428|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
83017429|NCT02103764|Desogestrel|desogestrel|mesh-list
83017430|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83017431|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83017432|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83017433|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
83017434|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83361599|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83361600|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83361601|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83361602|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361603|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
83361604|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361605|NCT01580969|Minocycline|minocycline|mesh-list
83017435|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017436|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83017437|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83017438|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83017439|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017440|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017441|NCT02103764|Progestins|progestins|mesh-ancestor
83017442|NCT02103764|Hormones|hormones|mesh-ancestor
83017443|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017444|NCT02110316|Voriconazole|voriconazole|mesh-list
83017445|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
83017446|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017447|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83017448|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83017449|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017450|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017451|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83017452|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
83017453|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017454|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017455|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83017456|NCT05625087|Fulvestrant|fulvestrant|mesh-list
83017457|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017458|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017459|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83017460|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83017461|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
83017462|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017463|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017464|NCT02110394|Rituximab|rituximab|mesh-list
83017465|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83017466|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017467|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017468|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
83017469|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017470|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017471|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83017472|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
83017473|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017474|NCT02373241|Losartan|losartan|mesh-list
83017475|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83017476|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83017477|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83017478|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83017479|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017480|NCT05656131|Fluzoparib|fluzoparib|mesh-list
83017481|NCT05656131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83017482|NCT05656131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017483|NCT05656131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017484|NCT05656131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017485|NCT02103998|Iodine|iodine|mesh-list
83017486|NCT02103998|Hormones|hormones|mesh-list
83017487|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017488|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017489|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83017490|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017491|NCT02103998|Trace Elements|trace elements|mesh-ancestor
83017492|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
83017493|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
83017494|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83017495|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83017496|NCT01941589|Prednisolone|prednisolone|mesh-list
83017497|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
83017498|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
83017499|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83017500|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83017501|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83017502|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83017503|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
83017504|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017505|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
83017506|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
83017507|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017508|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017509|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017510|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
83017511|NCT01941589|Hormones|hormones|mesh-ancestor
83017512|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017513|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83017514|NCT01941589|Protective Agents|protective agents|mesh-ancestor
83017515|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017516|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017517|NCT01845649|Estradiol|estradiol|mesh-list
83017518|NCT01845649|Estrogens|estrogens|mesh-ancestor
83017519|NCT01845649|Hormones|hormones|mesh-ancestor
83017520|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017521|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017522|NCT01345929|Levofloxacin|levofloxacin|mesh-list
83017523|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83017524|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017525|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83017526|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83017527|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83017528|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017529|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017530|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017531|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83017532|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83017533|NCT02107742|Lidocaine|lidocaine|mesh-list
83017534|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
83017535|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
83017536|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017537|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017538|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
83017539|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017540|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83017541|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83017542|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83017543|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83017544|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017545|NCT02250872|Cisplatin|cisplatin|mesh-list
83017546|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017547|NCT02110784|Piperaquine|piperaquine|mesh-list
83017548|NCT02110784|Artenimol|artenimol|mesh-list
83017549|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
83017550|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83017551|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83017552|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017553|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
83017554|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83017555|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83017556|NCT04988425|Prednisolone|prednisolone|mesh-list
83017557|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
83017558|NCT04988425|Antibodies|antibodies|mesh-list
83017559|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83017560|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83017561|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
83017562|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
83017563|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017564|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017565|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
83017566|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
83017567|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017568|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017569|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
83017570|NCT04988425|Hormones|hormones|mesh-ancestor
83017571|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017572|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83017573|NCT04988425|Protective Agents|protective agents|mesh-ancestor
83017574|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017575|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017576|NCT01343901|Bevacizumab|bevacizumab|mesh-list
83017577|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017578|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017579|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83017580|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83017581|NCT01343901|Growth Substances|growth substances|mesh-ancestor
83017582|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017583|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
83017584|NCT05617521|Caffeine|caffeine|mesh-list
83017585|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83017586|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017587|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83017588|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017589|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017590|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83017591|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83017592|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
83017593|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017594|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83017595|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017596|NCT02104700|Tenofovir|tenofovir|mesh-list
83017597|NCT02104700|Emtricitabine|emtricitabine|mesh-list
83017598|NCT02104700|Rilpivirine|rilpivirine|mesh-list
83017599|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
83017600|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017601|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83017602|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83017603|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017604|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017605|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83017606|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83017607|NCT02104778|Dexamethasone|dexamethasone|mesh-list
83017608|NCT02104778|Epinephrine|epinephrine|mesh-list
83017609|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017610|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
83017611|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
83017612|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017613|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017614|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017615|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
83017616|NCT02104778|Hormones|hormones|mesh-ancestor
83017617|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017618|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017619|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017620|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83017621|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83017622|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
83017623|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83431556|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017624|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017625|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83017626|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83017628|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
83017629|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
83017630|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
83017631|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83017632|NCT02108366|Oseltamivir|oseltamivir|mesh-list
83017633|NCT02108366|Celecoxib|celecoxib|mesh-list
83017634|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83017635|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017636|NCT02108366|Analgesics|analgesics|mesh-ancestor
83017637|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
83017638|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017639|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017640|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017641|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017642|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83017643|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83017644|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017645|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017646|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
83017647|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017648|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83017649|NCT05706207|Antibodies|antibodies|mesh-list
83017650|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
83017651|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83017652|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
83017653|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017654|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017655|NCT02105090|Anesthetics|anesthetics|mesh-list
83017656|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
83017657|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017658|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017659|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017660|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
83017661|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
83017662|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83017663|NCT03553628|Propolis|propolis|mesh-list
83017664|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83017665|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017666|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
83017667|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
83017668|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83017669|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
83017670|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017671|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017672|NCT02112032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83017673|NCT02112032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017674|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
83017675|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017676|NCT01343823|Ecallantide|ecallantide|mesh-list
83017677|NCT01343823|Analgesics|analgesics|mesh-ancestor
83017678|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
83017679|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017680|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017681|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83017682|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017683|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017684|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017685|NCT02251184|Aspirin|aspirin|mesh-list
83017686|NCT02251184|Dipyridamole|dipyridamole|mesh-list
83017687|NCT02251184|Lansoprazole|lansoprazole|mesh-list
83017688|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
83017689|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83017690|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83017691|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017692|NCT02251184|Analgesics|analgesics|mesh-ancestor
83017693|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
83017694|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017695|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017696|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017697|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017698|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83017699|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83017700|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017701|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83017702|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83017703|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017705|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83017706|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017707|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83017708|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83017709|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
83017710|NCT02108756|Pantoprazole|pantoprazole|mesh-list
83017711|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83017712|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017713|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83017714|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017715|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017716|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
83017717|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017718|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83017719|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017720|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017721|NCT01318083|Glimepiride|glimepiride|mesh-list
83017722|NCT01318083|Alogliptin|alogliptin|mesh-list
83017723|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83017724|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83017725|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017726|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83017727|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
83017728|NCT01318083|Incretins|incretins|mesh-ancestor
83017729|NCT01318083|Hormones|hormones|mesh-ancestor
83017730|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017731|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83017732|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017733|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017734|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017735|NCT05545137|Fosfomycin|fosfomycin|mesh-list
83017736|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
83017737|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83017738|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017739|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83017740|NCT02105714|Formaldehyde|formaldehyde|mesh-list
83017741|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
83017742|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017743|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83017744|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83017745|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017746|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83017747|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017748|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017749|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017750|NCT03817515|Sirolimus|sirolimus|mesh-list
83017751|NCT03817515|Temsirolimus|temsirolimus|mesh-list
83017752|NCT03817515|MTOR Inhibitors|mtor inhibitors|mesh-list
83017753|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83017754|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017755|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83017756|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017757|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
83017758|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83017759|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
83017760|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017761|NCT03817515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83017762|NCT03817515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017763|NCT03817515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017764|NCT02105870|Abciximab|abciximab|mesh-list
83017765|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
83017766|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83017767|NCT02112422|Dexamethasone|dexamethasone|mesh-list
83017768|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
83017769|NCT02112422|BB 1101|bb 1101|mesh-list
83017770|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017771|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
83017772|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
83017773|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017774|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017775|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017776|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
83017777|NCT02112422|Hormones|hormones|mesh-ancestor
83017778|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017780|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017781|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017782|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017783|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017784|NCT02109614|Niacin|niacin|mesh-list
83017785|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83017786|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
83017787|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017788|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83017789|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
83017790|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
83017791|NCT02109614|Vitamins|vitamins|mesh-ancestor
83017792|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
83017793|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017794|NCT02106104|Glimepiride|glimepiride|mesh-list
83017795|NCT02106104|Linagliptin|linagliptin|mesh-list
83017796|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83017797|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83017798|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017800|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
83017801|NCT02106104|Incretins|incretins|mesh-ancestor
83017802|NCT02106104|Hormones|hormones|mesh-ancestor
83017803|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017804|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83017805|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017806|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017807|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017808|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83017809|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83017810|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017811|NCT01376323|Incretins|incretins|mesh-ancestor
83017812|NCT01376323|Hormones|hormones|mesh-ancestor
83017813|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017814|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83017815|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
83017816|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017817|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017818|NCT02113904|Adalimumab|adalimumab|mesh-list
83017819|NCT02113904|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83017820|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017821|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017822|NCT05438979|Calcium|calcium|mesh-list
83017823|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83017824|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017825|NCT05432115|Amoxicillin|amoxicillin|mesh-list
83017826|NCT05432115|Tetracycline|tetracycline|mesh-list
83017827|NCT05432115|Esomeprazole|esomeprazole|mesh-list
83017828|NCT05432115|Bismuth|bismuth|mesh-list
83017829|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83017830|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017831|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83017832|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83017833|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83017834|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017835|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017836|NCT05432115|Antacids|antacids|mesh-ancestor
83017837|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83017838|NCT02114528|Amiodarone|amiodarone|mesh-list
83017839|NCT02114528|Sotalol|sotalol|mesh-list
83017840|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83017841|NCT02114528|Mexiletine|mexiletine|mesh-list
83017842|NCT02114528|Procainamide|procainamide|mesh-list
83017843|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
83017844|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83017845|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83017846|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017847|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83017848|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83017849|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83017850|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017851|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83017852|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83017853|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83017854|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83017855|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83017856|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
83017857|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017858|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017859|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
83017860|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
83017861|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017862|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83017863|NCT02113202|Bevacizumab|bevacizumab|mesh-list
83017864|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017865|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017866|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83017867|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83017868|NCT02113202|Growth Substances|growth substances|mesh-ancestor
83017869|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017870|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
83017871|NCT01376401|Prednisone|prednisone|mesh-list
83017872|NCT01376401|Bortezomib|bortezomib|mesh-list
83017873|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83017874|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017875|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
83017876|NCT01376401|Hormones|hormones|mesh-ancestor
83017877|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017878|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017879|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83017880|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017881|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83017882|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
83017883|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017884|NCT02119520|Atorvastatin|atorvastatin|mesh-list
83017885|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83017886|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83017887|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
83017888|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017889|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83017890|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83017891|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017892|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
83017893|NCT03961789|Narcotics|narcotics|mesh-ancestor
83017894|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017895|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017896|NCT03961789|Analgesics|analgesics|mesh-ancestor
83017897|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
83017898|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017899|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83017900|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
83017901|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
83017902|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017903|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017904|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83017905|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83017906|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83017907|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
83017908|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83017909|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83017910|NCT01376713|Dacarbazine|dacarbazine|mesh-list
83017911|NCT01376713|Ofatumumab|ofatumumab|mesh-list
83017912|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83017913|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83017914|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
83017915|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017916|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017917|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
83017918|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017919|NCT03728179|Aspirin|aspirin|mesh-list
83017920|NCT03728179|Celecoxib|celecoxib|mesh-list
83017921|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
83017922|NCT03728179|Nivolumab|nivolumab|mesh-list
83017923|NCT03728179|Ipilimumab|ipilimumab|mesh-list
83017924|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83017925|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
83017926|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017927|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83017928|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83017929|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
83017930|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017931|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83017932|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83017933|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83017934|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83017935|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83017936|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017937|NCT03728179|Analgesics|analgesics|mesh-ancestor
83017938|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
83017939|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017940|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017941|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83017942|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83017943|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83017944|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83017945|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83017946|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
83017947|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83017948|NCT01368536|Amlodipine|amlodipine|mesh-list
83017949|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
83017950|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83017951|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83017952|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83017953|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017954|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83017955|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017956|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
83017957|NCT01368536|Diuretics|diuretics|mesh-ancestor
83017958|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
83017959|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83017960|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
83017961|NCT05103735|Remifentanil|remifentanil|mesh-list
83017962|NCT05103735|Propofol|propofol|mesh-list
83017963|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83017964|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83017965|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017966|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83017967|NCT05103735|Analgesics|analgesics|mesh-ancestor
83017968|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
83017969|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83017970|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83017971|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83017972|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83017973|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
83017974|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017975|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017976|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83017977|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
83017978|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
83017979|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83017980|NCT05103735|Narcotics|narcotics|mesh-ancestor
83017981|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
83017982|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83017983|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83017984|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83017985|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83017986|NCT01319929|Hormones|hormones|mesh-ancestor
83017987|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83017988|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83017989|NCT03633565|Prednisolone|prednisolone|mesh-list
83017990|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83017991|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
83017992|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83017993|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
83017994|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
83017995|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83017996|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
83017997|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
83017998|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83017999|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
83018000|NCT03633565|Hormones|hormones|mesh-ancestor
83482277|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018001|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018002|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018003|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83018004|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018005|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
83018006|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
83018007|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018008|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018009|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83018010|NCT03633565|Protective Agents|protective agents|mesh-ancestor
83018011|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
83018012|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83018013|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018014|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018015|NCT03633565|Urological Agents|urological agents|mesh-ancestor
83018016|NCT02120066|Plasminogen|plasminogen|mesh-list
83018017|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83018018|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83018019|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83018020|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018021|NCT01373359|Misoprostol|misoprostol|mesh-list
83018022|NCT01373359|Oxytocin|oxytocin|mesh-list
83018023|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
83018024|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83018025|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018026|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83018027|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
83018028|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83018029|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018030|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
83018031|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83018032|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018033|NCT02251964|Rituximab|rituximab|mesh-list
83018034|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83018035|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018036|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
83018037|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018038|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018039|NCT04739995|Naltrexone|naltrexone|mesh-list
83018040|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83018041|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83018042|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018043|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
83018044|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018045|NCT02120612|Naloxone|naloxone|mesh-list
83018046|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83018047|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018048|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
83018049|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018050|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
83018051|NCT02115152|Fluorouracil|fluorouracil|mesh-list
83018052|NCT02115152|Capecitabine|capecitabine|mesh-list
83018053|NCT02115152|Epirubicin|epirubicin|mesh-list
83018054|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83018055|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
83018056|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018057|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018058|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83018059|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
83018060|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018061|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018062|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83018063|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
83018064|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83018065|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83018066|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83018067|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018068|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018069|NCT02115464|Metformin|metformin|mesh-list
83018070|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83018071|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018072|NCT02858076|Aflibercept|aflibercept|mesh-list
83018073|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
83018074|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83018075|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83018076|NCT02858076|Growth Substances|growth substances|mesh-ancestor
83018077|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018078|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
83018079|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018080|NCT01319695|Hormones|hormones|mesh-list
83018081|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83018082|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018083|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018084|NCT04594759|Isotretinoin|isotretinoin|mesh-list
83018085|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
83018086|NCT02123498|Omeprazole|omeprazole|mesh-list
83018087|NCT02123498|Pantoprazole|pantoprazole|mesh-list
83018088|NCT02123498|Ranitidine|ranitidine|mesh-list
83018089|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83018090|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83018091|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018092|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83018093|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018094|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018095|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83018096|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
83018097|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
83361607|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83018098|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018099|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018100|NCT02115776|Amoxicillin|amoxicillin|mesh-list
83018101|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
83018102|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
83018103|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
83018104|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83018105|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018106|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83018107|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
83018108|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83018109|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018110|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018111|NCT02123654|Asunaprevir|asunaprevir|mesh-list
83018112|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
83018113|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018114|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018115|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
83018116|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83018117|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83018118|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018119|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83018120|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83018121|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
83018122|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83018123|NCT03609294|Linagliptin|linagliptin|mesh-list
83018124|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83018125|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018126|NCT03609294|Incretins|incretins|mesh-ancestor
83018127|NCT03609294|Hormones|hormones|mesh-ancestor
83018128|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018129|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83018130|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
83018131|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018132|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018133|NCT01917552|Capecitabine|capecitabine|mesh-list
83018134|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83018135|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
83018136|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018137|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018138|NCT01873326|Paclitaxel|paclitaxel|mesh-list
83018139|NCT01873326|Etoposide|etoposide|mesh-list
83018140|NCT01873326|Ifosfamide|ifosfamide|mesh-list
83018141|NCT01873326|Bleomycin|bleomycin|mesh-list
83018142|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83018143|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018144|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83018145|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83018146|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83018147|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018148|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83018149|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018150|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018151|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83018153|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83018154|NCT01261728|Gemcitabine|gemcitabine|mesh-list
83018155|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018156|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83018157|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
83018158|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018159|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
83018160|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
83018161|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83018162|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018163|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018164|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
83018165|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83018166|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018167|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018168|NCT03119701|Interferons|interferons|mesh-list
83018169|NCT03119701|Interferon-beta|interferon-beta|mesh-list
83018170|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
83018171|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018172|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
83018174|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
83018175|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018176|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83018177|NCT03717129|Tenofovir|tenofovir|mesh-list
83018178|NCT03717129|Emtricitabine|emtricitabine|mesh-list
83018179|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83018180|NCT03717129|Cobicistat|cobicistat|mesh-list
83018181|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83018182|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83018183|NCT03717129|Elvitegravir|elvitegravir|mesh-list
83018184|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
83018185|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018186|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83018187|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83018188|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018189|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018190|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83018191|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83018192|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83018193|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83018194|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83018195|NCT03627039|Metformin|metformin|mesh-list
83018196|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
83018197|NCT03627039|Empagliflozin|empagliflozin|mesh-list
83018198|NCT03627039|Canagliflozin|canagliflozin|mesh-list
83018199|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83018200|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018201|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83018202|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018203|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
83018204|NCT01374373|Hematinics|hematinics|mesh-ancestor
83018205|NCT02116556|Rifaximin|rifaximin|mesh-list
83018206|NCT02116556|Prednisone|prednisone|mesh-list
83018207|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83018208|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
83018209|NCT02116556|Hormones|hormones|mesh-ancestor
83018210|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018211|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018212|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83018213|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018214|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83018215|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018216|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018217|NCT03634345|Fluconazole|fluconazole|mesh-list
83018218|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
83018219|NCT03634345|Abrocitinib|abrocitinib|mesh-list
83018220|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
83018221|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018222|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83018223|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83018224|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482278|NCT00528398|Cytarabine|cytarabine|mesh-list
83018225|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018226|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83018227|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
83018228|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018229|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018230|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83018231|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83018232|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83018233|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83018234|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018235|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83018236|NCT03634345|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83018237|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83018238|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83018239|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018240|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
83018241|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83018242|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
83018243|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83018244|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83018245|NCT03553238|Cytarabine|cytarabine|mesh-list
83018246|NCT03553238|Dexamethasone|dexamethasone|mesh-list
83018247|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
83018248|NCT03553238|Methotrexate|methotrexate|mesh-list
83018249|NCT03553238|Etoposide|etoposide|mesh-list
83018250|NCT03553238|Vincristine|vincristine|mesh-list
83018251|NCT03553238|Doxorubicin|doxorubicin|mesh-list
83018252|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
83018253|NCT03553238|Idarubicin|idarubicin|mesh-list
83018254|NCT03553238|Pegaspargase|pegaspargase|mesh-list
83018255|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83018256|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
83018257|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018258|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018259|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83018260|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
83018261|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018262|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018263|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83018264|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83018265|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
83018266|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
83018267|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018268|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018269|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
83018270|NCT03553238|Hormones|hormones|mesh-ancestor
83018271|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018272|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83018273|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83018274|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
83018275|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83018276|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83018277|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
83018278|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
83018279|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018280|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83018281|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83018282|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83431587|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
83018283|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83018284|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018285|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
83018286|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018287|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
83018288|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
83018289|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
83018290|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83018291|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
83018292|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83018293|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018294|NCT01373593|Lidocaine|lidocaine|mesh-list
83018295|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
83018296|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
83018297|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018298|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018299|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
83018300|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018301|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83018302|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83018303|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83018304|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83018305|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018306|NCT02116712|Saracatinib|saracatinib|mesh-list
83018307|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018308|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018309|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018310|NCT02116790|Naproxen|naproxen|mesh-list
83018311|NCT02116790|Levodopa|levodopa|mesh-list
83018312|NCT02116790|Carbidopa|carbidopa|mesh-list
83018313|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83018314|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83018315|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83018316|NCT02116790|Analgesics|analgesics|mesh-ancestor
83018317|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
83361608|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018318|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018319|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018320|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83018321|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018322|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
83018323|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83018324|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018325|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018326|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83018327|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83018329|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018330|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83018331|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83018332|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
83018333|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
83018334|NCT02859961|Leronlimab|leronlimab|mesh-list
83018335|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
83018336|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83018337|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83018338|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018339|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83018340|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83018341|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
83018342|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018343|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
83018344|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018345|NCT02124200|Nicotine|nicotine|mesh-list
83018346|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83018347|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
83018348|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018349|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018350|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83018351|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83018352|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
83018353|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018354|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018355|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
83018356|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83018357|NCT04503993|Antibodies|antibodies|mesh-list
83018358|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
83018359|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
83018360|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018361|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
83018362|NCT02116868|Nicardipine|nicardipine|mesh-list
83018363|NCT02116868|Urapidil|urapidil|mesh-list
83018364|NCT02116868|Remifentanil|remifentanil|mesh-list
83018365|NCT02116868|Esmolol|esmolol|mesh-list
83018366|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83018367|NCT02116868|Narcotics|narcotics|mesh-ancestor
83018368|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018369|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018370|NCT02116868|Analgesics|analgesics|mesh-ancestor
83018371|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
83018372|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018373|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83018374|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83018376|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
83018377|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018378|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018379|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83018380|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83018381|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83018382|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
83018383|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83018384|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
83018385|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83018386|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83018387|NCT02679781|Midazolam|midazolam|mesh-list
83018388|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83018389|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83018390|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018391|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018392|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83018393|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83018394|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83018395|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83018396|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
83018397|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
83018398|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
83018399|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
83018400|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018401|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018402|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
83018403|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83018404|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018405|NCT04373031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83018406|NCT04373031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018407|NCT02624869|Evolocumab|evolocumab|mesh-list
83018408|NCT02624869|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83018409|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83018410|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83018411|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
83018412|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018413|NCT02624869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83018414|NCT02624869|Protease Inhibitors|protease inhibitors|mesh-ancestor
83018415|NCT02624869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018416|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83018417|NCT02121782|Vaccines|vaccines|mesh-list
83018418|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
83018419|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018420|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
83018421|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
83018422|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018423|NCT03553082|Propofol|propofol|mesh-list
83018424|NCT03553082|Sevoflurane|sevoflurane|mesh-list
83018425|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83018426|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018427|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018428|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83018429|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
83018430|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
83431589|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
83018431|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83018432|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83018433|NCT03318393|Heparin|heparin|mesh-list
83018434|NCT03318393|Calcium heparin|calcium heparin|mesh-list
83018435|NCT03318393|Bivalirudin|bivalirudin|mesh-list
83018436|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
83018437|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83018438|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83018439|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018440|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
83018441|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83018442|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
83018443|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018444|NCT03110029|Efinaconazole|efinaconazole|mesh-list
83018445|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
83018446|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018447|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
83018448|NCT03552146|Propofol|propofol|mesh-list
83482279|NCT00528398|Idarubicin|idarubicin|mesh-list
83018449|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83018450|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018451|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018452|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83018453|NCT03552146|Analgesics|analgesics|mesh-ancestor
83018454|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
83018455|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018456|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83018457|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83018458|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83018459|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83018460|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018461|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018462|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83018463|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
83018464|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
83018465|NCT01374763|Oxycodone|oxycodone|mesh-list
83018466|NCT01374763|Naloxone|naloxone|mesh-list
83018467|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83018468|NCT01374763|Narcotics|narcotics|mesh-ancestor
83018480|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018481|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018482|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83018483|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018484|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83018485|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83018486|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83018487|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018488|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
83018489|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83018490|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018491|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018492|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83018493|NCT04454515|Analgesics|analgesics|mesh-ancestor
83018494|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
83018495|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018496|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83018497|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83018498|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83018499|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
83018500|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018501|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018502|NCT03608514|Terlipressin|terlipressin|mesh-list
83018503|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83018504|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83018515|NCT02117726|Midazolam|midazolam|mesh-list
83018516|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
83018517|NCT02117726|Propofol|propofol|mesh-list
83018518|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83018519|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018520|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018521|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83018522|NCT02117726|Analgesics|analgesics|mesh-ancestor
83018523|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
83018524|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018525|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83018526|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83018527|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83018528|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
83018529|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018530|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018531|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83018532|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
83018533|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
83018534|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83018535|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83018536|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83018537|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83018538|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
83018539|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
83018540|NCT02733432|Fluconazole|fluconazole|mesh-list
83018541|NCT02733432|Rezafungin|rezafungin|mesh-list
83018542|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
83361610|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83018543|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018545|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83018546|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018547|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018548|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83018549|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
83018550|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018551|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018552|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83018553|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83018554|NCT03634189|Cannabidiol|cannabidiol|mesh-list
83018555|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
83018556|NCT03608046|Irinotecan|irinotecan|mesh-list
83018557|NCT03608046|Cetuximab|cetuximab|mesh-list
83018558|NCT03608046|Avelumab|avelumab|mesh-list
83018559|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83018560|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018561|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018562|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018563|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018564|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83018565|NCT02122484|Colchicine|colchicine|mesh-list
83018566|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
83018567|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018568|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
83018569|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
83018570|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
83018571|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018572|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018573|NCT03606018|Insulin|insulin|mesh-list
83018574|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83018575|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
83018576|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83018577|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018578|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
83018579|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
83018580|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83018581|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83018582|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018583|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018584|NCT01373749|Urological Agents|urological agents|mesh-ancestor
83018585|NCT04045795|Dexamethasone|dexamethasone|mesh-list
83018586|NCT04045795|Pomalidomide|pomalidomide|mesh-list
83018587|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83018588|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83018589|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
83018590|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
83018591|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018592|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018593|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018594|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
83018595|NCT04045795|Hormones|hormones|mesh-ancestor
83018596|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018597|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83018598|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018599|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
83018600|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83018601|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83018602|NCT04045795|Growth Substances|growth substances|mesh-ancestor
83018603|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
83018604|NCT03605940|Methoxsalen|methoxsalen|mesh-list
83018605|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83018606|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
83018607|NCT03607734|Amoxicillin|amoxicillin|mesh-list
83018608|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83018609|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018610|NCT02035488|Tobramycin|tobramycin|mesh-list
83018611|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83018612|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018613|NCT03602430|Vitamin D|vitamin d|mesh-list
83018614|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
83018615|NCT03602430|Vitamins|vitamins|mesh-ancestor
83018616|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
83018617|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018618|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83018619|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83018621|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83018622|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83018623|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018624|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83018625|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018626|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018627|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018628|NCT05470647|Interleukin-4|interleukin-4|mesh-list
83018629|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83018630|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
83018631|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018632|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018633|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018634|NCT04409665|Ketamine|ketamine|mesh-list
83018635|NCT04409665|Analgesics|analgesics|mesh-ancestor
83018636|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
83018637|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018638|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018639|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83018640|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83018641|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
83018642|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
83018643|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018644|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83018645|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83018646|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018647|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018648|NCT02854800|Varenicline|varenicline|mesh-list
83018649|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83018650|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83018651|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
83018652|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018653|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018654|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018655|NCT03552770|Bevacizumab|bevacizumab|mesh-list
83018656|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83018657|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018658|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83018659|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83018660|NCT03552770|Growth Substances|growth substances|mesh-ancestor
83018661|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018662|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
83018663|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83018664|NCT02127164|Eusol|eusol|mesh-list
83018665|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
83018666|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018667|NCT02931539|Valganciclovir|valganciclovir|mesh-list
83018668|NCT02931539|Ganciclovir|ganciclovir|mesh-list
83018669|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83018670|NCT02931539|Cidofovir|cidofovir|mesh-list
83018671|NCT02931539|Foscarnet|foscarnet|mesh-list
83018672|NCT02931539|Maribavir|maribavir|mesh-list
83018673|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
83018674|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018675|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83018676|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018677|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018678|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83018679|NCT03602118|Phenobarbital|phenobarbital|mesh-list
83018680|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
83018681|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83018682|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018683|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018684|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83018685|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83018686|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018687|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018688|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
83018689|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
83018690|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83018691|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83018692|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83361611|NCT01580969|Growth Substances|growth substances|mesh-ancestor
83018694|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83018695|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83018696|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
83018697|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018698|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83018699|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83018700|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018701|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
83018702|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83018703|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83018704|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83018705|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018706|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
83018707|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018708|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018709|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83018710|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018711|NCT02131220|Tirofiban|tirofiban|mesh-list
83018712|NCT02131220|Saruplase|saruplase|mesh-list
83018713|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83018714|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83018715|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018716|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83018717|NCT04042077|Vancomycin|vancomycin|mesh-list
83018718|NCT04042077|Linezolid|linezolid|mesh-list
83018719|NCT04042077|Tazobactam|tazobactam|mesh-list
83018720|NCT04042077|Piperacillin|piperacillin|mesh-list
83018721|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83018722|NCT04042077|Tigecycline|tigecycline|mesh-list
83018723|NCT04042077|Delafloxacin|delafloxacin|mesh-list
83018724|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83018725|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018726|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83018727|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018728|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018729|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83018730|NCT03557359|Nivolumab|nivolumab|mesh-list
83018731|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83018732|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018733|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83018734|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018735|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83018736|NCT02127320|Ezetimibe|ezetimibe|mesh-list
83018737|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83018738|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83018739|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
83018740|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018741|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83018742|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83018743|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018744|NCT03522415|Methotrexate|methotrexate|mesh-list
83018745|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83018746|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
83018747|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83018748|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018749|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83018750|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
83018751|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018752|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018753|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
83018754|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018755|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83018756|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83018757|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
83018758|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018759|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83018760|NCT04226833|Entrectinib|entrectinib|mesh-list
83018761|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83018762|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018763|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018764|NCT02131298|Itraconazole|itraconazole|mesh-list
83018765|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83018766|NCT02131298|Palbociclib|palbociclib|mesh-list
83018767|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
83018768|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018769|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83018770|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83018771|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018772|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018773|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83018774|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
83018775|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018776|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018777|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83018778|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018779|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83018780|NCT01375387|Lacosamide|lacosamide|mesh-list
83018781|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
83018782|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83018783|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83018784|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83018785|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018786|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
83018787|NCT02853318|Bevacizumab|bevacizumab|mesh-list
83018788|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
83018789|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83018790|NCT02853318|Antibodies|antibodies|mesh-list
83018791|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
83018792|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83018793|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
83018794|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
83018795|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83018796|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
83018797|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018798|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83018799|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83018800|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
83018801|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018802|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018803|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83018804|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83018805|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83018806|NCT02853318|Growth Substances|growth substances|mesh-ancestor
83018807|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
83018808|NCT02853318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83018809|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
83018810|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83018811|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83018812|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
83018813|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
83018814|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018815|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018816|NCT03604224|Canagliflozin|canagliflozin|mesh-list
83018817|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83018818|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018819|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83018820|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018821|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83018822|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
83018823|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018824|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83018825|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83018826|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018827|NCT02404155|Clozapine|clozapine|mesh-list
83018828|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83018829|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
83018830|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018831|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018832|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018833|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83018834|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83018835|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83018836|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83018837|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
83361612|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361613|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
83018839|NCT02127788|Micafungin|micafungin|mesh-list
83018840|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
83018841|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018842|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
83018843|NCT02131688|Analgesics|analgesics|mesh-ancestor
83018844|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
83018845|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018846|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018847|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018848|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83018849|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018850|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018851|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018852|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83018853|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83018854|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
83018855|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018856|NCT02126462|Antacids|antacids|mesh-ancestor
83018857|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018858|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018859|NCT03113071|Decitabine|decitabine|mesh-list
83018860|NCT03113071|Digoxin|digoxin|mesh-list
83018861|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83018862|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
83018863|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018864|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018865|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018866|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83018867|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83018868|NCT03113071|Protective Agents|protective agents|mesh-ancestor
83018869|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018870|NCT03050307|Lansoprazole|lansoprazole|mesh-list
83018871|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
83018872|NCT03050307|Bismuth|bismuth|mesh-list
83018873|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83018874|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018875|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83018876|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018877|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018878|NCT03050307|Antacids|antacids|mesh-ancestor
83018879|NCT02127866|Beclomethasone|beclomethasone|mesh-list
83018880|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
83018881|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
83018882|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83018883|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
83018884|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018885|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018886|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83018887|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
83018888|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83018889|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83018890|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83018891|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
83018892|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83018893|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018894|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83018895|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83018896|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83018897|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
83018898|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83018899|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
83018900|NCT02127866|Hormones|hormones|mesh-ancestor
83018901|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018902|NCT03550508|Antibodies|antibodies|mesh-list
83018903|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83018904|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
83018905|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018906|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
83018907|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83018908|NCT03607578|Protective Agents|protective agents|mesh-ancestor
83018909|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018910|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
83018911|NCT05760079|Lactoferrin|lactoferrin|mesh-list
83018912|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83018913|NCT03603834|Leucovorin|leucovorin|mesh-list
83018914|NCT03603834|Fluorouracil|fluorouracil|mesh-list
83018916|NCT03603834|Irinotecan|irinotecan|mesh-list
83018917|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
83018918|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018919|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83018920|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018921|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83018922|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
83018923|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018924|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83018925|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018926|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018927|NCT03603834|Antidotes|antidotes|mesh-ancestor
83018928|NCT03603834|Protective Agents|protective agents|mesh-ancestor
83018929|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
83018930|NCT03603834|Vitamins|vitamins|mesh-ancestor
83018931|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
83018932|NCT03601338|Bemiparin|bemiparin|mesh-list
83018933|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
83018934|NCT02128022|Glyburide|glyburide|mesh-list
83018935|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83018936|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018937|NCT03256045|Dexamethasone|dexamethasone|mesh-list
83018938|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
83018939|NCT03256045|Panobinostat|panobinostat|mesh-list
83018940|NCT03256045|Ichthammol|ichthammol|mesh-list
83018941|NCT03256045|BB 1101|bb 1101|mesh-list
83018942|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83018943|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
83018944|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
83018945|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83018946|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018947|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83018948|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
83018949|NCT03256045|Hormones|hormones|mesh-ancestor
83018950|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83018951|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83018952|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018953|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
83018954|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018955|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018956|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83018957|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
83018958|NCT03603756|Paclitaxel|paclitaxel|mesh-list
83018959|NCT03603756|Irinotecan|irinotecan|mesh-list
83018960|NCT03603756|Apatinib|apatinib|mesh-list
83018961|NCT03603756|Nedaplatin|nedaplatin|mesh-list
83018962|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83018963|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018964|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
83018965|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
83018966|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
83018967|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018968|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83018969|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018970|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018971|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83018972|NCT02372409|Doxorubicin|doxorubicin|mesh-list
83018973|NCT02372409|Etoposide|etoposide|mesh-list
83018974|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
83018975|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83018976|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83018977|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83018978|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83018979|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018980|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018981|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83018982|NCT03626259|Losartan|losartan|mesh-list
83018983|NCT03626259|Amlodipine|amlodipine|mesh-list
83018984|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83018985|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83018986|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83018987|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018988|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83018989|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83018990|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
83018991|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83018992|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83018993|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83018994|NCT03601260|Allopurinol|allopurinol|mesh-list
83018995|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
83018996|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83018997|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83018998|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
83018999|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83019000|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83019001|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
83019002|NCT03601260|Protective Agents|protective agents|mesh-ancestor
83019003|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019004|NCT05193253|Liver Extracts|liver extracts|mesh-list
83019005|NCT05193253|Hematinics|hematinics|mesh-ancestor
83019006|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
83019007|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83019008|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019009|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
83019010|NCT03600948|Sirolimus|sirolimus|mesh-list
83019011|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83019012|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019013|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83019014|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019015|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
83019016|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83019017|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
83019018|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019019|NCT02132000|Tamoxifen|tamoxifen|mesh-list
83019020|NCT02132000|Toremifene|toremifene|mesh-list
83019021|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83019022|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
83019023|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83019024|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019025|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83019026|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019027|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83019028|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83019029|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83019030|NCT03118765|Bromides|bromides|mesh-list
83019031|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83019032|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
83019033|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83019034|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
83019035|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019036|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019037|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83019038|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019039|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
83019040|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83019041|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
83019042|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019043|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019044|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
83019045|NCT02128100|Leucovorin|leucovorin|mesh-list
83019046|NCT02128100|Fluorouracil|fluorouracil|mesh-list
83019047|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
83019048|NCT02128100|Irinotecan|irinotecan|mesh-list
83019049|NCT02128100|Folfirinox|folfirinox|mesh-list
83019050|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
83019051|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019052|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83019053|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019054|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83019055|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
83019056|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019057|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83019058|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83019059|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019060|NCT02128100|Antidotes|antidotes|mesh-ancestor
83019061|NCT02128100|Protective Agents|protective agents|mesh-ancestor
83019062|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
83019063|NCT02128100|Vitamins|vitamins|mesh-ancestor
83019064|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
83019065|NCT03603366|Aspirin|aspirin|mesh-list
83019066|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83361614|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83019068|NCT03603366|Analgesics|analgesics|mesh-ancestor
83019069|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
83019070|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019071|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019072|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83019073|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83019074|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83019075|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83019076|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019077|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83019078|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83019079|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019080|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
83019081|NCT02128178|Enoxaparin|enoxaparin|mesh-list
83019082|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
83019083|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
83019084|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83019085|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83019086|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019087|NCT03600870|Midodrine|midodrine|mesh-list
83019088|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
83019089|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
83019090|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019091|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019092|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83019093|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83019094|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83019095|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83019096|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019097|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019098|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019099|NCT02128334|Leuprolide|leuprolide|mesh-list
83019100|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83019101|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
83019102|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83431618|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83019103|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019104|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83019105|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019106|NCT01375699|Doxorubicin|doxorubicin|mesh-list
83019107|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83019108|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
83019109|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83019110|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019111|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83019112|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83019113|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019114|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019115|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019116|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83019117|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83019118|NCT01375699|Urological Agents|urological agents|mesh-ancestor
83019119|NCT01373983|Ziconotide|ziconotide|mesh-list
83019120|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83019121|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83019122|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019123|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83019124|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019125|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83019126|NCT01373983|Protective Agents|protective agents|mesh-ancestor
83019127|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019128|NCT01373983|Analgesics|analgesics|mesh-ancestor
83019129|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
83019130|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019131|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83019132|NCT05173597|Hormones|hormones|mesh-ancestor
83019133|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83019134|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019135|NCT05812612|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83019136|NCT05812612|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83019137|NCT05812612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83019138|NCT05812521|Methylene Blue|methylene blue|mesh-list
83019139|NCT05812521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019140|NCT05812521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019143|NCT05812430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83019144|NCT05812430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019145|NCT05812430|Tubulin Modulators|tubulin modulators|mesh-ancestor
83019146|NCT05812430|Antimitotic Agents|antimitotic agents|mesh-ancestor
83019147|NCT05812430|Mitosis Modulators|mitosis modulators|mesh-ancestor
83019148|NCT05812430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019149|NCT05812404|Fexuprazan|fexuprazan|mesh-list
83019150|NCT05812404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83019151|NCT03607110|Fentanyl|fentanyl|mesh-list
83019152|NCT03607110|Ketamine|ketamine|mesh-list
83019153|NCT03607110|Analgesics|analgesics|mesh-ancestor
83019154|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
83019155|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019156|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019157|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83019158|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83019159|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
83019160|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
83019161|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019162|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83019163|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83019164|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019165|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019166|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83019167|NCT03607110|Narcotics|narcotics|mesh-ancestor
83019168|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83019169|NCT05812300|Hyaluronic Acid|hyaluronic acid|mesh-list
83019170|NCT05812300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83019171|NCT05812300|Immunologic Factors|immunologic factors|mesh-ancestor
83019172|NCT05812300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019173|NCT05812300|Viscosupplements|viscosupplements|mesh-ancestor
83019174|NCT05812300|Protective Agents|protective agents|mesh-ancestor
83019175|NCT05811793|Bevacizumab|bevacizumab|mesh-list
83019176|NCT05811793|Tislelizumab|tislelizumab|mesh-list
83019177|NCT05811793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019178|NCT05811793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019179|NCT05811793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83019180|NCT05811793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83019181|NCT05811793|Growth Substances|growth substances|mesh-ancestor
83019182|NCT05811793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019183|NCT05811793|Growth Inhibitors|growth inhibitors|mesh-ancestor
83019184|NCT05811507|Testosterone|testosterone|mesh-list
83019185|NCT05811507|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83019186|NCT05811507|Androgens|androgens|mesh-ancestor
83019187|NCT05811507|Hormones|hormones|mesh-ancestor
83019188|NCT05811507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83019189|NCT05811507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019190|NCT05811507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83019191|NCT05811507|Immunologic Factors|immunologic factors|mesh-ancestor
83019192|NCT05811390|Erythritol|erythritol|mesh-list
83019193|NCT05811390|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019194|NCT05811377|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83019195|NCT05811377|Hematinics|hematinics|mesh-ancestor
83019196|NCT05811377|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83019197|NCT05811377|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83019198|NCT05811221|Anesthetics|anesthetics|mesh-list
83019199|NCT05811221|Esketamine|esketamine|mesh-list
83019200|NCT05811221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019201|NCT05811221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019202|NCT05811221|Antidepressive Agents|antidepressive agents|mesh-ancestor
83019203|NCT05811221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019204|NCT05811000|Donepezil|donepezil|mesh-list
83019205|NCT05811000|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83019206|NCT05811000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019207|NCT05811000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019208|NCT05811000|Cholinergic Agents|cholinergic agents|mesh-ancestor
83019209|NCT05811000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019210|NCT05811000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019211|NCT05811000|Nootropic Agents|nootropic agents|mesh-ancestor
83019212|NCT05810909|Calcium Carbonate|calcium carbonate|mesh-list
83019213|NCT05810909|Calcium|calcium|mesh-list
83019214|NCT05810909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83019215|NCT05810909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019216|NCT05810909|Antacids|antacids|mesh-ancestor
83019217|NCT05810909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019218|NCT05810909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83019220|NCT05810350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019221|NCT05810350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019222|NCT05810350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019223|NCT05810350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83019224|NCT05810350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83019225|NCT05807360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83019226|NCT05807360|Hyaluronic Acid|hyaluronic acid|mesh-list
83019227|NCT05807360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83019228|NCT05807360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83019229|NCT05807360|Immunologic Factors|immunologic factors|mesh-ancestor
83019230|NCT05807360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019231|NCT05807360|Viscosupplements|viscosupplements|mesh-ancestor
83019232|NCT05807360|Protective Agents|protective agents|mesh-ancestor
83019233|NCT05804123|Acetylcysteine|acetylcysteine|mesh-list
83019234|NCT05804123|Ciprofloxacin|ciprofloxacin|mesh-list
83019235|NCT05804123|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83019236|NCT05804123|Cefotaxime|cefotaxime|mesh-list
83019237|NCT05804123|Cefoxitin|cefoxitin|mesh-list
83019238|NCT05804123|Xylometazoline|xylometazoline|mesh-list
83019239|NCT05804123|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83019240|NCT05804123|Antiviral Agents|antiviral agents|mesh-ancestor
83019241|NCT05804123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019242|NCT05804123|Expectorants|expectorants|mesh-ancestor
83019243|NCT05804123|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019244|NCT05804123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83019245|NCT05804123|Antioxidants|antioxidants|mesh-ancestor
83019246|NCT05804123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019247|NCT05804123|Protective Agents|protective agents|mesh-ancestor
83019248|NCT05804123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019249|NCT05804123|Antidotes|antidotes|mesh-ancestor
83019250|NCT05804123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83019251|NCT05804123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83019252|NCT05804123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83019253|NCT05804123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019254|NCT05804123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019255|NCT05804123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83019256|NCT05804123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83019257|NCT05804123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83019258|NCT05804123|Nasal Decongestants|nasal decongestants|mesh-ancestor
83019259|NCT05804123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83019260|NCT05804084|Acetazolamide|acetazolamide|mesh-list
83019261|NCT05804084|Anticonvulsants|anticonvulsants|mesh-ancestor
83019262|NCT05804084|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83019263|NCT05804084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019264|NCT05804084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019265|NCT05804084|Diuretics|diuretics|mesh-ancestor
83019266|NCT05804084|Natriuretic Agents|natriuretic agents|mesh-ancestor
83019267|NCT05804084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019268|NCT05803655|Oxymetazoline|oxymetazoline|mesh-list
83019269|NCT05803655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83019270|NCT05803655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83019271|NCT05803655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019272|NCT05803655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019273|NCT05803655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019274|NCT05803655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019275|NCT05803655|Sympathomimetics|sympathomimetics|mesh-ancestor
83019276|NCT05803655|Autonomic Agents|autonomic agents|mesh-ancestor
83019277|NCT05803655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019278|NCT05803655|Nasal Decongestants|nasal decongestants|mesh-ancestor
83019279|NCT05803655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83019280|NCT05803655|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019281|NCT05801224|Nitric Oxide|nitric oxide|mesh-list
83019282|NCT05801224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83019283|NCT05801224|Autonomic Agents|autonomic agents|mesh-ancestor
83019284|NCT05801224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019285|NCT05801224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019286|NCT05801224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83019287|NCT05801224|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019288|NCT05801224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83019289|NCT05801224|Antioxidants|antioxidants|mesh-ancestor
83019290|NCT05801224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019291|NCT05801224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019292|NCT05801224|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83019306|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019307|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
83019308|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
83019309|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
83019310|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019311|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83019312|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
83019313|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019314|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83019315|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83019316|NCT05747625|Panitumumab|panitumumab|mesh-list
83019317|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019318|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019319|NCT05742347|Protective Agents|protective agents|mesh-list
83019320|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019321|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
83019322|NCT05729932|Narcotics|narcotics|mesh-ancestor
83019323|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019324|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019325|NCT05729932|Analgesics|analgesics|mesh-ancestor
83019326|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
83019327|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019339|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
83019340|NCT05708989|Ropivacaine|ropivacaine|mesh-list
83019341|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83019342|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019343|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019344|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019345|NCT05708989|Analgesics|analgesics|mesh-ancestor
83019346|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
83019347|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019348|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83019349|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83019350|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83019351|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019352|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019353|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019354|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
83019355|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
83019357|NCT05705427|Vaccines|vaccines|mesh-list
83019358|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
83019359|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019360|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
83019361|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019362|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83019363|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83019364|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019365|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019366|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83019367|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83019369|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
83019370|NCT05692869|Ephedrine|ephedrine|mesh-list
83019371|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83019372|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83019373|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019374|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019375|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019376|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019377|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83019378|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83019379|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019380|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83019381|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
83019382|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019383|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83019384|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019385|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
83019386|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83019387|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83019388|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
83019389|NCT05655468|Dronedarone|dronedarone|mesh-list
83019390|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83019391|NCT05654454|Paclitaxel|paclitaxel|mesh-list
83019392|NCT05654454|Bevacizumab|bevacizumab|mesh-list
83019394|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83019395|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019396|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
83019397|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
83019398|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
83019399|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019400|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019401|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83019402|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83019403|NCT05654454|Growth Substances|growth substances|mesh-ancestor
83019404|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019405|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
83019406|NCT05644353|Mirikizumab|mirikizumab|mesh-list
83019407|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83019408|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019409|NCT05644353|Analgesics|analgesics|mesh-ancestor
83019410|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
83019411|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019412|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019413|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83019414|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83019415|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83019416|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83019417|NCT05563389|Atorvastatin|atorvastatin|mesh-list
83019418|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83019419|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83019420|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
83019421|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019422|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83019423|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83019424|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019425|NCT05548660|Analgesics|analgesics|mesh-list
83019426|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
83019427|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019428|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019429|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83019430|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019431|NCT05525273|Trametinib|trametinib|mesh-list
83019432|NCT05525273|Dabrafenib|dabrafenib|mesh-list
83019433|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019434|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83019435|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019436|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019437|NCT05516849|Oxandrolone|oxandrolone|mesh-list
83019438|NCT05516849|Androgens|androgens|mesh-ancestor
83019439|NCT05516849|Hormones|hormones|mesh-ancestor
83019440|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83019441|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019442|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
83019443|NCT05511766|Allopurinol|allopurinol|mesh-list
83019444|NCT05511766|Atorvastatin|atorvastatin|mesh-list
83019445|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83019446|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83019447|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
83019448|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019449|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83019450|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83019451|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019452|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
83019453|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83019454|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83019455|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
83019456|NCT05511766|Protective Agents|protective agents|mesh-ancestor
83019457|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019458|NCT05479916|Caseins|caseins|mesh-list
83019459|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
83019460|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
83019461|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019462|NCT05476796|Trifluridine|trifluridine|mesh-list
83019463|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
83019464|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019465|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
83019466|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019467|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
83019468|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019470|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83019471|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
83019472|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019473|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019474|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83019475|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019476|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83019477|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83019478|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019479|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83019480|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019481|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83019482|NCT05466734|Protective Agents|protective agents|mesh-ancestor
83019483|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83019484|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83019485|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019486|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83019487|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019488|NCT05450029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019489|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019490|NCT05420402|Propofol|propofol|mesh-list
83019491|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83019492|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019493|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019494|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83019495|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
83019496|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
83019497|NCT05417646|Empagliflozin|empagliflozin|mesh-list
83019498|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83019499|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019500|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83019501|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019502|NCT05417087|Vortioxetine|vortioxetine|mesh-list
83019503|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
83019504|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019505|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83019506|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83019507|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019508|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019509|NCT05417087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83019510|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83019511|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83019512|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019513|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019514|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
83361615|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361616|NCT02696226|Aspirin|aspirin|mesh-list
83019515|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83019516|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83019517|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83019518|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83019519|NCT05416957|Vortioxetine|vortioxetine|mesh-list
83019520|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
83019521|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019522|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83019523|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83019524|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019525|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019526|NCT05416957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83019527|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83019528|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83019529|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019530|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019531|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
83019532|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83019533|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83019534|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83019535|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83019536|NCT05416762|Vortioxetine|vortioxetine|mesh-list
83019537|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
83019538|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019539|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83019540|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83019541|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019542|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019543|NCT05416762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83019544|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83019545|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83019546|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019547|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019548|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
83019549|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83019550|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83019551|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83019552|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83019553|NCT05383742|Rifampin|rifampin|mesh-list
83019554|NCT05383742|Isoniazid|isoniazid|mesh-list
83019555|NCT05383742|Linezolid|linezolid|mesh-list
83019556|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
83019557|NCT05383742|Ethambutol|ethambutol|mesh-list
83019558|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83019559|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
83019560|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83019561|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019562|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
83019563|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83019564|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019565|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019566|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83019567|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83019568|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83019569|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83019570|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83019571|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83019572|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83019573|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83019574|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
83019575|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83019576|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83019577|NCT05365802|FAPI-46|fapi-46|mesh-list
83019578|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83019579|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019580|NCT05358639|Olaparib|olaparib|mesh-list
83019581|NCT05358639|Navitoclax|navitoclax|mesh-list
83019582|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83019583|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019584|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019585|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019586|NCT05330871|Vaccines|vaccines|mesh-list
83019587|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
83019588|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019589|NCT05327595|Midazolam|midazolam|mesh-list
83019590|NCT05327595|Atorvastatin|atorvastatin|mesh-list
83019591|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83019592|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83019593|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019594|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019595|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83019596|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83019597|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019598|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83019599|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
83019600|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
83019601|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
83019602|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
83019603|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019604|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019605|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83019606|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83019607|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
83019608|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83019609|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83019611|NCT05314153|Brexanolone|brexanolone|mesh-list
83019612|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
83019613|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019614|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019615|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019616|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
83019617|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
83019618|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
83019619|NCT05283408|Esketamine|esketamine|mesh-list
83019620|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83019621|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019622|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019623|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019624|NCT05283408|Analgesics|analgesics|mesh-ancestor
83019625|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
83019626|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019627|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83019628|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83019629|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83019630|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019631|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019632|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019633|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
83019634|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019635|NCT05275400|Insulin|insulin|mesh-list
83019636|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83019637|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83019638|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019639|NCT05240755|Cannabidiol|cannabidiol|mesh-list
83019640|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
83019641|NCT05229315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83019642|NCT05229315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019643|NCT05229315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019644|NCT05229315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019645|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
83019646|NCT05220722|Nivolumab|nivolumab|mesh-list
83019647|NCT05220722|Ipilimumab|ipilimumab|mesh-list
83019648|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019649|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019650|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83019651|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019652|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83019653|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83019654|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83019655|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019656|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019657|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019658|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83019659|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83019660|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83019661|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019662|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019663|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019664|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83019665|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83019666|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
83019667|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83019668|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83019669|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
83019670|NCT05208931|Mitogens|mitogens|mesh-list
83019671|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
83019672|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83019673|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019674|NCT05208931|Growth Substances|growth substances|mesh-ancestor
83019675|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019676|NCT05191862|Cilostazol|cilostazol|mesh-list
83019677|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83019678|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
83019679|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019680|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019681|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83019682|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019683|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83019684|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83019685|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019686|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83019687|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019688|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83019689|NCT05191862|Protective Agents|protective agents|mesh-ancestor
83019690|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83019691|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83019692|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019693|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
83019694|NCT05189704|Narcotics|narcotics|mesh-ancestor
83019695|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019696|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019697|NCT05189704|Analgesics|analgesics|mesh-ancestor
83019698|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
83019699|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019700|NCT05179421|Oxytocin|oxytocin|mesh-list
83019701|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
83019702|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83019703|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019704|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83019705|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
83019706|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019707|NCT05100160|Gabapentin|gabapentin|mesh-list
83019708|NCT05100160|Analgesics|analgesics|mesh-ancestor
83019709|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
83019710|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019711|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019712|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
83019713|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83019714|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83019715|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019716|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019717|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83019718|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83019719|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019720|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019721|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
83019722|NCT05060822|Pirfenidone|pirfenidone|mesh-list
83019723|NCT05060822|Analgesics|analgesics|mesh-ancestor
83019724|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
83019725|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019726|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019727|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83019728|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019729|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83019730|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83019731|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019732|NCT05052931|Paclitaxel|paclitaxel|mesh-list
83019733|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
83019734|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83019735|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019736|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
83019737|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
83019738|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83019739|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019740|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
83019741|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83019742|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
83019743|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019744|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019745|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83019746|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019747|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83019748|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
83019749|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019750|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019751|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83019752|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019753|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
83019754|NCT05052229|Protective Agents|protective agents|mesh-ancestor
83019755|NCT05048212|Nivolumab|nivolumab|mesh-list
83019756|NCT05048212|Ipilimumab|ipilimumab|mesh-list
83019757|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019758|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019759|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83019760|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019761|NCT05037500|Decitabine|decitabine|mesh-list
83019762|NCT05037500|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83019763|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83019764|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
83019765|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019766|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019767|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019768|NCT05020769|Osimertinib|osimertinib|mesh-list
83019769|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019770|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83019771|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019772|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019773|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83019774|NCT05002738|Desogestrel|desogestrel|mesh-list
83019775|NCT05002738|Estradiol|estradiol|mesh-list
83019776|NCT05002738|Estrogens|estrogens|mesh-ancestor
83019777|NCT05002738|Hormones|hormones|mesh-ancestor
83019778|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83019779|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019780|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83019781|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
83019782|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83019783|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83019784|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83019785|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83019786|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83019787|NCT05002738|Progestins|progestins|mesh-ancestor
83019788|NCT04990284|Levodopa|levodopa|mesh-list
83019789|NCT04990284|Opicapone|opicapone|mesh-list
83019790|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83019791|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83019792|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
83019793|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019794|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019795|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019796|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83019797|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019798|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
83019799|NCT04955158|Ketamine|ketamine|mesh-list
83019800|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83019801|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019802|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019803|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019804|NCT04955158|Analgesics|analgesics|mesh-ancestor
83019805|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
83019806|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019807|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83019808|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83019809|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83019810|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019811|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361617|NCT02696226|Warfarin|warfarin|mesh-list
83019812|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019813|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83019814|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83019815|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
83019816|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
83019817|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83019818|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83019819|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
83019820|NCT04928391|Nalbuphine|nalbuphine|mesh-list
83019821|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83019822|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019823|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019824|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019825|NCT04928391|Analgesics|analgesics|mesh-ancestor
83019826|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
83019827|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019828|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83019829|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83019830|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83019831|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019832|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019833|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019834|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83019835|NCT04928391|Narcotics|narcotics|mesh-ancestor
83019836|NCT04928352|Bupivacaine|bupivacaine|mesh-list
83019837|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
83019838|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
83019839|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019840|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019841|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
83019842|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019843|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
83019844|NCT04928300|Ketamine|ketamine|mesh-list
83019845|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83019846|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83019847|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019848|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019849|NCT04928300|Analgesics|analgesics|mesh-ancestor
83019850|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
83019851|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019852|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83019853|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83019854|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83019855|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019856|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019857|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019858|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83019859|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83019860|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
83019861|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
83019862|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83019863|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83019864|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
83019865|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83019866|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
83019867|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019868|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019869|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83019870|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019871|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83019872|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
83019873|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019874|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019875|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83019876|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019877|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
83019878|NCT04920695|Protective Agents|protective agents|mesh-ancestor
83019879|NCT04915755|Niraparib|niraparib|mesh-list
83019880|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83019881|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019882|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361618|NCT02696226|Clopidogrel|clopidogrel|mesh-list
83019883|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019884|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
83019885|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83019886|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83019887|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019888|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
83019889|NCT04910464|Coagulants|coagulants|mesh-ancestor
83019890|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
83019891|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83019892|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83019893|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019894|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
83019895|NCT04905901|Coagulants|coagulants|mesh-ancestor
83019896|NCT04901988|Nivolumab|nivolumab|mesh-list
83019897|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019898|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019899|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83019900|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019901|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
83019902|NCT04899687|Fluoxetine|fluoxetine|mesh-list
83019903|NCT04899687|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83019904|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83019905|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83019906|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019907|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019908|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
83019909|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019910|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83019911|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
83019912|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83019913|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83019914|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83019915|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019916|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
83019917|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
83019918|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83019919|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83019920|NCT04823845|Adapalene|adapalene|mesh-list
83019921|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83019922|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83019923|NCT04823845|Analgesics|analgesics|mesh-ancestor
83019924|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
83019925|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83019926|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019927|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83019928|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83019929|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
83019930|NCT04792749|Metformin|metformin|mesh-list
83019931|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83019932|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019933|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
83019934|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83019935|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019936|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83019937|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019938|NCT04789070|Sirolimus|sirolimus|mesh-list
83019939|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83019940|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019941|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83019942|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019943|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
83019944|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83019945|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
83019946|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019947|NCT04756427|Citric Acid|citric acid|mesh-list
83019948|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
83431692|NCT04146116|Povidone|povidone|mesh-list
83019949|NCT04756427|Anticoagulants|anticoagulants|mesh-list
83019950|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83019951|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
83019952|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
83019953|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019954|NCT04722601|Azacitidine|azacitidine|mesh-list
83019955|NCT04722601|Venetoclax|venetoclax|mesh-list
83019956|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
83019957|NCT04722601|Cc-486|cc-486|mesh-list
83019959|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
83019960|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019961|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83019962|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019963|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83019964|NCT04692844|Propranolol|propranolol|mesh-list
83019965|NCT04692844|Primidone|primidone|mesh-list
83019966|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83019967|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83019968|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
83019969|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83019970|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019971|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019972|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83019973|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83019974|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
83019975|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
83019976|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
83019977|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
83019978|NCT04692077|Tenofovir|tenofovir|mesh-list
83019979|NCT04692077|Emtricitabine|emtricitabine|mesh-list
83019980|NCT04692077|Cabotegravir|cabotegravir|mesh-list
83019981|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
83019982|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83019983|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83019984|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83019985|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83019986|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83019987|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83019988|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83019989|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83019990|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83019991|NCT04657003|Tirzepatide|tirzepatide|mesh-list
83019992|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83019993|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83019994|NCT04657003|Incretins|incretins|mesh-ancestor
83019995|NCT04657003|Hormones|hormones|mesh-ancestor
83019996|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83019997|NCT04624906|Rituximab|rituximab|mesh-list
83019998|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83019999|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
83020000|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020001|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020002|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
83020003|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020004|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020005|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83020006|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
83020007|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020008|NCT04610320|Daratumumab|daratumumab|mesh-list
83020009|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020010|NCT04586426|Daratumumab|daratumumab|mesh-list
83020011|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020012|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
83020013|NCT04546399|Leucovorin|leucovorin|mesh-list
83020014|NCT04546399|Folic Acid|folic acid|mesh-list
83020015|NCT04546399|Cytarabine|cytarabine|mesh-list
83020016|NCT04546399|Dexamethasone|dexamethasone|mesh-list
83020017|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
83020018|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
83020019|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83020020|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83020021|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83020022|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
83020023|NCT04546399|Nivolumab|nivolumab|mesh-list
83020024|NCT04546399|Methotrexate|methotrexate|mesh-list
83020025|NCT04546399|Etoposide|etoposide|mesh-list
83020026|NCT04546399|Vincristine|vincristine|mesh-list
83020027|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
83020028|NCT04546399|Asparaginase|asparaginase|mesh-list
83020029|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
83020030|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
83020031|NCT04546399|Pegaspargase|pegaspargase|mesh-list
83020032|NCT04546399|Thioguanine|thioguanine|mesh-list
83020033|NCT04546399|Blinatumomab|blinatumomab|mesh-list
83020034|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83020035|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
83020036|NCT04546399|Antibodies|antibodies|mesh-list
83020037|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
83020038|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83020039|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83020040|NCT04546399|BB 1101|bb 1101|mesh-list
83020041|NCT04546399|Calcium|calcium|mesh-list
83020042|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
83020043|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
83020044|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020045|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
83020046|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020047|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020048|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83020049|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
83020050|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020051|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020052|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83020053|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020054|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
83020055|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
83020056|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020057|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83020058|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
83020059|NCT04546399|Hormones|hormones|mesh-ancestor
83020060|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020061|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83020062|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
83020063|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020064|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83020065|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83020066|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020067|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83020068|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
83020069|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83020070|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020071|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
83020072|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
83020073|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83020074|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83020075|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83020076|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83020077|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83020078|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
83020079|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020080|NCT04546399|Antidotes|antidotes|mesh-ancestor
83020081|NCT04546399|Protective Agents|protective agents|mesh-ancestor
83020082|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
83020083|NCT04546399|Vitamins|vitamins|mesh-ancestor
83020084|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
83020085|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
83020086|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
83020087|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83020088|NCT04546399|Hematinics|hematinics|mesh-ancestor
83020089|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
83020090|NCT04540120|Dapansutrile|dapansutrile|mesh-list
83020091|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020092|NCT04480086|Navitoclax|navitoclax|mesh-list
83020093|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020094|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83020095|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020096|NCT04441138|Durvalumab|durvalumab|mesh-list
83020097|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020098|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020099|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83020100|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83020101|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83020102|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83020103|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020104|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83020105|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83020106|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83020107|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83020108|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
83020109|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020110|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020111|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83362126|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83020112|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83020113|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
83020114|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83020115|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83020116|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
83020117|NCT04426825|Bevacizumab|bevacizumab|mesh-list
83020118|NCT04426825|Atezolizumab|atezolizumab|mesh-list
83020119|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020120|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020121|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83020122|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83020123|NCT04426825|Growth Substances|growth substances|mesh-ancestor
83020124|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020125|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
83020126|NCT04426825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020127|NCT04426825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020128|NCT04418479|Aspirin|aspirin|mesh-list
83020129|NCT04418479|Clopidogrel|clopidogrel|mesh-list
83020130|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83020131|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020132|NCT04418479|Analgesics|analgesics|mesh-ancestor
83020133|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
83020134|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020135|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020136|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020137|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020138|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83020139|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83020140|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020141|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83020142|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83020143|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020144|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
83020145|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83020146|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83020147|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83020148|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
83020149|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020150|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83020151|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83020152|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83431718|NCT02120261|Hormones|hormones|mesh-ancestor
83020153|NCT04408508|Amoxicillin|amoxicillin|mesh-list
83020154|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83020155|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020156|NCT04314375|Budesonide|budesonide|mesh-list
83020157|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020158|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83020159|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
83020160|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020161|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020162|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83020163|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
83020164|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
83020165|NCT04314375|Hormones|hormones|mesh-ancestor
83020166|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020167|NCT04865419|Voriconazole|voriconazole|mesh-list
83020168|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
83020169|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020170|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83020171|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83020172|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020173|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020174|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83020175|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
83020176|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020177|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020178|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83020179|NCT04262206|Atorvastatin|atorvastatin|mesh-list
83020180|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83020181|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83020182|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
83020183|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020184|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83020185|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83020186|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020188|NCT04181515|Yohimbine|yohimbine|mesh-list
83020189|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020190|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
83020191|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
83020192|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020193|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020194|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83020195|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83020196|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83020197|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
83020198|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020199|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020200|NCT04181515|Urological Agents|urological agents|mesh-ancestor
83020201|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
83020202|NCT04180969|Yohimbine|yohimbine|mesh-list
83020203|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020204|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
83020205|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
83020206|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020207|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020208|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83020209|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83020210|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83020211|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
83020212|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020213|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020214|NCT04180969|Urological Agents|urological agents|mesh-ancestor
83020215|NCT04123470|Atezolizumab|atezolizumab|mesh-list
83020216|NCT04123470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020217|NCT04123470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020218|NCT04123470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020219|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020220|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
83020221|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83020222|NCT04083495|Fludarabine|fludarabine|mesh-list
83020223|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020224|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
83020225|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020226|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020227|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83020228|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
83020229|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020230|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020231|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83020232|NCT04082442|Evolocumab|evolocumab|mesh-list
83020233|NCT04082442|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83020234|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83020235|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83020236|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
83020237|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020238|NCT04082442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83020239|NCT04082442|Protease Inhibitors|protease inhibitors|mesh-ancestor
83020240|NCT04082442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020241|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83020242|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
83020243|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83020244|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020245|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83020246|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020247|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
83020248|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83020249|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
83020250|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020251|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020252|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83020253|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
83020254|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83020255|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
83020256|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020257|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020258|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83020259|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
83020260|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
83020261|NCT04069052|Protective Agents|protective agents|mesh-ancestor
83020262|NCT04060108|Methamphetamine|methamphetamine|mesh-list
83020263|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83020264|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020265|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
83020266|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
83020267|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020268|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
83020269|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020270|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020271|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
83020272|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83020273|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83020274|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83020275|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83020276|NCT04038515|Menthol|menthol|mesh-list
83020277|NCT04038515|Nicotine|nicotine|mesh-list
83020278|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83020279|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
83020280|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020281|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020282|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83020283|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83020284|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
83020285|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020286|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020287|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
83020288|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
83020289|NCT04017598|Iron|iron|mesh-list
83020290|NCT04017598|Trace Elements|trace elements|mesh-ancestor
83020291|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
83020292|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020293|NCT04014803|Aspirin|aspirin|mesh-list
83020294|NCT04014803|Clopidogrel|clopidogrel|mesh-list
83020295|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83020296|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83020297|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020298|NCT04014803|Analgesics|analgesics|mesh-ancestor
83020299|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
83020300|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020301|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020302|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020303|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020304|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83020305|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83020306|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020307|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83020308|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83020309|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020310|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
83020311|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83020312|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83020313|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83020314|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
83020315|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020316|NCT03980184|Guanfacine|guanfacine|mesh-list
83020317|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83020318|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83020319|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83020320|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83020321|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83020322|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020323|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020324|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020325|NCT03945903|Golimumab|golimumab|mesh-list
83020326|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83020327|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020328|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020329|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
83020330|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020331|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
83020332|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83020333|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83020334|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83020335|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83020336|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020337|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
83020338|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020339|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020340|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83020341|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020342|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
83020343|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
83020344|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
83020345|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020346|NCT03942211|Selexipag|selexipag|mesh-list
83020347|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83020348|NCT03937219|Nivolumab|nivolumab|mesh-list
83020349|NCT03937219|Ipilimumab|ipilimumab|mesh-list
83020350|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020351|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020352|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020353|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020354|NCT03934684|Dexamethasone|dexamethasone|mesh-list
83020355|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
83020356|NCT03934684|Lenalidomide|lenalidomide|mesh-list
83020357|NCT03934684|BB 1101|bb 1101|mesh-list
83020358|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020359|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
83020360|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
83020361|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020362|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020363|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83020364|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
83020365|NCT03934684|Hormones|hormones|mesh-ancestor
83020366|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020367|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83020368|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020369|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
83020370|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020371|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020372|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
83020373|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83020374|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83020375|NCT03934684|Growth Substances|growth substances|mesh-ancestor
83020376|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83020377|NCT03875235|Durvalumab|durvalumab|mesh-list
83020378|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020379|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020380|NCT03873805|Vidarabine|vidarabine|mesh-list
83020381|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
83020382|NCT03873805|Fludarabine|fludarabine|mesh-list
83020383|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
83020384|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020385|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
83020386|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020387|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020388|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83020389|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
83020390|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020391|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020392|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83020393|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020394|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
83020395|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
83020396|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020397|NCT03869268|Aspirin|aspirin|mesh-list
83020398|NCT03869268|Ticagrelor|ticagrelor|mesh-list
83020399|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83020400|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020401|NCT03869268|Analgesics|analgesics|mesh-ancestor
83020402|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
83020403|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020404|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020405|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020406|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020407|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83020408|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83020409|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020410|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83020411|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83020412|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020413|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
83020414|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83020415|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83020416|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83020417|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
83020418|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020419|NCT03843463|Dexetimide|dexetimide|mesh-list
83020420|NCT03843463|Citalopram|citalopram|mesh-list
83020421|NCT03843463|Escitalopram|escitalopram|mesh-list
83020422|NCT03843463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83020423|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83020424|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83020425|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020426|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020427|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
83020428|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020429|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83020430|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83020431|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
83020432|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
83020433|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020434|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83020435|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83020436|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
83020437|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83020438|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
83020439|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83020440|NCT03805932|Rituximab|rituximab|mesh-list
83020441|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
83020442|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020443|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020444|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
83020445|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020446|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020447|NCT03805932|Immunotoxins|immunotoxins|mesh-ancestor
83020448|NCT03805932|Immunoconjugates|immunoconjugates|mesh-ancestor
83020449|NCT03775486|Paclitaxel|paclitaxel|mesh-list
83020450|NCT03775486|Cisplatin|cisplatin|mesh-list
83020451|NCT03775486|Carboplatin|carboplatin|mesh-list
83020452|NCT03775486|Gemcitabine|gemcitabine|mesh-list
83020453|NCT03775486|Pemetrexed|pemetrexed|mesh-list
83020454|NCT03775486|Durvalumab|durvalumab|mesh-list
83020455|NCT03775486|Olaparib|olaparib|mesh-list
83020456|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83020457|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83020458|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020459|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
83020460|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
83020461|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
83020462|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020463|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020464|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
83020465|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020466|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83020467|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83020468|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020469|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
83020470|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020471|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83020472|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
83020473|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83020474|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
83020475|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83020476|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
83020477|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020478|NCT03755791|Sorafenib|sorafenib|mesh-list
83020479|NCT03755791|Atezolizumab|atezolizumab|mesh-list
83020480|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020481|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83020482|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020483|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020484|NCT03755791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020485|NCT03755791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020486|NCT03660930|Sirolimus|sirolimus|mesh-list
83020487|NCT03660930|Temsirolimus|temsirolimus|mesh-list
83020488|NCT03660930|MTOR Inhibitors|mtor inhibitors|mesh-list
83020489|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83020490|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020491|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83020492|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020493|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
83020494|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020495|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
83020496|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020497|NCT03660930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83020498|NCT03660930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020499|NCT03660930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020500|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
83020501|NCT03643796|Ketamine|ketamine|mesh-list
83020502|NCT03643796|Remifentanil|remifentanil|mesh-list
83020503|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83020504|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83020505|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020506|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020507|NCT03643796|Analgesics|analgesics|mesh-ancestor
83020508|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
83020509|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020510|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83020511|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83020512|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83020513|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
83020514|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020515|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020516|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83020517|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83020518|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
83020519|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
83020520|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83431796|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83020521|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83020522|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83020523|NCT03643796|Narcotics|narcotics|mesh-ancestor
83020524|NCT03623854|Nivolumab|nivolumab|mesh-list
83020525|NCT03623854|Relatlimab|relatlimab|mesh-list
83020526|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
83020527|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
83020528|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020529|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020530|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020531|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020532|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
83020533|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020534|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83020535|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83020536|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020537|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
83020538|NCT03530215|Immunomodulating Agents|immunomodulating agents|mesh-list
83020539|NCT03530215|Immunologic Factors|immunologic factors|mesh-ancestor
83020540|NCT03530215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020541|NCT03475277|Ketamine|ketamine|mesh-list
83020542|NCT03475277|Analgesics|analgesics|mesh-ancestor
83020543|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
83020544|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020545|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020546|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83020547|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83020548|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
83020549|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
83020550|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83020551|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83020552|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83020553|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020554|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020555|NCT03472274|Durvalumab|durvalumab|mesh-list
83020556|NCT03472274|Tremelimumab|tremelimumab|mesh-list
83020557|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020558|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020559|NCT03436433|Lacosamide|lacosamide|mesh-list
83020572|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020573|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020574|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83020575|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
83020576|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020577|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020578|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83020579|NCT03415854|Paclitaxel|paclitaxel|mesh-list
83020580|NCT03415854|Cisplatin|cisplatin|mesh-list
83020581|NCT03415854|Gemcitabine|gemcitabine|mesh-list
83020582|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83020583|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83020584|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020585|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
83020586|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
83020587|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
83020588|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020589|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020590|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
83020591|NCT03405090|Fentanyl|fentanyl|mesh-list
83020592|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
83020593|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83020595|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83020596|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020597|NCT03405090|Analgesics|analgesics|mesh-ancestor
83020598|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
83020599|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020600|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83020601|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83020602|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
83020603|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
83020604|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
83020605|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83431807|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
83020606|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
83020621|NCT03284307|Midazolam|midazolam|mesh-list
83020622|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
83020623|NCT03284307|Ketamine|ketamine|mesh-list
83020624|NCT03284307|Propofol|propofol|mesh-list
83020625|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83020626|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83020627|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020628|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020629|NCT03284307|Analgesics|analgesics|mesh-ancestor
83020630|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
83020631|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020632|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83020633|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83020634|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83020635|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
83020636|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020637|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020638|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83020639|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
83020640|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
83020641|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83020642|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83020643|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83020644|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83020645|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83020646|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83020647|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83020648|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
83020649|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
83020651|NCT03279289|Folic Acid|folic acid|mesh-list
83020652|NCT03279289|Fluorouracil|fluorouracil|mesh-list
83020653|NCT03279289|Irinotecan|irinotecan|mesh-list
83020654|NCT03279289|Aflibercept|aflibercept|mesh-list
83020655|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
83020656|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
83020657|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020658|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020659|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020660|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020661|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
83020662|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431814|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
83020663|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83020664|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83020665|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020666|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83020667|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83020668|NCT03279289|Growth Substances|growth substances|mesh-ancestor
83020669|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
83020670|NCT03279289|Antidotes|antidotes|mesh-ancestor
83020671|NCT03279289|Protective Agents|protective agents|mesh-ancestor
83020672|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
83020673|NCT03279289|Vitamins|vitamins|mesh-ancestor
83020674|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
83020675|NCT03279289|Hematinics|hematinics|mesh-ancestor
83020676|NCT03207867|Spartalizumab|spartalizumab|mesh-list
83020677|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020678|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020679|NCT03207867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020680|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020681|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
83020682|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020683|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020684|NCT03186456|Aspirin|aspirin|mesh-list
83020685|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83020686|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020687|NCT03186456|Analgesics|analgesics|mesh-ancestor
83020688|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
83020689|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020690|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020691|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020692|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020693|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83020694|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83020695|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020696|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83020697|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83020698|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020699|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
83020700|NCT03184935|Decitabine|decitabine|mesh-list
83020701|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020702|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
83020703|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020704|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020705|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020706|NCT03176498|Aspirin|aspirin|mesh-list
83020707|NCT03176498|Atorvastatin|atorvastatin|mesh-list
83020708|NCT03176498|Calcium|calcium|mesh-list
83020709|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83020710|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020711|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83020712|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020713|NCT03176498|Analgesics|analgesics|mesh-ancestor
83020714|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
83020715|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020716|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020717|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020718|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83020719|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83020720|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020721|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83020722|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83020723|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020724|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
83020725|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83020726|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83020727|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
83020728|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83020729|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83020730|NCT03170960|Atezolizumab|atezolizumab|mesh-list
83020731|NCT03170960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020732|NCT03170960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020733|NCT03170960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020734|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020735|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
83020736|NCT03126591|Olaratumab|olaratumab|mesh-list
83020737|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020738|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020739|NCT03126591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020740|NCT03126591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020741|NCT03122197|Letrozole|letrozole|mesh-list
83020742|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020743|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83020744|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83020745|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020746|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020747|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83020748|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
83020749|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020750|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020751|NCT03091192|Sunitinib|sunitinib|mesh-list
83020752|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020753|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83020754|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83020755|NCT03091192|Growth Substances|growth substances|mesh-ancestor
83020756|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020757|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
83020758|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83020759|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020760|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020761|NCT03085004|Ethanol|ethanol|mesh-list
83020762|NCT03085004|Paclitaxel|paclitaxel|mesh-list
83020763|NCT03085004|Gemcitabine|gemcitabine|mesh-list
83020764|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83020765|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020766|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83020767|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83020768|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83020769|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020770|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020771|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
83020772|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83020773|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83020774|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83020775|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020776|NCT03059862|Tryptophan|tryptophan|mesh-list
83020777|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83020778|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
83020779|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83020780|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83020781|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020782|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361620|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020783|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020784|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83020786|NCT02949284|Cortisone|cortisone|mesh-list
83020787|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
83020788|NCT02949284|Hormones|hormones|mesh-list
83020789|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83020790|NCT02949284|Androgens|androgens|mesh-list
83020791|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
83020792|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020793|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
83020794|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020795|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020796|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83020797|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020798|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83020799|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020800|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020801|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
83020802|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83020803|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
83020804|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
83020805|NCT02916862|Calcium|calcium|mesh-list
83020806|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83020807|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020808|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83020809|NCT02891447|Cisplatin|cisplatin|mesh-list
83020810|NCT02891447|Mitomycins|mitomycins|mesh-list
83020811|NCT02891447|Mitomycin|mitomycin|mesh-list
83020812|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020813|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83020814|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
83020815|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020816|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83020817|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020818|NCT02885974|Celecoxib|celecoxib|mesh-list
83020819|NCT02885974|Gemcitabine|gemcitabine|mesh-list
83020820|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020821|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020822|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
83020823|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020824|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83020825|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83020826|NCT02885974|Analgesics|analgesics|mesh-ancestor
83020827|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
83020828|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020829|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020830|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020831|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83020832|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83020833|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83020834|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020835|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
83020836|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83020837|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83020838|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83020839|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
83020840|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020841|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020842|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020843|NCT02754726|Paclitaxel|paclitaxel|mesh-list
83020844|NCT02754726|Gemcitabine|gemcitabine|mesh-list
83020845|NCT02754726|Nivolumab|nivolumab|mesh-list
83020846|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83020847|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83020848|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020849|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
83020850|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
83020851|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
83020852|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020853|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020854|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
83431866|NCT04145102|Propolis|propolis|mesh-list
83020855|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361621|NCT02696226|Analgesics|analgesics|mesh-ancestor
83020856|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020857|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
83020858|NCT02680626|Ropivacaine|ropivacaine|mesh-list
83020859|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
83020860|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
83020861|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83020862|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020863|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
83020864|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020865|NCT02680626|Analgesics|analgesics|mesh-ancestor
83020866|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83020867|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
83020868|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83020869|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83020870|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020871|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83020872|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
83020873|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83020874|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
83020875|NCT02494583|Capecitabine|capecitabine|mesh-list
83020876|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020877|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020878|NCT02494583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020879|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020880|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83020881|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
83020882|NCT02473042|Promethazine|promethazine|mesh-list
83020883|NCT02473042|Dexamethasone|dexamethasone|mesh-list
83020884|NCT02473042|Ondansetron|ondansetron|mesh-list
83020885|NCT02473042|Famotidine|famotidine|mesh-list
83020886|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020887|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
83020888|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
83020889|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020890|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020891|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83020892|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
83020893|NCT02473042|Hormones|hormones|mesh-ancestor
83020894|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020895|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83020896|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020897|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
83020898|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
83020899|NCT02473042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83020900|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83020901|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
83020902|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83020903|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020904|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83020905|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83020906|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
83020907|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
83020908|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83020909|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83020910|NCT02359331|Amoxicillin|amoxicillin|mesh-list
83020911|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
83020912|NCT02359331|Metronidazole|metronidazole|mesh-list
83020913|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83020914|NCT02359331|Tetracycline|tetracycline|mesh-list
83020915|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
83020916|NCT02359331|Bismuth|bismuth|mesh-list
83020917|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83020918|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83020919|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83020920|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020921|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020922|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020923|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83020924|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83020925|NCT02359331|Antacids|antacids|mesh-ancestor
83020926|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83020927|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83020928|NCT02322814|Paclitaxel|paclitaxel|mesh-list
83020929|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83020930|NCT02322814|Atezolizumab|atezolizumab|mesh-list
83020931|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83020932|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020934|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
83020935|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
83020936|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020937|NCT02322814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83020938|NCT02322814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020939|NCT02136134|Dexamethasone|dexamethasone|mesh-list
83020940|NCT02136134|Bortezomib|bortezomib|mesh-list
83020941|NCT02136134|Daratumumab|daratumumab|mesh-list
83020942|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83020943|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
83020944|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
83020945|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83020946|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020947|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83020948|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
83020949|NCT02136134|Hormones|hormones|mesh-ancestor
83020950|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020951|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83020952|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020953|NCT02108964|Nazartinib|nazartinib|mesh-list
83020954|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020955|NCT02057133|Tamoxifen|tamoxifen|mesh-list
83020956|NCT02057133|Trastuzumab|trastuzumab|mesh-list
83020957|NCT02057133|Pertuzumab|pertuzumab|mesh-list
83020958|NCT02057133|Everolimus|everolimus|mesh-list
83020959|NCT02057133|Letrozole|letrozole|mesh-list
83020960|NCT02057133|Fulvestrant|fulvestrant|mesh-list
83020961|NCT02057133|Anastrozole|anastrozole|mesh-list
83020962|NCT02057133|Exemestane|exemestane|mesh-list
83020963|NCT02057133|Loperamide|loperamide|mesh-list
83020964|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83020965|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83020966|NCT02057133|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83020967|NCT02057133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83020968|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83020969|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83020970|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83020971|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
83020972|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020973|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83020974|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83020975|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83020976|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
83020977|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020978|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83020979|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83020980|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83020981|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83020982|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83020983|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
83020984|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83020985|NCT01894308|Testosterone|testosterone|mesh-list
83020986|NCT01894308|Androgens|androgens|mesh-ancestor
83020987|NCT01894308|Hormones|hormones|mesh-ancestor
83020988|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83020989|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83020990|NCT01837862|Mebendazole|mebendazole|mesh-list
83020991|NCT01837862|Piperazine|piperazine|mesh-list
83020992|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
83020993|NCT01837862|Bevacizumab|bevacizumab|mesh-list
83020994|NCT01837862|Carboplatin|carboplatin|mesh-list
83020995|NCT01837862|Irinotecan|irinotecan|mesh-list
83020996|NCT01837862|Vincristine|vincristine|mesh-list
83020997|NCT01837862|Temozolomide|temozolomide|mesh-list
83020998|NCT01837862|DMP 777|dmp 777|mesh-list
83020999|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83021000|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021001|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83021002|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83021003|NCT01837862|Growth Substances|growth substances|mesh-ancestor
83021004|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021005|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
83021006|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83021007|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83021008|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021009|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361622|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
83021010|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83021012|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
83021013|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
83021014|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021015|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
83021016|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
83021017|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
83021018|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83021019|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021020|NCT01675219|Mitomycins|mitomycins|mesh-list
83021021|NCT01675219|Mitomycin|mitomycin|mesh-list
83021022|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83021023|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021024|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
83021025|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021026|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83021027|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021028|NCT01590069|Aldesleukin|aldesleukin|mesh-list
83021029|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021030|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83021031|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83021032|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
83021033|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021034|NCT01529593|Metformin|metformin|mesh-list
83021035|NCT01529593|Sirolimus|sirolimus|mesh-list
83021036|NCT01529593|Temsirolimus|temsirolimus|mesh-list
83021037|NCT01529593|MTOR Inhibitors|mtor inhibitors|mesh-list
83021038|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83021039|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021040|NCT01529593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83021041|NCT01529593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021042|NCT01529593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021043|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021044|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
83021045|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021046|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021047|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021048|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83021049|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
83021050|NCT01446133|Rituximab|rituximab|mesh-list
83021051|NCT01446133|Lenalidomide|lenalidomide|mesh-list
83021052|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83021053|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021054|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
83021055|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021056|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021057|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83021058|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83021059|NCT01446133|Growth Substances|growth substances|mesh-ancestor
83021060|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
83021061|NCT01424982|Cytarabine|cytarabine|mesh-list
83021062|NCT01424982|Dexamethasone|dexamethasone|mesh-list
83021063|NCT01424982|Prednisone|prednisone|mesh-list
83021064|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
83021065|NCT01424982|Cortisone|cortisone|mesh-list
83021066|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
83021067|NCT01424982|Rituximab|rituximab|mesh-list
83021068|NCT01424982|Doxorubicin|doxorubicin|mesh-list
83021069|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83021070|NCT01424982|Methotrexate|methotrexate|mesh-list
83021071|NCT01424982|Vincristine|vincristine|mesh-list
83021072|NCT01424982|Daunorubicin|daunorubicin|mesh-list
83021073|NCT01424982|Ponatinib|ponatinib|mesh-list
83021074|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83021075|NCT01424982|Antibodies|antibodies|mesh-list
83021076|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
83021077|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83021078|NCT01424982|BB 1101|bb 1101|mesh-list
83021079|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021080|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
83021081|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021082|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021083|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021084|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
83021085|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021086|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021087|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83021088|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021089|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
83021090|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
83021091|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021092|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83021093|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
83021094|NCT01424982|Hormones|hormones|mesh-ancestor
83021095|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021096|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83021097|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83021098|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83021099|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83021100|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021101|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83021102|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
83021103|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83021104|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021105|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
83021106|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
83021107|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83021108|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83021109|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
83021110|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021111|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83021112|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
83021113|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
83021114|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
83021115|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
83021116|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83021117|NCT01333033|Leucovorin|leucovorin|mesh-list
83021118|NCT01333033|Paclitaxel|paclitaxel|mesh-list
83021119|NCT01333033|Carboplatin|carboplatin|mesh-list
83021120|NCT01333033|Fluorouracil|fluorouracil|mesh-list
83021121|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
83021122|NCT01333033|Calcium|calcium|mesh-list
83021123|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
83021124|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83021125|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021126|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83021127|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83021128|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83021129|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021130|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83021131|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021132|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
83021133|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021134|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021135|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
83021136|NCT01333033|Antidotes|antidotes|mesh-ancestor
83021137|NCT01333033|Protective Agents|protective agents|mesh-ancestor
83021138|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
83021139|NCT01333033|Vitamins|vitamins|mesh-ancestor
83021140|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
83021141|NCT01187199|Sirolimus|sirolimus|mesh-list
83021142|NCT01187199|Paclitaxel|paclitaxel|mesh-list
83021143|NCT01187199|Bevacizumab|bevacizumab|mesh-list
83021144|NCT01187199|Carboplatin|carboplatin|mesh-list
83021145|NCT01187199|Sorafenib|sorafenib|mesh-list
83021146|NCT01187199|Temsirolimus|temsirolimus|mesh-list
83021147|NCT01187199|MTOR Inhibitors|mtor inhibitors|mesh-list
83021148|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83021149|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021150|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83021151|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83021152|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83021153|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021154|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83021155|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83021156|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83021157|NCT01187199|Growth Substances|growth substances|mesh-ancestor
83021158|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021159|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
83021160|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83021161|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021162|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021163|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
83021164|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021165|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021166|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83021167|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
83021168|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
83021169|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83021170|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021171|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021172|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021173|NCT00778063|Analgesics|analgesics|mesh-ancestor
83021174|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
83021175|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021176|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83021177|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83021178|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83021179|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
83021180|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021181|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021182|NCT00547196|Cyclosporine|cyclosporine|mesh-list
83021183|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
83021184|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
83021185|NCT00547196|Melphalan|melphalan|mesh-list
83021186|NCT00547196|Busulfan|busulfan|mesh-list
83021187|NCT00547196|Fludarabine|fludarabine|mesh-list
83021188|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
83021189|NCT00547196|Cyclosporins|cyclosporins|mesh-list
83021190|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021191|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
83021192|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021193|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021194|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021195|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
83021196|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021197|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021198|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83021199|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021200|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
83021201|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021202|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
83021203|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021204|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
83021205|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83021206|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83021207|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83021208|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
83021209|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021210|NCT00330941|Lidocaine|lidocaine|mesh-list
83021211|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
83021212|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
83021213|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021214|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021215|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
83021216|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021217|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83021218|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83021219|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83021220|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021221|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021222|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
83021223|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83021224|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
83021225|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021226|NCT03149107|Expectorants|expectorants|mesh-ancestor
83021227|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
83021228|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83021229|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
83021230|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021231|NCT03149107|Protective Agents|protective agents|mesh-ancestor
83021232|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021233|NCT03149107|Antidotes|antidotes|mesh-ancestor
83021234|NCT03135301|Metformin|metformin|mesh-list
83021235|NCT03135301|Letrozole|letrozole|mesh-list
83021236|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83021237|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021238|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021239|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83021240|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83021241|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021242|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021243|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83021244|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
83021245|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021246|NCT03602898|Cyclosporine|cyclosporine|mesh-list
83021247|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
83021248|NCT03602898|Busulfan|busulfan|mesh-list
83021249|NCT03602898|Methotrexate|methotrexate|mesh-list
83021250|NCT03602898|Fludarabine|fludarabine|mesh-list
83021251|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
83021252|NCT03602898|Tacrolimus|tacrolimus|mesh-list
83021253|NCT03602898|Cyclosporins|cyclosporins|mesh-list
83021254|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83021255|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021256|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
83021257|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021258|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021259|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021260|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
83021261|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021262|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021263|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83021264|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83021265|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
83021266|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83021267|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021268|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
83021269|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
83021270|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021271|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83021272|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83021273|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83431907|NCT04144712|Caffeine|caffeine|mesh-list
83021274|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
83021275|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021276|NCT02983747|Loxoprofen|loxoprofen|mesh-list
83021277|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83021278|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021279|NCT02983747|Analgesics|analgesics|mesh-ancestor
83021280|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
83021281|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021282|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021283|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021284|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021285|NCT05759845|Topiramate|topiramate|mesh-list
83021286|NCT05759845|Amitriptyline|amitriptyline|mesh-list
83021287|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
83021288|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83021289|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021290|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83021291|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
83021292|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83021293|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021294|NCT05759845|Analgesics|analgesics|mesh-ancestor
83021295|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
83021296|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021297|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83021298|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83021299|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021300|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021301|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
83021302|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021303|NCT03931291|Azacitidine|azacitidine|mesh-list
83021304|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021305|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
83021306|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021307|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021308|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021309|NCT00799110|Imiquimod|imiquimod|mesh-list
83021310|NCT00799110|Vaccines|vaccines|mesh-list
83021311|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
83021312|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021313|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83021314|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021315|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
83021316|NCT05199727|Tadalafil|tadalafil|mesh-list
83021317|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
83021318|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83021319|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83021320|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021321|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021322|NCT05199727|Urological Agents|urological agents|mesh-ancestor
83021323|NCT02132234|Adalimumab|adalimumab|mesh-list
83021324|NCT02132234|Infliximab|infliximab|mesh-list
83021325|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
83021326|NCT02132234|Etanercept|etanercept|mesh-list
83021327|NCT02132234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83021328|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021329|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021330|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
83021331|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83021332|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83021333|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021334|NCT02132234|Analgesics|analgesics|mesh-ancestor
83021335|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
83021336|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021337|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021338|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021339|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
83021340|NCT02132390|Toremifene|toremifene|mesh-list
83021341|NCT02132390|Goserelin|goserelin|mesh-list
83021342|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83021343|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021344|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83021345|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83021346|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
83021347|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021348|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021349|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83021350|NCT02128646|Ketorolac|ketorolac|mesh-list
83021351|NCT02128646|Bupivacaine|bupivacaine|mesh-list
83021352|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
83021353|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
83021354|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021355|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021356|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
83021357|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021358|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83021359|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021360|NCT02128646|Analgesics|analgesics|mesh-ancestor
83021361|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021362|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021363|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83021364|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021365|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021366|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83021367|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
83021368|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
83021369|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021370|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021371|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
83021372|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83021373|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021374|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
83021375|NCT05198947|Ivermectin|ivermectin|mesh-list
83021376|NCT05198947|Permethrin|permethrin|mesh-list
83021377|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83021378|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021379|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021380|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021381|NCT01367834|Hormones|hormones|mesh-list
83021382|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021383|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021384|NCT03106753|Bupivacaine|bupivacaine|mesh-list
83021385|NCT03106753|Terbutaline|terbutaline|mesh-list
83021386|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
83021387|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
83021388|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021389|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021390|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
83021391|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021392|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83021393|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
83021394|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83021395|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
83021396|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
83021397|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
83021398|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83021399|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83021400|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83021401|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83021402|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
83021403|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021404|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021405|NCT02133014|Fluorouracil|fluorouracil|mesh-list
83021406|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
83021407|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021408|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021409|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021410|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021411|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
83021412|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021413|NCT05759455|Vitamin D|vitamin d|mesh-list
83021414|NCT05759455|Vitamins|vitamins|mesh-ancestor
83021415|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
83021416|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021417|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83021418|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83021419|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83021420|NCT02129114|Estradiol|estradiol|mesh-list
83021421|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83021422|NCT02129114|Estrogens|estrogens|mesh-ancestor
83021423|NCT02129114|Hormones|hormones|mesh-ancestor
83021424|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021425|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021426|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83021427|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
83021428|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83021429|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83021430|NCT02136992|Pirfenidone|pirfenidone|mesh-list
83021431|NCT02136992|Analgesics|analgesics|mesh-ancestor
83021432|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
83021433|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021434|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021435|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83021436|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021437|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021438|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021439|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021440|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
83021441|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021442|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021443|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83021444|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83021445|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021446|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021447|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021448|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83021449|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83021450|NCT02129270|Lidocaine|lidocaine|mesh-list
83021451|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
83021452|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
83021453|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021454|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021455|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
83021456|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021457|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83021458|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83021459|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83021460|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021461|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021462|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
83021463|NCT05370547|Fludarabine|fludarabine|mesh-list
83021464|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021465|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
83021466|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431934|NCT00496379|Sagopilone|sagopilone|mesh-list
83361623|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021467|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021468|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021469|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
83021470|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021471|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021472|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83021473|NCT02133326|Acetaminophen|acetaminophen|mesh-list
83021474|NCT02133326|Ibuprofen|ibuprofen|mesh-list
83021475|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021476|NCT02133326|Analgesics|analgesics|mesh-ancestor
83021477|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
83021478|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021479|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021480|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
83021481|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83021482|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021483|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021484|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83021485|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021486|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021487|NCT02137616|Olanzapine|olanzapine|mesh-list
83021488|NCT02137616|Risperidone|risperidone|mesh-list
83021489|NCT02137616|Aripiprazole|aripiprazole|mesh-list
83021490|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83021491|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83021492|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
83021493|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021494|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021495|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021496|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83021497|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83021498|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021499|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83021500|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83021501|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
83021502|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
83021503|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
83021504|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021505|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83021506|NCT02137616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83021507|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83021508|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021509|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
83021510|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
83021511|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83021512|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83021513|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83021514|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83021516|NCT02133638|Sevoflurane|sevoflurane|mesh-list
83021517|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83021518|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021519|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021520|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83021521|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
83021522|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
83021523|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83021524|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83021525|NCT02545283|Cytarabine|cytarabine|mesh-list
83021526|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021527|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
83021528|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021529|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021530|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
83021531|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021532|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021533|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
83021534|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021535|NCT02137928|Carboplatin|carboplatin|mesh-list
83021536|NCT02137928|Etoposide|etoposide|mesh-list
83021537|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
83021538|NCT02137928|Vincristine|vincristine|mesh-list
83021539|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021540|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83021541|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83021542|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83021543|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021544|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021545|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
83021546|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
83021547|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
83021548|NCT02138084|Ritonavir|ritonavir|mesh-list
83021549|NCT02138084|Fostemsavir|fostemsavir|mesh-list
83021550|NCT02138084|Rifabutin|rifabutin|mesh-list
83021551|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83021552|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83021553|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
83021554|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021555|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021556|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83021557|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83021558|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
83021559|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021560|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83021561|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83021562|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021563|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83021564|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
83021565|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83021566|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83021567|NCT02129582|Methotrexate|methotrexate|mesh-list
83021568|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
83021569|NCT02129582|Fludarabine|fludarabine|mesh-list
83021570|NCT02129582|Busulfan|busulfan|mesh-list
83021571|NCT02129582|Tacrolimus|tacrolimus|mesh-list
83021572|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
83021573|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83021574|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
83021575|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83021576|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
83021577|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83021578|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021579|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83021580|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
83021581|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021582|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021583|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83021584|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021585|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83021586|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021587|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
83021588|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021589|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83021591|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
83021592|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021593|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83021594|NCT02138396|Fentanyl|fentanyl|mesh-list
83021595|NCT02138396|Naltrexone|naltrexone|mesh-list
83021596|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83021597|NCT02138396|Narcotics|narcotics|mesh-ancestor
83021598|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021599|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021600|NCT02138396|Analgesics|analgesics|mesh-ancestor
83021601|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
83021602|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021603|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83021604|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83021605|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
83021606|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
83021607|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83021608|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83021609|NCT04560881|Vaccines|vaccines|mesh-list
83021610|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
83021611|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021612|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
83021613|NCT02828761|Calcium|calcium|mesh-list
83021614|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83021615|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021616|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83021617|NCT02875613|Avelumab|avelumab|mesh-list
83021618|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83021619|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021620|NCT02815267|Minocycline|minocycline|mesh-list
83021621|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021622|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021623|NCT02130440|Resveratrol|resveratrol|mesh-list
83021624|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
83021625|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021626|NCT02130440|Protective Agents|protective agents|mesh-ancestor
83021627|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021628|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021629|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83021630|NCT02138552|Octenidine|octenidine|mesh-list
83021631|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021632|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83021633|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83021634|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83021635|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83021636|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021637|NCT02138708|Adenosine|adenosine|mesh-list
83021638|NCT02138708|Acetylcholine|acetylcholine|mesh-list
83021639|NCT02138708|Analgesics|analgesics|mesh-ancestor
83021640|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
83021641|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021642|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021643|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83021644|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
83021645|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83021646|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
83021647|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
83021648|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021649|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021650|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83021651|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
83021652|NCT03633175|Progesterone|progesterone|mesh-list
83021653|NCT03633175|Progestins|progestins|mesh-ancestor
83021654|NCT03633175|Hormones|hormones|mesh-ancestor
83021655|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021656|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021657|NCT02539693|Lidocaine|lidocaine|mesh-list
83021658|NCT02539693|Clonidine|clonidine|mesh-list
83021659|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
83021660|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
83021661|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021662|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021663|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
83021664|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021665|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83021666|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83021667|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83021668|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021669|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021670|NCT02539693|Analgesics|analgesics|mesh-ancestor
83021671|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83021672|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
83021673|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
83021674|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83021675|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83021676|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83021677|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83021678|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021679|NCT05062135|Progesterone|progesterone|mesh-list
83021680|NCT05062135|Progestins|progestins|mesh-ancestor
83021681|NCT05062135|Hormones|hormones|mesh-ancestor
83021682|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021683|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021684|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83021685|NCT02134106|Polymyxins|polymyxins|mesh-list
83021686|NCT02134106|Doripenem|doripenem|mesh-list
83021687|NCT02134106|Polymyxin B|polymyxin b|mesh-list
83021688|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021689|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021690|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
83021691|NCT01354301|Everolimus|everolimus|mesh-list
83021692|NCT01354301|Tacrolimus|tacrolimus|mesh-list
83021693|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
83021694|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021696|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021697|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83021698|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021699|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021700|NCT01354301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83021701|NCT01354301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83021702|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021703|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83021704|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83021705|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
83021706|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021707|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021708|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
83021709|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83021710|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83021711|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
83021712|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021713|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83021714|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021715|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
83021716|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021717|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021718|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83021719|NCT01343277|Dacarbazine|dacarbazine|mesh-list
83021720|NCT01343277|Trabectedin|trabectedin|mesh-list
83021721|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83021722|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
83021723|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021724|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021725|NCT04856293|Crizotinib|crizotinib|mesh-list
83021726|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021727|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83021728|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021729|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021730|NCT02253212|Carboplatin|carboplatin|mesh-list
83021731|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021732|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
83021733|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
83021734|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
83021735|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83021736|NCT01355939|Protective Agents|protective agents|mesh-ancestor
83021737|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021738|NCT01356017|Amlodipine|amlodipine|mesh-list
83021739|NCT01356017|Telmisartan|telmisartan|mesh-list
83021740|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83021741|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83021742|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021743|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021744|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83021745|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021746|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
83021747|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83021748|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83021749|NCT02139098|Amitriptyline|amitriptyline|mesh-list
83021750|NCT02139098|Zolpidem|zolpidem|mesh-list
83021751|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83021752|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83021753|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021754|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021755|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83021756|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
83021757|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
83021758|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021759|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021760|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83021761|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
83021762|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83021763|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021764|NCT02139098|Analgesics|analgesics|mesh-ancestor
83021765|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
83021766|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021767|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83021768|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83021769|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021770|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83021771|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
83021772|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83021773|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021774|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
83021775|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
83021776|NCT02487979|Immunotoxins|immunotoxins|mesh-list
83021777|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83021778|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
83021779|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021780|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83021781|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021783|NCT02130830|Prilocaine|prilocaine|mesh-list
83021784|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
83021785|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
83021786|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021787|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021788|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
83021789|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021790|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83021791|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83021792|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83021793|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83021794|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021795|NCT04471727|Atezolizumab|atezolizumab|mesh-list
83021796|NCT04471727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83021797|NCT04471727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021798|NCT04471727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83021799|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021800|NCT01360151|Ranibizumab|ranibizumab|mesh-list
83021801|NCT01360151|Verteporfin|verteporfin|mesh-list
83021802|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83021803|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83021804|NCT01360151|Growth Substances|growth substances|mesh-ancestor
83021805|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021806|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
83021807|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021808|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83021809|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
83021810|NCT01363037|Maraviroc|maraviroc|mesh-list
83021811|NCT01363037|Dapivirine|dapivirine|mesh-list
83021812|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83021813|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83431976|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
83021814|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021815|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83021816|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83021817|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
83021818|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021819|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83021820|NCT01363115|Vitamin D|vitamin d|mesh-list
83021821|NCT01363115|Calcium|calcium|mesh-list
83021822|NCT01363115|Vitamins|vitamins|mesh-ancestor
83021823|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
83021824|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021825|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83021826|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83021827|NCT01356329|Heparin|heparin|mesh-list
83021828|NCT01356329|Enoxaparin|enoxaparin|mesh-list
83021829|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
83021830|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83021831|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83021832|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021833|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
83021834|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83021835|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
83021836|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021837|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
83021838|NCT05579522|Protective Agents|protective agents|mesh-ancestor
83021839|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83021840|NCT01363193|Heparin|heparin|mesh-list
83021841|NCT01363193|Calcium heparin|calcium heparin|mesh-list
83021842|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
83021843|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83021844|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83021845|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021847|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83021848|NCT01319279|Narcotics|narcotics|mesh-ancestor
83021849|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021850|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021851|NCT01319279|Analgesics|analgesics|mesh-ancestor
83021852|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
83021853|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021854|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
83021855|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
83021856|NCT01363271|Vancomycin|vancomycin|mesh-list
83021857|NCT01363271|Linezolid|linezolid|mesh-list
83021858|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021859|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021860|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83021861|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021862|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021863|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83021864|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021865|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83021866|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021867|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021868|NCT01360463|Methadone|methadone|mesh-list
83021869|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83021870|NCT01360463|Narcotics|narcotics|mesh-ancestor
83021871|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021872|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021873|NCT01360463|Analgesics|analgesics|mesh-ancestor
83021874|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
83021875|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021876|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
83021877|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83021878|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83021879|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021880|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83021881|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83021882|NCT03103087|Norethindrone|norethindrone|mesh-list
83021883|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
83021884|NCT03103087|Estradiol|estradiol|mesh-list
83021885|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83021886|NCT03103087|Relugolix|relugolix|mesh-list
83021887|NCT03103087|Estrogens|estrogens|mesh-ancestor
83021888|NCT03103087|Hormones|hormones|mesh-ancestor
83021889|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021890|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021891|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83021892|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
83021893|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83021894|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83021895|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83021896|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83021897|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83021898|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
83021899|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
83021900|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
83021901|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83021902|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
83021903|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
83021904|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021905|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021906|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83021907|NCT05579288|Analgesics|analgesics|mesh-ancestor
83021908|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
83021909|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021910|NCT03132467|Durvalumab|durvalumab|mesh-list
83021911|NCT03132467|Ipilimumab|ipilimumab|mesh-list
83021912|NCT03132467|Tremelimumab|tremelimumab|mesh-list
83021913|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
83021914|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83021915|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
83021916|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83021917|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021918|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
83021919|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021921|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021922|NCT02134964|Dapansutrile|dapansutrile|mesh-list
83021923|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021924|NCT01363583|Epoprostenol|epoprostenol|mesh-list
83021925|NCT01363583|Tezosentan|tezosentan|mesh-list
83021926|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83021927|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83021928|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
83021929|NCT02135120|Morphine|morphine|mesh-list
83021930|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83021931|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021932|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83021933|NCT02135120|Narcotics|narcotics|mesh-ancestor
83021934|NCT02135120|Analgesics|analgesics|mesh-ancestor
83021935|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
83021936|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021937|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
83021938|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021939|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83021940|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021941|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021942|NCT01319357|Saxagliptin|saxagliptin|mesh-list
83021943|NCT01319357|Incretins|incretins|mesh-ancestor
83021944|NCT01319357|Hormones|hormones|mesh-ancestor
83021945|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021946|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021947|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83021948|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
83021949|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021950|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021951|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83021952|NCT02135354|Azithromycin|azithromycin|mesh-list
83021953|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83021954|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83021955|NCT02055053|Bupivacaine|bupivacaine|mesh-list
83021956|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
83021957|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
83021958|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83431986|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83021959|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021960|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
83021961|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021962|NCT02303431|Edoxaban|edoxaban|mesh-list
83021963|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83021964|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
83021965|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83021966|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
83021967|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83021968|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021969|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
83021970|NCT02135510|Palonosetron|palonosetron|mesh-list
83021971|NCT02135510|Metoclopramide|metoclopramide|mesh-list
83021972|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
83021973|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
83021974|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021975|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021976|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83021977|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83021978|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83021979|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
83021980|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83021981|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83021982|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83021983|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83021984|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
83021985|NCT02004275|Dexamethasone|dexamethasone|mesh-list
83021986|NCT02004275|Pomalidomide|pomalidomide|mesh-list
83021987|NCT02004275|Ixazomib|ixazomib|mesh-list
83021988|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83021989|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
83021990|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
83021991|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83021992|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83021993|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83021994|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
83021995|NCT02004275|Hormones|hormones|mesh-ancestor
83021996|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83021997|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83021998|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83021999|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
83022000|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83022001|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83022002|NCT02004275|Growth Substances|growth substances|mesh-ancestor
83022003|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
83022004|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022005|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022006|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022008|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83022009|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022010|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022011|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022012|NCT02135588|Plasminogen|plasminogen|mesh-list
83022013|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83022014|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83022015|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83022016|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022017|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
83022018|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83022019|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022020|NCT05578664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83022021|NCT05578664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022022|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
83022023|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022024|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83022025|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022026|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022027|NCT01363817|Dexamethasone|dexamethasone|mesh-list
83022028|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022029|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
83022030|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
83022031|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83431987|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022032|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022033|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83022034|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
83022035|NCT01363817|Hormones|hormones|mesh-ancestor
83022036|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83022037|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83022038|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022039|NCT02140268|Midazolam|midazolam|mesh-list
83022040|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83022041|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83022042|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022043|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022044|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83022045|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83022046|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022047|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83022048|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
83022049|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
83022050|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
83022051|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
83022052|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022053|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022054|NCT05578352|Insulin|insulin|mesh-list
83022055|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83022056|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022057|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
83022058|NCT03602508|Mirabegron|mirabegron|mesh-list
83022059|NCT03602508|Fesoterodine|fesoterodine|mesh-list
83022060|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83022061|NCT03602508|Oxybutynin|oxybutynin|mesh-list
83022062|NCT03602508|Darifenacin|darifenacin|mesh-list
83022063|NCT03602508|Propiverine|propiverine|mesh-list
83022064|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83022065|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83022066|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
83022067|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022068|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022069|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022070|NCT03602508|Urological Agents|urological agents|mesh-ancestor
83022071|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83022072|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83022073|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83022074|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
83022075|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
83022076|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
83022077|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022078|NCT03549728|Lenograstim|lenograstim|mesh-list
83022079|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83022080|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
83022081|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022083|NCT01356797|Bupivacaine|bupivacaine|mesh-list
83022084|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
83022085|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
83022086|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
83022087|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022088|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022089|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
83022090|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022091|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83022092|NCT01356797|Narcotics|narcotics|mesh-ancestor
83022093|NCT01356797|Analgesics|analgesics|mesh-ancestor
83022094|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83022095|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83022096|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
83022097|NCT02238132|Ipratropium|ipratropium|mesh-list
83022098|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83022099|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
83022100|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022101|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022102|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83022103|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
83022104|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83022105|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
83022106|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022107|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022108|NCT05200429|Ivacaftor|ivacaftor|mesh-list
83022109|NCT05200429|Elexacaftor|elexacaftor|mesh-list
83022110|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83022111|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83022112|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022113|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83022114|NCT02135822|Paclitaxel|paclitaxel|mesh-list
83022115|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83022116|NCT02135822|Gemcitabine|gemcitabine|mesh-list
83022117|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83022118|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022119|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
83022120|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
83022121|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
83022122|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022123|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83022124|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
83022126|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83022127|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
83022128|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022129|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022130|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83022131|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
83022132|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83022133|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
83022134|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022135|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022136|NCT05739955|Disinfectants|disinfectants|mesh-list
83022137|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022138|NCT02978456|Sirolimus|sirolimus|mesh-list
83022139|NCT02978456|Temsirolimus|temsirolimus|mesh-list
83022140|NCT02978456|MTOR Inhibitors|mtor inhibitors|mesh-list
83022141|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83022142|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361624|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022143|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83022144|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022146|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83022147|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
83022148|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022149|NCT02978456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83022150|NCT02978456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022151|NCT02978456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022152|NCT05736913|Vaccines|vaccines|mesh-list
83022153|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
83022154|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022155|NCT03598452|Ganciclovir|ganciclovir|mesh-list
83022156|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83022157|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
83022158|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022159|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83022160|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022161|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022162|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83022163|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83022164|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83022165|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83022166|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022167|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022168|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022169|NCT03549026|Analgesics|analgesics|mesh-ancestor
83022170|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
83022171|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022172|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
83022173|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022174|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
83022175|NCT03101371|Iodine|iodine|mesh-list
83022176|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
83022177|NCT03101371|Povidone|povidone|mesh-list
83022178|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83022179|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022180|NCT03101371|Trace Elements|trace elements|mesh-ancestor
83022181|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
83022182|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022183|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
83022184|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
83022185|NCT03588078|Azacitidine|azacitidine|mesh-list
83022186|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83022187|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
83022188|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022189|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022190|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022191|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83022192|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
83022193|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83022194|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
83022195|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83022196|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022197|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83022198|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83022199|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022200|NCT05494190|Docetaxel|docetaxel|mesh-list
83022201|NCT05494190|Capecitabine|capecitabine|mesh-list
83022202|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022203|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
83022204|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
83022205|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
83022206|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022207|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83022208|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
83022209|NCT02850276|Bromides|bromides|mesh-list
83022210|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83022211|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
83022212|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83022213|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022214|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022215|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
83022216|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022217|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022218|NCT04961593|Caspofungin|caspofungin|mesh-list
83022219|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
83022220|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022221|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022222|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022223|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
83022225|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83022226|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022227|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83022228|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83022229|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022230|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022231|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022232|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83022233|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83022234|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83022235|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
83022236|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
83022237|NCT05577806|Progestins|progestins|mesh-ancestor
83022238|NCT05577806|Hormones|hormones|mesh-ancestor
83022239|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83022240|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83431990|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
83022241|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
83022242|NCT05465876|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83022243|NCT05465876|Antiviral Agents|antiviral agents|mesh-ancestor
83022244|NCT05465876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022245|NCT03548948|Iron|iron|mesh-list
83022246|NCT03548948|Trace Elements|trace elements|mesh-ancestor
83022247|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
83022248|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022249|NCT02238444|Aspirin|aspirin|mesh-list
83022250|NCT02238444|Heparin|heparin|mesh-list
83022251|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83022252|NCT02238444|Tinzaparin|tinzaparin|mesh-list
83022253|NCT02238444|Dalteparin|dalteparin|mesh-list
83022254|NCT02238444|Dipyridamole|dipyridamole|mesh-list
83022255|NCT02238444|Warfarin|warfarin|mesh-list
83022256|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83022257|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022258|NCT02238444|Analgesics|analgesics|mesh-ancestor
83022259|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
83022260|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022261|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022262|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022263|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022264|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83022265|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83022266|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022267|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83022268|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83022269|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022270|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
83022271|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
83022272|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83022273|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
83022274|NCT03131687|Dulaglutide|dulaglutide|mesh-list
83022275|NCT03131687|Tirzepatide|tirzepatide|mesh-list
83022276|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83022277|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022278|NCT03131687|Incretins|incretins|mesh-ancestor
83022279|NCT03131687|Hormones|hormones|mesh-ancestor
83022280|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83022281|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
83022282|NCT03579888|Fludarabine|fludarabine|mesh-list
83022283|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83022284|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
83022285|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022286|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022287|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83022288|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
83022289|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022290|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022291|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83022292|NCT05344027|Mitotane|mitotane|mesh-list
83022293|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83361625|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022294|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022295|NCT05430698|Antibodies|antibodies|mesh-list
83022296|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
83022297|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022298|NCT03585894|Ketorolac|ketorolac|mesh-list
83022299|NCT03585894|Sumatriptan|sumatriptan|mesh-list
83022300|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83022301|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022302|NCT03585894|Analgesics|analgesics|mesh-ancestor
83022303|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
83022304|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022305|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022306|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022307|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022308|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83022309|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022310|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022311|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83022312|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83022313|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83022314|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
83022315|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022316|NCT04912921|Palmidrol|palmidrol|mesh-list
83022317|NCT04912921|Curcumin|curcumin|mesh-list
83022318|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83022319|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022320|NCT04912921|Analgesics|analgesics|mesh-ancestor
83022321|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
83022322|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022323|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022324|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022325|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022326|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022327|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022328|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022329|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
83022330|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022331|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83022332|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83022333|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022334|NCT04912921|Hormones|hormones|mesh-ancestor
83022335|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83022336|NCT05420324|Paclitaxel|paclitaxel|mesh-list
83022337|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
83022338|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83022339|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022340|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
83022341|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
83022342|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
83022343|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022344|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83022345|NCT05420324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83022346|NCT02238288|Acetaminophen|acetaminophen|mesh-list
83022347|NCT02238288|Lidocaine|lidocaine|mesh-list
83022348|NCT02238288|Epinephrine|epinephrine|mesh-list
83022349|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
83022350|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
83022352|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022353|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022354|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
83022355|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022356|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83022357|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83022358|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83022359|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83022360|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022361|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022362|NCT02238288|Analgesics|analgesics|mesh-ancestor
83022363|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
83022364|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83022365|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83022366|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
83022367|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361626|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361627|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83022368|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83022369|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83022370|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
83022371|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83022372|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83022374|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
83022375|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83022376|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83022377|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83022378|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
83022379|NCT02238288|Coagulants|coagulants|mesh-ancestor
83022380|NCT01561040|Vitamin D|vitamin d|mesh-list
83022381|NCT01561040|Vitamin A|vitamin a|mesh-list
83022382|NCT01561040|Vitamins|vitamins|mesh-ancestor
83022383|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
83022384|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022385|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83022386|NCT03590496|Calcium|calcium|mesh-list
83432010|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83022387|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83022388|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022389|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
83022390|NCT05577260|Bupivacaine|bupivacaine|mesh-list
83022391|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
83022392|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
83022393|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022394|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022395|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
83022396|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022397|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83022398|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022399|NCT05577260|Analgesics|analgesics|mesh-ancestor
83022400|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83022401|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83022402|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83022403|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
83022404|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022405|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022406|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
83022407|NCT03760562|Hormones|hormones|mesh-ancestor
83022408|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83022409|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022410|NCT01357031|Amitriptyline|amitriptyline|mesh-list
83022411|NCT01357031|Melatonin|melatonin|mesh-list
83022412|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
83022413|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022414|NCT01357031|Protective Agents|protective agents|mesh-ancestor
83022415|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022416|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022417|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83022418|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
83022419|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022420|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022421|NCT01357031|Analgesics|analgesics|mesh-ancestor
83022422|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
83022423|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022424|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83022425|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83022426|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83022427|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
83022428|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022429|NCT01357109|Bosentan|bosentan|mesh-list
83022430|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83022431|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83022432|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022433|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83022434|NCT04792580|Lifitegrast|lifitegrast|mesh-list
83022435|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83022436|NCT02253446|Diclofenac|diclofenac|mesh-list
83022437|NCT02253446|Piroxicam|piroxicam|mesh-list
83022438|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83022439|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83022440|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022441|NCT02253446|Analgesics|analgesics|mesh-ancestor
83022442|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
83022443|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022444|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022445|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022446|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022447|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83022448|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022449|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022451|NCT05417893|Everolimus|everolimus|mesh-list
83022452|NCT05417893|MTOR Inhibitors|mtor inhibitors|mesh-list
83022453|NCT05417893|Temsirolimus|temsirolimus|mesh-list
83022454|NCT05417893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83022455|NCT05417893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022456|NCT05417893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022457|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83022458|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
83022459|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022460|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022461|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83022462|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022463|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83022464|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
83022465|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83022466|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83022467|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022468|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022469|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83022470|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
83022471|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022472|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022473|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83022474|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
83022475|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022476|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022477|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83022478|NCT01563224|Baclofen|baclofen|mesh-list
83022479|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83022480|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022481|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83022482|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022483|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83022484|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
83022485|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
83022486|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022487|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022488|NCT01369979|Imidacloprid|imidacloprid|mesh-list
83022489|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
83022490|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022491|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022492|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022493|NCT03577860|Bupivacaine|bupivacaine|mesh-list
83022494|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
83022495|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
83022496|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022497|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022498|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
83022499|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022500|NCT03577782|Vedolizumab|vedolizumab|mesh-list
83022501|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83022502|NCT03432065|Buspirone|buspirone|mesh-list
83022503|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83022504|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83022505|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022506|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022507|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83432013|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83022508|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83022509|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
83022510|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022511|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022512|NCT03577626|Hemay005|hemay005|mesh-list
83022513|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
83022514|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83022515|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83022516|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361628|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83022517|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022519|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83022520|NCT03412799|Gemcitabine|gemcitabine|mesh-list
83022521|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83022522|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022523|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
83022524|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
83022525|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
83022526|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022527|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83022528|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
83022529|NCT03579732|Aspirin|aspirin|mesh-list
83022530|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83022531|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022532|NCT03579732|Analgesics|analgesics|mesh-ancestor
83022533|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
83022534|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022535|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022536|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022537|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022538|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83022539|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83022540|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022541|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83022542|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83022543|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022544|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
83022545|NCT02259816|Amlodipine|amlodipine|mesh-list
83022546|NCT02259816|Telmisartan|telmisartan|mesh-list
83022547|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83022548|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83022549|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83022550|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022551|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83022552|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022553|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
83022554|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83022555|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83022556|NCT01567735|Simeprevir|simeprevir|mesh-list
83022557|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
83022558|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022559|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022560|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022561|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022562|NCT04631471|Ibudilast|ibudilast|mesh-list
83022563|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83022564|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
83022565|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022566|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022567|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83022568|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
83022569|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83022570|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022571|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022572|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83022573|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
83022574|NCT03577392|Capecitabine|capecitabine|mesh-list
83022575|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
83022576|NCT03577392|Endostatins|endostatins|mesh-list
83022577|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83022578|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
83432040|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022579|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022580|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022581|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83022582|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83022583|NCT03577392|Growth Substances|growth substances|mesh-ancestor
83022584|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022585|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
83022586|NCT03579576|Ribavirin|ribavirin|mesh-list
83022587|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
83022588|NCT03579576|Velpatasvir|velpatasvir|mesh-list
83022589|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
83022590|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022592|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022593|NCT01364519|Fluticasone|fluticasone|mesh-list
83022595|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022596|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83022597|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
83022598|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022599|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022600|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83022601|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
83022602|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83022603|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83022604|NCT03577158|Insulin|insulin|mesh-list
83022605|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83022606|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022607|NCT02253914|Ritonavir|ritonavir|mesh-list
83022608|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83022609|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83022610|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022611|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022612|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022613|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83022614|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83022615|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
83022616|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022617|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83022618|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83022619|NCT01364675|Metformin|metformin|mesh-list
83022620|NCT01364675|Enalapril|enalapril|mesh-list
83022621|NCT01364675|Simvastatin|simvastatin|mesh-list
83022622|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83022623|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022624|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83022625|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83022626|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
83022627|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022628|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83022629|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83022630|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022631|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83022632|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022633|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83022634|NCT02253758|Propofol|propofol|mesh-list
83022635|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83022636|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022637|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022638|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83022639|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
83022640|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
83022641|NCT03547232|Indomethacin|indomethacin|mesh-list
83022642|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83022643|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022644|NCT03547232|Analgesics|analgesics|mesh-ancestor
83022645|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
83022646|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022647|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022648|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022649|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022650|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
83022651|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
83022652|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83022653|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83022654|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022655|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022656|NCT02250534|Nicotine|nicotine|mesh-list
83022657|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83022658|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
83022659|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022660|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022661|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83022662|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83022663|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
83022664|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022665|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022666|NCT01370135|Ranibizumab|ranibizumab|mesh-list
83022667|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83022668|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83022669|NCT01370135|Growth Substances|growth substances|mesh-ancestor
83022670|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022671|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
83022672|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022673|NCT05266586|Ezetimibe|ezetimibe|mesh-list
83022674|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83022675|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83022676|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
83022677|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022678|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83022679|NCT01370291|Risperidone|risperidone|mesh-list
83022680|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83022681|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
83022682|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022683|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022684|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022685|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83022686|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83022687|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022688|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022689|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83022690|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
83022691|NCT05575544|Morphine|morphine|mesh-list
83022692|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83022693|NCT05575544|Narcotics|narcotics|mesh-ancestor
83022694|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022695|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022696|NCT05575544|Analgesics|analgesics|mesh-ancestor
83022697|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
83022698|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022699|NCT05179772|Olanzapine|olanzapine|mesh-list
83022700|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
83022701|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
83022702|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022703|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022704|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83022705|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83022706|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83022707|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022708|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022709|NCT05179772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83022710|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83022711|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83022712|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022713|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022714|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
83022715|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
83022716|NCT01364987|Peficitinib|peficitinib|mesh-list
83022717|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83022718|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022719|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83022720|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
83022721|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83022722|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022723|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022724|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022725|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83022726|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
83022727|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022728|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
83022730|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83022731|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022732|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022733|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022734|NCT01365923|Analgesics|analgesics|mesh-ancestor
83022735|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
83022736|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022737|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83022738|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83022739|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83022740|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
83022741|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022742|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022743|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83022744|NCT01365923|Narcotics|narcotics|mesh-ancestor
83022745|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
83022746|NCT05264168|Apixaban|apixaban|mesh-list
83022747|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83022748|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
83022749|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83022750|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022751|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022752|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022753|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
83022754|NCT01370915|Vitamins|vitamins|mesh-list
83022755|NCT01370915|Pregabalin|pregabalin|mesh-list
83022756|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
83022757|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022758|NCT01370915|Analgesics|analgesics|mesh-ancestor
83022759|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
83022760|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022761|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
83022762|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83022763|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83022764|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022765|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83022766|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83022767|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83022768|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022769|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022770|NCT05574998|Paclitaxel|paclitaxel|mesh-list
83022771|NCT05574998|Cisplatin|cisplatin|mesh-list
83022772|NCT05574998|Carboplatin|carboplatin|mesh-list
83022773|NCT05574998|Pemetrexed|pemetrexed|mesh-list
83022774|NCT05574998|Endostar protein|endostar protein|mesh-list
83022775|NCT05574998|Endostatins|endostatins|mesh-list
83022776|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83022777|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022778|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83022779|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83022780|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83022781|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022782|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022783|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83022784|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83022785|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83022786|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83022787|NCT05574998|Growth Substances|growth substances|mesh-ancestor
83022788|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022789|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
83022790|NCT03547778|Misoprostol|misoprostol|mesh-list
83022791|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83022792|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
83022793|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83022794|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022795|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83022796|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83022797|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
83022798|NCT03547700|Ixazomib|ixazomib|mesh-list
83022799|NCT03547700|Romidepsin|romidepsin|mesh-list
83022800|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022801|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022802|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022803|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022804|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83022805|NCT03547700|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83022806|NCT02239458|Saxagliptin|saxagliptin|mesh-list
83022807|NCT02239458|Incretins|incretins|mesh-ancestor
83022808|NCT02239458|Hormones|hormones|mesh-ancestor
83022809|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83022810|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022811|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83361629|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022812|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
83022813|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361630|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83022814|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022815|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83022816|NCT03578874|Capecitabine|capecitabine|mesh-list
83022817|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
83022818|NCT03578874|Sorafenib|sorafenib|mesh-list
83022819|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83022820|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
83022821|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022822|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022823|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83022824|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022825|NCT04586504|Midazolam|midazolam|mesh-list
83022826|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83022827|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83022828|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022829|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022830|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83022831|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83022832|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022833|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83022834|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
83022835|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
83022836|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
83022837|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
83022838|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022839|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022840|NCT01366001|Buprenorphine|buprenorphine|mesh-list
83022841|NCT01366001|ALKS-33|alks-33|mesh-list
83022842|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83022843|NCT01366001|Narcotics|narcotics|mesh-ancestor
83022844|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022845|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022846|NCT01366001|Analgesics|analgesics|mesh-ancestor
83022847|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
83022848|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022849|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83022850|NCT01365065|Vorinostat|vorinostat|mesh-list
83022851|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022852|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83022853|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022854|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022855|NCT03576456|Alprazolam|alprazolam|mesh-list
83022856|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83022857|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022858|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022859|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83022860|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83022861|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83022862|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
83022863|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
83022864|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022865|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022866|NCT03576378|Prednisone|prednisone|mesh-list
83022867|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
83022868|NCT03576378|Etoposide|etoposide|mesh-list
83022869|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
83022870|NCT03576378|Procarbazine|procarbazine|mesh-list
83022871|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83022872|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
83022873|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022874|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022875|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83022876|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
83022877|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022878|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022879|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83022880|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022881|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
83022882|NCT03576378|Hormones|hormones|mesh-ancestor
83022883|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83022884|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83022885|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83022886|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83022887|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83022888|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022890|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
83022891|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022892|NCT05572190|Hydrocodone|hydrocodone|mesh-list
83022893|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83022894|NCT05572190|Narcotics|narcotics|mesh-ancestor
83022895|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022896|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022897|NCT05572190|Analgesics|analgesics|mesh-ancestor
83022898|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
83022899|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022900|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
83022901|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
83022902|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83022903|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83022904|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
83022905|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83022906|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022907|NCT05567588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83022908|NCT05567588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022909|NCT03124199|Rifaximin|rifaximin|mesh-list
83022910|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83022911|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022912|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83022913|NCT03578640|Grazoprevir|grazoprevir|mesh-list
83022914|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
83022915|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022916|NCT04465916|Tenofovir|tenofovir|mesh-list
83022917|NCT04465916|Entecavir|entecavir|mesh-list
83022918|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
83022919|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022920|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83022921|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83022922|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83022923|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022924|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83022925|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83022926|NCT01366235|Chloroquine|chloroquine|mesh-list
83022927|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83022928|NCT01366235|Amebicides|amebicides|mesh-ancestor
83022929|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83022930|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83022931|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83022932|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
83022933|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83022934|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83022935|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022936|NCT01366235|Analgesics|analgesics|mesh-ancestor
83022937|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
83022938|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022939|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022940|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83022941|NCT01366235|Filaricides|filaricides|mesh-ancestor
83022942|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
83022943|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
83022944|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
83022945|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83022946|NCT04871165|Antibodies|antibodies|mesh-list
83022947|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
83022948|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022949|NCT04465760|Antibodies|antibodies|mesh-list
83022950|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
83022951|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
83022952|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022953|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
83022954|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83022955|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022956|NCT04249739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83022957|NCT04249739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022958|NCT01366313|Acetaminophen|acetaminophen|mesh-list
83022959|NCT01366313|Morphine|morphine|mesh-list
83022960|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83022961|NCT01366313|Narcotics|narcotics|mesh-ancestor
83022962|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83022963|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022964|NCT01366313|Analgesics|analgesics|mesh-ancestor
83022965|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
83022966|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022967|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83022968|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
83022969|NCT05561738|Niacinamide|niacinamide|mesh-list
83022970|NCT05561738|Niacin|niacin|mesh-list
83022971|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
83022972|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
83022973|NCT05561738|Vitamins|vitamins|mesh-ancestor
83022974|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
83022975|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022976|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83022977|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
83022978|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022979|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83022980|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
83022981|NCT02253524|Metoclopramide|metoclopramide|mesh-list
83022982|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
83022983|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
83022984|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
83022985|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83022986|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83022987|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83022988|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83022989|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83022990|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
83022991|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83022992|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83022993|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83022994|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
83022995|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
83022996|NCT03575598|Nivolumab|nivolumab|mesh-list
83022997|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83022998|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83022999|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023000|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023001|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83023002|NCT02253602|Hematinics|hematinics|mesh-ancestor
83023003|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83023004|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83023005|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
83023006|NCT03575520|Doxorubicin|doxorubicin|mesh-list
83023007|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83023008|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
83023009|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023010|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83023011|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83023012|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
83023013|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023014|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023015|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83023016|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83023017|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83023018|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023019|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023020|NCT01366391|Metformin|metformin|mesh-list
83023021|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83023022|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023023|NCT04408586|Topiramate|topiramate|mesh-list
83023024|NCT04408586|Phentermine|phentermine|mesh-list
83023025|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
83023026|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83023028|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83023029|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
83023030|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83023031|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
83023032|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
83023033|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023034|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
83023035|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023036|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023037|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83023038|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
83023039|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
83023040|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023041|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83023042|NCT02239614|Antacids|antacids|mesh-ancestor
83023043|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023044|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83023045|NCT03572400|Gemcitabine|gemcitabine|mesh-list
83023046|NCT03572400|Durvalumab|durvalumab|mesh-list
83023047|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83023048|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
83023049|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023050|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023051|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023052|NCT02253836|Ritonavir|ritonavir|mesh-list
83023053|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83023054|NCT02253836|Tipranavir|tipranavir|mesh-list
83023055|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83023056|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83023057|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
83023058|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023059|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023060|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83023061|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83023062|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
83023063|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023064|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83023065|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83023066|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83023067|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83023068|NCT02241018|Antibodies|antibodies|mesh-list
83023069|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83023070|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83023071|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
83023072|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023073|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023074|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023075|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
83023076|NCT04039022|Bupropion|bupropion|mesh-list
83023077|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83023078|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
83023079|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83023080|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83023081|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83023082|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83023083|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023084|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
83023085|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023086|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023087|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83023088|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83023089|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023090|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
83023091|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
83023092|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83023093|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83023094|NCT00109772|Lenalidomide|lenalidomide|mesh-list
83023095|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
83023096|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023097|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83023098|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83023099|NCT00109772|Growth Substances|growth substances|mesh-ancestor
83023101|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023102|NCT03572010|Fesoterodine|fesoterodine|mesh-list
83023103|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83023104|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83023105|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
83023106|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023107|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023108|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023109|NCT03572010|Urological Agents|urological agents|mesh-ancestor
83023110|NCT01560104|Paclitaxel|paclitaxel|mesh-list
83023111|NCT01560104|Carboplatin|carboplatin|mesh-list
83023112|NCT01560104|Veliparib|veliparib|mesh-list
83023113|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83023114|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023115|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
83023116|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
83023118|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023119|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83023120|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023121|NCT00101972|Antibodies|antibodies|mesh-list
83023122|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83023123|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
83023124|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023125|NCT02245932|Resveratrol|resveratrol|mesh-list
83023126|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
83023127|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023128|NCT02245932|Protective Agents|protective agents|mesh-ancestor
83023129|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023130|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023131|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83023132|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83023133|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83023134|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023135|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023136|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023137|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83023138|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
83023139|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83023140|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83023141|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023142|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
83023143|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
83023144|NCT04944368|Paraproteins|paraproteins|mesh-list
83023145|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
83023146|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023147|NCT04268498|Acetaminophen|acetaminophen|mesh-list
83023148|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
83023149|NCT04268498|Promethazine|promethazine|mesh-list
83023150|NCT04268498|Dexamethasone|dexamethasone|mesh-list
83023151|NCT04268498|Lenalidomide|lenalidomide|mesh-list
83023152|NCT04268498|Bortezomib|bortezomib|mesh-list
83023153|NCT04268498|Daratumumab|daratumumab|mesh-list
83023154|NCT04268498|Montelukast|montelukast|mesh-list
83023155|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023156|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
83023157|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
83023158|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023159|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023160|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83023161|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
83023162|NCT04268498|Hormones|hormones|mesh-ancestor
83023163|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023164|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83023165|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023166|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
83023167|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83023168|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83023169|NCT04268498|Growth Substances|growth substances|mesh-ancestor
83023170|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
83023171|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83023172|NCT04268498|Analgesics|analgesics|mesh-ancestor
83023173|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
83023174|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
83023175|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83023176|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
83023177|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83023178|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
83023179|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83023180|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83023181|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023182|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83023183|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83023184|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023185|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
83023186|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
83023187|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83023188|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
83023189|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
83023190|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023191|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83023192|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
83023193|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
83023194|NCT04260464|PF-06700841|pf-06700841|mesh-list
83023195|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83023196|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023197|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023198|NCT03651518|Rituximab|rituximab|mesh-list
83023199|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83023200|NCT03651518|Ustekinumab|ustekinumab|mesh-list
83023201|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023202|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023203|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
83023204|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023205|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83023206|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
83023207|NCT03546530|Interferons|interferons|mesh-list
83023208|NCT03546530|Resveratrol|resveratrol|mesh-list
83023209|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023210|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
83023211|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023212|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
83023213|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023214|NCT03546530|Protective Agents|protective agents|mesh-ancestor
83023215|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023216|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023217|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83023218|NCT03568994|Cytarabine|cytarabine|mesh-list
83023219|NCT03568994|Atovaquone|atovaquone|mesh-list
83023220|NCT03568994|Etoposide|etoposide|mesh-list
83023221|NCT03568994|Daunorubicin|daunorubicin|mesh-list
83023222|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
83023223|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83023224|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023225|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83023226|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023227|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023228|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023229|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83023230|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
83023231|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
83023232|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023233|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83023234|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
83023235|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023236|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83023237|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023238|NCT03568994|Immunotoxins|immunotoxins|mesh-ancestor
83023239|NCT03568994|Immunoconjugates|immunoconjugates|mesh-ancestor
83023240|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
83023241|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83023242|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83023243|NCT04203056|Aripiprazole|aripiprazole|mesh-list
83023244|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
83023245|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
83023246|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83023247|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83023248|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83023249|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023250|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023251|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
83023252|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
83023253|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023254|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023255|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83023256|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83023258|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83023259|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83023260|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83023261|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83023262|NCT04894994|Ipilimumab|ipilimumab|mesh-list
83023263|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023264|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023265|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023266|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023267|NCT01366547|Lamivudine|lamivudine|mesh-list
83023269|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
83023270|NCT01366547|Dolutegravir|dolutegravir|mesh-list
83023271|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83023272|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83023273|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023274|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023275|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
83023276|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023277|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83023278|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83023279|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83023280|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83023281|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
83023282|NCT05190341|Ibuprofen|ibuprofen|mesh-list
83023283|NCT05190341|Ketorolac|ketorolac|mesh-list
83023284|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83023285|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83023286|NCT05190341|Analgesics|analgesics|mesh-ancestor
83023287|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
83023288|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023289|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023290|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023291|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83023292|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83023293|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023294|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023295|NCT04347239|Leronlimab|leronlimab|mesh-list
83023296|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83023297|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83023298|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023299|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83023300|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83023301|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
83023302|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023303|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
83023304|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83023305|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83023306|NCT00109928|Prednisolone|prednisolone|mesh-list
83023307|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
83023308|NCT00109928|Gemcitabine|gemcitabine|mesh-list
83023309|NCT00109928|Etoposide|etoposide|mesh-list
83023310|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83023311|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
83023312|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023313|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83023314|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
83023315|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023316|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83023317|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83023318|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023319|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023320|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023321|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
83023322|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
83023323|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023324|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023325|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83023326|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
83023327|NCT00109928|Hormones|hormones|mesh-ancestor
83476451|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023328|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023329|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83023330|NCT00109928|Protective Agents|protective agents|mesh-ancestor
83023331|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83023332|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83023333|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023334|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
83023335|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023336|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023338|NCT00109850|Cetuximab|cetuximab|mesh-list
83023339|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023340|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83023341|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023342|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023343|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023344|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023345|NCT03318770|Dasatinib|dasatinib|mesh-list
83023346|NCT03318770|Blinatumomab|blinatumomab|mesh-list
83023347|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023348|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83023349|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023350|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023351|NCT01065519|Umirolimus|umirolimus|mesh-list
83023352|NCT01065519|Everolimus|everolimus|mesh-list
83023353|NCT01065519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83023354|NCT01065519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83023355|NCT01065519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023356|NCT01065519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023357|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83023358|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
83023359|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023360|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023361|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023362|NCT05539989|Vaccines|vaccines|mesh-list
83023363|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
83023364|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
83023365|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023366|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83023367|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83023368|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83023369|NCT01810016|Poly I-C|poly i-c|mesh-list
83023370|NCT01810016|Ipilimumab|ipilimumab|mesh-list
83023371|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83023372|NCT01810016|Vaccines|vaccines|mesh-list
83023373|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83023374|NCT01810016|Poly ICLC|poly iclc|mesh-list
83023375|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
83023376|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023377|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023378|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023379|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023380|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023381|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83023382|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
83023383|NCT01810016|Laxatives|laxatives|mesh-ancestor
83023384|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83023385|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
83023386|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023387|NCT01722266|Liraglutide|liraglutide|mesh-list
83023388|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83023389|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023390|NCT01722266|Incretins|incretins|mesh-ancestor
83023391|NCT01722266|Hormones|hormones|mesh-ancestor
83023392|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023393|NCT02254148|Metoprolol|metoprolol|mesh-list
83023394|NCT02254148|Digoxin|digoxin|mesh-list
83023395|NCT02254148|Midazolam|midazolam|mesh-list
83023396|NCT02254148|Caffeine|caffeine|mesh-list
83023397|NCT02254148|Omeprazole|omeprazole|mesh-list
83023398|NCT02254148|Warfarin|warfarin|mesh-list
83023399|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83023400|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83023401|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023402|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023403|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83023404|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83023405|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83023406|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83023407|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
83023408|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
83023409|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
83023410|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
83023411|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023412|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023413|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
83023414|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83023415|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83023416|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023417|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83023418|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83023419|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
83023420|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83023421|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83023422|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83023423|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83023424|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83023425|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
83023426|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
83023427|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023428|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83023429|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83023430|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83023431|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83023432|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83023433|NCT02254148|Protective Agents|protective agents|mesh-ancestor
83023434|NCT02842866|Vaccines|vaccines|mesh-list
83023435|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
83023436|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023437|NCT01316913|Bromides|bromides|mesh-list
83023438|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
83023439|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83023440|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
83023441|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023442|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023443|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83023444|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
83023445|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
83023446|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83023447|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
83023448|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023449|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023450|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
83023451|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
83023452|NCT02875067|Lenalidomide|lenalidomide|mesh-list
83023453|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023454|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023455|NCT02875067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83432075|NCT01980355|Coagulants|coagulants|mesh-ancestor
83023456|NCT02875067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023457|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
83023458|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023459|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83023460|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83023461|NCT02875067|Growth Substances|growth substances|mesh-ancestor
83023462|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
83023463|NCT03570294|Atosiban|atosiban|mesh-list
83023464|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
83023465|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023466|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023467|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
83023468|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83023469|NCT02143622|Cetuximab|cetuximab|mesh-list
83023470|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023471|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023472|NCT02781506|Nivolumab|nivolumab|mesh-list
83023473|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023474|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023475|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023476|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023477|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83023478|NCT03571230|Amoxicillin|amoxicillin|mesh-list
83023479|NCT03571230|Metronidazole|metronidazole|mesh-list
83023480|NCT03571230|Clarithromycin|clarithromycin|mesh-list
83023481|NCT03571230|Levofloxacin|levofloxacin|mesh-list
83023482|NCT03571230|Tetracycline|tetracycline|mesh-list
83023483|NCT03571230|Tinidazole|tinidazole|mesh-list
83023484|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83023485|NCT03571230|Furazolidone|furazolidone|mesh-list
83023486|NCT03571230|Bismuth|bismuth|mesh-list
83023487|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83023488|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023489|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
83023490|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83023491|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83023492|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83023493|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023494|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023495|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83023496|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83023497|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83023498|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83023499|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023500|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023501|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83023502|NCT03571230|Antacids|antacids|mesh-ancestor
83023503|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83023504|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83023505|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83023506|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83023507|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
83023508|NCT03368963|Trifluridine|trifluridine|mesh-list
83023509|NCT03368963|Irinotecan|irinotecan|mesh-list
83023510|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83023511|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023512|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023513|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023514|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023515|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
83023516|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
83023517|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023518|NCT05489211|Leucovorin|leucovorin|mesh-list
83023519|NCT05489211|Bevacizumab|bevacizumab|mesh-list
83023520|NCT05489211|Nivolumab|nivolumab|mesh-list
83023521|NCT05489211|Durvalumab|durvalumab|mesh-list
83023522|NCT05489211|Carboplatin|carboplatin|mesh-list
83023523|NCT05489211|Fluorouracil|fluorouracil|mesh-list
83023524|NCT05489211|Capecitabine|capecitabine|mesh-list
83023525|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023526|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023527|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83023528|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83023529|NCT05489211|Growth Substances|growth substances|mesh-ancestor
83023530|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83432078|NCT00555321|Tacrolimus|tacrolimus|mesh-list
83023531|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
83023532|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
83023533|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023534|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83023535|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83023536|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
83023537|NCT05489211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023538|NCT05489211|Antidotes|antidotes|mesh-ancestor
83023539|NCT05489211|Protective Agents|protective agents|mesh-ancestor
83023540|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
83023541|NCT05489211|Vitamins|vitamins|mesh-ancestor
83023542|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
83023543|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83023544|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83023545|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
83023546|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023547|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023548|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83023549|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
83023550|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83023551|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83023552|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83023553|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83023554|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023555|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023556|NCT02143934|Chloroquine|chloroquine|mesh-list
83023557|NCT02143934|Lumefantrine|lumefantrine|mesh-list
83023559|NCT02143934|Primaquine|primaquine|mesh-list
83023560|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83023561|NCT02143934|Amebicides|amebicides|mesh-ancestor
83023562|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83023563|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83023564|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023565|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
83023566|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83023567|NCT03096847|Letrozole|letrozole|mesh-list
83023568|NCT03096847|Goserelin|goserelin|mesh-list
83023569|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023570|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83023571|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83023572|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023573|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023574|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83023575|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
83023576|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023577|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023578|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83023579|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
83023580|NCT03545516|Bupivacaine|bupivacaine|mesh-list
83023581|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
83023582|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
83023583|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023584|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023585|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
83023586|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023587|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83023588|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83023589|NCT03545516|Analgesics|analgesics|mesh-ancestor
83023590|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83023591|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83023592|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83023593|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
83023594|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023595|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023596|NCT04753879|Paclitaxel|paclitaxel|mesh-list
83023597|NCT04753879|Gemcitabine|gemcitabine|mesh-list
83023598|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
83023599|NCT04753879|Capecitabine|capecitabine|mesh-list
83023600|NCT04753879|Irinotecan|irinotecan|mesh-list
83023601|NCT04753879|Olaparib|olaparib|mesh-list
83023602|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83023603|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023604|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
83023605|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
83023606|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
83023607|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023608|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83023609|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
83023610|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023611|NCT04753879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023612|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83023613|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023614|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023615|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83023616|NCT02846532|Aspirin|aspirin|mesh-list
83023617|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
83023618|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83023619|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
83023620|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83023621|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
83023622|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023623|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023624|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
83023625|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83023626|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83023627|NCT02846532|Analgesics|analgesics|mesh-ancestor
83023628|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
83023629|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023630|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023631|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023632|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83023633|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83023634|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83023635|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83023636|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83023638|NCT01371461|Paroxetine|paroxetine|mesh-list
83023639|NCT01371461|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83023640|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83023641|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83023642|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023643|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023644|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
83023645|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023646|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83023647|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
83023648|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83023649|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83023650|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83023651|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023652|NCT05324423|Colchicine|colchicine|mesh-list
83023653|NCT05324423|Febuxostat|febuxostat|mesh-list
83023654|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
83023655|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83023656|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
83023657|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
83023658|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
83023659|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023660|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023661|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
83023662|NCT04704219|Lenvatinib|lenvatinib|mesh-list
83023663|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023664|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023665|NCT04704219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023666|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023667|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83023668|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023669|NCT00842348|Lanreotide|lanreotide|mesh-list
83023670|NCT00842348|Somatostatin|somatostatin|mesh-list
83023671|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023672|NCT00842348|Hormones|hormones|mesh-ancestor
83023673|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023674|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023675|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
83023676|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83023677|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83023678|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83023679|NCT02144246|Norgestimate|norgestimate|mesh-list
83023680|NCT02144246|Norgestrel|norgestrel|mesh-list
83023681|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83023682|NCT02144246|Estradiol|estradiol|mesh-list
83023683|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83023684|NCT02144246|Estrogens|estrogens|mesh-ancestor
83023685|NCT02144246|Hormones|hormones|mesh-ancestor
83023686|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023687|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023688|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83023689|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
83023690|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83023691|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83023692|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83023693|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83023694|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83023695|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83023696|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023697|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83023698|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023699|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023700|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023701|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023702|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83023703|NCT03095521|Menthol|menthol|mesh-list
83023704|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
83023705|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
83023706|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
83023707|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023708|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
83023709|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83023710|NCT05242315|Tacrolimus|tacrolimus|mesh-list
83023711|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83023712|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
83023713|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023714|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83023715|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023716|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023717|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
83023718|NCT03569046|Bupivacaine|bupivacaine|mesh-list
83023719|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
83023720|NCT03569046|Anesthetics|anesthetics|mesh-list
83023721|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
83023722|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023723|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023724|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
83023725|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023726|NCT02935595|Ketamine|ketamine|mesh-list
83023727|NCT02935595|Analgesics|analgesics|mesh-ancestor
83023728|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
83023729|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023730|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023731|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83023732|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83023733|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
83023734|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
83023735|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023736|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83023737|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83023738|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023739|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023740|NCT02649673|Topotecan|topotecan|mesh-list
83023741|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83023742|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83023743|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023744|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023745|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023746|NCT03568968|Niacinamide|niacinamide|mesh-list
83023747|NCT03568968|Niacin|niacin|mesh-list
83023748|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
83023749|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
83023750|NCT03568968|Vitamins|vitamins|mesh-ancestor
83023751|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
83023752|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023753|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83023754|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
83023755|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023756|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83023757|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
83023758|NCT02817347|Tazobactam|tazobactam|mesh-list
83023759|NCT02817347|Piperacillin|piperacillin|mesh-list
83023760|NCT02817347|Dexamethasone|dexamethasone|mesh-list
83023761|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
83023762|NCT02817347|BB 1101|bb 1101|mesh-list
83023763|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023764|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
83023765|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
83023766|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023767|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023768|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83023769|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
83023770|NCT02817347|Hormones|hormones|mesh-ancestor
83023771|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023772|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83023773|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023774|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
83023775|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023776|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023777|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83023778|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023779|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83023780|NCT01373021|Fentanyl|fentanyl|mesh-list
83023781|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
83023782|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83023784|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023785|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83023786|NCT01373021|Analgesics|analgesics|mesh-ancestor
83023787|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
83023788|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023789|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83023790|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83023791|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83023792|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
83023793|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023794|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023795|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83023796|NCT01373021|Narcotics|narcotics|mesh-ancestor
83023797|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83023798|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83023799|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
83023800|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
83023801|NCT02690558|Gemcitabine|gemcitabine|mesh-list
83023802|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
83023803|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023804|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83023805|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
83023806|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023807|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83023808|NCT02690558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83023809|NCT03568578|Entecavir|entecavir|mesh-list
83023810|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
83023811|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023812|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
83023813|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83023814|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023815|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
83023816|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023817|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
83023818|NCT02140736|Hematinics|hematinics|mesh-ancestor
83023819|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
83023820|NCT05417035|Androgens|androgens|mesh-ancestor
83023821|NCT05417035|Hormones|hormones|mesh-ancestor
83023822|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023823|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023824|NCT05708742|Bupivacaine|bupivacaine|mesh-list
83023825|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
83023826|NCT05708742|Anesthetics|anesthetics|mesh-list
83023827|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023828|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023829|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
83023830|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023831|NCT03095287|Factor VIII|factor viii|mesh-list
83023832|NCT03095287|Coagulants|coagulants|mesh-ancestor
83023833|NCT01335581|Tretinoin|tretinoin|mesh-list
83023834|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023835|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
83023836|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
83023837|NCT05204563|Imipenem|imipenem|mesh-list
83023838|NCT05204563|Relebactam|relebactam|mesh-list
83023839|NCT05204563|Cilastatin|cilastatin|mesh-list
83023840|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83023841|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023842|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
83023843|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023844|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023845|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83023846|NCT02140814|Niacinamide|niacinamide|mesh-list
83023847|NCT02140814|Niacin|niacin|mesh-list
83023848|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
83023849|NCT02140814|Vitamins|vitamins|mesh-ancestor
83023850|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
83023851|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023852|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
83023853|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83023854|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
83023855|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023856|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83023857|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
83023858|NCT03015090|Theophylline|theophylline|mesh-list
83023859|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83023860|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
83023861|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023862|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023863|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83023864|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
83023865|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83023866|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023867|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023868|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
83023869|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83023870|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83023871|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
83023872|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023873|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
83023874|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83023875|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83023876|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023877|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
83023878|NCT02620748|Coagulants|coagulants|mesh-ancestor
83023880|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83023881|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83023882|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83023883|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023884|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83023885|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023886|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
83023887|NCT03566394|Gabapentin|gabapentin|mesh-list
83023888|NCT03566394|Analgesics|analgesics|mesh-ancestor
83023889|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
83023890|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023891|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023892|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
83023893|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83023894|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83023895|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83023896|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83023897|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83023898|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83023899|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023900|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023901|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
83023902|NCT00033293|Prednisone|prednisone|mesh-list
83023903|NCT00033293|Cortisone|cortisone|mesh-list
83023904|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
83023905|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
83023906|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83023907|NCT00033293|Antibodies|antibodies|mesh-list
83023908|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
83023909|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83023910|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
83023911|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83023912|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
83023913|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023914|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83023915|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83023916|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
83023917|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023918|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023919|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83023920|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83023921|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
83023922|NCT00033293|Hormones|hormones|mesh-ancestor
83023923|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83023924|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83023925|NCT03566316|Amlodipine|amlodipine|mesh-list
83023926|NCT03566316|Telmisartan|telmisartan|mesh-list
83023927|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83023928|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83023929|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83023930|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83023931|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83023932|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023933|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83476452|NCT01092923|Sevoflurane|sevoflurane|mesh-list
83023934|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023935|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
83023936|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83023937|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83023938|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
83023939|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83023940|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83023941|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023942|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83023943|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83023944|NCT02145104|Valsartan|valsartan|mesh-list
83023945|NCT02145104|Cilnidipine|cilnidipine|mesh-list
83023946|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83023947|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83023948|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83023949|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023950|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83361631|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83023951|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83023952|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83023953|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023954|NCT02145338|Trimethoprim|trimethoprim|mesh-list
83023955|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
83023957|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83023958|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83023959|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
83023960|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83023961|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83023962|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83023963|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023964|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023965|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83023966|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83023967|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83023968|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83023969|NCT03565536|Sorafenib|sorafenib|mesh-list
83023970|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83023971|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83023972|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83023973|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023974|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
83023975|NCT03565458|Empagliflozin|empagliflozin|mesh-list
83023976|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83023977|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023978|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83023979|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023980|NCT03565302|Terbutaline|terbutaline|mesh-list
83023981|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
83023982|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83023983|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
83023984|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83023985|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83023986|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83023987|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
83023988|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83023989|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83023990|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83023991|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
83023992|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83023993|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83023994|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
83023995|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
83023996|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83023997|NCT05193227|Lidocaine|lidocaine|mesh-list
83023998|NCT05193227|Bupivacaine|bupivacaine|mesh-list
83023999|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
83024000|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
83024001|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024002|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024003|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
83024004|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024005|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83476453|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83024006|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83024007|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83024008|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024009|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024010|NCT01372007|Lanreotide|lanreotide|mesh-list
83024011|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024012|NCT01373411|Ticagrelor|ticagrelor|mesh-list
83024013|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83024014|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83024015|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83024016|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83024017|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
83024018|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024019|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024020|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024021|NCT03567408|Bivalirudin|bivalirudin|mesh-list
83024022|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
83361632|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024023|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83024024|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
83024025|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024026|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024027|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
83024028|NCT05354076|Doxorubicin|doxorubicin|mesh-list
83024029|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83024030|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83024031|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024032|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83024033|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83024034|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024035|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024036|NCT05106335|Docetaxel|docetaxel|mesh-list
83024037|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024038|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
83024039|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83024040|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83024041|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024042|NCT05192681|Docetaxel|docetaxel|mesh-list
83024043|NCT05192681|Tislelizumab|tislelizumab|mesh-list
83024044|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024045|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
83024046|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
83024047|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
83024048|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024049|NCT05192681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024050|NCT05192213|Thiamine|thiamine|mesh-list
83024051|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
83024052|NCT05192213|Vitamins|vitamins|mesh-ancestor
83024053|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
83024054|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024055|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024056|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
83024057|NCT02039674|Paclitaxel|paclitaxel|mesh-list
83024058|NCT02039674|Bevacizumab|bevacizumab|mesh-list
83024059|NCT02039674|Carboplatin|carboplatin|mesh-list
83024060|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
83024061|NCT02039674|Pemetrexed|pemetrexed|mesh-list
83024062|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83024063|NCT02039674|Ipilimumab|ipilimumab|mesh-list
83024064|NCT02039674|Gefitinib|gefitinib|mesh-list
83024065|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83024066|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024067|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
83024068|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
83024069|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83024070|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024071|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024072|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83024073|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83024074|NCT02039674|Growth Substances|growth substances|mesh-ancestor
83024075|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024076|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
83024077|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83024078|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024079|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83024080|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83024082|NCT03099187|Pirfenidone|pirfenidone|mesh-list
83024083|NCT03099187|Analgesics|analgesics|mesh-ancestor
83024084|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
83024085|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024086|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024087|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83024088|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83024089|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024090|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024091|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024092|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
83024093|NCT04162756|Fludarabine|fludarabine|mesh-list
83024094|NCT04162756|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
83024095|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83024096|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
83024097|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024098|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024099|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83361633|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
83361634|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83361635|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83361636|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83024100|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
83024101|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024102|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024103|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83024104|NCT04162756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024106|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
83024107|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024108|NCT04895488|Vortioxetine|vortioxetine|mesh-list
83024109|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
83024110|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
83024111|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83024112|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83024113|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83024114|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024115|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024116|NCT04895488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83024117|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83024118|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024119|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024120|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024121|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
83024122|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83024123|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83024124|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83024125|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83024126|NCT04342715|Paromomycin|paromomycin|mesh-list
83024127|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83024128|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83024129|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024130|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83024131|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83024132|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
83024133|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83024134|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
83024135|NCT01373333|Amifampridine|amifampridine|mesh-list
83024136|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83024137|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024138|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024139|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83024140|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024141|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024142|NCT01368341|Amoxicillin|amoxicillin|mesh-list
83024143|NCT01368341|Doxycycline|doxycycline|mesh-list
83024144|NCT01368341|Penicillin V|penicillin v|mesh-list
83024145|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83024146|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024147|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
83024148|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83024149|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83024150|NCT01368419|Endostar protein|endostar protein|mesh-list
83024152|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83024153|NCT01368419|Growth Substances|growth substances|mesh-ancestor
83024154|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024155|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
83024156|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024157|NCT04639219|Trastuzumab|trastuzumab|mesh-list
83024158|NCT04639219|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83024159|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024160|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024161|NCT04639219|Immunoconjugates|immunoconjugates|mesh-ancestor
83024162|NCT04639219|Immunologic Factors|immunologic factors|mesh-ancestor
83024163|NCT04639219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024164|NCT04455100|Itraconazole|itraconazole|mesh-list
83024165|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
83024166|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024167|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83024168|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83024169|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361637|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
83024170|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024171|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83024172|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
83024173|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024174|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024175|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83024176|NCT04439578|Rifampin|rifampin|mesh-list
83024177|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83024178|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
83024179|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83024180|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024181|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
83024182|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83024183|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024184|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024185|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83024186|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83024187|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83024188|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83024189|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83024190|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83024191|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
83024192|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83024193|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83024194|NCT03110848|Prednisolone|prednisolone|mesh-list
83024195|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
83024196|NCT03110848|Atorvastatin|atorvastatin|mesh-list
83024197|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83024198|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
83024199|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
83024200|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83024201|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83024202|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
83024203|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024204|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83024205|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83024206|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024207|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024208|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
83024209|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
83024210|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024211|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024212|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83024213|NCT03110848|Hormones|hormones|mesh-ancestor
83024214|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024215|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83024216|NCT03110848|Protective Agents|protective agents|mesh-ancestor
83024217|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83024218|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024219|NCT03139474|Hormones|hormones|mesh-list
83024220|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
83476454|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83024221|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024222|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024224|NCT01368887|Niacin|niacin|mesh-list
83024225|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
83024226|NCT01368887|Calcipotriene|calcipotriene|mesh-list
83024227|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
83024228|NCT01368887|Vitamins|vitamins|mesh-ancestor
83024229|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
83024230|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024231|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83024232|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
83024233|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024234|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83024235|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
83024236|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
83024237|NCT01369043|Vitamins|vitamins|mesh-list
83024238|NCT01369043|Vitamin E|vitamin e|mesh-list
83024239|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
83024240|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024241|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
83024242|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024243|NCT01369043|Protective Agents|protective agents|mesh-ancestor
83024244|NCT04477096|Emtricitabine|emtricitabine|mesh-list
83024245|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
83024246|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024247|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83024248|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83024249|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024250|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024251|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83024252|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83024253|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
83024254|NCT01369121|Hormones|hormones|mesh-ancestor
83024255|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024256|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024257|NCT03868150|Amiodarone|amiodarone|mesh-list
83024258|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83024259|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
83024260|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83024261|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024262|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024263|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83024264|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83024265|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83024266|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024267|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83024268|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83024269|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83024270|NCT03521687|Apremilast|apremilast|mesh-list
83024271|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83024272|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83024273|NCT03521687|Analgesics|analgesics|mesh-ancestor
83024274|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
83024275|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024276|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024277|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024278|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024279|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83024280|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83024281|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024282|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024283|NCT03141658|Ketamine|ketamine|mesh-list
83024284|NCT03141658|Analgesics|analgesics|mesh-ancestor
83024285|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
83024286|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024287|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024288|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83024289|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83024290|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
83024291|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
83024292|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024293|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83024294|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83024295|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024296|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024297|NCT03498131|Melatonin|melatonin|mesh-list
83024298|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
83024299|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024300|NCT03498131|Protective Agents|protective agents|mesh-ancestor
83024301|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024302|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024303|NCT01319825|Milnacipran|milnacipran|mesh-list
83024304|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
83024305|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83024306|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83024307|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024308|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024309|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024310|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024311|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83024312|NCT01319825|Analgesics|analgesics|mesh-ancestor
83024313|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
83024314|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024315|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
83024316|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83024317|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
83024318|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
83024319|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024320|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024321|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
83024322|NCT01369277|Vitamins|vitamins|mesh-ancestor
83024323|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
83024324|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024325|NCT02983006|Nivolumab|nivolumab|mesh-list
83024326|NCT02983006|DS-8273a|ds-8273a|mesh-list
83024327|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024328|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024329|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83024330|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024331|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
83024332|NCT03811756|Vitamins|vitamins|mesh-ancestor
83024333|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
83024334|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024335|NCT03141268|Lactulose|lactulose|mesh-list
83024336|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83024337|NCT03316781|Adalimumab|adalimumab|mesh-list
83024338|NCT03316781|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83024339|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024340|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024341|NCT01319903|Antibodies|antibodies|mesh-list
83024342|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83024343|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
83024344|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024345|NCT02839200|Zolpidem|zolpidem|mesh-list
83024346|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83024347|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83024348|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024349|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024350|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83024351|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
83024352|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
83024353|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024354|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024355|NCT01369667|Vitamin D|vitamin d|mesh-list
83024356|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
83024357|NCT01369667|Vitamins|vitamins|mesh-ancestor
83024358|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
83024359|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024360|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83024361|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83024362|NCT03564912|Capecitabine|capecitabine|mesh-list
83024363|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
83024364|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83024365|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
83024366|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024367|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024368|NCT03551626|Trametinib|trametinib|mesh-list
83024369|NCT03551626|Dabrafenib|dabrafenib|mesh-list
83024370|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024371|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024372|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024373|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024374|NCT05760053|Cisplatin|cisplatin|mesh-list
83024375|NCT05760053|Carboplatin|carboplatin|mesh-list
83024376|NCT05760053|Etoposide|etoposide|mesh-list
83024377|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024378|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83024379|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83024380|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83024381|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024382|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024383|NCT03118739|Febuxostat|febuxostat|mesh-list
83024384|NCT03118739|Verinurad|verinurad|mesh-list
83024385|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
83024386|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361638|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024387|NCT03181126|Venetoclax|venetoclax|mesh-list
83024388|NCT03181126|Navitoclax|navitoclax|mesh-list
83024389|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024390|NCT05139875|Triamcinolone|triamcinolone|mesh-list
83024391|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83024392|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83024393|NCT05139875|Betamethasone|betamethasone|mesh-list
83024394|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
83024395|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83024396|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
83024397|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
83024398|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83024399|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83024400|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024401|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
83024402|NCT05139875|Hormones|hormones|mesh-ancestor
83024403|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024404|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024405|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83024406|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
83024407|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024408|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024409|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83024410|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
83024411|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83024412|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024413|NCT04799548|Tislelizumab|tislelizumab|mesh-list
83024414|NCT04799548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024415|NCT04799548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024416|NCT01375985|Radavirsen|radavirsen|mesh-list
83024417|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
83024418|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024419|NCT05384821|Irinotecan|irinotecan|mesh-list
83024420|NCT05384821|Etoposide|etoposide|mesh-list
83024421|NCT05384821|Vincristine|vincristine|mesh-list
83024422|NCT05384821|Temozolomide|temozolomide|mesh-list
83024423|NCT05384821|Tretinoin|tretinoin|mesh-list
83024424|NCT05384821|Isotretinoin|isotretinoin|mesh-list
83024425|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83024426|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83024427|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024428|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024429|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024430|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83024431|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83024432|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
83024433|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
83024434|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
83024435|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83024436|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
83024437|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
83024438|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
83024439|NCT02654080|Vaccines|vaccines|mesh-list
83024440|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
83024441|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024442|NCT05375305|Morphine|morphine|mesh-list
83024443|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83024444|NCT05375305|Narcotics|narcotics|mesh-ancestor
83024445|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024446|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024447|NCT05375305|Analgesics|analgesics|mesh-ancestor
83024448|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
83024449|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024450|NCT03140332|Sorafenib|sorafenib|mesh-list
83024451|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024452|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024453|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024454|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024455|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
83024456|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024457|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024458|NCT02835690|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83024459|NCT02835690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024460|NCT02832167|Nivolumab|nivolumab|mesh-list
83024461|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024462|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024463|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83024464|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024465|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
83024466|NCT04941040|Anesthetics|anesthetics|mesh-list
83024467|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024468|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024469|NCT04941040|Narcotics|narcotics|mesh-ancestor
83024470|NCT04941040|Analgesics|analgesics|mesh-ancestor
83024471|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
83024472|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024473|NCT00913705|Carboplatin|carboplatin|mesh-list
83024474|NCT00913705|Paclitaxel|paclitaxel|mesh-list
83024475|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83024476|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024477|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83024478|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
83024479|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
83024480|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
83024481|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024482|NCT04934410|Midazolam|midazolam|mesh-list
83024483|NCT04934410|Etomidate|etomidate|mesh-list
83024484|NCT04934410|Sevoflurane|sevoflurane|mesh-list
83024485|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83024486|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83024487|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024488|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024489|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83024490|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83024491|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83024492|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83024493|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
83024494|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
83024495|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
83024496|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
83024497|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024498|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024499|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83024500|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83024501|NCT02787239|Rituximab|rituximab|mesh-list
83024502|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024503|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024504|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
83024505|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024506|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024507|NCT03140956|Levodopa|levodopa|mesh-list
83024508|NCT03140956|Carbidopa|carbidopa|mesh-list
83024509|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83024510|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83024511|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
83024512|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024513|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024514|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024515|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83024516|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024517|NCT02681237|Olaparib|olaparib|mesh-list
83024518|NCT02681237|Cediranib|cediranib|mesh-list
83024519|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83024520|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024521|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024522|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024523|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024524|NCT00089245|Iodine|iodine|mesh-list
83024525|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
83024526|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83024527|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024528|NCT00089245|Trace Elements|trace elements|mesh-ancestor
83024529|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
83024530|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024531|NCT02674529|Escitalopram|escitalopram|mesh-list
83024532|NCT02674529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83024533|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83024534|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024535|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024536|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024537|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
83024538|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024539|NCT05081986|Cycloserine|cycloserine|mesh-list
83024540|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83024541|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024542|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83024543|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
83024544|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83024545|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
83024546|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024547|NCT05418907|Exenatide|exenatide|mesh-list
83024548|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83024549|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024550|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83024551|NCT05418907|Incretins|incretins|mesh-ancestor
83024552|NCT05418907|Hormones|hormones|mesh-ancestor
83024553|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024554|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83024555|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83024556|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024557|NCT03632317|Everolimus|everolimus|mesh-list
83024558|NCT03632317|Panobinostat|panobinostat|mesh-list
83024559|NCT03632317|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83024560|NCT03632317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024561|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024562|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024563|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83024564|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
83024565|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024566|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024567|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83024568|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
83024569|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83024570|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024571|NCT02653963|Triamcinolone|triamcinolone|mesh-list
83024572|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024573|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
83024574|NCT02653963|Hormones|hormones|mesh-ancestor
83024575|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024576|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024577|NCT03097861|Lubiprostone|lubiprostone|mesh-list
83024578|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83024579|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024580|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024581|NCT03910673|Fosfomycin|fosfomycin|mesh-list
83024582|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83024583|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024584|NCT01376141|Sumatriptan|sumatriptan|mesh-list
83024585|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83024586|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83024587|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83024588|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
83024589|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024590|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024591|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024592|NCT03642067|Nivolumab|nivolumab|mesh-list
83024593|NCT03642067|Relatlimab|relatlimab|mesh-list
83024595|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024596|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83024597|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024598|NCT01816139|Estradiol|estradiol|mesh-list
83024599|NCT01816139|Estrogens|estrogens|mesh-ancestor
83024600|NCT01816139|Hormones|hormones|mesh-ancestor
83024601|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024602|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024603|NCT04052776|Levodopa|levodopa|mesh-list
83024604|NCT04052776|Carbidopa|carbidopa|mesh-list
83024605|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83024606|NCT04052776|Buspirone|buspirone|mesh-list
83024607|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83024608|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83024609|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
83024610|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024611|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024612|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024613|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83024614|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024615|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83024616|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83024617|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024618|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83024619|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83024620|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
83024621|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83024622|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
83024623|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
83024624|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
83024625|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83024626|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83024627|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83024628|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024629|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024630|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
83024631|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024632|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024633|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83024634|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024635|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83024636|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83024637|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024638|NCT05041673|Metformin|metformin|mesh-list
83024639|NCT05041673|Liraglutide|liraglutide|mesh-list
83024640|NCT05041673|Empagliflozin|empagliflozin|mesh-list
83024641|NCT05041673|Vildagliptin|vildagliptin|mesh-list
83024642|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83024643|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024644|NCT05041673|Incretins|incretins|mesh-ancestor
83024645|NCT05041673|Hormones|hormones|mesh-ancestor
83024646|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024647|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83024648|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024649|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83024650|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
83024651|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024652|NCT03907540|Belumosudil|belumosudil|mesh-list
83024653|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024654|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024655|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024656|NCT05759429|Melatonin|melatonin|mesh-list
83024657|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
83024658|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024659|NCT05759429|Protective Agents|protective agents|mesh-ancestor
83024660|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024661|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024662|NCT04005209|Ketamine|ketamine|mesh-list
83024663|NCT04005209|Analgesics|analgesics|mesh-ancestor
83024664|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
83024665|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024666|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024667|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83024668|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83024669|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
83024670|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
83024671|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024672|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83024673|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83024674|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024675|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024676|NCT03904108|Ramucirumab|ramucirumab|mesh-list
83024677|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024678|NCT02833350|Folic Acid|folic acid|mesh-list
83024679|NCT02833350|Adalimumab|adalimumab|mesh-list
83432124|NCT04142762|Itraconazole|itraconazole|mesh-list
83024680|NCT02833350|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83024681|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024682|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024683|NCT02833350|Hematinics|hematinics|mesh-ancestor
83024684|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
83024685|NCT02833350|Vitamins|vitamins|mesh-ancestor
83024686|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
83024687|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024688|NCT03137134|Crizotinib|crizotinib|mesh-list
83024689|NCT03137134|Esomeprazole|esomeprazole|mesh-list
83024690|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83024691|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83024692|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83024693|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024694|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024695|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024696|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024697|NCT03137368|Tamoxifen|tamoxifen|mesh-list
83024698|NCT03137368|Exemestane|exemestane|mesh-list
83024699|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83024700|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
83024701|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024702|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024703|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83024704|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024705|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83024706|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83024707|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83024708|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83024709|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83024710|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024711|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024712|NCT03138616|Vitamin D|vitamin d|mesh-list
83024713|NCT03138616|Vitamins|vitamins|mesh-ancestor
83024714|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
83024715|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024716|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83024717|NCT03137290|Neostigmine|neostigmine|mesh-list
83024718|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83024719|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024720|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024721|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
83024722|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024723|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024724|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83024725|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
83024726|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024727|NCT03782818|Olaparib|olaparib|mesh-list
83024728|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83024729|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024730|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024731|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024732|NCT05391724|Brincidofovir|brincidofovir|mesh-list
83024733|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
83024734|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024735|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
83024736|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83024737|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024738|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024739|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83024740|NCT03355534|Analgesics|analgesics|mesh-ancestor
83024741|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
83024742|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024743|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83024744|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83024745|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83024746|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
83024747|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83432127|NCT04142762|Esomeprazole|esomeprazole|mesh-list
83024748|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024750|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83024751|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83024752|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
83024753|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83024754|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024755|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
83024756|NCT05385562|Hormones|hormones|mesh-ancestor
83024757|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024758|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024759|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83024760|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
83024761|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024762|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024763|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83024764|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
83024765|NCT05385562|Protective Agents|protective agents|mesh-ancestor
83024766|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
83024767|NCT01343043|Fludarabine|fludarabine|mesh-list
83024768|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83024769|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
83024770|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024771|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024772|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83024773|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
83024774|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024775|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024776|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83024777|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83024778|NCT03139708|Phenylephrine|phenylephrine|mesh-list
83024779|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
83024780|NCT03139708|Tropicamide|tropicamide|mesh-list
83024781|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83024782|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
83024783|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
83024784|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024785|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024786|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
83024787|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83024788|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
83024789|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
83024790|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83024791|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83024792|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83024793|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
83024794|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024795|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024796|NCT03139708|Protective Agents|protective agents|mesh-ancestor
83024797|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83024798|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83024799|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83024800|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83024801|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
83024802|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83024803|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83024804|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
83024805|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024806|NCT05330364|Cladribine|cladribine|mesh-list
83024807|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024808|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83024809|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
83024810|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024811|NCT05087368|Vaccines|vaccines|mesh-list
83024812|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
83024813|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024814|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83024815|NCT05087134|Choline|choline|mesh-list
83024816|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
83024818|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
83024819|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024820|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83024821|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83024822|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
83024823|NCT03048747|Tolvaptan|tolvaptan|mesh-list
83432134|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83024824|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83024825|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024826|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
83024827|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024828|NCT05086822|Irinotecan|irinotecan|mesh-list
83024829|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83024830|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83024831|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024832|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024833|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024834|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83024835|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83024836|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024837|NCT04051827|Midazolam|midazolam|mesh-list
83361640|NCT04547777|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
83024838|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83024839|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83024840|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024841|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024842|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83024843|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83024844|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83024845|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83024846|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
83024847|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
83024848|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
83024849|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
83024850|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024851|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024852|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
83024853|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024854|NCT05325502|Mannitol|mannitol|mesh-list
83024855|NCT05325502|Caffeine|caffeine|mesh-list
83024856|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83024857|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024858|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83024859|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024860|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024861|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83024862|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83024863|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
83024864|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024865|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83024866|NCT05325502|Diuretics|diuretics|mesh-ancestor
83024867|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
83024868|NCT02123823|Everolimus|everolimus|mesh-list
83024869|NCT02123823|Exemestane|exemestane|mesh-list
83024870|NCT02123823|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83024871|NCT02123823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83024872|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024873|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024874|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83024875|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
83024876|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024877|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024878|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83024879|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83024880|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83024881|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
83024882|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024883|NCT05085652|Anesthetics|anesthetics|mesh-list
83024884|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024885|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024886|NCT03136510|Apixaban|apixaban|mesh-list
83024887|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83024888|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
83024889|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83024891|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024892|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024893|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
83024894|NCT05692245|Dexamethasone|dexamethasone|mesh-list
83024895|NCT05692245|Ondansetron|ondansetron|mesh-list
83024896|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024897|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
83024898|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
83024899|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024900|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024901|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83024902|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
83024903|NCT05692245|Hormones|hormones|mesh-ancestor
83024904|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83024905|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83024906|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024907|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
83024908|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
83024909|NCT05692245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83024910|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83024911|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
83024912|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068777|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83024913|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024914|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
83024915|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83024916|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83024917|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83024918|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83024919|NCT05085106|Analgesics|analgesics|mesh-ancestor
83024920|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
83024921|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024922|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024923|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83024924|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024925|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
83024926|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83024927|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024928|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024929|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83024930|NCT05692167|Analgesics|analgesics|mesh-ancestor
83024931|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
83024932|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024933|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83024934|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83024935|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83024936|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83024937|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024938|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024939|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
83024940|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
83024941|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83024942|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83024943|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024944|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024945|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024946|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83024947|NCT00159796|Olanzapine|olanzapine|mesh-list
83024948|NCT00159796|Asenapine|asenapine|mesh-list
83024949|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
83024950|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
83024951|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83024952|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024953|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83024954|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83024955|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83024956|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83024957|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83024958|NCT00159796|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83024959|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83432143|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
83024960|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83024961|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024962|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83024963|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
83024964|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83024965|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83024966|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024967|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
83024968|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83024969|NCT03327844|Metronidazole|metronidazole|mesh-list
83024970|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
83024971|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83024972|NCT03327844|Calcium|calcium|mesh-list
83024973|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83024974|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024975|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83024976|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83024977|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
83024978|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83024979|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83024980|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83024981|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83024982|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024983|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024984|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024985|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83024986|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83024988|NCT05008510|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83024989|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
83024990|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
83024991|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83024992|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83024993|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83024994|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83024995|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83024996|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83024997|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83024998|NCT05194995|Cetuximab|cetuximab|mesh-list
83024999|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025000|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025001|NCT05187039|Anesthetics|anesthetics|mesh-list
83025002|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025003|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025004|NCT03136666|Candesartan|candesartan|mesh-list
83025005|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
83025006|NCT03136666|Nifedipine|nifedipine|mesh-list
83025007|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83025008|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83025009|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83025010|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025011|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83025012|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83025013|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83025014|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025015|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
83025016|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
83025017|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83025018|NCT03255083|Osimertinib|osimertinib|mesh-list
83025019|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025020|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025021|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025022|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025023|NCT04861558|Fluorouracil|fluorouracil|mesh-list
83025024|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
83025025|NCT04861558|Irinotecan|irinotecan|mesh-list
83025026|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
83025027|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025028|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83025029|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025030|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83025031|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
83025032|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025033|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83025034|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83025036|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
83025037|NCT03735537|Teriparatide|teriparatide|mesh-list
83025038|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83025039|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83025040|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025041|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83025042|NCT04531059|Metronidazole|metronidazole|mesh-list
83025043|NCT04531059|Minocycline|minocycline|mesh-list
83025044|NCT04531059|Tetracycline|tetracycline|mesh-list
83025045|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
83025046|NCT04531059|Esomeprazole|esomeprazole|mesh-list
83025047|NCT04531059|Bismuth|bismuth|mesh-list
83025048|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025049|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025050|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83025051|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83025052|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83025053|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83025054|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025055|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83025056|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025057|NCT04531059|Antacids|antacids|mesh-ancestor
83025058|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83025059|NCT04531059|Diuretics|diuretics|mesh-ancestor
83025060|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
83025061|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025062|NCT04531059|Expectorants|expectorants|mesh-ancestor
83025063|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
83025064|NCT05090176|Povidone|povidone|mesh-list
83025065|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
83025066|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
83025067|NCT04530981|Repaglinide|repaglinide|mesh-list
83025068|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83025069|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025070|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
83025071|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83025072|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83025073|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025074|NCT05659563|Tamoxifen|tamoxifen|mesh-list
83025075|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83025076|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025077|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025078|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025079|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83025080|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025081|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83025082|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83025083|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83025084|NCT04558294|Ketanserin|ketanserin|mesh-list
83025085|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83025086|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
83025087|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025088|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83025089|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83025090|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
83025091|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025092|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025093|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83025094|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83025095|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83025096|NCT05057247|Docetaxel|docetaxel|mesh-list
83025097|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025098|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025099|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025100|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
83025101|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025102|NCT05626257|Omalizumab|omalizumab|mesh-list
83025103|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83025104|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83025105|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
83025106|NCT04396821|Paclitaxel|paclitaxel|mesh-list
83025107|NCT04396821|Gemcitabine|gemcitabine|mesh-list
83025108|NCT04396821|Nivolumab|nivolumab|mesh-list
83025109|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83025110|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83025111|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025112|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025113|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025114|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
83025115|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025116|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83025117|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
83025118|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025119|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83025120|NCT03378466|Heparin|heparin|mesh-list
83025121|NCT03378466|Calcium heparin|calcium heparin|mesh-list
83025122|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
83025123|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83025124|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83025125|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025126|NCT05077540|Misoprostol|misoprostol|mesh-list
83025127|NCT05077540|Oxytocin|oxytocin|mesh-list
83025128|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
83025129|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83025130|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025131|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83025132|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
83025133|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83025134|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025135|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
83068778|NCT02086227|Hormones|hormones|mesh-ancestor
83025136|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025137|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025138|NCT04977375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83025139|NCT04977375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025141|NCT02470585|Carboplatin|carboplatin|mesh-list
83025142|NCT02470585|Veliparib|veliparib|mesh-list
83025143|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83025144|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025145|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025146|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025147|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83025148|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025149|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83025150|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025151|NCT02744898|Paclitaxel|paclitaxel|mesh-list
83025152|NCT02744898|Carboplatin|carboplatin|mesh-list
83025153|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83025154|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83025155|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025156|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025157|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025158|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
83025159|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025160|NCT03587311|Paclitaxel|paclitaxel|mesh-list
83025161|NCT03587311|Maytansine|maytansine|mesh-list
83025162|NCT03587311|Bevacizumab|bevacizumab|mesh-list
83025163|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83025164|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83025165|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
83025166|NCT03587311|Antibodies|antibodies|mesh-list
83025167|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
83025168|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83025169|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
83025170|NCT03587311|Anetumab ravtansine|anetumab ravtansine|mesh-list
83025171|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83025172|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025173|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025174|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025175|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
83025176|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025177|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83025178|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83025179|NCT03587311|Growth Substances|growth substances|mesh-ancestor
83025180|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025181|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
83025182|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
83025183|NCT03587311|Immunoconjugates|immunoconjugates|mesh-ancestor
83025184|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83025185|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
83025186|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
83025187|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025188|NCT03097315|Triamcinolone|triamcinolone|mesh-list
83025189|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83025190|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83025191|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83025192|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025193|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
83025194|NCT03097315|Hormones|hormones|mesh-ancestor
83025195|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025196|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025197|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83025198|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
83025199|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025200|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025201|NCT05530707|Niacinamide|niacinamide|mesh-list
83025202|NCT05530707|Niacin|niacin|mesh-list
83025203|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
83025204|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
83025205|NCT05530707|Vitamins|vitamins|mesh-ancestor
83025206|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
83025207|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025208|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83025209|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
83432185|NCT01590277|Ethanol|ethanol|mesh-list
83025210|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025211|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83025212|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
83025213|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83025214|NCT03093415|Grazoprevir|grazoprevir|mesh-list
83025215|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83025216|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
83025217|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025218|NCT01358526|Oxycodone|oxycodone|mesh-list
83025219|NCT01358526|Naloxone|naloxone|mesh-list
83432419|NCT00615433|Olanzapine|olanzapine|mesh-list
83432516|NCT03585140|Adapalene|adapalene|mesh-list
83025220|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83432715|NCT03583424|Cytarabine|cytarabine|mesh-list
83025221|NCT01358526|Narcotics|narcotics|mesh-ancestor
83025222|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025223|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025224|NCT01358526|Analgesics|analgesics|mesh-ancestor
83433087|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025225|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
83025226|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025227|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83025228|NCT05434689|Dexamethasone|dexamethasone|mesh-list
83025229|NCT05434689|Daratumumab|daratumumab|mesh-list
83025230|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025231|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
83025232|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
83025233|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025234|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025235|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025236|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
83025237|NCT05434689|Hormones|hormones|mesh-ancestor
83025238|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025239|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83433171|NCT00625729|Rituximab|rituximab|mesh-list
83433221|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025240|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025241|NCT01310010|Dasatinib|dasatinib|mesh-list
83025242|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433294|NCT00627367|Analgesics|analgesics|mesh-ancestor
83025243|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025244|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025245|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025246|NCT02830776|Bimatoprost|bimatoprost|mesh-list
83433596|NCT00586729|Mafenide|mafenide|mesh-list
83025247|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83025248|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83025249|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83025250|NCT03563664|Danazol|danazol|mesh-list
83025251|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83025252|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025253|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025254|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025255|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
83025256|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
83025257|NCT01904136|Melphalan|melphalan|mesh-list
83025258|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
83025259|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83025260|NCT01904136|Fludarabine|fludarabine|mesh-list
83025261|NCT01904136|Tacrolimus|tacrolimus|mesh-list
83025262|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83025263|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
83476455|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
83025264|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025265|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83025266|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83025267|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
83025268|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025269|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025270|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83025271|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83025272|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025273|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83025274|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83025275|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
83025276|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83025277|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025278|NCT03041181|Gemcitabine|gemcitabine|mesh-list
83025279|NCT03041181|Docetaxel|docetaxel|mesh-list
83025280|NCT03041181|Nivolumab|nivolumab|mesh-list
83025281|NCT03041181|Pemetrexed|pemetrexed|mesh-list
83025282|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83025283|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
83025284|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025285|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025286|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025287|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025288|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83361641|NCT04547777|Immunoconjugates|immunoconjugates|mesh-ancestor
83025289|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025290|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83025291|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025292|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83025293|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83025295|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83025296|NCT05351229|Narcotics|narcotics|mesh-ancestor
83025297|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025298|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025299|NCT05351229|Analgesics|analgesics|mesh-ancestor
83025300|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
83025301|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025302|NCT05121909|Listerine|listerine|mesh-list
83025303|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83025304|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
83025305|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
83025306|NCT05121909|Protective Agents|protective agents|mesh-ancestor
83025307|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025308|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025309|NCT02828124|Nivolumab|nivolumab|mesh-list
83025310|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025311|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025312|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83025313|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025314|NCT04761393|Xenon|xenon|mesh-list
83025315|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83025316|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
83025317|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
83025318|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025319|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025320|NCT02829996|Latanoprost|latanoprost|mesh-list
83025321|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83025322|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83025323|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
83025324|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025325|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025326|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025327|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025328|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83025329|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025330|NCT05197062|Aticaprant|aticaprant|mesh-list
83025331|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83025332|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025333|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
83025334|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025335|NCT05000736|Fulvestrant|fulvestrant|mesh-list
83025336|NCT05000736|Palbociclib|palbociclib|mesh-list
83025337|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83025338|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83025339|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025340|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83025341|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83025342|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025343|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025344|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025345|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025346|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025347|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025348|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83025349|NCT03828162|Anticoagulants|anticoagulants|mesh-list
83025350|NCT03563040|Methoxsalen|methoxsalen|mesh-list
83025351|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83025352|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
83025353|NCT03094416|Esomeprazole|esomeprazole|mesh-list
83025354|NCT03094416|Omeprazole|omeprazole|mesh-list
83025355|NCT03094416|Rabeprazole|rabeprazole|mesh-list
83025356|NCT03094416|Pantoprazole|pantoprazole|mesh-list
83025357|NCT03094416|Lansoprazole|lansoprazole|mesh-list
83025358|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
83025359|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83025360|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83025361|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025362|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025363|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025365|NCT05109429|Narcotics|narcotics|mesh-ancestor
83025366|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025367|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025368|NCT05109429|Analgesics|analgesics|mesh-ancestor
83025369|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
83025370|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025371|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
83025372|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83025373|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
83025374|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83025375|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025376|NCT01338870|Incretins|incretins|mesh-ancestor
83025377|NCT01338870|Hormones|hormones|mesh-ancestor
83025378|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025379|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83025380|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
83025381|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025382|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025383|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
83025384|NCT01338870|Vitamins|vitamins|mesh-ancestor
83025385|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
83025386|NCT02824224|Tamoxifen|tamoxifen|mesh-list
83025387|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83025388|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025389|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025390|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025391|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83025392|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025393|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83025394|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83025395|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83025396|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
83025397|NCT01338792|Pemetrexed|pemetrexed|mesh-list
83025398|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025399|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025400|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025401|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83025402|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83025403|NCT01314105|Carboplatin|carboplatin|mesh-list
83025404|NCT01314105|Nintedanib|nintedanib|mesh-list
83025405|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025406|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025407|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025408|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025409|NCT01966471|Maytansine|maytansine|mesh-list
83025410|NCT01966471|Docetaxel|docetaxel|mesh-list
83025411|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83025412|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
83025413|NCT01966471|Doxorubicin|doxorubicin|mesh-list
83025414|NCT01966471|Fluorouracil|fluorouracil|mesh-list
83025415|NCT01966471|Trastuzumab|trastuzumab|mesh-list
83025416|NCT01966471|Epirubicin|epirubicin|mesh-list
83025417|NCT01966471|Pertuzumab|pertuzumab|mesh-list
83025418|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83025419|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025420|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025421|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025422|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
83025423|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025424|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83025425|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
83025426|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025427|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83025428|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83025429|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
83025430|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83025431|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83025432|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83025433|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83025434|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025435|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
83025436|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83361642|NCT04547777|Immunologic Factors|immunologic factors|mesh-ancestor
83025437|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025438|NCT01966471|Immunotoxins|immunotoxins|mesh-ancestor
83025439|NCT01966471|Immunoconjugates|immunoconjugates|mesh-ancestor
83025440|NCT04188847|Apatinib|apatinib|mesh-list
83025441|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025442|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025443|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025444|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025445|NCT05255107|Riboflavin|riboflavin|mesh-list
83025446|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
83025447|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
83025448|NCT05255107|Vitamins|vitamins|mesh-ancestor
83025449|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
83025450|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025451|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83025452|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
83025453|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83025454|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83025455|NCT03227471|Ivacaftor|ivacaftor|mesh-list
83025456|NCT03227471|Elexacaftor|elexacaftor|mesh-list
83025457|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83025458|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83025459|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025460|NCT01354314|Fluconazole|fluconazole|mesh-list
83025461|NCT01354314|Paroxetine|paroxetine|mesh-list
83025462|NCT01354314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83025463|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83025464|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83025465|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025466|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025467|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
83025468|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025469|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83025470|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
83025471|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83025472|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83025473|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83025474|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025475|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
83025476|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025477|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83025478|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83025479|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025480|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025481|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83025482|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83025483|NCT04509336|Orphenadrine|orphenadrine|mesh-list
83025484|NCT04509336|Baclofen|baclofen|mesh-list
83025485|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83025486|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025487|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83025488|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025489|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83025491|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
83025492|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025493|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025494|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83025495|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83025496|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
83025497|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
83025498|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83025499|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83025500|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
83025501|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83025502|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83025503|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025504|NCT03194321|Tacrolimus|tacrolimus|mesh-list
83025505|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83025506|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
83025507|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025508|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83025509|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025510|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025511|NCT05231460|Narcotics|narcotics|mesh-list
83025512|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025513|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025514|NCT05231460|Analgesics|analgesics|mesh-ancestor
83025515|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
83025516|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025517|NCT01374581|Artesunate|artesunate|mesh-list
83025518|NCT01374581|Lumefantrine|lumefantrine|mesh-list
83025519|NCT01374581|Artemether|artemether|mesh-list
83025520|NCT01374581|Amodiaquine|amodiaquine|mesh-list
83025521|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83025522|NCT01374581|Quinine|quinine|mesh-list
83025523|NCT01374581|Clindamycin|clindamycin|mesh-list
83025524|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
83025525|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
83025526|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
83025527|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83025528|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83025529|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025530|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025531|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
83025532|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
83025533|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83025534|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
83025535|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83025536|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83025537|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025538|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025539|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83025540|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025541|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83025542|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025543|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83025544|NCT01374581|Analgesics|analgesics|mesh-ancestor
83025545|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
83025546|NCT01354938|Clarithromycin|clarithromycin|mesh-list
83025547|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83025548|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025549|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83025550|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025551|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025552|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83025553|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83025554|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83025555|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
83025556|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83025557|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025558|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025559|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83025560|NCT01374737|Analgesics|analgesics|mesh-ancestor
83025561|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
83025562|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025563|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83025564|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83025565|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83025566|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
83025567|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025568|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025570|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
83025571|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025572|NCT01376453|Fluorouracil|fluorouracil|mesh-list
83025573|NCT01376453|Sorafenib|sorafenib|mesh-list
83025574|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
83025575|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025576|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83025577|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025578|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83025579|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
83025580|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025581|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025582|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361643|NCT04547777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025583|NCT05107219|Linaclotide|linaclotide|mesh-list
83025584|NCT05107219|Plecanatide|plecanatide|mesh-list
83025585|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83361644|NCT03167112|Leucovorin|leucovorin|mesh-list
83025586|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
83025587|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025588|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025589|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83025590|NCT01568125|Incretins|incretins|mesh-list
83025591|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025592|NCT01568125|Hormones|hormones|mesh-ancestor
83025593|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025594|NCT03360721|Prednisone|prednisone|mesh-list
83025595|NCT03360721|Cortisone|cortisone|mesh-list
83025596|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
83025597|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025598|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
83025599|NCT03360721|Hormones|hormones|mesh-ancestor
83025600|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025601|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025602|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83025603|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025604|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83025605|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025606|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025607|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025608|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83025609|NCT02288897|Temozolomide|temozolomide|mesh-list
83025610|NCT02288897|Dacarbazine|dacarbazine|mesh-list
83025611|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83025612|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83025613|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
83025614|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025615|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025616|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025617|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
83025618|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83025619|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83025620|NCT05707572|Prednisolone|prednisolone|mesh-list
83025621|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
83025622|NCT05707572|Lidocaine|lidocaine|mesh-list
83025623|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83025624|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
83025625|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
83025626|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
83025627|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025628|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025629|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
83025630|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025631|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83025632|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83025633|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83025634|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83025635|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025636|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025637|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
83025638|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
83025639|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025640|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
83025641|NCT05707572|Hormones|hormones|mesh-ancestor
83025642|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025643|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83025644|NCT05707572|Protective Agents|protective agents|mesh-ancestor
83025645|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83025646|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025647|NCT02035800|Adalimumab|adalimumab|mesh-list
83025648|NCT02035800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83025649|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025650|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83025651|NCT03993912|Dexamethasone|dexamethasone|mesh-list
83025652|NCT03993912|Lenalidomide|lenalidomide|mesh-list
83025653|NCT03993912|Daratumumab|daratumumab|mesh-list
83025654|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025655|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
83025656|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
83025657|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025658|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025659|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025660|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
83025661|NCT03993912|Hormones|hormones|mesh-ancestor
83025662|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025663|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83025664|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025665|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
83025666|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83025667|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83025668|NCT03993912|Growth Substances|growth substances|mesh-ancestor
83025669|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
83025670|NCT01568749|Acetaminophen|acetaminophen|mesh-list
83025671|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83025672|NCT01568749|Analgesics|analgesics|mesh-ancestor
83025673|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
83025674|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025675|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025676|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
83025677|NCT02819310|Laxatives|laxatives|mesh-list
83025678|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025679|NCT03633773|Immunomodulating Agents|immunomodulating agents|mesh-list
83025680|NCT03633773|Immunologic Factors|immunologic factors|mesh-ancestor
83025681|NCT03633773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025682|NCT01375361|Albuterol|albuterol|mesh-list
83025683|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83025684|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
83025685|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025686|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025687|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83025688|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
83025689|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
83025690|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83025691|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83025692|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83025693|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83025694|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83025695|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025696|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025697|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83025698|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83025699|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
83025700|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025701|NCT01376765|Antacids|antacids|mesh-ancestor
83025702|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025703|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025704|NCT03278509|Metoprolol|metoprolol|mesh-list
83025705|NCT03278509|Bisoprolol|bisoprolol|mesh-list
83025706|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83025707|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83025708|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
83025709|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
83025710|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83476456|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
83025711|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025712|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83025713|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83025714|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83025715|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83025716|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025717|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025718|NCT05754593|Hormones|hormones|mesh-list
83025719|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025720|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025721|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
83025722|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
83025723|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83025724|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025725|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83025726|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025727|NCT01358201|Cytarabine|cytarabine|mesh-list
83025728|NCT01358201|Dexamethasone|dexamethasone|mesh-list
83025729|NCT01358201|Methotrexate|methotrexate|mesh-list
83025730|NCT01358201|Vincristine|vincristine|mesh-list
83025731|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025732|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
83025733|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
83025734|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025735|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025736|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83025737|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
83025738|NCT01358201|Hormones|hormones|mesh-ancestor
83025739|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025740|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83025741|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025742|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83025743|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
83025744|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83025745|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83025746|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
83025747|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025748|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
83025749|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025750|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83025751|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83025752|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
83025753|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83025754|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83025755|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83025756|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
83025757|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
83025758|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
83025759|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
83025760|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025761|NCT02969083|Cisplatin|cisplatin|mesh-list
83025762|NCT02969083|Gemcitabine|gemcitabine|mesh-list
83025763|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025764|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83025765|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
83025766|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025767|NCT04726475|Cannabidiol|cannabidiol|mesh-list
83025768|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
83025769|NCT02951767|Atezolizumab|atezolizumab|mesh-list
83025770|NCT02951767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83025771|NCT02951767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025772|NCT02951767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025773|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025774|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83025775|NCT03091777|Metronidazole|metronidazole|mesh-list
83025776|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025777|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83025778|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83025779|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83025780|NCT05603741|Lidocaine|lidocaine|mesh-list
83025781|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
83025782|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
83025783|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025784|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025785|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
83025786|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025787|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83025788|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83025789|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83025790|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83025791|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025792|NCT05392361|Gabapentin|gabapentin|mesh-list
83025793|NCT05392361|Baclofen|baclofen|mesh-list
83025794|NCT05392361|Analgesics|analgesics|mesh-ancestor
83025795|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
83025796|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025797|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025798|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
83025799|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83025800|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83025801|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025802|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83433781|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
83025803|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83025804|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83025805|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025806|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025807|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
83025808|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83025809|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83025810|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83025811|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
83025812|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
83025813|NCT05338541|Etoposide|etoposide|mesh-list
83025814|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83025815|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025816|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83025817|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83025818|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025819|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025820|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
83025821|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83025822|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025823|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025824|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83025825|NCT05335655|Analgesics|analgesics|mesh-ancestor
83025826|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
83025827|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025828|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83025829|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83025830|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83025831|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83025832|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025833|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025834|NCT04589351|Ezetimibe|ezetimibe|mesh-list
83025835|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83025836|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83025837|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
83025838|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025839|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83025840|NCT02818998|Aflibercept|aflibercept|mesh-list
83025841|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83025842|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83025843|NCT02818998|Growth Substances|growth substances|mesh-ancestor
83025844|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025845|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
83025846|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025847|NCT05760677|Metformin|metformin|mesh-list
83025848|NCT05760677|Pioglitazone|pioglitazone|mesh-list
83025849|NCT05760677|Orlistat|orlistat|mesh-list
83025850|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83025851|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025852|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025853|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025854|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83025855|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83025856|NCT02821416|Benralizumab|benralizumab|mesh-list
83025857|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83025858|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
83025859|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83025860|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83025861|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025862|NCT03108521|Incretins|incretins|mesh-ancestor
83025863|NCT03108521|Hormones|hormones|mesh-ancestor
83025864|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025865|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83025866|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
83025867|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025868|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025869|NCT04500509|Diclofenac|diclofenac|mesh-list
83025870|NCT04500509|Dinoprostone|dinoprostone|mesh-list
83025871|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83025872|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83025873|NCT04500509|Analgesics|analgesics|mesh-ancestor
83025874|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
83025875|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025876|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025877|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83025878|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83025879|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83025880|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025881|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025882|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
83361645|NCT03167112|Fluorouracil|fluorouracil|mesh-list
83025883|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83025884|NCT05760599|Bevacizumab|bevacizumab|mesh-list
83025885|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025886|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025887|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83025888|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83025889|NCT05760599|Growth Substances|growth substances|mesh-ancestor
83025890|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025891|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
83025892|NCT04441073|Lidocaine|lidocaine|mesh-list
83025893|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
83025894|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
83025895|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025896|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025897|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
83025898|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025899|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83025900|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83025901|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83025902|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83025903|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025904|NCT02817828|Drospirenone|drospirenone|mesh-list
83025905|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83025906|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025907|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025908|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025909|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83025910|NCT02817828|Diuretics|diuretics|mesh-ancestor
83025911|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
83025912|NCT03632681|Insulin|insulin|mesh-list
83025913|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83025914|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83025915|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025916|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
83025917|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83025918|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83025919|NCT05597917|Trabectedin|trabectedin|mesh-list
83025920|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83025921|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
83025922|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025923|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025924|NCT03796650|Vancomycin|vancomycin|mesh-list
83025925|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83025926|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025927|NCT05597527|Apatinib|apatinib|mesh-list
83025928|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025930|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025931|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025932|NCT05198609|Apatinib|apatinib|mesh-list
83025933|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025934|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83025935|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025936|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025937|NCT05198141|Letrozole|letrozole|mesh-list
83025938|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025939|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83025940|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83025941|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025942|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025943|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83025944|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
83025945|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83025946|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025947|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
83025948|NCT02813694|Lefamulin|lefamulin|mesh-list
83025949|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83025950|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83025951|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83025952|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83025953|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025954|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025955|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025956|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
83025957|NCT03632161|Bupivacaine|bupivacaine|mesh-list
83025958|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
83025959|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
83025960|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83025961|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025962|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
83025963|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83025964|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83025965|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83025966|NCT03632161|Analgesics|analgesics|mesh-ancestor
83025967|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83025968|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83025969|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83025970|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83025971|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025972|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025973|NCT03103919|Rotigotine|rotigotine|mesh-list
83025974|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
83025975|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
83025976|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83025977|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025978|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025979|NCT04173325|Nivolumab|nivolumab|mesh-list
83025980|NCT04173325|Irinotecan|irinotecan|mesh-list
83025981|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83025982|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025983|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83025984|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83025985|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83025986|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83025987|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83025988|NCT02810964|Sulforaphane|sulforaphane|mesh-list
83025989|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83025990|NCT02810964|Protective Agents|protective agents|mesh-ancestor
83025991|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025992|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025993|NCT05571319|Metformin|metformin|mesh-list
83025994|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83025995|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83025996|NCT04073147|Venetoclax|venetoclax|mesh-list
83025997|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
83025998|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83025999|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026000|NCT02707159|Paclitaxel|paclitaxel|mesh-list
83026001|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83026002|NCT02707159|Gemcitabine|gemcitabine|mesh-list
83026003|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026004|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026005|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026006|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026007|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026008|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026009|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026010|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
83026011|NCT04113187|Propranolol|propranolol|mesh-list
83026012|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83026013|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83026014|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
83026015|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026016|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026017|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026018|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83026019|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83026020|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
83026022|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
83026023|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83026024|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83026025|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83026026|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
83026027|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026028|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83026029|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83026030|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026031|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
83026032|NCT04011475|Olodaterol|olodaterol|mesh-list
83026033|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83026034|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
83026035|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026036|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026037|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83026038|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
83026039|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
83026040|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83026041|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
83026042|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026043|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026044|NCT05110781|Atezolizumab|atezolizumab|mesh-list
83026045|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83026046|NCT05110781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83026047|NCT05110781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026048|NCT05110781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026049|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026050|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
83026051|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026052|NCT04138277|Miglustat|miglustat|mesh-list
83026053|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026054|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026055|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83026056|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83026057|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
83026058|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83026059|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83026060|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83026061|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026062|NCT03663335|Tacrolimus|tacrolimus|mesh-list
83026063|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026064|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
83026065|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026066|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83026067|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026068|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026069|NCT03632915|Lacosamide|lacosamide|mesh-list
83026070|NCT03632915|Phenytoin|phenytoin|mesh-list
83026071|NCT03632915|Ketamine|ketamine|mesh-list
83026072|NCT03632915|Levetiracetam|levetiracetam|mesh-list
83026073|NCT03632915|Valproic Acid|valproic acid|mesh-list
83026074|NCT03632915|Phenobarbital|phenobarbital|mesh-list
83026075|NCT03632915|Analgesics|analgesics|mesh-ancestor
83026076|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
83026077|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026078|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026079|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83026080|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83026082|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
83026083|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026084|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83026085|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83026086|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026087|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026088|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
83026089|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
83026090|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026091|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
83026092|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
83026093|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83026094|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83026095|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83026096|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83026097|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026098|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83026099|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83026100|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83026101|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
83026102|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83026103|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83026104|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
83026105|NCT05649605|Testosterone|testosterone|mesh-list
83026106|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
83026107|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
83026108|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83026109|NCT05649605|Androgens|androgens|mesh-ancestor
83026110|NCT05649605|Hormones|hormones|mesh-ancestor
83026111|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026112|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026113|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83026114|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026115|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
83026116|NCT05640479|Pregabalin|pregabalin|mesh-list
83026117|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
83026118|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83026119|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026120|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026121|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026122|NCT05640479|Analgesics|analgesics|mesh-ancestor
83026123|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
83026124|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026125|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83026126|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83026127|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83026128|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83026129|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026130|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026131|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
83026132|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83026133|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026134|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83026135|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83026136|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83026137|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83026138|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
83026139|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83026140|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83026141|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026142|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
83026143|NCT05309525|Coagulants|coagulants|mesh-ancestor
83026144|NCT04905563|Acetaminophen|acetaminophen|mesh-list
83026145|NCT04905563|Ibuprofen|ibuprofen|mesh-list
83026146|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83026147|NCT04905563|Hydrocodone|hydrocodone|mesh-list
83026148|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026149|NCT04905563|Analgesics|analgesics|mesh-ancestor
83026150|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
83026151|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026152|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026153|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
83026154|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83026155|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026156|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83026157|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83026158|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026159|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026160|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83026161|NCT04905563|Narcotics|narcotics|mesh-ancestor
83026162|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026163|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
83026164|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
83026166|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026167|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026168|NCT02810418|Paclitaxel|paclitaxel|mesh-list
83026169|NCT02810418|LMB-100|lmb-100|mesh-list
83026170|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026171|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026172|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026173|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026174|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026175|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026176|NCT02810418|Immunoconjugates|immunoconjugates|mesh-ancestor
83026177|NCT02810418|Immunologic Factors|immunologic factors|mesh-ancestor
83026178|NCT02810418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026179|NCT02959541|Leucovorin|leucovorin|mesh-list
83026180|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
83026181|NCT02959541|Antidotes|antidotes|mesh-ancestor
83026182|NCT02959541|Protective Agents|protective agents|mesh-ancestor
83026183|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026184|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
83026185|NCT02959541|Vitamins|vitamins|mesh-ancestor
83026186|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
83026187|NCT02675465|Miglustat|miglustat|mesh-list
83026188|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026189|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026190|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83026191|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83026192|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
83026193|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83026194|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83026195|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83026196|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026197|NCT05705700|Dutasteride|dutasteride|mesh-list
83026198|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83026199|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83026200|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026201|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026202|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
83026203|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026204|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026205|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
83026206|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026207|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026208|NCT02260050|Epinastine|epinastine|mesh-list
83026209|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83026210|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
83026211|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
83026212|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026213|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026214|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026215|NCT02036736|Propofol|propofol|mesh-list
83026216|NCT02036736|Anesthetics|anesthetics|mesh-list
83026217|NCT02036736|Desflurane|desflurane|mesh-list
83026218|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83026219|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026220|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026221|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83026222|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
83026223|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83026224|NCT05693688|Atosiban|atosiban|mesh-list
83026225|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
83026226|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026227|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026228|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
83026229|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83026230|NCT02047422|Metolazone|metolazone|mesh-list
83026231|NCT02047422|Furosemide|furosemide|mesh-list
83026232|NCT02047422|Spironolactone|spironolactone|mesh-list
83026233|NCT02047422|Diuretics|diuretics|mesh-ancestor
83026234|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
83026235|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026236|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83026237|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026238|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026239|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83026240|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
83026241|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026242|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83026243|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83026244|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83026245|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
83026246|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83026247|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83026248|NCT02048358|Prednisolone|prednisolone|mesh-list
83026249|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
83026250|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83026251|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
83026252|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026253|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
83026254|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
83026255|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026256|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026257|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83026258|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
83026259|NCT02048358|Hormones|hormones|mesh-ancestor
83026260|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026261|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83026262|NCT02048358|Protective Agents|protective agents|mesh-ancestor
83026263|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83026264|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026265|NCT02928029|Dexamethasone|dexamethasone|mesh-list
83026266|NCT02928029|Bortezomib|bortezomib|mesh-list
83026267|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83026268|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026269|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
83026270|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
83026271|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026272|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026273|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83026274|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
83026275|NCT02928029|Hormones|hormones|mesh-ancestor
83026276|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026277|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83026278|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026279|NCT02050074|Metformin|metformin|mesh-list
83026280|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83026281|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83026282|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026283|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83026284|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83026285|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
83026286|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026287|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83026288|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
83026289|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83026290|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
83026291|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
83026292|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026293|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026294|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026295|NCT02050152|Analgesics|analgesics|mesh-ancestor
83026296|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
83026297|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026298|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
83026299|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
83026300|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83026301|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83026302|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
83026303|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026305|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83026306|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026307|NCT04740905|Aflibercept|aflibercept|mesh-list
83026308|NCT04740905|Faricimab|faricimab|mesh-list
83026309|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83026310|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83026311|NCT04740905|Growth Substances|growth substances|mesh-ancestor
83026312|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026313|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
83026314|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026315|NCT05176223|Edetic Acid|edetic acid|mesh-list
83026316|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83026317|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
83026318|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
83026319|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026320|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
83026321|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83026322|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83026323|NCT04717193|Epinephrine|epinephrine|mesh-list
83026324|NCT04717193|Racepinephrine|racepinephrine|mesh-list
83026325|NCT04717193|Bupivacaine|bupivacaine|mesh-list
83026326|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
83026327|NCT04717193|Anesthetics|anesthetics|mesh-list
83026328|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
83026329|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026330|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026331|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
83026332|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026333|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83026334|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83026335|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
83026336|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026337|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026338|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83026339|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83026340|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
83026341|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83026342|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
83026343|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
83026344|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
83026345|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83026346|NCT05212025|Gemcitabine|gemcitabine|mesh-list
83026347|NCT05212025|Adavosertib|adavosertib|mesh-list
83026348|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026349|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
83026350|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026351|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026352|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026353|NCT02051868|Paclitaxel|paclitaxel|mesh-list
83026354|NCT02051868|Carboplatin|carboplatin|mesh-list
83026355|NCT02051868|Fluorouracil|fluorouracil|mesh-list
83026356|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026357|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026358|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026359|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026360|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026361|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026362|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
83026363|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026364|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026365|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
83026366|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026367|NCT04696757|Capecitabine|capecitabine|mesh-list
83026368|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026369|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
83026370|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026371|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026372|NCT02049294|Omalizumab|omalizumab|mesh-list
83026373|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83026374|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83026375|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
83026376|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
83026377|NCT02051946|Diuretics|diuretics|mesh-ancestor
83026378|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
83026379|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026380|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026381|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026382|NCT02049606|Nabumetone|nabumetone|mesh-list
83026383|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83026384|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026385|NCT02049606|Analgesics|analgesics|mesh-ancestor
83026386|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
83026387|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026388|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026389|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026390|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83026391|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83026392|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83026393|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026394|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026395|NCT05071703|Carboplatin|carboplatin|mesh-list
83026396|NCT05071703|Etoposide|etoposide|mesh-list
83026397|NCT05071703|Topotecan|topotecan|mesh-list
83026398|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026399|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026400|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83026401|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83026402|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026403|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026404|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83026405|NCT02037516|Neostigmine|neostigmine|mesh-list
83026406|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83026407|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361646|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
83361647|NCT03167112|Irinotecan|irinotecan|mesh-list
83026408|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026409|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83026410|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026411|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026412|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83026413|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
83026414|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026415|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83026416|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
83026417|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83026418|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83026419|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83026420|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026421|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026422|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
83026423|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026424|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026425|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83026426|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026427|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83026428|NCT02037672|Metformin|metformin|mesh-list
83026429|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83026430|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026431|NCT02049762|Aspirin|aspirin|mesh-list
83026432|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83026433|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026434|NCT02049762|Analgesics|analgesics|mesh-ancestor
83026435|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
83026436|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026437|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026438|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026439|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83026440|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83026441|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83026442|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026443|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83026444|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83026445|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026446|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
83026447|NCT03561558|Ibuprofen|ibuprofen|mesh-list
83026448|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83026449|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026450|NCT03561558|Analgesics|analgesics|mesh-ancestor
83026451|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
83026452|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026453|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026454|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026455|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83026456|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83026457|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026458|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026459|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
83026460|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026461|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026462|NCT03099161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83026463|NCT03099161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026464|NCT04639115|Ozanimod|ozanimod|mesh-list
83026465|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83026466|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026467|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026468|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
83026469|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026470|NCT04260659|Lidocaine|lidocaine|mesh-list
83026471|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
83026472|NCT04260659|Fentanyl|fentanyl|mesh-list
83026473|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
83026474|NCT04260659|Ketamine|ketamine|mesh-list
83026475|NCT04260659|Remifentanil|remifentanil|mesh-list
83026476|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
83026477|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
83026478|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026479|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026480|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
83026481|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361648|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
83026482|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83026483|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83026484|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83026485|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026486|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026487|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83026488|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026489|NCT04260659|Analgesics|analgesics|mesh-ancestor
83026490|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83026491|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83026492|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83026493|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
83026494|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026495|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83026496|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83026497|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
83026498|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83026499|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83026500|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83026501|NCT04260659|Narcotics|narcotics|mesh-ancestor
83026502|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83026503|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
83026504|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83026505|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83026506|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
83026507|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83026508|NCT05068661|Fentanyl|fentanyl|mesh-list
83026509|NCT05068661|Bupivacaine|bupivacaine|mesh-list
83026510|NCT05068661|Ropivacaine|ropivacaine|mesh-list
83026511|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83026512|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
83026513|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
83026514|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026515|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026516|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
83026517|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026518|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83026519|NCT05068661|Narcotics|narcotics|mesh-ancestor
83026520|NCT05068661|Analgesics|analgesics|mesh-ancestor
83026521|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83026522|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83026523|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
83026525|NCT04455815|Camostat|camostat|mesh-list
83026526|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
83026527|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026528|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026529|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83026530|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83026531|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
83026532|NCT04197713|Olaparib|olaparib|mesh-list
83026533|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83026534|NCT04197713|Adavosertib|adavosertib|mesh-list
83026535|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026536|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026537|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026538|NCT04303403|Trametinib|trametinib|mesh-list
83026539|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026540|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026541|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026542|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026543|NCT04148495|Acetaminophen|acetaminophen|mesh-list
83026544|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026545|NCT04148495|Analgesics|analgesics|mesh-ancestor
83026546|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
83026547|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026548|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026549|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
83026550|NCT05060003|Atezolizumab|atezolizumab|mesh-list
83026551|NCT05060003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83026552|NCT05060003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026553|NCT05060003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026554|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026555|NCT04203641|Doxorubicin|doxorubicin|mesh-list
83026556|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83026557|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026558|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83026559|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83026560|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026561|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026562|NCT05051189|Fentanyl|fentanyl|mesh-list
83026563|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83026564|NCT05051189|Narcotics|narcotics|mesh-ancestor
83026565|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026566|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026567|NCT05051189|Analgesics|analgesics|mesh-ancestor
83026568|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
83026569|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026570|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83026571|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83026572|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
83026573|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
83026574|NCT04521647|Nicotine|nicotine|mesh-list
83026575|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83026576|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
83026577|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026578|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026579|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83026580|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83026581|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
83026582|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026583|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026584|NCT04172597|Loperamide|loperamide|mesh-list
83026585|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
83026586|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83026587|NCT00446225|Carboplatin|carboplatin|mesh-list
83026588|NCT00446225|Docetaxel|docetaxel|mesh-list
83026589|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83026590|NCT00446225|Gemcitabine|gemcitabine|mesh-list
83026591|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026592|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026593|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026594|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026595|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026596|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026597|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026598|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026600|NCT03080935|Evolocumab|evolocumab|mesh-list
83026601|NCT03080935|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83026602|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83026603|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83026604|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
83026605|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026606|NCT03080935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83026607|NCT03080935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83026608|NCT03080935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026609|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83026610|NCT04479449|Otaplimastat|otaplimastat|mesh-list
83026611|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83026612|NCT04479449|Protective Agents|protective agents|mesh-ancestor
83026613|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026614|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
83026615|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026616|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026617|NCT03674567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83026618|NCT03674567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026619|NCT04986605|Methoxsalen|methoxsalen|mesh-list
83026620|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83026621|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83026622|NCT04390399|Leucovorin|leucovorin|mesh-list
83026623|NCT04390399|Paclitaxel|paclitaxel|mesh-list
83026624|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
83026625|NCT04390399|Gemcitabine|gemcitabine|mesh-list
83026626|NCT04390399|Fluorouracil|fluorouracil|mesh-list
83026627|NCT04390399|Irinotecan|irinotecan|mesh-list
83026628|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026629|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026630|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026631|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026632|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026633|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026634|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026635|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
83026636|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026637|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83026638|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83026639|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
83026640|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83026641|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026642|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
83026643|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83026644|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83026645|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026646|NCT04390399|Antidotes|antidotes|mesh-ancestor
83026647|NCT04390399|Protective Agents|protective agents|mesh-ancestor
83026648|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
83026649|NCT04390399|Vitamins|vitamins|mesh-ancestor
83433840|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
83026650|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
83026651|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
83026652|NCT01383655|Analgesics|analgesics|mesh-ancestor
83026653|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
83026654|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026655|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026656|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
83026657|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026658|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83026659|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
83026660|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83026661|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026662|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026663|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83026664|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
83026665|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83026666|NCT01568281|Anastrozole|anastrozole|mesh-list
83026667|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83026668|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026669|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83026670|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83026671|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026672|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026673|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83026674|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
83026675|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026676|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026677|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
83026678|NCT02921789|Prednisone|prednisone|mesh-list
83026679|NCT02921789|Tacrolimus|tacrolimus|mesh-list
83026680|NCT02921789|Basiliximab|basiliximab|mesh-list
83026681|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026682|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
83026683|NCT02921789|Hormones|hormones|mesh-ancestor
83026684|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026685|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026686|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83026687|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026688|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026689|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
83026690|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83026691|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026692|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026693|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83026694|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83026695|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
83026696|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83026697|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83026698|NCT02564900|Camptothecin|camptothecin|mesh-list
83026699|NCT02564900|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83026700|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
83026701|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
83026702|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026703|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026704|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026705|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83026706|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83026707|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361649|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026708|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026709|NCT01568333|Decitabine|decitabine|mesh-list
83026710|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026711|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
83026712|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026713|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026714|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026715|NCT03437005|Ketoconazole|ketoconazole|mesh-list
83026716|NCT03437005|Desonide|desonide|mesh-list
83026717|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
83026718|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83026719|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83026720|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83026721|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026722|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026723|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83026724|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
83026725|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026726|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026727|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83026728|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026729|NCT03943823|Estrogens|estrogens|mesh-list
83026730|NCT03943823|Hormones|hormones|mesh-ancestor
83026731|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83026732|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026733|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83026734|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026735|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026736|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026737|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026738|NCT02484248|Ketotifen|ketotifen|mesh-list
83026739|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
83026740|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
83026741|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83026742|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
83026743|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
83026744|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026745|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026746|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026747|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83026748|NCT02419742|Paclitaxel|paclitaxel|mesh-list
83026749|NCT02419742|Docetaxel|docetaxel|mesh-list
83026750|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
83026751|NCT02419742|Carboplatin|carboplatin|mesh-list
83026752|NCT02419742|Doxorubicin|doxorubicin|mesh-list
83026753|NCT02419742|Trastuzumab|trastuzumab|mesh-list
83026754|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026755|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026756|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026757|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026758|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026759|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026760|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026761|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
83026762|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026763|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83026764|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83026765|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
83026766|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83026767|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83026768|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83026769|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83026770|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026771|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026772|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
83026773|NCT02409290|Levofloxacin|levofloxacin|mesh-list
83026774|NCT02409290|Isoniazid|isoniazid|mesh-list
83026775|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
83026776|NCT02409290|Ethambutol|ethambutol|mesh-list
83026777|NCT02409290|Bedaquiline|bedaquiline|mesh-list
83026778|NCT02409290|Clofazimine|clofazimine|mesh-list
83026779|NCT02409290|Kanamycin|kanamycin|mesh-list
83026780|NCT02409290|Prothionamide|prothionamide|mesh-list
83026781|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83026782|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83026783|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83026784|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83026785|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026786|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026787|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026788|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83026789|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83026790|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83026791|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
83026792|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83026793|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83026794|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
83026795|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83026796|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026797|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
83026798|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83026799|NCT02898077|Paclitaxel|paclitaxel|mesh-list
83026800|NCT02898077|Ramucirumab|ramucirumab|mesh-list
83026801|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026802|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026803|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026804|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026805|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026806|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026807|NCT02145884|Timolol|timolol|mesh-list
83026808|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026809|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83026810|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83026811|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
83026812|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026813|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026814|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83026815|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83026816|NCT03544814|Cisplatin|cisplatin|mesh-list
83026817|NCT03544814|Pemetrexed|pemetrexed|mesh-list
83026818|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026819|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026820|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026821|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83026822|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83026823|NCT03097133|Esketamine|esketamine|mesh-list
83026824|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
83026825|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83026826|NCT02148380|Carboplatin|carboplatin|mesh-list
83026827|NCT02148380|Pemetrexed|pemetrexed|mesh-list
83026828|NCT02148380|Gefitinib|gefitinib|mesh-list
83026829|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026830|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026831|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026832|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83026833|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83026834|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026835|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83026836|NCT02146118|Silybin|silybin|mesh-list
83026837|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026838|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026839|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026840|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026841|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026842|NCT02146118|Protective Agents|protective agents|mesh-ancestor
83026843|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026844|NCT02142140|Methylphenidate|methylphenidate|mesh-list
83026845|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83026846|NCT02142140|Adderall|adderall|mesh-list
83026847|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83026848|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
83026849|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83026850|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026851|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83026852|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83026853|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026854|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026855|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
83026856|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026857|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83026858|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
83026859|NCT02142218|Nivolumab|nivolumab|mesh-list
83026860|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026861|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026862|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83026863|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026864|NCT02142296|Aflibercept|aflibercept|mesh-list
83026865|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83026866|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83026867|NCT02142296|Growth Substances|growth substances|mesh-ancestor
83026868|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026869|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
83026870|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026871|NCT02142530|Belinostat|belinostat|mesh-list
83026872|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026873|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83026874|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026875|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026876|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
83026877|NCT01383343|Leucovorin|leucovorin|mesh-list
83026878|NCT01383343|Folic Acid|folic acid|mesh-list
83026879|NCT01383343|Bevacizumab|bevacizumab|mesh-list
83026880|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83026881|NCT01383343|Fluorouracil|fluorouracil|mesh-list
83026882|NCT01383343|Irinotecan|irinotecan|mesh-list
83026883|NCT01383343|Sorafenib|sorafenib|mesh-list
83026884|NCT01383343|Camptothecin|camptothecin|mesh-list
83026885|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
83026886|NCT01383343|Antibodies|antibodies|mesh-list
83026887|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
83026888|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83026889|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
83026890|NCT01383343|Calcium|calcium|mesh-list
83026891|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
83026892|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026893|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83026894|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83026895|NCT01383343|Growth Substances|growth substances|mesh-ancestor
83026896|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026897|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
83026898|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
83026899|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83026900|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83026901|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
83026902|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026903|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83026904|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026905|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83026906|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83026907|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026908|NCT01383343|Antidotes|antidotes|mesh-ancestor
83026909|NCT01383343|Protective Agents|protective agents|mesh-ancestor
83026910|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
83026911|NCT01383343|Vitamins|vitamins|mesh-ancestor
83026912|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
83026913|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026914|NCT01383343|Hematinics|hematinics|mesh-ancestor
83026915|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026916|NCT03631147|Rifaximin|rifaximin|mesh-list
83026917|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83026918|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83026919|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83026920|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
83026921|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83026922|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83026923|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026924|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83026925|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026926|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83026927|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
83026928|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83026929|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026930|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026931|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026932|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83026933|NCT05344495|Midazolam|midazolam|mesh-list
83026934|NCT05344495|Bupivacaine|bupivacaine|mesh-list
83026936|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
83026937|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83026938|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026939|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
83026940|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026941|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83026942|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83026943|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83026944|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83026945|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83026946|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83026947|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
83026948|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
83026949|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
83026950|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83026951|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026952|NCT01593241|Carboplatin|carboplatin|mesh-list
83026953|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026954|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83026955|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83026956|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026957|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
83026958|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83026959|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
83026960|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026961|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
83026962|NCT02782676|Protective Agents|protective agents|mesh-ancestor
83026963|NCT03033095|Etanercept|etanercept|mesh-list
83026964|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83026965|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83026966|NCT03033095|Analgesics|analgesics|mesh-ancestor
83026967|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
83026968|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83026969|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83026970|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83026971|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83026972|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83026973|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83026974|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
83026975|NCT02142920|Gedatolisib|gedatolisib|mesh-list
83026976|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83026977|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83026978|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026979|NCT01383785|Abciximab|abciximab|mesh-list
83026980|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
83026981|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83026982|NCT02923739|Paclitaxel|paclitaxel|mesh-list
83026983|NCT02923739|Bevacizumab|bevacizumab|mesh-list
83026984|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83026985|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83026986|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
83026987|NCT02923739|Antibodies|antibodies|mesh-list
83026988|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
83026989|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83026990|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
83026991|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83026992|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83026993|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
83026994|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
83026995|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
83026996|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83026997|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83026998|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83026999|NCT02923739|Growth Substances|growth substances|mesh-ancestor
83027000|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027001|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
83027002|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
83027003|NCT02146976|Propofol|propofol|mesh-list
83027004|NCT02146976|Sevoflurane|sevoflurane|mesh-list
83027005|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83027006|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027007|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027008|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83027009|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
83027010|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
83027011|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83027013|NCT02147054|Rocuronium|rocuronium|mesh-list
83027014|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83027015|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83027016|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83027017|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027018|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027019|NCT00107978|Vancomycin|vancomycin|mesh-list
83027020|NCT00107978|Telavancin|telavancin|mesh-list
83027021|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83027022|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027023|NCT02781818|Triamcinolone|triamcinolone|mesh-list
83027024|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83027025|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83027026|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83027027|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027028|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
83027029|NCT02781818|Hormones|hormones|mesh-ancestor
83027030|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027031|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027032|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83027033|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
83027034|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027035|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027036|NCT02149628|Propofol|propofol|mesh-list
83027037|NCT02149628|Desflurane|desflurane|mesh-list
83027038|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83027039|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027040|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027041|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83027042|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
83027043|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
83027044|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83027045|NCT02927873|Vaccines|vaccines|mesh-list
83027046|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
83027047|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027048|NCT02460419|Capecitabine|capecitabine|mesh-list
83027049|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83027050|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
83027051|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027053|NCT01568411|Itraconazole|itraconazole|mesh-list
83027054|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
83027055|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027056|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83027057|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83027058|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027059|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027060|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83027061|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027062|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027063|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027064|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83027065|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83027066|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
83027067|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
83027068|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027069|NCT03631901|Diazepam|diazepam|mesh-list
83027070|NCT03631901|Melatonin|melatonin|mesh-list
83027071|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
83027072|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027073|NCT03631901|Protective Agents|protective agents|mesh-ancestor
83027074|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027075|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027076|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83027077|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
83027078|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
83027079|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
83027080|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027081|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83027082|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83027083|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83027084|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83027085|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83027086|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83027087|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83027088|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83027089|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
83027090|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
83027091|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
83027092|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
83027093|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027094|NCT01383395|Cilostazol|cilostazol|mesh-list
83027095|NCT01383395|Simvastatin|simvastatin|mesh-list
83027096|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83027097|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83027098|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
83027099|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027100|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83027101|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83027102|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027103|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83027104|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
83027105|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027106|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027107|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83027108|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
83027109|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83027110|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83027111|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83027112|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
83027113|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83027114|NCT01383395|Protective Agents|protective agents|mesh-ancestor
83027115|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83027116|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83027117|NCT05084651|Itraconazole|itraconazole|mesh-list
83027118|NCT05084651|Lumefantrine|lumefantrine|mesh-list
83027119|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
83027120|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027121|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83027122|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83027123|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027124|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027125|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83027126|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027127|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027128|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027129|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83027130|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
83027131|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83027132|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83027133|NCT02781584|Firsocostat|firsocostat|mesh-list
83027134|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027135|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027136|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
83027137|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83027138|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
83027139|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027140|NCT02147678|Remifentanil|remifentanil|mesh-list
83027141|NCT02147678|Propofol|propofol|mesh-list
83027142|NCT02147678|Etomidate|etomidate|mesh-list
83027143|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
83027144|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027145|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027146|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83027147|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83027148|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
83027149|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83027150|NCT02147678|Narcotics|narcotics|mesh-ancestor
83027151|NCT02147678|Analgesics|analgesics|mesh-ancestor
83027152|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
83027153|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027154|NCT02151344|Vaccines|vaccines|mesh-list
83027155|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
83027156|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027157|NCT02155634|Lenalidomide|lenalidomide|mesh-list
83027158|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
83027159|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027160|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83027161|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83027162|NCT02155634|Growth Substances|growth substances|mesh-ancestor
83027163|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
83027164|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027165|NCT02151812|Paclitaxel|paclitaxel|mesh-list
83027166|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83027167|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83027168|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027169|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83027170|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83027171|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83027172|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027173|NCT02151968|Anesthetics|anesthetics|mesh-list
83027174|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
83027175|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027176|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027177|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
83027178|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027179|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83027180|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
83027181|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83027182|NCT02255084|Menthol|menthol|mesh-list
83027183|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
83027184|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
83027185|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83027186|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83027187|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
83027188|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027189|NCT02255162|Cytarabine|cytarabine|mesh-list
83027190|NCT02255162|Lenalidomide|lenalidomide|mesh-list
83027191|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83027192|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
83027193|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027194|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027195|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
83027196|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027197|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83027198|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
83027199|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027200|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83027201|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83027202|NCT02255162|Growth Substances|growth substances|mesh-ancestor
83027203|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
83027204|NCT02152514|Sufentanil|sufentanil|mesh-list
83027205|NCT02152514|Morphine|morphine|mesh-list
83027206|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83027207|NCT02152514|Narcotics|narcotics|mesh-ancestor
83027208|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027209|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027210|NCT02152514|Analgesics|analgesics|mesh-ancestor
83027211|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
83027212|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027213|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83027214|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83027215|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
83027216|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
83027217|NCT02261090|Pramipexole|pramipexole|mesh-list
83027218|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
83027219|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027220|NCT02261090|Protective Agents|protective agents|mesh-ancestor
83027221|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027222|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83027223|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83027224|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
83027225|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
83027226|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027227|NCT01307423|Thalidomide|thalidomide|mesh-list
83027228|NCT01307423|Apremilast|apremilast|mesh-list
83027229|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83027230|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027231|NCT01307423|Analgesics|analgesics|mesh-ancestor
83027232|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
83027233|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027234|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027235|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027236|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83027237|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83027238|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83027240|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027241|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83027242|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
83027243|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
83027244|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83027245|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027246|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83027247|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83027248|NCT01307423|Growth Substances|growth substances|mesh-ancestor
83027249|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
83027250|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027251|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
83027252|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83027253|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83027254|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83027255|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83027256|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027257|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
83027258|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027259|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027260|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83027261|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027262|NCT02156336|Ranolazine|ranolazine|mesh-list
83027263|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83027264|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83027265|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027266|NCT03542240|Curcumin|curcumin|mesh-list
83027267|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83027268|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027269|NCT03542240|Analgesics|analgesics|mesh-ancestor
83027270|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
83027271|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027272|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027273|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027274|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83027275|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027276|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027277|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027278|NCT00911183|Prednisone|prednisone|mesh-list
83027279|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
83027280|NCT00911183|Rituximab|rituximab|mesh-list
83027281|NCT00911183|Doxorubicin|doxorubicin|mesh-list
83027282|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83027283|NCT00911183|Vincristine|vincristine|mesh-list
83027284|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83027285|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
83027286|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027287|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83027288|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83027289|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
83027290|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027291|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027292|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83027293|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027294|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83027295|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83027296|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83027297|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027298|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027299|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
83027300|NCT00911183|Hormones|hormones|mesh-ancestor
83027301|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027302|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83027303|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83027304|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
83027305|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
83027306|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
83027307|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
83027308|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83027309|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361650|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83027310|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
83027311|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027312|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027313|NCT02768792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83027314|NCT02768792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027315|NCT05420441|Chitosan|chitosan|mesh-list
83027316|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83027317|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83027318|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
83027319|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027320|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83027321|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
83027322|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
83027323|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
83027324|NCT05420441|Coagulants|coagulants|mesh-ancestor
83027325|NCT05598593|Cytarabine|cytarabine|mesh-list
83027326|NCT05598593|Fludarabine|fludarabine|mesh-list
83027327|NCT05598593|Busulfan|busulfan|mesh-list
83027328|NCT05598593|Thiotepa|thiotepa|mesh-list
83027329|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027330|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83027331|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
83027332|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027333|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83027334|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
83027335|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027336|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
83027337|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027338|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
83027339|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83027340|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83027341|NCT05337449|Fluorides|fluorides|mesh-list
83027342|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
83027343|NCT05337449|Protective Agents|protective agents|mesh-ancestor
83027344|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027345|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
83027346|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83027347|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83027348|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83027349|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027350|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
83027351|NCT02150720|Coagulants|coagulants|mesh-ancestor
83027352|NCT02153060|Dexamethasone|dexamethasone|mesh-list
83027353|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
83027354|NCT02153060|BB 1101|bb 1101|mesh-list
83027355|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027356|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
83027357|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
83027358|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027359|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027360|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83027361|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
83027362|NCT02153060|Hormones|hormones|mesh-ancestor
83027363|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027364|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83027365|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027366|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
83027367|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027368|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027369|NCT02156570|Ribavirin|ribavirin|mesh-list
83027370|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
83027371|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
83027372|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027373|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
83027374|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027375|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
83027376|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83027377|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027378|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
83027379|NCT02156726|Fludarabine|fludarabine|mesh-list
83027380|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83027381|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
83027382|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027383|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83027384|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83027385|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
83027397|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027399|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027400|NCT05598281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83027401|NCT05598281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027402|NCT05598281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027403|NCT03092375|Ribavirin|ribavirin|mesh-list
83027404|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
83027405|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027406|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
83027407|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027408|NCT01995513|Prednisone|prednisone|mesh-list
83027409|NCT01995513|Prednisolone|prednisolone|mesh-list
83027410|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
83027411|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027412|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
83027413|NCT01995513|Hormones|hormones|mesh-ancestor
83027414|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027415|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027416|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83027417|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027418|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83027419|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027420|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027421|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027422|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83027435|NCT03180359|Vaccines|vaccines|mesh-list
83027436|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
83027437|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027438|NCT05199285|Nivolumab|nivolumab|mesh-list
83027439|NCT05199285|Ipilimumab|ipilimumab|mesh-list
83027440|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027441|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027442|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83027443|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027444|NCT01304511|Ganirelix|ganirelix|mesh-list
83027445|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027446|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027447|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027448|NCT04808973|Lamivudine|lamivudine|mesh-list
83027449|NCT04808973|Dolutegravir|dolutegravir|mesh-list
83027450|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83027451|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83027452|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027453|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027454|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
83027455|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027456|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83027457|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83027458|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83027459|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83027460|NCT00103610|Plerixafor|plerixafor|mesh-list
83027461|NCT00103610|Lenograstim|lenograstim|mesh-list
83027462|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83027463|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
83027464|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027465|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83027466|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83027467|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
83027468|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027469|NCT04871321|Paclitaxel|paclitaxel|mesh-list
83027470|NCT04871321|Gemcitabine|gemcitabine|mesh-list
83027471|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83027472|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027473|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
83027474|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
83027475|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
83027476|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027477|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83027478|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
83027479|NCT02156960|Denosumab|denosumab|mesh-list
83027480|NCT02156960|Teriparatide|teriparatide|mesh-list
83027481|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83027482|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027483|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83027484|NCT02153606|Glycerol|glycerol|mesh-list
83027485|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83027486|NCT02153606|Protective Agents|protective agents|mesh-ancestor
83027487|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027488|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
83027489|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83027490|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83027491|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83027492|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027493|NCT04687631|Bevacizumab|bevacizumab|mesh-list
83027494|NCT04687631|Cetuximab|cetuximab|mesh-list
83027495|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027496|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027497|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83027498|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83027499|NCT04687631|Growth Substances|growth substances|mesh-ancestor
83027500|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027501|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
83027502|NCT04833023|Olanzapine|olanzapine|mesh-list
83027503|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
83027504|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
83027505|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027506|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027507|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83027508|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83027509|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83027510|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027511|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83027512|NCT04833023|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83027513|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83027514|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83027515|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027516|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027517|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
83027518|NCT03091439|Dalbavancin|dalbavancin|mesh-list
83027519|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83027520|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027521|NCT03631823|Temozolomide|temozolomide|mesh-list
83027522|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83027523|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
83027524|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027525|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027527|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83027528|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
83027529|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83027530|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
83027531|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027532|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027533|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
83027534|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
83027535|NCT02154074|Isoflurane|isoflurane|mesh-list
83027536|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
83361651|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027537|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027538|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027539|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83027540|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027541|NCT02154074|Analgesics|analgesics|mesh-ancestor
83027542|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
83027543|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027544|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83027545|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83027546|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83027547|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
83027548|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027549|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027550|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83027551|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
83027552|NCT05593055|Eplerenone|eplerenone|mesh-list
83027553|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
83027554|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83027555|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027556|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027557|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027558|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83027559|NCT05593055|Diuretics|diuretics|mesh-ancestor
83027560|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
83027561|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83027562|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83027563|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83027564|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027565|NCT05460455|Antibodies|antibodies|mesh-list
83027566|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83027567|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
83027568|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027569|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83027570|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
83027571|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027572|NCT01382147|Daunorubicin|daunorubicin|mesh-list
83027573|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
83027574|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83027575|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027576|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83027577|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83027578|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027579|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027580|NCT01382147|Analgesics|analgesics|mesh-ancestor
83027581|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
83027582|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027583|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027584|NCT01381835|Simeprevir|simeprevir|mesh-list
83027585|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
83027586|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027587|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
83027588|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027589|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027590|NCT04429685|Ketamine|ketamine|mesh-list
83027591|NCT04429685|Analgesics|analgesics|mesh-ancestor
83027592|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
83027593|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027594|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027595|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83027596|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83027597|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
83027598|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
83027599|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027600|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83027601|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83027602|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027603|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027604|NCT01384279|Metformin|metformin|mesh-list
83027605|NCT01384279|Topiramate|topiramate|mesh-list
83027606|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83027607|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027608|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
83027609|NCT01381601|Bevacizumab|bevacizumab|mesh-list
83361652|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83027611|NCT01381601|Sorafenib|sorafenib|mesh-list
83027612|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027613|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027614|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83027615|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83027616|NCT01381601|Growth Substances|growth substances|mesh-ancestor
83027617|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027618|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
83027619|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83027620|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027621|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027622|NCT02823353|Fenofibrate|fenofibrate|mesh-list
83027623|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83027624|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
83027625|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027626|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83027627|NCT04509193|Warfarin|warfarin|mesh-list
83027628|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
83027629|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
83027630|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83027631|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
83027632|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83027633|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
83027634|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027635|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027636|NCT02697383|Dexamethasone|dexamethasone|mesh-list
83027637|NCT02697383|Ixazomib|ixazomib|mesh-list
83027638|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027639|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
83027640|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
83027641|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027642|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027643|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83027644|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
83027645|NCT02697383|Hormones|hormones|mesh-ancestor
83027646|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027647|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83027648|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027649|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
83027650|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027651|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027652|NCT04173949|Ramipril|ramipril|mesh-list
83027653|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83027654|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
83027655|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027656|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027657|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83027658|NCT05422001|Ketamine|ketamine|mesh-list
83027659|NCT05422001|Analgesics|analgesics|mesh-ancestor
83027660|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
83027661|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027662|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027663|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83027664|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83027665|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
83027666|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
83027667|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027668|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83027669|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83027670|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027671|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027672|NCT01382017|Lacosamide|lacosamide|mesh-list
83027673|NCT01382017|Carbamazepine|carbamazepine|mesh-list
83027674|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
83027675|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83027676|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83027677|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83027678|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027679|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
83027680|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83027681|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027682|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027683|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83027684|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027685|NCT01382017|Analgesics|analgesics|mesh-ancestor
83027686|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
83027687|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027688|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83027689|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83027690|NCT01381523|Naproxen|naproxen|mesh-list
83027691|NCT01381523|Sumatriptan|sumatriptan|mesh-list
83027692|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83027693|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027694|NCT01381523|Analgesics|analgesics|mesh-ancestor
83027695|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
83027696|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027697|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027698|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027699|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83027700|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
83027701|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83027702|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027703|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027704|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83027705|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83027706|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83027707|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
83027708|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027709|NCT04233047|Fostemsavir|fostemsavir|mesh-list
83027710|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83027711|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83027712|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
83027713|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027714|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83027715|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83027716|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027717|NCT01381445|Clobetasol|clobetasol|mesh-list
83027718|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027719|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
83027720|NCT01381445|Hormones|hormones|mesh-ancestor
83027721|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027722|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027723|NCT03083639|Esomeprazole|esomeprazole|mesh-list
83027724|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83027725|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83027726|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83027727|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027728|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027729|NCT02927431|Oseltamivir|oseltamivir|mesh-list
83027730|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
83027731|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027732|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027733|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027734|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
83027735|NCT05027893|Cefixime|cefixime|mesh-list
83027736|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83027737|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027738|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83027739|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83027740|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027741|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027742|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027743|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
83027744|NCT04113083|Provitamins|provitamins|mesh-ancestor
83027746|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
83027747|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027748|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83027749|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
83027750|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027751|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
83027752|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83027753|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
83027754|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027755|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
83027756|NCT04989361|Protective Agents|protective agents|mesh-ancestor
83027757|NCT01381289|Ivacaftor|ivacaftor|mesh-list
83361653|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
83027758|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83027759|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83027760|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027761|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83027763|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027764|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027765|NCT01381705|Rituximab|rituximab|mesh-list
83027766|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027767|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027768|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
83027769|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027770|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83027771|NCT04401709|Gemcitabine|gemcitabine|mesh-list
83027772|NCT04401709|Capecitabine|capecitabine|mesh-list
83027773|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83027774|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
83027775|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027776|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027777|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
83027778|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
83027779|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027780|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
83027781|NCT01381627|Remifentanil|remifentanil|mesh-list
83027782|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83027783|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027784|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027785|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027786|NCT01381627|Analgesics|analgesics|mesh-ancestor
83027787|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
83027788|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027789|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83027790|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83027791|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83027792|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83027793|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027794|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027795|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83027796|NCT01381627|Narcotics|narcotics|mesh-ancestor
83027797|NCT00974571|Cetirizine|cetirizine|mesh-list
83027798|NCT00974571|Montelukast|montelukast|mesh-list
83027799|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83027800|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
83027801|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83027802|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027803|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027804|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027805|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83027806|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83027807|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027808|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83027809|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83027810|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83027811|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
83027812|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
83027813|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027814|NCT02766608|Budesonide|budesonide|mesh-list
83027815|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
83027816|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83027817|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027818|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83027820|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027821|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027822|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83027823|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
83027824|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
83027825|NCT02766608|Hormones|hormones|mesh-ancestor
83027826|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027827|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83027828|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83027829|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83027830|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
83027831|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027832|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027833|NCT01382407|Cetuximab|cetuximab|mesh-list
83027834|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027835|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027836|NCT02235857|Dextrans|dextrans|mesh-list
83027837|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
83027838|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
83027839|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
83027840|NCT05082285|Vaccines|vaccines|mesh-list
83027841|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
83027842|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027843|NCT03317119|Trifluridine|trifluridine|mesh-list
83027844|NCT03317119|Trametinib|trametinib|mesh-list
83027845|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027846|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83027847|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027848|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027849|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
83027850|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
83027851|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027852|NCT04356495|Ciclesonide|ciclesonide|mesh-list
83027853|NCT04356495|Interferons|interferons|mesh-list
83027854|NCT04356495|Interferon-beta|interferon-beta|mesh-list
83027855|NCT04356495|Telmisartan|telmisartan|mesh-list
83027856|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
83027857|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027858|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027859|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
83027860|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83027861|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83027862|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83027863|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83027864|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027865|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
83027866|NCT04356495|Hormones|hormones|mesh-ancestor
83027867|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027868|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83027869|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
83027870|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83027871|NCT05345249|Ropivacaine|ropivacaine|mesh-list
83027872|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
83027873|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
83027874|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83027875|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027876|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
83027877|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027878|NCT02154230|Calcium|calcium|mesh-list
83027879|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83027880|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027881|NCT04200963|Nivolumab|nivolumab|mesh-list
83027882|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027883|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027884|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83027885|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027886|NCT02157428|Flumazenil|flumazenil|mesh-list
83027887|NCT02157428|Antidotes|antidotes|mesh-ancestor
83027888|NCT02157428|Protective Agents|protective agents|mesh-ancestor
83027889|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027890|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
83027892|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027893|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027894|NCT00960141|Loratadine|loratadine|mesh-list
83027895|NCT00960141|Montelukast|montelukast|mesh-list
83027896|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83027897|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
83027898|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83027899|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027900|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027901|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027902|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83027903|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83027904|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027906|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
83027907|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83027908|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83027909|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83027910|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
83027911|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
83027912|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027913|NCT00759655|Factor VIII|factor viii|mesh-list
83027914|NCT00759655|Coagulants|coagulants|mesh-ancestor
83027915|NCT03918915|Atropine|atropine|mesh-list
83027916|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83027917|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83027918|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83027919|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
83027920|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027921|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027922|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83027923|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
83027924|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
83027925|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
83027926|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83027927|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83027928|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
83027929|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83027930|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027931|NCT02255006|Glyburide|glyburide|mesh-list
83027932|NCT02255006|Celecoxib|celecoxib|mesh-list
83027933|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83027934|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027935|NCT02255006|Analgesics|analgesics|mesh-ancestor
83027936|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
83027937|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027938|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027939|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027940|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83027941|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83027942|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83027943|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027944|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027945|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83027946|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
83027947|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83027948|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83027949|NCT03396471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83027950|NCT03396471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027951|NCT00103142|Sargramostim|sargramostim|mesh-list
83027952|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
83027953|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027954|NCT00943683|Montelukast|montelukast|mesh-list
83027955|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83027956|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
83027957|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83027958|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027959|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027960|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027961|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83027962|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83027963|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027965|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83027966|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83027967|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027968|NCT02154464|Acetaminophen|acetaminophen|mesh-list
83027969|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83027970|NCT02154464|Analgesics|analgesics|mesh-ancestor
83027971|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
83027972|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83027973|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027974|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
83027975|NCT00911547|Beclomethasone|beclomethasone|mesh-list
83027976|NCT00911547|Montelukast|montelukast|mesh-list
83027977|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83027978|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
83027979|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83027980|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
83027981|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027982|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027983|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83027984|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83027985|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83027986|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027987|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
83027989|NCT02159690|Prednisone|prednisone|mesh-list
83027990|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
83027991|NCT02159690|Dutasteride|dutasteride|mesh-list
83027992|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83027993|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
83027994|NCT02159690|Hormones|hormones|mesh-ancestor
83027995|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83027996|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83027997|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83027998|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83433879|NCT03152474|Prednisolone|prednisolone|mesh-list
83027999|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83028000|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028001|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83435012|NCT00667615|Prednisone|prednisone|mesh-list
83435090|NCT03593408|Analgesics|analgesics|mesh-ancestor
83028002|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
83435611|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83028003|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83028004|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83028005|NCT02157818|Midazolam|midazolam|mesh-list
83435835|NCT03086720|Eusol|eusol|mesh-list
83028006|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
83028007|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83436060|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
83028008|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028009|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436285|NCT04388111|Analgesics|analgesics|mesh-ancestor
83436373|NCT00603187|Acyline|acyline|mesh-list
83028010|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028011|NCT02157818|Analgesics|analgesics|mesh-ancestor
83028012|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
83028013|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028014|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83028015|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83028016|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83028017|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
83028018|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028019|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028020|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83028021|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83028022|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83028023|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83028024|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83028025|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
83028026|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
83028027|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
83028028|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
83028029|NCT00899379|Rizatriptan|rizatriptan|mesh-list
83028030|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83028031|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
83028032|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028033|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028034|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028035|NCT04326439|Cytarabine|cytarabine|mesh-list
83028036|NCT04326439|Etoposide|etoposide|mesh-list
83028037|NCT04326439|Daunorubicin|daunorubicin|mesh-list
83028038|NCT04326439|Sorafenib|sorafenib|mesh-list
83028039|NCT04326439|Asparaginase|asparaginase|mesh-list
83028040|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
83028041|NCT04326439|Calicheamicins|calicheamicins|mesh-list
83028042|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83436588|NCT01893801|Paclitaxel|paclitaxel|mesh-list
83028043|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028044|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83028045|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83028046|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028047|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028048|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028049|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
83028050|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
83028051|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028052|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83028053|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
83028054|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028055|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83028056|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83028057|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83028058|NCT04326439|Immunotoxins|immunotoxins|mesh-ancestor
83028059|NCT04326439|Immunoconjugates|immunoconjugates|mesh-ancestor
83028060|NCT03541928|Valacyclovir|valacyclovir|mesh-list
83028061|NCT03541928|Leuprolide|leuprolide|mesh-list
83028062|NCT03541928|Bicalutamide|bicalutamide|mesh-list
83028063|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83028064|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
83028065|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028066|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028067|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83028068|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028069|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
83028070|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
83028071|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83436696|NCT00572117|Topiramate|topiramate|mesh-list
83028072|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
83028073|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028074|NCT00145795|Ritonavir|ritonavir|mesh-list
83028075|NCT00145795|Lopinavir|lopinavir|mesh-list
83028076|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83028077|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83028078|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
83028079|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028080|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028081|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83028082|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83028083|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
83028084|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028085|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83028086|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83028087|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83028088|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
83028089|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028090|NCT00898677|Sumatriptan|sumatriptan|mesh-list
83028091|NCT00898677|Rizatriptan|rizatriptan|mesh-list
83028092|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83028093|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83028094|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83028095|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
83028096|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028097|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028098|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028099|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
83028100|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83028101|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028102|NCT02154776|Letrozole|letrozole|mesh-list
83028103|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028104|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83028105|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83028106|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028107|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028108|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83028109|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
83028110|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028111|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028112|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83028113|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
83028114|NCT03388749|Annamycin|annamycin|mesh-list
83028115|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83028116|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028117|NCT02770820|Aldesleukin|aldesleukin|mesh-list
83028118|NCT02770820|Interleukin-2|interleukin-2|mesh-list
83028119|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028120|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028121|NCT02770820|Analgesics|analgesics|mesh-ancestor
83028122|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
83028123|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028124|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028125|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83028126|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83028127|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
83028128|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028129|NCT02154854|Tacrolimus|tacrolimus|mesh-list
83028130|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83028131|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
83028132|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028133|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83028134|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028135|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028136|NCT02160080|Interferons|interferons|mesh-list
83028137|NCT02160080|Ribavirin|ribavirin|mesh-list
83028138|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
83028139|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028140|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
83028141|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028142|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
83028143|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028144|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
83028145|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028146|NCT05422183|Lenvatinib|lenvatinib|mesh-list
83028147|NCT05422183|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83028148|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028149|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83028150|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028151|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028152|NCT02160158|Fesoterodine|fesoterodine|mesh-list
83028153|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83028154|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83028155|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83028156|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028157|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028158|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028159|NCT02160158|Urological Agents|urological agents|mesh-ancestor
83028160|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83028161|NCT02160236|Tenoxicam|tenoxicam|mesh-list
83028162|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028163|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028164|NCT02160236|Analgesics|analgesics|mesh-ancestor
83028165|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
83028166|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028167|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83436982|NCT00753337|Cobalt|cobalt|mesh-list
83028168|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028169|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028170|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83028171|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028172|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028173|NCT02154932|Misoprostol|misoprostol|mesh-list
83028174|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83028175|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
83028176|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028177|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028178|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83028179|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83028180|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
83028181|NCT02158286|Acetaminophen|acetaminophen|mesh-list
83028182|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028183|NCT02158286|Analgesics|analgesics|mesh-ancestor
83028184|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
83028185|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028186|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028187|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
83028189|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
83028190|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
83028191|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028192|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437034|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83028193|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
83028194|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028195|NCT02155088|Paclitaxel|paclitaxel|mesh-list
83028196|NCT02155088|Gemcitabine|gemcitabine|mesh-list
83028197|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83028198|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028199|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83028200|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83028201|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83028202|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028203|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028205|NCT02160548|Atropine|atropine|mesh-list
83028206|NCT02160548|Albuterol|albuterol|mesh-list
83028207|NCT02160548|Pralidoxime|pralidoxime|mesh-list
83028208|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83028209|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
83028210|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028211|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028212|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83028213|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
83028214|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
83028215|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028216|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83437150|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
83028217|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83028218|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83028219|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
83028220|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028221|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028222|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83028223|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83028224|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
83028225|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
83028226|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83028227|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83028228|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
83028229|NCT02160548|Antidotes|antidotes|mesh-ancestor
83028230|NCT02160548|Protective Agents|protective agents|mesh-ancestor
83028231|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
83028232|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
83028233|NCT02158598|Vitamin D|vitamin d|mesh-list
83028234|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
83028235|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
83028236|NCT02158598|Vitamins|vitamins|mesh-list
83028237|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
83028238|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028239|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83028240|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83028241|NCT03082729|Apremilast|apremilast|mesh-list
83028242|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028243|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028244|NCT03082729|Analgesics|analgesics|mesh-ancestor
83028245|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
83028246|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028247|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028248|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028249|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028250|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83028251|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83028252|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028253|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028254|NCT02160704|Enclomiphene|enclomiphene|mesh-list
83028255|NCT02160704|Clomiphene|clomiphene|mesh-list
83028256|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
83028257|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83028258|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
83028259|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83437270|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83028260|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028261|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83028262|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
83028263|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028264|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83028265|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83028266|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
83028267|NCT03542552|Nifedipine|nifedipine|mesh-list
83028268|NCT03542552|Analgesics|analgesics|mesh-ancestor
83028269|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
83028270|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028271|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028272|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
83028273|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028274|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83028275|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
83028276|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83028277|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83028278|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028279|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83028281|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028282|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
83028283|NCT02155166|Ibuprofen|ibuprofen|mesh-list
83028284|NCT02155166|Lidocaine|lidocaine|mesh-list
83028285|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
83028286|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
83028287|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028288|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028289|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
83028290|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028291|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83028292|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83028293|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83028294|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83028295|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028296|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028297|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028298|NCT02155166|Analgesics|analgesics|mesh-ancestor
83028299|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028300|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028301|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83028302|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028303|NCT00398931|Alendronate|alendronate|mesh-list
83028304|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028305|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83028306|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83028307|NCT00920361|Hormones|hormones|mesh-ancestor
83437439|NCT05711823|Granisetron|granisetron|mesh-list
83028308|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028309|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028310|NCT00651807|Etonogestrel|etonogestrel|mesh-list
83028311|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83028312|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
83028313|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028314|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028315|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83028316|NCT03246529|Lenograstim|lenograstim|mesh-list
83028317|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83028318|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
83028319|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028320|NCT02158910|Donepezil|donepezil|mesh-list
83028321|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83028322|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028323|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028324|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
83028325|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028326|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028327|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
83028328|NCT03077659|Paclitaxel|paclitaxel|mesh-list
83028329|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83028330|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028331|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
83028332|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
83028333|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
83028334|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028335|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
83028336|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83028337|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028338|NCT05052723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83028339|NCT05052723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028340|NCT02807883|Blinatumomab|blinatumomab|mesh-list
83028341|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028342|NCT05563155|Dexamethasone|dexamethasone|mesh-list
83028343|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028344|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
83028345|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
83028346|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83437542|NCT05346146|Gemcitabine|gemcitabine|mesh-list
83028347|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028348|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83028349|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
83028350|NCT05563155|Hormones|hormones|mesh-ancestor
83028351|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028352|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83028353|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028354|NCT04051047|Gemcitabine|gemcitabine|mesh-list
83028355|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028356|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
83028357|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028358|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028359|NCT00102440|Allopurinol|allopurinol|mesh-list
83028360|NCT00102440|Febuxostat|febuxostat|mesh-list
83028361|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
83028362|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028363|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028364|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
83028365|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028366|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83028367|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
83028368|NCT00102440|Protective Agents|protective agents|mesh-ancestor
83028369|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028370|NCT05224167|Melatonin|melatonin|mesh-list
83028371|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
83028372|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
83028373|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028374|NCT05224167|Protective Agents|protective agents|mesh-ancestor
83028375|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028376|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028377|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
83028378|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
83028379|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83028380|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
83028381|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
83028382|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028383|NCT01377259|Anesthetics|anesthetics|mesh-list
83028384|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028385|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028386|NCT02884219|Ibuprofen|ibuprofen|mesh-list
83028387|NCT02884219|Indomethacin|indomethacin|mesh-list
83028388|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
83028389|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028390|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028391|NCT02884219|Analgesics|analgesics|mesh-ancestor
83028392|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
83028393|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028394|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028395|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028396|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028397|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028398|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028399|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
83028400|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
83028401|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028402|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83028403|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83028404|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83028405|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028406|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028407|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83028408|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83028409|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028410|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
83028411|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028412|NCT03909607|Ketamine|ketamine|mesh-list
83028413|NCT03909607|Analgesics|analgesics|mesh-ancestor
83028414|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
83028415|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028416|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028417|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83028418|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83028419|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
83028420|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
83028421|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028422|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83028423|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83028424|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028425|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028426|NCT03902509|Pirfenidone|pirfenidone|mesh-list
83028428|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
83028429|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028430|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028431|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028432|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028433|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028434|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028435|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028436|NCT02166632|Bupivacaine|bupivacaine|mesh-list
83028437|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
83028438|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
83437654|NCT00249769|Vaccines|vaccines|mesh-list
83028439|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028440|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028441|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
83028442|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028443|NCT02161952|Pirfenidone|pirfenidone|mesh-list
83028444|NCT02161952|Analgesics|analgesics|mesh-ancestor
83028445|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
83028446|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028447|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028448|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028449|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028450|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028451|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028452|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028453|NCT04993677|Carboplatin|carboplatin|mesh-list
83028454|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
83028455|NCT04993677|Pemetrexed|pemetrexed|mesh-list
83028456|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028457|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83028458|NCT04993677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83028459|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028460|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028461|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83028462|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83028463|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
83028464|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83028465|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
83028466|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83028467|NCT04795869|Antibodies|antibodies|mesh-list
83028468|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
83028469|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83028470|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
83028471|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
83028472|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028473|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028474|NCT04795869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83028475|NCT04795869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028476|NCT04795869|Immunotoxins|immunotoxins|mesh-ancestor
83028477|NCT04050735|Ethanol|ethanol|mesh-list
83028478|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83028479|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028480|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028481|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028482|NCT04784559|Remdesivir|remdesivir|mesh-list
83028483|NCT04784559|Favipiravir|favipiravir|mesh-list
83028484|NCT04784559|Dexamethasone|dexamethasone|mesh-list
83028485|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028486|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
83028487|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
83028488|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028489|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028490|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83028491|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
83028492|NCT04784559|Hormones|hormones|mesh-ancestor
83028493|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028494|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83028495|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028496|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
83028497|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028498|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
83028499|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028500|NCT03704181|Colchicine|colchicine|mesh-list
83028501|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
83028502|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028503|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83028504|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83028505|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83028506|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028507|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028508|NCT03625011|Gabapentin|gabapentin|mesh-list
83028509|NCT03625011|Analgesics|analgesics|mesh-ancestor
83028510|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
83028511|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028512|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028513|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
83028514|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83028515|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83028516|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028517|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83028518|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83028519|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83028520|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028521|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028522|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
83028523|NCT03625167|Petrolatum|petrolatum|mesh-list
83028524|NCT03625167|Emollients|emollients|mesh-ancestor
83028525|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
83028526|NCT04718727|Olanzapine|olanzapine|mesh-list
83028527|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
83028528|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
83028529|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028530|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028531|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83028532|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83028533|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83028534|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028535|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83028536|NCT04718727|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83028537|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83028538|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83028539|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028540|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028541|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
83028542|NCT03701529|Anesthetics|anesthetics|mesh-list
83028543|NCT03701529|Propofol|propofol|mesh-list
83028544|NCT03701529|Sevoflurane|sevoflurane|mesh-list
83028545|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028546|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028547|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83028548|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83028549|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
83028550|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83028551|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83028552|NCT04535271|Gemcitabine|gemcitabine|mesh-list
83028553|NCT04535271|Dacarbazine|dacarbazine|mesh-list
83028554|NCT04535271|Trabectedin|trabectedin|mesh-list
83028555|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028556|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
83028557|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028558|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028559|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83028560|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
83028561|NCT04553133|Letrozole|letrozole|mesh-list
83028563|NCT04553133|Palbociclib|palbociclib|mesh-list
83028564|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028565|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83028566|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83028567|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028568|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028569|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83028570|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
83028571|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028572|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028573|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83028574|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83028575|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83028576|NCT03701451|Decitabine|decitabine|mesh-list
83028577|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028578|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
83028579|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028580|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028581|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028582|NCT03703089|Paclitaxel|paclitaxel|mesh-list
83028583|NCT03703089|Gemcitabine|gemcitabine|mesh-list
83028584|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83028585|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028586|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
83028587|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83028588|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83028589|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028590|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028591|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
83028592|NCT02807844|Spartalizumab|spartalizumab|mesh-list
83028593|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83028594|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028595|NCT02807844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83028596|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028597|NCT02763566|Letrozole|letrozole|mesh-list
83028598|NCT02763566|Fulvestrant|fulvestrant|mesh-list
83028599|NCT02763566|Anastrozole|anastrozole|mesh-list
83028600|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028601|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83028602|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83028603|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028604|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028605|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83028606|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
83028607|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028608|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028609|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83028610|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83028611|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
83028612|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83028613|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83028614|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83028615|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028616|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
83028617|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028618|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028619|NCT02052180|Bupivacaine|bupivacaine|mesh-list
83028620|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
83028621|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
83028622|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028623|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028624|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
83028625|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028626|NCT03561402|Teriflunomide|teriflunomide|mesh-list
83028627|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028628|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028629|NCT03561402|Analgesics|analgesics|mesh-ancestor
83028630|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
83028631|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028632|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028633|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028635|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83028636|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
83028637|NCT04542135|Sulindac|sulindac|mesh-list
83028638|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028639|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028640|NCT04542135|Analgesics|analgesics|mesh-ancestor
83028641|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
83028642|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028643|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028644|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028645|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028646|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028647|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83028648|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028649|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028651|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83028652|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028653|NCT04694781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83028654|NCT04694781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028655|NCT02805972|Naloxone|naloxone|mesh-list
83028656|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83028657|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028658|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
83028659|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028660|NCT02052258|Oxytocin|oxytocin|mesh-list
83028661|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
83028662|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028663|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028664|NCT02053818|Sufentanil|sufentanil|mesh-list
83028665|NCT02053818|Remifentanil|remifentanil|mesh-list
83028666|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83028667|NCT02053818|Narcotics|narcotics|mesh-ancestor
83028668|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028669|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028670|NCT02053818|Analgesics|analgesics|mesh-ancestor
83028671|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
83028672|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028673|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83028674|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83028675|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
83028676|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
83028677|NCT03702387|Anesthetics|anesthetics|mesh-list
83028678|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028679|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028680|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
83028681|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
83028682|NCT03031899|Coagulants|coagulants|mesh-ancestor
83028683|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
83028684|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028685|NCT03700905|Nivolumab|nivolumab|mesh-list
83028686|NCT03700905|Ipilimumab|ipilimumab|mesh-list
83028687|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83028688|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028689|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83028690|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028691|NCT03700749|Iodine|iodine|mesh-list
83028692|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
83028693|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83028694|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
83028695|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
83028696|NCT03700749|Povidone|povidone|mesh-list
83028697|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83028698|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028699|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
83028700|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83028701|NCT03700749|Trace Elements|trace elements|mesh-ancestor
83028702|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
83028703|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028704|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
83028705|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
83028706|NCT03086369|Paclitaxel|paclitaxel|mesh-list
83028707|NCT03086369|Gemcitabine|gemcitabine|mesh-list
83028708|NCT03086369|Olaratumab|olaratumab|mesh-list
83028709|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83028710|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028711|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83028712|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83028713|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83028714|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028715|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028716|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
83028717|NCT00101582|Cisplatin|cisplatin|mesh-list
83028718|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028719|NCT05326373|Fluorides|fluorides|mesh-list
83028720|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
83028721|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
83028722|NCT05326373|Protective Agents|protective agents|mesh-ancestor
83028723|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028724|NCT02166944|Tamoxifen|tamoxifen|mesh-list
83028725|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83028726|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
83028727|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028728|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028729|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83028730|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028731|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83028732|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83028733|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83028735|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028736|NCT04211675|Irinotecan|irinotecan|mesh-list
83028737|NCT04211675|Temozolomide|temozolomide|mesh-list
83028738|NCT04211675|Dinutuximab|dinutuximab|mesh-list
83028739|NCT04211675|Sargramostim|sargramostim|mesh-list
83028740|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83028741|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83028742|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028743|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028744|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028745|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83028746|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
83028747|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
83028748|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028749|NCT02162264|Donepezil|donepezil|mesh-list
83028750|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83028751|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028752|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028753|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
83028754|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028755|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028756|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
83028757|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
83028758|NCT03700515|Hematinics|hematinics|mesh-ancestor
83028759|NCT04740008|Nicotine|nicotine|mesh-list
83028760|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83028761|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
83028762|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028763|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028764|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83028765|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83028766|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
83028767|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028768|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028769|NCT03700359|Etoposide|etoposide|mesh-list
83028770|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83028771|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028772|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83028773|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83028774|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028775|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028776|NCT02167178|Polygeline|polygeline|mesh-list
83028777|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
83028778|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
83028779|NCT03625089|Atorvastatin|atorvastatin|mesh-list
83028780|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83028781|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83028782|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
83028783|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028784|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83028785|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83028786|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028787|NCT01378949|Morphine|morphine|mesh-list
83028788|NCT01378949|Bupivacaine|bupivacaine|mesh-list
83028790|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
83028791|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028792|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028793|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
83028794|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028795|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83028796|NCT01378949|Narcotics|narcotics|mesh-ancestor
83028797|NCT01378949|Analgesics|analgesics|mesh-ancestor
83028798|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
83028799|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83028800|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028801|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028802|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83361654|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028803|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83028804|NCT01381055|Protective Agents|protective agents|mesh-ancestor
83028805|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028806|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
83028807|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83028808|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
83028809|NCT04649229|Aprepitant|aprepitant|mesh-list
83028810|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83028811|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
83028812|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
83028813|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028814|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028815|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83028816|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83028817|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028818|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028819|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83028820|NCT03122613|Curcumin|curcumin|mesh-list
83028821|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028822|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028823|NCT03122613|Analgesics|analgesics|mesh-ancestor
83028824|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
83028825|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028826|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028827|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028828|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028829|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028830|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028831|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028832|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
83028833|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83028834|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83028835|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028836|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
83028837|NCT03540368|Coagulants|coagulants|mesh-ancestor
83028838|NCT02255396|Estradiol|estradiol|mesh-list
83028839|NCT02255396|Estrogens|estrogens|mesh-ancestor
83028840|NCT02255396|Hormones|hormones|mesh-ancestor
83028841|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028842|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028843|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
83028844|NCT02163980|Ropivacaine|ropivacaine|mesh-list
83028845|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83028846|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83028847|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028848|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028849|NCT02163980|Analgesics|analgesics|mesh-ancestor
83028850|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
83028851|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028852|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83028853|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83028854|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83028855|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
83028856|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028857|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028858|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
83028859|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
83028860|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83028861|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83028862|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
83028863|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028864|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028865|NCT01569035|Warfarin|warfarin|mesh-list
83028866|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
83028867|NCT03841565|Dexamethasone|dexamethasone|mesh-list
83028868|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
83028869|NCT03841565|Daratumumab|daratumumab|mesh-list
83028870|NCT03841565|Pomalidomide|pomalidomide|mesh-list
83028871|NCT03841565|Ichthammol|ichthammol|mesh-list
83028872|NCT03841565|BB 1101|bb 1101|mesh-list
83028873|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028874|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
83028875|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
83028876|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028877|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028878|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83028879|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
83028880|NCT03841565|Hormones|hormones|mesh-ancestor
83028881|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028882|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83028883|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028884|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
83028885|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028886|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028887|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
83028888|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83028889|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83028890|NCT03841565|Growth Substances|growth substances|mesh-ancestor
83028891|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
83028892|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83028893|NCT02162966|Colistin|colistin|mesh-list
83028894|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83028895|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83028896|NCT01595321|Leucovorin|leucovorin|mesh-list
83028897|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
83028898|NCT01595321|Fluorouracil|fluorouracil|mesh-list
83028899|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
83028900|NCT01595321|Irinotecan|irinotecan|mesh-list
83028901|NCT01595321|Folfirinox|folfirinox|mesh-list
83028902|NCT01595321|Vaccines|vaccines|mesh-list
83028903|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
83028904|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028905|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83028906|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028907|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83028908|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
83028909|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028910|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028911|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83028912|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
83028913|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83028914|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83028915|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83028916|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028917|NCT01595321|Antidotes|antidotes|mesh-ancestor
83028918|NCT01595321|Protective Agents|protective agents|mesh-ancestor
83028919|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
83028920|NCT01595321|Vitamins|vitamins|mesh-ancestor
83028921|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
83028922|NCT02164214|Etanercept|etanercept|mesh-list
83028923|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83028924|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83028925|NCT02164214|Analgesics|analgesics|mesh-ancestor
83028926|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
83028927|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028928|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028929|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83028930|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028931|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83028932|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83028933|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
83028934|NCT03722849|Adenosine|adenosine|mesh-list
83028935|NCT03722849|Capsaicin|capsaicin|mesh-list
83028936|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
83028937|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83028938|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
83028939|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028940|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028941|NCT03722849|Analgesics|analgesics|mesh-ancestor
83028942|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83028943|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
83028944|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83028945|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
83028946|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
83028947|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83028948|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028949|NCT02170844|Dabigatran|dabigatran|mesh-list
83028950|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
83028951|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83028952|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
83028953|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361655|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83028954|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028955|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
83028956|NCT02170922|Dabigatran|dabigatran|mesh-list
83028957|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
83028958|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83028959|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
83028960|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028961|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028962|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
83028963|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
83028964|NCT02167958|Fludarabine|fludarabine|mesh-list
83028965|NCT02167958|Tacrolimus|tacrolimus|mesh-list
83028966|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83028967|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
83028968|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028969|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83028970|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83028971|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
83028972|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83028973|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83028974|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83028975|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83028976|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83028977|NCT01384331|NuvaRing|nuvaring|mesh-list
83028978|NCT01384331|Desogestrel|desogestrel|mesh-list
83028979|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83028980|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
83028981|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83028982|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028983|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83028984|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83028985|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83028986|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83028987|NCT01384331|Progestins|progestins|mesh-ancestor
83028988|NCT01384331|Hormones|hormones|mesh-ancestor
83028989|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83028990|NCT03699423|Atropine|atropine|mesh-list
83028991|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83028992|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83028993|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83028994|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83028995|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83028996|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
83028997|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83028998|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83028999|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83029000|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
83029001|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
83029002|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
83029003|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83029004|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029005|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029006|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029007|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029008|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
83029009|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83029010|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029011|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029012|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83029013|NCT02164448|Analgesics|analgesics|mesh-ancestor
83029014|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
83029015|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029016|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83029017|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83029018|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83029019|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
83029020|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029021|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029022|NCT03612713|Oxycodone|oxycodone|mesh-list
83029023|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83029024|NCT03612713|Narcotics|narcotics|mesh-ancestor
83029025|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029026|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029027|NCT03612713|Analgesics|analgesics|mesh-ancestor
83029028|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
83029029|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029030|NCT01380509|Metronidazole|metronidazole|mesh-list
83029031|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029032|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83029033|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83029034|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83029035|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83029036|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83029037|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83029038|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
83029039|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029040|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83029041|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83029042|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029043|NCT04853043|Cetuximab|cetuximab|mesh-list
83029044|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029045|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029046|NCT00976131|Ubiquinone|ubiquinone|mesh-list
83029047|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
83029048|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
83029049|NCT00976131|Doxorubicin|doxorubicin|mesh-list
83029050|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83029051|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
83029052|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029053|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029054|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83029055|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
83029056|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029057|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029058|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83029059|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83029060|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83029061|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83029062|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029063|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
83029064|NCT00976131|Vitamins|vitamins|mesh-ancestor
83029065|NCT01384253|Trastuzumab|trastuzumab|mesh-list
83029066|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029067|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029068|NCT03631277|Calcium|calcium|mesh-list
83029069|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83029070|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029071|NCT02171000|Dabigatran|dabigatran|mesh-list
83029072|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
83029073|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029074|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029075|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029076|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029077|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
83029078|NCT04841265|Vitamin D|vitamin d|mesh-list
83029079|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
83029080|NCT04841265|Vitamins|vitamins|mesh-ancestor
83029081|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
83029082|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029083|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83029084|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83029085|NCT02164604|Ranibizumab|ranibizumab|mesh-list
83029086|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83029087|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83029088|NCT02164604|Growth Substances|growth substances|mesh-ancestor
83029089|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029090|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83029091|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029092|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
83029093|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83029094|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
83029095|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029096|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029097|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83029098|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
83029099|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029100|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029101|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83029102|NCT04571645|Heparin|heparin|mesh-list
83029103|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
83029104|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83029105|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83029106|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029107|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
83029108|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83029109|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
83029110|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
83029111|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029112|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029113|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83029114|NCT04050267|Analgesics|analgesics|mesh-ancestor
83029115|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
83029116|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029117|NCT02759120|Doxycycline|doxycycline|mesh-list
83029118|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83029119|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83029120|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
83029121|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
83029122|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83029123|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83029124|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83029125|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
83029126|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83029127|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
83029128|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83029129|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83029130|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83029131|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
83029132|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83029133|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029134|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83029135|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83029136|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83029137|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83029138|NCT01569113|Estrogens|estrogens|mesh-ancestor
83029139|NCT01569113|Hormones|hormones|mesh-ancestor
83029140|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029141|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83029142|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83029143|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83029144|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83029145|NCT03699033|Paclitaxel|paclitaxel|mesh-list
83029146|NCT03699033|Carboplatin|carboplatin|mesh-list
83029147|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83029148|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029149|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83029150|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83029151|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83029152|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029153|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
83029154|NCT03697239|Paclitaxel|paclitaxel|mesh-list
83029155|NCT03697239|Gemcitabine|gemcitabine|mesh-list
83029156|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83029157|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83029158|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029159|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
83029160|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
83029161|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
83029162|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029164|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
83029165|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029166|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83029167|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
83029168|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
83029169|NCT03697239|Protective Agents|protective agents|mesh-ancestor
83029170|NCT01380431|Lisinopril|lisinopril|mesh-list
83029171|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83029172|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029173|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029174|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029175|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83029176|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83029177|NCT01380431|Protective Agents|protective agents|mesh-ancestor
83029178|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029179|NCT03697161|Gaboxadol|gaboxadol|mesh-list
83029180|NCT03697161|Analgesics|analgesics|mesh-ancestor
83029181|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
83029182|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029183|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029184|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
83029185|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
83029186|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
83029187|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029188|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029189|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
83029190|NCT03164993|Doxorubicin|doxorubicin|mesh-list
83029191|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83029192|NCT03164993|Atezolizumab|atezolizumab|mesh-list
83029193|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83029194|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
83029195|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029196|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029197|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83029198|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
83029199|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029200|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029201|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83029202|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83029203|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83029204|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83029205|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029206|NCT03164993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83029207|NCT03164993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029208|NCT02171156|Nintedanib|nintedanib|mesh-list
83029209|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029210|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83029211|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029212|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029213|NCT01380353|Diclofenac|diclofenac|mesh-list
83029214|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83029215|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83029216|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83029217|NCT01380353|Analgesics|analgesics|mesh-ancestor
83029218|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
83029219|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029220|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029221|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83029222|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029223|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83029224|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029225|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029226|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
83029227|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83029228|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
83029229|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029230|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
83029231|NCT02168426|Protective Agents|protective agents|mesh-ancestor
83029232|NCT01380275|Docetaxel|docetaxel|mesh-list
83029233|NCT01380275|Irinotecan|irinotecan|mesh-list
83029234|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029235|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
83029236|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
83029237|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
83029238|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029239|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83029240|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83029241|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029242|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
83029243|NCT02171390|Testosterone|testosterone|mesh-list
83029244|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
83029245|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
83029246|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83029247|NCT02171390|Androgens|androgens|mesh-ancestor
83029248|NCT02171390|Hormones|hormones|mesh-ancestor
83029249|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029250|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029251|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83029252|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029253|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
83029254|NCT01378481|Vorinostat|vorinostat|mesh-list
83029255|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029256|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83029257|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029258|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029259|NCT02171468|Dabigatran|dabigatran|mesh-list
83029260|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
83029261|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029262|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029263|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029264|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029265|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
83029266|NCT03502031|Losartan|losartan|mesh-list
83029267|NCT03502031|Valsartan|valsartan|mesh-list
83029268|NCT03502031|Enalapril|enalapril|mesh-list
83029269|NCT03502031|Enalaprilat|enalaprilat|mesh-list
83029270|NCT03502031|Lisinopril|lisinopril|mesh-list
83029271|NCT03502031|Perindopril|perindopril|mesh-list
83029272|NCT03502031|Spironolactone|spironolactone|mesh-list
83029273|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83029274|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83029275|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83029276|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029277|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83029278|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83029279|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
83029280|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029281|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029282|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83029283|NCT03502031|Diuretics|diuretics|mesh-ancestor
83029284|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
83029285|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83029286|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029287|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029288|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83029289|NCT03502031|Protective Agents|protective agents|mesh-ancestor
83029290|NCT02171546|Fexofenadine|fexofenadine|mesh-list
83029291|NCT02171546|Quinidine|quinidine|mesh-list
83029292|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
83029293|NCT02171546|Dabigatran|dabigatran|mesh-list
83029294|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
83029295|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029296|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029297|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029298|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029299|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
83029300|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83029301|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83029302|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83029303|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
83029304|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
83029305|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029306|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029307|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83029308|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83029309|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83029310|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83029311|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
83029312|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83029313|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83029314|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029315|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83029316|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029317|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029318|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83029319|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83029320|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83029321|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83029322|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83029323|NCT02171624|Quinidine|quinidine|mesh-list
83029324|NCT02171624|Dabigatran|dabigatran|mesh-list
83029325|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
83029326|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029327|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029328|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029329|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029330|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
83029331|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83029332|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83029334|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029335|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029336|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83029337|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
83029338|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83029339|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83029340|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029341|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83029342|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029343|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029344|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83029345|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83029346|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83029347|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83029348|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83029349|NCT03705351|Temozolomide|temozolomide|mesh-list
83029350|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83029351|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
83029352|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029353|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029354|NCT03705195|Gliclazide|gliclazide|mesh-list
83029355|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83029356|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029357|NCT00101192|Cetuximab|cetuximab|mesh-list
83029358|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029359|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029360|NCT03688269|Dexamethasone|dexamethasone|mesh-list
83029361|NCT03688269|Ropivacaine|ropivacaine|mesh-list
83029362|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83029363|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
83029364|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
83029365|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029366|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029367|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83029368|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
83029369|NCT03688269|Hormones|hormones|mesh-ancestor
83029370|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029371|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83029372|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029373|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
83029374|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
83029375|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029376|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
83029377|NCT03688191|Sirolimus|sirolimus|mesh-list
83029378|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83029379|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029380|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83029381|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029382|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
83029383|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83029384|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
83029385|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029386|NCT02164838|Axitinib|axitinib|mesh-list
83029387|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029388|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83029389|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029390|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029391|NCT02171702|Afatinib|afatinib|mesh-list
83029392|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029393|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83029394|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029395|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029396|NCT02171780|Olodaterol|olodaterol|mesh-list
83029397|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83029398|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
83029399|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029400|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029401|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83029402|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
83029403|NCT02172014|Fentanyl|fentanyl|mesh-list
83029404|NCT02172014|Midazolam|midazolam|mesh-list
83029405|NCT02172014|Citric Acid|citric acid|mesh-list
83029417|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
83029418|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83029419|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83029420|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83029421|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83029422|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
83029423|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
83029424|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029425|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029426|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
83029427|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83029428|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
83029429|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
83029442|NCT02172170|Empagliflozin|empagliflozin|mesh-list
83029443|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83029444|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029445|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83029446|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029447|NCT02255942|Zinc|zinc|mesh-list
83029448|NCT02255942|Iron|iron|mesh-list
83029449|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
83029450|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
83029451|NCT02255942|Trace Elements|trace elements|mesh-ancestor
83029452|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
83029453|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029454|NCT02255942|Astringents|astringents|mesh-ancestor
83029455|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
83029456|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
83029457|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83029458|NCT02255942|Protective Agents|protective agents|mesh-ancestor
83029459|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
83029460|NCT03029247|Hematinics|hematinics|mesh-ancestor
83029461|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
83029462|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83029463|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83029464|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029465|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83029466|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83029467|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029468|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029469|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029470|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83029471|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
83029472|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83029473|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029474|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83029475|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83029476|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83029477|NCT03624309|Docetaxel|docetaxel|mesh-list
83029478|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029479|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
83029480|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
83029481|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
83029482|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029483|NCT04327791|Baloxavir|baloxavir|mesh-list
83029484|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
83029485|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029486|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029487|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029489|NCT03624231|Tremelimumab|tremelimumab|mesh-list
83029490|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029491|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029492|NCT03692013|Losartan|losartan|mesh-list
83029493|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83029494|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83029495|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83029496|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83029497|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029498|NCT03695835|Immunomodulating Agents|immunomodulating agents|mesh-list
83029499|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
83029500|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029501|NCT03687255|Tazobactam|tazobactam|mesh-list
83029502|NCT03687255|Piperacillin|piperacillin|mesh-list
83029503|NCT03687255|Cefepime|cefepime|mesh-list
83029504|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83029505|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
83029506|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83029507|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029508|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83029509|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029510|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029511|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
83029512|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83029513|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
83029514|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029515|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
83029516|NCT03691467|Protective Agents|protective agents|mesh-ancestor
83029517|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83029518|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029519|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029520|NCT02165930|Naltrexone|naltrexone|mesh-list
83029521|NCT02165930|Oxycodone|oxycodone|mesh-list
83029522|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83029523|NCT02165930|Narcotics|narcotics|mesh-ancestor
83029524|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029525|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029526|NCT02165930|Analgesics|analgesics|mesh-ancestor
83029527|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
83029528|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029529|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83029530|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83029531|NCT03694977|Spartalizumab|spartalizumab|mesh-list
83029532|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83029533|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029534|NCT03694977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029535|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029536|NCT02172248|Metformin|metformin|mesh-list
83029537|NCT02172248|Empagliflozin|empagliflozin|mesh-list
83029538|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83029539|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029540|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83029541|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029542|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
83029543|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83029544|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
83029545|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029546|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029547|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83029548|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
83029549|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
83029550|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029551|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029552|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029553|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029554|NCT02169596|Ticagrelor|ticagrelor|mesh-list
83029555|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83029556|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83029557|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83029558|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83029559|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
83029560|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029561|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029562|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029563|NCT02169752|Ambrisentan|ambrisentan|mesh-list
83029564|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83029565|NCT02172404|Ipratropium|ipratropium|mesh-list
83029566|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83029567|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
83029568|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029569|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029570|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83029571|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
83029572|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029573|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029574|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029575|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029576|NCT00109538|Lonafarnib|lonafarnib|mesh-list
83029577|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029578|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029579|NCT02172482|Bromides|bromides|mesh-list
83029580|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
83029581|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83029582|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
83029583|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029584|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029585|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83029586|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
83029587|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
83029588|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029589|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029590|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029591|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029592|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
83029593|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
83029594|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83029595|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
83029596|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029597|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029598|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83029599|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
83029600|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
83029601|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029602|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029603|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029604|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029605|NCT00106808|Pioglitazone|pioglitazone|mesh-list
83029606|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83029607|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029608|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
83029609|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83029610|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
83029611|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029612|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
83029613|NCT02166554|Protective Agents|protective agents|mesh-ancestor
83029614|NCT02174666|Vitamin D|vitamin d|mesh-list
83029615|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
83029616|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
83029617|NCT02174666|Vitamins|vitamins|mesh-list
83029618|NCT02174666|Genistein|genistein|mesh-list
83029619|NCT02174666|Biochanin A|biochanin a|mesh-list
83029620|NCT02174666|Daidzein|daidzein|mesh-list
83029621|NCT02174666|Formononetin|formononetin|mesh-list
83029622|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
83029623|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029624|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83029625|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83029626|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83029627|NCT02174666|Protective Agents|protective agents|mesh-ancestor
83029628|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029629|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83029630|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029631|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029632|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
83361656|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83029633|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83029635|NCT02174666|Hormones|hormones|mesh-ancestor
83029636|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029637|NCT03687021|Progesterone|progesterone|mesh-list
83029638|NCT03687021|Progestins|progestins|mesh-ancestor
83029639|NCT03687021|Hormones|hormones|mesh-ancestor
83029640|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029641|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029642|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
83029643|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
83029644|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029645|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
83029646|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83029647|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83029648|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
83029649|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029650|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029651|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83029652|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
83029653|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
83029654|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83029655|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029656|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029657|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029658|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83029659|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83029660|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83029661|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
83029662|NCT02174900|Lumefantrine|lumefantrine|mesh-list
83029663|NCT02174900|Artemether|artemether|mesh-list
83029664|NCT02174900|Primaquine|primaquine|mesh-list
83029665|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83029666|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
83029667|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83029668|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83029669|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029670|NCT02170610|Pantoprazole|pantoprazole|mesh-list
83029671|NCT02170610|Dabigatran|dabigatran|mesh-list
83029672|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83029673|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83029674|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83029675|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029676|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029677|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
83029678|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029679|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029680|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
83029681|NCT02173106|Cyclosporine|cyclosporine|mesh-list
83029682|NCT02173106|Cyclosporins|cyclosporins|mesh-list
83029683|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029684|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029685|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83029686|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
83029687|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029688|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
83029689|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029690|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83029691|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029692|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83029693|NCT03932721|Evolocumab|evolocumab|mesh-list
83029694|NCT03932721|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83029695|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83029696|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83029697|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
83029698|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029699|NCT03932721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029700|NCT03932721|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029701|NCT03932721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029702|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83029703|NCT00106340|Metformin|metformin|mesh-list
83029704|NCT00106340|Glimepiride|glimepiride|mesh-list
83029705|NCT00106340|Vildagliptin|vildagliptin|mesh-list
83029706|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83029707|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029708|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83029709|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83029710|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
83029711|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83029712|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029713|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029714|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029715|NCT03538496|Bupivacaine|bupivacaine|mesh-list
83029716|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
83029717|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
83029718|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029719|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029720|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
83029721|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029722|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
83029723|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83029724|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83029725|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029726|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
83029727|NCT03686787|Coagulants|coagulants|mesh-ancestor
83029729|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83029730|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83029731|NCT03694587|Analgesics|analgesics|mesh-ancestor
83029732|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
83029733|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029734|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029735|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83029736|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029737|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83029738|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029739|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029740|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83029741|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029742|NCT02170766|Pantoprazole|pantoprazole|mesh-list
83029743|NCT02170766|Dabigatran|dabigatran|mesh-list
83029744|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83029745|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83029746|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83029747|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029748|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029749|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
83029750|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029751|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029752|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
83029753|NCT04156659|Tisagenlecleucel|tisagenlecleucel|mesh-list
83029754|NCT04156659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029755|NCT04156659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029756|NCT03694119|Phenelzine|phenelzine|mesh-list
83029757|NCT03694119|Ozanimod|ozanimod|mesh-list
83029758|NCT03694119|Tyramine|tyramine|mesh-list
83029759|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83029760|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029761|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83029762|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
83029763|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029764|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
83029765|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83029766|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83029767|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029768|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
83029769|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
83029770|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029771|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83029772|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83029773|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83029774|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
83029775|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029776|NCT02178254|Fosfomycin|fosfomycin|mesh-list
83029777|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83029778|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029779|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
83029780|NCT02173262|Lenograstim|lenograstim|mesh-list
83029781|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83029782|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029783|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83361657|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029784|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83029785|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029786|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029787|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029788|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83029789|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83029790|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83029791|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
83029792|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029793|NCT02173418|Ropivacaine|ropivacaine|mesh-list
83029794|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
83029795|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
83029796|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029797|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029798|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
83029799|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029800|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
83029801|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029802|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
83029804|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83029805|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029806|NCT02178488|Vitamins|vitamins|mesh-ancestor
83029807|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
83029808|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83029809|NCT02173652|Linagliptin|linagliptin|mesh-list
83029810|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83029811|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029812|NCT02173652|Incretins|incretins|mesh-ancestor
83029813|NCT02173652|Hormones|hormones|mesh-ancestor
83029814|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029815|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83029816|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029817|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029818|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029819|NCT02173730|Pantoprazole|pantoprazole|mesh-list
83029820|NCT02173730|Dabigatran|dabigatran|mesh-list
83029821|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83029822|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83029823|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83029824|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029825|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029826|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
83029827|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83029828|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
83029829|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
83029830|NCT02175446|Bevacizumab|bevacizumab|mesh-list
83029831|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029832|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029833|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83029834|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83029835|NCT02175446|Growth Substances|growth substances|mesh-ancestor
83029836|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029837|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
83029838|NCT02178644|Capecitabine|capecitabine|mesh-list
83029839|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83029840|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
83029841|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029842|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029843|NCT03686163|Mitogens|mitogens|mesh-list
83029844|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83029845|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029846|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
83029847|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
83029848|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83029849|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
83029850|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83029851|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029852|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83029853|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83029854|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83029855|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83029856|NCT02173886|Bupropion|bupropion|mesh-list
83361658|NCT03167112|Antidotes|antidotes|mesh-ancestor
83361659|NCT03167112|Protective Agents|protective agents|mesh-ancestor
83029857|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83029858|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
83029859|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83029860|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83029861|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83029862|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83029863|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029864|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
83029865|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029866|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029867|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83029868|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83029869|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029870|NCT02173964|Pinaverium|pinaverium|mesh-list
83029871|NCT02173964|Bromides|bromides|mesh-list
83029872|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
83029873|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83029874|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83029875|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029876|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83029877|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029878|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
83029879|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
83029880|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029881|NCT02175602|Sertraline|sertraline|mesh-list
83029882|NCT02175602|Escitalopram|escitalopram|mesh-list
83029883|NCT02175602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83029884|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83029885|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83029886|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029887|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029888|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
83029889|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029890|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
83029891|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83029892|NCT03686085|Dinoprostone|dinoprostone|mesh-list
83029893|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
83029894|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83029895|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029896|NCT03693885|Oxytocin|oxytocin|mesh-list
83029897|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
83029898|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83029899|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029900|NCT02174120|Propofol|propofol|mesh-list
83029901|NCT02174120|Etomidate|etomidate|mesh-list
83029902|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83029903|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029904|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029905|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83029906|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
83029907|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
83029908|NCT02175914|Erythromycin|erythromycin|mesh-list
83029909|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
83029910|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83029911|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
83029912|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83029913|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83029914|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83029915|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83029916|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83029917|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029918|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
83029919|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83029920|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83029921|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029922|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
83029923|NCT02753816|Coagulants|coagulants|mesh-ancestor
83029924|NCT02179034|Menthol|menthol|mesh-list
83029925|NCT02179034|Nicotine|nicotine|mesh-list
83029926|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83029927|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
83029928|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029929|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029930|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83029931|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83029932|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
83029933|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029934|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029935|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
83029936|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
83029937|NCT02174588|Midazolam|midazolam|mesh-list
83029938|NCT02174588|Propofol|propofol|mesh-list
83029939|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83029940|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029941|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029942|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83029943|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
83029944|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
83029945|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83029946|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83029947|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83029948|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83029949|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
83029950|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
83029951|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83029952|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029953|NCT03693573|Bevacizumab|bevacizumab|mesh-list
83029954|NCT03693573|Atezolizumab|atezolizumab|mesh-list
83029955|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83029956|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029957|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83029958|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83029959|NCT03693573|Growth Substances|growth substances|mesh-ancestor
83029960|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029961|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
83029962|NCT03693573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83029963|NCT03693573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029964|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83029965|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
83029966|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83029967|NCT02176304|Prednisolone|prednisolone|mesh-list
83029968|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
83029969|NCT02176304|Lidocaine|lidocaine|mesh-list
83029970|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83029971|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
83029972|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
83029973|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
83029974|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83029975|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83029976|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
83029977|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83029978|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83029979|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83029980|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83029981|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83029982|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83029983|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83029984|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
83029985|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
83029986|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83029987|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
83029988|NCT02176304|Hormones|hormones|mesh-ancestor
83029989|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83029990|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83029991|NCT02176304|Protective Agents|protective agents|mesh-ancestor
83029992|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83029993|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83029994|NCT02176460|Colchicine|colchicine|mesh-list
83029995|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
83029996|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83029997|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
83029998|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
83029999|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83030000|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030001|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030002|NCT02256254|Simvastatin|simvastatin|mesh-list
83030003|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83030004|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83030005|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
83030006|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030007|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83030008|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83030009|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030010|NCT02182076|Nintedanib|nintedanib|mesh-list
83030011|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030012|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83030013|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030014|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030015|NCT02179268|Sertraline|sertraline|mesh-list
83030016|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83030017|NCT02179268|Citalopram|citalopram|mesh-list
83030018|NCT02179268|Reboxetine|reboxetine|mesh-list
83030019|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
83030020|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83030021|NCT02179268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83030022|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83030023|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83030024|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030025|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030026|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
83030027|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030028|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83030029|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83030030|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83030031|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030032|NCT02182154|Nintedanib|nintedanib|mesh-list
83030033|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030034|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83030035|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030036|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030037|NCT02182232|Paclitaxel|paclitaxel|mesh-list
83030038|NCT02182232|Carboplatin|carboplatin|mesh-list
83030039|NCT02182232|Nintedanib|nintedanib|mesh-list
83030040|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83030041|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030042|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
83030043|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
83030044|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
83030045|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030046|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83030047|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030048|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
83030049|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83030050|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030051|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83030052|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83030053|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030054|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030055|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030056|NCT02176850|Telmisartan|telmisartan|mesh-list
83030057|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83030058|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83030059|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83030060|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030061|NCT03537326|Budesonide|budesonide|mesh-list
83030062|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030063|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030064|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
83030065|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030066|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030067|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030068|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030069|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
83030070|NCT03537326|Hormones|hormones|mesh-ancestor
83030071|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030072|NCT02182544|Ketotifen|ketotifen|mesh-list
83030073|NCT02182544|Epinastine|epinastine|mesh-list
83030074|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
83030075|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
83030076|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83030077|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
83030078|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
83030079|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030080|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030081|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030082|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83030083|NCT02179658|Vancomycin|vancomycin|mesh-list
83030084|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
83030085|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83030086|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030087|NCT02177318|Bromides|bromides|mesh-list
83030088|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
83030089|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030090|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
83030091|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030092|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030093|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030094|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030095|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
83030096|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83030097|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
83030098|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030099|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030100|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
83030101|NCT02177396|Valsartan|valsartan|mesh-list
83030102|NCT02177396|Telmisartan|telmisartan|mesh-list
83030103|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83030104|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83030105|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83030106|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030107|NCT02030054|Atorvastatin|atorvastatin|mesh-list
83030108|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83030109|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83030110|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83030111|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
83030112|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030113|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83030114|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83030115|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030116|NCT02182622|Prednisone|prednisone|mesh-list
83030117|NCT02182622|Docetaxel|docetaxel|mesh-list
83030118|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030119|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83030120|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83030121|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83030122|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030123|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030124|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
83030125|NCT02182622|Hormones|hormones|mesh-ancestor
83030126|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030127|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030128|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83030129|NCT02182700|Bromides|bromides|mesh-list
83030130|NCT02182700|Albuterol|albuterol|mesh-list
83030131|NCT02182700|Ipratropium|ipratropium|mesh-list
83030132|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
83030133|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030134|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
83030135|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030136|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030137|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030138|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030139|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
83030140|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030141|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83030142|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83030143|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83030144|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030145|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030146|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030147|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83030148|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
83030150|NCT02182778|Gemcitabine|gemcitabine|mesh-list
83030151|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030152|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83030153|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
83030154|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030155|NCT03688971|Ketoconazole|ketoconazole|mesh-list
83030156|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
83030157|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030158|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83030159|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83030160|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030161|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030162|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83030163|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
83030164|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030165|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030166|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83030167|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
83030168|NCT02179814|Promethazine|promethazine|mesh-list
83030169|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83030170|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83030171|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030172|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030173|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
83030174|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
83030175|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
83030176|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030177|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
83030178|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
83030179|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83030180|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83030181|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
83030182|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
83030183|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030184|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030185|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83030186|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
83030187|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83030188|NCT02179970|Plerixafor|plerixafor|mesh-list
83030189|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83030190|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83030191|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
83030192|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030193|NCT03537950|Cannabidiol|cannabidiol|mesh-list
83030194|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
83030195|NCT02182856|Bromides|bromides|mesh-list
83030196|NCT02182856|Albuterol|albuterol|mesh-list
83030197|NCT02182856|Ipratropium|ipratropium|mesh-list
83030198|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
83030199|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030200|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
83030201|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030202|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030203|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030204|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030205|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
83030206|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030207|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83030208|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83030209|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83030210|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030211|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030212|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030213|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83030214|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
83030215|NCT02183012|Ibuprofen|ibuprofen|mesh-list
83030216|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83030217|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030218|NCT02183012|Analgesics|analgesics|mesh-ancestor
83030219|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
83030220|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030221|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030222|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030223|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030224|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83030225|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030226|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030227|NCT02180048|Caffeine|caffeine|mesh-list
83030228|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83030229|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030230|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83030231|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361660|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
83030232|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030233|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83030234|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83030235|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
83030236|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030237|NCT03688659|Vancomycin|vancomycin|mesh-list
83030238|NCT03688659|Gentamicins|gentamicins|mesh-list
83030239|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83030240|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030241|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83030242|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030243|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030244|NCT03683043|Leuprolide|leuprolide|mesh-list
83030245|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83030246|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
83030247|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030248|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030249|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83030250|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030251|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83030252|NCT02180204|Tenecteplase|tenecteplase|mesh-list
83030253|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83030254|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83030255|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030256|NCT02183090|Meloxicam|meloxicam|mesh-list
83030257|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83030258|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030259|NCT02183090|Analgesics|analgesics|mesh-ancestor
83030260|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
83030261|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030262|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030263|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030264|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030265|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83030266|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83030267|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030268|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030269|NCT02177552|Carboplatin|carboplatin|mesh-list
83030270|NCT02177552|Docetaxel|docetaxel|mesh-list
83030271|NCT02177552|Capecitabine|capecitabine|mesh-list
83030272|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
83030273|NCT02177552|Epirubicin|epirubicin|mesh-list
83030274|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030275|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
83030276|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
83030277|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
83030278|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030279|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83030280|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
83030281|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83030282|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83030283|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83030284|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030285|NCT03682653|Azithromycin|azithromycin|mesh-list
83030286|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83030287|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030288|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
83030289|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83030290|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83030291|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030293|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
83030294|NCT04062279|Autoantibodies|autoantibodies|mesh-list
83030295|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
83030296|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030297|NCT02183168|Indomethacin|indomethacin|mesh-list
83030298|NCT02183168|Meloxicam|meloxicam|mesh-list
83030299|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83030300|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030301|NCT02183168|Analgesics|analgesics|mesh-ancestor
83030302|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
83030303|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030304|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030305|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030306|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030307|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
83030308|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
83030309|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030310|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83030311|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030312|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030313|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83030314|NCT02183246|Porfiromycin|porfiromycin|mesh-list
83030315|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83030316|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030317|NCT02183324|Linagliptin|linagliptin|mesh-list
83030318|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83030319|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030320|NCT02183324|Incretins|incretins|mesh-ancestor
83030321|NCT02183324|Hormones|hormones|mesh-ancestor
83030322|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030323|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83030324|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
83030325|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030326|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030327|NCT02183402|Linagliptin|linagliptin|mesh-list
83030328|NCT02183402|Digoxin|digoxin|mesh-list
83030329|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83030330|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83030331|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030332|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030333|NCT02183402|Protective Agents|protective agents|mesh-ancestor
83030334|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030335|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83030336|NCT02183402|Incretins|incretins|mesh-ancestor
83030337|NCT02183402|Hormones|hormones|mesh-ancestor
83030338|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030339|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83030340|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
83030341|NCT02183480|Linagliptin|linagliptin|mesh-list
83030342|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83030343|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030344|NCT02183480|Incretins|incretins|mesh-ancestor
83030345|NCT02183480|Hormones|hormones|mesh-ancestor
83030346|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030347|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83030348|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
83030349|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030350|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030351|NCT05141864|Lidocaine|lidocaine|mesh-list
83030352|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
83030353|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
83030354|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030355|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030356|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
83030357|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030358|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83030359|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83030360|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83030361|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83030362|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030363|NCT02180516|Meloxicam|meloxicam|mesh-list
83030364|NCT02180516|Etodolac|etodolac|mesh-list
83030365|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83030366|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83030367|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030368|NCT02180516|Analgesics|analgesics|mesh-ancestor
83030369|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
83030370|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030371|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030372|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030373|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83030374|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83030375|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030376|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030377|NCT02183636|Pioglitazone|pioglitazone|mesh-list
83030378|NCT02183636|Linagliptin|linagliptin|mesh-list
83030379|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83361661|NCT03167112|Vitamins|vitamins|mesh-ancestor
83030380|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030381|NCT02183636|Incretins|incretins|mesh-ancestor
83030382|NCT02183636|Hormones|hormones|mesh-ancestor
83030383|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030384|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83030385|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
83030386|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030387|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030388|NCT02183948|Oxytocin|oxytocin|mesh-list
83030389|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
83030390|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030391|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030392|NCT02184104|Caffeine|caffeine|mesh-list
83030393|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83030394|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030395|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83030396|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030397|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030398|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83030399|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83030400|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
83030401|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030402|NCT02184260|Dipyrone|dipyrone|mesh-list
83030403|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83030404|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030405|NCT02184260|Analgesics|analgesics|mesh-ancestor
83030406|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
83030407|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030408|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030409|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030410|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030411|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
83030412|NCT03813147|Cytarabine|cytarabine|mesh-list
83030413|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
83030414|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83030415|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83030416|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83030417|NCT03813147|Methotrexate|methotrexate|mesh-list
83030418|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
83030419|NCT03813147|Azacitidine|azacitidine|mesh-list
83030420|NCT03813147|Fludarabine|fludarabine|mesh-list
83030421|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83030422|NCT03813147|Pevonedistat|pevonedistat|mesh-list
83030423|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83030424|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
83030425|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030426|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030427|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83030428|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
83030429|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030430|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030431|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
83030432|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83030433|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83030434|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
83030435|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030436|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83030437|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
83030438|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030439|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030441|NCT03684837|Vitamins|vitamins|mesh-ancestor
83030442|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
83030443|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030444|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83030445|NCT03810417|Digoxin|digoxin|mesh-list
83030446|NCT03810417|Antibodies|antibodies|mesh-list
83030447|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
83030448|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
83030449|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030450|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83030451|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83030452|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030453|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030454|NCT03810417|Protective Agents|protective agents|mesh-ancestor
83030455|NCT03808155|Tamsulosin|tamsulosin|mesh-list
83030456|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83030457|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83030458|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83030459|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030460|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030461|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030462|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030463|NCT03808155|Urological Agents|urological agents|mesh-ancestor
83030464|NCT02752958|Fluorides|fluorides|mesh-list
83030465|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
83030466|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
83030467|NCT02752958|Protective Agents|protective agents|mesh-ancestor
83030468|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030469|NCT02181218|Dexamethasone|dexamethasone|mesh-list
83030470|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
83030471|NCT02181218|Gemcitabine|gemcitabine|mesh-list
83030472|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
83030473|NCT02181218|Romidepsin|romidepsin|mesh-list
83030474|NCT02181218|BB 1101|bb 1101|mesh-list
83030475|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030476|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
83030477|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
83030478|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030479|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030480|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83030481|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
83030482|NCT02181218|Hormones|hormones|mesh-ancestor
83030483|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030484|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83030485|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030486|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
83030487|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030488|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030489|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83030490|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
83030491|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83030492|NCT02181218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83030493|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83030494|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
83030495|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83030496|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
83030497|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030498|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030499|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83030500|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83030501|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030502|NCT03682497|Spironolactone|spironolactone|mesh-list
83030503|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83030504|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
83030505|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030506|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030507|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83030508|NCT03682497|Diuretics|diuretics|mesh-ancestor
83030509|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
83030510|NCT02185898|Menthol|menthol|mesh-list
83030511|NCT02185898|Nicotine|nicotine|mesh-list
83030512|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83030513|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
83030514|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030515|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030516|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83030517|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83030518|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
83030519|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030520|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030521|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
83030522|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
83030523|NCT02805660|Durvalumab|durvalumab|mesh-list
83030524|NCT02805660|Mocetinostat|mocetinostat|mesh-list
83030525|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83030526|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030527|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83030528|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030529|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030530|NCT02186132|Atropine|atropine|mesh-list
83361662|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
83030531|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83030532|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83030533|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030534|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
83030535|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030536|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030537|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030538|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030539|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
83030540|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
83030541|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83030542|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83030543|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
83030544|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030545|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030546|NCT03536780|Gemcitabine|gemcitabine|mesh-list
83030547|NCT03536780|Avelumab|avelumab|mesh-list
83030548|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83030549|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
83030550|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030551|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030552|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83030553|NCT02052336|Clarithromycin|clarithromycin|mesh-list
83030554|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83030555|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030556|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83030557|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030558|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030559|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83030560|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83030561|NCT02181920|Dipyrone|dipyrone|mesh-list
83030562|NCT02181920|Diclofenac|diclofenac|mesh-list
83030563|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83030564|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030565|NCT02181920|Analgesics|analgesics|mesh-ancestor
83030566|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
83030567|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030568|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030569|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030570|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030571|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83030572|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030573|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030574|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
83030575|NCT02185118|Sevoflurane|sevoflurane|mesh-list
83030576|NCT02185118|Isoflurane|isoflurane|mesh-list
83030577|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83030578|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83030579|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
83030580|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
83030581|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030582|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030583|NCT02186366|Buspirone|buspirone|mesh-list
83030584|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83030585|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83030586|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030588|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83030589|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83030590|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
83030591|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030592|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030593|NCT02053974|Spironolactone|spironolactone|mesh-list
83030594|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83030595|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
83030596|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030597|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030598|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83030599|NCT02053974|Diuretics|diuretics|mesh-ancestor
83030600|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
83030601|NCT02185196|Vitamin D|vitamin d|mesh-list
83030602|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
83030603|NCT02185196|Vitamins|vitamins|mesh-ancestor
83030604|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
83030605|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030606|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83030607|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83030608|NCT02052492|Vitamin D|vitamin d|mesh-list
83030609|NCT02052492|Vitamins|vitamins|mesh-ancestor
83030610|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
83030611|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030612|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83030613|NCT02181998|Heparin|heparin|mesh-list
83030614|NCT02181998|Enoxaparin|enoxaparin|mesh-list
83030615|NCT02181998|Tenecteplase|tenecteplase|mesh-list
83030616|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
83030617|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83030618|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83030619|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030620|NCT02054052|Bevacizumab|bevacizumab|mesh-list
83030621|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83030622|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030623|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83030624|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83030625|NCT02054052|Growth Substances|growth substances|mesh-ancestor
83030626|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030627|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
83030628|NCT02185352|Cisplatin|cisplatin|mesh-list
83030629|NCT02185352|Etoposide|etoposide|mesh-list
83030630|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030631|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83030632|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83030633|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83030634|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030635|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030636|NCT02186600|Vitamin D|vitamin d|mesh-list
83030637|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
83030638|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
83030639|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
83030640|NCT02186600|Calcium|calcium|mesh-list
83030641|NCT02186600|Vitamins|vitamins|mesh-ancestor
83030642|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
83030643|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030644|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83030645|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83030646|NCT02186600|Antacids|antacids|mesh-ancestor
83030647|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030648|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83030649|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83030650|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83030651|NCT02052726|Vaccines|vaccines|mesh-list
83030652|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
83030653|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030654|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
83030655|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83030656|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030657|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030658|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030659|NCT02185430|Analgesics|analgesics|mesh-ancestor
83030660|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
83030661|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030662|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83030663|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83030664|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83030665|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030666|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030667|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030668|NCT03536390|Methylphenidate|methylphenidate|mesh-list
83030669|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83030670|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030671|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83030672|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83030673|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83030674|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030675|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
83030676|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030677|NCT03561870|Olaparib|olaparib|mesh-list
83030678|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83030679|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030680|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030681|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030683|NCT02186990|Etomidate|etomidate|mesh-list
83030684|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83030685|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030686|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030687|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83030688|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
83030689|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
83030690|NCT05657028|Lidocaine|lidocaine|mesh-list
83030691|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
83030692|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
83030693|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
83030694|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030695|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030696|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
83030697|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030698|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83030699|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83437758|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
83030700|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83030701|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83030702|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030703|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83030704|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030705|NCT05657028|Analgesics|analgesics|mesh-ancestor
83030706|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83030707|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83030708|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83030709|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030710|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030711|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
83030712|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83030713|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030714|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030715|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030716|NCT02187068|Analgesics|analgesics|mesh-ancestor
83030717|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
83030718|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030719|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83030720|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83030721|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83030722|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030723|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030724|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030725|NCT02054442|Methotrexate|methotrexate|mesh-list
83030726|NCT02054442|Cetuximab|cetuximab|mesh-list
83030727|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83030728|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
83030729|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030730|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030731|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83030732|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
83030733|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030734|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030735|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
83030736|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030737|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83030738|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83030739|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
83030740|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030741|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83030742|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83030743|NCT02054676|Ibuprofen|ibuprofen|mesh-list
83030744|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83030745|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030746|NCT02054676|Analgesics|analgesics|mesh-ancestor
83030747|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
83030748|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030749|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030750|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030751|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030752|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83030753|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030754|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030755|NCT02256956|Amitriptyline|amitriptyline|mesh-list
83030756|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83030757|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83030758|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
83030759|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83030760|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030761|NCT02256956|Analgesics|analgesics|mesh-ancestor
83030762|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
83030763|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030764|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030765|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83030766|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83030767|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83030768|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030769|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030770|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030771|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83030772|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83030773|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
83030774|NCT02256956|Urological Agents|urological agents|mesh-ancestor
83030775|NCT02187536|Telmisartan|telmisartan|mesh-list
83030776|NCT02187536|Simvastatin|simvastatin|mesh-list
83030777|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83030778|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83030779|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
83030780|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030781|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83030782|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83030783|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030784|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83030785|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83030786|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83030787|NCT02256722|Propranolol|propranolol|mesh-list
83030788|NCT02256722|Bisoprolol|bisoprolol|mesh-list
83030789|NCT02256722|Acipimox|acipimox|mesh-list
83030790|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83030791|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030792|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
83030793|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030794|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030795|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030796|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030797|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83030798|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83030799|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83030800|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030801|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030802|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030803|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83030804|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83030805|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83030806|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83030807|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
83030808|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
83030809|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83030810|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83030811|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
83030812|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83030813|NCT02193620|Nalbuphine|nalbuphine|mesh-list
83030814|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83030815|NCT02193620|Narcotics|narcotics|mesh-ancestor
83030816|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030817|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030818|NCT02193620|Analgesics|analgesics|mesh-ancestor
83030819|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
83030820|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030821|NCT02187614|Acetaminophen|acetaminophen|mesh-list
83030822|NCT02187614|Diclofenac|diclofenac|mesh-list
83030823|NCT02187614|Morphine|morphine|mesh-list
83030824|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83030825|NCT02187614|Narcotics|narcotics|mesh-ancestor
83030826|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030827|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030829|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
83030830|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030831|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83030832|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
83030833|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83030834|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030835|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83030836|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83030837|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030838|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030839|NCT02030678|Irinotecan|irinotecan|mesh-list
83030840|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83030841|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83030842|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030843|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030844|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030845|NCT02054988|Caffeine|caffeine|mesh-list
83030846|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83030847|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030848|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83030849|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030850|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030851|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83030852|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83030853|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
83030854|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030855|NCT02191124|Mirtazapine|mirtazapine|mesh-list
83030856|NCT02191124|Paroxetine|paroxetine|mesh-list
83030857|NCT02191124|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83030858|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83030859|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83030860|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030861|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030862|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
83030863|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030864|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83030865|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
83030866|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83030867|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83030868|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83030869|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030870|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83030871|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
83030872|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
83030873|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83030874|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83030875|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83030876|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83030877|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83030878|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83030879|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030880|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83030881|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83030882|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83030884|NCT02193698|Lenalidomide|lenalidomide|mesh-list
83030885|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030886|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
83030887|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
83030888|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030889|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030890|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83030891|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
83030892|NCT02193698|Hormones|hormones|mesh-ancestor
83030893|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030894|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83030895|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030896|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
83030897|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83030898|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83030899|NCT02193698|Growth Substances|growth substances|mesh-ancestor
83030900|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
83030901|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83030902|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83030903|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83030904|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030905|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
83030906|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83030907|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83030908|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83030909|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83030910|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83437768|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
83030911|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030912|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030913|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030914|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
83030915|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83030916|NCT02191280|Quercetin|quercetin|mesh-list
83030917|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
83030918|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030919|NCT02191280|Protective Agents|protective agents|mesh-ancestor
83030920|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030921|NCT02055378|Atropine|atropine|mesh-list
83030922|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83030923|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83030924|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030925|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
83030926|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030927|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030928|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030929|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030930|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
83030931|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
83030932|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83030933|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83030934|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
83030935|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030936|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030937|NCT04558190|Ubiquinone|ubiquinone|mesh-list
83030938|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83030939|NCT04558190|Albuterol|albuterol|mesh-list
83030940|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83030941|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
83030942|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030943|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030944|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83030945|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
83030946|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
83030947|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83030948|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83030949|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83030950|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83030951|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
83030952|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83030953|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030954|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83030955|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83030956|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83030957|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
83030958|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83030959|NCT02055456|Nandrolone|nandrolone|mesh-list
83030960|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83030961|NCT02055456|Androgens|androgens|mesh-ancestor
83030962|NCT02055456|Hormones|hormones|mesh-ancestor
83030963|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030964|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030965|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
83030966|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83030967|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83030968|NCT03676959|Antibodies|antibodies|mesh-list
83030969|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
83030970|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83030971|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
83361663|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
83361664|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
83030972|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030973|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83030974|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83030976|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83030977|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030978|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83030979|NCT02056938|Basiliximab|basiliximab|mesh-list
83030980|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
83030981|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030982|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83030983|NCT02191670|Tenecteplase|tenecteplase|mesh-list
83030984|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83030985|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83030986|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030987|NCT02057094|Caseins|caseins|mesh-list
83030988|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
83030989|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
83030990|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83030991|NCT02917941|Dexamethasone|dexamethasone|mesh-list
83030992|NCT02917941|Lenalidomide|lenalidomide|mesh-list
83030993|NCT02917941|Ixazomib|ixazomib|mesh-list
83030994|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83030995|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
83030996|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
83030997|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83030998|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83030999|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83031000|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
83031001|NCT02917941|Hormones|hormones|mesh-ancestor
83031002|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031003|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83031004|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031005|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
83031006|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83031007|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83031008|NCT02917941|Growth Substances|growth substances|mesh-ancestor
83031009|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
83031010|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
83031011|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031012|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031013|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
83031014|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83031015|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031016|NCT02191748|Triamcinolone|triamcinolone|mesh-list
83031017|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031018|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
83031019|NCT02191748|Hormones|hormones|mesh-ancestor
83031020|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031021|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031022|NCT02191826|Tolcapone|tolcapone|mesh-list
83031023|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83031024|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83031025|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83031026|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031027|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031028|NCT01333956|Pregabalin|pregabalin|mesh-list
83031029|NCT01333956|Analgesics|analgesics|mesh-ancestor
83031030|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
83031031|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031032|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031033|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
83031034|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83031035|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83031036|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031037|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83031038|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83031039|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83031040|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031041|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83031042|NCT02057328|Telmisartan|telmisartan|mesh-list
83031043|NCT02057328|Nebivolol|nebivolol|mesh-list
83031044|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83031045|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83031046|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83031047|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031049|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83031050|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83031051|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83031052|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
83031053|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031054|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031055|NCT02057484|Tacrolimus|tacrolimus|mesh-list
83031056|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83031057|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
83031058|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031059|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83031060|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031061|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031062|NCT02192060|Triclosan|triclosan|mesh-list
83031063|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83031064|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031065|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83031066|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83031067|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
83031068|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031069|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83031070|NCT02188394|Bupivacaine|bupivacaine|mesh-list
83031071|NCT02188394|Anesthetics|anesthetics|mesh-list
83031072|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
83031073|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031074|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031075|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
83031076|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031077|NCT01333722|Acetaminophen|acetaminophen|mesh-list
83031078|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83031079|NCT01333722|Hydrocodone|hydrocodone|mesh-list
83031080|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031081|NCT01333722|Analgesics|analgesics|mesh-ancestor
83031082|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
83031083|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031084|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031085|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
83031086|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83031087|NCT01333722|Narcotics|narcotics|mesh-ancestor
83031088|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031089|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
83031090|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
83031091|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83031092|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031093|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031094|NCT02188472|Trimethoprim|trimethoprim|mesh-list
83031095|NCT02188472|Penicillins|penicillins|mesh-list
83031096|NCT02188472|Penicillin V|penicillin v|mesh-list
83031097|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83031098|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031099|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
83031100|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83031101|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83031102|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83031103|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031104|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031105|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83031106|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83031107|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83031108|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031110|NCT02188550|Letrozole|letrozole|mesh-list
83031111|NCT02188550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83031112|NCT02188550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83031113|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031114|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031115|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83031116|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
83031117|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031118|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031119|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83031120|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83031121|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83031122|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
83031123|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031124|NCT02059590|Isavuconazole|isavuconazole|mesh-list
83031125|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
83031126|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031127|NCT02057796|Efavirenz|efavirenz|mesh-list
83031128|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83437771|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
83031129|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83031130|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83031131|NCT02057796|Rifampin|rifampin|mesh-list
83031132|NCT02057796|Isoniazid|isoniazid|mesh-list
83031133|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
83031134|NCT02057796|Ethambutol|ethambutol|mesh-list
83031135|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83031136|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83031137|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031138|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031139|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
83031140|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031141|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83031142|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83031143|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83031144|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83031145|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83031146|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83031147|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83031148|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83031149|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83031150|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
83031151|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031152|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
83031153|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83031154|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83031155|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83031156|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83031157|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83031158|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
83031159|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83031160|NCT02192450|Insulin|insulin|mesh-list
83031161|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83031162|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
83031163|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
83031164|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83031165|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031166|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031167|NCT03284385|Adavosertib|adavosertib|mesh-list
83031168|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031169|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031170|NCT03560856|Fulvestrant|fulvestrant|mesh-list
83031171|NCT03560856|Palbociclib|palbociclib|mesh-list
83031172|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83031173|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031174|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83031175|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83031176|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
83031177|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031178|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031179|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83031180|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031181|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031182|NCT03676413|Fluticasone|fluticasone|mesh-list
83031183|NCT03676413|Xhance|xhance|mesh-list
83031184|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83031185|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83031186|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031187|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83031188|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
83031189|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031190|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361665|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83031191|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83031192|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
83031193|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
83031194|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83031195|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83031196|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83031197|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83031198|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
83031199|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031200|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031201|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
83031202|NCT03676413|Hormones|hormones|mesh-ancestor
83031203|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031204|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
83031205|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83031206|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83031207|NCT01370694|Prednisolone|prednisolone|mesh-list
83031208|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
83031209|NCT01370694|Vincristine|vincristine|mesh-list
83031210|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83031211|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
83031212|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031213|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031214|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83031215|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
83031216|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031217|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031218|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83031219|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83031220|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83031221|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
83031222|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83031223|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031224|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
83031225|NCT01370694|Hormones|hormones|mesh-ancestor
83031226|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031227|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83031228|NCT02256878|Amitriptyline|amitriptyline|mesh-list
83031229|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83031230|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
83031231|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83031232|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031233|NCT02256878|Analgesics|analgesics|mesh-ancestor
83031234|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
83031235|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031236|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031237|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83031238|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83031239|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83031240|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031241|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
83031242|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031243|NCT02058186|Vitamin D|vitamin d|mesh-list
83031244|NCT02058186|Vitamins|vitamins|mesh-ancestor
83031245|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
83031246|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031247|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83031248|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
83031249|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83031250|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83031251|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031253|NCT03676023|Coagulants|coagulants|mesh-ancestor
83031254|NCT02260206|Colchicine|colchicine|mesh-list
83031255|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
83031256|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031257|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83031258|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83031259|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83031260|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031261|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031262|NCT02058576|Tamsulosin|tamsulosin|mesh-list
83031263|NCT02058576|Dutasteride|dutasteride|mesh-list
83031264|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83031265|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83031266|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83031267|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
83031268|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031269|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031270|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031271|NCT02058576|Urological Agents|urological agents|mesh-ancestor
83031272|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83031273|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83031274|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031275|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
83031276|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031277|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83031278|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
83031279|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83031280|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031281|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031282|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83031283|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83031284|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83031285|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
83031286|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031287|NCT02189720|Amifampridine|amifampridine|mesh-list
83031288|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83031289|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031290|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031291|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83031292|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83031293|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031294|NCT03675555|Dexamethasone|dexamethasone|mesh-list
83031295|NCT03675555|Mirtazapine|mirtazapine|mesh-list
83031296|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83031297|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031298|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
83031299|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
83031300|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031301|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031302|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83031303|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
83031304|NCT03675555|Hormones|hormones|mesh-ancestor
83031305|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031306|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83031307|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031308|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
83031309|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83031310|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83031311|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
83031312|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
83031313|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031314|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031315|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83031316|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83031317|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031318|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83031319|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83031320|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83031321|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
83031322|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83031323|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83031324|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
83031325|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83031326|NCT02194166|Paclitaxel|paclitaxel|mesh-list
83031327|NCT02194166|Docetaxel|docetaxel|mesh-list
83031328|NCT02194166|Trastuzumab|trastuzumab|mesh-list
83031329|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83031330|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031331|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
83031332|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
83031333|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
83031334|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031335|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83031336|NCT02194322|Olcegepant|olcegepant|mesh-list
83031337|NCT02194322|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83361666|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
83031338|NCT02194322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031339|NCT02194322|Analgesics|analgesics|mesh-ancestor
83031340|NCT02194322|Sensory System Agents|sensory system agents|mesh-ancestor
83031341|NCT02194322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031342|NCT02194322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031343|NCT02193308|Amlodipine|amlodipine|mesh-list
83031344|NCT02193308|Telmisartan|telmisartan|mesh-list
83031345|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83031346|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83031347|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83031348|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83031349|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031350|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83031351|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031352|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
83031353|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83031354|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83031355|NCT02060604|Ketorolac|ketorolac|mesh-list
83031356|NCT02060604|Ranibizumab|ranibizumab|mesh-list
83031357|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83031358|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83031359|NCT02060604|Growth Substances|growth substances|mesh-ancestor
83031360|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031361|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83031362|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031363|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83031364|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031365|NCT02060604|Analgesics|analgesics|mesh-ancestor
83031366|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
83031367|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031368|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031369|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031370|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83031371|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031372|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031373|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
83031374|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83031375|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031376|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83031377|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83031378|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031379|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031380|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031381|NCT02194556|Gemcitabine|gemcitabine|mesh-list
83031382|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83031383|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
83031384|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031385|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031386|NCT02030912|Amoxicillin|amoxicillin|mesh-list
83031387|NCT02030912|Minocycline|minocycline|mesh-list
83031388|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031389|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031390|NCT02060916|PAZ320|paz320|mesh-list
83031391|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031392|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031393|NCT02797080|Interferons|interferons|mesh-list
83031394|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
83031395|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031396|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
83031397|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031398|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
83031399|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83031400|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
83031401|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031402|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031403|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83031404|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
83031405|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
83031406|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83031407|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
83031408|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031409|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031410|NCT02915835|Riociguat|riociguat|mesh-list
83031411|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
83031412|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031413|NCT01370616|Amoxicillin|amoxicillin|mesh-list
83031414|NCT01370616|Tazobactam|tazobactam|mesh-list
83031415|NCT01370616|Piperacillin|piperacillin|mesh-list
83031416|NCT01370616|Ertapenem|ertapenem|mesh-list
83031417|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83031418|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031419|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031420|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83031421|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031422|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031423|NCT02688881|Sirolimus|sirolimus|mesh-list
83031424|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031425|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031426|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83031427|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031428|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
83031429|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83031430|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
83031431|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031432|NCT03560310|Ticagrelor|ticagrelor|mesh-list
83031433|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83031434|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83031435|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83031436|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83031437|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
83031438|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031439|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031440|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031441|NCT02197286|Vitamin D|vitamin d|mesh-list
83031442|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
83031443|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
83031444|NCT02197286|Vitamins|vitamins|mesh-list
83031445|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
83031446|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031447|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83031448|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83031449|NCT02197442|Valsartan|valsartan|mesh-list
83031450|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83031451|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83031452|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83031453|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031454|NCT03534674|Vitamin D|vitamin d|mesh-list
83031455|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
83031456|NCT03534674|Vitamins|vitamins|mesh-ancestor
83031457|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
83031458|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031459|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83031460|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83031461|NCT02063334|Vitamin D|vitamin d|mesh-list
83031462|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
83031463|NCT02063334|Vitamins|vitamins|mesh-ancestor
83031465|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031466|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83031467|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83031468|NCT02916927|Ketamine|ketamine|mesh-list
83031469|NCT02916927|Analgesics|analgesics|mesh-ancestor
83031470|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
83031471|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031472|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031473|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83031474|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83031475|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
83031476|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
83031477|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031478|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83031479|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83031480|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031481|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031482|NCT02197598|Nalmefene|nalmefene|mesh-list
83031483|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83031484|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031485|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
83031486|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031487|NCT02196662|Mesalamine|mesalamine|mesh-list
83031488|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83031489|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031490|NCT02196662|Analgesics|analgesics|mesh-ancestor
83031491|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
83031492|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031493|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031494|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031495|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031496|NCT02195180|Leucovorin|leucovorin|mesh-list
83031497|NCT02195180|Gemcitabine|gemcitabine|mesh-list
83031498|NCT02195180|Fluorouracil|fluorouracil|mesh-list
83031499|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
83031500|NCT02195180|Asparaginase|asparaginase|mesh-list
83031501|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83031502|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
83031503|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031504|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031505|NCT02195180|Antidotes|antidotes|mesh-ancestor
83031506|NCT02195180|Protective Agents|protective agents|mesh-ancestor
83031507|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031508|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
83031509|NCT02195180|Vitamins|vitamins|mesh-ancestor
83031510|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
83031511|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83031512|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
83031513|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
83031514|NCT03623529|Giapreza|giapreza|mesh-list
83031515|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
83031516|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83031517|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83031518|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
83031519|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031520|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031521|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
83031522|NCT03161379|Nivolumab|nivolumab|mesh-list
83031523|NCT03161379|Pancrelipase|pancrelipase|mesh-list
83031524|NCT03161379|Vaccines|vaccines|mesh-list
83031525|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
83031526|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031527|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83031528|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031529|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83031530|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
83031531|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031532|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031533|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83031534|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83031535|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83031536|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83031537|NCT02197676|Guadecitabine|guadecitabine|mesh-list
83031538|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031539|NCT02916693|Mirabegron|mirabegron|mesh-list
83031540|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83031541|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83031542|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83031543|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83031544|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031545|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031546|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031547|NCT02916693|Urological Agents|urological agents|mesh-ancestor
83031548|NCT02195336|Paclitaxel|paclitaxel|mesh-list
83031549|NCT02195336|Bevacizumab|bevacizumab|mesh-list
83031550|NCT02195336|Carboplatin|carboplatin|mesh-list
83031551|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83031552|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031553|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83031554|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
83031555|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83031556|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031557|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83031558|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83031559|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83031560|NCT02195336|Growth Substances|growth substances|mesh-ancestor
83031561|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361667|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031562|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
83031563|NCT03679065|Acetaminophen|acetaminophen|mesh-list
83031564|NCT03679065|Dexamethasone|dexamethasone|mesh-list
83031565|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
83031566|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83031567|NCT03679065|BB 1101|bb 1101|mesh-list
83031568|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031569|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
83031570|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
83031571|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031572|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031573|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83031574|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
83031575|NCT03679065|Hormones|hormones|mesh-ancestor
83031576|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031577|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83031578|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031579|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
83031580|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031581|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031582|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031583|NCT03679065|Analgesics|analgesics|mesh-ancestor
83031584|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
83031585|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
83031586|NCT02196740|Metronidazole|metronidazole|mesh-list
83031587|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
83031588|NCT02196740|Clindamycin|clindamycin|mesh-list
83031589|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
83031590|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
83031591|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
83031592|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031593|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031594|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83031595|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83031596|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83031597|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83031598|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031599|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031600|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031601|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83031602|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83031603|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83031604|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83031605|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83031606|NCT02195492|Hylan|hylan|mesh-list
83031607|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
83031608|NCT02195492|Protective Agents|protective agents|mesh-ancestor
83031609|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031610|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
83031611|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83031612|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031613|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83031614|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
83031615|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031616|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031617|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031618|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031619|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
83031620|NCT02919345|Glyburide|glyburide|mesh-list
83031621|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83031622|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031623|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031624|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031625|NCT02195804|Ranitidine|ranitidine|mesh-list
83031626|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83031627|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83031628|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83031629|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83031630|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
83031631|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
83031632|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031633|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031634|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031635|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
83031636|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
83031638|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031639|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031640|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
83031641|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031642|NCT03674463|Immunomodulating Agents|immunomodulating agents|mesh-list
83031643|NCT03674463|Immunologic Factors|immunologic factors|mesh-ancestor
83031644|NCT03674463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031645|NCT03674385|Vitamin E|vitamin e|mesh-list
83031646|NCT03674385|Metformin|metformin|mesh-list
83031647|NCT03674385|Clomiphene|clomiphene|mesh-list
83031648|NCT03674385|Enclomiphene|enclomiphene|mesh-list
83031649|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
83031650|NCT03674385|Vitamins|vitamins|mesh-ancestor
83031651|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
83031652|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031653|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031654|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031655|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
83031656|NCT03674385|Protective Agents|protective agents|mesh-ancestor
83031657|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83031658|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
83031659|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031660|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83031661|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
83031662|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83031663|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83031664|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83031665|NCT02574455|Gemcitabine|gemcitabine|mesh-list
83031666|NCT02574455|Capecitabine|capecitabine|mesh-list
83031667|NCT02574455|Vinorelbine|vinorelbine|mesh-list
83031668|NCT02574455|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83031669|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83031670|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
83031671|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031672|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031673|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83031674|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
83031675|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
83031676|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
83031677|NCT02574455|Immunoconjugates|immunoconjugates|mesh-ancestor
83031678|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
83031679|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031680|NCT02197988|Fentanyl|fentanyl|mesh-list
83031681|NCT02197988|Bupivacaine|bupivacaine|mesh-list
83031682|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
83031683|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
83031684|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031685|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031686|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
83031687|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031688|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83031689|NCT02197988|Narcotics|narcotics|mesh-ancestor
83031690|NCT02197988|Analgesics|analgesics|mesh-ancestor
83031691|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83031692|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83031693|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
83031694|NCT03672357|Liver Extracts|liver extracts|mesh-list
83031695|NCT03672357|Hematinics|hematinics|mesh-ancestor
83031696|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83031697|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
83031698|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031699|NCT03674073|Vaccines|vaccines|mesh-list
83031700|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
83031701|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031702|NCT03673995|Inositol|inositol|mesh-list
83031703|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
83031704|NCT03673995|Vitamins|vitamins|mesh-ancestor
83031705|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
83031706|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031707|NCT01378091|Prednisone|prednisone|mesh-list
83031708|NCT01378091|Docetaxel|docetaxel|mesh-list
83031709|NCT01378091|Lenalidomide|lenalidomide|mesh-list
83031710|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031711|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
83031712|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
83031713|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
83031714|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031715|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031717|NCT01378091|Hormones|hormones|mesh-ancestor
83031718|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031719|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031720|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83031721|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
83031722|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83031723|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83031724|NCT01378091|Growth Substances|growth substances|mesh-ancestor
83031725|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
83031726|NCT02794974|Anesthetics|anesthetics|mesh-list
83031727|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031728|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031729|NCT02063568|Oxytocin|oxytocin|mesh-list
83031730|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
83031731|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83031732|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031733|NCT02257502|Aflibercept|aflibercept|mesh-list
83031734|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83031735|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83031736|NCT02257502|Growth Substances|growth substances|mesh-ancestor
83031737|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031738|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
83031739|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031740|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
83031741|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83031742|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031743|NCT02907099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83031744|NCT02907099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031745|NCT02450123|Sunitinib|sunitinib|mesh-list
83031746|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031747|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83031748|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83031749|NCT02450123|Growth Substances|growth substances|mesh-ancestor
83031750|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031751|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
83031752|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83031753|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031754|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031755|NCT02063802|Metformin|metformin|mesh-list
83031756|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031757|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031758|NCT03672045|Carbetocin|carbetocin|mesh-list
83031759|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
83031760|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83031761|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031762|NCT02198300|Clopidogrel|clopidogrel|mesh-list
83031763|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83031764|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83031765|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83031766|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83031767|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
83031768|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031769|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031770|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031771|NCT03560232|Clindamycin|clindamycin|mesh-list
83031772|NCT03560232|Gentamicins|gentamicins|mesh-list
83031773|NCT03560232|Cefazolin|cefazolin|mesh-list
83031774|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
83031775|NCT03560232|Tazobactam|tazobactam|mesh-list
83031776|NCT03560232|Piperacillin|piperacillin|mesh-list
83031777|NCT03560232|Ampicillin|ampicillin|mesh-list
83031778|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83031779|NCT03560232|Sulbactam|sulbactam|mesh-list
83031780|NCT03560232|Sultamicillin|sultamicillin|mesh-list
83031781|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031782|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031783|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83031784|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031785|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031786|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83031787|NCT02201342|Udenafil|udenafil|mesh-list
83031788|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83031789|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83031790|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031791|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031793|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
83031794|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83031795|NCT02201576|Antibodies|antibodies|mesh-list
83031796|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
83031797|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83031798|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031799|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
83031800|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031801|NCT02198378|Acetaminophen|acetaminophen|mesh-list
83031802|NCT02198378|Morphine|morphine|mesh-list
83031803|NCT02198378|Entonox|entonox|mesh-list
83031804|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83031805|NCT02198378|Narcotics|narcotics|mesh-ancestor
83031806|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031807|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031808|NCT02198378|Analgesics|analgesics|mesh-ancestor
83031809|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
83031810|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031811|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031812|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
83031813|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83031814|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
83031815|NCT02063100|Losartan|losartan|mesh-list
83031816|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83031817|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83031818|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83031819|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83031820|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031821|NCT02198846|Insulin|insulin|mesh-list
83031822|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031823|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031824|NCT02198924|Celecoxib|celecoxib|mesh-list
83031825|NCT02198924|Parecoxib|parecoxib|mesh-list
83031826|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83031827|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031828|NCT02198924|Analgesics|analgesics|mesh-ancestor
83031829|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
83031830|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031831|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031832|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031833|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031834|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83031835|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83031836|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031837|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031838|NCT05462093|Liver Extracts|liver extracts|mesh-list
83031839|NCT05462093|Hematinics|hematinics|mesh-ancestor
83031840|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
83031841|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031842|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031843|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83031844|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83031845|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031846|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031847|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031849|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031850|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83031851|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031852|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031853|NCT02064504|Fluticasone|fluticasone|mesh-list
83031854|NCT02064504|Xhance|xhance|mesh-list
83031855|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031856|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83031857|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
83031858|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031859|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031860|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83031861|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83031862|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
83031863|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83031864|NCT02067936|Remifentanil|remifentanil|mesh-list
83031865|NCT02067936|Propofol|propofol|mesh-list
83031866|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83031867|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031868|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031869|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83031870|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
83031872|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83031873|NCT02067936|Narcotics|narcotics|mesh-ancestor
83031874|NCT02067936|Analgesics|analgesics|mesh-ancestor
83031875|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
83031876|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031877|NCT01377545|Anesthetics|anesthetics|mesh-list
83031878|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
83031879|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031880|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031881|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
83031882|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031883|NCT01379807|Docetaxel|docetaxel|mesh-list
83031884|NCT01379807|Panitumumab|panitumumab|mesh-list
83031885|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031886|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83031887|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83031888|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83031889|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031890|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83031891|NCT02202512|Naproxen|naproxen|mesh-list
83031892|NCT02202512|Cimetidine|cimetidine|mesh-list
83031893|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83031894|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83031895|NCT02202512|Analgesics|analgesics|mesh-ancestor
83031896|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
83031897|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031898|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031899|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83031900|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83031901|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
83031902|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83031903|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031904|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031905|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83031906|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83031907|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83031908|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
83031909|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
83031910|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031911|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83031912|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83031913|NCT02065752|Metformin|metformin|mesh-list
83031914|NCT02065752|Canagliflozin|canagliflozin|mesh-list
83031915|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83031916|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031917|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83031918|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031919|NCT02206490|Naltrexone|naltrexone|mesh-list
83031920|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
83031921|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83031922|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83031923|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031924|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
83031925|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031926|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
83031927|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
83031928|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83031929|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83031930|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83031931|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031932|NCT02068170|Azithromycin|azithromycin|mesh-list
83031933|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
83031934|NCT02068170|Clarithromycin|clarithromycin|mesh-list
83031935|NCT02068170|Levofloxacin|levofloxacin|mesh-list
83031936|NCT02068170|Erythromycin|erythromycin|mesh-list
83031937|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
83031938|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83031939|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
83031940|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83031941|NCT02068170|Itraconazole|itraconazole|mesh-list
83031942|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83031943|NCT02068170|Fluconazole|fluconazole|mesh-list
83031944|NCT02068170|Ketoconazole|ketoconazole|mesh-list
83031945|NCT02068170|Voriconazole|voriconazole|mesh-list
83031946|NCT02068170|Sunitinib|sunitinib|mesh-list
83031947|NCT02068170|Methadone|methadone|mesh-list
83031948|NCT02068170|Haloperidol|haloperidol|mesh-list
83031949|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
83031950|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83031951|NCT02068170|Tacrolimus|tacrolimus|mesh-list
83031952|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83031953|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
83031954|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83031955|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83031956|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83031957|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83031958|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83031959|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83031960|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83031961|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83031962|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83031963|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83031964|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
83031965|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83031966|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83031967|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83031968|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83031969|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83031970|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83031971|NCT02068170|Growth Substances|growth substances|mesh-ancestor
83031972|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
83031973|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83031974|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83031975|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83031976|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83031977|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
83031978|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83031979|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83031980|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
83031981|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83031982|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83031983|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83031984|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83031985|NCT02068170|Narcotics|narcotics|mesh-ancestor
83031986|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83031987|NCT02068170|Analgesics|analgesics|mesh-ancestor
83031988|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
83031989|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83031990|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
83031991|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
83031992|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83031993|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83031994|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
83031995|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
83031996|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83031997|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83031998|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83031999|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83032000|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83032001|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
83032002|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032003|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83032004|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
83032005|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83032006|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83032007|NCT05545020|Chromium|chromium|mesh-list
83032008|NCT05545020|Trace Elements|trace elements|mesh-ancestor
83032009|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
83032010|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032011|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
83032012|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
83032013|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83032014|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032015|NCT02206646|Tenecteplase|tenecteplase|mesh-list
83032016|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83361668|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83032017|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83032018|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032020|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032021|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032022|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83032023|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032024|NCT02068404|Nifedipine|nifedipine|mesh-list
83032025|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83032026|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83032027|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032028|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83032029|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032030|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
83032031|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
83032032|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83032033|NCT02068482|Rifaximin|rifaximin|mesh-list
83032034|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032035|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032036|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032037|NCT02206802|Minoxidil|minoxidil|mesh-list
83032038|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83032039|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
83032040|NCT02065986|Tenofovir|tenofovir|mesh-list
83032041|NCT02065986|Emtricitabine|emtricitabine|mesh-list
83032042|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83032043|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
83032044|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032045|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83032046|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83032047|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032048|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032049|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83032050|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83032051|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83032052|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
83032053|NCT02068560|Coagulants|coagulants|mesh-ancestor
83032054|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83032055|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
83032056|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032057|NCT01377103|Testosterone|testosterone|mesh-list
83032058|NCT01377103|Androgens|androgens|mesh-ancestor
83032059|NCT01377103|Hormones|hormones|mesh-ancestor
83032060|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032061|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032062|NCT01377025|Sorafenib|sorafenib|mesh-list
83032063|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032064|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83032065|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032066|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032067|NCT02342275|Propranolol|propranolol|mesh-list
83032068|NCT02342275|Atenolol|atenolol|mesh-list
83032069|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83032070|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83032071|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
83032072|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032073|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032074|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032075|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83032076|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83032077|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
83032078|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
83032079|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
83032080|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032081|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83032082|NCT01827553|Gemcitabine|gemcitabine|mesh-list
83032083|NCT01827553|Folfirinox|folfirinox|mesh-list
83032084|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032085|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
83032086|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032087|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032088|NCT02207348|Liraglutide|liraglutide|mesh-list
83032089|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83361669|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83032090|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032091|NCT02207348|Incretins|incretins|mesh-ancestor
83032092|NCT02207348|Hormones|hormones|mesh-ancestor
83032093|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032094|NCT02066454|Apixaban|apixaban|mesh-list
83032095|NCT02066454|Anticoagulants|anticoagulants|mesh-list
83032096|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83032097|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
83032098|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83032099|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032100|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032101|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032102|NCT00979693|Psilocybin|psilocybin|mesh-list
83032103|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
83032104|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032105|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83032106|NCT02207426|Tobramycin|tobramycin|mesh-list
83032107|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032108|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032109|NCT00777491|Cisplatin|cisplatin|mesh-list
83032110|NCT00777491|Gemcitabine|gemcitabine|mesh-list
83032111|NCT00777491|Fluorouracil|fluorouracil|mesh-list
83032112|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032113|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032114|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
83032115|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032116|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83032117|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
83032118|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032119|NCT02199392|Lenvatinib|lenvatinib|mesh-list
83032120|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032121|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83032122|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032123|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032124|NCT05320627|Edoxaban|edoxaban|mesh-list
83032125|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83032126|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
83032127|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83032128|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032129|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032130|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032131|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
83032132|NCT03559920|Propofol|propofol|mesh-list
83032133|NCT03559920|Anesthetics|anesthetics|mesh-list
83032134|NCT03559920|Sevoflurane|sevoflurane|mesh-list
83032135|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83032136|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032137|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032138|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83032139|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
83032140|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83032141|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83032142|NCT02203760|Gemcitabine|gemcitabine|mesh-list
83032143|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032144|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
83032145|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032146|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032147|NCT03703271|Methotrexate|methotrexate|mesh-list
83032148|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83032149|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
83032150|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83032151|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83437805|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
83032152|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032153|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
83032154|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032155|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032156|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
83032157|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032158|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83032159|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83032160|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
83032161|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83032162|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83032163|NCT03532802|Metoprolol|metoprolol|mesh-list
83032164|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83032165|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83032166|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
83032167|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
83032168|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032169|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032170|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83032171|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83032172|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83032173|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
83032174|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032175|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032176|NCT03430531|Lidocaine|lidocaine|mesh-list
83032177|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
83032178|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
83032179|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032180|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032181|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
83032182|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032183|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83032184|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83032185|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83032186|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83032187|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032188|NCT02066532|Trastuzumab|trastuzumab|mesh-list
83032189|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032190|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032191|NCT05763329|Lemborexant|lemborexant|mesh-list
83032192|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83032193|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032194|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032195|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83032196|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83032197|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032198|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032199|NCT04088513|Aspirin|aspirin|mesh-list
83032200|NCT04088513|Clopidogrel|clopidogrel|mesh-list
83032201|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83032202|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83032203|NCT04088513|Analgesics|analgesics|mesh-ancestor
83032204|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
83032205|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032206|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032207|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83032208|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83032209|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83032210|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83032211|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032212|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83032213|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83032214|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032215|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
83032216|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83032217|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83032218|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83032219|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
83032220|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032221|NCT02207660|Fluorouracil|fluorouracil|mesh-list
83032222|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032223|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
83032224|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032225|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032226|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83032227|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
83032228|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032229|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
83032230|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83032231|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032232|NCT02069418|Alovudine|alovudine|mesh-list
83032233|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83032234|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83032235|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032236|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
83032237|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361670|NCT03167034|Acetazolamide|acetazolamide|mesh-list
83032238|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
83032239|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032240|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032241|NCT03386357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83032242|NCT03386357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032243|NCT02208128|Bevacizumab|bevacizumab|mesh-list
83032244|NCT02208128|Sunitinib|sunitinib|mesh-list
83032245|NCT02208128|Everolimus|everolimus|mesh-list
83032246|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032247|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032248|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83032249|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83032250|NCT02208128|Growth Substances|growth substances|mesh-ancestor
83032251|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032252|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
83032253|NCT02208128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83032254|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83032255|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032256|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032257|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83032258|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
83032259|NCT02066610|Selenium|selenium|mesh-list
83032260|NCT02066610|Selenious Acid|selenious acid|mesh-list
83032261|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
83032262|NCT02066610|Selenic Acid|selenic acid|mesh-list
83032263|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
83032264|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032265|NCT02066610|Protective Agents|protective agents|mesh-ancestor
83032266|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032267|NCT02066610|Trace Elements|trace elements|mesh-ancestor
83032268|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
83032269|NCT03077711|Trimethoprim|trimethoprim|mesh-list
83032270|NCT03077711|Methenamine|methenamine|mesh-list
83032271|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
83032272|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
83032273|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83032274|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032275|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
83032276|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83032277|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83032278|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83032279|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032280|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032281|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83032282|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83032283|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83032284|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032285|NCT04374019|Artesunate|artesunate|mesh-list
83032286|NCT04374019|Ivermectin|ivermectin|mesh-list
83032287|NCT04374019|Camostat|camostat|mesh-list
83032288|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
83032289|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83032290|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83032291|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032292|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032293|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
83032294|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
83032295|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83032296|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
83032297|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032298|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032299|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032300|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83032301|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83032302|NCT02069808|Leuprolide|leuprolide|mesh-list
83032303|NCT02069808|Menotropins|menotropins|mesh-list
83032304|NCT02069808|Ganirelix|ganirelix|mesh-list
83032305|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83032306|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
83032307|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83032308|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032309|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83032310|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361671|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
83032311|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
83032312|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032313|NCT03673605|Warfarin|warfarin|mesh-list
83032314|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
83032315|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
83032316|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83032317|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
83032318|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83032319|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032320|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032321|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032322|NCT02069886|Deferasirox|deferasirox|mesh-list
83032323|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83032324|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
83032325|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
83032326|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032327|NCT04311463|Paroxetine|paroxetine|mesh-list
83032328|NCT04311463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83032329|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83032330|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83032331|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032332|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032333|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
83032334|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032335|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83032336|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
83032337|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83032338|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83032339|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83032340|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032341|NCT02065128|Capsaicin|capsaicin|mesh-list
83032342|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
83032343|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
83032344|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
83032345|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032346|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032347|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
83032348|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83032349|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
83032350|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032351|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
83032352|NCT03677895|Protective Agents|protective agents|mesh-ancestor
83032353|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83032354|NCT04295005|Empagliflozin|empagliflozin|mesh-list
83032355|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83032356|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032357|NCT04295005|Incretins|incretins|mesh-ancestor
83032358|NCT04295005|Hormones|hormones|mesh-ancestor
83032359|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032360|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83032361|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032362|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032363|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032364|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83032365|NCT03174353|Lanreotide|lanreotide|mesh-list
83032366|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032367|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83032368|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032369|NCT03054363|Letrozole|letrozole|mesh-list
83032370|NCT03054363|Palbociclib|palbociclib|mesh-list
83032371|NCT03054363|Tucatinib|tucatinib|mesh-list
83032372|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032373|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83032374|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83032375|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032376|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032377|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83032378|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
83032379|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032380|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032381|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83032382|NCT04080947|Montelukast|montelukast|mesh-list
83032383|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83032384|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
83032385|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83032386|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
83084035|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032387|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032388|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032389|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83032390|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83032391|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032393|NCT02066688|Vitamin D|vitamin d|mesh-list
83032394|NCT02066688|Folic Acid|folic acid|mesh-list
83032395|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
83032396|NCT02066688|Calcium|calcium|mesh-list
83032397|NCT02066688|Vitamins|vitamins|mesh-ancestor
83032398|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
83032399|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032400|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83032401|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83032402|NCT02066688|Hematinics|hematinics|mesh-ancestor
83032403|NCT03671733|Liraglutide|liraglutide|mesh-list
83032404|NCT03671733|Exenatide|exenatide|mesh-list
83032405|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83032406|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032407|NCT03671733|Incretins|incretins|mesh-ancestor
83032408|NCT03671733|Hormones|hormones|mesh-ancestor
83032409|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032410|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83032411|NCT03119363|Methamphetamine|methamphetamine|mesh-list
83032412|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83032413|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032414|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
83032415|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
83032416|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032417|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
83032418|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032419|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032420|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
83032421|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83032422|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83032423|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83032424|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83032425|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
83032426|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032427|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032428|NCT03671655|Paclitaxel|paclitaxel|mesh-list
83032429|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83032430|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032431|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83032432|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83032433|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83032434|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032435|NCT02200094|Telmisartan|telmisartan|mesh-list
83032436|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83437814|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
83032437|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83032438|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83032439|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032441|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83032442|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032443|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83032444|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032445|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032446|NCT03248297|Amoxicillin|amoxicillin|mesh-list
83032447|NCT03248297|Azithromycin|azithromycin|mesh-list
83032448|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032449|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032450|NCT02208596|Pentazocine|pentazocine|mesh-list
83032451|NCT02208596|Propofol|propofol|mesh-list
83032452|NCT02208596|Etomidate|etomidate|mesh-list
83032453|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83032454|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032455|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032456|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83032457|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
83032458|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
83032459|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83032460|NCT02208596|Narcotics|narcotics|mesh-ancestor
83032461|NCT02208596|Analgesics|analgesics|mesh-ancestor
83032462|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
83032463|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032464|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83032465|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83032466|NCT02070120|Mitomycins|mitomycins|mesh-list
83032467|NCT02070120|Mitomycin|mitomycin|mesh-list
83032468|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83032469|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032470|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
83032471|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032472|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83032473|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032474|NCT02200172|Melatonin|melatonin|mesh-list
83032475|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
83032476|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032477|NCT02200172|Protective Agents|protective agents|mesh-ancestor
83032478|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032479|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032480|NCT03673137|Gemcitabine|gemcitabine|mesh-list
83032481|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032482|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
83032483|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032484|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032485|NCT02066844|Betamethasone|betamethasone|mesh-list
83032486|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
83032487|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83032488|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
83032489|NCT02066844|Lidocaine|lidocaine|mesh-list
83032490|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83032491|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
83032492|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
83032493|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032494|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032495|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
83032496|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032497|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83032498|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83032499|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83032500|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83032501|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032502|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83032503|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
83032504|NCT02066844|Hormones|hormones|mesh-ancestor
83032505|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032506|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83032507|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
83032508|NCT03669783|Dactinomycin|dactinomycin|mesh-list
83032509|NCT03669783|Carboplatin|carboplatin|mesh-list
83032510|NCT03669783|Doxorubicin|doxorubicin|mesh-list
83032511|NCT03669783|Etoposide|etoposide|mesh-list
83032512|NCT03669783|Vincristine|vincristine|mesh-list
83032513|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032514|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83032515|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83032516|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83032517|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032518|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032519|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83032520|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032521|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032522|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83032523|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83032524|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
83032525|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
83032526|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
83032527|NCT02067078|Dexamethasone|dexamethasone|mesh-list
83032528|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
83032529|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83032530|NCT02067078|Clonidine|clonidine|mesh-list
83032531|NCT02067078|Epinephrine|epinephrine|mesh-list
83032532|NCT02067078|Racepinephrine|racepinephrine|mesh-list
83032533|NCT02067078|Ropivacaine|ropivacaine|mesh-list
83032534|NCT02067078|Bupivacaine|bupivacaine|mesh-list
83032535|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
83032536|NCT02067078|BB 1101|bb 1101|mesh-list
83032537|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83032538|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
83032539|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
83032540|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032541|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032542|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032543|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
83032545|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032546|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83032547|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032548|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032549|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032550|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032551|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
83032552|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
83032553|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032554|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
83032555|NCT02067078|Analgesics|analgesics|mesh-ancestor
83032556|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83032557|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
83032558|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83032559|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83032560|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83032561|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
83032562|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032563|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83032564|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83032565|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83032566|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
83032567|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
83032568|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
83032569|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83032570|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83032571|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83032572|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83032573|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83032574|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
83032575|NCT05461235|Nivolumab|nivolumab|mesh-list
83032576|NCT05461235|Tislelizumab|tislelizumab|mesh-list
83032577|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032578|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032579|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83032580|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032581|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83032582|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83032583|NCT02070198|Hormones|hormones|mesh-ancestor
83032584|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032585|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032586|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
83032587|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83032588|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
83032589|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83032590|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83032591|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83032593|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
83032594|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83032595|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83032596|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032597|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
83032598|NCT02918201|Coagulants|coagulants|mesh-ancestor
83032599|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83032600|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83032601|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83032602|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83032603|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032604|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032605|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032606|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
83032607|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83032608|NCT02204852|Iloprost|iloprost|mesh-list
83032609|NCT02204852|Eptifibatide|eptifibatide|mesh-list
83032610|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83032611|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
83032613|NCT02070510|Warfarin|warfarin|mesh-list
83032614|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
83032615|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83032616|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032617|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032618|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032619|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83032620|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83032621|NCT02070510|Protective Agents|protective agents|mesh-ancestor
83032622|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032623|NCT02200562|Ipilimumab|ipilimumab|mesh-list
83032624|NCT02200562|Dabrafenib|dabrafenib|mesh-list
83032625|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032626|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032627|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83032628|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032629|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83032630|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032631|NCT02200640|Losartan|losartan|mesh-list
83032632|NCT02200640|Telmisartan|telmisartan|mesh-list
83032633|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83032634|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83032635|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83032636|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83032637|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032638|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
83032639|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83032640|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
83032641|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032642|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83032643|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
83032644|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83032645|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
83032646|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83032647|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032648|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83032649|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83032650|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032651|NCT02067780|Levofloxacin|levofloxacin|mesh-list
83032652|NCT02067780|Ofloxacin|ofloxacin|mesh-list
83032653|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83032654|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032655|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032656|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83032657|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83032658|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032659|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032660|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032661|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83032662|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83032663|NCT02205164|Aprepitant|aprepitant|mesh-list
83032664|NCT02205164|Palonosetron|palonosetron|mesh-list
83032665|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
83032666|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
83032667|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032668|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032669|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032670|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83032671|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032672|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032673|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83032674|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83032675|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
83032676|NCT02071212|Ticagrelor|ticagrelor|mesh-list
83032677|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83032678|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83032679|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83032680|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83032681|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
83032682|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032683|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032684|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032685|NCT02072382|Metformin|metformin|mesh-list
83032686|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83032687|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032688|NCT02205242|Azithromycin|azithromycin|mesh-list
83032689|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032690|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032691|NCT02071368|Metformin|metformin|mesh-list
83032692|NCT02071368|Canagliflozin|canagliflozin|mesh-list
83032693|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83032694|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032695|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83032696|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032697|NCT03402841|Olaparib|olaparib|mesh-list
83032698|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83032699|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032700|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032701|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032702|NCT02205398|Cetuximab|cetuximab|mesh-list
83032703|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032704|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032705|NCT04130659|Omeprazole|omeprazole|mesh-list
83032706|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83032707|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032708|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83032709|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032710|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032711|NCT02220608|Bortezomib|bortezomib|mesh-list
83032712|NCT02220608|Lenograstim|lenograstim|mesh-list
83032713|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83032714|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
83032715|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032716|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032717|NCT03630367|Dexamethasone|dexamethasone|mesh-list
83032718|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83032719|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
83032720|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
83032721|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032722|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032723|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032724|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
83032725|NCT03630367|Hormones|hormones|mesh-ancestor
83032726|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032727|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83032728|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032729|NCT02258282|Etanercept|etanercept|mesh-list
83032730|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83032731|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83032732|NCT02258282|Analgesics|analgesics|mesh-ancestor
83032733|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
83032734|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032735|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032736|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83032737|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83032738|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032739|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83032740|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
83032741|NCT02076594|Docetaxel|docetaxel|mesh-list
83032742|NCT02076594|Capecitabine|capecitabine|mesh-list
83032743|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
83032744|NCT02076594|Epirubicin|epirubicin|mesh-list
83032745|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032746|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
83032747|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
83032748|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
83032749|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032750|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032751|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
83032752|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83032753|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83032754|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83032755|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032756|NCT04175509|Acetaminophen|acetaminophen|mesh-list
83032757|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83032758|NCT04175509|Analgesics|analgesics|mesh-ancestor
83032759|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
83084036|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
83032760|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032761|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032762|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
83032763|NCT02220842|Atezolizumab|atezolizumab|mesh-list
83032764|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
83032765|NCT02220842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83032766|NCT02220842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032767|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032768|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032769|NCT02205554|Tramadol|tramadol|mesh-list
83032770|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83032771|NCT02205554|Narcotics|narcotics|mesh-ancestor
83032772|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032773|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032774|NCT02205554|Analgesics|analgesics|mesh-ancestor
83032775|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
83032776|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032777|NCT02076750|Vitamin D|vitamin d|mesh-list
83032778|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
83032779|NCT02076750|Vitamins|vitamins|mesh-ancestor
83032780|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
83032781|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032782|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83032783|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83032784|NCT05262608|Olaparib|olaparib|mesh-list
83032785|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83032786|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032787|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032788|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032789|NCT01380457|Dronabinol|dronabinol|mesh-list
83032790|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
83032791|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032792|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83032793|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83032794|NCT01380457|Analgesics|analgesics|mesh-ancestor
83032795|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
83032796|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032797|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83032798|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83032799|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032800|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032801|NCT01380457|Hormones|hormones|mesh-ancestor
83032802|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032803|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83032804|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032805|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032806|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032807|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83032808|NCT01380301|Miltefosine|miltefosine|mesh-list
83032809|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
83032810|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032811|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032812|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83032813|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83032814|NCT02076828|Zinc|zinc|mesh-list
83032815|NCT02076828|Glycine|glycine|mesh-list
83032816|NCT02076828|Trace Elements|trace elements|mesh-ancestor
83032817|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
83032818|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032819|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
83032820|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83032821|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032822|NCT02221154|Folic Acid|folic acid|mesh-list
83032823|NCT02221154|Hematinics|hematinics|mesh-ancestor
83032824|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
83032825|NCT02221154|Vitamins|vitamins|mesh-ancestor
83032826|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
83032827|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032828|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
83032829|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83032830|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032831|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83032832|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83361672|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83032833|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032834|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032835|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032836|NCT03787849|Anesthetics|anesthetics|mesh-list
83032837|NCT03787849|Propofol|propofol|mesh-list
83032838|NCT03787849|Sevoflurane|sevoflurane|mesh-list
83032839|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032840|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032841|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83032842|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83032843|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
83032844|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83032845|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83032846|NCT03777319|Prednisolone|prednisolone|mesh-list
83032847|NCT03777319|Spironolactone|spironolactone|mesh-list
83032848|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83032849|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
83032850|NCT03777319|Hormones|hormones|mesh-ancestor
83032851|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032852|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032853|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83032854|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032855|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83032856|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
83032857|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83032858|NCT03777319|Diuretics|diuretics|mesh-ancestor
83032859|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
83032860|NCT03671265|Apatinib|apatinib|mesh-list
83032861|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032862|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83032863|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032864|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032865|NCT02881957|Vitamin D|vitamin d|mesh-list
83032866|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
83032867|NCT02881957|Vitamins|vitamins|mesh-ancestor
83032868|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
83032869|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032870|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83032871|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83032872|NCT02206022|Remifentanil|remifentanil|mesh-list
83032873|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83032874|NCT02206022|Narcotics|narcotics|mesh-ancestor
83032875|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032876|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032877|NCT02206022|Analgesics|analgesics|mesh-ancestor
83032878|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
83032879|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032880|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
83032881|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83032882|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
83032883|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032884|NCT02073552|Protective Agents|protective agents|mesh-ancestor
83032885|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032886|NCT02073552|Vitamins|vitamins|mesh-ancestor
83032887|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
83032888|NCT02073552|Laxatives|laxatives|mesh-ancestor
83032889|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83032890|NCT02210156|Micronutrients|micronutrients|mesh-list
83032891|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032892|NCT02080026|Chloroquine|chloroquine|mesh-list
83032893|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83032894|NCT02080026|Atovaquone|atovaquone|mesh-list
83032895|NCT02080026|Proguanil|proguanil|mesh-list
83032896|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83032897|NCT02080026|Amebicides|amebicides|mesh-ancestor
83032898|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83032899|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83032900|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032901|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
83032902|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83032903|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83032904|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83032905|NCT02080026|Analgesics|analgesics|mesh-ancestor
83032906|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
83032907|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032908|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032909|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83032910|NCT02080026|Filaricides|filaricides|mesh-ancestor
83032911|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
83032912|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
83032913|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032914|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032915|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
83032916|NCT02206178|Acetaminophen|acetaminophen|mesh-list
83032917|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
83032918|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83032919|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83032920|NCT02206178|Analgesics|analgesics|mesh-ancestor
83032921|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
83032922|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83032923|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032924|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
83032925|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
83032926|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032927|NCT02206178|Expectorants|expectorants|mesh-ancestor
83032928|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
83032929|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83032930|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
83032931|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032932|NCT02206178|Protective Agents|protective agents|mesh-ancestor
83032933|NCT02206178|Antidotes|antidotes|mesh-ancestor
83032934|NCT02080104|Oxytocin|oxytocin|mesh-list
83032935|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
83032936|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83032937|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032938|NCT03463057|Atezolizumab|atezolizumab|mesh-list
83032939|NCT03463057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83032940|NCT03463057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032941|NCT03463057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83032942|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032943|NCT02211326|Warfarin|warfarin|mesh-list
83032944|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
83032945|NCT02691793|Sunitinib|sunitinib|mesh-list
83032946|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83032947|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83032948|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83032949|NCT02691793|Growth Substances|growth substances|mesh-ancestor
83032950|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032951|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
83032952|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83032953|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032954|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032955|NCT02221622|Pregnanolone|pregnanolone|mesh-list
83032956|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83032957|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
83032958|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032959|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032960|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
83032961|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83032962|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
83032963|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032964|NCT02080182|Expectorants|expectorants|mesh-ancestor
83032965|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83032966|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83032967|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
83476457|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83032968|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032969|NCT02080182|Protective Agents|protective agents|mesh-ancestor
83032970|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032971|NCT02080182|Antidotes|antidotes|mesh-ancestor
83032972|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
83032973|NCT02750930|Incretins|incretins|mesh-ancestor
83032974|NCT02750930|Hormones|hormones|mesh-ancestor
83032975|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83032976|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83032977|NCT02080416|Nelfinavir|nelfinavir|mesh-list
83032978|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83032979|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83032980|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
83032981|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83032982|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032983|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83032984|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83032985|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
83032986|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83032987|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
83032988|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83032989|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83032990|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83032991|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
83032992|NCT02080494|Coagulants|coagulants|mesh-ancestor
83032993|NCT02213744|Gemcitabine|gemcitabine|mesh-list
83032994|NCT02213744|Capecitabine|capecitabine|mesh-list
83032995|NCT02213744|Trastuzumab|trastuzumab|mesh-list
83032996|NCT02213744|Vinorelbine|vinorelbine|mesh-list
83032997|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83032998|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
83032999|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033000|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033001|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033002|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83033003|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
83033004|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
83033005|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83033006|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
83033007|NCT01378741|Propofol|propofol|mesh-list
83033008|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83033009|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033010|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033011|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033012|NCT01378741|Analgesics|analgesics|mesh-ancestor
83033013|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
83033014|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033015|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83033016|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83033017|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83033018|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033019|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033020|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033021|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83033022|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
83033023|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
83033024|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
83033025|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033026|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83033027|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033028|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033029|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
83033030|NCT02225054|Ropivacaine|ropivacaine|mesh-list
83033031|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83033032|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033033|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033034|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033035|NCT02225054|Analgesics|analgesics|mesh-ancestor
83033036|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
83033037|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033038|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83033039|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83033040|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83033041|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033042|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033043|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033044|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
83033045|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
83033046|NCT02080728|Ropivacaine|ropivacaine|mesh-list
83033047|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
83033048|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
83033049|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033050|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033051|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
83033052|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033053|NCT03078907|Selexipag|selexipag|mesh-list
83033054|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83033055|NCT02225210|Fentanyl|fentanyl|mesh-list
83033056|NCT02225210|Midazolam|midazolam|mesh-list
83033057|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
83033058|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83033059|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033060|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033061|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033062|NCT02225210|Analgesics|analgesics|mesh-ancestor
83033063|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
83033064|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361673|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033065|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83033066|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83033067|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83033068|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033069|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033070|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033071|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83033073|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83033074|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83033075|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
83033076|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
83033077|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83033078|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83033079|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83033080|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
83033081|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
83033082|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
83033083|NCT02217020|Irinotecan|irinotecan|mesh-list
83033084|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033085|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83033086|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83033087|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033088|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033089|NCT03249714|Ofatumumab|ofatumumab|mesh-list
83033090|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83033091|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033092|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
83033093|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033094|NCT02222168|BI 409306|bi 409306|mesh-list
83033095|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83033096|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033097|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033098|NCT02925117|Upadacitinib|upadacitinib|mesh-list
83033099|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83033100|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83033101|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033102|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033103|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033104|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
83033105|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83033106|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033107|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
83033108|NCT02225756|Cyclosporine|cyclosporine|mesh-list
83033109|NCT02225756|Cyclosporins|cyclosporins|mesh-list
83033110|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033111|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033112|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83033113|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
83033114|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033115|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
83033116|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033117|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83033118|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033119|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83033120|NCT02225834|Atorvastatin|atorvastatin|mesh-list
83033121|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83033122|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83033123|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
83033124|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033125|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83033126|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83033127|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033128|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
83033129|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033130|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
83033131|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83033132|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033133|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83033134|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83033135|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033136|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033137|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033138|NCT02074800|Siltuximab|siltuximab|mesh-list
83033139|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83033140|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033141|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
83033142|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033144|NCT04504045|Efavirenz|efavirenz|mesh-list
83033145|NCT04504045|Losartan|losartan|mesh-list
83033146|NCT04504045|Metoprolol|metoprolol|mesh-list
83033147|NCT04504045|Midazolam|midazolam|mesh-list
83033148|NCT04504045|Caffeine|caffeine|mesh-list
83033149|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83033150|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033151|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83033152|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83033153|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033154|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83033155|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83033156|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83033157|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83033158|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
83033159|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
83033160|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
83033161|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
83033162|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033163|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033164|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83033165|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83033166|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83033167|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83033168|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83033169|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83033170|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033171|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83033172|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83033173|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
83033174|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83033175|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83033176|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
83033177|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033178|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83033179|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83033180|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83033181|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83033182|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83033183|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83033184|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
83033185|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
83033186|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033187|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83033188|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83033189|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83033190|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033191|NCT03283488|Megestrol|megestrol|mesh-list
83033192|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
83033193|NCT03283488|Mirtazapine|mirtazapine|mesh-list
83033194|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
83033195|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83033196|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83033197|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
83033198|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
83033199|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033200|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033201|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033202|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83033203|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83033204|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033205|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83033206|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83033207|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83033208|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033209|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83033210|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83033211|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
83033212|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83033213|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83033214|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83033215|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83033217|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83033218|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83033219|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83033220|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83033221|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033222|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
83033223|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83033225|NCT02258204|Analgesics|analgesics|mesh-ancestor
83033226|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
83033227|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033228|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033229|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83033230|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83033231|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
83033232|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
83033233|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033234|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83033235|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83033236|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033237|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033238|NCT02226068|Cyclosporine|cyclosporine|mesh-list
83033239|NCT02226068|Cyclosporins|cyclosporins|mesh-list
83033240|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033241|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033242|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83033243|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
83033244|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033245|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
83033246|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033247|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
83033248|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033249|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83033250|NCT02220218|Metformin|metformin|mesh-list
83033251|NCT02220218|Canagliflozin|canagliflozin|mesh-list
83033252|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83033253|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033254|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83033255|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033256|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83033257|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83033258|NCT02222480|Diuretics|diuretics|mesh-ancestor
83033259|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
83033260|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033261|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83033262|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83033263|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033264|NCT03670875|Curcumin|curcumin|mesh-list
83033265|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83033266|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033267|NCT03670875|Analgesics|analgesics|mesh-ancestor
83033268|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
83033269|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033270|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033271|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83033272|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033273|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033274|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033275|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033276|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
83033277|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83033278|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033279|NCT02220296|Insulin|insulin|mesh-list
83033280|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83033281|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
83033282|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83033283|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033284|NCT02074878|Sunitinib|sunitinib|mesh-list
83033285|NCT02074878|Crizotinib|crizotinib|mesh-list
83033286|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033287|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83033288|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83033289|NCT02074878|Growth Substances|growth substances|mesh-ancestor
83033290|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033291|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
83033292|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83033293|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033294|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033295|NCT03075163|Ondansetron|ondansetron|mesh-list
83033296|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
83033297|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
83033298|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033299|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033300|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83033301|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
83033302|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
83033303|NCT03075163|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83033304|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83033305|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
83033306|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033307|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033308|NCT02628405|Rituximab|rituximab|mesh-list
83033309|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83033310|NCT02628405|Carboplatin|carboplatin|mesh-list
83033311|NCT02628405|Etoposide|etoposide|mesh-list
83033312|NCT02628405|Lenalidomide|lenalidomide|mesh-list
83033313|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
83033314|NCT02628405|Ifosfamide|ifosfamide|mesh-list
83033315|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
83033316|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
83033317|NCT02628405|Antibodies|antibodies|mesh-list
83033318|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
83033319|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83033320|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
83033321|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033322|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033323|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033324|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83033325|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83033326|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83033327|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033328|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033329|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83033330|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83033331|NCT02628405|Growth Substances|growth substances|mesh-ancestor
83033332|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83033333|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83033334|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
83033335|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
83033336|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
83033337|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
83033338|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
83033339|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
83033340|NCT02220530|Fentanyl|fentanyl|mesh-list
83033341|NCT02220530|Midazolam|midazolam|mesh-list
83033342|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83033343|NCT02220530|Narcotics|narcotics|mesh-ancestor
83033344|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033345|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033346|NCT02220530|Analgesics|analgesics|mesh-ancestor
83033347|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
83033348|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033349|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83033350|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83033351|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
83033352|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
83033353|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83033354|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83033355|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83033356|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83033357|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
83033358|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
83033359|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033360|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362159|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83033361|NCT02078232|Pancrelipase|pancrelipase|mesh-list
83033362|NCT02078232|Pancreatin|pancreatin|mesh-list
83033363|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83033364|NCT02075034|ON 01910|on 01910|mesh-list
83033365|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033366|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83033367|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033368|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033369|NCT02567175|Domperidone|domperidone|mesh-list
83033370|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
83033371|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
83033372|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033373|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033374|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83033375|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83033376|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
83033377|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033378|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033379|NCT02078388|Doxorubicin|doxorubicin|mesh-list
83033380|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83033381|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033382|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83033383|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83033384|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033385|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033386|NCT02222636|Fentanyl|fentanyl|mesh-list
83033387|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
83033388|NCT02222636|Anesthetics|anesthetics|mesh-list
83033389|NCT02222636|Sevoflurane|sevoflurane|mesh-list
83033390|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033391|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033392|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83033393|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033394|NCT02222636|Analgesics|analgesics|mesh-ancestor
83033395|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
83033396|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033397|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83033398|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83033399|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83033400|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033401|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033402|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033403|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83033404|NCT02222636|Narcotics|narcotics|mesh-ancestor
83033405|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83033406|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83033407|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
83033408|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83033409|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83033410|NCT04058145|Plerixafor|plerixafor|mesh-list
83033411|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
83033412|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033413|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033414|NCT04058145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83033415|NCT04058145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033416|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83033417|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83033418|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
83033419|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033420|NCT02230982|Nintedanib|nintedanib|mesh-list
83033421|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033422|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83033423|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033424|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033425|NCT02075112|Genistein|genistein|mesh-list
83033426|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033427|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83033428|NCT02075112|Protective Agents|protective agents|mesh-ancestor
83033429|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033430|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83033431|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033432|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033433|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
83033434|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83033435|NCT02075112|Estrogens|estrogens|mesh-ancestor
83033436|NCT02075112|Hormones|hormones|mesh-ancestor
83033437|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83033438|NCT02223026|Metformin|metformin|mesh-list
83033439|NCT02223026|Linagliptin|linagliptin|mesh-list
83361674|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033440|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83033441|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033442|NCT02223026|Incretins|incretins|mesh-ancestor
83033443|NCT02223026|Hormones|hormones|mesh-ancestor
83033444|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83033445|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83033446|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
83033447|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033448|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033449|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83033450|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83033451|NCT02477384|Propranolol|propranolol|mesh-list
83033452|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83033453|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83033454|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033455|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033456|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033457|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033458|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83033459|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83033460|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
83033461|NCT02231294|Pramipexole|pramipexole|mesh-list
83033462|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
83033463|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033464|NCT02231294|Protective Agents|protective agents|mesh-ancestor
83033465|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033466|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83033467|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83033468|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
83033469|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
83033470|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033471|NCT02223416|Teriparatide|teriparatide|mesh-list
83033472|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83033473|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033474|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83033475|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
83033476|NCT02082054|Atropine|atropine|mesh-list
83033477|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
83033478|NCT02082054|Ephedrine|ephedrine|mesh-list
83033479|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83033480|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83033481|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83033482|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
83033483|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033484|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033485|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83033486|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
83033487|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
83033488|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
83033489|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83033490|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83033491|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
83033492|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033493|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033494|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
83033495|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83033496|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83033497|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
83033498|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033499|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
83033500|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
83033501|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83033502|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
83033503|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
83033504|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83033505|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83033506|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83033507|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
83033508|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033509|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033510|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83033511|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
83033512|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
83033513|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83033514|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033515|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83033516|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83033517|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83033518|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033519|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
83033520|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033522|NCT02226926|Dipyridamole|dipyridamole|mesh-list
83033523|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83033524|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83033525|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033526|NCT02226926|Analgesics|analgesics|mesh-ancestor
83033527|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
83033528|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033529|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033530|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83033531|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033532|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83033533|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83033534|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033535|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83033536|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83033537|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033538|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
83033539|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83033540|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
83033541|NCT02924883|Trastuzumab|trastuzumab|mesh-list
83033542|NCT02924883|Atezolizumab|atezolizumab|mesh-list
83033543|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83033544|NCT02924883|Maytansine|maytansine|mesh-list
83033545|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033546|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033547|NCT02924883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83033548|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033549|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83033550|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83033551|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83033552|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83033553|NCT02924883|Immunotoxins|immunotoxins|mesh-ancestor
83033554|NCT02924883|Immunoconjugates|immunoconjugates|mesh-ancestor
83033555|NCT02924883|Immunologic Factors|immunologic factors|mesh-ancestor
83033556|NCT02924883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033557|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
83033558|NCT02075970|Hematinics|hematinics|mesh-ancestor
83033559|NCT02231450|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83033560|NCT02231450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83033561|NCT02231450|Serotonin Agents|serotonin agents|mesh-ancestor
83033562|NCT02231450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033563|NCT02231450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033564|NCT02231450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033565|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
83033566|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83033567|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033568|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83033569|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033570|NCT02227082|Olaparib|olaparib|mesh-list
83033571|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83033572|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033573|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033574|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033575|NCT01369680|Ketamine|ketamine|mesh-list
83033576|NCT01369680|Analgesics|analgesics|mesh-ancestor
83033577|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
83033578|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033579|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033580|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83033581|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83033582|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
83033583|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
83033584|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033585|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83033586|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83033587|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033588|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033589|NCT04780321|Antibodies|antibodies|mesh-list
83033590|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83033591|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
83033592|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033593|NCT03670095|Memantine|memantine|mesh-list
83033594|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83033595|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83033596|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
83033597|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033598|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033599|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033600|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83033601|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83033602|NCT01378039|Budesonide|budesonide|mesh-list
83033603|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83033604|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83033605|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
83033606|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033607|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033608|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83033609|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83033610|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
83033611|NCT01378039|Hormones|hormones|mesh-ancestor
83033612|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83033613|NCT01377961|Lycopene|lycopene|mesh-list
83033614|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83033615|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
83033616|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033617|NCT01377961|Protective Agents|protective agents|mesh-ancestor
83033618|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033619|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83033620|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83033621|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033622|NCT03558750|Rituximab|rituximab|mesh-list
83033623|NCT03558750|Nivolumab|nivolumab|mesh-list
83033624|NCT03558750|Lenalidomide|lenalidomide|mesh-list
83033625|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033626|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033627|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
83033628|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033629|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033630|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83033631|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033632|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83033633|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83033634|NCT03558750|Growth Substances|growth substances|mesh-ancestor
83033635|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
83033636|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83033637|NCT02751320|Citric Acid|citric acid|mesh-list
83033638|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
83033639|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
83033640|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83033641|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
83033642|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
83033643|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033644|NCT04093219|Acetaminophen|acetaminophen|mesh-list
83033645|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033646|NCT04093219|Analgesics|analgesics|mesh-ancestor
83033647|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
83033648|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033649|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033650|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
83033651|NCT03559764|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
83033652|NCT03559764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033653|NCT03559764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033654|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
83033655|NCT04931641|Trace Elements|trace elements|mesh-ancestor
83033656|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
83033657|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033658|NCT02083536|Docetaxel|docetaxel|mesh-list
83033659|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361675|NCT03167034|Diuretics|diuretics|mesh-ancestor
83033660|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
83033661|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
83033662|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
83033663|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033664|NCT02231606|Methamphetamine|methamphetamine|mesh-list
83033665|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83033666|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033667|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
83033668|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
83033669|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033670|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
83033671|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033672|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033673|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
83033674|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83033675|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83033676|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83033677|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83033679|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83033680|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033681|NCT02227550|Vitamin K|vitamin k|mesh-list
83033682|NCT02227550|Warfarin|warfarin|mesh-list
83033683|NCT02227550|Apixaban|apixaban|mesh-list
83033684|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
83033685|NCT02227550|Fluindione|fluindione|mesh-list
83033686|NCT02227550|Vitamins|vitamins|mesh-ancestor
83033687|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
83033688|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033689|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
83033690|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83033691|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
83033692|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83033693|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
83033694|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033695|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033696|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83033697|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83033698|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
83033699|NCT02227550|Coagulants|coagulants|mesh-ancestor
83033700|NCT02206035|Methotrexate|methotrexate|mesh-list
83033701|NCT02206035|Tacrolimus|tacrolimus|mesh-list
83033702|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83033703|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
83033704|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83033705|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033706|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83033707|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
83033708|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033709|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033710|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
83033711|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033712|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83033713|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83033714|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
83033715|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033716|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83033717|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83033718|NCT02258828|Memantine|memantine|mesh-list
83033719|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83033720|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83033721|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
83033722|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033723|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033724|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033725|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83033726|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83033727|NCT02083068|Vaccines|vaccines|mesh-list
83033728|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83033729|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
83033730|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033731|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83033732|NCT02228252|Caseins|caseins|mesh-list
83033733|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
83033734|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
83033735|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033736|NCT02070549|Trametinib|trametinib|mesh-list
83033737|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033738|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83033739|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033740|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033741|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
83033742|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83033743|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83033744|NCT02591953|Prednisolone|prednisolone|mesh-list
83033745|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
83033746|NCT02591953|Lidocaine|lidocaine|mesh-list
83033747|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83033748|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
83033749|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
83033750|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
83033751|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033752|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033753|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
83033754|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033755|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83033756|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83033757|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83033758|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83033759|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033760|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83033761|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
83033762|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
83033763|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83033764|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
83033765|NCT02591953|Hormones|hormones|mesh-ancestor
83033766|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83033767|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83033768|NCT02591953|Protective Agents|protective agents|mesh-ancestor
83033769|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83033770|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033771|NCT02223884|Carboplatin|carboplatin|mesh-list
83033772|NCT02223884|Docetaxel|docetaxel|mesh-list
83033773|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033774|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
83033775|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
83033776|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
83033777|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033778|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83033779|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83033780|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
83033781|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033782|NCT02569489|Paclitaxel|paclitaxel|mesh-list
83033783|NCT02569489|Trastuzumab|trastuzumab|mesh-list
83033784|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83033785|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033786|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83033787|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83033788|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83033789|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033790|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033791|NCT02079558|Oxytocin|oxytocin|mesh-list
83033792|NCT02079558|Carbetocin|carbetocin|mesh-list
83033793|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
83033794|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83033795|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033796|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
83033797|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83033798|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83033799|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83033800|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83033801|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033802|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
83033803|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033804|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033805|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83033806|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033807|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83033808|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
83033809|NCT03669003|Coagulants|coagulants|mesh-ancestor
83033810|NCT04313959|Dexamethasone|dexamethasone|mesh-list
83033811|NCT04313959|Ropivacaine|ropivacaine|mesh-list
83033812|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83033813|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
83033814|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
83033815|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033816|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033817|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83033818|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
83033819|NCT04313959|Hormones|hormones|mesh-ancestor
83033820|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83033821|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83033822|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033823|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
83033824|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
83033825|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033826|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
83033827|NCT03073213|Ixekizumab|ixekizumab|mesh-list
83033828|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
83033829|NCT03070483|Vitamin D|vitamin d|mesh-list
83033830|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
83033831|NCT03070483|Vitamins|vitamins|mesh-ancestor
83033832|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
83033833|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033834|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83033835|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83033836|NCT05763667|Bupivacaine|bupivacaine|mesh-list
83033837|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
83033838|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
83033839|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033840|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033841|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
83033842|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033843|NCT04107727|Cytarabine|cytarabine|mesh-list
83033844|NCT04107727|Idarubicin|idarubicin|mesh-list
83033845|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83033846|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
83033847|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033848|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033849|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
83033850|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033851|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83033852|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
83033853|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033854|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83033855|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83033856|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83033857|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033858|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83033859|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83033860|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83033861|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83033862|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033863|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033864|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033865|NCT01074151|Analgesics|analgesics|mesh-ancestor
83033866|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
83033867|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033868|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
83033869|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83033870|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
83033871|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
83033872|NCT05761405|Amikacin|amikacin|mesh-list
83033873|NCT05761405|Mannitol|mannitol|mesh-list
83033874|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83033875|NCT05761405|Diuretics|diuretics|mesh-ancestor
83033876|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
83033877|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033878|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83033879|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033880|NCT03979885|Nicotine|nicotine|mesh-list
83033881|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83033882|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
83033883|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033884|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033885|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83033886|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83033887|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
83033888|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83033889|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033890|NCT02786329|Lidocaine|lidocaine|mesh-list
83033891|NCT02786329|Sevoflurane|sevoflurane|mesh-list
83033892|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83033893|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
83033894|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83033895|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033896|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
83033897|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033898|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83033899|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83033900|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83033901|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83033902|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033903|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83033904|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83033905|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
83033906|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
83033907|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033908|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033909|NCT05761951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83033910|NCT05761951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033911|NCT05761327|Curcumin|curcumin|mesh-list
83033912|NCT05761327|Resveratrol|resveratrol|mesh-list
83033913|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83033914|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83033915|NCT05761327|Analgesics|analgesics|mesh-ancestor
83033916|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
83033917|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033918|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033919|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83033920|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033921|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033922|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033923|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033924|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
83033925|NCT05761327|Protective Agents|protective agents|mesh-ancestor
83033926|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83033927|NCT02231762|Temozolomide|temozolomide|mesh-list
83033928|NCT02231762|Lanreotide|lanreotide|mesh-list
83033929|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83033930|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
83033931|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033932|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033933|NCT04507178|Nadroparin|nadroparin|mesh-list
83033934|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
83033935|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83033936|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83033937|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033938|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
83033939|NCT01191957|Busulfan|busulfan|mesh-list
83033940|NCT01191957|Fludarabine|fludarabine|mesh-list
83033941|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83033943|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033944|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83033945|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83033946|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
83033947|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033948|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033949|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83033950|NCT01050855|Busulfan|busulfan|mesh-list
83033951|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
83033952|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
83033953|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033954|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83033955|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
83033956|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033957|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83033958|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033959|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83361676|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
83362160|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
83033960|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83033961|NCT04459286|Ritonavir|ritonavir|mesh-list
83033962|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83033963|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
83033964|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83033965|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83033966|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
83033967|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033968|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033969|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83033970|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83033971|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
83033972|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033973|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83033974|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83033975|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83033976|NCT00744081|Topotecan|topotecan|mesh-list
83033977|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
83033978|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83033979|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83033980|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83033981|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033982|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033983|NCT00744081|Analgesics|analgesics|mesh-ancestor
83033984|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
83033985|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83033986|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033987|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83033988|NCT02229266|Cytarabine|cytarabine|mesh-list
83033989|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83033990|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
83033991|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83033992|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83033993|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
83033994|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83033995|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83033996|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
83033997|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83033998|NCT02224040|Azithromycin|azithromycin|mesh-list
83033999|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
83034000|NCT02224040|Cefixime|cefixime|mesh-list
83034001|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83034002|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034003|NCT04448834|Vincristine|vincristine|mesh-list
83034004|NCT04448834|Blinatumomab|blinatumomab|mesh-list
83437896|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83034005|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83034006|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034007|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
83034008|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
83034009|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
83034010|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034011|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
83034012|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034013|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034014|NCT02232308|Lisinopril|lisinopril|mesh-list
83034015|NCT02232308|Nizatidine|nizatidine|mesh-list
83034016|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83034017|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
83034018|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034019|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034020|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83034021|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83034022|NCT02232308|Protective Agents|protective agents|mesh-ancestor
83034023|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034024|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83034025|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83034026|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83034027|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
83034028|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
83034029|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034030|NCT02232386|Rituximab|rituximab|mesh-list
83034031|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034032|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034033|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
83034034|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034035|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83034036|NCT02229734|Androgens|androgens|mesh-list
83034037|NCT02229734|Hormones|hormones|mesh-ancestor
83034038|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034039|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034040|NCT04333160|Hylan|hylan|mesh-list
83034041|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
83034042|NCT04333160|Protective Agents|protective agents|mesh-ancestor
83034043|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034044|NCT02258906|Urinastatin|urinastatin|mesh-list
83034045|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83034046|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83034047|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
83034048|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034049|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034050|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83034051|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83034052|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83034053|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034054|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83034055|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83034056|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83034057|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83034058|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83034059|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034060|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
83034061|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034062|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83034063|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034064|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034065|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
83034066|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034067|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034068|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83034069|NCT03068455|Nivolumab|nivolumab|mesh-list
83034070|NCT03068455|Ipilimumab|ipilimumab|mesh-list
83034071|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034072|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034073|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83034074|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034075|NCT03646994|Crizotinib|crizotinib|mesh-list
83034076|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034077|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83034078|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034079|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034080|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
83034081|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
83034082|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83034083|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83034084|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
83034085|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034086|NCT04209296|Ketamine|ketamine|mesh-list
83034087|NCT04209296|Analgesics|analgesics|mesh-ancestor
83034088|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
83034089|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034090|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034091|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83034092|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83034093|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
83034095|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034096|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83034097|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83034098|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034099|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034100|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83034101|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83034102|NCT02232932|Capecitabine|capecitabine|mesh-list
83034103|NCT02232932|Liver Extracts|liver extracts|mesh-list
83034104|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83034105|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
83034106|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034107|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361677|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034125|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034126|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83034127|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83034128|NCT04049864|Growth Substances|growth substances|mesh-ancestor
83034129|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
83034130|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034131|NCT03475706|Solabegron|solabegron|mesh-list
83034132|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83034133|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83034134|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83034135|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
83034136|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034137|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034138|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034139|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83034140|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83034141|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83034142|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
83034143|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034144|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83034145|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83034146|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034147|NCT03928184|Lorecivivint|lorecivivint|mesh-list
83034148|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034149|NCT02259374|Ropivacaine|ropivacaine|mesh-list
83034150|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
83034151|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
83034152|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034153|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034154|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
83034155|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034161|NCT04921982|Propranolol|propranolol|mesh-list
83034162|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83034163|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83034164|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
83034165|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034166|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034167|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034168|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83034169|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83034170|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
83034171|NCT04874324|Levonadifloxacin|levonadifloxacin|mesh-list
83034172|NCT04874324|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83034173|NCT04874324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034174|NCT04874324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034175|NCT04874324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83034176|NCT04874324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034177|NCT04866056|Azacitidine|azacitidine|mesh-list
83034178|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83034179|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
83034180|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034181|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361678|NCT01578551|Metformin|metformin|mesh-list
83034182|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034183|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83034184|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83034185|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83034186|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034187|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034188|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83034189|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83034190|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034191|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
83034192|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034193|NCT04789148|Oxytocin|oxytocin|mesh-list
83034194|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
83034195|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83034196|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034197|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
83034198|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83034199|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
83034200|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83034201|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
83034202|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83437914|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83034203|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034204|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
83034205|NCT03881852|Reboxetine|reboxetine|mesh-list
83034206|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
83034207|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83034208|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83034209|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83034210|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83034211|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034212|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
83034213|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034214|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034215|NCT03818828|Iodine|iodine|mesh-list
83034216|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
83034217|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83034218|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034219|NCT03818828|Trace Elements|trace elements|mesh-ancestor
83034220|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
83034221|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034222|NCT02804282|Furosemide|furosemide|mesh-list
83034223|NCT02804282|Diuretics|diuretics|mesh-ancestor
83034224|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
83034225|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034226|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83034227|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83034228|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034229|NCT02233244|Midazolam|midazolam|mesh-list
83034230|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83034231|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83034232|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034233|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034234|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83034235|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83034236|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83034237|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83034238|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
83034239|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
83034240|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
83034241|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
83034242|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034243|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034244|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
83034245|NCT02234882|Fostemsavir|fostemsavir|mesh-list
83034246|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83034247|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83034248|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83034249|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
83034250|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034251|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83034252|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83034253|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034255|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83361679|NCT01578551|Biguanides|biguanides|mesh-list
83034256|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
83034257|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034258|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83034259|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83034260|NCT03729362|Miglustat|miglustat|mesh-list
83034261|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034262|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034263|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83034264|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83034265|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
83034266|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034267|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83034268|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83034269|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034270|NCT03727022|Lorecivivint|lorecivivint|mesh-list
83034271|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034272|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
83034273|NCT02233322|Hematinics|hematinics|mesh-ancestor
83034274|NCT02233400|Acetaminophen|acetaminophen|mesh-list
83034275|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83034276|NCT02233400|Analgesics|analgesics|mesh-ancestor
83034277|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
83034278|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034279|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034280|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
83034281|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83034282|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83034283|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
83034284|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034285|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83034286|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034287|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83034288|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034289|NCT02235194|Chromium|chromium|mesh-list
83034290|NCT02235194|Picolinic acid|picolinic acid|mesh-list
83034291|NCT02235194|Trace Elements|trace elements|mesh-ancestor
83034292|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
83034293|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034294|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83034295|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
83034296|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
83034297|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034298|NCT03684278|Infliximab|infliximab|mesh-list
83034299|NCT03684278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83034300|NCT03684278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034301|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83034302|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83034303|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83034304|NCT02726659|Celecoxib|celecoxib|mesh-list
83034305|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83034306|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83034307|NCT02726659|Analgesics|analgesics|mesh-ancestor
83034308|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
83034309|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034310|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034311|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034312|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83034313|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83034314|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83034315|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034316|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034317|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83034318|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83034319|NCT04446962|Lenalidomide|lenalidomide|mesh-list
83034320|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
83034321|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034322|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83034323|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83034324|NCT04446962|Growth Substances|growth substances|mesh-ancestor
83034325|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83034326|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034327|NCT03951961|Midostaurin|midostaurin|mesh-list
83034328|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034329|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83034330|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361680|NCT01578551|Paclitaxel|paclitaxel|mesh-list
83034331|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034332|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83034333|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83034334|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83034335|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83034336|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034337|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034338|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034339|NCT02232542|Analgesics|analgesics|mesh-ancestor
83034340|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
83034341|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034342|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
83034343|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83034344|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
83034345|NCT02600923|Letrozole|letrozole|mesh-list
83034346|NCT02600923|Palbociclib|palbociclib|mesh-list
83034347|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034348|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83034349|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83034350|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034351|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034352|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83034353|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
83034354|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034355|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034356|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83034357|NCT05761171|Cytarabine|cytarabine|mesh-list
83034358|NCT05761171|Prednisone|prednisone|mesh-list
83034359|NCT05761171|Prednisolone|prednisolone|mesh-list
83034360|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83034361|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
83034362|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83034363|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
83034364|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
83034365|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83034366|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83034367|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83034368|NCT05761171|Cortisone|cortisone|mesh-list
83034369|NCT05761171|Methotrexate|methotrexate|mesh-list
83034370|NCT05761171|Fludarabine|fludarabine|mesh-list
83034371|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
83034372|NCT05761171|Vincristine|vincristine|mesh-list
83034373|NCT05761171|Asparaginase|asparaginase|mesh-list
83034374|NCT05761171|Pegaspargase|pegaspargase|mesh-list
83034375|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83034376|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
83034377|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034378|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
83034379|NCT05761171|Hormones|hormones|mesh-ancestor
83034380|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034381|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034382|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83034383|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034384|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83034385|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
83034386|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83034387|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83034388|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
83034389|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034390|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
83034391|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034392|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83034393|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83034394|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
83034395|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83034396|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83034397|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
83034398|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034399|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83034400|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
83034401|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
83034402|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
83034403|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
83034404|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
83034405|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361681|NCT01578551|Bevacizumab|bevacizumab|mesh-list
83034406|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83034407|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83034408|NCT05761171|Protective Agents|protective agents|mesh-ancestor
83034409|NCT02232776|Losartan|losartan|mesh-list
83034410|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83034411|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83034412|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83034413|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83034414|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034415|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
83034416|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034417|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034418|NCT03847519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83034419|NCT03847519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034420|NCT02235428|Bromides|bromides|mesh-list
83034421|NCT02235428|Albuterol|albuterol|mesh-list
83034422|NCT02235428|Ipratropium|ipratropium|mesh-list
83034423|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
83034424|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83034425|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
83034426|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034427|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034428|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83034429|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
83034430|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
83034431|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83034432|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83034433|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83034434|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83034435|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
83034436|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034437|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034438|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83034439|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
83034440|NCT03070171|Dabigatran|dabigatran|mesh-list
83034441|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
83034442|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83034443|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
83034444|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034445|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034446|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
83034447|NCT02262572|Telmisartan|telmisartan|mesh-list
83034448|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83034449|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83034450|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83034451|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83034452|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034453|NCT02262572|Diuretics|diuretics|mesh-ancestor
83034454|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
83034455|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034456|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83034457|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83034458|NCT02235584|Dexamethasone|dexamethasone|mesh-list
83034459|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034460|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
83034461|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
83034462|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034463|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034464|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83034465|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
83034466|NCT02235584|Hormones|hormones|mesh-ancestor
83034467|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034468|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83034469|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034470|NCT02235662|Tenofovir|tenofovir|mesh-list
83034471|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
83034472|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
83034473|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034474|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83034475|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83034476|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034477|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034478|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83034479|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83034480|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83034481|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
83034482|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83034483|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034484|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83034485|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83034486|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83034488|NCT02262650|Clopidogrel|clopidogrel|mesh-list
83034489|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83034490|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83034491|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83034492|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83034493|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
83034494|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034495|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034496|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034497|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83034498|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83034499|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83034500|NCT01084252|Dexamethasone|dexamethasone|mesh-list
83034501|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
83034503|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034504|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
83034505|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
83034506|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034507|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034508|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83034509|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
83034510|NCT01084252|Hormones|hormones|mesh-ancestor
83034511|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034512|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83034513|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034514|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
83034515|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034516|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034517|NCT04106414|Nivolumab|nivolumab|mesh-list
83034518|NCT04106414|Linrodostat|linrodostat|mesh-list
83034519|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034520|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034521|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83034522|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034523|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034524|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
83034525|NCT02784002|Ridinilazole|ridinilazole|mesh-list
83034526|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83034527|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034528|NCT02233556|Memantine|memantine|mesh-list
83034529|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83034530|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83034531|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
83034532|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034533|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034534|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034535|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83034536|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83034537|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83034538|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83034539|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034540|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
83034541|NCT02236052|Vaccines|vaccines|mesh-list
83034542|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
83034543|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034544|NCT04122196|Pregabalin|pregabalin|mesh-list
83034545|NCT04122196|Analgesics|analgesics|mesh-ancestor
83034546|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
83034547|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034548|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034549|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
83034550|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83361682|NCT01578551|Carboplatin|carboplatin|mesh-list
83034551|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362161|NCT05339542|Hormones|hormones|mesh-ancestor
83034552|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034553|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83034554|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83034555|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83034556|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034557|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83034558|NCT04908592|Dexamethasone|dexamethasone|mesh-list
83034559|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034560|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
83034561|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
83437945|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
83034562|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034563|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034564|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83034565|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
83034566|NCT04908592|Hormones|hormones|mesh-ancestor
83034567|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034568|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83034569|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034570|NCT04759768|Naltrexone|naltrexone|mesh-list
83034571|NCT04759768|Nalmefene|nalmefene|mesh-list
83034572|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83034573|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034574|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
83034575|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034576|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83034577|NCT02564744|Rituximab|rituximab|mesh-list
83034578|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034579|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034580|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
83034581|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034582|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83034583|NCT05759767|Tamsulosin|tamsulosin|mesh-list
83034584|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83034585|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83034586|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83034587|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
83034588|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034589|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034590|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034591|NCT05759767|Urological Agents|urological agents|mesh-ancestor
83034592|NCT02750306|Suvorexant|suvorexant|mesh-list
83034593|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83034594|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83034595|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034596|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034597|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83034598|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034599|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034600|NCT03845140|Praziquantel|praziquantel|mesh-list
83034601|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
83034602|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83034603|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034604|NCT01816165|Acipimox|acipimox|mesh-list
83034605|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83034606|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
83034607|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034608|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83034609|NCT04476680|Vitamin D|vitamin d|mesh-list
83034610|NCT04476680|Vitamins|vitamins|mesh-ancestor
83034611|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
83034612|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034613|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83034614|NCT04952350|Atorvastatin|atorvastatin|mesh-list
83034615|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83034616|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83034617|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
83034618|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034619|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83034620|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83034622|NCT05376202|Cetuximab|cetuximab|mesh-list
83034623|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034624|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034625|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
83034626|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83034627|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83034628|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
83034629|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034630|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034631|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83034633|NCT04788550|Fluorides|fluorides|mesh-list
83034634|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
83034635|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
83034636|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
83034637|NCT04788550|Protective Agents|protective agents|mesh-ancestor
83034638|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034639|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83034640|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034641|NCT01677988|Folfirinox|folfirinox|mesh-list
83034642|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034643|NCT02233790|Clopidogrel|clopidogrel|mesh-list
83034644|NCT02233790|Ticagrelor|ticagrelor|mesh-list
83034645|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83034646|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83034647|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83034648|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83034649|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
83034650|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034651|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034652|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034653|NCT02547818|Ibuprofen|ibuprofen|mesh-list
83034654|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83034655|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83034656|NCT02547818|Analgesics|analgesics|mesh-ancestor
83034657|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
83034658|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034659|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034660|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83480682|NCT03504397|Vitamins|vitamins|mesh-ancestor
83034661|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83034662|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83034663|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034664|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034665|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
83034666|NCT04539808|Leucovorin|leucovorin|mesh-list
83034667|NCT04539808|Folic Acid|folic acid|mesh-list
83034668|NCT04539808|Fluorouracil|fluorouracil|mesh-list
83034669|NCT04539808|Capecitabine|capecitabine|mesh-list
83034670|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
83034671|NCT04539808|Irinotecan|irinotecan|mesh-list
83034672|NCT04539808|Camptothecin|camptothecin|mesh-list
83034673|NCT04539808|Losartan|losartan|mesh-list
83034674|NCT04539808|Calcium|calcium|mesh-list
83034675|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
83034676|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83034677|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034678|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83034679|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
83034680|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034681|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83034682|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034683|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83034684|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
83034685|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83034686|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83034687|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034688|NCT04539808|Antidotes|antidotes|mesh-ancestor
83034689|NCT04539808|Protective Agents|protective agents|mesh-ancestor
83034690|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
83034691|NCT04539808|Vitamins|vitamins|mesh-ancestor
83034692|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
83034693|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83034694|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83034695|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83034696|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83034697|NCT04539808|Hematinics|hematinics|mesh-ancestor
83034698|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83034699|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83034700|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
83034701|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83034702|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83034703|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83034704|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034705|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034706|NCT03752918|Niacin|niacin|mesh-list
83034707|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
83034708|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83034709|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83034710|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
83034711|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034712|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83034713|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
83034714|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
83034715|NCT03752918|Vitamins|vitamins|mesh-ancestor
83034716|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
83034717|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034718|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
83034719|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83034720|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
83034721|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034722|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83034723|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83034724|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83034725|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83034726|NCT04259320|Propolis|propolis|mesh-list
83034727|NCT04259320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034728|NCT04058158|Eculizumab|eculizumab|mesh-list
83034729|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83034730|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83034731|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
83034732|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034733|NCT02263196|Ethanol|ethanol|mesh-list
83034734|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
83034735|NCT02263196|Povidone|povidone|mesh-list
83034736|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83034737|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034738|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034739|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034740|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
83034741|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
83034742|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
83034743|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034744|NCT02926573|Gabapentin|gabapentin|mesh-list
83034745|NCT02926573|Analgesics|analgesics|mesh-ancestor
83034746|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
83034747|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034748|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034749|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
83034750|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83034751|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83034752|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034753|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83034754|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83034755|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83034756|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034757|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034758|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
83034759|NCT04477018|Iron|iron|mesh-list
83034760|NCT04477018|Chelating Agents|chelating agents|mesh-list
83034761|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
83034762|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034763|NCT04477018|Trace Elements|trace elements|mesh-ancestor
83034764|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034765|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
83034766|NCT00158860|Valacyclovir|valacyclovir|mesh-list
83034767|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
83034768|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034769|NCT02490488|Gemcitabine|gemcitabine|mesh-list
83034770|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83034771|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
83034772|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034773|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034774|NCT02654990|Dexamethasone|dexamethasone|mesh-list
83034775|NCT02654990|Bortezomib|bortezomib|mesh-list
83034776|NCT02654990|Panobinostat|panobinostat|mesh-list
83034777|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034778|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
83034779|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
83361683|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83034780|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034781|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034782|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83034783|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
83034784|NCT02654990|Hormones|hormones|mesh-ancestor
83034785|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83034786|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83034787|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034788|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83034789|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034790|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034791|NCT02471222|Amantadine|amantadine|mesh-list
83034792|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83034793|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83034794|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
83034795|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034796|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
83034797|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034798|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034799|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034800|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83034801|NCT02471222|Analgesics|analgesics|mesh-ancestor
83034802|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
83034803|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034804|NCT03136120|Bromides|bromides|mesh-list
83034805|NCT03136120|Ipratropium|ipratropium|mesh-list
83034806|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
83034807|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83034808|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
83034809|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034810|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034811|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83034812|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
83034813|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83034814|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
83034815|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034816|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034817|NCT01625234|Ensartinib|ensartinib|mesh-list
83034818|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034819|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83034820|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034821|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034822|NCT02264834|Sufentanil|sufentanil|mesh-list
83034823|NCT02264834|Dsuvia|dsuvia|mesh-list
83034824|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
83034825|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83034826|NCT02264834|Narcotics|narcotics|mesh-ancestor
83034827|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034828|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034829|NCT02264834|Analgesics|analgesics|mesh-ancestor
83034830|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
83034831|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034832|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83034833|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83034834|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
83034835|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
83034836|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
83034837|NCT05762419|Etoposide|etoposide|mesh-list
83034838|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
83034839|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83034840|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034841|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83034842|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83034843|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034844|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034845|NCT02264912|Clopidogrel|clopidogrel|mesh-list
83034846|NCT02264912|Ticagrelor|ticagrelor|mesh-list
83034847|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83034848|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83034849|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83034850|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83034851|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83034853|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034854|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034855|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034856|NCT02263352|Carotenoids|carotenoids|mesh-list
83034857|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
83034858|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034859|NCT02263352|Protective Agents|protective agents|mesh-ancestor
83034860|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034861|NCT01435226|Ribavirin|ribavirin|mesh-list
83034862|NCT01435226|Ledipasvir|ledipasvir|mesh-list
83034863|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
83034864|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034865|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
83034866|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034867|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83034868|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
83034869|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
83034870|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83034871|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83034872|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83034873|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034874|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83034875|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83034876|NCT04409509|Antibodies|antibodies|mesh-list
83034877|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83034878|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
83034879|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034880|NCT04401865|Riboflavin|riboflavin|mesh-list
83034881|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
83034882|NCT04401865|Vitamins|vitamins|mesh-ancestor
83034883|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
83034884|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034885|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83034886|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
83034887|NCT02609048|Seladelpar|seladelpar|mesh-list
83034888|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83034889|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
83034890|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034891|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83034892|NCT02265068|Ticagrelor|ticagrelor|mesh-list
83034893|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83034894|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83034895|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83034896|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83034897|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
83034898|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034899|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034900|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034901|NCT02262416|Leuprolide|leuprolide|mesh-list
83034902|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83034903|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
83034904|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83034905|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034906|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83034907|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034908|NCT01577654|Folic Acid|folic acid|mesh-list
83034909|NCT01577654|Docetaxel|docetaxel|mesh-list
83034910|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
83034911|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034912|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
83034913|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
83034914|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
83034915|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034916|NCT01577654|Hematinics|hematinics|mesh-ancestor
83034917|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
83034918|NCT01577654|Vitamins|vitamins|mesh-ancestor
83034919|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
83034920|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034921|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83034922|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83034923|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034924|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034925|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
83034926|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83361684|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034927|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
83034928|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034929|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034931|NCT01418222|Bevacizumab|bevacizumab|mesh-list
83034932|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034933|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034934|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83034935|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83034936|NCT01418222|Growth Substances|growth substances|mesh-ancestor
83034937|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034938|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
83034939|NCT01418222|Antidotes|antidotes|mesh-ancestor
83034940|NCT01418222|Protective Agents|protective agents|mesh-ancestor
83034941|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
83034942|NCT01418222|Vitamins|vitamins|mesh-ancestor
83034943|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
83034944|NCT05377606|Temazepam|temazepam|mesh-list
83034945|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83034946|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83034947|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034948|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83034949|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83034950|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83034951|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
83034952|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
83034953|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83034954|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034955|NCT01256762|Paclitaxel|paclitaxel|mesh-list
83034956|NCT01256762|Bevacizumab|bevacizumab|mesh-list
83034957|NCT01256762|Imetelstat|imetelstat|mesh-list
83034958|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
83034959|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83034960|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034961|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
83034962|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
83034963|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
83034964|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034965|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034966|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83034967|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83034968|NCT01256762|Growth Substances|growth substances|mesh-ancestor
83034969|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034970|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
83034971|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034972|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83034973|NCT01252628|Cetuximab|cetuximab|mesh-list
83034974|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83034975|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83034976|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83034977|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83034978|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83034979|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83034980|NCT04349371|Chloroquine|chloroquine|mesh-list
83034981|NCT04349371|Amebicides|amebicides|mesh-ancestor
83034982|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83034983|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83034984|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83034985|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
83034986|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83034987|NCT01410188|Latanoprost|latanoprost|mesh-list
83034988|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83034989|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83034990|NCT01408082|Azithromycin|azithromycin|mesh-list
83034991|NCT01408082|Dexamethasone|dexamethasone|mesh-list
83034992|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
83034993|NCT01408082|BB 1101|bb 1101|mesh-list
83034994|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83034995|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
83034996|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
83034997|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83034998|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83034999|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035000|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
83035001|NCT01408082|Hormones|hormones|mesh-ancestor
83035002|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035003|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83035004|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035005|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
83035006|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035007|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035008|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83035009|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035010|NCT03071263|Spironolactone|spironolactone|mesh-list
83035011|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83035012|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
83035013|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035014|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035015|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83035016|NCT03071263|Diuretics|diuretics|mesh-ancestor
83035017|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
83035018|NCT05200663|Tamoxifen|tamoxifen|mesh-list
83035019|NCT05200663|Vitamin E|vitamin e|mesh-list
83035020|NCT05200663|Vitamins|vitamins|mesh-ancestor
83035021|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
83035022|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035023|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83035024|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
83035025|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035026|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83035027|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035028|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83035029|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83035030|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83035031|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
83035032|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035033|NCT05200663|Protective Agents|protective agents|mesh-ancestor
83035034|NCT02268422|Buprenorphine|buprenorphine|mesh-list
83035035|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83035036|NCT02268422|Narcotics|narcotics|mesh-ancestor
83035037|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035038|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035039|NCT02268422|Analgesics|analgesics|mesh-ancestor
83035040|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
83035041|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035042|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83035043|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
83035044|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83035045|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035046|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035047|NCT05049343|Ketamine|ketamine|mesh-list
83035048|NCT05049343|Analgesics|analgesics|mesh-ancestor
83035049|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
83035050|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035051|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035052|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83035053|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83035054|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
83035055|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
83035056|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035057|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83035058|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83035059|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035060|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035061|NCT01569919|Folic Acid|folic acid|mesh-list
83035062|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
83035063|NCT01569919|Dexamethasone|dexamethasone|mesh-list
83035064|NCT01569919|Pemetrexed|pemetrexed|mesh-list
83035065|NCT01569919|Vitamins|vitamins|mesh-ancestor
83035066|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
83035067|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035068|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83035069|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
83035070|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
83035071|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035072|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035073|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
83035074|NCT01569919|Hormones|hormones|mesh-ancestor
83035075|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035076|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83035077|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035078|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035079|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035080|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83035081|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83035082|NCT01569919|Hematinics|hematinics|mesh-ancestor
83035083|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
83035084|NCT01399580|Atrasentan|atrasentan|mesh-list
83035085|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035086|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83035087|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83035088|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035089|NCT04069585|Lidocaine|lidocaine|mesh-list
83035090|NCT04069585|Anesthetics|anesthetics|mesh-list
83035091|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
83035092|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035093|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035094|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
83035095|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035096|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83035097|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83035098|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83035099|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035100|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035101|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
83035102|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035103|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
83035104|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035105|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83035106|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83035107|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
83035108|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035109|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035110|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83035111|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
83035112|NCT02265770|Cisplatin|cisplatin|mesh-list
83035113|NCT02265770|Carboplatin|carboplatin|mesh-list
83035114|NCT02265770|Methotrexate|methotrexate|mesh-list
83035115|NCT02265770|Etoposide|etoposide|mesh-list
83035116|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
83035117|NCT02265770|Vincristine|vincristine|mesh-list
83035118|NCT02265770|Valproic Acid|valproic acid|mesh-list
83035119|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035120|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
83035121|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035122|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83035123|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83035124|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
83035125|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035126|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035127|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83035128|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83035129|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
83035130|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83035131|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83035132|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
83035133|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
83035134|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035135|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83035136|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83035137|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83035138|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83035139|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83035140|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
83035141|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
83035142|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
83035143|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
83035144|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
83035145|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035146|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
83035147|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83035148|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035149|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83035150|NCT03066193|Palmidrol|palmidrol|mesh-list
83035151|NCT03066193|Dronabinol|dronabinol|mesh-list
83035152|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
83035153|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035154|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83035155|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83035156|NCT03066193|Analgesics|analgesics|mesh-ancestor
83035157|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
83035158|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035159|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83035160|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83035161|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035162|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035163|NCT03066193|Hormones|hormones|mesh-ancestor
83035164|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035165|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83035166|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83035167|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83035168|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
83035169|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035170|NCT02263976|Bromides|bromides|mesh-list
83035171|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
83035172|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
83035173|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83035174|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
83035175|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035176|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035177|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83035178|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
83035179|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
83035180|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83035181|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
83035182|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035183|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035184|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
83035185|NCT02263976|Miotics|miotics|mesh-ancestor
83035186|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83035187|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83035188|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83035189|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83035190|NCT01382654|Azelastine|azelastine|mesh-list
83035191|NCT01382654|Epinastine|epinastine|mesh-list
83035192|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83035193|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
83035194|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035195|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035196|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83035197|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
83035198|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83035199|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035200|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035201|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83035202|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83035203|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83035204|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
83035205|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
83035206|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035207|NCT01378676|Riluzole|riluzole|mesh-list
83035208|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
83035209|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83035210|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83035211|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035212|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035213|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035214|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83035215|NCT01378676|Protective Agents|protective agents|mesh-ancestor
83035216|NCT01377662|Methylphenidate|methylphenidate|mesh-list
83035217|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83035218|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035219|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83035220|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83035221|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035222|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035223|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
83035224|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035225|NCT01371578|Ribavirin|ribavirin|mesh-list
83361685|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
83035226|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83035227|NCT01371578|Ledipasvir|ledipasvir|mesh-list
83035228|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
83035229|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035230|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
83035231|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035232|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
83035233|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035234|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83035235|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035236|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035237|NCT01205048|Lidocaine|lidocaine|mesh-list
83035238|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
83035239|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
83035240|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035241|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035242|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
83035243|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035244|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83035245|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83035246|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83035247|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035248|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035249|NCT01498328|Bevacizumab|bevacizumab|mesh-list
83035250|NCT01498328|Rindopepimut|rindopepimut|mesh-list
83035251|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035252|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035253|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83035254|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83035255|NCT01498328|Growth Substances|growth substances|mesh-ancestor
83035256|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035257|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
83035258|NCT01497704|Apatinib|apatinib|mesh-list
83035259|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035260|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83035261|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035262|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035263|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83035264|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
83035265|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
83035266|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035267|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035268|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
83035269|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035270|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83035271|NCT03911713|Ivacaftor|ivacaftor|mesh-list
83035272|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83035273|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035274|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035275|NCT02264132|Pramipexole|pramipexole|mesh-list
83035276|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
83035277|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035278|NCT02264132|Protective Agents|protective agents|mesh-ancestor
83035279|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035280|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83035281|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83035282|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
83035283|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
83035284|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035285|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
83035286|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83035287|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035288|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035289|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83035290|NCT04540744|Tadalafil|tadalafil|mesh-list
83035291|NCT04540744|Macitentan|macitentan|mesh-list
83035292|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
83035293|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83035294|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83035296|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035297|NCT04540744|Urological Agents|urological agents|mesh-ancestor
83035298|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83361686|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
83035299|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83035300|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83035301|NCT05375734|Tislelizumab|tislelizumab|mesh-list
83035302|NCT05375734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035303|NCT05375734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035305|NCT01489046|Lamivudine|lamivudine|mesh-list
83035306|NCT01489046|Efavirenz|efavirenz|mesh-list
83035307|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
83035308|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035309|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83035310|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83035311|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035312|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035313|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83035314|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83035315|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83035316|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83035317|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83035318|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83035319|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83035320|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83035321|NCT01180634|Levofloxacin|levofloxacin|mesh-list
83035322|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83035323|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035324|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83035325|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83035326|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83035327|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035328|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035329|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035330|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83035331|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83035332|NCT02268890|Bortezomib|bortezomib|mesh-list
83035333|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035334|NCT02268968|Lidocaine|lidocaine|mesh-list
83035335|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
83035336|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
83035337|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035338|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035339|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
83035340|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035341|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83035342|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83035343|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83035344|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035345|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035346|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
83035347|NCT01359566|Baclofen|baclofen|mesh-list
83035348|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83035349|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035350|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83035351|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035352|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83035353|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
83035354|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
83035355|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035356|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035357|NCT04885816|Sirolimus|sirolimus|mesh-list
83035358|NCT04885816|Everolimus|everolimus|mesh-list
83035359|NCT04885816|MTOR Inhibitors|mtor inhibitors|mesh-list
83035360|NCT04885816|Temsirolimus|temsirolimus|mesh-list
83035361|NCT04885816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83035362|NCT04885816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035363|NCT04885816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035364|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035365|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
83035366|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035367|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035368|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83035369|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035370|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83035371|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
83035372|NCT04865614|Sevoflurane|sevoflurane|mesh-list
83035373|NCT04865614|Etomidate|etomidate|mesh-list
83035374|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83035375|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83035376|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
83035377|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
83035378|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035379|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035380|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83035381|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83035382|NCT02269046|Simvastatin|simvastatin|mesh-list
83035383|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83035384|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83035385|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
83035386|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035387|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83035388|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83035389|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035390|NCT01483742|Ritonavir|ritonavir|mesh-list
83035391|NCT01483742|Ribavirin|ribavirin|mesh-list
83035392|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83035393|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83035394|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83035395|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
83035396|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035397|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035398|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83035399|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83035400|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
83035401|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035402|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83035403|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83035404|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
83035405|NCT04691128|Anesthetics|anesthetics|mesh-list
83035406|NCT04691128|Propofol|propofol|mesh-list
83035407|NCT04691128|Desflurane|desflurane|mesh-list
83035408|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035409|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035410|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83035411|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83035412|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
83035413|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83035414|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
83035415|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035416|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035417|NCT02269202|Midazolam|midazolam|mesh-list
83035418|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83035419|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83035420|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035421|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035422|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83035423|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83035424|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83035425|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83035426|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
83035427|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
83035428|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
83035429|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
83035430|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035431|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035432|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
83035433|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83035434|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
83035435|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83035436|NCT01353248|Ribavirin|ribavirin|mesh-list
83035437|NCT01353248|Ledipasvir|ledipasvir|mesh-list
83035438|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
83035439|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035440|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
83035441|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035442|NCT05095636|Apatinib|apatinib|mesh-list
83035443|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035444|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83035445|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361687|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
83035446|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035447|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83035449|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035450|NCT05095480|Red yeast rice|red yeast rice|mesh-list
83035451|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83035452|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83035453|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83035454|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
83035455|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035456|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035457|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83035458|NCT02915016|Vaccines|vaccines|mesh-list
83035459|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83035460|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
83035461|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035462|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83035463|NCT02269280|Azacitidine|azacitidine|mesh-list
83035464|NCT02269280|Decitabine|decitabine|mesh-list
83035465|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83035466|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
83035467|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035468|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035469|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035470|NCT01170650|Doxorubicin|doxorubicin|mesh-list
83035471|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83035472|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83035473|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035474|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83035475|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83035476|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035477|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035478|NCT04533646|Insulin|insulin|mesh-list
83035479|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83035480|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035481|NCT01168310|Fluticasone|fluticasone|mesh-list
83035482|NCT01168310|Xhance|xhance|mesh-list
83035483|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
83035484|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83035485|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83035486|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
83035487|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035488|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035489|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83035490|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
83035491|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
83035492|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83035493|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83035494|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83035495|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83035496|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
83035497|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035498|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035499|NCT01472198|Gemcitabine|gemcitabine|mesh-list
83035500|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83035501|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
83035502|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035503|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035504|NCT04444492|Ranibizumab|ranibizumab|mesh-list
83035505|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83035506|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83035507|NCT04444492|Growth Substances|growth substances|mesh-ancestor
83035508|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035509|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
83035510|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035511|NCT02269358|Methotrexate|methotrexate|mesh-list
83035512|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83035513|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
83035514|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83035515|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035516|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83035517|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
83035518|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035519|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035520|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83035521|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035522|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83035523|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035524|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
83035525|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83035526|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83035528|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83035529|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035530|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83035531|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
83035532|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
83035533|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035534|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035535|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035536|NCT02088060|Cannabidiol|cannabidiol|mesh-list
83035537|NCT02088060|Olanzapine|olanzapine|mesh-list
83035538|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
83035539|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
83035540|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035541|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035542|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035543|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83035544|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83035545|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035546|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83035547|NCT02088060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83035548|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83035549|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035550|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035551|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035552|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
83035553|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
83035554|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
83035555|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83035556|NCT02269514|Nicotine|nicotine|mesh-list
83035557|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83035558|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
83035559|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035560|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035561|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83035562|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83035563|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
83035564|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035565|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035566|NCT01332812|Dexamethasone|dexamethasone|mesh-list
83035567|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
83035568|NCT01332812|BB 1101|bb 1101|mesh-list
83035569|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83035570|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
83035571|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
83035572|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035573|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035574|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035575|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
83035576|NCT01332812|Hormones|hormones|mesh-ancestor
83035577|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035578|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83035579|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035580|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
83035581|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035582|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035583|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
83035584|NCT03408652|Denosumab|denosumab|mesh-list
83035585|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83035586|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035587|NCT01332656|Paclitaxel|paclitaxel|mesh-list
83035588|NCT01332656|Carboplatin|carboplatin|mesh-list
83035589|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83035590|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035591|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
83035592|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
83035593|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
83035594|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035595|NCT02084472|Petrolatum|petrolatum|mesh-list
83035596|NCT02084472|Glycerol|glycerol|mesh-list
83035597|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83035599|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035600|NCT02084472|Emollients|emollients|mesh-ancestor
83035601|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
83035602|NCT02266784|Nicotine|nicotine|mesh-list
83035603|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83035604|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
83035605|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035606|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035607|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83035608|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83035609|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
83035610|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035611|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035612|NCT02090790|Dexamethasone|dexamethasone|mesh-list
83035613|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
83035614|NCT02090790|BB 1101|bb 1101|mesh-list
83035615|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83035616|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
83035617|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
83035618|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035619|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035620|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035621|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
83035622|NCT02090790|Hormones|hormones|mesh-ancestor
83035623|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035624|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83035625|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035626|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
83035627|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035628|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035629|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
83035630|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83035631|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83035632|NCT01443728|Vitamin D|vitamin d|mesh-list
83035633|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
83035634|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
83035635|NCT01443728|Vitamins|vitamins|mesh-list
83035636|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
83035637|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035638|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83035639|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83035640|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
83035641|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
83035642|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035643|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035644|NCT01312454|Travoprost|travoprost|mesh-list
83035645|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83035646|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83035647|NCT02084784|Methylene Blue|methylene blue|mesh-list
83035648|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035649|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035650|NCT03267589|Durvalumab|durvalumab|mesh-list
83035651|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035652|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035653|NCT02091180|Mannitol|mannitol|mesh-list
83035654|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83035655|NCT02091180|Diuretics|diuretics|mesh-ancestor
83035656|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
83035657|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035658|NCT02269748|Analgesics|analgesics|mesh-list
83035659|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
83035660|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035661|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035662|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
83035663|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83035664|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83035665|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
83035666|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035667|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035669|NCT03149809|Urological Agents|urological agents|mesh-ancestor
83035670|NCT04533880|Calcium|calcium|mesh-list
83035671|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83035672|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035673|NCT02269904|Fluorouracil|fluorouracil|mesh-list
83035674|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
83035675|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035676|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83035677|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035678|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035679|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
83035680|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035681|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
83035682|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035683|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035684|NCT01300208|CC-11050|cc-11050|mesh-list
83035685|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83035686|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83035687|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035688|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035689|NCT02085018|Omeprazole|omeprazole|mesh-list
83035690|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83035691|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035692|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83035693|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035694|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035695|NCT02091336|Metformin|metformin|mesh-list
83035696|NCT02091336|Glyburide|glyburide|mesh-list
83035697|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83035698|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035699|NCT01442090|Everolimus|everolimus|mesh-list
83035700|NCT01442090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83035701|NCT01442090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83035702|NCT01442090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035703|NCT01442090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035704|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035705|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
83035706|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035707|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035708|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
83035709|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83035710|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035711|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83035712|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035713|NCT02088450|Nitrendipine|nitrendipine|mesh-list
83035714|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83035715|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83035716|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035717|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035718|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83035719|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035720|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
83035721|NCT03688828|Amoxicillin|amoxicillin|mesh-list
83035722|NCT03688828|Clarithromycin|clarithromycin|mesh-list
83035723|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
83035724|NCT03688828|Esomeprazole|esomeprazole|mesh-list
83035725|NCT03688828|Bismuth|bismuth|mesh-list
83035726|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035727|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83035728|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035729|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83035730|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035731|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83035732|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035733|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83035734|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83438004|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
83035735|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83035736|NCT03688828|Antacids|antacids|mesh-ancestor
83035737|NCT03688828|Diuretics|diuretics|mesh-ancestor
83035738|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
83035739|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035740|NCT03688828|Expectorants|expectorants|mesh-ancestor
83035741|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
83035742|NCT02091492|Teriparatide|teriparatide|mesh-list
83035743|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83035744|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035745|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83035746|NCT02266940|DS-1971a|ds-1971a|mesh-list
83035747|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83035748|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83035749|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035750|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035751|NCT03981952|Vaccines|vaccines|mesh-list
83035752|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
83035753|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035754|NCT04475120|Lactoferrin|lactoferrin|mesh-list
83035755|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035756|NCT02088528|Mitomycins|mitomycins|mesh-list
83035757|NCT02088528|Mitomycin|mitomycin|mesh-list
83035758|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83035759|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035760|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
83035761|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035762|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83035763|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035764|NCT03634150|Doxorubicin|doxorubicin|mesh-list
83035765|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83035766|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035767|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83035768|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83035769|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035770|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035771|NCT02092038|Temozolomide|temozolomide|mesh-list
83035772|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83035773|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
83035774|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035775|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035776|NCT02272166|Propofol|propofol|mesh-list
83035777|NCT02272166|Sevoflurane|sevoflurane|mesh-list
83035778|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83035779|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83035780|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035781|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83035782|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
83035783|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
83035784|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83035785|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83035786|NCT02088684|Fulvestrant|fulvestrant|mesh-list
83035787|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83035788|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035789|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83035790|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83035791|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
83035792|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035793|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035794|NCT01137968|Bevacizumab|bevacizumab|mesh-list
83035795|NCT01137968|Imetelstat|imetelstat|mesh-list
83035796|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
83035797|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035798|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035799|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83035800|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83035801|NCT01137968|Growth Substances|growth substances|mesh-ancestor
83035802|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035803|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
83035804|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035805|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035806|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83035807|NCT01133990|Leucovorin|leucovorin|mesh-list
83035808|NCT01133990|Bevacizumab|bevacizumab|mesh-list
83035809|NCT01133990|Fluorouracil|fluorouracil|mesh-list
83035810|NCT01133990|Irinotecan|irinotecan|mesh-list
83035811|NCT01133990|Calcium|calcium|mesh-list
83035812|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
83035813|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035814|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035815|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83035816|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83035817|NCT01133990|Growth Substances|growth substances|mesh-ancestor
83035818|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035819|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
83035820|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83035821|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
83035822|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035823|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83035824|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035825|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
83035826|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83035827|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83035828|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035830|NCT01133990|Protective Agents|protective agents|mesh-ancestor
83035831|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
83035833|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
83035834|NCT02249910|Metformin|metformin|mesh-list
83035835|NCT02249910|Digoxin|digoxin|mesh-list
83035836|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83035837|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035838|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83035839|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83035840|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035841|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035842|NCT02249910|Protective Agents|protective agents|mesh-ancestor
83035843|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83035844|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83035845|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83035846|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035847|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
83035848|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035849|NCT02398396|Lactitol|lactitol|mesh-list
83035850|NCT02398396|Cathartics|cathartics|mesh-ancestor
83035851|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035852|NCT05628584|Metformin|metformin|mesh-list
83035853|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83035854|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035855|NCT02088918|Metformin|metformin|mesh-list
83035856|NCT02088918|Nateglinide|nateglinide|mesh-list
83035857|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83035858|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035859|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
83035860|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83035861|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035862|NCT02092428|Adenosine|adenosine|mesh-list
83035863|NCT02092428|Regadenoson|regadenoson|mesh-list
83035864|NCT02092428|Analgesics|analgesics|mesh-ancestor
83035865|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
83035866|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035867|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035868|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83035869|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
83035870|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83035871|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
83035872|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
83035873|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035874|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035875|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83035876|NCT02783404|Amoxicillin|amoxicillin|mesh-list
83035877|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
83035878|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
83035879|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83035880|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035881|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83035882|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035883|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035884|NCT01097018|Capecitabine|capecitabine|mesh-list
83035885|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83035886|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
83035887|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035888|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035889|NCT01096862|Peficitinib|peficitinib|mesh-list
83035890|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035891|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035892|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83035893|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
83035894|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035895|NCT02092506|Amoxicillin|amoxicillin|mesh-list
83035896|NCT02092506|Metronidazole|metronidazole|mesh-list
83035897|NCT02092506|Clarithromycin|clarithromycin|mesh-list
83035898|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83035899|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83035900|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035901|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83035902|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83035903|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83035904|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035905|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035906|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83035907|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83035908|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
83035909|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83035910|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035911|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83035912|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83035913|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
83035914|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035915|NCT01128530|Linezolid|linezolid|mesh-list
83035916|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83035917|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83035918|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83035919|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83035920|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035921|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83035922|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83035923|NCT02086032|Estradiol|estradiol|mesh-list
83035924|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83035925|NCT02086032|Estrogens|estrogens|mesh-list
83035926|NCT02086032|Progesterone|progesterone|mesh-list
83035927|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
83035928|NCT02086032|Hormones|hormones|mesh-ancestor
83035929|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035930|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035931|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83035932|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
83035933|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83035934|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83035935|NCT02086032|Progestins|progestins|mesh-ancestor
83035936|NCT02092818|Riociguat|riociguat|mesh-list
83035937|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
83035938|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035939|NCT02086188|Mirabegron|mirabegron|mesh-list
83035940|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83035941|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83035942|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83035943|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
83035944|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035945|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035946|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035947|NCT02086188|Urological Agents|urological agents|mesh-ancestor
83035948|NCT02267408|Warfarin|warfarin|mesh-list
83035949|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
83035950|NCT02092896|Liraglutide|liraglutide|mesh-list
83035951|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83035952|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035953|NCT02092896|Incretins|incretins|mesh-ancestor
83035954|NCT02092896|Hormones|hormones|mesh-ancestor
83035955|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83035956|NCT02092974|Citalopram|citalopram|mesh-list
83035957|NCT02092974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83035958|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83035959|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83035960|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035961|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035962|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
83035963|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035964|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83035965|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
83035966|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83035967|NCT05097508|Bromides|bromides|mesh-list
83035968|NCT05097508|Rocuronium|rocuronium|mesh-list
83035969|NCT05097508|Atracurium|atracurium|mesh-list
83035970|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
83035971|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83035972|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83035973|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83035974|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035975|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035976|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83035977|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83035978|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
83035979|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035980|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035982|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83035983|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
83035984|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83035985|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035986|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83035987|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83035988|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
83035989|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83035990|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83035991|NCT00153920|Bortezomib|bortezomib|mesh-list
83035992|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83035993|NCT05095714|Liver Extracts|liver extracts|mesh-list
83035994|NCT05095714|Hematinics|hematinics|mesh-ancestor
83035995|NCT02660242|Glucagon|glucagon|mesh-list
83035996|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83035997|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83035998|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83035999|NCT02660242|Hormones|hormones|mesh-ancestor
83036000|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036001|NCT02660242|Incretins|incretins|mesh-ancestor
83036002|NCT02089386|Tamoxifen|tamoxifen|mesh-list
83036003|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83036004|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
83036005|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036006|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036007|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036008|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036009|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83036010|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83036011|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83036012|NCT05628038|Capecitabine|capecitabine|mesh-list
83036013|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
83036014|NCT05628038|Antibodies|antibodies|mesh-list
83036015|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
83036016|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036017|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036018|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
83036019|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036020|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036021|NCT03557580|Isosorbide|isosorbide|mesh-list
83036022|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83036023|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83036024|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83036025|NCT03557580|Diuretics|diuretics|mesh-ancestor
83036026|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
83036027|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036028|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
83036029|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83036030|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036031|NCT02089542|Methylene Blue|methylene blue|mesh-list
83036032|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036033|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036034|NCT01295060|Octreotide|octreotide|mesh-list
83036035|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036036|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036037|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036038|NCT02086656|Bevacizumab|bevacizumab|mesh-list
83036039|NCT02086656|Capecitabine|capecitabine|mesh-list
83036040|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
83036041|NCT02086656|Irinotecan|irinotecan|mesh-list
83036042|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036043|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036044|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83036045|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83036046|NCT02086656|Growth Substances|growth substances|mesh-ancestor
83036047|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036048|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
83036049|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036050|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
83036051|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036052|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83036053|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83036054|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036055|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
83036056|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036057|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83036058|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036059|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036060|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
83036061|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83036062|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036063|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036064|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83036065|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83036066|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036067|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036068|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036069|NCT01126970|Orlistat|orlistat|mesh-list
83036070|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036071|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036072|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83036073|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83036074|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83036075|NCT03557424|Cathartics|cathartics|mesh-ancestor
83036076|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036077|NCT05057572|Carvedilol|carvedilol|mesh-list
83036078|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83036079|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83036080|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
83036081|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036082|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036083|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036084|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83036085|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
83036086|NCT05057572|Protective Agents|protective agents|mesh-ancestor
83036087|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83036088|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036089|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83036090|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
83036091|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83036092|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83036093|NCT02093598|Sirolimus|sirolimus|mesh-list
83036094|NCT02093598|Temsirolimus|temsirolimus|mesh-list
83036095|NCT02093598|MTOR Inhibitors|mtor inhibitors|mesh-list
83036096|NCT02093598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83036097|NCT02093598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036098|NCT02093598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036099|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83036100|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
83036101|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036102|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036103|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036104|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036105|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83036106|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
83036107|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
83036108|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83036109|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83036110|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83036111|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036112|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036113|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
83036114|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036115|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036116|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83036117|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036118|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
83036119|NCT02087202|Ketamine|ketamine|mesh-list
83036120|NCT02087202|Analgesics|analgesics|mesh-ancestor
83036121|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
83036122|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036123|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036124|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83036125|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83036126|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
83036127|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
83036128|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036129|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83036130|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83036131|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036132|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036133|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83036134|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
83036135|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83036136|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036137|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83036138|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
83036139|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83036140|NCT01283594|Levodopa|levodopa|mesh-list
83036141|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83036142|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83036143|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
83036144|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036145|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036146|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036147|NCT01281254|Trebananib|trebananib|mesh-list
83036148|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83036149|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83036150|NCT01281254|Growth Substances|growth substances|mesh-ancestor
83036151|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036152|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
83036153|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036154|NCT05104138|Eplerenone|eplerenone|mesh-list
83036155|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83036156|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
83036157|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036158|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036159|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83036160|NCT05104138|Diuretics|diuretics|mesh-ancestor
83036161|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
83036162|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83036163|NCT03072043|Azacitidine|azacitidine|mesh-list
83036164|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036165|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
83036166|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036167|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438025|NCT00619073|Aspirin|aspirin|mesh-list
83036168|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036169|NCT05626010|Acetaminophen|acetaminophen|mesh-list
83036170|NCT05626010|Ibuprofen|ibuprofen|mesh-list
83036171|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83036172|NCT05626010|Analgesics|analgesics|mesh-ancestor
83036173|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
83036174|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036175|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036176|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
83036177|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83036178|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83036179|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83036180|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83036181|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036182|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036183|NCT02089854|Toremifene|toremifene|mesh-list
83036184|NCT02089854|Anastrozole|anastrozole|mesh-list
83036185|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036186|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036187|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83036188|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83036189|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036190|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036191|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83036192|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
83036193|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036194|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361688|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036195|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83036196|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83036197|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83036198|NCT05624840|Ritonavir|ritonavir|mesh-list
83036199|NCT05624840|Nirmatrelvir|nirmatrelvir|mesh-list
83036200|NCT05624840|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83036201|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83036202|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83036203|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
83036204|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036205|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036206|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83036207|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83036208|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
83036209|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036210|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83036211|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83036212|NCT02093910|Dexamethasone|dexamethasone|mesh-list
83036213|NCT02093910|Bortezomib|bortezomib|mesh-list
83036214|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83036215|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
83036216|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
83036217|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036218|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036219|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036220|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
83036221|NCT02093910|Hormones|hormones|mesh-ancestor
83036222|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036223|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036224|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036225|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
83036226|NCT04437160|Epirubicin|epirubicin|mesh-list
83036227|NCT04437160|Pirarubicin|pirarubicin|mesh-list
83036228|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83036229|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
83036230|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036231|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83036232|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83036233|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
83036234|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036235|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036236|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83036237|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83036238|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83036239|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83036240|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036241|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
83036242|NCT02089932|Bupivacaine|bupivacaine|mesh-list
83036243|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
83036244|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
83036245|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036246|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036247|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
83036248|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036249|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83036250|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83036251|NCT02089932|Analgesics|analgesics|mesh-ancestor
83036252|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83036253|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83036254|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83036255|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
83036256|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036257|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036258|NCT01037036|Latanoprost|latanoprost|mesh-list
83036259|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83036260|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83036261|NCT05204641|Rifaximin|rifaximin|mesh-list
83036262|NCT05204641|Levodopa|levodopa|mesh-list
83036263|NCT05204641|Benserazide|benserazide|mesh-list
83036264|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83036265|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83036266|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
83036267|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036268|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036269|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036271|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036272|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036273|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036274|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
83036275|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
83036276|NCT03069313|Vitamins|vitamins|mesh-ancestor
83036277|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
83036278|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036279|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
83036280|NCT03069313|Hematinics|hematinics|mesh-ancestor
83036281|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
83036282|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83036283|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83036284|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036285|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
83036286|NCT02094066|Coagulants|coagulants|mesh-ancestor
83036287|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83036288|NCT01033292|Iniparib|iniparib|mesh-list
83036289|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036290|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036291|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036292|NCT03068767|Vitamin D|vitamin d|mesh-list
83036293|NCT03068767|Vitamins|vitamins|mesh-ancestor
83036294|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
83036295|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036296|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83036297|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
83036298|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036299|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
83036300|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
83036301|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
83036302|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83036303|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83036304|NCT01110902|Agomelatine|agomelatine|mesh-list
83036305|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83036306|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036307|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036308|NCT05204173|Paclitaxel|paclitaxel|mesh-list
83036309|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83036310|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036311|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
83036312|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
83036313|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83036314|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036315|NCT01025648|Epinephrine|epinephrine|mesh-list
83036316|NCT01025648|Racepinephrine|racepinephrine|mesh-list
83036317|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
83036318|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83036319|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83036320|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
83036321|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036322|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036323|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036324|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83036325|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83036326|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
83036327|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036328|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83036329|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
83036330|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
83036331|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
83036332|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83036333|NCT01110746|Insulin|insulin|mesh-list
83036334|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83036335|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036336|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036337|NCT05622968|Dinoprostone|dinoprostone|mesh-list
83036338|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
83036339|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83036340|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036341|NCT02268032|Androgens|androgens|mesh-list
83036342|NCT02268032|Hormones|hormones|mesh-ancestor
83036343|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036344|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036345|NCT03019965|Meropenem|meropenem|mesh-list
83036346|NCT03019965|Tazobactam|tazobactam|mesh-list
83036347|NCT03019965|Piperacillin|piperacillin|mesh-list
83036348|NCT03019965|Imipenem|imipenem|mesh-list
83036349|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83036350|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036351|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036352|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83036353|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036354|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036355|NCT01468831|Minocycline|minocycline|mesh-list
83036356|NCT01468831|Bevacizumab|bevacizumab|mesh-list
83036357|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036358|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036359|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83036360|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83036361|NCT01468831|Growth Substances|growth substances|mesh-ancestor
83036362|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036363|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83036364|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036365|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036366|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
83036367|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
83036368|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036369|NCT04475276|Protective Agents|protective agents|mesh-ancestor
83036370|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036371|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
83036372|NCT04475276|Vitamins|vitamins|mesh-ancestor
83036373|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
83036374|NCT05627414|Paclitaxel|paclitaxel|mesh-list
83036375|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83036376|NCT05627414|Tegafur|tegafur|mesh-list
83036377|NCT05627414|Disitamab vedotin|disitamab vedotin|mesh-list
83036378|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83036379|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036380|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
83036381|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
83036382|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
83036383|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036384|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036385|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
83036386|NCT05627414|Immunoconjugates|immunoconjugates|mesh-ancestor
83036387|NCT05627414|Immunologic Factors|immunologic factors|mesh-ancestor
83036388|NCT05627414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036389|NCT05617508|Niacinamide|niacinamide|mesh-list
83036391|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
83036392|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
83036393|NCT05617508|Vitamins|vitamins|mesh-ancestor
83036394|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
83036395|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036396|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83036397|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
83036398|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036399|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83036400|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
83036401|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83036402|NCT03018249|Entinostat|entinostat|mesh-list
83036403|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
83036404|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83036405|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83036406|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83036407|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83036408|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
83036409|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83036410|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036411|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83036412|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83036413|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83036414|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036415|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036417|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036418|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
83036419|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83036420|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83361689|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036421|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83036422|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036423|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036424|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
83036425|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036426|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036427|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83036428|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036429|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83036430|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036431|NCT05374252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036432|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036434|NCT04602975|Vaccines|vaccines|mesh-list
83036435|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
83036436|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036437|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83036438|NCT04602975|Antacids|antacids|mesh-ancestor
83036439|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036440|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036441|NCT00905606|Topiramate|topiramate|mesh-list
83036442|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
83036443|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036444|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036445|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
83036446|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
83036447|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
83036448|NCT03017235|Citric Acid|citric acid|mesh-list
83036449|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
83036450|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83036451|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
83036452|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
83036453|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036454|NCT03017235|Cathartics|cathartics|mesh-ancestor
83036455|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036456|NCT03017235|Antacids|antacids|mesh-ancestor
83036457|NCT05048134|Trametinib|trametinib|mesh-list
83036458|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036459|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83036460|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036461|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036462|NCT04438928|Micronutrients|micronutrients|mesh-list
83036463|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036464|NCT03667677|Amlodipine|amlodipine|mesh-list
83036465|NCT03667677|Tandospirone|tandospirone|mesh-list
83036466|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83036467|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83036468|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036469|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036470|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83036471|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036472|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
83036473|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83036474|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83036475|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036476|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83036477|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83036478|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
83036479|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036480|NCT04176718|Dexamethasone|dexamethasone|mesh-list
83036481|NCT04176718|Daratumumab|daratumumab|mesh-list
83036482|NCT04176718|Pomalidomide|pomalidomide|mesh-list
83036483|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83036484|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
83036485|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
83036486|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036487|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036488|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036489|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
83036490|NCT04176718|Hormones|hormones|mesh-ancestor
83036491|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036492|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036494|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
83036495|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83036496|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83036497|NCT04176718|Growth Substances|growth substances|mesh-ancestor
83036498|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
83036500|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036501|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036502|NCT02880371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83036503|NCT02880371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036504|NCT00813956|Carboplatin|carboplatin|mesh-list
83036505|NCT00813956|Gemcitabine|gemcitabine|mesh-list
83036506|NCT00813956|Iniparib|iniparib|mesh-list
83036507|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036508|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036509|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
83036510|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036511|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83036512|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036513|NCT01002248|Dexamethasone|dexamethasone|mesh-list
83036514|NCT01002248|Bortezomib|bortezomib|mesh-list
83036515|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83036516|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
83036517|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
83036518|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036519|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036520|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036521|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
83036522|NCT01002248|Hormones|hormones|mesh-ancestor
83036523|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036524|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036525|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036526|NCT02837029|Nivolumab|nivolumab|mesh-list
83036527|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036528|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036529|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83036530|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036531|NCT03667131|Enalapril|enalapril|mesh-list
83036532|NCT03667131|Enalaprilat|enalaprilat|mesh-list
83036533|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83036534|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83036535|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036536|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
83036537|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83036538|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83036539|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83036540|NCT02642965|Cytarabine|cytarabine|mesh-list
83036541|NCT02642965|Fludarabine|fludarabine|mesh-list
83036542|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
83036543|NCT02642965|Daunorubicin|daunorubicin|mesh-list
83036544|NCT02642965|Lenograstim|lenograstim|mesh-list
83036545|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036546|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036547|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
83036548|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036549|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83036550|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
83036551|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036552|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
83036553|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036554|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83036555|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83036556|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83036557|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83036558|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036559|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
83036560|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036561|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036562|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
83036563|NCT04976374|Gabapentin|gabapentin|mesh-list
83036564|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83036565|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036566|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036567|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83036568|NCT04976374|Analgesics|analgesics|mesh-ancestor
83036569|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
83036570|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036571|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83036572|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83036573|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83036574|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
83036575|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036576|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036577|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
83036578|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83036579|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83036580|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83036581|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83036582|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83036583|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
83036584|NCT02764541|Tamoxifen|tamoxifen|mesh-list
83036585|NCT02764541|Letrozole|letrozole|mesh-list
83036586|NCT02764541|Palbociclib|palbociclib|mesh-list
83036587|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036588|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83036589|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83036590|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036591|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036592|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83036593|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
83036594|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036595|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036596|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036597|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83036598|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83036599|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83036600|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83036601|NCT00894530|Azithromycin|azithromycin|mesh-list
83036602|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83036603|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83036604|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036605|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036606|NCT01376999|Hormones|hormones|mesh-list
83036607|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036608|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036609|NCT00892970|Azithromycin|azithromycin|mesh-list
83036610|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83036611|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83036612|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036613|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036614|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83036615|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036616|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036617|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83036618|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036619|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036620|NCT02201381|Metformin|metformin|mesh-list
83036621|NCT02201381|Doxycycline|doxycycline|mesh-list
83036622|NCT02201381|Mebendazole|mebendazole|mesh-list
83036623|NCT02201381|Atorvastatin|atorvastatin|mesh-list
83036624|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036625|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036626|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83036627|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83036628|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
83036629|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036630|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83036631|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83036632|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036633|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83036634|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036635|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
83036636|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83036637|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83036638|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
83036639|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
83036640|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
83036641|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
83036642|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
83036643|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036644|NCT00803114|Morphine|morphine|mesh-list
83036645|NCT00803114|Narcotics|narcotics|mesh-list
83036646|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83036647|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036648|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036649|NCT00803114|Analgesics|analgesics|mesh-ancestor
83036650|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
83036651|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036652|NCT02059499|Fluorouracil|fluorouracil|mesh-list
83036653|NCT02059499|Imiquimod|imiquimod|mesh-list
83036654|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
83036655|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036656|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036657|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036658|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83036659|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
83036660|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036661|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83036662|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
83036663|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
83036664|NCT05519384|Fludarabine|fludarabine|mesh-list
83036665|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83036666|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
83036667|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036668|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83036669|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83036670|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
83036671|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036672|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036673|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83036674|NCT05302271|Prednisone|prednisone|mesh-list
83036675|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83036676|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
83036677|NCT05302271|Hormones|hormones|mesh-ancestor
83036678|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036679|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036680|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83036681|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036682|NCT00799292|Vasopressins|vasopressins|mesh-list
83036683|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
83036684|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
83036685|NCT00799292|Coagulants|coagulants|mesh-ancestor
83036686|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83036687|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83036688|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
83036689|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036690|NCT02162849|Nicotine|nicotine|mesh-list
83036691|NCT02162849|Varenicline|varenicline|mesh-list
83036692|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83036693|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
83036694|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036695|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036696|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83036697|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83036698|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
83036699|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036700|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036701|NCT05371600|Midazolam|midazolam|mesh-list
83036702|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83036703|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83036704|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036705|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036706|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83036707|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83036708|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83036709|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83036710|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
83036711|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
83036712|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
83036713|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
83036714|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036715|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036716|NCT02914275|Vaccines|vaccines|mesh-list
83036717|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
83036718|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036720|NCT01941875|Progestins|progestins|mesh-ancestor
83361690|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83036721|NCT01941875|Hormones|hormones|mesh-ancestor
83036722|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036723|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036724|NCT05508074|Riluzole|riluzole|mesh-list
83036725|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
83036726|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83036727|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83036728|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036729|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036730|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036731|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83036732|NCT05508074|Protective Agents|protective agents|mesh-ancestor
83036733|NCT01814657|Lidocaine|lidocaine|mesh-list
83036734|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
83036735|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
83036736|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036737|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036738|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
83036739|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036740|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83036741|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83036742|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83036743|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036744|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036745|NCT01773395|Methotrexate|methotrexate|mesh-list
83036746|NCT01773395|Fludarabine|fludarabine|mesh-list
83036747|NCT01773395|Busulfan|busulfan|mesh-list
83036748|NCT01773395|Tacrolimus|tacrolimus|mesh-list
83036749|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83036750|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
83036751|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83036752|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036753|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83036754|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
83036755|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036756|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036757|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
83036758|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036759|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83036760|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83036761|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
83036762|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83036763|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83036764|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83036765|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
83036766|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83036767|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83036768|NCT01000922|Insulin|insulin|mesh-list
83036769|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83036770|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
83036771|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036772|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036773|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83036774|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036775|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
83036776|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
83036777|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83036778|NCT03666195|Protective Agents|protective agents|mesh-ancestor
83036779|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036780|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
83036781|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83036782|NCT00889382|Paclitaxel|paclitaxel|mesh-list
83036783|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83036784|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036785|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
83036786|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
83036787|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
83036788|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036789|NCT04059003|Taxane|taxane|mesh-list
83036790|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036791|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
83036792|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83036793|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036794|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036795|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83036796|NCT05375188|Analgesics|analgesics|mesh-ancestor
83036797|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
83036798|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036799|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83036800|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83036801|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83036802|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
83036803|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036804|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036805|NCT00994292|Darexaban|darexaban|mesh-list
83036806|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83036807|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
83036808|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83036809|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
83036810|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036811|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036812|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
83036813|NCT02604433|Luspatercept|luspatercept|mesh-list
83036814|NCT02604433|Hematinics|hematinics|mesh-ancestor
83036815|NCT04437004|Fenfluramine|fenfluramine|mesh-list
83036816|NCT04437004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83036817|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83036818|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036819|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036820|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036821|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
83036822|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036823|NCT00992732|Valganciclovir|valganciclovir|mesh-list
83036824|NCT00992732|Ganciclovir|ganciclovir|mesh-list
83036825|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83036826|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
83036827|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
83036828|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036829|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83036830|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036831|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036832|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036833|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
83036834|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83036835|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83036836|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83036837|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83036838|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036839|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
83036840|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036841|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036842|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83036843|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036844|NCT03006393|Infliximab|infliximab|mesh-list
83036845|NCT03006393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83036846|NCT03006393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83036847|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83036848|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036849|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83036850|NCT00991172|Fasinumab|fasinumab|mesh-list
83036851|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83036852|NCT00991172|Analgesics|analgesics|mesh-ancestor
83036853|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
83036854|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036855|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036856|NCT01383109|Pyronaridine|pyronaridine|mesh-list
83036857|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
83036858|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83036859|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83036860|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036861|NCT00882440|Losartan|losartan|mesh-list
83036862|NCT00882440|Enalapril|enalapril|mesh-list
83036863|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83036864|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83036865|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83036866|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83036867|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036868|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83036869|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
83036870|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036871|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
83036872|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036873|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83036874|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036875|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036876|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
83036877|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83036878|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
83036879|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036880|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036881|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83036882|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
83036883|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83036884|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83036885|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83036886|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
83036887|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83036888|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036889|NCT05214157|Bupivacaine|bupivacaine|mesh-list
83036890|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
83036891|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
83036892|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036893|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036894|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
83036895|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036897|NCT04549467|Lamivudine|lamivudine|mesh-list
83036898|NCT04549467|Emtricitabine|emtricitabine|mesh-list
83036899|NCT04549467|Dolutegravir|dolutegravir|mesh-list
83036900|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
83036901|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83036902|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83036903|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83036904|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036905|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036906|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83036907|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83036908|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83036909|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83036910|NCT03630341|Clomiphene|clomiphene|mesh-list
83036911|NCT03630341|Enclomiphene|enclomiphene|mesh-list
83036912|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
83036913|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83036914|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
83036915|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83036916|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036917|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83036918|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
83036919|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83036920|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83036921|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83036922|NCT02632396|Rituximab|rituximab|mesh-list
83036923|NCT02632396|Ixazomib|ixazomib|mesh-list
83036924|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036925|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036926|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
83036927|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036928|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83036929|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036930|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
83036931|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036932|NCT05102422|Propofol|propofol|mesh-list
83036933|NCT05102422|Sevoflurane|sevoflurane|mesh-list
83036934|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83036935|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036936|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036937|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83036938|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
83036939|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
83036940|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83036941|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83036942|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
83036943|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83036944|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
83036945|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036946|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83036947|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83036948|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
83036949|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036950|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036951|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83036952|NCT03665181|Bismuth|bismuth|mesh-list
83036953|NCT03665181|Antacids|antacids|mesh-ancestor
83036954|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036955|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83036956|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83036957|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036958|NCT05326906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036959|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036960|NCT05101954|Mitogens|mitogens|mesh-list
83036961|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
83036962|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036963|NCT00875108|Insulin|insulin|mesh-list
83036964|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83036965|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036966|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036967|NCT04044209|Nivolumab|nivolumab|mesh-list
83036968|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83036969|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83036970|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83036971|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036972|NCT03817463|Empagliflozin|empagliflozin|mesh-list
83036973|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83036974|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83036975|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83036976|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83036977|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036978|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
83036979|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83036980|NCT05207683|Antibodies|antibodies|mesh-list
83036981|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
83036982|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
83036983|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036984|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83036985|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
83036986|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036987|NCT05213065|Bupivacaine|bupivacaine|mesh-list
83036988|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
83036989|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
83036990|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83036991|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036992|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
83036993|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036994|NCT04578938|Ketamine|ketamine|mesh-list
83036995|NCT04578938|Analgesics|analgesics|mesh-ancestor
83036996|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
83036997|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83036998|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83036999|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83037000|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83037001|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
83037002|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
83037003|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037004|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83037005|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83037006|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037007|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037008|NCT00969722|Tretinoin|tretinoin|mesh-list
83037009|NCT00969722|Molgramostim|molgramostim|mesh-list
83037010|NCT00969722|Isotretinoin|isotretinoin|mesh-list
83037011|NCT00969722|Sargramostim|sargramostim|mesh-list
83037012|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037013|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
83037014|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
83037015|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
83037016|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037017|NCT05099614|Naloxone|naloxone|mesh-list
83037018|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83037019|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037020|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
83037021|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037022|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
83037023|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83037024|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83037025|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83037026|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037027|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037028|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
83037029|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037030|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037031|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83037032|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037033|NCT05283382|Cannabidiol|cannabidiol|mesh-list
83037034|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
83037035|NCT00869336|Luliconazole|luliconazole|mesh-list
83037036|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
83037037|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037038|NCT02371889|Topiramate|topiramate|mesh-list
83037039|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
83037040|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037041|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037042|NCT00860288|Metformin|metformin|mesh-list
83037043|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83037044|NCT00860288|Vildagliptin|vildagliptin|mesh-list
83037045|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037046|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037047|NCT00860288|Incretins|incretins|mesh-ancestor
83037048|NCT00860288|Hormones|hormones|mesh-ancestor
83037049|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83438051|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
83037050|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83037051|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037052|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037053|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037054|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83037055|NCT03630029|Hematinics|hematinics|mesh-ancestor
83037056|NCT05763953|Etripamil|etripamil|mesh-list
83037057|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83037058|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037059|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037060|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037061|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037062|NCT05212597|Losartan|losartan|mesh-list
83037063|NCT05212597|Amlodipine|amlodipine|mesh-list
83037064|NCT05212597|Valsartan|valsartan|mesh-list
83037065|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83037066|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83037067|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83037068|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037069|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037070|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037071|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037072|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
83037073|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83037074|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83037075|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037076|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83037077|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037078|NCT03629717|Vitamin D|vitamin d|mesh-list
83037079|NCT03629717|Denosumab|denosumab|mesh-list
83037081|NCT03629717|Vitamins|vitamins|mesh-ancestor
83037082|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
83037083|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037084|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037085|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83037086|NCT05108350|Metformin|metformin|mesh-list
83037087|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037088|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037089|NCT00859430|Levetiracetam|levetiracetam|mesh-list
83037090|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
83037091|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
83037092|NCT00855764|Paclitaxel|paclitaxel|mesh-list
83037093|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83361691|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83037094|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037095|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
83037096|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
83037097|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
83037098|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037099|NCT00959036|Methotrexate|methotrexate|mesh-list
83037100|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83037101|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
83037102|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83037103|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037104|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83037105|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
83037106|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037107|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037108|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
83037109|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037110|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83037111|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83037112|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
83037113|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83037114|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83037115|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
83037116|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
83037117|NCT04129723|Protective Agents|protective agents|mesh-ancestor
83037118|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037119|NCT04474262|Midodrine|midodrine|mesh-list
83037120|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
83037121|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
83037122|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037123|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037124|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83037125|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83037126|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83037127|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83037128|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
83037129|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037130|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037131|NCT05211583|Progesterone|progesterone|mesh-list
83037132|NCT05211583|Progestins|progestins|mesh-ancestor
83037133|NCT05211583|Hormones|hormones|mesh-ancestor
83037134|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037135|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037136|NCT04031599|Hormones|hormones|mesh-list
83037137|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037138|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037139|NCT04724759|Lidocaine|lidocaine|mesh-list
83037140|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
83037141|NCT04724759|Ketamine|ketamine|mesh-list
83037142|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
83037143|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
83037144|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037145|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037146|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
83037147|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037148|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037149|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83037150|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83037151|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037152|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037153|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83037154|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83037155|NCT04724759|Analgesics|analgesics|mesh-ancestor
83037156|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83037157|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83037158|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83037159|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
83037160|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037161|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83037162|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83037163|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
83037164|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83037165|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83037166|NCT04019821|Insulin|insulin|mesh-list
83037167|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83037168|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
83037169|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
83037170|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
83037171|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037172|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037173|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
83037174|NCT05186467|Analgesics|analgesics|mesh-ancestor
83037175|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
83037176|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037177|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037178|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
83037179|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037180|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037181|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
83037182|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83037183|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037184|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037185|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037186|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
83037187|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83037188|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83037189|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
83037190|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037191|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83037192|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83037193|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037194|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037195|NCT00768482|Buprenorphine|buprenorphine|mesh-list
83037196|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83037197|NCT00768482|Narcotics|narcotics|mesh-ancestor
83037198|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037199|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037200|NCT00768482|Analgesics|analgesics|mesh-ancestor
83037201|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
83037202|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037203|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83037204|NCT00840866|Cefprozil|cefprozil|mesh-list
83037205|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83037206|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037207|NCT05043116|Vitamin D|vitamin d|mesh-list
83037208|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
83037209|NCT05043116|Vitamins|vitamins|mesh-ancestor
83037210|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
83037211|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037212|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83037213|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037214|NCT00840632|Trandolapril|trandolapril|mesh-list
83037215|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83037216|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037217|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037218|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037219|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83037220|NCT00840476|Meloxicam|meloxicam|mesh-list
83037221|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83037222|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83037223|NCT00840476|Analgesics|analgesics|mesh-ancestor
83037224|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
83037225|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037226|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037227|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83037228|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83037229|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83037230|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83037231|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037232|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037233|NCT00765830|Vildagliptin|vildagliptin|mesh-list
83037234|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037235|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037236|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83037237|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037238|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037239|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037240|NCT03664869|Mitomycins|mitomycins|mesh-list
83037241|NCT03664869|Mitomycin|mitomycin|mesh-list
83037242|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83037243|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037244|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
83037245|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037246|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83037247|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037248|NCT00953420|Dexamethasone|dexamethasone|mesh-list
83037249|NCT00953420|Carboplatin|carboplatin|mesh-list
83037250|NCT00953420|Docetaxel|docetaxel|mesh-list
83037251|NCT00953420|Lenograstim|lenograstim|mesh-list
83037252|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83037253|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
83037254|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
83037255|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037256|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037257|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83037258|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
83037259|NCT00953420|Hormones|hormones|mesh-ancestor
83037260|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037261|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83037262|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037263|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83037264|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83037265|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83037266|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037267|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83037268|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
83037269|NCT01602562|Valacyclovir|valacyclovir|mesh-list
83037270|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
83037271|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037272|NCT01945775|Talazoparib|talazoparib|mesh-list
83037273|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83037274|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037275|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037276|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037277|NCT00839930|Cilostazol|cilostazol|mesh-list
83037278|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83037279|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
83037280|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037281|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037282|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83037283|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
83037284|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83037285|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83037286|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037287|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83037288|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
83037289|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83037290|NCT00839930|Protective Agents|protective agents|mesh-ancestor
83037291|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83037292|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83037293|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037294|NCT00838136|Lamotrigine|lamotrigine|mesh-list
83037295|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
83037296|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83037297|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037298|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037299|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037300|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037301|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83037302|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83037303|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037304|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037305|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83037306|NCT00944294|Adenosine|adenosine|mesh-list
83037307|NCT00944294|Binodenoson|binodenoson|mesh-list
83037308|NCT00944294|Analgesics|analgesics|mesh-ancestor
83037309|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
83037310|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037311|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037312|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037313|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
83037314|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83037315|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
83037316|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
83037317|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037318|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037319|NCT00758966|Naltrexone|naltrexone|mesh-list
83037320|NCT00758966|Fluoxetine|fluoxetine|mesh-list
83037321|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83037322|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83037323|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037324|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
83037325|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037326|NCT00758966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83037327|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83037328|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037329|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037330|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037331|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
83037332|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83037333|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
83037334|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037335|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83037336|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83037337|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037338|NCT03072719|Fluorides|fluorides|mesh-list
83037339|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
83037340|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
83037341|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
83037342|NCT03072719|Protective Agents|protective agents|mesh-ancestor
83037343|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037344|NCT05106400|Lidocaine|lidocaine|mesh-list
83037345|NCT05106400|Menthol|menthol|mesh-list
83037346|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
83037347|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
83037348|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037349|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037350|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
83037351|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037352|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037353|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83037354|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83037355|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037356|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037357|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
83037358|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
83037359|NCT00754988|Metformin|metformin|mesh-list
83037360|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83037361|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83037362|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037363|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037364|NCT00754988|Incretins|incretins|mesh-ancestor
83037365|NCT00754988|Hormones|hormones|mesh-ancestor
83037366|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037367|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83037368|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037369|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037370|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037371|NCT01416935|Amiodarone|amiodarone|mesh-list
83037372|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037373|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
83037374|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83037375|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037376|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037377|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83037378|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83037379|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83037380|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037381|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83037382|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83037383|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83037384|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
83037385|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83037386|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
83037387|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83037388|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037389|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037390|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
83037391|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037392|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037393|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83037394|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
83037395|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
83037396|NCT05012566|Protective Agents|protective agents|mesh-ancestor
83037397|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83037398|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037399|NCT05202665|Fluorides|fluorides|mesh-list
83037400|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
83037401|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
83037402|NCT05202665|Protective Agents|protective agents|mesh-ancestor
83037403|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037404|NCT04438772|Anesthetics|anesthetics|mesh-list
83037405|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037406|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037407|NCT04560634|Norepinephrine|norepinephrine|mesh-list
83037408|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83037409|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83037410|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
83037411|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037412|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037413|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037414|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
83037415|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
83037416|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037417|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83037418|NCT00927914|Ranirestat|ranirestat|mesh-list
83037419|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037420|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037421|NCT05261464|Metoprolol|metoprolol|mesh-list
83037422|NCT05261464|Diltiazem|diltiazem|mesh-list
83037423|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037424|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83037425|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
83037426|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
83037427|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037428|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037429|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83037430|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83037431|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83037432|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
83037433|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037434|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037435|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83037436|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037437|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037438|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
83037439|NCT05681377|Flumazenil|flumazenil|mesh-list
83037440|NCT05681377|Antidotes|antidotes|mesh-ancestor
83037441|NCT05681377|Protective Agents|protective agents|mesh-ancestor
83037442|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037443|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
83037444|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
83037445|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037446|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037447|NCT00835796|Finasteride|finasteride|mesh-list
83037449|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83037450|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037451|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037452|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
83037453|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037454|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037455|NCT00835796|Urological Agents|urological agents|mesh-ancestor
83037456|NCT05106712|Vitamin D|vitamin d|mesh-list
83037457|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
83037458|NCT05106712|Letrozole|letrozole|mesh-list
83037459|NCT05106712|Clomiphene|clomiphene|mesh-list
83037460|NCT05106712|Enclomiphene|enclomiphene|mesh-list
83037461|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
83037462|NCT05106712|Vitamins|vitamins|mesh-ancestor
83037463|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
83037464|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037465|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83361692|NCT01578551|Growth Substances|growth substances|mesh-ancestor
83037466|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037467|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83037468|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037469|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83037470|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83037471|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037472|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83037473|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
83037474|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037475|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83037476|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
83037477|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83037478|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83037479|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83037480|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
83037481|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83037482|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83037483|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037484|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037485|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037486|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037487|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037488|NCT00835640|Fexofenadine|fexofenadine|mesh-list
83037489|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83037490|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83037491|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83037492|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
83037493|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
83037494|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037495|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037496|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037497|NCT00752570|Trebananib|trebananib|mesh-list
83037498|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83037499|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83037500|NCT00752570|Growth Substances|growth substances|mesh-ancestor
83037501|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037502|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
83037503|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037504|NCT05083000|Topotecan|topotecan|mesh-list
83037505|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83037506|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83037507|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037508|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037509|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037510|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
83037511|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83037512|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83037513|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83037514|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037515|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037516|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
83037517|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037518|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037519|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83037520|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037521|NCT02942017|Brexanolone|brexanolone|mesh-list
83037522|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
83037523|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037524|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037525|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037526|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
83037527|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
83037528|NCT04447781|Citric Acid|citric acid|mesh-list
83037529|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
83037530|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
83037531|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83037532|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
83037533|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
83037534|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037535|NCT04364776|Durvalumab|durvalumab|mesh-list
83037536|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83037537|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037539|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83037540|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037541|NCT00835406|Alendronate|alendronate|mesh-list
83037542|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83037543|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037544|NCT05202275|Olanzapine|olanzapine|mesh-list
83037545|NCT05202275|Aprepitant|aprepitant|mesh-list
83037546|NCT05202275|Palonosetron|palonosetron|mesh-list
83037547|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
83037548|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
83037549|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037550|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037551|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83037552|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83037553|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83037554|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037555|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037556|NCT05202275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83037557|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83037558|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037559|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037560|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037561|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
83037562|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83037563|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83037564|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83037565|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
83037566|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037567|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83037568|NCT04369937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83037569|NCT04369937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037570|NCT00745316|Adenosine|adenosine|mesh-list
83037571|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
83037572|NCT00745316|Analgesics|analgesics|mesh-ancestor
83037573|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
83037574|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037575|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037576|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037577|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
83037578|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83037579|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
83037580|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
83037581|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037582|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037583|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83037584|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83037585|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83037586|NCT00744926|Incretins|incretins|mesh-ancestor
83037587|NCT00744926|Hormones|hormones|mesh-ancestor
83037588|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037589|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037590|NCT03838744|Olaparib|olaparib|mesh-list
83037591|NCT03838744|Trabectedin|trabectedin|mesh-list
83037592|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83037593|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037594|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037595|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037596|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83037597|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
83037598|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
83037599|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
83037600|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037601|NCT05327348|Protective Agents|protective agents|mesh-ancestor
83037602|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037603|NCT05327348|Vitamins|vitamins|mesh-ancestor
83037604|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
83037605|NCT04695106|Aspirin|aspirin|mesh-list
83037606|NCT04695106|Dabigatran|dabigatran|mesh-list
83037607|NCT04695106|Clopidogrel|clopidogrel|mesh-list
83037608|NCT04695106|Ticagrelor|ticagrelor|mesh-list
83037609|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83037610|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83037611|NCT04695106|Analgesics|analgesics|mesh-ancestor
83037612|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
83037613|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037614|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037615|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83037616|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83037617|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83037618|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83037619|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037620|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83037621|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83037622|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037623|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
83037624|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83037625|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83037626|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83037627|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
83037628|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037629|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
83037630|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83037631|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037632|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
83037633|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
83037634|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83037635|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
83037636|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83037637|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037638|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037639|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037640|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
83037641|NCT03629639|Metformin|metformin|mesh-list
83037642|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037643|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037644|NCT00835172|Glimepiride|glimepiride|mesh-list
83037645|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037646|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037647|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037648|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83037649|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
83037650|NCT04941755|Famotidine|famotidine|mesh-list
83037651|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83037652|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83037653|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83037654|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
83037655|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
83037656|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037657|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037658|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037659|NCT04921735|Cisatracurium|cisatracurium|mesh-list
83037660|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83037661|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83037662|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037663|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037664|NCT01676116|Liraglutide|liraglutide|mesh-list
83037665|NCT01676116|Exenatide|exenatide|mesh-list
83037666|NCT01676116|Xultophy|xultophy|mesh-list
83037667|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037668|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037669|NCT01676116|Incretins|incretins|mesh-ancestor
83037670|NCT01676116|Hormones|hormones|mesh-ancestor
83037671|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037672|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83037673|NCT05200793|Metformin|metformin|mesh-list
83037674|NCT05200793|Empagliflozin|empagliflozin|mesh-list
83037675|NCT05200793|Linagliptin|linagliptin|mesh-list
83037676|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83037677|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037678|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83037679|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037680|NCT05200793|Incretins|incretins|mesh-ancestor
83037681|NCT05200793|Hormones|hormones|mesh-ancestor
83037682|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037683|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83037684|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
83037685|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037686|NCT03383224|Nicotine|nicotine|mesh-list
83037687|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83037689|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037690|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037691|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83037692|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83037693|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
83037694|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037695|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037696|NCT04699357|Atropine|atropine|mesh-list
83037697|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83037698|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037699|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83037700|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
83037701|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037702|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037703|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83037704|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
83037705|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
83037706|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
83037707|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83037708|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83037709|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
83037710|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037711|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037712|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
83037713|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
83037714|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83037715|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83037716|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037717|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037718|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037719|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83037720|NCT05198531|Gemcitabine|gemcitabine|mesh-list
83037721|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037722|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83037723|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
83037724|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037725|NCT04177706|Ketamine|ketamine|mesh-list
83037726|NCT04177706|Analgesics|analgesics|mesh-ancestor
83037727|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
83037728|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037729|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037730|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83037731|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83037732|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
83037733|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
83037734|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037735|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83037736|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83037737|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037738|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037739|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
83037740|NCT01869829|Clotrimazole|clotrimazole|mesh-list
83037741|NCT01869829|Miconazole|miconazole|mesh-list
83037742|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037743|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83037744|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83037745|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83037746|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037747|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037748|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83037749|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
83037750|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037751|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037752|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83037753|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83037754|NCT02683018|Dronabinol|dronabinol|mesh-list
83037755|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
83037756|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037757|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037758|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83037759|NCT02683018|Analgesics|analgesics|mesh-ancestor
83037760|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
83037761|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037762|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83037763|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83037764|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037765|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037766|NCT02683018|Hormones|hormones|mesh-ancestor
83037767|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037768|NCT03982576|Nicotine|nicotine|mesh-list
83037769|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83037770|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
83037771|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037772|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037773|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83037774|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83037775|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
83037776|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037777|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037778|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
83037779|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037780|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83037781|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037782|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037783|NCT02675842|Dronabinol|dronabinol|mesh-list
83037784|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
83037785|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037786|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037787|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83037788|NCT02675842|Analgesics|analgesics|mesh-ancestor
83037789|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
83037790|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037791|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83037792|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83037793|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037794|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037795|NCT02675842|Hormones|hormones|mesh-ancestor
83037796|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83037797|NCT04528108|Hemostatics|hemostatics|mesh-list
83037798|NCT04528108|Coagulants|coagulants|mesh-ancestor
83037799|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
83037800|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83037801|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
83037802|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037803|NCT05074121|Expectorants|expectorants|mesh-ancestor
83037804|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83037805|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83037806|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
83037807|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037808|NCT05074121|Protective Agents|protective agents|mesh-ancestor
83037809|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037810|NCT05074121|Antidotes|antidotes|mesh-ancestor
83037811|NCT04251689|Mannitol|mannitol|mesh-list
83037812|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83037813|NCT04251689|Diuretics|diuretics|mesh-ancestor
83037814|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
83037815|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037816|NCT04232423|Olanzapine|olanzapine|mesh-list
83037817|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
83037818|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
83037819|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037820|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037821|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83037822|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83037823|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83037824|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037825|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037826|NCT04232423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83037827|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83037828|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037829|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037830|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037831|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
83037832|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83037833|NCT04178993|Methylphenidate|methylphenidate|mesh-list
83361693|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037834|NCT04178993|Methamphetamine|methamphetamine|mesh-list
83037835|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83037836|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037837|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83037838|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83037839|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037840|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037841|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
83037842|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037843|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83037845|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
83037846|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037847|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
83037848|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83037849|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
83037850|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
83037851|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
83037852|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83037853|NCT04436536|Methamphetamine|methamphetamine|mesh-list
83037854|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83037855|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037856|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
83037857|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
83037858|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037859|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
83037860|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037861|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037862|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
83037863|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83037864|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83037865|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037866|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83037867|NCT05762003|Interferons|interferons|mesh-list
83037868|NCT05762003|Teriflunomide|teriflunomide|mesh-list
83037869|NCT05762003|Rituximab|rituximab|mesh-list
83037870|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
83037871|NCT05762003|Ofatumumab|ofatumumab|mesh-list
83037872|NCT05762003|Cladribine|cladribine|mesh-list
83037873|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
83037874|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83037875|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
83037876|NCT05762003|Natalizumab|natalizumab|mesh-list
83037877|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83037878|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
83037879|NCT05762003|Ponesimod|ponesimod|mesh-list
83037880|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83037881|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037882|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
83037883|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037884|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83037885|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
83037886|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037887|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83037888|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83037889|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037890|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
83037891|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83037892|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83037893|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83037894|NCT05762003|Analgesics|analgesics|mesh-ancestor
83037895|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
83037896|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037897|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83037898|NCT04094012|Isoniazid|isoniazid|mesh-list
83037899|NCT04094012|Rifapentine|rifapentine|mesh-list
83037900|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
83037901|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83037902|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037903|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83037904|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83037905|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
83037906|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037907|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83037908|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83037909|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
83037910|NCT03679676|Omalizumab|omalizumab|mesh-list
83037911|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83037912|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83037913|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
83037914|NCT03001557|Lemborexant|lemborexant|mesh-list
83037915|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83037916|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037917|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037918|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83037919|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83037920|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037921|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037922|NCT03134612|Lidocaine|lidocaine|mesh-list
83037923|NCT03134612|Ondansetron|ondansetron|mesh-list
83037924|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
83037925|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
83037926|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037927|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037928|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
83037929|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037930|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83037931|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83037932|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83037933|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83037934|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037935|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
83037936|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
83037937|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83037938|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
83037939|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
83037940|NCT03134612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83037941|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83037942|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
83037943|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037944|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83037945|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83037946|NCT04365985|Naltrexone|naltrexone|mesh-list
83037947|NCT04365985|Ketamine|ketamine|mesh-list
83037948|NCT04365985|Analgesics|analgesics|mesh-ancestor
83037949|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
83037950|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037951|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037952|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83037953|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83037954|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
83037955|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
83037956|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83037957|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83037958|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83037959|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037960|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037961|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83037962|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83037963|NCT05111860|Bevacizumab|bevacizumab|mesh-list
83037964|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83037965|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83037966|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83037967|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83037968|NCT05111860|Growth Substances|growth substances|mesh-ancestor
83037969|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037970|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
83037971|NCT00830336|Azithromycin|azithromycin|mesh-list
83037972|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83037973|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83037974|NCT00830258|Pravastatin|pravastatin|mesh-list
83037975|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83037976|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83037977|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
83037978|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83037979|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83037980|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83037981|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83037982|NCT00830102|Fluticasone|fluticasone|mesh-list
83361694|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
83037983|NCT00830102|Xhance|xhance|mesh-list
83037984|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
83037985|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83037986|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83037987|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
83037988|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83037989|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83037990|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83037991|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
83037992|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83037993|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83037994|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83037995|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83037996|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83037997|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
83037998|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83037999|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038000|NCT03349775|Metformin|metformin|mesh-list
83038001|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038002|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038003|NCT00830024|Alprazolam|alprazolam|mesh-list
83038004|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83038005|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038006|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038007|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83038008|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83038009|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83038010|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
83038011|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
83038012|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038013|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038014|NCT00829868|Zaleplon|zaleplon|mesh-list
83038015|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
83038016|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83038017|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038018|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038019|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
83038020|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
83038021|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038022|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038023|NCT00721760|Enoxaparin|enoxaparin|mesh-list
83038024|NCT00721760|Semuloparin|semuloparin|mesh-list
83038025|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
83038026|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
83038027|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83038028|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83038029|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038030|NCT04491370|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83038031|NCT04491370|Immunoconjugates|immunoconjugates|mesh-ancestor
83038032|NCT04491370|Immunologic Factors|immunologic factors|mesh-ancestor
83038033|NCT04491370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038034|NCT00829790|Doxycycline|doxycycline|mesh-list
83038035|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038036|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038037|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
83038038|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83038039|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83038040|NCT03207815|Prednisone|prednisone|mesh-list
83038041|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038042|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
83038043|NCT03207815|Hormones|hormones|mesh-ancestor
83038044|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038045|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038046|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83038047|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038048|NCT02911935|Azithromycin|azithromycin|mesh-list
83038049|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038050|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038051|NCT05193487|Anesthetics|anesthetics|mesh-list
83038052|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038053|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038054|NCT03479762|Liraglutide|liraglutide|mesh-list
83038055|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038056|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038057|NCT03479762|Incretins|incretins|mesh-ancestor
83038058|NCT03479762|Hormones|hormones|mesh-ancestor
83084037|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83038059|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038060|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83038061|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83038062|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038063|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83038064|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83038065|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83038066|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038067|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
83038068|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038069|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83038070|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83038071|NCT05079802|Chitosan|chitosan|mesh-list
83038072|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038073|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
83038074|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83038075|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83038076|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
83038077|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038078|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83038079|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
83038080|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
83038081|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
83038082|NCT05079802|Coagulants|coagulants|mesh-ancestor
83038083|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83038084|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
83038085|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
83038086|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038087|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
83038088|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038089|NCT03899636|Folfirinox|folfirinox|mesh-list
83038090|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038091|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
83038092|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038093|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038094|NCT05761223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83038095|NCT05761223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038096|NCT03386942|Farletuzumab|farletuzumab|mesh-list
83038097|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038098|NCT04910230|Niacinamide|niacinamide|mesh-list
83038099|NCT04910230|Niacin|niacin|mesh-list
83038100|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
83038101|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
83038102|NCT04910230|Vitamins|vitamins|mesh-ancestor
83038103|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
83038104|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038105|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83038106|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
83038107|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038108|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83038109|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
83038110|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
83038111|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038112|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038113|NCT04995094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83038114|NCT04995094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038115|NCT05202821|Fluorides|fluorides|mesh-list
83038116|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
83038117|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
83038118|NCT05202821|Protective Agents|protective agents|mesh-ancestor
83038119|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038120|NCT02560805|Losartan|losartan|mesh-list
83038121|NCT02560805|Atenolol|atenolol|mesh-list
83038122|NCT02560805|Nitroprusside|nitroprusside|mesh-list
83038123|NCT02560805|Phenylephrine|phenylephrine|mesh-list
83038124|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
83038125|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83038126|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83038127|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83038128|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83038129|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038130|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83038131|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
83038132|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
83038133|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038134|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361695|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038135|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
83038136|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83038137|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
83038138|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
83038139|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83038140|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83038141|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83038142|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038143|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038144|NCT02560805|Protective Agents|protective agents|mesh-ancestor
83038145|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
83038146|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83038147|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83038148|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83038149|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
83038150|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83038151|NCT04615936|Methylene Blue|methylene blue|mesh-list
83038152|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038153|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038154|NCT03797222|Vitamin E|vitamin e|mesh-list
83038155|NCT03797222|Tocopherols|tocopherols|mesh-list
83038156|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
83038157|NCT03797222|Vitamins|vitamins|mesh-ancestor
83038158|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
83038159|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038160|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
83038161|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038162|NCT03797222|Protective Agents|protective agents|mesh-ancestor
83038163|NCT03755102|Osimertinib|osimertinib|mesh-list
83038164|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038165|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83038166|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038167|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038168|NCT04471675|Docetaxel|docetaxel|mesh-list
83038169|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038170|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
83038171|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
83038172|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
83038173|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038174|NCT04461028|Dexamethasone|dexamethasone|mesh-list
83038175|NCT04461028|Bupivacaine|bupivacaine|mesh-list
83038176|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038177|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
83038178|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
83038179|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038180|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038181|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83038182|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
83038183|NCT04461028|Hormones|hormones|mesh-ancestor
83038184|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038185|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83038186|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038187|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
83038188|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
83038189|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038190|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
83038191|NCT00716534|Paclitaxel|paclitaxel|mesh-list
83038192|NCT00716534|Carboplatin|carboplatin|mesh-list
83038193|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83038194|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038195|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
83038196|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
83038197|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
83038198|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038199|NCT02283476|Gemcitabine|gemcitabine|mesh-list
83038200|NCT02283476|Endostar protein|endostar protein|mesh-list
83038201|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038202|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83038203|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
83038204|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038205|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83038206|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83038207|NCT02283476|Growth Substances|growth substances|mesh-ancestor
83038208|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038209|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
83361696|NCT01692197|Cytarabine|cytarabine|mesh-list
83038210|NCT05156879|Aspirin|aspirin|mesh-list
83038211|NCT05156879|Drospirenone|drospirenone|mesh-list
83038212|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83038213|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83038214|NCT05156879|Estradiol|estradiol|mesh-list
83038215|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83038216|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83038217|NCT05156879|Analgesics|analgesics|mesh-ancestor
83038218|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
83038219|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038220|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038221|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038222|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038223|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83038224|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83038225|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038226|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83038227|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83038228|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038229|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
83038230|NCT05156879|Estrogens|estrogens|mesh-ancestor
83038231|NCT05156879|Hormones|hormones|mesh-ancestor
83038232|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038233|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83038234|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
83038235|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83038236|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83038237|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83038238|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83038239|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83038240|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
83038241|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83038242|NCT05156879|Diuretics|diuretics|mesh-ancestor
83038243|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
83038244|NCT02283554|Metformin|metformin|mesh-list
83038245|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038246|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038247|NCT00641732|Enoxaparin|enoxaparin|mesh-list
83038248|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
83038249|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
83038250|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83038251|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83038252|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038253|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83038254|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
83038255|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83038256|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
83038257|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038258|NCT00790829|Nicotine|nicotine|mesh-list
83038259|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83038260|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
83038261|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038262|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038263|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83038264|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83038265|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83038266|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038267|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038268|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83038269|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83038270|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
83038271|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038272|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038273|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83038274|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
83038275|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83038276|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83038277|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83038278|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038279|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038280|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038282|NCT03065933|Analgesics|analgesics|mesh-ancestor
83038283|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
83038284|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038285|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038286|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83038287|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
83038288|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
83038289|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83038290|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83038291|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83038292|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038293|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038294|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038295|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
83038296|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038297|NCT04256629|Allopurinol|allopurinol|mesh-list
83038298|NCT04256629|Verinurad|verinurad|mesh-list
83038299|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
83038300|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038301|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038302|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
83038303|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038304|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83038305|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
83038306|NCT04256629|Protective Agents|protective agents|mesh-ancestor
83038307|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038308|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
83038309|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83038310|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038311|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
83038312|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
83038313|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83038314|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83038315|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038316|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038317|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038318|NCT05125523|Sirolimus|sirolimus|mesh-list
83038319|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038320|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038321|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83038322|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038323|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
83038324|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038325|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
83038326|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038327|NCT00625664|Gemcitabine|gemcitabine|mesh-list
83038328|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038329|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83038330|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
83038331|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038332|NCT02947165|Spartalizumab|spartalizumab|mesh-list
83038333|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83038334|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038335|NCT02947165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038336|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038337|NCT03629093|Anesthetics|anesthetics|mesh-list
83038338|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
83038339|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038340|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038341|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
83038342|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83038343|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038344|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038345|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83038346|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83038347|NCT02283710|Protective Agents|protective agents|mesh-ancestor
83038348|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038349|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
83038350|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83038351|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
83038352|NCT05055947|Atezolizumab|atezolizumab|mesh-list
83038353|NCT05055947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83038354|NCT05055947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038355|NCT05055947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038356|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038357|NCT03943342|Venetoclax|venetoclax|mesh-list
83038358|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038359|NCT00357565|Cyclosporine|cyclosporine|mesh-list
83038360|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
83038361|NCT00357565|Fludarabine|fludarabine|mesh-list
83038362|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
83038363|NCT00357565|Melphalan|melphalan|mesh-list
83038364|NCT00357565|Busulfan|busulfan|mesh-list
83038365|NCT00357565|Cyclosporins|cyclosporins|mesh-list
83038366|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038367|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83038368|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
83038369|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038370|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038371|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
83038372|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038373|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038374|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
83038375|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038376|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83038377|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038378|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83038379|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83038380|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83038381|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
83038382|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038383|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83038384|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
83038385|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83038386|NCT00694928|Clindamycin|clindamycin|mesh-list
83038387|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
83038388|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
83038389|NCT00694928|Butoconazole|butoconazole|mesh-list
83038390|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038391|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038392|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83038393|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038394|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038395|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
83038396|NCT03272464|Trametinib|trametinib|mesh-list
83038397|NCT03272464|Dabrafenib|dabrafenib|mesh-list
83038398|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038399|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83038400|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038401|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038402|NCT00694382|Semuloparin|semuloparin|mesh-list
83038403|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83038404|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83038405|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83038406|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038407|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
83038408|NCT05116228|Rituximab|rituximab|mesh-list
83038409|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038410|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038411|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
83038412|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038413|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038414|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
83038415|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83038416|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038417|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
83038418|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038419|NCT05116150|Protective Agents|protective agents|mesh-ancestor
83038420|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038421|NCT00136903|Cyclosporine|cyclosporine|mesh-list
83038422|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
83038423|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
83038425|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
83038426|NCT00136903|Tacrolimus|tacrolimus|mesh-list
83038427|NCT00136903|Cyclosporins|cyclosporins|mesh-list
83038428|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038429|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
83038430|NCT00136903|Hormones|hormones|mesh-ancestor
83038431|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038432|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038433|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83038434|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038435|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038436|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
83038437|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83038438|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038439|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038440|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
83038441|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038442|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83038443|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038444|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83038445|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83038446|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
83038447|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038448|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
83038449|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
83038450|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038451|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83038452|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83038453|NCT00136903|Protective Agents|protective agents|mesh-ancestor
83038454|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
83038455|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
83038456|NCT04917029|Bupivacaine|bupivacaine|mesh-list
83038457|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
83038458|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
83038459|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038460|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038461|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
83038462|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038463|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83038464|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83038465|NCT04917029|Analgesics|analgesics|mesh-ancestor
83038466|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83038467|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83038468|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83038469|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038470|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038471|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038472|NCT04189510|Pancrelipase|pancrelipase|mesh-list
83038473|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83038474|NCT03632759|Liraglutide|liraglutide|mesh-list
83038475|NCT03632759|Golimumab|golimumab|mesh-list
83038476|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038477|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038478|NCT03632759|Incretins|incretins|mesh-ancestor
83038479|NCT03632759|Hormones|hormones|mesh-ancestor
83038480|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038481|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83038482|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038483|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038484|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
83038485|NCT02953093|Acarbose|acarbose|mesh-list
83038486|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83038487|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038488|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038489|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038490|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038491|NCT04518280|Capecitabine|capecitabine|mesh-list
83038492|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
83038493|NCT04518280|Antibodies|antibodies|mesh-list
83038494|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
83038495|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038496|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83038497|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
83038498|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038499|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038500|NCT00498836|Sorafenib|sorafenib|mesh-list
83038501|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038502|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83038503|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038504|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038505|NCT02283866|Desflurane|desflurane|mesh-list
83038506|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83038507|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
83038508|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
83038509|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038510|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038511|NCT04517110|Pregabalin|pregabalin|mesh-list
83038512|NCT04517110|Analgesics|analgesics|mesh-ancestor
83038513|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
83038514|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038515|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038516|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
83038517|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83038518|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83038519|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038520|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83038521|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83038522|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83038523|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038524|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83038525|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83038526|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83038527|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
83038528|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038529|NCT02281058|Abatacept|abatacept|mesh-list
83038530|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83038531|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038532|NCT02281058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038533|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038534|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038535|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
83038536|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038537|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038538|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
83038539|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83038540|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83038541|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83038542|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83038543|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038544|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
83038545|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038546|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038547|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83038548|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038549|NCT05205317|Metformin|metformin|mesh-list
83038550|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038551|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038552|NCT00691964|Etanercept|etanercept|mesh-list
83038553|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83038554|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83038555|NCT00691964|Analgesics|analgesics|mesh-ancestor
83038556|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
83038557|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038558|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038559|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038560|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038561|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83038562|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038563|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
83038565|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
83038566|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038567|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83038568|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038569|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038570|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038571|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038572|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83038573|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
83038574|NCT02281292|Ranibizumab|ranibizumab|mesh-list
83038575|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83038576|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83038577|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83038578|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83038579|NCT02281292|Growth Substances|growth substances|mesh-ancestor
83038580|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038581|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
83361697|NCT01692197|Dexamethasone|dexamethasone|mesh-list
83038582|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038583|NCT03723772|Insulin|insulin|mesh-list
83038584|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83038585|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038586|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038587|NCT02660827|Insulin|insulin|mesh-list
83038588|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038589|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038590|NCT00491738|Bevacizumab|bevacizumab|mesh-list
83038591|NCT00491738|Sunitinib|sunitinib|mesh-list
83038592|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038593|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038594|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83038595|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83038596|NCT00491738|Growth Substances|growth substances|mesh-ancestor
83038597|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038598|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
83038599|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83038600|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038601|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038602|NCT02281370|Cyclosporine|cyclosporine|mesh-list
83038603|NCT02281370|Cyclosporins|cyclosporins|mesh-list
83038604|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038605|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038606|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038607|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
83038608|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038609|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
83038610|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038611|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
83038612|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038613|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83038614|NCT00680342|Silymarin|silymarin|mesh-list
83038615|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
83038616|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038617|NCT00680342|Protective Agents|protective agents|mesh-ancestor
83038618|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038619|NCT04057365|Nivolumab|nivolumab|mesh-list
83038620|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83038621|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038622|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83038623|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038624|NCT00616148|Cenobamate|cenobamate|mesh-list
83038625|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
83038626|NCT03622827|Endostar protein|endostar protein|mesh-list
83038627|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83038628|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83038629|NCT03622827|Growth Substances|growth substances|mesh-ancestor
83038630|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038631|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
83038632|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038633|NCT00486512|Aspirin|aspirin|mesh-list
83038634|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
83038635|NCT00486512|Calcitriol|calcitriol|mesh-list
83038636|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83038637|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
83038638|NCT00486512|Calcium|calcium|mesh-list
83038639|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83038640|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038641|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83038642|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83038643|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83038644|NCT00486512|Analgesics|analgesics|mesh-ancestor
83038645|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
83038646|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038647|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038648|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038649|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83038650|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83038651|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038652|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83038653|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83038654|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038655|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
83038657|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83038658|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83038659|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83038660|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83038661|NCT00486512|Vitamins|vitamins|mesh-ancestor
83038662|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
83038663|NCT04057989|Ketamine|ketamine|mesh-list
83038664|NCT04057989|Analgesics|analgesics|mesh-ancestor
83038665|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
83038666|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038667|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038668|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83038669|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83038670|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
83038671|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
83038672|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038673|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83038674|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83038675|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038676|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038677|NCT00486200|Valacyclovir|valacyclovir|mesh-list
83038678|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
83038679|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038680|NCT00479258|Insulin|insulin|mesh-list
83038681|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83038682|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038683|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038684|NCT00612170|Reboxetine|reboxetine|mesh-list
83038685|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
83038686|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83038687|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83038688|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83038689|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83038690|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038691|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038692|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038693|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038694|NCT05068336|Anesthetics|anesthetics|mesh-list
83038695|NCT05068336|Sevoflurane|sevoflurane|mesh-list
83038696|NCT05068336|Desflurane|desflurane|mesh-list
83038697|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038698|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038699|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83038700|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83038701|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
83038702|NCT00607256|Reboxetine|reboxetine|mesh-list
83038703|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
83038704|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83038705|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83038706|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83038707|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83038708|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038709|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038710|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038711|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038712|NCT02774590|Timolol|timolol|mesh-list
83038713|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83038714|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83038715|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038716|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038717|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038718|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038719|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83038720|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83038721|NCT01069341|Ranibizumab|ranibizumab|mesh-list
83038722|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83038723|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83038724|NCT01069341|Growth Substances|growth substances|mesh-ancestor
83038725|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038726|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
83038727|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038728|NCT00676832|Prednisolone|prednisolone|mesh-list
83038729|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83038730|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
83038731|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83038732|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
83038733|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83038734|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
83038735|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038736|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
83038737|NCT00676832|Hormones|hormones|mesh-ancestor
83038738|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038739|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038740|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83038741|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038742|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
83038743|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
83038744|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038745|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83038746|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83038747|NCT00676832|Protective Agents|protective agents|mesh-ancestor
83038748|NCT01909414|Vaccines|vaccines|mesh-list
83038749|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
83038750|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038751|NCT00467402|Agomelatine|agomelatine|mesh-list
83038752|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83038753|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038754|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038755|NCT02996097|Triamcinolone|triamcinolone|mesh-list
83038756|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83038757|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83038758|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83038759|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038760|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
83038761|NCT02996097|Hormones|hormones|mesh-ancestor
83038762|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038763|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038764|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038765|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
83038766|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038767|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038768|NCT04054713|Acetic Acid|acetic acid|mesh-list
83038769|NCT04054713|Retinol acetate|retinol acetate|mesh-list
83038770|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038771|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038772|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83038773|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
83038774|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038775|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83038776|NCT04054713|Protective Agents|protective agents|mesh-ancestor
83038777|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038778|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
83038779|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83038780|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83038781|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038782|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
83038783|NCT02568124|Coagulants|coagulants|mesh-ancestor
83038784|NCT03314181|Dexamethasone|dexamethasone|mesh-list
83038785|NCT03314181|Bortezomib|bortezomib|mesh-list
83038786|NCT03314181|Venetoclax|venetoclax|mesh-list
83038787|NCT03314181|Daratumumab|daratumumab|mesh-list
83038788|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038789|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
83038790|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
83038791|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038792|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038793|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83038794|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
83038795|NCT03314181|Hormones|hormones|mesh-ancestor
82949485|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83038796|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038797|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83038798|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038799|NCT03133832|Praziquantel|praziquantel|mesh-list
83038800|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
83038801|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83038802|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038803|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
83038804|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83038805|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038806|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038807|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83038808|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83038809|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038810|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038811|NCT04161430|Incretins|incretins|mesh-ancestor
83038812|NCT04161430|Hormones|hormones|mesh-ancestor
83038813|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038814|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83038815|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
83038816|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038817|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038818|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
83038819|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83038820|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83038821|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
83038822|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038823|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038824|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83038825|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
83038826|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
83038827|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83038828|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
83038829|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038830|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038831|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83038832|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83038833|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83038834|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038835|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
83038836|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83038837|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
83038838|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038839|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038840|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83038841|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
83038842|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
83038843|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83038844|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
83038845|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038846|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038847|NCT04053699|Factor VIII|factor viii|mesh-list
83038848|NCT04053699|Coagulants|coagulants|mesh-ancestor
83038849|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
83038850|NCT04303000|Naloxone|naloxone|mesh-list
83038851|NCT04303000|Narcotics|narcotics|mesh-ancestor
83038852|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83038853|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038854|NCT04303000|Analgesics|analgesics|mesh-ancestor
83038855|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
83038856|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038857|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83038858|NCT00672386|Metformin|metformin|mesh-list
83038859|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83038860|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038861|NCT04056897|Teriflunomide|teriflunomide|mesh-list
83038862|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83438098|NCT00621179|Leuprolide|leuprolide|mesh-list
83038863|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83038864|NCT04056897|Analgesics|analgesics|mesh-ancestor
83038865|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
83038866|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038867|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038868|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83038869|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038870|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038871|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
83038872|NCT02281682|Fluorouracil|fluorouracil|mesh-list
83038873|NCT02281682|Imiquimod|imiquimod|mesh-list
83038874|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83038875|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
83038876|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038877|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83038878|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038879|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038880|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
83038881|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038882|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83038883|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
83038884|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83038885|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
83038886|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83038887|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83038888|NCT04056975|Antibodies|antibodies|mesh-list
83038889|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
83038890|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038891|NCT02281916|Immunomodulating Agents|immunomodulating agents|mesh-list
83038892|NCT02281916|Immunologic Factors|immunologic factors|mesh-ancestor
83038893|NCT02281916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038894|NCT03662763|Guanfacine|guanfacine|mesh-list
83038895|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83038896|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83038897|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83038898|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83038899|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
83038900|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038901|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038902|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038903|NCT00458978|Cediranib|cediranib|mesh-list
83038904|NCT00458978|Maleic acid|maleic acid|mesh-list
83038905|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038906|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038907|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038908|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83038909|NCT00458276|Tezosentan|tezosentan|mesh-list
83038910|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
83038911|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
83038912|NCT04520074|Carboplatin|carboplatin|mesh-list
83038913|NCT04520074|Etoposide|etoposide|mesh-list
83038914|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038915|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
83038916|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038917|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83038918|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83038919|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
83038920|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038921|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038922|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83038923|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83038924|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83038925|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83038926|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038927|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83038928|NCT00455156|ST 1435|st 1435|mesh-list
83038929|NCT00455156|Estradiol|estradiol|mesh-list
83038930|NCT00455156|Estrogens|estrogens|mesh-ancestor
83038931|NCT00455156|Hormones|hormones|mesh-ancestor
83038932|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83038933|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038934|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83038935|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
83038936|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83038937|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83038938|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83038939|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83038940|NCT03661515|Cytarabine|cytarabine|mesh-list
83038941|NCT03661515|Fludarabine|fludarabine|mesh-list
83038942|NCT03661515|Idarubicin|idarubicin|mesh-list
83038943|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83038944|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83038945|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
83038946|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038947|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83038948|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
83038949|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038950|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
83038951|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038952|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83038953|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83038954|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83038955|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038956|NCT01624480|Modafinil|modafinil|mesh-list
83038957|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83038958|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038959|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83361698|NCT01692197|Idarubicin|idarubicin|mesh-list
83038960|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83038961|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83038962|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038963|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83038964|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83038965|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83038966|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83038967|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038968|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038969|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038970|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83038971|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
83038972|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83038973|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
83038974|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83038976|NCT05073172|Mineral Oil|mineral oil|mesh-list
83038977|NCT05073172|Emollients|emollients|mesh-ancestor
83038978|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
83038979|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83038980|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83038981|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83038982|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83038983|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
83038984|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83038985|NCT02284412|Neostigmine|neostigmine|mesh-list
83038986|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83038987|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038988|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038989|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
83038990|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83038991|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83038992|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83038993|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
83038994|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83038995|NCT02789020|Rasagiline|rasagiline|mesh-list
83038996|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83038997|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83038998|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83038999|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83039000|NCT02789020|Protective Agents|protective agents|mesh-ancestor
83039001|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039002|NCT02284490|Pemetrexed|pemetrexed|mesh-list
83039003|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039004|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039005|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039006|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83039007|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83039008|NCT02273570|Vitamin D|vitamin d|mesh-list
83039009|NCT02273570|Calcium|calcium|mesh-list
83039010|NCT02273570|Vitamins|vitamins|mesh-ancestor
83039011|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
83039012|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039013|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83039014|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83039015|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
83039016|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83039017|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83039018|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83039019|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039020|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
83039021|NCT00579020|Dexamethasone|dexamethasone|mesh-list
83039022|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
83039023|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83039024|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83039025|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83039026|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83039027|NCT00579020|BB 1101|bb 1101|mesh-list
83039028|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039029|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
83039030|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
83039031|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039032|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039033|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039034|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
83039035|NCT00579020|Hormones|hormones|mesh-ancestor
83039036|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039037|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83039038|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039039|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
83039040|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039041|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039042|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83039043|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039044|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83039045|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83039046|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83039047|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
83039048|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83039049|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83039050|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83039051|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83039052|NCT04530604|Defibrotide|defibrotide|mesh-list
83039053|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83039054|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83039055|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039056|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83039057|NCT04169698|Denosumab|denosumab|mesh-list
83039058|NCT04169698|Alendronate|alendronate|mesh-list
83039059|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83039060|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039061|NCT04470752|Capsaicin|capsaicin|mesh-list
83039062|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83039063|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
83039064|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
83039065|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
83039066|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039067|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039068|NCT02273804|Topiramate|topiramate|mesh-list
83039069|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
83039070|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83039071|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039072|NCT00578474|Ofloxacin|ofloxacin|mesh-list
83039073|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83039074|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83039075|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039076|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83039077|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83039078|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83039079|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039080|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039081|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039082|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83039083|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83039084|NCT00577148|Rimonabant|rimonabant|mesh-list
83039085|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83039086|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83039087|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83039088|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039089|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039090|NCT00577148|Hormones|hormones|mesh-ancestor
83039091|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039092|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039093|NCT03673228|Nicotine|nicotine|mesh-list
83039094|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83039095|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
83039096|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039097|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039098|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83039099|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83039100|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
83039101|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039102|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039103|NCT05116462|Paclitaxel|paclitaxel|mesh-list
83039104|NCT05116462|Docetaxel|docetaxel|mesh-list
83039105|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83039106|NCT05116462|Carboplatin|carboplatin|mesh-list
83039107|NCT05116462|Gemcitabine|gemcitabine|mesh-list
83039109|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83039110|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039111|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83039112|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83039113|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83039114|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039115|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83039116|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
83039117|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039118|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83039119|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83039120|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
83039121|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83039122|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
83039123|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039124|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
83039125|NCT05116306|Protective Agents|protective agents|mesh-ancestor
83039126|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83039127|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
83039128|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039129|NCT00570752|Atorvastatin|atorvastatin|mesh-list
83039130|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83039131|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83039132|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
83039133|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039134|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83039135|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83039136|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039137|NCT02282384|Oseltamivir|oseltamivir|mesh-list
83039138|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
83039139|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
83039140|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039141|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039142|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039143|NCT02282384|Antacids|antacids|mesh-ancestor
83039144|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039145|NCT02989389|Itraconazole|itraconazole|mesh-list
83039146|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
83039147|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039148|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83039149|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83039150|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039151|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039152|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83039153|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
83039154|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039155|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039156|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83039157|NCT02653300|Insulin|insulin|mesh-list
83039158|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83039159|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039160|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83039161|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
83039162|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039164|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83039165|NCT03187509|Diuretics|diuretics|mesh-ancestor
83039166|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
83039167|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039168|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83039169|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83039170|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039171|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83039172|NCT00430508|Olmesartan|olmesartan|mesh-list
83039173|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83039174|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83039175|NCT00430508|Diuretics|diuretics|mesh-ancestor
83039176|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
83039177|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039178|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83039179|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83039180|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039181|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83039182|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83039183|NCT04221880|Lidocaine|lidocaine|mesh-list
83039184|NCT04221880|Bupivacaine|bupivacaine|mesh-list
83039185|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83039186|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
83039187|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
83039188|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039189|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039190|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
83039191|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039192|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83039193|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83039194|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83039195|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83039196|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039197|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
83039198|NCT04055415|Expectorants|expectorants|mesh-list
83039199|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
83039200|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039201|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039202|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83039203|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
83039204|NCT00427856|Rituximab|rituximab|mesh-list
83039205|NCT00427856|Obatoclax|obatoclax|mesh-list
83039206|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039207|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039208|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
83039209|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039210|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039211|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039212|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039213|NCT00427154|Insulin|insulin|mesh-list
83039214|NCT00427154|Metformin|metformin|mesh-list
83039215|NCT00427154|Glimepiride|glimepiride|mesh-list
83039216|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
83039217|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83039218|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83039219|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039220|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83039221|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83039222|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
83039223|NCT02988219|Epinephrine|epinephrine|mesh-list
83039224|NCT02988219|Fentanyl|fentanyl|mesh-list
83039225|NCT02988219|Bupivacaine|bupivacaine|mesh-list
83039226|NCT02988219|Anesthetics|anesthetics|mesh-list
83039227|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
83039228|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039229|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039230|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
83039231|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039232|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83039233|NCT02988219|Narcotics|narcotics|mesh-ancestor
83039234|NCT02988219|Analgesics|analgesics|mesh-ancestor
83039235|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83039236|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83039237|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
83039238|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83039239|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83039240|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
83039241|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039242|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039243|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83039244|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83039245|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
83039246|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83039247|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
83039248|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
83039249|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
83039250|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83039251|NCT01346059|Vancomycin|vancomycin|mesh-list
83039252|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83039253|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039254|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
83039255|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
83039256|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
83039257|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039258|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039259|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
83039260|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83039261|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83039262|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
83039263|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039264|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039265|NCT04548973|Esketamine|esketamine|mesh-list
83039266|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
83039267|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83039268|NCT02277938|Amantadine|amantadine|mesh-list
83039269|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83039270|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83039271|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
83039272|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039273|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
83039274|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039275|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039276|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039277|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039278|NCT02277938|Analgesics|analgesics|mesh-ancestor
83039279|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
83039280|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039281|NCT00415142|Escitalopram|escitalopram|mesh-list
83039282|NCT00415142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83039283|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83039284|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83039285|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039286|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039287|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
83039288|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039289|NCT04708145|Aflibercept|aflibercept|mesh-list
83039290|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83039291|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83039292|NCT04708145|Growth Substances|growth substances|mesh-ancestor
83039293|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039294|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
83039295|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039296|NCT03661125|Saracatinib|saracatinib|mesh-list
83039297|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039298|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039299|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039300|NCT00413114|Obatoclax|obatoclax|mesh-list
83039301|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039302|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039303|NCT03016013|Methotrexate|methotrexate|mesh-list
83039304|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83039305|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
83039306|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83039307|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039308|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83039309|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
83039310|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039311|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039312|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
83039313|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039314|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83039315|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83039316|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
83039317|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039318|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83039319|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
83039321|NCT01318915|Rituximab|rituximab|mesh-list
83039322|NCT01318915|Tacrolimus|tacrolimus|mesh-list
83039323|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
83039324|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83039325|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039326|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039327|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
83039328|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039329|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039330|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83039331|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83039332|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039333|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039335|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83039336|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
83039337|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83039338|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039339|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
83039340|NCT04688177|Nicotine|nicotine|mesh-list
83039341|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
83039342|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83039343|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
83039344|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039345|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039346|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83039347|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83039348|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
83039349|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039350|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039351|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
83039352|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
83039353|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
83039354|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039355|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039356|NCT04675294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83039357|NCT04675294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039358|NCT00411242|Agomelatine|agomelatine|mesh-list
83039359|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83039360|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039361|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039362|NCT05203913|Paclitaxel|paclitaxel|mesh-list
83039363|NCT05203913|Nivolumab|nivolumab|mesh-list
83039364|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83039365|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039366|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
83039367|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
83039368|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
83039369|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039370|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039371|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83039372|NCT00402428|Interferons|interferons|mesh-list
83039373|NCT00402428|Ribavirin|ribavirin|mesh-list
83039374|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
83039375|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
83039376|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83039377|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039378|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
83039379|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039380|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
83039381|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039382|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
83039383|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039384|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
83039385|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83039386|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83039387|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039388|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
83039389|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
83039390|NCT03660267|Caffeine|caffeine|mesh-list
83039391|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83039392|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039393|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83039394|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039395|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039396|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83039397|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83039398|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
83039399|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039400|NCT03950245|Glucagon|glucagon|mesh-list
83039401|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83039402|NCT03950245|Incretins|incretins|mesh-ancestor
83039403|NCT03950245|Hormones|hormones|mesh-ancestor
83039404|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039405|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039406|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039407|NCT00401570|Gemcitabine|gemcitabine|mesh-list
83039408|NCT00401570|Volociximab|volociximab|mesh-list
83039409|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83039410|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
83039411|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039412|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039413|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83039414|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83039415|NCT00401570|Growth Substances|growth substances|mesh-ancestor
83039416|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039417|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
83039418|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83039419|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
83039420|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
83039421|NCT05193565|Sirolimus|sirolimus|mesh-list
83039422|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83039423|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039424|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83039425|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
83039426|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83039427|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039428|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039429|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039430|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
83039431|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83039432|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
83039433|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039434|NCT04471922|Rabeprazole|rabeprazole|mesh-list
83039435|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83039436|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039437|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83039438|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039439|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039440|NCT04368364|Morphine|morphine|mesh-list
83039441|NCT04368364|Bupivacaine|bupivacaine|mesh-list
83039442|NCT04368364|Ropivacaine|ropivacaine|mesh-list
83039443|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
83039444|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
83039445|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039446|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039447|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
83039448|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039449|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83039450|NCT04368364|Narcotics|narcotics|mesh-ancestor
83039451|NCT04368364|Analgesics|analgesics|mesh-ancestor
83039452|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83039453|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
83039454|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039455|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
83039456|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039457|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
83039458|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039459|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83039460|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83476458|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039461|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039462|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83039463|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039464|NCT05229796|Empagliflozin|empagliflozin|mesh-list
83039465|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83039466|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039467|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83039468|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039469|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
83039470|NCT04189588|Promethazine|promethazine|mesh-list
83039471|NCT04189588|Cetirizine|cetirizine|mesh-list
83039472|NCT04189588|Paclitaxel|paclitaxel|mesh-list
83039473|NCT04189588|Rituximab|rituximab|mesh-list
83039474|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83039475|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039476|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
83039477|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
83039478|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
83039479|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039480|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039481|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
83039482|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039483|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039484|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83039485|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83039486|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039487|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
83039488|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
83039489|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
83039490|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039491|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
83039492|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
83039493|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039494|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83039495|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
83039496|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
83039497|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039498|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83039499|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
83039500|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
83039501|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83039502|NCT00151892|Mesalamine|mesalamine|mesh-list
83039503|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83039504|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039505|NCT00151892|Analgesics|analgesics|mesh-ancestor
83039506|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
83039507|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039508|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039509|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039510|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039511|NCT02740127|Dexamethasone|dexamethasone|mesh-list
83039512|NCT02740127|Clonidine|clonidine|mesh-list
83039513|NCT02740127|Epinephrine|epinephrine|mesh-list
83039514|NCT02740127|Propofol|propofol|mesh-list
83039515|NCT02740127|Ropivacaine|ropivacaine|mesh-list
83039516|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039517|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
83039518|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
83039519|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039520|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039521|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039522|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
83039523|NCT02740127|Hormones|hormones|mesh-ancestor
83039524|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039525|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83039526|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039527|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039528|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83039529|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039530|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83039531|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
83039532|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
83039533|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
83039534|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
83039535|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83039536|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83039537|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
83039538|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039539|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83039540|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83039541|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83039542|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
83039543|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
83039544|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
83039545|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83039546|NCT02740127|Analgesics|analgesics|mesh-ancestor
83039547|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83039548|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
83039549|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83039550|NCT05008783|Capecitabine|capecitabine|mesh-list
83039551|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
83039552|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83039553|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
83039554|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039555|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039556|NCT04450498|Vaccines|vaccines|mesh-list
83039557|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
83039558|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039559|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
83039560|NCT00654992|Hematinics|hematinics|mesh-ancestor
83039561|NCT02921919|Talazoparib|talazoparib|mesh-list
83039562|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83039563|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039564|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039565|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039566|NCT00393068|Paclitaxel|paclitaxel|mesh-list
83039567|NCT00393068|Bevacizumab|bevacizumab|mesh-list
83039568|NCT00393068|Carboplatin|carboplatin|mesh-list
83039569|NCT00393068|Fluorouracil|fluorouracil|mesh-list
83039570|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83039571|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83039572|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039573|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
83039574|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
83039575|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
83039576|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039577|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039578|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83039579|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83039580|NCT00393068|Growth Substances|growth substances|mesh-ancestor
83039581|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039582|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
83039583|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
83039584|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83039585|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83039586|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
83039587|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83039588|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039589|NCT02280278|Immunomodulating Agents|immunomodulating agents|mesh-list
83039590|NCT02280278|Immunologic Factors|immunologic factors|mesh-ancestor
83039591|NCT02280278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039592|NCT04769401|Progesterone|progesterone|mesh-list
83039593|NCT04769401|Progestins|progestins|mesh-ancestor
83039594|NCT04769401|Hormones|hormones|mesh-ancestor
83039595|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039596|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039597|NCT02094222|Glycerol|glycerol|mesh-list
83039598|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83039599|NCT02094222|Protective Agents|protective agents|mesh-ancestor
83039600|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039601|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83039602|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83039603|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83039604|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
83039605|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039606|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83039607|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83039608|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039609|NCT02090244|Teriparatide|teriparatide|mesh-list
83039610|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83039611|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476459|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83039612|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83039613|NCT02282774|Lidocaine|lidocaine|mesh-list
83039614|NCT02282774|Bupivacaine|bupivacaine|mesh-list
83039615|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
83039616|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
83039617|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039618|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039619|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
83039620|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039621|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83039622|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83039623|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83039624|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83039625|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039626|NCT02090322|Bevacizumab|bevacizumab|mesh-list
83039627|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039628|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039629|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83039630|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83039631|NCT02090322|Growth Substances|growth substances|mesh-ancestor
83039632|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039633|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
83039634|NCT03658785|Aldesleukin|aldesleukin|mesh-list
83039635|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
83039636|NCT03658785|Fludarabine|fludarabine|mesh-list
83039637|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83039638|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
83039639|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039640|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039641|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83039642|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
83039643|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039644|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039645|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83039646|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83039647|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83039648|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
83039649|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039650|NCT02095782|Paclitaxel|paclitaxel|mesh-list
83039651|NCT02095782|Carboplatin|carboplatin|mesh-list
83039652|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83039653|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83039654|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039655|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
83039656|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
83039657|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
83039658|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039659|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83039660|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039661|NCT02094378|Esketamine|esketamine|mesh-list
83039662|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
83039663|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83039664|NCT02285738|Aspirin|aspirin|mesh-list
83039665|NCT02285738|Simvastatin|simvastatin|mesh-list
83039666|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83039667|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039668|NCT02285738|Analgesics|analgesics|mesh-ancestor
83039669|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
83039670|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039671|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039672|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039673|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039674|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83039675|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83039676|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039677|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83039678|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83039679|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039680|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
83039681|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83039682|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83039683|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
83039684|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83039685|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83039686|NCT00650702|Latanoprost|latanoprost|mesh-list
83039687|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83039688|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83039689|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
83039690|NCT02090400|Calcium|calcium|mesh-list
83039691|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83039692|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039693|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83039694|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83039695|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
83438165|NCT00246259|Risperidone|risperidone|mesh-list
83039696|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039697|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83039698|NCT03134846|Cetuximab|cetuximab|mesh-list
83039699|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039700|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039701|NCT01068717|Metformin|metformin|mesh-list
83039702|NCT01068717|Saxagliptin|saxagliptin|mesh-list
83039703|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83039704|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039705|NCT01068717|Incretins|incretins|mesh-ancestor
83039706|NCT01068717|Hormones|hormones|mesh-ancestor
83084038|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039707|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039708|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83039709|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
83039710|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039711|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039712|NCT02095938|Amisulpride|amisulpride|mesh-list
83039713|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83039714|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83039715|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039716|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039717|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83039718|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83039719|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
83039720|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039721|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039722|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83039723|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
83039724|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83039726|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83039727|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039728|NCT02285972|Analgesics|analgesics|mesh-ancestor
83039729|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
83039730|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039731|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039732|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039733|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039734|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83039735|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039736|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039737|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
83039738|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83039739|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039740|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
83039741|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
83039742|NCT02921763|Progestins|progestins|mesh-ancestor
83039743|NCT02921763|Hormones|hormones|mesh-ancestor
83039744|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039745|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039746|NCT03658473|Naproxen|naproxen|mesh-list
83039747|NCT03658473|Rabeprazole|rabeprazole|mesh-list
83039748|NCT03658473|Rebamipide|rebamipide|mesh-list
83039749|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83039750|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039751|NCT03658473|Analgesics|analgesics|mesh-ancestor
83039752|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
83039753|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039754|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039755|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039756|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039757|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
83039758|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83039759|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476460|NCT03013439|Hematinics|hematinics|mesh-ancestor
83438177|NCT00673439|PENTA|penta|mesh-list
83039760|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039762|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039763|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83039764|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
83039765|NCT03658473|Protective Agents|protective agents|mesh-ancestor
83039766|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
83039767|NCT02096250|Edetic Acid|edetic acid|mesh-list
83039768|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
83039769|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
83039770|NCT02096250|Trace Elements|trace elements|mesh-ancestor
83039771|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
83039772|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039773|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83039774|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
83039775|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
83039776|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039777|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
83039778|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83039779|NCT02096250|Hematinics|hematinics|mesh-ancestor
83039780|NCT02096328|Murepavadin|murepavadin|mesh-list
83039781|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83039782|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83039783|NCT01318135|Metformin|metformin|mesh-list
83039784|NCT01318135|Glimepiride|glimepiride|mesh-list
83039785|NCT01318135|Alogliptin|alogliptin|mesh-list
83039786|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83039787|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039788|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83039789|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83039790|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
83039791|NCT01318135|Incretins|incretins|mesh-ancestor
83039792|NCT01318135|Hormones|hormones|mesh-ancestor
83039793|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039794|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83039795|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
83039796|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039797|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039798|NCT02094924|Candesartan|candesartan|mesh-list
83039799|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
83039800|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83039801|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83039802|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83039803|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039804|NCT02286206|Clozapine|clozapine|mesh-list
83039805|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83039806|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
83039807|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039808|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039809|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039810|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83039811|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83039812|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039813|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83039814|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
83039815|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
83039816|NCT03104283|Apatinib|apatinib|mesh-list
83039817|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039818|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83039819|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039820|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039821|NCT00529178|Pravastatin|pravastatin|mesh-list
83039822|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83039823|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83039824|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
83039825|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039826|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83039827|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83039828|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039829|NCT00382460|Pravastatin|pravastatin|mesh-list
83039830|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83039831|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83039832|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
83039833|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039834|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83039835|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83039836|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039837|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83039838|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83039839|NCT02286596|Heparin|heparin|mesh-list
83039840|NCT02286596|Dextrans|dextrans|mesh-list
83039841|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
83039842|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83039843|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83039844|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039845|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
83039846|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
83039847|NCT02098824|Methylphenidate|methylphenidate|mesh-list
83039848|NCT02098824|Galantamine|galantamine|mesh-list
83039849|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83039850|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039851|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83039852|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83039853|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83039854|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039855|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
83039857|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83039858|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039859|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
83039860|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83039861|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
83039862|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039863|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
83039864|NCT03658317|Uric Acid|uric acid|mesh-list
83039865|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
83039866|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039867|NCT03658317|Protective Agents|protective agents|mesh-ancestor
83039868|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039869|NCT02286752|Neostigmine|neostigmine|mesh-list
83039870|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83039871|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039872|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039873|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
83039874|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039875|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039876|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83039877|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
83039878|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039879|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
83039880|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83039881|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83039882|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039883|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039884|NCT04470050|Analgesics|analgesics|mesh-ancestor
83039885|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
83039886|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039887|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83039888|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83039889|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83039890|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
83039891|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039892|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039893|NCT02095314|Vaccines|vaccines|mesh-list
83039894|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
83039895|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039896|NCT02098980|Vitamin D|vitamin d|mesh-list
83039897|NCT02098980|Vitamins|vitamins|mesh-ancestor
83039898|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
83039899|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039900|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83039901|NCT00372944|Capecitabine|capecitabine|mesh-list
83039902|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83039903|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
83039904|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039905|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039906|NCT02099136|Celecoxib|celecoxib|mesh-list
83039907|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83039908|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039909|NCT02099136|Analgesics|analgesics|mesh-ancestor
83039910|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
83039911|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039912|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039913|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039914|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039915|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83039916|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83039917|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039918|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039919|NCT00117650|Etoposide|etoposide|mesh-list
83039920|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
83039921|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83039922|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039923|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83039924|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83039925|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039926|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039927|NCT02095548|Lorecivivint|lorecivivint|mesh-list
83039928|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83039929|NCT00113438|Paclitaxel|paclitaxel|mesh-list
83039930|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
83039931|NCT00113438|Combretastatin|combretastatin|mesh-list
83039932|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83039933|NCT00113438|Carboplatin|carboplatin|mesh-list
83039934|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83039935|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039936|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
83039937|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
83039938|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
83039939|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039940|NCT04087408|Hormones|hormones|mesh-list
83039941|NCT04087408|Progesterone|progesterone|mesh-list
83039942|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039943|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039944|NCT04087408|Progestins|progestins|mesh-ancestor
83039945|NCT02099292|Rituximab|rituximab|mesh-list
83039946|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83039947|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039948|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
83039949|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039950|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83039951|NCT02283242|Galantamine|galantamine|mesh-list
83039952|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83039953|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83039954|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039955|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
83039956|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83039957|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039958|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83039959|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
83039960|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039961|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
83039962|NCT02283320|Docetaxel|docetaxel|mesh-list
83039963|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83039964|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83039965|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83039966|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83039967|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83039968|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83039969|NCT03556098|Hormones|hormones|mesh-list
83039970|NCT03556098|Incretins|incretins|mesh-list
83039971|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039972|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83039973|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83039974|NCT02286986|Cannabidiol|cannabidiol|mesh-list
83039975|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
83039976|NCT04995874|Micronutrients|micronutrients|mesh-list
83039977|NCT04995874|Trace Elements|trace elements|mesh-list
83039978|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039979|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
83039980|NCT02287064|Antibodies|antibodies|mesh-list
83039981|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
83039982|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83039983|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83039984|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
83039985|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039986|NCT02095704|Acetaminophen|acetaminophen|mesh-list
83039987|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83039988|NCT02095704|Analgesics|analgesics|mesh-ancestor
83039989|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
83039990|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83039991|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83039992|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
83039993|NCT02099604|Vitamin D|vitamin d|mesh-list
83039994|NCT02099604|Interferons|interferons|mesh-list
83039995|NCT02099604|Ribavirin|ribavirin|mesh-list
83039996|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
83039997|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
83039998|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83039999|NCT02099604|Vitamins|vitamins|mesh-ancestor
83040000|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
83040001|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040002|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83040003|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040004|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
83040005|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040006|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
83040007|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040008|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
83040010|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040011|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83040012|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
83040013|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040014|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83040015|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
83040016|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83040017|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
83040018|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040019|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040020|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83040021|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83040022|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040023|NCT00366704|Risperidone|risperidone|mesh-list
83040024|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83040025|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
83040026|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040027|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040028|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040029|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83040030|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83040031|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040032|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83040033|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83040034|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
83040035|NCT02097264|Adalimumab|adalimumab|mesh-list
83040036|NCT02097264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83040037|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040038|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040039|NCT02097342|Linagliptin|linagliptin|mesh-list
83040040|NCT02097342|Voglibose|voglibose|mesh-list
83040041|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83040042|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040043|NCT02097342|Incretins|incretins|mesh-ancestor
83040044|NCT02097342|Hormones|hormones|mesh-ancestor
83040045|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83040046|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83040047|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
83040048|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040049|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040050|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83040051|NCT04294498|Entecavir|entecavir|mesh-list
83040052|NCT04294498|Durvalumab|durvalumab|mesh-list
83040053|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040054|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040055|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
83040056|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040057|NCT04059172|Ibuprofen|ibuprofen|mesh-list
83040058|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040059|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040060|NCT04059172|Analgesics|analgesics|mesh-ancestor
83040061|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
83040062|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040063|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040064|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040065|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040066|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83040067|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040068|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040070|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040071|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
83040072|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
83040073|NCT03530462|Rituximab|rituximab|mesh-list
83040074|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
83040075|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83040076|NCT03530462|Antibodies|antibodies|mesh-list
83040077|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
83040078|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83040079|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83040080|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
83040081|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040082|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040083|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040084|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
83040085|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040086|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040087|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83040088|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040089|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040090|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
83040091|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
83040092|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040093|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83040094|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
83040095|NCT03530462|Hormones|hormones|mesh-ancestor
83040096|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83040097|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83040098|NCT03530462|Protective Agents|protective agents|mesh-ancestor
83040099|NCT02103192|Antioxidants|antioxidants|mesh-list
83040100|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040101|NCT02103192|Protective Agents|protective agents|mesh-ancestor
83040102|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040103|NCT02097810|Entrectinib|entrectinib|mesh-list
83040104|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83040105|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040106|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040107|NCT02100462|Aspirin|aspirin|mesh-list
83040108|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83040109|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
83040110|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040111|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040112|NCT02100462|Analgesics|analgesics|mesh-ancestor
83040113|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
83040114|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040115|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040116|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040117|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040118|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83040119|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83040120|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040121|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83040122|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83040123|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040124|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
83040125|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83040126|NCT02100462|Diuretics|diuretics|mesh-ancestor
83040127|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
83040128|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83040129|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83040130|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
83040131|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83040132|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
83040133|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040134|NCT00150176|Asenapine|asenapine|mesh-list
83040135|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83040136|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83040137|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040138|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040139|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83040140|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
83040141|NCT00961792|Promethazine|promethazine|mesh-list
83040142|NCT00961792|Ethanol|ethanol|mesh-list
83040143|NCT00961792|Caffeine|caffeine|mesh-list
83040144|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83040145|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040146|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83040147|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040148|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040149|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83040150|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83040151|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
83040152|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040153|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83040154|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040155|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040156|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83361699|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040157|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83040158|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
83040159|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
83040160|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
83040161|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040162|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
83040163|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
83040164|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83040165|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83040166|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
83040167|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
83040168|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83040169|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
83040170|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83040171|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
83040172|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040173|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
83040174|NCT02100852|Chlorambucil|chlorambucil|mesh-list
83040175|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040176|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040177|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040178|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
83040179|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040180|NCT00057980|Celecoxib|celecoxib|mesh-list
83040181|NCT00057980|Epirubicin|epirubicin|mesh-list
83040182|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040183|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040184|NCT00057980|Analgesics|analgesics|mesh-ancestor
83040185|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
83040186|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040187|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040188|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040189|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040190|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83040191|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83040192|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040193|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040194|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83040195|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040196|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83040197|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83040198|NCT02985879|Tilavonemab|tilavonemab|mesh-list
83040199|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
83040200|NCT02097966|Ribavirin|ribavirin|mesh-list
83040201|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
83040202|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
83040203|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040204|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
83040205|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040206|NCT00052598|Aldesleukin|aldesleukin|mesh-list
83040207|NCT00052598|Interleukin-2|interleukin-2|mesh-list
83040208|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040209|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040210|NCT00052598|Analgesics|analgesics|mesh-ancestor
83040211|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
83040212|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040213|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040214|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83040215|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83040216|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
83040217|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040218|NCT05037994|Prednisolone|prednisolone|mesh-list
83040219|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83040220|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
83040221|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83040222|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
83040223|NCT05037994|Gabapentin|gabapentin|mesh-list
83040224|NCT05037994|Bupivacaine|bupivacaine|mesh-list
83040225|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83040226|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
83040227|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040228|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
83040229|NCT05037994|Hormones|hormones|mesh-ancestor
83040230|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83361700|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
83040231|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040232|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83040233|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040235|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
83040236|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040237|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83040238|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83040239|NCT05037994|Protective Agents|protective agents|mesh-ancestor
83040240|NCT05037994|Analgesics|analgesics|mesh-ancestor
83040241|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
83040242|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
83040243|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83040244|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83040245|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040246|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83040247|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83040248|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83040249|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040250|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040251|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
83040252|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
83040253|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
83040254|NCT00052520|Aldesleukin|aldesleukin|mesh-list
83040255|NCT00052520|Interleukin-2|interleukin-2|mesh-list
83040256|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040257|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040258|NCT00052520|Analgesics|analgesics|mesh-ancestor
83040259|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
83040260|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040261|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040262|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83040263|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83040264|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
83040265|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040266|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
83040267|NCT05036434|Lenvatinib|lenvatinib|mesh-list
83040268|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040269|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040270|NCT05036434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83040271|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040272|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83040273|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040274|NCT00051038|Entecavir|entecavir|mesh-list
83040275|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
83040276|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040277|NCT05035186|Amoxicillin|amoxicillin|mesh-list
83040278|NCT05035186|Clarithromycin|clarithromycin|mesh-list
83438196|NCT03029013|Apatinib|apatinib|mesh-list
83040279|NCT05035186|Levofloxacin|levofloxacin|mesh-list
83040280|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83040281|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040282|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83040283|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040284|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040285|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83040286|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83040287|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83040288|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83040289|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83040290|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040291|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83040293|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83040294|NCT01067469|Lomustine|lomustine|mesh-list
83040295|NCT01067469|Antibodies|antibodies|mesh-list
83040296|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
83040297|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83040298|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040299|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83040300|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83040301|NCT01067469|Growth Substances|growth substances|mesh-ancestor
83040302|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040303|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
83040304|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
83040305|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040306|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
83361701|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
83040307|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040308|NCT00050102|Ipilimumab|ipilimumab|mesh-list
83361702|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040309|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040310|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040311|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83040312|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040313|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83040314|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
83040315|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
83040316|NCT02103660|Progestins|progestins|mesh-list
83040317|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040318|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040319|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83040320|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83040321|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83040322|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83040323|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83040324|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83040325|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83040326|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040327|NCT02103660|Hormones|hormones|mesh-ancestor
83040328|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83040329|NCT02788773|Durvalumab|durvalumab|mesh-list
83040330|NCT02788773|Tremelimumab|tremelimumab|mesh-list
83040331|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040332|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040333|NCT00358982|Mocetinostat|mocetinostat|mesh-list
83040334|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83040335|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040336|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040337|NCT02101164|Denosumab|denosumab|mesh-list
83040338|NCT02101164|Pamidronate|pamidronate|mesh-list
83040339|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83040340|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040341|NCT00036608|Entecavir|entecavir|mesh-list
83040342|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
83040343|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040344|NCT02103738|Ranibizumab|ranibizumab|mesh-list
83040345|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83040346|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83040347|NCT02103738|Growth Substances|growth substances|mesh-ancestor
83040348|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040349|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
83040350|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040351|NCT02985021|Carboplatin|carboplatin|mesh-list
83040352|NCT02985021|Docetaxel|docetaxel|mesh-list
83040353|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040354|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83040355|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83040356|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83040357|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040358|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
83040359|NCT05714540|Ketamine|ketamine|mesh-list
83040360|NCT05714540|Analgesics|analgesics|mesh-ancestor
83040361|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
83040362|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040363|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040364|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83040365|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83040366|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
83040367|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
83040368|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040369|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83040370|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83040371|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040372|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040373|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83040374|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
83040375|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83040376|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83040377|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83040378|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
83040379|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040380|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
83040381|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83040383|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040384|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040385|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83040386|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83040387|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83040388|NCT04441424|Azithromycin|azithromycin|mesh-list
83040389|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
83040390|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83040391|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040392|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
83040393|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83040394|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83040395|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040396|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040397|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040398|NCT03530228|Esomeprazole|esomeprazole|mesh-list
83040399|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83040400|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83040401|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83040402|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040403|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040404|NCT01066923|Aspirin|aspirin|mesh-list
83040405|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040406|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040407|NCT01066923|Analgesics|analgesics|mesh-ancestor
83040408|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
83040409|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040410|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040411|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040412|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040413|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83040414|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83040415|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040416|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83040417|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83040418|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040419|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
83040420|NCT03530150|Pirfenidone|pirfenidone|mesh-list
83040421|NCT03530150|Analgesics|analgesics|mesh-ancestor
83040422|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
83040423|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040424|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040425|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040426|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040427|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040428|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040429|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040430|NCT02098590|Chloroquine|chloroquine|mesh-list
83040431|NCT02098590|Atovaquone|atovaquone|mesh-list
83040432|NCT02098590|Proguanil|proguanil|mesh-list
83040433|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83040434|NCT02098590|Amebicides|amebicides|mesh-ancestor
83040435|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83040436|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83040437|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040438|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
83040439|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040440|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040441|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040442|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
83040443|NCT03657381|Antibodies|antibodies|mesh-list
83040444|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83040445|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
83040446|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040447|NCT00005918|Lamivudine|lamivudine|mesh-list
83040448|NCT00005918|Efavirenz|efavirenz|mesh-list
83040449|NCT00005918|Stavudine|stavudine|mesh-list
83040450|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83040451|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83040452|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040453|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040454|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
83040455|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040456|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83040457|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83040458|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83040459|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83040460|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83040461|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83040462|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83040463|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83040464|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
83040466|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83040467|NCT02656797|Amebicides|amebicides|mesh-ancestor
83040468|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83040469|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83040470|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040471|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83040472|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
83040473|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
83040474|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83040475|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83040476|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83040477|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83040478|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040479|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
83040480|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040481|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040482|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83040483|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040484|NCT02101476|Acetaminophen|acetaminophen|mesh-list
83040485|NCT02101476|Oxycodone|oxycodone|mesh-list
83040486|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040487|NCT02101476|Analgesics|analgesics|mesh-ancestor
83040488|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
83040489|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040490|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040491|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
83040492|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83040493|NCT02101476|Narcotics|narcotics|mesh-ancestor
83040494|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040495|NCT02104128|Bupropion|bupropion|mesh-list
83040496|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83040497|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
83040498|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83040499|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83040500|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83040501|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83040502|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040503|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
83040504|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040505|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040506|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83040507|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83040508|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040509|NCT00004916|Paclitaxel|paclitaxel|mesh-list
83040510|NCT00004916|Ifosfamide|ifosfamide|mesh-list
83040511|NCT00004916|Teniposide|teniposide|mesh-list
83040512|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83040513|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040514|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
83040515|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
83040516|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
83040517|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040518|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040519|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
83040520|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83040521|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83040522|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040523|NCT02101632|Petrolatum|petrolatum|mesh-list
83040524|NCT02101632|Emollients|emollients|mesh-ancestor
83040525|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
83040526|NCT02101710|Isosorbide|isosorbide|mesh-list
83040527|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83040528|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83040529|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83040530|NCT02101710|Diuretics|diuretics|mesh-ancestor
83040531|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
83040532|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040534|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83040535|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040536|NCT03878368|Sulforaphane|sulforaphane|mesh-list
83040537|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83040538|NCT03878368|Protective Agents|protective agents|mesh-ancestor
83040539|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040540|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040541|NCT02910063|Blinatumomab|blinatumomab|mesh-list
83040542|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040543|NCT04441762|Ketorolac|ketorolac|mesh-list
83040544|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83040545|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040546|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040547|NCT04441762|Analgesics|analgesics|mesh-ancestor
83040548|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
83040549|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040550|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040551|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040552|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040553|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83040554|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040555|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040556|NCT02104284|Mannitol|mannitol|mesh-list
83040557|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
83040558|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83040559|NCT02104284|Diuretics|diuretics|mesh-ancestor
83040560|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
83040561|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040562|NCT02104284|Miotics|miotics|mesh-ancestor
83040563|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
83040564|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040565|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83040566|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83040567|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
83040568|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83040569|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83040570|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
83040571|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040572|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040573|NCT00337532|Paclitaxel|paclitaxel|mesh-list
83040574|NCT00337532|Cisplatin|cisplatin|mesh-list
83040575|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83040576|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040577|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
83040578|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
83040579|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
83040580|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040581|NCT02625441|Trastuzumab|trastuzumab|mesh-list
83040582|NCT02625441|Pertuzumab|pertuzumab|mesh-list
83040583|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040584|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040585|NCT04209868|Bupivacaine|bupivacaine|mesh-list
83040586|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
83040587|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
83040588|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
83040589|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040590|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040591|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
83040592|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040593|NCT02361801|Dobutamine|dobutamine|mesh-list
83040594|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83040595|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
83040596|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
83040597|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040598|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040599|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83040600|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83040601|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83040602|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
83040603|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040604|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040605|NCT02361801|Protective Agents|protective agents|mesh-ancestor
83040606|NCT03965728|Methotrexate|methotrexate|mesh-list
83040607|NCT03965728|Midazolam|midazolam|mesh-list
83040608|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83040609|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
83040610|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040611|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040612|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83040613|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
83040614|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040615|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040616|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
83040617|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040618|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83040619|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83040620|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
83040621|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040622|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83040623|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83040624|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83040625|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040626|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83040627|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83040628|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83040629|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83040630|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
83040631|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
83040632|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
83040633|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
83040634|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040635|NCT00337454|Dasatinib|dasatinib|mesh-list
83040636|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040637|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83040638|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040639|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040640|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
83040641|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83040642|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83040643|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040644|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
83040645|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040646|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040647|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
83040648|NCT00004898|Etoposide|etoposide|mesh-list
83040649|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83040650|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
83040651|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040652|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040653|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040654|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
83040655|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040656|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040657|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83040658|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83040659|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83040660|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83040661|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040662|NCT02106468|Prednisone|prednisone|mesh-list
83040663|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040664|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
83040665|NCT02106468|Hormones|hormones|mesh-ancestor
83040666|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83040667|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040668|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83040669|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040671|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83040672|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040673|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
83040674|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83040675|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83040676|NCT00325364|Insulin|insulin|mesh-list
83040677|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83040678|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83040679|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040680|NCT02104674|Montelukast|montelukast|mesh-list
83040681|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83040682|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
83040683|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83040684|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
83040685|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83040686|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040687|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83040688|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83040689|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040690|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
83040691|NCT01903330|Bevacizumab|bevacizumab|mesh-list
83040692|NCT01903330|Sargramostim|sargramostim|mesh-list
83040693|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83040694|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
83040695|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040696|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040697|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040698|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
83040699|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040700|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040701|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83040702|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040703|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83040704|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83040705|NCT01903330|Growth Substances|growth substances|mesh-ancestor
83040706|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83040707|NCT02907177|Ponesimod|ponesimod|mesh-list
83040708|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83040709|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040710|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83040711|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
83040712|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040713|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
83040714|NCT00004172|Ifosfamide|ifosfamide|mesh-list
83040715|NCT00004172|Thiotepa|thiotepa|mesh-list
83040716|NCT00004172|Carboplatin|carboplatin|mesh-list
83040717|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83040718|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
83040719|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040720|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040721|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040722|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
83040723|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040724|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040725|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83040726|NCT04353310|Curcumin|curcumin|mesh-list
83040727|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040728|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040729|NCT04353310|Analgesics|analgesics|mesh-ancestor
83040730|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
83040731|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040732|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040733|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040734|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040735|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040736|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040737|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040738|NCT00004166|Amifostine|amifostine|mesh-list
83040739|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83040740|NCT00004166|Protective Agents|protective agents|mesh-ancestor
83040741|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040742|NCT00004106|Temozolomide|temozolomide|mesh-list
83040743|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83040744|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
83040745|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040746|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040747|NCT00002246|Stavudine|stavudine|mesh-list
83040748|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
83040749|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040750|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83040751|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83040752|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040753|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
83040754|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040755|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83040756|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83040757|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83040758|NCT00002240|Nelfinavir|nelfinavir|mesh-list
83040759|NCT00002240|Didanosine|didanosine|mesh-list
83040760|NCT00002240|Stavudine|stavudine|mesh-list
83040761|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83040762|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83040763|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83040764|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040765|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040766|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83040767|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83040768|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
83040769|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040770|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
83040771|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83040772|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83040773|NCT02250924|Caffeine|caffeine|mesh-list
83040774|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83040775|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040776|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83040777|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040778|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040779|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83040780|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83040781|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
83040782|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040783|NCT03645148|Molgramostim|molgramostim|mesh-list
83040784|NCT03645148|Sargramostim|sargramostim|mesh-list
83040785|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
83040786|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040787|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040788|NCT04082728|Dipyrone|dipyrone|mesh-list
83040789|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83040790|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83040791|NCT04082728|Analgesics|analgesics|mesh-ancestor
83040792|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
83040793|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040794|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040795|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040796|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83040797|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
83040798|NCT02906709|Insulin|insulin|mesh-list
83040799|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83040800|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040801|NCT00321308|Pemetrexed|pemetrexed|mesh-list
83040802|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040803|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040804|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040805|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83040806|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83040807|NCT02110134|Hydroquinone|hydroquinone|mesh-list
83040808|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
83040809|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040810|NCT02110134|Protective Agents|protective agents|mesh-ancestor
83040811|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040812|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83040813|NCT00318656|Metformin|metformin|mesh-list
83040814|NCT00318656|Glimepiride|glimepiride|mesh-list
83040816|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83040817|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040818|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83040819|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83040820|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
83040821|NCT02110524|Paclitaxel|paclitaxel|mesh-list
83040822|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83040823|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040824|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
83040825|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
83040826|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
83040827|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040828|NCT00317486|Bosentan|bosentan|mesh-list
83040829|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83361703|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040830|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83040831|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040832|NCT02107170|Remifentanil|remifentanil|mesh-list
83040833|NCT02107170|Propofol|propofol|mesh-list
83040834|NCT02107170|Sevoflurane|sevoflurane|mesh-list
83040835|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83040836|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040837|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040838|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83040839|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
83040840|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
83040841|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83040842|NCT02107170|Narcotics|narcotics|mesh-ancestor
83040843|NCT02107170|Analgesics|analgesics|mesh-ancestor
83040844|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
83040845|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040846|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83040847|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83040848|NCT00313196|Bosentan|bosentan|mesh-list
83040849|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83040850|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83040851|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040853|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83040854|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040855|NCT03656679|Trace Elements|trace elements|mesh-ancestor
83040856|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
83040857|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040858|NCT03663166|Nivolumab|nivolumab|mesh-list
83040859|NCT03663166|Ipilimumab|ipilimumab|mesh-list
83040860|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040861|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040862|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83040863|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040864|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
83040865|NCT03554304|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
83040866|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83040867|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83040868|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040869|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83040870|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83040871|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040872|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040873|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040874|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83040875|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
83040876|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040877|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040878|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83040879|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83040880|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83040881|NCT02107716|Lidocaine|lidocaine|mesh-list
83040882|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
83040883|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
83040884|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040885|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040886|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
83040887|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040888|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83040889|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83040890|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83040891|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83040892|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040893|NCT02110992|Docetaxel|docetaxel|mesh-list
83040894|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040895|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83040896|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83040897|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83040898|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040899|NCT03306394|Trifluridine|trifluridine|mesh-list
83040900|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
83040901|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040902|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
83040903|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83040904|NCT03532178|Rocuronium|rocuronium|mesh-list
83040905|NCT03532178|Succinylcholine|succinylcholine|mesh-list
83040906|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83040907|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83040908|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83040909|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83040910|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040911|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83040912|NCT00311090|Idraparinux|idraparinux|mesh-list
83040913|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
83040914|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83040915|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
83040916|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83040917|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
83040918|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040919|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040920|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
83040921|NCT02105610|Anesthetics|anesthetics|mesh-list
83040922|NCT02105610|Sevoflurane|sevoflurane|mesh-list
83040924|NCT02105610|Isoflurane|isoflurane|mesh-list
83040925|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83040926|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040927|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040928|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83040929|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83040930|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
83040931|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
83040932|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040933|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
83040934|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83040935|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83040936|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040937|NCT00301262|Urological Agents|urological agents|mesh-ancestor
83040938|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83040939|NCT02254941|Antibodies|antibodies|mesh-list
83040940|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
83040941|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83040942|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
83040943|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040944|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040945|NCT03598270|Paclitaxel|paclitaxel|mesh-list
83040946|NCT03598270|Carboplatin|carboplatin|mesh-list
83040947|NCT03598270|Gemcitabine|gemcitabine|mesh-list
83040948|NCT03598270|Doxorubicin|doxorubicin|mesh-list
83040949|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83040950|NCT03598270|Atezolizumab|atezolizumab|mesh-list
83040951|NCT03598270|Niraparib|niraparib|mesh-list
83040952|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83040953|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83040954|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040955|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
83040956|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
83040957|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
83040958|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040959|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83040960|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
83040961|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83040962|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83040963|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83040964|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83040965|NCT03598270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83040966|NCT03598270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83040968|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040969|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83040970|NCT03077620|Suvorexant|suvorexant|mesh-list
83040971|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83040972|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83040973|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83040974|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040975|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83040976|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83040977|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040978|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
83040979|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83361704|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83040980|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83040981|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83040982|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
83040983|NCT03656445|Coagulants|coagulants|mesh-ancestor
83040984|NCT01903486|Prednisone|prednisone|mesh-list
83040985|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83040986|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
83040987|NCT01903486|Hormones|hormones|mesh-ancestor
83040988|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83040989|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040990|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83040991|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83040992|NCT03656289|Etonogestrel|etonogestrel|mesh-list
83040993|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83040994|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
83040995|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83040996|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83040997|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83040998|NCT00599170|Rituximab|rituximab|mesh-list
83040999|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041000|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041001|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
83041002|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041003|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041004|NCT04256434|Nalbuphine|nalbuphine|mesh-list
83041005|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83041006|NCT04256434|Narcotics|narcotics|mesh-ancestor
83041007|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041008|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041009|NCT04256434|Analgesics|analgesics|mesh-ancestor
83041010|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
83041011|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041012|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
83041013|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041014|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83041015|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83041016|NCT02107950|Carboplatin|carboplatin|mesh-list
83041017|NCT02107950|Gemcitabine|gemcitabine|mesh-list
83041018|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041019|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83041020|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
83041021|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041022|NCT02108106|Mitapivat|mitapivat|mesh-list
83041023|NCT02108106|Enzyme Activators|enzyme activators|mesh-ancestor
83041024|NCT02108106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041025|NCT02113800|Everolimus|everolimus|mesh-list
83041026|NCT02113800|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83041027|NCT02113800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83041028|NCT02113800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041029|NCT02113800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041030|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041031|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
83041032|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041033|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041034|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83041035|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
83041036|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83041037|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83041038|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83041039|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041040|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041041|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83041042|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83041043|NCT02112006|Bupivacaine|bupivacaine|mesh-list
83041044|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
83041045|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
83041046|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041047|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041048|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
83041049|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041050|NCT02251158|Ritonavir|ritonavir|mesh-list
83041051|NCT02251158|Tipranavir|tipranavir|mesh-list
83041052|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83041053|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83041054|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83041055|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
83041056|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041057|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041058|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83041059|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83041060|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
83041061|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041062|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83041063|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83041064|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
83041065|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041066|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
83041067|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041068|NCT05404516|Cytarabine|cytarabine|mesh-list
83041069|NCT05404516|Sorafenib|sorafenib|mesh-list
83041070|NCT05404516|Idarubicin|idarubicin|mesh-list
83041071|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83041072|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
83041073|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041074|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041075|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
83041076|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041077|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041078|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
83041079|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041080|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83041081|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041082|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83041083|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83041084|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83041085|NCT02114346|Atorvastatin|atorvastatin|mesh-list
83041086|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83041087|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83041088|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
83438217|NCT03311594|Ethanol|ethanol|mesh-list
83041089|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041090|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83041091|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83041092|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041093|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
83041094|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83041095|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83041096|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041097|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
83041098|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
83041099|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041100|NCT02108808|Clopidogrel|clopidogrel|mesh-list
83041101|NCT02108808|Ticagrelor|ticagrelor|mesh-list
83041102|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83041103|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83041104|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83041105|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83041106|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83041107|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
83041108|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041109|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041110|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041111|NCT02108886|Montelukast|montelukast|mesh-list
83041112|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83041113|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
83041114|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83041115|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
83041116|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041117|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041118|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83041119|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83041120|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041121|NCT02114502|Pyridoxine|pyridoxine|mesh-list
83041122|NCT02114502|Dexamethasone|dexamethasone|mesh-list
83041123|NCT02114502|Gemcitabine|gemcitabine|mesh-list
83041124|NCT02114502|Melphalan|melphalan|mesh-list
83041125|NCT02114502|Busulfan|busulfan|mesh-list
83041126|NCT02114502|Vorinostat|vorinostat|mesh-list
83041127|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041128|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
83041129|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
83361705|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
83041130|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041131|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041132|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83041133|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
83041134|NCT02114502|Hormones|hormones|mesh-ancestor
83041135|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041136|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83041137|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041138|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83041139|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
83041140|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041141|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83041142|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
83041143|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83041144|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041145|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
83041146|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83041147|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041148|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
83041149|NCT02114502|Vitamins|vitamins|mesh-ancestor
83041150|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
83041151|NCT03654027|Docetaxel|docetaxel|mesh-list
83041152|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041153|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041154|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041155|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041156|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041157|NCT02114658|Sorafenib|sorafenib|mesh-list
83041158|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041159|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83041160|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041161|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041162|NCT05126602|Vitamin D|vitamin d|mesh-list
83041163|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
83041164|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
83041165|NCT05126602|Vitamins|vitamins|mesh-list
83041166|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
83041167|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041168|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83041169|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83041170|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
83041171|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83041172|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83041173|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83041174|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041175|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
83041176|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041177|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041178|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83041179|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041180|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
83041181|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83041182|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041183|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83041184|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041185|NCT02112552|Paclitaxel|paclitaxel|mesh-list
83041186|NCT02112552|Carboplatin|carboplatin|mesh-list
83041187|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83041188|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041189|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041190|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041191|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041192|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041193|NCT02109354|Vaccines|vaccines|mesh-list
83041194|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
83041195|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041196|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
83041197|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
83041198|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83041199|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83041200|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041201|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041202|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041203|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041204|NCT02109510|Lidocaine|lidocaine|mesh-list
83041205|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
83041206|NCT02109510|Ketamine|ketamine|mesh-list
83041207|NCT02109510|Anesthetics|anesthetics|mesh-list
83041208|NCT02109510|Propofol|propofol|mesh-list
83041209|NCT02109510|Sevoflurane|sevoflurane|mesh-list
83041210|NCT02109510|Rocuronium|rocuronium|mesh-list
83041211|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
83041212|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041213|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041214|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
83041215|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041216|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83041217|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83041218|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83041219|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83041220|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041221|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83041222|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83041223|NCT02109510|Analgesics|analgesics|mesh-ancestor
83041224|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83041225|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83041226|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83041227|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83041228|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041229|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83041230|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
83041231|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83041232|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83041233|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83041234|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83041235|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83041236|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83041237|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83041238|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83041239|NCT02109666|Abatacept|abatacept|mesh-list
83041240|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83041241|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041242|NCT02109666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041243|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041244|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041245|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
83041246|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041247|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041248|NCT02865928|Bupivacaine|bupivacaine|mesh-list
83041249|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
83041250|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
83041251|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041252|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041253|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
83041254|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041255|NCT02109900|Progesterone|progesterone|mesh-list
83041256|NCT02109900|Progestins|progestins|mesh-ancestor
83041257|NCT02109900|Hormones|hormones|mesh-ancestor
83041258|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041259|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041260|NCT02112630|Interferons|interferons|mesh-list
83041261|NCT02112630|Ribavirin|ribavirin|mesh-list
83041262|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
83041263|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
83041264|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83041265|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83041266|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83041267|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041268|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
83041269|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041270|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
83041271|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041272|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
83041273|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041274|NCT04873375|Cemiplimab|cemiplimab|mesh-list
83041275|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041276|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041277|NCT05125588|Meloxicam|meloxicam|mesh-list
83041278|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83361706|NCT01692197|Hormones|hormones|mesh-ancestor
83041280|NCT05125588|Analgesics|analgesics|mesh-ancestor
83041281|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
83041282|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041283|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041284|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041285|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041286|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83041287|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83041288|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041289|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041290|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
83041291|NCT02115204|Docetaxel|docetaxel|mesh-list
83041292|NCT02115204|Fluorouracil|fluorouracil|mesh-list
83041293|NCT02115204|Methotrexate|methotrexate|mesh-list
83041294|NCT02115204|Epirubicin|epirubicin|mesh-list
83041295|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041296|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
83041297|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041298|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041299|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83041300|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
83041301|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041302|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041303|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83041304|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041305|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041306|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041307|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
83041308|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83041309|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83041310|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
83041311|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83041312|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
83041313|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041314|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83041315|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83041316|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83041317|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83041318|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83041319|NCT02115360|Calcitonin|calcitonin|mesh-list
83041320|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
83041321|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83041322|NCT02115360|Fentanyl|fentanyl|mesh-list
83041323|NCT02115360|Katacalcin|katacalcin|mesh-list
83041324|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83041325|NCT02115360|Narcotics|narcotics|mesh-ancestor
83041326|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041327|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041328|NCT02115360|Analgesics|analgesics|mesh-ancestor
83041329|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
83041330|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041331|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83041332|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83041333|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
83041334|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
83041335|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83041336|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83041337|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
83041338|NCT02432404|NuvaRing|nuvaring|mesh-list
83041339|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83041340|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
83041341|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83041342|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041343|NCT02113176|Minocycline|minocycline|mesh-list
83041344|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83041345|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041346|NCT02118870|Aspirin|aspirin|mesh-list
83041347|NCT02118870|Clopidogrel|clopidogrel|mesh-list
83041348|NCT02118870|Ticagrelor|ticagrelor|mesh-list
83041349|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83041350|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83041351|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83041352|NCT02118870|Analgesics|analgesics|mesh-ancestor
83041353|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
83041354|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041355|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041356|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041357|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041358|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83041359|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83041360|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041361|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83041362|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83041363|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041364|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
83041365|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83041366|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83041367|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83041368|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
83041369|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041370|NCT03552666|Vitamin D|vitamin d|mesh-list
83041371|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
83041372|NCT03552666|Vitamins|vitamins|mesh-ancestor
83041373|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
83041374|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041375|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83041376|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83041377|NCT02115594|Fulvestrant|fulvestrant|mesh-list
83041378|NCT02115594|Entinostat|entinostat|mesh-list
83041379|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83041380|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041381|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83041382|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83041383|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
83041384|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041385|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041386|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83041387|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041388|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041389|NCT05125042|Amiodarone|amiodarone|mesh-list
83041390|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83041391|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
83041392|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83041393|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83041394|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041395|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83041396|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83041397|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83041398|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041399|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83041400|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83041401|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83041402|NCT02113332|Liraglutide|liraglutide|mesh-list
83041403|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83041404|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041405|NCT02113332|Incretins|incretins|mesh-ancestor
83041406|NCT02113332|Hormones|hormones|mesh-ancestor
83041407|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041408|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83041409|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83041410|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
83041411|NCT02918877|Propofol|propofol|mesh-list
83041412|NCT02918877|Sevoflurane|sevoflurane|mesh-list
83041413|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83041414|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041415|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041416|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83041417|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
83041418|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
83041419|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83041420|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83041421|NCT03652857|Apatinib|apatinib|mesh-list
83041422|NCT03652857|Vinorelbine|vinorelbine|mesh-list
83041423|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041424|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83041425|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041426|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041427|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83041428|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041429|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041430|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041431|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
83041432|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83041433|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041434|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83041435|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
83041436|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83041437|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041438|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041439|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041441|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
83041442|NCT04221555|Durvalumab|durvalumab|mesh-list
83041443|NCT04221555|Tremelimumab|tremelimumab|mesh-list
83041444|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83041445|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041446|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041447|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041448|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041449|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041450|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041451|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
83041452|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041453|NCT02113566|Acetaminophen|acetaminophen|mesh-list
83041454|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83041455|NCT02113566|Analgesics|analgesics|mesh-ancestor
83041456|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
83041457|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041458|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041459|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
83041460|NCT05124730|Metformin|metformin|mesh-list
83041461|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83041462|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041463|NCT02251626|Ubiquinone|ubiquinone|mesh-list
83041464|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
83041465|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
83041466|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041467|NCT02251626|Vitamins|vitamins|mesh-ancestor
83041468|NCT02123004|Clopidogrel|clopidogrel|mesh-list
83041469|NCT02123004|Ticagrelor|ticagrelor|mesh-list
83041470|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83041471|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83041472|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83041473|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83041474|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
83041475|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041476|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041477|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041478|NCT01674712|Simvastatin|simvastatin|mesh-list
83041479|NCT01674712|Fenofibrate|fenofibrate|mesh-list
83041480|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83041481|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83041482|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
83041483|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041484|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83041485|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83041486|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041487|NCT01368432|Escitalopram|escitalopram|mesh-list
83041488|NCT01368432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83041489|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83041490|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83041491|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041492|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041493|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
83041494|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041496|NCT05122780|Anticoagulants|anticoagulants|mesh-list
83041497|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83041498|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83041499|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83041500|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
83041501|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041502|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041503|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041504|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
83041505|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83041506|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
83041507|NCT02119806|Fentanyl|fentanyl|mesh-list
83041508|NCT02119806|Midazolam|midazolam|mesh-list
83041509|NCT02119806|Propofol|propofol|mesh-list
83041510|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83041511|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041512|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041513|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83041514|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
83041515|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
83041516|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83041517|NCT02119806|Narcotics|narcotics|mesh-ancestor
83041518|NCT02119806|Analgesics|analgesics|mesh-ancestor
83041519|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
83041520|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041521|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83041522|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83041523|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83041524|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83041525|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
83041526|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
83041527|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041528|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041529|NCT02119884|Octreotide|octreotide|mesh-list
83041530|NCT02119884|Terlipressin|terlipressin|mesh-list
83041531|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83041532|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83041533|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041534|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83041535|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83041536|NCT05104918|Vortioxetine|vortioxetine|mesh-list
83041537|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83041538|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83041539|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83041540|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83041541|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041542|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041543|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041544|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83041545|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
83041546|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83041547|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83041548|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83041549|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041550|NCT05104918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83041551|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
83041552|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83041553|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83041554|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83041555|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83041556|NCT05089942|Insulin|insulin|mesh-list
83041557|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83041558|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83041559|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041560|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
83041561|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83041562|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041563|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041565|NCT04941508|Analgesics|analgesics|mesh-ancestor
83041566|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
83041567|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041568|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83041569|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83041570|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83041571|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
83041572|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041573|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041574|NCT01062555|Cyclosporine|cyclosporine|mesh-list
83041575|NCT01062555|Sirolimus|sirolimus|mesh-list
83041576|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
83041577|NCT01062555|Tacrolimus|tacrolimus|mesh-list
83041578|NCT01062555|Cyclosporins|cyclosporins|mesh-list
83041580|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
83041581|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041582|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83041583|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041584|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041585|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
83041586|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041587|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
83041588|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041589|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83041590|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041591|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83041592|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
83041593|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83041594|NCT03622047|Sufentanil|sufentanil|mesh-list
83041595|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
83041596|NCT03622047|Ropivacaine|ropivacaine|mesh-list
83041597|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83041598|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041599|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041600|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83041601|NCT03622047|Analgesics|analgesics|mesh-ancestor
83041602|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
83041603|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041604|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83041605|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83041606|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83041607|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83041608|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041609|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041610|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
83041611|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
83041612|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83041613|NCT03622047|Narcotics|narcotics|mesh-ancestor
83041614|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83041615|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83041616|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
83041617|NCT05128630|Durvalumab|durvalumab|mesh-list
83041618|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041619|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041620|NCT05073562|Folic Acid|folic acid|mesh-list
83041621|NCT05073562|Mebendazole|mebendazole|mesh-list
83041622|NCT05073562|Piperazine|piperazine|mesh-list
83041623|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
83041624|NCT05073562|DMP 777|dmp 777|mesh-list
83041625|NCT05073562|Hematinics|hematinics|mesh-ancestor
83041626|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
83041627|NCT05073562|Vitamins|vitamins|mesh-ancestor
83041628|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
83041629|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041630|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
83041631|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
83041632|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83041633|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041634|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041635|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041636|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041637|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041638|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041639|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041640|NCT01368276|Molgramostim|molgramostim|mesh-list
83041641|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83041642|NCT01368276|Sargramostim|sargramostim|mesh-list
83041643|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
83041644|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041645|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041646|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041647|NCT02116842|Fentanyl|fentanyl|mesh-list
83041648|NCT02116842|Bupivacaine|bupivacaine|mesh-list
83041649|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
83041650|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
83041651|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041652|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041653|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
83041654|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041655|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83041657|NCT02116842|Analgesics|analgesics|mesh-ancestor
83041658|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83041659|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83041660|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
83041661|NCT02120118|Docetaxel|docetaxel|mesh-list
83041662|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041663|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041664|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041665|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041666|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041667|NCT04054089|Tenofovir|tenofovir|mesh-list
83041668|NCT04054089|Lamivudine|lamivudine|mesh-list
83041669|NCT04054089|Emtricitabine|emtricitabine|mesh-list
83041670|NCT04054089|Dolutegravir|dolutegravir|mesh-list
83041671|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
83041672|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041673|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83041674|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83041675|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041676|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041677|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83041678|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83041679|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83041680|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83041681|NCT02120196|Rifaximin|rifaximin|mesh-list
83041682|NCT02120196|Norfloxacin|norfloxacin|mesh-list
83041683|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83041684|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041685|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83041686|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83041687|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83041688|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041689|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041690|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041691|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83041692|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83041693|NCT05001802|Ropivacaine|ropivacaine|mesh-list
83041694|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
83041695|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
83041696|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041697|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041698|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
83041699|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041700|NCT02120274|Vitamin D|vitamin d|mesh-list
83041701|NCT02120274|Vitamins|vitamins|mesh-list
83041702|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
83041703|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
83041704|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
83041705|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041706|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83041707|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
83041708|NCT02120274|Hematinics|hematinics|mesh-ancestor
83041709|NCT02402842|Docetaxel|docetaxel|mesh-list
83041710|NCT02402842|Fluorouracil|fluorouracil|mesh-list
83041711|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041712|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
83041713|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
83041714|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
83041715|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041716|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
83041717|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83041718|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041719|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
83041720|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041722|NCT02741570|Carboplatin|carboplatin|mesh-list
83041723|NCT02741570|Fluorouracil|fluorouracil|mesh-list
83041724|NCT02741570|Nivolumab|nivolumab|mesh-list
83041725|NCT02741570|Cetuximab|cetuximab|mesh-list
83041726|NCT02741570|Ipilimumab|ipilimumab|mesh-list
83041727|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041728|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
83041729|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041730|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83041731|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041732|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
83041733|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041734|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041736|NCT01061775|Exenatide|exenatide|mesh-list
83041737|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83041738|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041739|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83041740|NCT01061775|Incretins|incretins|mesh-ancestor
83041741|NCT01061775|Hormones|hormones|mesh-ancestor
83041742|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041743|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83041744|NCT02123628|Doxycycline|doxycycline|mesh-list
83041745|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
83041746|NCT02123628|Levofloxacin|levofloxacin|mesh-list
83041747|NCT02123628|Rifampin|rifampin|mesh-list
83041748|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
83041749|NCT02123628|Linezolid|linezolid|mesh-list
83041750|NCT02123628|Cefepime|cefepime|mesh-list
83041751|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83041752|NCT02123628|Cefotaxime|cefotaxime|mesh-list
83041753|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
83041754|NCT02123628|Trimethoprim|trimethoprim|mesh-list
83041755|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
83041756|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041757|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83041758|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
83041759|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
83041760|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83041761|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83041762|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83041763|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83041764|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041765|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041766|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041767|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83041768|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83041769|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83041770|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
83041771|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83041772|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83041773|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83041774|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83438285|NCT05686772|Dopamine|dopamine|mesh-list
83041775|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83041776|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83041777|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83041778|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83041779|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83041780|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83041781|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83041782|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
83041783|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
83041784|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
83041785|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83041786|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83041787|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041788|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041789|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041790|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
83041791|NCT03652467|Deferoxamine|deferoxamine|mesh-list
83041792|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83041793|NCT03652467|Estrogens|estrogens|mesh-ancestor
83041794|NCT03652467|Hormones|hormones|mesh-ancestor
83041795|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041796|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041797|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83041798|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041799|NCT03652467|Siderophores|siderophores|mesh-ancestor
83041800|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83041801|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
83041802|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
83041803|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041805|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83041806|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83041807|NCT03528824|Analgesics|analgesics|mesh-ancestor
83041809|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041810|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041811|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041812|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041813|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83041814|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041815|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041816|NCT05045638|Sotorasib|sotorasib|mesh-list
83041817|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83041818|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83041819|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83041820|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
83041821|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041822|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83041823|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83041824|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041825|NCT05045638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83041826|NCT05045638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041827|NCT05045638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041828|NCT00289640|Ipilimumab|ipilimumab|mesh-list
83041829|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041830|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041831|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83041832|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041833|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83041834|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
83041835|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83041836|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041837|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041838|NCT03552432|Alirocumab|alirocumab|mesh-list
83041839|NCT03552432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83041840|NCT03552432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83041841|NCT03552432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83041842|NCT03552432|Antimetabolites|antimetabolites|mesh-ancestor
83041843|NCT03552432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041844|NCT03552432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83041845|NCT03552432|Protease Inhibitors|protease inhibitors|mesh-ancestor
83041846|NCT03552432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041847|NCT03552432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83041848|NCT03765632|Busulfan|busulfan|mesh-list
83041849|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
83041850|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041851|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041852|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
83041853|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041854|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83041855|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041856|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83041857|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
83041858|NCT02973477|Glimepiride|glimepiride|mesh-list
83041859|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83041860|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041861|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83041862|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041863|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83041864|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041865|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
83041866|NCT03552354|Argatroban|argatroban|mesh-list
83041867|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
83041868|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83041869|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
83041870|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041871|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041872|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
83041873|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83041874|NCT02288000|Memantine|memantine|mesh-list
83041875|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83041876|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83041877|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
83041878|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041879|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041880|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362127|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041881|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83041882|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83041883|NCT02788656|Valsartan|valsartan|mesh-list
83041884|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
83041885|NCT02788656|Giapreza|giapreza|mesh-list
83041886|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
83041887|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83041888|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83041889|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83041890|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
83041891|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83041892|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83041893|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041894|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
83041895|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83041896|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83041897|NCT05258110|Midazolam|midazolam|mesh-list
83041898|NCT05258110|BI 425809|bi 425809|mesh-list
83041899|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83041900|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83041901|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83041902|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041903|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83041904|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83041905|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83041906|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83041907|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
83041908|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
83041909|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
83041910|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
83041911|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83041912|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041913|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
83041914|NCT03652233|Nivolumab|nivolumab|mesh-list
83041915|NCT03652233|Afatinib|afatinib|mesh-list
83041916|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041917|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041918|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83041919|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041920|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83041921|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041922|NCT02117466|Cetuximab|cetuximab|mesh-list
83041923|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041924|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041925|NCT02117622|Insulin|insulin|mesh-list
83041926|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83041927|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041928|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83041929|NCT04529902|Abatacept|abatacept|mesh-list
83041930|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83041931|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041932|NCT04529902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83041933|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041934|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83041935|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
83041936|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041937|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83041938|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041939|NCT04693468|Palbociclib|palbociclib|mesh-list
83041940|NCT04693468|Axitinib|axitinib|mesh-list
83041942|NCT04693468|Talazoparib|talazoparib|mesh-list
83041943|NCT04693468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83041944|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041945|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83041946|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041947|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041948|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83041949|NCT02288078|Dexamethasone|dexamethasone|mesh-list
83041950|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83041951|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83041952|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
83041953|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
83041954|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83041955|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041956|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83041957|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
83041958|NCT02288078|Hormones|hormones|mesh-ancestor
83438317|NCT04386577|Vitamin D|vitamin d|mesh-list
83041959|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83041960|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83041961|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041962|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041963|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041964|NCT02288234|Telavancin|telavancin|mesh-list
83041965|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83041966|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83041967|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83041968|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83041969|NCT04654312|Diuretics|diuretics|mesh-ancestor
83041970|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
83041971|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041972|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83041973|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83041974|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041975|NCT02973087|Factor VIII|factor viii|mesh-list
83041976|NCT02973087|Coagulants|coagulants|mesh-ancestor
83041977|NCT05284656|Folic Acid|folic acid|mesh-list
83041978|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
83041979|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
83041980|NCT05284656|Hematinics|hematinics|mesh-ancestor
83041981|NCT05284656|Vitamins|vitamins|mesh-ancestor
83041982|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
83041983|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83041984|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83041985|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83041986|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041987|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83041988|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83041989|NCT05284656|Protective Agents|protective agents|mesh-ancestor
83041990|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
83041991|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83041992|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
83041993|NCT02124174|Azacitidine|azacitidine|mesh-list
83041994|NCT02124174|Valproic Acid|valproic acid|mesh-list
83041995|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83041996|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
83041997|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83041998|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83041999|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042000|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
83042001|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
83042002|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042003|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042004|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
83042005|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83042006|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042007|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83042009|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83042010|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83042011|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
83042012|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042013|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83042014|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83042015|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042016|NCT02124330|Bentonite|bentonite|mesh-list
83042017|NCT02124330|Antidotes|antidotes|mesh-ancestor
83042018|NCT02124330|Protective Agents|protective agents|mesh-ancestor
83042019|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042020|NCT02118090|Chloroquine|chloroquine|mesh-list
83042021|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83042022|NCT02118090|Amebicides|amebicides|mesh-ancestor
83042023|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83042024|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83042025|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042026|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
83042027|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042028|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83042029|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83042030|NCT02118090|Analgesics|analgesics|mesh-ancestor
83042031|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
83042032|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042033|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042034|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83042035|NCT02118090|Filaricides|filaricides|mesh-ancestor
83042036|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
83042037|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
83042038|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
83042039|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042040|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042041|NCT03551808|Ketorolac|ketorolac|mesh-list
83042042|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83042043|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83042044|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83042045|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83042046|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83042047|NCT03551808|Analgesics|analgesics|mesh-ancestor
83042048|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
83042049|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042050|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042051|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83042052|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042053|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83042054|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042055|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042056|NCT04053543|CXA-10|cxa-10|mesh-list
83042057|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83042058|NCT04202458|Tenecteplase|tenecteplase|mesh-list
83042059|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83042060|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83042061|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042062|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
83042063|NCT00273650|Vitamins|vitamins|mesh-ancestor
83042064|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
83042065|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042066|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
83042067|NCT02121288|Clopidogrel|clopidogrel|mesh-list
83042068|NCT02121288|Ticagrelor|ticagrelor|mesh-list
83042069|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83042070|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83042071|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83042072|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83042073|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
83042074|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042075|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042076|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042077|NCT01525329|Fluorouracil|fluorouracil|mesh-list
83042079|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042080|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83042081|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042082|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83438349|NCT04278950|Povidone|povidone|mesh-list
83042083|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
83042084|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042085|NCT02121366|Ethanol|ethanol|mesh-list
83042086|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83042087|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042088|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042089|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042090|NCT02121444|Interferons|interferons|mesh-list
83042091|NCT02121444|Interferon-beta|interferon-beta|mesh-list
83042092|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
83042093|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042094|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
83042095|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042096|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
83042097|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042098|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83042099|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
83042100|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83042101|NCT04413526|Estrogens|estrogens|mesh-ancestor
83042102|NCT04413526|Hormones|hormones|mesh-ancestor
83042103|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042104|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362128|NCT01684943|Insulin|insulin|mesh-list
83042105|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83042106|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042107|NCT03665506|Trifluridine|trifluridine|mesh-list
83042108|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
83042109|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042110|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
83042111|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042112|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
83042113|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83042114|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
83042115|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042116|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
83042117|NCT03318874|Protective Agents|protective agents|mesh-ancestor
83042118|NCT03551652|Rocuronium|rocuronium|mesh-list
83042119|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83042120|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83042121|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83042122|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042123|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042124|NCT00263042|Rimonabant|rimonabant|mesh-list
83042125|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83042126|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83042127|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83042128|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042129|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042130|NCT00263042|Hormones|hormones|mesh-ancestor
83042131|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042132|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042133|NCT05002192|Eucalyptol|eucalyptol|mesh-list
83042134|NCT05002192|Ambroxol|ambroxol|mesh-list
83042135|NCT05002192|Expectorants|expectorants|mesh-list
83042136|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
83042137|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042138|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
83042139|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
83042140|NCT05002192|Protective Agents|protective agents|mesh-ancestor
83042141|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042142|NCT04973020|Efavirenz|efavirenz|mesh-list
83042143|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83042144|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83042145|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042146|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042147|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
83042148|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042149|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83042150|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83042151|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83042152|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83042153|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83042154|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83042155|NCT05724446|Prednisolone|prednisolone|mesh-list
83042156|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83042157|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
83042158|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83042159|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
83042160|NCT05724446|Clobetasol|clobetasol|mesh-list
83042161|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83042162|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
83042163|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83042164|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
83042165|NCT05724446|Hormones|hormones|mesh-ancestor
83042166|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042167|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042168|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83042169|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042170|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
83042171|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
83042172|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042173|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83042174|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83042175|NCT05724446|Protective Agents|protective agents|mesh-ancestor
83042176|NCT02124642|Folic Acid|folic acid|mesh-list
83042177|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
83042178|NCT02124642|Hematinics|hematinics|mesh-ancestor
83042179|NCT02124642|Vitamins|vitamins|mesh-ancestor
83362129|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83042180|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
83042181|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042182|NCT03094234|Propranolol|propranolol|mesh-list
83042183|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83042184|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83042185|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
83042186|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042187|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042188|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042189|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83042190|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83042191|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
83042192|NCT00260156|Vildagliptin|vildagliptin|mesh-list
83042193|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83042194|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042195|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83042196|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
83042197|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042198|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042199|NCT04367103|Phenylephrine|phenylephrine|mesh-list
83042200|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
83042201|NCT04367103|Norepinephrine|norepinephrine|mesh-list
83042202|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83042203|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
83042204|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
83042205|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042206|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042207|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
83042208|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83042209|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
83042210|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
83042211|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83042212|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83042213|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83042214|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
83042215|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042216|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042217|NCT04367103|Protective Agents|protective agents|mesh-ancestor
83042218|NCT00260078|Ritonavir|ritonavir|mesh-list
83042219|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83042220|NCT00260078|Darunavir|darunavir|mesh-list
83042221|NCT00260078|Tenofovir|tenofovir|mesh-list
83042222|NCT00260078|Nevirapine|nevirapine|mesh-list
83042223|NCT00260078|Efavirenz|efavirenz|mesh-list
83042224|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83042225|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83042226|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
83042227|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042228|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042229|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83042230|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83042231|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
83042232|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042233|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83042234|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83042235|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83042236|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83042237|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83042238|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83042239|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83042240|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83042241|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83042242|NCT03034564|Droxidopa|droxidopa|mesh-list
83042243|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83042244|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83042245|NCT05342532|Amoxicillin|amoxicillin|mesh-list
83042246|NCT05342532|Clarithromycin|clarithromycin|mesh-list
83042247|NCT05342532|Omeprazole|omeprazole|mesh-list
83042248|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042249|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042250|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83042251|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83042252|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83042253|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042254|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042255|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83042256|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83042257|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83042259|NCT04469114|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83042260|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042261|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042262|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042263|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
83042264|NCT02400567|Letrozole|letrozole|mesh-list
83042265|NCT02400567|Epirubicin|epirubicin|mesh-list
83042266|NCT02400567|Palbociclib|palbociclib|mesh-list
83042267|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042268|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
83042269|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042270|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042271|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83042272|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
83042273|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042274|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042275|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83042276|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83042277|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83042278|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042279|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83042280|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
83042281|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042282|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83042283|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042284|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042285|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042286|NCT02971683|Abatacept|abatacept|mesh-list
83042287|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83042288|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042289|NCT02971683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042290|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042291|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042292|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
83042293|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042294|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042295|NCT05501054|Nivolumab|nivolumab|mesh-list
83042296|NCT05501054|Ipilimumab|ipilimumab|mesh-list
83042297|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042298|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042299|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83042300|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042301|NCT00228176|Rimonabant|rimonabant|mesh-list
83042302|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83042303|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83042304|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83042305|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042306|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042307|NCT00228176|Hormones|hormones|mesh-ancestor
83042308|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042309|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042310|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
83042311|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
83042312|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042313|NCT01308190|Capecitabine|capecitabine|mesh-list
83042314|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83042315|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
83042316|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042317|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042318|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
83042319|NCT01210768|Doxorubicin|doxorubicin|mesh-list
83042320|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83042321|NCT01210768|Epirubicin|epirubicin|mesh-list
83042322|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042323|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
83042324|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042325|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042326|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83042327|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
83362130|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042328|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042329|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042330|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83042331|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83042332|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042333|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042334|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042335|NCT02971605|Psilocybin|psilocybin|mesh-list
83042336|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
83042337|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042338|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83042339|NCT04410874|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83042340|NCT04410874|Vaccines|vaccines|mesh-list
83042341|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
83042342|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042343|NCT04410874|Antiviral Agents|antiviral agents|mesh-ancestor
83042344|NCT04410874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042345|NCT02124954|Digoxin|digoxin|mesh-list
83042346|NCT02124954|Midazolam|midazolam|mesh-list
83042347|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83042348|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83042349|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042350|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042351|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83042352|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83042353|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83042354|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83042355|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
83042356|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
83042357|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
83042358|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
83042359|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042360|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042361|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83042362|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83042363|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042364|NCT02124954|Protective Agents|protective agents|mesh-ancestor
83042365|NCT04441112|Triamcinolone|triamcinolone|mesh-list
83042366|NCT04441112|Ketorolac|ketorolac|mesh-list
83042367|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83042368|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
83042369|NCT04441112|Hormones|hormones|mesh-ancestor
83042370|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042371|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042372|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042373|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042374|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83042375|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83042376|NCT04441112|Analgesics|analgesics|mesh-ancestor
83042377|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
83042378|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042379|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042380|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83042381|NCT02121990|Paclitaxel|paclitaxel|mesh-list
83042382|NCT02121990|Bevacizumab|bevacizumab|mesh-list
83042383|NCT02121990|Olaparib|olaparib|mesh-list
83042384|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83042385|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042386|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
83042387|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
83042388|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
83042389|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042390|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042391|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83042392|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83042393|NCT02121990|Growth Substances|growth substances|mesh-ancestor
83042394|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042395|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
83042396|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83042397|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042398|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
83042399|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83042400|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
83042401|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042402|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
83042403|NCT05724056|Protective Agents|protective agents|mesh-ancestor
83042404|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83042405|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
83042406|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
83042407|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042408|NCT01060059|Exenatide|exenatide|mesh-list
83042409|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83042410|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042411|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83042412|NCT01060059|Incretins|incretins|mesh-ancestor
83042413|NCT01060059|Hormones|hormones|mesh-ancestor
83042414|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042415|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
83042416|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
83042417|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83042418|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83042419|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042420|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042421|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042422|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042423|NCT04307797|Exenatide|exenatide|mesh-list
83042424|NCT04307797|Glucagon|glucagon|mesh-list
83042425|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83042426|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83042427|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042428|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83042429|NCT04307797|Incretins|incretins|mesh-ancestor
83042430|NCT04307797|Hormones|hormones|mesh-ancestor
83042431|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042432|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83042433|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83042434|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
83042435|NCT02125188|Coagulants|coagulants|mesh-ancestor
83042436|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83042437|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
83042438|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042439|NCT02125344|Paclitaxel|paclitaxel|mesh-list
83042440|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
83042441|NCT02125344|Carboplatin|carboplatin|mesh-list
83042442|NCT02125344|Doxorubicin|doxorubicin|mesh-list
83042443|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83042444|NCT02125344|Trastuzumab|trastuzumab|mesh-list
83042445|NCT02125344|Epirubicin|epirubicin|mesh-list
83042446|NCT02125344|Pertuzumab|pertuzumab|mesh-list
83042447|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83042448|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042449|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
83042450|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
83042451|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
83042452|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042453|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042454|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
83042455|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042456|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042457|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83042458|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
83042459|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83042460|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83042461|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042462|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042463|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042464|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042465|NCT05468840|Ketamine|ketamine|mesh-list
83042466|NCT05468840|Analgesics|analgesics|mesh-ancestor
83042467|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
83042468|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042469|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042470|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83042471|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83042472|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
83042473|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
83042474|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042475|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83042476|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83042477|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362131|NCT04739566|Trametinib|trametinib|mesh-list
83042478|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042479|NCT05723900|Castor Oil|castor oil|mesh-list
83042480|NCT05723900|Cathartics|cathartics|mesh-ancestor
83042481|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83042482|NCT02127138|Sirolimus|sirolimus|mesh-list
83042483|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042484|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042485|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83042486|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042487|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
83042488|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042489|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
83042490|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042491|NCT03651531|Metformin|metformin|mesh-list
83042492|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83042493|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042494|NCT02903511|Metformin|metformin|mesh-list
83042495|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83042496|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042497|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
83042498|NCT05325528|Tislelizumab|tislelizumab|mesh-list
83042499|NCT05325528|Tegafur|tegafur|mesh-list
83042500|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042501|NCT05325528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042502|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83042503|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
83042504|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042505|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
83042506|NCT02125500|Ledipasvir|ledipasvir|mesh-list
83042507|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
83042508|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042509|NCT02125578|Interferons|interferons|mesh-list
83042510|NCT02125578|Interferon-beta|interferon-beta|mesh-list
83042511|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
83042512|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042513|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
83042514|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042515|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
83042516|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042517|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83042518|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83042519|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83042520|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83042521|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83042522|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042523|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042524|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83042525|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83042526|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042527|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
83042528|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042529|NCT05606965|Vaccines|vaccines|mesh-list
83042530|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
83042531|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042532|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83042533|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83042534|NCT00141284|Lamivudine|lamivudine|mesh-list
83042535|NCT00141284|Zidovudine|zidovudine|mesh-list
83042536|NCT00141284|Nelfinavir|nelfinavir|mesh-list
83042537|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83042538|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83042539|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042540|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042541|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
83042542|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042543|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83042544|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83042545|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
83042546|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83042547|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83042548|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
83042549|NCT04328506|Vorolanib|vorolanib|mesh-list
83042550|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042551|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042552|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042553|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
83042554|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042555|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042556|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042557|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042558|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042559|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042560|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042561|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
83042562|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83042563|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83042564|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042565|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
83042566|NCT02125890|Coagulants|coagulants|mesh-ancestor
83042567|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
83042568|NCT05433116|Lenvatinib|lenvatinib|mesh-list
83042569|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042570|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042571|NCT05433116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83042572|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042573|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042574|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042575|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
83042576|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83042577|NCT05287984|Rituximab|rituximab|mesh-list
83042578|NCT05287984|Fludarabine|fludarabine|mesh-list
83042579|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
83042580|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042581|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
83042582|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042583|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042584|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83042586|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042587|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042588|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83042589|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042590|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042591|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042592|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
83042593|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83042594|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83042595|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
83042596|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042597|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042598|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042599|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
83042600|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
83042601|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042602|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
83042603|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83042604|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
83042605|NCT00134264|Atorvastatin|atorvastatin|mesh-list
83042606|NCT00134264|Torcetrapib|torcetrapib|mesh-list
83042607|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83042608|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83042609|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
83042610|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042611|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83042612|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83042613|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042614|NCT05285800|Bupivacaine|bupivacaine|mesh-list
83042615|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
83042616|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
83042617|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042618|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042619|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
83042620|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042621|NCT02122692|Itraconazole|itraconazole|mesh-list
83042622|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83042623|NCT02122692|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83042624|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
83042625|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042626|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83042627|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83042628|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362132|NCT04739566|Dabrafenib|dabrafenib|mesh-list
83042633|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042634|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83042636|NCT02122692|Serotonin Agents|serotonin agents|mesh-ancestor
83042637|NCT02122692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042638|NCT00131924|Estrogens|estrogens|mesh-list
83042639|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
83042640|NCT00131924|Hormones|hormones|mesh-ancestor
83042641|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042642|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042643|NCT05284474|Mitogens|mitogens|mesh-list
83042644|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
83042645|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042646|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83042647|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042648|NCT05609695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042649|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042650|NCT04246060|Cysteamine|cysteamine|mesh-list
83042651|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83042652|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042653|NCT05129176|Metronidazole|metronidazole|mesh-list
83042654|NCT05129176|Levofloxacin|levofloxacin|mesh-list
83042655|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042656|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042657|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83042658|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83042659|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83042660|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042661|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042662|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042663|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042664|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042665|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83042666|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83042667|NCT02127684|Ranibizumab|ranibizumab|mesh-list
83042668|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83042669|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83042670|NCT02127684|Growth Substances|growth substances|mesh-ancestor
83042671|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042672|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83042673|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438431|NCT05539053|Antidotes|antidotes|mesh-ancestor
83042680|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83042681|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83042682|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83042683|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
83042684|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042685|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83042686|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83042687|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042688|NCT02127840|Epinephrine|epinephrine|mesh-list
83042689|NCT02127840|Racepinephrine|racepinephrine|mesh-list
83042690|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
83042691|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83042692|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83042693|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
83042694|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042695|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042696|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042697|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83042698|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83042699|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
83042700|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042701|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83042702|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
83042703|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
83042704|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
83042705|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83042706|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
83042707|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
83042708|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
83042709|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83042710|NCT05031442|Protective Agents|protective agents|mesh-ancestor
83042711|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042712|NCT02127918|Clobazam|clobazam|mesh-list
83042713|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
83042714|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83042715|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83042716|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042717|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042718|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83042719|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83042720|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
83042721|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
83042722|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042723|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042724|NCT00127634|Insulin|insulin|mesh-list
83042725|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83042726|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
83042727|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83042728|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042729|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83042730|NCT02127996|Incretins|incretins|mesh-ancestor
83042731|NCT02127996|Hormones|hormones|mesh-ancestor
83042732|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042733|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042734|NCT02131350|Ranibizumab|ranibizumab|mesh-list
83042735|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83042736|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83042737|NCT02131350|Growth Substances|growth substances|mesh-ancestor
83042738|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042739|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
83042740|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042742|NCT02128308|Levofloxacin|levofloxacin|mesh-list
83042743|NCT02128308|Ofloxacin|ofloxacin|mesh-list
83042744|NCT02128308|Cycloserine|cycloserine|mesh-list
83042745|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
83042746|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83042747|NCT02128308|Streptomycin|streptomycin|mesh-list
83042748|NCT02128308|Kanamycin|kanamycin|mesh-list
83042749|NCT02128308|Prothionamide|prothionamide|mesh-list
83042750|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83042751|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042752|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042753|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042754|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042755|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042756|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042757|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042758|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83042759|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
83042760|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83042761|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042762|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83042763|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83042764|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83042765|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83042766|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83042767|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83042768|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83042769|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
83042770|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
83042771|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83042772|NCT02131506|Lapatinib|lapatinib|mesh-list
83042773|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83042774|NCT02131506|Doxorubicin|doxorubicin|mesh-list
83042775|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042776|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042777|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042785|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
83042786|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83042787|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83042788|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042789|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83042790|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042791|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83042792|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83042793|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042794|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83042795|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83042796|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042797|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
83042798|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042799|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
83042800|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
83042801|NCT01674010|Vitamins|vitamins|mesh-ancestor
83042802|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
83042810|NCT02252328|Simvastatin|simvastatin|mesh-list
83042811|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83042812|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83042813|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
83042814|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042815|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83042816|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83042817|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042818|NCT04656964|Midazolam|midazolam|mesh-list
83042819|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83042820|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83042821|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042822|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042823|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83042824|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83042825|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83438449|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
83042826|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83042827|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
83042828|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
83042829|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
83042830|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
83042831|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042832|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042834|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83042835|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
83042836|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
83042837|NCT02136030|Amebicides|amebicides|mesh-ancestor
83042838|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83042839|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83042840|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042841|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042842|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
83042843|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83042844|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83042845|NCT02131818|Amoxicillin|amoxicillin|mesh-list
83042846|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042847|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042848|NCT04605796|Bevacizumab|bevacizumab|mesh-list
83042849|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042850|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042851|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83042852|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83042853|NCT04605796|Growth Substances|growth substances|mesh-ancestor
83042854|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042855|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
83042856|NCT01345669|Afatinib|afatinib|mesh-list
83042857|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042858|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042859|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042860|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042861|NCT04313608|Gemcitabine|gemcitabine|mesh-list
83042862|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
83042863|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
83042864|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83042865|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
83042866|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042867|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042868|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042869|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
83042870|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83042871|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83042872|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83042873|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83042874|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042875|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
83042876|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042877|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042878|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83042879|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83042880|NCT03527732|Ivermectin|ivermectin|mesh-list
83042881|NCT03527732|Albendazole|albendazole|mesh-list
83042882|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83042883|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042884|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
83042885|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
83042886|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83042887|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83042888|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
83042889|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
83042890|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
83042891|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042892|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042893|NCT01673854|Ipilimumab|ipilimumab|mesh-list
83042894|NCT01673854|Vemurafenib|vemurafenib|mesh-list
83042895|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83042896|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042897|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83042898|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042899|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83042900|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042901|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
83042902|NCT03549702|Povidone|povidone|mesh-list
83042903|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
83042904|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
83042905|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83042906|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042907|NCT02529904|Vaccines|vaccines|mesh-list
83042908|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
83042909|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042910|NCT03099356|Sirolimus|sirolimus|mesh-list
83042911|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
83042912|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042913|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
83042914|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042915|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83042916|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83042917|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
83042918|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042919|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042920|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83042921|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042922|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042923|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83042924|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
83042925|NCT01367886|Fesoterodine|fesoterodine|mesh-list
83042926|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83042927|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83042928|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
83042929|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042930|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042931|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042932|NCT01367886|Urological Agents|urological agents|mesh-ancestor
83042933|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
83042934|NCT05222191|Spironolactone|spironolactone|mesh-list
83042935|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83042936|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
83042937|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042938|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042939|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83042940|NCT05222191|Diuretics|diuretics|mesh-ancestor
83042941|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
83042942|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83042943|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83042944|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83042945|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042946|NCT05706337|Propofol|propofol|mesh-list
83042947|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83042948|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042949|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042950|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83042951|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
83042952|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
83042953|NCT05222113|Remdesivir|remdesivir|mesh-list
83042954|NCT05222113|Favipiravir|favipiravir|mesh-list
83042955|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
83042956|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042957|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
83042958|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042959|NCT03854578|Citalopram|citalopram|mesh-list
83042960|NCT03854578|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83042961|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83042962|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949486|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042963|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042964|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83042965|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
83042966|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042967|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83042968|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
83042969|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83042970|NCT03038594|Hormones|hormones|mesh-list
83042971|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83042972|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042973|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
83042974|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83042975|NCT02136888|Ponesimod|ponesimod|mesh-list
83042976|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83042977|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83042978|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83042979|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83042980|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83042981|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83042982|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83042983|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83042984|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
83042985|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83042986|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83042987|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83042988|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83042989|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83042990|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83042991|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83042992|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
83042993|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83042994|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
83042995|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83042996|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83042997|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83042998|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83042999|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043000|NCT05252754|Indomethacin|indomethacin|mesh-list
83043001|NCT05252754|Tacrolimus|tacrolimus|mesh-list
83043002|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043003|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
83043004|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043005|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83043006|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043007|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043008|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83043009|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83043011|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
83043012|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043013|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043014|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043015|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
83043016|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
83043017|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83043018|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83043019|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
83043020|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
83043021|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
83043022|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043023|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043024|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83043025|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043026|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043027|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
83043028|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043029|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043030|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83043031|NCT02132442|Vitamin D|vitamin d|mesh-list
83043032|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
83043033|NCT02132442|Vitamins|vitamins|mesh-ancestor
83043034|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
83043035|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043036|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83043037|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83043038|NCT05010148|Lidocaine|lidocaine|mesh-list
83043039|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
83043040|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
83043041|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043042|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043043|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
83043044|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043045|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83043046|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83043047|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83043048|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83043049|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043050|NCT05138146|Doxorubicin|doxorubicin|mesh-list
83043051|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83043052|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83043053|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043054|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83043055|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83043056|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043057|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043059|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
83043060|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83043061|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83043062|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043063|NCT03450772|Pancrelipase|pancrelipase|mesh-list
83043064|NCT03450772|Pancreatin|pancreatin|mesh-list
83043065|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043066|NCT02129088|Esketamine|esketamine|mesh-list
83043067|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
83043068|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83043069|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
83043070|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83043071|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83043072|NCT05137522|Prednisolone|prednisolone|mesh-list
83043073|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
83043074|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83043075|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
83362133|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043076|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043077|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
83043078|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
83043079|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043080|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043081|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043082|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
83043083|NCT05137522|Hormones|hormones|mesh-ancestor
83043084|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043085|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83043086|NCT05137522|Protective Agents|protective agents|mesh-ancestor
83043087|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83043088|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043089|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
83043090|NCT02129166|Dasatinib|dasatinib|mesh-list
83043091|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83438497|NCT02291133|Bleomycin|bleomycin|mesh-list
83043092|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83043093|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043094|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043095|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
83043096|NCT02137278|Levodopa|levodopa|mesh-list
83043097|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
83043098|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
83043099|NCT02137278|Diuretics|diuretics|mesh-list
83043100|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83043101|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
83043102|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043103|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
83043104|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043105|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043106|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83043107|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83043108|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83043109|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043111|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043112|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83043113|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83043114|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83043115|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043116|NCT05204550|Heparin|heparin|mesh-list
83043117|NCT05204550|Calcium heparin|calcium heparin|mesh-list
83043118|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
83043119|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83043120|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83043121|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043122|NCT00085774|Albuterol|albuterol|mesh-list
83043123|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83043124|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
83043125|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043126|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043127|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83043128|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
83043129|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
83043130|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83043131|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83043132|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83043133|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83043134|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
83043135|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043136|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043137|NCT04491682|Megestrol|megestrol|mesh-list
83043138|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
83043139|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83043140|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83043141|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83043142|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
83043143|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043144|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83043145|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83043146|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043147|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83043148|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83043149|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83043150|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
83043151|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83043152|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043153|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83043154|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83043155|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83043156|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043157|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
83043158|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83043159|NCT05193968|Nitroprusside|nitroprusside|mesh-list
83043160|NCT05193968|Norepinephrine|norepinephrine|mesh-list
83043161|NCT05193968|Acetylcholine|acetylcholine|mesh-list
83043162|NCT05193968|Terbutaline|terbutaline|mesh-list
83043163|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83043164|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83043165|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
83043166|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949487|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83043167|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043168|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043169|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
83043170|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
83043171|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043172|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83043173|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83043174|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
83043175|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83043176|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83043177|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
83043178|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83043179|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83043180|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
83043181|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
83043182|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83043183|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83043184|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83043185|NCT02137356|Capecitabine|capecitabine|mesh-list
83043186|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83043187|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
83043188|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043189|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043190|NCT05137288|Atropine|atropine|mesh-list
83043191|NCT05137288|Ondansetron|ondansetron|mesh-list
83043192|NCT05137288|Bupivacaine|bupivacaine|mesh-list
83043193|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
83043194|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
83043195|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043196|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043197|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
83043198|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043199|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
83043200|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
83043201|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043202|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
83043203|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
83043204|NCT05137288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83043205|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83043206|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
83043207|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043208|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043209|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83043210|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83043211|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83043212|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83043213|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83043214|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
83043215|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
83043216|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83043217|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83043218|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
83043219|NCT05135182|Metronidazole|metronidazole|mesh-list
83043220|NCT05135182|Furazolidone|furazolidone|mesh-list
83043221|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043222|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83043223|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83043224|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83043225|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83043226|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83043227|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83043228|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83043229|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438500|NCT00680459|Ethanol|ethanol|mesh-list
83043230|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043231|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
83043232|NCT02137434|Calcium|calcium|mesh-list
83043233|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83043234|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043235|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83043236|NCT02137668|Vancomycin|vancomycin|mesh-list
83043237|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83043238|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043239|NCT04216472|Paclitaxel|paclitaxel|mesh-list
83043240|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83043241|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
83043242|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83043243|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043244|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
83043245|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
83043246|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
83043247|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043248|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043249|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
83043250|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
83043251|NCT03522428|Vitamins|vitamins|mesh-ancestor
83043252|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
83043253|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043254|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
83043255|NCT03522428|Hematinics|hematinics|mesh-ancestor
83043256|NCT05575999|Ketorolac|ketorolac|mesh-list
83043257|NCT05575999|Ketamine|ketamine|mesh-list
83043258|NCT05575999|Bupivacaine|bupivacaine|mesh-list
83043259|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
83043260|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
83043261|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043262|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043263|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
83043264|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043265|NCT05575999|Analgesics|analgesics|mesh-ancestor
83043266|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83043267|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83043268|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
83043269|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83043270|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83043271|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043272|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043273|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83043274|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83043275|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043276|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043277|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83043278|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043279|NCT01062399|Everolimus|everolimus|mesh-list
83043280|NCT01062399|Temozolomide|temozolomide|mesh-list
83043281|NCT01062399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83043282|NCT01062399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83043283|NCT01062399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043284|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043285|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043286|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
83043287|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043288|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043289|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83043290|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
83043291|NCT05136508|Propofol|propofol|mesh-list
83043292|NCT05136508|Sevoflurane|sevoflurane|mesh-list
83043293|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83043294|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043295|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043296|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83043297|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
83043298|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
83043299|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83043300|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83043301|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
83043303|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043304|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83043305|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043306|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043307|NCT05125978|Dipyrone|dipyrone|mesh-list
83043308|NCT05125978|Tramadol|tramadol|mesh-list
83043309|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83043310|NCT05125978|Narcotics|narcotics|mesh-ancestor
83043311|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043312|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043313|NCT05125978|Analgesics|analgesics|mesh-ancestor
83043314|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
83043315|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043316|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83043317|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83043318|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043319|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043320|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
83043321|NCT03767712|Antibodies|antibodies|mesh-list
83043322|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
83043324|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043325|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
83043326|NCT05221411|Tacrolimus|tacrolimus|mesh-list
83043327|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043328|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
83043329|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043330|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83043331|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043332|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043333|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83043334|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043335|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83043336|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
83043337|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83043338|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043339|NCT05306002|Antioxidants|antioxidants|mesh-list
83043340|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043341|NCT05306002|Protective Agents|protective agents|mesh-ancestor
83043342|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043343|NCT04346914|Carboplatin|carboplatin|mesh-list
83043344|NCT04346914|Etoposide|etoposide|mesh-list
83043345|NCT04346914|Antibodies|antibodies|mesh-list
83043346|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83043347|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
83043348|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043349|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043350|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83043351|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83043352|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83043353|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043354|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043355|NCT02129400|Anesthetics|anesthetics|mesh-list
83043356|NCT02129400|Xenon|xenon|mesh-list
83043357|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043358|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043359|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83043360|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
83043361|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83043362|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83043363|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043364|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043365|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83043366|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83043367|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043368|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
83043369|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043370|NCT02133378|Hemostatics|hemostatics|mesh-list
83043371|NCT02133378|Coagulants|coagulants|mesh-ancestor
83043372|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
83043373|NCT04171622|Lenvatinib|lenvatinib|mesh-list
83043374|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83043375|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043376|NCT04171622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83043377|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043379|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043380|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83043381|NCT02138058|Topiramate|topiramate|mesh-list
83043382|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
83043383|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83043384|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043385|NCT02129634|Paclitaxel|paclitaxel|mesh-list
83043386|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83043387|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043388|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83043389|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83043390|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83043391|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043392|NCT05174455|Niraparib|niraparib|mesh-list
83043393|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83043394|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043395|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043396|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043397|NCT05162053|Clopidogrel|clopidogrel|mesh-list
83043398|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83043399|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83043400|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83043401|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83043402|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
83043403|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043404|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043405|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043406|NCT02138292|Trametinib|trametinib|mesh-list
83043407|NCT02138292|Digoxin|digoxin|mesh-list
83043408|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043409|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83043410|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043411|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043412|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83043413|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83043414|NCT02138292|Protective Agents|protective agents|mesh-ancestor
83043415|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043416|NCT02133612|Paclitaxel|paclitaxel|mesh-list
83043417|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82949488|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
83043418|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83043419|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043420|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83043421|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83043422|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83043423|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043424|NCT03522194|Propofol|propofol|mesh-list
83043425|NCT03522194|Sevoflurane|sevoflurane|mesh-list
83043426|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83043427|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043428|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043429|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83043430|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
83043431|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
83043432|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83043433|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83043434|NCT04820686|Tenofovir|tenofovir|mesh-list
83043435|NCT04820686|Entecavir|entecavir|mesh-list
83043436|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
83043437|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043438|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83043439|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83043440|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043441|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043442|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83043443|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83043444|NCT02260908|Enoxaparin|enoxaparin|mesh-list
83043445|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
83043446|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83043447|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83043448|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043449|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
83043450|NCT02969655|Glycine|glycine|mesh-list
83043452|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
83043453|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043454|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043455|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043456|NCT04488874|Mannitol|mannitol|mesh-list
83043457|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83043458|NCT04488874|Diuretics|diuretics|mesh-ancestor
83043459|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
83043460|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043461|NCT03651219|Irinotecan|irinotecan|mesh-list
83043462|NCT03651219|Apatinib|apatinib|mesh-list
83043463|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83043464|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83043465|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043466|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043467|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043468|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83043469|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83043470|NCT02648698|Levofloxacin|levofloxacin|mesh-list
83043471|NCT02648698|Tinidazole|tinidazole|mesh-list
83043472|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043473|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83043474|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83043475|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83043476|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043477|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043478|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043479|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83043480|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83043481|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
83043482|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83043483|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83043484|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83043485|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
83043486|NCT04059458|Calcium|calcium|mesh-list
83043487|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83043488|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83438552|NCT01798979|Midazolam|midazolam|mesh-list
83043489|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83043490|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
83043491|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83043492|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043493|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043494|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83043495|NCT05304598|Analgesics|analgesics|mesh-ancestor
83043496|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
83043497|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043498|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83043499|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83043500|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83043501|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
83043502|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043503|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043504|NCT03524846|Vitamins|vitamins|mesh-list
83043505|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
83043506|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
83043507|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043508|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
83043509|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043510|NCT03524846|Protective Agents|protective agents|mesh-ancestor
83043511|NCT05134558|Xenon|xenon|mesh-list
83043512|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83043513|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
83043514|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
83043515|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043516|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043517|NCT02970669|Valsartan|valsartan|mesh-list
83043518|NCT02970669|Enalapril|enalapril|mesh-list
83043519|NCT02970669|Enalaprilat|enalaprilat|mesh-list
83043520|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83043521|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83043522|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83043523|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83043524|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043525|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83043526|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
83043527|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043528|NCT02134002|Disulfiram|disulfiram|mesh-list
83043529|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83043530|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83043531|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043532|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043533|NCT03650361|Adapalene|adapalene|mesh-list
83043534|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83043535|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83043536|NCT03650361|Analgesics|analgesics|mesh-ancestor
83438562|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
83043537|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
83043538|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043539|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043540|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043541|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043542|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83043543|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83043544|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
83043545|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043546|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83043547|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
83043548|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83043549|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
83043550|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83043551|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
83043552|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043553|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043554|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
83043555|NCT02902965|Dexamethasone|dexamethasone|mesh-list
83043556|NCT02902965|Bortezomib|bortezomib|mesh-list
83043557|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043558|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
83043559|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
83043560|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043561|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043562|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043563|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
83043564|NCT02902965|Hormones|hormones|mesh-ancestor
83043565|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043566|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83043567|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043568|NCT02130414|Cyclosporine|cyclosporine|mesh-list
83043569|NCT02130414|Cyclosporins|cyclosporins|mesh-list
83043570|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043571|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043572|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043573|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
83043574|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043575|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
83043576|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043577|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
83043578|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043579|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83043580|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83043581|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
83043582|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043583|NCT02134470|Testosterone|testosterone|mesh-list
83043584|NCT02134470|Androgens|androgens|mesh-ancestor
83043585|NCT02134470|Hormones|hormones|mesh-ancestor
83043586|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043587|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043588|NCT02134626|Simvastatin|simvastatin|mesh-list
83043589|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83043590|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83043591|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
83043592|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83438584|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
83043593|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83043594|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83043595|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043596|NCT02969187|Bupivacaine|bupivacaine|mesh-list
83043597|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
83043598|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
83043599|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362134|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83043600|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043601|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
83043602|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043603|NCT04893655|Dobutamine|dobutamine|mesh-list
83043604|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83043605|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
83043606|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
83043607|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043608|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043609|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83043610|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83043611|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83043612|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
83043613|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043614|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043615|NCT04893655|Protective Agents|protective agents|mesh-ancestor
83043616|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83043617|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83043618|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83043619|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
83043620|NCT05285085|Atorvastatin|atorvastatin|mesh-list
83043621|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83043622|NCT05285085|Simvastatin|simvastatin|mesh-list
83043623|NCT05285085|Pravastatin|pravastatin|mesh-list
83043624|NCT05285085|Pitavastatin|pitavastatin|mesh-list
83043625|NCT05285085|Lovastatin|lovastatin|mesh-list
83043626|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83043627|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83043628|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
83043629|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043630|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83043631|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83043632|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043633|NCT02139930|Nicotine|nicotine|mesh-list
83043634|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83043635|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
83043636|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043637|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043638|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83043639|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83043640|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
83043641|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043642|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043643|NCT04843111|Vaccines|vaccines|mesh-list
83043644|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
83043645|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043646|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83043647|NCT02130804|Salicylates|salicylates|mesh-list
83043648|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83043649|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83043650|NCT02130804|Analgesics|analgesics|mesh-ancestor
83043651|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
83043652|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043653|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043654|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043655|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043656|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83043657|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043658|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043659|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
83043660|NCT05303272|Abatacept|abatacept|mesh-list
83043661|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83043662|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043663|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83043664|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
83043665|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83043666|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043667|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043668|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043669|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83043670|NCT05303272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83043671|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043672|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
83043673|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043674|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043675|NCT03549312|Tenofovir|tenofovir|mesh-list
83043676|NCT03549312|Emtricitabine|emtricitabine|mesh-list
83043677|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
83043678|NCT03549312|Cobicistat|cobicistat|mesh-list
83043679|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83043680|NCT03549312|Velpatasvir|velpatasvir|mesh-list
83043681|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83043682|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83043683|NCT03549312|Elvitegravir|elvitegravir|mesh-list
83043684|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
83043685|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043686|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83043687|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83043688|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043689|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043690|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83043691|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83043692|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83043693|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83043694|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83043695|NCT03649269|Bezafibrate|bezafibrate|mesh-list
83043696|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83043697|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
83043698|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043699|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83043700|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83043701|NCT02134938|Cathartics|cathartics|mesh-ancestor
83043702|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043703|NCT05373446|Ritonavir|ritonavir|mesh-list
83043704|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83043705|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83043706|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
83043707|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043708|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043709|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83043710|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83043711|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
83043712|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043713|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83043714|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83043715|NCT04734028|Clopidogrel|clopidogrel|mesh-list
83043716|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043717|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043718|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83043719|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83043720|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83043721|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83043722|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
83043723|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043724|NCT05285397|Liraglutide|liraglutide|mesh-list
83043725|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83043726|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043727|NCT05285397|Incretins|incretins|mesh-ancestor
83043728|NCT05285397|Hormones|hormones|mesh-ancestor
83043729|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043730|NCT03050359|Lansoprazole|lansoprazole|mesh-list
83043731|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
83043732|NCT03050359|Bismuth|bismuth|mesh-list
83043733|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83043734|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043735|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83043736|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043737|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043738|NCT03050359|Antacids|antacids|mesh-ancestor
83043739|NCT02140242|Daunorubicin|daunorubicin|mesh-list
83438600|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
83043740|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83043741|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043742|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83043743|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83043744|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043745|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043746|NCT05302726|Estrogens|estrogens|mesh-list
83043747|NCT05302726|Hormones|hormones|mesh-ancestor
83043748|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043749|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043750|NCT02253264|Rituximab|rituximab|mesh-list
83043751|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83043752|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043753|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
83043754|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043755|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043757|NCT03648333|Amlodipine|amlodipine|mesh-list
83043758|NCT03648333|Valsartan|valsartan|mesh-list
83043759|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83043760|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83043761|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83043762|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83043763|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043764|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83043765|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043766|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
83043767|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83043768|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83043769|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83043770|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
83043771|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83043772|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
83043773|NCT03648333|Vitamins|vitamins|mesh-ancestor
83043774|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
83043775|NCT02252796|Paclitaxel|paclitaxel|mesh-list
83043776|NCT02252796|Carboplatin|carboplatin|mesh-list
83043777|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83043778|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043779|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83043780|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83043781|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83043782|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043783|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
83043784|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83043785|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043786|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83043787|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83043788|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043789|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043790|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043791|NCT04166474|Dolutegravir|dolutegravir|mesh-list
83043792|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83043793|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83043794|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043795|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043796|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83043797|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83043798|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
83043799|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043800|NCT04660123|Bismuth|bismuth|mesh-list
83043801|NCT04660123|Antacids|antacids|mesh-ancestor
83043802|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043803|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043804|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83043805|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83043806|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043807|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
83043808|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043809|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83043810|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
83043811|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83043812|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83043813|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043814|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
83043815|NCT05579418|Evolocumab|evolocumab|mesh-list
83043816|NCT05579418|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83043817|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83043818|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83043819|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
83043820|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043821|NCT05579418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83043822|NCT05579418|Protease Inhibitors|protease inhibitors|mesh-ancestor
83043823|NCT05579418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043824|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83043825|NCT02968173|Palivizumab|palivizumab|mesh-list
83043826|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
83043827|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043828|NCT02135640|Denosumab|denosumab|mesh-list
83043829|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83043830|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043831|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83043832|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83043833|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043834|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
83043835|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043836|NCT02253342|Levonadifloxacin|levonadifloxacin|mesh-list
83043837|NCT02253342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83043838|NCT02253342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043839|NCT02253342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043840|NCT02253342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83043841|NCT02253342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043842|NCT04038099|Lidocaine|lidocaine|mesh-list
83043843|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
83043844|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
83043845|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043846|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043847|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
83043848|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043849|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83043850|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83043851|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83043852|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83043853|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043854|NCT00495508|Lumefantrine|lumefantrine|mesh-list
83043855|NCT00495508|Artemether|artemether|mesh-list
83043856|NCT00495508|Quinine|quinine|mesh-list
83043857|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83043858|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
83043859|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83043860|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83043861|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83043862|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83043863|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043864|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83043865|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043866|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83043867|NCT00495508|Analgesics|analgesics|mesh-ancestor
83043868|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
83043869|NCT01554046|Methylphenidate|methylphenidate|mesh-list
83043870|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83043871|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043872|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83043873|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83043874|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83043875|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043876|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
83043877|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043878|NCT05284851|Vaccines|vaccines|mesh-list
83043879|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
83043880|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043881|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83043882|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83043883|NCT03049735|Norethindrone|norethindrone|mesh-list
83043884|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
83043885|NCT03049735|Estradiol|estradiol|mesh-list
83043886|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83043887|NCT03049735|Relugolix|relugolix|mesh-list
83043888|NCT03049735|Estrogens|estrogens|mesh-ancestor
83043889|NCT03049735|Hormones|hormones|mesh-ancestor
83043890|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043891|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043892|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83043893|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
83043894|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83043895|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83043896|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83043897|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83043898|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83043899|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
83043900|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
83043901|NCT04785638|Bupivacaine|bupivacaine|mesh-list
83043902|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
83043903|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
83043904|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043905|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043906|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
83043907|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043908|NCT04762472|Montelukast|montelukast|mesh-list
83043909|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83043910|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
83043911|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83043912|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
83043913|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043914|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043915|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83043916|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83043917|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043918|NCT01295944|Bevacizumab|bevacizumab|mesh-list
83043919|NCT01295944|Carboplatin|carboplatin|mesh-list
83043920|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83043921|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043922|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83043923|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83043924|NCT01295944|Growth Substances|growth substances|mesh-ancestor
83043925|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043926|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
83043927|NCT04742348|Levodopa|levodopa|mesh-list
83043928|NCT04742348|Carbidopa|carbidopa|mesh-list
83043929|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83043930|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83043931|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83043932|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
83043933|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043934|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043935|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043936|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83043937|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043938|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83043939|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
83043940|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
83043941|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
83043942|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83043943|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83043944|NCT02140632|Prednisolone|prednisolone|mesh-list
83043945|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
83043946|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83043947|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
83043948|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83043949|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
83043950|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
83043951|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83043952|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043953|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83043954|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
83043955|NCT02140632|Hormones|hormones|mesh-ancestor
83043956|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83043957|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83043958|NCT02140632|Protective Agents|protective agents|mesh-ancestor
83438604|NCT01279291|Gemcitabine|gemcitabine|mesh-list
83043959|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83043960|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043961|NCT04712942|Azacitidine|azacitidine|mesh-list
83043962|NCT04712942|Pevonedistat|pevonedistat|mesh-list
83043963|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83043964|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
83043965|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043966|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83043967|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043968|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
83043969|NCT05578404|Vitamin D|vitamin d|mesh-list
83043970|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83043971|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043972|NCT05578404|Vitamins|vitamins|mesh-ancestor
83043973|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
83362135|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83043975|NCT04848584|Vaccines|vaccines|mesh-list
83043976|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
83043977|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043978|NCT03521960|Buspirone|buspirone|mesh-list
83043979|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83043980|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83043981|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83043982|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043983|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83043984|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83043985|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
83043986|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83043987|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83043988|NCT05479578|Dexamethasone|dexamethasone|mesh-list
83043989|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
83043990|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
83043991|NCT05479578|Ichthammol|ichthammol|mesh-list
83043992|NCT05479578|BB 1101|bb 1101|mesh-list
83043993|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83043994|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
83043995|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83043996|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83043997|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83043998|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
83043999|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044000|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044001|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83044002|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044003|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
83044004|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
83044005|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044006|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044007|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
83044008|NCT05479578|Hormones|hormones|mesh-ancestor
83044009|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044010|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83044011|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
83044012|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044013|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
83044014|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83044015|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044016|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
83044017|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
83044018|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83044019|NCT05363462|Vancomycin|vancomycin|mesh-list
83044020|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044021|NCT04853628|Ethanol|ethanol|mesh-list
83044022|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83044023|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044024|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044025|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044026|NCT03521726|Amoxicillin|amoxicillin|mesh-list
83044027|NCT03521726|Rabeprazole|rabeprazole|mesh-list
83044028|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044029|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044030|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83044031|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044032|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83044033|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044034|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044035|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
83044036|NCT03546426|Interleukin-2|interleukin-2|mesh-list
83044037|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044038|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044039|NCT03546426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044040|NCT03546426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044041|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83044042|NCT03546426|Analgesics|analgesics|mesh-ancestor
83044043|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
83044044|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044045|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044046|NCT02897349|Linagliptin|linagliptin|mesh-list
83044047|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83044048|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044049|NCT02897349|Incretins|incretins|mesh-ancestor
83044050|NCT02897349|Hormones|hormones|mesh-ancestor
83044051|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044052|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83044053|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
83044054|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044055|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044056|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
83044057|NCT04767984|Atorvastatin|atorvastatin|mesh-list
83044058|NCT04767984|Calcium|calcium|mesh-list
83044059|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83044060|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044061|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83044062|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83044063|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83044064|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
83044065|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044066|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83044067|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83044068|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044069|NCT03134378|Amoxicillin|amoxicillin|mesh-list
83044070|NCT03134378|Clarithromycin|clarithromycin|mesh-list
83044071|NCT03134378|Rabeprazole|rabeprazole|mesh-list
83044072|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044073|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044074|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83044075|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044076|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044077|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83044078|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83044079|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83044080|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044081|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83044082|NCT05434104|Metronidazole|metronidazole|mesh-list
83044083|NCT05434104|Fluconazole|fluconazole|mesh-list
83044084|NCT05434104|Lactoferrin|lactoferrin|mesh-list
83044085|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044086|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044087|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83044088|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83044089|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
83044090|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83044091|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83044092|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044093|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044094|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83044095|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
83044096|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044097|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044098|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83044099|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83044100|NCT00488072|Mirtazapine|mirtazapine|mesh-list
83044101|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
83044102|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83044103|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83044104|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
83044105|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
83044106|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044107|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044108|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044109|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83044110|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83044111|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044112|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83044113|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83044114|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83044115|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83044116|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83044117|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83044118|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
83362136|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044119|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83044120|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83044121|NCT03523832|Celecoxib|celecoxib|mesh-list
83044122|NCT03523832|Pregabalin|pregabalin|mesh-list
83044123|NCT03523832|Analgesics|analgesics|mesh-ancestor
83044124|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
83044125|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044126|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044127|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
83044128|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83044129|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83044130|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044131|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83044132|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83044133|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83044134|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044135|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83044136|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83044137|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83044138|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044139|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044140|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83044141|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83044142|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044143|NCT05577624|Rifampin|rifampin|mesh-list
83044144|NCT05577624|Sotorasib|sotorasib|mesh-list
83044145|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83044146|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
83044147|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044148|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044149|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
83044150|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83044151|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044152|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044153|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83044154|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83044155|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83044156|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83044157|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83044158|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83044159|NCT05577624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044160|NCT05577624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044161|NCT05577624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044163|NCT03294694|Spartalizumab|spartalizumab|mesh-list
83044164|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83044165|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044166|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83044167|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83044168|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
83044169|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044170|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044171|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044172|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044173|NCT03294694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044174|NCT03523754|Isosorbide|isosorbide|mesh-list
83044175|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83044176|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83044177|NCT03523754|Misoprostol|misoprostol|mesh-list
83044178|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83044179|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
83044180|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83044181|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044182|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83044183|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044184|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
83044185|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83044186|NCT03523754|Diuretics|diuretics|mesh-ancestor
83044187|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
83044188|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
83044189|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83044190|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044191|NCT04727034|Propofol|propofol|mesh-list
83044192|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83044193|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044194|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044195|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044196|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
83044197|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
83044198|NCT03644511|Sorafenib|sorafenib|mesh-list
83044199|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044200|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83044201|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044202|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044203|NCT03290560|Kallikreins|kallikreins|mesh-list
83044204|NCT03290560|Coagulants|coagulants|mesh-ancestor
83044205|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83044206|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
83044207|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83044208|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044209|NCT01316419|Amlodipine|amlodipine|mesh-list
83044210|NCT01316419|Telmisartan|telmisartan|mesh-list
83044211|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83044212|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83044213|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83044214|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044215|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83044216|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044217|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
83044218|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83044219|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83044220|NCT03547362|Caseins|caseins|mesh-list
83044221|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
83044222|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
83044223|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044224|NCT04258150|Nivolumab|nivolumab|mesh-list
83044225|NCT04258150|Ipilimumab|ipilimumab|mesh-list
83044226|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044227|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044228|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044229|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044230|NCT02854696|Insulin|insulin|mesh-list
83044231|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83044232|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044233|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
83044234|NCT04664946|Protective Agents|protective agents|mesh-ancestor
83044235|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044236|NCT02289248|Ketamine|ketamine|mesh-list
83044237|NCT02289248|Analgesics|analgesics|mesh-ancestor
83044238|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
83044239|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044240|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044241|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83044242|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044243|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
83044244|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
83044245|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044246|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83044247|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83044248|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044249|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044250|NCT02782468|Azacitidine|azacitidine|mesh-list
83044251|NCT02782468|Pevonedistat|pevonedistat|mesh-list
83044252|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83044253|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
83044254|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044255|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044256|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044257|NCT02253420|Itraconazole|itraconazole|mesh-list
83044258|NCT02253420|Rifampin|rifampin|mesh-list
83044259|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
83044260|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044261|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83044262|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83044263|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044264|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044265|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83044266|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
83044267|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044268|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044269|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83044270|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83044271|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
83044272|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044273|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
83044274|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83044275|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83044276|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83044277|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83044278|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83044279|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83044280|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83044282|NCT02028364|Exemestane|exemestane|mesh-list
83044283|NCT02028364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83044284|NCT02028364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83044285|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044286|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044287|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83044288|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
83044289|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044290|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044291|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83044292|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83044293|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83044294|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83044295|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044296|NCT02897115|Adalimumab|adalimumab|mesh-list
83044297|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83044298|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83044299|NCT02897115|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83044300|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044301|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83044302|NCT02897115|Analgesics|analgesics|mesh-ancestor
83044303|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
83044304|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044305|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044306|NCT02289482|Ritonavir|ritonavir|mesh-list
83044307|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
83044308|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83044309|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83044310|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
83044311|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044312|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044313|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83044314|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83044315|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
83044316|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044317|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83044318|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83044319|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83044320|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
83044321|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044322|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83044323|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
83044324|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044325|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044326|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83044327|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83044328|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83044329|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
83044330|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
83044331|NCT04030195|Fludarabine|fludarabine|mesh-list
83044332|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83044333|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
83044334|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044335|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044336|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83362137|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
83044337|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
83044338|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044339|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044340|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83044341|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83044342|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
83044343|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83044344|NCT02253966|Prednisolone|prednisolone|mesh-list
83044345|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
83044346|NCT02253966|Lidocaine|lidocaine|mesh-list
83044347|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83044348|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
83044349|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
83044350|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
83044351|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044352|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044353|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
83044354|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044355|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83044356|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83044357|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83044358|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83044359|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044360|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044361|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
83044362|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
83044363|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044364|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
83044365|NCT02253966|Hormones|hormones|mesh-ancestor
83044366|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044367|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83044368|NCT02253966|Protective Agents|protective agents|mesh-ancestor
83044369|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83044370|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044371|NCT01673620|Loratadine|loratadine|mesh-list
83044372|NCT01673620|Montelukast|montelukast|mesh-list
83044373|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83044374|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
83044375|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83044376|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
83044377|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044378|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044379|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83044380|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83044381|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044382|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
83044383|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
83438619|NCT04367883|Amantadine|amantadine|mesh-list
83044384|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83044385|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83044386|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83044387|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
83044388|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
83044389|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044390|NCT04671355|Fluticasone|fluticasone|mesh-list
83044392|NCT04671355|Beclomethasone|beclomethasone|mesh-list
83044393|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
83044394|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
83044395|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044396|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83044397|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
83044398|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044399|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044400|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83044401|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
83044402|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83044403|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83044404|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83044405|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83044406|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83044407|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83044408|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044409|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044410|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83044411|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83044412|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83044413|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
83044414|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
83044415|NCT04671355|Hormones|hormones|mesh-ancestor
83044416|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044417|NCT03773107|Dexamethasone|dexamethasone|mesh-list
83044418|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044419|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
83044420|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
83044421|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044422|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044423|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044424|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
83044425|NCT03773107|Hormones|hormones|mesh-ancestor
83044426|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044427|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83044429|NCT03521492|Vitamin D|vitamin d|mesh-list
83044430|NCT03521492|Calcium|calcium|mesh-list
83044431|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
83044432|NCT03521492|Hormones|hormones|mesh-list
83044433|NCT03521492|Vitamins|vitamins|mesh-ancestor
83044434|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
83044435|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044436|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83044437|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83044438|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044439|NCT03521414|Sevoflurane|sevoflurane|mesh-list
83044440|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83044441|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83044442|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
83044443|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
83044444|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044445|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044446|NCT00432094|Paclitaxel|paclitaxel|mesh-list
83044447|NCT00432094|Etoposide|etoposide|mesh-list
83044448|NCT00432094|Carboplatin|carboplatin|mesh-list
83044449|NCT00432094|Ifosfamide|ifosfamide|mesh-list
83044450|NCT00432094|Thiotepa|thiotepa|mesh-list
83044451|NCT00432094|Mesna|mesna|mesh-list
83044452|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83044453|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044454|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
83044455|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
83044456|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
83044457|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044458|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83044459|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83044460|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044461|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
83044462|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044463|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83044464|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
83044465|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83044466|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83044467|NCT00432094|Protective Agents|protective agents|mesh-ancestor
83044468|NCT05575518|Rifamycins|rifamycins|mesh-list
83044469|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
83044470|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044471|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044472|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83044473|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044474|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044475|NCT04562779|Naltrexone|naltrexone|mesh-list
83044476|NCT04562779|Ketamine|ketamine|mesh-list
83044477|NCT04562779|Analgesics|analgesics|mesh-ancestor
83044478|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
83044479|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044480|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044481|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83044482|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044483|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
83044484|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
83044485|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044486|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83044487|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83044488|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044489|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044490|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83044491|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83044492|NCT03751761|Paclitaxel|paclitaxel|mesh-list
83044493|NCT03751761|Durvalumab|durvalumab|mesh-list
83044494|NCT03751761|Tremelimumab|tremelimumab|mesh-list
83044495|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83044496|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044497|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83044498|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83044499|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83044500|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044501|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044502|NCT03644823|Atezolizumab|atezolizumab|mesh-list
83044503|NCT03644823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044504|NCT03644823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044505|NCT03644823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044506|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044507|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
83044508|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83044509|NCT00072358|Irinotecan|irinotecan|mesh-list
83044510|NCT00072358|Temozolomide|temozolomide|mesh-list
83044511|NCT00072358|Molgramostim|molgramostim|mesh-list
83044512|NCT00072358|Isotretinoin|isotretinoin|mesh-list
83044513|NCT00072358|Antibodies|antibodies|mesh-list
83044514|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
83044515|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83044516|NCT00072358|Sargramostim|sargramostim|mesh-list
83044517|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
83044518|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
83044519|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044520|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044521|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83044522|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83044523|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044524|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044525|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83044526|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
83044527|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83044528|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83044529|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044530|NCT03104998|Ubiquinone|ubiquinone|mesh-list
83044531|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
83044532|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
83044533|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044534|NCT03104998|Vitamins|vitamins|mesh-ancestor
83044535|NCT03990766|Theophylline|theophylline|mesh-list
83044536|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83044537|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
83044538|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044539|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044540|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83044541|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
83044542|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83044543|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044544|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044545|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
83044546|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83044547|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83044548|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
83044549|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044550|NCT02294162|Ketamine|ketamine|mesh-list
83044551|NCT02294162|Analgesics|analgesics|mesh-ancestor
83044552|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
83044553|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044554|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044555|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83044556|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044557|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
83044558|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
83044559|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044560|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83044561|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83044562|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084039|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83044563|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044564|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83044565|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83044566|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83044567|NCT05176158|Analgesics|analgesics|mesh-ancestor
83044568|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
83044569|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044570|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044571|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044572|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044573|NCT02294240|Folic Acid|folic acid|mesh-list
83044574|NCT02294240|Hematinics|hematinics|mesh-ancestor
83044575|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
83044576|NCT02294240|Vitamins|vitamins|mesh-ancestor
83044577|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
83044578|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044579|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
83044580|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83044581|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83044583|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
83044584|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044585|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044586|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044587|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044588|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83044589|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
83044590|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044591|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83044592|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
83044593|NCT02298218|Meloxicam|meloxicam|mesh-list
83044594|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83044595|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83044596|NCT02298218|Analgesics|analgesics|mesh-ancestor
83044597|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
83044598|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044599|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044600|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044601|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044602|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83044603|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83044604|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044605|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044606|NCT03547830|Plerixafor|plerixafor|mesh-list
83044607|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83044608|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83044609|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
83044610|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044611|NCT04390945|Capecitabine|capecitabine|mesh-list
83044612|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83044613|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
83044614|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044615|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044616|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
83044617|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044618|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044619|NCT03734809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044620|NCT03734809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044621|NCT02291666|Tolbutamide|tolbutamide|mesh-list
83044622|NCT02291666|Midazolam|midazolam|mesh-list
83044623|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
83044624|NCT02291666|Caffeine|caffeine|mesh-list
83044625|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
83044626|NCT02291666|Bupropion|bupropion|mesh-list
83044627|NCT02291666|Omeprazole|omeprazole|mesh-list
83044628|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83044629|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83044630|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044631|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044632|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83044633|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83044634|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83044635|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044636|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
83044637|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
83044638|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
83044639|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
83044640|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044641|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044642|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83044643|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83044644|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044645|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83044646|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83044647|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
83044648|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83044649|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044650|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83044651|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83044653|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83044654|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83044655|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83044656|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
83044657|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83044658|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83044659|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
83044660|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
83044661|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83044662|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83044663|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83044664|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83044665|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83044666|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044667|NCT03102658|Micafungin|micafungin|mesh-list
83044668|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
83044669|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044670|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
83044671|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044672|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044673|NCT02646748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044674|NCT02646748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044675|NCT03624985|Lidocaine|lidocaine|mesh-list
83044676|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
83044677|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
83044678|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044679|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044680|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
83044681|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044682|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83044683|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83044684|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83044685|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83044686|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044687|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
83044688|NCT03521024|Ether|ether|mesh-list
83044689|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
83044690|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83044691|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044692|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044693|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
83044694|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83044695|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044696|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044697|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83044698|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
83044699|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
83044700|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
83044701|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044702|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044703|NCT02635672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044704|NCT02635672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044705|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
83044706|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
83044707|NCT02294552|Busulfan|busulfan|mesh-list
83044708|NCT02294552|Fludarabine|fludarabine|mesh-list
83044709|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
83044710|NCT02294552|Tacrolimus|tacrolimus|mesh-list
83044711|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362138|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83044712|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
83044713|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044714|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044715|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83044716|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
83044717|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044718|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044719|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83044720|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83044721|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
83044722|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83044723|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044724|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83044725|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83044726|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
83044727|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044728|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044729|NCT05574036|Vitamin E|vitamin e|mesh-list
83044730|NCT05574036|Febuxostat|febuxostat|mesh-list
83044731|NCT05574036|Vitamins|vitamins|mesh-ancestor
83044732|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
83044733|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044734|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
83044735|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044736|NCT05574036|Protective Agents|protective agents|mesh-ancestor
83044737|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
83044738|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044739|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
83044740|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83044741|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044742|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83044743|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
83044744|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83044745|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044746|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044747|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044748|NCT03869944|Lamivudine|lamivudine|mesh-list
83044749|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83044750|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83044751|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044752|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044753|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
83044754|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044755|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83044756|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83044757|NCT03864094|Phenylephrine|phenylephrine|mesh-list
83044758|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
83044759|NCT03864094|Norepinephrine|norepinephrine|mesh-list
83044760|NCT03864094|Ephedrine|ephedrine|mesh-list
83044761|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
83044762|NCT03864094|Remifentanil|remifentanil|mesh-list
83044763|NCT03864094|Propofol|propofol|mesh-list
83044764|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83044765|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044766|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044767|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044768|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
83044769|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
83044770|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83044771|NCT03864094|Narcotics|narcotics|mesh-ancestor
83044772|NCT03864094|Analgesics|analgesics|mesh-ancestor
83044773|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
83044774|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044775|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83044776|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
83044777|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
83044778|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
83044779|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83044780|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
83044781|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
83044782|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83044783|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83044784|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83044785|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83044786|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044787|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044788|NCT03864094|Protective Agents|protective agents|mesh-ancestor
83044789|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83044790|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83044791|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83044792|NCT05573802|Dexamethasone|dexamethasone|mesh-list
83044793|NCT05573802|Lenalidomide|lenalidomide|mesh-list
83044794|NCT05573802|Nirogacestat|nirogacestat|mesh-list
83044795|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044796|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
83044797|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
83044798|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044799|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044800|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83044801|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
83044802|NCT05573802|Hormones|hormones|mesh-ancestor
83044803|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044804|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83044805|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044806|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
83044807|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83044808|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83044809|NCT05573802|Growth Substances|growth substances|mesh-ancestor
83044810|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
83044811|NCT05573802|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83044812|NCT05573802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044813|NCT05573802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044814|NCT04435522|Maraviroc|maraviroc|mesh-list
83044815|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83044816|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83044817|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044818|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83044819|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83044820|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
83044821|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044822|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83044823|NCT03575325|Cytarabine|cytarabine|mesh-list
83044824|NCT03575325|Daunorubicin|daunorubicin|mesh-list
83044825|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83044826|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
83044827|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044828|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044829|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
83044830|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83044831|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83044832|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
83044833|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044834|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83044835|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83044836|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83044837|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044838|NCT03843970|Bupivacaine|bupivacaine|mesh-list
83044839|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
83044840|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83044841|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
83044842|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
83044843|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044844|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044845|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
83044846|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044847|NCT03043651|Treprostinil|treprostinil|mesh-list
83044848|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83044849|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83044850|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
83044851|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044852|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83044853|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83044854|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
83044855|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044856|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044857|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83044858|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83044859|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
83044860|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044861|NCT02298530|Caffeine|caffeine|mesh-list
83044862|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83044863|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044864|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83044865|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044866|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044867|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83044868|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83044869|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
83044870|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044871|NCT05051436|Tadalafil|tadalafil|mesh-list
83044872|NCT05051436|Mirabegron|mirabegron|mesh-list
83044873|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
83044874|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83044875|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83044876|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044877|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044878|NCT05051436|Urological Agents|urological agents|mesh-ancestor
83044879|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83044880|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83044881|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83044882|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83044883|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044884|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044885|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
83044886|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
83044887|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
83044888|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044889|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83044890|NCT03644589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83044891|NCT03644589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044892|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
83044893|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044894|NCT03514550|Propofol|propofol|mesh-list
83044895|NCT03514550|Sevoflurane|sevoflurane|mesh-list
83044896|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83044897|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044898|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044899|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044900|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
83044901|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
83044902|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83044903|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83044904|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
83044905|NCT04173988|Fludarabine|fludarabine|mesh-list
83044906|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83044907|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
83044908|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044909|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83044910|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83044911|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
83044912|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044913|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044914|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83044915|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
83044916|NCT01344759|Propofol|propofol|mesh-list
83044917|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83044918|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83044919|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044920|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83044921|NCT01344759|Analgesics|analgesics|mesh-ancestor
83044922|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
83044923|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044924|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83044925|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83044926|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83044927|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
83044928|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044929|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044930|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83044931|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
83044932|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
83044933|NCT05885386|Temozolomide|temozolomide|mesh-list
83044934|NCT05885386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83044935|NCT05885386|Alkylating Agents|alkylating agents|mesh-ancestor
83044936|NCT05885386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044937|NCT05885386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83044938|NCT05885360|Istradefylline|istradefylline|mesh-list
83044939|NCT05885360|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83044940|NCT05885360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83044941|NCT05885360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83044942|NCT05885360|Purinergic Agents|purinergic agents|mesh-ancestor
83044943|NCT05885360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044944|NCT05885360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044945|NCT05885360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044946|NCT05885269|Clobetasol|clobetasol|mesh-list
83044947|NCT05885269|Tacrolimus|tacrolimus|mesh-list
83044948|NCT05885269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83044949|NCT05885269|Immunologic Factors|immunologic factors|mesh-ancestor
83044950|NCT05885269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044951|NCT05885269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83044952|NCT05885269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83044953|NCT05885269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044954|NCT05885269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83044955|NCT05885269|Glucocorticoids|glucocorticoids|mesh-ancestor
83044956|NCT05885269|Hormones|hormones|mesh-ancestor
83044957|NCT05885269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83044958|NCT05885074|Empagliflozin|empagliflozin|mesh-list
83044959|NCT05885074|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83438636|NCT04329039|Hormones|hormones|mesh-ancestor
83044960|NCT05885074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044961|NCT05885074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83044962|NCT05885074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044963|NCT05885035|Calcium|calcium|mesh-list
83044964|NCT05885035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83044965|NCT05885035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044966|NCT05884983|Vaccines|vaccines|mesh-list
83044967|NCT05884983|Immunologic Factors|immunologic factors|mesh-ancestor
83044968|NCT05884983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044969|NCT05884970|Albuterol|albuterol|mesh-list
83044970|NCT05884970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83044971|NCT05884970|Autonomic Agents|autonomic agents|mesh-ancestor
83044972|NCT05884970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044973|NCT05884970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044974|NCT05884970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83044975|NCT05884970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83044976|NCT05884970|Tocolytic Agents|tocolytic agents|mesh-ancestor
83044977|NCT05884970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83044978|NCT05884970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83044979|NCT05884970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83044980|NCT05884970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83044981|NCT05884970|Adrenergic Agents|adrenergic agents|mesh-ancestor
83044982|NCT05884970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044983|NCT05884970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044984|NCT05884957|Nitric Oxide|nitric oxide|mesh-list
83044985|NCT05884957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83044986|NCT05884957|Autonomic Agents|autonomic agents|mesh-ancestor
83044987|NCT05884957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83044988|NCT05884957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83044989|NCT05884957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83044990|NCT05884957|Respiratory System Agents|respiratory system agents|mesh-ancestor
83044991|NCT05884957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83044992|NCT05884957|Antioxidants|antioxidants|mesh-ancestor
83044993|NCT05884957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83044994|NCT05884957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83044995|NCT05884957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83044996|NCT05884957|Vasodilator Agents|vasodilator agents|mesh-ancestor
83044997|NCT05884957|Gasotransmitters|gasotransmitters|mesh-ancestor
83044998|NCT05884957|Protective Agents|protective agents|mesh-ancestor
83044999|NCT05884866|Dapagliflozin|dapagliflozin|mesh-list
83045000|NCT05884866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83045001|NCT05884866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045002|NCT05884866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83045003|NCT05884866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045004|NCT05884671|Sulpiride|sulpiride|mesh-list
83045005|NCT05884671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83045006|NCT05884671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83045007|NCT05884671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045008|NCT05884671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045009|NCT05884671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83045010|NCT05884671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83045011|NCT05884671|Dopamine Agents|dopamine agents|mesh-ancestor
83045012|NCT05884671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045013|NCT05884671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045014|NCT05884671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83045015|NCT05884671|Antidepressive Agents|antidepressive agents|mesh-ancestor
83045016|NCT05884502|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83045017|NCT05884502|Ezetimibe|ezetimibe|mesh-list
83045018|NCT05884502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83045019|NCT05884502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83045020|NCT05884502|Antimetabolites|antimetabolites|mesh-ancestor
83045021|NCT05884502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045022|NCT05884502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83045023|NCT05884502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83045024|NCT05884502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045025|NCT05884463|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83045026|NCT05884463|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83045027|NCT05884463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045028|NCT05884320|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83045029|NCT05884320|Immunoconjugates|immunoconjugates|mesh-ancestor
83045030|NCT05884320|Immunologic Factors|immunologic factors|mesh-ancestor
83045031|NCT05884320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045032|NCT05884268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83045033|NCT05884268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83045034|NCT05884268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83045035|NCT05884268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83045036|NCT05884268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045037|NCT05884268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045038|NCT05884268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045039|NCT05884268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83045040|NCT05884268|Antidepressive Agents|antidepressive agents|mesh-ancestor
83045041|NCT05884268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83045042|NCT05884255|Octreotide|octreotide|mesh-list
83045043|NCT05884255|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83045044|NCT05884255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045045|NCT05884255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045046|NCT05884255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045047|NCT05884255|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83045048|NCT05884255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045049|NCT05884242|Adalimumab|adalimumab|mesh-list
83045050|NCT05884242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83045051|NCT05884242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045052|NCT05884242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045053|NCT05884151|Tranexamic Acid|tranexamic acid|mesh-list
83045054|NCT05884151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83045055|NCT05884151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83045056|NCT05884151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045057|NCT05884151|Hemostatics|hemostatics|mesh-ancestor
83045058|NCT05884151|Coagulants|coagulants|mesh-ancestor
83045059|NCT05883956|Azacitidine|azacitidine|mesh-list
83045060|NCT05883956|Decitabine|decitabine|mesh-list
83045061|NCT05883956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045062|NCT05883956|Antimetabolites|antimetabolites|mesh-ancestor
83045063|NCT05883956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045064|NCT05883956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045065|NCT05883956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045066|NCT05883891|Thrombin|thrombin|mesh-list
83045067|NCT05883891|Hemostatics|hemostatics|mesh-ancestor
83045068|NCT05883891|Coagulants|coagulants|mesh-ancestor
83045069|NCT05883865|Fenofibrate|fenofibrate|mesh-list
83045070|NCT05883865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83045071|NCT05883865|Antimetabolites|antimetabolites|mesh-ancestor
83045072|NCT05883865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045073|NCT05883865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83045074|NCT05883709|Lenalidomide|lenalidomide|mesh-list
83045075|NCT05883709|Immunologic Factors|immunologic factors|mesh-ancestor
83045076|NCT05883709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045077|NCT05883709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83045078|NCT05883709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83045079|NCT05883709|Growth Substances|growth substances|mesh-ancestor
83045080|NCT05883709|Growth Inhibitors|growth inhibitors|mesh-ancestor
83045081|NCT05883709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045082|NCT05883644|Durvalumab|durvalumab|mesh-list
83045083|NCT05883644|Tremelimumab|tremelimumab|mesh-list
83045084|NCT05883644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045085|NCT05883644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045086|NCT05883540|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83045087|NCT05883540|Hallucinogens|hallucinogens|mesh-ancestor
83045088|NCT05883540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045089|NCT05883540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83045090|NCT05883540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83045091|NCT05883540|Serotonin Agents|serotonin agents|mesh-ancestor
83045092|NCT05883540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045093|NCT05883540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045094|NCT05883540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83045095|NCT05883449|Cyclophosphamide|cyclophosphamide|mesh-list
83045096|NCT05883449|Fludarabine|fludarabine|mesh-list
83045097|NCT05883449|Interleukin-2|interleukin-2|mesh-list
83045098|NCT05883449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045099|NCT05883449|Immunologic Factors|immunologic factors|mesh-ancestor
83045100|NCT05883449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045101|NCT05883449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045102|NCT05883449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83045103|NCT05883449|Alkylating Agents|alkylating agents|mesh-ancestor
83045104|NCT05883449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045105|NCT05883449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045106|NCT05883449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83045107|NCT05883449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045108|NCT05883449|Analgesics|analgesics|mesh-ancestor
83045109|NCT05883449|Sensory System Agents|sensory system agents|mesh-ancestor
83045110|NCT05883449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045111|NCT05881720|Valsartan|valsartan|mesh-list
83045112|NCT05881720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83045113|NCT05881720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83045114|NCT05881720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83045115|NCT05881720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83045116|NCT05881720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045117|NCT05873725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83045118|NCT05873725|Hormones|hormones|mesh-ancestor
83045119|NCT05873725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045120|NCT05873725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045121|NCT05866315|Remifentanil|remifentanil|mesh-list
83045122|NCT05866315|Desflurane|desflurane|mesh-list
83045123|NCT05866315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83045124|NCT05866315|Narcotics|narcotics|mesh-ancestor
83045125|NCT05866315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045126|NCT05866315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045127|NCT05866315|Analgesics|analgesics|mesh-ancestor
83045128|NCT05866315|Sensory System Agents|sensory system agents|mesh-ancestor
83045129|NCT05866315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045130|NCT05866315|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83045131|NCT05866315|Anesthetics, General|anesthetics, general|mesh-ancestor
83045132|NCT05866315|Anesthetics|anesthetics|mesh-ancestor
83045133|NCT05862285|Ipatasertib|ipatasertib|mesh-list
83045134|NCT05862285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045135|NCT05862285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045136|NCT05862285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045137|NCT05862285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045138|NCT05860933|Itraconazole|itraconazole|mesh-list
83045139|NCT05860933|Carbamazepine|carbamazepine|mesh-list
83045140|NCT05860933|Antifungal Agents|antifungal agents|mesh-ancestor
83045141|NCT05860933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83045142|NCT05860933|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83045143|NCT05860933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83045144|NCT05860933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045145|NCT05860933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045146|NCT05860933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83045147|NCT05860933|Hormone Antagonists|hormone antagonists|mesh-ancestor
83045148|NCT05860933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045149|NCT05860933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045150|NCT05860933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83045151|NCT05860933|Anticonvulsants|anticonvulsants|mesh-ancestor
83045152|NCT05860933|Antimanic Agents|antimanic agents|mesh-ancestor
83045153|NCT05860933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83045154|NCT05860933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045155|NCT05860933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83045156|NCT05860933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045157|NCT05860933|Analgesics|analgesics|mesh-ancestor
83045158|NCT05860933|Sensory System Agents|sensory system agents|mesh-ancestor
83045159|NCT05860933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045160|NCT05860933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83045161|NCT05860933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83045162|NCT05860933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83045163|NCT05860933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83045164|NCT05860530|Olaparib|olaparib|mesh-list
83045165|NCT05860530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83045166|NCT05860530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045167|NCT05860530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045168|NCT05860530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045169|NCT05855798|Magnesium Sulfate|magnesium sulfate|mesh-list
83045170|NCT05855798|Ketamine|ketamine|mesh-list
83045171|NCT05855798|Bupivacaine|bupivacaine|mesh-list
83045172|NCT05855798|Anesthetics, Local|anesthetics, local|mesh-ancestor
83045173|NCT05855798|Anesthetics|anesthetics|mesh-ancestor
83045174|NCT05855798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045175|NCT05855798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045176|NCT05855798|Sensory System Agents|sensory system agents|mesh-ancestor
83045177|NCT05855798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045178|NCT05855798|Analgesics|analgesics|mesh-ancestor
83045179|NCT05855798|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83045180|NCT05855798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83045181|NCT05855798|Anesthetics, General|anesthetics, general|mesh-ancestor
83045182|NCT05855798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83045183|NCT05855798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83045184|NCT05855798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045185|NCT05855798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045186|NCT05855798|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83045187|NCT05855798|Anticonvulsants|anticonvulsants|mesh-ancestor
83045188|NCT05855798|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83045189|NCT05855798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83045190|NCT05855798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83045191|NCT05855798|Tocolytic Agents|tocolytic agents|mesh-ancestor
83045192|NCT05855798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83045193|NCT05845008|Acetaminophen|acetaminophen|mesh-list
83045194|NCT05845008|Naproxen|naproxen|mesh-list
83045195|NCT05845008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045196|NCT05845008|Analgesics|analgesics|mesh-ancestor
83045197|NCT05845008|Sensory System Agents|sensory system agents|mesh-ancestor
83045198|NCT05845008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045199|NCT05845008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045200|NCT05845008|Antipyretics|antipyretics|mesh-ancestor
83045201|NCT05845008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83045202|NCT05845008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045203|NCT05845008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045204|NCT05845008|Gout Suppressants|gout suppressants|mesh-ancestor
83045205|NCT05845008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83045206|NCT05845008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045207|NCT05845008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045208|NCT05844995|Acetaminophen|acetaminophen|mesh-list
83045209|NCT05844995|Naproxen|naproxen|mesh-list
83045210|NCT05844995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045211|NCT05844995|Analgesics|analgesics|mesh-ancestor
83045212|NCT05844995|Sensory System Agents|sensory system agents|mesh-ancestor
83045213|NCT05844995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045214|NCT05844995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045215|NCT05844995|Antipyretics|antipyretics|mesh-ancestor
83045216|NCT05844995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83045217|NCT05844995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045218|NCT05844995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045219|NCT05844995|Gout Suppressants|gout suppressants|mesh-ancestor
83045220|NCT05844995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83045221|NCT05844995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045222|NCT05844995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045223|NCT05833126|Bevacizumab|bevacizumab|mesh-list
83045224|NCT05833126|Atezolizumab|atezolizumab|mesh-list
83045225|NCT05833126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045226|NCT05833126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045227|NCT05833126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83045228|NCT05833126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83045229|NCT05833126|Growth Substances|growth substances|mesh-ancestor
83045230|NCT05833126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045231|NCT05833126|Growth Inhibitors|growth inhibitors|mesh-ancestor
83045232|NCT05833126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045233|NCT05833126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045234|NCT05830799|Tolbutamide|tolbutamide|mesh-list
83045236|NCT05830799|Midazolam|midazolam|mesh-list
83045237|NCT05830799|Caffeine|caffeine|mesh-list
83045238|NCT05830799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83045239|NCT05830799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83045240|NCT05830799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045241|NCT05830799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045242|NCT05830799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83045243|NCT05830799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83045244|NCT05830799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83045245|NCT05830799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83045246|NCT05830799|Anesthetics, General|anesthetics, general|mesh-ancestor
83045247|NCT05830799|Anesthetics|anesthetics|mesh-ancestor
83045248|NCT05830799|GABA Modulators|gaba modulators|mesh-ancestor
83045249|NCT05830799|GABA Agents|gaba agents|mesh-ancestor
83045250|NCT05830799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045251|NCT05830799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045252|NCT05830799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83045253|NCT05830799|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83045254|NCT05830799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045255|NCT05830799|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83045256|NCT05830799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83045257|NCT05830799|Purinergic Agents|purinergic agents|mesh-ancestor
83045258|NCT05830799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045259|NCT05830799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045260|NCT05830799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83045262|NCT05827523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045263|NCT05798156|Rituximab|rituximab|mesh-list
83045264|NCT05798156|Obinutuzumab|obinutuzumab|mesh-list
83045265|NCT05798156|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83045266|NCT05798156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045267|NCT05798156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045268|NCT05798156|Immunologic Factors|immunologic factors|mesh-ancestor
83045269|NCT05798156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045270|NCT05798156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045271|NCT05798156|Immunoconjugates|immunoconjugates|mesh-ancestor
83045272|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
83045273|NCT05766371|177Lu-PSMA-617|177lu-psma-617|mesh-list
83045274|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045275|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045276|NCT05766371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045277|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045278|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83045279|NCT05761574|Acetaminophen|acetaminophen|mesh-list
83045280|NCT05761574|Naproxen|naproxen|mesh-list
83045281|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045282|NCT05761574|Analgesics|analgesics|mesh-ancestor
83045283|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
83045284|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045285|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045286|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
83045287|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83045288|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045289|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045290|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
83045291|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83045292|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045293|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045294|NCT05754710|Tofacitinib|tofacitinib|mesh-list
83045295|NCT05754710|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83045296|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045297|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045298|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045299|NCT05743270|Paclitaxel|paclitaxel|mesh-list
83045300|NCT05743270|Carboplatin|carboplatin|mesh-list
83045301|NCT05743270|Nivolumab|nivolumab|mesh-list
83045302|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83045303|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045304|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
83045305|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
83045306|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
83045307|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045308|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045309|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045311|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
83045312|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83045313|NCT05721937|Abrocitinib|abrocitinib|mesh-list
83045314|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045315|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045316|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045317|NCT05720949|Dexamethasone|dexamethasone|mesh-list
83045318|NCT05720949|Bupivacaine|bupivacaine|mesh-list
83045319|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045320|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
83045321|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
83045322|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045323|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045324|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045325|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
83045326|NCT05720949|Hormones|hormones|mesh-ancestor
83045327|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045328|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045329|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045330|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
83045331|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
83045332|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045333|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
83045334|NCT05714631|Lidocaine|lidocaine|mesh-list
83045335|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
83045336|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
83045337|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045338|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045339|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
83045340|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045341|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83045342|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83045343|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83045344|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83045345|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045346|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
83045347|NCT05707377|Tacrolimus|tacrolimus|mesh-list
83045348|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045349|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
83045350|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045351|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83045352|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045353|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045354|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045355|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045356|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
83045357|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
83045358|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045359|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
83045360|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045361|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045362|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83045363|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
83045364|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045365|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045366|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83045367|NCT05679401|Hormones|hormones|mesh-ancestor
83045368|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045369|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83045370|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
83045371|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
83045372|NCT05674877|Ketamine|ketamine|mesh-list
83045373|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
83045374|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83045375|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045376|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045377|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045378|NCT05674877|Analgesics|analgesics|mesh-ancestor
83045379|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
83045380|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045381|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83045391|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83045392|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83045393|NCT05674877|Narcotics|narcotics|mesh-ancestor
83045396|NCT05650476|Talazoparib|talazoparib|mesh-list
83045397|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83045398|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045399|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045400|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045401|NCT05633563|Trimetazidine|trimetazidine|mesh-list
83045402|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
83045403|NCT05627271|Ofatumumab|ofatumumab|mesh-list
83045404|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
83045405|NCT05627271|Natalizumab|natalizumab|mesh-list
83045406|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045407|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
83045408|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045409|NCT05610735|Doxorubicin|doxorubicin|mesh-list
83045410|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83045411|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83045412|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045413|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83045414|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83045415|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045416|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045417|NCT05609370|Bevacizumab|bevacizumab|mesh-list
83045418|NCT05609370|Tislelizumab|tislelizumab|mesh-list
83045419|NCT05609370|Capecitabine|capecitabine|mesh-list
83045420|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045421|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045422|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83045423|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83045424|NCT05609370|Growth Substances|growth substances|mesh-ancestor
83045425|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045426|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83045427|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045428|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
83045429|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045430|NCT05605509|Gemcitabine|gemcitabine|mesh-list
83045431|NCT05605509|Trastuzumab|trastuzumab|mesh-list
83045432|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045433|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
83045434|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045435|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045436|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045444|NCT05601440|Gemcitabine|gemcitabine|mesh-list
83045445|NCT05601440|Fulvestrant|fulvestrant|mesh-list
83045446|NCT05601440|Niraparib|niraparib|mesh-list
83045447|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045448|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
83045449|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045450|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045451|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045452|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83045453|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83045454|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
83045455|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045463|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83045464|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045465|NCT05571514|Antacids|antacids|mesh-ancestor
83045466|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045467|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045468|NCT05562713|Denatonium|denatonium|mesh-list
83045469|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
83045470|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045471|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
83045472|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045473|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
83045474|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045475|NCT05556720|Vaccines|vaccines|mesh-list
83045476|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
83045477|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045478|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
83045479|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045480|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045481|NCT05518032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045482|NCT05518032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045483|NCT05513391|Vaccines|vaccines|mesh-list
83045484|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
83045485|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045486|NCT05498766|Capecitabine|capecitabine|mesh-list
83045487|NCT05498766|Tegafur|tegafur|mesh-list
83045488|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
83045489|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045490|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
83045491|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045492|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045493|NCT05498389|Osimertinib|osimertinib|mesh-list
83045494|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045495|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045496|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045497|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045498|NCT05468489|Carboplatin|carboplatin|mesh-list
83045499|NCT05468489|Etoposide|etoposide|mesh-list
83045500|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
83045501|NCT05468489|Atezolizumab|atezolizumab|mesh-list
83045502|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045503|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83045504|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83045505|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83045506|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045507|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045508|NCT05468489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045509|NCT05468489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045510|NCT05466578|Abrocitinib|abrocitinib|mesh-list
83045511|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045512|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045513|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045514|NCT05450562|Cemiplimab|cemiplimab|mesh-list
83045515|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045516|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045517|NCT05408429|Vaccines|vaccines|mesh-list
83045518|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83045519|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
83045520|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045540|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83045541|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83045542|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83045543|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045544|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045545|NCT05361395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045546|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045548|NCT05351541|Modafinil|modafinil|mesh-list
83045549|NCT05351541|Psilocybin|psilocybin|mesh-list
83045550|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83045551|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83045552|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045553|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83045554|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83045555|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83045556|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045557|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
83045558|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83045559|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83045560|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83045561|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045562|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83045563|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
83045564|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
83045565|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045566|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83045567|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
83045568|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83045569|NCT05339256|Buprenorphine|buprenorphine|mesh-list
83045570|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83045571|NCT05339256|Narcotics|narcotics|mesh-ancestor
83045572|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045573|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045574|NCT05339256|Analgesics|analgesics|mesh-ancestor
83045575|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
83045576|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045577|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83045578|NCT05334056|Cocaine|cocaine|mesh-list
83045579|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
83045580|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
83045581|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045582|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045583|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
83045584|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045585|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83045586|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83045587|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83045588|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83045589|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045590|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
83045591|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045592|NCT05328414|Prednisolone|prednisolone|mesh-list
83045593|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045594|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
83045595|NCT05328414|Hormones|hormones|mesh-ancestor
83045596|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045597|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045598|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045599|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045600|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83045601|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83045602|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83045603|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045613|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045615|NCT05291598|Meloxicam|meloxicam|mesh-list
83045616|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83045617|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045618|NCT05291598|Analgesics|analgesics|mesh-ancestor
83045619|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
83045620|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045621|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045622|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045623|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045624|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83045625|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045626|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045627|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83045628|NCT05288153|Metformin|metformin|mesh-list
83045629|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83045630|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045641|NCT05259722|Alitretinoin|alitretinoin|mesh-list
83045642|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045643|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
83045644|NCT05255003|Enoxaparin|enoxaparin|mesh-list
83045645|NCT05255003|Dalteparin|dalteparin|mesh-list
83045646|NCT05255003|Tinzaparin|tinzaparin|mesh-list
83045647|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83045648|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
83045649|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83045650|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83045651|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045652|NCT05190432|Taxifolin|taxifolin|mesh-list
83045653|NCT05190432|Ergothioneine|ergothioneine|mesh-list
83045654|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
83045655|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045656|NCT05190432|Protective Agents|protective agents|mesh-ancestor
83045657|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045658|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83045659|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83045660|NCT05190432|Analgesics|analgesics|mesh-ancestor
83045661|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
83045662|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045663|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045664|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83045665|NCT05180097|Dexamethasone|dexamethasone|mesh-list
83045666|NCT05180097|Gemcitabine|gemcitabine|mesh-list
83045667|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
83045668|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83045669|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045670|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
83045671|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
83045672|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045673|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045674|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045675|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
83045676|NCT05180097|Hormones|hormones|mesh-ancestor
83045677|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045678|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045679|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045686|NCT05180097|Immunoconjugates|immunoconjugates|mesh-ancestor
83045687|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
83045690|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
83045691|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
83045692|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
83045693|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045694|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045695|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045696|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045697|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
83045698|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045699|NCT05171166|Antidotes|antidotes|mesh-ancestor
83045700|NCT05171166|Protective Agents|protective agents|mesh-ancestor
83045701|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
83045702|NCT05171166|Vitamins|vitamins|mesh-ancestor
83045703|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
83045704|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83045705|NCT05171166|Estrogens|estrogens|mesh-ancestor
83045706|NCT05171166|Hormones|hormones|mesh-ancestor
83045707|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045708|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045716|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
83045717|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
83045718|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045719|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
83045720|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045721|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045722|NCT05127590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83045723|NCT05127590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045724|NCT05123131|Dexamethasone|dexamethasone|mesh-list
83045725|NCT05123131|Lenalidomide|lenalidomide|mesh-list
83045726|NCT05123131|Bortezomib|bortezomib|mesh-list
83045727|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045728|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
83045729|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
83045730|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045731|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045732|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045733|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
83045734|NCT05123131|Hormones|hormones|mesh-ancestor
83045735|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045736|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045737|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045738|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
83045739|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83045740|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83045741|NCT05123131|Growth Substances|growth substances|mesh-ancestor
83045742|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
83045743|NCT05102162|Meropenem|meropenem|mesh-list
83045744|NCT05102162|Tazobactam|tazobactam|mesh-list
83045745|NCT05102162|Piperacillin|piperacillin|mesh-list
83045746|NCT05102162|Cefepime|cefepime|mesh-list
83045747|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83045748|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83045749|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83045750|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83045751|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045752|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045753|NCT05101187|Amphotericin B|amphotericin b|mesh-list
83045754|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83045755|NCT05101187|Olorofim|olorofim|mesh-list
83045756|NCT05101187|Amebicides|amebicides|mesh-ancestor
83045757|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83045758|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83045759|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83045760|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83045761|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
83045763|NCT05065866|Cc-486|cc-486|mesh-list
83045764|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045765|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
83045766|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045767|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045768|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045769|NCT05024513|Fluorouracil|fluorouracil|mesh-list
83045770|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
83045771|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
83045772|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045773|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045774|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045775|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045776|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
83045777|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045778|NCT05024045|Pirtobrutinib|pirtobrutinib|mesh-list
83045779|NCT05024045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045780|NCT05024045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045781|NCT05024045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045782|NCT05000047|Silicon|silicon|mesh-list
83045783|NCT05000047|Trace Elements|trace elements|mesh-ancestor
83045784|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
83045785|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045786|NCT04982848|Talazoparib|talazoparib|mesh-list
83045787|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83045788|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045789|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045790|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045791|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
83045792|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83045793|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83045794|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
83045795|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83045796|NCT04974047|Tislelizumab|tislelizumab|mesh-list
83045797|NCT04974047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045798|NCT04974047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045799|NCT04973605|Dexamethasone|dexamethasone|mesh-list
83045800|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045801|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
83045802|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
83045803|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045804|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045805|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045806|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
83045807|NCT04973605|Hormones|hormones|mesh-ancestor
83045808|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045809|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045810|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045811|NCT04934800|Cladribine|cladribine|mesh-list
83045812|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045813|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045814|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
83045815|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045816|NCT04920942|Ivermectin|ivermectin|mesh-list
83045817|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83045818|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83045819|NCT04918186|Durvalumab|durvalumab|mesh-list
83045820|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045821|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045822|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83045823|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
83045824|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83045825|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83045826|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83045827|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
83045828|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83045829|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045830|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83045831|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83045832|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83045833|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045834|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045835|NCT04876248|Lenalidomide|lenalidomide|mesh-list
83045836|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
83045837|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045838|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83045839|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83045840|NCT04876248|Growth Substances|growth substances|mesh-ancestor
83045841|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
83045842|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045843|NCT04821687|Opicapone|opicapone|mesh-list
83045844|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83045845|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045846|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045847|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
83045848|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045849|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045850|NCT04821687|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83045851|NCT04821687|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83045852|NCT04821687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83045853|NCT04821622|Talazoparib|talazoparib|mesh-list
83045854|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83045855|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045856|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045857|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045858|NCT04764344|Haloperidol|haloperidol|mesh-list
83045859|NCT04764344|Ondansetron|ondansetron|mesh-list
83045860|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
83045861|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
83045862|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
83045863|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045864|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045865|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045866|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
83045867|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
83045868|NCT04764344|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83045869|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83045870|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
83045871|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83045872|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045873|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83045874|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83045875|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045876|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83045877|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83045878|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
83045879|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83045880|NCT04745026|Cannabidiol|cannabidiol|mesh-list
83045881|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
83045882|NCT04738981|Basiliximab|basiliximab|mesh-list
83045883|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045884|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
83045885|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045886|NCT04709185|Dexamethasone|dexamethasone|mesh-list
83045887|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83045888|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
83045889|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
83045890|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045891|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045892|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83045893|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
83045894|NCT04709185|Hormones|hormones|mesh-ancestor
83045895|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045896|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045897|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045898|NCT04693156|Bupivacaine|bupivacaine|mesh-list
83045899|NCT04693156|Prilocaine|prilocaine|mesh-list
83045900|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
83045901|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
83045902|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83045903|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045904|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
83045905|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83045906|NCT04685616|Doxorubicin|doxorubicin|mesh-list
83045907|NCT04685616|Bleomycin|bleomycin|mesh-list
83045911|NCT04685616|Mitogens|mitogens|mesh-list
83045912|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83045913|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045914|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83045915|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83045916|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045917|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045918|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
83045919|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83045920|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
83045921|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83045922|NCT04685616|Immunotoxins|immunotoxins|mesh-ancestor
83045923|NCT04685616|Immunoconjugates|immunoconjugates|mesh-ancestor
83045924|NCT04685616|Immunologic Factors|immunologic factors|mesh-ancestor
83045925|NCT04685616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045926|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83045927|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
83045928|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
83045929|NCT04623216|Azacitidine|azacitidine|mesh-list
83045930|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83045931|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
83045932|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045933|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045934|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045935|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
83045936|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83045937|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045938|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83045939|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045943|NCT04576156|Imetelstat|imetelstat|mesh-list
83045944|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
83045945|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045946|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045947|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045948|NCT04504331|Tamoxifen|tamoxifen|mesh-list
83045949|NCT04504331|Infigratinib|infigratinib|mesh-list
83045950|NCT04504331|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83045951|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83045952|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
83045953|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83045954|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045955|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83045956|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045957|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83045958|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83045959|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83045960|NCT04504331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045961|NCT04504331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045962|NCT04504331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045963|NCT04481919|Diuretics|diuretics|mesh-list
83045964|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
83045965|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045966|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83045967|NCT04466475|Melphalan|melphalan|mesh-list
83045968|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
83045969|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83045970|NCT04466475|Daratumumab|daratumumab|mesh-list
83045971|NCT04466475|Antibodies|antibodies|mesh-list
83045972|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
83045973|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83045974|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
83045975|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045976|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83045977|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83045978|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
83045979|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045980|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83045981|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045982|NCT04447911|Empagliflozin|empagliflozin|mesh-list
83045983|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83045984|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045985|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83045986|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045987|NCT04424303|Tofacitinib|tofacitinib|mesh-list
83045988|NCT04424303|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83045989|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83045990|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045991|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045992|NCT04420195|Tacrolimus|tacrolimus|mesh-list
83045993|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83045994|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
83045995|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83045996|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83045997|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83045998|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83045999|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
83046000|NCT04313985|Immunomodulating Agents|immunomodulating agents|mesh-list
83046001|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046002|NCT04283578|Oxytocin|oxytocin|mesh-list
83046003|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
83046004|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83046005|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046006|NCT04123873|Acetaminophen|acetaminophen|mesh-list
83046007|NCT04123873|Dexamethasone|dexamethasone|mesh-list
83046008|NCT04123873|Ibuprofen|ibuprofen|mesh-list
83046009|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046010|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
83046011|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
83046012|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046013|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046014|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046015|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
83046016|NCT04123873|Hormones|hormones|mesh-ancestor
83046017|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046018|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046019|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046020|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83046021|NCT04123873|Analgesics|analgesics|mesh-ancestor
83046022|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
83046023|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
83046024|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83046025|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046026|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83046027|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046028|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046029|NCT04116203|Metformin|metformin|mesh-list
83046030|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83046031|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046032|NCT04106362|Cisplatin|cisplatin|mesh-list
83046033|NCT04106362|Cetuximab|cetuximab|mesh-list
83046034|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83046035|NCT04106362|Antibodies|antibodies|mesh-list
83046036|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
83046037|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83046038|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
83046039|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046040|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046041|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
83046042|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83046043|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83046044|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046045|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
83046046|NCT04089865|Coagulants|coagulants|mesh-ancestor
83046047|NCT04079088|Interferons|interferons|mesh-list
83046048|NCT04079088|Interferon-beta|interferon-beta|mesh-list
83046049|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
83046050|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
83046051|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
83046052|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046053|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
83046054|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046055|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
83046056|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046057|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83046058|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046075|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046076|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046077|NCT04005352|Aflibercept|aflibercept|mesh-list
83046078|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83046079|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83046080|NCT04005352|Growth Substances|growth substances|mesh-ancestor
83046081|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046082|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
83046083|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046084|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83046085|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
83046086|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046087|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046088|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046105|NCT03819465|Paclitaxel|paclitaxel|mesh-list
83046106|NCT03819465|Carboplatin|carboplatin|mesh-list
83046107|NCT03819465|Gemcitabine|gemcitabine|mesh-list
83046108|NCT03819465|Pemetrexed|pemetrexed|mesh-list
83046109|NCT03819465|Durvalumab|durvalumab|mesh-list
83046110|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046111|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046112|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046113|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046114|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046115|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046116|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83046117|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
83046118|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046119|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83046120|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83046121|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046122|NCT03796273|Ketoconazole|ketoconazole|mesh-list
83046123|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
83046124|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046125|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83046126|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83046127|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046128|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046129|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83046130|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
83046131|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046132|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046133|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83046134|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
83046174|NCT03598257|Olaparib|olaparib|mesh-list
83046175|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83046176|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046177|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046178|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046179|NCT03567720|Paclitaxel|paclitaxel|mesh-list
83046180|NCT03567720|Carboplatin|carboplatin|mesh-list
83046181|NCT03567720|Gemcitabine|gemcitabine|mesh-list
83046182|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
83046183|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046184|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046185|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046186|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046187|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046188|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046189|NCT03567720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83046190|NCT03567720|Antimetabolites|antimetabolites|mesh-ancestor
83046191|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046192|NCT03567720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046193|NCT03539744|Dexamethasone|dexamethasone|mesh-list
83046194|NCT03539744|Venetoclax|venetoclax|mesh-list
83046195|NCT03539744|Pomalidomide|pomalidomide|mesh-list
83046196|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046197|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
83046198|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
83046199|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046200|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046201|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046202|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
83046203|NCT03539744|Hormones|hormones|mesh-ancestor
83046204|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046205|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046206|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046207|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
83361707|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046208|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83046209|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83046210|NCT03539744|Growth Substances|growth substances|mesh-ancestor
83046211|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
83046212|NCT03519906|Metoprolol|metoprolol|mesh-list
83046213|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83046214|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046215|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
83046216|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
83046217|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046218|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046219|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83046220|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83046221|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83046222|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
83046223|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046224|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046225|NCT03519893|Losartan|losartan|mesh-list
83046226|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83046227|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046228|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83046229|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83046230|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046231|NCT03519256|Nivolumab|nivolumab|mesh-list
83046232|NCT03519256|Linrodostat|linrodostat|mesh-list
83046233|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046234|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046235|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046236|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046237|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046238|NCT03507608|Flutamide|flutamide|mesh-list
83046239|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
83046240|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
83046241|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046242|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046243|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046244|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046245|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83046246|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83046247|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046248|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83046249|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83046250|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046251|NCT03343054|Talazoparib|talazoparib|mesh-list
83046252|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83046253|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046254|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046255|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046256|NCT03336398|Ketamine|ketamine|mesh-list
83046257|NCT03336398|Analgesics|analgesics|mesh-ancestor
83046258|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
83046259|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046260|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046261|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83046262|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83046263|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
83046264|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
83046265|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83046266|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83046267|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83046268|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046269|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046270|NCT03330847|Olaparib|olaparib|mesh-list
83046271|NCT03330847|Adavosertib|adavosertib|mesh-list
83046272|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83046273|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046274|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046275|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046276|NCT03215927|Abatacept|abatacept|mesh-list
83046277|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046278|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046279|NCT03215927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046280|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046281|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046282|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
83046283|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046284|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046285|NCT03073967|Foscarnet|foscarnet|mesh-list
83046286|NCT03073967|Pritelivir|pritelivir|mesh-list
83046287|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
83046288|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046289|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83046290|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83046291|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046292|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046293|NCT02999230|Listerine|listerine|mesh-list
83046294|NCT02999230|Fluorides|fluorides|mesh-list
83046295|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
83046296|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
83046297|NCT02999230|Protective Agents|protective agents|mesh-ancestor
83046298|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046299|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83046300|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046301|NCT02941315|Captopril|captopril|mesh-list
83046302|NCT02941315|Spironolactone|spironolactone|mesh-list
83046303|NCT02941315|Furosemide|furosemide|mesh-list
83046304|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83046305|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83046306|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
83046307|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046308|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046309|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83046310|NCT02941315|Diuretics|diuretics|mesh-ancestor
83046311|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
83046312|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83046313|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
83046314|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046315|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046316|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83046317|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
83046318|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046319|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046320|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83046321|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83046322|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83046323|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83046324|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046325|NCT02918721|Lidocaine|lidocaine|mesh-list
83046326|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
83046327|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
83046328|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
83046329|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83046330|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046331|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
83046332|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046333|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83046334|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83046335|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83046336|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83046337|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046338|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83046339|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
83046340|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
83046341|NCT02918721|Protective Agents|protective agents|mesh-ancestor
83046342|NCT02884180|Dexamethasone|dexamethasone|mesh-list
83046343|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046344|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
83046345|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
83046346|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046347|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046348|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046349|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
83046350|NCT02884180|Hormones|hormones|mesh-ancestor
83046351|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046352|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046353|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046354|NCT02799602|Docetaxel|docetaxel|mesh-list
83046355|NCT02799602|Androgens|androgens|mesh-list
83046356|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046357|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046358|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046359|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046360|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046361|NCT02799602|Hormones|hormones|mesh-ancestor
83046362|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046363|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046364|NCT02770040|Infliximab|infliximab|mesh-list
83046365|NCT02770040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83046366|NCT02770040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046367|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
83046368|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046369|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046370|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83046371|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83046372|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046373|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
83046374|NCT02612311|Chlorambucil|chlorambucil|mesh-list
83046375|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046376|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046377|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83438734|NCT05000294|Atezolizumab|atezolizumab|mesh-list
83046378|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
83046379|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046380|NCT02451423|Atezolizumab|atezolizumab|mesh-list
83046381|NCT02451423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046382|NCT02451423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046383|NCT02451423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046384|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046385|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
83046386|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046387|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046388|NCT02359565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046389|NCT02359565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046390|NCT02356159|Rituximab|rituximab|mesh-list
83046391|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046392|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046393|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
83046394|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046395|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046396|NCT02291705|Tramadol|tramadol|mesh-list
83046397|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83046398|NCT02291705|Narcotics|narcotics|mesh-ancestor
83046399|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83046400|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046401|NCT02291705|Analgesics|analgesics|mesh-ancestor
83046402|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
83046403|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046404|NCT02243709|Mifepristone|mifepristone|mesh-list
83046405|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83046406|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
83046407|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83046408|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046409|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83046410|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83046411|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83046412|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
83046413|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83046414|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83046415|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
83046416|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046417|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
83046418|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83046419|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83046420|NCT02027935|Aldesleukin|aldesleukin|mesh-list
83046421|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
83046422|NCT02027935|Ipilimumab|ipilimumab|mesh-list
83046423|NCT02027935|Interleukin-2|interleukin-2|mesh-list
83046424|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046425|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
83046426|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046427|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046428|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83046429|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
83046430|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046431|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046432|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83046433|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046434|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046435|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83046436|NCT02027935|Analgesics|analgesics|mesh-ancestor
83046437|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
83046438|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046439|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83046440|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83046441|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
83046442|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046444|NCT01969578|Carboplatin|carboplatin|mesh-list
83046445|NCT01969578|Doxorubicin|doxorubicin|mesh-list
83046446|NCT01969578|Bicalutamide|bicalutamide|mesh-list
83046447|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83046448|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046449|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046450|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046451|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046452|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046453|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046454|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83046455|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83046456|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83046457|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046458|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
83046459|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
83046460|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046461|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046462|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
83046463|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83046464|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
83046465|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83046466|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83046467|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046468|NCT01896011|Teriparatide|teriparatide|mesh-list
83046469|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83046470|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046471|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83046472|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
83046473|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83046474|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
83046475|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046476|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
83046477|NCT01891396|Protective Agents|protective agents|mesh-ancestor
83046478|NCT01835041|Leucovorin|leucovorin|mesh-list
83046479|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
83046480|NCT01835041|Fluorouracil|fluorouracil|mesh-list
83046481|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
83046482|NCT01835041|Irinotecan|irinotecan|mesh-list
83046483|NCT01835041|Calcium|calcium|mesh-list
83046484|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
83046485|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83046486|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046487|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
83046488|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046489|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83046490|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046491|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046492|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
83046493|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83046494|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83046495|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046496|NCT01835041|Antidotes|antidotes|mesh-ancestor
83046497|NCT01835041|Protective Agents|protective agents|mesh-ancestor
83046498|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
83046499|NCT01835041|Vitamins|vitamins|mesh-ancestor
83046500|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
83046501|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
83046502|NCT01746225|Paclitaxel|paclitaxel|mesh-list
83046503|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83362140|NCT05339542|Prednisolone|prednisolone|mesh-list
83046504|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046505|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046506|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046507|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046508|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046509|NCT01716806|Nivolumab|nivolumab|mesh-list
83046510|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83046511|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83046512|NCT01716806|Dacarbazine|dacarbazine|mesh-list
83046513|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046514|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046515|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046516|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046517|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83046518|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
83046519|NCT01716806|Immunotoxins|immunotoxins|mesh-ancestor
83046520|NCT01716806|Immunoconjugates|immunoconjugates|mesh-ancestor
83046521|NCT01716806|Immunologic Factors|immunologic factors|mesh-ancestor
83046523|NCT01650545|Cyclosporine|cyclosporine|mesh-list
83046524|NCT01650545|Sirolimus|sirolimus|mesh-list
83046525|NCT01650545|Tacrolimus|tacrolimus|mesh-list
83046526|NCT01650545|Cyclosporins|cyclosporins|mesh-list
83046527|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046528|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
83046529|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046530|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83046531|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046532|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046533|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
83046534|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046535|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
83046536|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046537|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83046538|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83046539|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046540|NCT01191008|Timolol|timolol|mesh-list
83046541|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83046542|NCT01191008|Latanoprost|latanoprost|mesh-list
83046543|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83046544|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046545|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83046546|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83046547|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
83046548|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046549|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046550|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83046551|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046552|NCT01155232|Teriparatide|teriparatide|mesh-list
83046553|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
83046554|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046555|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83046556|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83046557|NCT01063517|Paclitaxel|paclitaxel|mesh-list
83046558|NCT01063517|Olaparib|olaparib|mesh-list
83046559|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046560|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046561|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046562|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046563|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046564|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046565|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83046566|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046567|NCT00821587|Cyclosporine|cyclosporine|mesh-list
83046568|NCT00821587|Tacrolimus|tacrolimus|mesh-list
83046569|NCT00821587|Cyclosporins|cyclosporins|mesh-list
83046570|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046571|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
83046572|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046573|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83046574|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046575|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046576|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
83046577|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046578|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
83361708|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046579|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046580|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83046581|NCT00751829|Olmesartan|olmesartan|mesh-list
83046582|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83046583|NCT00751829|Nitrendipine|nitrendipine|mesh-list
83046584|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046585|NCT00751829|Diuretics|diuretics|mesh-ancestor
83046586|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
83046587|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046588|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83046589|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438747|NCT04998032|Metformin|metformin|mesh-list
83046590|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046591|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83046592|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83046593|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83046594|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83046595|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
83046596|NCT00645801|Lubiprostone|lubiprostone|mesh-list
83046597|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83046598|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83046599|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046600|NCT00424099|Methylphenidate|methylphenidate|mesh-list
83046601|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83046602|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046603|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83046604|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83046605|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83046606|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046607|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
83046608|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046609|NCT00382213|Olmesartan|olmesartan|mesh-list
83046610|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83046611|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046612|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83046613|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83046614|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046615|NCT00176267|Paclitaxel|paclitaxel|mesh-list
83046616|NCT00176267|Carboplatin|carboplatin|mesh-list
83046617|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046618|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046619|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046620|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046621|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046622|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046623|NCT00146562|Paclitaxel|paclitaxel|mesh-list
83046624|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
83046625|NCT00146562|Doxorubicin|doxorubicin|mesh-list
83046626|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
83046627|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046628|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046629|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046630|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046631|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046632|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046633|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046634|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
83046635|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046636|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046637|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83046638|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
83046639|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83046640|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83046641|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83046642|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83046643|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046644|NCT00146562|Hematinics|hematinics|mesh-ancestor
83046645|NCT04299438|Propranolol|propranolol|mesh-list
83046646|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83046647|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83046648|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
83046649|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046650|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046651|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046652|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83046653|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046654|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
83046655|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
83046656|NCT02298920|Zoliflodacin|zoliflodacin|mesh-list
83046657|NCT02298920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83046658|NCT02298920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83046659|NCT02298920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046660|NCT02298920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046661|NCT02298920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046662|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83046663|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83046664|NCT03517670|Milrinone|milrinone|mesh-list
83046665|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83046666|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83046667|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
83046668|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83046669|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83046670|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046671|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046672|NCT03517670|Protective Agents|protective agents|mesh-ancestor
83046673|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046674|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
83046675|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046676|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046677|NCT03316573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046678|NCT03316573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046679|NCT00109668|Beclomethasone|beclomethasone|mesh-list
83046680|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046681|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
83046683|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046684|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046685|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83046686|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
83046687|NCT03104140|Ketamine|ketamine|mesh-list
83046688|NCT03104140|Thiopental|thiopental|mesh-list
83046689|NCT03104140|Analgesics|analgesics|mesh-ancestor
83046690|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
83046691|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046692|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046693|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83046694|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83046695|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
83046696|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
83046697|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83046698|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83046699|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83046700|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046701|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046702|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
83046703|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83046704|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
83046705|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
83046706|NCT03520478|Bicalutamide|bicalutamide|mesh-list
83046707|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
83046708|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
83046709|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046710|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046711|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046712|NCT00102648|Temozolomide|temozolomide|mesh-list
83046713|NCT00102648|Lonafarnib|lonafarnib|mesh-list
83046714|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83046715|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
83046716|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046717|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046718|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046719|NCT03290287|Bromides|bromides|mesh-list
83046720|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
83046721|NCT02253888|Ritonavir|ritonavir|mesh-list
83046722|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83046723|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83046724|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83046725|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046726|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046727|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83046728|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83046729|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
83046730|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83438752|NCT04388033|Vaccines|vaccines|mesh-list
83046731|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83046732|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83046734|NCT05430802|Aflutinib|aflutinib|mesh-list
83046735|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046736|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046737|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046738|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83046739|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83046740|NCT05430802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83046741|NCT05524038|Dexamethasone|dexamethasone|mesh-list
83046742|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
83046743|NCT05524038|Bupivacaine|bupivacaine|mesh-list
83046744|NCT05524038|BB 1101|bb 1101|mesh-list
83046745|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046746|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
83046747|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
83046748|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046749|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046750|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046751|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
83046752|NCT05524038|Hormones|hormones|mesh-ancestor
83046753|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046754|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046755|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046756|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
83046757|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046758|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046759|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
83046760|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
83046761|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83046762|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
83046763|NCT03240835|Docetaxel|docetaxel|mesh-list
83046764|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046765|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046766|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046767|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046768|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046769|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
83046770|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046771|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046772|NCT04118868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046773|NCT04118868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046774|NCT04900350|Azacitidine|azacitidine|mesh-list
83046775|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83046776|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
83046777|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046778|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046779|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046780|NCT02292290|Pioglitazone|pioglitazone|mesh-list
83046781|NCT02292290|Liraglutide|liraglutide|mesh-list
83046782|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83046783|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046784|NCT02292290|Incretins|incretins|mesh-ancestor
83046785|NCT02292290|Hormones|hormones|mesh-ancestor
83046786|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046787|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
83046788|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83046789|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83046790|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046791|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83046792|NCT02299232|Analgesics|analgesics|mesh-ancestor
83046793|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
83046794|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046795|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83046796|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83046797|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83046798|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
83361709|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046799|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046800|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046801|NCT02963493|Dexamethasone|dexamethasone|mesh-list
83046802|NCT02963493|Melphalan|melphalan|mesh-list
83046803|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046804|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
83046805|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
83046806|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046807|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046808|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046809|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
83046810|NCT02963493|Hormones|hormones|mesh-ancestor
83046811|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046812|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046813|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046814|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83046815|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
83046816|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046818|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046819|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
83046820|NCT02299310|Valsartan|valsartan|mesh-list
83046821|NCT02299310|Perindopril|perindopril|mesh-list
83046822|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83046823|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83046824|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83046825|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046826|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83046827|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
83046828|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046829|NCT03519776|Progesterone|progesterone|mesh-list
83046830|NCT03519776|Progestins|progestins|mesh-ancestor
83046831|NCT03519776|Hormones|hormones|mesh-ancestor
83046832|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046833|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046834|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
83046835|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83046836|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
83046837|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046838|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046839|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83046840|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
83046841|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83046842|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
83046843|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046844|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046845|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83046846|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
83046847|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
83046848|NCT02295566|Protective Agents|protective agents|mesh-ancestor
83046849|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83046850|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
83046851|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046852|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83046853|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046854|NCT03738397|Upadacitinib|upadacitinib|mesh-list
83046855|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83046856|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
83046857|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046858|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83046859|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83046860|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046861|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046862|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046863|NCT03643497|Meropenem|meropenem|mesh-list
83046864|NCT03643497|Linezolid|linezolid|mesh-list
83046865|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
83046866|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83046867|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83046868|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046869|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046870|NCT03519542|Sunitinib|sunitinib|mesh-list
83046871|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046872|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83046876|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
83046877|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83046878|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046879|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046880|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83046881|NCT03516500|Hematinics|hematinics|mesh-ancestor
83046882|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
83046883|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83046884|NCT02293148|Glycine|glycine|mesh-list
83046885|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83046886|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83046887|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83046888|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83046889|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046890|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046891|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046892|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83046893|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
83046894|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83046895|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046896|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83046897|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83046898|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83046899|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
83046900|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83046906|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83046907|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83046908|NCT03519152|Analgesics|analgesics|mesh-ancestor
83046909|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
83046910|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046911|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046912|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83046913|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046914|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83046915|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046916|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046917|NCT02959983|Eluxadoline|eluxadoline|mesh-list
83046918|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046919|NCT03516188|Antacids|antacids|mesh-list
83046920|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046921|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83046922|NCT03512990|Bupivacaine|bupivacaine|mesh-list
83046923|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
83046924|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
83046925|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83046926|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046927|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
83046928|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83046929|NCT03512834|Paclitaxel|paclitaxel|mesh-list
83046930|NCT03512834|Avelumab|avelumab|mesh-list
83046931|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046932|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046933|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046934|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046935|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046936|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046937|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046938|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
83046939|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83046940|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83046941|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
83046942|NCT03640221|Diuretics|diuretics|mesh-ancestor
83046943|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
83046944|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046945|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83046946|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83046947|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046948|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83046949|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83046950|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83046951|NCT03518528|Estradiol|estradiol|mesh-list
83046952|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83046953|NCT03518528|Estrogens|estrogens|mesh-ancestor
83046954|NCT03518528|Hormones|hormones|mesh-ancestor
83046955|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83046956|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046957|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83046958|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
83046959|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83046960|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83046961|NCT03515798|Paclitaxel|paclitaxel|mesh-list
83046962|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83046963|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
83046964|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
83046965|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83046966|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046967|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
83046968|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83046969|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
83046970|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046971|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83046972|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
83046973|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046974|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83046975|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83046976|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
83046977|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83046978|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83046979|NCT03515798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83046980|NCT03041701|Dasatinib|dasatinib|mesh-list
83046981|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83046982|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046983|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83046984|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83046985|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83046986|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
83046987|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83046988|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83046989|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83046990|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
83046991|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83046992|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83046993|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83046994|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83046995|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83046996|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83046997|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83046998|NCT02956629|Ribavirin|ribavirin|mesh-list
83046999|NCT02956629|Ruzasvir|ruzasvir|mesh-list
83047000|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
83047001|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
83047002|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047003|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
83047004|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047005|NCT02297204|Aflibercept|aflibercept|mesh-list
83047006|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83047007|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83047008|NCT02297204|Growth Substances|growth substances|mesh-ancestor
83047009|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047010|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
83047011|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047012|NCT02294006|Metformin|metformin|mesh-list
83047013|NCT02294006|Everolimus|everolimus|mesh-list
83047014|NCT02294006|Octreotide|octreotide|mesh-list
83047015|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83047016|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047017|NCT02294006|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83047018|NCT02294006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83047019|NCT02294006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047020|NCT02294006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047021|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83047022|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
83047023|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047024|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83047025|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047026|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83047027|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83047028|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047029|NCT02294084|Incretins|incretins|mesh-ancestor
83047030|NCT02294084|Hormones|hormones|mesh-ancestor
83047031|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047032|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83047033|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
83047034|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047035|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047036|NCT01597258|Crizotinib|crizotinib|mesh-list
83047037|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047038|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83047039|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047040|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047041|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
83047042|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83047043|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
83047044|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047045|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
83047046|NCT02958267|Protective Agents|protective agents|mesh-ancestor
83047047|NCT02302430|Oxytocin|oxytocin|mesh-list
83047048|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
83047049|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83047050|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047051|NCT02300948|Folic Acid|folic acid|mesh-list
83047052|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
83047053|NCT02300948|Hematinics|hematinics|mesh-ancestor
83047054|NCT02300948|Vitamins|vitamins|mesh-ancestor
83047055|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
83047056|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047057|NCT02302508|Clopidogrel|clopidogrel|mesh-list
83047058|NCT02302508|Ticagrelor|ticagrelor|mesh-list
83047059|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83047060|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83047061|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83047062|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83047063|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83047064|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
83047065|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047066|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047067|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047068|NCT02297594|Ziresovir|ziresovir|mesh-list
83047069|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
83047070|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047071|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83047072|NCT02301026|Hematinics|hematinics|mesh-ancestor
83047073|NCT01952574|Erenumab|erenumab|mesh-list
83047074|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83047075|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83047076|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047077|NCT01952574|Analgesics|analgesics|mesh-ancestor
83047078|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
83047079|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047080|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047081|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
83047082|NCT02302586|Morphine|morphine|mesh-list
83047083|NCT02302586|Bupivacaine|bupivacaine|mesh-list
83047084|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
83047085|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
83047086|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047087|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047088|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
83047089|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047090|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83047091|NCT02302586|Narcotics|narcotics|mesh-ancestor
83047092|NCT02302586|Analgesics|analgesics|mesh-ancestor
83047093|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
83047094|NCT04484272|Narcotics|narcotics|mesh-ancestor
83047095|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047096|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047097|NCT04484272|Analgesics|analgesics|mesh-ancestor
83362141|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
83047098|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
83047099|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047100|NCT01551472|Vitamin E|vitamin e|mesh-list
83047101|NCT01551472|Vitamins|vitamins|mesh-ancestor
83047102|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
83047103|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047104|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
83047105|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047106|NCT01551472|Protective Agents|protective agents|mesh-ancestor
83047107|NCT02254044|Maytansine|maytansine|mesh-list
83047108|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
83047109|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83047110|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047111|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
83047112|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
83047113|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
83047114|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047115|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047116|NCT02254044|Immunotoxins|immunotoxins|mesh-ancestor
83047117|NCT02254044|Immunoconjugates|immunoconjugates|mesh-ancestor
83047118|NCT02254044|Immunologic Factors|immunologic factors|mesh-ancestor
83047119|NCT02254044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047120|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
83047121|NCT02959437|Azacitidine|azacitidine|mesh-list
83047122|NCT02959437|INCB057643|incb057643|mesh-list
83047123|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047124|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047125|NCT02959437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83047126|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047127|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83047128|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
83047129|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047130|NCT02297906|Ketorolac|ketorolac|mesh-list
83047131|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83047132|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83047133|NCT02297906|Analgesics|analgesics|mesh-ancestor
83047134|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
83047135|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047136|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047137|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83047138|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83047139|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83047140|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047141|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047142|NCT03511820|Amphotericin B|amphotericin b|mesh-list
83047143|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83047144|NCT03511820|Amebicides|amebicides|mesh-ancestor
83047145|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83047146|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83047147|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047148|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83047149|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
83047150|NCT02957331|Propranolol|propranolol|mesh-list
83047151|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83047152|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83047153|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
83047154|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047155|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047156|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047157|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83047158|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83047159|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
83047160|NCT02298062|Infliximab|infliximab|mesh-list
83047161|NCT02298062|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83047162|NCT02298062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83047163|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83047164|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83047165|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83047166|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
83047167|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
83047168|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047169|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83047170|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047171|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047172|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
83361710|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83438762|NCT04388033|Growth Substances|growth substances|mesh-ancestor
83047176|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83047177|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047178|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83047179|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83047180|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047181|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83047182|NCT03748966|Vitamins|vitamins|mesh-ancestor
83047183|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
83047184|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83047188|NCT05891262|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83047189|NCT05891262|Norethindrone|norethindrone|mesh-list
83047190|NCT05891262|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83047191|NCT05891262|Estradiol|estradiol|mesh-list
83047192|NCT05891262|Estrogens|estrogens|mesh-ancestor
83047193|NCT05891262|Hormones|hormones|mesh-ancestor
83047194|NCT05891262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047195|NCT05891262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047196|NCT05891262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83047197|NCT05891262|Contraceptive Agents|contraceptive agents|mesh-ancestor
83047198|NCT05891262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83047199|NCT05891262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83047200|NCT05891262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83047201|NCT05891262|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83047202|NCT05891262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83047203|NCT05891262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83047204|NCT05891262|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83047205|NCT05891249|Luspatercept|luspatercept|mesh-list
83047206|NCT05891249|Hematinics|hematinics|mesh-ancestor
83047208|NCT05891171|Carboplatin|carboplatin|mesh-list
83047209|NCT05891171|Fluorouracil|fluorouracil|mesh-list
83047210|NCT05891171|Oxaliplatin|oxaliplatin|mesh-list
83047211|NCT05891171|Pemetrexed|pemetrexed|mesh-list
83047212|NCT05891171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047213|NCT05891171|Antimetabolites|antimetabolites|mesh-ancestor
83047214|NCT05891171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047215|NCT05891171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83047216|NCT05891171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83047217|NCT05891171|Immunologic Factors|immunologic factors|mesh-ancestor
83047218|NCT05891171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047219|NCT05891171|Antidotes|antidotes|mesh-ancestor
83047220|NCT05891171|Protective Agents|protective agents|mesh-ancestor
83047221|NCT05891171|Vitamin B Complex|vitamin b complex|mesh-ancestor
83047222|NCT05891171|Vitamins|vitamins|mesh-ancestor
83047223|NCT05891171|Micronutrients|micronutrients|mesh-ancestor
83047224|NCT05891171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047225|NCT05891171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83047226|NCT05891171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83047227|NCT05891145|Midazolam|midazolam|mesh-list
83047228|NCT05891145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83047229|NCT05891145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83047230|NCT05891145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047231|NCT05891145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047232|NCT05891145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83047233|NCT05891145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83047234|NCT05891145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83047235|NCT05891145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83047236|NCT05891145|Anesthetics, General|anesthetics, general|mesh-ancestor
83047237|NCT05891145|Anesthetics|anesthetics|mesh-ancestor
83047238|NCT05891145|GABA Modulators|gaba modulators|mesh-ancestor
83047239|NCT05891145|GABA Agents|gaba agents|mesh-ancestor
83047240|NCT05891145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047241|NCT05891145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047242|NCT05891132|Lidocaine|lidocaine|mesh-list
83047243|NCT05891132|Prilocaine|prilocaine|mesh-list
83047244|NCT05891132|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83047245|NCT05891132|Anesthetics|anesthetics|mesh-list
83047246|NCT05891132|Anesthetics, Local|anesthetics, local|mesh-ancestor
83047247|NCT05891132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047248|NCT05891132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047249|NCT05891132|Sensory System Agents|sensory system agents|mesh-ancestor
83047250|NCT05891132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047251|NCT05891132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83047252|NCT05891132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83047253|NCT05891132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83047254|NCT05891132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83047255|NCT05891132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047256|NCT05891132|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83047258|NCT05891119|Metoprolol|metoprolol|mesh-list
83047259|NCT05891119|Midazolam|midazolam|mesh-list
83047260|NCT05891119|Caffeine|caffeine|mesh-list
83047261|NCT05891119|Caffeine citrate|caffeine citrate|mesh-list
83047262|NCT05891119|Omeprazole|omeprazole|mesh-list
83047263|NCT05891119|Warfarin|warfarin|mesh-list
83047264|NCT05891119|Vitamins|vitamins|mesh-ancestor
83047265|NCT05891119|Micronutrients|micronutrients|mesh-ancestor
83047266|NCT05891119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047267|NCT05891119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83047268|NCT05891119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83047269|NCT05891119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047270|NCT05891119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83047271|NCT05891119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83047272|NCT05891119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83047273|NCT05891119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83047274|NCT05891119|Anesthetics, General|anesthetics, general|mesh-ancestor
83047275|NCT05891119|Anesthetics|anesthetics|mesh-ancestor
83047276|NCT05891119|GABA Modulators|gaba modulators|mesh-ancestor
83047278|NCT05891119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047279|NCT05891119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047280|NCT05891119|Anticoagulants|anticoagulants|mesh-ancestor
83047281|NCT05891119|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83047282|NCT05891119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83047283|NCT05891119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047284|NCT05891119|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83047285|NCT05891119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83047286|NCT05891119|Purinergic Agents|purinergic agents|mesh-ancestor
83047287|NCT05891119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83047288|NCT05891119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83047289|NCT05891119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83047290|NCT05891119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83047291|NCT05891119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83047292|NCT05891119|Sympatholytics|sympatholytics|mesh-ancestor
83047293|NCT05891119|Autonomic Agents|autonomic agents|mesh-ancestor
83047294|NCT05891119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047295|NCT05891119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83047296|NCT05891119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83047297|NCT05891119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83047298|NCT05891119|Adrenergic Agents|adrenergic agents|mesh-ancestor
83047299|NCT05891119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83047300|NCT05891119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83047301|NCT05891119|Hemostatics|hemostatics|mesh-ancestor
83047302|NCT05891119|Coagulants|coagulants|mesh-ancestor
83047303|NCT05891093|Tamoxifen|tamoxifen|mesh-list
83047304|NCT05891093|Toremifene|toremifene|mesh-list
83047305|NCT05891093|Letrozole|letrozole|mesh-list
83047306|NCT05891093|Anastrozole|anastrozole|mesh-list
83047307|NCT05891093|Exemestane|exemestane|mesh-list
83047308|NCT05891093|Fluzoparib|fluzoparib|mesh-list
83047309|NCT05891093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047310|NCT05891093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83047311|NCT05891093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83047312|NCT05891093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047313|NCT05891093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047314|NCT05891093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83047315|NCT05891093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83047316|NCT05891093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047317|NCT05891093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047318|NCT05891093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047319|NCT05891093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83047320|NCT05891093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83047321|NCT05891093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83047322|NCT05891093|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83047323|NCT05891080|Paclitaxel|paclitaxel|mesh-list
83047324|NCT05891080|Carboplatin|carboplatin|mesh-list
83047325|NCT05891080|Pemetrexed|pemetrexed|mesh-list
83047326|NCT05891080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83047327|NCT05891080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047328|NCT05891080|Tubulin Modulators|tubulin modulators|mesh-ancestor
83047329|NCT05891080|Antimitotic Agents|antimitotic agents|mesh-ancestor
83047330|NCT05891080|Mitosis Modulators|mitosis modulators|mesh-ancestor
83047331|NCT05891080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047332|NCT05891080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047333|NCT05891080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83047334|NCT05891080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83047335|NCT05890911|Dopamine|dopamine|mesh-list
83047336|NCT05890911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83047337|NCT05890911|Sympathomimetics|sympathomimetics|mesh-ancestor
83047338|NCT05890911|Autonomic Agents|autonomic agents|mesh-ancestor
83047339|NCT05890911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047340|NCT05890911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047341|NCT05890911|Dopamine Agents|dopamine agents|mesh-ancestor
83047342|NCT05890911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047343|NCT05890911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047344|NCT05890911|Protective Agents|protective agents|mesh-ancestor
83047345|NCT05890898|Nitrous Oxide|nitrous oxide|mesh-list
83047346|NCT05890898|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83047347|NCT05890898|Anesthetics, General|anesthetics, general|mesh-ancestor
83047348|NCT05890898|Anesthetics|anesthetics|mesh-ancestor
83047349|NCT05890898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047350|NCT05890898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047351|NCT05890898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83047352|NCT05890898|Analgesics|analgesics|mesh-ancestor
83047353|NCT05890898|Sensory System Agents|sensory system agents|mesh-ancestor
83047354|NCT05890898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047355|NCT05890768|Risperidone|risperidone|mesh-list
83047356|NCT05890768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83047357|NCT05890768|Serotonin Agents|serotonin agents|mesh-ancestor
83047358|NCT05890768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047359|NCT05890768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047360|NCT05890768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047361|NCT05890768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83047362|NCT05890768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83047363|NCT05890768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047364|NCT05890768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83047365|NCT05890768|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83047366|NCT05890768|Dopamine Agents|dopamine agents|mesh-ancestor
83047367|NCT05890703|Lidocaine|lidocaine|mesh-list
83047368|NCT05890703|Tetracaine|tetracaine|mesh-list
83047369|NCT05890703|Anesthetics, Local|anesthetics, local|mesh-ancestor
83047370|NCT05890703|Anesthetics|anesthetics|mesh-ancestor
83047371|NCT05890703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047372|NCT05890703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047373|NCT05890703|Sensory System Agents|sensory system agents|mesh-ancestor
83047374|NCT05890703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047375|NCT05890703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83047376|NCT05890703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83047377|NCT05890703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83047378|NCT05890703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83047379|NCT05890703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047380|NCT05890664|Colchicine|colchicine|mesh-list
83047381|NCT05890664|Gout Suppressants|gout suppressants|mesh-ancestor
83047382|NCT05890664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83047383|NCT05890664|Tubulin Modulators|tubulin modulators|mesh-ancestor
83047384|NCT05890664|Antimitotic Agents|antimitotic agents|mesh-ancestor
83047385|NCT05890664|Mitosis Modulators|mitosis modulators|mesh-ancestor
83047386|NCT05890664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047387|NCT05890664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047388|NCT05890638|Albuterol|albuterol|mesh-list
83047389|NCT05890638|Ipratropium|ipratropium|mesh-list
83047390|NCT05890638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83047391|NCT05890638|Autonomic Agents|autonomic agents|mesh-ancestor
83047392|NCT05890638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047393|NCT05890638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047394|NCT05890638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83047395|NCT05890638|Respiratory System Agents|respiratory system agents|mesh-ancestor
83047396|NCT05890638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83047397|NCT05890638|Cholinergic Agents|cholinergic agents|mesh-ancestor
83047398|NCT05890638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047399|NCT05890638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047400|NCT05890638|Tocolytic Agents|tocolytic agents|mesh-ancestor
83361711|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
83047401|NCT05890638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83047402|NCT05890638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83047403|NCT05890638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83047404|NCT05890638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83047405|NCT05890638|Adrenergic Agents|adrenergic agents|mesh-ancestor
83047406|NCT05890586|Fluvoxamine|fluvoxamine|mesh-list
83047407|NCT05890586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047408|NCT05890586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047409|NCT05890586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83047410|NCT05890586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83047411|NCT05890586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047412|NCT05890586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047413|NCT05890586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83047414|NCT05890586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83047415|NCT05890586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83047416|NCT05890586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83047417|NCT05890586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047418|NCT05890586|Serotonin Agents|serotonin agents|mesh-ancestor
83047419|NCT05890586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83047420|NCT05890586|Antidepressive Agents|antidepressive agents|mesh-ancestor
83047421|NCT05890586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83047422|NCT05890586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83047423|NCT05890586|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83047425|NCT05890495|Anesthetics, Local|anesthetics, local|mesh-ancestor
83047426|NCT05890495|Anesthetics|anesthetics|mesh-ancestor
83047427|NCT05890495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047428|NCT05890495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047429|NCT05890495|Sensory System Agents|sensory system agents|mesh-ancestor
83047430|NCT05890495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047431|NCT05890495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83047432|NCT05890495|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83047433|NCT05890495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83047434|NCT05890495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83047435|NCT05890495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047436|NCT05890287|Tamoxifen|tamoxifen|mesh-list
83047437|NCT05890287|Letrozole|letrozole|mesh-list
83047438|NCT05890287|Fulvestrant|fulvestrant|mesh-list
83047439|NCT05890287|Anastrozole|anastrozole|mesh-list
83047440|NCT05890287|Exemestane|exemestane|mesh-list
83047441|NCT05890287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047442|NCT05890287|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83047443|NCT05890287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83047444|NCT05890287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047445|NCT05890287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047446|NCT05890287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83047447|NCT05890287|Hormone Antagonists|hormone antagonists|mesh-ancestor
83047448|NCT05890287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047449|NCT05890287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047450|NCT05890287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047451|NCT05890287|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83047452|NCT05890287|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83047453|NCT05890287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83047454|NCT05890287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83047455|NCT05890235|Tamsulosin|tamsulosin|mesh-list
83047456|NCT05890235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83047457|NCT05890235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83047458|NCT05890235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83047459|NCT05890235|Adrenergic Agents|adrenergic agents|mesh-ancestor
83047460|NCT05890235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047461|NCT05890235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047462|NCT05890235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047463|NCT05890235|Urological Agents|urological agents|mesh-ancestor
83047464|NCT05888233|Allopurinol|allopurinol|mesh-list
83047465|NCT05888233|Antimetabolites|antimetabolites|mesh-ancestor
83047466|NCT05888233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047467|NCT05888233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047468|NCT05888233|Gout Suppressants|gout suppressants|mesh-ancestor
83047469|NCT05888233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83047470|NCT05888233|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83047471|NCT05888233|Antioxidants|antioxidants|mesh-ancestor
83047472|NCT05888233|Protective Agents|protective agents|mesh-ancestor
83047473|NCT05888233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047474|NCT05887505|Vitamin D|vitamin d|mesh-list
83047475|NCT05887505|Vitamins|vitamins|mesh-ancestor
83047476|NCT05887505|Micronutrients|micronutrients|mesh-ancestor
83047477|NCT05887505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047478|NCT05887505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83047479|NCT05882162|Calcium|calcium|mesh-list
83047480|NCT05882162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83047481|NCT05882162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047482|NCT05881486|Ondansetron|ondansetron|mesh-list
83047483|NCT05881486|Fosaprepitant|fosaprepitant|mesh-list
83047484|NCT05881486|Aprepitant|aprepitant|mesh-list
83047485|NCT05881486|Antiemetics|antiemetics|mesh-ancestor
83047486|NCT05881486|Autonomic Agents|autonomic agents|mesh-ancestor
83047487|NCT05881486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047488|NCT05881486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047489|NCT05881486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83047490|NCT05881486|Antipruritics|antipruritics|mesh-ancestor
83047491|NCT05881486|Dermatologic Agents|dermatologic agents|mesh-ancestor
83047492|NCT05881486|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83047493|NCT05881486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83047494|NCT05881486|Serotonin Agents|serotonin agents|mesh-ancestor
83047495|NCT05881486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047496|NCT05881486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047497|NCT05881486|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83047499|NCT05874570|Doxycycline|doxycycline|mesh-list
83047500|NCT05874570|Tetracycline|tetracycline|mesh-list
83047501|NCT05874570|Potassium Citrate|potassium citrate|mesh-list
83047502|NCT05874570|Esomeprazole|esomeprazole|mesh-list
83047503|NCT05874570|Bismuth|bismuth|mesh-list
83047504|NCT05874570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047505|NCT05874570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047506|NCT05874570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83047507|NCT05874570|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83047508|NCT05874570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83047509|NCT05874570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83047510|NCT05874570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83047511|NCT05874570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83047512|NCT05874570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047513|NCT05874570|Antimalarials|antimalarials|mesh-ancestor
83047514|NCT05874570|Antacids|antacids|mesh-ancestor
83047515|NCT05874570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83047516|NCT05874570|Diuretics|diuretics|mesh-ancestor
83047517|NCT05874570|Natriuretic Agents|natriuretic agents|mesh-ancestor
83047518|NCT05874570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047519|NCT05874570|Expectorants|expectorants|mesh-ancestor
83047520|NCT05874570|Respiratory System Agents|respiratory system agents|mesh-ancestor
83047521|NCT05872425|Drospirenone|drospirenone|mesh-list
83047522|NCT05872425|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83047523|NCT05872425|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83047524|NCT05872425|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83047525|NCT05872425|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83047526|NCT05872425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83047527|NCT05872425|Contraceptive Agents|contraceptive agents|mesh-ancestor
83047528|NCT05872425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83047529|NCT05872425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047530|NCT05872425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83047531|NCT05872425|Estrogens|estrogens|mesh-ancestor
83047532|NCT05872425|Hormones|hormones|mesh-ancestor
83047533|NCT05872425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047534|NCT05872425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83047535|NCT05872425|Hormone Antagonists|hormone antagonists|mesh-ancestor
83047536|NCT05872425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83047537|NCT05872425|Diuretics|diuretics|mesh-ancestor
83047538|NCT05872425|Natriuretic Agents|natriuretic agents|mesh-ancestor
83047539|NCT05870579|Fulvestrant|fulvestrant|mesh-list
83047540|NCT05870579|Goserelin|goserelin|mesh-list
83047541|NCT05870579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047542|NCT05870579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047543|NCT05870579|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83047544|NCT05870579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83047545|NCT05870579|Hormone Antagonists|hormone antagonists|mesh-ancestor
83047546|NCT05870579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362142|NCT05339542|Lidocaine|lidocaine|mesh-list
83047547|NCT05870579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047548|NCT05856136|Fentanyl|fentanyl|mesh-list
83047549|NCT05856136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83047550|NCT05856136|Narcotics|narcotics|mesh-ancestor
83047551|NCT05856136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047552|NCT05856136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047553|NCT05856136|Analgesics|analgesics|mesh-ancestor
83047554|NCT05856136|Sensory System Agents|sensory system agents|mesh-ancestor
83047555|NCT05856136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047556|NCT05856136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83047557|NCT05856136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83047558|NCT05856136|Anesthetics, General|anesthetics, general|mesh-ancestor
83047559|NCT05856136|Anesthetics|anesthetics|mesh-ancestor
83047560|NCT05835258|Melatonin|melatonin|mesh-list
83047561|NCT05835258|Capsaicin|capsaicin|mesh-list
83047562|NCT05835258|Antioxidants|antioxidants|mesh-ancestor
83047563|NCT05835258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047564|NCT05835258|Protective Agents|protective agents|mesh-ancestor
83047565|NCT05835258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047566|NCT05835258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047567|NCT05835258|Antipruritics|antipruritics|mesh-ancestor
83047568|NCT05835258|Dermatologic Agents|dermatologic agents|mesh-ancestor
83047569|NCT05835258|Sensory System Agents|sensory system agents|mesh-ancestor
83047570|NCT05835258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047571|NCT05826912|Minocycline|minocycline|mesh-list
83047572|NCT05826912|Candesartan|candesartan|mesh-list
83047573|NCT05826912|Candesartan cilexetil|candesartan cilexetil|mesh-list
83047574|NCT05826912|Atorvastatin|atorvastatin|mesh-list
83047575|NCT05826912|Calcium|calcium|mesh-list
83047576|NCT05826912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83047577|NCT05826912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047578|NCT05826912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83047579|NCT05826912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83047580|NCT05826912|Antimetabolites|antimetabolites|mesh-ancestor
83047581|NCT05826912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047582|NCT05826912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83047583|NCT05826912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83047584|NCT05826912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047585|NCT05826912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83047586|NCT05826912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047587|NCT05826912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83047588|NCT05826912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83047589|NCT05826912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83047590|NCT05818124|Oseltamivir|oseltamivir|mesh-list
83047591|NCT05818124|Molnupiravir|molnupiravir|mesh-list
83047592|NCT05818124|Antiviral Agents|antiviral agents|mesh-ancestor
83047593|NCT05818124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047594|NCT05818124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047595|NCT05818124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047596|NCT05814042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83047597|NCT05810649|Hyaluronic Acid|hyaluronic acid|mesh-list
83047598|NCT05810649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83047599|NCT05810649|Immunologic Factors|immunologic factors|mesh-ancestor
83047600|NCT05810649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047601|NCT05810649|Viscosupplements|viscosupplements|mesh-ancestor
83047602|NCT05810649|Protective Agents|protective agents|mesh-ancestor
83047603|NCT05809830|Doxorubicin|doxorubicin|mesh-list
83047604|NCT05809830|LB100|lb100|mesh-list
83047605|NCT05809830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83047606|NCT05809830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047607|NCT05809830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83047608|NCT05809830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83047609|NCT05809830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047610|NCT05809830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047611|NCT05806060|Paclitaxel|paclitaxel|mesh-list
83047612|NCT05806060|Vinorelbine|vinorelbine|mesh-list
83047613|NCT05806060|Carboplatin|carboplatin|mesh-list
83047614|NCT05806060|Capecitabine|capecitabine|mesh-list
83047615|NCT05806060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83047616|NCT05806060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047617|NCT05806060|Tubulin Modulators|tubulin modulators|mesh-ancestor
83047618|NCT05806060|Antimitotic Agents|antimitotic agents|mesh-ancestor
83047619|NCT05806060|Mitosis Modulators|mitosis modulators|mesh-ancestor
83047620|NCT05806060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047621|NCT05806060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83047622|NCT05806060|Antimetabolites|antimetabolites|mesh-ancestor
83047623|NCT05770297|Propolis|propolis|mesh-list
83047624|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047625|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83047627|NCT05760378|Capecitabine|capecitabine|mesh-list
83047628|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047629|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83047630|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
83047631|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047632|NCT05751187|Folic Acid|folic acid|mesh-list
83047633|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
83047634|NCT05751187|Dexamethasone|dexamethasone|mesh-list
83047635|NCT05751187|Bevacizumab|bevacizumab|mesh-list
83047636|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
83047637|NCT05751187|Carboplatin|carboplatin|mesh-list
83047638|NCT05751187|Pemetrexed|pemetrexed|mesh-list
83047639|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047640|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047641|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83047642|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83047643|NCT05751187|Growth Substances|growth substances|mesh-ancestor
83047644|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047645|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
83047646|NCT05751187|Vitamins|vitamins|mesh-ancestor
83047647|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
83047648|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83047649|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
83047650|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
83047651|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047652|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83047653|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
83047654|NCT05751187|Hormones|hormones|mesh-ancestor
83047655|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047656|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047657|NCT05751187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83047658|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047659|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047660|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83047661|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83047662|NCT05751187|Hematinics|hematinics|mesh-ancestor
83047663|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
83047664|NCT05744635|Tacrolimus|tacrolimus|mesh-list
83047665|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83047666|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
83047667|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047668|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83047669|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047670|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047671|NCT05733689|Paclitaxel|paclitaxel|mesh-list
83047672|NCT05733689|Docetaxel|docetaxel|mesh-list
83047673|NCT05733689|Carboplatin|carboplatin|mesh-list
83047674|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
83047675|NCT05733689|Nivolumab|nivolumab|mesh-list
83047676|NCT05733689|Irinotecan|irinotecan|mesh-list
83047677|NCT05733689|Folfirinox|folfirinox|mesh-list
83047678|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83047679|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047680|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83047681|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83047682|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83047683|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047684|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047685|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83047686|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83047687|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83047688|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047689|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83047690|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83047691|NCT05723874|Bosentan|bosentan|mesh-list
83047692|NCT05723874|BI 425809|bi 425809|mesh-list
83047693|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83047694|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83047695|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047696|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
83047697|NCT05685225|Acetaminophen|acetaminophen|mesh-list
83047698|NCT05685225|Naltrexone|naltrexone|mesh-list
83047699|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83047700|NCT05685225|Analgesics|analgesics|mesh-ancestor
83047701|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
83047702|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047716|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
83047717|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047718|NCT05650554|Vaccines|vaccines|mesh-list
83047719|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
83047720|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047721|NCT05650164|Avelumab|avelumab|mesh-list
83047722|NCT05650164|Axitinib|axitinib|mesh-list
83047723|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047724|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047725|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83047726|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047727|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047740|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83047741|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83047742|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047743|NCT05608837|Dexamethasone|dexamethasone|mesh-list
83047744|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83047745|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
83047746|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
83047747|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047748|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047749|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83047750|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
83047751|NCT05608837|Hormones|hormones|mesh-ancestor
83476461|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83047752|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047753|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047754|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047755|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83047756|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83047776|NCT05568888|Thrombin|thrombin|mesh-list
83047777|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
83047778|NCT05568888|Coagulants|coagulants|mesh-ancestor
83047779|NCT05555706|Paclitaxel|paclitaxel|mesh-list
83047780|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83047781|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047782|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
83047783|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
83047784|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
83047785|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047786|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83047787|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
83047788|NCT05553132|Coagulants|coagulants|mesh-ancestor
83047789|NCT05521880|Oritavancin|oritavancin|mesh-list
83047790|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83047791|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047792|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83047793|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
83047794|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047795|NCT05489887|Ceritinib|ceritinib|mesh-list
83047796|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047797|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83047798|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047799|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047800|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
83047801|NCT05466799|Irinotecan|irinotecan|mesh-list
83047802|NCT05466799|Folfirinox|folfirinox|mesh-list
83047803|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047804|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83047805|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83047806|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047807|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047808|NCT05457257|Prednisone|prednisone|mesh-list
83047809|NCT05457257|Olaparib|olaparib|mesh-list
83047810|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
83047811|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83047812|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
83047813|NCT05457257|Hormones|hormones|mesh-ancestor
83047814|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047815|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047816|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047817|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047818|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83047819|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047820|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047821|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83047822|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
83047823|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83047824|NCT05446727|Ropivacaine|ropivacaine|mesh-list
83047825|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
83047826|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
83047827|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83047828|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047829|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
83047830|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83047831|NCT05354102|Nivolumab|nivolumab|mesh-list
83047832|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047833|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047834|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83047835|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047836|NCT05350202|Empagliflozin|empagliflozin|mesh-list
83047837|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83047838|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047839|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83047840|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047841|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
83047842|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047843|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047844|NCT05349890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83047845|NCT05349890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047846|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
83047847|NCT05311475|Azelastine|azelastine|mesh-list
83047848|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83047849|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83047850|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83047851|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83047852|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
83047858|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047859|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047860|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83047861|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83047862|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
83047864|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047865|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
83047866|NCT05301517|Hematinics|hematinics|mesh-ancestor
83047867|NCT05296304|Bexarotene|bexarotene|mesh-list
83047868|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047869|NCT05288283|Cannabidiol|cannabidiol|mesh-list
83047870|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
83047871|NCT05271448|Losartan|losartan|mesh-list
83047872|NCT05271448|Valsartan|valsartan|mesh-list
83047873|NCT05271448|Candesartan|candesartan|mesh-list
83047874|NCT05271448|Ramipril|ramipril|mesh-list
83047875|NCT05271448|Enalapril|enalapril|mesh-list
83047876|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83047877|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83047878|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83047879|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83047880|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047881|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83047882|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
83047883|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047884|NCT05267600|Prednisone|prednisone|mesh-list
83047885|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83047886|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
83047887|NCT05267600|Hormones|hormones|mesh-ancestor
83047888|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047889|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047890|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83047891|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047892|NCT05254405|Brexanolone|brexanolone|mesh-list
83047893|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
83047894|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83047895|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047896|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047897|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
83047898|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
83047906|NCT05223231|Antibodies|antibodies|mesh-list
83047907|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
83047908|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
83047909|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047910|NCT05215106|Durvalumab|durvalumab|mesh-list
83047911|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047912|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047913|NCT05203172|Cetuximab|cetuximab|mesh-list
83047914|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047915|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047916|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
83047917|NCT05187182|Nivolumab|nivolumab|mesh-list
83047918|NCT05187182|Trastuzumab|trastuzumab|mesh-list
83047919|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047920|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047921|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83047922|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047923|NCT05177731|Cytarabine|cytarabine|mesh-list
83047924|NCT05177731|Decitabine|decitabine|mesh-list
83047925|NCT05177731|Venetoclax|venetoclax|mesh-list
83047926|NCT05177731|Idarubicin|idarubicin|mesh-list
83047927|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83047928|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
83047929|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047930|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047932|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83047933|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83047934|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
83047935|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047936|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047937|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83047938|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83047939|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83047940|NCT05171387|Androgens|androgens|mesh-list
83047941|NCT05171387|Hormones|hormones|mesh-ancestor
83047942|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047943|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047944|NCT05156710|Rituximab|rituximab|mesh-list
83047945|NCT05156710|Tacrolimus|tacrolimus|mesh-list
83047946|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
83047947|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83047948|NCT05156710|Antibodies|antibodies|mesh-list
83047949|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83047950|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
83047951|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83047952|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047953|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047954|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
83047955|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047956|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83047957|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83047958|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83047959|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047960|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047961|NCT05142696|Carboplatin|carboplatin|mesh-list
83047962|NCT05142696|Etoposide|etoposide|mesh-list
83047963|NCT05142696|Tislelizumab|tislelizumab|mesh-list
83047964|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83047965|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83047966|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047967|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83047968|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83047969|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83047970|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047971|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047972|NCT05142696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047973|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
83047974|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
83047975|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83047976|NCT05130463|Empagliflozin|empagliflozin|mesh-list
83047977|NCT05130463|Linagliptin|linagliptin|mesh-list
83047978|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83047979|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047980|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83047981|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047982|NCT05130463|Incretins|incretins|mesh-ancestor
83047983|NCT05130463|Hormones|hormones|mesh-ancestor
83047984|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83047985|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83047986|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
83047987|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83047988|NCT05110482|Oxytocin|oxytocin|mesh-list
83047989|NCT05110482|Carbetocin|carbetocin|mesh-list
83047990|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
83047991|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83047992|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83047993|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
83047994|NCT05054348|Cemiplimab|cemiplimab|mesh-list
83047995|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83047996|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83047997|NCT05054348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83047998|NCT05054348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83047999|NCT05039619|Acetaminophen|acetaminophen|mesh-list
83048000|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
83048001|NCT05039619|Promethazine|promethazine|mesh-list
83048002|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
83048003|NCT05039619|Prednisone|prednisone|mesh-list
83048004|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
83048005|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
83048006|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048007|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
83048008|NCT05039619|Hormones|hormones|mesh-ancestor
83048009|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048010|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048011|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048012|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048013|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83048014|NCT05039619|Analgesics|analgesics|mesh-ancestor
83048015|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
83048016|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048017|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
83048018|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83048019|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83048020|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
83048021|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83048022|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048023|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048024|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048025|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
83048026|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
83048027|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048028|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83048029|NCT05039619|Protective Agents|protective agents|mesh-ancestor
83048030|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048031|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83048032|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83048033|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83048034|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
83048035|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
83048036|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83048037|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
83048038|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
83048039|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83048040|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83048041|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
83048042|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
83048043|NCT05029960|Brivaracetam|brivaracetam|mesh-list
83048044|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
83048045|NCT05005000|Triamcinolone|triamcinolone|mesh-list
83048046|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83048047|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83048048|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83048049|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048050|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
83048051|NCT05005000|Hormones|hormones|mesh-ancestor
83048052|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048053|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048054|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048055|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
83048056|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048057|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048058|NCT04989946|Nivolumab|nivolumab|mesh-list
83048059|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048060|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048061|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048062|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048063|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
83048064|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048065|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048066|NCT04987996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048067|NCT04987996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048068|NCT04916509|Fulvestrant|fulvestrant|mesh-list
83048069|NCT04916509|Palbociclib|palbociclib|mesh-list
83048070|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83048071|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048072|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048073|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83048074|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83048075|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
83048076|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048077|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048078|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048079|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362143|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83048095|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83048097|NCT04891770|Tenofovir|tenofovir|mesh-list
83048098|NCT04891770|Nivolumab|nivolumab|mesh-list
83048099|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048100|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048101|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048102|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048103|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
83048104|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048105|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83048106|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83048107|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048108|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83048109|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83048110|NCT04882774|Treprostinil|treprostinil|mesh-list
83048111|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83048128|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
83048129|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
83048130|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048131|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
83048132|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83048133|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048134|NCT04846920|Belzutifan|belzutifan|mesh-list
83048135|NCT04846920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048136|NCT04840615|Ipilimumab|ipilimumab|mesh-list
83048137|NCT04840615|LMB-100|lmb-100|mesh-list
83048138|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048139|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048140|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048141|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048142|NCT04840615|Immunoconjugates|immunoconjugates|mesh-ancestor
83048143|NCT04840615|Immunologic Factors|immunologic factors|mesh-ancestor
83048144|NCT04840615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048145|NCT04774406|Olaparib|olaparib|mesh-list
83048146|NCT04774406|Niraparib|niraparib|mesh-list
83048147|NCT04774406|Talazoparib|talazoparib|mesh-list
83048148|NCT04774406|Veliparib|veliparib|mesh-list
83048149|NCT04774406|Rucaparib|rucaparib|mesh-list
83048150|NCT04774406|Fluzoparib|fluzoparib|mesh-list
83048151|NCT04774406|Pamiparib|pamiparib|mesh-list
83048152|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83048153|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048154|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048155|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048156|NCT04771130|Posaconazole|posaconazole|mesh-list
83048157|NCT04771130|Azacitidine|azacitidine|mesh-list
83048158|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83048159|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
83048160|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048161|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048162|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048163|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
83048164|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048165|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83048166|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048167|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048168|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83048169|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83048170|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83048171|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
83048172|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048173|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048174|NCT04759833|Prucalopride|prucalopride|mesh-list
83048175|NCT04759833|Laxatives|laxatives|mesh-ancestor
83048176|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048177|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83048178|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83048179|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
83048180|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83048181|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048182|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048183|NCT04752813|Vitamin K|vitamin k|mesh-list
83048184|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
83048185|NCT04752813|Temozolomide|temozolomide|mesh-list
83048186|NCT04752813|Vitamins|vitamins|mesh-ancestor
83048187|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
83048188|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048189|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048190|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
83048191|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048192|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048193|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83048194|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83048195|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
83048196|NCT04752813|Coagulants|coagulants|mesh-ancestor
83048197|NCT04744831|Camptothecin|camptothecin|mesh-list
83048198|NCT04744831|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83048199|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
83048200|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
83048201|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048202|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83048203|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048204|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83048205|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83048206|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048207|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048208|NCT04735367|Letrozole|letrozole|mesh-list
83048209|NCT04735367|Palbociclib|palbociclib|mesh-list
83048210|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048211|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83048212|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83048213|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048214|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048215|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83048216|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
83048217|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048218|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048219|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048220|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
83048221|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83048222|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83048223|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048224|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83048225|NCT04720963|Analgesics|analgesics|mesh-ancestor
83048226|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
83048227|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048228|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83048229|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83048230|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83048231|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
83048232|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83048233|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048234|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
83048235|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
83048236|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83048237|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83048238|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048239|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048240|NCT04715113|Urological Agents|urological agents|mesh-ancestor
83048241|NCT04713657|Propranolol|propranolol|mesh-list
83048242|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83048243|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83048244|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
83048245|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83048246|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048247|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048248|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83048249|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83048250|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83048251|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83048252|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
83048253|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048254|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
83048255|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
83048256|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83048257|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83048258|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048259|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048260|NCT04706546|Urological Agents|urological agents|mesh-ancestor
83048261|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
83048262|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
83048263|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83048264|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83048265|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048266|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048267|NCT04704440|Urological Agents|urological agents|mesh-ancestor
83048268|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
83048269|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
83048270|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83048271|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83048272|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048273|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048274|NCT04697862|Urological Agents|urological agents|mesh-ancestor
83048275|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
83048276|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048277|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048278|NCT04696055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048279|NCT04696055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048280|NCT04696029|Eflornithine|eflornithine|mesh-list
83048281|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048282|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83048283|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048284|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048285|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048286|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83048287|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048288|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048289|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83048290|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
83048291|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83048292|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048293|NCT04666610|Brivaracetam|brivaracetam|mesh-list
83048294|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
83048295|NCT04652544|Vitamin D|vitamin d|mesh-list
83048296|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
83048297|NCT04652544|Vitamins|vitamins|mesh-ancestor
83048298|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
83048299|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048300|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83048301|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83048302|NCT04640545|Axitinib|axitinib|mesh-list
83048303|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048304|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048305|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048306|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048307|NCT04625699|Durvalumab|durvalumab|mesh-list
83048308|NCT04625699|Tremelimumab|tremelimumab|mesh-list
83048309|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048310|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048311|NCT04613492|Durvalumab|durvalumab|mesh-list
83048312|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048313|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048314|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83048315|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83048316|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83048317|NCT04510584|Bevacizumab|bevacizumab|mesh-list
83048318|NCT04510584|Atezolizumab|atezolizumab|mesh-list
83048319|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048320|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048321|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83048322|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83048323|NCT04510584|Growth Substances|growth substances|mesh-ancestor
83048324|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048325|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
83048326|NCT04510584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048327|NCT04510584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048328|NCT04500847|Emtricitabine|emtricitabine|mesh-list
83048329|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
83048330|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048331|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83048332|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83048333|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048334|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048335|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83048336|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83048337|NCT04484532|Vaccines|vaccines|mesh-list
83048338|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
83048339|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048340|NCT04483583|Clopidogrel|clopidogrel|mesh-list
83048341|NCT04483583|Ticagrelor|ticagrelor|mesh-list
83048342|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83048343|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83048344|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83048345|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83048346|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
83048347|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83048348|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048349|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048350|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
83048351|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
83048352|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83048353|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83048354|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048355|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048356|NCT04447989|Urological Agents|urological agents|mesh-ancestor
83048357|NCT04431453|Remdesivir|remdesivir|mesh-list
83048358|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
83048359|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048360|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
83048361|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048362|NCT04430738|Leucovorin|leucovorin|mesh-list
83048363|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
83048364|NCT04430738|Trastuzumab|trastuzumab|mesh-list
83048365|NCT04430738|Fluorouracil|fluorouracil|mesh-list
83048366|NCT04430738|Capecitabine|capecitabine|mesh-list
83048367|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
83048368|NCT04430738|Tucatinib|tucatinib|mesh-list
83048369|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048370|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048371|NCT04430738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048372|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048373|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
83048374|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83048375|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048376|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
83048377|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048378|NCT04430738|Antidotes|antidotes|mesh-ancestor
83048379|NCT04430738|Protective Agents|protective agents|mesh-ancestor
83048382|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
83048383|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048384|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048385|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
83048386|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048387|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048388|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048389|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048390|NCT04382898|Cemiplimab|cemiplimab|mesh-list
83048391|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048392|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048393|NCT04375527|Nivolumab|nivolumab|mesh-list
83048394|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048395|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048396|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048397|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048398|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83048399|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
83048400|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
83048401|NCT04336189|Piperaquine|piperaquine|mesh-list
83048402|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
83048403|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83048404|NCT04336189|Artenimol|artenimol|mesh-list
83048405|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
83048406|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048407|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048408|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048409|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83048410|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048411|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048412|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83048413|NCT04284774|Tipifarnib|tipifarnib|mesh-list
83048414|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048415|NCT04231877|Prednisone|prednisone|mesh-list
83048416|NCT04231877|Cortisone|cortisone|mesh-list
83048417|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
83048418|NCT04231877|Rituximab|rituximab|mesh-list
83048419|NCT04231877|Doxorubicin|doxorubicin|mesh-list
83048420|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83048421|NCT04231877|Etoposide|etoposide|mesh-list
83048422|NCT04231877|Daunorubicin|daunorubicin|mesh-list
83048423|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
83048424|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83048425|NCT04231877|Antibodies|antibodies|mesh-list
83048426|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
83048427|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83048428|NCT04231877|Lenograstim|lenograstim|mesh-list
83048429|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
83048430|NCT04231877|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83048431|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048432|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
83048433|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048434|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83048435|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048436|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
83048437|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048438|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048439|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83048440|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83048441|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83048442|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83048443|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048444|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048445|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
83048446|NCT04231877|Hormones|hormones|mesh-ancestor
83048447|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048448|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048449|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83048450|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83048451|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
83048452|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
83048453|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
83048454|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
83048455|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
83048526|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
83048527|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83048528|NCT04044690|Antibodies|antibodies|mesh-list
83048529|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
83048530|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
83048531|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048532|NCT04026776|Allopurinol|allopurinol|mesh-list
83048533|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
83048534|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048535|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048536|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
83048537|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83048538|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83048539|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
83048540|NCT04026776|Protective Agents|protective agents|mesh-ancestor
83048541|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048542|NCT03871348|Cemiplimab|cemiplimab|mesh-list
83048543|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048544|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048545|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
83048546|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048547|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048548|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048549|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048550|NCT03831113|Buprenorphine|buprenorphine|mesh-list
83048551|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83048552|NCT03831113|Narcotics|narcotics|mesh-ancestor
83048553|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83048554|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048555|NCT03831113|Analgesics|analgesics|mesh-ancestor
83048556|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
83048557|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048558|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83048559|NCT03824561|Vedolizumab|vedolizumab|mesh-list
83048560|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048561|NCT03821857|Corticosterone|corticosterone|mesh-list
83048562|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048563|NCT04305236|Fulvestrant|fulvestrant|mesh-list
83048564|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048565|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048566|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83048567|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83048568|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
83048569|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048570|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048571|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
83048572|NCT03774472|Letrozole|letrozole|mesh-list
83048573|NCT03774472|Palbociclib|palbociclib|mesh-list
83048574|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048575|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83048576|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83048577|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048578|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048579|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83048580|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
83048581|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048582|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048583|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
83048584|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048585|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048586|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048587|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83048588|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048589|NCT03727061|Carboplatin|carboplatin|mesh-list
83048590|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
83048591|NCT03727061|Fluorouracil|fluorouracil|mesh-list
83048592|NCT03727061|Nivolumab|nivolumab|mesh-list
83048593|NCT03727061|Cetuximab|cetuximab|mesh-list
83048594|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83048595|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
83048596|NCT03727061|Trioxsalen|trioxsalen|mesh-list
83048597|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048598|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048599|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048600|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048601|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
83048602|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83048603|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048604|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
83048605|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048606|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
83048607|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83048608|NCT03668340|Adavosertib|adavosertib|mesh-list
83048609|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048610|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048611|NCT03657160|Vedolizumab|vedolizumab|mesh-list
83048612|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048613|NCT03640481|Belumosudil|belumosudil|mesh-list
83048614|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048615|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048616|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048617|NCT03584516|Prednisone|prednisone|mesh-list
83048618|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
83048619|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83048620|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83048621|NCT03584516|Prednisolone|prednisolone|mesh-list
83048622|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
83048623|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83048624|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
83048625|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048626|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
83048627|NCT03584516|Hormones|hormones|mesh-ancestor
83048628|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048629|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048630|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048631|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048632|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
83048633|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
83048634|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048635|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048636|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83048637|NCT03584516|Protective Agents|protective agents|mesh-ancestor
83048638|NCT03581240|Eflornithine|eflornithine|mesh-list
83048639|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048640|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83048641|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048642|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048643|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048644|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83048645|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048646|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048647|NCT03530683|Dexamethasone|dexamethasone|mesh-list
83048648|NCT03530683|Azacitidine|azacitidine|mesh-list
83048649|NCT03530683|Venetoclax|venetoclax|mesh-list
83048650|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048651|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
83048652|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
83048653|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048654|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048655|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048656|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
83048657|NCT03530683|Hormones|hormones|mesh-ancestor
83048658|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048659|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048660|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048661|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83048662|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
83048663|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048664|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048665|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
83048666|NCT03508726|Vitamins|vitamins|mesh-ancestor
83048667|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
83048668|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048669|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
83048670|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048671|NCT03508726|Protective Agents|protective agents|mesh-ancestor
83048672|NCT03404661|Secretin|secretin|mesh-list
83048673|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048674|NCT03404661|Hormones|hormones|mesh-ancestor
82949497|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048675|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048676|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048677|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
83048678|NCT03399773|Thiotepa|thiotepa|mesh-list
83048679|NCT03399773|Fludarabine|fludarabine|mesh-list
83048680|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048681|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
83048682|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048683|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83048684|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048685|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
83361712|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048686|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048687|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048688|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83048689|NCT03370172|Factor VIII|factor viii|mesh-list
83048690|NCT03370172|Coagulants|coagulants|mesh-ancestor
83048691|NCT03345784|Cisplatin|cisplatin|mesh-list
83048692|NCT03345784|Adavosertib|adavosertib|mesh-list
83048693|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048694|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048695|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048696|NCT03342196|Fludarabine|fludarabine|mesh-list
83048697|NCT03342196|Melphalan|melphalan|mesh-list
83048698|NCT03342196|Thiotepa|thiotepa|mesh-list
83048699|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048700|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048701|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048702|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
83048703|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048704|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048705|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
83048706|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83048707|NCT03319537|Pemetrexed|pemetrexed|mesh-list
83048708|NCT03319537|Pevonedistat|pevonedistat|mesh-list
83048709|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048710|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048711|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048712|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83048713|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83048714|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
83048715|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048716|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048717|NCT03279692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048718|NCT03279692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048719|NCT03237780|Atezolizumab|atezolizumab|mesh-list
83048720|NCT03237780|Halichondrin B|halichondrin b|mesh-list
83048721|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83048722|NCT03237780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048723|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048724|NCT03237780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048725|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048726|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
83048727|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048728|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
83048729|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
83048730|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
83048732|NCT03158129|Carboplatin|carboplatin|mesh-list
83048733|NCT03158129|Docetaxel|docetaxel|mesh-list
83048734|NCT03158129|Nivolumab|nivolumab|mesh-list
83048735|NCT03158129|Pemetrexed|pemetrexed|mesh-list
83048736|NCT03158129|Ipilimumab|ipilimumab|mesh-list
83048737|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048738|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
83048739|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
83048740|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
83048741|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048742|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048743|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048744|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048745|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83048746|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83048747|NCT03100786|Dexamethasone|dexamethasone|mesh-list
83048748|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048749|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
83048750|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
83048751|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048752|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048753|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048754|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
83048755|NCT03100786|Hormones|hormones|mesh-ancestor
83048756|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048757|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048758|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048759|NCT03043053|Oxytocin|oxytocin|mesh-list
83048760|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
83048761|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83048762|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048763|NCT03036930|Vaccines|vaccines|mesh-list
83048764|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
83048765|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048766|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
83048767|NCT03025035|Olaparib|olaparib|mesh-list
83048768|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048769|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048770|NCT03025035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048771|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048772|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83048773|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048774|NCT03006172|Metformin|metformin|mesh-list
83048775|NCT03006172|Trastuzumab|trastuzumab|mesh-list
83048776|NCT03006172|Pertuzumab|pertuzumab|mesh-list
83048777|NCT03006172|Letrozole|letrozole|mesh-list
83048778|NCT03006172|Fulvestrant|fulvestrant|mesh-list
83048779|NCT03006172|Palbociclib|palbociclib|mesh-list
83048780|NCT03006172|Inavolisib|inavolisib|mesh-list
83048781|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83048782|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048783|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048784|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048785|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83048786|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83048787|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048788|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048789|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83048790|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
83048791|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048792|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83048793|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83048794|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048795|NCT03006172|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83048796|NCT03001882|Nivolumab|nivolumab|mesh-list
83048797|NCT03001882|Ipilimumab|ipilimumab|mesh-list
83048798|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048799|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048800|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83048801|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048802|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
83048803|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83048804|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048805|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83048806|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048807|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
83048808|NCT02932956|Fludarabine|fludarabine|mesh-list
83048809|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
83048810|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048811|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
83048812|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048813|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83048814|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048815|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
83048816|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048817|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048818|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83048819|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83048820|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
83048821|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83048822|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048823|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048824|NCT02843165|Immunomodulating Agents|immunomodulating agents|mesh-list
83048825|NCT02843165|Immunologic Factors|immunologic factors|mesh-list
83048826|NCT02843165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048827|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
83048828|NCT02807467|Propofol|propofol|mesh-list
83048829|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83048830|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83048831|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048832|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83048833|NCT02807467|Analgesics|analgesics|mesh-ancestor
83048834|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
83048835|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048836|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83048837|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83048838|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83048839|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
83048840|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83048841|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048842|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83048843|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
83048845|NCT02794428|Eflornithine|eflornithine|mesh-list
83048846|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048847|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83048848|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048849|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048850|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048851|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83048852|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048853|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048854|NCT02740179|Eplerenone|eplerenone|mesh-list
83048855|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83048856|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
83048857|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83048858|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048859|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83048860|NCT02740179|Diuretics|diuretics|mesh-ancestor
83048861|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
83048862|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83048863|NCT02679144|Eflornithine|eflornithine|mesh-list
83048864|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048865|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83048866|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048867|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048868|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048869|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83048870|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048871|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048872|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
83048874|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83048875|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
83048876|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048877|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83048878|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048879|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
83048880|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048881|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048882|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83048883|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83048884|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
83048885|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048886|NCT02619409|Bupivacaine|bupivacaine|mesh-list
83048887|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
83048888|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
83048889|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83048890|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048891|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
83048892|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048893|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
83048894|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83048895|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83048896|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048897|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
83048898|NCT02606045|Coagulants|coagulants|mesh-ancestor
83048899|NCT02603432|Avelumab|avelumab|mesh-list
83048900|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83048901|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048902|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048903|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
83048904|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048905|NCT02582866|Lacosamide|lacosamide|mesh-list
83048906|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
83048907|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83361713|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
83048908|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83048909|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83048910|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048911|NCT02562235|Riociguat|riociguat|mesh-list
83048912|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
83048913|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048914|NCT02559778|Eflornithine|eflornithine|mesh-list
83048915|NCT02559778|Sorafenib|sorafenib|mesh-list
83048916|NCT02559778|Dasatinib|dasatinib|mesh-list
83048917|NCT02559778|Vorinostat|vorinostat|mesh-list
83048918|NCT02559778|Ceritinib|ceritinib|mesh-list
83048919|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048920|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048921|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048922|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048923|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83048924|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83048925|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048926|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048927|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048928|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83048929|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
83048930|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048931|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
83048932|NCT02453373|Plasminogen|plasminogen|mesh-list
83048933|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83048934|NCT02453373|Propofol|propofol|mesh-list
83048935|NCT02453373|Etomidate|etomidate|mesh-list
83048936|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83048937|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83048938|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048939|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83048940|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
83048941|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
83048942|NCT02453373|Analgesics|analgesics|mesh-ancestor
83048943|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
83048944|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048945|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83048946|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
83048947|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83048948|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83048949|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048950|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83048951|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
83048952|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83048953|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83048954|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83048955|NCT02395666|Eflornithine|eflornithine|mesh-list
83048956|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048957|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83048958|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83048959|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83048960|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83048961|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83048962|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048963|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048964|NCT02180867|Doxorubicin|doxorubicin|mesh-list
83048965|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83048966|NCT02180867|Daunorubicin|daunorubicin|mesh-list
83048967|NCT02180867|Ifosfamide|ifosfamide|mesh-list
83048968|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
83048969|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83048970|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048971|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83048972|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83048973|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048974|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048975|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83048976|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
83048977|NCT02031419|Rituximab|rituximab|mesh-list
83048978|NCT02031419|Spebrutinib|spebrutinib|mesh-list
83048979|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83048980|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83048981|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
83048982|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048983|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83048984|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83048985|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83048986|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83048987|NCT01734928|Thalidomide|thalidomide|mesh-list
83048988|NCT01734928|Dexamethasone|dexamethasone|mesh-list
83048989|NCT01734928|Bortezomib|bortezomib|mesh-list
83048990|NCT01734928|Pomalidomide|pomalidomide|mesh-list
83048991|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83048992|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
83048993|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
83048994|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83048995|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83048996|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83048997|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
83048998|NCT01734928|Hormones|hormones|mesh-ancestor
83048999|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83049000|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83049001|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049002|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
83049003|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83049004|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83049005|NCT01734928|Growth Substances|growth substances|mesh-ancestor
83049006|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
83049007|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049008|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
83049009|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83049010|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049011|NCT01682616|Rituximab|rituximab|mesh-list
83049012|NCT01682616|Venetoclax|venetoclax|mesh-list
83049013|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049014|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049015|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
83049016|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049017|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049019|NCT01430572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83049020|NCT01430572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83049021|NCT01430572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049022|NCT01430572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049023|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049024|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
83049025|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049026|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049027|NCT00950430|Corticosterone|corticosterone|mesh-list
83049028|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83049029|NCT00909051|Acarbose|acarbose|mesh-list
83049030|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83049031|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049032|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049033|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049034|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049035|NCT00781612|Paclitaxel|paclitaxel|mesh-list
83049036|NCT00781612|Maytansine|maytansine|mesh-list
83049037|NCT00781612|Docetaxel|docetaxel|mesh-list
83049038|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83049039|NCT00781612|Trastuzumab|trastuzumab|mesh-list
83049040|NCT00781612|Atezolizumab|atezolizumab|mesh-list
83049041|NCT00781612|Pertuzumab|pertuzumab|mesh-list
83049042|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83049043|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049044|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83049045|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83049046|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
82949498|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049047|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049048|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049049|NCT00781612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83049050|NCT00781612|Immunotoxins|immunotoxins|mesh-ancestor
83049051|NCT00781612|Immunoconjugates|immunoconjugates|mesh-ancestor
83049052|NCT00781612|Immunologic Factors|immunologic factors|mesh-ancestor
83049053|NCT00781612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049054|NCT00750841|Cediranib|cediranib|mesh-list
83049055|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049056|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83049057|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049058|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049059|NCT05015608|Carboplatin|carboplatin|mesh-list
83049060|NCT05015608|Pemetrexed|pemetrexed|mesh-list
83049061|NCT05015608|Osimertinib|osimertinib|mesh-list
83049062|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049063|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049064|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049065|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83049066|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83049067|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83049068|NCT03510416|Apatinib|apatinib|mesh-list
83049069|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049070|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83049071|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049072|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049073|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
83049074|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83049075|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049076|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
83049077|NCT02646124|Naproxen|naproxen|mesh-list
83049078|NCT02646124|Diazepam|diazepam|mesh-list
83049079|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83049080|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83049081|NCT02646124|Analgesics|analgesics|mesh-ancestor
83049082|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
83049083|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049084|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049085|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83049086|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049087|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
83049088|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83049089|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049090|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049091|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83049092|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
83049093|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
83049094|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
83049095|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83049096|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83049097|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049098|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83049099|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83049100|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83049101|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83049102|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83049103|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83049104|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
83049105|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
83049106|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
83049107|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
83049108|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049109|NCT02306564|Cabergoline|cabergoline|mesh-list
83049110|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83049111|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83049112|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
83049113|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
83049114|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049115|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049116|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049117|NCT02301494|Fluocinonide|fluocinonide|mesh-list
83049118|NCT02301494|Imiquimod|imiquimod|mesh-list
83049119|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83049120|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
83049121|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049122|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049123|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
83049124|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83049125|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
83049126|NCT02301494|Hormones|hormones|mesh-ancestor
83049127|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83049128|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83049129|NCT03101800|Azathioprine|azathioprine|mesh-list
83049130|NCT03101800|Allopurinol|allopurinol|mesh-list
83049131|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
83049132|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049133|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049134|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
83049135|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049136|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83049137|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
83049138|NCT03101800|Protective Agents|protective agents|mesh-ancestor
83049139|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049140|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83049141|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049142|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049143|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
83049144|NCT03507842|Cytarabine|cytarabine|mesh-list
83049145|NCT03507842|Daunorubicin|daunorubicin|mesh-list
83049146|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83049147|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
83049148|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049149|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049150|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
83049151|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049152|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049153|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
83049154|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049155|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83049156|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83049157|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83049158|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049159|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
83049160|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
83049161|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049162|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
83049163|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049164|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049165|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83049166|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
83049167|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049168|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049169|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83049170|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049171|NCT03656926|Cyclosporine|cyclosporine|mesh-list
83049172|NCT03656926|Cyclosporins|cyclosporins|mesh-list
83049173|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049174|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049175|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049176|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
83049177|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049178|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
83049179|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049180|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
83049181|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049182|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83049183|NCT02301650|Tenofovir|tenofovir|mesh-list
83049184|NCT02301650|Lamivudine|lamivudine|mesh-list
83049185|NCT02301650|Telbivudine|telbivudine|mesh-list
83049186|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
83049187|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049188|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83049189|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83049190|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049191|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049192|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83049193|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83049194|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
83049195|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
83049196|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83049197|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83049198|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049199|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049200|NCT03510338|Urological Agents|urological agents|mesh-ancestor
83049201|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
83049202|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049203|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049204|NCT02303366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83049205|NCT02303366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049206|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83049207|NCT02301806|Glimepiride|glimepiride|mesh-list
83049208|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049209|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049210|NCT02301806|Incretins|incretins|mesh-ancestor
83049211|NCT02301806|Hormones|hormones|mesh-ancestor
83049212|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362144|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
83049213|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83049214|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
83049215|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049216|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049217|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83049218|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049219|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
83049220|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
83049221|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83049222|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049223|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
83049224|NCT02301962|Panitumumab|panitumumab|mesh-list
83049225|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049226|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049227|NCT03507374|Alirocumab|alirocumab|mesh-list
83049228|NCT03507374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83049229|NCT03507374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83049230|NCT03507374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83049231|NCT03507374|Antimetabolites|antimetabolites|mesh-ancestor
83049232|NCT03507374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049233|NCT03507374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83049234|NCT03507374|Protease Inhibitors|protease inhibitors|mesh-ancestor
83049235|NCT03507374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049236|NCT03507374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83049237|NCT02639650|Dactinomycin|dactinomycin|mesh-list
83049238|NCT02639650|Paclitaxel|paclitaxel|mesh-list
83049239|NCT02639650|Etoposide|etoposide|mesh-list
83049240|NCT02639650|Vincristine|vincristine|mesh-list
83049241|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
83049242|NCT02639650|Carboplatin|carboplatin|mesh-list
83049243|NCT02639650|Methotrexate|methotrexate|mesh-list
83049244|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83049245|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049246|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
83049247|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
83049248|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
83049249|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049250|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049251|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
83049252|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049253|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049254|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83049255|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
83049256|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83049257|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83049258|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
83049259|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83049260|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83049261|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
83049262|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
83049263|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049264|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82949499|NCT01174303|Insulin|insulin|mesh-list
83049265|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83049266|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83049267|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83049268|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83049269|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049270|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83049271|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83049272|NCT03581734|Vaccines|vaccines|mesh-list
83049273|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
83049274|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049275|NCT02306798|Mesalamine|mesalamine|mesh-list
83049276|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83049277|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83049278|NCT02306798|Analgesics|analgesics|mesh-ancestor
83049279|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
83049280|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049281|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049282|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83049283|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049284|NCT02306954|Aldesleukin|aldesleukin|mesh-list
83049285|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049286|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83049287|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83049288|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
83049289|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049290|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
83049291|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
83049292|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049293|NCT03509714|Protective Agents|protective agents|mesh-ancestor
83049294|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049295|NCT03509714|Vitamins|vitamins|mesh-ancestor
83049296|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
83049297|NCT02302274|Flecainide|flecainide|mesh-list
83049298|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83049299|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83049300|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83049301|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83049302|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049303|NCT02303600|Montelukast|montelukast|mesh-list
83049304|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83049305|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
83049306|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83049307|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
83049308|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83049309|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049310|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83049311|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83049312|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049313|NCT04463342|Methamphetamine|methamphetamine|mesh-list
83049314|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83049315|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049316|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
83049317|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
83049318|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049320|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049321|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049322|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
83049323|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83049324|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83049325|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83049326|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83049327|NCT02303912|Carboplatin|carboplatin|mesh-list
83049328|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049329|NCT01597492|Belimumab|belimumab|mesh-list
83049330|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049331|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
83049332|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049333|NCT04569994|Insulin|insulin|mesh-list
83049334|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049335|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049336|NCT00109590|Ritonavir|ritonavir|mesh-list
83049337|NCT00109590|Lopinavir|lopinavir|mesh-list
83049338|NCT00109590|Zidovudine|zidovudine|mesh-list
83049339|NCT00109590|Nevirapine|nevirapine|mesh-list
83049340|NCT00109590|Didanosine|didanosine|mesh-list
83049341|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83049342|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83049343|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
83049344|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049345|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049346|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83049347|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83049348|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
83049349|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049350|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83049351|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83049352|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
83049353|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83049354|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83049355|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83049356|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83049357|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
83049358|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83049359|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83049360|NCT05243446|Losartan|losartan|mesh-list
83049361|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83049362|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83049363|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83049364|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83049365|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049367|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83049368|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049369|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
83049370|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
83049371|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049372|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
83049373|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049374|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049375|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
83049376|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83049377|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83049378|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83049379|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83049380|NCT02143362|Remifentanil|remifentanil|mesh-list
83049381|NCT02143362|Anesthetics|anesthetics|mesh-list
83049382|NCT02143362|Propofol|propofol|mesh-list
83049383|NCT02143362|Cisatracurium|cisatracurium|mesh-list
83049384|NCT02143362|Atracurium|atracurium|mesh-list
83049385|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049386|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049387|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83049388|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83049389|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
83049390|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83049391|NCT02143362|Narcotics|narcotics|mesh-ancestor
83049392|NCT02143362|Analgesics|analgesics|mesh-ancestor
83049393|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
83049394|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049395|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83049396|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83049397|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83049398|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83049399|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83049400|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
83049401|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049402|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049403|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
83049404|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049405|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049406|NCT02143440|Insulin|insulin|mesh-list
83049407|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049408|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049409|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83049410|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
83049411|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83049412|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
83049413|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049414|NCT02143518|Antacids|antacids|mesh-ancestor
83049415|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049416|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83049417|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83049418|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
83049419|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049420|NCT03506828|Phenol|phenol|mesh-list
83049421|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83049422|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049423|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
83049424|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83049425|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83049426|NCT00054964|Albuterol|albuterol|mesh-list
83049427|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83049428|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
83049429|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049430|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049431|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83049432|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
83049433|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
83049434|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83049435|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83049436|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83049437|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83049438|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
83362145|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
83049439|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049440|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049441|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
83049442|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83049443|NCT02781558|Velpatasvir|velpatasvir|mesh-list
83049444|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
83049445|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049446|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
83049447|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83049448|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049449|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049450|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83049451|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83049452|NCT05073640|Protective Agents|protective agents|mesh-ancestor
83049453|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049454|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
83049455|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83049456|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
83049457|NCT05073094|Esmolol|esmolol|mesh-list
83049458|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83049459|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83049460|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83049461|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83049462|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049463|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049464|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049465|NCT03509246|Doxorubicin|doxorubicin|mesh-list
83049466|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83049467|NCT03509246|Bortezomib|bortezomib|mesh-list
83049468|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83049469|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049470|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83049471|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83049472|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049473|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049474|NCT03509168|Misoprostol|misoprostol|mesh-list
83049475|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83049476|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
83049477|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83049478|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049479|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83049480|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83049481|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
83049482|NCT05072938|Nizatidine|nizatidine|mesh-list
83049483|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83049484|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83049485|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83049486|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
83049487|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
83049488|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049489|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049490|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049491|NCT03041311|Carboplatin|carboplatin|mesh-list
83049492|NCT03041311|Etoposide|etoposide|mesh-list
83049493|NCT03041311|Atezolizumab|atezolizumab|mesh-list
83049494|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049495|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83049496|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83049497|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83049498|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049499|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049500|NCT03041311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83049501|NCT03041311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049502|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
83049503|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83049504|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83049505|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049506|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
83049507|NCT05072860|Coagulants|coagulants|mesh-ancestor
83049508|NCT02311946|Palbociclib|palbociclib|mesh-list
83049509|NCT02311946|Rabeprazole|rabeprazole|mesh-list
83049510|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83049511|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049512|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83049513|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049514|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049515|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83049516|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83049517|NCT04302766|Remdesivir|remdesivir|mesh-list
83049518|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
83049519|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049520|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
83049521|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049522|NCT02312102|Lenalidomide|lenalidomide|mesh-list
83049523|NCT02312102|Bortezomib|bortezomib|mesh-list
83049524|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
83049525|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049526|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83049527|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83049528|NCT02312102|Growth Substances|growth substances|mesh-ancestor
83049529|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83049530|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049531|NCT05408221|Lenvatinib|lenvatinib|mesh-list
83049532|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049533|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83049534|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049535|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049536|NCT02307968|Insulin|insulin|mesh-list
83049537|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049538|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049539|NCT02312180|Plasminogen|plasminogen|mesh-list
83049540|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83049541|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83049542|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049543|NCT03504566|Empagliflozin|empagliflozin|mesh-list
83049544|NCT03504566|Linagliptin|linagliptin|mesh-list
83049545|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83049546|NCT03504566|Telmisartan|telmisartan|mesh-list
83049547|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83049548|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049549|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049550|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049551|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83049552|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83049553|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83049554|NCT03504566|Incretins|incretins|mesh-ancestor
83049555|NCT03504566|Hormones|hormones|mesh-ancestor
83049556|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83049557|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83049558|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
83049559|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049560|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
83049561|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83049562|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
83049563|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83049564|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83049565|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83049566|NCT05070520|Lumefantrine|lumefantrine|mesh-list
83049567|NCT05070520|Artemether|artemether|mesh-list
83049568|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83049569|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
83049570|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83049571|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83049572|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049573|NCT05070598|Paclitaxel|paclitaxel|mesh-list
83049574|NCT05070598|Tegafur|tegafur|mesh-list
83049575|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83049576|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049577|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
83049578|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
83049579|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
83049580|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049581|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83049582|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
83049583|NCT03884452|Atorvastatin|atorvastatin|mesh-list
83049584|NCT03884452|Simvastatin|simvastatin|mesh-list
83049585|NCT03884452|Ezetimibe|ezetimibe|mesh-list
83049586|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83049587|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83049588|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
83362146|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
83049589|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049590|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83049591|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83049592|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049593|NCT03882892|Ezetimibe|ezetimibe|mesh-list
83049594|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83049595|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83049596|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
83049597|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049598|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83049599|NCT02305160|Poractant alfa|poractant alfa|mesh-list
83049600|NCT02305160|Beractant|beractant|mesh-list
83049601|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83049602|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
83049603|NCT02305394|Ketamine|ketamine|mesh-list
83049604|NCT02305394|Propofol|propofol|mesh-list
83049605|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83049606|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049607|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049608|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83049609|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
83049610|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
83049611|NCT02305394|Analgesics|analgesics|mesh-ancestor
83049612|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
83049613|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049614|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83049615|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83049616|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83049617|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049618|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049619|NCT05068960|Bupivacaine|bupivacaine|mesh-list
83049620|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
83049621|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
83049622|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049623|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049624|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
83049625|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049626|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
83049627|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83049628|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
83049629|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049630|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049631|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83049632|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
83049633|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83049634|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
83049635|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049636|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049637|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83049638|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
83049639|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
83049640|NCT02305550|Protective Agents|protective agents|mesh-ancestor
83049641|NCT03506516|Ethanol|ethanol|mesh-list
83049642|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83049643|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049644|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049645|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049646|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
83049647|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049648|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049649|NCT02643394|Acetaminophen|acetaminophen|mesh-list
83049650|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83049651|NCT02643394|Analgesics|analgesics|mesh-ancestor
83049652|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
83049653|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049654|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049655|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
83049656|NCT03101644|Darunavir|darunavir|mesh-list
83049657|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83049658|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83049659|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
83049660|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049661|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049662|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83049663|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83049664|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
83049665|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049666|NCT03132272|Autoantibodies|autoantibodies|mesh-list
83049667|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
83049668|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049669|NCT03503786|Paclitaxel|paclitaxel|mesh-list
83049670|NCT03503786|Carboplatin|carboplatin|mesh-list
83049671|NCT03503786|Avelumab|avelumab|mesh-list
83049672|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83049673|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049674|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
83049675|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
83049676|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
83049677|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049678|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049679|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
83049680|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83049681|NCT02308982|Antibodies|antibodies|mesh-list
83049682|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
83049683|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83049684|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
83049685|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049686|NCT05515627|Atezolizumab|atezolizumab|mesh-list
83049687|NCT05515627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83049688|NCT05515627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049689|NCT05515627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049690|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049691|NCT02178436|Paclitaxel|paclitaxel|mesh-list
83049692|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83049693|NCT02178436|Gemcitabine|gemcitabine|mesh-list
83049694|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83049695|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049697|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
83049698|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
83049699|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049700|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83049701|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
83049702|NCT02144064|Heparin|heparin|mesh-list
83049703|NCT02144064|Calcium heparin|calcium heparin|mesh-list
83049704|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
83049705|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83049706|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83049707|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049708|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
83049709|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83049710|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83049711|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83049712|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83049713|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
83049714|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049715|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83049716|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83049717|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049718|NCT02305940|Doxycycline|doxycycline|mesh-list
83049719|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83049720|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049721|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
83049722|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83049723|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83049724|NCT02312804|Paclitaxel|paclitaxel|mesh-list
83049725|NCT02312804|Carboplatin|carboplatin|mesh-list
83049726|NCT02312804|Infigratinib|infigratinib|mesh-list
83049727|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83049728|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049729|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83049730|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83049731|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83049732|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049733|NCT03099616|Propofol|propofol|mesh-list
83049734|NCT03099616|Desflurane|desflurane|mesh-list
83049735|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83049736|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049737|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049738|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83049739|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
83049740|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
83049741|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83049742|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
83049743|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83049744|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83049745|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049746|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
83049747|NCT04463966|Coagulants|coagulants|mesh-ancestor
83049748|NCT00794248|Fexofenadine|fexofenadine|mesh-list
83049749|NCT00794248|Desloratadine|desloratadine|mesh-list
83049750|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83049751|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
83049752|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049753|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049754|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049755|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83049756|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83049757|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
83049758|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
83049759|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83049760|NCT02309450|Asunaprevir|asunaprevir|mesh-list
83049761|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
83049762|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049763|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049764|NCT04475224|Mitogens|mitogens|mesh-list
83049765|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
83049766|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049767|NCT05370235|Afamelanotide|afamelanotide|mesh-list
83049768|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83049769|NCT00353496|Lanreotide|lanreotide|mesh-list
83049770|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049771|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
83049772|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83049773|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83049774|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
83049775|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049776|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949500|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83049777|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049778|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
83049779|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
83049780|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049781|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
83049782|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83049783|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
83049785|NCT03388190|Fluorouracil|fluorouracil|mesh-list
83049786|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
83049787|NCT03388190|Nivolumab|nivolumab|mesh-list
83049788|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
83049789|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
83049790|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049791|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83049792|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049793|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83049794|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
83049795|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049796|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049797|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83049798|NCT03388190|Antidotes|antidotes|mesh-ancestor
83049799|NCT03388190|Protective Agents|protective agents|mesh-ancestor
83049800|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
83049801|NCT03388190|Vitamins|vitamins|mesh-ancestor
83049802|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
83049803|NCT02313272|Bevacizumab|bevacizumab|mesh-list
83049804|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
83049805|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83049806|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049807|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83049808|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83049809|NCT02313272|Growth Substances|growth substances|mesh-ancestor
83049810|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049811|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
83049812|NCT02313272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83049813|NCT02313272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049814|NCT03473977|Benralizumab|benralizumab|mesh-list
83049815|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83049816|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
83049817|NCT01361464|Tipifarnib|tipifarnib|mesh-list
83049818|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049819|NCT04051255|Metronidazole|metronidazole|mesh-list
83049820|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049821|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83049822|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83049823|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83049824|NCT03505736|Adenosine|adenosine|mesh-list
83049825|NCT03505736|Regadenoson|regadenoson|mesh-list
83049826|NCT03505736|Analgesics|analgesics|mesh-ancestor
83049827|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
83049828|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049829|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049830|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83049831|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
83049832|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83049833|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
83049834|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
83049835|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049836|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049837|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83049838|NCT02316626|Progesterone|progesterone|mesh-list
83049839|NCT02316626|Progestins|progestins|mesh-ancestor
83049840|NCT02316626|Hormones|hormones|mesh-ancestor
83049841|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83049842|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049843|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
83049844|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83049845|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83049846|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049847|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
83049848|NCT03505502|Coagulants|coagulants|mesh-ancestor
83049849|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
83049850|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83049851|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049852|NCT02316704|Tacrine|tacrine|mesh-list
83049853|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83049854|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049855|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049856|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
83049857|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049858|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049859|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83049860|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
83049861|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049862|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
83049863|NCT03501680|Insulin|insulin|mesh-list
83049864|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83049865|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049866|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83049867|NCT02310074|Hormones|hormones|mesh-list
83049868|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83049869|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83049870|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049871|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83049872|NCT02313584|Dabigatran|dabigatran|mesh-list
83049873|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
83049874|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83049875|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
83049876|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049877|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049878|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
83049879|NCT05063578|Lidocaine|lidocaine|mesh-list
83049880|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
83049881|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
83049882|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049883|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049884|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
83049885|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049886|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83049887|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83049888|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83049889|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83049890|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049891|NCT05063422|Trimethoprim|trimethoprim|mesh-list
83049892|NCT05063422|Polymyxins|polymyxins|mesh-list
83049893|NCT05063422|Polymyxin B|polymyxin b|mesh-list
83049894|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83049895|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83049896|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83049897|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
83049898|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83049899|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83049900|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83049901|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049902|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049903|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83049904|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83049905|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83049906|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83049907|NCT05063422|Laxatives|laxatives|mesh-ancestor
83049908|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83049909|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
83049910|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83049911|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83049912|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049913|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
83049914|NCT03782350|Coagulants|coagulants|mesh-ancestor
83049916|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049917|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
83049918|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
83049919|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
83049920|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049921|NCT03098680|Verapamil|verapamil|mesh-list
83049922|NCT03098680|Nicardipine|nicardipine|mesh-list
83049923|NCT03098680|Phentolamine|phentolamine|mesh-list
83049924|NCT03098680|Phenylephrine|phenylephrine|mesh-list
83049925|NCT03098680|Dobutamine|dobutamine|mesh-list
83049926|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
83049927|NCT03098680|Albuterol|albuterol|mesh-list
83049928|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83049929|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
83049930|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049931|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049932|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83049933|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
83049934|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
83049935|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83049936|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83049937|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83049938|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83049939|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
83049940|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049941|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049942|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83049943|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
83049944|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
83049945|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83049946|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
83049947|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83049948|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83049949|NCT03098680|Protective Agents|protective agents|mesh-ancestor
83049950|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83049951|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83049952|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83049953|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83049954|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
83049955|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83049956|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83049957|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83049958|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83049959|NCT03098368|Rotigotine|rotigotine|mesh-list
83049960|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
83049961|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
83049962|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83049963|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049964|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049965|NCT05062486|Curcumin|curcumin|mesh-list
83049966|NCT05062486|Resveratrol|resveratrol|mesh-list
83049967|NCT05062486|Quercetin|quercetin|mesh-list
83049968|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83049969|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83049970|NCT05062486|Analgesics|analgesics|mesh-ancestor
83049971|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
83049972|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83049973|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049974|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83049975|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83049976|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83049977|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83049978|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049979|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
83049980|NCT05062486|Protective Agents|protective agents|mesh-ancestor
83049981|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83049983|NCT04474600|Desflurane|desflurane|mesh-list
83049984|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83049985|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83049986|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83049987|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83049988|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
83049989|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
83049990|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83049991|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83049992|NCT02314208|Resveratrol|resveratrol|mesh-list
83049993|NCT02314208|Atorvastatin|atorvastatin|mesh-list
83049994|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83049995|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83049996|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
82949501|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
83049997|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83049998|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83049999|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83050000|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050001|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
83050002|NCT02314208|Protective Agents|protective agents|mesh-ancestor
83050003|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050004|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83050005|NCT02314208|Cathartics|cathartics|mesh-ancestor
83050006|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83050007|NCT03100318|Dotinurad|dotinurad|mesh-list
83050008|NCT03100318|Benzbromarone|benzbromarone|mesh-list
83050009|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
83050010|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
83050011|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83050012|NCT02311010|Tacrolimus|tacrolimus|mesh-list
83050013|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83050014|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
83050015|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050016|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83050017|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050018|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050019|NCT05020600|Pregabalin|pregabalin|mesh-list
83050020|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83050021|NCT05020600|Amitriptyline|amitriptyline|mesh-list
83050022|NCT05020600|Analgesics|analgesics|mesh-ancestor
83050023|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
83050024|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050025|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050026|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
83050027|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83050028|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050029|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050030|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83050031|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83050032|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83050033|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050034|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83050035|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83050036|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83050037|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050038|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
83050039|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
83050040|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83050041|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83050042|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83050043|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
83050044|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83050045|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83050046|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83050047|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
83050048|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050049|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83050050|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83050051|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050053|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050054|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
83050055|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83050056|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050057|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83050058|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050059|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050060|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
83050061|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050062|NCT02311088|Caffeine|caffeine|mesh-list
83050063|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83050064|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050065|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83050066|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050067|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050068|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83438838|NCT02294253|Naloxone|naloxone|mesh-list
83050069|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83050070|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
83050071|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050072|NCT03501212|Anesthetics|anesthetics|mesh-list
83050073|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
83050074|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050075|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050076|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
83050077|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050078|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83050079|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
83050080|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050081|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83050082|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050083|NCT04435210|Hydralazine|hydralazine|mesh-list
83050085|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83050086|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050087|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050088|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83050089|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050090|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
83050091|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
83050092|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83050093|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83050094|NCT03501056|Antibodies|antibodies|mesh-list
83050095|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83050096|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
83050097|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050098|NCT03292146|Denosumab|denosumab|mesh-list
83050099|NCT03292146|Alendronate|alendronate|mesh-list
83050100|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83050101|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050102|NCT02144376|Psyllium|psyllium|mesh-list
83050103|NCT02144376|Cathartics|cathartics|mesh-ancestor
83050104|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83050105|NCT02314754|Misoprostol|misoprostol|mesh-list
83050106|NCT02314754|Mifepristone|mifepristone|mesh-list
83050107|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83050108|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
83050109|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83050110|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050111|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83050112|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83050113|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
83050114|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83050115|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83050116|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83050117|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83361714|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050118|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
83050119|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83050120|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83050121|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
83050122|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050123|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
83050124|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83050125|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83050126|NCT02317640|Testosterone|testosterone|mesh-list
83050127|NCT02317640|Androgens|androgens|mesh-ancestor
83050128|NCT02317640|Hormones|hormones|mesh-ancestor
83050129|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050130|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050131|NCT02716948|Nivolumab|nivolumab|mesh-list
83050132|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83050133|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050134|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83050135|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050136|NCT03500900|Vildagliptin|vildagliptin|mesh-list
83050137|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83050138|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050139|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83050140|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
83050141|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050142|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050143|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83050144|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
83050145|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050146|NCT02141100|Thioguanine|thioguanine|mesh-list
83050147|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83050148|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
83050149|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050150|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050151|NCT02141178|Bupivacaine|bupivacaine|mesh-list
83050152|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
83050153|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
83050154|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050155|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050156|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
83050157|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050158|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
83050159|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83050160|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050161|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050162|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83050163|NCT02141412|Analgesics|analgesics|mesh-ancestor
83050164|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
83050165|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050166|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83050167|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83050168|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83050169|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
83050170|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050171|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050172|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
83050173|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050174|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050175|NCT03210558|Testosterone|testosterone|mesh-list
83050176|NCT03210558|Androgens|androgens|mesh-ancestor
83050177|NCT03210558|Hormones|hormones|mesh-ancestor
83050178|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050179|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050180|NCT05046262|Calcium|calcium|mesh-list
83050181|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83050182|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050183|NCT05036824|Tinzaparin|tinzaparin|mesh-list
83050184|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83050185|NCT05036824|Dalteparin|dalteparin|mesh-list
83050186|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
83050187|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83050188|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83050189|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050190|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
83050191|NCT04462250|Narcotics|narcotics|mesh-ancestor
83050192|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050193|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050194|NCT04462250|Analgesics|analgesics|mesh-ancestor
83050195|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
83050196|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050197|NCT02144766|Ropivacaine|ropivacaine|mesh-list
83050198|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
83050199|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
83050200|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050201|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050202|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
83050203|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050204|NCT05045248|Apraclonidine|apraclonidine|mesh-list
83050205|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83050206|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83050207|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83050208|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
83050209|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050210|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050211|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050212|NCT02144922|Pitavastatin|pitavastatin|mesh-list
83050213|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83050214|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83050215|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83050216|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
83050217|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050218|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050219|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83050220|NCT02261064|Amlodipine|amlodipine|mesh-list
83050221|NCT02261064|Telmisartan|telmisartan|mesh-list
83050222|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83050223|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83050224|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83050225|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050226|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050227|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83050228|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050229|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
83050230|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83050231|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83050232|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83050233|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83050234|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050235|NCT05035498|Phenylephrine|phenylephrine|mesh-list
83050236|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
83050237|NCT05035498|Norepinephrine|norepinephrine|mesh-list
83050238|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83050239|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83050240|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
83050241|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
83050242|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050243|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050244|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
83050245|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
83050246|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
83050247|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83050248|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83050249|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83050250|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
83050251|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050252|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050253|NCT05035498|Protective Agents|protective agents|mesh-ancestor
83050254|NCT03498326|Celecoxib|celecoxib|mesh-list
83050255|NCT03498326|Gemcitabine|gemcitabine|mesh-list
83050256|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83050257|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
83050258|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050259|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050260|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83050261|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83050262|NCT03498326|Analgesics|analgesics|mesh-ancestor
83050263|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
83050264|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050265|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050266|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83050267|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83050268|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83050269|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83050270|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050271|NCT03498248|Lenograstim|lenograstim|mesh-list
83050272|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83050273|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
83050274|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050275|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
83050276|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
83050277|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83050278|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050279|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83050280|NCT03498170|Itraconazole|itraconazole|mesh-list
83050281|NCT03498170|Acumapimod|acumapimod|mesh-list
83050282|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
83050283|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050284|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83050285|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83050286|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050287|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050288|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83050289|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
83050290|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050291|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050292|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83050293|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83050294|NCT05055544|Fosfomycin|fosfomycin|mesh-list
83050295|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050296|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050297|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
83050298|NCT03498092|Bupivacaine|bupivacaine|mesh-list
83050299|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
83050300|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
83050301|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050302|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050303|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
83050304|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050305|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83050306|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83050307|NCT03498092|Analgesics|analgesics|mesh-ancestor
83050308|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83050309|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83050310|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83050311|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
83050312|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050313|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050314|NCT03500432|Lidocaine|lidocaine|mesh-list
83050315|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
83050316|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
83050317|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050318|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050319|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
83050320|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050321|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83050322|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83050323|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83050324|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050325|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050326|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
83050327|NCT01951885|Methotrexate|methotrexate|mesh-list
83361715|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83361716|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
83361717|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83361718|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83361719|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83361720|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361721|NCT03166644|Sufentanil|sufentanil|mesh-list
83361722|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83361723|NCT03166644|Narcotics|narcotics|mesh-ancestor
83361724|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361725|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361726|NCT03166644|Analgesics|analgesics|mesh-ancestor
83361727|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
83361728|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361729|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83361730|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83361731|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
83361732|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
83050328|NCT01951885|Tacrolimus|tacrolimus|mesh-list
83050329|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83050330|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
83050331|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83050332|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050333|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83050334|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
83050335|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050336|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050337|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83050338|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050339|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83050340|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83050341|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
83050342|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83050343|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83050344|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83050345|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83050346|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83050347|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
83050348|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050349|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050351|NCT02315690|Artenimol|artenimol|mesh-list
83050352|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
83050353|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83050354|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050355|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050356|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
83050357|NCT02639338|Velpatasvir|velpatasvir|mesh-list
83050358|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
83050359|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050360|NCT01754857|Rituximab|rituximab|mesh-list
83050361|NCT01754857|Lenalidomide|lenalidomide|mesh-list
83050362|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83050363|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83050364|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050365|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
83050366|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050367|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83050368|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83050369|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83050370|NCT01754857|Growth Substances|growth substances|mesh-ancestor
83050371|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
83050372|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83050373|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
83050374|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050375|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
83050376|NCT03497702|Docetaxel|docetaxel|mesh-list
83050377|NCT03497702|Doxorubicin|doxorubicin|mesh-list
83050378|NCT03497702|Letrozole|letrozole|mesh-list
83050379|NCT03497702|Leuprolide|leuprolide|mesh-list
83050380|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83050381|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
83050382|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050383|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361733|NCT01691885|Fluticasone|fluticasone|mesh-list
83050384|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83050385|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
83050386|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050387|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050388|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83050389|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
83050390|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
83050391|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
83050392|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83050393|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83050394|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83050395|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050396|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83050397|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83050398|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83050399|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
83050400|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050401|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83050402|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
83050403|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83050404|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83050405|NCT02900352|Zonisamide|zonisamide|mesh-list
83050406|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
83050407|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83050408|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050409|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050410|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83050411|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050412|NCT05034406|Lidocaine|lidocaine|mesh-list
83050413|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
83050414|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
83050415|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
83050416|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050417|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050418|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
83050419|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050420|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83050421|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83050422|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83050423|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050424|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050425|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
83050426|NCT02254668|Everolimus|everolimus|mesh-list
83050427|NCT02254668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83050428|NCT02254668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83050429|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050430|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050431|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83050432|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
83050433|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050434|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050435|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83050436|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83050437|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
83050438|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050439|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050440|NCT03095404|Lidocaine|lidocaine|mesh-list
83050441|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83050442|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
83050443|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
83050444|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050445|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050446|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
83050447|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050448|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83050449|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83050450|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83050451|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050452|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050453|NCT02145546|Amiodarone|amiodarone|mesh-list
83050454|NCT02145546|Sotalol|sotalol|mesh-list
83050455|NCT02145546|Propafenone|propafenone|mesh-list
83050456|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83050457|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
83050458|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83050459|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050460|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050461|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83050462|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83050463|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83050464|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050465|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83050466|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83050467|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83050468|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83050469|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83050470|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83050471|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050472|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050473|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
83050474|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
83050475|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050476|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83050477|NCT03039673|Interleukin-2|interleukin-2|mesh-list
83050478|NCT03039673|Riluzole|riluzole|mesh-list
83050479|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050480|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83050481|NCT03039673|Analgesics|analgesics|mesh-ancestor
83050482|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
83050483|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050484|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050485|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
83050486|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83050487|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83050488|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050489|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050490|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83050491|NCT03039673|Protective Agents|protective agents|mesh-ancestor
83050492|NCT02145624|Vaccines|vaccines|mesh-list
83050493|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
83050494|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050495|NCT02321384|Ritonavir|ritonavir|mesh-list
83050496|NCT02321384|Midazolam|midazolam|mesh-list
83050497|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83050498|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83050499|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050500|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050501|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83050502|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83050503|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83050504|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83050505|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
83050506|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
83050507|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
83050508|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
83050509|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050510|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050511|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83050512|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83050513|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
83050514|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050515|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83050516|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83050517|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
83050518|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050519|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83050520|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83050521|NCT03095326|Zinc|zinc|mesh-list
83050522|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
83050523|NCT03095326|Vaccines|vaccines|mesh-list
83050524|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
83050525|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050526|NCT03095326|Trace Elements|trace elements|mesh-ancestor
83050527|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
83050528|NCT03095326|Astringents|astringents|mesh-ancestor
83050529|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83050530|NCT02318810|Rocuronium|rocuronium|mesh-list
83050531|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83050532|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83361734|NCT01691885|Xhance|xhance|mesh-list
83050533|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83050534|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050535|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050536|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
83050538|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83050539|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83050540|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050541|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050542|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83050543|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83050544|NCT02141958|Fenretinide|fenretinide|mesh-list
83050545|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050546|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83050547|NCT02141958|Protective Agents|protective agents|mesh-ancestor
83050548|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050549|NCT02142036|Trastuzumab|trastuzumab|mesh-list
83050550|NCT02142036|Cetuximab|cetuximab|mesh-list
83050551|NCT02142036|Panitumumab|panitumumab|mesh-list
83050552|NCT02142036|Everolimus|everolimus|mesh-list
83050553|NCT02142036|Sunitinib|sunitinib|mesh-list
83050554|NCT02142036|Dasatinib|dasatinib|mesh-list
83050555|NCT02142036|Lapatinib|lapatinib|mesh-list
83050556|NCT02142036|Gefitinib|gefitinib|mesh-list
83050557|NCT02142036|Temsirolimus|temsirolimus|mesh-list
83050558|NCT02142036|Afatinib|afatinib|mesh-list
83050559|NCT02142036|Vemurafenib|vemurafenib|mesh-list
83050560|NCT02142036|Dabrafenib|dabrafenib|mesh-list
83050561|NCT02142036|Crizotinib|crizotinib|mesh-list
83050562|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83050563|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050564|NCT02142036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83050565|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83050566|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050567|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050568|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83050569|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
83050570|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050571|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83050572|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83050573|NCT02142036|Growth Substances|growth substances|mesh-ancestor
83050574|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
83050575|NCT05053594|Neostigmine|neostigmine|mesh-list
83050576|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83050577|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050578|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050579|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
83050580|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050581|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050582|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83050583|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
83050584|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050585|NCT02318888|Icodextrin|icodextrin|mesh-list
83050586|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
83050587|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83050588|NCT02142192|Natalizumab|natalizumab|mesh-list
83050589|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
83050590|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050591|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
83050592|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83050593|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050594|NCT02324582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83050595|NCT02324582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050596|NCT01255891|Androgens|androgens|mesh-list
83050597|NCT01255891|Hormones|hormones|mesh-ancestor
83050598|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050599|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050600|NCT02777190|Misoprostol|misoprostol|mesh-list
83050601|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83050602|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
83050603|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83050604|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050605|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83050606|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83050607|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
83050608|NCT03494426|Pregabalin|pregabalin|mesh-list
83050609|NCT03494426|Tramadol|tramadol|mesh-list
83050610|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
83050611|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
83050612|NCT03494426|Analgesics|analgesics|mesh-ancestor
83050613|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
83050614|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050615|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050616|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
83050617|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83050618|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050619|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050620|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83050621|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83050622|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83050623|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050624|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83050625|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83050626|NCT03494426|Narcotics|narcotics|mesh-ancestor
83050627|NCT02432209|Orlistat|orlistat|mesh-list
83050628|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050629|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050630|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83050631|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83050632|NCT00108732|Metronidazole|metronidazole|mesh-list
83050633|NCT00108732|Goserelin|goserelin|mesh-list
83050634|NCT00108732|Bicalutamide|bicalutamide|mesh-list
83050635|NCT00108732|Vaccines|vaccines|mesh-list
83050636|NCT00108732|Sargramostim|sargramostim|mesh-list
83050637|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
83050638|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050639|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050640|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83050641|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
83050642|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
83050643|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050644|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050645|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050646|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83050647|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050648|NCT02319200|Metformin|metformin|mesh-list
83050649|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83050650|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050651|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83050652|NCT02319278|Hematinics|hematinics|mesh-ancestor
83050653|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83050654|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83050655|NCT02324738|Piperaquine|piperaquine|mesh-list
83050656|NCT02324738|Artenimol|artenimol|mesh-list
83050657|NCT02324738|Mefloquine|mefloquine|mesh-list
83050658|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
83050659|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83050660|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050661|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050662|NCT02321852|Mannitol|mannitol|mesh-list
83050663|NCT02321852|Triflusal|triflusal|mesh-list
83050664|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83050665|NCT02321852|Diuretics|diuretics|mesh-ancestor
83050666|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
83050667|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050668|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83050669|NCT03499886|Ketamine|ketamine|mesh-list
83050670|NCT03499886|Analgesics|analgesics|mesh-ancestor
83050671|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
83050672|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050673|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050674|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83050675|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83050676|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
83050677|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
83050678|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050679|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83050680|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83050681|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050682|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050683|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
83050684|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83050685|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050686|NCT05084430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83084040|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
83050687|NCT05084430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050688|NCT02716038|Paclitaxel|paclitaxel|mesh-list
83050689|NCT02716038|Carboplatin|carboplatin|mesh-list
83050690|NCT02716038|Atezolizumab|atezolizumab|mesh-list
83050691|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83050692|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050693|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83050694|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83050695|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83050696|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050697|NCT02716038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83050698|NCT02716038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83050699|NCT02325050|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83050700|NCT02325050|Antiviral Agents|antiviral agents|mesh-ancestor
83050701|NCT02325050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050702|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83050703|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050704|NCT02322008|Adalimumab|adalimumab|mesh-list
83050705|NCT02322008|Infliximab|infliximab|mesh-list
83050706|NCT02322008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83050707|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83050708|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83050709|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
83050710|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83050711|NCT02647554|Urinastatin|urinastatin|mesh-list
83050712|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
83050713|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83050714|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
83050715|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050716|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050717|NCT03499730|Midazolam|midazolam|mesh-list
83050718|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83050719|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83050720|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050721|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050722|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83050723|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83050724|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83050725|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83050726|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
83050727|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
83050728|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
83050729|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
83050730|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050731|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050732|NCT02143050|Metformin|metformin|mesh-list
83050733|NCT02143050|Trametinib|trametinib|mesh-list
83050734|NCT02143050|Dabrafenib|dabrafenib|mesh-list
83050735|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83050736|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050737|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050738|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83050739|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050740|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050741|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
83050742|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83050743|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050744|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83050745|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050746|NCT02325362|Miglustat|miglustat|mesh-list
83050747|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
83050748|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050749|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050750|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83050751|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83050752|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
83050753|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050754|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83050755|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83050756|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050757|NCT04462094|Ketamine|ketamine|mesh-list
83050758|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
83050759|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050760|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050761|NCT04462094|Analgesics|analgesics|mesh-ancestor
83050762|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
83050763|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050764|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83050765|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83050766|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
83050767|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83050768|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83050769|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050770|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050771|NCT02325440|Natalizumab|natalizumab|mesh-list
83050772|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83050773|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
83050774|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050775|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83050776|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050777|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83050778|NCT03499184|Metronidazole|metronidazole|mesh-list
83050779|NCT03499184|Amoxicillin|amoxicillin|mesh-list
83050780|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050781|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050782|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83050783|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050784|NCT00107952|Vancomycin|vancomycin|mesh-list
83050785|NCT00107952|Telavancin|telavancin|mesh-list
83050786|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050787|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050788|NCT03499106|Itraconazole|itraconazole|mesh-list
83050789|NCT03499106|Praliciguat|praliciguat|mesh-list
83050790|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
83050791|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050792|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83050793|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83050794|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050795|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050796|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83050797|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
83050798|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050799|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050800|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83050801|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83050802|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
83050803|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83050804|NCT02146638|Fentanyl|fentanyl|mesh-list
83050805|NCT02146638|Morphine|morphine|mesh-list
83050806|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83050807|NCT02146638|Narcotics|narcotics|mesh-ancestor
83050808|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050809|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050810|NCT02146638|Analgesics|analgesics|mesh-ancestor
83050811|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
83050812|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050813|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83050814|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83050815|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
83050816|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
83050817|NCT02320448|Cisplatin|cisplatin|mesh-list
83050818|NCT02320448|Doxorubicin|doxorubicin|mesh-list
83050819|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
83050820|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050821|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83050822|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83050823|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83050824|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050825|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050826|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83050827|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
83050828|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050829|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83050830|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050831|NCT03493568|Dolutegravir|dolutegravir|mesh-list
83050832|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83050833|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83050834|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83050835|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050836|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050837|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83050838|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83050839|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
83050840|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050842|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83050843|NCT01366638|Simeprevir|simeprevir|mesh-list
83050844|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
83050845|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050846|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
83050847|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050848|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
83050849|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050850|NCT02147808|Midazolam|midazolam|mesh-list
83050851|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83050852|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83050853|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050854|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050855|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83050856|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83050857|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83050858|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83050859|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
83050860|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
83050861|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
83050862|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
83050863|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83050864|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050865|NCT03543072|Diphosphonates|diphosphonates|mesh-list
83050866|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83050867|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050868|NCT03493412|Verapamil|verapamil|mesh-list
83050869|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83050870|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83050871|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83050872|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050873|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83050874|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050875|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
83050876|NCT02147964|Ketoconazole|ketoconazole|mesh-list
83050877|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
83050878|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83050879|NCT02147964|Testosterone|testosterone|mesh-list
83050880|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
83050881|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
83050882|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83050883|NCT02147964|Dutasteride|dutasteride|mesh-list
83050884|NCT02147964|Acyline|acyline|mesh-list
83050885|NCT02147964|Androgens|androgens|mesh-ancestor
83050886|NCT02147964|Hormones|hormones|mesh-ancestor
83050887|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83050888|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050889|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83050890|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050891|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
83050892|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
83050893|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050894|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83050895|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83050896|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050897|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050898|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83050899|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
83050900|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83050901|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83050902|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83050903|NCT02780700|Capecitabine|capecitabine|mesh-list
83050904|NCT02780700|Nintedanib|nintedanib|mesh-list
83050905|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83050906|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
83050907|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050908|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050909|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83361735|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83050910|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050911|NCT02147262|Doxycycline|doxycycline|mesh-list
83050912|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050913|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050914|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
83050915|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83050916|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83050917|NCT02447276|Fasinumab|fasinumab|mesh-list
83050918|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83050919|NCT02447276|Analgesics|analgesics|mesh-ancestor
83050920|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
83050921|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050922|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050923|NCT05100134|Ceritinib|ceritinib|mesh-list
83050924|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050925|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83050926|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050927|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050928|NCT05079620|Amoxicillin|amoxicillin|mesh-list
83050929|NCT05079620|Vancomycin|vancomycin|mesh-list
83050930|NCT05079620|Levofloxacin|levofloxacin|mesh-list
83050931|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
83050932|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83050933|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
83050934|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
83050935|NCT05079620|Cefepime|cefepime|mesh-list
83050936|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050937|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050938|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83050939|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83050940|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83050941|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050942|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050943|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050944|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83050945|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83050946|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83050947|NCT02323412|Amoxicillin|amoxicillin|mesh-list
83050948|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050949|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050950|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
83050951|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
83050952|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050953|NCT03109730|Tenofovir|tenofovir|mesh-list
83050954|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83050955|NCT03109730|Entecavir|entecavir|mesh-list
83050956|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
83050957|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050958|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83050959|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83050960|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050961|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050962|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83050963|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83050964|NCT03495206|Edaravone|edaravone|mesh-list
83050965|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83050966|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
83050967|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050968|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83050969|NCT03495206|Protective Agents|protective agents|mesh-ancestor
83050970|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050971|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
83050972|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83050973|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83050974|NCT03491696|Metyrapone|metyrapone|mesh-list
83050975|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
83050976|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050977|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050978|NCT03492866|Gentamicins|gentamicins|mesh-list
83050979|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83050980|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83050981|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83050982|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83050983|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83050984|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
83050985|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83050986|NCT03492710|Antibodies|antibodies|mesh-list
83050987|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
83050988|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050989|NCT03954938|Cocaine|cocaine|mesh-list
83050990|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
83050991|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
83050992|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83050993|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83050994|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
83050995|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83050996|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83050997|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83050998|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83050999|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051000|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051001|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
83051002|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051003|NCT02148120|Beclomethasone|beclomethasone|mesh-list
83051004|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
83051005|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83051006|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
83051007|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051008|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051009|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83051010|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
83051011|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83051012|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83051013|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83051014|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
83051015|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051016|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051017|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83051018|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
83051019|NCT02148120|Hormones|hormones|mesh-ancestor
83051020|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051021|NCT03492632|Hormones|hormones|mesh-list
83051022|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051023|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051024|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
83051025|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83051026|NCT02147730|Anesthetics|anesthetics|mesh-list
83051027|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051028|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051029|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
83051030|NCT02151630|Salicylates|salicylates|mesh-list
83051031|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051032|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
83051033|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
83051034|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
83051035|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83051036|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83051037|NCT02151630|Analgesics|analgesics|mesh-ancestor
83051038|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
83051039|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051040|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051041|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83051042|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83051043|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83051044|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051045|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051046|NCT03494972|Tetracycline|tetracycline|mesh-list
83051047|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83051048|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051049|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83051050|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051051|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051052|NCT02224573|Cannabidiol|cannabidiol|mesh-list
83051053|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
83051054|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83051055|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83051056|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83051057|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051058|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051060|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051061|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83051062|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83051063|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
83051064|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83051065|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051066|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051067|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83051068|NCT02148432|Analgesics|analgesics|mesh-ancestor
83051069|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
83051070|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051071|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83051072|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83051073|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83051074|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
83051075|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051076|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051077|NCT03756961|Lidocaine|lidocaine|mesh-list
83051078|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
83051079|NCT03756961|Remifentanil|remifentanil|mesh-list
83051080|NCT03756961|Oxycodone|oxycodone|mesh-list
83051081|NCT03756961|Propofol|propofol|mesh-list
83051082|NCT03756961|Desflurane|desflurane|mesh-list
83051083|NCT03756961|Esketamine|esketamine|mesh-list
83051084|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
83051085|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
83051086|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051087|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051088|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
83051089|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051090|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83051091|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83051092|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83051093|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051094|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051095|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83051096|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83051098|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83051099|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83051100|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83051101|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83051102|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051103|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83051104|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
83051105|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83051106|NCT03756961|Narcotics|narcotics|mesh-ancestor
83051107|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83051108|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
83051109|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83051110|NCT03350984|Insulin|insulin|mesh-list
83051111|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83051112|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
83051113|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
83051114|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
83051115|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
83051116|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
83051117|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83051118|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051119|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
83051120|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83051121|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
83051122|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83051123|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051124|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051125|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051126|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
83051127|NCT03504423|Leucovorin|leucovorin|mesh-list
83051128|NCT03504423|Folic Acid|folic acid|mesh-list
83051129|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
83051130|NCT03504423|Irinotecan|irinotecan|mesh-list
83051131|NCT03504423|Folfirinox|folfirinox|mesh-list
83051132|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
83051133|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051134|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83051135|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051136|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051137|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051138|NCT03504423|Antidotes|antidotes|mesh-ancestor
83051139|NCT03504423|Protective Agents|protective agents|mesh-ancestor
83051140|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051141|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
83051142|NCT03504423|Vitamins|vitamins|mesh-ancestor
83051143|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
83051144|NCT03504423|Hematinics|hematinics|mesh-ancestor
83051145|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83051146|NCT03097198|Tropicamide|tropicamide|mesh-list
83051147|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83051148|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
83051149|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
83051150|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051151|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051152|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83051153|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83051154|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
83051155|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051156|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051157|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83051158|NCT02770248|Brinzolamide|brinzolamide|mesh-list
83051159|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83051160|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83051161|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83051162|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83051163|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
83051164|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051165|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051166|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051167|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83051168|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051169|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83051170|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83051171|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
83051172|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051173|NCT02686346|Etoposide|etoposide|mesh-list
83051174|NCT02686346|Ifosfamide|ifosfamide|mesh-list
83051175|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83051176|NCT02686346|Carboplatin|carboplatin|mesh-list
83051177|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83051178|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051179|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83051180|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051181|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051182|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051183|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83051184|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
83051185|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83051186|NCT02686346|Immunotoxins|immunotoxins|mesh-ancestor
83051187|NCT02686346|Immunoconjugates|immunoconjugates|mesh-ancestor
83051188|NCT02686346|Immunologic Factors|immunologic factors|mesh-ancestor
83051189|NCT02686346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051190|NCT03489044|Levetiracetam|levetiracetam|mesh-list
83051191|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
83051192|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
83051193|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83051194|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83051195|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83051196|NCT01344369|Norethindrone|norethindrone|mesh-list
83051197|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
83051198|NCT01344369|Estradiol|estradiol|mesh-list
83051199|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83051200|NCT01344369|Estrogens|estrogens|mesh-ancestor
83051201|NCT01344369|Hormones|hormones|mesh-ancestor
83051202|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051203|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051204|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83051205|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
83051206|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83051207|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83051208|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83051209|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83051210|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83051211|NCT03491072|Fentanyl|fentanyl|mesh-list
83051212|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83051214|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051215|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051216|NCT03491072|Analgesics|analgesics|mesh-ancestor
83051217|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
83051218|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051219|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83051220|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83051221|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
83051222|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
83051223|NCT03503409|Ivosidenib|ivosidenib|mesh-list
83051224|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051225|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051226|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051227|NCT03490994|Warfarin|warfarin|mesh-list
83051228|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
83051229|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
83051230|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83051231|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
83051232|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83051233|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051234|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051235|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051236|NCT01360762|Pentamidine|pentamidine|mesh-list
83051237|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
83051238|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051239|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83051240|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83051241|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83051242|NCT04382924|Ifenprodil|ifenprodil|mesh-list
83051243|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83051244|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83051245|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
83051246|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051247|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051248|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051249|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
83051250|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83051251|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83051252|NCT00002601|Doxorubicin|doxorubicin|mesh-list
83051253|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83051254|NCT00002601|Melphalan|melphalan|mesh-list
83051255|NCT00002601|Ifosfamide|ifosfamide|mesh-list
83051256|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051257|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83051258|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83051259|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051260|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051261|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051262|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
83051263|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051264|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83051265|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
83051266|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83051267|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83051268|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
83051269|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
83051270|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
83051271|NCT05693077|Vancomycin|vancomycin|mesh-list
83051272|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83051273|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051274|NCT02031861|Nifedipine|nifedipine|mesh-list
83051275|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83051276|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051277|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051278|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051279|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051280|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
83051281|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
83051282|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83051283|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
83051284|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83051285|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
83051286|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83051287|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051288|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361736|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83051289|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051290|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
83051291|NCT02645474|Ropivacaine|ropivacaine|mesh-list
83051292|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
83051293|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
83051294|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051295|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051296|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
83051297|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051298|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
83051299|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83051300|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
83051301|NCT05052814|Calcium|calcium|mesh-list
83051302|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051303|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051304|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83051305|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051306|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
83051307|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83051308|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
83051309|NCT03615417|Anesthetics|anesthetics|mesh-list
83051310|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051311|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051312|NCT02155530|Atorvastatin|atorvastatin|mesh-list
83051313|NCT02155530|Pravastatin|pravastatin|mesh-list
83051314|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83051315|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83051316|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
83051317|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051318|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83051319|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83051320|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051321|NCT05051956|Palbociclib|palbociclib|mesh-list
83051322|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051323|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83051324|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051325|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051326|NCT02769624|Treprostinil|treprostinil|mesh-list
83051327|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83051328|NCT03543774|Simvastatin|simvastatin|mesh-list
83051329|NCT03543774|Ezetimibe|ezetimibe|mesh-list
83051330|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83051331|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83051332|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83051333|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
83051334|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051335|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83051336|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83051337|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051338|NCT03261830|Clindamycin|clindamycin|mesh-list
83051339|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
83051340|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
83051341|NCT03261830|Cefazolin|cefazolin|mesh-list
83051342|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83051343|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051344|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83051345|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051346|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051347|NCT02152176|Morphine|morphine|mesh-list
83051348|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83051349|NCT02152176|Narcotics|narcotics|mesh-ancestor
83051350|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051351|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051352|NCT02152176|Analgesics|analgesics|mesh-ancestor
83051353|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
83051354|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051355|NCT03617055|Cystatins|cystatins|mesh-list
83051356|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83051357|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051358|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051359|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051360|NCT03488888|Bupivacaine|bupivacaine|mesh-list
83051361|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
83051362|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
83361737|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
83051363|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051364|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051365|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
83051366|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051367|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
83051368|NCT05031676|Anesthetics|anesthetics|mesh-list
83051369|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051370|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051371|NCT05031676|Narcotics|narcotics|mesh-ancestor
83051372|NCT05031676|Analgesics|analgesics|mesh-ancestor
83051373|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
83051374|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051376|NCT03488810|Androgens|androgens|mesh-list
83051377|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
83051378|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
83051379|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051380|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051381|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
83051382|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83051383|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051384|NCT03492242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83051385|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051386|NCT03572283|Bethanechol|bethanechol|mesh-list
83051387|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83051388|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
83051389|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051390|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051391|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83051392|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83051393|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
83051394|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051395|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051397|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83051398|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83051399|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
83051400|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051401|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83051402|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83051403|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051404|NCT01525316|Lactoferrin|lactoferrin|mesh-list
83051405|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051406|NCT01673386|Sunitinib|sunitinib|mesh-list
83051407|NCT01673386|Tivozanib|tivozanib|mesh-list
83051408|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051409|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83051410|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83051411|NCT01673386|Growth Substances|growth substances|mesh-ancestor
83051412|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051413|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
83051414|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83051415|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051416|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051417|NCT00103740|Vitamin D|vitamin d|mesh-list
83051418|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
83051419|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
83051420|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
83051421|NCT00103740|Calcium|calcium|mesh-list
83051422|NCT00103740|Vitamins|vitamins|mesh-ancestor
83051423|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
83051424|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051425|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051426|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83051427|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83051428|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051429|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051430|NCT03616509|Hormones|hormones|mesh-list
83051431|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051432|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051433|NCT02031939|Capecitabine|capecitabine|mesh-list
83051434|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
83051435|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83051436|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
83051437|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051439|NCT02869893|Secretin|secretin|mesh-list
83051440|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83051441|NCT02869893|Hormones|hormones|mesh-ancestor
83051442|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051443|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051444|NCT04907214|Empagliflozin|empagliflozin|mesh-list
83051445|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83051446|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051447|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83051448|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051449|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
83051450|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83051451|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83051452|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051453|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83051454|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051455|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051456|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051457|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051458|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83051459|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
83051460|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83051461|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051462|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83051463|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83051464|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83051465|NCT05118308|Liver Extracts|liver extracts|mesh-list
83051466|NCT05118308|Hematinics|hematinics|mesh-ancestor
83051467|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
83051468|NCT03617289|Analgesics|analgesics|mesh-ancestor
83051469|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
83051470|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051471|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051472|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
83051473|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051474|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83051475|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
83051476|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83051477|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051478|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051479|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051480|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
83051481|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83051482|NCT02152410|Morphine|morphine|mesh-list
83051483|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83051484|NCT02152410|Narcotics|narcotics|mesh-ancestor
83051485|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051486|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051487|NCT02152410|Analgesics|analgesics|mesh-ancestor
83051488|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
83051489|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051490|NCT05043688|Paclitaxel|paclitaxel|mesh-list
83051491|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83051492|NCT05043688|Carboplatin|carboplatin|mesh-list
83051493|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83051494|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051495|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
83051496|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
83051497|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
83051498|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051499|NCT03614715|Interferons|interferons|mesh-list
83051500|NCT03614715|Interferon-beta|interferon-beta|mesh-list
83051501|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
83051502|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051503|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
83051504|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051505|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
83051506|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051507|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83051508|NCT00363038|Vitamins|vitamins|mesh-list
83051509|NCT00363038|Vitamin K|vitamin k|mesh-list
83051510|NCT00363038|Vitamin A|vitamin a|mesh-list
83051512|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
83051513|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051514|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83051515|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83051516|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051517|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
83051518|NCT00363038|Coagulants|coagulants|mesh-ancestor
83051519|NCT00363038|Emollients|emollients|mesh-ancestor
83051520|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
83051521|NCT03489668|Metformin|metformin|mesh-list
83051522|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83051523|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051524|NCT02872311|Vaccines|vaccines|mesh-list
83051525|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
83051526|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051527|NCT03614403|Vitamin D|vitamin d|mesh-list
83051528|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
83051529|NCT03614403|Vitamins|vitamins|mesh-ancestor
83051530|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
83051531|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051532|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83051533|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051534|NCT03488186|Lansoprazole|lansoprazole|mesh-list
83051535|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
83051536|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83051537|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83051538|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83051539|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051540|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051541|NCT05103644|Atorvastatin|atorvastatin|mesh-list
83051542|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83051543|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83051544|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
83051545|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051546|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83051547|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83051548|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051550|NCT03887624|Escitalopram|escitalopram|mesh-list
83051551|NCT03887624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83051552|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83051553|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051554|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051555|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051556|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
83051557|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051558|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
83051559|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
83051560|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83051561|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051562|NCT03485846|Ritonavir|ritonavir|mesh-list
83051563|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83051564|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83051565|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051566|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051567|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051568|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83051569|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83051570|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
83051571|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051572|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83051573|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83051574|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
83051575|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83051576|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
83051577|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83051578|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
83051579|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051580|NCT03613857|Clopidogrel|clopidogrel|mesh-list
83051581|NCT03613857|Ticagrelor|ticagrelor|mesh-list
83051582|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83051583|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83051584|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83051585|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83051586|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
83051587|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051588|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051589|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051590|NCT03613389|Vitamin E|vitamin e|mesh-list
83051591|NCT03613389|Vitamins|vitamins|mesh-ancestor
83051592|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
83051593|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051594|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
83051595|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051596|NCT03613389|Protective Agents|protective agents|mesh-ancestor
83051597|NCT03614013|Immunomodulating Agents|immunomodulating agents|mesh-list
83051598|NCT03614013|Immunologic Factors|immunologic factors|mesh-ancestor
83051599|NCT03614013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051600|NCT02259777|Amlodipine|amlodipine|mesh-list
83051601|NCT02259777|Telmisartan|telmisartan|mesh-list
83051602|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83051603|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83051604|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83051605|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051606|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051607|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051608|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051609|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
83051610|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83051611|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83051612|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83051613|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
83051614|NCT03261375|Nifedipine|nifedipine|mesh-list
83051615|NCT03261375|Diuretics|diuretics|mesh-ancestor
83051616|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
83051617|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051618|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83051619|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051620|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051621|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83051622|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051623|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
83051624|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
83051625|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83051626|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83051627|NCT03613545|Rifaximin|rifaximin|mesh-list
83051628|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
83051629|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051630|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83051631|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83051632|NCT01361308|Paroxetine|paroxetine|mesh-list
83051633|NCT01361308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83051634|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83051635|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051636|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051637|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051638|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
83051639|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051640|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83051641|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
83051642|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83051643|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83051644|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83051645|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051646|NCT05043142|Antibodies|antibodies|mesh-list
83051647|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
83051648|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051649|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83051650|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051651|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
83051652|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83051653|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83051654|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83051655|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
83051656|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051657|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051658|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051660|NCT00103662|Lenograstim|lenograstim|mesh-list
83051661|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83051662|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
83051663|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051664|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83051665|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83051666|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
83051667|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051668|NCT03612219|Apatinib|apatinib|mesh-list
83051669|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051670|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83051671|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051672|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051673|NCT05030116|Domperidone|domperidone|mesh-list
83051674|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
83051675|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
83051676|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051677|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051678|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83051679|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83051680|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
83051681|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051682|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051683|NCT03015129|Durvalumab|durvalumab|mesh-list
83051684|NCT03015129|Tremelimumab|tremelimumab|mesh-list
83051685|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83051686|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051687|NCT02148978|Saxagliptin|saxagliptin|mesh-list
83051688|NCT02148978|Incretins|incretins|mesh-ancestor
83051689|NCT02148978|Hormones|hormones|mesh-ancestor
83051690|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051691|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051692|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83051693|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051694|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051695|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051696|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83051697|NCT05048914|Acetaminophen|acetaminophen|mesh-list
83051698|NCT05048914|Dipyrone|dipyrone|mesh-list
83051699|NCT05048914|Ibuprofen|ibuprofen|mesh-list
83051700|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83051701|NCT05048914|Analgesics|analgesics|mesh-ancestor
83051702|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
83051703|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051704|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051705|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
83051706|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83051707|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83051708|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83051709|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83051710|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051711|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051712|NCT03046017|Lidocaine|lidocaine|mesh-list
83051713|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
83051714|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
83051715|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051716|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051717|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
83051718|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051719|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83051720|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83051721|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83051722|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051723|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051724|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
83051725|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83051726|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83051727|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83051728|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83051729|NCT02149212|Aminaftone|aminaftone|mesh-list
83051730|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
83051731|NCT02149212|Coagulants|coagulants|mesh-ancestor
83051732|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
83051733|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
83051734|NCT03611985|Taxane|taxane|mesh-list
83051735|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051737|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
83051738|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051739|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83051740|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051741|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83051742|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051743|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82949502|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
83051744|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83051745|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
83051746|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051747|NCT00104676|Paclitaxel|paclitaxel|mesh-list
83051748|NCT00104676|Etoposide|etoposide|mesh-list
83051749|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
83051750|NCT00104676|Ifosfamide|ifosfamide|mesh-list
83051751|NCT00104676|Bleomycin|bleomycin|mesh-list
83051752|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83051753|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051754|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83051755|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83051756|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83051757|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051758|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83051759|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051760|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051761|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83051762|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
83051763|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83051764|NCT00354835|Dactinomycin|dactinomycin|mesh-list
83051765|NCT00354835|Cactinomycin|cactinomycin|mesh-list
83051766|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
83051767|NCT00354835|Irinotecan|irinotecan|mesh-list
83051768|NCT00354835|Vincristine|vincristine|mesh-list
83051769|NCT00354835|Camptothecin|camptothecin|mesh-list
83051770|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83051771|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
83051772|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051773|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83051774|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83051775|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
83051776|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051777|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051778|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83051779|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83051780|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051781|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051782|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83051783|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83051784|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83051785|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83051786|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83051787|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051788|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83051789|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83051790|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83051792|NCT02768298|Enalaprilat|enalaprilat|mesh-list
83051793|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83051794|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83051795|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051796|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051797|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051798|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83051799|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83051800|NCT05028322|Imiquimod|imiquimod|mesh-list
83051801|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83051802|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
83051803|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051804|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051805|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
83051806|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
83051807|NCT03096340|Irinotecan|irinotecan|mesh-list
83051808|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83051809|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051810|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83051811|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051812|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051813|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051814|NCT02152800|Valacyclovir|valacyclovir|mesh-list
83051815|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
83051816|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051817|NCT02149758|Etoricoxib|etoricoxib|mesh-list
83051818|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83051819|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83051820|NCT02149758|Analgesics|analgesics|mesh-ancestor
83051821|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
83051822|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051823|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051824|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83051825|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83051826|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83051827|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83051828|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051829|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051830|NCT03542214|Calcium|calcium|mesh-list
83051831|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051832|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051833|NCT03094468|Terbinafine|terbinafine|mesh-list
83051834|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
83051835|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051836|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051837|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051838|NCT03744546|Tilavonemab|tilavonemab|mesh-list
83051839|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
83051840|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
83051841|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
83051842|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83051843|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83051844|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051845|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051846|NCT03095872|Petrolatum|petrolatum|mesh-list
83051847|NCT03095872|Emollients|emollients|mesh-ancestor
83051848|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
83051849|NCT03096184|Apatinib|apatinib|mesh-list
83051850|NCT03096184|Tegafur|tegafur|mesh-list
83051851|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051852|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83051853|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051854|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051855|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83051856|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
83051857|NCT02157012|Tofacitinib|tofacitinib|mesh-list
83051858|NCT02157012|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83051859|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83051860|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051861|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051862|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
83051863|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
83051864|NCT03096028|Vitamins|vitamins|mesh-ancestor
83051865|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
83051866|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051867|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
83051868|NCT03096028|Hematinics|hematinics|mesh-ancestor
83051869|NCT02149914|Rabeprazole|rabeprazole|mesh-list
83051870|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83051871|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83051872|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83051873|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051874|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051875|NCT02149992|Inositol|inositol|mesh-list
83051876|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
83051877|NCT02149992|Vitamins|vitamins|mesh-ancestor
83051878|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
83051879|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051880|NCT04833582|Gemcitabine|gemcitabine|mesh-list
83051881|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83051882|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
83051883|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051884|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361738|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051885|NCT05041582|Citalopram|citalopram|mesh-list
83051886|NCT05041582|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83051887|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83051888|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051889|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051890|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051891|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
83051892|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051893|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83051894|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
83051895|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83051896|NCT02150070|ASP2408|asp2408|mesh-list
83051897|NCT02150070|Immunoconjugates|immunoconjugates|mesh-ancestor
83051898|NCT02150070|Immunologic Factors|immunologic factors|mesh-ancestor
83051899|NCT02150070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051900|NCT05041036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83051901|NCT05041036|Nirogacestat|nirogacestat|mesh-list
83051902|NCT05041036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051903|NCT05041036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051904|NCT02153424|Apixaban|apixaban|mesh-list
83051905|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83051906|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
83051907|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83051908|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
83051909|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051910|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051911|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
83051912|NCT05027386|Irinotecan|irinotecan|mesh-list
83051913|NCT05027386|Temozolomide|temozolomide|mesh-list
83051914|NCT05027386|Apatinib|apatinib|mesh-list
83051915|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83051916|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83051917|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051918|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051919|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051920|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83051921|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
83051922|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83051923|NCT04434430|Gabapentin|gabapentin|mesh-list
83051924|NCT04434430|Analgesics|analgesics|mesh-ancestor
83051925|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
83051926|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83051927|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051928|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
83051929|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83051930|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83051931|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83051932|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83051933|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83051934|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83051935|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051936|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051937|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
83051938|NCT03094156|Resveratrol|resveratrol|mesh-list
83051939|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83051940|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
83051941|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051942|NCT03094156|Protective Agents|protective agents|mesh-ancestor
83051943|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051944|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83051945|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83051946|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
83051947|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051948|NCT02964273|Tolvaptan|tolvaptan|mesh-list
83051949|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83051950|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051951|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
83051952|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051953|NCT05040724|Ivermectin|ivermectin|mesh-list
83051954|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83051955|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83051956|NCT03542058|Carvedilol|carvedilol|mesh-list
83051957|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83051958|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83051959|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
83051960|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83051961|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051962|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051963|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83051964|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
83051965|NCT03542058|Protective Agents|protective agents|mesh-ancestor
83051966|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83051967|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83051968|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83051969|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
83051970|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83051971|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83051972|NCT03321513|Bevacizumab|bevacizumab|mesh-list
83051973|NCT03321513|Aflibercept|aflibercept|mesh-list
83051974|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83051975|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051976|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83051977|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83051978|NCT03321513|Growth Substances|growth substances|mesh-ancestor
83051979|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051980|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
83051981|NCT02032797|Progesterone|progesterone|mesh-list
83051982|NCT02032797|Progestins|progestins|mesh-ancestor
83051984|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83051985|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83051986|NCT05024266|Paclitaxel|paclitaxel|mesh-list
83051987|NCT05024266|Carboplatin|carboplatin|mesh-list
83051988|NCT05024266|Tislelizumab|tislelizumab|mesh-list
83051989|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83051990|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83051991|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
83051992|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
83051993|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
83051994|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83051995|NCT05024266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83051997|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83051998|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
83051999|NCT02773368|Liraglutide|liraglutide|mesh-list
83052000|NCT02773368|Xultophy|xultophy|mesh-list
83052001|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052002|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052003|NCT02773368|Incretins|incretins|mesh-ancestor
83052004|NCT02773368|Hormones|hormones|mesh-ancestor
83052005|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052006|NCT02893917|Olaparib|olaparib|mesh-list
83052007|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83052008|NCT02893917|Cediranib|cediranib|mesh-list
83052009|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052010|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052011|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052012|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83052013|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
83052014|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83052015|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052016|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
83052017|NCT02157558|Fexofenadine|fexofenadine|mesh-list
83052018|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83052019|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83052020|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83052021|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
83052022|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
83052023|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052024|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052025|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052026|NCT05018182|Leucovorin|leucovorin|mesh-list
83052027|NCT05018182|Folic Acid|folic acid|mesh-list
83052028|NCT05018182|Fluorouracil|fluorouracil|mesh-list
83052029|NCT05018182|Capecitabine|capecitabine|mesh-list
83052030|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
83052031|NCT05018182|Irinotecan|irinotecan|mesh-list
83052032|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
83052033|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
83052034|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052035|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83052036|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052037|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052038|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
83052039|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052040|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83052041|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83052042|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052043|NCT05018182|Antidotes|antidotes|mesh-ancestor
83052044|NCT05018182|Protective Agents|protective agents|mesh-ancestor
83052045|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
83052046|NCT05018182|Vitamins|vitamins|mesh-ancestor
83052047|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
83052048|NCT05018182|Hematinics|hematinics|mesh-ancestor
83052049|NCT01336569|Timolol|timolol|mesh-list
83052050|NCT01336569|Travoprost|travoprost|mesh-list
83052051|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052052|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83052053|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83052054|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
83052055|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052056|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052057|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83052058|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83052059|NCT03092986|Paclitaxel|paclitaxel|mesh-list
83052060|NCT03092986|Vinblastine|vinblastine|mesh-list
83052061|NCT03092986|Carboplatin|carboplatin|mesh-list
83052062|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052063|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052064|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052065|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052066|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052067|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052068|NCT03092908|Acetic Acid|acetic acid|mesh-list
83052069|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052070|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052071|NCT03543306|Trametinib|trametinib|mesh-list
83052072|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052073|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83052074|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052075|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052076|NCT02157792|Carboplatin|carboplatin|mesh-list
83052077|NCT02157792|Gemcitabine|gemcitabine|mesh-list
83052079|NCT02157792|Etoposide|etoposide|mesh-list
83052080|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052081|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83052082|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
83052083|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052084|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83052085|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83052086|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052087|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052088|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83052089|NCT05023408|Bleomycin|bleomycin|mesh-list
83052090|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83052091|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052092|NCT02772978|Tolcapone|tolcapone|mesh-list
83052093|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83052094|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83052095|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83052096|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052097|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052098|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
83052099|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83052100|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052101|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052102|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83052103|NCT05164549|Buprenorphine|buprenorphine|mesh-list
83052104|NCT05164549|Methadone|methadone|mesh-list
83052105|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83052106|NCT05164549|Narcotics|narcotics|mesh-ancestor
83052107|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052108|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052109|NCT05164549|Analgesics|analgesics|mesh-ancestor
83052110|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
83052111|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052112|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83052113|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
83052114|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
83052115|NCT00104052|Ribavirin|ribavirin|mesh-list
83052116|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83052117|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
83052118|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
83052119|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052120|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
83052121|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052122|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
83052123|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052124|NCT05038072|Triamcinolone|triamcinolone|mesh-list
83052125|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83052126|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83052127|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83052128|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052129|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
83052130|NCT05038072|Hormones|hormones|mesh-ancestor
83052131|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052132|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052133|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052134|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
83052135|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052136|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052137|NCT02777970|Acetaminophen|acetaminophen|mesh-list
83052138|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83052139|NCT02777970|Tramadol|tramadol|mesh-list
83052140|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052141|NCT02777970|Analgesics|analgesics|mesh-ancestor
83052142|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
83052143|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052144|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052145|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
83052146|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83052147|NCT02777970|Narcotics|narcotics|mesh-ancestor
83052148|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052149|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83052150|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052151|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052152|NCT02150616|Sevoflurane|sevoflurane|mesh-list
83052153|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83052154|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83052155|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
83052156|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
83052157|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052158|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052159|NCT01336023|Insulin|insulin|mesh-list
83052160|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83052161|NCT01336023|Liraglutide|liraglutide|mesh-list
83052162|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
83052163|NCT01336023|Xultophy|xultophy|mesh-list
83052164|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052165|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052166|NCT01336023|Incretins|incretins|mesh-ancestor
83052167|NCT01336023|Hormones|hormones|mesh-ancestor
83052168|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052169|NCT02255292|Cannabidiol|cannabidiol|mesh-list
83052170|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
83052171|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83052172|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83052173|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
83052174|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052175|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83052176|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83052177|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052178|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052179|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83052180|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83052181|NCT02254980|Vitamin E|vitamin e|mesh-list
83052182|NCT02254980|Vitamins|vitamins|mesh-ancestor
83052183|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
83052184|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052185|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
83052186|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052187|NCT02254980|Protective Agents|protective agents|mesh-ancestor
83052188|NCT05281003|Paclitaxel|paclitaxel|mesh-list
83052189|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
83052190|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052191|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052192|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052193|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052194|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052195|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052196|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83052197|NCT05281003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83052198|NCT02158182|Rifaximin|rifaximin|mesh-list
83052199|NCT02158182|Lactulose|lactulose|mesh-list
83052200|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
83052201|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052202|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052203|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83052204|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83052205|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83052206|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052207|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052208|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052209|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
83052210|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83052211|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052212|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
83052213|NCT02154360|Aprepitant|aprepitant|mesh-list
83052214|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
83052215|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
83052216|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052217|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052218|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83052219|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83052220|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052221|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052222|NCT02033031|Bevacizumab|bevacizumab|mesh-list
83052223|NCT02033031|Ranibizumab|ranibizumab|mesh-list
83052224|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83052225|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052226|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83052227|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83052228|NCT02033031|Growth Substances|growth substances|mesh-ancestor
83052229|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052230|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
83052231|NCT05034367|Mannitol|mannitol|mesh-list
83052232|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83052233|NCT05034367|Diuretics|diuretics|mesh-ancestor
83052234|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
83052235|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052236|NCT02150928|Asparaginase|asparaginase|mesh-list
83052237|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052238|NCT03611049|Vitamin D|vitamin d|mesh-list
83052239|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
83052240|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
83052241|NCT03611049|Vitamins|vitamins|mesh-list
83052242|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
83052243|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052244|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83052245|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83052246|NCT04822350|Avelumab|avelumab|mesh-list
83052247|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83052248|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052249|NCT03610893|Dexamethasone|dexamethasone|mesh-list
83052250|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
83052251|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052252|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
83052253|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
83052254|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052255|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052256|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83052257|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
83052258|NCT03610893|Hormones|hormones|mesh-ancestor
83052259|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052260|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83052261|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052262|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83052263|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052264|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052266|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
83052267|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83052268|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83052269|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83052270|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
83052271|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052272|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052273|NCT04737109|Ipatasertib|ipatasertib|mesh-list
83052274|NCT04737109|Androgens|androgens|mesh-list
83052275|NCT04737109|Hormones|hormones|mesh-ancestor
83052276|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052277|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052278|NCT04737109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052279|NCT04737109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83052280|NCT04737109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052281|NCT04737109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052282|NCT02154438|Ketamine|ketamine|mesh-list
83052283|NCT02154438|Analgesics|analgesics|mesh-ancestor
83052284|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
83052285|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052286|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052287|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83052288|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83052289|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
83052290|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
83052291|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052292|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83052293|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83052294|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052295|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052296|NCT02520921|Aspirin|aspirin|mesh-list
83052297|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83052298|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052300|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
83052301|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052302|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052303|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052304|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052305|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83052306|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83052307|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052308|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83052309|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83052310|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052311|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
83052312|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
83052313|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83052314|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83052315|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052316|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
83052317|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
83052318|NCT03610347|Paclitaxel|paclitaxel|mesh-list
83052319|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052320|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052321|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052322|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052323|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052324|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052325|NCT01518517|Asparaginase|asparaginase|mesh-list
83052326|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052327|NCT02863575|Ibuprofen|ibuprofen|mesh-list
83052328|NCT02863575|Caffeine|caffeine|mesh-list
83052329|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83052330|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052331|NCT02863575|Analgesics|analgesics|mesh-ancestor
83052332|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
83052333|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052334|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052335|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052336|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052337|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83052338|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361739|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052339|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052340|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83052341|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83052342|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83052343|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83052344|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
83052345|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052346|NCT05021770|Thiotepa|thiotepa|mesh-list
83052347|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83052348|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
83052349|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052350|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052351|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83052352|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052353|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
83052354|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052355|NCT04722523|Carboplatin|carboplatin|mesh-list
83052356|NCT04722523|Docetaxel|docetaxel|mesh-list
83052357|NCT04722523|Cetuximab|cetuximab|mesh-list
83052358|NCT04722523|Cemiplimab|cemiplimab|mesh-list
83052359|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052360|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052361|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052362|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052363|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052364|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83052365|NCT05230303|Caffeine|caffeine|mesh-list
83052366|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83052367|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052368|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83052369|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052370|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052371|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83052372|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83052373|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
83052374|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052375|NCT04287790|Naltrexone|naltrexone|mesh-list
83052376|NCT04287790|Disulfiram|disulfiram|mesh-list
83052377|NCT04287790|Acamprosate|acamprosate|mesh-list
83052378|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83052379|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83052380|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052381|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
83052382|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052383|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83052384|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052385|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052386|NCT03723967|Paclitaxel|paclitaxel|mesh-list
83052387|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83052388|NCT03723967|Carboplatin|carboplatin|mesh-list
83052389|NCT03723967|Durvalumab|durvalumab|mesh-list
83052390|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83052391|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052392|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052393|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052394|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052395|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052396|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052397|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83052398|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
83052399|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052400|NCT05008666|Azacitidine|azacitidine|mesh-list
83052401|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83052402|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
83052403|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052404|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052405|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052406|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83052407|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052408|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052409|NCT03659461|Incretins|incretins|mesh-ancestor
83052410|NCT03659461|Hormones|hormones|mesh-ancestor
83052411|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052412|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83052413|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
83052414|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052415|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052416|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
83052417|NCT01227187|Protein C|protein c|mesh-list
83052418|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052419|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
83052420|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83052421|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83052422|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052423|NCT03088072|Aspirin|aspirin|mesh-list
83052424|NCT03088072|Warfarin|warfarin|mesh-list
83052425|NCT03088072|Edoxaban|edoxaban|mesh-list
83052426|NCT03088072|Clopidogrel|clopidogrel|mesh-list
83052427|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83052428|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052429|NCT03088072|Analgesics|analgesics|mesh-ancestor
83052430|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
83052431|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052432|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052433|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052434|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052435|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83052436|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83052437|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052438|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83052439|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83052440|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052441|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
83052442|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83052443|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83052444|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83052445|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
83052446|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052447|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
83052448|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83052449|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
83052450|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83052451|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
83052452|NCT01077817|Alendronate|alendronate|mesh-list
83052453|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
83052454|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
83052455|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83052456|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
83052457|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83052458|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052459|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83052460|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83052461|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052462|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83052463|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83052464|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
83052465|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052466|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83052467|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83052468|NCT02638012|Hemostatics|hemostatics|mesh-list
83052469|NCT02638012|Coagulants|coagulants|mesh-ancestor
83052470|NCT05014906|Minocycline|minocycline|mesh-list
83052471|NCT05014906|Azelaic acid|azelaic acid|mesh-list
83052472|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052473|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052474|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052475|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
83052476|NCT00103506|Doxorubicin|doxorubicin|mesh-list
83052477|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83052478|NCT00103506|Bortezomib|bortezomib|mesh-list
83052479|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83052480|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052481|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83052482|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83052483|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052484|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052485|NCT02151240|Acyclovir|acyclovir|mesh-list
83052486|NCT02151240|Foscarnet|foscarnet|mesh-list
83052487|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
83052489|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052490|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83052491|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83052492|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052493|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052494|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
83052495|NCT02159196|Albuterol|albuterol|mesh-list
83052496|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83052497|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
83052498|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052499|NCT02159196|Expectorants|expectorants|mesh-ancestor
83052500|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
83052501|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83052502|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
83052503|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052504|NCT02159196|Protective Agents|protective agents|mesh-ancestor
83052505|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052506|NCT02159196|Antidotes|antidotes|mesh-ancestor
83052507|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83052508|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
83052509|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052510|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83052511|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
83052512|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83052513|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83052514|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83052515|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83052516|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
83052517|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052518|NCT02765490|Simeprevir|simeprevir|mesh-list
83052519|NCT02765490|Odalasvir|odalasvir|mesh-list
83052520|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
83052521|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052522|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
83052523|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052524|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052525|NCT02762370|Triamcinolone|triamcinolone|mesh-list
83052526|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83052527|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83052528|NCT02762370|FX006|fx006|mesh-list
83052529|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83052530|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052531|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
83052532|NCT02762370|Hormones|hormones|mesh-ancestor
83052533|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052534|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052535|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052536|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
83052537|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052538|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052539|NCT02639182|Axitinib|axitinib|mesh-list
83052540|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052541|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83052542|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052543|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052544|NCT02863419|Liraglutide|liraglutide|mesh-list
83052545|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052546|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052547|NCT02863419|Incretins|incretins|mesh-ancestor
83052548|NCT02863419|Hormones|hormones|mesh-ancestor
83052549|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052550|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83052551|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83052552|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83052553|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052554|NCT04961632|Tamoxifen|tamoxifen|mesh-list
83052555|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83052556|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
83052557|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052558|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052559|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83052560|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052561|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83052562|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83052563|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83052564|NCT02155374|Insulin|insulin|mesh-list
83052565|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83052566|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
83052567|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
83052568|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052569|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052570|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
83052571|NCT02765100|Minocycline|minocycline|mesh-list
83052572|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052573|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052574|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
83052575|NCT03091894|Propofol|propofol|mesh-list
83052576|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83052577|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052578|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052579|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052580|NCT03091894|Analgesics|analgesics|mesh-ancestor
83052581|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
83052582|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052583|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83052584|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83052585|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83052586|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
83052587|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052588|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052589|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83052590|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
83052591|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
83052592|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
83052593|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83482280|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83052594|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052595|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052596|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052597|NCT02761980|Acetaminophen|acetaminophen|mesh-list
83052598|NCT02761980|Ibuprofen|ibuprofen|mesh-list
83052599|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052600|NCT02761980|Analgesics|analgesics|mesh-ancestor
83052601|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
83052602|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052603|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052604|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
83052605|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83052606|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052607|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052608|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83052609|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052610|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052611|NCT05007340|Dimercaprol|dimercaprol|mesh-list
83052612|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
83052613|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
83052614|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052615|NCT05014048|Vitamin D|vitamin d|mesh-list
83052616|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
83052617|NCT05014048|Vitamins|vitamins|mesh-ancestor
83052618|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
83052619|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052620|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83052621|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83052622|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
83052623|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83052624|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052625|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052626|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83052627|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83052628|NCT02163174|Protective Agents|protective agents|mesh-ancestor
83052629|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052630|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
83052631|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83052632|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
83052633|NCT01744912|Lenalidomide|lenalidomide|mesh-list
83052634|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
83052635|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052636|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83052637|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83052638|NCT01744912|Growth Substances|growth substances|mesh-ancestor
83052639|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
83052640|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052641|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
83052642|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
83052643|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83052644|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83052645|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052646|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052647|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052648|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052649|NCT02159820|Paclitaxel|paclitaxel|mesh-list
83052650|NCT02159820|Carboplatin|carboplatin|mesh-list
83052651|NCT02159820|Decitabine|decitabine|mesh-list
83052652|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052653|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052654|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052655|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052656|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052657|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052658|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83052659|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
83052660|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052661|NCT02862171|Dapivirine|dapivirine|mesh-list
83052662|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83052663|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83052664|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
83052665|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052666|NCT05013112|Metformin|metformin|mesh-list
83052667|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83052668|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052669|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052670|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052671|NCT05013034|Basiliximab|basiliximab|mesh-list
83052672|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052673|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
83052674|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052675|NCT02638948|Methotrexate|methotrexate|mesh-list
83052676|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83052677|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
83052678|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83052679|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052680|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83052681|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
83052682|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052683|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052684|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
83052685|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052686|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83052687|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052688|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
83052689|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052690|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83052691|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
83052692|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052693|NCT04465864|Dexamethasone|dexamethasone|mesh-list
83052694|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052695|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
83052696|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
83052697|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052698|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052699|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83052700|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
83052701|NCT04465864|Hormones|hormones|mesh-ancestor
83052702|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052703|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83052704|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052705|NCT03091504|Albuterol|albuterol|mesh-list
83052706|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83052707|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
83052708|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052709|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052710|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83052711|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83052712|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
83052713|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83052714|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83052715|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83052716|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83052717|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
83052718|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052719|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052720|NCT05019586|Amoxicillin|amoxicillin|mesh-list
83052721|NCT05019586|Clarithromycin|clarithromycin|mesh-list
83052722|NCT05019586|Levofloxacin|levofloxacin|mesh-list
83052723|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052724|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052725|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83052726|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052727|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052728|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83052729|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83052730|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83052731|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83052732|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83052733|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052734|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83052735|NCT03081676|Glimepiride|glimepiride|mesh-list
83052736|NCT03081676|Glucagon|glucagon|mesh-list
83052737|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83052738|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83052739|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83052740|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83052741|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052742|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052743|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
83052744|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83052745|NCT03081676|Hormones|hormones|mesh-ancestor
83052746|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052747|NCT03081676|Incretins|incretins|mesh-ancestor
83052748|NCT05013268|Paclitaxel|paclitaxel|mesh-list
83052749|NCT05013268|Docetaxel|docetaxel|mesh-list
83052750|NCT05013268|Carboplatin|carboplatin|mesh-list
83052751|NCT05013268|Tislelizumab|tislelizumab|mesh-list
83052752|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052753|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052754|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052755|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052756|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052757|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052758|NCT05013268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83052759|NCT00102960|Ritonavir|ritonavir|mesh-list
83052760|NCT00102960|Lopinavir|lopinavir|mesh-list
83052761|NCT00102960|Lamivudine|lamivudine|mesh-list
83052762|NCT00102960|Zidovudine|zidovudine|mesh-list
83052763|NCT00102960|Nevirapine|nevirapine|mesh-list
83052764|NCT00102960|Abacavir|abacavir|mesh-list
83052765|NCT00102960|Didanosine|didanosine|mesh-list
83052766|NCT00102960|Efavirenz|efavirenz|mesh-list
83052767|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83052768|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83052769|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
83052770|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052771|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052772|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83052773|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83052774|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
83052775|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052776|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83052777|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83052778|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83052779|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83052780|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
83052781|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83052782|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83052783|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83052784|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83052785|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83052786|NCT02858895|Interleukin-4|interleukin-4|mesh-list
83052787|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83052788|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
83052789|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052790|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052791|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83052792|NCT05018962|Paclitaxel|paclitaxel|mesh-list
83052793|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83052794|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052795|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
83052796|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
83052797|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
83052798|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052799|NCT02160054|Tacrolimus|tacrolimus|mesh-list
83052800|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052801|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
83052802|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052803|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83052804|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052805|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052806|NCT03609489|Capecitabine|capecitabine|mesh-list
83052807|NCT03609489|Apatinib|apatinib|mesh-list
83052808|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83052809|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
83052810|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052811|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052812|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83052813|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052814|NCT02033967|Milrinone|milrinone|mesh-list
83052815|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
83052816|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83052817|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83052818|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83482281|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
83052819|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83052820|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052821|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052822|NCT02033967|Protective Agents|protective agents|mesh-ancestor
83052823|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052824|NCT02163330|Acetazolamide|acetazolamide|mesh-list
83052825|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
83052826|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83052827|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052828|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052829|NCT02163330|Diuretics|diuretics|mesh-ancestor
83052830|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
83052831|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052832|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
83052833|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
83052834|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
83052835|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052836|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
83052837|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83052838|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83052839|NCT02160132|Prednisolone|prednisolone|mesh-list
83052840|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
83052841|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83052842|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
83052843|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83052844|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
83052845|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
83052846|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052847|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052848|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83052849|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
83052850|NCT02160132|Hormones|hormones|mesh-ancestor
83052851|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83052852|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83052853|NCT02160132|Protective Agents|protective agents|mesh-ancestor
83052854|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83052855|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052856|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83052857|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83052858|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052859|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83052860|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83052861|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83438888|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83052862|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052863|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
83052864|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052865|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
83052866|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
83052867|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052868|NCT02858037|Dapivirine|dapivirine|mesh-list
83052869|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83052870|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83052871|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
83052872|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052873|NCT01755975|Lenalidomide|lenalidomide|mesh-list
83052874|NCT01755975|Romidepsin|romidepsin|mesh-list
83052875|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
83052876|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052877|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83052878|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83052879|NCT01755975|Growth Substances|growth substances|mesh-ancestor
83052880|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
83052881|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052882|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83052883|NCT01755975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83052884|NCT01755975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052885|NCT01755975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052886|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
83052887|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052888|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83052889|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052890|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052891|NCT04266340|Midazolam|midazolam|mesh-list
83052892|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
83052893|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83052894|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052895|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052896|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83052897|NCT04266340|Analgesics|analgesics|mesh-ancestor
83052898|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
83052899|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052900|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83052901|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83052902|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83052903|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
83052904|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052905|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052906|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83052907|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83052908|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83052909|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83052910|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83052911|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
83052912|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
83052913|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
83052914|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
83052915|NCT02856555|Firsocostat|firsocostat|mesh-list
83052916|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052917|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052918|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
83052919|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052920|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052921|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83052922|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83052923|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83052924|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052925|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052926|NCT05000086|Diphosphonates|diphosphonates|mesh-list
83052927|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
83052928|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83052929|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052930|NCT05010538|Sarecycline|sarecycline|mesh-list
83052931|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052932|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052933|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
83052934|NCT01242267|Thalidomide|thalidomide|mesh-list
83052935|NCT01242267|Bortezomib|bortezomib|mesh-list
83052936|NCT01242267|Melphalan|melphalan|mesh-list
83052937|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83052938|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83052939|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
83052940|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052941|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83052942|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83052944|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052945|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
83052946|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052947|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052948|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83052949|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83052950|NCT01242267|Growth Substances|growth substances|mesh-ancestor
83052951|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
83052952|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83052953|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83052954|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83052955|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83052956|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83052957|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
83052958|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052959|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052960|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052961|NCT02635984|Olanzapine|olanzapine|mesh-list
83052962|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
83052963|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
83052964|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052965|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052966|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83052967|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83052968|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83052969|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052970|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83052971|NCT02635984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83052972|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83052973|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83052974|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83052975|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83052976|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
83052977|NCT03073408|Propofol|propofol|mesh-list
83052978|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83052979|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83052980|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052981|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83052982|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
83052983|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
83052984|NCT04993222|Amphotericin B|amphotericin b|mesh-list
83052985|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83052986|NCT04993222|Amebicides|amebicides|mesh-ancestor
83052987|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83052988|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83052989|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83052990|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83052991|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
83052992|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83052993|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83052994|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83052995|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83052996|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83052997|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83052998|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83052999|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053000|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
83053001|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053002|NCT02747043|Rituximab|rituximab|mesh-list
83053003|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83053004|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053005|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
83053006|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053007|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83053008|NCT05004142|Letrozole|letrozole|mesh-list
83053009|NCT05004142|Fulvestrant|fulvestrant|mesh-list
83053010|NCT05004142|Goserelin|goserelin|mesh-list
83053011|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053012|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83053013|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83053014|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053015|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053016|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83053017|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053018|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053019|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053020|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83053021|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83053022|NCT03076684|Allopurinol|allopurinol|mesh-list
83053023|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
83053024|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053025|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053026|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
83053027|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83053028|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83053029|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
83053030|NCT03076684|Protective Agents|protective agents|mesh-ancestor
83053031|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053032|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
83053033|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83053034|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
83053035|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053036|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053037|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83053038|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
83053039|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
83053040|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83053041|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
83053042|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053043|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053044|NCT03607851|Lacosamide|lacosamide|mesh-list
83053045|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
83053046|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83053047|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83053048|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83053049|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053050|NCT04999540|Fulvestrant|fulvestrant|mesh-list
83053051|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83053052|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053053|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83053054|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83053055|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053056|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053057|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053058|NCT03608007|Ensartinib|ensartinib|mesh-list
83053059|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053060|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83053061|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053062|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053063|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
83053064|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83053065|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83053066|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
83053067|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
83053068|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053069|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053070|NCT03075358|Lidocaine|lidocaine|mesh-list
83053071|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
83053072|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
83053073|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053074|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053075|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
83053076|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053077|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053078|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83053079|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83053080|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83053081|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053082|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
83053083|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83053084|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83361740|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83053085|NCT05003596|Prednisolone|prednisolone|mesh-list
83053086|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
83053087|NCT05003596|Narcotics|narcotics|mesh-list
83053088|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83053089|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
83053090|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053091|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
83053092|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
83053093|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053094|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053095|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83053096|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
83053097|NCT05003596|Hormones|hormones|mesh-ancestor
83053098|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053099|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83053100|NCT05003596|Protective Agents|protective agents|mesh-ancestor
83053101|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83053102|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053103|NCT05003596|Analgesics|analgesics|mesh-ancestor
83053104|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
83053105|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053106|NCT02854527|Metformin|metformin|mesh-list
83053107|NCT02854527|Digoxin|digoxin|mesh-list
83053108|NCT02854527|Furosemide|furosemide|mesh-list
83053109|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83053110|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053111|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053112|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83053113|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83053114|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
83053115|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053116|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83053117|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83053118|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053119|NCT02854527|Diuretics|diuretics|mesh-ancestor
83053120|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
83053121|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83053122|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83053123|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053124|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83053125|NCT02854527|Protective Agents|protective agents|mesh-ancestor
83053126|NCT04433572|Sirolimus|sirolimus|mesh-list
83053127|NCT04433572|Temsirolimus|temsirolimus|mesh-list
83053128|NCT04433572|MTOR Inhibitors|mtor inhibitors|mesh-list
83053129|NCT04433572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83053130|NCT04433572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053131|NCT04433572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053132|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83053133|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
83053134|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053135|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053136|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053137|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053138|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83053139|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
83053140|NCT03073018|Fosinopril|fosinopril|mesh-list
83053141|NCT03073018|Pravastatin|pravastatin|mesh-list
83053142|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83053143|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83053144|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
83053145|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053146|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83053147|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83053148|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053149|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83053150|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
83053151|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83053152|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83053153|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
83053154|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
83053155|NCT03608241|Estradiol|estradiol|mesh-list
83053156|NCT03608241|Estrogens|estrogens|mesh-ancestor
83053157|NCT03608241|Hormones|hormones|mesh-ancestor
83053158|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053159|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053160|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83053161|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83053162|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83053163|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83053164|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
83053165|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83053166|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053167|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053168|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83053169|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053170|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053171|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053172|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053173|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83053174|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
83053175|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83053176|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053177|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83053178|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83053179|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83053180|NCT03607383|Red yeast rice|red yeast rice|mesh-list
83053181|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83053182|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83053183|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83053184|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
83053185|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053186|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053187|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83053188|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
83053189|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
83053190|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
83053191|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053192|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053193|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
83053194|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053195|NCT03607149|Pemetrexed|pemetrexed|mesh-list
83053196|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053197|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053198|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053199|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83053200|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83053201|NCT04998838|Tenofovir|tenofovir|mesh-list
83053202|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
83053203|NCT04998838|Antibodies|antibodies|mesh-list
83053204|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
83053205|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83053206|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83053207|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
83053208|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053209|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83053210|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83053211|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053212|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053213|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83053214|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83053215|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
83053216|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053217|NCT03607071|Prednisolone|prednisolone|mesh-list
83053218|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053219|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
83053220|NCT03607071|Hormones|hormones|mesh-ancestor
83053221|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053222|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053223|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83053224|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053225|NCT02035215|Atorvastatin|atorvastatin|mesh-list
83053226|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83053227|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83053228|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
83053229|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053230|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83053231|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83053232|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053233|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
83053235|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83053236|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053237|NCT03605589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83053238|NCT03605589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053239|NCT05002270|Cetuximab|cetuximab|mesh-list
83053240|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83053241|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053242|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83053243|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83053244|NCT03074968|Benzydamine|benzydamine|mesh-list
83053245|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053246|NCT04991584|Amoxicillin|amoxicillin|mesh-list
83053247|NCT04991584|Levofloxacin|levofloxacin|mesh-list
83053248|NCT04991584|Tetracycline|tetracycline|mesh-list
83053249|NCT04991584|Furazolidone|furazolidone|mesh-list
83053250|NCT04991584|Esomeprazole|esomeprazole|mesh-list
83053251|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053252|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053253|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83053254|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83053255|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83053256|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053257|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053258|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83053259|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83053260|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053261|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053262|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83053263|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83053264|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83053265|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83053266|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83053267|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83053268|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83053269|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83053270|NCT05001412|Carboplatin|carboplatin|mesh-list
83053271|NCT05001412|Etoposide|etoposide|mesh-list
83053272|NCT05001412|Apatinib|apatinib|mesh-list
83053273|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053274|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83053275|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83053276|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053277|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053278|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053279|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83053280|NCT04991896|Metoprolol|metoprolol|mesh-list
83053281|NCT04991896|Sotalol|sotalol|mesh-list
83053282|NCT04991896|Flecainide|flecainide|mesh-list
83053283|NCT04991896|Bisoprolol|bisoprolol|mesh-list
83053284|NCT04991896|Betaxolol|betaxolol|mesh-list
83053285|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053286|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83053287|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
83053288|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
83053289|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053290|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053291|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83053292|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83053293|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83053294|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
83053295|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053296|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053297|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83053298|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83053299|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83053300|NCT03072394|Lidocaine|lidocaine|mesh-list
83053301|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
83053302|NCT03072394|Anesthetics|anesthetics|mesh-list
83053303|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053304|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053305|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
83053306|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053307|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053308|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83053309|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83053310|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83053311|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053312|NCT03072082|Aspirin|aspirin|mesh-list
83053313|NCT03072082|Metoprolol|metoprolol|mesh-list
83053314|NCT03072082|Isosorbide|isosorbide|mesh-list
83053315|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83053316|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83053317|NCT03072082|Trimetazidine|trimetazidine|mesh-list
83053318|NCT03072082|Clopidogrel|clopidogrel|mesh-list
83053319|NCT03072082|Atorvastatin|atorvastatin|mesh-list
83053320|NCT03072082|Calcium|calcium|mesh-list
83053321|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83053322|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053323|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83053324|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83053325|NCT03072082|Analgesics|analgesics|mesh-ancestor
83053326|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
83053327|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053328|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053329|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83053330|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83053331|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83053332|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053333|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83053334|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83053335|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053336|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
83053337|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83053338|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83053339|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
83053340|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83053341|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83053342|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83053343|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83053344|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83053345|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
83053346|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053347|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053348|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83053349|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
83053350|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
83053351|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83053352|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83053353|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83053354|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
83053355|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83053356|NCT03072082|Diuretics|diuretics|mesh-ancestor
83053357|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
83053358|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
83053359|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83053360|NCT04934020|Metronidazole|metronidazole|mesh-list
83053361|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053362|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053363|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83053364|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83053365|NCT04904614|Letermovir|letermovir|mesh-list
83053366|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83053367|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053368|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053369|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053370|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
83053371|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053372|NCT04987450|Prednisone|prednisone|mesh-list
83053373|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
83053374|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83053375|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83053376|NCT04987450|Prednisolone|prednisolone|mesh-list
83053377|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
83053378|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83053379|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
83053380|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053381|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
83053382|NCT04987450|Hormones|hormones|mesh-ancestor
83053383|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053384|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053385|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83053386|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053387|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
83053388|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
83053389|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053390|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83053391|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83053392|NCT04987450|Protective Agents|protective agents|mesh-ancestor
83053393|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83053394|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83053395|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
83053397|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053398|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053399|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053400|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053401|NCT04991194|Zamicastat|zamicastat|mesh-list
83053402|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053403|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053404|NCT02853435|Gepotidacin|gepotidacin|mesh-list
83053405|NCT02853435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053406|NCT02853435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053407|NCT02853435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053408|NCT02853435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053409|NCT03071770|Ivosidenib|ivosidenib|mesh-list
83053410|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053411|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053412|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053413|NCT04986982|Opicapone|opicapone|mesh-list
83053414|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83053415|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053416|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053417|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83053418|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83053419|NCT04996498|Oxytocin|oxytocin|mesh-list
83053420|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
83053421|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83053422|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053423|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
83053424|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83053425|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
83053426|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053427|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
83053428|NCT03074344|Protective Agents|protective agents|mesh-ancestor
83053429|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
83053430|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
83053431|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053432|NCT02035371|Insulin|insulin|mesh-list
83053433|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83053434|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
83053435|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
83053436|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83053437|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053438|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053439|NCT03069820|Docetaxel|docetaxel|mesh-list
83053440|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053441|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
83053442|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
83053443|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
83053444|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053445|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
83053446|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83053447|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
83053448|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83053449|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
83053450|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053451|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053452|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
83053453|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
83053454|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
83053455|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
83053456|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053457|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053458|NCT03270501|Golimumab|golimumab|mesh-list
83053459|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83053460|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053461|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83053462|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
83053463|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053464|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
83053465|NCT03606681|Calcium|calcium|mesh-list
83053466|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83053467|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053468|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83053469|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
83053470|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83053471|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
83053472|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83053473|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
83053474|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053475|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053476|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
83053477|NCT03605199|Denosumab|denosumab|mesh-list
83053478|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83053479|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053480|NCT03606369|Ondansetron|ondansetron|mesh-list
83053481|NCT03606369|Palonosetron|palonosetron|mesh-list
83053482|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
83053483|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
83053484|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053485|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053486|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83053487|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
83053488|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
83053489|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83053490|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83053491|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
83053492|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053493|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053494|NCT02635204|Clobetasol|clobetasol|mesh-list
83053495|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053496|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
83053497|NCT02635204|Hormones|hormones|mesh-ancestor
83053498|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053499|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053500|NCT00102804|Pemetrexed|pemetrexed|mesh-list
83053501|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053502|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053503|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053504|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83053505|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83053506|NCT03038113|Immunomodulating Agents|immunomodulating agents|mesh-list
83053507|NCT03038113|Immunologic Factors|immunologic factors|mesh-ancestor
83053508|NCT03038113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053509|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83053510|NCT02163720|Doxorubicin|doxorubicin|mesh-list
83053511|NCT02163720|Trabectedin|trabectedin|mesh-list
83053512|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83053513|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053514|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83053515|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053516|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053517|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053518|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83053519|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
83053520|NCT03487874|Ropivacaine|ropivacaine|mesh-list
83053521|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
83053522|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
83053523|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053524|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053525|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
83053526|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053527|NCT01494662|Capecitabine|capecitabine|mesh-list
83053528|NCT01494662|Trastuzumab|trastuzumab|mesh-list
83053529|NCT01494662|Maytansine|maytansine|mesh-list
83053530|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83053531|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83053532|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
83053533|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053534|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053535|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83053536|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83053537|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
83053538|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
83053539|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
83053540|NCT01494662|Immunotoxins|immunotoxins|mesh-ancestor
83053541|NCT01494662|Immunoconjugates|immunoconjugates|mesh-ancestor
83053542|NCT01494662|Immunologic Factors|immunologic factors|mesh-ancestor
83053543|NCT01494662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053544|NCT04989400|Misoprostol|misoprostol|mesh-list
83053545|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
83053546|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83053547|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
83053548|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83053549|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053550|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83053551|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83053552|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
83053553|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83053554|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
83053555|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83053556|NCT02163954|Clopidogrel|clopidogrel|mesh-list
83053557|NCT02163954|Ticagrelor|ticagrelor|mesh-list
83053558|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83053559|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83053560|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83053561|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83053562|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
83053563|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053564|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053565|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053566|NCT04985656|Decitabine|decitabine|mesh-list
83053567|NCT04985656|Pevonedistat|pevonedistat|mesh-list
83053568|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83053569|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
83053570|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053571|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053572|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053573|NCT02164032|Insulin|insulin|mesh-list
83053574|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83053575|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053576|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053577|NCT04682288|Levofloxacin|levofloxacin|mesh-list
83053578|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83053579|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053580|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053581|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83053582|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053583|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053584|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053585|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053586|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83053587|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83053588|NCT00968149|Montelukast|montelukast|mesh-list
83053589|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83053590|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83053591|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83053592|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053593|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053594|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053595|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83053596|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83053597|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053598|NCT04985344|Propranolol|propranolol|mesh-list
83053599|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83053600|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83053601|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
83053602|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053603|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053604|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053605|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053606|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83053607|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
83053608|NCT02164110|Vaccines|vaccines|mesh-list
83053609|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
83053610|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053611|NCT02167464|Coal Tar|coal tar|mesh-list
83053612|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83053613|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
83053614|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83053615|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053616|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053617|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053618|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83053619|NCT02167464|Diuretics|diuretics|mesh-ancestor
83053620|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
83053621|NCT03485456|Tobramycin|tobramycin|mesh-list
83053622|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053623|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053624|NCT03487562|Amoxicillin|amoxicillin|mesh-list
83053625|NCT03487562|Clarithromycin|clarithromycin|mesh-list
83053626|NCT03487562|Lansoprazole|lansoprazole|mesh-list
83053627|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
83053628|NCT03487562|Fexuprazan|fexuprazan|mesh-list
83053629|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053630|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053631|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83053632|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053633|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053634|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83053635|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83053636|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83053637|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83053638|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83053639|NCT03719924|Paclitaxel|paclitaxel|mesh-list
83053640|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83053641|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053642|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
83053643|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
83053644|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
83053645|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053646|NCT02167620|Metformin|metformin|mesh-list
83053647|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053648|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053649|NCT03485300|Warfarin|warfarin|mesh-list
83053650|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
83053651|NCT00963469|Loratadine|loratadine|mesh-list
83053652|NCT00963469|Montelukast|montelukast|mesh-list
83053653|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83053654|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
83053655|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83053656|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053657|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053658|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053659|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83053660|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83053661|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053662|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
83053663|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
83053664|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83053665|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83053666|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83053667|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
83053668|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
83053669|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053670|NCT00897949|Rizatriptan|rizatriptan|mesh-list
83053671|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83053672|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
83053673|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053674|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053675|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053676|NCT05119855|Vaccines|vaccines|mesh-list
83053677|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
83053678|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053679|NCT04741945|Metformin|metformin|mesh-list
83053680|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053681|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053682|NCT03487406|Aspirin|aspirin|mesh-list
83053683|NCT03487406|Ticagrelor|ticagrelor|mesh-list
83053684|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83053685|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83053686|NCT03487406|Analgesics|analgesics|mesh-ancestor
83053687|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
83053688|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053689|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053690|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053691|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83053692|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83053693|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83053694|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053695|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83053696|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83053697|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053698|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
83053699|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83053700|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83053701|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83053702|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
83053703|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053704|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83053705|NCT00725491|Ganirelix|ganirelix|mesh-list
83053706|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
83053707|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83053708|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
83053709|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83053710|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053711|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83053712|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83053713|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053714|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053715|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053716|NCT00724789|Ganirelix|ganirelix|mesh-list
83053717|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053718|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053719|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053720|NCT00711607|Estradiol|estradiol|mesh-list
83053721|NCT00711607|Estrogens|estrogens|mesh-ancestor
83053722|NCT00711607|Hormones|hormones|mesh-ancestor
83053723|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053724|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053725|NCT02164578|Aspirin|aspirin|mesh-list
83053726|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
83053727|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83053728|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83053729|NCT02164578|Analgesics|analgesics|mesh-ancestor
83053730|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
83053731|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053732|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053733|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053734|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83053735|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83053736|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83053737|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053738|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83053739|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83053740|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053741|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
83053742|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83053743|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
83053744|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83053745|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
83053746|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
83053747|NCT03893318|Lidocaine|lidocaine|mesh-list
83053748|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
83053749|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
83053750|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053751|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053752|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
83053753|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053754|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053755|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83053756|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83053757|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83053758|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053759|NCT03625531|Letrozole|letrozole|mesh-list
83053760|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053761|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83053762|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83053763|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053764|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053765|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83053766|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053767|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053768|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053769|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
83053770|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83053771|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83053772|NCT02167698|Prednisolone|prednisolone|mesh-list
83053773|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
83053774|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83053775|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
83053776|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83053777|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
83053778|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
83053779|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053780|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053781|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83053782|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
83053783|NCT02167698|Hormones|hormones|mesh-ancestor
83053784|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053785|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83053786|NCT02167698|Protective Agents|protective agents|mesh-ancestor
83053787|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83053788|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053790|NCT02634580|Evolocumab|evolocumab|mesh-list
83053791|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83053792|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83053793|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83053794|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
83053795|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053796|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83053797|NCT02634580|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83053798|NCT02634580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83053799|NCT02634580|Protease Inhibitors|protease inhibitors|mesh-ancestor
83053800|NCT02634580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053801|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
83053802|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053803|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83053804|NCT00697255|Hormones|hormones|mesh-list
83053805|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83053806|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053807|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053808|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83053809|NCT02164734|Remifentanil|remifentanil|mesh-list
83053810|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83053811|NCT02164734|Narcotics|narcotics|mesh-ancestor
83053812|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053813|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053814|NCT02164734|Analgesics|analgesics|mesh-ancestor
83053815|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
83053816|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053817|NCT00548912|Spironolactone|spironolactone|mesh-list
83053818|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83053819|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
83053820|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053821|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053822|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83053823|NCT00548912|Diuretics|diuretics|mesh-ancestor
83053824|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
83053825|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
83053826|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053827|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053828|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83053829|NCT03071068|Antibodies|antibodies|mesh-list
83361741|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
83053830|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
83053831|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83053832|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
83053833|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053834|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053835|NCT03487172|Mannitol|mannitol|mesh-list
83053836|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83053837|NCT03487172|Diuretics|diuretics|mesh-ancestor
83053838|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
83053839|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053840|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
83053841|NCT04995016|Axitinib|axitinib|mesh-list
83053842|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83053843|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053844|NCT04995016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83053845|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053846|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83053847|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053848|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
83053849|NCT04994860|Zamicastat|zamicastat|mesh-list
83053850|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
83053851|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83053852|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83053853|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053854|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053855|NCT04994860|Urological Agents|urological agents|mesh-ancestor
83053856|NCT03481400|Calcitonin|calcitonin|mesh-list
83053857|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
83053858|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83053859|NCT03481400|Katacalcin|katacalcin|mesh-list
83053860|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83053861|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053862|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83053863|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
83053864|NCT02851407|Defibrotide|defibrotide|mesh-list
83053865|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83053866|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83053867|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053868|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83053869|NCT02167854|Trastuzumab|trastuzumab|mesh-list
83053870|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83053871|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053872|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83053873|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83053874|NCT02161614|Estradiol|estradiol|mesh-list
83053875|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83053876|NCT02161614|Estrogens|estrogens|mesh-ancestor
83053877|NCT02161614|Hormones|hormones|mesh-ancestor
83053878|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83053879|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053880|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83053881|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
83053882|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83053883|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83053884|NCT04994626|Rituximab|rituximab|mesh-list
83053885|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83053886|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053887|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
83053888|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053889|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83053890|NCT02168010|Neurotropin|neurotropin|mesh-list
83053891|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83053892|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
83053893|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053894|NCT02168010|Analgesics|analgesics|mesh-ancestor
83053895|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
83053896|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053897|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
83053898|NCT04994314|Fluorides|fluorides|mesh-list
83053899|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053900|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
83053901|NCT04994314|Protective Agents|protective agents|mesh-ancestor
83053902|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
83053903|NCT02161692|Carboplatin|carboplatin|mesh-list
83053904|NCT02161692|Etoposide|etoposide|mesh-list
83053905|NCT02161692|Bleomycin|bleomycin|mesh-list
83053906|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83053907|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
83053908|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053909|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83053910|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83053911|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
83053912|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053913|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053914|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83053915|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83053916|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83053917|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053918|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053919|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83053920|NCT02746575|Metoprolol|metoprolol|mesh-list
83053921|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83053922|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83053923|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
83053924|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
83053925|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053926|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053927|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83053928|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83053929|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83053930|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
83053931|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053932|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053933|NCT02161770|Osimertinib|osimertinib|mesh-list
83053934|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053935|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83053936|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053937|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053939|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83053940|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
83053941|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053942|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053943|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
83053944|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83053945|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
83053946|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053947|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053948|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83053949|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
83053950|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83053951|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
83053952|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053953|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83053954|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83053955|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
83053956|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
83053957|NCT04988932|Protective Agents|protective agents|mesh-ancestor
83053958|NCT03625466|Ivacaftor|ivacaftor|mesh-list
83053959|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83053960|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83053961|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053962|NCT03604419|Metformin|metformin|mesh-list
83053963|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83053964|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053965|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83053966|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
83053967|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
83053968|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
83053969|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83053970|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83053971|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
83053972|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83053973|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83053974|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83053975|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83053976|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053977|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053978|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
83053979|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83053980|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83053981|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
83053982|NCT02164812|Efavirenz|efavirenz|mesh-list
83053983|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83053984|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83053985|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83053986|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83053987|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83053988|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83053989|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83053990|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83053991|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83053992|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
83053993|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83053994|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83053995|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83053996|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83053997|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83053998|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83053999|NCT04988776|Bupivacaine|bupivacaine|mesh-list
83054000|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054001|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
83054002|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054003|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054004|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
83054005|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054006|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
83054007|NCT02853123|Olodaterol|olodaterol|mesh-list
83054008|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83054009|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
83054010|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054011|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054012|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054013|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054014|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
83054015|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83054016|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
83054017|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054018|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054019|NCT02255370|Curcumin|curcumin|mesh-list
83054020|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83054021|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054022|NCT02255370|Analgesics|analgesics|mesh-ancestor
83054023|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
83054024|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054025|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054026|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054027|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054028|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054029|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054030|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054031|NCT04984408|Vaccines|vaccines|mesh-list
83054032|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
83054033|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054034|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
83054035|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83054036|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054037|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054038|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
83054039|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054040|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054041|NCT04459676|Mitogens|mitogens|mesh-list
83054042|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83054043|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054044|NCT05376111|Azacitidine|azacitidine|mesh-list
83054045|NCT05376111|Venetoclax|venetoclax|mesh-list
83054046|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83054047|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
83054048|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054049|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054050|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054051|NCT02164890|Micafungin|micafungin|mesh-list
83054052|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
83054053|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054054|NCT02634346|Olanzapine|olanzapine|mesh-list
83054055|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
83054056|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
83054057|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054058|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054059|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83054060|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83054061|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83054062|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054063|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83054064|NCT02634346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83054065|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83054066|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054067|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054068|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054069|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
83054070|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
83054071|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83054072|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054073|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054074|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
83054075|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054076|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054077|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
83054078|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054079|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83054080|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054081|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054083|NCT02165046|Procaterol|procaterol|mesh-list
83054084|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054085|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83054086|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
83054087|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054088|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054089|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054090|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054091|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
83054092|NCT02165046|Hormones|hormones|mesh-ancestor
83054093|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054094|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
83054095|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83054096|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83054097|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83054098|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
83054099|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054100|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054101|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83054102|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
83054103|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83054104|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054105|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83054106|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054107|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83054108|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054109|NCT03070678|Analgesics|analgesics|mesh-ancestor
83054110|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
83054111|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054112|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054113|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054114|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83054115|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054116|NCT00101166|Vaccines|vaccines|mesh-list
83054117|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
83054118|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054119|NCT04994236|Leucovorin|leucovorin|mesh-list
83054120|NCT04994236|Fluorouracil|fluorouracil|mesh-list
83054121|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
83054122|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
83054123|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054124|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83054125|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054126|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83054127|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
83054128|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054129|NCT04994236|Antidotes|antidotes|mesh-ancestor
83054130|NCT04994236|Protective Agents|protective agents|mesh-ancestor
83054131|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
83054133|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
83054134|NCT03601611|Prednisolone|prednisolone|mesh-list
83054135|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054136|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
83054137|NCT03601611|Hormones|hormones|mesh-ancestor
83054138|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054139|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054140|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83054141|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054142|NCT03597945|Lidocaine|lidocaine|mesh-list
83054143|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
83054144|NCT03597945|Epinephrine|epinephrine|mesh-list
83054145|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054146|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
83054147|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054148|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054149|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
83054150|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054151|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83054152|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83054153|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83054154|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054155|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054156|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83054157|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83054158|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
83054159|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054160|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83054161|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83054163|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054164|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054165|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
83054166|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
83054167|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83054168|NCT03597945|Analgesics|analgesics|mesh-ancestor
83054169|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
83054170|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83054171|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83054172|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
83054173|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054174|NCT03601533|Phenol|phenol|mesh-list
83054175|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83054176|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054177|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
83054178|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83054179|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83054180|NCT03486626|Metformin|metformin|mesh-list
83054181|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83054182|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054183|NCT04983550|Doxorubicin|doxorubicin|mesh-list
83054184|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83054185|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83054186|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054187|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83054188|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83054189|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054190|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054191|NCT02255682|Simvastatin|simvastatin|mesh-list
83054192|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83438900|NCT00685295|Analgesics|analgesics|mesh-ancestor
83054193|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83054194|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
83054195|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054196|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83054197|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83054198|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054199|NCT05153486|Ethanol|ethanol|mesh-list
83054200|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83054201|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054202|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054203|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054205|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
83054206|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054207|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054208|NCT03486548|Dexamethasone|dexamethasone|mesh-list
83054209|NCT03486548|Lidocaine|lidocaine|mesh-list
83054210|NCT03486548|Bupivacaine|bupivacaine|mesh-list
83054211|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054212|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
83054213|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
83054214|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054215|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054216|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83054217|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
83054218|NCT03486548|Hormones|hormones|mesh-ancestor
83054219|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054220|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83054221|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054222|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054223|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
83054224|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054225|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
83054226|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83054227|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83054228|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83054229|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054230|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054232|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
83054233|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054234|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054235|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
83054236|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054237|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83054238|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
83054239|NCT04983160|Protective Agents|protective agents|mesh-ancestor
83054240|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054241|NCT05431270|Antibodies|antibodies|mesh-list
83054242|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83054243|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
83054244|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054245|NCT02759016|BI 836826|bi 836826|mesh-list
83054246|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83054247|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054248|NCT05379166|Azacitidine|azacitidine|mesh-list
83054249|NCT05379166|Venetoclax|venetoclax|mesh-list
83054250|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83054251|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
83054252|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054253|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054254|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054255|NCT02852967|Belumosudil|belumosudil|mesh-list
83054256|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83054257|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054258|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054259|NCT03593044|Atropine|atropine|mesh-list
83054260|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83054261|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83054262|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83054263|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
83054264|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054265|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054266|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054267|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054268|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
83054269|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
83054270|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83054271|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83054272|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
83054273|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054274|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054275|NCT03597087|Anesthetics|anesthetics|mesh-list
83054276|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054277|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054278|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
83054279|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054280|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
83054281|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83054282|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054283|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054284|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054285|NCT03596775|Analgesics|analgesics|mesh-ancestor
83054286|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
83054287|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054288|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83054289|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83054290|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83054291|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83054292|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054293|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054294|NCT03066466|Methotrexate|methotrexate|mesh-list
83054295|NCT03066466|Atorvastatin|atorvastatin|mesh-list
83054296|NCT03066466|Tacrolimus|tacrolimus|mesh-list
83054297|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83054298|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
83054299|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054300|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054301|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83054302|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
83054303|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054304|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054305|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
83054306|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054307|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83054308|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83054309|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
83054310|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054311|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83054312|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83054313|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83054314|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83054315|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83054316|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83054317|NCT03603249|Trimetazidine|trimetazidine|mesh-list
83054318|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
83054319|NCT03068260|Acetaminophen|acetaminophen|mesh-list
83054320|NCT03068260|Ibuprofen|ibuprofen|mesh-list
83054321|NCT03068260|Morphine|morphine|mesh-list
83054322|NCT03068260|Ropivacaine|ropivacaine|mesh-list
83054323|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83054324|NCT03068260|Narcotics|narcotics|mesh-ancestor
83054325|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054326|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054327|NCT03068260|Analgesics|analgesics|mesh-ancestor
83054328|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
83054329|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054330|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054331|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
83054332|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054333|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
83054334|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83054335|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054336|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054337|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83054338|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054339|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054340|NCT02237859|Vancomycin|vancomycin|mesh-list
83054341|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83054342|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054343|NCT03594825|Valsartan|valsartan|mesh-list
83054344|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83054345|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83054346|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83054347|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054348|NCT02162550|Exenatide|exenatide|mesh-list
83054349|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83054350|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054351|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83054352|NCT02162550|Incretins|incretins|mesh-ancestor
83054353|NCT02162550|Hormones|hormones|mesh-ancestor
83054354|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054355|NCT03600831|Docetaxel|docetaxel|mesh-list
83054356|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054357|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
83054358|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
83054359|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
83054360|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054361|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
83054362|NCT02852265|Etonogestrel|etonogestrel|mesh-list
83054363|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054364|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054365|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83054366|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83054367|NCT02162784|Budesonide|budesonide|mesh-list
83054368|NCT02162784|Albuterol|albuterol|mesh-list
83054369|NCT02162784|Procaterol|procaterol|mesh-list
83054370|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054371|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83054372|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
83054373|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054374|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054375|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054376|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054377|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
83054378|NCT02162784|Hormones|hormones|mesh-ancestor
83054379|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054380|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
83054381|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054382|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83054383|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83054384|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83054385|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
83054386|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054387|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054388|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
83054389|NCT03539718|Taurolidine|taurolidine|mesh-list
83054390|NCT03539718|Heparin|heparin|mesh-list
83054391|NCT03539718|Calcium heparin|calcium heparin|mesh-list
83054392|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
83054393|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83054394|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83054395|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054396|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054397|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83054398|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054399|NCT02166450|Nystatin|nystatin|mesh-list
83054400|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83054401|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054402|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
83054403|NCT02166450|Ionophores|ionophores|mesh-ancestor
83054404|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054405|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054406|NCT03600363|Metformin|metformin|mesh-list
83054407|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83054408|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054409|NCT03600129|Ropivacaine|ropivacaine|mesh-list
83054410|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054411|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
83054412|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054413|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054414|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
83054415|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054416|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
83054417|NCT02169570|Vitamin D|vitamin d|mesh-list
83054418|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
83054419|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
83054420|NCT02169570|Vitamins|vitamins|mesh-list
83054421|NCT02169570|Calcium|calcium|mesh-list
83054422|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
83054423|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054424|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83054425|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83054426|NCT02169648|Ranibizumab|ranibizumab|mesh-list
83054427|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83054428|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83054429|NCT02169648|Growth Substances|growth substances|mesh-ancestor
83054430|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054431|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
83054432|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054433|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83054434|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054435|NCT02170896|Pantoprazole|pantoprazole|mesh-list
83054436|NCT02170896|Dabigatran|dabigatran|mesh-list
83054437|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83054438|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83054439|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83054440|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054441|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054442|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
83054443|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83054444|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
83054445|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
83054446|NCT03594513|Dipyrone|dipyrone|mesh-list
83054447|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
83054448|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83054449|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054450|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
83054451|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83054452|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054453|NCT03594513|Analgesics|analgesics|mesh-ancestor
83054454|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
83054455|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054456|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054457|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054459|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
83054460|NCT02633800|Carboplatin|carboplatin|mesh-list
83054461|NCT02633800|Cetuximab|cetuximab|mesh-list
83054462|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054463|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83054464|NCT02169804|Enclomiphene|enclomiphene|mesh-list
83054465|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83054466|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
83054467|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054468|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054469|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83438915|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
83054470|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
83054471|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054472|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83054473|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83054474|NCT02170974|Dabigatran|dabigatran|mesh-list
83054475|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
83054476|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83054477|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
83054478|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054479|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054480|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
83054481|NCT02174718|Vitamin D|vitamin d|mesh-list
83054482|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
83054483|NCT02174718|Vitamins|vitamins|mesh-ancestor
83054484|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
83054485|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054486|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83054487|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83054488|NCT05635162|Rituximab|rituximab|mesh-list
83054489|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
83054490|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83054491|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054492|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
83054493|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054494|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054495|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83054496|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054497|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054498|NCT02238171|Ipratropium|ipratropium|mesh-list
83054499|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83054500|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
83054501|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054502|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054503|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054504|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054505|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83054506|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
83054507|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054508|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054509|NCT02169882|Rifampin|rifampin|mesh-list
83054510|NCT02169882|Dexamethasone|dexamethasone|mesh-list
83054511|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054512|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
83054513|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
83054514|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054515|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054516|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83054517|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
83054518|NCT02169882|Hormones|hormones|mesh-ancestor
83054519|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054520|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83054521|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054522|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83054523|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
83054524|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83054525|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054526|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
83054527|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83054528|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054529|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054530|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83054531|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83054532|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83054533|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83054534|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83054535|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83054536|NCT03602547|Vorolanib|vorolanib|mesh-list
83054537|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83054538|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438929|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
83054539|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054540|NCT03602469|Bupivacaine|bupivacaine|mesh-list
83054541|NCT03602469|Propofol|propofol|mesh-list
83054542|NCT03602469|Sevoflurane|sevoflurane|mesh-list
83054543|NCT03602469|Rocuronium|rocuronium|mesh-list
83054544|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054545|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
83054546|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054547|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054548|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
83054549|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054550|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83054551|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83054552|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
83054553|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83054554|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83054555|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83054556|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83054557|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83054558|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83054559|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83054560|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83054561|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
83054562|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054563|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054564|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83054565|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83054566|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83054567|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83054568|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83054569|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83054570|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83054571|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83054572|NCT05001373|Vaccines|vaccines|mesh-list
83054573|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
83054574|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054575|NCT02171052|Digoxin|digoxin|mesh-list
83054576|NCT02171052|Dabigatran|dabigatran|mesh-list
83054577|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
83054578|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83054579|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
83054580|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054581|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054582|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
83054583|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83054584|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83054585|NCT02171052|Protective Agents|protective agents|mesh-ancestor
83054586|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054587|NCT03591549|Fulvestrant|fulvestrant|mesh-list
83054588|NCT03591549|Goserelin|goserelin|mesh-list
83054589|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83054590|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054591|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83054592|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83054593|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
83054594|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054595|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054596|NCT02261220|Durvalumab|durvalumab|mesh-list
83054597|NCT02261220|Tremelimumab|tremelimumab|mesh-list
83054598|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83054599|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054600|NCT02237937|Amitriptyline|amitriptyline|mesh-list
83054601|NCT02237937|Citalopram|citalopram|mesh-list
83054602|NCT02237937|Paroxetine|paroxetine|mesh-list
83054603|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83054604|NCT02237937|Sertraline|sertraline|mesh-list
83054605|NCT02237937|Nortriptyline|nortriptyline|mesh-list
83054606|NCT02237937|Trimipramine|trimipramine|mesh-list
83054607|NCT02237937|Escitalopram|escitalopram|mesh-list
83054608|NCT02237937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83054609|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83054610|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054611|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054612|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054613|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
83054614|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054615|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054616|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83054617|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
83054618|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83054619|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83054620|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83054621|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054622|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83054623|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83054624|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054625|NCT02237937|Analgesics|analgesics|mesh-ancestor
83054626|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
83054627|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83054628|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
83054629|NCT02170116|Dabigatran|dabigatran|mesh-list
83054630|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
83054631|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83054632|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
83054633|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054634|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054635|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
83054636|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83054637|NCT03539562|Promethazine|promethazine|mesh-list
83054638|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
83054639|NCT03539562|Morphine|morphine|mesh-list
83054640|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83054641|NCT03539562|Narcotics|narcotics|mesh-ancestor
83054642|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054643|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054644|NCT03539562|Analgesics|analgesics|mesh-ancestor
83054645|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
83054646|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054647|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
83054648|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
83054649|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83054650|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
83054651|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
83054652|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084041|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83054653|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054654|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83054655|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83054656|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83054657|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054658|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
83054659|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
83054660|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
83054661|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83054662|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
83054663|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83054664|NCT03604315|Fluorides|fluorides|mesh-list
83054665|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83054666|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054667|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
83054668|NCT03604315|Protective Agents|protective agents|mesh-ancestor
83054669|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054670|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
83054671|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
83054672|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054673|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83054674|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83054675|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054676|NCT00394069|Montelukast|montelukast|mesh-list
83054677|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054678|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054679|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83054680|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
83054681|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054682|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054683|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83054684|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83054685|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054686|NCT03598959|Tofacitinib|tofacitinib|mesh-list
83054687|NCT03598959|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83054688|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83054689|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054690|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054691|NCT02238717|Pregabalin|pregabalin|mesh-list
83054692|NCT02238717|PF-06372865|pf-06372865|mesh-list
83054693|NCT02238717|Analgesics|analgesics|mesh-ancestor
83054694|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
83054695|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054696|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054697|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
83054698|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83054699|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054700|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054701|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83054702|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83054703|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83054704|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054705|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83054706|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
83054707|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
83054708|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054709|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83054710|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83054711|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054712|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
83054713|NCT03470311|Benralizumab|benralizumab|mesh-list
83054714|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054715|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054716|NCT03580005|Methylphenidate|methylphenidate|mesh-list
83054717|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83054718|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054719|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83054720|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83054721|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054722|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054723|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
83054724|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054725|NCT03579927|Cytarabine|cytarabine|mesh-list
83361742|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83054726|NCT03579927|Rituximab|rituximab|mesh-list
83054727|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83054728|NCT03579927|Etoposide|etoposide|mesh-list
83054729|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
83054730|NCT03579927|Melphalan|melphalan|mesh-list
83054731|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
83054732|NCT03579927|Carmustine|carmustine|mesh-list
83054733|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
83054734|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83054735|NCT03579927|Antibodies|antibodies|mesh-list
83054736|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
83054737|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83054738|NCT03579927|Lenograstim|lenograstim|mesh-list
83054739|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
83054740|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054741|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054742|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054743|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83054744|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83054745|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83054746|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054747|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054748|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83054749|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
83054750|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
83054751|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054752|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83054753|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83054754|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83054755|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
83054756|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83054757|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
83054758|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
83054759|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
83054760|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
83054761|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
83054763|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83054764|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
83054765|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83054766|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054767|NCT03587025|Analgesics|analgesics|mesh-ancestor
83054768|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
83054769|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054770|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054771|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83054772|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83054773|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83054774|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054775|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
83054776|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054777|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83054778|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
83054779|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83054780|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
83054781|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054782|NCT00140881|Montelukast|montelukast|mesh-list
83054783|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054784|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054785|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83054786|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
83054787|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054788|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054789|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83054790|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83054791|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054792|NCT02848833|Empagliflozin|empagliflozin|mesh-list
83054793|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83054794|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054795|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83054796|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054797|NCT03539328|Paclitaxel|paclitaxel|mesh-list
83054798|NCT03539328|Gemcitabine|gemcitabine|mesh-list
83054799|NCT03539328|Doxorubicin|doxorubicin|mesh-list
83361743|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83054800|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83054801|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
83054802|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83054803|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054804|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
83054805|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
83054806|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
83054807|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054808|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83054809|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
83054810|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83054811|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83054812|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83054813|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054814|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83054815|NCT03539328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83054816|NCT00111709|Rizatriptan|rizatriptan|mesh-list
83054817|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054818|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054819|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054820|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83054821|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
83054822|NCT02171442|Dabigatran|dabigatran|mesh-list
83054823|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
83054824|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83054825|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
83054826|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054827|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054828|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
83054830|NCT02035527|Sorafenib|sorafenib|mesh-list
83054831|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054832|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
83054833|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
83054834|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
83054835|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054836|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83054837|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054838|NCT00092131|Montelukast|montelukast|mesh-list
83054839|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054840|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054841|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83054842|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
83054843|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054844|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054845|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83054846|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83054847|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054848|NCT02170584|Dabigatran|dabigatran|mesh-list
83054849|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
83054850|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83054851|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
83054852|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054853|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054854|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
83054855|NCT03577977|Interferons|interferons|mesh-list
83054856|NCT03577977|Interferon-beta|interferon-beta|mesh-list
83054857|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
83054858|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054859|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
83054860|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054861|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
83054862|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054863|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83054864|NCT02668783|Ibuprofen|ibuprofen|mesh-list
83054865|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83054866|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83054867|NCT02668783|Etonogestrel|etonogestrel|mesh-list
83054868|NCT02668783|Estradiol|estradiol|mesh-list
83054869|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83054870|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83054871|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83054872|NCT02668783|Analgesics|analgesics|mesh-ancestor
83054873|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
83054874|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054875|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054876|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054877|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054878|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83054879|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054880|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054881|NCT02668783|Estrogens|estrogens|mesh-ancestor
83054882|NCT02668783|Hormones|hormones|mesh-ancestor
83054883|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054884|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83054885|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
83054886|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054887|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83054888|NCT05010304|Amoxicillin|amoxicillin|mesh-list
83054889|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83054890|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83054891|NCT03577899|Aflibercept|aflibercept|mesh-list
83054892|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83054893|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83054894|NCT03577899|Growth Substances|growth substances|mesh-ancestor
83054895|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054896|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
83054897|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054898|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
83054899|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83054900|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
83054901|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054902|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054903|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054904|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054905|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
83054906|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83054907|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
83054908|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83054909|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054910|NCT02171520|Dabigatran|dabigatran|mesh-list
83054911|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
83054912|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83054913|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
83054914|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054915|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054916|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
83054917|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
83054918|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83054919|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054920|NCT00101010|Prednisone|prednisone|mesh-list
83054921|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
83054922|NCT00101010|Rituximab|rituximab|mesh-list
83054923|NCT00101010|Doxorubicin|doxorubicin|mesh-list
83054924|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83054925|NCT00101010|Vincristine|vincristine|mesh-list
83054926|NCT00101010|Lenograstim|lenograstim|mesh-list
83054927|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83054928|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
83054929|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054930|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83054931|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83054932|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
83054933|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054934|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054935|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83054936|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83054937|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83054938|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83054939|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83054940|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054941|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054942|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
83054943|NCT00101010|Hormones|hormones|mesh-ancestor
83054944|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054945|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83054946|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83054947|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83054948|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83054949|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83054950|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83054952|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054953|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83054954|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054955|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054956|NCT03209401|Carboplatin|carboplatin|mesh-list
83054957|NCT03209401|Niraparib|niraparib|mesh-list
83054958|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054959|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83054960|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83054961|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83054962|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
83054963|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
83054964|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054965|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83054966|NCT04576104|Metformin|metformin|mesh-list
83054967|NCT04576104|Megestrol|megestrol|mesh-list
83054968|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
83054969|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83054970|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054971|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83054972|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83054973|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83054974|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
83054975|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83054976|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83054977|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83054978|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83054979|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83054980|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
83054981|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83054982|NCT04859764|Betamethasone|betamethasone|mesh-list
83054983|NCT04859764|Bupivacaine|bupivacaine|mesh-list
83054984|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
83054985|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
83054986|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83054987|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83054988|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
83054989|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83054990|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83054991|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
83054992|NCT04859764|Hormones|hormones|mesh-ancestor
83054993|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83054994|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83054995|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
83054996|NCT02170740|Pantoprazole|pantoprazole|mesh-list
83054997|NCT02170740|Dabigatran|dabigatran|mesh-list
83054998|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83054999|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83055000|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83055001|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055002|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055003|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
83055004|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83055005|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055006|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
83055007|NCT02848599|Morphine|morphine|mesh-list
83055008|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
83055009|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83055010|NCT02848599|Narcotics|narcotics|mesh-ancestor
83055011|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055012|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055013|NCT02848599|Analgesics|analgesics|mesh-ancestor
83055014|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
83055015|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055016|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
83055017|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
83055018|NCT02171598|Dabigatran|dabigatran|mesh-list
83055019|NCT02171598|Clopidogrel|clopidogrel|mesh-list
83055020|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83055021|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83055022|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83055023|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83055024|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
83055025|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055026|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055027|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055028|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
83055029|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83055030|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055031|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055032|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
83055033|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83055034|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055035|NCT02171676|Docetaxel|docetaxel|mesh-list
83055036|NCT02171676|Afatinib|afatinib|mesh-list
83055037|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055038|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83055039|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83055040|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83055041|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055042|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83055043|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055044|NCT03577743|Bevacizumab|bevacizumab|mesh-list
83055045|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055046|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055047|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83055048|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83055049|NCT03577743|Growth Substances|growth substances|mesh-ancestor
83055050|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055051|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
83055052|NCT04794790|Buprenorphine|buprenorphine|mesh-list
83055053|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83055054|NCT04794790|Naloxone|naloxone|mesh-list
83055055|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83055056|NCT04794790|Narcotics|narcotics|mesh-ancestor
83055057|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055058|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055059|NCT04794790|Analgesics|analgesics|mesh-ancestor
83055060|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
83055061|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055062|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83055063|NCT02171754|Ritonavir|ritonavir|mesh-list
83055064|NCT02171754|Afatinib|afatinib|mesh-list
83055065|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83055066|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83055067|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055068|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055069|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055070|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83055071|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83055072|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
83055073|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055074|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83055075|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83055076|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055077|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83055078|NCT02171832|Olodaterol|olodaterol|mesh-list
83055079|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055080|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
83055081|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055082|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055083|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055084|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055085|NCT02171910|Doxapram|doxapram|mesh-list
83055086|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83055087|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055088|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055089|NCT02178306|Telmisartan|telmisartan|mesh-list
83055090|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055091|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83055092|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83055093|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055094|NCT05729386|Metformin|metformin|mesh-list
83055095|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055096|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055097|NCT05729308|Anesthetics|anesthetics|mesh-list
83055098|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055099|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055100|NCT00778999|Desogestrel|desogestrel|mesh-list
83055101|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83055102|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83055103|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83055104|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
83055105|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055106|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055107|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83055108|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83055109|NCT00778999|Progestins|progestins|mesh-ancestor
83055110|NCT00778999|Hormones|hormones|mesh-ancestor
83055111|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055112|NCT02171988|Propranolol|propranolol|mesh-list
83055113|NCT02171988|Bisoprolol|bisoprolol|mesh-list
83055114|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83055115|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83055116|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83055117|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055118|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055119|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055120|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055121|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83055122|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055123|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
83055124|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
83055125|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
83055126|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055127|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83055128|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83055129|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055130|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055131|NCT00725413|Etonogestrel|etonogestrel|mesh-list
83055132|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83055133|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
83055134|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055135|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055136|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83055137|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83055138|NCT00103038|Hematinics|hematinics|mesh-ancestor
83055139|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83055140|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83055141|NCT00620035|Etonogestrel|etonogestrel|mesh-list
83055142|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83055143|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
83055144|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055145|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055146|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83055147|NCT02175888|Iron|iron|mesh-list
83055148|NCT02175888|Trace Elements|trace elements|mesh-ancestor
83055149|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
83055150|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055151|NCT05577637|Tacrolimus|tacrolimus|mesh-list
83055152|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83055153|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
83055154|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055155|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83055156|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055157|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055158|NCT02763579|Carboplatin|carboplatin|mesh-list
83055159|NCT02763579|Etoposide|etoposide|mesh-list
83055160|NCT02763579|Atezolizumab|atezolizumab|mesh-list
83055161|NCT02763579|Antibodies|antibodies|mesh-list
83055162|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83055163|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
83055164|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055165|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055166|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83055167|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83055168|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83055169|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055170|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055171|NCT02763579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055172|NCT02763579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055173|NCT02176044|Nitroprusside|nitroprusside|mesh-list
83055174|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055176|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83055177|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055178|NCT02176122|Meropenem|meropenem|mesh-list
83055179|NCT02176122|Tazobactam|tazobactam|mesh-list
83055180|NCT02176122|Piperacillin|piperacillin|mesh-list
83055181|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83055182|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055183|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055184|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83055185|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055186|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055187|NCT04887064|Sotorasib|sotorasib|mesh-list
83055188|NCT04887064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055189|NCT04887064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055190|NCT04887064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055191|NCT04887064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055192|NCT02967757|Liraglutide|liraglutide|mesh-list
83055193|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055194|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055195|NCT02967757|Incretins|incretins|mesh-ancestor
83055196|NCT02967757|Hormones|hormones|mesh-ancestor
83055197|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055198|NCT02261298|Nivolumab|nivolumab|mesh-list
83055199|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055200|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055201|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055202|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055203|NCT02176200|Fenoterol|fenoterol|mesh-list
83438934|NCT03335540|Nivolumab|nivolumab|mesh-list
83055204|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83055205|NCT02176200|Ipratropium|ipratropium|mesh-list
83055206|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055207|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
83055208|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055209|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055210|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055211|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055212|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
83055213|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
83055214|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055215|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83055216|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83055217|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83055218|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055219|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055220|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055221|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83055222|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055223|NCT03537612|Clonidine|clonidine|mesh-list
83055224|NCT03537612|Morphine|morphine|mesh-list
83055225|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83055226|NCT03537612|Narcotics|narcotics|mesh-ancestor
83055227|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055228|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055229|NCT03537612|Analgesics|analgesics|mesh-ancestor
83055230|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
83055231|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055232|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055233|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
83055234|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
83055235|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83055236|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83055237|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83055238|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055239|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055240|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055241|NCT00336063|Azacitidine|azacitidine|mesh-list
83055242|NCT00336063|Vorinostat|vorinostat|mesh-list
83055243|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83055244|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
83055245|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055246|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055247|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361745|NCT03166800|Micronutrients|micronutrients|mesh-ancestor
83055248|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83055249|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
83055250|NCT02172144|Olodaterol|olodaterol|mesh-list
83055251|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055252|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055253|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83055254|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83055255|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055256|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055257|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055258|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055259|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055260|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
83055261|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055262|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055263|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055264|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
83055265|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
83055266|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83055267|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055268|NCT05729074|Analgesics|analgesics|mesh-ancestor
83055269|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
83055270|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055271|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055272|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055273|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83055274|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
83055275|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83055276|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
83438944|NCT00643097|Sargramostim|sargramostim|mesh-list
83055277|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83055278|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055279|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055280|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83055281|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83055282|NCT02176512|Telmisartan|telmisartan|mesh-list
83055283|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055284|NCT02176512|Diuretics|diuretics|mesh-ancestor
83055285|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
83055286|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055287|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83055288|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83055289|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055290|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83055291|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83055292|NCT03537534|Lidocaine|lidocaine|mesh-list
83055293|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
83055294|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
83055295|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055296|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055297|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
83055298|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055299|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83055300|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83055301|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83055302|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83055303|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055304|NCT03068650|Rindopepimut|rindopepimut|mesh-list
83055305|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055306|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055307|NCT04646005|Cemiplimab|cemiplimab|mesh-list
83055308|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055309|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055310|NCT02757768|Tamsulosin|tamsulosin|mesh-list
83055311|NCT02757768|Mirabegron|mirabegron|mesh-list
83055312|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83055313|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83055314|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83055315|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055316|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055317|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055318|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055319|NCT02757768|Urological Agents|urological agents|mesh-ancestor
83055320|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83055321|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83055322|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83055323|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
83055324|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
83055325|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
83055326|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055327|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
83055328|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055329|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055330|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
83055331|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83055332|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055333|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055334|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055335|NCT03067792|Leucovorin|leucovorin|mesh-list
83055336|NCT03067792|Docetaxel|docetaxel|mesh-list
83055337|NCT03067792|Fluorouracil|fluorouracil|mesh-list
83055338|NCT03067792|Irinotecan|irinotecan|mesh-list
83055339|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055340|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
83055341|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
83055342|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
83055343|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055344|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
83055345|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83055346|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83055347|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
83055348|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055349|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83055350|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83055351|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055352|NCT03067792|Antidotes|antidotes|mesh-ancestor
83055353|NCT03067792|Protective Agents|protective agents|mesh-ancestor
83055354|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
83055355|NCT03067792|Vitamins|vitamins|mesh-ancestor
83055356|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
83055357|NCT05224999|Nivolumab|nivolumab|mesh-list
83055358|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055359|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055360|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055361|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055362|NCT03066154|Ritonavir|ritonavir|mesh-list
83055363|NCT03066154|Docetaxel|docetaxel|mesh-list
83055364|NCT03066154|Androgens|androgens|mesh-list
83055365|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055366|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83055367|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83055368|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83055369|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055370|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83055371|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83055372|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055373|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055374|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83055375|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83055376|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
83055377|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055378|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83055379|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83055380|NCT03066154|Hormones|hormones|mesh-ancestor
83055381|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055382|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055383|NCT05224687|Daptomycin|daptomycin|mesh-list
83055384|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055385|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055386|NCT02753946|Tazobactam|tazobactam|mesh-list
83055387|NCT02753946|Piperacillin|piperacillin|mesh-list
83055388|NCT02753946|Fosfomycin|fosfomycin|mesh-list
83055389|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83055390|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055391|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055392|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83055393|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055394|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055395|NCT00431431|Tibolone|tibolone|mesh-list
83055396|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
83055397|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
83055398|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055399|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055400|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055401|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83055402|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055403|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83055404|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
83055406|NCT02172222|Linagliptin|linagliptin|mesh-list
83055407|NCT02172222|Empagliflozin|empagliflozin|mesh-list
83055408|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055409|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055410|NCT02172222|Incretins|incretins|mesh-ancestor
83055411|NCT02172222|Hormones|hormones|mesh-ancestor
83055412|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055413|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83055414|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055415|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055416|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055417|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83055418|NCT03625219|Prednisone|prednisone|mesh-list
83055419|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055420|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
83055421|NCT03625219|Hormones|hormones|mesh-ancestor
83055422|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055423|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055424|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83055425|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055426|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
83055427|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055428|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055429|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83055430|NCT02179008|Latanoprost|latanoprost|mesh-list
83055431|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83055432|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
83055433|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055434|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
83055435|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055436|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055437|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055438|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055439|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
83055440|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83055441|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055442|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055443|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055444|NCT05223907|Propofol|propofol|mesh-list
83055445|NCT05223907|Etomidate|etomidate|mesh-list
83055446|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83055447|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055448|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055449|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83055450|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
83055451|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
83055452|NCT03065998|Baclofen|baclofen|mesh-list
83055453|NCT03065998|Opipramol|opipramol|mesh-list
83055454|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83055455|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055456|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83055457|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055458|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83055459|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
83055460|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
83055461|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055462|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055463|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83055464|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
83055465|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83055466|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83055467|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83055468|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83055469|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055470|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
83055471|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055472|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
83055473|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055474|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055475|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055476|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055477|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
83055478|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83055479|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055480|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055481|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055482|NCT05728528|Factor VIII|factor viii|mesh-list
83055483|NCT05728528|Coagulants|coagulants|mesh-ancestor
83055484|NCT02256228|Ropivacaine|ropivacaine|mesh-list
83055485|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
83055486|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
83055487|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055488|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055489|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
83055490|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055491|NCT03067168|Bupivacaine|bupivacaine|mesh-list
83055492|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
83055493|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
83055494|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055495|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055496|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
83055497|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055498|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83055499|NCT04774237|Carbachol|carbachol|mesh-list
83055500|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055501|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83055502|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83055503|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83055504|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055505|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055506|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055507|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055508|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83055510|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
83055511|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055512|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83055513|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055514|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055515|NCT04774237|Analgesics|analgesics|mesh-ancestor
83055516|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
83055517|NCT04774237|Protective Agents|protective agents|mesh-ancestor
83055518|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
83055519|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055520|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
83055521|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055522|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055523|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055524|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055525|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
83055526|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83055527|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055528|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055529|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055530|NCT02172534|Bromides|bromides|mesh-list
83055531|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
83055532|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055533|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
83055534|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055535|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055536|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055537|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055538|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
83055539|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83055540|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055541|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055542|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055543|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
83055544|NCT04713631|Artesunate|artesunate|mesh-list
83055545|NCT04713631|Curcumin|curcumin|mesh-list
83055546|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83361746|NCT03166800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055547|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055548|NCT04713631|Analgesics|analgesics|mesh-ancestor
83055549|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
83055550|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055551|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055552|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055553|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83055554|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055555|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83438948|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055556|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055557|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
83055558|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83055559|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83055560|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055561|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
83055562|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
83055563|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83055564|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
83055565|NCT04459078|Apatinib|apatinib|mesh-list
83055566|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83055567|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055568|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83055569|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055570|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055571|NCT04459078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055572|NCT02756832|Alogliptin|alogliptin|mesh-list
83055573|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055574|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055575|NCT02756832|Incretins|incretins|mesh-ancestor
83055576|NCT02756832|Hormones|hormones|mesh-ancestor
83055577|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055578|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83055579|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055580|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055581|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055582|NCT00108810|Ketoprofen|ketoprofen|mesh-list
83055583|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83055584|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055585|NCT00108810|Analgesics|analgesics|mesh-ancestor
83055586|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
83055587|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055588|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055589|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055590|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83055591|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83055592|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055593|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055594|NCT04448392|Valacyclovir|valacyclovir|mesh-list
83055595|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
83055596|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055597|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
83055598|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83055599|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
83055600|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83055601|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055602|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055603|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055604|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
83055605|NCT02256150|Mizoribine|mizoribine|mesh-list
83055606|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
83055607|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83055608|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
83055609|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055610|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83055611|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83055612|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
83055613|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055614|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055615|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83055616|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83055617|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055618|NCT02256150|Analgesics|analgesics|mesh-ancestor
83055619|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
83361747|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
83055620|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055621|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055622|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055623|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055624|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83055625|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
83055626|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83055627|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83055628|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055629|NCT02177370|Fenoterol|fenoterol|mesh-list
83055630|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055631|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
83055632|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055633|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055634|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055635|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055636|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
83055637|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
83055638|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055639|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83055640|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83055641|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83055642|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055643|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055644|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055645|NCT03538704|Metformin|metformin|mesh-list
83055646|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055647|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055648|NCT02172768|Micafungin|micafungin|mesh-list
83055649|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
83055650|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055651|NCT02172846|Paclitaxel|paclitaxel|mesh-list
83055652|NCT02172846|Carboplatin|carboplatin|mesh-list
83055653|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83055654|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055655|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83055656|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83055657|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83055658|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055659|NCT00106626|Pemetrexed|pemetrexed|mesh-list
83055660|NCT00106626|Vorinostat|vorinostat|mesh-list
83055661|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055662|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055663|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055664|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83055665|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83055666|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83055667|NCT02177448|Enalapril|enalapril|mesh-list
83055668|NCT02177448|Enalaprilat|enalaprilat|mesh-list
83055669|NCT02177448|Telmisartan|telmisartan|mesh-list
83055670|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83055671|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055672|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055673|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055674|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83055675|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83055676|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83055677|NCT03537144|Acetaminophen|acetaminophen|mesh-list
83055678|NCT03537144|Indomethacin|indomethacin|mesh-list
83055679|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055680|NCT03537144|Analgesics|analgesics|mesh-ancestor
83055681|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
83055682|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055683|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055684|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
83055685|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83055686|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055687|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83055688|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
83055689|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
83055690|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055691|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83055692|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055693|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055694|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
83361748|NCT03166254|Vaccines|vaccines|mesh-list
83055695|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055696|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055697|NCT03065764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055698|NCT03065764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055700|NCT02755818|Calcium heparin|calcium heparin|mesh-list
83055701|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
83055702|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83055703|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83055704|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055705|NCT02177760|Sirolimus|sirolimus|mesh-list
83055706|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055707|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055708|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83055709|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055710|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
83055711|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83055712|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
83055713|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055714|NCT02173782|Fenoterol|fenoterol|mesh-list
83055715|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83055716|NCT02173782|Ipratropium|ipratropium|mesh-list
83055717|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055718|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
83055719|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055720|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055721|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055722|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055723|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
83055724|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
83055725|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055726|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83055727|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83055728|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83055729|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055730|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055731|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055732|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83055733|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
83055734|NCT05571592|Cannabidiol|cannabidiol|mesh-list
83055735|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
83055736|NCT05717374|Dexamethasone|dexamethasone|mesh-list
83055737|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
83055738|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
83055739|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83055740|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83055741|NCT05717374|Prednisolone|prednisolone|mesh-list
83055742|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
83055743|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83055744|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
83055745|NCT05717374|BB 1101|bb 1101|mesh-list
83055746|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055747|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
83055748|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
83055749|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055750|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055751|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83055752|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
83055753|NCT05717374|Hormones|hormones|mesh-ancestor
83055754|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055755|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83055756|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055757|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055758|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055759|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055760|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83055761|NCT05717374|Protective Agents|protective agents|mesh-ancestor
83055762|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
83055763|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
83055764|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83055765|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
83055766|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83055767|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055768|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83055769|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83055770|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83055772|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
83055773|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83055774|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83055775|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055776|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055777|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83055778|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83055779|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
83055780|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
83055781|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055782|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055783|NCT02174172|Interferons|interferons|mesh-list
83055784|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
83055785|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
83055786|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83055787|NCT02174172|Bevacizumab|bevacizumab|mesh-list
83055788|NCT02174172|Ipilimumab|ipilimumab|mesh-list
83055789|NCT02174172|Atezolizumab|atezolizumab|mesh-list
83055790|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
83055791|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055792|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055793|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83055794|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83055795|NCT02174172|Growth Substances|growth substances|mesh-ancestor
83055796|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055797|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
83055798|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
83055799|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055800|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055801|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055802|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
83055803|NCT02180334|Acetaminophen|acetaminophen|mesh-list
83055804|NCT02180334|Linagliptin|linagliptin|mesh-list
83055805|NCT02180334|Mosapride|mosapride|mesh-list
83055806|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055807|NCT02180334|Analgesics|analgesics|mesh-ancestor
83055808|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
83055809|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055810|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055811|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
83055812|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055813|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055814|NCT02180334|Incretins|incretins|mesh-ancestor
83055815|NCT02180334|Hormones|hormones|mesh-ancestor
83055816|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055817|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83055818|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055819|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055820|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83055821|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83055822|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
83055823|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055824|NCT02174250|Rifampin|rifampin|mesh-list
83055825|NCT02174250|Istradefylline|istradefylline|mesh-list
83055826|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83055827|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
83055828|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055829|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055830|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
83055831|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83055832|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055833|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055834|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83055835|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83055836|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83055837|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83055838|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83055839|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83055840|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83055841|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83055842|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83055843|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
83055844|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055845|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055847|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83055848|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83055849|NCT02174328|Analgesics|analgesics|mesh-ancestor
83055850|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
83055851|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055852|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055853|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83055854|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83055855|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83055856|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83055857|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055858|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83055859|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83055860|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055861|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
83055862|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
83055863|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83055864|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055865|NCT02755116|Olanzapine|olanzapine|mesh-list
83055866|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
83055867|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
83055868|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055869|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055870|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83055871|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83055872|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83055873|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055874|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83055875|NCT02755116|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83055876|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83055877|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83055878|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055879|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055880|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
83055881|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
83055882|NCT02178150|Antacids|antacids|mesh-ancestor
83055883|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055884|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83055885|NCT04411030|Itraconazole|itraconazole|mesh-list
83055886|NCT04411030|Midazolam|midazolam|mesh-list
83055887|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83055888|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83055889|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055890|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055891|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83055892|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83055893|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83055894|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83055895|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
83055896|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
83055897|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
83055898|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
83055899|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055900|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055901|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
83055902|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055903|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83055904|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83055905|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055906|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83055907|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
83055908|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83055909|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83055910|NCT04437654|Apixaban|apixaban|mesh-list
83055911|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83055912|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
83055913|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83055914|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
83055915|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055916|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055917|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
83055918|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
83055919|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83055920|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
83055921|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
83055922|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
83055923|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83055924|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055925|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
83055926|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055927|NCT02182050|Nintedanib|nintedanib|mesh-list
83055928|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055929|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83055930|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055931|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055932|NCT02182128|Nintedanib|nintedanib|mesh-list
83055933|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055934|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83055935|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055936|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055937|NCT02182206|Nintedanib|nintedanib|mesh-list
83055938|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055939|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83055940|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055941|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055942|NCT03963544|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83055943|NCT03963544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83055944|NCT03963544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055945|NCT03963544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055946|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
83055947|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055948|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
83055949|NCT02657889|Niraparib|niraparib|mesh-list
83055950|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055951|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055952|NCT02657889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055953|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055954|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83055955|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83055956|NCT03536208|Warfarin|warfarin|mesh-list
83055957|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
83055958|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83055959|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83055960|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
83055961|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83055962|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055963|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83055964|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
83055965|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83055966|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83055967|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83055968|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
83055969|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83055970|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055971|NCT02631538|Rituximab|rituximab|mesh-list
83055972|NCT02631538|Belimumab|belimumab|mesh-list
83055973|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055974|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055975|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
83055976|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055977|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83055978|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83055979|NCT03578679|Ivermectin|ivermectin|mesh-list
83055980|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83055981|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055982|NCT04930783|Nivolumab|nivolumab|mesh-list
83055983|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83055984|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83055985|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83055986|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055987|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83055988|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
83055989|NCT05666206|Coagulants|coagulants|mesh-ancestor
83055990|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
83055991|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83055992|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83055993|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83055994|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83055995|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83055996|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83055997|NCT02256462|Adalimumab|adalimumab|mesh-list
83055998|NCT02256462|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83055999|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056000|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056001|NCT02631148|Melatonin|melatonin|mesh-list
83056002|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
83056003|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056004|NCT02631148|Protective Agents|protective agents|mesh-ancestor
83056005|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056006|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056007|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
83056008|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83056009|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
83056010|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056011|NCT02239107|Expectorants|expectorants|mesh-ancestor
83056012|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
83056013|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83056014|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
83056015|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056016|NCT02239107|Protective Agents|protective agents|mesh-ancestor
83056017|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056018|NCT02239107|Antidotes|antidotes|mesh-ancestor
83056019|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
83056020|NCT02182518|Ephedrine|ephedrine|mesh-list
83056021|NCT02182518|Epinastine|epinastine|mesh-list
83056022|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83056023|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
83056024|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056025|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056026|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83056027|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
83056028|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
83056029|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83056030|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83056031|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
83056032|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
83056033|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056034|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056035|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83056036|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
83056037|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
83056038|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
83056039|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056040|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056041|NCT03881488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83056042|NCT03881488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056043|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83056044|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056045|NCT03810742|Irinotecan|irinotecan|mesh-list
83056046|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83056047|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83056048|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056049|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056050|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056051|NCT03574857|Metolazone|metolazone|mesh-list
83056052|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
83056053|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83056054|NCT03574857|Diuretics|diuretics|mesh-ancestor
83056055|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
83056056|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056057|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83056058|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056059|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056060|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
83056061|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83056062|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83056063|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056064|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
83056065|NCT02238639|Coagulants|coagulants|mesh-ancestor
83056066|NCT02186028|Vitamin D|vitamin d|mesh-list
83056067|NCT02186028|Vitamins|vitamins|mesh-ancestor
83056068|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
83056069|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056070|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83056071|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
83056072|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056073|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056074|NCT02182596|Immunotoxins|immunotoxins|mesh-ancestor
83056075|NCT02182596|Immunoconjugates|immunoconjugates|mesh-ancestor
83056076|NCT02182596|Immunologic Factors|immunologic factors|mesh-ancestor
83056077|NCT02182596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056078|NCT03574701|Vitamin A|vitamin a|mesh-list
83056079|NCT03574701|Vitamins|vitamins|mesh-ancestor
83056080|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
83056081|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056082|NCT02180880|Pregabalin|pregabalin|mesh-list
83056083|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
83056084|NCT02180880|Analgesics|analgesics|mesh-ancestor
83056085|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
83056086|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056087|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056088|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
83056089|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83056090|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056091|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056092|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83056093|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83056094|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83056095|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056096|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83056097|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83056098|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83056099|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83056100|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83056102|NCT02186106|Vitamin D|vitamin d|mesh-list
83056103|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83056104|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056105|NCT02186106|Vitamins|vitamins|mesh-ancestor
83056106|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
83056107|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83056108|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
83056109|NCT03943147|Deucravacitinib|deucravacitinib|mesh-list
83056110|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83056111|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056112|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83056113|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
83056114|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83056115|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056116|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056117|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056118|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
83056119|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83056120|NCT02182752|Tramadol|tramadol|mesh-list
83056121|NCT02182752|Ropivacaine|ropivacaine|mesh-list
83056122|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
83056123|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
83056124|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056125|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056126|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
83056127|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056128|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83056129|NCT02182752|Narcotics|narcotics|mesh-ancestor
83056130|NCT02182752|Analgesics|analgesics|mesh-ancestor
83056131|NCT03536598|Amlodipine|amlodipine|mesh-list
83056132|NCT03536598|Valsartan|valsartan|mesh-list
83056133|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83056134|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83056135|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83056136|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056137|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056138|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83056139|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056140|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
83056141|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83056142|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83056143|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
83056144|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83361749|NCT03166254|Poly ICLC|poly iclc|mesh-list
83056145|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83056146|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056147|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83056148|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83056149|NCT03576963|Nivolumab|nivolumab|mesh-list
83056150|NCT03576963|Guadecitabine|guadecitabine|mesh-list
83056151|NCT03576963|Azacitidine|azacitidine|mesh-list
83056152|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056153|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056154|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83056155|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056156|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83056157|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
83056158|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056159|NCT02186496|Amlodipine|amlodipine|mesh-list
83056160|NCT02186496|Candesartan|candesartan|mesh-list
83056161|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83056162|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83056163|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056164|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056165|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83056166|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056167|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
83056168|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83056169|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83056170|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
83056171|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83056172|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056173|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056174|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056175|NCT05615194|Analgesics|analgesics|mesh-ancestor
83056176|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
83056177|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056178|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83056179|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83056180|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83056181|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
83056182|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056183|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056184|NCT02186574|Tenofovir|tenofovir|mesh-list
83056185|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
83056186|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056187|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83056188|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83056189|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056190|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056191|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83056192|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83056193|NCT03066700|Hemostatics|hemostatics|mesh-list
83056194|NCT03066700|Coagulants|coagulants|mesh-ancestor
83056195|NCT03066544|Dexamethasone|dexamethasone|mesh-list
83056196|NCT03066544|Ketorolac|ketorolac|mesh-list
83056197|NCT03066544|Naratriptan|naratriptan|mesh-list
83056198|NCT03066544|Bupivacaine|bupivacaine|mesh-list
83056199|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056200|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
83056201|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
83056202|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056203|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056204|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056205|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
83056206|NCT03066544|Hormones|hormones|mesh-ancestor
83056207|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056208|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83056209|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056210|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
83056211|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
83056212|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056213|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
83056214|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056215|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056216|NCT03066544|Analgesics|analgesics|mesh-ancestor
83056217|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056218|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056219|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056220|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056221|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83056222|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83056223|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83056224|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
83056225|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056226|NCT03182179|Ondansetron|ondansetron|mesh-list
83056227|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
83056228|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
83056229|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056230|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056231|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056232|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
83056233|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
83056234|NCT03182179|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83056235|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83056236|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
83056237|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056238|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056239|NCT03576651|Bevacizumab|bevacizumab|mesh-list
83056240|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056241|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056242|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83056243|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83056244|NCT03576651|Growth Substances|growth substances|mesh-ancestor
83056245|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056246|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
83056248|NCT04116112|Hydralazine|hydralazine|mesh-list
83056249|NCT04116112|Nicardipine|nicardipine|mesh-list
83056250|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83056251|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83056252|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
83056253|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056254|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056255|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056256|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83056257|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
83056258|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
83056259|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056260|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83056261|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83056262|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
83056263|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83056264|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056265|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83056266|NCT03064906|Pancrelipase|pancrelipase|mesh-list
83056267|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056268|NCT03034135|Copper|copper|mesh-list
83056269|NCT03034135|Temozolomide|temozolomide|mesh-list
83056270|NCT03034135|Disulfiram|disulfiram|mesh-list
83056271|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83056272|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
83056273|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056274|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056275|NCT03034135|Trace Elements|trace elements|mesh-ancestor
83056276|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
83056277|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056278|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83056279|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83056280|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056281|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83056282|NCT02239731|Doxycycline|doxycycline|mesh-list
83056283|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056284|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
83056285|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83056286|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83056287|NCT03571815|Listerine|listerine|mesh-list
83056288|NCT03571815|Fluorides|fluorides|mesh-list
83056289|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
83056290|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
83056291|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
83056292|NCT03571815|Protective Agents|protective agents|mesh-ancestor
83056293|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056294|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83056295|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056296|NCT03571737|Ibuprofen|ibuprofen|mesh-list
83056297|NCT03571737|Lidocaine|lidocaine|mesh-list
83056298|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
83056299|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
83056300|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056301|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056302|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
83056303|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056304|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83056305|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83056306|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83056307|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056308|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056309|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056310|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056311|NCT03571737|Analgesics|analgesics|mesh-ancestor
83056312|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056313|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056314|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056315|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056316|NCT03573999|Mannitol|mannitol|mesh-list
83056317|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83056318|NCT03573999|Diuretics|diuretics|mesh-ancestor
83056319|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
83056320|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056321|NCT04606069|Regadenoson|regadenoson|mesh-list
83056322|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83056323|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83056324|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
83056325|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
83056326|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056327|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056328|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056330|NCT03063190|Vitamins|vitamins|mesh-ancestor
83056331|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
83056332|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056333|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83056339|NCT03573687|Caseins|caseins|mesh-list
83056340|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
83056341|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
83056342|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056343|NCT01671280|Azithromycin|azithromycin|mesh-list
83056344|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83056345|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056346|NCT04904302|Nivolumab|nivolumab|mesh-list
83056347|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056348|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056349|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83056350|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056351|NCT03575637|Olanzapine|olanzapine|mesh-list
83056352|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
83056353|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
83056354|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056355|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056356|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056357|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83056358|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83056359|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056360|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83056361|NCT03575637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83056362|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83056363|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056364|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056365|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056366|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
83056367|NCT03062800|Thalidomide|thalidomide|mesh-list
83056368|NCT03062800|Carboplatin|carboplatin|mesh-list
83056370|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056371|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056372|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056373|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83056374|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83056375|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83056376|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
83056377|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056378|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
83056379|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83056380|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056381|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83056382|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83056383|NCT03062800|Growth Substances|growth substances|mesh-ancestor
83056384|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83056385|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
83056386|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83056387|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83056388|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056389|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
83056390|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
83056391|NCT03418779|Prednisolone|prednisolone|mesh-list
83056392|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
83056393|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83056394|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
83056395|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056396|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056397|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83056398|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
83056399|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056400|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056401|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83056402|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056404|NCT03418779|Hormones|hormones|mesh-ancestor
83056405|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056406|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83056407|NCT03573063|Androgens|androgens|mesh-list
83056408|NCT03573063|Hormones|hormones|mesh-ancestor
83056409|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056410|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056411|NCT03572829|Dexamethasone|dexamethasone|mesh-list
83056412|NCT03572829|Ondansetron|ondansetron|mesh-list
83056413|NCT03572829|Aprepitant|aprepitant|mesh-list
83056414|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056415|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
83056416|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
83056417|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056418|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056419|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056420|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
83056421|NCT03572829|Hormones|hormones|mesh-ancestor
83056422|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056423|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83056424|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056425|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056426|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
83056427|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
83056428|NCT03572829|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83056429|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83056430|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
83056431|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056432|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83056433|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
83056434|NCT03575247|Hormones|hormones|mesh-ancestor
83056435|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056436|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056437|NCT03704623|Acetaminophen|acetaminophen|mesh-list
83056438|NCT03704623|Parecoxib|parecoxib|mesh-list
83056439|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056440|NCT03704623|Analgesics|analgesics|mesh-ancestor
83056441|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
83056442|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056443|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056444|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
83056445|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83056446|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056447|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056448|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056449|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056450|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056451|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056452|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83056453|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83056454|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056455|NCT03572517|Morphine|morphine|mesh-list
83056456|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83056457|NCT03572517|Narcotics|narcotics|mesh-ancestor
83056458|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056459|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056460|NCT03572517|Analgesics|analgesics|mesh-ancestor
83056461|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
83056462|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056463|NCT03570645|Dexamethasone|dexamethasone|mesh-list
83056464|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
83056465|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056466|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
83056467|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
83056468|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056469|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056470|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056471|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
83056472|NCT03570645|Hormones|hormones|mesh-ancestor
83056473|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056474|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83056475|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056476|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83056477|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056479|NCT03570645|Analgesics|analgesics|mesh-ancestor
83056480|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
83056481|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83056482|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83056483|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83056484|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
83056485|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056486|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056487|NCT03940690|Bevacizumab|bevacizumab|mesh-list
83056488|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056489|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056490|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83056491|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83056492|NCT03940690|Growth Substances|growth substances|mesh-ancestor
83056493|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056494|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
83056495|NCT03567135|Temozolomide|temozolomide|mesh-list
83056496|NCT03567135|Apatinib|apatinib|mesh-list
83056497|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83056498|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
83056499|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056500|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056501|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83056502|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056503|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
83056504|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83056505|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056506|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056507|NCT03698383|Trastuzumab|trastuzumab|mesh-list
83056508|NCT03698383|Gedatolisib|gedatolisib|mesh-list
83056509|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361755|NCT03166254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056510|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056511|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83056512|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056513|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056514|NCT04760782|Abaloparatide|abaloparatide|mesh-list
83056515|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83056516|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056517|NCT05708859|Tirzepatide|tirzepatide|mesh-list
83056518|NCT05708859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83056519|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056520|NCT05708859|Incretins|incretins|mesh-ancestor
83056521|NCT05708859|Hormones|hormones|mesh-ancestor
83056522|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056523|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
83056524|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83056525|NCT04740580|Glycine|glycine|mesh-list
83056526|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
83056527|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056528|NCT04740580|Expectorants|expectorants|mesh-ancestor
83056529|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
83056530|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83056531|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
83056532|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056533|NCT04740580|Protective Agents|protective agents|mesh-ancestor
83056534|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056535|NCT04740580|Antidotes|antidotes|mesh-ancestor
83056536|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
83056537|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056538|NCT03064282|Papaverine|papaverine|mesh-list
83056539|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83056540|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056541|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056542|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
83056543|NCT03064282|Urological Agents|urological agents|mesh-ancestor
83056544|NCT04679818|Fentanyl|fentanyl|mesh-list
83056545|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
83056546|NCT04679818|Narcotics|narcotics|mesh-ancestor
83056547|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056548|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056549|NCT04679818|Analgesics|analgesics|mesh-ancestor
83056550|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
83056551|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056552|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83056553|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83056554|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
83056555|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
83056556|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83056557|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056558|NCT03063112|Ethanol|ethanol|mesh-list
83056559|NCT03063112|Lidocaine|lidocaine|mesh-list
83056560|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
83056561|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
83056562|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056563|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056564|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
83056565|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056566|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83056567|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83056568|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83056569|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056570|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056571|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83056572|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056573|NCT04767217|Lumefantrine|lumefantrine|mesh-list
83056574|NCT04767217|Artemether|artemether|mesh-list
83056575|NCT04767217|Piperaquine|piperaquine|mesh-list
83056576|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83056577|NCT04767217|Artenimol|artenimol|mesh-list
83056578|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
83056579|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83056580|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83056581|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056582|NCT03701503|Hormones|hormones|mesh-list
83056583|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056584|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056585|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
83056586|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83056587|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83056588|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83056589|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056590|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056591|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
83056592|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056593|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056594|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83056595|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056596|NCT03698227|Doxorubicin|doxorubicin|mesh-list
83056597|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
83056598|NCT03698227|Razoxane|razoxane|mesh-list
83056599|NCT03698227|Olaratumab|olaratumab|mesh-list
83056600|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83056601|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056602|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83056603|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83056604|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056605|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056606|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83056607|NCT03698227|Protective Agents|protective agents|mesh-ancestor
83056608|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056609|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83056610|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83056611|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83056612|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056613|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83056614|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056615|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056616|NCT04434664|Metoprolol|metoprolol|mesh-list
83056617|NCT04434664|Amlodipine|amlodipine|mesh-list
83056618|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83056619|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83056620|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056621|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056622|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83056623|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056624|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
83056626|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
83056627|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
83056628|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056629|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83056630|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83056631|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83056632|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
83056633|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056634|NCT02181348|Vitamin E|vitamin e|mesh-list
83056635|NCT02181348|Vitamins|vitamins|mesh-ancestor
83056636|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
83056637|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056638|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
83056639|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056640|NCT02181348|Protective Agents|protective agents|mesh-ancestor
83056641|NCT02186886|Golimumab|golimumab|mesh-list
83056642|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83056643|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056644|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83056645|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
83056646|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056647|NCT03722680|Riluzole|riluzole|mesh-list
83056648|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
83056649|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83056650|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83056651|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056652|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056653|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056654|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83056655|NCT03722680|Protective Agents|protective agents|mesh-ancestor
83056656|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83056657|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
83056658|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056659|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
83361756|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
83056660|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
83056661|NCT03536910|Coagulants|coagulants|mesh-ancestor
83056662|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83056663|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83056664|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
83056665|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056666|NCT04308174|Durvalumab|durvalumab|mesh-list
83056667|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056668|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056669|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
83056670|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83056671|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83056672|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056673|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
83056674|NCT03697681|Coagulants|coagulants|mesh-ancestor
83056675|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83056676|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056677|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056678|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
83056679|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056680|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056681|NCT02683239|Fasinumab|fasinumab|mesh-list
83056682|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056683|NCT02683239|Analgesics|analgesics|mesh-ancestor
83056684|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
83056685|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056686|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056687|NCT02183064|Meloxicam|meloxicam|mesh-list
83056688|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056689|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056690|NCT02183064|Analgesics|analgesics|mesh-ancestor
83056691|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
83056692|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056693|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056694|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056695|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056696|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83056697|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056698|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056699|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056700|NCT03704077|Paclitaxel|paclitaxel|mesh-list
83056701|NCT03704077|Nivolumab|nivolumab|mesh-list
83056702|NCT03704077|Ramucirumab|ramucirumab|mesh-list
83056703|NCT03704077|Relatlimab|relatlimab|mesh-list
83056704|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83056705|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056706|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
83056707|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
83056708|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
83056709|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056710|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056711|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83056712|NCT03618550|Gemcitabine|gemcitabine|mesh-list
83056713|NCT03618550|Doxorubicin|doxorubicin|mesh-list
83056714|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83056715|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
83056716|NCT03618550|Vinorelbine|vinorelbine|mesh-list
83056717|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83056718|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
83056719|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056720|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056721|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83056722|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83056723|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83056724|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056725|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056726|NCT03618550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83056727|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83056728|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
83056729|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
83056730|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
83056731|NCT02183142|Meloxicam|meloxicam|mesh-list
83056732|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056733|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056734|NCT02183142|Analgesics|analgesics|mesh-ancestor
83056735|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
83361757|NCT02651428|Taurolidine|taurolidine|mesh-list
83056736|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056737|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056738|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056739|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056740|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83056741|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056742|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056743|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056744|NCT02183220|Aspirin|aspirin|mesh-list
83056745|NCT02183220|Dipyrone|dipyrone|mesh-list
83056746|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056747|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056748|NCT02183220|Analgesics|analgesics|mesh-ancestor
83056749|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
83056750|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056751|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056752|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056753|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056754|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83056755|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83056756|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056757|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83056758|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056759|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056760|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
83056761|NCT02187588|Ibuprofen|ibuprofen|mesh-list
83056762|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056763|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056764|NCT02187588|Analgesics|analgesics|mesh-ancestor
83056765|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
83056766|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056767|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056768|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056769|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056770|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056771|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056772|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056773|NCT05364489|Bevacizumab|bevacizumab|mesh-list
83056774|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
83056775|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056776|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056777|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83056778|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83056779|NCT05364489|Growth Substances|growth substances|mesh-ancestor
83056780|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056781|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
83056782|NCT02183298|Linagliptin|linagliptin|mesh-list
83056783|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83056784|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056785|NCT02183298|Incretins|incretins|mesh-ancestor
83056786|NCT02183298|Hormones|hormones|mesh-ancestor
83056787|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056788|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83056789|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
83056790|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056791|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056792|NCT03697057|Anesthetics|anesthetics|mesh-list
83056793|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056794|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056795|NCT02183376|Linagliptin|linagliptin|mesh-list
83056796|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83056797|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056798|NCT02183376|Incretins|incretins|mesh-ancestor
83056799|NCT02183376|Hormones|hormones|mesh-ancestor
83056800|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056801|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83056802|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
83056803|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056804|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056806|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056807|NCT03696901|Dalbavancin|dalbavancin|mesh-list
83056808|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83056809|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056810|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
83056811|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
83056812|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83056813|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056814|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83056815|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
83056816|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83056817|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056818|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056819|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056820|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83056821|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83056822|NCT02187900|Protective Agents|protective agents|mesh-ancestor
83056823|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056824|NCT03062644|Celecoxib|celecoxib|mesh-list
83056825|NCT03062644|Tramadol|tramadol|mesh-list
83056826|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83056827|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83056828|NCT03062644|Analgesics|analgesics|mesh-ancestor
83056829|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
83056830|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056831|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056832|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056833|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056834|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83056835|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83056836|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056837|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056838|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83056839|NCT03062644|Narcotics|narcotics|mesh-ancestor
83056840|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83056841|NCT02190318|Losartan|losartan|mesh-list
83056842|NCT02190318|Spironolactone|spironolactone|mesh-list
83056843|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83056844|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83056845|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83056846|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83056847|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056848|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83056849|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
83056850|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056851|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056852|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83056853|NCT02190318|Diuretics|diuretics|mesh-ancestor
83056854|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
83056855|NCT04743661|Antipyretics|antipyretics|mesh-list
83056856|NCT04743661|Dexamethasone|dexamethasone|mesh-list
83056857|NCT04743661|Bevacizumab|bevacizumab|mesh-list
83056858|NCT04743661|Irinotecan|irinotecan|mesh-list
83056859|NCT04743661|Temozolomide|temozolomide|mesh-list
83056860|NCT04743661|Antiemetics|antiemetics|mesh-list
83056861|NCT04743661|Emetics|emetics|mesh-list
83056862|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
83056863|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83056864|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056865|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056866|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83056867|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83056868|NCT04743661|Growth Substances|growth substances|mesh-ancestor
83056869|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056870|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
83056871|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056872|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
83056873|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056874|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056875|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
83056876|NCT04743661|Hormones|hormones|mesh-ancestor
83056877|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056878|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83438992|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
83056879|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83056880|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83056881|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056882|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056883|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83056884|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
83056885|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
83056886|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83056887|NCT02183532|Linagliptin|linagliptin|mesh-list
83056888|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83056889|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056890|NCT02183532|Incretins|incretins|mesh-ancestor
83056891|NCT02183532|Hormones|hormones|mesh-ancestor
83056892|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056893|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83056894|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
83056895|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056896|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056897|NCT03569631|BPN14770|bpn14770|mesh-list
83056898|NCT03569631|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83056899|NCT03569631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83056900|NCT03569631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056901|NCT03569631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056902|NCT02629822|Tenofovir|tenofovir|mesh-list
83056903|NCT02629822|Lamivudine|lamivudine|mesh-list
83056904|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
83056905|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83056906|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83056907|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83056908|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056909|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056910|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83056911|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83056912|NCT03700801|Insulin|insulin|mesh-list
83056913|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83056914|NCT03700801|Metformin|metformin|mesh-list
83056915|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
83056916|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
83056917|NCT03700801|Saxagliptin|saxagliptin|mesh-list
83056918|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83056919|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056920|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83056921|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056923|NCT03700801|Hormones|hormones|mesh-ancestor
83056924|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056925|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83056926|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
83056927|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056928|NCT03700645|Allopurinol|allopurinol|mesh-list
83056929|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
83056930|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056931|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056932|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
83056933|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83056934|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83056935|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
83056936|NCT03700645|Protective Agents|protective agents|mesh-ancestor
83056937|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056938|NCT04499053|Durvalumab|durvalumab|mesh-list
83056939|NCT04499053|Tremelimumab|tremelimumab|mesh-list
83056940|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056941|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056942|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
83056943|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
83056944|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83056945|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83056946|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83056947|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056948|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83056949|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83056950|NCT03567447|Droxidopa|droxidopa|mesh-list
83056951|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83056952|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83056953|NCT03567369|Dexamethasone|dexamethasone|mesh-list
83056954|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
83056955|NCT03567369|BB 1101|bb 1101|mesh-list
83056956|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056957|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
83056958|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
83056959|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056960|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056961|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056962|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
83056964|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056965|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83056966|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056967|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
83056968|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83056969|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056970|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
83056971|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83056972|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056973|NCT03397654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83056974|NCT03397654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83056975|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
83056976|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83056977|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83056978|NCT03266146|Prednisolone|prednisolone|mesh-list
83056979|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
83056980|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83056981|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
83056982|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83056983|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
83056984|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
83056985|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83056986|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83056987|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83056988|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
83056989|NCT03266146|Hormones|hormones|mesh-ancestor
83056990|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83056991|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83056992|NCT03266146|Protective Agents|protective agents|mesh-ancestor
83056993|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83056994|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83056995|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
83056996|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
83056997|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83056998|NCT03700489|Protective Agents|protective agents|mesh-ancestor
83056999|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057000|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
83057001|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83057002|NCT02800941|Warfarin|warfarin|mesh-list
83057003|NCT02800941|Anticoagulants|anticoagulants|mesh-list
83057004|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
83057005|NCT02800941|Fluindione|fluindione|mesh-list
83057006|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
83057007|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83057008|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
83057009|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
83057010|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057011|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057012|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83057013|NCT03695887|Analgesics|analgesics|mesh-ancestor
83057014|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
83057015|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057016|NCT04432714|Prednisone|prednisone|mesh-list
83057017|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
83057018|NCT04432714|Rituximab|rituximab|mesh-list
83057019|NCT04432714|Doxorubicin|doxorubicin|mesh-list
83057020|NCT04432714|Etoposide|etoposide|mesh-list
83057021|NCT04432714|Vincristine|vincristine|mesh-list
83057022|NCT04432714|Lenalidomide|lenalidomide|mesh-list
83057023|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057024|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
83057025|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057026|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057027|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83057028|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
83057029|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057030|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057031|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83057032|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057033|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83057034|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83057035|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83057036|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057037|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057038|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
83057040|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057041|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057042|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83057043|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
83057044|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
83057045|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
83057046|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83057047|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83057048|NCT04432714|Growth Substances|growth substances|mesh-ancestor
83057049|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
83057050|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
83057051|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057052|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057053|NCT02752074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83057054|NCT02752074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057055|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
83057056|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83057057|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057058|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057059|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83057060|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83057061|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
83057062|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83057063|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
83057064|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83057065|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057066|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057067|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83057068|NCT03624595|Analgesics|analgesics|mesh-ancestor
83057069|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
83057070|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057071|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83057072|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83057073|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83057074|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
83057075|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057076|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057077|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
83057078|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83057079|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83057080|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057081|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
83057082|NCT03063892|Coagulants|coagulants|mesh-ancestor
83057083|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83057084|NCT03063580|Rifampin|rifampin|mesh-list
83057085|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83057086|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
83057087|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057088|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057089|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
83057090|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057091|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057092|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057093|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83057094|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83057095|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83057096|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83057097|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83057098|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83057099|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83057100|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83057101|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057102|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83057103|NCT05353101|Cyclosporine|cyclosporine|mesh-list
83057104|NCT05353101|Tobramycin|tobramycin|mesh-list
83057105|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83057106|NCT05353101|Cyclosporins|cyclosporins|mesh-list
83057107|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057108|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057109|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057110|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
83057111|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057112|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
83057113|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057114|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83057115|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057116|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83057117|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83057118|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057119|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83057120|NCT03700333|Pemetrexed|pemetrexed|mesh-list
83057121|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057122|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057123|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057124|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83057125|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057126|NCT03700177|Dexamethasone|dexamethasone|mesh-list
83057127|NCT03700177|Ropivacaine|ropivacaine|mesh-list
83057128|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057129|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
83057130|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
83057131|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057132|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057133|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057134|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
83057135|NCT03700177|Hormones|hormones|mesh-ancestor
83057136|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057137|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057138|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057139|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
83057140|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
83057141|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057142|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
83057143|NCT02183610|Linagliptin|linagliptin|mesh-list
83057144|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83057145|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83057146|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057148|NCT02183610|Hormones|hormones|mesh-ancestor
83057149|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057150|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83057151|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
83057152|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057153|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057154|NCT02183688|Acetaminophen|acetaminophen|mesh-list
83057155|NCT02183688|Caffeine|caffeine|mesh-list
83057156|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83057157|NCT02183688|Analgesics|analgesics|mesh-ancestor
83057158|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
83057159|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057160|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057161|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
83057162|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83057163|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83057164|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057165|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057166|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83057167|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83057168|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
83057169|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057170|NCT02190708|Midazolam|midazolam|mesh-list
83057171|NCT02190708|Omeprazole|omeprazole|mesh-list
83057172|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83057173|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83057174|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83057175|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057176|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057177|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83057178|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83057179|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83057180|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83057181|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
83057182|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
83057183|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
83057184|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
83057185|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057186|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057187|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83057188|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057189|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057190|NCT05338983|Anesthetics|anesthetics|mesh-list
83057191|NCT05338983|Mepivacaine|mepivacaine|mesh-list
83057192|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
83057193|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057194|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057195|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
83057196|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057197|NCT03063658|Acetaminophen|acetaminophen|mesh-list
83057198|NCT03063658|Ibuprofen|ibuprofen|mesh-list
83057199|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83057200|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83057201|NCT03063658|Analgesics|analgesics|mesh-ancestor
83057202|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
83057203|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057204|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057205|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057206|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057207|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83057208|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057209|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057210|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
83057211|NCT03695107|Nifedipine|nifedipine|mesh-list
83057212|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83057213|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83057214|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057215|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83057216|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057217|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
83057218|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
83057219|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83057220|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
83057221|NCT02835339|Analgesics|analgesics|mesh-ancestor
83057222|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
83057223|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439013|NCT04682847|Hematinics|hematinics|mesh-ancestor
83057224|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057225|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
83057226|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057227|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83057228|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
83057229|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83057230|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83057231|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057232|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83057233|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
83057234|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83057235|NCT03695029|Tenofovir|tenofovir|mesh-list
83057236|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
83057237|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057238|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83057239|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057240|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057241|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057242|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057243|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057244|NCT02259855|Interferons|interferons|mesh-list
83057245|NCT02259855|Ritonavir|ritonavir|mesh-list
83057246|NCT02259855|Ribavirin|ribavirin|mesh-list
83057247|NCT02259855|Tipranavir|tipranavir|mesh-list
83057248|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057249|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
83057250|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057251|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83057252|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83057253|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83057254|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057255|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057256|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057257|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057258|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83057259|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83057260|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
83057261|NCT03703063|Leucovorin|leucovorin|mesh-list
83057262|NCT03703063|Paclitaxel|paclitaxel|mesh-list
83057263|NCT03703063|Gemcitabine|gemcitabine|mesh-list
83057264|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83057265|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057266|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
83057267|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
83057268|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
83057269|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057270|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83057271|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
83057272|NCT03703063|Antidotes|antidotes|mesh-ancestor
83057273|NCT03703063|Protective Agents|protective agents|mesh-ancestor
83057274|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057275|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
83057276|NCT03703063|Vitamins|vitamins|mesh-ancestor
83057277|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
83057278|NCT03702985|Capecitabine|capecitabine|mesh-list
83057279|NCT03702985|Irinotecan|irinotecan|mesh-list
83057280|NCT03702985|Amifostine|amifostine|mesh-list
83057281|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83057282|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
83057283|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057284|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057285|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83057286|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83057287|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057288|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83057289|NCT03702985|Protective Agents|protective agents|mesh-ancestor
83057290|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057291|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83057292|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83057293|NCT02184078|Nevirapine|nevirapine|mesh-list
83057294|NCT02184078|Rifabutin|rifabutin|mesh-list
83057295|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83057296|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057297|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057298|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057299|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
83057300|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057301|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057302|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057303|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83057304|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83057305|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057306|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83057307|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
83057308|NCT04323436|Spartalizumab|spartalizumab|mesh-list
83057309|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83057310|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057311|NCT04323436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057312|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057313|NCT03694873|Celecoxib|celecoxib|mesh-list
83057314|NCT03694873|Tramadol|tramadol|mesh-list
83057315|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83057316|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83057317|NCT03694873|Analgesics|analgesics|mesh-ancestor
83057318|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
83057319|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057320|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057321|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057322|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057323|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83057324|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83057325|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057326|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057327|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83057328|NCT03694873|Narcotics|narcotics|mesh-ancestor
83057329|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057330|NCT02191020|Acitretin|acitretin|mesh-list
83057331|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
83057332|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
83057333|NCT04476199|Decitabine|decitabine|mesh-list
83057334|NCT04476199|Venetoclax|venetoclax|mesh-list
83057335|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83057336|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
83057337|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057338|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057339|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057340|NCT02188368|Clarithromycin|clarithromycin|mesh-list
83057341|NCT02188368|Dexamethasone|dexamethasone|mesh-list
83057342|NCT02188368|Prednisone|prednisone|mesh-list
83057343|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
83057344|NCT02188368|Bortezomib|bortezomib|mesh-list
83057345|NCT02188368|Pomalidomide|pomalidomide|mesh-list
83057346|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057347|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
83057348|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057349|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057350|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83057351|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
83057352|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057353|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057354|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83057355|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057356|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
83057357|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
83057358|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057359|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057360|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
83057361|NCT02188368|Hormones|hormones|mesh-ancestor
83057362|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057363|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057364|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057365|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057366|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057367|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83057368|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83057369|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83057370|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83057371|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83057372|NCT02188368|Growth Substances|growth substances|mesh-ancestor
83057373|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
83057374|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
83057375|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
83057376|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83057377|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83057378|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83057379|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057380|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057381|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057383|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83057384|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057385|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057386|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057387|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
83057388|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057389|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057390|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057391|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83057392|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83057393|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
83057394|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057395|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057396|NCT04301011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83057397|NCT04301011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057398|NCT02191332|Nevirapine|nevirapine|mesh-list
83057399|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83057400|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057401|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057402|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057403|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
83057404|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057405|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057406|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83361758|NCT02651428|Heparin|heparin|mesh-list
83057407|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83057408|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83057409|NCT02256774|Ritonavir|ritonavir|mesh-list
83057410|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83057411|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83057412|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83057413|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
83057414|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057415|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057416|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057417|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057418|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
83057419|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057420|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83057421|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83057422|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83057423|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057424|NCT02189304|Budesonide|budesonide|mesh-list
83057425|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
83057426|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
83057427|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83057428|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057429|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83057430|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
83057431|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057432|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057433|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83057434|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83057435|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
83057436|NCT02189304|Hormones|hormones|mesh-ancestor
83057437|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057438|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83057439|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83057440|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83057441|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
83057442|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057443|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057444|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83057445|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83057446|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83057447|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
83057448|NCT02184858|Lisinopril|lisinopril|mesh-list
83057449|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83057450|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
83057451|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057452|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057453|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83057454|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83057455|NCT02184858|Protective Agents|protective agents|mesh-ancestor
83057456|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057457|NCT03535662|Itraconazole|itraconazole|mesh-list
83057458|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
83057459|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057460|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83057461|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83057462|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057463|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057464|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83057465|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
83057466|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057467|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057468|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83057469|NCT03702205|Betaine|betaine|mesh-list
83057470|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057471|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
83057472|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83057473|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
83057474|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057475|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83057476|NCT03698851|Methamphetamine|methamphetamine|mesh-list
83057477|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83057478|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057479|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
83057480|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
83057481|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057482|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
83057483|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057484|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057485|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
83057486|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83057487|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83057488|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83057489|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83057490|NCT03125902|Paclitaxel|paclitaxel|mesh-list
83057491|NCT03125902|Atezolizumab|atezolizumab|mesh-list
83057492|NCT03125902|Antibodies|antibodies|mesh-list
83057493|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83057494|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83057495|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057496|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
83057497|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
83057498|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
83057499|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057500|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
83057501|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057502|NCT03125902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83057503|NCT03125902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057504|NCT02189694|Hormones|hormones|mesh-list
83057505|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057506|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057507|NCT02189772|Metadoxine|metadoxine|mesh-list
83057508|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83057509|NCT02192424|Insulin|insulin|mesh-list
83057510|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83057511|NCT02192424|Metformin|metformin|mesh-list
83057512|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
83057513|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
83057514|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83057515|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057516|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
83057517|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83057518|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057519|NCT02257008|Ritonavir|ritonavir|mesh-list
83057520|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83057521|NCT02257008|Nelfinavir|nelfinavir|mesh-list
83057522|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83057523|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83057524|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
83057525|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057526|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057527|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057528|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057529|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
83057530|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057531|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83057532|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83057533|NCT03693391|Fluorides|fluorides|mesh-list
83057534|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
83057535|NCT03693391|Protective Agents|protective agents|mesh-ancestor
83057536|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057537|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
83057538|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057539|NCT02185326|Hormones|hormones|mesh-list
83057540|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057541|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057542|NCT04412707|Dexamethasone|dexamethasone|mesh-list
83057543|NCT04412707|Melphalan|melphalan|mesh-list
83057544|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057545|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
83057546|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
83057547|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057548|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057549|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057550|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
83057551|NCT04412707|Hormones|hormones|mesh-ancestor
83057552|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057553|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057554|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057555|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83057556|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
83057557|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057558|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83057559|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057560|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
83057561|NCT03698695|Mefloquine|mefloquine|mesh-list
83057562|NCT03698695|Donepezil|donepezil|mesh-list
83057563|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83057564|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057565|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057566|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
83057567|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057568|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057569|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
83057570|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
83057571|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83057572|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83057573|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057574|NCT04729296|Golimumab|golimumab|mesh-list
83057575|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83057576|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057577|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057578|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
83057579|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057580|NCT03698617|Propofol|propofol|mesh-list
83057581|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83057582|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439036|NCT00687167|Zonisamide|zonisamide|mesh-list
83057583|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057584|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83057585|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
83057586|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
83057587|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
83057588|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83057589|NCT02194374|Rituximab|rituximab|mesh-list
83057590|NCT02194374|Fludarabine|fludarabine|mesh-list
83057592|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057593|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
83057594|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057595|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057596|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83057597|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
83057598|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057599|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057600|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83057601|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057602|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83057603|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
83057604|NCT02194452|Octreotide|octreotide|mesh-list
83057605|NCT02194452|Edotreotide|edotreotide|mesh-list
83057606|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057607|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057608|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057609|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83057610|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057611|NCT01358721|Nivolumab|nivolumab|mesh-list
83057612|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057613|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057614|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83057615|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057616|NCT02194686|Cilostazol|cilostazol|mesh-list
83057617|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83057618|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
83057619|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057620|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057621|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83057622|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
83057623|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83057624|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83057625|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057626|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83057627|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
83057628|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83361759|NCT02651428|Calcium heparin|calcium heparin|mesh-list
83361760|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
83057629|NCT02194686|Protective Agents|protective agents|mesh-ancestor
83057630|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83057631|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83057632|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057633|NCT04622995|Diazepam|diazepam|mesh-list
83057634|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83057635|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
83057636|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
83057637|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
83057638|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057639|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057640|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057641|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83057642|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057643|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83057644|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83057645|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83057646|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83057647|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83057648|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83057649|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
83057650|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
83057651|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
83057652|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
83057653|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057654|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057655|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83057656|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
83057657|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057658|NCT02194764|Naltrexone|naltrexone|mesh-list
83057659|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83057660|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83057661|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057662|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
83057663|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057664|NCT02967640|Ketamine|ketamine|mesh-list
83057665|NCT02967640|Analgesics|analgesics|mesh-ancestor
83057666|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
83057667|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057668|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057669|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83057670|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83057671|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
83057672|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
83057673|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057674|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83057675|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83057676|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057677|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057678|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
83057679|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83057680|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057681|NCT00005584|Prednisone|prednisone|mesh-list
83057682|NCT00005584|Epirubicin|epirubicin|mesh-list
83057683|NCT00005584|Bleomycin|bleomycin|mesh-list
83057684|NCT00005584|Vinblastine|vinblastine|mesh-list
83057685|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057686|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
83057687|NCT00005584|Hormones|hormones|mesh-ancestor
83057688|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057689|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057690|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057691|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057692|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83057693|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83057694|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83057695|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057696|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057697|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83057698|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
83057699|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
83057700|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
83057701|NCT02194218|Nevirapine|nevirapine|mesh-list
83057702|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83361761|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057703|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83057704|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057705|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057706|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
83057707|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057708|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057709|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057710|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83057711|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83057712|NCT02194296|Ambroxol|ambroxol|mesh-list
83057713|NCT02194296|Expectorants|expectorants|mesh-ancestor
83057714|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
83057715|NCT02197026|Hylan|hylan|mesh-list
83057716|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
83057717|NCT02197026|Protective Agents|protective agents|mesh-ancestor
83057718|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057719|NCT02197104|Choline|choline|mesh-list
83057720|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
83057721|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83057722|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
83057723|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057724|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057725|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83057726|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
83057727|NCT02197182|Copper|copper|mesh-list
83057728|NCT02197182|Metronidazole|metronidazole|mesh-list
83057729|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057730|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057731|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83057732|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83057733|NCT02197182|Trace Elements|trace elements|mesh-ancestor
83057734|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
83057735|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057736|NCT02197260|Amoxicillin|amoxicillin|mesh-list
83057737|NCT02197260|Metronidazole|metronidazole|mesh-list
83057739|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057740|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83057741|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83057742|NCT03687931|Dexamethasone|dexamethasone|mesh-list
83057743|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057744|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
83057745|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
83057746|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057747|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057748|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057749|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
83057750|NCT03687931|Hormones|hormones|mesh-ancestor
83057751|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057752|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057753|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057754|NCT03534024|Curcumin|curcumin|mesh-list
83057755|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83057756|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83057757|NCT03534024|Analgesics|analgesics|mesh-ancestor
83057758|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
83057759|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057760|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057761|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057762|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057763|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057764|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057765|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057766|NCT02753686|Tamoxifen|tamoxifen|mesh-list
83057767|NCT02753686|Everolimus|everolimus|mesh-list
83057768|NCT02753686|Letrozole|letrozole|mesh-list
83057769|NCT02753686|Fulvestrant|fulvestrant|mesh-list
83057770|NCT02753686|Anastrozole|anastrozole|mesh-list
83057771|NCT02753686|Exemestane|exemestane|mesh-list
83057772|NCT02753686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83057773|NCT02753686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83057774|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057775|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057776|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057777|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
83057778|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057779|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057780|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83057781|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83057782|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83057783|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
83057784|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057785|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83057786|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83057787|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83057788|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83057789|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83057790|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
83057791|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83057792|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
83057793|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057794|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057795|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83057796|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83057797|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83057798|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
83057799|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057800|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057801|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83057802|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
83057803|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
83057804|NCT04216927|Protective Agents|protective agents|mesh-ancestor
83057805|NCT02329834|Furosemide|furosemide|mesh-list
83057806|NCT02329834|Diuretics|diuretics|mesh-ancestor
83057807|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
83057808|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057809|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83057810|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482357|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83057811|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057812|NCT02195466|Ritonavir|ritonavir|mesh-list
83057813|NCT02195466|Tipranavir|tipranavir|mesh-list
83057814|NCT02195466|Fluconazole|fluconazole|mesh-list
83057815|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83057816|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83057817|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
83057818|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057819|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057820|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83057821|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83057822|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
83057823|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057824|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83057825|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83057826|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
83057827|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83057828|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83057829|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
83057830|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057831|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057832|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83057833|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83057834|NCT02195544|Hylan|hylan|mesh-list
83057835|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
83057836|NCT02195544|Protective Agents|protective agents|mesh-ancestor
83057837|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057838|NCT02197494|Valsartan|valsartan|mesh-list
83057839|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83057840|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83057841|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83057842|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057843|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83057844|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
83057845|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057846|NCT03692299|Metronidazole|metronidazole|mesh-list
83057847|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057848|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057849|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83057850|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83361762|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83057852|NCT02197650|Eryaspase|eryaspase|mesh-list
83057853|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057854|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
83057855|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057856|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
83057857|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057858|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057859|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83057860|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
83057861|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057862|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057863|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83057864|NCT03682939|Vaccines|vaccines|mesh-list
83057865|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
83057866|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057867|NCT02201992|Crizotinib|crizotinib|mesh-list
83057868|NCT02201992|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83057869|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83057870|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057871|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057872|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057873|NCT03534492|Durvalumab|durvalumab|mesh-list
83057874|NCT03534492|Olaparib|olaparib|mesh-list
83057875|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83057876|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057877|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83057878|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057879|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057880|NCT03624283|Betahistine|betahistine|mesh-list
83057881|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
83057882|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
83057883|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
83057884|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057885|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057886|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057887|NCT03687463|Decitabine|decitabine|mesh-list
83057888|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83057889|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
83057890|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057891|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057892|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057893|NCT03692143|Alendronate|alendronate|mesh-list
83057894|NCT03692143|Teriparatide|teriparatide|mesh-list
83057895|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83057896|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057897|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83057898|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
83057899|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83057900|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057901|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83057902|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057903|NCT02197884|Clarithromycin|clarithromycin|mesh-list
83057904|NCT02197884|Itraconazole|itraconazole|mesh-list
83057905|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057906|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057907|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83057908|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057909|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057910|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83057911|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83057912|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
83057913|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83057914|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83057915|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
83057916|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83057917|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057918|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
83057919|NCT04196491|Fludarabine|fludarabine|mesh-list
83057920|NCT04196491|Lenalidomide|lenalidomide|mesh-list
83057921|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83057922|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
83057923|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057924|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057925|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83057926|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
83057927|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057928|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057929|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83057930|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83057931|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83057932|NCT04196491|Growth Substances|growth substances|mesh-ancestor
83057933|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
83057934|NCT02201082|Amikacin|amikacin|mesh-list
83057935|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057936|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057937|NCT03687229|Insulin|insulin|mesh-list
83057938|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83057939|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057940|NCT05085054|Osimertinib|osimertinib|mesh-list
83057941|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057942|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83057943|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057944|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057945|NCT03969121|Palbociclib|palbociclib|mesh-list
83057946|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057947|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83057948|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057949|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057950|NCT02201238|Diclofenac|diclofenac|mesh-list
83057951|NCT02201238|Menthol|menthol|mesh-list
83057952|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83057953|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83057954|NCT02201238|Analgesics|analgesics|mesh-ancestor
83057955|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
83057956|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057957|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057958|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057959|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83057960|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83057961|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057962|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057963|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
83057964|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
83057965|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
83057966|NCT02257398|Gepotidacin|gepotidacin|mesh-list
83057967|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83057968|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83057969|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83057970|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83057971|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83057972|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83057973|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057974|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83057975|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83057976|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
83057977|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83057978|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057979|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83057980|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83057981|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83057982|NCT02201316|Mosapride|mosapride|mesh-list
83057983|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83057984|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83057985|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83057986|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
83057987|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83057988|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057989|NCT02198820|Anesthetics|anesthetics|mesh-list
83057990|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83057991|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057992|NCT02257476|Dexamethasone|dexamethasone|mesh-list
83057993|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83057994|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
83057995|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
83057996|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83057997|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83057998|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058000|NCT02257476|Hormones|hormones|mesh-ancestor
83058001|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83058002|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83058003|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058004|NCT03946111|Naltrexone|naltrexone|mesh-list
83058005|NCT03946111|Bupropion|bupropion|mesh-list
83058006|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83058007|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83058008|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058009|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
83058010|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058011|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83058012|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
83058013|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83058014|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83058015|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83058016|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83058017|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058018|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
83058019|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058020|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83058021|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83058022|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058023|NCT03943927|Metoprolol|metoprolol|mesh-list
83058024|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83058025|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83058026|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
83058027|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
83058028|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058029|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058030|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83058031|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83058032|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83058033|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
83058034|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058035|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058036|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
83058037|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83058038|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058039|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
83058040|NCT03687073|Silybin|silybin|mesh-list
83058041|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
83058042|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83058043|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058044|NCT03687073|Protective Agents|protective agents|mesh-ancestor
83058045|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058046|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83058047|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
83058048|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83058049|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058050|NCT02198352|Olcegepant|olcegepant|mesh-list
83058051|NCT02198352|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83058052|NCT02198352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058053|NCT02198352|Analgesics|analgesics|mesh-ancestor
83058054|NCT02198352|Sensory System Agents|sensory system agents|mesh-ancestor
83058055|NCT02198352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058056|NCT02198352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058057|NCT02202564|Ganciclovir|ganciclovir|mesh-list
83058058|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83058059|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
83058060|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058061|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83058062|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058063|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058064|NCT03029143|Vedolizumab|vedolizumab|mesh-list
83058065|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058066|NCT02198508|Deferasirox|deferasirox|mesh-list
83058067|NCT02198508|Deferiprone|deferiprone|mesh-list
83361763|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83058068|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83058069|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
83058070|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
83058071|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058072|NCT02202720|Sevoflurane|sevoflurane|mesh-list
83058073|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83058074|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83058075|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
83058076|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
83058077|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058078|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058080|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83058081|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
83058082|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058083|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83058084|NCT03028129|Isoniazid|isoniazid|mesh-list
83058085|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058086|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
83058087|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83058088|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83058089|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
83058090|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058091|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83058092|NCT04059679|Aspirin|aspirin|mesh-list
83058093|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
83058094|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83058095|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058096|NCT04059679|Analgesics|analgesics|mesh-ancestor
83058097|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
83058098|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058099|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058100|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058101|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058102|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83058103|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83058104|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058105|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83058106|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83058107|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058108|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
83058109|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83058110|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
83058111|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83058112|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
83058113|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
83058114|NCT03533556|Caffeine|caffeine|mesh-list
83058115|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83058116|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058117|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83058118|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058119|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058120|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83058121|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83058122|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
83058123|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058124|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
83058125|NCT02206854|Tarenflurbil|tarenflurbil|mesh-list
83058126|NCT02206854|Analgesics|analgesics|mesh-ancestor
83058127|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
83058128|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058129|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058130|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83058131|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058132|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058133|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058134|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83058135|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058136|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058137|NCT02206854|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83058138|NCT03624205|Paclitaxel|paclitaxel|mesh-list
83058139|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83058140|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361764|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058142|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
83058143|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
83058144|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058145|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
83058146|NCT02206932|Simeprevir|simeprevir|mesh-list
83058147|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
83058148|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058149|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
83058150|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058151|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058152|NCT02207010|Adavosertib|adavosertib|mesh-list
83058153|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058154|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058155|NCT02203422|Cyclosporine|cyclosporine|mesh-list
83058156|NCT02203422|Cyclosporins|cyclosporins|mesh-list
83058157|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058158|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058159|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058160|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
83058161|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058162|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
83058163|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058164|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
83058165|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058166|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83058167|NCT03532854|Valsartan|valsartan|mesh-list
83058168|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83058169|NCT03532854|Ezetimibe|ezetimibe|mesh-list
83058170|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83058171|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83058172|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
83058173|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058174|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83058175|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83058176|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058177|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83058178|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83058179|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83058180|NCT02203500|Telmisartan|telmisartan|mesh-list
83058181|NCT02203500|Lacidipine|lacidipine|mesh-list
83058182|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83058183|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83058184|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83058185|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058186|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83058187|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83058188|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83058189|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058190|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
83058191|NCT02203656|Testosterone|testosterone|mesh-list
83058192|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
83058193|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
83058194|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83058195|NCT02203656|Androgens|androgens|mesh-ancestor
83058196|NCT02203656|Hormones|hormones|mesh-ancestor
83058197|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83058198|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058199|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83058200|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058201|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
83058202|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
83058203|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
83058204|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
83058205|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058206|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058207|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
83058208|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058209|NCT02199444|Sevelamer|sevelamer|mesh-list
83058210|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
83058211|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
83058212|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058213|NCT02199522|Propofol|propofol|mesh-list
83058214|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83361765|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83058215|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058216|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058217|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83058218|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
83058219|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
83058220|NCT03532698|Aspirin|aspirin|mesh-list
83058221|NCT03532698|Osimertinib|osimertinib|mesh-list
83058222|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83058223|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058224|NCT03532698|Analgesics|analgesics|mesh-ancestor
83058225|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
83058226|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058227|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058228|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058229|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058230|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83058231|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83058232|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058233|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83058234|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83058235|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058236|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
83058237|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058238|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83058239|NCT04169737|Venetoclax|venetoclax|mesh-list
83058240|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
83058241|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
83058242|NCT04169737|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83058243|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058244|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83058245|NCT04169737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83058246|NCT04169737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058247|NCT04169737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058248|NCT03690739|Paclitaxel|paclitaxel|mesh-list
83058249|NCT03690739|Bevacizumab|bevacizumab|mesh-list
83058250|NCT03690739|Carboplatin|carboplatin|mesh-list
83058251|NCT03690739|Gemcitabine|gemcitabine|mesh-list
83058253|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83058254|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058255|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
83058256|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
83058257|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
83058258|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058259|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83058260|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83058261|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83058262|NCT03690739|Growth Substances|growth substances|mesh-ancestor
83058263|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058264|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
83058265|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058266|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
83058267|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83058268|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
83058269|NCT02199678|Ketamine|ketamine|mesh-list
83058270|NCT02199678|Analgesics|analgesics|mesh-ancestor
83058271|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
83058272|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058273|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058274|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83058275|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83058276|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
83058277|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
83058278|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058279|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83058280|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83058281|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058282|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058283|NCT03681613|Pyrantel|pyrantel|mesh-list
83058284|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
83058285|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
83058286|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
83058287|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83058288|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058289|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83058290|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83058291|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83058292|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058293|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058295|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
83058296|NCT03690583|Trace Elements|trace elements|mesh-ancestor
83058297|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
83058298|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058299|NCT03690583|Astringents|astringents|mesh-ancestor
83058300|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83058301|NCT01309672|Prednisone|prednisone|mesh-list
83058302|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
83058303|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058304|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
83058305|NCT01309672|Hormones|hormones|mesh-ancestor
83058306|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83058307|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058308|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83058309|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058310|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83058311|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058312|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058313|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
83058314|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83058315|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83058316|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
83058317|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83058318|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83058319|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058320|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
83058321|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
83058322|NCT02200146|Prednisone|prednisone|mesh-list
83058323|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058324|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
83058325|NCT02200146|Hormones|hormones|mesh-ancestor
83058326|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83058327|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058328|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83058329|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058330|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
83058331|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83058332|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83058333|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058334|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058335|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058336|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058337|NCT02208492|Levetiracetam|levetiracetam|mesh-list
83058338|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
83058339|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
83058340|NCT01933048|Vaccines|vaccines|mesh-list
83058341|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
83058342|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058343|NCT02208882|Midazolam|midazolam|mesh-list
83058344|NCT02208882|BMS-986120|bms-986120|mesh-list
83058345|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83058346|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83058347|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058348|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058349|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83058350|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83058351|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83058352|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83058353|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
83058354|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
83058355|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
83058356|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
83058357|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058358|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058359|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83058360|NCT03690115|Ponatinib|ponatinib|mesh-list
83058361|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058362|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83058363|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058364|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058366|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83058367|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058368|NCT01886794|Estrogens|estrogens|mesh-list
83058369|NCT01886794|Hormones|hormones|mesh-ancestor
83058370|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83058371|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058372|NCT02209350|Aspirin|aspirin|mesh-list
83058373|NCT02209350|Clopidogrel|clopidogrel|mesh-list
83058374|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83058375|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058376|NCT02209350|Analgesics|analgesics|mesh-ancestor
83058377|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
83058378|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058379|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058380|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058381|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058382|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83058383|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83058384|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058385|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83058386|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83058387|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058388|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
83058389|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83058390|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83058391|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83058392|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
83058393|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058394|NCT02209428|Temozolomide|temozolomide|mesh-list
83058395|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83058396|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
83058397|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058398|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058399|NCT02200848|Rituximab|rituximab|mesh-list
83058400|NCT02200848|Lenalidomide|lenalidomide|mesh-list
83058401|NCT02200848|Glutarimide|glutarimide|mesh-list
83058402|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83058403|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058404|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
83058405|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058406|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058407|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83058408|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83058409|NCT02200848|Growth Substances|growth substances|mesh-ancestor
83058410|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
83058411|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83058412|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058413|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058415|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83058416|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058417|NCT02751450|Fluorides|fluorides|mesh-list
83058418|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
83058419|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
83058420|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
83058421|NCT02751450|Protective Agents|protective agents|mesh-ancestor
83058422|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058423|NCT02209740|Tenofovir|tenofovir|mesh-list
83058424|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
83058425|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058426|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83058427|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83058428|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058429|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058430|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83058431|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83058432|NCT02257788|Leronlimab|leronlimab|mesh-list
83058433|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83058434|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83058435|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058436|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83058437|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83058438|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
83361766|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058439|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058440|NCT02220660|Olodaterol|olodaterol|mesh-list
83058441|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83058442|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
83058443|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058444|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058445|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83058446|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
83058447|NCT01515748|Docetaxel|docetaxel|mesh-list
83058448|NCT01515748|Fluorouracil|fluorouracil|mesh-list
83058449|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
83058450|NCT01515748|Tegafur|tegafur|mesh-list
83058451|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058452|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
83058453|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
83058454|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
83058455|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058456|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
83058457|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058458|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058459|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
83058460|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058461|NCT04973722|Denosumab|denosumab|mesh-list
83058462|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83058463|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058464|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
83058465|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83058466|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058467|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83058468|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
83058469|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058470|NCT02209974|Fluticasone|fluticasone|mesh-list
83058471|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058472|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83058473|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
83058474|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058475|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058476|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83058477|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
83058478|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
83058479|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83058480|NCT02212392|Meropenem|meropenem|mesh-list
83058481|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83058482|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058483|NCT03679897|Ropivacaine|ropivacaine|mesh-list
83058484|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
83058485|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83058486|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
83058487|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
83058488|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058489|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058490|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
83058491|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058492|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
83058493|NCT03060070|Ketamine|ketamine|mesh-list
83058494|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83058495|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058496|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058497|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058498|NCT03060070|Analgesics|analgesics|mesh-ancestor
83058499|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
83058500|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058501|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83058502|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83058503|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83058504|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
83058505|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058506|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058507|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83058508|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83058509|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
83058510|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
83058511|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83058512|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83361767|NCT02686164|Lenvatinib|lenvatinib|mesh-list
83058513|NCT03683563|Citric Acid|citric acid|mesh-list
83058514|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
83058515|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
83058516|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83058517|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
83058518|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
83058519|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058520|NCT03563625|Bupivacaine|bupivacaine|mesh-list
83058521|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
83058522|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
83058523|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058524|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058525|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
83058526|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058527|NCT02832375|Fluorides|fluorides|mesh-list
83058528|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
83058529|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
83058530|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
83058531|NCT02832375|Protective Agents|protective agents|mesh-ancestor
83058532|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058533|NCT04834024|Antibodies|antibodies|mesh-list
83058534|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83058535|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
83058536|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058537|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83058538|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058539|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
83058540|NCT02218476|Vitamins|vitamins|mesh-ancestor
83058541|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
83058542|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058543|NCT02205996|Insulin|insulin|mesh-list
83058544|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83058545|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83058546|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058547|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
83058548|NCT02220036|Antacids|antacids|mesh-ancestor
83058549|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058550|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058551|NCT02220114|Vigabatrin|vigabatrin|mesh-list
83058552|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
83058553|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058554|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058555|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
83058556|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058557|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058558|NCT02221596|Vitamin D|vitamin d|mesh-list
83058559|NCT02221596|Vitamins|vitamins|mesh-ancestor
83058560|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
83058561|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058562|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83058563|NCT02221752|Folic Acid|folic acid|mesh-list
83058564|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
83058565|NCT02221752|Hematinics|hematinics|mesh-ancestor
83058566|NCT02221752|Vitamins|vitamins|mesh-ancestor
83058567|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
83058568|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058569|NCT04971382|Curcumin|curcumin|mesh-list
83058570|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83058571|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058572|NCT04971382|Analgesics|analgesics|mesh-ancestor
83058573|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
83058574|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058575|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058576|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058577|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058578|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058579|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058580|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058581|NCT04971304|Lenograstim|lenograstim|mesh-list
83058582|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83058583|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
83058584|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058585|NCT02220348|Linaclotide|linaclotide|mesh-list
83058586|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83058587|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
83058588|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058589|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058590|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
83058591|NCT04151680|Apixaban|apixaban|mesh-list
83058592|NCT04151680|Edoxaban|edoxaban|mesh-list
83058593|NCT04151680|Dabigatran|dabigatran|mesh-list
83058594|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83058595|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
83058596|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83058597|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
83058598|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058599|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058600|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
83058601|NCT02221830|Oxytocin|oxytocin|mesh-list
83058602|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
83058603|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83058604|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058605|NCT02224950|Emollients|emollients|mesh-list
83058606|NCT02224950|Chitosan|chitosan|mesh-list
83058607|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83058608|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83058609|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
83058610|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058611|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83058612|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
83058613|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
83058614|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
83058615|NCT02224950|Coagulants|coagulants|mesh-ancestor
83058616|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83058617|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83058618|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
83058619|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83058620|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
83058621|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058622|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058623|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83058624|NCT04970602|Methylene Blue|methylene blue|mesh-list
83058625|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058626|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058627|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83058628|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058629|NCT02831673|Tenofovir|tenofovir|mesh-list
83058630|NCT02831673|Lamivudine|lamivudine|mesh-list
83058631|NCT02831673|Emtricitabine|emtricitabine|mesh-list
83058632|NCT02831673|Dolutegravir|dolutegravir|mesh-list
83058633|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
83058634|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058635|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83058636|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83058637|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058638|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058639|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83058640|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83058641|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83058642|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83058643|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
83058644|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83058645|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058646|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058647|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83058648|NCT04962958|Leucovorin|leucovorin|mesh-list
83058649|NCT04962958|Fluorouracil|fluorouracil|mesh-list
83058650|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
83058651|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
83058652|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058653|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058654|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058655|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058656|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
83058657|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058658|NCT04962958|Antidotes|antidotes|mesh-ancestor
83058659|NCT04962958|Protective Agents|protective agents|mesh-ancestor
83058660|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
83058661|NCT04962958|Vitamins|vitamins|mesh-ancestor
83058662|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
83058663|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
83058664|NCT02031510|Bupivacaine|bupivacaine|mesh-list
83058665|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
83058666|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
83058667|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058668|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058669|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
83058670|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361768|NCT02686164|Midazolam|midazolam|mesh-list
83058671|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83058672|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058673|NCT02031510|Analgesics|analgesics|mesh-ancestor
83058674|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83058675|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83058676|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83058677|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83058678|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058679|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058680|NCT04961788|Antibodies|antibodies|mesh-list
83058681|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
83058682|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058683|NCT02222142|Anesthetics|anesthetics|mesh-list
83058684|NCT02222142|Isoflurane|isoflurane|mesh-list
83058685|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058686|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058687|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83058688|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
83058689|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
83058690|NCT04425382|Ritonavir|ritonavir|mesh-list
83058691|NCT04425382|Lopinavir|lopinavir|mesh-list
83058692|NCT04425382|Darunavir|darunavir|mesh-list
83058693|NCT04425382|Cobicistat|cobicistat|mesh-list
83058694|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83058695|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83058696|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83058697|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
83058698|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058699|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058700|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83058701|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83058702|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
83058703|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058704|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83058705|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83058706|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
83058707|NCT03563937|Apixaban|apixaban|mesh-list
83058708|NCT03563937|Edoxaban|edoxaban|mesh-list
83058709|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
83058710|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83058711|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
83058712|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83058713|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
83058714|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058715|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058716|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
83058717|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83058718|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83058719|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
83058720|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058721|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058722|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83058723|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
83058724|NCT02225418|Ropivacaine|ropivacaine|mesh-list
83058725|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
83058726|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
83058727|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058728|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058729|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
83058730|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058731|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83058732|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83058733|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
83058734|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058735|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058736|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83058737|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
83058738|NCT05057130|Cisplatin|cisplatin|mesh-list
83058739|NCT05057130|Doxorubicin|doxorubicin|mesh-list
83058740|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83058741|NCT05057130|Methotrexate|methotrexate|mesh-list
83058742|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058743|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83361769|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83058744|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83058745|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83058747|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058748|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83058749|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
83058750|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83058751|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058752|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058753|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
83058754|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
83058755|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83058756|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058757|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
83058758|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058759|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83058760|NCT02222220|Metoclopramide|metoclopramide|mesh-list
83058761|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
83058762|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
83058763|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058764|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058765|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058766|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83058767|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83058768|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
83058769|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058770|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058771|NCT03677323|Sufentanil|sufentanil|mesh-list
83058772|NCT03677323|Droperidol|droperidol|mesh-list
83058773|NCT03677323|Propofol|propofol|mesh-list
83058774|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83058775|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83058776|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058777|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83058778|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
83058779|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
83058780|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83058781|NCT03677323|Narcotics|narcotics|mesh-ancestor
83058782|NCT03677323|Analgesics|analgesics|mesh-ancestor
83058783|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
83058784|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058785|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83058786|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
83058787|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
83058788|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058789|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83058790|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83058791|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83058792|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83058793|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83058794|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
83058795|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058796|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058797|NCT02225652|Paclitaxel|paclitaxel|mesh-list
83058798|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
83058799|NCT02225652|Fluorouracil|fluorouracil|mesh-list
83058800|NCT02225652|Epirubicin|epirubicin|mesh-list
83058801|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83058802|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058803|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
83058804|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
83058805|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
83058806|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058807|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058808|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
83058809|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058810|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058811|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83058812|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
83058813|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83058814|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
83058815|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058816|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83058817|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83058818|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83058819|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058820|NCT02222376|Pirfenidone|pirfenidone|mesh-list
83058821|NCT02222376|Analgesics|analgesics|mesh-ancestor
83058822|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
83058823|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058824|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058825|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83058826|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83058827|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058829|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058830|NCT02231658|Liraglutide|liraglutide|mesh-list
83058831|NCT02231658|Lixisenatide|lixisenatide|mesh-list
83058832|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83058833|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058834|NCT02231658|Incretins|incretins|mesh-ancestor
83058835|NCT02231658|Hormones|hormones|mesh-ancestor
83058836|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83058837|NCT04542408|Heparin|heparin|mesh-list
83058838|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83058839|NCT04542408|Tinzaparin|tinzaparin|mesh-list
83058840|NCT04542408|Dalteparin|dalteparin|mesh-list
83058841|NCT04542408|Edoxaban|edoxaban|mesh-list
83058842|NCT04542408|Anticoagulants|anticoagulants|mesh-list
83058843|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83058844|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83058845|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058846|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83058847|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
83058848|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83058849|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
83058850|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058851|NCT03059134|Mirabegron|mirabegron|mesh-list
83058852|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83058853|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83058854|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83058855|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
83058856|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058857|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058858|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058859|NCT03059134|Urological Agents|urological agents|mesh-ancestor
83058860|NCT02928991|Vidarabine|vidarabine|mesh-list
83058861|NCT02928991|Fludarabine|fludarabine|mesh-list
83058863|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058864|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058865|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
83058866|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058867|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058868|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
83058869|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058870|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
83058871|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83058872|NCT03554317|Nivolumab|nivolumab|mesh-list
83058873|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
83058874|NCT03554317|Testosterone|testosterone|mesh-list
83058875|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
83058876|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
83058877|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83058878|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83058879|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058880|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83058881|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058882|NCT03554317|Androgens|androgens|mesh-ancestor
83058883|NCT03554317|Hormones|hormones|mesh-ancestor
83058884|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83058885|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058886|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83058887|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
83058888|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83058889|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83058890|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058891|NCT04957420|Rotigotine|rotigotine|mesh-list
83058892|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
83058893|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
83058894|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058895|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058896|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058897|NCT03350035|Ganaxolone|ganaxolone|mesh-list
83058898|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
83058899|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058900|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058901|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058902|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
83058903|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
83058904|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
83058905|NCT02905188|Fludarabine|fludarabine|mesh-list
83058906|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058907|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
83058908|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058909|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058910|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83058911|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
83058912|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058913|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058914|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83058915|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
83058916|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
83058917|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83058918|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
83058919|NCT03671941|Ticagrelor|ticagrelor|mesh-list
83058920|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83058921|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83058922|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83058923|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83058924|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
83058925|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058926|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058927|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058928|NCT03058900|Methotrexate|methotrexate|mesh-list
83058929|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83058930|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
83058931|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83058932|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058933|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058934|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
83058935|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058937|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
83058938|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83058939|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83058940|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83058941|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
83058942|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83058943|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83058944|NCT02226510|Metformin|metformin|mesh-list
83058945|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83058946|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058947|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83058948|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83058949|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83058950|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83058951|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058952|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
83058953|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058954|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058955|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
83058956|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
83058957|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058958|NCT02225886|Protective Agents|protective agents|mesh-ancestor
83058959|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058960|NCT02225886|Vitamins|vitamins|mesh-ancestor
83058961|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
83058962|NCT04956094|Uric Acid|uric acid|mesh-list
83058963|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
83058964|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058965|NCT04956094|Protective Agents|protective agents|mesh-ancestor
83058966|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058967|NCT03671707|Nicotine|nicotine|mesh-list
83058968|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83058969|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
83058970|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83058971|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058972|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83058973|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83058974|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
83058975|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83058976|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058977|NCT02226588|Misoprostol|misoprostol|mesh-list
83058978|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83058979|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
83058980|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83058981|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058982|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83058983|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058984|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
83058985|NCT03676621|Misoprostol|misoprostol|mesh-list
83058986|NCT03676621|Oxytocin|oxytocin|mesh-list
83058987|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
83058988|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83058989|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83058990|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83058991|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
83058992|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83058993|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83058994|NCT03678649|Capecitabine|capecitabine|mesh-list
83058995|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83058996|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
83058997|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83058998|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83058999|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
83059000|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83059001|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059002|NCT02845297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83059003|NCT02845297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059004|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83059005|NCT02232360|Fenofibrate|fenofibrate|mesh-list
83059006|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83059007|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83059008|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
83059009|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059011|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83059012|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059013|NCT02226978|Ritonavir|ritonavir|mesh-list
83059014|NCT02226978|Tipranavir|tipranavir|mesh-list
83059015|NCT02226978|Valacyclovir|valacyclovir|mesh-list
83059016|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83059017|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83059018|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
83059019|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059020|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059021|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83059022|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83059023|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
83059024|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059025|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83059026|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83059027|NCT02227056|Methylphenidate|methylphenidate|mesh-list
83059028|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83059029|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059030|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83059031|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83059032|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83059033|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059034|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
83059035|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059036|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
83059037|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83059038|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
83059039|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059040|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059041|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059042|NCT03058744|Clobetasol|clobetasol|mesh-list
83059043|NCT03058744|Halobetasol|halobetasol|mesh-list
83059044|NCT03058744|Tazarotene|tazarotene|mesh-list
83361770|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83059045|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059046|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
83059047|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83059048|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059049|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
83059050|NCT03058744|Hormones|hormones|mesh-ancestor
83059051|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059052|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059053|NCT02734537|Cisplatin|cisplatin|mesh-list
83059054|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059055|NCT03059056|Empagliflozin|empagliflozin|mesh-list
83059056|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83059057|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059058|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83059059|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059060|NCT03058666|Calfactant|calfactant|mesh-list
83059061|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83059062|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
83059063|NCT02227212|Insulin|insulin|mesh-list
83059064|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
83059065|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83059066|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059067|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
83059068|NCT00303849|Carboplatin|carboplatin|mesh-list
83059069|NCT00303849|Etoposide|etoposide|mesh-list
83059070|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
83059071|NCT00303849|Melphalan|melphalan|mesh-list
83059072|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
83059073|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
83059074|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83059075|NCT00303849|Mannitol|mannitol|mesh-list
83059076|NCT00303849|Antidotes|antidotes|mesh-list
83059077|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059078|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83059079|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83059080|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83059081|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059082|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059083|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059084|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
83059085|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83059086|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059087|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
83059088|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059089|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83059090|NCT00303849|Diuretics|diuretics|mesh-ancestor
83059091|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
83059092|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
83059093|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059094|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
83059095|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
83059096|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
83059097|NCT00303849|Protective Agents|protective agents|mesh-ancestor
83059098|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
83059099|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
83059100|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83059101|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059102|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
83059103|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
83059104|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
83059105|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83059106|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
83059107|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059108|NCT01355523|Melatonin|melatonin|mesh-list
83059109|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
83059110|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059111|NCT01355523|Protective Agents|protective agents|mesh-ancestor
83059112|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059113|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059114|NCT02227914|Sorafenib|sorafenib|mesh-list
83059115|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059116|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83059117|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059118|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059119|NCT04161456|Apremilast|apremilast|mesh-list
83059120|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83059121|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83059122|NCT04161456|Analgesics|analgesics|mesh-ancestor
83059123|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
83059124|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059125|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059126|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059127|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059128|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83059129|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83059130|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059131|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059132|NCT02224014|Brotizolam|brotizolam|mesh-list
83059133|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83059134|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059135|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059136|NCT03671161|Insulin|insulin|mesh-list
83059137|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83059138|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059139|NCT04950400|Apatinib|apatinib|mesh-list
83059140|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059141|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83059142|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059143|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059144|NCT04949932|Turmeric extract|turmeric extract|mesh-list
83059145|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
83059146|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059147|NCT04949932|Protective Agents|protective agents|mesh-ancestor
83059148|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059149|NCT02826603|Ustekinumab|ustekinumab|mesh-list
83059150|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059151|NCT02224170|Dexamethasone|dexamethasone|mesh-list
83059152|NCT02224170|Lidocaine|lidocaine|mesh-list
83059153|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059154|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
83059155|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
83059156|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059157|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059158|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059159|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
83059160|NCT02224170|Hormones|hormones|mesh-ancestor
83059161|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059162|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83059163|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059164|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
83059165|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
83059166|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059167|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
83059168|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83059169|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83059170|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83059171|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83059172|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059173|NCT03563235|Calcitriol|calcitriol|mesh-list
83059174|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83059175|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059176|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83059177|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83059178|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059179|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83059180|NCT03563235|Vitamins|vitamins|mesh-ancestor
83059181|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
83059182|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83059183|NCT01329900|Etoposide|etoposide|mesh-list
83059184|NCT01329900|Ifosfamide|ifosfamide|mesh-list
83059185|NCT01329900|Ofatumumab|ofatumumab|mesh-list
83059186|NCT01329900|Lenograstim|lenograstim|mesh-list
83059187|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83059188|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059189|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83059190|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83059191|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059192|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059193|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83361771|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059195|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83059196|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
83059197|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059198|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
83059199|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
83059200|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059201|NCT04948372|Terlipressin|terlipressin|mesh-list
83059202|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83059203|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83059204|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83059205|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059206|NCT04947826|Antibodies|antibodies|mesh-list
83059207|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
83059208|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
83059209|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059210|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
83059211|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
83059212|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83059213|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83059214|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
83059215|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059216|NCT02228616|Lactulose|lactulose|mesh-list
83059217|NCT02228616|Prucalopride|prucalopride|mesh-list
83059218|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059219|NCT02228616|Laxatives|laxatives|mesh-ancestor
83059220|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83059221|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83059222|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
83059223|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059224|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059225|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059226|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83059227|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
83059228|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059229|NCT02228772|Cytarabine|cytarabine|mesh-list
83059230|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
83059231|NCT02228772|Doxorubicin|doxorubicin|mesh-list
83059232|NCT02228772|Methotrexate|methotrexate|mesh-list
83059233|NCT02228772|Vincristine|vincristine|mesh-list
83059234|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
83059235|NCT02228772|Ixazomib|ixazomib|mesh-list
83059236|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059237|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
83059238|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059239|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059240|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059241|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
83059242|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059243|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059244|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83059245|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83059246|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83059247|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83059248|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059249|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83059250|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
83059251|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83059252|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83059253|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
83059254|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059255|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83059256|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83059257|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
83059258|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059259|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83059260|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83059261|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83059262|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83059263|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
83059264|NCT03646968|Docetaxel|docetaxel|mesh-list
83059265|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059266|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
83059267|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
83059268|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
83059269|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059270|NCT02228850|Alprostadil|alprostadil|mesh-list
83361772|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059271|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83059272|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
83059273|NCT02228850|Urological Agents|urological agents|mesh-ancestor
83059274|NCT02822508|Laxatives|laxatives|mesh-list
83059275|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059276|NCT03563001|Budesonide|budesonide|mesh-list
83059277|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
83059278|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059279|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83059280|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
83059281|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059282|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059283|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83059284|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
83059285|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
83059286|NCT03563001|Hormones|hormones|mesh-ancestor
83059287|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059288|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83059289|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83059290|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83059291|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
83059292|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059293|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059294|NCT02228928|Capsaicin|capsaicin|mesh-list
83059295|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
83059296|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059297|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
83059298|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059299|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059300|NCT03888378|Minocycline|minocycline|mesh-list
83059301|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83059302|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059303|NCT03603288|Idebenone|idebenone|mesh-list
83059304|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
83059305|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059306|NCT03603288|Protective Agents|protective agents|mesh-ancestor
83059307|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059308|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83059309|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83059310|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83059311|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83059312|NCT03844074|Bevacizumab|bevacizumab|mesh-list
83059313|NCT03844074|Ranibizumab|ranibizumab|mesh-list
83059314|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83059315|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059316|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83059317|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83059318|NCT03844074|Growth Substances|growth substances|mesh-ancestor
83059319|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059320|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
83059321|NCT02624986|Rituximab|rituximab|mesh-list
83059322|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
83059323|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83059324|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059325|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
83059326|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059327|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059328|NCT04946734|Aspirin|aspirin|mesh-list
83059329|NCT04946734|Clopidogrel|clopidogrel|mesh-list
83059330|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83059331|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83059332|NCT04946734|Analgesics|analgesics|mesh-ancestor
83059333|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
83059334|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059335|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059336|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059337|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059338|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83059339|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83059340|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059341|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83059342|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83059343|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059344|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
83361773|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83059345|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83059346|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83059347|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83059348|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
83059349|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059350|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
83059351|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059352|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
83059353|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059354|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059355|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059356|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
83059357|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059358|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059359|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83059360|NCT04945096|Cytarabine|cytarabine|mesh-list
83059361|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
83059362|NCT04945096|Cyclosporine|cyclosporine|mesh-list
83059363|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
83059364|NCT04945096|Busulfan|busulfan|mesh-list
83059365|NCT04945096|Semustine|semustine|mesh-list
83059366|NCT04945096|Decitabine|decitabine|mesh-list
83059367|NCT04945096|Cyclosporins|cyclosporins|mesh-list
83059368|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
83059369|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83059370|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059371|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
83059372|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059373|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059374|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059375|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
83059376|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059377|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059378|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83059379|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83059380|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
83059381|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
83059382|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059383|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059384|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
83059385|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059386|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83059387|NCT04945096|Expectorants|expectorants|mesh-ancestor
83059388|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
83059389|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83059390|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
83059391|NCT04945096|Protective Agents|protective agents|mesh-ancestor
83059392|NCT04944082|Ivermectin|ivermectin|mesh-list
83059393|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83059394|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059395|NCT04943692|Metformin|metformin|mesh-list
83059396|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83059397|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059398|NCT02587598|Cytarabine|cytarabine|mesh-list
83059399|NCT02587598|Azacitidine|azacitidine|mesh-list
83059400|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83059401|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
83059402|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059403|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059404|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
83059405|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059406|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059407|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
83059408|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059409|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059410|NCT04943536|Bicalutamide|bicalutamide|mesh-list
83059411|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
83059412|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
83059413|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059414|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059415|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059416|NCT04943146|Aspirin|aspirin|mesh-list
83059417|NCT04943146|Prednisone|prednisone|mesh-list
83059418|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059419|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
83059420|NCT04943146|Hormones|hormones|mesh-ancestor
83059421|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059422|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059423|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83059424|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059425|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83059426|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83059427|NCT04943146|Analgesics|analgesics|mesh-ancestor
83059428|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
83059429|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059430|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059431|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83059432|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83059433|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059434|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83059435|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83059436|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059437|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
83059438|NCT02485574|Calcium|calcium|mesh-list
83059439|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83059440|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059441|NCT04942834|Amiodarone|amiodarone|mesh-list
83059442|NCT04942834|Sotalol|sotalol|mesh-list
83059443|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83059444|NCT04942834|Dronedarone|dronedarone|mesh-list
83059445|NCT04942834|Propafenone|propafenone|mesh-list
83059446|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
83059447|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83059448|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83059449|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059450|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83059451|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83059452|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83059453|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059454|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83059455|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83059456|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83059457|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83059458|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83059459|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
83059460|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059461|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059462|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
83059463|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
83059464|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059465|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83059466|NCT04941976|Benzydamine|benzydamine|mesh-list
83059467|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059468|NCT01291004|Drospirenone|drospirenone|mesh-list
83059469|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83059470|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83059471|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
83059472|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83059473|NCT01291004|Desogestrel|desogestrel|mesh-list
83059474|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
83059475|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
83059477|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83059478|NCT01291004|Estrogens|estrogens|mesh-ancestor
83059479|NCT01291004|Hormones|hormones|mesh-ancestor
83059480|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059481|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059482|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83059483|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83059484|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83059485|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83059486|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83059487|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83059488|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83059489|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83059490|NCT01291004|Diuretics|diuretics|mesh-ancestor
83059491|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
83059492|NCT01291004|Progestins|progestins|mesh-ancestor
83059493|NCT04941118|Anesthetics|anesthetics|mesh-list
83059494|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
83059495|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361774|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83059496|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059497|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
83059498|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059499|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
83059500|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059501|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
83059502|NCT00374660|Irofulven|irofulven|mesh-list
83059503|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059504|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059505|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
83059506|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059507|NCT02624050|Propofol|propofol|mesh-list
83059508|NCT02624050|Methohexital|methohexital|mesh-list
83059509|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83059510|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059511|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059512|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83059513|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
83059514|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
83059515|NCT03131882|Triamcinolone|triamcinolone|mesh-list
83059516|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83059517|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83059518|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
83059519|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83059520|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059521|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
83059522|NCT03131882|Hormones|hormones|mesh-ancestor
83059523|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059524|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059525|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059526|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
83059527|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059528|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059529|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83059530|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
83059532|NCT03483350|Midazolam|midazolam|mesh-list
83059533|NCT03483350|Granisetron|granisetron|mesh-list
83059534|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83059535|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83059536|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059537|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059538|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83059539|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83059540|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83059541|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83059542|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
83059543|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
83059544|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
83059545|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
83059546|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059547|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059548|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
83059549|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
83059550|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059551|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059552|NCT03483350|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83059553|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83059554|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
83059555|NCT03480308|Dexamethasone|dexamethasone|mesh-list
83059556|NCT03480308|Fentanyl|fentanyl|mesh-list
83059557|NCT03480308|Bupivacaine|bupivacaine|mesh-list
83059558|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059559|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
83059560|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
83059561|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059562|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059563|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059564|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
83059565|NCT03480308|Hormones|hormones|mesh-ancestor
83059566|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059567|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83059568|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059569|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
83059570|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
83059571|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059572|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
83059573|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83059574|NCT03480308|Narcotics|narcotics|mesh-ancestor
83059575|NCT03480308|Analgesics|analgesics|mesh-ancestor
83059576|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83059577|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83059578|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
83059579|NCT05151614|Colchicine|colchicine|mesh-list
83059580|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
83059581|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059582|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
83059583|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
83059584|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
83059585|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059586|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059587|NCT04937140|Antibodies|antibodies|mesh-list
83059588|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
83059589|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059590|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83059591|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83059592|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059593|NCT03482960|Xenon|xenon|mesh-list
83059594|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83059595|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
83059596|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
83059597|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059598|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059599|NCT04409002|Niraparib|niraparib|mesh-list
83059600|NCT04409002|Dostarlimab|dostarlimab|mesh-list
83059601|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83059602|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059603|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059604|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059605|NCT00099086|Docetaxel|docetaxel|mesh-list
83059606|NCT00099086|Leuprolide|leuprolide|mesh-list
83059607|NCT00099086|Goserelin|goserelin|mesh-list
83059608|NCT00099086|Bicalutamide|bicalutamide|mesh-list
83059609|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059610|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
83059611|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
83059612|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
83059613|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059614|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83059615|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
83059616|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83059617|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059618|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83059619|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
83059620|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
83059621|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059622|NCT03479996|Bupivacaine|bupivacaine|mesh-list
83059623|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
83059624|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
83059625|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059626|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059627|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
83059628|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059629|NCT04936282|Tacrolimus|tacrolimus|mesh-list
83059630|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059631|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
83059632|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059633|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83059634|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059635|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059636|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
83059637|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
83059638|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83059639|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83059640|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059641|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059642|NCT02524184|Urological Agents|urological agents|mesh-ancestor
83059643|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
83059644|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83361775|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83059645|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
83059646|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059647|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
83059648|NCT04936204|Protective Agents|protective agents|mesh-ancestor
83059650|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83059651|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83059652|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059653|NCT04936126|Amantadine|amantadine|mesh-list
83059654|NCT04936126|Pramipexole|pramipexole|mesh-list
83059655|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83059656|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
83059657|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83059658|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83059659|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83059660|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059661|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059662|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
83059663|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059664|NCT04936126|Protective Agents|protective agents|mesh-ancestor
83059665|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83059666|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83059667|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
83059668|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
83059669|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059670|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
83059671|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059672|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83059673|NCT04936126|Analgesics|analgesics|mesh-ancestor
83059674|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
83059675|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059676|NCT03479918|Prednisone|prednisone|mesh-list
83059677|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
83059678|NCT03479918|Doxorubicin|doxorubicin|mesh-list
83059679|NCT03479918|Etoposide|etoposide|mesh-list
83059680|NCT03479918|Vincristine|vincristine|mesh-list
83059681|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059682|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
83059683|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059684|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059685|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059686|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
83059687|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059688|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059689|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83059690|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83059691|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83059692|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83059693|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059694|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83059695|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059696|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
83059697|NCT03479918|Hormones|hormones|mesh-ancestor
83059698|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059699|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83059700|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83059701|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83059702|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83059703|NCT03486080|Lenograstim|lenograstim|mesh-list
83059704|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83059705|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
83059706|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059707|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83059708|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
83059709|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
83059710|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83059711|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059712|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059713|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83059714|NCT03477344|Analgesics|analgesics|mesh-ancestor
83059715|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
83059716|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059717|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83059718|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83059719|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83059720|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
83059721|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059722|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059724|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059725|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059726|NCT03477266|Mosapride|mosapride|mesh-list
83059727|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059728|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83059729|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
83059730|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059731|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059732|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059733|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83059734|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83059735|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
83059736|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83059737|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
83059738|NCT03131336|Coagulants|coagulants|mesh-ancestor
83059739|NCT03482492|Acetaminophen|acetaminophen|mesh-list
83059740|NCT03482492|Tramadol|tramadol|mesh-list
83059741|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83059742|NCT03482492|Analgesics|analgesics|mesh-ancestor
83059743|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
83059744|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059745|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059746|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
83059747|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83059748|NCT03482492|Narcotics|narcotics|mesh-ancestor
83059749|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059750|NCT03477110|Temozolomide|temozolomide|mesh-list
83059751|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059752|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
83059753|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059754|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059755|NCT03874286|Liver Extracts|liver extracts|mesh-list
83059756|NCT03874286|Hematinics|hematinics|mesh-ancestor
83059757|NCT05259098|Sufentanil|sufentanil|mesh-list
83059758|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83059759|NCT05259098|Narcotics|narcotics|mesh-ancestor
83059760|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059761|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059762|NCT05259098|Analgesics|analgesics|mesh-ancestor
83059763|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
83059764|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059765|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83059766|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83059767|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
83059768|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
83059769|NCT03482180|Atorvastatin|atorvastatin|mesh-list
83059771|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83059772|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059773|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83059774|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83059775|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
83059776|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059777|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83059778|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83059779|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059780|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83059781|NCT04390646|Hormones|hormones|mesh-ancestor
83059782|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059783|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059784|NCT04294550|Naloxegol|naloxegol|mesh-list
83059785|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83059786|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059787|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
83059788|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059789|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
83059790|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83059791|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059792|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059793|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83059794|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83059795|NCT03476564|Protective Agents|protective agents|mesh-ancestor
83059796|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059797|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
83059798|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83059799|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
83059800|NCT05258474|Niacinamide|niacinamide|mesh-list
83059801|NCT05258474|Niacin|niacin|mesh-list
83059802|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
83059803|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
83059804|NCT05258474|Vitamins|vitamins|mesh-ancestor
83059805|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
83059806|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059807|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83059808|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
83059809|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059810|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83059811|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
83059812|NCT03478436|Doxycycline|doxycycline|mesh-list
83059813|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83059814|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059815|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
83059816|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83059817|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83059818|NCT01338987|Alovudine|alovudine|mesh-list
83059819|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
83059820|NCT01338987|Busulfan|busulfan|mesh-list
83059821|NCT01338987|Methotrexate|methotrexate|mesh-list
83059822|NCT01338987|Fludarabine|fludarabine|mesh-list
83059823|NCT01338987|Leuprolide|leuprolide|mesh-list
83059824|NCT01338987|Tacrolimus|tacrolimus|mesh-list
83059825|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83059826|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
83059827|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059828|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83059829|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83059830|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
83059831|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059832|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059833|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83059834|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83059835|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
83059836|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83059837|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83059838|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
83059839|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059840|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059841|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83059842|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83059843|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83059844|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83059845|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
83059846|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83059847|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
83059848|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059849|NCT03717896|Thiamine|thiamine|mesh-list
83059850|NCT03717896|Vitamins|vitamins|mesh-ancestor
83059851|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
83059852|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059853|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
83059854|NCT03478280|Brodalumab|brodalumab|mesh-list
83059855|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
83059856|NCT04856007|Metformin|metformin|mesh-list
83059857|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
83059858|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83059859|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059860|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83059861|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059862|NCT04736979|Amoxicillin|amoxicillin|mesh-list
83059863|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
83059864|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
83059865|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83059866|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83059867|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059868|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83059869|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059870|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059871|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83059872|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83059873|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
83059874|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059875|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059877|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
83059878|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
83059879|NCT03562923|Hormones|hormones|mesh-ancestor
83059880|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059881|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
83059882|NCT03593252|Metronidazole|metronidazole|mesh-list
83059883|NCT03593252|Cefazolin|cefazolin|mesh-list
83059884|NCT03593252|Neomycin|neomycin|mesh-list
83059885|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
83059886|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
83059887|NCT03593252|Citric Acid|citric acid|mesh-list
83059888|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
83059889|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059890|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83059891|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83059892|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83059893|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
83059894|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83059895|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
83059896|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
83059897|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059898|NCT03593252|Cathartics|cathartics|mesh-ancestor
83059899|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059900|NCT03593252|Antacids|antacids|mesh-ancestor
83059901|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83059902|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059903|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
83059904|NCT03476174|Interleukin-2|interleukin-2|mesh-list
83439128|NCT04858958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83059905|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83059906|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059907|NCT03476174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83059908|NCT03476174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059909|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83059910|NCT03476174|Analgesics|analgesics|mesh-ancestor
83059911|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
83059912|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059913|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059914|NCT02523638|Interferons|interferons|mesh-list
83059915|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
83059916|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
83059917|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059918|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
83059919|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059920|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
83059921|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059922|NCT05257148|Nebivolol|nebivolol|mesh-list
83059923|NCT05257148|Zofenopril|zofenopril|mesh-list
83059924|NCT05257148|Captopril|captopril|mesh-list
83059925|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83059926|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
83059927|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83059928|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83059929|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83059930|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83059931|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83059932|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059933|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059934|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83059935|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
83059936|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059937|NCT03481790|Folic Acid|folic acid|mesh-list
83059938|NCT03481790|Lactoferrin|lactoferrin|mesh-list
83059939|NCT03481790|Vitamins|vitamins|mesh-ancestor
83059940|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
83059941|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059942|NCT03481790|Hematinics|hematinics|mesh-ancestor
83059943|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
83059944|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059945|NCT03475862|Oxycodone|oxycodone|mesh-list
83059946|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83059947|NCT03475862|Narcotics|narcotics|mesh-ancestor
83059948|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83059949|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059950|NCT03475862|Analgesics|analgesics|mesh-ancestor
83059951|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
83059952|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059953|NCT03368066|Cosyntropin|cosyntropin|mesh-list
83059954|NCT03368066|Hormones|hormones|mesh-ancestor
83361776|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83059955|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059956|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059957|NCT03475628|Daratumumab|daratumumab|mesh-list
83059958|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059959|NCT05195450|Tenofovir|tenofovir|mesh-list
83059960|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
83059961|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059962|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83059963|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83059964|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059965|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059966|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83059967|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83059968|NCT03477422|Meropenem|meropenem|mesh-list
83059969|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
83059970|NCT03477422|Sulbactam|sulbactam|mesh-list
83059971|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83059972|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059973|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83059974|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059975|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059976|NCT01355289|Interferons|interferons|mesh-list
83059977|NCT01355289|Ribavirin|ribavirin|mesh-list
83059978|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059979|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
83059980|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83059981|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
83059982|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83059983|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83059984|NCT03473210|Erythromycin|erythromycin|mesh-list
83059985|NCT03473210|Ampicillin|ampicillin|mesh-list
83059986|NCT03473210|Dexamethasone|dexamethasone|mesh-list
83059987|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83059988|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
83059989|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
83059990|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83059991|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83059992|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83059993|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
83059995|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83059996|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83059997|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83059998|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83059999|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060000|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060001|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83060002|NCT03473132|Thrombin|thrombin|mesh-list
83060003|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
83060004|NCT03473132|Coagulants|coagulants|mesh-ancestor
83060005|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
83060006|NCT03475160|Citric Acid|citric acid|mesh-list
83060007|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
83060008|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
83060009|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83060010|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
83060011|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
83060012|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060013|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
83060014|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83060015|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83060016|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060017|NCT03475160|Urological Agents|urological agents|mesh-ancestor
83060018|NCT00308516|Leucovorin|leucovorin|mesh-list
83060019|NCT00308516|Bevacizumab|bevacizumab|mesh-list
83060020|NCT00308516|Fluorouracil|fluorouracil|mesh-list
83060021|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
83060022|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060023|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060024|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83060025|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83060026|NCT00308516|Growth Substances|growth substances|mesh-ancestor
83060027|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060028|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
83060029|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
83060030|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060031|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83060032|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060033|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
83060034|NCT00308516|Antidotes|antidotes|mesh-ancestor
83060035|NCT00308516|Protective Agents|protective agents|mesh-ancestor
83060036|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
83060037|NCT00308516|Vitamins|vitamins|mesh-ancestor
83060038|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
83060039|NCT05155592|Adalimumab|adalimumab|mesh-list
83060040|NCT05155592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83060041|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060042|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060043|NCT03474614|Propranolol|propranolol|mesh-list
83060044|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83060045|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83060046|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83060047|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060048|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060049|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060050|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83060051|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83060052|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
83060053|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
83060054|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
83060055|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83060056|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
83060057|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060058|NCT02737358|Expectorants|expectorants|mesh-ancestor
83060059|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
83060060|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83060061|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
83060062|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060063|NCT02737358|Protective Agents|protective agents|mesh-ancestor
83060064|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060065|NCT02737358|Antidotes|antidotes|mesh-ancestor
83060066|NCT05052710|Midazolam|midazolam|mesh-list
83060067|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83060068|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83060069|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060070|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060071|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83060072|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83060073|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060074|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83060075|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
83060076|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
83060077|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
83060078|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
83060079|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060080|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060081|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
83060082|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83060083|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83060084|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060085|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
83060086|NCT02866838|Coagulants|coagulants|mesh-ancestor
83060087|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
83060088|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83060089|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83060090|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060091|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
83060092|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
83060093|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
83060094|NCT01090154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83060095|NCT01090154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060096|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060097|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
83060098|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060099|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060100|NCT01354431|Nivolumab|nivolumab|mesh-list
83060101|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060102|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060103|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83060104|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060105|NCT02736578|Cetuximab|cetuximab|mesh-list
83060106|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060107|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060108|NCT02478788|Amphetamine|amphetamine|mesh-list
83060109|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83060110|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060111|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
83060112|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
83060113|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060114|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
83060115|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060116|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060117|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
83060118|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83060119|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83060120|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060121|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83060122|NCT05157542|Paclitaxel|paclitaxel|mesh-list
83060123|NCT05157542|Durvalumab|durvalumab|mesh-list
83060124|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83060125|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83060126|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060127|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83060128|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83060129|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83060130|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060131|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060132|NCT03472976|Imiquimod|imiquimod|mesh-list
83060133|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83060134|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
83060135|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060136|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060137|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
83060138|NCT03473600|Triamcinolone|triamcinolone|mesh-list
83060139|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83060140|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83060141|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83060142|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060143|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
83060144|NCT03473600|Hormones|hormones|mesh-ancestor
83060145|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060146|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060147|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060148|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
83060149|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060150|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060151|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83060152|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83060153|NCT02622724|Interferons|interferons|mesh-list
83060154|NCT02622724|Interferon-beta|interferon-beta|mesh-list
83060155|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
83060156|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060157|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
83060158|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060159|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
83060160|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060161|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83060162|NCT01354353|Aripiprazole|aripiprazole|mesh-list
83060163|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
83060164|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060165|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83060166|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83060167|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060168|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060169|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
83060170|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
83060171|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060172|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060173|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83060174|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83060175|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
83060176|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83060177|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83060178|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83060179|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83060180|NCT04931524|Mitogens|mitogens|mesh-list
83060181|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
83361777|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
83060182|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060184|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83060185|NCT03562611|Nalbuphine|nalbuphine|mesh-list
83060186|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83060187|NCT03562611|Narcotics|narcotics|mesh-ancestor
83060188|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060189|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060190|NCT03562611|Analgesics|analgesics|mesh-ancestor
83060191|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
83060192|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060193|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83060194|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83060195|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060196|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060197|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83060198|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439141|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
83060199|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060200|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83060201|NCT03057574|Hormones|hormones|mesh-ancestor
83060202|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060203|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060204|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83060205|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060206|NCT04929652|Irinotecan|irinotecan|mesh-list
83060207|NCT04929652|Molgramostim|molgramostim|mesh-list
83060208|NCT04929652|Sargramostim|sargramostim|mesh-list
83060209|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83060210|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83060211|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060212|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060213|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060214|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
83060215|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060216|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83060217|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83060218|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83060219|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060220|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060221|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060222|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060223|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
83060224|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060225|NCT04927936|Vaccines|vaccines|mesh-list
83060226|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
83060227|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060228|NCT04167813|Ondansetron|ondansetron|mesh-list
83060229|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
83060230|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
83060231|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060232|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060233|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83060234|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
83060235|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83060236|NCT04167813|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83060237|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83060238|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
83060239|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060240|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060241|NCT03562533|Paclitaxel|paclitaxel|mesh-list
83060242|NCT03562533|Carboplatin|carboplatin|mesh-list
83060243|NCT03562533|Doxorubicin|doxorubicin|mesh-list
83060244|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83060245|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83060246|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060247|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
83060248|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
83060249|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
83060250|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060251|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83060252|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83060253|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83060254|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060255|NCT04927858|Empagliflozin|empagliflozin|mesh-list
83060256|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83361778|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
83060257|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060258|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83060259|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060261|NCT04014387|Suvorexant|suvorexant|mesh-list
83060262|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83060263|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83060264|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060265|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060266|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83060267|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
83060268|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
83060269|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060270|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060271|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83060272|NCT05707455|Chrysarobin|chrysarobin|mesh-list
83060273|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83060274|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83060275|NCT05707455|Analgesics|analgesics|mesh-ancestor
83060276|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
83060277|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060278|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060279|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060280|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060281|NCT04927000|Tofacitinib|tofacitinib|mesh-list
83060282|NCT04927000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83060283|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83060284|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060285|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060286|NCT04926532|Sorafenib|sorafenib|mesh-list
83060287|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060288|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83060289|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060290|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060291|NCT03842709|Pramipexole|pramipexole|mesh-list
83060292|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
83060293|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060294|NCT03842709|Protective Agents|protective agents|mesh-ancestor
83060295|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060296|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83060297|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83060298|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
83060299|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
83060300|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060301|NCT05707533|Cefoxitin|cefoxitin|mesh-list
83060302|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83060303|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060304|NCT03056482|Haloperidol|haloperidol|mesh-list
83060305|NCT03056482|Ondansetron|ondansetron|mesh-list
83060306|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
83060307|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
83060308|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
83060309|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060310|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060311|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83060312|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
83060313|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
83060314|NCT03056482|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83060315|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83060316|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
83060317|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060318|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060319|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83060320|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83060321|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060322|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060323|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83060324|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
83060325|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83060326|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
83060327|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
83060328|NCT02817555|Hematinics|hematinics|mesh-ancestor
83060329|NCT04924192|Irinotecan|irinotecan|mesh-list
83361779|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
83060330|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83060331|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83060332|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060333|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060334|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060335|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
83060336|NCT02036073|Hematinics|hematinics|mesh-ancestor
83060337|NCT02036229|Ivermectin|ivermectin|mesh-list
83060338|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83060339|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060340|NCT04404088|Rituximab|rituximab|mesh-list
83060341|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83060342|NCT04404088|Lenalidomide|lenalidomide|mesh-list
83060343|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
83060344|NCT04404088|Antibodies|antibodies|mesh-list
83060345|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
83060346|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83060347|NCT04404088|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83060348|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
83060349|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060350|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060351|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060352|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83060353|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83060354|NCT04404088|Growth Substances|growth substances|mesh-ancestor
83060355|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
83060356|NCT04404088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83060357|NCT04404088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060358|NCT04404088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060359|NCT04922008|Capecitabine|capecitabine|mesh-list
83060360|NCT04922008|Trastuzumab|trastuzumab|mesh-list
83060361|NCT04922008|Vinorelbine|vinorelbine|mesh-list
83060362|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83060363|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
83060364|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060365|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060366|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060367|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83060369|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
83060370|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
83060371|NCT04921930|Artesunate|artesunate|mesh-list
83060372|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
83060373|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83060374|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83060375|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060376|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060377|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
83060378|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
83060379|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83060380|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
83060381|NCT03056092|Ranibizumab|ranibizumab|mesh-list
83060382|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83060383|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83060384|NCT03056092|Growth Substances|growth substances|mesh-ancestor
83060385|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060386|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
83060387|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060388|NCT04921306|Clenbuterol|clenbuterol|mesh-list
83060389|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83060390|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83060391|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83060392|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060393|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060394|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060395|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83060396|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
83060397|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060398|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83060399|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
83060400|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
83060401|NCT04920760|Vitamin A|vitamin a|mesh-list
83060402|NCT04920760|Vitamins|vitamins|mesh-ancestor
83060403|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
83060404|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060405|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
83060406|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
83361780|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
83060407|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060408|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060409|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060410|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
83060411|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83060412|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060413|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060414|NCT04920604|Anesthetics|anesthetics|mesh-list
83060415|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060416|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060417|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
83060418|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83060419|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
83060420|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060421|NCT04920448|Expectorants|expectorants|mesh-ancestor
83060422|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
83060423|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83060424|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
83060425|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060426|NCT04920448|Protective Agents|protective agents|mesh-ancestor
83060427|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060428|NCT04920448|Antidotes|antidotes|mesh-ancestor
83060429|NCT04969354|Immunomodulating Agents|immunomodulating agents|mesh-list
83060430|NCT04969354|Immunologic Factors|immunologic factors|mesh-ancestor
83060431|NCT04969354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060432|NCT03061006|Warfarin|warfarin|mesh-list
83060433|NCT03061006|Dabigatran|dabigatran|mesh-list
83060434|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
83060435|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
83060436|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83060437|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
83060438|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060439|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060440|NCT03060850|Abivertinib|abivertinib|mesh-list
83060441|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83060442|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060443|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060444|NCT04432558|Acetaminophen|acetaminophen|mesh-list
83060445|NCT04432558|Diclofenac|diclofenac|mesh-list
83060446|NCT04432558|Tramadol|tramadol|mesh-list
83060447|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83060448|NCT04432558|Analgesics|analgesics|mesh-ancestor
83060449|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
83060450|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060451|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060452|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
83060453|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83060454|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060455|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060456|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83060457|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060458|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060459|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83060460|NCT04432558|Narcotics|narcotics|mesh-ancestor
83060461|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060462|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
83060463|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83060464|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83060465|NCT04979650|Prednisolone|prednisolone|mesh-list
83060466|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
83060467|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83060468|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
83060469|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060470|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
83060471|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
83060472|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060473|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060474|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83060475|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
83060476|NCT04979650|Hormones|hormones|mesh-ancestor
83060477|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060478|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83060479|NCT04979650|Protective Agents|protective agents|mesh-ancestor
83060480|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83060481|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060484|NCT04979884|Cyclosporins|cyclosporins|mesh-list
83060485|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060486|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060487|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060488|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
83060489|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060490|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
83060491|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060492|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
83060493|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060494|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83060495|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060496|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83060497|NCT04979884|Analgesics|analgesics|mesh-ancestor
83060498|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
83060499|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060500|NCT04650152|Fenofibrate|fenofibrate|mesh-list
83060501|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83060502|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
83060503|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060504|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83060505|NCT04967950|Methotrexate|methotrexate|mesh-list
83060506|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83060507|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83060508|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
83060509|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83060510|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060511|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83060512|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
83060513|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060514|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060515|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83060516|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060517|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83060518|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060519|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
83060520|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060521|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83060522|NCT04967326|Carbamazepine|carbamazepine|mesh-list
83060523|NCT04967326|Phenytoin|phenytoin|mesh-list
83060524|NCT04967326|Valproic Acid|valproic acid|mesh-list
83060525|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
83060526|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060527|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060528|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
83060529|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060530|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060531|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
83060532|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83060533|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060534|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060535|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83060536|NCT04967326|Analgesics|analgesics|mesh-ancestor
83060537|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
83060538|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060539|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83060540|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060541|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83060542|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83060543|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83060544|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83060545|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83060546|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060547|NCT02620384|Metolazone|metolazone|mesh-list
83060548|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83060549|NCT02620384|Diuretics|diuretics|mesh-ancestor
83060550|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
83060551|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060552|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83060553|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060554|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060573|NCT03472508|Enalaprilat|enalaprilat|mesh-list
83060574|NCT03472508|Hematinics|hematinics|mesh-ancestor
83060575|NCT03472508|Vitamins|vitamins|mesh-ancestor
83060576|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
83060577|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060578|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060579|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060580|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83060581|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
83060582|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83060583|NCT04966234|Posaconazole|posaconazole|mesh-list
83060584|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
83060585|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060586|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83060587|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83060588|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83060589|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83060590|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83060591|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060592|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060593|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83060594|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
83060595|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060596|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060597|NCT03915860|Trifarotene|trifarotene|mesh-list
83060598|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83060599|NCT04170998|Metformin|metformin|mesh-list
83060600|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
83060601|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83060602|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060603|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83060604|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060605|NCT04965532|Anesthetics|anesthetics|mesh-list
83060606|NCT04965532|Propofol|propofol|mesh-list
83060607|NCT04965532|Sevoflurane|sevoflurane|mesh-list
83060608|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060609|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060610|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83060611|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83060612|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
83060613|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83060614|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83060615|NCT03055546|Oxytocin|oxytocin|mesh-list
83060616|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
83060617|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83060618|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060619|NCT04918264|Capecitabine|capecitabine|mesh-list
83060620|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83060621|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
83060622|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060623|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060624|NCT04917718|Tacrolimus|tacrolimus|mesh-list
83060625|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060626|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
83060627|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060628|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83060629|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060630|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361781|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060631|NCT04977778|Fluorides|fluorides|mesh-list
83060632|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
83060633|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
83060634|NCT04977778|Protective Agents|protective agents|mesh-ancestor
83060635|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060636|NCT03055234|Treprostinil|treprostinil|mesh-list
83060637|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83060638|NCT03055312|Bicalutamide|bicalutamide|mesh-list
83060639|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
83060640|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
83060641|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060642|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060643|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060644|NCT04977544|Sertraline|sertraline|mesh-list
83060645|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
83060646|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060647|NCT04977544|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83060648|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83060649|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060650|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060651|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060652|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
83060653|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060654|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
83060655|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83060656|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060657|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060658|NCT02626000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83060659|NCT02626000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060660|NCT03769376|Salvin|salvin|mesh-list
83060661|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83060662|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060663|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
83060664|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060665|NCT03769376|Protective Agents|protective agents|mesh-ancestor
83060666|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060667|NCT05156450|Prednisone|prednisone|mesh-list
83060668|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
83060669|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060670|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
83060671|NCT05156450|Hormones|hormones|mesh-ancestor
83060672|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060673|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060674|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83060675|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060676|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83060677|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060678|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060679|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
83060680|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83060681|NCT03060304|Tamoxifen|tamoxifen|mesh-list
83060682|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83060683|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83060684|NCT03060304|Estradiol|estradiol|mesh-list
83060685|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83060686|NCT03060304|Estrogens|estrogens|mesh-ancestor
83060687|NCT03060304|Hormones|hormones|mesh-ancestor
83060688|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060689|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060690|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83060691|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
83060692|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83060693|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83060694|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83060695|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
83060696|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83060697|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060698|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83060699|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83060700|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83060701|NCT04432402|Gemcitabine|gemcitabine|mesh-list
83060702|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
83060703|NCT04432402|Lenalidomide|lenalidomide|mesh-list
83060704|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060705|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
83060706|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060707|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83060708|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
83060709|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060710|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83060711|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83060712|NCT04432402|Growth Substances|growth substances|mesh-ancestor
83060713|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
83060714|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
83060715|NCT04432324|Antibodies|antibodies|mesh-list
83060716|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
83060717|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83060718|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83060719|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
83060720|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060721|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
83060722|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83060723|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83060724|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83060725|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060726|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060727|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
83060728|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060729|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060730|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83060731|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060732|NCT04977388|Droxidopa|droxidopa|mesh-list
83060733|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83060734|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83060735|NCT03470480|Methamphetamine|methamphetamine|mesh-list
83060736|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83060737|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060738|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
83060739|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
83060740|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060741|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
83060742|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060743|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060744|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
83060745|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83060746|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83060747|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060748|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83060749|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83060750|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83060751|NCT04917250|Dexamethasone|dexamethasone|mesh-list
83060752|NCT04917250|Gemcitabine|gemcitabine|mesh-list
83060753|NCT04917250|Etoposide|etoposide|mesh-list
83060754|NCT04917250|Pegaspargase|pegaspargase|mesh-list
83060755|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060756|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
83060757|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
83060758|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060759|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060761|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
83060762|NCT04917250|Hormones|hormones|mesh-ancestor
83060763|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060764|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83060765|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060766|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83060767|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
83060768|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060769|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83060770|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83060771|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83060772|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060773|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
83060774|NCT04859582|Fluorouracil|fluorouracil|mesh-list
83060775|NCT04859582|Capecitabine|capecitabine|mesh-list
83060776|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
83060777|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362147|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060778|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060779|NCT04859582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83060780|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060782|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83060783|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83060784|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
83060785|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060786|NCT03469700|Anesthetics|anesthetics|mesh-list
83060787|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060788|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060789|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
83060790|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
83060791|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83060792|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83060793|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060794|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060795|NCT04912726|Urological Agents|urological agents|mesh-ancestor
83060796|NCT02603900|Bupivacaine|bupivacaine|mesh-list
83060797|NCT02603900|Ropivacaine|ropivacaine|mesh-list
83060798|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
83060799|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
83060800|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060801|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060802|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
83060803|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060804|NCT01669798|Nintedanib|nintedanib|mesh-list
83060805|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060806|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83060807|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060808|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060809|NCT02334722|Levetiracetam|levetiracetam|mesh-list
83060810|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
83060811|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
83060812|NCT04458116|Curcumin|curcumin|mesh-list
83060813|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83060814|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83060815|NCT04458116|Analgesics|analgesics|mesh-ancestor
83060816|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
83060817|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060818|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060819|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060820|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83060821|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060822|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060823|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060824|NCT03469544|Hormones|hormones|mesh-list
83060825|NCT03469544|Antibodies|antibodies|mesh-list
83060826|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060827|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060828|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
83060829|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83060830|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060831|NCT04912258|Irinotecan|irinotecan|mesh-list
83060832|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83060833|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83060834|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060835|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060836|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060837|NCT01952288|Simvastatin|simvastatin|mesh-list
83060838|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83060839|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83060840|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
83060841|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060842|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83060843|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83060844|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060845|NCT03054532|Durvalumab|durvalumab|mesh-list
83060846|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83060847|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060848|NCT04975360|Caffeine|caffeine|mesh-list
83060849|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83060850|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060851|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83060852|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060853|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060854|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83060855|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83060856|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
83060857|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060858|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83060859|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
83060860|NCT00563576|Estradiol|estradiol|mesh-list
83060861|NCT00563576|Estrogens|estrogens|mesh-ancestor
83060862|NCT00563576|Hormones|hormones|mesh-ancestor
83060863|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060864|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060865|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83060866|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
83060867|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83060868|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83060869|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83060870|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83060871|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83060872|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83060873|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83060874|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060875|NCT04915846|Tamoxifen|tamoxifen|mesh-list
83060876|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83060877|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
83060878|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060879|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060880|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83060881|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060882|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83060883|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83060884|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83060885|NCT04974970|Immunomodulating Agents|immunomodulating agents|mesh-list
83060886|NCT04974970|Immunologic Factors|immunologic factors|mesh-ancestor
83060887|NCT04974970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060888|NCT03782636|Aldesleukin|aldesleukin|mesh-list
83060889|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060890|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83060891|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83060892|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
83060893|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060894|NCT04911244|Dimercaprol|dimercaprol|mesh-list
83060895|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
83060896|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
83060897|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060898|NCT03761810|Tretinoin|tretinoin|mesh-list
83060899|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83060900|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83060901|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060902|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
83060903|NCT04915456|Prednisolone|prednisolone|mesh-list
83060904|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83060905|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
83060906|NCT04915456|Hormones|hormones|mesh-ancestor
83060907|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83060908|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060909|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83060910|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060911|NCT04841668|Metformin|metformin|mesh-list
83060912|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83060913|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060914|NCT04914910|Insulin|insulin|mesh-list
83060915|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83060916|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060917|NCT03469310|Acetaminophen|acetaminophen|mesh-list
83060918|NCT03469310|Tramadol|tramadol|mesh-list
83060919|NCT03469310|Codeine|codeine|mesh-list
83060920|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83060921|NCT03469310|Analgesics|analgesics|mesh-ancestor
83060922|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
83060923|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060924|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362148|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060925|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
83060926|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83060927|NCT03469310|Narcotics|narcotics|mesh-ancestor
83060928|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060929|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
83060930|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
83060931|NCT03527186|Risperidone|risperidone|mesh-list
83060932|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83060933|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
83060934|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060935|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060936|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060937|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83060938|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83060939|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060940|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060941|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83060942|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
83060943|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
83060944|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83060945|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060946|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83060947|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060948|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83060949|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83060950|NCT04455464|Midodrine|midodrine|mesh-list
83060951|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
83060952|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
83060953|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83060954|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060955|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83060956|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83060957|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83060958|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83060959|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
83060960|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060961|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060962|NCT04914598|Cisplatin|cisplatin|mesh-list
83060963|NCT04914598|Endostar protein|endostar protein|mesh-list
83060964|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83060965|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83060966|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83060967|NCT04914598|Growth Substances|growth substances|mesh-ancestor
83060968|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060969|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
83060970|NCT03054220|Tramadol|tramadol|mesh-list
83060971|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83060972|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
83060973|NCT03054220|Paroxetine|paroxetine|mesh-list
83060974|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83060975|NCT03054220|Narcotics|narcotics|mesh-ancestor
83060976|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83060977|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83060978|NCT03054220|Analgesics|analgesics|mesh-ancestor
83060979|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
83060980|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482358|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83060981|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83060983|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83060984|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83060985|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83060986|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
83060987|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83060988|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
83060989|NCT03054220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83060990|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
83060991|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83060992|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83060993|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83060994|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83060995|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
83060996|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
83060997|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83060998|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83060999|NCT05388188|Sufentanil|sufentanil|mesh-list
83061000|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83061001|NCT05388188|Narcotics|narcotics|mesh-ancestor
83061002|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061003|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061004|NCT05388188|Analgesics|analgesics|mesh-ancestor
83061005|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
83061006|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061007|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83061008|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061009|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
83061010|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
83061011|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
83061012|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061013|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061014|NCT04118036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83061015|NCT04118036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061016|NCT04909918|Dexamethasone|dexamethasone|mesh-list
83061017|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
83061018|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83061019|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83061020|NCT04909918|Prednisolone|prednisolone|mesh-list
83061021|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
83061022|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83061023|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
83061024|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061025|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
83061026|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
83061027|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061028|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061029|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83061030|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
83061031|NCT04909918|Hormones|hormones|mesh-ancestor
83061032|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061033|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061034|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061035|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83061036|NCT04909918|Protective Agents|protective agents|mesh-ancestor
83061037|NCT04903678|Melphalan|melphalan|mesh-list
83061038|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83061039|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
83061040|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061041|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061042|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83061043|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061044|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
83061045|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061046|NCT04903366|Timolol|timolol|mesh-list
83061047|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061048|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83061049|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83061050|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
83061051|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061052|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061053|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83061054|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83061055|NCT03054610|Betamethasone|betamethasone|mesh-list
83061056|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
83061057|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83061058|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
83061059|NCT03054610|Ropivacaine|ropivacaine|mesh-list
83061060|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
83061061|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83061062|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
83061063|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83061064|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83061065|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061066|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
83061067|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061068|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061069|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
83061070|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061071|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83061072|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83061073|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061074|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
83061075|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061076|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061077|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
83061079|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061080|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83061081|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
83061082|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83061083|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83061084|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
83061085|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
83061086|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061087|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061088|NCT04909684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83439165|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061089|NCT04909684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061090|NCT03053830|Ketamine|ketamine|mesh-list
83061091|NCT03053830|Analgesics|analgesics|mesh-ancestor
83061092|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
83061093|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061094|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061095|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83061096|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061097|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
83061098|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
83061099|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061100|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83061101|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83061102|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061103|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061104|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
83061105|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83061106|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061107|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061108|NCT04913896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061109|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83061110|NCT03053284|Pasireotide|pasireotide|mesh-list
83061111|NCT03053284|Hormones|hormones|mesh-ancestor
83061112|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061113|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061114|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83061115|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83061116|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061117|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
83061118|NCT02811861|Everolimus|everolimus|mesh-list
83061119|NCT02811861|Sunitinib|sunitinib|mesh-list
83061120|NCT02811861|Lenvatinib|lenvatinib|mesh-list
83061121|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061122|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061123|NCT02811861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83061124|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061125|NCT02811861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83061126|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83061127|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061128|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061129|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
83061130|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061131|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83061132|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83061133|NCT02811861|Growth Substances|growth substances|mesh-ancestor
83061134|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83061136|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83061137|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83061138|NCT04908982|Analgesics|analgesics|mesh-ancestor
83061139|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
83061140|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061141|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061142|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061143|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83061144|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83061145|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83061146|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061147|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83061148|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83061150|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
83061151|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
83061152|NCT04430998|Polaprezinc|polaprezinc|mesh-list
83061153|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83061154|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061155|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
83061156|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83061157|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83061158|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
83061159|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
83439167|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
83061160|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83061161|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
83061162|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061163|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061164|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83061165|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
83061166|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83061167|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83061168|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83061169|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
83061170|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061171|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061172|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061173|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
83061174|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83061175|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
83061176|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83061177|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83061178|NCT04900948|Prednisolone|prednisolone|mesh-list
83061179|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
83061180|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
83061181|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
83061182|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83061183|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
83061184|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061185|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
83061186|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
83061187|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061188|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061189|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83061190|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
83061191|NCT04900948|Hormones|hormones|mesh-ancestor
83061192|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061193|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83061194|NCT04900948|Protective Agents|protective agents|mesh-ancestor
83061195|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061196|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061197|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83061198|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83061199|NCT04900948|Analgesics|analgesics|mesh-ancestor
83061200|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
83061201|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83061202|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
83061203|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061204|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
83061205|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83061206|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061207|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061208|NCT04901104|Thymalfasin|thymalfasin|mesh-list
83061209|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83061210|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
83061211|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061212|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
83061213|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83061214|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83061215|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061216|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
83061217|NCT04907812|Coagulants|coagulants|mesh-ancestor
83061218|NCT01889186|Venetoclax|venetoclax|mesh-list
83061219|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061220|NCT04892212|Sirolimus|sirolimus|mesh-list
83061221|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061222|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061223|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83061224|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061225|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
83061226|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061227|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
83061228|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061230|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83061231|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061232|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061233|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
83061234|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061235|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83061236|NCT04907344|Paclitaxel|paclitaxel|mesh-list
83061237|NCT04907344|Carboplatin|carboplatin|mesh-list
83061238|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83061239|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061240|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
83061241|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
83061242|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
83061243|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061244|NCT04906876|Gemcitabine|gemcitabine|mesh-list
83061245|NCT04906876|Docetaxel|docetaxel|mesh-list
83061246|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83061247|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
83061248|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061249|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061250|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
83061251|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
83061252|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
83061253|NCT04891744|Thalidomide|thalidomide|mesh-list
83061254|NCT04891744|Dexamethasone|dexamethasone|mesh-list
83061255|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061256|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
83061257|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
83061258|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061259|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061260|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83061261|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
83061262|NCT04891744|Hormones|hormones|mesh-ancestor
83061263|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061264|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061265|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061266|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061267|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
83061268|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
83061269|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061270|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061271|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83061272|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83061273|NCT04891744|Growth Substances|growth substances|mesh-ancestor
83061274|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
83061275|NCT04891900|Capecitabine|capecitabine|mesh-list
83061276|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
83061277|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83061278|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83061279|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
83482359|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
83061280|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061281|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061282|NCT04891900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061283|NCT04891588|Timolol|timolol|mesh-list
83061284|NCT04891588|Latanoprost|latanoprost|mesh-list
83061285|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83061286|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83061287|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061288|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83061289|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83061290|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
83061291|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061292|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061293|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83061294|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83061295|NCT03050866|Antiemetics|antiemetics|mesh-list
83061296|NCT03050866|Histamine|histamine|mesh-list
83061297|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
83061298|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83061300|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
83061301|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061302|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061303|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061304|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
83061305|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061306|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83061307|NCT03052660|Midazolam|midazolam|mesh-list
83061308|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83061309|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83061310|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061311|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061312|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83061313|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83061314|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83061315|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061316|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
83061317|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
83061318|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
83061319|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
83061320|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061321|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061322|NCT05162456|Antibodies|antibodies|mesh-list
83061323|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
83061324|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
83061325|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
83061326|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061327|NCT05137886|Decitabine|decitabine|mesh-list
83061328|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83061329|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83061330|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
83061331|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061332|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061333|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061334|NCT05137886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061335|NCT04890418|Ketamine|ketamine|mesh-list
83061336|NCT04890418|Analgesics|analgesics|mesh-ancestor
83061337|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
83061338|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061339|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061340|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83061341|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061342|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
83061343|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
83061344|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061345|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83061346|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83061347|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061348|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061349|NCT04455932|Liver Extracts|liver extracts|mesh-list
83061350|NCT04455932|Hematinics|hematinics|mesh-ancestor
83061351|NCT03051022|Dexamethasone|dexamethasone|mesh-list
83061352|NCT03051022|Morphine|morphine|mesh-list
83061353|NCT03051022|Bupivacaine|bupivacaine|mesh-list
83061354|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061355|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
83061356|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
83061357|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061358|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061359|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83061360|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
83061361|NCT03051022|Hormones|hormones|mesh-ancestor
83061362|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061363|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061364|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061365|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061366|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
83061367|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061368|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
83061369|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83061370|NCT03051022|Narcotics|narcotics|mesh-ancestor
83061371|NCT03051022|Analgesics|analgesics|mesh-ancestor
83061372|NCT04648826|Azacitidine|azacitidine|mesh-list
83061373|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83061374|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
83361782|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061375|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061376|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061377|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061378|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
83061379|NCT03052348|Betamethasone|betamethasone|mesh-list
83061380|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
83061381|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83061382|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
83061384|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83061385|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061386|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
83061387|NCT03052348|Hormones|hormones|mesh-ancestor
83061388|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061389|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061390|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83061391|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
83061392|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83061393|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
83061394|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
83061395|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061396|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061397|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061398|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83061399|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061400|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061401|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83061402|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061403|NCT03963518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061404|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061405|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
83061406|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
83061407|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
83061408|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83061409|NCT04101890|Protective Agents|protective agents|mesh-ancestor
83061410|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061411|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
83061412|NCT04456712|Levofloxacin|levofloxacin|mesh-list
83061413|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061414|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061415|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83061416|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83061417|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061418|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061419|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061420|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83061421|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83061422|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83061423|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83061424|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83061425|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061426|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061427|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
83061428|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83061429|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83061430|NCT04854434|Trifluridine|trifluridine|mesh-list
83061431|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
83061432|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061433|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061434|NCT04854434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83061435|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061436|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
83061437|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
83061438|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061439|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
83061440|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83061441|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
83061442|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83061443|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
83061444|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061445|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061446|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83061447|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
83061448|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83061449|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
83061450|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061451|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061452|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83061453|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
83061454|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
83061455|NCT04456088|Protective Agents|protective agents|mesh-ancestor
83061456|NCT04454840|Riluzole|riluzole|mesh-list
83061457|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
83061458|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83061459|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83061460|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061461|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061462|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061463|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83061464|NCT04454840|Protective Agents|protective agents|mesh-ancestor
83061465|NCT03050710|Lidocaine|lidocaine|mesh-list
83061466|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061467|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
83061468|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061469|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061470|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
83061471|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061472|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83061473|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83061474|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83061475|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83061476|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061477|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83061478|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83061479|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061480|NCT04897516|Benzonidazole|benzonidazole|mesh-list
83061481|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061482|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
83061483|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061484|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83061485|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83061486|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83061487|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061488|NCT03993314|Bupivacaine|bupivacaine|mesh-list
83061489|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
83061490|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061491|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
83061492|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061493|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061494|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
83061495|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061496|NCT04883164|Antibodies|antibodies|mesh-list
83061497|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
83061498|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061499|NCT03161054|Prednisone|prednisone|mesh-list
83061500|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
83061501|NCT03161054|Rituximab|rituximab|mesh-list
83061502|NCT03161054|Etoposide|etoposide|mesh-list
83061503|NCT03161054|Vinorelbine|vinorelbine|mesh-list
83061504|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061505|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
83061506|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061508|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83061509|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
83061510|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061511|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061512|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83061513|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061514|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061515|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
83061516|NCT03161054|Hormones|hormones|mesh-ancestor
83061517|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061518|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061519|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83361783|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061520|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83061521|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83061522|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061523|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
83061524|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
83061525|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
83061526|NCT03050554|Avelumab|avelumab|mesh-list
83061527|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061528|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061529|NCT03050164|Gefitinib|gefitinib|mesh-list
83061530|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061531|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83061532|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061533|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061534|NCT03049930|Ketamine|ketamine|mesh-list
83061535|NCT03049930|Analgesics|analgesics|mesh-ancestor
83061536|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
83061537|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061538|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061539|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83061540|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061541|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
83061542|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
83061543|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061544|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83061545|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83061546|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061547|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061548|NCT02036463|Prednisone|prednisone|mesh-list
83061549|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061550|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
83061551|NCT02036463|Hormones|hormones|mesh-ancestor
83061552|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061553|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061554|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061555|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061556|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
83061557|NCT04887844|Lidocaine|lidocaine|mesh-list
83061558|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061559|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
83061560|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061561|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061562|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
83061563|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061564|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83061565|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83061566|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83061567|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83061568|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061569|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061570|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
83061571|NCT04887844|Hormones|hormones|mesh-ancestor
83061572|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061573|NCT02595320|Capecitabine|capecitabine|mesh-list
83061574|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83061575|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
83061576|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061577|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061579|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061580|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061581|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
83061582|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061583|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83061584|NCT04666688|Paclitaxel|paclitaxel|mesh-list
83061585|NCT04666688|Gemcitabine|gemcitabine|mesh-list
83061586|NCT04666688|Tislelizumab|tislelizumab|mesh-list
83061587|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83061588|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061589|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
83061590|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
83061591|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
83061592|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061593|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83061594|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
83061595|NCT04666688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061596|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
83061597|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83061598|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83061599|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83061600|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83061601|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061602|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
83061603|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061604|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061605|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83061606|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061607|NCT02047539|Aspirin|aspirin|mesh-list
83061608|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83061609|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83061610|NCT02047539|Analgesics|analgesics|mesh-ancestor
83061611|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
83061612|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061613|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061614|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061615|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83061616|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83061617|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83061618|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061619|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83061620|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83061621|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061622|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
83061623|NCT02522858|Atropine|atropine|mesh-list
83061624|NCT02522858|Ephedrine|ephedrine|mesh-list
83061625|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
83061626|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83061627|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061628|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061629|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83061630|NCT02522858|Analgesics|analgesics|mesh-ancestor
83061631|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
83061632|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061633|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83061634|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83061635|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83061636|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
83061637|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061638|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061639|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83061640|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83061641|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83061642|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
83061643|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83061644|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
83061645|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
83061646|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
83061647|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83061648|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83061649|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
83061650|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83061652|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83061653|NCT02036697|Fentanyl|fentanyl|mesh-list
83061654|NCT02036697|Morphine|morphine|mesh-list
83061655|NCT02036697|Bupivacaine|bupivacaine|mesh-list
83061656|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061657|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
83061658|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061659|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061660|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
83061661|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061662|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83061663|NCT02036697|Narcotics|narcotics|mesh-ancestor
83061664|NCT02036697|Analgesics|analgesics|mesh-ancestor
83061665|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83061666|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061667|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
83061668|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
83061669|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061670|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061672|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83061673|NCT03106688|Narcotics|narcotics|mesh-ancestor
83061674|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061675|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061676|NCT03106688|Analgesics|analgesics|mesh-ancestor
83061677|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
83061678|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061679|NCT02037009|Anesthetics|anesthetics|mesh-list
83061680|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061681|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061682|NCT02260011|Bromides|bromides|mesh-list
83061683|NCT02260011|Norflurane|norflurane|mesh-list
83061684|NCT02260011|Ipratropium|ipratropium|mesh-list
83061685|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
83061686|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83061687|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
83061688|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061689|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061690|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83061691|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
83061692|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83061693|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
83061694|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061695|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061696|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
83061697|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061698|NCT02047773|Meropenem|meropenem|mesh-list
83061699|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061700|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061701|NCT04886752|Vitamins|vitamins|mesh-list
83061702|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
83061703|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
83061704|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
83061705|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061706|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
83061707|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061708|NCT04886752|Protective Agents|protective agents|mesh-ancestor
83061709|NCT04895800|Caffeine|caffeine|mesh-list
83061710|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83061711|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061712|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83061713|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061714|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061715|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83061716|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83061717|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
83061718|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061719|NCT04886362|Ivermectin|ivermectin|mesh-list
83061720|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83061721|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061722|NCT02048007|Azithromycin|azithromycin|mesh-list
83061723|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061724|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061725|NCT02048085|Clopidogrel|clopidogrel|mesh-list
83061726|NCT02048085|Ticagrelor|ticagrelor|mesh-list
83061727|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83061728|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83061729|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83061730|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83061731|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
83061732|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439191|NCT04606316|Ipilimumab|ipilimumab|mesh-list
83061733|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061734|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061735|NCT02808975|Adalimumab|adalimumab|mesh-list
83061736|NCT02808975|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83061737|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061738|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83061739|NCT04885894|Ozanimod|ozanimod|mesh-list
83061740|NCT04885894|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83061741|NCT04885894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061742|NCT04885894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061743|NCT04885894|Immunologic Factors|immunologic factors|mesh-ancestor
83061744|NCT04885894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061745|NCT04885660|Lisinopril|lisinopril|mesh-list
83061746|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83061747|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
83061748|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061749|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061750|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83061751|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83061752|NCT04885660|Protective Agents|protective agents|mesh-ancestor
83061753|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061754|NCT02037633|Fentanyl|fentanyl|mesh-list
83061755|NCT02037633|Ropivacaine|ropivacaine|mesh-list
83061756|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061757|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
83061758|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061759|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061760|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
83061761|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061762|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83061763|NCT02037633|Narcotics|narcotics|mesh-ancestor
83061764|NCT02037633|Analgesics|analgesics|mesh-ancestor
83061765|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83061766|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061767|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
83061768|NCT05684211|Cetuximab|cetuximab|mesh-list
83061769|NCT05684211|Antibodies|antibodies|mesh-list
83061770|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83061771|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
83061772|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061773|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83061774|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061775|NCT03130634|Silymarin|silymarin|mesh-list
83439208|NCT00646763|Mitogens|mitogens|mesh-list
83061776|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
83061777|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061778|NCT03130634|Protective Agents|protective agents|mesh-ancestor
83061779|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061780|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
83061781|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83061782|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83061783|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061784|NCT04880746|Cladribine|cladribine|mesh-list
83061785|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061786|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061787|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
83061788|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061789|NCT03050086|Minocycline|minocycline|mesh-list
83061790|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061791|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061792|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
83061793|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83061794|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83061795|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83061796|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
83061797|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061798|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061799|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061800|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
83061801|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83061802|NCT04885270|Cisplatin|cisplatin|mesh-list
83061803|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061804|NCT04885426|Metformin|metformin|mesh-list
83061805|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83061806|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061807|NCT04879420|Teriparatide|teriparatide|mesh-list
83061808|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
83061809|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83061810|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061811|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83061812|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83061813|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83061814|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061815|NCT02808819|Benralizumab|benralizumab|mesh-list
83061816|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83061817|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
83061818|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
83061819|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83061821|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83061822|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061823|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83061824|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83061825|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83061826|NCT04872322|Ropivacaine|ropivacaine|mesh-list
83061827|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83061828|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061829|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
83061830|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061831|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061832|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
83061833|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061834|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
83061835|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
83061836|NCT04879030|Levofloxacin|levofloxacin|mesh-list
83061837|NCT04879030|Meropenem|meropenem|mesh-list
83061838|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
83061839|NCT04879030|Tazobactam|tazobactam|mesh-list
83061840|NCT04879030|Piperacillin|piperacillin|mesh-list
83061841|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
83061842|NCT04879030|Imipenem|imipenem|mesh-list
83061843|NCT04879030|Ceftazidime|ceftazidime|mesh-list
83061844|NCT04879030|Ertapenem|ertapenem|mesh-list
83061845|NCT04879030|Lactams|lactams|mesh-list
83061846|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83061847|NCT04879030|Cefotaxime|cefotaxime|mesh-list
83061848|NCT04879030|Cefixime|cefixime|mesh-list
83061849|NCT04879030|beta-Lactams|beta-lactams|mesh-list
83061850|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
83061851|NCT04879030|Ticarcillin|ticarcillin|mesh-list
83061852|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061853|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061854|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83061855|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83061856|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061857|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061858|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061859|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83061860|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83061861|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83061862|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83061863|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83061864|NCT04878718|Vancomycin|vancomycin|mesh-list
83061865|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061866|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061867|NCT04878016|Carboplatin|carboplatin|mesh-list
83061868|NCT04878016|Etoposide|etoposide|mesh-list
83061869|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061870|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83061871|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83061872|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83061873|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061874|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061875|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83061876|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83061877|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83061878|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061879|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061880|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83061881|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83061882|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061883|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
83061884|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061885|NCT04870372|Selegiline|selegiline|mesh-list
83061886|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
83061887|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83061888|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83061889|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83061890|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83061891|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061892|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061893|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83061894|NCT04870372|Protective Agents|protective agents|mesh-ancestor
83061895|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061896|NCT02048319|Ethanol|ethanol|mesh-list
83061897|NCT02048319|Pasireotide|pasireotide|mesh-list
83061898|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83061899|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061900|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061901|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061902|NCT02048319|Hormones|hormones|mesh-ancestor
83061903|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061904|NCT01594762|Pexiganan|pexiganan|mesh-list
83061905|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061906|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061907|NCT02048475|Desflurane|desflurane|mesh-list
83061908|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83061909|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
83061910|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
83061911|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061912|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061913|NCT03562143|Iron|iron|mesh-list
83061914|NCT03562143|Trace Elements|trace elements|mesh-ancestor
83061915|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
83061916|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061917|NCT02048865|Apixaban|apixaban|mesh-list
83061918|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83061919|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
83061920|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83061921|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
83061922|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061923|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061924|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
83061925|NCT02048943|Paclitaxel|paclitaxel|mesh-list
83061926|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83061927|NCT02048943|Gemcitabine|gemcitabine|mesh-list
83061928|NCT02048943|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83061929|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83061930|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061931|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
83061932|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
83061933|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
83061934|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061935|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83061936|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
83061937|NCT02048943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83061938|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061939|NCT02050893|Midazolam|midazolam|mesh-list
83061940|NCT02050893|Propofol|propofol|mesh-list
83061941|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83061942|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061943|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061944|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83061945|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
83061946|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
83061947|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83061948|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83061949|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83061950|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83061951|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
83061952|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
83061953|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83061954|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061955|NCT02806947|Sirolimus|sirolimus|mesh-list
83061956|NCT02806947|Prednisone|prednisone|mesh-list
83061957|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061958|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
83061959|NCT02806947|Hormones|hormones|mesh-ancestor
83061960|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061961|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061962|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061963|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061964|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83061965|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83061966|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83061967|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
83061968|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83061969|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
83361784|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83061970|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
83061971|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061972|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
83061973|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83061974|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061975|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83061977|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83061978|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
83061979|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
83061980|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83061981|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061982|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83061983|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
83061984|NCT02037399|Hormones|hormones|mesh-ancestor
83061985|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83061986|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83061987|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83061988|NCT02260089|Telmisartan|telmisartan|mesh-list
83061989|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83439245|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83061990|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83061991|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83061992|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83061993|NCT02049255|Bupivacaine|bupivacaine|mesh-list
83061994|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
83061995|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83061996|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
83061997|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83061998|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83061999|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
83062000|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062001|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
83062002|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062003|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
83062004|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062005|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062006|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
83062007|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062008|NCT03561675|Acetazolamide|acetazolamide|mesh-list
83062009|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
83062010|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83062011|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062012|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062013|NCT03561675|Diuretics|diuretics|mesh-ancestor
83062014|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
83062015|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062016|NCT02049411|Ketamine|ketamine|mesh-list
83062017|NCT02049411|Analgesics|analgesics|mesh-ancestor
83062018|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
83062019|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062020|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062021|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83062022|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83062023|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
83062024|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
83062025|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062026|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83062027|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83062028|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062029|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062030|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
83062031|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062032|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
83062033|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
83062034|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
83062035|NCT02051751|Paclitaxel|paclitaxel|mesh-list
83062036|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83062037|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062038|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83062039|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83062040|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83062041|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062042|NCT02049801|Cytarabine|cytarabine|mesh-list
83062043|NCT02049801|Idarubicin|idarubicin|mesh-list
83062044|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83062045|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
83062046|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062047|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062048|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
83062049|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062050|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83062051|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
83062052|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062053|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83062054|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83062055|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83062056|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062057|NCT02802345|Nintedanib|nintedanib|mesh-list
83062058|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
83062059|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
83062060|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83439247|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83062061|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83062062|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062063|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062064|NCT02802345|Urological Agents|urological agents|mesh-ancestor
83062065|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062066|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062067|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83062068|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
83062069|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83062070|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
83062071|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83062072|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062073|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83062074|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83062075|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062076|NCT02056041|Liver Extracts|liver extracts|mesh-list
83062077|NCT02056041|Hematinics|hematinics|mesh-ancestor
83062078|NCT02053857|Amoxicillin|amoxicillin|mesh-list
83062079|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83062080|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062081|NCT02053935|Dopamine|dopamine|mesh-list
83062082|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83062083|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
83062084|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
83062085|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062086|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062087|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
83062088|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062089|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062090|NCT02053935|Protective Agents|protective agents|mesh-ancestor
83062091|NCT02056353|Insulin|insulin|mesh-list
83062092|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83062093|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062094|NCT02056587|Everolimus|everolimus|mesh-list
83062095|NCT02056587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83062096|NCT02056587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062097|NCT02056587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062098|NCT02056587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062099|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83062100|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
83062101|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062102|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062103|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83062104|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83062105|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
83062106|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
83062107|NCT02038335|Etonogestrel|etonogestrel|mesh-list
83062108|NCT02038335|Norethindrone|norethindrone|mesh-list
83062109|NCT02038335|Estradiol|estradiol|mesh-list
83062110|NCT02038335|Estrogens|estrogens|mesh-ancestor
83062111|NCT02038335|Hormones|hormones|mesh-ancestor
83062112|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062113|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062114|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83062115|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
83062116|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83062117|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83062118|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83062119|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83062120|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83062121|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83062122|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83062123|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062124|NCT02056665|Minocycline|minocycline|mesh-list
83062125|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83062126|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062127|NCT02056743|Fexofenadine|fexofenadine|mesh-list
83062128|NCT02056743|Losartan|losartan|mesh-list
83062129|NCT02056743|Midazolam|midazolam|mesh-list
83062130|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
83062131|NCT02056743|Caffeine|caffeine|mesh-list
83062132|NCT02056743|Omeprazole|omeprazole|mesh-list
83062133|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83062134|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83062135|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062136|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062137|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83062138|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83062139|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83062140|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83062141|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
83062142|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
83062143|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
83062144|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
83062145|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062146|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062147|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83062148|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83062149|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83062150|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83062151|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83062152|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83062153|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062154|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83062155|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83062156|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
83062157|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83062158|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062159|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83062160|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
83062161|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
83062162|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83062163|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83062164|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83062165|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83062166|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83062167|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
83062168|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
83062169|NCT02052375|ASP2408|asp2408|mesh-list
83062170|NCT02052375|Immunoconjugates|immunoconjugates|mesh-ancestor
83062171|NCT02052375|Immunologic Factors|immunologic factors|mesh-ancestor
83062172|NCT02052375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062173|NCT02054637|Lanreotide|lanreotide|mesh-list
83062174|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062175|NCT02052609|Brodalumab|brodalumab|mesh-list
83062176|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
83062177|NCT02054793|Itraconazole|itraconazole|mesh-list
83062178|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
83062179|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062180|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83062181|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83062182|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062183|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062184|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83062185|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
83062186|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062187|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062188|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83062190|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83062191|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
83062192|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062193|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062194|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
83062195|NCT02057289|Micafungin|micafungin|mesh-list
83062196|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
83062197|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062198|NCT02057367|Bupivacaine|bupivacaine|mesh-list
83062199|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062200|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
83062201|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062202|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062203|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
83062204|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062205|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
83062206|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83062207|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
83062208|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062209|NCT02054949|Expectorants|expectorants|mesh-ancestor
83062210|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
83062211|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83062212|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
83062213|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062214|NCT02054949|Protective Agents|protective agents|mesh-ancestor
83062215|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062216|NCT02054949|Antidotes|antidotes|mesh-ancestor
83062217|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83062218|NCT02748057|Ezetimibe|ezetimibe|mesh-list
83062219|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83062220|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83062221|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
83062222|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062223|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83062224|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83062225|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062226|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
83062227|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062228|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
83062229|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062230|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062231|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
83062232|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062233|NCT02057679|Amoxicillin|amoxicillin|mesh-list
83062234|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83062235|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062236|NCT02038491|Anesthetics|anesthetics|mesh-list
83062237|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062238|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062239|NCT02055183|Antitoxins|antitoxins|mesh-list
83062240|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
83062241|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
83062242|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062243|NCT02748213|Docetaxel|docetaxel|mesh-list
83062244|NCT02748213|Capecitabine|capecitabine|mesh-list
83062245|NCT02748213|Trastuzumab|trastuzumab|mesh-list
83062246|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062247|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
83062248|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
83062249|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
83062250|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062251|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83062252|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
83062253|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062254|NCT03804099|Aflibercept|aflibercept|mesh-list
83062255|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83062256|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83062257|NCT03804099|Growth Substances|growth substances|mesh-ancestor
83062258|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062259|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
83062260|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062261|NCT02058303|Bupivacaine|bupivacaine|mesh-list
83062262|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062263|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
83062264|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062265|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062266|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
83062267|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062268|NCT05256472|Axitinib|axitinib|mesh-list
83062269|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062270|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062271|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062272|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062273|NCT04870060|Curcumin|curcumin|mesh-list
83062274|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83062275|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062276|NCT04870060|Analgesics|analgesics|mesh-ancestor
83062277|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
83062278|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062279|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062280|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062281|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83062282|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062283|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062284|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062285|NCT02613910|Acetaminophen|acetaminophen|mesh-list
83062286|NCT02613910|Cetirizine|cetirizine|mesh-list
83062287|NCT02613910|Prednisone|prednisone|mesh-list
83062288|NCT02613910|Prednisolone|prednisolone|mesh-list
83062289|NCT02613910|Ofatumumab|ofatumumab|mesh-list
83062290|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
83062291|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83062292|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062293|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
83062294|NCT02613910|Hormones|hormones|mesh-ancestor
83062295|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062296|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062297|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83062298|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062299|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062300|NCT02613910|Analgesics|analgesics|mesh-ancestor
83062301|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
83062302|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062303|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
83062304|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83062305|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83062306|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
83062307|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062308|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062309|NCT02802735|Apremilast|apremilast|mesh-list
83062310|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83062311|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062312|NCT02802735|Analgesics|analgesics|mesh-ancestor
83062313|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
83062314|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062315|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062316|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062317|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83062318|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83062319|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83062320|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062321|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062322|NCT03048214|Anesthetics|anesthetics|mesh-list
83062323|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062324|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062325|NCT02060955|Bevacizumab|bevacizumab|mesh-list
83062326|NCT02060955|Irinotecan|irinotecan|mesh-list
83062327|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062328|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062329|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83062330|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83062331|NCT02060955|Growth Substances|growth substances|mesh-ancestor
83062332|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062333|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
83062334|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83062335|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83062336|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062337|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062338|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83062339|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062340|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062341|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062342|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062343|NCT04877626|Artesunate|artesunate|mesh-list
83062344|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
83062345|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83062346|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83062347|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062348|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062349|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
83062350|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
83062351|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83062352|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
83062353|NCT05255848|Heparin|heparin|mesh-list
83062354|NCT05255848|Calcium heparin|calcium heparin|mesh-list
83062355|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
83062356|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83062357|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83062358|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062359|NCT04430062|Anesthetics|anesthetics|mesh-list
83062360|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062361|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062362|NCT02799381|Levodopa|levodopa|mesh-list
83062363|NCT02799381|Carbidopa|carbidopa|mesh-list
83062364|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83062365|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
83062366|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83062367|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
83062368|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062369|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062370|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062371|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83062372|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062373|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83062374|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
83062375|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
83062376|NCT04387942|Aldesleukin|aldesleukin|mesh-list
83062377|NCT04387942|Interleukin-2|interleukin-2|mesh-list
83062378|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062379|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062380|NCT04387942|Analgesics|analgesics|mesh-ancestor
83062381|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
83062382|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062383|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062384|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83062385|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83062386|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
83062387|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062388|NCT01333059|Fentanyl|fentanyl|mesh-list
83062389|NCT01333059|Midazolam|midazolam|mesh-list
83062390|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83062391|NCT01333059|Narcotics|narcotics|mesh-ancestor
83062392|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062393|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062394|NCT01333059|Analgesics|analgesics|mesh-ancestor
83062395|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
83062396|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062397|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83062398|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83062399|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
83062400|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
83062401|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83062402|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83062403|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83062404|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83062405|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
83062406|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
83062407|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062408|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062409|NCT02060253|Paclitaxel|paclitaxel|mesh-list
83062410|NCT02060253|Trastuzumab|trastuzumab|mesh-list
83062411|NCT02060253|Pertuzumab|pertuzumab|mesh-list
83062412|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83062413|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062414|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
83062415|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
83062416|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
83062417|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062418|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062419|NCT04364620|Docetaxel|docetaxel|mesh-list
83062420|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062421|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
83062422|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
83062423|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
83062424|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062425|NCT03560973|Gemcitabine|gemcitabine|mesh-list
83062426|NCT03560973|Ramucirumab|ramucirumab|mesh-list
83062427|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83062428|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
83062429|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062430|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062431|NCT04383574|Vaccines|vaccines|mesh-list
83062432|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
83062433|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062434|NCT03046108|Triamcinolone|triamcinolone|mesh-list
83062435|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83062436|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83062437|NCT03046108|Mepivacaine|mepivacaine|mesh-list
83062438|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83062439|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062440|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
83062441|NCT03046108|Hormones|hormones|mesh-ancestor
83062442|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062443|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062444|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83062445|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
83062446|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062447|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062448|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062449|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
83062450|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062451|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
83062452|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062453|NCT02061267|Niacin|niacin|mesh-list
83062454|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
83062455|NCT02061267|Vitamins|vitamins|mesh-ancestor
83062456|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
83062457|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062458|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
83062459|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83062460|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
83062461|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062462|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83062463|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
83062464|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83062465|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83062466|NCT01370655|Diuretics|diuretics|mesh-ancestor
83062467|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
83062468|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062469|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83062470|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83062471|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062472|NCT02612194|Crizotinib|crizotinib|mesh-list
83062473|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062474|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062475|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062476|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062477|NCT03044626|Nivolumab|nivolumab|mesh-list
83062478|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062479|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062480|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83062481|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062482|NCT04865224|Chrysarobin|chrysarobin|mesh-list
83062483|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83062484|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062485|NCT04865224|Analgesics|analgesics|mesh-ancestor
83062486|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
83062487|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062488|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062489|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062490|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83062491|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
83062492|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83439270|NCT03231722|Leucovorin|leucovorin|mesh-list
83062493|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83062494|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062495|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
83062496|NCT04865380|Coagulants|coagulants|mesh-ancestor
83062497|NCT04869046|Acetaminophen|acetaminophen|mesh-list
83062498|NCT04869046|Ibuprofen|ibuprofen|mesh-list
83062499|NCT04869046|Analgesics|analgesics|mesh-list
83062500|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
83062501|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062502|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
83062503|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062504|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062505|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
83062506|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83062507|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062508|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83062509|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83062510|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062511|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062512|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062513|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
83062514|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062515|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
83062516|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83062517|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83062518|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062519|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
83062520|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
83062521|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83062522|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
83062523|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062524|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83062525|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83062526|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83062527|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83062528|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
83062529|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062530|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83062531|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83062532|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062533|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83062534|NCT05654415|Melatonin|melatonin|mesh-list
83062535|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
83062536|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062537|NCT05654415|Protective Agents|protective agents|mesh-ancestor
83062538|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062539|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062540|NCT03044938|Albuterol|albuterol|mesh-list
83062541|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83062542|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
83062543|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062544|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062545|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83062546|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
83062547|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
83062548|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83062549|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83062550|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83062551|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83062552|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
83062553|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062554|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062555|NCT03045484|Oxycodone|oxycodone|mesh-list
83062556|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83062557|NCT03045484|Narcotics|narcotics|mesh-ancestor
83062558|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062559|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062560|NCT03045484|Analgesics|analgesics|mesh-ancestor
83062561|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
83062562|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062563|NCT04874506|TEMPO|tempo|mesh-list
83062564|NCT04874506|TEMPOL-H|tempol-h|mesh-list
83062565|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
83062566|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062567|NCT04874506|Protective Agents|protective agents|mesh-ancestor
83062568|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062569|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83062570|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
83062571|NCT04874428|Apixaban|apixaban|mesh-list
83062572|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83062573|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
83062574|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83062575|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
83062576|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062577|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062578|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
83062579|NCT04867720|Everolimus|everolimus|mesh-list
83062580|NCT04867720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83062581|NCT04867720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062582|NCT04867720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062583|NCT04867720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062584|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83062585|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
83062586|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062587|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062588|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83062589|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83062590|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83062591|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
83062592|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83062593|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062594|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
83062595|NCT03045406|Dalteparin|dalteparin|mesh-list
83062596|NCT03045406|Tinzaparin|tinzaparin|mesh-list
83062597|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83062598|NCT03045406|Apixaban|apixaban|mesh-list
83062599|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83062600|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
83062601|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83062602|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
83062603|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062604|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062605|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
83062606|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83062607|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83062608|NCT02798835|Dexamethasone|dexamethasone|mesh-list
83062609|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
83062610|NCT02798835|Fentanyl|fentanyl|mesh-list
83062611|NCT02798835|Bupivacaine|bupivacaine|mesh-list
83062612|NCT02798835|Ropivacaine|ropivacaine|mesh-list
83062613|NCT02798835|BB 1101|bb 1101|mesh-list
83062614|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062615|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
83062616|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
83062617|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062618|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062619|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062620|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
83062621|NCT02798835|Hormones|hormones|mesh-ancestor
83062622|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062623|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83062624|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062625|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
83062626|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062627|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062628|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062629|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
83062630|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062631|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
83062632|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83062633|NCT02798835|Narcotics|narcotics|mesh-ancestor
83062634|NCT02798835|Analgesics|analgesics|mesh-ancestor
83062635|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83062636|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83062637|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
83062638|NCT02061657|Misoprostol|misoprostol|mesh-list
83062639|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83062640|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
83062641|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83062642|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062643|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83062644|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062645|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
83062646|NCT03048136|Nivolumab|nivolumab|mesh-list
83062647|NCT03048136|Ipilimumab|ipilimumab|mesh-list
83062648|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062649|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062650|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83062651|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062652|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
83062653|NCT02062203|Glycine|glycine|mesh-list
83062654|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83062655|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062656|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83062657|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83062658|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062659|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062660|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062661|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062662|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
83062663|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062664|NCT04863742|Prednisolone|prednisolone|mesh-list
83062665|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83062666|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
83062667|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83062668|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
83062669|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83062670|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
83062671|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062672|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
83062673|NCT04863742|Hormones|hormones|mesh-ancestor
83062674|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062675|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062676|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83062677|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062678|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
83062679|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
83062680|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062681|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062682|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83062683|NCT04863742|Protective Agents|protective agents|mesh-ancestor
83062684|NCT02611882|Edetic Acid|edetic acid|mesh-list
83062685|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
83062686|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83062687|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
83062688|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
83062689|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062690|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
83062691|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83062692|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83062693|NCT02062281|Vaccines|vaccines|mesh-list
83062694|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83062695|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
83062696|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062697|NCT05590455|Adalimumab|adalimumab|mesh-list
83062698|NCT05590455|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83062699|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062700|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83062701|NCT03560583|Metoclopramide|metoclopramide|mesh-list
83062702|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
83062703|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
83062704|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062705|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062706|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062707|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83062708|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83062709|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
83062710|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062711|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062712|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83062713|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83062714|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83062715|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83062716|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062717|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062718|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062719|NCT03560427|Analgesics|analgesics|mesh-ancestor
83062720|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
83062721|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062722|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
83062723|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83062724|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
83062725|NCT03797547|Aflibercept|aflibercept|mesh-list
83062726|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83062727|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83062728|NCT03797547|Growth Substances|growth substances|mesh-ancestor
83062729|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062730|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
83062731|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062733|NCT04867252|Metformin|metformin|mesh-list
83062734|NCT04867252|Pioglitazone|pioglitazone|mesh-list
83062735|NCT04867252|Resveratrol|resveratrol|mesh-list
83062736|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83062737|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062738|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
83062739|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062740|NCT04867252|Protective Agents|protective agents|mesh-ancestor
83062741|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062742|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83062743|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
83062744|NCT04867252|Vitamins|vitamins|mesh-ancestor
83062745|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
83062746|NCT04863274|Atorvastatin|atorvastatin|mesh-list
83062747|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83062748|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83062749|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
83062750|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062751|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83062752|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83062753|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062754|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
83062755|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83062756|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
83062757|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062758|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
83062759|NCT02063373|Protective Agents|protective agents|mesh-ancestor
83062760|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
83062761|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062762|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83062763|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
83062764|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83062765|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
83062766|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062767|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062768|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83062769|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
83062770|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83062771|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83062772|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83062773|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83062774|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062775|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062776|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83062777|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83062778|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83062779|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83062780|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062781|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062782|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83062783|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83062784|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062785|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
83062786|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062787|NCT04429282|Ibuprofen|ibuprofen|mesh-list
83062788|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83062789|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062790|NCT04429282|Analgesics|analgesics|mesh-ancestor
83062791|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
83062792|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062793|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062794|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83062795|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83062796|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83062797|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062798|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062799|NCT02063529|Leucovorin|leucovorin|mesh-list
83062800|NCT02063529|Fluorouracil|fluorouracil|mesh-list
83062801|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
83062802|NCT02063529|Irinotecan|irinotecan|mesh-list
83062803|NCT02063529|Cetuximab|cetuximab|mesh-list
83062804|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
83062805|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
83062806|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062807|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83062808|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062809|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83062810|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
83062811|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062812|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83062813|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83062814|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062815|NCT02063529|Antidotes|antidotes|mesh-ancestor
83062816|NCT02063529|Protective Agents|protective agents|mesh-ancestor
83062817|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
83062818|NCT02063529|Vitamins|vitamins|mesh-ancestor
83062819|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
83062820|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062821|NCT02062983|Trastuzumab|trastuzumab|mesh-list
83062822|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062823|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062824|NCT02613208|Paclitaxel|paclitaxel|mesh-list
83062825|NCT02613208|Bevacizumab|bevacizumab|mesh-list
83062826|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83062827|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062828|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
83062829|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
83062830|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
83062831|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062832|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062833|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83062834|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83062835|NCT02613208|Growth Substances|growth substances|mesh-ancestor
83062836|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062837|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
83062838|NCT02063841|Bismuth|bismuth|mesh-list
83062839|NCT02063841|Antacids|antacids|mesh-ancestor
83062840|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062841|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062842|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
83062843|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83062844|NCT04872634|Cetuximab|cetuximab|mesh-list
83062845|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062846|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062847|NCT01668784|Nivolumab|nivolumab|mesh-list
83062848|NCT01668784|Everolimus|everolimus|mesh-list
83062849|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062850|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062851|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83062852|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062853|NCT01668784|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83062854|NCT01668784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062855|NCT01668784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062856|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83062857|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
83062858|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062859|NCT02750514|Nivolumab|nivolumab|mesh-list
83062860|NCT02750514|Ipilimumab|ipilimumab|mesh-list
83062861|NCT02750514|Relatlimab|relatlimab|mesh-list
83062862|NCT02750514|Dasatinib|dasatinib|mesh-list
83062863|NCT02750514|Linrodostat|linrodostat|mesh-list
83062864|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062865|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062866|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83062867|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062868|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83062869|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83062870|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
83062871|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83062872|NCT02229240|Incretins|incretins|mesh-ancestor
83062873|NCT02229240|Hormones|hormones|mesh-ancestor
83062874|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062875|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062876|NCT02820714|Laxatives|laxatives|mesh-list
83062877|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062878|NCT02259426|Piperaquine|piperaquine|mesh-list
83062879|NCT02259426|Primaquine|primaquine|mesh-list
83062880|NCT02259426|Artenimol|artenimol|mesh-list
83062881|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
83062882|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83062883|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83062884|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83062885|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83062886|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83062888|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062889|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062890|NCT03412890|Norethindrone|norethindrone|mesh-list
83062891|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
83062892|NCT03412890|Estradiol|estradiol|mesh-list
83062893|NCT03412890|Relugolix|relugolix|mesh-list
83062894|NCT03412890|Estrogens|estrogens|mesh-ancestor
83062895|NCT03412890|Hormones|hormones|mesh-ancestor
83062896|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83062897|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062898|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83062899|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
83062900|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83062901|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83062902|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83062903|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83062904|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83062905|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
83062906|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
83062907|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
83062908|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83062909|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062910|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
83062911|NCT03340974|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83062912|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
83062913|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062914|NCT03340974|Protective Agents|protective agents|mesh-ancestor
83062915|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062916|NCT02229786|Acetaminophen|acetaminophen|mesh-list
83062917|NCT02229786|Scopolamine|scopolamine|mesh-list
83062918|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83062919|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83062920|NCT02229786|Analgesics|analgesics|mesh-ancestor
83062921|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
83062922|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062923|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062924|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
83062925|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
83062926|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
83062927|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83062928|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83062929|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
83062930|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062931|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062932|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83062933|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
83062934|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83062935|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
83062936|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83062937|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83062938|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
83062939|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062940|NCT02229942|Rituximab|rituximab|mesh-list
83062941|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83062942|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062943|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
83062944|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062945|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83062946|NCT03047278|Cetirizine|cetirizine|mesh-list
83062947|NCT03047278|Gabapentin|gabapentin|mesh-list
83062948|NCT03047278|Analgesics|analgesics|mesh-ancestor
83062949|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
83062950|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062951|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062952|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
83062953|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83062954|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83062955|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062956|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83062957|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83062958|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83062959|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062960|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062961|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
83062962|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83062963|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83062964|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83062965|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
83062966|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
83062967|NCT03045016|Prazosin|prazosin|mesh-list
83062968|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83062969|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83062970|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83062971|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83062972|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
83062973|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062974|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062975|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062976|NCT04849858|Bupivacaine|bupivacaine|mesh-list
83062977|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
83062978|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
83062979|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83062980|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062981|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
83062982|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83062983|NCT03043612|Doxazosin|doxazosin|mesh-list
83062984|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83062985|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83062986|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83062987|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83062988|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
83062989|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83062990|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83062991|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062992|NCT02230176|Sunitinib|sunitinib|mesh-list
83062993|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83062994|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83062995|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83062996|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83062997|NCT02230176|Growth Substances|growth substances|mesh-ancestor
83062998|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83062999|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
83063000|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83063001|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439292|NCT02298933|Eculizumab|eculizumab|mesh-list
83063002|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063003|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83063004|NCT02232516|Lenalidomide|lenalidomide|mesh-list
83063005|NCT02232516|Romidepsin|romidepsin|mesh-list
83063006|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
83063007|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063008|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83063009|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83063010|NCT02232516|Growth Substances|growth substances|mesh-ancestor
83063011|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
83063012|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063013|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83063014|NCT02232516|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83063015|NCT02232516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063016|NCT02232516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063017|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
83063018|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83063019|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
83063020|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83063021|NCT03647592|Bevacizumab|bevacizumab|mesh-list
83063022|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83063023|NCT03647592|Gefitinib|gefitinib|mesh-list
83063024|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83063025|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063026|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83063027|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83063028|NCT03647592|Growth Substances|growth substances|mesh-ancestor
83063029|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063030|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
83063031|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83361785|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361786|NCT02651584|Buprenorphine|buprenorphine|mesh-list
83063032|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063033|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063034|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83063035|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83063036|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
83063037|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063038|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063039|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83063040|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
83063041|NCT03180684|Imiquimod|imiquimod|mesh-list
83063042|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83063043|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
83063044|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063045|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063046|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
83063047|NCT04858516|Trastuzumab|trastuzumab|mesh-list
83063048|NCT04858516|Palbociclib|palbociclib|mesh-list
83063049|NCT04858516|Exemestane|exemestane|mesh-list
83063050|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83063051|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063052|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83063053|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063054|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063055|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83063056|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83063057|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83063058|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
83063059|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063060|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063061|NCT03148860|Methotrexate|methotrexate|mesh-list
83063062|NCT03148860|Ustekinumab|ustekinumab|mesh-list
83063063|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83063064|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
83063065|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83063066|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063067|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83063068|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
83063069|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063070|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063071|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83063072|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063073|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83063074|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83063075|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
83063076|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83063077|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83063078|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83063079|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83063080|NCT02232672|Choline|choline|mesh-list
83063081|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
83063082|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063083|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
83063084|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063085|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063086|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063087|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
83063088|NCT05072262|Dexamethasone|dexamethasone|mesh-list
83063089|NCT05072262|Nepafenac|nepafenac|mesh-list
83063090|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83063091|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
83063092|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
83063093|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063094|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063095|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063096|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
83063097|NCT05072262|Hormones|hormones|mesh-ancestor
83063098|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063099|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83063100|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063101|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83063102|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83063103|NCT05072262|Analgesics|analgesics|mesh-ancestor
83063104|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
83063105|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83063106|NCT05001984|Alirocumab|alirocumab|mesh-list
83063107|NCT05001984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83063108|NCT05001984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83063109|NCT05001984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063110|NCT05001984|Antimetabolites|antimetabolites|mesh-ancestor
83063111|NCT05001984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063112|NCT05001984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83063113|NCT05001984|Protease Inhibitors|protease inhibitors|mesh-ancestor
83063114|NCT05001984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063115|NCT05001984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063116|NCT04858048|Anesthetics|anesthetics|mesh-list
83063117|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063118|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063119|NCT02234466|Dexamethasone|dexamethasone|mesh-list
83063120|NCT02234466|Ondansetron|ondansetron|mesh-list
83063121|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83063122|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
83063123|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
83063124|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063125|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063126|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063127|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
83063128|NCT02234466|Hormones|hormones|mesh-ancestor
83063129|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063130|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83063131|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063132|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
83063133|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
83063134|NCT02234466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83063135|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83063136|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
83063137|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063138|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063139|NCT02230800|Tocovid|tocovid|mesh-list
83063140|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
83063141|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83063142|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063143|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063144|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83063145|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83063146|NCT02230800|Protective Agents|protective agents|mesh-ancestor
83063147|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063148|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
83063149|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83063150|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
83063151|NCT02230800|Vitamins|vitamins|mesh-ancestor
83063152|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
83063153|NCT02234544|Vitamin D|vitamin d|mesh-list
83063154|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
83063155|NCT02234544|Ezetimibe|ezetimibe|mesh-list
83063156|NCT02234544|Vitamins|vitamins|mesh-ancestor
83063157|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
83063158|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063159|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83063160|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83063161|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83063162|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063163|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
83063164|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063165|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063166|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83063167|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83063168|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063169|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
83063170|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
83063171|NCT04860076|Nivolumab|nivolumab|mesh-list
83063172|NCT04860076|Ipilimumab|ipilimumab|mesh-list
83063173|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83063174|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063175|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83063176|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063177|NCT04856878|Vancomycin|vancomycin|mesh-list
83063178|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063179|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063180|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
83063181|NCT04856644|Rifapentine|rifapentine|mesh-list
83063182|NCT04856644|Rifampin|rifampin|mesh-list
83063183|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063184|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063185|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83063186|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83063187|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063188|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063189|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063190|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83063191|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
83063192|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
83063193|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83063194|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83063195|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83063196|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83063197|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83063198|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83063199|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83063200|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
83063201|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
83063202|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063203|NCT04984278|Nabiximols|nabiximols|mesh-list
83063204|NCT04984278|Analgesics|analgesics|mesh-ancestor
83063205|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
83063206|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063207|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063208|NCT02233218|Amlodipine|amlodipine|mesh-list
83063209|NCT02233218|Telmisartan|telmisartan|mesh-list
83063210|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83063211|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83063212|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83063213|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063214|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063215|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83063216|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063217|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83063218|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83063219|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063220|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
83063221|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063222|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83063223|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063224|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83063225|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83063226|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
83063227|NCT02262546|Pramipexole|pramipexole|mesh-list
83063228|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83063229|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063230|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063231|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83063232|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83063233|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063234|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063235|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063236|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83063237|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
83063238|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83063239|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063240|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83063241|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83063242|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83063243|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
83063244|NCT02262546|Protective Agents|protective agents|mesh-ancestor
83063245|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83063246|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83063247|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
83063248|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
83063249|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063250|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
83063251|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83063252|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063253|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361787|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83063254|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
83063255|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063256|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063257|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
83063258|NCT04856098|Bromides|bromides|mesh-list
83063259|NCT04856098|Maleic acid|maleic acid|mesh-list
83063260|NCT04856098|Charcoal|charcoal|mesh-list
83063261|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
83063262|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063263|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063264|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83063265|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83063266|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83063267|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
83063268|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063269|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063270|NCT04856098|Antidotes|antidotes|mesh-ancestor
83063271|NCT04856098|Protective Agents|protective agents|mesh-ancestor
83063272|NCT04859452|Metformin|metformin|mesh-list
83063273|NCT04859452|Glyburide|glyburide|mesh-list
83063274|NCT04859452|Valsartan|valsartan|mesh-list
83063275|NCT04859452|Simvastatin|simvastatin|mesh-list
83063276|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83063277|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063278|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83063279|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063280|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
83063281|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063282|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063283|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83063284|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063285|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83063286|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83063287|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83063288|NCT02262624|Telmisartan|telmisartan|mesh-list
83063289|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83063290|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83063291|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83063292|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83063293|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063294|NCT02262624|Diuretics|diuretics|mesh-ancestor
83063295|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
83063296|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063297|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83063298|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063299|NCT02233452|Ketamine|ketamine|mesh-list
83063300|NCT02233452|Methadone|methadone|mesh-list
83063301|NCT02233452|Analgesics|analgesics|mesh-ancestor
83063302|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
83063303|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063304|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063305|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83063306|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83063307|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
83063308|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
83063309|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063310|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83063311|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83063312|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063313|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063314|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83063315|NCT02233452|Narcotics|narcotics|mesh-ancestor
83063316|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
83063317|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
83063318|NCT02262702|Acetaminophen|acetaminophen|mesh-list
83063319|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83063320|NCT02262702|Analgesics|analgesics|mesh-ancestor
83063321|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
83063322|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063323|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063324|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
83063325|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83063326|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83063327|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063328|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
83063329|NCT04845880|Paraproteins|paraproteins|mesh-list
83063330|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
83063331|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063332|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83063333|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063334|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063335|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83063336|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063337|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063339|NCT03041506|Midazolam|midazolam|mesh-list
83063340|NCT03041506|Ketamine|ketamine|mesh-list
83063341|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
83063342|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
83063343|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063344|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063345|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
83063346|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063347|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83063348|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83063349|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83063350|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063351|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063352|NCT03041506|Analgesics|analgesics|mesh-ancestor
83063353|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83063354|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83063355|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
83063356|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83063357|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83063358|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063359|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83063360|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83063361|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83063362|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83063363|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83063364|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
83063365|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
83063366|NCT02580708|Trametinib|trametinib|mesh-list
83063367|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063368|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83063369|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063370|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063371|NCT02262780|Telmisartan|telmisartan|mesh-list
83063372|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83063373|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83063374|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83063375|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063376|NCT04845646|Itraconazole|itraconazole|mesh-list
83063377|NCT04845646|Phenytoin|phenytoin|mesh-list
83063378|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
83063379|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063380|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83063381|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83063382|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063383|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063384|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83063385|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83063386|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063387|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063388|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83063390|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83063391|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83063392|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063393|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83063394|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83063395|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
83063396|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
83063397|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
83063398|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063399|NCT03038776|Coagulants|coagulants|mesh-ancestor
83063400|NCT02570490|Linezolid|linezolid|mesh-list
83063401|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
83361788|NCT02651584|Narcotics|narcotics|mesh-ancestor
83063402|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063403|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063404|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83063405|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063406|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063407|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
83063408|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83063409|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83063410|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83063411|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063412|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063413|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
83063414|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063415|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063416|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83063417|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063418|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
83063419|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063420|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063421|NCT02262858|Telmisartan|telmisartan|mesh-list
83063422|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83063423|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83063424|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83063425|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83063426|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063427|NCT02262858|Diuretics|diuretics|mesh-ancestor
83063428|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
83063429|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063430|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83063431|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063432|NCT02235012|Ketamine|ketamine|mesh-list
83063433|NCT02235012|Analgesics|analgesics|mesh-ancestor
83063434|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
83063435|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063436|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063437|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83063438|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83063439|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
83063440|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
83063441|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063442|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83063443|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83063444|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063445|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063446|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83063447|NCT02262936|Fesoterodine|fesoterodine|mesh-list
83063448|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83063449|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83063450|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
83063451|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063452|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063453|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063454|NCT02262936|Urological Agents|urological agents|mesh-ancestor
83063455|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
83063456|NCT02262936|Coagulants|coagulants|mesh-ancestor
83063457|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83063458|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
83063459|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
83063460|NCT04838704|Methotrexate|methotrexate|mesh-list
83063461|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83063462|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
83063463|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83063464|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063465|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83063466|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
83063467|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063468|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063469|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
83063470|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063471|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83063472|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83063473|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
83063474|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83063475|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83063476|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83063477|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83063478|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
83063479|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063480|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063482|NCT02259738|Coagulants|coagulants|mesh-ancestor
83063483|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83063484|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
83063485|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83063486|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063487|NCT04854460|Ivermectin|ivermectin|mesh-list
83063488|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83063489|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063490|NCT04854538|Budesonide|budesonide|mesh-list
83063491|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83063492|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83063493|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
83063494|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063495|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063496|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83063497|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
83063498|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
83063499|NCT04854538|Hormones|hormones|mesh-ancestor
83063500|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063501|NCT05331690|Dexamethasone|dexamethasone|mesh-list
83063502|NCT05331690|Nepafenac|nepafenac|mesh-list
83063503|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83063504|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
83063505|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
83063506|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063507|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063508|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063509|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
83063510|NCT05331690|Hormones|hormones|mesh-ancestor
83063511|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063512|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83063513|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063514|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83063515|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83063516|NCT05331690|Analgesics|analgesics|mesh-ancestor
83063517|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
83063518|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83063519|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83063520|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063521|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063522|NCT02263170|Phenobarbital|phenobarbital|mesh-list
83063523|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
83063524|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83063525|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063526|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063527|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83063528|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83063529|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063530|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063531|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
83063532|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
83063533|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83063534|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83063535|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83063536|NCT02543268|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83063537|NCT02543268|Antiviral Agents|antiviral agents|mesh-ancestor
83063538|NCT02543268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063540|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
83063541|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83063542|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063543|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83063544|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063545|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
83063546|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063547|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063548|NCT03038230|Antibodies|antibodies|mesh-list
83063549|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83063550|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
83063551|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063553|NCT04853758|Enalapril|enalapril|mesh-list
83063554|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83063555|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83063556|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83063557|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83063558|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83063559|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83063560|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063561|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
83063562|NCT02784288|Paclitaxel|paclitaxel|mesh-list
83063563|NCT02784288|Carboplatin|carboplatin|mesh-list
83063564|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83063565|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063566|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
83063567|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
83063568|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
83063569|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063570|NCT03040180|Bleomycin|bleomycin|mesh-list
83063571|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83063572|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063573|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
83063574|NCT02235246|Analgesics|analgesics|mesh-ancestor
83063575|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
83063576|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063577|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063578|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
83063579|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063580|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83063581|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
83063582|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83063583|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063584|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063585|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83063586|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
83063587|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83063588|NCT02235324|Leucovorin|leucovorin|mesh-list
83063589|NCT02235324|Fluorouracil|fluorouracil|mesh-list
83063590|NCT02235324|Aflibercept|aflibercept|mesh-list
83063591|NCT02235324|Calcium|calcium|mesh-list
83063592|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
83063593|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
83063594|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83063595|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063596|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
83063597|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063598|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83063599|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063600|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83063601|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
83063602|NCT02235324|Antidotes|antidotes|mesh-ancestor
83063603|NCT02235324|Protective Agents|protective agents|mesh-ancestor
83063604|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
83063605|NCT02235324|Vitamins|vitamins|mesh-ancestor
83063606|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
83063607|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83063608|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83063609|NCT02235324|Growth Substances|growth substances|mesh-ancestor
83063610|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
83063611|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
83063612|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83063613|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
83063614|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83063615|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063616|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83063617|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83063618|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83063619|NCT02263248|Buprenorphine|buprenorphine|mesh-list
83063620|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83063621|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83063622|NCT02263248|Narcotics|narcotics|mesh-ancestor
83063623|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063624|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063625|NCT02263248|Analgesics|analgesics|mesh-ancestor
83063626|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
83063627|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063628|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83063629|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83063630|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83063631|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063632|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063633|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063634|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83063635|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
83063636|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83063637|NCT04838860|Siltuximab|siltuximab|mesh-list
83063638|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063639|NCT04853524|Tenofovir|tenofovir|mesh-list
83063640|NCT04853524|Emtricitabine|emtricitabine|mesh-list
83063641|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
83063642|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
83063643|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063644|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83063645|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83063646|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063647|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063648|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83063649|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83063650|NCT04852510|Metformin|metformin|mesh-list
83063651|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83063652|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063653|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
83063654|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83063655|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063656|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063657|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83063658|NCT05163704|Analgesics|analgesics|mesh-ancestor
83063659|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
83063660|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063661|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83063662|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83063663|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83063664|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
83063665|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063666|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063667|NCT03130556|Rabeprazole|rabeprazole|mesh-list
83063668|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83063669|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063670|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83063671|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063672|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063673|NCT04838080|Vaccines|vaccines|mesh-list
83063674|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
83063675|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063677|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83063678|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063679|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
83063680|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
83063681|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
83063682|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063683|NCT03037606|Rabeprazole|rabeprazole|mesh-list
83063684|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83063685|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063686|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83063687|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063688|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063689|NCT04842370|PHI-101|phi-101|mesh-list
83063690|NCT04842370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83063691|NCT04842370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063692|NCT04842370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83063693|NCT04842370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063694|NCT03037372|Atorvastatin|atorvastatin|mesh-list
83063695|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83063696|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83063697|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83063698|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063699|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
83063700|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063701|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063702|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063703|NCT04842526|Irinotecan|irinotecan|mesh-list
83063704|NCT04842526|Temozolomide|temozolomide|mesh-list
83063705|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83063706|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83063707|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063708|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063709|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063710|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83063711|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
83063712|NCT04850950|Tenofovir|tenofovir|mesh-list
83063713|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
83063714|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063715|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83063716|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83063717|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063718|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063719|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83063720|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83063721|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
83063722|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83063723|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063724|NCT04850560|Decitabine|decitabine|mesh-list
83063725|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83063726|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
83063727|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063728|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063729|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063730|NCT04850404|Ropivacaine|ropivacaine|mesh-list
83063731|NCT04850404|Rocuronium|rocuronium|mesh-list
83063732|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
83063733|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
83063734|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063735|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063736|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
83063737|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063738|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83063739|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83063740|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83063741|NCT04428814|Ustekinumab|ustekinumab|mesh-list
83063742|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83063743|NCT03036514|Sufentanil|sufentanil|mesh-list
83063744|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83063745|NCT03036514|Narcotics|narcotics|mesh-ancestor
83063746|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063747|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063748|NCT03036514|Analgesics|analgesics|mesh-ancestor
83063749|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
83063750|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063751|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83063752|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83063753|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
83063754|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
83063755|NCT04835896|Paclitaxel|paclitaxel|mesh-list
83063756|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83063757|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063758|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
83063759|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
83063760|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
83063761|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063762|NCT01668004|Golimumab|golimumab|mesh-list
83063763|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83063764|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83063765|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83063766|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
83063767|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063768|NCT04835350|Pancrelipase|pancrelipase|mesh-list
83063769|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063770|NCT01667926|Ketamine|ketamine|mesh-list
83063771|NCT01667926|Analgesics|analgesics|mesh-ancestor
83063772|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
83063773|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063774|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063775|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83063776|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83063777|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
83063779|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063780|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83063781|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83063782|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063783|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063784|NCT03039478|Erythritol|erythritol|mesh-list
83063785|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
83063786|NCT04832776|Bevacizumab|bevacizumab|mesh-list
83063787|NCT04832776|Cetuximab|cetuximab|mesh-list
83063788|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83063789|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063790|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83063791|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83063792|NCT04832776|Growth Substances|growth substances|mesh-ancestor
83063793|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063794|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
83063795|NCT04835116|Acetaminophen|acetaminophen|mesh-list
83063796|NCT04835116|Tramadol|tramadol|mesh-list
83063797|NCT04835116|Analgesics|analgesics|mesh-list
83063798|NCT04835116|Orphenadrine|orphenadrine|mesh-list
83063799|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
83063800|NCT04835116|Bupivacaine|bupivacaine|mesh-list
83063801|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
83063802|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
83063803|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063804|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063805|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
83063806|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063807|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83063808|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
83063809|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83063810|NCT04835116|Narcotics|narcotics|mesh-ancestor
83063811|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83063812|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83063813|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83063814|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83063815|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
83063816|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
83063817|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83063818|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83063819|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
83063820|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063821|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063822|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83063823|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83063824|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063825|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
83063826|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83063827|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83063828|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
83063829|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
83063831|NCT03036826|Tazobactam|tazobactam|mesh-list
83063832|NCT03036826|Piperacillin|piperacillin|mesh-list
83063833|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83063834|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83063835|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063836|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83063837|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063838|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063839|NCT03036046|Fluconazole|fluconazole|mesh-list
83063840|NCT03036046|Posaconazole|posaconazole|mesh-list
83063841|NCT03036046|Olorofim|olorofim|mesh-list
83063842|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
83063843|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063844|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83063845|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83063846|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063847|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063848|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83063849|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
83063850|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063851|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063852|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83063853|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83063854|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83063855|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83063856|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83063857|NCT04831528|Bevacizumab|bevacizumab|mesh-list
83063858|NCT04831528|Trastuzumab|trastuzumab|mesh-list
83063859|NCT04831528|Cetuximab|cetuximab|mesh-list
83063860|NCT04831528|Pertuzumab|pertuzumab|mesh-list
83063861|NCT04831528|Lapatinib|lapatinib|mesh-list
83063862|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83063863|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063864|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83063865|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83063866|NCT04831528|Growth Substances|growth substances|mesh-ancestor
83063867|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063868|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
83063869|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83063870|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063871|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063872|NCT04824586|Insulin|insulin|mesh-list
83063873|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83063874|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83063875|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063876|NCT04824898|Simvastatin|simvastatin|mesh-list
83063877|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83063878|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063879|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
83063880|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063881|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063882|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83063883|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063884|NCT04824352|Apatinib|apatinib|mesh-list
83063885|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063886|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83063887|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063888|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063889|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
83063890|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83063891|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83063892|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063893|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
83063894|NCT04319614|Coagulants|coagulants|mesh-ancestor
83063895|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
83063896|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83063897|NCT04823260|Niacinamide|niacinamide|mesh-list
83063898|NCT04823260|Niacin|niacin|mesh-list
83063899|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
83063900|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
83063901|NCT04823260|Vitamins|vitamins|mesh-ancestor
83063902|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
83063903|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063904|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83063905|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
83063906|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063907|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83063908|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
83063909|NCT04816240|Midodrine|midodrine|mesh-list
83063910|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
83063911|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
83063912|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063913|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063914|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83063915|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83063916|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83063917|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83063918|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83063919|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83063920|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063921|NCT04822012|Antibodies|antibodies|mesh-list
83063922|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
83063923|NCT04822012|Progesterone|progesterone|mesh-list
83063924|NCT04822012|Estrogens|estrogens|mesh-list
83063925|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
83063926|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063928|NCT04822012|Hormones|hormones|mesh-ancestor
83063929|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063930|NCT05399732|Cyclosporine|cyclosporine|mesh-list
83063931|NCT05399732|Luspatercept|luspatercept|mesh-list
83063932|NCT05399732|Cyclosporins|cyclosporins|mesh-list
83063933|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063934|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063935|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83063936|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
83063937|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063938|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
83063939|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063940|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
83063941|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83063942|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83063943|NCT05399732|Hematinics|hematinics|mesh-ancestor
83063944|NCT05399576|Nicorandil|nicorandil|mesh-list
83063945|NCT05399576|Verapamil|verapamil|mesh-list
83063946|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83063947|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83063948|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83063949|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063950|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83063951|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063952|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
83063953|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83063954|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
83063955|NCT05399576|Vitamins|vitamins|mesh-ancestor
83063956|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
83063957|NCT05398718|Sotrovimab|sotrovimab|mesh-list
83063958|NCT05398718|Antiviral Agents|antiviral agents|mesh-ancestor
83063959|NCT05398718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063960|NCT05255900|Metyrapone|metyrapone|mesh-list
83063961|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
83063962|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83063963|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83063964|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83063965|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83063966|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063967|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
83063968|NCT05397938|Alendronate|alendronate|mesh-list
83063969|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83063970|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063971|NCT05133674|Tamoxifen|tamoxifen|mesh-list
83063972|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83063973|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
83063974|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83063975|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063976|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83063977|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83439367|NCT00654329|Analgesics|analgesics|mesh-ancestor
83063978|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83063979|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83063980|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83063981|NCT02522936|Muramidase|muramidase|mesh-list
83063982|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83063983|NCT04525898|Methadone|methadone|mesh-list
83063984|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83063985|NCT04525898|Narcotics|narcotics|mesh-ancestor
83063986|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83063987|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83063988|NCT04525898|Analgesics|analgesics|mesh-ancestor
83063989|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
83063990|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83063991|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
83063992|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83063993|NCT04282070|Paclitaxel|paclitaxel|mesh-list
83063994|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83063995|NCT04282070|Cisplatin|cisplatin|mesh-list
83063996|NCT04282070|Gemcitabine|gemcitabine|mesh-list
83063997|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83063998|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83063999|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064000|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064001|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064002|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064003|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83064004|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
83064005|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
83064006|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83064007|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83064008|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064009|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
83064010|NCT04347122|Coagulants|coagulants|mesh-ancestor
83064011|NCT03467438|Polaprezinc|polaprezinc|mesh-list
83064012|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83064013|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83064014|NCT05397236|Dexamethasone|dexamethasone|mesh-list
83064015|NCT05397236|Bupivacaine|bupivacaine|mesh-list
83064016|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83064017|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
83064018|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
83064019|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064020|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064021|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83064022|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
83064023|NCT05397236|Hormones|hormones|mesh-ancestor
83064024|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83064025|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83064026|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064027|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
83064028|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
83064029|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064030|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
83064031|NCT05439278|Temozolomide|temozolomide|mesh-list
83064032|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83064033|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
83064034|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064035|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064036|NCT03130010|Nefopam|nefopam|mesh-list
83064037|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83064038|NCT03130010|Analgesics|analgesics|mesh-ancestor
83439377|NCT00654329|Narcotics|narcotics|mesh-ancestor
83064039|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
83064040|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064041|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064042|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
83064043|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83064044|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
83064045|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
83064046|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064047|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064048|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83064049|NCT05396144|Analgesics|analgesics|mesh-ancestor
83064050|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
83064051|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064052|NCT00157248|Dabigatran|dabigatran|mesh-list
83064053|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
83064054|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83064055|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
83064056|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064057|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064058|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
83064059|NCT02504580|Bupivacaine|bupivacaine|mesh-list
83064060|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
83064061|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
83064062|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064063|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064064|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
83064065|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064066|NCT02235402|Lacidipine|lacidipine|mesh-list
83064067|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
83064068|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83064069|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83064070|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064071|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064072|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83064073|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064074|NCT02235402|Diuretics|diuretics|mesh-ancestor
83064075|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
83064076|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83064077|NCT02235480|Tazarotene|tazarotene|mesh-list
83064078|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
83064079|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
83064080|NCT02235558|Verapamil|verapamil|mesh-list
83064081|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83064082|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83064083|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064084|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064085|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83064086|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064087|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
83064088|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
83064089|NCT04214418|Atezolizumab|atezolizumab|mesh-list
83064090|NCT04214418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83064091|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064092|NCT04214418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064093|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064094|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
83064095|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83064096|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83439392|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
83064097|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064098|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064099|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064100|NCT02233920|Oxitropium|oxitropium|mesh-list
83064101|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
83064102|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
83064103|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064104|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064105|NCT02235948|Folic Acid|folic acid|mesh-list
83064106|NCT02235948|Hematinics|hematinics|mesh-ancestor
83064107|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
83064108|NCT02235948|Vitamins|vitamins|mesh-ancestor
83064109|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
83064110|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064111|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
83064112|NCT02236026|ST 1435|st 1435|mesh-list
83064113|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064114|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064115|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83064116|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83064117|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064118|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064119|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064120|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83064121|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
83064122|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83064123|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064124|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83064125|NCT02236182|Bromides|bromides|mesh-list
83064126|NCT02236182|Ipratropium|ipratropium|mesh-list
83064127|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
83064128|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83064129|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
83064130|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064131|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064132|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83064133|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83064134|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83064135|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
83064136|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064137|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064138|NCT04453280|Antibodies|antibodies|mesh-list
83064139|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
83064140|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064141|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83064142|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83064143|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064144|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83064145|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83064146|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064147|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064148|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
83064149|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064150|NCT03466502|Vancomycin|vancomycin|mesh-list
83361789|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064151|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064152|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064153|NCT05392634|Amoxicillin|amoxicillin|mesh-list
83064154|NCT05392634|Meropenem|meropenem|mesh-list
83064155|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
83064156|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
83064157|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83064158|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064159|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064160|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064161|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064162|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83064163|NCT01593228|Paclitaxel|paclitaxel|mesh-list
83064164|NCT01593228|Carboplatin|carboplatin|mesh-list
83064165|NCT01593228|Gemcitabine|gemcitabine|mesh-list
83064166|NCT01593228|Doxorubicin|doxorubicin|mesh-list
83064167|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83064168|NCT01593228|Irinotecan|irinotecan|mesh-list
83064169|NCT01593228|Topotecan|topotecan|mesh-list
83064170|NCT01593228|Iniparib|iniparib|mesh-list
83064171|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83064172|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064173|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064174|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064175|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064176|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064177|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83064178|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
83064179|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83064180|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83064181|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83064182|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064183|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83064184|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83064185|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83064186|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064187|NCT02236260|Lidocaine|lidocaine|mesh-list
83064188|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
83064189|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
83064190|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064191|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064192|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
83064193|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064194|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83064195|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83064196|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83064197|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064198|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064199|NCT01555554|Propranolol|propranolol|mesh-list
83064200|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83064201|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83064202|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
83064203|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064204|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064205|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064206|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83064207|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83064208|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83064209|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
83064210|NCT01435044|Ribavirin|ribavirin|mesh-list
83064211|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
83064212|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064213|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
83064214|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064215|NCT01434498|Ribavirin|ribavirin|mesh-list
83064216|NCT01434498|Ledipasvir|ledipasvir|mesh-list
83064217|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
83064218|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064219|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
83064220|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064221|NCT03735966|Carboplatin|carboplatin|mesh-list
83064222|NCT03735966|Docetaxel|docetaxel|mesh-list
83064223|NCT03735966|Trastuzumab|trastuzumab|mesh-list
83064224|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064225|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064226|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064227|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064228|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064229|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064230|NCT01554696|Methotrexate|methotrexate|mesh-list
83064231|NCT01554696|Peficitinib|peficitinib|mesh-list
83064232|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83064233|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
83064234|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83064235|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064236|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83064237|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
83064238|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064239|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064240|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
83064241|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064242|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83064243|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83064244|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
83064245|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064246|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83064247|NCT02265276|Pioglitazone|pioglitazone|mesh-list
83064248|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83064249|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064250|NCT02263872|Minocycline|minocycline|mesh-list
83064251|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064252|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064253|NCT02261376|DS-1971a|ds-1971a|mesh-list
83064254|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83064255|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83064256|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064257|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064258|NCT01535508|Vitamin D|vitamin d|mesh-list
83064259|NCT01535508|Vitamins|vitamins|mesh-ancestor
83064260|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
83064261|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064262|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83064263|NCT02626338|Cytarabine|cytarabine|mesh-list
83064264|NCT02626338|Fludarabine|fludarabine|mesh-list
83064265|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
83064266|NCT02626338|Etoposide|etoposide|mesh-list
83064267|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
83064268|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
83064269|NCT02626338|Idarubicin|idarubicin|mesh-list
83064270|NCT02626338|Crenolanib|crenolanib|mesh-list
83064271|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064272|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83064273|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
83064274|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064275|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83064276|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
83064277|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064278|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
83064279|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064280|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83064281|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83064282|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83064283|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064284|NCT02626338|Analgesics|analgesics|mesh-ancestor
83064285|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
83064286|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064287|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83064288|NCT01416402|Colchicine|colchicine|mesh-list
83064289|NCT01416402|Febuxostat|febuxostat|mesh-list
83064290|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
83064291|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064292|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064293|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064294|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064295|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064296|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064297|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83064298|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83064299|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064300|NCT01414920|Incretins|incretins|mesh-ancestor
83064301|NCT01414920|Hormones|hormones|mesh-ancestor
83064302|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83064303|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83064304|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
83064305|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064306|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064307|NCT02263950|Artemether|artemether|mesh-list
83064308|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
83064309|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83064310|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83064311|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064312|NCT02261844|Resveratrol|resveratrol|mesh-list
83064313|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
83064314|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064315|NCT02261844|Protective Agents|protective agents|mesh-ancestor
83064316|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064317|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064318|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83064319|NCT02261922|Ticagrelor|ticagrelor|mesh-list
83064320|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83064321|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83064322|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83064323|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83064324|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83064325|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
83064326|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064327|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064328|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064329|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83064330|NCT02264106|Pantoprazole|pantoprazole|mesh-list
83064331|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83064332|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83064333|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83064334|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064335|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064336|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
83064337|NCT02262156|Serotonin|serotonin|mesh-list
83064338|NCT02262156|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83064339|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83064340|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83064341|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
83064342|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064343|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064344|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064345|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83064346|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064347|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
83064348|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83064349|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064350|NCT01516476|Liraglutide|liraglutide|mesh-list
83064351|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83064352|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064353|NCT01516476|Incretins|incretins|mesh-ancestor
83064354|NCT01516476|Hormones|hormones|mesh-ancestor
83482360|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83064355|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83064356|NCT01516086|Fluticasone|fluticasone|mesh-list
83064357|NCT01516086|Xhance|xhance|mesh-list
83064358|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83064359|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83064360|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
83064361|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064362|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064363|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83064364|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83064365|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
83064366|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83064367|NCT01497834|Asunaprevir|asunaprevir|mesh-list
83064368|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
83064369|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064370|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064371|NCT02265822|Midazolam|midazolam|mesh-list
83064372|NCT02265822|Melatonin|melatonin|mesh-list
83064373|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83064374|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83064375|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064376|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064377|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83064378|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83064379|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83064380|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83064381|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
83064382|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
83064383|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
83064384|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
83064385|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064386|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064387|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
83064388|NCT02265822|Protective Agents|protective agents|mesh-ancestor
83064390|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83064391|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83064392|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064393|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064394|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
83064395|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064396|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83064397|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83064398|NCT02264184|Paroxetine|paroxetine|mesh-list
83064399|NCT02264184|Tamsulosin|tamsulosin|mesh-list
83064400|NCT02264184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83064401|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83064402|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064403|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064404|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064405|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
83064406|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064407|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83064408|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
83064409|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83064410|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83064411|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83064412|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064413|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83064414|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83064415|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83064416|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83064417|NCT02264184|Urological Agents|urological agents|mesh-ancestor
83064418|NCT01260870|Paclitaxel|paclitaxel|mesh-list
83064419|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83064420|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064421|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064422|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064423|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064424|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064425|NCT02266056|Rocuronium|rocuronium|mesh-list
83064426|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83064427|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83064428|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83064429|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064430|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064431|NCT01482390|Ribavirin|ribavirin|mesh-list
83064432|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83064433|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
83064434|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064435|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
83064436|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064437|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
83064438|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83064439|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
83064440|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064441|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064442|NCT01366014|Oxycodone|oxycodone|mesh-list
83064443|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83064444|NCT01366014|Narcotics|narcotics|mesh-ancestor
83064445|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064446|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064447|NCT01366014|Analgesics|analgesics|mesh-ancestor
83064448|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
83064449|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064450|NCT01361802|Ambroxol|ambroxol|mesh-list
83064451|NCT01361802|Expectorants|expectorants|mesh-ancestor
83064452|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
83064453|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
83064455|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
83064456|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
83064457|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83064458|NCT01235754|Androgens|androgens|mesh-ancestor
83064459|NCT01235754|Hormones|hormones|mesh-ancestor
83064460|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83064461|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064462|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83064463|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064464|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
83064465|NCT01234038|Paclitaxel|paclitaxel|mesh-list
83064466|NCT01234038|Carboplatin|carboplatin|mesh-list
83064467|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83064468|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064469|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064470|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064471|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064472|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064473|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
83064474|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83064475|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
83064476|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064477|NCT01229982|Latanoprost|latanoprost|mesh-list
83064478|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83064479|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83064480|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83064481|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
83064482|NCT01225380|Ribavirin|ribavirin|mesh-list
83064483|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
83064484|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064485|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
83064486|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064487|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
83064488|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064489|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
83064490|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83064491|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
83064492|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064493|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064494|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83064495|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
83064496|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83064497|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83064498|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83064499|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
83064500|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064501|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064502|NCT02266524|Tamsulosin|tamsulosin|mesh-list
83064503|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83064504|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83064505|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83064506|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
83064507|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064508|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064509|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064510|NCT02266524|Urological Agents|urological agents|mesh-ancestor
83064512|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
83064513|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064514|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064515|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064516|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064517|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064518|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064519|NCT01455090|Ribavirin|ribavirin|mesh-list
83064520|NCT01455090|Asunaprevir|asunaprevir|mesh-list
83064521|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
83064522|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064523|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
83064524|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064525|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
83064526|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064527|NCT02056782|Heparin|heparin|mesh-list
83064528|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
83064529|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83064530|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83064531|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064533|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064534|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064535|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83064536|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83064537|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064538|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064539|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064540|NCT01194960|Docetaxel|docetaxel|mesh-list
83064541|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064542|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064543|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064544|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064545|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064546|NCT01331850|Ritonavir|ritonavir|mesh-list
83064547|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83064548|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
83064549|NCT01331850|Ribavirin|ribavirin|mesh-list
83064550|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83064551|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83064552|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83064553|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064554|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064555|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83064556|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83064557|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
83064558|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064559|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83064560|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83064561|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
83064562|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064563|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
83064564|NCT02101034|Cetuximab|cetuximab|mesh-list
83064565|NCT02101034|Palbociclib|palbociclib|mesh-list
83064566|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064567|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064568|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83064569|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064570|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064571|NCT01328808|Acetaminophen|acetaminophen|mesh-list
83064572|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83064573|NCT01328808|Analgesics|analgesics|mesh-ancestor
83064574|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
83064575|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064576|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064577|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
83064578|NCT01968590|Vitamin D|vitamin d|mesh-list
83064579|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
83064580|NCT01968590|Vitamins|vitamins|mesh-ancestor
83064581|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
83064582|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482361|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064583|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83064584|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83064585|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
83064586|NCT05626998|Gabapentin|gabapentin|mesh-list
83064587|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83064588|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064589|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064590|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83064591|NCT05626998|Analgesics|analgesics|mesh-ancestor
83064592|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
83064593|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064594|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83064595|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83064596|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83439430|NCT00655811|Capsaicin|capsaicin|mesh-list
83064597|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
83064598|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064599|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064600|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
83064601|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83064602|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83064603|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83064604|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83064605|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83064606|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
83064607|NCT01314222|Pregabalin|pregabalin|mesh-list
83064608|NCT01314222|Analgesics|analgesics|mesh-ancestor
83064609|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
83064610|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064611|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064612|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
83064613|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83064614|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064615|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064616|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83064617|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83064618|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83064619|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064620|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83064621|NCT05222828|Mepivacaine|mepivacaine|mesh-list
83064622|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
83064623|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
83064624|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064625|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064626|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
83064627|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064628|NCT01309932|Interferons|interferons|mesh-list
83064629|NCT01309932|Ribavirin|ribavirin|mesh-list
83064630|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
83064631|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
83064632|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83064633|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83064634|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
83064635|NCT01309932|Asunaprevir|asunaprevir|mesh-list
83064636|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064637|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
83064638|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064639|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
83064640|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064641|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
83064642|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064643|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064644|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83064645|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83064646|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83064647|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83064648|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83064649|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064650|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83064651|NCT01101594|Doxorubicin|doxorubicin|mesh-list
83064652|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83064653|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064654|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83064655|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83064656|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064657|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064658|NCT02269176|Losartan|losartan|mesh-list
83064659|NCT02269176|Telmisartan|telmisartan|mesh-list
83064660|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83064661|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83064662|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83064663|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83064664|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064665|NCT01094262|Oxycodone|oxycodone|mesh-list
83064666|NCT01094262|Analgesics|analgesics|mesh-list
83064667|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83064668|NCT01094262|Narcotics|narcotics|mesh-ancestor
83064669|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064670|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064671|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
83064672|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064673|NCT04476186|Acyclovir|acyclovir|mesh-list
83064674|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
83064675|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064676|NCT03440216|Meropenem|meropenem|mesh-list
83064677|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
83064678|NCT03440216|Temocillin|temocillin|mesh-list
83064679|NCT03440216|Penicillins|penicillins|mesh-list
83064680|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064681|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064682|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
83064683|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83064684|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
83064685|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83064686|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064687|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83064688|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83064689|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83064690|NCT05370716|Pregabalin|pregabalin|mesh-list
83064691|NCT05370716|Analgesics|analgesics|mesh-ancestor
83064692|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
83064693|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064694|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064695|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
83064696|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83064697|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83064698|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064699|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83064700|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83064701|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83064702|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064703|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83064704|NCT01038804|Docetaxel|docetaxel|mesh-list
83064705|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064706|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064707|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064708|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064709|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064710|NCT05118776|Bevacizumab|bevacizumab|mesh-list
83064711|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064712|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064713|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83064714|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83064715|NCT05118776|Growth Substances|growth substances|mesh-ancestor
83064716|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064717|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
83064718|NCT02269644|Azithromycin|azithromycin|mesh-list
83064719|NCT02269644|Linezolid|linezolid|mesh-list
83064720|NCT02269644|Dalbavancin|dalbavancin|mesh-list
83064721|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064722|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064723|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83064724|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064725|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064726|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
83064727|NCT03367988|Anesthetics|anesthetics|mesh-list
83064728|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064729|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064730|NCT03367988|Narcotics|narcotics|mesh-ancestor
83064731|NCT03367988|Analgesics|analgesics|mesh-ancestor
83064732|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
83064733|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064734|NCT03465488|Albendazole|albendazole|mesh-list
83064735|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
83064736|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83064737|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064738|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
83064739|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83064740|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83064741|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064742|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064743|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064744|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064745|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064747|NCT02267304|Naloxone|naloxone|mesh-list
83064748|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83064749|NCT02267304|Narcotics|narcotics|mesh-ancestor
83064750|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064751|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064752|NCT02267304|Analgesics|analgesics|mesh-ancestor
83064753|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
83064754|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064755|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83361790|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064757|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83064758|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
83064759|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064760|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83064761|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064762|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064763|NCT02522234|Lenograstim|lenograstim|mesh-list
83064764|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83064765|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
83064766|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064767|NCT00154284|Cyclosporine|cyclosporine|mesh-list
83064768|NCT00154284|Prednisone|prednisone|mesh-list
83064769|NCT00154284|Everolimus|everolimus|mesh-list
83064770|NCT00154284|Cyclosporins|cyclosporins|mesh-list
83064771|NCT00154284|Basiliximab|basiliximab|mesh-list
83064772|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83064773|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
83064774|NCT00154284|Hormones|hormones|mesh-ancestor
83064775|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83064776|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064777|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83064778|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064779|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064780|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064781|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83064782|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
83064783|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
83064784|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064785|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
83064786|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064787|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83064788|NCT00154284|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83064789|NCT00154284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83064790|NCT04973306|Tislelizumab|tislelizumab|mesh-list
83064791|NCT04973306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064792|NCT04973306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064793|NCT01037166|Entecavir|entecavir|mesh-list
83064794|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
83064795|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064796|NCT04491032|Anesthetics|anesthetics|mesh-list
83064797|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064798|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064799|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83064800|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83064801|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064802|NCT04487756|Carboplatin|carboplatin|mesh-list
83064803|NCT04487756|Atezolizumab|atezolizumab|mesh-list
83064804|NCT04487756|Vaccines|vaccines|mesh-list
83064805|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
83064806|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064807|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064808|NCT04487756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83064809|NCT04487756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064810|NCT04487756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064811|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83064812|NCT01281462|Cephalosporins|cephalosporins|mesh-list
83064813|NCT01281462|Avibactam|avibactam|mesh-list
83064814|NCT01281462|Doripenem|doripenem|mesh-list
83064815|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064816|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064817|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83064818|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064819|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064820|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83064821|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064822|NCT01024062|Paclitaxel|paclitaxel|mesh-list
83064823|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83064824|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064825|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064826|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064827|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064828|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064829|NCT04453436|Tenofovir|tenofovir|mesh-list
83064830|NCT04453436|Lamivudine|lamivudine|mesh-list
83064831|NCT04453436|Dolutegravir|dolutegravir|mesh-list
83064832|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
83064833|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064834|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83064835|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83064836|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064837|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064838|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83064839|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83064840|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83064841|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83064842|NCT02267616|Etonogestrel|etonogestrel|mesh-list
83064843|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83064844|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
83064845|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83064846|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064847|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83064848|NCT05232734|Caffeine|caffeine|mesh-list
83064849|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
83064850|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064851|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83064852|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064853|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83064854|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064855|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83064856|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83064857|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
83064858|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064859|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83064860|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83064861|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064862|NCT01023204|Paclitaxel|paclitaxel|mesh-list
83064863|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83064864|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064865|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064866|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064867|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064868|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064869|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
83064870|NCT04460456|Cemiplimab|cemiplimab|mesh-list
83064871|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064872|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064873|NCT04460456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83064874|NCT04460456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064875|NCT02268006|Capecitabine|capecitabine|mesh-list
83064876|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83064877|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
83064878|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064879|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064880|NCT03462212|Paclitaxel|paclitaxel|mesh-list
83064881|NCT03462212|Bevacizumab|bevacizumab|mesh-list
83064883|NCT03462212|Rucaparib|rucaparib|mesh-list
83064884|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83064885|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064886|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
83064887|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
83064888|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
83064889|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064890|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064891|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83064892|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83064893|NCT03462212|Growth Substances|growth substances|mesh-ancestor
83064894|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064895|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
83064896|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83064897|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064898|NCT01016808|Morphine|morphine|mesh-list
83064899|NCT01016808|Oxycodone|oxycodone|mesh-list
83064900|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83064901|NCT01016808|Narcotics|narcotics|mesh-ancestor
83064902|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064903|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064904|NCT01016808|Analgesics|analgesics|mesh-ancestor
83064905|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
83361791|NCT02651584|Analgesics|analgesics|mesh-ancestor
83064906|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064907|NCT01014078|Azithromycin|azithromycin|mesh-list
83064908|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83064909|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83064910|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064911|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064912|NCT02522078|Misoprostol|misoprostol|mesh-list
83064913|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83064914|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
83064915|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83064916|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064917|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83064918|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83064919|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
83064920|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
83064921|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83064922|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064923|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83064924|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
83064925|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83064926|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83064927|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064928|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064929|NCT03468296|Aflibercept|aflibercept|mesh-list
83064930|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83064931|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83064932|NCT03468296|Growth Substances|growth substances|mesh-ancestor
83064933|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064934|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
83064935|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064936|NCT01130142|Gemcitabine|gemcitabine|mesh-list
83064937|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83064938|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
83064939|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064940|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064941|NCT03464864|Treprostinil|treprostinil|mesh-list
83064942|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83064943|NCT03468140|Eculizumab|eculizumab|mesh-list
83064944|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83064945|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83064946|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
83064947|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064948|NCT01009242|Methotrexate|methotrexate|mesh-list
83064949|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83064950|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
83064951|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83064952|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064953|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83064954|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
83064955|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064956|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83064957|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
83064958|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064959|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83064960|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83064961|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
83064962|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064963|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83064964|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
83064965|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83064966|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83064967|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064968|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83064969|NCT03468062|Analgesics|analgesics|mesh-ancestor
83064970|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
83064971|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064972|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83064973|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83064974|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83064975|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83064976|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83064977|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064979|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83064980|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83064981|NCT03464552|Analgesics|analgesics|mesh-ancestor
83064982|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
83064983|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83064984|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064985|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83064986|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83064987|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83064988|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83064989|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83064990|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83064991|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83064992|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
83064993|NCT05628558|Coagulants|coagulants|mesh-ancestor
83064994|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83064995|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
83064996|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83064997|NCT01007292|Rituximab|rituximab|mesh-list
83064998|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83064999|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065000|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
83065001|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065002|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83065003|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83065004|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
83065005|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065006|NCT01005108|Gabapentin|gabapentin|mesh-list
83065007|NCT01005108|Analgesics|analgesics|mesh-ancestor
83065008|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
83065009|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065010|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065011|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
83065012|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83065013|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83065014|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065015|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065016|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83065017|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83065018|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065019|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065020|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
83065021|NCT00905346|Topiramate|topiramate|mesh-list
83065022|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
83065023|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83065024|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065025|NCT00902928|Enoxaparin|enoxaparin|mesh-list
83065026|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
83065027|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83065028|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83065029|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065030|NCT04777994|Mitogens|mitogens|mesh-list
83065031|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
83065032|NCT04777994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83065033|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
83065034|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065035|NCT04777994|Growth Substances|growth substances|mesh-ancestor
83065036|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065037|NCT04777994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83065038|NCT04777994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065039|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83065040|NCT04316702|Analgesics|analgesics|mesh-ancestor
83065041|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
83065042|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065043|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065044|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065045|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065046|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065047|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83065048|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83065049|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065050|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
83065051|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
83065052|NCT01129674|Olanzapine|olanzapine|mesh-list
83361792|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
83065053|NCT01129674|Risperidone|risperidone|mesh-list
83065054|NCT01129674|Aripiprazole|aripiprazole|mesh-list
83065055|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83065056|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83065057|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
83065058|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065059|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065060|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065061|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83065062|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83065063|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065064|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065065|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83065066|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
83065067|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
83065068|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
83065069|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065070|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83065071|NCT01129674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83065072|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83065073|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065074|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
83065075|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
83065076|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83065077|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83065078|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83065079|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83065080|NCT04750616|Niacinamide|niacinamide|mesh-list
83065082|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
83065083|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
83065084|NCT04750616|Vitamins|vitamins|mesh-ancestor
83065085|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
83065086|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065087|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83065088|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
83065089|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065090|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83065091|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065092|NCT05045378|Midazolam|midazolam|mesh-list
83065093|NCT05045378|Ketamine|ketamine|mesh-list
83065094|NCT05045378|Analgesics|analgesics|mesh-ancestor
83065095|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
83065096|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065097|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065098|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83065099|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83065100|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
83065101|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
83065102|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065103|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83065104|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83065105|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065106|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065107|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83065108|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83065109|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83065110|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83065111|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065112|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
83065113|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
83065114|NCT05209152|Azacitidine|azacitidine|mesh-list
83065115|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065116|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
83065117|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065118|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065119|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065120|NCT03460964|Pilocarpine|pilocarpine|mesh-list
83065121|NCT03460964|Miotics|miotics|mesh-ancestor
83065122|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
83065123|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065124|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065125|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83065126|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83065127|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
83065128|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065137|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065138|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83065139|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83065140|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065142|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065143|NCT03460808|Expectorants|expectorants|mesh-ancestor
83065144|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
83065145|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83065146|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
83065147|NCT03460808|Protective Agents|protective agents|mesh-ancestor
83065148|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065149|NCT03460808|Antidotes|antidotes|mesh-ancestor
83065150|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83065151|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
83065152|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065153|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83065154|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83065155|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
83065156|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065157|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065158|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83065159|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
83065160|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
83065161|NCT04946630|Hormones|hormones|mesh-ancestor
83065162|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065163|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
83065164|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83065165|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83065166|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
83065167|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065168|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83065169|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
83065170|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065179|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83065180|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83065181|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065182|NCT01120470|Prednisone|prednisone|mesh-list
83065183|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83065184|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
83065185|NCT01120470|Hormones|hormones|mesh-ancestor
83065186|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065187|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065188|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83065189|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065190|NCT01117584|Metformin|metformin|mesh-list
83065191|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
83065192|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83065193|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065194|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83065195|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065197|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83065198|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065199|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83065200|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065201|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065202|NCT00991068|Lidocaine|lidocaine|mesh-list
83065203|NCT00991068|Tetracaine|tetracaine|mesh-list
83065204|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
83065205|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
83065206|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065207|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065208|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
83065209|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065210|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83065211|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83065212|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83065213|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065214|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065215|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83065216|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83065217|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83065218|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065219|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065220|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065221|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065222|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83065223|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
83065224|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065225|NCT01114308|Buprenorphine|buprenorphine|mesh-list
83065226|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83065227|NCT01114308|Narcotics|narcotics|mesh-ancestor
83065228|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065229|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065230|NCT01114308|Analgesics|analgesics|mesh-ancestor
83065231|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
83065232|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065233|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83065234|NCT05469126|Clarithromycin|clarithromycin|mesh-list
83065235|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065236|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065237|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83065238|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065239|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065240|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83065241|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83065242|NCT00887250|Losartan|losartan|mesh-list
83065243|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83065244|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83065245|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83065246|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83065247|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065248|NCT00990912|Carboplatin|carboplatin|mesh-list
83065249|NCT00990912|Irinotecan|irinotecan|mesh-list
83065250|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065251|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83065252|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83065253|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065254|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065255|NCT00973284|Mannitol|mannitol|mesh-list
83065256|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83065257|NCT00973284|Diuretics|diuretics|mesh-ancestor
83065258|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
83065259|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065260|NCT02599402|Nivolumab|nivolumab|mesh-list
83065261|NCT02599402|Ipilimumab|ipilimumab|mesh-list
83065262|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83065263|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065264|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83065265|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065266|NCT00879762|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83065268|NCT00879762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065269|NCT04768166|Miglustat|miglustat|mesh-list
83065270|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065271|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065272|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83065273|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83065275|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065276|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83065277|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83065278|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065279|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
83065280|NCT04822090|Antibodies|antibodies|mesh-list
83065281|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
83065282|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83065283|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83065284|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
83065285|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065286|NCT03463382|Bupivacaine|bupivacaine|mesh-list
83065287|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
83065288|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
83065289|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439503|NCT03889275|Durvalumab|durvalumab|mesh-list
83065290|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065291|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
83065292|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065293|NCT05618236|Atropine|atropine|mesh-list
83065294|NCT05618236|Neostigmine|neostigmine|mesh-list
83065295|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83065296|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83065297|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83065298|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
83065299|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065300|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065301|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83065302|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
83065303|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
83065304|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
83065305|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83065306|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83065307|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
83065308|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065309|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065310|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83065311|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065312|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83065313|NCT00872430|Laxatives|laxatives|mesh-list
83065314|NCT00872430|Cathartics|cathartics|mesh-list
83065315|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83065316|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
83065317|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83065318|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
83065319|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065320|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065321|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83065322|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83065323|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
83065324|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83065325|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
83065326|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065327|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065328|NCT04814056|Afatinib|afatinib|mesh-list
83065329|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065330|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83065331|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065332|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065333|NCT05627154|Citalopram|citalopram|mesh-list
83065334|NCT05627154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83065335|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83065336|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065337|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065338|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065339|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
83065340|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065341|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83065342|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
83065343|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065344|NCT03974854|Gemcitabine|gemcitabine|mesh-list
83065345|NCT03974854|Capecitabine|capecitabine|mesh-list
83065346|NCT03974854|Irinotecan|irinotecan|mesh-list
83065347|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065348|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
83361793|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065349|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065350|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065351|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83065352|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83065353|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065354|NCT00957918|Nicotine|nicotine|mesh-list
83065355|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83065356|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
83065357|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065358|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065359|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83065360|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83065361|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
83065362|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065363|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065364|NCT02734862|Fluconazole|fluconazole|mesh-list
83065365|NCT02734862|Caspofungin|caspofungin|mesh-list
83065366|NCT02734862|Rezafungin|rezafungin|mesh-list
83065367|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
83065368|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065369|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83065370|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83065371|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065372|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065373|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83065374|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
83065375|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065376|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065377|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83065378|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83065379|NCT00818844|Nepafenac|nepafenac|mesh-list
83065380|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83065381|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83065382|NCT00818844|Analgesics|analgesics|mesh-ancestor
83065383|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
83065384|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065385|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065386|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83065387|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83065388|NCT00862524|Gemcitabine|gemcitabine|mesh-list
83065389|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065390|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
83065391|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065392|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065393|NCT00858702|Olmesartan|olmesartan|mesh-list
83065394|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83065395|NCT00858702|Diuretics|diuretics|mesh-list
83065396|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83065397|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83065398|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83065399|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065400|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
83065401|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065402|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
83065403|NCT00817986|Baclofen|baclofen|mesh-list
83065404|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83065405|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065406|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83065407|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065408|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83065409|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
83065410|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
83065411|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065412|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065413|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
83065414|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83065415|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065416|NCT00817362|Trastuzumab|trastuzumab|mesh-list
83065417|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83065418|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065419|NCT04176848|Durvalumab|durvalumab|mesh-list
83065420|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83065421|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065422|NCT04163978|Budesonide|budesonide|mesh-list
83065423|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
83065424|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83065425|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83065426|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
83065427|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065428|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065429|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83065430|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
83065431|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
83065432|NCT04163978|Hormones|hormones|mesh-ancestor
83065433|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065434|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83065435|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
83065436|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065437|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065438|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83065439|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065440|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
83065441|NCT04163978|Protective Agents|protective agents|mesh-ancestor
83065442|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
83065443|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
83065444|NCT02598622|Vitamins|vitamins|mesh-ancestor
83065445|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
83065446|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065447|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
83065448|NCT00810732|Nifedipine|nifedipine|mesh-list
83065449|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
83065450|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83065451|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065452|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065453|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83065454|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065455|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065456|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
83065457|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83065458|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83065459|NCT03463070|Misoprostol|misoprostol|mesh-list
83065460|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83065461|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
83065462|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83065463|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065464|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83065465|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83065466|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
83065467|NCT00807612|Paclitaxel|paclitaxel|mesh-list
83065468|NCT00807612|Carboplatin|carboplatin|mesh-list
83065469|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83065470|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83065471|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065472|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83065473|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83065474|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83065475|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065476|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
83065477|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065478|NCT00805350|SR 46349B|sr 46349b|mesh-list
83065479|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83065480|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83065481|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065482|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83065483|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83065484|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
83065485|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065486|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065487|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
83065488|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83065489|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065490|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065491|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065492|NCT03462836|Lidocaine|lidocaine|mesh-list
83065493|NCT03462836|Ketamine|ketamine|mesh-list
83065494|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
83065495|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
83065496|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065497|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065498|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
83065499|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439515|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
83065500|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83065501|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83065502|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83065503|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065504|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065505|NCT03462836|Analgesics|analgesics|mesh-ancestor
83065506|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83065507|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83065508|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
83065509|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83065510|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83065511|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065512|NCT00849576|Insulin|insulin|mesh-list
83065513|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83065514|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
83065515|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83065516|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065517|NCT00841698|Paroxetine|paroxetine|mesh-list
83065518|NCT00841698|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83065519|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83065520|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065521|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065522|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065523|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
83065524|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065525|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83065526|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
83065527|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83065528|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83065529|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83065530|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065531|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
83065532|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83065533|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
83065534|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065535|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065536|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83065537|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
83065538|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83065539|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
83065540|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065541|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065542|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83065543|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065544|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
83065545|NCT04383002|Protective Agents|protective agents|mesh-ancestor
83065546|NCT00841542|Amlodipine|amlodipine|mesh-list
83065547|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83065548|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83065549|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065550|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065551|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83065552|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065553|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065554|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
83065555|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83065556|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
83065557|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065558|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83065559|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83065560|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
83065561|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065562|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065563|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83065564|NCT00840840|Amoxicillin|amoxicillin|mesh-list
83065565|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
83065566|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
83065567|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83361794|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83065568|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065569|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065570|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83065571|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065572|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065573|NCT03595982|Nifedipine|nifedipine|mesh-list
83065574|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83065575|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065576|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065577|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83065578|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065579|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065580|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
83065581|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83065582|NCT00944970|Adenosine|adenosine|mesh-list
83065583|NCT00944970|Binodenoson|binodenoson|mesh-list
83065584|NCT00944970|Analgesics|analgesics|mesh-ancestor
83065585|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
83065586|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065587|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065588|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83065589|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065590|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83065591|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
83065592|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
83065593|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065594|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065595|NCT00840216|Clarithromycin|clarithromycin|mesh-list
83065596|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065597|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065598|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83065599|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065600|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065601|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83065602|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83065603|NCT03462446|Vitamin K|vitamin k|mesh-list
83065604|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
83065605|NCT03462446|Vitamins|vitamins|mesh-ancestor
83065606|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
83065607|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065608|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83065609|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
83065610|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83065611|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
83065612|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065613|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065614|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
83065615|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83065616|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83065617|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
83065618|NCT03462446|Coagulants|coagulants|mesh-ancestor
83065619|NCT00944892|Fasinumab|fasinumab|mesh-list
83065620|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83065621|NCT00944892|Analgesics|analgesics|mesh-ancestor
83065622|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
83065623|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065624|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065625|NCT00939276|Nepafenac|nepafenac|mesh-list
83065626|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83065627|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83065628|NCT00939276|Analgesics|analgesics|mesh-ancestor
83065629|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
83065630|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065631|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065632|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83065633|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83065634|NCT03455426|Letrozole|letrozole|mesh-list
83065635|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065636|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83065637|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83065638|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065639|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065640|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83065641|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
83084042|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065642|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065643|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065644|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83065645|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83065646|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065647|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065648|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
83065649|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065650|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065651|NCT00791154|Carboplatin|carboplatin|mesh-list
83065652|NCT00791154|Etoposide|etoposide|mesh-list
83065653|NCT00791154|Rilotumumab|rilotumumab|mesh-list
83065654|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065655|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83065656|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83065657|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83065658|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065659|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065660|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83065661|NCT00938652|Carboplatin|carboplatin|mesh-list
83065662|NCT00938652|Gemcitabine|gemcitabine|mesh-list
83065663|NCT00938652|Iniparib|iniparib|mesh-list
83065664|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065665|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065666|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
83065667|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065668|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83065669|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065670|NCT00928590|Timolol|timolol|mesh-list
83065671|NCT00928590|Travoprost|travoprost|mesh-list
83065672|NCT00928590|Cloprostenol|cloprostenol|mesh-list
83065673|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065674|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83065675|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83065676|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
83065677|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065678|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065679|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83065680|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83065681|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
83065682|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83065683|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
83065684|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83065685|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83065686|NCT03512756|Sirolimus|sirolimus|mesh-list
83065687|NCT03512756|Gemcitabine|gemcitabine|mesh-list
83065688|NCT03512756|Capecitabine|capecitabine|mesh-list
83065689|NCT03512756|Phenytoin|phenytoin|mesh-list
83065690|NCT03512756|Methoxsalen|methoxsalen|mesh-list
83065691|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065692|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
83065693|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065694|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065695|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065696|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065697|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83065698|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
83065699|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83065700|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
83065701|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065702|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
83065703|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83065704|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83065705|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83065706|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83065707|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83065709|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83065710|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
83065711|NCT04697940|Fludarabine|fludarabine|mesh-list
83065712|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
83065713|NCT04697940|Decitabine|decitabine|mesh-list
83065714|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83065715|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
83361795|NCT02685072|Progesterone|progesterone|mesh-list
83065716|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065717|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83065718|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83065719|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
83065720|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065721|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065722|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83065723|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065724|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
83065725|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065726|NCT00836706|Clarithromycin|clarithromycin|mesh-list
83065727|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065728|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065729|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83065730|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065731|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065732|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83065733|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83065734|NCT00836472|Metformin|metformin|mesh-list
83065735|NCT00836472|Glyburide|glyburide|mesh-list
83065736|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83065737|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065738|NCT04473846|Anesthetics|anesthetics|mesh-list
83065739|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065740|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065741|NCT03129698|Apatinib|apatinib|mesh-list
83065742|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065743|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83065744|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065745|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065746|NCT03355118|Anesthetics|anesthetics|mesh-list
83065747|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065748|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065749|NCT03263078|Propofol|propofol|mesh-list
83065750|NCT03263078|Sevoflurane|sevoflurane|mesh-list
83065751|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83065752|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065753|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065754|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83065755|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
83065756|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
83065757|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83065758|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83065759|NCT05349006|Azathioprine|azathioprine|mesh-list
83065760|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
83065761|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065762|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065763|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065764|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83065765|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
83065766|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065767|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83065768|NCT00785226|Sorafenib|sorafenib|mesh-list
83065769|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065770|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83065771|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065772|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065773|NCT02598388|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83065774|NCT02598388|Antiviral Agents|antiviral agents|mesh-ancestor
83065775|NCT02598388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065776|NCT03448640|Tropicamide|tropicamide|mesh-list
83065777|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
83065778|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
83065779|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065780|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065781|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83065782|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83065783|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
83065784|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065785|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065786|NCT00836004|Clindamycin|clindamycin|mesh-list
83065787|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
83361796|NCT02685072|Progestins|progestins|mesh-ancestor
83361797|NCT02685072|Hormones|hormones|mesh-ancestor
83065788|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
83065789|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065790|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065791|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83065792|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065793|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065794|NCT00917826|Valganciclovir|valganciclovir|mesh-list
83065795|NCT00917826|Ganciclovir|ganciclovir|mesh-list
83065796|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83065797|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
83065798|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
83065799|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065800|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83065801|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065802|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065803|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065804|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
83065805|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065806|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065807|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83065808|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83065809|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065810|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065811|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065812|NCT03102320|Gemcitabine|gemcitabine|mesh-list
83065813|NCT03102320|Maytansine|maytansine|mesh-list
83065814|NCT03102320|Anetumab ravtansine|anetumab ravtansine|mesh-list
83065815|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065816|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065817|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
83065818|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065819|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83065820|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
83065821|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
83065822|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
83065823|NCT03102320|Immunoconjugates|immunoconjugates|mesh-ancestor
83065824|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
83065825|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065826|NCT00835692|Clarithromycin|clarithromycin|mesh-list
83065827|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065828|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065829|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83065830|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065831|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065832|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83065833|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83065834|NCT00835614|Cefprozil|cefprozil|mesh-list
83065835|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83065836|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065837|NCT00835536|Ribavirin|ribavirin|mesh-list
83065838|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
83065839|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065840|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
83065841|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83065842|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
83065843|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83065844|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065845|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83065846|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065847|NCT04060628|Docetaxel|docetaxel|mesh-list
83065848|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065849|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
83065850|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
83065851|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
83065852|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065854|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
83065855|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83065856|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
83065857|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83065858|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065859|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83065860|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83065861|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065863|NCT04037072|Mitomycin|mitomycin|mesh-list
83065864|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83065865|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065866|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
83065867|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065868|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83065869|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065870|NCT04819438|Riluzole|riluzole|mesh-list
83065871|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
83065872|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83065873|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83065874|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065875|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065876|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065877|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83065878|NCT04819438|Protective Agents|protective agents|mesh-ancestor
83065879|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
83065880|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83065881|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
83065882|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065883|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065884|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83065885|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
83065886|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83065887|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
83065888|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065889|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065890|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83065891|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
83065892|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
83065893|NCT05616910|Protective Agents|protective agents|mesh-ancestor
83065894|NCT04537026|Dexamethasone|dexamethasone|mesh-list
83065895|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
83065896|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83065897|NCT04537026|BB 1101|bb 1101|mesh-list
83065898|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83065899|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
83065900|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
83065901|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065902|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065903|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83065904|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
83065905|NCT04537026|Hormones|hormones|mesh-ancestor
83065906|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065907|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83065908|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065909|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
83065910|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065911|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065912|NCT04819828|Diclofenac|diclofenac|mesh-list
83065913|NCT04819828|Tamsulosin|tamsulosin|mesh-list
83065914|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83065915|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83065916|NCT04819828|Analgesics|analgesics|mesh-ancestor
83065917|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
83065918|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065919|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065920|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83065921|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83065922|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83065923|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065924|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065925|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83065926|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83065927|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83065928|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
83065929|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065930|NCT04819828|Urological Agents|urological agents|mesh-ancestor
83065932|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83065933|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
83065934|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065935|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065937|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83065938|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
83065939|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83065940|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065941|NCT03745352|Azacitidine|azacitidine|mesh-list
83065942|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83065943|NCT03745352|Pevonedistat|pevonedistat|mesh-list
83065944|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83065945|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
83065946|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065947|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065948|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83065949|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83065950|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065951|NCT05617690|Propofol|propofol|mesh-list
83065952|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83065953|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83065954|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065955|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83065956|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
83065957|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
83065958|NCT03448094|Resveratrol|resveratrol|mesh-list
83065959|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
83065960|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83065961|NCT03448094|Protective Agents|protective agents|mesh-ancestor
83065962|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065963|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83065964|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83065965|NCT04819204|Cetrorelix|cetrorelix|mesh-list
83065966|NCT04819204|Testosterone|testosterone|mesh-list
83065967|NCT04819204|Androgens|androgens|mesh-ancestor
83065968|NCT04819204|Hormones|hormones|mesh-ancestor
83065969|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065970|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065971|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83065972|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
83065973|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83065974|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
83065975|NCT02807454|Dexamethasone|dexamethasone|mesh-list
83065976|NCT02807454|Durvalumab|durvalumab|mesh-list
83065977|NCT02807454|Daratumumab|daratumumab|mesh-list
83065978|NCT02807454|Pomalidomide|pomalidomide|mesh-list
83065979|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83065980|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
83065981|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
83065982|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83065983|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83065984|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83065985|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
83065986|NCT02807454|Hormones|hormones|mesh-ancestor
83065987|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83065988|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83065989|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83065990|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83065991|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
83065992|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83065993|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83065994|NCT02807454|Growth Substances|growth substances|mesh-ancestor
83065995|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
83065996|NCT03718286|Alirocumab|alirocumab|mesh-list
83065997|NCT03718286|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83065998|NCT03718286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83065999|NCT03718286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83066000|NCT03718286|Antimetabolites|antimetabolites|mesh-ancestor
83066001|NCT03718286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066002|NCT03718286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83066003|NCT03718286|Protease Inhibitors|protease inhibitors|mesh-ancestor
83066004|NCT03718286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066005|NCT03718286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83066006|NCT05320874|Antibodies|antibodies|mesh-list
83066007|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83066008|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
83066009|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066010|NCT04501614|Ponatinib|ponatinib|mesh-list
83066011|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066012|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83066013|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066014|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066015|NCT05320640|Decitabine|decitabine|mesh-list
83066016|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83066017|NCT05320640|Antibodies|antibodies|mesh-list
83066018|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
83066019|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066020|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066021|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
83066022|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066023|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066024|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066025|NCT05320640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066026|NCT00835146|Ribavirin|ribavirin|mesh-list
83066027|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
83066028|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066029|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
83066030|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066031|NCT04472910|Folfirinox|folfirinox|mesh-list
83066032|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066033|NCT01479842|Rituximab|rituximab|mesh-list
83066034|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83066035|NCT01479842|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83066036|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066037|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066038|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
83066039|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066040|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066041|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83066042|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
83066043|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066044|NCT01479842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83066045|NCT01479842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066046|NCT04818736|Vaccines|vaccines|mesh-list
83066047|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
83066048|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066049|NCT03719430|Doxorubicin|doxorubicin|mesh-list
83066050|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83066051|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066052|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83066053|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83066054|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066055|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066056|NCT04811326|Latanoprost|latanoprost|mesh-list
83066057|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83066058|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83066059|NCT00834990|Valproic Acid|valproic acid|mesh-list
83066060|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
83066061|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066062|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066063|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
83066064|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066065|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066066|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
83066067|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83439539|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83066068|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066069|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83066070|NCT04479072|Aspirin|aspirin|mesh-list
83066071|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83066072|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066073|NCT04479072|Analgesics|analgesics|mesh-ancestor
83066074|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
83066075|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066076|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066077|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066078|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066079|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83066080|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83066081|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066082|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83066083|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83066084|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066085|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
83066086|NCT04425018|Paclitaxel|paclitaxel|mesh-list
83066088|NCT04425018|Pertuzumab|pertuzumab|mesh-list
83066089|NCT04425018|Margetuximab|margetuximab|mesh-list
83066090|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83066091|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066092|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83066093|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83066094|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83066095|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066096|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066097|NCT03036202|Epinephrine|epinephrine|mesh-list
83066098|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83066099|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83066100|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066101|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066102|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066103|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066104|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83066105|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83066106|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
83066107|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066108|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83066109|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
83066110|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
83066111|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
83066112|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83066113|NCT03245918|Aprepitant|aprepitant|mesh-list
83066114|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
83066115|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
83066116|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
83066117|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066118|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066119|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83066120|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83066121|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066122|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066123|NCT02597062|Dexamethasone|dexamethasone|mesh-list
83066124|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
83066125|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83066126|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
83066127|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066128|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066129|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83066130|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
83066131|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066132|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066133|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83066134|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066135|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
83066136|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
83066137|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066138|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83066139|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
83066140|NCT02597062|Hormones|hormones|mesh-ancestor
83066141|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066142|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83066143|NCT00834756|Azithromycin|azithromycin|mesh-list
83066144|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83066145|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066146|NCT00828854|Entinostat|entinostat|mesh-list
83066147|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83066148|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83066149|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066150|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066151|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83066152|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
83066153|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066154|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066155|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066156|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83066157|NCT00834522|Granisetron|granisetron|mesh-list
83066158|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
83066159|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
83066160|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066161|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066162|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83066163|NCT00834522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83066164|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83066165|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
83066166|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066167|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066168|NCT00834444|Famciclovir|famciclovir|mesh-list
83066169|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
83066170|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066171|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83066172|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066173|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066174|NCT05174858|Hemostatics|hemostatics|mesh-list
83066175|NCT05174858|Coagulants|coagulants|mesh-ancestor
83066176|NCT04831294|Cannabidiol|cannabidiol|mesh-list
83066177|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
83066178|NCT00834132|Azithromycin|azithromycin|mesh-list
83066179|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83066180|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066181|NCT00833586|Terbinafine|terbinafine|mesh-list
83066182|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
83066183|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066184|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066185|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066186|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83066187|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
83066188|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066189|NCT03447470|Nivolumab|nivolumab|mesh-list
83066190|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066191|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066192|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83066193|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066194|NCT04817800|Azelastine|azelastine|mesh-list
83066195|NCT04817800|Beclomethasone|beclomethasone|mesh-list
83066196|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066197|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
83066198|NCT04817800|Hormones|hormones|mesh-ancestor
83066199|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066200|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066201|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83066202|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
83066203|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83066204|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
83066205|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066206|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83066207|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066208|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066209|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83066210|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83066211|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83066212|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
83066213|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
83066214|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066215|NCT00765804|Dexamethasone|dexamethasone|mesh-list
83066216|NCT00765804|Citric Acid|citric acid|mesh-list
83066217|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
83066218|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83066219|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83066220|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83066221|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066223|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
83066224|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066225|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066226|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83066227|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
83066228|NCT00765804|Hormones|hormones|mesh-ancestor
83066229|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066230|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83066231|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066232|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066233|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
83066234|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83066235|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
83362149|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
83066236|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
83066237|NCT00764634|Vaccines|vaccines|mesh-list
83066238|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
83066239|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066240|NCT04345146|Bevacizumab|bevacizumab|mesh-list
83066241|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066242|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066243|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83066244|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83066245|NCT04345146|Growth Substances|growth substances|mesh-ancestor
83066246|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066247|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
83066248|NCT03443726|Epinephrine|epinephrine|mesh-list
83066249|NCT03443726|Carticaine|carticaine|mesh-list
83066250|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83066251|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83066252|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066253|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066254|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066255|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066256|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83066257|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83066258|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
83066259|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066260|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83066261|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
83066262|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
83066263|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
83066264|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83066265|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
83066266|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
83066267|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066268|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
83066269|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83066270|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83066271|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066272|NCT00760344|Incretins|incretins|mesh-ancestor
83066273|NCT00760344|Hormones|hormones|mesh-ancestor
83066274|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066275|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83066276|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
83066277|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066278|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066279|NCT03443570|Rituximab|rituximab|mesh-list
83066280|NCT03443570|Bortezomib|bortezomib|mesh-list
83066281|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066282|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066283|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
83066284|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066285|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066286|NCT02718404|Analgesics|analgesics|mesh-list
83066287|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
83066288|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066289|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066290|NCT03443492|Leucovorin|leucovorin|mesh-list
83066291|NCT03443492|Gemcitabine|gemcitabine|mesh-list
83066292|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
83066293|NCT03443492|Irinotecan|irinotecan|mesh-list
83066294|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
83066295|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066296|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
83066297|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066298|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066299|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83066300|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83066301|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066302|NCT03443492|Antidotes|antidotes|mesh-ancestor
83066303|NCT03443492|Protective Agents|protective agents|mesh-ancestor
83066304|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066305|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
83066307|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
83066308|NCT00724698|Desloratadine|desloratadine|mesh-list
83066309|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83066310|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
83066311|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362150|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066312|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066313|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066314|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83066315|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83066316|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
83066317|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
83066318|NCT00722592|Doxorubicin|doxorubicin|mesh-list
83066319|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83066320|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83066321|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066322|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83066323|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83066324|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066325|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066326|NCT00829998|Zaleplon|zaleplon|mesh-list
83066327|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
83066328|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83066329|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066330|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066331|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
83066332|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
83066333|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066334|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066335|NCT00722358|Asunaprevir|asunaprevir|mesh-list
83066336|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
83066337|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066338|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066339|NCT00719550|Capecitabine|capecitabine|mesh-list
83066340|NCT00719550|Epirubicin|epirubicin|mesh-list
83066341|NCT00719550|Rilotumumab|rilotumumab|mesh-list
83066342|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066343|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066344|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
83066345|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066346|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83066347|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83066348|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83066349|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066350|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066351|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
83066352|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83066353|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
83066354|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066355|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066356|NCT05016518|Propofol|propofol|mesh-list
83066357|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83066358|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066359|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066360|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83066361|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
83066362|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
83066363|NCT03446534|Amoxicillin|amoxicillin|mesh-list
83066364|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83066365|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066366|NCT00829764|Doxycycline|doxycycline|mesh-list
83066367|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83066368|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066369|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
83066370|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83066371|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83066372|NCT00718224|Enoxaparin|enoxaparin|mesh-list
83066373|NCT00718224|Semuloparin|semuloparin|mesh-list
83066374|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
83066375|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83066376|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83066377|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066378|NCT03129542|Midodrine|midodrine|mesh-list
83066379|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
83066380|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
83066381|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066382|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066383|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83066384|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83066385|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83066386|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83066387|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066388|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066389|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066390|NCT03129074|Capecitabine|capecitabine|mesh-list
83066391|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066392|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
83066393|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066394|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066395|NCT03449654|Liraglutide|liraglutide|mesh-list
83066396|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83066397|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066398|NCT03449654|Incretins|incretins|mesh-ancestor
83066399|NCT03449654|Hormones|hormones|mesh-ancestor
83066400|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066401|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
83066402|NCT03388008|Prednisone|prednisone|mesh-list
83066403|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
83066404|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83066405|NCT03388008|Abatacept|abatacept|mesh-list
83066406|NCT03388008|Tacrolimus|tacrolimus|mesh-list
83066407|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
83066408|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066409|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
83066410|NCT03388008|Hormones|hormones|mesh-ancestor
83066411|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066412|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066413|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83066414|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066415|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83066416|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
83066417|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83066418|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066419|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066420|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83066421|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83066422|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
83066423|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83066424|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066425|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
83066426|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
83066427|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066428|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83066429|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83066430|NCT03388008|Protective Agents|protective agents|mesh-ancestor
83066431|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83439554|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83066432|NCT03388008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066433|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066434|NCT00710580|Etanercept|etanercept|mesh-list
83066435|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83066436|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066437|NCT00710580|Analgesics|analgesics|mesh-ancestor
83066438|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
83066439|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066440|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066441|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066442|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066443|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83066444|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83066445|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
83066446|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83066447|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83066448|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066449|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83066450|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
83066451|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83066452|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83066454|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83066455|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
83066456|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066457|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066458|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83066459|NCT01377194|Milnacipran|milnacipran|mesh-list
83066460|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
83066461|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83066462|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83066463|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83066464|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066465|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066466|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066467|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
83066468|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83066469|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066470|NCT01377194|Analgesics|analgesics|mesh-ancestor
83066471|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
83066472|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066473|NCT00829452|Ramipril|ramipril|mesh-list
83066474|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83066475|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
83066476|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066477|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066478|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83066479|NCT00747318|Fluticasone|fluticasone|mesh-list
83066480|NCT00747318|Xhance|xhance|mesh-list
83066481|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
83066482|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066483|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83066484|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
83066485|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066486|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066487|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83066488|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
83066489|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83066490|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83066491|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83066492|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83066493|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83066494|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066495|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066496|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066497|NCT00744276|Danazol|danazol|mesh-list
83066498|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83066499|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
83066500|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066501|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066502|NCT03438344|Vaccines|vaccines|mesh-list
83066503|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
83066504|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066505|NCT04640402|Vaccines|vaccines|mesh-list
83066506|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
83066507|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066508|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83066509|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83066510|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066511|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
83066512|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83066513|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
83066514|NCT00692484|Povidone|povidone|mesh-list
83066515|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83066516|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066517|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
83066518|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83066519|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
83066520|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
83066522|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83066523|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066524|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83066525|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
83066526|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066527|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066528|NCT03256344|Atezolizumab|atezolizumab|mesh-list
83066529|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83066530|NCT03256344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83066531|NCT03256344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066532|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066533|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066534|NCT02063139|Fluticasone|fluticasone|mesh-list
83066535|NCT02063139|Beclomethasone|beclomethasone|mesh-list
83066536|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066537|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83066538|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
83066539|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066540|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066541|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83066542|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
83066543|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
83066544|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83066545|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
83066546|NCT02063139|Hormones|hormones|mesh-ancestor
83066547|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066548|NCT00690456|Metformin|metformin|mesh-list
83066549|NCT00690456|Rimonabant|rimonabant|mesh-list
83066550|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83066551|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066552|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83066553|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83066554|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83066555|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066556|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066557|NCT00690456|Hormones|hormones|mesh-ancestor
83066558|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066559|NCT01370499|Serotonin|serotonin|mesh-list
83066560|NCT01370499|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83066561|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83066562|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
83066563|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066564|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066565|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066566|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83066567|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83066568|NCT03445286|Fluorides|fluorides|mesh-list
83066569|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
83066570|NCT03445286|Protective Agents|protective agents|mesh-ancestor
83066571|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066572|NCT00626106|Fulvestrant|fulvestrant|mesh-list
83066573|NCT00626106|Exemestane|exemestane|mesh-list
83066574|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83066575|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83066576|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066577|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83066578|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83066579|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
83066580|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066581|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066582|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83066583|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83066584|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066585|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066586|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
83066587|NCT02064465|Lamotrigine|lamotrigine|mesh-list
83066588|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
83066589|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83066590|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83066591|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066592|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83066593|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066594|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83066595|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83066596|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066597|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83066598|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83066599|NCT04530656|Vaccines|vaccines|mesh-list
83066600|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
83066601|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066602|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
83066603|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066604|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
83066605|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066606|NCT04509596|Capecitabine|capecitabine|mesh-list
83066607|NCT04509596|Trastuzumab|trastuzumab|mesh-list
83362151|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83066608|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066609|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
83066610|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066611|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066612|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066613|NCT01370265|Adenosine|adenosine|mesh-list
83066614|NCT01370265|Regadenoson|regadenoson|mesh-list
83066615|NCT01370265|Analgesics|analgesics|mesh-ancestor
83066616|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
83066617|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066618|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066619|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83066620|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
83066621|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83066622|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
83066623|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
83066624|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066625|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066626|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83066627|NCT00734292|Fluticasone|fluticasone|mesh-list
83066628|NCT00734292|Xhance|xhance|mesh-list
83066629|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
83066630|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066631|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83066632|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
83066633|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066634|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066635|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83066636|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
83066637|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
83066638|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83066639|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83066640|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83066641|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83066642|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066643|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066644|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066645|NCT00687882|Anticoagulants|anticoagulants|mesh-list
83066646|NCT02064621|Amlodipine|amlodipine|mesh-list
83066647|NCT02064621|Candesartan|candesartan|mesh-list
83066648|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
83066649|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83066650|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83066651|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83066652|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066653|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83066654|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066655|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
83066656|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83066657|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83066658|NCT00684918|Obatoclax|obatoclax|mesh-list
83066659|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066660|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066661|NCT00726336|Tenofovir|tenofovir|mesh-list
83066662|NCT00726336|Dolutegravir|dolutegravir|mesh-list
83066663|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
83066664|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066665|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83066666|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83066667|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066668|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066669|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83066670|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83066671|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83066672|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83066673|NCT02280720|Tryptophan|tryptophan|mesh-list
83066674|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83066675|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
83066676|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83066677|NCT02068131|Capecitabine|capecitabine|mesh-list
83066678|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066679|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
83066680|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066681|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066682|NCT02989584|Gemcitabine|gemcitabine|mesh-list
83066683|NCT02989584|Atezolizumab|atezolizumab|mesh-list
83066684|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066685|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066686|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
83066687|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066688|NCT02989584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83066689|NCT02989584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066690|NCT02068209|Tramadol|tramadol|mesh-list
83066691|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83066692|NCT02068209|Narcotics|narcotics|mesh-ancestor
83066693|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066694|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066695|NCT02068209|Analgesics|analgesics|mesh-ancestor
83066696|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
83066697|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066698|NCT00680784|Ketoprofen|ketoprofen|mesh-list
83066699|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83066700|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066701|NCT00680784|Analgesics|analgesics|mesh-ancestor
83066702|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
83066703|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066704|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066705|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066706|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066707|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83066708|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066709|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066710|NCT02068287|Esmolol|esmolol|mesh-list
83066711|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83066712|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83066713|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83066714|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066715|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83439564|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
83066716|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066717|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066718|NCT02280876|Andrographolide|andrographolide|mesh-list
83066719|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066720|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83066721|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066722|NCT02280876|Analgesics|analgesics|mesh-ancestor
83066723|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
83066724|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066725|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066726|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066727|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83066728|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83066729|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066730|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
83066731|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83066732|NCT00680472|Ketoprofen|ketoprofen|mesh-list
83066733|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83066734|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066735|NCT00680472|Analgesics|analgesics|mesh-ancestor
83066736|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
83066737|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066738|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066740|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066741|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83066742|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066743|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066744|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83066745|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
83066746|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83066747|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83066748|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066749|NCT03444506|Analgesics|analgesics|mesh-ancestor
83066750|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
83066751|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066752|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066753|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066754|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066755|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83066756|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83066757|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83066758|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
83066759|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
83066760|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066761|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066762|NCT02065947|Lidocaine|lidocaine|mesh-list
83066763|NCT02065947|Epinephrine|epinephrine|mesh-list
83066764|NCT02065947|Racepinephrine|racepinephrine|mesh-list
83066765|NCT02065947|Fentanyl|fentanyl|mesh-list
83066766|NCT02065947|Midazolam|midazolam|mesh-list
83066767|NCT02065947|Ketamine|ketamine|mesh-list
83066768|NCT02065947|Bupivacaine|bupivacaine|mesh-list
83066769|NCT02065947|Propofol|propofol|mesh-list
83066770|NCT02065947|Sevoflurane|sevoflurane|mesh-list
83066771|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
83066772|NCT02065947|Atracurium|atracurium|mesh-list
83066773|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
83066774|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
83066775|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066776|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066777|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
83066778|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066779|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83066780|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83066781|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83066782|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83066783|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066784|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83066785|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83066786|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
83066787|NCT02065947|Analgesics|analgesics|mesh-ancestor
83066788|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83066789|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83066790|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83066791|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066792|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83066793|NCT02065947|Narcotics|narcotics|mesh-ancestor
83066794|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83066795|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83066796|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83066797|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83066798|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
83066799|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
83066800|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83066801|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83066802|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83066803|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83066804|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066805|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83066806|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83066807|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
83066808|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83066809|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
83066810|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
83066811|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
83066812|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83066813|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83066814|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83066815|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83066816|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83066817|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83066818|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
83066819|NCT01359592|Prednisone|prednisone|mesh-list
83066820|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
83066821|NCT01359592|Rituximab|rituximab|mesh-list
83066822|NCT01359592|Doxorubicin|doxorubicin|mesh-list
83066823|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83066824|NCT01359592|Vincristine|vincristine|mesh-list
83066825|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83066826|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83066827|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
83066828|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066829|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83066830|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83066831|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
83066832|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066833|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066834|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83066835|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83066836|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83066837|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83066838|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83066839|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066840|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066841|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
83066843|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066844|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83066845|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83066846|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
83066847|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
83066848|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
83066849|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83066850|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
83066851|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83066852|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066853|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066854|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066855|NCT03436472|Analgesics|analgesics|mesh-ancestor
83066856|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
83066857|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066858|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83066859|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83066860|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83066861|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066862|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066863|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066864|NCT02066103|Paclitaxel|paclitaxel|mesh-list
83066865|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83066866|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066867|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
83066868|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
83066869|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
83066870|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066871|NCT04809532|Tramadol|tramadol|mesh-list
83066872|NCT04809532|Bupivacaine|bupivacaine|mesh-list
83066873|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
83066874|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
83066875|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066876|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066877|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
83066878|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066879|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83066880|NCT04809532|Narcotics|narcotics|mesh-ancestor
83066881|NCT04809532|Analgesics|analgesics|mesh-ancestor
83066882|NCT04809142|Gemcitabine|gemcitabine|mesh-list
83066883|NCT04809142|Capecitabine|capecitabine|mesh-list
83066884|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
83066885|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83066886|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
83066887|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066888|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066889|NCT02064777|Tacrolimus|tacrolimus|mesh-list
83066890|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83066891|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
83066892|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066893|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83066894|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066895|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066897|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83066898|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066899|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83066900|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066901|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066902|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
83066903|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066904|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83066905|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
83066906|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066907|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
83066908|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
83066909|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066910|NCT03347331|Befiradol|befiradol|mesh-list
83066911|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83066912|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83066913|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
83066914|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066915|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066916|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066917|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83066918|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
83066919|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066920|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066921|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
83066922|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83066923|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83066924|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066925|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
83066926|NCT03109652|Coagulants|coagulants|mesh-ancestor
83066927|NCT02069301|Fluoxetine|fluoxetine|mesh-list
83066928|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
83066929|NCT02069301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83066930|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83066931|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83066932|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066933|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066934|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
83066935|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066936|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83439569|NCT01963845|Incretins|incretins|mesh-ancestor
83066937|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83066938|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83066939|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83066940|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83066941|NCT03035656|Ropivacaine|ropivacaine|mesh-list
83066942|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
83066943|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
83066944|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066945|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066946|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
83066947|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066948|NCT03443960|Amitriptyline|amitriptyline|mesh-list
83066949|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
83066950|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83066951|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
83066952|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83066953|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83066954|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066955|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83066956|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83066957|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83066958|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83066959|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83066960|NCT03443960|Analgesics|analgesics|mesh-ancestor
83066961|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
83066962|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83066963|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83066964|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83066965|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066966|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
83066967|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83066968|NCT05616754|Vaccines|vaccines|mesh-list
83066969|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
83066970|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066971|NCT03440996|Listerine|listerine|mesh-list
83066972|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
83066973|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
83066974|NCT03440996|Protective Agents|protective agents|mesh-ancestor
83066975|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066976|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83066977|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83066978|NCT04451174|Prednisone|prednisone|mesh-list
83066979|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83066980|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
83066981|NCT04451174|Hormones|hormones|mesh-ancestor
83066982|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83066983|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066984|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83066985|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83066986|NCT04828642|Vitamins|vitamins|mesh-list
83066987|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
83066988|NCT04828642|Vitamin E|vitamin e|mesh-list
83066989|NCT04828642|Tocopherols|tocopherols|mesh-list
83066990|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
83066991|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83066992|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
83066993|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83066994|NCT04828642|Protective Agents|protective agents|mesh-ancestor
83066995|NCT03433352|Methimazole|methimazole|mesh-list
83066996|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
83066997|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
83066998|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
83066999|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067000|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067001|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
83067002|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067003|NCT04828564|Ribavirin|ribavirin|mesh-list
83067004|NCT04828564|Favipiravir|favipiravir|mesh-list
83067005|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
83067006|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067007|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
83067008|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067009|NCT03435302|Temozolomide|temozolomide|mesh-list
83067010|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067011|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83067012|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
83067013|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067014|NCT04973150|Anesthetics|anesthetics|mesh-list
83067015|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067016|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067017|NCT03433196|Atorvastatin|atorvastatin|mesh-list
83067018|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83067019|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83067020|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
83067021|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067022|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83067023|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83067024|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067025|NCT02792829|Lenvatinib|lenvatinib|mesh-list
83067026|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067027|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83067028|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067029|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067030|NCT02066571|Droxidopa|droxidopa|mesh-list
83067031|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83067032|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83067033|NCT02066649|Carvedilol|carvedilol|mesh-list
83067034|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83067035|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83067036|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067037|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067038|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067039|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067040|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83067041|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
83067042|NCT02066649|Protective Agents|protective agents|mesh-ancestor
83067043|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83067044|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067045|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83067046|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
83067047|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83067048|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83067049|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
83067050|NCT02070003|Narcotics|narcotics|mesh-ancestor
83067051|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067052|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067053|NCT02070003|Analgesics|analgesics|mesh-ancestor
83067054|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
83067055|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067057|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83067058|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83067059|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83067060|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83067061|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83067062|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
83067063|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067064|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067065|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067066|NCT05619328|Vitamins|vitamins|mesh-list
83067067|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
83067068|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
83067069|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067070|NCT05559099|Tecovirimat|tecovirimat|mesh-list
83067071|NCT05559099|Antiviral Agents|antiviral agents|mesh-ancestor
83067072|NCT05559099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067073|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
83067074|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
83067075|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83067076|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067077|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83067078|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83067079|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067080|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067081|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067082|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83067083|NCT04827784|Anesthetics|anesthetics|mesh-list
83067084|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
83067085|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067086|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067087|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
83067088|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067089|NCT03986996|Amoxicillin|amoxicillin|mesh-list
83067090|NCT03986996|Metronidazole|metronidazole|mesh-list
83067091|NCT03986996|Doxycycline|doxycycline|mesh-list
83067092|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83067093|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067094|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83067095|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83067096|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
83067097|NCT04827472|Fexuprazan|fexuprazan|mesh-list
83067098|NCT04827472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83067099|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
83067100|NCT04796428|Empagliflozin|empagliflozin|mesh-list
83067101|NCT04796428|Canagliflozin|canagliflozin|mesh-list
83067102|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83067103|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067104|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067105|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067106|NCT03432728|Anesthetics|anesthetics|mesh-list
83067107|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067108|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067109|NCT04450160|Temozolomide|temozolomide|mesh-list
83067110|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83067111|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
83067112|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067113|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067114|NCT03432572|Riboflavin|riboflavin|mesh-list
83067115|NCT03432572|Thiamine|thiamine|mesh-list
83067116|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
83067117|NCT03432572|Vitamins|vitamins|mesh-ancestor
83067118|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
83067119|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067120|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83067121|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83067122|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
83067123|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
83067124|NCT03854370|Povidone|povidone|mesh-list
83067125|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83067126|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067127|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
83067128|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
83067129|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
83067130|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
83067131|NCT02805504|Bupivacaine|bupivacaine|mesh-list
83067132|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
83067134|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067135|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067136|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
83067137|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067138|NCT02783508|Meperidine|meperidine|mesh-list
83067139|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
83067140|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83067141|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
83067142|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
83067143|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067144|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067145|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83067146|NCT02783508|Analgesics|analgesics|mesh-ancestor
83067147|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
83067148|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067149|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83067150|NCT02783508|Narcotics|narcotics|mesh-ancestor
83067151|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83067152|NCT02071407|Midazolam|midazolam|mesh-list
83067153|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83067154|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83067155|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067156|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067157|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83067158|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83067159|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83067160|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83067161|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
83067162|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
83067163|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
83067164|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
83067165|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067166|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067167|NCT02281266|Entecavir|entecavir|mesh-list
83067168|NCT02281266|Thymalfasin|thymalfasin|mesh-list
83067169|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
83067170|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067171|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83067172|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
83067173|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067174|NCT00625326|Calcipotriene|calcipotriene|mesh-list
83067175|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83067176|NCT03434054|Losartan|losartan|mesh-list
83067177|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83067178|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83067179|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83067180|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83067181|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067182|NCT03433976|Anesthetics|anesthetics|mesh-list
83067183|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067184|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067185|NCT04473144|Urinastatin|urinastatin|mesh-list
83067186|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83067187|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83067188|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
83067189|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067190|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067191|NCT02605642|Infliximab|infliximab|mesh-list
83067192|NCT02605642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83067193|NCT02605642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067194|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
83067195|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83067196|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83067197|NCT00624858|Naltrexone|naltrexone|mesh-list
83067198|NCT00624858|Bupropion|bupropion|mesh-list
83067199|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83067200|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83067201|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067202|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
83067203|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067204|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83067205|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
83067206|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83067207|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83084043|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067208|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83067209|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83439581|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067210|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067211|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
83067212|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067213|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83067214|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83067215|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067216|NCT03128528|Empagliflozin|empagliflozin|mesh-list
83067217|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83067218|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067219|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067220|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067221|NCT02071641|Sunitinib|sunitinib|mesh-list
83067222|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067223|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83067224|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83067225|NCT02071641|Growth Substances|growth substances|mesh-ancestor
83067226|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067227|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
83067228|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83067229|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067230|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067231|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
83067232|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83067233|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83067234|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067235|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
83067236|NCT02253810|Coagulants|coagulants|mesh-ancestor
83067237|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
83067238|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
83067239|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067240|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
83067241|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067242|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067243|NCT03298893|Nivolumab|nivolumab|mesh-list
83067244|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067245|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83067246|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83067247|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067248|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
83067249|NCT00673062|Ephedrine|ephedrine|mesh-list
83067250|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83067251|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
83067252|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067253|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067254|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83067255|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
83067256|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
83067257|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83067258|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83067259|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
83067260|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067261|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067262|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067263|NCT03559803|Cisplatin|cisplatin|mesh-list
83067264|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067265|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
83067266|NCT03439358|Analgesics|analgesics|mesh-ancestor
83067267|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
83067268|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067269|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067270|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
83067271|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067272|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83067273|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
83067274|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83067275|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067276|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067277|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83067278|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
83067279|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83067280|NCT02072031|Sunitinib|sunitinib|mesh-list
83067282|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83067283|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83067284|NCT02072031|Growth Substances|growth substances|mesh-ancestor
83067285|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067286|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
83067287|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83067288|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067289|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067290|NCT05616442|Vitamin E|vitamin e|mesh-list
83067291|NCT05616442|Ketotifen|ketotifen|mesh-list
83067292|NCT05616442|Vitamins|vitamins|mesh-ancestor
83067293|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
83067294|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067295|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
83067296|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067297|NCT05616442|Protective Agents|protective agents|mesh-ancestor
83067298|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
83067299|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
83067300|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83067301|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
83067302|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
83067303|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067304|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83067305|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83067306|NCT02065401|Antacids|antacids|mesh-ancestor
83067307|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067308|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83067309|NCT00620256|Timolol|timolol|mesh-list
83067310|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83067311|NCT00620256|Latanoprost|latanoprost|mesh-list
83067312|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83067313|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83067314|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83067315|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067316|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067317|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067318|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067319|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83067320|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83067321|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
83067322|NCT04805710|Clopidogrel|clopidogrel|mesh-list
83067323|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83067324|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83067325|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83067326|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83067327|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
83067328|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067329|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067330|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067331|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83067332|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
83067333|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83067334|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
83067335|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067336|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
83067337|NCT02076477|Docetaxel|docetaxel|mesh-list
83067338|NCT02076477|Pemetrexed|pemetrexed|mesh-list
83067339|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067340|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83067341|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83067342|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83067343|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067344|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067345|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83067346|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83067347|NCT04472832|Mitapivat|mitapivat|mesh-list
83067348|NCT04472832|Enzyme Activators|enzyme activators|mesh-ancestor
83067349|NCT04472832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067350|NCT04879550|Antithrombins|antithrombins|mesh-list
83067351|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
83067352|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83067353|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
83067354|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067355|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067357|NCT00613002|Testosterone|testosterone|mesh-list
83067358|NCT00613002|Androgens|androgens|mesh-ancestor
83067359|NCT00613002|Hormones|hormones|mesh-ancestor
83067360|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067361|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067362|NCT02076945|Lidocaine|lidocaine|mesh-list
83067363|NCT02076945|Bupivacaine|bupivacaine|mesh-list
83067364|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
83067365|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
83067366|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067367|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067368|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
83067369|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067370|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83067371|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83067372|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83067373|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067374|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067375|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
83067376|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83067377|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067378|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
83067379|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
83067380|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83067381|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83067382|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
83067383|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067384|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067385|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83067386|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
83067387|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
83067388|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83067389|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
83067390|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067391|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067392|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83067393|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83067394|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83067395|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067396|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83067397|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83067398|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
83067399|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067400|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83067401|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83067402|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83067403|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
83067404|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067405|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83067406|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83067407|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067408|NCT02732912|Zopiclone|zopiclone|mesh-list
83067409|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83067410|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067411|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067412|NCT02792517|Erenumab|erenumab|mesh-list
83067413|NCT02792517|Norgestimate|norgestimate|mesh-list
83067414|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
83067415|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
83067416|NCT02792517|Estradiol|estradiol|mesh-list
83067417|NCT02792517|Estrogens|estrogens|mesh-ancestor
83067418|NCT02792517|Hormones|hormones|mesh-ancestor
83067419|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067420|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067421|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83067422|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83067423|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83067424|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83067425|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067426|NCT02792517|Analgesics|analgesics|mesh-ancestor
83067427|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
83067428|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067430|NCT03431714|Artesunate|artesunate|mesh-list
83067431|NCT03431714|Piperaquine|piperaquine|mesh-list
83067432|NCT03431714|Amodiaquine|amodiaquine|mesh-list
83067433|NCT03431714|Artenimol|artenimol|mesh-list
83067434|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
83067435|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83067436|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83067437|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067438|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067439|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
83067440|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
83067441|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83067442|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
83067443|NCT03433586|Aspirin|aspirin|mesh-list
83067444|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83067445|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83067446|NCT03433586|Analgesics|analgesics|mesh-ancestor
83067447|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
83067448|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067449|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067450|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067451|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83067452|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83067453|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83067454|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067455|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83067456|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83067457|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067458|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
83067459|NCT03431558|Lactoferrin|lactoferrin|mesh-list
83067460|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067461|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83067462|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067463|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
83067464|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067465|NCT02273622|Protective Agents|protective agents|mesh-ancestor
83067466|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067467|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83067468|NCT02077803|Metformin|metformin|mesh-list
83067469|NCT02077803|Canagliflozin|canagliflozin|mesh-list
83067470|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067471|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067472|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83067473|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067474|NCT02072811|Cytarabine|cytarabine|mesh-list
83067475|NCT02072811|Daunorubicin|daunorubicin|mesh-list
83067476|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
83067477|NCT02072811|Cladribine|cladribine|mesh-list
83067478|NCT02072811|Lenograstim|lenograstim|mesh-list
83067479|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83067480|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
83067481|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067482|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067483|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
83067484|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067485|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83067486|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
83067487|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067488|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83067489|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83067490|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83067491|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067492|NCT02072811|Analgesics|analgesics|mesh-ancestor
83067493|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
83067494|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067495|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83067496|NCT02080377|Glyburide|glyburide|mesh-list
83067497|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067498|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067499|NCT02072967|Rituximab|rituximab|mesh-list
83067500|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83067501|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83439609|NCT00699491|Sirolimus|sirolimus|mesh-list
83067502|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067503|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
83067504|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067505|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83067506|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83067507|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
83067508|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067509|NCT02073357|Anesthetics|anesthetics|mesh-list
83067510|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067511|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067512|NCT02073669|Interferons|interferons|mesh-list
83067513|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
83067514|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067515|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
83067516|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067517|NCT03428282|Anesthetics|anesthetics|mesh-list
83067518|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067519|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067520|NCT00463242|Agomelatine|agomelatine|mesh-list
83067521|NCT00463242|Paroxetine|paroxetine|mesh-list
83067522|NCT00463242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83067523|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83067524|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067525|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067526|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067527|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
83067528|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067529|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83067530|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
83067531|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83067532|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83067533|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83067534|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067535|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83067536|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067537|NCT02074137|Prednisone|prednisone|mesh-list
83067538|NCT02074137|Prednisolone|prednisolone|mesh-list
83067539|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067540|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
83067541|NCT02074137|Hormones|hormones|mesh-ancestor
83067542|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067543|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067544|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83067545|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067546|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83067547|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83067548|NCT00594984|Irinotecan|irinotecan|mesh-list
83067549|NCT00594984|Cetuximab|cetuximab|mesh-list
83067550|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83067551|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83067552|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067553|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067554|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067555|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83067556|NCT01369485|Caffeine|caffeine|mesh-list
83067557|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83067558|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067559|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83067560|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067561|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067562|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83067563|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83067565|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067566|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
83067567|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83067568|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067569|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067570|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83067571|NCT03422978|Analgesics|analgesics|mesh-ancestor
83067572|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
83067573|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067574|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83067575|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83067576|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83067577|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067578|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067579|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067580|NCT02278692|Vitamin K|vitamin k|mesh-list
83067581|NCT02278692|Vitamins|vitamins|mesh-ancestor
83067582|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
83067583|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067584|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83067585|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83067586|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067587|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
83067588|NCT02278692|Coagulants|coagulants|mesh-ancestor
83067589|NCT02281968|Naproxen|naproxen|mesh-list
83067590|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83067591|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83067592|NCT02281968|Analgesics|analgesics|mesh-ancestor
83067593|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
83067594|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067595|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067596|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067597|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83067598|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
83067599|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83067600|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067601|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067602|NCT02080845|Theobromine|theobromine|mesh-list
83067603|NCT02080845|Caffeine|caffeine|mesh-list
83067604|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83067605|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067606|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83067607|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067608|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067609|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83067610|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83067611|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
83067612|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067613|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83067614|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
83067615|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067616|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83067617|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
83067618|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
83067619|NCT02284230|Liraglutide|liraglutide|mesh-list
83067620|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067621|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067622|NCT02284230|Incretins|incretins|mesh-ancestor
83067623|NCT02284230|Hormones|hormones|mesh-ancestor
83067624|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067625|NCT02792088|Tenofovir|tenofovir|mesh-list
83067626|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
83067627|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067628|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83067629|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83067630|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067631|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067632|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83067633|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83067634|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83067635|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83067636|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83067637|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067638|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067639|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83067640|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067641|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067642|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
83067643|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067644|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
83067645|NCT00451152|Anecortave|anecortave|mesh-list
83067646|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83067647|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83067648|NCT00451152|Growth Substances|growth substances|mesh-ancestor
83067649|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067650|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83067651|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361798|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067652|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067653|NCT02078583|Fentanyl|fentanyl|mesh-list
83067654|NCT02078583|Remifentanil|remifentanil|mesh-list
83067655|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83067656|NCT02078583|Narcotics|narcotics|mesh-ancestor
83067657|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067658|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067659|NCT02078583|Analgesics|analgesics|mesh-ancestor
83067660|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
83067661|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067662|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83067663|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83067664|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
83067665|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
83067666|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
83067667|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83067668|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067669|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067670|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83067671|NCT03069638|Analgesics|analgesics|mesh-ancestor
83067672|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
83067673|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067674|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83067675|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83067676|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83067677|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067678|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067679|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067680|NCT02948660|Zolpidem|zolpidem|mesh-list
83067681|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83067682|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83067683|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067684|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067685|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83067686|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
83067687|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
83067688|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067689|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067690|NCT02074605|Interferons|interferons|mesh-list
83067691|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
83067692|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067693|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
83067694|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067695|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
83067696|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067697|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
83067698|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83067699|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067700|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83067701|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83067702|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067703|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067704|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067705|NCT00583830|Paclitaxel|paclitaxel|mesh-list
83067706|NCT00583830|Carboplatin|carboplatin|mesh-list
83067707|NCT00583830|Mapatumumab|mapatumumab|mesh-list
83067708|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83067709|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83067710|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067712|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
83067713|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
83067714|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067715|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
83067716|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067717|NCT03430544|Cariprazine|cariprazine|mesh-list
83067718|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83067719|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83067720|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067721|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067722|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83067723|NCT00583674|Cisplatin|cisplatin|mesh-list
83067724|NCT00583674|Capecitabine|capecitabine|mesh-list
83067725|NCT00583674|Trebananib|trebananib|mesh-list
83067726|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067727|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83067728|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
83067729|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067730|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83067731|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83067732|NCT00583674|Growth Substances|growth substances|mesh-ancestor
83067733|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067734|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
83067735|NCT03422510|CXA-10|cxa-10|mesh-list
83067736|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067737|NCT03430466|Fulvestrant|fulvestrant|mesh-list
83067738|NCT03430466|Tremelimumab|tremelimumab|mesh-list
83067739|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83067740|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067741|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83067742|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83067743|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
83067744|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067745|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067746|NCT02280174|Linagliptin|linagliptin|mesh-list
83067747|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067748|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067749|NCT02280174|Incretins|incretins|mesh-ancestor
83067750|NCT02280174|Hormones|hormones|mesh-ancestor
83067751|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067752|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83067753|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
83067754|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067755|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067756|NCT00447564|Buprenorphine|buprenorphine|mesh-list
83067757|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83067758|NCT00447564|Narcotics|narcotics|mesh-ancestor
83067759|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067760|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067761|NCT00447564|Analgesics|analgesics|mesh-ancestor
83067762|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
83067763|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067764|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83067765|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
83067766|NCT00576810|Cathartics|cathartics|mesh-ancestor
83067767|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83067768|NCT00576342|Timolol|timolol|mesh-list
83067769|NCT00576342|Dorzolamide|dorzolamide|mesh-list
83067770|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83067771|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83067772|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83067773|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83067774|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067775|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067776|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067777|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067778|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83067779|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83067780|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83067781|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067782|NCT02282280|Prilocaine|prilocaine|mesh-list
83067783|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
83067784|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
83067785|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067786|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067787|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
83067788|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067789|NCT03429998|Evolocumab|evolocumab|mesh-list
83067790|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83067791|NCT03429998|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83067792|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83067793|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83067794|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
83067795|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067796|NCT03429998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83067797|NCT03429998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83067798|NCT03429998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067799|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83067800|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
83067801|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067802|NCT00658008|Paroxetine|paroxetine|mesh-list
83067803|NCT00658008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83067804|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83067805|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067806|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067807|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067808|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
83067809|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067810|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83067811|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
83067812|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83067813|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83067814|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83067815|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067816|NCT03427502|Epinephrine|epinephrine|mesh-list
83067817|NCT03427502|Bupivacaine|bupivacaine|mesh-list
83067818|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
83067819|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
83067820|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067821|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067822|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
83067823|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067824|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83067825|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83067826|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067827|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067828|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067829|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83067830|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83067831|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
83067832|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83067833|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
83067834|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
83067835|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
83067836|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83067837|NCT00440388|Rituximab|rituximab|mesh-list
83067838|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83067839|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067840|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
83067841|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067842|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83067843|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83067844|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83067845|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067846|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
83067847|NCT04449224|Etanercept|etanercept|mesh-list
83067848|NCT04449224|Abatacept|abatacept|mesh-list
83067849|NCT04449224|Tofacitinib|tofacitinib|mesh-list
83067850|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83067851|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83067852|NCT04449224|Analgesics|analgesics|mesh-ancestor
83067853|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
83067854|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067855|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067856|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067857|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83067858|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83067859|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83067860|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
83067862|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067863|NCT04449224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83067864|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067865|NCT04449224|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83067866|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83067867|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067868|NCT00437112|Insulin|insulin|mesh-list
83067869|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83067870|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
83067871|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067872|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067873|NCT00434850|Gusperimus|gusperimus|mesh-list
83067874|NCT00434850|Sirolimus|sirolimus|mesh-list
83067875|NCT00434850|Etanercept|etanercept|mesh-list
83067876|NCT00434850|Tacrolimus|tacrolimus|mesh-list
83067877|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83067878|NCT00434850|Basiliximab|basiliximab|mesh-list
83067879|NCT00434850|Daclizumab|daclizumab|mesh-list
83067880|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83067881|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
83067882|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067883|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83067884|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067885|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067886|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83067887|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067888|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83067889|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067890|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
83067891|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83067892|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83067893|NCT00434850|Analgesics|analgesics|mesh-ancestor
83067894|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
83067895|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067896|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83067897|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83067898|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83067899|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067900|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83067901|NCT00434850|Protective Agents|protective agents|mesh-ancestor
83067902|NCT04449380|Interferons|interferons|mesh-list
83067903|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067904|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
83067905|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83067906|NCT03128216|Bupivacaine|bupivacaine|mesh-list
83067907|NCT03128216|Ropivacaine|ropivacaine|mesh-list
83067908|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
83067909|NCT03128216|Anesthetics|anesthetics|mesh-list
83067910|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067911|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067912|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
83067913|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067914|NCT00566202|Escitalopram|escitalopram|mesh-list
83067915|NCT00566202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83067916|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83067917|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067918|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067919|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067920|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
83067921|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067922|NCT02280486|Glimepiride|glimepiride|mesh-list
83067923|NCT02280486|Saxagliptin|saxagliptin|mesh-list
83067924|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83067925|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83067926|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067927|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83067928|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
83067929|NCT02280486|Incretins|incretins|mesh-ancestor
83067930|NCT02280486|Hormones|hormones|mesh-ancestor
83067931|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83067932|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83067933|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
83067934|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067935|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067936|NCT00434226|Paclitaxel|paclitaxel|mesh-list
83067937|NCT00434226|Bevacizumab|bevacizumab|mesh-list
83067938|NCT00434226|Carboplatin|carboplatin|mesh-list
83067939|NCT00434226|Sunitinib|sunitinib|mesh-list
83067940|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83067941|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83067942|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
83067943|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
83067944|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
83067945|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067946|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83067947|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83067948|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83067949|NCT00434226|Growth Substances|growth substances|mesh-ancestor
83067950|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067951|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
83067952|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83067953|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067954|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83067955|NCT00430950|Olmesartan|olmesartan|mesh-list
83067956|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83067957|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83067958|NCT00430950|Diuretics|diuretics|mesh-ancestor
83067959|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
83067960|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067961|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83067962|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067963|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067964|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83067965|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83067966|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
83067967|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83067968|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83067969|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067970|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067971|NCT02081391|Tapentadol|tapentadol|mesh-list
83067972|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83067973|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83067974|NCT02081391|Narcotics|narcotics|mesh-ancestor
83067975|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83067976|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067977|NCT02081391|Analgesics|analgesics|mesh-ancestor
83067978|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
83067979|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83067980|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83067981|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83067982|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83067983|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067984|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83067985|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83067986|NCT00549510|Lisinopril|lisinopril|mesh-list
83067987|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83067988|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
83067989|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83067990|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83067991|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83067992|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83067993|NCT00549510|Protective Agents|protective agents|mesh-ancestor
83067994|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83067995|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
83067996|NCT00430092|Difluprednate|difluprednate|mesh-list
83067997|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
83067998|NCT00430092|Hormones|hormones|mesh-ancestor
83067999|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068000|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068001|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068002|NCT00427440|Rilotumumab|rilotumumab|mesh-list
83068003|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83068004|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83068005|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068006|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
83068007|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068008|NCT00650832|Darunavir|darunavir|mesh-list
83068009|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83068010|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83068011|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
83068012|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068013|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068014|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83068015|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83068016|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
83068017|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068018|NCT00425100|Fesoterodine|fesoterodine|mesh-list
83068019|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83068020|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83068021|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
83068022|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068023|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068024|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068025|NCT00425100|Urological Agents|urological agents|mesh-ancestor
83068026|NCT00546780|Bortezomib|bortezomib|mesh-list
83068027|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068028|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83068029|NCT00420888|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
83068030|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
83068031|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
83068032|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068033|NCT00543582|Azacitidine|azacitidine|mesh-list
83068034|NCT00543582|Mocetinostat|mocetinostat|mesh-list
83068035|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83068036|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
83068037|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068038|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068039|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068040|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83068041|NCT00542724|Insulin|insulin|mesh-list
83068042|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83068043|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83068044|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068045|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83068046|NCT00412932|Olmesartan|olmesartan|mesh-list
83068047|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83068048|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83068049|NCT00412932|Diuretics|diuretics|mesh-ancestor
83068050|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
83068051|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068052|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83068053|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068054|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068055|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83068056|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83068057|NCT00411528|Prednisone|prednisone|mesh-list
83068058|NCT00411528|Docetaxel|docetaxel|mesh-list
83068059|NCT00411528|Epothilone B|epothilone b|mesh-list
83068060|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068061|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
83068062|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
83068063|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
83068064|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068065|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068066|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
83068067|NCT00411528|Hormones|hormones|mesh-ancestor
83068068|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068069|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068070|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83068071|NCT00384150|Galiximab|galiximab|mesh-list
83068072|NCT00384150|Rituximab|rituximab|mesh-list
83068073|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83068074|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068075|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
83068076|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83439629|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83068077|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068078|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068079|NCT00532038|Ketoprofen|ketoprofen|mesh-list
83068080|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83068081|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068082|NCT00532038|Analgesics|analgesics|mesh-ancestor
83068083|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
83068084|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068085|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068086|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068087|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068088|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83068089|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068090|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068091|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
83068092|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83068093|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068094|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83068095|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
83068096|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83068097|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068098|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068099|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068100|NCT00401388|Allopurinol|allopurinol|mesh-list
83068101|NCT00401388|Antiemetics|antiemetics|mesh-list
83068102|NCT00401388|Loperamide|loperamide|mesh-list
83068103|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
83068104|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
83068105|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068106|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068107|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
83068108|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068109|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83068110|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
83068111|NCT00401388|Protective Agents|protective agents|mesh-ancestor
83068112|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068113|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068114|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
83068115|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068116|NCT02282826|Acyclovir|acyclovir|mesh-list
83068117|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
83068118|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068119|NCT00374166|Paroxetine|paroxetine|mesh-list
83068120|NCT00374166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83068121|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83068122|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068123|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068124|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068125|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
83068126|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068127|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83068128|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
83068129|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83068130|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83068131|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83068132|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068133|NCT03559413|Imiquimod|imiquimod|mesh-list
83068134|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83068135|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
83068136|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068137|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068138|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
83068139|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
83068140|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83068141|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83068142|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83068143|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068144|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068145|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
83068146|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068147|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068148|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83439631|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
83068149|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068150|NCT02078973|Tolvaptan|tolvaptan|mesh-list
83068151|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83068152|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068153|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
83068154|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068155|NCT00397254|Rizatriptan|rizatriptan|mesh-list
83068156|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83068157|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
83068158|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068159|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068160|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068161|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
83068162|NCT01369641|Cisplatin|cisplatin|mesh-list
83068163|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068164|NCT01369641|Antidotes|antidotes|mesh-ancestor
83068165|NCT01369641|Protective Agents|protective agents|mesh-ancestor
83068166|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068167|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
83068168|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068169|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
83068170|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83068171|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068172|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
83068173|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
83068174|NCT02283060|Tenofovir|tenofovir|mesh-list
83068175|NCT02283060|Emtricitabine|emtricitabine|mesh-list
83068176|NCT02283060|Efavirenz|efavirenz|mesh-list
83068177|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83068178|NCT02283060|Cobicistat|cobicistat|mesh-list
83068179|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83068180|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83068181|NCT02283060|Elvitegravir|elvitegravir|mesh-list
83068182|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
83068183|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068184|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83068185|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83068186|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068187|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068188|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83068189|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83068190|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83068191|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83068192|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83068193|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83068194|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83068195|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83068196|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83068197|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83068198|NCT03559725|Menthol|menthol|mesh-list
83068199|NCT03559725|Nicotine|nicotine|mesh-list
83068200|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83068201|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
83068202|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068203|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068204|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83068205|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83068206|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
83068207|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068208|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068209|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
83068210|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
83068211|NCT00529152|Deferiprone|deferiprone|mesh-list
83068212|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83068213|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
83068214|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
83068215|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068216|NCT00525330|Metformin|metformin|mesh-list
83068217|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83068218|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068219|NCT02287272|Cimetidine|cimetidine|mesh-list
83068220|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83068221|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068222|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83068223|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
83068224|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
83068225|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068226|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068227|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068228|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83068229|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83068230|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068231|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
83068232|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83068233|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068234|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83068235|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83068236|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068237|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068238|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068239|NCT04470414|Antibodies|antibodies|mesh-list
83068240|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
83068241|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
83068242|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068243|NCT00363636|Galiximab|galiximab|mesh-list
83068244|NCT00363636|Rituximab|rituximab|mesh-list
83068245|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83068246|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068247|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
83068248|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068249|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068250|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068251|NCT02605174|Lasmiditan|lasmiditan|mesh-list
83068252|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83068253|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
83068254|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068255|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068256|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068257|NCT00522834|Paclitaxel|paclitaxel|mesh-list
83068258|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83068259|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068260|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
83068261|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
83068262|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
83068263|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068264|NCT02075619|Amlodipine|amlodipine|mesh-list
83068265|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83068266|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83068267|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83068268|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068269|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068270|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83068271|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068272|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
83068273|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83068274|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83068275|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
83068276|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83068277|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83068278|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068279|NCT00358878|Satavaptan|satavaptan|mesh-list
83068280|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83068281|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068282|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
83068283|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068284|NCT02283372|Paclitaxel|paclitaxel|mesh-list
83068285|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83068286|NCT02283372|Gemcitabine|gemcitabine|mesh-list
83068287|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83068288|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068289|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83068290|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83068291|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83068292|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068293|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83068294|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
83068295|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83068296|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83068297|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83068298|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068299|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068300|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068301|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068302|NCT00507936|Analgesics|analgesics|mesh-ancestor
83068303|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
83068304|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068305|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
83068306|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83068307|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
83068308|NCT04427020|Caseins|caseins|mesh-list
83068309|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
83068310|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
83068311|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068312|NCT02083575|Vitamins|vitamins|mesh-list
83068313|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
83068314|NCT02083575|Deferiprone|deferiprone|mesh-list
83068315|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
83068316|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068317|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
83068318|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068319|NCT02083575|Protective Agents|protective agents|mesh-ancestor
83361799|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068320|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83068322|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
83068323|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
83068324|NCT02286258|Edetic Acid|edetic acid|mesh-list
83068325|NCT02286258|Calcium|calcium|mesh-list
83068326|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83068327|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068328|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83068329|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
83068330|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
83068331|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068332|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
83068333|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83068334|NCT02088411|Diclofenac|diclofenac|mesh-list
83068335|NCT02088411|Wobenzym|wobenzym|mesh-list
83068336|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83068337|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068338|NCT02088411|Analgesics|analgesics|mesh-ancestor
83068339|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
83068340|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068341|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068342|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068343|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068344|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83068345|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068346|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068347|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83068348|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
83068349|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
83068350|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
83068351|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068352|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068353|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068354|NCT02604550|Naproxen|naproxen|mesh-list
83068355|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83068356|NCT02604550|Ropivacaine|ropivacaine|mesh-list
83068357|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
83068358|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
83068359|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068360|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068361|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
83068362|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068363|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83068364|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068365|NCT02604550|Analgesics|analgesics|mesh-ancestor
83068366|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068367|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068368|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
83068369|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83068370|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068371|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068372|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83068373|NCT02604550|Narcotics|narcotics|mesh-ancestor
83068374|NCT02084043|Amikacin|amikacin|mesh-list
83068375|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83068376|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068377|NCT03530670|Midazolam|midazolam|mesh-list
83068378|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83068379|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83068380|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068381|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068382|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83068383|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83068384|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83068385|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83068386|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
83068387|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
83068388|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
83068389|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
83068390|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068391|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068392|NCT00120042|Misoprostol|misoprostol|mesh-list
83068393|NCT00120042|Oxytocin|oxytocin|mesh-list
83068394|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
83068395|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83068396|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068397|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83068398|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
83068399|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83068400|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068401|NCT02084355|Fentanyl|fentanyl|mesh-list
83068402|NCT02084355|Oxycodone|oxycodone|mesh-list
83068403|NCT02084355|Hydromorphone|hydromorphone|mesh-list
83068404|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83068405|NCT02084355|Narcotics|narcotics|mesh-ancestor
83068406|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068407|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068408|NCT02084355|Analgesics|analgesics|mesh-ancestor
83068409|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
83068410|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068411|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83068412|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83068413|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
83068414|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
83068415|NCT00353574|Darusentan|darusentan|mesh-list
83068416|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83068417|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068418|NCT02082405|Dexamethasone|dexamethasone|mesh-list
83068419|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
83068420|NCT02082405|Bortezomib|bortezomib|mesh-list
83068421|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83068422|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
83068423|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068424|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068425|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83068426|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
83068427|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068428|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068429|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83068430|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068431|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
83068432|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
83068433|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068434|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068435|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
83068436|NCT02082405|Hormones|hormones|mesh-ancestor
83068437|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068438|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83068439|NCT04428268|Chloroquine|chloroquine|mesh-list
83068440|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83068441|NCT04428268|Losartan|losartan|mesh-list
83068442|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83068443|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83068444|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83068445|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83068446|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068447|NCT04428268|Amebicides|amebicides|mesh-ancestor
83068448|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83068449|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83068450|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068451|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
83068452|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83068453|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83068454|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068455|NCT04428268|Analgesics|analgesics|mesh-ancestor
83068456|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
83068457|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068458|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068459|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068460|NCT04428268|Filaricides|filaricides|mesh-ancestor
83068461|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
83068462|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
83068463|NCT02084433|Anesthetics|anesthetics|mesh-list
83068464|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068465|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068466|NCT04427098|Enoxaparin|enoxaparin|mesh-list
83068467|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
83068468|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
83068469|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83068470|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83068471|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068472|NCT00352560|Irbesartan|irbesartan|mesh-list
83068473|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83068474|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83068475|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83068476|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068477|NCT00115050|Darunavir|darunavir|mesh-list
83068478|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83068479|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83068480|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
83068481|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068482|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068483|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83068484|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83068485|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
83068486|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068487|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
83068488|NCT05616364|Tramadol|tramadol|mesh-list
83068489|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83068490|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068491|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068492|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068493|NCT05616364|Analgesics|analgesics|mesh-ancestor
83068494|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
83068495|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068496|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83068497|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83068498|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83068499|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
83068500|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068501|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068502|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83068503|NCT05616364|Narcotics|narcotics|mesh-ancestor
83068504|NCT00345618|Biotin|biotin|mesh-list
83068505|NCT00345618|Enoxaparin|enoxaparin|mesh-list
83068506|NCT00345618|Warfarin|warfarin|mesh-list
83068507|NCT00345618|Idraparinux|idraparinux|mesh-list
83068508|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
83068509|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
83068510|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83068511|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83068512|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83439642|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
83068513|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83068514|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
83068515|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83068516|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
83068517|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068518|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
83068519|NCT00345618|Vitamins|vitamins|mesh-ancestor
83068520|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
83068521|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068522|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
83068523|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83068524|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068525|NCT03611868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83068526|NCT03611868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068527|NCT00116298|Lamivudine|lamivudine|mesh-list
83068528|NCT00116298|Efavirenz|efavirenz|mesh-list
83068529|NCT00116298|Stavudine|stavudine|mesh-list
83068530|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83068531|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83068532|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068533|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068534|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
83068535|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068536|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83068537|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83068538|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83068539|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83068540|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83068541|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83068542|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83068543|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83068544|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
83068545|NCT01866111|Cenobamate|cenobamate|mesh-list
83068546|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
83068547|NCT02084589|Fentanyl|fentanyl|mesh-list
83068548|NCT02084589|Ropivacaine|ropivacaine|mesh-list
83068549|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
83068550|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
83068551|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068552|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068553|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
83068554|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068555|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83068556|NCT02084589|Narcotics|narcotics|mesh-ancestor
83068557|NCT02084589|Analgesics|analgesics|mesh-ancestor
83068558|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83068559|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83068560|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
83068561|NCT03557853|Golimumab|golimumab|mesh-list
83068562|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83068563|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068564|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83068565|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
83068566|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068567|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
83068568|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83068569|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068570|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068571|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068572|NCT04346290|Analgesics|analgesics|mesh-ancestor
83068573|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
83068574|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068575|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83068576|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83068577|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83068578|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
83068579|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068580|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068581|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
83068582|NCT04426552|Sevoflurane|sevoflurane|mesh-list
83068583|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83068584|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83439643|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
83068585|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068586|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068587|NCT04426552|Analgesics|analgesics|mesh-ancestor
83068588|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
83068589|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068590|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83068591|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83068592|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83068593|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
83068594|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068595|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068596|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83068597|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83068598|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
83068599|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
83068600|NCT04803370|Antibodies|antibodies|mesh-list
83068601|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
83068602|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068603|NCT01369329|Ustekinumab|ustekinumab|mesh-list
83068604|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
83068605|NCT04802980|Paclitaxel|paclitaxel|mesh-list
83068606|NCT04802980|Carboplatin|carboplatin|mesh-list
83068607|NCT04802980|Gemcitabine|gemcitabine|mesh-list
83068608|NCT04802980|Capecitabine|capecitabine|mesh-list
83068609|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
83068610|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83068611|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068612|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
83068613|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
83068614|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
83068615|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068616|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83068617|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
83068618|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
83068619|NCT02088645|Gastrins|gastrins|mesh-list
83068620|NCT02088645|Hormones|hormones|mesh-ancestor
83068621|NCT02088645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068622|NCT02088645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068623|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83068624|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068625|NCT03558477|Esomeprazole|esomeprazole|mesh-list
83068626|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83068627|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068628|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83068629|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068630|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068631|NCT04792840|Letrozole|letrozole|mesh-list
83068632|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068633|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83068634|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83068635|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068636|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068637|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83068638|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
83068639|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068640|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068641|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
83068642|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
83068643|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
83068644|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
83068645|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
83068646|NCT02085291|Norepinephrine|norepinephrine|mesh-list
83068647|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83068648|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83068649|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
83068650|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068651|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068652|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068653|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
83068654|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
83068655|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068656|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83068657|NCT04792138|Phenobarbital|phenobarbital|mesh-list
83068658|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
83068659|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83068660|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068661|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068662|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83068663|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83068664|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068665|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068666|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
83068667|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
83068668|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83068669|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83068670|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83068671|NCT04802122|Propofol|propofol|mesh-list
83068672|NCT04802122|Sevoflurane|sevoflurane|mesh-list
83068673|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83068674|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068675|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068676|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83068677|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
83068678|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
83068679|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83068680|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83068681|NCT04784728|Lidocaine|lidocaine|mesh-list
83068682|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
83068683|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
83068684|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068685|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068686|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
83068687|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068688|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83068689|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83068690|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83068691|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068692|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068693|NCT02085603|Saracatinib|saracatinib|mesh-list
83068694|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068695|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068696|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068698|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
83068699|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83068700|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068701|NCT04801888|Vaccines|vaccines|mesh-list
83068702|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
83068703|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068704|NCT02089503|Ranibizumab|ranibizumab|mesh-list
83068705|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83068706|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83068707|NCT02089503|Growth Substances|growth substances|mesh-ancestor
83068708|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068709|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
83068710|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068711|NCT02091063|Ricolinostat|ricolinostat|mesh-list
83068712|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068713|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83068714|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068715|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068716|NCT02091219|Vitamin D|vitamin d|mesh-list
83068717|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
83068718|NCT02091219|Calcifediol|calcifediol|mesh-list
83068719|NCT02091219|Vitamins|vitamins|mesh-ancestor
83068720|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
83068721|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068722|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83068723|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83068724|NCT02091297|Acetaminophen|acetaminophen|mesh-list
83068725|NCT02091297|Morphine|morphine|mesh-list
83068726|NCT02091297|Ropivacaine|ropivacaine|mesh-list
83068727|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83068728|NCT02091297|Narcotics|narcotics|mesh-ancestor
83439649|NCT04399148|Aprepitant|aprepitant|mesh-list
83068729|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068730|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068731|NCT02091297|Analgesics|analgesics|mesh-ancestor
83068732|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
83068733|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068734|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
83068735|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
83068736|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068737|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
83068738|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
83068739|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83068740|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83068741|NCT04791202|Prednisolone|prednisolone|mesh-list
83068742|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
83068743|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83068744|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
83068745|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83068746|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
83068747|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
83068748|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068749|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068750|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068751|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
83068752|NCT04791202|Hormones|hormones|mesh-ancestor
83068753|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068754|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83068755|NCT04791202|Protective Agents|protective agents|mesh-ancestor
83068756|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83068757|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068758|NCT04801342|Memantine|memantine|mesh-list
83068759|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83068760|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83068761|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
83068762|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068763|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068764|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068765|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83068766|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83068767|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83068768|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
83068769|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83068770|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068771|NCT02590588|Idelalisib|idelalisib|mesh-list
83068772|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068773|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068774|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068779|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068780|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068781|NCT02086227|Incretins|incretins|mesh-ancestor
83068782|NCT02086929|Trazodone|trazodone|mesh-list
83068783|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83068784|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83068785|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83068786|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068787|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068788|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068789|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068790|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83068791|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
83068792|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83068793|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83068794|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83068795|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068796|NCT02086929|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83068797|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
83068798|NCT02249013|Paclitaxel|paclitaxel|mesh-list
83068799|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83068800|NCT02249013|Carboplatin|carboplatin|mesh-list
83068801|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83068802|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068803|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83068804|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83068805|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83068806|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068807|NCT02249871|Omeprazole|omeprazole|mesh-list
83068808|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83068809|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83068810|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83068811|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068812|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068813|NCT02087007|Cilostazol|cilostazol|mesh-list
83068814|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83068815|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
83068816|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068817|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068818|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83068819|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
83068820|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83068821|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83068822|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068823|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83068824|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
83068825|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83068826|NCT02087007|Protective Agents|protective agents|mesh-ancestor
83068827|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83068828|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83068829|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068830|NCT01434602|Everolimus|everolimus|mesh-list
83068831|NCT01434602|Sorafenib|sorafenib|mesh-list
83068832|NCT01434602|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83068833|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83068834|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068835|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068836|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83068837|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
83068838|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068839|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068840|NCT02087475|Fluorouracil|fluorouracil|mesh-list
83068841|NCT02087475|Irinotecan|irinotecan|mesh-list
83068842|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
83068843|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068844|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83068845|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83068846|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83068847|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
83068848|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068849|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83068850|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83068851|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068852|NCT05486949|Itraconazole|itraconazole|mesh-list
83068853|NCT05486949|Carbamazepine|carbamazepine|mesh-list
83068854|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
83068855|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068856|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83068857|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83068858|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068859|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068860|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83068861|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
83068862|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83068863|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068864|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83068865|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
83068866|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
83068867|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83068868|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068869|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83068870|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83068871|NCT05486949|Analgesics|analgesics|mesh-ancestor
83068872|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
83068873|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068874|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83068875|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068876|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83068877|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83068878|NCT03558243|Hemostatics|hemostatics|mesh-list
83068879|NCT03558243|Coagulants|coagulants|mesh-ancestor
83068880|NCT03426956|Canagliflozin|canagliflozin|mesh-list
83068881|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83068882|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068883|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83068884|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068885|NCT03557229|Vitamins|vitamins|mesh-list
83068886|NCT03557229|Vitamin E|vitamin e|mesh-list
83068887|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
83068888|NCT03557229|Melatonin|melatonin|mesh-list
83068889|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83068890|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
83068891|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068892|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
83068893|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068894|NCT03557229|Protective Agents|protective agents|mesh-ancestor
83068895|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068896|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
83068897|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068898|NCT03557229|Expectorants|expectorants|mesh-ancestor
83068899|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
83068900|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83068901|NCT03557229|Antidotes|antidotes|mesh-ancestor
83068902|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83068903|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
83068904|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83068905|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83068906|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83068907|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068908|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068909|NCT00940940|Vaccines|vaccines|mesh-list
83068910|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
83068911|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068912|NCT03557840|Temocillin|temocillin|mesh-list
83068913|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83068914|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068915|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
83068916|NCT02092701|Vitamin D|vitamin d|mesh-list
83068917|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83068918|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068919|NCT02092701|Vitamins|vitamins|mesh-ancestor
83068920|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
83068921|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83068922|NCT01767129|Quinidine|quinidine|mesh-list
83068923|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
83068924|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
83068925|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
83068926|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83068927|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83361800|NCT04782258|Tolvaptan|tolvaptan|mesh-list
83068928|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068929|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068930|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068931|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83068932|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83068933|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
83068934|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83068935|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
83068936|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83068937|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83068938|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068939|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068940|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83068941|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83068942|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
83068943|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83068944|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83068945|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83068946|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83068947|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83068948|NCT01309191|Minoxidil|minoxidil|mesh-list
83068949|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83068950|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83068951|NCT03420638|Epinephrine|epinephrine|mesh-list
83068952|NCT03420638|Bupivacaine|bupivacaine|mesh-list
83068953|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
83068954|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
83068955|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068956|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068957|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
83068958|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068959|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83068960|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83068961|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
83068962|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068963|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068964|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83068965|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83068966|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
83068967|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83068968|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
83068969|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
83068970|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
83068971|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83068972|NCT00715988|Methadone|methadone|mesh-list
83068973|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83068974|NCT00715988|Narcotics|narcotics|mesh-ancestor
83068975|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83068976|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068977|NCT00715988|Analgesics|analgesics|mesh-ancestor
83068978|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
83068979|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83068980|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
83068981|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
83068982|NCT02093091|Vitremer|vitremer|mesh-list
83068983|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
83068984|NCT02093091|Protective Agents|protective agents|mesh-ancestor
83068985|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068987|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
83068988|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83068989|NCT03556917|Caffeine|caffeine|mesh-list
83068990|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83068991|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83068992|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83068993|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83068994|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83068995|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83068996|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83068997|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
83068998|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83068999|NCT02090439|Silodosin|silodosin|mesh-list
83069000|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83069001|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83069002|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83069004|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069005|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069006|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069007|NCT02090439|Urological Agents|urological agents|mesh-ancestor
83069008|NCT02696564|Losartan|losartan|mesh-list
83069009|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83069010|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83069011|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83069012|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83069013|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069014|NCT02093403|Decitabine|decitabine|mesh-list
83069015|NCT02093403|Azacitidine|azacitidine|mesh-list
83069016|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83069017|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
83069018|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069019|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069020|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069021|NCT03426176|Oxytocin|oxytocin|mesh-list
83069022|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
83069023|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83069024|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069025|NCT02095899|Rufinamide|rufinamide|mesh-list
83069026|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
83069027|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83069028|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83069029|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83069030|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069031|NCT03525002|Bromocriptine|bromocriptine|mesh-list
83069032|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83069033|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83069034|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
83069035|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83069036|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069037|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
83069038|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
83069039|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069040|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069041|NCT03426020|Midazolam|midazolam|mesh-list
83069042|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83069043|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83069044|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069045|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069046|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83069047|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83069048|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83069049|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83069050|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
83069051|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
83069052|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
83069053|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
83069054|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069055|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069056|NCT03428906|Oxytocin|oxytocin|mesh-list
83069057|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
83069058|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83069059|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069060|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83069061|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
83069062|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83069063|NCT02521298|Prednisolone|prednisolone|mesh-list
83069064|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
83069065|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83069066|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
83069067|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83069068|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
83069069|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
83069070|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069071|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069072|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83069073|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
83069074|NCT02521298|Hormones|hormones|mesh-ancestor
83069075|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83069094|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
83069095|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069096|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83069097|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069114|NCT03419858|Naloxone|naloxone|mesh-list
83069115|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83069116|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069117|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
83069118|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069119|NCT03417206|Remifentanil|remifentanil|mesh-list
83069120|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83069121|NCT03417206|Narcotics|narcotics|mesh-ancestor
83069122|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069123|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069124|NCT03417206|Analgesics|analgesics|mesh-ancestor
83069125|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
83069126|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069127|NCT00003716|Rituximab|rituximab|mesh-list
83069128|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069129|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069130|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
83069131|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069132|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069133|NCT02593786|Nivolumab|nivolumab|mesh-list
83069134|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069135|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069136|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069137|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069138|NCT03425708|Febuxostat|febuxostat|mesh-list
83069139|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
83069140|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069141|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83069142|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83069143|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83069144|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069145|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069146|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83069147|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83069148|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83069149|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
83069150|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069151|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069152|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83069153|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83069154|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
83069155|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
83069156|NCT03425474|Propofol|propofol|mesh-list
83069157|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83069158|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069159|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069160|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83069161|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
83069162|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
83069163|NCT03419624|Metformin|metformin|mesh-list
83069164|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
83069165|NCT03419624|Exenatide|exenatide|mesh-list
83069166|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83069167|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069168|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83069169|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069170|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83069171|NCT03419624|Incretins|incretins|mesh-ancestor
83069173|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83069174|NCT02096055|Idarubicin|idarubicin|mesh-list
83069175|NCT02096055|Cladribine|cladribine|mesh-list
83069176|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83069177|NCT02096055|Guadecitabine|guadecitabine|mesh-list
83069178|NCT02096055|Azacitidine|azacitidine|mesh-list
83069179|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83069180|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069181|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83069182|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83069183|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069184|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069185|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069186|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
83069187|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069188|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83069189|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
83069190|NCT03425162|Morphine|morphine|mesh-list
83069191|NCT03425162|Bupivacaine|bupivacaine|mesh-list
83069192|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
83069193|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
83069194|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069195|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069196|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
83069197|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069198|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83069199|NCT03425162|Narcotics|narcotics|mesh-ancestor
83069200|NCT03425162|Analgesics|analgesics|mesh-ancestor
83069201|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
83069202|NCT02096133|Vitamin D|vitamin d|mesh-list
83069203|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83069204|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069205|NCT02096133|Vitamins|vitamins|mesh-ancestor
83069206|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
83069207|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83069208|NCT02096289|Thioridazine|thioridazine|mesh-list
83069209|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83069210|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83069211|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069212|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069213|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83069214|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83069215|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
83069216|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069217|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069218|NCT02090673|Exenatide|exenatide|mesh-list
83069219|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83069220|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069221|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83069222|NCT02090673|Incretins|incretins|mesh-ancestor
83069223|NCT02090673|Hormones|hormones|mesh-ancestor
83069224|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83069225|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
83069226|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83069227|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
83069228|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069229|NCT03556371|Expectorants|expectorants|mesh-ancestor
83069230|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
83069231|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83069232|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
83069233|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069234|NCT03556371|Protective Agents|protective agents|mesh-ancestor
83069235|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069236|NCT03556371|Antidotes|antidotes|mesh-ancestor
83069237|NCT02827526|Ketamine|ketamine|mesh-list
83069238|NCT02827526|Analgesics|analgesics|mesh-ancestor
83069239|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
83069240|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069241|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069242|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83069243|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83069244|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
83069245|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
83069246|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069247|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83069249|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069250|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069251|NCT04799314|Tislelizumab|tislelizumab|mesh-list
83069252|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83069253|NCT04799314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069254|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069255|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069256|NCT03425084|Morphine|morphine|mesh-list
83069257|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83069258|NCT03425084|Narcotics|narcotics|mesh-ancestor
83069259|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069260|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069261|NCT03425084|Analgesics|analgesics|mesh-ancestor
83069262|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
83069263|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069264|NCT03424928|Thalidomide|thalidomide|mesh-list
83069265|NCT03424928|Pomalidomide|pomalidomide|mesh-list
83069266|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
83069267|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069268|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83069269|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83069270|NCT03424928|Growth Substances|growth substances|mesh-ancestor
83069271|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
83069272|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069273|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069274|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
83069275|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83069276|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069277|NCT04799002|Melphalan|melphalan|mesh-list
83069278|NCT04799002|Topotecan|topotecan|mesh-list
83069279|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83069280|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
83069281|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069282|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069283|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83069284|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069285|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
83069286|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069287|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83069288|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83069289|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069290|NCT02098785|Caffeine|caffeine|mesh-list
83069291|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
83069292|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069293|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83069294|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069295|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83069296|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069297|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83069298|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83069299|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
83069300|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069301|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83361801|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83069302|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
83069303|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069304|NCT02521064|Prednisone|prednisone|mesh-list
83069305|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83069306|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
83069307|NCT02521064|Hormones|hormones|mesh-ancestor
83069308|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83069309|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069310|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83069311|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069312|NCT02096913|Ibuprofen|ibuprofen|mesh-list
83069313|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83069314|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83069315|NCT02096913|Analgesics|analgesics|mesh-ancestor
83069316|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
83069317|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069318|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069319|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83069320|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069321|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83069322|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069323|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069324|NCT03418610|Azelaic acid|azelaic acid|mesh-list
83069325|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069326|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83069327|NCT04604366|Alprostadil|alprostadil|mesh-list
83069328|NCT04604366|Misoprostol|misoprostol|mesh-list
83069329|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83069330|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
83069331|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83069332|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069333|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83069334|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83069335|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
83069336|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83069337|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
83069338|NCT04604366|Urological Agents|urological agents|mesh-ancestor
83069339|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
83069340|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83069341|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069342|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069343|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83069344|NCT02099253|Analgesics|analgesics|mesh-ancestor
83069345|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
83069346|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069347|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83069348|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83069349|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83069350|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83069351|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069352|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069353|NCT05818111|Lidocaine|lidocaine|mesh-list
83069354|NCT05818111|Anesthetics, Local|anesthetics, local|mesh-ancestor
83069355|NCT05818111|Anesthetics|anesthetics|mesh-ancestor
83069356|NCT05818111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069357|NCT05818111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069358|NCT05818111|Sensory System Agents|sensory system agents|mesh-ancestor
83069359|NCT05818111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069360|NCT05818111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83069361|NCT05818111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83069362|NCT05818111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83069363|NCT05818111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83069364|NCT05818111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069365|NCT05818085|Allopurinol|allopurinol|mesh-list
83069366|NCT05818085|Antimetabolites|antimetabolites|mesh-ancestor
83069367|NCT05818085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069368|NCT05818085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069369|NCT05818085|Gout Suppressants|gout suppressants|mesh-ancestor
83069370|NCT05818085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069371|NCT05818085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83069372|NCT05818085|Antioxidants|antioxidants|mesh-ancestor
83069373|NCT05818085|Protective Agents|protective agents|mesh-ancestor
83069374|NCT05818085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069375|NCT05818007|Hyaluronic Acid|hyaluronic acid|mesh-list
83069376|NCT05818007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83069377|NCT05818007|Immunologic Factors|immunologic factors|mesh-ancestor
83069378|NCT05818007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069379|NCT05818007|Viscosupplements|viscosupplements|mesh-ancestor
83069380|NCT05818007|Protective Agents|protective agents|mesh-ancestor
83069381|NCT05817955|Azacitidine|azacitidine|mesh-list
83069382|NCT05817955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83069383|NCT05817955|Antimetabolites|antimetabolites|mesh-ancestor
83069384|NCT05817955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069385|NCT05817955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069386|NCT05817955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069387|NCT05817851|Vitamins|vitamins|mesh-list
83069388|NCT05817851|Thiamine|thiamine|mesh-list
83069389|NCT05817851|Micronutrients|micronutrients|mesh-ancestor
83069390|NCT05817851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069391|NCT05817851|Vitamin B Complex|vitamin b complex|mesh-ancestor
83069392|NCT05817409|Baclofen|baclofen|mesh-list
83069393|NCT05817409|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83069394|NCT05817409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069395|NCT05817409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83069396|NCT05817409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069397|NCT05817409|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83069398|NCT05817409|GABA Agonists|gaba agonists|mesh-ancestor
83069399|NCT05817409|GABA Agents|gaba agents|mesh-ancestor
83069400|NCT05817409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069401|NCT05817409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069402|NCT05817253|Coal Tar|coal tar|mesh-list
83069403|NCT05817253|Keratolytic Agents|keratolytic agents|mesh-ancestor
83069404|NCT05817253|Dermatologic Agents|dermatologic agents|mesh-ancestor
83069405|NCT05817240|Nintedanib|nintedanib|mesh-list
83069406|NCT05817240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069407|NCT05817240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83069408|NCT05817240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069409|NCT05817240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069410|NCT05817201|Tegafur|tegafur|mesh-list
83069411|NCT05817201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83069412|NCT05817201|Antimetabolites|antimetabolites|mesh-ancestor
83069413|NCT05817201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069414|NCT05817201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069415|NCT05817097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83069416|NCT05817097|Protease Inhibitors|protease inhibitors|mesh-ancestor
83069417|NCT05817097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439676|NCT00699803|Prednisone|prednisone|mesh-list
83069418|NCT05817097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069419|NCT05817097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83069420|NCT05817097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069421|NCT05817019|Neostigmine|neostigmine|mesh-list
83069422|NCT05817019|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83069423|NCT05817019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069424|NCT05817019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069425|NCT05817019|Cholinergic Agents|cholinergic agents|mesh-ancestor
83069426|NCT05817019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069427|NCT05817019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069428|NCT05817019|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83069429|NCT05817019|Autonomic Agents|autonomic agents|mesh-ancestor
83069430|NCT05817019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069431|NCT05816772|Calcium|calcium|mesh-list
83069432|NCT05816772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83069433|NCT05816772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069434|NCT05816733|Dapagliflozin|dapagliflozin|mesh-list
83069435|NCT05816733|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83069436|NCT05816733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069437|NCT05816733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83069438|NCT05816733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069439|NCT05816720|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83069440|NCT05816720|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83069441|NCT05816720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069442|NCT05816707|Turmeric extract|turmeric extract|mesh-list
83069443|NCT05816707|Antioxidants|antioxidants|mesh-ancestor
83069444|NCT05816707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069445|NCT05816707|Protective Agents|protective agents|mesh-ancestor
83069446|NCT05816707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069447|NCT05816694|Paclitaxel|paclitaxel|mesh-list
83069448|NCT05816694|Cyclophosphamide|cyclophosphamide|mesh-list
83069449|NCT05816694|Cisplatin|cisplatin|mesh-list
83069451|NCT05816694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83069452|NCT05816694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069453|NCT05816694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83069454|NCT05816694|Antimitotic Agents|antimitotic agents|mesh-ancestor
83069455|NCT05816694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83069456|NCT05816694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069457|NCT05816694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069458|NCT05816694|Immunologic Factors|immunologic factors|mesh-ancestor
83069459|NCT05816694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069460|NCT05816694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069461|NCT05816694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83069462|NCT05816694|Alkylating Agents|alkylating agents|mesh-ancestor
83069463|NCT05816694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83069464|NCT05816694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83069465|NCT05816694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83069466|NCT05816694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83069467|NCT05816694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069469|NCT05816668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83069470|NCT05816668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83069471|NCT05816668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069472|NCT05816668|Hemostatics|hemostatics|mesh-ancestor
83069473|NCT05816668|Coagulants|coagulants|mesh-ancestor
83069474|NCT05816655|Fulvestrant|fulvestrant|mesh-list
83069475|NCT05816655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83069476|NCT05816655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069477|NCT05816655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83069478|NCT05816655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83069479|NCT05816655|Hormone Antagonists|hormone antagonists|mesh-ancestor
83069480|NCT05816655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83069481|NCT05816655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069482|NCT05816642|Sunitinib|sunitinib|mesh-list
83069483|NCT05816642|Axitinib|axitinib|mesh-list
83069484|NCT05816642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83069485|NCT05816642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069486|NCT05816642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83069487|NCT05816642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83069488|NCT05816642|Growth Substances|growth substances|mesh-ancestor
83069489|NCT05816642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069490|NCT05816642|Growth Inhibitors|growth inhibitors|mesh-ancestor
83069491|NCT05816642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83069492|NCT05816642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069493|NCT05816642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069494|NCT05816642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069495|NCT05816616|Xenon|xenon|mesh-list
83069496|NCT05816616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83069497|NCT05816616|Anesthetics, General|anesthetics, general|mesh-ancestor
83069498|NCT05816616|Anesthetics|anesthetics|mesh-ancestor
83069499|NCT05816616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069500|NCT05816616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069501|NCT05816538|Anesthetics|anesthetics|mesh-list
83069502|NCT05816538|Levobupivacaine|levobupivacaine|mesh-list
83069503|NCT05816538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069504|NCT05816538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069505|NCT05816538|Anesthetics, Local|anesthetics, local|mesh-ancestor
83069506|NCT05816538|Sensory System Agents|sensory system agents|mesh-ancestor
83069507|NCT05816538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069508|NCT05813847|Anesthetics|anesthetics|mesh-list
83069509|NCT05813847|Anesthetics, Local|anesthetics, local|mesh-list
83069510|NCT05813847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069511|NCT05813847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069512|NCT05813847|Sensory System Agents|sensory system agents|mesh-ancestor
83069513|NCT05813847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069514|NCT05809583|Ozanimod|ozanimod|mesh-list
83069515|NCT05809583|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83069516|NCT05809583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069517|NCT05809583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069518|NCT05809583|Immunologic Factors|immunologic factors|mesh-ancestor
83069519|NCT05809583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069520|NCT05809453|Lidocaine|lidocaine|mesh-list
83069521|NCT05809453|Cocaine|cocaine|mesh-list
83069522|NCT05809453|Anesthetics, Local|anesthetics, local|mesh-ancestor
83069523|NCT05809453|Anesthetics|anesthetics|mesh-ancestor
83069524|NCT05809453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069525|NCT05809453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069526|NCT05809453|Sensory System Agents|sensory system agents|mesh-ancestor
83069527|NCT05809453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069528|NCT05809453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83069529|NCT05809453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83069530|NCT05809453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83069531|NCT05809453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83069532|NCT05809453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069533|NCT05809453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83069534|NCT05809453|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83069535|NCT05809453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83069536|NCT05809453|Dopamine Agents|dopamine agents|mesh-ancestor
83069537|NCT05809453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069538|NCT05803629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83069539|NCT05803629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83069540|NCT05803629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069542|NCT05803434|Anticonvulsants|anticonvulsants|mesh-ancestor
83069543|NCT05788081|Rituximab|rituximab|mesh-list
83069544|NCT05788081|Nivolumab|nivolumab|mesh-list
83069545|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069546|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069547|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
83069548|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069549|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069550|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069551|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069552|NCT05784246|Mirikizumab|mirikizumab|mesh-list
83069553|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83069554|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83069555|NCT05784246|Analgesics|analgesics|mesh-ancestor
83069556|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
83069557|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069558|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069559|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83069560|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069561|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83069562|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83069563|NCT05781542|MEDI9197|medi9197|mesh-list
83069564|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83069565|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
83069566|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069567|NCT05777226|Epalrestat|epalrestat|mesh-list
83069568|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069569|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069570|NCT05776160|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83069571|NCT05776160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069572|NCT05776160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069573|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83069574|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83069575|NCT05769010|Bevacizumab|bevacizumab|mesh-list
83069576|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069577|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069578|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83069579|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83069580|NCT05769010|Growth Substances|growth substances|mesh-ancestor
83069581|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069582|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
83069583|NCT05767021|Mirikizumab|mirikizumab|mesh-list
83069584|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83069585|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83069586|NCT05767021|Analgesics|analgesics|mesh-ancestor
83069587|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
83069588|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069589|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069590|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83069591|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069592|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83069593|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83069594|NCT05719883|Sirolimus|sirolimus|mesh-list
83069595|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83069596|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069597|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83361802|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069598|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069599|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
83069600|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069601|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
83069602|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069603|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
83069604|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83069605|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83069606|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83069607|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83069608|NCT05715411|Methamphetamine|methamphetamine|mesh-list
83069609|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83069610|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069611|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
83069612|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
83069613|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069614|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
83069615|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069616|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069617|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
83069618|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83069619|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83069620|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83069621|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83069622|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83069623|NCT05688579|Mineralocorticoids|mineralocorticoids|mesh-list
83069624|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
83069625|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83069626|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069627|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83069629|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
83069630|NCT05688579|Hormones|hormones|mesh-ancestor
83069631|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83069632|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
83069633|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
83069634|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83069635|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069636|NCT05659927|Antibodies|antibodies|mesh-list
83069637|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83069638|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
83069639|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069640|NCT05659823|Fentanyl|fentanyl|mesh-list
83069641|NCT05659823|Morphine|morphine|mesh-list
83069642|NCT05659823|Bupivacaine|bupivacaine|mesh-list
83069643|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
83069644|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
83069645|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069646|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069647|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
83069648|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069649|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83069650|NCT05659823|Narcotics|narcotics|mesh-ancestor
83069651|NCT05659823|Analgesics|analgesics|mesh-ancestor
83069652|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83069653|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83069654|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
83069655|NCT05640453|Pregabalin|pregabalin|mesh-list
83069656|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
83069657|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83069658|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069659|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069660|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83069661|NCT05640453|Analgesics|analgesics|mesh-ancestor
83069662|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
83069663|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069664|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83069665|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83069666|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83069667|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
83069668|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069669|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069670|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
83069671|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83069672|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83069673|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83069674|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83069675|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83069676|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83069677|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
83069678|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
83069679|NCT05622071|Tislelizumab|tislelizumab|mesh-list
83069680|NCT05622071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069681|NCT05622071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069682|NCT05603832|Acetaminophen|acetaminophen|mesh-list
83069683|NCT05603832|Bupivacaine|bupivacaine|mesh-list
83069684|NCT05603832|Methocarbamol|methocarbamol|mesh-list
83069685|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
83069686|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
83069687|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069688|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069689|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
83069690|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069691|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83069692|NCT05603832|Analgesics|analgesics|mesh-ancestor
83069693|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
83069694|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83069695|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83069697|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
83069698|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069699|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
83069700|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
83069701|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
83069702|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069703|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069704|NCT05599789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069705|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
83069706|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83069707|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069708|NCT05583617|Lenalidomide|lenalidomide|mesh-list
83069709|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
83069710|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069711|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83069712|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83069713|NCT05583617|Growth Substances|growth substances|mesh-ancestor
83069714|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
83069715|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069716|NCT05581901|Methadone|methadone|mesh-list
83069717|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83069718|NCT05581901|Narcotics|narcotics|mesh-ancestor
83069719|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069720|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069721|NCT05581901|Analgesics|analgesics|mesh-ancestor
83069722|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
83069723|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069724|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
83069725|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
83069726|NCT05564637|Treprostinil|treprostinil|mesh-list
83069727|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83069728|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83069729|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069730|NCT05520814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069731|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069732|NCT05508061|Insulin|insulin|mesh-list
83069733|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83069734|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
83069735|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83069736|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069737|NCT05504642|Nivolumab|nivolumab|mesh-list
83069738|NCT05504642|Ipilimumab|ipilimumab|mesh-list
83069739|NCT05504642|Immunomodulating Agents|immunomodulating agents|mesh-list
83069740|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
83069741|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069742|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069743|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069744|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069745|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069746|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
83069747|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83361803|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
83069748|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069749|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069750|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83069751|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83069752|NCT05490953|Protective Agents|protective agents|mesh-ancestor
83069753|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069754|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
83069755|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83069757|NCT05475483|Bevantolol|bevantolol|mesh-list
83069758|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83069759|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83069760|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83069761|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
83069762|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069763|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069764|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069765|NCT05474729|Minocycline|minocycline|mesh-list
83069766|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83069767|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069768|NCT05474001|Fentanyl|fentanyl|mesh-list
83069769|NCT05474001|Bupivacaine|bupivacaine|mesh-list
83069770|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
83069771|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
83069772|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069773|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069774|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
83069775|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069776|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83069777|NCT05474001|Narcotics|narcotics|mesh-ancestor
83069778|NCT05474001|Analgesics|analgesics|mesh-ancestor
83069779|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83069780|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83069781|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
83069782|NCT05445232|Midazolam|midazolam|mesh-list
83069783|NCT05445232|Caffeine|caffeine|mesh-list
83069784|NCT05445232|Warfarin|warfarin|mesh-list
83069785|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83069786|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83069787|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069788|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069789|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83069790|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83069791|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83069792|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83069793|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
83069794|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
83069795|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
83069796|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
83069797|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069798|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069799|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
83069800|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83069801|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83069802|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069803|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83069804|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83069805|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
83069806|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
83069807|NCT05420805|Butyric Acid|butyric acid|mesh-list
83069808|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
83069809|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
83069810|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83069811|NCT05420805|Protective Agents|protective agents|mesh-ancestor
83069812|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069813|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
83069814|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
83069815|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069816|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069817|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
83069818|NCT05406583|Dolutegravir|dolutegravir|mesh-list
83069819|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83069820|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83069821|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069822|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069823|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83069824|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83069825|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
83069826|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069827|NCT05395533|Antibodies|antibodies|mesh-list
83069828|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83069829|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
83069830|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069831|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
83069832|NCT05389527|Lenvatinib|lenvatinib|mesh-list
83069833|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069834|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069835|NCT05389527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069836|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069837|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83069838|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069839|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
83069840|NCT05358522|Narcotics|narcotics|mesh-ancestor
83069841|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069842|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069843|NCT05358522|Analgesics|analgesics|mesh-ancestor
83069844|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
83069845|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069846|NCT05355974|Norepinephrine|norepinephrine|mesh-list
83069847|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
83069848|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83069849|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83069850|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
83069851|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83069852|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069853|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069854|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
83069855|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
83069856|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83069857|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83069858|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83069859|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83069860|NCT05340413|Olaparib|olaparib|mesh-list
83069861|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83069862|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069863|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069864|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069865|NCT05323955|Trastuzumab|trastuzumab|mesh-list
83069866|NCT05323955|Pertuzumab|pertuzumab|mesh-list
83069867|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83069868|NCT05323955|Maytansine|maytansine|mesh-list
83069869|NCT05323955|Tucatinib|tucatinib|mesh-list
83069870|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069871|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069872|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83069873|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83069874|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83069875|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83069876|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069877|NCT05323955|Immunotoxins|immunotoxins|mesh-ancestor
83069878|NCT05323955|Immunoconjugates|immunoconjugates|mesh-ancestor
83069879|NCT05323955|Immunologic Factors|immunologic factors|mesh-ancestor
83069880|NCT05323955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069881|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83069882|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069883|NCT05312385|Propofol|propofol|mesh-list
83069884|NCT05312385|Isoflurane|isoflurane|mesh-list
83069885|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83069886|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83069887|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069888|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83069889|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
83069890|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
83069891|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83069892|NCT05291338|Doxorubicin|doxorubicin|mesh-list
83069893|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
83069894|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83069895|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069896|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83069897|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83069898|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069899|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069900|NCT05291039|Adalimumab|adalimumab|mesh-list
83069901|NCT05291039|Infliximab|infliximab|mesh-list
83069902|NCT05291039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83069903|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83069904|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069905|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
83069906|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83069907|NCT05289193|Nivolumab|nivolumab|mesh-list
83069908|NCT05289193|Ipilimumab|ipilimumab|mesh-list
83069909|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069910|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069911|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069912|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069913|NCT05259137|Enalaprilat|enalaprilat|mesh-list
83069914|NCT05259137|Enalapril|enalapril|mesh-list
83069915|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83069916|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
83069917|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069918|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069919|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83069921|NCT05225558|Delpazolid|delpazolid|mesh-list
83069922|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
83069923|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83069924|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069925|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83069926|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069927|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069928|NCT05200988|Nivolumab|nivolumab|mesh-list
83069929|NCT05200988|Ipilimumab|ipilimumab|mesh-list
83069930|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069931|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069932|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069933|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069934|NCT05159830|Cannabidiol|cannabidiol|mesh-list
83069935|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
83069936|NCT05148715|Tacrolimus|tacrolimus|mesh-list
83069937|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069938|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
83069939|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069940|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83069941|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069942|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069943|NCT05121883|Edaravone|edaravone|mesh-list
83069944|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83069945|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
83069946|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069947|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83069948|NCT05121883|Protective Agents|protective agents|mesh-ancestor
83069949|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069950|NCT05112211|Doxycycline|doxycycline|mesh-list
83069951|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83069952|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069953|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
83069954|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83069955|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83069956|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83069957|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
83069958|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069959|NCT05107427|Avelumab|avelumab|mesh-list
83069960|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069961|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069962|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
83069963|NCT05104567|Cetuximab|cetuximab|mesh-list
83069964|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83069965|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069966|NCT05104567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83069967|NCT05104567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069968|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83069969|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83069970|NCT05036226|Metformin|metformin|mesh-list
83069971|NCT05036226|Sirolimus|sirolimus|mesh-list
83069972|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
83069973|NCT05036226|Nelfinavir|nelfinavir|mesh-list
83069974|NCT05036226|Temsirolimus|temsirolimus|mesh-list
83069975|NCT05036226|Dasatinib|dasatinib|mesh-list
83069976|NCT05036226|MTOR Inhibitors|mtor inhibitors|mesh-list
83069977|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83069978|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83069979|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83069980|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83069981|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83069982|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83069983|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
83069984|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83069985|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
83069986|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83069987|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83069988|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83069989|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
83069990|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83069991|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83069992|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83069993|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83069994|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83069995|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
83069996|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83069997|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83069998|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
83069999|NCT05035745|Talazoparib|talazoparib|mesh-list
83070000|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83070001|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070002|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070003|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070005|NCT05033080|Elexacaftor|elexacaftor|mesh-list
83070006|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83070007|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070008|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070009|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
83070010|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
83070011|NCT05005897|Vitamins|vitamins|mesh-ancestor
83070012|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
83070013|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070014|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
83070015|NCT05005897|Hematinics|hematinics|mesh-ancestor
83070016|NCT04994977|Carboplatin|carboplatin|mesh-list
83070017|NCT04994977|Melphalan|melphalan|mesh-list
83070018|NCT04994977|Topotecan|topotecan|mesh-list
83070019|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070020|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83070021|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
83070022|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070023|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83070024|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070025|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
83070026|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070027|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83070028|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83070029|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070030|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83070031|NCT04931615|Thrombin|thrombin|mesh-list
83070032|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
83070033|NCT04931615|Coagulants|coagulants|mesh-ancestor
83070034|NCT04878211|Interferons|interferons|mesh-list
83070035|NCT04878211|Ofatumumab|ofatumumab|mesh-list
83070036|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
83070037|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
83070038|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070039|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
83070040|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070041|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83070042|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
83070043|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070044|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070045|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070046|NCT04869943|Exemestane|exemestane|mesh-list
83070047|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070048|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83070049|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83070050|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070051|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070052|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83070053|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
83070054|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070055|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070056|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
83070057|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83070058|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
83070059|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070060|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
83070061|NCT04866706|Protective Agents|protective agents|mesh-ancestor
83070062|NCT04846478|Talazoparib|talazoparib|mesh-list
83070063|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83070064|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070065|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070066|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070067|NCT04844606|Mirikizumab|mirikizumab|mesh-list
83070068|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83070069|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83070070|NCT04844606|Analgesics|analgesics|mesh-ancestor
83070071|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
83070072|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070073|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070074|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070075|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070076|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83070077|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070078|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
83070079|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070080|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070081|NCT04834973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070082|NCT04834973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070083|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
83070084|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070085|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070086|NCT04798781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070087|NCT04798781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070088|NCT04764825|Morphine|morphine|mesh-list
83070089|NCT04764825|Methadone|methadone|mesh-list
83070090|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83070091|NCT04764825|Narcotics|narcotics|mesh-ancestor
83070092|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070093|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070094|NCT04764825|Analgesics|analgesics|mesh-ancestor
83070095|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
83070096|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070097|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
83070098|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
83070099|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
83070100|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83070101|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
83070102|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070103|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83070104|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
83070105|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070106|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
83070107|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070108|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83070109|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
83070110|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83070111|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
83070112|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070113|NCT04736199|Androgens|androgens|mesh-list
83070114|NCT04736199|Hormones|hormones|mesh-ancestor
83070115|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070116|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070117|NCT04706910|Furosemide|furosemide|mesh-list
83070118|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83070119|NCT04706910|Diuretics|diuretics|mesh-ancestor
83070120|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
83070121|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070122|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83070123|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070124|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070125|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
83070126|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070127|NCT04704271|Dronabinol|dronabinol|mesh-list
83070128|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
83070129|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070130|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83070132|NCT04704271|Analgesics|analgesics|mesh-ancestor
83070133|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
83070134|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070135|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83070136|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83070137|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070138|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070139|NCT04704271|Hormones|hormones|mesh-ancestor
83070140|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070141|NCT04693234|Tislelizumab|tislelizumab|mesh-list
83070142|NCT04693234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070143|NCT04693234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070144|NCT04680286|Methadone|methadone|mesh-list
83070145|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83070147|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070148|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070149|NCT04680286|Analgesics|analgesics|mesh-ancestor
83070150|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
83070151|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070152|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
83070153|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
83070154|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83070155|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83070156|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070157|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070158|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
83070159|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070160|NCT04672018|Omeprazole|omeprazole|mesh-list
83070161|NCT04672018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83070162|NCT04672018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070163|NCT04672018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83070164|NCT04672018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070165|NCT04672018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070166|NCT04665570|Metformin|metformin|mesh-list
83070167|NCT04665570|Acarbose|acarbose|mesh-list
83070168|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83070169|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070170|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83070171|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070172|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070173|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83070174|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
83070175|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83070176|NCT04656184|Antibodies|antibodies|mesh-list
83070177|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
83070178|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83070179|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
83070180|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070181|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070182|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
83070183|NCT04638881|Analgesics|analgesics|mesh-ancestor
83070184|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
83070185|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070186|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070187|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
83070188|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070189|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83070190|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
83070191|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83070192|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070193|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070194|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83070195|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
83070196|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83070197|NCT04627753|Rituximab|rituximab|mesh-list
83070198|NCT04627753|Lenalidomide|lenalidomide|mesh-list
83070199|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070200|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070201|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
83070202|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070203|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070204|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83070205|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83070206|NCT04627753|Growth Substances|growth substances|mesh-ancestor
83070207|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
83070208|NCT04569032|Prednisone|prednisone|mesh-list
83070209|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
83070210|NCT04569032|Doxorubicin|doxorubicin|mesh-list
83070211|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83070212|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070213|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
83070214|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070215|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070216|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83070217|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
83070218|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070219|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070220|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83070221|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83070222|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83070223|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83070224|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070225|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070226|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
83070227|NCT04569032|Hormones|hormones|mesh-ancestor
83070228|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070229|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83070230|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070231|NCT04569032|Immunotoxins|immunotoxins|mesh-ancestor
83070232|NCT04569032|Immunoconjugates|immunoconjugates|mesh-ancestor
83070233|NCT04564612|Itraconazole|itraconazole|mesh-list
83070234|NCT04564612|Rabeprazole|rabeprazole|mesh-list
83070235|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
83070236|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070237|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83070238|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83070239|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070240|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070241|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83070242|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
83070243|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070244|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070245|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83070246|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83070247|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070248|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83070249|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83070250|NCT04549311|Amoxicillin|amoxicillin|mesh-list
83070251|NCT04549311|Metronidazole|metronidazole|mesh-list
83070252|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
83070253|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
83070254|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
83070255|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83070256|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83070257|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070258|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
83070259|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83070260|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83070261|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83070262|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83070263|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070264|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070265|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070266|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83070267|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83070268|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83070269|NCT04533451|Carboplatin|carboplatin|mesh-list
83070270|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
83070271|NCT04533451|Pemetrexed|pemetrexed|mesh-list
83070272|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070273|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070274|NCT04533451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070275|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070276|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070277|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83070278|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83070279|NCT04518319|Olanzapine|olanzapine|mesh-list
83070280|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
83070281|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
83070282|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070283|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070284|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070285|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83070286|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83070287|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070288|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83070289|NCT04518319|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83070290|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83070291|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070292|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070293|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070294|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
83070295|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
83070296|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83070297|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83070298|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070299|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
83070300|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
83070301|NCT04495868|Lidocaine|lidocaine|mesh-list
83070302|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
83070303|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
83070304|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070305|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070306|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
83070307|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070308|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83070309|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83070310|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83070311|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070312|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070313|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
83070314|NCT04483544|Olaparib|olaparib|mesh-list
83070315|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070316|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070317|NCT04483544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070318|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070319|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83070320|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070321|NCT04475029|Morphine|morphine|mesh-list
83070322|NCT04475029|Methadone|methadone|mesh-list
83070323|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83070324|NCT04475029|Narcotics|narcotics|mesh-ancestor
83070325|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070326|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070327|NCT04475029|Analgesics|analgesics|mesh-ancestor
83070328|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
83070329|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070330|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
83070331|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
83070332|NCT04457089|Simvastatin|simvastatin|mesh-list
83070333|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83070334|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83070335|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
83070336|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070337|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83070338|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83070339|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070340|NCT04455750|Leuprolide|leuprolide|mesh-list
83070341|NCT04455750|Goserelin|goserelin|mesh-list
83070342|NCT04455750|Rucaparib|rucaparib|mesh-list
83070343|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83070344|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
83070345|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83070346|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070347|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83070348|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070349|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83070350|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070351|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070352|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
83070353|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83070354|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070356|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83070357|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83070358|NCT04402385|Analgesics|analgesics|mesh-ancestor
83070359|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
83070360|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070361|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070362|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070363|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070364|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83070365|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83482362|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83070366|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070367|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83070368|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83070369|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070370|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
83070371|NCT04311502|Pyridoxine|pyridoxine|mesh-list
83070372|NCT04311502|Pyridoxal|pyridoxal|mesh-list
83070373|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
83070374|NCT04311502|Rifampin|rifampin|mesh-list
83070375|NCT04311502|Rifapentine|rifapentine|mesh-list
83070376|NCT04311502|Clofazimine|clofazimine|mesh-list
83070377|NCT04311502|Isoniazid|isoniazid|mesh-list
83070378|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
83070379|NCT04311502|Ethambutol|ethambutol|mesh-list
83070380|NCT04311502|Vitamins|vitamins|mesh-ancestor
83070381|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
83070382|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070383|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
83070384|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83070385|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
83070386|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83070387|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070388|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
83070389|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83070390|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070391|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070392|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83070393|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83070394|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83070395|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83070396|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83070397|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83070398|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83070399|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83070400|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
83070401|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83070402|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070403|NCT04307485|Ticagrelor|ticagrelor|mesh-list
83070404|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83070405|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83070406|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83070407|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83070408|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
83070409|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070410|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070411|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070412|NCT04289467|Fenfluramine|fenfluramine|mesh-list
83070413|NCT04289467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83070414|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83070415|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070416|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070417|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070418|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
83070419|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070420|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
83070421|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
83070422|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83070423|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070424|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070425|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
83070426|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83070427|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070428|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070430|NCT04253561|Pertuzumab|pertuzumab|mesh-list
83070431|NCT04253561|Ipatasertib|ipatasertib|mesh-list
83070432|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070433|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070434|NCT04253561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83070435|NCT04253561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070436|NCT04253561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070437|NCT04248569|Nivolumab|nivolumab|mesh-list
83070438|NCT04248569|Ipilimumab|ipilimumab|mesh-list
83070439|NCT04248569|Poly ICLC|poly iclc|mesh-list
83070440|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070441|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070442|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070443|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070444|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
83070445|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
83070446|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070447|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
83070448|NCT04240171|Glimepiride|glimepiride|mesh-list
83070449|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83439702|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070450|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070451|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83070452|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070453|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83070454|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070455|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
83070456|NCT04191616|Dexamethasone|dexamethasone|mesh-list
83070457|NCT04191616|Pomalidomide|pomalidomide|mesh-list
83070458|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070459|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
83070460|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
83070461|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070462|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070463|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070464|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
83070465|NCT04191616|Hormones|hormones|mesh-ancestor
83070466|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070467|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83070468|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070469|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
83070470|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83070471|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83070472|NCT04191616|Growth Substances|growth substances|mesh-ancestor
83070473|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
83070474|NCT04170738|Amphetamine|amphetamine|mesh-list
83070475|NCT04170738|Adderall|adderall|mesh-list
83070476|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
83070477|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83070478|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070479|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
83070480|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
83070481|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070482|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
83070483|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070484|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070485|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
83070486|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83070487|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83070488|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070489|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83070490|NCT04094142|Lenalidomide|lenalidomide|mesh-list
83070491|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
83070492|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070493|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
83070494|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070495|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83070496|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83070497|NCT04094142|Growth Substances|growth substances|mesh-ancestor
83070498|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
83070499|NCT04089514|Adalimumab|adalimumab|mesh-list
83070500|NCT04089514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83070501|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070502|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070503|NCT04088409|Adalimumab|adalimumab|mesh-list
83070504|NCT04088409|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83070505|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070506|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070507|NCT04084314|Erenumab|erenumab|mesh-list
83070508|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83070509|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070510|NCT04084314|Analgesics|analgesics|mesh-ancestor
83070511|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
83070512|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070513|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070514|NCT04068207|Minocycline|minocycline|mesh-list
83070515|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83070516|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070517|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
83070518|NCT04024761|Fludarabine|fludarabine|mesh-list
83070519|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070520|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
83070521|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070522|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070523|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83070524|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
83070525|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070526|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070527|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83070528|NCT04015180|Aflibercept|aflibercept|mesh-list
83070529|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83070530|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83070531|NCT04015180|Growth Substances|growth substances|mesh-ancestor
83070532|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070533|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
83070534|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070535|NCT04013854|Nivolumab|nivolumab|mesh-list
83070536|NCT04013854|Ipilimumab|ipilimumab|mesh-list
83070537|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070538|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070539|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070540|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070541|NCT04004988|Tirzepatide|tirzepatide|mesh-list
83070542|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83070543|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070544|NCT04004988|Incretins|incretins|mesh-ancestor
83070545|NCT04004988|Hormones|hormones|mesh-ancestor
83070546|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070547|NCT03950817|Ketamine|ketamine|mesh-list
83070548|NCT03950817|Analgesics|analgesics|mesh-ancestor
83070549|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
83070550|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070551|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070552|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83070553|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83070554|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
83070555|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
83070556|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070557|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83070558|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83070559|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070560|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070561|NCT03934840|Prednisone|prednisone|mesh-list
83070562|NCT03934840|Carboplatin|carboplatin|mesh-list
83070563|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070564|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070565|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
83070566|NCT03934840|Hormones|hormones|mesh-ancestor
83070567|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070568|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070569|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83070570|NCT03909165|Atropine|atropine|mesh-list
83070571|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
83070572|NCT03909165|Neostigmine|neostigmine|mesh-list
83070573|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83070574|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83070575|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83070576|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
83070577|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070578|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070579|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83070580|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
83070581|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
83070582|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
83070583|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83070584|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83070585|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
83070586|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070587|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070588|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83070589|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070590|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83070591|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
83070592|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83070593|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
83070594|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
83070595|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070596|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070597|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83070598|NCT03879538|Analgesics|analgesics|mesh-ancestor
83070599|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
83070600|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070602|NCT03800134|Cisplatin|cisplatin|mesh-list
83070603|NCT03800134|Carboplatin|carboplatin|mesh-list
83070604|NCT03800134|Gemcitabine|gemcitabine|mesh-list
83070605|NCT03800134|Pemetrexed|pemetrexed|mesh-list
83070606|NCT03800134|Durvalumab|durvalumab|mesh-list
83070607|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83070608|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070609|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
83070610|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
83070611|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
83070612|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070613|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83070614|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
83070615|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070616|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83070617|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83070618|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070619|NCT03783442|Paclitaxel|paclitaxel|mesh-list
83070620|NCT03783442|Fluorouracil|fluorouracil|mesh-list
83070621|NCT03783442|Capecitabine|capecitabine|mesh-list
83070622|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
83070623|NCT03783442|Tislelizumab|tislelizumab|mesh-list
83070624|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83070625|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070626|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83070627|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83070628|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83070629|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070630|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
83070631|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83070632|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070633|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
83070634|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070635|NCT03783442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070636|NCT03781765|Methylphenidate|methylphenidate|mesh-list
83070637|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83070638|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83070639|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070640|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83070641|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83070642|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070643|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070644|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
83070645|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070646|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83070647|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83070648|NCT03781752|Methylphenidate|methylphenidate|mesh-list
83070649|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83070650|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070651|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83070652|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83070653|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070654|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070655|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
83070656|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070657|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
83070658|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83070659|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
83070660|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83070661|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
83070662|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070663|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070664|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
83070665|NCT03718065|Lofexidine|lofexidine|mesh-list
83070666|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83070667|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83070668|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070669|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
83070670|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439707|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
83070671|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83070672|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83070673|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83070674|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
83070675|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070676|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070677|NCT03714958|Trametinib|trametinib|mesh-list
83070678|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070679|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83070680|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070681|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070682|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
83070683|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83070684|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070685|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070686|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83070687|NCT03708315|Analgesics|analgesics|mesh-ancestor
83070688|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
83070689|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070690|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83070691|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83070692|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83070693|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
83070694|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070695|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070696|NCT03693300|Durvalumab|durvalumab|mesh-list
83070697|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070698|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070699|NCT03582033|Dexamethasone|dexamethasone|mesh-list
83070700|NCT03582033|Pomalidomide|pomalidomide|mesh-list
83070701|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070702|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
83070703|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
83070704|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070705|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070706|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070707|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
83070708|NCT03582033|Hormones|hormones|mesh-ancestor
83070709|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070710|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83070711|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070712|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
83070713|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83070714|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83070715|NCT03582033|Growth Substances|growth substances|mesh-ancestor
83070716|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
83070717|NCT03579966|Amifampridine|amifampridine|mesh-list
83070718|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83070719|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070720|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070721|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83070722|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070723|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361804|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361805|NCT02653144|Dexamethasone|dexamethasone|mesh-list
83361806|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
83361807|NCT02653144|Ropivacaine|ropivacaine|mesh-list
83361808|NCT02653144|Anesthetics|anesthetics|mesh-list
83070724|NCT03551691|Omeprazole|omeprazole|mesh-list
83070725|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83070726|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070727|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83070728|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070729|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070730|NCT03543189|Nivolumab|nivolumab|mesh-list
83070731|NCT03543189|Androgens|androgens|mesh-list
83070732|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070733|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070734|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83361809|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83361810|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
83361811|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
83361812|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361813|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361814|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83361815|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
83070735|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070736|NCT03543189|Hormones|hormones|mesh-ancestor
83070737|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070738|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070739|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83070740|NCT03510208|Panitumumab|panitumumab|mesh-list
83070741|NCT03510208|Antibodies|antibodies|mesh-list
83070742|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
83070743|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83070744|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
83070745|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070746|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070747|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83070748|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83070749|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83070750|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83070751|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83070752|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83070753|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83070754|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
83070755|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070756|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070757|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070758|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83070759|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070760|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
83070761|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83070762|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070763|NCT03507699|Nivolumab|nivolumab|mesh-list
83070764|NCT03507699|Ipilimumab|ipilimumab|mesh-list
83070765|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070766|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070767|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070768|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070769|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
83070770|NCT03497923|Analgesics|analgesics|mesh-ancestor
83070771|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
83070772|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070773|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070774|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
83070775|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070776|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83070777|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
83070778|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83070779|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070780|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070781|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83070782|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
83070783|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83070784|NCT03493685|Irbesartan|irbesartan|mesh-list
83070785|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83070786|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83070787|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83070788|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070790|NCT03383692|Itraconazole|itraconazole|mesh-list
83070791|NCT03383692|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83070792|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83070793|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83070794|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
83070795|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83439719|NCT00551447|Ezetimibe|ezetimibe|mesh-list
83070796|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070797|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83070798|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83070799|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
83070800|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070801|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83070802|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83070803|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
83070804|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83070805|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83070806|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
83070807|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070808|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070809|NCT03383692|Immunoconjugates|immunoconjugates|mesh-ancestor
83070810|NCT03383692|Immunologic Factors|immunologic factors|mesh-ancestor
83070811|NCT03377387|Capecitabine|capecitabine|mesh-list
83070812|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83070813|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
83070814|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070815|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070816|NCT03372837|Rituximab|rituximab|mesh-list
83070817|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070818|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070819|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
83070820|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070821|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070822|NCT03312699|Vaccines|vaccines|mesh-list
83070823|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
83070824|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070825|NCT03300557|Exemestane|exemestane|mesh-list
83070826|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070827|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83070828|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83070829|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070830|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070831|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83070832|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
83070833|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070834|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070835|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
83070836|NCT03290079|Lenvatinib|lenvatinib|mesh-list
83070837|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070838|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070839|NCT03290079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070840|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070841|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83070842|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070843|NCT03269136|Thalidomide|thalidomide|mesh-list
83070844|NCT03269136|Dexamethasone|dexamethasone|mesh-list
83070845|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
83070846|NCT03269136|Lenalidomide|lenalidomide|mesh-list
83070847|NCT03269136|Pomalidomide|pomalidomide|mesh-list
83070848|NCT03269136|Antibodies|antibodies|mesh-list
83070849|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
83070850|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83070851|NCT03269136|BB 1101|bb 1101|mesh-list
83070852|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
83070853|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070854|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070855|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
83070856|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
83070857|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070858|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83070859|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
83070860|NCT03269136|Hormones|hormones|mesh-ancestor
83361817|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83361818|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83361819|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361820|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83361821|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361822|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83361823|NCT02653144|Analgesics|analgesics|mesh-ancestor
83361824|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
83361825|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83361826|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83070861|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83070862|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83070863|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070864|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
83070865|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070866|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070867|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83070868|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83070869|NCT03269136|Growth Substances|growth substances|mesh-ancestor
83070870|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
83070871|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070872|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
83070873|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83070874|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070875|NCT03261284|Heparin|heparin|mesh-list
83070876|NCT03261284|Calcium heparin|calcium heparin|mesh-list
83070877|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
83070878|NCT03261284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83070879|NCT03261284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83070880|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070881|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
83070882|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
83070883|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070884|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070885|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070886|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
83070887|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
83070888|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
83070889|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
83070890|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
83070891|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070892|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83070893|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070894|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83070895|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
83070896|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070897|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070898|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83070899|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83070900|NCT03219450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83070901|NCT03198078|Aripiprazole|aripiprazole|mesh-list
83070902|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
83070903|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
83070904|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83070905|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83070906|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83070907|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070908|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070909|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
83070910|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
83070911|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070912|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070913|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83070914|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83070915|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
83070916|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83070917|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83070918|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83070919|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83070920|NCT03177291|Pirfenidone|pirfenidone|mesh-list
83070921|NCT03177291|Paclitaxel|paclitaxel|mesh-list
83070922|NCT03177291|Carboplatin|carboplatin|mesh-list
83070923|NCT03177291|Pemetrexed|pemetrexed|mesh-list
83070924|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83070925|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070926|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83070927|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83361827|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83361828|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
83361829|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361830|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361831|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
83361832|NCT00118365|Eflornithine|eflornithine|mesh-list
83070928|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83070929|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070930|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070931|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83070932|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83070933|NCT03177291|Analgesics|analgesics|mesh-ancestor
83070934|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
83070935|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070936|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070937|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83070939|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83070940|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83070941|NCT03127267|Riluzole|riluzole|mesh-list
83070942|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
83070943|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83070944|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83070945|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83070946|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070947|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070948|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83070949|NCT03127267|Protective Agents|protective agents|mesh-ancestor
83070950|NCT03092466|Ropivacaine|ropivacaine|mesh-list
83070951|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
83070952|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
83070953|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070954|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070955|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
83070956|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070957|NCT03017872|Ritonavir|ritonavir|mesh-list
83070958|NCT03017872|Darunavir|darunavir|mesh-list
83070959|NCT03017872|Dolutegravir|dolutegravir|mesh-list
83070960|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83070961|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83070962|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
83070963|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070964|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070965|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83070966|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83070967|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
83070968|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83070969|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83070970|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83070971|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83070972|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83070973|NCT03000205|Lidocaine|lidocaine|mesh-list
83070974|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
83070975|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
83070976|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83070977|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83070978|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
83070979|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83070980|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83070981|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83070982|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83070983|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83070984|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070985|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83070986|NCT02942095|Ixazomib|ixazomib|mesh-list
83070987|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83070988|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83070989|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83070996|NCT02882282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83070998|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
83070999|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83071000|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071001|NCT02781519|Dronabinol|dronabinol|mesh-list
83071002|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
83071003|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071004|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83071005|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83071006|NCT02781519|Analgesics|analgesics|mesh-ancestor
83071007|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
83071008|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071009|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83071010|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83071011|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071012|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071013|NCT02781519|Hormones|hormones|mesh-ancestor
83482363|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83071014|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071015|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
83071016|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071017|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071018|NCT02706353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83071019|NCT02706353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071028|NCT02650401|Entrectinib|entrectinib|mesh-list
83071029|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83071030|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071031|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071032|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
83071033|NCT02638090|Vorinostat|vorinostat|mesh-list
83071034|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071035|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071036|NCT02638090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83071037|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071038|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83071039|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071040|NCT02617277|Durvalumab|durvalumab|mesh-list
83071041|NCT02617277|Adavosertib|adavosertib|mesh-list
83071042|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071043|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071044|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071045|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071046|NCT02584465|Tamoxifen|tamoxifen|mesh-list
83071047|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83071048|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
83071049|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071050|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071051|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071052|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071053|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83071054|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83071055|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83071056|NCT02536664|Rituximab|rituximab|mesh-list
83071057|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071058|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071059|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
83071060|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071061|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071062|NCT02426892|Nivolumab|nivolumab|mesh-list
83071063|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071064|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071065|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83071066|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071067|NCT02375555|Dexamethasone|dexamethasone|mesh-list
83071068|NCT02375555|Lenalidomide|lenalidomide|mesh-list
83071069|NCT02375555|Bortezomib|bortezomib|mesh-list
83071070|NCT02375555|Elotuzumab|elotuzumab|mesh-list
83071071|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83071072|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
83071073|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
83071074|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071075|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071076|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83071077|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
83071078|NCT02375555|Hormones|hormones|mesh-ancestor
83071079|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071080|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071081|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071082|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
83071083|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83071084|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83071085|NCT02375555|Growth Substances|growth substances|mesh-ancestor
83071086|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
83071087|NCT02364713|Paclitaxel|paclitaxel|mesh-list
83071088|NCT02364713|Bevacizumab|bevacizumab|mesh-list
83071089|NCT02364713|Gemcitabine|gemcitabine|mesh-list
83071090|NCT02364713|Doxorubicin|doxorubicin|mesh-list
83071091|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83071092|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83071093|NCT02364713|Topotecan|topotecan|mesh-list
83071094|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83071095|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
83071096|NCT02364713|Antibodies|antibodies|mesh-list
83071097|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
83071098|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83071099|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
83071100|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83071101|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071102|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
83071103|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
83071104|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
83071105|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071106|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83071107|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83071108|NCT02364713|Growth Substances|growth substances|mesh-ancestor
83071109|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071110|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
83071111|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
83071112|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83071113|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
83071114|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83071115|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83071116|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83071117|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071118|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83071119|NCT02231775|Trametinib|trametinib|mesh-list
83071120|NCT02231775|Dabrafenib|dabrafenib|mesh-list
83071121|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071122|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83071123|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071124|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071125|NCT02107703|Fulvestrant|fulvestrant|mesh-list
83071126|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071127|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071128|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83071129|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83071130|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
83071131|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071132|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071133|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
83071134|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83071135|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
83071136|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071137|NCT02094625|Expectorants|expectorants|mesh-ancestor
83071138|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
83071139|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83071140|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
83071141|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071142|NCT02094625|Protective Agents|protective agents|mesh-ancestor
83071143|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071144|NCT02094625|Antidotes|antidotes|mesh-ancestor
83071145|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
83071146|NCT02054520|Nivolumab|nivolumab|mesh-list
83071147|NCT02054520|Ipilimumab|ipilimumab|mesh-list
83071148|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071149|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071150|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83071151|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071152|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
83071153|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83071154|NCT01922921|Trastuzumab|trastuzumab|mesh-list
83071155|NCT01922921|Pertuzumab|pertuzumab|mesh-list
83071156|NCT01922921|Antibodies|antibodies|mesh-list
83071157|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
83071158|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83071159|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
83071160|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071161|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071162|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83071163|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83071164|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
83071165|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071166|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
83071167|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83071168|NCT01922921|Protective Agents|protective agents|mesh-ancestor
83071169|NCT01546987|Leuprolide|leuprolide|mesh-list
83071170|NCT01546987|Goserelin|goserelin|mesh-list
83071171|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83071173|NCT01546987|Bicalutamide|bicalutamide|mesh-list
83071174|NCT01546987|Buserelin|buserelin|mesh-list
83071175|NCT01546987|Androgens|androgens|mesh-list
83071176|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-list
83071177|NCT01546987|Hormones|hormones|mesh-ancestor
83071178|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071179|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071180|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83071181|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
83071182|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83071183|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071184|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071185|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
83071186|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
83071187|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83071188|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
83071189|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83071190|NCT01012817|Topotecan|topotecan|mesh-list
83071191|NCT01012817|Veliparib|veliparib|mesh-list
83071192|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83071193|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83071194|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071195|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071196|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071197|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83071198|NCT00977691|Sirolimus|sirolimus|mesh-list
83071199|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
83071200|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
83071201|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83071202|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
83071203|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071204|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071205|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83071206|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
83071207|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071208|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071209|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83071210|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83071211|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071212|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83071213|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
83071214|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071215|NCT00676715|Interferons|interferons|mesh-list
83071216|NCT00676715|Interferon-beta|interferon-beta|mesh-list
83071217|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
83071218|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071219|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
83071220|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071221|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
83071222|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071223|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
83071224|NCT00588185|Testosterone|testosterone|mesh-list
83071225|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
83071226|NCT00588185|Androgens|androgens|mesh-ancestor
83071227|NCT00588185|Hormones|hormones|mesh-ancestor
83071228|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071229|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071230|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
83071231|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071232|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
83071233|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071234|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
83071235|NCT00268476|Metformin|metformin|mesh-list
83071236|NCT00268476|Prednisone|prednisone|mesh-list
83071237|NCT00268476|Prednisolone|prednisolone|mesh-list
83071238|NCT00268476|Celecoxib|celecoxib|mesh-list
83071239|NCT00268476|Docetaxel|docetaxel|mesh-list
83071240|NCT00268476|Estradiol|estradiol|mesh-list
83071241|NCT00268476|Androgens|androgens|mesh-list
83071242|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83071243|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071244|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071245|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
83071246|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
83071247|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
83071248|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482364|NCT05271084|Protective Agents|protective agents|mesh-ancestor
83071249|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83071250|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
83071251|NCT00268476|Hormones|hormones|mesh-ancestor
83071252|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071253|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071254|NCT00268476|Estrogens|estrogens|mesh-ancestor
83071255|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071256|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83071257|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83071258|NCT00268476|Analgesics|analgesics|mesh-ancestor
83071259|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
83071260|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071261|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83071262|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83071263|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071264|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83071265|NCT00261443|Valproic Acid|valproic acid|mesh-list
83071266|NCT00261443|Aripiprazole|aripiprazole|mesh-list
83071267|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
83071268|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
83071269|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83071270|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83071271|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83071272|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071273|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071274|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
83071275|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
83071276|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071277|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071278|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83071279|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83071280|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
83071281|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83071282|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83071283|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83071284|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83071285|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071286|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
83071287|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
83071288|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
83071289|NCT00093379|Capecitabine|capecitabine|mesh-list
83071290|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
83071291|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83071292|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
83071293|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071294|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071296|NCT00000524|Prednisone|prednisone|mesh-list
83071297|NCT00000524|Cyclosporins|cyclosporins|mesh-list
83071298|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83071299|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
83071300|NCT00000524|Hormones|hormones|mesh-ancestor
83071301|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071302|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071303|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071304|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071305|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071306|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071307|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83071308|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
83071309|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
83071310|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071311|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
83071312|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071313|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83071314|NCT02099331|Melatonin|melatonin|mesh-list
83071315|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
83071316|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071317|NCT02099331|Protective Agents|protective agents|mesh-ancestor
83071318|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071319|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071320|NCT05328388|Lycopene|lycopene|mesh-list
83071321|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83071322|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
83071323|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071324|NCT05328388|Protective Agents|protective agents|mesh-ancestor
83071325|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071326|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83071327|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83071328|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071329|NCT02097069|Folic Acid|folic acid|mesh-list
83071330|NCT02097069|Inositol|inositol|mesh-list
83071331|NCT02097069|Hematinics|hematinics|mesh-ancestor
83071332|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
83071333|NCT02097069|Vitamins|vitamins|mesh-ancestor
83071334|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
83071335|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071336|NCT03424226|Acetazolamide|acetazolamide|mesh-list
83071337|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
83071338|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83071339|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071340|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071341|NCT03424226|Diuretics|diuretics|mesh-ancestor
83071342|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
83071343|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071344|NCT02250729|Pholcodine|pholcodine|mesh-list
83071345|NCT02250729|Analgesics|analgesics|mesh-ancestor
83071346|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
83071347|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071348|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071349|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
83071350|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
83071351|NCT02097147|Paroxetine|paroxetine|mesh-list
83071352|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83071353|NCT02097147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83071354|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83071355|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83071356|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071357|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071358|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
83071359|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071360|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83071361|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
83071362|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83071363|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83071364|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83071365|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071366|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83071367|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83071369|NCT00304070|Doxorubicin|doxorubicin|mesh-list
83071370|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83071371|NCT00304070|Etoposide|etoposide|mesh-list
83071372|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
83071373|NCT00304070|Podophyllotoxin|podophyllotoxin|mesh-list
83071374|NCT00304070|Mitotane|mitotane|mesh-list
83071375|NCT00304070|Lenograstim|lenograstim|mesh-list
83071376|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071377|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83071378|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83071379|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83071380|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071381|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071382|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83071383|NCT00304070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83071384|NCT00304070|Immunologic Factors|immunologic factors|mesh-ancestor
83071385|NCT00304070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071386|NCT00304070|Keratolytic Agents|keratolytic agents|mesh-ancestor
83071387|NCT00304070|Dermatologic Agents|dermatologic agents|mesh-ancestor
83071388|NCT00304070|Tubulin Modulators|tubulin modulators|mesh-ancestor
83071389|NCT00304070|Antimitotic Agents|antimitotic agents|mesh-ancestor
83071390|NCT00304070|Mitosis Modulators|mitosis modulators|mesh-ancestor
83071391|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071392|NCT03556839|Paclitaxel|paclitaxel|mesh-list
83071393|NCT03556839|Bevacizumab|bevacizumab|mesh-list
83071394|NCT03556839|Carboplatin|carboplatin|mesh-list
83071395|NCT03556839|Atezolizumab|atezolizumab|mesh-list
83071396|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83071397|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071398|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
83071399|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
83071400|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
83071401|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071402|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071403|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83071404|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83071405|NCT03556839|Growth Substances|growth substances|mesh-ancestor
83071406|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071407|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
83071408|NCT03556839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83071409|NCT03415802|Paclitaxel|paclitaxel|mesh-list
83071410|NCT03415802|Tegafur|tegafur|mesh-list
83071411|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83071412|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071413|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
83071414|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
83071415|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
83071416|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071417|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83071418|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
83071419|NCT02099877|Fentanyl|fentanyl|mesh-list
83071420|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83071421|NCT02099877|Narcotics|narcotics|mesh-ancestor
83071422|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071423|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071424|NCT02099877|Analgesics|analgesics|mesh-ancestor
83071425|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
83071426|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071427|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83071428|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83071429|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
83071430|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
83071431|NCT02097381|Ritonavir|ritonavir|mesh-list
83071432|NCT02097381|Lopinavir|lopinavir|mesh-list
83071433|NCT02097381|Darunavir|darunavir|mesh-list
83071434|NCT02097381|Tenofovir|tenofovir|mesh-list
83071435|NCT02097381|Emtricitabine|emtricitabine|mesh-list
83071436|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83071437|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83071438|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
83071439|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071440|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071441|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83071442|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83071443|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
83071444|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071445|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83071446|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83071447|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83071448|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83071449|NCT02099955|Vitamin D|vitamin d|mesh-list
83071450|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
83071451|NCT02099955|Vitamins|vitamins|mesh-ancestor
83071452|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
83071453|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071454|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83071455|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83071456|NCT02097459|Tamoxifen|tamoxifen|mesh-list
83071457|NCT02097459|Toremifene|toremifene|mesh-list
83071458|NCT02097459|Anastrozole|anastrozole|mesh-list
83071459|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83071460|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
83071461|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071462|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071463|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071464|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071465|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83071466|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83071467|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83071468|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83071469|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83071470|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071471|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071472|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
83071473|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83071474|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83071475|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071476|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
83071477|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
83071478|NCT02590432|Linaclotide|linaclotide|mesh-list
83071479|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83071480|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
83071481|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071482|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83071483|NCT02094339|Analgesics|analgesics|mesh-list
83071484|NCT02094339|Ropivacaine|ropivacaine|mesh-list
83071485|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
83071486|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
83071487|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071488|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071489|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
83071490|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071491|NCT03415646|Morphine|morphine|mesh-list
83071492|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83071493|NCT03415646|Narcotics|narcotics|mesh-ancestor
83071494|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071495|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071496|NCT03415646|Analgesics|analgesics|mesh-ancestor
83071497|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
83071498|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071499|NCT03417518|Propofol|propofol|mesh-list
83071500|NCT03417518|Desflurane|desflurane|mesh-list
83071501|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83071502|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071503|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071504|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83071505|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
83071506|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
83071507|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83071508|NCT05169554|Amoxicillin|amoxicillin|mesh-list
83071509|NCT05169554|Clarithromycin|clarithromycin|mesh-list
83071510|NCT05169554|Rifampin|rifampin|mesh-list
83071511|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
83071512|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
83071513|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83071514|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83071515|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071516|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83071517|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071518|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071519|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83071520|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83071522|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
83071523|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
83071524|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83071525|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83071526|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83071527|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83071528|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83071529|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83071530|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83071531|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83071534|NCT02094651|Valproic Acid|valproic acid|mesh-list
83071535|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
83071536|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071537|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071538|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
83071539|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071540|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071541|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
83071542|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83071543|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071544|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83071545|NCT02094807|Acetaminophen|acetaminophen|mesh-list
83071546|NCT02094807|Diclofenac|diclofenac|mesh-list
83071547|NCT02094807|Oxycodone|oxycodone|mesh-list
83071548|NCT02094807|Tramadol|tramadol|mesh-list
83071549|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071550|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071551|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83071552|NCT02094807|Analgesics|analgesics|mesh-ancestor
83071553|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
83071554|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071555|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
83071556|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83071557|NCT02094807|Narcotics|narcotics|mesh-ancestor
83071558|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83071559|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83071560|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071561|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83071562|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071563|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071564|NCT05139472|Empagliflozin|empagliflozin|mesh-list
83071565|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83071566|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071567|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83071568|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071569|NCT04757090|Trastuzumab|trastuzumab|mesh-list
83071570|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071571|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071572|NCT03397862|Donepezil|donepezil|mesh-list
83071573|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83071574|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071575|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071576|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
83071577|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071578|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071579|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
83071580|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
83071581|NCT02100267|Miotics|miotics|mesh-ancestor
83071582|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
83071583|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071584|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071585|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83071586|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83071587|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
83071588|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83071589|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83071590|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
83071591|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071592|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071593|NCT02094963|Clopidogrel|clopidogrel|mesh-list
83071594|NCT02094963|Ticagrelor|ticagrelor|mesh-list
83071595|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83071596|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83071597|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83071598|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83071599|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
83071600|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071601|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071602|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071603|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83071604|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83071605|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071606|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
83071607|NCT02098317|Vitamin D|vitamin d|mesh-list
83071608|NCT02098317|Vitamins|vitamins|mesh-ancestor
83071609|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
83071610|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071611|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83071612|NCT02100423|Vitamin D|vitamin d|mesh-list
83071613|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
83071614|NCT02100423|Curcumin|curcumin|mesh-list
83071615|NCT02100423|Vitamins|vitamins|mesh-ancestor
83071616|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
83071617|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071618|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83071619|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83071620|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83071621|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83071622|NCT02100423|Analgesics|analgesics|mesh-ancestor
83071623|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
83071624|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071625|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83071626|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071627|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071628|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071629|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071630|NCT05614648|Clonidine|clonidine|mesh-list
83071631|NCT05614648|Analgesics|analgesics|mesh-ancestor
83071632|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
83071633|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071634|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071635|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83071636|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
83071637|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
83071638|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83071639|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83071640|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83071641|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
83071642|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071643|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071644|NCT02520752|Midazolam|midazolam|mesh-list
83071645|NCT02520752|Caffeine|caffeine|mesh-list
83071646|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83071647|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83071648|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071649|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071650|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83071651|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83071652|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83071653|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83071654|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
83071655|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
83071656|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
83071657|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
83071658|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071659|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071660|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83071661|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83071662|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071663|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83071664|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83071665|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
83071666|NCT02095119|Gemcitabine|gemcitabine|mesh-list
83071667|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
83071668|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071669|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83071670|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
83071671|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071672|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071673|NCT02098629|Milrinone|milrinone|mesh-list
83071674|NCT02098629|Esmolol|esmolol|mesh-list
83071675|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83071676|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83071677|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83071678|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
83071679|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071680|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071681|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071682|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83071683|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83071684|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83071685|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83071686|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83071687|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071688|NCT02098629|Protective Agents|protective agents|mesh-ancestor
83071689|NCT02095509|Enoxaparin|enoxaparin|mesh-list
83071690|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
83071691|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83071692|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83071693|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071694|NCT03397082|Lidocaine|lidocaine|mesh-list
83071695|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
83071696|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
83071697|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071698|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071699|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
83071700|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071701|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83071702|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83071703|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83482365|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
83071704|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83071705|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071706|NCT02101047|Phenylephrine|phenylephrine|mesh-list
83071707|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
83071708|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83071709|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
83071710|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
83071711|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071712|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071713|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
83071714|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83071715|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
83071716|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83071717|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83071718|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83071719|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83071720|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83071721|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071722|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071723|NCT02101047|Protective Agents|protective agents|mesh-ancestor
83071724|NCT02095665|Acetaminophen|acetaminophen|mesh-list
83071725|NCT02095665|Tamsulosin|tamsulosin|mesh-list
83071726|NCT02095665|Mirabegron|mirabegron|mesh-list
83071727|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83071728|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83071729|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83071730|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
83071731|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071732|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071733|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071734|NCT02095665|Urological Agents|urological agents|mesh-ancestor
83071735|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83071736|NCT02095665|Analgesics|analgesics|mesh-ancestor
83071737|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
83071738|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071739|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
83071740|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83071741|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83071742|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83071744|NCT03548428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83071745|NCT03548428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071746|NCT03548428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071747|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071748|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83071749|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83071750|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83071751|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
83071752|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071753|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83071754|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83071755|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071756|NCT02101203|Buspirone|buspirone|mesh-list
83071757|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83071758|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83071759|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071760|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071761|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83071762|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83071763|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
83071764|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071765|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071766|NCT04523246|Vaccines|vaccines|mesh-list
83071767|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
83071768|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071769|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
83071770|NCT03396380|Vitamin D|vitamin d|mesh-list
83071771|NCT03396380|Citric Acid|citric acid|mesh-list
83071772|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
83071773|NCT03396380|Clomiphene|clomiphene|mesh-list
83071774|NCT03396380|Enclomiphene|enclomiphene|mesh-list
83071775|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
83071776|NCT03396380|Calcium|calcium|mesh-list
83071777|NCT03396380|Vitamins|vitamins|mesh-ancestor
83071778|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
83071779|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071780|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83071781|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83071782|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
83071783|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83071784|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
83071785|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
83071786|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071787|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83071788|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
83071789|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071790|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83071791|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
83071792|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83071793|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83071794|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83071795|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
83071796|NCT05040568|Fludarabine|fludarabine|mesh-list
83071797|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
83071798|NCT05040568|Cetuximab|cetuximab|mesh-list
83071799|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83071800|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
83071801|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071802|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071803|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83071804|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
83071805|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071806|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071807|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83071808|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83071809|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
83071810|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071811|NCT03414164|Procyanidin|procyanidin|mesh-list
83071812|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
83071813|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071814|NCT03414164|Protective Agents|protective agents|mesh-ancestor
83071815|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071816|NCT05613478|Apatinib|apatinib|mesh-list
83071817|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
83071818|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071819|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83071820|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071821|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071822|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83071823|NCT05613478|Estrogens|estrogens|mesh-ancestor
83071824|NCT05613478|Hormones|hormones|mesh-ancestor
83071825|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071826|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071827|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071828|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83071829|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83071830|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83071831|NCT03406988|Nifedipine|nifedipine|mesh-list
83071832|NCT03406988|Iloprost|iloprost|mesh-list
83071833|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83071834|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83071835|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071836|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83071837|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071838|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
83071839|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
83071840|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83071841|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83071842|NCT03406832|Nitroprusside|nitroprusside|mesh-list
83071843|NCT03406832|Tirofiban|tirofiban|mesh-list
83071844|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83071845|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
83071846|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83071847|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071848|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83071849|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83071850|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83071851|NCT03405974|Aspirin|aspirin|mesh-list
83071852|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83071853|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83071854|NCT03405974|Analgesics|analgesics|mesh-ancestor
83071855|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
83071856|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071857|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071858|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83071859|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83071860|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83071861|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83071862|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071863|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83071864|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83071865|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071866|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
83071867|NCT04337060|Lidocaine|lidocaine|mesh-list
83071868|NCT04337060|Morphine|morphine|mesh-list
83071869|NCT04337060|Bupivacaine|bupivacaine|mesh-list
83071870|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
83071871|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
83071872|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071873|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071874|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
83071875|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071876|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83071877|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83071878|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83071879|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83071880|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071881|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83071882|NCT04337060|Narcotics|narcotics|mesh-ancestor
83071883|NCT04337060|Analgesics|analgesics|mesh-ancestor
83071884|NCT04339036|Capecitabine|capecitabine|mesh-list
83071885|NCT04339036|Temozolomide|temozolomide|mesh-list
83071886|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83071887|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
83071888|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071889|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071890|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83071891|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
83361835|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83361836|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83361837|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83071893|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071894|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83071895|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071896|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071897|NCT02977156|Ipilimumab|ipilimumab|mesh-list
83071898|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071899|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071900|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83071901|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071902|NCT02413138|Hormones|hormones|mesh-list
83071903|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071904|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071905|NCT01014598|Cisplatin|cisplatin|mesh-list
83071906|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071907|NCT03404804|Amoxicillin|amoxicillin|mesh-list
83071908|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83071909|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071910|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
83071911|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
83071912|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83071913|NCT05611372|Rasagiline|rasagiline|mesh-list
83071914|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83071915|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071916|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071917|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83071918|NCT05611372|Protective Agents|protective agents|mesh-ancestor
83071919|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071920|NCT04776148|Trifluridine|trifluridine|mesh-list
83071921|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
83071922|NCT04776148|Lenvatinib|lenvatinib|mesh-list
83071923|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83071924|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071925|NCT04776148|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83482366|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83071926|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071927|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83071928|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071929|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
83071930|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
83071931|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83071932|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83071933|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
83071934|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83071935|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83071936|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83071937|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
83071938|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83071939|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071940|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83071941|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83071942|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83071943|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83071944|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071945|NCT05613166|Everolimus|everolimus|mesh-list
83071946|NCT05613166|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83071947|NCT05613166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83071948|NCT05613166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071949|NCT05613166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071950|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83071951|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
83071952|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071953|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071954|NCT05166668|Letrozole|letrozole|mesh-list
83071955|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83071956|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83071957|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83071958|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071959|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071960|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83071961|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
83361838|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83439888|NCT00250445|Diclofenac|diclofenac|mesh-list
83071962|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83071963|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361839|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83361840|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071964|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
83071965|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071966|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
83071967|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83071968|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83071969|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071970|NCT05558176|Urological Agents|urological agents|mesh-ancestor
83071971|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
83071972|NCT04748224|Bupivacaine|bupivacaine|mesh-list
83071973|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
83071974|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
83071975|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83071976|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83071977|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
83071978|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83071979|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83071980|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83071981|NCT04748224|Analgesics|analgesics|mesh-ancestor
83071982|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83071983|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83071984|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83071985|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
83071986|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83071987|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071988|NCT03413150|Amiodarone|amiodarone|mesh-list
83071989|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83071990|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
83071991|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83071992|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83071993|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83071994|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83482367|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
83071995|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83071996|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83071997|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83071998|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83071999|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83072000|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83072001|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83072002|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83072003|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83072004|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83072005|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83072006|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83072007|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83072008|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072009|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072010|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072011|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072012|NCT03126578|Midazolam|midazolam|mesh-list
83072013|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83072014|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83072015|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072016|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072017|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83072018|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83072019|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83072020|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83072021|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
83072022|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
83072023|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
83072024|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
83072025|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072026|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072027|NCT03412994|Apatinib|apatinib|mesh-list
83072028|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072029|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83072030|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072031|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072032|NCT02588248|Peppermint oil|peppermint oil|mesh-list
83072033|NCT02588248|Menthol|menthol|mesh-list
83072034|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
83072035|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
83072036|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
83072037|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
83072038|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072039|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072040|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072041|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
83072042|NCT03412682|Budesonide|budesonide|mesh-list
83072043|NCT03412682|Mesalamine|mesalamine|mesh-list
83072044|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072045|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83072046|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
83072047|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072048|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072049|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83072050|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
83072051|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
83072052|NCT03412682|Hormones|hormones|mesh-ancestor
83072053|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072054|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83072055|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072056|NCT03412682|Analgesics|analgesics|mesh-ancestor
83072057|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
83072058|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072059|NCT03412526|Fludarabine|fludarabine|mesh-list
83072060|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072061|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
83072062|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83072063|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072064|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072065|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072066|NCT03126422|Analgesics|analgesics|mesh-ancestor
83072067|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
83072068|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072069|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83072070|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83072071|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83072072|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072073|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072074|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072075|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
83072076|NCT03395132|Betamethasone|betamethasone|mesh-list
83072077|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072078|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
83072079|NCT03395132|Hormones|hormones|mesh-ancestor
83072080|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072081|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072082|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83072083|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
83072084|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83072085|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072086|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83072087|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072088|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072089|NCT03127124|Leucovorin|leucovorin|mesh-list
83072090|NCT03127124|Fluorouracil|fluorouracil|mesh-list
83072091|NCT03127124|Bevacizumab|bevacizumab|mesh-list
83072092|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
83072093|NCT03127124|Calcium|calcium|mesh-list
83072094|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
83072095|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83072096|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072097|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
83072098|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072099|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83072100|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072101|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072102|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
83072103|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83072104|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83072105|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83072106|NCT03127124|Growth Substances|growth substances|mesh-ancestor
83072107|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
83072109|NCT03127124|Protective Agents|protective agents|mesh-ancestor
83072110|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
83072111|NCT03127124|Vitamins|vitamins|mesh-ancestor
83072112|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
83072113|NCT03399110|Capecitabine|capecitabine|mesh-list
83072114|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
83072115|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83072116|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
83072117|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072118|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072119|NCT05111912|Liraglutide|liraglutide|mesh-list
83072120|NCT05111912|Glucagon|glucagon|mesh-list
83072121|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83072122|NCT05111912|Incretins|incretins|mesh-ancestor
83072123|NCT05111912|Hormones|hormones|mesh-ancestor
83072124|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072125|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072126|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072127|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83072128|NCT03127046|Aceclofenac|aceclofenac|mesh-list
83072129|NCT03127046|Diclofenac|diclofenac|mesh-list
83072130|NCT03127046|Esomeprazole|esomeprazole|mesh-list
83072131|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83072132|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072133|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83072134|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072135|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072136|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83072137|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072138|NCT03127046|Analgesics|analgesics|mesh-ancestor
83072139|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
83072140|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83439947|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83072141|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072142|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072143|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072144|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83072145|NCT05105672|Cisplatin|cisplatin|mesh-list
83072146|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072148|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
83072149|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072150|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072151|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072152|NCT03394820|Dexamethasone|dexamethasone|mesh-list
83072153|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072154|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
83072155|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
83072156|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072157|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072158|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072159|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
83072160|NCT03394820|Hormones|hormones|mesh-ancestor
83072161|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072162|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83072163|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072164|NCT01328054|Lapatinib|lapatinib|mesh-list
83072165|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072166|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83072167|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072168|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072169|NCT05067920|Antibodies|antibodies|mesh-list
83072170|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
83072171|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072172|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83072173|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83072174|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83072175|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83072176|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
83072177|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072178|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83072179|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83072180|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072181|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83072182|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83072183|NCT03398876|Nicotine|nicotine|mesh-list
83072184|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83072185|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
83072186|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072187|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072188|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83072189|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83072190|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
83072191|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072192|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072193|NCT03394586|Golimumab|golimumab|mesh-list
83072194|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83072195|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072196|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072197|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
83072198|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072199|NCT03394430|Midazolam|midazolam|mesh-list
83072200|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
83072201|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83072202|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072203|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072204|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072205|NCT03394430|Analgesics|analgesics|mesh-ancestor
83072206|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
83072207|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072208|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83072209|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83072210|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83072211|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072212|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072213|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072214|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83072215|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83072216|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83072217|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83072218|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83072219|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
83072220|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
83072222|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
83072223|NCT03394196|Ritonavir|ritonavir|mesh-list
83072224|NCT03394196|Lopinavir|lopinavir|mesh-list
83072225|NCT03394196|Darunavir|darunavir|mesh-list
83072226|NCT03394196|Tenofovir|tenofovir|mesh-list
83072227|NCT03394196|Lamivudine|lamivudine|mesh-list
83072228|NCT03394196|Emtricitabine|emtricitabine|mesh-list
83072229|NCT03394196|Zidovudine|zidovudine|mesh-list
83072230|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
83072231|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83072232|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83072233|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
83072234|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072235|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072236|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83072237|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83072238|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
83072239|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072240|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83072241|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83072242|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83072243|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83072244|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
83072245|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83072246|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83072247|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83072248|NCT03398018|Hormones|hormones|mesh-ancestor
83072249|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072250|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072251|NCT03411434|Methylphenidate|methylphenidate|mesh-list
83072252|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83072253|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072254|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83072255|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83072256|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83072257|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072258|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
83072260|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
83072261|NCT03126656|Testosterone|testosterone|mesh-list
83072262|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
83072263|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
83072264|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83072265|NCT03126656|Androgens|androgens|mesh-ancestor
83072266|NCT03126656|Hormones|hormones|mesh-ancestor
83072267|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072268|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072269|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83072270|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072271|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
83072272|NCT03385382|Dexamethasone|dexamethasone|mesh-list
83072273|NCT03385382|Ranibizumab|ranibizumab|mesh-list
83072274|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072275|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
83072276|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
83072277|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072278|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072279|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072280|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
83072281|NCT03385382|Hormones|hormones|mesh-ancestor
83072282|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072283|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83072284|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072285|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83072286|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83072287|NCT03385382|Growth Substances|growth substances|mesh-ancestor
83072288|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
83072289|NCT03394118|Osimertinib|osimertinib|mesh-list
83072290|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072291|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83072292|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072293|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072294|NCT03389672|Anesthetics|anesthetics|mesh-list
83072295|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072296|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072297|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
83072298|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83072299|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072300|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83072301|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83072302|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072303|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072304|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072305|NCT01907360|Methylphenidate|methylphenidate|mesh-list
83072306|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83072307|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072308|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83072309|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83072310|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83072311|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072312|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
83072313|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072315|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83072316|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
83072317|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83072318|NCT03126188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83072319|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83072320|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83072321|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072322|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072323|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
83072324|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072325|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83072326|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83072327|NCT04446338|Antibodies|antibodies|mesh-list
83072328|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
83072329|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072330|NCT03393728|Propranolol|propranolol|mesh-list
83072332|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83072333|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072334|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072335|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072336|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072337|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83072338|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83072339|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
83072340|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
83072341|NCT03393572|Nalbuphine|nalbuphine|mesh-list
83072342|NCT03393572|Bupivacaine|bupivacaine|mesh-list
83072343|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
83072344|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
83072345|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072346|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072347|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
83072348|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072349|NCT03393572|Analgesics|analgesics|mesh-ancestor
83072350|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83072351|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
83072352|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83072353|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83072354|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072355|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83072356|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
83072357|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83072358|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83072359|NCT03393572|Narcotics|narcotics|mesh-ancestor
83072360|NCT03393416|Antibodies|antibodies|mesh-list
83072361|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
83072362|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072363|NCT04445948|Amoxicillin|amoxicillin|mesh-list
83072364|NCT04445948|Metronidazole|metronidazole|mesh-list
83072365|NCT04445948|Clarithromycin|clarithromycin|mesh-list
83072366|NCT04445948|Lactoferrin|lactoferrin|mesh-list
83072367|NCT04445948|Esomeprazole|esomeprazole|mesh-list
83072368|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83072369|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072370|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83072371|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83072372|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83072373|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072374|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83072375|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072376|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072377|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83072378|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83072379|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83072380|NCT02479646|Lenograstim|lenograstim|mesh-list
83072381|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83072382|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
83072383|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072384|NCT02467868|Lenograstim|lenograstim|mesh-list
83072385|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83072386|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
83072387|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072388|NCT02103465|Rotigotine|rotigotine|mesh-list
83072389|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
83072390|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
83072391|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072392|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072393|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072394|NCT02102139|Propofol|propofol|mesh-list
83072395|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83072396|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072397|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072398|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83072399|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
83072400|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
83072401|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
83072402|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
83072403|NCT02102295|Fluorides|fluorides|mesh-list
83072404|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
83072405|NCT02102295|Protective Agents|protective agents|mesh-ancestor
83072406|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072407|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
83072408|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072410|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
83072411|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072412|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83072413|NCT02102373|Laxatives|laxatives|mesh-ancestor
83072414|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072415|NCT02103777|Caffeine|caffeine|mesh-list
83072416|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
83072417|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072418|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83072419|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072420|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83072421|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072422|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83072423|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83072424|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
83072425|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072426|NCT02104011|Propranolol|propranolol|mesh-list
83072427|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83072428|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83072429|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072430|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072431|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072432|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072433|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83072434|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83072435|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
83072436|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
83072437|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83072438|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072439|NCT02251041|Tocopherols|tocopherols|mesh-list
83072440|NCT02251041|Vitamin E|vitamin e|mesh-list
83072441|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
83072442|NCT02251041|Infliximab|infliximab|mesh-list
83072443|NCT02251041|Epoprostenol|epoprostenol|mesh-list
83072444|NCT02251041|Tezosentan|tezosentan|mesh-list
83072445|NCT02251041|Melatonin|melatonin|mesh-list
83072446|NCT02251041|Antithrombins|antithrombins|mesh-list
83072447|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
83072448|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
83072449|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83072451|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072452|NCT02251041|Protective Agents|protective agents|mesh-ancestor
83072453|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072454|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072455|NCT02251041|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83072456|NCT02251041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072457|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
83072458|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072459|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072460|NCT02251041|Hematinics|hematinics|mesh-ancestor
83072461|NCT02251041|Vitamins|vitamins|mesh-ancestor
83072462|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
83072463|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83072464|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
83072465|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072466|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
83072467|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83072468|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83072469|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
83072470|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83072471|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072472|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
83072473|NCT02104323|Endostatins|endostatins|mesh-list
83072474|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072475|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83072476|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83072477|NCT02104323|Growth Substances|growth substances|mesh-ancestor
83072478|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072479|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
83072480|NCT02107365|Interferons|interferons|mesh-list
83072481|NCT02107365|Ribavirin|ribavirin|mesh-list
83072482|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
83072483|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
83072484|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83072485|NCT02107365|Asunaprevir|asunaprevir|mesh-list
83072486|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072487|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
83072488|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072489|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
83072490|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072491|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
83072492|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072493|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
83072494|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072495|NCT02110719|Acetaminophen|acetaminophen|mesh-list
83072496|NCT02110719|Dexamethasone|dexamethasone|mesh-list
83072497|NCT02110719|Ibuprofen|ibuprofen|mesh-list
83072498|NCT02110719|Celecoxib|celecoxib|mesh-list
83072499|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83072500|NCT02110719|Oxycodone|oxycodone|mesh-list
83072501|NCT02110719|Gabapentin|gabapentin|mesh-list
83072502|NCT02110719|Hydromorphone|hydromorphone|mesh-list
83072503|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072504|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
83072505|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
83072506|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072507|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072508|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072509|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
83072510|NCT02110719|Hormones|hormones|mesh-ancestor
83072511|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072512|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83072513|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072514|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072515|NCT02110719|Analgesics|analgesics|mesh-ancestor
83072516|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
83072517|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
83072518|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83072519|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072520|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83072521|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072522|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072523|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83072524|NCT02110719|Narcotics|narcotics|mesh-ancestor
83072525|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072526|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
83072527|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83072528|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83072529|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83072530|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83072531|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83072532|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072533|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
83072534|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83072535|NCT02105103|Insulin|insulin|mesh-list
83072536|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83072537|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072538|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83072539|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83072540|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83072541|NCT02107755|Ipilimumab|ipilimumab|mesh-list
83072542|NCT02107755|Antibodies|antibodies|mesh-list
83072543|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
83072544|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83072545|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
83072546|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072547|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072548|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83072549|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072550|NCT02110953|Irinotecan|irinotecan|mesh-list
83072551|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83072552|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83072553|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072554|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072555|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072556|NCT03554109|Leucovorin|leucovorin|mesh-list
83072557|NCT03554109|Paclitaxel|paclitaxel|mesh-list
83072558|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83072559|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
83072560|NCT03554109|Doxorubicin|doxorubicin|mesh-list
83072561|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83072563|NCT03554109|Avelumab|avelumab|mesh-list
83072564|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83072565|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072566|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
83072567|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
83072568|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
83072569|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072570|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072571|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
83072572|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072573|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072574|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83072575|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
83072576|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83072577|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83072578|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83072579|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83072580|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072581|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
83072582|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83072583|NCT03554109|Antidotes|antidotes|mesh-ancestor
83072584|NCT03554109|Protective Agents|protective agents|mesh-ancestor
83072585|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
83072586|NCT03554109|Vitamins|vitamins|mesh-ancestor
83072587|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
83072588|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83072589|NCT03554031|Hormones|hormones|mesh-list
83072590|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072591|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072592|NCT02111265|Sufentanil|sufentanil|mesh-list
83072593|NCT02111265|Remifentanil|remifentanil|mesh-list
83072594|NCT02111265|Cisatracurium|cisatracurium|mesh-list
83072595|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83072596|NCT02111265|Narcotics|narcotics|mesh-ancestor
83072597|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072598|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072599|NCT02111265|Analgesics|analgesics|mesh-ancestor
83072600|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
83072601|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072602|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83072603|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83072604|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
83072605|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
83072606|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83072607|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83072608|NCT02251119|Ritonavir|ritonavir|mesh-list
83072609|NCT02251119|Tipranavir|tipranavir|mesh-list
83072610|NCT02251119|Loperamide|loperamide|mesh-list
83072611|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
83072612|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83072613|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83072614|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
83072615|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072616|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072617|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83072618|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83072619|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
83072620|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072621|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83072622|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83072623|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072624|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
83072625|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
83072626|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
83072627|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83072628|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072629|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072630|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072631|NCT02111421|Analgesics|analgesics|mesh-ancestor
83072632|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
83072633|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072634|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83072635|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83072636|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83072637|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072639|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072640|NCT02108301|Cyclosporine|cyclosporine|mesh-list
83072641|NCT02108301|Tacrolimus|tacrolimus|mesh-list
83072642|NCT02108301|Cyclosporins|cyclosporins|mesh-list
83072643|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072644|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
83072645|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072646|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83072647|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072648|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072649|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
83072650|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072651|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
83072652|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072653|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
83072654|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83072655|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83072656|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072657|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83072658|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83072659|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
83072660|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83072661|NCT02114073|Cyclosporine|cyclosporine|mesh-list
83072662|NCT02114073|Betamethasone|betamethasone|mesh-list
83072663|NCT02114073|Cyclosporins|cyclosporins|mesh-list
83072664|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072665|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072666|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072667|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
83072668|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072669|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
83072670|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072671|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
83072672|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072673|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83072674|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072675|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
83072676|NCT02114073|Hormones|hormones|mesh-ancestor
83072677|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072678|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83072679|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
83072680|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
83072681|NCT02114463|Analgesics|analgesics|mesh-list
83072682|NCT02114463|Ropivacaine|ropivacaine|mesh-list
83072683|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
83072684|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
83072685|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072686|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072687|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
83072688|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072689|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83072690|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072691|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072692|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072693|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83072694|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072695|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072696|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83072697|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83072698|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83072699|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
83072700|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072701|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83072702|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83072703|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072704|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
83072705|NCT02114775|Hormones|hormones|mesh-list
83072706|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072707|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072708|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
83072709|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83072710|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83072711|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072712|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072713|NCT02114775|Urological Agents|urological agents|mesh-ancestor
83072714|NCT02108847|Ropivacaine|ropivacaine|mesh-list
83072715|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
83072716|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
83072717|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072718|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072719|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
83072720|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072721|NCT03553329|Trametinib|trametinib|mesh-list
83072722|NCT03553329|Dabrafenib|dabrafenib|mesh-list
83072723|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072724|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83072725|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072726|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072727|NCT02115087|Morphine|morphine|mesh-list
83072728|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83072729|NCT02115087|Narcotics|narcotics|mesh-ancestor
83072730|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072731|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072732|NCT02115087|Analgesics|analgesics|mesh-ancestor
83072733|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
83072734|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072735|NCT02115243|Ipilimumab|ipilimumab|mesh-list
83072736|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83072737|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072738|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83072739|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072740|NCT02109315|Liraglutide|liraglutide|mesh-list
83072741|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072742|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83072743|NCT02109315|Incretins|incretins|mesh-ancestor
83072744|NCT02109315|Hormones|hormones|mesh-ancestor
83072745|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072746|NCT02112903|Vortioxetine|vortioxetine|mesh-list
83072747|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
83072748|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83072749|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83072750|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83072751|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072752|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072753|NCT02112903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83072754|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83072755|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83072756|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072757|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072758|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
83072759|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83072760|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83072761|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83072762|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83072763|NCT02112981|Sirolimus|sirolimus|mesh-list
83072764|NCT02112981|Everolimus|everolimus|mesh-list
83072765|NCT02112981|MTOR Inhibitors|mtor inhibitors|mesh-list
83072766|NCT02112981|Temsirolimus|temsirolimus|mesh-list
83072767|NCT02112981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83072768|NCT02112981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072769|NCT02112981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072770|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072771|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
83072772|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072773|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072774|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83072775|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072776|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83072777|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
83072778|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
83072779|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
83072780|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
83072781|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072782|NCT02116257|Propacetamol|propacetamol|mesh-list
83072783|NCT02116257|Analgesics|analgesics|mesh-ancestor
83072784|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
83072785|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072786|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072787|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83072788|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072789|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072790|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83072791|NCT02109627|Cytarabine|cytarabine|mesh-list
83072792|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83072793|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
83072794|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072795|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072796|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
83072797|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072798|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072799|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
83072800|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072801|NCT02116569|Daratumumab|daratumumab|mesh-list
83072802|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072803|NCT02109783|Caffeine|caffeine|mesh-list
83072804|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83072805|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072806|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83072807|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072808|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072809|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83072810|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83072811|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
83072812|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072813|NCT02109861|Dexamethasone|dexamethasone|mesh-list
83072814|NCT02109861|Bortezomib|bortezomib|mesh-list
83072815|NCT02109861|Melphalan|melphalan|mesh-list
83072816|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83072817|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
83072818|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
83072819|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072820|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072821|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83072822|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
83072823|NCT02109861|Hormones|hormones|mesh-ancestor
83072824|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072825|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83072826|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072827|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83072828|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
83072829|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072830|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83072831|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072832|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
83072833|NCT02118753|Eplerenone|eplerenone|mesh-list
83072834|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83072835|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
83072836|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072837|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072838|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83072839|NCT02118753|Diuretics|diuretics|mesh-ancestor
83072840|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
83072841|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83072842|NCT02118909|Itraconazole|itraconazole|mesh-list
83072843|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
83072844|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
83072845|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440069|NCT00592475|Conivaptan|conivaptan|mesh-list
83072846|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83072847|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83072848|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072849|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072850|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83072851|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
83072852|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072853|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072854|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83072855|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83072856|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83072857|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83072858|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072859|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83072860|NCT02118987|Omalizumab|omalizumab|mesh-list
83072861|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83072862|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83072863|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
83072864|NCT02119143|Vitamins|vitamins|mesh-list
83072865|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
83072866|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072867|NCT02116959|Carboplatin|carboplatin|mesh-list
83072868|NCT02116959|Etoposide|etoposide|mesh-list
83072869|NCT02116959|Vincristine|vincristine|mesh-list
83072870|NCT02116959|Melphalan|melphalan|mesh-list
83072871|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83072872|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83072873|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83072874|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83072875|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072876|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072877|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
83072878|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
83072879|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
83072880|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83072881|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
83072882|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83072883|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83072884|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
83072885|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072886|NCT03553173|Bupropion|bupropion|mesh-list
83072887|NCT03553173|Varenicline|varenicline|mesh-list
83072888|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83072889|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
83072890|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83072891|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83072892|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83072893|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83072894|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072895|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
83072896|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072897|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072898|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83072899|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83072900|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072901|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83072902|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83072903|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
83072905|NCT01330017|Phenylephrine|phenylephrine|mesh-list
83072906|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
83072907|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83072908|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
83072909|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
83072910|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072911|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072912|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
83072913|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83072914|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
83072915|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
83072916|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83072917|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83072918|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83072919|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072920|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072921|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072922|NCT01330017|Protective Agents|protective agents|mesh-ancestor
83072923|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
83072924|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
83072925|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83072926|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83072927|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83072928|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
83072929|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
83072930|NCT02123121|Resveratrol|resveratrol|mesh-list
83072931|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
83072932|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072933|NCT02123121|Protective Agents|protective agents|mesh-ancestor
83072935|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072936|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83072937|NCT02117583|Oxycodone|oxycodone|mesh-list
83072938|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83072939|NCT02117583|Narcotics|narcotics|mesh-ancestor
83072940|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072941|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072942|NCT02117583|Analgesics|analgesics|mesh-ancestor
83072943|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
83072944|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072945|NCT02117739|Dapsone|dapsone|mesh-list
83072946|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83072947|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
83072948|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83072949|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83072950|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83072951|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83072952|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072953|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
83072954|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83072955|NCT02251509|Metoprolol|metoprolol|mesh-list
83072956|NCT02251509|Carvedilol|carvedilol|mesh-list
83072957|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83072958|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83072959|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
83072960|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
83072961|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83072962|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072963|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83072964|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83072965|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83072966|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83072967|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83072968|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83072969|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
83072970|NCT02251509|Protective Agents|protective agents|mesh-ancestor
83072971|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83072972|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83072973|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83072974|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
83072975|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83072976|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83072977|NCT02986659|Metformin|metformin|mesh-list
83072978|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83072979|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072980|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83072982|NCT02118051|Ganirelix|ganirelix|mesh-list
83072983|NCT02118051|Progestins|progestins|mesh-ancestor
83072984|NCT02118051|Hormones|hormones|mesh-ancestor
83072985|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83072986|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072987|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
83072988|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83072989|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
83072990|NCT02123355|Remifentanil|remifentanil|mesh-list
83072991|NCT02123355|Sevoflurane|sevoflurane|mesh-list
83072992|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
83072993|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
83072994|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83072995|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83072996|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83072997|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83072998|NCT02123355|Analgesics|analgesics|mesh-ancestor
83072999|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
83073000|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073001|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83073002|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83073003|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83073004|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83073005|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073006|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073007|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83073008|NCT02123355|Narcotics|narcotics|mesh-ancestor
83073010|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83073011|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
83073012|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83073013|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83073014|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83073015|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83073016|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83073017|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
83073018|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83073019|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
83073020|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073021|NCT02123589|Fentanyl|fentanyl|mesh-list
83073022|NCT02123589|Midazolam|midazolam|mesh-list
83073023|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83073024|NCT02123589|Narcotics|narcotics|mesh-ancestor
83073025|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073026|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073027|NCT02123589|Analgesics|analgesics|mesh-ancestor
83073028|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
83073029|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073030|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83073031|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83073032|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
83073033|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
83073034|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83073035|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83073036|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83073037|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83073038|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
83073039|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
83073040|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073041|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073042|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
83073043|NCT02120547|Liver Extracts|liver extracts|mesh-list
83073044|NCT02120547|Hematinics|hematinics|mesh-ancestor
83073045|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83073046|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073047|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83073048|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83073049|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
83073050|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073051|NCT02120703|Pregabalin|pregabalin|mesh-list
83073052|NCT02120703|Gabapentin|gabapentin|mesh-list
83073053|NCT02120703|Analgesics|analgesics|mesh-ancestor
83073054|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
83073055|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073056|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073057|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
83073058|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83073059|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83073060|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073061|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83073062|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83073063|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83073064|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073065|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83073066|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83073067|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83073068|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073069|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
83073070|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
83073071|NCT02118285|Fludarabine|fludarabine|mesh-list
83073072|NCT02118285|Interleukin-2|interleukin-2|mesh-list
83073073|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073074|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
83073075|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073076|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073077|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83073078|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
83073079|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073080|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073081|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83073082|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83073083|NCT02118285|Analgesics|analgesics|mesh-ancestor
83073085|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073086|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
83073087|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83073088|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83073089|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073090|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
83073091|NCT03552705|Coagulants|coagulants|mesh-ancestor
83073092|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
83073093|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073094|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83073095|NCT02118675|Protective Agents|protective agents|mesh-ancestor
83073096|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073097|NCT02123979|Rotigotine|rotigotine|mesh-list
83073098|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
83073099|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
83073100|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073101|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073102|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073103|NCT03552315|Chromium|chromium|mesh-list
83073104|NCT03552315|Trace Elements|trace elements|mesh-ancestor
83073105|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
83073106|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073107|NCT02120859|Paclitaxel|paclitaxel|mesh-list
83073108|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83073109|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073110|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
83073111|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
83073112|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
83073113|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073114|NCT02126943|Macitentan|macitentan|mesh-list
83073115|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83073116|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83073117|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073118|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83073119|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83073120|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83073121|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440112|NCT01973205|Analgesics|analgesics|mesh-ancestor
83073122|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
83073123|NCT00150462|Dexamethasone|dexamethasone|mesh-list
83073124|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073125|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
83073126|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
83073127|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073128|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073129|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83073130|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
83073131|NCT00150462|Hormones|hormones|mesh-ancestor
83073132|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073133|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83073134|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073135|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83073136|NCT00095550|Irbesartan|irbesartan|mesh-list
83073137|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073138|NCT00095550|Diuretics|diuretics|mesh-ancestor
83073139|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
83073140|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073141|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83073142|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83073143|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073144|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83073145|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83073146|NCT00095394|Irbesartan|irbesartan|mesh-list
83073147|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073148|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83073149|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83073150|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073151|NCT00093132|Satraplatin|satraplatin|mesh-list
83073152|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073153|NCT05717400|Ribavirin|ribavirin|mesh-list
83073154|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
83073155|NCT05717400|Velpatasvir|velpatasvir|mesh-list
83073156|NCT05717400|Bevacizumab|bevacizumab|mesh-list
83073157|NCT05717400|Atezolizumab|atezolizumab|mesh-list
83073158|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83073159|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073160|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83073161|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83073162|NCT05717400|Growth Substances|growth substances|mesh-ancestor
83073163|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073164|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
83073165|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
83073166|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073167|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
83073168|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073169|NCT05717400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83073170|NCT00080106|Vaccines|vaccines|mesh-list
83073171|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
83073172|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073173|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
83073174|NCT00333216|Anecortave|anecortave|mesh-list
83073175|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83073176|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83073177|NCT00333216|Growth Substances|growth substances|mesh-ancestor
83073178|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073179|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
83073180|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073181|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073182|NCT00332748|Taxane|taxane|mesh-list
83073183|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073184|NCT03530436|Curcumin|curcumin|mesh-list
83073185|NCT03530436|Turmeric extract|turmeric extract|mesh-list
83073186|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83073187|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83073188|NCT03530436|Analgesics|analgesics|mesh-ancestor
83073189|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
83073190|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073191|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073192|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073193|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073194|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073195|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073196|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073197|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
83073198|NCT03530436|Protective Agents|protective agents|mesh-ancestor
83073199|NCT03530280|Pregabalin|pregabalin|mesh-list
83073200|NCT03530280|Bupivacaine|bupivacaine|mesh-list
83073201|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
83073202|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
83073203|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073204|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073205|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
83073206|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073207|NCT03530280|Analgesics|analgesics|mesh-ancestor
83073208|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
83073209|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83073210|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83073211|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073212|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83073213|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83073214|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83073215|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83073216|NCT00079482|Cytarabine|cytarabine|mesh-list
83073217|NCT00079482|Etoposide|etoposide|mesh-list
83073218|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
83073219|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83073220|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073221|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83073222|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83073223|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073224|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073225|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073226|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
83073227|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
83073228|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073229|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073230|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
83073231|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073232|NCT00079482|Analgesics|analgesics|mesh-ancestor
83073233|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
83073234|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073235|NCT00073866|Celecoxib|celecoxib|mesh-list
83073236|NCT00073866|Docetaxel|docetaxel|mesh-list
83073237|NCT00073866|Irinotecan|irinotecan|mesh-list
83073238|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073239|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
83073240|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
83073241|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
83073242|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073243|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83073244|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83073245|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073246|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83073247|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83073248|NCT00073866|Analgesics|analgesics|mesh-ancestor
83073249|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
83073250|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073251|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073252|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073253|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073254|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83073255|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83073256|NCT00325650|Rimonabant|rimonabant|mesh-list
83073257|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83073258|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83073259|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83073260|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073261|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073262|NCT00325650|Hormones|hormones|mesh-ancestor
83073263|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073264|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073265|NCT00070590|Bosentan|bosentan|mesh-list
83073266|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073267|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83073268|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073269|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83073270|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83073271|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83073272|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
83073273|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073274|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073275|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83073276|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83073277|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
83073278|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073279|NCT00058266|Genistein|genistein|mesh-list
83073280|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83073281|NCT00058266|Protective Agents|protective agents|mesh-ancestor
83073282|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073283|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073284|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83073285|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073286|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073287|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
83073288|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83073289|NCT00058266|Estrogens|estrogens|mesh-ancestor
83073290|NCT00058266|Hormones|hormones|mesh-ancestor
83073291|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073292|NCT00313794|Tremelimumab|tremelimumab|mesh-list
83073293|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073294|NCT00313248|Sagopilone|sagopilone|mesh-list
83073295|NCT00313248|Epothilones|epothilones|mesh-list
83073296|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073297|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
83073298|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
83073299|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
83073300|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073301|NCT00310830|Bosentan|bosentan|mesh-list
83073302|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073303|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83073304|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073305|NCT00035568|Metformin|metformin|mesh-list
83073306|NCT00035568|Glyburide|glyburide|mesh-list
83073307|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83073308|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361841|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073309|NCT00031512|Pleconaril|pleconaril|mesh-list
83073310|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
83073311|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073312|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
83073313|NCT00307398|Anecortave|anecortave|mesh-list
83073314|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83073315|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83073316|NCT00307398|Growth Substances|growth substances|mesh-ancestor
83073317|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073318|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
83073319|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073320|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073321|NCT01368081|Metformin|metformin|mesh-list
83073322|NCT01368081|Empagliflozin|empagliflozin|mesh-list
83073323|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83073324|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073325|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83073326|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073327|NCT02127489|Bupivacaine|bupivacaine|mesh-list
83073328|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
83073329|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
83073330|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073331|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073332|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
83073333|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073334|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
83073335|NCT00004914|Hematinics|hematinics|mesh-ancestor
83073336|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
83073337|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83073338|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073339|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83073340|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
83073341|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83073342|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073343|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83073344|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83073345|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83073346|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
83073347|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073348|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
83073349|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073350|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073351|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83073352|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
83482368|NCT00531518|Lamotrigine|lamotrigine|mesh-list
83073353|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073354|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073355|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83073356|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
83073357|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073359|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073360|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
83073361|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83073362|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073363|NCT03551067|Midazolam|midazolam|mesh-list
83073364|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
83073365|NCT03551067|Ketamine|ketamine|mesh-list
83073366|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83073367|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073368|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073369|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83073370|NCT03551067|Analgesics|analgesics|mesh-ancestor
83073371|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
83073372|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073373|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83073374|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83073375|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83073376|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
83073377|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073378|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073379|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83073380|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83073381|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
83073382|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
83073383|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83073384|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83073385|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83073386|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83073387|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83073388|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83073389|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
83073390|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
83073391|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83073392|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
83073393|NCT03529266|Coagulants|coagulants|mesh-ancestor
83073394|NCT02128191|Ibuprofen|ibuprofen|mesh-list
83073395|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83073396|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83073397|NCT02128191|Analgesics|analgesics|mesh-ancestor
83073398|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
83073399|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073400|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073401|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073402|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073403|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83073404|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073405|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073406|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
83073407|NCT00004896|Busulfan|busulfan|mesh-list
83073408|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073409|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
83073410|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073411|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073412|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83073413|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
83073414|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073415|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073416|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83073417|NCT02121951|Lidocaine|lidocaine|mesh-list
83073418|NCT02121951|Fentanyl|fentanyl|mesh-list
83073419|NCT02121951|Midazolam|midazolam|mesh-list
83073420|NCT02121951|Anesthetics|anesthetics|mesh-list
83073421|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
83073422|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
83073423|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83073424|NCT02121951|Narcotics|narcotics|mesh-ancestor
83073425|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073426|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073427|NCT02121951|Analgesics|analgesics|mesh-ancestor
83073428|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
83073429|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073430|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83073431|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83073432|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
83073433|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83073434|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83073435|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83073436|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83073437|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
83073438|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
83073439|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073440|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073441|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83073442|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83073443|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83073444|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83073445|NCT05473858|Phentolamine|phentolamine|mesh-list
83073446|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83073447|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83073448|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
83073449|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073450|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073451|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073452|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073454|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83073455|NCT00004584|Saquinavir|saquinavir|mesh-list
83073456|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83073457|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83073458|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
83073459|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073460|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073462|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83073463|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
83073464|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073465|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83073466|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83073467|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
83073468|NCT00004230|Captopril|captopril|mesh-list
83073469|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073470|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
83073471|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073472|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073473|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83073474|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
83073475|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073476|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073477|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83073478|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83073479|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
83073480|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073481|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073482|NCT02252367|Tadalafil|tadalafil|mesh-list
83073483|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
83073484|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83073485|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83073486|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073487|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073488|NCT02252367|Urological Agents|urological agents|mesh-ancestor
83073489|NCT00004182|Irinotecan|irinotecan|mesh-list
83073490|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83073491|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83073492|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073493|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073494|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073495|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
83073496|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83073497|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
83073498|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073499|NCT02124525|Expectorants|expectorants|mesh-ancestor
83073500|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
83073501|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83073502|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
83073503|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073504|NCT02124525|Protective Agents|protective agents|mesh-ancestor
83073505|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073507|NCT04331002|Triamcinolone|triamcinolone|mesh-list
83073508|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83073509|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83073510|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83073511|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073512|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
83073513|NCT04331002|Hormones|hormones|mesh-ancestor
83073514|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073515|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073516|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073517|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
83073518|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073519|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073520|NCT05725512|Prednisolone|prednisolone|mesh-list
83073521|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073522|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
83073523|NCT05725512|Hormones|hormones|mesh-ancestor
83073524|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073525|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073526|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83073527|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073528|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
83073529|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
83073530|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83073531|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83073532|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073533|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073534|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073535|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073536|NCT02128425|Leucovorin|leucovorin|mesh-list
83073537|NCT02128425|Fluorouracil|fluorouracil|mesh-list
83073538|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
83073539|NCT02128425|Irinotecan|irinotecan|mesh-list
83073540|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
83073541|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
83073542|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073543|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073544|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073545|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073546|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
83073547|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073548|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83073549|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83073550|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073551|NCT02128425|Antidotes|antidotes|mesh-ancestor
83073552|NCT02128425|Protective Agents|protective agents|mesh-ancestor
83073553|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
83073554|NCT02128425|Vitamins|vitamins|mesh-ancestor
83073555|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
83073556|NCT05641194|Caffeine|caffeine|mesh-list
83073557|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83073558|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073559|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83073560|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440127|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
83073561|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073562|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83073563|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83073564|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
83073565|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073566|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
83073567|NCT03532620|Atorvastatin|atorvastatin|mesh-list
83073568|NCT03532620|Pitavastatin|pitavastatin|mesh-list
83073569|NCT03532620|Calcium|calcium|mesh-list
83073570|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83073571|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073572|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83073573|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83073574|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83073575|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
83073576|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073577|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83073578|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83073579|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073580|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
83073581|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83073582|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
83073583|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83073584|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073585|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83073587|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83073588|NCT03529032|Narcotics|narcotics|mesh-ancestor
83073589|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073590|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073591|NCT03529032|Analgesics|analgesics|mesh-ancestor
83073592|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
83073593|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073594|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
83073595|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
83073596|NCT02122731|Amiloride|amiloride|mesh-list
83073597|NCT02122731|Diuretics|diuretics|mesh-ancestor
83073598|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
83073599|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073600|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83073601|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83073602|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83073603|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073604|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83073605|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83073606|NCT05458726|Paclitaxel|paclitaxel|mesh-list
83073607|NCT05458726|Carboplatin|carboplatin|mesh-list
83073608|NCT05458726|Pemetrexed|pemetrexed|mesh-list
83073609|NCT05458726|Osimertinib|osimertinib|mesh-list
83073610|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83073611|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073612|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
83073613|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
83073614|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
83073615|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073616|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073617|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83073618|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83073619|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83073620|NCT02122809|Chiauranib|chiauranib|mesh-list
83073621|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073622|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83073623|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073624|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073625|NCT00150618|Guanfacine|guanfacine|mesh-list
83073626|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073627|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83073628|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83073629|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83073630|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
83073631|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073632|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073633|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073634|NCT05455294|Decitabine|decitabine|mesh-list
83073635|NCT05455294|Venetoclax|venetoclax|mesh-list
83073636|NCT05455294|Navitoclax|navitoclax|mesh-list
83073637|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073638|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
83073639|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073640|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073641|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073642|NCT03532464|Azithromycin|azithromycin|mesh-list
83073643|NCT03532464|Doxycycline|doxycycline|mesh-list
83073644|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83073645|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073646|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
83073647|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83073648|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83073649|NCT02128893|Isavuconazole|isavuconazole|mesh-list
83073650|NCT02128893|Esomeprazole|esomeprazole|mesh-list
83073651|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83073652|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83073653|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83073654|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073655|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073656|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
83073657|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073658|NCT02124369|Paclitaxel|paclitaxel|mesh-list
83073659|NCT02124369|Gemcitabine|gemcitabine|mesh-list
83073660|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83073661|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83073662|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073663|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83073664|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
83073665|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83073666|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073667|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073668|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
83073669|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
83073670|NCT02128971|Trace Elements|trace elements|mesh-ancestor
83073671|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
83073672|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073673|NCT02288208|Tenofovir|tenofovir|mesh-list
83073674|NCT02288208|Entecavir|entecavir|mesh-list
83073675|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
83073676|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073677|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83073678|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83073679|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073680|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073681|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83073682|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83073683|NCT02288286|Vaccines|vaccines|mesh-list
83073684|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
83073685|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073686|NCT02251977|Leucovorin|leucovorin|mesh-list
83073687|NCT02251977|Fluorouracil|fluorouracil|mesh-list
83073688|NCT02251977|Capecitabine|capecitabine|mesh-list
83073689|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073690|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
83073691|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073692|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073693|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073694|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073695|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
83073696|NCT02251977|Antidotes|antidotes|mesh-ancestor
83073697|NCT02251977|Protective Agents|protective agents|mesh-ancestor
83073698|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
83073699|NCT02251977|Vitamins|vitamins|mesh-ancestor
83073700|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
83073701|NCT03528954|Propofol|propofol|mesh-list
83073702|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83073703|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073704|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073705|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83073706|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
83073707|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
83073708|NCT02125227|Metformin|metformin|mesh-list
83073709|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83073710|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83073711|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073712|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83073713|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83073714|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
83073715|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073716|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83073717|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83073718|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073719|NCT02129127|Paclitaxel|paclitaxel|mesh-list
83073720|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83073721|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073722|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
83073723|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
83073724|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
83073725|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073726|NCT05554822|Aspirin|aspirin|mesh-list
83073727|NCT05554822|Clopidogrel|clopidogrel|mesh-list
83073728|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83073729|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83073730|NCT05554822|Analgesics|analgesics|mesh-ancestor
83073731|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
83073732|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073733|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073734|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073735|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073736|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83073737|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83073738|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073739|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83073740|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83073741|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073742|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
83073743|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83073744|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83073745|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83073746|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
83073747|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073748|NCT02125305|Metformin|metformin|mesh-list
83073749|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83073750|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073751|NCT00254904|Cisplatin|cisplatin|mesh-list
83073752|NCT00254904|Gemcitabine|gemcitabine|mesh-list
83073753|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073754|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073755|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
83073756|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073757|NCT05725122|Tamsulosin|tamsulosin|mesh-list
83073758|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83073759|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83073760|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83073761|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
83073763|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073764|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073765|NCT05725122|Urological Agents|urological agents|mesh-ancestor
83073766|NCT03880396|Cisplatin|cisplatin|mesh-list
83073767|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073768|NCT05554276|Antibodies|antibodies|mesh-list
83073769|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
83073770|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073771|NCT00253968|SR 46349B|sr 46349b|mesh-list
83073772|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83073773|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83073774|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073775|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83073776|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83073777|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
83073778|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073779|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073780|NCT03544606|Pyridoxine|pyridoxine|mesh-list
83073781|NCT03544606|Isosorbide|isosorbide|mesh-list
83073782|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83073783|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83073784|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83073785|NCT03544606|Diuretics|diuretics|mesh-ancestor
83073786|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
83073787|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073788|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
83073789|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83073790|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073791|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
83073792|NCT03544606|Vitamins|vitamins|mesh-ancestor
83073793|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
83073794|NCT02741310|Sumatriptan|sumatriptan|mesh-list
83073795|NCT02741310|Erenumab|erenumab|mesh-list
83073796|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83073797|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83073798|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83073799|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
83073800|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073801|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073802|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073803|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83073804|NCT02741310|Analgesics|analgesics|mesh-ancestor
83073805|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
83073806|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073807|NCT05700448|Gemcitabine|gemcitabine|mesh-list
83073808|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
83073809|NCT05700448|Pegaspargase|pegaspargase|mesh-list
83073810|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073811|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
83073812|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073813|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073814|NCT00243906|Plasminogen|plasminogen|mesh-list
83073815|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83073816|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83073817|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83073818|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073819|NCT03532360|Immunomodulating Agents|immunomodulating agents|mesh-list
83073820|NCT03532360|Immunologic Factors|immunologic factors|mesh-ancestor
83073821|NCT03532360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073822|NCT01367457|Sirolimus|sirolimus|mesh-list
83073823|NCT01367457|Temsirolimus|temsirolimus|mesh-list
83073824|NCT01367457|MTOR Inhibitors|mtor inhibitors|mesh-list
83073825|NCT01367457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83073826|NCT01367457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073827|NCT01367457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073828|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073829|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
83073830|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073831|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073832|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83073833|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073834|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83073835|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
83361842|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83073836|NCT05553496|Cyclosporine|cyclosporine|mesh-list
83073837|NCT05553496|Dexamethasone|dexamethasone|mesh-list
83073838|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
83073839|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
83073840|NCT05553496|Rituximab|rituximab|mesh-list
83073841|NCT05553496|Tacrolimus|tacrolimus|mesh-list
83073842|NCT05553496|Cyclosporins|cyclosporins|mesh-list
83073843|NCT05553496|BB 1101|bb 1101|mesh-list
83073844|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073845|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
83073846|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073847|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073848|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83073849|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
83073850|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073851|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073852|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83073853|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83073854|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073855|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
83073856|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
83073857|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073858|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83073859|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
83073860|NCT05553496|Hormones|hormones|mesh-ancestor
83073861|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073862|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83073863|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
83073864|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073865|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83073866|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
83073867|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073868|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
83073869|NCT00239694|Vaccines|vaccines|mesh-list
83073870|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83073871|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
83073872|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073873|NCT05549284|Rituximab|rituximab|mesh-list
83073874|NCT05549284|Methotrexate|methotrexate|mesh-list
83073875|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83073876|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073877|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
83073878|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073879|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83073880|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83073881|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
83073882|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83073883|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83073884|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
83073885|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073886|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
83073887|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073888|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83073889|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073890|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83073891|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83073892|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83073893|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073894|NCT00232752|Sirolimus|sirolimus|mesh-list
83073895|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83073896|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073897|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83073898|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073899|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
83073900|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83073901|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
83073902|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073903|NCT02125617|Prednisolone|prednisolone|mesh-list
83073904|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073905|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
83073906|NCT02125617|Hormones|hormones|mesh-ancestor
83073907|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073908|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073909|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83073910|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073911|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83073912|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
83073913|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83073914|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83073915|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83073916|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83073917|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073919|NCT00229008|Ceftazidime|ceftazidime|mesh-list
83073920|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
83073921|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83073922|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83073923|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073924|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83073925|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073926|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073927|NCT05553184|Niacin|niacin|mesh-list
83073928|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
83073929|NCT05553184|Niacinamide|niacinamide|mesh-list
83073930|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
83073931|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83073932|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
83073933|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073934|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073935|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83073936|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
83073937|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83073938|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83073939|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83073940|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
83073941|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83073942|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073943|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83073944|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
83073945|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83073946|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
83073947|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
83073948|NCT05553184|Vitamins|vitamins|mesh-ancestor
83073949|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
83073950|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
83073951|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
83073952|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073953|NCT05242029|Psilocybin|psilocybin|mesh-list
83073954|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
83073955|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073956|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83073958|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83073959|NCT03528564|Hematinics|hematinics|mesh-ancestor
83073960|NCT03531372|Antacids|antacids|mesh-list
83073961|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073962|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83073963|NCT02129595|Resveratrol|resveratrol|mesh-list
83073964|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
83073965|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073966|NCT02129595|Protective Agents|protective agents|mesh-ancestor
83073967|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073968|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073969|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83073970|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83073971|NCT02129673|Latanoprost|latanoprost|mesh-list
83073972|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83073973|NCT02260557|Selexipag|selexipag|mesh-list
83073974|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83073975|NCT02129829|Tenofovir|tenofovir|mesh-list
83073976|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
83073977|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83073978|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83073979|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83073980|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073981|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83073982|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83073983|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83073984|NCT02494882|Dexamethasone|dexamethasone|mesh-list
83073985|NCT02494882|Dasatinib|dasatinib|mesh-list
83073986|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83073987|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
83073988|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
83073989|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83073990|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83073991|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83073992|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
83073993|NCT02494882|Hormones|hormones|mesh-ancestor
83440153|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83073994|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83073995|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83073996|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83073997|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83073998|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83073999|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074000|NCT02129985|Metformin|metformin|mesh-list
83074001|NCT02129985|Exenatide|exenatide|mesh-list
83074002|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83074003|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074004|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83074005|NCT02129985|Incretins|incretins|mesh-ancestor
83074006|NCT02129985|Hormones|hormones|mesh-ancestor
83074007|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074008|NCT01730638|Histamine|histamine|mesh-list
83074009|NCT01730638|Glycine|glycine|mesh-list
83074010|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
83074011|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
83074012|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074013|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074014|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074015|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
83074016|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
83074017|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83074018|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074019|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074020|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074021|NCT02252523|Analgesics|analgesics|mesh-ancestor
83074022|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
83074023|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074024|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83074025|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83074026|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83074027|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074028|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074029|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074030|NCT02132091|Vitamins|vitamins|mesh-list
83074031|NCT02132091|Vitamin E|vitamin e|mesh-list
83074032|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
83074033|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074034|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
83074035|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074036|NCT02132091|Protective Agents|protective agents|mesh-ancestor
83074037|NCT05548348|Aflutinib|aflutinib|mesh-list
83074038|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83074039|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074040|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074041|NCT05726370|Carboplatin|carboplatin|mesh-list
83074042|NCT05726370|Docetaxel|docetaxel|mesh-list
83074043|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
83074044|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074045|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
83074046|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
83074047|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
83074048|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074049|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074050|NCT05726370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83074051|NCT04469010|Iron|iron|mesh-list
83074052|NCT04469010|Chelating Agents|chelating agents|mesh-list
83074053|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
83074054|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074055|NCT04469010|Trace Elements|trace elements|mesh-ancestor
83074056|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074057|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
83074058|NCT01121224|Clopidogrel|clopidogrel|mesh-list
83074059|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83074060|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83074061|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83074062|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83074064|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074065|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074066|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074067|NCT00138762|Atorvastatin|atorvastatin|mesh-list
83074068|NCT00138762|Torcetrapib|torcetrapib|mesh-list
83074069|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83074070|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83074071|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
83074072|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074073|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83074074|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83074075|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074076|NCT03531294|Aflibercept|aflibercept|mesh-list
83074077|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83074078|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83074079|NCT03531294|Growth Substances|growth substances|mesh-ancestor
83074080|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074081|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
83074082|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074083|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
83074084|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83074085|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83074086|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83074087|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074088|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074089|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
83074090|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074091|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074092|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83074093|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074094|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
83074095|NCT05551624|Atorvastatin|atorvastatin|mesh-list
83074096|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83074097|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83074098|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83074099|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
83074100|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074101|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83074102|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83074103|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074104|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
83074105|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074106|NCT05551624|Expectorants|expectorants|mesh-ancestor
83074107|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
83074109|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
83074110|NCT05551624|Protective Agents|protective agents|mesh-ancestor
83074111|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074112|NCT05551624|Antidotes|antidotes|mesh-ancestor
83074113|NCT00134238|Atorvastatin|atorvastatin|mesh-list
83074114|NCT00134238|Torcetrapib|torcetrapib|mesh-list
83074115|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83074116|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83074117|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
83074118|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074119|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83074120|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83074121|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074122|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83074123|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83074124|NCT03550677|Anesthetics|anesthetics|mesh-list
83074125|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074126|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074127|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
83074128|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074129|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
83074130|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074131|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074132|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83074133|NCT02132403|Milk fat globule|milk fat globule|mesh-list
83074134|NCT02132403|Gemcitabine|gemcitabine|mesh-list
83074135|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83074136|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
83074137|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074138|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074139|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074141|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83074142|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
83074143|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074144|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074145|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074146|NCT05699824|Carvedilol|carvedilol|mesh-list
83074147|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83074148|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83074149|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074150|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074151|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074152|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074153|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83074154|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
83074155|NCT05699824|Protective Agents|protective agents|mesh-ancestor
83074156|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83074157|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074158|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83074159|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
83074160|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83074161|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83074162|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83074163|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83074164|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
83074165|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074166|NCT00126984|Vaccines|vaccines|mesh-list
83074167|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
83074168|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074169|NCT02136147|Guanfacine|guanfacine|mesh-list
83074170|NCT02136147|Methylphenidate|methylphenidate|mesh-list
83074171|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83074172|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83074173|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83074174|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074175|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83074176|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83074177|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074178|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074179|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
83482369|NCT00531518|Aripiprazole|aripiprazole|mesh-list
83074180|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074181|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83074182|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074183|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83074184|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83074185|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83074186|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83074188|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
83074189|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83074190|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
83074191|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074192|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074193|NCT03549897|Albuterol|albuterol|mesh-list
83074194|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83074195|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
83074196|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074197|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074198|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83074199|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
83074200|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
83074201|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83074202|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83074203|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83074204|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83074205|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074206|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074207|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074208|NCT02133105|Simendan|simendan|mesh-list
83074209|NCT02133105|Dobutamine|dobutamine|mesh-list
83074210|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83074211|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
83074212|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83074213|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83074214|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074215|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074216|NCT02133105|Protective Agents|protective agents|mesh-ancestor
83074217|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074218|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
83074219|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
83074220|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074221|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83074222|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83074223|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83074224|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074225|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074226|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
83074227|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074228|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
83074229|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
83074230|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83074231|NCT02136693|Psyllium|psyllium|mesh-list
83074232|NCT02136693|Cathartics|cathartics|mesh-ancestor
83074233|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83074234|NCT02136771|Vitamin D|vitamin d|mesh-list
83074235|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
83074236|NCT02136771|Vitamins|vitamins|mesh-ancestor
83074237|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
83074238|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074239|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83074240|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83074241|NCT00125970|Vaccines|vaccines|mesh-list
83074242|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
83074243|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074244|NCT03549663|Prednisone|prednisone|mesh-list
83074245|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
83074246|NCT03549663|Tacrolimus|tacrolimus|mesh-list
83074247|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074248|NCT03549663|Hormones|hormones|mesh-ancestor
83074249|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074250|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074251|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83074252|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074253|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074254|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
83074255|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83074256|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074257|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074258|NCT02137083|Docetaxel|docetaxel|mesh-list
83074259|NCT02137083|Fulvestrant|fulvestrant|mesh-list
83074260|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074261|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83074262|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83074263|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83074264|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074265|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83074266|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83074267|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83074268|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
83074269|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074270|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074271|NCT02137161|Tobramycin|tobramycin|mesh-list
83074272|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
83074273|NCT02137161|Dexamethasone|dexamethasone|mesh-list
83074274|NCT02137161|Bromfenac|bromfenac|mesh-list
83074275|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83074276|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074277|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
83074278|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
83074279|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074280|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074281|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83074282|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
83074283|NCT02137161|Hormones|hormones|mesh-ancestor
83361843|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074284|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074285|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83074286|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074287|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83074288|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83074289|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074290|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83074291|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074292|NCT02137161|Analgesics|analgesics|mesh-ancestor
83074293|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
83074294|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074295|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83074296|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074297|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
83074298|NCT03527628|Dacarbazine|dacarbazine|mesh-list
83074299|NCT03527628|Doxorubicin|doxorubicin|mesh-list
83074300|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83074301|NCT03527628|Bleomycin|bleomycin|mesh-list
83074302|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83074303|NCT03527628|Vinblastine|vinblastine|mesh-list
83074304|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074305|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
83074306|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074307|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074308|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83074309|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
83074310|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074311|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074312|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83074313|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83074314|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83074315|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83074316|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074317|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074318|NCT03527628|Immunotoxins|immunotoxins|mesh-ancestor
83074319|NCT03527628|Immunoconjugates|immunoconjugates|mesh-ancestor
83074320|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83074321|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
83074322|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
83074323|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
83074324|NCT04466670|Aspirin|aspirin|mesh-list
83074325|NCT04466670|Heparin|heparin|mesh-list
83074326|NCT04466670|Calcium heparin|calcium heparin|mesh-list
83074327|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83074328|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074329|NCT04466670|Analgesics|analgesics|mesh-ancestor
83074330|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
83074332|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074333|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074334|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074335|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83074336|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83074337|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074338|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83074339|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83074340|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074341|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
83074342|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
83074343|NCT04468542|Triamcinolone|triamcinolone|mesh-list
83074344|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83074345|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83074346|NCT04468542|Bupivacaine|bupivacaine|mesh-list
83074347|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83074348|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
83074349|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
83074350|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074351|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074352|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
83074353|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074354|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074355|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
83074356|NCT04468542|Hormones|hormones|mesh-ancestor
83074357|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074358|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074359|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
83074360|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361844|NCT00118365|Analgesics|analgesics|mesh-ancestor
83074361|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074362|NCT03525522|Betamethasone|betamethasone|mesh-list
83074363|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83074364|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074365|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
83074366|NCT03525522|Hormones|hormones|mesh-ancestor
83074367|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074368|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074369|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83074370|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
83074371|NCT03228732|Fluoxetine|fluoxetine|mesh-list
83074372|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83074373|NCT03228732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83074374|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83074375|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074376|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074377|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074378|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
83074379|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074380|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83074381|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
83074382|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83074383|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83074384|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83074385|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074386|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83074387|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
83074388|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83074389|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83074390|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074391|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074392|NCT03222492|Immunotoxins|immunotoxins|mesh-ancestor
83074393|NCT03222492|Immunoconjugates|immunoconjugates|mesh-ancestor
83074394|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
83074395|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074396|NCT04466436|Tryptophan|tryptophan|mesh-list
83074397|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83074398|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
83074399|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83074400|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83074401|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
83074402|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83074403|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83074404|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83074405|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074406|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074407|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
83074408|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074409|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074410|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83074411|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074412|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074414|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83074415|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074416|NCT03008382|Metoprolol|metoprolol|mesh-list
83074417|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83074418|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83074419|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
83074420|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
83074421|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074422|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074423|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83074424|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83074425|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83074426|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074427|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074428|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074429|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
83074430|NCT02137239|Prednisone|prednisone|mesh-list
83074431|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
83074432|NCT02137239|Everolimus|everolimus|mesh-list
83074433|NCT02137239|Abatacept|abatacept|mesh-list
83074434|NCT02137239|Tacrolimus|tacrolimus|mesh-list
83074435|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
83074436|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074437|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
83074438|NCT02137239|Hormones|hormones|mesh-ancestor
83074439|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074440|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074441|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83074442|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074443|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074444|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
83074445|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83074446|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074447|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074448|NCT02137239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83074449|NCT02137239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83074450|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83074451|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83074452|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
83074453|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83074454|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074455|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
83074456|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
83074457|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074458|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83074459|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83074460|NCT02137239|Protective Agents|protective agents|mesh-ancestor
83074461|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83074462|NCT02137239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074463|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074464|NCT02137395|Dexamethasone|dexamethasone|mesh-list
83074465|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074466|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
83074467|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
83074468|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074469|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074470|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83074471|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
83074472|NCT02137395|Hormones|hormones|mesh-ancestor
83074473|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074474|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83074475|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074476|NCT02137629|Azacitidine|azacitidine|mesh-list
83074477|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83074478|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
83074479|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074480|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074481|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074482|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83074483|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83074484|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074485|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074486|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
83074487|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074488|NCT02261025|Aspirin|aspirin|mesh-list
83074489|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83074490|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074491|NCT02261025|Analgesics|analgesics|mesh-ancestor
83074492|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
83074493|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074494|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074495|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074496|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074497|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83074498|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83074499|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074500|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83074501|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83074502|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074503|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
83074504|NCT02925234|Bevacizumab|bevacizumab|mesh-list
83074505|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
83074506|NCT02925234|Nivolumab|nivolumab|mesh-list
83074507|NCT02925234|Trastuzumab|trastuzumab|mesh-list
83074508|NCT02925234|Ipilimumab|ipilimumab|mesh-list
83074509|NCT02925234|Atezolizumab|atezolizumab|mesh-list
83074510|NCT02925234|Durvalumab|durvalumab|mesh-list
83074511|NCT02925234|Pertuzumab|pertuzumab|mesh-list
83074512|NCT02925234|Panitumumab|panitumumab|mesh-list
83074513|NCT02925234|Sunitinib|sunitinib|mesh-list
83074514|NCT02925234|Lenvatinib|lenvatinib|mesh-list
83074515|NCT02925234|Olaparib|olaparib|mesh-list
83074516|NCT02925234|Palbociclib|palbociclib|mesh-list
83074517|NCT02925234|Trametinib|trametinib|mesh-list
83074518|NCT02925234|Axitinib|axitinib|mesh-list
83074519|NCT02925234|Afatinib|afatinib|mesh-list
83074520|NCT02925234|Vemurafenib|vemurafenib|mesh-list
83074521|NCT02925234|Dabrafenib|dabrafenib|mesh-list
83074522|NCT02925234|Crizotinib|crizotinib|mesh-list
83074523|NCT02925234|Talazoparib|talazoparib|mesh-list
83074524|NCT02925234|Rucaparib|rucaparib|mesh-list
83074525|NCT02925234|Entrectinib|entrectinib|mesh-list
83074526|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074527|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074528|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83074529|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83074530|NCT02925234|Growth Substances|growth substances|mesh-ancestor
83074531|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074532|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
83074533|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83074534|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074535|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83074536|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074537|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83074538|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
83074539|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83074540|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074541|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074542|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074543|NCT02137863|Analgesics|analgesics|mesh-ancestor
83074544|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
83074545|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074546|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83074547|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83074548|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83074549|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074550|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074551|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074552|NCT05177796|Paclitaxel|paclitaxel|mesh-list
83074553|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
83074554|NCT05177796|Carboplatin|carboplatin|mesh-list
83074555|NCT05177796|Doxorubicin|doxorubicin|mesh-list
83074556|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83074557|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
83074558|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83074559|NCT05177796|Daunorubicin|daunorubicin|mesh-list
83074560|NCT05177796|Panitumumab|panitumumab|mesh-list
83074561|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83074562|NCT05177796|Antibodies|antibodies|mesh-list
83074563|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
83074564|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83074565|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83074566|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074567|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83074568|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83074569|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83074570|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074571|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440176|NCT02998385|Cisplatin|cisplatin|mesh-list
83074572|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
83074573|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074574|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074575|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83074576|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
83074577|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83074578|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83074579|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83074580|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83074581|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074582|NCT05177796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83074583|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83074584|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
83074585|NCT02138019|Coagulants|coagulants|mesh-ancestor
83074586|NCT02133885|Minocycline|minocycline|mesh-list
83074587|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83074588|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074589|NCT02138409|Fentanyl|fentanyl|mesh-list
83074590|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83074591|NCT02138409|Narcotics|narcotics|mesh-ancestor
83074592|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074593|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074594|NCT02138409|Analgesics|analgesics|mesh-ancestor
83074595|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
83074596|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074597|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83074598|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83074599|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
83074600|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
83074601|NCT02138799|Rifampin|rifampin|mesh-list
83074602|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83074603|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
83074604|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83074605|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074606|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
83074607|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83074608|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074609|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074610|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83074611|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83074612|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83074613|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83074614|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83074615|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83074616|NCT05578287|Celecoxib|celecoxib|mesh-list
83074617|NCT05578287|Tislelizumab|tislelizumab|mesh-list
83074618|NCT05578287|Disitamab vedotin|disitamab vedotin|mesh-list
83074619|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83074620|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074621|NCT05578287|Analgesics|analgesics|mesh-ancestor
83074622|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
83074623|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074624|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074625|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83074626|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074627|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83074628|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83074629|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074630|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074631|NCT05578287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074632|NCT05578287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074633|NCT05578287|Immunoconjugates|immunoconjugates|mesh-ancestor
83074634|NCT05578287|Immunologic Factors|immunologic factors|mesh-ancestor
83074635|NCT02975271|Serlopitant|serlopitant|mesh-list
83074636|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83440186|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
83074637|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074638|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074639|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074640|NCT02741076|Oxymorphone|oxymorphone|mesh-list
83074641|NCT02741076|Morphine|morphine|mesh-list
83074642|NCT02741076|Oxycodone|oxycodone|mesh-list
83074643|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
83074644|NCT02741076|Narcotics|narcotics|mesh-ancestor
83074645|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074646|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074647|NCT02741076|Analgesics|analgesics|mesh-ancestor
83074648|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
83074649|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074650|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83074651|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83074652|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
83074653|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
83074654|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074655|NCT01666444|Doxorubicin|doxorubicin|mesh-list
83074656|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83074657|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83074658|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074659|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83074660|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83074661|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074662|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074664|NCT05543122|Methotrexate|methotrexate|mesh-list
83074665|NCT05543122|Atenolol|atenolol|mesh-list
83074666|NCT05543122|Lamotrigine|lamotrigine|mesh-list
83074667|NCT05543122|Lacosamide|lacosamide|mesh-list
83074668|NCT05543122|Levetiracetam|levetiracetam|mesh-list
83074669|NCT05543122|Brivaracetam|brivaracetam|mesh-list
83074670|NCT05543122|Bupropion|bupropion|mesh-list
83074671|NCT05543122|Ezetimibe|ezetimibe|mesh-list
83074672|NCT05543122|Escitalopram|escitalopram|mesh-list
83074673|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83074674|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
83074675|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83074676|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074677|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83074678|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
83074679|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074680|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074681|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
83074682|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074683|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83074684|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074685|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
83074686|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83074687|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83074688|NCT05543122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83074689|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83074690|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074691|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074692|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
83074693|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
83074694|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074695|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83074696|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
83074697|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83074698|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83074699|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83074700|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83074701|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83074702|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
83074703|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83074704|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83440193|NCT04397510|Heparin|heparin|mesh-list
83074705|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
83074706|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
83074707|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
83074708|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074709|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83074710|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83074711|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
83074712|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074713|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83074714|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83074715|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83074716|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83074717|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83074718|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83074719|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074720|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83074721|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83074722|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83074723|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83074724|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
83074725|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83074726|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83074727|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83074728|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074729|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83074730|NCT05120934|Amitriptyline|amitriptyline|mesh-list
83074731|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83074732|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83074733|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074734|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074735|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074736|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074737|NCT05120934|Analgesics|analgesics|mesh-ancestor
83074738|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
83074739|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074740|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
83074741|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83074742|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
83074743|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83074744|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074745|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83074746|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074747|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
83074748|NCT03548493|Fentanyl|fentanyl|mesh-list
83074749|NCT03548493|Propofol|propofol|mesh-list
83074750|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83074751|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074752|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074753|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83074754|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
83074755|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
83074756|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83074757|NCT03548493|Narcotics|narcotics|mesh-ancestor
83074758|NCT03548493|Analgesics|analgesics|mesh-ancestor
83074759|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
83074760|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074761|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83074762|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83074763|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
83074764|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83074765|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074766|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074767|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83074768|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
83074769|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83074770|NCT02139267|Vaccines|vaccines|mesh-list
83074771|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
83440198|NCT00704717|Ribavirin|ribavirin|mesh-list
83074772|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074773|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83074774|NCT03549819|Cannabidiol|cannabidiol|mesh-list
83074775|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
83074776|NCT03549741|Cabergoline|cabergoline|mesh-list
83074777|NCT03549741|Clomiphene|clomiphene|mesh-list
83074778|NCT03549741|Enclomiphene|enclomiphene|mesh-list
83074779|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
83074780|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074781|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83074782|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
83074783|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83074784|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074785|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83074786|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
83074787|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83074788|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83074789|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83074790|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83074791|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83074792|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
83074793|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
83074794|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074795|NCT03522402|Sevoflurane|sevoflurane|mesh-list
83074796|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83074797|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83074798|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
83074799|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
83074800|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074801|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074802|NCT02134899|Everolimus|everolimus|mesh-list
83074803|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83074804|NCT02134899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83074805|NCT02134899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83074806|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074807|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074808|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074809|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
83074810|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074811|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074812|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
83074813|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83074814|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074815|NCT02135055|Midazolam|midazolam|mesh-list
83074816|NCT02135055|Morphine|morphine|mesh-list
83074817|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83074818|NCT02135055|Narcotics|narcotics|mesh-ancestor
83074819|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074820|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074821|NCT02135055|Analgesics|analgesics|mesh-ancestor
83074822|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
83074823|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074824|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83074825|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83074826|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83074827|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83074828|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83074829|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83074830|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
83074831|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
83074832|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
83074833|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
83074834|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074835|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074836|NCT05546710|Anesthetics|anesthetics|mesh-list
83074837|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074838|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074839|NCT02139579|Bevacizumab|bevacizumab|mesh-list
83074840|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074841|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074842|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83074843|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83074844|NCT02139579|Growth Substances|growth substances|mesh-ancestor
83074845|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074846|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
83074847|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
83074848|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
83074849|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074850|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
83074851|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83074852|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074853|NCT04076826|Midazolam|midazolam|mesh-list
83074854|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
83074855|NCT04076826|Propofol|propofol|mesh-list
83074856|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83074857|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074858|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074859|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83074860|NCT04076826|Analgesics|analgesics|mesh-ancestor
83074861|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
83074862|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074863|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83074864|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83074865|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83074866|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
83074867|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074868|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074869|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83074870|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
83074871|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
83074872|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83074873|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83074874|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83074875|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83074876|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
83074877|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
83074878|NCT05577585|Midazolam|midazolam|mesh-list
83074879|NCT05577585|Ketamine|ketamine|mesh-list
83074880|NCT05577585|Analgesics|analgesics|mesh-ancestor
83074881|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
83074882|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074883|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074884|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83074885|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83074886|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
83074887|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
83074888|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074889|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83074890|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83074891|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074892|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074893|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83074894|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83074895|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83074896|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83074897|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83074898|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
83074899|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
83074900|NCT04465968|Durvalumab|durvalumab|mesh-list
83074901|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83074902|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074903|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83074904|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
83074905|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074906|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
83074907|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83074908|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074909|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
83074910|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
83074911|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
83074912|NCT05577507|Calcium|calcium|mesh-list
83074913|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83074914|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074915|NCT05577507|Antacids|antacids|mesh-ancestor
83074916|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074917|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83074918|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83074919|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83074920|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
83074921|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83074922|NCT01565655|Peficitinib|peficitinib|mesh-list
83074923|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074924|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074925|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83074926|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
83074927|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074928|NCT05535322|Insulin|insulin|mesh-list
83074929|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83074930|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074932|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
83074933|NCT05577273|Penicillins|penicillins|mesh-list
83074934|NCT05577273|Cefuroxime|cefuroxime|mesh-list
83074935|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
83074936|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83074937|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83074938|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
83074939|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83074940|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83074941|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83074942|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83074943|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074944|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83074945|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83074946|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83074947|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83074948|NCT02252913|Docetaxel|docetaxel|mesh-list
83074949|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074950|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
83074951|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
83074952|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
83074953|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074954|NCT02253459|Capecitabine|capecitabine|mesh-list
83074955|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83074956|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
83074957|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074958|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83074959|NCT02140047|Vaccines|vaccines|mesh-list
83074960|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
83074961|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074962|NCT02135913|Vitamin D|vitamin d|mesh-list
83074963|NCT02135913|Vitamins|vitamins|mesh-ancestor
83074964|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
83074965|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074966|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83074967|NCT02140125|ASP2408|asp2408|mesh-list
83074968|NCT02140125|Immunoconjugates|immunoconjugates|mesh-ancestor
83074969|NCT02140125|Immunologic Factors|immunologic factors|mesh-ancestor
83074970|NCT02140125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074971|NCT05505279|Nicotine|nicotine|mesh-list
83074972|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83074973|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
83074974|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074975|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074976|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83074977|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83074978|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
83074979|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83074980|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074981|NCT05541640|Lidocaine|lidocaine|mesh-list
83074982|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
83074983|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
83074984|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83074985|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074986|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
83074987|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83074988|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83074989|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83074990|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83074991|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83074992|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83074993|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
83074994|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
83074995|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83074996|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83074997|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83074998|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83074999|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075000|NCT02140281|Cefadroxil|cefadroxil|mesh-list
83075001|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83075002|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075003|NCT05541328|Tisagenlecleucel|tisagenlecleucel|mesh-list
83075004|NCT05541328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075006|NCT05545462|Doxycycline|doxycycline|mesh-list
83075007|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83075008|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075009|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
83075010|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83075011|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83075012|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
83075013|NCT05541172|Testosterone|testosterone|mesh-list
83075014|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
83075015|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
83075016|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83075017|NCT05541172|Androgens|androgens|mesh-ancestor
83075018|NCT05541172|Hormones|hormones|mesh-ancestor
83075019|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075020|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075021|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83075022|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075023|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
83075024|NCT05478993|Dexamethasone|dexamethasone|mesh-list
83075025|NCT05478993|Pomalidomide|pomalidomide|mesh-list
83075026|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075027|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
83075028|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
83075029|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075030|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075031|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83075032|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
83075033|NCT05478993|Hormones|hormones|mesh-ancestor
83075034|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075035|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83075036|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075037|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
83075038|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83075039|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83075040|NCT05478993|Growth Substances|growth substances|mesh-ancestor
83075041|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
83075042|NCT05699356|Estrogens|estrogens|mesh-list
83075043|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83075044|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075045|NCT05699356|Hormones|hormones|mesh-ancestor
83075046|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075047|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83075048|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075049|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075050|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83075051|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
83075052|NCT02140437|Fulvestrant|fulvestrant|mesh-list
83075053|NCT02140437|Anastrozole|anastrozole|mesh-list
83075054|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83075055|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075056|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83075057|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83075058|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
83075059|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075060|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075061|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83075062|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83075063|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075064|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075065|NCT05591560|Itraconazole|itraconazole|mesh-list
83075066|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
83075067|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075068|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83075069|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83075070|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075071|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075072|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83075073|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
83075074|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075075|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075076|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83075077|NCT05540470|Chloroquine|chloroquine|mesh-list
83075078|NCT05540470|Primaquine|primaquine|mesh-list
83075079|NCT05540470|Tafenoquine|tafenoquine|mesh-list
83075080|NCT05540470|Amebicides|amebicides|mesh-ancestor
83075081|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83075082|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83075083|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075084|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
83075085|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83075086|NCT05575167|Vitamin D|vitamin d|mesh-list
83075087|NCT05575167|Alendronate|alendronate|mesh-list
83075088|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
83075089|NCT05575167|Vitamins|vitamins|mesh-ancestor
83075090|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
83075091|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075092|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83075093|NCT02140515|Hormones|hormones|mesh-list
83075094|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83075095|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075096|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075097|NCT02260947|Ibuprofen|ibuprofen|mesh-list
83075098|NCT02260947|Pregabalin|pregabalin|mesh-list
83075099|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83075100|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83075101|NCT02260947|Analgesics|analgesics|mesh-ancestor
83075102|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
83075103|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075104|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075105|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075106|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83075107|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83075108|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075109|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075110|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
83075111|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83075112|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83075113|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83075114|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83075115|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83075116|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075117|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83075118|NCT03547791|Betamethasone|betamethasone|mesh-list
83075119|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
83075120|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83075121|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
83075122|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83075123|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
83075124|NCT03547791|Hormones|hormones|mesh-ancestor
83075125|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075126|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440212|NCT03632642|Floxacillin|floxacillin|mesh-list
83075127|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075128|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075129|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075130|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
83075131|NCT04818177|Antibodies|antibodies|mesh-list
83075132|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
83075133|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83075134|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83075135|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
83075136|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075137|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83075138|NCT04425460|Favipiravir|favipiravir|mesh-list
83075139|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
83075140|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075141|NCT05576272|Gemcitabine|gemcitabine|mesh-list
83075142|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075143|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83075144|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
83075145|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075146|NCT05576116|Pancrelipase|pancrelipase|mesh-list
83075147|NCT05576116|Pancreatin|pancreatin|mesh-list
83075148|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83075149|NCT04765137|Atorvastatin|atorvastatin|mesh-list
83075150|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83075151|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83075152|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
83075153|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075154|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83075155|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83075156|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075157|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
83075158|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
83075159|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
83075160|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075161|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075162|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
83075163|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075164|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
83075165|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
83075166|NCT04703673|Ephedrine|ephedrine|mesh-list
83075167|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
83075168|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83075169|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075170|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83075171|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075172|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
83075173|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075174|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
83075175|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075176|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075177|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83075178|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075179|NCT05543746|Brexanolone|brexanolone|mesh-list
83075180|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
83075181|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075182|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075183|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075184|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
83075185|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
83075186|NCT03526536|Insulin|insulin|mesh-list
83075187|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83075188|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83075189|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075190|NCT05306301|Ponatinib|ponatinib|mesh-list
83075191|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075192|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075193|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075194|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075195|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
83075196|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83075197|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
83075198|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075199|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
83075200|NCT05543434|Protective Agents|protective agents|mesh-ancestor
83075201|NCT01858896|Glucagon|glucagon|mesh-list
83075202|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83075203|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83075204|NCT01858896|Hormones|hormones|mesh-ancestor
83075205|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075206|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075207|NCT01858896|Incretins|incretins|mesh-ancestor
83075208|NCT04940286|Paclitaxel|paclitaxel|mesh-list
83075209|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83075210|NCT04940286|Gemcitabine|gemcitabine|mesh-list
83075211|NCT04940286|Durvalumab|durvalumab|mesh-list
83075212|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
83075213|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83075214|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
83075215|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83075216|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075217|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
83075218|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
83075219|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
83075220|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075221|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83075222|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
83075223|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075224|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
83075225|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075226|NCT05538988|Cemiplimab|cemiplimab|mesh-list
83075227|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075228|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075229|NCT04667637|Edaravone|edaravone|mesh-list
83075230|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83075231|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
83075232|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075233|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83075234|NCT04667637|Protective Agents|protective agents|mesh-ancestor
83075235|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075236|NCT02253927|Ritonavir|ritonavir|mesh-list
83075237|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83075238|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83075239|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
83075240|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075241|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075242|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83075243|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83075244|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
83075245|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075246|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83075247|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83075248|NCT05572749|Metformin|metformin|mesh-list
83075249|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83075250|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075251|NCT03745144|Cladribine|cladribine|mesh-list
83075252|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83075253|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83075254|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075255|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075256|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
83075257|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075258|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83075259|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
83075260|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83075261|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83075262|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83075263|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83075264|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83075265|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83075266|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83075267|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83075268|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83075269|NCT05697016|Sivelestat|sivelestat|mesh-list
83075270|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83075271|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
83075272|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075273|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075274|NCT04634877|Paclitaxel|paclitaxel|mesh-list
83075275|NCT04634877|Docetaxel|docetaxel|mesh-list
83075276|NCT04634877|Cisplatin|cisplatin|mesh-list
83075277|NCT04634877|Carboplatin|carboplatin|mesh-list
83075278|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
83075279|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83075280|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075281|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
83075282|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
83075283|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
83075284|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075285|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075286|NCT04634877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83075287|NCT04629495|Sirolimus|sirolimus|mesh-list
83075288|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83075289|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075290|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83075291|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075292|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
83075293|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075294|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
83075295|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075296|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
83075297|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075298|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
83075299|NCT01567995|Hormones|hormones|mesh-ancestor
83075300|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075301|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075302|NCT05567523|Midazolam|midazolam|mesh-list
83075303|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
83075304|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83075305|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075306|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075307|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83075308|NCT05567523|Analgesics|analgesics|mesh-ancestor
83075309|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
83075310|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075311|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83075312|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83075313|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83075314|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83075315|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075316|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075317|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83075318|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83075319|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83075320|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83075321|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83075322|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
83075323|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
83075324|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
83075325|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
83075326|NCT02584504|Atorvastatin|atorvastatin|mesh-list
83075327|NCT02584504|Alirocumab|alirocumab|mesh-list
83075328|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83075329|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83075330|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
83075331|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075332|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83075333|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83075334|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075335|NCT02584504|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83075336|NCT02584504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83361845|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
83075337|NCT02584504|Protease Inhibitors|protease inhibitors|mesh-ancestor
83075338|NCT04599777|Sorafenib|sorafenib|mesh-list
83075339|NCT04599777|Tislelizumab|tislelizumab|mesh-list
83075340|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075341|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075342|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075343|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075344|NCT04599777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075345|NCT05180799|Nivolumab|nivolumab|mesh-list
83075346|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075347|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075348|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83075349|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075350|NCT05044468|Lidocaine|lidocaine|mesh-list
83075351|NCT05044468|Bupivacaine|bupivacaine|mesh-list
83075352|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
83075353|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
83075354|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075355|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075356|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
83075357|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075358|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83075359|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83075360|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83075361|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83075362|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075363|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
83075364|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075365|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075366|NCT05176509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83075367|NCT05176509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075368|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
83075369|NCT05007262|Calcium|calcium|mesh-list
83075370|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83075371|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075372|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
83075373|NCT05007262|Coagulants|coagulants|mesh-ancestor
83075374|NCT03546075|Resveratrol|resveratrol|mesh-list
83075375|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
83482370|NCT00531518|Bupropion|bupropion|mesh-list
83075376|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075377|NCT03546075|Protective Agents|protective agents|mesh-ancestor
83075378|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075379|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075380|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83075381|NCT05537584|Bupropion|bupropion|mesh-list
83075382|NCT05537584|Sertraline|sertraline|mesh-list
83075383|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83075384|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
83075385|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83075386|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83075387|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83075388|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83075389|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075390|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
83075391|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075392|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075393|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83075394|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83075395|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075396|NCT05537584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83075397|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
83075398|NCT01801072|Levetiracetam|levetiracetam|mesh-list
83075399|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
83075400|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
83075401|NCT04459377|Ketamine|ketamine|mesh-list
83075402|NCT04459377|Esketamine|esketamine|mesh-list
83075403|NCT04459377|Analgesics|analgesics|mesh-ancestor
83075404|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
83075405|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075406|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075407|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83075408|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83075409|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
83075410|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
83075411|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440238|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
83075412|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83075413|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83075414|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075415|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075416|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
83075417|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83075418|NCT00748618|Vitamin D|vitamin d|mesh-list
83075419|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
83075420|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
83075421|NCT00748618|Vitamins|vitamins|mesh-list
83075422|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
83075423|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075424|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83075425|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83075426|NCT04447755|Lenvatinib|lenvatinib|mesh-list
83075427|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075428|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075429|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075430|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075431|NCT02254005|Maytansine|maytansine|mesh-list
83075432|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
83075433|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83075434|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075435|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83075436|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83075437|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83075438|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075439|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075440|NCT02254005|Immunotoxins|immunotoxins|mesh-ancestor
83075441|NCT02254005|Immunoconjugates|immunoconjugates|mesh-ancestor
83075442|NCT02254005|Immunologic Factors|immunologic factors|mesh-ancestor
83075443|NCT02254005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075444|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
83075445|NCT04404387|Vitamins|vitamins|mesh-ancestor
83075446|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
83075447|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075448|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
83075449|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075450|NCT04404387|Protective Agents|protective agents|mesh-ancestor
83075451|NCT03546855|Apatinib|apatinib|mesh-list
83075452|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075453|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075454|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075455|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075456|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83075457|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075458|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
83075459|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075460|NCT05679310|Protective Agents|protective agents|mesh-ancestor
83075461|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075462|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83075463|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
83075464|NCT05537272|Tadalafil|tadalafil|mesh-list
83075465|NCT05537272|Tamsulosin|tamsulosin|mesh-list
83075466|NCT05537272|Vitamins|vitamins|mesh-ancestor
83075467|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
83075468|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075469|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
83075470|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075471|NCT05537272|Protective Agents|protective agents|mesh-ancestor
83075472|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
83075473|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83075474|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83075475|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075476|NCT05537272|Urological Agents|urological agents|mesh-ancestor
83075477|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83075478|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83075479|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83075480|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
83075481|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075482|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
83075483|NCT05537194|Calcium|calcium|mesh-list
83075484|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83075485|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361846|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075486|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83075487|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83075488|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075489|NCT05536882|Adapalene|adapalene|mesh-list
83075490|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83075491|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
83075492|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83075493|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83075494|NCT05536882|Analgesics|analgesics|mesh-ancestor
83075495|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
83075496|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075497|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075498|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075499|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83075500|NCT04605094|Benralizumab|benralizumab|mesh-list
83075501|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075502|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075503|NCT03931161|Evolocumab|evolocumab|mesh-list
83075504|NCT03931161|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83075505|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83075506|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83075507|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
83075508|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075509|NCT03931161|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83075510|NCT03931161|Protease Inhibitors|protease inhibitors|mesh-ancestor
83075511|NCT03931161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075512|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83075513|NCT05037123|Ketamine|ketamine|mesh-list
83075514|NCT05037123|Analgesics|analgesics|mesh-ancestor
83075515|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
83075516|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075517|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075518|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83075519|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83075520|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
83075521|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
83075522|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075523|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83075524|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83075525|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075526|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075527|NCT04354155|Enoxaparin|enoxaparin|mesh-list
83075528|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
83075529|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83075530|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83075531|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075532|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83075533|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
83075534|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075535|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
83075536|NCT04350021|Capecitabine|capecitabine|mesh-list
83075537|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075538|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
83075539|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075540|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83075541|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83075542|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
83075543|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075544|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075545|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83075546|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83075547|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
83075548|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83075549|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83075550|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075551|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075552|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83075553|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83075554|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075555|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
83075556|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075557|NCT03877965|Digoxin|digoxin|mesh-list
83075558|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83075560|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075561|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075562|NCT03877965|Protective Agents|protective agents|mesh-ancestor
83075563|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075564|NCT02253849|Ritonavir|ritonavir|mesh-list
83075565|NCT02253849|Tipranavir|tipranavir|mesh-list
83075566|NCT02253849|Carbamazepine|carbamazepine|mesh-list
83075567|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83075568|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83075569|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
83075570|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075571|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075572|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83075573|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83075574|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
83075575|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075576|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83075577|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83075578|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
83075579|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
83075580|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83075581|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075582|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075583|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83075584|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83075585|NCT02253849|Analgesics|analgesics|mesh-ancestor
83075586|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
83075587|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075588|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83075589|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83075590|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83075591|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83075592|NCT03545997|Montelukast|montelukast|mesh-list
83075593|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075594|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075595|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83075596|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
83482371|NCT00531518|Fluoxetine|fluoxetine|mesh-list
83075597|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075598|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075599|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83075600|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83075601|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075602|NCT05696548|Nivolumab|nivolumab|mesh-list
83075603|NCT05696548|Lenvatinib|lenvatinib|mesh-list
83075604|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075605|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075606|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83075607|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075608|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075609|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075610|NCT03810495|Naltrexone|naltrexone|mesh-list
83075611|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83075612|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83075613|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075614|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
83075615|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075616|NCT04980885|Azacitidine|azacitidine|mesh-list
83075617|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83075618|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
83075619|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075620|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075621|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075622|NCT04184505|Azacitidine|azacitidine|mesh-list
83075623|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83075624|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
83075625|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075626|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075627|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075628|NCT03691935|Ropivacaine|ropivacaine|mesh-list
83075629|NCT03691935|Anesthetics|anesthetics|mesh-list
83075630|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
83075631|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361847|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075632|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075633|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
83075634|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075635|NCT03760458|Lamivudine|lamivudine|mesh-list
83075636|NCT03760458|Abacavir|abacavir|mesh-list
83075637|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
83075638|NCT03760458|Dolutegravir|dolutegravir|mesh-list
83075639|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83075640|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83075641|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075642|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075643|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
83075644|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075645|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83075646|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83075647|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83075648|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83075649|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
83075650|NCT02066415|Erenumab|erenumab|mesh-list
83075651|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83075652|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075653|NCT02066415|Analgesics|analgesics|mesh-ancestor
83075654|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
83075655|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075656|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075657|NCT04467918|Cannabidiol|cannabidiol|mesh-list
83075658|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
83075659|NCT04720612|Omalizumab|omalizumab|mesh-list
83075660|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83075661|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075662|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075663|NCT01981551|Nirogacestat|nirogacestat|mesh-list
83075664|NCT01981551|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83075665|NCT01981551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075666|NCT01981551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075667|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
83075668|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83075669|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
83075670|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83075671|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
83075672|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075673|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075674|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
83075675|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83075676|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
83075677|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075678|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83075679|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83075680|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075681|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83075682|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075683|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075684|NCT04315558|Bromides|bromides|mesh-list
83075685|NCT04315558|Ipratropium|ipratropium|mesh-list
83075686|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
83075687|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83075688|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
83075689|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075690|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075691|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075692|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075693|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83075694|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
83075695|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075696|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075697|NCT04466904|Dulaglutide|dulaglutide|mesh-list
83075698|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83075699|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075700|NCT03524274|Antibodies|antibodies|mesh-list
83075701|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83075702|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
83075703|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075704|NCT02143479|Tacrolimus|tacrolimus|mesh-list
83075705|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075706|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
83075707|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075708|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83075709|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075710|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075711|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83075712|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83075713|NCT02254239|Everolimus|everolimus|mesh-list
83075714|NCT02254239|Antibodies|antibodies|mesh-list
83075715|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
83075716|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83075717|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
83075718|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
83075719|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075720|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075721|NCT02254239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83075722|NCT02254239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075723|NCT02254239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075724|NCT02254239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075725|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075726|NCT02254239|Immunotoxins|immunotoxins|mesh-ancestor
83075727|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
83075728|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83075729|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83075730|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
83075731|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075732|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075733|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83075734|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
83075735|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83075736|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
83075737|NCT05088369|Protective Agents|protective agents|mesh-ancestor
83075738|NCT05681182|Amiodarone|amiodarone|mesh-list
83075739|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83075740|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
83075741|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83075742|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83075743|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075744|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83075745|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83075746|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83075747|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075748|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83075749|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83075750|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83075751|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83075752|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83075753|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83075754|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
83075755|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075756|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83075757|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83075758|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075760|NCT02144025|Cyclosporins|cyclosporins|mesh-list
83075761|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075762|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075763|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075764|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
83075765|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075766|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
83075767|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075768|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
83075769|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83075770|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83075771|NCT03523650|Propranolol|propranolol|mesh-list
83075772|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83075773|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83075774|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
83075775|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83075776|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075777|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075778|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83075779|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83075780|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
83075781|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
83075782|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075783|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075784|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075785|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075786|NCT02582632|Ritonavir|ritonavir|mesh-list
83075787|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83075788|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83075789|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
83075790|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075791|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075792|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83075793|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83075794|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
83075795|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075796|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83075797|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83075798|NCT05414032|Cetuximab|cetuximab|mesh-list
83075799|NCT05414032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075800|NCT05414032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075801|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83075802|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
83075803|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075804|NCT05381974|Psilocybin|psilocybin|mesh-list
83075805|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
83075806|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075807|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83075808|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
83075809|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075810|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075811|NCT02178722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83075812|NCT02178722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075813|NCT03523572|Nivolumab|nivolumab|mesh-list
83075814|NCT03523572|Trastuzumab|trastuzumab|mesh-list
83075815|NCT03523572|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83075816|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075817|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075818|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83075819|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075820|NCT03523572|Immunoconjugates|immunoconjugates|mesh-ancestor
83075821|NCT03523572|Immunologic Factors|immunologic factors|mesh-ancestor
83075822|NCT03523572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075824|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
83075825|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075826|NCT03526224|Teriflunomide|teriflunomide|mesh-list
83075827|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83075828|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
83075829|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075830|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
83075831|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075832|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83075833|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83075834|NCT03526224|Analgesics|analgesics|mesh-ancestor
83075835|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
83075836|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075837|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075838|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83075839|NCT03639246|Paclitaxel|paclitaxel|mesh-list
83075840|NCT03639246|Doxorubicin|doxorubicin|mesh-list
83075841|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83075842|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83075843|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075844|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
83075845|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
83075846|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
83075847|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075848|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83075849|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83075850|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83075851|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075852|NCT00545324|Fluticasone|fluticasone|mesh-list
83075853|NCT00545324|Montelukast|montelukast|mesh-list
83075854|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83075855|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83075864|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83075865|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
83075866|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83075867|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83075868|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83075869|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
83075870|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
83075871|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83075872|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83075873|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075884|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
83075885|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83075886|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
83075887|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075888|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
83075889|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075890|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
83075891|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075892|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075893|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83075894|NCT03609840|Thiotepa|thiotepa|mesh-list
83075895|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
83075896|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
83075897|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
83075898|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075899|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83075900|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83075901|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
83075902|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075903|NCT03389126|Avelumab|avelumab|mesh-list
83075904|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83075905|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075906|NCT04212364|Naloxone|naloxone|mesh-list
83075907|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83075908|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075909|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
83075910|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075911|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
83075912|NCT04446104|Ivermectin|ivermectin|mesh-list
83075913|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
83075914|NCT04446104|Povidone|povidone|mesh-list
83075915|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
83075916|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83075917|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83075918|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075919|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075920|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075921|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83075922|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
83075923|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
83075924|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83075925|NCT03388970|Vitamin K|vitamin k|mesh-list
83075926|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
83075927|NCT03388970|Vitamins|vitamins|mesh-ancestor
83075928|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
83075929|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075930|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83075931|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83075932|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075933|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
83075934|NCT03388970|Coagulants|coagulants|mesh-ancestor
83075935|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83075936|NCT00616941|Poly ICLC|poly iclc|mesh-list
83075937|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83075938|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
83075939|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075940|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
83075941|NCT05677282|Azithromycin|azithromycin|mesh-list
83075942|NCT05677282|Rifaximin|rifaximin|mesh-list
83075943|NCT05677282|Loperamide|loperamide|mesh-list
83075944|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
83075945|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83075946|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075947|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83075948|NCT03388892|Paclitaxel|paclitaxel|mesh-list
83075949|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83075950|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075951|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
83075952|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
83075953|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
83075954|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075955|NCT02577718|Ethanol|ethanol|mesh-list
83075956|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
83075957|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83075958|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83075959|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075960|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075961|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
83075962|NCT00520533|Sunitinib|sunitinib|mesh-list
83075963|NCT00520533|Antibodies|antibodies|mesh-list
83075964|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83075965|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
83075966|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075967|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075968|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83075969|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83075970|NCT00520533|Growth Substances|growth substances|mesh-ancestor
83075971|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
83075972|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83075973|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075974|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075975|NCT03388814|Bupivacaine|bupivacaine|mesh-list
83075976|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
83075977|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
83075978|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83075979|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83075980|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
83075981|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83075982|NCT04680988|Paclitaxel|paclitaxel|mesh-list
83075983|NCT04680988|Gemcitabine|gemcitabine|mesh-list
83075984|NCT04680988|Pemetrexed|pemetrexed|mesh-list
83075985|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83075986|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83075987|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075988|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
83075989|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
83075990|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
83075991|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83075992|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83075993|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
83075994|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83075995|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83075996|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83075997|NCT02289144|Ceritinib|ceritinib|mesh-list
83075998|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83075999|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83076000|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076001|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076002|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83076003|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83076004|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83076005|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076006|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076007|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83076008|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83076009|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83076010|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83076011|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
83076012|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076013|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076014|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83076015|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83076016|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
83076017|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83076018|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83076019|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
83076021|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83076022|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
83076023|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83076024|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076025|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
83076026|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
83076027|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076028|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
83076029|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076030|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076031|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
83076032|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83076033|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83076034|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076035|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83076036|NCT02739984|Evolocumab|evolocumab|mesh-list
83076037|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83076038|NCT02739984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83076039|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83076040|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83076041|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
83076042|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076043|NCT02739984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83076044|NCT02739984|Protease Inhibitors|protease inhibitors|mesh-ancestor
83076045|NCT02739984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076046|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83076047|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
83076048|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076049|NCT00496730|Atorvastatin|atorvastatin|mesh-list
83076050|NCT00496730|Simvastatin|simvastatin|mesh-list
83076051|NCT00496730|Ezetimibe|ezetimibe|mesh-list
83076052|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83076053|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83076054|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
83076055|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076056|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83076057|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83076058|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076059|NCT00446186|Montelukast|montelukast|mesh-list
83076060|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076061|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076062|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
83076063|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83076064|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83076066|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076067|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83076068|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83076069|NCT02140983|Liraglutide|liraglutide|mesh-list
83076070|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83076071|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076072|NCT02140983|Incretins|incretins|mesh-ancestor
83076073|NCT02140983|Hormones|hormones|mesh-ancestor
83076074|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076075|NCT00394160|Montelukast|montelukast|mesh-list
83076076|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83076077|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
83076078|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83361849|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361850|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83076079|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
83076080|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076081|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076082|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83076083|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83076084|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076085|NCT03392792|Plasminogen|plasminogen|mesh-list
83076086|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83076087|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83076088|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83076089|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076090|NCT02739828|Adalimumab|adalimumab|mesh-list
83076091|NCT02739828|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83076092|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076093|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076094|NCT02141139|Ibuprofen|ibuprofen|mesh-list
83076095|NCT02141139|Ketorolac|ketorolac|mesh-list
83076096|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83076097|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83076098|NCT02141139|Analgesics|analgesics|mesh-ancestor
83076099|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
83076100|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076101|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076102|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076103|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076104|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83076105|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076106|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076107|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
83076108|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076109|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076110|NCT03108495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83076111|NCT03108495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076112|NCT05297032|Quercetin|quercetin|mesh-list
83076113|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
83076114|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076115|NCT05297032|Protective Agents|protective agents|mesh-ancestor
83076116|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076117|NCT03388580|Dimercaprol|dimercaprol|mesh-list
83076118|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
83076119|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
83076120|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076121|NCT03525912|Ketamine|ketamine|mesh-list
83076122|NCT03525912|Analgesics|analgesics|mesh-list
83076123|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
83076124|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076125|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076126|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83076127|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83076128|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
83076129|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
83076130|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076131|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83076132|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83076133|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076134|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076136|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
83076137|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076138|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
83076139|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
83076140|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
83076141|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076142|NCT03851614|Durvalumab|durvalumab|mesh-list
83076143|NCT03851614|Olaparib|olaparib|mesh-list
83076144|NCT03851614|Cediranib|cediranib|mesh-list
83076145|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076146|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076147|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83076148|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076149|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076150|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83076151|NCT04565600|Etoricoxib|etoricoxib|mesh-list
83076152|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83076153|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83076154|NCT04565600|Analgesics|analgesics|mesh-ancestor
83076155|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
83076156|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076157|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076158|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076159|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076160|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83076161|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83076162|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076163|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076164|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
83076165|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
83076166|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83076167|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83076168|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076169|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076170|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076171|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076172|NCT03388346|Edetic Acid|edetic acid|mesh-list
83076173|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83076174|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
83076175|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
83076176|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076177|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
83076178|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83076179|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83076180|NCT05631730|Metoprolol|metoprolol|mesh-list
83076181|NCT05631730|Flecainide|flecainide|mesh-list
83076182|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83076183|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83076184|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
83076185|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
83076186|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076187|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076188|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83076189|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83076190|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83076191|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
83076192|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076193|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076194|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83076195|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83076196|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076197|NCT00092144|Montelukast|montelukast|mesh-list
83076198|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076199|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076200|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83076201|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83076202|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83076203|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
83076204|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076205|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83076206|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83076207|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
83076208|NCT02289768|Salicylates|salicylates|mesh-list
83076209|NCT02289768|Fluorouracil|fluorouracil|mesh-list
83076210|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
83076211|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076212|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83076213|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076214|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076215|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
83076216|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076217|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076218|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
83076219|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
83076220|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
83076221|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83076222|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83076223|NCT02289768|Analgesics|analgesics|mesh-ancestor
83361851|NCT03165240|Eplerenone|eplerenone|mesh-list
83076224|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
83076225|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076226|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076227|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076228|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83076229|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076230|NCT05526586|Ethanol|ethanol|mesh-list
83076231|NCT05526586|Listerine|listerine|mesh-list
83076232|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83076233|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076234|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076235|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076236|NCT04330430|Nivolumab|nivolumab|mesh-list
83076237|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076238|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076239|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83076240|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076241|NCT03387956|Dexamethasone|dexamethasone|mesh-list
83076242|NCT03387956|Atropine|atropine|mesh-list
83076243|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076244|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
83076245|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
83076246|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076247|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076248|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83076249|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
83076250|NCT03387956|Hormones|hormones|mesh-ancestor
83076251|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076252|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83076253|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076254|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83076255|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83076256|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83076257|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83076258|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
83076259|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
83076260|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
83076261|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83076262|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83076263|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
83076264|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076265|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076266|NCT03384524|Metoprolol|metoprolol|mesh-list
83076267|NCT03384524|Bromocriptine|bromocriptine|mesh-list
83076268|NCT03384524|Tamsulosin|tamsulosin|mesh-list
83076269|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83076270|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83076271|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
83076272|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
83076273|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076274|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076275|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83076276|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83076277|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83076278|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
83076279|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076280|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076281|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83076282|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83076283|NCT03384524|Urological Agents|urological agents|mesh-ancestor
83076284|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83076285|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83076286|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
83076287|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076288|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
83076289|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
83076290|NCT02289924|Aflibercept|aflibercept|mesh-list
83076291|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83076292|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83076293|NCT02289924|Growth Substances|growth substances|mesh-ancestor
83076294|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076295|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
83076296|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076297|NCT03387644|Pregabalin|pregabalin|mesh-list
83076298|NCT03387644|Analgesics|analgesics|mesh-ancestor
83076299|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
83076300|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076301|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076302|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
83076303|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83076304|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076305|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076306|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83076307|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83076308|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83076309|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076310|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83076311|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
83076312|NCT02290002|Calcium|calcium|mesh-list
83076313|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83076314|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076315|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
83076316|NCT02290002|Coagulants|coagulants|mesh-ancestor
83076317|NCT02294292|Carvedilol|carvedilol|mesh-list
83076318|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83076319|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83076320|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
83076321|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076322|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076323|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076324|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83076325|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
83076326|NCT02294292|Protective Agents|protective agents|mesh-ancestor
83076327|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83076328|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076329|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83076330|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
83076331|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83076332|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83076333|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
83076334|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
83076335|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
83076336|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076337|NCT03387566|Growth Substances|growth substances|mesh-ancestor
83076338|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
83076339|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83076340|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
83076341|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076342|NCT03391856|Expectorants|expectorants|mesh-ancestor
83076343|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
83076344|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83076345|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
83076346|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076347|NCT03391856|Protective Agents|protective agents|mesh-ancestor
83076348|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076349|NCT03391856|Antidotes|antidotes|mesh-ancestor
83076350|NCT01664494|Capecitabine|capecitabine|mesh-list
83076351|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83076352|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
83482372|NCT00531518|Sertraline|sertraline|mesh-list
83440272|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
83076353|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076354|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076355|NCT02290470|Dexamethasone|dexamethasone|mesh-list
83076356|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
83076357|NCT02290470|Paclitaxel|paclitaxel|mesh-list
83076358|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83076359|NCT02290470|Carboplatin|carboplatin|mesh-list
83076360|NCT02290470|Olanzapine|olanzapine|mesh-list
83076361|NCT02290470|Palonosetron|palonosetron|mesh-list
83076362|NCT02290470|BB 1101|bb 1101|mesh-list
83076363|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83076364|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076365|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
83076366|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
83076367|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
83076368|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076369|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076370|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
83076371|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
83076372|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076373|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076374|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83076375|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
83076377|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076378|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83076379|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
83076380|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076381|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83076382|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83076383|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076384|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83076385|NCT02290470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83076386|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83076387|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076388|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076389|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
83076390|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83076391|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83076392|NCT05172518|Capecitabine|capecitabine|mesh-list
83076394|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83076395|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
83076396|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076397|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076398|NCT03724084|Cytarabine|cytarabine|mesh-list
83076399|NCT03724084|Daunorubicin|daunorubicin|mesh-list
83076400|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83076401|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
83076402|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076403|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076404|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
83076405|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076406|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076407|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
83076408|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076409|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83076410|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83076411|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83076412|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076413|NCT05172440|Tislelizumab|tislelizumab|mesh-list
83076414|NCT05172440|Axitinib|axitinib|mesh-list
83076415|NCT05172440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076416|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076417|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83076418|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076419|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076420|NCT02298582|Fentanyl|fentanyl|mesh-list
83076421|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83076422|NCT02298582|Narcotics|narcotics|mesh-ancestor
83076423|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076424|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076425|NCT02298582|Analgesics|analgesics|mesh-ancestor
83076426|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
83076427|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076428|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83076429|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83076430|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
83076431|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
83076432|NCT04446416|Bevacizumab|bevacizumab|mesh-list
83076433|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076434|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076435|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83076436|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83076437|NCT04446416|Growth Substances|growth substances|mesh-ancestor
83076438|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076439|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
83076440|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
83076441|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83076442|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83076443|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83076444|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076445|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076446|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
83076447|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076448|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076449|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83076450|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076451|NCT01396408|Sirolimus|sirolimus|mesh-list
83076452|NCT01396408|Sunitinib|sunitinib|mesh-list
83076453|NCT01396408|Temsirolimus|temsirolimus|mesh-list
83076454|NCT01396408|MTOR Inhibitors|mtor inhibitors|mesh-list
83076455|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076456|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83076457|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83076458|NCT01396408|Growth Substances|growth substances|mesh-ancestor
83076459|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076460|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
83076461|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83076462|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076463|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076464|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076465|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
83076466|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83076467|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076468|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83076469|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
83076470|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83076471|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83076472|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076473|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076474|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83076475|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076476|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076477|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
83076478|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076479|NCT05440942|Trametinib|trametinib|mesh-list
83076480|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076481|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83076482|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076483|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076484|NCT02291094|Lidocaine|lidocaine|mesh-list
83076485|NCT02291094|Remifentanil|remifentanil|mesh-list
83076486|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
83076487|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
83076488|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076489|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076490|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
83076491|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076492|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83076493|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83076494|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83076495|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076496|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076497|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83076498|NCT02291094|Narcotics|narcotics|mesh-ancestor
83076499|NCT02291094|Analgesics|analgesics|mesh-ancestor
83076500|NCT03387098|Leucovorin|leucovorin|mesh-list
83076501|NCT03387098|Paclitaxel|paclitaxel|mesh-list
83076502|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
83076503|NCT03387098|Bevacizumab|bevacizumab|mesh-list
83076505|NCT03387098|Capecitabine|capecitabine|mesh-list
83076506|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
83076507|NCT03387098|Avelumab|avelumab|mesh-list
83076508|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83076509|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076510|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
83076511|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
83076512|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
83076513|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076514|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076515|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
83076516|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076517|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076518|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83076519|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
83076520|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83076521|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076522|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83076523|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83076524|NCT03387098|Growth Substances|growth substances|mesh-ancestor
83076525|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
83076526|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
83076527|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83076528|NCT03387098|Antidotes|antidotes|mesh-ancestor
83076529|NCT03387098|Protective Agents|protective agents|mesh-ancestor
83076530|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
83076532|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
83076533|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83076534|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
83076535|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83076536|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076537|NCT02577016|Incretins|incretins|mesh-ancestor
83076538|NCT02577016|Hormones|hormones|mesh-ancestor
83076539|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076540|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83076541|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
83076542|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076543|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076544|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83076545|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
83076546|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83076547|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076548|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
83076549|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076550|NCT04465110|Protective Agents|protective agents|mesh-ancestor
83076551|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076552|NCT03391700|Rocuronium|rocuronium|mesh-list
83076553|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83076554|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83076555|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83076556|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076557|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076558|NCT02294838|Citric Acid|citric acid|mesh-list
83076559|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
83076560|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
83076561|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83076562|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
83076563|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
83076564|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076565|NCT03383822|Insulin|insulin|mesh-list
83076566|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83076567|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83076568|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076569|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83076570|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076571|NCT03383744|Vitamin A|vitamin a|mesh-list
83076572|NCT03383744|Vitamins|vitamins|mesh-ancestor
83076573|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
83076574|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076575|NCT05662358|Denosumab|denosumab|mesh-list
83076576|NCT05662358|Alendronate|alendronate|mesh-list
83076577|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83076578|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076579|NCT02294994|Tirofiban|tirofiban|mesh-list
83076580|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83076582|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076583|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83076584|NCT03386630|Sufentanil|sufentanil|mesh-list
83076585|NCT03386630|Morphine|morphine|mesh-list
83076586|NCT03386630|Dsuvia|dsuvia|mesh-list
83076587|NCT03386630|Bupivacaine|bupivacaine|mesh-list
83076588|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
83076589|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
83076590|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076591|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076592|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
83076593|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076594|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83076595|NCT03386630|Narcotics|narcotics|mesh-ancestor
83076596|NCT03386630|Analgesics|analgesics|mesh-ancestor
83076597|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83076598|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83076599|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
83076600|NCT03132714|Amoxicillin|amoxicillin|mesh-list
83076601|NCT03132714|Metronidazole|metronidazole|mesh-list
83076602|NCT03132714|Clarithromycin|clarithromycin|mesh-list
83076603|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83076604|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076605|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83076606|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83076607|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83076608|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076609|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076610|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83076611|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83076612|NCT03386318|Oxycodone|oxycodone|mesh-list
83076613|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83076614|NCT03386318|Narcotics|narcotics|mesh-ancestor
83076615|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076616|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076617|NCT03386318|Analgesics|analgesics|mesh-ancestor
83076618|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
83076619|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076620|NCT03339284|Dexamethasone|dexamethasone|mesh-list
83076621|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
83076622|NCT03339284|Ropivacaine|ropivacaine|mesh-list
83076623|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83076624|NCT03339284|BB 1101|bb 1101|mesh-list
83076625|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076626|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
83076627|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
83076628|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076629|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076630|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83076631|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
83076632|NCT03339284|Hormones|hormones|mesh-ancestor
83076633|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076634|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83076635|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076636|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
83076637|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
83076638|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076639|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
83076640|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
83076641|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076642|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076643|NCT02291562|Dronabinol|dronabinol|mesh-list
83076644|NCT02291562|Cannabidiol|cannabidiol|mesh-list
83076645|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
83076646|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
83076647|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076648|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83076649|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83076650|NCT02291562|Analgesics|analgesics|mesh-ancestor
83481127|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
83076651|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
83076652|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076653|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83076654|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83076655|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076656|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076657|NCT02291562|Hormones|hormones|mesh-ancestor
83076658|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076659|NCT03316586|Nivolumab|nivolumab|mesh-list
83076660|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076661|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076662|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83076663|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076664|NCT02994927|Prednisone|prednisone|mesh-list
83076665|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
83076666|NCT02994927|Rituximab|rituximab|mesh-list
83076667|NCT02994927|Azathioprine|azathioprine|mesh-list
83076668|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076669|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
83076670|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076671|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076672|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83076673|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
83076674|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076675|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076676|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83076677|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076678|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076679|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
83076680|NCT02994927|Hormones|hormones|mesh-ancestor
83076681|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076682|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83076683|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
83076684|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83076685|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83076686|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076687|NCT02295150|Nadroparin|nadroparin|mesh-list
83076688|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
83076689|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83076690|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83076691|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076692|NCT03390608|Trastuzumab|trastuzumab|mesh-list
83076693|NCT03390608|Estrogens|estrogens|mesh-list
83076694|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076695|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076696|NCT03390608|Hormones|hormones|mesh-ancestor
83076697|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076698|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076699|NCT03513822|Midazolam|midazolam|mesh-list
83076700|NCT03513822|Ketamine|ketamine|mesh-list
83076701|NCT03513822|Analgesics|analgesics|mesh-ancestor
83076702|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
83076703|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076704|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076705|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83076706|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83076707|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
83076708|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
83076709|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076710|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83076711|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83076712|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076713|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076714|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83076715|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83076716|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83076717|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83076718|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83076719|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
83076720|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
83076721|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83076722|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076723|NCT03513432|Ethanol|ethanol|mesh-list
83076724|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83076725|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076726|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076727|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076728|NCT02299440|Ketamine|ketamine|mesh-list
83076729|NCT02299440|Analgesics|analgesics|mesh-ancestor
83076730|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
83076731|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076732|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076733|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83076734|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83076735|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
83076736|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
83076737|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076738|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83076739|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83076740|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076741|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076742|NCT02145195|Vitamin D|vitamin d|mesh-list
83076743|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
83076744|NCT02145195|Vitamins|vitamins|mesh-ancestor
83076745|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
83076746|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076747|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83076748|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83076749|NCT03517020|Nebivolol|nebivolol|mesh-list
83076750|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83076751|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
83076752|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83076753|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83076754|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83076755|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
83076756|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076757|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076758|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076759|NCT02254629|Laxatives|laxatives|mesh-list
83076760|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83076761|NCT02145585|Anesthetics|anesthetics|mesh-list
83076762|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076763|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076764|NCT02291796|Bezafibrate|bezafibrate|mesh-list
83076765|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83076766|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
83076767|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076768|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83076769|NCT03544827|Atropine|atropine|mesh-list
83076770|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83076771|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83076772|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83076773|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
83076774|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076775|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076776|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83076777|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
83076778|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
83076779|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
83076780|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83076781|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83076782|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
83076783|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076784|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076785|NCT00107991|Etanercept|etanercept|mesh-list
83076786|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83076787|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83076788|NCT00107991|Analgesics|analgesics|mesh-ancestor
83076789|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
83076790|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076791|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076792|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83076793|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076794|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83076795|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076796|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
83076797|NCT03513276|Epinephrine|epinephrine|mesh-list
83076798|NCT03513276|Racepinephrine|racepinephrine|mesh-list
83076799|NCT03513276|Ropivacaine|ropivacaine|mesh-list
83076800|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
83076801|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
83076802|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
83076803|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076804|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076805|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
83076806|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076807|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83076808|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83076809|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
83076810|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076811|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076812|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83076813|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83076815|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83076816|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
83076817|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
83076818|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
83076819|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83076820|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
83076821|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83076822|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076823|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83076824|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076825|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
83076826|NCT03516630|Trazodone|trazodone|mesh-list
83076827|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83076828|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076834|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076835|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83076836|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83076837|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076838|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83076839|NCT03516630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83076840|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83076841|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076842|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83076843|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
83076844|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83076845|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
83076846|NCT02142075|Daptomycin|daptomycin|mesh-list
83076847|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83076848|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076849|NCT02145975|Fentanyl|fentanyl|mesh-list
83076850|NCT02145975|Morphine|morphine|mesh-list
83076851|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
83076852|NCT02145975|Narcotics|narcotics|mesh-ancestor
83076853|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076854|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076855|NCT02145975|Analgesics|analgesics|mesh-ancestor
83076856|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
83076857|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076858|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83076859|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83076860|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
83076861|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
83076862|NCT02295852|Calcium|calcium|mesh-list
83076863|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83076864|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076870|NCT02295930|Bevacizumab|bevacizumab|mesh-list
83076871|NCT02295930|Cetuximab|cetuximab|mesh-list
83076872|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076873|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076874|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83076875|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83076876|NCT02295930|Growth Substances|growth substances|mesh-ancestor
83076877|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076878|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
83076879|NCT02142309|Pioglitazone|pioglitazone|mesh-list
83076880|NCT02142309|Glimepiride|glimepiride|mesh-list
83076881|NCT02142309|Canagliflozin|canagliflozin|mesh-list
83076882|NCT02142309|Vildagliptin|vildagliptin|mesh-list
83076883|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83076884|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076885|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83076886|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076887|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
83076888|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83076889|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076890|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83076891|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
83076892|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076893|NCT02146209|Metronidazole|metronidazole|mesh-list
83076894|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076895|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83076896|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83076897|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83076898|NCT02299908|Bupivacaine|bupivacaine|mesh-list
83076899|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
83076900|NCT02299908|Anesthetics|anesthetics|mesh-list
83076901|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83076902|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83076903|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076904|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
83076905|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83076906|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
83076907|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
83076908|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
83076909|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83076910|NCT02142543|Protective Agents|protective agents|mesh-ancestor
83076911|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076912|NCT03390374|Nystatin|nystatin|mesh-list
83076913|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83076914|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076915|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
83076916|NCT03390374|Ionophores|ionophores|mesh-ancestor
83076917|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076918|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076919|NCT03545373|Amoxicillin|amoxicillin|mesh-list
83076920|NCT03545373|Azithromycin|azithromycin|mesh-list
83076921|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83076922|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83076923|NCT00492856|Methotrexate|methotrexate|mesh-list
83076924|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
83076925|NCT00492856|Tretinoin|tretinoin|mesh-list
83076926|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83076927|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
83076928|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83076929|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076930|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83076931|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
83076932|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076933|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076934|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
83076935|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076936|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83076937|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076938|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
83076939|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83076940|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83076941|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
83076942|NCT02142777|Equol|equol|mesh-list
83076943|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
83076944|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83076945|NCT02142777|Estrogens|estrogens|mesh-ancestor
83076946|NCT02142777|Hormones|hormones|mesh-ancestor
83076947|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076948|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076949|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
83076950|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076951|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076952|NCT02955758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83076953|NCT02955758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076954|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
83076955|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83076956|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83076957|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076958|NCT03544671|Vitamin D|vitamin d|mesh-list
83076959|NCT03544671|Vitamins|vitamins|mesh-ancestor
83076960|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
83076961|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076962|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83076963|NCT03390062|Apatinib|apatinib|mesh-list
83076964|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076965|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83076966|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076967|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076969|NCT03382886|Nivolumab|nivolumab|mesh-list
83076970|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83076971|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076972|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83076973|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83076974|NCT03382886|Growth Substances|growth substances|mesh-ancestor
83076975|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076976|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
83076977|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83076978|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076979|NCT03125486|Belimumab|belimumab|mesh-list
83076980|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83076981|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
83076982|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076983|NCT02147925|Metformin|metformin|mesh-list
83076984|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
83076985|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83076986|NCT02147925|Liraglutide|liraglutide|mesh-list
83076987|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83076988|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83076989|NCT02147925|Incretins|incretins|mesh-ancestor
83076990|NCT02147925|Hormones|hormones|mesh-ancestor
83076991|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83076992|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83076993|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
83076994|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83076995|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83076996|NCT03544047|Paclitaxel|paclitaxel|mesh-list
83076997|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83076998|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83076999|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
83077000|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
83077001|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
83077002|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077003|NCT03544125|Durvalumab|durvalumab|mesh-list
83077004|NCT03544125|Olaparib|olaparib|mesh-list
83077005|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83077006|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
83077007|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83077008|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
83077009|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077010|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077011|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
83077012|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077013|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077014|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077015|NCT02146911|Bupropion|bupropion|mesh-list
83077016|NCT02146911|Varenicline|varenicline|mesh-list
83077017|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83077018|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
83077019|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83077020|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83077021|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83077022|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077023|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077024|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
83077025|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077026|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077027|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83077028|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83077029|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077030|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83077031|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83077032|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
83077033|NCT02776683|Bevacizumab|bevacizumab|mesh-list
83077034|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077035|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077036|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83077037|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83077038|NCT02776683|Growth Substances|growth substances|mesh-ancestor
83077039|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077040|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
83077041|NCT02963714|Vaccines|vaccines|mesh-list
83077042|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
83077043|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077044|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83077045|NCT02148393|Estradiol|estradiol|mesh-list
83077046|NCT02148393|Progesterone|progesterone|mesh-list
83077047|NCT02148393|Estrogens|estrogens|mesh-ancestor
83077048|NCT02148393|Hormones|hormones|mesh-ancestor
83077049|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077050|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077051|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83077052|NCT02148393|Progestins|progestins|mesh-ancestor
83077053|NCT00104871|Bortezomib|bortezomib|mesh-list
83077054|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077056|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83077057|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83077058|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83077059|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83077060|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
83077061|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077062|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077063|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077064|NCT03380468|Pemetrexed|pemetrexed|mesh-list
83077065|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077066|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077067|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077068|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83077069|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83077070|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83077071|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83077072|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83077073|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077074|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077075|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83077076|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83077077|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83077078|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83077079|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077080|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077081|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077082|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83077083|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83077084|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
83077085|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83077086|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83077087|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
83077088|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
83077089|NCT02148549|Irinotecan|irinotecan|mesh-list
83077090|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077091|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83077092|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83077093|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077094|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077095|NCT03375398|PAZ320|paz320|mesh-list
83077096|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83077097|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077098|NCT02147535|Methylphenidate|methylphenidate|mesh-list
83077099|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83077100|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077101|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83077102|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83077103|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077104|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077105|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
83077106|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077107|NCT03446612|Nitroprusside|nitroprusside|mesh-list
83077108|NCT03446612|Acetylcholine|acetylcholine|mesh-list
83077109|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
83077110|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83077111|NCT03446612|Hematinics|hematinics|mesh-ancestor
83077112|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83077113|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
83077114|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83077115|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077116|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83077117|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
83077118|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077119|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077120|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077122|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83077123|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077124|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83077125|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83077126|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077127|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077128|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
83077129|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077130|NCT02155803|Hormones|hormones|mesh-list
83077131|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83077132|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83077133|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
83077134|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077135|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077136|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077137|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077138|NCT02148861|Insulin|insulin|mesh-list
83077139|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83077140|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83077141|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077142|NCT02152059|Nintedanib|nintedanib|mesh-list
83077143|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077144|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83077145|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077146|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077147|NCT02149095|Treprostinil|treprostinil|mesh-list
83077148|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83077149|NCT02149329|Meropenem|meropenem|mesh-list
83077150|NCT02149329|Imipenem|imipenem|mesh-list
83077151|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83077152|NCT02149329|Cilastatin|cilastatin|mesh-list
83077153|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83077154|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077155|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
83077156|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077157|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077158|NCT03255512|Isosorbide|isosorbide|mesh-list
83077159|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83077160|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83077161|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83077162|NCT03255512|Diuretics|diuretics|mesh-ancestor
83077163|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
83077164|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077165|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
83077166|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83077167|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077168|NCT02149407|Glycerol|glycerol|mesh-list
83077169|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83077170|NCT02149407|Protective Agents|protective agents|mesh-ancestor
83077171|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077172|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
83077173|NCT03543657|Hematinics|hematinics|mesh-ancestor
83077174|NCT04925193|Dexamethasone|dexamethasone|mesh-list
83077175|NCT04925193|Daratumumab|daratumumab|mesh-list
83077176|NCT04925193|Pomalidomide|pomalidomide|mesh-list
83077177|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077178|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
83077179|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
83077180|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077181|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077182|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83077183|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
83077184|NCT04925193|Hormones|hormones|mesh-ancestor
83077185|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077186|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83077187|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077188|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
83077189|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83077190|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83077191|NCT04925193|Growth Substances|growth substances|mesh-ancestor
83077193|NCT02580058|Doxorubicin|doxorubicin|mesh-list
83077194|NCT02580058|Avelumab|avelumab|mesh-list
83077195|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83077196|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077197|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83077198|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83077199|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077200|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077201|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077202|NCT03542955|Etoricoxib|etoricoxib|mesh-list
83077203|NCT03542955|Analgesics|analgesics|mesh-list
83077204|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
83077205|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077206|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077207|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83077208|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077209|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077210|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077211|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83077212|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83077213|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077214|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077215|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
83077216|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077217|NCT03458260|Rituximab|rituximab|mesh-list
83077218|NCT03458260|Etoposide|etoposide|mesh-list
83077219|NCT03458260|Ifosfamide|ifosfamide|mesh-list
83077220|NCT03458260|Pixantrone|pixantrone|mesh-list
83077221|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077222|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077223|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
83077224|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077225|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077226|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83077227|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83077228|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83077229|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077230|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077231|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83077232|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
83077233|NCT04988074|Cemiplimab|cemiplimab|mesh-list
83077234|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077235|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077236|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
83077237|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077238|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
83077239|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83077240|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83077241|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077242|NCT00104637|Urological Agents|urological agents|mesh-ancestor
83077243|NCT04810208|Docetaxel|docetaxel|mesh-list
83077244|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077245|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
83077246|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
83077247|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
83077248|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077249|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
83077250|NCT04445636|Morphine|morphine|mesh-list
83077251|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83077252|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077253|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077254|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077255|NCT04445636|Analgesics|analgesics|mesh-ancestor
83077256|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
83077257|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077258|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83077259|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83077260|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83077261|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077262|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077263|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077264|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83077265|NCT04445636|Narcotics|narcotics|mesh-ancestor
83077266|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
83077267|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83077268|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83077269|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077270|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
83077271|NCT02152917|Coagulants|coagulants|mesh-ancestor
83077272|NCT03111212|Iloprost|iloprost|mesh-list
83077273|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83077274|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
83077275|NCT03170206|Palbociclib|palbociclib|mesh-list
83077276|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077277|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83077278|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077279|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077280|NCT05424016|Propranolol|propranolol|mesh-list
83077281|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83077282|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83077283|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077284|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077285|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077286|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077287|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83077288|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83077289|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
83077290|NCT02149953|Glycine|glycine|mesh-list
83077291|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
83077292|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077293|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077294|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077295|NCT03380936|Tacrolimus|tacrolimus|mesh-list
83077296|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
83077297|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83077298|NCT03380936|Antibodies|antibodies|mesh-list
83077299|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
83077300|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83077301|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83077302|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
83077303|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077304|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83077305|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077306|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077307|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
83077308|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83077309|NCT02150031|Lidocaine|lidocaine|mesh-list
83077310|NCT02150031|Epinephrine|epinephrine|mesh-list
83077311|NCT02150031|Racepinephrine|racepinephrine|mesh-list
83077312|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
83077313|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
83077314|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
83077315|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077316|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077317|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
83077318|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077319|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83077320|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83077321|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83077322|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077323|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077324|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83077325|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077326|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
83077327|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
83077328|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83077329|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83077330|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077331|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077332|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83077333|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83077334|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
83077335|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83077336|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
83077337|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
83077338|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
83077339|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83077340|NCT04655170|Albuterol|albuterol|mesh-list
83077341|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
83077342|NCT04655170|Ipratropium|ipratropium|mesh-list
83077343|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83077344|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83077345|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
83077346|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077347|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077348|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83077349|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
83077350|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83077351|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83077352|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83077353|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077354|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077355|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077356|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
83077357|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83077358|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
83077360|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83077361|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
83077362|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077363|NCT02156661|Oxytocin|oxytocin|mesh-list
83077364|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
83077365|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83077366|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077367|NCT03065062|Palbociclib|palbociclib|mesh-list
83077368|NCT03065062|Gedatolisib|gedatolisib|mesh-list
83077369|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077370|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83077371|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077372|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077373|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83077374|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83077375|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077376|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
83077377|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077378|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077379|NCT04827862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83077380|NCT04827862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077381|NCT03374540|Vitamin K|vitamin k|mesh-list
83077382|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
83077383|NCT03374540|Vitamins|vitamins|mesh-ancestor
83077384|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
83077385|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077386|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83077387|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
83077388|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83077389|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
83077390|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077391|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077392|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
83077393|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83077394|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83077395|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
83077396|NCT03374540|Coagulants|coagulants|mesh-ancestor
83077397|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83077398|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83077399|NCT03378674|Remifentanil|remifentanil|mesh-list
83077400|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83077401|NCT03378674|Narcotics|narcotics|mesh-ancestor
83077402|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077403|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077404|NCT03378674|Analgesics|analgesics|mesh-ancestor
83077405|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
83077406|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077407|NCT02157207|Vitamins|vitamins|mesh-list
83077408|NCT02157207|Vitamin E|vitamin e|mesh-list
83077409|NCT02157207|Antioxidants|antioxidants|mesh-list
83077410|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
83077411|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077412|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077413|NCT02157207|Protective Agents|protective agents|mesh-ancestor
83077414|NCT02261103|Pramipexole|pramipexole|mesh-list
83077415|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
83077416|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077417|NCT02261103|Protective Agents|protective agents|mesh-ancestor
83077418|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077419|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83077420|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83077421|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
83077422|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
83077423|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077424|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
83077425|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077426|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077427|NCT02766777|Lubiprostone|lubiprostone|mesh-list
83077428|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83077429|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077431|NCT03374306|Atropine|atropine|mesh-list
83077432|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
83077433|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83077434|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83077435|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83077436|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
83077437|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077438|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077439|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83077440|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
83077441|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
83077442|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
83077443|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83077444|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83077445|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
83077446|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077447|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077448|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83077449|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83077450|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
83077451|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83077452|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83077453|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077454|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077455|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077456|NCT05534230|Analgesics|analgesics|mesh-ancestor
83077457|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
83077458|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077459|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83077460|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83077461|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83440319|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
83077462|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077463|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077464|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077465|NCT03369782|Rocuronium|rocuronium|mesh-list
83077466|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83077467|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83077468|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83077469|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077470|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077471|NCT00157014|Cyclosporine|cyclosporine|mesh-list
83077472|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
83077473|NCT00157014|Prednisone|prednisone|mesh-list
83077474|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
83077475|NCT00157014|Tacrolimus|tacrolimus|mesh-list
83077476|NCT00157014|Cyclosporins|cyclosporins|mesh-list
83077477|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077478|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
83077479|NCT00157014|Hormones|hormones|mesh-ancestor
83077480|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077481|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077482|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83077483|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077484|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83077485|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
83077486|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83077487|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077488|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077489|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
83077490|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077491|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
83077492|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077493|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83077494|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83077495|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
83077496|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83077497|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
83077498|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
83077499|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077500|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83077501|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83077502|NCT00157014|Protective Agents|protective agents|mesh-ancestor
83077503|NCT03374228|Linrodostat|linrodostat|mesh-list
83077505|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077506|NCT02778867|Fluticasone|fluticasone|mesh-list
83077507|NCT02778867|Xhance|xhance|mesh-list
83077508|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077509|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83077510|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
83077511|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077512|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077513|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83077514|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
83077515|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
83077516|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83077517|NCT04232072|Ibuprofen|ibuprofen|mesh-list
83077518|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83077519|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077520|NCT04232072|Analgesics|analgesics|mesh-ancestor
83077521|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
83077522|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077523|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077524|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077525|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077526|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83077527|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077528|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077529|NCT02300064|Antioxidants|antioxidants|mesh-list
83077530|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077531|NCT02300064|Protective Agents|protective agents|mesh-ancestor
83077532|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077533|NCT02688712|Fluorouracil|fluorouracil|mesh-list
83077534|NCT02688712|Capecitabine|capecitabine|mesh-list
83077535|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
83077536|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077537|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83077538|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077539|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83077540|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
83077541|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077542|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83077543|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83077544|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077545|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
83077546|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
83077547|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83077548|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83077549|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83077550|NCT02519582|Niclosamide|niclosamide|mesh-list
83077551|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
83077552|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83077553|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
83077554|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83077555|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077556|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
83077557|NCT02467582|Aspirin|aspirin|mesh-list
83077558|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83077559|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077560|NCT02467582|Analgesics|analgesics|mesh-ancestor
83077561|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
83077562|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077563|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077564|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077565|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077566|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83077567|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83077568|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077569|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83077570|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83077571|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077572|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
83077573|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
83077574|NCT05467462|Oxytocin|oxytocin|mesh-list
83077575|NCT05467462|Carbetocin|carbetocin|mesh-list
83077576|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
83077577|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83077578|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077580|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83077581|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077582|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
83077583|NCT05467462|Coagulants|coagulants|mesh-ancestor
83077584|NCT03369002|Seladelpar|seladelpar|mesh-list
83077585|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83077586|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
83077587|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077588|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83077589|NCT05533606|Lactams|lactams|mesh-list
83077590|NCT05533606|beta-Lactams|beta-lactams|mesh-list
83077591|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83077592|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077593|NCT02300376|Edetic Acid|edetic acid|mesh-list
83077594|NCT02300376|Calcium|calcium|mesh-list
83077595|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
83077596|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83077597|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077598|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
83077599|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83077600|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
83077601|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
83077602|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077603|NCT02300376|Antidotes|antidotes|mesh-ancestor
83077604|NCT02300376|Protective Agents|protective agents|mesh-ancestor
83077605|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83077606|NCT02296398|Romidepsin|romidepsin|mesh-list
83077607|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83077608|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077609|NCT02296398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83077610|NCT02296398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077611|NCT02296398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077612|NCT03520062|Liraglutide|liraglutide|mesh-list
83077613|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83077614|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077615|NCT03520062|Incretins|incretins|mesh-ancestor
83077616|NCT03520062|Hormones|hormones|mesh-ancestor
83077617|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077618|NCT02206984|Tamoxifen|tamoxifen|mesh-list
83077619|NCT02206984|Fulvestrant|fulvestrant|mesh-list
83077620|NCT02206984|Anastrozole|anastrozole|mesh-list
83077621|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83077622|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
83077623|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077624|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077625|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83077626|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077627|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83077628|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83077629|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83077630|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83077631|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83077632|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83077633|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077634|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077635|NCT03512574|Pregabalin|pregabalin|mesh-list
83077636|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
83077637|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83077638|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077639|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077640|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077641|NCT03512574|Analgesics|analgesics|mesh-ancestor
83077642|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
83077643|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077644|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83077645|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83077646|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83077647|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077648|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077649|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077650|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
83077651|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83077652|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077653|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83077654|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83077655|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83077656|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83077657|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83077658|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83077659|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077660|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
83077661|NCT03377348|Triamcinolone|triamcinolone|mesh-list
83077662|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83077663|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83077664|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83077665|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077666|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
83077668|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077669|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077670|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83077671|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
83077672|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077673|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077674|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83077675|NCT02255253|Telmisartan|telmisartan|mesh-list
83077676|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83077677|NCT02255253|Diuretics|diuretics|mesh-ancestor
83077678|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
83077679|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077680|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83077681|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077682|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077683|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83077684|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83077685|NCT02300688|Maleic acid|maleic acid|mesh-list
83077686|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077687|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077688|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83077689|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077690|NCT02151279|Chitosan|chitosan|mesh-list
83077691|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83077692|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83077693|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
83077694|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077695|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83077696|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
83077697|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
83077698|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
83077699|NCT02151279|Coagulants|coagulants|mesh-ancestor
83077700|NCT02159313|Riociguat|riociguat|mesh-list
83077701|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
83077702|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077703|NCT03515772|Darunavir|darunavir|mesh-list
83077704|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83077705|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83077706|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
83077707|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077708|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077709|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83077710|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83077711|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
83077712|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077713|NCT03519750|Melatonin|melatonin|mesh-list
83077714|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
83077715|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077716|NCT03519750|Protective Agents|protective agents|mesh-ancestor
83077717|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077718|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077719|NCT02158143|Vitamin D|vitamin d|mesh-list
83077720|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
83077721|NCT02158143|Vitamins|vitamins|mesh-ancestor
83077722|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
83077723|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077724|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83077725|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83077726|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83077728|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077729|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
83077730|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077731|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077732|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
83077733|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83077734|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83077735|NCT02301000|Metronidazole|metronidazole|mesh-list
83077736|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077737|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83077738|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83077739|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83077740|NCT02292732|Trametinib|trametinib|mesh-list
83077741|NCT02292732|Norinyl|norinyl|mesh-list
83077742|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077743|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83077744|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077745|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077746|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83077747|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83077748|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83077749|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
83077750|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83077751|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077752|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83077753|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83077754|NCT03376958|Apatinib|apatinib|mesh-list
83077755|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077756|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83077757|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077758|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077759|NCT03367676|Docetaxel|docetaxel|mesh-list
83077760|NCT03367676|Trastuzumab|trastuzumab|mesh-list
83077761|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077762|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
83077763|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
83077764|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
83077765|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077766|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077767|NCT03515538|Cisplatin|cisplatin|mesh-list
83077768|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077769|NCT02158689|Letrozole|letrozole|mesh-list
83077770|NCT02158689|Menotropins|menotropins|mesh-list
83077771|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077772|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83077773|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83077774|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077775|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077776|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83077777|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
83077778|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077779|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077780|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83077781|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
83077782|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83077783|NCT03372200|Febuxostat|febuxostat|mesh-list
83077784|NCT03372200|Dotinurad|dotinurad|mesh-list
83077785|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
83077786|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077787|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
83077788|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
83077789|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83077790|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83077791|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077792|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
83077793|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
83077794|NCT02158845|Leuprolide|leuprolide|mesh-list
83077795|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
83077796|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83077797|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
83077798|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83077799|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077800|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83077801|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077802|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83077803|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
83077804|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83077805|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83077806|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83077807|NCT02292966|Asunaprevir|asunaprevir|mesh-list
83077808|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
83077809|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077810|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077811|NCT02519660|Lidocaine|lidocaine|mesh-list
83077812|NCT02519660|Tetracaine|tetracaine|mesh-list
83077813|NCT02519660|Prilocaine|prilocaine|mesh-list
83077814|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83077815|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
83077816|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
83077817|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077818|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077819|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
83077820|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077821|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83077822|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83077823|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83077824|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077825|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077826|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83077827|NCT02297490|Immunomodulating Agents|immunomodulating agents|mesh-list
83077828|NCT02297490|Immunologic Factors|immunologic factors|mesh-ancestor
83077829|NCT02297490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077830|NCT02297568|Vitamin D|vitamin d|mesh-list
83077831|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
83077832|NCT02297568|Vitamins|vitamins|mesh-ancestor
83077833|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
83077834|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077835|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83077836|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83077837|NCT03515382|Itraconazole|itraconazole|mesh-list
83077838|NCT03515382|Voriconazole|voriconazole|mesh-list
83077839|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
83077840|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077841|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83077842|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83077843|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077844|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077845|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83077846|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
83077847|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077848|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077849|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83077850|NCT03511560|Tacrolimus|tacrolimus|mesh-list
83077851|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83077852|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
83077853|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077854|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83077855|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077856|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077857|NCT03688802|Varenicline|varenicline|mesh-list
83077858|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83077859|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83077860|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
83077861|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077862|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077863|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077864|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
83077865|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83077866|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077867|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
83077868|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83077869|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
83077870|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83077871|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83077872|NCT03371498|Prednisolone|prednisolone|mesh-list
83077873|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
83077874|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83077875|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
83077876|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077877|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
83077878|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
83077879|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077880|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077881|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83077882|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
83077883|NCT03371498|Hormones|hormones|mesh-ancestor
83077884|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83077885|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83077886|NCT03371498|Protective Agents|protective agents|mesh-ancestor
83077887|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83077888|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077889|NCT03376178|Lidocaine|lidocaine|mesh-list
83077890|NCT03376178|Ropivacaine|ropivacaine|mesh-list
83077891|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
83077892|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
83077893|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077894|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077895|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
83077896|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077897|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83077898|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83077899|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83077900|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077901|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077902|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
83077903|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83077904|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
83077905|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077906|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077907|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83077908|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
83077909|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077910|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077911|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83077912|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83077913|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83077914|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077915|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077916|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83077917|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077918|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077919|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
83077920|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077921|NCT02302326|Folic Acid|folic acid|mesh-list
83077922|NCT02302326|Inositol|inositol|mesh-list
83077923|NCT02302326|Metformin|metformin|mesh-list
83077924|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83077925|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077926|NCT02302326|Hematinics|hematinics|mesh-ancestor
83077927|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
83077928|NCT02302326|Vitamins|vitamins|mesh-ancestor
83077929|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
83077930|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
83077931|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
83077932|NCT02293590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83077933|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077934|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83077935|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
83077936|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077937|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077938|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83077939|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83077940|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077941|NCT02293590|Analgesics|analgesics|mesh-ancestor
83077942|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
83077943|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077944|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83077945|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83077947|NCT03124082|Clonidine|clonidine|mesh-list
83077948|NCT03124082|Ketamine|ketamine|mesh-list
83077949|NCT03124082|Remifentanil|remifentanil|mesh-list
83077950|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
83077951|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
83361852|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83077952|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83077953|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077954|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
83077955|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077956|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83077957|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83077958|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83077959|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83077960|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077961|NCT03124082|Analgesics|analgesics|mesh-ancestor
83077962|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83077963|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83077964|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
83077965|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83077966|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83077967|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83077968|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83077969|NCT03124082|Narcotics|narcotics|mesh-ancestor
83077970|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83077971|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
83077972|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
83077973|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83077974|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83077975|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83077976|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
83077977|NCT03518502|Sorafenib|sorafenib|mesh-list
83077978|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83077979|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83077980|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077981|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077982|NCT02301780|Aspirin|aspirin|mesh-list
83077983|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83077984|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83077985|NCT02301780|Analgesics|analgesics|mesh-ancestor
83077986|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
83077987|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83077988|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83077989|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83077990|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83077991|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83077992|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83077993|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83077994|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83077995|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83077996|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83077997|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
83077998|NCT04527068|Bevacizumab|bevacizumab|mesh-list
83077999|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078000|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078001|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83078002|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83078003|NCT04527068|Growth Substances|growth substances|mesh-ancestor
83078004|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078005|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
83078006|NCT02739360|Idelalisib|idelalisib|mesh-list
83078007|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078008|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078009|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078010|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
83078011|NCT03123770|Docetaxel|docetaxel|mesh-list
83078012|NCT03123770|Doxorubicin|doxorubicin|mesh-list
83078013|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83078014|NCT03123770|Epirubicin|epirubicin|mesh-list
83078015|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078016|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
83078017|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078018|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078019|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83078021|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078022|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078023|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83078024|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
83361853|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
83361854|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83361855|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361856|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83361857|NCT03165240|Diuretics|diuretics|mesh-ancestor
83078025|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
83078026|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
83078027|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83078028|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83078029|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83078030|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078031|NCT04464642|Methotrexate|methotrexate|mesh-list
83078032|NCT04464642|Tofacitinib|tofacitinib|mesh-list
83078033|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83078034|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
83078035|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078036|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078037|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83078038|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
83078039|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078040|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078041|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
83078042|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078043|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83078044|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078045|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
83078046|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078047|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83078048|NCT04464642|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83078049|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83078051|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078052|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83078053|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83078054|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078055|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078056|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83078057|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
83078058|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078059|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078060|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
83078061|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
83078062|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
83078063|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078064|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83078065|NCT04526210|Choline|choline|mesh-list
83078066|NCT04526210|Bupropion|bupropion|mesh-list
83078067|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83078068|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
83078069|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83078070|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83078071|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83078072|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83078073|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078074|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
83078075|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078076|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078077|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83078078|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83078079|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078080|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
83078081|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83078082|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
83078083|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078084|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83078085|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
83078086|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
83078087|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
83078089|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83078090|NCT04526210|Growth Substances|growth substances|mesh-ancestor
83078091|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
83078092|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078093|NCT03375632|Dotinurad|dotinurad|mesh-list
83078094|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
83078095|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
83078096|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078097|NCT02302170|Vaccines|vaccines|mesh-list
83078098|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
83078099|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078100|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
83078101|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078102|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078103|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
83078104|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83078105|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83078106|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
83078107|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078108|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83078109|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83078110|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078111|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078112|NCT02293824|Caffeine|caffeine|mesh-list
83078113|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
83078114|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078115|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83078116|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078117|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83078118|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078119|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83078120|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83078121|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
83078122|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078123|NCT03366584|Vitamin D|vitamin d|mesh-list
83078124|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
83078125|NCT03366584|Beta Carotene|beta carotene|mesh-list
83078126|NCT03366584|Zinc|zinc|mesh-list
83078127|NCT03366584|Dexamethasone|dexamethasone|mesh-list
83078128|NCT03366584|Carotenoids|carotenoids|mesh-list
83078129|NCT03366584|Picolinic acid|picolinic acid|mesh-list
83078130|NCT03366584|Vitamins|vitamins|mesh-ancestor
83078131|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
83078132|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078133|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078134|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
83078135|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
83078136|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078137|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078138|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
83078139|NCT03366584|Hormones|hormones|mesh-ancestor
83078140|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078141|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83078142|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078143|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83078144|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83078145|NCT03366584|Trace Elements|trace elements|mesh-ancestor
83078146|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
83078147|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078148|NCT03366584|Protective Agents|protective agents|mesh-ancestor
83078149|NCT03366584|Provitamins|provitamins|mesh-ancestor
83078150|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83078151|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
83078152|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
83078153|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
83078154|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83078155|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078156|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078157|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83078158|NCT03370562|Analgesics|analgesics|mesh-ancestor
83078159|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
83078160|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078161|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83078162|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83078163|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83078164|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
83078165|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078166|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078168|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
83078169|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
83078170|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361858|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
83078171|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078172|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078173|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
83078175|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
83078176|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83078177|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83078178|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078179|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83078180|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078181|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83078182|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83078183|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078184|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83078185|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83078186|NCT04525664|Amoxicillin|amoxicillin|mesh-list
83078187|NCT04525664|Clarithromycin|clarithromycin|mesh-list
83078188|NCT04525664|Omeprazole|omeprazole|mesh-list
83078189|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078190|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078191|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83078192|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078193|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83078194|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078195|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078196|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83078197|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83078198|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83078199|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83078200|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83078201|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078202|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078203|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
83078204|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078205|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078206|NCT03505008|Adalimumab|adalimumab|mesh-list
83078207|NCT03505008|Methotrexate|methotrexate|mesh-list
83078208|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83078209|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
83078210|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078211|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078212|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83078213|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
83078214|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078215|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078216|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
83078217|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078218|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83078219|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078220|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
83078221|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078222|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83078223|NCT03505008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83078224|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078225|NCT03507426|Ketamine|ketamine|mesh-list
83078226|NCT03507426|Analgesics|analgesics|mesh-ancestor
83078227|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
83078228|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078229|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078230|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83078231|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83078232|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
83078233|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
83078234|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078235|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83078236|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83078237|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078238|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078239|NCT02311530|Felodipine|felodipine|mesh-list
83078240|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83078241|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83078242|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83361859|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83078243|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83078244|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078245|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83078246|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078247|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
83078248|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
83078249|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
83078250|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83078251|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83078252|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078253|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078254|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078255|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078256|NCT02306772|Mesalamine|mesalamine|mesh-list
83078257|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83078258|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83078259|NCT02306772|Analgesics|analgesics|mesh-ancestor
83078260|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
83078261|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078262|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078263|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078264|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078265|NCT03507348|Rituximab|rituximab|mesh-list
83078266|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078267|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078268|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
83078269|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078270|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078271|NCT02518802|Pemetrexed|pemetrexed|mesh-list
83078272|NCT02518802|Gefitinib|gefitinib|mesh-list
83078273|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078274|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078275|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078276|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83078277|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83078278|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83078279|NCT04524026|Letrozole|letrozole|mesh-list
83078280|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83078281|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078282|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83078283|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078284|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078285|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83078286|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
83078287|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078288|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078289|NCT02311608|Octreotide|octreotide|mesh-list
83078290|NCT02311608|Terlipressin|terlipressin|mesh-list
83078291|NCT02311608|Somatostatin|somatostatin|mesh-list
83078292|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078293|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83078294|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078295|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83078296|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83078297|NCT02311608|Hormones|hormones|mesh-ancestor
83078298|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078299|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078300|NCT02307006|Vancomycin|vancomycin|mesh-list
83078301|NCT02307006|Cefazolin|cefazolin|mesh-list
83078302|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83078303|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078304|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078305|NCT03362684|Cetuximab|cetuximab|mesh-list
83078306|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078307|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078308|NCT02311686|Ethanol|ethanol|mesh-list
83078309|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83078310|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078311|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078312|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078313|NCT02311764|Carboplatin|carboplatin|mesh-list
83078314|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078315|NCT03365726|Dobutamine|dobutamine|mesh-list
83078316|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83078317|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
83078318|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
83078319|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078320|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078321|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83078322|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83078323|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83078324|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
83078325|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078326|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078327|NCT03365726|Protective Agents|protective agents|mesh-ancestor
83078328|NCT02303418|Oxytocin|oxytocin|mesh-list
83078329|NCT02303418|Carbetocin|carbetocin|mesh-list
83078330|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
83078331|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078332|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078333|NCT03510000|Empagliflozin|empagliflozin|mesh-list
83078334|NCT03510000|Pancrelipase|pancrelipase|mesh-list
83078335|NCT03510000|Hormones|hormones|mesh-list
83078336|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078337|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078338|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83078339|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078340|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83078341|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078342|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
83078343|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83078344|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83078345|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83078346|NCT03358082|Tacrolimus|tacrolimus|mesh-list
83078347|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078348|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
83078349|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078350|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83078351|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078352|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078353|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078354|NCT03358004|Capecitabine|capecitabine|mesh-list
83078355|NCT03358004|Vinorelbine|vinorelbine|mesh-list
83078356|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83078357|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
83078358|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078359|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078360|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83078361|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83078362|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83078363|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83078364|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
83078365|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83078366|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83078367|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078368|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83078369|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83078370|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
83078371|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078372|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078373|NCT03365336|Oseltamivir|oseltamivir|mesh-list
83078374|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
83078375|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078376|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078377|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078378|NCT03362216|Diclofenac|diclofenac|mesh-list
83078379|NCT03362216|Salicylates|salicylates|mesh-list
83078380|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
83078381|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83078382|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83078383|NCT03362216|Analgesics|analgesics|mesh-ancestor
83078384|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
83078385|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078386|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078387|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078388|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078389|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83078390|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361860|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
83078391|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078392|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83078393|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
83078394|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83078395|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
83078396|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078397|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078398|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83078399|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83078400|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078401|NCT02307396|Haloperidol|haloperidol|mesh-list
83078402|NCT02307396|Pimozide|pimozide|mesh-list
83078403|NCT02307396|Olanzapine|olanzapine|mesh-list
83078404|NCT02307396|Risperidone|risperidone|mesh-list
83078405|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83078406|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83078407|NCT02307396|Ziprasidone|ziprasidone|mesh-list
83078408|NCT02307396|Amisulpride|amisulpride|mesh-list
83078409|NCT02307396|Perphenazine|perphenazine|mesh-list
83078410|NCT02307396|Sertindole|sertindole|mesh-list
83078411|NCT02307396|Sulpiride|sulpiride|mesh-list
83078412|NCT02307396|Fluphenazine|fluphenazine|mesh-list
83078413|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
83078414|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
83078415|NCT02307396|Thioridazine|thioridazine|mesh-list
83078416|NCT02307396|Clopenthixol|clopenthixol|mesh-list
83078417|NCT02307396|Fluspirilene|fluspirilene|mesh-list
83078418|NCT02307396|Benperidol|benperidol|mesh-list
83078419|NCT02307396|Bromperidol|bromperidol|mesh-list
83078420|NCT02307396|Perazine|perazine|mesh-list
83078421|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83078422|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
83078423|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078424|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078425|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078426|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83078427|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83078428|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078429|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83078430|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83078431|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
83078432|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
83078433|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
83078434|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078435|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078436|NCT02307396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83078437|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83078438|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83078439|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
83078440|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83078441|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83078442|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83078443|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83078444|NCT03509688|Entecavir|entecavir|mesh-list
83078445|NCT03509688|Resveratrol|resveratrol|mesh-list
83078446|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
83078447|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078448|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
83078449|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078450|NCT03509688|Protective Agents|protective agents|mesh-ancestor
83078451|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078452|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078453|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83078454|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
83078455|NCT02303730|Exenatide|exenatide|mesh-list
83078456|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83078457|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078458|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83078459|NCT02303730|Incretins|incretins|mesh-ancestor
83078460|NCT02303730|Hormones|hormones|mesh-ancestor
83078461|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078462|NCT04524728|Letrozole|letrozole|mesh-list
83078463|NCT04524728|Fulvestrant|fulvestrant|mesh-list
83078464|NCT04524728|Palbociclib|palbociclib|mesh-list
83078465|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078466|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83078467|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83078468|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361861|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83078469|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078470|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83078471|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
83078472|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078473|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078474|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83078475|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83078476|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83078478|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83078479|NCT04523792|Narcotics|narcotics|mesh-ancestor
83078480|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078481|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078482|NCT04523792|Analgesics|analgesics|mesh-ancestor
83078483|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
83078484|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078485|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83078486|NCT02312232|Levodopa|levodopa|mesh-list
83078487|NCT02312232|Carbidopa|carbidopa|mesh-list
83078488|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83078489|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83078490|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
83078491|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078492|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078493|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078494|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83078495|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078496|NCT02303886|Methylene Blue|methylene blue|mesh-list
83078497|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078498|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078499|NCT02518958|Nivolumab|nivolumab|mesh-list
83078500|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078501|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078502|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83078503|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078504|NCT03506802|Aldesleukin|aldesleukin|mesh-list
83078505|NCT03506802|Plerixafor|plerixafor|mesh-list
83078506|NCT03506802|Lenalidomide|lenalidomide|mesh-list
83078507|NCT03506802|Melphalan|melphalan|mesh-list
83078508|NCT03506802|Interleukin-2|interleukin-2|mesh-list
83078509|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
83078510|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83078511|NCT03506802|Lenograstim|lenograstim|mesh-list
83078512|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83078513|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
83078514|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078515|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83078516|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83078517|NCT03506802|Growth Substances|growth substances|mesh-ancestor
83078518|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
83078519|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078520|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83078521|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
83078522|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078523|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83078524|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078525|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83078526|NCT03506802|Analgesics|analgesics|mesh-ancestor
83078527|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
83078528|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078529|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83078530|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83078531|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
83078532|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078533|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
83078534|NCT02307864|Tramadol|tramadol|mesh-list
83078535|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83078536|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078537|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078538|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83078539|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83078541|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078542|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361862|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
83078543|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83078544|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
83078545|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078546|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078547|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83078548|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83078549|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83078550|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83078551|NCT02307864|Narcotics|narcotics|mesh-ancestor
83078552|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078553|NCT02307864|Analgesics|analgesics|mesh-ancestor
83078554|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
83078555|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078556|NCT02304042|Oxytocin|oxytocin|mesh-list
83078557|NCT02304042|Carbetocin|carbetocin|mesh-list
83078558|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
83078559|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078560|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078561|NCT02308098|Budesonide|budesonide|mesh-list
83078562|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
83078563|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83078564|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078565|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83078566|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
83078567|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078568|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078569|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83078570|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
83078571|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
83078572|NCT02308098|Hormones|hormones|mesh-ancestor
83078573|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078574|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83078575|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83078576|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83078577|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
83078578|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078579|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078580|NCT03504072|Etanercept|etanercept|mesh-list
83078581|NCT03504072|Tofacitinib|tofacitinib|mesh-list
83078582|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83078583|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83078584|NCT03504072|Analgesics|analgesics|mesh-ancestor
83078585|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
83078586|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078587|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078588|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078589|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078590|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078591|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078592|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
83078593|NCT03504072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83078594|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83078595|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078596|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078597|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83078598|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83078599|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
83078600|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078601|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078602|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078603|NCT02308254|Lixisenatide|lixisenatide|mesh-list
83078604|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83078605|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078606|NCT03361124|Oxytocin|oxytocin|mesh-list
83078607|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
83078608|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078609|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078610|NCT03364088|Oxycodone|oxycodone|mesh-list
83078611|NCT03364088|Anesthetics|anesthetics|mesh-list
83078612|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078613|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078614|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83078615|NCT03364088|Narcotics|narcotics|mesh-ancestor
83078616|NCT03364088|Analgesics|analgesics|mesh-ancestor
83078617|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
83078618|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078620|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83078621|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83078622|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078623|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078624|NCT02304276|Calcium|calcium|mesh-list
83078625|NCT02304276|Fluorides|fluorides|mesh-list
83078626|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83078627|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078628|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
83078629|NCT02304276|Protective Agents|protective agents|mesh-ancestor
83078630|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83078631|NCT02308332|Tenofovir|tenofovir|mesh-list
83078632|NCT02308332|Emtricitabine|emtricitabine|mesh-list
83078633|NCT02308332|Rilpivirine|rilpivirine|mesh-list
83078634|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
83078635|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078636|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83078637|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83078638|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078639|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078640|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83078641|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83078642|NCT03509298|Antibodies|antibodies|mesh-list
83078643|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83078644|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
83078645|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078646|NCT03503994|Beclomethasone|beclomethasone|mesh-list
83078647|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078648|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
83078649|NCT03503994|Hormones|hormones|mesh-ancestor
83078650|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078651|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078652|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83078653|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
83078654|NCT01796002|Romidepsin|romidepsin|mesh-list
83078655|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83078656|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078657|NCT01796002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83078658|NCT01796002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078659|NCT01796002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078660|NCT03509142|Sirolimus|sirolimus|mesh-list
83078661|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078662|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078663|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83078664|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078665|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
83078666|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078667|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
83078668|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078669|NCT03356912|Prednisone|prednisone|mesh-list
83078670|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078671|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
83078672|NCT03356912|Hormones|hormones|mesh-ancestor
83078673|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078674|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078675|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83078676|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078677|NCT00102687|Azacitidine|azacitidine|mesh-list
83078678|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83078679|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
83078680|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078681|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078682|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078683|NCT04509440|Triamcinolone|triamcinolone|mesh-list
83078684|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83078685|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83078686|NCT04509440|Anesthetics|anesthetics|mesh-list
83078687|NCT04509440|Mepivacaine|mepivacaine|mesh-list
83078688|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
83078690|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078691|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078692|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078693|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
83078694|NCT04509440|Hormones|hormones|mesh-ancestor
83078695|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078696|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078697|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
83078698|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078699|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078700|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
83078701|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078702|NCT02312544|Timolol|timolol|mesh-list
83078703|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83078704|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83078705|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
83078706|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078707|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078708|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078709|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83078710|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83078711|NCT03360734|Cetuximab|cetuximab|mesh-list
83078712|NCT03360734|Panitumumab|panitumumab|mesh-list
83078713|NCT03360734|Necitumumab|necitumumab|mesh-list
83078714|NCT03360734|Antibodies|antibodies|mesh-list
83078715|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
83078716|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078717|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078718|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078719|NCT02308644|Bevacizumab|bevacizumab|mesh-list
83078720|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078721|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078722|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83078723|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83078724|NCT02308644|Growth Substances|growth substances|mesh-ancestor
83078725|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078726|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
83078727|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
83078728|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83078729|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078730|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078731|NCT04510636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83078732|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078733|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83078734|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
83078735|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83078736|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078737|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078738|NCT03540849|Immunotoxins|immunotoxins|mesh-ancestor
83078739|NCT03540849|Immunoconjugates|immunoconjugates|mesh-ancestor
83078740|NCT03540849|Immunologic Factors|immunologic factors|mesh-ancestor
83078741|NCT03540849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078742|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83078743|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078744|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
83078745|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078746|NCT04520126|Protective Agents|protective agents|mesh-ancestor
83078747|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078748|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83078749|NCT02304354|Rituximab|rituximab|mesh-list
83078750|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078751|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078752|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
83078753|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078754|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83078755|NCT03356600|Apatinib|apatinib|mesh-list
83078756|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078757|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83078758|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078759|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078760|NCT04454476|Trametinib|trametinib|mesh-list
83078761|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078762|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83078763|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078764|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078765|NCT00102531|Cisplatin|cisplatin|mesh-list
83361863|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078766|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078767|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
83078768|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83078769|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078770|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078771|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83078772|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83078773|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
83078774|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83078775|NCT03360266|Listerine|listerine|mesh-list
83078776|NCT03360266|Fluorides|fluorides|mesh-list
83078777|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
83078778|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
83078779|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
83078780|NCT03360266|Protective Agents|protective agents|mesh-ancestor
83078781|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078782|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83078783|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078784|NCT02154789|Polidocanol|polidocanol|mesh-list
83078785|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83078786|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83078787|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83078788|NCT03506256|Norfloxacin|norfloxacin|mesh-list
83078789|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078790|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078791|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83078792|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83078793|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078794|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078795|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078796|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83078797|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83078798|NCT03356444|Docetaxel|docetaxel|mesh-list
83078799|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
83078800|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078801|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
83078802|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
83078803|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
83078804|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078805|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83078806|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078807|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
83078808|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078809|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078810|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83078811|NCT03503604|Leucovorin|leucovorin|mesh-list
83078812|NCT03503604|Paclitaxel|paclitaxel|mesh-list
83078813|NCT03503604|Carboplatin|carboplatin|mesh-list
83078814|NCT03503604|Gemcitabine|gemcitabine|mesh-list
83078815|NCT03503604|Fluorouracil|fluorouracil|mesh-list
83078816|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
83078817|NCT03503604|Irinotecan|irinotecan|mesh-list
83078818|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83078819|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078820|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
83078821|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
83078822|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
83078823|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078824|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83078825|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
83078826|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83078827|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
83078828|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078829|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83078830|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83078831|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078832|NCT03503604|Antidotes|antidotes|mesh-ancestor
83078833|NCT03503604|Protective Agents|protective agents|mesh-ancestor
83078834|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
83078835|NCT03503604|Vitamins|vitamins|mesh-ancestor
83078836|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
83078837|NCT04508816|Cetuximab|cetuximab|mesh-list
83078838|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
83078839|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078841|NCT03359876|Warfarin|warfarin|mesh-list
83078842|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
83078844|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83078845|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
83078846|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83078847|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
83078848|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078849|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078850|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
83078851|NCT04508894|Ketamine|ketamine|mesh-list
83078852|NCT04508894|Bupivacaine|bupivacaine|mesh-list
83078853|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
83078854|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
83078855|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078856|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078857|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
83078858|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078859|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83078860|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83078861|NCT04508894|Analgesics|analgesics|mesh-ancestor
83078862|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83078863|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83078864|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83078865|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
83078866|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078867|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078868|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83078869|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83078870|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
83078871|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83078872|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83078873|NCT05226832|Triamcinolone|triamcinolone|mesh-list
83078874|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83078875|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
83078876|NCT05226832|Hormones|hormones|mesh-ancestor
83078877|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078878|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078879|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
83078880|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83078881|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
83078882|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078883|NCT03354572|Expectorants|expectorants|mesh-ancestor
83078884|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
83078885|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83078886|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
83078887|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078888|NCT03354572|Protective Agents|protective agents|mesh-ancestor
83078889|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078890|NCT03354572|Antidotes|antidotes|mesh-ancestor
83078891|NCT03359798|Narcotics|narcotics|mesh-list
83078892|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078893|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078894|NCT03359798|Analgesics|analgesics|mesh-ancestor
83078895|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
83078896|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078897|NCT02309346|Clindamycin|clindamycin|mesh-list
83078898|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
83078899|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
83078900|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078901|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078902|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83078903|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078904|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078905|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83078906|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83078907|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078908|NCT03356054|Immunotoxins|immunotoxins|mesh-ancestor
83078909|NCT03356054|Immunoconjugates|immunoconjugates|mesh-ancestor
83078910|NCT03356054|Immunologic Factors|immunologic factors|mesh-ancestor
83078911|NCT03356054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078912|NCT03354494|Desogestrel|desogestrel|mesh-list
83078913|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83078914|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83078915|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83078917|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83078918|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078919|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83078920|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83078921|NCT03354494|Progestins|progestins|mesh-ancestor
83078922|NCT03354494|Hormones|hormones|mesh-ancestor
83078923|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83078924|NCT05530954|Calcium|calcium|mesh-list
83078925|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83078926|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078927|NCT03354338|Amoxicillin|amoxicillin|mesh-list
83078928|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078929|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078930|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
83078931|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078932|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078933|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83078934|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83078935|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078936|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078937|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078938|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83078939|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83078940|NCT02309424|Acetic Acid|acetic acid|mesh-list
83078941|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83078942|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83078943|NCT03506178|Phenylephrine|phenylephrine|mesh-list
83078944|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
83078945|NCT03506178|Menthol|menthol|mesh-list
83078946|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
83078947|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
83078948|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83078949|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83078950|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
83078951|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078952|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078953|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078954|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
83078955|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
83078956|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078957|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
83078958|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83078959|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
83078960|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83078961|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
83078962|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83078963|NCT03506178|Protective Agents|protective agents|mesh-ancestor
83078964|NCT05210374|Copper|copper|mesh-list
83078965|NCT05210374|Doxorubicin|doxorubicin|mesh-list
83078966|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83078967|NCT05210374|Disulfiram|disulfiram|mesh-list
83078968|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83078969|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83078970|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83078971|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83078972|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83078973|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078974|NCT05210374|Trace Elements|trace elements|mesh-ancestor
83078975|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
83078976|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078977|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83078978|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83078979|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
83078980|NCT02578186|Promethazine|promethazine|mesh-list
83078981|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83078982|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83078983|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83078984|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83078985|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
83078986|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
83078987|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
83078988|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83078989|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
83078991|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83078992|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83078993|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
83078994|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
83078995|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83078996|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83078997|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83078998|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
83078999|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
83079000|NCT04128436|Progesterone|progesterone|mesh-list
83079001|NCT04128436|Progestins|progestins|mesh-ancestor
83079002|NCT04128436|Hormones|hormones|mesh-ancestor
83079003|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079004|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079005|NCT02309658|Cisplatin|cisplatin|mesh-list
83079006|NCT02309658|Gemcitabine|gemcitabine|mesh-list
83079007|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079008|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079009|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
83079010|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079011|NCT05532280|Etoricoxib|etoricoxib|mesh-list
83079012|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83079013|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83079014|NCT05532280|Analgesics|analgesics|mesh-ancestor
83079015|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
83079016|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079017|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079018|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079019|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83079020|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83079021|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83079022|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079023|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079024|NCT04517162|Povidone|povidone|mesh-list
83079025|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
83079026|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
83079027|NCT02155023|Insulin|insulin|mesh-list
83079028|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83079029|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83079030|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079031|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
83079032|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83079033|NCT02163213|Antibodies|antibodies|mesh-list
83079034|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
83079035|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079036|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
83079037|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83079038|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83079039|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079040|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
83079041|NCT04443920|Coagulants|coagulants|mesh-ancestor
83079042|NCT03359018|Apatinib|apatinib|mesh-list
83079043|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079044|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83079045|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079046|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079047|NCT05530252|Minocycline|minocycline|mesh-list
83079048|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83079049|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
83079050|NCT02163291|Paclitaxel|paclitaxel|mesh-list
83079051|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83079052|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079053|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83079054|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83079055|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83079056|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079057|NCT03505788|Acetazolamide|acetazolamide|mesh-list
83079058|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
83079059|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83079060|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079061|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079062|NCT03505788|Diuretics|diuretics|mesh-ancestor
83079063|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
83079064|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079065|NCT02309970|Aspirin|aspirin|mesh-list
83079066|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83079067|NCT02309970|Warfarin|warfarin|mesh-list
83079068|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
83079069|NCT02309970|Dabigatran|dabigatran|mesh-list
83079070|NCT02309970|Apixaban|apixaban|mesh-list
83079071|NCT02309970|Clopidogrel|clopidogrel|mesh-list
83079072|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83079073|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83079074|NCT02309970|Analgesics|analgesics|mesh-ancestor
83079075|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
83079076|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079077|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079078|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079079|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83079080|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83079081|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83079082|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079083|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83079084|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83079085|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079086|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
83079087|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83079088|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83079089|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83079090|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
83079091|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079092|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
83079093|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83079094|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
83079095|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83079096|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
83079097|NCT03353948|Metformin|metformin|mesh-list
83079098|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83079099|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079100|NCT02161653|Pyridoxine|pyridoxine|mesh-list
83079101|NCT02161653|Prednisone|prednisone|mesh-list
83079102|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
83079103|NCT02161653|Metadoxine|metadoxine|mesh-list
83079104|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079105|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
83079106|NCT02161653|Hormones|hormones|mesh-ancestor
83079107|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079108|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079109|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83079110|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079111|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83079112|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079113|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079114|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83079115|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83079116|NCT02161653|Protective Agents|protective agents|mesh-ancestor
83079117|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
83079118|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83079119|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
83079120|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83079121|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
83079122|NCT02161653|Vitamins|vitamins|mesh-ancestor
83079123|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
83079124|NCT02576938|Triamcinolone|triamcinolone|mesh-list
83079125|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079126|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
83079127|NCT02576938|Hormones|hormones|mesh-ancestor
83079128|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079129|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079130|NCT02305836|Donepezil|donepezil|mesh-list
83079131|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83079132|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079133|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079134|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
83079135|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079136|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079137|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
83079138|NCT03503136|Cisplatin|cisplatin|mesh-list
83079139|NCT03503136|Docetaxel|docetaxel|mesh-list
83079140|NCT03503136|Fluorouracil|fluorouracil|mesh-list
83079141|NCT03503136|Capecitabine|capecitabine|mesh-list
83079142|NCT03503136|Nedaplatin|nedaplatin|mesh-list
83079143|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079144|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
83079145|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
83079146|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
83079147|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079149|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079150|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079152|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079153|NCT02305992|Bupivacaine|bupivacaine|mesh-list
83079154|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
83079155|NCT02305992|Anesthetics|anesthetics|mesh-list
83079156|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079157|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079158|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
83079159|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079160|NCT03355352|Sufentanil|sufentanil|mesh-list
83079161|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83079162|NCT03355352|Narcotics|narcotics|mesh-ancestor
83079163|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079164|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079165|NCT03355352|Analgesics|analgesics|mesh-ancestor
83079166|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
83079167|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079168|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83079169|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83079170|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
83079171|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
83079172|NCT05529940|Folfirinox|folfirinox|mesh-list
83079173|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079174|NCT04463784|Efavirenz|efavirenz|mesh-list
83079175|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83079176|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83079177|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079178|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079179|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
83079180|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079181|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83079182|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83079183|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83079184|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83079185|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83079186|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83079187|NCT02310360|Fallypride|fallypride|mesh-list
83079188|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83079189|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83079190|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
83079191|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079192|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079193|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079194|NCT03353480|Azithromycin|azithromycin|mesh-list
83079195|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079196|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079197|NCT02306070|Metformin|metformin|mesh-list
83079198|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83079199|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079200|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
83079201|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83079202|NCT03353324|Bevacizumab|bevacizumab|mesh-list
83079203|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079204|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079205|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83079206|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83079207|NCT03353324|Growth Substances|growth substances|mesh-ancestor
83079208|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079209|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084044|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084045|NCT04862468|Dexamethasone|dexamethasone|mesh-list
83084046|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084047|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
83084048|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
83084049|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084050|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084051|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084052|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
83084053|NCT04862468|Hormones|hormones|mesh-ancestor
83084054|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084055|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83361864|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361865|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83361866|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
83361867|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
83361868|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83361869|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
83079210|NCT03354962|Nivolumab|nivolumab|mesh-list
83079211|NCT03354962|Ipilimumab|ipilimumab|mesh-list
83079212|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079213|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079214|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83079215|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079216|NCT04511468|Copper|copper|mesh-list
83079217|NCT04511468|Chromium|chromium|mesh-list
83079218|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
83079219|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079220|NCT04511468|Trace Elements|trace elements|mesh-ancestor
83079221|NCT05531422|Fentanyl|fentanyl|mesh-list
83079222|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83079223|NCT05531422|Narcotics|narcotics|mesh-ancestor
83079224|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079225|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079226|NCT05531422|Analgesics|analgesics|mesh-ancestor
83079227|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
83079228|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079229|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83079230|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83079231|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
83079232|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
83079233|NCT04646356|Tacrolimus|tacrolimus|mesh-list
83079234|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079235|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
83079236|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079237|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83079238|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079239|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079240|NCT03354806|Analgesics|analgesics|mesh-list
83079241|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
83079242|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079243|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079244|NCT05523934|Capsaicin|capsaicin|mesh-list
83079245|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
83079246|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
83079247|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
83079248|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079249|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079250|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
83079251|NCT05529082|Narcotics|narcotics|mesh-ancestor
83079252|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079253|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079254|NCT05529082|Analgesics|analgesics|mesh-ancestor
83079255|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
83079256|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079257|NCT03350126|Nivolumab|nivolumab|mesh-list
83079258|NCT03350126|Ipilimumab|ipilimumab|mesh-list
83079259|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079260|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079261|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83079262|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079263|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83079264|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83079265|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079266|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079267|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
83079268|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079269|NCT02314182|Bevacizumab|bevacizumab|mesh-list
83079270|NCT02314182|Capecitabine|capecitabine|mesh-list
83079271|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
83079272|NCT02314182|Irinotecan|irinotecan|mesh-list
83079273|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079274|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079275|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83079276|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83079277|NCT02314182|Growth Substances|growth substances|mesh-ancestor
83079278|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079279|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
83079280|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079281|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
83079282|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079283|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83079284|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83079285|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079286|NCT05531344|Tamsulosin|tamsulosin|mesh-list
83079287|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83079288|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83079289|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83079290|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
83079291|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079292|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079293|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079294|NCT05531344|Urological Agents|urological agents|mesh-ancestor
83079295|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
83079296|NCT05531266|Hormones|hormones|mesh-ancestor
83079297|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079298|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079299|NCT03349658|Anesthetics|anesthetics|mesh-list
83079300|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079301|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079302|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
83079303|NCT03353012|Etonogestrel|etonogestrel|mesh-list
83079304|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83079305|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
83079306|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83079307|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079308|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83079309|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83079310|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83079311|NCT04462614|Heparin|heparin|mesh-list
83079312|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
83079313|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83079314|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83079315|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079316|NCT03349424|Somatostatin|somatostatin|mesh-list
83079317|NCT03349424|Hormones|hormones|mesh-ancestor
83079318|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079319|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079320|NCT03349346|Rituximab|rituximab|mesh-list
83079321|NCT03349346|Carboplatin|carboplatin|mesh-list
83079322|NCT03349346|Etoposide|etoposide|mesh-list
83079323|NCT03349346|Ifosfamide|ifosfamide|mesh-list
83079324|NCT03349346|Idelalisib|idelalisib|mesh-list
83079325|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079326|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079327|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
83079328|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079329|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83079330|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83079331|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83079332|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83079333|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079334|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079335|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83079336|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
83079337|NCT03502434|Petrolatum|petrolatum|mesh-list
83079338|NCT03502434|Emollients|emollients|mesh-ancestor
83079339|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
83079340|NCT03352700|Dyclonine|dyclonine|mesh-list
83079341|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079342|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
83079343|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079344|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079345|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
83079346|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079347|NCT05522998|Propofol|propofol|mesh-list
83079348|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83079349|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079351|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83079352|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
83079353|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
83079354|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
83079355|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83079357|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83079358|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079359|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83079360|NCT03498534|Isoniazid|isoniazid|mesh-list
83079361|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
83079362|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079363|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079364|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83079365|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83079366|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
83079367|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079368|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83079369|NCT03502356|Azithromycin|azithromycin|mesh-list
83079370|NCT03502356|Cefazolin|cefazolin|mesh-list
83079371|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079372|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079373|NCT03498456|Amoxicillin|amoxicillin|mesh-list
83079374|NCT03498456|Clarithromycin|clarithromycin|mesh-list
83079375|NCT03498456|Lansoprazole|lansoprazole|mesh-list
83079376|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
83079377|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079378|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079379|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83079380|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079381|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079382|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83079383|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83079384|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83079385|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83079386|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83079387|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
83079388|NCT02317146|Analgesics|analgesics|mesh-ancestor
83079389|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
83079390|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079391|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079392|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
83079393|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079394|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83079395|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
83079396|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83079397|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079398|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079399|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83079400|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
83079401|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83079402|NCT05528146|Psyllium|psyllium|mesh-list
83079403|NCT05528146|Cathartics|cathartics|mesh-ancestor
83079404|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83079405|NCT03349112|Lidocaine|lidocaine|mesh-list
83079406|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079407|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
83079408|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079409|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079410|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
83079411|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079412|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83079413|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83079414|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83079415|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079416|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079417|NCT03498222|Carboplatin|carboplatin|mesh-list
83079418|NCT03498222|Pemetrexed|pemetrexed|mesh-list
83079419|NCT03498222|Atezolizumab|atezolizumab|mesh-list
83079420|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079421|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079422|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079423|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83079424|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83079425|NCT03498222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83079426|NCT03498222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079427|NCT02518022|Insulin|insulin|mesh-list
83079428|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
83079429|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
83079430|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83079431|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079432|NCT05504252|Fluorouracil|fluorouracil|mesh-list
83079433|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
83079434|NCT05504252|Nivolumab|nivolumab|mesh-list
83079435|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
83079436|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079437|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079438|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079439|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079440|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
83079441|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079442|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079443|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83079444|NCT03497988|Oxytocin|oxytocin|mesh-list
83079445|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
83079446|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83079447|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079448|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
83079449|NCT04610476|Prednisolone|prednisolone|mesh-list
83079450|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83079451|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
83079452|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83079453|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
83079454|NCT04610476|Adalimumab|adalimumab|mesh-list
83079455|NCT04610476|Infliximab|infliximab|mesh-list
83079456|NCT04610476|Etanercept|etanercept|mesh-list
83079457|NCT04610476|Apremilast|apremilast|mesh-list
83079458|NCT04610476|Golimumab|golimumab|mesh-list
83079459|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
83079460|NCT04610476|Methotrexate|methotrexate|mesh-list
83079461|NCT04610476|Abatacept|abatacept|mesh-list
83079462|NCT04610476|Ustekinumab|ustekinumab|mesh-list
83079463|NCT04610476|Ixekizumab|ixekizumab|mesh-list
83079464|NCT04610476|Tofacitinib|tofacitinib|mesh-list
83079465|NCT04610476|Leflunomide|leflunomide|mesh-list
83079466|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83079467|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
83079468|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83079469|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
83079470|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83079471|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079472|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079473|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
83079474|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079475|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079476|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
83079477|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079478|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83079479|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079480|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
83079481|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83079482|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83079483|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079484|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
83079485|NCT04610476|Hormones|hormones|mesh-ancestor
83079486|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079487|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83079488|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
83079489|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
83079490|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079491|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83079492|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83079493|NCT04610476|Protective Agents|protective agents|mesh-ancestor
83079494|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83440389|NCT00742573|Bupropion|bupropion|mesh-list
83079495|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83079496|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83079497|NCT04610476|Analgesics|analgesics|mesh-ancestor
83079498|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
83079499|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83079500|NCT04610476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079501|NCT04610476|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83079502|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83079503|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83079504|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83079505|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079506|NCT03348800|Anesthetics|anesthetics|mesh-list
83079507|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079508|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079509|NCT02314806|Clindamycin|clindamycin|mesh-list
83079510|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
83079511|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
83079512|NCT02314806|Gentamicins|gentamicins|mesh-list
83079513|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83079514|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079515|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079516|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83079517|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079518|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079519|NCT00709202|Betahistine|betahistine|mesh-list
83079520|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
83079521|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
83079522|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
83079523|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079524|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079525|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079526|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
83079527|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83079528|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83079529|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83079530|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079531|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079532|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
83079533|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079534|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079535|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83079536|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079537|NCT02321280|Denosumab|denosumab|mesh-list
83079538|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83079539|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079540|NCT05016310|Vitamin D|vitamin d|mesh-list
83079541|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
83079542|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
83079543|NCT05016310|Vitamins|vitamins|mesh-list
83079544|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
83079545|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079546|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83079547|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83079548|NCT05527444|Thalidomide|thalidomide|mesh-list
83079549|NCT05527444|Adalimumab|adalimumab|mesh-list
83079550|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83079551|NCT05527444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83079552|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079553|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83079554|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079555|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
83079556|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079557|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
83079558|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079559|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079560|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83079561|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83079562|NCT05527444|Growth Substances|growth substances|mesh-ancestor
83079563|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
83079564|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079565|NCT05439902|Tamsulosin|tamsulosin|mesh-list
83079566|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83079567|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83079568|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83079569|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83079570|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079571|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079572|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079573|NCT05439902|Urological Agents|urological agents|mesh-ancestor
83079574|NCT02315118|Rituximab|rituximab|mesh-list
83079575|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079576|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079577|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
83079578|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079579|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83079580|NCT03122756|Dexamethasone|dexamethasone|mesh-list
83079581|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079582|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
83079583|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
83079584|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079585|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079586|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83079587|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
83079588|NCT03122756|Hormones|hormones|mesh-ancestor
83079589|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079590|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83079591|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079592|NCT03122678|Thiamine|thiamine|mesh-list
83079593|NCT03122678|Vitamins|vitamins|mesh-ancestor
83079594|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
83079595|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079596|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
83079597|NCT02317770|Lidocaine|lidocaine|mesh-list
83079598|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079599|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
83079600|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079601|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079602|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
83079603|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079604|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83079605|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83079606|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83079607|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079608|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079609|NCT05527054|Diuretics|diuretics|mesh-list
83079610|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
83079611|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079612|NCT04506242|Apatinib|apatinib|mesh-list
83079613|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079614|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83079615|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079616|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079617|NCT05526898|Triamcinolone|triamcinolone|mesh-list
83079618|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079619|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
83079620|NCT05526898|Hormones|hormones|mesh-ancestor
83079621|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079622|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079623|NCT05526820|Vaccines|vaccines|mesh-list
83079624|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
83079625|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079626|NCT03352076|Danazol|danazol|mesh-list
83079627|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83079628|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
83079629|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079630|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079631|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83079632|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83079633|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83079634|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83079635|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83079636|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83079637|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079638|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079639|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079640|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83079641|NCT02738580|Hormones|hormones|mesh-ancestor
83079642|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079643|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079644|NCT03497364|Bupivacaine|bupivacaine|mesh-list
83079645|NCT03497364|Ropivacaine|ropivacaine|mesh-list
83079646|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079647|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
83079648|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079649|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079650|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
83079651|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079652|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83079653|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83079654|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079655|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
83079656|NCT05521048|Doxycycline|doxycycline|mesh-list
83079657|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079658|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079659|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
83079660|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83079661|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83079662|NCT05516446|Chromium|chromium|mesh-list
83079663|NCT05516446|Paclitaxel|paclitaxel|mesh-list
83079664|NCT05516446|Everolimus|everolimus|mesh-list
83079665|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83079666|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079667|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
83079668|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
83079669|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
83079670|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079671|NCT05516446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83079672|NCT05516446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83079673|NCT05516446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079674|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079675|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
83079676|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079677|NCT05516446|Trace Elements|trace elements|mesh-ancestor
83079678|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
83079679|NCT02318082|Aldesleukin|aldesleukin|mesh-list
83079680|NCT02318082|Interleukin-2|interleukin-2|mesh-list
83079681|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079682|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83079683|NCT02318082|Analgesics|analgesics|mesh-ancestor
83079684|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
83079685|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079686|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079687|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83079688|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83079689|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
83079690|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079691|NCT03348098|Paclitaxel|paclitaxel|mesh-list
83079692|NCT03348098|Apatinib|apatinib|mesh-list
83079693|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83079694|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079695|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
83079696|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
83079697|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
83079698|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079699|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83079700|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079701|NCT03351842|Cisplatin|cisplatin|mesh-list
83079702|NCT03351842|Carboplatin|carboplatin|mesh-list
83079703|NCT03351842|Pemetrexed|pemetrexed|mesh-list
83079704|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079705|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079706|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079707|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83079708|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83079709|NCT02447406|Docetaxel|docetaxel|mesh-list
83079710|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079711|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83079712|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83079713|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83079714|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079715|NCT04505228|Atropine|atropine|mesh-list
83079716|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83079717|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83079718|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83079719|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
83079720|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079721|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079722|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83079723|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
83079724|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
83079725|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
83079726|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83079727|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83079728|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
83079729|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079730|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079731|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83079732|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
83079733|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079735|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
83079736|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079737|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079738|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83079739|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83079740|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079741|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
83079742|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
83079743|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
83079744|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079745|NCT03161028|Protective Agents|protective agents|mesh-ancestor
83079746|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079747|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
83079748|NCT03161028|Vitamins|vitamins|mesh-ancestor
83079749|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
83079750|NCT02322372|Bupivacaine|bupivacaine|mesh-list
83079751|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
83079752|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079753|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079754|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079755|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
83079756|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079757|NCT01376804|Valganciclovir|valganciclovir|mesh-list
83079758|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
83079759|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079760|NCT05526118|Tenofovir|tenofovir|mesh-list
83079761|NCT05526118|Emtricitabine|emtricitabine|mesh-list
83079762|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83079763|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
83079764|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079765|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83079766|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83079767|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079768|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079769|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83079770|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83079771|NCT03122132|Ritonavir|ritonavir|mesh-list
83079772|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83079773|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83079774|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
83079775|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079776|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079777|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83079778|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83079779|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
83079780|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079781|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83079782|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83079783|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
83079784|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83079785|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83079786|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079787|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
83079788|NCT03351686|Coagulants|coagulants|mesh-ancestor
83079789|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
83079790|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83079791|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079792|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
83079793|NCT02319018|Leucovorin|leucovorin|mesh-list
83079794|NCT02319018|Folic Acid|folic acid|mesh-list
83079795|NCT02319018|Fluorouracil|fluorouracil|mesh-list
83079796|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
83079797|NCT02319018|Calcium|calcium|mesh-list
83079798|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
83079799|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83079800|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079801|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83079802|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
83079803|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079804|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079805|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079806|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079807|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
83079808|NCT02319018|Antidotes|antidotes|mesh-ancestor
83079809|NCT02319018|Protective Agents|protective agents|mesh-ancestor
83079810|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
83079812|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
83079813|NCT02319018|Hematinics|hematinics|mesh-ancestor
83079814|NCT02574520|Bupivacaine|bupivacaine|mesh-list
83079815|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83079816|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079817|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
83079818|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079819|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079820|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
83079821|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079822|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
83079823|NCT04425226|Lenvatinib|lenvatinib|mesh-list
83079824|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83079825|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079826|NCT04425226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83079827|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079828|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83079829|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079830|NCT05520658|Fluorouracil|fluorouracil|mesh-list
83079831|NCT05520658|Digoxin|digoxin|mesh-list
83079832|NCT05520658|Furosemide|furosemide|mesh-list
83079833|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
83079834|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079835|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079836|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079837|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079838|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
83079839|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079840|NCT05520658|Diuretics|diuretics|mesh-ancestor
83079841|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
83079842|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83079843|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079844|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83079845|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83079846|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079847|NCT05520658|Protective Agents|protective agents|mesh-ancestor
83079848|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83079849|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83079850|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079851|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83079852|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
83079853|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079854|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83079855|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83079856|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079857|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079858|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83079859|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83079860|NCT03351062|Tamoxifen|tamoxifen|mesh-list
83079861|NCT03351062|Toremifene|toremifene|mesh-list
83079862|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83079863|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
83079864|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440396|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
83079865|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079866|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83079867|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079868|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83079869|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83079870|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83079871|NCT03496740|Bupivacaine|bupivacaine|mesh-list
83079872|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079873|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
83079874|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079875|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079876|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
83079877|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079878|NCT05515822|Oxycodone|oxycodone|mesh-list
83079879|NCT05515822|Dezocine|dezocine|mesh-list
83079880|NCT05515822|Esketamine|esketamine|mesh-list
83079881|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83079882|NCT05515822|Narcotics|narcotics|mesh-ancestor
83079883|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079884|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079886|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
83079887|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079888|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
83079889|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83079890|NCT04294654|Vortioxetine|vortioxetine|mesh-list
83079891|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
83079892|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83079893|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83079894|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83079895|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079896|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079897|NCT04294654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83079898|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83079899|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079900|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079901|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079902|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
83079903|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83079904|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83079905|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83079906|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83079907|NCT03496506|Selexipag|selexipag|mesh-list
83079908|NCT03496506|Clopidogrel|clopidogrel|mesh-list
83079909|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83079910|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83079911|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83079912|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83079913|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
83079914|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079915|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079916|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079917|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83079918|NCT04766684|Lidocaine|lidocaine|mesh-list
83079919|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
83079920|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
83079921|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83079922|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079923|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
83079924|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079925|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83079926|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83079927|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83079928|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83079929|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079930|NCT02325024|Nabiximols|nabiximols|mesh-list
83079931|NCT02325024|Analgesics|analgesics|mesh-ancestor
83079932|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
83079933|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079934|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079935|NCT02319564|Beclomethasone|beclomethasone|mesh-list
83079936|NCT02319564|Albuterol|albuterol|mesh-list
83079937|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83079938|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
83079939|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079940|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079941|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83079942|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
83079943|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
83079944|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83079945|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83079946|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83079947|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83079948|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
83079949|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079950|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079951|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83079952|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
83079953|NCT02319564|Hormones|hormones|mesh-ancestor
83079954|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83079955|NCT05056402|Vaccines|vaccines|mesh-list
83079956|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
83079957|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079958|NCT02325180|Lumefantrine|lumefantrine|mesh-list
83079959|NCT02325180|Artemether|artemether|mesh-list
83079960|NCT02325180|Piperaquine|piperaquine|mesh-list
83079961|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83079962|NCT02325180|Artenimol|artenimol|mesh-list
83079963|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
83079964|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83079965|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83079966|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079967|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
83079968|NCT00709592|Tacrolimus|tacrolimus|mesh-list
83079969|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
83079970|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83079971|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83079972|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
83079973|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079974|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83079975|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83079976|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079977|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83079978|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83079979|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83079980|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
83079981|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83079982|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83079983|NCT05515354|Nicotine|nicotine|mesh-list
83079984|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83079985|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
83079986|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83079987|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83079988|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83079989|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83079990|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
83079991|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83079992|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079993|NCT02437370|Gemcitabine|gemcitabine|mesh-list
83079994|NCT02437370|Docetaxel|docetaxel|mesh-list
83079995|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
83079996|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83079997|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
83079998|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83079999|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080000|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
83080001|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
83080002|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
83080003|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83080004|NCT02437370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83080005|NCT05515120|Aspirin|aspirin|mesh-list
83080006|NCT05515120|Vitamin K|vitamin k|mesh-list
83080007|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
83080008|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
83080009|NCT05515120|Vitamins|vitamins|mesh-ancestor
83080010|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
83080011|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080012|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83080013|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080014|NCT05515120|Analgesics|analgesics|mesh-ancestor
83080015|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
83080016|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080017|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83080018|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080019|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83080020|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83080021|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080022|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83080023|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83080024|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080025|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
83080026|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83080027|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
83080028|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83080029|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080030|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
83080031|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83080032|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
83080033|NCT05515120|Coagulants|coagulants|mesh-ancestor
83080034|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
83080035|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83080036|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
83080037|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080038|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080039|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83080040|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
83080041|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080042|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080043|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83080044|NCT05042128|Paclitaxel|paclitaxel|mesh-list
83080045|NCT05042128|Gemcitabine|gemcitabine|mesh-list
83080046|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83080047|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080048|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
83080049|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
83080050|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
83080051|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080052|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83080053|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
83080054|NCT03495804|Mannitol|mannitol|mesh-list
83080055|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83080056|NCT03495804|Diuretics|diuretics|mesh-ancestor
83080057|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
83080058|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080059|NCT05519410|Lenvatinib|lenvatinib|mesh-list
83080060|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080061|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83080062|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080063|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080064|NCT05578586|Meropenem|meropenem|mesh-list
83080065|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080066|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080067|NCT02570074|Fosfomycin|fosfomycin|mesh-list
83080068|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080069|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080070|NCT02569996|Rituximab|rituximab|mesh-list
83080071|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83080072|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080073|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
83080074|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080075|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080076|NCT02325882|Fentanyl|fentanyl|mesh-list
83080077|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
83080078|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83080079|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080080|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080081|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080082|NCT02325882|Analgesics|analgesics|mesh-ancestor
83080083|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
83080084|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080085|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83080086|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83080087|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83080088|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83080089|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080090|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080091|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83080092|NCT02325882|Narcotics|narcotics|mesh-ancestor
83080093|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83080094|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83080095|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
83080096|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
83080097|NCT00708500|Interferons|interferons|mesh-list
83080098|NCT00708500|Ribavirin|ribavirin|mesh-list
83080099|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
83080100|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
83080101|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83080102|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080103|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
83080104|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080106|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080107|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
83080108|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080109|NCT05144100|Cisplatin|cisplatin|mesh-list
83080110|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080111|NCT02320032|Aripiprazole|aripiprazole|mesh-list
83080112|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
83080113|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
83080114|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83080115|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83080116|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83080117|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080118|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080119|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
83080120|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
83080121|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080122|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080123|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83080124|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83080125|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
83080126|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83080127|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83080128|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83080129|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83080130|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
83080131|NCT05514652|Anesthetics|anesthetics|mesh-list
83080132|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080133|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080134|NCT05514652|Narcotics|narcotics|mesh-ancestor
83080135|NCT05514652|Analgesics|analgesics|mesh-ancestor
83080136|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
83080137|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080138|NCT00673244|Furosemide|furosemide|mesh-list
83080139|NCT00673244|Diuretics|diuretics|mesh-ancestor
83080140|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
83080141|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080142|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83080143|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83080144|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080145|NCT02517788|Interferons|interferons|mesh-list
83080146|NCT02517788|Interferon-beta|interferon-beta|mesh-list
83080147|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
83080148|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080149|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
83080150|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080151|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
83080152|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080153|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83080154|NCT04599790|Lenvatinib|lenvatinib|mesh-list
83080155|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080156|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83080157|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080158|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080159|NCT03132168|Anesthetics|anesthetics|mesh-list
83080160|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080161|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080162|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83080163|NCT04937062|Glycerol|glycerol|mesh-list
83080164|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83080165|NCT04937062|Protective Agents|protective agents|mesh-ancestor
83080166|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080167|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080168|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83080169|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83080170|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080171|NCT02324010|Incretins|incretins|mesh-ancestor
83080172|NCT02324010|Hormones|hormones|mesh-ancestor
83080173|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83080174|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83080175|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080176|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080177|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080178|NCT02320734|Rocuronium|rocuronium|mesh-list
83080179|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83080180|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83080181|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83080182|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080183|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361870|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080185|NCT03346226|Propofol|propofol|mesh-list
83080186|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83080187|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080188|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080189|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080190|NCT03346226|Analgesics|analgesics|mesh-ancestor
83080191|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
83080192|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080193|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83080194|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83080195|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83080196|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83080197|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080198|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080199|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83080200|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
83080201|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
83080202|NCT03347240|Baclofen|baclofen|mesh-list
83080203|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83080204|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080205|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83080206|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080207|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83080208|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
83080209|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
83080210|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080211|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080212|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
83080213|NCT02324088|Docetaxel|docetaxel|mesh-list
83080214|NCT02324088|Epirubicin|epirubicin|mesh-list
83080215|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83080216|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
83080217|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080218|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080219|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83080220|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
83080221|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080222|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080223|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83080224|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83080225|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83080226|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83080227|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83080228|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83080229|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83080230|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080231|NCT02324166|Cefazolin|cefazolin|mesh-list
83080232|NCT02324166|Lidocaine|lidocaine|mesh-list
83080233|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
83080234|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
83080235|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080236|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080237|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
83080238|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080239|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83080240|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83080241|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83080242|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83080243|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080244|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080245|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080246|NCT03346538|Edaravone|edaravone|mesh-list
83080247|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83080248|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
83080249|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080250|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83080251|NCT03346538|Protective Agents|protective agents|mesh-ancestor
83080252|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080253|NCT02513342|Docetaxel|docetaxel|mesh-list
83080254|NCT02513342|Endostar protein|endostar protein|mesh-list
83080255|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080256|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
83080257|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
83080258|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
83080259|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080260|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83080261|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83080262|NCT02513342|Growth Substances|growth substances|mesh-ancestor
83080263|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080264|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
83080265|NCT03495024|Varenicline|varenicline|mesh-list
83080266|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83080267|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83080268|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
83080269|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080270|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080271|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080272|NCT04188314|Desflurane|desflurane|mesh-list
83080273|NCT04188314|Isoflurane|isoflurane|mesh-list
83080274|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83080275|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
83080276|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
83080277|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080278|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080279|NCT05512780|Letrozole|letrozole|mesh-list
83080280|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080281|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83080282|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83080283|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080284|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080285|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83080286|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
83080287|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83080288|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080289|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83080290|NCT02517164|Calcifediol|calcifediol|mesh-list
83080291|NCT02517164|Vitamins|vitamins|mesh-ancestor
83080292|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
83080293|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080294|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83080295|NCT04834362|Insulin|insulin|mesh-list
83080296|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83080297|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
83080298|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
83080299|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83080300|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080301|NCT05512702|Heparin|heparin|mesh-list
83080302|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83080303|NCT05512702|Plasminogen|plasminogen|mesh-list
83080304|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83080305|NCT05512702|Tinzaparin|tinzaparin|mesh-list
83080306|NCT05512702|Dalteparin|dalteparin|mesh-list
83080307|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
83080308|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83080309|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83080310|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080311|NCT05512546|Aspirin|aspirin|mesh-list
83080312|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83080313|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080314|NCT05512546|Analgesics|analgesics|mesh-ancestor
83080315|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
83080316|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080317|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080318|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83080319|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080320|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83080321|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83080322|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080323|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83080324|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83080325|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080326|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
83080327|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
83080328|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83080329|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080330|NCT03345134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83080331|NCT03345134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080332|NCT02512562|Simeprevir|simeprevir|mesh-list
83080333|NCT02512562|Odalasvir|odalasvir|mesh-list
83080334|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
83361871|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080335|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080336|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080337|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080338|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080339|NCT02516774|Adalimumab|adalimumab|mesh-list
83080340|NCT02516774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83080341|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83080342|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080343|NCT05510986|Fentanyl|fentanyl|mesh-list
83080344|NCT05510986|Oxycodone|oxycodone|mesh-list
83080345|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83080346|NCT05510986|Narcotics|narcotics|mesh-ancestor
83080347|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080348|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080349|NCT05510986|Analgesics|analgesics|mesh-ancestor
83080350|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
83080351|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080352|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83080353|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83080354|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
83080355|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
83080356|NCT04872400|Vancomycin|vancomycin|mesh-list
83080357|NCT04872400|Tobramycin|tobramycin|mesh-list
83080358|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080359|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080360|NCT00101907|Gemcitabine|gemcitabine|mesh-list
83080361|NCT00101907|Panitumumab|panitumumab|mesh-list
83080362|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
83080363|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080364|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83080365|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
83080366|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080367|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83080368|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83080369|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080370|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
83080371|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
83080372|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080373|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080374|NCT04769206|Galantamine|galantamine|mesh-list
83080375|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83080376|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83440412|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83080377|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080378|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
83080379|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080380|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080381|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83080382|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
83080383|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080384|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
83080385|NCT03492996|Delpazolid|delpazolid|mesh-list
83080386|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080387|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080388|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83080389|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080390|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080391|NCT03772028|Cisplatin|cisplatin|mesh-list
83080392|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080393|NCT02161965|Warfarin|warfarin|mesh-list
83080394|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
83080395|NCT02161965|Fluindione|fluindione|mesh-list
83080396|NCT02161965|Phenindione|phenindione|mesh-list
83080397|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
83080398|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83080399|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
83080400|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83080401|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080402|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080403|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080404|NCT02050308|Nicotine|nicotine|mesh-list
83080405|NCT02050308|Varenicline|varenicline|mesh-list
83080406|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83080407|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
83080408|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080409|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080410|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83080411|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83361872|NCT03028909|Oseltamivir|oseltamivir|mesh-list
83080412|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
83080413|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080414|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080415|NCT02516618|Fasinumab|fasinumab|mesh-list
83080416|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080417|NCT02516618|Analgesics|analgesics|mesh-ancestor
83080418|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
83080419|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080420|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080421|NCT05507554|Analgesics|analgesics|mesh-list
83080422|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83080423|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080424|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
83080425|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080426|NCT02516462|Hormones|hormones|mesh-list
83080427|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83080428|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83080429|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080430|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
83080431|NCT04501250|Insulin|insulin|mesh-list
83080432|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83080433|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83080434|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080435|NCT02761629|Interferons|interferons|mesh-list
83080436|NCT02761629|Ribavirin|ribavirin|mesh-list
83080437|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
83080438|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
83080439|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83080440|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080441|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
83080442|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080443|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
83080444|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080445|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
83080446|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080447|NCT03345992|Clarithromycin|clarithromycin|mesh-list
83080448|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080449|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080450|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83080451|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080452|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080453|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83080454|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83080455|NCT02162121|Ketorolac|ketorolac|mesh-list
83080456|NCT02162121|Buprenorphine|buprenorphine|mesh-list
83080457|NCT02162121|Anesthetics|anesthetics|mesh-list
83080458|NCT02162121|Ropivacaine|ropivacaine|mesh-list
83080459|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
83080460|NCT02162121|Mepivacaine|mepivacaine|mesh-list
83080461|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
83080462|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080463|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080464|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
83080465|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080466|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83080467|NCT02162121|Narcotics|narcotics|mesh-ancestor
83080468|NCT02162121|Analgesics|analgesics|mesh-ancestor
83080469|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83080470|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83080471|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080472|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83080473|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080474|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83080475|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080476|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080477|NCT02511704|Nicotine|nicotine|mesh-list
83080478|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83080479|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
83080480|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080481|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080482|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83080483|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83080484|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
83080485|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080486|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080487|NCT04500704|Carboplatin|carboplatin|mesh-list
83080489|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080490|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080491|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080492|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83080493|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83080494|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
83080495|NCT02164773|Analgesics|analgesics|mesh-ancestor
83080496|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
83080497|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080498|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080499|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
83080500|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080501|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83080502|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
83080503|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83080504|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83080505|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080506|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83080507|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
83080508|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83080509|NCT00101439|Ezetimibe|ezetimibe|mesh-list
83080510|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83080511|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83080512|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
83080513|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080514|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83080515|NCT03344822|Choline|choline|mesh-list
83080516|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83080517|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
83080518|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83080519|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
83080520|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080521|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080522|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83080523|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
83080524|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83080525|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83080526|NCT02506790|Toremifene|toremifene|mesh-list
83080527|NCT02506790|Metformin|metformin|mesh-list
83080528|NCT02506790|Melatonin|melatonin|mesh-list
83080529|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83080530|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080531|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
83080532|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080533|NCT02506790|Protective Agents|protective agents|mesh-ancestor
83080534|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080535|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83080536|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080537|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83080538|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83080539|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
83080540|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83080541|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83080542|NCT04500002|Isoniazid|isoniazid|mesh-list
83080543|NCT04500002|Misoprostol|misoprostol|mesh-list
83080544|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83080545|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
83080546|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83080547|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080548|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83080549|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080550|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
83080551|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
83080552|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080553|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080554|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83080555|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83080556|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
83080557|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080558|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83080559|NCT02515682|Equol|equol|mesh-list
83080560|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
83361873|NCT03028909|MEDI8852|medi8852|mesh-list
83080561|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83080562|NCT02515682|Estrogens|estrogens|mesh-ancestor
83080563|NCT02515682|Hormones|hormones|mesh-ancestor
83080564|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83080565|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080566|NCT02515604|Misoprostol|misoprostol|mesh-list
83080567|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83080568|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
83080569|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83080570|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080571|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83080572|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080573|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
83080574|NCT02510534|Menotropins|menotropins|mesh-list
83080575|NCT02510534|Progesterone|progesterone|mesh-list
83080576|NCT02510534|Progestins|progestins|mesh-ancestor
83080577|NCT02510534|Hormones|hormones|mesh-ancestor
83080578|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83080579|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080580|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83080581|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
83080582|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83080583|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
83080584|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83080585|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080586|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080587|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080588|NCT02510612|Analgesics|analgesics|mesh-ancestor
83080589|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
83080590|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080591|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83080592|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83080593|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83080594|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
83080595|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080596|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080597|NCT03749616|Acetaminophen|acetaminophen|mesh-list
83080598|NCT03749616|Ibuprofen|ibuprofen|mesh-list
83080599|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080600|NCT03749616|Analgesics|analgesics|mesh-ancestor
83080601|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
83080602|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080603|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080604|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
83080605|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83080606|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83080607|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080608|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83080609|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080610|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080611|NCT00101283|Carboplatin|carboplatin|mesh-list
83080612|NCT00101283|Gemcitabine|gemcitabine|mesh-list
83080613|NCT00101283|Pemetrexed|pemetrexed|mesh-list
83080614|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080615|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83080616|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
83080617|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080618|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080619|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83080620|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83080621|NCT04532502|Anesthetics|anesthetics|mesh-list
83080622|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
83080623|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080624|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080625|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
83080626|NCT02515526|Tolbutamide|tolbutamide|mesh-list
83080627|NCT02515526|Ethanol|ethanol|mesh-list
83080628|NCT02515526|Digoxin|digoxin|mesh-list
83080629|NCT02515526|Midazolam|midazolam|mesh-list
83080630|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
83080631|NCT02515526|Caffeine|caffeine|mesh-list
83080632|NCT02515526|Omeprazole|omeprazole|mesh-list
83080633|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83080634|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83080635|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080636|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080637|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83080638|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83080639|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83080640|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83080641|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
83080643|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
83080644|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
83080645|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080646|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080647|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83080648|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83080649|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080650|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83080651|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83080652|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
83080653|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83080654|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080655|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83080656|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83080657|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080658|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83080659|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83080660|NCT02515526|Protective Agents|protective agents|mesh-ancestor
83080661|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
83080662|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
83080663|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83080664|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83080665|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83080666|NCT02515448|Gentamicins|gentamicins|mesh-list
83080667|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080668|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080669|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83080670|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080671|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080672|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
83080673|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83080674|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
83080675|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080676|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
83080677|NCT02170857|Protective Agents|protective agents|mesh-ancestor
83080678|NCT04460820|Doxorubicin|doxorubicin|mesh-list
83080679|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83080680|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83080681|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080682|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83080683|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83080684|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080685|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080686|NCT02170935|Dabigatran|dabigatran|mesh-list
83080687|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
83080688|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83080689|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080690|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080691|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080692|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
83080693|NCT03488316|Calcium|calcium|mesh-list
83080694|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83080695|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080696|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
83080697|NCT02510222|Analgesics|analgesics|mesh-ancestor
83080698|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
83080699|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080700|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080701|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
83080702|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080703|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83080704|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
83080705|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83080706|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83080707|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080708|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83080709|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
83361875|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080710|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83080711|NCT05100264|Acetic Acid|acetic acid|mesh-list
83080712|NCT05100264|Retinol acetate|retinol acetate|mesh-list
83080713|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080714|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080715|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83080716|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
83080717|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080718|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83080719|NCT05100264|Protective Agents|protective agents|mesh-ancestor
83080720|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080721|NCT02505776|Bimatoprost|bimatoprost|mesh-list
83080722|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83080723|NCT02171013|Dabigatran|dabigatran|mesh-list
83080724|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
83080725|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83080726|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080727|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080728|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080729|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
83080730|NCT02167425|Methadone|methadone|mesh-list
83080731|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83080732|NCT02167425|Narcotics|narcotics|mesh-ancestor
83080733|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080734|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080735|NCT02167425|Analgesics|analgesics|mesh-ancestor
83080736|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
83080737|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080738|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
83080739|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
83080740|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
83080741|NCT03111732|Capecitabine|capecitabine|mesh-list
83080742|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
83080743|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83080744|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080745|NCT03111732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83080746|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080747|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83080748|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
83080749|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
83080750|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080751|NCT02505386|Ertapenem|ertapenem|mesh-list
83080752|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080753|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080754|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
83080755|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83080756|NCT02514980|Ketamine|ketamine|mesh-list
83080757|NCT02514980|Bupivacaine|bupivacaine|mesh-list
83080758|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
83080759|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
83080760|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080761|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080762|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
83080763|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080764|NCT02514980|Analgesics|analgesics|mesh-ancestor
83080765|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83080766|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83080767|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
83080768|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83080769|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83080770|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080771|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080772|NCT02165475|Loperamide|loperamide|mesh-list
83080773|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
83080774|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080775|NCT04862338|Niacinamide|niacinamide|mesh-list
83080776|NCT04862338|Niacin|niacin|mesh-list
83080777|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
83080778|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
83080779|NCT04862338|Vitamins|vitamins|mesh-ancestor
83080780|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
83080781|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080782|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83080783|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
83080784|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080785|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83080786|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
83080787|NCT02171325|Irinotecan|irinotecan|mesh-list
83080788|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83080789|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83080790|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080791|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080792|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080793|NCT02509286|Leucovorin|leucovorin|mesh-list
83080794|NCT02509286|Paclitaxel|paclitaxel|mesh-list
83080795|NCT02509286|Docetaxel|docetaxel|mesh-list
83080796|NCT02509286|Carboplatin|carboplatin|mesh-list
83080797|NCT02509286|Fluorouracil|fluorouracil|mesh-list
83080798|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
83080799|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83080800|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080801|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
83080802|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
83080803|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
83080804|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080805|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
83080806|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83080807|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83080808|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
83080809|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080810|NCT02509286|Antidotes|antidotes|mesh-ancestor
83080811|NCT02509286|Protective Agents|protective agents|mesh-ancestor
83080812|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
83080813|NCT02509286|Vitamins|vitamins|mesh-ancestor
83080814|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
83080815|NCT03065244|Infliximab|infliximab|mesh-list
83080816|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
83080817|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83080818|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
83080819|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83080820|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
83080821|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080822|NCT03065244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83080823|NCT03065244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83080824|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
83080825|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080826|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83080827|NCT02171481|Dabigatran|dabigatran|mesh-list
83080828|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
83080829|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83080830|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080831|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080832|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080833|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
83080834|NCT02171559|Enoxaparin|enoxaparin|mesh-list
83080835|NCT02171559|Dabigatran|dabigatran|mesh-list
83080836|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
83080837|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83080838|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83080839|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080840|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
83080841|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83080842|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
83080843|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080844|NCT04901754|Apatinib|apatinib|mesh-list
83080845|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080846|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83080847|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080848|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080849|NCT02509208|Hemostatics|hemostatics|mesh-list
83080850|NCT02509208|Coagulants|coagulants|mesh-ancestor
83080851|NCT02504996|Acetaminophen|acetaminophen|mesh-list
83080852|NCT02504996|Morphine|morphine|mesh-list
83080853|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83080854|NCT02504996|Narcotics|narcotics|mesh-ancestor
83080855|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080856|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080857|NCT02504996|Analgesics|analgesics|mesh-ancestor
83080858|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
83080859|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080860|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83080861|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
83080863|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080864|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080865|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83080866|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
83080867|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080868|NCT00100815|Bevacizumab|bevacizumab|mesh-list
83080869|NCT00100815|Gemcitabine|gemcitabine|mesh-list
83080870|NCT00100815|Capecitabine|capecitabine|mesh-list
83080871|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83080872|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080873|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83080874|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83080875|NCT00100815|Growth Substances|growth substances|mesh-ancestor
83080876|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080877|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83080878|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83080879|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
83080880|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080881|NCT00708422|Travoprost|travoprost|mesh-list
83080882|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83080883|NCT00708422|Latanoprost|latanoprost|mesh-list
83080884|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83080885|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83080886|NCT02514200|Riboflavin|riboflavin|mesh-list
83080887|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
83080888|NCT02514200|Vitamins|vitamins|mesh-ancestor
83080889|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
83080890|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080891|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83080892|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
83080893|NCT02504450|Haloperidol|haloperidol|mesh-list
83080894|NCT02504450|Ziprasidone|ziprasidone|mesh-list
83080895|NCT02504450|Loxapine|loxapine|mesh-list
83080896|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
83080897|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
83080898|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080899|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080900|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080901|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83080902|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83080903|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080904|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83080905|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83080906|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
83080907|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080908|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080909|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83080910|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83080911|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
83080912|NCT02171637|Afatinib|afatinib|mesh-list
83080913|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080914|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83080915|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080916|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080917|NCT02171715|Afatinib|afatinib|mesh-list
83080918|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080919|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83080920|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080921|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080922|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
83080923|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83080924|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83080925|NCT02504372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83080926|NCT02504372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080927|NCT02760069|Ondansetron|ondansetron|mesh-list
83080928|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
83080929|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
83080930|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080931|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080932|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83080933|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
83080934|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83080935|NCT02760069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83080936|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83080937|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
83080938|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361876|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080939|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080940|NCT02504138|Anesthetics|anesthetics|mesh-list
83080941|NCT02504138|Propofol|propofol|mesh-list
83080943|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080944|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080945|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83080946|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83080947|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
83080948|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83080949|NCT02508584|Antibodies|antibodies|mesh-list
83080950|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
83080951|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080952|NCT02171793|Olodaterol|olodaterol|mesh-list
83080953|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83080954|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
83080955|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080956|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080957|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83080958|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
83080959|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
83080960|NCT02508350|Daptomycin|daptomycin|mesh-list
83080961|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83080962|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080963|NCT02503826|Midazolam|midazolam|mesh-list
83080964|NCT02503826|Sufentanil|sufentanil|mesh-list
83080966|NCT02503826|Propofol|propofol|mesh-list
83080967|NCT02503826|Cisatracurium|cisatracurium|mesh-list
83080968|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83080969|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83080970|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83080971|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83080972|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
83080973|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
83080974|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83080975|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83080976|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83080977|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83080978|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
83080979|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
83080980|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83080981|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080982|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83080983|NCT02503826|Narcotics|narcotics|mesh-ancestor
83080984|NCT02503826|Analgesics|analgesics|mesh-ancestor
83080985|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
83080986|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83080987|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83080988|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83080989|NCT03121664|Itraconazole|itraconazole|mesh-list
83080990|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
83080991|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83080992|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83080993|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83080994|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83080995|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83080996|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83080997|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
83080998|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83080999|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081000|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83081001|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83081002|NCT02503904|Metronidazole|metronidazole|mesh-list
83081003|NCT02503904|Lidocaine|lidocaine|mesh-list
83081004|NCT02503904|Epinephrine|epinephrine|mesh-list
83081005|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
83081006|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
83081007|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081008|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081009|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
83081010|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081011|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83081012|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83081013|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83081014|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081015|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081016|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081017|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83081018|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83081019|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83081020|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081021|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83081022|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081023|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
83081024|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081025|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081026|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
83081027|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
83081028|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83081029|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83081030|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83081031|NCT02172105|Olodaterol|olodaterol|mesh-list
83081032|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081033|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
83081034|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081035|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081036|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081037|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081038|NCT03121352|Paclitaxel|paclitaxel|mesh-list
83081039|NCT03121352|Carboplatin|carboplatin|mesh-list
83081040|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
83081041|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83081042|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081043|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83081044|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83081045|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83081046|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081047|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081048|NCT03121352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83081049|NCT02513654|Lamotrigine|lamotrigine|mesh-list
83081050|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
83081051|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83081052|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081053|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081054|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83081055|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081056|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83081057|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83081058|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081059|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83081060|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83081061|NCT02513888|Vitamin D|vitamin d|mesh-list
83081062|NCT02513888|Vitamins|vitamins|mesh-ancestor
83081063|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
83081064|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081065|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83081066|NCT00101595|Dasatinib|dasatinib|mesh-list
83081067|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081068|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83081069|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081070|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081071|NCT02174757|Doxycycline|doxycycline|mesh-list
83081072|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83081073|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081074|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
83081075|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83081076|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83081077|NCT02168127|Methylphenidate|methylphenidate|mesh-list
83081078|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83081079|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081080|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83081081|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83081082|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081083|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081084|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
83081085|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081086|NCT02255955|Acetaminophen|acetaminophen|mesh-list
83081087|NCT02255955|Naproxen|naproxen|mesh-list
83081088|NCT02255955|Codeine|codeine|mesh-list
83081089|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081090|NCT02255955|Analgesics|analgesics|mesh-ancestor
83081091|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
83081092|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081093|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081095|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081096|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081097|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081098|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
83081099|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83081100|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081101|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081102|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83081103|NCT02255955|Narcotics|narcotics|mesh-ancestor
83081104|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081105|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
83081106|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081107|NCT02172261|Glimepiride|glimepiride|mesh-list
83081108|NCT02172261|Empagliflozin|empagliflozin|mesh-list
83081109|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83081110|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83081111|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081112|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83081113|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
83081114|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83081115|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081116|NCT02501564|Naproxen|naproxen|mesh-list
83081117|NCT02501564|Codeine|codeine|mesh-list
83081118|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081119|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081120|NCT02501564|Analgesics|analgesics|mesh-ancestor
83081121|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
83081122|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081123|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081124|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081125|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081126|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
83081127|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83081128|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081129|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081130|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83081131|NCT02501564|Narcotics|narcotics|mesh-ancestor
83081132|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081133|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
83081134|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081135|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
83081136|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081137|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
83081138|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081139|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081140|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081141|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081142|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
83081143|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83081144|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
83081145|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081146|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081147|NCT02172417|Ranitidine|ranitidine|mesh-list
83081148|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83081149|NCT02172417|Cimetidine|cimetidine|mesh-list
83081150|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
83081151|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081152|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
83081153|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081154|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081155|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081156|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081157|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
83081158|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83081159|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
83081160|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081161|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081162|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83081163|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83081164|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83081165|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
83081166|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
83081167|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83081168|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83081169|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081170|NCT02168205|Pomalidomide|pomalidomide|mesh-list
83081171|NCT02168205|Caffeine|caffeine|mesh-list
83081172|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83081173|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081174|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83081175|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081176|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081177|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83081178|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83081179|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
83081180|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081181|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
83081182|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83081183|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83081184|NCT02168205|Growth Substances|growth substances|mesh-ancestor
83081185|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
83081186|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081187|NCT03343652|Nivolumab|nivolumab|mesh-list
83081188|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83081189|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081190|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081191|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83081192|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081193|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83081194|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
83081195|NCT02175069|Ropivacaine|ropivacaine|mesh-list
83081196|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
83081197|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
83081198|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081199|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081200|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
83081201|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081202|NCT04498520|Fulvestrant|fulvestrant|mesh-list
83081203|NCT04498520|Palbociclib|palbociclib|mesh-list
83081204|NCT04498520|Abexinostat|abexinostat|mesh-list
83081205|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83081206|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081207|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83081208|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83081209|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
83081210|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83081211|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081212|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83081213|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081214|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081215|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83081216|NCT02172495|Bromides|bromides|mesh-list
83081217|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
83081218|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081219|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
83081220|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081221|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081222|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081223|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081224|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
83081225|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83081226|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
83081227|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081228|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081229|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
83081230|NCT02172573|Pramipexole|pramipexole|mesh-list
83081231|NCT02172573|Bromocriptine|bromocriptine|mesh-list
83081232|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
83081233|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081234|NCT02172573|Protective Agents|protective agents|mesh-ancestor
83081235|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081236|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83081237|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83081238|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
83081239|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
83081241|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
83081242|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83081243|NCT02175381|Carboplatin|carboplatin|mesh-list
83081244|NCT02175381|Gemcitabine|gemcitabine|mesh-list
83081245|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081246|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83081247|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
83081248|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081249|NCT03540225|Progesterone|progesterone|mesh-list
83081250|NCT03540225|Progestins|progestins|mesh-ancestor
83081251|NCT03540225|Hormones|hormones|mesh-ancestor
83081252|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83081253|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081254|NCT02507648|Oseltamivir|oseltamivir|mesh-list
83081255|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
83081256|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081257|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081258|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081259|NCT02172729|Lidocaine|lidocaine|mesh-list
83081260|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
83081261|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
83081262|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081263|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081264|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
83081265|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081266|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83081267|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83081268|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83081269|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081270|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081271|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
83081272|NCT02172807|Oxitropium|oxitropium|mesh-list
83081273|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081274|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
83081275|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081276|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081277|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081278|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081279|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
83081280|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83081281|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
83081282|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081283|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081284|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83081285|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
83081286|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081287|NCT02502968|Cytarabine|cytarabine|mesh-list
83081288|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83081289|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
83081290|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081291|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081292|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
83081293|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081294|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83081295|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
83081296|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081297|NCT02168751|Propofol|propofol|mesh-list
83081298|NCT02168751|Sevoflurane|sevoflurane|mesh-list
83081299|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83081300|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081301|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081302|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83081303|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
83081304|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
83081305|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83081306|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83081307|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83081308|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081309|NCT03344042|Fentanyl|fentanyl|mesh-list
83081310|NCT03344042|Sufentanil|sufentanil|mesh-list
83081311|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83081312|NCT03344042|Narcotics|narcotics|mesh-ancestor
83081313|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081314|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081315|NCT03344042|Analgesics|analgesics|mesh-ancestor
83081316|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
83081317|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081318|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83081319|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83081320|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
83081321|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
83081322|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83081323|NCT02175927|Amoxicillin|amoxicillin|mesh-list
83081324|NCT02175927|Metronidazole|metronidazole|mesh-list
83081325|NCT02175927|Tetracycline|tetracycline|mesh-list
83081326|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83081327|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
83081328|NCT02175927|Lansoprazole|lansoprazole|mesh-list
83081329|NCT02175927|Bismuth|bismuth|mesh-list
83081330|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83081331|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081332|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081333|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
83081334|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83081335|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83081336|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83081337|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83081338|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081339|NCT02175927|Antacids|antacids|mesh-ancestor
83081340|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83081341|NCT02175927|Diuretics|diuretics|mesh-ancestor
83081342|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
83081343|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081344|NCT02175927|Expectorants|expectorants|mesh-ancestor
83081345|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081346|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83081347|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
83081348|NCT00707486|Coagulants|coagulants|mesh-ancestor
83081349|NCT02496182|Pirfenidone|pirfenidone|mesh-list
83081350|NCT02496182|Analgesics|analgesics|mesh-ancestor
83081351|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
83081352|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081353|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081354|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081355|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081356|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081357|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081358|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081359|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
83081360|NCT02168907|Rituximab|rituximab|mesh-list
83081361|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83081362|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081363|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081364|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
83081365|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081366|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081367|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83081368|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
83081369|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081370|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
83081371|NCT02168907|Protective Agents|protective agents|mesh-ancestor
83081372|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
83081373|NCT02168907|Vitamins|vitamins|mesh-ancestor
83081374|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
83081375|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
83081376|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081377|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
83081378|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081379|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081380|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081381|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081382|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83081383|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83081384|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83081385|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
83081386|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081387|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081388|NCT02500940|Leucovorin|leucovorin|mesh-list
83081389|NCT02500940|Fluorouracil|fluorouracil|mesh-list
83081390|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081391|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081392|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
83084056|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081393|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081394|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83081395|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83081396|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
83081397|NCT02500940|Antidotes|antidotes|mesh-ancestor
83081398|NCT02500940|Protective Agents|protective agents|mesh-ancestor
83081399|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
83081401|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
83081402|NCT02495636|Atezolizumab|atezolizumab|mesh-list
83081403|NCT02495636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83081404|NCT02495636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081405|NCT02495636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081406|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081407|NCT02169063|Listerine|listerine|mesh-list
83081408|NCT02169063|Fluorides|fluorides|mesh-list
83081409|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
83081410|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
83081411|NCT02169063|Protective Agents|protective agents|mesh-ancestor
83081412|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081413|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83081414|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081415|NCT04496882|Tenofovir|tenofovir|mesh-list
83081416|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
83081417|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081418|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83081419|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83081420|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081421|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081422|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83081423|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83081424|NCT02502500|Celecoxib|celecoxib|mesh-list
83081425|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081426|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081427|NCT02502500|Analgesics|analgesics|mesh-ancestor
83081428|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
83081429|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081430|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081431|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081432|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081433|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83081434|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83081435|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081436|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081437|NCT02173665|Linagliptin|linagliptin|mesh-list
83081438|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83081439|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081440|NCT02173665|Incretins|incretins|mesh-ancestor
83081441|NCT02173665|Hormones|hormones|mesh-ancestor
83081442|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83081443|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83081444|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
83081445|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081446|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081447|NCT02495324|Valsartan|valsartan|mesh-list
83081448|NCT02495324|Olmesartan|olmesartan|mesh-list
83081449|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83081450|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83081451|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83081452|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83081453|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081454|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
83081455|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
83081456|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081457|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
83081458|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081459|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081460|NCT04625283|Ketamine|ketamine|mesh-list
83081461|NCT04625283|Analgesics|analgesics|mesh-ancestor
83081462|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
83081463|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081464|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081465|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83081466|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83081468|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
83081469|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081470|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83081471|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83081472|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081473|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081474|NCT02256033|Istradefylline|istradefylline|mesh-list
83081475|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83081476|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83081477|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83081478|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
83081479|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081480|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081481|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081482|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83081483|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83081484|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83081485|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
83081486|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081487|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83081488|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83081489|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081491|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83081492|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081493|NCT02174211|Ranibizumab|ranibizumab|mesh-list
83081494|NCT02174211|Aflibercept|aflibercept|mesh-list
83081495|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83081496|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83081497|NCT02174211|Growth Substances|growth substances|mesh-ancestor
83081498|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081499|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
83081500|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081501|NCT04496492|Tocotrienols|tocotrienols|mesh-list
83081502|NCT04496492|Vitamin E|vitamin e|mesh-list
83081503|NCT04496492|Tocopherols|tocopherols|mesh-list
83081504|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
83081505|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081506|NCT04496492|Protective Agents|protective agents|mesh-ancestor
83081507|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081508|NCT04496492|Vitamins|vitamins|mesh-ancestor
83081509|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
83081510|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83081511|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83081512|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081513|NCT02502032|Cisatracurium|cisatracurium|mesh-list
83081514|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83081515|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83081516|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081517|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081518|NCT02494856|Naproxen|naproxen|mesh-list
83081519|NCT02494856|Esomeprazole|esomeprazole|mesh-list
83081520|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83081521|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83081522|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83081523|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081524|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081525|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081526|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081527|NCT02494856|Analgesics|analgesics|mesh-ancestor
83081528|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
83081529|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081530|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081531|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081532|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081533|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
83081534|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83081535|NCT04495010|Nivolumab|nivolumab|mesh-list
83081536|NCT04495010|Ipilimumab|ipilimumab|mesh-list
83081537|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081538|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081539|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83084057|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
83081541|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83081542|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
83081543|NCT03343418|Coagulants|coagulants|mesh-ancestor
83081544|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83081545|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
83081546|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081547|NCT02501798|Methylphenidate|methylphenidate|mesh-list
83081548|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83081549|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081550|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83081551|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83081552|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081553|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081554|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
83081555|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081556|NCT02169609|Interleukin-2|interleukin-2|mesh-list
83081557|NCT02169609|Dinutuximab|dinutuximab|mesh-list
83081558|NCT02169609|Isotretinoin|isotretinoin|mesh-list
83081559|NCT02169609|Sargramostim|sargramostim|mesh-list
83081560|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
83081561|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081562|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081563|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081564|NCT02169609|Analgesics|analgesics|mesh-ancestor
83081565|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
83081566|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081567|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
83081569|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081570|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83081571|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081572|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081573|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
83081574|NCT02169843|Sevoflurane|sevoflurane|mesh-list
83081575|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83081576|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081577|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081578|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081579|NCT02169843|Analgesics|analgesics|mesh-ancestor
83081580|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
83081581|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081582|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83081583|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83081584|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83081585|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
83081586|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081587|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081588|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83081589|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83081590|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
83081591|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
83081592|NCT03341390|Aspirin|aspirin|mesh-list
83081593|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081594|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081595|NCT03341390|Analgesics|analgesics|mesh-ancestor
83081596|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
83081597|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081598|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081599|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081600|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081601|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83081602|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83081603|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081604|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83081605|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83081606|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081607|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
83081608|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
83081609|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081610|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83081611|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081612|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081614|NCT00707174|Tazarotene|tazarotene|mesh-list
83081615|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83081616|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
83081617|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081618|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081619|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
83081620|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
83081621|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
83081622|NCT03341234|Bupivacaine|bupivacaine|mesh-list
83081623|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
83081624|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
83081625|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081626|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081627|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
83081628|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081629|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
83081630|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081631|NCT03120494|Tenofovir|tenofovir|mesh-list
83081632|NCT03120494|Emtricitabine|emtricitabine|mesh-list
83081633|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
83081634|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081635|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83081636|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83081637|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081638|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081639|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83081640|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83081641|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
83081642|NCT03537573|Narcotics|narcotics|mesh-ancestor
83081643|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081644|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081645|NCT03537573|Analgesics|analgesics|mesh-ancestor
83081646|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
83081647|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081648|NCT03120962|Famciclovir|famciclovir|mesh-list
83081649|NCT03120962|Oxycodone|oxycodone|mesh-list
83081650|NCT03120962|Gabapentin|gabapentin|mesh-list
83081651|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83081652|NCT03120962|Narcotics|narcotics|mesh-ancestor
83081653|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081654|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081655|NCT03120962|Analgesics|analgesics|mesh-ancestor
83081656|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
83081657|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081658|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
83081659|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83081660|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83081661|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83081662|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83081663|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83081664|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081665|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081666|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
83081667|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
83081668|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081669|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83081670|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081671|NCT02178813|Minocycline|minocycline|mesh-list
83081672|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83081673|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081674|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
83081675|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
83081676|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081677|NCT02177253|Bromides|bromides|mesh-list
83081678|NCT02177253|Albuterol|albuterol|mesh-list
83081679|NCT02177253|Ipratropium|ipratropium|mesh-list
83081680|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
83081681|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83081682|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
83081683|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081684|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081685|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081686|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081687|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
83081688|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83081689|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83081691|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83081692|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83081693|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081694|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081695|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83081696|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
83081697|NCT02177331|Lacidipine|lacidipine|mesh-list
83081698|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83081699|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83081700|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081701|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081702|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83081703|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081704|NCT02177409|Amlodipine|amlodipine|mesh-list
83081705|NCT02177409|Telmisartan|telmisartan|mesh-list
83081706|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83081707|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83081708|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081709|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081710|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83081711|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081712|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
83081713|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83081714|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83081715|NCT02170623|Pantoprazole|pantoprazole|mesh-list
83081716|NCT02170623|Dabigatran|dabigatran|mesh-list
83081717|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83081718|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83081719|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83081720|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081721|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081722|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
83081723|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83081724|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
83081725|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
83081726|NCT02170701|Dabigatran|dabigatran|mesh-list
83081727|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
83081728|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83081729|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
83081730|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081731|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081732|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
83081733|NCT02498756|Ipilimumab|ipilimumab|mesh-list
83081734|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081735|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081736|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83081737|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081738|NCT03336632|Cyclosporine|cyclosporine|mesh-list
83081739|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
83081740|NCT03336632|Cyclosporins|cyclosporins|mesh-list
83081741|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83081742|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
83081743|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081744|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081745|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83081746|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
83081747|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081748|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081749|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83081750|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081751|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
83081752|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081753|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
83081754|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83081755|NCT02498288|Isotretinoin|isotretinoin|mesh-list
83081756|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
83081757|NCT02756403|Azithromycin|azithromycin|mesh-list
83081758|NCT02756403|Metronidazole|metronidazole|mesh-list
83081759|NCT02756403|Doxycycline|doxycycline|mesh-list
83081760|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83081761|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081762|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83081763|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83081764|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
83081765|NCT02494466|Montelukast|montelukast|mesh-list
83081766|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83081767|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081768|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83081769|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
83081770|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83081771|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081772|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83081773|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83081774|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081775|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83081776|NCT02177487|Telmisartan|telmisartan|mesh-list
83081777|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83081778|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83081779|NCT02177487|Diuretics|diuretics|mesh-ancestor
83081780|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
83081781|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081782|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83081783|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83081784|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081785|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83081786|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83081787|NCT02177643|Diacerein|diacerein|mesh-list
83081788|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081789|NCT03340376|Doxorubicin|doxorubicin|mesh-list
83081790|NCT03340376|Atezolizumab|atezolizumab|mesh-list
83081791|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83081792|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081793|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83081794|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83081795|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081796|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081797|NCT03340376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83081798|NCT03340376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081799|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
83081800|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83081801|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
83081802|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081803|NCT02182167|Expectorants|expectorants|mesh-ancestor
83081804|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83081805|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83081806|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
83081807|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081808|NCT02182167|Protective Agents|protective agents|mesh-ancestor
83081809|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081810|NCT02182167|Antidotes|antidotes|mesh-ancestor
83081811|NCT03336242|Cannabidiol|cannabidiol|mesh-list
83081812|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
83081813|NCT02182245|Paclitaxel|paclitaxel|mesh-list
83081814|NCT02182245|Carboplatin|carboplatin|mesh-list
83081815|NCT02182245|Nintedanib|nintedanib|mesh-list
83081816|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83081817|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081818|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
83081819|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
83081820|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
83081821|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081822|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83081823|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081824|NCT05233124|Aspirin|aspirin|mesh-list
83081825|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
83081826|NCT05233124|Clopidogrel|clopidogrel|mesh-list
83081827|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081828|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081829|NCT05233124|Analgesics|analgesics|mesh-ancestor
83081830|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
83081831|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081832|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081833|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081834|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081835|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83081836|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83081837|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081838|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83081839|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83081840|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081842|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83081843|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83081844|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83081845|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
83081846|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081847|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83081848|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
83081849|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83081850|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
83081851|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
83081852|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83081853|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83081854|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83081855|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
83081856|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081857|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83081858|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83081859|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081860|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
83081861|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83081862|NCT03339362|Bupivacaine|bupivacaine|mesh-list
83081863|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
83081864|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
83081865|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081866|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081867|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
83081868|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081869|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081870|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
83081871|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
83081872|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83081873|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
83081874|NCT03339362|Hormones|hormones|mesh-ancestor
83081875|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83081876|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83081877|NCT03339362|Protective Agents|protective agents|mesh-ancestor
83081878|NCT02497820|Aspirin|aspirin|mesh-list
83081879|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83081880|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081881|NCT02497820|Analgesics|analgesics|mesh-ancestor
83081882|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
83081883|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081884|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081885|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83081886|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83081887|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83081888|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83081889|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081890|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83081891|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83081892|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081893|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
83081894|NCT02497508|Nivolumab|nivolumab|mesh-list
83081895|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83081896|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081897|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83081898|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081899|NCT03338426|Atorvastatin|atorvastatin|mesh-list
83081900|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83081901|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83081902|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
83081903|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081904|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83081905|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83081906|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081907|NCT03338348|Azacitidine|azacitidine|mesh-list
83081908|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83081909|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
83081910|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081911|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081912|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081913|NCT03334838|Nifurtimox|nifurtimox|mesh-list
83081914|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83081915|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83081916|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83081917|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83081919|NCT02497118|Endostatins|endostatins|mesh-list
83081920|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83081921|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83081922|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83081923|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83081924|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83081925|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081926|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83081927|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83081928|NCT02497118|Growth Substances|growth substances|mesh-ancestor
83081929|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081930|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
83081931|NCT02496962|Atorvastatin|atorvastatin|mesh-list
83081932|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83081933|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83081934|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
83081935|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081936|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83081937|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83081938|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83081939|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83081940|NCT03334136|Calcifediol|calcifediol|mesh-list
83081941|NCT03334136|Vitamins|vitamins|mesh-ancestor
83081942|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
83081943|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081944|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83081945|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83081946|NCT03120728|Etonogestrel|etonogestrel|mesh-list
83081947|NCT03120728|NuvaRing|nuvaring|mesh-list
83081948|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
83081949|NCT03120728|Estradiol|estradiol|mesh-list
83081950|NCT03120728|Estrogens|estrogens|mesh-ancestor
83081951|NCT03120728|Hormones|hormones|mesh-ancestor
83081952|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83081953|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081954|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83081955|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83081956|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83081957|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83081958|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83081959|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
83081960|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83081961|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081962|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081963|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83081964|NCT02496650|Analgesics|analgesics|mesh-ancestor
83081965|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
83081966|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83081967|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83081968|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83081969|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83081970|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
83081971|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081972|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081973|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83081974|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
83081975|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081976|NCT03342170|Thrombin|thrombin|mesh-list
83081977|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
83081978|NCT03342170|Coagulants|coagulants|mesh-ancestor
83081979|NCT03333824|Midazolam|midazolam|mesh-list
83081980|NCT03333824|Granisetron|granisetron|mesh-list
83081981|NCT03333824|Caffeine|caffeine|mesh-list
83081982|NCT03333824|Omeprazole|omeprazole|mesh-list
83081983|NCT03333824|Adavosertib|adavosertib|mesh-list
83081984|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83081985|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83081986|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83081987|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83081988|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83081989|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83081990|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83081991|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83081992|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
83081993|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
83081994|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
83081995|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
83081996|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83081997|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83081998|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83081999|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83082000|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082001|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83082002|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83082003|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
83082004|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83082005|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83082006|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83082007|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
83082008|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
83082009|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082010|NCT03333824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83082011|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83082012|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
83082013|NCT02496494|Tacrolimus|tacrolimus|mesh-list
83082014|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082015|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
83082016|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082017|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83082018|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082019|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082020|NCT03333278|Vitamins|vitamins|mesh-list
83082021|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
83082022|NCT03333278|Thiamine|thiamine|mesh-list
83082023|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
83082024|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83082025|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
83082026|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082027|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082028|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
83082029|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082030|NCT03333278|Protective Agents|protective agents|mesh-ancestor
83082031|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
83082032|NCT04847596|Ofatumumab|ofatumumab|mesh-list
83082033|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082034|NCT00706628|Nintedanib|nintedanib|mesh-list
83082035|NCT00706628|Afatinib|afatinib|mesh-list
83082036|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082037|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83082038|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082039|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082040|NCT05465330|Propofol|propofol|mesh-list
83082041|NCT05465330|Desflurane|desflurane|mesh-list
83082042|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082043|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082044|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082045|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082046|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
83082047|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
83082048|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83082049|NCT05463614|Propranolol|propranolol|mesh-list
83082050|NCT05463614|Propafenone|propafenone|mesh-list
83082051|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83082052|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83082053|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83082054|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082055|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082056|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082057|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83082058|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83082059|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
83082060|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83082061|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83082062|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83082063|NCT03332888|Rituximab|rituximab|mesh-list
83082064|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83082065|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082066|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
83082067|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082068|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082069|NCT03332732|Metronidazole|metronidazole|mesh-list
83082070|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082071|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83082072|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83082073|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83082075|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082076|NCT02492282|Remifentanil|remifentanil|mesh-list
83082077|NCT02492282|Propofol|propofol|mesh-list
83082078|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082079|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082080|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082081|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082082|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
83082083|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
83082084|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83082085|NCT02492282|Narcotics|narcotics|mesh-ancestor
83082086|NCT02492282|Analgesics|analgesics|mesh-ancestor
83082087|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
83082088|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082089|NCT02492126|Citric Acid|citric acid|mesh-list
83082090|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
83082091|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
83082092|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83082093|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
83082094|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
83082095|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082096|NCT05464862|Lidocaine|lidocaine|mesh-list
83082097|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082098|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
83082099|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082100|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082101|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
83082102|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082103|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83082104|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83082105|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83082106|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83082107|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082108|NCT03324776|Insulin|insulin|mesh-list
83082109|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83082110|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83082111|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082112|NCT02561806|Ustekinumab|ustekinumab|mesh-list
83082113|NCT02561806|Ixekizumab|ixekizumab|mesh-list
83082114|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082115|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
83082116|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082117|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
83082118|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082119|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082120|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83082121|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
83082122|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082123|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082124|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83082125|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83440491|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
83082126|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83082127|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
83082128|NCT03330860|Hormones|hormones|mesh-ancestor
83082129|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082130|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082131|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082132|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082133|NCT03324542|Ranibizumab|ranibizumab|mesh-list
83082134|NCT03324542|Aflibercept|aflibercept|mesh-list
83082135|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082136|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83082137|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83082138|NCT03324542|Growth Substances|growth substances|mesh-ancestor
83082139|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082140|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
83082141|NCT03330782|Remifentanil|remifentanil|mesh-list
83361877|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082142|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83082143|NCT03330782|Narcotics|narcotics|mesh-ancestor
83082144|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082145|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082146|NCT03330782|Analgesics|analgesics|mesh-ancestor
83082147|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
83082148|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082149|NCT05506462|Ketamine|ketamine|mesh-list
83082150|NCT05506462|Analgesics|analgesics|mesh-ancestor
83082151|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
83082152|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082153|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082154|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83082155|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082156|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
83082157|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
83082158|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082159|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83082160|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83082161|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082162|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082163|NCT05501704|Tamoxifen|tamoxifen|mesh-list
83082164|NCT05501704|Anastrozole|anastrozole|mesh-list
83082165|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83082166|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
83082167|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082168|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082169|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83082170|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082171|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83082172|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83082173|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83082174|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83082175|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83082176|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082177|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082178|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
83082179|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83082180|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082181|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83082182|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082183|NCT02491268|Cilostazol|cilostazol|mesh-list
83082184|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83082185|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
83082186|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082187|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082188|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83082189|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
83082190|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83082191|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83082192|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082193|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83082194|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
83082195|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83082196|NCT02491268|Protective Agents|protective agents|mesh-ancestor
83082197|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83082198|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83082199|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082200|NCT03323684|Acetaminophen|acetaminophen|mesh-list
83082201|NCT03323684|Ketorolac|ketorolac|mesh-list
83082202|NCT03323684|Fentanyl|fentanyl|mesh-list
83082203|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83082204|NCT03323684|Narcotics|narcotics|mesh-ancestor
83082205|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082206|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082207|NCT03323684|Analgesics|analgesics|mesh-ancestor
83082208|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
83082209|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082210|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83082211|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082212|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
83082213|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
83082214|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082215|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
83482521|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83082216|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83082217|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082218|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082219|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83082220|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082221|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082222|NCT02182401|Tolbutamide|tolbutamide|mesh-list
83082223|NCT02182401|Midazolam|midazolam|mesh-list
83082224|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83082225|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082226|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082227|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082228|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83082229|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83082230|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83082231|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082232|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
83082233|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
83082234|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
83082235|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
83082236|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082237|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082238|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83082239|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83082240|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082241|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082242|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
83082243|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082244|NCT02177955|Midazolam|midazolam|mesh-list
83082245|NCT02177955|Diazepam|diazepam|mesh-list
83082246|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83082247|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082248|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082249|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082250|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83082251|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83082252|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83082253|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082254|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
83082255|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
83082256|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
83082257|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
83082258|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082259|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082260|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
83082261|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
83082262|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
83082263|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082264|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83082265|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83082266|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83082267|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83082268|NCT03323528|Benzocaine|benzocaine|mesh-list
83082269|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082270|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
83082271|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082272|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082273|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
83082274|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082275|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83082276|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082277|NCT05501158|Tamoxifen|tamoxifen|mesh-list
83082278|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83082279|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
83082280|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082281|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082282|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83082283|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082284|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83082285|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83082286|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83082287|NCT03537807|Riluzole|riluzole|mesh-list
83082288|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
83082289|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83361878|NCT02654860|Acetaminophen|acetaminophen|mesh-list
83082290|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83082291|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082292|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082293|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082294|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83082295|NCT03537807|Protective Agents|protective agents|mesh-ancestor
83082296|NCT02182479|Fenoterol|fenoterol|mesh-list
83082297|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83082298|NCT02182479|Ipratropium|ipratropium|mesh-list
83082299|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83082300|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
83082301|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082302|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082303|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83082304|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
83082305|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
83082306|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
83082307|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83082308|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83082309|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83082310|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83082311|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83082312|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082313|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082314|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83082315|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
83082316|NCT02560558|Abatacept|abatacept|mesh-list
83082317|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83082318|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082319|NCT02560558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83082320|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082321|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082322|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
83082323|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082324|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082325|NCT03329456|Ropivacaine|ropivacaine|mesh-list
83082326|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082327|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
83082328|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082329|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082330|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
83082331|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082332|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83082333|NCT02491736|Ketoprofen|ketoprofen|mesh-list
83082334|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83082335|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082336|NCT02491736|Analgesics|analgesics|mesh-ancestor
83082337|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
83082338|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082339|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082340|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082341|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082342|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83082343|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082344|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082345|NCT05501080|Spironolactone|spironolactone|mesh-list
83082346|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83082347|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
83082348|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082349|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082350|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83082351|NCT05501080|Diuretics|diuretics|mesh-ancestor
83082352|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
83082353|NCT02491970|Fluticasone|fluticasone|mesh-list
83082354|NCT02491970|Xhance|xhance|mesh-list
83082355|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
83082356|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83082357|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83082358|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082359|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83082360|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
83082361|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084058|NCT02472626|Cytarabine|cytarabine|mesh-list
83361879|NCT02654860|Bupivacaine|bupivacaine|mesh-list
83082362|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082363|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83082364|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83082365|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082366|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83082367|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83082368|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83082369|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83082370|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
83082371|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082372|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082373|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
83082374|NCT02491970|Hormones|hormones|mesh-ancestor
83082375|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082376|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
83082377|NCT02182557|Ketotifen|ketotifen|mesh-list
83082378|NCT02182557|Epinastine|epinastine|mesh-list
83082379|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
83082380|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082381|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83082382|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
83082383|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
83082384|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082385|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082386|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082387|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83082388|NCT02182635|Oxitropium|oxitropium|mesh-list
83082389|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
83082390|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
83082391|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082392|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082393|NCT02182713|Bromides|bromides|mesh-list
83082394|NCT02182713|Albuterol|albuterol|mesh-list
83082395|NCT02182713|Ipratropium|ipratropium|mesh-list
83082396|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
83082397|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83082398|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
83082399|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082400|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082401|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83082402|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
83082403|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
83082404|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83082405|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83082406|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83082407|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83082408|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83082409|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082410|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082411|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83082412|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
83082413|NCT03323372|Listerine|listerine|mesh-list
83082414|NCT03323372|Fluorides|fluorides|mesh-list
83082415|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
83082416|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
83082417|NCT03323372|Protective Agents|protective agents|mesh-ancestor
83082418|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082419|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83082420|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082421|NCT02180529|Methylphenidate|methylphenidate|mesh-list
83082422|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83082423|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082424|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83082425|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83082426|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83082427|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082428|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
83082429|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082430|NCT02182791|Nevirapine|nevirapine|mesh-list
83082431|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83082432|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83082433|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082434|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082435|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
83082436|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082438|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83082439|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83082440|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83082441|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83082442|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
83082443|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082444|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83082445|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83082446|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082447|NCT02488538|Fluoxetine|fluoxetine|mesh-list
83082448|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
83082449|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
83082450|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83082451|NCT02488538|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83082452|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83082453|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83082454|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082455|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082456|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
83082457|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082458|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83082459|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
83082460|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83082461|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83082462|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83082463|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082464|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83082465|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83082466|NCT02568046|Leucovorin|leucovorin|mesh-list
83082467|NCT02568046|Fluorouracil|fluorouracil|mesh-list
83082468|NCT02568046|Irinotecan|irinotecan|mesh-list
83082469|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
83082470|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082471|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83082472|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082473|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082474|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
83082475|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082476|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83082477|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83082478|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082479|NCT02568046|Antidotes|antidotes|mesh-ancestor
83082480|NCT02568046|Protective Agents|protective agents|mesh-ancestor
83082481|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
83082482|NCT02568046|Vitamins|vitamins|mesh-ancestor
83082483|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
83082484|NCT03536481|Ensartinib|ensartinib|mesh-list
83082485|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082486|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83082487|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082488|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082489|NCT02488616|Insulin|insulin|mesh-list
83082490|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83082491|NCT02488616|Hormones|hormones|mesh-list
83082492|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83082493|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082494|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082495|NCT02256423|Ibuprofen|ibuprofen|mesh-list
83082496|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83082497|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082498|NCT02256423|Analgesics|analgesics|mesh-ancestor
83082499|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
83082500|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082501|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082502|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082503|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082504|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83082505|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082506|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082507|NCT03320486|Ketoconazole|ketoconazole|mesh-list
83082508|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
83082509|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082510|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83082511|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83082512|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082513|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082514|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83082515|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
83082516|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082517|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082518|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83082519|NCT02567656|Tenalisib|tenalisib|mesh-list
83082520|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83082521|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082522|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082523|NCT02185833|Dirithromycin|dirithromycin|mesh-list
83082524|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83082525|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082526|NCT02180997|Tamsulosin|tamsulosin|mesh-list
83082527|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
83082528|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83082529|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83082530|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83082531|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83082532|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082533|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082534|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082535|NCT02180997|Urological Agents|urological agents|mesh-ancestor
83082536|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83082537|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83082538|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
83082539|NCT02560012|Sirolimus|sirolimus|mesh-list
83082540|NCT02560012|Everolimus|everolimus|mesh-list
83082541|NCT02560012|Temsirolimus|temsirolimus|mesh-list
83082542|NCT02560012|MTOR Inhibitors|mtor inhibitors|mesh-list
83082543|NCT02560012|Sorafenib|sorafenib|mesh-list
83082544|NCT02560012|Sunitinib|sunitinib|mesh-list
83082545|NCT02560012|Axitinib|axitinib|mesh-list
83082546|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83082547|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082548|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082549|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082550|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
83082551|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082552|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082553|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83082554|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83082555|NCT02560012|Growth Substances|growth substances|mesh-ancestor
83082556|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
83082557|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83082558|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082559|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83082560|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
83082561|NCT03320174|Tafenoquine|tafenoquine|mesh-list
83082562|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
83082563|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83082564|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83082565|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082566|NCT03328364|Docetaxel|docetaxel|mesh-list
83082567|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082568|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
83082569|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
83082570|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
83082571|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082572|NCT04515472|Hormones|hormones|mesh-list
83082573|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082574|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082575|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
83082576|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83082577|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
83082578|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83082579|NCT04514302|Antibodies|antibodies|mesh-list
83082580|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
83082581|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082582|NCT03319784|Triamcinolone|triamcinolone|mesh-list
83082583|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83082584|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83082585|NCT03319784|Ketorolac|ketorolac|mesh-list
83082586|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83082587|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082588|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
83082590|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082591|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082592|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082593|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
83082594|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082595|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082596|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83082597|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082598|NCT03319784|Analgesics|analgesics|mesh-ancestor
83082599|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
83082600|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082601|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082602|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83082603|NCT03319706|Olmesartan|olmesartan|mesh-list
83082604|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83082605|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83082606|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83082607|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83082608|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082609|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
83082610|NCT03322358|Promethazine|promethazine|mesh-list
83082611|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83082612|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082613|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082614|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082615|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082616|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
83082617|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
83082618|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082619|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
83082620|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
83082621|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83082622|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83082623|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
83082624|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
83082625|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082626|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082627|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83082628|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
83082629|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082630|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
83082631|NCT05045170|Propofol|propofol|mesh-list
83082632|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
83082633|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082634|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082635|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082636|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082637|NCT05045170|Analgesics|analgesics|mesh-ancestor
83082638|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
83082639|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082640|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83082641|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83082642|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83082643|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
83082644|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082645|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082646|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082647|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
83082648|NCT05500690|Folic Acid|folic acid|mesh-list
83082649|NCT05500690|Hematinics|hematinics|mesh-ancestor
83082650|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
83082651|NCT05500690|Vitamins|vitamins|mesh-ancestor
83082652|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
83082653|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082654|NCT03322124|Octenidine|octenidine|mesh-list
83082655|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83082656|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83082657|NCT04442984|Leucovorin|leucovorin|mesh-list
83082658|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
83082659|NCT04442984|Irinotecan|irinotecan|mesh-list
83082660|NCT04442984|Fluorouracil|fluorouracil|mesh-list
83082661|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082662|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83082663|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83082664|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082665|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082666|NCT04442984|Antidotes|antidotes|mesh-ancestor
83082667|NCT04442984|Protective Agents|protective agents|mesh-ancestor
83082668|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082669|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
83082670|NCT04442984|Vitamins|vitamins|mesh-ancestor
83082671|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
83082672|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
83082673|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83082674|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082675|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
83082676|NCT03327506|Alprazolam|alprazolam|mesh-list
83082677|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082678|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082679|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082680|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83082681|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83082682|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83082683|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
83082684|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
83082685|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082686|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082687|NCT02487914|Lidocaine|lidocaine|mesh-list
83082688|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082689|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
83440514|NCT01276067|Donepezil|donepezil|mesh-list
83082690|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082691|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082692|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
83082693|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082694|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83082695|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83082696|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83082697|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83082698|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082699|NCT02487680|Chromium|chromium|mesh-list
83082700|NCT02487680|Picolinic acid|picolinic acid|mesh-list
83082701|NCT02487680|Trace Elements|trace elements|mesh-ancestor
83082702|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
83082703|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082704|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83082705|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
83082706|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
83082707|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082708|NCT03319550|Caseins|caseins|mesh-list
83082709|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
83082710|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
83082711|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082712|NCT04442906|Fentanyl|fentanyl|mesh-list
83082713|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
83082714|NCT04442906|Bupivacaine|bupivacaine|mesh-list
83082715|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082716|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
83082717|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082718|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082719|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
83082720|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082721|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082722|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082723|NCT04442906|Analgesics|analgesics|mesh-ancestor
83082724|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83082725|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83082726|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83082727|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
83082728|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082729|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082730|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83082731|NCT04442906|Narcotics|narcotics|mesh-ancestor
83082732|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83082733|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082734|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
83082735|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
83082736|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
83361881|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
83082737|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082738|NCT03327350|Anticoagulants|anticoagulants|mesh-list
83082739|NCT04695340|Psyllium|psyllium|mesh-list
83082740|NCT04695340|Cathartics|cathartics|mesh-ancestor
83082741|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83082742|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
83082743|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83082744|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83082745|NCT03327272|Prednisolone|prednisolone|mesh-list
83082746|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
83082747|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83082748|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
83082749|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082750|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
83082751|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
83082752|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082753|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082754|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83082755|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
83082756|NCT03327272|Hormones|hormones|mesh-ancestor
83082757|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082758|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83082759|NCT03327272|Protective Agents|protective agents|mesh-ancestor
83082760|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83082761|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082762|NCT05508178|Vaccines|vaccines|mesh-list
83082763|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
83440523|NCT04183868|Glimepiride|glimepiride|mesh-list
83082764|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082765|NCT03327116|Methotrexate|methotrexate|mesh-list
83082766|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83082767|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
83082768|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83082769|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082770|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83082771|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
83082772|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082773|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082774|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082775|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082776|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83082777|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082778|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
83082779|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082780|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83082781|NCT03326960|Propofol|propofol|mesh-list
83082782|NCT03326960|Sevoflurane|sevoflurane|mesh-list
83082783|NCT03326960|Desflurane|desflurane|mesh-list
83082784|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83082785|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082786|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082787|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082788|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
83082789|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
83082790|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83082791|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83082792|NCT03319238|Ketamine|ketamine|mesh-list
83082793|NCT03319238|Analgesics|analgesics|mesh-ancestor
83082794|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
83082795|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082796|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082797|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83082798|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83082799|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
83082800|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
83082801|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082802|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83082803|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83082804|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082805|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082806|NCT03321890|Prednisone|prednisone|mesh-list
83082807|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
83082808|NCT03321890|Methotrexate|methotrexate|mesh-list
83082809|NCT03321890|Etoposide|etoposide|mesh-list
83082810|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082811|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
83082812|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082813|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082814|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83082815|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
83082816|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082817|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082818|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83082819|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082820|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
83082821|NCT03321890|Hormones|hormones|mesh-ancestor
83082822|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082823|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83082824|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83082825|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
83082826|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83082827|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83082828|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
83082829|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082830|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082831|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83082832|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83082833|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83440526|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83082834|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83082835|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83082836|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
83082837|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83082838|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83082839|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082840|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
83082841|NCT05464394|Coagulants|coagulants|mesh-ancestor
83082842|NCT05499598|Vitamin A|vitamin a|mesh-list
83082843|NCT05499598|Vitamins|vitamins|mesh-ancestor
83082844|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
83082845|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082846|NCT03321734|Caffeine|caffeine|mesh-list
83082847|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83082848|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082849|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83082850|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082851|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082852|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83082853|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83082854|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
83082855|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082856|NCT04442750|Bupivacaine|bupivacaine|mesh-list
83082857|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
83082858|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
83082859|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83082860|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082861|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
83082862|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082863|NCT02753127|Leucovorin|leucovorin|mesh-list
83082864|NCT02753127|Bevacizumab|bevacizumab|mesh-list
83082865|NCT02753127|Fluorouracil|fluorouracil|mesh-list
83082866|NCT02753127|Irinotecan|irinotecan|mesh-list
83082867|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83082868|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082869|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83082870|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83082871|NCT02753127|Growth Substances|growth substances|mesh-ancestor
83082872|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082873|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
83082874|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
83082875|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082876|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83082877|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082878|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
83082879|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83082880|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83082881|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082882|NCT02753127|Antidotes|antidotes|mesh-ancestor
83082883|NCT02753127|Protective Agents|protective agents|mesh-ancestor
83082884|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
83082885|NCT02753127|Vitamins|vitamins|mesh-ancestor
83082886|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
83082887|NCT03326258|Nivolumab|nivolumab|mesh-list
83082888|NCT03326258|Ipilimumab|ipilimumab|mesh-list
83082889|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
83082890|NCT03326258|Antibodies|antibodies|mesh-list
83082891|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
83082892|NCT03326258|Immunotoxins|immunotoxins|mesh-list
83082893|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83082894|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
83082895|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
83082896|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082897|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83082898|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082899|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83082900|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082901|NCT03326102|Paclitaxel|paclitaxel|mesh-list
83082902|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83082903|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83082904|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082905|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
83082906|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
83082907|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
83082908|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082909|NCT02487212|Clobetasol|clobetasol|mesh-list
83082910|NCT02487212|Petrolatum|petrolatum|mesh-list
83082911|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082912|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
83082913|NCT02487212|Hormones|hormones|mesh-ancestor
83082914|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082915|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082916|NCT02487212|Emollients|emollients|mesh-ancestor
83082917|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
83082918|NCT04583488|Docetaxel|docetaxel|mesh-list
83082919|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082920|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
83082921|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
83082922|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
83082923|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082924|NCT03318536|Granisetron|granisetron|mesh-list
83082925|NCT03318536|Serotonin|serotonin|mesh-list
83082926|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
83082927|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
83082928|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082929|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082930|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83082931|NCT03318536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83082932|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83082933|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
83082934|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83082935|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082936|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83082937|NCT03537027|Vitamin D|vitamin d|mesh-list
83082938|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
83082939|NCT03537027|Vitamins|vitamins|mesh-ancestor
83082940|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
83082941|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082942|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83082943|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83082944|NCT02183025|Meloxicam|meloxicam|mesh-list
83082945|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
83082946|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83082947|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082948|NCT02183025|Analgesics|analgesics|mesh-ancestor
83082949|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
83082950|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082951|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082952|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082953|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082954|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83082955|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83082956|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082957|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082958|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
83082959|NCT04282174|Melphalan|melphalan|mesh-list
83082960|NCT04282174|Busulfan|busulfan|mesh-list
83082961|NCT04282174|Thiotepa|thiotepa|mesh-list
83082962|NCT04282174|Fludarabine|fludarabine|mesh-list
83082963|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83082964|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
83082965|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082967|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83082968|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
83082969|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082970|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082971|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83082973|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83082974|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83082975|NCT02181309|Analgesics|analgesics|mesh-ancestor
83082976|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
83082977|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082978|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082979|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082980|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83082981|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83082982|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83082983|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83082984|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83082985|NCT02186145|Metronidazole|metronidazole|mesh-list
83082986|NCT02186145|Nystatin|nystatin|mesh-list
83082987|NCT02186145|Dexamethasone|dexamethasone|mesh-list
83082988|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83082989|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
83082990|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
83082991|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83082992|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83082993|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83082994|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
83082995|NCT02186145|Hormones|hormones|mesh-ancestor
83082996|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83082997|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83082998|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83082999|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083000|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83083001|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83083002|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83083003|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
83083004|NCT02186145|Ionophores|ionophores|mesh-ancestor
83083005|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83083006|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083007|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
83083008|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83083009|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
83083010|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83083011|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083012|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83083013|NCT02183103|Meloxicam|meloxicam|mesh-list
83083014|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83083015|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083016|NCT02183103|Analgesics|analgesics|mesh-ancestor
83083017|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
83083018|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083019|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083020|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083021|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083022|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83083023|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83083024|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083025|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083026|NCT03325790|Ebselen|ebselen|mesh-list
83083027|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83083028|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083029|NCT03325790|Analgesics|analgesics|mesh-ancestor
83083030|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
83083031|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083032|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083033|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083034|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083035|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83083036|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83083037|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
83083038|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083039|NCT03325790|Protective Agents|protective agents|mesh-ancestor
83083040|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83083041|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083042|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83083043|NCT02181543|Clonidine|clonidine|mesh-list
83083044|NCT02181543|Analgesics|analgesics|mesh-ancestor
83083045|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
83083046|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083047|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083048|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83083049|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
83083050|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
83083051|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83083052|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83083053|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83083054|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
83083055|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083056|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083057|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
83083058|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83083059|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083060|NCT02490176|Liraglutide|liraglutide|mesh-list
83083061|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83083062|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083063|NCT02490176|Incretins|incretins|mesh-ancestor
83083064|NCT02490176|Hormones|hormones|mesh-ancestor
83083065|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083066|NCT02183181|Meloxicam|meloxicam|mesh-list
83083067|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83083068|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083069|NCT02183181|Analgesics|analgesics|mesh-ancestor
83083070|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
83083071|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083072|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083073|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083074|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083075|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83083076|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83083077|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083078|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083079|NCT02490098|Insulin|insulin|mesh-list
83083080|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83083081|NCT02490098|Glucagon|glucagon|mesh-list
83083082|NCT02490098|Hormones|hormones|mesh-list
83083083|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83083084|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083085|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083086|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83083087|NCT02486822|Oxytocin|oxytocin|mesh-list
83083088|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
83083089|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83083090|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083091|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83083092|NCT02186457|Polymyxins|polymyxins|mesh-list
83083093|NCT02186457|Polymyxin B|polymyxin b|mesh-list
83083094|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083095|NCT02186535|Vitamin D|vitamin d|mesh-list
83083096|NCT02186535|Calcium|calcium|mesh-list
83083097|NCT02186535|Vitamins|vitamins|mesh-ancestor
83083098|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
83083099|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083100|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83083101|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83083102|NCT03325400|Fluorides|fluorides|mesh-list
83083103|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
83083104|NCT03325400|Protective Agents|protective agents|mesh-ancestor
83083105|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083106|NCT02181933|Lamivudine|lamivudine|mesh-list
83083107|NCT02181933|Zidovudine|zidovudine|mesh-list
83083108|NCT02181933|Nevirapine|nevirapine|mesh-list
83083109|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83083110|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83083111|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083112|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083113|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
83083114|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083115|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83083116|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83083117|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
83083118|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83083119|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83083120|NCT02183337|Pioglitazone|pioglitazone|mesh-list
83083121|NCT02183337|Linagliptin|linagliptin|mesh-list
83083122|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83083123|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083124|NCT02183337|Incretins|incretins|mesh-ancestor
83083125|NCT02183337|Hormones|hormones|mesh-ancestor
83083126|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083127|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83083128|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
83083129|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083130|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083131|NCT02489786|Digoxin|digoxin|mesh-list
83083132|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83083133|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83083134|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083135|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083136|NCT02489786|Protective Agents|protective agents|mesh-ancestor
83083137|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083138|NCT02489864|Terlipressin|terlipressin|mesh-list
83083139|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83083140|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83083141|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83083142|NCT02182011|Tenecteplase|tenecteplase|mesh-list
83083143|NCT02182011|Streptokinase|streptokinase|mesh-list
83083144|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83083145|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83083146|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083147|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83083148|NCT02486744|Hormones|hormones|mesh-ancestor
83083149|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083150|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083151|NCT02186769|Risperidone|risperidone|mesh-list
83083152|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83083153|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
83083154|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083155|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083156|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083157|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83083158|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83083159|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083160|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83083161|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83083162|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
83083163|NCT02486432|Levodopa|levodopa|mesh-list
83083164|NCT02486432|Carbidopa|carbidopa|mesh-list
83083165|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83083166|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83083167|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83083168|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
83083169|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083170|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083171|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083172|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83083173|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083174|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83083175|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
83083176|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
83083177|NCT02489240|Vitamin D|vitamin d|mesh-list
83083178|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
83083179|NCT02489240|Vitamins|vitamins|mesh-ancestor
83083180|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
83083181|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083182|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83083183|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83083184|NCT02183415|Linagliptin|linagliptin|mesh-list
83083185|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83083186|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083187|NCT02183415|Incretins|incretins|mesh-ancestor
83083188|NCT02183415|Hormones|hormones|mesh-ancestor
83083189|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084059|NCT02472626|Daunorubicin|daunorubicin|mesh-list
83083190|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83083192|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083193|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083195|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83083196|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83083197|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083198|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83083199|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83083200|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
83083201|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083202|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83083203|NCT04493528|Lidocaine|lidocaine|mesh-list
83083204|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
83083205|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
83083206|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083207|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083208|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
83083209|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083210|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83083211|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83083212|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83083213|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83083214|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083215|NCT02183493|Linagliptin|linagliptin|mesh-list
83083216|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83083217|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083218|NCT02183493|Incretins|incretins|mesh-ancestor
83083219|NCT02183493|Hormones|hormones|mesh-ancestor
83083220|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083221|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83083222|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
83083223|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083224|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083225|NCT02187081|Sorafenib|sorafenib|mesh-list
83083226|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083227|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83083228|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083229|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083230|NCT02485106|Rifaximin|rifaximin|mesh-list
83083231|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
83083232|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83083233|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083234|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83083235|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83083236|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083237|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083238|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83083239|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83083240|NCT02485106|Protective Agents|protective agents|mesh-ancestor
83083241|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083242|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
83083243|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83083244|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
83083245|NCT02485028|Mirodenafil|mirodenafil|mesh-list
83083246|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83083247|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83083248|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083249|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083250|NCT02183571|Metformin|metformin|mesh-list
83083251|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83083252|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083253|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83083254|NCT03318146|Latanoprost|latanoprost|mesh-list
83083255|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83083256|NCT02183649|Carbetapentane|carbetapentane|mesh-list
83083257|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
83083258|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
83083259|NCT02187315|Cisplatin|cisplatin|mesh-list
83083260|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083261|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
83083262|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
83083263|NCT02256735|Ritobegron|ritobegron|mesh-list
83083264|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83083265|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083266|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83083267|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83083268|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083269|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083270|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083271|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083272|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
83083273|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
83083274|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083275|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
83083276|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83083277|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83083278|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83083279|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
83083280|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083281|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
83083282|NCT02183805|Carboplatin|carboplatin|mesh-list
83083283|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83083284|NCT02183805|Paclitaxel|paclitaxel|mesh-list
83083285|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83083286|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
83083287|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083288|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083289|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83083290|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
83083291|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083292|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083293|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83083294|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83083295|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
83083296|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
83083297|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083298|NCT03316352|Bupivacaine|bupivacaine|mesh-list
83083299|NCT03316352|Anesthetics|anesthetics|mesh-list
83083300|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
83083301|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083302|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083303|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
83083304|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083305|NCT02187705|Telmisartan|telmisartan|mesh-list
83083306|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83083307|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83083308|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83083309|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083310|NCT03317912|Lidocaine|lidocaine|mesh-list
83083311|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
83083312|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
83083313|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083314|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083315|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
83083316|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083317|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83083318|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83083319|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83083320|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83083321|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083322|NCT03321110|Ubiquinone|ubiquinone|mesh-list
83083323|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
83083324|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
83083325|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083326|NCT03321110|Vitamins|vitamins|mesh-ancestor
83083327|NCT03317600|Lidocaine|lidocaine|mesh-list
83083328|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
83083329|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
83440543|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
83083330|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083331|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083332|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
83083333|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083334|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83083335|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83083336|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83361882|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083337|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83083338|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083340|NCT02184117|Analgesics|analgesics|mesh-ancestor
83083341|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
83083342|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083343|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083344|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83083345|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
83083346|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83083347|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
83083348|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
83083349|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083350|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083351|NCT02184273|Dipyrone|dipyrone|mesh-list
83083352|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83083353|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083354|NCT02184273|Analgesics|analgesics|mesh-ancestor
83083355|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
83083356|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083357|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083358|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083359|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083360|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
83083361|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
83083362|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083363|NCT02188173|Dexamethasone|dexamethasone|mesh-list
83083364|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083365|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
83083366|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
83083367|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083368|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083369|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83083370|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
83083371|NCT02188173|Hormones|hormones|mesh-ancestor
83083372|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083373|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83083374|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083375|NCT02184351|Clotrimazole|clotrimazole|mesh-list
83083376|NCT02184351|Miconazole|miconazole|mesh-list
83083377|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83083378|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083379|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
83083380|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83083381|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83083382|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083383|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083384|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83083385|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
83083386|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083387|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083388|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83083389|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83083390|NCT02184429|PF-06669571|pf-06669571|mesh-list
83083391|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
83083392|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
83083393|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83440559|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83083394|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083395|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083396|NCT02484170|Mannitol|mannitol|mesh-list
83083397|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83083398|NCT02484170|Diuretics|diuretics|mesh-ancestor
83083399|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
83083400|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083401|NCT02188407|Propofol|propofol|mesh-list
83083402|NCT02188407|Sevoflurane|sevoflurane|mesh-list
83083403|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83083404|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083405|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083406|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83083407|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
83083408|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
83083409|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83083410|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83083411|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
83083412|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83083413|NCT03317210|Hematinics|hematinics|mesh-ancestor
83083415|NCT02488694|Afatinib|afatinib|mesh-list
83083416|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083417|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083418|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083419|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83083420|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83083421|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83083422|NCT03316898|Memantine|memantine|mesh-list
83083423|NCT03316898|Donepezil|donepezil|mesh-list
83083424|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83083425|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083426|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083427|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
83083428|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083429|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083430|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
83083431|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83083432|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83083433|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
83083434|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83083435|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83083436|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
83083437|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
83083438|NCT02188953|Calcium|calcium|mesh-list
83083439|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83083440|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083441|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83083442|NCT02188953|Antacids|antacids|mesh-ancestor
83083443|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083444|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83083445|NCT02184819|Riboflavin|riboflavin|mesh-list
83083446|NCT02184819|Simendan|simendan|mesh-list
83083447|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
83083448|NCT02184819|Vitamins|vitamins|mesh-ancestor
83083449|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
83083450|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083451|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83083452|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
83083453|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83083454|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
83083455|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83083456|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83083457|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083458|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083459|NCT02184819|Protective Agents|protective agents|mesh-ancestor
83083460|NCT02256813|Vitamin K|vitamin k|mesh-list
83083461|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
83083462|NCT02256813|Midazolam|midazolam|mesh-list
83083463|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
83083464|NCT02256813|Caffeine|caffeine|mesh-list
83083465|NCT02256813|Omeprazole|omeprazole|mesh-list
83083466|NCT02256813|Warfarin|warfarin|mesh-list
83083467|NCT02256813|Vitamins|vitamins|mesh-ancestor
83083468|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
83440566|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
83083469|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083470|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83083471|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83083472|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083473|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83083474|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83083475|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83083476|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83083477|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
83083478|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
83083479|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
83083480|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
83083481|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083482|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083483|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
83083484|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83083485|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83083486|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083487|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83083488|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83361883|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083489|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
83083490|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83083491|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83083492|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83083493|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83083494|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83083495|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
83083496|NCT02256813|Coagulants|coagulants|mesh-ancestor
83083497|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
83083498|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
83083499|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83083500|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83083501|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
83083502|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
83083503|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83083504|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83083505|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
83083506|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
83083507|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83083508|NCT02483624|Protective Agents|protective agents|mesh-ancestor
83083509|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083510|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083511|NCT02184897|Lenograstim|lenograstim|mesh-list
83083512|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83083513|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
83083514|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083515|NCT02184975|Hemostatics|hemostatics|mesh-list
83083516|NCT02184975|Coagulants|coagulants|mesh-ancestor
83083517|NCT02189343|Thalidomide|thalidomide|mesh-list
83083518|NCT02189343|Dexamethasone|dexamethasone|mesh-list
83083519|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
83083520|NCT02189343|Pomalidomide|pomalidomide|mesh-list
83083521|NCT02189343|Ricolinostat|ricolinostat|mesh-list
83083523|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083524|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
83083525|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
83083526|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083527|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083528|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83083529|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
83083530|NCT02189343|Hormones|hormones|mesh-ancestor
83083531|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083532|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83083533|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083534|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
83083535|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083536|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083537|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
83083538|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83083539|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83083540|NCT02189343|Growth Substances|growth substances|mesh-ancestor
83083541|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
83083542|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83083543|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
83083544|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83083545|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083546|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83083547|NCT03535701|Paclitaxel|paclitaxel|mesh-list
83083548|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83083549|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83083550|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083551|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
83083552|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
83083553|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083554|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083555|NCT02486276|Cilostazol|cilostazol|mesh-list
83083556|NCT02486276|Sumatriptan|sumatriptan|mesh-list
83083557|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83083558|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
83083559|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083560|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083561|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83083562|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
83083563|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83083564|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83083565|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083566|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83083567|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
83083568|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83083569|NCT02486276|Protective Agents|protective agents|mesh-ancestor
83083570|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83083571|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83083572|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083573|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83083574|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83083575|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83083576|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
83083577|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083578|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
83083579|NCT02189577|Bromides|bromides|mesh-list
83083580|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
83083581|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83083582|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83083583|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83083584|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
83083585|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083586|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083587|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083588|NCT02189655|Bupivacaine|bupivacaine|mesh-list
83083589|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
83083590|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
83083591|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083592|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083593|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
83083594|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083595|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
83083596|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83083597|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83083598|NCT02193633|Paclitaxel|paclitaxel|mesh-list
83083599|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83083600|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83083601|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083602|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
83083603|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
83083604|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083605|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083606|NCT03315338|Prednisone|prednisone|mesh-list
83083607|NCT03315338|Cortisone|cortisone|mesh-list
83083608|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083609|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
83083610|NCT03315338|Hormones|hormones|mesh-ancestor
83083611|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083612|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083613|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83083614|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083615|NCT05713838|Durvalumab|durvalumab|mesh-list
83083616|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83083617|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083618|NCT02483156|Ribavirin|ribavirin|mesh-list
83083619|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
83083620|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
83083621|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083622|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
83083623|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083624|NCT00706004|Lubiprostone|lubiprostone|mesh-list
83083625|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83083626|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83083627|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083628|NCT02485340|Isosorbide|isosorbide|mesh-list
83083629|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83083630|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83083631|NCT02485340|Sumatriptan|sumatriptan|mesh-list
83083632|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83083633|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83083634|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83083635|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
83083636|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083637|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083638|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083639|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83361884|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
83083640|NCT02485340|Diuretics|diuretics|mesh-ancestor
83083641|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
83083642|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
83083643|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83083644|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
83083645|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083646|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
83083647|NCT02485262|Simeprevir|simeprevir|mesh-list
83083648|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
83083649|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083650|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
83083651|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083652|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083653|NCT02479490|Prednisone|prednisone|mesh-list
83083654|NCT02479490|Everolimus|everolimus|mesh-list
83083655|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083656|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
83083657|NCT02479490|Hormones|hormones|mesh-ancestor
83083658|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083659|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083660|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83083661|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083662|NCT02479490|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83083663|NCT02479490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83083664|NCT02479490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083665|NCT02479490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083666|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83083667|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
83083668|NCT02479256|Tamoxifen|tamoxifen|mesh-list
83083669|NCT02479256|Citric Acid|citric acid|mesh-list
83083670|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
83083671|NCT02479256|Clomiphene|clomiphene|mesh-list
83083672|NCT02479256|Enclomiphene|enclomiphene|mesh-list
83083673|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
83083674|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
83083675|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83083676|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
83083677|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
83083678|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083679|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83083680|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
83083681|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083682|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083683|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83083684|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083685|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83083686|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83083687|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83083688|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83083689|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
83083690|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83083691|NCT02482766|Poractant alfa|poractant alfa|mesh-list
83083692|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83083693|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
83083694|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
83083695|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
83083696|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083697|NCT02479178|Docetaxel|docetaxel|mesh-list
83083698|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083699|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
83083700|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
83083701|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083702|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083703|NCT03314792|Oxycodone|oxycodone|mesh-list
83083704|NCT03314792|Tapentadol|tapentadol|mesh-list
83083705|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83083706|NCT03314792|Narcotics|narcotics|mesh-ancestor
83083707|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083708|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083709|NCT03314792|Analgesics|analgesics|mesh-ancestor
83083710|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
83083711|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083712|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83083713|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83083714|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83083715|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361885|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083716|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
83083717|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083718|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
83083719|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83083720|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
83083721|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083722|NCT02476526|Expectorants|expectorants|mesh-ancestor
83083723|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
83083724|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83083725|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
83083726|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083727|NCT02476526|Protective Agents|protective agents|mesh-ancestor
83083728|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083729|NCT02476526|Antidotes|antidotes|mesh-ancestor
83083730|NCT02479022|Insulin|insulin|mesh-list
83083731|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83083732|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
83083733|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83083734|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083735|NCT02476760|Insulin|insulin|mesh-list
83083736|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83083737|NCT02476760|Metformin|metformin|mesh-list
83083738|NCT02476760|Pioglitazone|pioglitazone|mesh-list
83083739|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83083740|NCT02476760|Liraglutide|liraglutide|mesh-list
83083741|NCT02476760|Exenatide|exenatide|mesh-list
83083742|NCT02476760|Glimepiride|glimepiride|mesh-list
83083743|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
83083744|NCT02476760|Vildagliptin|vildagliptin|mesh-list
83083745|NCT02476760|Saxagliptin|saxagliptin|mesh-list
83083746|NCT02476760|Acarbose|acarbose|mesh-list
83083747|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83083748|NCT02476760|Repaglinide|repaglinide|mesh-list
83083749|NCT02476760|Gliclazide|gliclazide|mesh-list
83083750|NCT02476760|Glipizide|glipizide|mesh-list
83083751|NCT02476760|Biguanides|biguanides|mesh-list
83083752|NCT02476760|Tolbutamide|tolbutamide|mesh-list
83083753|NCT02476760|Voglibose|voglibose|mesh-list
83083754|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83083755|NCT02476760|Nateglinide|nateglinide|mesh-list
83083756|NCT02476760|Miglitol|miglitol|mesh-list
83083757|NCT02476760|Meglitinide|meglitinide|mesh-list
83083758|NCT02476760|Troglitazone|troglitazone|mesh-list
83083759|NCT02476760|Acetohexamide|acetohexamide|mesh-list
83083760|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
83083761|NCT02476760|Phenformin|phenformin|mesh-list
83083762|NCT02476760|Buformin|buformin|mesh-list
83083763|NCT02476760|Glibornuride|glibornuride|mesh-list
83083764|NCT02476760|Tolazamide|tolazamide|mesh-list
83083765|NCT02476760|Carbutamide|carbutamide|mesh-list
83083766|NCT02476760|Gliquidone|gliquidone|mesh-list
83083767|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83083768|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83083769|NCT02476760|Incretins|incretins|mesh-list
83083770|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083771|NCT02476760|Hormones|hormones|mesh-ancestor
82949503|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83083772|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083773|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
83083774|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083775|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083776|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83083777|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83083778|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83083779|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
83083780|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
83083781|NCT05460338|Vitamin D|vitamin d|mesh-list
83083782|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83083783|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083784|NCT05460338|Vitamins|vitamins|mesh-ancestor
83083785|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
83083786|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83083787|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83083788|NCT02476136|Fluoxetine|fluoxetine|mesh-list
83083789|NCT02476136|Paroxetine|paroxetine|mesh-list
83083790|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83083791|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83083792|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83083793|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83083794|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083795|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083796|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083797|NCT02476136|Analgesics|analgesics|mesh-ancestor
83083799|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083800|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
83083801|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83083802|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
83083803|NCT02476136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83083804|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
83083805|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83083806|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83083807|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83083808|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083810|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
83083811|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083812|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83083813|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83083814|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083815|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083816|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83083817|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
83083818|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083819|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083820|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83083821|NCT05413772|Temocillin|temocillin|mesh-list
83083822|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83083823|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083824|NCT05713292|Pirfenidone|pirfenidone|mesh-list
83083825|NCT05713292|Analgesics|analgesics|mesh-ancestor
83083826|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
83083827|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083828|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083829|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83083830|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083831|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083832|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083833|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083834|NCT02475824|Midazolam|midazolam|mesh-list
83083835|NCT02475824|Meperidine|meperidine|mesh-list
83083836|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
83083837|NCT02475824|Propofol|propofol|mesh-list
83083838|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83083839|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83083840|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083841|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083842|NCT02475824|Analgesics|analgesics|mesh-ancestor
83083843|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
83083844|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083845|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82949504|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
83083846|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83083847|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83083848|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
83083849|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083850|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083851|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83083852|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
83083853|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
83083854|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83083855|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83083856|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83083857|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83083858|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
83083859|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
83083860|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83083861|NCT02475824|Narcotics|narcotics|mesh-ancestor
83083862|NCT02478242|Nafamostat|nafamostat|mesh-list
83083863|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83083864|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083865|NCT02478242|Analgesics|analgesics|mesh-ancestor
83083866|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
83083867|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083868|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083869|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083870|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083871|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
83361886|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780096|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82780097|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82780098|NCT00539994|Retapamulin|retapamulin|mesh-list
82780099|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82780100|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780101|NCT04508790|Dexamethasone|dexamethasone|mesh-list
82780102|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
82780103|NCT04508790|Pomalidomide|pomalidomide|mesh-list
82780104|NCT04508790|Ichthammol|ichthammol|mesh-list
82780105|NCT04508790|BB 1101|bb 1101|mesh-list
82780106|NCT04508790|Leflunomide|leflunomide|mesh-list
82780107|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780108|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
82780109|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
82780110|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780111|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780112|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82780113|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
82780114|NCT04508790|Hormones|hormones|mesh-ancestor
82780115|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780116|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780117|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780118|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
82780119|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780120|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780121|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
82780122|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82780123|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82780124|NCT04508790|Growth Substances|growth substances|mesh-ancestor
82780125|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
82780126|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780127|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780128|NCT04005222|Selenium|selenium|mesh-list
82780129|NCT04005222|Melatonin|melatonin|mesh-list
82780130|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
82780131|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780132|NCT04005222|Protective Agents|protective agents|mesh-ancestor
82780133|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780134|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780135|NCT04005222|Trace Elements|trace elements|mesh-ancestor
82780136|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
82780137|NCT00098839|Leucovorin|leucovorin|mesh-list
82780138|NCT00098839|Cytarabine|cytarabine|mesh-list
82780139|NCT00098839|Prednisone|prednisone|mesh-list
82780140|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
82780141|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82780142|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82780143|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82780144|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
82780145|NCT00098839|Doxorubicin|doxorubicin|mesh-list
82780146|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82780147|NCT00098839|Methotrexate|methotrexate|mesh-list
82780148|NCT00098839|Etoposide|etoposide|mesh-list
82780149|NCT00098839|Vincristine|vincristine|mesh-list
82780150|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
82780151|NCT00098839|Asparaginase|asparaginase|mesh-list
82780152|NCT00098839|Pegaspargase|pegaspargase|mesh-list
82780153|NCT00098839|Epratuzumab|epratuzumab|mesh-list
82780154|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
82780155|NCT00098839|Razoxane|razoxane|mesh-list
82780156|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
82780157|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780158|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
82780159|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780160|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780161|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82780162|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
82780163|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780164|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780165|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82780166|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83361887|NCT02654860|Analgesics|analgesics|mesh-ancestor
82780167|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82780168|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82780169|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780170|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780171|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
82780172|NCT00098839|Hormones|hormones|mesh-ancestor
82780173|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780174|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780175|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82780176|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
82780177|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780178|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82780179|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
82780180|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780181|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82780182|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82780183|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82780184|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
82780185|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780187|NCT00098839|Protective Agents|protective agents|mesh-ancestor
82780188|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
82780189|NCT00098839|Vitamins|vitamins|mesh-ancestor
82780190|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
82780191|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
82780192|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
82780193|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
82780194|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82780195|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82780196|NCT05268744|Micronutrients|micronutrients|mesh-list
82780197|NCT05268744|Trace Elements|trace elements|mesh-list
82780198|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780199|NCT02531191|Peficitinib|peficitinib|mesh-list
82780200|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780201|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780202|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780203|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
82780204|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780205|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82780206|NCT01081639|Hormones|hormones|mesh-ancestor
82780207|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780208|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780209|NCT01081717|Golimumab|golimumab|mesh-list
82780210|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82780211|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780212|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780213|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
82780214|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780215|NCT01085383|Aripiprazole|aripiprazole|mesh-list
82780216|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
82780217|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82780218|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82780219|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82780220|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83440579|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
82780221|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780222|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
82780223|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
82780224|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780225|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780226|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82780227|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82780228|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
82780229|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82780230|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82780231|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82780232|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82780233|NCT00485589|Methotrexate|methotrexate|mesh-list
82780234|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
82780235|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82780236|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
82780237|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780238|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780239|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82780240|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
82780241|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780242|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780243|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780244|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780245|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82780246|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780247|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
82780248|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780249|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82780250|NCT00490971|Olanzapine|olanzapine|mesh-list
82780251|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82780252|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
82780253|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
82780254|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780255|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780256|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82780257|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82780258|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82780259|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780260|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82780261|NCT00490971|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82780262|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82780263|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82780264|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780265|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780266|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
82780267|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82780268|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82780269|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82780270|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82780271|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
82780272|NCT04286295|Nicotine|nicotine|mesh-list
82780273|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82780274|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
82780275|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780276|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780277|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82780278|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82780279|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
82780280|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780281|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780282|NCT00750347|Acetaminophen|acetaminophen|mesh-list
82780283|NCT00750347|Rimonabant|rimonabant|mesh-list
82780284|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780285|NCT00750347|Analgesics|analgesics|mesh-ancestor
82780286|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
82780287|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780288|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780289|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
82780290|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82780291|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
82780292|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82780293|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780294|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780295|NCT00750347|Hormones|hormones|mesh-ancestor
82780296|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780297|NCT00750425|Cediranib|cediranib|mesh-list
82780298|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780299|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82780300|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780301|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780302|NCT00745589|Sevelamer|sevelamer|mesh-list
82780303|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
82780304|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
82780305|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780306|NCT00750581|Indomethacin|indomethacin|mesh-list
82780307|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82780308|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780309|NCT00750581|Analgesics|analgesics|mesh-ancestor
82780310|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
82780311|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780312|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780313|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780314|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780315|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
82780316|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
82780317|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780318|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82780319|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780320|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780321|NCT00685763|Gemcitabine|gemcitabine|mesh-list
82780322|NCT00685763|Capecitabine|capecitabine|mesh-list
82780323|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82780324|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
82780325|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780326|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780327|NCT00098293|Lamivudine|lamivudine|mesh-list
82780328|NCT00098293|Zidovudine|zidovudine|mesh-list
82780329|NCT00098293|Efavirenz|efavirenz|mesh-list
82780330|NCT00098293|Maraviroc|maraviroc|mesh-list
82780331|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82780332|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82780333|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780334|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780335|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
82780336|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780337|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82780338|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82780339|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
82780340|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82780341|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82780342|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82780343|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82780344|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82780345|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82780346|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82780347|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82780348|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82780349|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
82780350|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780351|NCT00685685|Lovastatin|lovastatin|mesh-list
82780352|NCT00685685|L 647318|l 647318|mesh-list
82780353|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
82780354|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82780355|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82780356|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
82780357|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780358|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82780359|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82780360|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780361|NCT01087567|Insulin|insulin|mesh-list
82780362|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82780363|NCT01087567|Metformin|metformin|mesh-list
82780364|NCT01087567|Pioglitazone|pioglitazone|mesh-list
82780365|NCT01087567|Glimepiride|glimepiride|mesh-list
82780366|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82780367|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780368|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82780369|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780370|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
82780371|NCT00751049|Timolol|timolol|mesh-list
82780372|NCT00751049|Latanoprost|latanoprost|mesh-list
82780373|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82780374|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82780375|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
82780376|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780377|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780378|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780379|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82780380|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82780381|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82780382|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82780383|NCT00500331|Pioglitazone|pioglitazone|mesh-list
82780384|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82780385|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780386|NCT01019109|Cobalt|cobalt|mesh-list
82780387|NCT01019109|Trace Elements|trace elements|mesh-ancestor
82780388|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
82780389|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780390|NCT00499863|Methylphenidate|methylphenidate|mesh-list
82780391|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82780392|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780393|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82780394|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82780395|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82780396|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780397|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
82780398|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780400|NCT04475835|Bivalirudin|bivalirudin|mesh-list
82780401|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
82780402|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82780403|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82780404|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780405|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
82780406|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82780407|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
82780408|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780409|NCT01014507|Goserelin|goserelin|mesh-list
82780410|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
82780411|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
82780412|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780413|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780414|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780415|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780416|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82780417|NCT00097981|Thalidomide|thalidomide|mesh-list
82780418|NCT00097981|Dexamethasone|dexamethasone|mesh-list
82780419|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780420|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
82780421|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
82780422|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780423|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780424|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82780425|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
82780426|NCT00097981|Hormones|hormones|mesh-ancestor
82780427|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780428|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780429|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780430|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780431|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
82780432|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
82780433|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82780434|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780435|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82780436|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82780437|NCT00097981|Growth Substances|growth substances|mesh-ancestor
82780438|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
82780439|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
82780440|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82780441|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82780442|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780443|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780444|NCT01016223|Beclomethasone|beclomethasone|mesh-list
82780445|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780446|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
82780447|NCT01016223|Hormones|hormones|mesh-ancestor
82780448|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780449|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780450|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82780451|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
82780452|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82780453|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
82780454|NCT04151017|Coagulants|coagulants|mesh-ancestor
82780455|NCT01019265|Buprenorphine|buprenorphine|mesh-list
82780456|NCT01019265|Tramadol|tramadol|mesh-list
82780457|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82780458|NCT01019265|Narcotics|narcotics|mesh-ancestor
82780459|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780460|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780461|NCT01019265|Analgesics|analgesics|mesh-ancestor
82780462|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
82780463|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780464|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82780465|NCT01085617|Cytarabine|cytarabine|mesh-list
82780466|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
82780467|NCT01085617|Melphalan|melphalan|mesh-list
82780468|NCT01085617|Rituximab|rituximab|mesh-list
82780469|NCT01085617|Methotrexate|methotrexate|mesh-list
82780470|NCT01085617|Fludarabine|fludarabine|mesh-list
82780471|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
82780472|NCT01085617|Etoposide|etoposide|mesh-list
82780473|NCT01085617|Vincristine|vincristine|mesh-list
82780474|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
83361888|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
82780475|NCT01085617|Daunorubicin|daunorubicin|mesh-list
82780476|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
82780477|NCT01085617|Pegaspargase|pegaspargase|mesh-list
82780478|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780479|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
82780480|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780481|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780482|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82780483|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
82780484|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780485|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780486|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82780487|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82780488|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82780489|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
82780490|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780491|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82780492|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
82780493|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780494|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780495|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82780496|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82780497|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82780498|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82780499|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82780500|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
82780501|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780502|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
82780503|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
82780504|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
82780505|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82780506|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82780507|NCT00499083|Tamoxifen|tamoxifen|mesh-list
82780508|NCT00499083|Paclitaxel|paclitaxel|mesh-list
82780509|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
82780510|NCT00499083|Doxorubicin|doxorubicin|mesh-list
82780511|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82780512|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82780513|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82780514|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780515|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
82780516|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
82780517|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
82780518|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780519|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780520|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
82780521|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780522|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780523|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82780524|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
82780525|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82780526|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82780527|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82780528|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82780529|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780530|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82780531|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
82780532|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780533|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780534|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82780535|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82780536|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82780537|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82780538|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82780539|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82780540|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82780541|NCT01087879|Etonogestrel|etonogestrel|mesh-list
82780542|NCT01087879|Desogestrel|desogestrel|mesh-list
82780543|NCT01087879|NuvaRing|nuvaring|mesh-list
82780544|NCT01087879|Norelgestromin|norelgestromin|mesh-list
82780545|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
82780546|NCT01087879|Estradiol|estradiol|mesh-list
82780547|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82780548|NCT01087879|Estrogens|estrogens|mesh-ancestor
82780549|NCT01087879|Hormones|hormones|mesh-ancestor
82780550|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780551|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780552|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82780553|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780554|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82780555|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82780556|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82780557|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82780558|NCT01087879|Progestins|progestins|mesh-ancestor
82780559|NCT01019421|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
82780560|NCT01019421|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82780561|NCT01019421|Serotonin Agents|serotonin agents|mesh-ancestor
82780562|NCT01019421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780563|NCT01019421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780564|NCT01019421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780565|NCT01085695|Rabeprazole|rabeprazole|mesh-list
82780566|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82780567|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82780568|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82780569|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780570|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780571|NCT01088035|Carboplatin|carboplatin|mesh-list
82780572|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780573|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
82780574|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82780575|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82780576|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
82780577|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
82780578|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780579|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780580|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780581|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
82780582|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780583|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82780584|NCT00751127|Timolol|timolol|mesh-list
82780585|NCT00751127|Latanoprost|latanoprost|mesh-list
82780586|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82780587|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82780588|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
82780589|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780590|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780591|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780592|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82780593|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82780594|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82780595|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82780596|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
82780597|NCT00751205|Prednisone|prednisone|mesh-list
82780598|NCT00751205|Prednisolone|prednisolone|mesh-list
82780599|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82780600|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
82780601|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82780602|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
82780603|NCT00751205|Sagopilone|sagopilone|mesh-list
82780604|NCT00751205|Epothilones|epothilones|mesh-list
82780605|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82780606|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
82780607|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780608|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
82780609|NCT00751205|Hormones|hormones|mesh-ancestor
82780610|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780611|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780612|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780613|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780614|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
82780615|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
82780616|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780617|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82780618|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82780619|NCT00751205|Protective Agents|protective agents|mesh-ancestor
82780620|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
82780621|NCT00751205|Vitamins|vitamins|mesh-ancestor
82780622|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
82780623|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
82780624|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
82780625|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
82780626|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083872|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
82780627|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780629|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
82780630|NCT00752063|Sorafenib|sorafenib|mesh-list
82780631|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82780632|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
82780633|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780634|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780635|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82780636|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780637|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
82780638|NCT00752141|Oxybutynin|oxybutynin|mesh-list
82780639|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
82780640|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
82780641|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780642|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780643|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82780644|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82780645|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
82780646|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780647|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780648|NCT00752141|Urological Agents|urological agents|mesh-ancestor
82780649|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82780650|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780651|NCT00752375|Trimethoprim|trimethoprim|mesh-list
82780652|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82780653|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
82780654|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82780655|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780656|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
82780657|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82780658|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82780659|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82780660|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780661|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780662|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82780663|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82780664|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82780665|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82780666|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
82780667|NCT00751517|Methotrexate|methotrexate|mesh-list
82780668|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780669|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
82780670|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780671|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780672|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82780673|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
82780674|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780675|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780676|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82780677|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82780678|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
82780679|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780680|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82780681|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
82780682|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780683|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780684|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82780685|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82780686|NCT02561117|Metronidazole|metronidazole|mesh-list
82780687|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780688|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82780689|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82780690|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82780691|NCT00684515|Aspirin|aspirin|mesh-list
82780692|NCT00684515|Vorapaxar|vorapaxar|mesh-list
82780693|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82780694|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780695|NCT00684515|Analgesics|analgesics|mesh-ancestor
82780696|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
82780697|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780698|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780699|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780700|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780701|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82780702|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82780703|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780704|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82780705|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82780706|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780708|NCT00751751|Losartan|losartan|mesh-list
82780709|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82780710|NCT00751751|Olmesartan|olmesartan|mesh-list
82780711|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82780712|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82780713|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82780714|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82780715|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82780716|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780717|NCT00751751|Diuretics|diuretics|mesh-ancestor
82780718|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
82780719|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780720|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82780721|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82780722|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82780723|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780724|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
82780725|NCT00490815|Hormones|hormones|mesh-ancestor
82780726|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780727|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780728|NCT04453137|Adalimumab|adalimumab|mesh-list
82780729|NCT04453137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82780730|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780731|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780732|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
82780733|NCT03855189|Beclomethasone|beclomethasone|mesh-list
82780734|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780735|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780736|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82780737|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
82780738|NCT03855189|Hormones|hormones|mesh-ancestor
82780739|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780740|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780741|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82780742|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
82780743|NCT03853551|Osimertinib|osimertinib|mesh-list
82780744|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780745|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82780746|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780747|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780748|NCT00423670|Ribavirin|ribavirin|mesh-list
82780749|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82780750|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
82780751|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780752|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
82780753|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780754|NCT01019655|Nadroparin|nadroparin|mesh-list
82780755|NCT01019655|Calcium|calcium|mesh-list
82780756|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82780757|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780758|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
82780759|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82780760|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82780761|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780762|NCT00483717|Ketorolac|ketorolac|mesh-list
82780763|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82780764|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82780765|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780766|NCT00483717|Analgesics|analgesics|mesh-ancestor
82780767|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
82780768|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780769|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780770|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780771|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780772|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82780773|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780774|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780775|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82780776|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82780777|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82780778|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82780779|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780780|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
82780781|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780782|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780783|NCT01037842|Mitiglinide|mitiglinide|mesh-list
82780784|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82780785|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780786|NCT00483405|Capecitabine|capecitabine|mesh-list
82780787|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
82780788|NCT00483405|Cetuximab|cetuximab|mesh-list
82780789|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82780790|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
82780791|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780792|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780793|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82780794|NCT00483327|Megestrol|megestrol|mesh-list
82780795|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
82780796|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82780797|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82780798|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82780799|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
82780800|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780801|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780802|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82780803|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82780804|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82780805|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780806|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
82780807|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82780808|NCT00684203|Aspirin|aspirin|mesh-list
82780809|NCT00684203|Clopidogrel|clopidogrel|mesh-list
82780810|NCT00684203|Vorapaxar|vorapaxar|mesh-list
82780811|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82780812|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780813|NCT00684203|Analgesics|analgesics|mesh-ancestor
82780814|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
82780815|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780816|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780817|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780818|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780819|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82780820|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82780821|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780822|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82780823|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82780824|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780825|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
82780826|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82780827|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82780828|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82780829|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
82780830|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780831|NCT00423592|Ambrisentan|ambrisentan|mesh-list
82780832|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82780833|NCT01037998|Gefitinib|gefitinib|mesh-list
82780834|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780835|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82780836|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780837|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780838|NCT00751907|Atorvastatin|atorvastatin|mesh-list
82780839|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82780840|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82780841|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
82780842|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780843|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82780844|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82780845|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780846|NCT00752843|Mifepristone|mifepristone|mesh-list
82780847|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83361889|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
82780848|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
82780849|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780850|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780851|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82780852|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82780853|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82780854|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
82780855|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82780856|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82780857|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
82780858|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780859|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
82780860|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82780861|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82780862|NCT00752921|Etoricoxib|etoricoxib|mesh-list
83440613|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
82780863|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82780864|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780865|NCT00752921|Analgesics|analgesics|mesh-ancestor
82780866|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
82780867|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780868|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780869|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780870|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780871|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82780872|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82780873|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780874|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780875|NCT00683657|Saxagliptin|saxagliptin|mesh-list
82780876|NCT00683657|Incretins|incretins|mesh-ancestor
82780877|NCT00683657|Hormones|hormones|mesh-ancestor
82780878|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780879|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780880|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82780881|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
82780882|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780883|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780884|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82780885|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
82780886|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780887|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82780888|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780889|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780890|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
82780891|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780892|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780893|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82780894|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82780895|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82780896|NCT00755963|Estradiol|estradiol|mesh-list
82780897|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82780898|NCT00755963|Progesterone|progesterone|mesh-list
82780899|NCT00755963|Estrogens|estrogens|mesh-ancestor
82780900|NCT00755963|Hormones|hormones|mesh-ancestor
82780901|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82780902|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780903|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82780904|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
82780905|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82780906|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82780907|NCT00755963|Progestins|progestins|mesh-ancestor
82780908|NCT00753311|Rizatriptan|rizatriptan|mesh-list
82780909|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82780910|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
82780911|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780912|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780913|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780914|NCT00753389|Anesthetics|anesthetics|mesh-list
82780915|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780916|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780917|NCT00753467|Interferons|interferons|mesh-list
82780918|NCT00753467|Adefovir|adefovir|mesh-list
82780919|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82780920|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
82780921|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780922|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
82780923|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82780924|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82780925|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82780926|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780927|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780928|NCT00482703|Dasatinib|dasatinib|mesh-list
82780929|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780930|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82780931|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780932|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780933|NCT04052867|Lidocaine|lidocaine|mesh-list
82780934|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
82780935|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
82780936|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82780937|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780938|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
82780939|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780940|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82780941|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82780942|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82780943|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82780944|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780945|NCT00482391|Paclitaxel|paclitaxel|mesh-list
82780946|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
82780947|NCT00482391|Doxorubicin|doxorubicin|mesh-list
82780948|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82780949|NCT00482391|Trastuzumab|trastuzumab|mesh-list
82780950|NCT00482391|Lapatinib|lapatinib|mesh-list
82780951|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82780952|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82780953|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
82780954|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
82780955|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
82780956|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780957|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82780958|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
82780959|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780960|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780961|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82780962|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
82780963|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82780964|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82780965|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82780966|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82780967|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780968|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82780969|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82780970|NCT00753779|Simvastatin|simvastatin|mesh-list
82780971|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82780972|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82780973|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82780974|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
82780975|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780976|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82780977|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82780978|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82780979|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
82780980|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82780981|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780982|NCT00757523|Analgesics|analgesics|mesh-ancestor
82780983|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
82780984|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82780985|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780986|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82780987|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82780988|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
82780989|NCT00757679|Milnacipran|milnacipran|mesh-list
82780990|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
82780991|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82780992|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82780993|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82780994|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82780995|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82780996|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82780997|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82780998|NCT00757679|Analgesics|analgesics|mesh-ancestor
82780999|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
82781000|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781001|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
82781002|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82781003|NCT00496587|Bevacizumab|bevacizumab|mesh-list
82781004|NCT00496587|Gemcitabine|gemcitabine|mesh-list
82781005|NCT00496587|Capecitabine|capecitabine|mesh-list
82781006|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82781007|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781008|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781009|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781010|NCT00496587|Growth Substances|growth substances|mesh-ancestor
82781011|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781012|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781013|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82781014|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
82781015|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781016|NCT00757835|Timolol|timolol|mesh-list
82781017|NCT00757835|Latanoprost|latanoprost|mesh-list
82781018|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82781019|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82781020|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
82781021|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781022|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781023|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781024|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82781025|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82781026|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82781027|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82781028|NCT01038154|Pravastatin|pravastatin|mesh-list
82781029|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82781030|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82781031|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
82781032|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781033|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82781034|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82781035|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781036|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
82781037|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82781038|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781039|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82781040|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
82781041|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781042|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781043|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781044|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781045|NCT01324180|Metformin|metformin|mesh-list
82781046|NCT01324180|Dexamethasone|dexamethasone|mesh-list
82781047|NCT01324180|Doxorubicin|doxorubicin|mesh-list
82781048|NCT01324180|Vincristine|vincristine|mesh-list
82781049|NCT01324180|Asparaginase|asparaginase|mesh-list
82781050|NCT01324180|Pegaspargase|pegaspargase|mesh-list
82781051|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781052|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
82781053|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
82781054|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781055|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781056|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781057|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
82781058|NCT01324180|Hormones|hormones|mesh-ancestor
82781059|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781060|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82781061|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781062|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781063|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82781064|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82781065|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82781066|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083873|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781067|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781068|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82781069|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
82781070|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
82781071|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
82781072|NCT02560649|Tenofovir|tenofovir|mesh-list
82781073|NCT02560649|Lamivudine|lamivudine|mesh-list
82781074|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82781075|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
82781076|NCT02560649|Entecavir|entecavir|mesh-list
82781077|NCT02560649|Adefovir|adefovir|mesh-list
82781078|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82781079|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
83440616|NCT03568838|Enoxaparin|enoxaparin|mesh-list
82781080|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781081|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82781082|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82781083|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781084|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781085|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82781086|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82781087|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
82781088|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781089|NCT00754403|Metformin|metformin|mesh-list
82781090|NCT00754403|Pioglitazone|pioglitazone|mesh-list
82781091|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781092|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781093|NCT00758225|Idebenone|idebenone|mesh-list
82781094|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
82781095|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781096|NCT00758225|Protective Agents|protective agents|mesh-ancestor
82781097|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781098|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
82781099|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82781100|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781101|NCT00422734|Tadalafil|tadalafil|mesh-list
82781102|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
82781103|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82781104|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82781105|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781106|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781107|NCT00422734|Urological Agents|urological agents|mesh-ancestor
82781108|NCT00422422|Brivaracetam|brivaracetam|mesh-list
82781109|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
82781110|NCT00413374|Enoxaparin|enoxaparin|mesh-list
82781111|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
82781112|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82781113|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82781114|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781115|NCT00682643|Fluticasone|fluticasone|mesh-list
82781116|NCT00682643|Xhance|xhance|mesh-list
82781117|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781118|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82781119|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
82781120|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781121|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781122|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82781123|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
82781124|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
82781125|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82781126|NCT00758381|Sorafenib|sorafenib|mesh-list
82781127|NCT00758381|Cisplatin|cisplatin|mesh-list
82781128|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781129|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82781130|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781131|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781132|NCT00754871|Dienogest|dienogest|mesh-list
82781133|NCT00754871|Nandrolone|nandrolone|mesh-list
82781134|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82781135|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
82781136|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82781137|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781138|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82781139|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82781140|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82781141|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82781142|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
82781143|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781144|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82781145|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781146|NCT00754871|Androgens|androgens|mesh-ancestor
82781147|NCT00754871|Hormones|hormones|mesh-ancestor
82781148|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
82781149|NCT00755027|Rasagiline|rasagiline|mesh-list
82781150|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82781151|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781152|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781153|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82781154|NCT00755027|Protective Agents|protective agents|mesh-ancestor
82781155|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781156|NCT05435729|Levodopa|levodopa|mesh-list
82781157|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82781158|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82781159|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
82781160|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781161|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781162|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781163|NCT01038388|Dexamethasone|dexamethasone|mesh-list
82781164|NCT01038388|Lenalidomide|lenalidomide|mesh-list
82781165|NCT01038388|Bortezomib|bortezomib|mesh-list
82781166|NCT01038388|Vorinostat|vorinostat|mesh-list
82781167|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781168|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
82781169|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
82781170|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781171|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781172|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781173|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
82781174|NCT01038388|Hormones|hormones|mesh-ancestor
82781175|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781176|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82781177|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781178|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
82781179|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781180|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781181|NCT01038388|Growth Substances|growth substances|mesh-ancestor
82781182|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781183|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82781184|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781185|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781186|NCT04050059|Lidocaine|lidocaine|mesh-list
82781187|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82781188|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
82781189|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
82781190|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781191|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781192|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
82781193|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781194|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82781195|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82781196|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82781197|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82781198|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781199|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82781200|NCT02150967|Infigratinib|infigratinib|mesh-list
82781201|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781202|NCT00482001|Donepezil|donepezil|mesh-list
82781203|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82781204|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781205|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781206|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
82781207|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781208|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781209|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
82781210|NCT00490035|Brivaracetam|brivaracetam|mesh-list
82781211|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
82781212|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
82781213|NCT00421174|Etanercept|etanercept|mesh-list
82781214|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781215|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
82781216|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
82781217|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781218|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781219|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781220|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
82781221|NCT00421174|Hormones|hormones|mesh-ancestor
82781222|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83440623|NCT00726713|Vitamins|vitamins|mesh-ancestor
82781223|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82781224|NCT00421174|Protective Agents|protective agents|mesh-ancestor
82781225|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82781226|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82781227|NCT00421174|Analgesics|analgesics|mesh-ancestor
82781228|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
82781229|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781230|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781231|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
82781232|NCT00496197|Fluconazole|fluconazole|mesh-list
82781233|NCT00496197|Voriconazole|voriconazole|mesh-list
82781234|NCT00496197|Anidulafungin|anidulafungin|mesh-list
82781235|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
82781236|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781237|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82781238|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82781239|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781240|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781241|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82781242|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
82781243|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781244|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781245|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82781246|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82781247|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82781248|NCT03996993|Bicalutamide|bicalutamide|mesh-list
82781249|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
82781250|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
82781251|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781252|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781253|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781254|NCT01015053|Ropivacaine|ropivacaine|mesh-list
82781255|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
82781256|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
82781257|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781258|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781259|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
82781260|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781261|NCT00404092|Caspofungin|caspofungin|mesh-list
82781262|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
82781263|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781264|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781265|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781266|NCT00481767|Vaccines|vaccines|mesh-list
82781267|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
82781268|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781269|NCT00489489|Interferons|interferons|mesh-list
82781270|NCT00489489|Interferon-beta|interferon-beta|mesh-list
82781271|NCT00489489|Teriflunomide|teriflunomide|mesh-list
82781272|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
82781273|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781274|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
82781275|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781276|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82781277|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
82781278|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781279|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82781280|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82781281|NCT00489489|Analgesics|analgesics|mesh-ancestor
82781282|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
82781283|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781284|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781285|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781286|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781287|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82781288|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82781289|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82781290|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82781291|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781292|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781293|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781294|NCT00489411|Analgesics|analgesics|mesh-ancestor
82781295|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
82781296|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781297|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
82781298|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82781299|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
82781300|NCT00420784|Interferons|interferons|mesh-list
82781301|NCT00420784|Ribavirin|ribavirin|mesh-list
82781302|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
82781303|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
82781304|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82781305|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781306|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
82781307|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781308|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
82781309|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781310|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
82781311|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781312|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82781313|NCT00420628|Tobramycin|tobramycin|mesh-list
82781314|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781315|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781316|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82781317|NCT00413218|Voriconazole|voriconazole|mesh-list
82781318|NCT00413218|Caspofungin|caspofungin|mesh-list
82781319|NCT00413218|Isavuconazole|isavuconazole|mesh-list
82781320|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
82781321|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781322|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82781323|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82781324|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781325|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781326|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82781327|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
82781328|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781329|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781330|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82781331|NCT00494871|Warfarin|warfarin|mesh-list
82781332|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
82781333|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
82781334|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82781335|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
82781336|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82781337|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
82781338|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781339|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781340|NCT00420238|Etanercept|etanercept|mesh-list
82781341|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82781342|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82781343|NCT00420238|Analgesics|analgesics|mesh-ancestor
82781344|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
82781345|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781346|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781347|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781348|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781349|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781350|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781351|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
82781352|NCT00420004|Escitalopram|escitalopram|mesh-list
82781353|NCT00420004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82781354|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82781355|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82781356|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781357|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781358|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
82781359|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781360|NCT00494481|Docetaxel|docetaxel|mesh-list
82781361|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781362|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
82781363|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
82781364|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
82781365|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781367|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83361890|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83440626|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
82781368|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82781369|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82781370|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82781371|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82781372|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
82781373|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781374|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781375|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781377|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
82781378|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82781379|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781380|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82781381|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781382|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781383|NCT00419926|Cyclosporine|cyclosporine|mesh-list
82781384|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
82781385|NCT00419926|Prednisone|prednisone|mesh-list
82781386|NCT00419926|Cyclosporins|cyclosporins|mesh-list
82781387|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781388|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
82781389|NCT00419926|Hormones|hormones|mesh-ancestor
82781390|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781391|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781392|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82781393|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781394|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781395|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781396|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781397|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
82781398|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
82781399|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781400|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
82781401|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781402|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82781403|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82781404|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82781405|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
82781406|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781407|NCT00419770|Amphotericin B|amphotericin b|mesh-list
82781408|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82781409|NCT00419770|Deferasirox|deferasirox|mesh-list
82781410|NCT00419770|Amebicides|amebicides|mesh-ancestor
82781411|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82781412|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82781413|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781414|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781415|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
82781416|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82781417|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
82781418|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
82781419|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781420|NCT00080119|Isoniazid|isoniazid|mesh-list
82781421|NCT00080119|Trimethoprim|trimethoprim|mesh-list
82781422|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
82781423|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
82781424|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781425|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781426|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82781427|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82781428|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
82781429|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781430|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82781431|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82781432|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
82781433|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82781434|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82781435|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82781436|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781437|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82781438|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82781439|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82781440|NCT01034878|Sunitinib|sunitinib|mesh-list
82781441|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781442|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781443|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781444|NCT01034878|Growth Substances|growth substances|mesh-ancestor
82781445|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781446|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781447|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82781448|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781449|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781450|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82781451|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82781452|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82781453|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781454|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781455|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82781456|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82781457|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82781458|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82781459|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
82781460|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781461|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781462|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82781463|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82781464|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
82781465|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82781466|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82781467|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
82781468|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82781469|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82781470|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781471|NCT00494091|Sirolimus|sirolimus|mesh-list
82781472|NCT00494091|Temsirolimus|temsirolimus|mesh-list
82781473|NCT00494091|MTOR Inhibitors|mtor inhibitors|mesh-list
82781474|NCT00494091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82781475|NCT00494091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781476|NCT00494091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781477|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781478|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
82781479|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781480|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781481|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781482|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781483|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82781484|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
82781485|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
82781486|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82781487|NCT01017159|Antibodies|antibodies|mesh-list
82781488|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
82781489|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781490|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
82781491|NCT00494013|Protamines|protamines|mesh-list
82781492|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781493|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781494|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
82781495|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781496|NCT00494013|Coagulants|coagulants|mesh-ancestor
82781497|NCT00079339|Tipifarnib|tipifarnib|mesh-list
82781498|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781499|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
82781500|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82781501|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
82781502|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781503|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
82781504|NCT01088191|Protective Agents|protective agents|mesh-ancestor
82781505|NCT01082341|Vaccines|vaccines|mesh-list
82781506|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
82781507|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781508|NCT00541866|Cytarabine|cytarabine|mesh-list
82781509|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82781510|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
82781511|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781512|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781513|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
82781514|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781515|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781516|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
82781517|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781518|NCT00493467|Rituximab|rituximab|mesh-list
82781519|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82781520|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781521|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
82781522|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781523|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781524|NCT00090493|Immunomodulating Agents|immunomodulating agents|mesh-list
82781525|NCT00090493|Immunologic Factors|immunologic factors|mesh-ancestor
82781526|NCT00090493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781527|NCT01088347|Mapatumumab|mapatumumab|mesh-list
82781528|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781529|NCT05257824|Aspirin|aspirin|mesh-list
82781530|NCT05257824|Clopidogrel|clopidogrel|mesh-list
82781531|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82781532|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82781533|NCT05257824|Analgesics|analgesics|mesh-ancestor
82781534|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
82781535|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781536|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781537|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781538|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781539|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82781540|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82781541|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781542|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82781543|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82781544|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781545|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
82781546|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82781547|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82781548|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82781549|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
82781550|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781551|NCT04221828|Paclitaxel|paclitaxel|mesh-list
82781552|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82781553|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82781554|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781555|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
82781556|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
82781557|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
82781558|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781559|NCT04221750|Metformin|metformin|mesh-list
82781560|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781561|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781562|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
82781563|NCT04198428|Narcotics|narcotics|mesh-ancestor
82781564|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781565|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781566|NCT04198428|Analgesics|analgesics|mesh-ancestor
82781567|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
82781568|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781569|NCT04113018|Dexamethasone|dexamethasone|mesh-list
82781570|NCT04113018|Lenalidomide|lenalidomide|mesh-list
82781571|NCT04113018|Daratumumab|daratumumab|mesh-list
82781572|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781573|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
82781574|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
82781575|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781576|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781577|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781578|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
82781579|NCT04113018|Hormones|hormones|mesh-ancestor
82781580|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781581|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82781582|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781583|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
82781584|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781585|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781586|NCT04113018|Growth Substances|growth substances|mesh-ancestor
82781587|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781588|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
82781589|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82781590|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
82781591|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781592|NCT01017393|Ketamine|ketamine|mesh-list
82781593|NCT01017393|Analgesics|analgesics|mesh-ancestor
82781594|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
82781595|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781596|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781597|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82781598|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82781599|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
82781600|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
82781601|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781602|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82781603|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82781604|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781605|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781606|NCT00493311|Acetaminophen|acetaminophen|mesh-list
82781607|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82781608|NCT00493311|Analgesics|analgesics|mesh-ancestor
82781609|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
82781610|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781611|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781612|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
82781613|NCT00571649|Enoxaparin|enoxaparin|mesh-list
82781614|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
82781615|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
82781616|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82781617|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
82781618|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82781619|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
82781620|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781621|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781622|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
82781623|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82781624|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82781625|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82781626|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
82781627|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781628|NCT03917472|Aflibercept|aflibercept|mesh-list
82781629|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781630|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781631|NCT03917472|Growth Substances|growth substances|mesh-ancestor
82781632|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781633|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781634|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781635|NCT00681863|Pramipexole|pramipexole|mesh-list
82781636|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
82781637|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781638|NCT00681863|Protective Agents|protective agents|mesh-ancestor
82781639|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781640|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82781641|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82781642|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
82781643|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
82781644|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781645|NCT02559791|Reslizumab|reslizumab|mesh-list
82781646|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82781647|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
82781648|NCT05677620|Propofol|propofol|mesh-list
82781649|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82781650|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781651|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781652|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82781653|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
82781654|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
82781655|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82781656|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
82781657|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82781658|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82781659|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82781660|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781661|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781662|NCT00969176|Acetaminophen|acetaminophen|mesh-list
82781663|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82781665|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
82781666|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781667|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781668|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
82781669|NCT04503252|Cefazolin|cefazolin|mesh-list
82781670|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781671|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781672|NCT00679367|Dexamethasone|dexamethasone|mesh-list
82781673|NCT00679367|Lenalidomide|lenalidomide|mesh-list
82781674|NCT00679367|Melphalan|melphalan|mesh-list
82781675|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781676|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
82781677|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
82781678|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781679|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781680|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781681|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
82781682|NCT00679367|Hormones|hormones|mesh-ancestor
82781683|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781684|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82781685|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781686|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
82781687|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781688|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781689|NCT00679367|Growth Substances|growth substances|mesh-ancestor
82781690|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781691|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82781692|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
82781693|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781694|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82781695|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781696|NCT00969566|Metformin|metformin|mesh-list
82781697|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82781698|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781699|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781700|NCT00969566|Incretins|incretins|mesh-ancestor
82781701|NCT00969566|Hormones|hormones|mesh-ancestor
82781702|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781703|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82781704|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
82781705|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781706|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781707|NCT00755495|Doxepin|doxepin|mesh-list
82781708|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82781709|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82781710|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781711|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781712|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82781713|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
82781714|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82781715|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
82781716|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
82781717|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781718|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781719|NCT00964184|Metformin|metformin|mesh-list
82781720|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781721|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781722|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
82781723|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
82781724|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
82781725|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781726|NCT00964262|Exenatide|exenatide|mesh-list
82781727|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781728|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781729|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82781730|NCT00964262|Incretins|incretins|mesh-ancestor
82781731|NCT00964262|Hormones|hormones|mesh-ancestor
82781732|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781733|NCT00973778|Capecitabine|capecitabine|mesh-list
82781734|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82781735|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
82781736|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781737|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781739|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82781740|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781741|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781742|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82781743|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83361891|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
82781744|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781746|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781747|NCT00964418|Insulin|insulin|mesh-list
82781748|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82781749|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
82781750|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781751|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781752|NCT00974012|Valproic Acid|valproic acid|mesh-list
82781753|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
82781754|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781755|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781756|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
82781757|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82781758|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781759|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
82781760|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82781761|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781762|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82781763|NCT00964574|Insulin|insulin|mesh-list
82781764|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82781765|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
82781766|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
82781767|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82781768|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781769|NCT00970580|Paclitaxel|paclitaxel|mesh-list
82781770|NCT00970580|Carboplatin|carboplatin|mesh-list
82781771|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
82781772|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82781773|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781774|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
82781775|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
82781776|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
82781777|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781778|NCT00974324|Endostar protein|endostar protein|mesh-list
82781779|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781780|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781781|NCT00974324|Growth Substances|growth substances|mesh-ancestor
82781782|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781783|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781784|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781785|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
82781786|NCT00545714|Rituximab|rituximab|mesh-list
82781787|NCT00545714|Fludarabine|fludarabine|mesh-list
82781788|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781789|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
82781790|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781791|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781792|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82781793|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
82781794|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781795|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781796|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82781797|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82781798|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
82781799|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781800|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781801|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82781802|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82781803|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781804|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781805|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781806|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
82781807|NCT00539838|Prednisone|prednisone|mesh-list
82781808|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
82781809|NCT00539838|Methotrexate|methotrexate|mesh-list
82781810|NCT00539838|Azathioprine|azathioprine|mesh-list
82781811|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82781812|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
82781813|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781814|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
82781815|NCT00539838|Hormones|hormones|mesh-ancestor
82781816|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82781817|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781818|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82781819|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781820|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82781821|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
82781822|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82781823|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82781825|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781826|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
82781827|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781828|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82781829|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
82781830|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781831|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82781832|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82781833|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82781834|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
82781835|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781836|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781837|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
82781838|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
82781839|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781840|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781841|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82781842|NCT00539838|Protective Agents|protective agents|mesh-ancestor
82781843|NCT00970892|Warfarin|warfarin|mesh-list
82781844|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
82781845|NCT00964808|Oxycodone|oxycodone|mesh-list
82781846|NCT00964808|Buprenorphine|buprenorphine|mesh-list
82781847|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82781848|NCT00964808|Narcotics|narcotics|mesh-ancestor
82781849|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781850|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781851|NCT00964808|Analgesics|analgesics|mesh-ancestor
82781852|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
82781853|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781854|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82781855|NCT00970970|Bevacizumab|bevacizumab|mesh-list
82781856|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
82781857|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82781858|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781859|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781860|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781861|NCT00970970|Growth Substances|growth substances|mesh-ancestor
82781862|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781863|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781864|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82781865|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781866|NCT03765450|Infliximab|infliximab|mesh-list
82781867|NCT03765450|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82781868|NCT03765450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82781869|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
82781870|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82781871|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781872|NCT00971126|Thalidomide|thalidomide|mesh-list
82781873|NCT00971126|Sorafenib|sorafenib|mesh-list
82781874|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781875|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82781876|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781877|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781878|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781879|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
82781880|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781881|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
82781882|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781883|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781884|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82781885|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82781886|NCT00971126|Growth Substances|growth substances|mesh-ancestor
82781887|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
82781888|NCT00964964|Insulin|insulin|mesh-list
82781889|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82781890|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
82781892|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781893|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
82781894|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82781895|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781896|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781897|NCT03676764|Azithromycin|azithromycin|mesh-list
82781898|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82781899|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781900|NCT00974792|Leucovorin|leucovorin|mesh-list
82781901|NCT00974792|Cytarabine|cytarabine|mesh-list
82781902|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
82781903|NCT00974792|Ifosfamide|ifosfamide|mesh-list
82781904|NCT00974792|Rituximab|rituximab|mesh-list
82781905|NCT00974792|Doxorubicin|doxorubicin|mesh-list
82781906|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82781907|NCT00974792|Methotrexate|methotrexate|mesh-list
82781908|NCT00974792|Etoposide|etoposide|mesh-list
82781909|NCT00974792|Vincristine|vincristine|mesh-list
82781910|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
82781911|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
82781912|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82781913|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
82781914|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781915|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82781916|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82781917|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
82781918|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781919|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781920|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82781921|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82781922|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82781923|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82781924|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82781925|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781926|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82781927|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
82781928|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82781929|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82781930|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
82781931|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
82781932|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82781933|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82781934|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82781935|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
82781936|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781937|NCT00974792|Antidotes|antidotes|mesh-ancestor
82781938|NCT00974792|Protective Agents|protective agents|mesh-ancestor
82781939|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
82781940|NCT00974792|Vitamins|vitamins|mesh-ancestor
82781941|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
82781942|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
82781943|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
82781944|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
82781945|NCT00965120|Bradykinin|bradykinin|mesh-list
82781946|NCT00965120|Kininogens|kininogens|mesh-list
82781947|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
82781948|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
82781949|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82781950|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
82781951|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781952|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781953|NCT00679289|Interferons|interferons|mesh-list
82781954|NCT00679289|Ecromeximab|ecromeximab|mesh-list
82781955|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781956|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
82781957|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82781958|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82781959|NCT00679211|Trastuzumab|trastuzumab|mesh-list
82781960|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82781961|NCT00679211|Maytansine|maytansine|mesh-list
82781962|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82781963|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781964|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82781965|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
82781966|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
82781967|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
82781968|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781970|NCT00679211|Immunoconjugates|immunoconjugates|mesh-ancestor
82781971|NCT00679211|Immunologic Factors|immunologic factors|mesh-ancestor
82781972|NCT00679211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781973|NCT00545948|Cisplatin|cisplatin|mesh-list
82781974|NCT00545948|Pemetrexed|pemetrexed|mesh-list
82781975|NCT00545948|Vinorelbine|vinorelbine|mesh-list
82781976|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82781977|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82781978|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781979|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82781980|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82781981|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82781982|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
82781983|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
82781984|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
82781985|NCT00755573|Pregabalin|pregabalin|mesh-list
82781986|NCT00755573|Analgesics|analgesics|mesh-ancestor
82781987|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
82781988|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82781989|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82781990|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
82781991|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82781992|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82781993|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82781994|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82781995|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82781996|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82781997|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82781998|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82781999|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82782000|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
82782001|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782002|NCT04008290|Liraglutide|liraglutide|mesh-list
82782003|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82782004|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782005|NCT04008290|Incretins|incretins|mesh-ancestor
82782006|NCT04008290|Hormones|hormones|mesh-ancestor
82782007|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782008|NCT02559167|Cannabidiol|cannabidiol|mesh-list
82782009|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
82782010|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82782011|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782012|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82782013|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782014|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782015|NCT05271071|Lidocaine|lidocaine|mesh-list
82782016|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
82782017|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
82782018|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82782019|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782020|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
82782021|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782022|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82782023|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82782024|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82782025|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782026|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782027|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
82782028|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82782029|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
82782030|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782031|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782032|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82782033|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
83440647|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82782034|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82782035|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82782036|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82782037|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
82782038|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782039|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782040|NCT00972218|Adalimumab|adalimumab|mesh-list
82782041|NCT00972218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82782042|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782043|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782044|NCT05230901|Dihydralazine|dihydralazine|mesh-list
82782045|NCT05230901|Spironolactone|spironolactone|mesh-list
82782046|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83361892|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782047|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
82782048|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782049|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782050|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82782051|NCT05230901|Diuretics|diuretics|mesh-ancestor
82782052|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
82782053|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82782054|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
82782055|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82782056|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782057|NCT03927950|Bupropion|bupropion|mesh-list
82782058|NCT03927950|Escitalopram|escitalopram|mesh-list
82782059|NCT03927950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82782060|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82782061|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782062|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782063|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782064|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
82782065|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782066|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82782067|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
82782068|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82782069|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82782070|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
82782071|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82782072|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82782073|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782074|NCT00972842|Lenalidomide|lenalidomide|mesh-list
82782075|NCT00972842|Vorinostat|vorinostat|mesh-list
82782076|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
82782077|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782078|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82782079|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82782080|NCT00972842|Growth Substances|growth substances|mesh-ancestor
82782081|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
82782082|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782083|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82782084|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782085|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782086|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
82782087|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
82782088|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82782089|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82782090|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782091|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782092|NCT00975494|Urological Agents|urological agents|mesh-ancestor
82782093|NCT00975572|Vaccines|vaccines|mesh-list
82782094|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
82782095|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782096|NCT00965666|Etanercept|etanercept|mesh-list
82782097|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82782098|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82782099|NCT00965666|Analgesics|analgesics|mesh-ancestor
82782100|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
82782101|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782102|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782103|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782104|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782105|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82782106|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82782107|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
82782108|NCT00975728|Antioxidants|antioxidants|mesh-list
82782109|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782110|NCT00975728|Protective Agents|protective agents|mesh-ancestor
82782111|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782112|NCT04049747|Bicalutamide|bicalutamide|mesh-list
82782113|NCT04049747|Finasteride|finasteride|mesh-list
82782114|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
82782115|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
82782116|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782117|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782118|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782119|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82782120|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82782121|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782122|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782123|NCT04049747|Urological Agents|urological agents|mesh-ancestor
82782125|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782126|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
82782127|NCT00973154|Hormones|hormones|mesh-ancestor
82782128|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782129|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782130|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82782131|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782132|NCT00965900|Propranolol|propranolol|mesh-list
82782133|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82782134|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82782135|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
82782136|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782137|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782138|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782139|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82782140|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82782141|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
82782142|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
82782143|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782144|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782145|NCT03486197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82782146|NCT03486197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782147|NCT00973232|Acetaminophen|acetaminophen|mesh-list
82782148|NCT00973232|Tramadol|tramadol|mesh-list
82782149|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82782150|NCT00973232|Analgesics|analgesics|mesh-ancestor
82782151|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
82782152|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782153|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782154|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
82782155|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82782156|NCT00973232|Narcotics|narcotics|mesh-ancestor
82782157|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82782158|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82782159|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782160|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82782161|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782162|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782163|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
82782164|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782165|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782166|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82782167|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82782168|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782169|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782170|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782171|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82782172|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82782173|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82782174|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782175|NCT00966056|Mitomycins|mitomycins|mesh-list
82782176|NCT00966056|Mitomycin|mitomycin|mesh-list
82782177|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82782178|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782179|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
82782180|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782181|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782182|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782183|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82782184|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
82782185|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782186|NCT03523728|Venglustat|venglustat|mesh-list
82782187|NCT03523728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782188|NCT03523728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782189|NCT00979706|Cyclosporine|cyclosporine|mesh-list
82782190|NCT00979706|Interleukin-2|interleukin-2|mesh-list
82782191|NCT00979706|Cyclosporins|cyclosporins|mesh-list
82782192|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782193|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782194|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82782195|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
82782196|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782197|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
82782198|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782199|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
82782200|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782201|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82782202|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782203|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82782204|NCT00979706|Analgesics|analgesics|mesh-ancestor
82782205|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
82782206|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782207|NCT00979862|Cediranib|cediranib|mesh-list
82782208|NCT00979862|Maleic acid|maleic acid|mesh-list
82782209|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782210|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782211|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782212|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82782213|NCT00966290|Warfarin|warfarin|mesh-list
82782214|NCT00966290|Anticoagulants|anticoagulants|mesh-list
82782215|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
82782216|NCT00966290|Fluindione|fluindione|mesh-list
82782217|NCT00966290|Phenindione|phenindione|mesh-list
82782218|NCT00966368|Insulin|insulin|mesh-list
82782219|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82782220|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
82782221|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82782222|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782223|NCT00980408|Cycloserine|cycloserine|mesh-list
82782224|NCT00980408|Memantine|memantine|mesh-list
82782225|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82782226|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82782227|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
82782228|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782229|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782230|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782231|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82782232|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82782233|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82782234|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782235|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82782236|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
82782237|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782238|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
82782239|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
82782240|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
82782241|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782242|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782243|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782244|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82782245|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82782246|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782247|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782248|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782249|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82782250|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82782251|NCT05279040|Ivacaftor|ivacaftor|mesh-list
82782252|NCT05279040|Elexacaftor|elexacaftor|mesh-list
82782253|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82782254|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782255|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782256|NCT00989898|Insulin|insulin|mesh-list
82782257|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82782258|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782259|NCT00990054|Plerixafor|plerixafor|mesh-list
82782260|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82782261|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82782262|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
82782263|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782265|NCT03388632|Ipilimumab|ipilimumab|mesh-list
82782266|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782267|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782268|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82782269|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782270|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
82782271|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82782272|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782273|NCT05590572|Etoposide|etoposide|mesh-list
82782274|NCT05590572|Ifosfamide|ifosfamide|mesh-list
82782275|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
82782276|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82782277|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782278|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82782279|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82782280|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782281|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782282|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82782283|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
82782284|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
82782285|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82782286|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782287|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782288|NCT03069378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82782289|NCT03069378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782290|NCT05590416|Adalimumab|adalimumab|mesh-list
82782291|NCT05590416|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82782292|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782293|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782294|NCT00990444|Insulin|insulin|mesh-list
82782295|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82782296|NCT00990444|Dextrans|dextrans|mesh-list
82782297|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82782298|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782299|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
82782300|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
82782301|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
82782302|NCT00990600|Tenofovir|tenofovir|mesh-list
82782303|NCT00990600|Emtricitabine|emtricitabine|mesh-list
82782304|NCT00990600|Efavirenz|efavirenz|mesh-list
82782305|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
82782306|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782307|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82782308|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782309|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782310|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782311|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82782312|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82782313|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82782314|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82782315|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82782316|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82782317|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82782318|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82782319|NCT02897076|Betamethasone|betamethasone|mesh-list
82782320|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
82782321|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82782322|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
82782323|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82782324|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782325|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
82782326|NCT02897076|Hormones|hormones|mesh-ancestor
82782327|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782328|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782329|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82782330|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
82782331|NCT02797548|Aspirin|aspirin|mesh-list
82782332|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82782333|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82782334|NCT02797548|Analgesics|analgesics|mesh-ancestor
82782335|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
82782336|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782337|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782338|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782339|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782340|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82782341|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82782342|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782343|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82782344|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82782345|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782346|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
82782347|NCT00990678|Vitamin D|vitamin d|mesh-list
82782348|NCT00990678|Calcitriol|calcitriol|mesh-list
82782349|NCT00990678|Calcium|calcium|mesh-list
82782350|NCT00990678|Vitamins|vitamins|mesh-ancestor
82782351|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
82782352|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782353|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82782354|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82782355|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82782356|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782357|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782358|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82782359|NCT00538590|Mitomycins|mitomycins|mesh-list
82782360|NCT00538590|Mitomycin|mitomycin|mesh-list
82782361|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82782362|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782363|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
82782364|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782365|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782366|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782367|NCT00990834|Simvastatin|simvastatin|mesh-list
82782368|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82782369|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82782370|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
82782371|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782372|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82782373|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82782374|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782375|NCT00990990|Linezolid|linezolid|mesh-list
82782376|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
82782377|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782378|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782379|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82782380|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782381|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782382|NCT05589402|Lidocaine|lidocaine|mesh-list
82782383|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
82782384|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
82782385|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82782386|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782387|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
82782388|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782389|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82782390|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82782391|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82782392|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782393|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782394|NCT00466947|Vaccines|vaccines|mesh-list
82782395|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82782396|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
82782397|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782398|NCT00537810|Sibutramine|sibutramine|mesh-list
82782399|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
82782400|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82782401|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
82782402|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82782403|NCT01829568|Rituximab|rituximab|mesh-list
82782404|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82782405|NCT01829568|Lenalidomide|lenalidomide|mesh-list
82782406|NCT01829568|Antibodies|antibodies|mesh-list
82782407|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
82782408|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82782409|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
82782410|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782411|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782412|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782413|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82782414|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82782415|NCT01829568|Growth Substances|growth substances|mesh-ancestor
82782416|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
82782417|NCT00848328|Rituximab|rituximab|mesh-list
82782418|NCT00848328|Lenalidomide|lenalidomide|mesh-list
82782419|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782420|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782421|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
82782422|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782423|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782424|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82782425|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82782426|NCT00848328|Growth Substances|growth substances|mesh-ancestor
82782427|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
82782429|NCT00989352|Methotrexate|methotrexate|mesh-list
82782430|NCT00989352|Lomustine|lomustine|mesh-list
82782431|NCT00989352|Procarbazine|procarbazine|mesh-list
82782432|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782433|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782434|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
82782435|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782436|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782437|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82782438|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
82782439|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82782440|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82782441|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
82782442|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782443|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
82782444|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782445|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82782446|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82782447|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782448|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82782449|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
82782450|NCT05566626|Tropicamide|tropicamide|mesh-list
82782451|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
82782452|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
82782453|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782454|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782455|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82782456|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82782457|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
82782458|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782459|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782460|NCT00989508|Perhexiline|perhexiline|mesh-list
82782461|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82782462|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782463|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782464|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82782465|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782466|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
82782467|NCT05360394|Paclitaxel|paclitaxel|mesh-list
82782468|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82782469|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82782470|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782471|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
82782472|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
82782473|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
82782474|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782475|NCT00090259|Losartan|losartan|mesh-list
82782476|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82782477|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82782478|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82782479|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82782480|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782481|NCT00079183|Sirolimus|sirolimus|mesh-list
82782482|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782483|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782484|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82782485|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782486|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
82782487|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82782488|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
82782489|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782490|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82782491|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
82782492|NCT01086085|Adefovir|adefovir|mesh-list
82782493|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
82782494|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782517|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782518|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82782519|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82782520|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82782521|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82782522|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82782547|NCT00078325|Modafinil|modafinil|mesh-list
82782548|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82782549|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782550|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82782551|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82782552|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82782553|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782554|NCT03963193|Cisplatin|cisplatin|mesh-list
82782555|NCT03963193|Irinotecan|irinotecan|mesh-list
82782556|NCT03963193|Etoposide|etoposide|mesh-list
82782557|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782558|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82782559|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82782560|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782561|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782562|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82782563|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82782564|NCT03961867|Docetaxel|docetaxel|mesh-list
82782565|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
82782566|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782567|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
82782568|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
82782569|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
82782570|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782571|NCT00077857|Docetaxel|docetaxel|mesh-list
82782572|NCT00077857|Capecitabine|capecitabine|mesh-list
82782573|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782574|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
82782575|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
82782576|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
82782577|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782578|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82782579|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
82782580|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
82782581|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82782582|NCT00545402|Tacrolimus|tacrolimus|mesh-list
82782583|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82782584|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
82782585|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782586|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82782587|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782588|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782589|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82782590|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782591|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82782592|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
82782593|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782594|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782595|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782596|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
82782597|NCT00545402|Hormones|hormones|mesh-ancestor
82782598|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782599|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82782600|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82782601|NCT00545402|Protective Agents|protective agents|mesh-ancestor
82782602|NCT03963115|Epinephrine|epinephrine|mesh-list
82782603|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82782604|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82782605|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
82782606|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782607|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782608|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782609|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82782610|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82782611|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
82782612|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782613|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82782614|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
82782615|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
82782616|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
82782617|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82782618|NCT01583023|Bupropion|bupropion|mesh-list
82782619|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82782620|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
82782621|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82782622|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82782623|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82782624|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782625|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782626|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
82782627|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782628|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782629|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82782630|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82782631|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782632|NCT00976976|Cisplatin|cisplatin|mesh-list
82782633|NCT00976976|Docetaxel|docetaxel|mesh-list
82782634|NCT00976976|Capecitabine|capecitabine|mesh-list
82782635|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782636|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
82782637|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
82782638|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
82782639|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782640|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82782641|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
82782642|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82782643|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
82782644|NCT00977054|Ribavirin|ribavirin|mesh-list
82782645|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
82782646|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82782647|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
82782648|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782649|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
82782650|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782651|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
82782652|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782653|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782654|NCT00977132|Lenalidomide|lenalidomide|mesh-list
82782655|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
82782656|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782657|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82782658|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82782659|NCT00977132|Growth Substances|growth substances|mesh-ancestor
82782660|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
82782661|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782662|NCT00545792|Bevacizumab|bevacizumab|mesh-list
82782663|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782664|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782665|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82782666|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82782667|NCT00545792|Growth Substances|growth substances|mesh-ancestor
82782668|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782669|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
82782670|NCT00977288|Atorvastatin|atorvastatin|mesh-list
82782671|NCT00977288|Anacetrapib|anacetrapib|mesh-list
82782672|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82782673|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82782674|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
82782675|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782676|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82782677|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82782678|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782679|NCT00966602|Ivacaftor|ivacaftor|mesh-list
82782680|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82782681|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782682|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782683|NCT00966680|Anesthetics|anesthetics|mesh-list
82782684|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82782685|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782686|NCT00977444|Prednisolone|prednisolone|mesh-list
82782687|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82782688|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
82782689|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82782690|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
82782691|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82782692|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
82782693|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782694|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
82782696|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782697|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782698|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82782699|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782700|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
82782701|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
82782702|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782703|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82782704|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82782705|NCT00977444|Protective Agents|protective agents|mesh-ancestor
82782706|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
82782707|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782708|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
82782709|NCT00966836|Valganciclovir|valganciclovir|mesh-list
82782710|NCT00966836|Everolimus|everolimus|mesh-list
82782711|NCT00966836|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82782712|NCT00966836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82782713|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782714|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782715|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82782716|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
82782717|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782718|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782719|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82782720|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82782721|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
82782722|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782723|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782724|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
82782725|NCT00967070|Nicotine|nicotine|mesh-list
82782726|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82782727|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
82782728|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782729|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782730|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82782731|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82782732|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
82782733|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782734|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782735|NCT00977756|Ritonavir|ritonavir|mesh-list
82782736|NCT00977756|Lopinavir|lopinavir|mesh-list
82782737|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82782738|NCT00977756|Darunavir|darunavir|mesh-list
82782739|NCT00977756|Tenofovir|tenofovir|mesh-list
82782740|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
82782741|NCT00977756|Maraviroc|maraviroc|mesh-list
82782742|NCT00977756|Etravirine|etravirine|mesh-list
82782743|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82782744|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82782745|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
82782746|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782747|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782748|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82782749|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82782750|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
82782751|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782752|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82782753|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82782754|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82782755|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782756|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82782757|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82782758|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82782759|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82782760|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82782761|NCT00967148|Tinzaparin|tinzaparin|mesh-list
82782762|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82782763|NCT00967148|Dalteparin|dalteparin|mesh-list
82782764|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
82782765|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82782766|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82782767|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782768|NCT04007588|Nivolumab|nivolumab|mesh-list
82782769|NCT04007588|Ipilimumab|ipilimumab|mesh-list
82782770|NCT04007588|Linrodostat|linrodostat|mesh-list
82782771|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782772|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782773|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82782774|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782775|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782776|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
82782777|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782778|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
82782779|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782780|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782781|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782782|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
82782783|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82782784|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782785|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82782786|NCT00967382|Dalteparin|dalteparin|mesh-list
82782787|NCT00967382|Tinzaparin|tinzaparin|mesh-list
82782788|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82782789|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
82782790|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82782791|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82782792|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782793|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
82782794|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82782795|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782797|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82782798|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782799|NCT00967538|Etanercept|etanercept|mesh-list
82782800|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82782801|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82782802|NCT00967538|Analgesics|analgesics|mesh-ancestor
82782803|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
82782804|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782805|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782806|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82782807|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782808|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82782809|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82782810|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
82782811|NCT00982358|Valsartan|valsartan|mesh-list
82782812|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82782813|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82782814|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82782815|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782816|NCT00982436|Carboplatin|carboplatin|mesh-list
82782817|NCT00982436|Docetaxel|docetaxel|mesh-list
82782818|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782819|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
82782820|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
82782821|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
82782822|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782823|NCT00545168|Permethrin|permethrin|mesh-list
82782824|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782825|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782826|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82782827|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82782828|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82782829|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
82782830|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782831|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82782832|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82782833|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782834|NCT00983138|Asparaginase|asparaginase|mesh-list
82782835|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782836|NCT00544544|Riluzole|riluzole|mesh-list
82782837|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
82782838|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82782839|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82782840|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782841|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782842|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782843|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82782844|NCT00544544|Protective Agents|protective agents|mesh-ancestor
82782845|NCT00979160|Dasatinib|dasatinib|mesh-list
82782846|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83440705|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82782847|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82782848|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782849|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782850|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
82782851|NCT00979316|BMS 708163|bms 708163|mesh-list
82782852|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782853|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782854|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82782855|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82782856|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782857|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782858|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782859|NCT00979316|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82782860|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82782861|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
82782862|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
82782863|NCT00983450|Hormones|hormones|mesh-ancestor
82782864|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782865|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782866|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361893|NCT01587001|Expectorants|expectorants|mesh-ancestor
82782867|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782868|NCT00983996|Alendronate|alendronate|mesh-list
82782869|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82782870|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782871|NCT00985244|Azithromycin|azithromycin|mesh-list
82782872|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82782873|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782874|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
82782875|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82782876|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82782877|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
82782878|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782879|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782880|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782881|NCT00979472|Urological Agents|urological agents|mesh-ancestor
82782882|NCT00984152|Efavirenz|efavirenz|mesh-list
82782883|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82782884|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
82782885|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82782886|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82782887|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782888|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782889|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
82782890|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782891|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82782892|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82782893|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82782894|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82782895|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82782896|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82782897|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82782898|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82782899|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82782900|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82782901|NCT00985322|Ramipril|ramipril|mesh-list
82782902|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
82782903|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82782904|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
82782905|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782906|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782907|NCT00984230|Lactoferrin|lactoferrin|mesh-list
82782908|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82782909|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82782910|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82782911|NCT00984386|Estradiol|estradiol|mesh-list
82782912|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82782913|NCT00984386|Estrogens|estrogens|mesh-ancestor
82782914|NCT00984386|Hormones|hormones|mesh-ancestor
82782915|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82782916|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782917|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82782918|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
82782919|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82782920|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82782921|NCT00984464|Paclitaxel|paclitaxel|mesh-list
82782922|NCT00984464|Carboplatin|carboplatin|mesh-list
82782923|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82782924|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782925|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
82782926|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
82782927|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
82782928|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782929|NCT00985556|Capecitabine|capecitabine|mesh-list
82782930|NCT00985556|Tegafur|tegafur|mesh-list
82782931|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
82782932|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82782933|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
82782934|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782935|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782936|NCT05537402|Bevacizumab|bevacizumab|mesh-list
82782937|NCT05537402|Atezolizumab|atezolizumab|mesh-list
82782938|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782939|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782940|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82782941|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82782943|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782944|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
82782945|NCT05537402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82782946|NCT05537402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782947|NCT04445246|Iloprost|iloprost|mesh-list
82782948|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82782949|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
82782950|NCT00541346|Methylphenidate|methylphenidate|mesh-list
82782951|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82782952|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782953|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82782954|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82782955|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82782956|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782957|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
82782958|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82782959|NCT00988520|Bromides|bromides|mesh-list
82782960|NCT00988520|Propofol|propofol|mesh-list
82782961|NCT00988520|Sevoflurane|sevoflurane|mesh-list
82782962|NCT00988520|Rocuronium|rocuronium|mesh-list
82782963|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82782964|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82782965|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782966|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82782967|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
82782968|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
82782969|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82782970|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82782971|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
82782972|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82782973|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82782974|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82782975|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82782976|NCT05498090|Fenofibrate|fenofibrate|mesh-list
82782977|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82782978|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
82782979|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782980|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82782981|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
82782982|NCT00077623|Hematinics|hematinics|mesh-ancestor
82782983|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
82782984|NCT00541034|Rituximab|rituximab|mesh-list
82782985|NCT00541034|Pentostatin|pentostatin|mesh-list
82782986|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83440710|NCT03085628|Oxytocin|oxytocin|mesh-list
82782987|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
82782988|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82782989|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82782990|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82782991|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
82782992|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82782993|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82782994|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82782995|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82782996|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82782997|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82782998|NCT00540644|Prednisone|prednisone|mesh-list
82782999|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
82783000|NCT00540644|Lenalidomide|lenalidomide|mesh-list
82783001|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783002|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
82783003|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783004|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783005|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783006|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
82783007|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783008|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783009|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82783010|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783011|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
82783012|NCT00540644|Hormones|hormones|mesh-ancestor
82783013|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783014|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82783015|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82783016|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82783017|NCT00540644|Growth Substances|growth substances|mesh-ancestor
82783018|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
82783019|NCT05470400|Vaccines|vaccines|mesh-list
82783020|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
82783021|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783022|NCT05450900|Biotin|biotin|mesh-list
82783023|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82783024|NCT05450900|Vitamins|vitamins|mesh-ancestor
82783025|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
82783026|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783027|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
82783028|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82783029|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
82783030|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
82783031|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82783032|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82783033|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783034|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82783035|NCT00986336|Topiramate|topiramate|mesh-list
82783036|NCT00986336|Risperidone|risperidone|mesh-list
82783037|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82783038|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
82783039|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783040|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783041|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783042|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82783043|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82783044|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783045|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82783046|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82783047|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
82783048|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
82783049|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82783050|NCT00989300|Omeprazole|omeprazole|mesh-list
82783051|NCT00989300|Rabeprazole|rabeprazole|mesh-list
82783052|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82783053|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82783054|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82783055|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783056|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783057|NCT01563614|Cytarabine|cytarabine|mesh-list
82783058|NCT01563614|Lomustine|lomustine|mesh-list
82783059|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83440714|NCT01276613|Gemcitabine|gemcitabine|mesh-list
82783060|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
82783061|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783062|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783063|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
82783064|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783065|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783066|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
82783067|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783068|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783069|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
82783070|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82783071|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783072|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
82783073|NCT00543296|Hormones|hormones|mesh-ancestor
82783074|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783075|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783076|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
82783077|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
82783078|NCT00543062|Loxapine|loxapine|mesh-list
82783079|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783080|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783081|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82783082|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82783083|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783084|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783085|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783086|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783087|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
82783088|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
82783089|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783090|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82783091|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82783092|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82783093|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783094|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82783095|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82783096|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
82783097|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783098|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82783099|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82783100|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783101|NCT00986804|Decitabine|decitabine|mesh-list
82783102|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82783103|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
82783104|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783105|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783106|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783107|NCT00676091|Vaccines|vaccines|mesh-list
82783108|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82783109|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
82783110|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783111|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82783112|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
82783113|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783114|NCT02558933|Protective Agents|protective agents|mesh-ancestor
82783115|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783116|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82783117|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82783118|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783119|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82783120|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
82783121|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82783122|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783123|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783124|NCT03903822|PF-06700841|pf-06700841|mesh-list
82783125|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82783126|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783127|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783128|NCT04003350|Acetaminophen|acetaminophen|mesh-list
82783129|NCT04003350|Meloxicam|meloxicam|mesh-list
82783130|NCT04003350|Oxycodone|oxycodone|mesh-list
82783131|NCT04003350|Tramadol|tramadol|mesh-list
82783132|NCT04003350|Gabapentin|gabapentin|mesh-list
82783133|NCT04003350|Esomeprazole|esomeprazole|mesh-list
82783134|NCT04003350|Metaxalone|metaxalone|mesh-list
82783135|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82783136|NCT04003350|Narcotics|narcotics|mesh-ancestor
82783137|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783138|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783139|NCT04003350|Analgesics|analgesics|mesh-ancestor
82783140|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
82783141|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783142|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
82783143|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82783144|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82783145|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82783146|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82783147|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82783148|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783149|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783150|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
82783151|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82783152|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82783153|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82783154|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783155|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82783156|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
82783157|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82783158|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783159|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783160|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82783161|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82783162|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82783163|NCT00748007|Rivastigmine|rivastigmine|mesh-list
82783164|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
82783165|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783166|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783167|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
82783168|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783169|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783170|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82783171|NCT00748007|Protective Agents|protective agents|mesh-ancestor
82783172|NCT00748163|Paclitaxel|paclitaxel|mesh-list
82783173|NCT00748163|Sunitinib|sunitinib|mesh-list
82783174|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82783175|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82783176|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783177|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
82783178|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
82783179|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
82783180|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783181|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82783182|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82783183|NCT00748163|Growth Substances|growth substances|mesh-ancestor
82783184|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783185|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
82783186|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82783187|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783188|NCT00687401|Infliximab|infliximab|mesh-list
82783189|NCT00687401|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82783190|NCT00687401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783191|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783192|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82783193|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783194|NCT00485693|Epinephrine|epinephrine|mesh-list
82783195|NCT00485693|Bupivacaine|bupivacaine|mesh-list
82783196|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
82783197|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
82783198|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783199|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783200|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
82783201|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783202|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82783203|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82783204|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
82783205|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783206|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783207|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82783208|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82783209|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
82783210|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82783211|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
82783212|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
82783213|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
82783214|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82783215|NCT00538902|Adalimumab|adalimumab|mesh-list
82783216|NCT00538902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82783217|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783218|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783219|NCT00541970|Vaccines|vaccines|mesh-list
82783220|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
82783221|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783222|NCT00687323|Temozolomide|temozolomide|mesh-list
82783223|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783224|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
82783225|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783226|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783227|NCT00989742|Doxycycline|doxycycline|mesh-list
82783228|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783229|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783230|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
82783231|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82783232|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82783233|NCT05408208|Triamcinolone|triamcinolone|mesh-list
82783234|NCT05408208|Methotrexate|methotrexate|mesh-list
82783235|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82783236|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
82783237|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82783238|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783239|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82783240|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
82783241|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361894|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
82783242|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783243|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783244|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783245|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82783246|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783247|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
82783248|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783249|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82783250|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783251|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
82783252|NCT05408208|Hormones|hormones|mesh-ancestor
82783253|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783254|NCT00758693|Rituximab|rituximab|mesh-list
82783255|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82783256|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783257|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783258|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
82783259|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783260|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783261|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783262|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
82783263|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783264|NCT00989820|Coal Tar|coal tar|mesh-list
82783265|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
82783266|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783267|NCT05357820|Itraconazole|itraconazole|mesh-list
82783268|NCT05357820|Rifampin|rifampin|mesh-list
82783269|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
82783270|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783271|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82783272|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82783273|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783274|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783275|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82783276|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
83440721|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82783277|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783278|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783279|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82783280|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82783281|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
82783282|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783283|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
82783284|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82783285|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82783286|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82783287|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82783288|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82783289|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82783290|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82783292|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
82783293|NCT00748787|Cathartics|cathartics|mesh-ancestor
82783294|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82783295|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
82783296|NCT05712044|Folic Acid|folic acid|mesh-list
82783297|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
82783298|NCT05712044|Hematinics|hematinics|mesh-ancestor
82783299|NCT05712044|Vitamins|vitamins|mesh-ancestor
82783300|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
82783301|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783302|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82783303|NCT00986960|Hormones|hormones|mesh-ancestor
82783304|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783305|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783306|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82783307|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
82783308|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
82783309|NCT00759005|Propranolol|propranolol|mesh-list
82783310|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82783311|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82783312|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
82783313|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783314|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783315|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783316|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82783317|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82783318|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
82783319|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783320|NCT04360070|Ketamine|ketamine|mesh-list
82783321|NCT04360070|Analgesics|analgesics|mesh-ancestor
82783322|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
82783323|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783324|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783325|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82783326|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82783327|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
82783328|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
82783329|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783330|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82783331|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82783332|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783333|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783334|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
82783335|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
82783336|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
82783337|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783338|NCT00749021|Ranibizumab|ranibizumab|mesh-list
82783339|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82783340|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82783341|NCT00749021|Growth Substances|growth substances|mesh-ancestor
82783342|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783343|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
82783344|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783345|NCT04048889|Ropivacaine|ropivacaine|mesh-list
82783346|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82783347|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
82783348|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
82783349|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783350|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783351|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
82783352|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783353|NCT00987038|Midazolam|midazolam|mesh-list
82783354|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82783355|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82783356|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783357|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783358|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82783359|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82783360|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82783361|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82783362|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
82783363|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
82783364|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
82783365|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
82783366|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783367|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783368|NCT05711810|Ubiquinone|ubiquinone|mesh-list
82783369|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
82783370|NCT05711810|Tocopherols|tocopherols|mesh-list
82783371|NCT05711810|Vitamin E|vitamin e|mesh-list
82783372|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
82783373|NCT05711810|Metoprolol|metoprolol|mesh-list
82783374|NCT05711810|Enalapril|enalapril|mesh-list
82783375|NCT05711810|Enalaprilat|enalaprilat|mesh-list
82783376|NCT05711810|Nifedipine|nifedipine|mesh-list
82783377|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82783378|NCT05711810|Lansoprazole|lansoprazole|mesh-list
82783379|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
82783380|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82783381|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82783382|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82783383|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783384|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783385|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783386|NCT05711810|Analgesics|analgesics|mesh-ancestor
82783387|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
82783388|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783389|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
83361895|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82783390|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82783391|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
82783392|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783393|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82783394|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82783395|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
82783396|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
82783397|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82783398|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82783399|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82783400|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
82783401|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82783402|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82783403|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82783404|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82783405|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82783406|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
82783407|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
82783408|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82783409|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82783410|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
82783411|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
82783412|NCT05711810|Vitamins|vitamins|mesh-ancestor
82783413|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
82783414|NCT05711810|Protective Agents|protective agents|mesh-ancestor
82783415|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82783416|NCT00759083|Bivalirudin|bivalirudin|mesh-list
82783417|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
82783418|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82783419|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
82783420|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783421|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783422|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
82783423|NCT00759239|Timolol|timolol|mesh-list
82783424|NCT00759239|Travoprost|travoprost|mesh-list
82783425|NCT00759239|Maleic acid|maleic acid|mesh-list
82783426|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783427|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783428|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82783429|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82783430|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
82783431|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783432|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783433|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82783434|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82783435|NCT03742908|Clindamycin|clindamycin|mesh-list
82783436|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
82783437|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
82783438|NCT03742908|Cefazolin|cefazolin|mesh-list
82783439|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783440|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783441|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82783442|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783443|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783444|NCT05357196|Gemcitabine|gemcitabine|mesh-list
82783445|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82783446|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
82783447|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783448|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783449|NCT05232630|Fenfluramine|fenfluramine|mesh-list
82783450|NCT05232630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82783451|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82783452|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82783453|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783454|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783455|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
82783456|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783457|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
82783458|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
82783459|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783460|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783461|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783462|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
82783463|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
82783464|NCT01004874|Bevacizumab|bevacizumab|mesh-list
82783465|NCT01004874|Temozolomide|temozolomide|mesh-list
83361896|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
82783466|NCT01004874|Topotecan|topotecan|mesh-list
82783467|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783468|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783469|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82783470|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82783471|NCT01004874|Growth Substances|growth substances|mesh-ancestor
82783472|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783473|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
82783474|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783475|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
82783476|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783477|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82783478|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82783479|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783480|NCT00987116|Prednisone|prednisone|mesh-list
82783481|NCT00987116|Azathioprine|azathioprine|mesh-list
82783482|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783483|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
82783484|NCT00987116|Hormones|hormones|mesh-ancestor
82783485|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783486|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783487|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82783488|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783489|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
82783490|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783491|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82783492|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783493|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
82783494|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783495|NCT05711732|Busulfan|busulfan|mesh-list
82783496|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
82783497|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783498|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783499|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
82783500|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783501|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783502|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783503|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82783504|NCT04004702|Levetiracetam|levetiracetam|mesh-list
82783505|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
82783506|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
82783507|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
82783508|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
82783509|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82783510|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
82783511|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783512|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783513|NCT04731974|Melatonin|melatonin|mesh-list
82783514|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
82783515|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783516|NCT04731974|Protective Agents|protective agents|mesh-ancestor
82783517|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783518|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783519|NCT00987662|Amlodipine|amlodipine|mesh-list
82783520|NCT00987662|Irbesartan|irbesartan|mesh-list
82783521|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82783522|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82783523|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82783524|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783525|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82783526|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783527|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
82783528|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82783529|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82783530|NCT04430426|Glycolic acid|glycolic acid|mesh-list
82783531|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
82783532|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783533|NCT00090103|Tamsulosin|tamsulosin|mesh-list
82783534|NCT00090103|Dutasteride|dutasteride|mesh-list
82783535|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82783536|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82783537|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82783538|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
82783539|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783540|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783541|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783542|NCT00090103|Urological Agents|urological agents|mesh-ancestor
82783543|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82783544|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82783545|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783546|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
82783547|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783548|NCT01088659|Tenofovir|tenofovir|mesh-list
82783549|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82783550|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
82783551|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783552|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82783553|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82783554|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783555|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783556|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82783557|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82783558|NCT00087607|Ribavirin|ribavirin|mesh-list
82783559|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82783560|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82783561|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
82783562|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783563|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
82783564|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783565|NCT01088737|Imiquimod|imiquimod|mesh-list
82783566|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82783567|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
82783568|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783569|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783570|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
82783571|NCT00069823|Esomeprazole|esomeprazole|mesh-list
82783572|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82783573|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82783574|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82783575|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783576|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783577|NCT01088815|Paclitaxel|paclitaxel|mesh-list
82783578|NCT01088815|Gemcitabine|gemcitabine|mesh-list
82783579|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82783580|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783581|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
82783582|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
82783583|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
82783584|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783585|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82783586|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
82783587|NCT00086515|Metformin|metformin|mesh-list
82783588|NCT00086515|Pioglitazone|pioglitazone|mesh-list
82783589|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82783590|NCT00086515|Glipizide|glipizide|mesh-list
82783591|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82783592|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783593|NCT00086515|Incretins|incretins|mesh-ancestor
82783594|NCT00086515|Hormones|hormones|mesh-ancestor
82783595|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783596|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82783597|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
82783598|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783599|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783600|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
82783601|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
82783602|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82783603|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82783604|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783605|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82783606|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783607|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82783608|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82783609|NCT04378868|Metronidazole|metronidazole|mesh-list
82783610|NCT04378868|Cefuroxime|cefuroxime|mesh-list
82783611|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
82783612|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82783613|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83440742|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783614|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
83361897|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783615|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82783616|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82783617|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82783618|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783619|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783620|NCT04334174|Immunotoxins|immunotoxins|mesh-ancestor
82783621|NCT04334174|Immunoconjugates|immunoconjugates|mesh-ancestor
82783622|NCT04334174|Immunologic Factors|immunologic factors|mesh-ancestor
82783623|NCT04334174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783624|NCT04333706|Capecitabine|capecitabine|mesh-list
82783625|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82783626|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
82783627|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783628|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783629|NCT00987974|Atorvastatin|atorvastatin|mesh-list
82783630|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82783631|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82783632|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82783633|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
82783634|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783635|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82783636|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82783637|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783638|NCT03519074|Cisplatin|cisplatin|mesh-list
82783639|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783640|NCT03767582|Nivolumab|nivolumab|mesh-list
82783641|NCT03767582|Vaccines|vaccines|mesh-list
82783642|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
82783643|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783644|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783645|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783646|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82783647|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783648|NCT03905642|Amikacin|amikacin|mesh-list
82783649|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783650|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783651|NCT04126538|Pirfenidone|pirfenidone|mesh-list
82783652|NCT04126538|Analgesics|analgesics|mesh-ancestor
82783653|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
82783654|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783655|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783656|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82783657|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82783658|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783659|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783660|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783661|NCT04004234|Manganese|manganese|mesh-list
82783662|NCT04004234|Paclitaxel|paclitaxel|mesh-list
82783663|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82783664|NCT04004234|Gemcitabine|gemcitabine|mesh-list
82783665|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82783666|NCT04004234|Antibodies|antibodies|mesh-list
82783667|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
82783668|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82783669|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783670|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
82783671|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
82783672|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
82783673|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783674|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
82783675|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783676|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82783677|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
82783678|NCT04004234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783679|NCT04004234|Trace Elements|trace elements|mesh-ancestor
82783680|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
82783681|NCT00990158|Vitamin K|vitamin k|mesh-list
82783682|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
82783683|NCT00990158|Vitamins|vitamins|mesh-ancestor
82783684|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
82783685|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783686|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82783687|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82783688|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783689|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
82783690|NCT00990158|Coagulants|coagulants|mesh-ancestor
82783691|NCT00412984|Warfarin|warfarin|mesh-list
82783692|NCT00412984|Apixaban|apixaban|mesh-list
82783693|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
82783694|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82783695|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
82783696|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82783697|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
82783698|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783699|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783700|NCT03471182|Cocaine|cocaine|mesh-list
82783701|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
82783702|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
82783703|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783704|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783705|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
82783706|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783707|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82783708|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82783709|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82783710|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82783711|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783712|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
82783713|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783714|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
82783715|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
82783716|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
82783717|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783718|NCT00539864|Coagulants|coagulants|mesh-ancestor
82783719|NCT04003376|Vitamin D|vitamin d|mesh-list
82783720|NCT04003376|Triamcinolone|triamcinolone|mesh-list
82783721|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82783722|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82783723|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82783724|NCT04003376|Vitamins|vitamins|mesh-ancestor
82783725|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
82783726|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783727|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82783728|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783729|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
82783730|NCT04003376|Hormones|hormones|mesh-ancestor
83482522|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82783731|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783732|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783734|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783735|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783736|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82783737|NCT04086212|Icodextrin|icodextrin|mesh-list
82783738|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
82783739|NCT05404490|Bupivacaine|bupivacaine|mesh-list
82783740|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
82783741|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
82783742|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783743|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783744|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
82783745|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783746|NCT05359874|Bevacizumab|bevacizumab|mesh-list
82783747|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783748|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783749|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82783750|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82783751|NCT05359874|Growth Substances|growth substances|mesh-ancestor
82783752|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783753|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
82783754|NCT00990392|Polymyxins|polymyxins|mesh-list
82783755|NCT00990392|Bacitracin|bacitracin|mesh-list
82783756|NCT00990392|Polymyxin B|polymyxin b|mesh-list
82783757|NCT00990392|Gramicidin|gramicidin|mesh-list
82783758|NCT00990392|Petrolatum|petrolatum|mesh-list
82783759|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783760|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783761|NCT00990392|Emollients|emollients|mesh-ancestor
82783762|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783763|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82783764|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
82783765|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783766|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783767|NCT03367754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82783768|NCT03367754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783769|NCT03335072|Azithromycin|azithromycin|mesh-list
82783770|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783771|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783772|NCT01034956|Calcium|calcium|mesh-list
82783773|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
82783774|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82783775|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783776|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82783777|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
82783778|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
82783779|NCT01034956|Protective Agents|protective agents|mesh-ancestor
82783780|NCT01580878|Butenafine|butenafine|mesh-list
82783781|NCT01580878|Clotrimazole|clotrimazole|mesh-list
82783782|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
82783783|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783784|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82783785|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82783786|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82783787|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783788|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783789|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82783790|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
82783791|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82783792|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783793|NCT05589974|Verteporfin|verteporfin|mesh-list
82783794|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82783795|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783796|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
82783797|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
82783798|NCT05589896|Busulfan|busulfan|mesh-list
82783799|NCT05589896|Fludarabine|fludarabine|mesh-list
82783800|NCT05589896|Tacrolimus|tacrolimus|mesh-list
82783801|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783802|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
82783803|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783804|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783805|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783806|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
82783807|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783808|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783809|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82783810|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82783811|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783812|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82783813|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82783814|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
82783815|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783816|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783817|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82783818|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783819|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82783820|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783821|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783823|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
82783824|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82783825|NCT04003844|Antibodies|antibodies|mesh-list
82783826|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
82783827|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
82783828|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783829|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82783830|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82783831|NCT04003844|Analgesics|analgesics|mesh-ancestor
82783832|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
82783833|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783834|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783835|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783836|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82783837|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82783838|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783839|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82783840|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82783841|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783842|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
82783843|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
83361898|NCT01587001|Protective Agents|protective agents|mesh-ancestor
82783844|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82783845|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
82783846|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783847|NCT05589584|Expectorants|expectorants|mesh-ancestor
82783848|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
82783849|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82783850|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
82783851|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783852|NCT05589584|Protective Agents|protective agents|mesh-ancestor
82783853|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783854|NCT05589584|Antidotes|antidotes|mesh-ancestor
82783855|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82783856|NCT00412750|Telbivudine|telbivudine|mesh-list
82783857|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
82783858|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783859|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82783860|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783861|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783862|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
82783863|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82783864|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82783865|NCT05361278|Eusol|eusol|mesh-list
82783866|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82783867|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82783868|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783869|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
82783870|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783871|NCT00764855|Propofol|propofol|mesh-list
82783872|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82783873|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783874|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783875|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82783876|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
82783877|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
82783878|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82783879|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82783880|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82783881|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82783882|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783883|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783884|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783885|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82783886|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
82783887|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82783888|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82783889|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
82783890|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783891|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783892|NCT01041040|Immunotoxins|immunotoxins|mesh-ancestor
82783893|NCT01041040|Immunoconjugates|immunoconjugates|mesh-ancestor
82783894|NCT01041040|Immunologic Factors|immunologic factors|mesh-ancestor
82783895|NCT01041040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783896|NCT00765011|Cetuximab|cetuximab|mesh-list
82783897|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82783898|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783899|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
82783900|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82783901|NCT00765167|Triclosan|triclosan|mesh-list
82783902|NCT00765167|Fluorides|fluorides|mesh-list
82783903|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
82783904|NCT00765167|Protective Agents|protective agents|mesh-ancestor
82783905|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783906|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82783907|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783908|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
82783909|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783910|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82783911|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82783912|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
82783913|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783914|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82783915|NCT00759551|Olmesartan|olmesartan|mesh-list
82783916|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82783917|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82783918|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82783919|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82783920|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783921|NCT03905096|Donepezil|donepezil|mesh-list
82783922|NCT03905096|BI 425809|bi 425809|mesh-list
82783923|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82783924|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783925|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783926|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
82783927|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783928|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783929|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
82783930|NCT00412360|Cyclosporine|cyclosporine|mesh-list
82783931|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
82783932|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
82783933|NCT00412360|Fludarabine|fludarabine|mesh-list
82783934|NCT00412360|Cyclosporins|cyclosporins|mesh-list
82783935|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783936|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
82783937|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783938|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783939|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82783940|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
82783941|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783942|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783943|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82783944|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783945|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
82783946|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82783947|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
82783948|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82783949|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82783950|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82783951|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
82783952|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82783953|NCT00761501|Naproxen|naproxen|mesh-list
82783954|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82783955|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82783956|NCT00761501|Analgesics|analgesics|mesh-ancestor
82783957|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
82783958|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783959|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783960|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783961|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82783962|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
82783963|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82783964|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783965|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783967|NCT01088893|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82783968|NCT01088893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82783969|NCT01088893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783970|NCT01088893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783971|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82783972|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
82783973|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783974|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783975|NCT03026036|Raclopride|raclopride|mesh-list
82783976|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82783977|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82783978|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82783979|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783980|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82783981|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82783982|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
82783983|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82783984|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783985|NCT00990860|Doxorubicin|doxorubicin|mesh-list
82783986|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82783987|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82783988|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82783989|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82783990|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82783991|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82783992|NCT01035190|Budesonide|budesonide|mesh-list
82783993|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82783994|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82783996|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82783997|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82783998|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82783999|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
82784000|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
82784001|NCT01035190|Hormones|hormones|mesh-ancestor
82784002|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784003|NCT00571103|Acamprosate|acamprosate|mesh-list
82784004|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82784005|NCT00084799|Antibodies|antibodies|mesh-list
82784006|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82784007|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
82784008|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784009|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82784010|NCT00765557|Laxatives|laxatives|mesh-ancestor
82784011|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784012|NCT01086553|Budesonide|budesonide|mesh-list
82784013|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784014|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82784015|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
82784016|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784017|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784018|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82784019|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
82784020|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
82784021|NCT01086553|Hormones|hormones|mesh-ancestor
82784022|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784023|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
82784024|NCT04049513|Fludarabine|fludarabine|mesh-list
82784025|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784026|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
82784027|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784028|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784029|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82784030|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
82784031|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784033|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82784034|NCT01041508|Cyclosporine|cyclosporine|mesh-list
82784035|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
82784036|NCT01041508|Clofarabine|clofarabine|mesh-list
82784037|NCT01041508|Cyclosporins|cyclosporins|mesh-list
82784038|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784039|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784040|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784041|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
82784042|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784043|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
82784044|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784045|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
82784046|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784047|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82784048|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82784049|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784050|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82784051|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
82784052|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82784053|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82784054|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
82784055|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82784056|NCT00766025|Calcium|calcium|mesh-list
82784057|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82784058|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784059|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82784060|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82784061|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
82784062|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784063|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82784064|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82784065|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784066|NCT00766181|Lidocaine|lidocaine|mesh-list
82784067|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
82784068|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
82784069|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784070|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784071|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
82784072|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784073|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82784074|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82784075|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82784076|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784077|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784078|NCT04048577|Natalizumab|natalizumab|mesh-list
82784079|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
82784080|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784081|NCT00991250|Temozolomide|temozolomide|mesh-list
82784082|NCT00991250|Dacarbazine|dacarbazine|mesh-list
82784083|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82784084|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
82784085|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784086|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784087|NCT00418522|Insulin|insulin|mesh-list
82784088|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82784089|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
82784090|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82784091|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784092|NCT00760175|Vaccines|vaccines|mesh-list
82784093|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
82784094|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784095|NCT00766337|Sirolimus|sirolimus|mesh-list
82784096|NCT00766337|Temsirolimus|temsirolimus|mesh-list
82784097|NCT00766337|Ranibizumab|ranibizumab|mesh-list
82784098|NCT00766337|MTOR Inhibitors|mtor inhibitors|mesh-list
82784099|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82784100|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784101|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82784102|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784103|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
82784104|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784105|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
82784106|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784107|NCT00766337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82784108|NCT00766337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784109|NCT00766337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784110|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82784111|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82784112|NCT00766337|Growth Substances|growth substances|mesh-ancestor
82784113|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
82784114|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
82784115|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82784116|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82784117|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784118|NCT00991562|Immunotoxins|immunotoxins|mesh-ancestor
82784119|NCT00991562|Immunoconjugates|immunoconjugates|mesh-ancestor
82784120|NCT00991562|Immunologic Factors|immunologic factors|mesh-ancestor
82784121|NCT00991562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784122|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82784123|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
82784124|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
82784125|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
82784126|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784128|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82784129|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784130|NCT00762671|Analgesics|analgesics|mesh-ancestor
82784131|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
82784132|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784133|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784134|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784135|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784136|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82784137|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784138|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
82784139|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784140|NCT00762671|Protective Agents|protective agents|mesh-ancestor
82784141|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82784142|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784143|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82784144|NCT02558387|Nintedanib|nintedanib|mesh-list
82784145|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784146|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82784147|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784148|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784149|NCT00766805|Propranolol|propranolol|mesh-list
82784150|NCT00766805|Isosorbide|isosorbide|mesh-list
82784151|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82784152|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82784153|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82784154|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82784155|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784156|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784157|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784158|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784159|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82784160|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82784161|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
82784162|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82784163|NCT00766805|Diuretics|diuretics|mesh-ancestor
82784164|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
82784165|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82784166|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
82784167|NCT00762749|Promethazine|promethazine|mesh-list
82784168|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82784169|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82784170|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784171|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784172|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
82784173|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
82784174|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
82784175|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784176|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
82784177|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
82784178|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784179|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82784180|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
82784181|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
82784182|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784183|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784184|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82784185|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
82784186|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
82784187|NCT00403546|Ziprasidone|ziprasidone|mesh-list
82784188|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82784189|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
82784190|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784191|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784192|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784193|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82784194|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82784195|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784196|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82784197|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82784198|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
82784199|NCT00767117|Ritonavir|ritonavir|mesh-list
82784200|NCT00767117|Lopinavir|lopinavir|mesh-list
82784201|NCT00767117|Etravirine|etravirine|mesh-list
82784202|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82784203|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82784204|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
82784205|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784206|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784207|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82784208|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82784209|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
82784210|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784211|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82784212|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82784213|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82784214|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82784215|NCT00762983|Loratadine|loratadine|mesh-list
82784216|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
82784217|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
82784218|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83361899|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784219|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82784220|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82784221|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
82784222|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
82784223|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784224|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784225|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784226|NCT00403234|Buprenorphine|buprenorphine|mesh-list
82784227|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82784228|NCT00403234|Narcotics|narcotics|mesh-ancestor
82784229|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784230|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784231|NCT00403234|Analgesics|analgesics|mesh-ancestor
82784232|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
82784233|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784234|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82784235|NCT04049201|Midazolam|midazolam|mesh-list
82784236|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82784237|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82784238|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784239|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784240|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82784241|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82784242|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82784243|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82784244|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
82784245|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
82784246|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
82784247|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
82784248|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784249|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784250|NCT00767663|Dipyridamole|dipyridamole|mesh-list
82784251|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82784252|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784253|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784254|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82784255|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
82784257|NCT00402688|Ofloxacin|ofloxacin|mesh-list
82784258|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82784259|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784260|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82784261|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82784262|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82784263|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784264|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784265|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784266|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82784267|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82784268|NCT04049045|Empagliflozin|empagliflozin|mesh-list
82784269|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82784270|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784271|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82784272|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784273|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82784274|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82784275|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784276|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
82784277|NCT01035580|Curcumin|curcumin|mesh-list
82784278|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82784279|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784280|NCT01035580|Analgesics|analgesics|mesh-ancestor
82784281|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
82784282|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784283|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784284|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784285|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784286|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784287|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784288|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784289|NCT00671879|Carisoprodol|carisoprodol|mesh-list
82784290|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82784291|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784292|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82784293|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784294|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82784295|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
82784296|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784297|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82784298|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
82784299|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784300|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784301|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82784302|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82784303|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784304|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784305|NCT00767975|Rifampin|rifampin|mesh-list
82784306|NCT00767975|Isoniazid|isoniazid|mesh-list
82784307|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82784308|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
82784309|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82784310|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784311|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
82784312|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82784313|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784314|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784315|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82784316|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82784317|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82784318|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82784319|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82784320|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82784321|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82784322|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82784323|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
82784324|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82784325|NCT00768131|Paclitaxel|paclitaxel|mesh-list
82784326|NCT00768131|Carboplatin|carboplatin|mesh-list
82784327|NCT00768131|Cetuximab|cetuximab|mesh-list
82784328|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82784329|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784330|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
82784331|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
82784332|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
82784333|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784334|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82784335|NCT00401830|Lacosamide|lacosamide|mesh-list
82784336|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
82784337|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82784338|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82784339|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784340|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784341|NCT00768209|Topiramate|topiramate|mesh-list
82784342|NCT00768209|Phentermine|phentermine|mesh-list
82784343|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
82784344|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82784345|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784346|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82784347|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
82784348|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82784349|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
82784350|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
82784351|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784352|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784353|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784354|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784355|NCT02471144|Etanercept|etanercept|mesh-list
82784356|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82784357|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82784358|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784359|NCT02471144|Analgesics|analgesics|mesh-ancestor
82784360|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
82784361|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784362|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784363|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784364|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784365|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784366|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784367|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
82784368|NCT00401752|Esomeprazole|esomeprazole|mesh-list
82784369|NCT00401752|Ranitidine|ranitidine|mesh-list
82784370|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82784371|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82784372|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784373|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82784374|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784375|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784376|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82784377|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
82784378|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
82784379|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784380|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784381|NCT00770471|Temozolomide|temozolomide|mesh-list
82784382|NCT00770471|Veliparib|veliparib|mesh-list
82784383|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82784384|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
82784385|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784386|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784387|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82784388|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784389|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
82784390|NCT00539240|Nortriptyline|nortriptyline|mesh-list
82784391|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
82784392|NCT00539240|Rabeprazole|rabeprazole|mesh-list
82784393|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82784394|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784395|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82784396|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784397|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784398|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82784399|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82784400|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82784401|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784402|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784403|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784404|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784405|NCT00417976|Bevacizumab|bevacizumab|mesh-list
82784406|NCT00417976|Gemcitabine|gemcitabine|mesh-list
82784407|NCT00417976|Fluorouracil|fluorouracil|mesh-list
82784408|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82784409|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784410|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82784411|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82784412|NCT00417976|Growth Substances|growth substances|mesh-ancestor
82784413|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784414|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
82784415|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82784416|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
82784417|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784418|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784419|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
82784420|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
82784421|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82784422|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82784423|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784424|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784425|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784426|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784427|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82784428|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
82784429|NCT00991796|Paclitaxel|paclitaxel|mesh-list
82784430|NCT00991796|Carboplatin|carboplatin|mesh-list
82784431|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82784432|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784433|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
82784434|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
82784435|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
82784436|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784437|NCT00673673|Bevacizumab|bevacizumab|mesh-list
82784438|NCT00673673|Fluorouracil|fluorouracil|mesh-list
82784439|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82784440|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361900|NCT01587001|Antidotes|antidotes|mesh-ancestor
82784441|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82784442|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82784443|NCT00673673|Growth Substances|growth substances|mesh-ancestor
82784444|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784445|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
82784446|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
82784447|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784448|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82784449|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784450|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
82784451|NCT00763685|Etoricoxib|etoricoxib|mesh-list
82784452|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82784453|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784454|NCT00763685|Analgesics|analgesics|mesh-ancestor
82784455|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
82784456|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784457|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784458|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784459|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784460|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82784461|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82784462|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784463|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784464|NCT04048655|Neostigmine|neostigmine|mesh-list
82784465|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82784466|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784467|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784468|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
82784469|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784470|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784471|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82784472|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
82784473|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784474|NCT00768677|Topiramate|topiramate|mesh-list
82784475|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
82784476|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82784477|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784478|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
82784479|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82784480|NCT02557451|Growth Substances|growth substances|mesh-ancestor
82784481|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784482|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
82784483|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784484|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82784485|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784486|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82784487|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784489|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82784490|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784491|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
82784492|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
82784493|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
82784494|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784495|NCT00763763|Interferons|interferons|mesh-list
82784496|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82784497|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
82784498|NCT00763763|Dexamethasone|dexamethasone|mesh-list
82784499|NCT00763763|Vincristine|vincristine|mesh-list
82784500|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
82784501|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784502|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
82784503|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
82784504|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784505|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784506|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784507|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
82784508|NCT00763763|Hormones|hormones|mesh-ancestor
82784509|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784510|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82784511|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784512|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
82784513|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784514|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82784515|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
82784516|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
82784517|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
82784518|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784519|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82784520|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784521|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
82784522|NCT01037140|Vitamin D|vitamin d|mesh-list
82784523|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
82784524|NCT01037140|Vitamins|vitamins|mesh-ancestor
82784525|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
82784526|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784527|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82784528|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82784529|NCT05357456|Epinephrine|epinephrine|mesh-list
82784530|NCT05357456|Racepinephrine|racepinephrine|mesh-list
82784531|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
82784532|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82784533|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82784534|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784535|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784536|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784537|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784538|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82784539|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82784540|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
82784541|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784542|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82784543|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
82784544|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
82784545|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
82784546|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82784547|NCT00069121|Leucovorin|leucovorin|mesh-list
82784548|NCT00069121|Fluorouracil|fluorouracil|mesh-list
82784549|NCT00069121|Capecitabine|capecitabine|mesh-list
82784550|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
82784551|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
82784552|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784553|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82784554|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784555|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784556|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
82784557|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784558|NCT00069121|Antidotes|antidotes|mesh-ancestor
82784559|NCT00069121|Protective Agents|protective agents|mesh-ancestor
82784560|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
82784561|NCT00069121|Vitamins|vitamins|mesh-ancestor
82784562|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
82784563|NCT00768911|Temozolomide|temozolomide|mesh-list
82784564|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82784565|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
82784566|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784567|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784568|NCT00769145|Ranibizumab|ranibizumab|mesh-list
82784569|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82784570|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82784571|NCT00769145|Growth Substances|growth substances|mesh-ancestor
82784572|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784573|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
82784574|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784575|NCT00763997|Acetaminophen|acetaminophen|mesh-list
82784576|NCT00763997|Dipyrone|dipyrone|mesh-list
82784577|NCT00763997|Ibuprofen|ibuprofen|mesh-list
82784578|NCT00763997|Parecoxib|parecoxib|mesh-list
82784579|NCT00763997|Valdecoxib|valdecoxib|mesh-list
82784580|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784581|NCT00763997|Analgesics|analgesics|mesh-ancestor
82784582|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
82784583|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784584|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784585|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
82784586|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82784587|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784588|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784589|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82784590|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784591|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784592|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82784593|NCT00771251|Golimumab|golimumab|mesh-list
82784594|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82784595|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784596|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784597|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
82784598|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784599|NCT01420250|Bicalutamide|bicalutamide|mesh-list
82784600|NCT01420250|Hormones|hormones|mesh-list
82784601|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82784602|NCT01420250|Androgens|androgens|mesh-list
82784603|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
82784604|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784605|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784606|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
82784607|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784608|NCT00399568|Acetaminophen|acetaminophen|mesh-list
82784609|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784610|NCT00399568|Analgesics|analgesics|mesh-ancestor
82784611|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
82784612|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784613|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784614|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
82784615|NCT05088356|Plerixafor|plerixafor|mesh-list
82784616|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
82784617|NCT05088356|Melphalan|melphalan|mesh-list
82784618|NCT05088356|Fludarabine|fludarabine|mesh-list
82784619|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
82784620|NCT05088356|Tacrolimus|tacrolimus|mesh-list
82784621|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
82784622|NCT05088356|Lenograstim|lenograstim|mesh-list
82784623|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784624|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
82784625|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784626|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784627|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83482523|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
83440799|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
82784628|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784629|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784630|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82784631|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82784632|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
82784633|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
82784634|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784635|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82784636|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82784637|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784638|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82784639|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82784640|NCT01039558|Ecabet|ecabet|mesh-list
82784641|NCT01039558|Lansoprazole|lansoprazole|mesh-list
82784642|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
82784643|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82784644|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784645|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82784646|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784647|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784648|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784649|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
82784650|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82784651|NCT01039558|Protective Agents|protective agents|mesh-ancestor
82784652|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784653|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784654|NCT01324258|Gemcitabine|gemcitabine|mesh-list
82784655|NCT01324258|Trametinib|trametinib|mesh-list
82784656|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82784657|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
82784658|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784659|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784660|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82784661|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784662|NCT01415882|Dexamethasone|dexamethasone|mesh-list
82784663|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
82784664|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
82784665|NCT01415882|Daratumumab|daratumumab|mesh-list
82784666|NCT01415882|Ixazomib|ixazomib|mesh-list
82784667|NCT01415882|Ichthammol|ichthammol|mesh-list
82784668|NCT01415882|BB 1101|bb 1101|mesh-list
83361901|NCT01568047|Levodopa|levodopa|mesh-list
82784669|NCT01415882|Glycine|glycine|mesh-list
82784670|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784671|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
83361902|NCT01568047|Carbidopa|carbidopa|mesh-list
82784672|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784673|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784674|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82784675|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
82784676|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784677|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784678|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82784679|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784680|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
82784681|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
82784682|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784683|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82784684|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
82784685|NCT01415882|Hormones|hormones|mesh-ancestor
82784686|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784687|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82784688|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
82784689|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784690|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
82784691|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
82784692|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784693|NCT00068419|Tamoxifen|tamoxifen|mesh-list
82784694|NCT00068419|Sulindac|sulindac|mesh-list
82784695|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784696|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82784697|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
82784698|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784699|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784700|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82784701|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784702|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82784703|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82784704|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82784705|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82784706|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784708|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
82784709|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784710|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784711|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784712|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82784713|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784714|NCT02557373|Vitamins|vitamins|mesh-list
82784715|NCT02557373|Vitamin A|vitamin a|mesh-list
82784716|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
82784717|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
82784718|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784719|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
82784720|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784721|NCT02557373|Protective Agents|protective agents|mesh-ancestor
82784722|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82784723|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784724|NCT01757626|Molgramostim|molgramostim|mesh-list
82784725|NCT01757626|Sargramostim|sargramostim|mesh-list
82784726|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
82784727|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784728|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784729|NCT04048811|Propofol|propofol|mesh-list
82784730|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82784731|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784732|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784733|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82784734|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
82784735|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
82784736|NCT01086631|Rituximab|rituximab|mesh-list
82784737|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82784738|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784739|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
82784740|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784741|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784742|NCT00399490|Tanezumab|tanezumab|mesh-list
82784743|NCT00399490|Analgesics|analgesics|mesh-ancestor
82784744|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
82784745|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784746|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784747|NCT00398866|Triamcinolone|triamcinolone|mesh-list
82784748|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82784749|NCT00398866|Bupivacaine|bupivacaine|mesh-list
82784750|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
82784751|NCT00398866|Hylan|hylan|mesh-list
82784752|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
82784753|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
82784754|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784755|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784756|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
82784757|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784758|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784759|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
82784760|NCT00398866|Hormones|hormones|mesh-ancestor
82784761|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784762|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784763|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
82784764|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82784765|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
82784766|NCT00398866|Protective Agents|protective agents|mesh-ancestor
82784767|NCT00771563|Cisplatin|cisplatin|mesh-list
82784768|NCT00771563|Docetaxel|docetaxel|mesh-list
82784769|NCT00771563|Enoxaparin|enoxaparin|mesh-list
82784770|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784771|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
82784772|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
82784773|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
82784774|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784775|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
82784776|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82784777|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82784778|NCT00775073|Bevacizumab|bevacizumab|mesh-list
82784779|NCT00775073|Everolimus|everolimus|mesh-list
82784780|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82784781|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784782|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82784783|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82784784|NCT00775073|Growth Substances|growth substances|mesh-ancestor
82784785|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784786|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
82784787|NCT00775073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82784788|NCT00775073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82784789|NCT00775073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784790|NCT00775073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784791|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784792|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
82784793|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82784794|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82784795|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82784796|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784797|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784798|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784799|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784801|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
82784802|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784803|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
82784804|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82784805|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
82784806|NCT01589146|Heparin|heparin|mesh-list
82784807|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82784808|NCT01589146|Tinzaparin|tinzaparin|mesh-list
82784809|NCT01589146|Dalteparin|dalteparin|mesh-list
82784810|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
82784811|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82784812|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82784813|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784814|NCT00775151|Amlodipine|amlodipine|mesh-list
82784815|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82784816|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82784817|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784818|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784819|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82784820|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784821|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
82784822|NCT04694300|Acetaminophen|acetaminophen|mesh-list
82784823|NCT04694300|Naproxen|naproxen|mesh-list
82784824|NCT04694300|Tramadol|tramadol|mesh-list
82784825|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82784826|NCT04694300|Analgesics|analgesics|mesh-ancestor
82784827|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
82784828|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784829|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784830|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
82784831|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82784832|NCT04694300|Narcotics|narcotics|mesh-ancestor
82784833|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784834|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82784835|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784836|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784837|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
82784838|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82784839|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784840|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784841|NCT04642820|Methamphetamine|methamphetamine|mesh-list
82784842|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82784843|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784844|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
82784845|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
82784846|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784847|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
82784848|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784849|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784850|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784851|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82784852|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82784853|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784854|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82784856|NCT00771641|Trace Elements|trace elements|mesh-ancestor
82784857|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
82784858|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784859|NCT05408000|Propofol|propofol|mesh-list
82784860|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82784861|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784862|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784863|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82784864|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
82784865|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
82784866|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
82784867|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82784868|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82784869|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82784870|NCT00673361|Temozolomide|temozolomide|mesh-list
82784871|NCT00673361|Sorafenib|sorafenib|mesh-list
82784872|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82784873|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
82784874|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784875|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784876|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82784877|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784878|NCT00393718|Liraglutide|liraglutide|mesh-list
82784879|NCT00393718|Glyburide|glyburide|mesh-list
82784880|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82784881|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784882|NCT00393718|Incretins|incretins|mesh-ancestor
82784883|NCT00393718|Hormones|hormones|mesh-ancestor
82784884|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784885|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82784886|NCT00669071|Tretinoin|tretinoin|mesh-list
82784887|NCT00669071|Hydroquinone|hydroquinone|mesh-list
82784888|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784889|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
82784890|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
82784891|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82784892|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
82784893|NCT00669071|Hormones|hormones|mesh-ancestor
82784894|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82784895|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784896|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
82784897|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784898|NCT00669071|Protective Agents|protective agents|mesh-ancestor
82784899|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82784900|NCT00398320|Bevacizumab|bevacizumab|mesh-list
82784901|NCT00398320|Capecitabine|capecitabine|mesh-list
82784902|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
82784903|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82784904|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784905|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82784906|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82784907|NCT00398320|Growth Substances|growth substances|mesh-ancestor
82784908|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784909|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
82784910|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82784911|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
82784912|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784913|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
82784914|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82784915|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784916|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784917|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82784918|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82784919|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
82784920|NCT04003688|Analgesics|analgesics|mesh-ancestor
82784921|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
82784922|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784923|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784924|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
82784925|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784926|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82784927|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
82784928|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82784929|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784930|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784931|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82784932|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
82784933|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82784934|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
82784935|NCT00779129|Doxorubicin|doxorubicin|mesh-list
82784936|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82784937|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
82784938|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784939|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82784940|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82784941|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
82784942|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784943|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82784944|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82784945|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82784946|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82784947|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82784948|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82784949|NCT00772187|Fentanyl|fentanyl|mesh-list
82784950|NCT00772187|Morphine|morphine|mesh-list
82784951|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
82784952|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784953|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784954|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82784955|NCT00772187|Narcotics|narcotics|mesh-ancestor
82784956|NCT00772187|Analgesics|analgesics|mesh-ancestor
82784957|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
82784958|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82784959|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82784960|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82784961|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
82784962|NCT00772265|Insulin|insulin|mesh-list
82784963|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
82784964|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82784965|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784966|NCT00779441|Zolpidem|zolpidem|mesh-list
82784967|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82784968|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82784969|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82784970|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784971|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82784972|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
82784973|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
82784974|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784975|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784976|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
82784977|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82784978|NCT02556437|Antibodies|antibodies|mesh-list
82784979|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
82784980|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784981|NCT04946006|Oxytocin|oxytocin|mesh-list
82784982|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
82784983|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82784984|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784985|NCT00775619|Carvedilol|carvedilol|mesh-list
82784986|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82784987|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82784988|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
82784989|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82784990|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82784991|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82784992|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82784993|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
82784994|NCT00775619|Protective Agents|protective agents|mesh-ancestor
82784995|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82784996|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82784997|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82784998|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
82784999|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82785000|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82785001|NCT00775697|Montelukast|montelukast|mesh-list
82785002|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
82785003|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82785004|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
82785005|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
83482524|NCT00538616|Propofol|propofol|mesh-list
82785006|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82785007|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785008|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82785009|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82785010|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785011|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
82785012|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82785013|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
82785014|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
82785015|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785016|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785017|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82785018|NCT05357066|Analgesics|analgesics|mesh-ancestor
82785019|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
82785020|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785021|NCT02556905|Dexamethasone|dexamethasone|mesh-list
82785022|NCT02556905|Lenalidomide|lenalidomide|mesh-list
82785023|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785024|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
82785025|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
82785026|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785027|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785028|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785029|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
82785030|NCT02556905|Hormones|hormones|mesh-ancestor
82785031|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82785032|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82785033|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785034|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
82785035|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82785036|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82785037|NCT02556905|Growth Substances|growth substances|mesh-ancestor
82785038|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
82785039|NCT00539006|Fluticasone|fluticasone|mesh-list
82785041|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785042|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83440830|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
82785043|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
82785044|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785045|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785046|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82785047|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
82785048|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
82785049|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82785050|NCT04047329|Anesthetics|anesthetics|mesh-list
82785051|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785052|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785053|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
82785054|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82785055|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82785056|NCT00537056|Sunitinib|sunitinib|mesh-list
82785057|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82785058|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785059|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82785060|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82785061|NCT00537056|Growth Substances|growth substances|mesh-ancestor
82785062|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785063|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
82785064|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82785065|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785066|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785067|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82785068|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
82785069|NCT00779831|Ephedrine|ephedrine|mesh-list
82785070|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82785071|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
82785072|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785073|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785074|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82785075|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
82785076|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
82785077|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82785078|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82785079|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
82785080|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
82785082|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785083|NCT00535262|Selegiline|selegiline|mesh-list
82785084|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
82785085|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82785086|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82785087|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82785088|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82785089|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785090|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785091|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82785092|NCT00535262|Protective Agents|protective agents|mesh-ancestor
82785093|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785094|NCT00772499|Atenolol|atenolol|mesh-list
82785095|NCT00772499|Amlodipine|amlodipine|mesh-list
82785096|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82785097|NCT00772499|Olmesartan|olmesartan|mesh-list
82785098|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82785099|NCT00772499|Hydralazine|hydralazine|mesh-list
82785100|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82785101|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82785102|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82785103|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785104|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82785105|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785106|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
82785107|NCT00772499|Diuretics|diuretics|mesh-ancestor
82785108|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
82785109|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82785110|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82785111|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82785112|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82785113|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
82785114|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
82785115|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785116|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82785117|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82785118|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82785119|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
82785120|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785121|NCT00989690|Docetaxel|docetaxel|mesh-list
82785122|NCT00989690|Pemetrexed|pemetrexed|mesh-list
82785123|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82785124|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785125|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
82785126|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
82785127|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
82785128|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785129|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785130|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82785131|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82785132|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82785133|NCT00074581|Ritonavir|ritonavir|mesh-list
82785134|NCT00074581|Lopinavir|lopinavir|mesh-list
82785135|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82785136|NCT00074581|Tenofovir|tenofovir|mesh-list
82785137|NCT00074581|Lamivudine|lamivudine|mesh-list
82785138|NCT00074581|Emtricitabine|emtricitabine|mesh-list
82785139|NCT00074581|Zidovudine|zidovudine|mesh-list
82785140|NCT00074581|Nevirapine|nevirapine|mesh-list
82785141|NCT00074581|Didanosine|didanosine|mesh-list
82785142|NCT00074581|Stavudine|stavudine|mesh-list
82785143|NCT00074581|Efavirenz|efavirenz|mesh-list
82785144|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82785145|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82785146|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
82785147|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785148|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785149|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82785150|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82785151|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
82785152|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785153|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82785154|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82785155|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82785156|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82785157|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
82785158|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82785159|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82785160|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82785161|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82785162|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82785163|NCT00776477|Aspirin|aspirin|mesh-list
82785164|NCT00776477|Clopidogrel|clopidogrel|mesh-list
82785165|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82785166|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82785167|NCT00776477|Analgesics|analgesics|mesh-ancestor
82785168|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
82785169|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785170|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785171|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785172|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785173|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82785174|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82785175|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785176|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82785177|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82785178|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785179|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
82785180|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82785181|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82785182|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82785183|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
82785184|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785185|NCT00772655|Rituximab|rituximab|mesh-list
82785186|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785187|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785188|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
82785189|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785190|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785191|NCT04272086|Bupivacaine|bupivacaine|mesh-list
82785192|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
82785193|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
82785194|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785195|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785196|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
82785197|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785198|NCT00776633|Aspirin|aspirin|mesh-list
82785199|NCT00776633|Clopidogrel|clopidogrel|mesh-list
82785200|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82785201|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82785202|NCT00776633|Analgesics|analgesics|mesh-ancestor
82785203|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
82785204|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785205|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785206|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785207|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785208|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82785209|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82785210|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785211|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82785212|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82785213|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785214|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
82785215|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82785216|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82785217|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82785218|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
82785219|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785220|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82785221|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82785222|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785223|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82785224|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82785225|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82785226|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785227|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
82785228|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785229|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
82785230|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785231|NCT03961087|Ubiquinone|ubiquinone|mesh-list
82785232|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
82785233|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
82785234|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
82785235|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785236|NCT03961087|Vitamins|vitamins|mesh-ancestor
82785237|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82785238|NCT03961087|Protective Agents|protective agents|mesh-ancestor
82785239|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
82785240|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
82785241|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82785242|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785243|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785244|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82785245|NCT03960775|Analgesics|analgesics|mesh-ancestor
82785246|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
82785247|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785248|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82785249|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82785250|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82785251|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
82785252|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785253|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785254|NCT00536978|Cytarabine|cytarabine|mesh-list
82785255|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
82785256|NCT00536978|Melphalan|melphalan|mesh-list
82785257|NCT00536978|Carmustine|carmustine|mesh-list
82785258|NCT00536978|Rituximab|rituximab|mesh-list
82785259|NCT00536978|Methotrexate|methotrexate|mesh-list
82785260|NCT00536978|Fludarabine|fludarabine|mesh-list
82785261|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
82785262|NCT00536978|Etoposide|etoposide|mesh-list
82785263|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
82785264|NCT00536978|Tacrolimus|tacrolimus|mesh-list
82785265|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82785266|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
82785267|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785268|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785269|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82785270|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
82785271|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785272|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785273|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82785274|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785275|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82785276|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
82785277|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82785278|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82785279|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
82785280|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
82785281|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785282|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82785283|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82785284|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
82785285|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785286|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82785287|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82785288|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82785289|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82785290|NCT03809611|Choline|choline|mesh-list
82785291|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
82785292|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82785293|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
82785294|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785295|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785296|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82785297|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
82785298|NCT05360342|Vitamins|vitamins|mesh-list
82785299|NCT05360342|Vitamin K|vitamin k|mesh-list
82785300|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
82785301|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
82785302|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785303|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82785304|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82785305|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785306|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
82785307|NCT05360342|Coagulants|coagulants|mesh-ancestor
82785309|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785310|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82785311|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785312|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785313|NCT04026230|Atorvastatin|atorvastatin|mesh-list
82785314|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82785315|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82785316|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
82785317|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785318|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82785319|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82785320|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785321|NCT00536510|Niacin|niacin|mesh-list
82785322|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82785323|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
82785324|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785325|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82785326|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
82785327|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
82785328|NCT00536510|Vitamins|vitamins|mesh-ancestor
82785329|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
82785330|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785331|NCT04424264|Tenofovir|tenofovir|mesh-list
82785332|NCT04424264|Lamivudine|lamivudine|mesh-list
82785333|NCT04424264|Emtricitabine|emtricitabine|mesh-list
82785334|NCT04424264|Efavirenz|efavirenz|mesh-list
82785335|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82785336|NCT04424264|Rifampin|rifampin|mesh-list
82785337|NCT04424264|Isoniazid|isoniazid|mesh-list
82785338|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
82785339|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785340|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82785341|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82785342|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785343|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785344|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82785345|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82785346|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82785347|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82785348|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82785349|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83361903|NCT01568047|Opicapone|opicapone|mesh-list
82785350|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82785351|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82785352|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82785353|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
82785354|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82785355|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
82785356|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82785357|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82785358|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82785359|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82785360|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82785361|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
82785362|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82785363|NCT03790670|Sargramostim|sargramostim|mesh-list
82785364|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
82785365|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785366|NCT00398086|Paclitaxel|paclitaxel|mesh-list
82785367|NCT00398086|Gemcitabine|gemcitabine|mesh-list
82785368|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82785369|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82785370|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785371|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
82785372|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
82785373|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
82785374|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785375|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82785376|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
82785377|NCT04364360|Sulforaphane|sulforaphane|mesh-list
82785378|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82785379|NCT04364360|Protective Agents|protective agents|mesh-ancestor
82785380|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785381|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785382|NCT00536198|Sertraline|sertraline|mesh-list
82785383|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
82785384|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82785385|NCT00536198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82785386|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82785387|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82785388|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785389|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785390|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
82785391|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785392|NCT00393484|Lamivudine|lamivudine|mesh-list
82785393|NCT00393484|Entecavir|entecavir|mesh-list
82785394|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82785395|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82785396|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785397|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785398|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
82785399|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785400|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82785401|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82785402|NCT00667823|Macitentan|macitentan|mesh-list
82785403|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82785404|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82785405|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785406|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82785407|NCT00536120|Natalizumab|natalizumab|mesh-list
82785408|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
82785409|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
82785410|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83440849|NCT01276925|Bupivacaine|bupivacaine|mesh-list
82785411|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82785412|NCT00057811|Leucovorin|leucovorin|mesh-list
82785413|NCT00057811|Cytarabine|cytarabine|mesh-list
82785414|NCT00057811|Prednisone|prednisone|mesh-list
82785415|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
82785416|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82785417|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82785418|NCT00057811|Prednisolone|prednisolone|mesh-list
82785419|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
82785420|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
82785421|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82785422|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82785423|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82785424|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
82785425|NCT00057811|Rituximab|rituximab|mesh-list
82785426|NCT00057811|Doxorubicin|doxorubicin|mesh-list
82785427|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82785428|NCT00057811|Methotrexate|methotrexate|mesh-list
82785429|NCT00057811|Etoposide|etoposide|mesh-list
82785430|NCT00057811|Vincristine|vincristine|mesh-list
82785431|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
82785432|NCT00057811|Rasburicase|rasburicase|mesh-list
82785433|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82785434|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
82785435|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
82785436|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82785437|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
82785438|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785439|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785440|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82785441|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
82785442|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785443|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785444|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82785445|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785446|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82785447|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82785448|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82785449|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785450|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785451|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
82785452|NCT00057811|Hormones|hormones|mesh-ancestor
82785453|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82785454|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82785455|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82785456|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
82785457|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82785458|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82785459|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
82785460|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
82785461|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82785462|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82785463|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82785464|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
82785465|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785466|NCT00057811|Antidotes|antidotes|mesh-ancestor
82785467|NCT00057811|Protective Agents|protective agents|mesh-ancestor
82785468|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
82785469|NCT00057811|Vitamins|vitamins|mesh-ancestor
82785470|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
82785471|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
82785472|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
82785473|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
82785474|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
82785475|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
82785476|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785477|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785478|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82785479|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
82785480|NCT03502148|Cisplatin|cisplatin|mesh-list
82785481|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785482|NCT02530801|Bevacizumab|bevacizumab|mesh-list
82785483|NCT02530801|Fluorouracil|fluorouracil|mesh-list
82785484|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785485|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785486|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82785487|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82785488|NCT02530801|Growth Substances|growth substances|mesh-ancestor
82785489|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785490|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
82785491|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
82785492|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785493|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82785494|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82785495|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
82785496|NCT01091077|Naringenin|naringenin|mesh-list
82785497|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82785498|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785499|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82785500|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
82785501|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82785502|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785503|NCT01094275|Omeprazole|omeprazole|mesh-list
82785504|NCT01094275|Clopidogrel|clopidogrel|mesh-list
82785505|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82785506|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82785507|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82785508|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82785509|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
82785510|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785511|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785512|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785513|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82785514|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785515|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82785516|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785517|NCT01089205|Metformin|metformin|mesh-list
82785518|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82785519|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785520|NCT02866682|Tacrolimus|tacrolimus|mesh-list
82785521|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82785522|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
82785523|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785524|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82785525|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785526|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785527|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
82785528|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82785529|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
82785530|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785531|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785532|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82785533|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
82785534|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82785535|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
82785536|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785537|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785538|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82785539|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
82785540|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
82785541|NCT01089439|Protective Agents|protective agents|mesh-ancestor
82785542|NCT00992030|Rituximab|rituximab|mesh-list
82785543|NCT00992030|Doxorubicin|doxorubicin|mesh-list
82785544|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82785545|NCT00992030|Dacarbazine|dacarbazine|mesh-list
82785546|NCT00992030|Bleomycin|bleomycin|mesh-list
82785547|NCT00992030|Vinblastine|vinblastine|mesh-list
82785548|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785549|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785550|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
82785551|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785552|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785553|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82785554|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82785555|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82785556|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785557|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785558|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82785559|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
82785560|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82785561|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
82785562|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
82785563|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
82785564|NCT01976390|Sirolimus|sirolimus|mesh-list
82785565|NCT01976390|Everolimus|everolimus|mesh-list
82785566|NCT01976390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82785567|NCT01976390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82785568|NCT01976390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785569|NCT01976390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785570|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82785571|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
82785572|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785573|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785574|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82785575|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785576|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82785577|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
82785578|NCT00570713|Gemcitabine|gemcitabine|mesh-list
82785579|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82785580|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
82785581|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785582|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785583|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
82785584|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82785585|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82785586|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82785587|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785588|NCT00780377|Bradykinin|bradykinin|mesh-list
82785589|NCT00780377|Kininogens|kininogens|mesh-list
82785590|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
82785591|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82785592|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
82785593|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785594|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785595|NCT05219942|Insulin|insulin|mesh-list
82785596|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
82785597|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82785598|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785599|NCT00669617|Fluticasone|fluticasone|mesh-list
82785600|NCT00669617|Xhance|xhance|mesh-list
82785601|NCT00669617|Albuterol|albuterol|mesh-list
82785602|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82785603|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785604|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82785605|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
82785606|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785607|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785608|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82785609|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
82785610|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
82785611|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82785612|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82785613|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82785614|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82785615|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
82785616|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785617|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785618|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
82785619|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82785620|NCT03979352|Empagliflozin|empagliflozin|mesh-list
82785621|NCT03979352|Pancrelipase|pancrelipase|mesh-list
82785622|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82785623|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785624|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82785625|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785626|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785627|NCT00773201|Sotalol|sotalol|mesh-list
82785628|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82785629|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82785630|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
82785631|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785632|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785633|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785634|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82785635|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
82785636|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
82785637|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785638|NCT00777413|Minocycline|minocycline|mesh-list
82785639|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82785640|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785641|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
82785642|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82785643|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785644|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82785645|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785646|NCT00992576|Hydromorphone|hydromorphone|mesh-list
82785647|NCT00992576|Naloxone|naloxone|mesh-list
82785648|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82785649|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785650|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
82785651|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785652|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82785653|NCT00992576|Narcotics|narcotics|mesh-ancestor
82785654|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785655|NCT00992576|Analgesics|analgesics|mesh-ancestor
82785656|NCT00777569|Nicotine|nicotine|mesh-list
82785657|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82785658|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
82785659|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785660|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785661|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82785662|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82785663|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
82785664|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785665|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785666|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82785667|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785668|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82785669|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785670|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785671|NCT00535730|Vaccines|vaccines|mesh-list
82785672|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82785673|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
82785674|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785675|NCT00992654|Maraviroc|maraviroc|mesh-list
82785676|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82785677|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82785678|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785679|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82785680|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82785681|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
82785682|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785683|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82785684|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82785685|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
82785686|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82785687|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82785688|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785689|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785690|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82785691|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82785692|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785693|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
82785694|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785695|NCT00995306|Capsaicin|capsaicin|mesh-list
82785696|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
82785697|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
82785698|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
82785699|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785700|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785701|NCT00666965|Rotigotine|rotigotine|mesh-list
82785702|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
82785703|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
82785704|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785705|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785706|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785707|NCT00781157|Phenylephrine|phenylephrine|mesh-list
82785708|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
82785709|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82785710|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
82785711|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
82785712|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785713|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785714|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
82785715|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82785716|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
82785717|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
82785718|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82785719|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82785720|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82785721|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
82785722|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785723|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785724|NCT00781157|Protective Agents|protective agents|mesh-ancestor
82785725|NCT00777959|Sirolimus|sirolimus|mesh-list
82785726|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83361904|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83361905|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83361906|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
83361907|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361908|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361909|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361910|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83361911|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361912|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83361913|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83361915|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83361916|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83361917|NCT01688921|Vaccines|vaccines|mesh-list
82785727|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785728|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82785729|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785730|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
82785731|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82785732|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
82785733|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785734|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
82785735|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82785736|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
82785737|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82785738|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82785739|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785740|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82785741|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785742|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82785743|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785745|NCT00778115|Loperamide|loperamide|mesh-list
82785746|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
82785747|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785748|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
82785749|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785750|NCT00778115|Emollients|emollients|mesh-ancestor
82785751|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
82785752|NCT00993122|Ribavirin|ribavirin|mesh-list
82785753|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
82785754|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785755|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
82785756|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785757|NCT00778193|Aspirin|aspirin|mesh-list
82785758|NCT00778193|Celecoxib|celecoxib|mesh-list
82785759|NCT00778193|Naproxen|naproxen|mesh-list
82785760|NCT00778193|Clopidogrel|clopidogrel|mesh-list
82785761|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82785762|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82785763|NCT00778193|Analgesics|analgesics|mesh-ancestor
82785764|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
82785765|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785766|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785767|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785768|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785769|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82785770|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82785771|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785772|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82785773|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82785774|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785775|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
82785776|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82785777|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82785778|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82785779|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
82785780|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785781|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82785782|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
82785783|NCT00778271|Gabapentin|gabapentin|mesh-list
82785784|NCT00778271|Analgesics|analgesics|mesh-ancestor
82785785|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
82785786|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785787|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785788|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
82785789|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82785790|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82785791|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785792|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82785793|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82785794|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82785795|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785796|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785797|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
82785798|NCT00778349|Metformin|metformin|mesh-list
82785799|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82785800|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785801|NCT00995618|Tranilast|tranilast|mesh-list
82785802|NCT00995618|Febuxostat|febuxostat|mesh-list
82785803|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
82785804|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785805|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82785806|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82785807|NCT00995618|Analgesics|analgesics|mesh-ancestor
82785808|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
82785809|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785810|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785811|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785812|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82785813|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82785814|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785815|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82785816|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82785817|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
82785818|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
82785819|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785820|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82785821|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82785822|NCT00778427|Metformin|metformin|mesh-list
82785823|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82785824|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785825|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82785826|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82785827|NCT00667355|Adalimumab|adalimumab|mesh-list
82785828|NCT00667355|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82785829|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785830|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785831|NCT00778505|Remifentanil|remifentanil|mesh-list
82785832|NCT00778505|Propofol|propofol|mesh-list
82785833|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82785834|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785835|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785836|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82785837|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
82785838|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
82785839|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82785840|NCT00778505|Narcotics|narcotics|mesh-ancestor
82785841|NCT00778505|Analgesics|analgesics|mesh-ancestor
82785842|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
82785843|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785844|NCT00532844|Vitamins|vitamins|mesh-list
82785845|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
82785846|NCT00532844|Verapamil|verapamil|mesh-list
82785847|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
82785848|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785849|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
82785850|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785851|NCT00532844|Protective Agents|protective agents|mesh-ancestor
82785852|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82785853|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82785854|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82785855|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82785856|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
82785857|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
82785858|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82785859|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785860|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82785861|NCT00778661|Amoxicillin|amoxicillin|mesh-list
82785862|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82785863|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785864|NCT00993356|Lanreotide|lanreotide|mesh-list
82785865|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785866|NCT00781547|Hormones|hormones|mesh-list
82785867|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82785868|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785869|NCT00778739|Cefprozil|cefprozil|mesh-list
82785870|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82785871|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785872|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
82785873|NCT00781625|Methenamine|methenamine|mesh-list
82785874|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
82785875|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82785876|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785877|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82785878|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
82785879|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785880|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785881|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82785882|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
82785883|NCT00666263|Antibodies|antibodies|mesh-list
82785884|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
82785885|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82785886|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82785887|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
82785888|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785889|NCT00667277|Bevacizumab|bevacizumab|mesh-list
82785890|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785891|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785892|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82785893|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82785894|NCT00667277|Growth Substances|growth substances|mesh-ancestor
82785895|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785896|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
82785898|NCT00774527|Fludarabine|fludarabine|mesh-list
82785899|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82785900|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82785901|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
82785902|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785903|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785904|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82785905|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
82785906|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785907|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785908|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82785909|NCT00778973|Sertraline|sertraline|mesh-list
82785910|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
82785911|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82785912|NCT00778973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82785913|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82785914|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83440864|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785915|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785916|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785917|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
82785918|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785919|NCT00774605|Varenicline|varenicline|mesh-list
82785920|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82785921|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82785922|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
82785923|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785924|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785925|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785926|NCT00779051|Zolpidem|zolpidem|mesh-list
82785927|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82785928|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82785929|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82785930|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785931|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82785932|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
82785933|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
82785934|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82785935|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785936|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
82785937|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83361918|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
82785938|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82785939|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
82785940|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82785941|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82785942|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82785943|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785944|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785945|NCT00782093|Volociximab|volociximab|mesh-list
82785946|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82785947|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82785948|NCT00782093|Growth Substances|growth substances|mesh-ancestor
82785949|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785950|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
82785951|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785952|NCT00784511|Vitamin D|vitamin d|mesh-list
82785953|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
82785954|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
82785955|NCT00784511|Vitamins|vitamins|mesh-list
82785956|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
82785957|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785958|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82785959|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82785960|NCT00784589|Rituximab|rituximab|mesh-list
82785961|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785962|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785963|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
82785964|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785965|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82785966|NCT00784667|Cetuximab|cetuximab|mesh-list
82785967|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82785968|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785969|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785970|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82785971|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82785972|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785973|NCT00784745|Dexamethasone|dexamethasone|mesh-list
82785974|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82785975|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
82785976|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
82785977|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82785978|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82785979|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82785980|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
82785981|NCT00784745|Hormones|hormones|mesh-ancestor
82785982|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82785983|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82785984|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785985|NCT00993512|Bleomycin|bleomycin|mesh-list
82785986|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82785987|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785988|NCT00662129|Paclitaxel|paclitaxel|mesh-list
82785989|NCT00662129|Bevacizumab|bevacizumab|mesh-list
82785990|NCT00662129|Gemcitabine|gemcitabine|mesh-list
82785991|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82785992|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82785993|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82785994|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
82785995|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
82785996|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
82785997|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82785998|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82785999|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82786000|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82786001|NCT00662129|Growth Substances|growth substances|mesh-ancestor
82786002|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786003|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
82786004|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82786005|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
82786006|NCT05346224|Pertuzumab|pertuzumab|mesh-list
82786007|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82786008|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786009|NCT00993746|Lidocaine|lidocaine|mesh-list
83361919|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786010|NCT00993746|Bupivacaine|bupivacaine|mesh-list
82786011|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
82786012|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
82786013|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361920|NCT00118755|Bevacizumab|bevacizumab|mesh-list
82786014|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786015|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
82786016|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786017|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82786018|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82786019|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82786020|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786021|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786022|NCT00789971|Triamcinolone|triamcinolone|mesh-list
82786023|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82786024|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82786025|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82786026|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82786027|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
82786028|NCT00789971|Hormones|hormones|mesh-ancestor
82786029|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786030|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786031|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786032|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
82786033|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786034|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786035|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82786036|NCT05345522|Antibodies|antibodies|mesh-list
82786037|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
82786038|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82786039|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
82786040|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786041|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786042|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82786044|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
82786045|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82786046|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82786047|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82786048|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786049|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786050|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82786051|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
82786052|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
82786053|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786054|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786055|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82786056|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82786057|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82786058|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82786059|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
82786060|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82786061|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82786062|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
82786063|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82786064|NCT05343260|Propofol|propofol|mesh-list
82786065|NCT05343260|Sevoflurane|sevoflurane|mesh-list
82786066|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82786067|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786068|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786069|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82786070|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
82786071|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
82786072|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82786073|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82786074|NCT00664859|Atorvastatin|atorvastatin|mesh-list
82786075|NCT00664859|Fenofibrate|fenofibrate|mesh-list
82786076|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82786077|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82786078|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
82786079|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786080|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82786081|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82786082|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786083|NCT00996788|Rebamipide|rebamipide|mesh-list
82786084|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82786085|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786086|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
82786087|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786088|NCT00996788|Protective Agents|protective agents|mesh-ancestor
82786089|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786090|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786091|NCT01564550|Insulin|insulin|mesh-list
82786092|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82786093|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82786094|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786095|NCT00996866|Vitamin D|vitamin d|mesh-list
82786096|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
82786097|NCT00996866|Vitamins|vitamins|mesh-ancestor
82786098|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
82786099|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786100|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82786101|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82786102|NCT00790439|Cyclosporine|cyclosporine|mesh-list
82786103|NCT00790439|Sirolimus|sirolimus|mesh-list
82786104|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
82786105|NCT00790439|Heparin|heparin|mesh-list
82786106|NCT00790439|Calcium heparin|calcium heparin|mesh-list
82786107|NCT00790439|Dextrans|dextrans|mesh-list
82786108|NCT00790439|Tacrolimus|tacrolimus|mesh-list
82786109|NCT00790439|Cyclosporins|cyclosporins|mesh-list
82786110|NCT00790439|Basiliximab|basiliximab|mesh-list
82786111|NCT00790439|Daclizumab|daclizumab|mesh-list
82786112|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786113|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
82786114|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786115|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82786116|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786117|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786118|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
82786119|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786120|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
82786121|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82786122|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82786123|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786124|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82786125|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
82786126|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82786127|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
82786128|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82786129|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82786130|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
82786131|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
82786132|NCT00785603|Tramadol|tramadol|mesh-list
82786133|NCT00785603|Paroxetine|paroxetine|mesh-list
82786134|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82786135|NCT00785603|Narcotics|narcotics|mesh-ancestor
82786136|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786137|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786138|NCT00785603|Analgesics|analgesics|mesh-ancestor
82786139|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
82786140|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786141|NCT00785603|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82786142|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82786143|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786144|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786145|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786146|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
82786147|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82786148|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
82786149|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82786150|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82786151|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82786152|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786153|NCT00570401|Dasatinib|dasatinib|mesh-list
82786154|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786155|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786156|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786157|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786158|NCT00532298|Vaccines|vaccines|mesh-list
82786159|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
82786160|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786161|NCT04047017|Apatinib|apatinib|mesh-list
82786162|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786163|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786164|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786165|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786166|NCT00997022|Sorafenib|sorafenib|mesh-list
82786167|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786168|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786169|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786170|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786171|NCT00786149|Varenicline|varenicline|mesh-list
82786172|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82786173|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82786174|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
82786175|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786176|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786177|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786178|NCT00410410|Abatacept|abatacept|mesh-list
82786179|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82786180|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786181|NCT00410410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82786182|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786183|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786184|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
82786185|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786186|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82786187|NCT00782951|Morphine|morphine|mesh-list
82786188|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82786189|NCT00782951|Narcotics|narcotics|mesh-ancestor
82786190|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786191|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786193|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
82786194|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786195|NCT02555813|Paclitaxel|paclitaxel|mesh-list
82786196|NCT02555813|Gemcitabine|gemcitabine|mesh-list
82786197|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82786198|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82786199|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786200|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
82786201|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
82786202|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
82786203|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786204|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82786205|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
82786206|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
82786207|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82786208|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786209|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82786210|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
82786211|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82786212|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786213|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786214|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786215|NCT00783107|Cyclosporine|cyclosporine|mesh-list
82786216|NCT00783107|Cyclosporins|cyclosporins|mesh-list
82786217|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786218|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786219|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786220|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
82786221|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786222|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
82786223|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786224|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
82786225|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82786226|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82786227|NCT00534404|Nicotine|nicotine|mesh-list
82786228|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82786229|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
82786230|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786231|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786232|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82786233|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82786234|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
82786235|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786236|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786237|NCT00393094|Bevacizumab|bevacizumab|mesh-list
82786238|NCT00393094|Irinotecan|irinotecan|mesh-list
83361921|NCT00118755|Capecitabine|capecitabine|mesh-list
82786239|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82786240|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786241|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82786242|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82786243|NCT00393094|Growth Substances|growth substances|mesh-ancestor
82786244|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786245|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
82786246|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82786247|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82786248|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786249|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786250|NCT00783653|Sunitinib|sunitinib|mesh-list
82786251|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786252|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82786253|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82786254|NCT00783653|Growth Substances|growth substances|mesh-ancestor
82786255|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786256|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
82786257|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786258|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786259|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786260|NCT00786305|Amikacin|amikacin|mesh-list
82786261|NCT00786305|Ceftazidime|ceftazidime|mesh-list
82786262|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82786263|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786264|NCT01044004|Modafinil|modafinil|mesh-list
82786265|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82786266|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786267|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82786268|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82786269|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82786270|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786271|NCT00786383|Ramucirumab|ramucirumab|mesh-list
82786272|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786273|NCT00790595|Sunitinib|sunitinib|mesh-list
82786274|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786275|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82786276|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82786277|NCT00790595|Growth Substances|growth substances|mesh-ancestor
82786278|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786279|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
82786280|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786281|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786282|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786283|NCT00783731|Midazolam|midazolam|mesh-list
82786284|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82786285|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82786286|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786287|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786288|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82786289|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82786290|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82786291|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82786292|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
82786293|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
82786294|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
82786295|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
82786296|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786297|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786298|NCT00409708|Methylphenidate|methylphenidate|mesh-list
82786299|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82786300|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786301|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82786302|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82786303|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786304|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786305|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
82786306|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786307|NCT00790985|Naproxen|naproxen|mesh-list
82786308|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82786309|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82786310|NCT00790985|Analgesics|analgesics|mesh-ancestor
83361922|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
82786312|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786313|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786314|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82786315|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82786316|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
82786317|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82786318|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786319|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786320|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
82786321|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
82786322|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786323|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82786324|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786325|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786326|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
82786327|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786328|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82786329|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786330|NCT01324492|Everolimus|everolimus|mesh-list
82786331|NCT01324492|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82786332|NCT01324492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786333|NCT01324492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786334|NCT01324492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786335|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786336|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
82786337|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786338|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786339|NCT01039948|Gefitinib|gefitinib|mesh-list
82786340|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786341|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786342|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786343|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786344|NCT00391846|Metoprolol|metoprolol|mesh-list
82786345|NCT00391846|Valsartan|valsartan|mesh-list
82786346|NCT00391846|Carvedilol|carvedilol|mesh-list
82786347|NCT00391846|Candesartan|candesartan|mesh-list
82786348|NCT00391846|Ramipril|ramipril|mesh-list
82786349|NCT00391846|Enalapril|enalapril|mesh-list
82786350|NCT00391846|Lisinopril|lisinopril|mesh-list
82786351|NCT00391846|Eplerenone|eplerenone|mesh-list
82786352|NCT00391846|Bisoprolol|bisoprolol|mesh-list
82786353|NCT00391846|Captopril|captopril|mesh-list
82786354|NCT00391846|Trandolapril|trandolapril|mesh-list
82786355|NCT00391846|Spironolactone|spironolactone|mesh-list
82786356|NCT00391846|Diuretics|diuretics|mesh-list
82786357|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82786358|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82786359|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82786360|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786361|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82786362|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
82786363|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
82786364|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786365|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786366|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82786367|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82786368|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82786369|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
82786370|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786371|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82786372|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
82786373|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786374|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82786375|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
82786376|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
82786377|NCT00391846|Protective Agents|protective agents|mesh-ancestor
82786378|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82786379|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786380|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82786381|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
82786382|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82786383|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82786384|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82786385|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
82786386|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786387|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82786388|NCT00391768|Oseltamivir|oseltamivir|mesh-list
82786389|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
82786390|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786391|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786392|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786393|NCT00391222|Olanzapine|olanzapine|mesh-list
82786394|NCT00391222|Risperidone|risperidone|mesh-list
82786395|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82786396|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
82786397|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786398|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786399|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786400|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82786401|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82786402|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786403|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82786404|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83440898|NCT03186326|Bevacizumab|bevacizumab|mesh-list
82786405|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
82786406|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
82786407|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
82786408|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786409|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786410|NCT00391222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82786411|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82786412|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786413|NCT00409006|Pemetrexed|pemetrexed|mesh-list
82786414|NCT00409006|Gefitinib|gefitinib|mesh-list
82786415|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786416|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786417|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786418|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82786419|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82786420|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786421|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
82786422|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82786423|NCT00997880|Calcium|calcium|mesh-list
82786424|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82786425|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786426|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82786427|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82786428|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82786429|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
82786430|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786431|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82786432|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82786433|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786434|NCT00408928|Bortezomib|bortezomib|mesh-list
82786435|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786436|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
82786437|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82786438|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786439|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82786440|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
82786441|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82786442|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786443|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786444|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786445|NCT00998036|Sirolimus|sirolimus|mesh-list
82786446|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82786447|NCT00998036|Temsirolimus|temsirolimus|mesh-list
82786448|NCT00998036|MTOR Inhibitors|mtor inhibitors|mesh-list
82786449|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786450|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786451|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786452|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786453|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786454|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
82786455|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786456|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82786457|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786458|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82786459|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
82786460|NCT05254808|Fosfomycin|fosfomycin|mesh-list
82786461|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
82786462|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82786463|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786464|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82786465|NCT02275286|Trabectedin|trabectedin|mesh-list
82786466|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82786467|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
82786468|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786469|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786470|NCT00998192|Paclitaxel|paclitaxel|mesh-list
82786471|NCT00998192|Carboplatin|carboplatin|mesh-list
82786472|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82786473|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786474|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
82786475|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
82786476|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
82786477|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786478|NCT00994526|Vitamin E|vitamin e|mesh-list
82786479|NCT00994526|Calcium|calcium|mesh-list
82786480|NCT00994526|Vitamins|vitamins|mesh-ancestor
82786481|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
82786482|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786483|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82786484|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
82786485|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786486|NCT00994526|Protective Agents|protective agents|mesh-ancestor
82786487|NCT00998504|Resveratrol|resveratrol|mesh-list
82786488|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
82786489|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786490|NCT00998504|Protective Agents|protective agents|mesh-ancestor
82786491|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786492|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786493|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82786494|NCT00788684|Rituximab|rituximab|mesh-list
82786495|NCT00788684|Navitoclax|navitoclax|mesh-list
82786496|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82786497|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786498|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
82786499|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786500|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82786501|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
82786502|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82786503|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
82786504|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786505|NCT00998972|Expectorants|expectorants|mesh-ancestor
82786506|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
82786507|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82786508|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
82786509|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786510|NCT00998972|Protective Agents|protective agents|mesh-ancestor
82786511|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786512|NCT00998972|Antidotes|antidotes|mesh-ancestor
82786513|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82786514|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
82786515|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786516|NCT00998816|Pregabalin|pregabalin|mesh-list
82786517|NCT00998816|Analgesics|analgesics|mesh-ancestor
82786518|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
82786519|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786520|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786521|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
82786522|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82786523|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786524|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786525|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82786526|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82786527|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82786528|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786529|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82786530|NCT00533702|Dacarbazine|dacarbazine|mesh-list
82786531|NCT00533702|Ramucirumab|ramucirumab|mesh-list
82786532|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82786533|NCT00533702|Imidazole|imidazole|mesh-list
82786534|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82786535|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
82786536|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786537|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786538|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
82786539|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786540|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786541|NCT00408694|Bevacizumab|bevacizumab|mesh-list
82786542|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82786543|NCT00408694|Cisplatin|cisplatin|mesh-list
82786544|NCT00408694|Fluorouracil|fluorouracil|mesh-list
82786545|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
82786546|NCT00408694|Antibodies|antibodies|mesh-list
82786547|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
82786548|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82786549|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
82786550|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786551|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82786552|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82786553|NCT00408694|Growth Substances|growth substances|mesh-ancestor
82786554|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786555|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
82786556|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
82786557|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
82786558|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786559|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82786560|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786561|NCT00999128|Rabeprazole|rabeprazole|mesh-list
82786562|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82786563|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786564|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82786565|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786566|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786567|NCT00999206|Vaccines|vaccines|mesh-list
82786568|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
82786569|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786570|NCT01043224|Clobetasol|clobetasol|mesh-list
82786571|NCT01043224|Calcipotriene|calcipotriene|mesh-list
82786572|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82786573|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
82786574|NCT01043224|Hormones|hormones|mesh-ancestor
82786575|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786576|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786577|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
82786578|NCT01044238|Methylphenidate|methylphenidate|mesh-list
82786579|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82786580|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786581|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82786582|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82786583|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786584|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786585|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
82786586|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786587|NCT01043380|Atorvastatin|atorvastatin|mesh-list
82786588|NCT01043380|Ezetimibe|ezetimibe|mesh-list
82786589|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82786590|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82786591|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
82786592|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786593|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82786594|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82786595|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786596|NCT01044394|Bisacodyl|bisacodyl|mesh-list
82786597|NCT01044394|Cathartics|cathartics|mesh-ancestor
82786598|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786599|NCT01044394|Laxatives|laxatives|mesh-ancestor
82786600|NCT03474094|Atezolizumab|atezolizumab|mesh-list
82786601|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82786602|NCT03474094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82786603|NCT03474094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786604|NCT03474094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82786605|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786606|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
82786607|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786608|NCT01043536|Temozolomide|temozolomide|mesh-list
82786609|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83361923|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361924|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786610|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
82786611|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786612|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786613|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82786614|NCT00056407|Dutasteride|dutasteride|mesh-list
82786615|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82786616|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82786617|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786618|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786619|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
82786620|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786621|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786622|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
82786623|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786624|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82786625|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
82786627|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82786628|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82786629|NCT00073021|Analgesics|analgesics|mesh-ancestor
82786630|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
82786631|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786632|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786633|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82786634|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82786635|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
82786636|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82786637|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
82786638|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786639|NCT00395746|Liraglutide|liraglutide|mesh-list
82786640|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82786641|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786642|NCT00395746|Incretins|incretins|mesh-ancestor
82786643|NCT00395746|Hormones|hormones|mesh-ancestor
82786644|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786645|NCT01004900|Timolol|timolol|mesh-list
82786646|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82786647|NCT01004900|Travoprost|travoprost|mesh-list
82786648|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82786649|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82786650|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
82786651|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786652|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786653|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786654|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82786655|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82786656|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82786657|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82786658|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82786659|NCT04001348|Diazepam|diazepam|mesh-list
82786660|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82786661|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
82786662|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
82786663|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
82786664|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786665|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786666|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786667|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82786668|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786669|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82786670|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82786671|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82786672|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82786673|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82786674|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82786675|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
82786676|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
82786677|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
82786678|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
82786679|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786680|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786681|NCT00395512|Pioglitazone|pioglitazone|mesh-list
82786682|NCT00395512|Alogliptin|alogliptin|mesh-list
82786683|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82786684|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786686|NCT00395512|Hormones|hormones|mesh-ancestor
82786687|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786688|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82786689|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
82786690|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786691|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786692|NCT03956017|Ubiquinone|ubiquinone|mesh-list
82786693|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
82786694|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
82786695|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786696|NCT03956017|Vitamins|vitamins|mesh-ancestor
82786697|NCT00994916|Amifampridine|amifampridine|mesh-list
82786698|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82786699|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786700|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786701|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82786702|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786703|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786704|NCT00999440|Methadone|methadone|mesh-list
82786705|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82786706|NCT00999440|Narcotics|narcotics|mesh-ancestor
82786707|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786708|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786709|NCT00999440|Analgesics|analgesics|mesh-ancestor
82786710|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
82786711|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786712|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
82786713|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
82786714|NCT00054691|Gefitinib|gefitinib|mesh-list
82786715|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786716|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786717|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786718|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786719|NCT02530879|Esomeprazole|esomeprazole|mesh-list
82786720|NCT02530879|Omeprazole|omeprazole|mesh-list
82786721|NCT02530879|Lansoprazole|lansoprazole|mesh-list
82786722|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
82786723|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82786724|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786725|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82786726|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786727|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786728|NCT03957499|Dexamethasone|dexamethasone|mesh-list
82786729|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
82786730|NCT03957499|Bupivacaine|bupivacaine|mesh-list
82786731|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82786732|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
82786733|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
82786734|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786735|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786736|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786737|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
82786738|NCT03957499|Hormones|hormones|mesh-ancestor
82786739|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786740|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82786741|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786742|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
82786743|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
82786744|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786745|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
82786746|NCT03957499|Analgesics|analgesics|mesh-ancestor
82786747|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82786748|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
82786749|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82786750|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786751|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786752|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82786753|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
82786754|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82786755|NCT01040338|Nicotine|nicotine|mesh-list
82786756|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82786757|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
82786758|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361925|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82786759|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786760|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82786761|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82786762|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
82786763|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786764|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786765|NCT00066703|Tamoxifen|tamoxifen|mesh-list
82786766|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82786767|NCT00066703|Exemestane|exemestane|mesh-list
82786768|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82786769|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
82786770|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786771|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786772|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82786773|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786774|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82786775|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82786776|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82786777|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82786778|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82786779|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786780|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786781|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
82786782|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82786783|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
82786784|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82786785|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82786786|NCT03955939|Midazolam|midazolam|mesh-list
82786787|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82786788|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82786789|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786790|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786791|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82786792|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82786793|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82786794|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82786795|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
82786796|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
82786797|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
82786798|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
82786799|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786800|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786801|NCT01094821|ATI 7505|ati 7505|mesh-list
82786802|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82786803|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82786804|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
82786805|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786806|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786807|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786808|NCT00072475|Vatalanib|vatalanib|mesh-list
82786809|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786810|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786811|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786812|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
82786813|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82786814|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82786815|NCT00066469|Prednisone|prednisone|mesh-list
82786816|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
82786817|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82786818|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82786819|NCT00066469|Prednisolone|prednisolone|mesh-list
82786820|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
82786821|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
82786822|NCT00066469|Rituximab|rituximab|mesh-list
82786823|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82786824|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
82786825|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786826|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
82786827|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786828|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82786829|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82786830|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
82786831|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786843|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786844|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82786845|NCT00066469|Protective Agents|protective agents|mesh-ancestor
82786846|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
82786847|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82786848|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82786849|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786850|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
82786851|NCT01094977|Coagulants|coagulants|mesh-ancestor
82786852|NCT01095133|Amiloride|amiloride|mesh-list
82786853|NCT01095133|Diuretics|diuretics|mesh-ancestor
82786854|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
82786855|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786856|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82786857|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82786858|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82786859|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786860|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82786861|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82786862|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
82786863|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82786864|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
82786865|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786866|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786867|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82786868|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
82786869|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
82786870|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82786871|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
82786872|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82786873|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786886|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
82786887|NCT01095211|Vitamins|vitamins|mesh-ancestor
82786888|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
82786889|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786890|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82786891|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82786892|NCT00053365|Irofulven|irofulven|mesh-list
82786893|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82786894|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
82786895|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786896|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786897|NCT00387010|Fentanyl|fentanyl|mesh-list
82786898|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82786899|NCT00387010|Narcotics|narcotics|mesh-ancestor
82786900|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82786901|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786902|NCT00387010|Analgesics|analgesics|mesh-ancestor
82786903|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
82786904|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786905|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82786906|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82786907|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
82786908|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
82786909|NCT01092091|BCT-100|bct-100|mesh-list
82786910|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786911|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
82786912|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82786913|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786914|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
82786915|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82786916|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82786917|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786918|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
82786919|NCT00386308|Coagulants|coagulants|mesh-ancestor
82786920|NCT00064987|Hormones|hormones|mesh-list
82786921|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82786922|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786923|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786924|NCT00374140|Everolimus|everolimus|mesh-list
82786925|NCT00374140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82786926|NCT00374140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82786927|NCT00374140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786928|NCT00374140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786929|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82786930|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
82786931|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786932|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786933|NCT00665561|Maraviroc|maraviroc|mesh-list
82786934|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82786935|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82786936|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82786937|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786938|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82786939|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
82786940|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786941|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82786942|NCT03955705|Nefopam|nefopam|mesh-list
82786943|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82786944|NCT03955705|Analgesics|analgesics|mesh-ancestor
82786945|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
82786946|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82786947|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786948|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
82786949|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82786950|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786951|NCT00786695|Esomeprazole|esomeprazole|mesh-list
82786952|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82786953|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82786954|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82786955|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82786956|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786957|NCT00786851|Lenalidomide|lenalidomide|mesh-list
82786958|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
82786959|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786960|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82786961|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82786962|NCT00786851|Growth Substances|growth substances|mesh-ancestor
82786963|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
82786964|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786965|NCT00787007|Equol|equol|mesh-list
82786966|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
82786967|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82786968|NCT00787007|Estrogens|estrogens|mesh-ancestor
82786969|NCT00787007|Hormones|hormones|mesh-ancestor
83440957|NCT02991599|Vaccines|vaccines|mesh-list
82786970|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82786971|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786972|NCT00791141|Cetuximab|cetuximab|mesh-list
82786973|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82786974|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82786975|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
82786976|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
82786977|NCT00386152|Hematinics|hematinics|mesh-ancestor
82786978|NCT00787553|Cefazolin|cefazolin|mesh-list
82786979|NCT00787553|Tinidazole|tinidazole|mesh-list
82786980|NCT00787553|Imidazole|imidazole|mesh-list
82786981|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82786982|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82786983|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084060|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82786984|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82786985|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
82786986|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82786987|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82786988|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82786989|NCT00795353|Alefacept|alefacept|mesh-list
82786990|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
82786991|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
82786992|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786993|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
82786994|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82786995|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
82786996|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82786997|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82786998|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82786999|NCT01045876|Dexamethasone|dexamethasone|mesh-list
82787000|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787001|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
82787002|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
82787003|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787004|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787005|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82787006|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
82787007|NCT01045876|Hormones|hormones|mesh-ancestor
82787008|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787009|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82787010|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787011|NCT00385762|Paroxetine|paroxetine|mesh-list
82787012|NCT00385762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82787013|NCT00385762|Serotonin|serotonin|mesh-list
82787014|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82787015|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82787016|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787017|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787018|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
82787019|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787020|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82787021|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
82787022|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82787023|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82787024|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82787025|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787026|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82787027|NCT00385684|Acetaminophen|acetaminophen|mesh-list
82787028|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82787029|NCT00385684|Hydrocodone|hydrocodone|mesh-list
82787030|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82787031|NCT00385684|Narcotics|narcotics|mesh-ancestor
82787032|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787033|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787035|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
82787036|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787037|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
82787038|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
82787039|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82787040|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
82787041|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82787042|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787043|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787044|NCT00661661|Tofacitinib|tofacitinib|mesh-list
82787045|NCT00661661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82787046|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82787047|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787048|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787049|NCT00038467|Tamoxifen|tamoxifen|mesh-list
82787050|NCT00038467|Exemestane|exemestane|mesh-list
82787051|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82787052|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
82787053|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787054|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787055|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82787056|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084061|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
82787057|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82787058|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82787059|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82787060|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82787061|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82787062|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787063|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787064|NCT01095445|Ribavirin|ribavirin|mesh-list
82787065|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82787066|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
82787067|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787068|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
82787069|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787070|NCT00660179|Macitentan|macitentan|mesh-list
82787071|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82787072|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82787073|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787074|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82787075|NCT00050167|Paclitaxel|paclitaxel|mesh-list
82787076|NCT00050167|Docetaxel|docetaxel|mesh-list
82787077|NCT00050167|Capecitabine|capecitabine|mesh-list
82787078|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82787079|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787080|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
82787081|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
82787082|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
82787083|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787084|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82787085|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
82787086|NCT01096927|Amoxicillin|amoxicillin|mesh-list
82787087|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
82787088|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
82787089|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82787090|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787091|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787092|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787093|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82787094|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
82787095|NCT00660023|Hematinics|hematinics|mesh-ancestor
82787096|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
82787097|NCT02554955|Daclizumab|daclizumab|mesh-list
82787098|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82787099|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787100|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82787101|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
82787102|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82787103|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787104|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787105|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787106|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787107|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
82787108|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787109|NCT00062647|Vancomycin|vancomycin|mesh-list
82787110|NCT00062647|Cloxacillin|cloxacillin|mesh-list
82787111|NCT00062647|Oxacillin|oxacillin|mesh-list
82787112|NCT00062647|Telavancin|telavancin|mesh-list
82787113|NCT00062647|Nafcillin|nafcillin|mesh-list
82787114|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82787115|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787116|NCT00570323|Fulvestrant|fulvestrant|mesh-list
82787117|NCT00570323|Anastrozole|anastrozole|mesh-list
82787118|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82787119|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787120|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82787121|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82787122|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
82787123|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787124|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787125|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82787126|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82787127|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787128|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787129|NCT00791531|Methotrexate|methotrexate|mesh-list
82787130|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83361926|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82787131|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
82787132|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82787133|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787134|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82787135|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
82787136|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787137|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787138|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787139|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787140|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82787141|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787142|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
82787143|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787144|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82787145|NCT00788099|Gemcitabine|gemcitabine|mesh-list
82787146|NCT00788099|Sorafenib|sorafenib|mesh-list
82787147|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82787148|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
82787149|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787150|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787151|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82787152|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787153|NCT00795587|Mannitol|mannitol|mesh-list
82787154|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82787155|NCT00795587|Diuretics|diuretics|mesh-ancestor
82787156|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
82787157|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787158|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
82787159|NCT00661505|Hematinics|hematinics|mesh-ancestor
82787160|NCT00788333|Trastuzumab|trastuzumab|mesh-list
82787161|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787162|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787163|NCT00795899|Paclitaxel|paclitaxel|mesh-list
82787164|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
82787165|NCT00795899|Trastuzumab|trastuzumab|mesh-list
82787166|NCT00795899|Epirubicin|epirubicin|mesh-list
82787167|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82787168|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787169|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
82787170|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
82787171|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
82787172|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787173|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787174|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
82787175|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787176|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787177|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82787178|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
82787179|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82787180|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787181|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82787182|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82787183|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82787184|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787185|NCT00795977|Picibanil|picibanil|mesh-list
82787186|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787187|NCT00796211|Nortriptyline|nortriptyline|mesh-list
82787188|NCT00796211|Calcipotriene|calcipotriene|mesh-list
82787189|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787190|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82787191|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
82787192|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82787193|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82787194|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82787195|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82787196|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787197|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787198|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787199|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787200|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
82787201|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82787202|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787203|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82787204|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
82787205|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82787206|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787207|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787208|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787209|NCT00662909|Mirabegron|mirabegron|mesh-list
82787210|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82787211|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82787212|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82787213|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787214|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787215|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787216|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787217|NCT00662909|Urological Agents|urological agents|mesh-ancestor
82787218|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
82787219|NCT00050011|Letrozole|letrozole|mesh-list
82787220|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787221|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82787222|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82787223|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787224|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787225|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82787226|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
82787227|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787228|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787229|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82787230|NCT00661427|Cetuximab|cetuximab|mesh-list
82787231|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787232|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787233|NCT00049543|Gefitinib|gefitinib|mesh-list
82787234|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787235|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82787236|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787237|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787238|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82787239|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82787240|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787241|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
82787242|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787243|NCT00035815|Mitogens|mitogens|mesh-list
82787244|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
82787245|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787246|NCT00662831|Dalteparin|dalteparin|mesh-list
82787247|NCT00662831|Tinzaparin|tinzaparin|mesh-list
82787248|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82787249|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
82787250|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82787251|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82787252|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787253|NCT02555423|Anesthetics|anesthetics|mesh-list
82787254|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
82787255|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
82787256|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787257|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787258|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
82787259|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787260|NCT00792779|Propofol|propofol|mesh-list
82787261|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82787262|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787263|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787264|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82787265|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
82787266|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
82787267|NCT00662363|Lubiprostone|lubiprostone|mesh-list
82787268|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82787269|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82787270|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787271|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82787272|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82787273|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82787274|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787275|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787276|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82787277|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82787278|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82787279|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
83361927|NCT00118755|Growth Substances|growth substances|mesh-ancestor
82787280|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787281|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787282|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82787283|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82787284|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
82787285|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
82787286|NCT00792857|Vitamins|vitamins|mesh-ancestor
82787287|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
82787288|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787289|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82787290|NCT02554175|Propofol|propofol|mesh-list
82787291|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82787292|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787293|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787294|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82787295|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
82787296|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
82787297|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82787298|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82787299|NCT00789503|Vitamin D|vitamin d|mesh-list
82787300|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
82787301|NCT00789503|Calcium|calcium|mesh-list
82787302|NCT00789503|Vitamins|vitamins|mesh-ancestor
82787303|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
82787304|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787305|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82787306|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82787307|NCT00797303|Bevacizumab|bevacizumab|mesh-list
82787308|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787309|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787310|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82787311|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82787312|NCT00797303|Growth Substances|growth substances|mesh-ancestor
82787313|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787314|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
82787315|NCT00661193|Paclitaxel|paclitaxel|mesh-list
82787316|NCT00661193|Carboplatin|carboplatin|mesh-list
82787317|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82787318|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82787319|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787320|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
82787321|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
82787322|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
82787323|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787324|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82787325|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787326|NCT00801047|Remifentanil|remifentanil|mesh-list
82787327|NCT00801047|Bupivacaine|bupivacaine|mesh-list
82787328|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
82787329|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
82787330|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787331|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787332|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
82787333|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787334|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82787335|NCT00801047|Narcotics|narcotics|mesh-ancestor
82787336|NCT00801047|Analgesics|analgesics|mesh-ancestor
82787337|NCT00801125|Natalizumab|natalizumab|mesh-list
82787338|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
82787339|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787340|NCT00801281|Prednisone|prednisone|mesh-list
82787341|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
82787342|NCT00801281|Rituximab|rituximab|mesh-list
82787343|NCT00801281|Doxorubicin|doxorubicin|mesh-list
82787344|NCT00801281|Vincristine|vincristine|mesh-list
82787345|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787346|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
82787347|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787348|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787349|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82787350|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
82787351|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787352|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787353|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82787354|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787355|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82787356|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82787357|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82787358|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787359|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787360|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
82787361|NCT00801281|Hormones|hormones|mesh-ancestor
82787362|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787363|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82787364|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82787365|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
82787366|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
82787367|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
82787368|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82787369|NCT00801515|Maraviroc|maraviroc|mesh-list
82787370|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82787371|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82787372|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787373|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82787374|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82787375|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
82787376|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787377|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82787378|NCT00797693|Misoprostol|misoprostol|mesh-list
82787379|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82787380|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
82787381|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82787382|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787383|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82787384|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82787385|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
82787386|NCT00797771|Insulin|insulin|mesh-list
82787387|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82787388|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787389|NCT00793559|Terlipressin|terlipressin|mesh-list
82787390|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82787391|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82787392|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82787393|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
82787394|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
82787395|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82787396|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82787397|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787398|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787399|NCT00798083|Lidocaine|lidocaine|mesh-list
82787400|NCT00798083|Ketamine|ketamine|mesh-list
82787401|NCT00798083|Amitriptyline|amitriptyline|mesh-list
82787402|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
82787403|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
82787404|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787405|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787406|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
82787407|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787408|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82787409|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82787410|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82787411|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82787412|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787413|NCT00798083|Analgesics|analgesics|mesh-ancestor
82787414|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82787415|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82787416|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
82787417|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82787418|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82787419|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787420|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82787421|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
82787422|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82787423|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82787424|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82787425|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82787426|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787427|NCT00798395|Zopiclone|zopiclone|mesh-list
82787428|NCT00798395|Mirtazapine|mirtazapine|mesh-list
82787429|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82787430|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787431|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787432|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
82787433|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82787434|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82787435|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
82787436|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
82787437|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787438|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787439|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82787440|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82787441|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82787442|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82787443|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82787444|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787445|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82787446|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82787447|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
82787448|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82787450|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82787451|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82787452|NCT00801905|Analgesics|analgesics|mesh-ancestor
82787453|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
82787454|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787455|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787456|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787457|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787458|NCT00658541|Zolpidem|zolpidem|mesh-list
82787459|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82787460|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82787461|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787462|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787463|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82787464|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
82787465|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
82787466|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787467|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787468|NCT00048061|Vitamin D|vitamin d|mesh-list
82787469|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
82787470|NCT00048061|Calcium|calcium|mesh-list
82787471|NCT00048061|Vitamins|vitamins|mesh-ancestor
82787472|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
82787473|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787474|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82787475|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82787476|NCT00802139|Iron|iron|mesh-list
82787477|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82787478|NCT00802139|Trace Elements|trace elements|mesh-ancestor
82787479|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
82787480|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787481|NCT00802139|Hematinics|hematinics|mesh-ancestor
82787482|NCT00802217|Capsaicin|capsaicin|mesh-list
82787483|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
82787484|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787485|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
82787486|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787487|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787488|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
82787489|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82787490|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82787491|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82787492|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
82787493|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787494|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787495|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787496|NCT00802373|Urological Agents|urological agents|mesh-ancestor
82787497|NCT03957109|Anesthetics|anesthetics|mesh-list
82787498|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787499|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787500|NCT00802451|Mesalamine|mesalamine|mesh-list
82787501|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82787502|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82787503|NCT00802451|Analgesics|analgesics|mesh-ancestor
82787504|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
82787505|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787506|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787507|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787508|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787509|NCT03956953|Deucravacitinib|deucravacitinib|mesh-list
82787510|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787511|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82787512|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787513|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787514|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
82787515|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82787516|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787517|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
82787518|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82787519|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787520|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82787521|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82787522|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787523|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787524|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787525|NCT01097317|Carboplatin|carboplatin|mesh-list
82787526|NCT01097317|Vinorelbine|vinorelbine|mesh-list
82787527|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787528|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82787529|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
82787530|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
82787531|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
82787532|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787533|NCT01095679|Baclofen|baclofen|mesh-list
82787534|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82787535|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787536|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82787537|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787538|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82787539|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
82787540|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
82787541|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787542|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787543|NCT00794261|Lenograstim|lenograstim|mesh-list
82787544|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82787545|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
82787546|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787547|NCT03953287|Acetaminophen|acetaminophen|mesh-list
82787548|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82787549|NCT03953287|Analgesics|analgesics|mesh-ancestor
82787550|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
82787551|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787552|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787553|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
82787554|NCT01097551|Phenylephrine|phenylephrine|mesh-list
82787555|NCT01097551|Acetylcholine|acetylcholine|mesh-list
82787556|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
82787557|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
82787558|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82787559|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
82787560|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787561|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787562|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787563|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82787564|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
82787565|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
82787566|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787567|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
82787568|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82787569|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
82787570|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
82787571|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82787572|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82787573|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82787574|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787575|NCT01097551|Protective Agents|protective agents|mesh-ancestor
83441024|NCT00716963|Xhance|xhance|mesh-list
82787576|NCT00803309|Interferons|interferons|mesh-list
82787578|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
82787579|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
82787580|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82787581|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787582|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
82787583|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787584|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
82787585|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787586|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
82787587|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787588|NCT03953209|Spironolactone|spironolactone|mesh-list
82787589|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82787590|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
82787591|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787592|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787593|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82787594|NCT03953209|Diuretics|diuretics|mesh-ancestor
82787595|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
82787596|NCT01583959|Folic Acid|folic acid|mesh-list
82787597|NCT01583959|Hematinics|hematinics|mesh-ancestor
82787598|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
82787599|NCT01583959|Vitamins|vitamins|mesh-ancestor
82787600|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
82787601|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787602|NCT00803387|Travoprost|travoprost|mesh-list
82787603|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82787604|NCT02553551|Vitamins|vitamins|mesh-list
82787605|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
82787606|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787607|NCT00803465|Fluticasone|fluticasone|mesh-list
82787608|NCT00803465|Xhance|xhance|mesh-list
82787609|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787610|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82787611|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
82787612|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787613|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787614|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82787615|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
82787616|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787617|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82787618|NCT00803699|Selenium|selenium|mesh-list
82787619|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
82787620|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787621|NCT00803699|Protective Agents|protective agents|mesh-ancestor
82787622|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787623|NCT00803699|Trace Elements|trace elements|mesh-ancestor
82787624|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
82787625|NCT00798785|Rituximab|rituximab|mesh-list
82787626|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787627|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787628|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
82787629|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787630|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787631|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82787632|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82787633|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787634|NCT01095991|Incretins|incretins|mesh-ancestor
82787635|NCT01095991|Hormones|hormones|mesh-ancestor
82787636|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787637|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82787638|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
82787639|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787640|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787641|NCT00794807|Alefacept|alefacept|mesh-list
82787642|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787643|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
82787644|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787645|NCT00794885|Folic Acid|folic acid|mesh-list
82787646|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
82787647|NCT00794885|Enalapril|enalapril|mesh-list
82787648|NCT00794885|Enalaprilat|enalaprilat|mesh-list
82787649|NCT00794885|Maleic acid|maleic acid|mesh-list
82787650|NCT00794885|Hematinics|hematinics|mesh-ancestor
82787651|NCT00794885|Vitamins|vitamins|mesh-ancestor
82787652|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
82787653|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787654|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787655|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787656|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82787657|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
82787658|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82787659|NCT00803933|Pentamidine|pentamidine|mesh-list
83361928|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787660|NCT00803933|Pafuramidine|pafuramidine|mesh-list
82787661|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
82787662|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787663|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82787664|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82787665|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82787666|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
82787667|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82787668|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787669|NCT00799175|Ketorolac|ketorolac|mesh-list
82787670|NCT00799175|Epinephrine|epinephrine|mesh-list
82787671|NCT00799175|Ropivacaine|ropivacaine|mesh-list
82787672|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
82787673|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
82787674|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787675|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787676|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
82787677|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787678|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82787679|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82787680|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787681|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787682|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787683|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82787684|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82787685|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
82787686|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82787687|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
82787688|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
82787689|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
82787690|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82787691|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82787692|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82787693|NCT00799175|Analgesics|analgesics|mesh-ancestor
82787694|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787695|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787696|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82787697|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787698|NCT00656513|Pilocarpine|pilocarpine|mesh-list
82787699|NCT00656513|Miotics|miotics|mesh-ancestor
82787700|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
82787701|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787702|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787703|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82787704|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82787705|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
82787706|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787707|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787708|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82787710|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787711|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787712|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82787713|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787714|NCT00804245|Choline|choline|mesh-list
82787715|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
82787716|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82787717|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
82787718|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787719|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82787720|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82787721|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
82787722|NCT00804401|Naproxen|naproxen|mesh-list
82787723|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82787724|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82787725|NCT00804401|Analgesics|analgesics|mesh-ancestor
82787726|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
82787727|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787728|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787729|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787730|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787731|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
82787732|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82787733|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787734|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787735|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82787736|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
83361929|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
83361930|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82787737|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82787738|NCT02553083|Amoxicillin|amoxicillin|mesh-list
82787739|NCT02553083|Doxycycline|doxycycline|mesh-list
82787740|NCT02553083|Esomeprazole|esomeprazole|mesh-list
82787741|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82787742|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787743|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
82787744|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82787745|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82787746|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82787747|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82787748|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82787749|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787750|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787751|NCT00804947|Melphalan|melphalan|mesh-list
82787752|NCT00804947|Busulfan|busulfan|mesh-list
82787753|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82787754|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
82787755|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787756|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787757|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82787758|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787759|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
82787760|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787761|NCT00806663|Sunitinib|sunitinib|mesh-list
82787762|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787763|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82787764|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82787765|NCT00806663|Growth Substances|growth substances|mesh-ancestor
82787766|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787767|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
82787768|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82787769|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787770|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787771|NCT00806741|Phenylephrine|phenylephrine|mesh-list
82787772|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
82787773|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
82787774|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82787775|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
82787776|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
82787777|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787778|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787779|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
82787780|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82787781|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
82787782|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
82787783|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82787784|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82787785|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82787786|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787787|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787788|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787789|NCT00806741|Protective Agents|protective agents|mesh-ancestor
82787790|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787791|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
82787792|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82787793|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787794|NCT00805649|Dexamethasone|dexamethasone|mesh-list
82787795|NCT00805649|Bevacizumab|bevacizumab|mesh-list
82787796|NCT00805649|Temazepam|temazepam|mesh-list
82787797|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787798|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787799|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83441033|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787800|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82787801|NCT00805649|Growth Substances|growth substances|mesh-ancestor
82787802|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787803|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
82787804|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787805|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
82787806|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
82787807|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787808|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83361931|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
82787809|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
82787810|NCT00805649|Hormones|hormones|mesh-ancestor
82787811|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787812|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82787813|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82787814|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787815|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82787816|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82787817|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82787818|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
82787819|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
82787820|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787821|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787822|NCT00807053|Ciclesonide|ciclesonide|mesh-list
82787823|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
82787824|NCT00807053|Hormones|hormones|mesh-ancestor
82787825|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787826|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787827|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82787828|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
82787829|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82787830|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82787831|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787832|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
82787833|NCT00809393|Coagulants|coagulants|mesh-ancestor
82787834|NCT00658775|Esomeprazole|esomeprazole|mesh-list
82787835|NCT00658775|Rabeprazole|rabeprazole|mesh-list
82787836|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82787837|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82787838|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82787839|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787840|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787841|NCT00488631|Golimumab|golimumab|mesh-list
82787842|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82787843|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82787844|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787845|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787846|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
82787847|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787848|NCT00809549|Lenograstim|lenograstim|mesh-list
82787849|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82787850|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
82787851|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787852|NCT00809627|Caffeine|caffeine|mesh-list
82787853|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82787854|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787855|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82787856|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787857|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787858|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82787859|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82787860|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
82787861|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787862|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82787863|NCT00809705|Incretins|incretins|mesh-ancestor
82787864|NCT00809705|Hormones|hormones|mesh-ancestor
82787865|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787866|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787867|NCT00655499|Irinotecan|irinotecan|mesh-list
82787868|NCT00655499|Panitumumab|panitumumab|mesh-list
82787869|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82787870|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82787871|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787872|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787873|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787874|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787875|NCT00800267|Timolol|timolol|mesh-list
82787876|NCT00800267|Latanoprost|latanoprost|mesh-list
82787877|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82787878|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82787879|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787880|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787881|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787882|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787883|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82787884|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82787885|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82787886|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82787888|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82787889|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82787890|NCT00809939|Progestins|progestins|mesh-ancestor
82787891|NCT00809939|Hormones|hormones|mesh-ancestor
82787892|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787893|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787894|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82787895|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
82787896|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
82787897|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82787898|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82787899|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
82787900|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82787901|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82787902|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82787903|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787904|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787905|NCT00807521|Dexamethasone|dexamethasone|mesh-list
82787906|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787907|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
82787908|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
82787909|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787910|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787911|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82787912|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
82787913|NCT00807521|Hormones|hormones|mesh-ancestor
82787914|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787915|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82787916|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787917|NCT00800423|Timolol|timolol|mesh-list
82787918|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82787919|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787920|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82787921|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82787922|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
82787923|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787924|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787925|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82787926|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82787927|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82787928|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82787929|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82787930|NCT00651755|Prednisone|prednisone|mesh-list
82787931|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
82787933|NCT00651755|Doxorubicin|doxorubicin|mesh-list
82787934|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82787935|NCT00651755|Vincristine|vincristine|mesh-list
82787936|NCT00651755|Ondansetron|ondansetron|mesh-list
82787938|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787939|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
82787940|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787941|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82787942|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82787943|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
82787944|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787945|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787946|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82787947|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82787948|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82787949|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82787950|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82787951|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787952|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82787953|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
82787954|NCT00651755|Hormones|hormones|mesh-ancestor
82787955|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82787956|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82787957|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82787958|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
82787959|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
82787960|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
82787961|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
82787962|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
82787963|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787964|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82787965|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
82787966|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
82787967|NCT00651755|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82787968|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82787969|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
82787970|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82787971|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82787972|NCT00807755|Carboplatin|carboplatin|mesh-list
82787973|NCT00807755|Etoposide|etoposide|mesh-list
82787974|NCT00807755|Everolimus|everolimus|mesh-list
82787975|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82787976|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82787977|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82787978|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82787979|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82787980|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787981|NCT00807755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82787982|NCT00807755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82787983|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82787984|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
82787985|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787986|NCT00813527|Fenofibrate|fenofibrate|mesh-list
82787987|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82787988|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
82787989|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82787990|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82787991|NCT00810563|Bupivacaine|bupivacaine|mesh-list
82787992|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
82787993|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
82787994|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82787995|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82787996|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
82787997|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82787998|NCT00808145|Cisplatin|cisplatin|mesh-list
82787999|NCT00808145|Gemcitabine|gemcitabine|mesh-list
82788000|NCT00808145|Sorafenib|sorafenib|mesh-list
82788001|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788002|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788003|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
82788004|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788005|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788006|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788008|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
82788009|NCT02552459|Dsuvia|dsuvia|mesh-list
82788010|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82788011|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82788012|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788013|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82788014|NCT02552459|Analgesics|analgesics|mesh-ancestor
82788015|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
82788016|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788017|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82788018|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82788019|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82788020|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
82788021|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788022|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788023|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82788024|NCT02552459|Narcotics|narcotics|mesh-ancestor
82788025|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82788026|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82788027|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
82788028|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
82788029|NCT00810953|Pentamidine|pentamidine|mesh-list
82788030|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
82788031|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788032|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82788033|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82788034|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82788035|NCT00811031|Prednisone|prednisone|mesh-list
82788036|NCT00811031|Docetaxel|docetaxel|mesh-list
82788037|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788038|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788039|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788040|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788041|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788042|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788043|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
82788044|NCT00811031|Hormones|hormones|mesh-ancestor
82788045|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788046|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788047|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788048|NCT02552537|Mannitol|mannitol|mesh-list
82788049|NCT02552537|Omeprazole|omeprazole|mesh-list
82788050|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82788051|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82788052|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82788053|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788054|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788055|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82788056|NCT02552537|Diuretics|diuretics|mesh-ancestor
82788057|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
82788058|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788059|NCT00808223|Alefacept|alefacept|mesh-list
82788060|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788061|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
82788062|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788063|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
82788064|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
82788065|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82788066|NCT00811421|Mefloquine|mefloquine|mesh-list
82788067|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
82788068|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82788069|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82788070|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788071|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82788072|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788073|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788074|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82788075|NCT00569777|Ketotifen|ketotifen|mesh-list
82788076|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
82788077|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788078|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82788079|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
82788080|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
82788081|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788082|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788083|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788084|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82788085|NCT00654095|Atorvastatin|atorvastatin|mesh-list
82788086|NCT00654095|Ezetimibe|ezetimibe|mesh-list
82788087|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82788088|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82788089|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
82788090|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788091|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82788092|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82788093|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788094|NCT00811967|Ribavirin|ribavirin|mesh-list
82788095|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82788096|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
82788097|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
82788098|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788099|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
82788100|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788101|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
82788102|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788103|NCT04046159|Tamoxifen|tamoxifen|mesh-list
82788104|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82788105|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
82788106|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788107|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788108|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788109|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788110|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82788111|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82788112|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82788113|NCT00653939|Paclitaxel|paclitaxel|mesh-list
82788114|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
82788115|NCT00653939|Combretastatin|combretastatin|mesh-list
82788116|NCT00653939|Bevacizumab|bevacizumab|mesh-list
82788117|NCT00653939|Carboplatin|carboplatin|mesh-list
82788118|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82788119|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788120|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788121|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788122|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788123|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788124|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788125|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82788126|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82788127|NCT00653939|Growth Substances|growth substances|mesh-ancestor
82788128|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788129|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
82788130|NCT00812123|Cyclosporine|cyclosporine|mesh-list
82788131|NCT00812123|Sirolimus|sirolimus|mesh-list
82788132|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
82788133|NCT00812123|Prednisone|prednisone|mesh-list
82788134|NCT00812123|Cyclosporins|cyclosporins|mesh-list
82788135|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788136|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
82788137|NCT00812123|Hormones|hormones|mesh-ancestor
82788138|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788139|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788140|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788141|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788142|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788143|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788144|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788145|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
82788146|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
82788147|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788148|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788149|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788150|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82788151|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82788152|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82788153|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
82788154|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82788155|NCT00646451|Pregabalin|pregabalin|mesh-list
82788156|NCT00646451|Analgesics|analgesics|mesh-ancestor
82788157|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
82788158|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788159|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788160|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
82788161|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82788162|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788163|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788164|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82788165|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82788166|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82788167|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82788168|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82788169|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
82788170|NCT00809237|Gefitinib|gefitinib|mesh-list
82788171|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
82788172|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82788173|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82788174|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788175|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788176|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788177|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788178|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788179|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788180|NCT00817583|Docetaxel|docetaxel|mesh-list
82788181|NCT00817583|Fluorouracil|fluorouracil|mesh-list
82788182|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788183|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788184|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788185|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788186|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788187|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
82788188|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788190|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
82788191|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788192|NCT00817661|Vitamin A|vitamin a|mesh-list
82788193|NCT00817661|Vitamins|vitamins|mesh-ancestor
82788194|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
82788195|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788196|NCT00642707|Leronlimab|leronlimab|mesh-list
82788197|NCT00642707|Antibodies|antibodies|mesh-list
82788198|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82788199|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
82788200|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788201|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82788202|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82788203|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788204|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82788205|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82788206|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
82788207|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788208|NCT02551523|Dolutegravir|dolutegravir|mesh-list
82788209|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82788210|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82788211|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82788212|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788213|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788214|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82788215|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
82788216|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788217|NCT00817739|Leuprolide|leuprolide|mesh-list
82788218|NCT00817739|Flutamide|flutamide|mesh-list
82788219|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82788220|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
82788221|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82788222|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788223|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788224|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788225|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
82788226|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
82788227|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788228|NCT00817895|Cisplatin|cisplatin|mesh-list
82788229|NCT00817895|Fluorouracil|fluorouracil|mesh-list
82788230|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788231|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
82788232|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788233|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788234|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788235|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
82788236|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788237|NCT00814229|Vaccines|vaccines|mesh-list
82788238|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
82788239|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
82788240|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788241|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82788242|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82788243|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82788244|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82788245|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788246|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788247|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
82788248|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788249|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788250|NCT00061945|Leucovorin|leucovorin|mesh-list
82788251|NCT00061945|Cytarabine|cytarabine|mesh-list
82788252|NCT00061945|Acyclovir|acyclovir|mesh-list
82788253|NCT00061945|Trimethoprim|trimethoprim|mesh-list
82788254|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
82788255|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82788256|NCT00061945|Dexamethasone|dexamethasone|mesh-list
82788257|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
82788258|NCT00061945|Methotrexate|methotrexate|mesh-list
82788259|NCT00061945|Vincristine|vincristine|mesh-list
82788260|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
82788261|NCT00061945|Daunorubicin|daunorubicin|mesh-list
82788262|NCT00061945|Asparaginase|asparaginase|mesh-list
82788263|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
82788264|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
82788265|NCT00061945|Allopurinol|allopurinol|mesh-list
82788266|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
82788267|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788268|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
82788269|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788270|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788271|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82788272|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
82788273|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788274|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788275|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82788276|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788277|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
82788278|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
82788279|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788280|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82788281|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
82788282|NCT00061945|Hormones|hormones|mesh-ancestor
82788283|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788284|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788285|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82788286|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
82788287|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82788288|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788289|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
82788290|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788291|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788292|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82788293|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82788294|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
82788295|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788296|NCT00061945|Antidotes|antidotes|mesh-ancestor
82788297|NCT00061945|Protective Agents|protective agents|mesh-ancestor
82788298|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
82788299|NCT00061945|Vitamins|vitamins|mesh-ancestor
82788300|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
82788301|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82788302|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788303|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788304|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788305|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788306|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82788307|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82788308|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82788309|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788310|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
82788311|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82788312|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
82788313|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82788314|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
82788316|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82788317|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82788318|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82788319|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82788320|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82788321|NCT00817973|Caseins|caseins|mesh-list
82788322|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
82788323|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
82788324|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788325|NCT01097941|Vaccines|vaccines|mesh-list
82788326|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
82788327|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788328|NCT00642473|Metronidazole|metronidazole|mesh-list
82788329|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82788330|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788331|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788332|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788333|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788334|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788335|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82788336|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82788337|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82788338|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82788339|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82788340|NCT00366340|Vaccines|vaccines|mesh-list
82788341|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82788342|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
82788343|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788344|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
82788345|NCT03992326|Fludarabine|fludarabine|mesh-list
82788346|NCT03992326|Interleukin-2|interleukin-2|mesh-list
82788347|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788348|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
82788349|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788350|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788351|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82788352|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
82788353|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788354|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788355|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82788356|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82788357|NCT03992326|Analgesics|analgesics|mesh-ancestor
82788358|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
82788359|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788360|NCT01045954|Insulin|insulin|mesh-list
82788361|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
82788362|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
82788363|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82788364|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788365|NCT01046032|Metformin|metformin|mesh-list
82788366|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82788367|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788368|NCT00061633|Vancomycin|vancomycin|mesh-list
82788369|NCT00061633|Penicillins|penicillins|mesh-list
82788370|NCT00061633|Telavancin|telavancin|mesh-list
82788371|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82788372|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788373|NCT00645593|Gemcitabine|gemcitabine|mesh-list
82788374|NCT00645593|Cetuximab|cetuximab|mesh-list
82788375|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788376|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788377|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
82788378|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788379|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788380|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
82788381|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
82788382|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788383|NCT02550977|Gestodene|gestodene|mesh-list
82788384|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82788385|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82788386|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82788387|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
82788388|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82788389|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788390|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82788391|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82788392|NCT02550977|Progestins|progestins|mesh-ancestor
82788393|NCT02550977|Hormones|hormones|mesh-ancestor
82788394|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788395|NCT01045018|Mesalamine|mesalamine|mesh-list
82788396|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82788397|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82788398|NCT01045018|Analgesics|analgesics|mesh-ancestor
82788399|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
82788400|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788401|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788402|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788403|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788404|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
82788405|NCT01049464|Analgesics|analgesics|mesh-ancestor
82788406|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
82788407|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788408|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788409|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
82788410|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82788411|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82788412|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
82788413|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82788414|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788415|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788416|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82788417|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
82788418|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82788419|NCT01046266|Cetuximab|cetuximab|mesh-list
82788420|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788421|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788422|NCT00365794|Testosterone|testosterone|mesh-list
82788423|NCT00365794|Androgens|androgens|mesh-ancestor
82788424|NCT00365794|Hormones|hormones|mesh-ancestor
82788425|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788426|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788427|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
82788428|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82788429|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82788430|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82788431|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788432|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788433|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
82788434|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788435|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788436|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82788437|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788438|NCT00365716|Vaccines|vaccines|mesh-list
82788439|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
82788440|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788441|NCT01049542|Astressin|astressin|mesh-list
82788442|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82788443|NCT01049542|Protective Agents|protective agents|mesh-ancestor
82788444|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788445|NCT01049620|Capecitabine|capecitabine|mesh-list
82788446|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
82788447|NCT01049620|Everolimus|everolimus|mesh-list
82788448|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788449|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
82788450|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788451|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788452|NCT01049620|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82788453|NCT01049620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788454|NCT01049620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788455|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788456|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
82788457|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788458|NCT00059839|Prednisone|prednisone|mesh-list
82788459|NCT00059839|Doxorubicin|doxorubicin|mesh-list
82788460|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82788461|NCT00059839|Methotrexate|methotrexate|mesh-list
82788462|NCT00059839|Vincristine|vincristine|mesh-list
82788463|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
82788464|NCT00059839|Vinblastine|vinblastine|mesh-list
82788465|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82788466|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788467|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82788468|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82788469|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788470|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788471|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788472|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
82788473|NCT00059839|Hormones|hormones|mesh-ancestor
82788474|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788475|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788476|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788477|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82788478|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
82788479|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82788480|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788481|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
82788482|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788483|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82788484|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788485|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
82788486|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788487|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82788488|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82788489|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788490|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788491|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788492|NCT00059215|Clopidogrel|clopidogrel|mesh-list
82788493|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82788494|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82788495|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82788496|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82788497|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82788498|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
82788499|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788500|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788501|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788502|NCT00058825|Cyclosporine|cyclosporine|mesh-list
82788503|NCT00058825|Fludarabine|fludarabine|mesh-list
82788504|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
82788505|NCT00058825|Tacrolimus|tacrolimus|mesh-list
82788506|NCT00058825|Cyclosporins|cyclosporins|mesh-list
82788507|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788508|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788509|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788510|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
82788511|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788512|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82788513|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788514|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
82788515|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788516|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788517|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788518|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788519|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82788520|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
82788521|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788522|NCT03953989|Ranolazine|ranolazine|mesh-list
82788523|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82788524|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788525|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788526|NCT01096225|Vaccines|vaccines|mesh-list
82788527|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
82788528|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788529|NCT02535130|Amikacin|amikacin|mesh-list
82788530|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82788531|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788532|NCT01046500|Inositol|inositol|mesh-list
82788533|NCT01046500|Metformin|metformin|mesh-list
82788534|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82788535|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788536|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
82788537|NCT01046500|Vitamins|vitamins|mesh-ancestor
82788538|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
82788539|NCT01046578|Letrozole|letrozole|mesh-list
82788540|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788541|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82788542|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82788543|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788544|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788545|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82788546|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
82788547|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788548|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788549|NCT00372424|Docetaxel|docetaxel|mesh-list
82788550|NCT00372424|Trastuzumab|trastuzumab|mesh-list
82788551|NCT00372424|Sunitinib|sunitinib|mesh-list
82788552|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788553|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788554|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788555|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788556|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788557|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788558|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82788559|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82788560|NCT00372424|Growth Substances|growth substances|mesh-ancestor
82788561|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788562|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
82788563|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788564|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788565|NCT02530411|Fulvestrant|fulvestrant|mesh-list
82788566|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788567|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788568|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83361932|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788569|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82788570|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
82788571|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788572|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788573|NCT01327027|Vasopressins|vasopressins|mesh-list
82788574|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
82788575|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
82788576|NCT01327027|Coagulants|coagulants|mesh-ancestor
82788577|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82788578|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82788579|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
82788580|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788581|NCT01093807|Enalapril|enalapril|mesh-list
82788582|NCT01093807|Enalaprilat|enalaprilat|mesh-list
82788583|NCT01093807|Lercanidipine|lercanidipine|mesh-list
82788584|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82788585|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
82788586|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788587|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788588|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82788589|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82788590|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788591|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82788592|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788593|NCT00044083|Tolcapone|tolcapone|mesh-list
82788594|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82788595|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82788596|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82788597|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788598|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788599|NCT00058123|Poly ICLC|poly iclc|mesh-list
82788600|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
82788601|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
82788602|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788603|NCT00022633|Paclitaxel|paclitaxel|mesh-list
82788604|NCT00022633|Gemcitabine|gemcitabine|mesh-list
82788605|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82788606|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788607|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788608|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788609|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788610|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788611|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788612|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
82788613|NCT00021541|Tipifarnib|tipifarnib|mesh-list
82788614|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788615|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
82788616|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788617|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788618|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788619|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788621|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82788622|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788623|NCT00488475|Etanercept|etanercept|mesh-list
82788624|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82788625|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82788626|NCT00488475|Analgesics|analgesics|mesh-ancestor
82788627|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
82788628|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788629|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788630|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788631|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788632|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82788633|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788634|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
82788635|NCT01020279|Celecoxib|celecoxib|mesh-list
82788636|NCT01020279|Ketoprofen|ketoprofen|mesh-list
82788637|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82788638|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82788639|NCT01020279|Analgesics|analgesics|mesh-ancestor
82788640|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
82788641|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788642|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788643|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788644|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788645|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82788646|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82788647|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788648|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788649|NCT01020357|Caffeine|caffeine|mesh-list
82788650|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
82788651|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788652|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82788653|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788654|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82788655|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788656|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82788657|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82788658|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
82788659|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788660|NCT00042991|Gefitinib|gefitinib|mesh-list
82788661|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788662|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788663|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788664|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788665|NCT00466167|Pramipexole|pramipexole|mesh-list
82788666|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
82788667|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788668|NCT00466167|Protective Agents|protective agents|mesh-ancestor
82788669|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788670|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82788671|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82788672|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
82788673|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
82788674|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788675|NCT01017939|Prednisone|prednisone|mesh-list
82788676|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
82788677|NCT01017939|Theophylline|theophylline|mesh-list
82788678|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
82788679|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788680|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
82788681|NCT01017939|Hormones|hormones|mesh-ancestor
82788682|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788683|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788684|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82788685|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788686|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82788687|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788688|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788689|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
82788690|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82788691|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
82788692|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
82788693|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82788694|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82788695|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788696|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82788698|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788699|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82788700|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82788701|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
82788702|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82788703|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82788704|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
82788705|NCT00480441|Dronabinol|dronabinol|mesh-list
82788706|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
82788707|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788708|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82788709|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82788710|NCT00480441|Analgesics|analgesics|mesh-ancestor
82788711|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
82788712|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788713|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82788714|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82788715|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361933|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82788716|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788718|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788719|NCT01022463|Atenolol|atenolol|mesh-list
82788720|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82788721|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82788722|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
82788723|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
82788724|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788725|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788726|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82788727|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82788728|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82788729|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
82788730|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788731|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788732|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82788733|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82788734|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82788735|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82788736|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788737|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82788738|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82788739|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82788740|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
82788741|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788742|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788743|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82788744|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82788745|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
82788746|NCT01018251|Alovudine|alovudine|mesh-list
82788747|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
82788748|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788749|NCT00463047|Fentanyl|fentanyl|mesh-list
82788750|NCT00463047|Oxycodone|oxycodone|mesh-list
82788751|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82788752|NCT00463047|Narcotics|narcotics|mesh-ancestor
82788753|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82788754|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788755|NCT00463047|Analgesics|analgesics|mesh-ancestor
82788756|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
82788757|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788758|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82788759|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82788760|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
82788761|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
82788762|NCT00487539|Golimumab|golimumab|mesh-list
82788763|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82788764|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82788765|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788766|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788767|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
82788768|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788769|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
82788770|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82788771|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788772|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788773|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82788774|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82788775|NCT00486759|Bevacizumab|bevacizumab|mesh-list
82788776|NCT00486759|Rituximab|rituximab|mesh-list
82788777|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788778|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788779|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82788780|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82788781|NCT00486759|Growth Substances|growth substances|mesh-ancestor
82788782|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788783|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
82788784|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
82788785|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788786|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
82788787|NCT00486603|Temozolomide|temozolomide|mesh-list
83361934|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82788788|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82788789|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
82788790|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788791|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788792|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
82788793|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82788794|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82788795|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788796|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788797|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788798|NCT00474045|Insulin|insulin|mesh-list
82788799|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82788800|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
82788801|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
82788802|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
82788803|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
82788804|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
82788805|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82788806|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788807|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82788808|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
82788809|NCT01020825|Coagulants|coagulants|mesh-ancestor
82788810|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
82788811|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82788812|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82788813|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82788814|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788815|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788816|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
82788817|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788818|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788819|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82788820|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788821|NCT00462501|Leucovorin|leucovorin|mesh-list
82788822|NCT00462501|Bevacizumab|bevacizumab|mesh-list
82788823|NCT00462501|Fluorouracil|fluorouracil|mesh-list
82788824|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
82788825|NCT00462501|Calcium|calcium|mesh-list
82788826|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
83441071|NCT01271153|Dobutamine|dobutamine|mesh-list
82788827|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788828|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788829|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82788830|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82788831|NCT00462501|Growth Substances|growth substances|mesh-ancestor
82788832|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788833|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
82788834|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82788835|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
82788836|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788837|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788838|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788839|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
82788840|NCT00462501|Antidotes|antidotes|mesh-ancestor
82788841|NCT00462501|Protective Agents|protective agents|mesh-ancestor
82788842|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
82788843|NCT00462501|Vitamins|vitamins|mesh-ancestor
82788844|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
82788845|NCT03996603|Estrogens|estrogens|mesh-list
82788846|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82788847|NCT03996603|Hormones|hormones|mesh-ancestor
82788848|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82788849|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788850|NCT00462345|Rituximab|rituximab|mesh-list
82788851|NCT00462345|Methotrexate|methotrexate|mesh-list
82788852|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788853|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788854|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
82788855|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788856|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788857|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82788858|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
82788859|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82788860|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788861|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
82788862|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788863|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788864|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788865|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82788866|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788867|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82788868|NCT01022541|Bevacizumab|bevacizumab|mesh-list
82788869|NCT01022541|Capecitabine|capecitabine|mesh-list
82788870|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
82788871|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788872|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788873|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82788874|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82788875|NCT01022541|Growth Substances|growth substances|mesh-ancestor
82788876|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788877|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
82788878|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788879|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
82788880|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788881|NCT01047202|Vaccines|vaccines|mesh-list
82788882|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
82788883|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788884|NCT01049854|Vidarabine|vidarabine|mesh-list
82788885|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
82788886|NCT01049854|Thiotepa|thiotepa|mesh-list
82788887|NCT01049854|Busulfan|busulfan|mesh-list
82788888|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
82788889|NCT01049854|Fludarabine|fludarabine|mesh-list
82788890|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82788891|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788892|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
82788893|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788894|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82788895|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82788896|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
82788897|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441073|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
82788898|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788899|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82788900|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788901|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
82788902|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
82788903|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788904|NCT00453999|Oseltamivir|oseltamivir|mesh-list
82788905|NCT00453999|Peramivir|peramivir|mesh-list
82788906|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
82788907|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82788908|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788909|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788910|NCT00453921|Methylphenidate|methylphenidate|mesh-list
82788911|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82788912|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788913|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82788914|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82788915|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82788916|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788917|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
82788918|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82788920|NCT00382720|Capecitabine|capecitabine|mesh-list
82788921|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
82788922|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788923|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788924|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788925|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788926|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788927|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788928|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
82788929|NCT01025349|Bevacizumab|bevacizumab|mesh-list
82788930|NCT01025349|Docetaxel|docetaxel|mesh-list
82788931|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82788932|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788933|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82788934|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82788935|NCT01025349|Growth Substances|growth substances|mesh-ancestor
82788936|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788937|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
82788938|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
82788939|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
82788940|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
82788941|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788942|NCT02473276|Morphine|morphine|mesh-list
82788943|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82788945|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82788946|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788947|NCT02473276|Analgesics|analgesics|mesh-ancestor
82788948|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
82788949|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82788950|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
82788951|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788952|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
82788953|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82788954|NCT00371566|Lapatinib|lapatinib|mesh-list
82788955|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788956|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788957|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788958|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788959|NCT00371254|Dasatinib|dasatinib|mesh-list
82788960|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788961|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788962|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788963|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788964|NCT00452673|Capecitabine|capecitabine|mesh-list
82788965|NCT00452673|Dasatinib|dasatinib|mesh-list
82788966|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82788967|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
82788968|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82788969|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788970|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82788971|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82788972|NCT00461253|Copper|copper|mesh-list
82788973|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
82788974|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82788975|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
82788976|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82788977|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788978|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82788979|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82788980|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82788981|NCT00461253|Trace Elements|trace elements|mesh-ancestor
82788982|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
82788983|NCT00469833|Insulin|insulin|mesh-list
82788984|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82788985|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
82788986|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
82788987|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82788988|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788989|NCT00641537|Cladribine|cladribine|mesh-list
82788990|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82788991|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82788992|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
82788993|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82788994|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82788995|NCT00814541|Dexamethasone|dexamethasone|mesh-list
82788996|NCT00814541|Doxorubicin|doxorubicin|mesh-list
82788997|NCT00814541|Bortezomib|bortezomib|mesh-list
82788998|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82788999|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
82789000|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
82789001|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789002|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789003|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82789004|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
82789005|NCT00814541|Hormones|hormones|mesh-ancestor
82789006|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82789007|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82789008|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789009|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789010|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82789011|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82789012|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789013|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789014|NCT00814619|Capecitabine|capecitabine|mesh-list
82789015|NCT00814619|Panitumumab|panitumumab|mesh-list
82789016|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82789017|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
82789018|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361935|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83361936|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789019|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789020|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789021|NCT00641147|Curcumin|curcumin|mesh-list
82789022|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82789023|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82789024|NCT00641147|Analgesics|analgesics|mesh-ancestor
82789025|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
82789026|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789027|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789028|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82789029|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789030|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789031|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789032|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789033|NCT00460239|Morphine|morphine|mesh-list
82789034|NCT00460239|Buprenorphine|buprenorphine|mesh-list
82789035|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82789036|NCT00460239|Narcotics|narcotics|mesh-ancestor
82789037|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789038|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789039|NCT00460239|Analgesics|analgesics|mesh-ancestor
82789040|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
82789041|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789042|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82789043|NCT00640835|Buprenorphine|buprenorphine|mesh-list
82789044|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82789045|NCT00640835|Naloxone|naloxone|mesh-list
82789046|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82789047|NCT00640835|Narcotics|narcotics|mesh-ancestor
82789048|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789049|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789050|NCT00640835|Analgesics|analgesics|mesh-ancestor
82789051|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
82789052|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789053|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82789054|NCT03839355|Warfarin|warfarin|mesh-list
82789055|NCT03839355|Apixaban|apixaban|mesh-list
82789056|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
82789057|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82789058|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
82789059|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82789060|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
82789061|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789062|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789063|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82789064|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
82789065|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82789066|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82789067|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82789068|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789069|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789070|NCT02551133|Dexamethasone|dexamethasone|mesh-list
82789071|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82789072|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
82789073|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
82789074|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789075|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789076|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82789077|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
82789078|NCT02551133|Hormones|hormones|mesh-ancestor
82789079|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82789080|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82789081|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789082|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
82789083|NCT00452439|Vitamin D|vitamin d|mesh-list
82789084|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
82789085|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
82789086|NCT00452439|Calcium|calcium|mesh-list
82789087|NCT00452439|Vitamins|vitamins|mesh-ancestor
82789088|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
82789089|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789090|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82789091|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82789092|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82789093|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789094|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789095|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82789096|NCT01023087|Colistin|colistin|mesh-list
82789097|NCT01023087|Polymyxins|polymyxins|mesh-list
82789098|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82789099|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789100|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
82789101|NCT00381940|Bortezomib|bortezomib|mesh-list
82789102|NCT00381940|Vinorelbine|vinorelbine|mesh-list
82789103|NCT00381940|Ifosfamide|ifosfamide|mesh-list
82789104|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789105|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82789106|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
82789107|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
82789108|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
82789109|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789110|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82789111|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
82789112|NCT00818675|Sirolimus|sirolimus|mesh-list
82789113|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82789114|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789115|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789116|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789117|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
82789118|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789119|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
82789120|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789121|NCT00364156|Nicotine|nicotine|mesh-list
82789122|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82789123|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
82789124|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789125|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789126|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82789127|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82789128|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
82789129|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789130|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789131|NCT00452361|Cyclosporine|cyclosporine|mesh-list
82789132|NCT00452361|Sirolimus|sirolimus|mesh-list
82789133|NCT00452361|Tacrolimus|tacrolimus|mesh-list
82789134|NCT00452361|Cyclosporins|cyclosporins|mesh-list
82789135|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82789136|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789137|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
82789138|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789139|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789140|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789142|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789143|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
82789144|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789145|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82789146|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789147|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789148|NCT03334318|Allopurinol|allopurinol|mesh-list
82789149|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
82789150|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789151|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789152|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
82789153|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789154|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82789155|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
82789156|NCT03334318|Protective Agents|protective agents|mesh-ancestor
82789157|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789158|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
82789159|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82789160|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82789161|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789162|NCT03877809|Sirolimus|sirolimus|mesh-list
82789163|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82789164|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789165|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789166|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789167|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
83361937|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789168|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789169|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
82789170|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789172|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82789173|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82789174|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789175|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789176|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
82789177|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789178|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82789179|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82789180|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
82789181|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82789182|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
82789183|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82789184|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82789185|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82789186|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83481368|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789187|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789188|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
82789189|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789190|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789191|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82789192|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789193|NCT01047748|Digoxin|digoxin|mesh-list
82789194|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82789195|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82789196|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789197|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789198|NCT01047748|Protective Agents|protective agents|mesh-ancestor
82789199|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789200|NCT00568451|Paclitaxel|paclitaxel|mesh-list
82789201|NCT00568451|Carboplatin|carboplatin|mesh-list
82789202|NCT00568451|Temozolomide|temozolomide|mesh-list
82789203|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82789204|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789205|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
82789206|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
82789207|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
82789208|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789209|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82789210|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
82789211|NCT00459537|Terbinafine|terbinafine|mesh-list
82789212|NCT00459537|Amorolfine|amorolfine|mesh-list
82789213|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
82789214|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789215|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789216|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789217|NCT03866421|Liver Extracts|liver extracts|mesh-list
82789218|NCT03866421|Hematinics|hematinics|mesh-ancestor
82789219|NCT00819377|Milrinone|milrinone|mesh-list
82789220|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82789221|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82789222|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
82789223|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82789224|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82789225|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789226|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789227|NCT00819377|Protective Agents|protective agents|mesh-ancestor
82789228|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789229|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
82789230|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
82789231|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82789232|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789233|NCT01023243|Aspirin|aspirin|mesh-list
82789234|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82789235|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82789236|NCT01023243|Analgesics|analgesics|mesh-ancestor
82789237|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
82789238|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789239|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789240|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82789241|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789242|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83361938|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82789243|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82789244|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789245|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82789246|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82789247|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789248|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
82789249|NCT03762915|Minocycline|minocycline|mesh-list
82789250|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82789251|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789252|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
82789253|NCT00469209|Bortezomib|bortezomib|mesh-list
82789254|NCT00469209|Melphalan|melphalan|mesh-list
82789255|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
82789256|NCT00469209|Vitamins|vitamins|mesh-ancestor
82789257|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
82789258|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789259|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789260|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82789261|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
82789262|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789263|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82789264|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789265|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
82789266|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
82789267|NCT00469209|Protective Agents|protective agents|mesh-ancestor
82789268|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82789269|NCT00635219|Vortioxetine|vortioxetine|mesh-list
82789270|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82789271|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82789272|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789273|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789274|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789275|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789276|NCT00635219|Analgesics|analgesics|mesh-ancestor
82789277|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
82789278|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789279|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
82789280|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82789281|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
82789282|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82789283|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82789284|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789285|NCT00635219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82789286|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
82789287|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82789288|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82789289|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82789290|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82789291|NCT01026129|Lidocaine|lidocaine|mesh-list
82789292|NCT01026129|Remifentanil|remifentanil|mesh-list
82789293|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
82789294|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
82789295|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789296|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789297|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
82789298|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789299|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82789300|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82789301|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82789302|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789303|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789304|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82789305|NCT01026129|Narcotics|narcotics|mesh-ancestor
82789306|NCT01026129|Analgesics|analgesics|mesh-ancestor
82789307|NCT01026285|Risperidone|risperidone|mesh-list
82789308|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
82789309|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82789310|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
82789311|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789312|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789313|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789314|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82789315|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789316|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83361939|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82789317|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82789318|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
82789320|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
82789321|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
82789322|NCT01026363|Calcitriol|calcitriol|mesh-list
82789323|NCT01026363|Vitamins|vitamins|mesh-list
82789324|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
82789325|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789326|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82789327|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82789328|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82789329|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789330|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789331|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82789332|NCT01023399|Artesunate|artesunate|mesh-list
82789333|NCT01023399|Amodiaquine|amodiaquine|mesh-list
82789334|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
82789335|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82789336|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82789337|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789338|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789339|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
82789340|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
82789341|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82789342|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
82789343|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
82789344|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82789345|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82789346|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82789347|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789348|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789349|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
82789350|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789351|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789352|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82789353|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789354|NCT00451035|Panobinostat|panobinostat|mesh-list
82789355|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789356|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82789357|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789358|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789359|NCT00468585|Bevacizumab|bevacizumab|mesh-list
82789360|NCT00468585|Capecitabine|capecitabine|mesh-list
82789361|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789362|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789363|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789364|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789365|NCT00468585|Growth Substances|growth substances|mesh-ancestor
82789366|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789367|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789368|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82789369|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
82789370|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789371|NCT01026597|Alirocumab|alirocumab|mesh-list
82789372|NCT01026597|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82789373|NCT01026597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82789374|NCT01026597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82789375|NCT01026597|Antimetabolites|antimetabolites|mesh-ancestor
82789376|NCT01026597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789377|NCT01026597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82789378|NCT01026597|Protease Inhibitors|protease inhibitors|mesh-ancestor
82789379|NCT01026597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789380|NCT01026597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82789381|NCT00450801|Leucovorin|leucovorin|mesh-list
82789382|NCT00450801|Cytarabine|cytarabine|mesh-list
82789383|NCT00450801|Thalidomide|thalidomide|mesh-list
82789384|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
82789385|NCT00450801|Ifosfamide|ifosfamide|mesh-list
82789386|NCT00450801|Rituximab|rituximab|mesh-list
82789387|NCT00450801|Doxorubicin|doxorubicin|mesh-list
82789388|NCT00450801|Methotrexate|methotrexate|mesh-list
82789389|NCT00450801|Etoposide|etoposide|mesh-list
82789390|NCT00450801|Vincristine|vincristine|mesh-list
82789391|NCT00450801|Granisetron|granisetron|mesh-list
82789392|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789393|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
82789394|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789395|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789396|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82789397|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
82789398|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789399|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789400|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82789401|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789402|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789403|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82789404|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82789405|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789406|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82789407|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
82789408|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82789409|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82789410|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
82789411|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
82789412|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82789413|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82789414|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82789415|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
82789416|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789417|NCT00450801|Antidotes|antidotes|mesh-ancestor
82789418|NCT00450801|Protective Agents|protective agents|mesh-ancestor
82789419|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
82789420|NCT00450801|Vitamins|vitamins|mesh-ancestor
82789421|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
82789422|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
82789423|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
82789424|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
82789425|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
82789426|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
82789427|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789428|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82789429|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
82789430|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82789431|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789432|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789433|NCT00450801|Growth Substances|growth substances|mesh-ancestor
82789434|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789435|NCT00450801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82789436|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82789437|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
82789438|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789439|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
82789440|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789441|NCT00458211|Ziprasidone|ziprasidone|mesh-list
82789442|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82789443|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
82789444|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789445|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789446|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789447|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82789448|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82789449|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789450|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82789451|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82789452|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
82789453|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
82789454|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82789455|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789457|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82789458|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789459|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789460|NCT00633893|Apixaban|apixaban|mesh-list
82789461|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82789462|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
82789463|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82789464|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
82789465|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789466|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789467|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
82789468|NCT02550665|Donepezil|donepezil|mesh-list
82789469|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82789471|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789472|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
82789473|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789474|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789475|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
82789476|NCT00819845|Carvedilol|carvedilol|mesh-list
82789477|NCT00819845|Ramipril|ramipril|mesh-list
82789478|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82789479|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82789480|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82789481|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
82789482|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789483|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789484|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789485|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82789486|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
82789487|NCT00819845|Protective Agents|protective agents|mesh-ancestor
82789488|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82789489|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789490|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82789491|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
82789492|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82789493|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82789494|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
82789495|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789496|NCT00457743|Sunitinib|sunitinib|mesh-list
82789497|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789498|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789499|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789500|NCT00457743|Growth Substances|growth substances|mesh-ancestor
82789501|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789502|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789503|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82789504|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789505|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789506|NCT01023867|Donepezil|donepezil|mesh-list
82789507|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82789508|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789509|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789510|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
82789511|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789512|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789513|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
82789514|NCT00820469|Rituximab|rituximab|mesh-list
82789515|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789516|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789517|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
82789518|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789519|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789521|NCT00815399|Pioglitazone|pioglitazone|mesh-list
82789522|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82789523|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789524|NCT00644969|Varenicline|varenicline|mesh-list
82789525|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82789526|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82789527|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
82789528|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789529|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789530|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789531|NCT00812435|Eptifibatide|eptifibatide|mesh-list
82789532|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82789533|NCT00812513|Becaplermin|becaplermin|mesh-list
82789534|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
82789535|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
82789536|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789537|NCT00812513|Growth Substances|growth substances|mesh-ancestor
82789538|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789539|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
82789540|NCT00820547|Bevacizumab|bevacizumab|mesh-list
82789541|NCT00820547|Docetaxel|docetaxel|mesh-list
82789542|NCT00820547|Fluorouracil|fluorouracil|mesh-list
82789543|NCT00820547|Epirubicin|epirubicin|mesh-list
82789544|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789545|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
82789546|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789547|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789548|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82789549|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
82789550|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789551|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789552|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82789553|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789554|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789555|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789556|NCT00820547|Growth Substances|growth substances|mesh-ancestor
82789557|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789558|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
82789559|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
82789560|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
82789561|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
82789562|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82789563|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789564|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82789565|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82789566|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789567|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
82789568|NCT00815867|Hematinics|hematinics|mesh-ancestor
82789569|NCT00815945|Carboplatin|carboplatin|mesh-list
82789570|NCT00815945|Doxorubicin|doxorubicin|mesh-list
82789571|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789572|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789573|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82789574|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82789575|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789576|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789577|NCT00812825|Prednisolone|prednisolone|mesh-list
82789578|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82789579|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
82789580|NCT00812825|Hormones|hormones|mesh-ancestor
82789581|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82789582|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789583|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82789584|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789585|NCT00628355|Lidocaine|lidocaine|mesh-list
82789586|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
82789587|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
82789588|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789589|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789590|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
82789591|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789592|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82789593|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82789594|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82789595|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789596|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789598|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82789599|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82789600|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
82789601|NCT00647699|Vitamins|vitamins|mesh-ancestor
82789602|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
82789603|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789604|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82789605|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
82789606|NCT00813059|Bevacizumab|bevacizumab|mesh-list
82789607|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789608|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789609|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789610|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789611|NCT00813059|Growth Substances|growth substances|mesh-ancestor
82789612|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789613|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789614|NCT00467649|Insulin|insulin|mesh-list
82789615|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82789616|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
82789617|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
82789618|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
82789619|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
82789620|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
82789621|NCT00467649|Pramlintide|pramlintide|mesh-list
82789622|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
82789623|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82789624|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789625|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
82789626|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82789627|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789628|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82789629|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789630|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
82789631|NCT00450333|Hematinics|hematinics|mesh-ancestor
82789632|NCT00643565|Bevacizumab|bevacizumab|mesh-list
82789633|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789634|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789635|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789636|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789637|NCT00643565|Growth Substances|growth substances|mesh-ancestor
82789638|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789639|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789640|NCT00450255|Aflibercept|aflibercept|mesh-list
82789641|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
82789642|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789643|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789644|NCT00450255|Growth Substances|growth substances|mesh-ancestor
82789645|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789646|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789647|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789648|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82789649|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82789650|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789651|NCT00816413|Cyclosporine|cyclosporine|mesh-list
82789652|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
82789653|NCT00816413|Pentostatin|pentostatin|mesh-list
82789654|NCT00816413|Cyclosporins|cyclosporins|mesh-list
82789655|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789656|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789657|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789658|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
82789659|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789660|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
82789661|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789662|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
82789663|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789664|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82789665|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789666|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789667|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82789668|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
82789669|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82789670|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82789671|NCT00813137|Endostar protein|endostar protein|mesh-list
82789672|NCT00813137|Endostatins|endostatins|mesh-list
82789673|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789674|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789675|NCT00813137|Growth Substances|growth substances|mesh-ancestor
82789676|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789677|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789678|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789680|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82789681|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789682|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82789683|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789684|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
82789685|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789686|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
82789687|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789688|NCT00821483|Frovatriptan|frovatriptan|mesh-list
82789689|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83441100|NCT03006926|Lenvatinib|lenvatinib|mesh-list
82789690|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
82789691|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789692|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789693|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789694|NCT02551367|Letrozole|letrozole|mesh-list
82789695|NCT02551367|Clomiphene|clomiphene|mesh-list
82789696|NCT02551367|Enclomiphene|enclomiphene|mesh-list
83361940|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82789697|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
82789698|NCT02551367|Hormones|hormones|mesh-list
82789699|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789700|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82789701|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789702|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789703|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82789704|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82789705|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789706|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82789707|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
82789708|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82789709|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
82789710|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82789711|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82789712|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82789713|NCT00813449|Dacarbazine|dacarbazine|mesh-list
82789714|NCT00813449|Endostar protein|endostar protein|mesh-list
82789715|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82789716|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
82789717|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789718|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789719|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789720|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789721|NCT00813449|Growth Substances|growth substances|mesh-ancestor
82789722|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789723|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789724|NCT00822029|Alendronate|alendronate|mesh-list
82789725|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82789726|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789727|NCT00467259|Testosterone|testosterone|mesh-list
82789728|NCT00467259|Androgens|androgens|mesh-ancestor
82789729|NCT00467259|Hormones|hormones|mesh-ancestor
82789730|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82789731|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789732|NCT01022151|Aminophylline|aminophylline|mesh-list
82789733|NCT01022151|Doxapram|doxapram|mesh-list
82789734|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82789735|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
82789736|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789737|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789738|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82789739|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
82789740|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82789741|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82789742|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789743|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789744|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82789745|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82789746|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
82789747|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789748|NCT01022151|Protective Agents|protective agents|mesh-ancestor
82789749|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82789751|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
82789752|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
82789753|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789754|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
82789755|NCT00449787|Naproxen|naproxen|mesh-list
82789756|NCT00449787|Sumatriptan|sumatriptan|mesh-list
82789757|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82789758|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82789759|NCT00449787|Analgesics|analgesics|mesh-ancestor
82789760|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
82789761|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789762|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789763|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82789764|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789765|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
82789766|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82789767|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789768|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789769|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82789770|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82789771|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82789772|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
82789773|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789774|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82789775|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789776|NCT01566279|Everolimus|everolimus|mesh-list
82789777|NCT01566279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82789778|NCT01566279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82789779|NCT01566279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789780|NCT01566279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789781|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789782|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
82789783|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789784|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789785|NCT00449163|Leucovorin|leucovorin|mesh-list
82789786|NCT00449163|Bevacizumab|bevacizumab|mesh-list
82789787|NCT00449163|Irinotecan|irinotecan|mesh-list
82789788|NCT00449163|Floxuridine|floxuridine|mesh-list
82789789|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
82789790|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82789791|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789792|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789793|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789794|NCT00449163|Growth Substances|growth substances|mesh-ancestor
82789795|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789796|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789797|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82789798|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82789799|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789800|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789801|NCT00449163|Antidotes|antidotes|mesh-ancestor
82789802|NCT00449163|Protective Agents|protective agents|mesh-ancestor
82789803|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
82789804|NCT00449163|Vitamins|vitamins|mesh-ancestor
82789805|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
82789806|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82789807|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
82789808|NCT01026987|Plerixafor|plerixafor|mesh-list
82789809|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82789810|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82789811|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
82789812|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789813|NCT00448539|Rufinamide|rufinamide|mesh-list
82789814|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
82789815|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82789816|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82789817|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789818|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789820|NCT00457665|Nelfinavir|nelfinavir|mesh-list
82789821|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82789822|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82789823|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789824|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789825|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
82789826|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789827|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82789828|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82789829|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82789830|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82789831|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82789832|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82789833|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82789834|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82789835|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
82789836|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82789837|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82789838|NCT00447603|Losartan|losartan|mesh-list
82789839|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82789840|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82789841|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82789842|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82789843|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82789844|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789845|NCT00447603|Diuretics|diuretics|mesh-ancestor
82789846|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
82789847|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789848|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82789849|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789850|NCT00447057|Pemetrexed|pemetrexed|mesh-list
82789851|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82789852|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789853|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789854|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789855|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82789856|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82789857|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82789858|NCT01027611|Lidocaine|lidocaine|mesh-list
82789859|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
82789860|NCT01027611|Propoxycaine|propoxycaine|mesh-list
82789861|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
82789862|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
82789863|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789864|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789865|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
82789866|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789867|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82789868|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82789869|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82789870|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789871|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789872|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82789873|NCT01024413|Gefitinib|gefitinib|mesh-list
82789874|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789875|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82789876|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789877|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789878|NCT00446511|Valsartan|valsartan|mesh-list
82789879|NCT00446511|Enalapril|enalapril|mesh-list
82789880|NCT00446511|Enalaprilat|enalaprilat|mesh-list
82789881|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82789882|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82789883|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82789884|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789885|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82789886|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
82789887|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789888|NCT01024491|Paroxetine|paroxetine|mesh-list
82789889|NCT01024491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82789890|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82789891|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82789892|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789893|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789894|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
82789895|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789896|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82789897|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
82789898|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82789899|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82789900|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82789901|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789902|NCT00446199|Drospirenone|drospirenone|mesh-list
82789903|NCT00446199|Estradiol|estradiol|mesh-list
82789904|NCT00446199|Estrogens|estrogens|mesh-ancestor
82789905|NCT00446199|Hormones|hormones|mesh-ancestor
82789906|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82789907|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789908|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82789909|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
82789910|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82789911|NCT00446199|Diuretics|diuretics|mesh-ancestor
82789912|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
82789913|NCT01027689|Alprazolam|alprazolam|mesh-list
82789914|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82789915|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82789916|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789917|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83361941|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
82789918|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82789919|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82789920|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
82789921|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
82789922|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789923|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789924|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
82789925|NCT01024647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82789926|NCT01024647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82789927|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789928|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
82789929|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789930|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82789932|NCT01027923|Plerixafor|plerixafor|mesh-list
82789933|NCT01027923|Etoposide|etoposide|mesh-list
82789934|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
82789935|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82789936|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789937|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82789938|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82789939|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789940|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789941|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82789942|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
82789943|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
82789944|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789945|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82789946|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
82789947|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789948|NCT01027923|Analgesics|analgesics|mesh-ancestor
82789949|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
82789950|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82789951|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82789952|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82789953|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
82789954|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
82789955|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82789956|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82789957|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789958|NCT01027065|Tenofovir|tenofovir|mesh-list
82789959|NCT01027065|Entecavir|entecavir|mesh-list
82789960|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
82789961|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82789962|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82789963|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82789964|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789965|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789966|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82789967|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82789968|NCT00456495|Ranibizumab|ranibizumab|mesh-list
82789969|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789970|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789971|NCT00456495|Growth Substances|growth substances|mesh-ancestor
82789972|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789973|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789974|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789975|NCT00445341|Alvocidib|alvocidib|mesh-list
82789976|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789977|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789978|NCT00445341|Growth Substances|growth substances|mesh-ancestor
82789979|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789980|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82789981|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789982|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789983|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82789984|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82789985|NCT00444951|Vaccines|vaccines|mesh-list
82789986|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
82789987|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789988|NCT00444795|Sunitinib|sunitinib|mesh-list
82789989|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82789990|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82789991|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82789992|NCT00444795|Growth Substances|growth substances|mesh-ancestor
83361942|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82789993|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82789994|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
82789995|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82789996|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82789997|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82789998|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
82789999|NCT03846219|Calcium|calcium|mesh-list
82790000|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82790001|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790002|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82790003|NCT00455325|Chloroquine|chloroquine|mesh-list
82790004|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82790005|NCT00455325|Amebicides|amebicides|mesh-ancestor
82790006|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82790007|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82790008|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790009|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
82790010|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790011|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82790012|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82790013|NCT00455325|Analgesics|analgesics|mesh-ancestor
82790014|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
82790015|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790016|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790017|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790018|NCT00455325|Filaricides|filaricides|mesh-ancestor
82790019|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
82790020|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
82790021|NCT01028079|Aspirin|aspirin|mesh-list
82790022|NCT01028079|Ibuprofen|ibuprofen|mesh-list
82790023|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82790024|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82790025|NCT01028079|Analgesics|analgesics|mesh-ancestor
82790026|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
82790027|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790028|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790029|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790030|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790031|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82790032|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82790033|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790034|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82790035|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82790036|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790037|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
82790038|NCT00443781|Anesthetics|anesthetics|mesh-list
82790039|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82790040|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790041|NCT00443703|Ritonavir|ritonavir|mesh-list
82790042|NCT00443703|Lopinavir|lopinavir|mesh-list
82790043|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
82790044|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82790045|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82790046|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
82790047|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790048|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790049|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82790050|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82790051|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
82790052|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790053|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82790054|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82790055|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82790056|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82790057|NCT00381706|Leucovorin|leucovorin|mesh-list
82790058|NCT00381706|Cisplatin|cisplatin|mesh-list
82790059|NCT00381706|Fluorouracil|fluorouracil|mesh-list
82790060|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
82790061|NCT00381706|Irinotecan|irinotecan|mesh-list
82790062|NCT00381706|Cetuximab|cetuximab|mesh-list
82790063|NCT00381706|Epirubicin|epirubicin|mesh-list
82790064|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790065|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
82790066|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790067|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82790068|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82790069|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
82790070|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790071|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82790072|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82790073|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790074|NCT00381706|Antidotes|antidotes|mesh-ancestor
82790075|NCT00381706|Protective Agents|protective agents|mesh-ancestor
82790076|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
82790077|NCT00381706|Vitamins|vitamins|mesh-ancestor
82790078|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
82790079|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790080|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790081|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82790082|NCT01045642|Omeprazole|omeprazole|mesh-list
82790083|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82790084|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790085|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82790086|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790087|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790088|NCT05357430|Propofol|propofol|mesh-list
82790089|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82790090|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82790091|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790092|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82790093|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
82790094|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
82790095|NCT00370552|Paclitaxel|paclitaxel|mesh-list
82790096|NCT00370552|Epothilones|epothilones|mesh-list
82790097|NCT00370552|Bevacizumab|bevacizumab|mesh-list
82790098|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82790099|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790100|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
82790101|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
82790102|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
82790103|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790104|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790105|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82790106|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82790107|NCT00370552|Growth Substances|growth substances|mesh-ancestor
82790108|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790109|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
82790110|NCT00537030|Asparaginase|asparaginase|mesh-list
82790111|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790112|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
82790113|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82790114|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790116|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790117|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790118|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
82790119|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790120|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790121|NCT04928820|Edetic Acid|edetic acid|mesh-list
82790122|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82790123|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
82790124|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
82790125|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790126|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
82790127|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82790128|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82790129|NCT04429152|Tenofovir|tenofovir|mesh-list
82790130|NCT04429152|Lamivudine|lamivudine|mesh-list
82790131|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
82790132|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790133|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82790134|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82790135|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790136|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790137|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82790138|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82790139|NCT04001400|Rabeprazole|rabeprazole|mesh-list
82790140|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82790141|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790142|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82790143|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790144|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790145|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82790146|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82790147|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82790148|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790149|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790150|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
82790151|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790152|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790153|NCT04285866|Durvalumab|durvalumab|mesh-list
82790154|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790155|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790156|NCT01047982|Folic Acid|folic acid|mesh-list
82790157|NCT01047982|Inositol|inositol|mesh-list
82790158|NCT01047982|Hematinics|hematinics|mesh-ancestor
82790159|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
82790160|NCT01047982|Vitamins|vitamins|mesh-ancestor
82790161|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
82790162|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790163|NCT00536874|Gemcitabine|gemcitabine|mesh-list
82790164|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
82790165|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82790166|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
82790167|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790168|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790169|NCT00991848|Lidocaine|lidocaine|mesh-list
82790170|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
82790171|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
82790172|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82790173|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790174|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
82790175|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790176|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82790177|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82790178|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82790179|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790180|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790181|NCT05281068|Danazol|danazol|mesh-list
82790182|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82790183|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
82790184|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790185|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790186|NCT00380068|Ambrisentan|ambrisentan|mesh-list
82790187|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790188|NCT00991926|Orlistat|orlistat|mesh-list
82790189|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790190|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790191|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82790192|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82790193|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
82790194|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790195|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790196|NCT04230954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82790197|NCT04230954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790198|NCT00536484|Fesoterodine|fesoterodine|mesh-list
82790199|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82790200|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82790201|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
82790202|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790203|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790204|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790205|NCT00536484|Urological Agents|urological agents|mesh-ancestor
82790206|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82790207|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
82790208|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790209|NCT00992004|Turmeric extract|turmeric extract|mesh-list
82790210|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
82790211|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790212|NCT00992004|Protective Agents|protective agents|mesh-ancestor
82790213|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790214|NCT03862716|Insulin|insulin|mesh-list
82790215|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82790216|NCT03862716|Metformin|metformin|mesh-list
82790217|NCT03862716|Liraglutide|liraglutide|mesh-list
82790218|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
82790219|NCT03862716|Xultophy|xultophy|mesh-list
82790220|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82790221|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790223|NCT03862716|Hormones|hormones|mesh-ancestor
82790224|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790225|NCT00992082|Ketorolac|ketorolac|mesh-list
82790226|NCT00992082|Epinephrine|epinephrine|mesh-list
82790227|NCT00992082|Morphine|morphine|mesh-list
82790228|NCT00992082|Ropivacaine|ropivacaine|mesh-list
82790229|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82790230|NCT00992082|Narcotics|narcotics|mesh-ancestor
82790231|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82790232|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790233|NCT00992082|Analgesics|analgesics|mesh-ancestor
82790234|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
82790235|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790236|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
82790237|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
82790238|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82790239|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82790240|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
82790241|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790242|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790243|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82790244|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82790245|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
82790246|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82790247|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
82790248|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
82790249|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
82790250|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82790251|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82790252|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82790253|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790254|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790255|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82790256|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790257|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
82790258|NCT00455013|Sirolimus|sirolimus|mesh-list
82790259|NCT00455013|Abatacept|abatacept|mesh-list
82790260|NCT00455013|Tacrolimus|tacrolimus|mesh-list
82790261|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
82790262|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82790263|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
82790264|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790265|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82790266|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790267|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790268|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790269|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790270|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82790271|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
82790272|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82790273|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790274|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
82790275|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82790276|NCT00455013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790277|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790278|NCT00363298|Caffeine|caffeine|mesh-list
82790279|NCT00363298|Amphetamine|amphetamine|mesh-list
82790280|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
82790281|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82790282|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790283|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82790284|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790285|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790286|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82790287|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82790288|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
82790289|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790290|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
82790291|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
82790292|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790293|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
82790294|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
82790295|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82790296|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82790297|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790298|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82790299|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
82790301|NCT05254548|Omeprazole|omeprazole|mesh-list
82790302|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82790303|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82790304|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82790305|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790306|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82790307|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82790308|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82790309|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82790310|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
82790311|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
82790312|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
82790313|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
82790314|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790315|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790316|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82790317|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790318|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82790319|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790320|NCT05254548|Analgesics|analgesics|mesh-ancestor
82790321|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
82790322|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790323|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82790324|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82790325|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790326|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790327|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82790328|NCT00363142|Ritonavir|ritonavir|mesh-list
82790329|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
82790330|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82790331|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82790332|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
82790333|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790334|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790335|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82790336|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82790337|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
82790338|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790339|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82790340|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82790341|NCT05246982|Capecitabine|capecitabine|mesh-list
82790342|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
82790344|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
82790345|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790346|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790347|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
82790348|NCT04002024|Salicylates|salicylates|mesh-list
82790349|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790350|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
82790351|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
82790352|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
82790353|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82790354|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82790355|NCT04002024|Analgesics|analgesics|mesh-ancestor
82790356|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
82790357|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790358|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790359|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790360|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790361|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82790362|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790363|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790364|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
82790365|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82790366|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82790367|NCT01028313|Prednisolone|prednisolone|mesh-list
82790368|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
82790369|NCT01028313|Panobinostat|panobinostat|mesh-list
82790370|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82790371|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
82790372|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790373|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
82790374|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
82790375|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790376|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790377|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790378|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
82790379|NCT01028313|Hormones|hormones|mesh-ancestor
82790380|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790381|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82790382|NCT01028313|Protective Agents|protective agents|mesh-ancestor
82790383|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82790384|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790385|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82790386|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790387|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790388|NCT04001712|Caffeine|caffeine|mesh-list
82790389|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
82790390|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790391|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82790392|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790393|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82790394|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790395|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82790396|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82790397|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
82790398|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790399|NCT01027377|Factor VIII|factor viii|mesh-list
82790400|NCT01027377|Coagulants|coagulants|mesh-ancestor
82790401|NCT00992160|Vestipitant|vestipitant|mesh-list
82790402|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82790403|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790404|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790405|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790406|NCT00379912|Azacitidine|azacitidine|mesh-list
82790407|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
82790408|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82790409|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
82790410|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790411|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790412|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790413|NCT00379912|Hematinics|hematinics|mesh-ancestor
82790414|NCT00992238|Flavoxate|flavoxate|mesh-list
82790415|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
82790416|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
82790417|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790418|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790419|NCT00992238|Urological Agents|urological agents|mesh-ancestor
82790420|NCT00379834|Timolol|timolol|mesh-list
82790421|NCT00379834|Dorzolamide|dorzolamide|mesh-list
82790422|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82790423|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82790424|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
82790425|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790426|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790427|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790428|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82790429|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790430|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82790431|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790432|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
82790433|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
82790434|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790435|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
82790436|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
82790437|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
82790438|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790439|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790440|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790441|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82790442|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82790443|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82790444|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82790445|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82790446|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
82790447|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790448|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790450|NCT03453840|Artemether|artemether|mesh-list
82790451|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82790452|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
82790453|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82790454|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82790455|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790456|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
82790457|NCT03439254|Cathartics|cathartics|mesh-ancestor
82790458|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790459|NCT05354700|Carboplatin|carboplatin|mesh-list
82790460|NCT05354700|Etoposide|etoposide|mesh-list
82790461|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790462|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82790463|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82790464|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82790465|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790466|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790467|NCT03339258|Doxazosin|doxazosin|mesh-list
82790468|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790469|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82790470|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82790471|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82790472|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
82790473|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790474|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790475|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790476|NCT00992706|Doxorubicin|doxorubicin|mesh-list
82790477|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82790478|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790479|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790480|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82790481|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82790482|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790483|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790484|NCT00454779|Cisplatin|cisplatin|mesh-list
82790485|NCT00454779|Docetaxel|docetaxel|mesh-list
82790486|NCT00454779|Panitumumab|panitumumab|mesh-list
82790487|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790488|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
82790489|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
82790490|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
82790491|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790492|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790493|NCT00992862|Moexipril|moexipril|mesh-list
82790494|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82790495|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
82790496|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790497|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790498|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790499|NCT00993096|Insulin|insulin|mesh-list
82790500|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82790501|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
82790502|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
82790503|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82790504|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
82790505|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82790506|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
82790507|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82790508|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790509|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
82790510|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790511|NCT00993408|Selexipag|selexipag|mesh-list
82790512|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790513|NCT03994107|Paclitaxel|paclitaxel|mesh-list
82790514|NCT03994107|Doxorubicin|doxorubicin|mesh-list
82790515|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82790516|NCT03994107|Trastuzumab|trastuzumab|mesh-list
82790517|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82790518|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82790519|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790520|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
82790521|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
82790522|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
82790523|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790524|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790525|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82790526|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82790527|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790528|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790529|NCT03469713|Nivolumab|nivolumab|mesh-list
82790530|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790531|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790532|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82790533|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790534|NCT00427635|Esomeprazole|esomeprazole|mesh-list
82790535|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82790536|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790537|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82790538|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790539|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790540|NCT00993642|Panobinostat|panobinostat|mesh-list
82790541|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790542|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82790543|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790544|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790545|NCT01028547|Dexamethasone|dexamethasone|mesh-list
82790546|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790547|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
82790548|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
82790549|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790550|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790551|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82790552|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
82790553|NCT01028547|Hormones|hormones|mesh-ancestor
82790554|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790555|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82790556|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790557|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
82790558|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
82790559|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82790560|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82790561|NCT01031355|Calcium|calcium|mesh-list
82790562|NCT01031355|Estradiol|estradiol|mesh-list
82790563|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82790564|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82790565|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790566|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82790567|NCT01031355|Estrogens|estrogens|mesh-ancestor
82790568|NCT01031355|Hormones|hormones|mesh-ancestor
82790569|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790570|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82790571|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
82790572|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82790573|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82790574|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
82790575|NCT01031355|Vitamins|vitamins|mesh-ancestor
82790576|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
82790577|NCT00993720|Liraglutide|liraglutide|mesh-list
82790578|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82790579|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790580|NCT00993720|Incretins|incretins|mesh-ancestor
82790581|NCT00993720|Hormones|hormones|mesh-ancestor
82790582|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790583|NCT03891264|Cannabidiol|cannabidiol|mesh-list
82790584|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
82790585|NCT00425607|Lonafarnib|lonafarnib|mesh-list
82790586|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790587|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790588|NCT00437073|Capecitabine|capecitabine|mesh-list
82790589|NCT00437073|Topotecan|topotecan|mesh-list
82790590|NCT00437073|Lapatinib|lapatinib|mesh-list
82790591|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82790592|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
82790593|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790594|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790595|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82790596|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82790597|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790598|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82790599|NCT00425373|Amlodipine|amlodipine|mesh-list
82790600|NCT00425373|Valsartan|valsartan|mesh-list
82790601|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790602|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82790603|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790604|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790605|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82790606|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790607|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
82790608|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82790609|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82790610|NCT01031589|Rilpivirine|rilpivirine|mesh-list
82790611|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82790612|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82790613|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790614|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790615|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
82790616|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790617|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82790618|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82790619|NCT03894540|Paclitaxel|paclitaxel|mesh-list
82790620|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
82790621|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82790622|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790623|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
82790624|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
82790625|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
82790626|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790627|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790628|NCT03894540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82790629|NCT00993876|Citalopram|citalopram|mesh-list
82790630|NCT00993876|Reboxetine|reboxetine|mesh-list
82790631|NCT00993876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82790632|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82790633|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790634|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790635|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790636|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
82790637|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790638|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82790639|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
82790640|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82790641|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82790642|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
82790643|NCT05129358|Furosemide|furosemide|mesh-list
82790644|NCT05129358|Diuretics|diuretics|mesh-ancestor
82790645|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
82790646|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790647|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82790648|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790649|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790650|NCT01646814|Aspirin|aspirin|mesh-list
82790651|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82790652|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82790653|NCT01646814|Analgesics|analgesics|mesh-ancestor
82790654|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
82790655|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790656|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790657|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790658|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790659|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82790660|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82790661|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790662|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82790663|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82790664|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790665|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
82790666|NCT00994344|Ritonavir|ritonavir|mesh-list
82790667|NCT00994344|Lopinavir|lopinavir|mesh-list
82790668|NCT00994344|Darunavir|darunavir|mesh-list
82790669|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82790670|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82790671|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
82790672|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790673|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790674|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82790675|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82790676|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
82790677|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790678|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82790679|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82790680|NCT00994500|Bortezomib|bortezomib|mesh-list
82790681|NCT00994500|Vorinostat|vorinostat|mesh-list
82790682|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790683|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82790684|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790685|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790686|NCT01416636|Treprostinil|treprostinil|mesh-list
82790687|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790688|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
82790689|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82790690|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82790691|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82790692|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790693|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790694|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
82790695|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790696|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790697|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82790698|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790699|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82790700|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82790701|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790702|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
82790703|NCT00999258|Sirolimus|sirolimus|mesh-list
82790704|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82790705|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790706|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790707|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790708|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
82790709|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82790710|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
82790711|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790712|NCT00994734|Mifepristone|mifepristone|mesh-list
82790713|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82790714|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
82790715|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82790716|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790717|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82790718|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82790719|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82790720|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
82790721|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82790722|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82790723|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
82790724|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790725|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
82790726|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82790727|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82790728|NCT00999336|Betrixaban|betrixaban|mesh-list
82790729|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82790730|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
82790731|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82790732|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
82790733|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790734|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790735|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
82790736|NCT00995826|Laninamivir|laninamivir|mesh-list
82790737|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
82790738|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790739|NCT00994812|Metformin|metformin|mesh-list
82790740|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82790741|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790742|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
82790743|NCT00994968|Docetaxel|docetaxel|mesh-list
82790744|NCT00994968|Doxorubicin|doxorubicin|mesh-list
82790745|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82790746|NCT00994968|Tegafur|tegafur|mesh-list
82790747|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82790748|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
82790749|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790750|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790751|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82790752|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
82790753|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790754|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790755|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82790756|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
82790757|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
82790758|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
82790759|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790760|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82790761|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82790762|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790763|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82790764|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
82790765|NCT03887442|Paclitaxel|paclitaxel|mesh-list
82790766|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82790767|NCT03887442|Cetuximab|cetuximab|mesh-list
82790768|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82790769|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790770|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
82790771|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
82790772|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
82790773|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83441154|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790774|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790775|NCT00996060|Hydralazine|hydralazine|mesh-list
82790776|NCT00996060|Valproic Acid|valproic acid|mesh-list
82790777|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
82790778|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790779|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790780|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
82790781|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790782|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790783|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
82790784|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82790785|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82790786|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82790787|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790788|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
82790789|NCT00995046|Factor VIII|factor viii|mesh-list
82790790|NCT00995046|Coagulants|coagulants|mesh-ancestor
82790791|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82790792|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
82790793|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790794|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
82790795|NCT04000932|Hormones|hormones|mesh-ancestor
82790796|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790797|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790798|NCT05170230|Terlipressin|terlipressin|mesh-list
82790799|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82790800|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82790801|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82790802|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
82790803|NCT01000116|Coagulants|coagulants|mesh-ancestor
82790804|NCT00996684|Plasminogen|plasminogen|mesh-list
82790805|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82790806|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82790807|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790808|NCT00996762|Lapatinib|lapatinib|mesh-list
82790809|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790810|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82790811|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790812|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790813|NCT05162196|Niraparib|niraparib|mesh-list
82790814|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82790815|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790816|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790817|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790818|NCT00997074|Ibuprofen|ibuprofen|mesh-list
82790819|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82790820|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82790821|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82790822|NCT00997074|Analgesics|analgesics|mesh-ancestor
82790823|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
82790824|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790825|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790826|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790827|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82790828|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790829|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790830|NCT05249712|Androgens|androgens|mesh-list
82790831|NCT05249712|Hormones|hormones|mesh-ancestor
82790832|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790833|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790834|NCT01000896|Paclitaxel|paclitaxel|mesh-list
82790835|NCT01000896|Carboplatin|carboplatin|mesh-list
82790836|NCT01000896|Saracatinib|saracatinib|mesh-list
82790837|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82790838|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790839|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
82790840|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
82790841|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
82790842|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790843|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790844|NCT00997542|Allopurinol|allopurinol|mesh-list
82790845|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
82790846|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790847|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790848|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
82790849|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790850|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82790851|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
82790852|NCT00997542|Protective Agents|protective agents|mesh-ancestor
82790853|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790854|NCT01001130|Fluticasone|fluticasone|mesh-list
82790855|NCT01001130|Xhance|xhance|mesh-list
82790856|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790857|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82790858|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
82790859|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790860|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790861|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82790862|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
82790863|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
82790864|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82790865|NCT00424827|Gemcitabine|gemcitabine|mesh-list
82790866|NCT00424827|Fluorouracil|fluorouracil|mesh-list
82790867|NCT00424827|Cetuximab|cetuximab|mesh-list
82790868|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82790869|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
82790870|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790871|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790872|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82790873|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
82790874|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790875|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790876|NCT01001364|Budesonide|budesonide|mesh-list
82790877|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
82790878|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790879|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82790880|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
82790881|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790882|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790883|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82790884|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
82790885|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
82790886|NCT01001364|Hormones|hormones|mesh-ancestor
82790887|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790888|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82790889|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82790890|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82790891|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
82790892|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790893|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790894|NCT01031667|Cilostazol|cilostazol|mesh-list
82790895|NCT01031667|Probucol|probucol|mesh-list
82790896|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82790898|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790899|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790900|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82790901|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
82790902|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82790903|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82790904|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790905|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82790906|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
82790907|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82790908|NCT01031667|Protective Agents|protective agents|mesh-ancestor
82790909|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82790910|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82790911|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790912|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82790913|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82790914|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
82790915|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82790916|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
82790917|NCT03995277|Biotin|biotin|mesh-list
82790918|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
82790919|NCT03995277|Vitamins|vitamins|mesh-ancestor
82790920|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
82790921|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790922|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
82790923|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
82790924|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
82790925|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82790926|NCT04000386|Protective Agents|protective agents|mesh-ancestor
82790927|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790928|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
82790929|NCT00998088|Hematinics|hematinics|mesh-ancestor
82790930|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
82790931|NCT00377962|Everolimus|everolimus|mesh-list
82790932|NCT00377962|Azathioprine|azathioprine|mesh-list
82790933|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82790934|NCT00377962|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82790935|NCT00377962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82790936|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790937|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790938|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82790939|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
82790940|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790941|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790942|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
82790943|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82790944|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790945|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790946|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82790947|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
82790948|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82790949|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790950|NCT00424749|Prednisone|prednisone|mesh-list
82790951|NCT00424749|Rituximab|rituximab|mesh-list
82790952|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82790953|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790954|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
82790955|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790956|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790957|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82790958|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
82790959|NCT00424749|Hormones|hormones|mesh-ancestor
82790960|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82790961|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82790962|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82790963|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82790964|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82790965|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82790966|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790967|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82790968|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790969|NCT00424593|Analgesics|analgesics|mesh-ancestor
82790970|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
82790971|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82790972|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
82790973|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82790974|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
82790975|NCT00369382|Cyclosporine|cyclosporine|mesh-list
82790976|NCT00369382|Sirolimus|sirolimus|mesh-list
82790977|NCT00369382|Tacrolimus|tacrolimus|mesh-list
82790978|NCT00369382|Cyclosporins|cyclosporins|mesh-list
82790979|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82790980|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
82790981|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82790982|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82790983|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790984|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790985|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
82790986|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82790987|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
82790988|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82790989|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82790990|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82790991|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790992|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
82790993|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82790994|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82790995|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82790996|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82790997|NCT05131204|Eculizumab|eculizumab|mesh-list
82790998|NCT05131204|Ravulizumab|ravulizumab|mesh-list
82790999|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82791000|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791001|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
82791002|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791003|NCT00377260|Amoxicillin|amoxicillin|mesh-list
82791004|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
82791005|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
82791006|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82791007|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82791008|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791009|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82791010|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791011|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791012|NCT00441441|Fluticasone|fluticasone|mesh-list
82791014|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82791015|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791016|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82791017|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
82791018|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791019|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791020|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82791021|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
82791022|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
82791023|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82791024|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82791025|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82791026|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82791027|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
82791028|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791029|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791030|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
82791031|NCT00436917|Letrozole|letrozole|mesh-list
82791032|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791033|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82791034|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82791035|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791036|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791037|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82791038|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
82791039|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791040|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791041|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82791042|NCT00436605|Dasatinib|dasatinib|mesh-list
82791043|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791044|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82791045|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791046|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791048|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791049|NCT01028781|Thalidomide|thalidomide|mesh-list
82791050|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791051|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
82791052|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791053|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
82791054|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82791055|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791056|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791057|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791058|NCT01028781|Growth Substances|growth substances|mesh-ancestor
82791059|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791060|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791061|NCT01031901|Sirolimus|sirolimus|mesh-list
82791062|NCT01031901|Temsirolimus|temsirolimus|mesh-list
82791063|NCT01031901|MTOR Inhibitors|mtor inhibitors|mesh-list
82791064|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82791065|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791066|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82791067|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791068|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
82791069|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791070|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
82791071|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791072|NCT01031901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82791073|NCT01031901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791074|NCT01031901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791075|NCT00368992|Paclitaxel|paclitaxel|mesh-list
82791076|NCT00368992|Bevacizumab|bevacizumab|mesh-list
82791077|NCT00368992|Cetuximab|cetuximab|mesh-list
82791078|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82791079|NCT00368992|Antibodies|antibodies|mesh-list
82791080|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
82791081|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82791082|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791083|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791084|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791085|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791086|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791087|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791088|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791089|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791090|NCT00368992|Growth Substances|growth substances|mesh-ancestor
82791091|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791092|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791093|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
82791094|NCT00376246|Ezetimibe|ezetimibe|mesh-list
82791095|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82791096|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82791097|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
82791098|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791099|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82791100|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82791101|NCT00375934|Diclofenac|diclofenac|mesh-list
82791102|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82791103|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82791104|NCT00375934|Analgesics|analgesics|mesh-ancestor
82791105|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
82791106|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791107|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791108|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791109|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82791110|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82791111|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791112|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791113|NCT01052584|Chloroquine|chloroquine|mesh-list
82791114|NCT01052584|Lumefantrine|lumefantrine|mesh-list
82791115|NCT01052584|Artemether|artemether|mesh-list
82791116|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82791117|NCT01052584|Amebicides|amebicides|mesh-ancestor
82791118|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82791119|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82791120|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791121|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
82791122|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82791123|NCT02534506|Nivolumab|nivolumab|mesh-list
82791125|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791126|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82791127|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791128|NCT01050322|Gemcitabine|gemcitabine|mesh-list
82791129|NCT01050322|Capecitabine|capecitabine|mesh-list
82791130|NCT01050322|Vinorelbine|vinorelbine|mesh-list
82791131|NCT01050322|Lapatinib|lapatinib|mesh-list
82791132|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82791133|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
82791134|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791135|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791136|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791137|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791138|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791139|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791140|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82791141|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791142|NCT00531960|Bevacizumab|bevacizumab|mesh-list
82791143|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82791144|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791145|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791146|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791147|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791148|NCT00531960|Growth Substances|growth substances|mesh-ancestor
82791149|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791150|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791151|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82791152|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791153|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791154|NCT01001676|Paclitaxel|paclitaxel|mesh-list
82791155|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791156|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791157|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791158|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791159|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791160|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791161|NCT00816959|Bleomycin|bleomycin|mesh-list
82791162|NCT00816959|Dacarbazine|dacarbazine|mesh-list
82791163|NCT00816959|Vinblastine|vinblastine|mesh-list
82791164|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82791165|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791166|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791167|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82791168|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
82791169|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791170|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791171|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791172|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791173|NCT01001754|Ribavirin|ribavirin|mesh-list
82791174|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82791175|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
82791176|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791177|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
82791178|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791179|NCT00825851|Nicotine|nicotine|mesh-list
82791180|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82791181|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
82791182|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791183|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791184|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82791185|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82791186|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
82791187|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791188|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791189|NCT00361504|Oxycodone|oxycodone|mesh-list
82791190|NCT00361504|Tapentadol|tapentadol|mesh-list
82791191|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82791192|NCT00361504|Narcotics|narcotics|mesh-ancestor
82791193|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791194|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791195|NCT00361504|Analgesics|analgesics|mesh-ancestor
82791196|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
82791197|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791199|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82791200|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82791201|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791202|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
82791203|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791204|NCT00361270|Complement Factor H|complement factor h|mesh-list
82791205|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82791206|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791207|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
82791208|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791209|NCT00826163|Budesonide|budesonide|mesh-list
82791210|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791211|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82791212|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
82791213|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791214|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791215|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82791216|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
82791217|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
82791218|NCT00826163|Hormones|hormones|mesh-ancestor
82791219|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791220|NCT00998166|Bevacizumab|bevacizumab|mesh-list
82791221|NCT00998166|Pemetrexed|pemetrexed|mesh-list
82791222|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791223|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791224|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791225|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791226|NCT00998166|Growth Substances|growth substances|mesh-ancestor
82791227|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791228|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791229|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791230|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791231|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82791232|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82791233|NCT03990922|Morphine|morphine|mesh-list
82791234|NCT03990922|Ropivacaine|ropivacaine|mesh-list
82791235|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82791236|NCT03990922|Narcotics|narcotics|mesh-ancestor
82791237|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791238|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791239|NCT03990922|Analgesics|analgesics|mesh-ancestor
82791240|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
82791241|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791242|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
82791243|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
82791244|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
82791245|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82791246|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
82791247|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791248|NCT00822263|Expectorants|expectorants|mesh-ancestor
82791249|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
82791250|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82791251|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
82791252|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791253|NCT00822263|Protective Agents|protective agents|mesh-ancestor
82791254|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791255|NCT00822263|Antidotes|antidotes|mesh-ancestor
82791256|NCT03992170|Daratumumab|daratumumab|mesh-list
82791257|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791258|NCT00817037|Nifedipine|nifedipine|mesh-list
82791259|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
82791260|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82791261|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82791262|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791263|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82791264|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791265|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
82791266|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
82791267|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82791268|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82791269|NCT00998322|Gemcitabine|gemcitabine|mesh-list
82791270|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82791271|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
82791272|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791273|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791274|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
82791275|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82791276|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791277|NCT01002300|Oxytocin|oxytocin|mesh-list
82791278|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
82791279|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82791280|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791281|NCT00822419|Lidocaine|lidocaine|mesh-list
82791282|NCT00822419|Ketamine|ketamine|mesh-list
82791283|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
82791284|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
82791285|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791286|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791287|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
82791288|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791289|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82791290|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82791291|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82791292|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82791293|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791294|NCT00822419|Analgesics|analgesics|mesh-ancestor
82791295|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82791296|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82791297|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
82791298|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82791299|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82791300|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791301|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82791302|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
82791303|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82791304|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82791305|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791306|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791307|NCT01002534|Urological Agents|urological agents|mesh-ancestor
82791308|NCT00817271|Glucagon|glucagon|mesh-list
82791309|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82791310|NCT00817271|Hormones|hormones|mesh-ancestor
82791311|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791312|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791313|NCT01052896|Gabapentin|gabapentin|mesh-list
82791314|NCT01052896|Analgesics|analgesics|mesh-ancestor
82791315|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
82791316|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791317|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791318|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
82791319|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82791320|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82791321|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791322|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82791323|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82791324|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82791325|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791326|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791327|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
82791328|NCT01002690|Etoricoxib|etoricoxib|mesh-list
82791329|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82791330|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82791331|NCT01002690|Analgesics|analgesics|mesh-ancestor
82791332|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
82791333|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791334|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791335|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791336|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82791337|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82791338|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82791339|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791340|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791341|NCT01048684|Mannitol|mannitol|mesh-list
82791342|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82791343|NCT01048684|Diuretics|diuretics|mesh-ancestor
82791344|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
82791345|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791347|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82791348|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
82791349|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82791350|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791351|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82791352|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82791353|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82791354|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791355|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791356|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82791357|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82791358|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82791359|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
82791360|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441175|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82791361|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791362|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82791363|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82791364|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
82791365|NCT00998556|Bromocriptine|bromocriptine|mesh-list
82791366|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82791367|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82791368|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
82791369|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791370|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791371|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
82791372|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
82791373|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791374|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791375|NCT01052974|Ropivacaine|ropivacaine|mesh-list
82791376|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
82791377|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
82791378|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791379|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791380|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
82791381|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791382|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
82791383|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
82791384|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82791385|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791386|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791387|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
82791388|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82791389|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791390|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791391|NCT01003002|Levodopa|levodopa|mesh-list
82791392|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82791393|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82791394|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
82791395|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791396|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791397|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791399|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791400|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791401|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791402|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791403|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791404|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791405|NCT03883386|Loratadine|loratadine|mesh-list
82791406|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
82791407|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
82791408|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82791409|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82791410|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82791411|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
82791412|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
82791413|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791414|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791415|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791416|NCT00530946|Amlodipine|amlodipine|mesh-list
82791417|NCT00530946|Atorvastatin|atorvastatin|mesh-list
82791418|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82791419|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82791420|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
82791421|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791422|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82791423|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82791424|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791425|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82791426|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82791427|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82791428|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82791429|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791430|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
82791431|NCT00424047|Dexamethasone|dexamethasone|mesh-list
82791432|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
82791433|NCT00424047|Lenalidomide|lenalidomide|mesh-list
82791434|NCT00424047|BB 1101|bb 1101|mesh-list
82791435|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791436|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
82791437|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
82791438|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791439|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791440|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82791441|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
82791442|NCT00424047|Hormones|hormones|mesh-ancestor
82791443|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791444|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82791445|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791446|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
82791447|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791448|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791449|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
82791450|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791451|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791452|NCT00424047|Growth Substances|growth substances|mesh-ancestor
82791453|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791454|NCT00530790|Ropinirole|ropinirole|mesh-list
82791455|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82791456|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82791457|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
82791458|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
82791459|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791460|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791461|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791462|NCT01032057|Gemcitabine|gemcitabine|mesh-list
82791463|NCT01032057|Capecitabine|capecitabine|mesh-list
82791464|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82791465|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
82791466|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791467|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791468|NCT01003314|Vaccines|vaccines|mesh-list
82791469|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
82791470|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791471|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
82791472|NCT00530088|Trioxsalen|trioxsalen|mesh-list
82791473|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791474|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
82791475|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82791476|NCT01006668|Propofol|propofol|mesh-list
82791477|NCT01006668|Sevoflurane|sevoflurane|mesh-list
82791478|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82791479|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791480|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791481|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82791482|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
82791483|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
82791484|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82791485|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82791486|NCT00360568|Levodopa|levodopa|mesh-list
82791487|NCT00360568|Carbidopa|carbidopa|mesh-list
82791488|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82791489|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82791490|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82791491|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
82791492|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791493|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361943|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791494|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791495|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82791497|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82791498|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
82791499|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
82791500|NCT00436215|Bevacizumab|bevacizumab|mesh-list
82791501|NCT00436215|Sorafenib|sorafenib|mesh-list
82791502|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791503|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791504|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791505|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791506|NCT00436215|Growth Substances|growth substances|mesh-ancestor
82791507|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791508|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791509|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82791510|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791511|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791512|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
82791513|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82791514|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
82791515|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791516|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
82791517|NCT05734248|Protective Agents|protective agents|mesh-ancestor
82791518|NCT00441363|Bromocriptine|bromocriptine|mesh-list
82791519|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82791520|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82791521|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
82791522|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791523|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791524|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
82791525|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
82791526|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791527|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791528|NCT00626795|Mupirocin|mupirocin|mesh-list
82791529|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82791530|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791531|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82791532|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791533|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791534|NCT00826553|Midazolam|midazolam|mesh-list
82791535|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
82791536|NCT00826553|Lorazepam|lorazepam|mesh-list
82791537|NCT00826553|Propofol|propofol|mesh-list
82791538|NCT00826553|GABA Agonists|gaba agonists|mesh-list
82791539|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82791540|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791541|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791542|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82791543|NCT00826553|Analgesics|analgesics|mesh-ancestor
82791544|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
82791545|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791546|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82791547|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82791548|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82791549|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
82791550|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791551|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791552|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82791553|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
82791554|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
82791555|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82791556|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82791557|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82791558|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82791559|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
82791560|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
82791561|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
82791562|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
82791563|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
82791564|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82791565|NCT00626639|Cisplatin|cisplatin|mesh-list
82791566|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791567|NCT00626561|Paclitaxel|paclitaxel|mesh-list
82791568|NCT00626561|Bevacizumab|bevacizumab|mesh-list
82791569|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791570|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791571|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791572|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791573|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791574|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791575|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791576|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791577|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791578|NCT00626561|Growth Substances|growth substances|mesh-ancestor
82791579|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791580|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791581|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
82791582|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82791583|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82791584|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82791585|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
82791586|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791587|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791588|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791589|NCT00423891|Entecavir|entecavir|mesh-list
82791590|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
82791591|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791592|NCT00830609|Ribavirin|ribavirin|mesh-list
82791593|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82791594|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
82791595|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
82791596|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791597|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
82791598|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791599|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
82791600|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791601|NCT00822809|Prednisolone|prednisolone|mesh-list
82791602|NCT00822809|Catumaxomab|catumaxomab|mesh-list
82791603|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791604|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
82791605|NCT00822809|Hormones|hormones|mesh-ancestor
82791606|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791607|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791608|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82791609|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791610|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82791611|NCT02549651|Durvalumab|durvalumab|mesh-list
82791612|NCT02549651|Tremelimumab|tremelimumab|mesh-list
82791613|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791614|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791615|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
82791616|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82791617|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
82791618|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791619|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
82791620|NCT03999372|Protective Agents|protective agents|mesh-ancestor
82791621|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
82791622|NCT05733468|Calcium|calcium|mesh-list
82791623|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82791624|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791625|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82791626|NCT00830843|Propofol|propofol|mesh-list
82791627|NCT00830843|Isoflurane|isoflurane|mesh-list
82791628|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82791629|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82791630|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791631|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82791632|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
82791633|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
82791634|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82791635|NCT00826787|Levetiracetam|levetiracetam|mesh-list
82791636|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
82791637|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
82791638|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82791639|NCT00823121|Buserelin|buserelin|mesh-list
82791640|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82791641|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791642|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82791643|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
82791644|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82791645|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82791646|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791648|NCT00626405|Bevacizumab|bevacizumab|mesh-list
82791649|NCT00626405|Carboplatin|carboplatin|mesh-list
82791650|NCT00626405|Temozolomide|temozolomide|mesh-list
82791651|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82791652|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791653|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791654|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791655|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791656|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791657|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791658|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82791659|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82791660|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82791661|NCT00626405|Growth Substances|growth substances|mesh-ancestor
82791662|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791663|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
82791664|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82791665|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
82791666|NCT00826865|Levetiracetam|levetiracetam|mesh-list
82791667|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
82791668|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
82791669|NCT00358150|Eliglustat|eliglustat|mesh-list
82791670|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791671|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791672|NCT05427630|Dronabinol|dronabinol|mesh-list
82791673|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
82791674|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791675|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82791676|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82791677|NCT05427630|Analgesics|analgesics|mesh-ancestor
82791678|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
82791679|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791680|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82791681|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82791682|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791683|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791684|NCT05427630|Hormones|hormones|mesh-ancestor
82791685|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791686|NCT01050556|Folic Acid|folic acid|mesh-list
82791687|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
82791688|NCT01050556|Hematinics|hematinics|mesh-ancestor
82791689|NCT01050556|Vitamins|vitamins|mesh-ancestor
82791690|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
82791691|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791692|NCT05890027|Phenylephrine|phenylephrine|mesh-list
82791693|NCT05890027|Oxymetazoline|oxymetazoline|mesh-list
82791694|NCT05890027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82791695|NCT05890027|Mydriatics|mydriatics|mesh-ancestor
82791696|NCT05890027|Autonomic Agents|autonomic agents|mesh-ancestor
82791697|NCT05890027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791698|NCT05890027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791699|NCT05890027|Sympathomimetics|sympathomimetics|mesh-ancestor
82791700|NCT05890027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82791701|NCT05890027|Nasal Decongestants|nasal decongestants|mesh-ancestor
82791702|NCT05890027|Respiratory System Agents|respiratory system agents|mesh-ancestor
82791703|NCT05890027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82791704|NCT05890027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82791705|NCT05890027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82791706|NCT05890027|Adrenergic Agents|adrenergic agents|mesh-ancestor
82791707|NCT05890027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791708|NCT05890027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791709|NCT05890027|Protective Agents|protective agents|mesh-ancestor
82791710|NCT05889871|Apatinib|apatinib|mesh-list
82791711|NCT05889871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791712|NCT05889871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82791713|NCT05889871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791714|NCT05889871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791715|NCT05889624|Amitriptyline|amitriptyline|mesh-list
82791716|NCT05889624|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82791717|NCT05889624|Antidepressive Agents|antidepressive agents|mesh-ancestor
82791718|NCT05889624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82791719|NCT05889624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82791720|NCT05889624|Analgesics|analgesics|mesh-ancestor
82791721|NCT05889624|Sensory System Agents|sensory system agents|mesh-ancestor
82791722|NCT05889624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791723|NCT05889624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791724|NCT05889624|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82791725|NCT05889624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82791726|NCT05889624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82791727|NCT05889624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791728|NCT05889624|Adrenergic Agents|adrenergic agents|mesh-ancestor
82791729|NCT05889624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791730|NCT05889468|Aspirin|aspirin|mesh-list
82791731|NCT05889468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82791732|NCT05889468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82791733|NCT05889468|Analgesics|analgesics|mesh-ancestor
82791734|NCT05889468|Sensory System Agents|sensory system agents|mesh-ancestor
82791735|NCT05889468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791736|NCT05889468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791737|NCT05889468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791738|NCT05889468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82791739|NCT05889468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82791740|NCT05889468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82791741|NCT05889468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791742|NCT05889468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82791743|NCT05889468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82791744|NCT05889468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791745|NCT05889468|Antipyretics|antipyretics|mesh-ancestor
82791746|NCT05889455|Sildenafil Citrate|sildenafil citrate|mesh-list
82791747|NCT05889455|Vasodilator Agents|vasodilator agents|mesh-ancestor
82791748|NCT05889455|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82791749|NCT05889455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82791750|NCT05889455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791751|NCT05889455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791752|NCT05889455|Urological Agents|urological agents|mesh-ancestor
82791753|NCT05889442|Cromakalim|cromakalim|mesh-list
82791754|NCT05889442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82791755|NCT05889442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82791756|NCT05889442|Autonomic Agents|autonomic agents|mesh-ancestor
82791757|NCT05889442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791758|NCT05889442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791759|NCT05889442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82791760|NCT05889442|Respiratory System Agents|respiratory system agents|mesh-ancestor
82791761|NCT05889442|Parasympatholytics|parasympatholytics|mesh-ancestor
82791762|NCT05889442|Vasodilator Agents|vasodilator agents|mesh-ancestor
82791763|NCT05889390|Paclitaxel|paclitaxel|mesh-list
82791764|NCT05889390|Cyclophosphamide|cyclophosphamide|mesh-list
82791765|NCT05889390|Carboplatin|carboplatin|mesh-list
82791766|NCT05889390|Doxorubicin|doxorubicin|mesh-list
82791767|NCT05889390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82791768|NCT05889390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791769|NCT05889390|Tubulin Modulators|tubulin modulators|mesh-ancestor
82791770|NCT05889390|Antimitotic Agents|antimitotic agents|mesh-ancestor
82791771|NCT05889390|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791772|NCT05889390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791773|NCT05889390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791774|NCT05889390|Immunologic Factors|immunologic factors|mesh-ancestor
82791775|NCT05889390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791776|NCT05889390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82791777|NCT05889390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82791778|NCT05889390|Alkylating Agents|alkylating agents|mesh-ancestor
82791779|NCT05889390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82791780|NCT05889390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82791781|NCT05889390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82791782|NCT05889390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82791783|NCT05889390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791784|NCT05889338|Adalimumab|adalimumab|mesh-list
82791785|NCT05889338|Methotrexate|methotrexate|mesh-list
82791786|NCT05889338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82791787|NCT05889338|Abortifacient Agents|abortifacient agents|mesh-ancestor
82791788|NCT05889338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82791789|NCT05889338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791790|NCT05889338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82791791|NCT05889338|Antimetabolites|antimetabolites|mesh-ancestor
82791792|NCT05889338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791793|NCT05889338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791794|NCT05889338|Dermatologic Agents|dermatologic agents|mesh-ancestor
82791795|NCT05889338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361944|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82791801|NCT05889338|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82791809|NCT05889143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82791810|NCT05889143|Ezetimibe|ezetimibe|mesh-list
82791811|NCT05889143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82791812|NCT05889143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82791813|NCT05889143|Antimetabolites|antimetabolites|mesh-ancestor
82791814|NCT05889143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791815|NCT05889143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82791816|NCT05889143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82791817|NCT05889143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791818|NCT05889052|Pyrimethamine|pyrimethamine|mesh-list
82791819|NCT05889052|Sulfadoxine|sulfadoxine|mesh-list
82791820|NCT05889052|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82791821|NCT05889052|Antimalarials|antimalarials|mesh-ancestor
82791822|NCT05889052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82791823|NCT05889052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82791824|NCT05889052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791825|NCT05889052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82791826|NCT05889052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791827|NCT05889052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791828|NCT05889052|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82791829|NCT05889026|Botulinum Toxins|botulinum toxins|mesh-list
82791830|NCT05889026|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82791831|NCT05889026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82791832|NCT05889026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791833|NCT05889026|Cholinergic Agents|cholinergic agents|mesh-ancestor
82791834|NCT05889026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791835|NCT05889026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791836|NCT05889013|Nitric Oxide|nitric oxide|mesh-list
82791837|NCT05889013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82791838|NCT05889013|Autonomic Agents|autonomic agents|mesh-ancestor
82791839|NCT05889013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791840|NCT05889013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791841|NCT05889013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82791842|NCT05889013|Respiratory System Agents|respiratory system agents|mesh-ancestor
82791843|NCT05889013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82791844|NCT05889013|Antioxidants|antioxidants|mesh-ancestor
82791845|NCT05889013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791846|NCT05889013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791847|NCT05889013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82791848|NCT05889013|Vasodilator Agents|vasodilator agents|mesh-ancestor
82791849|NCT05889013|Gasotransmitters|gasotransmitters|mesh-ancestor
82791850|NCT05889013|Protective Agents|protective agents|mesh-ancestor
82791851|NCT05888922|Minoxidil|minoxidil|mesh-list
82791852|NCT05888922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82791853|NCT05888922|Vasodilator Agents|vasodilator agents|mesh-ancestor
82791854|NCT05888597|Menthol|menthol|mesh-list
82791855|NCT05888597|Antipruritics|antipruritics|mesh-ancestor
82791856|NCT05888597|Dermatologic Agents|dermatologic agents|mesh-ancestor
82791857|NCT05888493|Prednisone|prednisone|mesh-list
82791858|NCT05888493|Prednisolone|prednisolone|mesh-list
82791860|NCT05888493|Rituximab|rituximab|mesh-list
82791861|NCT05888493|Doxorubicin|doxorubicin|mesh-list
82791862|NCT05888493|Vincristine|vincristine|mesh-list
82791863|NCT05888493|Lenalidomide|lenalidomide|mesh-list
82791864|NCT05888493|Tisagenlecleucel|tisagenlecleucel|mesh-list
82791865|NCT05888493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791866|NCT05888493|Immunologic Factors|immunologic factors|mesh-ancestor
82791867|NCT05888493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791868|NCT05888493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82791869|NCT05888493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82791870|NCT05888493|Alkylating Agents|alkylating agents|mesh-ancestor
82791871|NCT05888493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791894|NCT05888350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82791895|NCT05888350|Autonomic Agents|autonomic agents|mesh-ancestor
82791896|NCT05888350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791897|NCT05888350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791898|NCT05888350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82791899|NCT05888350|Respiratory System Agents|respiratory system agents|mesh-ancestor
82791900|NCT05888350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82791901|NCT05888350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82791902|NCT05888350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82791903|NCT05888350|Adrenergic Agents|adrenergic agents|mesh-ancestor
82791904|NCT05888350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791905|NCT05888350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791906|NCT05888350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791907|NCT05888350|Glucocorticoids|glucocorticoids|mesh-ancestor
82791908|NCT05888350|Hormones|hormones|mesh-ancestor
82791909|NCT05888350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791932|NCT05887947|Nicotine|nicotine|mesh-list
82791933|NCT05887947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82791934|NCT05887947|Autonomic Agents|autonomic agents|mesh-ancestor
82791935|NCT05887947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791936|NCT05887947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791937|NCT05887947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82791938|NCT05887947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82791939|NCT05887947|Cholinergic Agents|cholinergic agents|mesh-ancestor
82791940|NCT05887947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82791941|NCT05887947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791942|NCT05887908|Imipenem|imipenem|mesh-list
82791943|NCT05887908|Cefepime|cefepime|mesh-list
82791944|NCT05887908|Aztreonam|aztreonam|mesh-list
83361945|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82791945|NCT05887908|Cilastatin|cilastatin|mesh-list
82791946|NCT05887908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82791947|NCT05887908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82791948|NCT05887908|Protease Inhibitors|protease inhibitors|mesh-ancestor
82791949|NCT05887908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791950|NCT05887908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791951|NCT05887882|Mitogens|mitogens|mesh-list
82791952|NCT05887882|Mitosis Modulators|mitosis modulators|mesh-ancestor
82791953|NCT05887882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791954|NCT05887778|Dexamethasone|dexamethasone|mesh-list
82791955|NCT05887778|Dexamethasone acetate|dexamethasone acetate|mesh-list
82791956|NCT05887778|BB 1101|bb 1101|mesh-list
82791957|NCT05887778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791958|NCT05887778|Antiemetics|antiemetics|mesh-ancestor
82791959|NCT05887778|Autonomic Agents|autonomic agents|mesh-ancestor
82791960|NCT05887778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791961|NCT05887778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791962|NCT05887778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82791963|NCT05887778|Glucocorticoids|glucocorticoids|mesh-ancestor
82791964|NCT05887778|Hormones|hormones|mesh-ancestor
82791965|NCT05887778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791966|NCT05887778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82791967|NCT05887778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791968|NCT05887778|Protease Inhibitors|protease inhibitors|mesh-ancestor
82791969|NCT05887778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791970|NCT05887778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791971|NCT05887765|Dexamethasone|dexamethasone|mesh-list
82791972|NCT05887765|Dexamethasone acetate|dexamethasone acetate|mesh-list
82791973|NCT05887765|BB 1101|bb 1101|mesh-list
82791974|NCT05887765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82791975|NCT05887765|Antiemetics|antiemetics|mesh-ancestor
82791976|NCT05887765|Autonomic Agents|autonomic agents|mesh-ancestor
82791977|NCT05887765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82791978|NCT05887765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791979|NCT05887765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82791980|NCT05887765|Glucocorticoids|glucocorticoids|mesh-ancestor
82791981|NCT05887765|Hormones|hormones|mesh-ancestor
82791982|NCT05887765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82791983|NCT05887765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82791984|NCT05887765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82791985|NCT05887765|Protease Inhibitors|protease inhibitors|mesh-ancestor
82791986|NCT05887765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82791987|NCT05887765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82791988|NCT05887726|Prednisone|prednisone|mesh-list
82791989|NCT05887726|Cyclophosphamide|cyclophosphamide|mesh-list
82791990|NCT05887726|Rituximab|rituximab|mesh-list
82791991|NCT05887726|Vincristine|vincristine|mesh-list
82791992|NCT05887726|Epirubicin|epirubicin|mesh-list
82791993|NCT05887726|Zanubrutinib|zanubrutinib|mesh-list
82791994|NCT05887726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82791995|NCT05887726|Immunologic Factors|immunologic factors|mesh-ancestor
82791996|NCT05887726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82791997|NCT05887726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83441198|NCT00637832|Doxorubicin|doxorubicin|mesh-list
82791998|NCT05887726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82791999|NCT05887726|Alkylating Agents|alkylating agents|mesh-ancestor
82792000|NCT05887726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792001|NCT05887726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792002|NCT05887726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82792003|NCT05887726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792004|NCT05887726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82792005|NCT05887726|Glucocorticoids|glucocorticoids|mesh-ancestor
82792006|NCT05887726|Hormones|hormones|mesh-ancestor
82792007|NCT05887726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82792008|NCT05887726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82792009|NCT05887726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792010|NCT05887726|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792011|NCT05887726|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792012|NCT05887726|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792013|NCT05887726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82792014|NCT05887726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82792015|NCT05887726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82792016|NCT05887726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792017|NCT05887726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792018|NCT05887609|Olaparib|olaparib|mesh-list
82792019|NCT05887609|Maytansine|maytansine|mesh-list
83361946|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
82792020|NCT05887609|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
82792021|NCT05887609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82792022|NCT05887609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792023|NCT05887609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792024|NCT05887609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792025|NCT05887609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792026|NCT05887609|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792027|NCT05887609|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792028|NCT05887609|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792029|NCT05887609|Immunoconjugates|immunoconjugates|mesh-ancestor
82792030|NCT05887609|Immunologic Factors|immunologic factors|mesh-ancestor
82792031|NCT05887609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792032|NCT05886712|Naloxone|naloxone|mesh-list
82792033|NCT05886712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82792034|NCT05886712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792035|NCT05886712|Sensory System Agents|sensory system agents|mesh-ancestor
82792036|NCT05886712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792037|NCT05881382|Lenograstim|lenograstim|mesh-list
82792038|NCT05881382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82792039|NCT05881382|Immunologic Factors|immunologic factors|mesh-ancestor
82792040|NCT05881382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792041|NCT05881291|Alfentanil|alfentanil|mesh-list
82792042|NCT05881291|Propofol|propofol|mesh-list
82792043|NCT05881291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82792044|NCT05881291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792045|NCT05881291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792046|NCT05881291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82792047|NCT05881291|Anesthetics, General|anesthetics, general|mesh-ancestor
82792048|NCT05881291|Anesthetics|anesthetics|mesh-ancestor
82792049|NCT05881291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82792050|NCT05881291|Narcotics|narcotics|mesh-ancestor
82792051|NCT05881291|Analgesics|analgesics|mesh-ancestor
82792052|NCT05881291|Sensory System Agents|sensory system agents|mesh-ancestor
82792053|NCT05881291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792054|NCT05874414|Trametinib|trametinib|mesh-list
82792055|NCT05874414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792056|NCT05874414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792057|NCT05874414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792058|NCT05874414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792059|NCT05851677|Disitamab vedotin|disitamab vedotin|mesh-list
82792060|NCT05851677|Immunoconjugates|immunoconjugates|mesh-ancestor
82792061|NCT05851677|Immunologic Factors|immunologic factors|mesh-ancestor
82792062|NCT05851677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792063|NCT05849753|Pancrelipase|pancrelipase|mesh-list
82792064|NCT05849753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82792065|NCT05843708|Ciprofloxacin|ciprofloxacin|mesh-list
82792066|NCT05843708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82792067|NCT05843708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792068|NCT05843708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82792069|NCT05843708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82792070|NCT05843708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792071|NCT05843708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792072|NCT05843708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792073|NCT05843708|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82792074|NCT05843708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82792075|NCT05836584|Calcium, Dietary|calcium, dietary|mesh-list
82792076|NCT05836584|Leucovorin|leucovorin|mesh-list
82792077|NCT05836584|Folic Acid|folic acid|mesh-list
82792078|NCT05836584|Docetaxel|docetaxel|mesh-list
82792079|NCT05836584|Fluorouracil|fluorouracil|mesh-list
82792080|NCT05836584|Capecitabine|capecitabine|mesh-list
82792081|NCT05836584|Oxaliplatin|oxaliplatin|mesh-list
82792082|NCT05836584|Atezolizumab|atezolizumab|mesh-list
82792083|NCT05836584|Calcium|calcium|mesh-list
82792084|NCT05836584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82792085|NCT05836584|Levoleucovorin|levoleucovorin|mesh-list
82792086|NCT05836584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792087|NCT05836584|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792088|NCT05836584|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792089|NCT05836584|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792090|NCT05836584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792091|NCT05836584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82792092|NCT05836584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792093|NCT05836584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82792094|NCT05836584|Antimetabolites|antimetabolites|mesh-ancestor
82792095|NCT05836584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792099|NCT05836584|Protective Agents|protective agents|mesh-ancestor
82792100|NCT05836584|Vitamin B Complex|vitamin b complex|mesh-ancestor
82792101|NCT05836584|Vitamins|vitamins|mesh-ancestor
82792102|NCT05836584|Micronutrients|micronutrients|mesh-ancestor
82792103|NCT05836584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792104|NCT05836584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792105|NCT05836584|Hematinics|hematinics|mesh-ancestor
82792106|NCT05805826|Vaccines|vaccines|mesh-list
82792107|NCT05805826|Immunologic Factors|immunologic factors|mesh-ancestor
82792108|NCT05805826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792109|NCT05802693|Mitogens|mitogens|mesh-list
82792110|NCT05802693|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792111|NCT05802693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792112|NCT05796388|Linaclotide|linaclotide|mesh-list
82792113|NCT05796388|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82792114|NCT05796388|Enzyme Activators|enzyme activators|mesh-ancestor
82792115|NCT05796388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792116|NCT05796388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82792117|NCT05785832|Insulin|insulin|mesh-list
82792118|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82792119|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792120|NCT05779020|Vaccines|vaccines|mesh-list
82792121|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
82792122|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792123|NCT05774899|Venetoclax|venetoclax|mesh-list
82792124|NCT05774899|Lenvatinib|lenvatinib|mesh-list
82792125|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792126|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792127|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792128|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792129|NCT05759949|Fulvestrant|fulvestrant|mesh-list
82792130|NCT05759949|Palbociclib|palbociclib|mesh-list
82792131|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82792132|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792133|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82792134|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82792135|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
82792136|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82792137|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792138|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792139|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792140|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792141|NCT05754073|Oxytocin|oxytocin|mesh-list
82792142|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
82792143|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82792144|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792148|NCT05748834|Doxorubicin|doxorubicin|mesh-list
82792149|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82792150|NCT05748834|Tucatinib|tucatinib|mesh-list
82792151|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82792152|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792153|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82792154|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82792155|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792156|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792157|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792158|NCT05743946|Ivacaftor|ivacaftor|mesh-list
82792159|NCT05743946|Elexacaftor|elexacaftor|mesh-list
82792160|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82792161|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82792162|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792163|NCT05742789|Propofol|propofol|mesh-list
82792164|NCT05742789|Sevoflurane|sevoflurane|mesh-list
82792165|NCT05742789|Isoflurane|isoflurane|mesh-list
82792166|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82792167|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792168|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792169|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82792170|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
82792171|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
82792172|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82792173|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82792174|NCT05741385|Metoprolol|metoprolol|mesh-list
82792175|NCT05741385|Midazolam|midazolam|mesh-list
82792176|NCT05741385|Caffeine|caffeine|mesh-list
82792177|NCT05741385|Omeprazole|omeprazole|mesh-list
82792178|NCT05741385|Warfarin|warfarin|mesh-list
82792179|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82792180|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82792181|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792182|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792183|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82792184|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82792185|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82792186|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82792187|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
82792188|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
82792189|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
82792190|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
82792191|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792192|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792193|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
82792194|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82792195|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82792196|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792197|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82792198|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82792199|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
82792200|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82792201|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82792202|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82792203|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82792204|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82792205|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
82792206|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
82792207|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792208|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82792209|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82792210|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82792211|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
82792212|NCT05741372|Metformin|metformin|mesh-list
82792213|NCT05741372|Digoxin|digoxin|mesh-list
82792214|NCT05741372|Furosemide|furosemide|mesh-list
82792215|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82792216|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82792217|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792218|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82792219|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82792220|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
82792221|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792222|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82792223|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82792224|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792225|NCT05741372|Diuretics|diuretics|mesh-ancestor
82792226|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
82792227|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82792228|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82792229|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82792230|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82792231|NCT05741372|Protective Agents|protective agents|mesh-ancestor
82792232|NCT05731895|BI 425809|bi 425809|mesh-list
82792233|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
82792234|NCT05721846|Nivolumab|nivolumab|mesh-list
82792235|NCT05721846|Ipilimumab|ipilimumab|mesh-list
82792236|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792237|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792238|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792239|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792240|NCT05704049|Dexamethasone|dexamethasone|mesh-list
82792241|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
82792242|NCT05704049|BB 1101|bb 1101|mesh-list
82792243|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82792244|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
82792245|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
82792246|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792247|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792248|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82792249|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
82792250|NCT05704049|Hormones|hormones|mesh-ancestor
82792262|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792263|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792264|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
82792265|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792266|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82792267|NCT05696613|Hormones|hormones|mesh-ancestor
82792268|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82792269|NCT05669833|Golimumab|golimumab|mesh-list
82792270|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82792271|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82792272|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792273|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
82792274|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792275|NCT05645146|Nicotine|nicotine|mesh-list
82792276|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82792277|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
82792278|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792279|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792280|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82792281|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82792282|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
82792283|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792284|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792285|NCT05636111|Paclitaxel|paclitaxel|mesh-list
82792286|NCT05636111|Bevacizumab|bevacizumab|mesh-list
82792287|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792288|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792289|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792290|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792291|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792292|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792293|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792294|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82792295|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82792296|NCT05636111|Growth Substances|growth substances|mesh-ancestor
82792297|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792298|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
82792311|NCT05631236|Methamphetamine|methamphetamine|mesh-list
82792312|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82792313|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792314|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
82792315|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
82792316|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792317|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
82792318|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792319|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792320|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
82792321|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82792322|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82792323|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82792324|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82792325|NCT05624281|Nintedanib|nintedanib|mesh-list
82792326|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792327|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792328|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792329|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792330|NCT05618353|Colchicine|colchicine|mesh-list
82792331|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
82792332|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82792333|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792334|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792335|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792336|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792337|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792338|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
82792339|NCT05610072|Hydromorphone|hydromorphone|mesh-list
82792340|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82792341|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
82792342|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792343|NCT05610072|Expectorants|expectorants|mesh-ancestor
82792344|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
82792345|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82792346|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
82792347|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792348|NCT05610072|Protective Agents|protective agents|mesh-ancestor
82792349|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792350|NCT05610072|Antidotes|antidotes|mesh-ancestor
82792351|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82792352|NCT05610072|Narcotics|narcotics|mesh-ancestor
82792353|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792354|NCT05610072|Analgesics|analgesics|mesh-ancestor
82792355|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
82792356|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792357|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82792358|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792359|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792360|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82792361|NCT05597085|Immunotoxins|immunotoxins|mesh-ancestor
82792362|NCT05597085|Immunoconjugates|immunoconjugates|mesh-ancestor
82792363|NCT05597085|Immunologic Factors|immunologic factors|mesh-ancestor
82792364|NCT05597085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792365|NCT05595642|Astegolimab|astegolimab|mesh-list
82792366|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82792367|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82792368|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
82792369|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792370|NCT05581004|Atezolizumab|atezolizumab|mesh-list
82792371|NCT05581004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792372|NCT05581004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792373|NCT05581004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792374|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792375|NCT05577702|Tislelizumab|tislelizumab|mesh-list
82792376|NCT05577702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792377|NCT05577702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792378|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
82792379|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82792380|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
82792381|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792382|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
82792383|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82792384|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792385|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82792387|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82792388|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792389|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792390|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792391|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
82792392|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792393|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
82792394|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792395|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792396|NCT05484622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792397|NCT05484622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361947|NCT02662036|Bupivacaine|bupivacaine|mesh-list
82792398|NCT05480306|Bevacizumab|bevacizumab|mesh-list
82792414|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792416|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792417|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792418|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792419|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
82792420|NCT05389514|Gemcitabine|gemcitabine|mesh-list
82792421|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
82792422|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792423|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
82792424|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792425|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82792426|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82792427|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
82792428|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792429|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792430|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82792431|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792432|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
82792433|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792434|NCT05389514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792435|NCT05362955|Fluorouracil|fluorouracil|mesh-list
82792436|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
82792437|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792438|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792439|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792440|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792441|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
82792442|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792458|NCT05327777|Oxycodone|oxycodone|mesh-list
82792459|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82792460|NCT05327777|Narcotics|narcotics|mesh-ancestor
82792461|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792462|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792463|NCT05327777|Analgesics|analgesics|mesh-ancestor
82792464|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
82792465|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792466|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
82792467|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792468|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792469|NCT05309187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792470|NCT05309187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792471|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
83361948|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
82792472|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792473|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792474|NCT05304546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792475|NCT05304546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792476|NCT05261490|Doxorubicin|doxorubicin|mesh-list
82792477|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82792478|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82792479|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792480|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82792481|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82792482|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792483|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792484|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82792485|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82792486|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792487|NCT05180773|Bromocriptine|bromocriptine|mesh-list
82792488|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
82792489|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82792490|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
82792491|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82792492|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
82792493|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792494|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792495|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
82792496|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82792497|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82792498|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
82792499|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82792500|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792501|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
82792502|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
82792503|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792504|NCT05161533|Cisplatin|cisplatin|mesh-list
82792505|NCT05161533|Carboplatin|carboplatin|mesh-list
82792506|NCT05161533|Etoposide|etoposide|mesh-list
82792507|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
82792508|NCT05161533|Durvalumab|durvalumab|mesh-list
82792509|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
82792510|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
82792511|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82792512|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
82792513|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792514|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792515|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82792516|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82792517|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792518|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792519|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792520|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
82792521|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792522|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
82792523|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
82792524|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792525|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792526|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792527|NCT05160922|Crizotinib|crizotinib|mesh-list
82792528|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792529|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792530|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792531|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792532|NCT05092360|Paclitaxel|paclitaxel|mesh-list
82792533|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82792534|NCT05092360|Gemcitabine|gemcitabine|mesh-list
82792535|NCT05092360|Doxorubicin|doxorubicin|mesh-list
82792536|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82792537|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
82792538|NCT05092360|Topotecan|topotecan|mesh-list
82792539|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792540|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792541|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792542|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792543|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792544|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792545|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792546|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
82792547|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82792548|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82792549|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82792550|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792551|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792552|NCT05092360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792553|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82792555|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82792556|NCT05019430|Cocaine|cocaine|mesh-list
82792557|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
82792558|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
82792559|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
82792560|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792561|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792562|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
82792563|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792564|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82792565|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82792566|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82792567|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82792568|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792569|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
82792570|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792571|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82792572|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82792573|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
82792574|NCT05011058|Valganciclovir|valganciclovir|mesh-list
82792575|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
82792576|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792577|NCT04978493|Ustekinumab|ustekinumab|mesh-list
82792578|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
82792579|NCT04957758|Varenicline|varenicline|mesh-list
82792580|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82792581|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82792582|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
82792583|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792584|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792585|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792586|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
82792587|NCT04934722|Androgens|androgens|mesh-list
82792588|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792589|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792590|NCT04934722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792591|NCT04934722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792592|NCT04934722|Hormones|hormones|mesh-ancestor
82792593|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82792594|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792595|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
82792596|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82792597|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
82792598|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
82792599|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792600|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792601|NCT04920383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792602|NCT04920383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792603|NCT04899349|Metformin|metformin|mesh-list
82792604|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
82792605|NCT04899349|Fulvestrant|fulvestrant|mesh-list
82792606|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82792607|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792608|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82792609|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792610|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82792611|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792612|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82792613|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82792614|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
82792615|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82792616|NCT04897841|Bupivacaine|bupivacaine|mesh-list
82792617|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
82792618|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
82792619|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792620|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792621|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
82792622|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792623|NCT04850599|Pomalidomide|pomalidomide|mesh-list
82792624|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82792625|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
82792626|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792627|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82792628|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82792629|NCT04850599|Growth Substances|growth substances|mesh-ancestor
82792630|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
82792631|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792632|NCT04827134|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
82792633|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82792634|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82792635|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
82792636|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792637|NCT04792073|Avelumab|avelumab|mesh-list
82792638|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792640|NCT04785820|Nivolumab|nivolumab|mesh-list
82792641|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792642|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792643|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792644|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792645|NCT04765059|Cisplatin|cisplatin|mesh-list
82792646|NCT04765059|Carboplatin|carboplatin|mesh-list
82792647|NCT04765059|Pemetrexed|pemetrexed|mesh-list
82792648|NCT04765059|Osimertinib|osimertinib|mesh-list
82792649|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792650|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792651|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792652|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82792653|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82792654|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792655|NCT04742101|Azacitidine|azacitidine|mesh-list
82792656|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792657|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
82792658|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792659|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792660|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792661|NCT04736953|Sirolimus|sirolimus|mesh-list
82792662|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82792663|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792664|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82792665|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792666|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
82792667|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792668|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
82792669|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792670|NCT04725617|Varenicline|varenicline|mesh-list
82792671|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82792672|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82792673|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
82792674|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792675|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792676|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792677|NCT04707391|Vaccines|vaccines|mesh-list
82792678|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
82792679|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792680|NCT04703075|Rifapentine|rifapentine|mesh-list
82792681|NCT04703075|Rifampin|rifampin|mesh-list
82792682|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82792683|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
82792684|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82792685|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792686|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
82792687|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82792688|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792689|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792690|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82792691|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82792692|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82792693|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82792694|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82792695|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82792696|NCT04702737|AMG 757|amg 757|mesh-list
82792697|NCT04702737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792698|NCT04691986|Niacinamide|niacinamide|mesh-list
82792699|NCT04691986|Niacin|niacin|mesh-list
82792700|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
82792701|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
82792702|NCT04691986|Vitamins|vitamins|mesh-ancestor
82792703|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
82792704|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792705|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82792706|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
82792707|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792708|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82792709|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
82792710|NCT04685421|Bupivacaine|bupivacaine|mesh-list
82792711|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
82792712|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
82792713|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792714|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792715|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
82792716|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82792718|NCT04682158|Carboplatin|carboplatin|mesh-list
82792719|NCT04682158|Propranolol|propranolol|mesh-list
82792720|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792721|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792722|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792723|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792724|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792725|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792726|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82792727|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82792728|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
82792729|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792730|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792731|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82792732|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82792733|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
82792734|NCT04680975|Belumosudil|belumosudil|mesh-list
82792735|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792736|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792737|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792738|NCT04673786|Ustekinumab|ustekinumab|mesh-list
82792739|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
82792740|NCT04624243|Risperidone|risperidone|mesh-list
82792741|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82792742|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
82792743|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792744|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792745|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792746|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82792747|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82792748|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792749|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82792750|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82792751|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
82792752|NCT04623775|Paclitaxel|paclitaxel|mesh-list
82792753|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82792754|NCT04623775|Carboplatin|carboplatin|mesh-list
82792755|NCT04623775|Nivolumab|nivolumab|mesh-list
82792756|NCT04623775|Pemetrexed|pemetrexed|mesh-list
82792757|NCT04623775|Relatlimab|relatlimab|mesh-list
82792758|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792759|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792760|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792761|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792762|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792763|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792764|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792765|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792766|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792767|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82792768|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82792769|NCT04606446|Letrozole|letrozole|mesh-list
82792770|NCT04606446|Fulvestrant|fulvestrant|mesh-list
82792771|NCT04606446|Palbociclib|palbociclib|mesh-list
82792772|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792780|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792781|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82792782|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82792783|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792784|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82792785|NCT04602533|Durvalumab|durvalumab|mesh-list
82792786|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792787|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792788|NCT04597671|Durvalumab|durvalumab|mesh-list
82792789|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792790|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792791|NCT04583969|Remdesivir|remdesivir|mesh-list
82792792|NCT04583969|Lenzilumab|lenzilumab|mesh-list
82792793|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
82792794|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792795|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
82792796|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792797|NCT04583969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82792799|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82792800|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82792801|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
82792802|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792803|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82792804|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82792805|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792806|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82792807|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
82792808|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792809|NCT04546425|Vaccines|vaccines|mesh-list
82792810|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82792811|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
82792812|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792813|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
82792814|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792815|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792816|NCT04520711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792817|NCT04520711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792827|NCT04502706|Rituximab|rituximab|mesh-list
82792828|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792829|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792830|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
82792831|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792832|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82792833|NCT04486833|Cisplatin|cisplatin|mesh-list
82792834|NCT04486833|Carboplatin|carboplatin|mesh-list
82792835|NCT04486833|Osimertinib|osimertinib|mesh-list
82792836|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792837|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82792838|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792839|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792840|NCT04468776|Zolpidem|zolpidem|mesh-list
82792841|NCT04468776|Trazodone|trazodone|mesh-list
82792842|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82792843|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82792844|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82792845|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792846|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82792847|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
82792849|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792850|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792851|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82792852|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82792853|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82792854|NCT04468776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82792855|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82792856|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82792857|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
82792858|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82792859|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
82792860|NCT04461639|Factor VIII|factor viii|mesh-list
82792861|NCT04461639|Coagulants|coagulants|mesh-ancestor
82792862|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
82792863|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
82792864|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792865|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792866|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792867|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82792868|NCT04416269|Insulin|insulin|mesh-list
82792869|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82792870|NCT04416269|Metformin|metformin|mesh-list
82792871|NCT04416269|Pioglitazone|pioglitazone|mesh-list
82792872|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82792873|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82792874|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792875|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
82792876|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792877|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792878|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
82792879|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
82792880|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792881|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
82792882|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82792883|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
82792884|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82792885|NCT04374461|Expectorants|expectorants|mesh-ancestor
82792886|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
82792887|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82792888|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
82792889|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792890|NCT04374461|Protective Agents|protective agents|mesh-ancestor
82792891|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792892|NCT04374461|Antidotes|antidotes|mesh-ancestor
82792893|NCT04363801|Leucovorin|leucovorin|mesh-list
82792894|NCT04363801|Fluorouracil|fluorouracil|mesh-list
82792895|NCT04363801|Capecitabine|capecitabine|mesh-list
82792896|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
82792897|NCT04363801|Tislelizumab|tislelizumab|mesh-list
82792898|NCT04363801|Calcium|calcium|mesh-list
82792899|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
82792900|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82792901|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792902|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
82792903|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792904|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792905|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792906|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792907|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
82792908|NCT04363801|Antidotes|antidotes|mesh-ancestor
82792909|NCT04363801|Protective Agents|protective agents|mesh-ancestor
82792910|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
82792911|NCT04363801|Vitamins|vitamins|mesh-ancestor
82792912|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
82792913|NCT04363801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792914|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
82792915|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82792916|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82792917|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792918|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
82792919|NCT04344860|Coagulants|coagulants|mesh-ancestor
82792920|NCT04333420|Vilobelimab|vilobelimab|mesh-list
82792921|NCT04333420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82792922|NCT04333420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792923|NCT04333420|Immunologic Factors|immunologic factors|mesh-ancestor
82792924|NCT04333420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792925|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
82792926|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792927|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792928|NCT04317534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792929|NCT04317534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792930|NCT04247165|Paclitaxel|paclitaxel|mesh-list
82792931|NCT04247165|Gemcitabine|gemcitabine|mesh-list
82792932|NCT04247165|Nivolumab|nivolumab|mesh-list
82792933|NCT04247165|Ipilimumab|ipilimumab|mesh-list
82792934|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82792935|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792936|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
82792937|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
82792938|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
82792939|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792940|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792941|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
82792942|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792943|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82792944|NCT04245865|Leucovorin|leucovorin|mesh-list
82792945|NCT04245865|Tocotrienols|tocotrienols|mesh-list
82792946|NCT04245865|Vitamin E|vitamin e|mesh-list
82792947|NCT04245865|Tocopherols|tocopherols|mesh-list
82792948|NCT04245865|Bevacizumab|bevacizumab|mesh-list
82792949|NCT04245865|Fluorouracil|fluorouracil|mesh-list
82792950|NCT04245865|Capecitabine|capecitabine|mesh-list
82792951|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
82792952|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
82792953|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82792954|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792955|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82792956|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82792957|NCT04245865|Growth Substances|growth substances|mesh-ancestor
82792958|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792959|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
82792961|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792962|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82792963|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82792964|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
82792965|NCT04245865|Antidotes|antidotes|mesh-ancestor
82792966|NCT04245865|Protective Agents|protective agents|mesh-ancestor
82792967|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
82792968|NCT04245865|Vitamins|vitamins|mesh-ancestor
82792969|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
82792970|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
82792971|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
82792972|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82792973|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792974|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82792975|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792976|NCT04234048|Fenretinide|fenretinide|mesh-list
82792977|NCT04234048|Retinamide|retinamide|mesh-list
82792978|NCT04234048|Tretinoin|tretinoin|mesh-list
82792979|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82792980|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82792981|NCT04234048|Protective Agents|protective agents|mesh-ancestor
82792982|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792983|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
82792984|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
82792985|NCT04219280|Methylphenidate|methylphenidate|mesh-list
82792986|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82792987|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82792988|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82792989|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82792990|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82792991|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792992|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
82792993|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82792994|NCT04192981|GDC-0084|gdc-0084|mesh-list
82792995|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82792996|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82792997|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
82792998|NCT04191096|Androgens|androgens|mesh-list
82792999|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793000|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793001|NCT04191096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793002|NCT04191096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793003|NCT04191096|Hormones|hormones|mesh-ancestor
82793004|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793005|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793006|NCT04177693|Letrozole|letrozole|mesh-list
82793007|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82793008|NCT04177693|Clomiphene|clomiphene|mesh-list
82793009|NCT04177693|Enclomiphene|enclomiphene|mesh-list
82793010|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
82793011|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793012|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793013|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82793014|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82793015|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793016|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82793017|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
82793018|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793019|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793020|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82793021|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
82793022|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82793023|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82793024|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82793025|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
82793026|NCT04177693|Protective Agents|protective agents|mesh-ancestor
82793027|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82793028|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82793029|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82793030|NCT04118387|Acetazolamide|acetazolamide|mesh-list
82793031|NCT04118387|Zolpidem|zolpidem|mesh-list
82793032|NCT04118387|Buspirone|buspirone|mesh-list
82793033|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82793035|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793036|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793037|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82793038|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
82793039|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
82793040|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793041|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793042|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
82793043|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82793044|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793045|NCT04118387|Diuretics|diuretics|mesh-ancestor
82793046|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
82793047|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82793048|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82793049|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82793050|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82793051|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
82793052|NCT04112199|Terlipressin|terlipressin|mesh-list
82793053|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82793054|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82793055|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
82793056|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793057|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793058|NCT04105335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793059|NCT04105335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793060|NCT04072952|Palbociclib|palbociclib|mesh-list
82793061|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793062|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793063|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793064|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793065|NCT04068194|Avelumab|avelumab|mesh-list
82793066|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82793067|NCT04068194|Peposertib|peposertib|mesh-list
82793068|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793069|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793070|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
82793071|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793072|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83361950|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793073|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793074|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793076|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793077|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793078|NCT04032418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793079|NCT04032418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793080|NCT04029480|Metformin|metformin|mesh-list
82793081|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
82793082|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82793083|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793084|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82793085|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793086|NCT04026412|Nivolumab|nivolumab|mesh-list
82793087|NCT04026412|Ipilimumab|ipilimumab|mesh-list
82793088|NCT04026412|Durvalumab|durvalumab|mesh-list
82793089|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793090|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793091|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793092|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793093|NCT04006522|Atezolizumab|atezolizumab|mesh-list
82793094|NCT04006522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793095|NCT04006522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793096|NCT04006522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793097|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793098|NCT03971734|Regadenoson|regadenoson|mesh-list
82793099|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82793100|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82793101|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
82793102|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
82793103|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793104|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793105|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793106|NCT03964727|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
82793107|NCT03964727|Immunoconjugates|immunoconjugates|mesh-ancestor
82793108|NCT03964727|Immunologic Factors|immunologic factors|mesh-ancestor
82793109|NCT03964727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793110|NCT03922048|Bupivacaine|bupivacaine|mesh-list
82793111|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
82793112|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
82793113|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793114|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793115|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
82793116|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793117|NCT03914742|Temozolomide|temozolomide|mesh-list
82793118|NCT03914742|Pamiparib|pamiparib|mesh-list
82793119|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82793120|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82793121|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
82793122|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793123|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793124|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793125|NCT03907475|Paclitaxel|paclitaxel|mesh-list
82793126|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82793127|NCT03907475|Carboplatin|carboplatin|mesh-list
82793128|NCT03907475|Gemcitabine|gemcitabine|mesh-list
82793129|NCT03907475|Doxorubicin|doxorubicin|mesh-list
82793130|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82793131|NCT03907475|Capecitabine|capecitabine|mesh-list
82793132|NCT03907475|Durvalumab|durvalumab|mesh-list
82793133|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
82793134|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82793135|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
82793136|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82793137|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793138|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
82793139|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
82793140|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
82793141|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793142|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82793143|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
82793144|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82793145|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82793146|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82793147|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793148|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793150|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793151|NCT03891667|Disulfiram|disulfiram|mesh-list
82793152|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82793153|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82793154|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793155|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793156|NCT03866174|Niacin|niacin|mesh-list
82793157|NCT03866174|Psilocybin|psilocybin|mesh-list
82793158|NCT03866174|Vitamins|vitamins|mesh-ancestor
82793159|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
82793160|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793161|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
82793162|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82793163|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
82793164|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793165|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82793166|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
82793167|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
82793168|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82793169|NCT03864926|Tacrolimus|tacrolimus|mesh-list
82793170|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82793171|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
82793172|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793173|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82793174|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793175|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793176|NCT03859869|Pancrelipase|pancrelipase|mesh-list
82793177|NCT03859869|Pancreatin|pancreatin|mesh-list
82793178|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82793179|NCT03831932|Osimertinib|osimertinib|mesh-list
82793180|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793181|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793182|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793183|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793185|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82793186|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82793187|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82793188|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82793189|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
82793190|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793191|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793192|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793193|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82793194|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82793195|NCT03740204|Estradiol|estradiol|mesh-list
82793196|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82793197|NCT03740204|Progesterone|progesterone|mesh-list
82793198|NCT03740204|Estrogens|estrogens|mesh-ancestor
82793199|NCT03740204|Hormones|hormones|mesh-ancestor
82793200|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793201|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793202|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82793203|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
82793204|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82793205|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82793206|NCT03740204|Progestins|progestins|mesh-ancestor
82793207|NCT03735563|Fentanyl|fentanyl|mesh-list
82793208|NCT03735563|Ketamine|ketamine|mesh-list
82793209|NCT03735563|Analgesics|analgesics|mesh-ancestor
82793210|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
82793211|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793212|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793213|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82793214|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82793215|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
82793216|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
82793217|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793218|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82793219|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82793220|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793221|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793222|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82793235|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82793236|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793237|NCT03685773|Niacin|niacin|mesh-list
82793238|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
82793239|NCT03685773|Niacinamide|niacinamide|mesh-list
82793240|NCT03685773|Diazoxide|diazoxide|mesh-list
82793241|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82793242|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
82793243|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793244|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82793245|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
82793246|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
82793247|NCT03685773|Vitamins|vitamins|mesh-ancestor
82793248|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
82793249|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793250|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82793251|NCT03683277|Dexamethasone|dexamethasone|mesh-list
82793252|NCT03683277|Pomalidomide|pomalidomide|mesh-list
82793253|NCT03683277|Ixazomib|ixazomib|mesh-list
82793254|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793255|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
82793256|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
82793257|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793258|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793259|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82793260|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
82793261|NCT03683277|Hormones|hormones|mesh-ancestor
82793262|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793263|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82793264|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793265|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
82793266|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82793267|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82793268|NCT03683277|Growth Substances|growth substances|mesh-ancestor
82793269|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
82793270|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
82793271|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793272|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793274|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82793275|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793276|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
82793277|NCT03660683|Saxagliptin|saxagliptin|mesh-list
82793278|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82793279|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793280|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82793281|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793282|NCT03660683|Incretins|incretins|mesh-ancestor
82793283|NCT03660683|Hormones|hormones|mesh-ancestor
82793284|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793285|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82793286|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
82793287|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793301|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82793302|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793304|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793305|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793306|NCT03566511|Diazoxide|diazoxide|mesh-list
82793307|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82793308|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
82793309|NCT03464136|Adalimumab|adalimumab|mesh-list
82793310|NCT03464136|Ustekinumab|ustekinumab|mesh-list
82793311|NCT03464136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82793312|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793313|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793314|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
82793315|NCT03397706|Valganciclovir|valganciclovir|mesh-list
82793316|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
82793317|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793318|NCT03382587|Aflibercept|aflibercept|mesh-list
82793319|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82793320|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82793321|NCT03382587|Growth Substances|growth substances|mesh-ancestor
82793322|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793323|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
82793324|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793325|NCT03361306|Elotuzumab|elotuzumab|mesh-list
82793326|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793327|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
82793328|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82793329|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793330|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793331|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82793332|NCT03325972|Analgesics|analgesics|mesh-ancestor
82793333|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
82793334|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793335|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82793336|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82793337|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82793338|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
82793339|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793340|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793341|NCT03274492|Prednisone|prednisone|mesh-list
82793342|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
82793343|NCT03274492|Rituximab|rituximab|mesh-list
82793344|NCT03274492|Doxorubicin|doxorubicin|mesh-list
82793345|NCT03274492|Vincristine|vincristine|mesh-list
82793346|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82793347|NCT03274492|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
82793348|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
82793349|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82793350|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
82793351|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793352|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793353|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82793354|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
82793355|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793356|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793357|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82793358|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793359|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82793360|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82793361|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82793362|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793363|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793364|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
82793365|NCT03274492|Hormones|hormones|mesh-ancestor
82793366|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793367|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82793368|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82793369|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
82793370|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
82793371|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
82793372|NCT03247712|Nivolumab|nivolumab|mesh-list
82793373|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793374|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793375|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793376|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793377|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
82793378|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793379|NCT03213652|Ensartinib|ensartinib|mesh-list
82793380|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793381|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793382|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793383|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793384|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
82793385|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793386|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793387|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
82793388|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793389|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
82793390|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793391|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793392|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82793393|NCT03125642|Cytarabine|cytarabine|mesh-list
82793394|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
82793395|NCT03125642|Melphalan|melphalan|mesh-list
82793396|NCT03125642|Carmustine|carmustine|mesh-list
82793397|NCT03125642|Etoposide|etoposide|mesh-list
82793398|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82793399|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
82793400|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793401|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793402|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82793403|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
82793404|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793405|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793406|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82793407|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82793408|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82793409|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82793410|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793411|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82793412|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
82793413|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
82793414|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793415|NCT03048825|Colchicine|colchicine|mesh-list
82793416|NCT03048825|Spironolactone|spironolactone|mesh-list
82793417|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
82793418|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793419|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
82793420|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
82793421|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
82793422|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793423|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793424|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82793425|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
82793426|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793427|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793428|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82793429|NCT03048825|Diuretics|diuretics|mesh-ancestor
82793430|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
82793432|NCT03039413|Trace Elements|trace elements|mesh-ancestor
82793433|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
82793434|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793435|NCT03026790|Buprenorphine|buprenorphine|mesh-list
82793436|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82793438|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82793439|NCT03026790|Narcotics|narcotics|mesh-ancestor
82793440|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793441|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793442|NCT03026790|Analgesics|analgesics|mesh-ancestor
82793443|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
82793444|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793445|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82793446|NCT02998528|Paclitaxel|paclitaxel|mesh-list
82793447|NCT02998528|Vinorelbine|vinorelbine|mesh-list
82793448|NCT02998528|Docetaxel|docetaxel|mesh-list
82793449|NCT02998528|Carboplatin|carboplatin|mesh-list
82793450|NCT02998528|Gemcitabine|gemcitabine|mesh-list
82793451|NCT02998528|Nivolumab|nivolumab|mesh-list
82793452|NCT02998528|Pemetrexed|pemetrexed|mesh-list
82793453|NCT02998528|Ipilimumab|ipilimumab|mesh-list
82793454|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82793455|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793456|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
82793457|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
82793458|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
82793459|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793460|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82793461|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
82793462|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793463|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793464|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793465|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82793466|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82793467|NCT02974725|Trametinib|trametinib|mesh-list
82793468|NCT02974725|Naporafenib|naporafenib|mesh-list
82793469|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793470|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793471|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793472|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793473|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
82793474|NCT02955290|Nivolumab|nivolumab|mesh-list
82793475|NCT02955290|Vaccines|vaccines|mesh-list
82793476|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82793477|NCT02955290|Mitogens|mitogens|mesh-list
82793478|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
82793479|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793480|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793481|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793482|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82793483|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793484|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
82793485|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82793486|NCT02735707|Aspirin|aspirin|mesh-list
82793487|NCT02735707|Vitamins|vitamins|mesh-list
82793488|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
82793489|NCT02735707|Interferons|interferons|mesh-list
82793490|NCT02735707|Ritonavir|ritonavir|mesh-list
82793491|NCT02735707|Lopinavir|lopinavir|mesh-list
82793492|NCT02735707|Interferon-beta|interferon-beta|mesh-list
82793493|NCT02735707|Oseltamivir|oseltamivir|mesh-list
82793494|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
82793495|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
82793496|NCT02735707|Baloxavir|baloxavir|mesh-list
82793497|NCT02735707|Amoxicillin|amoxicillin|mesh-list
82793498|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
82793499|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
82793500|NCT02735707|Levofloxacin|levofloxacin|mesh-list
82793501|NCT02735707|Ivermectin|ivermectin|mesh-list
82793502|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
82793503|NCT02735707|Tazobactam|tazobactam|mesh-list
82793504|NCT02735707|Piperacillin|piperacillin|mesh-list
82793505|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
82793506|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82793507|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82793508|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82793509|NCT02735707|Dexamethasone|dexamethasone|mesh-list
82793510|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
82793511|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82793512|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82793513|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82793514|NCT02735707|Apremilast|apremilast|mesh-list
82793515|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82793516|NCT02735707|Losartan|losartan|mesh-list
82793518|NCT02735707|Telmisartan|telmisartan|mesh-list
82793519|NCT02735707|Candesartan|candesartan|mesh-list
82793520|NCT02735707|Ramipril|ramipril|mesh-list
82793521|NCT02735707|Olmesartan|olmesartan|mesh-list
82793522|NCT02735707|Enalapril|enalapril|mesh-list
82793523|NCT02735707|Lisinopril|lisinopril|mesh-list
82793524|NCT02735707|Irbesartan|irbesartan|mesh-list
82793525|NCT02735707|Perindopril|perindopril|mesh-list
82793526|NCT02735707|Captopril|captopril|mesh-list
82793527|NCT02735707|Trandolapril|trandolapril|mesh-list
82793528|NCT02735707|Clopidogrel|clopidogrel|mesh-list
82793529|NCT02735707|Ticagrelor|ticagrelor|mesh-list
82793530|NCT02735707|Simvastatin|simvastatin|mesh-list
82793531|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82793532|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
82793533|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82793534|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82793535|NCT02735707|Cysteamine|cysteamine|mesh-list
83361951|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793536|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
82793537|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793538|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793539|NCT02735707|Antiemetics|antiemetics|mesh-ancestor
82793540|NCT02735707|Autonomic Agents|autonomic agents|mesh-ancestor
82793541|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793542|NCT02735707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82793543|NCT02735707|Glucocorticoids|glucocorticoids|mesh-ancestor
82793544|NCT02735707|Hormones|hormones|mesh-ancestor
83441278|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82793545|NCT02735707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793546|NCT02735707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82793547|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793548|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793549|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82793550|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82793551|NCT02735707|Analgesics|analgesics|mesh-ancestor
82793552|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
82793553|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793554|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82793555|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82793556|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793557|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82793558|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82793559|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
82793560|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82793561|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82793562|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
82793563|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82793564|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82793565|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82793566|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82793567|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82793568|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82793569|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82793570|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
82793571|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793572|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793573|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82793574|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82793575|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
82793576|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82793577|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82793578|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82793579|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82793580|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
82793581|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82793582|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82793583|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
82793584|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82793585|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82793586|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82793587|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
82793588|NCT02735707|Protective Agents|protective agents|mesh-ancestor
82793589|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82793590|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82793591|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82793592|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82793593|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82793594|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82793595|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82793596|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
82793597|NCT02697448|Propofol|propofol|mesh-list
82793598|NCT02697448|Sevoflurane|sevoflurane|mesh-list
82793599|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82793600|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793601|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793602|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82793603|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
82793604|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
82793605|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82793606|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82793607|NCT02647203|Fluorides|fluorides|mesh-list
82793608|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
82793609|NCT02647203|Protective Agents|protective agents|mesh-ancestor
82793610|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793611|NCT02637973|Empagliflozin|empagliflozin|mesh-list
82793612|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82793613|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793614|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82793615|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793616|NCT02575794|Masoprocol|masoprocol|mesh-list
82793617|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
82793618|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793619|NCT02575794|Protective Agents|protective agents|mesh-ancestor
82793620|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793621|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82793622|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793623|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82793624|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82793625|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82793626|NCT02575794|Analgesics|analgesics|mesh-ancestor
82793627|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
82793628|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793629|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793630|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793631|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
82793632|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
82793633|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793634|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
82793635|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82793636|NCT02527681|Cephalosporins|cephalosporins|mesh-list
82793637|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793638|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793639|NCT02516696|Clarithromycin|clarithromycin|mesh-list
82793640|NCT02516696|Dexamethasone|dexamethasone|mesh-list
82793641|NCT02516696|Lenalidomide|lenalidomide|mesh-list
82793642|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793643|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
82793644|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
82793645|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793646|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793647|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82793648|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
82793649|NCT02516696|Hormones|hormones|mesh-ancestor
82793650|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793651|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82793652|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793653|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
82793654|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82793655|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82793656|NCT02516696|Growth Substances|growth substances|mesh-ancestor
82793657|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
82793658|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793659|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793660|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82793661|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793662|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793663|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82793664|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82793665|NCT02513329|Bupivacaine|bupivacaine|mesh-list
82793666|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
82793667|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
82793668|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793669|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793670|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
82793671|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793672|NCT02425826|Thalidomide|thalidomide|mesh-list
82793673|NCT02425826|Apremilast|apremilast|mesh-list
82793674|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82793675|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82793676|NCT02425826|Analgesics|analgesics|mesh-ancestor
82793677|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
82793678|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793679|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793680|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793681|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793682|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82793683|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82793684|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793685|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793686|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82793687|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
82793688|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
82793689|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793690|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793691|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82793692|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82793693|NCT02425826|Growth Substances|growth substances|mesh-ancestor
82793694|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
82793695|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793696|NCT02386774|Benoxinate|benoxinate|mesh-list
82793697|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82793698|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82793699|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
82793700|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
82793701|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793702|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793703|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
82793704|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793705|NCT02278120|Tamoxifen|tamoxifen|mesh-list
82793706|NCT02278120|Letrozole|letrozole|mesh-list
82793707|NCT02278120|Anastrozole|anastrozole|mesh-list
82793708|NCT02278120|Goserelin|goserelin|mesh-list
82793709|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793710|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82793711|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82793712|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793713|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793714|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82793715|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
82793716|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793717|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793718|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82793719|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82793720|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82793721|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82793722|NCT02274155|Antibodies|antibodies|mesh-list
82793723|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
82793724|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793725|NCT02255357|Oxytocin|oxytocin|mesh-list
82793726|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
82793727|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82793728|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793729|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82793730|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793731|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793732|NCT02155647|Avelumab|avelumab|mesh-list
82793733|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793734|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793735|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82793736|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82793737|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793738|NCT02057107|Docetaxel|docetaxel|mesh-list
82793739|NCT02057107|Cetuximab|cetuximab|mesh-list
82793740|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793741|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
82793742|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
82793743|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
82793744|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793745|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793746|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
82793747|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
82793748|NCT01861106|Busulfan|busulfan|mesh-list
82793749|NCT01861106|Fludarabine|fludarabine|mesh-list
82793750|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
82793751|NCT01861106|Tacrolimus|tacrolimus|mesh-list
82793752|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82793753|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82793754|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
82793755|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793756|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793757|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82793758|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
83361952|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
82793759|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793760|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441288|NCT03808129|Lidocaine|lidocaine|mesh-list
82793761|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82793762|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82793763|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
82793764|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82793765|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793766|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82793767|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82793768|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
82793769|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793770|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793771|NCT01479075|Insulin|insulin|mesh-list
82793772|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82793773|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82793774|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793775|NCT01082679|Buprenorphine|buprenorphine|mesh-list
82793776|NCT01082679|Methadone|methadone|mesh-list
82793777|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82793778|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82793779|NCT01082679|Narcotics|narcotics|mesh-ancestor
82793780|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793781|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793782|NCT01082679|Analgesics|analgesics|mesh-ancestor
82793783|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
82793784|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793785|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82793786|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
82793787|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
82793788|NCT00976963|Fosfomycin|fosfomycin|mesh-list
82793789|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793790|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793791|NCT00958633|Bupropion|bupropion|mesh-list
82793792|NCT00958633|Escitalopram|escitalopram|mesh-list
82793793|NCT00958633|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82793794|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82793795|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82793796|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793797|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793798|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
82793799|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793800|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82793801|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
82793802|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82793803|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82793804|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
82793805|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82793806|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82793807|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793808|NCT00393783|Trastuzumab|trastuzumab|mesh-list
82793809|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793810|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793811|NCT00074269|Cyclosporine|cyclosporine|mesh-list
82793812|NCT00074269|Methotrexate|methotrexate|mesh-list
82793813|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
82793814|NCT00074269|Fludarabine|fludarabine|mesh-list
82793815|NCT00074269|Melphalan|melphalan|mesh-list
82793816|NCT00074269|Cyclosporins|cyclosporins|mesh-list
82793817|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82793818|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82793819|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
82793820|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82793821|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793822|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82793823|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
82793824|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793825|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793826|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
82793827|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793828|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82793829|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82793830|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
82793831|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82793832|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82793833|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
82793841|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793842|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793843|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793844|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
82793845|NCT01032213|Analgesics|analgesics|mesh-ancestor
82793846|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
82793847|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793848|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793849|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
82793850|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82793851|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82793852|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
82793853|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82793854|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82793855|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793856|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82793857|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
82793858|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82793860|NCT00357994|Carbidopa|carbidopa|mesh-list
82793861|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82793862|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82793863|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82793864|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
82793865|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793866|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793867|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793868|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82793869|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793870|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82793871|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
82793872|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
82793873|NCT00823433|Penicillins|penicillins|mesh-list
82793874|NCT00823433|Penicillin V|penicillin v|mesh-list
82793875|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793876|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793877|NCT00423657|Vancomycin|vancomycin|mesh-list
82793878|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82793879|NCT00423657|Aztreonam|aztreonam|mesh-list
82793880|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82793881|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793882|NCT00831155|Nicotine|nicotine|mesh-list
82793883|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82793884|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
82793885|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793886|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793887|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82793888|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82793889|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
82793890|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793891|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793892|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
82793893|NCT00827021|Hematinics|hematinics|mesh-list
82793901|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
82793902|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
82793903|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793904|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
82793905|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793906|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793907|NCT02407509|Everolimus|everolimus|mesh-list
82793909|NCT02407509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793910|NCT02407509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793911|NCT02407509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793912|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82793913|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
82793914|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793915|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793916|NCT02550119|Dexamethasone|dexamethasone|mesh-list
82793917|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
82793918|NCT02550119|Aprepitant|aprepitant|mesh-list
82793919|NCT02550119|Dolasetron|dolasetron|mesh-list
82793920|NCT02550119|Ichthammol|ichthammol|mesh-list
82793921|NCT02550119|BB 1101|bb 1101|mesh-list
82793922|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82793923|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
82793924|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
82793925|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82793926|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793927|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82793928|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
82793929|NCT02550119|Hormones|hormones|mesh-ancestor
82793930|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793931|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82793932|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793933|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
82793934|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793935|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793936|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82793937|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793938|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
82793939|NCT02550119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82793940|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82793941|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
82793942|NCT02548403|Simethicone|simethicone|mesh-list
82793943|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
82793944|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793945|NCT02548403|Emollients|emollients|mesh-ancestor
82793946|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
82793947|NCT00367432|Levetiracetam|levetiracetam|mesh-list
82793948|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
82793949|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
82793950|NCT00623363|Piclozotan|piclozotan|mesh-list
82793951|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82793952|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82793953|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
82793954|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82793955|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793956|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793957|NCT00827177|Sorafenib|sorafenib|mesh-list
82793958|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793959|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82793960|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793961|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793962|NCT00423267|Fluconazole|fluconazole|mesh-list
82793963|NCT00423267|Posaconazole|posaconazole|mesh-list
82793964|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
82793965|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82793966|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82793967|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82793968|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82793969|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793970|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82793971|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
82793972|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82793973|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793974|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82793975|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82793976|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82793977|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82793978|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82793979|NCT02549261|Etoposide|etoposide|mesh-list
82793980|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
82793981|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793982|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82793983|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82793984|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82793986|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82793987|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82793988|NCT00357760|Aflibercept|aflibercept|mesh-list
82793989|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
82793990|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82793991|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82793992|NCT00357760|Growth Substances|growth substances|mesh-ancestor
82793993|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82793994|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
82793995|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793996|NCT04396535|Docetaxel|docetaxel|mesh-list
82793997|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82793998|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
82793999|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
82794000|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
82794001|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794002|NCT00622739|Ziprasidone|ziprasidone|mesh-list
82794003|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82794004|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
82794005|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794006|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794007|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794008|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82794009|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82794010|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794011|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794012|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82794013|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
82794014|NCT03742336|Dabigatran|dabigatran|mesh-list
82794015|NCT03742336|Abrocitinib|abrocitinib|mesh-list
82794016|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
82794017|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82794018|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
82794019|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794020|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794021|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
82794022|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794023|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82794024|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
82794025|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794026|NCT00824057|Midazolam|midazolam|mesh-list
82794027|NCT00824057|Caffeine|caffeine|mesh-list
82794028|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82794029|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82794030|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794031|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794032|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82794033|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82794034|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794035|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82794036|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
82794037|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
82794038|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
82794039|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
82794040|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794041|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794042|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82794043|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82794044|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794045|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82794046|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82794047|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
82794048|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
82794049|NCT01053208|Promethazine|promethazine|mesh-list
82794050|NCT01053208|Ibuprofen|ibuprofen|mesh-list
82794051|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794052|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82794053|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82794054|NCT01053208|Analgesics|analgesics|mesh-ancestor
82794055|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
82794056|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794057|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794058|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794059|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794060|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82794061|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794062|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82794063|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82794064|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794065|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
82794066|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
82794067|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
82794068|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
82794069|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794070|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82794071|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
82794072|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
82794073|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794074|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82794075|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
82794076|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
82794077|NCT00423189|Ranibizumab|ranibizumab|mesh-list
82794078|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82794079|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82794080|NCT00423189|Growth Substances|growth substances|mesh-ancestor
82794081|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794082|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
82794083|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794084|NCT00831545|Temozolomide|temozolomide|mesh-list
82794085|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82794086|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
82794087|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794088|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794089|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
82794091|NCT00824135|Melphalan|melphalan|mesh-list
82794092|NCT00824135|Thiotepa|thiotepa|mesh-list
82794093|NCT00824135|Clofarabine|clofarabine|mesh-list
82794094|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
82794095|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794096|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794097|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
82794098|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794099|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794100|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82794101|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82794102|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
82794103|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794104|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794105|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794106|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794107|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82794108|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
82794109|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82794110|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82794111|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82794112|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
82794113|NCT00422799|Rituximab|rituximab|mesh-list
82794114|NCT00422799|Bortezomib|bortezomib|mesh-list
82794115|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794116|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794117|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
82794118|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794119|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794120|NCT00827411|Aspirin|aspirin|mesh-list
82794121|NCT00827411|Clopidogrel|clopidogrel|mesh-list
82794122|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82794123|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82794124|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82794125|NCT00827411|Analgesics|analgesics|mesh-ancestor
82794126|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
82794127|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794128|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794129|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794130|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794131|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82794132|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82794133|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794134|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82794135|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82794136|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794137|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
82794138|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82794139|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82794140|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82794141|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
82794142|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794143|NCT00435045|Atorvastatin|atorvastatin|mesh-list
82794144|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82794145|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82794146|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
82794147|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794148|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82794149|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82794150|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794151|NCT00441129|Insulin|insulin|mesh-list
82794152|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794153|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794154|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
82794155|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82794156|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794157|NCT00831857|Bevacizumab|bevacizumab|mesh-list
82794158|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
82794159|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794160|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794161|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82794162|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82794163|NCT00831857|Growth Substances|growth substances|mesh-ancestor
82794164|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794165|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
82794166|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82794167|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794168|NCT00832013|Propofol|propofol|mesh-list
82794169|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82794170|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794171|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794172|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82794173|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
82794174|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
82794175|NCT00832481|Metformin|metformin|mesh-list
82794176|NCT00832481|Repaglinide|repaglinide|mesh-list
82794177|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794178|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794179|NCT00350272|Tenofovir|tenofovir|mesh-list
82794180|NCT00350272|Lamivudine|lamivudine|mesh-list
82794181|NCT00350272|Efavirenz|efavirenz|mesh-list
82794182|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
82794183|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
82794184|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794185|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82794186|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82794187|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794188|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794189|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82794190|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82794191|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82794192|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82794193|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82794194|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82794195|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82794196|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82794197|NCT04044287|Misoprostol|misoprostol|mesh-list
82794198|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82794199|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
82794200|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82794201|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794202|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82794203|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794204|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
82794205|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
82794206|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82794207|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794208|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794209|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794210|NCT00825071|Dexamethasone|dexamethasone|mesh-list
82794211|NCT00825071|Ondansetron|ondansetron|mesh-list
82794212|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794213|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
82794214|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
82794215|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794216|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794217|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794218|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
82794219|NCT00825071|Hormones|hormones|mesh-ancestor
82794220|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82794221|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82794222|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794223|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
82794224|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
82794225|NCT00825071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82794226|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82794227|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
82794228|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794229|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794230|NCT00574847|Escitalopram|escitalopram|mesh-list
82794231|NCT00574847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82794232|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82794233|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794234|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794235|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794236|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
82794237|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794238|NCT00348790|Vatalanib|vatalanib|mesh-list
82794239|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794240|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794241|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794242|NCT00825149|Prednisone|prednisone|mesh-list
82794243|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
82794244|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82794245|NCT00825149|Doxorubicin|doxorubicin|mesh-list
82794246|NCT00825149|Fludarabine|fludarabine|mesh-list
82794247|NCT00825149|Vincristine|vincristine|mesh-list
82794248|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
82794249|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82794250|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
82794251|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794252|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794253|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82794254|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
82794255|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794256|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794257|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82794258|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82794259|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82794260|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82794261|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794262|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794263|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
82794264|NCT00825149|Hormones|hormones|mesh-ancestor
82794265|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82794266|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82794267|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82794268|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
82794269|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
82794270|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
82794271|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794272|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82794273|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
82794274|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
82794275|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82794276|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
82794277|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82794278|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794279|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82794280|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82794281|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82794282|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83361953|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794283|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82794284|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82794285|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794287|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82794288|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
82794289|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
82794290|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794291|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794292|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
82794293|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794294|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82794295|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82794296|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82794297|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794298|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794299|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82794300|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
82794301|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82794302|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
82794303|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794304|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794305|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82794306|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
82794307|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
82794308|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82794309|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
82794310|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794311|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794312|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
82794313|NCT02549963|Anticoagulants|anticoagulants|mesh-list
82794314|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82794315|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
82794316|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82794317|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
82794318|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794319|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794320|NCT00624065|Carvedilol|carvedilol|mesh-list
82794321|NCT00624065|Lisinopril|lisinopril|mesh-list
82794322|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82794323|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82794324|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
82794325|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794326|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794327|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794328|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82794329|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
82794330|NCT00624065|Protective Agents|protective agents|mesh-ancestor
82794331|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82794332|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794333|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82794334|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
82794335|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82794336|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82794337|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82794338|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
82794339|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794340|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82794341|NCT00833339|Mifepristone|mifepristone|mesh-list
82794342|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82794343|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
82794344|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82794345|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794346|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82794347|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82794348|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82794349|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
82794350|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82794351|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82794352|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
82794353|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82794354|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
82794355|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82794356|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82794357|NCT00825617|Hormones|hormones|mesh-list
82794358|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82794359|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794360|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
82794361|NCT00360334|Exenatide|exenatide|mesh-list
82794362|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794363|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794364|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82794365|NCT00360334|Incretins|incretins|mesh-ancestor
82794366|NCT00360334|Hormones|hormones|mesh-ancestor
82794367|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82794368|NCT00422097|Epothilones|epothilones|mesh-list
82794369|NCT00422097|Famotidine|famotidine|mesh-list
82794370|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
82794371|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
82794372|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
82794373|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794374|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794375|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82794376|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794377|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82794378|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
82794379|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
82794380|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794381|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794382|NCT01051102|Insulin|insulin|mesh-list
82794383|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82794384|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
82794385|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
82794386|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82794387|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
82794388|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82794389|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794390|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794391|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82794392|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
82794393|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794394|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82794395|NCT00434967|Candesartan|candesartan|mesh-list
82794396|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
82794397|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82794398|NCT00434967|Diuretics|diuretics|mesh-ancestor
82794399|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
82794400|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794401|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82794402|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794403|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794404|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82794405|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82794406|NCT00833729|Etanercept|etanercept|mesh-list
82794407|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82794408|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82794409|NCT00833729|Analgesics|analgesics|mesh-ancestor
82794410|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
82794411|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794412|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794413|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794414|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794415|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794416|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82794417|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
82794418|NCT00837239|Gemcitabine|gemcitabine|mesh-list
82794419|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82794420|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
82794421|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794422|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794423|NCT00833807|Paclitaxel|paclitaxel|mesh-list
82794424|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82794425|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82794426|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794427|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
82794428|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
82794429|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
82794430|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794431|NCT00833963|Trastuzumab|trastuzumab|mesh-list
82794432|NCT00833963|Pertuzumab|pertuzumab|mesh-list
82794433|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82794434|NCT00833963|Maytansine|maytansine|mesh-list
82794435|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794436|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794437|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82794438|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
82794439|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
82794440|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
82794441|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794442|NCT00833963|Immunotoxins|immunotoxins|mesh-ancestor
82794443|NCT00833963|Immunoconjugates|immunoconjugates|mesh-ancestor
82794444|NCT00833963|Immunologic Factors|immunologic factors|mesh-ancestor
82794445|NCT00833963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794446|NCT00837317|Phenol|phenol|mesh-list
82794447|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82794448|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794449|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
82794450|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82794451|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82794452|NCT04043897|Rifaximin|rifaximin|mesh-list
82794453|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794454|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794455|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794456|NCT00356590|Etanercept|etanercept|mesh-list
82794457|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82794458|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82794459|NCT00356590|Analgesics|analgesics|mesh-ancestor
82794460|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
82794461|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794462|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794463|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794464|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794465|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794466|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82794467|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
82794468|NCT00828503|Valganciclovir|valganciclovir|mesh-list
82794469|NCT00828503|Everolimus|everolimus|mesh-list
82794470|NCT00828503|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82794471|NCT00828503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794472|NCT00828503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794473|NCT00828503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794474|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82794475|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
82794476|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794477|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794478|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
82794479|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794480|NCT00834665|Molgramostim|molgramostim|mesh-list
82794481|NCT00834665|Sargramostim|sargramostim|mesh-list
82794482|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
82794483|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794484|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794485|NCT00837707|Aripiprazole|aripiprazole|mesh-list
82794486|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
82794487|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794488|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82794489|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82794490|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794491|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794492|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
82794493|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
82794494|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794495|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794496|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82794497|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82794498|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
82794499|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82794500|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82794501|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82794502|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82794503|NCT01055938|Valproic Acid|valproic acid|mesh-list
82794504|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
82794505|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794506|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794507|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
82794508|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794509|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794510|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
82794511|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82794512|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794513|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794514|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82794515|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
82794516|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82794517|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
82794518|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794519|NCT00356278|Cycloserine|cycloserine|mesh-list
82794520|NCT00356278|Alprazolam|alprazolam|mesh-list
82794521|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82794522|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794523|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82794524|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
82794525|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794526|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
82794527|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794528|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82794529|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794530|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794531|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82794532|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82794533|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794534|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
82794535|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
82794536|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794537|NCT03991780|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82794538|NCT03991780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794539|NCT03991780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794540|NCT03991780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794541|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
82794542|NCT00837941|Promethazine|promethazine|mesh-list
82794543|NCT00837941|Pregabalin|pregabalin|mesh-list
82794544|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82794545|NCT00837941|Analgesics|analgesics|mesh-ancestor
82794546|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
82794547|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794548|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794549|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
82794550|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82794551|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794552|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794553|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82794554|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82794555|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82794556|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794557|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794558|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82794559|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82794560|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794561|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
82794562|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
82794563|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82794564|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82794565|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
82794566|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
82794567|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
82794568|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
82794569|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82794570|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82794571|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
82794572|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
82794573|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82794574|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
82794575|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
82794576|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
82794577|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82794578|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
82794579|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
82794580|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794581|NCT00356200|Fluphenazine|fluphenazine|mesh-list
82794582|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
82794583|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
82794584|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82794585|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82794586|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794587|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794588|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794589|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82794590|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
82794591|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794592|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794593|NCT00356122|Bevacizumab|bevacizumab|mesh-list
82794595|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
82794596|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794597|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794598|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82794599|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82794600|NCT00356122|Growth Substances|growth substances|mesh-ancestor
82794601|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794602|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
82794603|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
82794604|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
82794605|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
82794606|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794607|NCT00828815|Etravirine|etravirine|mesh-list
82794608|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82794609|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82794610|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794611|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794612|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
82794613|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794614|NCT01053520|Navitoclax|navitoclax|mesh-list
82794615|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794616|NCT00347932|Besifloxacin|besifloxacin|mesh-list
82794617|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794618|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794619|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82794620|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82794621|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794622|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794623|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794624|NCT00828971|Amoxicillin|amoxicillin|mesh-list
82794625|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
82794626|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82794627|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794628|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794629|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82794630|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82794631|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794632|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794633|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794634|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82794635|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
82794636|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82794637|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794638|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82794639|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82794640|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82794641|NCT00528996|Bromides|bromides|mesh-list
82794642|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
82794643|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82794644|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
82794645|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794646|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794647|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82794648|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
82794649|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
82794650|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82794651|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
82794652|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794653|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794654|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
82794655|NCT00359788|Albuterol|albuterol|mesh-list
82794656|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
82794657|NCT00359788|Ipratropium|ipratropium|mesh-list
82794658|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82794659|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
82794660|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794661|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794662|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82794663|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
82794664|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
82794665|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82794666|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
82794667|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794668|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794669|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
82794670|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82794671|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82794672|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82794673|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82794674|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
82794675|NCT05416476|Anisodine|anisodine|mesh-list
82794676|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82794677|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82794678|NCT05416476|Analgesics|analgesics|mesh-ancestor
82794679|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
82794680|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794681|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794682|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794683|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794684|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
82794685|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
82794686|NCT00623597|Ritonavir|ritonavir|mesh-list
82794687|NCT00623597|Saquinavir|saquinavir|mesh-list
82794688|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82794689|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82794690|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
82794691|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794692|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794693|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82794694|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82794695|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
82794696|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794697|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82794698|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82794699|NCT01056172|Ribavirin|ribavirin|mesh-list
82794700|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82794701|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
82794702|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
82794703|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794704|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
82794705|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794706|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
82794707|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794708|NCT00838955|Sirolimus|sirolimus|mesh-list
82794709|NCT00838955|Temsirolimus|temsirolimus|mesh-list
82794710|NCT00838955|MTOR Inhibitors|mtor inhibitors|mesh-list
82794711|NCT00838955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794712|NCT00838955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794713|NCT00838955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794714|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82794715|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
82794716|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794717|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794718|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794719|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794720|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82794721|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
82794722|NCT00347776|Azithromycin|azithromycin|mesh-list
82794723|NCT00347776|Tetracycline|tetracycline|mesh-list
82794724|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794725|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794726|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82794727|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794728|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794730|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82794731|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794732|NCT00829205|Rituximab|rituximab|mesh-list
82794733|NCT00829205|Carboplatin|carboplatin|mesh-list
82794734|NCT00829205|Etoposide|etoposide|mesh-list
82794735|NCT00829205|Ifosfamide|ifosfamide|mesh-list
82794736|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
82794737|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794738|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794739|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
82794740|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794741|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794742|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82794743|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82794744|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82794745|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794746|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794747|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82794748|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
82794749|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82794750|NCT00829205|Protective Agents|protective agents|mesh-ancestor
82794751|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82794752|NCT04944888|Eliglustat|eliglustat|mesh-list
82794753|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794754|NCT04944888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794755|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794756|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794757|NCT00839111|Irinotecan|irinotecan|mesh-list
82794758|NCT00839111|Sorafenib|sorafenib|mesh-list
82794759|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82794760|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82794761|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794762|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794763|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794764|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794765|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82794766|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82794767|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82794768|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
82794769|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794770|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794771|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794772|NCT00836381|Urological Agents|urological agents|mesh-ancestor
82794773|NCT02533336|Abamectin|abamectin|mesh-list
82794774|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
82794775|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82794776|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794777|NCT05367960|BPN14770|bpn14770|mesh-list
82794778|NCT05367960|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82794779|NCT05367960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82794780|NCT05367960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794781|NCT05367960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794782|NCT01053910|Ramipril|ramipril|mesh-list
82794783|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82794784|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
82794785|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794786|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794787|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82794788|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82794789|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
82794790|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794791|NCT01008384|Vitamin D|vitamin d|mesh-list
82794792|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
82794793|NCT01008384|Vitamins|vitamins|mesh-ancestor
82794794|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
82794795|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794796|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82794797|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82794798|NCT02547155|Anesthetics|anesthetics|mesh-list
83441315|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
82794799|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794800|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794801|NCT00836849|Sertraline|sertraline|mesh-list
82794802|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
82794803|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82794804|NCT00836849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82794805|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82794806|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794807|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794808|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794809|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
82794810|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794811|NCT00839345|Clopidogrel|clopidogrel|mesh-list
82794812|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82794813|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82794814|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82794815|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82794816|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
82794817|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794818|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794819|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794820|NCT00839501|Acetazolamide|acetazolamide|mesh-list
82794821|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
82794822|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82794823|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794824|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794825|NCT00839501|Diuretics|diuretics|mesh-ancestor
82794826|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
82794827|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794828|NCT00529542|Atorvastatin|atorvastatin|mesh-list
82794829|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82794830|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82794831|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
82794832|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794833|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82794834|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82794835|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794836|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
82794837|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794838|NCT00621959|Levocetirizine|levocetirizine|mesh-list
82794839|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82794840|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82794841|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
82794842|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
82794843|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82794844|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794845|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794846|NCT00839657|Warfarin|warfarin|mesh-list
82794847|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
82794848|NCT05259696|Cemiplimab|cemiplimab|mesh-list
82794849|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794850|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794851|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
82794852|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
82794853|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
82794854|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
82794855|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794856|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794857|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
82794858|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82794859|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794860|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794861|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794862|NCT00840125|Docetaxel|docetaxel|mesh-list
82794863|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82794864|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794865|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
82794866|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
82794867|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
82794868|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794869|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794870|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794871|NCT00830531|Bumetanide|bumetanide|mesh-list
82794872|NCT00830531|Diuretics|diuretics|mesh-ancestor
82794873|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
82794874|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794875|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82794876|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794877|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794878|NCT05014542|Analgesics|analgesics|mesh-list
82794879|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
82794880|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794881|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794882|NCT04926324|Niraparib|niraparib|mesh-list
82794883|NCT04926324|Dostarlimab|dostarlimab|mesh-list
82794884|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82794885|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794886|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794887|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794888|NCT00621257|Vitamin D|vitamin d|mesh-list
82794889|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
82794890|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
82794891|NCT00621257|Vitamins|vitamins|mesh-list
82794892|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
82794893|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794894|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82794895|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82794896|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
82794897|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82794898|NCT00840671|Protective Agents|protective agents|mesh-ancestor
82794899|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794900|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
82794901|NCT02546531|Gemcitabine|gemcitabine|mesh-list
82794902|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
82794903|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82794904|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
82794905|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794906|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794907|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794908|NCT02546531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82794909|NCT05205720|Ropivacaine|ropivacaine|mesh-list
82794910|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
82794911|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
82794912|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794913|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794914|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
82794915|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794916|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
82794917|NCT04043195|Nivolumab|nivolumab|mesh-list
82794918|NCT04043195|Ipilimumab|ipilimumab|mesh-list
82794919|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794920|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82794921|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82794922|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794923|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
82794924|NCT00841061|Trace Elements|trace elements|mesh-ancestor
82794925|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
82794926|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794927|NCT04042805|Lenvatinib|lenvatinib|mesh-list
82794928|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794929|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82794930|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794931|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794932|NCT05643846|Bupivacaine|bupivacaine|mesh-list
82794933|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
82794934|NCT05643846|Anesthetics|anesthetics|mesh-list
82794935|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794936|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794937|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
82794938|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794939|NCT00841139|Perhexiline|perhexiline|mesh-list
82794940|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82794941|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794942|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794943|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82794944|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794945|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
82794946|NCT00844337|Amoxicillin|amoxicillin|mesh-list
82794947|NCT00844337|Gentamicins|gentamicins|mesh-list
82794948|NCT00844337|Penicillins|penicillins|mesh-list
82794949|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82794950|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82794951|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82794952|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82794953|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794954|NCT00841373|Ranibizumab|ranibizumab|mesh-list
82794955|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82794956|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82794957|NCT00841373|Growth Substances|growth substances|mesh-ancestor
82794958|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794959|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
82794960|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82794961|NCT00851513|Lidocaine|lidocaine|mesh-list
82794962|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
82794963|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
82794964|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82794965|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794966|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
82794967|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794968|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82794969|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82794970|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82794971|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82794972|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82794973|NCT00841841|Acetaminophen|acetaminophen|mesh-list
82794974|NCT00841841|Dipyrone|dipyrone|mesh-list
82794975|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82794976|NCT00841841|Analgesics|analgesics|mesh-ancestor
82794977|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
82794978|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82794979|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794980|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
82794981|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82794982|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82794983|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82794984|NCT02545751|Thymalfasin|thymalfasin|mesh-list
82794985|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82794986|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
82794987|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794988|NCT00841919|Insulin|insulin|mesh-list
82794989|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82794990|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
82794991|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
82794992|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
82794993|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
82794994|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
82794995|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82794996|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82794997|NCT00852059|Methylphenidate|methylphenidate|mesh-list
82794998|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82794999|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795000|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82795001|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82795002|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795003|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795004|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
82795005|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795006|NCT00844727|Rofecoxib|rofecoxib|mesh-list
82795007|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82795008|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82795009|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795010|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795011|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82795012|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82795013|NCT00844727|Analgesics|analgesics|mesh-ancestor
82795014|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
82795015|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795016|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795017|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795018|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795019|NCT00528528|Ribavirin|ribavirin|mesh-list
82795020|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
82795021|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
82795022|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82795023|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82795024|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82795025|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
82795026|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795027|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
83361954|NCT01687673|Sirolimus|sirolimus|mesh-list
82795028|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795029|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
82795030|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795031|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795032|NCT00620555|Gabapentin|gabapentin|mesh-list
82795033|NCT00620555|Analgesics|analgesics|mesh-ancestor
82795034|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
82795035|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795036|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795037|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
82795038|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82795039|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82795040|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82795041|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82795042|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82795043|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82795044|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795045|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795046|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
82795047|NCT00845351|Bexarotene|bexarotene|mesh-list
82795048|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795049|NCT02546141|Caseins|caseins|mesh-list
82795050|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
82795051|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
82795052|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795054|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
82795055|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82795056|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
82795057|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
82795058|NCT00845819|Nystatin|nystatin|mesh-list
82795059|NCT00845819|Povidone|povidone|mesh-list
82795060|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82795061|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795062|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
82795063|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
82795064|NCT00845819|Trace Elements|trace elements|mesh-ancestor
82795065|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
82795066|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795067|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
82795068|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
82795069|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82795070|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
82795071|NCT00845819|Ionophores|ionophores|mesh-ancestor
82795072|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795073|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795074|NCT02546843|Rocuronium|rocuronium|mesh-list
82795075|NCT02546843|Atracurium|atracurium|mesh-list
82795076|NCT02546843|Cisatracurium|cisatracurium|mesh-list
82795077|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82795078|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82795079|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82795080|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795081|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795082|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82795083|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82795084|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
82795085|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441324|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82795086|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795087|NCT03998982|Dexamethasone|dexamethasone|mesh-list
82795088|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
82795089|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795090|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
82795091|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
82795092|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795093|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795094|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82795095|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
82795096|NCT03998982|Hormones|hormones|mesh-ancestor
82795097|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795098|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82795099|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795100|NCT00620321|Cytarabine|cytarabine|mesh-list
82795101|NCT00620321|Idarubicin|idarubicin|mesh-list
82795102|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82795103|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
82795104|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795105|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795106|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
82795107|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795108|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795109|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
82795110|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795111|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82795112|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82795113|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82795114|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795116|NCT00621023|Decitabine|decitabine|mesh-list
82795117|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
82795118|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82795119|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
82795120|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795121|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795122|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795123|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
82795124|NCT00621023|Protective Agents|protective agents|mesh-ancestor
82795125|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795126|NCT00621023|Vitamins|vitamins|mesh-ancestor
82795127|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
82795128|NCT00848861|Midazolam|midazolam|mesh-list
82795129|NCT00848861|Meperidine|meperidine|mesh-list
82795130|NCT00848861|Propofol|propofol|mesh-list
82795131|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82795132|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82795133|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795134|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82795135|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
82795136|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
82795137|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82795138|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82795139|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82795140|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82795141|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
82795142|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
82795143|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795144|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795145|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82795146|NCT00848861|Narcotics|narcotics|mesh-ancestor
82795147|NCT00848861|Analgesics|analgesics|mesh-ancestor
82795148|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
82795149|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795150|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
82795151|NCT00852371|Piperaquine|piperaquine|mesh-list
82795152|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
82795153|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82795154|NCT00852371|Amodiaquine|amodiaquine|mesh-list
82795155|NCT00852371|Artenimol|artenimol|mesh-list
82795156|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
82795157|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82795158|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82795159|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795160|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82795161|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795162|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795163|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82795164|NCT00528372|Metformin|metformin|mesh-list
82795165|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
82795166|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82795167|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795168|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82795169|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795170|NCT01564680|Acetaminophen|acetaminophen|mesh-list
82795171|NCT01564680|Lornoxicam|lornoxicam|mesh-list
82795172|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82795173|NCT01564680|Analgesics|analgesics|mesh-ancestor
82795174|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
82795175|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795176|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795177|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
82795178|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82795179|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795180|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795181|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
82795182|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361955|NCT01687673|Sorafenib|sorafenib|mesh-list
82795183|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795184|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795185|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795186|NCT00527982|Celecoxib|celecoxib|mesh-list
82795187|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82795188|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82795189|NCT00527982|Analgesics|analgesics|mesh-ancestor
82795190|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
82795191|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795192|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795193|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795194|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795195|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82795196|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82795197|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795198|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795199|NCT00527904|Naproxen|naproxen|mesh-list
82795200|NCT00527904|Esomeprazole|esomeprazole|mesh-list
82795201|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82795202|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82795203|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82795204|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795205|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795206|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82795207|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82795208|NCT00527904|Analgesics|analgesics|mesh-ancestor
82795209|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
82795210|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795211|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795212|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795213|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795214|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
82795215|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82795216|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82795217|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82795218|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82795219|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795220|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795221|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795222|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795223|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
82795224|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82795225|NCT00848939|Treprostinil|treprostinil|mesh-list
82795226|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82795227|NCT00842933|Prednisone|prednisone|mesh-list
82795228|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
82795229|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
82795230|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82795231|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82795232|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82795233|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795234|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
82795235|NCT00842933|Hormones|hormones|mesh-ancestor
82795236|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795237|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795238|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82795239|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795240|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
82795241|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
82795242|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795243|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82795244|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82795245|NCT00842933|Protective Agents|protective agents|mesh-ancestor
82795246|NCT00849095|Budesonide|budesonide|mesh-list
82795247|NCT00849095|Terbutaline|terbutaline|mesh-list
82795248|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
82795249|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82795250|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795251|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82795252|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
82795253|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795254|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361956|NCT01687673|Temsirolimus|temsirolimus|mesh-list
82795255|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82795256|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
82795257|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
82795258|NCT00849095|Hormones|hormones|mesh-ancestor
82795259|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795260|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82795261|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82795262|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82795263|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
82795264|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795265|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795266|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
82795267|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
82795268|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82795269|NCT00527826|Fluticasone|fluticasone|mesh-list
82795270|NCT00527826|Xhance|xhance|mesh-list
82795271|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82795272|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795273|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82795274|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
82795275|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795276|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795277|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82795278|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
82795279|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
82795280|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82795281|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82795282|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82795283|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82795284|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
82795285|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795286|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795287|NCT00849329|Lapatinib|lapatinib|mesh-list
82795288|NCT00849329|Esomeprazole|esomeprazole|mesh-list
82795289|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82795290|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82795291|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82795292|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795293|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795294|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795295|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795296|NCT03998670|Methamphetamine|methamphetamine|mesh-list
82795297|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82795298|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795299|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
82795300|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
82795301|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795302|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
82795303|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795304|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795305|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
82795306|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82795307|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82795308|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795309|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82795310|NCT00852683|Pregabalin|pregabalin|mesh-list
82795311|NCT00852683|Analgesics|analgesics|mesh-ancestor
82795312|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
82795313|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795314|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795315|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
82795316|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82795317|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795318|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795319|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82795320|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82795321|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82795322|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82795323|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82795324|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
82795325|NCT00619307|Ibuprofen|ibuprofen|mesh-list
82795326|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82795327|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83361957|NCT01687673|MTOR Inhibitors|mtor inhibitors|mesh-list
82795328|NCT00619307|Analgesics|analgesics|mesh-ancestor
82795329|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
82795330|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795331|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795332|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795333|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795334|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82795335|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795336|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795337|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82795338|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
82795339|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795340|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
82795341|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795342|NCT00855881|Tegafur|tegafur|mesh-list
82795343|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82795344|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
82795345|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795346|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795347|NCT00619229|Alprostadil|alprostadil|mesh-list
82795348|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82795349|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
82795350|NCT00619229|Urological Agents|urological agents|mesh-ancestor
82795351|NCT02546297|Budesonide|budesonide|mesh-list
82795352|NCT02546297|Bromides|bromides|mesh-list
82795353|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
82795354|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
82795355|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82795356|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795357|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82795358|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
82795359|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795360|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795361|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82795362|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
82795363|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
82795364|NCT02546297|Hormones|hormones|mesh-ancestor
82795365|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795366|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82795367|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82795368|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82795369|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
82795370|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795371|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795372|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
82795373|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82795374|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
82795375|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
82795376|NCT00618995|Niacin|niacin|mesh-list
82795377|NCT00618995|Niacinamide|niacinamide|mesh-list
82795378|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
82795379|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82795380|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
82795381|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795382|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82795383|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
82795384|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
82795385|NCT00618995|Vitamins|vitamins|mesh-ancestor
82795386|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
82795387|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795388|NCT03685344|Durvalumab|durvalumab|mesh-list
82795389|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82795390|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82795391|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82795392|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795393|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
82795394|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795395|NCT00856037|Doxorubicin|doxorubicin|mesh-list
82795396|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82795397|NCT00856037|Topotecan|topotecan|mesh-list
82795398|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82795399|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795400|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82795401|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82795402|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795403|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795404|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82795405|NCT00856271|Losartan|losartan|mesh-list
82795406|NCT00856271|Olmesartan|olmesartan|mesh-list
82795407|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82795408|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82795409|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82795410|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82795411|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82795412|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795413|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
82795414|NCT00856505|Everolimus|everolimus|mesh-list
82795415|NCT00856505|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82795416|NCT00856505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795417|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795418|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795419|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795420|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
82795421|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795422|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795423|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82795424|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82795425|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
82795426|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82795427|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795428|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
82795429|NCT02544893|Bupivacaine|bupivacaine|mesh-list
82795430|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
82795431|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
82795432|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82795433|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795434|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
82795435|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795436|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82795437|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82795438|NCT02544893|Analgesics|analgesics|mesh-ancestor
82795439|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82795440|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82795441|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82795442|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
82795443|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795444|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795445|NCT00520572|Etanercept|etanercept|mesh-list
82795446|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82795447|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82795448|NCT00520572|Analgesics|analgesics|mesh-ancestor
82795449|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
82795450|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795451|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795452|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795453|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795454|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82795455|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795456|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
82795457|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
82795458|NCT00853697|Testosterone|testosterone|mesh-list
82795459|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
82795460|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
82795461|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82795462|NCT00853697|Dutasteride|dutasteride|mesh-list
82795463|NCT00853697|Androgens|androgens|mesh-ancestor
82795464|NCT00853697|Hormones|hormones|mesh-ancestor
82795465|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795466|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795467|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82795468|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795469|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
82795470|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82795471|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82795472|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795473|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795474|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
82795475|NCT00861419|Niacinamide|niacinamide|mesh-list
82795476|NCT00861419|Bevacizumab|bevacizumab|mesh-list
82795477|NCT00861419|Sunitinib|sunitinib|mesh-list
82795479|NCT00861419|Sorafenib|sorafenib|mesh-list
82795480|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
82795481|NCT00861419|Imetelstat|imetelstat|mesh-list
82795482|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82795483|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795484|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82795485|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82795486|NCT00861419|Growth Substances|growth substances|mesh-ancestor
82795487|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795488|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
82795489|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795490|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795491|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795492|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
82795493|NCT00861419|Vitamins|vitamins|mesh-ancestor
82795494|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
82795495|NCT00527514|Amlodipine|amlodipine|mesh-list
82795496|NCT00527514|Olmesartan|olmesartan|mesh-list
82795497|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82795498|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82795499|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82795500|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795501|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795502|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82795503|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795504|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
82795505|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82795506|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82795507|NCT03998826|Piroxicam|piroxicam|mesh-list
82795508|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82795509|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82795510|NCT03998826|Analgesics|analgesics|mesh-ancestor
82795511|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
82795512|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795513|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795514|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795515|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795516|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82795517|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795518|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795519|NCT00853931|Panitumumab|panitumumab|mesh-list
82795520|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82795521|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795522|NCT00854009|BLI-489|bli-489|mesh-list
82795523|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82795524|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795525|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795526|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82795527|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795528|NCT03998592|Vaccines|vaccines|mesh-list
82795529|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
82795530|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795531|NCT00861731|Simvastatin|simvastatin|mesh-list
82795532|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82795533|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82795534|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
82795535|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795536|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82795537|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82795538|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795539|NCT02544659|Pamidronate|pamidronate|mesh-list
82795540|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82795541|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795542|NCT00861887|Vancomycin|vancomycin|mesh-list
82795543|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82795544|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795545|NCT00857519|Carboplatin|carboplatin|mesh-list
82795546|NCT00857519|Melphalan|melphalan|mesh-list
82795547|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795548|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82795549|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
82795550|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795551|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83361958|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795552|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795553|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
82795554|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795555|NCT00618449|Azithromycin|azithromycin|mesh-list
82795556|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82795557|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795558|NCT00857597|Esomeprazole|esomeprazole|mesh-list
82795560|NCT00857597|Rabeprazole|rabeprazole|mesh-list
82795561|NCT00857597|Pantoprazole|pantoprazole|mesh-list
82795562|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82795563|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82795564|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82795565|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795566|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795567|NCT00857753|Fentanyl|fentanyl|mesh-list
82795568|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82795569|NCT00857753|Narcotics|narcotics|mesh-ancestor
82795570|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82795571|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795572|NCT00857753|Analgesics|analgesics|mesh-ancestor
82795573|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
82795574|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795575|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82795576|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82795577|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
82795578|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
82795579|NCT00854321|Rituximab|rituximab|mesh-list
82795580|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82795581|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795582|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
82795583|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795584|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795585|NCT03684642|Metformin|metformin|mesh-list
82795586|NCT03684642|Dulaglutide|dulaglutide|mesh-list
82795587|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
82795588|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82795589|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795590|NCT00857831|Vitamin D|vitamin d|mesh-list
82795591|NCT00857831|Calcium|calcium|mesh-list
82795592|NCT00857831|Vitamins|vitamins|mesh-ancestor
82795593|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
82795594|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795595|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82795596|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82795597|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
82795598|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795599|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
82795600|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82795601|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82795602|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795603|NCT00862043|Urological Agents|urological agents|mesh-ancestor
82795604|NCT00519636|Fluticasone|fluticasone|mesh-list
82795605|NCT00519636|Xhance|xhance|mesh-list
82795606|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795607|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82795608|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
82795609|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795610|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795611|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82795612|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
82795613|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
82795614|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82795615|NCT00857909|Amiloride|amiloride|mesh-list
82795616|NCT00857909|Spironolactone|spironolactone|mesh-list
82795617|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82795618|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
82795619|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795620|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795621|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82795622|NCT00857909|Diuretics|diuretics|mesh-ancestor
82795623|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
82795624|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82795625|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82795626|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795627|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795628|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82795630|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
82795631|NCT00854477|Capecitabine|capecitabine|mesh-list
82795632|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82795633|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
82795634|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795635|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795636|NCT00854633|Lactoferrin|lactoferrin|mesh-list
82795637|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
82795638|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795639|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795640|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
82795641|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82795642|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82795643|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
82795644|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795645|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82795646|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82795647|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795648|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795649|NCT00858299|Valsartan|valsartan|mesh-list
82795650|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82795651|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82795652|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82795653|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795654|NCT00526890|Selenium|selenium|mesh-list
82795655|NCT00526890|Paclitaxel|paclitaxel|mesh-list
82795656|NCT00526890|Carboplatin|carboplatin|mesh-list
82795657|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82795658|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795659|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
82795660|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
82795661|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
82795662|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795663|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
82795664|NCT00526890|Protective Agents|protective agents|mesh-ancestor
82795665|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795666|NCT00526890|Trace Elements|trace elements|mesh-ancestor
82795667|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
82795668|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
82795669|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
82795670|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795671|NCT04041167|Protective Agents|protective agents|mesh-ancestor
82795672|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795673|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
82795674|NCT04041167|Vitamins|vitamins|mesh-ancestor
82795675|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
82795676|NCT00858377|Complement Factor H|complement factor h|mesh-list
82795677|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82795678|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795679|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
82795680|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795681|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
82795682|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82795683|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
82795684|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795685|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795686|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82795687|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
82795688|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82795689|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
82795690|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795691|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795692|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82795693|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
82795694|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
82795695|NCT00854711|Protective Agents|protective agents|mesh-ancestor
82795696|NCT00858455|Dolutegravir|dolutegravir|mesh-list
82795697|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82795698|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82795699|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795700|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795701|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82795702|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82795703|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
82795704|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795706|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795707|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795708|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795709|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795711|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795712|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82795713|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82795714|NCT00526656|Growth Substances|growth substances|mesh-ancestor
82795715|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795716|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
82795717|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795718|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795719|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795720|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
82795721|NCT00858767|Vitamin K|vitamin k|mesh-list
82795722|NCT00858767|Menaquinone 7|menaquinone 7|mesh-list
82795723|NCT00858767|Caseins|caseins|mesh-list
82795724|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
82795725|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
82795726|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795727|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82795728|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82795729|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
82795730|NCT00858767|Coagulants|coagulants|mesh-ancestor
82795731|NCT00858767|Vitamins|vitamins|mesh-ancestor
82795732|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
82795733|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795734|NCT00617903|Azelaic acid|azelaic acid|mesh-list
82795735|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795736|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
82795737|NCT00526110|Docetaxel|docetaxel|mesh-list
82795738|NCT00526110|Fluorouracil|fluorouracil|mesh-list
82795739|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
82795740|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795741|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
82795742|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
82795743|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
82795744|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795745|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
82795746|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82795747|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795748|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
82795749|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795750|NCT04565730|Anesthetics|anesthetics|mesh-list
82795751|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82795752|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795753|NCT00859079|Insulin|insulin|mesh-list
82795754|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82795755|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82795756|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82795757|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795758|NCT00859079|Incretins|incretins|mesh-ancestor
82795759|NCT00859079|Hormones|hormones|mesh-ancestor
82795760|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795761|NCT02544425|Dexamethasone|dexamethasone|mesh-list
82795762|NCT02544425|Etoposide|etoposide|mesh-list
82795763|NCT02544425|Melphalan|melphalan|mesh-list
82795764|NCT02544425|Busulfan|busulfan|mesh-list
82795765|NCT02544425|Asparaginase|asparaginase|mesh-list
82795766|NCT02544425|Ifosfamide|ifosfamide|mesh-list
82795767|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795768|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
82795769|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
82795770|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795771|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795772|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82795773|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
82795774|NCT02544425|Hormones|hormones|mesh-ancestor
82795775|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795776|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82795778|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82795779|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82795780|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82795782|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795783|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82795784|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
82795785|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82795786|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795787|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
82795788|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
82795789|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82795790|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82795791|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795792|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
82795793|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
82795794|NCT04523688|Temozolomide|temozolomide|mesh-list
82795795|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82795796|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
82795797|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795798|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795799|NCT00511836|Naltrexone|naltrexone|mesh-list
82795800|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82795801|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82795802|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795803|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
82795804|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795805|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
82795806|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82795807|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795808|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795809|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82795810|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795811|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82795812|NCT03998436|Esmolol|esmolol|mesh-list
82795813|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82795814|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82795815|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82795816|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
82795817|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795818|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795819|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795820|NCT00855101|Voriconazole|voriconazole|mesh-list
82795821|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
82795822|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795823|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82795824|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82795825|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795826|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795827|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82795828|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
82795829|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795830|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795831|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82795832|NCT00573755|Sorafenib|sorafenib|mesh-list
82795833|NCT00573755|Letrozole|letrozole|mesh-list
82795834|NCT00573755|Anastrozole|anastrozole|mesh-list
82795835|NCT00573755|Exemestane|exemestane|mesh-list
82795836|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795837|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795838|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795839|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795840|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82795841|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82795842|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82795843|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
82795844|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82795845|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795846|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82795847|NCT02544191|Goserelin|goserelin|mesh-list
82795848|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82795849|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795850|NCT00524316|Doxorubicin|doxorubicin|mesh-list
82795851|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82795852|NCT00524316|Sunitinib|sunitinib|mesh-list
82795853|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82795854|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795855|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82795856|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82795857|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795858|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795859|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82795860|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82795861|NCT00524316|Growth Substances|growth substances|mesh-ancestor
82795862|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795863|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
82795864|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82795865|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
82795866|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82795867|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82795868|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82795869|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795870|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795871|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
82795872|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795873|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795874|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82795875|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795876|NCT02544269|Bupivacaine|bupivacaine|mesh-list
82795877|NCT02544269|Ropivacaine|ropivacaine|mesh-list
82795878|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
82795879|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
82795880|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82795881|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795882|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
82795883|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795885|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
82795886|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795887|NCT00865085|Dexetimide|dexetimide|mesh-list
82795888|NCT00865085|Citalopram|citalopram|mesh-list
82795889|NCT00865085|Escitalopram|escitalopram|mesh-list
82795890|NCT00865085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82795891|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82795892|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82795893|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795894|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795895|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
82795896|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795897|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82795898|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
82795899|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82795900|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82795901|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82795902|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
82795903|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
82795904|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795905|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82795906|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82795907|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
82795908|NCT00796068|Cyclosporine|cyclosporine|mesh-list
82795909|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
82795910|NCT00796068|Fludarabine|fludarabine|mesh-list
82795911|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
82795912|NCT00796068|Treosulfan|treosulfan|mesh-list
82795913|NCT00796068|Busulfan|busulfan|mesh-list
82795914|NCT00796068|Cyclosporins|cyclosporins|mesh-list
82795915|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795916|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82795917|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
82795918|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795919|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795920|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
82795921|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795922|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795923|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
82795924|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795925|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
82795926|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795927|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82795928|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82795929|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82795930|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
82795931|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82795932|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82795933|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
82795934|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82795936|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82795937|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795938|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795939|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
82795940|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795941|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795942|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
82795943|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
82795944|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82795945|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82795946|NCT03783078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82795947|NCT03783078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795948|NCT01009476|Nicergoline|nicergoline|mesh-list
82795949|NCT01009476|Piracetam|piracetam|mesh-list
82795950|NCT01009476|Galantamine|galantamine|mesh-list
82795951|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
82795952|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82795953|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795954|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795955|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
82795956|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82795957|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795958|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82795959|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
82795960|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82795961|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82795962|NCT01009476|Protective Agents|protective agents|mesh-ancestor
82795963|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82795964|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82795965|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
82795966|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
82795967|NCT00517296|Adalimumab|adalimumab|mesh-list
82795968|NCT00517296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82795969|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82795970|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82795971|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
82795972|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82795973|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82795974|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795975|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
82795976|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
82795977|NCT00523848|Thalidomide|thalidomide|mesh-list
82795978|NCT00523848|Doxorubicin|doxorubicin|mesh-list
82795979|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82795980|NCT00523848|Bortezomib|bortezomib|mesh-list
82795981|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82795982|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441341|NCT00749515|Deferoxamine|deferoxamine|mesh-list
82795983|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82795984|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82795985|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82795986|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82795987|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82795988|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
82795989|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82795990|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
82795991|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82795992|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82795993|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82795994|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82795995|NCT00523848|Growth Substances|growth substances|mesh-ancestor
82795996|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
82795997|NCT04414722|Amoxicillin|amoxicillin|mesh-list
82795998|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
82795999|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
82796000|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82796001|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82796002|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361959|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83361960|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796003|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82796004|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796005|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796007|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796008|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
82796009|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
82796010|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
82796011|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796012|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
82796013|NCT04018157|Ketamine|ketamine|mesh-list
82796014|NCT04018157|Propofol|propofol|mesh-list
82796015|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82796016|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796017|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796018|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796019|NCT04018157|Analgesics|analgesics|mesh-ancestor
82796020|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
82796021|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796022|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82796023|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82796024|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796025|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796026|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796027|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796028|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82796029|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
82796030|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
82796031|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82796032|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82796033|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82796034|NCT00865241|Metformin|metformin|mesh-list
82796035|NCT00865241|Glyburide|glyburide|mesh-list
82796036|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82796037|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796038|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82796039|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
82796040|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82796041|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796042|NCT00860639|Immunotoxins|immunotoxins|mesh-ancestor
82796043|NCT00860639|Immunoconjugates|immunoconjugates|mesh-ancestor
82796044|NCT00860639|Immunologic Factors|immunologic factors|mesh-ancestor
82796045|NCT00860639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796046|NCT00863291|Buprenorphine|buprenorphine|mesh-list
82796047|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82796048|NCT00863291|Narcotics|narcotics|mesh-ancestor
82796049|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796050|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796051|NCT00863291|Analgesics|analgesics|mesh-ancestor
82796052|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
82796053|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796054|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82796055|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
82796056|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82796057|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82796058|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796059|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
82796060|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
82796061|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796062|NCT03639714|Nivolumab|nivolumab|mesh-list
82796063|NCT03639714|Ipilimumab|ipilimumab|mesh-list
82796064|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82796065|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796066|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82796067|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796068|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
82796069|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82796070|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82796071|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796073|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82796074|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796075|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796076|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796077|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82796078|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
82796079|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82796080|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796081|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82796082|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82796083|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82796084|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
82796085|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82796086|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796087|NCT00861107|Vaccines|vaccines|mesh-list
82796088|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
82796089|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796090|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
82796091|NCT00510510|Bromides|bromides|mesh-list
82796092|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
82796093|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82796094|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82796095|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82796096|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
82796097|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796098|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796099|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796100|NCT04685694|Misoprostol|misoprostol|mesh-list
82796101|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82796102|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
82796103|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82796104|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796105|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82796106|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796107|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
82796108|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
82796109|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
82796110|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796111|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796112|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796113|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
82796114|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796115|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796116|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796117|NCT00865631|Gabapentin|gabapentin|mesh-list
82796118|NCT00865631|Analgesics|analgesics|mesh-ancestor
82796119|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
82796120|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796121|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796122|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
82796123|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82796124|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796125|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796126|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796127|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82796128|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82796129|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796130|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796131|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
82796132|NCT00863837|Terlipressin|terlipressin|mesh-list
82796133|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82796134|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82796135|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796136|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796137|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796138|NCT00863915|Ramipril|ramipril|mesh-list
82796139|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82796140|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
82796141|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796142|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796143|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796144|NCT01009944|Atenolol|atenolol|mesh-list
82796145|NCT01009944|Lisinopril|lisinopril|mesh-list
82796146|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82796147|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
82796148|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796149|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796150|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796151|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82796152|NCT01009944|Protective Agents|protective agents|mesh-ancestor
82796153|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796154|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82796156|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
82796157|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796158|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82796159|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82796160|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82796161|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796162|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796163|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82796164|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
82796165|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
82796166|NCT00864071|Griseofulvin|griseofulvin|mesh-list
82796167|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
82796168|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796169|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82796170|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
82796171|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796172|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796173|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
82796174|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796175|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796176|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82796177|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82796178|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796179|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796180|NCT00864149|Carvedilol|carvedilol|mesh-list
82796181|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82796182|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82796183|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83441358|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
82796184|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796185|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796186|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796187|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796188|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
82796189|NCT00864149|Protective Agents|protective agents|mesh-ancestor
82796190|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82796191|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796192|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82796193|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
82796194|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82796195|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82796196|NCT01010100|Acarbose|acarbose|mesh-list
82796197|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82796198|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796199|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796200|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82796201|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796202|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82796203|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82796204|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
82796205|NCT01010178|Theophylline|theophylline|mesh-list
82796206|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82796207|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
82796208|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796209|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796210|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82796211|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
82796212|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82796213|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796214|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796215|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
82796216|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82796217|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82796218|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
82796219|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796220|NCT00617591|Dexamethasone|dexamethasone|mesh-list
82796221|NCT00617591|Doxorubicin|doxorubicin|mesh-list
82796222|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82796223|NCT00617591|Lenalidomide|lenalidomide|mesh-list
82796224|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796225|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
82796226|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
82796227|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796228|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796229|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796230|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
82796231|NCT00617591|Hormones|hormones|mesh-ancestor
82796232|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796233|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82796234|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796235|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82796236|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82796237|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82796238|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796239|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796240|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
82796241|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82796242|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82796243|NCT00617591|Growth Substances|growth substances|mesh-ancestor
82796244|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
82796245|NCT00864305|Gabapentin|gabapentin|mesh-list
82796246|NCT00864305|Analgesics|analgesics|mesh-ancestor
82796247|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
82796248|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796249|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796250|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
82796251|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82796252|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796253|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796254|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83441368|NCT00761137|Tropicamide|tropicamide|mesh-list
82796255|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82796256|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82796257|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796258|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796259|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
82796260|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82796261|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82796262|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82796263|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796264|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796265|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796266|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796267|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796268|NCT00864617|Nifedipine|nifedipine|mesh-list
82796269|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82796270|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796271|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796272|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82796273|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796274|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
82796275|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
82796276|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82796277|NCT00865943|Dexetimide|dexetimide|mesh-list
82796278|NCT00865943|Citalopram|citalopram|mesh-list
82796279|NCT00865943|Escitalopram|escitalopram|mesh-list
82796280|NCT00865943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82796281|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82796282|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796283|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796284|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796285|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
82796286|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796287|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82796288|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
82796289|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796290|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82796291|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82796292|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
82796293|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
82796294|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796295|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82796296|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82796297|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
82796299|NCT00866021|Lopinavir|lopinavir|mesh-list
82796300|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82796301|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82796302|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
82796303|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796304|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796305|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82796306|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82796307|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
82796308|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796309|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82796310|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82796311|NCT00871247|Finasteride|finasteride|mesh-list
82796312|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82796313|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82796314|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796315|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796316|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
82796317|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796318|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796319|NCT00871247|Urological Agents|urological agents|mesh-ancestor
82796320|NCT02543879|Azacitidine|azacitidine|mesh-list
82796321|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82796322|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
82796323|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796324|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83441370|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
82796325|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796326|NCT04137120|Aflibercept|aflibercept|mesh-list
82796327|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82796328|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82796329|NCT04137120|Growth Substances|growth substances|mesh-ancestor
82796330|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796331|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
82796332|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796333|NCT00616655|Eszopiclone|eszopiclone|mesh-list
82796334|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82796335|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796336|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796337|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
82796338|NCT00864773|Growth Substances|growth substances|mesh-ancestor
82796339|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796340|NCT01010490|Dipivefrin|dipivefrin|mesh-list
82796341|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796342|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796343|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796344|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796345|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796346|NCT00516048|Exenatide|exenatide|mesh-list
82796347|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82796348|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796349|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82796350|NCT00516048|Incretins|incretins|mesh-ancestor
82796351|NCT00516048|Hormones|hormones|mesh-ancestor
82796352|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796353|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
82796354|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796355|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82796356|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796357|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796358|NCT00865007|Ritonavir|ritonavir|mesh-list
82796359|NCT00865007|Lopinavir|lopinavir|mesh-list
82796360|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82796361|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82796362|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
82796363|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796364|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796365|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82796366|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82796367|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
82796368|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796369|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82796370|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82796371|NCT00872417|Lamivudine|lamivudine|mesh-list
82796372|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82796373|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82796374|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796375|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796377|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796378|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82796379|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82796380|NCT00876317|Etoricoxib|etoricoxib|mesh-list
82796381|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82796382|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796383|NCT00876317|Analgesics|analgesics|mesh-ancestor
82796384|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
82796385|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796386|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796387|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796388|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796389|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82796390|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82796391|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796392|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796393|NCT00866645|Haloperidol|haloperidol|mesh-list
82796394|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
82796395|NCT00866645|Sulpiride|sulpiride|mesh-list
82796396|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82796397|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
82796398|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
82796399|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796400|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796401|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796402|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82796403|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796404|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796405|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796406|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82796407|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
82796408|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796409|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796410|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82796411|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82796412|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
82796413|NCT00872651|Timolol|timolol|mesh-list
82796414|NCT00872651|Travoprost|travoprost|mesh-list
82796415|NCT00872651|Latanoprost|latanoprost|mesh-list
82796416|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82796417|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82796418|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796419|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796420|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796421|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796422|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82796423|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796424|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82796425|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82796426|NCT00872963|Vaccines|vaccines|mesh-list
82796427|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
82796428|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796429|NCT00873197|Granisetron|granisetron|mesh-list
82796430|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
82796431|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
82796432|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796433|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796434|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796435|NCT00873197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82796436|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82796437|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
82796438|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796439|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796440|NCT00873353|Capecitabine|capecitabine|mesh-list
82796441|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82796442|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82796444|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796445|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796446|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82796447|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796449|NCT00877097|Trisequens|trisequens|mesh-list
82796450|NCT00877097|Norethindrone|norethindrone|mesh-list
82796451|NCT00877097|Estradiol|estradiol|mesh-list
82796452|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82796453|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796454|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82796455|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82796456|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82796457|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
82796458|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82796459|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82796460|NCT00877097|Estrogens|estrogens|mesh-ancestor
82796461|NCT00877097|Hormones|hormones|mesh-ancestor
82796462|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796463|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82796464|NCT00877175|Phenylephrine|phenylephrine|mesh-list
82796465|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
82796466|NCT00877175|Tropicamide|tropicamide|mesh-list
82796467|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82796468|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
82796469|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
82796470|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796471|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796472|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
82796473|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82796474|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
82796475|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
82796476|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82796477|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82796478|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796479|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796480|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796481|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796482|NCT00877175|Protective Agents|protective agents|mesh-ancestor
82796483|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82796484|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82796485|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
82796486|NCT00420927|Adalimumab|adalimumab|mesh-list
82796487|NCT00420927|Methotrexate|methotrexate|mesh-list
82796488|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82796489|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
82796490|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82796491|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796492|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82796493|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
82796494|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796495|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796496|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
82796497|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796498|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82796499|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82796500|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
82796501|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796502|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82796503|NCT00420927|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82796504|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796505|NCT00573443|Quinidine|quinidine|mesh-list
82796506|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
82796507|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
82796508|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
82796509|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
82796510|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82796511|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82796512|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796513|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796514|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796515|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82796516|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82796517|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796518|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82796519|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
82796520|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82796521|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82796522|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796523|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796524|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82796525|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82796526|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
82796527|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82796528|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82796529|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796530|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82796531|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82796532|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
82796534|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82796535|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
82796536|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796537|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796538|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82796539|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
82796540|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796541|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796542|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82796543|NCT00873509|Buspirone|buspirone|mesh-list
82796544|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82796545|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796546|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796547|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796548|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796549|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82796550|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
82796551|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796552|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796553|NCT00877253|Carboplatin|carboplatin|mesh-list
82796554|NCT00877253|genexol-PM|genexol-pm|mesh-list
82796555|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796556|NCT00877253|Tubulin Modulators|tubulin modulators|mesh-ancestor
82796557|NCT00877253|Antimitotic Agents|antimitotic agents|mesh-ancestor
82796558|NCT00877253|Mitosis Modulators|mitosis modulators|mesh-ancestor
82796559|NCT00877253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796560|NCT05225753|Chrysarobin|chrysarobin|mesh-list
82796561|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82796562|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796563|NCT05225753|Analgesics|analgesics|mesh-ancestor
82796564|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
82796565|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796566|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796567|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796568|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796569|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82796570|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
82796571|NCT00874133|Domperidone|domperidone|mesh-list
82796572|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
82796573|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
82796574|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796575|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796576|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796577|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82796578|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
82796579|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796580|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796581|NCT00867737|Fluticasone|fluticasone|mesh-list
82796582|NCT00867737|Budesonide|budesonide|mesh-list
82796583|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
82796584|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82796585|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82796586|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82796587|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796588|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82796589|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
82796590|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796591|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796592|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82796593|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
82796594|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
82796595|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82796596|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
82796598|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796599|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82796600|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82796601|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796602|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796603|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796604|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796605|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
82796606|NCT04551677|Vaccines|vaccines|mesh-list
82796607|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
82796608|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796609|NCT04040465|Aspirin|aspirin|mesh-list
82796610|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82796611|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796612|NCT04040465|Analgesics|analgesics|mesh-ancestor
82796613|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
82796614|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796615|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796616|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796617|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796618|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82796619|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82796620|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796621|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82796622|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82796623|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796624|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
82796625|NCT00420849|Dexamethasone|dexamethasone|mesh-list
82796626|NCT00420849|Lenalidomide|lenalidomide|mesh-list
82796627|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796628|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
82796629|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
82796630|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796631|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796632|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796633|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
82796634|NCT00420849|Hormones|hormones|mesh-ancestor
82796635|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796636|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82796637|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796638|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
82796639|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82796640|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82796641|NCT00420849|Growth Substances|growth substances|mesh-ancestor
82796642|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
82796643|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
82796644|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82796645|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82796646|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82796647|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
82796648|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796649|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82796650|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82796651|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796652|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796653|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82796654|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82796655|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
82796656|NCT00874601|Valsartan|valsartan|mesh-list
82796657|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796658|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82796659|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82796660|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796661|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82796662|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
82796663|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82796664|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82796665|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796666|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796667|NCT00874679|Urological Agents|urological agents|mesh-ancestor
82796668|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82796669|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82796670|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82796671|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796672|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796673|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796674|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796675|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796677|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82796678|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796679|NCT00420303|Analgesics|analgesics|mesh-ancestor
82796680|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
82796681|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796682|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796683|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796684|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796685|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796686|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82796687|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
82796688|NCT00617123|Vorapaxar|vorapaxar|mesh-list
82796689|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82796690|NCT00877955|Alprazolam|alprazolam|mesh-list
82796691|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82796692|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796693|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796694|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82796695|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796696|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796697|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
82796698|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
82796699|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796700|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796701|NCT00419757|Budesonide|budesonide|mesh-list
82796702|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
82796703|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82796704|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796705|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82796706|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
82796707|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796708|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796709|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82796710|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
82796711|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
82796712|NCT00419757|Hormones|hormones|mesh-ancestor
82796713|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796714|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82796715|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82796716|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796717|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796718|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796719|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796720|NCT00434109|Sunitinib|sunitinib|mesh-list
82796721|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796722|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82796723|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82796724|NCT00434109|Growth Substances|growth substances|mesh-ancestor
82796725|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796726|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
82796727|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82796728|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796729|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796730|NCT00875069|Ethanol|ethanol|mesh-list
82796731|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82796732|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796733|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796734|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796735|NCT01029639|Insulin|insulin|mesh-list
82796736|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
82796737|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82796738|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82796739|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796740|NCT00875147|Bevacizumab|bevacizumab|mesh-list
82796741|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82796742|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796744|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82796745|NCT00875147|Growth Substances|growth substances|mesh-ancestor
82796746|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796747|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
82796748|NCT00433329|Bosentan|bosentan|mesh-list
82796749|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
82796750|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
82796751|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82796752|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82796753|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796754|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796755|NCT00433329|Urological Agents|urological agents|mesh-ancestor
82796756|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796757|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82796758|NCT01035021|Rocuronium|rocuronium|mesh-list
82796759|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82796760|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82796761|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82796762|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796763|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796764|NCT00878345|Pentobarbital|pentobarbital|mesh-list
82796765|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
82796766|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82796767|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796768|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796769|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796770|NCT00878345|Analgesics|analgesics|mesh-ancestor
82796771|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
82796772|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796773|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82796774|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82796775|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796776|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796777|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796778|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796779|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82796780|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
82796781|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
82796782|NCT00433017|Ranibizumab|ranibizumab|mesh-list
82796783|NCT00433017|Verteporfin|verteporfin|mesh-list
82796784|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82796785|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82796786|NCT00433017|Growth Substances|growth substances|mesh-ancestor
82796787|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796788|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
82796789|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796790|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82796791|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
82796792|NCT03726671|Choline|choline|mesh-list
82796793|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
82796794|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82796795|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
82796796|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796797|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796798|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82796799|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
82796800|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
82796801|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82796802|NCT00868283|Protective Agents|protective agents|mesh-ancestor
82796803|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796804|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
82796805|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
82796806|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82796807|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796808|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82796809|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
82796810|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82796811|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796812|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796813|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796814|NCT00875537|Capsaicin|capsaicin|mesh-list
82796815|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
82796816|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
82796817|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
82796818|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796819|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796821|NCT00875771|Capecitabine|capecitabine|mesh-list
82796822|NCT00875771|Irinotecan|irinotecan|mesh-list
82796823|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82796824|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796825|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82796826|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82796827|NCT00875771|Growth Substances|growth substances|mesh-ancestor
82796828|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796829|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
82796830|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82796831|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
82796832|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796833|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82796834|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82796835|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796836|NCT00875849|Cetuximab|cetuximab|mesh-list
82796837|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796838|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82796839|NCT00875927|Zinc|zinc|mesh-list
82796840|NCT00875927|Propolis|propolis|mesh-list
82796841|NCT00875927|Trace Elements|trace elements|mesh-ancestor
82796842|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
82796843|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796844|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796845|NCT00878657|Gemcitabine|gemcitabine|mesh-list
82796846|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82796847|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
82796848|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796849|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796850|NCT00868829|Chromium|chromium|mesh-list
82796851|NCT00868829|Sirolimus|sirolimus|mesh-list
82796852|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82796853|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796854|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82796855|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796856|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
82796857|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82796858|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
82796859|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796860|NCT00868829|Trace Elements|trace elements|mesh-ancestor
82796861|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
82796862|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
82796863|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
82796864|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82796865|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796866|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796867|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82796868|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796869|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82796870|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82796871|NCT00868985|Laxatives|laxatives|mesh-ancestor
82796872|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796873|NCT00869063|Diclofenac|diclofenac|mesh-list
82796874|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82796875|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796876|NCT00869063|Analgesics|analgesics|mesh-ancestor
82796877|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
82796878|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796879|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796880|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796881|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796882|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82796883|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796884|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796885|NCT00869219|Nepafenac|nepafenac|mesh-list
82796886|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82796887|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82796888|NCT00869219|Analgesics|analgesics|mesh-ancestor
82796889|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
82796890|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796891|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796893|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796894|NCT03994965|Pimavanserin|pimavanserin|mesh-list
82796895|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82796896|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82796897|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82796898|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796899|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796900|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796901|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796902|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82796903|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82796904|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
82796905|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796906|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796907|NCT00531284|Dexamethasone|dexamethasone|mesh-list
82796908|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796909|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
82796910|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
82796911|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796912|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796913|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796914|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
82796915|NCT00531284|Hormones|hormones|mesh-ancestor
82796916|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796917|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82796918|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796919|NCT00531206|Ritonavir|ritonavir|mesh-list
82796920|NCT00531206|Tipranavir|tipranavir|mesh-list
82796921|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82796922|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82796923|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
82796924|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796925|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796926|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82796927|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82796928|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
82796929|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82796930|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82796931|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82796932|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
82796933|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
82796934|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
82796935|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82796936|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796937|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
82796938|NCT00994994|Coagulants|coagulants|mesh-ancestor
82796939|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
82796940|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82796941|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82796942|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82796943|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82796944|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82796945|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82796946|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796947|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82796948|NCT00999752|Nebivolol|nebivolol|mesh-list
82796949|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82796950|NCT00999752|Diuretics|diuretics|mesh-ancestor
82796951|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
82796952|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796953|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82796954|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82796955|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796956|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
82796957|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82796958|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82796959|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82796960|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
82796961|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82796962|NCT01005758|Cytarabine|cytarabine|mesh-list
82796963|NCT01005758|Dexamethasone|dexamethasone|mesh-list
82796964|NCT01005758|Prednisone|prednisone|mesh-list
82796965|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
82796966|NCT01005758|Prednisolone|prednisolone|mesh-list
82796967|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
82796968|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82796969|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82796970|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82796971|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
82796972|NCT01005758|Doxorubicin|doxorubicin|mesh-list
82796973|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82796974|NCT01005758|Methotrexate|methotrexate|mesh-list
82796975|NCT01005758|Etoposide|etoposide|mesh-list
82796976|NCT01005758|Vincristine|vincristine|mesh-list
82796977|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
82796978|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
82796979|NCT01005758|Pegaspargase|pegaspargase|mesh-list
82796980|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
82796981|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82796982|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
82796983|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82796984|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82796985|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82796986|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
82796987|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82796988|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82796989|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82796990|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82796991|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
82796992|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
82796993|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82796994|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82796995|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
82796996|NCT01005758|Hormones|hormones|mesh-ancestor
82796997|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82796998|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82796999|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82797000|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82797001|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82797002|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797003|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82797004|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
82797005|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82797006|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82797007|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
82797008|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
82797009|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82797010|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82797011|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82797012|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
82797013|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797014|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
82797015|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
82797016|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
82797017|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82797018|NCT01005758|Protective Agents|protective agents|mesh-ancestor
82797019|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82797020|NCT05152472|Atezolizumab|atezolizumab|mesh-list
82797021|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
82797022|NCT05152472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82797023|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797024|NCT05152472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797025|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797026|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82797027|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797028|NCT00879047|Ethanol|ethanol|mesh-list
82797029|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82797030|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797031|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797032|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797033|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
82797034|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82797035|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
82797036|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797037|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82797038|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82797039|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
82797040|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797041|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797042|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82797044|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82797045|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82797046|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82797047|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797048|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797049|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
82797050|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82797051|NCT01000298|Amoxicillin|amoxicillin|mesh-list
82797052|NCT01000298|Cefdinir|cefdinir|mesh-list
82797053|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82797054|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797055|NCT00614939|Saxagliptin|saxagliptin|mesh-list
82797056|NCT00614939|Incretins|incretins|mesh-ancestor
82797057|NCT00614939|Hormones|hormones|mesh-ancestor
82797058|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797059|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797060|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82797061|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
82797062|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797063|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797064|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82797065|NCT05176964|Capecitabine|capecitabine|mesh-list
82797066|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
82797067|NCT05176964|Tislelizumab|tislelizumab|mesh-list
82797068|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82797069|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
82797070|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797071|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797072|NCT05176964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797073|NCT00879827|PENTA|penta|mesh-list
82797074|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
82797075|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82797076|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82797077|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797078|NCT01007084|Propranolol|propranolol|mesh-list
82797079|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82797080|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82797081|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
82797082|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797083|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797084|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797085|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82797086|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82797087|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
82797088|NCT04040309|Lidocaine|lidocaine|mesh-list
82797089|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
82797090|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
82797091|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797092|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797093|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
82797094|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797095|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82797096|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82797097|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82797098|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797099|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797100|NCT01000688|Vildagliptin|vildagliptin|mesh-list
82797101|NCT01000688|Acarbose|acarbose|mesh-list
82797102|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82797103|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797104|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82797105|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
82797106|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797107|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797108|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82797109|NCT00879983|Azithromycin|azithromycin|mesh-list
82797110|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82797111|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797112|NCT00880061|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
82797113|NCT00880061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797114|NCT00869765|Cycloserine|cycloserine|mesh-list
82797115|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82797116|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797117|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82797118|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
82797119|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82797120|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
82797121|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797122|NCT00880373|Ibuprofen|ibuprofen|mesh-list
82797123|NCT00880373|Morphine|morphine|mesh-list
82797124|NCT00880373|Heroin|heroin|mesh-list
82797125|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82797126|NCT00880373|Narcotics|narcotics|mesh-ancestor
82797127|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797128|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797129|NCT00880373|Analgesics|analgesics|mesh-ancestor
82797130|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
82797131|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797132|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82797133|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82797134|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82797135|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82797136|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82797137|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797138|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797139|NCT01007630|Rasagiline|rasagiline|mesh-list
82797140|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82797141|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797142|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797143|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82797144|NCT01007630|Protective Agents|protective agents|mesh-ancestor
82797145|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797146|NCT05883384|Caseins|caseins|mesh-list
82797147|NCT05883384|Chelating Agents|chelating agents|mesh-ancestor
82797148|NCT05883384|Sequestering Agents|sequestering agents|mesh-ancestor
82797149|NCT05883384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797150|NCT05883358|Clonidine|clonidine|mesh-list
82797151|NCT05883358|Buprenorphine|buprenorphine|mesh-list
82797152|NCT05883358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82797153|NCT05883358|Narcotics|narcotics|mesh-ancestor
82797154|NCT05883358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797155|NCT05883358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797156|NCT05883358|Analgesics|analgesics|mesh-ancestor
82797157|NCT05883358|Sensory System Agents|sensory system agents|mesh-ancestor
82797158|NCT05883358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797159|NCT05883358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82797160|NCT05883358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82797161|NCT05883358|Sympatholytics|sympatholytics|mesh-ancestor
82797162|NCT05883358|Autonomic Agents|autonomic agents|mesh-ancestor
82797163|NCT05883358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82797164|NCT05883358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82797165|NCT05883358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82797166|NCT05883358|Adrenergic Agents|adrenergic agents|mesh-ancestor
82797167|NCT05883358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797168|NCT05883358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797169|NCT05883345|Immunoglobulins|immunoglobulins|mesh-list
82797170|NCT05883345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82797171|NCT05883345|Antibodies|antibodies|mesh-list
82797172|NCT05883345|Immunoglobulin G|immunoglobulin g|mesh-list
82797173|NCT05883345|Gastrins|gastrins|mesh-list
82797174|NCT05883345|Immunologic Factors|immunologic factors|mesh-ancestor
82797175|NCT05883345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797176|NCT05883345|Hormones|hormones|mesh-ancestor
82797177|NCT05883345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797178|NCT05883332|Nitrous Oxide|nitrous oxide|mesh-list
82797179|NCT05883332|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82797180|NCT05883332|Anesthetics, General|anesthetics, general|mesh-ancestor
82797181|NCT05883332|Anesthetics|anesthetics|mesh-ancestor
82797182|NCT05883332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797183|NCT05883332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797184|NCT05883332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82797185|NCT05883332|Analgesics|analgesics|mesh-ancestor
82797186|NCT05883332|Sensory System Agents|sensory system agents|mesh-ancestor
82797187|NCT05883332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797188|NCT05883176|Bevacizumab|bevacizumab|mesh-list
82797189|NCT05883176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797190|NCT05883176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797191|NCT05883176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82797192|NCT05883176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82797193|NCT05883176|Growth Substances|growth substances|mesh-ancestor
82797194|NCT05883176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797195|NCT05883176|Growth Inhibitors|growth inhibitors|mesh-ancestor
82797196|NCT05883150|Midazolam|midazolam|mesh-list
82797197|NCT05883150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82797198|NCT05883150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82797199|NCT05883150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797200|NCT05883150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797201|NCT05883150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82797202|NCT05883150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82797203|NCT05883150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82797204|NCT05883150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82797205|NCT05883150|Anesthetics, General|anesthetics, general|mesh-ancestor
82797206|NCT05883150|Anesthetics|anesthetics|mesh-ancestor
82797207|NCT05883150|GABA Modulators|gaba modulators|mesh-ancestor
82797208|NCT05883150|GABA Agents|gaba agents|mesh-ancestor
82797209|NCT05883150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797210|NCT05883150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797211|NCT05883124|Rivastigmine|rivastigmine|mesh-list
82797212|NCT05883124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82797213|NCT05883124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797214|NCT05883124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797215|NCT05883124|Cholinergic Agents|cholinergic agents|mesh-ancestor
82797216|NCT05883124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797217|NCT05883124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797218|NCT05883124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82797219|NCT05883124|Protective Agents|protective agents|mesh-ancestor
82797220|NCT05883046|Performance-Enhancing Substances|performance-enhancing substances|mesh-list
82797221|NCT05883046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797222|NCT05882903|Betamethasone|betamethasone|mesh-list
82797223|NCT05882903|Betamethasone Valerate|betamethasone valerate|mesh-list
82797224|NCT05882903|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82797225|NCT05882903|Betamethasone benzoate|betamethasone benzoate|mesh-list
82797226|NCT05882903|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82797227|NCT05882903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82797228|NCT05882903|Glucocorticoids|glucocorticoids|mesh-ancestor
82797229|NCT05882903|Hormones|hormones|mesh-ancestor
82797230|NCT05882903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797231|NCT05882903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797232|NCT05882903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82797233|NCT05882903|Respiratory System Agents|respiratory system agents|mesh-ancestor
82797234|NCT05882864|Triamcinolone|triamcinolone|mesh-list
82797235|NCT05882864|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82797236|NCT05882864|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82797237|NCT05882864|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82797238|NCT05882864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82797239|NCT05882864|Glucocorticoids|glucocorticoids|mesh-ancestor
82797240|NCT05882864|Hormones|hormones|mesh-ancestor
82797241|NCT05882864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797242|NCT05882864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797243|NCT05882864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82797244|NCT05882864|Immunologic Factors|immunologic factors|mesh-ancestor
82797245|NCT05882864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797246|NCT05882864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797247|NCT05882734|Cemiplimab|cemiplimab|mesh-list
82797248|NCT05882734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797249|NCT05882734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797250|NCT05882630|Carboplatin|carboplatin|mesh-list
82797251|NCT05882630|Etoposide|etoposide|mesh-list
82797252|NCT05882630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797253|NCT05882630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82797254|NCT05882630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82797255|NCT05882630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82797256|NCT05882630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797257|NCT05882630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797258|NCT05882604|Mesna|mesna|mesh-list
82797259|NCT05882604|Protective Agents|protective agents|mesh-ancestor
82797260|NCT05882604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797261|NCT05882357|Ivacaftor|ivacaftor|mesh-list
82797262|NCT05882357|Elexacaftor|elexacaftor|mesh-list
82797263|NCT05882357|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82797264|NCT05882357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482525|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82797265|NCT05882357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797266|NCT05882214|Niacinamide|niacinamide|mesh-list
82797267|NCT05882214|Niacin|niacin|mesh-list
82797268|NCT05882214|Nicotinic Acids|nicotinic acids|mesh-list
82797269|NCT05882214|Vitamin B Complex|vitamin b complex|mesh-ancestor
82797270|NCT05882214|Vitamins|vitamins|mesh-ancestor
82797271|NCT05882214|Micronutrients|micronutrients|mesh-ancestor
82797272|NCT05882214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797273|NCT05882214|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82797274|NCT05882214|Antimetabolites|antimetabolites|mesh-ancestor
82797275|NCT05882214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797276|NCT05882214|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82797277|NCT05882214|Vasodilator Agents|vasodilator agents|mesh-ancestor
82797278|NCT05881980|Itraconazole|itraconazole|mesh-list
82797279|NCT05881980|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
82797280|NCT05881980|Terbinafine|terbinafine|mesh-list
82797281|NCT05881980|Antifungal Agents|antifungal agents|mesh-ancestor
82797282|NCT05881980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797283|NCT05881980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82797284|NCT05881980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82797285|NCT05881980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797286|NCT05881980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797287|NCT05881980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82797288|NCT05881980|Hormone Antagonists|hormone antagonists|mesh-ancestor
82797289|NCT05881980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797290|NCT05881980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797291|NCT05881980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82797292|NCT05881928|Lamotrigine|lamotrigine|mesh-list
82797293|NCT05881928|Valproic Acid|valproic acid|mesh-list
82797294|NCT05881928|Anticonvulsants|anticonvulsants|mesh-ancestor
82797295|NCT05881928|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82797296|NCT05881928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797297|NCT05881928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797298|NCT05881928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82797299|NCT05881928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797300|NCT05881928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82797301|NCT05881928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82797302|NCT05881928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797303|NCT05881928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82797304|NCT05881928|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82797305|NCT05881928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797306|NCT05881928|GABA Agents|gaba agents|mesh-ancestor
82797307|NCT05881928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797308|NCT05881928|Antimanic Agents|antimanic agents|mesh-ancestor
82797309|NCT05881915|Phenylephrine|phenylephrine|mesh-list
82797310|NCT05881915|Epinephrine|epinephrine|mesh-list
82797311|NCT05881915|Oxymetazoline|oxymetazoline|mesh-list
82797312|NCT05881915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82797313|NCT05881915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82797314|NCT05881915|Adrenergic Agents|adrenergic agents|mesh-ancestor
82797315|NCT05881915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797316|NCT05881915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797317|NCT05881915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797318|NCT05881915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82797319|NCT05881915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82797320|NCT05881915|Autonomic Agents|autonomic agents|mesh-ancestor
82797321|NCT05881915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797322|NCT05881915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82797323|NCT05881915|Respiratory System Agents|respiratory system agents|mesh-ancestor
82797324|NCT05881915|Mydriatics|mydriatics|mesh-ancestor
82797325|NCT05881915|Sympathomimetics|sympathomimetics|mesh-ancestor
82797326|NCT05881915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82797327|NCT05881915|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82797328|NCT05881915|Nasal Decongestants|nasal decongestants|mesh-ancestor
82797329|NCT05881915|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82797330|NCT05881915|Protective Agents|protective agents|mesh-ancestor
82797331|NCT05881746|Liver Extracts|liver extracts|mesh-list
82797332|NCT05881746|Hematinics|hematinics|mesh-ancestor
82797333|NCT05881525|Paclitaxel|paclitaxel|mesh-list
82797334|NCT05881525|Cyclophosphamide|cyclophosphamide|mesh-list
82797335|NCT05881525|Fludarabine|fludarabine|mesh-list
82797336|NCT05881525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82797337|NCT05881525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797338|NCT05881525|Tubulin Modulators|tubulin modulators|mesh-ancestor
82797339|NCT05881525|Antimitotic Agents|antimitotic agents|mesh-ancestor
82797340|NCT05881525|Mitosis Modulators|mitosis modulators|mesh-ancestor
82797341|NCT05881525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797342|NCT05881525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82797343|NCT05881525|Immunologic Factors|immunologic factors|mesh-ancestor
82797344|NCT05881525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797345|NCT05881525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82797346|NCT05881525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82797347|NCT05881525|Alkylating Agents|alkylating agents|mesh-ancestor
82797348|NCT05881525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82797349|NCT05881265|Venetoclax|venetoclax|mesh-list
82797350|NCT05881265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797351|NCT05881187|Riboflavin|riboflavin|mesh-list
82797352|NCT05881187|Antifungal Agents|antifungal agents|mesh-list
82797353|NCT05881187|Clotrimazole|clotrimazole|mesh-list
82797354|NCT05881187|Miconazole|miconazole|mesh-list
82797355|NCT05881187|Vitamin B Complex|vitamin b complex|mesh-ancestor
82797356|NCT05881187|Vitamins|vitamins|mesh-ancestor
82797357|NCT05881187|Micronutrients|micronutrients|mesh-ancestor
82797358|NCT05881187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797359|NCT05881187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82797360|NCT05881187|Dermatologic Agents|dermatologic agents|mesh-ancestor
82797361|NCT05881187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797362|NCT05881187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82797363|NCT05881187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82797364|NCT05881187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82797365|NCT05881187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797366|NCT05881187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797367|NCT05881187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82797368|NCT05881187|Hormone Antagonists|hormone antagonists|mesh-ancestor
82797369|NCT05881187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797370|NCT05881187|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82797371|NCT05881187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82797372|NCT05881135|Choline|choline|mesh-list
82797373|NCT05881135|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
82797374|NCT05881135|Lipotropic Agents|lipotropic agents|mesh-ancestor
82797375|NCT05881135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82797376|NCT05881135|Antimetabolites|antimetabolites|mesh-ancestor
82797377|NCT05881135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797378|NCT05881135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82797379|NCT05881135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82797380|NCT05881135|Nootropic Agents|nootropic agents|mesh-ancestor
82797381|NCT05880849|Choline|choline|mesh-list
82797382|NCT05880849|Lipotropic Agents|lipotropic agents|mesh-ancestor
82797383|NCT05880849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82797384|NCT05880849|Antimetabolites|antimetabolites|mesh-ancestor
82797385|NCT05880849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797386|NCT05880849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82797387|NCT05880849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82797388|NCT05880849|Nootropic Agents|nootropic agents|mesh-ancestor
82797389|NCT05880732|Magnesium Sulfate|magnesium sulfate|mesh-list
82797390|NCT05880732|Analgesics|analgesics|mesh-ancestor
82797391|NCT05880732|Sensory System Agents|sensory system agents|mesh-ancestor
82797392|NCT05880732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797393|NCT05880732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797394|NCT05880732|Anesthetics|anesthetics|mesh-ancestor
82797395|NCT05880732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797396|NCT05880732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82797397|NCT05880732|Anticonvulsants|anticonvulsants|mesh-ancestor
82797398|NCT05880732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82797399|NCT05880732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797400|NCT05880732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797401|NCT05880732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82797402|NCT05880732|Tocolytic Agents|tocolytic agents|mesh-ancestor
82797403|NCT05880732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82797404|NCT05880706|Osimertinib|osimertinib|mesh-list
82797405|NCT05880706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797406|NCT05880706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82797407|NCT05880706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797408|NCT05880706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797409|NCT05880693|Magnesium Sulfate|magnesium sulfate|mesh-list
82797410|NCT05880693|Dexmedetomidine|dexmedetomidine|mesh-list
82797411|NCT05880693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82797412|NCT05880693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797413|NCT05880693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797414|NCT05880693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82797415|NCT05880693|Analgesics|analgesics|mesh-ancestor
82797416|NCT05880693|Sensory System Agents|sensory system agents|mesh-ancestor
82797417|NCT05880693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797418|NCT05880693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82797419|NCT05880693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82797420|NCT05880693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82797421|NCT05880693|Adrenergic Agents|adrenergic agents|mesh-ancestor
82797422|NCT05880693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797423|NCT05880693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797424|NCT05880693|Anesthetics|anesthetics|mesh-ancestor
82797425|NCT05880693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82797426|NCT05880693|Anticonvulsants|anticonvulsants|mesh-ancestor
82797427|NCT05880693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82797428|NCT05880693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797429|NCT05880693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82797430|NCT05880693|Tocolytic Agents|tocolytic agents|mesh-ancestor
82797431|NCT05880693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82797432|NCT05880459|Magnesium Sulfate|magnesium sulfate|mesh-list
82797433|NCT05880459|Nalbuphine|nalbuphine|mesh-list
82797434|NCT05880459|Propofol|propofol|mesh-list
82797435|NCT05880459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82797436|NCT05880459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797437|NCT05880459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797438|NCT05880459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82797439|NCT05880459|Anesthetics, General|anesthetics, general|mesh-ancestor
82797440|NCT05880459|Anesthetics|anesthetics|mesh-ancestor
82797441|NCT05880459|Analgesics|analgesics|mesh-ancestor
82797442|NCT05880459|Sensory System Agents|sensory system agents|mesh-ancestor
82797443|NCT05880459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797444|NCT05880459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82797445|NCT05880459|Anticonvulsants|anticonvulsants|mesh-ancestor
82797446|NCT05880459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82797447|NCT05880459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797448|NCT05880459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797449|NCT05880459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82797450|NCT05880459|Tocolytic Agents|tocolytic agents|mesh-ancestor
82797451|NCT05880459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82797452|NCT05880459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82797453|NCT05880459|Narcotics|narcotics|mesh-ancestor
82797454|NCT05880355|Dapansutrile|dapansutrile|mesh-list
82797455|NCT05880355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82797456|NCT05880342|Methylphenidate|methylphenidate|mesh-list
82797457|NCT05880342|Reboxetine|reboxetine|mesh-list
82797458|NCT05880342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82797459|NCT05880342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797460|NCT05880342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82797461|NCT05880342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82797462|NCT05880342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797463|NCT05880342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797464|NCT05880342|Dopamine Agents|dopamine agents|mesh-ancestor
82797465|NCT05880342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797466|NCT05880342|Antidepressive Agents|antidepressive agents|mesh-ancestor
82797467|NCT05880342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82797468|NCT05880342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82797469|NCT05880342|Adrenergic Agents|adrenergic agents|mesh-ancestor
82797470|NCT05880186|Caffeine|caffeine|mesh-list
82797471|NCT05880186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82797472|NCT05880186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797473|NCT05880186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82797474|NCT05880186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441496|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82797475|NCT05880186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797476|NCT05880186|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82797477|NCT05880186|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82797478|NCT05880186|Purinergic Agents|purinergic agents|mesh-ancestor
82797479|NCT05880186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797480|NCT05880082|Cisplatin|cisplatin|mesh-list
82797481|NCT05880082|Carboplatin|carboplatin|mesh-list
82797482|NCT05880082|Tislelizumab|tislelizumab|mesh-list
82797483|NCT05880082|Nedaplatin|nedaplatin|mesh-list
82797484|NCT05880082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797485|NCT05880082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797486|NCT05880030|Vitamin D|vitamin d|mesh-list
82797487|NCT05880030|Cholecalciferol|cholecalciferol|mesh-list
82797488|NCT05880030|Vitamins|vitamins|mesh-ancestor
82797490|NCT05880030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797491|NCT05880030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82797492|NCT05880030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82797494|NCT05880017|Bupivacaine|bupivacaine|mesh-list
82797495|NCT05880017|Anesthetics, Local|anesthetics, local|mesh-ancestor
82797496|NCT05880017|Anesthetics|anesthetics|mesh-ancestor
82797497|NCT05880017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797498|NCT05880017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797499|NCT05880017|Sensory System Agents|sensory system agents|mesh-ancestor
82797500|NCT05880017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797501|NCT05880017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82797502|NCT05880017|Narcotics|narcotics|mesh-ancestor
82797503|NCT05880017|Analgesics|analgesics|mesh-ancestor
82797504|NCT05879926|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82797505|NCT05879926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82797506|NCT05879926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797507|NCT05879926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797508|NCT05879926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82797509|NCT05879926|Hormone Antagonists|hormone antagonists|mesh-ancestor
82797510|NCT05879926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797511|NCT05879926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797512|NCT05879796|Cisplatin|cisplatin|mesh-list
82797513|NCT05879796|Endostatins|endostatins|mesh-list
82797514|NCT05879796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797515|NCT05879796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82797516|NCT05879796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82797517|NCT05879796|Growth Substances|growth substances|mesh-ancestor
82797518|NCT05879796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797519|NCT05879796|Growth Inhibitors|growth inhibitors|mesh-ancestor
82797520|NCT05879653|Pembrolizumab|pembrolizumab|mesh-list
82797521|NCT05879653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797522|NCT05879653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797523|NCT05879653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82797524|NCT05879653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797525|NCT05879627|Exatecan|exatecan|mesh-list
82797526|NCT05879627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82797527|NCT05879627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82797528|NCT05879627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797529|NCT05879627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797530|NCT05879627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797531|NCT05879536|Tramadol|tramadol|mesh-list
82797532|NCT05879536|Ondansetron|ondansetron|mesh-list
82797533|NCT05879536|Ropivacaine|ropivacaine|mesh-list
82797534|NCT05879536|Anesthetics, Local|anesthetics, local|mesh-ancestor
82797535|NCT05879536|Anesthetics|anesthetics|mesh-ancestor
82797536|NCT05879536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797537|NCT05879536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797538|NCT05879536|Sensory System Agents|sensory system agents|mesh-ancestor
82797539|NCT05879536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797540|NCT05879536|Antiemetics|antiemetics|mesh-ancestor
82797541|NCT05879536|Autonomic Agents|autonomic agents|mesh-ancestor
82797542|NCT05879536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82797543|NCT05879536|Antipruritics|antipruritics|mesh-ancestor
82797544|NCT05879536|Dermatologic Agents|dermatologic agents|mesh-ancestor
82797545|NCT05879536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82797546|NCT05879536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82797547|NCT05879536|Serotonin Agents|serotonin agents|mesh-ancestor
82797548|NCT05879536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797549|NCT05879536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797550|NCT05879536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82797551|NCT05879536|Narcotics|narcotics|mesh-ancestor
82797552|NCT05879536|Analgesics|analgesics|mesh-ancestor
82797553|NCT05879419|Benzocaine|benzocaine|mesh-list
82797554|NCT05879419|Anesthetics, Local|anesthetics, local|mesh-ancestor
82797555|NCT05879419|Anesthetics|anesthetics|mesh-ancestor
82797556|NCT05879419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797557|NCT05879419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797558|NCT05879419|Sensory System Agents|sensory system agents|mesh-ancestor
82797559|NCT05879419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797560|NCT05879367|Eflornithine|eflornithine|mesh-list
82797561|NCT05879367|Temozolomide|temozolomide|mesh-list
82797562|NCT05879367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82797563|NCT05879367|Alkylating Agents|alkylating agents|mesh-ancestor
82797564|NCT05879367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797565|NCT05879367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797566|NCT05879367|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82797567|NCT05879367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82797568|NCT05879367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82797569|NCT05879367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797570|NCT05879367|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
82797571|NCT05879367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797572|NCT05879276|Empagliflozin|empagliflozin|mesh-list
82797573|NCT05879276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82797574|NCT05879276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797575|NCT05879276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82797576|NCT05879276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797578|NCT05879237|Cholecalciferol|cholecalciferol|mesh-list
82797579|NCT05879237|Vitamins|vitamins|mesh-ancestor
82797580|NCT05879237|Micronutrients|micronutrients|mesh-ancestor
82797581|NCT05879237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797582|NCT05879237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82797583|NCT05879237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82797584|NCT05879146|Nirogacestat|nirogacestat|mesh-list
82797585|NCT05879146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82797586|NCT05879146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797587|NCT05879146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797588|NCT05879120|Pembrolizumab|pembrolizumab|mesh-list
82797589|NCT05879120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797590|NCT05879120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797591|NCT05879120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82797592|NCT05879120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797593|NCT05879068|Paclitaxel|paclitaxel|mesh-list
82797594|NCT05879068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82797595|NCT05879068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797596|NCT05879068|Tubulin Modulators|tubulin modulators|mesh-ancestor
82797597|NCT05879068|Antimitotic Agents|antimitotic agents|mesh-ancestor
82797598|NCT05879068|Mitosis Modulators|mitosis modulators|mesh-ancestor
82797599|NCT05879068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797600|NCT05879029|Rabeprazole|rabeprazole|mesh-list
82797601|NCT05879029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82797602|NCT05879029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82797603|NCT05879029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82797604|NCT05879029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797605|NCT05879029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797606|NCT05878977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82797607|NCT05878977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797608|NCT05878977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797609|NCT05878977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797610|NCT05878964|Mitogens|mitogens|mesh-list
82797611|NCT05878964|Mitosis Modulators|mitosis modulators|mesh-ancestor
82797612|NCT05878964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797613|NCT05878951|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82797614|NCT05878951|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82797615|NCT05878951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82797616|NCT05878951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797617|NCT05878951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797618|NCT05878951|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82797619|NCT05878951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83441506|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
82797620|NCT05878951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797621|NCT05878951|Cholinergic Agents|cholinergic agents|mesh-ancestor
82797622|NCT05878951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797623|NCT05878691|Pembrolizumab|pembrolizumab|mesh-list
82797624|NCT05878691|Atezolizumab|atezolizumab|mesh-list
82797625|NCT05878691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797626|NCT05878691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797627|NCT05878691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82797628|NCT05878691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797629|NCT05878535|Metformin|metformin|mesh-list
82797630|NCT05878535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82797631|NCT05878535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797632|NCT05876806|Trametinib|trametinib|mesh-list
82797633|NCT05876806|Dabrafenib|dabrafenib|mesh-list
82797634|NCT05876806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797635|NCT05876806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82797636|NCT05876806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797637|NCT05876806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797638|NCT05876273|Pancrelipase|pancrelipase|mesh-list
82797639|NCT05876273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82797641|NCT05875506|Chitosan|chitosan|mesh-list
82797642|NCT05875506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82797643|NCT05875506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797644|NCT05875506|Antimalarials|antimalarials|mesh-ancestor
82797645|NCT05875506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82797646|NCT05875506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82797647|NCT05875506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82797648|NCT05875506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82797649|NCT05875506|Antimetabolites|antimetabolites|mesh-ancestor
82797650|NCT05875506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797651|NCT05875506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82797652|NCT05875506|Chelating Agents|chelating agents|mesh-ancestor
82797653|NCT05875506|Sequestering Agents|sequestering agents|mesh-ancestor
82797654|NCT05875506|Hemostatics|hemostatics|mesh-ancestor
82797655|NCT05875506|Coagulants|coagulants|mesh-ancestor
82797656|NCT05875441|Moxidectin|moxidectin|mesh-list
82797657|NCT05875441|Anthelmintics|anthelmintics|mesh-ancestor
82797658|NCT05875441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82797659|NCT05875441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797660|NCT05875441|Antinematodal Agents|antinematodal agents|mesh-ancestor
82797661|NCT05875350|Anesthetics|anesthetics|mesh-list
82797662|NCT05875350|Anesthetics, Local|anesthetics, local|mesh-list
82797663|NCT05875350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797664|NCT05875350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797665|NCT05875350|Sensory System Agents|sensory system agents|mesh-ancestor
82797666|NCT05875350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797667|NCT05874037|Fluvoxamine|fluvoxamine|mesh-list
82797668|NCT05874037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82797669|NCT05874037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82797670|NCT05874037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797671|NCT05874037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797672|NCT05874037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82797673|NCT05874037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82797674|NCT05874037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82797675|NCT05874037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797676|NCT05874037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797677|NCT05874037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797678|NCT05874037|Serotonin Agents|serotonin agents|mesh-ancestor
82797679|NCT05874037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82797680|NCT05874037|Antidepressive Agents|antidepressive agents|mesh-ancestor
82797681|NCT05874037|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82797682|NCT05874037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82797683|NCT05874037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797684|NCT05874037|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82797685|NCT05872542|Listerine|listerine|mesh-list
82797686|NCT05872542|Fluorides|fluorides|mesh-list
82797687|NCT05872542|Sodium Fluoride|sodium fluoride|mesh-list
82797688|NCT05872542|Fluorides, Topical|fluorides, topical|mesh-list
82797689|NCT05872542|Cariostatic Agents|cariostatic agents|mesh-ancestor
82797690|NCT05872542|Protective Agents|protective agents|mesh-ancestor
82797691|NCT05872542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797692|NCT05872542|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82797693|NCT05872542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797694|NCT05871086|Ubiquinone|ubiquinone|mesh-list
82797695|NCT05871086|Coenzyme Q10|coenzyme q10|mesh-list
82797696|NCT05871086|Micronutrients|micronutrients|mesh-ancestor
82797697|NCT05871086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797698|NCT05871086|Vitamins|vitamins|mesh-ancestor
82797699|NCT05868837|Rituximab|rituximab|mesh-list
82797700|NCT05868837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797701|NCT05868837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797702|NCT05868837|Immunologic Factors|immunologic factors|mesh-ancestor
82797703|NCT05868837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797704|NCT05868837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82797705|NCT05866536|BCG Vaccine|bcg vaccine|mesh-list
82797706|NCT05866536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82797707|NCT05866536|Immunologic Factors|immunologic factors|mesh-ancestor
82797708|NCT05866536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797709|NCT05864755|Bevacizumab|bevacizumab|mesh-list
82797710|NCT05864755|Durvalumab|durvalumab|mesh-list
82797711|NCT05864755|Tremelimumab|tremelimumab|mesh-list
82797712|NCT05864755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797713|NCT05864755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797714|NCT05864755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82797715|NCT05864755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82797716|NCT05864755|Growth Substances|growth substances|mesh-ancestor
83361961|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797717|NCT05864755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797718|NCT05864755|Growth Inhibitors|growth inhibitors|mesh-ancestor
82797719|NCT05864404|Dexmedetomidine|dexmedetomidine|mesh-list
82797720|NCT05864404|Remifentanil|remifentanil|mesh-list
82797721|NCT05864404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82797722|NCT05864404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797723|NCT05864404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797724|NCT05864404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82797725|NCT05864404|Analgesics|analgesics|mesh-ancestor
82797726|NCT05864404|Sensory System Agents|sensory system agents|mesh-ancestor
82797727|NCT05864404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797728|NCT05864404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82797729|NCT05864404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82797730|NCT05864404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82797731|NCT05864404|Adrenergic Agents|adrenergic agents|mesh-ancestor
82797732|NCT05864404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797733|NCT05864404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797734|NCT05864404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82797735|NCT05864404|Narcotics|narcotics|mesh-ancestor
82797736|NCT05856981|Pembrolizumab|pembrolizumab|mesh-list
82797737|NCT05856981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82797738|NCT05856981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797739|NCT05856981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82797740|NCT05856981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797741|NCT05856357|Pyrimethamine|pyrimethamine|mesh-list
82797742|NCT05856357|Sulfadoxine|sulfadoxine|mesh-list
82797743|NCT05856357|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82797744|NCT05856357|Antimalarials|antimalarials|mesh-ancestor
82797745|NCT05856357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82797746|NCT05856357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82797747|NCT05856357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797748|NCT05856357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82797749|NCT05856357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797750|NCT05856357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797751|NCT05856357|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82797752|NCT05846906|Sildenafil Citrate|sildenafil citrate|mesh-list
82797753|NCT05846906|Citric Acid|citric acid|mesh-list
82797754|NCT05846906|Sodium Citrate|sodium citrate|mesh-list
82797755|NCT05846906|Clomiphene|clomiphene|mesh-list
82797756|NCT05846906|Enclomiphene|enclomiphene|mesh-list
82797757|NCT05846906|Zuclomiphene|zuclomiphene|mesh-list
82797758|NCT05846906|Anticoagulants|anticoagulants|mesh-ancestor
82797759|NCT05846906|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82797760|NCT05846906|Chelating Agents|chelating agents|mesh-ancestor
82797761|NCT05846906|Sequestering Agents|sequestering agents|mesh-ancestor
82797762|NCT05846906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797763|NCT05846906|Vasodilator Agents|vasodilator agents|mesh-ancestor
82797764|NCT05846906|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82797765|NCT05846906|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82797766|NCT05846906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797767|NCT05846906|Urological Agents|urological agents|mesh-ancestor
82797768|NCT05846906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82797769|NCT05846906|Hormone Antagonists|hormone antagonists|mesh-ancestor
82797770|NCT05846906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797771|NCT05846906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797772|NCT05846906|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82797773|NCT05846906|Fertility Agents|fertility agents|mesh-ancestor
82797774|NCT05846906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82797775|NCT05846906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82797776|NCT05846906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82797777|NCT05844735|Ciprofloxacin|ciprofloxacin|mesh-list
82797778|NCT05844735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82797779|NCT05844735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797780|NCT05844735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82797781|NCT05844735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82797782|NCT05844735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797783|NCT05844735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797784|NCT05844735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797785|NCT05844735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82797786|NCT05844735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82797787|NCT05844462|Tadalafil|tadalafil|mesh-list
82797788|NCT05844462|Vasodilator Agents|vasodilator agents|mesh-ancestor
82797789|NCT05844462|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82797807|NCT05838521|Immunologic Factors|immunologic factors|mesh-ancestor
82797808|NCT05838521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797810|NCT05835245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797811|NCT05835245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82797812|NCT05835245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797813|NCT05835245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797833|NCT05832255|Psilocybin|psilocybin|mesh-list
82797834|NCT05832255|Hallucinogens|hallucinogens|mesh-ancestor
82797835|NCT05832255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797836|NCT05832255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82797840|NCT05826327|Sufentanil|sufentanil|mesh-list
82797841|NCT05826327|Esketamine|esketamine|mesh-list
82797842|NCT05826327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82797843|NCT05826327|Narcotics|narcotics|mesh-ancestor
82797844|NCT05826327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797845|NCT05826327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797846|NCT05826327|Analgesics|analgesics|mesh-ancestor
82797847|NCT05826327|Sensory System Agents|sensory system agents|mesh-ancestor
82797848|NCT05826327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797849|NCT05826327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82797850|NCT05826327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82797851|NCT05826327|Anesthetics, General|anesthetics, general|mesh-ancestor
82797852|NCT05826327|Anesthetics|anesthetics|mesh-ancestor
82797853|NCT05826327|Antidepressive Agents|antidepressive agents|mesh-ancestor
82797854|NCT05826327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82797855|NCT05823116|Vancomycin|vancomycin|mesh-list
82797856|NCT05823116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82797857|NCT05823116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82797858|NCT05817721|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82797859|NCT05817721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797860|NCT05817721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797890|NCT05809011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82797891|NCT05809011|Glucocorticoids|glucocorticoids|mesh-ancestor
82797892|NCT05809011|Hormones|hormones|mesh-ancestor
82797893|NCT05809011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82797894|NCT05809011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82797895|NCT05809011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797896|NCT05801757|Propofol|propofol|mesh-list
82797897|NCT05801757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82797898|NCT05801757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82797899|NCT05801757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797900|NCT05801757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82797901|NCT05801757|Anesthetics, General|anesthetics, general|mesh-ancestor
82797902|NCT05801757|Anesthetics|anesthetics|mesh-ancestor
82797903|NCT05801146|Botulinum Toxins|botulinum toxins|mesh-list
82797904|NCT05801146|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82797905|NCT05801146|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82797906|NCT05801146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82797907|NCT05801146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82797908|NCT05801146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797909|NCT05801146|Cholinergic Agents|cholinergic agents|mesh-ancestor
82797910|NCT05801146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797911|NCT05801146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797912|NCT05801146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82797913|NCT05801146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797914|NCT05795647|Tocopherols|tocopherols|mesh-list
82797915|NCT05795647|Vitamin E|vitamin e|mesh-list
82797916|NCT05795647|Tocotrienols|tocotrienols|mesh-list
82797917|NCT05795647|alpha-Tocopherol|alpha-tocopherol|mesh-list
82797918|NCT05795647|Pentoxifylline|pentoxifylline|mesh-list
82797919|NCT05795647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82797920|NCT05795647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797921|NCT05795647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797922|NCT05795647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82797923|NCT05795647|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82797924|NCT05795647|Protective Agents|protective agents|mesh-ancestor
82797925|NCT05795647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797926|NCT05795647|Vasodilator Agents|vasodilator agents|mesh-ancestor
82797927|NCT05795647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82797928|NCT05795647|Antioxidants|antioxidants|mesh-ancestor
82797929|NCT05795647|Vitamins|vitamins|mesh-ancestor
82797930|NCT05795647|Micronutrients|micronutrients|mesh-ancestor
82797931|NCT05794399|Warfarin|warfarin|mesh-list
82797932|NCT05794399|Rivaroxaban|rivaroxaban|mesh-list
82797933|NCT05794399|Anticoagulants|anticoagulants|mesh-ancestor
82797934|NCT05794399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82797935|NCT05794399|Antithrombins|antithrombins|mesh-ancestor
82797936|NCT05794399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82797937|NCT05794399|Protease Inhibitors|protease inhibitors|mesh-ancestor
82797938|NCT05794399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797939|NCT05794399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797940|NCT05790486|Nicotine|nicotine|mesh-list
82797941|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82797942|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
82797943|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797956|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82797957|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82797958|NCT05781035|Analgesics|analgesics|mesh-ancestor
82797959|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
82797960|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797961|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82797962|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82797963|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82797964|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
82797965|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82797966|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797967|NCT05774704|Curcumin|curcumin|mesh-list
82797968|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82797969|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82797970|NCT05774704|Analgesics|analgesics|mesh-ancestor
82797971|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
82797972|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82797973|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82797974|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82797975|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82797976|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797977|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82797978|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797979|NCT05771480|Paclitaxel|paclitaxel|mesh-list
82797980|NCT05771480|Cisplatin|cisplatin|mesh-list
82797981|NCT05771480|Carboplatin|carboplatin|mesh-list
82797982|NCT05771480|Gemcitabine|gemcitabine|mesh-list
82797983|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
82797984|NCT05771480|Durvalumab|durvalumab|mesh-list
82797985|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82797986|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82797987|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82797988|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
82797989|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
82797990|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
82797991|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82797992|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82797993|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
82797994|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798000|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
82798001|NCT05764395|ON 01910|on 01910|mesh-list
82798002|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798003|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798004|NCT05764395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798005|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798006|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798007|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798016|NCT05756166|Interferons|interferons|mesh-list
82798017|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
82798042|NCT05746546|Nicotine|nicotine|mesh-list
82798043|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82798044|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
82798045|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798046|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798047|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82798048|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82798049|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
82798050|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82798051|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798052|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
82798053|NCT05741164|Propranolol|propranolol|mesh-list
82798054|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798055|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798056|NCT05741164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798057|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798058|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82798059|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82798060|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
82798061|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82798062|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798063|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82798064|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82798065|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
82798117|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
82798118|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798119|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798120|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82798132|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
82798133|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
82798134|NCT05706259|Vitamins|vitamins|mesh-list
82798135|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
82798136|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798137|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82798138|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82798139|NCT05704374|Pregabalin|pregabalin|mesh-list
82798140|NCT05704374|Analgesics|analgesics|mesh-ancestor
82798141|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
82798142|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798143|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798144|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
82798145|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82798146|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82798147|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798148|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82798149|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82798150|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82798151|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798152|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82798153|NCT05704166|Pirfenidone|pirfenidone|mesh-list
82798154|NCT05704166|Analgesics|analgesics|mesh-ancestor
82798155|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
82798156|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798157|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798158|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82798159|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82798160|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82798161|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82798162|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798163|NCT05687266|Paclitaxel|paclitaxel|mesh-list
82798164|NCT05687266|Carboplatin|carboplatin|mesh-list
82798165|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
82798166|NCT05687266|Pemetrexed|pemetrexed|mesh-list
82798167|NCT05687266|Durvalumab|durvalumab|mesh-list
82798168|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82798169|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798170|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
82798171|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
82798172|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
82798173|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798174|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798175|NCT05687266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798176|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798177|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82798178|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82798179|NCT05680558|Methoxsalen|methoxsalen|mesh-list
82798180|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82798181|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
82798182|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82798183|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82798184|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
82798185|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798186|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798187|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798188|NCT05671510|Docetaxel|docetaxel|mesh-list
82798189|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798190|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
82798191|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
82798192|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
83482526|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798193|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798194|NCT05667324|Dexamethasone|dexamethasone|mesh-list
82798195|NCT05667324|Ropivacaine|ropivacaine|mesh-list
82798196|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82798197|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
82798198|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
82798199|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798200|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798201|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82798202|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
82798203|NCT05667324|Hormones|hormones|mesh-ancestor
82798204|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798205|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82798206|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798207|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
82798208|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
82798209|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798210|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
82798211|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
82798212|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798213|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798214|NCT05665595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798215|NCT05665595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798216|NCT05663242|Anesthetics|anesthetics|mesh-list
82798217|NCT05663242|Propofol|propofol|mesh-list
82798218|NCT05663242|Sevoflurane|sevoflurane|mesh-list
82798219|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798220|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798221|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82798222|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82798223|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
82798224|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82798225|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82798226|NCT05662319|Antithrombins|antithrombins|mesh-list
82798227|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
82798228|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82798229|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
82798230|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798231|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798232|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
82798233|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82798234|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
82798235|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82798236|NCT05656521|Dexamethasone|dexamethasone|mesh-list
82798237|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82798238|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
83441519|NCT00707759|Prednisone|prednisone|mesh-list
82798239|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
82798240|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798241|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798242|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82798244|NCT05656521|Hormones|hormones|mesh-ancestor
82798245|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798246|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82798247|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798248|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
82798249|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82798250|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798251|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
82798252|NCT05653271|Fludarabine|fludarabine|mesh-list
82798253|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
82798254|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82798255|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
82798256|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798257|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82798258|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82798259|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
82798260|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798261|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798262|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82798263|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798264|NCT05644184|Vaccines|vaccines|mesh-list
82798265|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
82798266|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798267|NCT05644041|Gemcitabine|gemcitabine|mesh-list
82798268|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82798269|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
82798270|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798271|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798272|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82798273|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
82798274|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798276|NCT05628623|Azacitidine|azacitidine|mesh-list
82798277|NCT05628623|Daunorubicin|daunorubicin|mesh-list
82798278|NCT05628623|Venetoclax|venetoclax|mesh-list
82798279|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82798280|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
82798281|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798282|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798283|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
82798284|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798285|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82798286|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
82798287|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798288|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798289|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82798290|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82798291|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82798292|NCT05616923|Trametinib|trametinib|mesh-list
82798293|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798294|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798295|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798296|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798297|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82798298|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
82798299|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
82798300|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798301|NCT05608200|Lenvatinib|lenvatinib|mesh-list
82798302|NCT05608200|Chlorotrianisene|chlorotrianisene|mesh-list
82798303|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798304|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798305|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798306|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798307|NCT05608200|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82798308|NCT05608200|Estrogens|estrogens|mesh-ancestor
82798309|NCT05608200|Hormones|hormones|mesh-ancestor
82798310|NCT05608200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798311|NCT05608200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441524|NCT00707759|Hormones|hormones|mesh-ancestor
82798312|NCT05608200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82798313|NCT05606692|Propofol|propofol|mesh-list
82798314|NCT05606692|Sevoflurane|sevoflurane|mesh-list
82798315|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82798316|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798317|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798318|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82798319|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
82798320|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
82798321|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82798322|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82798323|NCT05603104|Lamotrigine|lamotrigine|mesh-list
82798325|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82798326|NCT05603104|Valproic Acid|valproic acid|mesh-list
82798327|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82798328|NCT05603104|Clozapine|clozapine|mesh-list
82798329|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
82798330|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82798331|NCT05603104|Sertraline|sertraline|mesh-list
82798332|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
82798333|NCT05603104|Esketamine|esketamine|mesh-list
82798334|NCT05603104|Escitalopram|escitalopram|mesh-list
82798335|NCT05603104|Analgesics|analgesics|mesh-ancestor
82798336|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
82798337|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798338|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798339|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82798340|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82798341|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
82798342|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
82798343|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798344|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82798345|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82798346|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82798347|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798348|NCT05603104|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82798349|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82798350|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82798351|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
82798352|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82798353|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82798354|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82798355|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82798356|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
82798357|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798358|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
82798359|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
82798360|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82798361|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82798362|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82798363|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
82798364|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82798365|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
82798366|NCT05601336|Metformin|metformin|mesh-list
82798367|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
82798368|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82798369|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798370|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82798371|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798372|NCT05599243|Dutasteride|dutasteride|mesh-list
82798373|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82798374|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82798375|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798376|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798377|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
82798378|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798379|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798380|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
82798381|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82798382|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798383|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798384|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82798385|NCT05595083|Analgesics|analgesics|mesh-ancestor
82798386|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
82798387|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798388|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82798389|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82798390|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82798406|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798407|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798408|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798409|NCT05557110|Blinatumomab|blinatumomab|mesh-list
82798410|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798412|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82798413|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798414|NCT05556889|Trace Elements|trace elements|mesh-ancestor
82798415|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
82798416|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798417|NCT05556512|Tirzepatide|tirzepatide|mesh-list
82798418|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82798419|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798420|NCT05556512|Incretins|incretins|mesh-ancestor
82798421|NCT05556512|Hormones|hormones|mesh-ancestor
82798422|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798428|NCT05544136|Carboplatin|carboplatin|mesh-list
82798429|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798430|NCT05542407|Atezolizumab|atezolizumab|mesh-list
82798431|NCT05542407|TIC10 compound|tic10 compound|mesh-list
82798432|NCT05542407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798433|NCT05542407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798434|NCT05542407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798435|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798436|NCT05541471|Digoxin|digoxin|mesh-list
82798437|NCT05541471|Midazolam|midazolam|mesh-list
82798438|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82798439|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82798440|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798441|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798442|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82798443|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82798444|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82798445|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82798446|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
82798447|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
82798448|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
82798449|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
82798450|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82798451|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798452|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82798453|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82798454|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798455|NCT05541471|Protective Agents|protective agents|mesh-ancestor
82798456|NCT05540522|Vaccines|vaccines|mesh-list
82798457|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
82798458|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798474|NCT05516914|Tislelizumab|tislelizumab|mesh-list
82798475|NCT05516914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798476|NCT05516914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82798477|NCT05516914|Antimetabolites|antimetabolites|mesh-ancestor
82798478|NCT05516914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798479|NCT05516914|Tubulin Modulators|tubulin modulators|mesh-ancestor
82798480|NCT05516914|Antimitotic Agents|antimitotic agents|mesh-ancestor
82798481|NCT05516914|Mitosis Modulators|mitosis modulators|mesh-ancestor
82798482|NCT05516914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798483|NCT05514054|Tamoxifen|tamoxifen|mesh-list
82798484|NCT05514054|Letrozole|letrozole|mesh-list
82798485|NCT05514054|Anastrozole|anastrozole|mesh-list
82798486|NCT05514054|Exemestane|exemestane|mesh-list
82798487|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798488|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82798489|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82798490|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798491|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798492|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82798493|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
82798494|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798495|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798496|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82798497|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82798498|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82798499|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82798500|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82798501|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82798502|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798503|NCT05504278|Carboplatin|carboplatin|mesh-list
82798504|NCT05504278|Pemetrexed|pemetrexed|mesh-list
82798505|NCT05504278|Cisplatin|cisplatin|mesh-list
82798506|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798507|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798508|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798509|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82798510|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82798511|NCT05501600|Lidocaine|lidocaine|mesh-list
82798512|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
82798513|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
82798514|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798515|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798516|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
82798517|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798518|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82798519|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82798520|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82798521|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82798522|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798523|NCT05498792|Nivolumab|nivolumab|mesh-list
82798524|NCT05498792|Ipilimumab|ipilimumab|mesh-list
82798525|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798526|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798527|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798528|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798530|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82798531|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798532|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
82798533|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798534|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
82798535|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798536|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798537|NCT05479812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798538|NCT05479812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798539|NCT05475613|Immunomodulating Agents|immunomodulating agents|mesh-list
82798540|NCT05475613|Immunologic Factors|immunologic factors|mesh-ancestor
82798541|NCT05475613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798542|NCT05453968|Berotralstat|berotralstat|mesh-list
82798598|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
82798599|NCT05422885|Protective Agents|protective agents|mesh-ancestor
82798600|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798601|NCT05418049|Memantine|memantine|mesh-list
82798602|NCT05418049|Baclofen|baclofen|mesh-list
82798603|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82798604|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82798605|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
82798606|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82798607|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798608|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798609|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82798610|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82798611|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82798612|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82798613|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798614|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82798615|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
82798616|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
82798617|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82798618|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
82798619|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798632|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82798633|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
82798634|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798635|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798636|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798637|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
82798638|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
82798639|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82798640|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82798641|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798642|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82798643|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82798644|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798645|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798646|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798647|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82798648|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
82798649|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82798650|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798651|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82798652|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82798653|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82798654|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
82798655|NCT05379634|Hormones|hormones|mesh-ancestor
82798656|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798657|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798658|NCT05369676|Ritonavir|ritonavir|mesh-list
82798659|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82798660|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82798661|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
82798662|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798663|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798664|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82798665|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82798666|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
82798667|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798668|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82798669|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82798689|NCT05327010|Talazoparib|talazoparib|mesh-list
82798690|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82798691|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798692|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798705|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82798706|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82798707|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798708|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82798709|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82798710|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82798711|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82798712|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82798713|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798714|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
82798715|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82798716|NCT05316467|Megestrol|megestrol|mesh-list
82798717|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
82798718|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82798719|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82798720|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82798721|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
82798722|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82798723|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798724|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82798725|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82798726|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82798727|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798728|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
82798729|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82798730|NCT05309928|Amoxicillin|amoxicillin|mesh-list
82798731|NCT05309928|Probenecid|probenecid|mesh-list
82798732|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82798733|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798734|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
82798735|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
82798736|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82798737|NCT05304949|Ranibizumab|ranibizumab|mesh-list
82798738|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82798739|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82798740|NCT05304949|Growth Substances|growth substances|mesh-ancestor
82798741|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798742|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
82798743|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798755|NCT05294341|Norethindrone|norethindrone|mesh-list
82798756|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
82798757|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82798758|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82798759|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82798760|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
82798761|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82798762|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798763|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82798764|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82798765|NCT05293964|Everolimus|everolimus|mesh-list
82798766|NCT05293964|Palbociclib|palbociclib|mesh-list
82798767|NCT05293964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82798768|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798769|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798770|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798771|NCT05293964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82798772|NCT05293964|Immunologic Factors|immunologic factors|mesh-ancestor
82798773|NCT05293964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798774|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798775|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82798776|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798777|NCT05281471|Paclitaxel|paclitaxel|mesh-list
82798778|NCT05281471|Docetaxel|docetaxel|mesh-list
82798779|NCT05281471|Bevacizumab|bevacizumab|mesh-list
82798780|NCT05281471|Carboplatin|carboplatin|mesh-list
82798781|NCT05281471|Gemcitabine|gemcitabine|mesh-list
82798782|NCT05281471|Doxorubicin|doxorubicin|mesh-list
82798783|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82798784|NCT05281471|Taxane|taxane|mesh-list
82798785|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82798786|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798787|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
82798788|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
82798789|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
82798790|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798791|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798792|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82798793|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82798794|NCT05281471|Growth Substances|growth substances|mesh-ancestor
82798795|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798796|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
82798797|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82798798|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
82798799|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82798800|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82798801|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82798802|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798803|NCT05275010|Trastuzumab|trastuzumab|mesh-list
82798804|NCT05275010|Pertuzumab|pertuzumab|mesh-list
82798805|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798806|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798807|NCT05274269|Ivacaftor|ivacaftor|mesh-list
82798808|NCT05274269|Elexacaftor|elexacaftor|mesh-list
82798809|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82798810|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82798811|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798812|NCT05271240|Bevacizumab|bevacizumab|mesh-list
82798813|NCT05271240|Temozolomide|temozolomide|mesh-list
82798814|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82798815|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798816|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82798817|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82798818|NCT05271240|Growth Substances|growth substances|mesh-ancestor
82798819|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798820|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
82798821|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82798822|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
82798823|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798824|NCT05269459|Cannabidiol|cannabidiol|mesh-list
82798825|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
82798826|NCT05264883|Azacitidine|azacitidine|mesh-list
82798827|NCT05264883|Decitabine|decitabine|mesh-list
82798828|NCT05264883|Venetoclax|venetoclax|mesh-list
82798829|NCT05264883|Aclarubicin|aclarubicin|mesh-list
82798830|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82798831|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
82798832|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798833|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798834|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798835|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82798836|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82798837|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82798838|NCT05263453|Vemurafenib|vemurafenib|mesh-list
82798839|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798840|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798841|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798842|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798843|NCT05257629|Nicotine|nicotine|mesh-list
82798844|NCT05257629|Varenicline|varenicline|mesh-list
82798845|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82798846|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
82798847|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798848|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798849|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82798850|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82798851|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
82798852|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82798853|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798854|NCT05245669|Denosumab|denosumab|mesh-list
82798855|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82798856|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798857|NCT05233332|Vemurafenib|vemurafenib|mesh-list
82798858|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798859|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798860|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798861|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798862|NCT05232084|Fentanyl|fentanyl|mesh-list
82798863|NCT05232084|Bupivacaine|bupivacaine|mesh-list
82798864|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
82798865|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
82798866|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82798867|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798868|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
82798869|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82798870|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82798871|NCT05232084|Narcotics|narcotics|mesh-ancestor
82798872|NCT05232084|Analgesics|analgesics|mesh-ancestor
82798873|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82798874|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82798875|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
82798876|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
82798877|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
82798878|NCT05231980|Clomiphene|clomiphene|mesh-list
82798879|NCT05231980|Enclomiphene|enclomiphene|mesh-list
82798880|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
82798881|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798882|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82798883|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798884|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82798885|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82798886|NCT05231980|Protective Agents|protective agents|mesh-ancestor
82798887|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798888|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
82798889|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82798890|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
82798891|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82798892|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
82798893|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83481451|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
82798894|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82798895|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
82798896|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82798897|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82798898|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82798899|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
82798900|NCT05231980|Vitamins|vitamins|mesh-ancestor
82798901|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
82798902|NCT05231122|Bevacizumab|bevacizumab|mesh-list
82798903|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82798904|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
82798905|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
82798906|NCT05231122|Antibodies|antibodies|mesh-list
82798907|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
82798908|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82798909|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
82798910|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798911|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82798912|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82798913|NCT05231122|Growth Substances|growth substances|mesh-ancestor
82798914|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798915|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
82798916|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
82798917|NCT05231122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82798918|NCT05231122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798919|NCT05205252|Dexamethasone|dexamethasone|mesh-list
82798920|NCT05205252|Lenalidomide|lenalidomide|mesh-list
82798921|NCT05205252|Daratumumab|daratumumab|mesh-list
82798935|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82798936|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798937|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
82798938|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82798939|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82798940|NCT05205252|Growth Substances|growth substances|mesh-ancestor
82798941|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
82798942|NCT05205252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82798943|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798944|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798946|NCT05195619|Vaccines|vaccines|mesh-list
82798947|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
82798948|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798949|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82798950|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82798951|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82798952|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
82798953|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798954|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82798955|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82798969|NCT05178862|Fluconazole|fluconazole|mesh-list
82798970|NCT05178862|Caspofungin|caspofungin|mesh-list
82798971|NCT05178862|Micafungin|micafungin|mesh-list
82798972|NCT05178862|Anidulafungin|anidulafungin|mesh-list
82798973|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
82798974|NCT05178862|Echinocandins|echinocandins|mesh-list
82798975|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
82798976|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82798977|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82798978|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82798979|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82798980|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82798981|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82798982|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
82798983|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82798984|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82798985|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82798986|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83361962|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82799006|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799007|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82799008|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82799009|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82799010|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799011|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799012|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82799013|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82799014|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799015|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
82799016|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799017|NCT05132231|Brodalumab|brodalumab|mesh-list
82799018|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
82799019|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
82799020|NCT05114421|Lenvatinib|lenvatinib|mesh-list
82799021|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799022|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799023|NCT05114421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799024|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799025|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799026|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799027|NCT05099107|Albuterol|albuterol|mesh-list
82799028|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82799029|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
82799030|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799031|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799032|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82799033|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
82799034|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
82799035|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82799036|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82799037|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82799038|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82799039|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
82799040|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799041|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799044|NCT05090280|Nafamostat|nafamostat|mesh-list
82799045|NCT05090280|Naltrexone|naltrexone|mesh-list
82799046|NCT05090280|Oxycodone|oxycodone|mesh-list
82799047|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82799048|NCT05090280|Narcotics|narcotics|mesh-ancestor
82799049|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82799050|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799051|NCT05090280|Analgesics|analgesics|mesh-ancestor
82799052|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
82799053|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799054|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82799055|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82799056|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82799057|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82799058|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82799059|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799060|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
82799061|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
82799062|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799063|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799064|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82799065|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82799066|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82799067|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82799119|NCT05063552|Growth Substances|growth substances|mesh-ancestor
82799120|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799121|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
82799122|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
82799123|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799124|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799125|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799126|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799127|NCT05063552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799128|NCT05061134|Durvalumab|durvalumab|mesh-list
82799129|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799130|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799141|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
82799142|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82799143|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
82799144|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82799145|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
82799146|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799147|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799148|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
82799149|NCT05017571|Colchicine|colchicine|mesh-list
82799150|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
82799151|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799152|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799153|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799154|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799155|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799156|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799157|NCT05017012|Paclitaxel|paclitaxel|mesh-list
82799158|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82799159|NCT05017012|Carboplatin|carboplatin|mesh-list
82799160|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
82799161|NCT05017012|Pemetrexed|pemetrexed|mesh-list
82799162|NCT05017012|Axitinib|axitinib|mesh-list
82799163|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82799164|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799165|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799166|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799167|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799168|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799169|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799170|NCT05017012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799171|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799172|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82799173|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82799174|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799175|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82799176|NCT05001750|Doxycycline|doxycycline|mesh-list
82799177|NCT05001750|Nafcillin|nafcillin|mesh-list
82799178|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82799179|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82799180|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
82799181|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
82799182|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82799183|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82799184|NCT04998786|Dexamethasone|dexamethasone|mesh-list
82799185|NCT04998786|Ixazomib|ixazomib|mesh-list
82799186|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82799187|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
82799188|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
82799189|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799190|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799191|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82799192|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
82799194|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799195|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82799196|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799197|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
82799198|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799199|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799200|NCT04998500|Hormones|hormones|mesh-list
82799201|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799202|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799203|NCT04992624|Dronabinol|dronabinol|mesh-list
82799204|NCT04992624|Cannabidiol|cannabidiol|mesh-list
82799205|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
82799206|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
82799207|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799208|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82799209|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82799210|NCT04992624|Analgesics|analgesics|mesh-ancestor
82799211|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
82799212|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799213|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82799214|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82799215|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799216|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799217|NCT04992624|Hormones|hormones|mesh-ancestor
82799218|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799219|NCT04990258|Infliximab|infliximab|mesh-list
82799220|NCT04990258|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82799221|NCT04990258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83361964|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799233|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82799234|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799235|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799236|NCT04965493|Rituximab|rituximab|mesh-list
82799237|NCT04965493|Venetoclax|venetoclax|mesh-list
82799238|NCT04965493|Pirtobrutinib|pirtobrutinib|mesh-list
82799239|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799240|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799241|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
82799242|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799243|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799244|NCT04965493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799245|NCT04965493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799246|NCT04965493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799247|NCT04964089|Aflibercept|aflibercept|mesh-list
82799248|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82799249|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82799250|NCT04964089|Growth Substances|growth substances|mesh-ancestor
82799251|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799252|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
82799253|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799265|NCT04940299|Nivolumab|nivolumab|mesh-list
82799266|NCT04940299|Ipilimumab|ipilimumab|mesh-list
82799267|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
82799268|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
82799269|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799270|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799271|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799272|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799273|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
82799274|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799290|NCT04935359|Paclitaxel|paclitaxel|mesh-list
82799291|NCT04935359|Gemcitabine|gemcitabine|mesh-list
82799292|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82799293|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799294|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799295|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799296|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799297|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799351|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82799352|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
82799354|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799355|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799356|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82799357|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799358|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82799359|NCT04918147|Analgesics|analgesics|mesh-ancestor
82799360|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
82799361|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799362|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
82799363|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
82799364|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
82799365|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82799366|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82799367|NCT04918147|Protective Agents|protective agents|mesh-ancestor
82799368|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82799369|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82799370|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82799371|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
82799372|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
82799373|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82799374|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
82799381|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82799382|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82799384|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82799385|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82799386|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799387|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82799388|NCT04916197|Analgesics|analgesics|mesh-ancestor
82799389|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
82799390|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799391|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82799392|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82799393|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82799394|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
82799395|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799396|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799397|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82799398|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82799399|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
82799400|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799401|NCT04915768|Antacids|antacids|mesh-ancestor
82799402|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799403|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82799406|NCT04902625|Naltrexone|naltrexone|mesh-list
82799407|NCT04902625|Bupropion|bupropion|mesh-list
82799408|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82799409|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82799410|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799411|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
82799412|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799413|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82799414|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
82799415|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82799416|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82799417|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82799418|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82799419|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799420|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
82799421|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799422|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82799423|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82799424|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799425|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
82799426|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799427|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799428|NCT04897022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799429|NCT04897022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799430|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
82799431|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799434|NCT04849416|Pirtobrutinib|pirtobrutinib|mesh-list
82799435|NCT04849416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799436|NCT04849416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799437|NCT04849416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799438|NCT04848792|Sulforaphane|sulforaphane|mesh-list
82799439|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82799440|NCT04848792|Protective Agents|protective agents|mesh-ancestor
82799441|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799442|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799447|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799454|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
82799455|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82799456|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799457|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
82799458|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799459|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799460|NCT04796194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799461|NCT04796194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799468|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
82799469|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82799470|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82799471|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
82799472|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799473|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799474|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82799475|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
82799476|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82799477|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
82799478|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799479|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799480|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82799481|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
82799482|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
82799483|NCT04755647|Protective Agents|protective agents|mesh-ancestor
82799484|NCT04739761|Trastuzumab|trastuzumab|mesh-list
82799485|NCT04739761|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82799486|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799487|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799488|NCT04739761|Immunoconjugates|immunoconjugates|mesh-ancestor
82799489|NCT04739761|Immunologic Factors|immunologic factors|mesh-ancestor
82799490|NCT04739761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799491|NCT04733040|Felzartamab|felzartamab|mesh-list
82799492|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799493|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
82799494|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799495|NCT04711252|Palbociclib|palbociclib|mesh-list
82799496|NCT04711252|Anastrozole|anastrozole|mesh-list
82799497|NCT04711252|Hormones|hormones|mesh-list
82799498|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82799499|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799500|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799501|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799502|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799503|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799504|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799505|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82799506|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82799507|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82799508|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82799509|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
82799510|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
82799511|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799512|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799513|NCT04699123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799514|NCT04699123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799515|NCT04677972|Ebselen|ebselen|mesh-list
82799516|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82799517|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82799518|NCT04677972|Analgesics|analgesics|mesh-ancestor
82799519|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
82799520|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799529|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82799530|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799531|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82799534|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
82799535|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
82799536|NCT04662255|Pirtobrutinib|pirtobrutinib|mesh-list
82799537|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799538|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799539|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799540|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799559|NCT04657081|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82799560|NCT04657081|Venetoclax|venetoclax|mesh-list
82799561|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799562|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
82799563|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799564|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799565|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799566|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
82799567|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82799568|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
82799569|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799570|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799571|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82799572|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
82799573|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799574|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799575|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82799576|NCT04648020|Clonidine|clonidine|mesh-list
82799577|NCT04648020|Analgesics|analgesics|mesh-ancestor
82799578|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
82799579|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799580|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799581|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82799582|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
82799583|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
82799584|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82799585|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82799586|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82799587|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
82799588|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799589|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799590|NCT04640623|Gemcitabine|gemcitabine|mesh-list
82799591|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799592|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
82799593|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799594|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799598|NCT04630145|Rifabutin|rifabutin|mesh-list
82799599|NCT04630145|Bedaquiline|bedaquiline|mesh-list
82799600|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82799601|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82799602|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82799603|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799604|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799605|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82799606|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82799607|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82799608|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
82799609|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
82799610|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82799611|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82799612|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82799613|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82799614|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82799615|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82799616|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82799619|NCT04629651|Captopril|captopril|mesh-list
82799620|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82799621|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
82799622|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799623|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799624|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82799625|NCT04627870|Paclitaxel|paclitaxel|mesh-list
82799626|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82799627|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799628|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799629|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799630|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799631|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799633|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
82799634|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82799635|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799636|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799637|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
82799638|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82799639|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82799640|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799641|NCT04622319|Trastuzumab|trastuzumab|mesh-list
82799642|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82799643|NCT04622319|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82799644|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799645|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799646|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799647|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799648|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799649|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799650|NCT04622319|Immunotoxins|immunotoxins|mesh-ancestor
82799651|NCT04622319|Immunoconjugates|immunoconjugates|mesh-ancestor
82799652|NCT04622319|Immunologic Factors|immunologic factors|mesh-ancestor
82799653|NCT04622319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441549|NCT01273727|Hormones|hormones|mesh-ancestor
82799654|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
82799655|NCT04621526|Ketamine|ketamine|mesh-list
82799656|NCT04621526|Propofol|propofol|mesh-list
82799657|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82799658|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82799659|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799660|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82799661|NCT04621526|Analgesics|analgesics|mesh-ancestor
82799662|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
82799663|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799664|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82799665|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82799666|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82799667|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
82799668|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82799669|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799670|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82799671|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
82799672|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
82799673|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82799674|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82799675|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82799676|NCT04614194|Letrozole|letrozole|mesh-list
82799677|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799678|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82799679|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82799680|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799681|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799682|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82799683|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
82799684|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799685|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799686|NCT04603001|Azacitidine|azacitidine|mesh-list
82799687|NCT04603001|Venetoclax|venetoclax|mesh-list
82799688|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799689|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
82799690|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799691|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799692|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799693|NCT04593654|Dalteparin|dalteparin|mesh-list
82799694|NCT04593654|Tinzaparin|tinzaparin|mesh-list
82799695|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82799696|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
82799697|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82799698|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82799699|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799700|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
82799701|NCT04591210|Giapreza|giapreza|mesh-list
82799702|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82799703|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
82799704|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82799705|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82799706|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799707|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82799708|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82799709|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
82799710|NCT04585893|Rituximab|rituximab|mesh-list
82799711|NCT04585893|Etoposide|etoposide|mesh-list
82799712|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799713|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799714|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
82799715|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799716|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799717|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82799718|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82799719|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82799720|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799721|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799722|NCT04573478|Atrasentan|atrasentan|mesh-list
82799723|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799724|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82799725|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82799726|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799727|NCT04547946|Trametinib|trametinib|mesh-list
82799728|NCT04547946|Dabrafenib|dabrafenib|mesh-list
82799729|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799730|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82799731|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799732|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799733|NCT04546009|Letrozole|letrozole|mesh-list
82799734|NCT04546009|Palbociclib|palbociclib|mesh-list
82799735|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799736|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82799737|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82799738|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799739|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799740|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82799741|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
83361965|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82799750|NCT04542824|Rituximab|rituximab|mesh-list
82799751|NCT04542824|Gemcitabine|gemcitabine|mesh-list
82799752|NCT04542824|Doxorubicin|doxorubicin|mesh-list
82799753|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
82799754|NCT04542824|Vincristine|vincristine|mesh-list
82799755|NCT04542824|Lenalidomide|lenalidomide|mesh-list
82799756|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82799757|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
82799758|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799759|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799760|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82799761|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
82799762|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799763|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799764|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82799765|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799766|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799767|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
82799768|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82799769|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82799770|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82799771|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799772|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82799773|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
82799774|NCT04542824|Hormones|hormones|mesh-ancestor
82799775|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799776|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82799777|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82799778|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799779|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799780|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799781|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82799782|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82799783|NCT04542824|Growth Substances|growth substances|mesh-ancestor
82799784|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
82799794|NCT04535700|Pioglitazone|pioglitazone|mesh-list
82799795|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82799807|NCT04526795|Cytarabine|cytarabine|mesh-list
82799808|NCT04526795|Fludarabine|fludarabine|mesh-list
82799809|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799810|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799811|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
82799812|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799813|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82799814|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
82799815|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799816|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
82799817|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82799846|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799847|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82799848|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82799849|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
82799850|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799851|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799852|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82799853|NCT04503551|Ranibizumab|ranibizumab|mesh-list
82799854|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82799855|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82799856|NCT04503551|Growth Substances|growth substances|mesh-ancestor
82799857|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799858|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
82799859|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799884|NCT04485949|Temozolomide|temozolomide|mesh-list
82799885|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82799886|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
82799887|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799888|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799889|NCT04478279|Temozolomide|temozolomide|mesh-list
82799890|NCT04478279|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82799901|NCT04471428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799902|NCT04471428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799914|NCT04437225|Glycolic acid|glycolic acid|mesh-list
82799915|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
82799916|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
82799919|NCT04429555|Ibudilast|ibudilast|mesh-list
82799920|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82799921|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
82799922|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799923|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799924|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82799925|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
82799926|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82799927|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82799928|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799929|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82799930|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
82799931|NCT04421378|Bevacizumab|bevacizumab|mesh-list
82799932|NCT04421378|Temozolomide|temozolomide|mesh-list
82799933|NCT04421378|Carmustine|carmustine|mesh-list
82799934|NCT04421378|Lomustine|lomustine|mesh-list
82799935|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799936|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799937|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82799938|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82799939|NCT04421378|Growth Substances|growth substances|mesh-ancestor
82799940|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799941|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
82799942|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82799943|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
82799944|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799945|NCT04414475|Dexamethasone|dexamethasone|mesh-list
82799946|NCT04414475|Bortezomib|bortezomib|mesh-list
82799947|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82799948|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
82799949|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
82799950|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82799951|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799952|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82799953|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
82799954|NCT04414475|Hormones|hormones|mesh-ancestor
82799955|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82799956|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82799957|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799958|NCT04408638|Gemcitabine|gemcitabine|mesh-list
82799959|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
82799960|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
82799961|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799962|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
82799963|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799964|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799965|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799966|NCT04400474|Atezolizumab|atezolizumab|mesh-list
82799967|NCT04400474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799968|NCT04400474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799969|NCT04400474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799970|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799971|NCT04393389|Paclitaxel|paclitaxel|mesh-list
82799972|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82799973|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799974|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799975|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799976|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799977|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799978|NCT04390763|Paclitaxel|paclitaxel|mesh-list
82799979|NCT04390763|Gemcitabine|gemcitabine|mesh-list
82799980|NCT04390763|Spartalizumab|spartalizumab|mesh-list
82799981|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82799982|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82799983|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
82799984|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
82799985|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
82799986|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82799987|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82799988|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
82799989|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82799990|NCT04390763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82799991|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82799992|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82799993|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82799994|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82799995|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82799996|NCT04319627|Calcium|calcium|mesh-list
82799997|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82799998|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82799999|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82800000|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82800001|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
82800002|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800003|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82800004|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82800005|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800006|NCT04307576|Dexamethasone|dexamethasone|mesh-list
82800007|NCT04307576|Doxorubicin|doxorubicin|mesh-list
82800008|NCT04307576|Vincristine|vincristine|mesh-list
82800009|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
82800010|NCT04307576|Blinatumomab|blinatumomab|mesh-list
82800011|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82800012|NCT04307576|Thioguanine|thioguanine|mesh-list
82800013|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800014|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
82800015|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
82800016|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800017|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800018|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800019|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
82800020|NCT04307576|Hormones|hormones|mesh-ancestor
82800021|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800022|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800023|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800024|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82800025|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82800026|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82800027|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482527|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800028|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800029|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82800030|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
82800031|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
82800032|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
82800033|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800034|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800035|NCT04307576|Immunotoxins|immunotoxins|mesh-ancestor
82800036|NCT04307576|Immunoconjugates|immunoconjugates|mesh-ancestor
82800037|NCT04307576|Immunologic Factors|immunologic factors|mesh-ancestor
82800038|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82800039|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
82800040|NCT04305496|Fulvestrant|fulvestrant|mesh-list
82800141|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82800176|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82800184|NCT04145440|Felzartamab|felzartamab|mesh-list
82800185|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800186|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
82800187|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800243|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800244|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800245|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
82800246|NCT04036305|Lidocaine|lidocaine|mesh-list
82800247|NCT04036305|Bupivacaine|bupivacaine|mesh-list
82800248|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
82800249|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
82800250|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82800251|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800252|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
82800253|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800254|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82800255|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82800256|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82800257|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82800258|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800265|NCT04021108|Nivolumab|nivolumab|mesh-list
82800266|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800267|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800268|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800269|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800270|NCT04019327|Temozolomide|temozolomide|mesh-list
82800271|NCT04019327|Talazoparib|talazoparib|mesh-list
82800272|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82800273|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
82800274|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800275|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800276|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82800277|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800278|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82800279|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
82800280|NCT03989466|Antibodies|antibodies|mesh-list
82800281|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
82800282|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82800283|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
82800284|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800285|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800286|NCT03970655|Dexamethasone|dexamethasone|mesh-list
82800287|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
82800288|NCT03970655|Epinephrine|epinephrine|mesh-list
82800289|NCT03970655|Racepinephrine|racepinephrine|mesh-list
82800290|NCT03970655|Bupivacaine|bupivacaine|mesh-list
82800291|NCT03970655|Ropivacaine|ropivacaine|mesh-list
82800292|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
82800293|NCT03970655|BB 1101|bb 1101|mesh-list
82800294|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800295|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
82800296|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
82800297|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800298|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800299|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800300|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
82800301|NCT03970655|Hormones|hormones|mesh-ancestor
82800302|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800303|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800304|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800305|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
82800307|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800308|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
82800309|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
82800310|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82800311|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
82800312|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82800313|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82800314|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
82800315|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82800316|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82800317|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82800318|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83441556|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82800319|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
82800320|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
82800321|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
82800322|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82800323|NCT03967977|Carboplatin|carboplatin|mesh-list
82800324|NCT03967977|Gemcitabine|gemcitabine|mesh-list
82800325|NCT03967977|Tislelizumab|tislelizumab|mesh-list
82800326|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800327|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82800328|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
82800329|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800330|NCT03967977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800331|NCT03956056|Poly I-C|poly i-c|mesh-list
82800332|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82800333|NCT03956056|Poly ICLC|poly iclc|mesh-list
82800334|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
82800335|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
82800336|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800337|NCT03956056|Laxatives|laxatives|mesh-ancestor
82800338|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800339|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
82800340|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800341|NCT03949855|Rituximab|rituximab|mesh-list
82800342|NCT03949855|Belimumab|belimumab|mesh-list
82800343|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800344|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800345|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
82800358|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800359|NCT03911453|Rucaparib|rucaparib|mesh-list
82800360|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82800361|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800362|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800363|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800373|NCT03897127|Cytarabine|cytarabine|mesh-list
82800374|NCT03897127|Daunorubicin|daunorubicin|mesh-list
82800375|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82800376|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
82800377|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800378|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800379|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
82800380|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800381|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800382|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
82800383|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800384|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82800385|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82800386|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82800387|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800388|NCT03870919|Palbociclib|palbociclib|mesh-list
82800389|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800390|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800391|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800392|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800393|NCT03865290|Ondansetron|ondansetron|mesh-list
82800394|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
82800395|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
82800396|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800397|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800398|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800399|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
82800400|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
82800401|NCT03865290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82800402|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82800403|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
82800404|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82800405|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800406|NCT03843359|Dostarlimab|dostarlimab|mesh-list
82800407|NCT03843359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800408|NCT03840291|Edoxaban|edoxaban|mesh-list
82800409|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82800410|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
82800411|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82800412|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
82800413|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800414|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800415|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
82800416|NCT03837626|Amiloride|amiloride|mesh-list
82800417|NCT03837626|Diuretics|diuretics|mesh-ancestor
82800418|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
82800419|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800420|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82800421|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82800431|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800432|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800433|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800434|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82800435|NCT03773237|SMOFlipid|smoflipid|mesh-list
82800436|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82800437|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82800438|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82800443|NCT03754725|Deferiprone|deferiprone|mesh-list
82800444|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82800445|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
82800446|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
82800447|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800448|NCT03748641|Prednisone|prednisone|mesh-list
82800449|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
82800450|NCT03748641|Niraparib|niraparib|mesh-list
82800451|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800452|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
82800453|NCT03748641|Hormones|hormones|mesh-ancestor
82800454|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800455|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800456|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800457|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800458|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82800459|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800460|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800461|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
82800462|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82800463|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82800464|NCT03747484|Interferons|interferons|mesh-list
82800465|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
82800466|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
82800467|NCT03747484|Avelumab|avelumab|mesh-list
82800468|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
82800469|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
82800470|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82800471|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800472|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800473|NCT03747484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800474|NCT03747484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800475|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
82800476|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800477|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
82800478|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800479|NCT03745950|Olaparib|olaparib|mesh-list
82800480|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82800481|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800482|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800483|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800490|NCT03694808|Vaccines|vaccines|mesh-list
82800491|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
82800492|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800493|NCT03677973|Quemliclustat|quemliclustat|mesh-list
82800494|NCT03677973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800495|NCT03677973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800496|NCT03677973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800497|NCT03677973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800498|NCT03659539|Propofol|propofol|mesh-list
82800499|NCT03659539|Desflurane|desflurane|mesh-list
82800500|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82800501|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82800502|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800503|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82800504|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
82800505|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
82800506|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82800507|NCT03659136|Everolimus|everolimus|mesh-list
82800508|NCT03659136|Exemestane|exemestane|mesh-list
82800509|NCT03659136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82800510|NCT03659136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800511|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800512|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800513|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800514|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
82800515|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800516|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800517|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82800518|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82800519|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82800520|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
82800521|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800522|NCT03632044|Ropivacaine|ropivacaine|mesh-list
82800523|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
82800524|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
82800525|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82800526|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800527|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
82800528|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800529|NCT03629418|Phenylephrine|phenylephrine|mesh-list
82800530|NCT03629418|Norepinephrine|norepinephrine|mesh-list
82800531|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82800532|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
82800533|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
82800534|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800535|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800536|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
82800537|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82800538|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
82800539|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
82800540|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82800541|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82800542|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82800543|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
82800544|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82800545|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800546|NCT03629418|Protective Agents|protective agents|mesh-ancestor
82800547|NCT03606499|Ustekinumab|ustekinumab|mesh-list
82800548|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
82800549|NCT03606213|Vaccines|vaccines|mesh-list
82800550|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
82800551|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800552|NCT03605719|Dexamethasone|dexamethasone|mesh-list
82800553|NCT03605719|Nivolumab|nivolumab|mesh-list
82800554|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800555|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
82800556|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
82800557|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800558|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800559|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800560|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
82800561|NCT03605719|Hormones|hormones|mesh-ancestor
82800562|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800563|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800564|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800565|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800566|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800567|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800568|NCT03596645|Infliximab|infliximab|mesh-list
82800569|NCT03596645|Golimumab|golimumab|mesh-list
82800570|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82800571|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800572|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
82800573|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800574|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800575|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800576|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
82800577|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800578|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
82800579|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800580|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800581|NCT03529422|Durvalumab|durvalumab|mesh-list
82800582|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800583|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800584|NCT03518203|Eculizumab|eculizumab|mesh-list
82800585|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82800586|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800587|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
82800588|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800589|NCT03514108|Metformin|metformin|mesh-list
82800590|NCT03514108|Hydralazine|hydralazine|mesh-list
82800591|NCT03514108|Isosorbide|isosorbide|mesh-list
82800592|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82800593|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82800594|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82800595|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800596|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82800597|NCT03514108|Diuretics|diuretics|mesh-ancestor
82800598|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
82800599|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
82800600|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82800601|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800602|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82800603|NCT03473743|Carboplatin|carboplatin|mesh-list
82800604|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800605|NCT03466411|Ustekinumab|ustekinumab|mesh-list
82800606|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82800607|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
82800608|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
82800609|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800610|NCT03457142|Dexamethasone|dexamethasone|mesh-list
82800611|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
82800612|NCT03457142|Abatacept|abatacept|mesh-list
82800613|NCT03457142|Ixazomib|ixazomib|mesh-list
82800614|NCT03457142|Ichthammol|ichthammol|mesh-list
82800615|NCT03457142|BB 1101|bb 1101|mesh-list
82800616|NCT03457142|Glycine|glycine|mesh-list
82800617|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800618|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
82800619|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
82800620|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800621|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800622|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800623|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
82800624|NCT03457142|Hormones|hormones|mesh-ancestor
82800625|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800626|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800627|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800628|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800629|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
82800630|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800631|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800632|NCT03457142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800633|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800634|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
82800635|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800636|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
82800637|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
82800638|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82800639|NCT03431350|Prednisone|prednisone|mesh-list
82800640|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
82800641|NCT03431350|Niraparib|niraparib|mesh-list
82800642|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800643|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
82800644|NCT03431350|Hormones|hormones|mesh-ancestor
82800645|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800646|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800647|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800648|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800651|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800652|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
82800653|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82800654|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82800655|NCT03390504|Docetaxel|docetaxel|mesh-list
82800656|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
82800657|NCT03390504|Mitogens|mitogens|mesh-list
82800658|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800659|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
82800660|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
82800661|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
82800662|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800663|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800664|NCT03390504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800665|NCT03390036|Triamcinolone|triamcinolone|mesh-list
82800666|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82800667|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82800668|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82800669|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800670|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
82800671|NCT03390036|Hormones|hormones|mesh-ancestor
82800672|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800673|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800674|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800675|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
82800676|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800677|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800678|NCT03379506|Grazoprevir|grazoprevir|mesh-list
82800679|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
82800680|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800681|NCT03375788|Hormones|hormones|mesh-list
82800682|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
82800683|NCT03375788|Tesamorelin|tesamorelin|mesh-list
82800684|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800685|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800686|NCT03375788|Growth Substances|growth substances|mesh-ancestor
82800687|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
82800688|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800689|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800690|NCT03366844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800691|NCT03366844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800692|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
82800693|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
82800694|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800695|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
82800696|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800697|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800698|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82800699|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
82800700|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800701|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800702|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82800703|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800704|NCT03349450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800705|NCT03348969|Mitomycins|mitomycins|mesh-list
82800706|NCT03348969|Mitomycin|mitomycin|mesh-list
82800707|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82800708|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800709|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
82800710|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800711|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82800712|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800713|NCT03341936|Nivolumab|nivolumab|mesh-list
82800714|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800715|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800716|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800717|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800720|NCT03318900|Aldesleukin|aldesleukin|mesh-list
82800721|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
82800722|NCT03318900|Interleukin-2|interleukin-2|mesh-list
82800723|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82800724|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
82800725|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800726|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
82800727|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800728|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800729|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82800730|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
82800731|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800732|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800733|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82800734|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82800735|NCT03318900|Analgesics|analgesics|mesh-ancestor
82800736|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
82800737|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800738|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82800739|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82800740|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
82800741|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800742|NCT03306446|Adalimumab|adalimumab|mesh-list
82800743|NCT03306446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82800744|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800745|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800746|NCT03306264|Decitabine|decitabine|mesh-list
82800747|NCT03306264|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82800748|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82800749|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
82800750|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800751|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800752|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800753|NCT03301220|Daratumumab|daratumumab|mesh-list
82800754|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800755|NCT03292133|Gefitinib|gefitinib|mesh-list
82800756|NCT03292133|Nazartinib|nazartinib|mesh-list
82800757|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800758|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800759|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800760|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800761|NCT03289728|Dobutamine|dobutamine|mesh-list
82800762|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82800763|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
82800764|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
82800765|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800766|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800767|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82800768|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82800769|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82800770|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
82800771|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82800772|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800773|NCT03289728|Protective Agents|protective agents|mesh-ancestor
82800774|NCT03283917|Dexamethasone|dexamethasone|mesh-list
82800775|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
82800776|NCT03283917|Daratumumab|daratumumab|mesh-list
82800777|NCT03283917|Ixazomib|ixazomib|mesh-list
82800778|NCT03283917|Ichthammol|ichthammol|mesh-list
82800779|NCT03283917|BB 1101|bb 1101|mesh-list
82800780|NCT03283917|Glycine|glycine|mesh-list
82800781|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800782|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
82800783|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
82800784|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800785|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800786|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800787|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
82800788|NCT03283917|Hormones|hormones|mesh-ancestor
82800789|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800790|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800791|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800792|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
82800793|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800794|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800795|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
83361966|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800796|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
82800797|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82800798|NCT03275415|Budesonide|budesonide|mesh-list
82800799|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800800|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82800801|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
82800802|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800803|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800804|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82800805|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
82800806|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
82800807|NCT03275415|Hormones|hormones|mesh-ancestor
82800808|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800809|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
82800810|NCT03233724|Decitabine|decitabine|mesh-list
82800811|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
82800812|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800813|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800814|NCT03233724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800815|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800816|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82800817|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
82800818|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800819|NCT03230734|Docetaxel|docetaxel|mesh-list
82800820|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800821|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
82800822|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
82800823|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
82800824|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800825|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
82800826|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82800827|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82800828|NCT03229408|Analgesics|analgesics|mesh-ancestor
82800829|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
82800830|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800831|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800832|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82800833|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800834|NCT03182244|Cytarabine|cytarabine|mesh-list
82800835|NCT03182244|Fludarabine|fludarabine|mesh-list
82800836|NCT03182244|Etoposide|etoposide|mesh-list
82800837|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
82800838|NCT03182244|Lenograstim|lenograstim|mesh-list
82800839|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800840|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82800841|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
82800842|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800843|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800844|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
82800845|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800846|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82800847|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82800848|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82800849|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800850|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
82800851|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800852|NCT03182244|Analgesics|analgesics|mesh-ancestor
82800853|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
82800854|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82800855|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82800856|NCT03174197|Temozolomide|temozolomide|mesh-list
82800857|NCT03174197|Atezolizumab|atezolizumab|mesh-list
82800858|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82800859|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82800860|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
82800861|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800862|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800863|NCT03174197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800864|NCT03174197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800865|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
82800866|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800867|NCT03170518|Canagliflozin|canagliflozin|mesh-list
82800868|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82800869|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800870|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82800871|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800872|NCT03164928|Denosumab|denosumab|mesh-list
82800921|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82800922|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82800923|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
82800924|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800925|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800926|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82800927|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82800928|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
82800929|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82800930|NCT02998268|Paclitaxel|paclitaxel|mesh-list
82800931|NCT02998268|Carboplatin|carboplatin|mesh-list
82800932|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
82800933|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82800934|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800935|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
82800936|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
82800937|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
82800938|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800939|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800940|NCT02998268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800941|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
82800942|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82800943|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800944|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
82800945|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800946|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82800947|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82800958|NCT02947685|Exemestane|exemestane|mesh-list
82800959|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82800960|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800961|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82800962|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82800963|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82800964|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800965|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82800966|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
82800967|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82800968|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800969|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82800970|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82800971|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82800981|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82800982|NCT02879695|Nivolumab|nivolumab|mesh-list
82800983|NCT02879695|Ipilimumab|ipilimumab|mesh-list
82800984|NCT02879695|Blinatumomab|blinatumomab|mesh-list
82800985|NCT02879695|Antibodies|antibodies|mesh-list
82800986|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
82800987|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82800988|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
82800989|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82800990|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
82800991|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82800992|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82800993|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82800994|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82800995|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82800996|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
82800997|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82800998|NCT02824276|Morphine|morphine|mesh-list
82800999|NCT02824276|Oxycodone|oxycodone|mesh-list
82801000|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82801001|NCT02824276|Narcotics|narcotics|mesh-ancestor
82801002|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801003|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801004|NCT02824276|Analgesics|analgesics|mesh-ancestor
82801005|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
82801006|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801007|NCT02813135|Cytarabine|cytarabine|mesh-list
82801008|NCT02813135|Dexamethasone|dexamethasone|mesh-list
82801009|NCT02813135|Cyclophosphamide|cyclophosphamide|mesh-list
82801010|NCT02813135|Temozolomide|temozolomide|mesh-list
82801011|NCT02813135|Carboplatin|carboplatin|mesh-list
82801012|NCT02813135|Nivolumab|nivolumab|mesh-list
82801013|NCT02813135|Irinotecan|irinotecan|mesh-list
82801014|NCT02813135|Everolimus|everolimus|mesh-list
82801015|NCT02813135|Topotecan|topotecan|mesh-list
82801016|NCT02813135|Olaparib|olaparib|mesh-list
82801017|NCT02813135|Futibatinib|futibatinib|mesh-list
82801018|NCT02813135|Adavosertib|adavosertib|mesh-list
82801019|NCT02813135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801020|NCT02813135|Immunologic Factors|immunologic factors|mesh-ancestor
82801021|NCT02813135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801022|NCT02813135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801023|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801024|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
82801025|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801026|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801040|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801041|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801042|NCT02813135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801043|NCT02813135|Antimetabolites|antimetabolites|mesh-ancestor
82801044|NCT02813135|Antiviral Agents|antiviral agents|mesh-ancestor
82801045|NCT02813135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801046|NCT02813135|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82801047|NCT02813135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801048|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82801049|NCT02797470|Cytarabine|cytarabine|mesh-list
82801050|NCT02797470|Etoposide|etoposide|mesh-list
82801051|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
82801052|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
82801053|NCT02797470|Melphalan|melphalan|mesh-list
82801054|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
82801055|NCT02797470|Carmustine|carmustine|mesh-list
82801056|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82801057|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801058|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801059|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82801060|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801061|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801062|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801063|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801064|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
82801065|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
82801066|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801067|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801068|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
82801069|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801070|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801071|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
82801072|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801073|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
82801074|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
82801075|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801076|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801077|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801092|NCT02764762|Adalimumab|adalimumab|mesh-list
82801093|NCT02764762|Methotrexate|methotrexate|mesh-list
82801094|NCT02764762|Vedolizumab|vedolizumab|mesh-list
82801095|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82801096|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
82801097|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82801098|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801099|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801100|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
82801101|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801102|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801131|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82801132|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801133|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82801134|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801135|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801136|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801137|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
82801138|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801139|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82801140|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82801141|NCT02659930|Growth Substances|growth substances|mesh-ancestor
82801142|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
82801172|NCT02609776|Carboplatin|carboplatin|mesh-list
82801173|NCT02609776|Pemetrexed|pemetrexed|mesh-list
82801174|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
82801175|NCT02609776|Lazertinib|lazertinib|mesh-list
82801176|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82801177|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801178|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801185|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801186|NCT02598661|Imetelstat|imetelstat|mesh-list
82801187|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
82801188|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801189|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801190|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801197|NCT02520362|Denosumab|denosumab|mesh-list
82801198|NCT02520362|Diphosphonates|diphosphonates|mesh-list
82801199|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82801200|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801201|NCT02478710|Vancomycin|vancomycin|mesh-list
82801202|NCT02478710|Tobramycin|tobramycin|mesh-list
82801203|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82801204|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801205|NCT02477826|Paclitaxel|paclitaxel|mesh-list
82801206|NCT02477826|Carboplatin|carboplatin|mesh-list
82801207|NCT02477826|Gemcitabine|gemcitabine|mesh-list
82801208|NCT02477826|Nivolumab|nivolumab|mesh-list
82801209|NCT02477826|Pemetrexed|pemetrexed|mesh-list
82801210|NCT02477826|Ipilimumab|ipilimumab|mesh-list
82801211|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801212|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801213|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801214|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801215|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801216|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801217|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801218|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
82801219|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801220|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82801221|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801222|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82801223|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82801224|NCT02476279|Indomethacin|indomethacin|mesh-list
82801225|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82801226|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82801227|NCT02476279|Analgesics|analgesics|mesh-ancestor
82801228|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
82801229|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801230|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801231|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801232|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801233|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
82801234|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
82801235|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82801236|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82801237|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801238|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801239|NCT02425865|Golimumab|golimumab|mesh-list
82801240|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82801241|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801242|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801243|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
82801244|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801245|NCT02425852|Prednisolone|prednisolone|mesh-list
82801246|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
82801247|NCT02425852|Infliximab|infliximab|mesh-list
82801248|NCT02425852|Azathioprine|azathioprine|mesh-list
82801249|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801250|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
82801251|NCT02425852|Hormones|hormones|mesh-ancestor
82801252|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801253|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801254|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801255|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801256|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801257|NCT02425852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82801258|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
82801259|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801260|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
82801261|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801262|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801263|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801264|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
82801265|NCT02382549|Vaccines|vaccines|mesh-list
82801266|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
82801267|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801268|NCT02333188|Leucovorin|leucovorin|mesh-list
82801269|NCT02333188|Paclitaxel|paclitaxel|mesh-list
82801270|NCT02333188|Fluorouracil|fluorouracil|mesh-list
82801271|NCT02333188|Irinotecan|irinotecan|mesh-list
82801272|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82801273|NCT02333188|Calcium|calcium|mesh-list
82801274|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
82801275|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801276|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801277|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801278|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801279|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801280|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801281|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82801282|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801283|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
82801284|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801285|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801286|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
82801287|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82801288|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801289|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801290|NCT02333188|Antidotes|antidotes|mesh-ancestor
82801291|NCT02333188|Protective Agents|protective agents|mesh-ancestor
82801292|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
82801293|NCT02333188|Vitamins|vitamins|mesh-ancestor
82801294|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
82801295|NCT02316106|Daratumumab|daratumumab|mesh-list
82801296|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82801297|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801298|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
82801299|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801300|NCT02282358|Mocetinostat|mocetinostat|mesh-list
82801301|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82801302|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801303|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801304|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
82801305|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
82801306|NCT02248597|Busulfan|busulfan|mesh-list
82801307|NCT02248597|Fludarabine|fludarabine|mesh-list
82801308|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
82801309|NCT02248597|Tacrolimus|tacrolimus|mesh-list
82801310|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801311|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
82801312|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801313|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801314|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801315|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
82801316|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801317|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801318|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801319|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801320|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
82801321|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82801322|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801323|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82801324|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82801325|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
82801326|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82801327|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801328|NCT02177578|Temozolomide|temozolomide|mesh-list
82801329|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801330|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
82801331|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801332|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801333|NCT02166463|Prednisone|prednisone|mesh-list
82801334|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
82801335|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82801336|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82801337|NCT02166463|Prednisolone|prednisolone|mesh-list
82801338|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
82801339|NCT02166463|Cortisone|cortisone|mesh-list
82801340|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
82801341|NCT02166463|Doxorubicin|doxorubicin|mesh-list
82801342|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82801343|NCT02166463|Etoposide|etoposide|mesh-list
82801344|NCT02166463|Vincristine|vincristine|mesh-list
82801345|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
82801346|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82801347|NCT02166463|Bleomycin|bleomycin|mesh-list
82801348|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
82801349|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82801350|NCT02166463|Antibodies|antibodies|mesh-list
82801351|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
82801352|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82801353|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82801354|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
82801355|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
82801356|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801357|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
82801358|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801359|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801360|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801361|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
82801362|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801363|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801364|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801365|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82801366|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82801367|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801368|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801369|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801370|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
82801371|NCT02166463|Hormones|hormones|mesh-ancestor
82801372|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801373|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801374|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801375|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801376|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801377|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801378|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
82801379|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
82801380|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801381|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801382|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82801383|NCT02166463|Protective Agents|protective agents|mesh-ancestor
82801384|NCT02166463|Immunotoxins|immunotoxins|mesh-ancestor
82801385|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
82801386|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
82801387|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
82801388|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801389|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
82801390|NCT02094794|Etoposide|etoposide|mesh-list
82801391|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
82801392|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801393|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
82801394|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801395|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801396|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801397|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
82801398|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801399|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801400|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801401|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801402|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82801403|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801404|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801405|NCT01909453|Vemurafenib|vemurafenib|mesh-list
82801406|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801407|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801408|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801409|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801410|NCT01902173|Trametinib|trametinib|mesh-list
82801411|NCT01902173|Dabrafenib|dabrafenib|mesh-list
82801412|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82801413|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801414|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801415|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801416|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801417|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82801418|NCT01902173|Protective Agents|protective agents|mesh-ancestor
82801419|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801420|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82801421|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
82801422|NCT01892709|Hydromorphone|hydromorphone|mesh-list
82801423|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82801424|NCT01892709|Narcotics|narcotics|mesh-ancestor
82801425|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801426|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801427|NCT01892709|Analgesics|analgesics|mesh-ancestor
82801428|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
82801429|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801430|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
82801431|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801432|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
82801433|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801434|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801435|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801436|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
82801437|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801438|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801439|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801440|NCT01806571|Cytarabine|cytarabine|mesh-list
82801441|NCT01806571|Daunorubicin|daunorubicin|mesh-list
82801442|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801443|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
82801444|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801445|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801446|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
82801447|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801448|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801449|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
82801450|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801451|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82801452|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82801453|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801454|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801455|NCT01772472|Trastuzumab|trastuzumab|mesh-list
83441610|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
82801456|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82801457|NCT01772472|Maytansine|maytansine|mesh-list
82801458|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801459|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801460|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801461|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801462|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801463|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801464|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801465|NCT01772472|Immunotoxins|immunotoxins|mesh-ancestor
82801466|NCT01772472|Immunoconjugates|immunoconjugates|mesh-ancestor
82801467|NCT01772472|Immunologic Factors|immunologic factors|mesh-ancestor
82801468|NCT01772472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801469|NCT01633177|Vitamin D|vitamin d|mesh-list
82801470|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
82801471|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
82801472|NCT01633177|Vitamins|vitamins|mesh-list
82801473|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
82801474|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801475|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82801476|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82801477|NCT01522976|Lenalidomide|lenalidomide|mesh-list
82801478|NCT01522976|Azacitidine|azacitidine|mesh-list
82801479|NCT01522976|Vorinostat|vorinostat|mesh-list
82801480|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
82801481|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801482|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82801483|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82801484|NCT01522976|Growth Substances|growth substances|mesh-ancestor
82801485|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
82801486|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801487|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801488|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
82801489|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801490|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801491|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82801492|NCT01517451|Androgens|androgens|mesh-list
82801493|NCT01517451|Hormones|hormones|mesh-ancestor
82801494|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801495|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801496|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
82801497|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
82801498|NCT01409200|Axitinib|axitinib|mesh-list
82801499|NCT01409200|Hormones|hormones|mesh-list
82801500|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82801501|NCT01409200|Androgens|androgens|mesh-list
82801502|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
82801503|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801504|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801505|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
82801506|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801507|NCT01409200|Protective Agents|protective agents|mesh-ancestor
82801508|NCT01409200|Vitamins|vitamins|mesh-ancestor
82801509|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
82801510|NCT01409200|Estrogens|estrogens|mesh-ancestor
82801511|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801512|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801513|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
82801514|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801515|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801516|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
82801517|NCT01204216|Biotin|biotin|mesh-list
82801518|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
82801519|NCT01204216|Vitamins|vitamins|mesh-ancestor
82801520|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
82801521|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801522|NCT01104350|Gemcitabine|gemcitabine|mesh-list
82801523|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801524|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
82801525|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801526|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801527|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
82801528|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82801529|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801530|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
82801531|NCT01025089|Doxorubicin|doxorubicin|mesh-list
82801532|NCT01025089|Cetuximab|cetuximab|mesh-list
82801533|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801534|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
82801535|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801536|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801537|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801538|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
82801539|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801540|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801541|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801542|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82801543|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82801544|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801545|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801546|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801547|NCT00999037|Sevelamer|sevelamer|mesh-list
82801548|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
82801549|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
82801550|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801551|NCT00921856|Acetylcholine|acetylcholine|mesh-list
82801552|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
82801553|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82801554|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
82801555|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801556|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801557|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801558|NCT00861705|Paclitaxel|paclitaxel|mesh-list
82801559|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
82801560|NCT00861705|Bevacizumab|bevacizumab|mesh-list
82801561|NCT00861705|Carboplatin|carboplatin|mesh-list
82801563|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82801564|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82801565|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82801566|NCT00861705|Antibodies|antibodies|mesh-list
82801567|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
82801568|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82801569|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
82801570|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
82801571|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801572|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801573|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801574|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801575|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801576|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801577|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801578|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
82801579|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801580|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801581|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801582|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
82801583|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801584|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82801585|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82801586|NCT00861705|Growth Substances|growth substances|mesh-ancestor
82801587|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
82801588|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82801589|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82801590|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801591|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801592|NCT00833664|Terbinafine|terbinafine|mesh-list
82801593|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
82801594|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801595|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801596|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801597|NCT00696111|Leuprolide|leuprolide|mesh-list
82801598|NCT00696111|Progesterone|progesterone|mesh-list
82801599|NCT00696111|Estrogens|estrogens|mesh-list
82801600|NCT00696111|Progestins|progestins|mesh-ancestor
82801601|NCT00696111|Hormones|hormones|mesh-ancestor
82801602|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801603|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801604|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82801605|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
82801606|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82801607|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801608|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801609|NCT00354393|Methotrexate|methotrexate|mesh-list
82801610|NCT00354393|Vinorelbine|vinorelbine|mesh-list
82801611|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801612|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82801613|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
82801614|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82801615|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801616|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801617|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
82801618|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801619|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
82801620|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801621|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82801622|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801623|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
82801624|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801625|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82801626|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801627|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801628|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801629|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801630|NCT00224393|Etanercept|etanercept|mesh-list
82801631|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82801632|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82801633|NCT00224393|Analgesics|analgesics|mesh-ancestor
82801634|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
82801635|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801636|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801637|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801639|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801640|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801641|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
82801642|NCT00199862|Antibodies|antibodies|mesh-list
82801643|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
82801644|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801645|NCT00128310|Gemcitabine|gemcitabine|mesh-list
82801646|NCT00128310|Vinorelbine|vinorelbine|mesh-list
82801647|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82801648|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
82801649|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801650|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801651|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82801652|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801653|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801654|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801655|NCT00885443|Propofol|propofol|mesh-list
82801657|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82801658|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801659|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801660|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82801661|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
82801662|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
82801663|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82801664|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82801665|NCT00882869|Sorafenib|sorafenib|mesh-list
82801666|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801667|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801668|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801669|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801670|NCT00882947|Iloprost|iloprost|mesh-list
82801671|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82801672|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
82801673|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82801674|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82801675|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
82801676|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801677|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801678|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82801679|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
82801680|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82801681|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82801682|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82801683|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
82801684|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801685|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801686|NCT00530348|Interferons|interferons|mesh-list
82801687|NCT00530348|Interferon-beta|interferon-beta|mesh-list
82801688|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
82801689|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
82801690|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801691|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
82801692|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801693|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801694|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
82801695|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801696|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82801697|NCT01007864|Pramipexole|pramipexole|mesh-list
82801698|NCT01007864|Ropinirole|ropinirole|mesh-list
82801699|NCT01007864|Piribedil|piribedil|mesh-list
82801700|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
82801701|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801702|NCT01007864|Protective Agents|protective agents|mesh-ancestor
82801703|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801704|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82801705|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82801706|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
82801707|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
82801708|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801709|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82801710|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
82801711|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801712|NCT01008020|Protective Agents|protective agents|mesh-ancestor
82801713|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801714|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82801715|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82801716|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801717|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82801718|NCT01008098|Escitalopram|escitalopram|mesh-list
82801719|NCT01008098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82801720|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82801721|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82801722|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801723|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801724|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
82801725|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801726|NCT00530270|Dexamethasone|dexamethasone|mesh-list
82801727|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801728|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
82801729|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
82801730|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801731|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801732|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801733|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
82801735|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801736|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801737|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801738|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82801739|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801740|NCT01001624|Hydroquinone|hydroquinone|mesh-list
82801741|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
82801742|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801743|NCT01001624|Protective Agents|protective agents|mesh-ancestor
82801744|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801745|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82801746|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
82801747|NCT01001780|Rituximab|rituximab|mesh-list
82801748|NCT01001780|Pentostatin|pentostatin|mesh-list
82801749|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801750|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
82801751|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801752|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801753|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801754|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
82801755|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801756|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801757|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801758|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801759|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82801760|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801761|NCT01008566|Sorafenib|sorafenib|mesh-list
82801762|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82801763|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801764|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801765|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801766|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801767|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
82801768|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801769|NCT03885596|Acetaminophen|acetaminophen|mesh-list
82801770|NCT03885596|Celecoxib|celecoxib|mesh-list
82801771|NCT03885596|Ketorolac|ketorolac|mesh-list
82801772|NCT03885596|Lidocaine|lidocaine|mesh-list
82801773|NCT03885596|Fentanyl|fentanyl|mesh-list
82801774|NCT03885596|Bupivacaine|bupivacaine|mesh-list
82801775|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
82801776|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
82801777|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801778|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801779|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
82801780|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801781|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82801782|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82801783|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82801784|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82801785|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801786|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82801787|NCT03885596|Narcotics|narcotics|mesh-ancestor
82801788|NCT03885596|Analgesics|analgesics|mesh-ancestor
82801789|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82801790|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82801791|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
82801792|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82801793|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
82801794|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82801795|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801796|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801797|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82801798|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82801799|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801800|NCT01002092|Endostar protein|endostar protein|mesh-list
82801801|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82801802|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82801803|NCT01002092|Growth Substances|growth substances|mesh-ancestor
82801804|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801805|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
82801806|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801807|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
82801808|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
82801809|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
82801810|NCT00529100|Cisplatin|cisplatin|mesh-list
82801811|NCT00529100|Pemetrexed|pemetrexed|mesh-list
82801812|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801813|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801814|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801815|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82801816|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82801817|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
82801818|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801819|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
82801820|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801821|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82801822|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801823|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
82801824|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801825|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801826|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801827|NCT00529802|Everolimus|everolimus|mesh-list
82801828|NCT00529802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82801829|NCT00529802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82801830|NCT00529802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801831|NCT00529802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801832|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801833|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
82801834|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801835|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801836|NCT00528866|Docetaxel|docetaxel|mesh-list
82801837|NCT00528866|Bicalutamide|bicalutamide|mesh-list
82801838|NCT00528866|Flutamide|flutamide|mesh-list
82801839|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801840|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
82801841|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
82801842|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
82801843|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801844|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
82801845|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
82801846|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801847|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801848|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801849|NCT05730920|Methadone|methadone|mesh-list
82801850|NCT05730920|Bupivacaine|bupivacaine|mesh-list
82801851|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
82801852|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
82801853|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801854|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801855|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
82801856|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801857|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82801858|NCT05730920|Narcotics|narcotics|mesh-ancestor
82801859|NCT05730920|Analgesics|analgesics|mesh-ancestor
82801860|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
82801861|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
82801862|NCT03999008|Budesonide|budesonide|mesh-list
83361967|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83361968|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
82801863|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801864|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82801865|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
82801866|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801867|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801868|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82801869|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
82801870|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
82801871|NCT03999008|Hormones|hormones|mesh-ancestor
82801872|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801873|NCT05140148|Amantadine|amantadine|mesh-list
82801874|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82801875|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82801876|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
82801877|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801878|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
82801879|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801880|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801881|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801882|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82801883|NCT05140148|Analgesics|analgesics|mesh-ancestor
82801884|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
82801885|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801886|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
82801887|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83441635|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
82801888|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801889|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801890|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82801891|NCT04932746|Analgesics|analgesics|mesh-ancestor
82801892|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
82801893|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801894|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82801895|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82801896|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82801897|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
82801898|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801899|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801900|NCT00614393|Irinotecan|irinotecan|mesh-list
82801901|NCT00614393|Cetuximab|cetuximab|mesh-list
82801902|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82801903|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82801904|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82801905|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801906|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801907|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801908|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82801909|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
82801910|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801911|NCT00880529|Morphine|morphine|mesh-list
82801912|NCT00880529|Bupivacaine|bupivacaine|mesh-list
82801913|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
82801914|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
82801915|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801916|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801917|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
82801918|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801919|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82801920|NCT00880529|Narcotics|narcotics|mesh-ancestor
82801921|NCT00880529|Analgesics|analgesics|mesh-ancestor
82801922|NCT00880841|Buprenorphine|buprenorphine|mesh-list
82801923|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82801924|NCT00880841|Naloxone|naloxone|mesh-list
82801925|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82801926|NCT00880841|Narcotics|narcotics|mesh-ancestor
82801927|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82801928|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801929|NCT00880841|Analgesics|analgesics|mesh-ancestor
82801930|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
82801931|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801932|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82801933|NCT00883259|Metformin|metformin|mesh-list
82801934|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82801935|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801936|NCT00885599|Listerine|listerine|mesh-list
82801937|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82801938|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801939|NCT04366115|Dexamethasone|dexamethasone|mesh-list
82801940|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
82801941|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82801942|NCT04366115|BB 1101|bb 1101|mesh-list
82801943|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801944|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
82801945|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
82801946|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801947|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801948|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801949|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
82801950|NCT04366115|Hormones|hormones|mesh-ancestor
82801951|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801952|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801953|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801954|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
82801955|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801956|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801957|NCT04038125|Dexamethasone|dexamethasone|mesh-list
82801958|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82801959|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
82801960|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
82801961|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82801962|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83441643|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
82801963|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82801964|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
82801965|NCT04038125|Hormones|hormones|mesh-ancestor
82801966|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82801967|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82801968|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801969|NCT00881153|Cefprozil|cefprozil|mesh-list
82801970|NCT00881153|Cephalosporins|cephalosporins|mesh-list
82801971|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82801972|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82801973|NCT00885833|Fludarabine|fludarabine|mesh-list
82801974|NCT00885833|Busulfan|busulfan|mesh-list
82801975|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
82801976|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801977|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801978|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82801979|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
82801980|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82801981|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
82801982|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82801983|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82801984|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
82801985|NCT00612677|Pemetrexed|pemetrexed|mesh-list
82801986|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82801987|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82801988|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801989|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82801990|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82801991|NCT04038749|Cabergoline|cabergoline|mesh-list
82801992|NCT04038749|Bromocriptine|bromocriptine|mesh-list
82801993|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82801994|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82801995|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
82801996|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
82801997|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82801998|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82801999|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802000|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
82802001|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802002|NCT00881231|Cilostazol|cilostazol|mesh-list
82802003|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82802004|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
82802005|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802006|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802007|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82802008|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
82802009|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82802010|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82802011|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802012|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82802013|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
82802014|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82802015|NCT00881231|Protective Agents|protective agents|mesh-ancestor
82802016|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82802017|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82802018|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802019|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
82802020|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82802021|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82802022|NCT00881387|Rituximab|rituximab|mesh-list
82802023|NCT00881387|Gemcitabine|gemcitabine|mesh-list
82802024|NCT00881387|Vinorelbine|vinorelbine|mesh-list
82802025|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82802026|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802027|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
82802028|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802029|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802030|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82802031|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
82802032|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802033|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82802034|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
82802035|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
82802036|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
82802037|NCT00883883|Cefdinir|cefdinir|mesh-list
82802038|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82802039|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802040|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82802041|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82802042|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82802043|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802044|NCT00881543|Incretins|incretins|mesh-ancestor
82802045|NCT00881543|Hormones|hormones|mesh-ancestor
82802046|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802047|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
82802048|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802049|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802050|NCT00881855|Cefprozil|cefprozil|mesh-list
82802051|NCT00881855|Cephalosporins|cephalosporins|mesh-list
82802052|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82802053|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802054|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
82802055|NCT04015115|Narcotics|narcotics|mesh-ancestor
82802056|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802057|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802058|NCT04015115|Analgesics|analgesics|mesh-ancestor
82802059|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
82802060|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802061|NCT02543645|Atezolizumab|atezolizumab|mesh-list
82802062|NCT02543645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82802063|NCT02543645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802064|NCT02543645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82802065|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802066|NCT02543411|Lidocaine|lidocaine|mesh-list
82802067|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
82802068|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
82802069|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802070|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802071|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
82802072|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802073|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82802074|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82802075|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82802076|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82802077|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802078|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
82802079|NCT00882323|Fludarabine|fludarabine|mesh-list
82802080|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
82802081|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802082|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
82802083|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802084|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802085|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82802086|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
83361969|NCT00121251|Gemcitabine|gemcitabine|mesh-list
83361970|NCT00121251|Capecitabine|capecitabine|mesh-list
82802087|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802088|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802089|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82802090|NCT00882401|Vitamin D|vitamin d|mesh-list
82802091|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
82802092|NCT00882401|Vitamins|vitamins|mesh-ancestor
82802093|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
82802094|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802095|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82802096|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82802097|NCT00886457|Interferons|interferons|mesh-list
82802098|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
82802099|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
82802100|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82802101|NCT00886457|Decitabine|decitabine|mesh-list
82802102|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802103|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
82802104|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802105|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
82802106|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802107|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82802108|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
83441645|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82802109|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802110|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802111|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
82802112|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82802113|NCT04038671|Charcoal|charcoal|mesh-list
82802114|NCT04038671|Antidotes|antidotes|mesh-ancestor
82802115|NCT04038671|Protective Agents|protective agents|mesh-ancestor
82802116|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802117|NCT02543099|Policosanol|policosanol|mesh-list
82802118|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82802119|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82802120|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
82802121|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802122|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82802123|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82802124|NCT00882635|Heparin|heparin|mesh-list
82802125|NCT00882635|Enoxaparin|enoxaparin|mesh-list
82802126|NCT00882635|Calcium heparin|calcium heparin|mesh-list
82802127|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
82802128|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82802129|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82802130|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802131|NCT00609869|Rituximab|rituximab|mesh-list
82802132|NCT00609869|Lenalidomide|lenalidomide|mesh-list
82802133|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82802134|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802135|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
82802136|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802137|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802138|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82802139|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82802140|NCT00609869|Growth Substances|growth substances|mesh-ancestor
82802141|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
82802142|NCT00888797|Etodolac|etodolac|mesh-list
82802143|NCT00888797|Propranolol|propranolol|mesh-list
82802144|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82802145|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82802146|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
82802147|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802148|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802149|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802150|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82802151|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82802152|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
82802153|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82802154|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802155|NCT00888797|Analgesics|analgesics|mesh-ancestor
82802156|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
82802157|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802158|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802159|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802160|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82802161|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82802162|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361971|NCT00121251|Sorafenib|sorafenib|mesh-list
82802163|NCT00884663|Propranolol|propranolol|mesh-list
82802164|NCT00884663|Candesartan|candesartan|mesh-list
82802165|NCT00884663|Candesartan cilexetil|candesartan cilexetil|mesh-list
82802166|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82802167|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82802168|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
82802169|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802170|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802171|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802172|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82802173|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82802174|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
82802175|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82802176|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82802177|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
82802178|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82802179|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82802180|NCT00887003|Prednisolone|prednisolone|mesh-list
82802181|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
82802182|NCT00887003|Bupivacaine|bupivacaine|mesh-list
82802183|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82802184|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
82802185|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
82802186|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
82802187|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802188|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802189|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
82802190|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802191|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802192|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
82802193|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
82802194|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802195|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
82802196|NCT00887003|Hormones|hormones|mesh-ancestor
82802197|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802198|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82802199|NCT00887003|Protective Agents|protective agents|mesh-ancestor
82802200|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82802201|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802202|NCT00887081|Ribavirin|ribavirin|mesh-list
82802203|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
82802204|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
82802205|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82802206|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82802207|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82802208|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
82802209|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802210|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
82802211|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802212|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
82802213|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802214|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802215|NCT03998696|Cisplatin|cisplatin|mesh-list
82802216|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802217|NCT00611975|Bupropion|bupropion|mesh-list
82802218|NCT00611975|Fluoxetine|fluoxetine|mesh-list
82802219|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82802220|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
82802221|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82802222|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82802223|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82802224|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82802225|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802226|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
82802227|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802228|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802229|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82802230|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82802231|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802232|NCT00611975|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82802233|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
82802234|NCT05695352|Meloxicam|meloxicam|mesh-list
82802235|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
82802236|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82802237|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
82802238|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82802239|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802240|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82802241|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82802242|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82802243|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82802244|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802245|NCT05695352|Analgesics|analgesics|mesh-ancestor
82802246|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
82802247|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802248|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802249|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802250|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82802251|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82802252|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802253|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802254|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
82802255|NCT04895306|Testosterone|testosterone|mesh-list
82802256|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
82802257|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
82802258|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82802259|NCT04895306|Androgens|androgens|mesh-ancestor
82802261|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802262|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802263|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82802264|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802265|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
82802266|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82802267|NCT00889343|Leucovorin|leucovorin|mesh-list
82802268|NCT00889343|Fluorouracil|fluorouracil|mesh-list
82802269|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
82802270|NCT00889343|Irinotecan|irinotecan|mesh-list
82802271|NCT00889343|Sorafenib|sorafenib|mesh-list
82802272|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
82802273|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802274|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82802275|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802276|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802277|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
82802278|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802279|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82802280|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82802281|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802282|NCT00889343|Antidotes|antidotes|mesh-ancestor
82802283|NCT00889343|Protective Agents|protective agents|mesh-ancestor
82802284|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
82802285|NCT00889343|Vitamins|vitamins|mesh-ancestor
82802286|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
82802287|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82802288|NCT00884819|Fenofibrate|fenofibrate|mesh-list
82802289|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82802290|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
82802291|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802292|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82802293|NCT04974398|Cisplatin|cisplatin|mesh-list
82802294|NCT04974398|Gemcitabine|gemcitabine|mesh-list
82802295|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802296|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82802297|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
82802298|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802299|NCT00573131|Paclitaxel|paclitaxel|mesh-list
82802300|NCT00573131|Cisplatin|cisplatin|mesh-list
82802301|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82802302|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802303|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
82802304|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
82802305|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
82802306|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802307|NCT01565018|Rotigotine|rotigotine|mesh-list
82802308|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
82802309|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
82802310|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802311|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802312|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802313|NCT01565096|Metformin|metformin|mesh-list
83361972|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82802314|NCT01565096|Glimepiride|glimepiride|mesh-list
82802315|NCT01565096|Vildagliptin|vildagliptin|mesh-list
82802316|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82802317|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802318|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82802319|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802320|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
82802321|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82802322|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
82802323|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802324|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802325|NCT00889499|Tropisetron|tropisetron|mesh-list
82802326|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
82802327|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
82802328|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802329|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802330|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802331|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82802332|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82802333|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
82802334|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802335|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802336|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82802337|NCT00889655|Laxatives|laxatives|mesh-ancestor
82802338|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802339|NCT05002946|Naltrexone|naltrexone|mesh-list
82802340|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82802341|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82802342|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802343|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
82802344|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802345|NCT04641338|Dipyrone|dipyrone|mesh-list
82802346|NCT04641338|Codeine|codeine|mesh-list
82802347|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82802348|NCT04641338|Narcotics|narcotics|mesh-ancestor
82802349|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802350|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802351|NCT04641338|Analgesics|analgesics|mesh-ancestor
82802352|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
82802353|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802354|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
82802355|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
82802356|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82802357|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802358|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802359|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802360|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
82802361|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
82802362|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82802363|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802364|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802365|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802366|NCT04635098|Analgesics|analgesics|mesh-ancestor
82802367|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
82802368|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802369|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82802370|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82802371|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82802372|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
82802373|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802374|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802375|NCT00521144|Topotecan|topotecan|mesh-list
82802376|NCT00521144|Obatoclax|obatoclax|mesh-list
82802377|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82802378|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82802379|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802380|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802381|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802382|NCT00520676|Carboplatin|carboplatin|mesh-list
82802383|NCT00520676|Docetaxel|docetaxel|mesh-list
82802384|NCT00520676|Pemetrexed|pemetrexed|mesh-list
82802385|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802386|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
82802387|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
82802388|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
82802389|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802390|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802391|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82802392|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82802394|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802395|NCT00887627|Conivaptan|conivaptan|mesh-list
82802396|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82802397|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802398|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
82802399|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802400|NCT00885287|Lumefantrine|lumefantrine|mesh-list
82802401|NCT00885287|Artemether|artemether|mesh-list
82802402|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82802403|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
82802404|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82802405|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82802406|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802407|NCT02542007|Sirolimus|sirolimus|mesh-list
82802408|NCT02542007|Temsirolimus|temsirolimus|mesh-list
82802409|NCT02542007|MTOR Inhibitors|mtor inhibitors|mesh-list
82802410|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82802411|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802412|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82802413|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802414|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
82802415|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802416|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
82802417|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802418|NCT02542007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82802419|NCT02542007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802420|NCT02542007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802421|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82802422|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82802423|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82802424|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802425|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802426|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82802427|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82802428|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82802429|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
82802430|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802431|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802432|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82802433|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82802434|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
82802435|NCT00890279|Imidapril|imidapril|mesh-list
82802436|NCT00890279|Cilnidipine|cilnidipine|mesh-list
82802437|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82802438|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82802439|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802440|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82802441|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802442|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82802443|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
82802444|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802445|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82802446|NCT00608543|Aripiprazole|aripiprazole|mesh-list
82802447|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
82802448|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82802449|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82802450|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82802451|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802452|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802453|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
82802454|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
82802455|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441669|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802456|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802457|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82802458|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82802459|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
82802460|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82802461|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83361973|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
82802462|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82802463|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82802464|NCT02541383|Thalidomide|thalidomide|mesh-list
82802465|NCT02541383|Dexamethasone|dexamethasone|mesh-list
82802466|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
82802467|NCT02541383|Bortezomib|bortezomib|mesh-list
82802468|NCT02541383|Daratumumab|daratumumab|mesh-list
82802469|NCT02541383|BB 1101|bb 1101|mesh-list
82802470|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82802471|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802472|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
82802473|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
82802474|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802475|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802476|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802477|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
82802478|NCT02541383|Hormones|hormones|mesh-ancestor
82802479|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802480|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82802481|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802482|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
82802483|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802484|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802485|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802486|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
82802487|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
82802488|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82802489|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802490|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82802491|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82802492|NCT02541383|Growth Substances|growth substances|mesh-ancestor
82802493|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
82802494|NCT04036487|Propofol|propofol|mesh-list
82802495|NCT04036487|Desflurane|desflurane|mesh-list
82802496|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82802497|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802498|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802499|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82802500|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
82802501|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
82802502|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82802503|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
82802504|NCT05278793|Trace Elements|trace elements|mesh-ancestor
82802505|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
82802506|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802507|NCT04037657|Propofol|propofol|mesh-list
82802508|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82802509|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802510|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802511|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82802512|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
82802513|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
82802514|NCT00893009|Theophylline|theophylline|mesh-list
82802515|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82802516|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
82802517|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802518|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802519|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82802520|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
82802521|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82802522|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802523|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802524|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
82802525|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82802526|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82802527|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
82802528|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802529|NCT00890747|Sunitinib|sunitinib|mesh-list
82802530|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802531|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82802532|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82802533|NCT00890747|Growth Substances|growth substances|mesh-ancestor
82802534|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802535|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
82802536|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82802537|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802538|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802540|NCT04017845|Lidocaine|lidocaine|mesh-list
82802541|NCT04017845|Diltiazem|diltiazem|mesh-list
82802542|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
82802543|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
82802544|NCT04017845|Bisacodyl|bisacodyl|mesh-list
82802545|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
82802546|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
82802547|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802548|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802549|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
82802550|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802551|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82802552|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82802553|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82802554|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82802555|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802556|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82802557|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
82802558|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82802559|NCT04017845|Cathartics|cathartics|mesh-ancestor
82802560|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802561|NCT04017845|Laxatives|laxatives|mesh-ancestor
82802562|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82802563|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802564|NCT04017845|Analgesics|analgesics|mesh-ancestor
82802565|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802566|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802567|NCT00520130|Cytarabine|cytarabine|mesh-list
82802568|NCT00520130|Cyclosporine|cyclosporine|mesh-list
82802569|NCT00520130|Rituximab|rituximab|mesh-list
82802570|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
82802571|NCT00520130|Fludarabine|fludarabine|mesh-list
82802572|NCT00520130|Cyclosporins|cyclosporins|mesh-list
82802573|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82802574|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802575|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
82802576|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802577|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802578|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82802579|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
82802580|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802581|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802582|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
82802583|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802584|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802585|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
82802586|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
82802587|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82802588|NCT00519896|Sunitinib|sunitinib|mesh-list
82802589|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802590|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82802591|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82802592|NCT00519896|Growth Substances|growth substances|mesh-ancestor
82802593|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802594|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
82802595|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82802596|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802597|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802598|NCT00527618|Valacyclovir|valacyclovir|mesh-list
82802599|NCT00527618|Acyclovir|acyclovir|mesh-list
82802600|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
82802601|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802602|NCT00527072|Infliximab|infliximab|mesh-list
82802603|NCT00527072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82802604|NCT00527072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802605|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
82802606|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802607|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802608|NCT00519428|Dexetimide|dexetimide|mesh-list
82802609|NCT00519428|Citalopram|citalopram|mesh-list
82802610|NCT00519428|Bupropion|bupropion|mesh-list
82802611|NCT00519428|Escitalopram|escitalopram|mesh-list
82802612|NCT00519428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82802613|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82802614|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82802615|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802616|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802617|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
82802618|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802619|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82802620|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82802621|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
82802622|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
82802623|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802624|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82802625|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82802626|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
82802627|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82802628|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
82802629|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82802630|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82802631|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
82802632|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82802633|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82802634|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802635|NCT00431847|Anesthetics|anesthetics|mesh-list
82802636|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802637|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802638|NCT00431067|Afatinib|afatinib|mesh-list
82802639|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802640|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82802641|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802642|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802643|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
82802644|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82802645|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
82802646|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
82802647|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82802648|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802649|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802650|NCT00430989|Analgesics|analgesics|mesh-ancestor
82802651|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
82802652|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802653|NCT00518882|Liraglutide|liraglutide|mesh-list
82802654|NCT00518882|Exenatide|exenatide|mesh-list
82802655|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82802656|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802657|NCT00518882|Incretins|incretins|mesh-ancestor
82802658|NCT00518882|Hormones|hormones|mesh-ancestor
82802659|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802660|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82802661|NCT00518180|Lactitol|lactitol|mesh-list
82802662|NCT00518180|Vaccines|vaccines|mesh-list
82802663|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
82802664|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802665|NCT00518180|Cathartics|cathartics|mesh-ancestor
82802666|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802667|NCT00525902|Adalimumab|adalimumab|mesh-list
82802668|NCT00525902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82802669|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802670|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802671|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82802672|NCT00525824|Simvastatin|simvastatin|mesh-list
82802673|NCT00525824|Ezetimibe|ezetimibe|mesh-list
82802674|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82802675|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82802676|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
82802677|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802678|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82802679|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82802680|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802681|NCT00525590|Carmustine|carmustine|mesh-list
82802682|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82802683|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
82802684|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802685|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802686|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
82802687|NCT00430677|Prednisone|prednisone|mesh-list
82802688|NCT00430677|Prednisolone|prednisolone|mesh-list
82802689|NCT00430677|Abatacept|abatacept|mesh-list
83361974|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802690|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802692|NCT00430677|Hormones|hormones|mesh-ancestor
82802693|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802694|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802695|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82802696|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802697|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82802698|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82802699|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
82802700|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82802701|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802702|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802703|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802704|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82802705|NCT00430677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82802706|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802707|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
82802708|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802709|NCT02631759|Levetiracetam|levetiracetam|mesh-list
82802710|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
82802711|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
82802712|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
82802713|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82802714|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802715|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
82802716|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82802717|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
82802718|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802719|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802720|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82802721|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
82802722|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
82802723|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82802724|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
82802725|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802726|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802727|NCT04501406|Pioglitazone|pioglitazone|mesh-list
82802728|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82802729|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802730|NCT03656666|Thalidomide|thalidomide|mesh-list
82802731|NCT03656666|Apremilast|apremilast|mesh-list
82802732|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82802733|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802734|NCT03656666|Analgesics|analgesics|mesh-ancestor
82802735|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
82802736|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802737|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802738|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802739|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802740|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82802741|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82802742|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802743|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802744|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802745|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
82802746|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
82802747|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82802748|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802749|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82802750|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82802751|NCT03656666|Growth Substances|growth substances|mesh-ancestor
82802752|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
82802753|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802754|NCT00430521|Vaccines|vaccines|mesh-list
82802755|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
82802756|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802757|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82802758|NCT01036035|Pilocarpine|pilocarpine|mesh-list
82802759|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82802760|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82802761|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
82802762|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802763|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802764|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802765|NCT01036035|Urological Agents|urological agents|mesh-ancestor
82802766|NCT01036035|Miotics|miotics|mesh-ancestor
82802767|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
82802768|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802769|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82802770|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82802771|NCT01036659|Ecallantide|ecallantide|mesh-list
82802772|NCT01036659|Bradykinin|bradykinin|mesh-list
82802773|NCT01036659|Kallikreins|kallikreins|mesh-list
82802774|NCT01036659|Kininogens|kininogens|mesh-list
82802775|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
82802776|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82802777|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
82802778|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802779|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802780|NCT01036659|Analgesics|analgesics|mesh-ancestor
82802781|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
82802782|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802783|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802784|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82802785|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802786|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802787|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802788|NCT01036659|Coagulants|coagulants|mesh-ancestor
82802789|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
82802790|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
82802791|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82802792|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
82802793|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82802794|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
82802795|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802796|NCT01033149|Expectorants|expectorants|mesh-ancestor
82802797|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
82802798|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82802799|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
82802800|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802801|NCT01033149|Protective Agents|protective agents|mesh-ancestor
82802802|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802803|NCT01033149|Antidotes|antidotes|mesh-ancestor
82802804|NCT00440271|Ritonavir|ritonavir|mesh-list
82802805|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
82802806|NCT00440271|Maraviroc|maraviroc|mesh-list
82802807|NCT00440271|Tipranavir|tipranavir|mesh-list
82802808|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
82802809|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82802810|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82802811|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82802812|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
82802813|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802814|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802815|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82802816|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82802817|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
82802818|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802819|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82802820|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82802821|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82802822|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82802823|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82802824|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82802825|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82802826|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82802827|NCT00346216|Ibuprofen|ibuprofen|mesh-list
82802828|NCT00346216|Celecoxib|celecoxib|mesh-list
82802829|NCT00346216|Naproxen|naproxen|mesh-list
82802830|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82802831|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82802832|NCT00346216|Analgesics|analgesics|mesh-ancestor
82802833|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
82802834|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802835|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802836|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802837|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802838|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82802839|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802840|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802841|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82802842|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
82802843|NCT01051648|Triamcinolone|triamcinolone|mesh-list
82802844|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82802845|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82802846|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82802847|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802848|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
82802849|NCT01051648|Hormones|hormones|mesh-ancestor
82802850|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802851|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802852|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82802853|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
82802854|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802855|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802856|NCT00429273|Guanfacine|guanfacine|mesh-list
82802857|NCT00429273|Methylphenidate|methylphenidate|mesh-list
82802858|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
82802859|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82802860|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802861|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82802862|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82802863|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82802864|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802865|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
82802866|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802867|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82802868|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82802869|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82802870|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82802871|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
82802872|NCT00359632|Linezolid|linezolid|mesh-list
82802873|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82802874|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802875|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82802876|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802877|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802878|NCT01324960|Aldesleukin|aldesleukin|mesh-list
82802879|NCT01324960|Azacitidine|azacitidine|mesh-list
82802880|NCT01324960|Histamine|histamine|mesh-list
82802881|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82802882|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
82802883|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802884|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802885|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802886|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802887|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82802888|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82802889|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
82802890|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802891|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
82802892|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
82802893|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802894|NCT00417885|Sunitinib|sunitinib|mesh-list
82802895|NCT00417885|Exemestane|exemestane|mesh-list
82802896|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802897|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82802898|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82802899|NCT00417885|Growth Substances|growth substances|mesh-ancestor
82802900|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802901|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
82802902|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82802903|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802904|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802905|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82802906|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82802907|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82802908|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
82802909|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82802910|NCT01036893|Prucalopride|prucalopride|mesh-list
82802911|NCT01036893|Laxatives|laxatives|mesh-ancestor
82802912|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82802913|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82802914|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82802915|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
82802916|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802917|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802918|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802919|NCT00525044|Ambroxol|ambroxol|mesh-list
82802920|NCT00525044|Expectorants|expectorants|mesh-ancestor
82802921|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
82802922|NCT00355342|Fluticasone|fluticasone|mesh-list
82802923|NCT00355342|Xhance|xhance|mesh-list
82802924|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82802925|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82802926|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82802927|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
82802928|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82802929|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802930|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82802931|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
82802932|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
82802933|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82802934|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82802935|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82802936|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82802937|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
82802938|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82802939|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802940|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82802941|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
82802942|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82802943|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
82802944|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
82802945|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82802946|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82802947|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802948|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802949|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802950|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802951|NCT03989830|Endostatins|endostatins|mesh-list
82802952|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82802953|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82802954|NCT03989830|Growth Substances|growth substances|mesh-ancestor
82802955|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802956|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
82802957|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802958|NCT02533648|Allopurinol|allopurinol|mesh-list
82802959|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
82802960|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802961|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802962|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
82802963|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82802964|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82802965|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
82802966|NCT02533648|Protective Agents|protective agents|mesh-ancestor
82802967|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802968|NCT02533492|Triclosan|triclosan|mesh-list
82802969|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82802970|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802971|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82802972|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82802973|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
82802974|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802975|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82802976|NCT01056874|Maraviroc|maraviroc|mesh-list
82802977|NCT01056874|Digoxin|digoxin|mesh-list
82802978|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82802979|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82802980|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82802981|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82802982|NCT01056874|Protective Agents|protective agents|mesh-ancestor
82802983|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802984|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82802985|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82802986|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82802987|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82802988|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
82802989|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82802990|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82802991|NCT00355030|Leuprolide|leuprolide|mesh-list
82802992|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82802993|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
82802994|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82802995|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82802996|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82802997|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82802998|NCT01057030|BMS 708163|bms 708163|mesh-list
82802999|NCT01057030|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82803000|NCT01057030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803001|NCT01057030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803002|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
82803003|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82803004|NCT01057186|Sevelamer|sevelamer|mesh-list
82803005|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
82803006|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
82803007|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803008|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82803009|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803010|NCT01057186|Vitamins|vitamins|mesh-ancestor
82803011|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
82803012|NCT01057264|Paclitaxel|paclitaxel|mesh-list
82803013|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82803014|NCT01057264|Bevacizumab|bevacizumab|mesh-list
82803015|NCT01057264|Gemcitabine|gemcitabine|mesh-list
82803016|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803017|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803018|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803019|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803020|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803021|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803022|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82803023|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82803024|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82803025|NCT01057264|Growth Substances|growth substances|mesh-ancestor
82803026|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803027|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
82803028|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803029|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
82803030|NCT03991312|Itraconazole|itraconazole|mesh-list
82803031|NCT03991312|Rifampin|rifampin|mesh-list
82803032|NCT03991312|Mitapivat|mitapivat|mesh-list
82803033|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
82803034|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803035|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82803036|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82803037|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803038|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803039|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82803040|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
82803041|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803042|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803043|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82803044|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82803045|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
82803046|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82803047|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
82803048|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82803049|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82803050|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82803051|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82803052|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82803053|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82803054|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82803055|NCT03991312|Enzyme Activators|enzyme activators|mesh-ancestor
82803056|NCT01057342|Paclitaxel|paclitaxel|mesh-list
82803057|NCT01057342|Carboplatin|carboplatin|mesh-list
82803058|NCT01057342|Vadimezan|vadimezan|mesh-list
82803059|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803060|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803061|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803062|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803063|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803064|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803066|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82803067|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82803068|NCT01057498|Analgesics|analgesics|mesh-ancestor
82803069|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
82803070|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803071|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803072|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803073|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803074|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82803075|NCT03742258|Prednisone|prednisone|mesh-list
82803076|NCT03742258|Cortisone|cortisone|mesh-list
82803077|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
82803078|NCT03742258|Rituximab|rituximab|mesh-list
82803079|NCT03742258|Doxorubicin|doxorubicin|mesh-list
82803080|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82803081|NCT03742258|Vincristine|vincristine|mesh-list
82803082|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82803083|NCT03742258|Antibodies|antibodies|mesh-list
82803084|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
82803085|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82803086|NCT03742258|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82803087|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803088|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
82803089|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803090|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803091|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82803092|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
82803093|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803094|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803095|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82803096|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82803097|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82803098|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82803099|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803100|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803101|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
82803102|NCT03742258|Hormones|hormones|mesh-ancestor
82803103|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803104|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803105|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803106|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803107|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803108|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803109|NCT03742258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82803110|NCT00354172|Cyclosporine|cyclosporine|mesh-list
82803111|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
82803112|NCT00354172|Aldesleukin|aldesleukin|mesh-list
82803113|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
82803114|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82803115|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82803116|NCT00354172|Prednisolone|prednisolone|mesh-list
82803117|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
82803118|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
82803119|NCT00354172|Fludarabine|fludarabine|mesh-list
82803120|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
82803121|NCT00354172|Interleukin-2|interleukin-2|mesh-list
82803122|NCT00354172|Cyclosporins|cyclosporins|mesh-list
82803123|NCT00354172|Lenograstim|lenograstim|mesh-list
82803124|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82803125|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
82803126|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803127|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
82803128|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803129|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803130|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82803131|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
82803132|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803133|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803134|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82803135|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803136|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
82803137|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82803138|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803139|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
82803140|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803141|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
82803143|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82803144|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82803145|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
82803146|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82803147|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803148|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
82803149|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
82803150|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803151|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803152|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
82803153|NCT00354172|Hormones|hormones|mesh-ancestor
82803154|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803155|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82803156|NCT00354172|Protective Agents|protective agents|mesh-ancestor
82803157|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803158|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82803159|NCT00354172|Analgesics|analgesics|mesh-ancestor
82803160|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
82803161|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82803162|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82803163|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
82803164|NCT00353704|Pregabalin|pregabalin|mesh-list
82803165|NCT00353704|Morphine|morphine|mesh-list
82803167|NCT00353704|Narcotics|narcotics|mesh-ancestor
82803168|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82803169|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803170|NCT00353704|Analgesics|analgesics|mesh-ancestor
82803171|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
82803172|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803173|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
82803174|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82803175|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82803176|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803177|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82803178|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82803179|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82803180|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82803181|NCT03742180|Ketorolac|ketorolac|mesh-list
82803182|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
82803183|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82803184|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82803185|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803186|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82803187|NCT03742180|Analgesics|analgesics|mesh-ancestor
82803188|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
82803189|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803190|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82803191|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82803192|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82803193|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
82803194|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803195|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803196|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82803197|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803198|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803199|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82803200|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803201|NCT00512252|Cytarabine|cytarabine|mesh-list
82803202|NCT00512252|Plerixafor|plerixafor|mesh-list
82803203|NCT00512252|Etoposide|etoposide|mesh-list
82803204|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
82803205|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803206|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803207|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82803208|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82803209|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803210|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803211|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803212|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
82803213|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
82803214|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803215|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803216|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
82803217|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803218|NCT00512252|Analgesics|analgesics|mesh-ancestor
82803219|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
82803220|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803221|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82803222|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82803223|NCT00516386|Mecasermin|mecasermin|mesh-list
82803224|NCT00516386|Growth Substances|growth substances|mesh-ancestor
82803225|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803226|NCT00512096|Paclitaxel|paclitaxel|mesh-list
82803227|NCT00512096|Cisplatin|cisplatin|mesh-list
82803228|NCT00512096|Ifosfamide|ifosfamide|mesh-list
82803229|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803230|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803231|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803232|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803233|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803234|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803235|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82803236|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
82803237|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
82803238|NCT04462796|Cathartics|cathartics|mesh-ancestor
82803239|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803240|NCT00524030|Pregabalin|pregabalin|mesh-list
82803242|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
82803243|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803244|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803245|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
82803246|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82803247|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82803248|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803249|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82803250|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82803251|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82803252|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82803253|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82803254|NCT00523718|Riluzole|riluzole|mesh-list
82803255|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
82803256|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82803257|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82803258|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803259|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803260|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803261|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82803262|NCT00523718|Protective Agents|protective agents|mesh-ancestor
82803263|NCT00523640|Bevacizumab|bevacizumab|mesh-list
82803264|NCT00523640|Gemcitabine|gemcitabine|mesh-list
82803265|NCT00523640|Capecitabine|capecitabine|mesh-list
82803266|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82803267|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803268|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82803269|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82803270|NCT00523640|Growth Substances|growth substances|mesh-ancestor
82803271|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803272|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
82803273|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803274|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
82803275|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803276|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82803277|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
82803278|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803279|NCT00516074|Exenatide|exenatide|mesh-list
82803280|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82803281|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803282|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82803283|NCT00516074|Incretins|incretins|mesh-ancestor
82803284|NCT00516074|Hormones|hormones|mesh-ancestor
82803285|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803286|NCT01057654|Pravastatin|pravastatin|mesh-list
82803287|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82803288|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82803289|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
82803290|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803291|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82803292|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82803293|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803294|NCT00515294|Caffeine|caffeine|mesh-list
82803295|NCT00515294|Methamphetamine|methamphetamine|mesh-list
82803296|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82803297|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803298|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82803299|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803300|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803301|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82803302|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82803303|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
82803304|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803305|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
82803306|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
82803307|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803308|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
82803309|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
82803310|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82803311|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82803312|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82803313|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82803314|NCT00345046|Prednisolone|prednisolone|mesh-list
82803315|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82803316|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
82803317|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82803318|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
82803319|NCT00345046|Prednisone|prednisone|mesh-list
82803320|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82803321|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
82803322|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803323|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
82803324|NCT00345046|Hormones|hormones|mesh-ancestor
82803325|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803326|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803327|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803328|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803329|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
82803330|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
82803331|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803332|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803333|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82803334|NCT00345046|Protective Agents|protective agents|mesh-ancestor
82803335|NCT00515216|Leucovorin|leucovorin|mesh-list
82803336|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
82803337|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
82803338|NCT00515216|Fluorouracil|fluorouracil|mesh-list
82803339|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
82803340|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
82803341|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
82803342|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803343|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803344|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803345|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803346|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
82803347|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803348|NCT00515216|Antidotes|antidotes|mesh-ancestor
82803349|NCT00515216|Protective Agents|protective agents|mesh-ancestor
82803350|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
82803351|NCT00515216|Vitamins|vitamins|mesh-ancestor
82803352|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
82803353|NCT01004978|Cisplatin|cisplatin|mesh-list
82803354|NCT01004978|Doxorubicin|doxorubicin|mesh-list
82803355|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82803356|NCT01004978|Sorafenib|sorafenib|mesh-list
82803357|NCT01004978|Mitomycins|mitomycins|mesh-list
82803358|NCT01004978|Mitomycin|mitomycin|mesh-list
82803359|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803360|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82803361|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82803362|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82803363|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803364|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803365|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82803366|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
82803367|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82803368|NCT00440193|Enoxaparin|enoxaparin|mesh-list
82803369|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
82803370|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82803371|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
82803372|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82803373|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
82803374|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803375|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803376|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
82803377|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82803378|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82803379|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
82803380|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82803381|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803382|NCT01033305|Cyclosporine|cyclosporine|mesh-list
82803383|NCT01033305|Cyclosporins|cyclosporins|mesh-list
82803384|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803385|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803386|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803387|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
82803388|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803389|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
82803390|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803391|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
82803392|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803393|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82803394|NCT00514904|Vaccines|vaccines|mesh-list
82803395|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
82803396|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803397|NCT00440115|Bupropion|bupropion|mesh-list
82803398|NCT00440115|Nicotine|nicotine|mesh-list
82803399|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82803400|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
82803401|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803402|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803403|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82803404|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82803405|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
82803406|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803407|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803408|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82803409|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
82803410|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82803411|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82803412|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82803413|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82803414|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
82803415|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82803416|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82803417|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803418|NCT01033461|Calcium|calcium|mesh-list
82803419|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82803420|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803421|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
82803422|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82803423|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82803424|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803425|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
82803426|NCT00416715|Vitamin D|vitamin d|mesh-list
82803427|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
82803428|NCT00416715|Letrozole|letrozole|mesh-list
82803429|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
82803430|NCT00416715|Citric Acid|citric acid|mesh-list
82803431|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
82803432|NCT00416715|Calcium|calcium|mesh-list
82803433|NCT00416715|Vitamins|vitamins|mesh-ancestor
82803434|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
82803435|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803436|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82803437|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82803438|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
82803439|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82803440|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
82803441|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
82803442|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803443|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803444|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82803445|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82803446|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803447|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82803448|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
83441747|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82803449|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803450|NCT00416715|Antacids|antacids|mesh-ancestor
82803451|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803452|NCT01037517|Plerixafor|plerixafor|mesh-list
82803453|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82803454|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82803455|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
82803456|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803457|NCT00406029|Levodopa|levodopa|mesh-list
82803458|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82803459|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82803460|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
82803461|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803462|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803463|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803464|NCT00514514|Cyclosporine|cyclosporine|mesh-list
82803465|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
82803466|NCT00514514|Everolimus|everolimus|mesh-list
82803467|NCT00514514|Cyclosporins|cyclosporins|mesh-list
82803468|NCT00514514|Basiliximab|basiliximab|mesh-list
82803469|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803470|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803471|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803472|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
82803473|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803474|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
82803475|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803476|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
82803477|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803478|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82803479|NCT00514514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82803480|NCT00514514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82803481|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803482|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82803483|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82803484|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
82803485|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82803486|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82803487|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
82803488|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803489|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
82803490|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82803491|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
82803492|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82803493|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
82803494|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803495|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803496|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
82803497|NCT00521586|Vaccines|vaccines|mesh-list
82803498|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82803499|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
82803500|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803501|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
82803502|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82803503|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
82803504|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803505|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803506|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82803507|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
82803508|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
82803509|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82803510|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
82803511|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803512|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803513|NCT03336216|Leucovorin|leucovorin|mesh-list
82803514|NCT03336216|Paclitaxel|paclitaxel|mesh-list
82803515|NCT03336216|Gemcitabine|gemcitabine|mesh-list
82803516|NCT03336216|Fluorouracil|fluorouracil|mesh-list
82803517|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
82803518|NCT03336216|Nivolumab|nivolumab|mesh-list
82803519|NCT03336216|Irinotecan|irinotecan|mesh-list
82803520|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803521|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803522|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803523|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803524|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803525|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803526|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803527|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
82803528|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803529|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
82803530|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803531|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82803532|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82803533|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82803534|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82803535|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803536|NCT03336216|Antidotes|antidotes|mesh-ancestor
82803537|NCT03336216|Protective Agents|protective agents|mesh-ancestor
82803538|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
82803539|NCT03336216|Vitamins|vitamins|mesh-ancestor
82803540|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
82803541|NCT01010646|Ribavirin|ribavirin|mesh-list
82803542|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
82803543|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
82803544|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82803545|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
82803546|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803547|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
82803548|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803549|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
82803550|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803551|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803552|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
82803553|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82803554|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803555|NCT00515112|Testosterone|testosterone|mesh-list
82803556|NCT00515112|Androgens|androgens|mesh-ancestor
82803557|NCT00515112|Hormones|hormones|mesh-ancestor
82803558|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803559|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803560|NCT03742557|Ketamine|ketamine|mesh-list
82803561|NCT03742557|Analgesics|analgesics|mesh-ancestor
82803562|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
82803563|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803564|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803565|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82803566|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82803567|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
82803568|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
82803569|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82803570|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82803571|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82803572|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803573|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803574|NCT01324089|Resveratrol|resveratrol|mesh-list
82803575|NCT01324089|Piperine|piperine|mesh-list
82803576|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
82803577|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803578|NCT01324089|Protective Agents|protective agents|mesh-ancestor
82803579|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803580|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803581|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82803582|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82803583|NCT00404547|Ciclesonide|ciclesonide|mesh-list
82803584|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
82803585|NCT00404547|Hormones|hormones|mesh-ancestor
82803586|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803587|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803588|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82803589|NCT00515034|Imipenem|imipenem|mesh-list
82803590|NCT00515034|Doripenem|doripenem|mesh-list
82803591|NCT00515034|Cilastatin|cilastatin|mesh-list
82803592|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82803593|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803594|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
82803595|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803596|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803597|NCT00404235|Paclitaxel|paclitaxel|mesh-list
82803598|NCT00404235|Carboplatin|carboplatin|mesh-list
82803599|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82803600|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803601|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803602|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803603|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803604|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803605|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803606|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82803608|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82803609|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803610|NCT00509262|Incretins|incretins|mesh-ancestor
82803611|NCT00509262|Hormones|hormones|mesh-ancestor
82803612|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803613|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82803614|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
82803615|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803616|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803617|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
82803618|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82803619|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82803620|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803621|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82803622|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82803623|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82803624|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82803625|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803626|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
82803627|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803628|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803629|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82803630|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803631|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
82803633|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803634|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803635|NCT00509028|Budesonide|budesonide|mesh-list
82803636|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803637|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82803638|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
82803639|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803640|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803641|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82803642|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
82803643|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
82803644|NCT00509028|Hormones|hormones|mesh-ancestor
82803645|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803646|NCT00352846|Vitamin D|vitamin d|mesh-list
82803647|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
82803648|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
82803649|NCT00352846|Calcium|calcium|mesh-list
82803650|NCT00352846|Vitamins|vitamins|mesh-ancestor
82803651|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
82803652|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803653|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82803654|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82803655|NCT00352846|Antacids|antacids|mesh-ancestor
82803656|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803657|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803658|NCT00508872|Leucovorin|leucovorin|mesh-list
82803659|NCT00508872|Bevacizumab|bevacizumab|mesh-list
82803660|NCT00508872|Fluorouracil|fluorouracil|mesh-list
82803661|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
82803662|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82803663|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803664|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82803665|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82803666|NCT00508872|Growth Substances|growth substances|mesh-ancestor
82803667|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803668|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
82803669|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
82803670|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803671|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803672|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803673|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
82803675|NCT00508872|Protective Agents|protective agents|mesh-ancestor
82803676|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
82803677|NCT00508872|Vitamins|vitamins|mesh-ancestor
82803678|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
82803679|NCT00508482|Lactulose|lactulose|mesh-list
82803680|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803681|NCT00344032|Vaccines|vaccines|mesh-list
82803682|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
82803683|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803684|NCT00607373|Mipomersen|mipomersen|mesh-list
82803685|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82803686|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82803687|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
82803688|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803689|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82803690|NCT00508404|Panitumumab|panitumumab|mesh-list
82803691|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82803692|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803693|NCT00352690|Paclitaxel|paclitaxel|mesh-list
82803694|NCT00352690|Carboplatin|carboplatin|mesh-list
82803695|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
82803696|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803697|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803698|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803699|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803700|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803701|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803702|NCT00895505|Warfarin|warfarin|mesh-list
82803703|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
82803704|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
82803705|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
82803706|NCT03502577|Fludarabine|fludarabine|mesh-list
82803707|NCT03502577|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82803708|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803709|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
82803710|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803711|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803712|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82803713|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
82803714|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803715|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803716|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82803717|NCT03502577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803718|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
82803719|NCT03249012|Calcitriol|calcitriol|mesh-list
82803720|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
82803721|NCT03249012|Calcium|calcium|mesh-list
82803722|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82803723|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803724|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82803725|NCT03249012|Antacids|antacids|mesh-ancestor
82803726|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803727|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803728|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82803729|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82803730|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82803731|NCT03249012|Vitamins|vitamins|mesh-ancestor
82803732|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
82803733|NCT03477539|Lenalidomide|lenalidomide|mesh-list
82803734|NCT03477539|Daratumumab|daratumumab|mesh-list
82803735|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
82803736|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803737|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82803738|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82803739|NCT03477539|Growth Substances|growth substances|mesh-ancestor
82803740|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
82803741|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803742|NCT00893477|Rituximab|rituximab|mesh-list
82803743|NCT00893477|Sargramostim|sargramostim|mesh-list
82803744|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82803745|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803746|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
82803747|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803748|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803749|NCT00609245|Valproic Acid|valproic acid|mesh-list
82803750|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
82803751|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803752|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803753|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
82803754|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803755|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803756|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
82803757|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82803758|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82803759|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82803760|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
82803761|NCT01010802|Hematinics|hematinics|mesh-ancestor
82803762|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
82803763|NCT04036253|Hematinics|hematinics|mesh-ancestor
82803764|NCT00893555|Voriconazole|voriconazole|mesh-list
82803765|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
82803766|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803767|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82803768|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82803769|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803770|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803771|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82803772|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
83482528|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82803773|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803774|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803775|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82803776|NCT02541071|Clonidine|clonidine|mesh-list
82803777|NCT02541071|Yohimbine|yohimbine|mesh-list
82803778|NCT02541071|Analgesics|analgesics|mesh-ancestor
82803779|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
82803780|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803781|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803782|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82803783|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
82803784|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
82803785|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82803786|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82803787|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82803788|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
82803789|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803790|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803791|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
82803792|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82803793|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82803794|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82803795|NCT02541071|Urological Agents|urological agents|mesh-ancestor
82803796|NCT01058824|Lincomycin|lincomycin|mesh-list
82803797|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82803798|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803799|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82803800|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803801|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803802|NCT00895739|Cyclosporine|cyclosporine|mesh-list
82803803|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
82803804|NCT00895739|Cyclosporins|cyclosporins|mesh-list
82803805|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803806|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803807|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803808|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
82803809|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803810|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
82803811|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82803812|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
82803813|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803814|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82803815|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82803816|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803817|NCT01058902|Aspirin|aspirin|mesh-list
82803818|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82803819|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82803820|NCT01058902|Analgesics|analgesics|mesh-ancestor
82803821|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
82803822|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803823|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803824|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803825|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803826|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82803827|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82803828|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803829|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82803830|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82803831|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803832|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
82803833|NCT00609167|Dexamethasone|dexamethasone|mesh-list
82803834|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
82803835|NCT00609167|Bortezomib|bortezomib|mesh-list
82803836|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803837|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
82803838|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803839|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803840|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82803841|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
82803842|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803843|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803844|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82803845|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803847|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
82803848|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803849|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803850|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
82803851|NCT00609167|Hormones|hormones|mesh-ancestor
82803852|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803853|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803854|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
82803855|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
82803856|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
82803857|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82803858|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
82803859|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
82803860|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803861|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803862|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803863|NCT00606281|Aripiprazole|aripiprazole|mesh-list
82803864|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
82803865|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82803866|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82803867|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82803868|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82803869|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803870|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
82803871|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
82803872|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803873|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803874|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82803875|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82803876|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
82803877|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82803878|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82803879|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82803880|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82803881|NCT00506142|Vincristine|vincristine|mesh-list
82803882|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803883|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803884|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803885|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803886|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803887|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803888|NCT00891605|Paclitaxel|paclitaxel|mesh-list
82803889|NCT00891605|Navitoclax|navitoclax|mesh-list
82803890|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82803891|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803892|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
82803893|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
82803894|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
82803895|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803896|NCT00893711|Vitamin D|vitamin d|mesh-list
82803897|NCT00893711|Vitamins|vitamins|mesh-ancestor
82803898|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
82803899|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803900|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82803901|NCT00514020|Leucovorin|leucovorin|mesh-list
82803903|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
82803904|NCT00514020|Calcium|calcium|mesh-list
82803905|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
82803906|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82803907|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803908|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
82803909|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803910|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82803911|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803912|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803913|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
82803914|NCT00514020|Antidotes|antidotes|mesh-ancestor
82803915|NCT00514020|Protective Agents|protective agents|mesh-ancestor
82803916|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
82803917|NCT00514020|Vitamins|vitamins|mesh-ancestor
82803918|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
82803919|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
82803920|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
82803921|NCT03570827|Androgens|androgens|mesh-list
82803922|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82803923|NCT03570827|Hormones|hormones|mesh-ancestor
82803924|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803925|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803926|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
82803927|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803928|NCT03570827|Protective Agents|protective agents|mesh-ancestor
82803929|NCT03570827|Vitamins|vitamins|mesh-ancestor
82803930|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
82803931|NCT03570827|Estrogens|estrogens|mesh-ancestor
82803932|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803933|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803934|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
82803935|NCT03560531|Palbociclib|palbociclib|mesh-list
82803936|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803937|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82803938|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803939|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803940|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82803941|NCT00896285|Analgesics|analgesics|mesh-list
82803942|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
82803943|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
82803944|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803945|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803946|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82803947|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803948|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82803949|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82803950|NCT00896285|Narcotics|narcotics|mesh-ancestor
82803951|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82803952|NCT00891761|Dexamethasone|dexamethasone|mesh-list
82803953|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
82803954|NCT00891761|Ondansetron|ondansetron|mesh-list
82803955|NCT00891761|Casopitant|casopitant|mesh-list
82803956|NCT00891761|BB 1101|bb 1101|mesh-list
82803957|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82803958|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
82803959|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
82803960|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82803961|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803962|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82803963|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
82803964|NCT00891761|Hormones|hormones|mesh-ancestor
82803965|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82803966|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82803967|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82803968|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
82803969|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803970|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803971|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
82803972|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
82803973|NCT00891761|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82803974|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82803975|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
82803976|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803977|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82803978|NCT01012830|Huperzine A|huperzine a|mesh-list
82803979|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82803980|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82803981|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82803982|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
82803983|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82803984|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82803985|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82803986|NCT01012830|Protective Agents|protective agents|mesh-ancestor
82803987|NCT00513474|Cyclosporine|cyclosporine|mesh-list
82803988|NCT00513474|Sirolimus|sirolimus|mesh-list
82803989|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
82803990|NCT00513474|Busulfan|busulfan|mesh-list
82803991|NCT00513474|Methotrexate|methotrexate|mesh-list
82803992|NCT00513474|Fludarabine|fludarabine|mesh-list
82803993|NCT00513474|Etoposide|etoposide|mesh-list
82803994|NCT00513474|Allopurinol|allopurinol|mesh-list
82803995|NCT00513474|Rasburicase|rasburicase|mesh-list
82803996|NCT00513474|Tacrolimus|tacrolimus|mesh-list
82803997|NCT00513474|Cyclosporins|cyclosporins|mesh-list
82803998|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82803999|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
82804000|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804002|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82804003|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
82804004|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804005|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804006|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82804007|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82804008|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
82804009|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82804010|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82804011|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
82804012|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
82804013|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804014|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82804015|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82804016|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82804017|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82804018|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82804019|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82804020|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
82804021|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804022|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82804023|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82804024|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
82804025|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82804026|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
82804027|NCT00513474|Protective Agents|protective agents|mesh-ancestor
82804028|NCT01010958|Valproic Acid|valproic acid|mesh-list
82804029|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
82804030|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804031|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804032|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
82804033|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804034|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804035|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
82804036|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82804037|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804038|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804039|NCT00896519|Prednisone|prednisone|mesh-list
82804040|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
82804041|NCT00896519|Rituximab|rituximab|mesh-list
82804042|NCT00896519|Doxorubicin|doxorubicin|mesh-list
82804043|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82804044|NCT00896519|Vincristine|vincristine|mesh-list
82804045|NCT00896519|Sargramostim|sargramostim|mesh-list
82804046|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82804047|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
82804048|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804049|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804050|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82804051|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
82804052|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804053|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804054|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82804055|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804056|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82804057|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82804058|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82804059|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804060|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804061|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
82804062|NCT00896519|Hormones|hormones|mesh-ancestor
82804063|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804064|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82804065|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82804066|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
82804067|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
82804068|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
82804069|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82804070|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82804071|NCT00505752|Hormones|hormones|mesh-ancestor
82804072|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83482529|NCT00538616|Analgesics|analgesics|mesh-ancestor
82804073|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804074|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82804075|NCT01011036|Clonazepam|clonazepam|mesh-list
82804076|NCT01011036|Clobazam|clobazam|mesh-list
82804077|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82804078|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82804079|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82804080|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
82804081|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804082|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804083|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804084|NCT01011036|Urological Agents|urological agents|mesh-ancestor
82804085|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
82804086|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
82804087|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
82804088|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82804089|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82804090|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804091|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804092|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82804093|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
82804094|NCT03601637|Ivacaftor|ivacaftor|mesh-list
82804095|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82804096|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804097|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804098|NCT00894023|Abciximab|abciximab|mesh-list
82804099|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
82804100|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82804101|NCT00892073|Metformin|metformin|mesh-list
82804102|NCT00892073|Diazoxide|diazoxide|mesh-list
82804103|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82804104|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804105|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82804106|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804107|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
82804108|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
82804109|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82804110|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804111|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804112|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804113|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
82804114|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82804115|NCT02541227|Protective Agents|protective agents|mesh-ancestor
82804116|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804117|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
82804118|NCT00896987|Lamotrigine|lamotrigine|mesh-list
82804119|NCT00896987|Carbamazepine|carbamazepine|mesh-list
82804120|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
82804121|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82804122|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804123|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804124|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82804125|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804126|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82804127|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82804128|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804129|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804130|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82804131|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
82804132|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804133|NCT00896987|Analgesics|analgesics|mesh-ancestor
82804134|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
82804135|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804136|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82804137|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82804138|NCT00897065|Antibodies|antibodies|mesh-list
82804139|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
82804140|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804141|NCT00343252|Teriparatide|teriparatide|mesh-list
82804142|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
82804143|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
82804144|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82804145|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804146|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82804147|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82804148|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804149|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804150|NCT00892229|Misoprostol|misoprostol|mesh-list
82804151|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82804152|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
82804153|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82804154|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804155|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82804156|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82804157|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
82804158|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82804159|NCT00897221|Deferiprone|deferiprone|mesh-list
82804160|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82804161|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
82804162|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
82804163|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804165|NCT00892307|Analgesics|analgesics|mesh-ancestor
82804166|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
82804167|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804168|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804169|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804170|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804171|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82804172|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
82804173|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
82804174|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804175|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804176|NCT00342628|Vaccines|vaccines|mesh-list
82804177|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
82804178|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804179|NCT00897377|Temozolomide|temozolomide|mesh-list
82804180|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82804181|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
82804182|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804183|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804184|NCT00894569|Paclitaxel|paclitaxel|mesh-list
82804185|NCT00894569|Carboplatin|carboplatin|mesh-list
82804186|NCT00894569|Cetuximab|cetuximab|mesh-list
82804187|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82804188|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804189|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
82804190|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
82804191|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
82804192|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804193|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804194|NCT00337168|Cytarabine|cytarabine|mesh-list
82804195|NCT00337168|Clofarabine|clofarabine|mesh-list
82804196|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82804197|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
82804198|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804199|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804200|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
82804201|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804202|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82804203|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
82804204|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804205|NCT00892385|Temozolomide|temozolomide|mesh-list
82804206|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82804207|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
82804208|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804209|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804210|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82804211|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
82804212|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804213|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82804214|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82804215|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804216|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804217|NCT01011114|Cinacalcet|cinacalcet|mesh-list
82804218|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82804219|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804220|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82804221|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
82804222|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804224|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
82804225|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82804226|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82804227|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
82804228|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804229|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
82804230|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
82804231|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804232|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804233|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804234|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
82804235|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82804236|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804237|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804238|NCT03063762|Bevacizumab|bevacizumab|mesh-list
82804239|NCT03063762|Atezolizumab|atezolizumab|mesh-list
82804240|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804241|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804242|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82804243|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82804244|NCT03063762|Growth Substances|growth substances|mesh-ancestor
82804245|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804246|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
82804247|NCT03063762|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82804248|NCT03063762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804249|NCT05278637|Aspirin|aspirin|mesh-list
82804250|NCT05278637|Ticagrelor|ticagrelor|mesh-list
82804251|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82804252|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804253|NCT05278637|Analgesics|analgesics|mesh-ancestor
82804254|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
82804255|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804256|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804257|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804258|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804259|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82804260|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82804261|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804262|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82804263|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82804264|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804265|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
82804266|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82804267|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82804268|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82804269|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
82804270|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804271|NCT04017377|Paclitaxel|paclitaxel|mesh-list
82804272|NCT04017377|Cisplatin|cisplatin|mesh-list
82804273|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82804274|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804275|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
82804276|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
82804277|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
83361976|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82804278|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804279|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82804280|NCT04035707|Rocuronium|rocuronium|mesh-list
82804281|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804282|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82804283|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82804284|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82804285|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804286|NCT02539745|Vitamin D|vitamin d|mesh-list
82804287|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
82804288|NCT02539745|Vitamins|vitamins|mesh-ancestor
82804289|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
82804290|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804291|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82804292|NCT00894959|Heparin|heparin|mesh-list
82804293|NCT00894959|Calcium heparin|calcium heparin|mesh-list
82804294|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
82804295|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82804296|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82804297|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804298|NCT00895115|Vitamin E|vitamin e|mesh-list
82804299|NCT00895115|Vitamins|vitamins|mesh-ancestor
82804300|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
82804301|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804302|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
82804303|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804304|NCT00895115|Protective Agents|protective agents|mesh-ancestor
82804305|NCT00901745|Norepinephrine|norepinephrine|mesh-list
82804306|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
82804307|NCT00901745|Giapreza|giapreza|mesh-list
82804308|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
82804309|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82804310|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82804311|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
82804312|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804313|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804314|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804315|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
82804316|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
82804317|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804318|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82804319|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82804320|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
82804321|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804322|NCT02540837|Bupivacaine|bupivacaine|mesh-list
82804323|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
82804324|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
82804325|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804326|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804327|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
82804328|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804329|NCT00901823|Diazoxide|diazoxide|mesh-list
82804330|NCT00901823|Choline|choline|mesh-list
82804331|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
82804332|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82804333|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
82804334|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804335|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82804336|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82804337|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
82804338|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82804339|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804340|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82804341|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
82804342|NCT00902057|Coagulants|coagulants|mesh-ancestor
82804343|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82804344|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
82804345|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804346|NCT00902135|Interferons|interferons|mesh-list
82804347|NCT00902135|Interferon-beta|interferon-beta|mesh-list
82804348|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
82804349|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804350|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
82804351|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804352|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
82804353|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804354|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82804355|NCT02540369|Aflibercept|aflibercept|mesh-list
83361977|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361978|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
83361979|NCT02664220|Povidone|povidone|mesh-list
83361980|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
83361981|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
83361982|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82804356|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82804357|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82804358|NCT02540369|Growth Substances|growth substances|mesh-ancestor
82804359|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804360|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
82804361|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804362|NCT00605267|Tamoxifen|tamoxifen|mesh-list
82804363|NCT00605267|Goserelin|goserelin|mesh-list
82804364|NCT00605267|Anastrozole|anastrozole|mesh-list
82804365|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82804366|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
83476462|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82804367|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804368|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361983|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361984|NCT04339348|Lidocaine|lidocaine|mesh-list
83361985|NCT04339348|Prilocaine|prilocaine|mesh-list
83361986|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83361987|NCT04339348|Misoprostol|misoprostol|mesh-list
83361988|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
83361989|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
83361990|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361991|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361992|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
82804369|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82804370|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804371|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82804372|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82804373|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82804374|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82804375|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82804376|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804377|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804378|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82804379|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
82804380|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804381|NCT00902603|Iloprost|iloprost|mesh-list
82804382|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82804383|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804384|NCT00902681|Fesoterodine|fesoterodine|mesh-list
82804385|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82804386|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82804387|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
82804388|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804389|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804390|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804391|NCT00902681|Urological Agents|urological agents|mesh-ancestor
82804392|NCT00906113|Melphalan|melphalan|mesh-list
82804393|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82804394|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
82804395|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804396|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804397|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82804398|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82804399|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
82804400|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804401|NCT00902837|Oxycodone|oxycodone|mesh-list
82804402|NCT00902837|Naloxone|naloxone|mesh-list
82804403|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82804404|NCT00902837|Narcotics|narcotics|mesh-ancestor
82804405|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804406|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804407|NCT00902837|Analgesics|analgesics|mesh-ancestor
82804408|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
82804409|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804410|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82804411|NCT00605813|Sertraline|sertraline|mesh-list
82804412|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
82804413|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804414|NCT00605813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82804415|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82804417|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804418|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804419|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
82804420|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804421|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
82804422|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804423|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82804424|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82804425|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804426|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804427|NCT00906269|Urological Agents|urological agents|mesh-ancestor
82804428|NCT00902915|Dexamethasone|dexamethasone|mesh-list
82804429|NCT00902915|Lenalidomide|lenalidomide|mesh-list
82804430|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804431|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
82804432|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
82804433|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804434|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804435|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82804436|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
82804437|NCT00902915|Hormones|hormones|mesh-ancestor
82804438|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804439|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82804440|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804441|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
82804442|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82804443|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82804444|NCT00902915|Growth Substances|growth substances|mesh-ancestor
82804445|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
82804446|NCT04034771|Propofol|propofol|mesh-list
82804447|NCT04034771|Melatonin|melatonin|mesh-list
82804448|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82804449|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804450|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804451|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82804452|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
82804453|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
82804454|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
82804455|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804456|NCT04034771|Protective Agents|protective agents|mesh-ancestor
82804457|NCT00899483|Insulin|insulin|mesh-list
82804458|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82804459|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804460|NCT02539199|Misoprostol|misoprostol|mesh-list
82804461|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82804462|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
82804463|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82804464|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804465|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82804466|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82804467|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
82804468|NCT00903227|Fluticasone|fluticasone|mesh-list
82804470|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804471|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82804472|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
82804473|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804474|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804475|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82804476|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
82804477|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
82804478|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82804479|NCT00605657|Valproic Acid|valproic acid|mesh-list
82804480|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
82804481|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804482|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804483|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
82804484|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804485|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804486|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
82804487|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82804488|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804489|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804490|NCT00899951|Fentanyl|fentanyl|mesh-list
82804491|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82804492|NCT00899951|Narcotics|narcotics|mesh-ancestor
82804493|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804494|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804495|NCT00899951|Analgesics|analgesics|mesh-ancestor
82804496|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
82804497|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804498|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82804499|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82804500|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
82804501|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
82804502|NCT02539979|Acetaminophen|acetaminophen|mesh-list
82804503|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804504|NCT02539979|Analgesics|analgesics|mesh-ancestor
82804505|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
82804506|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804507|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804508|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
82804509|NCT05277701|Lazertinib|lazertinib|mesh-list
82804510|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82804511|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804512|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804513|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
82804514|NCT00605345|Hematinics|hematinics|mesh-ancestor
82804515|NCT00903851|Lidocaine|lidocaine|mesh-list
82804516|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
82804517|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
82804518|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804519|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804520|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
82804521|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804522|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804523|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82804524|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82804525|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804526|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804527|NCT00900887|Ketorolac|ketorolac|mesh-list
82804528|NCT00900887|Nepafenac|nepafenac|mesh-list
82804529|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82804530|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804531|NCT00900887|Analgesics|analgesics|mesh-ancestor
82804532|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
82804533|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804534|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804535|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804536|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804537|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82804538|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804539|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804540|NCT00904085|Oxymorphone|oxymorphone|mesh-list
82804541|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82804542|NCT00904085|Narcotics|narcotics|mesh-ancestor
82804543|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804544|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804545|NCT00904085|Analgesics|analgesics|mesh-ancestor
82804546|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
82804547|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804548|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82804549|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
82804550|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
82804551|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82804552|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804553|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804554|NCT00908531|Letrozole|letrozole|mesh-list
82804555|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804556|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82804557|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82804558|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804559|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804560|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82804561|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
82804562|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804563|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804564|NCT00904397|Celecoxib|celecoxib|mesh-list
82804565|NCT00904397|Lidocaine|lidocaine|mesh-list
82804566|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
82804567|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
82804568|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804569|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804570|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
82804571|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804572|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804573|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82804574|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82804575|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804576|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804577|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82804578|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804579|NCT00904397|Analgesics|analgesics|mesh-ancestor
82804580|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804581|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804582|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82804583|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82804584|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804585|NCT00904475|Lidocaine|lidocaine|mesh-list
82804586|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
82804587|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
82804588|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804589|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804590|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
82804591|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804592|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804593|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82804594|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82804595|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804596|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804597|NCT00908921|Glimepiride|glimepiride|mesh-list
82804598|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804599|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82804600|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804601|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82804602|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
82804603|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
82804604|NCT00904631|Salicylates|salicylates|mesh-list
82804605|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804606|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
82804607|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
82804608|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
82804609|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82804610|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804611|NCT00904631|Analgesics|analgesics|mesh-ancestor
82804612|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
82804613|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804614|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804615|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804616|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804617|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82804618|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804619|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804620|NCT00909077|Dexamethasone|dexamethasone|mesh-list
82804621|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
82804622|NCT00909077|Rituximab|rituximab|mesh-list
82804623|NCT00909077|BB 1101|bb 1101|mesh-list
82804624|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804625|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804626|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
82804627|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804628|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804629|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804630|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
82804631|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
82804632|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804633|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82804634|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
82804635|NCT00909077|Hormones|hormones|mesh-ancestor
82804636|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804637|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83361993|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804638|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
82804639|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804640|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804641|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
82804642|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82804643|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82804644|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804645|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
82804646|NCT00904709|Coagulants|coagulants|mesh-ancestor
82804647|NCT00340834|Interferons|interferons|mesh-list
82804648|NCT00340834|Interferon-beta|interferon-beta|mesh-list
82804649|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
82804650|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82804651|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804652|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
82804653|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804654|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82804655|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804656|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82804657|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
82804658|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804659|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82804661|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
82804662|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804663|NCT00603941|Paclitaxel|paclitaxel|mesh-list
82804664|NCT00603941|Efatutazone|efatutazone|mesh-list
82804665|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82804666|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804667|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
82804668|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
82804669|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
82804670|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804671|NCT00340678|Losartan|losartan|mesh-list
82804672|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804673|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82804674|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82804675|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82804676|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804677|NCT01055470|Diclofenac|diclofenac|mesh-list
82804678|NCT01055470|Lornoxicam|lornoxicam|mesh-list
82804679|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82804680|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804681|NCT01055470|Analgesics|analgesics|mesh-ancestor
82804682|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
82804683|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804684|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804685|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82804686|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804687|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82804688|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804689|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804690|NCT03986008|Liraglutide|liraglutide|mesh-list
82804691|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82804692|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804693|NCT03986008|Incretins|incretins|mesh-ancestor
82804694|NCT03986008|Hormones|hormones|mesh-ancestor
82804695|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804696|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82804697|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804698|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82804699|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82804700|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804701|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804702|NCT00909233|Urological Agents|urological agents|mesh-ancestor
82804703|NCT00909311|Ritonavir|ritonavir|mesh-list
82804704|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82804705|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82804706|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
82804707|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804708|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804709|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82804710|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82804711|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
82804712|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804713|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82804714|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82804715|NCT00907751|Rituximab|rituximab|mesh-list
82804716|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804717|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804718|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
82804719|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804720|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804721|NCT00905333|Felodipine|felodipine|mesh-list
82804722|NCT00905333|Candesartan|candesartan|mesh-list
82804723|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
82804724|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82804725|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82804726|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82804727|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804728|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804729|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82804730|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804731|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82804732|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804733|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804734|NCT00907829|Lidocaine|lidocaine|mesh-list
82804735|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
82804736|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
82804737|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804738|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804739|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
82804740|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804741|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804742|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82804743|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82804744|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804745|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804746|NCT00336544|Clarithromycin|clarithromycin|mesh-list
82804747|NCT00336544|Cethromycin|cethromycin|mesh-list
82804748|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82804749|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804750|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82804751|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804752|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804753|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82804754|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82804755|NCT01059058|Fluorides|fluorides|mesh-list
82804756|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
82804757|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
82804758|NCT01059058|Protective Agents|protective agents|mesh-ancestor
82804759|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804760|NCT00605033|Buprenorphine|buprenorphine|mesh-list
82804761|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82804762|NCT00605033|Naloxone|naloxone|mesh-list
82804763|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82804764|NCT00605033|Narcotics|narcotics|mesh-ancestor
82804765|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804766|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804767|NCT00605033|Analgesics|analgesics|mesh-ancestor
82804768|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
82804769|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804770|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82804771|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82804772|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82804773|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804774|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804775|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82804776|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
82804777|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804778|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804779|NCT00905723|Estradiol|estradiol|mesh-list
82804780|NCT00905723|Estrogens|estrogens|mesh-ancestor
82804781|NCT00905723|Hormones|hormones|mesh-ancestor
82804782|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804783|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804784|NCT00907985|Lamotrigine|lamotrigine|mesh-list
82804785|NCT00907985|Vofopitant|vofopitant|mesh-list
82804786|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
82804787|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82804788|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804789|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804790|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82804791|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804792|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82804793|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82804794|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804795|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804796|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82804797|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
82804798|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
82804799|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804800|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82804801|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82804802|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804803|NCT01325194|Cytarabine|cytarabine|mesh-list
82804804|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82804805|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
82804806|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804807|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804808|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
82804809|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804810|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82804811|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
82804812|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804813|NCT00908219|Bevacizumab|bevacizumab|mesh-list
82804814|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804815|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804816|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82804817|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82804818|NCT00908219|Growth Substances|growth substances|mesh-ancestor
82804819|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804820|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
82804821|NCT00908297|Ubiquinone|ubiquinone|mesh-list
82804822|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
82804823|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
82804824|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804825|NCT00908297|Vitamins|vitamins|mesh-ancestor
82804826|NCT00927407|Malathion|malathion|mesh-list
82804827|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82804828|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804829|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804830|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
82804831|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804832|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804833|NCT00931697|Mefloquine|mefloquine|mesh-list
82804834|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
82804835|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82804836|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82804837|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82804838|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
82804839|NCT00927797|Rituximab|rituximab|mesh-list
82804840|NCT00927797|Pentostatin|pentostatin|mesh-list
82804841|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82804842|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
82804843|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804844|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82804845|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82804846|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
82804847|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804848|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804849|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82804850|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804851|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82804852|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804853|NCT00338962|Naltrexone|naltrexone|mesh-list
82804854|NCT00338962|Paroxetine|paroxetine|mesh-list
82804855|NCT00338962|Desipramine|desipramine|mesh-list
82804856|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82804857|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82804858|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804859|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
82804860|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804861|NCT00338962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82804862|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82804863|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82804864|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804865|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804866|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
82804867|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82804868|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
82804869|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82804870|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82804871|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82804872|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804873|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82804874|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82804875|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
82804876|NCT00931775|Pindolol|pindolol|mesh-list
82804877|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82804878|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82804879|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
82804880|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441809|NCT01275599|Buprenorphine|buprenorphine|mesh-list
82804881|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804882|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804883|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82804884|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82804885|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
82804886|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804887|NCT00927875|Carboplatin|carboplatin|mesh-list
82804888|NCT00927875|Etoposide|etoposide|mesh-list
82804889|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804890|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82804891|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82804892|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82804893|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804894|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804895|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
82804896|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82804897|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
82804898|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804899|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804900|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82804901|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
82804902|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82804903|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
82804904|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804905|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804906|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82804907|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
82804908|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
82804909|NCT00568061|Protective Agents|protective agents|mesh-ancestor
82804910|NCT03547427|Acetaminophen|acetaminophen|mesh-list
82804911|NCT03547427|Insulin|insulin|mesh-list
82804912|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82804913|NCT03547427|Pramlintide|pramlintide|mesh-list
82804914|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82804915|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804916|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82804917|NCT03547427|Analgesics|analgesics|mesh-ancestor
82804918|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
82804919|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82804920|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
82804921|NCT00338884|Sunitinib|sunitinib|mesh-list
82804922|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804923|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82804924|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82804925|NCT00338884|Growth Substances|growth substances|mesh-ancestor
82804926|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804927|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
82804928|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82804929|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804930|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804931|NCT03038100|Paclitaxel|paclitaxel|mesh-list
82804932|NCT03038100|Bevacizumab|bevacizumab|mesh-list
82804933|NCT03038100|Carboplatin|carboplatin|mesh-list
82804934|NCT03038100|Atezolizumab|atezolizumab|mesh-list
82804935|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83361994|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82804936|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82804937|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804938|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
82804939|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
82804940|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
82804941|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804942|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804943|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82804944|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82804945|NCT03038100|Growth Substances|growth substances|mesh-ancestor
82804946|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804947|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
82804948|NCT03038100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82804949|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
82804950|NCT00338728|Letrozole|letrozole|mesh-list
82804951|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
82804952|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804953|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82804954|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82804955|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804956|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804957|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82804958|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
82804959|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804960|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804961|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82804962|NCT01059136|Spironolactone|spironolactone|mesh-list
82804963|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82804964|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
82804965|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82804966|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804967|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82804968|NCT01059136|Diuretics|diuretics|mesh-ancestor
82804969|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
82804970|NCT00336856|Irinotecan|irinotecan|mesh-list
82804971|NCT00336856|Cetuximab|cetuximab|mesh-list
82804972|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82804973|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82804974|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804975|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804976|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82804977|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82804978|NCT00566501|Donepezil|donepezil|mesh-list
82804979|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82804980|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82804981|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804982|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
82804983|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804984|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804985|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
82804986|NCT00504894|Thiopental|thiopental|mesh-list
82804987|NCT00504894|Propofol|propofol|mesh-list
82804988|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82804989|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82804990|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82804991|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82804992|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
82804993|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
82804994|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
82804995|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
82804996|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
82804997|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82804998|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82804999|NCT00924755|Caffeine|caffeine|mesh-list
82805000|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82805001|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805002|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82805003|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805004|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805005|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82805006|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82805007|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
82805008|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805009|NCT01011348|Ubiquinone|ubiquinone|mesh-list
82805010|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
82805011|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
82805012|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805013|NCT01011348|Vitamins|vitamins|mesh-ancestor
82805014|NCT00928655|Acetazolamide|acetazolamide|mesh-list
82805015|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
82805016|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82805017|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805018|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805019|NCT00928655|Diuretics|diuretics|mesh-ancestor
82805020|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
82805021|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805022|NCT01011426|Bisacodyl|bisacodyl|mesh-list
82805023|NCT01011426|Cathartics|cathartics|mesh-ancestor
82805024|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82805025|NCT01011426|Laxatives|laxatives|mesh-ancestor
82805026|NCT00932555|Factor VIII|factor viii|mesh-list
82805027|NCT00932555|Coagulants|coagulants|mesh-ancestor
82805028|NCT04722575|Atezolizumab|atezolizumab|mesh-list
82805029|NCT04722575|Vemurafenib|vemurafenib|mesh-list
82805030|NCT04722575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82805031|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805032|NCT04722575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82805033|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805034|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82805035|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805036|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
82805037|NCT00513240|Hematinics|hematinics|mesh-ancestor
82805038|NCT00928811|Basiliximab|basiliximab|mesh-list
82805039|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805040|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
82805041|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805042|NCT00932867|Telmisartan|telmisartan|mesh-list
82805043|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82805044|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82805045|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82805046|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805047|NCT00928967|Interferons|interferons|mesh-list
82805048|NCT00928967|Interferon-beta|interferon-beta|mesh-list
82805049|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
82805050|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805051|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
82805052|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805053|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
82805054|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805055|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82805056|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
82805057|NCT00933023|Betamethasone|betamethasone|mesh-list
82805058|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82805059|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
82805060|NCT00933023|Hormones|hormones|mesh-ancestor
82805061|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805062|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805063|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82805064|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
82805065|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
82805066|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82805067|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
82805068|NCT00933179|Gestodene|gestodene|mesh-list
82805069|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82805070|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
82805071|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82805072|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805073|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82805074|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82805075|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82805076|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82805077|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82805078|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
82805079|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82805080|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82805081|NCT00933179|Progestins|progestins|mesh-ancestor
82805082|NCT00933179|Hormones|hormones|mesh-ancestor
82805083|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805084|NCT00504348|Tacrolimus|tacrolimus|mesh-list
82805085|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805086|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
82805087|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805088|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82805089|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83441821|NCT02992457|Ribavirin|ribavirin|mesh-list
82805090|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805091|NCT00929045|Hormones|hormones|mesh-list
82805092|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805093|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805094|NCT00925457|Domperidone|domperidone|mesh-list
82805095|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82805096|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805097|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805098|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
82805100|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805101|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805102|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82805103|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82805104|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
82805105|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805106|NCT00929279|Abciximab|abciximab|mesh-list
82805107|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
82805108|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82805109|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
82805110|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82805111|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805112|NCT00335764|Sirolimus|sirolimus|mesh-list
82805113|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82805114|NCT00335764|Sorafenib|sorafenib|mesh-list
82805115|NCT00335764|Temsirolimus|temsirolimus|mesh-list
82805116|NCT00335764|Tipifarnib|tipifarnib|mesh-list
82805117|NCT00335764|MTOR Inhibitors|mtor inhibitors|mesh-list
82805118|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805119|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82805120|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805121|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805122|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805123|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
82805124|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805125|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805126|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805127|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82805128|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
82805129|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
82805130|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82805131|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805132|NCT03981484|Thrombin|thrombin|mesh-list
82805133|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
82805134|NCT03981484|Coagulants|coagulants|mesh-ancestor
82805135|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82805136|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805137|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82805138|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805139|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805140|NCT01063660|Treosulfan|treosulfan|mesh-list
82805141|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82805142|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
82805143|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805144|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805145|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
82805146|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
82805147|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82805148|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805149|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805150|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
82805151|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82805152|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805153|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805154|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
82805155|NCT00492726|Ertapenem|ertapenem|mesh-list
82805156|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82805157|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805158|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805159|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82805161|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805162|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805163|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805164|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82805165|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
82805166|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82805167|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805168|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82805169|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82805170|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82805171|NCT00309946|Cediranib|cediranib|mesh-list
82805172|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805173|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805174|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805175|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82805177|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
82805178|NCT00929591|Doxorubicin|doxorubicin|mesh-list
82805179|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82805180|NCT00929591|Fluorouracil|fluorouracil|mesh-list
82805181|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805182|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
82805183|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805184|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805185|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82805186|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
82805187|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805188|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805189|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82805190|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82805191|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82805192|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82805193|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805194|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
82805195|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82805196|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82805197|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
82805198|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805199|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82805200|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82805201|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82805202|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82805203|NCT03997500|Norepinephrine|norepinephrine|mesh-list
82805204|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82805205|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82805206|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
82805207|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805208|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805209|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805210|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
82805211|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
82805212|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805213|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82805214|NCT01011660|Amlodipine|amlodipine|mesh-list
82805215|NCT01011660|Telmisartan|telmisartan|mesh-list
82805216|NCT01011660|Amiloride|amiloride|mesh-list
82805217|NCT01011660|Simvastatin|simvastatin|mesh-list
82805218|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82805219|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82805220|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805221|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805222|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82805223|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805224|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
82805225|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82805226|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82805227|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
82805228|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82805229|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82805230|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805231|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82805232|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82805233|NCT01011660|Diuretics|diuretics|mesh-ancestor
82805234|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
82805235|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82805236|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82805237|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82805238|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82805239|NCT01015248|Rituximab|rituximab|mesh-list
82805240|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82805241|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82805242|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805243|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
82805244|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805245|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805246|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82805247|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
82805248|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805249|NCT00506922|Methotrexate|methotrexate|mesh-list
82805250|NCT00506922|Pentostatin|pentostatin|mesh-list
82805251|NCT00506922|Tacrolimus|tacrolimus|mesh-list
82805252|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82805253|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
82805254|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82805255|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805256|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82805257|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
82805258|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805259|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805260|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
82805261|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805262|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82805263|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805264|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
82805265|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805266|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82805267|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82805268|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82805269|NCT00934193|Gabapentin|gabapentin|mesh-list
82805270|NCT00934193|Analgesics|analgesics|mesh-ancestor
82805271|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
82805272|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805273|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805274|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
82805275|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82805276|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82805277|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805278|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82805279|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82805280|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82805281|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805282|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805283|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
82805284|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
82805285|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82805286|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805287|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805288|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82805289|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82805290|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805291|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805292|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805293|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82805294|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
82805295|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82805296|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805297|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82805298|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82805299|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82805300|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
82805301|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
82805302|NCT00926315|Calcitriol|calcitriol|mesh-list
82805303|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82805304|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805305|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82805306|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805307|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805308|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82805309|NCT00926315|Vitamins|vitamins|mesh-ancestor
82805310|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
82805311|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82805312|NCT01013454|Varenicline|varenicline|mesh-list
82805313|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82805314|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82805315|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
82805316|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805317|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805318|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805319|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82805320|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
82805321|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805322|NCT00926627|Bosentan|bosentan|mesh-list
82805323|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82805324|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82805325|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805326|NCT00934739|Thalidomide|thalidomide|mesh-list
82805327|NCT00934739|Dexamethasone|dexamethasone|mesh-list
82805328|NCT00934739|Celecoxib|celecoxib|mesh-list
82805329|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
82805330|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805331|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
82805332|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805333|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805334|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82805335|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
82805336|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805337|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805338|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82805339|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82805340|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
82805341|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
82805342|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805343|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82805344|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
82805345|NCT00934739|Hormones|hormones|mesh-ancestor
82805346|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805347|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82805348|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
82805349|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805350|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805351|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82805352|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82805353|NCT00934739|Growth Substances|growth substances|mesh-ancestor
82805354|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
82805355|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82805356|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82805357|NCT00934739|Analgesics|analgesics|mesh-ancestor
82805358|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
82805359|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82805360|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82805361|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805362|NCT01015482|Midazolam|midazolam|mesh-list
82805363|NCT01015482|Remifentanil|remifentanil|mesh-list
82805364|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82805365|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82805366|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805367|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805368|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82805369|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82805370|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82805371|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82805372|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
82805373|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
82805374|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
82805375|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
82805376|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83441835|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805377|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805378|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82805379|NCT01015482|Narcotics|narcotics|mesh-ancestor
82805380|NCT01015482|Analgesics|analgesics|mesh-ancestor
82805381|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
82805382|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805383|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
82805384|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82805385|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805386|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
82805387|NCT00934817|Metformin|metformin|mesh-list
82805388|NCT00934817|Glimepiride|glimepiride|mesh-list
82805389|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82805390|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805391|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82805392|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805393|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
82805394|NCT01013532|Aspirin|aspirin|mesh-list
82805395|NCT01013532|Cilostazol|cilostazol|mesh-list
82805396|NCT01013532|Probucol|probucol|mesh-list
82805397|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82805398|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82805399|NCT01013532|Analgesics|analgesics|mesh-ancestor
82805400|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
82805401|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805402|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805403|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82805404|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805405|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82805406|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82805407|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805408|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82805409|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82805410|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805411|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
82805412|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82805413|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
82805414|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82805415|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
82805416|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
82805417|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82805418|NCT01013532|Protective Agents|protective agents|mesh-ancestor
82805419|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82805420|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82805421|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82805422|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82805423|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
82805424|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82805425|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
82805426|NCT00934895|Paclitaxel|paclitaxel|mesh-list
82805427|NCT00934895|Everolimus|everolimus|mesh-list
82805428|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82805429|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82805430|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805431|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
82805432|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
82805433|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
82805434|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805435|NCT00934895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82805436|NCT00934895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82805437|NCT00934895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805438|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805439|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
82805440|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805441|NCT00926705|Fentanyl|fentanyl|mesh-list
82805442|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
82805443|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82805444|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805445|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805446|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82805447|NCT00926705|Analgesics|analgesics|mesh-ancestor
82805448|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
82805449|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805450|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82805451|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82805452|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82805453|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
82805454|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805455|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805456|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82805457|NCT00926705|Narcotics|narcotics|mesh-ancestor
82805458|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82805459|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82805460|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
82805461|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
82805462|NCT01012284|Bedaquiline|bedaquiline|mesh-list
82805463|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
82805464|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805465|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805466|NCT00934973|Mebeverine|mebeverine|mesh-list
82805467|NCT00934973|Alverine|alverine|mesh-list
82805468|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
82805469|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
82805470|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
82805471|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805472|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805473|NCT00485472|Lacosamide|lacosamide|mesh-list
82805474|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
82805475|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82805476|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82805477|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805478|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805479|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
82805480|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82805481|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805482|NCT01018836|Riluzole|riluzole|mesh-list
82805483|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
82805484|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82805485|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82805486|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805487|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805488|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805489|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82805490|NCT01018836|Protective Agents|protective agents|mesh-ancestor
82805491|NCT04015661|Paclitaxel|paclitaxel|mesh-list
82805492|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82805493|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82805494|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805495|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
82805496|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
82805497|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
82805498|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805499|NCT00491400|Atorvastatin|atorvastatin|mesh-list
82805500|NCT00491400|Fenofibrate|fenofibrate|mesh-list
82805501|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82805502|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82805503|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
82805504|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805505|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82805506|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82805507|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805508|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
82805509|NCT00491322|Vitamin D|vitamin d|mesh-list
82805510|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82805511|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805512|NCT00491322|Vitamins|vitamins|mesh-ancestor
82805513|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
82805514|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82805515|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82805516|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
82805517|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805518|NCT04314570|Ropivacaine|ropivacaine|mesh-list
82805519|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
82805520|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
82805521|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805522|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805523|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
82805524|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805525|NCT00930839|Aspirin|aspirin|mesh-list
82805527|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
82805528|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82805529|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82805530|NCT00930839|Analgesics|analgesics|mesh-ancestor
82805531|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
82805532|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805533|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361995|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82805534|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82805535|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805536|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82805537|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82805538|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805539|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82805540|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82805541|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805542|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
82805543|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82805544|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
82805545|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82805546|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
82805547|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
82805548|NCT00930839|Vitamins|vitamins|mesh-ancestor
82805549|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
82805550|NCT01015794|Ephedrine|ephedrine|mesh-list
82805551|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
82805552|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82805553|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805554|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
82805555|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
82805556|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805557|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82805558|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
82805559|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805560|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805561|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82805562|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82805563|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
82805564|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
82805565|NCT00935363|Glyburide|glyburide|mesh-list
82805566|NCT00935363|Rifampin|rifampin|mesh-list
82805567|NCT00935363|Fluconazole|fluconazole|mesh-list
82805568|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82805569|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
82805570|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805571|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805572|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
82805573|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82805574|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805575|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805576|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82805577|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82805578|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82805579|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82805580|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82805581|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82805582|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
82805583|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82805584|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82805585|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82805586|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
82805587|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805588|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805589|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82805590|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82805591|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82805592|NCT00930995|Candesartan|candesartan|mesh-list
82805593|NCT00930995|Candesartan cilexetil|candesartan cilexetil|mesh-list
82805594|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82805595|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82805596|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82805597|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805598|NCT00931073|Ketoconazole|ketoconazole|mesh-list
82805599|NCT00931073|Omeprazole|omeprazole|mesh-list
82805600|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82805601|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82805602|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82805603|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805604|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805605|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
82805606|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805607|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82805608|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82805609|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82805610|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
82805611|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805612|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805613|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82805614|NCT00936689|Doxorubicin|doxorubicin|mesh-list
82805615|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
82805616|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82805617|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805618|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82805619|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82805620|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805621|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805622|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82805624|NCT00936689|Hormones|hormones|mesh-ancestor
82805625|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805626|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805627|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82805628|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
82805629|NCT01018914|Tacrolimus|tacrolimus|mesh-list
82805630|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805631|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
82805632|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805633|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82805634|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805635|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805636|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82805637|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805638|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82805639|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
82805640|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805641|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805642|NCT01019070|Asunaprevir|asunaprevir|mesh-list
82805643|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
82805644|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805645|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805646|NCT00936767|Artesunate|artesunate|mesh-list
82805647|NCT00936767|Mefloquine|mefloquine|mesh-list
82805648|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
82805649|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82805650|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82805651|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805652|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805653|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
82805654|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
82805655|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82805656|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
82805657|NCT00931229|Entecavir|entecavir|mesh-list
82805658|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
82805659|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805660|NCT00936923|Furosemide|furosemide|mesh-list
82805661|NCT00936923|Diuretics|diuretics|mesh-list
82805662|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
82805663|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805664|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83441848|NCT00743093|Acetaminophen|acetaminophen|mesh-list
82805665|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805666|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805667|NCT01019382|Gemcitabine|gemcitabine|mesh-list
82805668|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82805669|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
82805670|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805671|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805672|NCT00935675|Escitalopram|escitalopram|mesh-list
82805673|NCT00935675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82805674|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82805675|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805676|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805677|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361996|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82805678|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
82805679|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805680|NCT01016184|Vitamin D|vitamin d|mesh-list
82805681|NCT01016184|Vitamins|vitamins|mesh-ancestor
82805682|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
82805683|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805684|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82805685|NCT02567825|Amoxicillin|amoxicillin|mesh-list
82805686|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
82805687|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
82805688|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
82805689|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82805690|NCT02567825|Ofloxacin|ofloxacin|mesh-list
82805691|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805692|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805693|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82805694|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805695|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805696|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82805697|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82805698|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82805699|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805700|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82805701|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82805702|NCT00490776|Panobinostat|panobinostat|mesh-list
82805703|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805704|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82805705|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805706|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805707|NCT00566735|Galantamine|galantamine|mesh-list
82805708|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82805709|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805710|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805711|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
82805712|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805713|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805714|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82805715|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
82805716|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805717|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
82805718|NCT00936143|Infliximab|infliximab|mesh-list
82805719|NCT00936143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82805720|NCT00936143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82805721|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
82805722|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82805723|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805724|NCT00937079|Exenatide|exenatide|mesh-list
82805725|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82805726|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805727|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82805728|NCT00937079|Incretins|incretins|mesh-ancestor
82805729|NCT00937079|Hormones|hormones|mesh-ancestor
82805730|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805731|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
82805732|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805733|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805734|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
82805735|NCT00937625|Fludarabine|fludarabine|mesh-list
82805736|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
82805737|NCT00937625|Interleukin-2|interleukin-2|mesh-list
82805738|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82805739|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
82805740|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805741|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82805742|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82805743|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
82805744|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805745|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805746|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82805747|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82805748|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
82805749|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82805750|NCT00937625|Analgesics|analgesics|mesh-ancestor
82805751|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
82805752|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805753|NCT04014101|Apatinib|apatinib|mesh-list
82805754|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805755|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82805756|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805757|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805758|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82805759|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82805760|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
82805761|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82805762|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805763|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805764|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
82805765|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805766|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805767|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82805768|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805769|NCT00564629|Acetaminophen|acetaminophen|mesh-list
82805770|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82805771|NCT00564629|Analgesics|analgesics|mesh-ancestor
82805772|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
82805773|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805774|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805775|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
82805776|NCT00564395|Insulin|insulin|mesh-list
82805777|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82805778|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
82805779|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82805780|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805781|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
82805782|NCT04013243|Analgesics|analgesics|mesh-ancestor
82805783|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
82805784|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805785|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805786|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
82805787|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805788|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82805789|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
82805790|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82805791|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805792|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805793|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82805794|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
82805795|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82805796|NCT00938171|Anesthetics|anesthetics|mesh-list
82805797|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805798|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805799|NCT05280275|Dexamethasone|dexamethasone|mesh-list
82805800|NCT05280275|Lenalidomide|lenalidomide|mesh-list
82805801|NCT05280275|Daratumumab|daratumumab|mesh-list
82805802|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82805803|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
82805804|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
82805805|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805806|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805807|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82805808|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
82805809|NCT05280275|Hormones|hormones|mesh-ancestor
82805810|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805811|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82805812|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805813|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
82805814|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82805815|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82805816|NCT05280275|Growth Substances|growth substances|mesh-ancestor
82805817|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
82805818|NCT00939497|Risperidone|risperidone|mesh-list
82805819|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82805820|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
82805821|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805822|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805823|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805824|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82805825|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82805826|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82805827|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82805828|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82805829|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
82805830|NCT00502242|Ramipril|ramipril|mesh-list
82805831|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82805832|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
82805833|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805834|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805835|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82805836|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82805837|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82805838|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82805839|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
82805840|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805841|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82805843|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82805844|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
82805845|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82805846|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805847|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82805848|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805849|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82805850|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82805851|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82805852|NCT02991365|Insulin|insulin|mesh-list
82805853|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82805854|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805855|NCT03972137|Nicotine|nicotine|mesh-list
82805856|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82805857|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
82805858|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805859|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805860|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82805861|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82805862|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
82805863|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805864|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805865|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
82805866|NCT00490698|Atorvastatin|atorvastatin|mesh-list
82805867|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82805868|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82805869|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
82805870|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805871|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82805872|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82805873|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805874|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82805875|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805876|NCT04492254|Enoxaparin|enoxaparin|mesh-list
82805877|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
82805878|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82805879|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82805880|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805881|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
82805882|NCT03855228|Loratadine|loratadine|mesh-list
82805883|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82805884|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
82805885|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82805886|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
82805887|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82805888|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82805889|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
82805890|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
82805891|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805892|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805893|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805894|NCT04013477|Donepezil|donepezil|mesh-list
82805895|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82805896|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805897|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805898|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
82805899|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805900|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805901|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
82805902|NCT00940667|Losartan|losartan|mesh-list
82805903|NCT00940667|Amlodipine|amlodipine|mesh-list
82805904|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82805905|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82805906|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805907|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805908|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82805909|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805910|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
82805911|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82805912|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82805913|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82805914|NCT01019772|Vaccines|vaccines|mesh-list
82805915|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
82805916|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805917|NCT00513500|Amoxicillin|amoxicillin|mesh-list
82805918|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82805919|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82805920|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805921|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
82805922|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82805923|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82805924|NCT00511004|Albendazole|albendazole|mesh-list
82805925|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
82805926|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
82805927|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82805928|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82805929|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
82805930|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82805931|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82805932|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
82805933|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
82805934|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83441872|NCT02992301|Alirocumab|alirocumab|mesh-list
82805935|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805936|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805937|NCT00511004|Filaricides|filaricides|mesh-ancestor
82805938|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
82805939|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82805940|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805941|NCT02550197|Vaccines|vaccines|mesh-list
82805942|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
82805943|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805944|NCT00939965|Isotretinoin|isotretinoin|mesh-list
82805945|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
82805946|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
82805947|NCT02877134|Ustekinumab|ustekinumab|mesh-list
82805948|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
82805949|NCT00563381|Bromides|bromides|mesh-list
82805950|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
82805951|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82805952|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82805953|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
82805954|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82805955|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805956|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82805957|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
82805958|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
82805959|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82805960|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
82805961|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805962|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805963|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82805964|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82805965|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82805966|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
82805967|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
82805968|NCT00512798|Temozolomide|temozolomide|mesh-list
82805969|NCT00512798|Bortezomib|bortezomib|mesh-list
82805970|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82805971|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
82805972|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805973|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805974|NCT00940121|Mirabegron|mirabegron|mesh-list
82805975|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82805976|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82805977|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82805978|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83361997|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82805979|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82805980|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805981|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805982|NCT00940121|Urological Agents|urological agents|mesh-ancestor
82805983|NCT04012619|Cisplatin|cisplatin|mesh-list
82805984|NCT04012619|Carboplatin|carboplatin|mesh-list
82805985|NCT04012619|Pemetrexed|pemetrexed|mesh-list
82805986|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82805987|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82805988|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82805989|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82805990|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82805992|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
82805993|NCT00941057|Dienogest|dienogest|mesh-list
82805994|NCT00941057|Calcium|calcium|mesh-list
82805995|NCT00941057|Nandrolone|nandrolone|mesh-list
82805996|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82805997|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82805998|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82805999|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82806000|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
82806001|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82806002|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82806003|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82806004|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82806005|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82806006|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
82806007|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806008|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806009|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806010|NCT00941057|Androgens|androgens|mesh-ancestor
82806011|NCT00941057|Hormones|hormones|mesh-ancestor
82806012|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
82806013|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
82806014|NCT00941057|Vitamins|vitamins|mesh-ancestor
82806015|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
82806016|NCT00561821|Mirtazapine|mirtazapine|mesh-list
82806017|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
82806018|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82806019|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82806020|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
82806021|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
82806022|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806023|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806024|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806025|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82806026|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82806027|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806028|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82806029|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82806030|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82806031|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
82806032|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82806033|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82806034|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
82806035|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82806036|NCT03684044|Baloxavir|baloxavir|mesh-list
82806037|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
82806038|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806039|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806040|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806041|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
82806042|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82806043|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82806044|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806045|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
82806046|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82806047|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
82806048|NCT00335452|Clopidogrel|clopidogrel|mesh-list
82806049|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82806050|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82806051|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82806052|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82806053|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
82806054|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806055|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806056|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806057|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
82806058|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82806059|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806060|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82806061|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
82806062|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82806063|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806064|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806065|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806066|NCT00522392|Dexamethasone|dexamethasone|mesh-list
82806067|NCT00522392|Lenalidomide|lenalidomide|mesh-list
82806068|NCT00522392|Bortezomib|bortezomib|mesh-list
82806069|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806070|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
82806071|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
83441886|NCT00744965|Glyburide|glyburide|mesh-list
82806072|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806073|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806074|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806075|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
82806076|NCT00522392|Hormones|hormones|mesh-ancestor
82806077|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806078|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806079|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806080|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
82806081|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806082|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806083|NCT00522392|Growth Substances|growth substances|mesh-ancestor
82806084|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806085|NCT00335140|Leucovorin|leucovorin|mesh-list
82806086|NCT00335140|Cytarabine|cytarabine|mesh-list
82806087|NCT00335140|Dexamethasone|dexamethasone|mesh-list
82806088|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
82806089|NCT00335140|Rituximab|rituximab|mesh-list
82806090|NCT00335140|Methotrexate|methotrexate|mesh-list
82806091|NCT00335140|Vincristine|vincristine|mesh-list
82806092|NCT00335140|Procarbazine|procarbazine|mesh-list
82806093|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82806094|NCT00335140|BB 1101|bb 1101|mesh-list
82806095|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
82806096|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806097|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806098|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
82806099|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806100|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806101|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806102|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
82806103|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
82806104|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806105|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806106|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
82806107|NCT00335140|Hormones|hormones|mesh-ancestor
82806108|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806109|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806110|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
82806111|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806112|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806113|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82806114|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
82806115|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82806116|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806117|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
82806118|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
82806119|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82806120|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806121|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82806122|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
82806123|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806124|NCT00335140|Antidotes|antidotes|mesh-ancestor
82806125|NCT00335140|Protective Agents|protective agents|mesh-ancestor
82806126|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
82806127|NCT00335140|Vitamins|vitamins|mesh-ancestor
82806128|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
82806129|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82806131|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806132|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
82806133|NCT01061320|Tocopherols|tocopherols|mesh-list
82806134|NCT01061320|Vitamin E|vitamin e|mesh-list
82806135|NCT01061320|Tocotrienols|tocotrienols|mesh-list
82806136|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
82806137|NCT01061320|Vitamins|vitamins|mesh-ancestor
82806138|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
82806139|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806140|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
82806141|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806142|NCT01061320|Protective Agents|protective agents|mesh-ancestor
82806143|NCT01012544|Clopidogrel|clopidogrel|mesh-list
82806144|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82806145|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82806146|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82806147|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82806148|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
82806149|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806150|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806151|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806152|NCT01012700|Poly ICLC|poly iclc|mesh-list
82806153|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
82806154|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
82806155|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806156|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
82806157|NCT01565720|Isavuconazole|isavuconazole|mesh-list
82806158|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82806159|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806160|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82806161|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82806162|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806163|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806164|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806165|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
82806166|NCT00309244|Insulin|insulin|mesh-list
82806167|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82806168|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
82806169|NCT00309244|Protamines|protamines|mesh-list
82806170|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82806171|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806172|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
82806173|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806174|NCT00309244|Coagulants|coagulants|mesh-ancestor
82806175|NCT00483756|Cyclosporine|cyclosporine|mesh-list
82806176|NCT00483756|Cyclosporins|cyclosporins|mesh-list
82806177|NCT00483756|Tofacitinib|tofacitinib|mesh-list
82806178|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806179|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806180|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806181|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
82806182|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806183|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
82806184|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806185|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
82806186|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806187|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82806188|NCT00483756|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82806189|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82806190|NCT00309166|Vaccines|vaccines|mesh-list
82806191|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
82806192|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806193|NCT01063816|Carboplatin|carboplatin|mesh-list
82806194|NCT01063816|Gemcitabine|gemcitabine|mesh-list
82806195|NCT01063816|Veliparib|veliparib|mesh-list
82806196|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806197|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806198|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
82806199|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806200|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82806201|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806202|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
82806203|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
82806204|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82806205|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
82806206|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806207|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806208|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82806209|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
82806210|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
82806211|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82806212|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
82806213|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806214|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806215|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82806216|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82806217|NCT00482274|Docetaxel|docetaxel|mesh-list
82806218|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806219|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
82806220|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806221|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
82806222|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806223|NCT00490542|Ziprasidone|ziprasidone|mesh-list
82806224|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82806225|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
82806226|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806227|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806228|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806229|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82806230|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82806231|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806232|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82806233|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82806234|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
82806235|NCT01059604|Naproxen|naproxen|mesh-list
82806236|NCT01059604|Sumatriptan|sumatriptan|mesh-list
82806237|NCT01059604|Naratriptan|naratriptan|mesh-list
82806238|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82806239|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82806240|NCT01059604|Analgesics|analgesics|mesh-ancestor
82806241|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
82806242|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806243|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806244|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806245|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806246|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
82806247|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82806248|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806249|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806250|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82806251|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82806252|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82806253|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
82806254|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806255|NCT02532634|Dexamethasone|dexamethasone|mesh-list
82806256|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
82806257|NCT02532634|Aprepitant|aprepitant|mesh-list
82806258|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
82806259|NCT02532634|Palonosetron|palonosetron|mesh-list
82806260|NCT02532634|Ramosetron|ramosetron|mesh-list
82806261|NCT02532634|BB 1101|bb 1101|mesh-list
82806262|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806263|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
82806264|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
82806265|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806266|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806267|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806268|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
82806269|NCT02532634|Hormones|hormones|mesh-ancestor
82806270|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806271|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806272|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806273|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
82806274|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806275|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806276|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82806277|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806278|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82806279|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82806280|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
82806281|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
82806282|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
82806283|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82806284|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806285|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806287|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82806288|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806289|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806290|NCT01014156|Epoprostenol|epoprostenol|mesh-list
82806291|NCT01014156|Tezosentan|tezosentan|mesh-list
82806292|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82806293|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82806294|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
82806295|NCT00322348|Goserelin|goserelin|mesh-list
82806296|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806297|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806298|NCT01014234|Cyclosporine|cyclosporine|mesh-list
82806299|NCT01014234|Sirolimus|sirolimus|mesh-list
82806300|NCT01014234|Cyclosporins|cyclosporins|mesh-list
82806301|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806302|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806303|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806304|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
82806305|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806306|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
82806307|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806308|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
82806309|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806310|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82806311|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82806312|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82806313|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806314|NCT00501228|Lenograstim|lenograstim|mesh-list
82806315|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82806316|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
82806317|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806318|NCT00308620|Chloroquine|chloroquine|mesh-list
82806319|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82806320|NCT00308620|Amebicides|amebicides|mesh-ancestor
82806321|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82806322|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82806323|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806324|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
82806325|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806326|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82806327|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82806328|NCT00308620|Analgesics|analgesics|mesh-ancestor
82806329|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
82806330|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806331|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806332|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806333|NCT00308620|Filaricides|filaricides|mesh-ancestor
82806334|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
82806335|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
82806336|NCT00492752|Sorafenib|sorafenib|mesh-list
82806337|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806338|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82806339|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806340|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806341|NCT00308308|Insulin|insulin|mesh-list
82806342|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82806343|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806344|NCT00505934|Levetiracetam|levetiracetam|mesh-list
82806345|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
82806346|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
82806347|NCT02532790|Prednisone|prednisone|mesh-list
82806348|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806349|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
82806350|NCT02532790|Hormones|hormones|mesh-ancestor
82806351|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806352|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806353|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806354|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806355|NCT00505778|Mesalamine|mesalamine|mesh-list
82806356|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82806357|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82806358|NCT00505778|Analgesics|analgesics|mesh-ancestor
82806359|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
82806360|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806361|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806362|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806363|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806364|NCT00308074|Aripiprazole|aripiprazole|mesh-list
82806365|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
82806366|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82806367|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82806368|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82806369|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806370|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806371|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
82806372|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
82806373|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806374|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806375|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82806377|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
82806378|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82806379|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82806380|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82806381|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82806382|NCT03997058|Estazolam|estazolam|mesh-list
82806383|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
82806384|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82806385|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82806386|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806387|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806388|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82806389|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
82806390|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
82806391|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806392|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806393|NCT00500760|Panitumumab|panitumumab|mesh-list
82806394|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806395|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806396|NCT01016730|Bortezomib|bortezomib|mesh-list
82806397|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806398|NCT01012934|Alendronate|alendronate|mesh-list
82806399|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82806400|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806401|NCT04334330|Trastuzumab|trastuzumab|mesh-list
82806402|NCT04334330|Fulvestrant|fulvestrant|mesh-list
82806403|NCT04334330|Palbociclib|palbociclib|mesh-list
82806404|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806405|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806406|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806407|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82806408|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82806409|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
82806410|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806411|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806412|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82806413|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806414|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806415|NCT01015196|Daunorubicin|daunorubicin|mesh-list
82806416|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82806417|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806418|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82806419|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82806420|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806421|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806422|NCT01009892|Codeine|codeine|mesh-list
82806423|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82806424|NCT01009892|Narcotics|narcotics|mesh-ancestor
82806425|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806426|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806427|NCT01009892|Analgesics|analgesics|mesh-ancestor
82806428|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
82806429|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806430|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
82806431|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
82806432|NCT00307684|Methylphenidate|methylphenidate|mesh-list
82806433|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82806435|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82806436|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82806437|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82806438|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806439|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
82806440|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806441|NCT00489918|Teriparatide|teriparatide|mesh-list
82806442|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82806443|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806444|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82806445|NCT01061788|Everolimus|everolimus|mesh-list
82806446|NCT01061788|Panitumumab|panitumumab|mesh-list
82806447|NCT01061788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82806448|NCT01061788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82806449|NCT01061788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806450|NCT01061788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806451|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806452|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
82806453|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806454|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806455|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806456|NCT00307294|Thalidomide|thalidomide|mesh-list
82806457|NCT00307294|Doxorubicin|doxorubicin|mesh-list
82806458|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82806459|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806460|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82806461|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82806462|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806463|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806464|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806465|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
82806466|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806467|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
82806468|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82806469|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806470|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806471|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806472|NCT00307294|Growth Substances|growth substances|mesh-ancestor
82806473|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806474|NCT03981094|Pirfenidone|pirfenidone|mesh-list
82806475|NCT03981094|Analgesics|analgesics|mesh-ancestor
82806476|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
82806477|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806478|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806479|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82806480|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82806481|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806482|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806483|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806484|NCT03963401|PF-06700841|pf-06700841|mesh-list
82806485|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82806486|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806487|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806488|NCT04410965|Teriflunomide|teriflunomide|mesh-list
82806489|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82806490|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82806491|NCT04410965|Analgesics|analgesics|mesh-ancestor
82806492|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
82806493|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806494|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806495|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806496|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806497|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806498|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
82806499|NCT04012775|Insulin|insulin|mesh-list
82806500|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82806501|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82806502|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806503|NCT00944723|Vitamins|vitamins|mesh-list
82806504|NCT00944723|Zinc|zinc|mesh-list
82806505|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
82806506|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
82806507|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
82806508|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806509|NCT00944723|Trace Elements|trace elements|mesh-ancestor
82806510|NCT00944723|Astringents|astringents|mesh-ancestor
82806511|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
82806512|NCT00944801|Doxorubicin|doxorubicin|mesh-list
82806513|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82806514|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82806515|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806516|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82806517|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82806518|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806519|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806520|NCT01060228|Valproic Acid|valproic acid|mesh-list
82806521|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82806522|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82806523|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82806524|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806525|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806526|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82806527|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82806528|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82806529|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
82806530|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806531|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806532|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82806533|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82806534|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
82806535|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
82806536|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806537|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
82806538|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
82806539|NCT00306670|Prednisone|prednisone|mesh-list
82806540|NCT00306670|Rituximab|rituximab|mesh-list
82806541|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806542|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806543|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
82806544|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806545|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806546|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806547|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
82806548|NCT00306670|Hormones|hormones|mesh-ancestor
82806549|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806550|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806551|NCT00306592|Natalizumab|natalizumab|mesh-list
82806552|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
82806553|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806554|NCT00321646|Bevacizumab|bevacizumab|mesh-list
82806555|NCT00321646|Docetaxel|docetaxel|mesh-list
82806556|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806557|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806558|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806559|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806560|NCT00321646|Growth Substances|growth substances|mesh-ancestor
82806561|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806562|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806563|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
82806564|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806565|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
82806566|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806567|NCT00403767|Warfarin|warfarin|mesh-list
82806568|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
82806569|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
82806570|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82806571|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
82806572|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82806573|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
82806574|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806575|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806576|NCT00492284|Dexamethasone|dexamethasone|mesh-list
82806577|NCT00492284|Ranibizumab|ranibizumab|mesh-list
82806578|NCT00492284|Verteporfin|verteporfin|mesh-list
82806579|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806580|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
82806581|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
82806582|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806583|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806584|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806585|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
82806587|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806588|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806589|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806590|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806591|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806592|NCT00492284|Growth Substances|growth substances|mesh-ancestor
82806593|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806594|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82806595|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
82806596|NCT01013012|Dexamethasone|dexamethasone|mesh-list
82806597|NCT01013012|Ramosetron|ramosetron|mesh-list
82806598|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806599|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
82806600|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
82806601|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806602|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806603|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806604|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
82806605|NCT01013012|Hormones|hormones|mesh-ancestor
82806606|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806607|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806608|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806609|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82806610|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
82806611|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806612|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806613|NCT01009970|Prednisone|prednisone|mesh-list
82806614|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
82806615|NCT01009970|Rituximab|rituximab|mesh-list
82806616|NCT01009970|Doxorubicin|doxorubicin|mesh-list
82806617|NCT01009970|Vincristine|vincristine|mesh-list
82806618|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806619|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
82806620|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806621|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806622|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82806623|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
82806624|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806625|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806626|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82806627|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806628|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82806629|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82806630|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82806631|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806632|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806633|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
82806634|NCT01009970|Hormones|hormones|mesh-ancestor
82806635|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806636|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806637|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82806638|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
82806639|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806640|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
82806641|NCT01015352|Azacitidine|azacitidine|mesh-list
82806642|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
82806643|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806644|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
82806645|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806646|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806647|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806648|NCT01015352|Hematinics|hematinics|mesh-ancestor
82806649|NCT03563157|Leucovorin|leucovorin|mesh-list
82806650|NCT03563157|Paclitaxel|paclitaxel|mesh-list
82806651|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
82806652|NCT03563157|Fluorouracil|fluorouracil|mesh-list
82806653|NCT03563157|Capecitabine|capecitabine|mesh-list
82806654|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
82806655|NCT03563157|Cetuximab|cetuximab|mesh-list
82806656|NCT03563157|Avelumab|avelumab|mesh-list
82806657|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82806658|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806659|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
82806660|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806661|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
82806662|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806663|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806664|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
82806665|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806666|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806667|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82806668|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
82806669|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82806670|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
82806671|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806672|NCT03563157|Antidotes|antidotes|mesh-ancestor
82806673|NCT03563157|Protective Agents|protective agents|mesh-ancestor
82806674|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
82806675|NCT03563157|Vitamins|vitamins|mesh-ancestor
82806676|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
82806677|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806678|NCT01010048|Nifedipine|nifedipine|mesh-list
82806679|NCT01010048|Bromides|bromides|mesh-list
82806680|NCT01010048|Propantheline|propantheline|mesh-list
82806681|NCT01010048|Tamsulosin|tamsulosin|mesh-list
82806682|NCT01010048|Progesterone|progesterone|mesh-list
82806683|NCT01010048|Progestins|progestins|mesh-ancestor
82806684|NCT01010048|Hormones|hormones|mesh-ancestor
82806685|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806686|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806687|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
82806688|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82806689|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82806690|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82806691|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
82806692|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806693|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806694|NCT01010048|Urological Agents|urological agents|mesh-ancestor
82806695|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82806696|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82806697|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82806698|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
82806699|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
82806700|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82806701|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82806702|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806703|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82806704|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82806705|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
82806706|NCT01589055|Nicotine|nicotine|mesh-list
82806707|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82806708|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
82806709|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806710|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806711|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82806712|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82806713|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
82806714|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806715|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806716|NCT00414765|Aldesleukin|aldesleukin|mesh-list
82806717|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806718|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82806719|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82806720|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
82806721|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806722|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82806723|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82806724|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82806725|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806726|NCT01013402|Insulin|insulin|mesh-list
82806727|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82806728|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82806729|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806730|NCT01013480|Baclofen|baclofen|mesh-list
82806731|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82806732|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806733|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82806734|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806735|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82806736|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
83361998|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361999|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83362000|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
83362001|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83362002|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83362003|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362004|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
82806737|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
82806738|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806739|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806741|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82806742|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806743|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82806744|NCT00500370|Incretins|incretins|mesh-ancestor
82806745|NCT00500370|Hormones|hormones|mesh-ancestor
82806746|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806747|NCT00320788|Aflibercept|aflibercept|mesh-list
82806748|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806749|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806750|NCT00320788|Growth Substances|growth substances|mesh-ancestor
82806751|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806752|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806753|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806754|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
82806755|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
82806756|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
82806757|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82806758|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
82806759|NCT03996486|Paraproteins|paraproteins|mesh-list
82806760|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
82806761|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806762|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
82806763|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82806764|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82806765|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806766|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82806767|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
82806768|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806769|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82806770|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
82806771|NCT01014468|Bevacizumab|bevacizumab|mesh-list
82806772|NCT01014468|Ranibizumab|ranibizumab|mesh-list
82806773|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806774|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806775|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806776|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806777|NCT01014468|Growth Substances|growth substances|mesh-ancestor
82806778|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806779|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806781|NCT00503984|Docetaxel|docetaxel|mesh-list
82806782|NCT00503984|Azacitidine|azacitidine|mesh-list
82806783|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806784|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
82806785|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806786|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
82806787|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806788|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806789|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
82806790|NCT00503984|Hormones|hormones|mesh-ancestor
82806791|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82806792|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806793|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806794|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806795|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
82806796|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806797|NCT03996564|Acetaminophen|acetaminophen|mesh-list
82806798|NCT03996564|Diclofenac|diclofenac|mesh-list
82806799|NCT03996564|Ketorolac|ketorolac|mesh-list
82806800|NCT03996564|Diazepam|diazepam|mesh-list
82806801|NCT03996564|Hydrocodone|hydrocodone|mesh-list
82806802|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82806803|NCT03996564|Analgesics|analgesics|mesh-ancestor
82806804|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
82806805|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806806|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806807|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
82806808|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82806810|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806811|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82806812|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806813|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806814|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82806815|NCT03996564|Narcotics|narcotics|mesh-ancestor
82806816|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806817|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
82806818|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
82806819|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82806820|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
82806821|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
82806822|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
82806823|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806824|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82806825|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82806826|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82806827|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82806828|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82806829|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82806830|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82806831|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
82806832|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
82806833|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
82806834|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
82806835|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806836|NCT00565409|Etanercept|etanercept|mesh-list
82806837|NCT00565409|Methotrexate|methotrexate|mesh-list
82806838|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82806839|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
82806840|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82806841|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806842|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806843|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
82806844|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806845|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806846|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
82806847|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806848|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82806849|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806850|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
82806851|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806852|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82806853|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82806854|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82806855|NCT00565409|Analgesics|analgesics|mesh-ancestor
82806856|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
82806857|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806858|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806859|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82806860|NCT00394251|Paclitaxel|paclitaxel|mesh-list
82806861|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
82806862|NCT00394251|Bevacizumab|bevacizumab|mesh-list
82806863|NCT00394251|Doxorubicin|doxorubicin|mesh-list
82806864|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82806865|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82806866|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82806867|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806868|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
82806869|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806870|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
82806871|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806872|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806873|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
82806874|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806875|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82806876|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82806877|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
82806878|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82806879|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806880|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82806881|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806882|NCT00394251|Growth Substances|growth substances|mesh-ancestor
82806883|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806884|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82806885|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82806886|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82806887|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806888|NCT02532400|Goserelin|goserelin|mesh-list
82806889|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82806890|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806891|NCT00394095|Topiramate|topiramate|mesh-list
82806892|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
82806893|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82806894|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806895|NCT00503906|Paclitaxel|paclitaxel|mesh-list
82806896|NCT00503906|Bevacizumab|bevacizumab|mesh-list
82806897|NCT00503906|Gemcitabine|gemcitabine|mesh-list
82806898|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82806899|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82806900|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806901|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
82806902|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
82806903|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476463|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82806904|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806905|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82806907|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82806908|NCT00503906|Growth Substances|growth substances|mesh-ancestor
82806909|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806910|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
82806911|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806912|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
82806913|NCT00305110|Hydromorphone|hydromorphone|mesh-list
82806914|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82806915|NCT00305110|Narcotics|narcotics|mesh-ancestor
82806916|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806917|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806918|NCT00305110|Analgesics|analgesics|mesh-ancestor
82806919|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
82806920|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806921|NCT03984760|Sevelamer|sevelamer|mesh-list
82806922|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
82806923|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
82806924|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806925|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
82806926|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82806927|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82806928|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82806929|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
82806930|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806931|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806932|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806933|NCT01060618|Maraviroc|maraviroc|mesh-list
82806934|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82806935|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82806936|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806937|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82806938|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82806939|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
82806940|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82806941|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82806942|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
82806943|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82806944|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
82806945|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82806946|NCT00500292|Leucovorin|leucovorin|mesh-list
82806947|NCT00500292|Folic Acid|folic acid|mesh-list
82806948|NCT00500292|Fluorouracil|fluorouracil|mesh-list
82806949|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
82806950|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
82806951|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
82806952|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806953|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82806954|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82806955|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82806956|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
82806957|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806958|NCT00500292|Antidotes|antidotes|mesh-ancestor
82806959|NCT00500292|Protective Agents|protective agents|mesh-ancestor
83362005|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82806960|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
82806961|NCT00500292|Vitamins|vitamins|mesh-ancestor
82806962|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
82806963|NCT00500292|Hematinics|hematinics|mesh-ancestor
82806964|NCT01013558|Remifentanil|remifentanil|mesh-list
82806965|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82806966|NCT01013558|Narcotics|narcotics|mesh-ancestor
82806967|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806968|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806969|NCT01013558|Analgesics|analgesics|mesh-ancestor
82806970|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
82806971|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806972|NCT00499746|Tramadol|tramadol|mesh-list
82806973|NCT00499746|Hydromorphone|hydromorphone|mesh-list
82806974|NCT00499746|Methylphenidate|methylphenidate|mesh-list
82806975|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82806976|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82806977|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82806978|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82806979|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82806980|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806982|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82806983|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82806984|NCT00499746|Narcotics|narcotics|mesh-ancestor
82806985|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82806986|NCT00499746|Analgesics|analgesics|mesh-ancestor
82806987|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
82806988|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82806989|NCT01010516|Niacin|niacin|mesh-list
82806990|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82806991|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82806992|NCT01010516|Fenofibrate|fenofibrate|mesh-list
82806993|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82806994|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82806995|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
82806996|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82806997|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82806998|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82806999|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
82807000|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
82807001|NCT01010516|Vitamins|vitamins|mesh-ancestor
82807002|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
82807003|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807004|NCT01020162|Gabapentin|gabapentin|mesh-list
82807005|NCT01020162|Amitriptyline|amitriptyline|mesh-list
82807006|NCT01020162|Analgesics|analgesics|mesh-ancestor
82807007|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
82807008|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807009|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807010|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
82807011|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82807012|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82807013|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82807014|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82807015|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82807016|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82807017|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807018|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807019|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
82807020|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82807021|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
82807022|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82807023|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82807024|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82807025|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82807026|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
82807027|NCT01016886|Bisoprolol|bisoprolol|mesh-list
82807028|NCT01016886|Perindopril|perindopril|mesh-list
82807029|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82807030|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
82807031|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
82807032|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807033|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807034|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83362006|NCT02664922|Ketamine|ketamine|mesh-list
82807035|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82807036|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82807037|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
82807038|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807039|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807040|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82807041|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
82807042|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807043|NCT00499590|Ranibizumab|ranibizumab|mesh-list
82807044|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807045|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807046|NCT00499590|Growth Substances|growth substances|mesh-ancestor
82807047|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807048|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807049|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807050|NCT00510146|Olanzapine|olanzapine|mesh-list
82807051|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
82807052|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
82807053|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807054|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807055|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807056|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82807057|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82807058|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82807059|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82807060|NCT00510146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82807061|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82807062|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82807063|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807064|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807065|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
82807066|NCT04250064|Bevacizumab|bevacizumab|mesh-list
82807067|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82807068|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807069|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807070|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807071|NCT04250064|Growth Substances|growth substances|mesh-ancestor
82807072|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807073|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807074|NCT00480636|Dalteparin|dalteparin|mesh-list
82807075|NCT00480636|Tinzaparin|tinzaparin|mesh-list
82807076|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82807077|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
82807078|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82807079|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82807080|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807081|NCT01017198|Antacids|antacids|mesh-list
82807082|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807083|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807084|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
82807085|NCT00499122|Docetaxel|docetaxel|mesh-list
82807086|NCT00499122|Doxorubicin|doxorubicin|mesh-list
82807087|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807088|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
82807089|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807090|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807091|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82807092|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
82807093|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807094|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807095|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82807096|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
82807097|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
82807098|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
82807099|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807100|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82807101|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82807102|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807103|NCT00393939|Docetaxel|docetaxel|mesh-list
82807104|NCT00393939|Sunitinib|sunitinib|mesh-list
82807105|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807106|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
82807107|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
82807108|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
83362007|NCT02664922|Remifentanil|remifentanil|mesh-list
82807109|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807110|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807111|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807112|NCT00393939|Growth Substances|growth substances|mesh-ancestor
82807113|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807114|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807115|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82807116|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807117|NCT00488982|Docetaxel|docetaxel|mesh-list
82807118|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807119|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
82807120|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
82807121|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
82807122|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807123|NCT00488826|Vaccines|vaccines|mesh-list
82807124|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82807125|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
82807126|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807127|NCT01017354|Calcifediol|calcifediol|mesh-list
82807128|NCT01017354|Vitamins|vitamins|mesh-ancestor
82807129|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
82807130|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807131|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82807132|NCT00393861|Bevacizumab|bevacizumab|mesh-list
82807133|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
82807134|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82807135|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807136|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807137|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807138|NCT00393861|Growth Substances|growth substances|mesh-ancestor
82807139|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807140|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807141|NCT01040559|Idarubicin|idarubicin|mesh-list
82807142|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807143|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807144|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82807145|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82807146|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807147|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807148|NCT01020396|Metronidazole|metronidazole|mesh-list
82807149|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807150|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807151|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82807152|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82807153|NCT00488592|Molgramostim|molgramostim|mesh-list
82807154|NCT00488592|Sargramostim|sargramostim|mesh-list
82807155|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82807156|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
82807157|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807158|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807159|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82807160|NCT00488514|Naproxen|naproxen|mesh-list
82807161|NCT00488514|Sumatriptan|sumatriptan|mesh-list
82807162|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82807163|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82807164|NCT00488514|Analgesics|analgesics|mesh-ancestor
82807165|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
82807166|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807167|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807168|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807169|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807170|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
82807171|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82807172|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807173|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807174|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82807175|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82807176|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82807177|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
82807178|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807179|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
82807180|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82807181|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807182|NCT00320398|PENTA|penta|mesh-list
82807183|NCT00320398|Fondaparinux|fondaparinux|mesh-list
83362008|NCT02664922|Propofol|propofol|mesh-list
82807184|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82807186|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82807187|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
82807188|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807189|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807190|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
82807191|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82807192|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82807193|NCT00498186|Rotigotine|rotigotine|mesh-list
82807194|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
82807195|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
82807196|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807197|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807198|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807199|NCT03984526|Atropine|atropine|mesh-list
82807200|NCT03984526|Ephedrine|ephedrine|mesh-list
82807201|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82807202|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82807203|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82807205|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807206|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807207|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82807208|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
82807209|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
82807210|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
82807211|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82807212|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82807213|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
82807214|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807215|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807216|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82807217|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
82807218|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82807219|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
82807220|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
82807221|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
82807222|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82807223|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82807224|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
82807225|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807226|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807227|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807228|NCT01017744|Anesthetics|anesthetics|mesh-list
82807229|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82807230|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807231|NCT00477594|Mipomersen|mipomersen|mesh-list
82807232|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82807233|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82807234|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
82807235|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807236|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82807237|NCT00304954|Sirolimus|sirolimus|mesh-list
82807238|NCT00304954|Infliximab|infliximab|mesh-list
82807239|NCT00304954|Daclizumab|daclizumab|mesh-list
82807240|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807241|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807242|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807243|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807244|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
82807245|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807246|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
82807247|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807248|NCT00304954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82807249|NCT00304954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807250|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
82807251|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807252|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807253|NCT00475176|Ribavirin|ribavirin|mesh-list
82807254|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82807255|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
82807256|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807257|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
82807258|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807259|NCT00393705|Insulin|insulin|mesh-list
82807260|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82807261|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
82807262|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82807263|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807264|NCT00303628|Leucovorin|leucovorin|mesh-list
82807265|NCT00303628|Bevacizumab|bevacizumab|mesh-list
82807266|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82807267|NCT00303628|Fluorouracil|fluorouracil|mesh-list
82807268|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
82807269|NCT00303628|Antibodies|antibodies|mesh-list
82807270|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
82807271|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82807272|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
82807273|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807274|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807275|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807276|NCT00303628|Growth Substances|growth substances|mesh-ancestor
82807277|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807278|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807280|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
82807281|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807282|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82807283|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807284|NCT00303628|Antidotes|antidotes|mesh-ancestor
82807285|NCT00303628|Protective Agents|protective agents|mesh-ancestor
82807286|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
82807287|NCT00303628|Vitamins|vitamins|mesh-ancestor
82807288|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
82807289|NCT00414453|Lidocaine|lidocaine|mesh-list
82807290|NCT00414453|Oxycodone|oxycodone|mesh-list
82807291|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
82807292|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
82807293|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82807294|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807295|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
82807296|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807297|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82807298|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82807299|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82807300|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82807301|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807302|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82807303|NCT00414453|Narcotics|narcotics|mesh-ancestor
82807304|NCT00414453|Analgesics|analgesics|mesh-ancestor
82807305|NCT01037595|Turmeric extract|turmeric extract|mesh-list
82807306|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
82807307|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807308|NCT01037595|Protective Agents|protective agents|mesh-ancestor
82807309|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807310|NCT01041027|Paclitaxel|paclitaxel|mesh-list
82807311|NCT01041027|Carboplatin|carboplatin|mesh-list
82807312|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82807313|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807314|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
82807315|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
82807316|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
82807317|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807318|NCT00332488|Insulin|insulin|mesh-list
82807319|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82807320|NCT00332488|Metformin|metformin|mesh-list
82807321|NCT00332488|Secretagogues|secretagogues|mesh-list
82807322|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82807323|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807324|NCT00332332|Etanercept|etanercept|mesh-list
82807325|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82807326|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82807327|NCT00332332|Analgesics|analgesics|mesh-ancestor
82807328|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
82807329|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807330|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807331|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807332|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807333|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807334|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807335|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
82807336|NCT00392925|Pramlintide|pramlintide|mesh-list
82807337|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
82807338|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82807339|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807340|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
82807341|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82807342|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
82807343|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807344|NCT00474786|Sirolimus|sirolimus|mesh-list
82807345|NCT00474786|Sorafenib|sorafenib|mesh-list
82807346|NCT00474786|Temsirolimus|temsirolimus|mesh-list
82807347|NCT00474786|MTOR Inhibitors|mtor inhibitors|mesh-list
82807348|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807349|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82807350|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807351|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807352|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807353|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
82807354|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807355|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807356|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807357|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807358|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
82807359|NCT00392769|Cetuximab|cetuximab|mesh-list
82807360|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82807361|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807362|NCT01041183|Ramosetron|ramosetron|mesh-list
82807363|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
82807364|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
82807365|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807366|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807367|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807368|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82807369|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
82807370|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807371|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807372|NCT00319696|Bosentan|bosentan|mesh-list
82807373|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82807374|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82807375|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807376|NCT00474630|Naltrexone|naltrexone|mesh-list
82807377|NCT00474630|Bupropion|bupropion|mesh-list
82807378|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82807379|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82807380|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807381|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
82807382|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807383|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82807384|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
82807385|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82807386|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82807387|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82807388|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82807389|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807390|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
82807391|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807392|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82807393|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82807394|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807395|NCT01064752|Minocycline|minocycline|mesh-list
82807396|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807397|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807398|NCT00392379|Nicotine|nicotine|mesh-list
82807399|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82807400|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
82807401|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807402|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807403|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82807404|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82807405|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
82807406|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807407|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807408|NCT01038063|Lumefantrine|lumefantrine|mesh-list
82807409|NCT01038063|Artemether|artemether|mesh-list
82807410|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82807411|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
82807412|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82807413|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82807414|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807415|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
82807416|NCT01043991|Hematinics|hematinics|mesh-ancestor
82807417|NCT01020630|Sunitinib|sunitinib|mesh-list
82807418|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807419|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807420|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807421|NCT01020630|Growth Substances|growth substances|mesh-ancestor
82807422|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807423|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807424|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82807425|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807426|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807427|NCT00403455|Paroxetine|paroxetine|mesh-list
82807428|NCT00403455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82807429|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82807430|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82807431|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807432|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807433|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
82807434|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807435|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82807436|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
82807437|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82807438|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82807439|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82807440|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807441|NCT00318370|Farletuzumab|farletuzumab|mesh-list
82807442|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807443|NCT00510068|Everolimus|everolimus|mesh-list
82807444|NCT00510068|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82807445|NCT00510068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82807446|NCT00510068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807447|NCT00510068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807448|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807449|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
82807450|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807451|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807452|NCT00509600|Etanercept|etanercept|mesh-list
82807453|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82807454|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82807455|NCT00509600|Analgesics|analgesics|mesh-ancestor
82807456|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
82807457|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807458|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807459|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807460|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807461|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807462|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807463|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
82807464|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
82807465|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82807466|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82807467|NCT01014104|Prednisolone|prednisolone|mesh-list
82807468|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
82807469|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82807470|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
82807471|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807472|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
82807473|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
82807474|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807475|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807476|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807477|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
82807478|NCT01014104|Hormones|hormones|mesh-ancestor
82807479|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82807480|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82807481|NCT01014104|Protective Agents|protective agents|mesh-ancestor
82807482|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82807483|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807484|NCT00402987|Celecoxib|celecoxib|mesh-list
82807485|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82807486|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82807487|NCT00402987|Analgesics|analgesics|mesh-ancestor
82807488|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
82807489|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807490|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807491|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807492|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807493|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82807494|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82807495|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807496|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807497|NCT01015664|Sirolimus|sirolimus|mesh-list
82807498|NCT01015664|Cetuximab|cetuximab|mesh-list
82807499|NCT01015664|Temsirolimus|temsirolimus|mesh-list
82807500|NCT01015664|MTOR Inhibitors|mtor inhibitors|mesh-list
82807501|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807502|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82807503|NCT01015664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82807504|NCT01015664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807505|NCT01015664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807506|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807507|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
82807508|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807509|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807510|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807511|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807512|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
82807513|NCT00501644|Interferons|interferons|mesh-list
82807514|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
82807515|NCT00501644|Carboplatin|carboplatin|mesh-list
82807516|NCT00501644|Molgramostim|molgramostim|mesh-list
82807517|NCT00501644|Sargramostim|sargramostim|mesh-list
82807518|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807519|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
82807520|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807521|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
82807522|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807523|NCT01014260|Doxycycline|doxycycline|mesh-list
82807524|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807525|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807526|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
82807527|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82807528|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82807529|NCT01010672|Sirolimus|sirolimus|mesh-list
82807530|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807531|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807532|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807533|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807534|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
82807535|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807536|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
82807537|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807538|NCT01014338|Fosinopril|fosinopril|mesh-list
82807539|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82807540|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
82807541|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807542|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807543|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82807544|NCT01014416|Tolvaptan|tolvaptan|mesh-list
82807545|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82807546|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807547|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
82807548|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807549|NCT00497796|Ganciclovir|ganciclovir|mesh-list
82807550|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82807551|NCT00497796|Maribavir|maribavir|mesh-list
82807552|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
82807553|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807554|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82807555|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807556|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807557|NCT01017822|Gemcitabine|gemcitabine|mesh-list
82807558|NCT01017822|Capecitabine|capecitabine|mesh-list
82807559|NCT01017822|Conatumumab|conatumumab|mesh-list
82807560|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82807561|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
82807562|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807563|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807564|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82807565|NCT00496782|Maraviroc|maraviroc|mesh-list
82807566|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82807567|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82807568|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807569|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82807570|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82807571|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
82807572|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807573|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82807574|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
82807575|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
82807576|NCT01020708|Mesalamine|mesalamine|mesh-list
82807577|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82807578|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
82807579|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807580|NCT01020708|Expectorants|expectorants|mesh-ancestor
82807581|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
82807582|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82807583|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
82807584|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807585|NCT01020708|Protective Agents|protective agents|mesh-ancestor
82807586|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807587|NCT01020708|Antidotes|antidotes|mesh-ancestor
82807588|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82807589|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82807590|NCT01020708|Analgesics|analgesics|mesh-ancestor
82807591|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
82807592|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807593|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807594|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807595|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
82807596|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807597|NCT01020864|Carboplatin|carboplatin|mesh-list
82807598|NCT01020864|Cetuximab|cetuximab|mesh-list
82807599|NCT01020864|Vinorelbine|vinorelbine|mesh-list
82807600|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807601|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82807602|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82807603|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
82807604|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
82807605|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
82807606|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807607|NCT04428372|Mannitol|mannitol|mesh-list
82807608|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82807609|NCT04428372|Diuretics|diuretics|mesh-ancestor
82807610|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
82807611|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807612|NCT01014858|Donepezil|donepezil|mesh-list
82807613|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82807614|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807615|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807616|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
82807617|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807618|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807619|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
82807620|NCT00471276|Sunitinib|sunitinib|mesh-list
82807621|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807622|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807623|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807624|NCT00471276|Growth Substances|growth substances|mesh-ancestor
82807625|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807626|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807627|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82807628|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807629|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807630|NCT00470262|Pioglitazone|pioglitazone|mesh-list
82807631|NCT00470262|Fenofibrate|fenofibrate|mesh-list
82807632|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82807633|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807634|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82807635|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
82807636|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807637|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82807638|NCT04034862|Lamivudine|lamivudine|mesh-list
82807639|NCT04034862|Dolutegravir|dolutegravir|mesh-list
82807640|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82807641|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82807642|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807643|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807644|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
82807645|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807646|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82807647|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82807648|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82807649|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82807650|NCT00496470|Budesonide|budesonide|mesh-list
82807651|NCT00496470|Bromides|bromides|mesh-list
82807652|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
82807653|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
82807654|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82807655|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807656|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82807657|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
82807658|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807659|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807660|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82807661|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
82807662|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
82807664|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82807665|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82807666|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82807667|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82807668|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
82807669|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807670|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807671|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
82807672|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82807673|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
82807674|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
82807675|NCT01021176|Diltiazem|diltiazem|mesh-list
82807676|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82807677|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82807678|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82807679|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807680|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82807681|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807682|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
82807683|NCT01018368|Rifampin|rifampin|mesh-list
82807684|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82807685|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
82807686|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807687|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807688|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
82807689|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82807690|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807691|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807692|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82807693|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82807694|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82807695|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82807696|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82807697|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82807698|NCT00487578|Naratriptan|naratriptan|mesh-list
82807699|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82807700|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82807701|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82807702|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
82807703|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807704|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807705|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807706|NCT00495612|Omalizumab|omalizumab|mesh-list
82807707|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82807708|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82807709|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
82807711|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82807712|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82807713|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82807714|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
82807715|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807716|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82807717|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82807718|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807719|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
82807720|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82807721|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82807722|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82807723|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
82807724|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
82807725|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807726|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82807727|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82807728|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807729|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82807730|NCT00509366|Cisplatin|cisplatin|mesh-list
82807731|NCT00509366|Gemcitabine|gemcitabine|mesh-list
82807732|NCT00509366|Docetaxel|docetaxel|mesh-list
82807733|NCT00509366|Pemetrexed|pemetrexed|mesh-list
82807734|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807735|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82807736|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
82807737|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807738|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
82807739|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
82807740|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
82807741|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807742|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82807743|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82807744|NCT01016054|Carboplatin|carboplatin|mesh-list
82807745|NCT01016054|Gemcitabine|gemcitabine|mesh-list
82807746|NCT01016054|Doxorubicin|doxorubicin|mesh-list
82807747|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82807748|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807749|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82807750|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
82807751|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807752|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807753|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82807754|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82807755|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807756|NCT00500318|Bromides|bromides|mesh-list
82807757|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
82807758|NCT00499694|Bevacizumab|bevacizumab|mesh-list
82807759|NCT00499694|Satraplatin|satraplatin|mesh-list
82807760|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82807761|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807762|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82807763|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82807764|NCT00499694|Growth Substances|growth substances|mesh-ancestor
82807765|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807766|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
82807767|NCT00486954|Paclitaxel|paclitaxel|mesh-list
82807768|NCT00486954|Lapatinib|lapatinib|mesh-list
82807769|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82807770|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807771|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
82807772|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
82807773|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
83442016|NCT01270841|Clomiphene|clomiphene|mesh-list
82807774|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807775|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82807776|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807777|NCT00494676|Methamphetamine|methamphetamine|mesh-list
82807778|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82807779|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807780|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
82807781|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
82807782|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807783|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
82807784|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807785|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807786|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
82807787|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82807788|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82807789|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82807790|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82807791|NCT00486720|Vorinostat|vorinostat|mesh-list
82807792|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807793|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82807794|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807795|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807796|NCT00486330|Ritonavir|ritonavir|mesh-list
82807797|NCT00486330|Tipranavir|tipranavir|mesh-list
82807798|NCT00486330|Buprenorphine|buprenorphine|mesh-list
82807799|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82807800|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82807801|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
82807802|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807803|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807804|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82807805|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82807806|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
82807807|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807808|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82807809|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82807810|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82807811|NCT00486330|Narcotics|narcotics|mesh-ancestor
82807812|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82807813|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807814|NCT00486330|Analgesics|analgesics|mesh-ancestor
82807815|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
82807816|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807817|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82807818|NCT01021566|Methadone|methadone|mesh-list
82807819|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82807820|NCT01021566|Narcotics|narcotics|mesh-ancestor
82807821|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82807822|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807823|NCT01021566|Analgesics|analgesics|mesh-ancestor
82807824|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
82807825|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807826|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
82807827|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
82807828|NCT00494442|Olaparib|olaparib|mesh-list
82807829|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82807830|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807831|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807832|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807833|NCT00493974|Zileuton|zileuton|mesh-list
82807834|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82807835|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82807836|NCT00493974|Analgesics|analgesics|mesh-ancestor
82807837|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
82807838|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807839|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807840|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807841|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807842|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82807843|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807844|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807845|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82807846|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
82807847|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82807848|NCT01018446|Busulfan|busulfan|mesh-list
82807849|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
82807850|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807851|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807852|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
82807853|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807854|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82807855|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807856|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82807857|NCT01018602|Vildagliptin|vildagliptin|mesh-list
82807858|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82807859|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807860|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82807861|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
82807862|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807863|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807864|NCT01018758|Palonosetron|palonosetron|mesh-list
82807865|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
82807866|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
82807867|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807868|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807869|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807870|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82807871|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82807872|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
82807873|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82807874|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807875|NCT00469092|Insulin|insulin|mesh-list
82807876|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82807877|NCT00469092|Metformin|metformin|mesh-list
82807878|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
82807879|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
82807880|NCT00469092|Glimepiride|glimepiride|mesh-list
82807881|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
82807882|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82807883|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807884|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82807885|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807886|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
82807887|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
82807888|NCT00499616|Carboplatin|carboplatin|mesh-list
82807889|NCT00499616|Doxorubicin|doxorubicin|mesh-list
82807890|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82807891|NCT00499616|Etoposide|etoposide|mesh-list
82807892|NCT00499616|Topotecan|topotecan|mesh-list
82807893|NCT00499616|Isotretinoin|isotretinoin|mesh-list
82807894|NCT00499616|Lenograstim|lenograstim|mesh-list
82807895|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807896|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
82807897|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807898|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82807899|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82807900|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
82807901|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807902|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807903|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82807904|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82807905|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82807906|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82807907|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807908|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82807909|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82807910|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82807911|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
82807912|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
82807913|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82807914|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
82807915|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82807916|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
82807917|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807918|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807919|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
82807920|NCT00469014|Fludarabine|fludarabine|mesh-list
82807921|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
82807922|NCT00469014|Busulfan|busulfan|mesh-list
82807923|NCT00469014|Clofarabine|clofarabine|mesh-list
82807924|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
82807925|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82807926|NCT00469014|Lenograstim|lenograstim|mesh-list
82807927|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807928|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82807929|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
82807930|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807931|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807932|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
82807933|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807934|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82807935|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
82807936|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82807937|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82807938|NCT00493038|Amoxicillin|amoxicillin|mesh-list
82807939|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
82807940|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
82807941|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
82807942|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82807943|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82807944|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807945|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807946|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82807947|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82807948|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807949|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807950|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807951|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82807952|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
82807953|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82807954|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807955|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82807956|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82807958|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82807959|NCT00392223|Azithromycin|azithromycin|mesh-list
82807960|NCT00392223|Minocycline|minocycline|mesh-list
82807961|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82807962|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82807964|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82807965|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
82807966|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807967|NCT00402285|Protective Agents|protective agents|mesh-ancestor
82807968|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807969|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82807970|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82807971|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807972|NCT03747159|Belimumab|belimumab|mesh-list
82807973|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82807974|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
82807975|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807976|NCT00413283|Carboplatin|carboplatin|mesh-list
82807977|NCT00413283|Gemcitabine|gemcitabine|mesh-list
82807978|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807979|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82807980|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
82807981|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807982|NCT00402051|Carboplatin|carboplatin|mesh-list
82807983|NCT00402051|Pemetrexed|pemetrexed|mesh-list
82807984|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82807985|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82807986|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82807987|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82807988|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82807989|NCT00401973|Metformin|metformin|mesh-list
82807990|NCT00401973|Amantadine|amantadine|mesh-list
82807991|NCT00401973|Zonisamide|zonisamide|mesh-list
82807992|NCT00401973|Olanzapine|olanzapine|mesh-list
82807993|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82807994|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82807995|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
82807996|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
82807997|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82807998|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82807999|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82808000|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82808001|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808002|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82808003|NCT00401973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82808004|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82808005|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808006|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808007|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808008|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
82808009|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82808010|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82808011|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
82808012|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808014|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82808015|NCT00401973|Analgesics|analgesics|mesh-ancestor
82808016|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
82808017|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
82808018|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82808019|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82808020|NCT01038453|Vitamin D|vitamin d|mesh-list
82808021|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
82808022|NCT01038453|Vitamins|vitamins|mesh-ancestor
82808023|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
82808024|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808025|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82808026|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82808027|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
82808028|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82808029|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82808030|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808031|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
82808032|NCT00401193|Coagulants|coagulants|mesh-ancestor
82808033|NCT00400569|Sunitinib|sunitinib|mesh-list
82808034|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808035|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82808036|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82808037|NCT00400569|Growth Substances|growth substances|mesh-ancestor
82808038|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808039|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
82808040|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808041|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808042|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808043|NCT00413049|Amlodipine|amlodipine|mesh-list
82808044|NCT00413049|Valsartan|valsartan|mesh-list
82808045|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82808046|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82808047|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808048|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808049|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82808050|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808051|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
82808052|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82808053|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82808054|NCT03732495|Denosumab|denosumab|mesh-list
82808055|NCT03732495|Lenvatinib|lenvatinib|mesh-list
82808056|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808057|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808058|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808059|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808060|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82808061|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808062|NCT01041729|Atorvastatin|atorvastatin|mesh-list
82808063|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82808064|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82808065|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
82808066|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808067|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82808068|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82808069|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808070|NCT01324245|Fenoldopam|fenoldopam|mesh-list
82808071|NCT01324245|Enalaprilat|enalaprilat|mesh-list
82808072|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82808073|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
82808074|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
82808075|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
82808076|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808077|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808078|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808079|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82808080|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
82808081|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808082|NCT00454194|Pemetrexed|pemetrexed|mesh-list
82808083|NCT00454194|Sorafenib|sorafenib|mesh-list
82808084|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808085|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808086|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808088|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82808089|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808090|NCT00468546|Methotrexate|methotrexate|mesh-list
82808091|NCT00468546|Rituximab|rituximab|mesh-list
82808092|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82808093|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
82808094|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82808095|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808096|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808097|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
82808098|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808099|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808100|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
82808101|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808102|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82808103|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808104|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
82808105|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808106|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82808107|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808108|NCT00303316|Vaccines|vaccines|mesh-list
82808109|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
82808110|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808111|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
82808112|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82808113|NCT01064986|Epinephrine|epinephrine|mesh-list
82808114|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82808115|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82808116|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
82808117|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808118|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808119|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808120|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82808121|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82808122|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
82808123|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808124|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82808125|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
82808126|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
82808127|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
82808128|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82808129|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808130|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
82808131|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808132|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
82808133|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82808134|NCT03980002|Thalidomide|thalidomide|mesh-list
82808135|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808136|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
82808137|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808138|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
82808139|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82808140|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808141|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82808142|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82808143|NCT03980002|Growth Substances|growth substances|mesh-ancestor
82808144|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
82808145|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808146|NCT00331864|Ranibizumab|ranibizumab|mesh-list
82808147|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82808148|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82808149|NCT00331864|Growth Substances|growth substances|mesh-ancestor
82808150|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808151|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
82808152|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808154|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82808155|NCT00331630|Lapatinib|lapatinib|mesh-list
82808156|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82808157|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808158|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
82808159|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
82808160|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
82808161|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808162|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808163|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808164|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
82808165|NCT00331552|Doxorubicin|doxorubicin|mesh-list
82808166|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82808167|NCT00331552|Trastuzumab|trastuzumab|mesh-list
82808168|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82808169|NCT00331552|Antibodies|antibodies|mesh-list
82808170|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
82808171|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82808172|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808173|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
82808174|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808175|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808176|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82808177|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
82808178|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808179|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808180|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82808181|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82808182|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82808183|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82808184|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808185|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82808186|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808187|NCT00331006|Rituximab|rituximab|mesh-list
82808188|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808189|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808190|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
82808191|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808192|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808193|NCT00302458|Methylphenidate|methylphenidate|mesh-list
82808194|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82808195|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808196|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82808197|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82808198|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808199|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808200|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
82808201|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808202|NCT00391053|Vaccines|vaccines|mesh-list
82808203|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
82808204|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808205|NCT00317044|Esomeprazole|esomeprazole|mesh-list
82808206|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82808207|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82808208|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82808209|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808210|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808211|NCT00301834|Cyclosporine|cyclosporine|mesh-list
82808212|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
82808213|NCT00301834|Methotrexate|methotrexate|mesh-list
82808214|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
82808215|NCT00301834|Fludarabine|fludarabine|mesh-list
82808216|NCT00301834|Busulfan|busulfan|mesh-list
82808217|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
82808218|NCT00301834|Cyclosporins|cyclosporins|mesh-list
82808219|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82808220|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
82808221|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82808222|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808223|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808224|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
82808225|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808226|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808227|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
82808228|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808229|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82808230|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808231|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
82808232|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808233|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82808234|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
82808235|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808236|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82808237|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808238|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
82808239|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
82808240|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808241|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82808242|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
82808243|NCT00301834|Hormones|hormones|mesh-ancestor
82808244|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808245|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82808246|NCT00301834|Protective Agents|protective agents|mesh-ancestor
82808247|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
82808248|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82808249|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82808250|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808251|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
82808252|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82808253|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808254|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808255|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82808256|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82808257|NCT00466440|Prednisone|prednisone|mesh-list
82808258|NCT00466440|Docetaxel|docetaxel|mesh-list
82808259|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808260|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
82808261|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
82808262|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
82808263|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808264|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808265|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
82808267|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808268|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808269|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82808270|NCT00465972|Doxepin|doxepin|mesh-list
82808271|NCT00465972|Temazepam|temazepam|mesh-list
82808272|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82808273|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82808274|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808275|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808276|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82808277|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
82808278|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82808279|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
82808280|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
82808281|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808282|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808283|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82808284|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82808285|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
82808286|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
82808287|NCT03926754|Mirabegron|mirabegron|mesh-list
82808288|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82808289|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82808290|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82808291|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
82808292|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808293|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808294|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808295|NCT03926754|Urological Agents|urological agents|mesh-ancestor
82808296|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82808297|NCT00465894|Estradiol|estradiol|mesh-list
82808298|NCT00465894|Estrogens|estrogens|mesh-ancestor
82808299|NCT00465894|Hormones|hormones|mesh-ancestor
82808300|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808301|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808302|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82808303|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82808304|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
82808305|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808306|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808307|NCT00465894|Urological Agents|urological agents|mesh-ancestor
82808308|NCT00330460|Denosumab|denosumab|mesh-list
82808309|NCT00330460|Alendronate|alendronate|mesh-list
82808310|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82808311|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808312|NCT01062490|Treosulfan|treosulfan|mesh-list
82808313|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82808314|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
82808315|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808316|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808317|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
82808318|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82808319|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82808320|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82808321|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82808322|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808323|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808324|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
82808325|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808326|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808327|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82808328|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808329|NCT00400179|Cisplatin|cisplatin|mesh-list
82808330|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808331|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
82808332|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82808333|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82808334|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808335|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808336|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
82808337|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82808338|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808339|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808340|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82808342|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
82808343|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808344|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82808345|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82808346|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82808347|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
82808348|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808349|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808350|NCT00412893|Voriconazole|voriconazole|mesh-list
82808351|NCT00412893|Isavuconazole|isavuconazole|mesh-list
82808352|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
82808353|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808354|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82808355|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82808356|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808357|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808358|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82808359|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
82808360|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808361|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808362|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82808363|NCT00412737|Oseltamivir|oseltamivir|mesh-list
82808364|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
82808365|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808366|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808367|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808368|NCT00508742|Vaccines|vaccines|mesh-list
82808369|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82808370|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
82808371|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808372|NCT01041963|Losartan|losartan|mesh-list
82808373|NCT01041963|Enalapril|enalapril|mesh-list
82808374|NCT01041963|Enalaprilat|enalaprilat|mesh-list
82808375|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82808376|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82808377|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82808378|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82808379|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808380|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82808381|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
82808382|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808386|NCT00508274|Capecitabine|capecitabine|mesh-list
82808387|NCT00508274|Lapatinib|lapatinib|mesh-list
82808388|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808389|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
82808390|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808391|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808392|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808393|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808394|NCT01042041|Doxorubicin|doxorubicin|mesh-list
82808395|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82808396|NCT01042041|Sorafenib|sorafenib|mesh-list
82808397|NCT01042041|Mitomycins|mitomycins|mesh-list
82808398|NCT01042041|Mitomycin|mitomycin|mesh-list
82808399|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808400|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82808401|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82808402|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82808403|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808404|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808405|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808406|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
82808407|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82808408|NCT00499460|Oxycodone|oxycodone|mesh-list
82808409|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82808410|NCT00499460|Narcotics|narcotics|mesh-ancestor
82808411|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808412|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808413|NCT00499460|Analgesics|analgesics|mesh-ancestor
82808414|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
82808415|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808416|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
82808418|NCT00412113|Atorvastatin|atorvastatin|mesh-list
82808419|NCT00412113|Calcium|calcium|mesh-list
82808420|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82808421|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808422|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82808423|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82808424|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82808425|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
82808426|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808427|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82808428|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82808429|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808430|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82808431|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82808432|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808433|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
82808437|NCT01014650|Glycine|glycine|mesh-list
82808438|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
82808439|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808440|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808441|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808442|NCT00411645|Maribavir|maribavir|mesh-list
82808443|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
82808444|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808445|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82808446|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
82808447|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808448|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
82808449|NCT01039155|Azacitidine|azacitidine|mesh-list
82808450|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808451|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808452|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
82808453|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808454|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808455|NCT01039233|Bicalutamide|bicalutamide|mesh-list
82808456|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
82808457|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
82808458|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362010|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82808459|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808460|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808461|NCT00490646|Docetaxel|docetaxel|mesh-list
82808462|NCT00490646|Trastuzumab|trastuzumab|mesh-list
82808463|NCT00490646|Epothilones|epothilones|mesh-list
82808464|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808465|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
82808466|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
82808467|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
82808468|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808469|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808470|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
82808471|NCT03992937|Progesterone|progesterone|mesh-list
82808472|NCT03992937|Progestins|progestins|mesh-ancestor
82808473|NCT03992937|Hormones|hormones|mesh-ancestor
82808474|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808475|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808476|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82808477|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
82808478|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82808479|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82808480|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82808481|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82808482|NCT01039545|Norfloxacin|norfloxacin|mesh-list
82808483|NCT01039545|Diclofenac|diclofenac|mesh-list
82808484|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82808485|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82808486|NCT01039545|Analgesics|analgesics|mesh-ancestor
82808487|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
82808488|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808489|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808490|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808491|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808492|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82808493|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808494|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808495|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82808496|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808497|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82808498|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82808499|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808500|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82808501|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82808502|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
82808503|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82808504|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808505|NCT00561353|Ribavirin|ribavirin|mesh-list
82808506|NCT00561353|Simeprevir|simeprevir|mesh-list
82808507|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
82808508|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808509|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
82808510|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808511|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
82808512|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808513|NCT00859781|Ketoconazole|ketoconazole|mesh-list
82808514|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
82808515|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808516|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
82808517|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808518|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82808519|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82808520|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808521|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808522|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82808523|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
82808524|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808525|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808526|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82808527|NCT00944957|Efavirenz|efavirenz|mesh-list
82808528|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
82808529|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82808530|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82808531|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808532|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808533|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
82808534|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808535|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82808536|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82808537|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82808538|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82808539|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82808540|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82808541|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82808542|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82808543|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82808544|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82808546|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808547|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808548|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82808549|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82808550|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
82808551|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808552|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82808553|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82808554|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808555|NCT00941135|Docetaxel|docetaxel|mesh-list
82808556|NCT00941135|Cetuximab|cetuximab|mesh-list
82808557|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808558|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
82808559|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
82808560|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
82808561|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808562|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808563|NCT00556439|Abatacept|abatacept|mesh-list
82808564|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82808565|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808566|NCT00556439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808567|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808568|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808569|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
82808570|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808571|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808572|NCT04012307|Candesartan|candesartan|mesh-list
82808573|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
82808574|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82808575|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82808576|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82808577|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808578|NCT00387465|Azacitidine|azacitidine|mesh-list
82808579|NCT00387465|Entinostat|entinostat|mesh-list
82808580|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82808581|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808582|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
82808583|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808584|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808585|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808586|NCT01042665|Latanoprost|latanoprost|mesh-list
82808587|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83442034|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
82808588|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82808589|NCT00949949|Gemcitabine|gemcitabine|mesh-list
82808590|NCT00949949|Everolimus|everolimus|mesh-list
82808591|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808592|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808593|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
82808594|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808595|NCT00949949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82808596|NCT00949949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808597|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808598|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808599|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
82808600|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808601|NCT00941369|Insulin|insulin|mesh-list
82808602|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
82808603|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
82808604|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
82808605|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
82808606|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82808607|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808609|NCT00950027|Povidone|povidone|mesh-list
82808610|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
82808611|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
82808612|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82808613|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808614|NCT00941525|Latanoprost|latanoprost|mesh-list
82808615|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82808616|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82808617|NCT00456261|Bevacizumab|bevacizumab|mesh-list
82808618|NCT00456261|Carboplatin|carboplatin|mesh-list
82808619|NCT00456261|Gemcitabine|gemcitabine|mesh-list
82808620|NCT00456261|Pemetrexed|pemetrexed|mesh-list
82808621|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808622|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808623|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82808624|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82808625|NCT00456261|Growth Substances|growth substances|mesh-ancestor
82808626|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808627|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
82808628|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808629|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
82808630|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808631|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808632|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82808633|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82808634|NCT00386607|Valsartan|valsartan|mesh-list
82808635|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82808636|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82808637|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82808638|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82808639|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808640|NCT00386607|Diuretics|diuretics|mesh-ancestor
82808641|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
82808642|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808643|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82808644|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808645|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
82808646|NCT00410163|Fludarabine|fludarabine|mesh-list
82808647|NCT00410163|Ofatumumab|ofatumumab|mesh-list
82808648|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82808649|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808650|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
82808651|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808652|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808653|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82808654|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
82808655|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808656|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808657|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82808658|NCT03617523|Vaccines|vaccines|mesh-list
82808659|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
82808660|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808661|NCT00409617|Adalimumab|adalimumab|mesh-list
82808662|NCT00409617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82808663|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808664|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808665|NCT00300274|Cyclosporine|cyclosporine|mesh-list
82808666|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
82808667|NCT00300274|Everolimus|everolimus|mesh-list
82808668|NCT00300274|Cyclosporins|cyclosporins|mesh-list
82808669|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808670|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808671|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808672|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
82808673|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808674|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
82808675|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808676|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
82808677|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808678|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82808679|NCT00300274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82808680|NCT00300274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808681|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808682|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82808683|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82808684|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
82808685|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82808687|NCT01043211|Epinephrine|epinephrine|mesh-list
82808688|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
82808689|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
82808690|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808691|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808692|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
82808693|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808694|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82808695|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82808696|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82808697|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808698|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808699|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82808700|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82808701|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
82808702|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808703|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82808704|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82808705|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
82808706|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82808707|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
82808708|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
82808709|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
82808710|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82808711|NCT01043445|Glycerol|glycerol|mesh-list
82808712|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82808713|NCT01043445|Protective Agents|protective agents|mesh-ancestor
82808714|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808715|NCT00396591|Aflibercept|aflibercept|mesh-list
82808716|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82808717|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82808718|NCT00396591|Growth Substances|growth substances|mesh-ancestor
82808719|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808720|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
82808721|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808722|NCT00316264|Palivizumab|palivizumab|mesh-list
82808723|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
82808724|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808725|NCT00385827|Prednisone|prednisone|mesh-list
82808726|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
82808727|NCT00385827|Siltuximab|siltuximab|mesh-list
82808728|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808729|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
82808730|NCT00385827|Hormones|hormones|mesh-ancestor
82808731|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808732|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808733|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82808734|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808735|NCT00385827|Analgesics|analgesics|mesh-ancestor
82808736|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
82808737|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83442038|NCT01278173|Vigabatrin|vigabatrin|mesh-list
82808738|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82808739|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82808740|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808741|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808742|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
82808743|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82808744|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
82808745|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808746|NCT00507728|Bupropion|bupropion|mesh-list
82808747|NCT00507728|Varenicline|varenicline|mesh-list
82808748|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82808749|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
82808750|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82808751|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82808752|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82808753|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808754|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808755|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
82808756|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808757|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808758|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82808759|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82808760|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808761|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82808762|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82808763|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
82808764|NCT00498368|Rituximab|rituximab|mesh-list
82808765|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
82808766|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82808767|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808768|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
82808769|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808770|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808771|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82808772|NCT04460066|Paclitaxel|paclitaxel|mesh-list
82808773|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82808774|NCT04460066|Antibodies|antibodies|mesh-list
82808775|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82808776|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808777|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
82808778|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
82808779|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
82808780|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808781|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
82808782|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808783|NCT00385671|Pregabalin|pregabalin|mesh-list
82808784|NCT00385671|Gabapentin|gabapentin|mesh-list
82808785|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82808786|NCT00385671|Analgesics|analgesics|mesh-ancestor
82808787|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
82808788|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808789|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808790|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
82808791|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82808792|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808793|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808794|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82808795|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82808796|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82808797|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808798|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82808799|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82808800|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82808801|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808802|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
82808803|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82808804|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82808805|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
82808806|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
82808807|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
82808808|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82808809|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
82808810|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82808811|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82808812|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82808813|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82808814|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808815|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
82808816|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808817|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808818|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82808819|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808820|NCT01011062|Losartan|losartan|mesh-list
82808821|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82808822|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82808823|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82808824|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82808825|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808826|NCT00490490|Iodine|iodine|mesh-list
82808827|NCT00490490|Lugol's solution|lugol's solution|mesh-list
82808828|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82808829|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82808830|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808831|NCT00490490|Trace Elements|trace elements|mesh-ancestor
82808832|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
82808833|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808834|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
82808835|NCT00490490|Coagulants|coagulants|mesh-ancestor
82808836|NCT05049980|Mifepristone|mifepristone|mesh-list
82808837|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82808838|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
82808839|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82808840|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808841|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82808842|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82808843|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82808844|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
82808845|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82808846|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82808847|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
82808848|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808849|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
82808850|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82808851|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82808852|NCT05176418|Nicotine|nicotine|mesh-list
82808853|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82808854|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
82808855|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808856|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808857|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82808858|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82808859|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
82808860|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808861|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808863|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
82808864|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82808865|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808866|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82808867|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
82808868|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808869|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808870|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82808871|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
82808872|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
82808874|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808875|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82808876|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82808877|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82808878|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
82808879|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808880|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808881|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
82808882|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82808883|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82808884|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
82808885|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808886|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808887|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808888|NCT01015040|Urological Agents|urological agents|mesh-ancestor
82808889|NCT00495170|Paclitaxel|paclitaxel|mesh-list
82808890|NCT00495170|Carboplatin|carboplatin|mesh-list
82808891|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82808892|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808893|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
82808894|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
82808895|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
82808896|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808897|NCT01011374|Ranibizumab|ranibizumab|mesh-list
82808898|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82808899|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82808900|NCT01011374|Growth Substances|growth substances|mesh-ancestor
82808901|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808902|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
82808903|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808904|NCT00385203|Cediranib|cediranib|mesh-list
82808905|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808906|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82808907|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808908|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808909|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
82808910|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82808911|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
82808912|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808913|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808914|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82808915|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
82808916|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82808917|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82808918|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82808919|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
82808920|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808921|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808922|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82808923|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
82808924|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82808925|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82808926|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82808927|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808928|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808929|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82808930|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82808931|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82808933|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808934|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82808935|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808936|NCT00408993|Analgesics|analgesics|mesh-ancestor
82808937|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
82808938|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808939|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
82808940|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82808941|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
82808942|NCT00395967|Plerixafor|plerixafor|mesh-list
82808943|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82808944|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82808945|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
82808946|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808947|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82808948|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82808949|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808950|NCT00395343|Incretins|incretins|mesh-ancestor
82808951|NCT00395343|Hormones|hormones|mesh-ancestor
82808952|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82808953|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82808954|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
82808955|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808956|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808957|NCT00560573|Gemcitabine|gemcitabine|mesh-list
82808958|NCT00560573|Pemetrexed|pemetrexed|mesh-list
82808959|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808960|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82808961|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
82808962|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808963|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808964|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82808965|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82808966|NCT00950105|Semapimod|semapimod|mesh-list
82808967|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82808968|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82808969|NCT00950105|Analgesics|analgesics|mesh-ancestor
82808970|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
82808971|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808972|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808973|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82808974|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82808975|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82808976|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
82808977|NCT00950261|Cisplatin|cisplatin|mesh-list
82808978|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82808979|NCT05280197|Bupivacaine|bupivacaine|mesh-list
82808980|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
82808981|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
82808982|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82808983|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82808984|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
82808985|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82808986|NCT00946595|Ritonavir|ritonavir|mesh-list
82808987|NCT00946595|Lopinavir|lopinavir|mesh-list
82808988|NCT00946595|Tenofovir|tenofovir|mesh-list
82808989|NCT00946595|Efavirenz|efavirenz|mesh-list
82808990|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82808991|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82808992|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
82808993|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82808994|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82808995|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82808996|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82808997|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
82808998|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82808999|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82809000|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82809001|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82809002|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82809003|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82809004|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82809005|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82809006|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82809007|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82809009|NCT00494780|Prednisolone|prednisolone|mesh-list
82809010|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
82809011|NCT00494780|Doxorubicin|doxorubicin|mesh-list
82809012|NCT00494780|Vincristine|vincristine|mesh-list
82809013|NCT00494780|Ofatumumab|ofatumumab|mesh-list
82809014|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82809015|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
82809016|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809017|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809018|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82809019|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
82809020|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809021|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809022|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82809023|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82809024|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82809025|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82809026|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809027|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809028|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
82809029|NCT00494780|Hormones|hormones|mesh-ancestor
82809030|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809031|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82809032|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82809033|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
82809034|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
82809035|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
82809036|NCT01011452|Montelukast|montelukast|mesh-list
82809037|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82809038|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
82809039|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82809040|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
82809041|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809042|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809043|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82809044|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82809045|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809046|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
82809047|NCT00490022|Androgens|androgens|mesh-ancestor
82809048|NCT00490022|Hormones|hormones|mesh-ancestor
82809049|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809050|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809051|NCT01011530|Pevonedistat|pevonedistat|mesh-list
82809052|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809053|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809054|NCT00493454|Rituximab|rituximab|mesh-list
82809055|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82809056|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809057|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809058|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
82809059|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809060|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809061|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
82809062|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82809063|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809064|NCT00950339|Omeprazole|omeprazole|mesh-list
82809065|NCT00950339|Pantoprazole|pantoprazole|mesh-list
82809066|NCT00950339|Famotidine|famotidine|mesh-list
82809067|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82809068|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809069|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82809070|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809071|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809072|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82809073|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
82809074|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
82809075|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809076|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809077|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
82809078|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809079|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809081|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809082|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82809083|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809084|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809085|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
82809086|NCT00394953|Hematinics|hematinics|mesh-ancestor
82809087|NCT00946751|Levetiracetam|levetiracetam|mesh-list
82809088|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
82809089|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
82809090|NCT00485732|Vaccines|vaccines|mesh-list
82809091|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
82809092|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809093|NCT00946829|Telmisartan|telmisartan|mesh-list
82809094|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82809095|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82809096|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82809097|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809098|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82809099|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
82809100|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809101|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
82809102|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
82809103|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809104|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809105|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809106|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
82809107|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809108|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809109|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809110|NCT00560417|Insulin|insulin|mesh-list
82809111|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82809112|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
82809113|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
82809114|NCT00560417|Protamines|protamines|mesh-list
82809115|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82809116|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809117|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
82809118|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809119|NCT00560417|Coagulants|coagulants|mesh-ancestor
82809120|NCT01040091|Tenofovir|tenofovir|mesh-list
82809121|NCT01040091|Emtricitabine|emtricitabine|mesh-list
82809122|NCT01040091|Efavirenz|efavirenz|mesh-list
82809123|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82809124|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
82809125|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809126|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83362011|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362012|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809127|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82809128|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809129|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809130|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82809131|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82809132|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82809133|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82809134|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82809135|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82809136|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82809137|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82809138|NCT00946907|Aspirin|aspirin|mesh-list
82809139|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82809140|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82809141|NCT00946907|Analgesics|analgesics|mesh-ancestor
82809142|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
82809143|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809144|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809145|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809146|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809147|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82809148|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82809149|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809150|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82809151|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82809152|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809154|NCT00942539|Midazolam|midazolam|mesh-list
82809155|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82809156|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82809157|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809158|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809159|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82809160|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809161|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809162|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82809163|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
82809164|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
82809165|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
82809166|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
82809167|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809168|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809169|NCT00947063|Promethazine|promethazine|mesh-list
82809170|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
82809171|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
82809172|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
82809173|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82809174|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
82809175|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
82809176|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83442046|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809177|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809178|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809179|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82809180|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82809181|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82809182|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809183|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
82809184|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
82809185|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
82809186|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809187|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
82809188|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
82809189|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809190|NCT00942617|Aspirin|aspirin|mesh-list
82809191|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82809192|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82809193|NCT00942617|Analgesics|analgesics|mesh-ancestor
82809194|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
82809195|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809196|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809197|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809198|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809199|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82809200|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82809201|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809202|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82809203|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82809204|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809205|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
82809206|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
82809207|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809208|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809209|NCT03968159|Pimavanserin|pimavanserin|mesh-list
82809210|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82809211|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82809212|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82809213|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809214|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809215|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809216|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809217|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82809218|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82809219|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
82809220|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809221|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809222|NCT00947141|Valganciclovir|valganciclovir|mesh-list
82809223|NCT00947141|Ganciclovir|ganciclovir|mesh-list
82809224|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82809225|NCT00947141|Foscarnet|foscarnet|mesh-list
82809226|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
82809227|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
82809228|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809229|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82809230|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809231|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809232|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82809233|NCT03966365|Timolol|timolol|mesh-list
82809234|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82809235|NCT03966365|Dorzolamide|dorzolamide|mesh-list
82809236|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82809237|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82809238|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
82809239|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809240|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809241|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809242|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82809243|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82809244|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82809245|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82809246|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82809247|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82809248|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809249|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
82809250|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82809251|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809252|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82809253|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809254|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809255|NCT03965351|Probenecid|probenecid|mesh-list
82809256|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
82809257|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
82809258|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809259|NCT00947375|Lamotrigine|lamotrigine|mesh-list
82809260|NCT00947375|Haloperidol|haloperidol|mesh-list
82809261|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
82809262|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
82809263|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
82809264|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809265|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809266|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809267|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82809268|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809269|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809270|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809271|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82809272|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
82809273|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362013|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83362014|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
82809274|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809275|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82809276|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
82809277|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82809278|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82809279|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82809280|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82809281|NCT00947453|Montelukast|montelukast|mesh-list
82809282|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82809283|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
82809284|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82809285|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
82809286|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809287|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809288|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82809289|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82809290|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809291|NCT00942773|Voriconazole|voriconazole|mesh-list
82809292|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
82809293|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809294|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82809295|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82809296|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809297|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809298|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82809299|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
82809300|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809301|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809302|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82809304|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809305|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
82809306|NCT04364555|Hormones|hormones|mesh-ancestor
82809307|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809308|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809309|NCT00374907|Metformin|metformin|mesh-list
82809310|NCT00374907|Saxagliptin|saxagliptin|mesh-list
82809311|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82809312|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809313|NCT00374907|Incretins|incretins|mesh-ancestor
82809314|NCT00374907|Hormones|hormones|mesh-ancestor
82809315|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809316|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82809317|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
82809318|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809319|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809320|NCT01045083|Methylphenidate|methylphenidate|mesh-list
82809321|NCT01045083|Escitalopram|escitalopram|mesh-list
82809322|NCT01045083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82809323|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82809324|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82809325|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809326|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809327|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
82809328|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809329|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82809330|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82809331|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
82809332|NCT01040325|Vaccines|vaccines|mesh-list
82809333|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
82809334|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809335|NCT00947843|Aspirin|aspirin|mesh-list
82809336|NCT00947843|Clopidogrel|clopidogrel|mesh-list
82809337|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82809338|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82809339|NCT00947843|Analgesics|analgesics|mesh-ancestor
82809340|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
82809341|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809342|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809343|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809344|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809345|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82809346|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82809347|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809348|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82809349|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82809350|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809351|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
82809352|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82809353|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82809354|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82809355|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
82809356|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809357|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
82809358|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
82809359|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82809360|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809361|NCT00407745|Pregabalin|pregabalin|mesh-list
82809362|NCT00407745|Analgesics|analgesics|mesh-ancestor
82809363|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
82809364|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809365|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809366|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
82809367|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82809368|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82809369|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809370|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82809371|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82809372|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809373|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809374|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809375|NCT00951431|Esomeprazole|esomeprazole|mesh-list
82809376|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82809377|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809378|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82809379|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809380|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809381|NCT00299494|Rituximab|rituximab|mesh-list
82809382|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82809383|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809384|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809385|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
82809386|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809387|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809388|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82809389|NCT00299494|Immunotoxins|immunotoxins|mesh-ancestor
82809390|NCT00299494|Immunoconjugates|immunoconjugates|mesh-ancestor
82809391|NCT00943553|Decitabine|decitabine|mesh-list
82809392|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82809393|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
82809394|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809395|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809396|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809397|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
82809398|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82809399|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
82809400|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809401|NCT00453180|Expectorants|expectorants|mesh-ancestor
82809402|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
82809403|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82809404|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
82809405|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809406|NCT00453180|Protective Agents|protective agents|mesh-ancestor
82809407|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809408|NCT00453180|Antidotes|antidotes|mesh-ancestor
82809409|NCT00943709|Insulin|insulin|mesh-list
82809410|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82809411|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
82809412|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82809413|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809414|NCT00464178|Bortezomib|bortezomib|mesh-list
82809415|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809416|NCT00316186|Carboplatin|carboplatin|mesh-list
82809417|NCT00316186|Topotecan|topotecan|mesh-list
82809418|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809419|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82809420|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82809421|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809422|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809423|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
82809424|NCT01065220|Testolactone|testolactone|mesh-list
82809425|NCT01065220|Lynestrenol|lynestrenol|mesh-list
82809426|NCT01065220|Estradiol|estradiol|mesh-list
82809427|NCT01065220|Cyproterone|cyproterone|mesh-list
82809428|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
82809429|NCT01065220|Estrogens|estrogens|mesh-ancestor
82809430|NCT01065220|Hormones|hormones|mesh-ancestor
82809431|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809432|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809433|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82809434|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
82809435|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82809436|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82809437|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
82809438|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
82809439|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809440|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82809441|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82809442|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809443|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809444|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82809445|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82809446|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82809447|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82809448|NCT00943943|Plerixafor|plerixafor|mesh-list
82809449|NCT00943943|Sorafenib|sorafenib|mesh-list
82809450|NCT00943943|Lenograstim|lenograstim|mesh-list
82809451|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809452|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82809453|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809454|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809455|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82809456|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
82809457|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809458|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82809459|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82809460|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
82809461|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809462|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82809463|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82809464|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809465|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
82809466|NCT00453102|Rituximab|rituximab|mesh-list
82809467|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809468|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809469|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
82809470|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809471|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809472|NCT00299182|Cytarabine|cytarabine|mesh-list
82809473|NCT00299182|Dexamethasone|dexamethasone|mesh-list
82809474|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
82809475|NCT00299182|Rituximab|rituximab|mesh-list
82809476|NCT00299182|Doxorubicin|doxorubicin|mesh-list
82809477|NCT00299182|Methotrexate|methotrexate|mesh-list
82809478|NCT00299182|Vincristine|vincristine|mesh-list
82809479|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82809480|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
82809481|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809482|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809483|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82809484|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
82809485|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809486|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809487|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82809488|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809489|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809490|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
82809491|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
82809492|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809493|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809494|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
82809495|NCT00299182|Hormones|hormones|mesh-ancestor
83362015|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
82809496|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809497|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82809498|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82809499|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82809500|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82809501|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809502|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82809503|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
82809504|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82809505|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82809506|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
82809507|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
82809508|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82809509|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82809510|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
82809511|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809512|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82809513|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
82809514|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
82809515|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
82809516|NCT00467142|Leucovorin|leucovorin|mesh-list
82809517|NCT00467142|Bevacizumab|bevacizumab|mesh-list
82809518|NCT00467142|Fluorouracil|fluorouracil|mesh-list
82809519|NCT00467142|Irinotecan|irinotecan|mesh-list
82809521|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
82809522|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442070|NCT00750815|Hormones|hormones|mesh-ancestor
82809523|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809524|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82809525|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82809526|NCT00467142|Growth Substances|growth substances|mesh-ancestor
82809527|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809528|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
82809529|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82809530|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
82809531|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809532|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82809533|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82809534|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
82809535|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82809536|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82809537|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809538|NCT00467142|Antidotes|antidotes|mesh-ancestor
82809539|NCT00467142|Protective Agents|protective agents|mesh-ancestor
82809540|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
82809541|NCT00467142|Vitamins|vitamins|mesh-ancestor
82809542|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
82809543|NCT01065376|Cabergoline|cabergoline|mesh-list
82809544|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82809545|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82809546|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
82809547|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
82809548|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809549|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809550|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809551|NCT00944177|Metformin|metformin|mesh-list
82809552|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82809553|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809554|NCT00553475|Pregabalin|pregabalin|mesh-list
82809555|NCT00553475|Analgesics|analgesics|mesh-ancestor
82809556|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
82809557|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809558|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809559|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
82809560|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82809561|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82809562|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809563|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82809564|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82809565|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809566|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809567|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809568|NCT00329602|Ropinirole|ropinirole|mesh-list
82809569|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82809570|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82809571|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
82809572|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
82809573|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809574|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809575|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809576|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
82809577|NCT01060696|Scopolamine|scopolamine|mesh-list
82809578|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82809579|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82809580|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
82809581|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
82809582|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809583|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809584|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809585|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
82809586|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82809587|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
82809588|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809589|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809590|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82809591|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
82809592|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82809593|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82809594|NCT01060696|Analgesics|analgesics|mesh-ancestor
82809595|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
82809596|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809597|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809598|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82809599|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809601|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
82809602|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82809603|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809604|NCT00463866|Budesonide|budesonide|mesh-list
82809605|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
82809606|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809607|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82809608|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
82809609|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809610|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809611|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82809612|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
82809613|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
82809614|NCT00463866|Hormones|hormones|mesh-ancestor
82809615|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809616|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82809617|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82809618|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82809619|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
82809620|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809621|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809622|NCT00313846|Buprenorphine|buprenorphine|mesh-list
82809623|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82809624|NCT00313846|Narcotics|narcotics|mesh-ancestor
82809625|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809626|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809627|NCT00313846|Analgesics|analgesics|mesh-ancestor
82809628|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
82809629|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809630|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82809631|NCT00949247|Bevacizumab|bevacizumab|mesh-list
82809632|NCT00949247|Trastuzumab|trastuzumab|mesh-list
82809633|NCT00949247|Carboplatin|carboplatin|mesh-list
82809634|NCT00949247|Docetaxel|docetaxel|mesh-list
82809635|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809636|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809637|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82809638|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82809639|NCT00949247|Growth Substances|growth substances|mesh-ancestor
82809640|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809641|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
82809642|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
82809643|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
82809644|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
82809645|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809646|NCT00551135|Pregabalin|pregabalin|mesh-list
82809647|NCT00551135|Analgesics|analgesics|mesh-ancestor
82809648|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
82809649|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809650|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809651|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
82809652|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82809653|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82809654|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809655|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82809656|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82809657|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809658|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809659|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809660|NCT00944333|Clopidogrel|clopidogrel|mesh-list
82809661|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82809662|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82809663|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82809664|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82809665|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
82809666|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809667|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809668|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809669|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
82809670|NCT00299104|Rituximab|rituximab|mesh-list
82809671|NCT00299104|Methotrexate|methotrexate|mesh-list
82809672|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809673|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809674|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
82809675|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809676|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809677|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82809678|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
82809679|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82809680|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82809681|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
82809682|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809683|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
82809684|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809685|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82809686|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82809687|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82809688|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809689|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
82809690|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
82809691|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809692|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809693|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
82809694|NCT00299104|Hormones|hormones|mesh-ancestor
82809695|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809696|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82809697|NCT00299104|Protective Agents|protective agents|mesh-ancestor
82809698|NCT03979456|Rituximab|rituximab|mesh-list
82809699|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809700|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809701|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
82809702|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809703|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82809704|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
82809705|NCT00313612|Topotecan|topotecan|mesh-list
82809706|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809707|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82809708|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82809709|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809710|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809711|NCT00507416|Thalidomide|thalidomide|mesh-list
82809712|NCT00507416|Dexamethasone|dexamethasone|mesh-list
82809713|NCT00507416|Prednisone|prednisone|mesh-list
82809714|NCT00507416|Bortezomib|bortezomib|mesh-list
82809715|NCT00507416|Melphalan|melphalan|mesh-list
82809716|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809717|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
82809718|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
82809719|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809720|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809721|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809722|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
82809723|NCT00507416|Hormones|hormones|mesh-ancestor
82809724|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809725|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82809726|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809727|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82809728|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
82809729|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809730|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82809731|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82809732|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
82809733|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
82809734|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82809735|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809736|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82809737|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82809738|NCT00507416|Growth Substances|growth substances|mesh-ancestor
82809739|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
82809740|NCT00489476|Loxapine|loxapine|mesh-list
82809741|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82809742|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809743|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809744|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809745|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809746|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82809747|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
82809748|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809749|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809750|NCT04216043|Caseins|caseins|mesh-list
82809751|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
82809752|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
82809753|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809754|NCT00957125|Bevacizumab|bevacizumab|mesh-list
82809755|NCT00957125|Docetaxel|docetaxel|mesh-list
82809756|NCT00957125|Epirubicin|epirubicin|mesh-list
82809757|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809758|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809759|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82809760|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82809761|NCT00957125|Growth Substances|growth substances|mesh-ancestor
82809762|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809763|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
82809764|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
82809765|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
82809766|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
82809767|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809768|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82809769|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82809770|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82809771|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809772|NCT00957203|Istradefylline|istradefylline|mesh-list
82809773|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
82809774|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82809775|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82809776|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
82809777|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809778|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809779|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809780|NCT00952913|Lansoprazole|lansoprazole|mesh-list
82809781|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
82809782|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82809783|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809784|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82809785|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809786|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809787|NCT00952991|Vildagliptin|vildagliptin|mesh-list
82809788|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82809789|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809790|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82809791|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
82809792|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809793|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809794|NCT00953303|Dexamethasone|dexamethasone|mesh-list
82809795|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
82809796|NCT00953303|Prednisone|prednisone|mesh-list
82809798|NCT00953303|Dobutamine|dobutamine|mesh-list
82809799|NCT00953303|Dopamine|dopamine|mesh-list
82809800|NCT00953303|Furosemide|furosemide|mesh-list
82809801|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
82809802|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
82809803|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82809804|NCT00953303|BB 1101|bb 1101|mesh-list
82809805|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809806|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
82809807|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
82809808|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809809|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809810|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809811|NCT00953303|Hormones|hormones|mesh-ancestor
82809812|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809813|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82809814|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809815|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
82809816|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809817|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809818|NCT00953303|Diuretics|diuretics|mesh-ancestor
82809819|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
82809820|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82809821|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82809822|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
82809823|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82809824|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
82809825|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82809826|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82809827|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82809828|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
82809829|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809830|NCT00953303|Protective Agents|protective agents|mesh-ancestor
82809831|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
82809832|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82809833|NCT05300555|Warfarin|warfarin|mesh-list
82809834|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
82809835|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
82809836|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82809837|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
82809838|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82809839|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
82809840|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809841|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809842|NCT04010669|Somatostatin|somatostatin|mesh-list
82809843|NCT04010669|Hormones|hormones|mesh-ancestor
82809844|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809845|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809846|NCT00452790|Vaccines|vaccines|mesh-list
82809847|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82809848|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
82809849|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809850|NCT00953381|Omeprazole|omeprazole|mesh-list
82809851|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82809852|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809853|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82809854|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809855|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809856|NCT05300477|Acetazolamide|acetazolamide|mesh-list
82809857|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
82809858|NCT05300477|Hematinics|hematinics|mesh-ancestor
82809859|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
82809860|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82809861|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809862|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809863|NCT05300477|Diuretics|diuretics|mesh-ancestor
82809864|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
82809865|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809866|NCT00953459|Sunitinib|sunitinib|mesh-list
82809867|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82809868|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809869|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82809870|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82809871|NCT00953459|Growth Substances|growth substances|mesh-ancestor
82809872|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809873|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
82809874|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82809875|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809876|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809877|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82809878|NCT00953537|Capecitabine|capecitabine|mesh-list
82809879|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82809880|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
82809881|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809882|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809883|NCT00463788|Cisplatin|cisplatin|mesh-list
82809884|NCT00463788|Cetuximab|cetuximab|mesh-list
82809885|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809886|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82809887|NCT00548249|Iron|iron|mesh-list
82809888|NCT00548249|Trace Elements|trace elements|mesh-ancestor
82809889|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
82809890|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809891|NCT01025466|Memantine|memantine|mesh-list
82809892|NCT01025466|Rivastigmine|rivastigmine|mesh-list
82809893|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82809894|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82809895|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
82809896|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809897|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809898|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809899|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82809900|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82809901|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82809902|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809903|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
82809904|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82809905|NCT01025466|Protective Agents|protective agents|mesh-ancestor
82809906|NCT01025544|Vaccines|vaccines|mesh-list
82809907|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
82809908|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809909|NCT03839940|Dexamethasone|dexamethasone|mesh-list
82809910|NCT03839940|Everolimus|everolimus|mesh-list
82809911|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809912|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
82809913|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
82809914|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809915|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809916|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809917|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
82809918|NCT03839940|Hormones|hormones|mesh-ancestor
82809919|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809920|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82809921|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809922|NCT03839940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82809923|NCT03839940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82809924|NCT03839940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809925|NCT03839940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809926|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82809927|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
82809928|NCT03905928|Nicotine|nicotine|mesh-list
82809929|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82809930|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
82809931|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809932|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809933|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82809934|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82809935|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
82809936|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82809937|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809938|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
82809939|NCT01027494|Dexamethasone|dexamethasone|mesh-list
82809940|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82809941|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
82809942|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
82809943|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809944|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809945|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809946|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
82809947|NCT01027494|Hormones|hormones|mesh-ancestor
82809948|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82809949|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82809950|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82809951|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82809952|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809953|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82809954|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82809955|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82809956|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809957|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82809958|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82809959|NCT01025700|Nabilone|nabilone|mesh-list
82809960|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
82809961|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
82809962|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809963|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809964|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809965|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82809966|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82809967|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809968|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82809969|NCT00462462|Ethanol|ethanol|mesh-list
82809970|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82809971|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809972|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809973|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809974|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
82809975|NCT00462384|Hematinics|hematinics|mesh-ancestor
82809976|NCT00452400|Olodaterol|olodaterol|mesh-list
82809977|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82809978|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
82809979|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82809980|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809981|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82809982|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
82809983|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
82809984|NCT03576690|Atoltivimab|atoltivimab|mesh-list
82809985|NCT03576690|Odesivimab|odesivimab|mesh-list
82809986|NCT03576690|Maftivimab|maftivimab|mesh-list
82809987|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
82809988|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82809989|NCT01566474|Melatonin|melatonin|mesh-list
82809990|NCT01566474|Omeprazole|omeprazole|mesh-list
82809991|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
82809992|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82809993|NCT01566474|Protective Agents|protective agents|mesh-ancestor
82809994|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82809995|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82809996|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82809997|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82809998|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82809999|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810000|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
82810001|NCT01025778|Thiotepa|thiotepa|mesh-list
82810002|NCT01025778|Etoposide|etoposide|mesh-list
82810003|NCT01025778|Clofarabine|clofarabine|mesh-list
82810004|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810005|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
82810006|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810007|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810008|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82810009|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
82810010|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810011|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810012|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82810013|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82810014|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82810015|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82810016|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810017|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810018|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
82810019|NCT00443430|Prednisone|prednisone|mesh-list
82810020|NCT00443430|Prednisolone|prednisolone|mesh-list
82810021|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82810022|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
82810023|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82810024|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
82810025|NCT00443430|Etanercept|etanercept|mesh-list
82810026|NCT00443430|Methotrexate|methotrexate|mesh-list
82810027|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82810028|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
82810029|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810030|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
82810031|NCT00443430|Hormones|hormones|mesh-ancestor
82810032|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810033|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810034|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82810035|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810036|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82810037|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
82810038|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82810039|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810040|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
82810041|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810042|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810043|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810044|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82810045|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810046|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
82810047|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810048|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82810049|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
82810050|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
82810051|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810052|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82810053|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82810054|NCT00443430|Protective Agents|protective agents|mesh-ancestor
82810055|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810056|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810057|NCT00443430|Analgesics|analgesics|mesh-ancestor
82810058|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
82810059|NCT03898986|Vaccines|vaccines|mesh-list
82810060|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
82810061|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810062|NCT01022658|Insulin|insulin|mesh-list
82810063|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
82810064|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
82810065|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82810066|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810067|NCT01022736|Gabapentin|gabapentin|mesh-list
82810068|NCT01022736|Analgesics|analgesics|mesh-ancestor
82810069|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
82810070|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810071|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810072|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
82810073|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82810074|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82810075|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82810076|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82810077|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82810078|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82810079|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810080|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810081|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
82810082|NCT01025934|Bevacizumab|bevacizumab|mesh-list
82810083|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810084|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810085|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82810086|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82810087|NCT01025934|Growth Substances|growth substances|mesh-ancestor
82810088|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810089|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
82810090|NCT01026090|Dronedarone|dronedarone|mesh-list
82810091|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82810092|NCT00460746|Ritonavir|ritonavir|mesh-list
82810093|NCT00460746|Darunavir|darunavir|mesh-list
82810094|NCT00460746|Etravirine|etravirine|mesh-list
82810095|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82810096|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82810097|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
82810098|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810099|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810100|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82810101|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82810102|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
82810103|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810104|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82810105|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82810106|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82810107|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82810109|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82810110|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82810111|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810112|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82810113|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810114|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810115|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810116|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810117|NCT00459342|Dasatinib|dasatinib|mesh-list
82810118|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810119|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810120|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810121|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810122|NCT00442962|Tenofovir|tenofovir|mesh-list
82810123|NCT00442962|Emtricitabine|emtricitabine|mesh-list
82810124|NCT00442962|Efavirenz|efavirenz|mesh-list
82810125|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82810126|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
82810127|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810128|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82810129|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82810130|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810131|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810132|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82810133|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82810134|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82810135|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82810136|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82810137|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82810138|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82810139|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82810140|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82810141|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
82810142|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82810143|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810144|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810145|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82810146|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82810147|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810148|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810149|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82810150|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
82810151|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82810152|NCT01026636|Cephalosporins|cephalosporins|mesh-list
82810153|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82810154|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810155|NCT00313300|Apixaban|apixaban|mesh-list
82810156|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82810157|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
82810158|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82810159|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
82810160|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810161|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810162|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
82810163|NCT00459186|Prednisone|prednisone|mesh-list
82810164|NCT00459186|Docetaxel|docetaxel|mesh-list
82810165|NCT00459186|Everolimus|everolimus|mesh-list
82810166|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810167|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
82810168|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
82810169|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
82810170|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810171|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810172|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
82810173|NCT00459186|Hormones|hormones|mesh-ancestor
82810174|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810175|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810176|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82810177|NCT00459186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82810178|NCT00459186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810179|NCT00459186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810180|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810181|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
82810183|NCT01026714|Rifampin|rifampin|mesh-list
82810184|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
82810185|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
82810186|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810187|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82810188|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82810189|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810190|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810191|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82810192|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
82810193|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810194|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810195|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82810196|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82810197|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82810198|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
82810199|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82810200|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
82810201|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82810202|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82810203|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82810204|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82810205|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82810206|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82810207|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82810208|NCT01026714|Analgesics|analgesics|mesh-ancestor
82810209|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
82810210|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810211|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810212|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810213|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810214|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810215|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82810216|NCT03996252|Calcitriol|calcitriol|mesh-list
82810217|NCT03996252|Fluorouracil|fluorouracil|mesh-list
82810218|NCT03996252|Calcipotriene|calcipotriene|mesh-list
82810219|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
82810220|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810221|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810222|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810223|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810224|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
82810225|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810226|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810227|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82810228|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82810229|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810230|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82810231|NCT03996252|Vitamins|vitamins|mesh-ancestor
82810232|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
82810233|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82810234|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
82810235|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82810236|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810237|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810238|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82810239|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82810240|NCT00459108|Dasatinib|dasatinib|mesh-list
82810241|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810242|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810243|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810244|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810245|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
82810246|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810247|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810248|NCT00450450|Lenograstim|lenograstim|mesh-list
82810249|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82810250|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
82810251|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810252|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
82810253|NCT03440892|Methotrexate|methotrexate|mesh-list
82810254|NCT03440892|Abatacept|abatacept|mesh-list
82810255|NCT03440892|Tofacitinib|tofacitinib|mesh-list
82810256|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82810257|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
82810258|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82810259|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810260|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810261|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
82810262|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810263|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810264|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810265|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810266|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82810267|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810268|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
82810269|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810270|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82810271|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82810272|NCT03440892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810273|NCT03440892|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82810274|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810275|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810276|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810277|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810278|NCT03440892|Analgesics|analgesics|mesh-ancestor
82810279|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
82810280|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810281|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810282|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82810283|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82810284|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
82810285|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810286|NCT01023360|Esomeprazole|esomeprazole|mesh-list
82810287|NCT01023360|Rabeprazole|rabeprazole|mesh-list
82810288|NCT01023360|Pantoprazole|pantoprazole|mesh-list
82810289|NCT01023360|Clopidogrel|clopidogrel|mesh-list
82810290|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82810291|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82810292|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82810293|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82810294|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82810295|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
82810296|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810297|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810298|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810299|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82810300|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82810301|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810302|NCT03685890|Nivolumab|nivolumab|mesh-list
82810303|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810304|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810305|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82810306|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810307|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
82810308|NCT00442416|Hematinics|hematinics|mesh-ancestor
82810309|NCT03674424|Avelumab|avelumab|mesh-list
82810310|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810311|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810312|NCT00441792|Midazolam|midazolam|mesh-list
82810313|NCT00441792|Etomidate|etomidate|mesh-list
82810314|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82810315|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82810316|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82810317|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810318|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82810319|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82810320|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82810321|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82810322|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
82810323|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
82810324|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
82810325|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
82810326|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810327|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810328|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
82810329|NCT00312208|Docetaxel|docetaxel|mesh-list
82810330|NCT00312208|Doxorubicin|doxorubicin|mesh-list
82810331|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82810332|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810333|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
82810334|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810335|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810336|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82810337|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
82810338|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810339|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810340|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82810341|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
82810342|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
82810343|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
82810344|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82810345|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82810346|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82810347|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810348|NCT00297778|Pramipexole|pramipexole|mesh-list
82810349|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
82810350|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810352|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810353|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82810354|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82810355|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
82810356|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
82810357|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810358|NCT03848832|Cannabidiol|cannabidiol|mesh-list
82810359|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
82810360|NCT00327340|Docetaxel|docetaxel|mesh-list
82810361|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
82810362|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810363|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
82810364|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
82810365|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
82810366|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810367|NCT00327340|Analgesics|analgesics|mesh-ancestor
82810368|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
82810369|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810370|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810371|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82810372|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82810373|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810374|NCT00958139|Permethrin|permethrin|mesh-list
82810375|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810376|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810377|NCT00450216|Ibuprofen|ibuprofen|mesh-list
82810378|NCT00450216|Famotidine|famotidine|mesh-list
82810379|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810380|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810381|NCT00450216|Analgesics|analgesics|mesh-ancestor
82810382|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
82810383|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810384|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810385|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810386|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810387|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82810388|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810389|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810390|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82810391|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82810392|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82810393|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
82810394|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
82810395|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810396|NCT00953771|Danazol|danazol|mesh-list
82810397|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82810398|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
83362016|NCT02664922|Analgesics|analgesics|mesh-ancestor
82810399|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810401|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
82810402|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
82810403|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82810404|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810405|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82810406|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
82810407|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82810408|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810409|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810410|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810411|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82810412|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
82810413|NCT00958451|Vitamin D|vitamin d|mesh-list
82810414|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82810415|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810416|NCT00958451|Vitamins|vitamins|mesh-ancestor
82810417|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
82810418|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82810419|NCT05352191|Beclomethasone|beclomethasone|mesh-list
82810420|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810421|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
82810422|NCT05352191|Hormones|hormones|mesh-ancestor
82810423|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810424|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810425|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82810426|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
82810427|NCT00954005|Rituximab|rituximab|mesh-list
82810428|NCT00954005|Gemcitabine|gemcitabine|mesh-list
82810429|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
82810430|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810431|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810432|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
82810433|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810434|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810435|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810436|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
82810437|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810438|NCT01023750|Fenofibrate|fenofibrate|mesh-list
82810439|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82810440|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
82810441|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810442|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82810443|NCT05300009|Methotrexate|methotrexate|mesh-list
82810444|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82810445|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
82810446|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82810447|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810448|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810449|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
82810450|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810451|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810452|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810453|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810454|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82810455|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810456|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
82810457|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810458|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82810459|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
82810460|NCT05352113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82810461|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82810462|NCT05352113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82810463|NCT05352113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810464|NCT05352113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810465|NCT05352113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810466|NCT05352113|Serotonin Agents|serotonin agents|mesh-ancestor
82810467|NCT05352113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810468|NCT00547703|Nortriptyline|nortriptyline|mesh-list
82810469|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82810470|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
82810471|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82810472|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82810473|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82810474|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810475|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810476|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
82810477|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810478|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810479|NCT00297232|Natalizumab|natalizumab|mesh-list
82810480|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
82810481|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810482|NCT01062802|Atorvastatin|atorvastatin|mesh-list
82810483|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82810484|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82810485|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
82810486|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810487|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82810488|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82810489|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810490|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
82810491|NCT03867383|Calcium|calcium|mesh-list
82810492|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82810493|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810494|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82810495|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
82810496|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
82810497|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82810498|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82810499|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810500|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
82810501|NCT00954395|Coagulants|coagulants|mesh-ancestor
82810502|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
82810503|NCT03741101|Trametinib|trametinib|mesh-list
82810504|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810505|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810506|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810507|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810508|NCT00449670|Vaccines|vaccines|mesh-list
82810509|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
82810510|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810511|NCT04010903|Insulin|insulin|mesh-list
82810512|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82810513|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810514|NCT05299931|Ustekinumab|ustekinumab|mesh-list
82810515|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810516|NCT00296374|Atorvastatin|atorvastatin|mesh-list
82810517|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82810518|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82810519|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82810520|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
82810521|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810522|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82810523|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82810524|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810525|NCT03387761|Nivolumab|nivolumab|mesh-list
82810526|NCT03387761|Ipilimumab|ipilimumab|mesh-list
82810527|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810528|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810529|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82810530|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810531|NCT01060774|Lidocaine|lidocaine|mesh-list
82810532|NCT01060774|Bupivacaine|bupivacaine|mesh-list
82810533|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
82810534|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
82810535|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82810536|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810537|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
82810538|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810539|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82810540|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82810541|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82810542|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810543|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810544|NCT00954785|Diclofenac|diclofenac|mesh-list
82810545|NCT00954785|Etoricoxib|etoricoxib|mesh-list
82810546|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810547|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810548|NCT00954785|Analgesics|analgesics|mesh-ancestor
82810549|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
82810550|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810551|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810552|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810553|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810554|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82810555|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810556|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810557|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82810558|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
82810559|NCT00548717|Sirolimus|sirolimus|mesh-list
82810560|NCT00548717|Bortezomib|bortezomib|mesh-list
82810561|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82810562|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810563|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82810564|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
82810565|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82810566|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810567|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810568|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810569|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
82810570|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810571|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
82810572|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810573|NCT00441168|Dexamethasone|dexamethasone|mesh-list
82810574|NCT00441168|Vincristine|vincristine|mesh-list
82810575|NCT00441168|Doxorubicin|doxorubicin|mesh-list
82810576|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82810578|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810579|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
82810580|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
82810581|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810582|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810583|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82810584|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
82810585|NCT00441168|Hormones|hormones|mesh-ancestor
82810586|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810587|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82810588|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810589|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82810590|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
82810591|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
82810592|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
82810593|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810594|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82810595|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82810596|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82810597|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810598|NCT01062958|Vitamins|vitamins|mesh-list
82810599|NCT01062958|Folic Acid|folic acid|mesh-list
82810600|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
82810601|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
82810602|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
82810603|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810604|NCT01062958|Hematinics|hematinics|mesh-ancestor
82810605|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
82810606|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
82810607|NCT01028976|Vitamins|vitamins|mesh-ancestor
82810608|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
82810609|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810610|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
82810611|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810612|NCT01028976|Protective Agents|protective agents|mesh-ancestor
82810613|NCT01024140|Escitalopram|escitalopram|mesh-list
82810614|NCT01024140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82810615|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82810616|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810617|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810618|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810619|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
82810620|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810622|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82810623|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82810624|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83442103|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82810625|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810626|NCT02748707|Celecoxib|celecoxib|mesh-list
82810627|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82810628|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810629|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810630|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810631|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810632|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810633|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810634|NCT02748707|Analgesics|analgesics|mesh-ancestor
82810635|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
82810636|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810637|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810638|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810639|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810640|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82810641|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82810642|NCT05014061|Adenosine|adenosine|mesh-list
82810643|NCT05014061|Analgesics|analgesics|mesh-ancestor
82810644|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
82810645|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810646|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810647|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82810648|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
82810649|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82810650|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
82810651|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
82810652|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810653|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810654|NCT00373113|Capecitabine|capecitabine|mesh-list
82810656|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810657|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
82810658|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810659|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810660|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82810661|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82810662|NCT00373113|Growth Substances|growth substances|mesh-ancestor
82810663|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810664|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
82810665|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810666|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810667|NCT01045941|Gemcitabine|gemcitabine|mesh-list
82810668|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810669|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
82810670|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810671|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810672|NCT00407511|Pregabalin|pregabalin|mesh-list
82810673|NCT00407511|Analgesics|analgesics|mesh-ancestor
82810674|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
82810675|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810676|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810677|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
82810678|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82810679|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810680|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810681|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82810682|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82810683|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82810684|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82810685|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82810686|NCT00384189|Ciclesonide|ciclesonide|mesh-list
82810687|NCT00384189|Albuterol|albuterol|mesh-list
82810688|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82810689|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
82810690|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810691|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810692|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83362017|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
82810693|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
82810694|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
82810695|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82810696|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82810697|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82810698|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82810699|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
82810700|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810701|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810702|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
82810704|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810705|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82810706|NCT00326716|Ritonavir|ritonavir|mesh-list
82810707|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82810708|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82810709|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82810710|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82810711|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
82810712|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810713|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810714|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82810715|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82810716|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
82810717|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810718|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82810719|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82810720|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82810721|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82810722|NCT01063192|Leucovorin|leucovorin|mesh-list
82810723|NCT01063192|Gemcitabine|gemcitabine|mesh-list
82810724|NCT01063192|Fluorouracil|fluorouracil|mesh-list
82810725|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
82810726|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810727|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
82810728|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810729|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810730|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810731|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
82810732|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810733|NCT01063192|Antidotes|antidotes|mesh-ancestor
82810734|NCT01063192|Protective Agents|protective agents|mesh-ancestor
82810735|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
82810736|NCT01063192|Vitamins|vitamins|mesh-ancestor
82810737|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
82810738|NCT03978988|Aspirin|aspirin|mesh-list
82810739|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810740|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810741|NCT03978988|Analgesics|analgesics|mesh-ancestor
82810742|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
82810743|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810744|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810745|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810746|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810747|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82810748|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82810749|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810750|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82810751|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82810752|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810753|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
82810754|NCT01063426|Enoxaparin|enoxaparin|mesh-list
82810755|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
82810756|NCT01063426|Atorvastatin|atorvastatin|mesh-list
82810757|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82810758|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82810759|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
82810760|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810761|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82810762|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82810763|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810764|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
82810765|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82810766|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82810767|NCT00548405|Interferons|interferons|mesh-list
82810769|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
82810770|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
82810771|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810772|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
82810773|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810774|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810775|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
82810776|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810777|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82810778|NCT04919369|Vitamins|vitamins|mesh-list
82810779|NCT04919369|Vitamin A|vitamin a|mesh-list
82810780|NCT04919369|Atezolizumab|atezolizumab|mesh-list
82810781|NCT04919369|Tretinoin|tretinoin|mesh-list
82810782|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
82810783|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82810784|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
82810785|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810786|NCT04919369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82810787|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810788|NCT04919369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810789|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810790|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
82810791|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
82810792|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810793|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
82810794|NCT04919369|Protective Agents|protective agents|mesh-ancestor
82810795|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82810797|NCT00959075|Vitamins|vitamins|mesh-ancestor
82810798|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
82810799|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810800|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
82810801|NCT00295750|Leuprolide|leuprolide|mesh-list
82810802|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82810803|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
82810804|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82810805|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810806|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82810807|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810808|NCT00959231|Cyclosporine|cyclosporine|mesh-list
82810809|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
82810810|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
82810811|NCT00959231|Fludarabine|fludarabine|mesh-list
82810812|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
82810813|NCT00959231|Cyclosporins|cyclosporins|mesh-list
82810814|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810815|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
82810816|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810817|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810818|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82810819|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
82810820|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810821|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810822|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82810823|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82810824|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
82810825|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810826|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
82810827|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810828|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
82810829|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82810830|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82810831|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82810832|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
82810833|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82810834|NCT03948581|Vedolizumab|vedolizumab|mesh-list
82810835|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82810836|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82810837|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82810838|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82810839|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810840|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810841|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
82810842|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810843|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810844|NCT04720547|Zolpidem|zolpidem|mesh-list
82810845|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83442109|NCT01276847|Etanercept|etanercept|mesh-list
82810846|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82810847|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82810848|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810849|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82810850|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
82810852|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810853|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810854|NCT00959387|Paclitaxel|paclitaxel|mesh-list
82810855|NCT00959387|Cisplatin|cisplatin|mesh-list
82810856|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82810857|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810858|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
82810859|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
82810860|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
82810861|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810862|NCT04718285|Favipiravir|favipiravir|mesh-list
82810863|NCT04718285|Montelukast|montelukast|mesh-list
82810864|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82810865|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
82810866|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82810867|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
82810868|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82810869|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810870|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82810871|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82810872|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810873|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
82810874|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810875|NCT00959621|Aspirin|aspirin|mesh-list
82810876|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810877|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810878|NCT00959621|Analgesics|analgesics|mesh-ancestor
82810879|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
82810880|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810881|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810882|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810883|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810884|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82810885|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82810886|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810887|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82810888|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82810889|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810890|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
82810891|NCT00959777|Lenograstim|lenograstim|mesh-list
82810892|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82810893|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
82810894|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810895|NCT00959933|Ribavirin|ribavirin|mesh-list
82810896|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
82810897|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810898|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
82810899|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810900|NCT00960245|Nadolol|nadolol|mesh-list
82810901|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82810902|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82810903|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
82810904|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810905|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810906|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810907|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82810908|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82810909|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
82810910|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
82810911|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810912|NCT00406653|Abatacept|abatacept|mesh-list
82810913|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82810914|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810915|NCT00406653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810916|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810917|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810919|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810920|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810921|NCT00547157|Cisplatin|cisplatin|mesh-list
82810922|NCT00547157|Panitumumab|panitumumab|mesh-list
82810923|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810924|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810925|NCT00960479|Ribavirin|ribavirin|mesh-list
82810926|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
82810927|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810928|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
82810929|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82810930|NCT00960557|Combretastatin|combretastatin|mesh-list
82810931|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82810932|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810933|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
82810934|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
82810935|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
82810936|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810937|NCT00960635|Vitamin D|vitamin d|mesh-list
82810938|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
82810939|NCT00960635|Calcitriol|calcitriol|mesh-list
82810940|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
82810941|NCT00960635|Vitamins|vitamins|mesh-ancestor
82810942|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
82810943|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810944|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82810945|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82810946|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82810947|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810948|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810949|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82810950|NCT00960713|Rituximab|rituximab|mesh-list
82810951|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82810952|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810953|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
82810954|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810955|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810956|NCT04009889|Silicon|silicon|mesh-list
82810957|NCT04009889|Trace Elements|trace elements|mesh-ancestor
82810958|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
82810959|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810960|NCT00962507|Everolimus|everolimus|mesh-list
82810961|NCT00962507|Panobinostat|panobinostat|mesh-list
82810962|NCT00962507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82810963|NCT00962507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82810964|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810965|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810966|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82810967|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
82810968|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810969|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82810970|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82810971|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82810972|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82810973|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82810974|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82810975|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82810976|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810977|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82810978|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82810979|NCT00384033|Analgesics|analgesics|mesh-ancestor
82810980|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
82810981|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810982|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
82810983|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82810984|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
82810985|NCT00962663|Ibuprofen|ibuprofen|mesh-list
82810986|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82810987|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82810988|NCT00962663|Analgesics|analgesics|mesh-ancestor
82810989|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
82810990|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810991|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362018|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82810992|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82810993|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82810994|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82810995|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82810996|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82810997|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82810998|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
82810999|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811000|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
82811001|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
82811002|NCT00075387|Carboplatin|carboplatin|mesh-list
82811003|NCT00075387|Etoposide|etoposide|mesh-list
82811004|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
82811005|NCT00075387|Antidotes|antidotes|mesh-list
82811006|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82811007|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
82811008|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811009|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811010|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82811011|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
82811012|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811013|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811014|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82811015|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82811016|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82811017|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811018|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811019|NCT00075387|Protective Agents|protective agents|mesh-ancestor
82811020|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
82811021|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
82811022|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82811023|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811024|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
82811025|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
82811026|NCT00963131|Antioxidants|antioxidants|mesh-list
82811027|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811028|NCT00963131|Protective Agents|protective agents|mesh-ancestor
82811029|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811030|NCT00963209|Tamoxifen|tamoxifen|mesh-list
82811031|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82811032|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
82811033|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811034|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811035|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82811036|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811037|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82811038|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82811039|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82811040|NCT00963443|Aspirin|aspirin|mesh-list
82811041|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
82811042|NCT00963443|Ephedrine|ephedrine|mesh-list
82811043|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82811044|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82811045|NCT00963443|Analgesics|analgesics|mesh-ancestor
82811046|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
82811047|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811048|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811049|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811050|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811051|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82811052|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82811053|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811054|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82811055|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82811056|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811057|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
82811058|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82811059|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
82811060|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82811061|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
82811062|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
82811063|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82811064|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82811065|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
82811066|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
82811067|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811069|NCT00963833|Interferon-beta|interferon-beta|mesh-list
82811070|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
82811071|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811072|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
82811073|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811074|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
82811075|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811076|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82811077|NCT00967655|Capecitabine|capecitabine|mesh-list
82811078|NCT00967655|Irinotecan|irinotecan|mesh-list
82811079|NCT00967655|Panitumumab|panitumumab|mesh-list
82811080|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811081|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
82811082|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811083|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811084|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82811085|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811086|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811087|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811088|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
82811089|NCT00546377|Rituximab|rituximab|mesh-list
82811090|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
82811091|NCT00546377|Pentostatin|pentostatin|mesh-list
82811092|NCT00546377|Sargramostim|sargramostim|mesh-list
82811093|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82811094|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
82811095|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811096|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811097|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82811098|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
82811099|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811100|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811101|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82811102|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811103|NCT00546377|Analgesics|analgesics|mesh-ancestor
82811104|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
82811105|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811106|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82811107|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811108|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811109|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82811110|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
82811111|NCT00967967|Desloratadine|desloratadine|mesh-list
82811112|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811113|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
82811114|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82811115|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82811116|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
82811117|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811118|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811119|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811120|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82811121|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82811122|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
82811123|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
82811124|NCT00964457|Cetuximab|cetuximab|mesh-list
82811125|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811126|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811127|NCT00964535|Budesonide|budesonide|mesh-list
82811128|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
82811129|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82811130|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811131|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82811132|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
82811133|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811134|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811135|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82811136|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
82811137|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
82811138|NCT00964535|Hormones|hormones|mesh-ancestor
82811139|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811140|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82811141|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82811142|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82811143|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
82811144|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811145|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811146|NCT00964691|Chloroquine|chloroquine|mesh-list
82811147|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
82811148|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
82811149|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82811150|NCT00964691|Amebicides|amebicides|mesh-ancestor
82811151|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82811152|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82811153|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811154|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
82811155|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811156|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82811157|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811158|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811159|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82811160|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82811161|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
82811162|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811163|NCT00968435|Bevacizumab|bevacizumab|mesh-list
82811164|NCT00968435|Cetuximab|cetuximab|mesh-list
82811165|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811166|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811167|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82811168|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82811169|NCT00968435|Growth Substances|growth substances|mesh-ancestor
82811170|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811171|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
82811172|NCT05253287|Hormones|hormones|mesh-list
82811173|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811174|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811175|NCT00968591|Everolimus|everolimus|mesh-list
82811176|NCT00968591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82811177|NCT00968591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811178|NCT00968591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811179|NCT00968591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811180|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82811181|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
82811182|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811183|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811184|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
82811185|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82811186|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82811187|NCT00968903|Prednisolone|prednisolone|mesh-list
82811188|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
82811189|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82811190|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
82811191|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811192|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
82811193|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
82811194|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811195|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811196|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82811197|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
82811198|NCT00968903|Hormones|hormones|mesh-ancestor
82811199|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811200|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82811201|NCT00968903|Protective Agents|protective agents|mesh-ancestor
82811202|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82811203|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811204|NCT00969137|Nicotine|nicotine|mesh-list
82811205|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82811206|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
82811207|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811208|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811209|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82811210|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82811211|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
82811212|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811213|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811214|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82811215|NCT00965315|Fenofibrate|fenofibrate|mesh-list
82811216|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82811217|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82811218|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
82811219|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811220|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82811221|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82811222|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811223|NCT00969293|Ecallantide|ecallantide|mesh-list
82811224|NCT00969293|Analgesics|analgesics|mesh-ancestor
82811225|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
82811226|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811227|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811228|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82811229|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82811230|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811231|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811233|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82811234|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82811235|NCT00969449|Analgesics|analgesics|mesh-ancestor
82811236|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
82811237|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811238|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811239|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811240|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811241|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
82811242|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82811243|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811244|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811245|NCT00965393|Bradykinin|bradykinin|mesh-list
82811246|NCT00965393|Kininogens|kininogens|mesh-list
82811247|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
82811248|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
82811249|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82811250|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
82811251|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811252|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811253|NCT00965549|Insulin|insulin|mesh-list
82811254|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82811255|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
82811256|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
82811257|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
82811258|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82811259|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811260|NCT00966251|Pidilizumab|pidilizumab|mesh-list
82811261|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811262|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811263|NCT00966329|Maraviroc|maraviroc|mesh-list
82811264|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82811265|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82811266|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811267|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82811268|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82811269|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
82811270|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811271|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82811272|NCT00970697|Becaplermin|becaplermin|mesh-list
82811273|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
82811274|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
82811275|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82811276|NCT00970697|Growth Substances|growth substances|mesh-ancestor
82811277|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811278|NCT00967031|Capecitabine|capecitabine|mesh-list
82811279|NCT00967031|Lapatinib|lapatinib|mesh-list
82811280|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811281|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
82811282|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811283|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811284|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811285|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811286|NCT00967109|Chrysarobin|chrysarobin|mesh-list
82811287|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82811288|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82811289|NCT00967109|Analgesics|analgesics|mesh-ancestor
82811290|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
82811291|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811292|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811293|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811294|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811295|NCT00545753|Permethrin|permethrin|mesh-list
82811296|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811297|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811298|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
82811299|NCT00970931|Amiloride|amiloride|mesh-list
82811300|NCT00970931|Diuretics|diuretics|mesh-list
82811301|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
82811302|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811303|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82811304|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82811305|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82811306|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811307|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82811308|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82811309|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82811310|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82811311|NCT00406419|Methotrexate|methotrexate|mesh-list
82811312|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
82811313|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82811314|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
82811315|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82811316|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811317|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811318|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
82811319|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811321|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
82811322|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811323|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82811324|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82811325|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
82811326|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811327|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82811328|NCT00967421|Ethanol|ethanol|mesh-list
82811329|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82811330|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811331|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82811332|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811333|NCT00971165|Losartan|losartan|mesh-list
82811334|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
82811335|NCT00971165|Amiloride|amiloride|mesh-list
82811336|NCT00971165|Diuretics|diuretics|mesh-list
82811337|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82811338|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82811339|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82811340|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82811341|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811342|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
82811343|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811344|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82811345|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82811346|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82811347|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82811348|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82811349|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82811350|NCT00971399|Ondansetron|ondansetron|mesh-list
82811351|NCT00971399|Ramosetron|ramosetron|mesh-list
82811352|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
82811353|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
82811354|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811355|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811356|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82811357|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
83442123|NCT00945269|Aldesleukin|aldesleukin|mesh-list
82811358|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
82811359|NCT00971399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82811360|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82811361|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
82811362|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811363|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811364|NCT00973505|Anastrozole|anastrozole|mesh-list
82811365|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82811366|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811367|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82811368|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811369|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811370|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82811371|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
82811372|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811373|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811374|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82811375|NCT00973583|Vitamin D|vitamin d|mesh-list
82811376|NCT00973583|Vitamins|vitamins|mesh-ancestor
82811377|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
82811378|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811379|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82811380|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
82811381|NCT00972101|Rituximab|rituximab|mesh-list
82811382|NCT00972101|Fludarabine|fludarabine|mesh-list
82811383|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
82811384|NCT00972101|Etoposide|etoposide|mesh-list
82811385|NCT00972101|Melphalan|melphalan|mesh-list
82811386|NCT00972101|Thiotepa|thiotepa|mesh-list
82811387|NCT00972101|Tacrolimus|tacrolimus|mesh-list
82811388|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82811389|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811390|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811391|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
82811392|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811393|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811394|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811395|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
82811396|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811397|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82811398|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811399|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82811400|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82811401|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811402|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811403|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82811404|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82811405|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82811406|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
82811407|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82811408|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82811409|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
82811410|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82811412|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82811413|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811414|NCT00972257|Timolol|timolol|mesh-list
82811415|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82811416|NCT00972257|Dorzolamide|dorzolamide|mesh-list
82811417|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82811418|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82811419|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
82811420|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811421|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811422|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811423|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82811424|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82811425|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82811426|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82811427|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82811428|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82811429|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811430|NCT00311584|Irinotecan|irinotecan|mesh-list
82811431|NCT00311584|Temozolomide|temozolomide|mesh-list
83442124|NCT00945269|Interleukin-2|interleukin-2|mesh-list
82811432|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82811433|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811434|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811435|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811436|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811437|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82811438|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
82811439|NCT00383331|Gemcitabine|gemcitabine|mesh-list
82811440|NCT00383331|Pemetrexed|pemetrexed|mesh-list
82811441|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811442|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
82811443|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811444|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811445|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811446|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82811447|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82811448|NCT03934541|Vaccines|vaccines|mesh-list
82811449|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
82811450|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811451|NCT00325234|Carboplatin|carboplatin|mesh-list
82811452|NCT00325234|Gemcitabine|gemcitabine|mesh-list
82811453|NCT00325234|Pemetrexed|pemetrexed|mesh-list
82811454|NCT00325234|Vinorelbine|vinorelbine|mesh-list
82811455|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811456|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811457|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
82811458|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811459|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811460|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82811461|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82811462|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82811463|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
82811464|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
82811465|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
82811466|NCT01063504|Teriparatide|teriparatide|mesh-list
82811467|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82811468|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811469|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82811470|NCT00366249|Ertapenem|ertapenem|mesh-list
82811471|NCT00366249|Tigecycline|tigecycline|mesh-list
82811472|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82811473|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811474|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82811475|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811476|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811477|NCT03927911|Bupivacaine|bupivacaine|mesh-list
82811478|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
82811479|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
82811480|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82811481|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811482|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
82811483|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811484|NCT00383019|Latanoprost|latanoprost|mesh-list
82811485|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82811486|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82811487|NCT00310804|Vaccines|vaccines|mesh-list
82811488|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
82811489|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811490|NCT00590187|Sapacitabine|sapacitabine|mesh-list
82811491|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811492|NCT03978364|Azacitidine|azacitidine|mesh-list
82811493|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811494|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
82811495|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811496|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811497|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811498|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
82811499|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
82811500|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82811501|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
82811502|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811503|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811504|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82811505|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
82811506|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811507|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811508|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82811509|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811510|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811511|NCT03978286|Vortioxetine|vortioxetine|mesh-list
82811512|NCT03978286|Sertraline|sertraline|mesh-list
82811513|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
82811514|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82811515|NCT03978286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82811516|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82811517|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82811518|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811519|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811521|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811522|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82811523|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82811524|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82811525|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82811526|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82811527|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82811528|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82811529|NCT03933449|Paclitaxel|paclitaxel|mesh-list
82811530|NCT03933449|Docetaxel|docetaxel|mesh-list
82811531|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
82811532|NCT03933449|Irinotecan|irinotecan|mesh-list
82811533|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82811534|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811535|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
82811536|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
82811537|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
82811538|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811539|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811540|NCT03933449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82811541|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82811542|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811543|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811545|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
82811546|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811547|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811548|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
82811549|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811550|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811551|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
82811552|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82811553|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82811554|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82811555|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
82811556|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82811557|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82811558|NCT01049451|Prednisolone|prednisolone|mesh-list
82811559|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
82811560|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82811561|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
82811562|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811563|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
82811564|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
82811565|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811566|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811567|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82811568|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
82811569|NCT01049451|Hormones|hormones|mesh-ancestor
82811570|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811571|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82811572|NCT01049451|Protective Agents|protective agents|mesh-ancestor
82811573|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82811574|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811575|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82811576|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
82811577|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811578|NCT00974753|Ketorolac|ketorolac|mesh-list
82811579|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83442129|NCT00945269|Analgesics|analgesics|mesh-ancestor
82811580|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82811581|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82811582|NCT00974753|Analgesics|analgesics|mesh-ancestor
82811583|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
82811584|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811585|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811586|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811587|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811588|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82811589|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362019|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82811590|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811592|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82811593|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811594|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
82811595|NCT02908269|Vaccines|vaccines|mesh-list
82811596|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
82811597|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811598|NCT00974987|Temozolomide|temozolomide|mesh-list
82811599|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82811600|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
82811601|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811602|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811603|NCT00975065|Metformin|metformin|mesh-list
82811604|NCT00975065|Vildagliptin|vildagliptin|mesh-list
82811605|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82811606|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811607|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82811608|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
82811609|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811610|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811611|NCT00972881|Capecitabine|capecitabine|mesh-list
82811612|NCT00972881|Irinotecan|irinotecan|mesh-list
82811613|NCT00972881|Cetuximab|cetuximab|mesh-list
82811614|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811615|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
82811616|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811617|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811618|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82811619|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811620|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811621|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811622|NCT00290758|Genistein|genistein|mesh-list
82811623|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82811624|NCT00290758|Protective Agents|protective agents|mesh-ancestor
82811625|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811626|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811627|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811628|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811629|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811630|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
82811631|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82811632|NCT00290758|Estrogens|estrogens|mesh-ancestor
82811633|NCT00290758|Hormones|hormones|mesh-ancestor
82811634|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811635|NCT00975299|Bombesin|bombesin|mesh-list
82811636|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811637|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811638|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811639|NCT01060930|Epinephrine|epinephrine|mesh-list
82811640|NCT01060930|Norepinephrine|norepinephrine|mesh-list
82811641|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
82811642|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82811643|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82811644|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
82811645|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811646|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811647|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811648|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82811649|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82811650|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
82811651|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811652|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82811653|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
82811654|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
82811655|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
82811656|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82811657|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811658|NCT00973037|Tamoxifen|tamoxifen|mesh-list
82811659|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82811660|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
82811661|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811662|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811663|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82811664|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811665|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82811666|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82811667|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82811668|NCT00973115|Simvastatin|simvastatin|mesh-list
82811669|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82811670|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82811671|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
82811672|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811673|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82811674|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82811675|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811676|NCT00973193|Panitumumab|panitumumab|mesh-list
82811677|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811678|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811679|NCT00975533|Insulin|insulin|mesh-list
82811680|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82811681|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811682|NCT00372567|Sunitinib|sunitinib|mesh-list
82811683|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
82811684|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811685|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82811686|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82811687|NCT00372567|Growth Substances|growth substances|mesh-ancestor
82811688|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811689|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
82811690|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811691|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811692|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811693|NCT00973271|Atorvastatin|atorvastatin|mesh-list
82811694|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
82811695|NCT00973271|Fenofibrate|fenofibrate|mesh-list
82811696|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82811697|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82811698|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
82811699|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811700|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82811701|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82811702|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811703|NCT00975767|Docetaxel|docetaxel|mesh-list
82811704|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82811705|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811706|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
82811707|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
82811708|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
82811709|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811710|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811711|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811712|NCT00365547|Bevacizumab|bevacizumab|mesh-list
82811713|NCT00365547|Topotecan|topotecan|mesh-list
82811714|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811715|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811716|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82811717|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82811718|NCT00365547|Growth Substances|growth substances|mesh-ancestor
82811719|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811720|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
82811721|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82811722|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82811723|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811724|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811725|NCT00979589|Aspirin|aspirin|mesh-list
82811726|NCT00979589|Clopidogrel|clopidogrel|mesh-list
82811727|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82811728|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82811729|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82811730|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82811731|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
82811732|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811733|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811734|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811735|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82811736|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82811738|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
82811739|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811740|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811741|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82811742|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82811743|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82811744|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82811745|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811746|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
82811747|NCT00294658|Prednisone|prednisone|mesh-list
82811748|NCT00294658|Prednisolone|prednisolone|mesh-list
82811749|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811750|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
82811751|NCT00294658|Hormones|hormones|mesh-ancestor
82811752|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811753|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811754|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82811755|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811756|NCT00979667|Oseltamivir|oseltamivir|mesh-list
82811757|NCT00979667|Zanamivir|zanamivir|mesh-list
82811758|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
82811759|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811760|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811761|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811762|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82811763|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
82811764|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811765|NCT03978052|Protective Agents|protective agents|mesh-ancestor
82811766|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811767|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82811768|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82811769|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811770|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82811771|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
82811773|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82811774|NCT03923933|Diuretics|diuretics|mesh-ancestor
82811775|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
82811776|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811777|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82811778|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82811779|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811780|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82811781|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
82811782|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811783|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811784|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811785|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811786|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
82811787|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82811788|NCT00980213|Sunitinib|sunitinib|mesh-list
82811789|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811790|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82811791|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82811792|NCT00980213|Growth Substances|growth substances|mesh-ancestor
82811793|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811794|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
82811795|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811796|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811797|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811798|NCT00976469|Vaccines|vaccines|mesh-list
82811799|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
82811800|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811801|NCT00980603|Docetaxel|docetaxel|mesh-list
82811802|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811803|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
82811804|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
82811805|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
82811806|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811807|NCT00274456|Paclitaxel|paclitaxel|mesh-list
82811808|NCT00274456|Docetaxel|docetaxel|mesh-list
82811809|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82811810|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82811811|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811812|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
82811813|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
82811814|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
82811815|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811816|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
82811817|NCT00977093|Antidotes|antidotes|mesh-ancestor
82811818|NCT00977093|Protective Agents|protective agents|mesh-ancestor
82811819|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811820|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
82811821|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
82811822|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811823|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82811824|NCT00977249|Varenicline|varenicline|mesh-list
82811825|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82811826|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82811827|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
82811828|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811829|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811830|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811831|NCT01069822|Midazolam|midazolam|mesh-list
82811832|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82811833|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82811834|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82811835|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811836|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82811837|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82811838|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82811839|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82811840|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
82811841|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
82811842|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
82811843|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
82811844|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811845|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811846|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
82811847|NCT00364923|Aminopterin|aminopterin|mesh-list
82811848|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82811849|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811850|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811851|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811852|NCT00273052|Metoprolol|metoprolol|mesh-list
82811853|NCT00273052|Carvedilol|carvedilol|mesh-list
82811854|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82811855|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82811856|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
82811857|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
82811858|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811859|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811860|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82811861|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82811862|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82811863|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
82811864|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811865|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811866|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
82811867|NCT00273052|Protective Agents|protective agents|mesh-ancestor
82811868|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82811869|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82811870|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82811871|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
82811872|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82811873|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82811874|NCT01046721|Exenatide|exenatide|mesh-list
82811875|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82811876|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811877|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82811878|NCT01046721|Incretins|incretins|mesh-ancestor
82811879|NCT01046721|Hormones|hormones|mesh-ancestor
82811880|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82811881|NCT01046799|Entecavir|entecavir|mesh-list
82811882|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
82811883|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811884|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
82811885|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
82811886|NCT00290290|Povidone|povidone|mesh-list
83362020|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82811887|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82811888|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811889|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
82811890|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
82811891|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
82811892|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82811893|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
82811894|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811895|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
82811896|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82811897|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82811898|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811899|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
82811900|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
82811901|NCT02534961|Cefazolin|cefazolin|mesh-list
82811902|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82811903|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811904|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
82811905|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
82811906|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82811907|NCT01046955|Daclizumab|daclizumab|mesh-list
82811908|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
82811909|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811910|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82811911|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82811912|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811913|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82811914|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811915|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811916|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811917|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811918|NCT00271024|Naltrexone|naltrexone|mesh-list
82811919|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82811920|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82811921|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811922|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
82811923|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811924|NCT00381693|Azacitidine|azacitidine|mesh-list
82811925|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82811926|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
82811927|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811928|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811929|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811930|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
82811931|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82811932|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811933|NCT00977405|Gentamicins|gentamicins|mesh-list
82811934|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82811935|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811936|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82811937|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811938|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811939|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82811940|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82811941|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
82811942|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
82811943|NCT00977873|Vitamin D|vitamin d|mesh-list
82811944|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82811945|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811946|NCT00977873|Vitamins|vitamins|mesh-ancestor
82811947|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
82811948|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82811949|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82811950|NCT00457392|Sunitinib|sunitinib|mesh-list
82811951|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82811952|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82811953|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811954|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811955|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82811956|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82811957|NCT00457392|Growth Substances|growth substances|mesh-ancestor
82811958|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811959|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
82811960|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
82811961|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83362021|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82811962|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811963|NCT00381615|Vaccines|vaccines|mesh-list
82811964|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
82811965|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811966|NCT00978107|Flucytosine|flucytosine|mesh-list
82811967|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
82811968|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811969|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
82811970|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811971|NCT01029132|Galantamine|galantamine|mesh-list
82811972|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82811973|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811974|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811975|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
82811976|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82811977|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811978|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82811979|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
82811980|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82811981|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
82811982|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
82811983|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
82811984|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82811985|NCT01049763|Oseltamivir|oseltamivir|mesh-list
82811986|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
82811987|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811988|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82811989|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811990|NCT00981773|Maraviroc|maraviroc|mesh-list
82811991|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82811992|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82811993|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82811994|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82811995|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82811996|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
82811997|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82811998|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82811999|NCT01049841|Sirolimus|sirolimus|mesh-list
82812000|NCT01049841|Temsirolimus|temsirolimus|mesh-list
82812001|NCT01049841|MTOR Inhibitors|mtor inhibitors|mesh-list
82812002|NCT01049841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812003|NCT01049841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812004|NCT01049841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812005|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812006|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
82812007|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812008|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812009|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812010|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812011|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812012|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
82812013|NCT00978263|Metformin|metformin|mesh-list
82812014|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82812015|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812016|NCT00981851|Albuterol|albuterol|mesh-list
82812017|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
82812018|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82812019|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
82812020|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812021|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812022|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82812023|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
82812024|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
82812025|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82812026|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
82812027|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812028|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812029|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
82812030|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82812031|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82812032|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82812033|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82812034|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
82812035|NCT00981929|Losartan|losartan|mesh-list
82812036|NCT00981929|Tramadol|tramadol|mesh-list
82812037|NCT00981929|Caffeine|caffeine|mesh-list
82812038|NCT00981929|Omeprazole|omeprazole|mesh-list
82812039|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82812040|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82812041|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82812042|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82812043|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812044|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82812045|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812046|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82812047|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812048|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82812049|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82812050|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
82812051|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812052|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82812053|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82812054|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82812055|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82812056|NCT00981929|Narcotics|narcotics|mesh-ancestor
82812057|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82812058|NCT00981929|Analgesics|analgesics|mesh-ancestor
82812059|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
82812060|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812061|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
82812062|NCT00364845|Hematinics|hematinics|mesh-ancestor
82812063|NCT00978653|Allopurinol|allopurinol|mesh-list
82812064|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
82812065|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812066|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812067|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
82812068|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812069|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82812070|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
82812071|NCT00978653|Protective Agents|protective agents|mesh-ancestor
82812072|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812073|NCT00293722|Etanercept|etanercept|mesh-list
82812074|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82812075|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82812076|NCT00293722|Analgesics|analgesics|mesh-ancestor
82812077|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
82812078|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812079|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812080|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82812081|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812082|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82812083|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812084|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
82812085|NCT00381303|Ritonavir|ritonavir|mesh-list
82812086|NCT00381303|Darunavir|darunavir|mesh-list
82812087|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82812088|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82812089|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
82812090|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812091|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812092|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82812093|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82812094|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
82812095|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812096|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82812097|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82812098|NCT00364689|Rifaximin|rifaximin|mesh-list
82812099|NCT00364689|Lactulose|lactulose|mesh-list
82812100|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812101|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812102|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82812103|NCT00545129|Tanezumab|tanezumab|mesh-list
82812104|NCT00545129|Analgesics|analgesics|mesh-ancestor
82812105|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
82812106|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812107|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812108|NCT00956111|Vaccines|vaccines|mesh-list
82812109|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
82812110|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812111|NCT00982631|Sirolimus|sirolimus|mesh-list
82812112|NCT00982631|Temsirolimus|temsirolimus|mesh-list
83362022|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812113|NCT00982631|MTOR Inhibitors|mtor inhibitors|mesh-list
82812114|NCT00982631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812115|NCT00982631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812116|NCT00982631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812117|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812118|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
82812119|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812120|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812121|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812122|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812123|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812124|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
82812125|NCT00364611|Bevacizumab|bevacizumab|mesh-list
82812126|NCT00364611|Trastuzumab|trastuzumab|mesh-list
82812127|NCT00364611|Docetaxel|docetaxel|mesh-list
82812128|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812129|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812130|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82812131|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82812132|NCT00364611|Growth Substances|growth substances|mesh-ancestor
82812133|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812134|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
82812135|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
82812136|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
82812137|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
82812138|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812139|NCT00956189|Aripiprazole|aripiprazole|mesh-list
82812140|NCT00956189|Amisulpride|amisulpride|mesh-list
82812141|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
82812142|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82812143|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82812144|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82812145|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82812146|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812147|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
82812148|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
82812149|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812150|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812151|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82812152|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82812153|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
82812154|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82812155|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82812156|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82812157|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82812158|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82812159|NCT00956267|Letrozole|letrozole|mesh-list
82812160|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812161|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82812162|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82812163|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812164|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812165|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82812166|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
82812167|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82812168|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812169|NCT04007003|Insulin|insulin|mesh-list
82812170|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82812171|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812172|NCT00364533|Oxycodone|oxycodone|mesh-list
82812173|NCT00364533|Tapentadol|tapentadol|mesh-list
82812174|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82812175|NCT00364533|Narcotics|narcotics|mesh-ancestor
82812176|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82812177|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812178|NCT00364533|Analgesics|analgesics|mesh-ancestor
82812179|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
82812180|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812181|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82812182|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82812183|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82812184|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812185|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
82812186|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812187|NCT01047423|Simvastatin|simvastatin|mesh-list
82812188|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82812189|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82812190|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
82812191|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812192|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82812193|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82812194|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812195|NCT00984737|Insulin|insulin|mesh-list
82812196|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82812197|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812198|NCT01047579|Rivastigmine|rivastigmine|mesh-list
82812199|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82812200|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812201|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812202|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
82812203|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812204|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812205|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82812206|NCT01047579|Protective Agents|protective agents|mesh-ancestor
82812207|NCT04006847|Dasatinib|dasatinib|mesh-list
82812208|NCT04006847|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82812209|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812210|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812211|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812212|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812213|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
82812214|NCT00984893|Diphosphonates|diphosphonates|mesh-list
82812215|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82812216|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812217|NCT00983021|Insulin|insulin|mesh-list
82812218|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82812219|NCT00983021|Liraglutide|liraglutide|mesh-list
82812220|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
82812221|NCT00983021|Xultophy|xultophy|mesh-list
82812222|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82812223|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812224|NCT00983021|Incretins|incretins|mesh-ancestor
82812225|NCT00983021|Hormones|hormones|mesh-ancestor
82812226|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82812227|NCT00984971|Tenofovir|tenofovir|mesh-list
82812228|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
82812229|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812230|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82812231|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82812232|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812233|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812234|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82812235|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82812236|NCT00544817|Temozolomide|temozolomide|mesh-list
82812237|NCT00544817|Sorafenib|sorafenib|mesh-list
82812238|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82812239|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
82812240|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812241|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812242|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812243|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812244|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82812245|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82812246|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812247|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812248|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
82812249|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812250|NCT00983177|Colchicine|colchicine|mesh-list
82812251|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
82812252|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812253|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
82812254|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
82812255|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
82812256|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812257|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812258|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
82812259|NCT00983255|Tedizolid|tedizolid|mesh-list
82812260|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
82812261|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812262|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812263|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82812264|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812265|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812267|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812268|NCT00988481|Topiramate|topiramate|mesh-list
82812269|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
82812270|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82812271|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812272|NCT00289900|Atorvastatin|atorvastatin|mesh-list
82812273|NCT00289900|Simvastatin|simvastatin|mesh-list
82812274|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82812275|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82812276|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
82812277|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812278|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82812279|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82812280|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812281|NCT00543725|Efavirenz|efavirenz|mesh-list
82812282|NCT00543725|Rilpivirine|rilpivirine|mesh-list
82812283|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82812284|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82812285|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812286|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812287|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
82812288|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812289|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82812290|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82812291|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82812292|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82812293|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82812294|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82812296|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82812297|NCT00985361|Vitamin D|vitamin d|mesh-list
82812298|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
82812299|NCT00985361|Vitamins|vitamins|mesh-list
82812300|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
82812301|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812302|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82812303|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82812304|NCT00269152|Carboplatin|carboplatin|mesh-list
82812305|NCT00269152|Pemetrexed|pemetrexed|mesh-list
82812306|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812307|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812308|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812309|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82812310|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82812311|NCT00988715|Cyclosporine|cyclosporine|mesh-list
82812312|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
82812313|NCT00988715|Fludarabine|fludarabine|mesh-list
82812314|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
82812315|NCT00988715|Cyclosporins|cyclosporins|mesh-list
82812316|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812317|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82812318|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
82812319|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812320|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812321|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
82812322|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812323|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812324|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
82812325|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812326|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
82812327|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812328|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82812329|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812330|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82812331|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
82812332|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812333|NCT03975166|Fluticasone|fluticasone|mesh-list
82812334|NCT03975166|Xhance|xhance|mesh-list
82812335|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82812336|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82812337|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82812338|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82812339|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
82812340|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812341|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812342|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82812343|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
82812344|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
82812345|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82812346|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82812347|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82812348|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82812349|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
82812350|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812351|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812352|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
82812353|NCT03975166|Hormones|hormones|mesh-ancestor
82812354|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82812355|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
82812356|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82812357|NCT01325818|Pravastatin|pravastatin|mesh-list
82812358|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82812359|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82812360|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
82812361|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812362|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82812363|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82812364|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812366|NCT00379899|Cinacalcet|cinacalcet|mesh-list
82812367|NCT00379899|Vitamins|vitamins|mesh-ancestor
82812368|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
82812369|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812370|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82812371|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82812372|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82812373|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
83481533|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82812374|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82812375|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
82812376|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82812377|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82812378|NCT02535039|Prednisolone|prednisolone|mesh-list
82812379|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
82812380|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82812381|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
82812382|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82812383|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
82812384|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
82812385|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812386|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812387|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82812388|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
82812389|NCT02535039|Hormones|hormones|mesh-ancestor
82812390|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82812391|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82812392|NCT02535039|Protective Agents|protective agents|mesh-ancestor
82812393|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82812394|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812395|NCT00363129|Vitamin E|vitamin e|mesh-list
82812396|NCT00363129|Vitamins|vitamins|mesh-ancestor
82812397|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
82812398|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812399|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
82812400|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812401|NCT00363129|Protective Agents|protective agents|mesh-ancestor
82812402|NCT00268996|Darapladib|darapladib|mesh-list
82812403|NCT00268996|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
82812404|NCT00268996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812405|NCT00268996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812406|NCT00379587|Rituximab|rituximab|mesh-list
82812407|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812408|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812409|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
82812410|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812411|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812412|NCT00363051|Everolimus|everolimus|mesh-list
83362023|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812413|NCT00363051|Octreotide|octreotide|mesh-list
82812414|NCT00363051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82812415|NCT00363051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812416|NCT00363051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812417|NCT00363051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812418|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812419|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
82812420|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812421|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812422|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82812423|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82812424|NCT00379353|Thalidomide|thalidomide|mesh-list
82812425|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812426|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
82812427|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812428|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
82812429|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812430|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812431|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82812432|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82812433|NCT00379353|Growth Substances|growth substances|mesh-ancestor
82812434|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
82812435|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812436|NCT01047657|Orlistat|orlistat|mesh-list
82812437|NCT01047657|Sibutramine|sibutramine|mesh-list
82812438|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812439|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812440|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82812441|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82812442|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
82812443|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82812444|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
82812445|NCT00378573|Bevacizumab|bevacizumab|mesh-list
82812446|NCT00378573|Gemcitabine|gemcitabine|mesh-list
82812447|NCT00378573|Docetaxel|docetaxel|mesh-list
82812448|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812449|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812450|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82812451|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82812452|NCT00378573|Growth Substances|growth substances|mesh-ancestor
82812453|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812454|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
82812455|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82812456|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
82812457|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812458|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
82812459|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
82812460|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
82812461|NCT02346747|Immunomodulating Agents|immunomodulating agents|mesh-list
82812462|NCT02346747|Immunologic Factors|immunologic factors|mesh-list
82812463|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812464|NCT01047891|Sorafenib|sorafenib|mesh-list
82812465|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812466|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812467|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812468|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812469|NCT02534571|Epinephrine|epinephrine|mesh-list
82812470|NCT02534571|Hemostatics|hemostatics|mesh-list
82812471|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82812472|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82812473|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
82812474|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812475|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812476|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812477|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82812478|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82812479|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
82812480|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812481|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82812482|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
82812483|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
82812484|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
82812485|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82812486|NCT02534571|Coagulants|coagulants|mesh-ancestor
83362024|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82812487|NCT00457002|Enoxaparin|enoxaparin|mesh-list
82812488|NCT00457002|Apixaban|apixaban|mesh-list
82812489|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
82812490|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82812491|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82812492|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812493|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82812494|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
82812495|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82812496|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
82812497|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812498|NCT00362115|Olmesartan|olmesartan|mesh-list
82812499|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82812500|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82812501|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82812502|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82812503|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812504|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
82812505|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82812506|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82812507|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
82812508|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812509|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82812510|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82812511|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812512|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812513|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
82812515|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82812516|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
82812517|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812518|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82812519|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83481534|NCT05300802|Analgesics|analgesics|mesh-ancestor
82812520|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812521|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812522|NCT03975010|Naltrexone|naltrexone|mesh-list
82812523|NCT03975010|Buprenorphine|buprenorphine|mesh-list
82812524|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82812525|NCT03975010|Narcotics|narcotics|mesh-ancestor
82812526|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82812527|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812528|NCT03975010|Analgesics|analgesics|mesh-ancestor
82812529|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
82812530|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812531|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82812532|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82812533|NCT01016990|Valproic Acid|valproic acid|mesh-list
82812534|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
82812535|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812536|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812537|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
82812538|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812539|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812540|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
82812541|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82812542|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82812543|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82812544|NCT01048047|Amlodipine|amlodipine|mesh-list
82812545|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82812546|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82812547|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82812548|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812549|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82812550|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812551|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
82812552|NCT01324635|Panobinostat|panobinostat|mesh-list
82812553|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82812554|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812555|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812556|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812557|NCT00456846|Paclitaxel|paclitaxel|mesh-list
82812558|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82812559|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82812560|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362025|NCT02664922|Narcotics|narcotics|mesh-ancestor
82812561|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
82812562|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
82812563|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
82812564|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812565|NCT03324282|Avelumab|avelumab|mesh-list
82812566|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812567|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812568|NCT00484094|Sirolimus|sirolimus|mesh-list
82812569|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812570|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812571|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812572|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812573|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
82812574|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812575|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
82812576|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812577|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82812578|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812579|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
82812580|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82812581|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812582|NCT01029522|Atorvastatin|atorvastatin|mesh-list
82812583|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82812584|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82812585|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
82812586|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812587|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83442164|NCT01276457|Cyclosporine|cyclosporine|mesh-list
82812588|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82812589|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812590|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
82812591|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82812592|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82812593|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82812594|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82812595|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812596|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
82812597|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812598|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812599|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82812600|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812601|NCT01565772|Etoposide|etoposide|mesh-list
82812602|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812603|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82812604|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82812605|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82812606|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812607|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812608|NCT00456300|Exenatide|exenatide|mesh-list
82812609|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82812610|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812611|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82812612|NCT00456300|Incretins|incretins|mesh-ancestor
82812613|NCT00456300|Hormones|hormones|mesh-ancestor
82812614|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82812615|NCT00267748|Sunitinib|sunitinib|mesh-list
82812616|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812617|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82812618|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82812619|NCT00267748|Growth Substances|growth substances|mesh-ancestor
82812620|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812621|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
82812622|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812623|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812624|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812625|NCT00267202|Omalizumab|omalizumab|mesh-list
82812626|NCT00267202|Immunomodulating Agents|immunomodulating agents|mesh-list
82812627|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
82812628|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812629|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82812630|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82812631|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
82812632|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
82812633|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83362026|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82812634|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82812635|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812637|NCT01067638|Coagulants|coagulants|mesh-ancestor
82812638|NCT00267046|Doxorubicin|doxorubicin|mesh-list
82812639|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82812640|NCT00267046|Vincristine|vincristine|mesh-list
82812641|NCT00267046|Ifosfamide|ifosfamide|mesh-list
82812642|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812643|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812644|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82812645|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82812646|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812647|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812648|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82812649|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
82812650|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
82812651|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
82812652|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82812653|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
82812654|NCT01029678|Vinorelbine|vinorelbine|mesh-list
82812655|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812656|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82812657|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
82812658|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
82812659|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
82812660|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812661|NCT00286468|Alogliptin|alogliptin|mesh-list
82812662|NCT00286468|Glyburide|glyburide|mesh-list
82812663|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82812664|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812665|NCT00286468|Incretins|incretins|mesh-ancestor
82812666|NCT00286468|Hormones|hormones|mesh-ancestor
82812667|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82812668|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82812669|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
82812670|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812671|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812672|NCT00507026|Diclofenac|diclofenac|mesh-list
82812673|NCT00507026|Ketorolac|ketorolac|mesh-list
82812674|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82812675|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82812676|NCT00507026|Analgesics|analgesics|mesh-ancestor
82812677|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
82812678|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812679|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812680|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82812681|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812682|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82812683|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812684|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812685|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
82812686|NCT01019174|Lenalidomide|lenalidomide|mesh-list
82812687|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812688|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
82812689|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812690|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812691|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82812692|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
82812693|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812694|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812695|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82812696|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82812697|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82812698|NCT01019174|Growth Substances|growth substances|mesh-ancestor
82812699|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
82812700|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82812701|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82812702|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812703|NCT01011920|Cytarabine|cytarabine|mesh-list
82812704|NCT01011920|Rituximab|rituximab|mesh-list
82812705|NCT01011920|Methotrexate|methotrexate|mesh-list
82812706|NCT01011920|Thiotepa|thiotepa|mesh-list
82812707|NCT01011920|Carmustine|carmustine|mesh-list
82812708|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812709|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812710|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
82812711|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812712|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812713|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82812714|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
82812715|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82812716|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82812717|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
82812718|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812719|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
82812720|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812721|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82812722|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812723|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82812724|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
82812725|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812726|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82812727|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
82812728|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82812729|NCT03976102|Rituximab|rituximab|mesh-list
82812730|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812731|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812732|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
82812733|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812734|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812735|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
82812736|NCT00506948|Sirolimus|sirolimus|mesh-list
82812738|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82812739|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812740|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812741|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82812742|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
82812743|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812744|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812745|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812746|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812747|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
82812748|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812749|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
82812750|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812752|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
82812753|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82812754|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
82812755|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812756|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82812757|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
82812758|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
82812759|NCT00286234|Vitamins|vitamins|mesh-ancestor
82812760|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
82812761|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812762|NCT01019408|Chloroquine|chloroquine|mesh-list
82812763|NCT01019408|Amebicides|amebicides|mesh-ancestor
82812764|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82812765|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82812766|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812767|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
82812768|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812769|NCT01067950|Pancrelipase|pancrelipase|mesh-list
82812770|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82812771|NCT00445848|Bevacizumab|bevacizumab|mesh-list
82812772|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82812773|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812774|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812775|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82812776|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82812777|NCT00445848|Growth Substances|growth substances|mesh-ancestor
82812778|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812779|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
82812780|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82812781|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362027|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82812782|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812783|NCT00286156|Sirolimus|sirolimus|mesh-list
82812784|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812785|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812786|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812787|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812788|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
82812789|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812790|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
82812791|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812792|NCT00455520|Tapentadol|tapentadol|mesh-list
82812793|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82812794|NCT00455520|Narcotics|narcotics|mesh-ancestor
82812795|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82812796|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812797|NCT00455520|Analgesics|analgesics|mesh-ancestor
82812798|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
82812799|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812800|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82812801|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82812802|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82812803|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812804|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
82812805|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812806|NCT00284050|Ranibizumab|ranibizumab|mesh-list
82812807|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82812808|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82812809|NCT00284050|Growth Substances|growth substances|mesh-ancestor
82812810|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812812|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812813|NCT00293020|Fentanyl|fentanyl|mesh-list
82812814|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82812815|NCT00293020|Narcotics|narcotics|mesh-ancestor
82812816|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82812817|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812818|NCT00293020|Analgesics|analgesics|mesh-ancestor
82812819|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
82812820|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812821|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82812822|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82812823|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
82812824|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
82812825|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
82812826|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
82812827|NCT00377637|Azathioprine|azathioprine|mesh-list
82812828|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812829|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
82812830|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812831|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812832|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82812833|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
82812834|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812835|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812836|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82812837|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812838|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82812839|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
82812840|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812841|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812842|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812843|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
82812844|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82812845|NCT00377403|Acetaminophen|acetaminophen|mesh-list
82812846|NCT00377403|Amoxicillin|amoxicillin|mesh-list
82812847|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
82812848|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
82812849|NCT00377403|Ephedrine|ephedrine|mesh-list
82812850|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
82812851|NCT00377403|Guaifenesin|guaifenesin|mesh-list
82812852|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82812853|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82812854|NCT00377403|Analgesics|analgesics|mesh-ancestor
82812855|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
82812856|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812857|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812858|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
82812859|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82812860|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812861|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
82812862|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
82812863|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82812864|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82812865|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812866|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812867|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82812868|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
82812869|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82812870|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
82812871|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82812872|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82812873|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
82812874|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
82812875|NCT00377403|Expectorants|expectorants|mesh-ancestor
82812876|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82812877|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82812878|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
82812879|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82812880|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82812881|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812882|NCT00292942|Artesunate|artesunate|mesh-list
82812883|NCT00292942|Mannitol|mannitol|mesh-list
82812884|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
82812885|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82812886|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82812887|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812888|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812890|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
82812891|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82812892|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
82812893|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82812894|NCT00292942|Diuretics|diuretics|mesh-ancestor
82812895|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
82812896|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812897|NCT00483938|Interferons|interferons|mesh-list
82812898|NCT00483938|Ribavirin|ribavirin|mesh-list
82812899|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
82812900|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
82812901|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82812902|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812903|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
82812904|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812905|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
82812906|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812907|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
82812908|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812909|NCT00370071|Interferons|interferons|mesh-list
82812910|NCT00370071|Interferon-beta|interferon-beta|mesh-list
82812911|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
82812912|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812913|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
82812914|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82812915|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
82812916|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812917|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82812918|NCT00369915|Scopolamine|scopolamine|mesh-list
82812919|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82812920|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82812921|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
82812922|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
82812923|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812924|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812925|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82812926|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
82812927|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82812928|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
82812929|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812930|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812931|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82812932|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
82812933|NCT03991845|Levocetirizine|levocetirizine|mesh-list
82812934|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82812935|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82812936|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
82812937|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
82812938|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812939|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812940|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812941|NCT01017380|Celecoxib|celecoxib|mesh-list
82812942|NCT01017380|Etoricoxib|etoricoxib|mesh-list
82812943|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82812944|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82812945|NCT01017380|Analgesics|analgesics|mesh-ancestor
82812946|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
82812947|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82812948|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812949|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82812950|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812951|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82812952|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82812953|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812954|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812955|NCT00369681|Rituximab|rituximab|mesh-list
82812956|NCT00369681|Doxorubicin|doxorubicin|mesh-list
82812957|NCT00369681|Dacarbazine|dacarbazine|mesh-list
82812958|NCT00369681|Bleomycin|bleomycin|mesh-list
82812959|NCT00369681|Vinblastine|vinblastine|mesh-list
82812960|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82812961|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812962|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
82812963|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812964|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82812965|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82812966|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82812967|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82812968|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82812969|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812970|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82812971|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
82812972|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82812973|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
82812974|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
82812975|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
82812976|NCT00266812|Temozolomide|temozolomide|mesh-list
82812977|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82812978|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
82812979|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812980|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82812981|NCT04249544|Pramipexole|pramipexole|mesh-list
82812982|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
82812983|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82812984|NCT04249544|Protective Agents|protective agents|mesh-ancestor
82812985|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812986|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82812987|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82812988|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
82812989|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
82812990|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82812991|NCT00488774|Golimumab|golimumab|mesh-list
82812992|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82812993|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82812994|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82812995|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82812996|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
82812997|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82812998|NCT00361569|Estrogens|estrogens|mesh-list
82812999|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82813000|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
82813001|NCT00361569|Hormones|hormones|mesh-ancestor
82813002|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813003|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813004|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
82813005|NCT01011998|Valproic Acid|valproic acid|mesh-list
82813006|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813007|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82813008|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813009|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813010|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
82813011|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
82813012|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813013|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813014|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
82813015|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813016|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813017|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813018|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
82813019|NCT01017458|Testosterone|testosterone|mesh-list
82813020|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
82813021|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
82813022|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82813023|NCT01017458|Androgens|androgens|mesh-ancestor
82813024|NCT01017458|Hormones|hormones|mesh-ancestor
82813025|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813026|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813027|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82813028|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813029|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
82813030|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
82813031|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82813032|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
82813033|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813034|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
82813035|NCT02534415|Protective Agents|protective agents|mesh-ancestor
82813036|NCT00488618|Cariprazine|cariprazine|mesh-list
82813037|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82813038|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813039|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813040|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813041|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813042|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
82813043|NCT01019642|Vitamin D|vitamin d|mesh-list
82813044|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82813045|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813046|NCT01019642|Vitamins|vitamins|mesh-ancestor
82813047|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
82813048|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82813049|NCT00266656|Hormones|hormones|mesh-list
82813050|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813051|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813052|NCT00483548|Ziprasidone|ziprasidone|mesh-list
82813053|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82813054|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
82813055|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813056|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813057|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813058|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82813059|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813060|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813061|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813062|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82813063|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
82813064|NCT00445770|Etanercept|etanercept|mesh-list
82813065|NCT00445770|Methotrexate|methotrexate|mesh-list
82813066|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82813067|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
82813068|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813069|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813070|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82813071|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
82813072|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813073|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813074|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813075|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813076|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82813077|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813078|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
82813079|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813080|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82813081|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82813082|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82813083|NCT00445770|Analgesics|analgesics|mesh-ancestor
82813084|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
82813085|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813086|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813087|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813089|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82813090|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
82813091|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813092|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813093|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82813094|NCT00266032|Diuretics|diuretics|mesh-ancestor
82813095|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
82813096|NCT01019798|Docetaxel|docetaxel|mesh-list
82813097|NCT01019798|Sunitinib|sunitinib|mesh-list
82813098|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813099|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
82813100|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83362028|NCT02666950|Cytarabine|cytarabine|mesh-list
83362029|NCT02666950|Adavosertib|adavosertib|mesh-list
83362030|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83362031|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
83362032|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362033|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362034|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
83362035|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362036|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362037|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
83362038|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362039|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362040|NCT02668432|Amiodarone|amiodarone|mesh-list
83362041|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83362042|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
82813101|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
82813102|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813103|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82813104|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82813105|NCT01019798|Growth Substances|growth substances|mesh-ancestor
82813106|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813107|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
82813108|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82813109|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813110|NCT00483002|Varenicline|varenicline|mesh-list
82813111|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82813112|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82813113|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
82813114|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813115|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813116|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813117|NCT00482612|Mirtazapine|mirtazapine|mesh-list
82813118|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
82813119|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813120|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82813121|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
82813122|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
82813123|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813124|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813125|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813126|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82813127|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813128|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813129|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82813130|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82813131|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82813132|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
82813133|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82813134|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82813135|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
82813136|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82813137|NCT00282568|Tacrolimus|tacrolimus|mesh-list
82813138|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813139|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
82813140|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813141|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82813142|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813143|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813144|NCT02532322|Acetaminophen|acetaminophen|mesh-list
82813145|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362043|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82813146|NCT02532322|Analgesics|analgesics|mesh-ancestor
82813147|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
82813148|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813149|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813150|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
82813151|NCT00445692|Clarithromycin|clarithromycin|mesh-list
82813152|NCT00445692|Dexamethasone|dexamethasone|mesh-list
82813153|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
82813154|NCT00445692|Lenalidomide|lenalidomide|mesh-list
82813156|NCT00445692|BB 1101|bb 1101|mesh-list
82813157|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813158|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
82813159|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
82813160|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813161|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813162|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813163|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
82813164|NCT00445692|Hormones|hormones|mesh-ancestor
82813165|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813166|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82813167|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813168|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
82813169|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82813170|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82813171|NCT00445692|Growth Substances|growth substances|mesh-ancestor
82813172|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
82813173|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82813174|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813175|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82813176|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813177|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813178|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82813179|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82813180|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
82813181|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813183|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
82813184|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
82813185|NCT00282412|Fludarabine|fludarabine|mesh-list
82813186|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
82813187|NCT00282412|Cyclosporins|cyclosporins|mesh-list
82813188|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813189|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
82813190|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813191|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813192|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82813193|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
82813194|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813195|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813196|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82813197|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813198|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
82813199|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813200|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813201|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82813202|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82813203|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82813204|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
82813205|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82813206|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82813207|NCT03974932|Acetaminophen|acetaminophen|mesh-list
82813208|NCT03974932|Ibuprofen|ibuprofen|mesh-list
82813209|NCT03974932|Celecoxib|celecoxib|mesh-list
82813210|NCT03974932|Bupivacaine|bupivacaine|mesh-list
82813211|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
82813212|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
82813213|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813214|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813215|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
82813216|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813217|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82813218|NCT03974932|Analgesics|analgesics|mesh-ancestor
82813219|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
82813220|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82813221|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813222|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813223|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82813224|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813225|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813226|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82813227|NCT00282256|Tacrolimus|tacrolimus|mesh-list
82813228|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813229|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
82813230|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813231|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82813232|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813233|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813234|NCT00265330|Ziprasidone|ziprasidone|mesh-list
82813235|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82813236|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
82813237|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813238|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813239|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813240|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82813241|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813242|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813243|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813244|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82813245|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
82813246|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
82813247|NCT00543569|Alefacept|alefacept|mesh-list
82813248|NCT00543569|Tacrolimus|tacrolimus|mesh-list
82813249|NCT00543569|Basiliximab|basiliximab|mesh-list
82813250|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813251|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
82813252|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813253|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82813254|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813255|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813256|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82813257|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813258|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82813259|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
82813260|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82813261|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813262|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813263|NCT00984347|Oxytocin|oxytocin|mesh-list
82813264|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
82813265|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813266|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813267|NCT00984425|Sorafenib|sorafenib|mesh-list
82813268|NCT00984425|Lapatinib|lapatinib|mesh-list
82813269|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813270|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82813271|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813272|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813273|NCT05596955|Naltrexone|naltrexone|mesh-list
82813274|NCT05596955|Buprenorphine|buprenorphine|mesh-list
82813275|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82813276|NCT05596955|Narcotics|narcotics|mesh-ancestor
82813277|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813278|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813279|NCT05596955|Analgesics|analgesics|mesh-ancestor
82813280|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
82813281|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813282|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82813283|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82813284|NCT00445458|Paclitaxel|paclitaxel|mesh-list
82813285|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82813286|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813287|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
82813288|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
82813289|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
82813290|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813291|NCT03914417|Imiquimod|imiquimod|mesh-list
82813292|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82813293|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
82813294|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813295|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813296|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
82813297|NCT05586113|Bismuth|bismuth|mesh-list
83362044|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82813298|NCT05586113|Antacids|antacids|mesh-ancestor
82813299|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813300|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813301|NCT00541385|Artesunate|artesunate|mesh-list
82813302|NCT00541385|Lumefantrine|lumefantrine|mesh-list
82813303|NCT00541385|Pyronaridine|pyronaridine|mesh-list
82813304|NCT00541385|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
82813305|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
82813306|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82813307|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82813308|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813309|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813310|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
82813311|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
82813312|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82813313|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
82813314|NCT00988949|Spiradoline|spiradoline|mesh-list
82813315|NCT00988949|Analgesics|analgesics|mesh-ancestor
82813316|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
82813317|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813318|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813319|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82813320|NCT00988949|Diuretics|diuretics|mesh-ancestor
82813321|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
82813322|NCT00989027|Oxytocin|oxytocin|mesh-list
82813323|NCT00989027|Carboprost|carboprost|mesh-list
82813324|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
82813325|NCT00989027|Ergonovine|ergonovine|mesh-list
82813326|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
82813327|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813328|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813329|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82813331|NCT00265096|Golimumab|golimumab|mesh-list
82813332|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82813333|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82813334|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813335|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813336|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
82813337|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813338|NCT02201108|Teriflunomide|teriflunomide|mesh-list
82813339|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82813340|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82813341|NCT02201108|Analgesics|analgesics|mesh-ancestor
82813342|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
82813343|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813344|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813345|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813346|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813347|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813348|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
82813349|NCT00986609|Poly I-C|poly i-c|mesh-list
82813350|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82813351|NCT00986609|Vaccines|vaccines|mesh-list
82813352|NCT00986609|Poly ICLC|poly iclc|mesh-list
82813353|NCT00986609|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
82813354|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
82813355|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813356|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
82813357|NCT00986609|Laxatives|laxatives|mesh-ancestor
82813358|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813359|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
82813360|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813361|NCT00986609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82813362|NCT00281320|Asenapine|asenapine|mesh-list
82813363|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82813364|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813365|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813366|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813367|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813368|NCT00541307|Heparin|heparin|mesh-list
82813369|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
82813370|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82813371|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82813372|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813373|NCT05003258|Dexamethasone|dexamethasone|mesh-list
82813374|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813375|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
82813376|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
82813377|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813379|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813380|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
82813381|NCT05003258|Hormones|hormones|mesh-ancestor
82813382|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813383|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82813384|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813385|NCT05499689|Bupivacaine|bupivacaine|mesh-list
82813386|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
82813387|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
82813388|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813389|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813390|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
82813391|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813392|NCT01012232|Ropivacaine|ropivacaine|mesh-list
82813393|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
82813394|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
82813395|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813396|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813397|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
82813398|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813399|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82813400|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82813401|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813402|NCT00541229|Incretins|incretins|mesh-ancestor
82813403|NCT00541229|Hormones|hormones|mesh-ancestor
82813404|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813405|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82813406|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
82813407|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813408|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813409|NCT04006691|Mitomycins|mitomycins|mesh-list
82813410|NCT04006691|Mitomycin|mitomycin|mesh-list
82813411|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82813412|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813413|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
82813414|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813415|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82813416|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813417|NCT00986765|Aspirin|aspirin|mesh-list
82813418|NCT00986765|Enoxaparin|enoxaparin|mesh-list
82813419|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82813420|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82813421|NCT00986765|Analgesics|analgesics|mesh-ancestor
82813422|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
82813423|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813424|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813425|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813426|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813427|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82813428|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82813429|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813430|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82813431|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82813432|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813433|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
82813434|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
82813435|NCT00986843|Irinotecan|irinotecan|mesh-list
82813436|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82813437|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82813438|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813439|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813440|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813441|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
82813442|NCT01019876|Fludarabine|fludarabine|mesh-list
82813443|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813444|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
83442210|NCT00766753|Vaccines|vaccines|mesh-list
82813445|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813446|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813447|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82813448|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
82813449|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813450|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813452|NCT05463419|Vaccines|vaccines|mesh-list
82813453|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
82813454|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813455|NCT01017770|Artesunate|artesunate|mesh-list
82813456|NCT01017770|Lumefantrine|lumefantrine|mesh-list
82813457|NCT01017770|Artemether|artemether|mesh-list
82813458|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82813459|NCT01017770|Amodiaquine|amodiaquine|mesh-list
82813460|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
82813461|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82813462|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82813463|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813464|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813465|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
82813466|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
82813467|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82813468|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
82813469|NCT05712707|Lofexidine|lofexidine|mesh-list
82813470|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82813471|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82813472|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813473|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
82813474|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813475|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82813476|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82813477|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82813478|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
82813479|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813480|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813481|NCT01017926|Triazolam|triazolam|mesh-list
82813482|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82813483|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82813484|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813485|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813486|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813487|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813488|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
82813489|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
82813490|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813491|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813492|NCT00481832|Cyclosporine|cyclosporine|mesh-list
82813493|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
82813494|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
82813495|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82813496|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82813497|NCT00481832|Prednisolone|prednisolone|mesh-list
82813498|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
82813499|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
82813500|NCT00481832|Carmustine|carmustine|mesh-list
82813501|NCT00481832|Rituximab|rituximab|mesh-list
82813502|NCT00481832|Etoposide|etoposide|mesh-list
82813503|NCT00481832|Cyclosporins|cyclosporins|mesh-list
82813504|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82813505|NCT00481832|Lenograstim|lenograstim|mesh-list
82813506|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82813507|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
82813508|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813509|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
82813510|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813511|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813512|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82813513|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
82813514|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813515|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813516|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82813517|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82813518|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82813519|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82813520|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82813521|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813522|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82813523|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
82813524|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813525|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813526|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82813527|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82813529|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
82813530|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82813531|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813532|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
82813533|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
82813534|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813535|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813536|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
82813537|NCT00481832|Hormones|hormones|mesh-ancestor
82813538|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813539|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82813540|NCT00481832|Protective Agents|protective agents|mesh-ancestor
82813541|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82813542|NCT00481676|Omalizumab|omalizumab|mesh-list
82813543|NCT00481676|Loratadine|loratadine|mesh-list
82813544|NCT00481676|Clemastine|clemastine|mesh-list
82813545|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82813546|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82813547|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82813548|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
82813549|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
82813550|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813551|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
82813552|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813553|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82813554|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82813555|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
82813556|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
82813557|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813558|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813559|NCT00987233|Triamcinolone|triamcinolone|mesh-list
82813560|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82813561|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82813562|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82813563|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813564|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
82813565|NCT00987233|Hormones|hormones|mesh-ancestor
82813566|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813567|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813568|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813569|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
82813570|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813571|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813572|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
82813573|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82813574|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82813575|NCT04377503|Prednisolone|prednisolone|mesh-list
82813576|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
82813577|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82813578|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
82813579|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813580|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
82813581|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
82813582|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813583|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813584|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813585|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
82813586|NCT04377503|Hormones|hormones|mesh-ancestor
82813587|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813588|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82813589|NCT04377503|Protective Agents|protective agents|mesh-ancestor
82813590|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82813591|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813592|NCT00542789|Esomeprazole|esomeprazole|mesh-list
82813593|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82813594|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813595|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82813596|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813597|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813598|NCT00464672|Vaccines|vaccines|mesh-list
82813599|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
82813600|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813601|NCT03996434|Cetrorelix|cetrorelix|mesh-list
82813602|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83362045|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813603|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
82813604|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813605|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813606|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
82813607|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813608|NCT00987779|Gabapentin|gabapentin|mesh-list
82813609|NCT00987779|Analgesics|analgesics|mesh-ancestor
82813610|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
82813611|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813612|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813613|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
82813614|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82813615|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813616|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813617|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813618|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82813619|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82813620|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813621|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813622|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
82813623|NCT01018160|Rabeprazole|rabeprazole|mesh-list
82813624|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82813625|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813626|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82813627|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813628|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813629|NCT00473876|Metformin|metformin|mesh-list
82813630|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82813631|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813632|NCT00463580|Infliximab|infliximab|mesh-list
82813633|NCT00463580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82813634|NCT00463580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813635|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813636|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813637|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813638|NCT01020734|Cyclosporine|cyclosporine|mesh-list
82813639|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
82813640|NCT01020734|Busulfan|busulfan|mesh-list
82813641|NCT01020734|Methotrexate|methotrexate|mesh-list
82813642|NCT01020734|Fludarabine|fludarabine|mesh-list
82813643|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
82813644|NCT01020734|Cyclosporins|cyclosporins|mesh-list
82813645|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82813646|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813647|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
82813648|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813649|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813650|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82813651|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
82813652|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813653|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813654|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82813655|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82813656|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
82813657|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813658|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82813659|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
82813660|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813661|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813662|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82813663|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82813664|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
82813665|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813666|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82813667|NCT00540449|Efavirenz|efavirenz|mesh-list
82813668|NCT00540449|Rilpivirine|rilpivirine|mesh-list
82813669|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82813670|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82813671|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813672|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813673|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
82813674|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362046|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82813675|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82813676|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82813677|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82813678|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82813679|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82813680|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82813681|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82813682|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82813683|NCT04891289|Dexamethasone|dexamethasone|mesh-list
82813684|NCT04891289|Gemcitabine|gemcitabine|mesh-list
82813685|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
82813686|NCT04891289|Floxuridine|floxuridine|mesh-list
82813687|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813688|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
82813689|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
82813690|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813691|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813692|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813693|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
82813694|NCT04891289|Hormones|hormones|mesh-ancestor
82813695|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813696|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82813697|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813698|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82813699|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
82813700|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813701|NCT03911843|Vitamin D|vitamin d|mesh-list
82813702|NCT03911843|Vitamins|vitamins|mesh-ancestor
82813703|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
82813704|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813705|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82813706|NCT00361335|Golimumab|golimumab|mesh-list
82813707|NCT00361335|Methotrexate|methotrexate|mesh-list
82813708|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82813709|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
82813710|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813711|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813712|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82813713|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
82813714|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813715|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813716|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813717|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813718|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82813719|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813720|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
82813721|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813722|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82813723|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82813724|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813725|NCT00264550|Golimumab|golimumab|mesh-list
82813726|NCT00264550|Methotrexate|methotrexate|mesh-list
82813727|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82813728|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82813729|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
82813730|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813731|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813732|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82813733|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
82813734|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813735|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813736|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
82813737|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813738|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82813739|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82813740|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
82813741|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82813742|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82813743|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82813744|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813745|NCT04004507|Phentolamine|phentolamine|mesh-list
82813746|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82813747|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82813748|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82813749|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82813750|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
82813751|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813752|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813753|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813754|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82813755|NCT01070290|Capecitabine|capecitabine|mesh-list
82813756|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
82813757|NCT01070290|Irinotecan|irinotecan|mesh-list
82813758|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82813759|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
82813760|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813761|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813762|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82813763|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82813764|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813765|NCT01070446|Choline|choline|mesh-list
82813766|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
82813767|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82813768|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
82813769|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813770|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813771|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82813772|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
82813773|NCT01050387|Vitamin D|vitamin d|mesh-list
82813774|NCT01050387|Vitamins|vitamins|mesh-ancestor
82813775|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
82813776|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813777|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82813778|NCT01070524|Budesonide|budesonide|mesh-list
82813779|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82813780|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82813781|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82813782|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
82813783|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813784|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813785|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82813786|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
82813787|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
82813789|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813790|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
82813791|NCT01071304|Midazolam|midazolam|mesh-list
82813792|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82813793|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82813794|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813795|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813796|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82813797|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813798|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813799|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82813800|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
82813801|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
82813802|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
82813803|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
82813804|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813805|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813806|NCT01069042|Enalapril|enalapril|mesh-list
82813807|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82813808|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
82813809|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813810|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813811|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82813812|NCT00368979|Dutasteride|dutasteride|mesh-list
82813813|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82813814|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82813815|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813816|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813817|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
82813818|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813819|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813820|NCT00264238|Memantine|memantine|mesh-list
82813821|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82813822|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82813823|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
82813824|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362047|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83362048|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82813825|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813826|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813827|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82813828|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82813829|NCT00540293|Atorvastatin|atorvastatin|mesh-list
82813830|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82813831|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82813832|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
82813833|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813834|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82813835|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82813836|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813837|NCT00375609|Enoxaparin|enoxaparin|mesh-list
82813838|NCT00375609|Betrixaban|betrixaban|mesh-list
82813839|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
82813840|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82813841|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82813842|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813843|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82813844|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
82813845|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82813846|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
82813847|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813848|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
82813849|NCT01050621|Vitamins|vitamins|mesh-ancestor
82813850|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
82813851|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813852|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
82813853|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813854|NCT01050621|Protective Agents|protective agents|mesh-ancestor
82813855|NCT00359073|Montelukast|montelukast|mesh-list
82813856|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82813857|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
82813858|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82813859|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
82813860|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82813861|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813862|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82813863|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82813864|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813865|NCT00368745|Pregabalin|pregabalin|mesh-list
82813866|NCT00368745|Analgesics|analgesics|mesh-ancestor
82813867|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
82813868|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813869|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813870|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
82813871|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82813872|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82813873|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813874|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82813875|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82813876|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813877|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813878|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813879|NCT03235739|Naloxegol|naloxegol|mesh-list
82813880|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82813881|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813882|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
82813883|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813884|NCT04573673|Emodin|emodin|mesh-list
82813885|NCT04573673|Cathartics|cathartics|mesh-ancestor
82813886|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813887|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82813888|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813889|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813890|NCT01050699|Fentanyl|fentanyl|mesh-list
82813891|NCT01050699|Midazolam|midazolam|mesh-list
82813892|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
82813893|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82813894|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82813895|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813896|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82813897|NCT01050699|Analgesics|analgesics|mesh-ancestor
82813898|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
82813899|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82813900|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82813901|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82813902|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82813903|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
82813904|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813905|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813906|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82813908|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82813909|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82813910|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
82813911|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
82813912|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82813913|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82813914|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82813915|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
82813916|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
82813917|NCT02408315|Misoprostol|misoprostol|mesh-list
82813918|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82813919|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
82813920|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82813921|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813922|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82813923|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82813924|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
82813925|NCT05711693|Bepridil|bepridil|mesh-list
82813926|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82813927|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82813928|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82813929|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82813930|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813931|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82813932|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813933|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
82813934|NCT04005365|Propranolol|propranolol|mesh-list
82813935|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82813936|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82813937|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
82813938|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813939|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813940|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813941|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82813942|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82813943|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
82813944|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
82813945|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82813946|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82813947|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
82813948|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813949|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82813950|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82813951|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813952|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813953|NCT00358917|Ritonavir|ritonavir|mesh-list
82813954|NCT00358917|Lopinavir|lopinavir|mesh-list
82813955|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82813956|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82813957|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82813958|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
82813959|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813960|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813961|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82813962|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82813963|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
82813964|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813965|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82813966|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82813967|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82813968|NCT01048515|Caffeine|caffeine|mesh-list
82813969|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82813970|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813971|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83362049|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813972|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813973|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813974|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82813975|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82813976|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
82813977|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82813978|NCT01050777|Paromomycin|paromomycin|mesh-list
82813979|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
82813980|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82813981|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813982|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82813983|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82813984|NCT00264004|Cediranib|cediranib|mesh-list
82813985|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813986|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82813987|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82813988|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813989|NCT01069198|Vitamin A|vitamin a|mesh-list
82813990|NCT01069198|Albendazole|albendazole|mesh-list
82813991|NCT01069198|Vitamins|vitamins|mesh-ancestor
82813992|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
82813993|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82813994|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82813995|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82813996|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
82813997|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82813998|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82813999|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
82814000|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82814002|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814003|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814004|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814005|NCT00368355|Cytarabine|cytarabine|mesh-list
82814006|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
82814007|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
82814008|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814009|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
82814010|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814011|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814012|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82814013|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
82814014|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814015|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814016|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82814017|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82814018|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
82814019|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
82814020|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814021|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814022|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
82814023|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82814024|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814025|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814026|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814027|NCT01070680|Analgesics|analgesics|mesh-ancestor
82814028|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
82814029|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814030|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82814031|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82814032|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82814033|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
82814034|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814035|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814036|NCT00445146|Elvitegravir|elvitegravir|mesh-list
82814037|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82814038|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82814039|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
82814040|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814041|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82814042|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814043|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814044|NCT01581736|Insulin|insulin|mesh-list
82814045|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82814046|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814047|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814048|NCT01030302|Bortezomib|bortezomib|mesh-list
82814049|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814050|NCT00368277|Amlodipine|amlodipine|mesh-list
82814051|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82814052|NCT00368277|Ramipril|ramipril|mesh-list
82814053|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82814054|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82814055|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82814056|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814057|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82814058|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814059|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
82814060|NCT00368277|Diuretics|diuretics|mesh-ancestor
82814061|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
82814062|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82814063|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82814064|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
82814065|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814066|NCT00280150|Paclitaxel|paclitaxel|mesh-list
82814067|NCT00280150|Bevacizumab|bevacizumab|mesh-list
82814068|NCT00280150|Carboplatin|carboplatin|mesh-list
82814069|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82814070|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82814071|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814072|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814073|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814074|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814075|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814076|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814078|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82814079|NCT00280150|Growth Substances|growth substances|mesh-ancestor
82814080|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814081|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
82814082|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82814083|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814084|NCT00279916|Triamcinolone|triamcinolone|mesh-list
82814085|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82814086|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82814087|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82814088|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814089|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
82814090|NCT00279916|Hormones|hormones|mesh-ancestor
82814091|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814092|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814093|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814094|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
82814095|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814096|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814097|NCT02534337|Leucovorin|leucovorin|mesh-list
82814098|NCT02534337|Gemcitabine|gemcitabine|mesh-list
82814099|NCT02534337|Fluorouracil|fluorouracil|mesh-list
82814100|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
82814101|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82814102|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
82814103|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814104|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814105|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814106|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
82814107|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814108|NCT02534337|Antidotes|antidotes|mesh-ancestor
82814109|NCT02534337|Protective Agents|protective agents|mesh-ancestor
82814110|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
82814111|NCT02534337|Vitamins|vitamins|mesh-ancestor
82814112|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
82814113|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82814114|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
82814115|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814116|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
82814117|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
82814118|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814119|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
82814120|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814121|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362050|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82814122|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
82814123|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814124|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
82814125|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82814126|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
82814127|NCT00251758|Lansoprazole|lansoprazole|mesh-list
82814128|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82814129|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814130|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82814131|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814132|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814133|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
82814134|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814135|NCT00262834|Vorinostat|vorinostat|mesh-list
82814136|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814137|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82814138|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814139|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814140|NCT04417361|Erenumab|erenumab|mesh-list
82814141|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82814142|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814143|NCT04417361|Analgesics|analgesics|mesh-ancestor
82814144|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
82814145|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814146|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814147|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
82814148|NCT03396575|Fludarabine|fludarabine|mesh-list
82814149|NCT03396575|Vaccines|vaccines|mesh-list
82814150|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
82814151|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814152|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814153|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814154|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82814155|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
82814156|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814157|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814158|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82814159|NCT00541775|Metformin|metformin|mesh-list
82814160|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82814161|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
82814162|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814163|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814164|NCT00541775|Incretins|incretins|mesh-ancestor
82814165|NCT00541775|Hormones|hormones|mesh-ancestor
82814166|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814167|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82814168|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
82814169|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814170|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814171|NCT04004117|Fentanyl|fentanyl|mesh-list
82814172|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82814173|NCT04004117|Narcotics|narcotics|mesh-ancestor
82814174|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814175|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814176|NCT04004117|Analgesics|analgesics|mesh-ancestor
82814177|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
82814178|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814179|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82814180|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82814181|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
82814182|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
82814183|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
82814184|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82814185|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
82814186|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814187|NCT00539513|Expectorants|expectorants|mesh-ancestor
82814188|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
82814189|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82814190|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
82814191|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814192|NCT00539513|Protective Agents|protective agents|mesh-ancestor
82814193|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814194|NCT00539513|Antidotes|antidotes|mesh-ancestor
82814195|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82814196|NCT02997761|Blinatumomab|blinatumomab|mesh-list
82814197|NCT02997761|Antibodies|antibodies|mesh-list
83362051|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82814198|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
82814199|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82814200|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
82814201|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82814202|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
82814203|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814204|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814205|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814206|NCT00454584|Etanercept|etanercept|mesh-list
82814207|NCT00454584|Ustekinumab|ustekinumab|mesh-list
82814208|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82814209|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814210|NCT00454584|Analgesics|analgesics|mesh-ancestor
82814211|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
82814212|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814213|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814214|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814215|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814216|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814217|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814218|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
82814219|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
82814220|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82814221|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
82814222|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814223|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
82814224|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814225|NCT04204343|Bupivacaine|bupivacaine|mesh-list
82814226|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
82814228|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814229|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814230|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
82814231|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814232|NCT02845271|Acetaminophen|acetaminophen|mesh-list
82814233|NCT02845271|Tramadol|tramadol|mesh-list
82814234|NCT02845271|Codeine|codeine|mesh-list
82814235|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814236|NCT02845271|Analgesics|analgesics|mesh-ancestor
82814237|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
82814238|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814239|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814240|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
82814241|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82814242|NCT02845271|Narcotics|narcotics|mesh-ancestor
82814243|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814244|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
82814245|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
82814246|NCT00445068|Panobinostat|panobinostat|mesh-list
82814247|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814248|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82814249|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814250|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814251|NCT02404337|Betaine|betaine|mesh-list
82814252|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814253|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
82814254|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82814255|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
82814256|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814257|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82814258|NCT05360147|Metformin|metformin|mesh-list
82814259|NCT05360147|Liraglutide|liraglutide|mesh-list
82814260|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82814261|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
82814262|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814263|NCT05360147|Incretins|incretins|mesh-ancestor
82814264|NCT05360147|Hormones|hormones|mesh-ancestor
82814265|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814266|NCT00444912|Plerixafor|plerixafor|mesh-list
82814267|NCT00444912|Rituximab|rituximab|mesh-list
82814268|NCT00444912|Lenograstim|lenograstim|mesh-list
82814269|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814270|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814271|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
82814272|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814273|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814274|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82814276|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82814277|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
82814278|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814279|NCT00538733|Clarithromycin|clarithromycin|mesh-list
82814280|NCT00538733|Thalidomide|thalidomide|mesh-list
82814281|NCT00538733|Dexamethasone|dexamethasone|mesh-list
82814282|NCT00538733|Lenalidomide|lenalidomide|mesh-list
82814283|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814284|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
82814285|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
82814286|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814287|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814288|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814289|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
82814290|NCT00538733|Hormones|hormones|mesh-ancestor
82814291|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814292|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82814293|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814294|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
82814295|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82814296|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82814297|NCT00538733|Growth Substances|growth substances|mesh-ancestor
82814298|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
82814299|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82814300|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814301|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82814302|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814303|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814304|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82814305|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82814306|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814307|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
82814308|NCT00444678|Capecitabine|capecitabine|mesh-list
82814309|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
82814310|NCT00444678|Cetuximab|cetuximab|mesh-list
82814311|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82814312|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
82814313|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814314|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814315|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814316|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
82814317|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
82814318|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814319|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
82814320|NCT00539981|Coagulants|coagulants|mesh-ancestor
82814321|NCT00990197|Nicotine|nicotine|mesh-list
82814322|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82814323|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
82814324|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814325|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814326|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82814327|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82814328|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
82814329|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814330|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814331|NCT01051011|Metformin|metformin|mesh-list
82814332|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
82814333|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82814334|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814335|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814336|NCT01051011|Incretins|incretins|mesh-ancestor
82814337|NCT01051011|Hormones|hormones|mesh-ancestor
82814338|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814339|NCT01048827|Busulfan|busulfan|mesh-list
82814340|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
82814341|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814342|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814343|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
82814344|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814345|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82814346|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814347|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82814348|NCT02023463|Leuprolide|leuprolide|mesh-list
82814349|NCT02023463|Goserelin|goserelin|mesh-list
82814350|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82814351|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
82814352|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82814353|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814354|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82814355|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814356|NCT01302327|Exenatide|exenatide|mesh-list
82814357|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814358|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814359|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82814360|NCT01302327|Incretins|incretins|mesh-ancestor
82814361|NCT01302327|Hormones|hormones|mesh-ancestor
82814362|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814363|NCT01048983|Minocycline|minocycline|mesh-list
82814364|NCT01048983|Curcumin|curcumin|mesh-list
82814365|NCT01048983|Modafinil|modafinil|mesh-list
82814366|NCT01048983|Bupropion|bupropion|mesh-list
82814367|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82814368|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
82814369|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82814370|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82814371|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82814372|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82814373|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814374|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
82814375|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814376|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814377|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82814378|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82814379|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814380|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82814381|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814382|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82814383|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814384|NCT01048983|Analgesics|analgesics|mesh-ancestor
82814385|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
82814386|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814387|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814388|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814389|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814390|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82814391|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83442243|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
82814392|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82814393|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82814394|NCT00990275|Ethanol|ethanol|mesh-list
82814395|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82814396|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814397|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814398|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814399|NCT01340417|Melatonin|melatonin|mesh-list
82814400|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
82814401|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814402|NCT01340417|Protective Agents|protective agents|mesh-ancestor
82814403|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814404|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814405|NCT01049061|Farletuzumab|farletuzumab|mesh-list
82814406|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814407|NCT00367341|Escitalopram|escitalopram|mesh-list
82814408|NCT00367341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82814409|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82814410|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82814411|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814412|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814413|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
82814414|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814415|NCT01052961|Oseltamivir|oseltamivir|mesh-list
82814416|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
82814417|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814418|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814419|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814420|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
82814421|NCT00440466|Hematinics|hematinics|mesh-ancestor
82814422|NCT01051167|Cetuximab|cetuximab|mesh-list
82814423|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814424|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814425|NCT01325441|Paclitaxel|paclitaxel|mesh-list
82814426|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82814427|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814428|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814429|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814430|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814431|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814432|NCT00616967|Paclitaxel|paclitaxel|mesh-list
82814433|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82814434|NCT00616967|Carboplatin|carboplatin|mesh-list
82814435|NCT00616967|Vorinostat|vorinostat|mesh-list
82814436|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82814437|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814438|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814439|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814440|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814441|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814442|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82814443|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814444|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
82814445|NCT05360537|Liraglutide|liraglutide|mesh-list
82814446|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814447|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814448|NCT05360537|Incretins|incretins|mesh-ancestor
82814449|NCT05360537|Hormones|hormones|mesh-ancestor
82814450|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814451|NCT05590637|Pimavanserin|pimavanserin|mesh-list
82814452|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82814453|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
82814454|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82814455|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82814456|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82814457|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814458|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814459|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82814460|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82814461|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82814462|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82814463|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
82814464|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814465|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814466|NCT00989651|Paclitaxel|paclitaxel|mesh-list
82814467|NCT00989651|Bevacizumab|bevacizumab|mesh-list
82814468|NCT00989651|Cisplatin|cisplatin|mesh-list
82814469|NCT00989651|Carboplatin|carboplatin|mesh-list
82814470|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82814471|NCT00989651|Veliparib|veliparib|mesh-list
82814472|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82814473|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
82814474|NCT00989651|Antibodies|antibodies|mesh-list
82814475|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
82814476|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82814477|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
82814478|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82814479|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814480|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814481|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814482|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814483|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814484|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82814485|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82814486|NCT00989651|Growth Substances|growth substances|mesh-ancestor
82814487|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814488|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
82814489|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
82814490|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82814491|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814492|NCT05590559|Morphine|morphine|mesh-list
82814493|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82814494|NCT05590559|Narcotics|narcotics|mesh-ancestor
82814495|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814496|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814497|NCT05590559|Analgesics|analgesics|mesh-ancestor
82814498|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
82814499|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814500|NCT05590325|Dolutegravir|dolutegravir|mesh-list
82814501|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82814502|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82814503|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814504|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814505|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82814506|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82814507|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
82814508|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814509|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
82814510|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82814511|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82814512|NCT00989729|Prednisolone|prednisolone|mesh-list
82814513|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
82814514|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82814515|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
82814516|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814517|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
82814518|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
82814519|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814520|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814521|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814522|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
82814523|NCT00989729|Hormones|hormones|mesh-ancestor
82814524|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814525|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82814526|NCT00989729|Protective Agents|protective agents|mesh-ancestor
82814527|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82814528|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814529|NCT00989807|Aztreonam|aztreonam|mesh-list
82814530|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82814531|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814532|NCT00990587|Ciclopirox|ciclopirox|mesh-list
82814533|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
82814534|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814535|NCT00537329|Anidulafungin|anidulafungin|mesh-list
82814536|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
82814537|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814538|NCT03905135|Avelumab|avelumab|mesh-list
82814539|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814540|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814541|NCT00991055|Pioglitazone|pioglitazone|mesh-list
82814542|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814543|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814544|NCT00991133|Clofarabine|clofarabine|mesh-list
82814545|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814546|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814547|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82814548|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
82814549|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
82814550|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82814551|NCT00991211|Doxorubicin|doxorubicin|mesh-list
82814552|NCT00991211|Vincristine|vincristine|mesh-list
82814553|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814554|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
82814555|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814556|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814557|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82814558|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
82814559|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814560|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814561|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82814562|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82814563|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82814564|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82814565|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814566|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82814567|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814568|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814569|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814570|NCT00357903|Etanercept|etanercept|mesh-list
82814571|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82814572|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814573|NCT00357903|Analgesics|analgesics|mesh-ancestor
82814574|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
82814575|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814576|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814577|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814578|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814579|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814580|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814581|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
82814583|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82814584|NCT01053039|Narcotics|narcotics|mesh-ancestor
82814585|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814586|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814587|NCT01053039|Analgesics|analgesics|mesh-ancestor
82814588|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
82814589|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814590|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82814591|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82814592|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82814593|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
82814594|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814595|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82814596|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82814597|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814598|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
82814599|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
82814600|NCT00348933|Betaine|betaine|mesh-list
82814601|NCT00348933|Vitamins|vitamins|mesh-ancestor
82814602|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
82814603|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814604|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
82814605|NCT00348933|Hematinics|hematinics|mesh-ancestor
82814606|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814607|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
82814608|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82814609|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
82814610|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814611|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82814612|NCT01051479|Choline|choline|mesh-list
82814613|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
82814614|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82814615|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
82814616|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814617|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814618|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82814619|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
82814620|NCT01055691|Metformin|metformin|mesh-list
82814621|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
82814622|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814623|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814624|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82814625|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814626|NCT03896477|Vaccines|vaccines|mesh-list
82814627|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82814628|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
82814629|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814630|NCT00444600|Triamcinolone|triamcinolone|mesh-list
82814631|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82814632|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82814633|NCT00444600|Ranibizumab|ranibizumab|mesh-list
82814634|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82814635|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82814636|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82814637|NCT00444600|Growth Substances|growth substances|mesh-ancestor
82814638|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814639|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
82814640|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814641|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814642|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
82814643|NCT00444600|Hormones|hormones|mesh-ancestor
82814644|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814645|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814646|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
82814647|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814648|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814649|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
82814650|NCT05357027|Fludarabine|fludarabine|mesh-list
82814651|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82814652|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
82814653|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814655|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82814656|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
82814657|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814658|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814659|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82814660|NCT00443898|Terbinafine|terbinafine|mesh-list
82814661|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
82814662|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814663|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814664|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814665|NCT00537017|Levodopa|levodopa|mesh-list
82814666|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82814667|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82814668|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
82814669|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814670|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814671|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814672|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
82814673|NCT00348309|Donepezil|donepezil|mesh-list
82814674|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82814675|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814676|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814677|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
82814678|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814679|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814680|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
82814681|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814682|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
83442262|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
82814683|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82814684|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814685|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814686|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814687|NCT05493683|Tislelizumab|tislelizumab|mesh-list
82814688|NCT05493683|Disitamab vedotin|disitamab vedotin|mesh-list
82814689|NCT05493683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814690|NCT05493683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814691|NCT05493683|Immunoconjugates|immunoconjugates|mesh-ancestor
82814692|NCT05493683|Immunologic Factors|immunologic factors|mesh-ancestor
82814693|NCT05493683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814694|NCT05440487|Chelating Agents|chelating agents|mesh-list
82814695|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
82814696|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814697|NCT00440310|Talaporfin|talaporfin|mesh-list
82814698|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814699|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82814700|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
82814701|NCT01055847|Aztreonam|aztreonam|mesh-list
82814702|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82814703|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814704|NCT02533791|Vaccines|vaccines|mesh-list
82814705|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
82814706|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814707|NCT05426681|Glyburide|glyburide|mesh-list
82814708|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814709|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814710|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82814711|NCT01055925|Laxatives|laxatives|mesh-ancestor
82814712|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814713|NCT00440232|Frovatriptan|frovatriptan|mesh-list
82814714|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82814715|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
82814716|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814717|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814718|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814719|NCT01564199|Fluticasone|fluticasone|mesh-list
82814720|NCT01564199|Xhance|xhance|mesh-list
82814721|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82814722|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814723|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82814724|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
82814725|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814726|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814727|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82814728|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
83362052|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82814729|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
82814730|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82814731|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82814732|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82814733|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82814734|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
82814735|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814736|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814737|NCT02533323|Gemcitabine|gemcitabine|mesh-list
82814738|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
82814739|NCT02533323|Pegaspargase|pegaspargase|mesh-list
82814740|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82814741|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
82814742|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814743|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814744|NCT05379959|Methamphetamine|methamphetamine|mesh-list
82814745|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82814746|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814747|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
82814748|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
82814749|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814750|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
82814751|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814752|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814753|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
82814754|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82814755|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82814756|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82814757|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82814758|NCT04791228|Doxorubicin|doxorubicin|mesh-list
82814759|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82814761|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814762|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82814763|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82814764|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814765|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814766|NCT05357885|Antibodies|antibodies|mesh-list
82814767|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
82814768|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814769|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82814770|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
82814771|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814772|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814773|NCT00356889|Bevacizumab|bevacizumab|mesh-list
82814774|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82814775|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82814776|NCT00356889|Antibodies|antibodies|mesh-list
82814777|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
82814778|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82814779|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814780|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82814781|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82814782|NCT00356889|Growth Substances|growth substances|mesh-ancestor
82814783|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814784|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
82814785|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
82814786|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82814787|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814788|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814789|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
82814790|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
82814791|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82814792|NCT05186363|Amodiaquine|amodiaquine|mesh-list
82814793|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
82814794|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82814795|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82814796|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814797|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82814798|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814799|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814800|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82814801|NCT03742323|Idelalisib|idelalisib|mesh-list
82814802|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814803|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814804|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814805|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
82814806|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
82814807|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814808|NCT04715022|Protective Agents|protective agents|mesh-ancestor
82814809|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814810|NCT04715022|Vitamins|vitamins|mesh-ancestor
82814811|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
82814812|NCT00356811|Paclitaxel|paclitaxel|mesh-list
82814813|NCT00356811|Lapatinib|lapatinib|mesh-list
82814814|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82814815|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814816|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814817|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814818|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814819|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814820|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82814821|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814822|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
82814823|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814824|NCT01030614|Dexamethasone|dexamethasone|mesh-list
82814825|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814826|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
82814827|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
82814828|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814829|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814830|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814831|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
82814832|NCT01030614|Hormones|hormones|mesh-ancestor
82814833|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814834|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82814836|NCT01030692|Rivastigmine|rivastigmine|mesh-list
82814837|NCT01030692|Huperzine A|huperzine a|mesh-list
82814838|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82814839|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814840|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814841|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
82814842|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814843|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814844|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82814845|NCT01030692|Protective Agents|protective agents|mesh-ancestor
82814846|NCT03138252|Oxytocin|oxytocin|mesh-list
82814847|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
82814848|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82814849|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814850|NCT04994561|Niacinamide|niacinamide|mesh-list
82814851|NCT04994561|Metformin|metformin|mesh-list
82814852|NCT04994561|Dasatinib|dasatinib|mesh-list
82814853|NCT04994561|Resveratrol|resveratrol|mesh-list
82814854|NCT04994561|Quercetin|quercetin|mesh-list
82814855|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814856|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814857|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814858|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82814859|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814860|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814861|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
82814862|NCT04994561|Protective Agents|protective agents|mesh-ancestor
82814863|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82814864|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
82814865|NCT04994561|Vitamins|vitamins|mesh-ancestor
82814866|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
82814867|NCT01030770|Ranibizumab|ranibizumab|mesh-list
82814868|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82814869|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82814870|NCT01030770|Growth Substances|growth substances|mesh-ancestor
82814871|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814872|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
82814873|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814874|NCT04941443|Ibuprofen|ibuprofen|mesh-list
82814875|NCT04941443|Methadone|methadone|mesh-list
82814876|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82814877|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814878|NCT04941443|Analgesics|analgesics|mesh-ancestor
82814879|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
83362053|NCT01687283|Fluticasone|fluticasone|mesh-list
82814880|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814881|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814882|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814883|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814884|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82814885|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814886|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814887|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82814888|NCT04941443|Narcotics|narcotics|mesh-ancestor
82814889|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814890|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
82814891|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
82814892|NCT03994692|Ether|ether|mesh-list
82814893|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82814894|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
82814895|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
82814896|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82814897|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814898|NCT01030926|Insulin|insulin|mesh-list
82814899|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82814900|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
82814901|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814902|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814903|NCT00536939|Paclitaxel|paclitaxel|mesh-list
82814904|NCT00536939|Bevacizumab|bevacizumab|mesh-list
82814905|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82814906|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814907|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
82814908|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
82814909|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
82814910|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814911|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82814912|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82814913|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82814914|NCT00536939|Growth Substances|growth substances|mesh-ancestor
82814915|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814916|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
82814917|NCT04597697|Insulin|insulin|mesh-list
82814918|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814919|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814920|NCT00347919|Lapatinib|lapatinib|mesh-list
82814921|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814922|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82814923|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814924|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814925|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
82814926|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82814927|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82814928|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82814929|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82814930|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814931|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
82814932|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814933|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814934|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82814935|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814936|NCT00356421|Insulin|insulin|mesh-list
82814937|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82814938|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
82814939|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82814940|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814941|NCT03990129|Dipyrone|dipyrone|mesh-list
82814942|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82814943|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814944|NCT03990129|Analgesics|analgesics|mesh-ancestor
82814945|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
82814946|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814947|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814948|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814949|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814950|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
82814951|NCT01051947|Metoprolol|metoprolol|mesh-list
82814952|NCT01051947|Nebivolol|nebivolol|mesh-list
82814953|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82814954|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82814955|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
82814956|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
82814957|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814958|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814959|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82814960|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82814961|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82814962|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
82814963|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82814964|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814965|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
82814966|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82814967|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82814968|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82814969|NCT01052025|Curcumin|curcumin|mesh-list
82814970|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82814971|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82814972|NCT01052025|Analgesics|analgesics|mesh-ancestor
82814973|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
82814974|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814975|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814976|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814977|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82814978|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814979|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82814980|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814981|NCT00443820|Terbinafine|terbinafine|mesh-list
82814982|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
82814983|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82814984|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476464|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82814985|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82814986|NCT00438672|Dexamethasone|dexamethasone|mesh-list
82814987|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82814988|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
82814989|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
82814990|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82814991|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82814992|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82814993|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
82814994|NCT00438672|Hormones|hormones|mesh-ancestor
82814995|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82814996|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82814997|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82814998|NCT00438360|Cyclosporine|cyclosporine|mesh-list
82814999|NCT00438360|Cyclosporins|cyclosporins|mesh-list
82815000|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815001|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815002|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815003|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
82815004|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815005|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
82815006|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815007|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
82815008|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815009|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82815010|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82815011|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82815012|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82815013|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82815014|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815015|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815016|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815017|NCT00536471|Analgesics|analgesics|mesh-ancestor
82815018|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
82815019|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815020|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
82815021|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815022|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
82815023|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82815024|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
82815025|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82815026|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82815027|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82815028|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
82815029|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82815030|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815031|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82815032|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82815033|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82815034|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82815035|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815036|NCT04002635|Letrozole|letrozole|mesh-list
82815037|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82815038|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82815039|NCT04002635|Estradiol|estradiol|mesh-list
82815040|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82815041|NCT04002635|Progesterone|progesterone|mesh-list
82815042|NCT04002635|Estrogens|estrogens|mesh-ancestor
82815043|NCT04002635|Hormones|hormones|mesh-ancestor
82815044|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815045|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815046|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82815047|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
82815048|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82815049|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82815050|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815051|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82815052|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82815053|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442266|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815054|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815055|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82815056|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
82815057|NCT04002635|Progestins|progestins|mesh-ancestor
82815058|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
82815059|NCT01052181|Vitamin D|vitamin d|mesh-list
82815060|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82815061|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815062|NCT01052181|Vitamins|vitamins|mesh-ancestor
82815063|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
82815064|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82815065|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
82815066|NCT01056237|Azathioprine|azathioprine|mesh-list
82815067|NCT01056237|Tacrolimus|tacrolimus|mesh-list
82815068|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815069|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
82815070|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815071|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82815072|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815073|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815074|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82815075|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815076|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82815077|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
82815078|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82815079|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815080|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
82815081|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82815082|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815083|NCT02533557|Lidocaine|lidocaine|mesh-list
82815084|NCT02533557|Epinephrine|epinephrine|mesh-list
82815085|NCT02533557|Racepinephrine|racepinephrine|mesh-list
82815086|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
82815087|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
82815088|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
82815089|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815090|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815091|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
82815092|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815093|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82815094|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82815095|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82815096|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82815097|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815098|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82815099|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82815100|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
82815101|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815102|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82815103|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82815104|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
82815105|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82815106|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
82815107|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
82815108|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
82815109|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82815110|NCT00356265|Phenylephrine|phenylephrine|mesh-list
82815111|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
82815112|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82815113|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
82815114|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
82815115|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815116|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815117|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
82815118|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82815119|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
82815120|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
82815121|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82815122|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82815123|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82815124|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
82815125|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815126|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815127|NCT00356265|Protective Agents|protective agents|mesh-ancestor
82815128|NCT01052259|Gusperimus|gusperimus|mesh-list
82815129|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82815130|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815131|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815132|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815133|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815134|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
82815135|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82815136|NCT01052259|Protective Agents|protective agents|mesh-ancestor
82815137|NCT01056549|Exenatide|exenatide|mesh-list
82815138|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815139|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815140|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82815141|NCT01056549|Incretins|incretins|mesh-ancestor
82815142|NCT01056549|Hormones|hormones|mesh-ancestor
82815143|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815144|NCT01052337|Anesthetics|anesthetics|mesh-list
82815145|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815146|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815147|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82815148|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82815149|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815150|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815151|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815152|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815153|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82815154|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82815155|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
82815156|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815157|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815158|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82815159|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82815160|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
82815161|NCT01056627|Valproic Acid|valproic acid|mesh-list
82815162|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
82815163|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815164|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815165|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
82815166|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815167|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815168|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
82815169|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815170|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815171|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815172|NCT04273061|Atezolizumab|atezolizumab|mesh-list
82815173|NCT04273061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82815174|NCT04273061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815175|NCT04273061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815176|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815177|NCT01053585|Baclofen|baclofen|mesh-list
83362055|NCT01687283|Budesonide|budesonide|mesh-list
82815178|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82815179|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815180|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82815181|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815182|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82815183|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
82815185|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815186|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815187|NCT01564355|Triamcinolone|triamcinolone|mesh-list
82815188|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82815189|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
82815190|NCT01564355|Hormones|hormones|mesh-ancestor
82815191|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815192|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815193|NCT01056705|Vaccines|vaccines|mesh-list
82815194|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
82815195|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815196|NCT00437268|Irinotecan|irinotecan|mesh-list
82815197|NCT00437268|Cetuximab|cetuximab|mesh-list
83442273|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
82815198|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82815199|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82815200|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815201|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815202|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815203|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815204|NCT04002089|Bupivacaine|bupivacaine|mesh-list
82815205|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
82815206|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
82815207|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815208|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815209|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
82815210|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815211|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82815212|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815214|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82815215|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82815216|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82815217|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82815218|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815219|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
82815220|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815221|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815222|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82815223|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815224|NCT05355467|Tenofovir|tenofovir|mesh-list
82815225|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
82815226|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815227|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82815228|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82815229|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815230|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815231|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82815232|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82815233|NCT04139525|Heparin|heparin|mesh-list
82815234|NCT04139525|Calcium heparin|calcium heparin|mesh-list
82815235|NCT04139525|Citric Acid|citric acid|mesh-list
82815236|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
82815237|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
82815238|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82815239|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
82815240|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
82815241|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815242|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82815243|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82815244|NCT00437034|Aflibercept|aflibercept|mesh-list
82815245|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
82815246|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82815247|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82815248|NCT00437034|Growth Substances|growth substances|mesh-ancestor
82815249|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815250|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
82815251|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815252|NCT00337467|Ritonavir|ritonavir|mesh-list
82815254|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82815255|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82815256|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
82815257|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815258|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815259|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82815260|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82815261|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
82815262|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815263|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82815264|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82815265|NCT00428220|Sunitinib|sunitinib|mesh-list
82815266|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815267|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82815268|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82815269|NCT00428220|Growth Substances|growth substances|mesh-ancestor
82815270|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815271|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
82815272|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82815273|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815274|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815275|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82815276|NCT01057329|Olanzapine|olanzapine|mesh-list
82815277|NCT01057329|Aripiprazole|aripiprazole|mesh-list
82815278|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82815279|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
82815280|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
82815281|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815282|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815283|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82815284|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82815285|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815286|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815288|NCT01057329|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82815289|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82815290|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82815291|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815292|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815293|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
82815294|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
82815295|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
82815296|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
82815297|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82815298|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82815299|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82815300|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82815301|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82815302|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82815303|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82815304|NCT01057329|Analgesics|analgesics|mesh-ancestor
82815305|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
82815306|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82815307|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
82815308|NCT01057407|Sevelamer|sevelamer|mesh-list
82815309|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
82815310|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
82815311|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815312|NCT02873975|Prexasertib|prexasertib|mesh-list
82815313|NCT02873975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82815314|NCT02873975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815315|NCT02873975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815316|NCT01057563|Paclitaxel|paclitaxel|mesh-list
82815317|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82815318|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82815319|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815320|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
82815321|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
82815322|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
82815323|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815324|NCT00345579|PENTA|penta|mesh-list
82815325|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
82815326|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82815327|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82815328|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815329|NCT04002323|Lamivudine|lamivudine|mesh-list
82815330|NCT04002323|Dolutegravir|dolutegravir|mesh-list
82815331|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82815332|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82815333|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815334|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815335|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
82815336|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815337|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82815338|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82815339|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82815340|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82815341|NCT04001855|Acetic Acid|acetic acid|mesh-list
82815342|NCT04001855|Retinol acetate|retinol acetate|mesh-list
82815343|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82815344|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815345|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82815346|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
82815347|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815348|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82815349|NCT04001855|Protective Agents|protective agents|mesh-ancestor
82815350|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815351|NCT00335829|Bevacizumab|bevacizumab|mesh-list
82815352|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815353|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815354|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82815355|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82815356|NCT00335829|Growth Substances|growth substances|mesh-ancestor
82815357|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815358|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
82815359|NCT02533011|Heparin|heparin|mesh-list
82815360|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
82815361|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82815362|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82815363|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815364|NCT05262257|Metformin|metformin|mesh-list
82815365|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
82815366|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815367|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815368|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82815369|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815370|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
82815371|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82815372|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
82815373|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82815374|NCT03989817|Protective Agents|protective agents|mesh-ancestor
82815375|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815376|NCT01059123|Amoxicillin|amoxicillin|mesh-list
82815377|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82815378|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815379|NCT03986385|Capecitabine|capecitabine|mesh-list
82815380|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
82815381|NCT03986385|Apatinib|apatinib|mesh-list
82815382|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82815383|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
82815384|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815385|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815386|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82815387|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815388|NCT00344019|Atorvastatin|atorvastatin|mesh-list
82815389|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82815390|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82815391|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
82815392|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815393|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82815394|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82815395|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815396|NCT00535847|Interferons|interferons|mesh-list
82815397|NCT00535847|Ribavirin|ribavirin|mesh-list
82815398|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
82815399|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
82815400|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83362056|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82815402|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
82815403|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815404|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
82815405|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815406|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
82815407|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815408|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
82815409|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82815410|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82815411|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815412|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
82815413|NCT03606785|Coagulants|coagulants|mesh-ancestor
82815414|NCT05356169|Venetoclax|venetoclax|mesh-list
82815415|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815416|NCT01057875|Caffeine|caffeine|mesh-list
82815417|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82815418|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815419|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82815420|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815421|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815422|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82815423|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82815424|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
82815425|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815426|NCT04001387|Anesthetics|anesthetics|mesh-list
82815427|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815428|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815429|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
82815430|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
82815431|NCT00334737|Hematinics|hematinics|mesh-ancestor
82815432|NCT03986073|Linagliptin|linagliptin|mesh-list
82815433|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815434|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815436|NCT03986073|Hormones|hormones|mesh-ancestor
82815437|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815438|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82815439|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
82815440|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815441|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815442|NCT05347199|Amisulpride|amisulpride|mesh-list
82815443|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82815444|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815445|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815446|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815447|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815448|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82815449|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
82815450|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815451|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815452|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82815453|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
82815454|NCT01060137|Fentanyl|fentanyl|mesh-list
82815455|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82815456|NCT01060137|Narcotics|narcotics|mesh-ancestor
82815457|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815458|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815459|NCT01060137|Analgesics|analgesics|mesh-ancestor
82815460|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
82815461|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815462|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82815463|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82815464|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
82815465|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
82815466|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
82815467|NCT01058109|Calcium|calcium|mesh-list
82815468|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82815469|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815470|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82815471|NCT00992069|Efavirenz|efavirenz|mesh-list
82815472|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82815473|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82815474|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815475|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815476|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
82815477|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815478|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82815479|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82815480|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82815481|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82815482|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82815483|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82815484|NCT01060293|Dopamine|dopamine|mesh-list
82815485|NCT01060293|Furosemide|furosemide|mesh-list
82815486|NCT01060293|Diuretics|diuretics|mesh-ancestor
82815487|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
82815488|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815489|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83442282|NCT00786643|Leucovorin|leucovorin|mesh-list
82815490|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82815491|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815492|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82815493|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
82815494|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
82815495|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815496|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
82815497|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815498|NCT01060293|Protective Agents|protective agents|mesh-ancestor
82815499|NCT05343767|Metformin|metformin|mesh-list
82815500|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815501|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815502|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82815503|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815504|NCT03989037|Carboplatin|carboplatin|mesh-list
82815505|NCT03989037|Docetaxel|docetaxel|mesh-list
82815506|NCT03989037|Trastuzumab|trastuzumab|mesh-list
82815507|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815508|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
82815510|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
82815511|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815512|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815513|NCT00416598|Cytarabine|cytarabine|mesh-list
82815514|NCT00416598|Etoposide|etoposide|mesh-list
82815515|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
82815516|NCT00416598|Daunorubicin|daunorubicin|mesh-list
82815517|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
82815518|NCT00416598|Busulfan|busulfan|mesh-list
82815519|NCT00416598|Decitabine|decitabine|mesh-list
82815520|NCT00416598|Lenograstim|lenograstim|mesh-list
82815521|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82815522|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815523|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82815524|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82815525|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815526|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815527|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82815528|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
82815529|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
82815530|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815531|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815532|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
82815533|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815534|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82815535|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
82815536|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82815537|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82815538|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82815539|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
82815540|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
82815541|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
82815542|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
82815543|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
82815544|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82815545|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
82815546|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815547|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82815548|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815549|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815550|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815552|NCT04001465|Miotics|miotics|mesh-ancestor
82815553|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
82815554|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815555|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815556|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82815557|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
82815558|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
82815559|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82815560|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82815561|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
82815562|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815563|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815564|NCT00992381|Naproxen|naproxen|mesh-list
82815565|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82815566|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82815567|NCT00992381|Analgesics|analgesics|mesh-ancestor
82815568|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
82815569|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815570|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815571|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82815572|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815573|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
82815574|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82815575|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815576|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815577|NCT00992537|Insulin|insulin|mesh-list
82815578|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82815579|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
82815580|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
82815581|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82815582|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815583|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815584|NCT00992693|Ribavirin|ribavirin|mesh-list
82815585|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
82815586|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815587|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
82815588|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815589|NCT00992771|Varenicline|varenicline|mesh-list
82815590|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82815591|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82815592|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
82815593|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815594|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815595|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815596|NCT00992849|Bevacizumab|bevacizumab|mesh-list
82815597|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815598|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815599|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82815600|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82815601|NCT00992849|Growth Substances|growth substances|mesh-ancestor
82815602|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815603|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
82815604|NCT04001231|Exenatide|exenatide|mesh-list
82815605|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815606|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815607|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82815608|NCT04001231|Incretins|incretins|mesh-ancestor
82815609|NCT04001231|Hormones|hormones|mesh-ancestor
82815610|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815611|NCT03892889|Aripiprazole|aripiprazole|mesh-list
82815612|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
82815613|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815614|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82815615|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815616|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815617|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815618|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
82815619|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
82815620|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815621|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815622|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82815623|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82815624|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
82815625|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82815626|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82815627|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82815628|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82815629|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
82815630|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82815631|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
82815632|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815633|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
82815634|NCT00993707|Protective Agents|protective agents|mesh-ancestor
82815635|NCT00473330|Ranibizumab|ranibizumab|mesh-list
82815636|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82815637|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82815638|NCT00473330|Growth Substances|growth substances|mesh-ancestor
82815639|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815640|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
82815641|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815642|NCT00416520|Sevelamer|sevelamer|mesh-list
82815643|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
82815644|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
82815645|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815646|NCT00533429|Bevacizumab|bevacizumab|mesh-list
82815647|NCT00533429|Carboplatin|carboplatin|mesh-list
82815648|NCT00533429|Pemetrexed|pemetrexed|mesh-list
82815649|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815650|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815651|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82815652|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82815653|NCT00533429|Growth Substances|growth substances|mesh-ancestor
82815654|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815655|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
82815656|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815657|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815658|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82815659|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82815661|NCT01034124|Midazolam|midazolam|mesh-list
82815662|NCT01034124|Warfarin|warfarin|mesh-list
82815663|NCT01034124|Vitamins|vitamins|mesh-ancestor
82815664|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
82815665|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815666|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82815667|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82815668|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815669|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82815670|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815671|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815672|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82815673|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
82815674|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
82815675|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
82815676|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
82815677|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815678|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815679|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
82815680|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82815681|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82815682|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
82815683|NCT01034124|Coagulants|coagulants|mesh-ancestor
82815684|NCT00339183|Panitumumab|panitumumab|mesh-list
82815685|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815686|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815687|NCT01060605|Sirolimus|sirolimus|mesh-list
82815688|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82815689|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815690|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82815691|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815692|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
82815693|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815694|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
82815695|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815696|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
82815697|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815698|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
82815699|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815700|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815701|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82815702|NCT00993863|Ibuprofen|ibuprofen|mesh-list
82815703|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82815704|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82815705|NCT00993863|Analgesics|analgesics|mesh-ancestor
82815706|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
82815707|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815708|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815709|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82815710|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815711|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82815712|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815713|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815714|NCT00995423|Paclitaxel|paclitaxel|mesh-list
82815715|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82815716|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815717|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
82815718|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
82815719|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
82815720|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815721|NCT00995657|Fluticasone|fluticasone|mesh-list
82815722|NCT00995657|Xhance|xhance|mesh-list
82815723|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82815724|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82815725|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
82815726|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815727|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815728|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82815729|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
82815730|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
82815731|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82815732|NCT00994097|Gemcitabine|gemcitabine|mesh-list
82815733|NCT00994097|Pemetrexed|pemetrexed|mesh-list
82815734|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815735|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82815736|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
82815737|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815738|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815739|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82815740|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82815741|NCT04000919|Carbidopa|carbidopa|mesh-list
82815742|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82815743|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82815744|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
82815745|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815746|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815747|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815748|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82815749|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815750|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82815751|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82815752|NCT00994253|Diuretics|diuretics|mesh-ancestor
82815753|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
82815754|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815755|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82815756|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82815757|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815758|NCT00338949|Olanzapine|olanzapine|mesh-list
82815759|NCT00338949|Risperidone|risperidone|mesh-list
82815760|NCT00338949|Ziprasidone|ziprasidone|mesh-list
82815761|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82815762|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
82815763|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815764|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815765|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815766|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82815767|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815768|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815769|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815770|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82815771|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
82815772|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
82815773|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
82815774|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815775|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362057|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82815776|NCT00338949|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82815777|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82815778|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82815779|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82815780|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82815781|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815782|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
82815784|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815785|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82815786|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82815787|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815788|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815789|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82815790|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
82815791|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815792|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815793|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82815794|NCT03988725|Vitamin E|vitamin e|mesh-list
82815795|NCT03988725|Vitamins|vitamins|mesh-ancestor
82815796|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
82815797|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815798|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
82815799|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815800|NCT03988725|Protective Agents|protective agents|mesh-ancestor
82815801|NCT00332241|Aripiprazole|aripiprazole|mesh-list
82815802|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
82815803|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815804|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82815805|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815806|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815807|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815808|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
82815809|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
82815810|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815811|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815812|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82815813|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82815815|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82815816|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82815817|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82815818|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82815819|NCT01058577|Somatostatin|somatostatin|mesh-list
82815820|NCT01058577|Hormones|hormones|mesh-ancestor
82815821|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815822|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815823|NCT03983889|Fentanyl|fentanyl|mesh-list
82815824|NCT03983889|Midazolam|midazolam|mesh-list
82815825|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
82815826|NCT03983889|Remifentanil|remifentanil|mesh-list
82815827|NCT03983889|Propofol|propofol|mesh-list
82815828|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82815829|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82815830|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815831|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82815832|NCT03983889|Analgesics|analgesics|mesh-ancestor
82815833|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
82815834|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815835|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82815836|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82815837|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82815838|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
82815839|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82815840|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815841|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82815842|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
82815843|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
82815844|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82815845|NCT03983889|Narcotics|narcotics|mesh-ancestor
82815846|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82815847|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82815848|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82815849|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82815850|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
82815851|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
82815852|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
82815853|NCT00337935|Hematinics|hematinics|mesh-ancestor
82815854|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
82815855|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
82815856|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82815857|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
82815858|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815859|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815860|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815861|NCT00352755|Leucovorin|leucovorin|mesh-list
82815862|NCT00352755|Fluorouracil|fluorouracil|mesh-list
82815863|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
82815864|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
82815865|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815866|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82815867|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815868|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815869|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
82815870|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815871|NCT00352755|Antidotes|antidotes|mesh-ancestor
82815872|NCT00352755|Protective Agents|protective agents|mesh-ancestor
82815873|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
82815874|NCT00352755|Vitamins|vitamins|mesh-ancestor
82815875|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
82815876|NCT00533897|Abatacept|abatacept|mesh-list
82815877|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82815878|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815879|NCT00533897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815880|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815881|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815882|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
82815883|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815884|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815885|NCT00426660|Maraviroc|maraviroc|mesh-list
82815886|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82815887|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82815888|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815889|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82815890|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82815891|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
82815892|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815893|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82815894|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
82815895|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
82815896|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815897|NCT00330681|Edaravone|edaravone|mesh-list
82815898|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82815899|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
82815900|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815901|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82815902|NCT00330681|Protective Agents|protective agents|mesh-ancestor
82815903|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815904|NCT00329901|Vaccines|vaccines|mesh-list
82815905|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
82815906|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815907|NCT00436956|Prednisone|prednisone|mesh-list
82815908|NCT00436956|Cediranib|cediranib|mesh-list
82815909|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82815910|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
82815911|NCT00436956|Hormones|hormones|mesh-ancestor
82815912|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82815913|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815914|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82815915|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815916|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82815917|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815918|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815919|NCT00436644|Topotecan|topotecan|mesh-list
82815920|NCT00436644|Lapatinib|lapatinib|mesh-list
82815921|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82815922|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82815923|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815924|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815925|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815926|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82815928|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82815929|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
82815930|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
82815931|NCT00324987|Antibodies|antibodies|mesh-list
82815932|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
82815933|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82815934|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
82815935|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815936|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82815937|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82815938|NCT00324987|Growth Substances|growth substances|mesh-ancestor
82815939|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815940|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
82815941|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
82815942|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82815943|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815944|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815945|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
82815946|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82815947|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815948|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
82815949|NCT01055145|Levofloxacin|levofloxacin|mesh-list
82815950|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82815951|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82815952|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82815953|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82815954|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815955|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815956|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815957|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82815958|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82815959|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82815960|NCT00436566|Paclitaxel|paclitaxel|mesh-list
82815961|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
82815962|NCT00436566|Doxorubicin|doxorubicin|mesh-list
82815963|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82815964|NCT00436566|Trastuzumab|trastuzumab|mesh-list
82815965|NCT00436566|Lapatinib|lapatinib|mesh-list
82815966|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82815967|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82815968|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
82815969|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
82815970|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
82815971|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82815972|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82815973|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
82815974|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815975|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815976|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82815977|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
82815978|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82815979|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82815980|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82815981|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82815982|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82815983|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82815984|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82815985|NCT01060683|Chrysarobin|chrysarobin|mesh-list
82815986|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82815987|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82815988|NCT01060683|Analgesics|analgesics|mesh-ancestor
82815989|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
82815990|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82815991|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82815992|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82815993|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82815994|NCT01055301|Thalidomide|thalidomide|mesh-list
82815995|NCT01055301|Dexamethasone|dexamethasone|mesh-list
82815996|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
82815997|NCT01055301|Melphalan|melphalan|mesh-list
82815998|NCT01055301|Doxorubicin|doxorubicin|mesh-list
82815999|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82816000|NCT01055301|Etoposide|etoposide|mesh-list
82816001|NCT01055301|Lenalidomide|lenalidomide|mesh-list
82816002|NCT01055301|Bortezomib|bortezomib|mesh-list
83362058|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
82816003|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82816004|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
82816005|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816006|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82816007|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82816008|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
82816009|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816010|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816011|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82816012|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816013|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
82816014|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
82816015|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816016|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82816017|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
82816018|NCT01055301|Hormones|hormones|mesh-ancestor
82816019|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816020|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82816021|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82816022|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82816023|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82816024|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816025|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82816026|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82816027|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82816028|NCT01055301|Growth Substances|growth substances|mesh-ancestor
82816029|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
82816030|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
82816031|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816032|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816033|NCT01055379|Rasagiline|rasagiline|mesh-list
82816034|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82816035|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816036|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816037|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82816039|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816040|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82816041|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82816042|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82816043|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
82816044|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816045|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82816046|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82816047|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816048|NCT00352365|Lenalidomide|lenalidomide|mesh-list
82816049|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
82816050|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816051|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82816052|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82816053|NCT00352365|Growth Substances|growth substances|mesh-ancestor
82816054|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
82816055|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816056|NCT01055535|Plasminogen|plasminogen|mesh-list
82816057|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82816058|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82816059|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816060|NCT03987867|Paclitaxel|paclitaxel|mesh-list
82816061|NCT03987867|Carboplatin|carboplatin|mesh-list
82816062|NCT03987867|Pemetrexed|pemetrexed|mesh-list
82816063|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82816064|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82816065|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816066|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
82816067|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
82816068|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
82816069|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816070|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816071|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82816072|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82816073|NCT03987867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82816074|NCT00532493|Prazosin|prazosin|mesh-list
82816075|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83362059|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816076|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82816078|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82816079|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
82816080|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816081|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83442300|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
82816082|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816083|NCT00996515|Azacitidine|azacitidine|mesh-list
82816084|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82816085|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82816086|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
82816087|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816088|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816089|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816090|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816091|NCT00994799|Ranibizumab|ranibizumab|mesh-list
82816092|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82816093|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82816094|NCT00994799|Growth Substances|growth substances|mesh-ancestor
82816095|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816096|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
82816097|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816098|NCT00533507|Vaccines|vaccines|mesh-list
82816099|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82816100|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
82816101|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816102|NCT00352053|Tenofovir|tenofovir|mesh-list
82816103|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
82816104|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816105|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82816106|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82816107|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816108|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816109|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82816110|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82816111|NCT00995033|Varenicline|varenicline|mesh-list
82816112|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82816113|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82816114|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
82816115|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816116|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816117|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816118|NCT00997061|Topotecan|topotecan|mesh-list
82816119|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82816120|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82816121|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816122|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816123|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816124|NCT00351819|Testosterone|testosterone|mesh-list
82816125|NCT00351819|Androgens|androgens|mesh-ancestor
82816126|NCT00351819|Hormones|hormones|mesh-ancestor
82816127|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816128|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816129|NCT00998933|Testosterone|testosterone|mesh-list
82816130|NCT00998933|Androgens|androgens|mesh-ancestor
82816131|NCT00998933|Hormones|hormones|mesh-ancestor
82816132|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816133|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816134|NCT00323115|Temozolomide|temozolomide|mesh-list
82816135|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82816136|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
82816137|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816138|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816139|NCT00322881|Paclitaxel|paclitaxel|mesh-list
82816140|NCT00322881|Carboplatin|carboplatin|mesh-list
82816141|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82816142|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816143|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
82816144|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
82816145|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
82816146|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816147|NCT00415194|Pemetrexed|pemetrexed|mesh-list
82816148|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362060|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816149|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816150|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816151|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82816152|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82816153|NCT00436332|Bevacizumab|bevacizumab|mesh-list
82816154|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82816155|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82816156|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816157|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82816158|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82816159|NCT00436332|Growth Substances|growth substances|mesh-ancestor
82816160|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816161|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
82816162|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816163|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816164|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816165|NCT00532259|Pidilizumab|pidilizumab|mesh-list
82816166|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82816167|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816168|NCT00322491|Plerixafor|plerixafor|mesh-list
82816169|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82816170|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82816171|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
82816172|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816173|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
82816174|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82816175|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816176|NCT00997607|Vaccines|vaccines|mesh-list
82816177|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
82816178|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816179|NCT00997685|Capecitabine|capecitabine|mesh-list
82816180|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
82816181|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82816182|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
82816183|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816184|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816185|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82816186|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
82816187|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816188|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
82816189|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82816190|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816191|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816192|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82816193|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82816194|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816195|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816196|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816197|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82816198|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
82816199|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82816200|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816201|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82816202|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82816203|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82816204|NCT00998075|Esomeprazole|esomeprazole|mesh-list
82816205|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816206|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816207|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82816208|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82816209|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82816211|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
82816212|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82816213|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82816214|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82816215|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82816216|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816217|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816218|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82816219|NCT00531947|Protective Agents|protective agents|mesh-ancestor
82816220|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816221|NCT01003847|Fenofibrate|fenofibrate|mesh-list
82816222|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82816223|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
82816224|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816225|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82816226|NCT00530855|Lacosamide|lacosamide|mesh-list
82816227|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
82816228|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82816229|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82816230|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82816231|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816232|NCT01004237|Valsartan|valsartan|mesh-list
82816233|NCT01004237|Pravastatin|pravastatin|mesh-list
82816234|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82816235|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82816236|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82816237|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816238|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82816239|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82816240|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
82816241|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82816242|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82816243|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816244|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82816245|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82816246|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82816247|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
82816248|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816249|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816250|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816251|NCT01004315|Urological Agents|urological agents|mesh-ancestor
82816252|NCT05239637|Heparin|heparin|mesh-list
82816253|NCT05239637|Calcium heparin|calcium heparin|mesh-list
82816254|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
82816255|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82816256|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82816257|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816259|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
82816260|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
82816261|NCT01005095|Vitamins|vitamins|mesh-list
82816262|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
82816263|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816264|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82816265|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82816266|NCT01005641|Lapatinib|lapatinib|mesh-list
82816267|NCT01005641|Exemestane|exemestane|mesh-list
82816268|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816269|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816270|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816271|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816272|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82816273|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82816274|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82816275|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
82816276|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816277|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816278|NCT01005797|Sorafenib|sorafenib|mesh-list
82816279|NCT01005797|Panobinostat|panobinostat|mesh-list
82816280|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816281|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816282|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816283|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816284|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82816285|NCT01006031|Interferons|interferons|mesh-list
82816286|NCT01006031|Ribavirin|ribavirin|mesh-list
82816287|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
82816288|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
82816289|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82816290|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816291|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
82816292|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816293|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
82816294|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816295|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
82816296|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816297|NCT01006187|Lidocaine|lidocaine|mesh-list
82816298|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
82816299|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
82816300|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82816301|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816302|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
82816303|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816304|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82816305|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82816306|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82816307|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82816308|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816309|NCT00530777|Valacyclovir|valacyclovir|mesh-list
82816310|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
82816311|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816312|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
82816313|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82816314|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816315|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816316|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82816317|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82816318|NCT01006499|Protective Agents|protective agents|mesh-ancestor
82816319|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816320|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
82816321|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82816322|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
82816323|NCT03882047|Fluticasone|fluticasone|mesh-list
82816324|NCT03882047|Xhance|xhance|mesh-list
82816325|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
82816326|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816327|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82816328|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
82816329|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816330|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816331|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82816332|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
82816333|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
82816334|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82816335|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82816336|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82816337|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82816338|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
82816339|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816340|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82816341|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82816342|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816343|NCT00530621|Pemetrexed|pemetrexed|mesh-list
82816344|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816345|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816346|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816347|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82816348|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82816349|NCT00531479|Voriconazole|voriconazole|mesh-list
82816350|NCT00531479|Anidulafungin|anidulafungin|mesh-list
82816351|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
82816352|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816353|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82816354|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82816355|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442325|NCT01276379|Antidotes|antidotes|mesh-ancestor
82816356|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816357|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82816358|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
82816359|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816360|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816361|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82816362|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
82816363|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82816364|NCT00999479|Norethindrone|norethindrone|mesh-list
82816365|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
82816366|NCT00999479|Estradiol|estradiol|mesh-list
82816367|NCT00999479|Estrogens|estrogens|mesh-ancestor
82816368|NCT00999479|Hormones|hormones|mesh-ancestor
82816369|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816370|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816371|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82816373|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82816374|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82816375|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82816376|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82816377|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82816378|NCT00999479|Trace Elements|trace elements|mesh-ancestor
82816379|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
82816380|NCT00999557|Bimatoprost|bimatoprost|mesh-list
82816381|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82816382|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82816383|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82816384|NCT01008137|Vaccines|vaccines|mesh-list
82816385|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
82816386|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816387|NCT00999791|Diclofenac|diclofenac|mesh-list
82816388|NCT00999791|Bevacizumab|bevacizumab|mesh-list
82816389|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82816390|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816391|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82816392|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82816393|NCT00999791|Growth Substances|growth substances|mesh-ancestor
82816394|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816395|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
82816396|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82816397|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82816398|NCT00999791|Analgesics|analgesics|mesh-ancestor
82816399|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
82816400|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816401|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816402|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82816403|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82816404|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816405|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816406|NCT00999869|Triamcinolone|triamcinolone|mesh-list
82816407|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82816408|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82816410|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82816411|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82816412|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82816413|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82816414|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82816415|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816416|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
82816417|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816418|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816419|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816420|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
82816421|NCT00999869|Hormones|hormones|mesh-ancestor
82816422|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816423|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82816424|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
82816425|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816426|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82816427|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816428|NCT01008293|Lactulose|lactulose|mesh-list
82816429|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82816430|NCT01008527|Poly ICLC|poly iclc|mesh-list
82816431|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
82816432|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
82816433|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816434|NCT01000415|Cisplatin|cisplatin|mesh-list
82816435|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816436|NCT01008761|Azithromycin|azithromycin|mesh-list
82816437|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816438|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816439|NCT01008917|Sirolimus|sirolimus|mesh-list
82816440|NCT01008917|Sorafenib|sorafenib|mesh-list
82816441|NCT01008917|Temsirolimus|temsirolimus|mesh-list
82816442|NCT01008917|MTOR Inhibitors|mtor inhibitors|mesh-list
82816443|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816444|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816445|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816446|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816447|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82816448|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
82816449|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816450|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816451|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816452|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82816453|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
82816454|NCT01009073|Irinotecan|irinotecan|mesh-list
82816455|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82816456|NCT01009073|Navitoclax|navitoclax|mesh-list
82816457|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82816458|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82816459|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816460|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816461|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816462|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816463|NCT00530075|Gusperimus|gusperimus|mesh-list
82816464|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82816465|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816466|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82816467|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816468|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82816469|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
82816470|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82816471|NCT00530075|Protective Agents|protective agents|mesh-ancestor
82816472|NCT01001585|Sevoflurane|sevoflurane|mesh-list
82816473|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82816474|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82816475|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
82816476|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
82816477|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82816478|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816479|NCT01001897|Misoprostol|misoprostol|mesh-list
82816480|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82816481|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
82816482|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82816483|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816484|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82816485|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82816486|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
82816487|NCT05734001|Hemostatics|hemostatics|mesh-list
82816488|NCT05734001|Coagulants|coagulants|mesh-ancestor
82816489|NCT01002911|Cefazolin|cefazolin|mesh-list
82816490|NCT01002911|Cephalexin|cephalexin|mesh-list
82816491|NCT01002911|Bacitracin|bacitracin|mesh-list
82816492|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816493|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816494|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82816495|NCT05059535|Acetaminophen|acetaminophen|mesh-list
82816496|NCT05059535|Analgesics|analgesics|mesh-list
82816497|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82816498|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
82816499|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816500|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816501|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
82816502|NCT00531011|Paclitaxel|paclitaxel|mesh-list
82816503|NCT00531011|Everolimus|everolimus|mesh-list
82816504|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83442334|NCT01275547|Esketamine|esketamine|mesh-list
82816505|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816506|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
82816507|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
82816508|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
82816509|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816510|NCT00531011|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82816511|NCT00531011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816512|NCT00531011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816513|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82816514|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
82816515|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816516|NCT04000295|Paclitaxel|paclitaxel|mesh-list
82816517|NCT04000295|Etoposide|etoposide|mesh-list
82816518|NCT04000295|Apatinib|apatinib|mesh-list
82816519|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82816520|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816521|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
82816522|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
82816523|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
82816524|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816525|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82816526|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82816527|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816528|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816529|NCT01003613|Tranilast|tranilast|mesh-list
82816530|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82816531|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82816532|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82816533|NCT01003613|Analgesics|analgesics|mesh-ancestor
82816534|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
82816535|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816536|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816537|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816538|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82816539|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82816540|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82816541|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816542|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82816543|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82816544|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
82816545|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
82816546|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816547|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82816548|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82816549|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
82816550|NCT01003613|Coagulants|coagulants|mesh-ancestor
82816551|NCT00471146|Gemcitabine|gemcitabine|mesh-list
82816552|NCT00471146|Axitinib|axitinib|mesh-list
82816553|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82816554|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
82816555|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816556|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816557|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816558|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816559|NCT01021358|Ketoconazole|ketoconazole|mesh-list
82816560|NCT01021358|Navitoclax|navitoclax|mesh-list
82816561|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
82816562|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816563|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82816564|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82816565|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816566|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816567|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82816568|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
82816569|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816570|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816571|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82816572|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816573|NCT00469898|Carboplatin|carboplatin|mesh-list
82816574|NCT00469898|Irinotecan|irinotecan|mesh-list
82816575|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816576|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82816577|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82816578|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816579|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816580|NCT01021436|Amikacin|amikacin|mesh-list
82816581|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816582|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816583|NCT00529763|Dasatinib|dasatinib|mesh-list
82816584|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816585|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816586|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816587|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816588|NCT00486902|Ketamine|ketamine|mesh-list
82816589|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
82816590|NCT00486902|Analgesics|analgesics|mesh-ancestor
82816591|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
82816592|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816593|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816594|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82816595|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82816596|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
82816597|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
82816598|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362061|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82816599|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82816600|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82816601|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816602|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816603|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
82816604|NCT03687827|Insulin|insulin|mesh-list
82816605|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82816606|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
82816607|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82816608|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816609|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82816610|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82816611|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
82816612|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816613|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816614|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82816615|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
82816616|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82816617|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82816618|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82816619|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
82816620|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816621|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816622|NCT05685953|Vaccines|vaccines|mesh-list
82816623|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
82816624|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816625|NCT00486434|Calcitonin|calcitonin|mesh-list
82816626|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
82816627|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82816628|NCT00486434|Katacalcin|katacalcin|mesh-list
82816629|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82816630|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816631|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82816632|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
82816633|NCT00529451|Ramipril|ramipril|mesh-list
82816634|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82816635|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
82816636|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816637|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816638|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82816639|NCT05641259|Azacitidine|azacitidine|mesh-list
82816640|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82816641|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
82816642|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816643|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816644|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816645|NCT05405387|Budesonide|budesonide|mesh-list
82816646|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816647|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82816648|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
82816649|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816650|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816651|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82816652|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
82816653|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
82816654|NCT05405387|Hormones|hormones|mesh-ancestor
82816655|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816656|NCT03999437|Terbinafine|terbinafine|mesh-list
82816657|NCT03999437|Butenafine|butenafine|mesh-list
82816658|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
82816659|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816660|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816661|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816662|NCT05638217|Listerine|listerine|mesh-list
82816663|NCT05638217|Fluorides|fluorides|mesh-list
82816664|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
82816665|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
82816666|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
82816667|NCT05638217|Protective Agents|protective agents|mesh-ancestor
82816668|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816669|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82816670|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816671|NCT05637281|Indomethacin|indomethacin|mesh-list
82816672|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82816673|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82816674|NCT05637281|Analgesics|analgesics|mesh-ancestor
82816675|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
82816676|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816677|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816678|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816679|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82816680|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
82816681|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
82816682|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82816683|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82816684|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816685|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816686|NCT00321711|Azacitidine|azacitidine|mesh-list
82816687|NCT00321711|Decitabine|decitabine|mesh-list
82816688|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82816689|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
82816690|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816691|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816692|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816693|NCT00486044|Simvastatin|simvastatin|mesh-list
82816694|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82816695|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82816696|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
82816697|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816698|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82816699|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82816700|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816701|NCT00351273|Azithromycin|azithromycin|mesh-list
82816702|NCT00351273|Doxycycline|doxycycline|mesh-list
82816703|NCT00351273|Rifampin|rifampin|mesh-list
82816704|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816705|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816706|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
82816707|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82816708|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82816709|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82816710|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
82816711|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
82816712|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82816713|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816714|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816715|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82816716|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82816717|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82816718|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82816719|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82816720|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82816721|NCT00327717|Zonisamide|zonisamide|mesh-list
82816722|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
82816723|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82816724|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82816725|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816726|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82816727|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816728|NCT00463346|Acamprosate|acamprosate|mesh-list
82816729|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82816730|NCT01022528|Dexamethasone|dexamethasone|mesh-list
82816731|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
82816732|NCT01022528|BB 1101|bb 1101|mesh-list
82816733|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816734|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
82816735|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
82816736|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816737|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816738|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82816739|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
82816740|NCT01022528|Hormones|hormones|mesh-ancestor
82816741|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816742|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82816743|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816744|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
83362062|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
82816745|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816746|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816747|NCT01025102|Sufentanil|sufentanil|mesh-list
82816748|NCT01025102|Ropivacaine|ropivacaine|mesh-list
82816749|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82816750|NCT01025102|Narcotics|narcotics|mesh-ancestor
82816751|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82816752|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816753|NCT01025102|Analgesics|analgesics|mesh-ancestor
82816754|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
82816755|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816756|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82816757|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82816758|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
82816759|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
82816760|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
82816761|NCT00424476|Belimumab|belimumab|mesh-list
82816762|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82816763|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
82816764|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816765|NCT01037634|Oseltamivir|oseltamivir|mesh-list
82816766|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
82816767|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816768|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816769|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816770|NCT01037712|Valacyclovir|valacyclovir|mesh-list
82816771|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
82816772|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816773|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82816774|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816775|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816776|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816777|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816778|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
82816779|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82816780|NCT00461786|Pemetrexed|pemetrexed|mesh-list
82816781|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816782|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482530|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
82816783|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816784|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82816785|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82816786|NCT01021592|Bortezomib|bortezomib|mesh-list
82816787|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816788|NCT00435162|Valsartan|valsartan|mesh-list
82816789|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82816790|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82816791|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82816792|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816793|NCT03836664|Timolol|timolol|mesh-list
82816794|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82816795|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82816796|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82816797|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82816798|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
82816799|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816800|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816801|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816802|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82816803|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82816804|NCT00350727|Lapatinib|lapatinib|mesh-list
82816805|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816806|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816807|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816808|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816809|NCT01032486|Rasagiline|rasagiline|mesh-list
82816810|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82816811|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816812|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816813|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82816814|NCT01032486|Protective Agents|protective agents|mesh-ancestor
82816815|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816816|NCT01061697|Pregabalin|pregabalin|mesh-list
82816817|NCT01061697|Analgesics|analgesics|mesh-ancestor
82816818|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
82816819|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816820|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816821|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
82816822|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82816823|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82816824|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816825|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82816826|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82816827|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82816828|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82816829|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82816831|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82816832|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82816833|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
82816834|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
82816835|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816836|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816837|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816838|NCT00424008|Fluticasone|fluticasone|mesh-list
82816839|NCT00424008|Xhance|xhance|mesh-list
82816840|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
82816841|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
82816842|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82816843|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82816844|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816845|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82816846|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
82816847|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816848|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816849|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82816850|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
82816851|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
82816852|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82816853|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82816854|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82816855|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82816856|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
82816857|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816858|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816859|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
82816860|NCT00424008|Hormones|hormones|mesh-ancestor
82816861|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816862|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
82816863|NCT00423930|Bevacizumab|bevacizumab|mesh-list
82816864|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82816865|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816866|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82816867|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82816868|NCT00423930|Growth Substances|growth substances|mesh-ancestor
82816869|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816870|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
82816871|NCT00423852|Paclitaxel|paclitaxel|mesh-list
82816872|NCT00423852|Carboplatin|carboplatin|mesh-list
82816873|NCT00423852|Ifosfamide|ifosfamide|mesh-list
82816874|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82816875|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816876|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
82816877|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
82816878|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
82816879|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816880|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82816881|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
82816882|NCT00461708|Gemcitabine|gemcitabine|mesh-list
82816883|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82816884|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82816885|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
82816886|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816887|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816888|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82816889|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816890|NCT00327171|Aflibercept|aflibercept|mesh-list
82816891|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82816892|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82816893|NCT00327171|Growth Substances|growth substances|mesh-ancestor
82816894|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816895|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
82816896|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816897|NCT01038024|Antioxidants|antioxidants|mesh-list
82816898|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816899|NCT01038024|Protective Agents|protective agents|mesh-ancestor
82816900|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816902|NCT00461630|Simvastatin|simvastatin|mesh-list
82816903|NCT00461630|Ezetimibe|ezetimibe|mesh-list
82816904|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
82816905|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82816906|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82816907|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
82816908|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816909|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82816910|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82816911|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816912|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
82816913|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
82816914|NCT00461630|Vitamins|vitamins|mesh-ancestor
82816915|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
82816916|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816917|NCT01061853|Sirolimus|sirolimus|mesh-list
82816918|NCT01061853|Betamethasone|betamethasone|mesh-list
82816919|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816920|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816921|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82816922|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816923|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
82816924|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82816925|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
82816926|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816927|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816928|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
82816929|NCT01061853|Hormones|hormones|mesh-ancestor
82816930|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816931|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82816932|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
82816933|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
82816934|NCT01325415|Naloxegol|naloxegol|mesh-list
82816935|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82816936|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82816937|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82816938|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82816939|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816940|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816941|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816942|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816943|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82816944|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
82816945|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816946|NCT01022840|Ketamine|ketamine|mesh-list
82816947|NCT01022840|Esketamine|esketamine|mesh-list
82816948|NCT01022840|Analgesics|analgesics|mesh-ancestor
82816949|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
82816950|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82816951|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816952|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82816953|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82816954|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
82816955|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
82816956|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82816957|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82816958|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82816959|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82816960|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816961|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
82816962|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82816963|NCT01025570|Gemcitabine|gemcitabine|mesh-list
82816964|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82816965|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
82816966|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816967|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816968|NCT03983876|Adalimumab|adalimumab|mesh-list
82816969|NCT03983876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82816970|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816971|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82816972|NCT00327015|Metformin|metformin|mesh-list
82816973|NCT00327015|Pioglitazone|pioglitazone|mesh-list
82816974|NCT00327015|Saxagliptin|saxagliptin|mesh-list
82816975|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82816976|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816977|NCT00327015|Incretins|incretins|mesh-ancestor
82816978|NCT00327015|Hormones|hormones|mesh-ancestor
82816979|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816980|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82816981|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
82816982|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82816983|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816984|NCT00434148|Pasireotide|pasireotide|mesh-list
82816985|NCT00434148|Hormones|hormones|mesh-ancestor
82816986|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82816987|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82816988|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
82816989|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82816990|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82816991|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82816992|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82816993|NCT01063647|Treosulfan|treosulfan|mesh-list
82816994|NCT01063647|Busulfan|busulfan|mesh-list
82816995|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82816996|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
82816997|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82816998|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82816999|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817000|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
82817001|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817002|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82817003|NCT00468728|Vancomycin|vancomycin|mesh-list
82817004|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817005|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817006|NCT00433914|Vaccines|vaccines|mesh-list
82817007|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
82817008|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817009|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
82817010|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817011|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
82817012|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82817013|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82817014|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817015|NCT00468650|Urological Agents|urological agents|mesh-ancestor
82817016|NCT00423150|Temozolomide|temozolomide|mesh-list
82817017|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82817018|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
82817019|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817020|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817021|NCT00433836|Valsartan|valsartan|mesh-list
82817022|NCT00433836|Enalapril|enalapril|mesh-list
82817023|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82817024|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82817025|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82817026|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817027|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82817028|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
82817029|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817030|NCT01022918|Bevacizumab|bevacizumab|mesh-list
82817031|NCT01022918|Temozolomide|temozolomide|mesh-list
82817032|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817033|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817034|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82817035|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82817036|NCT01022918|Growth Substances|growth substances|mesh-ancestor
82817037|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817038|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
82817039|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82817040|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
82817041|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817042|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
82817043|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82817044|NCT00433446|Siltuximab|siltuximab|mesh-list
82817045|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817046|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82817047|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82817048|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82817049|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817050|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
82817051|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
82817052|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82817053|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
82817054|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817055|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817056|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82817057|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82817058|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82817059|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82817060|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817061|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817062|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817063|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817064|NCT00433290|Analgesics|analgesics|mesh-ancestor
82817065|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
82817066|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817067|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
82817068|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82817069|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
82817070|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
82817071|NCT00467870|Testosterone|testosterone|mesh-list
82817072|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
82817073|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
82817074|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82817075|NCT00467870|Androgens|androgens|mesh-ancestor
82817076|NCT00467870|Hormones|hormones|mesh-ancestor
82817077|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817078|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817079|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82817080|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817081|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
82817082|NCT00467558|Naltrexone|naltrexone|mesh-list
82817083|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82817084|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82817085|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817086|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
82817087|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817088|NCT00422292|Vaccines|vaccines|mesh-list
82817089|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
82817090|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817091|NCT00452348|Fluticasone|fluticasone|mesh-list
82817092|NCT00452348|Xhance|xhance|mesh-list
82817093|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82817094|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82817095|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82817096|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82817097|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
82817098|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817099|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817100|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82817101|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
82817102|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
82817103|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82817104|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82817105|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82817106|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82817107|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
82817108|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817109|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817110|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
82817111|NCT00452348|Hormones|hormones|mesh-ancestor
82817112|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817113|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
82817114|NCT01323062|Bavituximab|bavituximab|mesh-list
82817115|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817116|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817117|NCT00320541|Paclitaxel|paclitaxel|mesh-list
82817118|NCT00320541|Bevacizumab|bevacizumab|mesh-list
82817119|NCT00320541|Gemcitabine|gemcitabine|mesh-list
82817120|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82817121|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817122|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
82817123|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
82817124|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
82817125|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817126|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817127|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82817128|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82817129|NCT00320541|Growth Substances|growth substances|mesh-ancestor
82817130|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817131|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
82817132|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82817133|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
82817134|NCT00320385|Trastuzumab|trastuzumab|mesh-list
82817135|NCT00320385|Lapatinib|lapatinib|mesh-list
82817136|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817137|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817138|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82817139|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817140|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817141|NCT00309777|Simvastatin|simvastatin|mesh-list
82817142|NCT00309777|Pitavastatin|pitavastatin|mesh-list
82817143|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82817144|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82817145|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
83442362|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817146|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817147|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82817148|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82817149|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817150|NCT00325143|Edetic Acid|edetic acid|mesh-list
82817151|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
82817152|NCT00325143|Antidotes|antidotes|mesh-ancestor
82817153|NCT00325143|Protective Agents|protective agents|mesh-ancestor
82817154|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817155|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
82817156|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
82817157|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817158|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82817159|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
82817160|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82817161|NCT00319839|Paclitaxel|paclitaxel|mesh-list
82817162|NCT00319839|Cetuximab|cetuximab|mesh-list
82817163|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82817164|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82817165|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817166|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
82817167|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
82817168|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
82817169|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817170|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817171|NCT01062087|Lidocaine|lidocaine|mesh-list
82817172|NCT01062087|Bupivacaine|bupivacaine|mesh-list
82817173|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
82817174|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
82817175|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82817176|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817177|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
82817178|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817179|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82817180|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82817181|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82817182|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817183|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817184|NCT00319449|Atorvastatin|atorvastatin|mesh-list
82817185|NCT00319449|Ezetimibe|ezetimibe|mesh-list
82817186|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82817187|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82817188|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
82817189|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817190|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83362063|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
83362064|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83362065|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
82817191|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82817192|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817193|NCT00308685|Albuterol|albuterol|mesh-list
82817194|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82817195|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
82817196|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817197|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817198|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82817199|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
82817200|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
82817201|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82817202|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82817203|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82817204|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82817205|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
82817206|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817207|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817208|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82817209|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817210|NCT03981081|Prednisone|prednisone|mesh-list
82817211|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82817212|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
82817213|NCT03981081|Hormones|hormones|mesh-ancestor
82817214|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817215|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817216|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82817217|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817218|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
82817219|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82817220|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
82817221|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82817222|NCT00316719|Lamivudine|lamivudine|mesh-list
82817223|NCT00316719|Adefovir|adefovir|mesh-list
82817224|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82817225|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82817226|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82817227|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817228|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817229|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
82817230|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817231|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82817232|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82817233|NCT01065987|Tizanidine|tizanidine|mesh-list
82817234|NCT01065987|Analgesics|analgesics|mesh-ancestor
82817235|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
82817236|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817237|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817238|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
82817239|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82817240|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82817241|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
82817242|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
82817243|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82817244|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82817245|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82817246|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
82817247|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817248|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817249|NCT01064115|Cetirizine|cetirizine|mesh-list
82817250|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82817251|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82817252|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82817253|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
82817254|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
82817255|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817256|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817257|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817258|NCT00422058|Liraglutide|liraglutide|mesh-list
82817259|NCT00422058|Orlistat|orlistat|mesh-list
82817260|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817261|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817262|NCT00422058|Incretins|incretins|mesh-ancestor
82817263|NCT00422058|Hormones|hormones|mesh-ancestor
82817264|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817265|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817266|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817267|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82817268|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82817269|NCT01032798|Mepivacaine|mepivacaine|mesh-list
82817270|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
82817271|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
82817272|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82817273|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817274|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
82817275|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817276|NCT00413244|Testosterone|testosterone|mesh-list
82817277|NCT00413244|Androgens|androgens|mesh-ancestor
82817278|NCT00413244|Hormones|hormones|mesh-ancestor
82817279|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817280|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817281|NCT01033032|Amrubicin|amrubicin|mesh-list
82817282|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817283|NCT01038570|Oxytocin|oxytocin|mesh-list
82817284|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
82817285|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82817286|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817287|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82817288|NCT00420342|Drospirenone|drospirenone|mesh-list
82817289|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82817290|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82817291|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
82817292|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82817293|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82817294|NCT00420342|Estradiol|estradiol|mesh-list
82817295|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82817296|NCT00420342|Estrogens|estrogens|mesh-ancestor
82817297|NCT00420342|Hormones|hormones|mesh-ancestor
82817298|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817299|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817300|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82817301|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
82817302|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82817303|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82817304|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82817305|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82817306|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82817307|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82817308|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82817309|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817310|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82817311|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
82817312|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82817314|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
82817315|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82817316|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817317|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817318|NCT01038648|Incretins|incretins|mesh-ancestor
82817319|NCT01038648|Hormones|hormones|mesh-ancestor
82817320|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817321|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82817322|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
82817323|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817324|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817325|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82817326|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82817327|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817328|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817329|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82817330|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817331|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817332|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
82817333|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817334|NCT00451958|Leuprolide|leuprolide|mesh-list
82817335|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82817336|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
82817337|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82817338|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817339|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82817340|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817342|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82817343|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
82817344|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817345|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817346|NCT01026116|Paclitaxel|paclitaxel|mesh-list
82817347|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
82817348|NCT01026116|Epirubicin|epirubicin|mesh-list
82817349|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82817350|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817351|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
82817352|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
82817353|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
82817354|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817355|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817356|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
82817357|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817358|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82817359|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82817360|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
82817361|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82817362|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82817363|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82817364|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82817365|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817366|NCT00432276|Metformin|metformin|mesh-list
82817367|NCT00432276|Pioglitazone|pioglitazone|mesh-list
82817368|NCT00432276|Alogliptin|alogliptin|mesh-list
82817369|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817370|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817371|NCT00432276|Incretins|incretins|mesh-ancestor
82817372|NCT00432276|Hormones|hormones|mesh-ancestor
82817373|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817374|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82817375|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
82817376|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817377|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817378|NCT01027520|Monensin|monensin|mesh-list
82817379|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
82817380|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817381|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82817382|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82817383|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
82817384|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
82817385|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
82817386|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817387|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817388|NCT01027520|Ionophores|ionophores|mesh-ancestor
82817389|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817390|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
82817391|NCT01023230|Entecavir|entecavir|mesh-list
82817392|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
82817393|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817394|NCT01027832|Tazobactam|tazobactam|mesh-list
82817395|NCT01027832|Piperacillin|piperacillin|mesh-list
82817396|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82817397|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817398|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817399|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82817400|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817401|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817402|NCT00413010|Pregabalin|pregabalin|mesh-list
82817403|NCT00413010|Analgesics|analgesics|mesh-ancestor
82817404|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
82817405|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817406|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817407|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
82817408|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82817409|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817410|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817411|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82817412|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82817413|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82817414|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82817415|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82817416|NCT00459290|Mifepristone|mifepristone|mesh-list
82817417|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82817418|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
82817419|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82817420|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817421|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82817422|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82817423|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82817424|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
82817425|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82817426|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82817427|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
82817428|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817429|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
82817430|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82817431|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82817432|NCT00443534|Sunitinib|sunitinib|mesh-list
82817433|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817434|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82817435|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82817436|NCT00443534|Growth Substances|growth substances|mesh-ancestor
82817437|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817438|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
82817439|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82817440|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817441|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817442|NCT00419952|Budesonide|budesonide|mesh-list
82817443|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
82817444|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82817445|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82817446|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82817447|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
82817448|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817449|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817450|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82817451|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
82817452|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
82817453|NCT00419952|Hormones|hormones|mesh-ancestor
82817454|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817455|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82817456|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82817457|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82817458|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
82817459|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817460|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817461|NCT00443456|Amlodipine|amlodipine|mesh-list
82817462|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82817463|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82817464|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817465|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817466|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82817467|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817468|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
82817469|NCT00419562|Insulin|insulin|mesh-list
82817470|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817471|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817472|NCT03557294|Varenicline|varenicline|mesh-list
82817473|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82817474|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82817475|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
82817476|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817477|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817478|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817479|NCT01026350|Antibodies|antibodies|mesh-list
82817480|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
82817481|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817482|NCT01026428|Levodopa|levodopa|mesh-list
82817483|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82817484|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82817485|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
82817486|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817487|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817488|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817490|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817491|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817492|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82817493|NCT00308139|Incretins|incretins|mesh-ancestor
82817494|NCT00308139|Hormones|hormones|mesh-ancestor
82817495|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817496|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82817497|NCT00459056|Carvedilol|carvedilol|mesh-list
82817498|NCT00459056|Lisinopril|lisinopril|mesh-list
82817499|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82817500|NCT00459056|Diuretics|diuretics|mesh-ancestor
82817501|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
82817502|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817503|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82817504|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817505|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817506|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82817507|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82817508|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
82817509|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817510|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
82817511|NCT00459056|Protective Agents|protective agents|mesh-ancestor
82817512|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82817513|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82817514|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
82817515|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82817516|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82817517|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82817518|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
82817519|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817520|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82817521|NCT01062477|Vaccines|vaccines|mesh-list
82817522|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
82817523|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817524|NCT01323374|Carbidopa|carbidopa|mesh-list
82817525|NCT01323374|Droxidopa|droxidopa|mesh-list
82817526|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82817527|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82817528|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
82817529|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817530|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817531|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817532|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82817533|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817534|NCT00431964|Azithromycin|azithromycin|mesh-list
82817535|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817536|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817537|NCT00431496|Cinacalcet|cinacalcet|mesh-list
82817538|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82817539|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817540|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82817541|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
82817542|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817543|NCT00316173|Carboplatin|carboplatin|mesh-list
82817544|NCT00316173|Topotecan|topotecan|mesh-list
82817545|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817546|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82817547|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82817548|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817549|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817550|NCT00412542|Thalidomide|thalidomide|mesh-list
82817551|NCT00412542|Irinotecan|irinotecan|mesh-list
82817552|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82817553|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82817554|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817555|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817556|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817557|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817558|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
82817559|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817560|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
82817561|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817562|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817563|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82817564|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82817565|NCT00412542|Growth Substances|growth substances|mesh-ancestor
82817566|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
82817567|NCT00316017|Dextrans|dextrans|mesh-list
82817568|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
82817569|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
82817570|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
82817571|NCT00451178|Prednisone|prednisone|mesh-list
82817572|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
82817573|NCT00451178|Rituximab|rituximab|mesh-list
82817574|NCT00451178|Doxorubicin|doxorubicin|mesh-list
82817575|NCT00451178|Vincristine|vincristine|mesh-list
82817576|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817577|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
82817578|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817579|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82817580|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82817581|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
82817582|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817583|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817584|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82817585|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817586|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82817587|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82817588|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82817589|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817590|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82817591|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
82817592|NCT00451178|Hormones|hormones|mesh-ancestor
82817593|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817594|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82817595|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82817596|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
82817597|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
82817598|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
82817599|NCT00450866|Epothilones|epothilones|mesh-list
82817600|NCT00450866|Epothilone B|epothilone b|mesh-list
82817601|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
82817602|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
82817603|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
82817604|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817605|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817606|NCT01026584|Aripiprazole|aripiprazole|mesh-list
82817607|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
82817608|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82817609|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82817610|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82817611|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82817612|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817613|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
82817614|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
82817615|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817616|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817617|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82817618|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82817619|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
82817620|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82817621|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82817622|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82817623|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82817624|NCT01023464|Emollients|emollients|mesh-list
82817625|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82817626|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82817627|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
82817628|NCT01023542|Everolimus|everolimus|mesh-list
82817629|NCT01023542|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82817630|NCT01023542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82817631|NCT01023542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817632|NCT01023542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817633|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817634|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
82817635|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362066|NCT01687283|Hormones|hormones|mesh-ancestor
82817636|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817637|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
82817638|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
82817639|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817640|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817641|NCT01028534|Olmesartan|olmesartan|mesh-list
82817642|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82817643|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
82817644|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
82817645|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82817646|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82817647|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817648|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82817649|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82817650|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817651|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82817652|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817653|NCT00441974|Adefovir|adefovir|mesh-list
82817654|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82817655|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
82817656|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817657|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82817658|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82817659|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817660|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817661|NCT00441584|Ribavirin|ribavirin|mesh-list
82817662|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82817663|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
82817664|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
82817665|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817666|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
82817667|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817668|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
82817669|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817670|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
82817671|NCT00430716|Citric Acid|citric acid|mesh-list
82817672|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
82817673|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
82817674|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82817675|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
82817676|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
82817677|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817678|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
82817679|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82817680|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82817681|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817682|NCT00430716|Urological Agents|urological agents|mesh-ancestor
82817683|NCT01028768|Teduglutide|teduglutide|mesh-list
82817684|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82817685|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82817686|NCT01028768|Protective Agents|protective agents|mesh-ancestor
82817687|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817688|NCT00441272|Pioglitazone|pioglitazone|mesh-list
82817689|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817690|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817691|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82817692|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
82817693|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817694|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82817695|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82817696|NCT01028924|Teduglutide|teduglutide|mesh-list
82817697|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82817698|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82817699|NCT01028924|Protective Agents|protective agents|mesh-ancestor
82817700|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817701|NCT01029002|Vitamin D|vitamin d|mesh-list
82817702|NCT01029002|Vitamins|vitamins|mesh-ancestor
82817703|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
82817704|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817705|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82817706|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82817707|NCT00430638|Olmesartan|olmesartan|mesh-list
82817708|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82817709|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82817710|NCT00430638|Diuretics|diuretics|mesh-ancestor
82817711|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
82817712|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817713|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82817714|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817715|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817716|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82817717|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82817718|NCT03671330|Letrozole|letrozole|mesh-list
82817719|NCT03671330|Goserelin|goserelin|mesh-list
82817720|NCT03671330|Anastrozole|anastrozole|mesh-list
82817721|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817722|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82817723|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82817724|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817725|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817726|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82817727|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
82817728|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817729|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817730|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82817731|NCT01038882|Midazolam|midazolam|mesh-list
82817732|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82817733|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82817734|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82817735|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817736|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82817737|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82817738|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82817739|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82817740|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
82817741|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
82817742|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
82817743|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
82817744|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817745|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817746|NCT00449930|Metformin|metformin|mesh-list
82817747|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82817748|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817749|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817750|NCT00449930|Incretins|incretins|mesh-ancestor
82817751|NCT00449930|Hormones|hormones|mesh-ancestor
82817752|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817753|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82817754|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
82817755|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817756|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817757|NCT00441116|Dutasteride|dutasteride|mesh-list
82817758|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82817759|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82817760|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817761|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817762|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
82817763|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817764|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817765|NCT01024322|Diclofenac|diclofenac|mesh-list
82817766|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
82817767|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82817768|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
82817769|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82817770|NCT01024322|Prednisolone|prednisolone|mesh-list
82817771|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82817772|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
82817773|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82817774|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82817775|NCT01024322|Analgesics|analgesics|mesh-ancestor
82817776|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
82817777|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817778|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817779|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82817780|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82817781|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82817782|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817783|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817784|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817785|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
82817786|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
82817787|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82817788|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
82817789|NCT01024322|Hormones|hormones|mesh-ancestor
82817790|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817791|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82817792|NCT01024322|Protective Agents|protective agents|mesh-ancestor
82817793|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82817794|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82817795|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817796|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817797|NCT01566266|Amoxicillin|amoxicillin|mesh-list
82817798|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817799|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817800|NCT00430248|Allopurinol|allopurinol|mesh-list
82817801|NCT00430248|Febuxostat|febuxostat|mesh-list
82817802|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
82817803|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817804|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817805|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
82817806|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82817807|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82817808|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
82817809|NCT00430248|Protective Agents|protective agents|mesh-ancestor
82817810|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817811|NCT00411762|Capecitabine|capecitabine|mesh-list
82817812|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82817813|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
82817814|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817815|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817816|NCT00429858|Gemcitabine|gemcitabine|mesh-list
82817817|NCT00429858|Tegafur|tegafur|mesh-list
82817818|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82817819|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
82817820|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817821|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817822|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
82817823|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82817824|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
82817825|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817827|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82817828|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
82817829|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82817830|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817831|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
82817832|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82817833|NCT00428844|Vancomycin|vancomycin|mesh-list
82817834|NCT00428844|Daptomycin|daptomycin|mesh-list
82817835|NCT00428844|Teicoplanin|teicoplanin|mesh-list
82817836|NCT00428844|Floxacillin|floxacillin|mesh-list
82817837|NCT00428844|Oxacillin|oxacillin|mesh-list
82817838|NCT00428844|Nafcillin|nafcillin|mesh-list
82817839|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817840|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817841|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82817842|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
82817843|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817844|NCT01039194|Galantamine|galantamine|mesh-list
82817845|NCT01039194|BMS 708163|bms 708163|mesh-list
82817846|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82817847|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817848|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817849|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
82817850|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817851|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817852|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82817853|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
82817854|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817855|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
82817856|NCT01039194|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82817857|NCT00449072|Loratadine|loratadine|mesh-list
82817858|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
82817859|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
82817860|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82817861|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82817862|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82817863|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
82817864|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
82817865|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817866|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817867|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817869|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
82817870|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
82817871|NCT00448916|Pregabalin|pregabalin|mesh-list
82817872|NCT00448916|Analgesics|analgesics|mesh-ancestor
82817873|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
82817874|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82817875|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817876|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
82817877|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82817878|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82817879|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817880|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82817881|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82817882|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82817883|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82817884|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82817885|NCT00418938|Leucovorin|leucovorin|mesh-list
82817886|NCT00418938|Bevacizumab|bevacizumab|mesh-list
82817887|NCT00418938|Panitumumab|panitumumab|mesh-list
82817888|NCT00418938|Fluorouracil|fluorouracil|mesh-list
82817889|NCT00418938|Irinotecan|irinotecan|mesh-list
82817890|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817891|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817892|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82817893|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82817894|NCT00418938|Growth Substances|growth substances|mesh-ancestor
82817895|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817896|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
82817897|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
82817898|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817899|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82817900|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817901|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
82817902|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82817903|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82817904|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817905|NCT00418938|Antidotes|antidotes|mesh-ancestor
82817906|NCT00418938|Protective Agents|protective agents|mesh-ancestor
82817907|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
82817908|NCT00418938|Vitamins|vitamins|mesh-ancestor
82817909|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
82817910|NCT00448760|Leucovorin|leucovorin|mesh-list
82817911|NCT00448760|Docetaxel|docetaxel|mesh-list
82817912|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
82817913|NCT00448760|Floxuridine|floxuridine|mesh-list
82817914|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817915|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
82817916|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
82817917|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
82817918|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817919|NCT00448760|Antidotes|antidotes|mesh-ancestor
82817920|NCT00448760|Protective Agents|protective agents|mesh-ancestor
82817921|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817922|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
82817923|NCT00448760|Vitamins|vitamins|mesh-ancestor
82817924|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
82817925|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82817926|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
82817927|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
82817928|NCT01039350|Hematinics|hematinics|mesh-ancestor
82817929|NCT01039506|Irinotecan|irinotecan|mesh-list
82817930|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82817931|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82817932|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817933|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817934|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817935|NCT01033500|Abatacept|abatacept|mesh-list
82817936|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82817937|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817938|NCT01033500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82817939|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817940|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817941|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
82817942|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817943|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82817944|NCT01035450|Sirolimus|sirolimus|mesh-list
82817945|NCT01035450|Everolimus|everolimus|mesh-list
82817946|NCT01035450|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82817947|NCT01035450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82817948|NCT01035450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817949|NCT01035450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817950|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817951|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
82817952|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817953|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817954|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82817955|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82817956|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82817957|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
82817958|NCT01035528|Metformin|metformin|mesh-list
82817959|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
82817960|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82817961|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817962|NCT01033656|Methotrexate|methotrexate|mesh-list
82817963|NCT01033656|Azathioprine|azathioprine|mesh-list
82817964|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82817965|NCT01033656|Leflunomide|leflunomide|mesh-list
82817966|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82817967|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
82817968|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82817969|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817970|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82817971|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
82817972|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817973|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82817974|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
82817975|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82817976|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82817977|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82817978|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
82817979|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82817980|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82817981|NCT01039740|Mirtazapine|mirtazapine|mesh-list
82817982|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
82817983|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82817984|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82817985|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
82817986|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
82817987|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82817988|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82817989|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82817990|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82817991|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82817992|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82817993|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82817994|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82817995|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82817996|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
82817997|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82817998|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82817999|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
82818000|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82818001|NCT00448136|Bevacizumab|bevacizumab|mesh-list
82818002|NCT00448136|Streptozocin|streptozocin|mesh-list
82818003|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818004|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818005|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82818006|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82818007|NCT00448136|Growth Substances|growth substances|mesh-ancestor
82818008|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818009|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
82818010|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82818011|NCT00447902|Ritonavir|ritonavir|mesh-list
82818012|NCT00447902|Tipranavir|tipranavir|mesh-list
82818013|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82818014|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82818015|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
82818016|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818017|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818018|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82818019|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82818020|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
82818021|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818022|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82818023|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82818024|NCT00307437|Ustekinumab|ustekinumab|mesh-list
82818025|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
82818026|NCT00440726|Cytarabine|cytarabine|mesh-list
82818027|NCT00440726|Dexamethasone|dexamethasone|mesh-list
82818028|NCT00440726|Doxorubicin|doxorubicin|mesh-list
82818029|NCT00440726|Methotrexate|methotrexate|mesh-list
82818030|NCT00440726|Vincristine|vincristine|mesh-list
82818031|NCT00440726|Bortezomib|bortezomib|mesh-list
82818032|NCT00440726|Asparaginase|asparaginase|mesh-list
82818033|NCT00440726|Pegaspargase|pegaspargase|mesh-list
82818034|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82818035|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
82818036|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
82818037|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818038|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818039|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82818040|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
82818041|NCT00440726|Hormones|hormones|mesh-ancestor
82818042|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818043|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82818044|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818045|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82818046|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82818047|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82818048|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818049|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818050|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82818051|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
82818052|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82818053|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82818054|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
82818055|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
82818056|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82818057|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818058|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
82818059|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818060|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82818061|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
82818062|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818063|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82818064|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818065|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818066|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818067|NCT01030016|Atenolol|atenolol|mesh-list
82818068|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82818069|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82818070|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
82818071|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818072|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818073|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818074|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82818075|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82818076|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
82818077|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
82818078|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818079|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82818080|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
82818081|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
82818082|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818083|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818084|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82818085|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82818086|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82818087|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818088|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818089|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
82818091|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818092|NCT01030094|Topiramate|topiramate|mesh-list
82818093|NCT01030094|Carbamazepine|carbamazepine|mesh-list
82818094|NCT01030094|Valproic Acid|valproic acid|mesh-list
82818095|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
82818096|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82818097|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818098|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818099|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818100|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
82818101|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818102|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
82818103|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82818104|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82818105|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82818106|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82818107|NCT01030094|Analgesics|analgesics|mesh-ancestor
82818108|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
82818109|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818110|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82818111|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818112|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82818113|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82818114|NCT01565798|Copper|copper|mesh-list
82818115|NCT01565798|Trace Elements|trace elements|mesh-ancestor
82818116|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
82818117|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818118|NCT01030328|Fenofibrate|fenofibrate|mesh-list
82818119|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82818120|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
82818121|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818122|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82818123|NCT00405756|Aspirin|aspirin|mesh-list
82818124|NCT00405756|Prednisone|prednisone|mesh-list
82818125|NCT00405756|Lenalidomide|lenalidomide|mesh-list
82818126|NCT00405756|Melphalan|melphalan|mesh-list
82818127|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82818128|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
82818129|NCT00405756|Hormones|hormones|mesh-ancestor
82818130|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818131|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818132|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82818133|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818134|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82818135|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82818136|NCT00405756|Analgesics|analgesics|mesh-ancestor
82818137|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
82818138|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818139|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818140|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82818141|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82818142|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818143|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82818144|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82818145|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818146|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
82818147|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
82818148|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82818149|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82818150|NCT00405756|Growth Substances|growth substances|mesh-ancestor
82818151|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
82818152|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818153|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
82818154|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82818155|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818156|NCT00456092|Apremilast|apremilast|mesh-list
82818157|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82818158|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82818159|NCT00456092|Analgesics|analgesics|mesh-ancestor
82818160|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
82818161|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818162|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818163|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82818164|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818165|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82818166|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82818168|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818169|NCT01030640|Tanezumab|tanezumab|mesh-list
82818170|NCT01030640|Analgesics|analgesics|mesh-ancestor
82818171|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
82818172|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818173|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818174|NCT00411450|Panitumumab|panitumumab|mesh-list
82818175|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818176|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818177|NCT00404820|Vitamin D|vitamin d|mesh-list
82818178|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
82818179|NCT00404820|Alendronate|alendronate|mesh-list
82818180|NCT00404820|Calcium|calcium|mesh-list
82818181|NCT00404820|Vitamins|vitamins|mesh-ancestor
82818182|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
82818183|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818184|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82818185|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82818186|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
82818187|NCT00446030|Bevacizumab|bevacizumab|mesh-list
82818188|NCT00446030|Carboplatin|carboplatin|mesh-list
82818189|NCT00446030|Docetaxel|docetaxel|mesh-list
82818190|NCT00446030|Doxorubicin|doxorubicin|mesh-list
82818191|NCT00446030|Trastuzumab|trastuzumab|mesh-list
82818192|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818193|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
82818194|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818195|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818196|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818197|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
82818198|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818199|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818200|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82818201|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818202|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82818203|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82818204|NCT00446030|Growth Substances|growth substances|mesh-ancestor
82818205|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
82818206|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818207|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818208|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818209|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82818210|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82818211|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82818212|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818213|NCT00410514|Mirabegron|mirabegron|mesh-list
82818214|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82818215|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82818216|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82818217|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
82818218|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818219|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818220|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818221|NCT00410514|Urological Agents|urological agents|mesh-ancestor
82818222|NCT03847610|Penicillins|penicillins|mesh-list
82818223|NCT03847610|Penicillin V|penicillin v|mesh-list
82818224|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82818225|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818226|NCT01036854|Ondansetron|ondansetron|mesh-list
82818227|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
82818228|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
82818229|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818230|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818231|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82818232|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
82818233|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
82818234|NCT01036854|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82818235|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82818236|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
82818237|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818238|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818239|NCT01030796|Caffeine|caffeine|mesh-list
82818240|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82818241|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362067|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818242|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82818243|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818244|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818245|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82818246|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82818247|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
82818248|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818249|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
82818250|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82818251|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818252|NCT00439556|Cytarabine|cytarabine|mesh-list
82818253|NCT00439556|Rituximab|rituximab|mesh-list
82818254|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82818255|NCT00439556|Methotrexate|methotrexate|mesh-list
82818256|NCT00439556|Etoposide|etoposide|mesh-list
82818257|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
82818258|NCT00439556|Bortezomib|bortezomib|mesh-list
82818259|NCT00439556|Melphalan|melphalan|mesh-list
82818260|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
82818261|NCT00439556|Carmustine|carmustine|mesh-list
82818262|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
82818263|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82818264|NCT00439556|Antibodies|antibodies|mesh-list
82818265|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
82818266|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82818267|NCT00439556|Lenograstim|lenograstim|mesh-list
82818268|NCT00439556|Tacrolimus|tacrolimus|mesh-list
82818269|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
82818270|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82818271|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
82818272|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818273|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818274|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818275|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82818276|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
82818277|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82818278|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82818279|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
82818280|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818281|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
82818282|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818283|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82818284|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818285|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82818286|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82818287|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82818288|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82818289|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
82818290|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818291|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82818292|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82818293|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818294|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
82818295|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82818296|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
82818297|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818298|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818299|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818300|NCT00410202|Tenofovir|tenofovir|mesh-list
82818301|NCT00410202|Lamivudine|lamivudine|mesh-list
82818302|NCT00410202|Entecavir|entecavir|mesh-list
82818303|NCT00410202|Adefovir|adefovir|mesh-list
82818304|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
82818305|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818306|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82818307|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82818308|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818309|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818310|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82818311|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82818312|NCT03802058|Paclitaxel|paclitaxel|mesh-list
82818313|NCT03802058|Carboplatin|carboplatin|mesh-list
82818314|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82818315|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818316|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818317|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818318|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818319|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818320|NCT00445328|Heparin|heparin|mesh-list
82818321|NCT00445328|Calcium heparin|calcium heparin|mesh-list
82818322|NCT00445328|Dalteparin|dalteparin|mesh-list
82818323|NCT00445328|Tinzaparin|tinzaparin|mesh-list
82818324|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82818325|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
82818326|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82818327|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82818328|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818329|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
82818330|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
82818331|NCT00455312|Fludarabine|fludarabine|mesh-list
82818332|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
82818333|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
82818334|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82818335|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818336|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
82818337|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818338|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818339|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818340|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
82818341|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818342|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818343|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82818344|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82818345|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
82818346|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
82818347|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818348|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82818349|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
82818350|NCT00455312|Hormones|hormones|mesh-ancestor
82818351|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818352|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82818353|NCT00455312|Protective Agents|protective agents|mesh-ancestor
82818354|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818355|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
82818356|NCT01031030|Fluorouracil|fluorouracil|mesh-list
82818357|NCT01031030|Methotrexate|methotrexate|mesh-list
82818358|NCT01031030|Epirubicin|epirubicin|mesh-list
82818359|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818360|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
82818361|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818362|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818363|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818365|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818366|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818367|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82818368|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
82818369|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82818370|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82818371|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
82818372|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82818373|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
82818374|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818375|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82818376|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82818377|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82818378|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82818379|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82818380|NCT01024712|Paclitaxel|paclitaxel|mesh-list
82818381|NCT01024712|Carboplatin|carboplatin|mesh-list
82818382|NCT01024712|Gefitinib|gefitinib|mesh-list
82818383|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82818384|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818385|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818386|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818387|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818388|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818389|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82818390|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818391|NCT01323452|Entecavir|entecavir|mesh-list
82818392|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
82818393|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818394|NCT00444626|Lidocaine|lidocaine|mesh-list
82818395|NCT00444626|Prilocaine|prilocaine|mesh-list
82818396|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82818397|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
82818398|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
82818399|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
82818400|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82818401|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818402|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
82818403|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818404|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82818405|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82818406|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82818407|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818408|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818409|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82818410|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
82818411|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
82818412|NCT00444626|Protective Agents|protective agents|mesh-ancestor
82818413|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82818414|NCT01024868|Ropivacaine|ropivacaine|mesh-list
82818415|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
82818416|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
82818417|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82818418|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818419|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
82818420|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818421|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
82818422|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82818423|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
82818424|NCT03795194|Ampicillin|ampicillin|mesh-list
82818425|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82818426|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818427|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818428|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82818429|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818430|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
82818431|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82818432|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
82818433|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818434|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818435|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
82818436|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818438|NCT00439244|Teriparatide|teriparatide|mesh-list
82818439|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82818440|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818441|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82818442|NCT04844762|Menthol|menthol|mesh-list
82818443|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
82818444|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
82818445|NCT01323218|Vitamin D|vitamin d|mesh-list
82818446|NCT01323218|Vitamins|vitamins|mesh-ancestor
82818447|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
82818448|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818449|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82818450|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82818451|NCT01323296|Hematinics|hematinics|mesh-ancestor
82818452|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82818453|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82818454|NCT00438464|Finasteride|finasteride|mesh-list
82818455|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82818456|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82818457|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818458|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818459|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
82818460|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818461|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818462|NCT00438464|Urological Agents|urological agents|mesh-ancestor
82818463|NCT00437294|Capecitabine|capecitabine|mesh-list
82818464|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82818465|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
82818466|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818467|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818468|NCT01033760|Ritonavir|ritonavir|mesh-list
83362068|NCT02684370|Ustekinumab|ustekinumab|mesh-list
82818469|NCT01033760|Darunavir|darunavir|mesh-list
82818470|NCT01033760|Tenofovir|tenofovir|mesh-list
82818471|NCT01033760|Emtricitabine|emtricitabine|mesh-list
82818472|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
82818473|NCT01033760|Maraviroc|maraviroc|mesh-list
82818474|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82818475|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82818476|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
82818477|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818478|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818479|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82818480|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82818481|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
82818482|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818483|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82818484|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82818485|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82818486|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82818487|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82818488|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82818489|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82818490|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82818491|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82818492|NCT01031732|Tacrine|tacrine|mesh-list
82818493|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82818494|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818495|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818496|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
82818497|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818498|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818499|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82818500|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
82818501|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818502|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
82818503|NCT01033994|Mitogens|mitogens|mesh-list
82818504|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818505|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818506|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82818507|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82818508|NCT00436826|Interferons|interferons|mesh-list
82818509|NCT00436826|Interferon-beta|interferon-beta|mesh-list
82818510|NCT00436826|Cladribine|cladribine|mesh-list
82818511|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
82818512|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818514|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818515|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
82818516|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818517|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818518|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82818519|NCT00410124|Everolimus|everolimus|mesh-list
82818520|NCT00410124|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82818521|NCT00410124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82818522|NCT00410124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818523|NCT00410124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818524|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818525|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
82818526|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818527|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818528|NCT01036932|Lenograstim|lenograstim|mesh-list
82818529|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82818530|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
82818531|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818532|NCT00410046|Etanercept|etanercept|mesh-list
82818533|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82818534|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82818535|NCT00410046|Analgesics|analgesics|mesh-ancestor
82818536|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
82818537|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818538|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818539|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82818540|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818541|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82818542|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818543|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
82818544|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
83362069|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82818545|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
82818546|NCT00416624|Hematinics|hematinics|mesh-ancestor
82818547|NCT02501954|Paclitaxel|paclitaxel|mesh-list
82818548|NCT02501954|Carboplatin|carboplatin|mesh-list
82818549|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82818550|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818551|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818552|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818553|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818554|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818555|NCT00262600|Warfarin|warfarin|mesh-list
82818556|NCT00262600|Dabigatran|dabigatran|mesh-list
82818557|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
82818558|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
82818559|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82818560|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
82818561|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818562|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818563|NCT00409578|Valsartan|valsartan|mesh-list
82818564|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82818565|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82818566|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82818567|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818568|NCT01037322|Cannabidiol|cannabidiol|mesh-list
82818569|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
82818570|NCT01070758|Lanreotide|lanreotide|mesh-list
82818571|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818572|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
82818573|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82818574|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818575|NCT01031966|Thymalfasin|thymalfasin|mesh-list
82818576|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82818577|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
82818578|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818579|NCT00436436|Temozolomide|temozolomide|mesh-list
82818580|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
82818581|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818582|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
82818583|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818584|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818585|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818586|NCT00262522|Ritonavir|ritonavir|mesh-list
82818587|NCT00262522|Lopinavir|lopinavir|mesh-list
82818588|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82818589|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82818590|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82818591|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
82818592|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818593|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818594|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82818595|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82818596|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
82818597|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818598|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82818599|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83442425|NCT00789997|Hormones|hormones|mesh-ancestor
82818600|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82818601|NCT00436280|Rituximab|rituximab|mesh-list
82818602|NCT00436280|Gemcitabine|gemcitabine|mesh-list
82818603|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
82818604|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818605|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818606|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
82818607|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818608|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818609|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82818610|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
82818611|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818612|NCT00394836|Ofatumumab|ofatumumab|mesh-list
82818613|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82818614|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818615|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
82818616|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818617|NCT01040598|Omalizumab|omalizumab|mesh-list
82818618|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83362070|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
82818619|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82818620|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
82818621|NCT01039974|Ketoconazole|ketoconazole|mesh-list
83362071|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
82818622|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
82818623|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818624|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82818625|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82818626|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818627|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818628|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82818629|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
82818630|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818631|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818632|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82818633|NCT01032122|Rituximab|rituximab|mesh-list
82818634|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818635|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818636|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
82818637|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818638|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818639|NCT03819660|Amifampridine|amifampridine|mesh-list
82818640|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82818641|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818642|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818643|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82818644|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818645|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818646|NCT00394524|Insulin|insulin|mesh-list
82818647|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82818648|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818649|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
82818650|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82818651|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82818652|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818653|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82818654|NCT00409344|Analgesics|analgesics|mesh-ancestor
82818655|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
82818656|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818657|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82818658|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82818659|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82818660|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
82818661|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818662|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818663|NCT00415610|Nicardipine|nicardipine|mesh-list
82818664|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82818665|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83442429|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818666|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818667|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818668|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82818669|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818670|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
82818671|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
82818672|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
82818673|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
82818674|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818675|NCT01722812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82818676|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82818677|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82818678|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
82818679|NCT00250432|Caspofungin|caspofungin|mesh-list
82818680|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
82818681|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818682|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818683|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818684|NCT03741478|Insulin|insulin|mesh-list
82818685|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82818686|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
82818687|NCT03741478|Olanzapine|olanzapine|mesh-list
82818688|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82818689|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818690|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
82818691|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
82818692|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818693|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82818694|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82818695|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82818696|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82818697|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82818698|NCT03741478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82818699|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82818700|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818701|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818702|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818703|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
82818704|NCT00249808|Antibodies|antibodies|mesh-list
82818705|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82818706|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
82818707|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818708|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
82818709|NCT00278512|Fludarabine|fludarabine|mesh-list
82818710|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
82818711|NCT00278512|Tacrolimus|tacrolimus|mesh-list
82818712|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
82818713|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818714|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
82818715|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818716|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818717|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818718|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
82818719|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818720|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818721|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82818722|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82818723|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818724|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818725|NCT01072240|Rituximab|rituximab|mesh-list
82818726|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818727|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818728|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
82818729|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818730|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818731|NCT00427934|Maraviroc|maraviroc|mesh-list
82818732|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82818733|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82818734|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818735|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82818736|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82818737|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
82818738|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818739|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82818740|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82818742|NCT00427700|Enclomiphene|enclomiphene|mesh-list
82818743|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
82818744|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82818745|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
82818746|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818747|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818748|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82818749|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
82818750|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82818751|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82818752|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82818753|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82818754|NCT01324076|Doxorubicin|doxorubicin|mesh-list
82818755|NCT01324076|Sorafenib|sorafenib|mesh-list
82818756|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82818757|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818758|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82818759|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82818760|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818761|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818762|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82818763|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
82818764|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818765|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
82818766|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818767|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82818768|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82818769|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
82818770|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818771|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818772|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82818773|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
82818774|NCT00434954|Exenatide|exenatide|mesh-list
82818775|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82818776|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818777|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82818778|NCT00434954|Incretins|incretins|mesh-ancestor
82818779|NCT00434954|Hormones|hormones|mesh-ancestor
82818780|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818781|NCT00276484|Atorvastatin|atorvastatin|mesh-list
82818782|NCT00276484|Ezetimibe|ezetimibe|mesh-list
82818783|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82818784|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82818785|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
82818786|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818787|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82818788|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82818789|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818790|NCT00426842|Midodrine|midodrine|mesh-list
82818791|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
82818792|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
82818793|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818794|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818795|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82818796|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82818797|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82818798|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82818799|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
82818800|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818801|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818802|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82818803|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
82818804|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82818805|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82818806|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82818807|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82818808|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818809|NCT01072318|Letrozole|letrozole|mesh-list
82818810|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818811|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82818812|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82818813|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818814|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818815|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82818816|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
82818817|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818818|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818819|NCT00276094|Tamoxifen|tamoxifen|mesh-list
82818820|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82818821|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
82818822|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818823|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818824|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82818825|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818826|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82818827|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82818828|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82818829|NCT03975088|Ranibizumab|ranibizumab|mesh-list
82818830|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82818831|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82818832|NCT03975088|Growth Substances|growth substances|mesh-ancestor
82818833|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818834|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
82818835|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818836|NCT00276016|Phenylephrine|phenylephrine|mesh-list
82818837|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
82818838|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
82818839|NCT00276016|Ephedrine|ephedrine|mesh-list
82818840|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83362072|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818841|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
82818842|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
82818843|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818844|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818845|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
82818846|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82818847|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
82818848|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
82818849|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82818850|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82818851|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82818852|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
82818853|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818854|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818855|NCT00276016|Protective Agents|protective agents|mesh-ancestor
82818856|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82818857|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82818858|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82818859|NCT00434642|Bevacizumab|bevacizumab|mesh-list
82818860|NCT00434642|Carboplatin|carboplatin|mesh-list
82818861|NCT00434642|Gemcitabine|gemcitabine|mesh-list
82818862|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818863|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818864|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82818865|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82818866|NCT00434642|Growth Substances|growth substances|mesh-ancestor
82818867|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818868|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
82818869|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82818870|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
82818871|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818872|NCT01032434|Sertraline|sertraline|mesh-list
82818873|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
82818874|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82818875|NCT01032434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82818876|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82818877|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818878|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818879|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818880|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
82818881|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818882|NCT00426764|Romidepsin|romidepsin|mesh-list
82818883|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82818884|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818885|NCT00426764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82818886|NCT00426764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818887|NCT00426764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818888|NCT01032668|Clopidogrel|clopidogrel|mesh-list
82818889|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82818890|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82818891|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82818892|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82818893|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
82818894|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818895|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818896|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818897|NCT00434252|Paclitaxel|paclitaxel|mesh-list
82818898|NCT00434252|Bevacizumab|bevacizumab|mesh-list
82818899|NCT00434252|Carboplatin|carboplatin|mesh-list
82818900|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82818901|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818902|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818903|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818904|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818905|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818906|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818907|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82818908|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82818909|NCT00434252|Growth Substances|growth substances|mesh-ancestor
82818910|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818911|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
82818912|NCT00425750|Docetaxel|docetaxel|mesh-list
82818913|NCT00425750|Bortezomib|bortezomib|mesh-list
82818914|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818915|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
82818916|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
82818917|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
82818918|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818919|NCT00414908|Pancrelipase|pancrelipase|mesh-list
82818921|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82818922|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
82818923|NCT00242710|Estrogens|estrogens|mesh-list
82818924|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82818925|NCT00242710|Hormones|hormones|mesh-ancestor
82818926|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818927|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818928|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82818929|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82818930|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
82818931|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82818932|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82818933|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82818934|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82818935|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82818936|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818937|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818938|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818939|NCT00408876|Analgesics|analgesics|mesh-ancestor
82818940|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
82818941|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82818942|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
82818943|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82818944|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
82818945|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
82818946|NCT00240994|Sirolimus|sirolimus|mesh-list
82818947|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
82818948|NCT00240994|Tacrolimus|tacrolimus|mesh-list
82818949|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82818950|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
82818951|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818952|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82818953|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82818954|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818955|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82818956|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818957|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82818958|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
82818959|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82818960|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82818961|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
82818962|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82818963|NCT01070836|Natalizumab|natalizumab|mesh-list
82818964|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
82818965|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818966|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
82818967|NCT00239590|Testosterone|testosterone|mesh-list
82818968|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
82818969|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
82818970|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82818971|NCT00239590|Androgens|androgens|mesh-ancestor
82818972|NCT00239590|Hormones|hormones|mesh-ancestor
82818973|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82818974|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818975|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82818976|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82818977|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
82818978|NCT00433160|Teriparatide|teriparatide|mesh-list
82818979|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82818980|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818981|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82818982|NCT00239356|Aripiprazole|aripiprazole|mesh-list
82818983|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
82818984|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82818985|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82818986|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82818987|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82818988|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82818989|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
82818990|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
82818991|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82818992|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82818993|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82818994|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82818995|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
82818996|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82818997|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82818998|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82818999|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82819000|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
82819001|NCT00425438|Prednisolone|prednisolone|mesh-list
82819002|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
82819003|NCT00425438|Azathioprine|azathioprine|mesh-list
82819004|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819005|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
82819006|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819007|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819008|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819009|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
82819010|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819011|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819012|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82819013|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82819014|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82819015|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
82819016|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82819017|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819018|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819019|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819020|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
82819021|NCT00425438|Hormones|hormones|mesh-ancestor
82819022|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819023|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819024|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
82819025|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819026|NCT01041066|Labetalol|labetalol|mesh-list
82819028|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82819029|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82819030|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
82819031|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819032|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819033|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819034|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82819035|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
82819036|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
82819037|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819038|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82819039|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82819040|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82819041|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82819042|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82819043|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
82819044|NCT01323608|Vitamin D|vitamin d|mesh-list
82819045|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
82819046|NCT01323608|Vitamins|vitamins|mesh-ancestor
82819047|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
82819048|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819049|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82819050|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82819051|NCT00275002|Temozolomide|temozolomide|mesh-list
82819052|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
82819053|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819054|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
82819055|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819056|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819057|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819058|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
82819059|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82819060|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
82819061|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82819072|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
82819073|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819074|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
82819075|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819076|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819077|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
82819078|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82819079|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82819080|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82819081|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82819082|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
82819083|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
82819084|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82819085|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819086|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
82819087|NCT01040286|Analgesics|analgesics|mesh-ancestor
82819088|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
82819089|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819090|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819091|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82819092|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82819093|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819094|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819095|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82819096|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819097|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819098|NCT01041378|Dexamethasone|dexamethasone|mesh-list
82819099|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819100|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
82819101|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
82819102|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819103|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819104|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819105|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
82819106|NCT01041378|Hormones|hormones|mesh-ancestor
82819107|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819108|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819109|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819110|NCT03546192|Vaccines|vaccines|mesh-list
82819111|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
82819112|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819113|NCT01043952|Remifentanil|remifentanil|mesh-list
82819114|NCT01043952|Propofol|propofol|mesh-list
82819115|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82819116|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82819117|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819118|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82819119|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
82819120|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
82819121|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82819122|NCT01043952|Narcotics|narcotics|mesh-ancestor
82819123|NCT01043952|Analgesics|analgesics|mesh-ancestor
82819124|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
82819125|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362073|NCT02669914|Durvalumab|durvalumab|mesh-list
82819189|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82819190|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82819191|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819192|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82819193|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82819194|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82819195|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82819196|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
82819197|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
82819198|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
82819199|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
82819200|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819201|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819202|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82819203|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82819204|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
82819205|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82819206|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82819207|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819208|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82819209|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82819210|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82819211|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82819212|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
82819213|NCT00414440|Everolimus|everolimus|mesh-list
82819214|NCT00414440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82819215|NCT00414440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82819216|NCT00414440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819217|NCT00414440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819218|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819219|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
82819220|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819221|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819222|NCT00209560|Fospropofol|fospropofol|mesh-list
82819223|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82819224|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82819225|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819226|NCT01073800|Atorvastatin|atorvastatin|mesh-list
82819227|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82819228|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82819229|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
82819230|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819231|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82819232|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82819233|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819234|NCT01037660|Metformin|metformin|mesh-list
82819235|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82819236|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819237|NCT00236080|Modafinil|modafinil|mesh-list
82819238|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82819239|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819240|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82819241|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82819242|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82819243|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819244|NCT01033058|Atorvastatin|atorvastatin|mesh-list
82819245|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82819246|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82819247|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
82819248|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819249|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82819250|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82819251|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819252|NCT03973138|Ranibizumab|ranibizumab|mesh-list
82819253|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82819254|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82819255|NCT03973138|Growth Substances|growth substances|mesh-ancestor
82819256|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819257|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
82819258|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819259|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
82819260|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82819261|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819262|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819263|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819264|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819265|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819266|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819267|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82819268|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82819269|NCT00234052|Bevacizumab|bevacizumab|mesh-list
82819270|NCT00234052|Carboplatin|carboplatin|mesh-list
82819271|NCT00234052|Pemetrexed|pemetrexed|mesh-list
82819272|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819273|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819274|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82819275|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82819276|NCT00234052|Growth Substances|growth substances|mesh-ancestor
82819277|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819278|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
82819279|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819280|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819281|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82819282|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82819283|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
82819284|NCT00408408|Bevacizumab|bevacizumab|mesh-list
82819285|NCT00408408|Gemcitabine|gemcitabine|mesh-list
82819286|NCT00408408|Docetaxel|docetaxel|mesh-list
82819287|NCT00408408|Doxorubicin|doxorubicin|mesh-list
82819289|NCT00408408|Capecitabine|capecitabine|mesh-list
82819290|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819291|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
82819292|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819293|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819294|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819295|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
82819296|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819297|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819298|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82819299|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819300|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82819301|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82819302|NCT00408408|Growth Substances|growth substances|mesh-ancestor
82819303|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
82819304|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819305|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
82819306|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
82819307|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
82819308|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
82819309|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82819310|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819311|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819312|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819313|NCT00414050|Vaccines|vaccines|mesh-list
82819314|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
82819315|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819316|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
82819317|NCT03973840|Testosterone|testosterone|mesh-list
82819318|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
82819319|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
82819320|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82819321|NCT03973840|Androgens|androgens|mesh-ancestor
82819322|NCT03973840|Hormones|hormones|mesh-ancestor
82819323|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819324|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819325|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819326|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819327|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
82819328|NCT00413972|Simvastatin|simvastatin|mesh-list
82819329|NCT00413972|Ezetimibe|ezetimibe|mesh-list
82819330|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82819331|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82819332|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
82819333|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819334|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82819335|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82819336|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819337|NCT00259012|Pantoprazole|pantoprazole|mesh-list
82819338|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82819339|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819340|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82819341|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819342|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819343|NCT01044186|Deferasirox|deferasirox|mesh-list
82819344|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82819345|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
82819346|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
82819347|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819348|NCT00209170|Escitalopram|escitalopram|mesh-list
82819349|NCT00209170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82819350|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82819351|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82819352|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819353|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819354|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
82819355|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819356|NCT01071694|Interferons|interferons|mesh-list
82819357|NCT01071694|Interferon-beta|interferon-beta|mesh-list
82819358|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
82819359|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819360|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
82819361|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819363|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819364|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82819365|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
82819366|NCT00413894|Hematinics|hematinics|mesh-ancestor
82819367|NCT03972748|Itraconazole|itraconazole|mesh-list
82819368|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
82819369|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819370|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82819371|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82819372|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819373|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819374|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82819375|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
82819376|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819377|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819378|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82819379|NCT01581814|Metformin|metformin|mesh-list
82819380|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82819381|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82819382|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82819383|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819384|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82819385|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82819386|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82819387|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82819388|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
82819389|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82819390|NCT01581814|Estrogens|estrogens|mesh-ancestor
82819391|NCT01581814|Hormones|hormones|mesh-ancestor
82819392|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819393|NCT00407550|Gemcitabine|gemcitabine|mesh-list
82819394|NCT00407550|Pemetrexed|pemetrexed|mesh-list
82819395|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819396|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
82819397|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819398|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819399|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819400|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82819401|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82819402|NCT00209092|Docetaxel|docetaxel|mesh-list
82819403|NCT00209092|Capecitabine|capecitabine|mesh-list
82819404|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819405|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
82819406|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
82819407|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
82819408|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819409|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819410|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
82819411|NCT03972982|Insulin|insulin|mesh-list
82819412|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82819413|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82819414|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819415|NCT00403494|Verapamil|verapamil|mesh-list
82819416|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82819417|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82819418|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82819419|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819420|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82819421|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819422|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
82819423|NCT00403260|Artesunate|artesunate|mesh-list
82819424|NCT00403260|Mefloquine|mefloquine|mesh-list
82819425|NCT00403260|Pyronaridine|pyronaridine|mesh-list
82819426|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
82819427|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82819428|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82819429|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819430|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819431|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
82819432|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
82819433|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82819434|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
82819435|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82819436|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82819437|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82819438|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82819439|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819440|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819441|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819442|NCT00406848|Analgesics|analgesics|mesh-ancestor
82819443|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
82819444|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819445|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
82819446|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82819447|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
82819448|NCT00406692|Zonisamide|zonisamide|mesh-list
82819449|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
82819450|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82819451|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82819452|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819453|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82819454|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819455|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
82819456|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819457|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
82819458|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82819459|NCT00004494|Protective Agents|protective agents|mesh-ancestor
82819460|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819461|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
82819462|NCT00315705|Etoposide|etoposide|mesh-list
82819463|NCT00315705|Clofarabine|clofarabine|mesh-list
82819464|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819465|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
82819466|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819467|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819468|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819469|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
83482531|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819470|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819471|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819472|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82819473|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82819474|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819475|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819476|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819477|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819478|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
82819480|NCT03982173|Tremelimumab|tremelimumab|mesh-list
82819481|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819482|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819483|NCT01062633|Erythritol|erythritol|mesh-list
82819484|NCT01062633|Sorbitol|sorbitol|mesh-list
82819485|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
82819486|NCT01062633|Cathartics|cathartics|mesh-ancestor
82819487|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819488|NCT00307125|Rituximab|rituximab|mesh-list
82819489|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819490|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819491|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
82819492|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819493|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819494|NCT01066299|Oxytocin|oxytocin|mesh-list
82819495|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
82819496|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82819497|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819498|NCT00307047|Paclitaxel|paclitaxel|mesh-list
82819499|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82819500|NCT00307047|Everolimus|everolimus|mesh-list
82819501|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82819502|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819503|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
82819504|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
82819505|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
82819506|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819507|NCT00307047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82819508|NCT00307047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82819509|NCT00307047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819510|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819512|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819513|NCT01066377|Sulfalene|sulfalene|mesh-list
82819514|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819515|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82819516|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
82819517|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82819518|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82819519|NCT00306891|Cediranib|cediranib|mesh-list
82819520|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819521|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82819522|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819523|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819524|NCT03980847|Alendronate|alendronate|mesh-list
82819525|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82819526|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819527|NCT00391872|Clopidogrel|clopidogrel|mesh-list
82819528|NCT00391872|Ticagrelor|ticagrelor|mesh-list
82819529|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82819530|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82819531|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82819532|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82819533|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
82819534|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819535|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819536|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819537|NCT00391170|Dexamethasone|dexamethasone|mesh-list
82819538|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819539|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
82819540|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
82819541|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819542|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819543|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819544|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
82819545|NCT00391170|Hormones|hormones|mesh-ancestor
83482532|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82819546|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819547|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819549|NCT00402324|Valproic Acid|valproic acid|mesh-list
82819550|NCT00402324|Olanzapine|olanzapine|mesh-list
82819551|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
82819552|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
82819553|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819554|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819555|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819556|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82819557|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82819558|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82819559|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82819560|NCT00402324|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82819561|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82819562|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82819563|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819564|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819565|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
82819566|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
82819567|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819568|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
82819569|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
82819570|NCT00294723|Liraglutide|liraglutide|mesh-list
82819571|NCT00294723|Glimepiride|glimepiride|mesh-list
82819572|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82819573|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819574|NCT00294723|Incretins|incretins|mesh-ancestor
82819575|NCT00294723|Hormones|hormones|mesh-ancestor
82819576|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819577|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82819578|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819579|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
82819580|NCT00375492|Exenatide|exenatide|mesh-list
82819581|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82819582|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819583|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82819584|NCT00375492|Incretins|incretins|mesh-ancestor
82819585|NCT00375492|Hormones|hormones|mesh-ancestor
82819587|NCT00306189|Denosumab|denosumab|mesh-list
82819588|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82819589|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819590|NCT00305877|Bevacizumab|bevacizumab|mesh-list
82819591|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82819592|NCT00305877|Cetuximab|cetuximab|mesh-list
82819593|NCT00305877|Gemcitabine|gemcitabine|mesh-list
82819594|NCT00305877|Capecitabine|capecitabine|mesh-list
82819595|NCT00305877|Antibodies|antibodies|mesh-list
82819596|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
82819597|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82819598|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819599|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82819600|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82819601|NCT00305877|Growth Substances|growth substances|mesh-ancestor
82819602|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819603|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
82819604|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
82819605|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819606|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
82819607|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819608|NCT00312195|Buprenorphine|buprenorphine|mesh-list
82819609|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82819610|NCT00312195|Narcotics|narcotics|mesh-ancestor
82819611|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82819612|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819613|NCT00312195|Analgesics|analgesics|mesh-ancestor
82819614|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
82819615|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819616|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82819617|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
82819618|NCT02532777|Prednisone|prednisone|mesh-list
82819619|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
82819620|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
82819621|NCT02532777|Leflunomide|leflunomide|mesh-list
82819622|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82819623|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82819624|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819625|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
82819626|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819627|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819628|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819629|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
82819630|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819631|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819632|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82819633|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819634|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
82819635|NCT02532777|Hormones|hormones|mesh-ancestor
82819636|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819637|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819638|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82819639|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82819640|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
82819641|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82819642|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819643|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
82819644|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
82819645|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819646|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819647|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82819648|NCT02532777|Protective Agents|protective agents|mesh-ancestor
82819649|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
82819650|NCT01062945|Doxazosin|doxazosin|mesh-list
82819651|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82819652|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82819653|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82819654|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82819655|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
82819656|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819657|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819658|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819659|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
82819685|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819686|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819687|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
82819688|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819689|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819690|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
82819691|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82819692|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
82819693|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
82819694|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819719|NCT00293709|Etanercept|etanercept|mesh-list
82819720|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82819721|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82819722|NCT00293709|Analgesics|analgesics|mesh-ancestor
82819723|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
82819724|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819725|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819726|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819727|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819728|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819729|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819730|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
82819731|NCT01063257|Clofarabine|clofarabine|mesh-list
82819732|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819733|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
82819734|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819735|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819736|NCT03977649|Erenumab|erenumab|mesh-list
82819737|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82819738|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819739|NCT03977649|Analgesics|analgesics|mesh-ancestor
82819740|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
82819741|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819742|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819743|NCT01066767|Fexofenadine|fexofenadine|mesh-list
82819744|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82819745|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82819747|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
82819748|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
82819749|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819750|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819751|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819752|NCT03980379|Rituximab|rituximab|mesh-list
82819753|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819754|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819755|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
82819756|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819757|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819758|NCT01064271|Risperidone|risperidone|mesh-list
82819759|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82819760|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
82819761|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819762|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819763|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819764|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82819765|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82819766|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82819767|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82819768|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82819769|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
82819770|NCT01066845|Tadalafil|tadalafil|mesh-list
82819771|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
82819772|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82819773|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82819774|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819775|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819776|NCT01066845|Urological Agents|urological agents|mesh-ancestor
82819777|NCT01064349|Trastuzumab|trastuzumab|mesh-list
82819778|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819779|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819780|NCT00293397|Doxorubicin|doxorubicin|mesh-list
82819781|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82819782|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82819783|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819784|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819785|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819786|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819787|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819788|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
82819789|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82819790|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819791|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82819792|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82819793|NCT01069263|Protective Agents|protective agents|mesh-ancestor
82819794|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819795|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82819796|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
82819797|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819798|NCT01067235|Modafinil|modafinil|mesh-list
82819799|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82819800|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819801|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82819802|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82819803|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82819804|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819805|NCT00290745|Tamoxifen|tamoxifen|mesh-list
82819806|NCT00290745|Letrozole|letrozole|mesh-list
82819807|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819808|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819809|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82819810|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82819811|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819812|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82819813|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
82819814|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819815|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819816|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819817|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82819819|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82819820|NCT03980223|Doxycycline|doxycycline|mesh-list
82819821|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82819822|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819823|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
82819824|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82819825|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82819826|NCT01067391|Tadalafil|tadalafil|mesh-list
82819827|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
82819828|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82819829|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82819830|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819831|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819832|NCT01067391|Urological Agents|urological agents|mesh-ancestor
82819833|NCT00402168|Cyclosporine|cyclosporine|mesh-list
82819834|NCT00402168|Abatacept|abatacept|mesh-list
82819835|NCT00402168|Tacrolimus|tacrolimus|mesh-list
82819836|NCT00402168|Cyclosporins|cyclosporins|mesh-list
82819837|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819838|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
82819839|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819840|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82819841|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819842|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819843|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
82819844|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819845|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
82819846|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819847|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82819848|NCT00402168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819849|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819850|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
82819851|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82819852|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82819853|NCT00290589|Prednisolone|prednisolone|mesh-list
82819854|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
82819855|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82819856|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
82819857|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819858|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
82819859|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
82819860|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819861|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819862|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819863|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
82819864|NCT00290589|Hormones|hormones|mesh-ancestor
82819865|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819866|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82819867|NCT00290589|Protective Agents|protective agents|mesh-ancestor
82819868|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819869|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819871|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82819872|NCT01067547|Trace Elements|trace elements|mesh-ancestor
82819873|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
82819874|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819875|NCT01067547|Hematinics|hematinics|mesh-ancestor
82819876|NCT00290511|Dexamethasone|dexamethasone|mesh-list
82819877|NCT00290511|Rituximab|rituximab|mesh-list
82819878|NCT00290511|Fludarabine|fludarabine|mesh-list
82819879|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
82819880|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
82819881|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819882|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819883|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
82819884|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819885|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819886|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819888|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
82819889|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819890|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819891|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
82819892|NCT00290511|Hormones|hormones|mesh-ancestor
82819893|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819894|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819895|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819896|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
82819897|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819898|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819899|NCT00290511|Analgesics|analgesics|mesh-ancestor
82819900|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
82819901|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819902|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819903|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819904|NCT00290433|Cytarabine|cytarabine|mesh-list
82819905|NCT00290433|Dexamethasone|dexamethasone|mesh-list
82819906|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
82819907|NCT00290433|Doxorubicin|doxorubicin|mesh-list
82819908|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82819909|NCT00290433|Methotrexate|methotrexate|mesh-list
82819910|NCT00290433|Vincristine|vincristine|mesh-list
82819911|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82819912|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
82819913|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819914|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82819915|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819916|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
82819917|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819918|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819919|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82819920|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82819921|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
82819922|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
82819923|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82819924|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82819925|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
82819926|NCT00290433|Hormones|hormones|mesh-ancestor
82819927|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82819928|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82819929|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82819930|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819931|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819932|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819933|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82819934|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
82819935|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82819936|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82819937|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
82819938|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
82819939|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82819940|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82819941|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
82819942|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82819943|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82819944|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
82819945|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
82819946|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
82819947|NCT00304083|Doxorubicin|doxorubicin|mesh-list
82819948|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82819949|NCT00304083|Etoposide|etoposide|mesh-list
82819950|NCT00304083|Ifosfamide|ifosfamide|mesh-list
82819951|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82819952|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819953|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82819954|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82819955|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819956|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819957|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82819958|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82819959|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
82819960|NCT01069965|BGP 15|bgp 15|mesh-list
82819961|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819962|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819963|NCT00391092|Bevacizumab|bevacizumab|mesh-list
82819964|NCT00391092|Trastuzumab|trastuzumab|mesh-list
82819965|NCT00391092|Docetaxel|docetaxel|mesh-list
82819966|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82819967|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819968|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82819969|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82819970|NCT00391092|Growth Substances|growth substances|mesh-ancestor
82819971|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819972|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
82819973|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
82819974|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
82819975|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
82819976|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819977|NCT00374868|Pemetrexed|pemetrexed|mesh-list
82819978|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82819979|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819980|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819981|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82819982|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82819983|NCT01044342|Donepezil|donepezil|mesh-list
82819984|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82819985|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82819986|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82819987|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
82819988|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82819989|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819990|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
82819991|NCT00374556|Eszopiclone|eszopiclone|mesh-list
82819992|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82819993|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82819994|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819995|NCT01064973|Baclofen|baclofen|mesh-list
82819996|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82819997|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82819998|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82819999|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820000|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82820001|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
82820002|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
82820003|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820004|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820005|NCT00374322|Lapatinib|lapatinib|mesh-list
82820006|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820007|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820008|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820009|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820010|NCT00303459|Bosentan|bosentan|mesh-list
82820011|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82820012|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82820013|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820014|NCT00289887|Losartan|losartan|mesh-list
82820015|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82820016|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82820017|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82820018|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82820019|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820020|NCT01068093|Ezetimibe|ezetimibe|mesh-list
82820021|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82820022|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82820023|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
82820024|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820025|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82820026|NCT00401544|Dextrans|dextrans|mesh-list
82820027|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
82820028|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
82820029|NCT00401544|Hematinics|hematinics|mesh-ancestor
82820030|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
82820031|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
82820032|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
82820033|NCT00292461|Lamotrigine|lamotrigine|mesh-list
82820034|NCT00292461|Zonisamide|zonisamide|mesh-list
82820035|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
82820036|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82820037|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820038|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820039|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82820040|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820041|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82820042|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82820043|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820044|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82820045|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82820046|NCT00288639|Pregabalin|pregabalin|mesh-list
82820047|NCT00288639|Analgesics|analgesics|mesh-ancestor
82820048|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
82820049|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820050|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820051|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
82820052|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82820053|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820054|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820055|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82820056|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82820057|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82820058|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820059|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82820060|NCT00390858|Deferasirox|deferasirox|mesh-list
82820061|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82820062|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
82820063|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
82820064|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820065|NCT00390780|Clotrimazole|clotrimazole|mesh-list
82820066|NCT00390780|Miconazole|miconazole|mesh-list
82820067|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82820068|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820069|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
82820070|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82820071|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82820072|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820073|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820074|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82820075|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
82820076|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820077|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820078|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82820079|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82820080|NCT00390546|Propranolol|propranolol|mesh-list
82820081|NCT00390546|Digoxin|digoxin|mesh-list
82820082|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82820083|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82820084|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
82820085|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820086|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820087|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820088|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82820089|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82820090|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
82820091|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82820092|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820093|NCT00390546|Protective Agents|protective agents|mesh-ancestor
82820094|NCT00400764|Rituximab|rituximab|mesh-list
82820095|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820096|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820097|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
82820098|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820099|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820100|NCT00302211|Bosentan|bosentan|mesh-list
82820101|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
82820102|NCT00302211|Iloprost|iloprost|mesh-list
82820103|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
82820104|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82820105|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82820106|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820107|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820108|NCT00302211|Urological Agents|urological agents|mesh-ancestor
82820109|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82820110|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82820111|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82820112|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
82820113|NCT01045902|Ampicillin|ampicillin|mesh-list
82820114|NCT01045902|Sulbactam|sulbactam|mesh-list
82820115|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82820116|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82820117|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820118|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82820119|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82820120|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820121|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820122|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820123|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82820124|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
82820125|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82820126|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820127|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82820128|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82820129|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82820130|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82820131|NCT01041690|Bevacizumab|bevacizumab|mesh-list
82820132|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820133|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820134|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82820135|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82820136|NCT01041690|Growth Substances|growth substances|mesh-ancestor
82820137|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820138|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
82820139|NCT00288015|Bevacizumab|bevacizumab|mesh-list
82820140|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820141|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820142|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82820143|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82820144|NCT00288015|Growth Substances|growth substances|mesh-ancestor
82820145|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820146|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
82820147|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82820148|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
82820149|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82820150|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82820151|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82820152|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820153|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820154|NCT01068327|Leucovorin|leucovorin|mesh-list
82820155|NCT01068327|Nelfinavir|nelfinavir|mesh-list
82820156|NCT01068327|Gemcitabine|gemcitabine|mesh-list
82820157|NCT01068327|Fluorouracil|fluorouracil|mesh-list
82820158|NCT01068327|Calcium|calcium|mesh-list
82820159|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
82820160|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82820161|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
82820162|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820163|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820164|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82820165|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820166|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820167|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
82820168|NCT01068327|Antidotes|antidotes|mesh-ancestor
82820169|NCT01068327|Protective Agents|protective agents|mesh-ancestor
82820170|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
82820171|NCT01068327|Vitamins|vitamins|mesh-ancestor
82820172|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
82820173|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82820174|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82820175|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
82820176|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820177|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82820178|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82820179|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
82820180|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820181|NCT01045980|Vitamin D|vitamin d|mesh-list
82820182|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
82820183|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
82820185|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
82820186|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820187|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82820188|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82820189|NCT00388674|Entecavir|entecavir|mesh-list
82820190|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
82820191|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820192|NCT00388362|Sirolimus|sirolimus|mesh-list
82820193|NCT00388362|Prednisone|prednisone|mesh-list
82820194|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82820195|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
82820196|NCT00388362|Hormones|hormones|mesh-ancestor
82820197|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820198|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820199|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82820200|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820201|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82820202|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820203|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82820204|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
82820205|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820206|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
82820207|NCT01046058|Simeprevir|simeprevir|mesh-list
82820208|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
82820209|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820210|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
82820211|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820212|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820213|NCT01046214|Bupropion|bupropion|mesh-list
82820214|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82820215|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
82820216|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82820217|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82820218|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82820219|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820220|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820221|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
82820222|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820223|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820224|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82820225|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82820226|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820227|NCT01324284|Lubiprostone|lubiprostone|mesh-list
82820228|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82820229|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820230|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820231|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82820232|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820233|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820234|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820235|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820236|NCT00387426|Sunitinib|sunitinib|mesh-list
82820237|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820238|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82820239|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82820240|NCT00387426|Growth Substances|growth substances|mesh-ancestor
82820241|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820242|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
82820243|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820244|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820245|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820246|NCT00387348|Dexetimide|dexetimide|mesh-list
82820247|NCT00387348|Citalopram|citalopram|mesh-list
82820248|NCT00387348|Escitalopram|escitalopram|mesh-list
82820249|NCT00387348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82820250|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82820251|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820252|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820253|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820254|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
82820255|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820264|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82820265|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
82820266|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82820267|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82820268|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
82820269|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
82820270|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820271|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820272|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
82820273|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820274|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82820276|NCT00413660|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82820277|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820278|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820279|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820280|NCT01234532|Anastrozole|anastrozole|mesh-list
82820281|NCT01234532|Entinostat|entinostat|mesh-list
82820282|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82820283|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820284|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82820285|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82820286|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820287|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820288|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82820289|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
82820290|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820291|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820292|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82820293|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
82820294|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82820295|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82820296|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820297|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82820298|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
82820299|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820300|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82820301|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82820302|NCT02594384|Rituximab|rituximab|mesh-list
82820303|NCT02594384|Atezolizumab|atezolizumab|mesh-list
82820304|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820305|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820306|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
82820307|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820308|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820309|NCT02594384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82820310|NCT02594384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820311|NCT00430352|Rituximab|rituximab|mesh-list
82820312|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820313|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820314|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
82820315|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820316|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820318|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82820319|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
82820320|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82820321|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820322|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82820323|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
82820324|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820325|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820326|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
82820327|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820328|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82820329|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820330|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
82820331|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820332|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82820333|NCT00429572|Fludarabine|fludarabine|mesh-list
82820334|NCT00429572|Melphalan|melphalan|mesh-list
82820335|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820336|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820337|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820338|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
82820339|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820340|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82820341|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
82820342|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82820343|NCT00429494|Leuprolide|leuprolide|mesh-list
82820344|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82820345|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
82820346|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82820347|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820348|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82820349|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820351|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
82820352|NCT00429416|Fludarabine|fludarabine|mesh-list
82820353|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
82820354|NCT00429416|Molgramostim|molgramostim|mesh-list
82820355|NCT00429416|Tacrolimus|tacrolimus|mesh-list
82820356|NCT00429416|Sargramostim|sargramostim|mesh-list
82820357|NCT00429416|Mesna|mesna|mesh-list
82820358|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820359|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
82820360|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820361|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820362|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82820363|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
82820364|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820365|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820366|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82820367|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82820368|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
82820369|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
82820370|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820371|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82820372|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820373|NCT00429416|Protective Agents|protective agents|mesh-ancestor
82820374|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
82820375|NCT00429182|Thiotepa|thiotepa|mesh-list
82820376|NCT00429182|Carboplatin|carboplatin|mesh-list
82820377|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820378|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
82820379|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820380|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820381|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82820382|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
82820383|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820384|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820385|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82820386|NCT00429104|Trastuzumab|trastuzumab|mesh-list
82820387|NCT00429104|Sargramostim|sargramostim|mesh-list
82820388|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820389|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820390|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
82820391|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820392|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
82820393|NCT00429026|Melphalan|melphalan|mesh-list
82820394|NCT00429026|Fludarabine|fludarabine|mesh-list
82820395|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820396|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
82820397|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820398|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820399|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82820400|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
82820401|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820402|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820403|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82820404|NCT00301821|Prednisone|prednisone|mesh-list
82820405|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
82820406|NCT00301821|Rituximab|rituximab|mesh-list
82820407|NCT00301821|Doxorubicin|doxorubicin|mesh-list
82820408|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82820409|NCT00301821|Vincristine|vincristine|mesh-list
82820410|NCT00301821|Epratuzumab|epratuzumab|mesh-list
82820411|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820412|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
82820413|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820414|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820415|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82820416|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
82820417|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820418|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820419|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82820420|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820421|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82820422|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82820423|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82820424|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820425|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82820426|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
82820427|NCT00301821|Hormones|hormones|mesh-ancestor
82820428|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820429|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82820430|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82820431|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
82820432|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
82820433|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
82820434|NCT03976713|Bromides|bromides|mesh-list
82820435|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
82820436|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82820437|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
82820438|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820439|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442486|NCT00791323|Analgesics|analgesics|mesh-ancestor
82820440|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82820441|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
82820442|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
82820443|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82820444|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
82820445|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820446|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820447|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
82820448|NCT00372996|Fulvestrant|fulvestrant|mesh-list
82820449|NCT00372996|Exemestane|exemestane|mesh-list
82820450|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82820451|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820452|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82820453|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82820454|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
82820455|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820456|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820457|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82820458|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82820459|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820460|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820461|NCT00399360|Metformin|metformin|mesh-list
82820462|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82820463|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820464|NCT00428948|Tolvaptan|tolvaptan|mesh-list
82820465|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82820466|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820468|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820469|NCT00428792|Methylphenidate|methylphenidate|mesh-list
82820470|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82820471|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820472|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82820473|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82820474|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820475|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820476|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
82820477|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820478|NCT00300885|Paclitaxel|paclitaxel|mesh-list
82820479|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82820480|NCT00300885|Carboplatin|carboplatin|mesh-list
82820481|NCT00300885|Sorafenib|sorafenib|mesh-list
82820482|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82820483|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820484|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
82820485|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
82820486|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
82820487|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820488|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820489|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820490|NCT00386334|Eszopiclone|eszopiclone|mesh-list
82820491|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82820492|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820493|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820494|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
82820495|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82820496|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820497|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
82820498|NCT00292227|Rotigotine|rotigotine|mesh-list
82820499|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82820500|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820501|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82820502|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82820503|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820504|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820505|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820506|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820507|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
82820508|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
82820509|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820511|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82820512|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820513|NCT00300495|Amiodarone|amiodarone|mesh-list
82820514|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82820515|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
82820516|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82820517|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820518|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820519|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82820520|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82820521|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82820522|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820523|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82820524|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82820525|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82820526|NCT03979989|Tapentadol|tapentadol|mesh-list
82820527|NCT03979989|Omeprazole|omeprazole|mesh-list
82820528|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82820529|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82820530|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82820531|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820532|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820533|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82820534|NCT03979989|Narcotics|narcotics|mesh-ancestor
82820535|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820536|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820537|NCT03979989|Analgesics|analgesics|mesh-ancestor
82820538|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
82820539|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820540|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82820541|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82820542|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820543|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
82820544|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820546|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820547|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
82820548|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820549|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82820550|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820551|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820552|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82820553|NCT00386022|Estrogens|estrogens|mesh-list
82820554|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
82820555|NCT00386022|Hormones|hormones|mesh-ancestor
82820556|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820557|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820558|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
82820559|NCT01068795|Enoxaparin|enoxaparin|mesh-list
82820560|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
82820561|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82820562|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82820563|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820564|NCT00286455|Alogliptin|alogliptin|mesh-list
82820565|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82820566|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820567|NCT00286455|Incretins|incretins|mesh-ancestor
82820568|NCT00286455|Hormones|hormones|mesh-ancestor
82820569|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820570|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82820571|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
82820572|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820573|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820575|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82820576|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82820577|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82820578|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82820579|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82820580|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
82820581|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820582|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820583|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820584|NCT00286221|Fentanyl|fentanyl|mesh-list
82820585|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82820586|NCT00286221|Narcotics|narcotics|mesh-ancestor
82820587|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820588|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820589|NCT00286221|Analgesics|analgesics|mesh-ancestor
82820590|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
82820591|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820592|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82820593|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82820594|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
82820595|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
82820596|NCT00398112|Sunitinib|sunitinib|mesh-list
82820597|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820598|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82820599|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82820600|NCT00398112|Growth Substances|growth substances|mesh-ancestor
82820601|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820602|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
82820603|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820604|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820605|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820606|NCT01065129|Plerixafor|plerixafor|mesh-list
82820607|NCT01065129|Azacitidine|azacitidine|mesh-list
82820608|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82820609|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
82820610|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820612|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820613|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82820614|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82820615|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
82820616|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820617|NCT01042314|Donepezil|donepezil|mesh-list
82820618|NCT01042314|BMS 708163|bms 708163|mesh-list
82820619|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82820620|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820621|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820622|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
82820623|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820624|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820625|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
82820626|NCT01042314|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82820627|NCT00372528|Pregabalin|pregabalin|mesh-list
82820628|NCT00372528|Analgesics|analgesics|mesh-ancestor
82820629|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
82820630|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820631|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820632|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
82820633|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82820634|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820635|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820636|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82820637|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82820638|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82820639|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820640|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82820641|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
82820642|NCT00283803|Hormones|hormones|mesh-list
82820643|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82820644|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
82820645|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820646|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820647|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820648|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
82820649|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82820650|NCT00283803|Protective Agents|protective agents|mesh-ancestor
82820651|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82820652|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820653|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820654|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82820655|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82820656|NCT00283803|Analgesics|analgesics|mesh-ancestor
82820657|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
82820658|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820659|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82820660|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820662|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82820663|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82820664|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820665|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820666|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
82820667|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820668|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82820669|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82820670|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82820671|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82820672|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82820673|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82820674|NCT01033370|Clevidipine|clevidipine|mesh-list
82820675|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82820676|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82820677|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820678|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82820679|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820680|NCT01044888|Heparin|heparin|mesh-list
82820681|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
82820683|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82820684|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820686|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82820687|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82820688|NCT03742466|Prednisolone|prednisolone|mesh-list
82820689|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
82820690|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82820691|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
82820692|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82820693|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
82820694|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
82820695|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820696|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820697|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82820698|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
82820699|NCT03742466|Hormones|hormones|mesh-ancestor
82820700|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820701|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82820702|NCT03742466|Protective Agents|protective agents|mesh-ancestor
82820703|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82820704|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820705|NCT01065285|Vaccines|vaccines|mesh-list
82820706|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
82820707|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820708|NCT01033526|Aspirin|aspirin|mesh-list
82820709|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82820710|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82820711|NCT01033526|Analgesics|analgesics|mesh-ancestor
82820712|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
82820713|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820714|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820715|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82820716|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820717|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82820718|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82820719|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820720|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82820721|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82820722|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820723|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
82820724|NCT00397488|Sunitinib|sunitinib|mesh-list
82820725|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820726|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82820727|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82820728|NCT00397488|Growth Substances|growth substances|mesh-ancestor
82820729|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820730|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
82820731|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820732|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820733|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820734|NCT01581411|Plasminogen|plasminogen|mesh-list
82820735|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82820736|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82820737|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82820738|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820739|NCT02900664|Trametinib|trametinib|mesh-list
82820740|NCT02900664|Spartalizumab|spartalizumab|mesh-list
82820741|NCT02900664|Nazartinib|nazartinib|mesh-list
82820742|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820743|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820744|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820745|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820746|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82820747|NCT02900664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820748|NCT01324596|Prednisolone|prednisolone|mesh-list
82820749|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82820750|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
82820751|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82820752|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
82820753|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
82820754|NCT01324596|Rituximab|rituximab|mesh-list
82820755|NCT01324596|Doxorubicin|doxorubicin|mesh-list
82820757|NCT01324596|Vincristine|vincristine|mesh-list
82820758|NCT01324596|Bortezomib|bortezomib|mesh-list
82820759|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82820760|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
82820761|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820762|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
82820763|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820764|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820765|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82820766|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
82820767|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820768|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820769|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82820770|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820771|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82820772|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82820773|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82820774|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820775|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82820776|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
82820777|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
82820778|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
82820779|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82820780|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
82820781|NCT01324596|Hormones|hormones|mesh-ancestor
82820782|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820783|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82820784|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
82820785|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
82820786|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820787|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82820788|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82820789|NCT01324596|Protective Agents|protective agents|mesh-ancestor
82820790|NCT00424190|Vancomycin|vancomycin|mesh-list
82820791|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82820792|NCT00424190|Aztreonam|aztreonam|mesh-list
82820793|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82820794|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820795|NCT02859012|Axitinib|axitinib|mesh-list
82820796|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820797|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820798|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820799|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820800|NCT00274287|Sargramostim|sargramostim|mesh-list
82820801|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
82820802|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820803|NCT01045278|Interferons|interferons|mesh-list
82820804|NCT01045278|Ribavirin|ribavirin|mesh-list
82820805|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
82820806|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
82820807|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82820808|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820809|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
82820810|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820811|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
82820812|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820813|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
82820814|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820815|NCT00423800|Interferons|interferons|mesh-list
82820816|NCT00423800|Ribavirin|ribavirin|mesh-list
82820817|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
82820818|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
82820819|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82820820|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820821|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
82820822|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820823|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
82820824|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820825|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
82820826|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820827|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82820828|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
82820829|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820830|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
82820831|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82820833|NCT00282243|Tacrolimus|tacrolimus|mesh-list
82820834|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820835|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
82820836|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820837|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82820838|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820839|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820840|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
82820841|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82820842|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82820843|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820844|NCT00282087|Gemcitabine|gemcitabine|mesh-list
82820845|NCT00282087|Docetaxel|docetaxel|mesh-list
82820846|NCT00282087|Doxorubicin|doxorubicin|mesh-list
82820847|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82820848|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
82820849|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820850|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820851|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
82820852|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
82820853|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
82820854|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82820855|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82820856|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82820857|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820858|NCT00281697|Bevacizumab|bevacizumab|mesh-list
82820859|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820860|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820861|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82820862|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82820863|NCT00281697|Growth Substances|growth substances|mesh-ancestor
82820864|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820865|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
82820866|NCT00232180|Eplerenone|eplerenone|mesh-list
82820867|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82820868|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
82820869|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82820870|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820871|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82820872|NCT00232180|Diuretics|diuretics|mesh-ancestor
82820873|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
82820874|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82820875|NCT01070277|Albendazole|albendazole|mesh-list
82820876|NCT01070277|Tinidazole|tinidazole|mesh-list
82820877|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
82820878|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82820879|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820880|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
82820881|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82820882|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82820883|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
82820884|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
82820885|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
82820886|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820887|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820888|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
82820889|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82820890|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82820891|NCT00270231|Naltrexone|naltrexone|mesh-list
82820892|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82820893|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82820894|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820895|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
82820896|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820897|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82820898|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82820899|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82820900|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
82820901|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820902|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82820903|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82820906|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
82820907|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820908|NCT00269919|Risperidone|risperidone|mesh-list
82820909|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82820910|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
82820911|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820912|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820913|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820914|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82820915|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82820916|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82820917|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82820918|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82820919|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
82820920|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
82820921|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820922|NCT00257920|Vitamins|vitamins|mesh-ancestor
82820923|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
82820924|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82820926|NCT00268983|Rituximab|rituximab|mesh-list
82820927|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
82820928|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82820929|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820930|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820931|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
82820932|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820933|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82820934|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82820935|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820936|NCT00268983|Trace Elements|trace elements|mesh-ancestor
82820937|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
82820938|NCT01070511|Tadalafil|tadalafil|mesh-list
82820939|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
82820940|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82820941|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82820942|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820943|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820944|NCT01070511|Urological Agents|urological agents|mesh-ancestor
82820945|NCT01070667|Dronedarone|dronedarone|mesh-list
82820946|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82820947|NCT00257608|Bevacizumab|bevacizumab|mesh-list
82820948|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82820949|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82820950|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820951|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82820952|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82820953|NCT00257608|Growth Substances|growth substances|mesh-ancestor
82820954|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820955|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
82820956|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82820957|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820958|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820959|NCT00231478|Granisetron|granisetron|mesh-list
82820960|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
82820961|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
82820962|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82820963|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82820964|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82820965|NCT00231478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82820966|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82820967|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
82820968|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82820969|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820971|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82820972|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82820973|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82820974|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
82820975|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820976|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820977|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82820978|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82820979|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
82820980|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82820981|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82820982|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82820983|NCT00268905|Carboplatin|carboplatin|mesh-list
82820984|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820986|NCT00206518|Doxorubicin|doxorubicin|mesh-list
82820987|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82820988|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
82820989|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82820990|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
82820991|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
82820992|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
82820993|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82820994|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82820995|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82820996|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82820997|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82820998|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82820999|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
82821000|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821001|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821002|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82821003|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
82821004|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82821005|NCT00206440|Esomeprazole|esomeprazole|mesh-list
82821006|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82821007|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82821008|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82821009|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821010|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821011|NCT00268437|Carboplatin|carboplatin|mesh-list
82821012|NCT00268437|Pemetrexed|pemetrexed|mesh-list
82821013|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821014|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821015|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821016|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82821017|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82821018|NCT00423488|Simvastatin|simvastatin|mesh-list
82821019|NCT00423488|Ezetimibe|ezetimibe|mesh-list
82821020|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82821021|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82821022|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
82821023|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821024|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82821025|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82821026|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821027|NCT00404066|Dexamethasone|dexamethasone|mesh-list
82821028|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
82821029|NCT00404066|Docetaxel|docetaxel|mesh-list
82821030|NCT00404066|Doxorubicin|doxorubicin|mesh-list
82821031|NCT00404066|Trastuzumab|trastuzumab|mesh-list
82821032|NCT00404066|Lapatinib|lapatinib|mesh-list
82821033|NCT00404066|Lenograstim|lenograstim|mesh-list
82821034|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821035|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
82821036|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821037|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821038|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82821039|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
82821040|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821041|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821042|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82821043|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821044|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
82821045|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
82821046|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821047|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82821048|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
82821049|NCT00404066|Hormones|hormones|mesh-ancestor
82821050|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821051|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82821052|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
82821053|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
82821055|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821056|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82821057|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82821058|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821059|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821060|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82821061|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821063|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821064|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821065|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821066|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821067|NCT00413036|Lenalidomide|lenalidomide|mesh-list
82821068|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
82821069|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821070|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82821071|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82821072|NCT00413036|Growth Substances|growth substances|mesh-ancestor
82821073|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
82821074|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821075|NCT00412958|Plasminogen|plasminogen|mesh-list
82821076|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
82821077|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82821078|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82821079|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821080|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82821081|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82821082|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821083|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
82821084|NCT01040702|Methylphenidate|methylphenidate|mesh-list
82821085|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82821086|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821087|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82821088|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82821089|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821090|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821091|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
82821092|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821093|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
82821094|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821095|NCT00384930|Tadalafil|tadalafil|mesh-list
82821096|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
82821097|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82821098|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82821099|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821100|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821101|NCT00384930|Urological Agents|urological agents|mesh-ancestor
82821102|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
82821103|NCT00423098|Prednisone|prednisone|mesh-list
82821104|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
82821105|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82821106|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82821107|NCT00423098|Prednisolone|prednisolone|mesh-list
82821108|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
82821109|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82821110|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
82821111|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821112|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
82821113|NCT00423098|Hormones|hormones|mesh-ancestor
82821114|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821115|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821116|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82821117|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821118|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821119|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82821120|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
82821121|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821122|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821123|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821124|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821125|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
82821126|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
82821127|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821128|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82821129|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82821130|NCT00423098|Protective Agents|protective agents|mesh-ancestor
82821131|NCT01042704|Aspirin|aspirin|mesh-list
82821132|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82821133|NCT01042704|Dexamethasone|dexamethasone|mesh-list
82821134|NCT01042704|Lenalidomide|lenalidomide|mesh-list
82821135|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82821136|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821137|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
82821138|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
82821139|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821140|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821141|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82821142|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
82821143|NCT01042704|Hormones|hormones|mesh-ancestor
82821144|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821145|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82821146|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821147|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82821148|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82821149|NCT01042704|Analgesics|analgesics|mesh-ancestor
82821150|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
82821151|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821152|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82821153|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82821154|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821155|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82821156|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82821157|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821158|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
82821159|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
82821160|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82821161|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82821162|NCT01042704|Growth Substances|growth substances|mesh-ancestor
82821163|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
82821164|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821165|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82821166|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
82821167|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82821168|NCT00750698|Entinostat|entinostat|mesh-list
82821169|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821170|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821171|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821172|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821173|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82821174|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
82821175|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
82821176|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82821177|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82821178|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821179|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821180|NCT01046838|Urological Agents|urological agents|mesh-ancestor
82821181|NCT01042782|Everolimus|everolimus|mesh-list
82821182|NCT01042782|Mitomycin|mitomycin|mesh-list
82821183|NCT01042782|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82821184|NCT01042782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821185|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821186|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821187|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821188|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
82821189|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821190|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821191|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
82821192|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821193|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82821194|NCT00411788|Sirolimus|sirolimus|mesh-list
82821195|NCT00411788|Trastuzumab|trastuzumab|mesh-list
82821196|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821197|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821198|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821199|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821200|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821201|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
82821203|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
82821204|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821205|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82821206|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821207|NCT01040936|Atorvastatin|atorvastatin|mesh-list
82821208|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82821209|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82821210|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
82821211|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821212|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82821213|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82821214|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821215|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82821216|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82821217|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
82821218|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821219|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821220|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82821221|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82821222|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82821223|NCT01041170|Rimonabant|rimonabant|mesh-list
82821224|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82821225|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
82821226|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82821227|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821228|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821229|NCT01041170|Hormones|hormones|mesh-ancestor
82821230|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821231|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821232|NCT01041482|Sorafenib|sorafenib|mesh-list
82821233|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821234|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821235|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821236|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821237|NCT00422942|Rituximab|rituximab|mesh-list
82821238|NCT00422942|Methotrexate|methotrexate|mesh-list
82821239|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821240|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821241|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
82821242|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821243|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821244|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82821245|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
82821246|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82821247|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821248|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
82821249|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821250|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821251|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821252|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82821253|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821254|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82821255|NCT01039142|Acitretin|acitretin|mesh-list
82821256|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
82821257|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821258|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82821259|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82821260|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82821261|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821262|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821263|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821264|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821265|NCT00422162|Analgesics|analgesics|mesh-ancestor
82821266|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
82821267|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821268|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
82821269|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82821270|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
82821271|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82821272|NCT00411632|Bexarotene|bexarotene|mesh-list
82821273|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821274|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821275|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821276|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821277|NCT00422084|Artesunate|artesunate|mesh-list
82821278|NCT00422084|Lumefantrine|lumefantrine|mesh-list
82821279|NCT00422084|Artemether|artemether|mesh-list
82821280|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82821281|NCT00422084|Pyronaridine|pyronaridine|mesh-list
82821282|NCT00422084|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
82821283|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
82821284|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82821285|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82821286|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821287|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821288|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
82821289|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
82821290|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82821291|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
82821292|NCT00421928|Oxycodone|oxycodone|mesh-list
82821293|NCT00421928|Tapentadol|tapentadol|mesh-list
82821294|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82821295|NCT00421928|Narcotics|narcotics|mesh-ancestor
82821296|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821297|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821298|NCT00421928|Analgesics|analgesics|mesh-ancestor
82821299|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
82821300|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821301|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82821302|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82821303|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821304|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821305|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
82821306|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821307|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
82821308|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
82821309|NCT01047072|Rituximab|rituximab|mesh-list
82821310|NCT01047072|Fludarabine|fludarabine|mesh-list
82821311|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
82821312|NCT01047072|Tacrolimus|tacrolimus|mesh-list
82821313|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821314|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
82821315|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821316|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821317|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82821318|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
82821319|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821320|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821321|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82821322|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821323|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821324|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
82821325|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82821326|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821327|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821328|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82821329|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
82821330|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821331|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821332|NCT00372060|Pioglitazone|pioglitazone|mesh-list
82821333|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82821334|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82821335|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821336|NCT00372060|Incretins|incretins|mesh-ancestor
82821337|NCT00372060|Hormones|hormones|mesh-ancestor
82821338|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821339|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82821340|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
82821341|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821342|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821343|NCT01043172|Gemcitabine|gemcitabine|mesh-list
82821344|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821345|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
82821346|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821347|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821348|NCT01045434|Omeprazole|omeprazole|mesh-list
82821349|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82821350|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82821351|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82821352|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821353|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821354|NCT01043484|Bevacizumab|bevacizumab|mesh-list
82821355|NCT01043484|Capecitabine|capecitabine|mesh-list
82821356|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821357|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821358|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82821359|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82821360|NCT01043484|Growth Substances|growth substances|mesh-ancestor
82821361|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821362|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
82821363|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821364|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
83442562|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821365|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821366|NCT00396318|Tenecteplase|tenecteplase|mesh-list
82821367|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82821368|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82821369|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821370|NCT00381888|PENTA|penta|mesh-list
82821371|NCT00381888|Fondaparinux|fondaparinux|mesh-list
82821372|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82821373|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
82821374|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82821375|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
82821376|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821377|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821378|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
82821379|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82821380|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82821381|NCT00267969|Ustekinumab|ustekinumab|mesh-list
82821382|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821383|NCT00280293|Lamotrigine|lamotrigine|mesh-list
82821384|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
82821385|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82821386|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821387|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821388|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82821389|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821390|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82821391|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82821392|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821393|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82821394|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82821395|NCT00421148|Bromides|bromides|mesh-list
82821396|NCT00421148|Rocuronium|rocuronium|mesh-list
82821397|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
82821398|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82821399|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82821400|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82821401|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821402|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821403|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82821404|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82821405|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
82821406|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821407|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821408|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82821409|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
82821410|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82821411|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82821412|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82821413|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
82821414|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821415|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821416|NCT00280059|Pregabalin|pregabalin|mesh-list
82821417|NCT00280059|Lamotrigine|lamotrigine|mesh-list
82821418|NCT00280059|Analgesics|analgesics|mesh-ancestor
82821419|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
82821420|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821421|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821422|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
82821424|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821425|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821426|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82821427|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82821428|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82821429|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821430|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82821431|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82821432|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82821433|NCT00403130|Paclitaxel|paclitaxel|mesh-list
82821434|NCT00403130|Bevacizumab|bevacizumab|mesh-list
82821435|NCT00403130|Gemcitabine|gemcitabine|mesh-list
82821436|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82821437|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821438|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
82821439|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
82821440|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
82821441|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821442|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821443|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82821444|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82821445|NCT00403130|Growth Substances|growth substances|mesh-ancestor
82821446|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821447|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
82821448|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821449|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
82821450|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
82821451|NCT01039610|Linezolid|linezolid|mesh-list
82821452|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821453|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821454|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82821455|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82821456|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821457|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821458|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821459|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82821460|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82821461|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821462|NCT00267189|Cyclosporine|cyclosporine|mesh-list
82821463|NCT00267189|Everolimus|everolimus|mesh-list
82821464|NCT00267189|Azathioprine|azathioprine|mesh-list
82821465|NCT00267189|Tacrolimus|tacrolimus|mesh-list
82821466|NCT00267189|Cyclosporins|cyclosporins|mesh-list
82821467|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82821468|NCT00267189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82821469|NCT00267189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821470|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821471|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821472|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821473|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
82821474|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821475|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821476|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821478|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821479|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821480|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
82821481|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821482|NCT00402116|Temozolomide|temozolomide|mesh-list
82821483|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82821484|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
82821485|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821486|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821487|NCT00401960|Daptomycin|daptomycin|mesh-list
82821488|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821489|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83442565|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
82821490|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82821491|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82821492|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82821493|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821494|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821495|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821496|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821497|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82821499|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82821500|NCT00371826|Cyclosporine|cyclosporine|mesh-list
82821501|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
82821502|NCT00371826|Prednisone|prednisone|mesh-list
82821503|NCT00371826|Everolimus|everolimus|mesh-list
82821504|NCT00371826|Cyclosporins|cyclosporins|mesh-list
82821505|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82821506|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821507|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
82821508|NCT00371826|Hormones|hormones|mesh-ancestor
82821509|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821510|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821511|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82821512|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821513|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821514|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821515|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821516|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
82821517|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
82821518|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821519|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821520|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821521|NCT00371826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82821522|NCT00371826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821523|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821524|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82821525|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
82821526|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821527|NCT03993366|Pramlintide|pramlintide|mesh-list
82821528|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
82821529|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82821530|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821531|NCT02457702|Glycerol|glycerol|mesh-list
82821532|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82821533|NCT02457702|Protective Agents|protective agents|mesh-ancestor
82821534|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821535|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
82821536|NCT00396084|Levofloxacin|levofloxacin|mesh-list
82821537|NCT00396084|Isoniazid|isoniazid|mesh-list
82821538|NCT00396084|Linezolid|linezolid|mesh-list
82821539|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
82821540|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821541|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821542|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82821543|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82821544|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821545|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821546|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821547|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82821548|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82821549|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82821550|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
82821551|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82821552|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82821553|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
82821554|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82821555|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82821556|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82821557|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82821558|NCT00395850|Disulfiram|disulfiram|mesh-list
82821559|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82821560|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82821561|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821562|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821563|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82821564|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821565|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821566|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
82821567|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821568|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82821569|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82821570|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82821571|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821572|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821573|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821574|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821576|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
82821577|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821578|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
82821579|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82821580|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
82821581|NCT00380874|Pregabalin|pregabalin|mesh-list
82821582|NCT00380874|Analgesics|analgesics|mesh-ancestor
82821583|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
82821584|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821585|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821586|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
82821587|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82821588|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821589|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821590|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82821591|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82821592|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82821593|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821594|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82821595|NCT00420056|Palbociclib|palbociclib|mesh-list
82821596|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821597|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821598|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821599|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821600|NCT00411554|Inositol|inositol|mesh-list
82821601|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82821602|NCT00411554|Voglibose|voglibose|mesh-list
82821603|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82821604|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821605|NCT00411554|Incretins|incretins|mesh-ancestor
82821606|NCT00411554|Hormones|hormones|mesh-ancestor
82821607|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821608|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82821609|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
82821610|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821611|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821612|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82821613|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
82821614|NCT00411554|Vitamins|vitamins|mesh-ancestor
82821615|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
82821616|NCT00380718|Pemetrexed|pemetrexed|mesh-list
82821617|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821618|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821619|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821620|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82821621|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82821622|NCT00380250|Lubiprostone|lubiprostone|mesh-list
82821623|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82821624|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821625|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821626|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
82821627|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821628|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821629|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82821630|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
82821631|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821632|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821633|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821634|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821635|NCT00395694|Lamotrigine|lamotrigine|mesh-list
82821636|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
82821637|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82821638|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821639|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821640|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82821641|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821642|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82821644|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821646|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82821647|NCT00419744|Budesonide|budesonide|mesh-list
82821648|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
82821649|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82821650|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821651|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82821652|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
82821653|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821654|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821655|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82821656|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
82821657|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
82821658|NCT00419744|Hormones|hormones|mesh-ancestor
82821659|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821660|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82821661|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82821662|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82821663|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
82821664|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821665|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821666|NCT01047774|Caseins|caseins|mesh-list
82821667|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
82821668|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
82821669|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821670|NCT00395304|Fluticasone|fluticasone|mesh-list
82821671|NCT00395304|Xhance|xhance|mesh-list
82821672|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82821673|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82821674|NCT00395304|Montelukast|montelukast|mesh-list
82821675|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821676|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82821677|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
82821678|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821679|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821680|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82821681|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
82821682|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821683|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82821684|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82821685|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82821686|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82821687|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
82821688|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821689|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821690|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82821691|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
82821692|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821693|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82821694|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82821695|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
82821696|NCT00395304|Hormones|hormones|mesh-ancestor
82821697|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
82821698|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
82821699|NCT00395226|Astringents|astringents|mesh-ancestor
82821700|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821701|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821702|NCT00394914|Pleconaril|pleconaril|mesh-list
82821703|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
82821704|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821705|NCT00366444|Diclofenac|diclofenac|mesh-list
82821706|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82821707|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82821708|NCT00366444|Analgesics|analgesics|mesh-ancestor
82821709|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
82821710|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821711|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821712|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821713|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821714|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82821715|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821716|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821718|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82821719|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821720|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821721|NCT00378534|Cyclosporine|cyclosporine|mesh-list
82821722|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
82821723|NCT00378534|Fludarabine|fludarabine|mesh-list
82821724|NCT00378534|Cyclosporins|cyclosporins|mesh-list
82821725|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821726|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
82821727|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821728|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821729|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82821730|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
82821731|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821732|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821733|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82821734|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821735|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
82821736|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821737|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821738|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82821739|NCT00377676|Bromocriptine|bromocriptine|mesh-list
82821740|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82821741|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82821742|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
82821743|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82821744|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821745|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
82821746|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
82821747|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821748|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821749|NCT00377520|Pemetrexed|pemetrexed|mesh-list
82821750|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821751|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821752|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821753|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82821754|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82821755|NCT00377364|Acetaminophen|acetaminophen|mesh-list
82821756|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82821757|NCT00377364|Analgesics|analgesics|mesh-ancestor
82821758|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
82821759|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821760|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821761|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
82821762|NCT00365508|Nicotine|nicotine|mesh-list
82821763|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82821764|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
82821765|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821766|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821767|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82821768|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82821769|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
82821770|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821771|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821772|NCT00365352|Gabapentin|gabapentin|mesh-list
82821773|NCT00365352|Analgesics|analgesics|mesh-ancestor
82821774|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
82821775|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821776|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821777|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
82821778|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82821779|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82821780|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821781|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82821782|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82821783|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82821784|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821785|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821786|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
82821787|NCT00410384|Belimumab|belimumab|mesh-list
82821788|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821789|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
82821790|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821791|NCT00370032|Alosetron|alosetron|mesh-list
82821792|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82821793|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82821794|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
82821795|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82821796|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821797|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821798|NCT00410072|Tenofovir|tenofovir|mesh-list
82821799|NCT00410072|Entecavir|entecavir|mesh-list
82821800|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
82821801|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821802|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82821803|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82821804|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821805|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821806|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82821807|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82821808|NCT00409838|Methotrexate|methotrexate|mesh-list
82821809|NCT00409838|Abatacept|abatacept|mesh-list
82821810|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82821811|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
82821812|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82821813|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821814|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821815|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
82821816|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821817|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821818|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
82821819|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821820|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82821821|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821822|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
82821823|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821824|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82821825|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82821826|NCT00409838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821827|NCT01041872|Lidocaine|lidocaine|mesh-list
82821828|NCT01041872|Propofol|propofol|mesh-list
82821829|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
82821830|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
82821831|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821832|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821833|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
82821834|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821835|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82821836|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82821837|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82821838|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821839|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821840|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82821841|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82821842|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
82821843|NCT00399542|Lubiprostone|lubiprostone|mesh-list
82821844|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82821845|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821846|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821847|NCT01039766|Oxytocin|oxytocin|mesh-list
82821848|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
82821849|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82821850|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821851|NCT00409682|Adalimumab|adalimumab|mesh-list
82821852|NCT00409682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82821853|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82821854|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821855|NCT01039844|Paclitaxel|paclitaxel|mesh-list
82821856|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82821857|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821858|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
82821859|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
82821860|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
82821861|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821862|NCT01042028|Capecitabine|capecitabine|mesh-list
82821863|NCT01042028|Irinotecan|irinotecan|mesh-list
82821864|NCT01042028|Cetuximab|cetuximab|mesh-list
82821866|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
82821867|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821868|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
82821869|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821870|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821871|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82821872|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82821873|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821874|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821875|NCT01042028|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82821876|NCT01042028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821877|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821878|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
82821879|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821880|NCT03993626|Nivolumab|nivolumab|mesh-list
82821881|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821882|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821883|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82821884|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821885|NCT00398216|Edoxaban|edoxaban|mesh-list
82821886|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
82821887|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
82821888|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82821889|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
82821890|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821891|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821892|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
82821893|NCT00398138|Sargramostim|sargramostim|mesh-list
82821894|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
82821895|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
82821896|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821897|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82821898|NCT04566380|Bevacizumab|bevacizumab|mesh-list
82821899|NCT04566380|Nivolumab|nivolumab|mesh-list
82821900|NCT04566380|Capecitabine|capecitabine|mesh-list
82821901|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
82821902|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821903|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821904|NCT04566380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82821905|NCT04566380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82821906|NCT04566380|Growth Substances|growth substances|mesh-ancestor
82821907|NCT04566380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821908|NCT04566380|Growth Inhibitors|growth inhibitors|mesh-ancestor
82821909|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82821910|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
82821911|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821912|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82821913|NCT00397982|Sirolimus|sirolimus|mesh-list
82821914|NCT00397982|Bevacizumab|bevacizumab|mesh-list
82821915|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82821916|NCT00397982|Temsirolimus|temsirolimus|mesh-list
82821917|NCT00397982|MTOR Inhibitors|mtor inhibitors|mesh-list
82821918|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
82821919|NCT00397982|Antibodies|antibodies|mesh-list
82821920|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
82821921|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82821922|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
82821923|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821924|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82821925|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82821926|NCT00397982|Growth Substances|growth substances|mesh-ancestor
82821927|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821928|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
82821929|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
82821930|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82821931|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821932|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82821933|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
82821934|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82821935|NCT00397982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82821936|NCT00397982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821937|NCT00397982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821939|NCT03715166|Diuretics|diuretics|mesh-ancestor
82821940|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
82821941|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821942|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82821943|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821944|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821946|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82821947|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82821948|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821949|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82821950|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821951|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
82821952|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82821953|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82821954|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
82821955|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82821956|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82821957|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82821958|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821959|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821960|NCT01040078|Vaccines|vaccines|mesh-list
82821961|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
82821962|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821963|NCT01035320|Simvastatin|simvastatin|mesh-list
82821964|NCT01035320|Ezetimibe|ezetimibe|mesh-list
82821965|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82821966|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82821967|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
82821968|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821969|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82821970|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82821971|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821972|NCT01042730|Pitavastatin|pitavastatin|mesh-list
82821973|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82821974|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82821975|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82821976|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
82821977|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821978|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82821979|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82821980|NCT00396812|Rituximab|rituximab|mesh-list
82821981|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82821982|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82821983|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
82821984|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821985|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82821986|NCT01566578|Mitogens|mitogens|mesh-list
82821987|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
82821988|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82821989|NCT01040234|Bupivacaine|bupivacaine|mesh-list
82821990|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
82821991|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
82821992|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82821993|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82821994|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
82821995|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82821996|NCT00396656|Atenolol|atenolol|mesh-list
82821997|NCT00396656|Valsartan|valsartan|mesh-list
82821998|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82821999|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82822000|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82822001|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82822002|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822003|NCT00396656|Diuretics|diuretics|mesh-ancestor
82822004|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
82822005|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822006|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82822007|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822008|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82822009|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
82822010|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
82822011|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822012|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82822013|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82822014|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82822015|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
82822016|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822017|NCT00408434|Efatutazone|efatutazone|mesh-list
82822018|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822019|NCT00418886|Pemetrexed|pemetrexed|mesh-list
82822020|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822021|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822022|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822023|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82822024|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82822025|NCT01040312|Cisplatin|cisplatin|mesh-list
82822026|NCT01040312|Carboplatin|carboplatin|mesh-list
82822027|NCT01040312|Nedaplatin|nedaplatin|mesh-list
82822028|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822029|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82822030|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82822031|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82822032|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822033|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822034|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82822035|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822036|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822037|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
82822038|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822039|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82822040|NCT00406640|Escitalopram|escitalopram|mesh-list
82822041|NCT00406640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82822042|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82822043|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822044|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822045|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822046|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
82822047|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822048|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
82822049|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822050|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82822051|NCT01043510|Insulin|insulin|mesh-list
82822052|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82822053|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
82822054|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82822055|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822056|NCT01043666|Mirabegron|mirabegron|mesh-list
82822057|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82822058|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82822059|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82822060|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82822061|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
82822062|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822063|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822064|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822065|NCT01043666|Urological Agents|urological agents|mesh-ancestor
82822066|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82822067|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82822068|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
82822069|NCT00394472|Lesogaberan|lesogaberan|mesh-list
82822070|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822071|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82822072|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
82822073|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
82822074|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482533|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82822075|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822076|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822077|NCT00395486|Atorvastatin|atorvastatin|mesh-list
82822078|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82822079|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82822080|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82822081|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
82822082|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822083|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82822084|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82822085|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822086|NCT01043744|Lumefantrine|lumefantrine|mesh-list
82822088|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82822089|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
82822090|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82822091|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82822092|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822094|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
82822095|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822096|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
82822097|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82822098|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82822099|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822100|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
82822101|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822102|NCT00375518|Atorvastatin|atorvastatin|mesh-list
82822103|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82822104|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82822105|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
82822106|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822107|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82822108|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82822109|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822110|NCT01045772|Rilonacept|rilonacept|mesh-list
82822111|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82822112|NCT01045928|Rituximab|rituximab|mesh-list
82822113|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82822114|NCT01045928|Lenalidomide|lenalidomide|mesh-list
82822115|NCT01045928|Antibodies|antibodies|mesh-list
82822116|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
82822117|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82822118|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
82822119|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822120|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822121|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82822122|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82822123|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82822124|NCT01045928|Growth Substances|growth substances|mesh-ancestor
82822125|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
82822126|NCT00256750|Cyclosporine|cyclosporine|mesh-list
82822127|NCT00256750|Abatacept|abatacept|mesh-list
82822128|NCT00256750|Cyclosporins|cyclosporins|mesh-list
82822129|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442628|NCT02305017|Acetaminophen|acetaminophen|mesh-list
82822130|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822131|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822132|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
82822133|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822134|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
82822135|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822136|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822137|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82822138|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82822139|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82822140|NCT00256750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82822141|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822142|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
82822143|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
82822144|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
82822145|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
82822146|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
82822147|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82822148|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822149|NCT00203476|Niacin|niacin|mesh-list
82822150|NCT00203476|Ezetimibe|ezetimibe|mesh-list
82822151|NCT00203476|Colestipol|colestipol|mesh-list
82822152|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82822153|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82822154|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
82822155|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822156|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82822157|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
82822158|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
82822159|NCT00203476|Vitamins|vitamins|mesh-ancestor
82822160|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
82822161|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822162|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
82822163|NCT00203242|Valproic Acid|valproic acid|mesh-list
82822164|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
82822165|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822166|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822167|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
82822168|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822169|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822170|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
82822171|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82822172|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822173|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822174|NCT00200356|Ozagrel|ozagrel|mesh-list
82822175|NCT00200356|Edaravone|edaravone|mesh-list
82822176|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82822177|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
82822178|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822179|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82822180|NCT00200356|Protective Agents|protective agents|mesh-ancestor
82822181|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822182|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822183|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82822184|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82822185|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
82822186|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
82822187|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822188|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82822189|NCT00227266|Valproic Acid|valproic acid|mesh-list
82822190|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
82822191|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822192|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822193|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
82822194|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822195|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822196|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
82822197|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82822198|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822199|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822200|NCT00256282|Docetaxel|docetaxel|mesh-list
82822201|NCT00256282|Vinorelbine|vinorelbine|mesh-list
82822202|NCT00256282|Sargramostim|sargramostim|mesh-list
82822203|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822204|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
82822205|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
82822206|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
82822207|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822208|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82822209|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
82822210|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822211|NCT00256204|Rasagiline|rasagiline|mesh-list
82822212|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82822213|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822214|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822215|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82822216|NCT00256204|Protective Agents|protective agents|mesh-ancestor
82822217|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822218|NCT03972358|Misoprostol|misoprostol|mesh-list
82822219|NCT03972358|Mifepristone|mifepristone|mesh-list
82822220|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82822221|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
82822222|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82822223|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822224|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82822225|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822226|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
82822227|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82822228|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82822229|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82822230|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82822231|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
82822232|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82822233|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82822234|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
82822235|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82822236|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
82822237|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82822238|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82822239|NCT01073332|Antioxidants|antioxidants|mesh-list
82822240|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822241|NCT01073332|Protective Agents|protective agents|mesh-ancestor
82822242|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822243|NCT03972046|Trametinib|trametinib|mesh-list
82822244|NCT03972046|Dabrafenib|dabrafenib|mesh-list
82822245|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82822246|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822247|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82822248|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822249|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822250|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82822251|NCT01071772|Insulin|insulin|mesh-list
82822252|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82822253|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822254|NCT01074346|Interferons|interferons|mesh-list
82822255|NCT01074346|Interferon-beta|interferon-beta|mesh-list
82822256|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
82822257|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822258|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
82822259|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822260|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
82822261|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822262|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82822263|NCT00278889|Leucovorin|leucovorin|mesh-list
82822264|NCT00278889|Bevacizumab|bevacizumab|mesh-list
82822265|NCT00278889|Fluorouracil|fluorouracil|mesh-list
82822266|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
82822267|NCT00278889|Cediranib|cediranib|mesh-list
82822268|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82822269|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822270|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82822271|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82822272|NCT00278889|Growth Substances|growth substances|mesh-ancestor
82822273|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822274|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
82822275|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
82822276|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822277|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82822278|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822279|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
82822280|NCT00278889|Antidotes|antidotes|mesh-ancestor
82822281|NCT00278889|Protective Agents|protective agents|mesh-ancestor
82822282|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
82822283|NCT00278889|Vitamins|vitamins|mesh-ancestor
82822284|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
82822285|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82822286|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822287|NCT01070745|Ibuprofen|ibuprofen|mesh-list
82822288|NCT01070745|Indomethacin|indomethacin|mesh-list
82822289|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82822290|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82822291|NCT01070745|Analgesics|analgesics|mesh-ancestor
82822292|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
82822293|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822294|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822295|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82822296|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82822297|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82822298|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822299|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822300|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
82822301|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
82822302|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82822303|NCT01071057|Morphine|morphine|mesh-list
82822304|NCT01071057|Naloxone|naloxone|mesh-list
82822305|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82822306|NCT01071057|Narcotics|narcotics|mesh-ancestor
82822307|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822308|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822309|NCT01071057|Analgesics|analgesics|mesh-ancestor
82822310|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
82822311|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822312|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82822313|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
82822314|NCT00278109|Doxorubicin|doxorubicin|mesh-list
82822315|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822316|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
82822317|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822318|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82822319|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82822320|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
82822321|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822322|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822323|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82822324|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82822325|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82822326|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82822327|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822328|NCT00296517|Bupropion|bupropion|mesh-list
82822329|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82822330|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
82822331|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822332|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82822333|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82822334|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822335|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822336|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
82822337|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822338|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822339|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82822340|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83442641|NCT01976871|Rotigotine|rotigotine|mesh-list
82822341|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822342|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82822343|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82822344|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82822345|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822346|NCT00266409|Alprazolam|alprazolam|mesh-list
82822347|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82822348|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822349|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822350|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82822351|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82822352|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822353|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
82822354|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
82822355|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822356|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822357|NCT00265785|Pemetrexed|pemetrexed|mesh-list
82822358|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822359|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822360|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822361|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82822362|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82822363|NCT02532153|Ketamine|ketamine|mesh-list
82822364|NCT02532153|Analgesics|analgesics|mesh-ancestor
82822365|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
82822366|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822367|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822368|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82822369|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82822370|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
82822371|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
82822372|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822373|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82822374|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82822375|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822376|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822377|NCT00265395|Interferons|interferons|mesh-list
82822378|NCT00265395|Ribavirin|ribavirin|mesh-list
82822379|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
82822380|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
82822381|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82822382|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822383|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
82822384|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822385|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
82822386|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822387|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
82822388|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822389|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
82822390|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
82822391|NCT00195442|Factor VIII|factor viii|mesh-list
82822392|NCT00195442|Coagulants|coagulants|mesh-ancestor
82822393|NCT01070823|Natalizumab|natalizumab|mesh-list
82822394|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
82822395|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822396|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82822397|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
82822398|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822399|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82822400|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82822401|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822402|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822403|NCT00275301|Olanzapine|olanzapine|mesh-list
82822404|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
82822405|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
82822406|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822407|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822408|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822409|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82822410|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82822411|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822412|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822413|NCT00275301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82822414|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82822415|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822416|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822417|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822418|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
82822419|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82822420|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822421|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822422|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
82822423|NCT00251745|Lansoprazole|lansoprazole|mesh-list
82822424|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82822425|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822426|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82822427|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822428|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822429|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
82822430|NCT00255190|Lansoprazole|lansoprazole|mesh-list
82822431|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82822432|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822433|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82822434|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822435|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822436|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82822437|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82822438|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82822439|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822440|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
82822441|NCT01049646|Giapreza|giapreza|mesh-list
82822442|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
82822443|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82822444|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82822445|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
82822446|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822447|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822448|NCT02286414|Vitamins|vitamins|mesh-list
82822449|NCT02286414|Vitamin K|vitamin k|mesh-list
82822450|NCT02286414|Warfarin|warfarin|mesh-list
82822451|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
82822452|NCT02286414|Dabigatran|dabigatran|mesh-list
82822453|NCT02286414|Apixaban|apixaban|mesh-list
82822454|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
82822455|NCT02286414|Fluindione|fluindione|mesh-list
82822456|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
82822457|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822458|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
82822459|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82822460|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
82822461|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82822462|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
82822463|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822464|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822465|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82822466|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82822467|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
82822468|NCT02286414|Coagulants|coagulants|mesh-ancestor
82822470|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82822471|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
82822472|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
82822473|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822474|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
82822475|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822476|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
82822477|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822478|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
82822479|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822480|NCT00254566|Azithromycin|azithromycin|mesh-list
82822481|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
82822482|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82822483|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82822484|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822485|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82822486|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82822487|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822488|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822489|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822490|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82822491|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
82822492|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82822493|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822494|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82822495|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82822496|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82822497|NCT02531854|Pemetrexed|pemetrexed|mesh-list
82822498|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822499|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822500|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822501|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82822502|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82822503|NCT01048086|Tretinoin|tretinoin|mesh-list
82822504|NCT01048086|Isotretinoin|isotretinoin|mesh-list
82822505|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822506|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
82822507|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822508|NCT03830892|Nicotine|nicotine|mesh-list
82822509|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82822510|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
82822511|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822512|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822513|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82822514|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82822515|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
82822516|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822517|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822518|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
82822519|NCT01049880|Gemcitabine|gemcitabine|mesh-list
82822520|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82822521|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
82822522|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822523|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822524|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
82822525|NCT01049880|Protective Agents|protective agents|mesh-ancestor
82822526|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822527|NCT01049880|Vitamins|vitamins|mesh-ancestor
82822528|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
82822529|NCT00253630|Vorinostat|vorinostat|mesh-list
82822530|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822531|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82822532|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822533|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822534|NCT00358644|Decitabine|decitabine|mesh-list
82822535|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82822536|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
82822537|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822538|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822539|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822540|NCT01048320|Gemcitabine|gemcitabine|mesh-list
82822541|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
82822542|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
82822543|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82822545|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822546|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822547|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82822548|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822549|NCT03990480|Amlodipine|amlodipine|mesh-list
82822550|NCT03990480|Valsartan|valsartan|mesh-list
82822551|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82822552|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82822553|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822554|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822555|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82822556|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822557|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
82822558|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82822559|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82822560|NCT00369486|Triamcinolone|triamcinolone|mesh-list
82822561|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82822562|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82822563|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82822564|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82822565|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
82822566|NCT00369486|Hormones|hormones|mesh-ancestor
82822567|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82822568|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822569|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822570|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
82822571|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822572|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822573|NCT00363480|Fluticasone|fluticasone|mesh-list
82822574|NCT00363480|Albuterol|albuterol|mesh-list
82822575|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82822576|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82822577|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82822578|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
82822579|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822580|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822581|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82822582|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
82822583|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822584|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82822585|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82822586|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82822587|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82822588|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
82822589|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822590|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822591|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
82822592|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82822593|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82822594|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82822595|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822596|NCT01048398|Acetaminophen|acetaminophen|mesh-list
82822597|NCT01048398|Remifentanil|remifentanil|mesh-list
82822598|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82822599|NCT01048398|Analgesics|analgesics|mesh-ancestor
82822600|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
82822601|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822602|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822603|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
82822604|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82822605|NCT01048398|Narcotics|narcotics|mesh-ancestor
82822606|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822607|NCT01073644|Sunitinib|sunitinib|mesh-list
82822608|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822609|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83442720|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82822610|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82822611|NCT01073644|Growth Substances|growth substances|mesh-ancestor
82822612|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822613|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
82822614|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82822615|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822616|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822617|NCT03992586|Methamphetamine|methamphetamine|mesh-list
82822619|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822620|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
82822621|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
82822622|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822623|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
82822624|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822625|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822626|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
82822627|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82822628|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82822629|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822630|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82822631|NCT00221104|Pravastatin|pravastatin|mesh-list
82822632|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82822633|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82822634|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
82822635|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822636|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82822637|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82822638|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822639|NCT00189202|Sirolimus|sirolimus|mesh-list
82822640|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82822641|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822642|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82822643|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822644|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
82822645|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822646|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
82822647|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822648|NCT01071928|Docetaxel|docetaxel|mesh-list
82822649|NCT01071928|Vadimezan|vadimezan|mesh-list
82822650|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822651|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
82822652|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
82822653|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
82822654|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822655|NCT00187486|Temozolomide|temozolomide|mesh-list
82822656|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82822657|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82822658|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
82822659|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822660|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822661|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82822662|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822663|NCT00220636|Aripiprazole|aripiprazole|mesh-list
82822664|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
82822665|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822666|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82822667|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82822668|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822669|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822670|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
82822671|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
82822672|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822673|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822674|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82822675|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82822676|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
82822677|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82822678|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82822679|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82822680|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82822681|NCT00362232|Enoxaparin|enoxaparin|mesh-list
82822682|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
82822683|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
82822684|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82822685|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
82822686|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82822687|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
82822688|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822689|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822690|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
82822691|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82822692|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82822694|NCT01048554|Temozolomide|temozolomide|mesh-list
82822695|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82822696|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822697|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82822698|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82822699|NCT01048554|Growth Substances|growth substances|mesh-ancestor
82822700|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822701|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
82822702|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82822703|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
82822704|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822705|NCT00219544|Pregabalin|pregabalin|mesh-list
82822706|NCT00219544|Analgesics|analgesics|mesh-ancestor
82822707|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
82822708|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822709|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822710|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
82822711|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82822712|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822713|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822714|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82822715|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82822716|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82822717|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822718|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822719|NCT00357552|Ritonavir|ritonavir|mesh-list
82822720|NCT00357552|Lopinavir|lopinavir|mesh-list
82822721|NCT00357552|Tenofovir|tenofovir|mesh-list
82822722|NCT00357552|Emtricitabine|emtricitabine|mesh-list
82822723|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82822724|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82822725|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82822726|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
82822727|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822728|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822729|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82822730|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82822731|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
82822732|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822733|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82822734|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82822735|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82822736|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82822737|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
82822738|NCT00187096|Fludarabine|fludarabine|mesh-list
82822739|NCT00187096|Etoposide|etoposide|mesh-list
82822740|NCT00187096|Interleukin-2|interleukin-2|mesh-list
82822741|NCT00187096|Clofarabine|clofarabine|mesh-list
82822742|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822743|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
82822744|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822745|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82822746|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82822747|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
82822748|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822749|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822750|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82822751|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82822752|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
82822753|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82822754|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82822755|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82822756|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822757|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82822758|NCT00187096|Analgesics|analgesics|mesh-ancestor
82822759|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
82822760|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822761|NCT00357396|Melphalan|melphalan|mesh-list
82822762|NCT00357396|Busulfan|busulfan|mesh-list
82822763|NCT00357396|Thiotepa|thiotepa|mesh-list
82822764|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82822765|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
82822767|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822768|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82822769|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822771|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822772|NCT00186628|Acetaminophen|acetaminophen|mesh-list
82822773|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
82822774|NCT00186628|Promethazine|promethazine|mesh-list
82822775|NCT00186628|Cyclosporine|cyclosporine|mesh-list
82822776|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
82822777|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
82822778|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82822779|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82822780|NCT00186628|Prednisolone|prednisolone|mesh-list
82822781|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
82822782|NCT00186628|Rituximab|rituximab|mesh-list
82822783|NCT00186628|Granisetron|granisetron|mesh-list
82822784|NCT00186628|Lenograstim|lenograstim|mesh-list
82822785|NCT00186628|Cyclosporins|cyclosporins|mesh-list
82822786|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
82822787|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82822788|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82822789|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
82822790|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82822791|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822792|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
82822793|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822794|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82822795|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82822796|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822797|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822798|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822799|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
82822800|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822801|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822802|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82822803|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82822804|NCT00186628|Analgesics|analgesics|mesh-ancestor
82822805|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
82822806|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822807|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
82822808|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82822809|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
82822810|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
82822811|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822812|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
82822813|NCT00186628|Hormones|hormones|mesh-ancestor
82822814|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82822815|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82822816|NCT00186628|Protective Agents|protective agents|mesh-ancestor
82822817|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82822818|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82822819|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82822820|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82822821|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
82822822|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
82822823|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82822824|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
82822825|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
82822826|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822827|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82822828|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
82822829|NCT00186628|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82822830|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82822831|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
82822832|NCT00368550|Sertraline|sertraline|mesh-list
82822833|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
82822834|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82822835|NCT00368550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82822836|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82822837|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822838|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822839|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822840|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
82822841|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822843|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
82822844|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822845|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822846|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
82822847|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822848|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82822849|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822850|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82822851|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82822852|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82822853|NCT00357006|Estradiol|estradiol|mesh-list
82822854|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82822855|NCT00357006|Estrogens|estrogens|mesh-ancestor
82822856|NCT00357006|Hormones|hormones|mesh-ancestor
82822857|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82822858|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822859|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82822860|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
82822861|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82822862|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82822863|NCT01050114|Oxybutynin|oxybutynin|mesh-list
82822864|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82822865|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82822866|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822867|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822868|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82822869|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82822870|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822871|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
82822872|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822873|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
82822874|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
82822875|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82822876|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82822877|NCT01050114|Urological Agents|urological agents|mesh-ancestor
82822878|NCT01048632|Oxandrolone|oxandrolone|mesh-list
82822879|NCT01048632|Androgens|androgens|mesh-ancestor
82822880|NCT01048632|Hormones|hormones|mesh-ancestor
82822881|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82822882|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822883|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
82822884|NCT00165646|Rabeprazole|rabeprazole|mesh-list
82822885|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82822886|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822887|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82822888|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822889|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822890|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
82822891|NCT01050270|Ondansetron|ondansetron|mesh-list
82822892|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82822893|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
82822894|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
82822895|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82822896|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822897|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82822898|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
82822899|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822900|NCT01050270|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82822901|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82822902|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
82822903|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82822904|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822905|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
82822906|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822907|NCT01050270|Expectorants|expectorants|mesh-ancestor
82822908|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
82822909|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82822910|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
82822911|NCT01050270|Protective Agents|protective agents|mesh-ancestor
82822912|NCT01050270|Antidotes|antidotes|mesh-ancestor
82822913|NCT00367770|Bosentan|bosentan|mesh-list
82822914|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82822915|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82822916|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822917|NCT00185614|Cyclosporine|cyclosporine|mesh-list
82822918|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
82822919|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
82822920|NCT00185614|Melphalan|melphalan|mesh-list
82822921|NCT00185614|Cyclosporins|cyclosporins|mesh-list
82822922|NCT00185614|Lenograstim|lenograstim|mesh-list
82822923|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822924|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
82822925|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822926|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82822927|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82822928|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
82822929|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822930|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822931|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82822932|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82822933|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822934|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
82822935|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822936|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
82822937|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82822938|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82822939|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82822940|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
82822941|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82822942|NCT01075438|Vaccines|vaccines|mesh-list
82822943|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82822944|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
82822945|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822946|NCT00361842|Irinotecan|irinotecan|mesh-list
82822947|NCT00361842|Floxuridine|floxuridine|mesh-list
82822948|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82822949|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82822950|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822951|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822952|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822953|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82822954|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
82822955|NCT01324752|Losartan|losartan|mesh-list
82822956|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82822957|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82822958|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82822959|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82822960|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822961|NCT01050348|Atorvastatin|atorvastatin|mesh-list
82822962|NCT01050348|Calcium|calcium|mesh-list
82822963|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82822964|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83442774|NCT02986503|Cisplatin|cisplatin|mesh-list
82822965|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82822966|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82822967|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
82822968|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822969|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82822970|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82822971|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822972|NCT01053390|Leucovorin|leucovorin|mesh-list
82822973|NCT01053390|Fluorouracil|fluorouracil|mesh-list
82822974|NCT01053390|Epirubicin|epirubicin|mesh-list
82822975|NCT01053390|Somatostatin|somatostatin|mesh-list
82822976|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82822977|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
82822978|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82822979|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82822980|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82822981|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
82822982|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82822983|NCT01053390|Antidotes|antidotes|mesh-ancestor
82822984|NCT01053390|Protective Agents|protective agents|mesh-ancestor
82822985|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
82822986|NCT01053390|Vitamins|vitamins|mesh-ancestor
82822987|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
82822988|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82822989|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82822990|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82822991|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82822993|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82822995|NCT00356148|Sulbactam|sulbactam|mesh-list
82822996|NCT00356148|Sultamicillin|sultamicillin|mesh-list
82822997|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82822998|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82822999|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82823000|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823001|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823002|NCT00361218|Citalopram|citalopram|mesh-list
82823003|NCT00361218|Escitalopram|escitalopram|mesh-list
82823004|NCT00361218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82823005|NCT00361218|Serotonin|serotonin|mesh-list
82823006|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82823007|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823008|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823009|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823010|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
82823011|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823012|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82823013|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
82823014|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823015|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82823016|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
82823017|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82823018|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82823019|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823020|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82823021|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82823022|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823023|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823024|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823025|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82823026|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
82823027|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82823028|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823029|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82823030|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82823031|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82823032|NCT02534610|Etoricoxib|etoricoxib|mesh-list
82823033|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82823034|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82823035|NCT02534610|Analgesics|analgesics|mesh-ancestor
82823036|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
82823037|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823038|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823039|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823040|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823041|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82823042|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82823043|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823044|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823045|NCT01050426|Leucovorin|leucovorin|mesh-list
82823046|NCT01050426|Cetuximab|cetuximab|mesh-list
82823047|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
82823048|NCT01050426|Antidotes|antidotes|mesh-ancestor
82823049|NCT01050426|Protective Agents|protective agents|mesh-ancestor
82823050|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823051|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
82823052|NCT01050426|Vitamins|vitamins|mesh-ancestor
82823053|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
82823054|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823055|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823056|NCT00367458|Atorvastatin|atorvastatin|mesh-list
82823057|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82823058|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82823059|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
82823060|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823061|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82823062|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82823063|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823064|NCT00252694|Candesartan|candesartan|mesh-list
82823066|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82823067|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82823068|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82823069|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823071|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82823072|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
82823073|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82823074|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823075|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82823076|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82823077|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82823078|NCT01077466|Natalizumab|natalizumab|mesh-list
82823079|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
82823080|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823081|NCT00160654|Levetiracetam|levetiracetam|mesh-list
82823082|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
82823083|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
82823084|NCT01582672|Sunitinib|sunitinib|mesh-list
82823085|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823086|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82823087|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82823088|NCT01582672|Growth Substances|growth substances|mesh-ancestor
82823089|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823090|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
82823091|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82823092|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823093|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823094|NCT00366678|Vaccines|vaccines|mesh-list
82823095|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82823096|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
83442787|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
82823097|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823098|NCT01049178|Silymarin|silymarin|mesh-list
82823099|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
82823100|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823101|NCT01049178|Protective Agents|protective agents|mesh-ancestor
82823102|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823103|NCT02534454|Nicotine|nicotine|mesh-list
82823104|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82823105|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
82823106|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823107|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823108|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82823109|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82823110|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
82823111|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823112|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823113|NCT00355368|Rocuronium|rocuronium|mesh-list
82823114|NCT00355368|Succinylcholine|succinylcholine|mesh-list
82823115|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82823116|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82823117|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82823118|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823119|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823120|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
82823121|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
82823122|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82823123|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823124|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82823125|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823126|NCT00360282|Rizatriptan|rizatriptan|mesh-list
82823127|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82823128|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
82823129|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823130|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823131|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823132|NCT00373958|Vaccines|vaccines|mesh-list
82823133|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82823134|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
82823135|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823136|NCT00373880|Cocaine|cocaine|mesh-list
82823137|NCT00373880|Aripiprazole|aripiprazole|mesh-list
82823138|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
82823139|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823140|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82823141|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82823142|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823143|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823144|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
82823145|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
82823146|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823147|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823148|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82823149|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82823150|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
82823151|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82823152|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82823153|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82823154|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82823155|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
82823156|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
82823157|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
82823158|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823159|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82823160|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82823161|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82823162|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823163|NCT00184600|Insulin|insulin|mesh-list
82823164|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82823165|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
82823166|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
82823167|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82823168|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
82823169|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
82823170|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82823171|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823172|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82823173|NCT00265317|Sunitinib|sunitinib|mesh-list
82823174|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823175|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82823176|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823177|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823178|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82823179|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82823180|NCT00265317|Growth Substances|growth substances|mesh-ancestor
82823181|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823182|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
82823183|NCT00373490|Vorinostat|vorinostat|mesh-list
82823184|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823185|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82823186|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823187|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823188|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82823189|NCT00251589|Vorinostat|vorinostat|mesh-list
82823190|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823191|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82823192|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823193|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823194|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82823195|NCT00265239|Edaravone|edaravone|mesh-list
82823196|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82823197|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
82823198|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823199|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82823200|NCT00265239|Protective Agents|protective agents|mesh-ancestor
82823201|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823202|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
82823203|NCT00159874|Citric Acid|citric acid|mesh-list
82823204|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
82823205|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
82823206|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82823207|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
82823208|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
82823209|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823210|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
82823211|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82823212|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82823213|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823214|NCT00159874|Urological Agents|urological agents|mesh-ancestor
82823215|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
82823216|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
82823217|NCT00184054|Vitamins|vitamins|mesh-ancestor
82823218|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
82823219|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823220|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
82823221|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823222|NCT00184054|Protective Agents|protective agents|mesh-ancestor
82823223|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823224|NCT02533908|Fentanyl|fentanyl|mesh-list
82823225|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82823226|NCT02533908|Narcotics|narcotics|mesh-ancestor
82823227|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823228|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823229|NCT02533908|Analgesics|analgesics|mesh-ancestor
82823230|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
82823231|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823232|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82823233|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82823234|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
82823235|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
82823236|NCT00183430|Prazosin|prazosin|mesh-list
82823237|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82823238|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82823239|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82823240|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82823241|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
82823242|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823243|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823244|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823245|NCT00183274|Norepinephrine|norepinephrine|mesh-list
82823246|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82823247|NCT00183274|Serotonin|serotonin|mesh-list
82823248|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
82823249|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82823250|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82823251|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
82823252|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823253|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823254|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823255|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
82823256|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
82823257|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823258|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82823259|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82823260|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823261|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82823262|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
82823263|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823264|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82823265|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
82823266|NCT00183196|Naltrexone|naltrexone|mesh-list
82823267|NCT00183196|Gabapentin|gabapentin|mesh-list
82823268|NCT00183196|Analgesics|analgesics|mesh-ancestor
82823269|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
82823270|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823271|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823272|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
82823273|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82823274|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82823275|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823276|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823277|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82823278|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82823279|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823280|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823281|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
82823282|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82823283|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82823284|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
82823285|NCT00349752|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82823287|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823288|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
82823289|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823290|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823291|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
82823292|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82823293|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823294|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82823295|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823296|NCT00348816|Prednisone|prednisone|mesh-list
82823297|NCT00348816|Docetaxel|docetaxel|mesh-list
82823298|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823299|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823300|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823301|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823302|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823303|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823304|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
82823305|NCT00348816|Hormones|hormones|mesh-ancestor
82823306|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823307|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823308|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82823309|NCT03989310|Manganese|manganese|mesh-list
82823310|NCT03989310|Paclitaxel|paclitaxel|mesh-list
82823311|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82823312|NCT03989310|Gemcitabine|gemcitabine|mesh-list
82823313|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82823314|NCT03989310|Antibodies|antibodies|mesh-list
82823315|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
82823316|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823317|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823318|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823319|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823320|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823321|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823322|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
82823323|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823324|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82823325|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
82823326|NCT03989310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823327|NCT03989310|Trace Elements|trace elements|mesh-ancestor
82823328|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
82823329|NCT03966898|Letrozole|letrozole|mesh-list
82823330|NCT03966898|Anastrozole|anastrozole|mesh-list
82823331|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823332|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82823333|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82823334|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823335|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823336|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82823337|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
82823338|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823339|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823340|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82823341|NCT03989700|Thiamine|thiamine|mesh-list
82823342|NCT03989700|Vitamins|vitamins|mesh-ancestor
82823343|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
82823344|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823345|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
82823346|NCT01051284|Gemcitabine|gemcitabine|mesh-list
82823347|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82823348|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
82823349|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823350|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823351|NCT01051362|Carboplatin|carboplatin|mesh-list
82823352|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823353|NCT01055808|Insulin|insulin|mesh-list
82823354|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82823355|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823356|NCT00265083|Golimumab|golimumab|mesh-list
82823357|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82823358|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82823359|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823360|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823361|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
82823362|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823364|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82823365|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82823366|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
82823367|NCT01073709|Acetaminophen|acetaminophen|mesh-list
82823368|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82823369|NCT01073709|Analgesics|analgesics|mesh-ancestor
82823370|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
82823371|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823372|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823373|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
82823374|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82823375|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82823376|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82823377|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823378|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823379|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823380|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823381|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82823382|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
82823383|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823384|NCT01071291|Niacin|niacin|mesh-list
82823385|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
82823386|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82823387|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
82823388|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823389|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82823390|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
82823391|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
82823392|NCT01071291|Vitamins|vitamins|mesh-ancestor
82823393|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
82823394|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823395|NCT00129766|Palivizumab|palivizumab|mesh-list
82823396|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
82823397|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823398|NCT00150592|Guanfacine|guanfacine|mesh-list
82823399|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82823400|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82823401|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82823402|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82823403|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
82823404|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823405|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823406|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823407|NCT00149890|Cyclosporine|cyclosporine|mesh-list
82823408|NCT00149890|Cyclosporins|cyclosporins|mesh-list
82823409|NCT00149890|Basiliximab|basiliximab|mesh-list
82823410|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823411|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823412|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823413|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
82823414|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823415|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
82823416|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823417|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
82823418|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823419|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82823420|NCT00174382|Donepezil|donepezil|mesh-list
82823421|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82823422|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823423|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823424|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
82823425|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823426|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823427|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
82823428|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82823429|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82823430|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823431|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823432|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
82823433|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823434|NCT00171730|Pasireotide|pasireotide|mesh-list
82823435|NCT00171730|Hormones|hormones|mesh-ancestor
83482534|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82823436|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823439|NCT00348348|Besifloxacin|besifloxacin|mesh-list
82823440|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82823441|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823442|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82823443|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82823444|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823445|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823446|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823447|NCT00354744|Dactinomycin|dactinomycin|mesh-list
82823448|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
82823449|NCT00354744|Ifosfamide|ifosfamide|mesh-list
82823450|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
82823451|NCT00354744|Doxorubicin|doxorubicin|mesh-list
82823452|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82823453|NCT00354744|Irinotecan|irinotecan|mesh-list
82823454|NCT00354744|Etoposide|etoposide|mesh-list
82823455|NCT00354744|Vincristine|vincristine|mesh-list
82823456|NCT00354744|Camptothecin|camptothecin|mesh-list
82823457|NCT00354744|Lenograstim|lenograstim|mesh-list
82823458|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823459|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
82823460|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823461|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823462|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82823463|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
82823464|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823465|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823466|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82823467|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82823468|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82823469|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82823470|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823471|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82823472|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823473|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82823474|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823475|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823476|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823477|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82823478|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823479|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82823480|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82823481|NCT01055964|Tacrolimus|tacrolimus|mesh-list
82823482|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823483|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
82823484|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823485|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82823486|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823487|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823488|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82823489|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82823490|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
82823491|NCT01056042|Gestodene|gestodene|mesh-list
82823492|NCT01056042|Estradiol|estradiol|mesh-list
82823493|NCT01056042|Estrogens|estrogens|mesh-ancestor
82823494|NCT01056042|Hormones|hormones|mesh-ancestor
82823495|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823496|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823497|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82823498|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
82823499|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82823500|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82823501|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82823502|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82823503|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82823504|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82823505|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82823506|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823507|NCT01056042|Progestins|progestins|mesh-ancestor
82823508|NCT00373256|Paclitaxel|paclitaxel|mesh-list
82823509|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82823510|NCT00373256|Bevacizumab|bevacizumab|mesh-list
82823511|NCT00373256|Sunitinib|sunitinib|mesh-list
82823512|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823513|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823515|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823516|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823517|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823518|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823519|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82823520|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82823521|NCT00373256|Growth Substances|growth substances|mesh-ancestor
82823522|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823523|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
82823524|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82823525|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823526|NCT01324544|Buprenorphine|buprenorphine|mesh-list
82823527|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82823528|NCT01324544|Narcotics|narcotics|mesh-ancestor
82823529|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823530|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823531|NCT01324544|Analgesics|analgesics|mesh-ancestor
82823532|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
82823533|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823534|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82823536|NCT00394082|Bevacizumab|bevacizumab|mesh-list
82823537|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82823538|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823539|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823540|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823541|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823542|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823543|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823544|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823545|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82823546|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82823547|NCT00394082|Growth Substances|growth substances|mesh-ancestor
82823548|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823549|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
82823550|NCT00393848|Ketoconazole|ketoconazole|mesh-list
82823551|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
82823552|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823553|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82823554|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82823555|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823556|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823557|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82823558|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
82823559|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823560|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823561|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82823562|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
82823563|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82823564|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
82823565|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823566|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823567|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82823568|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
82823569|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82823570|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82823571|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82823572|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
82823573|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823574|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823575|NCT01046006|Dexamethasone|dexamethasone|mesh-list
82823576|NCT01046006|Rituximab|rituximab|mesh-list
82823577|NCT01046006|Bortezomib|bortezomib|mesh-list
82823578|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823579|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823580|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
82823581|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823582|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823583|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823584|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
82823585|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
82823586|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823587|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82823588|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
82823589|NCT01046006|Hormones|hormones|mesh-ancestor
82823590|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823591|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82823592|NCT01046162|Alprazolam|alprazolam|mesh-list
82823593|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82823594|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823595|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823596|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82823597|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82823598|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823599|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
82823600|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
82823601|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823602|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823603|NCT00417482|Risperidone|risperidone|mesh-list
82823604|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82823605|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
82823606|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823607|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823608|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823609|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82823610|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82823611|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823612|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823613|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82823614|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
82823615|NCT00417248|Etoposide|etoposide|mesh-list
82823616|NCT00417248|Sorafenib|sorafenib|mesh-list
82823617|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823618|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823619|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82823620|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82823621|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823622|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823623|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82823624|NCT01046240|Palonosetron|palonosetron|mesh-list
82823625|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
82823626|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
82823627|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823628|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823629|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82823630|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82823631|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82823632|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
82823633|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823634|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823635|NCT00392288|Ciclesonide|ciclesonide|mesh-list
82823636|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
82823637|NCT00392288|Hormones|hormones|mesh-ancestor
82823638|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823639|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823640|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82823641|NCT00417170|Amlodipine|amlodipine|mesh-list
82823642|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82823643|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82823644|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823645|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823646|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82823647|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823648|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
82823649|NCT00392990|Cytarabine|cytarabine|mesh-list
82823650|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
82823651|NCT00392990|Ifosfamide|ifosfamide|mesh-list
82823652|NCT00392990|Rituximab|rituximab|mesh-list
82823653|NCT00392990|Doxorubicin|doxorubicin|mesh-list
82823654|NCT00392990|Methotrexate|methotrexate|mesh-list
82823655|NCT00392990|Etoposide|etoposide|mesh-list
82823656|NCT00392990|Vincristine|vincristine|mesh-list
82823657|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
82823658|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82823659|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
82823660|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823661|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
83442838|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
82823662|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823663|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823664|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82823665|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
82823666|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823667|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823668|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82823669|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823670|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82823671|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82823672|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82823673|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823674|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82823675|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
82823676|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82823677|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82823678|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
82823679|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
82823680|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82823681|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82823682|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823683|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
82823684|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823685|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823686|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823687|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823688|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
82823689|NCT00249873|Clopidogrel|clopidogrel|mesh-list
82823690|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82823691|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82823692|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82823693|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82823694|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
82823695|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823696|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823697|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823698|NCT01037348|Ranibizumab|ranibizumab|mesh-list
82823699|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82823700|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82823701|NCT01037348|Growth Substances|growth substances|mesh-ancestor
82823702|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823703|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
82823704|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823705|NCT03490292|Paclitaxel|paclitaxel|mesh-list
82823706|NCT03490292|Carboplatin|carboplatin|mesh-list
82823707|NCT03490292|Avelumab|avelumab|mesh-list
82823708|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823709|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823710|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823711|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823712|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823713|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823714|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823715|NCT01046630|Ketamine|ketamine|mesh-list
82823716|NCT01046630|Analgesics|analgesics|mesh-ancestor
82823717|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
82823718|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823719|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823720|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82823721|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82823722|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
82823723|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
82823724|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823725|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82823726|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82823727|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823728|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823729|NCT01046708|Progesterone|progesterone|mesh-list
82823730|NCT01046708|Progestins|progestins|mesh-ancestor
82823731|NCT01046708|Hormones|hormones|mesh-ancestor
82823732|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823733|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823734|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
82823736|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82823738|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
82823739|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82823740|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
82823741|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823742|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
82823743|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
82823744|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823745|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823746|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82823747|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
82823748|NCT01046786|Hormones|hormones|mesh-ancestor
82823749|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823750|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82823751|NCT01046786|Protective Agents|protective agents|mesh-ancestor
82823752|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82823753|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823754|NCT00391976|Tobramycin|tobramycin|mesh-list
82823755|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82823756|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823757|NCT00762554|Fentanyl|fentanyl|mesh-list
82823758|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82823759|NCT00762554|Narcotics|narcotics|mesh-ancestor
82823760|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823761|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823762|NCT00762554|Analgesics|analgesics|mesh-ancestor
82823763|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
82823764|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823765|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82823766|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82823767|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
82823768|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
82823769|NCT00391898|Levodopa|levodopa|mesh-list
82823770|NCT00391898|Carbidopa|carbidopa|mesh-list
82823771|NCT00391898|Entacapone|entacapone|mesh-list
82823772|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82823773|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82823774|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
82823775|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823776|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823777|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823778|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82823779|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823780|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82823781|NCT01046864|Leucovorin|leucovorin|mesh-list
82823782|NCT01046864|Fluorouracil|fluorouracil|mesh-list
82823783|NCT01046864|Irinotecan|irinotecan|mesh-list
82823784|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
82823785|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823786|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82823787|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823788|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823789|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
82823790|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823791|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82823792|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82823793|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823794|NCT01046864|Antidotes|antidotes|mesh-ancestor
82823795|NCT01046864|Protective Agents|protective agents|mesh-ancestor
82823796|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
82823797|NCT01046864|Vitamins|vitamins|mesh-ancestor
82823798|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
82823799|NCT01046942|Aspirin|aspirin|mesh-list
82823800|NCT01046942|Clopidogrel|clopidogrel|mesh-list
82823801|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82823802|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82823803|NCT01046942|Analgesics|analgesics|mesh-ancestor
82823804|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
82823805|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823806|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823807|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823808|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823809|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82823810|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82823811|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823813|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82823814|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823815|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
82823816|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82823817|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82823818|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82823819|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
82823820|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823821|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82823822|NCT01049438|Doxycycline|doxycycline|mesh-list
82823823|NCT01049438|Minocycline|minocycline|mesh-list
82823824|NCT01049438|Mupirocin|mupirocin|mesh-list
82823825|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82823826|NCT01049438|Trimethoprim|trimethoprim|mesh-list
82823827|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
82823828|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
82823829|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823830|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
82823831|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82823832|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82823833|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82823834|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82823835|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823836|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823837|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82823838|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82823839|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82823840|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82823841|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82823842|NCT01047098|Iron|iron|mesh-list
82823843|NCT01047098|Trace Elements|trace elements|mesh-ancestor
82823844|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
82823845|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823846|NCT00391586|Paclitaxel|paclitaxel|mesh-list
82823847|NCT00391586|Etoposide|etoposide|mesh-list
82823848|NCT00391586|Vinorelbine|vinorelbine|mesh-list
82823849|NCT00391586|Docetaxel|docetaxel|mesh-list
82823850|NCT00391586|Gemcitabine|gemcitabine|mesh-list
82823851|NCT00391586|Irinotecan|irinotecan|mesh-list
82823852|NCT00391586|Pemetrexed|pemetrexed|mesh-list
82823853|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82823854|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823855|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823856|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823857|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823858|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823859|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823860|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82823861|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
82823862|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82823863|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82823864|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823865|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82823866|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82823867|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82823868|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82823869|NCT00391430|Sertraline|sertraline|mesh-list
82823870|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
82823871|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823872|NCT00391430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82823873|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82823874|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823875|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823876|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823877|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
82823878|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823879|NCT00391274|Docetaxel|docetaxel|mesh-list
82823880|NCT00391274|Pemetrexed|pemetrexed|mesh-list
82823881|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823882|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823883|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823884|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
83362074|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83442847|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
82823885|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823887|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82823888|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82823889|NCT00391118|Paclitaxel|paclitaxel|mesh-list
82823890|NCT00391118|Carboplatin|carboplatin|mesh-list
82823891|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82823892|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823893|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
82823894|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
82823895|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
82823896|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823897|NCT00390884|Vaccines|vaccines|mesh-list
82823898|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
82823899|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823900|NCT01047488|Pregabalin|pregabalin|mesh-list
82823901|NCT01047488|Imipramine|imipramine|mesh-list
82823902|NCT01047488|Analgesics|analgesics|mesh-ancestor
82823903|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
82823904|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823905|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823906|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
82823907|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82823908|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823909|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823910|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82823911|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82823912|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82823913|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823914|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82823915|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82823916|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
82823917|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82823918|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82823919|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
82823920|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823921|NCT01047566|Digoxin|digoxin|mesh-list
82823922|NCT01047566|Dronedarone|dronedarone|mesh-list
82823923|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
82823924|NCT01047566|Calcium|calcium|mesh-list
82823925|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82823926|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82823927|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823928|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82823929|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82823930|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823931|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823932|NCT01047566|Protective Agents|protective agents|mesh-ancestor
82823933|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82823934|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
82823935|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823936|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823937|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
82823938|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82823939|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823940|NCT00264537|Golimumab|golimumab|mesh-list
82823941|NCT00264537|Methotrexate|methotrexate|mesh-list
82823942|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82823943|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82823944|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
82823945|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82823946|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823947|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82823948|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
82823949|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823950|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82823951|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
82823952|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82823953|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82823954|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82823955|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
82823956|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82823957|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82823958|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82823960|NCT00371150|Entecavir|entecavir|mesh-list
82823961|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
82823962|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82823963|NCT00264303|Levocetirizine|levocetirizine|mesh-list
82823964|NCT00264303|Desloratadine|desloratadine|mesh-list
82823965|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82823966|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82823967|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
82823968|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
82823969|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82823970|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823971|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823972|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82823973|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
82823975|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
82823976|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82823977|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
82823978|NCT01071369|Lidocaine|lidocaine|mesh-list
82823979|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82823980|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
82823981|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
82823982|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82823983|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82823984|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
82823985|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82823986|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82823987|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82823988|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82823989|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82823990|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82823991|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82823992|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
82823993|NCT01071369|Hormones|hormones|mesh-ancestor
82823994|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82823995|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82823996|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
82823997|NCT00370682|Vaccines|vaccines|mesh-list
82823998|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
82823999|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824000|NCT00264147|Diclofenac|diclofenac|mesh-list
82824001|NCT00264147|Etoricoxib|etoricoxib|mesh-list
82824002|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82824003|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82824004|NCT00264147|Analgesics|analgesics|mesh-ancestor
82824005|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
82824006|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824007|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824008|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824009|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824010|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82824011|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824012|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824013|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82824014|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
82824015|NCT01044446|Icodextrin|icodextrin|mesh-list
82824016|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82824017|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
82824018|NCT03971019|Atorvastatin|atorvastatin|mesh-list
82824019|NCT03971019|Simvastatin|simvastatin|mesh-list
82824020|NCT03971019|Calcium|calcium|mesh-list
82824021|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82824022|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824023|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82824024|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82824025|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82824026|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
82824027|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824028|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82824029|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82824030|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824031|NCT03974685|Niacinamide|niacinamide|mesh-list
82824034|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
82824035|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
82824036|NCT03974685|Vitamins|vitamins|mesh-ancestor
82824037|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
82824038|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824039|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82824040|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
82824041|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824042|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82824043|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
82824044|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824045|NCT00263211|Aspirin|aspirin|mesh-list
82824046|NCT00263211|Clopidogrel|clopidogrel|mesh-list
82824047|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82824048|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82824049|NCT00263211|Analgesics|analgesics|mesh-ancestor
82824050|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
82824051|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824052|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824053|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824054|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824055|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82824056|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82824057|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824058|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82824059|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82824060|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824061|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
82824062|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82824063|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82824064|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82824065|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
82824066|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824067|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
82824068|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82824069|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
82824070|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824071|NCT00248625|Expectorants|expectorants|mesh-ancestor
82824072|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
82824073|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82824074|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
82824075|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824076|NCT00248625|Protective Agents|protective agents|mesh-ancestor
82824077|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824078|NCT00248625|Antidotes|antidotes|mesh-ancestor
82824079|NCT00262821|Tirapazamine|tirapazamine|mesh-list
82824080|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824081|NCT01326117|Tadalafil|tadalafil|mesh-list
82824082|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
82824083|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82824084|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82824085|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824086|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824087|NCT01326117|Urological Agents|urological agents|mesh-ancestor
82824088|NCT03970239|Ketanserin|ketanserin|mesh-list
82824089|NCT03970239|Fluorides|fluorides|mesh-list
82824090|NCT03970239|Altanserin|altanserin|mesh-list
82824091|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
82824092|NCT03970239|Protective Agents|protective agents|mesh-ancestor
82824093|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824094|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82824095|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
82824096|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824097|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824098|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82824099|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82824100|NCT00170950|Amlodipine|amlodipine|mesh-list
82824101|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82824102|NCT00170950|Benazepril|benazepril|mesh-list
82824103|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82824104|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82824105|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824106|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824107|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82824108|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824109|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
82824110|NCT00170950|Diuretics|diuretics|mesh-ancestor
82824111|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
82824112|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82824113|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82824114|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
82824115|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824117|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
82824118|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824119|NCT00208767|Valsartan|valsartan|mesh-list
82824120|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82824121|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82824122|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82824123|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824124|NCT02531529|Fentanyl|fentanyl|mesh-list
82824125|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82824126|NCT02531529|Narcotics|narcotics|mesh-ancestor
82824127|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824128|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824129|NCT02531529|Analgesics|analgesics|mesh-ancestor
82824130|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
82824131|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824132|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82824133|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82824134|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
82824135|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
82824136|NCT01071525|Niacin|niacin|mesh-list
82824137|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82824138|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
82824139|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824140|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82824141|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
82824142|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
82824143|NCT01071525|Vitamins|vitamins|mesh-ancestor
82824144|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
82824145|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824146|NCT01072695|Ribavirin|ribavirin|mesh-list
82824147|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82824148|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
82824149|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824150|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
82824151|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824152|NCT00390806|Topotecan|topotecan|mesh-list
82824153|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82824154|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824155|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824156|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824157|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824158|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
82824159|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824160|NCT01047722|Aspirin|aspirin|mesh-list
82824161|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82824162|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82824163|NCT01047722|Analgesics|analgesics|mesh-ancestor
82824164|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
82824165|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824166|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824167|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824168|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824169|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82824170|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82824171|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824172|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82824173|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82824174|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824175|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
82824176|NCT00390416|Leucovorin|leucovorin|mesh-list
82824177|NCT00390416|Bevacizumab|bevacizumab|mesh-list
82824178|NCT00390416|Docetaxel|docetaxel|mesh-list
82824179|NCT00390416|Fluorouracil|fluorouracil|mesh-list
82824180|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82824181|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824182|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82824183|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82824184|NCT00390416|Growth Substances|growth substances|mesh-ancestor
82824185|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824186|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
82824187|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
82824188|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
82824189|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
82824190|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824191|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
82824192|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82824193|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82824194|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
82824196|NCT00390416|Protective Agents|protective agents|mesh-ancestor
82824197|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
82824198|NCT00390416|Vitamins|vitamins|mesh-ancestor
82824199|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
82824200|NCT00261495|Oxycodone|oxycodone|mesh-list
82824201|NCT00261495|Hydromorphone|hydromorphone|mesh-list
82824202|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82824203|NCT00261495|Narcotics|narcotics|mesh-ancestor
82824204|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824205|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824206|NCT00261495|Analgesics|analgesics|mesh-ancestor
82824207|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
82824208|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824209|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
82824210|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82824211|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
82824212|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824213|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824214|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82824215|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
82824216|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
82824217|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82824218|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
82824219|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824220|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824221|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
82824222|NCT00365456|Hormones|hormones|mesh-list
82824223|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
82824224|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82824225|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824226|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82824227|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824228|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824229|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82824230|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82824231|NCT01047956|Methadone|methadone|mesh-list
82824232|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82824233|NCT01047956|Narcotics|narcotics|mesh-ancestor
82824234|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824235|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824236|NCT01047956|Analgesics|analgesics|mesh-ancestor
82824237|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
82824238|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824239|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
82824240|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
82824241|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
82824242|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82824243|NCT03480698|Protective Agents|protective agents|mesh-ancestor
82824244|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824245|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
82824246|NCT00206427|Lapatinib|lapatinib|mesh-list
82824247|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824248|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82824249|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83442858|NCT01979445|Cangrelor|cangrelor|mesh-list
82824250|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824251|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
82824252|NCT00389324|Antibodies|antibodies|mesh-list
82824253|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
82824254|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82824255|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82824256|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
82824257|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
82824258|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824259|NCT00365300|Pantoprazole|pantoprazole|mesh-list
82824260|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82824261|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824262|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82824263|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824264|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824265|NCT01048034|Azacitidine|azacitidine|mesh-list
82824266|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
82824267|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82824268|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
82824269|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824270|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824271|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824272|NCT01048034|Hematinics|hematinics|mesh-ancestor
82824274|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824275|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824276|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824277|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82824278|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82824279|NCT01049672|Alfentanil|alfentanil|mesh-list
82824280|NCT01049672|Heroin|heroin|mesh-list
82824281|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82824282|NCT01049672|Narcotics|narcotics|mesh-ancestor
82824283|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824284|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824285|NCT01049672|Analgesics|analgesics|mesh-ancestor
82824286|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
82824287|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824288|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82824289|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
82824290|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
82824291|NCT01048190|Vaccines|vaccines|mesh-list
82824292|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
82824293|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824294|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
82824295|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824296|NCT01048268|Incretins|incretins|mesh-ancestor
82824297|NCT01048268|Hormones|hormones|mesh-ancestor
82824298|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82824299|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824300|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82824301|NCT03993236|Ezetimibe|ezetimibe|mesh-list
82824302|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82824303|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82824304|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
82824305|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824306|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82824307|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82824308|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824309|NCT00388154|Cisplatin|cisplatin|mesh-list
82824310|NCT00388154|Gemcitabine|gemcitabine|mesh-list
82824311|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824312|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82824313|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
82824314|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824315|NCT02535104|Ranpirnase|ranpirnase|mesh-list
82824316|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824317|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82824318|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824319|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824320|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
82824321|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83442867|NCT03802565|Tolperisone|tolperisone|mesh-list
82824322|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824323|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824324|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82824325|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824326|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82824327|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
82824328|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82824329|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824330|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82824331|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
82824332|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82824333|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824334|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824335|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824336|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
82824337|NCT00529373|Vitamin D|vitamin d|mesh-list
82824338|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
82824339|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
82824340|NCT00529373|Calcium|calcium|mesh-list
82824341|NCT00529373|Vitamins|vitamins|mesh-ancestor
82824342|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
82824343|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824344|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82824345|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82824346|NCT00529373|Antacids|antacids|mesh-ancestor
82824347|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824348|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824349|NCT00369122|Bevacizumab|bevacizumab|mesh-list
82824350|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82824351|NCT00369122|Cisplatin|cisplatin|mesh-list
82824352|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
82824353|NCT00369122|Antibodies|antibodies|mesh-list
82824354|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
82824355|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82824356|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
82824357|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824358|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82824359|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82824360|NCT00369122|Growth Substances|growth substances|mesh-ancestor
82824361|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824362|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
82824363|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
82824364|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
82824365|NCT03999203|Citric Acid|citric acid|mesh-list
82824366|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
82824367|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82824368|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
82824369|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824370|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824371|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82824372|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
82824373|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82824374|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
82824375|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824376|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824377|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82824378|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
82824379|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
82824380|NCT03999203|Protective Agents|protective agents|mesh-ancestor
82824381|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
82824382|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82824383|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
82824384|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
82824385|NCT04854395|Bupivacaine|bupivacaine|mesh-list
82824386|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
82824387|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
82824388|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824389|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824390|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
82824391|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824392|NCT05173493|Amoxicillin|amoxicillin|mesh-list
82824393|NCT05173493|Levofloxacin|levofloxacin|mesh-list
82824394|NCT05173493|Tetracycline|tetracycline|mesh-list
82824395|NCT05173493|Furazolidone|furazolidone|mesh-list
82824396|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82824397|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824398|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82824399|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82824400|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824401|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824402|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824403|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824404|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82824405|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82824406|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82824407|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82824408|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82824409|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82824410|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82824411|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82824412|NCT03872843|Ibuprofen|ibuprofen|mesh-list
82824413|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82824414|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82824415|NCT03872843|Analgesics|analgesics|mesh-ancestor
82824416|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
82824417|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824418|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824419|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824420|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824421|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82824422|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824423|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824424|NCT03966040|Vaccines|vaccines|mesh-list
82824425|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
82824426|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824427|NCT03999125|Dexamethasone|dexamethasone|mesh-list
82824428|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
82824429|NCT03999125|Ranibizumab|ranibizumab|mesh-list
82824430|NCT03999125|Aflibercept|aflibercept|mesh-list
82824431|NCT03999125|BB 1101|bb 1101|mesh-list
82824432|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824433|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
82824434|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
82824435|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824436|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824437|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824438|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
82824439|NCT03999125|Hormones|hormones|mesh-ancestor
82824440|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82824441|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82824442|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824443|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
82824444|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824445|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824446|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82824447|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82824448|NCT03999125|Growth Substances|growth substances|mesh-ancestor
82824449|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
82824450|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
82824451|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82824452|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
83442872|NCT04382443|Colchicine|colchicine|mesh-list
82824453|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824454|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82824455|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824456|NCT00166114|Desipramine|desipramine|mesh-list
82824457|NCT00166114|Escitalopram|escitalopram|mesh-list
82824458|NCT00166114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82824459|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82824460|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824461|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824462|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824463|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
82824464|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824465|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
82824466|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82824467|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82824468|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824469|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82824470|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
82824471|NCT05032781|Minocycline|minocycline|mesh-list
82824472|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82824473|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824474|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
82824475|NCT00129376|Docetaxel|docetaxel|mesh-list
82824476|NCT00129376|Doxorubicin|doxorubicin|mesh-list
82824477|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82824478|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
82824479|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824480|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824481|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82824482|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
82824483|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824484|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824485|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82824487|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
82824488|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
82824489|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82824490|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82824491|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824492|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824494|NCT04878107|Apatinib|apatinib|mesh-list
82824495|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824496|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
82824497|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
82824498|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
82824499|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824500|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82824501|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824502|NCT03998969|Pantoprazole|pantoprazole|mesh-list
82824503|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82824504|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824505|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82824506|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824507|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824508|NCT00129220|Haloperidol|haloperidol|mesh-list
82824509|NCT00129220|Olanzapine|olanzapine|mesh-list
82824510|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
82824511|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
82824512|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
82824513|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824514|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824515|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824516|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82824517|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82824518|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824519|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82824520|NCT00129220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82824521|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82824522|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824523|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824524|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824525|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
82824526|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82824527|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
82824528|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82824529|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
82824530|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824531|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
82824532|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82824533|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82824534|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824535|NCT03686813|Urological Agents|urological agents|mesh-ancestor
82824536|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82824537|NCT00128830|Etravirine|etravirine|mesh-list
82824538|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
82824539|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
82824540|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
82824541|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82824542|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824543|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824544|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
82824545|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824546|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82824547|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82824548|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82824549|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82824550|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82824551|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82824552|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
82824553|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
82824554|NCT01074892|Progestins|progestins|mesh-list
82824555|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82824556|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
82824557|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82824558|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824559|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82824560|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82824561|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82824562|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82824563|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82824564|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82824565|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824567|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82824568|NCT00128206|Rifampin|rifampin|mesh-list
82824569|NCT00128206|Isoniazid|isoniazid|mesh-list
82824570|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82824571|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
82824572|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82824573|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824574|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
82824575|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82824576|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824577|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824578|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82824579|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82824580|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82824581|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82824582|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82824583|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82824584|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82824585|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82824586|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
82824587|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82824588|NCT01075828|Cetuximab|cetuximab|mesh-list
82824589|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82824590|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824591|NCT01074970|Cisplatin|cisplatin|mesh-list
82824592|NCT01074970|Rucaparib|rucaparib|mesh-list
82824593|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824594|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82824595|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824596|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824597|NCT03968146|Acetaminophen|acetaminophen|mesh-list
82824598|NCT03968146|Ketorolac|ketorolac|mesh-list
82824599|NCT03968146|Fentanyl|fentanyl|mesh-list
82824600|NCT03968146|Meperidine|meperidine|mesh-list
82824601|NCT03968146|Morphine|morphine|mesh-list
82824602|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82824603|NCT03968146|Narcotics|narcotics|mesh-ancestor
82824604|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824605|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824606|NCT03968146|Analgesics|analgesics|mesh-ancestor
82824607|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
82824608|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824609|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82824610|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82824611|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
82824612|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
82824613|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82824614|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
82824615|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82824616|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824617|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824618|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82824619|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824620|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824621|NCT03966118|Paclitaxel|paclitaxel|mesh-list
82824622|NCT03966118|Avelumab|avelumab|mesh-list
82824623|NCT03966118|Ramucirumab|ramucirumab|mesh-list
82824624|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82824625|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824626|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
82824627|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
82824628|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
82824629|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824630|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82824631|NCT03968224|Metformin|metformin|mesh-list
82824632|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
82824633|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82824634|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824635|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82824636|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824637|NCT01075126|Valproic Acid|valproic acid|mesh-list
82824638|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82824639|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824640|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824641|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
82824642|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82824643|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824644|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824645|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
82824646|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
82824647|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824648|NCT03823378|Upadacitinib|upadacitinib|mesh-list
82824649|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82824650|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82824651|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824652|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824653|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824654|NCT00141778|Ramipril|ramipril|mesh-list
82824655|NCT00141778|Spironolactone|spironolactone|mesh-list
82824656|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
82824657|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82824658|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82824659|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
82824660|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
82824661|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82824662|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824663|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82824664|NCT00141778|Diuretics|diuretics|mesh-ancestor
82824665|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
82824666|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
82824667|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824668|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82824669|NCT00141778|Hormones|hormones|mesh-ancestor
82824670|NCT01079884|Esomeprazole|esomeprazole|mesh-list
82824671|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82824672|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824673|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82824674|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824675|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824676|NCT01075906|Colchicine|colchicine|mesh-list
82824677|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
82824678|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824679|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
82824680|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
82824681|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
82824682|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824683|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824684|NCT01076062|Misoprostol|misoprostol|mesh-list
82824685|NCT01076062|Oxytocin|oxytocin|mesh-list
82824686|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
82824687|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82824688|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824689|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82824690|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
82824691|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82824692|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824693|NCT00115336|Ibuprofen|ibuprofen|mesh-list
82824694|NCT00115336|Ketorolac|ketorolac|mesh-list
82824695|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82824696|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82824697|NCT00115336|Analgesics|analgesics|mesh-ancestor
82824698|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
82824699|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824700|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824701|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824702|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82824703|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82824704|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824705|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824706|NCT01076140|Lisinopril|lisinopril|mesh-list
82824707|NCT01076140|Nebivolol|nebivolol|mesh-list
82824708|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82824709|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
82824711|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824712|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82824713|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82824714|NCT01076140|Protective Agents|protective agents|mesh-ancestor
82824715|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824716|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
82824717|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82824718|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82824719|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82824720|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
82824721|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824722|NCT00205803|Vaccines|vaccines|mesh-list
83482535|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
82824723|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82824724|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
82824725|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824726|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82824727|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82824728|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824729|NCT00127192|Incretins|incretins|mesh-ancestor
82824730|NCT00127192|Hormones|hormones|mesh-ancestor
82824731|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82824732|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82824733|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
82824734|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824735|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824736|NCT00127036|Bevacizumab|bevacizumab|mesh-list
82824737|NCT00127036|Capecitabine|capecitabine|mesh-list
82824738|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
82824739|NCT00127036|Irinotecan|irinotecan|mesh-list
82824740|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82824741|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824742|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82824743|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82824744|NCT00127036|Growth Substances|growth substances|mesh-ancestor
82824745|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824746|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
82824747|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82824748|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
82824749|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824750|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82824751|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824752|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824753|NCT00259857|Alendronate|alendronate|mesh-list
82824754|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82824755|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824756|NCT01071681|Telmisartan|telmisartan|mesh-list
82824757|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82824758|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82824759|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82824760|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824761|NCT00203307|Olanzapine|olanzapine|mesh-list
82824762|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
82824763|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
82824764|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824765|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824766|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824767|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82824768|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82824769|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824770|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82824771|NCT00203307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82824772|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82824773|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824774|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824775|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824776|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
82824777|NCT00126568|Sorafenib|sorafenib|mesh-list
82824778|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824779|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82824780|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824781|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824783|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82824784|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
82824785|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
82824786|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824787|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
82824788|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824789|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
82824790|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824791|NCT00126490|Aldesleukin|aldesleukin|mesh-list
82824792|NCT00126490|Bevacizumab|bevacizumab|mesh-list
82824793|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82824794|NCT00126490|Interleukin-2|interleukin-2|mesh-list
82824795|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
82824797|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
82824798|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82824799|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
82824800|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824801|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83442914|NCT04894123|Trifluridine|trifluridine|mesh-list
82824802|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82824803|NCT00126490|Growth Substances|growth substances|mesh-ancestor
82824804|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824805|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
82824806|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
82824807|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82824808|NCT00126490|Analgesics|analgesics|mesh-ancestor
82824809|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
82824810|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824811|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82824812|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82824813|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
82824814|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824815|NCT00200967|Beclomethasone|beclomethasone|mesh-list
82824816|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82824817|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82824818|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
82824819|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824820|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824821|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82824822|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
82824823|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82824824|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82824825|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82824826|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
82824827|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824828|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824829|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82824830|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
82824831|NCT00200967|Hormones|hormones|mesh-ancestor
82824832|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82824833|NCT02533440|Anesthetics|anesthetics|mesh-list
82824834|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
82824835|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824836|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824837|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
82824838|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824839|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82824840|NCT00354432|Caseins|caseins|mesh-list
82824841|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82824842|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82824843|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824844|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824845|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824846|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824847|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82824848|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
82824849|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82824850|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
82824851|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
82824852|NCT00140140|Paclitaxel|paclitaxel|mesh-list
82824853|NCT00140140|Vinorelbine|vinorelbine|mesh-list
82824854|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82824855|NCT00140140|Trastuzumab|trastuzumab|mesh-list
82824856|NCT00140140|Lenograstim|lenograstim|mesh-list
82824857|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82824858|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824859|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
82824860|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
82824861|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
82824862|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824863|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82824864|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82824865|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
82824866|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824867|NCT00346398|Immunomodulating Agents|immunomodulating agents|mesh-list
82824868|NCT00346398|Immunologic Factors|immunologic factors|mesh-ancestor
82824869|NCT00346398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824870|NCT00346164|Doxorubicin|doxorubicin|mesh-list
82824871|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82824872|NCT00346164|Ifosfamide|ifosfamide|mesh-list
82824873|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82824874|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824875|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82824876|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824877|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824878|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824879|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82824880|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
82824882|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82824883|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824884|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82824885|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824886|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824887|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824888|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824889|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82824890|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82824891|NCT00114244|Gemcitabine|gemcitabine|mesh-list
82824892|NCT00114244|Sorafenib|sorafenib|mesh-list
82824893|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82824894|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
82824895|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824896|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824897|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82824898|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824899|NCT01054872|Vaccines|vaccines|mesh-list
82824900|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
82824901|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824902|NCT00337662|Olanzapine|olanzapine|mesh-list
82824903|NCT00337662|Risperidone|risperidone|mesh-list
82824904|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82824905|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
82824906|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824907|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824908|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824909|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82824910|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82824911|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82824912|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82824913|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82824914|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
82824915|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
82824916|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
82824917|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82824918|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82824919|NCT00337662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82824920|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82824921|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824922|NCT00138424|Cidofovir|cidofovir|mesh-list
82824923|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
82824924|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824925|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824926|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824927|NCT00368966|Vaccines|vaccines|mesh-list
82824928|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82824929|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
82824930|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824932|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82824933|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824934|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824935|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824936|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824937|NCT00337428|Vaccines|vaccines|mesh-list
82824938|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
82824939|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824940|NCT00235989|Interferons|interferons|mesh-list
82824941|NCT00235989|Interferon-beta|interferon-beta|mesh-list
82824942|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
82824943|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824944|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
82824945|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824946|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
82824947|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824948|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82824949|NCT00113386|Docetaxel|docetaxel|mesh-list
82824950|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824951|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
82824952|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
82824953|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
82824954|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824955|NCT00353262|Capecitabine|capecitabine|mesh-list
82824956|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
82824957|NCT00353262|Bevacizumab|bevacizumab|mesh-list
82824958|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82824959|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
82824960|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824961|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824962|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82824963|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82824964|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82824965|NCT00353262|Growth Substances|growth substances|mesh-ancestor
82824966|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824967|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
82824968|NCT00125164|Mecasermin|mecasermin|mesh-list
82824969|NCT00125164|Growth Substances|growth substances|mesh-ancestor
82824970|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824971|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
82824972|NCT03985410|Durlobactam|durlobactam|mesh-list
82824973|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82824974|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824975|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82824976|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82824977|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82824978|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824979|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824980|NCT03985410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82824981|NCT00136318|Ribavirin|ribavirin|mesh-list
82824982|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82824983|NCT00136318|Escitalopram|escitalopram|mesh-list
82824984|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
82824985|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82824986|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
82824987|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82824988|NCT00136318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82824989|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82824990|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82824991|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82824992|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
82824993|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82824994|NCT01058850|Rindopepimut|rindopepimut|mesh-list
82824995|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82824996|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82824997|NCT00136084|Cytarabine|cytarabine|mesh-list
82824998|NCT00136084|Dexamethasone|dexamethasone|mesh-list
82824999|NCT00136084|Prednisone|prednisone|mesh-list
82825000|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
82825001|NCT00136084|Methotrexate|methotrexate|mesh-list
82825002|NCT00136084|Etoposide|etoposide|mesh-list
82825003|NCT00136084|Vincristine|vincristine|mesh-list
82825004|NCT00136084|Daunorubicin|daunorubicin|mesh-list
82825005|NCT00136084|Asparaginase|asparaginase|mesh-list
82825006|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
82825007|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
82825008|NCT00136084|Cladribine|cladribine|mesh-list
82825010|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82825011|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
82825012|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825013|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825014|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82825015|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
82825016|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825017|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825018|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82825019|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825020|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
82825021|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
82825022|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825023|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82825024|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
82825025|NCT00136084|Hormones|hormones|mesh-ancestor
82825026|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825027|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82825028|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82825029|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
82825030|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82825031|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82825032|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
82825033|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
82825034|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825035|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82825036|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82825037|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825038|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825039|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825040|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
82825041|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825042|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825043|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825044|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825045|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82825046|NCT00136084|Analgesics|analgesics|mesh-ancestor
82825047|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
82825048|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825049|NCT00136084|Immunotoxins|immunotoxins|mesh-ancestor
82825050|NCT00136084|Immunoconjugates|immunoconjugates|mesh-ancestor
82825051|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
82825052|NCT00364832|Hematinics|hematinics|mesh-ancestor
82825053|NCT00235755|Ezogabine|ezogabine|mesh-list
82825054|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
82825055|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82825056|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825057|NCT01581879|Ziprasidone|ziprasidone|mesh-list
82825058|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82825059|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
82825060|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825061|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825062|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825063|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82825064|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82825065|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82825066|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82825067|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82825068|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
82825069|NCT00337194|Gemcitabine|gemcitabine|mesh-list
82825070|NCT00337194|Doxorubicin|doxorubicin|mesh-list
82825071|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82825072|NCT00337194|Vinorelbine|vinorelbine|mesh-list
82825073|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82825074|NCT00337194|Antibodies|antibodies|mesh-list
82825075|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82825076|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
82825077|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825078|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82825079|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
82825080|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825081|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825082|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82825083|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825084|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825085|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825086|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825087|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825088|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825089|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825090|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825092|NCT00337194|Immunoconjugates|immunoconjugates|mesh-ancestor
82825093|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
82825094|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825095|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825096|NCT01074333|Cetuximab|cetuximab|mesh-list
82825097|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825098|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825099|NCT00385736|Adalimumab|adalimumab|mesh-list
82825100|NCT00385736|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82825101|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825102|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825104|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825105|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825106|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82825107|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82825108|NCT01057212|Growth Substances|growth substances|mesh-ancestor
82825109|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825110|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
82825111|NCT03988452|Ritonavir|ritonavir|mesh-list
82825112|NCT03988452|Darunavir|darunavir|mesh-list
82825113|NCT03988452|Tenofovir|tenofovir|mesh-list
82825114|NCT03988452|Lamivudine|lamivudine|mesh-list
82825115|NCT03988452|Zidovudine|zidovudine|mesh-list
82825116|NCT03988452|Dolutegravir|dolutegravir|mesh-list
82825117|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82825118|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82825119|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
82825120|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825121|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825122|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82825123|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82825124|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
82825125|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825126|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82825127|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82825128|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82825129|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82825130|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
82825131|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82825132|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82825133|NCT01048580|Capecitabine|capecitabine|mesh-list
82825134|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82825135|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
82825136|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825137|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825138|NCT00195819|Adalimumab|adalimumab|mesh-list
82825139|NCT00195819|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82825140|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825141|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825142|NCT00527735|Paclitaxel|paclitaxel|mesh-list
82825143|NCT00527735|Carboplatin|carboplatin|mesh-list
82825144|NCT00527735|Ipilimumab|ipilimumab|mesh-list
82825145|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825146|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825147|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825148|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825149|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825150|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825151|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825152|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82825153|NCT00336492|Infliximab|infliximab|mesh-list
82825154|NCT00336492|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82825155|NCT00336492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825156|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
82825157|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82825158|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825159|NCT00194025|Valproic Acid|valproic acid|mesh-list
82825160|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
82825162|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825163|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
82825164|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825165|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825166|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
82825167|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82825168|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82825169|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82825170|NCT00521339|Apremilast|apremilast|mesh-list
82825171|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82825172|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82825173|NCT00521339|Analgesics|analgesics|mesh-ancestor
82825174|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
82825175|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825176|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825177|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825178|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825179|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82825180|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82825181|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825182|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825183|NCT00363896|Bromides|bromides|mesh-list
82825184|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
82825185|NCT00527423|Aflibercept|aflibercept|mesh-list
82825186|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82825187|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82825188|NCT00527423|Growth Substances|growth substances|mesh-ancestor
82825189|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825190|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
82825191|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825192|NCT00527111|Fluorouracil|fluorouracil|mesh-list
82825193|NCT00527111|Cetuximab|cetuximab|mesh-list
82825194|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
82825195|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825196|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82825197|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825198|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82825199|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
82825200|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825201|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825202|NCT00336024|Leucovorin|leucovorin|mesh-list
82825203|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
82825204|NCT00336024|Thiotepa|thiotepa|mesh-list
82825205|NCT00336024|Carboplatin|carboplatin|mesh-list
82825206|NCT00336024|Methotrexate|methotrexate|mesh-list
82825207|NCT00336024|Etoposide|etoposide|mesh-list
82825208|NCT00336024|Vincristine|vincristine|mesh-list
82825209|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
82825210|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
82825211|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82825212|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
82825213|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825214|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825215|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82825216|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
82825217|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825218|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825219|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82825220|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82825221|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
82825222|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82825223|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82825224|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
82825225|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
82825226|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825227|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82825228|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82825229|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825230|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825231|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825232|NCT00336024|Antidotes|antidotes|mesh-ancestor
82825233|NCT00336024|Protective Agents|protective agents|mesh-ancestor
82825234|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
82825235|NCT00336024|Vitamins|vitamins|mesh-ancestor
82825237|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825238|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825239|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825240|NCT00384956|Azacitidine|azacitidine|mesh-list
82825241|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82825242|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
82825243|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825244|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825245|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825246|NCT04090697|Oxandrolone|oxandrolone|mesh-list
82825247|NCT04090697|Androgens|androgens|mesh-ancestor
82825248|NCT04090697|Hormones|hormones|mesh-ancestor
82825249|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825250|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825251|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
82825252|NCT00367640|Immunomodulating Agents|immunomodulating agents|mesh-list
82825253|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
82825254|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825255|NCT01325220|Baclofen|baclofen|mesh-list
82825256|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82825257|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825258|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82825259|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825260|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82825261|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
82825262|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
82825263|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825264|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825265|NCT00367484|Interferons|interferons|mesh-list
82825266|NCT00367484|Interferon-beta|interferon-beta|mesh-list
82825267|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
82825268|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825269|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
82825270|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825271|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
82825272|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825273|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82825274|NCT00526799|Sorafenib|sorafenib|mesh-list
82825275|NCT00526799|Topotecan|topotecan|mesh-list
82825276|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825277|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82825278|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825279|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825280|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82825281|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825282|NCT01059084|Valacyclovir|valacyclovir|mesh-list
82825283|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
82825284|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825285|NCT03992144|Amoxicillin|amoxicillin|mesh-list
82825286|NCT03992144|Metronidazole|metronidazole|mesh-list
82825287|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82825288|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825289|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82825290|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82825291|NCT02534870|Ritonavir|ritonavir|mesh-list
82825292|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82825293|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82825294|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
82825295|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825296|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825297|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82825298|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82825299|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
82825300|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825301|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82825302|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82825303|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
82825304|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
82825305|NCT03992066|Hematinics|hematinics|mesh-ancestor
82825306|NCT03986268|Vitamin D|vitamin d|mesh-list
82825307|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
82825308|NCT03986268|Vitamins|vitamins|mesh-ancestor
82825309|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
82825310|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825311|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82825312|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82825313|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
82825314|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82825315|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
82825316|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825317|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825318|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82825319|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
82825320|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825321|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825322|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82825323|NCT01259648|Remifentanil|remifentanil|mesh-list
82825324|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82825325|NCT01259648|Narcotics|narcotics|mesh-ancestor
82825326|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82825327|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825328|NCT01259648|Analgesics|analgesics|mesh-ancestor
82825329|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
82825330|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825331|NCT01049048|Vitamin D|vitamin d|mesh-list
82825332|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
82825333|NCT01049048|Vitamins|vitamins|mesh-ancestor
82825334|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
82825335|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825336|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82825337|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82825338|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82825339|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
82825340|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825341|NCT01044992|Levodopa|levodopa|mesh-list
82825342|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82825343|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82825344|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
82825345|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825346|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825347|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825348|NCT00520403|Interferons|interferons|mesh-list
82825349|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
82825350|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
82825351|NCT00520403|Bevacizumab|bevacizumab|mesh-list
82825352|NCT00520403|Vinblastine|vinblastine|mesh-list
82825353|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825354|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825355|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82825356|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82825357|NCT00520403|Growth Substances|growth substances|mesh-ancestor
82825358|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825359|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
82825360|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
82825361|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825362|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
82825363|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825364|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825365|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825366|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825367|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825368|NCT00520013|Paclitaxel|paclitaxel|mesh-list
82825369|NCT00520013|Bevacizumab|bevacizumab|mesh-list
82825370|NCT00520013|Carboplatin|carboplatin|mesh-list
82825371|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82825372|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825373|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825374|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825375|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825376|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825377|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825378|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825379|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82825380|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82825381|NCT00520013|Growth Substances|growth substances|mesh-ancestor
82825382|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825383|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
82825384|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82825385|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825386|NCT00526097|Bisacodyl|bisacodyl|mesh-list
82825387|NCT00526097|Cathartics|cathartics|mesh-ancestor
82825388|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82825390|NCT00525785|Leucovorin|leucovorin|mesh-list
82825391|NCT00525785|Folic Acid|folic acid|mesh-list
82825392|NCT00525785|Fluorouracil|fluorouracil|mesh-list
82825393|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
82825394|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
82825395|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
82825396|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825397|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83442935|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
82825398|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825399|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82825400|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
82825401|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825402|NCT00525785|Antidotes|antidotes|mesh-ancestor
82825403|NCT00525785|Protective Agents|protective agents|mesh-ancestor
82825404|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
82825405|NCT00525785|Vitamins|vitamins|mesh-ancestor
82825406|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
82825407|NCT00525785|Hematinics|hematinics|mesh-ancestor
82825408|NCT00525161|Sorafenib|sorafenib|mesh-list
82825409|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825410|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82825411|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825412|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825414|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82825415|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825416|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
82825417|NCT00135694|Hormones|hormones|mesh-ancestor
82825418|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825419|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825420|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82825421|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825422|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825423|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825424|NCT00524459|Docetaxel|docetaxel|mesh-list
82825425|NCT00524459|Doxorubicin|doxorubicin|mesh-list
82825426|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82825427|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825428|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825429|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825430|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825431|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825432|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82825433|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825434|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825435|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825436|NCT00519623|Insulin|insulin|mesh-list
82825437|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82825438|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825439|NCT01076530|Temozolomide|temozolomide|mesh-list
82825440|NCT01076530|Vorinostat|vorinostat|mesh-list
82825441|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82825442|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
82825443|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825444|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825445|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82825446|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825447|NCT00519077|Gefitinib|gefitinib|mesh-list
82825448|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825449|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82825450|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825451|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825452|NCT00124618|Cetuximab|cetuximab|mesh-list
82825453|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825454|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825455|NCT00124072|Folic Acid|folic acid|mesh-list
82825456|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
82825457|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
82825458|NCT00124072|Simvastatin|simvastatin|mesh-list
82825459|NCT00124072|Vitamins|vitamins|mesh-ancestor
82825460|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
82825461|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825462|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82825463|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82825464|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
82825465|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825467|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82825468|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825469|NCT00124072|Hematinics|hematinics|mesh-ancestor
82825470|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
82825471|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
82825473|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
82825474|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825475|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
82825476|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825477|NCT01080352|Protective Agents|protective agents|mesh-ancestor
82825478|NCT00524303|Paclitaxel|paclitaxel|mesh-list
82825479|NCT00524303|Trastuzumab|trastuzumab|mesh-list
82825480|NCT00524303|Lapatinib|lapatinib|mesh-list
82825481|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825482|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825483|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825484|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825485|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825486|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825487|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825488|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82825489|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825490|NCT04461041|Empagliflozin|empagliflozin|mesh-list
82825491|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82825492|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825493|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82825494|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825496|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
82825497|NCT00335556|Carboplatin|carboplatin|mesh-list
82825498|NCT00335556|Doxorubicin|doxorubicin|mesh-list
82825499|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82825500|NCT00335556|Irinotecan|irinotecan|mesh-list
82825501|NCT00335556|Etoposide|etoposide|mesh-list
82825502|NCT00335556|Vincristine|vincristine|mesh-list
82825503|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82825504|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
82825505|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825506|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825507|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82825508|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
82825509|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825510|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825511|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82825512|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82825513|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825514|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825515|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825516|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82825517|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825518|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825519|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825520|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825521|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82825522|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825523|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82825524|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82825525|NCT00518687|Vaccines|vaccines|mesh-list
82825526|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
82825527|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825528|NCT00134056|Prednisone|prednisone|mesh-list
82825529|NCT00134056|Docetaxel|docetaxel|mesh-list
82825530|NCT00134056|Atrasentan|atrasentan|mesh-list
82825531|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825532|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825533|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825534|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825535|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825536|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825537|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
82825538|NCT00134056|Hormones|hormones|mesh-ancestor
82825539|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825540|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825541|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82825542|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82825543|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82825545|NCT00518531|Alendronate|alendronate|mesh-list
82825546|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82825547|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825548|NCT01326442|Vitamin D|vitamin d|mesh-list
82825549|NCT01326442|Vitamins|vitamins|mesh-ancestor
82825550|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
82825551|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825552|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82825553|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
82825554|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82825555|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
82825556|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825557|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825558|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82825559|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
82825560|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
82825561|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82825562|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
82825563|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825564|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825565|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
82825566|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825568|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825569|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825570|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82825571|NCT00345540|Carboplatin|carboplatin|mesh-list
82825572|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825573|NCT00335322|Ritonavir|ritonavir|mesh-list
82825574|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82825575|NCT00335322|Tenofovir|tenofovir|mesh-list
82825576|NCT00335322|Emtricitabine|emtricitabine|mesh-list
82825577|NCT00335322|Zidovudine|zidovudine|mesh-list
82825578|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82825579|NCT00335322|Abacavir|abacavir|mesh-list
82825580|NCT00335322|Efavirenz|efavirenz|mesh-list
82825581|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82825582|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82825583|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
82825584|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825585|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825586|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82825587|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82825588|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
82825589|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825590|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82825591|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82825592|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82825593|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82825594|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
82825595|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82825596|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82825597|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82825598|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82825599|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82825600|NCT01059396|Propranolol|propranolol|mesh-list
82825601|NCT01059396|Carvedilol|carvedilol|mesh-list
82825602|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82825603|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82825604|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
82825605|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825606|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825607|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825608|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82825609|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82825610|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
82825611|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
82825612|NCT01059396|Protective Agents|protective agents|mesh-ancestor
82825613|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82825614|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82825615|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82825616|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82825617|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82825618|NCT01059552|Vorinostat|vorinostat|mesh-list
82825619|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825620|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82825621|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825622|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825623|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
82825624|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82825625|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825626|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
82825627|NCT03755765|Amoxicillin|amoxicillin|mesh-list
82825628|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
82825629|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
82825630|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82825631|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82825632|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825633|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82825634|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825635|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825636|NCT01061112|Tolbutamide|tolbutamide|mesh-list
82825637|NCT01061112|Fluconazole|fluconazole|mesh-list
82825638|NCT01061112|Ketoprofen|ketoprofen|mesh-list
82825639|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
82825640|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
82825641|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825642|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82825643|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82825644|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825645|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825646|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82825647|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
82825648|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825649|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825650|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82825651|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82825652|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82825653|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82825654|NCT01061112|Analgesics|analgesics|mesh-ancestor
82825655|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
82825656|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825657|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825658|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825659|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82825660|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82825661|NCT01061190|Propranolol|propranolol|mesh-list
82825662|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82825663|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82825664|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
82825665|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825666|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825667|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825668|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82825669|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82825670|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
82825671|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82825672|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825673|NCT00517829|Docetaxel|docetaxel|mesh-list
82825674|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
82825675|NCT00517829|Cetuximab|cetuximab|mesh-list
82825676|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825677|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825678|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825679|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825680|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825681|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825682|NCT00343512|Docetaxel|docetaxel|mesh-list
82825683|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825684|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825685|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825686|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825687|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825688|NCT00334542|Simvastatin|simvastatin|mesh-list
82825689|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82825690|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82825691|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
82825692|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825693|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82825694|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82825695|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825696|NCT00112294|Paclitaxel|paclitaxel|mesh-list
82825697|NCT00112294|Docetaxel|docetaxel|mesh-list
82825698|NCT00112294|Carboplatin|carboplatin|mesh-list
82825699|NCT00112294|Cetuximab|cetuximab|mesh-list
82825700|NCT00112294|Taxane|taxane|mesh-list
82825701|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825702|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825703|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825704|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825705|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825706|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825707|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825708|NCT00235443|Lacosamide|lacosamide|mesh-list
82825709|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
82825710|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82825711|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82825712|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82825713|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825714|NCT00234039|Gemcitabine|gemcitabine|mesh-list
82825715|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82825717|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825718|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825719|NCT02531451|Aspirin|aspirin|mesh-list
82825720|NCT02531451|Ibuprofen|ibuprofen|mesh-list
82825721|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82825722|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82825723|NCT02531451|Analgesics|analgesics|mesh-ancestor
82825724|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
82825725|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825726|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825727|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825728|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825729|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82825730|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825731|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825732|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82825733|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82825734|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82825735|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
82825736|NCT01073007|Simvastatin|simvastatin|mesh-list
82825737|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82825738|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82825739|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
82825740|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825741|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82825742|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82825743|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825744|NCT03741621|Psyllium|psyllium|mesh-list
82825745|NCT03741621|Cathartics|cathartics|mesh-ancestor
82825746|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82825747|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
82825748|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
82825749|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82825750|NCT00323622|Amodiaquine|amodiaquine|mesh-list
82825751|NCT00323622|Vaccines|vaccines|mesh-list
82825752|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
82825753|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825754|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
82825755|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82825756|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82825757|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825758|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82825759|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825760|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825761|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82825762|NCT01326039|Bupivacaine|bupivacaine|mesh-list
82825763|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
82825764|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
82825765|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82825766|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825767|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
82825768|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825769|NCT01057758|Simvastatin|simvastatin|mesh-list
82825770|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82825771|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82825772|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
82825773|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825774|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82825775|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82825776|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825777|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
82825778|NCT00186537|Fenofibrate|fenofibrate|mesh-list
82825779|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82825780|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825781|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82825782|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
82825783|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825784|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82825785|NCT03968835|Bacitracin|bacitracin|mesh-list
82825786|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82825787|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825788|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82825789|NCT00322842|Plerixafor|plerixafor|mesh-list
82825790|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82825791|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82825792|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
82825793|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825795|NCT04726085|Indomethacin|indomethacin|mesh-list
82825796|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82825797|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82825798|NCT04726085|Analgesics|analgesics|mesh-ancestor
82825799|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
82825800|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825801|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825802|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825803|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82825804|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82825805|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825806|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825807|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
82825808|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
82825809|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82825810|NCT00255723|Carboplatin|carboplatin|mesh-list
82825811|NCT00255723|Etoposide|etoposide|mesh-list
82825812|NCT00255723|Ifosfamide|ifosfamide|mesh-list
82825813|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825814|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825815|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825816|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825817|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825818|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825819|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82825820|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
82825821|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
82825822|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82825823|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82825824|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825825|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
82825826|NCT01060176|Coagulants|coagulants|mesh-ancestor
82825827|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
82825828|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82825829|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825830|NCT03982992|Blinatumomab|blinatumomab|mesh-list
82825831|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825832|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
82825833|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825834|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825835|NCT03695471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82825836|NCT03695471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825837|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82825838|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
82825839|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82825841|NCT00517361|Carboplatin|carboplatin|mesh-list
82825842|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825843|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825844|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82825845|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82825846|NCT00517361|Growth Substances|growth substances|mesh-ancestor
82825847|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825848|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
82825849|NCT00516893|Natalizumab|natalizumab|mesh-list
82825850|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
82825851|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825852|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
82825853|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825854|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825855|NCT03657641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82825856|NCT03657641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825857|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
82825858|NCT03649841|Prednisone|prednisone|mesh-list
82825859|NCT03649841|Cortisone|cortisone|mesh-list
82825860|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
82825861|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
82825862|NCT03649841|Hormones|hormones|mesh-list
82825863|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82825864|NCT03649841|Androgens|androgens|mesh-list
82825865|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
82825866|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825867|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
82825868|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825869|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825870|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82825871|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825872|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82825873|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825874|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825875|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
82825876|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82825877|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
82825878|NCT03649841|Protective Agents|protective agents|mesh-ancestor
82825879|NCT03649841|Vitamins|vitamins|mesh-ancestor
82825880|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
82825881|NCT03649841|Estrogens|estrogens|mesh-ancestor
82825882|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
82825883|NCT00522431|Testosterone|testosterone|mesh-list
82825884|NCT00522431|Androgens|androgens|mesh-ancestor
82825885|NCT00522431|Hormones|hormones|mesh-ancestor
82825886|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825887|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825888|NCT00185211|Interferons|interferons|mesh-list
82825889|NCT00185211|Interferon-beta|interferon-beta|mesh-list
82825890|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
82825891|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825892|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
82825893|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82825894|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
82825895|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825896|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82825897|NCT00516737|Rizatriptan|rizatriptan|mesh-list
82825898|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82825899|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
82825900|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825901|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825902|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825903|NCT03540485|Melatonin|melatonin|mesh-list
82825904|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
82825905|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825906|NCT03540485|Protective Agents|protective agents|mesh-ancestor
82825907|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825908|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82825909|NCT00132730|MK 0873|mk 0873|mesh-list
82825910|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82825911|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82825912|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825913|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825914|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
82825915|NCT02531841|Dexamethasone|dexamethasone|mesh-list
82825917|NCT02531841|Etoposide|etoposide|mesh-list
82825918|NCT02531841|Ifosfamide|ifosfamide|mesh-list
82825919|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
82825920|NCT02531841|Thiotepa|thiotepa|mesh-list
82825921|NCT02531841|Carmustine|carmustine|mesh-list
82825922|NCT02531841|Busulfan|busulfan|mesh-list
82825923|NCT02531841|BB 1101|bb 1101|mesh-list
82825924|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82825925|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
82825926|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
82825927|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825928|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825929|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82825930|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
82825931|NCT02531841|Hormones|hormones|mesh-ancestor
82825932|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82825933|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82825934|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825935|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
82825936|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825937|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825938|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825939|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825940|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825941|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82825942|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
82825943|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82825944|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82825945|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
82825946|NCT01074411|Carboplatin|carboplatin|mesh-list
82825947|NCT01074411|Bortezomib|bortezomib|mesh-list
82825948|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825949|NCT03973047|Ondansetron|ondansetron|mesh-list
82825950|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
82825951|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
82825952|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82825953|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825954|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82825955|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
82825956|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
82825957|NCT03973047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82825958|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82825959|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
82825960|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82825961|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825962|NCT00522275|Lacosamide|lacosamide|mesh-list
82825963|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
82825964|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82825965|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82825966|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82825967|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825968|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82825969|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82825970|NCT01074567|Protective Agents|protective agents|mesh-ancestor
82825971|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82825972|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82825973|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
82825974|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825975|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
82825976|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
82825977|NCT03519971|Paclitaxel|paclitaxel|mesh-list
82825978|NCT03519971|Etoposide|etoposide|mesh-list
82825979|NCT03519971|Cisplatin|cisplatin|mesh-list
82825980|NCT03519971|Carboplatin|carboplatin|mesh-list
82825981|NCT03519971|Pemetrexed|pemetrexed|mesh-list
82825982|NCT03519971|Durvalumab|durvalumab|mesh-list
82825983|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82825984|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825985|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
82825986|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
82825987|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
82825988|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82825989|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82825990|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82825991|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825992|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82825993|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82825994|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82825995|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
82825996|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82825997|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
82825998|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82825999|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826000|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82826001|NCT00340704|Tamsulosin|tamsulosin|mesh-list
82826002|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82826003|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82826004|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82826005|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
82826006|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826007|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826008|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826009|NCT00340704|Urological Agents|urological agents|mesh-ancestor
82826010|NCT00132496|Rabeprazole|rabeprazole|mesh-list
82826011|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82826012|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826013|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82826014|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826015|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826016|NCT01080586|Cyclosporine|cyclosporine|mesh-list
82826017|NCT01080586|Cyclosporins|cyclosporins|mesh-list
82826018|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482536|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826019|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826020|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826021|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
82826022|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826023|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
82826024|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826025|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
82826026|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826027|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82826029|NCT00231777|Aprepitant|aprepitant|mesh-list
82826030|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
82826031|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
82826032|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826033|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826034|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826035|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
82826036|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
82826037|NCT00231777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82826038|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82826039|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
82826040|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826041|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826042|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82826043|NCT01076842|Insulin|insulin|mesh-list
82826044|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82826045|NCT01076842|Exenatide|exenatide|mesh-list
82826046|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
82826047|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82826048|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826049|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82826050|NCT01076842|Incretins|incretins|mesh-ancestor
82826051|NCT01076842|Hormones|hormones|mesh-ancestor
82826052|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826053|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
82826054|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826055|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
82826056|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826057|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826058|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82826059|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
82826060|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826061|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826062|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82826063|NCT00231465|Docetaxel|docetaxel|mesh-list
82826064|NCT00231465|Gefitinib|gefitinib|mesh-list
82826065|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826066|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
82826067|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
82826068|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
82826069|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826070|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826071|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826073|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82826074|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
82826075|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82826076|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826077|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82826078|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826079|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
82826080|NCT00254163|Rituximab|rituximab|mesh-list
82826081|NCT00254163|Fludarabine|fludarabine|mesh-list
82826082|NCT00254163|Pentostatin|pentostatin|mesh-list
82826083|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826084|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
82826085|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826086|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826087|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82826088|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
82826089|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826090|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826091|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82826092|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82826093|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82826094|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826096|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82826097|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826098|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82826099|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
82826100|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826101|NCT00182637|Bortezomib|bortezomib|mesh-list
82826102|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826103|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82826104|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
82826105|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82826106|NCT00122278|Dexamethasone|dexamethasone|mesh-list
82826107|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82826108|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
82826109|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
82826110|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826111|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826112|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826113|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
82826114|NCT00122278|Hormones|hormones|mesh-ancestor
82826115|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826116|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82826117|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826118|NCT00182091|Hormones|hormones|mesh-list
82826119|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826120|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826121|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82826122|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
82826123|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826124|NCT01072071|Furosemide|furosemide|mesh-list
82826125|NCT01072071|Diuretics|diuretics|mesh-ancestor
82826126|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
82826127|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826128|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82826129|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826130|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826131|NCT00181155|Allopurinol|allopurinol|mesh-list
82826132|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
82826133|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826134|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826135|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
82826136|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826137|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82826138|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
82826139|NCT00181155|Protective Agents|protective agents|mesh-ancestor
82826140|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826141|NCT00322452|Paclitaxel|paclitaxel|mesh-list
82826143|NCT00322452|Gefitinib|gefitinib|mesh-list
82826144|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82826145|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826146|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
82826147|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
82826148|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
82826149|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826150|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826151|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826152|NCT00110812|Aldesleukin|aldesleukin|mesh-list
82826153|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826154|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82826155|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82826156|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
82826157|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826158|NCT00516269|Methylphenidate|methylphenidate|mesh-list
82826159|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82826160|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826161|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82826162|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82826163|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826164|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826165|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
82826166|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826167|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82826168|NCT00228813|Lenograstim|lenograstim|mesh-list
82826169|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82826170|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
82826171|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826173|NCT00322374|Epothilones|epothilones|mesh-list
82826174|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82826175|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826176|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82826177|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82826178|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826179|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826180|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
82826181|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
82826182|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
82826183|NCT00174447|Ziprasidone|ziprasidone|mesh-list
82826184|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82826185|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
82826186|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826187|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826188|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826189|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82826190|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82826191|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826192|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826193|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82826194|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
82826195|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
82826196|NCT00321984|Lansoprazole|lansoprazole|mesh-list
82826197|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82826198|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826199|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82826200|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826201|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826202|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
82826203|NCT01060488|Hormones|hormones|mesh-ancestor
82826204|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826205|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826206|NCT01060566|Ivacaftor|ivacaftor|mesh-list
82826207|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82826208|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826209|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826210|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
82826211|NCT02533284|Analgesics|analgesics|mesh-ancestor
82826212|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
82826213|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826214|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826215|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
82826217|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82826218|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
82826219|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82826220|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826221|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826222|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82826223|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
82826224|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82826225|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
82826226|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82826227|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
82826228|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826229|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826230|NCT00110266|Deferasirox|deferasirox|mesh-list
82826231|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82826232|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
82826233|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
82826234|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826235|NCT00366548|Vaccines|vaccines|mesh-list
82826236|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82826237|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
82826238|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826239|NCT01074645|Tenofovir|tenofovir|mesh-list
82826240|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
82826241|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826242|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82826243|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82826244|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826245|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826246|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82826247|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82826248|NCT00132028|Vorinostat|vorinostat|mesh-list
82826249|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826250|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82826251|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826252|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826253|NCT01045304|Carboplatin|carboplatin|mesh-list
82826254|NCT01045304|Gemcitabine|gemcitabine|mesh-list
82826255|NCT01045304|Iniparib|iniparib|mesh-list
82826256|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826257|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82826258|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
82826259|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826260|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82826261|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826262|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82826263|NCT01080742|Bisoprolol|bisoprolol|mesh-list
82826264|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82826265|NCT01080742|Diuretics|diuretics|mesh-ancestor
82826266|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
82826267|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826268|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82826269|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826270|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826271|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
82826272|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
82826273|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826274|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82826275|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82826276|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82826277|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
82826278|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826279|NCT00131248|Metoclopramide|metoclopramide|mesh-list
82826280|NCT00131248|Ranitidine|ranitidine|mesh-list
82826281|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82826282|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
82826283|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
82826284|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826285|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826286|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826287|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82826288|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82826289|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
82826290|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826291|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826292|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82826293|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82826294|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
82826295|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
82826297|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
82826298|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826299|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
82826300|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
82826301|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826302|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82826303|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82826304|NCT01049204|Maraviroc|maraviroc|mesh-list
82826305|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82826306|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82826307|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826308|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82826309|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82826310|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
82826311|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826312|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82826313|NCT00096382|Aldesleukin|aldesleukin|mesh-list
82826314|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
82826315|NCT00096382|Fludarabine|fludarabine|mesh-list
82826316|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
82826317|NCT00096382|Interleukin-2|interleukin-2|mesh-list
82826318|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826319|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
82826320|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826321|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826322|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82826323|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
82826324|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826325|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826326|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82826327|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82826328|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
82826329|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82826330|NCT00096382|Analgesics|analgesics|mesh-ancestor
82826331|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
82826332|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826333|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82826334|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82826335|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
82826336|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826337|NCT00384332|Olanzapine|olanzapine|mesh-list
82826338|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
82826339|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
82826340|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826341|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826342|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826343|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82826344|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82826345|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826346|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826347|NCT00384332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82826348|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82826349|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826350|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826351|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826352|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
82826353|NCT00096226|Paclitaxel|paclitaxel|mesh-list
82826354|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82826355|NCT00096226|Carboplatin|carboplatin|mesh-list
82826356|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82826357|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826358|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
82826359|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
82826360|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
82826361|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826362|NCT01078714|Bumetanide|bumetanide|mesh-list
82826363|NCT01078714|Diuretics|diuretics|mesh-ancestor
82826364|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
82826365|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826366|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82826367|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826368|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826369|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
82826370|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82826371|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
82826372|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826373|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826374|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82826375|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
82826376|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82826377|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
82826378|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826379|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826380|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82826381|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
82826382|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
82826383|NCT03964324|Protective Agents|protective agents|mesh-ancestor
82826384|NCT01082848|Aripiprazole|aripiprazole|mesh-list
82826385|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
82826386|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826387|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82826388|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82826389|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826390|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826391|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
82826392|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
82826393|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826394|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826395|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82826396|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82826397|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
82826398|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82826399|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82826400|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82826401|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82826402|NCT01082926|Aldesleukin|aldesleukin|mesh-list
82826403|NCT01082926|Interleukin-2|interleukin-2|mesh-list
82826404|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826405|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82826406|NCT01082926|Analgesics|analgesics|mesh-ancestor
82826407|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
82826408|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826409|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826410|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82826411|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82826412|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
82826413|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826414|NCT03962920|Tigecycline|tigecycline|mesh-list
82826415|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82826416|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826417|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82826418|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826419|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826420|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82826421|NCT01078870|Escitalopram|escitalopram|mesh-list
82826422|NCT01078870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82826423|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82826424|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826425|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826426|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826427|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
82826428|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826429|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826430|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
82826431|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826432|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82826433|NCT01078870|Analgesics|analgesics|mesh-ancestor
82826434|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
82826435|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
82826436|NCT00105196|Aripiprazole|aripiprazole|mesh-list
82826438|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826439|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82826440|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82826441|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826442|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826443|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
82826444|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
82826445|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826446|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826447|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82826448|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82826449|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
82826450|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82826451|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82826452|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82826453|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82826454|NCT00104572|Vitamin D|vitamin d|mesh-list
82826455|NCT00104572|Anastrozole|anastrozole|mesh-list
82826456|NCT00104572|Calcium|calcium|mesh-list
82826457|NCT00104572|Testosterone|testosterone|mesh-list
82826458|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82826459|NCT00104572|Vitamins|vitamins|mesh-ancestor
82826460|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
82826461|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826462|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82826463|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82826464|NCT00104572|Androgens|androgens|mesh-ancestor
82826465|NCT00104572|Hormones|hormones|mesh-ancestor
82826466|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826467|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82826468|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826469|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82826470|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826471|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826472|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82826473|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
82826474|NCT00514943|Cetuximab|cetuximab|mesh-list
82826475|NCT00514943|Afatinib|afatinib|mesh-list
82826476|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82826477|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826478|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826479|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826480|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826481|NCT00103402|Alfuzosin|alfuzosin|mesh-list
82826482|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82826483|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82826484|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82826485|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
82826486|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826487|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826488|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826489|NCT00103402|Urological Agents|urological agents|mesh-ancestor
82826490|NCT00095836|Gefitinib|gefitinib|mesh-list
82826491|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826492|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826493|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826494|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826495|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
82826496|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82826497|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
82826498|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826499|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826500|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82826501|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
82826502|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
82826503|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82826504|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
82826505|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826506|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826507|NCT03330821|Cytarabine|cytarabine|mesh-list
82826508|NCT03330821|Idarubicin|idarubicin|mesh-list
82826509|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82826510|NCT03330821|Pevonedistat|pevonedistat|mesh-list
82826511|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82826512|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
82826513|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826514|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826515|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
82826516|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826517|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826518|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
82826519|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826520|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82826521|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82826522|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82826523|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
82826524|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82826525|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82826526|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82826527|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82826528|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826529|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826530|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
82826531|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826532|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826533|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82826534|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826535|NCT03235505|Nicotine|nicotine|mesh-list
82826536|NCT03235505|Varenicline|varenicline|mesh-list
82826537|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82826538|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
82826539|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826540|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826541|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82826542|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82826543|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
82826544|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826545|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826546|NCT00251979|Esomeprazole|esomeprazole|mesh-list
82826547|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82826548|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826549|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82826550|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826551|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826552|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
82826553|NCT00511901|Hematinics|hematinics|mesh-ancestor
82826554|NCT04580147|Aflibercept|aflibercept|mesh-list
82826555|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82826556|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82826557|NCT04580147|Growth Substances|growth substances|mesh-ancestor
82826558|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826559|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
82826560|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826561|NCT03147287|Fulvestrant|fulvestrant|mesh-list
82826562|NCT03147287|Palbociclib|palbociclib|mesh-list
82826563|NCT03147287|Avelumab|avelumab|mesh-list
82826564|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82826565|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826566|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82826567|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82826568|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
82826569|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826570|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826571|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826572|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826573|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826574|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82826575|NCT00228423|Clopidogrel|clopidogrel|mesh-list
82826576|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82826577|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82826578|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82826579|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82826580|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
82826581|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826582|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826583|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826585|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
82826586|NCT00513695|Doxorubicin|doxorubicin|mesh-list
82826587|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82826588|NCT00513695|Sunitinib|sunitinib|mesh-list
82826589|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82826590|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826591|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
82826592|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
82826593|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
82826594|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826595|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826596|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
82826597|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826598|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826599|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82826600|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
82826601|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82826602|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82826603|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82826604|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82826605|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826606|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82826607|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82826608|NCT00513695|Growth Substances|growth substances|mesh-ancestor
82826609|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
82826610|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826611|NCT00162981|Clobazam|clobazam|mesh-list
82826612|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
82826613|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82826614|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82826615|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826616|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826617|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826618|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82826619|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
82826620|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
82826621|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826622|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826624|NCT00099268|Carbidopa|carbidopa|mesh-list
82826625|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82826626|NCT00099268|Entacapone|entacapone|mesh-list
82826627|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82826628|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82826629|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
82826630|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826631|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826632|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826633|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82826634|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826635|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82826636|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
82826637|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
82826638|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82826639|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
82826640|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82826641|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82826642|NCT00511355|Estradiol|estradiol|mesh-list
82826643|NCT00511355|Estrogens|estrogens|mesh-ancestor
82826644|NCT00511355|Hormones|hormones|mesh-ancestor
82826645|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826646|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826647|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82826648|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
82826649|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82826650|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82826651|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82826652|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82826653|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83442968|NCT00245063|Cediranib|cediranib|mesh-list
82826654|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82826655|NCT01083784|Valproic Acid|valproic acid|mesh-list
82826656|NCT01083784|Clonazepam|clonazepam|mesh-list
82826657|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
82826658|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826660|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
82826661|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826662|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826663|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
82826664|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82826665|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826666|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826667|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
82826668|NCT00095212|Testosterone|testosterone|mesh-list
82826669|NCT00095212|Androgens|androgens|mesh-ancestor
82826670|NCT00095212|Hormones|hormones|mesh-ancestor
82826671|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826672|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826673|NCT02834975|Paclitaxel|paclitaxel|mesh-list
82826674|NCT02834975|Carboplatin|carboplatin|mesh-list
82826675|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
82826676|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82826677|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826678|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
82826679|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
82826680|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
82826681|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826682|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82826683|NCT02834975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82826684|NCT00120874|Memantine|memantine|mesh-list
82826685|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82826686|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82826687|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
82826688|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826689|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826690|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826691|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82826692|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82826693|NCT00120250|Eszopiclone|eszopiclone|mesh-list
82826694|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82826695|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826696|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826697|NCT01081600|Trastuzumab|trastuzumab|mesh-list
82826698|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82826699|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826700|NCT01079338|Caffeine|caffeine|mesh-list
82826701|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82826702|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826703|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82826704|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826705|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826706|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82826707|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82826708|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
82826709|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826710|NCT00384176|Leucovorin|leucovorin|mesh-list
82826711|NCT00384176|Bevacizumab|bevacizumab|mesh-list
82826712|NCT00384176|Fluorouracil|fluorouracil|mesh-list
82826713|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
82826714|NCT00384176|Cediranib|cediranib|mesh-list
82826715|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82826716|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826717|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82826718|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82826719|NCT00384176|Growth Substances|growth substances|mesh-ancestor
82826720|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826721|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
82826722|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
83442973|NCT02151487|Dexamethasone|dexamethasone|mesh-list
82826723|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826724|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82826725|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826726|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
82826727|NCT00384176|Antidotes|antidotes|mesh-ancestor
82826728|NCT00384176|Protective Agents|protective agents|mesh-ancestor
82826729|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
82826730|NCT00384176|Vitamins|vitamins|mesh-ancestor
82826731|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
82826732|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826733|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826734|NCT00513305|Cytarabine|cytarabine|mesh-list
82826735|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
82826736|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82826737|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
82826738|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826739|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826740|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
82826741|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826742|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826743|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
82826744|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826745|NCT00513071|Saracatinib|saracatinib|mesh-list
82826746|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826747|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826748|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826749|NCT00510887|Dexamethasone|dexamethasone|mesh-list
82826750|NCT00510887|Rituximab|rituximab|mesh-list
82826751|NCT00510887|Fludarabine|fludarabine|mesh-list
82826752|NCT00510887|Bortezomib|bortezomib|mesh-list
82826753|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
82826754|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82826755|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826756|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
82826757|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826758|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826759|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82826760|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
82826761|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
82826762|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826763|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826764|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
82826765|NCT00510887|Hormones|hormones|mesh-ancestor
82826766|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826767|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82826768|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826769|NCT00510887|Analgesics|analgesics|mesh-ancestor
82826770|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
82826771|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82826772|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82826773|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826774|NCT01012349|Aspirin|aspirin|mesh-list
82826775|NCT01012349|Citric Acid|citric acid|mesh-list
82826776|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
82826777|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82826778|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82826779|NCT01012349|Analgesics|analgesics|mesh-ancestor
82826780|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
82826781|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826782|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826783|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82826784|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826785|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82826786|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82826787|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826788|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82826789|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82826790|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826791|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
82826792|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
82826793|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82826794|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
82826795|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
82826796|NCT00358826|Atreleuton|atreleuton|mesh-list
82826797|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82826798|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826799|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826800|NCT01009541|Pregabalin|pregabalin|mesh-list
82826801|NCT01009541|Analgesics|analgesics|mesh-ancestor
82826802|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
82826803|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826804|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826805|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
82826806|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82826807|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826808|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826809|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82826810|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82826811|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82826812|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826813|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82826814|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
82826815|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826816|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82826817|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826818|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826819|NCT01009697|Codeine|codeine|mesh-list
82826820|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82826821|NCT01009697|Narcotics|narcotics|mesh-ancestor
82826822|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826823|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826824|NCT01009697|Analgesics|analgesics|mesh-ancestor
82826825|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
82826826|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826827|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
82826828|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
82826829|NCT01009853|Codeine|codeine|mesh-list
82826830|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82826831|NCT01009853|Narcotics|narcotics|mesh-ancestor
82826832|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826833|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826834|NCT01009853|Analgesics|analgesics|mesh-ancestor
82826835|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
82826836|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826837|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
82826838|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
82826839|NCT00506285|Methylphenidate|methylphenidate|mesh-list
82826840|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82826841|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826842|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82826843|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82826844|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82826845|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826846|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
82826847|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826848|NCT00506129|Fludarabine|fludarabine|mesh-list
82826849|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
82826850|NCT00506129|Melphalan|melphalan|mesh-list
82826851|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
82826852|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82826853|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826854|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82826855|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
82826856|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826857|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82826858|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
82826859|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826860|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82826861|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
82826862|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82826863|NCT00358670|Infliximab|infliximab|mesh-list
82826864|NCT00358670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82826865|NCT00358670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83442979|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
82826866|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
82826867|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826868|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826869|NCT01010087|Oseltamivir|oseltamivir|mesh-list
82826870|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
82826871|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82826872|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826873|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826874|NCT00505661|Letrozole|letrozole|mesh-list
82826875|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826876|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82826877|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82826878|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826879|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826880|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82826881|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
82826882|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826884|NCT00383786|Vofopitant|vofopitant|mesh-list
82826885|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
82826886|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
82826887|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826888|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826889|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826890|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82826891|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826892|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826893|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82826894|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
82826895|NCT05358977|Coagulants|coagulants|mesh-ancestor
82826896|NCT01010243|Pioglitazone|pioglitazone|mesh-list
82826897|NCT01010243|Dexamethasone|dexamethasone|mesh-list
82826898|NCT01010243|Lenalidomide|lenalidomide|mesh-list
82826899|NCT01010243|Treosulfan|treosulfan|mesh-list
82826900|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82826901|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
82826902|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
82826903|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826904|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826905|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82826906|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
82826907|NCT01010243|Hormones|hormones|mesh-ancestor
82826908|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82826909|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82826910|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826911|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
82826912|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82826913|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82826914|NCT01010243|Growth Substances|growth substances|mesh-ancestor
82826915|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
82826916|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82826917|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82826918|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
82826919|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826920|NCT00383708|Lanreotide|lanreotide|mesh-list
82826921|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82826922|NCT00504881|Brivaracetam|brivaracetam|mesh-list
82826923|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
82826925|NCT00504725|Analgesics|analgesics|mesh-ancestor
82826926|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
82826927|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826928|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826929|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82826930|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82826931|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
82826932|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
82826933|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82826934|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82826935|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82826936|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826937|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826938|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
82826939|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
82826940|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82826941|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
82826942|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826943|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826944|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82826945|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
82826946|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82826947|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82826948|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82826949|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
82826950|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826951|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826952|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82826953|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
82826954|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82826955|NCT05130788|Nicotine|nicotine|mesh-list
82826956|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82826957|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
82826958|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826959|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826960|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82826961|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82826962|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
82826963|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826964|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826966|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82826967|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82826968|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
82826969|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826970|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82826971|NCT00383162|Naproxen|naproxen|mesh-list
82826972|NCT00383162|Sumatriptan|sumatriptan|mesh-list
82826973|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82826974|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82826975|NCT00383162|Analgesics|analgesics|mesh-ancestor
82826976|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
82826977|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826978|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826979|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82826980|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826981|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
82826982|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82826983|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82826984|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82826985|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82826986|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82826987|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82826988|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
82826989|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82826990|NCT01052792|Naproxen|naproxen|mesh-list
82826991|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82826992|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82826993|NCT01052792|Analgesics|analgesics|mesh-ancestor
82826994|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
82826995|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82826996|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82826997|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82826998|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82826999|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
82827000|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82827001|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827002|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827003|NCT01052870|Finasteride|finasteride|mesh-list
82827004|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82827005|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82827006|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827007|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827008|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
82827009|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827010|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827011|NCT01052870|Urological Agents|urological agents|mesh-ancestor
82827012|NCT00358436|Bromides|bromides|mesh-list
82827013|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
82827014|NCT01053026|Olmesartan|olmesartan|mesh-list
82827015|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82827016|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82827017|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82827018|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827019|NCT01045538|Capecitabine|capecitabine|mesh-list
82827020|NCT01045538|Vorinostat|vorinostat|mesh-list
82827021|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827022|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827023|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
82827024|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827025|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82827026|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827027|NCT00361634|Etanercept|etanercept|mesh-list
82827028|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82827029|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82827030|NCT00361634|Analgesics|analgesics|mesh-ancestor
82827032|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827033|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827034|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827035|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827036|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82827037|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827038|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
82827039|NCT00357968|Clopidogrel|clopidogrel|mesh-list
82827040|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82827041|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82827042|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82827043|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82827044|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82827045|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
82827046|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827047|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827048|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827049|NCT00357656|Factor VIII|factor viii|mesh-list
82827050|NCT00357656|Coagulants|coagulants|mesh-ancestor
82827051|NCT00357500|Thalidomide|thalidomide|mesh-list
82827052|NCT00357500|Celecoxib|celecoxib|mesh-list
82827053|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
82827054|NCT00357500|Etoposide|etoposide|mesh-list
82827055|NCT00357500|Fenofibrate|fenofibrate|mesh-list
82827056|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827057|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
82827058|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827059|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827060|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82827061|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
82827062|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827063|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827064|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82827065|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82827066|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82827067|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82827068|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827069|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82827071|NCT00357500|Analgesics|analgesics|mesh-ancestor
82827072|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
82827073|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827074|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827075|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82827076|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82827077|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
82827078|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82827079|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827080|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82827081|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82827082|NCT00357500|Growth Substances|growth substances|mesh-ancestor
82827083|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
82827084|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82827085|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
82827086|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82827087|NCT00357110|Fulvestrant|fulvestrant|mesh-list
82827088|NCT00357110|Anastrozole|anastrozole|mesh-list
82827089|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82827090|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827091|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82827092|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82827093|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
82827094|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827095|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827096|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82827097|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82827098|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827099|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827100|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82827101|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82827102|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827103|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82827106|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827107|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
82827108|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827109|NCT00098722|Maraviroc|maraviroc|mesh-list
82827110|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82827111|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82827112|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827113|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82827114|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82827115|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
82827116|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827117|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82827118|NCT02531152|Latanoprost|latanoprost|mesh-list
82827119|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82827120|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82827121|NCT01084408|Paclitaxel|paclitaxel|mesh-list
82827122|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82827123|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82827124|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827125|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827126|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827127|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827128|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827129|NCT00098254|Sorafenib|sorafenib|mesh-list
82827130|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827131|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827132|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827133|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827134|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82827135|NCT00095056|Glipizide|glipizide|mesh-list
82827136|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827137|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827138|NCT00095056|Incretins|incretins|mesh-ancestor
82827139|NCT00095056|Hormones|hormones|mesh-ancestor
82827140|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827141|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82827142|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
82827143|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827144|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827145|NCT00098020|Isotretinoin|isotretinoin|mesh-list
82827146|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827148|NCT00381680|Cytarabine|cytarabine|mesh-list
82827149|NCT00381680|Dexamethasone|dexamethasone|mesh-list
82827150|NCT00381680|Prednisone|prednisone|mesh-list
82827151|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
82827152|NCT00381680|Doxorubicin|doxorubicin|mesh-list
82827153|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82827154|NCT00381680|Methotrexate|methotrexate|mesh-list
82827155|NCT00381680|Etoposide|etoposide|mesh-list
82827156|NCT00381680|Vincristine|vincristine|mesh-list
82827157|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
82827158|NCT00381680|Asparaginase|asparaginase|mesh-list
82827159|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
82827160|NCT00381680|Pegaspargase|pegaspargase|mesh-list
82827161|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
82827162|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827163|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
82827164|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827165|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827166|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82827167|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
82827168|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827169|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827170|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82827171|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827172|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
82827173|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
82827174|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827175|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82827176|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
82827177|NCT00381680|Hormones|hormones|mesh-ancestor
82827178|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827180|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82827181|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82827182|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82827183|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827184|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82827185|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
82827186|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82827187|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827188|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
82827189|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827190|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82827191|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82827192|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82827193|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
82827194|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827195|NCT00381680|Antidotes|antidotes|mesh-ancestor
82827196|NCT00381680|Protective Agents|protective agents|mesh-ancestor
82827197|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
82827198|NCT00381680|Vitamins|vitamins|mesh-ancestor
82827199|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
82827200|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827201|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827202|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827203|NCT03292250|Durvalumab|durvalumab|mesh-list
82827204|NCT03292250|Tremelimumab|tremelimumab|mesh-list
82827205|NCT03292250|Nintedanib|nintedanib|mesh-list
82827206|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82827207|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827208|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827209|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827210|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827211|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
82827212|NCT01053338|Promethazine|promethazine|mesh-list
82827213|NCT01053338|Ibuprofen|ibuprofen|mesh-list
82827214|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827215|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82827216|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82827217|NCT01053338|Analgesics|analgesics|mesh-ancestor
82827218|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
82827219|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827220|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827221|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827223|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82827224|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827225|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82827226|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82827227|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827228|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
82827229|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
82827230|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
82827231|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
83443004|NCT05318339|Trastuzumab|trastuzumab|mesh-list
82827232|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82827233|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82827234|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
82827235|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
82827236|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827237|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82827238|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
82827239|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827240|NCT01050374|Albendazole|albendazole|mesh-list
82827241|NCT01050374|Praziquantel|praziquantel|mesh-list
82827242|NCT01050374|Mebendazole|mebendazole|mesh-list
82827243|NCT01050374|Piperazine|piperazine|mesh-list
82827244|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
82827245|NCT01050374|DMP 777|dmp 777|mesh-list
82827246|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
82827247|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82827248|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827249|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
82827250|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82827251|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82827252|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827253|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827254|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827255|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827256|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827257|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
82827258|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827260|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82827261|NCT00360698|Metformin|metformin|mesh-list
82827262|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
82827263|NCT00360698|Glimepiride|glimepiride|mesh-list
82827264|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
82827265|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827266|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827267|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82827268|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827269|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
82827270|NCT03990194|Leuprolide|leuprolide|mesh-list
82827271|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82827272|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
82827273|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82827274|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827275|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82827276|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827277|NCT00380978|Narcotics|narcotics|mesh-list
82827278|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827279|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827280|NCT00380978|Analgesics|analgesics|mesh-ancestor
82827281|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
82827282|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827283|NCT00162123|Ipilimumab|ipilimumab|mesh-list
82827284|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82827285|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827286|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82827287|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827288|NCT00227721|Gemcitabine|gemcitabine|mesh-list
82827289|NCT00227721|Docetaxel|docetaxel|mesh-list
82827290|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827291|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
82827292|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827293|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827294|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827295|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827296|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827297|NCT01074723|Carotenoids|carotenoids|mesh-list
82827298|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
82827299|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827300|NCT01074723|Protective Agents|protective agents|mesh-ancestor
82827301|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827302|NCT01074801|Insulin|insulin|mesh-list
82827303|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82827304|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827305|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827306|NCT01074879|Caseins|caseins|mesh-list
82827307|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
82827308|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
82827309|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827310|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
82827311|NCT00226941|Promethazine|promethazine|mesh-list
82827312|NCT00226941|Capecitabine|capecitabine|mesh-list
82827313|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
82827314|NCT00226941|Cetuximab|cetuximab|mesh-list
82827315|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827316|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
82827317|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827318|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827319|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82827320|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82827321|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82827322|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827323|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827324|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
82827325|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
82827326|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
82827327|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827328|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
82827329|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
82827330|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82827331|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82827332|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
82827333|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
82827334|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827335|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82827336|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
82827337|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827338|NCT01075503|Ropivacaine|ropivacaine|mesh-list
82827339|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
82827340|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
82827341|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827342|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827343|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
82827344|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827345|NCT01075581|Epinephrine|epinephrine|mesh-list
82827346|NCT01075581|Racepinephrine|racepinephrine|mesh-list
82827347|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
82827348|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82827349|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82827350|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
82827351|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827352|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827353|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827354|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82827355|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82827356|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
82827357|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827358|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82827359|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
82827360|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
82827361|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
82827362|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82827363|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
82827364|NCT00356408|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82827365|NCT00356408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827366|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827367|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
82827368|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827369|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827370|NCT00509795|Ranibizumab|ranibizumab|mesh-list
82827371|NCT00509795|Aflibercept|aflibercept|mesh-list
82827372|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82827373|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82827374|NCT00509795|Growth Substances|growth substances|mesh-ancestor
82827375|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827376|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
82827377|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827380|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82827381|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827382|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82827383|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82827384|NCT00504257|Growth Substances|growth substances|mesh-ancestor
82827385|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827386|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
82827387|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827388|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827389|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827390|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827391|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
82827392|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827393|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827394|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827395|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827396|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82827397|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
82827398|NCT05358509|Hematinics|hematinics|mesh-ancestor
82827399|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
82827400|NCT00160641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82827401|NCT00160641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827402|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827403|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
82827404|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827405|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827406|NCT00493025|Paclitaxel|paclitaxel|mesh-list
82827407|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82827408|NCT00493025|Cisplatin|cisplatin|mesh-list
82827409|NCT00493025|Gefitinib|gefitinib|mesh-list
82827410|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82827411|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827413|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827414|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827415|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827416|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827417|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827418|NCT01075113|Sorafenib|sorafenib|mesh-list
82827419|NCT01075113|Vorinostat|vorinostat|mesh-list
82827420|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827421|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827422|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827423|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827424|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82827425|NCT01073319|Rivastigmine|rivastigmine|mesh-list
82827426|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82827427|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827428|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827429|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
82827430|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827431|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827432|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82827433|NCT01073319|Protective Agents|protective agents|mesh-ancestor
82827434|NCT00160563|Levocetirizine|levocetirizine|mesh-list
82827435|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82827436|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82827437|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
82827438|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
82827439|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827440|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827441|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827442|NCT01050452|Ivermectin|ivermectin|mesh-list
82827443|NCT01050452|Albendazole|albendazole|mesh-list
82827444|NCT01050452|Mebendazole|mebendazole|mesh-list
82827445|NCT01050452|Piperazine|piperazine|mesh-list
82827446|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
82827447|NCT01050452|DMP 777|dmp 777|mesh-list
82827448|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82827449|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827450|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
82827451|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
82827452|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82827453|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82827454|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827455|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827457|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827458|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827459|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
82827460|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827461|NCT00380588|Gemcitabine|gemcitabine|mesh-list
82827462|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827463|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827464|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
82827465|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827466|NCT00379808|Montelukast|montelukast|mesh-list
82827467|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82827468|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
82827469|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82827470|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
82827471|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827472|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827473|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82827474|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82827475|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827476|NCT03990038|Ropivacaine|ropivacaine|mesh-list
82827477|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
82827478|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
82827479|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827480|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827481|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
82827482|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827483|NCT00355784|Hormones|hormones|mesh-list
82827484|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827486|NCT02534636|Interferons|interferons|mesh-list
82827487|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
82827488|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
82827489|NCT02534636|Deucravacitinib|deucravacitinib|mesh-list
82827490|NCT02534636|Famotidine|famotidine|mesh-list
82827491|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827492|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
82827493|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827494|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
82827495|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827496|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82827497|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82827498|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82827499|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
82827500|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
82827501|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827502|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827503|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827504|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827505|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827506|NCT01053650|Acetaminophen|acetaminophen|mesh-list
82827507|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82827508|NCT01053650|Analgesics|analgesics|mesh-ancestor
82827509|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
82827510|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827511|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827512|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
82827513|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
82827514|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827515|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827516|NCT01050608|Ethanol|ethanol|mesh-list
82827517|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82827518|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827519|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827520|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827521|NCT01053806|Lenalidomide|lenalidomide|mesh-list
82827522|NCT01053806|Azacitidine|azacitidine|mesh-list
82827523|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
82827524|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827525|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82827526|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82827527|NCT01053806|Growth Substances|growth substances|mesh-ancestor
82827528|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
82827529|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827530|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827531|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
82827532|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827533|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827534|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
82827535|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827536|NCT01053884|Anidulafungin|anidulafungin|mesh-list
82827537|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
82827538|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827539|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82827540|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
82827541|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827542|NCT01010789|Modafinil|modafinil|mesh-list
82827543|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82827544|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827545|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82827546|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82827547|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82827548|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827549|NCT01015235|Ketorolac|ketorolac|mesh-list
82827550|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82827551|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82827552|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82827553|NCT01015235|Analgesics|analgesics|mesh-ancestor
82827554|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
82827555|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827556|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827557|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827559|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82827560|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827561|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827562|NCT00508157|Olanzapine|olanzapine|mesh-list
82827563|NCT00508157|Risperidone|risperidone|mesh-list
82827564|NCT00508157|Aripiprazole|aripiprazole|mesh-list
82827565|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82827566|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
82827567|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82827568|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
82827569|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827570|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827571|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827572|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82827573|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827574|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82827575|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82827576|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
82827577|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
82827578|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
82827579|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827580|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82827581|NCT00508157|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82827582|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82827583|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82827584|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
82827585|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
82827586|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82827587|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82827588|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82827589|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82827590|NCT04331717|Leuprolide|leuprolide|mesh-list
82827591|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82827592|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
82827593|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82827594|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827595|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82827596|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827597|NCT01015391|Azathioprine|azathioprine|mesh-list
82827598|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
82827599|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827600|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827601|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827602|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827603|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
82827604|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827605|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827606|NCT01010945|Paclitaxel|paclitaxel|mesh-list
82827607|NCT01010945|Gemcitabine|gemcitabine|mesh-list
82827608|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82827609|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82827610|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827611|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827612|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827613|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827614|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827615|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827616|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
82827617|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827618|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827619|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
82827620|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82827621|NCT00507689|Antibodies|antibodies|mesh-list
82827622|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
82827623|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827624|NCT00491387|Metoprolol|metoprolol|mesh-list
82827625|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82827626|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82827627|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
82827628|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
82827629|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827630|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827631|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82827632|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82827633|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82827634|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
82827635|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827636|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827637|NCT01011257|Clopidogrel|clopidogrel|mesh-list
82827638|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82827639|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82827640|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82827641|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82827642|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
82827643|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827644|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827645|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827646|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
82827647|NCT01015547|Infliximab|infliximab|mesh-list
82827648|NCT01015547|Methotrexate|methotrexate|mesh-list
82827649|NCT01015547|Naltrexone|naltrexone|mesh-list
82827650|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82827651|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
82827652|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82827653|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827654|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827655|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
82827656|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827657|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827658|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827659|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827660|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82827661|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827662|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
82827663|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82827664|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82827665|NCT01015547|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82827666|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827667|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82827668|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827669|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82827670|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82827671|NCT01015547|Analgesics|analgesics|mesh-ancestor
82827672|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
82827673|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827674|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82827675|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82827676|NCT00491075|Gemcitabine|gemcitabine|mesh-list
82827677|NCT00491075|Pemetrexed|pemetrexed|mesh-list
82827678|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82827679|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
82827680|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827681|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827682|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827683|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82827684|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82827686|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
82827687|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82827688|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82827689|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82827690|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
82827691|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827692|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827693|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827694|NCT00507455|Urological Agents|urological agents|mesh-ancestor
82827695|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82827696|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82827697|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
82827698|NCT04275713|Metformin|metformin|mesh-list
82827699|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827700|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827701|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
82827702|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827703|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827704|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362075|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827705|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827706|NCT00490919|Buprenorphine|buprenorphine|mesh-list
82827707|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82827708|NCT00490919|Narcotics|narcotics|mesh-ancestor
82827709|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827710|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827711|NCT00490919|Analgesics|analgesics|mesh-ancestor
82827712|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
82827713|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827714|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82827715|NCT01015937|Losartan|losartan|mesh-list
82827716|NCT01015937|Enalapril|enalapril|mesh-list
82827717|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
82827718|NCT01015937|Giapreza|giapreza|mesh-list
82827719|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82827720|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
82827721|NCT01015937|Turmeric extract|turmeric extract|mesh-list
82827722|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82827723|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82827724|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82827725|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82827726|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827727|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
82827728|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827729|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
82827730|NCT01015937|Protective Agents|protective agents|mesh-ancestor
82827731|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827732|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82827733|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82827734|NCT01012193|Cilostazol|cilostazol|mesh-list
82827735|NCT01012193|Clopidogrel|clopidogrel|mesh-list
82827736|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82827737|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82827738|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82827739|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82827740|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
82827741|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827742|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827743|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827744|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82827745|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
82827746|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827747|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82827748|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
82827749|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82827750|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82827751|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
82827752|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82827753|NCT01012193|Protective Agents|protective agents|mesh-ancestor
82827754|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82827755|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82827756|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827757|NCT00503399|Teriparatide|teriparatide|mesh-list
82827758|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
82827759|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82827760|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827761|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82827762|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82827763|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82827764|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827765|NCT00506519|Antithrombins|antithrombins|mesh-list
82827766|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
82827767|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82827768|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
82827769|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827770|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827771|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
82827772|NCT00503009|Fluticasone|fluticasone|mesh-list
82827774|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82827775|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827776|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82827777|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
82827778|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827779|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827780|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82827781|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
82827782|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827783|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82827784|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82827785|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82827786|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82827787|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
82827788|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827789|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827790|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
82827791|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82827792|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827793|NCT00160251|Ribavirin|ribavirin|mesh-list
82827794|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82827795|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
82827796|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827797|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
82827798|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827799|NCT01075425|Bortezomib|bortezomib|mesh-list
82827800|NCT01075425|Belinostat|belinostat|mesh-list
82827801|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827802|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82827803|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827804|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827805|NCT00378014|Everolimus|everolimus|mesh-list
82827806|NCT00378014|Basiliximab|basiliximab|mesh-list
82827807|NCT00378014|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82827808|NCT00378014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827809|NCT00378014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827810|NCT00378014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827811|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827812|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
82827813|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827814|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827815|NCT00485303|Prednisone|prednisone|mesh-list
82827816|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
82827817|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827818|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
82827819|NCT00485303|Hormones|hormones|mesh-ancestor
82827820|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83443022|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
82827821|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827822|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82827823|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827824|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82827825|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827826|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827828|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82827829|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
82827830|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82827831|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827832|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827833|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827834|NCT01016249|Epinephrine|epinephrine|mesh-list
82827835|NCT01016249|Racepinephrine|racepinephrine|mesh-list
82827836|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
82827837|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82827838|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82827839|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
82827840|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827841|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827842|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827843|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82827844|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82827845|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
82827846|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827847|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82827848|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
82827849|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
82827850|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
82827851|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82827852|NCT00377858|Insulin|insulin|mesh-list
82827853|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82827854|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
82827856|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827857|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827858|NCT00502775|Fluticasone|fluticasone|mesh-list
82827859|NCT00502775|Xhance|xhance|mesh-list
82827860|NCT00502775|Fexofenadine|fexofenadine|mesh-list
82827861|NCT00502775|Terfenadine|terfenadine|mesh-list
82827862|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827863|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82827864|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
82827865|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82827866|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827867|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82827868|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
82827869|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
82827870|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82827871|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82827872|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82827873|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
82827874|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
82827875|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827876|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827877|NCT01013675|Vaccines|vaccines|mesh-list
82827878|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
82827879|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827880|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82827881|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82827882|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827883|NCT01054118|Incretins|incretins|mesh-ancestor
82827884|NCT01054118|Hormones|hormones|mesh-ancestor
82827885|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827886|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82827887|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
82827888|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827889|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827890|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82827891|NCT01050842|Bicalutamide|bicalutamide|mesh-list
82827892|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
82827893|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
82827894|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827895|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827896|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827897|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82827898|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82827899|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82827900|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82827901|NCT00485069|Levodopa|levodopa|mesh-list
82827902|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82827903|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82827904|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
82827905|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827906|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827907|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827908|NCT03989336|Manganese|manganese|mesh-list
82827909|NCT03989336|Paclitaxel|paclitaxel|mesh-list
82827910|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82827911|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82827912|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82827913|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827914|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
82827915|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
82827916|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
82827917|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827918|NCT03989336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82827919|NCT03989336|Trace Elements|trace elements|mesh-ancestor
82827920|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
82827921|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827922|NCT00355082|Lamotrigine|lamotrigine|mesh-list
82827923|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
82827924|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82827925|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82827926|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827927|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82827929|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82827930|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82827931|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82827932|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82827933|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82827934|NCT00502307|Tivozanib|tivozanib|mesh-list
82827935|NCT00502307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827936|NCT00502307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827937|NCT00502307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827938|NCT00484679|Triamcinolone|triamcinolone|mesh-list
82827939|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82827940|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82827941|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82827942|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82827943|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
82827944|NCT00484679|Hormones|hormones|mesh-ancestor
82827945|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827946|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827947|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827948|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
82827949|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827950|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827951|NCT00377312|Hormones|hormones|mesh-list
82827952|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
82827953|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827954|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827955|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82827956|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
82827957|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
82827958|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82827959|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82827960|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827961|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83443026|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
82827962|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827963|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82827964|NCT00376688|Sirolimus|sirolimus|mesh-list
82827965|NCT00376688|Temsirolimus|temsirolimus|mesh-list
82827966|NCT00376688|MTOR Inhibitors|mtor inhibitors|mesh-list
82827967|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82827968|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82827969|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82827970|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827971|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
82827972|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82827973|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
82827974|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827975|NCT00376688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82827977|NCT00376688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827978|NCT00376220|Riluzole|riluzole|mesh-list
82827979|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
82827980|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82827981|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82827982|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82827983|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827984|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827985|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82827986|NCT00376220|Protective Agents|protective agents|mesh-ancestor
82827987|NCT00375752|Letrozole|letrozole|mesh-list
82827988|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82827989|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82827990|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82827991|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82827992|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82827993|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82827994|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
82827995|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82827996|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82827997|NCT00484289|Abatacept|abatacept|mesh-list
82827998|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82827999|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828000|NCT00484289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82828001|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828002|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828003|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
82828004|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828005|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828006|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82828007|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828008|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828009|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828010|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828011|NCT01013909|Terbinafine|terbinafine|mesh-list
82828012|NCT01013909|Bifonazole|bifonazole|mesh-list
82828013|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
82828014|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828015|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828016|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828017|NCT01013987|Ritonavir|ritonavir|mesh-list
82828018|NCT01013987|Darunavir|darunavir|mesh-list
82828019|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
82828020|NCT01013987|Maraviroc|maraviroc|mesh-list
82828021|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82828022|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82828023|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828024|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828025|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828026|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82828027|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82828028|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
82828029|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828030|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82828031|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82828032|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82828033|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82828034|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82828035|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82828036|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82828037|NCT01019291|Formaldehyde|formaldehyde|mesh-list
82828038|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
82828039|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828040|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
82828041|NCT01019447|Triclosan|triclosan|mesh-list
82828042|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82828043|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82828044|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82828045|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82828046|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
82828047|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828048|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82828050|NCT00490529|Rituximab|rituximab|mesh-list
82828051|NCT00490529|Vaccines|vaccines|mesh-list
82828052|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
82828053|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828054|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828055|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828056|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82828057|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
82828058|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828059|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828060|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82828061|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82828062|NCT00333840|Interferons|interferons|mesh-list
82828063|NCT00333840|Cytarabine|cytarabine|mesh-list
82828064|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
82828065|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
82828066|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
82828067|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828068|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
82828069|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828070|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828071|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
82828072|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828073|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828074|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
82828075|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828076|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828077|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828078|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
82828079|NCT01019603|Tazarotene|tazarotene|mesh-list
82828080|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
82828081|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
82828082|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
82828083|NCT01019603|Vitamins|vitamins|mesh-ancestor
82828084|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
82828085|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828086|NCT00321906|Sirolimus|sirolimus|mesh-list
82828087|NCT00321906|Azathioprine|azathioprine|mesh-list
82828088|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828089|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828090|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82828091|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828092|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
82828093|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828094|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
82828095|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828096|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828097|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
82828098|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828099|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828100|NCT00339144|Dasatinib|dasatinib|mesh-list
82828101|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828102|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828103|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828104|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828105|NCT00321828|Leucovorin|leucovorin|mesh-list
82828106|NCT00321828|Bevacizumab|bevacizumab|mesh-list
82828107|NCT00321828|Fluorouracil|fluorouracil|mesh-list
82828108|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
82828109|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
82828110|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82828111|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828112|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82828113|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82828114|NCT00321828|Growth Substances|growth substances|mesh-ancestor
82828115|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828116|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
82828117|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
82828118|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828119|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828120|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828121|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
82828122|NCT00321828|Antidotes|antidotes|mesh-ancestor
82828123|NCT00321828|Protective Agents|protective agents|mesh-ancestor
82828124|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
82828125|NCT00321828|Vitamins|vitamins|mesh-ancestor
82828126|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
82828127|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82828128|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82828129|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828130|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828131|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
82828132|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828133|NCT01061658|Vaccines|vaccines|mesh-list
82828134|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
82828135|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828136|NCT01058382|Progesterone|progesterone|mesh-list
82828137|NCT01058382|Progestins|progestins|mesh-ancestor
82828138|NCT01058382|Hormones|hormones|mesh-ancestor
82828139|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828140|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828141|NCT01061814|Mipomersen|mipomersen|mesh-list
82828142|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82828143|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82828144|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
82828145|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828146|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82828147|NCT00331422|Paclitaxel|paclitaxel|mesh-list
82828148|NCT00331422|Carboplatin|carboplatin|mesh-list
82828149|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82828150|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828151|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
82828152|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
82828153|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
82828154|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828155|NCT00331344|Prednisone|prednisone|mesh-list
82828156|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
82828157|NCT00331344|Epothilone B|epothilone b|mesh-list
82828158|NCT00331344|Epothilones|epothilones|mesh-list
82828159|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828160|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
82828161|NCT00331344|Hormones|hormones|mesh-ancestor
82828162|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828163|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828164|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82828165|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828166|NCT00331344|Analgesics|analgesics|mesh-ancestor
82828167|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
82828168|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828169|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82828170|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82828171|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828172|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828173|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
82828174|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
82828175|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
82828176|NCT00321672|Capsaicin|capsaicin|mesh-list
82828177|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
82828178|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
82828179|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
82828180|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828181|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828182|NCT00330174|Acamprosate|acamprosate|mesh-list
82828183|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82828184|NCT00320424|PENTA|penta|mesh-list
82828185|NCT00320424|Fondaparinux|fondaparinux|mesh-list
82828186|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82828187|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
82828188|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82828189|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828190|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828191|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828192|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
82828193|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82828194|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82828195|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
82828196|NCT00338286|Hematinics|hematinics|mesh-ancestor
82828197|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
82828198|NCT00329550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82828199|NCT00329550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828200|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828201|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
82828202|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828203|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828204|NCT00375674|Sunitinib|sunitinib|mesh-list
82828205|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828206|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82828207|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82828208|NCT00375674|Growth Substances|growth substances|mesh-ancestor
82828209|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828210|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
82828211|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828212|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828213|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828214|NCT03991910|Ramipril|ramipril|mesh-list
82828215|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82828216|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828217|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828218|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828219|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82828220|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
82828221|NCT00320190|Dasatinib|dasatinib|mesh-list
82828222|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828223|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828224|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828225|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828226|NCT02534402|Prednisone|prednisone|mesh-list
82828227|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828228|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
82828229|NCT02534402|Hormones|hormones|mesh-ancestor
82828230|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828231|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828232|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82828233|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828234|NCT00319956|Azithromycin|azithromycin|mesh-list
82828235|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828236|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828237|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82828238|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82828239|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828240|NCT01062048|Incretins|incretins|mesh-ancestor
82828241|NCT01062048|Hormones|hormones|mesh-ancestor
82828242|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828243|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82828244|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828245|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828246|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828247|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
82828248|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828249|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828250|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82828251|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828252|NCT03987698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82828253|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828254|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
82828255|NCT01054508|Niacin|niacin|mesh-list
82828256|NCT01054508|Niacinamide|niacinamide|mesh-list
82828257|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
82828258|NCT01054508|Vitamins|vitamins|mesh-ancestor
82828259|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
82828260|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828261|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82828262|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
82828263|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828264|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82828265|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
82828266|NCT00348686|Felodipine|felodipine|mesh-list
82828267|NCT00348686|Candesartan|candesartan|mesh-list
82828268|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
82828269|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82828270|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82828271|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82828272|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828273|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82828274|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82828275|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828276|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82828278|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
82828279|NCT00360230|Vaccines|vaccines|mesh-list
82828280|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
82828281|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828282|NCT03989024|Clomiphene|clomiphene|mesh-list
82828283|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82828284|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82828285|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
82828286|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828287|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828288|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82828289|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
82828290|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82828291|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82828292|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82828293|NCT03989024|Hormones|hormones|mesh-ancestor
82828294|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
82828295|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82828296|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828297|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
82828298|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82828299|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828300|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82828301|NCT03742232|Laxatives|laxatives|mesh-ancestor
82828302|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82828304|NCT00352664|Donepezil|donepezil|mesh-list
82828305|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82828306|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828307|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828308|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
82828309|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828310|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828311|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
82828312|NCT03991442|Amlodipine|amlodipine|mesh-list
82828313|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82828314|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82828315|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828316|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828317|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82828318|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828319|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
82828320|NCT03742310|Vitamin D|vitamin d|mesh-list
82828321|NCT03742310|Calcitriol|calcitriol|mesh-list
82828322|NCT03742310|Vitamins|vitamins|mesh-ancestor
82828323|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
82828324|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828325|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82828326|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82828327|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82828328|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828329|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828330|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82828331|NCT00490139|Trastuzumab|trastuzumab|mesh-list
82828332|NCT00490139|Lapatinib|lapatinib|mesh-list
82828333|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82828334|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828335|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828336|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828337|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828338|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
82828339|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82828340|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828341|NCT01051388|Rabeprazole|rabeprazole|mesh-list
82828342|NCT01051388|Gefarnate|gefarnate|mesh-list
82828343|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82828344|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82828345|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82828346|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828347|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828348|NCT00490061|Lapatinib|lapatinib|mesh-list
82828349|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828350|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828351|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828352|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828353|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
82828354|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
82828355|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82828356|NCT00483119|Antibodies|antibodies|mesh-list
82828357|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
82828358|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82828359|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828360|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
82828361|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828362|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828363|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82828364|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
82828365|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828366|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828367|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82828368|NCT01016639|Capecitabine|capecitabine|mesh-list
82828369|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
82828370|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828371|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
82828372|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828373|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828374|NCT00501293|Methylphenidate|methylphenidate|mesh-list
82828375|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82828376|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828377|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82828378|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82828379|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828380|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828381|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
82828382|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828383|NCT01014221|Prednisolone|prednisolone|mesh-list
82828384|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828385|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
82828386|NCT01014221|Hormones|hormones|mesh-ancestor
82828387|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828388|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828389|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82828390|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828391|NCT00482729|Metformin|metformin|mesh-list
82828392|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82828393|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82828394|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828395|NCT00482729|Incretins|incretins|mesh-ancestor
82828396|NCT00482729|Hormones|hormones|mesh-ancestor
82828397|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828398|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82828399|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828400|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828401|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828402|NCT00359762|Exenatide|exenatide|mesh-list
82828403|NCT00359762|Glimepiride|glimepiride|mesh-list
82828404|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82828405|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828406|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82828407|NCT00359762|Incretins|incretins|mesh-ancestor
82828408|NCT00359762|Hormones|hormones|mesh-ancestor
82828409|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828410|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82828411|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828412|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
82828413|NCT03988010|Amantadine|amantadine|mesh-list
82828414|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82828415|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82828416|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
82828417|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828418|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
82828419|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828420|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828421|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828422|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828423|NCT03988010|Analgesics|analgesics|mesh-ancestor
82828424|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
82828425|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828426|NCT01055522|Interleukin-2|interleukin-2|mesh-list
82828427|NCT01055522|Dacarbazine|dacarbazine|mesh-list
82828428|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828429|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828430|NCT01055522|Analgesics|analgesics|mesh-ancestor
82828431|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
82828432|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828433|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828434|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82828435|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
82828436|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828437|NCT03987152|Sirolimus|sirolimus|mesh-list
82828438|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828439|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828440|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82828441|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828442|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
82828443|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828444|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
82828445|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828446|NCT00347438|Capecitabine|capecitabine|mesh-list
82828447|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828448|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
82828449|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828450|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828451|NCT00329238|Warfarin|warfarin|mesh-list
82828453|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
82828454|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
83443057|NCT04382209|Meperidine|meperidine|mesh-list
82828455|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82828456|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828457|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828458|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828459|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82828460|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82828461|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82828462|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
82828463|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828464|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82828465|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82828466|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828467|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82828469|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82828470|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828471|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828472|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82828473|NCT00347360|Carvedilol|carvedilol|mesh-list
82828474|NCT00347360|Lisinopril|lisinopril|mesh-list
82828475|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82828476|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82828477|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
82828478|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828479|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828480|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828481|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82828482|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
82828483|NCT00347360|Protective Agents|protective agents|mesh-ancestor
82828484|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82828485|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828486|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82828487|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
82828488|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82828489|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82828490|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82828491|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828492|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828493|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82828494|NCT00319020|Bosentan|bosentan|mesh-list
82828495|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82828496|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82828497|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828498|NCT01056224|Remifentanil|remifentanil|mesh-list
82828499|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82828500|NCT01056224|Narcotics|narcotics|mesh-ancestor
82828501|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828502|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828503|NCT01056224|Analgesics|analgesics|mesh-ancestor
82828504|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
82828505|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828506|NCT03982680|Gemcitabine|gemcitabine|mesh-list
82828507|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828508|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
82828509|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828510|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828511|NCT00352118|Docetaxel|docetaxel|mesh-list
82828512|NCT00352118|Fluorouracil|fluorouracil|mesh-list
82828513|NCT00352118|Lenograstim|lenograstim|mesh-list
82828514|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828515|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
82828516|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
82828517|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
82828518|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828519|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
82828520|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828521|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828522|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
82828523|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828524|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82828526|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82828527|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82828528|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82828529|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828530|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82828531|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
82828532|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828533|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828534|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828535|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828536|NCT00350870|Disulfiram|disulfiram|mesh-list
82828537|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82828538|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82828539|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828540|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828541|NCT00350792|Carboplatin|carboplatin|mesh-list
82828542|NCT00350792|Pemetrexed|pemetrexed|mesh-list
82828543|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828544|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828545|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828546|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82828547|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82828548|NCT00317772|Topotecan|topotecan|mesh-list
82828549|NCT00317772|Gefitinib|gefitinib|mesh-list
82828550|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82828551|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82828552|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828553|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828554|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828555|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828556|NCT01325298|Riboflavin|riboflavin|mesh-list
82828557|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
82828558|NCT01325298|Vitamins|vitamins|mesh-ancestor
82828559|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
82828560|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828561|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82828562|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
82828563|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
82828564|NCT00350636|Oxybutynin|oxybutynin|mesh-list
82828565|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
82828566|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
82828567|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828568|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828569|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82828570|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82828571|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
82828572|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828573|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828574|NCT00350636|Urological Agents|urological agents|mesh-ancestor
82828575|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82828576|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828577|NCT01051544|Factor VIII|factor viii|mesh-list
82828578|NCT01051544|Coagulants|coagulants|mesh-ancestor
82828580|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
82828581|NCT01058720|Vitamins|vitamins|mesh-ancestor
82828582|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
82828583|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828584|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82828585|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82828586|NCT00346268|Parecoxib|parecoxib|mesh-list
82828587|NCT00346268|Morphine|morphine|mesh-list
82828588|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82828589|NCT00346268|Narcotics|narcotics|mesh-ancestor
82828590|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828591|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828592|NCT00346268|Analgesics|analgesics|mesh-ancestor
82828593|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
82828594|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828595|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82828596|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82828597|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828598|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828599|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82828600|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828601|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828602|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828603|NCT00327444|Aflibercept|aflibercept|mesh-list
82828604|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82828605|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82828606|NCT00327444|Growth Substances|growth substances|mesh-ancestor
82828607|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828608|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
82828609|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828610|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
82828611|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82828612|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828613|NCT03982134|Panobinostat|panobinostat|mesh-list
82828614|NCT03982134|Spartalizumab|spartalizumab|mesh-list
82828615|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828616|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82828617|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828618|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828619|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82828620|NCT03982134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82828621|NCT00337610|Metformin|metformin|mesh-list
82828622|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82828623|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82828624|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828625|NCT00337610|Incretins|incretins|mesh-ancestor
82828626|NCT00337610|Hormones|hormones|mesh-ancestor
82828627|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828628|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82828629|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
82828630|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828631|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828632|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82828633|NCT01062204|Laxatives|laxatives|mesh-ancestor
82828634|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82828635|NCT01062282|Iloprost|iloprost|mesh-list
82828636|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82828637|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
82828638|NCT03985280|Anesthetics|anesthetics|mesh-list
82828639|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
82828640|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828641|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828642|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
82828643|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828644|NCT01058876|Nicotine|nicotine|mesh-list
82828645|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82828646|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
82828647|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828648|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828649|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82828650|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82828651|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
82828652|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828653|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828654|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
82828655|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
82828656|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828657|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828658|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828659|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828660|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82828661|NCT01051934|Paclitaxel|paclitaxel|mesh-list
82828662|NCT01051934|Bevacizumab|bevacizumab|mesh-list
82828663|NCT01051934|Carboplatin|carboplatin|mesh-list
82828664|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82828665|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828666|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
82828667|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
82828668|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
82828669|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828670|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82828671|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82828672|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82828673|NCT01051934|Growth Substances|growth substances|mesh-ancestor
82828674|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828675|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
82828676|NCT01325168|Oxytocin|oxytocin|mesh-list
82828677|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
82828678|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82828679|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828680|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
82828681|NCT00316914|Calcium|calcium|mesh-list
82828682|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82828683|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828684|NCT00316914|Analgesics|analgesics|mesh-ancestor
82828685|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
82828686|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828687|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
82828688|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828689|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82828690|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
82828691|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82828692|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828693|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828694|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
82828695|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82828696|NCT00316602|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82828697|NCT00316602|Antiviral Agents|antiviral agents|mesh-ancestor
82828698|NCT00316602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828699|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
82828700|NCT00335972|Remifentanil|remifentanil|mesh-list
82828701|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82828702|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828703|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828704|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828705|NCT00335972|Analgesics|analgesics|mesh-ancestor
82828706|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
82828707|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828708|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82828709|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82828710|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82828711|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
82828712|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828713|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828714|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82828715|NCT00335972|Narcotics|narcotics|mesh-ancestor
82828716|NCT03983460|Betamethasone|betamethasone|mesh-list
82828717|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
82828718|NCT03983460|Clobetasol|clobetasol|mesh-list
82828719|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828720|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
82828721|NCT03983460|Hormones|hormones|mesh-ancestor
82828722|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82828723|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828725|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
82828726|NCT01056614|Methotrexate|methotrexate|mesh-list
82828727|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
82828728|NCT01056614|Fludarabine|fludarabine|mesh-list
82828729|NCT01056614|Busulfan|busulfan|mesh-list
82828730|NCT01056614|Tacrolimus|tacrolimus|mesh-list
82828731|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
82828732|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82828733|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
82828734|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82828735|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
82828736|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82828737|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828738|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828739|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
82828740|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828741|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828742|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
82828743|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828744|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82828745|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828746|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
82828747|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828748|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82828749|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82828750|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
82828751|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82828752|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82828753|NCT00346034|Pregabalin|pregabalin|mesh-list
82828754|NCT00346034|Analgesics|analgesics|mesh-ancestor
82828755|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
82828756|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828757|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828758|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
82828759|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82828760|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828761|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828762|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82828763|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82828764|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82828765|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828766|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82828767|NCT00345878|Vaccines|vaccines|mesh-list
82828768|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
82828769|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828770|NCT01059110|Salicylates|salicylates|mesh-list
82828771|NCT01059110|Imiquimod|imiquimod|mesh-list
82828772|NCT01059110|Fluorouracil|fluorouracil|mesh-list
82828773|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82828774|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
82828775|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828776|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828777|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
82828778|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
82828779|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828780|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828781|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828782|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82828783|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828784|NCT01059110|Analgesics|analgesics|mesh-ancestor
82828785|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
82828786|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828787|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828788|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828789|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82828790|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828791|NCT03991364|Methamphetamine|methamphetamine|mesh-list
82828792|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82828793|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828794|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
82828795|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
82828796|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828797|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
82828798|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828799|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828800|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
82828801|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82828802|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82828803|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828804|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82828805|NCT00335738|Carboplatin|carboplatin|mesh-list
82828806|NCT00335738|Etoposide|etoposide|mesh-list
82828807|NCT00335738|Vincristine|vincristine|mesh-list
82828808|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
82828809|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828810|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82828811|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82828812|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82828813|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828814|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828815|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
82828816|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
82828817|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
82828818|NCT02533076|Capsaicin|capsaicin|mesh-list
82828819|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
82828820|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
82828821|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
82828822|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828823|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828825|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828826|NCT01056926|Nicotine|nicotine|mesh-list
82828827|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82828828|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
82828829|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828830|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828831|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82828832|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82828833|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
82828834|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828835|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828836|NCT01059422|Lamivudine|lamivudine|mesh-list
82828837|NCT01059422|Abacavir|abacavir|mesh-list
82828838|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
82828839|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82828840|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82828841|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828842|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828843|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
82828844|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828845|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82828846|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82828847|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82828848|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82828849|NCT01052246|Clindamycin|clindamycin|mesh-list
82828850|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
82828851|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
82828852|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82828853|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828854|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828855|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82828856|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828857|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828858|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
82828859|NCT00334958|Rufinamide|rufinamide|mesh-list
82828860|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
82828861|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82828862|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82828863|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82828864|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828865|NCT00326898|Sorafenib|sorafenib|mesh-list
82828866|NCT00326898|Sunitinib|sunitinib|mesh-list
82828867|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828868|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82828869|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828870|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828871|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82828872|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82828873|NCT00326898|Growth Substances|growth substances|mesh-ancestor
82828874|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828875|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
82828876|NCT01062360|Aspirin|aspirin|mesh-list
82828877|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
82828878|NCT01062360|Ephedrine|ephedrine|mesh-list
82828879|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82828880|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828881|NCT01062360|Analgesics|analgesics|mesh-ancestor
82828882|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
82828883|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828884|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828885|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828886|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828887|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82828888|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82828889|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828890|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82828891|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82828892|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828893|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
82828894|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82828895|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
82828896|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82828897|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
82828898|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
82828899|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82828900|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82828901|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
82828902|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
82828903|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828905|NCT01063842|Tramadol|tramadol|mesh-list
82828906|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828907|NCT01063842|Analgesics|analgesics|mesh-ancestor
82828908|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
82828909|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828910|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828911|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
82828912|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82828913|NCT01063842|Narcotics|narcotics|mesh-ancestor
82828914|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828915|NCT01063920|Naproxen|naproxen|mesh-list
82828916|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82828917|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82828918|NCT01063920|Analgesics|analgesics|mesh-ancestor
82828919|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
82828920|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828921|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828922|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82828923|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82828924|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
82828925|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82828926|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828927|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828928|NCT01062516|Esomeprazole|esomeprazole|mesh-list
82828929|NCT01062516|Famotidine|famotidine|mesh-list
82828930|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82828931|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82828932|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82828933|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82828934|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828935|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82828936|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
82828937|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
82828938|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828939|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828940|NCT00334802|Paclitaxel|paclitaxel|mesh-list
82828941|NCT00334802|Gemcitabine|gemcitabine|mesh-list
82828942|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82828943|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828944|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
82828945|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
82828946|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
82828947|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828948|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82828949|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
82828950|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
82828951|NCT03985358|Narcotics|narcotics|mesh-ancestor
82828952|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828953|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828954|NCT03985358|Analgesics|analgesics|mesh-ancestor
82828955|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
82828956|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828957|NCT01052324|Remifentanil|remifentanil|mesh-list
82828958|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82828959|NCT01052324|Narcotics|narcotics|mesh-ancestor
82828960|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82828961|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828962|NCT01052324|Analgesics|analgesics|mesh-ancestor
82828963|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
82828964|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82828965|NCT01059890|Metronidazole|metronidazole|mesh-list
82828966|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
82828967|NCT01059890|Cefotaxime|cefotaxime|mesh-list
82828968|NCT01059890|Cefoxitin|cefoxitin|mesh-list
82828969|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82828970|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82828971|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82828972|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82828973|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82828974|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82828976|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828977|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828978|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82828979|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82828981|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82828982|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
82828983|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82828984|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828985|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828986|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
82828987|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82828988|NCT00307086|Bortezomib|bortezomib|mesh-list
82828989|NCT00307086|Melphalan|melphalan|mesh-list
82828990|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82828991|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82828992|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
82828993|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82828994|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82828995|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82828996|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
82828997|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82828998|NCT02533544|Tenofovir|tenofovir|mesh-list
82828999|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
82829000|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829001|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82829002|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82829003|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829004|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829005|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82829006|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82829007|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
82829008|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
82829009|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82829010|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82829011|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829012|NCT00325416|Melphalan|melphalan|mesh-list
82829013|NCT00325416|Topotecan|topotecan|mesh-list
82829014|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82829015|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
82829016|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829017|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829018|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82829019|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829020|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
82829021|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829022|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82829023|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82829024|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829025|NCT00314808|Dronabinol|dronabinol|mesh-list
82829026|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
82829027|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829028|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82829029|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82829031|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
82829032|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829033|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82829034|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82829035|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829036|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829037|NCT00314808|Hormones|hormones|mesh-ancestor
82829038|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829039|NCT01060514|Vinorelbine|vinorelbine|mesh-list
82829040|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82829041|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829042|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
82829043|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
82829044|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
82829045|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829046|NCT01061216|Insulin|insulin|mesh-list
82829047|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82829048|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829049|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829050|NCT00314574|Omalizumab|omalizumab|mesh-list
82829051|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82829052|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82829053|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
82829054|NCT01064154|Carvedilol|carvedilol|mesh-list
82829055|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82829056|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82829057|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
82829058|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829059|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829060|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829061|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82829062|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
82829063|NCT01064154|Protective Agents|protective agents|mesh-ancestor
82829064|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82829065|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829066|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82829067|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
82829068|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82829069|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82829070|NCT00314340|Acetaminophen|acetaminophen|mesh-list
82829071|NCT00314340|Morphine|morphine|mesh-list
82829072|NCT00314340|Hydrocodone|hydrocodone|mesh-list
82829073|NCT00314340|Phenobarbital|phenobarbital|mesh-list
82829074|NCT00314340|Amphetamine|amphetamine|mesh-list
82829075|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82829076|NCT00314340|Narcotics|narcotics|mesh-ancestor
82829077|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829078|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829079|NCT00314340|Analgesics|analgesics|mesh-ancestor
82829080|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
82829081|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829082|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82829083|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
82829084|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
82829085|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
82829086|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82829087|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
82829088|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
82829089|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
82829090|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829091|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829092|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
82829093|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82829094|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82829095|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829096|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82829097|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
82829098|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82829099|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82829100|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82829101|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
82829102|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
82829103|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82829104|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82829105|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82829106|NCT00306852|Mitomycins|mitomycins|mesh-list
82829107|NCT00306852|Mitomycin|mitomycin|mesh-list
82829108|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82829109|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829110|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
82829111|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83443092|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
82829112|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82829113|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829114|NCT00314262|Celecoxib|celecoxib|mesh-list
82829115|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82829116|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829117|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82829118|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829119|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829120|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82829121|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82829122|NCT00314262|Analgesics|analgesics|mesh-ancestor
82829123|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
82829124|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829125|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829126|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829127|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829128|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82829129|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82829130|NCT00333866|Pregabalin|pregabalin|mesh-list
82829131|NCT00333866|Analgesics|analgesics|mesh-ancestor
82829132|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
82829133|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829134|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829135|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
82829136|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82829137|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829138|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829139|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82829140|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82829141|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82829142|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829143|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82829144|NCT00324740|Vorinostat|vorinostat|mesh-list
82829145|NCT00324740|Isotretinoin|isotretinoin|mesh-list
82829146|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829147|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82829148|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829149|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829150|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
82829151|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
82829152|NCT00333788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82829153|NCT00333788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829154|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829155|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
82829156|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829157|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829158|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
82829159|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82829160|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82829161|NCT00332696|Prednisolone|prednisolone|mesh-list
82829162|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
82829163|NCT00332696|Octreotide|octreotide|mesh-list
82829164|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82829165|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
82829166|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829167|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
82829168|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
82829169|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829170|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829171|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82829172|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
82829173|NCT00332696|Hormones|hormones|mesh-ancestor
82829174|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829175|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82829176|NCT00332696|Protective Agents|protective agents|mesh-ancestor
82829177|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82829178|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829180|NCT00313716|Hematinics|hematinics|mesh-ancestor
82829181|NCT00313170|Fulvestrant|fulvestrant|mesh-list
83443097|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
82829182|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82829183|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829184|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82829185|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82829186|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
82829187|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829188|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829189|NCT00332462|Cyclosporine|cyclosporine|mesh-list
82829190|NCT00332462|Cyclosporins|cyclosporins|mesh-list
82829191|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829192|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829193|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829194|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
82829195|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829196|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
82829197|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829198|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
82829199|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829200|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82829202|NCT00324038|Buprenorphine|buprenorphine|mesh-list
82829203|NCT00324038|Codeine|codeine|mesh-list
82829204|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82829205|NCT00324038|Analgesics|analgesics|mesh-ancestor
82829206|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
82829207|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829208|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829209|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
82829210|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82829211|NCT00324038|Narcotics|narcotics|mesh-ancestor
82829212|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829213|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82829214|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
82829215|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
82829216|NCT03984110|Dexamethasone|dexamethasone|mesh-list
82829217|NCT03984110|Aflibercept|aflibercept|mesh-list
82829218|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829219|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
82829220|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
82829221|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829222|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829223|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82829224|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
82829225|NCT03984110|Hormones|hormones|mesh-ancestor
82829226|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829227|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82829228|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829229|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82829230|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82829231|NCT03984110|Growth Substances|growth substances|mesh-ancestor
82829232|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
82829233|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
82829234|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829235|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
82829236|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82829237|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82829238|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829239|NCT00159861|Urological Agents|urological agents|mesh-ancestor
82829240|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
82829241|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82829242|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829243|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829244|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829245|NCT00331760|Cisplatin|cisplatin|mesh-list
82829246|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829247|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82829248|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82829249|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829250|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
82829251|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829252|NCT00313014|Oxycodone|oxycodone|mesh-list
82829253|NCT00313014|Buprenorphine|buprenorphine|mesh-list
82829254|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82829255|NCT00313014|Narcotics|narcotics|mesh-ancestor
83443100|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829256|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829257|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829258|NCT00313014|Analgesics|analgesics|mesh-ancestor
82829259|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
82829260|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829261|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82829262|NCT01075659|Nicotine|nicotine|mesh-list
82829263|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82829264|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
82829265|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829266|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829267|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82829268|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82829269|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
82829270|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829271|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829272|NCT01077453|Letrozole|letrozole|mesh-list
82829274|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82829275|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82829276|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829277|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829278|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82829279|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
82829280|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829281|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829282|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
82829283|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829284|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
82829285|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829286|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829287|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82829288|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
82829289|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829290|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829291|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82829292|NCT00312858|Vaccines|vaccines|mesh-list
82829293|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82829294|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
82829295|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829296|NCT00156819|Fluticasone|fluticasone|mesh-list
82829297|NCT00156819|Xhance|xhance|mesh-list
82829298|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82829299|NCT00156819|Montelukast|montelukast|mesh-list
82829300|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829301|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82829302|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
82829303|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829304|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829305|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82829306|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
82829307|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
82829308|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82829309|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82829310|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82829311|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82829312|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
82829313|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829314|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829315|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82829316|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
82829317|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829318|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82829319|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82829320|NCT00224133|Silodosin|silodosin|mesh-list
82829321|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82829322|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82829323|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82829324|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
82829325|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829326|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829327|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829328|NCT00224133|Urological Agents|urological agents|mesh-ancestor
82829329|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
82829330|NCT00224055|Hematinics|hematinics|mesh-ancestor
82829332|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
82829333|NCT00150969|Vitamins|vitamins|mesh-ancestor
82829334|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
82829335|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829336|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82829337|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82829338|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829339|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
82829340|NCT00150969|Coagulants|coagulants|mesh-ancestor
82829341|NCT00150345|Voriconazole|voriconazole|mesh-list
82829342|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
82829343|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829344|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82829345|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82829347|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829348|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82829349|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
82829350|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829351|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829352|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82829353|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
82829354|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82829355|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
82829356|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82829357|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
82829358|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829359|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829360|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
82829361|NCT01077609|Fluticasone|fluticasone|mesh-list
82829362|NCT01077609|Xhance|xhance|mesh-list
82829363|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829364|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82829365|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
82829366|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829367|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829368|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82829369|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
82829370|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
82829371|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82829372|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
82829373|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
82829374|NCT00223977|Hematinics|hematinics|mesh-ancestor
82829375|NCT00148941|Vaccines|vaccines|mesh-list
82829376|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
82829377|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829378|NCT01073553|Cephalexin|cephalexin|mesh-list
82829379|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82829380|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829381|NCT00148317|Dexamethasone|dexamethasone|mesh-list
82829382|NCT00148317|Doxorubicin|doxorubicin|mesh-list
82829383|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82829384|NCT00148317|Bortezomib|bortezomib|mesh-list
82829385|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829386|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
82829387|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
82829388|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829389|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829390|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82829391|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
82829392|NCT00148317|Hormones|hormones|mesh-ancestor
82829393|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829394|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82829395|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829396|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82829397|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82829398|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82829399|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829400|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829401|NCT00323882|Ipilimumab|ipilimumab|mesh-list
82829402|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82829403|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829404|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82829405|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829407|NCT00331682|Alvocidib|alvocidib|mesh-list
83443102|NCT03378297|Metformin|metformin|mesh-list
82829408|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829409|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
82829410|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
82829411|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
82829412|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829413|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
82829414|NCT00331682|Growth Substances|growth substances|mesh-ancestor
82829415|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829416|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82829417|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829418|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82829419|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82829420|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82829421|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829422|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829423|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
82829424|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829425|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82829426|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82829427|NCT00331136|Artesunate|artesunate|mesh-list
82829428|NCT00331136|Pyronaridine|pyronaridine|mesh-list
82829429|NCT00331136|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
82829430|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
82829431|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82829432|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82829433|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829434|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829435|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
82829436|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
82829437|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82829438|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
82829439|NCT00330668|Mecasermin|mecasermin|mesh-list
82829440|NCT00330668|Growth Substances|growth substances|mesh-ancestor
82829441|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829442|NCT00306384|Alogliptin|alogliptin|mesh-list
82829443|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829444|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829445|NCT00306384|Incretins|incretins|mesh-ancestor
82829446|NCT00306384|Hormones|hormones|mesh-ancestor
82829447|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829448|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82829449|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
82829450|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829451|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829452|NCT01062906|Lidocaine|lidocaine|mesh-list
82829453|NCT01062906|Fentanyl|fentanyl|mesh-list
82829454|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
82829455|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
82829456|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829457|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829458|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
82829459|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829460|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82829461|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82829462|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82829463|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829464|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829465|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82829466|NCT01062906|Narcotics|narcotics|mesh-ancestor
82829467|NCT01062906|Analgesics|analgesics|mesh-ancestor
82829468|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82829469|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82829470|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
82829471|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82829472|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829473|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829474|NCT00305604|Incretins|incretins|mesh-ancestor
82829475|NCT00305604|Hormones|hormones|mesh-ancestor
82829476|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829477|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82829478|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
82829479|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829480|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829481|NCT01064232|Risperidone|risperidone|mesh-list
82829482|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82829483|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
82829484|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829485|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829486|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829487|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82829488|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82829489|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829490|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82829491|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82829492|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
82829493|NCT00501059|Aspirin|aspirin|mesh-list
82829494|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82829496|NCT00501059|Analgesics|analgesics|mesh-ancestor
82829497|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
82829498|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829499|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829500|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829501|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829502|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82829503|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82829504|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829505|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82829506|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82829507|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829508|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
82829509|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82829510|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
82829511|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829512|NCT00322868|Pioglitazone|pioglitazone|mesh-list
82829513|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829514|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829515|NCT01016717|Omeprazole|omeprazole|mesh-list
82829516|NCT01016717|Pantoprazole|pantoprazole|mesh-list
82829517|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82829518|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82829519|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82829520|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829521|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829522|NCT01016795|Lenograstim|lenograstim|mesh-list
82829523|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82829524|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
82829525|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829526|NCT00343382|Pilocarpine|pilocarpine|mesh-list
82829527|NCT00343382|Miotics|miotics|mesh-ancestor
82829528|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
82829529|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829530|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829531|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82829532|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82829533|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
82829534|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829535|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829536|NCT00481871|Vitamins|vitamins|mesh-list
82829537|NCT00481871|Folic Acid|folic acid|mesh-list
82829538|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
82829539|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
82829540|NCT00481871|Gemcitabine|gemcitabine|mesh-list
82829541|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
82829542|NCT00481871|Aminopterin|aminopterin|mesh-list
82829543|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
82829544|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829545|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82829546|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
82829547|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829548|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829549|NCT00481871|Hematinics|hematinics|mesh-ancestor
82829550|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82829551|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829552|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
82829553|NCT00329420|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82829554|NCT00329420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829555|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829556|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
82829557|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829558|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829559|NCT00329108|Olanzapine|olanzapine|mesh-list
82829560|NCT00329108|Ziprasidone|ziprasidone|mesh-list
82829561|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
82829562|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
82829563|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829564|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829565|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82829566|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82829567|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82829568|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829569|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82829570|NCT00329108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82829571|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82829572|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829573|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829574|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829575|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
82829576|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82829577|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82829578|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
82829579|NCT00329030|Rituximab|rituximab|mesh-list
82829580|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
82829581|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82829582|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829583|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
82829584|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829585|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829586|NCT00328562|Gefitinib|gefitinib|mesh-list
82829587|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829588|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82829589|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829590|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829591|NCT00328172|Metformin|metformin|mesh-list
82829592|NCT00328172|Linagliptin|linagliptin|mesh-list
82829593|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829594|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829595|NCT00328172|Incretins|incretins|mesh-ancestor
82829596|NCT00328172|Hormones|hormones|mesh-ancestor
82829597|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829598|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82829599|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
82829600|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829601|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829602|NCT01061372|Pregabalin|pregabalin|mesh-list
82829603|NCT01061372|Analgesics|analgesics|mesh-ancestor
82829604|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
82829605|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829606|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829607|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
82829608|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82829609|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829610|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829611|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82829612|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82829613|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82829614|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829615|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82829616|NCT00328094|Insulin|insulin|mesh-list
82829617|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82829618|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829619|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829620|NCT00295932|Prednisone|prednisone|mesh-list
82829621|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
82829622|NCT00295932|Rituximab|rituximab|mesh-list
82829623|NCT00295932|Bortezomib|bortezomib|mesh-list
82829624|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829625|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
82829626|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829627|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829628|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82829629|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
82829630|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829631|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829632|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82829633|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82829634|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829635|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
82829636|NCT00295932|Hormones|hormones|mesh-ancestor
82829637|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829638|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82829639|NCT01063140|Vaccines|vaccines|mesh-list
82829640|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
82829641|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829642|NCT00305448|Fulvestrant|fulvestrant|mesh-list
82829643|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82829644|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362076|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
82829645|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82829646|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82829647|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
82829648|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829649|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829650|NCT01063218|Emollients|emollients|mesh-list
82829651|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
82829652|NCT00305058|Morphine|morphine|mesh-list
82829653|NCT00305058|Hydromorphone|hydromorphone|mesh-list
82829654|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82829655|NCT00305058|Narcotics|narcotics|mesh-ancestor
82829656|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829657|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829658|NCT00305058|Analgesics|analgesics|mesh-ancestor
82829659|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
82829660|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829661|NCT01061450|Simvastatin|simvastatin|mesh-list
82829662|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82829663|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82829664|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
82829665|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829666|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82829667|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82829668|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829669|NCT03986294|Leucovorin|leucovorin|mesh-list
82829670|NCT03986294|Antidotes|antidotes|mesh-ancestor
82829671|NCT03986294|Protective Agents|protective agents|mesh-ancestor
82829672|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829673|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
82829674|NCT03986294|Vitamins|vitamins|mesh-ancestor
82829675|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
82829676|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
82829677|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82829678|NCT00322556|Antibodies|antibodies|mesh-list
82829679|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
82829680|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829681|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
82829682|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
82829683|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
82829684|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
82829685|NCT00321932|Calcium|calcium|mesh-list
83443122|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829686|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82829687|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829688|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82829689|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829690|NCT00321932|Vitamins|vitamins|mesh-ancestor
82829691|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
82829692|NCT00321932|Antacids|antacids|mesh-ancestor
82829693|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82829694|NCT00326612|Midazolam|midazolam|mesh-list
82829695|NCT00326612|Diazepam|diazepam|mesh-list
82829696|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82829697|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82829698|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829699|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829700|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82829701|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82829702|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82829703|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82829704|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
82829705|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
82829706|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
82829707|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
82829708|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829709|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829710|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
82829711|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
82829712|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
82829713|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829714|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82829715|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82829716|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82829717|NCT01060826|Somatostatin|somatostatin|mesh-list
82829719|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829720|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829721|NCT00321854|Pramipexole|pramipexole|mesh-list
82829722|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
82829723|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829724|NCT00321854|Protective Agents|protective agents|mesh-ancestor
82829725|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829726|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82829727|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82829728|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
82829730|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829731|NCT03982862|Triamcinolone|triamcinolone|mesh-list
82829732|NCT03982862|Lidocaine|lidocaine|mesh-list
82829733|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
82829734|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82829735|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82829736|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
82829737|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
82829738|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829739|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829740|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
82829741|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829742|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82829743|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82829744|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82829745|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829746|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829747|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82829748|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
82829749|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829750|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829751|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
82829752|NCT03982862|Hormones|hormones|mesh-ancestor
82829753|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829754|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82829755|NCT01060904|Doxorubicin|doxorubicin|mesh-list
82829756|NCT01060904|Bleomycin|bleomycin|mesh-list
82829757|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82829758|NCT01060904|Dacarbazine|dacarbazine|mesh-list
82829759|NCT01060904|Vinblastine|vinblastine|mesh-list
82829760|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82829761|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82829762|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829763|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82829764|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82829765|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829766|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829767|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82829768|NCT01060904|Immunotoxins|immunotoxins|mesh-ancestor
82829769|NCT01060904|Immunoconjugates|immunoconjugates|mesh-ancestor
82829770|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
82829771|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829772|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82829773|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
82829774|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82829775|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
82829776|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
82829777|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
82829778|NCT01058174|Fluconazole|fluconazole|mesh-list
82829779|NCT01058174|Amphotericin B|amphotericin b|mesh-list
82829780|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82829781|NCT01058174|Caspofungin|caspofungin|mesh-list
82829782|NCT01058174|Micafungin|micafungin|mesh-list
82829783|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
82829784|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829785|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82829786|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82829787|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829788|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829789|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82829790|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
82829791|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829792|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829793|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82829794|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82829795|NCT01058174|Amebicides|amebicides|mesh-ancestor
82829796|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82829797|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82829798|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82829799|NCT01058252|Indomethacin|indomethacin|mesh-list
82829800|NCT01058252|Letrozole|letrozole|mesh-list
82829801|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829802|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82829803|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82829804|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829805|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829806|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82829807|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
82829808|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829809|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829810|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82829811|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82829812|NCT01058252|Analgesics|analgesics|mesh-ancestor
82829813|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
82829814|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829815|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82829816|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829817|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
82829818|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
82829819|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82829820|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82829821|NCT01058408|Cisplatin|cisplatin|mesh-list
82829822|NCT01058408|Everolimus|everolimus|mesh-list
82829823|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829824|NCT01058408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82829825|NCT01058408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82829826|NCT01058408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829827|NCT01058408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829828|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829829|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
82829830|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829831|NCT01061060|Epoprostenol|epoprostenol|mesh-list
82829832|NCT01061060|Beraprost|beraprost|mesh-list
82829833|NCT01061060|Tezosentan|tezosentan|mesh-list
82829834|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82829835|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
82829836|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82829837|NCT00310388|Ezogabine|ezogabine|mesh-list
82829838|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
82829839|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829840|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829841|NCT03981770|Anesthetics|anesthetics|mesh-list
82829842|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829843|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829844|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82829845|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
82829846|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829847|NCT01063556|Donepezil|donepezil|mesh-list
82829848|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82829849|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829850|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829851|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
82829852|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829853|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829854|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
82829855|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
82829856|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82829857|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
82829858|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829859|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
82829860|NCT03981458|Protective Agents|protective agents|mesh-ancestor
82829861|NCT00309842|Cyclosporine|cyclosporine|mesh-list
82829862|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
82829863|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
82829864|NCT00309842|Fludarabine|fludarabine|mesh-list
82829865|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
82829866|NCT00309842|Cyclosporins|cyclosporins|mesh-list
82829867|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829868|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
82829869|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829870|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829871|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82829872|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
82829873|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829874|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829875|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82829876|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82829877|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
82829878|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829879|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
82829880|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829881|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
82829882|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82829883|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82829884|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82829885|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
82829886|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82829887|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
82829888|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82829889|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82829890|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82829891|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82829892|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829893|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
82829894|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82829895|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829896|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82829897|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829898|NCT00499889|Vidarabine|vidarabine|mesh-list
82829899|NCT00499889|Methotrexate|methotrexate|mesh-list
82829900|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
82829901|NCT00499889|Fludarabine|fludarabine|mesh-list
82829902|NCT00499889|Busulfan|busulfan|mesh-list
82829903|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
82829904|NCT00499889|Tacrolimus|tacrolimus|mesh-list
82829905|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
82829906|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82829907|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82829908|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
82829909|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82829910|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829911|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82829912|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
82829913|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829914|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829915|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
82829916|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829917|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82829918|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829919|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
82829920|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82829921|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82829922|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
82829923|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829924|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82829925|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
82829926|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82829927|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82829928|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82829929|NCT00309608|Glimepiride|glimepiride|mesh-list
82829930|NCT00309608|Linagliptin|linagliptin|mesh-list
82829931|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82829932|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82829933|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829934|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82829935|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
82829936|NCT00309608|Incretins|incretins|mesh-ancestor
82829937|NCT00309608|Hormones|hormones|mesh-ancestor
82829938|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82829939|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82829940|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
82829941|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829942|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829943|NCT00308750|Carboplatin|carboplatin|mesh-list
82829944|NCT00308750|Docetaxel|docetaxel|mesh-list
82829945|NCT00308750|Pemetrexed|pemetrexed|mesh-list
82829946|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829947|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
82829948|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
82829949|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
82829950|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829951|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829952|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82829953|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82829954|NCT00489359|Carboplatin|carboplatin|mesh-list
82829955|NCT00489359|Pemetrexed|pemetrexed|mesh-list
82829956|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829957|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829958|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829959|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82829960|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82829961|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
82829962|NCT00481247|Dasatinib|dasatinib|mesh-list
82829963|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829964|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82829965|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82829966|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829967|NCT04101461|Iron|iron|mesh-list
82829968|NCT04101461|Hepcidins|hepcidins|mesh-list
82829969|NCT04101461|Trace Elements|trace elements|mesh-ancestor
82829970|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
82829971|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829972|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829973|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
82829974|NCT01017107|Protein C|protein c|mesh-list
82829975|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
82829976|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82829977|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82829978|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829979|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82829980|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
82829981|NCT03997019|Narcotics|narcotics|mesh-ancestor
82829982|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82829983|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82829984|NCT03997019|Analgesics|analgesics|mesh-ancestor
82829985|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
82829986|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82829987|NCT00480857|Docetaxel|docetaxel|mesh-list
82829988|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829989|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
82829990|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
82829991|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
82829992|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82829993|NCT00499031|Cetuximab|cetuximab|mesh-list
82829994|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82829995|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829996|NCT00498797|Prednisolone|prednisolone|mesh-list
82829997|NCT00498797|Docetaxel|docetaxel|mesh-list
82829998|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82829999|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
82830000|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
82830001|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
82830002|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830003|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830004|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
82830005|NCT00498797|Hormones|hormones|mesh-ancestor
82830006|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830007|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830008|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82830009|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
82830010|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82830011|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82830012|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
82830013|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
82830014|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82830015|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830016|NCT04242329|Immunomodulating Agents|immunomodulating agents|mesh-list
82830017|NCT04242329|Immunologic Factors|immunologic factors|mesh-ancestor
82830018|NCT04242329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830019|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82830020|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82830021|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82830022|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830023|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830026|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830027|NCT00295620|Anastrozole|anastrozole|mesh-list
82830028|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82830029|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830030|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82830031|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82830032|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830033|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830034|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82830035|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
82830036|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830037|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830038|NCT03980496|Omeprazole|omeprazole|mesh-list
82830039|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82830040|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830041|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82830042|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830043|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830044|NCT01063530|Fluorides|fluorides|mesh-list
82830045|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
82830046|NCT01063530|Protective Agents|protective agents|mesh-ancestor
82830047|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830048|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
82830049|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82830050|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830051|NCT01069302|Clopidogrel|clopidogrel|mesh-list
82830052|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82830053|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82830054|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82830055|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82830056|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
82830057|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830058|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830059|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830060|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
82830061|NCT00321620|Denosumab|denosumab|mesh-list
82830062|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82830063|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830064|NCT00304278|Cisplatin|cisplatin|mesh-list
82830065|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82830066|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830067|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830068|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830069|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830070|NCT03981068|Nimorazole|nimorazole|mesh-list
82830071|NCT03981068|Cisplatin|cisplatin|mesh-list
82830072|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830073|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82830074|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82830075|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82830076|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830077|NCT01064102|Cetirizine|cetirizine|mesh-list
82830078|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82830079|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82830080|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82830081|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
82830082|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
82830083|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830084|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830086|NCT02532114|Niclosamide|niclosamide|mesh-list
82830087|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
82830088|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82830089|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
82830090|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82830091|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830092|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
82830093|NCT00307736|Bevacizumab|bevacizumab|mesh-list
82830094|NCT00307736|Fluorouracil|fluorouracil|mesh-list
82830095|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82830096|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830097|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830098|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82830099|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82830101|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830102|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
82830103|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
82830104|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830105|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82830106|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830107|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
82830108|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830109|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830110|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82830111|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82830112|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82830113|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830114|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830115|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
82830116|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830117|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830118|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
82830119|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82830120|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
82830121|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830122|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
82830123|NCT03979586|Protective Agents|protective agents|mesh-ancestor
82830124|NCT00294762|Paclitaxel|paclitaxel|mesh-list
82830125|NCT00294762|Carboplatin|carboplatin|mesh-list
83443142|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
82830126|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82830127|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82830128|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830129|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
82830130|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
82830131|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
82830132|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830133|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830134|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830135|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
82830136|NCT00294684|Prednisolone|prednisolone|mesh-list
82830137|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830138|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
82830139|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
82830140|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830141|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830142|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830143|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
82830144|NCT00294684|Hormones|hormones|mesh-ancestor
82830145|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830146|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82830147|NCT00294684|Protective Agents|protective agents|mesh-ancestor
82830148|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82830149|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830150|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82830151|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
82830152|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830153|NCT01061996|Basiliximab|basiliximab|mesh-list
82830154|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830155|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
82830156|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830157|NCT01064180|Carvedilol|carvedilol|mesh-list
82830158|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82830159|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82830160|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
82830161|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830162|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830163|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830164|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82830165|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
82830166|NCT01064180|Protective Agents|protective agents|mesh-ancestor
82830167|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82830168|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830169|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830171|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82830173|NCT01069536|Metoclopramide|metoclopramide|mesh-list
82830174|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
82830175|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
82830176|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830177|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830178|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830179|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82830180|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82830181|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
82830182|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830183|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830184|NCT00320216|Ustekinumab|ustekinumab|mesh-list
82830185|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830186|NCT00290706|Gemcitabine|gemcitabine|mesh-list
82830187|NCT00290706|Bortezomib|bortezomib|mesh-list
82830188|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82830189|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
82830190|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830191|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830192|NCT03978156|Dronabinol|dronabinol|mesh-list
82830193|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
82830194|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830195|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82830196|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82830197|NCT03978156|Analgesics|analgesics|mesh-ancestor
82830198|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
82830199|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830200|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83443144|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82830201|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82830202|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830203|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830204|NCT03978156|Hormones|hormones|mesh-ancestor
82830205|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830206|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82830207|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82830208|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82830209|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830210|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830211|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
82830212|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830213|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830214|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82830215|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830216|NCT01066494|Cytarabine|cytarabine|mesh-list
82830217|NCT01066494|Amonafide|amonafide|mesh-list
82830218|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82830219|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
82830220|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830221|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830222|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
82830223|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830224|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830225|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
82830226|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830227|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830228|NCT01069770|Sunitinib|sunitinib|mesh-list
82830229|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830230|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82830231|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82830232|NCT01069770|Growth Substances|growth substances|mesh-ancestor
82830233|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830234|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
82830235|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830237|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830238|NCT00303108|Carboplatin|carboplatin|mesh-list
82830239|NCT00303108|Doxorubicin|doxorubicin|mesh-list
82830240|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82830241|NCT00303108|Trastuzumab|trastuzumab|mesh-list
82830242|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830243|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82830244|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82830245|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82830246|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830247|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830248|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830250|NCT00302952|L 647318|l 647318|mesh-list
82830251|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
82830252|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82830253|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82830254|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
82830255|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830256|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82830257|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82830258|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830259|NCT01066572|Lisinopril|lisinopril|mesh-list
82830260|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82830261|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830262|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830263|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830264|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82830265|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82830266|NCT01066572|Protective Agents|protective agents|mesh-ancestor
82830267|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830268|NCT01066650|Everolimus|everolimus|mesh-list
82830269|NCT01066650|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82830270|NCT01066650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830271|NCT01066650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830272|NCT01066650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830273|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830274|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
82830275|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830276|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830277|NCT01066728|Theophylline|theophylline|mesh-list
82830278|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82830279|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
82830280|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830281|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830282|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82830283|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
82830284|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82830285|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830286|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830287|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
82830288|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82830289|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82830290|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
82830291|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830292|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
82830293|NCT01325610|Vitamin D|vitamin d|mesh-list
82830294|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830295|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830296|NCT01325610|Vitamins|vitamins|mesh-ancestor
82830297|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
82830298|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82830299|NCT00301080|Cycloserine|cycloserine|mesh-list
82830300|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82830301|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830302|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82830303|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
82830304|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82830305|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
82830306|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830307|NCT01066806|Calcium|calcium|mesh-list
82830308|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830309|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830310|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82830311|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82830312|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830313|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82830314|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830315|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830317|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830318|NCT02532270|Phenylephrine|phenylephrine|mesh-list
82830319|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
82830320|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82830321|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
82830322|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
82830323|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830324|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830325|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
82830326|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82830327|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
82830328|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
82830329|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82830330|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82830331|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82830332|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
82830333|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830334|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830335|NCT02532270|Protective Agents|protective agents|mesh-ancestor
82830336|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
82830337|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82830338|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
82830339|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
82830340|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82830341|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830342|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82830343|NCT01581450|Analgesics|analgesics|mesh-ancestor
82830344|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
82830345|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830346|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82830347|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83443147|NCT03364491|Coagulants|coagulants|mesh-ancestor
82830348|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830349|NCT00289848|Incretins|incretins|mesh-ancestor
82830351|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830352|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82830353|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830354|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830355|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830356|NCT00289536|Factor VIII|factor viii|mesh-list
82830357|NCT00289536|Coagulants|coagulants|mesh-ancestor
82830358|NCT01066962|Ritonavir|ritonavir|mesh-list
82830359|NCT01066962|Darunavir|darunavir|mesh-list
82830360|NCT01066962|Tenofovir|tenofovir|mesh-list
82830361|NCT01066962|Emtricitabine|emtricitabine|mesh-list
82830362|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
82830363|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82830364|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82830365|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830366|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830367|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830368|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82830369|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82830370|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
82830371|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830372|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82830373|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82830374|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82830375|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82830376|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82830377|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82830378|NCT01067118|Insulin|insulin|mesh-list
82830379|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82830380|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
82830381|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82830382|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830383|NCT01067274|Cytarabine|cytarabine|mesh-list
82830384|NCT01067274|Azacitidine|azacitidine|mesh-list
82830385|NCT01067274|Tretinoin|tretinoin|mesh-list
82830386|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82830387|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
82830388|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830389|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830390|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
82830391|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830393|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
82830394|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830395|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830396|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
82830397|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830399|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830400|NCT01325844|Anesthetics|anesthetics|mesh-list
82830401|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82830402|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830403|NCT01067430|Diclofenac|diclofenac|mesh-list
82830404|NCT01067430|Etoricoxib|etoricoxib|mesh-list
82830405|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82830406|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82830407|NCT01067430|Analgesics|analgesics|mesh-ancestor
82830408|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
82830409|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830410|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830411|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830412|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830413|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82830414|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830415|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830416|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82830417|NCT00305864|Temozolomide|temozolomide|mesh-list
82830418|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
82830419|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82830420|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
82830421|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830422|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830423|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82830424|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830425|NCT03982784|Morphine|morphine|mesh-list
82830426|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82830427|NCT03982784|Narcotics|narcotics|mesh-ancestor
82830428|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82830429|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830430|NCT03982784|Analgesics|analgesics|mesh-ancestor
82830431|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
82830432|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830433|NCT03978884|Losartan|losartan|mesh-list
82830434|NCT03978884|Amlodipine|amlodipine|mesh-list
82830435|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82830436|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82830437|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82830438|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830439|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830440|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830441|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830442|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
82830443|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82830444|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82830445|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82830446|NCT03978884|Diuretics|diuretics|mesh-ancestor
82830447|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
82830448|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82830449|NCT00319982|Diltiazem|diltiazem|mesh-list
82830450|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82830451|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82830452|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830453|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830454|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830455|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830456|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
82830457|NCT00319592|Vaccines|vaccines|mesh-list
82830458|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
82830459|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830460|NCT03980990|Metformin|metformin|mesh-list
82830461|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82830462|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830463|NCT03980756|Esomeprazole|esomeprazole|mesh-list
82830464|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82830465|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830467|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830468|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830470|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830471|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
82830472|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830473|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82830474|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830475|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830477|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830478|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
82830479|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830480|NCT01581164|Vaccines|vaccines|mesh-list
82830481|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
82830482|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830483|NCT00319046|Miglustat|miglustat|mesh-list
82830484|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830485|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830486|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82830487|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82830488|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
82830489|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830490|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82830491|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82830492|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830493|NCT00303602|Olanzapine|olanzapine|mesh-list
82830494|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
82830495|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
82830496|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830497|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830498|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830499|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82830500|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82830501|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82830502|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83443148|NCT04294069|Azithromycin|azithromycin|mesh-list
82830503|NCT00303602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82830504|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82830505|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830506|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830507|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830508|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
82830509|NCT03979976|Ramipril|ramipril|mesh-list
82830510|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82830511|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82830512|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830513|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830514|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82830515|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
82830516|NCT00299130|Rituximab|rituximab|mesh-list
82830517|NCT00299130|Methotrexate|methotrexate|mesh-list
82830518|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830519|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830520|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
82830521|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830522|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830523|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82830524|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
82830525|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82830526|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82830527|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
82830528|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830529|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830530|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830531|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82830532|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830533|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82830534|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830535|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
82830536|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
82830537|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830538|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830539|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
82830540|NCT00299130|Hormones|hormones|mesh-ancestor
82830541|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830542|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82830543|NCT00299130|Protective Agents|protective agents|mesh-ancestor
82830544|NCT00288054|Docetaxel|docetaxel|mesh-list
82830545|NCT00288054|Cetuximab|cetuximab|mesh-list
82830546|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830547|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
82830548|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
82830549|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
82830550|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830551|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830552|NCT00287586|Testosterone|testosterone|mesh-list
82830553|NCT00287586|Androgens|androgens|mesh-ancestor
82830554|NCT00287586|Hormones|hormones|mesh-ancestor
82830555|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830556|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830557|NCT01070160|Metformin|metformin|mesh-list
82830558|NCT01070160|Progesterone|progesterone|mesh-list
82830559|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82830560|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830561|NCT01070160|Progestins|progestins|mesh-ancestor
82830562|NCT01070160|Hormones|hormones|mesh-ancestor
82830563|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830564|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
82830565|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82830566|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830567|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
82830568|NCT03977220|Paclitaxel|paclitaxel|mesh-list
82830569|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82830570|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830571|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
82830572|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
82830573|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
82830574|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830575|NCT00293202|Etanercept|etanercept|mesh-list
82830576|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82830577|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82830578|NCT00293202|Analgesics|analgesics|mesh-ancestor
82830579|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
82830580|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830581|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830582|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830583|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830584|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830585|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830586|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
82830587|NCT00286494|Pioglitazone|pioglitazone|mesh-list
82830588|NCT00286494|Alogliptin|alogliptin|mesh-list
82830589|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82830590|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830591|NCT00286494|Incretins|incretins|mesh-ancestor
82830592|NCT00286494|Hormones|hormones|mesh-ancestor
82830593|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830594|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82830595|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830596|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830597|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830598|NCT00298740|Insulin|insulin|mesh-list
82830599|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82830600|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830601|NCT01067898|Vitamin D|vitamin d|mesh-list
82830602|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
82830603|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
82830604|NCT01067898|Vitamins|vitamins|mesh-list
82830605|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
82830606|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
82830607|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830608|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830609|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82830610|NCT01067898|Antacids|antacids|mesh-ancestor
82830611|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830612|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830613|NCT03979248|Deucravacitinib|deucravacitinib|mesh-list
82830614|NCT03979248|Rabeprazole|rabeprazole|mesh-list
82830615|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82830616|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830617|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82830618|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830619|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830620|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830621|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830622|NCT00285012|Varenicline|varenicline|mesh-list
82830623|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82830624|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82830625|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
82830626|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830627|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830628|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830629|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
82830631|NCT00284934|Tacrolimus|tacrolimus|mesh-list
82830632|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830633|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
82830634|NCT00284934|Hormones|hormones|mesh-ancestor
82830635|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830636|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830637|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82830638|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830639|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830640|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
82830641|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82830642|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830643|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830644|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82830645|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82830646|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
82830647|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82830648|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830649|NCT00284856|Fluticasone|fluticasone|mesh-list
82830650|NCT00284856|Montelukast|montelukast|mesh-list
82830651|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830652|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82830653|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
82830654|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830655|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830656|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82830657|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
82830658|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830659|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82830660|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82830661|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
82830662|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830663|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82830664|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82830665|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830666|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
82830667|NCT00298272|Adalimumab|adalimumab|mesh-list
82830668|NCT00298272|Etanercept|etanercept|mesh-list
82830669|NCT00298272|Rituximab|rituximab|mesh-list
82830670|NCT00298272|Methotrexate|methotrexate|mesh-list
82830671|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830672|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830673|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
82830674|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830675|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830676|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82830677|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
82830678|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82830679|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82830680|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
82830681|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830682|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830683|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830684|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82830685|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830686|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82830687|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830688|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
82830689|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
82830690|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830691|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830692|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
82830694|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830695|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82830696|NCT00298272|Protective Agents|protective agents|mesh-ancestor
82830697|NCT00298272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82830698|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82830699|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82830700|NCT00298272|Analgesics|analgesics|mesh-ancestor
82830701|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
82830702|NCT01068054|Cyclosporine|cyclosporine|mesh-list
82830703|NCT01068054|Tacrolimus|tacrolimus|mesh-list
82830704|NCT01068054|Cyclosporins|cyclosporins|mesh-list
82830705|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830706|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
82830707|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830708|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82830709|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830710|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830711|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
82830712|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830713|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830714|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830715|NCT00298038|Rifaximin|rifaximin|mesh-list
82830716|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82830717|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830718|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830719|NCT00283686|Telmisartan|telmisartan|mesh-list
82830720|NCT00283686|Lisinopril|lisinopril|mesh-list
82830721|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82830722|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82830723|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82830724|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82830725|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830726|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830727|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830728|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82830729|NCT00283686|Protective Agents|protective agents|mesh-ancestor
82830730|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830731|NCT00297882|Artesunate|artesunate|mesh-list
82830732|NCT00297882|Lumefantrine|lumefantrine|mesh-list
82830733|NCT00297882|Artemether|artemether|mesh-list
82830734|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82830735|NCT00297882|Amodiaquine|amodiaquine|mesh-list
82830736|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
82830737|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82830738|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82830739|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830740|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830741|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
82830742|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
82830743|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82830744|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
82830745|NCT01065870|Gemcitabine|gemcitabine|mesh-list
82830746|NCT01065870|Capecitabine|capecitabine|mesh-list
82830747|NCT01065870|Docetaxel|docetaxel|mesh-list
82830748|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82830749|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
82830750|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830751|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830752|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
82830753|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
82830754|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
82830755|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
82830756|NCT00297648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82830757|NCT00297648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830758|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830759|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
82830760|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830761|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830762|NCT01068132|Cetuximab|cetuximab|mesh-list
82830763|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830764|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830765|NCT00297492|Nicotine|nicotine|mesh-list
82830766|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82830768|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830769|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830770|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82830771|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82830772|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
82830773|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830774|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830776|NCT00496769|Apixaban|apixaban|mesh-list
82830777|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82830778|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82830779|NCT00496769|Analgesics|analgesics|mesh-ancestor
82830780|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
83443173|NCT00814255|Lisinopril|lisinopril|mesh-list
82830781|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830782|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830783|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830784|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830785|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82830786|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82830787|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830788|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82830789|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82830790|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830791|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
82830792|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82830793|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
82830794|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82830795|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830796|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
82830797|NCT01014845|Vaccines|vaccines|mesh-list
82830798|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
82830799|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830800|NCT00488345|Tigecycline|tigecycline|mesh-list
82830801|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82830802|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830803|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82830804|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830805|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830806|NCT00283062|Docetaxel|docetaxel|mesh-list
82830807|NCT00283062|Leuprolide|leuprolide|mesh-list
82830808|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830809|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
82830810|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
82830811|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
82830812|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830813|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82830814|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
82830815|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82830816|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830817|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82830818|NCT00282984|Varenicline|varenicline|mesh-list
82830819|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82830820|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82830821|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
82830822|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830823|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830824|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830825|NCT00296400|Atorvastatin|atorvastatin|mesh-list
82830826|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82830827|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82830828|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82830829|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
82830830|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830831|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82830832|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82830833|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830834|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
82830835|NCT00296244|Prednisone|prednisone|mesh-list
82830836|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
82830837|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82830838|NCT00296244|Tacrolimus|tacrolimus|mesh-list
82830839|NCT00296244|Basiliximab|basiliximab|mesh-list
82830840|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830841|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
82830843|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830844|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830845|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82830846|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830847|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830848|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
82830849|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82830850|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830851|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830853|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
82830854|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830855|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830856|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82830857|NCT00296244|Protective Agents|protective agents|mesh-ancestor
82830858|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82830859|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82830860|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
82830861|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82830862|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830863|NCT01068444|Pioglitazone|pioglitazone|mesh-list
82830864|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82830865|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830867|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830868|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82830869|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830870|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830871|NCT00474539|Vaccines|vaccines|mesh-list
82830872|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82830873|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
82830874|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830875|NCT01017809|Aprepitant|aprepitant|mesh-list
82830876|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
82830877|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
82830878|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830879|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830880|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830881|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82830882|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830883|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830884|NCT01020539|Fludarabine|fludarabine|mesh-list
82830885|NCT01020539|Busulfan|busulfan|mesh-list
82830886|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
82830887|NCT01020539|Isotretinoin|isotretinoin|mesh-list
82830888|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
82830889|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82830890|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830891|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830892|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830893|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
82830894|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830895|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
82830896|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82830897|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82830898|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
82830899|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830900|NCT01020539|Immunotoxins|immunotoxins|mesh-ancestor
82830901|NCT01020539|Immunoconjugates|immunoconjugates|mesh-ancestor
82830902|NCT00281580|Amlodipine|amlodipine|mesh-list
82830903|NCT00281580|Telmisartan|telmisartan|mesh-list
82830904|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82830905|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82830906|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830907|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830908|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830909|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830910|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
82830911|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82830912|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82830913|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
82830914|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82830916|NCT01070862|Thalidomide|thalidomide|mesh-list
82830917|NCT01070862|Dexamethasone|dexamethasone|mesh-list
82830918|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
82830919|NCT01070862|Doxorubicin|doxorubicin|mesh-list
82830920|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82830921|NCT01070862|Melphalan|melphalan|mesh-list
82830922|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
82830923|NCT01070862|Vincristine|vincristine|mesh-list
82830924|NCT01070862|BB 1101|bb 1101|mesh-list
82830925|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82830926|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
82830927|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
82830928|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830929|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830930|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82830931|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
82830932|NCT01070862|Hormones|hormones|mesh-ancestor
82830933|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82830934|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82830935|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82830936|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
82830937|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830938|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830939|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82830940|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82830941|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82830942|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82830943|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
82830944|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82830945|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82830946|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
82830947|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
82830948|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82830949|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830950|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82830951|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82830952|NCT01070862|Growth Substances|growth substances|mesh-ancestor
82830953|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
82830954|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82830955|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82830956|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
82830957|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
82830958|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
82830959|NCT00495677|PF 232798|pf 232798|mesh-list
82830960|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82830961|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830962|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82830963|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82830964|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
82830965|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830966|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
82830967|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
82830968|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82830969|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82830970|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
82830971|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82830972|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82830973|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830974|NCT00292188|Pregabalin|pregabalin|mesh-list
82830975|NCT00292188|Analgesics|analgesics|mesh-ancestor
82830976|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
82830977|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82830978|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830979|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
82830980|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82830981|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830982|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830983|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82830984|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82830985|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82830986|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82830987|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82830988|NCT00271596|Citalopram|citalopram|mesh-list
82830989|NCT00271596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82830991|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82830992|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82830993|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82830994|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
82830995|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82830996|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82830998|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82830999|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
82831000|NCT01068756|Rifampin|rifampin|mesh-list
82831001|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82831002|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831003|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82831004|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831005|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82831006|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
82831007|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831008|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831009|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
82831010|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82831011|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831012|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82831013|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82831014|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82831015|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82831016|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82831017|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82831018|NCT00291642|Cetirizine|cetirizine|mesh-list
82831019|NCT00291642|Levocetirizine|levocetirizine|mesh-list
82831020|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82831021|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82831022|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82831023|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
82831024|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
82831025|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831026|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831027|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831028|NCT01070472|Misoprostol|misoprostol|mesh-list
82831029|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82831030|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
82831031|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82831032|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831033|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82831034|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831035|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
82831036|NCT00280566|Ziprasidone|ziprasidone|mesh-list
82831037|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82831038|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
82831039|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831040|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831041|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831042|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82831043|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82831044|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831045|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82831046|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82831047|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
82831048|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
82831049|NCT00270894|Docetaxel|docetaxel|mesh-list
82831050|NCT00270894|Trastuzumab|trastuzumab|mesh-list
82831051|NCT00270894|Epirubicin|epirubicin|mesh-list
82831052|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831053|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
82831054|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831055|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831056|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82831057|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
82831058|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831059|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831060|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82831061|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831062|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831063|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831064|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831065|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82831066|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82831067|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82831068|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831069|NCT01070628|Levodopa|levodopa|mesh-list
82831070|NCT01070628|Carbidopa|carbidopa|mesh-list
82831071|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82831072|NCT01070628|Entacapone|entacapone|mesh-list
82831073|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82831074|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82831075|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
82831076|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831077|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831078|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831079|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82831080|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831081|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82831082|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
82831083|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
82831084|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82831085|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
82831086|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831087|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831088|NCT00317642|Cytarabine|cytarabine|mesh-list
82831089|NCT00317642|Clofarabine|clofarabine|mesh-list
82831090|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831091|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
82831092|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831093|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831094|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
82831095|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831096|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831097|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
82831098|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831099|NCT01064726|Fluticasone|fluticasone|mesh-list
82831100|NCT01064726|Xhance|xhance|mesh-list
82831101|NCT01064726|Ibuprofen|ibuprofen|mesh-list
82831102|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82831103|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82831104|NCT01064726|Analgesics|analgesics|mesh-ancestor
82831105|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
82831106|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831107|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831108|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831109|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831110|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82831111|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831112|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831113|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82831114|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
82831115|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82831116|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
82831117|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831118|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82831119|NCT00295022|Montelukast|montelukast|mesh-list
82831120|NCT00295022|Levocetirizine|levocetirizine|mesh-list
82831121|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82831122|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
82831123|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82831124|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
82831125|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831126|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831127|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82831128|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82831129|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831130|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82831131|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82831132|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
82831133|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
82831134|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831135|NCT01062152|Lenalidomide|lenalidomide|mesh-list
82831137|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831138|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82831139|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82831140|NCT01062152|Growth Substances|growth substances|mesh-ancestor
82831141|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
82831142|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831143|NCT00303446|Dutasteride|dutasteride|mesh-list
82831144|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82831145|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82831146|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831147|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831148|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
82831149|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831150|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831151|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
82831152|NCT01065038|Anagrelide|anagrelide|mesh-list
82831153|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831154|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
82831155|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831156|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831157|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82831158|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82831159|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82831160|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82831161|NCT00291486|Capecitabine|capecitabine|mesh-list
82831162|NCT00291486|Antibodies|antibodies|mesh-list
82831163|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82831164|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
82831165|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831166|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831167|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
82831168|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831169|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831170|NCT00301964|Bevacizumab|bevacizumab|mesh-list
82831171|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82831172|NCT00301964|Antibodies|antibodies|mesh-list
82831173|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
82831174|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82831175|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831176|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82831177|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82831178|NCT00301964|Growth Substances|growth substances|mesh-ancestor
82831179|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831180|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
82831181|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
82831182|NCT01070706|Paclitaxel|paclitaxel|mesh-list
82831183|NCT01070706|Gemcitabine|gemcitabine|mesh-list
82831184|NCT01070706|Sunitinib|sunitinib|mesh-list
82831185|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82831186|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831187|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831188|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831189|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831190|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831191|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831192|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
82831193|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82831194|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82831195|NCT01070706|Growth Substances|growth substances|mesh-ancestor
82831196|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831197|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
82831198|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831199|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831200|NCT00268242|Gemcitabine|gemcitabine|mesh-list
82831201|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
82831202|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831203|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
82831204|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831205|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831206|NCT00268242|Analgesics|analgesics|mesh-ancestor
82831207|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
82831208|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831209|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831210|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82831211|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82831212|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831214|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82831215|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82831216|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
82831217|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831218|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831219|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831220|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82831221|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82831222|NCT00294398|Fluticasone|fluticasone|mesh-list
82831223|NCT00294398|Xhance|xhance|mesh-list
82831224|NCT00294398|Budesonide|budesonide|mesh-list
82831225|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831226|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82831227|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
82831228|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831229|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831230|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82831231|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
82831232|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831233|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82831234|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
82831235|NCT00294398|Hormones|hormones|mesh-ancestor
82831236|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831237|NCT00279708|Atorvastatin|atorvastatin|mesh-list
82831238|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82831239|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82831240|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
82831241|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831242|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82831243|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82831244|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831245|NCT00299702|Aripiprazole|aripiprazole|mesh-list
82831246|NCT00299702|Risperidone|risperidone|mesh-list
82831247|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
82831248|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82831249|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82831250|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82831251|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831252|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831253|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
82831254|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
82831255|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831256|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831257|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82831258|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82831259|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
82831260|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82831261|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82831262|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82831263|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82831264|NCT00291330|Warfarin|warfarin|mesh-list
82831265|NCT00291330|Dabigatran|dabigatran|mesh-list
82831266|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
82831267|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
82831268|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82831269|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
82831270|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831271|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831272|NCT03975036|Antibodies|antibodies|mesh-list
82831273|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
82831274|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831275|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
82831276|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82831277|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831278|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82831279|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
82831280|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831281|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831282|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831283|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831284|NCT01582230|Vildagliptin|vildagliptin|mesh-list
82831285|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82831286|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831287|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82831288|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
82831289|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831290|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831292|NCT00278148|Carboplatin|carboplatin|mesh-list
82831293|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82831294|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82831295|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831296|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831297|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831298|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831299|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831300|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831301|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831302|NCT00299546|Golimumab|golimumab|mesh-list
82831303|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82831304|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82831305|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831306|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831307|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
82831308|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831309|NCT03975270|Paclitaxel|paclitaxel|mesh-list
82831310|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82831311|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831312|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831313|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831314|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831315|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831316|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82831317|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
82831318|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82831319|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82831320|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831321|NCT03977792|Docosanol|docosanol|mesh-list
82831322|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
82831323|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831324|NCT01066598|Rituximab|rituximab|mesh-list
82831325|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831326|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831327|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
82831328|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831329|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831330|NCT01066676|Ibuprofen|ibuprofen|mesh-list
82831331|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82831332|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82831333|NCT01066676|Analgesics|analgesics|mesh-ancestor
82831334|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
82831335|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831336|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831337|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831338|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831339|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82831340|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831341|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831342|NCT01065194|Simendan|simendan|mesh-list
82831343|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82831344|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
82831345|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82831346|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82831347|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831348|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831349|NCT01065194|Protective Agents|protective agents|mesh-ancestor
82831350|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831351|NCT01065272|Dexamethasone|dexamethasone|mesh-list
82831352|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831353|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
82831354|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
82831355|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831356|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831357|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831358|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
82831359|NCT01065272|Hormones|hormones|mesh-ancestor
82831361|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82831362|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831363|NCT00299156|Clofarabine|clofarabine|mesh-list
82831364|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831365|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
82831366|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831367|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831368|NCT00277212|Lamotrigine|lamotrigine|mesh-list
82831369|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
82831370|NCT00277212|Aripiprazole|aripiprazole|mesh-list
82831371|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
82831372|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82831373|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82831374|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82831375|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831376|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831377|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
82831378|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
82831379|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831380|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831381|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82831382|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82831383|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
82831384|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82831385|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82831386|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82831387|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82831388|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82831389|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82831390|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82831391|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82831392|NCT01066754|Fexofenadine|fexofenadine|mesh-list
82831393|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82831394|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82831395|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82831396|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
82831397|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
82831398|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831399|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831400|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831401|NCT00276744|Sirolimus|sirolimus|mesh-list
82831402|NCT00276744|Gemcitabine|gemcitabine|mesh-list
82831403|NCT00276744|Capecitabine|capecitabine|mesh-list
82831404|NCT00276744|Docetaxel|docetaxel|mesh-list
82831405|NCT00276744|Irinotecan|irinotecan|mesh-list
82831406|NCT00276744|Cetuximab|cetuximab|mesh-list
82831407|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82831408|NCT00276744|Mitomycins|mitomycins|mesh-list
82831409|NCT00276744|Mitomycin|mitomycin|mesh-list
82831410|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831411|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
82831412|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831413|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831414|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831415|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831416|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831417|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82831418|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82831419|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831420|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831421|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831422|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831423|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831424|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82831425|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
82831426|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831427|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
82831428|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831429|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
82831430|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82831431|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
82831432|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
82831438|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831439|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831441|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
82831442|NCT02532192|Fluconazole|fluconazole|mesh-list
82831443|NCT02532192|Dexamethasone|dexamethasone|mesh-list
82831444|NCT02532192|Rituximab|rituximab|mesh-list
82831445|NCT02532192|Cisplatin|cisplatin|mesh-list
82831446|NCT02532192|Belinostat|belinostat|mesh-list
82831447|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831448|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831449|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
82831450|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831451|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831452|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831453|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
82831454|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
82831455|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831456|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831457|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
82831459|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831460|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82831461|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831462|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
82831463|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831464|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
82831465|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831466|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831467|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831468|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82831469|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82831470|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831471|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82831472|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82831473|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
82831474|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82831475|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82831476|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
82831477|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82831478|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82831479|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82831480|NCT00293462|Sargramostim|sargramostim|mesh-list
82831481|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
82831482|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831483|NCT00316082|Metformin|metformin|mesh-list
82831484|NCT00316082|Saxagliptin|saxagliptin|mesh-list
82831485|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82831486|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831487|NCT00316082|Incretins|incretins|mesh-ancestor
82831488|NCT00316082|Hormones|hormones|mesh-ancestor
82831489|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831490|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82831491|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
82831492|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831493|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831494|NCT00316004|Dextrans|dextrans|mesh-list
82831495|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
82831496|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
82831497|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
82831498|NCT01066832|Paclitaxel|paclitaxel|mesh-list
82831499|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82831500|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831501|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831502|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831503|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831504|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831505|NCT00298766|Bortezomib|bortezomib|mesh-list
82831506|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831507|NCT03979664|Dexamethasone|dexamethasone|mesh-list
82831508|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831509|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
82831510|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
82831511|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831512|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831513|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831514|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
82831515|NCT03979664|Hormones|hormones|mesh-ancestor
82831516|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831517|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82831518|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831519|NCT01325558|Gemcitabine|gemcitabine|mesh-list
82831520|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831521|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
83443196|NCT02000973|Ropivacaine|ropivacaine|mesh-list
82831522|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831523|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831524|NCT00315458|Buprenorphine|buprenorphine|mesh-list
82831525|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82831526|NCT00315458|Narcotics|narcotics|mesh-ancestor
82831527|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831528|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831529|NCT00315458|Analgesics|analgesics|mesh-ancestor
82831530|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
82831531|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831532|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82831534|NCT01065662|Temsirolimus|temsirolimus|mesh-list
82831535|NCT01065662|MTOR Inhibitors|mtor inhibitors|mesh-list
82831536|NCT01065662|Cediranib|cediranib|mesh-list
82831537|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831538|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831539|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831540|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831541|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
82831542|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831543|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831544|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831545|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831546|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82831547|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
82831548|NCT01581242|Adefovir|adefovir|mesh-list
82831549|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82831550|NCT01581242|Clevudine|clevudine|mesh-list
82831551|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
82831552|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831553|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82831554|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82831555|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831556|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831557|NCT03982238|Metformin|metformin|mesh-list
82831558|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
82831559|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82831560|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831561|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82831562|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831563|NCT00293384|Dexamethasone|dexamethasone|mesh-list
82831564|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
82831565|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
82831566|NCT00293384|Aprepitant|aprepitant|mesh-list
82831567|NCT00293384|Granisetron|granisetron|mesh-list
82831568|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82831569|NCT00293384|BB 1101|bb 1101|mesh-list
82831570|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831571|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
82831572|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831573|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831574|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82831575|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
82831576|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831577|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831578|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82831579|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831580|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
82831581|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
82831582|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831583|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831584|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
82831585|NCT00293384|Hormones|hormones|mesh-ancestor
82831586|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831587|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82831588|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
82831589|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831590|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82831591|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831592|NCT00293384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82831593|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82831594|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
82831595|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
82831596|NCT00297830|Alendronate|alendronate|mesh-list
82831597|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82831598|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831599|NCT00296816|Bevacizumab|bevacizumab|mesh-list
82831600|NCT00296816|Docetaxel|docetaxel|mesh-list
82831601|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
82831602|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831603|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831604|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82831605|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82831607|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831608|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
82831609|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831610|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831611|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831612|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831613|NCT01066988|Emollients|emollients|mesh-list
82831614|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82831615|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82831616|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831617|NCT00097786|Nateglinide|nateglinide|mesh-list
82831618|NCT00097786|Valsartan|valsartan|mesh-list
82831619|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82831620|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82831621|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82831622|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831623|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82831624|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831625|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82831626|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82831627|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831628|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
82831629|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82831630|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
82831631|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82831632|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82831633|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831634|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82831635|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831636|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82831637|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831638|NCT01084486|Metformin|metformin|mesh-list
82831639|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82831640|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831641|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82831642|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82831643|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82831644|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831645|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831646|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82831647|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82831648|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82831649|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82831650|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
82831651|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831652|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831653|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82831654|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82831655|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
82831656|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82831657|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82831658|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
82831659|NCT01084720|V0034CR|v0034cr|mesh-list
82831660|NCT01084720|Emollients|emollients|mesh-ancestor
82831661|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831662|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
82831663|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82831664|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82831665|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831666|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
82831667|NCT03963466|Coagulants|coagulants|mesh-ancestor
82831668|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
82831669|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831670|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82831671|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831672|NCT01084876|Paclitaxel|paclitaxel|mesh-list
82831673|NCT01084876|Trastuzumab|trastuzumab|mesh-list
82831674|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82831675|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831676|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831677|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831678|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831679|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831680|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831681|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82831682|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82831683|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82831684|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82831685|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831686|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831687|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
82831688|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831689|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82831690|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82831691|NCT00251004|Cyclosporine|cyclosporine|mesh-list
82831692|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
82831694|NCT00251004|Cyclosporins|cyclosporins|mesh-list
82831695|NCT00251004|Basiliximab|basiliximab|mesh-list
82831696|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831697|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831698|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831699|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
82831700|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831701|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
82831702|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831703|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831704|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831705|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82831706|NCT00251004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82831707|NCT00251004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831708|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831709|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82831710|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82831711|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
82831712|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831713|NCT00275262|Leuprolide|leuprolide|mesh-list
82831714|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82831715|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
82831716|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82831717|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831718|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82831719|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831720|NCT00275028|Cediranib|cediranib|mesh-list
82831721|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831722|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831723|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831724|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831725|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
82831726|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831727|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831728|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831729|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831731|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
82831732|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
82831733|NCT00493649|Docetaxel|docetaxel|mesh-list
82831734|NCT00493649|Trastuzumab|trastuzumab|mesh-list
82831735|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831736|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
82831737|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831738|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831739|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82831740|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
82831741|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831742|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831743|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82831744|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831745|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831746|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831747|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831748|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
82831749|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82831750|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
82831751|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831752|NCT01021163|Expectorants|expectorants|mesh-ancestor
82831753|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
82831754|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82831755|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
82831756|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831757|NCT01021163|Protective Agents|protective agents|mesh-ancestor
82831758|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831759|NCT01021163|Antidotes|antidotes|mesh-ancestor
82831760|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
82831761|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82831762|NCT01022333|Protective Agents|protective agents|mesh-ancestor
82831763|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831764|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831765|NCT00117598|Sirolimus|sirolimus|mesh-list
82831766|NCT00117598|Temsirolimus|temsirolimus|mesh-list
82831767|NCT00117598|MTOR Inhibitors|mtor inhibitors|mesh-list
82831768|NCT00117598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82831769|NCT00117598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831770|NCT00117598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831771|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831772|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
82831773|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831774|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831775|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831776|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831777|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82831778|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
82831779|NCT01082458|Lidocaine|lidocaine|mesh-list
82831780|NCT01082458|Remifentanil|remifentanil|mesh-list
82831781|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
82831782|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
82831783|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831784|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831785|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
82831786|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831787|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82831788|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82831789|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82831790|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82831791|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831792|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82831793|NCT01082458|Narcotics|narcotics|mesh-ancestor
82831794|NCT01082458|Analgesics|analgesics|mesh-ancestor
82831795|NCT00469859|Cytarabine|cytarabine|mesh-list
82831796|NCT00469859|Idarubicin|idarubicin|mesh-list
82831797|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831798|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
82831799|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831800|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831801|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
82831802|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831803|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82831805|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831806|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82831807|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82831808|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82831809|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831810|NCT01021475|Domperidone|domperidone|mesh-list
82831811|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
82831812|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
82831813|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831814|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831815|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831816|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82831817|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
82831818|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831819|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831820|NCT01085032|Nicotine|nicotine|mesh-list
82831821|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82831822|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
82831823|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831824|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831825|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82831826|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82831827|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
82831828|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831829|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831830|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
82831831|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
82831832|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82831833|NCT01021787|Protective Agents|protective agents|mesh-ancestor
82831834|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831835|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831836|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82831837|NCT00093808|Capecitabine|capecitabine|mesh-list
82831838|NCT00093808|Trastuzumab|trastuzumab|mesh-list
82831839|NCT00093808|Vinorelbine|vinorelbine|mesh-list
82831840|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831841|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
82831842|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831843|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831844|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831845|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82831846|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
82831847|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
82831848|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
82831849|NCT00469079|Nicotine|nicotine|mesh-list
82831850|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82831851|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
82831852|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831853|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831854|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82831855|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82831856|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
82831857|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831858|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831859|NCT01326754|Artesunate|artesunate|mesh-list
82831860|NCT01326754|Lumefantrine|lumefantrine|mesh-list
82831861|NCT01326754|Artemether|artemether|mesh-list
82831862|NCT01326754|Piperaquine|piperaquine|mesh-list
82831863|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82831864|NCT01326754|Amodiaquine|amodiaquine|mesh-list
82831865|NCT01326754|Artenimol|artenimol|mesh-list
82831866|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
82831867|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
82831868|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82831869|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82831870|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831871|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831872|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
82831873|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
82831874|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82831875|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
82831876|NCT00093496|Gemcitabine|gemcitabine|mesh-list
82831877|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82831878|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
82831879|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831880|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831881|NCT00265122|Ustekinumab|ustekinumab|mesh-list
82831882|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
82831883|NCT00096538|Valganciclovir|valganciclovir|mesh-list
82831884|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
82831885|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831886|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82831887|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82831888|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831889|NCT03971214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82831890|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82831891|NCT01073748|Acetaminophen|acetaminophen|mesh-list
82831892|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82831893|NCT01073748|Analgesics|analgesics|mesh-ancestor
82831894|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
82831895|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831896|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831897|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
82831898|NCT00468845|Pregabalin|pregabalin|mesh-list
82831899|NCT00468845|Analgesics|analgesics|mesh-ancestor
82831900|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
82831901|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831902|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831903|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
82831904|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82831905|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82831906|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831907|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82831908|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82831909|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82831910|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82831911|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82831912|NCT00468299|Misoprostol|misoprostol|mesh-list
82831913|NCT00468299|Mifepristone|mifepristone|mesh-list
82831914|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82831915|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
82831916|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82831917|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831918|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82831919|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831920|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
82831921|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82831922|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82831923|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82831924|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82831925|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
82831926|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82831927|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82831928|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
82831929|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831930|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
82831931|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82831932|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82831933|NCT01021865|Glucagon|glucagon|mesh-list
82831934|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82831935|NCT01021865|Regadenoson|regadenoson|mesh-list
82831936|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831937|NCT01021865|Hormones|hormones|mesh-ancestor
82831938|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831939|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831940|NCT01021865|Incretins|incretins|mesh-ancestor
82831941|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82831942|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82831943|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
82831944|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
82831945|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82831946|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831947|NCT00468143|Adderall|adderall|mesh-list
82831948|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82831949|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831950|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
82831951|NCT00467831|Erythromycin|erythromycin|mesh-list
82831952|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
82831953|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82831954|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
82831955|NCT00467831|Zileuton|zileuton|mesh-list
82831956|NCT00467831|Losartan|losartan|mesh-list
82831957|NCT00467831|Pravastatin|pravastatin|mesh-list
82831958|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82831959|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82831960|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82831961|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82831962|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82831963|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831964|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
82831965|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82831966|NCT00467831|Expectorants|expectorants|mesh-ancestor
82831967|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
82831968|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82831969|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
82831970|NCT00467831|Protective Agents|protective agents|mesh-ancestor
82831971|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82831972|NCT00467831|Antidotes|antidotes|mesh-ancestor
82831973|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82831974|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82831975|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
82831976|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82831977|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82831978|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82831979|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82831980|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82831981|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82831982|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82831984|NCT00467831|Analgesics|analgesics|mesh-ancestor
82831985|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
82831986|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82831987|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82831988|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82831989|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82831990|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82831991|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
82831992|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82831993|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
82831994|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
82831995|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82831996|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82831997|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82831998|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82831999|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82832000|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82832001|NCT01021943|Spironolactone|spironolactone|mesh-list
82832002|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82832003|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
82832004|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832005|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832006|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82832007|NCT01021943|Diuretics|diuretics|mesh-ancestor
82832008|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
82832009|NCT00116272|Etanercept|etanercept|mesh-list
82832010|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82832011|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82832012|NCT00116272|Analgesics|analgesics|mesh-ancestor
82832013|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
82832014|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832015|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832016|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832017|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832018|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832019|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832020|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
82832021|NCT01022021|Rituximab|rituximab|mesh-list
82832022|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82832023|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832024|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832025|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
82832026|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832027|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832028|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832029|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
82832030|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832032|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82832033|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82832034|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
82832035|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832036|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832037|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832038|NCT00115804|Fluoxetine|fluoxetine|mesh-list
82832039|NCT00115804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82832040|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82832041|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82832042|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832043|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832044|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
82832045|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832046|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82832047|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
82832048|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82832049|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82832050|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82832051|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832052|NCT00467363|Aspirin|aspirin|mesh-list
82832053|NCT00467363|Folic Acid|folic acid|mesh-list
82832054|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82832055|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82832056|NCT00467363|Analgesics|analgesics|mesh-ancestor
82832057|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
82832058|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832059|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832060|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832061|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832062|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82832063|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82832064|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832065|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82832066|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82832067|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832068|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
82832069|NCT00467363|Hematinics|hematinics|mesh-ancestor
82832070|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
82832071|NCT00467363|Vitamins|vitamins|mesh-ancestor
82832072|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
82832073|NCT01071174|Dapivirine|dapivirine|mesh-list
82832074|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82832075|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82832076|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
82832077|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832078|NCT00466505|Celecoxib|celecoxib|mesh-list
82832079|NCT00466505|Cetuximab|cetuximab|mesh-list
82832080|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832081|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832082|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82832083|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82832084|NCT00466505|Analgesics|analgesics|mesh-ancestor
82832085|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
82832086|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832087|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832088|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832089|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832090|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82832091|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82832092|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832093|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832094|NCT02531568|Warfarin|warfarin|mesh-list
82832095|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
82832096|NCT00467051|Paclitaxel|paclitaxel|mesh-list
82832097|NCT00467051|Carboplatin|carboplatin|mesh-list
82832098|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82832099|NCT00467051|Ifosfamide|ifosfamide|mesh-list
82832100|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
82832101|NCT00467051|Lenograstim|lenograstim|mesh-list
82832102|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82832104|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832105|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832106|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832107|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832108|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82832109|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
82832110|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832111|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832112|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
82832113|NCT00264498|Carboplatin|carboplatin|mesh-list
82832114|NCT00264498|Gemcitabine|gemcitabine|mesh-list
82832115|NCT00264498|Gefitinib|gefitinib|mesh-list
82832116|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832117|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832118|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
82832119|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832120|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832121|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832122|NCT00466193|Zolpidem|zolpidem|mesh-list
82832123|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82832124|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82832125|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832126|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832127|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82832128|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
82832129|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
82832130|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482614|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82832131|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832132|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
82832133|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82832134|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832135|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82832136|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832137|NCT01072734|Vaccines|vaccines|mesh-list
82832138|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
82832139|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832140|NCT03970668|Insulin|insulin|mesh-list
82832141|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82832142|NCT03970668|Linagliptin|linagliptin|mesh-list
82832143|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82832144|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832145|NCT03970668|Incretins|incretins|mesh-ancestor
82832146|NCT03970668|Hormones|hormones|mesh-ancestor
82832147|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832148|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82832149|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
82832150|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832151|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832152|NCT00454181|Interferons|interferons|mesh-list
82832153|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
82832154|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832155|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
82832156|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832157|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
82832158|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832159|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82832160|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82832161|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832162|NCT01073826|Incretins|incretins|mesh-ancestor
82832163|NCT01073826|Hormones|hormones|mesh-ancestor
82832164|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832165|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82832166|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
82832167|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832168|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832169|NCT01072812|Phenserine|phenserine|mesh-list
82832170|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82832171|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832172|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832173|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
82832174|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832175|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832176|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
82832177|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82832178|NCT00237042|Estradiol|estradiol|mesh-list
82832179|NCT00237042|Estrogens|estrogens|mesh-ancestor
82832180|NCT00237042|Hormones|hormones|mesh-ancestor
82832181|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832182|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832183|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82832184|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
82832185|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82832186|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82832187|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82832188|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82832189|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82832190|NCT00465647|Hydromorphone|hydromorphone|mesh-list
82832191|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82832192|NCT00465647|Narcotics|narcotics|mesh-ancestor
82832193|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832194|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832195|NCT00465647|Analgesics|analgesics|mesh-ancestor
82832196|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
82832197|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832198|NCT00090766|Valganciclovir|valganciclovir|mesh-list
82832199|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
82832200|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832201|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
82832202|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82832203|NCT03961828|Ledipasvir|ledipasvir|mesh-list
82832204|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
82832205|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832207|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832208|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82832209|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82832210|NCT00465179|Growth Substances|growth substances|mesh-ancestor
82832211|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832212|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
82832213|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832214|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832215|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832216|NCT00084136|Tenofovir|tenofovir|mesh-list
82832217|NCT00084136|Lamivudine|lamivudine|mesh-list
82832218|NCT00084136|Emtricitabine|emtricitabine|mesh-list
82832219|NCT00084136|Zidovudine|zidovudine|mesh-list
82832220|NCT00084136|Efavirenz|efavirenz|mesh-list
82832221|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82832222|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82832223|NCT00084136|Didanosine|didanosine|mesh-list
82832224|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82832225|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
82832226|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832227|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82832228|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82832229|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832230|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832231|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82832232|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82832233|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
82832234|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82832235|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82832236|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82832237|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82832238|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82832239|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82832240|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82832241|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82832242|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
82832243|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
82832244|NCT03812380|Cathartics|cathartics|mesh-ancestor
82832245|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832246|NCT01085422|Temozolomide|temozolomide|mesh-list
82832247|NCT01085422|Veliparib|veliparib|mesh-list
82832248|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832249|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
82832250|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832251|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832254|NCT01085656|Combretastatin|combretastatin|mesh-list
82832255|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82832256|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832257|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832258|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832259|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832260|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832261|NCT01087138|Calcium|calcium|mesh-list
82832262|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82832263|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832264|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82832265|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
82832266|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832267|NCT00464087|Heparin|heparin|mesh-list
82832268|NCT00464087|Calcium heparin|calcium heparin|mesh-list
82832269|NCT00464087|PENTA|penta|mesh-list
82832270|NCT00464087|Bivalirudin|bivalirudin|mesh-list
82832271|NCT00464087|Fondaparinux|fondaparinux|mesh-list
82832272|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
82832273|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82832274|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82832275|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832276|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
82832277|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82832278|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
82832279|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832280|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82832281|NCT00452699|Fluticasone|fluticasone|mesh-list
82832282|NCT00452699|Xhance|xhance|mesh-list
82832283|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82832284|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832285|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82832286|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
82832287|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832288|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832289|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82832290|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
82832291|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
82832292|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82832293|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82832294|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82832295|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82832296|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
82832297|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832298|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832299|NCT00069784|Insulin|insulin|mesh-list
82832300|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82832301|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
82832302|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82832303|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832304|NCT00090610|Carboplatin|carboplatin|mesh-list
82832305|NCT00090610|Docetaxel|docetaxel|mesh-list
82832306|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832307|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832308|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832309|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832310|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832311|NCT01326988|Anesthetics|anesthetics|mesh-list
82832312|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832313|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832314|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
82832315|NCT03962296|Calcium|calcium|mesh-list
82832316|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82832317|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832318|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
82832319|NCT03962296|Coagulants|coagulants|mesh-ancestor
82832320|NCT01086046|Heparin|heparin|mesh-list
82832321|NCT01086046|Enoxaparin|enoxaparin|mesh-list
82832322|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82832323|NCT01086046|Tinzaparin|tinzaparin|mesh-list
82832324|NCT01086046|Dalteparin|dalteparin|mesh-list
82832325|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
82832326|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82832327|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82832328|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832329|NCT01090648|Etravirine|etravirine|mesh-list
82832330|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82832331|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82832332|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832333|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832334|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
82832335|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832336|NCT03741244|Temozolomide|temozolomide|mesh-list
82832337|NCT03741244|Apatinib|apatinib|mesh-list
82832338|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832339|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
82832340|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832341|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832342|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832343|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832344|NCT00463385|Thalidomide|thalidomide|mesh-list
82832345|NCT00463385|Prednisone|prednisone|mesh-list
82832346|NCT00463385|Pomalidomide|pomalidomide|mesh-list
82832347|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832348|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
82832349|NCT00463385|Hormones|hormones|mesh-ancestor
82832350|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832351|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832352|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82832353|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832354|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
82832355|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82832356|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82832357|NCT00463385|Growth Substances|growth substances|mesh-ancestor
82832358|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
82832359|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832360|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
82832361|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82832362|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832363|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
82832364|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82832365|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82832366|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82832367|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82832368|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832369|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
82832370|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832371|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832372|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82832373|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832375|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
82832376|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
82832377|NCT00068692|Fluorouracil|fluorouracil|mesh-list
82832378|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
82832379|NCT00068692|Irinotecan|irinotecan|mesh-list
82832380|NCT00068692|Camptothecin|camptothecin|mesh-list
82832381|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
82832382|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832383|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
82832384|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832385|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832386|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832387|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832388|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
82832389|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82832390|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82832391|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832392|NCT00068692|Antidotes|antidotes|mesh-ancestor
82832393|NCT00068692|Protective Agents|protective agents|mesh-ancestor
82832394|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
82832395|NCT00068692|Vitamins|vitamins|mesh-ancestor
82832396|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
82832397|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82832398|NCT00463151|Rebamipide|rebamipide|mesh-list
82832399|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82832400|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832401|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
82832402|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832403|NCT00463151|Protective Agents|protective agents|mesh-ancestor
82832405|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832406|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
82832407|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832408|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832409|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832410|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832411|NCT00067990|Losartan|losartan|mesh-list
82832412|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82832413|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82832414|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82832415|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82832416|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832417|NCT00263328|Tacrolimus|tacrolimus|mesh-list
82832418|NCT00263328|Tofacitinib|tofacitinib|mesh-list
82832419|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832420|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
82832421|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832422|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82832423|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832424|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832425|NCT00263328|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82832426|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832427|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
82832428|NCT03741660|Cathartics|cathartics|mesh-ancestor
82832429|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832430|NCT00262860|Gemcitabine|gemcitabine|mesh-list
82832431|NCT00262860|Bortezomib|bortezomib|mesh-list
82832432|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832433|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
82832434|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832435|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832436|NCT00236184|Rabeprazole|rabeprazole|mesh-list
82832437|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82832438|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832439|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82832440|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832441|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832442|NCT00296504|Ritonavir|ritonavir|mesh-list
82832443|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
82832444|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82832445|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82832446|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
82832447|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832448|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832449|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82832450|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82832451|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
82832452|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832453|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82832454|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82832455|NCT00313820|Pregabalin|pregabalin|mesh-list
82832456|NCT00313820|Analgesics|analgesics|mesh-ancestor
82832457|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
82832458|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832459|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832460|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
82832461|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82832462|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82832463|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832464|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82832465|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82832466|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82832467|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832468|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82832469|NCT00235872|Adalimumab|adalimumab|mesh-list
82832470|NCT00235872|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82832471|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832472|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832473|NCT00461981|Vaccines|vaccines|mesh-list
82832474|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
82832475|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832476|NCT00296036|Pyridoxine|pyridoxine|mesh-list
82832477|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
82832478|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
82832479|NCT00296036|Vitamins|vitamins|mesh-ancestor
82832480|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
82832481|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832482|NCT01072890|Sirolimus|sirolimus|mesh-list
82832483|NCT01072890|Temsirolimus|temsirolimus|mesh-list
82832484|NCT01072890|MTOR Inhibitors|mtor inhibitors|mesh-list
82832485|NCT01072890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832486|NCT01072890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832487|NCT01072890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832488|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832489|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
82832490|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832491|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832492|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82832493|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832494|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82832495|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
82832496|NCT00089674|Denosumab|denosumab|mesh-list
82832497|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82832498|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832499|NCT01090882|Bupivacaine|bupivacaine|mesh-list
82832500|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
82832501|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
82832502|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832503|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832504|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
82832505|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832506|NCT01090960|Ipatasertib|ipatasertib|mesh-list
82832507|NCT01090960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832508|NCT01090960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832509|NCT01090960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832510|NCT01090960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832511|NCT01067066|Temozolomide|temozolomide|mesh-list
82832512|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832513|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
82832514|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832515|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832516|NCT00313586|Azacitidine|azacitidine|mesh-list
82832517|NCT00313586|Entinostat|entinostat|mesh-list
82832518|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82832519|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832520|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
82832521|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832522|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832523|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832524|NCT01069328|Paclitaxel|paclitaxel|mesh-list
82832525|NCT01069328|Bevacizumab|bevacizumab|mesh-list
82832526|NCT01069328|Carboplatin|carboplatin|mesh-list
82832527|NCT01069328|Sorafenib|sorafenib|mesh-list
82832528|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82832529|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832530|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832531|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832532|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832533|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832534|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832535|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82832536|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82832537|NCT01069328|Growth Substances|growth substances|mesh-ancestor
82832538|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832539|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
82832540|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832541|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832542|NCT01067222|Modafinil|modafinil|mesh-list
82832543|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82832544|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832545|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82832546|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82832547|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82832548|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832549|NCT00312572|Buprenorphine|buprenorphine|mesh-list
82832550|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82832551|NCT00312572|Narcotics|narcotics|mesh-ancestor
82832552|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832553|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832554|NCT00312572|Analgesics|analgesics|mesh-ancestor
82832555|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
82832556|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832557|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82832558|NCT00290732|Doxorubicin|doxorubicin|mesh-list
82832559|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82832560|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82832561|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832562|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82832563|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82832564|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832565|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832566|NCT00312494|Ziprasidone|ziprasidone|mesh-list
82832567|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82832568|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
82832569|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832570|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832571|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832572|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82832573|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82832574|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832575|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82832576|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82832577|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
82832578|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
82832579|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82832580|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82832581|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832582|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82832583|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82832584|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832585|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832586|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832587|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82832588|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
82832589|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82832590|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832591|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82832592|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82832593|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82832594|NCT00290498|Cytarabine|cytarabine|mesh-list
82832595|NCT00290498|Dexamethasone|dexamethasone|mesh-list
82832596|NCT00290498|Prednisone|prednisone|mesh-list
82832597|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
82832598|NCT00290498|Rituximab|rituximab|mesh-list
82832599|NCT00290498|Doxorubicin|doxorubicin|mesh-list
82832600|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82832601|NCT00290498|Methotrexate|methotrexate|mesh-list
82832602|NCT00290498|Vincristine|vincristine|mesh-list
82832603|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832604|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
82832605|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832606|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832607|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832608|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
82832609|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832610|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832611|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82832612|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832613|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832614|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
82832615|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
82832616|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832617|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832618|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
82832619|NCT00290498|Hormones|hormones|mesh-ancestor
82832620|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832621|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82832622|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82832623|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82832624|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82832625|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832626|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82832627|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
82832629|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832630|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
82832631|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
82832632|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82832633|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82832634|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
82832635|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832636|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82832637|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832638|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832639|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832640|NCT01069796|Paclitaxel|paclitaxel|mesh-list
82832641|NCT01069796|Bevacizumab|bevacizumab|mesh-list
82832642|NCT01069796|Capecitabine|capecitabine|mesh-list
82832643|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82832644|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832645|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832646|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832647|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832648|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832649|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832650|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82832651|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82832652|NCT01069796|Growth Substances|growth substances|mesh-ancestor
82832653|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832654|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
82832655|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832656|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
82832657|NCT01067534|Albuterol|albuterol|mesh-list
82832658|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82832659|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
82832660|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832661|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832662|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82832663|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
82832664|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
82832665|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82832666|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82832667|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82832668|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82832669|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
82832670|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832671|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832672|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
82832673|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82832674|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
82832675|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
82832676|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832677|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
82832678|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832679|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82832680|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832681|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82832682|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82832683|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82832684|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832685|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
82832686|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82832687|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832688|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
82832689|NCT01069874|Vitamin D|vitamin d|mesh-list
82832690|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
82832691|NCT01069874|Vitamins|vitamins|mesh-ancestor
82832692|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
82832693|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832694|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82832695|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82832696|NCT01022645|Copper|copper|mesh-list
82832697|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
82832698|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82832699|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
82832700|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82832701|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832702|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82832704|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82832705|NCT01022645|Trace Elements|trace elements|mesh-ancestor
82832706|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
82832707|NCT01025765|Metformin|metformin|mesh-list
82832708|NCT01025765|Pioglitazone|pioglitazone|mesh-list
82832709|NCT01025765|Acarbose|acarbose|mesh-list
82832710|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82832711|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832712|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82832713|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832714|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832715|NCT03824912|Ketoconazole|ketoconazole|mesh-list
82832716|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
82832717|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832718|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82832719|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82832720|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832721|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832722|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82832723|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
82832724|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832725|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832726|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82832727|NCT01062776|Furosemide|furosemide|mesh-list
82832728|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82832729|NCT01062776|Diuretics|diuretics|mesh-ancestor
82832730|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
82832731|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832732|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82832733|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82832734|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832735|NCT01025921|Colistin|colistin|mesh-list
82832736|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82832737|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832738|NCT01070030|Amlodipine|amlodipine|mesh-list
82832739|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82832741|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82832742|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82832743|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832744|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82832745|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832746|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
82832747|NCT01070030|Diuretics|diuretics|mesh-ancestor
82832748|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
82832749|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82832750|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82832751|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
82832752|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82832753|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82832754|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832755|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832756|NCT00461123|Urological Agents|urological agents|mesh-ancestor
82832757|NCT00290342|Edetic Acid|edetic acid|mesh-list
82832758|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
82832759|NCT00290342|Antidotes|antidotes|mesh-ancestor
82832760|NCT00290342|Protective Agents|protective agents|mesh-ancestor
82832761|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832762|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
82832763|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
82832764|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832765|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82832766|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
82832767|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82832768|NCT00460811|Linaclotide|linaclotide|mesh-list
82832769|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82832770|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
82832771|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832772|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832773|NCT01070108|Ketamine|ketamine|mesh-list
82832774|NCT01070108|Analgesics|analgesics|mesh-ancestor
82832775|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
82832776|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832777|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832778|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82832779|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82832780|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
82832782|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82832783|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82832784|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82832785|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832786|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832787|NCT01067690|Indinavir|indinavir|mesh-list
82832788|NCT01067690|Bleomycin|bleomycin|mesh-list
82832789|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82832790|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82832791|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
82832792|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832793|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832794|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82832795|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82832796|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
82832797|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832798|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82832799|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832800|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
82832801|NCT03982004|Imiquimod|imiquimod|mesh-list
82832802|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832803|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832804|NCT03982004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82832805|NCT03982004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832806|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82832807|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
82832808|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832809|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
82832810|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82832811|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832812|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832813|NCT01026233|Immunotoxins|immunotoxins|mesh-ancestor
82832814|NCT01026233|Immunoconjugates|immunoconjugates|mesh-ancestor
82832815|NCT01026233|Immunologic Factors|immunologic factors|mesh-ancestor
82832816|NCT01026233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832817|NCT01062932|Cycloserine|cycloserine|mesh-list
82832818|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82832819|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832820|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82832821|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
82832822|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82832823|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
82832824|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832825|NCT01026311|Ubiquinone|ubiquinone|mesh-list
82832826|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
82832827|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
82832828|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832829|NCT01026311|Vitamins|vitamins|mesh-ancestor
82832830|NCT01063010|Bevacizumab|bevacizumab|mesh-list
82832831|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832832|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832833|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82832834|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82832835|NCT01063010|Growth Substances|growth substances|mesh-ancestor
82832836|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832837|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
82832838|NCT00460577|Bromides|bromides|mesh-list
82832839|NCT00460577|Fenoterol|fenoterol|mesh-list
82832840|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
82832841|NCT00460577|Ipratropium|ipratropium|mesh-list
82832842|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82832843|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
82832844|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832845|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832846|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82832847|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
82832848|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82832849|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82832850|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82832852|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82832853|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832854|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
82832855|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82832856|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
82832857|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
82832858|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
82832859|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82832860|NCT01581320|Vitamin D|vitamin d|mesh-list
82832861|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
82832862|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
82832863|NCT01581320|Vitamins|vitamins|mesh-ancestor
82832864|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
82832865|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832866|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82832867|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82832868|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82832869|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832870|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832871|NCT00288704|Rilonacept|rilonacept|mesh-list
82832872|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832873|NCT00288626|Cytarabine|cytarabine|mesh-list
82832874|NCT00288626|Prednisone|prednisone|mesh-list
82832875|NCT00288626|Etoposide|etoposide|mesh-list
82832876|NCT00288626|Melphalan|melphalan|mesh-list
82832877|NCT00288626|Carmustine|carmustine|mesh-list
82832878|NCT00288626|Lenograstim|lenograstim|mesh-list
82832879|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832880|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
82832881|NCT00288626|Hormones|hormones|mesh-ancestor
82832882|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832883|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832884|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82832885|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832886|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82832887|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82832888|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82832889|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832890|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832891|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832892|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
82832893|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
82832894|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832895|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832896|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
82832897|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832898|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
82832899|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82832900|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82832902|NCT00087490|Linezolid|linezolid|mesh-list
82832903|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82832904|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82832905|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82832906|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832907|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832908|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
82832909|NCT00087178|Doxorubicin|doxorubicin|mesh-list
82832910|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82832911|NCT00087178|Fluorouracil|fluorouracil|mesh-list
82832912|NCT00087178|Epirubicin|epirubicin|mesh-list
82832913|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832914|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
82832915|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832916|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82832917|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82832918|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
82832919|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832920|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832921|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82832922|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82832923|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82832924|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82832925|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832926|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
82832927|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832928|NCT00288080|Dexamethasone|dexamethasone|mesh-list
82832929|NCT00288080|Prednisone|prednisone|mesh-list
82832930|NCT00288080|Docetaxel|docetaxel|mesh-list
82832931|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
82832932|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832933|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
82832934|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
82832935|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82832936|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832937|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82832938|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
82832939|NCT00288080|Hormones|hormones|mesh-ancestor
82832940|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832941|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82832942|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832943|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832944|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832945|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832946|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832947|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
82832948|NCT01068392|Prednisolone|prednisolone|mesh-list
82832949|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
82832950|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832951|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82832952|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
82832953|NCT01068392|Hormones|hormones|mesh-ancestor
82832954|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832955|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832956|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82832957|NCT01086826|Cisplatin|cisplatin|mesh-list
82832958|NCT01086826|Docetaxel|docetaxel|mesh-list
82832959|NCT01086826|Fluorouracil|fluorouracil|mesh-list
82832960|NCT01086826|Cetuximab|cetuximab|mesh-list
82832961|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832962|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
82832963|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
82832964|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
82832965|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832966|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
82832967|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82832968|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82832969|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
82832970|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832971|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82832972|NCT00287690|Genistein|genistein|mesh-list
82832973|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82832974|NCT00287690|Protective Agents|protective agents|mesh-ancestor
82832975|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832976|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832977|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832978|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832979|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832980|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
82832981|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82832982|NCT00287690|Estrogens|estrogens|mesh-ancestor
82832983|NCT00287690|Hormones|hormones|mesh-ancestor
82832984|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82832985|NCT01070186|Sunitinib|sunitinib|mesh-list
82832986|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832987|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82832988|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82832989|NCT01070186|Growth Substances|growth substances|mesh-ancestor
82832990|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82832991|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
82832992|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82832993|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82832994|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82832995|NCT00066742|Etoposide|etoposide|mesh-list
82832996|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
82832997|NCT00066742|Tirapazamine|tirapazamine|mesh-list
82832998|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82832999|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82833000|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82833001|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833002|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833003|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833005|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833006|NCT01094158|Cholic Acids|cholic acids|mesh-list
82833007|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833008|NCT00460109|Rituximab|rituximab|mesh-list
82833009|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
82833010|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833011|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833012|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
82833013|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833014|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833015|NCT03956212|Doxycycline|doxycycline|mesh-list
82833016|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833017|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833018|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
82833019|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82833020|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82833021|NCT01091818|Midazolam|midazolam|mesh-list
82833022|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
82833023|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82833024|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833025|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833026|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82833027|NCT01091818|Analgesics|analgesics|mesh-ancestor
82833028|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
82833029|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833030|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82833031|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82833032|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82833033|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
82833034|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833035|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833036|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82833037|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82833038|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82833039|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833040|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82833041|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
82833042|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
82833043|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
82833044|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
82833045|NCT01091896|Bevacizumab|bevacizumab|mesh-list
82833046|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833047|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833048|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833049|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833050|NCT01091896|Growth Substances|growth substances|mesh-ancestor
82833051|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833052|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833054|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
82833055|NCT00065260|Cyclosporins|cyclosporins|mesh-list
82833056|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
82833057|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82833058|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833059|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833060|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833061|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
82833062|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833063|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
82833064|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833065|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
82833066|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833067|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82833068|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833069|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833070|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
82833071|NCT01327066|Droxidopa|droxidopa|mesh-list
82833072|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833073|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833074|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82833075|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833076|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833077|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833078|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833079|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82833080|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82833081|NCT01094626|Secretin|secretin|mesh-list
82833082|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833083|NCT01094626|Hormones|hormones|mesh-ancestor
82833084|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833085|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833086|NCT03956134|Tapentadol|tapentadol|mesh-list
82833087|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82833088|NCT03956134|Narcotics|narcotics|mesh-ancestor
82833089|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833090|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833091|NCT03956134|Analgesics|analgesics|mesh-ancestor
82833092|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
82833093|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833094|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82833095|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82833096|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82833097|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833098|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
82833099|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833100|NCT00460031|Ketoconazole|ketoconazole|mesh-list
82833101|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
82833102|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82833103|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82833104|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82833105|NCT00460031|Lenalidomide|lenalidomide|mesh-list
82833106|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
82833107|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833108|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833109|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833110|NCT00460031|Growth Substances|growth substances|mesh-ancestor
82833111|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833112|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833113|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833114|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
82833115|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833116|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82833117|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82833118|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833119|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833120|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82833121|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
82833122|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833123|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82833124|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
82833125|NCT00451217|Neostigmine|neostigmine|mesh-list
82833126|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82833127|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833128|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833129|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
82833130|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833131|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833132|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82833133|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
82833134|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833135|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82833136|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82833137|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82833138|NCT00459953|Nicotine|nicotine|mesh-list
82833139|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82833140|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
82833141|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833142|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833143|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82833144|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82833145|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
82833146|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833147|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833148|NCT00459875|Sunitinib|sunitinib|mesh-list
82833149|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833150|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833151|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833152|NCT00459875|Growth Substances|growth substances|mesh-ancestor
82833154|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833155|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83443237|NCT02061969|Incretins|incretins|mesh-ancestor
82833156|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833157|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833158|NCT00311402|Aspirin|aspirin|mesh-list
82833159|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
82833160|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82833161|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82833162|NCT00311402|Analgesics|analgesics|mesh-ancestor
82833163|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
82833164|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833165|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833166|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833167|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833168|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82833169|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82833170|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833171|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82833172|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82833173|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833174|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
82833175|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82833176|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82833177|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833178|NCT00450749|Lycopene|lycopene|mesh-list
82833179|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833180|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
82833181|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833182|NCT00450749|Protective Agents|protective agents|mesh-ancestor
82833183|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833184|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82833185|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82833186|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833187|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82833188|NCT00292370|Paroxetine|paroxetine|mesh-list
82833189|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
82833190|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833191|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82833192|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82833193|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833194|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833195|NCT00292370|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82833197|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82833198|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833199|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833200|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
82833201|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82833202|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82833203|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82833204|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833205|NCT00065182|Docetaxel|docetaxel|mesh-list
82833206|NCT00065182|Topotecan|topotecan|mesh-list
82833207|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833208|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
82833209|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
82833210|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
82833211|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833212|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82833213|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833214|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833215|NCT01026701|Bortezomib|bortezomib|mesh-list
82833216|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833217|NCT01092130|Vitamin D|vitamin d|mesh-list
82833218|NCT01092130|Vitamins|vitamins|mesh-ancestor
82833219|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
82833220|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833221|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82833222|NCT00064792|Simvastatin|simvastatin|mesh-list
82833223|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82833224|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82833225|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
82833227|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82833228|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82833229|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833230|NCT01095016|Fenoterol|fenoterol|mesh-list
82833231|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82833232|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
82833233|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833234|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833235|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82833236|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
82833237|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
82833238|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
82833239|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82833240|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82833241|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82833242|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82833243|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
82833244|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833245|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833246|NCT01095172|Prednisolone|prednisolone|mesh-list
82833247|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82833248|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
82833249|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82833250|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
82833251|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
82833252|NCT01095172|Rituximab|rituximab|mesh-list
82833253|NCT01095172|Tacrolimus|tacrolimus|mesh-list
82833254|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82833255|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
82833256|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833257|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833258|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
82833259|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833260|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833261|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833262|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82833263|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833264|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833265|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833266|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
82833267|NCT01095172|Hormones|hormones|mesh-ancestor
82833268|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833269|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82833270|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
82833271|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
82833272|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833273|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833274|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82833275|NCT01095172|Protective Agents|protective agents|mesh-ancestor
82833276|NCT00286442|Metformin|metformin|mesh-list
82833277|NCT00286442|Alogliptin|alogliptin|mesh-list
82833278|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82833279|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833280|NCT00286442|Incretins|incretins|mesh-ancestor
82833281|NCT00286442|Hormones|hormones|mesh-ancestor
82833282|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833283|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82833284|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
82833285|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833286|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833287|NCT00063934|Docetaxel|docetaxel|mesh-list
82833288|NCT00063934|Doxorubicin|doxorubicin|mesh-list
82833289|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82833290|NCT00063934|Oblimersen|oblimersen|mesh-list
82833291|NCT00063934|Lenograstim|lenograstim|mesh-list
82833292|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833293|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
82833294|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
82833295|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
82833296|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833297|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82833298|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82833299|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833300|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833301|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82833302|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
82833303|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833305|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833306|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833307|NCT01092520|Gabapentin|gabapentin|mesh-list
82833308|NCT01092520|Analgesics|analgesics|mesh-ancestor
82833309|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
82833310|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833311|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833312|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
82833313|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82833314|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82833315|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833316|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833317|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82833318|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82833319|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833320|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833321|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
82833322|NCT00458705|Thalidomide|thalidomide|mesh-list
82833323|NCT00458705|Dexamethasone|dexamethasone|mesh-list
82833324|NCT00458705|Doxorubicin|doxorubicin|mesh-list
82833325|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82833326|NCT00458705|Bortezomib|bortezomib|mesh-list
82833327|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833328|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
82833329|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
82833330|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833331|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833332|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833333|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
82833334|NCT00458705|Hormones|hormones|mesh-ancestor
82833335|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833336|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82833337|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833338|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82833339|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82833340|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833341|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833342|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833343|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833344|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
82833345|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
82833346|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833347|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833348|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833349|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833350|NCT00458705|Growth Substances|growth substances|mesh-ancestor
82833351|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833352|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
82833353|NCT00062374|Alovudine|alovudine|mesh-list
82833354|NCT00062374|Cisplatin|cisplatin|mesh-list
82833355|NCT00062374|Irinotecan|irinotecan|mesh-list
82833356|NCT00062374|Camptothecin|camptothecin|mesh-list
82833357|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82833358|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833359|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82833360|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833361|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833362|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833363|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82833364|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82833365|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
82833366|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
82833367|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833368|NCT00285818|Mifepristone|mifepristone|mesh-list
82833369|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82833370|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
82833371|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82833372|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833373|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82833374|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82833375|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82833376|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
82833377|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82833378|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82833379|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
82833380|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833381|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
82833382|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82833383|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82833384|NCT01023347|Paclitaxel|paclitaxel|mesh-list
82833385|NCT01023347|genexol-PM|genexol-pm|mesh-list
82833386|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82833387|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82833388|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833389|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
82833390|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
82833391|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
82833392|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833393|NCT01023425|Donepezil|donepezil|mesh-list
82833394|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82833395|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833396|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833397|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
82833398|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833399|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833400|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
82833401|NCT00285584|Bupropion|bupropion|mesh-list
82833402|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82833403|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
82833404|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833405|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82833406|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82833407|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82833408|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833409|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
82833410|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833411|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833412|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82833413|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82833414|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833415|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82833416|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833417|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833418|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833419|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82833420|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
82833422|NCT00291668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833423|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833424|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
82833425|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833426|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833427|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82833428|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82833429|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82833430|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833431|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833432|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
82833433|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833434|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82833435|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82833436|NCT03955354|Apatinib|apatinib|mesh-list
82833437|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833438|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833439|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833440|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833441|NCT01095484|Rotigotine|rotigotine|mesh-list
82833442|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
82833443|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
82833444|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833445|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833446|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833447|NCT01063478|Everolimus|everolimus|mesh-list
82833448|NCT01063478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82833449|NCT01063478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833450|NCT01063478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833451|NCT01063478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833452|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833453|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
82833454|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833455|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833456|NCT01327144|Acyclovir|acyclovir|mesh-list
82833457|NCT01327144|Famciclovir|famciclovir|mesh-list
82833458|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
82833459|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833460|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82833461|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833462|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833463|NCT01323101|Doxycycline|doxycycline|mesh-list
82833464|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833465|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833466|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
82833467|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82833468|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82833469|NCT00310856|Vaccines|vaccines|mesh-list
82833470|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
82833471|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833472|NCT03670355|Tenofovir|tenofovir|mesh-list
82833473|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
82833474|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833475|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82833476|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82833477|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833478|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833479|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82833480|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82833481|NCT02532062|Vitamin D|vitamin d|mesh-list
82833482|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
82833483|NCT02532062|Vitamins|vitamins|mesh-ancestor
82833484|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
82833485|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833486|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82833487|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82833488|NCT00283712|Infliximab|infliximab|mesh-list
82833489|NCT00283712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82833490|NCT00283712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833491|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
82833492|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833493|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833494|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82833495|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
82833496|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833497|NCT00449033|Gemcitabine|gemcitabine|mesh-list
82833498|NCT00449033|Sorafenib|sorafenib|mesh-list
82833499|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833500|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833501|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
82833502|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833503|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833504|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833505|NCT01024205|Sunitinib|sunitinib|mesh-list
82833506|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833507|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833508|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833509|NCT01024205|Growth Substances|growth substances|mesh-ancestor
82833510|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833511|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833512|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833513|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833514|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833515|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
82833516|NCT00448019|Bevacizumab|bevacizumab|mesh-list
82833517|NCT00448019|Rituximab|rituximab|mesh-list
82833518|NCT00448019|Fludarabine|fludarabine|mesh-list
82833519|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
82833520|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833521|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
82833522|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833523|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833524|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82833526|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833527|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833528|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82833529|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833530|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833531|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833532|NCT00448019|Growth Substances|growth substances|mesh-ancestor
82833533|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833534|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833535|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
82833536|NCT00457691|Leucovorin|leucovorin|mesh-list
82833537|NCT00457691|Fluorouracil|fluorouracil|mesh-list
82833538|NCT00457691|Irinotecan|irinotecan|mesh-list
82833539|NCT00457691|Sunitinib|sunitinib|mesh-list
82833540|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
82833541|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
82833542|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833543|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833544|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833545|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833546|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
82833547|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833548|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82833549|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833550|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833551|NCT00457691|Antidotes|antidotes|mesh-ancestor
82833552|NCT00457691|Protective Agents|protective agents|mesh-ancestor
82833553|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
82833554|NCT00457691|Vitamins|vitamins|mesh-ancestor
82833555|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
82833556|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833557|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833558|NCT00457691|Growth Substances|growth substances|mesh-ancestor
82833559|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833560|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833561|NCT00447005|Axitinib|axitinib|mesh-list
82833562|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833563|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833564|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833565|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833566|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
82833567|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
82833568|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833569|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833570|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833571|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
82833572|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82833573|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833574|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833575|NCT00446849|Mesalamine|mesalamine|mesh-list
82833576|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82833577|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82833578|NCT00446849|Analgesics|analgesics|mesh-ancestor
82833579|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
82833580|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833581|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833582|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833583|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833584|NCT01565837|Ipilimumab|ipilimumab|mesh-list
82833585|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833586|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833587|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82833588|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833589|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
82833590|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82833591|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833592|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82833593|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
82833594|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833595|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833596|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833597|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833598|NCT00456599|Gemcitabine|gemcitabine|mesh-list
82833600|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833601|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
82833602|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833603|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833604|NCT00456521|Naltrexone|naltrexone|mesh-list
82833605|NCT00456521|Bupropion|bupropion|mesh-list
82833606|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82833607|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82833608|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833609|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
82833610|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833611|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82833612|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
82833613|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833614|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82833615|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82833616|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82833617|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833618|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
82833619|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833620|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82833621|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82833622|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833623|NCT00456365|Pravastatin|pravastatin|mesh-list
82833624|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82833625|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82833626|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
82833627|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833628|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82833629|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82833630|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833631|NCT03843047|Nicotine|nicotine|mesh-list
82833632|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82833633|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
82833634|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833635|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833636|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82833637|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82833638|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
82833639|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833640|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833641|NCT00455741|Estradiol|estradiol|mesh-list
82833642|NCT00455741|Progesterone|progesterone|mesh-list
82833643|NCT00455741|Estrogens|estrogens|mesh-ancestor
82833644|NCT00455741|Hormones|hormones|mesh-ancestor
82833645|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833646|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833647|NCT00455741|Progestins|progestins|mesh-ancestor
82833648|NCT00445679|Paroxetine|paroxetine|mesh-list
82833649|NCT00445679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82833650|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82833651|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82833652|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833653|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833654|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
82833655|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833656|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82833657|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
82833658|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833659|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82833660|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82833661|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833662|NCT00445601|Gemcitabine|gemcitabine|mesh-list
82833663|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833664|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
82833665|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833666|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833667|NCT00444587|Trastuzumab|trastuzumab|mesh-list
82833668|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833669|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833670|NCT00235716|Vitamins|vitamins|mesh-list
82833673|NCT00235716|Tocotrienols|tocotrienols|mesh-list
82833674|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
82833675|NCT00235716|Memantine|memantine|mesh-list
82833676|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
82833677|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833678|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
82833679|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833680|NCT00235716|Protective Agents|protective agents|mesh-ancestor
82833681|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82833682|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82833683|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
82833684|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833685|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82833686|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82833687|NCT00274742|Blinatumomab|blinatumomab|mesh-list
82833688|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82833689|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833690|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
82833691|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833692|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
82833693|NCT03970044|Exenatide|exenatide|mesh-list
82833694|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82833695|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833696|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82833697|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833698|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82833699|NCT03970044|Incretins|incretins|mesh-ancestor
82833700|NCT03970044|Hormones|hormones|mesh-ancestor
82833701|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833702|NCT00444275|Esomeprazole|esomeprazole|mesh-list
82833703|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82833704|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833705|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82833706|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833707|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833708|NCT00454805|Fulvestrant|fulvestrant|mesh-list
82833709|NCT00454805|Cediranib|cediranib|mesh-list
82833710|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82833711|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833712|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82833713|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82833714|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
82833715|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833716|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833717|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833718|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833719|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833720|NCT00283244|Gemcitabine|gemcitabine|mesh-list
82833721|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82833722|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833723|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
82833724|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833725|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833726|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833727|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833728|NCT00282464|Ziprasidone|ziprasidone|mesh-list
82833729|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82833730|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
82833731|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833732|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833733|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833734|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82833735|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82833736|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833737|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82833738|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82833739|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
82833740|NCT03841331|Serlopitant|serlopitant|mesh-list
82833741|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82833742|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833743|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833744|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833745|NCT00262080|Ecallantide|ecallantide|mesh-list
82833746|NCT00262080|Analgesics|analgesics|mesh-ancestor
82833747|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
82833748|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833749|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833750|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82833751|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82833752|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833753|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833754|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
82833755|NCT01073904|Norgestrel|norgestrel|mesh-list
82833756|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82833757|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
82833758|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82833759|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833760|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82833761|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82833762|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82833763|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82833764|NCT00282308|Rituximab|rituximab|mesh-list
82833765|NCT00282308|Methotrexate|methotrexate|mesh-list
82833766|NCT00282308|Vaccines|vaccines|mesh-list
82833767|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82833768|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
82833769|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
82833770|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833771|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833772|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833773|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833774|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82833775|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
82833776|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82833777|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833778|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
82833779|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833780|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
82833781|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833782|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82833783|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833784|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82833785|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82833786|NCT00281840|Bevacizumab|bevacizumab|mesh-list
82833787|NCT00281840|Docetaxel|docetaxel|mesh-list
82833788|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833789|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833790|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833791|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833792|NCT00281840|Growth Substances|growth substances|mesh-ancestor
82833793|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833794|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833795|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
82833796|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
82833797|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
82833798|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833799|NCT00272792|Verapamil|verapamil|mesh-list
82833800|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82833801|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82833802|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82833803|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833804|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82833805|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833806|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
82833807|NCT01069094|Leuprolide|leuprolide|mesh-list
82833808|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82833809|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
82833810|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82833811|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833812|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82833813|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833814|NCT00048568|Methotrexate|methotrexate|mesh-list
82833815|NCT00048568|Abatacept|abatacept|mesh-list
82833816|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82833817|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
82833819|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833820|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82833821|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
82833822|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833823|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833824|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
82833825|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833826|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82833827|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833828|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
82833829|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833830|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82833831|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82833832|NCT00048568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833833|NCT00262002|Vaccines|vaccines|mesh-list
82833834|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
82833835|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833836|NCT01584076|Donepezil|donepezil|mesh-list
82833837|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82833838|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833839|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833840|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
82833841|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82833842|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833843|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
82833844|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
82833845|NCT03954964|Narcotics|narcotics|mesh-ancestor
82833846|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833847|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833848|NCT03954964|Analgesics|analgesics|mesh-ancestor
82833849|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
82833850|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833851|NCT00281528|Paclitaxel|paclitaxel|mesh-list
82833852|NCT00281528|Bevacizumab|bevacizumab|mesh-list
82833853|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82833854|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82833855|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833856|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
82833857|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
82833858|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
82833859|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833860|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833861|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82833862|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82833863|NCT00281528|Growth Substances|growth substances|mesh-ancestor
82833864|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833865|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
82833866|NCT01095640|Adapalene|adapalene|mesh-list
82833867|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82833868|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82833869|NCT01095640|Analgesics|analgesics|mesh-ancestor
82833870|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
82833871|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833873|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833874|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833875|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
82833876|NCT00280748|Pemetrexed|pemetrexed|mesh-list
82833877|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833878|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833879|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833880|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82833881|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82833882|NCT03975374|Tobramycin|tobramycin|mesh-list
82833883|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
82833884|NCT03975374|Dexamethasone|dexamethasone|mesh-list
82833885|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82833886|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833887|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
82833888|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
82833889|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833890|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833893|NCT03975374|Hormones|hormones|mesh-ancestor
82833894|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833895|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82833896|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833897|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833898|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833899|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82833900|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
82833901|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82833902|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833903|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82833904|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
82833905|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
82833906|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833907|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
82833908|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833909|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82833910|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82833911|NCT03976544|Estradiol|estradiol|mesh-list
82833912|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82833913|NCT03976544|Progesterone|progesterone|mesh-list
82833914|NCT03976544|Estrogens|estrogens|mesh-ancestor
82833915|NCT03976544|Hormones|hormones|mesh-ancestor
82833916|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82833917|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833918|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82833919|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
82833920|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82833921|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82833922|NCT03976544|Progestins|progestins|mesh-ancestor
82833923|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
82833924|NCT03741686|Cathartics|cathartics|mesh-ancestor
82833925|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833926|NCT00279812|Selenium|selenium|mesh-list
82833927|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
82833928|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833929|NCT00279812|Protective Agents|protective agents|mesh-ancestor
82833930|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833931|NCT00279812|Trace Elements|trace elements|mesh-ancestor
82833932|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
82833933|NCT01070732|Acetaminophen|acetaminophen|mesh-list
82833934|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82833935|NCT01070732|Analgesics|analgesics|mesh-ancestor
82833936|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
82833937|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833938|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833939|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
82833940|NCT00207714|Infliximab|infliximab|mesh-list
82833941|NCT00207714|Golimumab|golimumab|mesh-list
82833942|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82833943|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82833944|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
82833945|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82833946|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82833947|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82833948|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
82833949|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833950|NCT00207090|Rifampin|rifampin|mesh-list
82833951|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82833952|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
82833953|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82833954|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82833955|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
82833956|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82833957|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833958|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833959|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82833960|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82833961|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82833962|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82833963|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82833964|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82833966|NCT00059332|Analgesics|analgesics|mesh-ancestor
82833967|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
82833968|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82833969|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82833970|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
82833971|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82833972|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82833973|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
82833974|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82833975|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82833976|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833977|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82833978|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
82833979|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82833980|NCT00233454|Midostaurin|midostaurin|mesh-list
82833981|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833982|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82833983|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833984|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833985|NCT00047320|Carboplatin|carboplatin|mesh-list
82833986|NCT00047320|Etoposide|etoposide|mesh-list
82833987|NCT00047320|Ifosfamide|ifosfamide|mesh-list
82833988|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
82833989|NCT00047320|Thiotepa|thiotepa|mesh-list
82833990|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82833991|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82833992|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82833993|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82833994|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82833995|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82833996|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82833997|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
82833998|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82833999|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834000|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
82834001|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834002|NCT00233064|Palivizumab|palivizumab|mesh-list
82834003|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
82834004|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834005|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
82834006|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82834007|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82834008|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834009|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834010|NCT03973086|Protective Agents|protective agents|mesh-ancestor
82834011|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834012|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
82834013|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82834014|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834015|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82834016|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
82834017|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834018|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834019|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834020|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834021|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
82834022|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82834023|NCT00278954|Antibodies|antibodies|mesh-list
82834024|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
82834026|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
82834027|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834028|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
82834029|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82834030|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82834031|NCT00278564|Prednisolone|prednisolone|mesh-list
82834032|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
82834033|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
82834034|NCT00278564|Rituximab|rituximab|mesh-list
82834035|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82834036|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
82834037|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834038|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
82834039|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834040|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834041|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82834042|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
82834043|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834044|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834045|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82834046|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834047|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834048|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
82834049|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
82834050|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834051|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834052|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
82834053|NCT00278564|Hormones|hormones|mesh-ancestor
82834054|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834055|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82834056|NCT00278564|Protective Agents|protective agents|mesh-ancestor
82834057|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834058|NCT01071564|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82834059|NCT01071564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82834060|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834061|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834062|NCT00268346|Gefitinib|gefitinib|mesh-list
82834063|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834064|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82834065|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834066|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834067|NCT00250718|Levofloxacin|levofloxacin|mesh-list
82834068|NCT00250718|Ofloxacin|ofloxacin|mesh-list
82834069|NCT00250718|Dexamethasone|dexamethasone|mesh-list
82834070|NCT00250718|Rituximab|rituximab|mesh-list
82834071|NCT00250718|Etoposide|etoposide|mesh-list
82834072|NCT00250718|Vincristine|vincristine|mesh-list
82834073|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834074|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834075|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
82834076|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834077|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834078|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834079|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
82834080|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
82834081|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834082|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834083|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
82834084|NCT00250718|Hormones|hormones|mesh-ancestor
82834085|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834086|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834087|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82834088|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82834089|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82834090|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834091|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834092|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
82834093|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
82834094|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
82834095|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82834096|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834097|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834098|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82834099|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82834100|NCT00276614|Bortezomib|bortezomib|mesh-list
82834101|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834102|NCT00276458|Atorvastatin|atorvastatin|mesh-list
82834103|NCT00276458|Ezetimibe|ezetimibe|mesh-list
82834104|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82834105|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82834106|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
82834107|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834108|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82834109|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82834110|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834111|NCT00276380|Aspirin|aspirin|mesh-list
82834112|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82834113|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82834115|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
82834116|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834117|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834118|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834119|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834120|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82834121|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82834122|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834123|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82834124|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82834125|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834126|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
82834127|NCT02531984|Azithromycin|azithromycin|mesh-list
82834128|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834129|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834130|NCT00267956|Ustekinumab|ustekinumab|mesh-list
82834131|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
82834132|NCT00267488|Topotecan|topotecan|mesh-list
82834133|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82834134|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82834135|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834136|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834137|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834138|NCT01073696|Granisetron|granisetron|mesh-list
82834139|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
82834140|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
82834141|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834142|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834143|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834144|NCT01073696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82834145|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82834146|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
82834147|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834148|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834149|NCT00046930|Cytarabine|cytarabine|mesh-list
82834150|NCT00046930|Daunorubicin|daunorubicin|mesh-list
82834151|NCT00046930|Molgramostim|molgramostim|mesh-list
82834152|NCT00046930|Lenograstim|lenograstim|mesh-list
82834153|NCT00046930|Sargramostim|sargramostim|mesh-list
82834154|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82834155|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
82834156|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834157|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834158|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
82834159|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834160|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834161|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
82834162|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834163|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82834164|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82834165|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82834166|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82834167|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834168|NCT00058552|Pertuzumab|pertuzumab|mesh-list
82834169|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834170|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834171|NCT01093768|Vasopressins|vasopressins|mesh-list
82834172|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
82834173|NCT01093768|Oxytocin|oxytocin|mesh-list
82834174|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
82834175|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82834176|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834177|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
82834178|NCT01093768|Coagulants|coagulants|mesh-ancestor
82834179|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82834180|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82834181|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
82834183|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834184|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82834185|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834186|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834187|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
82834188|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
82834189|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
82834190|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834191|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834192|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
82834193|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834195|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
82834196|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82834197|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834198|NCT03953716|Desogestrel|desogestrel|mesh-list
82834199|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82834200|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82834201|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82834202|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
82834203|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82834204|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834205|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82834206|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82834207|NCT03953716|Progestins|progestins|mesh-ancestor
82834208|NCT03953716|Hormones|hormones|mesh-ancestor
82834209|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834210|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
82834211|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82834212|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
82834213|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82834214|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834215|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82834216|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82834217|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82834218|NCT00147537|Paclitaxel|paclitaxel|mesh-list
82834219|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82834220|NCT00147537|Carboplatin|carboplatin|mesh-list
82834221|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82834222|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82834223|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82834224|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834225|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
82834226|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
82834227|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
82834228|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834229|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82834230|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834231|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
82834232|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834233|NCT00222729|Bevacizumab|bevacizumab|mesh-list
82834234|NCT00222729|Pemetrexed|pemetrexed|mesh-list
82834235|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834236|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834237|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82834238|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82834239|NCT00222729|Growth Substances|growth substances|mesh-ancestor
82834240|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834241|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
82834242|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834243|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834244|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82834245|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82834246|NCT00147225|Carboplatin|carboplatin|mesh-list
82834247|NCT00147225|Doxorubicin|doxorubicin|mesh-list
82834248|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82834249|NCT00147225|Ifosfamide|ifosfamide|mesh-list
82834250|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834251|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82834252|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82834253|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82834254|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834255|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834256|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82834257|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
82834258|NCT00222105|Thalidomide|thalidomide|mesh-list
82834259|NCT00222105|Dexamethasone|dexamethasone|mesh-list
82834260|NCT00222105|Doxorubicin|doxorubicin|mesh-list
82834261|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82834262|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834263|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
82834264|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
82834266|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834267|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834268|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
82834269|NCT00222105|Hormones|hormones|mesh-ancestor
82834270|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834271|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834272|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834273|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82834274|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82834275|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82834276|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834277|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834278|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834279|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
82834280|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
82834281|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834282|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834283|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82834284|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82834285|NCT00222105|Growth Substances|growth substances|mesh-ancestor
82834286|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
82834287|NCT00247676|Sunitinib|sunitinib|mesh-list
82834288|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834289|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82834290|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82834291|NCT00247676|Growth Substances|growth substances|mesh-ancestor
82834292|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834293|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
82834294|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82834295|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834296|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834297|NCT00267020|Gemcitabine|gemcitabine|mesh-list
82834298|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82834299|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
82834300|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834301|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834302|NCT03975062|Dabigatran|dabigatran|mesh-list
82834303|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
82834304|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82834305|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
82834306|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834307|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834308|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
82834309|NCT03970772|Glucagon|glucagon|mesh-list
82834310|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834311|NCT03970772|Hormones|hormones|mesh-ancestor
82834312|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834313|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834314|NCT00242216|Ritonavir|ritonavir|mesh-list
82834315|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82834316|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
82834317|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82834318|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82834319|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
82834320|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834321|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834322|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82834323|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82834324|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
82834325|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834326|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82834327|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82834328|NCT00240110|Valproic Acid|valproic acid|mesh-list
82834329|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
82834330|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
82834331|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834332|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834333|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834334|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
82834335|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82834336|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834337|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834339|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
82834340|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834341|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
82834342|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
82834343|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834344|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834345|NCT02532140|Cefepime|cefepime|mesh-list
82834346|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834347|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834348|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
82834349|NCT00266864|Testosterone|testosterone|mesh-list
82834350|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
82834351|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
82834352|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82834353|NCT00266864|Androgens|androgens|mesh-ancestor
82834354|NCT00266864|Hormones|hormones|mesh-ancestor
82834355|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834356|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834357|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834358|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834359|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
82834360|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
82834361|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
82834362|NCT00266708|Diphosphonates|diphosphonates|mesh-list
82834363|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82834364|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82834365|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834366|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82834367|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834368|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82834369|NCT00266630|Carbamazepine|carbamazepine|mesh-list
82834370|NCT00266630|Valproic Acid|valproic acid|mesh-list
82834371|NCT00266630|Olanzapine|olanzapine|mesh-list
82834372|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
82834373|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
82834374|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834375|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834376|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834377|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82834378|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82834379|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834380|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834381|NCT00266630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82834382|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82834383|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82834384|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834385|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834386|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
82834387|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834388|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
82834389|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
82834390|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
82834391|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82834392|NCT00266630|Analgesics|analgesics|mesh-ancestor
82834393|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
82834394|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82834395|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82834396|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82834397|NCT02531672|Choline|choline|mesh-list
82834398|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
82834399|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82834400|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
82834401|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834402|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834403|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82834404|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
82834405|NCT00129129|Vaccines|vaccines|mesh-list
82834406|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
82834407|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834408|NCT00221403|Valproic Acid|valproic acid|mesh-list
82834409|NCT00221403|Risperidone|risperidone|mesh-list
82834410|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82834411|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82834412|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
82834413|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834414|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834415|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834416|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82834417|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82834418|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834419|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834420|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82834421|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
82834422|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
82834423|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834424|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
82834425|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
82834426|NCT00145977|Vitamin D|vitamin d|mesh-list
82834427|NCT00145977|Alendronate|alendronate|mesh-list
82834428|NCT00145977|Calcium|calcium|mesh-list
82834429|NCT00145977|Vitamins|vitamins|mesh-ancestor
82834430|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
82834431|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834432|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82834433|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82834434|NCT00238238|Rituximab|rituximab|mesh-list
82834435|NCT00238238|Lenalidomide|lenalidomide|mesh-list
82834436|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834437|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834438|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
82834439|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834440|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834441|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82834442|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82834443|NCT00238238|Growth Substances|growth substances|mesh-ancestor
82834444|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
82834445|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
82834446|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
82834447|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82834448|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82834449|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834450|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834451|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834452|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834453|NCT01071122|Valsartan|valsartan|mesh-list
82834454|NCT01071122|Nifedipine|nifedipine|mesh-list
82834455|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82834456|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82834457|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82834458|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834459|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82834460|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82834461|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82834462|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834463|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
82834464|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
82834465|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82834466|NCT01072604|Aspirin|aspirin|mesh-list
82834467|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82834468|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82834469|NCT01072604|Analgesics|analgesics|mesh-ancestor
82834470|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
82834471|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834472|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834473|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834474|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834475|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82834476|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82834477|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834478|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82834479|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82834480|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834481|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
82834482|NCT00128661|Vaccines|vaccines|mesh-list
82834483|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
82834484|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834485|NCT00145509|Asenapine|asenapine|mesh-list
82834486|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82834487|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82834488|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834489|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834490|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834491|NCT03965871|Esketamine|esketamine|mesh-list
82834492|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
82834493|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834494|NCT03965949|Hormones|hormones|mesh-list
82834495|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834496|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834497|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
82834498|NCT00220779|Antibodies|antibodies|mesh-list
82834499|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
82834500|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82834501|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82834502|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
82834503|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
82834504|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834505|NCT00207740|Golimumab|golimumab|mesh-list
82834506|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82834507|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834508|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834509|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
82834510|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834511|NCT00265382|Ziprasidone|ziprasidone|mesh-list
82834512|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82834513|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
82834514|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834515|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834516|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834517|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82834518|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82834519|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834520|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834521|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82834522|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
82834523|NCT03974984|Anesthetics|anesthetics|mesh-list
82834524|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834525|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834526|NCT00206726|Fludarabine|fludarabine|mesh-list
82834527|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
82834528|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834529|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834530|NCT00237458|Lacosamide|lacosamide|mesh-list
82834531|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
82834532|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82834533|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82834534|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82834535|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834536|NCT01581788|Valproic Acid|valproic acid|mesh-list
82834537|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
82834538|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834539|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834540|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
82834541|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834542|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834543|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
82834544|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82834545|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834546|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834547|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
82834548|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82834549|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834550|NCT00043186|Denosumab|denosumab|mesh-list
82834551|NCT00043186|Alendronate|alendronate|mesh-list
82834552|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82834553|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834554|NCT00041470|Paclitaxel|paclitaxel|mesh-list
82834555|NCT00041470|Vinorelbine|vinorelbine|mesh-list
82834556|NCT00041470|Trastuzumab|trastuzumab|mesh-list
82834557|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82834558|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834559|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82834560|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82834561|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82834562|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834563|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834565|NCT03953950|Spironolactone|spironolactone|mesh-list
82834566|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82834567|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82834568|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82834569|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82834570|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834571|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82834572|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
82834573|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834574|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834575|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82834576|NCT03953950|Diuretics|diuretics|mesh-ancestor
82834577|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
82834578|NCT00206102|Risperidone|risperidone|mesh-list
82834579|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82834580|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82834581|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
82834582|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834583|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834584|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834585|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82834586|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82834587|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834588|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82834589|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82834590|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
82834591|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
82834592|NCT03954262|Propofol|propofol|mesh-list
82834593|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82834594|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834595|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834596|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82834597|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
82834598|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
82834599|NCT00041080|Tamoxifen|tamoxifen|mesh-list
82834600|NCT00041080|Thalidomide|thalidomide|mesh-list
82834601|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82834602|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
82834603|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834604|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834605|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834606|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834607|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82834608|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82834609|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82834610|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834611|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
82834612|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
82834613|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834614|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834615|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82834616|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82834617|NCT00041080|Growth Substances|growth substances|mesh-ancestor
82834618|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
82834619|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
82834620|NCT00205712|Ketamine|ketamine|mesh-list
82834621|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82834622|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834623|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834624|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82834625|NCT00205712|Analgesics|analgesics|mesh-ancestor
82834626|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
82834627|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834628|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82834629|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82834630|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82834631|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
82834632|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834633|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834634|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82834635|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82834636|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
82834637|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
82834638|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82834639|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82834641|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
82834642|NCT03969758|Cefixime|cefixime|mesh-list
82834643|NCT03969758|Liver Extracts|liver extracts|mesh-list
82834644|NCT03969758|Hematinics|hematinics|mesh-ancestor
82834645|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834646|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834647|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82834648|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82834649|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82834650|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82834651|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834652|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834653|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834654|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82834655|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82834656|NCT00203294|Triamcinolone|triamcinolone|mesh-list
82834657|NCT00203294|Lidocaine|lidocaine|mesh-list
82834658|NCT00203294|Bupivacaine|bupivacaine|mesh-list
82834659|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
82834660|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
82834661|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82834662|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834663|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
82834664|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834665|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82834666|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82834667|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82834668|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82834669|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834670|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834671|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
82834672|NCT00203294|Hormones|hormones|mesh-ancestor
82834673|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834674|NCT01074086|Everolimus|everolimus|mesh-list
82834675|NCT01074086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82834676|NCT01074086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82834677|NCT01074086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834678|NCT01074086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834679|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834680|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
82834681|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834682|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834683|NCT00264290|Valganciclovir|valganciclovir|mesh-list
82834684|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
82834685|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834686|NCT00234494|Bevacizumab|bevacizumab|mesh-list
82834687|NCT00234494|Gemcitabine|gemcitabine|mesh-list
82834688|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834689|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834690|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82834691|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82834692|NCT00234494|Growth Substances|growth substances|mesh-ancestor
82834693|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834694|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
82834695|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82834696|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
82834697|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834698|NCT00234104|Tolvaptan|tolvaptan|mesh-list
82834699|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82834700|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834701|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
82834702|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834703|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
82834704|NCT01582568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82834705|NCT01582568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834706|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834707|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
82834708|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834709|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834710|NCT00195338|Etanercept|etanercept|mesh-list
82834711|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82834712|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82834713|NCT00195338|Analgesics|analgesics|mesh-ancestor
82834714|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
82834715|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834716|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834717|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834718|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834719|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834720|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834721|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
82834723|NCT00039130|Cytarabine|cytarabine|mesh-list
82834724|NCT00039130|Dexamethasone|dexamethasone|mesh-list
82834725|NCT00039130|Prednisone|prednisone|mesh-list
82834726|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
82834727|NCT00039130|Ifosfamide|ifosfamide|mesh-list
82834728|NCT00039130|Rituximab|rituximab|mesh-list
82834729|NCT00039130|Doxorubicin|doxorubicin|mesh-list
82834730|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82834731|NCT00039130|Methotrexate|methotrexate|mesh-list
82834732|NCT00039130|Etoposide|etoposide|mesh-list
82834733|NCT00039130|Vincristine|vincristine|mesh-list
82834734|NCT00039130|Allopurinol|allopurinol|mesh-list
82834735|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
82834736|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834737|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
82834738|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834739|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834740|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82834741|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
82834742|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834743|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834744|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82834745|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834746|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834747|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
82834748|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
82834749|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834750|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834751|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
82834752|NCT00039130|Hormones|hormones|mesh-ancestor
82834753|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834754|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834755|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82834756|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82834757|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82834758|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834759|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82834760|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
82834761|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82834762|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82834763|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
82834764|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
82834765|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82834766|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82834767|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82834768|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
82834769|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834770|NCT00039130|Antidotes|antidotes|mesh-ancestor
82834771|NCT00039130|Protective Agents|protective agents|mesh-ancestor
82834772|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
82834773|NCT00039130|Vitamins|vitamins|mesh-ancestor
82834774|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
82834775|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
82834776|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
82834777|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
82834778|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
82834779|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82834780|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
82834781|NCT01096654|Epinephrine|epinephrine|mesh-list
82834782|NCT01096654|Racepinephrine|racepinephrine|mesh-list
82834783|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
82834784|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82834785|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82834786|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
82834787|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834788|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834789|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834790|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82834791|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82834793|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834794|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82834795|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
82834796|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
82834797|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
82834798|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82834799|NCT00035932|Ritonavir|ritonavir|mesh-list
82834800|NCT00035932|Lopinavir|lopinavir|mesh-list
82834801|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82834802|NCT00035932|Saquinavir|saquinavir|mesh-list
82834803|NCT00035932|Tenofovir|tenofovir|mesh-list
82834804|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82834805|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82834806|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
82834807|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834808|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834809|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82834810|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82834811|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
82834812|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834813|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82834814|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82834815|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82834816|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82834817|NCT03953326|Nitroprusside|nitroprusside|mesh-list
82834818|NCT03953326|Acetylcholine|acetylcholine|mesh-list
82834819|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82834820|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
82834821|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82834822|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834823|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82834824|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
82834825|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82834826|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834827|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
82834828|NCT01097278|Vitamin D|vitamin d|mesh-list
82834829|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82834830|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834831|NCT01097278|Vitamins|vitamins|mesh-ancestor
82834832|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
82834833|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82834834|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
82834835|NCT00022516|Methotrexate|methotrexate|mesh-list
82834836|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82834837|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
82834838|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834839|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834840|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82834841|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
82834842|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834843|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834844|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82834845|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82834846|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
82834847|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82834848|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82834849|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
82834850|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
82834851|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834852|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82834853|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82834854|NCT01097512|Gemcitabine|gemcitabine|mesh-list
82834855|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82834856|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
82834857|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834858|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834859|NCT00033514|Trastuzumab|trastuzumab|mesh-list
82834860|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82834861|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834862|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834863|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82834864|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834865|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834866|NCT00006916|Bleomycin|bleomycin|mesh-list
82834867|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82834868|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834869|NCT02529982|Curcumin|curcumin|mesh-list
82834870|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82834871|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82834872|NCT02529982|Analgesics|analgesics|mesh-ancestor
82834873|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
82834874|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834875|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834876|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834877|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834878|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834879|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834880|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834881|NCT00454649|Paclitaxel|paclitaxel|mesh-list
82834882|NCT00454649|Docetaxel|docetaxel|mesh-list
82834883|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82834884|NCT00454649|Cisplatin|cisplatin|mesh-list
82834885|NCT00454649|Carboplatin|carboplatin|mesh-list
82834886|NCT00454649|Gemcitabine|gemcitabine|mesh-list
82834887|NCT00454649|Capecitabine|capecitabine|mesh-list
82834888|NCT00454649|Pemetrexed|pemetrexed|mesh-list
82834889|NCT00454649|Axitinib|axitinib|mesh-list
82834890|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82834891|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834892|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
82834893|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
82834894|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
82834895|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834896|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82834897|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
82834898|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834899|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82834900|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82834901|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82834902|NCT00454571|Leuprolide|leuprolide|mesh-list
82834903|NCT00454571|Goserelin|goserelin|mesh-list
82834904|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82834905|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
82834906|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82834907|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834908|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834909|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834910|NCT01323257|Ritonavir|ritonavir|mesh-list
82834911|NCT01323257|Darunavir|darunavir|mesh-list
82834912|NCT01323257|Erythromycin|erythromycin|mesh-list
82834913|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
82834914|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82834915|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
82834916|NCT01323257|Simeprevir|simeprevir|mesh-list
82834917|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82834918|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82834919|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
82834920|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834921|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834922|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82834923|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82834924|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
82834925|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834926|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82834927|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82834928|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82834929|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834930|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82834931|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82834932|NCT01323335|Rasburicase|rasburicase|mesh-list
82834933|NCT01323335|Uric Acid|uric acid|mesh-list
82834934|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
82834935|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834936|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
82834937|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834938|NCT01323335|Protective Agents|protective agents|mesh-ancestor
82834939|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834940|NCT03836729|Tenofovir|tenofovir|mesh-list
82834941|NCT03836729|Emtricitabine|emtricitabine|mesh-list
82834942|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
82834943|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834944|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82834946|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834947|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834948|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82834949|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82834950|NCT01027481|Ranibizumab|ranibizumab|mesh-list
82834951|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82834952|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82834953|NCT01027481|Growth Substances|growth substances|mesh-ancestor
82834954|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834955|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
82834956|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834957|NCT00443729|Ritonavir|ritonavir|mesh-list
82834958|NCT00443729|Lopinavir|lopinavir|mesh-list
82834959|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
82834960|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82834961|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82834962|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
82834963|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82834964|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82834965|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82834966|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82834967|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
82834968|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82834969|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82834970|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82834971|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82834972|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82834973|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82834974|NCT00443651|Rituximab|rituximab|mesh-list
82834975|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82834976|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834977|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
82834978|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834979|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82834980|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
82834981|NCT03567473|Dexamethasone|dexamethasone|mesh-list
82834982|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
82834983|NCT03567473|Epinephrine|epinephrine|mesh-list
82834984|NCT03567473|Racepinephrine|racepinephrine|mesh-list
82834985|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
82834986|NCT03567473|BB 1101|bb 1101|mesh-list
82834987|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82834988|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
82834989|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
82834990|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82834991|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82834992|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82834993|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
82834994|NCT03567473|Hormones|hormones|mesh-ancestor
82834995|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82834996|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82834997|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82834998|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
82834999|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835000|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835001|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82835002|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82835003|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
82835004|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835005|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82835006|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82835007|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82835008|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835009|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
82835010|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
82835011|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82835012|NCT00443261|Azacitidine|azacitidine|mesh-list
82835013|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835014|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835015|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
82835016|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835017|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835018|NCT00439517|Cetuximab|cetuximab|mesh-list
82835019|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82835020|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835021|NCT01028261|CKD732|ckd732|mesh-list
82835022|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82835023|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82835024|NCT01028261|Growth Substances|growth substances|mesh-ancestor
82835025|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835026|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
82835027|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835028|NCT01028339|Mannitol|mannitol|mesh-list
82835029|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82835030|NCT01028339|Diuretics|diuretics|mesh-ancestor
82835031|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
82835032|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835033|NCT01031459|Interferons|interferons|mesh-list
82835034|NCT01031459|Interferon-beta|interferon-beta|mesh-list
82835035|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
82835036|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835037|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
82835038|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835039|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
82835040|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835041|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82835042|NCT00438815|Complement C1s|complement c1s|mesh-list
82835043|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82835044|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
82835045|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
82835046|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835047|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82835048|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835049|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
82835050|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835051|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
82835052|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82835053|NCT01028495|Gemcitabine|gemcitabine|mesh-list
82835054|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835055|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
82835056|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835057|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835058|NCT00437645|Amlodipine|amlodipine|mesh-list
82835059|NCT00437645|Valsartan|valsartan|mesh-list
82835060|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82835061|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82835062|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82835063|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835064|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82835065|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835066|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
82835067|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82835068|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82835069|NCT03995147|Prednisone|prednisone|mesh-list
82835070|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
82835071|NCT03995147|Doxorubicin|doxorubicin|mesh-list
82835072|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
82835073|NCT03995147|Vincristine|vincristine|mesh-list
82835074|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835075|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
82835076|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835077|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835078|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82835079|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
83443293|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835080|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835081|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835082|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82835083|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82835084|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835085|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835086|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835087|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835088|NCT03995147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82835089|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835090|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
82835092|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835093|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82835094|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835095|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835096|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835097|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835098|NCT00437489|Insulin|insulin|mesh-list
82835099|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82835100|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82835101|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835102|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82835103|NCT01028573|Laxatives|laxatives|mesh-ancestor
82835104|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82835105|NCT04683575|Selenium|selenium|mesh-list
82835106|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
82835107|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835108|NCT04683575|Protective Agents|protective agents|mesh-ancestor
82835109|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835110|NCT04683575|Trace Elements|trace elements|mesh-ancestor
82835111|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
82835112|NCT00442559|Montelukast|montelukast|mesh-list
82835113|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82835114|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835115|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82835116|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
82835117|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835118|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835119|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82835120|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82835121|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835122|NCT01323491|Nicotine|nicotine|mesh-list
82835123|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82835124|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
82835125|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835126|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835127|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82835128|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82835129|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
82835130|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835131|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835132|NCT00441545|Sevelamer|sevelamer|mesh-list
82835133|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
82835134|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
82835135|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835136|NCT00436553|Ranibizumab|ranibizumab|mesh-list
82835137|NCT00436553|Verteporfin|verteporfin|mesh-list
82835138|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82835139|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82835140|NCT00436553|Growth Substances|growth substances|mesh-ancestor
82835141|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835142|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
82835143|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835144|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82835145|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
82835146|NCT01028729|Gemcitabine|gemcitabine|mesh-list
82835147|NCT01028729|Endostar protein|endostar protein|mesh-list
82835148|NCT01028729|Endostatins|endostatins|mesh-list
82835149|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835150|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835151|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
82835152|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835153|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82835154|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82835155|NCT01028729|Growth Substances|growth substances|mesh-ancestor
82835156|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835157|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
82835158|NCT03357419|Clindamycin|clindamycin|mesh-list
82835159|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
82835160|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
82835161|NCT03357419|Cephalexin|cephalexin|mesh-list
82835162|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82835163|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835164|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82835165|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835166|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835167|NCT01031927|Glycine|glycine|mesh-list
82835168|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
82835169|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835170|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835171|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835172|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
82835173|NCT03331289|Exenatide|exenatide|mesh-list
82835174|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82835175|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835176|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82835177|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835178|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82835179|NCT03331289|Incretins|incretins|mesh-ancestor
82835180|NCT03331289|Hormones|hormones|mesh-ancestor
82835181|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835182|NCT01032083|Citalopram|citalopram|mesh-list
82835183|NCT01032083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82835184|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82835185|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82835186|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835187|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835188|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
82835189|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835190|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82835191|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
82835192|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82835193|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82835194|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
82835195|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835196|NCT01028963|Pioglitazone|pioglitazone|mesh-list
82835197|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82835198|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835199|NCT00006604|Ritonavir|ritonavir|mesh-list
82835200|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82835201|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82835202|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
82835203|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835204|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835205|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82835206|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82835207|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
82835208|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835209|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82835210|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82835211|NCT00006478|Sargramostim|sargramostim|mesh-list
82835212|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
82835213|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
82835214|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835215|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82835216|NCT01097902|Ibuprofen|ibuprofen|mesh-list
82835217|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82835218|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82835219|NCT01097902|Analgesics|analgesics|mesh-ancestor
82835220|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
82835221|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835222|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835223|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835224|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835225|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82835226|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835227|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835228|NCT00436007|Vaccines|vaccines|mesh-list
82835229|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
82835230|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835231|NCT00435461|Fluticasone|fluticasone|mesh-list
82835233|NCT00435461|Fexofenadine|fexofenadine|mesh-list
82835234|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835235|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82835236|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
82835237|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835238|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835239|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82835240|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835241|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
82835242|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82835243|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82835244|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82835245|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
82835246|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
82835247|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835248|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835249|NCT00006436|Prednisone|prednisone|mesh-list
82835250|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
82835251|NCT00006436|Rituximab|rituximab|mesh-list
82835252|NCT00006436|Doxorubicin|doxorubicin|mesh-list
82835253|NCT00006436|Etoposide|etoposide|mesh-list
82835254|NCT00006436|Vincristine|vincristine|mesh-list
82835255|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82835256|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835257|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
82835258|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835259|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835260|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82835261|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
82835262|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835263|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835264|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82835265|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82835266|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835267|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835268|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835269|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835270|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835271|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
82835272|NCT00006436|Hormones|hormones|mesh-ancestor
82835273|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835274|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82835275|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835276|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835277|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835278|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835279|NCT01097980|Trazodone|trazodone|mesh-list
82835280|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82835281|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82835282|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82835283|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835284|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82835285|NCT01097980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82835286|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82835287|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82835288|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835289|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835290|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
82835291|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82835292|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
82835293|NCT01029275|Octreotide|octreotide|mesh-list
82835294|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82835295|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82835296|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835297|NCT04829903|Liraglutide|liraglutide|mesh-list
82835298|NCT04829903|Dulaglutide|dulaglutide|mesh-list
82835299|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82835300|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835301|NCT04829903|Incretins|incretins|mesh-ancestor
82835302|NCT04829903|Hormones|hormones|mesh-ancestor
82835303|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835304|NCT00440999|Artesunate|artesunate|mesh-list
82835305|NCT00440999|Chloroquine|chloroquine|mesh-list
82835306|NCT00440999|Pyronaridine|pyronaridine|mesh-list
82835307|NCT00440999|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
82835308|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
82835309|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82835310|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82835311|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835312|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835313|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
82835314|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
82835315|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82835317|NCT00440999|Amebicides|amebicides|mesh-ancestor
82835318|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835319|NCT00434213|Methylphenidate|methylphenidate|mesh-list
82835320|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82835321|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835322|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82835323|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82835324|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82835325|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835326|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
82835327|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835328|NCT01029743|Aspirin|aspirin|mesh-list
82835329|NCT01029743|PENTA|penta|mesh-list
82835330|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
82835331|NCT01029743|Fondaparinux|fondaparinux|mesh-list
82835332|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82835333|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82835334|NCT01029743|Analgesics|analgesics|mesh-ancestor
82835335|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
82835336|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835337|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835338|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835339|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835340|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82835341|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82835342|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835343|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82835344|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82835345|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835346|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
82835347|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82835348|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
82835349|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82835350|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
82835351|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
82835352|NCT01029821|Heparin|heparin|mesh-list
82835353|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82835354|NCT01029821|Tinzaparin|tinzaparin|mesh-list
82835355|NCT01029821|Dalteparin|dalteparin|mesh-list
82835356|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
82835357|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82835358|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82835359|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835360|NCT00006184|Cyclosporine|cyclosporine|mesh-list
82835361|NCT00006184|Prednisone|prednisone|mesh-list
82835362|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
82835363|NCT00006184|Doxorubicin|doxorubicin|mesh-list
82835364|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82835365|NCT00006184|Methotrexate|methotrexate|mesh-list
82835366|NCT00006184|Fludarabine|fludarabine|mesh-list
82835367|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
82835368|NCT00006184|Etoposide|etoposide|mesh-list
82835369|NCT00006184|Vincristine|vincristine|mesh-list
82835370|NCT00006184|Bortezomib|bortezomib|mesh-list
82835371|NCT00006184|Molgramostim|molgramostim|mesh-list
82835372|NCT00006184|Cyclosporins|cyclosporins|mesh-list
82835373|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
82835374|NCT00006184|Lenograstim|lenograstim|mesh-list
82835375|NCT00006184|Sargramostim|sargramostim|mesh-list
82835376|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
82835377|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835378|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
82835379|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835380|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835381|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82835382|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
82835383|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835384|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835385|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82835386|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835387|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835388|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835389|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835390|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835391|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
82835392|NCT00006184|Hormones|hormones|mesh-ancestor
82835393|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835394|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82835395|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82835397|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82835398|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835399|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
82835400|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
82835401|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82835402|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82835403|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835404|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835405|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835406|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835407|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
82835408|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835409|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82835410|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82835411|NCT00433199|Testosterone|testosterone|mesh-list
82835412|NCT00433199|Androgens|androgens|mesh-ancestor
82835413|NCT00433199|Hormones|hormones|mesh-ancestor
82835414|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835415|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835416|NCT00006046|Antibodies|antibodies|mesh-list
82835417|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82835418|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
82835419|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835420|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82835421|NCT01098448|Amoxicillin|amoxicillin|mesh-list
82835422|NCT01098448|Metronidazole|metronidazole|mesh-list
82835423|NCT01098448|Tetracycline|tetracycline|mesh-list
82835424|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835425|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82835426|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82835427|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82835428|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835429|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835430|NCT01098526|Efavirenz|efavirenz|mesh-list
82835431|NCT01098526|Dolutegravir|dolutegravir|mesh-list
82835432|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82835433|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82835434|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835435|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835436|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
82835437|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835438|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82835439|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82835440|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82835441|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82835442|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82835443|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82835444|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82835445|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82835446|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82835447|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82835448|NCT00005908|Tamoxifen|tamoxifen|mesh-list
82835449|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
82835450|NCT00005908|Docetaxel|docetaxel|mesh-list
82835451|NCT00005908|Doxorubicin|doxorubicin|mesh-list
82835452|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82835453|NCT00005908|Capecitabine|capecitabine|mesh-list
82835454|NCT00005908|Anastrozole|anastrozole|mesh-list
82835455|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835456|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
82835457|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835458|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835459|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82835460|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
82835461|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835462|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835463|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82835464|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835465|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835466|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835467|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835468|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835469|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835470|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835471|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835472|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
82835473|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82835474|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
82835475|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835477|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82835478|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82835479|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82835480|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82835481|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82835482|NCT00431951|Tecovirimat|tecovirimat|mesh-list
82835483|NCT00431951|Antiviral Agents|antiviral agents|mesh-ancestor
82835484|NCT00431951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835485|NCT00004978|Aldesleukin|aldesleukin|mesh-list
82835486|NCT00004978|Interleukin-2|interleukin-2|mesh-list
82835487|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835488|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82835489|NCT00004978|Analgesics|analgesics|mesh-ancestor
82835490|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
82835491|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835492|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835493|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82835494|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82835495|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
82835496|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835497|NCT01030601|Dexamethasone|dexamethasone|mesh-list
82835498|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
82835499|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82835500|NCT01030601|BB 1101|bb 1101|mesh-list
82835501|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835502|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
82835503|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
82835504|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835505|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835506|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82835507|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
82835508|NCT01030601|Hormones|hormones|mesh-ancestor
82835509|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835510|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82835511|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835512|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
82835513|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835514|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835515|NCT00430937|Vancomycin|vancomycin|mesh-list
82835516|NCT00430937|Daptomycin|daptomycin|mesh-list
82835517|NCT00430937|Teicoplanin|teicoplanin|mesh-list
82835518|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82835519|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835520|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
82835521|NCT01101412|Ethanol|ethanol|mesh-list
82835522|NCT01101412|Trimethoprim|trimethoprim|mesh-list
82835523|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
82835524|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82835525|NCT01101412|Edetic Acid|edetic acid|mesh-list
82835526|NCT01101412|Calcium|calcium|mesh-list
82835527|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
82835528|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82835529|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835530|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82835531|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82835532|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835533|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82835534|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82835535|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
82835536|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82835537|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82835538|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82835539|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835540|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835541|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82835542|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82835543|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82835544|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82835545|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
82835546|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82835547|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
82835548|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
82835549|NCT01101412|Antidotes|antidotes|mesh-ancestor
82835551|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82835552|NCT00004888|Docetaxel|docetaxel|mesh-list
82835553|NCT00004888|Doxorubicin|doxorubicin|mesh-list
82835554|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82835555|NCT00004888|Trastuzumab|trastuzumab|mesh-list
82835556|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835557|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835558|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835559|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835560|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835561|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835562|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835563|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835564|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835565|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82835566|NCT01098760|Sorafenib|sorafenib|mesh-list
82835567|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835568|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82835569|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835570|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835571|NCT03950830|Disulfiram|disulfiram|mesh-list
82835572|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82835573|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82835574|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835575|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835576|NCT00430781|Lapatinib|lapatinib|mesh-list
82835577|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835578|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82835579|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835580|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835581|NCT01033097|Betamethasone|betamethasone|mesh-list
82835582|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835583|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
82835584|NCT01033097|Hormones|hormones|mesh-ancestor
82835585|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835586|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835587|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82835588|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835589|NCT00429299|Paclitaxel|paclitaxel|mesh-list
82835590|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
82835591|NCT00429299|Fluorouracil|fluorouracil|mesh-list
82835592|NCT00429299|Trastuzumab|trastuzumab|mesh-list
82835593|NCT00429299|Lapatinib|lapatinib|mesh-list
82835594|NCT00429299|Epirubicin|epirubicin|mesh-list
82835595|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835596|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835597|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835598|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835599|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835600|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835601|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835602|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
82835603|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835604|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835605|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82835606|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
82835607|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82835608|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
82835609|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835610|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82835611|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82835612|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835613|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835614|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835615|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835616|NCT01033877|Vaccines|vaccines|mesh-list
82835617|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
82835618|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835619|NCT00428597|Sunitinib|sunitinib|mesh-list
82835620|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835621|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82835622|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82835623|NCT00428597|Growth Substances|growth substances|mesh-ancestor
82835624|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835625|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
82835626|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82835627|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835628|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835629|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82835630|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82835631|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82835632|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
82835633|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835634|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82835635|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82835636|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835637|NCT00428441|Warfarin|warfarin|mesh-list
82835638|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
82835639|NCT02488967|Paclitaxel|paclitaxel|mesh-list
82835640|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
82835641|NCT02488967|Carboplatin|carboplatin|mesh-list
82835642|NCT02488967|Doxorubicin|doxorubicin|mesh-list
82835643|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82835644|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82835645|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835646|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835647|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835648|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835649|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835650|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835651|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835652|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
82835653|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835654|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835655|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82835656|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
82835657|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82835658|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835659|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835660|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835661|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835662|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
82835663|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82835664|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
82835665|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835666|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835667|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82835668|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835669|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
82835670|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82835671|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
83443312|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
82835672|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835673|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835674|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
82835675|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82835676|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
82835677|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835678|NCT03967665|Expectorants|expectorants|mesh-ancestor
82835679|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835680|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82835681|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
82835682|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835683|NCT03967665|Protective Agents|protective agents|mesh-ancestor
82835684|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835685|NCT03967665|Antidotes|antidotes|mesh-ancestor
82835686|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
82835687|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82835688|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82835689|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835690|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82835691|NCT00127803|Vaccines|vaccines|mesh-list
82835692|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
82835693|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835694|NCT01077999|Paclitaxel|paclitaxel|mesh-list
82835695|NCT01077999|Carboplatin|carboplatin|mesh-list
82835696|NCT01077999|Panitumumab|panitumumab|mesh-list
82835697|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835698|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835699|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835700|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835701|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835702|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835703|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82835704|NCT01033409|Vaccines|vaccines|mesh-list
82835705|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
82835706|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835707|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
82835708|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82835709|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
82835710|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835711|NCT01037465|Expectorants|expectorants|mesh-ancestor
82835712|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835713|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82835714|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
82835715|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835716|NCT01037465|Protective Agents|protective agents|mesh-ancestor
82835717|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835718|NCT01037465|Antidotes|antidotes|mesh-ancestor
82835719|NCT01582425|Isavuconazole|isavuconazole|mesh-list
82835720|NCT01582425|Methadone|methadone|mesh-list
82835721|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82835722|NCT01582425|Narcotics|narcotics|mesh-ancestor
82835723|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82835724|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835725|NCT01582425|Analgesics|analgesics|mesh-ancestor
82835726|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
82835727|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835728|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
82835729|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
82835730|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
82835731|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835732|NCT00143403|Leucovorin|leucovorin|mesh-list
82835733|NCT00143403|Folic Acid|folic acid|mesh-list
82835734|NCT00143403|Irinotecan|irinotecan|mesh-list
82835735|NCT00143403|Fluorouracil|fluorouracil|mesh-list
82835736|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
82835737|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82835738|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835739|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835740|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835741|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835742|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
82835743|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835744|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835745|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
82835746|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835747|NCT00143403|Antidotes|antidotes|mesh-ancestor
82835748|NCT00143403|Protective Agents|protective agents|mesh-ancestor
82835749|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
82835750|NCT00143403|Vitamins|vitamins|mesh-ancestor
82835751|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
82835752|NCT00143403|Hematinics|hematinics|mesh-ancestor
82835753|NCT00220701|Dexetimide|dexetimide|mesh-list
82835754|NCT00220701|Citalopram|citalopram|mesh-list
82835755|NCT00220701|Escitalopram|escitalopram|mesh-list
82835756|NCT00220701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82835757|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82835758|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82835759|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835760|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835761|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
82835762|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835763|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82835764|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82835765|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
82835766|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
82835767|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835768|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82835769|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82835770|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
82835771|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82835772|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
82835773|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82835774|NCT00127101|Vorinostat|vorinostat|mesh-list
82835775|NCT00127101|Bexarotene|bexarotene|mesh-list
82835776|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835777|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82835778|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835779|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835780|NCT00126555|Gefitinib|gefitinib|mesh-list
82835781|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835782|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82835783|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835784|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835785|NCT00004228|Leucovorin|leucovorin|mesh-list
82835786|NCT00004228|Cytarabine|cytarabine|mesh-list
82835787|NCT00004228|Dexamethasone|dexamethasone|mesh-list
82835788|NCT00004228|Prednisone|prednisone|mesh-list
82835789|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
82835790|NCT00004228|Doxorubicin|doxorubicin|mesh-list
82835791|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82835792|NCT00004228|Methotrexate|methotrexate|mesh-list
82835793|NCT00004228|Vincristine|vincristine|mesh-list
82835794|NCT00004228|Daunorubicin|daunorubicin|mesh-list
82835795|NCT00004228|Asparaginase|asparaginase|mesh-list
82835796|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
82835797|NCT00004228|Thioguanine|thioguanine|mesh-list
82835798|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
82835799|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835800|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
82835801|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835802|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835803|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82835804|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
82835805|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835806|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835807|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82835808|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835809|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
82835810|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
82835811|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835812|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82835813|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
82835814|NCT00004228|Hormones|hormones|mesh-ancestor
82835815|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82835816|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82835817|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835818|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82835819|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82835820|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835821|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82835822|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
82835823|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83443314|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835824|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835825|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
82835826|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
82835827|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82835828|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82835829|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
82835830|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835831|NCT00004228|Antidotes|antidotes|mesh-ancestor
82835832|NCT00004228|Protective Agents|protective agents|mesh-ancestor
82835833|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
82835834|NCT00004228|Vitamins|vitamins|mesh-ancestor
82835835|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
82835836|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835837|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835838|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835839|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835840|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82835841|NCT01101568|Simvastatin|simvastatin|mesh-list
82835842|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82835843|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82835844|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
82835845|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835846|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82835847|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82835848|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835849|NCT01087840|Tenofovir|tenofovir|mesh-list
82835850|NCT01087840|Emtricitabine|emtricitabine|mesh-list
82835851|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
82835852|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
82835853|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835854|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82835855|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82835856|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835857|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835859|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82835860|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82835861|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82835862|NCT01098994|Vitamin E|vitamin e|mesh-list
82835863|NCT01098994|Tocopherols|tocopherols|mesh-list
82835864|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
82835865|NCT01098994|Vitamins|vitamins|mesh-ancestor
82835866|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
82835867|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835868|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
82835869|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835870|NCT01098994|Protective Agents|protective agents|mesh-ancestor
82835871|NCT01099072|Methylphenidate|methylphenidate|mesh-list
82835872|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82835873|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835874|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82835875|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82835876|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82835877|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835878|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
82835879|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835880|NCT00031486|Valacyclovir|valacyclovir|mesh-list
82835881|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
82835882|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835883|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
82835884|NCT01099150|Procyanidin|procyanidin|mesh-list
82835885|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
82835886|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835887|NCT01099150|Protective Agents|protective agents|mesh-ancestor
82835888|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835889|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82835890|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82835891|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835892|NCT02530060|Tenofovir|tenofovir|mesh-list
82835893|NCT02530060|Emtricitabine|emtricitabine|mesh-list
82835894|NCT02530060|Rilpivirine|rilpivirine|mesh-list
82835895|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
82835896|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835897|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82835898|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82835899|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835900|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835901|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82835902|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82835903|NCT01101646|Rabeprazole|rabeprazole|mesh-list
82835904|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82835905|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82835906|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82835907|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835908|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835909|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
82835910|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82835911|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835912|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82835913|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
82835914|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82835915|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835916|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835917|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835918|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82835919|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835920|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835921|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835922|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82835923|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
82835924|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82835925|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82835926|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835927|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
82835928|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82835929|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835930|NCT01099462|Ibuprofen|ibuprofen|mesh-list
82835931|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82835932|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82835933|NCT01099462|Analgesics|analgesics|mesh-ancestor
82835934|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
82835935|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835936|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835937|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82835938|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82835939|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82835940|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82835941|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835942|NCT00003298|Leucovorin|leucovorin|mesh-list
82835943|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
82835944|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
82835945|NCT00003298|Paclitaxel|paclitaxel|mesh-list
82835946|NCT00003298|Cisplatin|cisplatin|mesh-list
82835947|NCT00003298|Fluorouracil|fluorouracil|mesh-list
82835948|NCT00003298|Calcium|calcium|mesh-list
82835949|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
82835950|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82835951|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835952|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
82835953|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
82835954|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
82835955|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835956|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82835957|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835958|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
82835959|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835960|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835961|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
82835962|NCT00003298|Antidotes|antidotes|mesh-ancestor
82835963|NCT00003298|Protective Agents|protective agents|mesh-ancestor
82835964|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
82835965|NCT00003298|Vitamins|vitamins|mesh-ancestor
82835966|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
82835967|NCT03960970|Azithromycin|azithromycin|mesh-list
82835968|NCT03960970|Cefoxitin|cefoxitin|mesh-list
82835969|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82835970|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82835971|NCT00002842|Leucovorin|leucovorin|mesh-list
82835972|NCT00002842|Fluorouracil|fluorouracil|mesh-list
82835973|NCT00002842|Floxuridine|floxuridine|mesh-list
82835974|NCT00002842|Calcium|calcium|mesh-list
82835975|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
82835976|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82835977|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835978|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
82835979|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82835980|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82835981|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82835982|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82835983|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
82835984|NCT00002842|Antidotes|antidotes|mesh-ancestor
82835985|NCT00002842|Protective Agents|protective agents|mesh-ancestor
82835986|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
82835987|NCT00002842|Vitamins|vitamins|mesh-ancestor
82835988|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
82835989|NCT00143247|Insulin|insulin|mesh-list
82835990|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82835991|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82835992|NCT00125853|Atenolol|atenolol|mesh-list
82835993|NCT00125853|Nebivolol|nebivolol|mesh-list
82835994|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82835995|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82835996|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
82835997|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
82835998|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82835999|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836000|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82836001|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82836002|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82836003|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
82836004|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482615|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82836005|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836006|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
82836007|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82836008|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82836009|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82836010|NCT00219141|Losartan|losartan|mesh-list
82836011|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82836012|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82836013|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82836014|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82836015|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836016|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
82836017|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
82836018|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836019|NCT00233948|Nelfinavir|nelfinavir|mesh-list
82836020|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82836021|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82836022|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
82836023|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836024|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836025|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82836026|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82836027|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
82836028|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836029|NCT00233480|Atorvastatin|atorvastatin|mesh-list
82836030|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82836031|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82836032|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
82836033|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836034|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82836035|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82836036|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836037|NCT03801928|Infliximab|infliximab|mesh-list
82836038|NCT03801928|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82836039|NCT03801928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836040|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
82836041|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82836042|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836043|NCT02530918|Ranibizumab|ranibizumab|mesh-list
82836044|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82836045|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82836046|NCT02530918|Growth Substances|growth substances|mesh-ancestor
82836047|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836048|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
82836049|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836050|NCT03950518|Levamisole|levamisole|mesh-list
82836051|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82836052|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
82836053|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836054|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
82836055|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
82836056|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82836057|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836058|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836059|NCT01100164|Eszopiclone|eszopiclone|mesh-list
82836060|NCT01100164|Zopiclone|zopiclone|mesh-list
82836061|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82836062|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836063|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836064|NCT01102114|Vaccines|vaccines|mesh-list
82836065|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
82836066|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836067|NCT01327222|Bevacizumab|bevacizumab|mesh-list
82836068|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836069|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836070|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82836071|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82836072|NCT01327222|Growth Substances|growth substances|mesh-ancestor
82836073|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836074|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
82836075|NCT03950362|Avelumab|avelumab|mesh-list
82836076|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836077|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836078|NCT00263588|Lapatinib|lapatinib|mesh-list
82836079|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836080|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836081|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836082|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836083|NCT00213135|Cladribine|cladribine|mesh-list
82836084|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836086|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
82836087|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836088|NCT00077974|Sunitinib|sunitinib|mesh-list
82836089|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836090|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82836091|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82836092|NCT00077974|Growth Substances|growth substances|mesh-ancestor
82836093|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836094|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
82836095|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836096|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836097|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836098|NCT00141921|Etanercept|etanercept|mesh-list
82836099|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82836100|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82836101|NCT00141921|Analgesics|analgesics|mesh-ancestor
82836102|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
82836103|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836104|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836105|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836106|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836107|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82836108|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836109|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
82836110|NCT01088620|Pemetrexed|pemetrexed|mesh-list
82836111|NCT01088620|Panitumumab|panitumumab|mesh-list
82836112|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836113|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836114|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836115|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82836116|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82836117|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836118|NCT00026494|Temozolomide|temozolomide|mesh-list
83443324|NCT02397291|Inositol|inositol|mesh-list
82836119|NCT00026494|Vinorelbine|vinorelbine|mesh-list
82836120|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82836121|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
82836122|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836123|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836124|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82836125|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836126|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836127|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836128|NCT03950050|Ambroxol|ambroxol|mesh-list
82836129|NCT03950050|Expectorants|expectorants|mesh-ancestor
82836130|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
82836131|NCT00023764|Bortezomib|bortezomib|mesh-list
82836132|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836133|NCT03961126|Clobetasol|clobetasol|mesh-list
82836134|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836135|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
82836136|NCT03961126|Hormones|hormones|mesh-ancestor
82836137|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82836138|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836139|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
82836140|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
82836141|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836142|NCT00189488|Methotrexate|methotrexate|mesh-list
82836143|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82836144|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
82836145|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82836146|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836147|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836148|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
82836149|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836150|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836151|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
82836152|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836153|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82836154|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836155|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
82836156|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836157|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82836158|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82836167|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
82836168|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836169|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82836170|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82836171|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
82836172|NCT01088932|SRX246|srx246|mesh-list
82836173|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82836174|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836175|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
82836176|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836177|NCT03961048|Ropivacaine|ropivacaine|mesh-list
82836178|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82836179|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
82836180|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
82836181|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836182|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836183|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
82836184|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836185|NCT00022672|Trastuzumab|trastuzumab|mesh-list
82836186|NCT00022672|Anastrozole|anastrozole|mesh-list
82836187|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836188|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836189|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82836190|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82836191|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82836192|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836193|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836194|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82836195|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
83443326|NCT02397291|Vitamins|vitamins|mesh-ancestor
82836196|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82836197|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836198|NCT00141453|Olmesartan|olmesartan|mesh-list
82836199|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82836200|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82836201|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82836202|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82836203|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836204|NCT00076570|Sirolimus|sirolimus|mesh-list
82836205|NCT00076570|Tacrolimus|tacrolimus|mesh-list
82836206|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836207|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
82836208|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836209|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82836210|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836211|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836212|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836213|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836214|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82836215|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836216|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
82836217|NCT00124449|Abatacept|abatacept|mesh-list
82836218|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82836219|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836220|NCT00124449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836221|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836222|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836223|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
82836224|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836225|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836226|NCT00076336|Lamivudine|lamivudine|mesh-list
82836227|NCT00076336|Telbivudine|telbivudine|mesh-list
82836228|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82836229|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82836230|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836231|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836232|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
82836233|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836234|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82836235|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82836236|NCT00185588|Gemcitabine|gemcitabine|mesh-list
82836237|NCT00185588|Vatalanib|vatalanib|mesh-list
82836238|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836239|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
82836240|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836241|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836242|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836243|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836245|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836246|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82836247|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
82836248|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836249|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
82836250|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82836251|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836252|NCT00076102|Pirfenidone|pirfenidone|mesh-list
82836253|NCT00076102|Analgesics|analgesics|mesh-ancestor
82836254|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
82836255|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836256|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836257|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82836258|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82836259|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836260|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836261|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836262|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
82836263|NCT03968588|Tacrolimus|tacrolimus|mesh-list
82836264|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836265|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
82836266|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836267|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82836268|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836269|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836270|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82836271|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836272|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82836273|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
82836274|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836275|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836276|NCT01582646|Terbutaline|terbutaline|mesh-list
82836277|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82836278|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
82836279|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836280|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836281|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82836282|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
82836283|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
82836284|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
82836285|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82836286|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82836287|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82836288|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82836289|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
82836290|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836291|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836292|NCT03974360|Erenumab|erenumab|mesh-list
82836293|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82836294|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836295|NCT03974360|Analgesics|analgesics|mesh-ancestor
82836296|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
82836297|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836298|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836300|NCT00184028|Docetaxel|docetaxel|mesh-list
82836301|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836302|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836303|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836304|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836305|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836306|NCT00183872|Docetaxel|docetaxel|mesh-list
82836307|NCT00183872|Irinotecan|irinotecan|mesh-list
82836308|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836309|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836310|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836311|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836312|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836313|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82836314|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82836315|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836316|NCT03815175|Aspirin|aspirin|mesh-list
82836317|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82836318|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82836319|NCT03815175|Analgesics|analgesics|mesh-ancestor
82836320|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
82836321|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836322|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836323|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836324|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836325|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82836326|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82836327|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836328|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82836329|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82836330|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836331|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
82836332|NCT01080027|Interferons|interferons|mesh-list
82836333|NCT01080027|Interferon-beta|interferon-beta|mesh-list
82836334|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
82836335|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836336|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
82836337|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836338|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
82836339|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836340|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82836341|NCT00262028|Vaccines|vaccines|mesh-list
82836342|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
82836343|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836344|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
82836345|NCT00183248|Sirolimus|sirolimus|mesh-list
82836346|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
82836347|NCT00183248|Tacrolimus|tacrolimus|mesh-list
82836348|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836349|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
82836350|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836351|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82836352|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836353|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836354|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82836355|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836356|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82836357|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
82836358|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836359|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836360|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
82836361|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836362|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
82836363|NCT00230282|Fludarabine|fludarabine|mesh-list
82836364|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
82836365|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836366|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
82836367|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836368|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836369|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82836370|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
82836371|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836372|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836373|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82836374|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836375|NCT00261950|Cinacalcet|cinacalcet|mesh-list
82836376|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82836377|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836378|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82836379|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
82836380|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82836381|NCT00229658|Pramlintide|pramlintide|mesh-list
82836382|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82836383|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836384|NCT00182078|Sertraline|sertraline|mesh-list
82836385|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
82836386|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82836387|NCT00182078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82836388|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83443340|NCT00817219|Hormones|hormones|mesh-ancestor
82836389|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82836390|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836391|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836392|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
82836393|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836394|NCT00181844|Lamotrigine|lamotrigine|mesh-list
82836395|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
82836396|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82836397|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82836398|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836399|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82836400|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836401|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82836402|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82836403|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836404|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82836405|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82836406|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82836407|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82836408|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82836409|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82836410|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836411|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
82836412|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836413|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836414|NCT00180674|Warfarin|warfarin|mesh-list
82836415|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
82836416|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82836417|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82836418|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82836419|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836420|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836421|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82836422|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82836423|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82836424|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82836425|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
82836426|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836427|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836428|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82836429|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82836430|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
82836431|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82836432|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82836433|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
82836434|NCT00076024|Docetaxel|docetaxel|mesh-list
82836435|NCT00076024|Axitinib|axitinib|mesh-list
82836436|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836437|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836438|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836439|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836440|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836441|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836442|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836443|NCT01103050|Cetirizine|cetirizine|mesh-list
82836444|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82836445|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82836447|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
82836448|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
82836449|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836450|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836451|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836452|NCT00075478|Cyclosporine|cyclosporine|mesh-list
82836453|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
82836454|NCT00075478|Fludarabine|fludarabine|mesh-list
82836455|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
82836456|NCT00075478|Cyclosporins|cyclosporins|mesh-list
82836457|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836458|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836459|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
82836460|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836461|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836462|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
82836463|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836464|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836465|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
82836466|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836467|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
82836468|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836469|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82836470|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82836471|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82836472|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
82836473|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836474|NCT00175916|Brivaracetam|brivaracetam|mesh-list
82836475|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
82836476|NCT01089088|Gemcitabine|gemcitabine|mesh-list
82836477|NCT01089088|Sunitinib|sunitinib|mesh-list
82836478|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836479|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836480|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
82836481|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836482|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82836483|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82836484|NCT01089088|Growth Substances|growth substances|mesh-ancestor
82836485|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836486|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
82836487|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836488|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836489|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
82836490|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836491|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836492|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836493|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836494|NCT01103206|Cinacalcet|cinacalcet|mesh-list
82836495|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82836496|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836497|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82836498|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
82836499|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82836500|NCT00228566|Modafinil|modafinil|mesh-list
82836501|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82836502|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836503|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82836504|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82836505|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82836506|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836507|NCT05625724|Aspirin|aspirin|mesh-list
82836508|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82836509|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82836510|NCT05625724|Analgesics|analgesics|mesh-ancestor
82836511|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
82836512|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836513|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836514|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836515|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836516|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82836517|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83362077|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82836518|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836519|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82836520|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82836521|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836522|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
82836523|NCT01089166|Metformin|metformin|mesh-list
82836524|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82836525|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836526|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
82836527|NCT00203502|Bevacizumab|bevacizumab|mesh-list
82836528|NCT00203502|Docetaxel|docetaxel|mesh-list
82836529|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836530|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
82836531|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836532|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836533|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82836534|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
82836535|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836536|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836537|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82836538|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836539|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82836540|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82836541|NCT00203502|Growth Substances|growth substances|mesh-ancestor
82836542|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
82836543|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836544|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836545|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836546|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
82836547|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82836548|NCT01103518|Estradiol|estradiol|mesh-list
82836549|NCT01103518|Cyproterone|cyproterone|mesh-list
82836550|NCT01103518|Estrogens|estrogens|mesh-ancestor
82836551|NCT01103518|Hormones|hormones|mesh-ancestor
82836552|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82836553|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836554|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82836555|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
82836556|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82836557|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82836558|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82836559|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82836560|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
82836561|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
82836562|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836563|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82836564|NCT01327534|Clopidogrel|clopidogrel|mesh-list
82836565|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82836566|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82836567|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82836568|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82836569|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82836570|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
82836571|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836572|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836573|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836574|NCT00232596|Ezogabine|ezogabine|mesh-list
82836575|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
82836576|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82836577|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836578|NCT00073918|Iodine|iodine|mesh-list
82836579|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
82836580|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
82836581|NCT00073918|Etoposide|etoposide|mesh-list
82836582|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
82836583|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
82836584|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82836585|NCT00073918|Antibodies|antibodies|mesh-list
82836586|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
82836587|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82836588|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836589|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
83443370|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
82836590|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836591|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836592|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82836593|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
82836594|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836596|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82836597|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82836598|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82836599|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82836600|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836601|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82836602|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836603|NCT00073918|Trace Elements|trace elements|mesh-ancestor
82836604|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
82836605|NCT00231894|Pioglitazone|pioglitazone|mesh-list
82836606|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82836607|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836608|NCT00203424|Bevacizumab|bevacizumab|mesh-list
82836609|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82836610|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836611|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836612|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82836613|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82836614|NCT00203424|Growth Substances|growth substances|mesh-ancestor
82836615|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836616|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
82836617|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836618|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836619|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836620|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
82836621|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82836622|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
82836623|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
82836624|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836625|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836626|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836627|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82836628|NCT00203268|Analgesics|analgesics|mesh-ancestor
82836629|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
82836630|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836631|NCT00168818|Enoxaparin|enoxaparin|mesh-list
82836632|NCT00168818|Dabigatran|dabigatran|mesh-list
82836633|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
82836634|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82836635|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82836636|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836637|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
82836638|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82836639|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
82836640|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836641|NCT00260832|Cytarabine|cytarabine|mesh-list
82836642|NCT00260832|Decitabine|decitabine|mesh-list
82836643|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836644|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
82836645|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836646|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836647|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
82836648|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836649|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836650|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
82836651|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836652|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836653|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
82836654|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82836655|NCT00168038|Antibodies|antibodies|mesh-list
82836656|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
82836657|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836658|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
82836659|NCT00166712|Sirolimus|sirolimus|mesh-list
82836660|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
82836661|NCT00166712|Tacrolimus|tacrolimus|mesh-list
82836662|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836663|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
82836664|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836665|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82836666|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836667|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836668|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82836669|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836670|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82836671|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
82836672|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836673|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836674|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
82836675|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836676|NCT00073528|Letrozole|letrozole|mesh-list
82836677|NCT00073528|Lapatinib|lapatinib|mesh-list
82836678|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836679|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82836680|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82836681|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836682|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836683|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82836684|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
82836685|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82836686|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836687|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836688|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
82836689|NCT03801148|Lansoprazole|lansoprazole|mesh-list
82836690|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82836691|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82836692|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82836693|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836694|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836695|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
82836696|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82836697|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836698|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
82836699|NCT01103830|Lumefantrine|lumefantrine|mesh-list
82836700|NCT01103830|Artemether|artemether|mesh-list
82836701|NCT01103830|Piperaquine|piperaquine|mesh-list
82836702|NCT01103830|Artenimol|artenimol|mesh-list
82836703|NCT01103830|Artemisinins|artemisinins|mesh-list
82836704|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82836705|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82836706|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836707|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836708|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82836709|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82836710|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836711|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836712|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836713|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82836714|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
82836715|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82836716|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836717|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82836718|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82836719|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82836720|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
82836721|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82836722|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82836723|NCT00072280|Dactinomycin|dactinomycin|mesh-list
82836724|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
82836725|NCT00072280|Ifosfamide|ifosfamide|mesh-list
82836726|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
82836727|NCT00072280|Etoposide|etoposide|mesh-list
82836728|NCT00072280|Vincristine|vincristine|mesh-list
82836729|NCT00072280|Lenograstim|lenograstim|mesh-list
82836730|NCT00072280|Mesna|mesna|mesh-list
82836731|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836732|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
82836733|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836734|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836735|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82836736|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
82836737|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836738|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836739|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82836740|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82836741|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82836742|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82836743|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836744|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82836745|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836746|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836747|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836748|NCT00072280|Protective Agents|protective agents|mesh-ancestor
82836749|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836750|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836751|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82836752|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82836753|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82836755|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82836756|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836757|NCT01106716|Lidocaine|lidocaine|mesh-list
82836758|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
82836759|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
82836760|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836761|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836762|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
82836763|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836764|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82836765|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82836766|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82836767|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82836768|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836769|NCT00071812|Belimumab|belimumab|mesh-list
82836770|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836771|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
82836772|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836773|NCT01104298|Doxorubicin|doxorubicin|mesh-list
82836774|NCT01104298|Trabectedin|trabectedin|mesh-list
82836775|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82836776|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836777|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82836778|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82836779|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836780|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836781|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82836782|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
82836783|NCT01106872|Bevacizumab|bevacizumab|mesh-list
82836784|NCT01106872|Gemcitabine|gemcitabine|mesh-list
82836785|NCT01106872|Docetaxel|docetaxel|mesh-list
82836786|NCT01106872|Valproic Acid|valproic acid|mesh-list
82836787|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836788|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836789|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82836790|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82836791|NCT01106872|Growth Substances|growth substances|mesh-ancestor
82836792|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836793|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
82836794|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836795|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
82836796|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836797|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836798|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836799|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836800|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
82836801|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836802|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
82836803|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836804|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
82836805|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82836806|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836807|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82836808|NCT03960268|Brodalumab|brodalumab|mesh-list
82836809|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
82836810|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
82836811|NCT05485480|Narcotics|narcotics|mesh-ancestor
82836812|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836813|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836814|NCT05485480|Analgesics|analgesics|mesh-ancestor
82836815|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
82836816|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836817|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
82836818|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836819|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
82836820|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836821|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836822|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82836824|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82836825|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
82836826|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82836827|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836828|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82836829|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
82836830|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
82836831|NCT00259610|Etanercept|etanercept|mesh-list
82836832|NCT00259610|Methotrexate|methotrexate|mesh-list
82836833|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82836834|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
82836835|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82836836|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836837|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836838|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
82836839|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836840|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836841|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
82836842|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836843|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82836844|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82836845|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
82836846|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836847|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82836848|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
82836849|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82836850|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82836851|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82836852|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82836853|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82836854|NCT00259610|Analgesics|analgesics|mesh-ancestor
82836855|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
82836856|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836857|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836858|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82836859|NCT05371132|Deferoxamine|deferoxamine|mesh-list
82836860|NCT05371132|Siderophores|siderophores|mesh-ancestor
82836861|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82836862|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
82836863|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
82836864|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836865|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
82836866|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
82836867|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82836868|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82836869|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82836870|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82836871|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836872|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
82836873|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836874|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836875|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82836876|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836877|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82836878|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
82836879|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836880|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
82836881|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82836882|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82836883|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836884|NCT00165698|Vitamins|vitamins|mesh-ancestor
82836885|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
82836886|NCT01075022|Vitamin D|vitamin d|mesh-list
82836887|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
82836888|NCT01075022|Vitamins|vitamins|mesh-ancestor
82836889|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
82836890|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836891|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82836892|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82836893|NCT00225758|Lapatinib|lapatinib|mesh-list
82836894|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362078|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82836895|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82836896|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836897|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836898|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82836899|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
82836900|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82836901|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836902|NCT01104532|Incretins|incretins|mesh-ancestor
82836903|NCT01104532|Hormones|hormones|mesh-ancestor
82836904|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82836905|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82836906|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
82836907|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836908|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836909|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82836910|NCT01107574|Gabapentin|gabapentin|mesh-list
82836911|NCT01107574|Analgesics|analgesics|mesh-ancestor
82836912|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
82836913|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836914|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836915|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
82836916|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82836917|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82836918|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836919|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82836920|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82836921|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82836922|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836923|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836924|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
82836925|NCT03971500|Ticagrelor|ticagrelor|mesh-list
82836926|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836927|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836928|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82836929|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82836930|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82836931|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82836932|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
82836933|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836934|NCT00259298|Teriparatide|teriparatide|mesh-list
82836935|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82836936|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836937|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82836938|NCT01108744|Mannitol|mannitol|mesh-list
82836939|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82836940|NCT01108744|Diuretics|diuretics|mesh-ancestor
82836941|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
82836942|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836943|NCT01581866|Ziprasidone|ziprasidone|mesh-list
82836944|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82836945|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
82836946|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82836947|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836948|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836949|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82836950|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82836951|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82836952|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82836953|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82836954|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
82836955|NCT03892642|Avelumab|avelumab|mesh-list
82836956|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82836957|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836958|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
82836959|NCT01107808|Vitamin D|vitamin d|mesh-list
82836960|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
82836961|NCT01107808|Metformin|metformin|mesh-list
82836962|NCT01107808|Calcium|calcium|mesh-list
82836963|NCT01107808|Vitamins|vitamins|mesh-ancestor
82836964|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
82836965|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836966|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82836967|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82836968|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82836969|NCT01104844|Acetaminophen|acetaminophen|mesh-list
82836971|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82836972|NCT01104844|Analgesics|analgesics|mesh-ancestor
82836973|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
82836974|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82836975|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836976|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
82836977|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82836978|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82836979|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82836980|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82836981|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82836982|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836983|NCT03750136|Furosemide|furosemide|mesh-list
82836984|NCT03750136|Diuretics|diuretics|mesh-ancestor
82836985|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
82836986|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82836987|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82836988|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82836989|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836991|NCT01108042|Fluorouracil|fluorouracil|mesh-list
82836992|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82836993|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
82836994|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
82836995|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
82836996|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82836997|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
82836998|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82836999|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837000|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
82837001|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837002|NCT01105234|Vitamin D|vitamin d|mesh-list
82837003|NCT01105234|Calcipotriene|calcipotriene|mesh-list
82837004|NCT01105234|Vitamins|vitamins|mesh-ancestor
82837005|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
82837006|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837007|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82837008|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
82837009|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
82837010|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837011|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
82837012|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82837013|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
82837014|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
82837015|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82837016|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82837017|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837018|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837019|NCT01108900|Urological Agents|urological agents|mesh-ancestor
82837020|NCT01105390|Pemetrexed|pemetrexed|mesh-list
82837021|NCT01105390|Rilotumumab|rilotumumab|mesh-list
82837022|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82837023|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837024|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837025|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837026|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82837027|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82837028|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837029|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
82837030|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837031|NCT03947242|Trastuzumab|trastuzumab|mesh-list
82837032|NCT03947242|Vinorelbine|vinorelbine|mesh-list
82837033|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837034|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837035|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82837036|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
82837037|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
82837038|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
82837039|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837040|NCT03944980|Docetaxel|docetaxel|mesh-list
82837041|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837042|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
82837043|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
82837044|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
82837046|NCT03576664|Carvedilol|carvedilol|mesh-list
82837047|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82837048|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82837049|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
82837050|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837051|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837052|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837053|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837054|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
82837055|NCT03576664|Protective Agents|protective agents|mesh-ancestor
82837056|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82837057|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837058|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82837059|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
82837060|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82837061|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82837063|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82837064|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82837065|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837066|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82837067|NCT01108588|Aspirin|aspirin|mesh-list
82837068|NCT01108588|Clopidogrel|clopidogrel|mesh-list
82837069|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82837070|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82837071|NCT01108588|Analgesics|analgesics|mesh-ancestor
82837072|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
82837073|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837074|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837075|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837076|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837077|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82837078|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82837079|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837080|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82837081|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82837082|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837083|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
82837084|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82837085|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82837086|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82837087|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
82837088|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837089|NCT01208740|Metformin|metformin|mesh-list
82837090|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837091|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837092|NCT01208818|Dexamethasone|dexamethasone|mesh-list
82837093|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
82837094|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
82837095|NCT01208818|Bortezomib|bortezomib|mesh-list
82837096|NCT01208818|BB 1101|bb 1101|mesh-list
82837097|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837098|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
82837099|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837100|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837101|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82837102|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
82837103|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837104|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837105|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82837106|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837107|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
82837108|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
82837109|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837110|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837111|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
82837112|NCT01208818|Hormones|hormones|mesh-ancestor
82837113|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837114|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82837115|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
82837116|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837117|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
82837119|NCT03942796|Pregabalin|pregabalin|mesh-list
82837120|NCT03942796|Analgesics|analgesics|mesh-ancestor
82837121|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
82837122|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837123|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837124|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
82837125|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82837126|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837127|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837128|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82837129|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82837130|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82837131|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837132|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837133|NCT01114282|Bortezomib|bortezomib|mesh-list
82837134|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837135|NCT01109212|Bindarit|bindarit|mesh-list
82837136|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837137|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82837138|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837139|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837140|NCT01111864|Micronutrients|micronutrients|mesh-list
82837141|NCT01111864|Trace Elements|trace elements|mesh-list
82837142|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837143|NCT01111942|Cisplatin|cisplatin|mesh-list
82837144|NCT01111942|Carboplatin|carboplatin|mesh-list
82837145|NCT01111942|Docetaxel|docetaxel|mesh-list
82837146|NCT01111942|Fluorouracil|fluorouracil|mesh-list
82837147|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837148|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
82837149|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
82837150|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
82837151|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837152|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
82837153|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82837154|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837155|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
82837156|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837157|NCT01211860|Diazoxide|diazoxide|mesh-list
82837158|NCT01211860|Choline|choline|mesh-list
82837159|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
82837160|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82837161|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
82837162|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837163|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837164|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82837165|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
82837166|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837167|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
82837168|NCT01211938|Cetuximab|cetuximab|mesh-list
82837169|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837170|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837171|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
82837172|NCT02947438|Hematinics|hematinics|mesh-ancestor
82837173|NCT01209130|Rituximab|rituximab|mesh-list
82837174|NCT01209130|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
82837175|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837176|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837177|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
82837178|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837179|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837180|NCT01209130|Immunoconjugates|immunoconjugates|mesh-ancestor
82837181|NCT01209208|Budesonide|budesonide|mesh-list
82837182|NCT01209208|Mesalamine|mesalamine|mesh-list
82837183|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837184|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82837185|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
82837186|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837187|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837188|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82837189|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
82837190|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
82837191|NCT01209208|Hormones|hormones|mesh-ancestor
82837192|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837193|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82837194|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82837195|NCT01209208|Analgesics|analgesics|mesh-ancestor
82837196|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
82837197|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837198|NCT01114750|Dextrans|dextrans|mesh-list
82837199|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
82837200|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
82837201|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
82837202|NCT01328470|Cilostazol|cilostazol|mesh-list
82837203|NCT01328470|Clopidogrel|clopidogrel|mesh-list
82837204|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82837205|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82837206|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82837207|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82837208|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
82837209|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837210|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837211|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837212|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82837213|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
82837214|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837215|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82837216|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
82837217|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82837218|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82837219|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
82837220|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82837221|NCT01328470|Protective Agents|protective agents|mesh-ancestor
82837222|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82837223|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82837224|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837225|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82837226|NCT03940378|Levamisole|levamisole|mesh-list
82837227|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82837228|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
82837229|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837230|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
82837231|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
82837232|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82837233|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837234|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837235|NCT01115062|Lidocaine|lidocaine|mesh-list
82837236|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
82837237|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
82837238|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837239|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837240|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
82837241|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837242|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82837243|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82837244|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82837245|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837246|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837247|NCT01115140|Folic Acid|folic acid|mesh-list
82837248|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
82837249|NCT01115140|Metformin|metformin|mesh-list
82837250|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837251|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837252|NCT01115140|Hematinics|hematinics|mesh-ancestor
82837253|NCT01115140|Vitamins|vitamins|mesh-ancestor
82837254|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
82837255|NCT01112644|Oxycodone|oxycodone|mesh-list
82837256|NCT01112644|Naloxone|naloxone|mesh-list
82837257|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82837258|NCT01112644|Narcotics|narcotics|mesh-ancestor
82837259|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837260|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837261|NCT01112644|Analgesics|analgesics|mesh-ancestor
82837262|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
82837263|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837264|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82837265|NCT01112722|Histamine|histamine|mesh-list
82837266|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
82837267|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
82837268|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837269|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837270|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837271|NCT01015222|Paclitaxel|paclitaxel|mesh-list
82837272|NCT01015222|Bevacizumab|bevacizumab|mesh-list
82837274|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82837275|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837276|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
82837277|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
82837278|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
82837279|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837280|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837281|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82837282|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82837283|NCT01015222|Growth Substances|growth substances|mesh-ancestor
82837284|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837285|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
82837286|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82837287|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837288|NCT01212250|Carvedilol|carvedilol|mesh-list
82837289|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82837290|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82837291|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
82837292|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837293|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837294|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837295|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837296|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
82837297|NCT01212250|Protective Agents|protective agents|mesh-ancestor
82837298|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82837299|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837300|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82837301|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
82837302|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82837303|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82837304|NCT01209988|Tamsulosin|tamsulosin|mesh-list
82837305|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82837306|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82837307|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82837308|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
82837309|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837310|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837311|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837312|NCT01209988|Urological Agents|urological agents|mesh-ancestor
82837313|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
82837314|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82837315|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
82837316|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837317|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
82837318|NCT03943186|Protective Agents|protective agents|mesh-ancestor
82837319|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82837320|NCT01210066|Fentanyl|fentanyl|mesh-list
82837321|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
82837322|NCT01210066|Narcotics|narcotics|mesh-ancestor
82837323|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837324|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837325|NCT01210066|Analgesics|analgesics|mesh-ancestor
82837326|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
82837327|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837328|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82837329|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82837330|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
82837331|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
82837332|NCT01112878|Clonidine|clonidine|mesh-list
82837333|NCT01112878|Gabapentin|gabapentin|mesh-list
82837334|NCT01112878|Analgesics|analgesics|mesh-ancestor
82837335|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
82837336|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837337|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837338|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
82837339|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82837340|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82837341|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837342|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837343|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82837344|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82837345|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837346|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837348|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837349|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
82837350|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
82837351|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82837352|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82837353|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82837354|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
82837355|NCT01212406|Vitamin D|vitamin d|mesh-list
82837356|NCT01212406|Vitamins|vitamins|mesh-ancestor
82837357|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
82837358|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837359|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82837360|NCT01109758|Fenofibrate|fenofibrate|mesh-list
82837361|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82837362|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
82837363|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837364|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82837365|NCT01328236|Dexamethasone|dexamethasone|mesh-list
82837366|NCT01328236|Doxorubicin|doxorubicin|mesh-list
82837367|NCT01328236|Bortezomib|bortezomib|mesh-list
82837368|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837369|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
82837370|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
82837371|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837372|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837373|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837374|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
82837375|NCT01328236|Hormones|hormones|mesh-ancestor
82837376|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837377|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82837378|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837379|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82837380|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82837381|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82837382|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837383|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837384|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
82837385|NCT01328392|Lansoprazole|lansoprazole|mesh-list
82837386|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82837387|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837388|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82837389|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837390|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837391|NCT01115842|Vitamin D|vitamin d|mesh-list
82837392|NCT01115842|Vitamins|vitamins|mesh-ancestor
82837393|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
82837394|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837395|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82837396|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
82837397|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
82837398|NCT01116154|Lenalidomide|lenalidomide|mesh-list
82837399|NCT01116154|Vorinostat|vorinostat|mesh-list
82837400|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
82837401|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837402|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82837403|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82837404|NCT01116154|Growth Substances|growth substances|mesh-ancestor
82837405|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
82837406|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837407|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82837408|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837409|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837410|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
82837411|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82837412|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
82837413|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837414|NCT01210456|Expectorants|expectorants|mesh-ancestor
82837415|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
82837416|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82837417|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
82837418|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837419|NCT01210456|Protective Agents|protective agents|mesh-ancestor
82837420|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837421|NCT01210456|Antidotes|antidotes|mesh-ancestor
82837422|NCT01116310|Glycine|glycine|mesh-list
82837423|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
82837425|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837426|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837427|NCT01210846|Tivozanib|tivozanib|mesh-list
82837428|NCT01210846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82837429|NCT01210846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837430|NCT01210846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837431|NCT01116388|Caseins|caseins|mesh-list
82837432|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
82837433|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
82837434|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837435|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82837436|NCT01116622|Bexarotene|bexarotene|mesh-list
82837437|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837438|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82837439|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837440|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837441|NCT03941626|Immunomodulating Agents|immunomodulating agents|mesh-list
82837442|NCT03941626|Immunologic Factors|immunologic factors|mesh-ancestor
82837443|NCT03941626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837444|NCT01211002|Endostatins|endostatins|mesh-list
82837445|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837446|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82837447|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82837448|NCT01211002|Growth Substances|growth substances|mesh-ancestor
82837449|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837450|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
82837451|NCT01211080|Propranolol|propranolol|mesh-list
82837452|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82837453|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82837454|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
82837455|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837456|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837457|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837458|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82837459|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837460|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
82837461|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
82837462|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82837463|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837464|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837465|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82837466|NCT01116700|Analgesics|analgesics|mesh-ancestor
82837467|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
82837468|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837469|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82837470|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82837471|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82837472|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
82837473|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837474|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837475|NCT01113424|Nicotine|nicotine|mesh-list
82837476|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82837477|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
82837478|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837479|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837480|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82837481|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82837482|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
82837483|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837484|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837485|NCT01211158|Ketamine|ketamine|mesh-list
82837486|NCT01211158|Propofol|propofol|mesh-list
82837487|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82837488|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837489|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837490|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82837491|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
82837492|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
82837493|NCT01211158|Analgesics|analgesics|mesh-ancestor
82837494|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
82837495|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837496|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82837497|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82837498|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82837499|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837500|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837501|NCT01110226|Cisplatin|cisplatin|mesh-list
82837502|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
82837503|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837504|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837505|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837506|NCT03789292|Adalimumab|adalimumab|mesh-list
82837507|NCT03789292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82837508|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837509|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837510|NCT01211314|Enalapril|enalapril|mesh-list
82837511|NCT01211314|Lercanidipine|lercanidipine|mesh-list
82837512|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82837513|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
82837514|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837515|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837516|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837517|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82837518|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837519|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82837520|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837522|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
82837523|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837524|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837525|NCT02529514|Baclofen|baclofen|mesh-list
82837526|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82837527|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837528|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82837529|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837530|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82837531|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
82837532|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
82837533|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837534|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837535|NCT01211470|Daptomycin|daptomycin|mesh-list
82837536|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82837537|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837538|NCT01114048|Thalidomide|thalidomide|mesh-list
82837539|NCT01114048|Dexamethasone|dexamethasone|mesh-list
82837540|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
82837541|NCT01114048|Bortezomib|bortezomib|mesh-list
82837542|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837543|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
82837544|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837545|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837546|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82837547|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
82837548|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837549|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837550|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82837551|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837552|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
82837553|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
82837554|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837555|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837556|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
82837557|NCT01114048|Hormones|hormones|mesh-ancestor
82837558|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837559|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82837560|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
82837561|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82837562|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837563|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82837564|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82837565|NCT01114048|Growth Substances|growth substances|mesh-ancestor
82837566|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
82837567|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
82837568|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837569|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82837570|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82837571|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82837572|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837573|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837574|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837575|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82837576|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82837577|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
82837578|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837579|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837580|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82837581|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82837582|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
82837583|NCT02529670|Lidocaine|lidocaine|mesh-list
82837584|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
82837585|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
82837586|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837587|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837588|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
82837589|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837590|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83482616|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82837591|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82837592|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82837593|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837594|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837596|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82837597|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82837598|NCT01117636|Analgesics|analgesics|mesh-ancestor
82837599|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
82837600|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837601|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837602|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837603|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837604|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82837605|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82837606|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837607|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82837608|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82837609|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837610|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
82837611|NCT03938740|Insulin|insulin|mesh-list
82837612|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82837613|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
82837614|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
82837615|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837616|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837617|NCT01110616|Lorazepam|lorazepam|mesh-list
82837618|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
82837619|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
82837620|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
82837621|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837622|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837623|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837624|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82837625|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837626|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82837627|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82837628|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837629|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
82837630|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
82837631|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837632|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837633|NCT03938662|Choline|choline|mesh-list
82837634|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
82837635|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82837636|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
82837637|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837638|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837639|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82837640|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
82837641|NCT01213498|Atorvastatin|atorvastatin|mesh-list
82837642|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82837643|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82837644|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
82837645|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837646|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82837648|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837649|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82837650|NCT01111084|Hormones|hormones|mesh-ancestor
82837651|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837652|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837653|NCT01118260|Anesthetics|anesthetics|mesh-list
82837654|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837655|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837656|NCT01121770|PENTA|penta|mesh-list
82837657|NCT01121770|Fondaparinux|fondaparinux|mesh-list
82837658|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82837659|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
82837660|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82837661|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
82837662|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837663|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837664|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
82837665|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82837666|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82837667|NCT01121848|Leucovorin|leucovorin|mesh-list
82837668|NCT01121848|Fluorouracil|fluorouracil|mesh-list
82837669|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
82837670|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
82837671|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837672|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82837673|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837674|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837675|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
82837676|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837677|NCT01121848|Antidotes|antidotes|mesh-ancestor
82837678|NCT01121848|Protective Agents|protective agents|mesh-ancestor
82837679|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
82837680|NCT01121848|Vitamins|vitamins|mesh-ancestor
82837681|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
82837682|NCT01122004|Pregabalin|pregabalin|mesh-list
82837683|NCT01122004|Analgesics|analgesics|mesh-ancestor
82837684|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
82837685|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837686|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837687|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
82837688|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82837689|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837690|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837691|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82837692|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82837693|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82837694|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837695|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837696|NCT03933982|Vinorelbine|vinorelbine|mesh-list
82837697|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82837698|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837699|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
82837700|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
82837701|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
82837702|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837703|NCT01118572|Celecoxib|celecoxib|mesh-list
82837704|NCT01118572|Etodolac|etodolac|mesh-list
82837705|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82837706|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82837707|NCT01118572|Analgesics|analgesics|mesh-ancestor
82837708|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
82837709|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837710|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837711|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837712|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837713|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82837714|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82837715|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837716|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837717|NCT03937648|Lasmiditan|lasmiditan|mesh-list
82837718|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82837719|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
82837720|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837722|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837723|NCT01219036|Budesonide|budesonide|mesh-list
82837724|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837725|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82837726|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
82837727|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837728|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837729|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82837730|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
82837731|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
82837732|NCT01219036|Hormones|hormones|mesh-ancestor
82837733|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837734|NCT03936010|Canagliflozin|canagliflozin|mesh-list
82837735|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82837736|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82837737|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837738|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837739|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443447|NCT02010645|Decitabine|decitabine|mesh-list
82837740|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
82837741|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837742|NCT01124500|Methylphenidate|methylphenidate|mesh-list
82837743|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82837744|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837745|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82837746|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82837747|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837748|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837749|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
82837750|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837751|NCT01118884|Promethazine|promethazine|mesh-list
82837752|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
82837753|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
82837754|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
82837755|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82837756|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
82837757|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
82837758|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837759|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837760|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837761|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82837762|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82837763|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82837764|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837765|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
82837766|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
82837767|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
82837768|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837769|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
82837770|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
82837771|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837772|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
82837774|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82837775|NCT01213888|Trientine|trientine|mesh-list
82837776|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
82837777|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
82837778|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837779|NCT01119430|Fluoxetine|fluoxetine|mesh-list
82837780|NCT01119430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82837781|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82837782|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837783|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837784|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837785|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
82837786|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837787|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82837788|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
82837789|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837790|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82837791|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82837794|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
82837795|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
82837796|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837797|NCT03780244|Mannitol|mannitol|mesh-list
82837798|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82837799|NCT03780244|Diuretics|diuretics|mesh-ancestor
82837800|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
82837801|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837802|NCT01119742|Butenafine|butenafine|mesh-list
82837803|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
82837804|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837805|NCT01216696|Ipilimumab|ipilimumab|mesh-list
82837806|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837807|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837808|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82837809|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837810|NCT03937258|Probenecid|probenecid|mesh-list
82837811|NCT03937258|Abrocitinib|abrocitinib|mesh-list
82837812|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
82837813|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
82837814|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837815|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82837816|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837817|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837818|NCT01124656|Pioglitazone|pioglitazone|mesh-list
82837819|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82837820|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837821|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837822|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82837823|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82837824|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837825|NCT01122472|Lenalidomide|lenalidomide|mesh-list
82837826|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
82837827|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837828|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82837829|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82837830|NCT01122472|Growth Substances|growth substances|mesh-ancestor
82837831|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
82837832|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837833|NCT01214122|Warfarin|warfarin|mesh-list
82837834|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
82837835|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
82837836|NCT03935152|Progestins|progestins|mesh-ancestor
82837837|NCT03935152|Hormones|hormones|mesh-ancestor
82837838|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837839|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837840|NCT01216852|Losartan|losartan|mesh-list
82837841|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82837842|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837843|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82837844|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82837845|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837846|NCT03933748|Teicoplanin|teicoplanin|mesh-list
82837847|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82837848|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837849|NCT01120366|Methotrexate|methotrexate|mesh-list
82837850|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82837851|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
82837852|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82837853|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837854|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82837855|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
82837856|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837857|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837858|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
82837859|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837860|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82837861|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837862|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
82837863|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837864|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82837865|NCT01217086|Infliximab|infliximab|mesh-list
82837867|NCT01217086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82837868|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
82837869|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82837870|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82837871|NCT01120444|Insulin|insulin|mesh-list
82837872|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837873|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837874|NCT01217398|Bevacizumab|bevacizumab|mesh-list
82837875|NCT01217398|Temozolomide|temozolomide|mesh-list
82837876|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837877|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837878|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82837879|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82837880|NCT01217398|Growth Substances|growth substances|mesh-ancestor
82837881|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837882|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
82837883|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82837884|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
82837885|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837886|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
82837887|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82837888|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837889|NCT01214746|Atorvastatin|atorvastatin|mesh-list
82837890|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82837891|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82837892|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
83482617|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837893|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837894|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82837895|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82837896|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837897|NCT03935074|Melphalan|melphalan|mesh-list
82837898|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82837899|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
82837900|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837901|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837902|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82837903|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837904|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
82837905|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837906|NCT01217632|Entecavir|entecavir|mesh-list
82837907|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
82837908|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82837909|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
82837910|NCT03933280|Nalbuphine|nalbuphine|mesh-list
82837911|NCT03933280|Propofol|propofol|mesh-list
82837912|NCT03933280|Benoxinate|benoxinate|mesh-list
82837913|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82837914|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82837915|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837916|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837917|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82837918|NCT03933280|Analgesics|analgesics|mesh-ancestor
82837919|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
82837920|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82837921|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82837922|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82837923|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82837924|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
82837925|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837926|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837927|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82837928|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
82837929|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
82837930|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82837931|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82837932|NCT03933280|Narcotics|narcotics|mesh-ancestor
82837933|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
82837934|NCT01120912|Insulin|insulin|mesh-list
82837935|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837936|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837937|NCT01219582|Metformin|metformin|mesh-list
82837938|NCT01219582|Acarbose|acarbose|mesh-list
82837939|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82837940|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837941|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82837942|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837943|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837944|NCT03933358|Hormones|hormones|mesh-list
82837945|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82837946|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837947|NCT01122940|Phenytoin|phenytoin|mesh-list
82837948|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
82837949|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82837950|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82837951|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837952|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837953|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82837954|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82837955|NCT01219816|Epratuzumab|epratuzumab|mesh-list
82837956|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82837957|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837958|NCT01215136|Paclitaxel|paclitaxel|mesh-list
82837959|NCT01215136|Everolimus|everolimus|mesh-list
82837960|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82837961|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82837962|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
82837963|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
82837964|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
82837965|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837966|NCT01215136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82837967|NCT01215136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82837968|NCT01215136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82837969|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82837970|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
82837971|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837973|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82837974|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82837975|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82837976|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82837977|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837978|NCT01121458|Clevidipine|clevidipine|mesh-list
82837979|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82837980|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82837981|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837982|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82837983|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837984|NCT01215214|Midazolam|midazolam|mesh-list
82837985|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82837986|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82837987|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82837988|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82837989|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82837990|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82837991|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82837992|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82837993|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
82837994|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
82837995|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
82837996|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
82837997|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82837998|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82837999|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82838000|NCT01125670|Darexaban|darexaban|mesh-list
82838001|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82838002|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
82838003|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82838004|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
82838005|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838006|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838007|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
82838008|NCT03934450|Primaquine|primaquine|mesh-list
82838009|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
82838010|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82838011|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82838012|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838013|NCT01215682|Vitamin D|vitamin d|mesh-list
82838014|NCT01215682|Vitamins|vitamins|mesh-ancestor
82838015|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
82838016|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838017|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82838018|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82838019|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838021|NCT01123408|Olanzapine|olanzapine|mesh-list
82838022|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
82838023|NCT01123408|Clozapine|clozapine|mesh-list
82838024|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
82838025|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
82838026|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838027|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838028|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838029|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82838030|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82838031|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838032|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82838033|NCT01123408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82838034|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82838035|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838036|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838037|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838038|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
82838039|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82838040|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
82838041|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82838042|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82838043|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
82838045|NCT00141297|Palbociclib|palbociclib|mesh-list
82838046|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838047|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838048|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838049|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838050|NCT01123486|Hydromorphone|hydromorphone|mesh-list
82838051|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82838052|NCT01123486|Narcotics|narcotics|mesh-ancestor
82838053|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838054|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838055|NCT01123486|Analgesics|analgesics|mesh-ancestor
82838056|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
82838057|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838058|NCT01123564|Ranibizumab|ranibizumab|mesh-list
82838059|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82838060|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82838061|NCT01123564|Growth Substances|growth substances|mesh-ancestor
82838062|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838063|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
82838064|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838065|NCT01222312|Docetaxel|docetaxel|mesh-list
82838066|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
82838067|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838068|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
82838069|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
82838070|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838071|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838072|NCT03932266|Docetaxel|docetaxel|mesh-list
82838073|NCT03932266|Endostar protein|endostar protein|mesh-list
82838074|NCT03932266|Endostatins|endostatins|mesh-list
82838075|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838076|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
82838077|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
82838078|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838079|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838080|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82838081|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82838082|NCT03932266|Growth Substances|growth substances|mesh-ancestor
82838083|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838084|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
82838085|NCT00141219|Pregabalin|pregabalin|mesh-list
82838086|NCT00141219|Analgesics|analgesics|mesh-ancestor
82838087|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
82838088|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838089|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838090|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
82838092|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838093|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838094|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82838096|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82838097|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838098|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82838099|NCT01222468|Nabilone|nabilone|mesh-list
82838100|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
82838101|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
82838102|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838103|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838104|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838105|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82838106|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82838107|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838108|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82838109|NCT01220284|Vinorelbine|vinorelbine|mesh-list
82838110|NCT01220284|Satraplatin|satraplatin|mesh-list
82838111|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82838112|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838113|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
82838114|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
82838115|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838116|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838117|NCT01127464|Poly ICLC|poly iclc|mesh-list
82838118|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
82838119|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
82838120|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838121|NCT01222780|Vincristine|vincristine|mesh-list
82838122|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82838123|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838124|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
82838125|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
82838126|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838127|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838128|NCT01222936|Panobinostat|panobinostat|mesh-list
82838129|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838130|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82838131|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838132|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838133|NCT01125904|Crizotinib|crizotinib|mesh-list
82838134|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838135|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838136|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838137|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838138|NCT01125982|Propofol|propofol|mesh-list
82838139|NCT01125982|Desflurane|desflurane|mesh-list
82838140|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82838141|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838142|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838143|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82838144|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
82838145|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
82838146|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82838147|NCT01220362|Fentanyl|fentanyl|mesh-list
82838148|NCT01220362|Bupivacaine|bupivacaine|mesh-list
82838149|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
82838150|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
82838151|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838152|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838153|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
82838154|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838155|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82838156|NCT01220362|Narcotics|narcotics|mesh-ancestor
82838157|NCT01220362|Analgesics|analgesics|mesh-ancestor
82838158|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82838159|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82838160|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
82838161|NCT01220440|Methylphenidate|methylphenidate|mesh-list
82838162|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
82838163|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82838164|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838165|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82838166|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82838167|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838168|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838170|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838171|NCT01123876|Veliparib|veliparib|mesh-list
82838172|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82838173|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838174|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838175|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838176|NCT01124032|Methylphenidate|methylphenidate|mesh-list
82838177|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82838178|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838179|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82838180|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82838181|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838182|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838183|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
82838184|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838185|NCT03934294|Metoclopramide|metoclopramide|mesh-list
82838186|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
82838187|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
82838188|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838189|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838190|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838191|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82838192|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82838193|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
82838194|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838195|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838196|NCT01218568|Rifaximin|rifaximin|mesh-list
82838197|NCT01218568|Lactulose|lactulose|mesh-list
82838198|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82838199|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838200|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838201|NCT01127542|Lenalidomide|lenalidomide|mesh-list
82838202|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
82838203|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838204|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82838205|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82838206|NCT01127542|Growth Substances|growth substances|mesh-ancestor
82838207|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
82838208|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838209|NCT01127620|Cetirizine|cetirizine|mesh-list
82838210|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82838211|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82838212|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82838213|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
82838214|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
82838215|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838216|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838217|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838218|NCT01220518|Infliximab|infliximab|mesh-list
82838219|NCT01220518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82838220|NCT01220518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838221|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
82838222|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838223|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838224|NCT01220596|Interferons|interferons|mesh-list
82838225|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82838226|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
82838227|NCT01220596|Entecavir|entecavir|mesh-list
82838228|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838229|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
82838230|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838231|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
82838232|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838233|NCT01218724|Losartan|losartan|mesh-list
82838234|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82838235|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82838236|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82838237|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82838238|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82838240|NCT01218724|Diuretics|diuretics|mesh-ancestor
82838241|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
82838242|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838243|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82838244|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838245|NCT01126216|Paclitaxel|paclitaxel|mesh-list
82838246|NCT01126216|Cisplatin|cisplatin|mesh-list
82838247|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82838248|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838249|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
82838250|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
82838251|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838252|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838253|NCT01329016|Metformin|metformin|mesh-list
82838254|NCT01329016|Glyburide|glyburide|mesh-list
82838255|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838256|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838257|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
82838258|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82838259|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
82838260|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838261|NCT01223326|Expectorants|expectorants|mesh-ancestor
82838262|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
82838263|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82838264|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
82838265|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838266|NCT01223326|Protective Agents|protective agents|mesh-ancestor
82838267|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838268|NCT01223326|Antidotes|antidotes|mesh-ancestor
82838269|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
82838270|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838271|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838272|NCT01126294|Melatonin|melatonin|mesh-list
82838273|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
82838274|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838275|NCT01126294|Protective Agents|protective agents|mesh-ancestor
82838276|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838277|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838279|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82838280|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838281|NCT00162266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82838282|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838283|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838284|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
82838285|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838286|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838287|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82838288|NCT01126450|Cetuximab|cetuximab|mesh-list
82838289|NCT01126450|Lenalidomide|lenalidomide|mesh-list
82838290|NCT01126450|Antibodies|antibodies|mesh-list
82838291|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
82838292|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82838293|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
82838294|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838295|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838296|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82838297|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82838298|NCT01126450|Growth Substances|growth substances|mesh-ancestor
82838299|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
82838300|NCT01073384|Beclomethasone|beclomethasone|mesh-list
82838301|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838302|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
82838303|NCT01073384|Hormones|hormones|mesh-ancestor
82838304|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82838305|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838306|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82838307|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
82838308|NCT01126528|Vitamin D|vitamin d|mesh-list
82838309|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
82838310|NCT01126528|Vitamins|vitamins|mesh-ancestor
82838311|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
82838312|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838313|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82838314|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82838315|NCT00225212|Rituximab|rituximab|mesh-list
82838316|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82838317|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838318|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
82838319|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838320|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838321|NCT03853330|Bupivacaine|bupivacaine|mesh-list
82838322|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
82838323|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
82838324|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838325|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838326|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
82838327|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838328|NCT01581944|Goserelin|goserelin|mesh-list
82838329|NCT01581944|Hormones|hormones|mesh-list
82838330|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82838331|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838332|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82838333|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838334|NCT01226056|Everolimus|everolimus|mesh-list
82838335|NCT01226056|Sorafenib|sorafenib|mesh-list
82838336|NCT01226056|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82838337|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838338|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838339|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838340|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838341|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
82838342|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838343|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838344|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
82838345|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82838346|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838347|NCT01126606|Glycerol|glycerol|mesh-list
82838348|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82838349|NCT01126606|Protective Agents|protective agents|mesh-ancestor
82838350|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838351|NCT01329406|Milnacipran|milnacipran|mesh-list
82838352|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
82838353|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82838354|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82838355|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838356|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838357|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838358|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838359|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82838360|NCT01329406|Analgesics|analgesics|mesh-ancestor
82838361|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
82838362|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838363|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
82838364|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82838365|NCT01126684|Atorvastatin|atorvastatin|mesh-list
82838366|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82838367|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82838368|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
82838369|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838370|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82838371|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82838372|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838373|NCT01224028|Tacrolimus|tacrolimus|mesh-list
82838374|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838375|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
82838376|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838377|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82838378|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443491|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82838379|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838380|NCT01226212|Sulfalene|sulfalene|mesh-list
82838381|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838382|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82838383|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
82838384|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82838385|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82838386|NCT01075490|Clonidine|clonidine|mesh-list
82838387|NCT01075490|Analgesics|analgesics|mesh-ancestor
82838388|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
82838389|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838390|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838391|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82838392|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
82838393|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
82838394|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82838395|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82838396|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82838397|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
82838398|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838399|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838400|NCT01126138|Docetaxel|docetaxel|mesh-list
82838401|NCT01126138|Capecitabine|capecitabine|mesh-list
82838402|NCT01126138|Vinorelbine|vinorelbine|mesh-list
82838403|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838404|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
82838405|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
82838406|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838407|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838408|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82838409|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
82838410|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82838411|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82838412|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82838413|NCT03930706|Estradiol|estradiol|mesh-list
82838414|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82838415|NCT03930706|Estrogens|estrogens|mesh-ancestor
82838416|NCT03930706|Hormones|hormones|mesh-ancestor
82838417|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82838418|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838419|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82838420|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
82838421|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82838422|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82838424|NCT03932578|Metoclopramide|metoclopramide|mesh-list
82838425|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82838426|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82838427|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82838428|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
82838429|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838430|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838431|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82838432|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
82838433|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
82838434|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
82838435|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82838436|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82838437|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
82838438|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838439|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838440|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
82838441|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838442|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82838443|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82838444|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
82838445|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
82838446|NCT00258440|Hematinics|hematinics|mesh-ancestor
82838447|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
82838448|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82838449|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838450|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82838451|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82838452|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838453|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838454|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838455|NCT00224120|Silodosin|silodosin|mesh-list
82838456|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82838457|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82838458|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82838459|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
82838460|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838461|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838462|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838464|NCT01226446|Vitamin D|vitamin d|mesh-list
82838465|NCT01226446|Vitamins|vitamins|mesh-ancestor
82838466|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
82838467|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838468|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82838469|NCT01224418|Tacrolimus|tacrolimus|mesh-list
82838470|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838471|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
82838472|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838473|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82838474|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838475|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838476|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
82838477|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82838478|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82838479|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82838480|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838481|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838482|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
82838483|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838484|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838485|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82838486|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838487|NCT01129180|Azacitidine|azacitidine|mesh-list
82838488|NCT01129180|Bortezomib|bortezomib|mesh-list
82838489|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82838490|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
82838491|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838492|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838493|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838494|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
82838495|NCT00224042|Hematinics|hematinics|mesh-ancestor
82838496|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
82838497|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838498|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838500|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838501|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838502|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838503|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838504|NCT01224652|Paclitaxel|paclitaxel|mesh-list
82838505|NCT01224652|Irinotecan|irinotecan|mesh-list
82838506|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82838507|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838508|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
82838509|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
82838510|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838511|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838512|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82838513|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82838514|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838515|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
82838516|NCT00160706|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82838517|NCT00160706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838518|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838519|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
82838520|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838521|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838522|NCT03928210|Digoxin|digoxin|mesh-list
82838523|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82838524|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82838525|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838526|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838527|NCT03928210|Protective Agents|protective agents|mesh-ancestor
83443495|NCT04349241|Favipiravir|favipiravir|mesh-list
82838528|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838529|NCT01226602|Ticagrelor|ticagrelor|mesh-list
82838530|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82838531|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82838532|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82838533|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82838534|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
82838535|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838536|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838537|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838539|NCT01226680|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82838540|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838541|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838542|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838543|NCT00257192|Ziprasidone|ziprasidone|mesh-list
82838544|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82838545|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
82838546|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838547|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838548|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838549|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82838550|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82838551|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838552|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82838553|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82838554|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
82838555|NCT01224964|Montelukast|montelukast|mesh-list
82838556|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82838557|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
82838558|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82838559|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
82838560|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82838561|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838562|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82838563|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82838564|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838565|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
82838566|NCT03967964|Testosterone|testosterone|mesh-list
82838567|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
82838568|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
82838569|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82838570|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82838571|NCT03967964|Androgens|androgens|mesh-ancestor
82838572|NCT03967964|Hormones|hormones|mesh-ancestor
82838573|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82838574|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838575|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82838576|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838577|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
82838578|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82838579|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
82838580|NCT01129414|Omeprazole|omeprazole|mesh-list
82838581|NCT01129414|Clopidogrel|clopidogrel|mesh-list
82838582|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82838583|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82838584|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82838585|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82838586|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
82838587|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838588|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838589|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838590|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82838591|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838592|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82838593|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838594|NCT03967886|Esomeprazole|esomeprazole|mesh-list
82838595|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82838596|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838597|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82838598|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838599|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838600|NCT03968042|Thiamine|thiamine|mesh-list
82838601|NCT03968042|Edaravone|edaravone|mesh-list
82838602|NCT03968042|Mitogens|mitogens|mesh-list
82838603|NCT03968042|Vitamins|vitamins|mesh-ancestor
82838604|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
82838605|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838606|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
82838607|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838608|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
82838609|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82838610|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
82838611|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82838612|NCT03968042|Protective Agents|protective agents|mesh-ancestor
82838614|NCT01128322|Amlodipine|amlodipine|mesh-list
82838615|NCT01128322|Telmisartan|telmisartan|mesh-list
82838616|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82838617|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82838618|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838619|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838620|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82838621|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838622|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
82838623|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82838624|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82838625|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82838626|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
82838627|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82838628|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
82838629|NCT01128322|Vitamins|vitamins|mesh-ancestor
82838630|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
82838631|NCT01129570|Silybin|silybin|mesh-list
82838632|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82838633|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838634|NCT01129570|Protective Agents|protective agents|mesh-ancestor
82838635|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838636|NCT01073540|Cephalexin|cephalexin|mesh-list
82838637|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82838638|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838639|NCT03740386|Phentolamine|phentolamine|mesh-list
82838640|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82838641|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82838642|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
82838643|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838644|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838645|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838646|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82838647|NCT03927352|Adalimumab|adalimumab|mesh-list
82838648|NCT03927352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82838649|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838650|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838651|NCT01225198|Vitamins|vitamins|mesh-list
82838652|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
82838653|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838654|NCT01226992|Vancomycin|vancomycin|mesh-list
82838655|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82838656|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838657|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
82838658|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82838659|NCT03740464|Lenograstim|lenograstim|mesh-list
82838660|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82838661|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
82838662|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838663|NCT03927118|Dexamethasone|dexamethasone|mesh-list
82838664|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
82838665|NCT03927118|BB 1101|bb 1101|mesh-list
82838666|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838667|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
82838668|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
82838669|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838670|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838671|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838672|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
82838673|NCT03927118|Hormones|hormones|mesh-ancestor
82838674|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82838675|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82838676|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838677|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
82838678|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838679|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838680|NCT01227148|Insulin|insulin|mesh-list
82838681|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838682|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838683|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
82838684|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82838685|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82838687|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82838688|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838689|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838690|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838691|NCT01128712|Pregabalin|pregabalin|mesh-list
82838692|NCT01128712|Analgesics|analgesics|mesh-ancestor
82838693|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
82838694|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838695|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838696|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
82838697|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82838698|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838699|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838700|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82838701|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82838702|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82838703|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838704|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82838705|NCT01127386|Lenalidomide|lenalidomide|mesh-list
82838706|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
82838707|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838708|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82838709|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82838710|NCT01127386|Growth Substances|growth substances|mesh-ancestor
82838711|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
82838712|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838713|NCT01130194|Procarbazine|procarbazine|mesh-list
82838714|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838715|NCT03925090|Cisplatin|cisplatin|mesh-list
82838716|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838717|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
82838718|NCT01225744|Irinotecan|irinotecan|mesh-list
82838719|NCT01225744|Cetuximab|cetuximab|mesh-list
82838720|NCT01225744|Tegafur|tegafur|mesh-list
82838721|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838722|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82838723|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82838724|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838725|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838726|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82838727|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82838728|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
82838729|NCT03926806|Vitamins|vitamins|mesh-list
82838730|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
82838731|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
82838732|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838733|NCT03926962|Nafithromycin|nafithromycin|mesh-list
82838734|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82838735|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838736|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82838737|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838738|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838739|NCT01228240|Metformin|metformin|mesh-list
82838740|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838741|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838742|NCT03919786|Anesthetics|anesthetics|mesh-list
82838743|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838744|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838745|NCT03924544|Mitomycins|mitomycins|mesh-list
82838746|NCT03924544|Mitomycin|mitomycin|mesh-list
82838747|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82838748|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838749|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
82838750|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838751|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82838752|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838753|NCT01131364|Doxorubicin|doxorubicin|mesh-list
82838754|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82838755|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838756|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82838757|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82838758|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838759|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838760|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
82838762|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82838763|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838764|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82838765|NCT02529202|Analgesics|analgesics|mesh-ancestor
82838766|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
82838767|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838768|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82838769|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82838770|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82838771|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
82838772|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838773|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838774|NCT00154310|Cyclosporine|cyclosporine|mesh-list
82838775|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
82838776|NCT00154310|Everolimus|everolimus|mesh-list
82838777|NCT00154310|Cyclosporins|cyclosporins|mesh-list
82838778|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838779|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838780|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838781|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
82838782|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838783|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
82838784|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838785|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
82838786|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838787|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82838788|NCT00154310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82838789|NCT00154310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838790|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838791|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82838792|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82838793|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
82838794|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82838795|NCT03770728|Metformin|metformin|mesh-list
82838796|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
82838797|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838798|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838799|NCT01132222|Ibuprofen|ibuprofen|mesh-list
82838800|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
82838801|NCT01132222|Ephedrine|ephedrine|mesh-list
82838802|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82838803|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82838804|NCT01132222|Analgesics|analgesics|mesh-ancestor
82838805|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
82838806|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838807|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838808|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838809|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838810|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82838811|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838812|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838813|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82838814|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
82838815|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82838816|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
82838817|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
82838818|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82838819|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82838820|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
82838821|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
82838822|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838823|NCT03926182|Aflutinib|aflutinib|mesh-list
82838824|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838825|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838826|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838827|NCT01130506|Cytarabine|cytarabine|mesh-list
82838828|NCT01130506|Decitabine|decitabine|mesh-list
82838829|NCT01130506|Vorinostat|vorinostat|mesh-list
82838830|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82838831|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
82838832|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838833|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838834|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
82838835|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838844|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
82838845|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838846|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82838847|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838848|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82838850|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838851|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838852|NCT01228552|Ketoprofen|ketoprofen|mesh-list
82838853|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82838854|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82838855|NCT01228552|Analgesics|analgesics|mesh-ancestor
82838856|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
82838857|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838858|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838859|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838860|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838861|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82838862|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838863|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838864|NCT03919084|Nicotine|nicotine|mesh-list
82838865|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82838866|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
82838867|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838868|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838869|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82838870|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82838871|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
82838872|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838873|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838874|NCT03923842|Denosumab|denosumab|mesh-list
82838875|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82838876|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838877|NCT01132768|Atenolol|atenolol|mesh-list
82838878|NCT01132768|Olmesartan|olmesartan|mesh-list
82838879|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82838880|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82838881|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82838882|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82838883|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838884|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82838885|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
82838886|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
82838887|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838888|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838889|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82838890|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82838891|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82838892|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
82838893|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838894|NCT01230034|Ramipril|ramipril|mesh-list
82838895|NCT01230034|Imidapril|imidapril|mesh-list
82838896|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82838897|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
82838898|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838899|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838900|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82838901|NCT03918616|Dopamine|dopamine|mesh-list
82838902|NCT03918616|Memantine|memantine|mesh-list
82838903|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
82838904|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82838905|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82838906|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
82838907|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838908|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838909|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838910|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82838911|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82838912|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82838913|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
82838914|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
82838915|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838916|NCT03918616|Protective Agents|protective agents|mesh-ancestor
82838917|NCT01228630|Loratadine|loratadine|mesh-list
82838918|NCT01228630|Fexofenadine|fexofenadine|mesh-list
82838919|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
82838920|NCT01228630|Ephedrine|ephedrine|mesh-list
82838921|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
82838922|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
82838923|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82838924|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82838925|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82838926|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
82838927|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
82838928|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838929|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838930|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838931|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82838932|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
82838933|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838934|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82838935|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
82838936|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
82838937|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82838938|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82838939|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
82838940|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
82838941|NCT01134406|Hylan|hylan|mesh-list
82838942|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
82838943|NCT01134406|Protective Agents|protective agents|mesh-ancestor
82838944|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838945|NCT01231828|Lactulose|lactulose|mesh-list
82838946|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82838947|NCT03923218|Vitamin D|vitamin d|mesh-list
82838948|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
82838949|NCT03923218|Vitamins|vitamins|mesh-ancestor
82838950|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
82838951|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838952|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82838953|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82838954|NCT03923140|Tranilast|tranilast|mesh-list
82838955|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82838956|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82838957|NCT03923140|Analgesics|analgesics|mesh-ancestor
82838958|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
82838959|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838960|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838961|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838962|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82838963|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82838964|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82838965|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838966|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82838967|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82838968|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
82838969|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
82838970|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82838971|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82838972|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82838973|NCT01133080|Minocycline|minocycline|mesh-list
82838974|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82838975|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838976|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82838977|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
82838978|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
82838979|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
82838980|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82838981|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82838982|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82838983|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82838984|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82838985|NCT01585792|Glimepiride|glimepiride|mesh-list
82838986|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82838987|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82838988|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838989|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82838990|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
82838991|NCT01134484|Thalidomide|thalidomide|mesh-list
82838992|NCT01134484|Dexamethasone|dexamethasone|mesh-list
82838993|NCT01134484|Bortezomib|bortezomib|mesh-list
82838994|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82838995|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
82838996|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
82838997|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82838998|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82838999|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839000|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
82839001|NCT01134484|Hormones|hormones|mesh-ancestor
82839002|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839003|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839004|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839005|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839006|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
82839007|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
82839008|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82839009|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839010|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82839011|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82839012|NCT01134484|Growth Substances|growth substances|mesh-ancestor
82839013|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
82839014|NCT01133470|Fexofenadine|fexofenadine|mesh-list
82839015|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
82839016|NCT01133470|Ephedrine|ephedrine|mesh-list
82839017|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82839018|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
82839019|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839020|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839021|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82839022|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
82839023|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
82839024|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82839025|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82839026|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
82839027|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
82839028|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839029|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839030|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82839031|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82839032|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82839033|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
82839034|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
82839035|NCT01134718|Simeprevir|simeprevir|mesh-list
82839036|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
82839037|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839038|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839039|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839040|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839041|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
82839042|NCT03917758|Empagliflozin|empagliflozin|mesh-list
82839043|NCT03917758|Canagliflozin|canagliflozin|mesh-list
82839044|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82839045|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839046|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82839047|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839048|NCT01230736|Timolol|timolol|mesh-list
82839049|NCT01230736|Travoprost|travoprost|mesh-list
82839050|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82839051|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82839052|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82839053|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82839054|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
82839055|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839056|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839057|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839058|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82839059|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82839060|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
82839061|NCT01133548|Testosterone|testosterone|mesh-list
82839062|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
82839063|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
82839064|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82839065|NCT01133548|Androgens|androgens|mesh-ancestor
82839066|NCT01133548|Hormones|hormones|mesh-ancestor
82839067|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839068|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839069|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839070|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839071|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
82839072|NCT03917134|Metronidazole|metronidazole|mesh-list
82839073|NCT03917134|Cephalosporins|cephalosporins|mesh-list
82839074|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839075|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82839076|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82839077|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82839078|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82839079|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839080|NCT01231126|Misoprostol|misoprostol|mesh-list
82839081|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82839082|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
82839083|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82839084|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839085|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82839086|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839087|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
82839088|NCT03769090|Budesonide|budesonide|mesh-list
82839089|NCT03769090|Albuterol|albuterol|mesh-list
82839090|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839091|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82839092|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
82839093|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839094|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839095|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82839096|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
82839097|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
82839098|NCT03769090|Hormones|hormones|mesh-ancestor
82839099|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839100|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
82839101|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82839102|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82839103|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82839104|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82839105|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
82839106|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839107|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839108|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82839109|NCT03921736|Perindopril|perindopril|mesh-list
82839110|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82839111|NCT03921736|Diuretics|diuretics|mesh-ancestor
82839112|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
82839113|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839114|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82839115|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82839116|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839117|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82839118|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839119|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839120|NCT05401006|Acitretin|acitretin|mesh-list
82839121|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
82839122|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
82839123|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
82839124|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839125|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839126|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
82839127|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82839128|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839129|NCT01131754|Heparin|heparin|mesh-list
82839130|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
82839131|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82839132|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82839133|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839134|NCT01231594|Trametinib|trametinib|mesh-list
82839135|NCT01231594|Dabrafenib|dabrafenib|mesh-list
82839136|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
82839137|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839138|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839139|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839140|NCT01136278|Clonidine|clonidine|mesh-list
82839141|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82839142|NCT01136278|Analgesics|analgesics|mesh-ancestor
82839143|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
82839144|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839145|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839146|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82839147|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
82839148|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
82839149|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82839150|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82839151|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82839152|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
82839153|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839154|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839155|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
82839156|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82839157|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
82839158|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82839159|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82839160|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82839161|NCT05402722|Antibodies|antibodies|mesh-list
82839162|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
82839163|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839164|NCT05480488|Midazolam|midazolam|mesh-list
82839165|NCT05480488|Warfarin|warfarin|mesh-list
82839166|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82839167|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82839168|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839169|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839170|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82839171|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82839172|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82839173|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82839174|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
82839175|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
82839176|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
82839177|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
82839178|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839179|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839180|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
82839181|NCT01229332|Carbidopa|carbidopa|mesh-list
82839182|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82839183|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82839184|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
82839185|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839186|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839187|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839188|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82839189|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839190|NCT03921034|Ropivacaine|ropivacaine|mesh-list
82839191|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
82839192|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
82839193|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839194|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839195|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
82839196|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839197|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
82839198|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82839199|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82839200|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839201|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
82839202|NCT01136590|Coagulants|coagulants|mesh-ancestor
82839203|NCT03920878|Aflibercept|aflibercept|mesh-list
82839204|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82839205|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82839207|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839208|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
82839209|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839210|NCT03920644|Scopolamine|scopolamine|mesh-list
82839211|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82839212|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82839213|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
82839214|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
82839215|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839216|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839217|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839218|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
82839219|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82839220|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
82839221|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839222|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839223|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82839224|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
82839225|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
82839226|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839227|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839228|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839229|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839230|NCT01137994|Paclitaxel|paclitaxel|mesh-list
82839231|NCT01137994|Vinorelbine|vinorelbine|mesh-list
82839232|NCT01137994|Docetaxel|docetaxel|mesh-list
82839233|NCT01137994|Trastuzumab|trastuzumab|mesh-list
82839234|NCT01137994|Lapatinib|lapatinib|mesh-list
82839235|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82839236|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839237|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
82839238|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
82839239|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
82839240|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839241|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839242|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839243|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839244|NCT01138072|Atorvastatin|atorvastatin|mesh-list
82839245|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82839246|NCT01138072|Simvastatin|simvastatin|mesh-list
82839247|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82839248|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82839249|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
82839250|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839251|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82839252|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82839253|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839254|NCT01131910|Vaccines|vaccines|mesh-list
82839255|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
82839256|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839257|NCT03739606|Antibodies|antibodies|mesh-list
82839258|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
82839259|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82839260|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82839261|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
82839262|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839263|NCT01138384|Lapatinib|lapatinib|mesh-list
82839264|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839265|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839266|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839267|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839268|NCT05533372|Methotrexate|methotrexate|mesh-list
82839269|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82839270|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
82839271|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82839272|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839273|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82839274|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
82839275|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839276|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839277|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
82839278|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839279|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82839280|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839281|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
82839282|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839283|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82839284|NCT01233622|Vildagliptin|vildagliptin|mesh-list
82839285|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82839286|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839287|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82839288|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839289|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839290|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839291|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
82839292|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
82839293|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839294|NCT01138774|Protective Agents|protective agents|mesh-ancestor
82839295|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839296|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
82839297|NCT01138774|Vitamins|vitamins|mesh-ancestor
82839298|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
82839299|NCT01131988|Tacrolimus|tacrolimus|mesh-list
82839300|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839301|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
82839302|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839303|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82839304|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839305|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839306|NCT01138852|Ampicillin|ampicillin|mesh-list
82839307|NCT01138852|Cefuroxime|cefuroxime|mesh-list
82839308|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
82839309|NCT01138852|Sulbactam|sulbactam|mesh-list
82839310|NCT01138852|Sultamicillin|sultamicillin|mesh-list
82839311|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82839312|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839313|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82839314|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839315|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839316|NCT05487196|Clonidine|clonidine|mesh-list
82839317|NCT05487196|Fentanyl|fentanyl|mesh-list
82839318|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
82839319|NCT05487196|Ropivacaine|ropivacaine|mesh-list
82839320|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82839321|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839322|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839323|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82839324|NCT05487196|Analgesics|analgesics|mesh-ancestor
82839325|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
82839326|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839327|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82839328|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82839329|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82839330|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
82839331|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839332|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839333|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
82839334|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
82839335|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82839336|NCT05487196|Narcotics|narcotics|mesh-ancestor
82839337|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82839338|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82839339|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
82839340|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82839341|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
82839342|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
82839343|NCT01585870|Sorafenib|sorafenib|mesh-list
82839344|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839345|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839346|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839347|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839348|NCT05210140|Escitalopram|escitalopram|mesh-list
82839349|NCT05210140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82839350|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82839351|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82839352|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839353|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839354|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
82839355|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839356|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
82839357|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82839358|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82839359|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
82839360|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
82839361|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839362|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839363|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839364|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
82839365|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
82839366|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82839367|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82839368|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82839369|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839370|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82839371|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82839372|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839373|NCT05195944|Incretins|incretins|mesh-ancestor
82839374|NCT05195944|Hormones|hormones|mesh-ancestor
82839375|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839376|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82839377|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839378|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839379|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839380|NCT01236586|Dexamethasone|dexamethasone|mesh-list
82839381|NCT01236586|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82839382|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839383|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
82839384|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
82839385|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839386|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839387|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839388|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
82839389|NCT01236586|Hormones|hormones|mesh-ancestor
82839390|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839391|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839392|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839393|NCT01236586|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82839394|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839395|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839396|NCT01234792|Nicotine|nicotine|mesh-list
82839397|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82839398|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
82839399|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839400|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839401|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82839402|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82839403|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
82839404|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839405|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839406|NCT03513328|Thiotepa|thiotepa|mesh-list
82839407|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82839408|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
82839409|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839410|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839411|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82839412|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839413|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
82839414|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839415|NCT03467932|Insulin|insulin|mesh-list
82839416|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82839417|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82839418|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839419|NCT05109052|Bevacizumab|bevacizumab|mesh-list
82839420|NCT05109052|Atezolizumab|atezolizumab|mesh-list
82839421|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839422|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839423|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82839424|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82839425|NCT05109052|Growth Substances|growth substances|mesh-ancestor
82839426|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839427|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
82839428|NCT05109052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82839429|NCT05109052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839430|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
82839431|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
82839432|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82839433|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82839434|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839435|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839436|NCT03199612|Urological Agents|urological agents|mesh-ancestor
82839437|NCT01140100|Thiopental|thiopental|mesh-list
82839438|NCT01140100|Propofol|propofol|mesh-list
82839439|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82839440|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839441|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839442|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82839443|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
82839444|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
82839445|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
82839446|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
82839447|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
82839448|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839449|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839450|NCT01141036|Midazolam|midazolam|mesh-list
82839451|NCT01141036|Propofol|propofol|mesh-list
82839452|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82839453|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839454|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839455|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82839456|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
82839457|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
82839458|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82839459|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82839460|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82839461|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82839462|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
82839463|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
82839464|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839465|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839466|NCT04917406|Dexamethasone|dexamethasone|mesh-list
82839467|NCT04917406|Lidocaine|lidocaine|mesh-list
82839468|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839469|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
82839470|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
82839471|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839472|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839473|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839474|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
82839475|NCT04917406|Hormones|hormones|mesh-ancestor
82839476|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839477|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839478|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839479|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
82839480|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
82839481|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839482|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
82839483|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82839484|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82839485|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82839486|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82839487|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839488|NCT02685826|Dexamethasone|dexamethasone|mesh-list
82839489|NCT02685826|Lenalidomide|lenalidomide|mesh-list
82839491|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839492|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
82839493|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
82839494|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839495|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839496|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839497|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
82839498|NCT02685826|Hormones|hormones|mesh-ancestor
82839499|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839500|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839501|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839502|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
82839503|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82839504|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82839505|NCT02685826|Growth Substances|growth substances|mesh-ancestor
82839506|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
82839507|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839508|NCT04906720|Colchicine|colchicine|mesh-list
82839509|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
82839510|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839511|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
82839512|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
82839513|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
82839514|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839515|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839516|NCT01141192|Vitamin D|vitamin d|mesh-list
82839517|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
82839518|NCT01141192|Vitamins|vitamins|mesh-ancestor
82839519|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
82839520|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839521|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82839522|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82839523|NCT01144000|Daptomycin|daptomycin|mesh-list
82839524|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82839525|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839526|NCT01140412|Ritonavir|ritonavir|mesh-list
82839527|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
82839528|NCT01140412|Maraviroc|maraviroc|mesh-list
82839529|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82839530|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82839531|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839532|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839533|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839534|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82839535|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82839536|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
82839537|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839538|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82839539|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82839540|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82839541|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82839542|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82839543|NCT01234324|Cisplatin|cisplatin|mesh-list
82839544|NCT01234324|Capecitabine|capecitabine|mesh-list
82839545|NCT01234324|Epirubicin|epirubicin|mesh-list
82839546|NCT01234324|Panitumumab|panitumumab|mesh-list
82839547|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839548|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82839549|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
82839550|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839551|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82839552|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82839553|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82839554|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839555|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839556|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
82839557|NCT02334124|Floxacillin|floxacillin|mesh-list
82839558|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82839559|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839560|NCT01144156|Adalimumab|adalimumab|mesh-list
82839561|NCT01144156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82839562|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839563|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839564|NCT01235260|Becaplermin|becaplermin|mesh-list
82839565|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
82839566|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
82839567|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82839568|NCT01235260|Growth Substances|growth substances|mesh-ancestor
82839569|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839570|NCT01144312|Fentanyl|fentanyl|mesh-list
82839571|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82839572|NCT01144312|Narcotics|narcotics|mesh-ancestor
82839573|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839574|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839575|NCT01144312|Analgesics|analgesics|mesh-ancestor
82839576|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
82839577|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839578|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82839579|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82839580|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
82839581|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
82839582|NCT01144390|Methadone|methadone|mesh-list
82839583|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82839584|NCT01144390|Narcotics|narcotics|mesh-ancestor
82839585|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839586|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839587|NCT01144390|Analgesics|analgesics|mesh-ancestor
82839588|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
82839589|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839590|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
82839591|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
82839592|NCT01329640|Paclitaxel|paclitaxel|mesh-list
82839593|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
82839594|NCT01329640|Trastuzumab|trastuzumab|mesh-list
82839595|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82839596|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839597|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
82839598|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
82839599|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
82839600|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839601|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839602|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
82839603|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839604|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839605|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82839606|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
82839607|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82839608|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839609|NCT05335018|Lenalidomide|lenalidomide|mesh-list
82839610|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
82839611|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839612|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82839613|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82839614|NCT05335018|Growth Substances|growth substances|mesh-ancestor
82839615|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
82839616|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839617|NCT00114777|Cyclosporine|cyclosporine|mesh-list
82839618|NCT00114777|Abatacept|abatacept|mesh-list
82839619|NCT00114777|Cyclosporins|cyclosporins|mesh-list
82839620|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839621|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839622|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839623|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
82839624|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839625|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
82839626|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839627|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
82839628|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839629|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82839630|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82839631|NCT00114777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83443538|NCT02069847|Budesonide|budesonide|mesh-list
82839632|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839633|NCT00139737|Ziprasidone|ziprasidone|mesh-list
82839634|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82839635|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
82839636|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839637|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839638|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839639|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82839640|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82839641|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839642|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82839643|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82839645|NCT00139659|Insulin|insulin|mesh-list
82839646|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82839647|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82839648|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839649|NCT01076439|Fluticasone|fluticasone|mesh-list
82839650|NCT01076439|Xhance|xhance|mesh-list
82839651|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
82839652|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839653|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82839654|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
82839655|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839656|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839657|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82839658|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
82839659|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
82839660|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82839661|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82839662|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82839663|NCT01076439|Analgesics|analgesics|mesh-ancestor
82839664|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
82839665|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839666|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82839667|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82839668|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
82839669|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
82839670|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839671|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839672|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
82839673|NCT03965637|Vitamins|vitamins|mesh-ancestor
82839674|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
82839675|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839676|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
82839677|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839678|NCT03965637|Protective Agents|protective agents|mesh-ancestor
82839679|NCT01078779|Chloroquine|chloroquine|mesh-list
82839680|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82839681|NCT01078779|Amebicides|amebicides|mesh-ancestor
82839682|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82839683|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82839684|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839685|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
82839686|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839687|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82839688|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82839689|NCT01078779|Analgesics|analgesics|mesh-ancestor
82839690|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
82839691|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839692|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839693|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839694|NCT01078779|Filaricides|filaricides|mesh-ancestor
82839695|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
82839696|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
82839697|NCT00114231|Capecitabine|capecitabine|mesh-list
82839698|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
82839699|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82839700|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
82839701|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839702|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839703|NCT00113919|Busulfan|busulfan|mesh-list
82839704|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
82839705|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839706|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839707|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
82839708|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839709|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82839710|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839711|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82839712|NCT00113841|Curcumin|curcumin|mesh-list
82839713|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82839714|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82839715|NCT00113841|Analgesics|analgesics|mesh-ancestor
82839716|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
82839717|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839718|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839719|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839720|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839721|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839722|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839723|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839724|NCT00113607|Dexamethasone|dexamethasone|mesh-list
82839725|NCT00113607|Trabectedin|trabectedin|mesh-list
82839726|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839727|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
82839728|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
82839729|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839730|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839731|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839732|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
82839733|NCT00113607|Hormones|hormones|mesh-ancestor
82839734|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839735|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839736|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839737|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82839738|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
82839739|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839740|NCT00113529|Sunitinib|sunitinib|mesh-list
82839741|NCT00113529|Gefitinib|gefitinib|mesh-list
82839742|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839743|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82839744|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82839745|NCT00113529|Growth Substances|growth substances|mesh-ancestor
82839746|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839747|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
82839748|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839749|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839750|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839751|NCT01079013|Treosulfan|treosulfan|mesh-list
82839752|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82839753|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
82839754|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839755|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839756|NCT00134901|Memantine|memantine|mesh-list
82839757|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82839758|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82839759|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
82839760|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839761|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839762|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839763|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82839764|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82839765|NCT01076595|Interferons|interferons|mesh-list
82839766|NCT01076595|Interferon-beta|interferon-beta|mesh-list
82839767|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
82839768|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839769|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
82839770|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839771|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
82839772|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839773|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82839774|NCT00113373|Lapatinib|lapatinib|mesh-list
82839775|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839776|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839777|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839778|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839779|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82839780|NCT00113295|Paroxetine|paroxetine|mesh-list
82839781|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
82839782|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82839783|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82839784|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82839785|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839786|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839787|NCT00113295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82839788|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82839789|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82839790|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839791|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839792|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
82839793|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82839794|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82839795|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82839796|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839797|NCT00112905|Sorafenib|sorafenib|mesh-list
82839798|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839799|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839800|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839801|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839802|NCT00427895|Vaccines|vaccines|mesh-list
82839803|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82839804|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
82839805|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839806|NCT00427349|Octreotide|octreotide|mesh-list
82839807|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
82839808|NCT00427349|Imetelstat|imetelstat|mesh-list
82839809|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839810|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839811|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839812|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82839813|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839814|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839815|NCT01034189|Paclitaxel|paclitaxel|mesh-list
82839816|NCT01034189|Cetuximab|cetuximab|mesh-list
82839817|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82839818|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839819|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
82839820|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
82839821|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
82839822|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839823|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839824|NCT00425945|Pycnogenols|pycnogenols|mesh-list
82839825|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82839826|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
82839827|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839828|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
82839829|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839830|NCT00425945|Protective Agents|protective agents|mesh-ancestor
82839831|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82839832|NCT00121641|Metformin|metformin|mesh-list
82839833|NCT00121641|Saxagliptin|saxagliptin|mesh-list
82839834|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82839835|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839836|NCT00121641|Incretins|incretins|mesh-ancestor
82839837|NCT00121641|Hormones|hormones|mesh-ancestor
82839838|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839839|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82839840|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839841|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839842|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839843|NCT00425555|Panobinostat|panobinostat|mesh-list
82839844|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839845|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82839846|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839847|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839848|NCT00424775|Vorinostat|vorinostat|mesh-list
82839849|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839850|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82839851|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839852|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839853|NCT01034345|Sirolimus|sirolimus|mesh-list
82839854|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82839855|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82839856|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839857|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82839858|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839859|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
82839860|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82839861|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
82839862|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839863|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839864|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839865|NCT01763866|Atorvastatin|atorvastatin|mesh-list
82839866|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82839867|NCT01763866|Simvastatin|simvastatin|mesh-list
82839868|NCT01763866|Ezetimibe|ezetimibe|mesh-list
82839869|NCT01763866|Evolocumab|evolocumab|mesh-list
82839870|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82839871|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82839872|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82839873|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
82839874|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839875|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82839876|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82839877|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839878|NCT01763866|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82839879|NCT01763866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82839880|NCT01763866|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839881|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
82839882|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839884|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82839885|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82839886|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
82839887|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
82839888|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839889|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839890|NCT01588925|Dexamethasone|dexamethasone|mesh-list
82839891|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
82839892|NCT01588925|BB 1101|bb 1101|mesh-list
82839893|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
82839894|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82839895|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
82839896|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
82839897|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839898|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839899|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839900|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
82839901|NCT01588925|Hormones|hormones|mesh-ancestor
82839902|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82839903|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82839904|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839905|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
82839906|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839907|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839908|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82839909|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
82839910|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
82839911|NCT01588925|Protective Agents|protective agents|mesh-ancestor
82839912|NCT01238146|Rituximab|rituximab|mesh-list
82839913|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82839914|NCT01238146|Obatoclax|obatoclax|mesh-list
82839915|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839916|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839917|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
82839918|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839919|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82839920|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82839921|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
82839922|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839923|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839924|NCT01141894|Phenylephrine|phenylephrine|mesh-list
82839925|NCT01141894|Dobutamine|dobutamine|mesh-list
82839926|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
82839927|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82839928|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82839929|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
82839930|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
82839931|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839932|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839933|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
82839934|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82839935|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
82839936|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
82839937|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82839938|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82839939|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82839940|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
82839941|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82839942|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839943|NCT01141894|Protective Agents|protective agents|mesh-ancestor
82839944|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82839945|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82839946|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
82839947|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
82839949|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
82839950|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82839951|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82839952|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82839953|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839954|NCT01238224|Urological Agents|urological agents|mesh-ancestor
82839955|NCT01237444|Ritonavir|ritonavir|mesh-list
82839956|NCT01237444|Lopinavir|lopinavir|mesh-list
82839957|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82839958|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82839961|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839962|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82839963|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82839964|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
82839965|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839966|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82839967|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82839968|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
82839969|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82839970|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839971|NCT01141972|Vitamin D|vitamin d|mesh-list
82839972|NCT01141972|Vitamins|vitamins|mesh-ancestor
82839973|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
82839974|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839975|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82839976|NCT04316806|Rifaximin|rifaximin|mesh-list
82839977|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82839978|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839979|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82839980|NCT01145326|Lidocaine|lidocaine|mesh-list
82839981|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
82839982|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
82839983|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82839984|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82839985|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
82839986|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82839987|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82839988|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82839989|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82839990|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82839991|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82839992|NCT01144702|Artesunate|artesunate|mesh-list
82839993|NCT01144702|Mefloquine|mefloquine|mesh-list
82839994|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
82839995|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82839996|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82839997|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82839998|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82839999|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
82840000|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
82840001|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82840002|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
82840003|NCT01145404|Capecitabine|capecitabine|mesh-list
82840004|NCT01145404|Lapatinib|lapatinib|mesh-list
82840005|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82840006|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
82840007|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840008|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840009|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840010|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840011|NCT01237522|Metformin|metformin|mesh-list
82840012|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82840013|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840014|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
82840015|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840016|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840017|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840018|NCT04246996|Gentamicins|gentamicins|mesh-list
82840019|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82840020|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840021|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82840022|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840023|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840024|NCT00424463|Edaravone|edaravone|mesh-list
82840025|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82840026|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
82840027|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840028|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82840029|NCT00424463|Protective Agents|protective agents|mesh-ancestor
82840030|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840031|NCT01324115|Nitroarginine|nitroarginine|mesh-list
82840032|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840033|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840034|NCT01037621|Valacyclovir|valacyclovir|mesh-list
82840035|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
82840036|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840037|NCT00424385|Sorafenib|sorafenib|mesh-list
82840038|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
82840039|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840040|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840041|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840042|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840043|NCT03994055|Antioxidants|antioxidants|mesh-list
82840044|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840045|NCT03994055|Protective Agents|protective agents|mesh-ancestor
82840046|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840047|NCT01037699|Hormones|hormones|mesh-list
82840048|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82840049|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840050|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840051|NCT00423917|Bevacizumab|bevacizumab|mesh-list
82840052|NCT00423917|Fulvestrant|fulvestrant|mesh-list
82840053|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82840054|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840055|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82840056|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82840057|NCT00423917|Growth Substances|growth substances|mesh-ancestor
82840058|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840059|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
82840060|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82840061|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82840062|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82840063|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
82840064|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840065|NCT00845026|Olanzapine|olanzapine|mesh-list
82840066|NCT00845026|Risperidone|risperidone|mesh-list
82840067|NCT00845026|Aripiprazole|aripiprazole|mesh-list
82840068|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82840069|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
82840070|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840071|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840072|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840073|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82840074|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82840075|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840076|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82840077|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82840078|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
82840079|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
82840080|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
82840081|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840082|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840083|NCT00845026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82840084|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82840085|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82840086|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
82840087|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
82840088|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82840089|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82840090|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82840091|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82840092|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82840093|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
82840094|NCT02445131|Idelalisib|idelalisib|mesh-list
82840095|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82840096|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
82840097|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840098|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840099|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82840100|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840101|NCT00003838|Cyclosporine|cyclosporine|mesh-list
82840102|NCT00003838|Methotrexate|methotrexate|mesh-list
82840103|NCT00003838|Cyclosporins|cyclosporins|mesh-list
82840104|NCT00003838|Lenograstim|lenograstim|mesh-list
82840105|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82840106|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
82840108|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840109|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82840110|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
82840111|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840112|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840113|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
82840114|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840115|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82840116|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840117|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
82840118|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840119|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82840120|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
82840121|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840122|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82840123|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82840124|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
82840125|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840126|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
82840127|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840128|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840129|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82840130|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
82840131|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840132|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840133|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82840134|NCT01145950|Etanercept|etanercept|mesh-list
82840135|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82840136|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82840137|NCT01145950|Analgesics|analgesics|mesh-ancestor
82840138|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
82840139|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840140|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840141|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82840142|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840143|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840144|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840145|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
82840146|NCT01238926|Vitamins|vitamins|mesh-list
82840147|NCT01238926|Folic Acid|folic acid|mesh-list
82840148|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
82840149|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
82840150|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
82840151|NCT01238926|Pyridoxal|pyridoxal|mesh-list
82840152|NCT01238926|Pyridoxine|pyridoxine|mesh-list
82840153|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
82840154|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
82840155|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840156|NCT01238926|Hematinics|hematinics|mesh-ancestor
82840157|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82840158|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82840159|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82840160|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
82840161|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840162|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82840163|NCT01142518|Interferons|interferons|mesh-list
82840164|NCT01142518|Interferon-beta|interferon-beta|mesh-list
82840165|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
82840166|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840167|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
82840168|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840169|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
82840170|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840171|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82840172|NCT00423449|Gemcitabine|gemcitabine|mesh-list
82840173|NCT00423449|Vorinostat|vorinostat|mesh-list
82840174|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82840175|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
82840176|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840177|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840178|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82840179|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840180|NCT00423293|Fluorouracil|fluorouracil|mesh-list
82840181|NCT00423293|Mitomycins|mitomycins|mesh-list
82840182|NCT00423293|Mitomycin|mitomycin|mesh-list
82840183|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
82840184|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840186|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840187|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840188|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
82840189|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840190|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82840191|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
82840192|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82840193|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840194|NCT00422903|Letrozole|letrozole|mesh-list
82840195|NCT00422903|Lapatinib|lapatinib|mesh-list
82840196|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840197|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82840198|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82840199|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840200|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840201|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82840202|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
82840203|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840204|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840205|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840206|NCT00422591|Cytarabine|cytarabine|mesh-list
82840207|NCT00422591|Idarubicin|idarubicin|mesh-list
82840208|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82840209|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
82840210|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840211|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840212|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
82840213|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840214|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840215|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
82840216|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840217|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82840218|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82840219|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82840220|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840221|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
82840222|NCT00422513|Hematinics|hematinics|mesh-ancestor
82840223|NCT00202878|Simvastatin|simvastatin|mesh-list
82840224|NCT00202878|Ezetimibe|ezetimibe|mesh-list
82840225|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
82840226|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82840227|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82840228|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
82840229|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840230|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82840231|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82840232|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840233|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
82840234|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
82840235|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82840236|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840237|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82840238|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82840239|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840240|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840241|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840242|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82840243|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82840244|NCT00260208|Cyclosporine|cyclosporine|mesh-list
82840245|NCT00260208|Tacrolimus|tacrolimus|mesh-list
82840246|NCT00260208|Cyclosporins|cyclosporins|mesh-list
82840247|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840248|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
82840249|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840250|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82840251|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840252|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840253|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
82840254|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840255|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
82840256|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840257|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
82840259|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840260|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
82840261|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840262|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840263|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82840264|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82840265|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82840266|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82840267|NCT00259740|Denosumab|denosumab|mesh-list
82840268|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82840269|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840270|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82840271|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82840272|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840273|NCT01236040|Vaccines|vaccines|mesh-list
82840274|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
82840275|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840276|NCT03812224|Erenumab|erenumab|mesh-list
82840277|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82840278|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840279|NCT03812224|Analgesics|analgesics|mesh-ancestor
82840280|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
82840281|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840282|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840283|NCT01146028|Tizanidine|tizanidine|mesh-list
82840284|NCT01146028|Analgesics|analgesics|mesh-ancestor
82840285|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
82840286|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83443564|NCT02348359|Ranibizumab|ranibizumab|mesh-list
82840287|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840288|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
82840289|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82840290|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82840291|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
82840292|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
82840293|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82840294|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82840295|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82840296|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
82840297|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840298|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840299|NCT03530800|Dronabinol|dronabinol|mesh-list
82840300|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
82840301|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840302|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82840303|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82840304|NCT03530800|Analgesics|analgesics|mesh-ancestor
82840305|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
82840306|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840307|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82840308|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82840309|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840310|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840311|NCT03530800|Hormones|hormones|mesh-ancestor
82840312|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840313|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
82840314|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82840315|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
82840316|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840317|NCT04982146|Expectorants|expectorants|mesh-ancestor
82840318|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
82840319|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82840320|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
82840321|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840322|NCT04982146|Protective Agents|protective agents|mesh-ancestor
82840323|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840324|NCT04982146|Antidotes|antidotes|mesh-ancestor
82840325|NCT04958746|Propofol|propofol|mesh-list
82840326|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82840327|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840328|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840329|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82840330|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
82840331|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
82840333|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82840335|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
82840336|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840337|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82840338|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82840339|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840340|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
82840341|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82840342|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
82840343|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840344|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
82840345|NCT03431584|Protective Agents|protective agents|mesh-ancestor
82840346|NCT00259272|Olanzapine|olanzapine|mesh-list
82840347|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
82840348|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
82840349|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840350|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840351|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840352|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82840353|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82840354|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840355|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82840356|NCT00259272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82840357|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82840358|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82840359|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840360|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840361|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
82840362|NCT03106324|Lenalidomide|lenalidomide|mesh-list
82840363|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
82840364|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840365|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82840366|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82840367|NCT03106324|Growth Substances|growth substances|mesh-ancestor
82840368|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
82840369|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840370|NCT01147276|Vildagliptin|vildagliptin|mesh-list
82840371|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82840372|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840373|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82840374|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
82840375|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840376|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840377|NCT01239940|Paclitaxel|paclitaxel|mesh-list
82840378|NCT01239940|Everolimus|everolimus|mesh-list
82840379|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82840380|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840381|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
82840382|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
82840383|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
82840384|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840385|NCT01239940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82840386|NCT01239940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840387|NCT01239940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840388|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840389|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
82840390|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840391|NCT02526004|Tobramycin|tobramycin|mesh-list
82840392|NCT02526004|Ceftazidime|ceftazidime|mesh-list
82840393|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82840394|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840395|NCT00421889|Paclitaxel|paclitaxel|mesh-list
82840396|NCT00421889|Carboplatin|carboplatin|mesh-list
82840397|NCT00421889|Belinostat|belinostat|mesh-list
82840398|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82840399|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840400|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
82840402|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
82840403|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840404|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82840405|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840408|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840409|NCT03913468|Protective Agents|protective agents|mesh-ancestor
82840410|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840411|NCT03913468|Vitamins|vitamins|mesh-ancestor
82840412|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
82840413|NCT01147354|Selenium|selenium|mesh-list
82840414|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
82840415|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840416|NCT01147354|Protective Agents|protective agents|mesh-ancestor
82840417|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840418|NCT01147354|Trace Elements|trace elements|mesh-ancestor
82840419|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
82840420|NCT04744480|Anesthetics|anesthetics|mesh-list
82840421|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840422|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840423|NCT01147432|Capsaicin|capsaicin|mesh-list
82840424|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
82840425|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
82840426|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
82840427|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840428|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840429|NCT01147510|Montelukast|montelukast|mesh-list
82840430|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83443572|NCT02406885|Apixaban|apixaban|mesh-list
82840431|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
82840432|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82840433|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
82840434|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840435|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840436|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82840437|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82840438|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840439|NCT03916432|Sirolimus|sirolimus|mesh-list
82840440|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82840441|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840442|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82840443|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840444|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
82840445|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840446|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
82840447|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840448|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
82840449|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82840450|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840451|NCT00421733|Vitamins|vitamins|mesh-ancestor
82840452|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
82840453|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82840454|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
82840455|NCT00421343|Vitamin D|vitamin d|mesh-list
82840456|NCT00421343|Alendronate|alendronate|mesh-list
82840457|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
82840458|NCT00421343|Calcium|calcium|mesh-list
82840459|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82840460|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840461|NCT00421343|Vitamins|vitamins|mesh-ancestor
82840462|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
82840463|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82840464|NCT00421343|Antacids|antacids|mesh-ancestor
82840465|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840466|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840467|NCT01147588|Esomeprazole|esomeprazole|mesh-list
82840468|NCT01147588|Omeprazole|omeprazole|mesh-list
82840469|NCT01147588|Lansoprazole|lansoprazole|mesh-list
82840470|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
82840471|NCT01147588|Clopidogrel|clopidogrel|mesh-list
82840472|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82840473|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82840474|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82840475|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82840476|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
82840477|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840478|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840479|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840480|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82840481|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840482|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82840483|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840484|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
82840485|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840486|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840487|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840488|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82840490|NCT00230178|Rasburicase|rasburicase|mesh-list
82840491|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
82840492|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840493|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840494|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
82840495|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840496|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82840497|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
82840498|NCT00230178|Protective Agents|protective agents|mesh-ancestor
82840499|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840500|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
82840501|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82840502|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82840503|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82840504|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82840505|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840506|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
82840507|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840508|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840509|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82840510|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840511|NCT01251172|Melphalan|melphalan|mesh-list
82840512|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
82840513|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82840514|NCT01251172|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82840515|NCT01251172|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82840516|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82840517|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
82840518|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840519|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840520|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82840521|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840522|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
82840523|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840524|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840525|NCT00413777|Tolvaptan|tolvaptan|mesh-list
82840526|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82840527|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840528|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
82840529|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840530|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82840531|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82840532|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82840533|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82840534|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82840535|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
82840536|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840537|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840538|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840539|NCT01074060|Plerixafor|plerixafor|mesh-list
82840540|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
82840541|NCT01074060|Lenograstim|lenograstim|mesh-list
82840542|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840543|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
82840544|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840545|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840546|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82840547|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
82840548|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840549|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840550|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82840551|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82840552|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82840553|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82840554|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
82840555|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840556|NCT03915340|Propafenone|propafenone|mesh-list
82840557|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82840558|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82840559|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82840560|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82840561|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840562|NCT01581918|Carbamazepine|carbamazepine|mesh-list
82840563|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
82840564|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
82840565|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82840566|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840567|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840568|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82840569|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82840570|NCT01581918|Analgesics|analgesics|mesh-ancestor
82840571|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
82840572|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840573|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83443582|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
82840574|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82840575|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840576|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82840577|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82840578|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82840579|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
82840580|NCT01582542|Coagulants|coagulants|mesh-ancestor
82840581|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82840582|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
82840583|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840584|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
82840585|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
82840586|NCT03912766|Coagulants|coagulants|mesh-ancestor
82840587|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82840588|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82840589|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
82840590|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840591|NCT01251328|Anesthetics|anesthetics|mesh-list
82840592|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840593|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840594|NCT00420641|Paroxetine|paroxetine|mesh-list
82840595|NCT00420641|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82840596|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82840597|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82840598|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840599|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840600|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
82840601|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840602|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82840603|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
82840604|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82840605|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82840606|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82840607|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840608|NCT00257556|Menotropins|menotropins|mesh-list
82840609|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82840610|NCT00257556|Hormones|hormones|mesh-ancestor
82840611|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840612|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840613|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82840614|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
82840615|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82840616|NCT03906916|Micafungin|micafungin|mesh-list
82840617|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
82840618|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840619|NCT01250470|Sargramostim|sargramostim|mesh-list
82840620|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82840621|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
82840622|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840623|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82840624|NCT01250548|Apremilast|apremilast|mesh-list
82840625|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82840626|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82840627|NCT01250548|Analgesics|analgesics|mesh-ancestor
82840628|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
82840629|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840630|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840631|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82840632|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840633|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82840634|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82840635|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840636|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840637|NCT03906838|Ropivacaine|ropivacaine|mesh-list
82840638|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
82840639|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
82840640|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840641|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840642|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
82840643|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840644|NCT01251484|Nintedanib|nintedanib|mesh-list
82840645|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840646|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840647|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840648|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840649|NCT03914638|Albuterol|albuterol|mesh-list
82840650|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82840651|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
82840652|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840653|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840654|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82840655|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
82840656|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
82840657|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82840658|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82840659|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82840660|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82840661|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
82840662|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840663|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840664|NCT01148446|Prednisone|prednisone|mesh-list
82840665|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
82840666|NCT01148446|Rituximab|rituximab|mesh-list
82840667|NCT01148446|Doxorubicin|doxorubicin|mesh-list
82840668|NCT01148446|Vincristine|vincristine|mesh-list
82840669|NCT01148446|Epirubicin|epirubicin|mesh-list
82840670|NCT01148446|Vinblastine|vinblastine|mesh-list
82840671|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840672|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
82840673|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840674|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840675|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82840676|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
82840677|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840678|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840679|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82840680|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82840681|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82840682|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82840683|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82840684|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840685|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82840686|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
82840687|NCT01148446|Hormones|hormones|mesh-ancestor
82840688|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840689|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82840690|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82840691|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
82840692|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
82840693|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
82840694|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
82840695|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
82840696|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840697|NCT03914404|Protective Agents|protective agents|mesh-ancestor
82840698|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840699|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
82840700|NCT03914404|Vitamins|vitamins|mesh-ancestor
82840702|NCT01251640|Gemcitabine|gemcitabine|mesh-list
82840703|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82840704|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
82840705|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840706|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840707|NCT00257166|Ziprasidone|ziprasidone|mesh-list
82840708|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82840709|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
82840710|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840711|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840712|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840713|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82840714|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82840715|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840716|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82840717|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83443586|NCT02408445|Hormones|hormones|mesh-ancestor
82840718|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
82840719|NCT03914092|Triamcinolone|triamcinolone|mesh-list
82840720|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82840721|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82840722|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82840723|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82840724|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
82840726|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840727|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840728|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840729|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
82840730|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840731|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840732|NCT01251718|Donepezil|donepezil|mesh-list
82840733|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82840734|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840735|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840736|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
82840737|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840738|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840739|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
82840740|NCT03913858|Anesthetics|anesthetics|mesh-list
82840741|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840742|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840743|NCT00227370|Valganciclovir|valganciclovir|mesh-list
82840744|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
82840745|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840746|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82840747|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840748|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840749|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840750|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840751|NCT01251874|Alovudine|alovudine|mesh-list
82840752|NCT01251874|Carboplatin|carboplatin|mesh-list
82840753|NCT01251874|Veliparib|veliparib|mesh-list
82840754|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840755|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82840756|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840757|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840758|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
82840759|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840760|NCT03911440|Azithromycin|azithromycin|mesh-list
82840761|NCT03911440|Doxycycline|doxycycline|mesh-list
82840762|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82840763|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840764|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
82840765|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82840766|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82840767|NCT00191100|Gemcitabine|gemcitabine|mesh-list
82840768|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840769|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82840770|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
82840771|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840772|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
82840773|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82840774|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840775|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840777|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
82840778|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82840779|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840781|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
82840782|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840783|NCT03904732|Aspirin|aspirin|mesh-list
82840784|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82840785|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82840786|NCT03904732|Analgesics|analgesics|mesh-ancestor
82840787|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
82840788|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840789|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840790|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82840791|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82840792|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82840793|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82840794|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840795|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82840796|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82840797|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840798|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
82840799|NCT01252420|Enoxaparin|enoxaparin|mesh-list
82840800|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
82840801|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82840802|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82840803|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840804|NCT01149304|Enoxaparin|enoxaparin|mesh-list
82840805|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
82840806|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82840807|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
82840808|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82840809|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82840810|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840811|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82840812|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840813|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82840814|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82840815|NCT01149304|Protective Agents|protective agents|mesh-ancestor
82840816|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840817|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
82840818|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82840819|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
82840820|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82840821|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840822|NCT01254526|Paclitaxel|paclitaxel|mesh-list
82840823|NCT01254526|Bevacizumab|bevacizumab|mesh-list
82840824|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82840825|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840826|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
82840827|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
82840828|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
82840829|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840830|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82840831|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82840832|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82840833|NCT01254526|Growth Substances|growth substances|mesh-ancestor
82840834|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840835|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
82840836|NCT01148992|Lofexidine|lofexidine|mesh-list
82840837|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82840838|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82840839|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840840|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
82840841|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840842|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82840843|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82840844|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82840845|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
82840846|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840847|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840848|NCT03901612|Ropivacaine|ropivacaine|mesh-list
82840849|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
82840850|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
82840851|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82840852|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840853|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
82840854|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840856|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
82840857|NCT03903952|Vitamins|vitamins|mesh-ancestor
82840858|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
82840859|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840860|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
82840861|NCT03903952|Hematinics|hematinics|mesh-ancestor
82840862|NCT00257010|Almotriptan|almotriptan|mesh-list
82840863|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82840864|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
82840865|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443590|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840866|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840867|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840868|NCT03901768|Dexamethasone|dexamethasone|mesh-list
82840869|NCT03901768|Triamcinolone|triamcinolone|mesh-list
82840870|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82840871|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
82840872|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
82840873|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840874|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840875|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82840876|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
82840877|NCT03901768|Hormones|hormones|mesh-ancestor
82840878|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840879|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82840880|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840881|NCT03903718|Oseltamivir|oseltamivir|mesh-list
82840882|NCT03903718|MEDI8852|medi8852|mesh-list
82840883|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
82840884|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840885|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840886|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840887|NCT03910504|Rocuronium|rocuronium|mesh-list
82840888|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82840889|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82840890|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82840891|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82840892|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840893|NCT03901690|Imiquimod|imiquimod|mesh-list
82840894|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82840895|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
82840896|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840897|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840898|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
82840899|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
82840900|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82840901|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840902|NCT03901378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82840903|NCT03901378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840904|NCT00256854|Ropinirole|ropinirole|mesh-list
82840905|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82840906|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82840907|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
82840908|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
82840909|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82840910|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840911|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840912|NCT00189462|Montelukast|montelukast|mesh-list
82840913|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82840914|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
82840915|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82840916|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
82840917|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840918|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840919|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82840920|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82840921|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840922|NCT01150318|Iodine|iodine|mesh-list
82840923|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82840924|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840925|NCT01150318|Trace Elements|trace elements|mesh-ancestor
82840926|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
82840927|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840928|NCT05667298|Immunomodulating Agents|immunomodulating agents|mesh-list
82840929|NCT05667298|Immunologic Factors|immunologic factors|mesh-ancestor
82840930|NCT05667298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840931|NCT01256632|Ranibizumab|ranibizumab|mesh-list
82840932|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82840933|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82840934|NCT01256632|Growth Substances|growth substances|mesh-ancestor
82840935|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840936|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
82840937|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840938|NCT00256698|Fulvestrant|fulvestrant|mesh-list
82840939|NCT00256698|Anastrozole|anastrozole|mesh-list
82840940|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82840941|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840942|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82840943|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82840944|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
82840945|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82840946|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840947|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82840948|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82840949|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840950|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840951|NCT01150630|Gemcitabine|gemcitabine|mesh-list
82840952|NCT01150630|Capecitabine|capecitabine|mesh-list
82840953|NCT01150630|Epirubicin|epirubicin|mesh-list
82840954|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840955|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82840956|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
82840957|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840958|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82840959|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82840960|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82840961|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840962|NCT00189306|Imiquimod|imiquimod|mesh-list
82840963|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82840964|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
82840965|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840966|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840967|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
82840968|NCT03898336|Micronutrients|micronutrients|mesh-list
82840969|NCT03898336|Trace Elements|trace elements|mesh-list
82840970|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840971|NCT03972462|Sirolimus|sirolimus|mesh-list
82840972|NCT03972462|Temsirolimus|temsirolimus|mesh-list
82840973|NCT03972462|MTOR Inhibitors|mtor inhibitors|mesh-list
82840974|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82840975|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82840976|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82840977|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840978|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
82840979|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82840980|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
82840981|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840982|NCT03972462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82840983|NCT03972462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82840984|NCT03972462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840985|NCT01150786|Selenium|selenium|mesh-list
82840986|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
82840987|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82840988|NCT01150786|Protective Agents|protective agents|mesh-ancestor
82840989|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840990|NCT01150786|Trace Elements|trace elements|mesh-ancestor
82840991|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
82840992|NCT03909724|Sunitinib|sunitinib|mesh-list
82840993|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82840994|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82840995|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82840996|NCT03909724|Growth Substances|growth substances|mesh-ancestor
82840997|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82840998|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
82840999|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82841000|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841001|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841002|NCT03909646|Fluorouracil|fluorouracil|mesh-list
82841003|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82841004|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
82841005|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
82841006|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841007|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82841008|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841009|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82841010|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
82841011|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841012|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82841013|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
82841014|NCT01256866|Midazolam|midazolam|mesh-list
82841015|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
82841016|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82841017|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841018|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841019|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82841020|NCT01256866|Analgesics|analgesics|mesh-ancestor
82841021|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
82841022|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841023|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82841024|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82841025|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82841026|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
82841027|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841028|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841029|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82841030|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82841031|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82841032|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82841033|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82841034|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
82841035|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
82841036|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
82841037|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
82841038|NCT03902782|Dexamethasone|dexamethasone|mesh-list
82841039|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
82841040|NCT03902782|Epinephrine|epinephrine|mesh-list
82841041|NCT03902782|Bupivacaine|bupivacaine|mesh-list
82841042|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841043|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
82841044|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
82841045|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841046|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841047|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841048|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
82841049|NCT03902782|Hormones|hormones|mesh-ancestor
82841050|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82841051|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82841052|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841053|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
82841054|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
82841055|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841056|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
82841057|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82841058|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82841059|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
82841060|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841061|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841062|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82841063|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82841064|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82841065|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841066|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
82841067|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
82841068|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82841069|NCT03908944|Methadone|methadone|mesh-list
82841070|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82841071|NCT03908944|Narcotics|narcotics|mesh-ancestor
82841072|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841073|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841074|NCT03908944|Analgesics|analgesics|mesh-ancestor
82841075|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
82841076|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841077|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
82841078|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841080|NCT03899506|Olanzapine|olanzapine|mesh-list
82841081|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82841082|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82841083|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841084|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841085|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82841086|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82841087|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82841088|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82841089|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
82841090|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
82841091|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
82841092|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
82841093|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841094|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841095|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
82841096|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
82841097|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841098|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841099|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82841100|NCT03899506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82841101|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82841102|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841103|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
82841104|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
82841105|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82841106|NCT03896932|Antibodies|antibodies|mesh-list
82841107|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
82841108|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82841109|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
82841110|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841111|NCT01257334|Empagliflozin|empagliflozin|mesh-list
82841112|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82841113|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841114|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82841115|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841116|NCT01151176|Insulin|insulin|mesh-list
82841117|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82841118|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82841119|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841120|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
82841121|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82841122|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841123|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82841124|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841125|NCT01257490|Bupropion|bupropion|mesh-list
82841126|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82841127|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
82841128|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82841129|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82841130|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82841131|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841132|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841133|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
82841134|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841135|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841136|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82841137|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82841138|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841139|NCT03894280|Fluticasone|fluticasone|mesh-list
82841140|NCT03894280|Xhance|xhance|mesh-list
82841141|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82841142|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82841143|NCT03894280|Charcoal|charcoal|mesh-list
82841144|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841145|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82841146|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
82841147|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841148|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841150|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841151|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
82841152|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82841153|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82841154|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82841155|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82841156|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
82841157|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841158|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841159|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
82841160|NCT03894280|Hormones|hormones|mesh-ancestor
82841161|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82841162|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
82841163|NCT03894280|Antidotes|antidotes|mesh-ancestor
82841164|NCT03894280|Protective Agents|protective agents|mesh-ancestor
82841165|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
82841166|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82841167|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841168|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841169|NCT01150162|Omeprazole|omeprazole|mesh-list
82841170|NCT01150162|Rebamipide|rebamipide|mesh-list
82841171|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82841172|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841173|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82841174|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841175|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841176|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
82841177|NCT01150162|Protective Agents|protective agents|mesh-ancestor
82841178|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841179|NCT03893734|Methadone|methadone|mesh-list
82841180|NCT03893734|Hydromorphone|hydromorphone|mesh-list
82841181|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82841182|NCT03893734|Narcotics|narcotics|mesh-ancestor
82841183|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841184|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841185|NCT03893734|Analgesics|analgesics|mesh-ancestor
82841186|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
82841187|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841188|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
82841189|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841190|NCT03899194|Escitalopram|escitalopram|mesh-list
82841191|NCT03899194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82841192|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82841193|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841194|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841195|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841196|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
82841197|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841198|NCT01151800|Benzocaine|benzocaine|mesh-list
82841199|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
82841200|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
82841201|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841202|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841203|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
82841204|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841205|NCT03896074|Bevacizumab|bevacizumab|mesh-list
82841206|NCT03896074|Atezolizumab|atezolizumab|mesh-list
82841207|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82841208|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841209|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82841210|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82841211|NCT03896074|Growth Substances|growth substances|mesh-ancestor
82841212|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841213|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
82841214|NCT03896074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82841215|NCT03896074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841216|NCT03899038|Anesthetics|anesthetics|mesh-list
82841217|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841218|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841219|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
82841220|NCT01151878|Cathartics|cathartics|mesh-ancestor
82841221|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841222|NCT03898882|Oxytocin|oxytocin|mesh-list
82841223|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
82841224|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82841225|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841226|NCT01151254|Propofol|propofol|mesh-list
82841227|NCT01151254|Sevoflurane|sevoflurane|mesh-list
82841228|NCT01151254|Isoflurane|isoflurane|mesh-list
82841229|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82841230|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841231|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841232|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82841233|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
82841234|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
82841235|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82841236|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82841237|NCT01255774|Ranibizumab|ranibizumab|mesh-list
82841238|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82841239|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82841240|NCT01255774|Growth Substances|growth substances|mesh-ancestor
82841241|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841242|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
82841243|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841244|NCT01255852|Atorvastatin|atorvastatin|mesh-list
82841245|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82841246|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82841247|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
82841248|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841249|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82841250|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82841251|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841252|NCT03895528|Lonafarnib|lonafarnib|mesh-list
82841253|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841254|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841255|NCT01257958|Vitamin D|vitamin d|mesh-list
82841256|NCT01257958|Vitamins|vitamins|mesh-ancestor
82841257|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
82841258|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841259|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82841260|NCT03893032|Modafinil|modafinil|mesh-list
82841261|NCT03893032|Amphetamine|amphetamine|mesh-list
82841262|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82841263|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841264|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82841265|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82841266|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82841267|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841268|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
82841269|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
82841270|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841271|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
82841272|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841273|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
82841274|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82841275|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82841276|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841277|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82841278|NCT01258036|Hormones|hormones|mesh-list
82841279|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82841280|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841281|NCT03889366|Aprepitant|aprepitant|mesh-list
82841282|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
82841283|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
82841284|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841285|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841286|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841287|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82841288|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841289|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841290|NCT03894826|Vorinostat|vorinostat|mesh-list
82841291|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841292|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82841293|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841294|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841295|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
82841296|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82841297|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82841298|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82841299|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362079|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82841300|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841301|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
82841302|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841303|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841304|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82841305|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841306|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
82841307|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841308|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82841309|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841310|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841311|NCT03888664|Interferons|interferons|mesh-list
82841312|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
82841313|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841314|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
82841315|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841316|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
82841317|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841319|NCT01153828|Retapamulin|retapamulin|mesh-list
82841320|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
82841321|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82841322|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841323|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82841324|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841325|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841326|NCT01151722|Bevacizumab|bevacizumab|mesh-list
82841327|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82841328|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841329|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82841330|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82841331|NCT01151722|Growth Substances|growth substances|mesh-ancestor
82841332|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841333|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
82841334|NCT01258192|Paclitaxel|paclitaxel|mesh-list
82841335|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82841336|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82841337|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841338|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
82841339|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
82841340|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
82841341|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841342|NCT01326078|Propofol|propofol|mesh-list
82841343|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82841344|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841345|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841346|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82841347|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
82841348|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
82841349|NCT01260376|Acipimox|acipimox|mesh-list
82841350|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82841351|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
82841352|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841353|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82841354|NCT01259050|Copper|copper|mesh-list
82841355|NCT01259050|Trace Elements|trace elements|mesh-ancestor
82841356|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
82841357|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841358|NCT00255840|Ritonavir|ritonavir|mesh-list
82841359|NCT00255840|Lopinavir|lopinavir|mesh-list
82841360|NCT00255840|Lamivudine|lamivudine|mesh-list
82841361|NCT00255840|Nevirapine|nevirapine|mesh-list
82841362|NCT00255840|Stavudine|stavudine|mesh-list
82841363|NCT00255840|Efavirenz|efavirenz|mesh-list
82841364|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82841365|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82841366|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
82841367|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841368|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841369|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82841370|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82841371|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
82841372|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841373|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82841374|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82841375|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82841376|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82841377|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82841378|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82841379|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82841380|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82841381|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82841382|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
82841383|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
82841384|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
82841386|NCT00224874|Pentostatin|pentostatin|mesh-list
82841387|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
82841388|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82841389|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841390|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82841391|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
82841392|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82841393|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841394|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841395|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841396|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82841397|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82841398|NCT00224874|Analgesics|analgesics|mesh-ancestor
82841399|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
82841400|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841401|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841402|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841403|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841404|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841405|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82841406|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
82841407|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82841408|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
82841409|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
82841410|NCT03892330|Doxorubicin|doxorubicin|mesh-list
82841411|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82841412|NCT03892330|Vincristine|vincristine|mesh-list
82841413|NCT03892330|Pirarubicin|pirarubicin|mesh-list
82841414|NCT03892330|Epirubicin|epirubicin|mesh-list
82841415|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82841416|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
82841417|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841418|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841419|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82841420|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
82841421|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841422|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841423|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82841424|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82841425|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82841426|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82841427|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841428|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82841429|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
82841430|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
82841431|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
82841432|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82841433|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841434|NCT00186186|Valproic Acid|valproic acid|mesh-list
82841435|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
82841436|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841437|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841438|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
82841439|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841440|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841441|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
82841442|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82841443|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841444|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82841445|NCT00185640|Cyclosporine|cyclosporine|mesh-list
82841446|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
82841447|NCT00185640|Lenograstim|lenograstim|mesh-list
82841448|NCT00185640|Cyclosporins|cyclosporins|mesh-list
82841449|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
82841450|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82841451|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82841452|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
82841453|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83443610|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
82841455|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841456|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82841457|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
82841458|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841459|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
82841460|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841461|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82841462|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82841463|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841464|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82841465|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
82841466|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82841467|NCT03885388|Dactinomycin|dactinomycin|mesh-list
82841468|NCT03885388|Methotrexate|methotrexate|mesh-list
82841469|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82841470|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
82841471|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82841472|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841473|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82841474|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
82841475|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841476|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841477|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
82841478|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841479|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82841480|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82841481|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
82841482|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841483|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82841484|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82841485|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841486|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82841487|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82841488|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
82841489|NCT03968640|Vitamins|vitamins|mesh-ancestor
82841490|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
82841491|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841492|NCT01152346|Azacitidine|azacitidine|mesh-list
82841493|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82841494|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
82841495|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841496|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841497|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841498|NCT01260610|Tenofovir|tenofovir|mesh-list
82841499|NCT01260610|Telbivudine|telbivudine|mesh-list
82841500|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
82841501|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841502|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82841503|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82841504|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841505|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841506|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82841507|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82841508|NCT01155700|Omalizumab|omalizumab|mesh-list
82841509|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82841510|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82841511|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841512|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82841513|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82841514|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
82841515|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841516|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82841517|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82841518|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
82841519|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
82841520|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841521|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841522|NCT03887650|Dexamethasone|dexamethasone|mesh-list
82841523|NCT03887650|Epinephrine|epinephrine|mesh-list
82841524|NCT03887650|Bupivacaine|bupivacaine|mesh-list
82841525|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841527|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
82841528|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841529|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841530|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841531|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
82841532|NCT03887650|Hormones|hormones|mesh-ancestor
82841533|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82841534|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82841535|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841536|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841537|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
82841538|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
82841539|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841540|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
82841541|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82841542|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82841543|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
82841544|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841545|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82841546|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82841547|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82841548|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841549|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
82841550|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
82841551|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82841552|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
82841553|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82841554|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841555|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
82841556|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
82841557|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82841558|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841559|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82841560|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841561|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82841562|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
82841563|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841564|NCT03891472|Fluorouracil|fluorouracil|mesh-list
82841565|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
82841566|NCT03891472|Irinotecan|irinotecan|mesh-list
82841567|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
82841568|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841569|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82841570|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841571|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82841572|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
82841573|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841574|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82841575|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82841576|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841577|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
82841578|NCT01262482|Sorafenib|sorafenib|mesh-list
82841579|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841580|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82841581|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841582|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841583|NCT01261078|Epinephrine|epinephrine|mesh-list
82841584|NCT01261078|Racepinephrine|racepinephrine|mesh-list
82841585|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
82841586|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82841587|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82841588|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
82841589|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841590|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841591|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841592|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82841593|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82841594|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
82841595|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841596|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82841597|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841598|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
82841599|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
82841600|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82841601|NCT01155934|Risperidone|risperidone|mesh-list
82841602|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82841604|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841605|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841606|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841607|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82841608|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82841609|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841610|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82841611|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82841612|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
82841613|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82841614|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
82841615|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841616|NCT01261156|Diltiazem|diltiazem|mesh-list
82841617|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82841618|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82841619|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841620|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841621|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82841622|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841623|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
82841624|NCT03884530|Aspirin|aspirin|mesh-list
82841625|NCT03884530|Ticagrelor|ticagrelor|mesh-list
82841626|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82841627|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82841628|NCT03884530|Analgesics|analgesics|mesh-ancestor
82841629|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
82841630|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841631|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841632|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841633|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841634|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82841635|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82841636|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841637|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82841638|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82841639|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841640|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
82841641|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82841642|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82841643|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82841644|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
82841645|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841646|NCT03891316|Sevoflurane|sevoflurane|mesh-list
82841647|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82841648|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82841649|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
82841650|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
82841651|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841652|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841653|NCT03887260|Fentanyl|fentanyl|mesh-list
82841654|NCT03887260|Morphine|morphine|mesh-list
82841655|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82841656|NCT03887260|Narcotics|narcotics|mesh-ancestor
82841657|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841658|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841659|NCT03887260|Analgesics|analgesics|mesh-ancestor
82841660|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
82841661|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841662|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82841663|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82841664|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
82841665|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
82841666|NCT03883984|Cysteamine|cysteamine|mesh-list
82841667|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
82841668|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841669|NCT01586494|Tramadol|tramadol|mesh-list
82841670|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82841671|NCT01586494|Narcotics|narcotics|mesh-ancestor
82841672|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841673|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841674|NCT01586494|Analgesics|analgesics|mesh-ancestor
82841675|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
82841676|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841677|NCT03886948|Mirikizumab|mirikizumab|mesh-list
82841678|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82841679|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82841680|NCT03886948|Analgesics|analgesics|mesh-ancestor
82841681|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
82841682|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841683|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841684|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841685|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841686|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82841687|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841688|NCT01259362|Cocaine|cocaine|mesh-list
82841689|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
82841690|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
82841691|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841692|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841693|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
82841694|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841695|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82841696|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82841697|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82841698|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841699|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841700|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
82841701|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841702|NCT03891238|Avelumab|avelumab|mesh-list
82841703|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82841704|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841705|NCT01261234|Cilostazol|cilostazol|mesh-list
82841706|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82841707|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
82841708|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841709|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841710|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82841711|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
82841712|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82841713|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82841714|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841715|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82841716|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
82841717|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82841718|NCT01261234|Protective Agents|protective agents|mesh-ancestor
82841719|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82841720|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82841721|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841722|NCT01152736|Nicotine|nicotine|mesh-list
82841723|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82841724|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
82841725|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841726|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841727|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82841728|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82841729|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
82841730|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841731|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841732|NCT01154764|Ketoconazole|ketoconazole|mesh-list
82841733|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
82841734|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841735|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82841736|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82841737|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841738|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841739|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82841740|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
82841741|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82841742|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841743|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82841744|NCT01261546|Dexamethasone|dexamethasone|mesh-list
82841745|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841746|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
82841747|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
82841748|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841749|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841751|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
82841752|NCT01261546|Hormones|hormones|mesh-ancestor
82841753|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82841754|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82841755|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841756|NCT03883360|Cannabidiol|cannabidiol|mesh-list
82841757|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
82841758|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
82841759|NCT01261702|Analgesics|analgesics|mesh-ancestor
82841760|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
82841761|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841762|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841763|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
82841764|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841765|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82841766|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
82841767|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82841768|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82841769|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841770|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82841771|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
82841772|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82841773|NCT01156246|Metformin|metformin|mesh-list
82841774|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
82841775|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82841776|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841777|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82841778|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841779|NCT03890770|Deucravacitinib|deucravacitinib|mesh-list
82841780|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
82841781|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82841782|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841783|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841784|NCT03883204|Risperidone|risperidone|mesh-list
82841785|NCT03883204|Aripiprazole|aripiprazole|mesh-list
82841786|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82841787|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
82841788|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841789|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841790|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841791|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82841792|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82841793|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841794|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82841795|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82841796|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
82841797|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
82841798|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
82841799|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82841800|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82841801|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82841802|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82841803|NCT01263418|Ofatumumab|ofatumumab|mesh-list
82841804|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841805|NCT03882814|Meperidine|meperidine|mesh-list
82841806|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82841807|NCT03882814|Narcotics|narcotics|mesh-ancestor
82841808|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841809|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841810|NCT03882814|Analgesics|analgesics|mesh-ancestor
82841811|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
82841812|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841813|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82841814|NCT03647566|Listerine|listerine|mesh-list
82841815|NCT03647566|Fluorides|fluorides|mesh-list
82841816|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
82841817|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
82841818|NCT03647566|Protective Agents|protective agents|mesh-ancestor
82841819|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841820|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82841821|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841822|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
82841823|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
82841824|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82841825|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82841826|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841827|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841828|NCT01156636|Urological Agents|urological agents|mesh-ancestor
82841830|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
82841831|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841832|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841833|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
82841834|NCT01153204|Citric Acid|citric acid|mesh-list
82841835|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
82841836|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
82841837|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82841838|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
82841839|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
82841840|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841841|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
82841842|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82841843|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82841844|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841845|NCT01153204|Urological Agents|urological agents|mesh-ancestor
82841846|NCT03760666|Ribavirin|ribavirin|mesh-list
82841847|NCT03760666|Brequinar|brequinar|mesh-list
82841848|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
82841849|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841850|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
82841851|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841852|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841853|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841854|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82841855|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
82841856|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841857|NCT01263574|Ethanol|ethanol|mesh-list
82841858|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82841859|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841860|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841861|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841862|NCT03464734|Paclitaxel|paclitaxel|mesh-list
82841863|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
82841864|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82841865|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82841866|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841867|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
82841868|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
82841869|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
82841870|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841871|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82841872|NCT03464734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82841873|NCT01156948|Misoprostol|misoprostol|mesh-list
82841874|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82841875|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
82841876|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82841877|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841878|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82841879|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82841880|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
82841881|NCT01157026|Tamoxifen|tamoxifen|mesh-list
82841882|NCT01157026|Tocotrienols|tocotrienols|mesh-list
82841883|NCT01157026|Vitamin E|vitamin e|mesh-list
82841884|NCT01157026|Tocopherols|tocopherols|mesh-list
82841885|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82841886|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
82841887|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82841888|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841889|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82841890|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83443625|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
82841891|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82841892|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82841893|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82841894|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
82841895|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841896|NCT01157026|Protective Agents|protective agents|mesh-ancestor
82841897|NCT01157026|Vitamins|vitamins|mesh-ancestor
82841898|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
82841899|NCT01263652|Dipyrone|dipyrone|mesh-list
82841900|NCT01263652|Diclofenac|diclofenac|mesh-list
82841901|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
82841902|NCT01263652|Tramadol|tramadol|mesh-list
82841903|NCT01263652|Orphenadrine|orphenadrine|mesh-list
82841904|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82841905|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82841906|NCT01263652|Analgesics|analgesics|mesh-ancestor
82841907|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
82841908|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841909|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841910|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841911|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841912|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82841913|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841914|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841915|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82841916|NCT01263652|Narcotics|narcotics|mesh-ancestor
82841917|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82841918|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
82841919|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82841920|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82841921|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82841922|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82841923|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
82841924|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
82841925|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82841926|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82841927|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
82841928|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841929|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
82841930|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82841931|NCT03881644|Sumatriptan|sumatriptan|mesh-list
82841932|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
82841933|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82841934|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82841935|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82841936|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
82841937|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841938|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841939|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841940|NCT03881644|Growth Substances|growth substances|mesh-ancestor
82841941|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
82841942|NCT01259830|Etoricoxib|etoricoxib|mesh-list
82841943|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82841944|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82841945|NCT01259830|Analgesics|analgesics|mesh-ancestor
82841946|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
82841947|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841948|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841949|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82841950|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82841951|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82841952|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82841953|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841954|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841955|NCT00224484|Vaccines|vaccines|mesh-list
82841956|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
82841957|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841958|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
82841959|NCT01265680|Hematinics|hematinics|mesh-ancestor
82841960|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
82841961|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82841962|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841963|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82841964|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82841965|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841966|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841967|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82841968|NCT01157572|Metoprolol|metoprolol|mesh-list
82841969|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82841970|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82841971|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
82841972|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
82841973|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82841974|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82841975|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82841976|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82841977|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82841978|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
82841979|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82841980|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841981|NCT01074372|Alirocumab|alirocumab|mesh-list
82841982|NCT01074372|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82841983|NCT01074372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82841984|NCT01074372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82841985|NCT01074372|Antimetabolites|antimetabolites|mesh-ancestor
82841986|NCT01074372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841987|NCT01074372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82841988|NCT01074372|Protease Inhibitors|protease inhibitors|mesh-ancestor
82841989|NCT01074372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841990|NCT01074372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82841991|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82841992|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82841993|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82841994|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82841995|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82841996|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82841997|NCT00254982|Infliximab|infliximab|mesh-list
82841998|NCT00254982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82841999|NCT00254982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842000|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
82842001|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842002|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842003|NCT01586572|Vaccines|vaccines|mesh-list
82842004|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
82842005|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842006|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
82842007|NCT00224016|Oxybutynin|oxybutynin|mesh-list
82842008|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
82842009|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
82842010|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842011|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842012|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82842013|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82842014|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
82842015|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842016|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842017|NCT00224016|Urological Agents|urological agents|mesh-ancestor
82842018|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82842019|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842020|NCT02527174|Cytarabine|cytarabine|mesh-list
82842021|NCT02527174|Idarubicin|idarubicin|mesh-list
82842022|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82842023|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
82842024|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842025|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842026|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
82842027|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842028|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842029|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
82842030|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842031|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82842032|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82842033|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82842034|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842035|NCT01161940|Nizatidine|nizatidine|mesh-list
82842036|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82842037|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842038|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82842039|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
82842040|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
82842041|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842042|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842043|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842044|NCT01160068|Metformin|metformin|mesh-list
82842045|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82842046|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842047|NCT01266694|Colchicine|colchicine|mesh-list
82842048|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
82842049|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842050|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
82842051|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
82842052|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
82842053|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842054|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842055|NCT03876886|Paclitaxel|paclitaxel|mesh-list
82842056|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82842057|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
82842058|NCT03876886|Carboplatin|carboplatin|mesh-list
82842059|NCT03876886|Epirubicin|epirubicin|mesh-list
82842060|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82842061|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842062|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
82842063|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
82842064|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
82842065|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842066|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842067|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
82842068|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842069|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842070|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82842071|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
82842072|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82842073|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82842074|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82842075|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82842076|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842077|NCT01266772|Budesonide|budesonide|mesh-list
82842078|NCT01266772|Montelukast|montelukast|mesh-list
82842079|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842080|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82842081|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
82842082|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842083|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842084|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82842085|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
82842086|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
82842087|NCT01266772|Hormones|hormones|mesh-ancestor
82842088|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842089|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82842090|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
82842091|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82842092|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82842093|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842094|NCT01264354|Adefovir|adefovir|mesh-list
82842095|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82842096|NCT01264354|Clevudine|clevudine|mesh-list
82842097|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
82842098|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842099|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82842100|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82842101|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842102|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842103|NCT01264432|Veliparib|veliparib|mesh-list
83443635|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82842104|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82842105|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842106|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842107|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842108|NCT02527096|Lamivudine|lamivudine|mesh-list
82842109|NCT02527096|Dolutegravir|dolutegravir|mesh-list
82842110|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82842111|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82842112|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842113|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842114|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
82842115|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842116|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82842117|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82842118|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82842119|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82842120|NCT01160302|Curcumin|curcumin|mesh-list
82842121|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82842122|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82842124|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
82842125|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842126|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842127|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842128|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842129|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842130|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842131|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842133|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82842134|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82842135|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
82842136|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842137|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842138|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842139|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
82842140|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
82842141|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842142|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
82842143|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82842144|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
82842145|NCT01268176|Vitamin D|vitamin d|mesh-list
82842146|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
82842147|NCT01268176|Vitamins|vitamins|mesh-ancestor
82842148|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
82842149|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842150|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82842151|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82842152|NCT01264588|Calcium|calcium|mesh-list
82842153|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82842154|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842155|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
82842156|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82842157|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82842158|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842159|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
82842160|NCT05075200|Coagulants|coagulants|mesh-ancestor
82842161|NCT01158274|Capecitabine|capecitabine|mesh-list
82842162|NCT01158274|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82842163|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82842164|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
82842165|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842166|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842167|NCT01158274|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82842168|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842169|NCT01267084|Ketoconazole|ketoconazole|mesh-list
82842170|NCT01267084|Dexamethasone|dexamethasone|mesh-list
82842171|NCT01267084|Trabectedin|trabectedin|mesh-list
82842172|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842173|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
82842174|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
82842175|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842176|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842177|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842178|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
82842179|NCT01267084|Hormones|hormones|mesh-ancestor
82842180|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842181|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82842182|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842183|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
82842184|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842185|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82842186|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82842187|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842188|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842189|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82842190|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
82842191|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82842192|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82842193|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
82842194|NCT01264822|Rabeprazole|rabeprazole|mesh-list
82842195|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82842196|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842197|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82842198|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842199|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842201|NCT03876574|Gemcitabine|gemcitabine|mesh-list
82842202|NCT03876574|Floxuridine|floxuridine|mesh-list
82842203|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842204|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
82842205|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
82842206|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842207|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842208|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842209|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
82842210|NCT03876574|Hormones|hormones|mesh-ancestor
82842211|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842212|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82842213|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842214|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82842215|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
82842216|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842217|NCT01161082|Alirocumab|alirocumab|mesh-list
82842218|NCT01161082|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82842219|NCT01161082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82842220|NCT01161082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82842221|NCT01161082|Antimetabolites|antimetabolites|mesh-ancestor
82842222|NCT01161082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842223|NCT01161082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82842224|NCT01161082|Protease Inhibitors|protease inhibitors|mesh-ancestor
82842225|NCT01161082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842226|NCT01161082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82842227|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
82842228|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
82842229|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
82842230|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842231|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842232|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
82842233|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842234|NCT01267396|Sertraline|sertraline|mesh-list
82842235|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
82842236|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82842237|NCT01267396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82842238|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82842239|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82842240|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842241|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842242|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
82842243|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842244|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
82842245|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82842246|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82842247|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
82842248|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842249|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82842250|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82842251|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842252|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842253|NCT01161316|Cetuximab|cetuximab|mesh-list
82842254|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82842255|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842256|NCT01161550|Cytarabine|cytarabine|mesh-list
82842257|NCT01161550|Tretinoin|tretinoin|mesh-list
82842258|NCT01161550|Cladribine|cladribine|mesh-list
82842259|NCT01161550|Midostaurin|midostaurin|mesh-list
82842260|NCT01161550|Lenograstim|lenograstim|mesh-list
82842261|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82842262|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
82842263|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842264|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842265|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
82842266|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842267|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842268|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
82842269|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842270|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82842271|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
82842272|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
82842274|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842276|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
82842277|NCT01159210|Coagulants|coagulants|mesh-ancestor
82842278|NCT03879460|Naltrexone|naltrexone|mesh-list
82842279|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82842280|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82842281|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842282|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
82842283|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842284|NCT03877120|Diazepam|diazepam|mesh-list
82842285|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
82842286|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82842287|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842288|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842289|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82842290|NCT03877120|Analgesics|analgesics|mesh-ancestor
82842291|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
82842292|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842293|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82842294|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82842295|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82842296|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
82842297|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842298|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842299|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82842300|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
82842301|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
82842302|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
82842303|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842304|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82842305|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82842306|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82842307|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82842308|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82842309|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82842310|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
82842311|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
82842312|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
82842313|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
82842314|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
82842315|NCT03879382|Fludarabine|fludarabine|mesh-list
82842316|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842317|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
82842318|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842319|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842320|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82842321|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
82842322|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842323|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842324|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82842325|NCT01166932|Amoxicillin|amoxicillin|mesh-list
82842326|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
82842327|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
82842328|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
82842329|NCT01166932|Oxacillin|oxacillin|mesh-list
82842330|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82842331|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842332|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842333|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842334|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82842335|NCT01167010|Budesonide|budesonide|mesh-list
82842336|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
82842337|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842338|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82842339|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
82842340|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842341|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842342|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82842343|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
82842344|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
82842345|NCT01167010|Hormones|hormones|mesh-ancestor
82842346|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842347|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82842348|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82842350|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
82842351|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842352|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842353|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82842354|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
82842355|NCT01280188|Coagulants|coagulants|mesh-ancestor
82842356|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82842357|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
82842358|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842360|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82842361|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842362|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82842363|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842364|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
82842365|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842366|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
82842367|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842368|NCT01165060|Bezafibrate|bezafibrate|mesh-list
82842369|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82842370|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
82842371|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842372|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82842373|NCT01165294|Ketamine|ketamine|mesh-list
82842374|NCT01165294|Analgesics|analgesics|mesh-ancestor
82842375|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
82842376|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842377|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842378|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82842379|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82842380|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
82842381|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
82842382|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842383|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82842384|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82842385|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842386|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842387|NCT01165372|Artesunate|artesunate|mesh-list
82842388|NCT01165372|Piperaquine|piperaquine|mesh-list
82842389|NCT01165372|Artenimol|artenimol|mesh-list
82842390|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
82842391|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82842392|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82842393|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842394|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842395|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
82842396|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
82842397|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82842398|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
82842399|NCT01280734|Melatonin|melatonin|mesh-list
82842400|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
82842401|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842402|NCT01280734|Protective Agents|protective agents|mesh-ancestor
82842403|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842404|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842405|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82842406|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82842407|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842408|NCT01587430|Cytarabine|cytarabine|mesh-list
82842409|NCT01587430|Daunorubicin|daunorubicin|mesh-list
82842410|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
82842411|NCT01587430|Idarubicin|idarubicin|mesh-list
82842412|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82842413|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
82842414|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842415|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842416|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
82842417|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842418|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842419|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
82842420|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842421|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82842422|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82842423|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82842424|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842430|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842431|NCT03757234|Levofloxacin|levofloxacin|mesh-list
82842432|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82842433|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842434|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82842435|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82842436|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82842437|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842438|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842439|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842440|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82842441|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82842442|NCT03874156|Atorvastatin|atorvastatin|mesh-list
82842443|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82842444|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82842445|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
82842446|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842447|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82842448|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82842449|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842450|NCT01167478|Caffeine|caffeine|mesh-list
82842451|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82842452|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842453|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82842454|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842455|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842456|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82842457|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82842458|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
82842459|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842460|NCT01587196|Naltrexone|naltrexone|mesh-list
82842461|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82842462|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82842463|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842464|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
82842465|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842466|NCT01281514|Carboplatin|carboplatin|mesh-list
82842467|NCT01281514|Doxorubicin|doxorubicin|mesh-list
82842468|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82842469|NCT01281514|Everolimus|everolimus|mesh-list
82842470|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842471|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82842472|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82842473|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82842474|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842475|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842476|NCT01281514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82842477|NCT01281514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82842478|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842479|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
82842480|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842481|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82842482|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
82842483|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842484|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82842485|NCT00223080|Antacids|antacids|mesh-ancestor
82842486|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842487|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842488|NCT03971604|Vitamins|vitamins|mesh-list
82842489|NCT03971604|Vitamin E|vitamin e|mesh-list
82842490|NCT03971604|Vitamin A|vitamin a|mesh-list
82842491|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
82842492|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842493|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
82842494|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842497|NCT02531490|Methyldopa|methyldopa|mesh-list
82842498|NCT02531490|Nifedipine|nifedipine|mesh-list
82842499|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82842500|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82842501|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842502|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82842503|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842504|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
82842505|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
82842506|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82842507|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82842508|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82842509|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
82842510|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842511|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82842512|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
82842513|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
82842514|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842515|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82842516|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82842517|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
82842518|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82842519|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82842520|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82842521|NCT03871114|Triamcinolone|triamcinolone|mesh-list
82842522|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82842523|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82842524|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82842525|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842526|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
82842527|NCT03871114|Hormones|hormones|mesh-ancestor
82842528|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842529|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842530|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842531|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
82842532|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842533|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842534|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
82842535|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82842536|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82842537|NCT01281748|Prednisolone|prednisolone|mesh-list
82842538|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
82842539|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82842540|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
82842541|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842542|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
82842543|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
82842544|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842545|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842546|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842547|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
82842548|NCT01281748|Hormones|hormones|mesh-ancestor
82842549|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842550|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82842551|NCT01281748|Protective Agents|protective agents|mesh-ancestor
82842552|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82842553|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842554|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
82842555|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82842556|NCT00220740|Antibodies|antibodies|mesh-list
82842557|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
82842558|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82842559|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
82842560|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
82842561|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842562|NCT01273402|Antibodies|antibodies|mesh-list
82842563|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
82842564|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82842565|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
82842566|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842567|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
82842568|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82842569|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
82842570|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842571|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842572|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82842573|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
82842574|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82842576|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842577|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842578|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82842579|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
82842580|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
82842581|NCT03873298|Protective Agents|protective agents|mesh-ancestor
82842582|NCT00184002|Prednisone|prednisone|mesh-list
82842583|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
82842584|NCT00184002|Doxorubicin|doxorubicin|mesh-list
82842585|NCT00184002|Vincristine|vincristine|mesh-list
82842586|NCT00184002|Rituximab|rituximab|mesh-list
82842587|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842588|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
82842589|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842590|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842591|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82842592|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
82842593|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842594|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842595|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82842596|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82842597|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82842598|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82842599|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842600|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842601|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
82842602|NCT00184002|Hormones|hormones|mesh-ancestor
82842603|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842604|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82842605|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82842606|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
82842607|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
82842608|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
82842609|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82842610|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
82842611|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82842612|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82842613|NCT01167946|Prednisolone|prednisolone|mesh-list
82842614|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
82842615|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82842616|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
82842617|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842618|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
82842619|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
82842620|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842621|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842622|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842623|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
82842624|NCT01167946|Hormones|hormones|mesh-ancestor
82842625|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842626|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82842627|NCT01167946|Protective Agents|protective agents|mesh-ancestor
82842628|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82842629|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842630|NCT01275508|Adalimumab|adalimumab|mesh-list
82842631|NCT01275508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82842632|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842633|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842634|NCT01073670|Acetaminophen|acetaminophen|mesh-list
82842635|NCT01073670|Indomethacin|indomethacin|mesh-list
82842636|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82842637|NCT01073670|Analgesics|analgesics|mesh-ancestor
82842638|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
82842639|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842640|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842641|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
82842642|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82842643|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842644|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842657|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
82842658|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842659|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842660|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842661|NCT00165672|Rabeprazole|rabeprazole|mesh-list
82842662|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82842663|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842664|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82842665|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842666|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842667|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
82842668|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82842669|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
82842670|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842671|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
82842672|NCT03870646|Protective Agents|protective agents|mesh-ancestor
82842674|NCT01168492|Analgesics|analgesics|mesh-ancestor
82842675|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
82842676|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842677|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842678|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82842679|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82842680|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
82842681|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
82842682|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842683|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82842684|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82842685|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842686|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842687|NCT03870490|Cefepime|cefepime|mesh-list
82842688|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82842689|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842690|NCT01278082|Budesonide|budesonide|mesh-list
82842691|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842692|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82842693|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
82842694|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842695|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842696|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82842697|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
82842698|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
82842699|NCT01278082|Hormones|hormones|mesh-ancestor
82842700|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842701|NCT03870256|Misoprostol|misoprostol|mesh-list
82842702|NCT03870256|Carbetocin|carbetocin|mesh-list
82842703|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82842704|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
82842705|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82842706|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842707|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82842717|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842719|NCT00169104|Vinorelbine|vinorelbine|mesh-list
82842720|NCT00169104|Lenograstim|lenograstim|mesh-list
82842721|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82842722|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842723|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82842724|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
82842725|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842726|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82842727|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
82842728|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
82842729|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
82842730|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842731|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
82842732|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82842733|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82842734|NCT03872830|Analgesics|analgesics|mesh-ancestor
82842735|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
82842736|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842737|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842738|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842739|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842740|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82842741|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
82842742|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82842743|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
82842744|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842745|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82842746|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
82842747|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82842748|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82842749|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82842750|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842751|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842752|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82842753|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82842754|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82842755|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
82842756|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842757|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842758|NCT00163020|Progestins|progestins|mesh-ancestor
82842759|NCT00163020|Hormones|hormones|mesh-ancestor
82842760|NCT01168804|Dexamethasone|dexamethasone|mesh-list
82842761|NCT01168804|Bortezomib|bortezomib|mesh-list
82842762|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82842763|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842764|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
82842765|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
82842766|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842767|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842768|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842769|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
82842770|NCT01168804|Hormones|hormones|mesh-ancestor
82842771|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842772|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82842773|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842779|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
82842780|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842781|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842782|NCT01282528|Infliximab|infliximab|mesh-list
82842783|NCT01282528|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82842784|NCT01282528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842785|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
82842786|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842787|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842788|NCT01169506|Silicon|silicon|mesh-list
82842789|NCT01169506|Trace Elements|trace elements|mesh-ancestor
82842790|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
82842791|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842792|NCT01169740|Bilirubin|bilirubin|mesh-list
82842793|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
82842794|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842795|NCT01169740|Protective Agents|protective agents|mesh-ancestor
82842796|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842797|NCT01169584|Molgramostim|molgramostim|mesh-list
82842798|NCT01169584|Sargramostim|sargramostim|mesh-list
82842799|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
82842800|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842801|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842802|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
82842803|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82842804|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842805|NCT01282762|Vaccines|vaccines|mesh-list
82842806|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
82842807|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842808|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82842809|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82842810|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82842811|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
82842812|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842813|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842814|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842815|NCT01282840|Urological Agents|urological agents|mesh-ancestor
82842816|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
82842817|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842818|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82842819|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842820|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842821|NCT01172626|Valproic Acid|valproic acid|mesh-list
82842822|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
82842823|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842824|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842825|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
82842826|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842827|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842828|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
82842829|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82842830|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842831|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82842832|NCT01172782|Hydromorphone|hydromorphone|mesh-list
82842833|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82842834|NCT01172782|Narcotics|narcotics|mesh-ancestor
82842835|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842836|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842837|NCT01172782|Analgesics|analgesics|mesh-ancestor
82842838|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
82842839|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842840|NCT03866746|Aflibercept|aflibercept|mesh-list
82842841|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82842842|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82842843|NCT03866746|Growth Substances|growth substances|mesh-ancestor
82842845|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
82842846|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842847|NCT03869398|Calcitriol|calcitriol|mesh-list
82842848|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82842849|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842850|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82842851|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82842852|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842853|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82842854|NCT03869398|Vitamins|vitamins|mesh-ancestor
82842855|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
82842856|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82842857|NCT01170052|Sirolimus|sirolimus|mesh-list
82842858|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82842859|NCT01170052|Temsirolimus|temsirolimus|mesh-list
82842860|NCT01170052|MTOR Inhibitors|mtor inhibitors|mesh-list
82842861|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82842862|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
82842863|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842864|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842865|NCT01170052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82842866|NCT01170052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842867|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842868|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
82842869|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842870|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82842871|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82842872|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82842873|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
82842874|NCT01284478|Dexamethasone|dexamethasone|mesh-list
82842875|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82842876|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
82842877|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
82842878|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842879|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842880|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82842881|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
82842882|NCT01284478|Hormones|hormones|mesh-ancestor
82842883|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82842884|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82842885|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842886|NCT00252720|Candesartan|candesartan|mesh-list
82842887|NCT00252720|Candesartan cilexetil|candesartan cilexetil|mesh-list
82842888|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82842889|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82842890|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82842891|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842892|NCT01284556|Phenobarbital|phenobarbital|mesh-list
82842893|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
82842894|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82842895|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842896|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842897|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82842898|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82842899|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842900|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842901|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
82842902|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
82842903|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82842904|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82842905|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82842906|NCT01170130|Lidocaine|lidocaine|mesh-list
82842907|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
82842908|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
82842909|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82842910|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842911|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
82842912|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842913|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82842914|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82842915|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82842917|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842919|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842920|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82842921|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82842922|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842923|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
82842924|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842925|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
82842926|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842927|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82842928|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82842929|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
82842930|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842931|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842932|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82842933|NCT01163500|Ubiquinone|ubiquinone|mesh-list
82842934|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
82842935|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
82842936|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842937|NCT01163500|Vitamins|vitamins|mesh-ancestor
82842938|NCT01163734|Ranolazine|ranolazine|mesh-list
82842939|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82842940|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82842941|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842942|NCT01284868|Propranolol|propranolol|mesh-list
82842943|NCT01284868|Bisoprolol|bisoprolol|mesh-list
82842944|NCT01284868|Mirabegron|mirabegron|mesh-list
82842945|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82842946|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82842947|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
82842948|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82842949|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842950|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842951|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82842952|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82842953|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
82842954|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82842955|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82842956|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82842957|NCT01284868|Urological Agents|urological agents|mesh-ancestor
82842958|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
82842959|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
82842960|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82842961|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82842962|NCT01170442|Vitamin D|vitamin d|mesh-list
82842963|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
82842964|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
82842965|NCT01170442|Vitamins|vitamins|mesh-list
82842966|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
82842967|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842968|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82842969|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82842970|NCT00252564|Leucovorin|leucovorin|mesh-list
82842971|NCT00252564|Bevacizumab|bevacizumab|mesh-list
82842972|NCT00252564|Cetuximab|cetuximab|mesh-list
82842973|NCT00252564|Fluorouracil|fluorouracil|mesh-list
82842974|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
82842975|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82842976|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82842977|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82842978|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82842979|NCT00252564|Growth Substances|growth substances|mesh-ancestor
82842980|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82842981|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
82842982|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
82842983|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82842984|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82842985|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82842986|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
82842987|NCT00252564|Antidotes|antidotes|mesh-ancestor
82842988|NCT00252564|Protective Agents|protective agents|mesh-ancestor
82842989|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
82842990|NCT00252564|Vitamins|vitamins|mesh-ancestor
82842999|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
82843000|NCT01173562|DMP 777|dmp 777|mesh-list
82843001|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
82843002|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
82843003|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82843004|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843005|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
82843006|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
82843007|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
82843008|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843009|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843010|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843011|NCT00166296|Escitalopram|escitalopram|mesh-list
82843012|NCT00166296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82843013|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82843014|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843015|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843016|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843017|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
82843018|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843019|NCT01173640|Midazolam|midazolam|mesh-list
82843020|NCT01173640|Resveratrol|resveratrol|mesh-list
82843021|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82843022|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82843023|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843024|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843025|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82843026|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82843027|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82843028|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82843029|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
82843030|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
82843031|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
82843032|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
82843033|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843034|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843035|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
82843036|NCT01173640|Protective Agents|protective agents|mesh-ancestor
82843037|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843038|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82843039|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82843040|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
82843041|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843042|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82843043|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
82843044|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843045|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843046|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82843047|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82843048|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843049|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
82843050|NCT03868306|Chrysarobin|chrysarobin|mesh-list
82843051|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82843052|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843053|NCT03868306|Analgesics|analgesics|mesh-ancestor
82843054|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
82843055|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843056|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843057|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843058|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843060|NCT01164046|Heparin|heparin|mesh-list
82843061|NCT01164046|Enoxaparin|enoxaparin|mesh-list
82843062|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82843063|NCT01164046|Tinzaparin|tinzaparin|mesh-list
82843064|NCT01164046|Dalteparin|dalteparin|mesh-list
82843065|NCT01164046|Nadroparin|nadroparin|mesh-list
82843066|NCT01164046|Reviparin|reviparin|mesh-list
82843067|NCT01164046|Warfarin|warfarin|mesh-list
82843068|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
82843069|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
82843070|NCT01164046|Bemiparin|bemiparin|mesh-list
82843071|NCT01164046|Certoparin|certoparin|mesh-list
82843072|NCT01164046|Vitamins|vitamins|mesh-ancestor
82843073|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
82843074|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843075|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
82843076|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82843077|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82843078|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843079|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82843080|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
82843081|NCT01164046|Coagulants|coagulants|mesh-ancestor
82843082|NCT01075464|Paclitaxel|paclitaxel|mesh-list
82843083|NCT01075464|Bevacizumab|bevacizumab|mesh-list
82843084|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82843085|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843086|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
82843087|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
82843088|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
82843089|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843090|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82843091|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82843092|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82843093|NCT01075464|Growth Substances|growth substances|mesh-ancestor
82843094|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843095|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
82843096|NCT01074996|Leucovorin|leucovorin|mesh-list
82843097|NCT01074996|Antidotes|antidotes|mesh-ancestor
82843098|NCT01074996|Protective Agents|protective agents|mesh-ancestor
82843099|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843100|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
82843101|NCT01074996|Vitamins|vitamins|mesh-ancestor
82843102|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
82843103|NCT00160680|Levocetirizine|levocetirizine|mesh-list
82843104|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82843105|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82843106|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
82843107|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
82843108|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843109|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843110|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843111|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
82843112|NCT00160524|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82843113|NCT00160524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843114|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843115|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
82843116|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843117|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843118|NCT01077570|Repaglinide|repaglinide|mesh-list
82843119|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82843120|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843121|NCT01075698|Telmisartan|telmisartan|mesh-list
82843122|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82843123|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82843124|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82843125|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843126|NCT00159822|Voriconazole|voriconazole|mesh-list
82843127|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
82843128|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843129|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82843130|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82843131|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843132|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843133|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82843134|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
82843135|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843136|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843137|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82843138|NCT00158262|Propranolol|propranolol|mesh-list
82843139|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82843140|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82843141|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
82843142|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843143|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843144|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843145|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82843146|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82843147|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
82843148|NCT03868072|Tofacitinib|tofacitinib|mesh-list
82843149|NCT03868072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82843150|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82843151|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843152|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843154|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
82843155|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843156|NCT01283932|Pantoprazole|pantoprazole|mesh-list
82843157|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82843158|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843159|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82843160|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843161|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843162|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82843163|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843164|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843165|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82843166|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82843167|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843168|NCT01171378|Ofatumumab|ofatumumab|mesh-list
82843169|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843170|NCT01171456|Metformin|metformin|mesh-list
82843171|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82843172|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843173|NCT03865888|Cyclosporine|cyclosporine|mesh-list
82843174|NCT03865888|Tacrolimus|tacrolimus|mesh-list
82843175|NCT03865888|Cyclosporins|cyclosporins|mesh-list
82843176|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843177|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
82843178|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843179|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82843180|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843181|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843182|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
82843183|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843184|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
82843185|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843186|NCT01284166|Timolol|timolol|mesh-list
82843187|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82843188|NCT01284166|Dorzolamide|dorzolamide|mesh-list
82843189|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82843190|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82843191|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82843192|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82843193|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
82843194|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843195|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843196|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843197|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82843198|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82843199|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82843200|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82843201|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82843202|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82843203|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843204|NCT01285414|Temozolomide|temozolomide|mesh-list
82843205|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82843206|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
82843207|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843208|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843209|NCT01172002|Azathioprine|azathioprine|mesh-list
82843212|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843214|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843215|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843216|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
82843217|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843218|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843219|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843220|NCT03867994|Carvedilol|carvedilol|mesh-list
82843221|NCT03867994|Atorvastatin|atorvastatin|mesh-list
82843222|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82843223|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82843224|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
82843225|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843226|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82843227|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82843228|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843229|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82843230|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82843231|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
82843232|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843233|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843234|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82843235|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
82843236|NCT03867994|Protective Agents|protective agents|mesh-ancestor
82843237|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82843238|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843239|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82843240|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
82843241|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82843242|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82843243|NCT01172236|Lactoferrin|lactoferrin|mesh-list
82843244|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843245|NCT02525848|Dexamethasone|dexamethasone|mesh-list
82843246|NCT02525848|Gabapentin|gabapentin|mesh-list
82843247|NCT02525848|Aprepitant|aprepitant|mesh-list
82843248|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843249|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
82843250|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
82843251|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843252|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843253|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843254|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
82843255|NCT02525848|Hormones|hormones|mesh-ancestor
82843256|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843257|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82843258|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843259|NCT02525848|Analgesics|analgesics|mesh-ancestor
82843260|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
82843261|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
82843262|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82843263|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82843264|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843265|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82843266|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82843267|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82843268|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843269|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843270|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
82843271|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82843272|NCT01269112|Citric Acid|citric acid|mesh-list
82843273|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
82843274|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
82843275|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82843276|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
82843277|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
82843278|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843279|NCT01174420|Mitomycins|mitomycins|mesh-list
82843280|NCT01174420|Mitomycin|mitomycin|mesh-list
82843281|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82843282|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843283|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
82843284|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843285|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82843286|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843287|NCT01164826|Nabumetone|nabumetone|mesh-list
82843288|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82843289|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843290|NCT01164826|Analgesics|analgesics|mesh-ancestor
82843291|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
82843292|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843293|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843294|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843295|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843296|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82843297|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82843298|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843299|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843300|NCT03867370|Lenvatinib|lenvatinib|mesh-list
82843301|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843302|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82843303|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843304|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843305|NCT01172392|Interferons|interferons|mesh-list
82843306|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
82843307|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
82843308|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82843309|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843310|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
82843311|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843312|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
82843313|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843314|NCT01172470|Carboplatin|carboplatin|mesh-list
82843315|NCT01172470|Gemcitabine|gemcitabine|mesh-list
82843316|NCT01172470|Pemetrexed|pemetrexed|mesh-list
82843317|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843318|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82843319|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
82843320|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843321|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843322|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82843323|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82843324|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
82843325|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82843326|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843327|NCT03864016|Sufentanil|sufentanil|mesh-list
82843329|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
82843330|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843331|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843332|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82843333|NCT03864016|Narcotics|narcotics|mesh-ancestor
82843334|NCT03864016|Analgesics|analgesics|mesh-ancestor
82843335|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
82843336|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843337|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82843338|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82843339|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
82843340|NCT03860662|Baclofen|baclofen|mesh-list
82843341|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82843342|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843343|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82843344|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843345|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82843346|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
82843347|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
82843348|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843349|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843350|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
82843351|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
82843352|NCT01177852|Promethazine|promethazine|mesh-list
82843353|NCT01177852|Brompheniramine|brompheniramine|mesh-list
82843354|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
82843355|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
82843356|NCT01177852|Ephedrine|ephedrine|mesh-list
82843357|NCT01177852|Dipropizine|dipropizine|mesh-list
82843358|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843359|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82843360|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82843361|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843362|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843363|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
82843365|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
82843366|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843367|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
82843368|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
82843369|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843370|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82843371|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
82843372|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
82843373|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843374|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82843375|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
82843376|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
82843377|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82843378|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82843379|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
82843380|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
82843381|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82843382|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82843383|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
82843384|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
82843385|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
82843386|NCT03863392|Misoprostol|misoprostol|mesh-list
82843387|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82843388|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
82843389|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82843390|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843391|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82843392|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843393|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
82843394|NCT01175200|Lansoprazole|lansoprazole|mesh-list
82843395|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
82843396|NCT01175200|Clopidogrel|clopidogrel|mesh-list
82843397|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82843398|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82843399|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82843400|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82843401|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82843402|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
82843403|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843404|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843405|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843406|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82843407|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843408|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82843409|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843410|NCT03863626|Furosemide|furosemide|mesh-list
82843411|NCT03863626|Diuretics|diuretics|mesh-ancestor
82843412|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
82843413|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843414|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82843415|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843416|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843417|NCT01288378|Caspofungin|caspofungin|mesh-list
82843418|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
82843419|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843420|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843421|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843422|NCT01178320|Niacin|niacin|mesh-list
82843423|NCT01178320|Niacinamide|niacinamide|mesh-list
82843424|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
82843425|NCT01178320|Simvastatin|simvastatin|mesh-list
82843426|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82843427|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82843428|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
82843429|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843430|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82843431|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82843432|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843433|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
82843434|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
82843436|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
82843437|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843438|NCT01175512|Naltrexone|naltrexone|mesh-list
82843439|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82843440|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82843441|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843442|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
82843443|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843444|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
82843445|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82843446|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843447|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843448|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82843449|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82843450|NCT03859570|Protective Agents|protective agents|mesh-ancestor
82843451|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843452|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
82843453|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82843454|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
82843455|NCT03745222|Tislelizumab|tislelizumab|mesh-list
82843456|NCT03745222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82843457|NCT03745222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843458|NCT01286584|Varenicline|varenicline|mesh-list
82843459|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82843460|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82843461|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
82843462|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843463|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843464|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843465|NCT03743038|Minocycline|minocycline|mesh-list
82843466|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82843467|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843468|NCT03864250|Prednisone|prednisone|mesh-list
82843469|NCT03864250|Tacrolimus|tacrolimus|mesh-list
82843470|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843471|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
82843472|NCT03864250|Hormones|hormones|mesh-ancestor
82843473|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843474|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843475|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82843476|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843477|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843478|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
82843479|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82843480|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443751|NCT02413203|Celecoxib|celecoxib|mesh-list
82843481|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843482|NCT01175746|Nicardipine|nicardipine|mesh-list
82843483|NCT01175746|Remifentanil|remifentanil|mesh-list
82843484|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82843485|NCT01175746|Narcotics|narcotics|mesh-ancestor
82843486|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843487|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843488|NCT01175746|Analgesics|analgesics|mesh-ancestor
82843489|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
82843490|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843491|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82843492|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82843493|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843494|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843495|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82843496|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
82843497|NCT01174810|Exenatide|exenatide|mesh-list
82843498|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82843499|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843500|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82843501|NCT01174810|Incretins|incretins|mesh-ancestor
82843502|NCT01174810|Hormones|hormones|mesh-ancestor
82843503|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843504|NCT01178710|Simvastatin|simvastatin|mesh-list
82843505|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82843506|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82843507|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
82843508|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843515|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
82843516|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
82843517|NCT01174888|Bortezomib|bortezomib|mesh-list
82843518|NCT01174888|Midostaurin|midostaurin|mesh-list
82843519|NCT01174888|Staurosporine|staurosporine|mesh-list
82843520|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82843521|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843522|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82843523|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82843524|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843525|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843526|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82843527|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
82843528|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
82843529|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843530|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843531|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
82843532|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843533|NCT01174888|Analgesics|analgesics|mesh-ancestor
82843534|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
82843535|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843536|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
82843537|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
82843538|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
82843539|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
82843540|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
82843541|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82843542|NCT01178788|Progesterone|progesterone|mesh-list
82843543|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82843544|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82843545|NCT01178788|Progestins|progestins|mesh-ancestor
82843546|NCT01178788|Hormones|hormones|mesh-ancestor
82843547|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843548|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843549|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82843550|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
82843551|NCT00153816|Vitamin D|vitamin d|mesh-list
82843552|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
82843553|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
82843554|NCT00153816|Calcium|calcium|mesh-list
82843555|NCT00153816|Vitamins|vitamins|mesh-ancestor
82843556|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
82843557|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843558|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82843559|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82843560|NCT00153816|Antacids|antacids|mesh-ancestor
82843561|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843562|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843563|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82843564|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
82843565|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843566|NCT01077648|Trastuzumab|trastuzumab|mesh-list
82843567|NCT01077648|Lapatinib|lapatinib|mesh-list
82843568|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82843569|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843570|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82843571|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843572|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843573|NCT00151476|Celecoxib|celecoxib|mesh-list
82843574|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82843575|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843576|NCT00151476|Analgesics|analgesics|mesh-ancestor
82843577|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
82843578|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843579|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843587|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82843588|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
82843589|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843590|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843592|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
82843593|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
82843594|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843595|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843596|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
82843597|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843598|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82843599|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82843600|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82843601|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843602|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843603|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
82843604|NCT03864172|Calcium|calcium|mesh-list
82843605|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82843606|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843607|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82843608|NCT02525302|Halofuginone|halofuginone|mesh-list
82843609|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843610|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
82843611|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82843612|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82843613|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843614|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82843615|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843616|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843617|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82843618|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82843619|NCT02525302|Growth Substances|growth substances|mesh-ancestor
82843620|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843621|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
82843623|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82843624|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843625|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82843626|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843627|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843628|NCT01179256|Curcumin|curcumin|mesh-list
82843629|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82843630|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843631|NCT01179256|Analgesics|analgesics|mesh-ancestor
82843632|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
82843633|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843634|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843635|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843636|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843637|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843638|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843639|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843640|NCT01179412|Iodine|iodine|mesh-list
82843641|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
82843642|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
82843643|NCT01179412|Povidone|povidone|mesh-list
82843644|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82843645|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843647|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
82843648|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843649|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
82843650|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
82843651|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82843652|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82843653|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843654|NCT03862768|Sunitinib|sunitinib|mesh-list
82843655|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
82843656|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843657|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82843658|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82843659|NCT03862768|Growth Substances|growth substances|mesh-ancestor
82843660|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843661|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
82843662|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82843663|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843664|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843665|NCT03862456|Azithromycin|azithromycin|mesh-list
82843666|NCT03862456|Metronidazole|metronidazole|mesh-list
82843667|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82843668|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843669|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82843670|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82843671|NCT03859102|Acetaminophen|acetaminophen|mesh-list
82843672|NCT03859102|Dexamethasone|dexamethasone|mesh-list
82843673|NCT03859102|Gabapentin|gabapentin|mesh-list
82843674|NCT03859102|Ondansetron|ondansetron|mesh-list
82843675|NCT03859102|Anesthetics|anesthetics|mesh-list
82843676|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
82843677|NCT03859102|Lansoprazole|lansoprazole|mesh-list
82843678|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
82843679|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843680|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
82843681|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
82843682|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843683|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843684|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843685|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
82843686|NCT03859102|Hormones|hormones|mesh-ancestor
82843687|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843688|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82843689|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843690|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843691|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843692|NCT03859102|Analgesics|analgesics|mesh-ancestor
82843693|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
82843694|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
82843695|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
82843696|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82843697|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82843698|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82843699|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82843700|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82843701|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843702|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843703|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
82843704|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
82843705|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
82843706|NCT03859102|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82843707|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82843708|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
82843709|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82843710|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82843711|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843712|NCT00149994|Cyclosporine|cyclosporine|mesh-list
82843714|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
82843715|NCT00149994|Tacrolimus|tacrolimus|mesh-list
82843716|NCT00149994|Cyclosporins|cyclosporins|mesh-list
82843717|NCT00149994|Basiliximab|basiliximab|mesh-list
82843718|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843719|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
82843720|NCT00149994|Hormones|hormones|mesh-ancestor
82843721|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843722|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843723|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82843724|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843725|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843726|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
82843727|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82843728|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843729|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843730|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
82843731|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843732|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
82843733|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843734|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
82843735|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
82843736|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843737|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843738|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82843739|NCT00149994|Protective Agents|protective agents|mesh-ancestor
82843740|NCT01179646|Pantoprazole|pantoprazole|mesh-list
82843741|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82843742|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843743|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82843744|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843745|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843746|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
82843747|NCT01075776|Acetylcholine|acetylcholine|mesh-list
82843748|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
82843749|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82843750|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
82843751|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843752|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843753|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843754|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
82843755|NCT01079910|Fluorides|fluorides|mesh-list
82843756|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
82843757|NCT01079910|Protective Agents|protective agents|mesh-ancestor
82843758|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843759|NCT01286896|Sunitinib|sunitinib|mesh-list
82843760|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843761|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82843762|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82843763|NCT01286896|Growth Substances|growth substances|mesh-ancestor
82843764|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843765|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
82843766|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82843767|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843768|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843769|NCT03857854|Pirfenidone|pirfenidone|mesh-list
82843770|NCT03857854|Analgesics|analgesics|mesh-ancestor
82843771|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
82843772|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843773|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843774|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82843775|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843776|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843777|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843778|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843779|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
82843780|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82843781|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
82843782|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
82843783|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843784|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843785|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843786|NCT01287052|Analgesics|analgesics|mesh-ancestor
82843787|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
82843788|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843789|NCT01288924|Parecoxib|parecoxib|mesh-list
82843790|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82843791|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82843792|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843793|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843794|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82843795|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843796|NCT01288924|Analgesics|analgesics|mesh-ancestor
82843797|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
82843798|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843799|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843800|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843801|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843802|NCT01179724|Pantoprazole|pantoprazole|mesh-list
82843803|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82843804|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82843805|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843806|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843807|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843808|NCT03862612|Anesthetics|anesthetics|mesh-list
82843809|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843810|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843811|NCT01287130|Cetuximab|cetuximab|mesh-list
82843812|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82843813|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843814|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
82843815|NCT00149214|Docetaxel|docetaxel|mesh-list
82843816|NCT00149214|Doxorubicin|doxorubicin|mesh-list
82843817|NCT00149214|Pemetrexed|pemetrexed|mesh-list
82843818|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843819|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
82843820|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843821|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843822|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82843823|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
82843824|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843825|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843826|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82843827|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
82843828|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
82843829|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
82843830|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82843831|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82843832|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82843833|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843834|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82843835|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82843836|NCT03034018|Suvorexant|suvorexant|mesh-list
82843837|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82843838|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82843839|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843840|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843841|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82843842|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843843|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843844|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
82843845|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
82843846|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82843847|NCT02525458|Protective Agents|protective agents|mesh-ancestor
82843848|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843849|NCT02555254|Methamphetamine|methamphetamine|mesh-list
82843850|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82843851|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843852|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
82843853|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
82843854|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843855|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
82843856|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843857|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843858|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
82843859|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82843860|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82843861|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843862|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82843863|NCT00114972|Paclitaxel|paclitaxel|mesh-list
82843864|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82843865|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82843866|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843867|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
82843868|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
82843869|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
82843870|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843871|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
82843873|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
82843874|NCT02444728|Azathioprine|azathioprine|mesh-list
82843875|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82843876|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
82843877|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843878|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843879|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82843880|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
82843881|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843882|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843883|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82843884|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843885|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
82843886|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
82843887|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843888|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843889|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
82843890|NCT02444728|Hormones|hormones|mesh-ancestor
82843891|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843892|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82843893|NCT02444728|Protective Agents|protective agents|mesh-ancestor
82843894|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
82843895|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82843896|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82843897|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843898|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843899|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
82843900|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82843901|NCT00129402|Simvastatin|simvastatin|mesh-list
82843902|NCT00129402|Ezetimibe|ezetimibe|mesh-list
82843903|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82843904|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82843905|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
82843906|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843907|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82843908|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82843909|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843910|NCT03739528|Levofloxacin|levofloxacin|mesh-list
82843911|NCT03739528|Ofloxacin|ofloxacin|mesh-list
82843912|NCT03739528|Tobramycin|tobramycin|mesh-list
82843913|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
82843914|NCT03739528|Dexamethasone|dexamethasone|mesh-list
82843915|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
82843916|NCT03739528|BB 1101|bb 1101|mesh-list
82843917|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82843918|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
82843919|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
82843920|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843921|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843922|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843923|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
82843925|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82843926|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82843927|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843928|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
82843929|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82843930|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843931|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82843932|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843933|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82843934|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82843935|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82843936|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82843937|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82843938|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82843939|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82843940|NCT03857386|Anesthetics|anesthetics|mesh-list
82843941|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843942|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843943|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82843944|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
82843945|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82843946|NCT01289236|Milnacipran|milnacipran|mesh-list
82843948|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82843949|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82843950|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843951|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843952|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843953|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843954|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82843955|NCT01289236|Analgesics|analgesics|mesh-ancestor
82843956|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
82843957|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843958|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
82843959|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82843960|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
82843961|NCT01289938|Promethazine|promethazine|mesh-list
82843962|NCT01289938|Metoclopramide|metoclopramide|mesh-list
82843963|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82843964|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82843965|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82843966|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843967|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
82843968|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
82843969|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
82843970|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82843971|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
82843972|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
82843973|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82843974|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82843975|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
82843976|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
82843977|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82843978|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843979|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82843980|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
82843981|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
82843982|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82843983|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82843984|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
82843985|NCT00114738|Rituximab|rituximab|mesh-list
82843986|NCT00114738|Bortezomib|bortezomib|mesh-list
82843987|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82843988|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82843989|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
82843990|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82843991|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82843992|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
82843993|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82843994|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82843995|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82843996|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82843997|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82843998|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
82843999|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844000|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844001|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82844002|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844003|NCT01180426|Tosedostat|tosedostat|mesh-list
82844004|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844005|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844006|NCT00148122|Docetaxel|docetaxel|mesh-list
82844007|NCT00148122|Capecitabine|capecitabine|mesh-list
82844008|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844009|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
82844010|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
82844011|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
82844012|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844013|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844014|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
82844015|NCT01182142|Capecitabine|capecitabine|mesh-list
82844016|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844017|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
82844018|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844019|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844020|NCT01180816|Temozolomide|temozolomide|mesh-list
82844021|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82844022|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
82844023|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844024|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844025|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
82844026|NCT01287598|Midazolam|midazolam|mesh-list
82844027|NCT01287598|Omeprazole|omeprazole|mesh-list
82844028|NCT01287598|Warfarin|warfarin|mesh-list
82844029|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82844030|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82844031|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844032|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844033|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82844034|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82844035|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82844036|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82844037|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
82844038|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
82844039|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
82844040|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
82844041|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844042|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844043|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
82844044|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82844045|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82844046|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82844047|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844048|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82844049|NCT03862144|Palonosetron|palonosetron|mesh-list
82844050|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
82844051|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
82844052|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844053|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844054|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82844055|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82844056|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82844057|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
82844058|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844059|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844060|NCT01290172|Somatostatin|somatostatin|mesh-list
82844061|NCT01290172|Hormones|hormones|mesh-ancestor
82844062|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844063|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844064|NCT03861598|Carvedilol|carvedilol|mesh-list
82844065|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82844066|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82844067|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
82844068|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83443787|NCT00828061|Prednisone|prednisone|mesh-list
82844069|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844070|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844071|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82844072|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
82844073|NCT03861598|Protective Agents|protective agents|mesh-ancestor
82844074|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82844075|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844076|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82844077|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
82844078|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82844079|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82844080|NCT01184482|Cetuximab|cetuximab|mesh-list
82844081|NCT01184482|Lapatinib|lapatinib|mesh-list
82844082|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82844083|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844084|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82844085|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844086|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844087|NCT01184560|Orlistat|orlistat|mesh-list
82844088|NCT01184560|Sibutramine|sibutramine|mesh-list
82844089|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844090|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844091|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82844092|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82844093|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
82844094|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82844095|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
82844096|NCT01184638|Propofol|propofol|mesh-list
82844097|NCT01184638|Sevoflurane|sevoflurane|mesh-list
82844098|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82844099|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844100|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844101|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82844102|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
82844103|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
82844104|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82844105|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82844106|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
82844107|NCT01290328|Hematinics|hematinics|mesh-ancestor
82844109|NCT01184716|Vitamins|vitamins|mesh-ancestor
82844110|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
82844111|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844112|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82844113|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
82844114|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
82844115|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
82844116|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844117|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844118|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
82844119|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844120|NCT01587508|Meloxicam|meloxicam|mesh-list
82844121|NCT01587508|Amitriptyline|amitriptyline|mesh-list
82844122|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
82844123|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82844124|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82844125|NCT01587508|Analgesics|analgesics|mesh-ancestor
82844126|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
82844127|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844128|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844129|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844130|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844131|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82844132|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82844133|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844134|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844135|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82844136|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
82844137|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82844138|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82844139|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82844140|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82844141|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844142|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82844143|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82844144|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844145|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
82844146|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844147|NCT00147498|Tofacitinib|tofacitinib|mesh-list
82844148|NCT00147498|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82844149|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82844151|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844152|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82844153|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
82844154|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844155|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844156|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82844157|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844158|NCT01080066|Cetuximab|cetuximab|mesh-list
82844159|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82844160|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844161|NCT01185184|Tofacitinib|tofacitinib|mesh-list
82844162|NCT01185184|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82844163|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82844164|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844165|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844166|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
82844167|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82844168|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82844169|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844170|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
82844171|NCT00113568|Coagulants|coagulants|mesh-ancestor
82844172|NCT01185262|Rituximab|rituximab|mesh-list
82844173|NCT01185262|Lenalidomide|lenalidomide|mesh-list
82844174|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82844175|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844176|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
82844177|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844178|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844179|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82844180|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82844181|NCT01185262|Growth Substances|growth substances|mesh-ancestor
82844182|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
82844183|NCT00113490|Palivizumab|palivizumab|mesh-list
82844184|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
82844185|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844186|NCT00146640|Prednisone|prednisone|mesh-list
82844187|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844188|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
82844189|NCT00146640|Hormones|hormones|mesh-ancestor
82844190|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844191|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844192|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82844193|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844194|NCT01185418|Haloperidol|haloperidol|mesh-list
82844195|NCT01185418|Risperidone|risperidone|mesh-list
82844196|NCT01185418|Aripiprazole|aripiprazole|mesh-list
82844197|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
82844198|NCT01185418|Amisulpride|amisulpride|mesh-list
82844199|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82844200|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
82844201|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844202|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844203|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844204|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82844205|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82844206|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844207|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82844208|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82844209|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
82844210|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
82844211|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
82844212|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82844213|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82844214|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82844215|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82844216|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
82844217|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
82844218|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844219|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82844220|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82844221|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82844222|NCT01185574|Vitamin D|vitamin d|mesh-list
82844223|NCT01185574|Vitamins|vitamins|mesh-ancestor
82844224|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
82844225|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844226|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82844227|NCT03861364|Propofol|propofol|mesh-list
82844228|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82844229|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844230|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844231|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82844232|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
82844233|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
82844234|NCT01185808|Vitamin D|vitamin d|mesh-list
82844235|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
82844236|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
82844237|NCT01185808|Vitamins|vitamins|mesh-list
82844238|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
82844239|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844240|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82844241|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82844242|NCT01183624|Analgesics|analgesics|mesh-list
82844243|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
82844244|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844245|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844246|NCT01291186|Epinephrine|epinephrine|mesh-list
82844247|NCT01291186|Racepinephrine|racepinephrine|mesh-list
82844248|NCT01291186|Bupivacaine|bupivacaine|mesh-list
82844249|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
82844250|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
82844252|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844253|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844254|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
82844255|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844256|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82844257|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82844258|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
82844259|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844260|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844261|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82844262|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82844263|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
82844264|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82844265|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844266|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
82844267|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
82844268|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82844269|NCT04979338|Bupivacaine|bupivacaine|mesh-list
82844270|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
82844271|NCT04979338|Anesthetics|anesthetics|mesh-list
82844272|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844273|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844274|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
82844275|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844276|NCT01177306|Guanfacine|guanfacine|mesh-list
82844277|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82844278|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82844279|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82844280|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82844281|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
82844282|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844283|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844284|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844285|NCT01290406|Dactolisib|dactolisib|mesh-list
82844286|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844287|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
82844288|NCT03854812|Fentanyl|fentanyl|mesh-list
82844289|NCT03854812|Propofol|propofol|mesh-list
82844290|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82844291|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844292|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844293|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82844294|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
82844295|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
82844296|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82844297|NCT03854812|Narcotics|narcotics|mesh-ancestor
82844298|NCT03854812|Analgesics|analgesics|mesh-ancestor
82844299|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
82844300|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844301|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82844302|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82844304|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82844305|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844306|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844307|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82844308|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
82844309|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82844310|NCT01186120|Umirolimus|umirolimus|mesh-list
82844311|NCT01186120|Everolimus|everolimus|mesh-list
82844312|NCT01186120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82844313|NCT01186120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82844314|NCT01186120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844315|NCT01186120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844316|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82844317|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
82844318|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844319|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844320|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844321|NCT03855826|Amiodarone|amiodarone|mesh-list
82844322|NCT03855826|Nifekalant|nifekalant|mesh-list
82844323|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82844324|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
82844325|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82844326|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844327|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844328|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82844329|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82844330|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82844331|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844332|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82844333|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82844334|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82844336|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82844337|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82844338|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844339|NCT01186588|Canagliflozin|canagliflozin|mesh-list
82844340|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82844341|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844342|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82844343|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844344|NCT03854266|Heparin|heparin|mesh-list
82844345|NCT03854266|Calcium heparin|calcium heparin|mesh-list
82844346|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82844347|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
82844348|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82844349|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82844350|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844351|NCT01187992|Atorvastatin|atorvastatin|mesh-list
82844352|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82844353|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82844354|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
82844355|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844356|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82844357|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82844358|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844359|NCT01191034|Imiquimod|imiquimod|mesh-list
82844360|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82844361|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
82844362|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844363|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844364|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
82844365|NCT01188148|Memantine|memantine|mesh-list
82844366|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82844367|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82844368|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
82844369|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844370|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844371|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844372|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82844373|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82844374|NCT01187212|Cisplatin|cisplatin|mesh-list
82844375|NCT01187212|Capecitabine|capecitabine|mesh-list
82844377|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844378|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844379|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
82844380|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844381|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82844382|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844383|NCT03849508|Phenylephrine|phenylephrine|mesh-list
82844384|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
82844385|NCT03849508|Norepinephrine|norepinephrine|mesh-list
82844386|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82844387|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
82844388|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
82844389|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844390|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844391|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
82844392|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82844393|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
82844394|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844395|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82844396|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82844397|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82844399|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844400|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844401|NCT03849508|Protective Agents|protective agents|mesh-ancestor
82844403|NCT03849664|Niacinamide|niacinamide|mesh-list
82844404|NCT03849664|Niacin|niacin|mesh-list
82844405|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
82844406|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
82844407|NCT03849664|Povidone|povidone|mesh-list
82844408|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82844409|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844410|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
82844411|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
82844412|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
82844413|NCT03849664|Vitamins|vitamins|mesh-ancestor
82844414|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
82844415|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82844416|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
82844417|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82844418|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
82844419|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844420|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82844421|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
82844422|NCT01293838|Escitalopram|escitalopram|mesh-list
82844423|NCT01293838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82844424|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82844425|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844426|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844427|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844428|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
82844429|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844430|NCT01188304|Aspirin|aspirin|mesh-list
82844431|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82844432|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82844433|NCT01188304|Analgesics|analgesics|mesh-ancestor
83443795|NCT00849121|Vaccines|vaccines|mesh-list
82844434|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
82844435|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844436|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844437|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844438|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844439|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82844440|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82844441|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844442|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82844443|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82844444|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844445|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
82844446|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
82844447|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
82844448|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82844449|NCT02524444|Mefloquine|mefloquine|mesh-list
82844450|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
82844451|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82844452|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82844453|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844454|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82844455|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844456|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844457|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82844459|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82844460|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
82844461|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844462|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844463|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82844464|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844465|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82844466|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
82844467|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844468|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844469|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82844470|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
82844471|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
82844472|NCT03853642|Protective Agents|protective agents|mesh-ancestor
82844473|NCT02296918|Rituximab|rituximab|mesh-list
82844474|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
82844475|NCT02296918|Venetoclax|venetoclax|mesh-list
82844476|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
82844477|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82844478|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844479|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
82844480|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844481|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844482|NCT01294072|Curcumin|curcumin|mesh-list
82844483|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82844484|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82844485|NCT01294072|Analgesics|analgesics|mesh-ancestor
82844486|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
82844487|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844488|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844489|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844490|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844491|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844492|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844493|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844494|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
82844495|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82844496|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
82844497|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844498|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844499|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82844500|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844501|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82844502|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82844503|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82844504|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
82844505|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844506|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844507|NCT01291654|Acetaminophen|acetaminophen|mesh-list
82844508|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82844509|NCT01291654|Analgesics|analgesics|mesh-ancestor
82844510|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
82844511|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844512|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844513|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
82844514|NCT03853096|Cefazolin|cefazolin|mesh-list
82844515|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82844516|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844517|NCT05671276|Aspirin|aspirin|mesh-list
82844518|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
82844519|NCT05671276|Clopidogrel|clopidogrel|mesh-list
82844520|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82844521|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82844522|NCT05671276|Analgesics|analgesics|mesh-ancestor
82844523|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
82844524|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844525|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844526|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844527|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844528|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82844529|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82844530|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844531|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82844532|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82844533|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844535|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82844536|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82844537|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82844538|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
82844539|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844540|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82844541|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
82844542|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82844543|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
82844544|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
82844545|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82844546|NCT03852160|Mirtazapine|mirtazapine|mesh-list
82844547|NCT03852160|Trazodone|trazodone|mesh-list
82844548|NCT03852160|Agomelatine|agomelatine|mesh-list
82844550|NCT03852160|Sertraline|sertraline|mesh-list
82844551|NCT03852160|Esketamine|esketamine|mesh-list
82844552|NCT03852160|Escitalopram|escitalopram|mesh-list
82844553|NCT03852160|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82844554|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82844555|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844556|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844557|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844558|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
82844559|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844560|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844561|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82844562|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
82844563|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82844564|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82844565|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
82844566|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82844567|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82844568|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844569|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82844570|NCT03852160|Analgesics|analgesics|mesh-ancestor
82844571|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
82844572|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82844573|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
82844574|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
82844575|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82844576|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82844577|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844578|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82844579|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82844580|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82844581|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
82844582|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82844583|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82844584|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82844585|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82844586|NCT02524210|Omeprazole|omeprazole|mesh-list
82844587|NCT02524210|Rabeprazole|rabeprazole|mesh-list
82844588|NCT02524210|Dabigatran|dabigatran|mesh-list
82844589|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82844590|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82844591|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82844592|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844593|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844594|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
82844595|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82844596|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
82844597|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
82844598|NCT03847792|Dexamethasone|dexamethasone|mesh-list
82844599|NCT03847792|Fentanyl|fentanyl|mesh-list
82844600|NCT03847792|Bupivacaine|bupivacaine|mesh-list
82844601|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844602|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
82844603|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
82844604|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844605|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844606|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82844607|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
82844608|NCT03847792|Hormones|hormones|mesh-ancestor
82844609|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844610|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82844611|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844612|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
82844613|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
82844614|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844615|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
82844616|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82844617|NCT03847792|Narcotics|narcotics|mesh-ancestor
82844618|NCT03847792|Analgesics|analgesics|mesh-ancestor
82844619|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82844620|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82844621|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
82844622|NCT01294618|Interferons|interferons|mesh-list
82844623|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844624|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
82844625|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844626|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
82844627|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
82844628|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82844629|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82844630|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844631|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844632|NCT01194232|Urological Agents|urological agents|mesh-ancestor
82844633|NCT01296334|Morphine|morphine|mesh-list
82844634|NCT01296334|Buprenorphine|buprenorphine|mesh-list
82844635|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82844636|NCT01296334|Narcotics|narcotics|mesh-ancestor
82844637|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844638|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844639|NCT01296334|Analgesics|analgesics|mesh-ancestor
82844640|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
82844641|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844642|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82844643|NCT03847558|Hormones|hormones|mesh-list
82844644|NCT03847558|Testosterone|testosterone|mesh-list
82844645|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82844646|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844647|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844648|NCT03847558|Androgens|androgens|mesh-ancestor
82844649|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
82844650|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
82844651|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844652|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82844653|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82844654|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844655|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844656|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844657|NCT01292356|Cetuximab|cetuximab|mesh-list
82844658|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82844659|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844660|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82844661|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844662|NCT03847246|Entecavir|entecavir|mesh-list
82844663|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
82844664|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844665|NCT03849196|Bisacodyl|bisacodyl|mesh-list
82844666|NCT03849196|Cathartics|cathartics|mesh-ancestor
82844667|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82844668|NCT03849196|Laxatives|laxatives|mesh-ancestor
82844669|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82844670|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
82844671|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82844672|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
82844673|NCT01296802|Fenfluramine|fenfluramine|mesh-list
82844674|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
82844675|NCT01296802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82844676|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82844677|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844678|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844679|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844680|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
82844682|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82844683|NCT01296958|Niclosamide|niclosamide|mesh-list
82844684|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
82844685|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82844686|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
82844687|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82844688|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844689|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
82844690|NCT01295086|Docetaxel|docetaxel|mesh-list
82844691|NCT01295086|Capecitabine|capecitabine|mesh-list
82844692|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
82844693|NCT01295086|Trastuzumab|trastuzumab|mesh-list
82844694|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844695|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
82844696|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
82844697|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
82844698|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844699|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844700|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
82844701|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82844702|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82844703|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82844705|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844706|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844707|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82844708|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844709|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
82844710|NCT01194700|Hormones|hormones|mesh-ancestor
82844711|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844712|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
82844713|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82844714|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
82844715|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82844716|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82844717|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82844718|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844719|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844720|NCT01194778|Vitamins|vitamins|mesh-list
82844721|NCT01194778|Vitamin K|vitamin k|mesh-list
82844722|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
82844723|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
82844724|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
82844725|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844726|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82844727|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82844728|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844729|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
82844730|NCT01194778|Coagulants|coagulants|mesh-ancestor
82844731|NCT01194934|Lenograstim|lenograstim|mesh-list
82844732|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82844733|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
82844734|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844735|NCT01297036|Donepezil|donepezil|mesh-list
82844736|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82844737|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844738|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844739|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
82844740|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844741|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844742|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
82844743|NCT03848806|Calcitriol|calcitriol|mesh-list
82844744|NCT03848806|Calcipotriene|calcipotriene|mesh-list
82844745|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
82844746|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82844747|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844748|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82844749|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844750|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844751|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82844752|NCT03848806|Vitamins|vitamins|mesh-ancestor
82844753|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
82844754|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82844755|NCT03737110|Rilonacept|rilonacept|mesh-list
82844756|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844757|NCT01189864|Diclofenac|diclofenac|mesh-list
82844758|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
82844759|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82844760|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
82844761|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82844762|NCT01189864|Prednisolone|prednisolone|mesh-list
82844763|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82844764|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
82844765|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82844766|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82844767|NCT01189864|Analgesics|analgesics|mesh-ancestor
82844768|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
82844769|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844770|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844771|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844772|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844773|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82844774|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844775|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844777|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
82844778|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
82844779|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82844780|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
82844781|NCT01189864|Hormones|hormones|mesh-ancestor
82844782|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844783|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82844784|NCT01189864|Protective Agents|protective agents|mesh-ancestor
82844785|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82844786|NCT01195246|Vaccines|vaccines|mesh-list
82844787|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
82844788|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844789|NCT01191892|Carboplatin|carboplatin|mesh-list
82844790|NCT01191892|Gemcitabine|gemcitabine|mesh-list
82844791|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844792|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844793|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
82844794|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844795|NCT01293058|Naloxone|naloxone|mesh-list
82844796|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82844797|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844798|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
82844799|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844800|NCT01195324|Canagliflozin|canagliflozin|mesh-list
82844801|NCT01195324|Warfarin|warfarin|mesh-list
82844802|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
82844803|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82844804|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844805|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82844806|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844807|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
82844808|NCT01293136|Narcotics|narcotics|mesh-ancestor
82844809|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844810|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844811|NCT01293136|Analgesics|analgesics|mesh-ancestor
82844812|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
82844813|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844814|NCT01293292|Teriparatide|teriparatide|mesh-list
82844815|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82844816|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844817|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82844818|NCT03846388|Hormones|hormones|mesh-list
82844819|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82844820|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844821|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844822|NCT01195714|Ofatumumab|ofatumumab|mesh-list
82844823|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844824|NCT01190722|Diclofenac|diclofenac|mesh-list
82844825|NCT01190722|Etoricoxib|etoricoxib|mesh-list
82844826|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82844827|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82844828|NCT01190722|Analgesics|analgesics|mesh-ancestor
82844829|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
82844830|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844831|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844832|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844833|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82844834|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82844835|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844836|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844837|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82844838|NCT01196260|Capecitabine|capecitabine|mesh-list
82844839|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
82844840|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844841|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
82844842|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844843|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844844|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
82844845|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844846|NCT05412082|Leucovorin|leucovorin|mesh-list
82844847|NCT05412082|Fluorouracil|fluorouracil|mesh-list
82844848|NCT05412082|Capecitabine|capecitabine|mesh-list
82844849|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
82844850|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
82844851|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844852|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844854|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82844855|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
82844856|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844857|NCT05412082|Antidotes|antidotes|mesh-ancestor
82844858|NCT05412082|Protective Agents|protective agents|mesh-ancestor
82844859|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
82844860|NCT05412082|Vitamins|vitamins|mesh-ancestor
82844861|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
82844862|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82844863|NCT01193296|Vildagliptin|vildagliptin|mesh-list
82844864|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82844865|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844866|NCT01193296|Incretins|incretins|mesh-ancestor
82844867|NCT01193296|Hormones|hormones|mesh-ancestor
82844868|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844869|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82844870|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
82844871|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844872|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844873|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
82844874|NCT01197040|Prednisone|prednisone|mesh-list
82844875|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82844876|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
82844877|NCT01197040|Hormones|hormones|mesh-ancestor
82844878|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82844879|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844880|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82844881|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844882|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82844883|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82844884|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
82844885|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82844886|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844887|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844888|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844889|NCT01193452|Leucovorin|leucovorin|mesh-list
82844890|NCT01193452|Fluorouracil|fluorouracil|mesh-list
82844891|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
82844892|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
82844893|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844894|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844895|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844896|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82844897|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
82844898|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844899|NCT01193452|Antidotes|antidotes|mesh-ancestor
82844900|NCT01193452|Protective Agents|protective agents|mesh-ancestor
82844901|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
82844902|NCT01193452|Vitamins|vitamins|mesh-ancestor
82844903|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
82844904|NCT05670886|Carbetocin|carbetocin|mesh-list
82844905|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
82844906|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82844907|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844908|NCT01295632|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
82844909|NCT01295632|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82844910|NCT01295632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844911|NCT01295632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844912|NCT03844594|Eptifibatide|eptifibatide|mesh-list
82844913|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82844914|NCT03848182|Gemcitabine|gemcitabine|mesh-list
82844915|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844916|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
82844917|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844918|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844919|NCT00146328|Tipranavir|tipranavir|mesh-list
82844920|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82844921|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82844922|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
82844923|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844924|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
82844926|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82844927|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
82844928|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844929|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844930|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82844931|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844932|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82844933|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
82844934|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844935|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844936|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82844937|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
82844938|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
82844939|NCT01295866|Protective Agents|protective agents|mesh-ancestor
82844940|NCT03848104|Cefoxitin|cefoxitin|mesh-list
82844941|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82844942|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82844943|NCT05670808|Epinephrine|epinephrine|mesh-list
82844944|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82844945|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82844946|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
82844947|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82844948|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844949|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844950|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82844951|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82844952|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
82844953|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844954|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82844955|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
82844956|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
82844957|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
82844958|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82844959|NCT01197664|Fluorouracil|fluorouracil|mesh-list
82844960|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
82844961|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844962|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82844963|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844964|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82844965|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
82844966|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844967|NCT01199458|Alfentanil|alfentanil|mesh-list
82844968|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82844969|NCT01199458|Narcotics|narcotics|mesh-ancestor
82844970|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82844971|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844972|NCT01199458|Analgesics|analgesics|mesh-ancestor
82844973|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
82844974|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82844975|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82844976|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
82844977|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
82844978|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
82844979|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844980|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82844981|NCT01588522|Calcitriol|calcitriol|mesh-list
82844982|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82844983|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82844984|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82844985|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82844986|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844987|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82844988|NCT01588522|Vitamins|vitamins|mesh-ancestor
82844989|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
82844990|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82844991|NCT01296178|Idarubicin|idarubicin|mesh-list
82844992|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82844993|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82844994|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82844995|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82844996|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82844997|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82844998|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82844999|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82845000|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
82845001|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845002|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845003|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82845004|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
82845005|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845006|NCT03730012|Atezolizumab|atezolizumab|mesh-list
82845007|NCT03730012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82845008|NCT03730012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845009|NCT03730012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845010|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845011|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
82845012|NCT03844360|Bortezomib|bortezomib|mesh-list
82845013|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
82845014|NCT03844360|Dasatinib|dasatinib|mesh-list
82845015|NCT03844360|Pegaspargase|pegaspargase|mesh-list
82845016|NCT03844360|Lenograstim|lenograstim|mesh-list
82845017|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845018|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845019|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845020|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845021|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82845022|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
82845023|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845024|NCT01198054|Lenalidomide|lenalidomide|mesh-list
82845025|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
82845026|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845027|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82845028|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82845029|NCT01198054|Growth Substances|growth substances|mesh-ancestor
82845030|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
82845031|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845032|NCT01202032|Bevacizumab|bevacizumab|mesh-list
82845033|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845034|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845035|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82845036|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82845037|NCT01202032|Growth Substances|growth substances|mesh-ancestor
82845038|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845039|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
82845040|NCT03844984|Lidocaine|lidocaine|mesh-list
82845041|NCT03844984|Midazolam|midazolam|mesh-list
82845042|NCT03844984|Ketamine|ketamine|mesh-list
82845043|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
82845044|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
82845045|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845046|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845047|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
82845048|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845049|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82845050|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82845051|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82845052|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845053|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845054|NCT03844984|Analgesics|analgesics|mesh-ancestor
82845055|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82845056|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82845057|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
82845058|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82845059|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82845060|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845061|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82845062|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82845063|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82845064|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82845065|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845066|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
82845067|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
82845068|NCT03842020|Amiodarone|amiodarone|mesh-list
82845069|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82845070|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
82845071|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82845072|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362080|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845074|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82845075|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82845076|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82845077|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845078|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82845079|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82845080|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82845081|NCT01200004|Lenalidomide|lenalidomide|mesh-list
82845082|NCT01200004|Azacitidine|azacitidine|mesh-list
82845083|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
82845084|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845085|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82845086|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82845087|NCT01200004|Growth Substances|growth substances|mesh-ancestor
82845088|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
82845089|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845090|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82845091|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
82845092|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845093|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845094|NCT01198210|Dexamethasone|dexamethasone|mesh-list
82845095|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
82845096|NCT01198210|Ketamine|ketamine|mesh-list
82845097|NCT01198210|BB 1101|bb 1101|mesh-list
82845098|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845099|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
82845100|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
82845101|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845102|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845103|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82845104|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
82845105|NCT01198210|Hormones|hormones|mesh-ancestor
82845106|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845107|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82845108|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845109|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845110|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845111|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845112|NCT01198210|Analgesics|analgesics|mesh-ancestor
82845113|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
82845114|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82845115|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82845116|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
82845117|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
82845118|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845119|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82845120|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82845121|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845122|NCT03843736|Drospirenone|drospirenone|mesh-list
82845123|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
82845124|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82845125|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
82845126|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82845127|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82845128|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845129|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82845130|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82845131|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82845132|NCT03843736|Estrogens|estrogens|mesh-ancestor
82845133|NCT03843736|Hormones|hormones|mesh-ancestor
83476465|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845134|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845135|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82845136|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
82845137|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82845138|NCT03843736|Diuretics|diuretics|mesh-ancestor
82845139|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
82845140|NCT01200472|Apremilast|apremilast|mesh-list
82845141|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82845142|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82845143|NCT01200472|Analgesics|analgesics|mesh-ancestor
82845144|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
82845146|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845147|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845148|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845149|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82845150|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82845151|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845152|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845153|NCT04638790|Dexamethasone|dexamethasone|mesh-list
82845154|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
82845155|NCT04638790|Dacarbazine|dacarbazine|mesh-list
82845156|NCT04638790|Doxorubicin|doxorubicin|mesh-list
82845157|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82845159|NCT04638790|Vincristine|vincristine|mesh-list
82845160|NCT04638790|Bleomycin|bleomycin|mesh-list
82845161|NCT04638790|Vinblastine|vinblastine|mesh-list
82845162|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82845163|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
82845164|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845165|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845166|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82845167|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
82845168|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845169|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845170|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82845171|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845172|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
82845173|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
82845174|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845175|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82845176|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
82845177|NCT04638790|Hormones|hormones|mesh-ancestor
82845178|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845179|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82845180|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82845181|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82845182|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82845183|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845184|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82845185|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
82845186|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
82845187|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
82845188|NCT03249142|Durvalumab|durvalumab|mesh-list
82845189|NCT03249142|Tremelimumab|tremelimumab|mesh-list
82845190|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82845191|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845192|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845193|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
82845194|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845195|NCT01200706|Amoxicillin|amoxicillin|mesh-list
82845196|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82845197|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845198|NCT01200784|Niacinamide|niacinamide|mesh-list
82845199|NCT01200784|Niacin|niacin|mesh-list
82845200|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
82845201|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
82845202|NCT01200784|Vitamins|vitamins|mesh-ancestor
82845203|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
82845204|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845205|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82845206|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
82845207|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845208|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82845209|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
82845210|NCT03841474|Sertraline|sertraline|mesh-list
82845211|NCT03841474|Escitalopram|escitalopram|mesh-list
82845212|NCT03841474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82845213|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82845214|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845215|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845216|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845217|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
82845218|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845219|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
82845221|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82845222|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82845223|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845224|NCT05670184|Ethanol|ethanol|mesh-list
82845225|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
82845226|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82845227|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845228|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845229|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845230|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
82845231|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845232|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82845233|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
82845234|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845235|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845236|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82845237|NCT05084248|Vitamin D|vitamin d|mesh-list
82845238|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
82845239|NCT05084248|Vitamins|vitamins|mesh-ancestor
82845240|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
82845241|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845242|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82845243|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82845244|NCT03842800|Ketamine|ketamine|mesh-list
82845245|NCT03842800|Analgesics|analgesics|mesh-ancestor
82845246|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
82845247|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845248|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845249|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82845250|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82845251|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
82845252|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
82845253|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845254|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82845255|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82845256|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845257|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845258|NCT01202422|Pregabalin|pregabalin|mesh-list
82845259|NCT01202422|Analgesics|analgesics|mesh-ancestor
82845260|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
82845261|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845262|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845263|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
82845264|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82845265|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845266|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845267|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82845268|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82845269|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82845270|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845271|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845272|NCT03892018|Paclitaxel|paclitaxel|mesh-list
82845273|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82845274|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845275|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
82845276|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
82845277|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
82845278|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845279|NCT01198912|Doxycycline|doxycycline|mesh-list
82845280|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82845281|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845282|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
82845283|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82845284|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82845285|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
82845286|NCT03842488|Darunavir|darunavir|mesh-list
82845287|NCT03842488|Cobicistat|cobicistat|mesh-list
82845288|NCT03842488|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
82845289|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82845290|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82845291|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
82845292|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845293|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82845295|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845296|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845297|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82845298|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82845299|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845300|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82845301|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82845302|NCT04256824|Triclosan|triclosan|mesh-list
82845303|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82845304|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845305|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82845306|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82845307|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
82845308|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845309|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82845310|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
82845311|NCT03842254|Hematinics|hematinics|mesh-ancestor
82845312|NCT01201642|Prednisolone|prednisolone|mesh-list
82845313|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845314|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
82845315|NCT01201642|Hormones|hormones|mesh-ancestor
82845316|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845317|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845318|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82845319|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845320|NCT05004064|Rituximab|rituximab|mesh-list
82845321|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
82845322|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845323|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845324|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
82845325|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845326|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845327|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82845328|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82845329|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
82845330|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845331|NCT01202734|Methylphenidate|methylphenidate|mesh-list
82845332|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82845333|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845334|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82845335|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82845336|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845337|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845338|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
82845339|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845340|NCT03173092|Dexamethasone|dexamethasone|mesh-list
82845341|NCT03173092|Lenalidomide|lenalidomide|mesh-list
82845342|NCT03173092|Ixazomib|ixazomib|mesh-list
82845343|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845344|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
82845345|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
82845346|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845347|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845348|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82845349|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
82845350|NCT03173092|Hormones|hormones|mesh-ancestor
82845351|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845352|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82845353|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845354|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
82845355|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82845356|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82845357|NCT03173092|Growth Substances|growth substances|mesh-ancestor
82845358|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
82845359|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845360|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845361|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845362|NCT02966314|Omalizumab|omalizumab|mesh-list
82845363|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82845364|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82845365|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
82845366|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82845367|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82845380|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82845381|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82845383|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845384|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
82845385|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82845386|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82845387|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82845388|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845389|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845390|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
82845404|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82845405|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845406|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845407|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845408|NCT01204138|Apremilast|apremilast|mesh-list
82845409|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82845410|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82845411|NCT01204138|Analgesics|analgesics|mesh-ancestor
82845412|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
82845413|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845414|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845415|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845416|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845417|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82845418|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82845419|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845420|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845421|NCT02927392|Leuprolide|leuprolide|mesh-list
82845422|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82845423|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
82845424|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82845425|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845426|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82845427|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845428|NCT01204372|Gemcitabine|gemcitabine|mesh-list
82845429|NCT01204372|Trastuzumab|trastuzumab|mesh-list
82845430|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82845431|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82845432|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
82845433|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845434|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845435|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845436|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845437|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845438|NCT01204450|Sirolimus|sirolimus|mesh-list
82845439|NCT01204450|Temsirolimus|temsirolimus|mesh-list
82845440|NCT01204450|MTOR Inhibitors|mtor inhibitors|mesh-list
82845442|NCT01204450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845443|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83443881|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845444|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845445|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82845446|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
82845447|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845448|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845449|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82845450|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845451|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82845452|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
82845453|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
82845454|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
82845455|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845456|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
82845457|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82845458|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845459|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845460|NCT02605486|Palbociclib|palbociclib|mesh-list
82845461|NCT02605486|Bicalutamide|bicalutamide|mesh-list
82845462|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845463|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845465|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845466|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
82845467|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
82845468|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845469|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845470|NCT03834454|Bupivacaine|bupivacaine|mesh-list
82845471|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
82845472|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
82845473|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845474|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845475|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
82845476|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845478|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845479|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845480|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845481|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845482|NCT03829930|Entinostat|entinostat|mesh-list
82845483|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845484|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82845485|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845486|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845487|NCT01203202|Clomipramine|clomipramine|mesh-list
82845488|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82845489|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
82845490|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845491|NCT01203202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82845492|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82845493|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845494|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845495|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845496|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
82845497|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845498|NCT02047474|Leucovorin|leucovorin|mesh-list
82845499|NCT02047474|Fluorouracil|fluorouracil|mesh-list
82845500|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
82845501|NCT02047474|Irinotecan|irinotecan|mesh-list
82845502|NCT02047474|Calcium|calcium|mesh-list
82845503|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
82845504|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82845505|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845506|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
82845507|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845508|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82845509|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845510|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82845511|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
82845512|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82845513|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82845516|NCT02047474|Protective Agents|protective agents|mesh-ancestor
82845517|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
82845518|NCT02047474|Vitamins|vitamins|mesh-ancestor
82845519|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
82845520|NCT01298284|Propranolol|propranolol|mesh-list
82845521|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82845522|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82845523|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
82845524|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845525|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845526|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845527|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82845528|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82845529|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
82845530|NCT01204840|Hormones|hormones|mesh-list
82845531|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845532|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845533|NCT01203358|Beractant|beractant|mesh-list
82845534|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
82845535|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
82845536|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82845537|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82845538|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845539|NCT03832426|Ritonavir|ritonavir|mesh-list
82845541|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82845542|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845543|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845544|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845545|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82845546|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82845547|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
82845548|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845549|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82845550|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82845551|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
82845552|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82845553|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
82845554|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845555|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
82845556|NCT03840070|Protective Agents|protective agents|mesh-ancestor
82845557|NCT03272698|Ketamine|ketamine|mesh-list
82845558|NCT03272698|Analgesics|analgesics|mesh-ancestor
82845559|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
82845560|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845561|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845562|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82845563|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82845564|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
82845565|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
82845566|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845567|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82845568|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82845569|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845570|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845571|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
82845572|NCT01203514|Hematinics|hematinics|mesh-ancestor
82845573|NCT01204996|Paclitaxel|paclitaxel|mesh-list
82845574|NCT01204996|Docetaxel|docetaxel|mesh-list
82845575|NCT01204996|Carboplatin|carboplatin|mesh-list
82845576|NCT01204996|Gemcitabine|gemcitabine|mesh-list
82845577|NCT01204996|Doxorubicin|doxorubicin|mesh-list
82845578|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82845579|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82845580|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845581|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
82845582|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
82845583|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
82845584|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845585|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82845586|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
82845587|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82845588|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82845589|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82845590|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845591|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
82845592|NCT01297192|Mirabegron|mirabegron|mesh-list
82845593|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82845594|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82845595|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
82845596|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845597|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845598|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845599|NCT01297192|Urological Agents|urological agents|mesh-ancestor
82845600|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82845601|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82845602|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82845603|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
82845604|NCT01205074|Ethanol|ethanol|mesh-list
82845605|NCT01205074|Propranolol|propranolol|mesh-list
82845606|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82845607|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82845608|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
82845609|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845610|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845611|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845612|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82845613|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82845614|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
82845615|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82845616|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845617|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845619|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82845620|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82845621|NCT05667376|Analgesics|analgesics|mesh-ancestor
82845622|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
82845623|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845624|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845625|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845626|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845627|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845628|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845629|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845630|NCT03722524|Amlodipine|amlodipine|mesh-list
82845631|NCT03722524|Perindopril|perindopril|mesh-list
82845632|NCT03722524|Indapamide|indapamide|mesh-list
82845633|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
82845634|NCT03722524|Diuretics|diuretics|mesh-list
82845635|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82845636|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82845637|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82845638|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845639|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845640|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82845641|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845642|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
82845643|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
82845644|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845645|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845646|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82845647|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82845648|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82845649|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845650|NCT05667220|Incretins|incretins|mesh-ancestor
82845651|NCT05667220|Hormones|hormones|mesh-ancestor
82845652|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845653|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82845654|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845655|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845656|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845657|NCT01203592|Albuterol|albuterol|mesh-list
82845658|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82845659|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
82845660|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845661|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845662|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82845664|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
82845665|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82845666|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82845667|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82845668|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82845669|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
82845670|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845671|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845672|NCT05281276|Celecoxib|celecoxib|mesh-list
82845673|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82845674|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82845675|NCT05281276|Analgesics|analgesics|mesh-ancestor
82845676|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
82845677|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845678|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845679|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845680|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845681|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82845682|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82845683|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845684|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845685|NCT03829150|Amoxicillin|amoxicillin|mesh-list
82845686|NCT03829150|Metronidazole|metronidazole|mesh-list
82845687|NCT03829150|Clarithromycin|clarithromycin|mesh-list
82845688|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
82845689|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82845690|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845692|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82845693|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82845694|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845695|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845696|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82845697|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82845698|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82845699|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82845700|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82845701|NCT01205464|Doxycycline|doxycycline|mesh-list
82845702|NCT01205464|Tetracycline|tetracycline|mesh-list
82845703|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82845704|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845705|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
82845706|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82845707|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82845708|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82845709|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845710|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845711|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
82845712|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82845713|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845714|NCT03819010|Letrozole|letrozole|mesh-list
82845715|NCT03819010|Palbociclib|palbociclib|mesh-list
82845716|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845717|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82845718|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82845719|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845720|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845721|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82845722|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
82845723|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845724|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845725|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845726|NCT03818932|Acetaminophen|acetaminophen|mesh-list
82845727|NCT03818932|Celecoxib|celecoxib|mesh-list
82845728|NCT03818932|Ketorolac|ketorolac|mesh-list
82845729|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82845730|NCT03818932|Diazepam|diazepam|mesh-list
82845731|NCT03818932|Gabapentin|gabapentin|mesh-list
82845732|NCT03818932|Hydrocodone|hydrocodone|mesh-list
82845733|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82845734|NCT03818932|Analgesics|analgesics|mesh-ancestor
82845735|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
82845736|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845737|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845738|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
82845739|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82845740|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845741|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845742|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82845743|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82845744|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845745|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845746|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
82845747|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82845748|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82845749|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845750|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845751|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82845752|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82845753|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845754|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
82845755|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82845756|NCT03818932|Narcotics|narcotics|mesh-ancestor
82845757|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
82845758|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
82845759|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82845760|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
82845761|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
82845762|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82845763|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82845764|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82845766|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82845767|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
82845768|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
82845769|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
82845770|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
82845772|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
82845773|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82845774|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
82845775|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82845776|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845777|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845778|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845779|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
82845780|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82845781|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82845782|NCT01300780|Etoricoxib|etoricoxib|mesh-list
82845783|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82845784|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82845785|NCT01300780|Analgesics|analgesics|mesh-ancestor
82845786|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
82845787|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845788|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845789|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845790|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845791|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82845792|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82845793|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845794|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845795|NCT01297816|Minocycline|minocycline|mesh-list
82845796|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82845797|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845798|NCT01297894|Colistin|colistin|mesh-list
82845799|NCT01297894|Fosfomycin|fosfomycin|mesh-list
82845800|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82845801|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845802|NCT05666362|Benoxinate|benoxinate|mesh-list
82845803|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
82845804|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
82845805|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845806|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845807|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
82845808|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845809|NCT01206010|Varenicline|varenicline|mesh-list
82845810|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82845811|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82845812|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
82845813|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845814|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845815|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845817|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
82845818|NCT05665114|Fludarabine|fludarabine|mesh-list
82845819|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82845820|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
82845821|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845822|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845823|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82845824|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
82845825|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845826|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845827|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82845828|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82845829|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
82845830|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
82845831|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845832|NCT05345002|Tretinoin|tretinoin|mesh-list
82845833|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845834|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
82845835|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
82845836|NCT05618314|Probenecid|probenecid|mesh-list
82845837|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
82845838|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
82845839|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845840|NCT03814642|Esomeprazole|esomeprazole|mesh-list
82845841|NCT03814642|Clopidogrel|clopidogrel|mesh-list
82845842|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82845843|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82845844|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82845845|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82845846|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
82845847|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845848|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845849|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845850|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82845851|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82845852|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82845853|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845855|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
82845856|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
82845857|NCT03813784|Capecitabine|capecitabine|mesh-list
82845858|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
82845859|NCT03813784|Apatinib|apatinib|mesh-list
82845860|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82845861|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
82845862|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845863|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845864|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82845865|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845866|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
82845867|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82845868|NCT03818308|Velpatasvir|velpatasvir|mesh-list
82845869|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
82845870|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82845871|NCT03827044|Avelumab|avelumab|mesh-list
82845872|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845873|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845874|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
82845875|NCT00145626|Melphalan|melphalan|mesh-list
82845876|NCT00145626|Thiotepa|thiotepa|mesh-list
82845877|NCT00145626|Fludarabine|fludarabine|mesh-list
82845878|NCT00145626|Antibodies|antibodies|mesh-list
82845879|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82845880|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
82845881|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845882|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82845883|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82845884|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
82845885|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845886|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845887|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82845888|NCT01206946|Betamethasone|betamethasone|mesh-list
82845889|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82845890|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
82845892|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845893|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845894|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82845895|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
82845896|NCT03813940|Vaccines|vaccines|mesh-list
82845897|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
82845898|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845899|NCT03967938|Olaparib|olaparib|mesh-list
82845900|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82845901|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845902|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845903|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845904|NCT01299298|Mipomersen|mipomersen|mesh-list
82845905|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82845906|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82845907|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
82845908|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845909|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82845910|NCT00153062|Telmisartan|telmisartan|mesh-list
82845911|NCT00153062|Clopidogrel|clopidogrel|mesh-list
82845912|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
82845913|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82845914|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82845915|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82845916|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82845917|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
82845918|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845919|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845920|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845921|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82845922|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82845923|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82845924|NCT05264974|Vaccines|vaccines|mesh-list
82845925|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
82845926|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845927|NCT00145470|Asenapine|asenapine|mesh-list
82845928|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82845929|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82845930|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82845931|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845932|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82845933|NCT03813394|Bevacizumab|bevacizumab|mesh-list
82845934|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
82845935|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845936|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845937|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82845938|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82845939|NCT03813394|Growth Substances|growth substances|mesh-ancestor
82845940|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845941|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
82845942|NCT03813394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83443910|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845943|NCT03813394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845944|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82845945|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
82845946|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82845947|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82845948|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82845949|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845950|NCT03813316|Incretins|incretins|mesh-ancestor
82845951|NCT03813316|Hormones|hormones|mesh-ancestor
82845952|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82845953|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
82845954|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845955|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845956|NCT01301248|Cisplatin|cisplatin|mesh-list
82845957|NCT01301248|Cetuximab|cetuximab|mesh-list
82845958|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845959|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82845960|NCT03817684|BPN14770|bpn14770|mesh-list
82845961|NCT03817684|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82845962|NCT03817684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82845963|NCT03817684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82845964|NCT03817684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845966|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82845967|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845968|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82845969|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845970|NCT01302106|Clofarabine|clofarabine|mesh-list
82845971|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82845972|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
82845973|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845974|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82845975|NCT00152516|Levetiracetam|levetiracetam|mesh-list
82845976|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
82845977|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
82845978|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82845979|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82845980|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
82845981|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845982|NCT05624008|Methamphetamine|methamphetamine|mesh-list
82845983|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82845984|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82845985|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
82845986|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
82845987|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82845988|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
82845989|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82845990|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82845991|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
82845992|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82845993|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82845994|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82845995|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82845997|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82845998|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82845999|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
82846000|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846001|NCT01302340|Dronabinol|dronabinol|mesh-list
82846002|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
82846003|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846004|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82846005|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846006|NCT01302340|Analgesics|analgesics|mesh-ancestor
82846007|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
82846008|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846009|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83443922|NCT00765947|Diuretics|diuretics|mesh-ancestor
82846010|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82846011|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846012|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846013|NCT01302340|Hormones|hormones|mesh-ancestor
82846014|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846015|NCT00150800|Brivaracetam|brivaracetam|mesh-list
82846016|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
82846017|NCT03812770|Leucovorin|leucovorin|mesh-list
82846018|NCT03812770|Fluorouracil|fluorouracil|mesh-list
82846019|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
82846020|NCT03812770|Sorafenib|sorafenib|mesh-list
82846021|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
82846022|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846023|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82846024|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846025|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846026|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
82846027|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846028|NCT03812770|Antidotes|antidotes|mesh-ancestor
82846029|NCT03812770|Protective Agents|protective agents|mesh-ancestor
82846030|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
82846031|NCT03812770|Vitamins|vitamins|mesh-ancestor
82846032|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
82846033|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82846034|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846035|NCT00144300|Pramipexole|pramipexole|mesh-list
82846036|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
82846037|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846038|NCT00144300|Protective Agents|protective agents|mesh-ancestor
82846039|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846040|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82846041|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82846042|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
82846043|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
82846044|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846045|NCT00149630|Disulfiram|disulfiram|mesh-list
82846046|NCT00149630|Methadone|methadone|mesh-list
82846047|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82846048|NCT00149630|Narcotics|narcotics|mesh-ancestor
82846049|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83443930|NCT00766649|Sirolimus|sirolimus|mesh-list
82846050|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846051|NCT00149630|Analgesics|analgesics|mesh-ancestor
82846052|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
82846053|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846054|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
82846055|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
82846056|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82846057|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82846058|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846059|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846060|NCT01302496|Ipilimumab|ipilimumab|mesh-list
82846061|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82846062|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846063|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82846064|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846065|NCT00127842|Etanercept|etanercept|mesh-list
82846066|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846067|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846068|NCT00127842|Analgesics|analgesics|mesh-ancestor
82846069|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
82846070|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846071|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846072|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846073|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846074|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846075|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846076|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
82846077|NCT01075802|Tamoxifen|tamoxifen|mesh-list
82846078|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82846079|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
82846080|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846081|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846082|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82846083|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846084|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82846085|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82846086|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82846087|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
82846088|NCT03816592|Anesthetics|anesthetics|mesh-list
82846089|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846090|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846091|NCT03816592|Narcotics|narcotics|mesh-ancestor
82846092|NCT03816592|Analgesics|analgesics|mesh-ancestor
82846093|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
82846094|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846095|NCT01078038|Sirolimus|sirolimus|mesh-list
82846096|NCT01078038|Everolimus|everolimus|mesh-list
82846097|NCT01078038|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82846098|NCT01078038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82846099|NCT01078038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846100|NCT01078038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846101|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846102|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
82846103|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846104|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846105|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82846106|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846107|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82846108|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
82846109|NCT00223496|Aripiprazole|aripiprazole|mesh-list
82846110|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
82846111|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82846112|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82846114|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846115|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846116|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
82846117|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
82846118|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846119|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846120|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82846121|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82846122|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
82846123|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82846124|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82846125|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82846126|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82846127|NCT02531412|Spironolactone|spironolactone|mesh-list
82846128|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82846129|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
82846130|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846131|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846132|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82846133|NCT02531412|Diuretics|diuretics|mesh-ancestor
82846134|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
82846135|NCT00126672|Sirolimus|sirolimus|mesh-list
82846136|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82846137|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846138|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82846139|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846140|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
82846141|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846142|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
82846143|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846144|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82846145|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82846146|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82846147|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
82846148|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846149|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82846150|NCT05034562|Edetic Acid|edetic acid|mesh-list
82846151|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82846152|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
82846153|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
82846154|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846155|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
82846156|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82846157|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82846158|NCT00145496|Olanzapine|olanzapine|mesh-list
82846159|NCT00145496|Asenapine|asenapine|mesh-list
82846160|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
82846161|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
82846162|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846163|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846164|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846165|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82846166|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82846167|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846168|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82846169|NCT00145496|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82846170|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82846171|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846172|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846173|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846174|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
82846175|NCT01299922|Cyclosporine|cyclosporine|mesh-list
82846176|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
82846177|NCT01299922|Cyclosporins|cyclosporins|mesh-list
82846178|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846179|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846180|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846181|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
82846182|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846183|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
82846184|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846185|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
83443971|NCT00783965|Tazarotene|tazarotene|mesh-list
82846187|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82846188|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82846189|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846190|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82846191|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
82846192|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82846193|NCT05030818|Aspirin|aspirin|mesh-list
82846194|NCT05030818|Ramipril|ramipril|mesh-list
82846195|NCT05030818|Atorvastatin|atorvastatin|mesh-list
82846196|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82846197|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82846198|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
82846199|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846200|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82846201|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82846202|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846203|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846204|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846205|NCT05030818|Analgesics|analgesics|mesh-ancestor
82846206|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
82846207|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846208|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846209|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846210|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846211|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82846212|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82846213|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82846214|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82846215|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
82846216|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82846217|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
82846218|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82846219|NCT01582022|Bupivacaine|bupivacaine|mesh-list
82846220|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
82846221|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
82846222|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846223|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846224|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
82846225|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846226|NCT01582412|Isavuconazole|isavuconazole|mesh-list
82846227|NCT01582412|Digoxin|digoxin|mesh-list
82846228|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82846229|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82846230|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846231|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846232|NCT01582412|Protective Agents|protective agents|mesh-ancestor
82846233|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846234|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
82846235|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846236|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
82846237|NCT00255164|Lansoprazole|lansoprazole|mesh-list
82846238|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82846239|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846240|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82846241|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846242|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846243|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
82846244|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846245|NCT00126594|Interferons|interferons|mesh-list
82846246|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
82846247|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
82846248|NCT00126594|Sorafenib|sorafenib|mesh-list
82846249|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846250|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
82846251|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846252|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82846253|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846254|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846255|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
82846256|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846257|NCT01080456|Tacrolimus|tacrolimus|mesh-list
82846258|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846259|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
82846260|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846262|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846263|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846264|NCT03811054|Apatinib|apatinib|mesh-list
82846265|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846266|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82846267|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846268|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846269|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82846270|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846271|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846272|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846273|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82846274|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82846275|NCT01075854|Hormones|hormones|mesh-ancestor
82846276|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846277|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846278|NCT03967392|Lidocaine|lidocaine|mesh-list
82846279|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
82846280|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
82846281|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846282|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846283|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
82846284|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846285|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82846286|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82846287|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82846288|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846289|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846290|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
82846291|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846292|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
82846293|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82846294|NCT00142584|Metoprolol|metoprolol|mesh-list
82846295|NCT00142584|Nebivolol|nebivolol|mesh-list
82846296|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82846297|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82846298|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
82846299|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
82846300|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846301|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846302|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82846303|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82846304|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82846305|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83444005|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
82846306|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846307|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846308|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
82846309|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82846310|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82846311|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82846312|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
82846313|NCT04848064|Fludarabine|fludarabine|mesh-list
82846314|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
82846315|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
82846316|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
82846317|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846318|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
82846319|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846320|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846321|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82846322|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
82846323|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846324|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846325|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82846326|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
82846327|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82846328|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82846329|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82846330|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846331|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846332|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
82846333|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846334|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846335|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82846336|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846337|NCT01080534|Tacrolimus|tacrolimus|mesh-list
82846338|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846339|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
82846340|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846341|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82846342|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846343|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846344|NCT00125190|Mecasermin|mecasermin|mesh-list
82846345|NCT00125190|Growth Substances|growth substances|mesh-ancestor
82846346|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846347|NCT00141726|Etanercept|etanercept|mesh-list
82846348|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846349|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846350|NCT00141726|Analgesics|analgesics|mesh-ancestor
82846351|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
82846352|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846353|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846354|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846355|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846356|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846357|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846358|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
82846359|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82846360|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82846361|NCT01301716|Paclitaxel|paclitaxel|mesh-list
82846362|NCT01301716|Bevacizumab|bevacizumab|mesh-list
82846363|NCT01301716|Carboplatin|carboplatin|mesh-list
82846364|NCT01301716|Pemetrexed|pemetrexed|mesh-list
82846365|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82846366|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846367|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
82846368|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
82846369|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
82846370|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846371|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82846372|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82846373|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82846374|NCT01301716|Growth Substances|growth substances|mesh-ancestor
82846375|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846376|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
82846377|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846378|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82846379|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82846380|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
82846381|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
82846382|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82846383|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846384|NCT01300312|Diclofenac|diclofenac|mesh-list
82846385|NCT01300312|Eperisone|eperisone|mesh-list
82846386|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846387|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846388|NCT01300312|Analgesics|analgesics|mesh-ancestor
82846389|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
82846390|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846391|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846392|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846393|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846394|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82846395|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846396|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846397|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
82846398|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82846399|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846400|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82846401|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82846402|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82846403|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
82846404|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
82846405|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
82846406|NCT01567384|Pemetrexed|pemetrexed|mesh-list
82846407|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846409|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846410|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82846411|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82846413|NCT01080612|Analgesics|analgesics|mesh-ancestor
82846414|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
82846415|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846416|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846417|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
82846418|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82846419|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846420|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846421|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82846422|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82846423|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82846424|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846425|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82846426|NCT03815344|Misoprostol|misoprostol|mesh-list
82846427|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82846428|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
82846429|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82846430|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846431|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82846432|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846433|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
82846434|NCT03819790|Insulin|insulin|mesh-list
82846435|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82846436|NCT03819790|Metformin|metformin|mesh-list
82846437|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
82846438|NCT03819790|Lixisenatide|lixisenatide|mesh-list
82846439|NCT03819790|Gliclazide|gliclazide|mesh-list
82846440|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82846441|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846442|NCT01560442|Buprenorphine|buprenorphine|mesh-list
82846443|NCT01560442|Methadone|methadone|mesh-list
82846444|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82846445|NCT01560442|Narcotics|narcotics|mesh-ancestor
82846446|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846447|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846449|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
82846450|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846451|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82846452|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
82846453|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
82846454|NCT00110994|Sorafenib|sorafenib|mesh-list
82846455|NCT00110994|Dacarbazine|dacarbazine|mesh-list
82846456|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846457|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82846458|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846459|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846460|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82846461|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
82846462|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
82846463|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82846464|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82846465|NCT01560052|Prednisolone|prednisolone|mesh-list
82846466|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
82846467|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82846468|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
82846469|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846470|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
82846471|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
82846472|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846473|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846474|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846475|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
82846476|NCT01560052|Hormones|hormones|mesh-ancestor
82846477|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846478|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82846479|NCT01560052|Protective Agents|protective agents|mesh-ancestor
82846480|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82846481|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846482|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
82846484|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846485|NCT05098132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82846486|NCT05098132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846487|NCT04356352|Lidocaine|lidocaine|mesh-list
82846488|NCT04356352|Esmolol|esmolol|mesh-list
82846489|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
82846490|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
82846491|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846492|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846493|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
82846494|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846495|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82846496|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82846497|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82846498|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846499|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846500|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82846501|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82846502|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82846503|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
82846504|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846505|NCT05622994|Rimonabant|rimonabant|mesh-list
82846506|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82846507|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
82846508|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82846509|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846510|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846511|NCT05622994|Hormones|hormones|mesh-ancestor
82846512|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846513|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846514|NCT05622916|Ethanol|ethanol|mesh-list
82846515|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82846516|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846517|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846518|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846519|NCT03819556|Caseins|caseins|mesh-list
82846520|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
82846521|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
82846522|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846523|NCT03804034|Molybdenum|molybdenum|mesh-list
82846524|NCT03804034|Trace Elements|trace elements|mesh-ancestor
82846525|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
82846526|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846527|NCT04246762|Vitamin K|vitamin k|mesh-list
82846528|NCT04246762|Midazolam|midazolam|mesh-list
82846529|NCT04246762|Caffeine|caffeine|mesh-list
82846530|NCT04246762|Omeprazole|omeprazole|mesh-list
82846531|NCT04246762|Warfarin|warfarin|mesh-list
82846532|NCT04246762|Vitamins|vitamins|mesh-ancestor
82846533|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
82846534|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846535|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82846536|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82846537|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846538|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82846539|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82846540|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82846541|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82846542|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
82846543|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
82846544|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
82846545|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
82846546|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846547|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846548|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
82846549|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82846550|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82846551|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846552|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82846553|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82846554|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
82846555|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82846556|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846558|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82846559|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82846561|NCT04246762|Coagulants|coagulants|mesh-ancestor
82846562|NCT03799120|Tamsulosin|tamsulosin|mesh-list
82846563|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82846564|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82846565|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82846566|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
82846567|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846568|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846569|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846570|NCT03799120|Urological Agents|urological agents|mesh-ancestor
82846571|NCT03792724|Nivolumab|nivolumab|mesh-list
82846572|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82846573|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846574|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82846575|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846576|NCT00144170|Ritonavir|ritonavir|mesh-list
82846577|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
82846578|NCT00144170|Tipranavir|tipranavir|mesh-list
82846579|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
82846580|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82846581|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846582|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846583|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82846584|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82846585|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
82846586|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846587|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82846588|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82846589|NCT00255086|Memantine|memantine|mesh-list
82846590|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82846591|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82846592|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
82846593|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846594|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846595|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444022|NCT02312739|Lorazepam|lorazepam|mesh-list
82846596|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82846597|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82846599|NCT00110214|Bevacizumab|bevacizumab|mesh-list
82846600|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82846601|NCT00110214|Docetaxel|docetaxel|mesh-list
82846602|NCT00110214|Antibodies|antibodies|mesh-list
82846603|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
82846604|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82846605|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846606|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82846607|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82846608|NCT00110214|Growth Substances|growth substances|mesh-ancestor
82846609|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846610|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
82846611|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
82846612|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
82846613|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
82846614|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
82846615|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846616|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846617|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
82846618|NCT00110214|Hormones|hormones|mesh-ancestor
82846619|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846620|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82846621|NCT04176172|Nicotine|nicotine|mesh-list
82846622|NCT04176172|Varenicline|varenicline|mesh-list
82846623|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82846624|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
82846625|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846626|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846627|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82846628|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82846629|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
82846630|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846631|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846632|NCT03795844|Liver Extracts|liver extracts|mesh-list
82846633|NCT03795844|Hematinics|hematinics|mesh-ancestor
82846634|NCT05669170|Methylphenidate|methylphenidate|mesh-list
82846635|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82846636|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846637|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82846638|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82846639|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846640|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846641|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
82846642|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846643|NCT03799822|Vitamin K|vitamin k|mesh-list
82846644|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
82846645|NCT03799822|Vitamins|vitamins|mesh-ancestor
82846646|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
82846647|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846648|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82846649|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
82846650|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82846651|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
82846652|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846653|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846654|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
82846655|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82846656|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82846657|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
82846658|NCT03799822|Coagulants|coagulants|mesh-ancestor
82846659|NCT03799900|Ketamine|ketamine|mesh-list
82846660|NCT03799900|Analgesics|analgesics|mesh-ancestor
82846661|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
82846662|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846663|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846664|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82846665|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82846666|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
82846667|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
82846668|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846669|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82846670|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82846671|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846672|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846673|NCT05624866|Triamcinolone|triamcinolone|mesh-list
82846674|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
82846675|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82846676|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846677|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846678|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846679|NCT05624866|Analgesics|analgesics|mesh-ancestor
82846680|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
82846681|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846682|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82846683|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82846684|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82846685|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
82846686|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846687|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846688|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846689|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
82846690|NCT05624866|Hormones|hormones|mesh-ancestor
82846691|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846692|NCT01304602|Irinotecan|irinotecan|mesh-list
82846693|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82846694|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82846695|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846696|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846697|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846698|NCT01304134|Morphine|morphine|mesh-list
82846699|NCT01304134|Oxycodone|oxycodone|mesh-list
82846700|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82846701|NCT01304134|Narcotics|narcotics|mesh-ancestor
82846702|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846703|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846704|NCT01304134|Analgesics|analgesics|mesh-ancestor
82846705|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
82846707|NCT00124020|Vancomycin|vancomycin|mesh-list
82846708|NCT00124020|Telavancin|telavancin|mesh-list
82846709|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82846710|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846711|NCT05630794|TIC10 compound|tic10 compound|mesh-list
82846712|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846713|NCT01080846|Misoprostol|misoprostol|mesh-list
82846714|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82846715|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
82846716|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82846717|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846718|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82846719|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846720|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
82846721|NCT01076322|Albuterol|albuterol|mesh-list
82846722|NCT01076322|Procaterol|procaterol|mesh-list
82846723|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82846724|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
82846725|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846726|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846727|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82846728|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
82846729|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
82846730|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82846731|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82846732|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82846733|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82846734|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
82846735|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846736|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846737|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
82846738|NCT03966066|Erythromycin|erythromycin|mesh-list
82846739|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
82846740|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82846741|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
82846742|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82846743|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846744|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846745|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82846746|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846747|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846748|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82846749|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
82846750|NCT01304212|Ketorolac|ketorolac|mesh-list
82846751|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82846752|NCT01304212|Epinephrine|epinephrine|mesh-list
82846753|NCT01304212|Racepinephrine|racepinephrine|mesh-list
82846754|NCT01304212|Morphine|morphine|mesh-list
82846755|NCT01304212|Ropivacaine|ropivacaine|mesh-list
82846756|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
82846757|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82846758|NCT01304212|Narcotics|narcotics|mesh-ancestor
82846759|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846760|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846761|NCT01304212|Analgesics|analgesics|mesh-ancestor
82846762|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
82846763|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846764|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
82846765|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
82846766|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82846767|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82846768|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
82846769|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846770|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846771|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82846772|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82846773|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
82846774|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82846775|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
82846776|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
82846777|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
82846778|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82846779|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846780|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846781|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846783|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82846784|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846785|NCT00143390|Anastrozole|anastrozole|mesh-list
82846786|NCT00143390|Exemestane|exemestane|mesh-list
82846787|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82846788|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846789|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82846790|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82846791|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846792|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846793|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82846794|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
82846795|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846796|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846797|NCT03238534|Omeprazole|omeprazole|mesh-list
82846798|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82846799|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846800|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82846801|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846802|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846803|NCT00141102|Celecoxib|celecoxib|mesh-list
82846804|NCT00141102|Diclofenac|diclofenac|mesh-list
82846805|NCT00141102|Omeprazole|omeprazole|mesh-list
82846806|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846807|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846808|NCT00141102|Analgesics|analgesics|mesh-ancestor
82846809|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
82846810|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846811|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846812|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846813|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846814|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82846815|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82846816|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846817|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846818|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82846819|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82846820|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82846821|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82846822|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82846823|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846824|NCT01078428|Petrolatum|petrolatum|mesh-list
82846825|NCT01078428|Emollients|emollients|mesh-ancestor
82846826|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
82846827|NCT01081002|Lidocaine|lidocaine|mesh-list
82846828|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
82846829|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
82846830|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82846831|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846832|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
82846833|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846834|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82846835|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82846836|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82846837|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846838|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846839|NCT03789058|Ibuprofen|ibuprofen|mesh-list
82846840|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846841|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846842|NCT03789058|Analgesics|analgesics|mesh-ancestor
82846843|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
82846844|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846845|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846846|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846847|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846848|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82846849|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846850|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846851|NCT03788902|Methylphenidate|methylphenidate|mesh-list
82846852|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82846853|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846854|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82846855|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82846856|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846857|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846858|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
82846859|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82846860|NCT05669092|Capecitabine|capecitabine|mesh-list
82846861|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
82846862|NCT05669092|Irinotecan|irinotecan|mesh-list
82846863|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82846864|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82846865|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
82846866|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846867|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846868|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82846869|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82846870|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846871|NCT05669092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82846872|NCT00255008|Ribavirin|ribavirin|mesh-list
82846873|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82846874|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
82846875|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
82846876|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846877|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
82846878|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846879|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
82846880|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846881|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82846882|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
82846883|NCT03714022|Abatacept|abatacept|mesh-list
82846884|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82846885|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846886|NCT03714022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82846887|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846888|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82846889|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
82846890|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846891|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846892|NCT00143312|Voriconazole|voriconazole|mesh-list
82846893|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
82846894|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846895|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82846896|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82846897|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846898|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846899|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82846900|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
82846901|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846902|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846903|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82846904|NCT04833946|Andrographolide|andrographolide|mesh-list
82846905|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846906|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846907|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846908|NCT04833946|Analgesics|analgesics|mesh-ancestor
82846909|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
82846910|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846911|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846912|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846913|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82846914|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82846915|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82846916|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
82846917|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82846918|NCT01077206|Simvastatin|simvastatin|mesh-list
82846919|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82846920|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82846921|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
82846922|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846923|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82846924|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82846925|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846926|NCT05623540|Diphosphonates|diphosphonates|mesh-list
82846927|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82846929|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82846930|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
82846931|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82846932|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82846933|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
82846934|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846935|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846936|NCT01306318|Diclofenac|diclofenac|mesh-list
82846937|NCT01306318|Eperisone|eperisone|mesh-list
82846938|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846939|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846940|NCT01306318|Analgesics|analgesics|mesh-ancestor
82846941|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
82846942|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846943|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846944|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846945|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846946|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82846947|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846948|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846949|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
82846950|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82846951|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82846952|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82846953|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82846954|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82846955|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
82846956|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
82846957|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
82846958|NCT00254540|Sunitinib|sunitinib|mesh-list
82846959|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846960|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82846961|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82846962|NCT00254540|Growth Substances|growth substances|mesh-ancestor
82846963|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846964|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
82846965|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82846966|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846967|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846968|NCT01326494|Prednisone|prednisone|mesh-list
82846969|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846970|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
82846971|NCT01326494|Hormones|hormones|mesh-ancestor
82846972|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82846973|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846974|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82846975|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82846976|NCT05316220|Mesalamine|mesalamine|mesh-list
82846977|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82846978|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82846979|NCT05316220|Analgesics|analgesics|mesh-ancestor
82846980|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
82846981|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82846982|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82846983|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82846984|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82846985|NCT01305850|Losartan|losartan|mesh-list
82846986|NCT01305850|Enalapril|enalapril|mesh-list
82846987|NCT01305850|Enalaprilat|enalaprilat|mesh-list
82846988|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82846989|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82846990|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82846991|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82846992|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82846993|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82846994|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
82846995|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82846996|NCT01306630|Capecitabine|capecitabine|mesh-list
82846997|NCT01306630|Tivozanib|tivozanib|mesh-list
82846998|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82846999|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
83444064|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82847000|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847001|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847002|NCT01306630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847003|NCT01306630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847005|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82847006|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
82847007|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82847008|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82847009|NCT01306708|Analgesics|analgesics|mesh-ancestor
82847010|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
82847011|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847012|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847013|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82847014|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82847015|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847016|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847017|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
82847018|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847019|NCT03794518|Pioglitazone|pioglitazone|mesh-list
82847020|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82847021|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847022|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
82847023|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82847024|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847025|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82847026|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82847027|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847028|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847029|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847030|NCT03790540|Benzocaine|benzocaine|mesh-list
82847031|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
82847032|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
82847033|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847034|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847035|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
82847036|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847037|NCT03794596|Aspirin|aspirin|mesh-list
82847038|NCT03794596|Avelumab|avelumab|mesh-list
82847039|NCT03794596|Lansoprazole|lansoprazole|mesh-list
82847040|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
82847041|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82847042|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82847043|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82847044|NCT03794596|Analgesics|analgesics|mesh-ancestor
82847045|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
82847046|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847047|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847048|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847049|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847050|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82847051|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82847052|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847053|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82847054|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82847055|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847056|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
82847057|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82847058|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847059|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82847060|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82847061|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
82847062|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
82847063|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847064|NCT05571748|Protective Agents|protective agents|mesh-ancestor
82847065|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847066|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
82847067|NCT05571748|Vitamins|vitamins|mesh-ancestor
82847068|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
82847069|NCT03790618|Methamphetamine|methamphetamine|mesh-list
82847070|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82847071|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
82847072|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847073|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82847074|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
82847075|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847076|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847078|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82847079|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847080|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
82847081|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82847082|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
82847083|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
82847084|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847085|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
82847086|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82847087|NCT03790228|Carboplatin|carboplatin|mesh-list
82847088|NCT03790228|Pemetrexed|pemetrexed|mesh-list
82847089|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847090|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847091|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847092|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82847093|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847094|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
82847095|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
82847096|NCT01304836|Prednisolone|prednisolone|mesh-list
82847097|NCT01304836|Tacrolimus|tacrolimus|mesh-list
82847098|NCT01304836|Basiliximab|basiliximab|mesh-list
82847099|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847100|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
82847101|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847102|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82847103|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847104|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847105|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82847106|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847107|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82847108|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
82847109|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82847110|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847111|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847112|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
82847113|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
82847114|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847115|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82847116|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
82847117|NCT01304836|Hormones|hormones|mesh-ancestor
82847118|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847119|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82847120|NCT01304836|Protective Agents|protective agents|mesh-ancestor
82847121|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82847122|NCT01306864|Hemostatics|hemostatics|mesh-list
82847123|NCT01306864|Coagulants|coagulants|mesh-ancestor
82847124|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
82847125|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82847126|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847127|NCT03790384|Mitomycins|mitomycins|mesh-list
82847129|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
82847130|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82847131|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847132|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
82847133|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847134|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847135|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847136|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82847137|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
82847138|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847139|NCT01307488|Ritonavir|ritonavir|mesh-list
82847140|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82847141|NCT01307488|Lamivudine|lamivudine|mesh-list
82847142|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82847143|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82847144|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
82847145|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847146|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847147|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82847148|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82847149|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
82847150|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847151|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82847152|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82847153|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82847154|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847155|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
82847156|NCT03790072|Fludarabine|fludarabine|mesh-list
82847157|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847158|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
82847159|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847160|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847161|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82847162|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
82847163|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847164|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847165|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82847166|NCT01306006|Vaccines|vaccines|mesh-list
82847167|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
82847168|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847169|NCT03794440|Sorafenib|sorafenib|mesh-list
82847170|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847171|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847172|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847173|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847174|NCT00139776|Celecoxib|celecoxib|mesh-list
82847175|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82847176|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82847177|NCT00139776|Analgesics|analgesics|mesh-ancestor
82847178|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
82847179|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847180|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847181|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847182|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847183|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82847184|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82847185|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847186|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847187|NCT00413699|Tofacitinib|tofacitinib|mesh-list
82847188|NCT00413699|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82847189|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847190|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847191|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847192|NCT03713320|Vorinostat|vorinostat|mesh-list
82847193|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847194|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82847195|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847196|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847197|NCT03712930|Pamiparib|pamiparib|mesh-list
82847198|NCT03712930|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82847199|NCT03712930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847200|NCT03712930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847201|NCT03712930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847202|NCT00420407|Vasopressins|vasopressins|mesh-list
82847203|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
82847204|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
82847205|NCT00420407|Coagulants|coagulants|mesh-ancestor
82847206|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82847207|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82847208|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
82847209|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847210|NCT03789370|Propofol|propofol|mesh-list
82847211|NCT03789370|Sevoflurane|sevoflurane|mesh-list
82847212|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82847213|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847214|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847215|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82847216|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
82847217|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
82847218|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82847219|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82847220|NCT00420095|Insulin|insulin|mesh-list
82847221|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82847222|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
82847223|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82847224|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847225|NCT04904692|Dimercaprol|dimercaprol|mesh-list
82847227|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
82847228|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847229|NCT01038089|Resveratrol|resveratrol|mesh-list
82847230|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
82847231|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847232|NCT01038089|Protective Agents|protective agents|mesh-ancestor
82847233|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847234|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847235|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82847236|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
82847237|NCT05495464|Rituximab|rituximab|mesh-list
82847238|NCT05495464|Fludarabine|fludarabine|mesh-list
82847239|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
82847240|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
82847241|NCT05495464|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
82847242|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847243|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
82847244|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847245|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847246|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82847247|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
82847248|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847249|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847250|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82847251|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82847252|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82847253|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
82847254|NCT00419393|Levetiracetam|levetiracetam|mesh-list
82847255|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
82847256|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
82847257|NCT01038167|Cyclosporine|cyclosporine|mesh-list
82847258|NCT01038167|Tacrolimus|tacrolimus|mesh-list
82847259|NCT01038167|Cyclosporins|cyclosporins|mesh-list
82847260|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847261|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
82847262|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847263|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82847264|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847265|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847266|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
82847267|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847268|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
82847269|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847270|NCT03787030|Vitamin E|vitamin e|mesh-list
82847271|NCT03787030|Tocopherols|tocopherols|mesh-list
82847272|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
82847273|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
82847274|NCT03787030|Vitamins|vitamins|mesh-ancestor
82847275|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
82847276|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847277|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
82847278|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847279|NCT03787030|Protective Agents|protective agents|mesh-ancestor
82847280|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
82847281|NCT02174549|Tirapazamine|tirapazamine|mesh-list
82847282|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847283|NCT03786562|Morphine|morphine|mesh-list
82847284|NCT03786562|Nalbuphine|nalbuphine|mesh-list
82847285|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82847286|NCT03786562|Narcotics|narcotics|mesh-ancestor
82847287|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847288|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847289|NCT03786562|Analgesics|analgesics|mesh-ancestor
82847290|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
82847291|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847292|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
82847293|NCT05694364|Fludarabine|fludarabine|mesh-list
82847294|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847295|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
82847296|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847297|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847298|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82847299|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
82847300|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847301|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847302|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82847303|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
82847304|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82847305|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
82847306|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847307|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
82847308|NCT05694286|Protective Agents|protective agents|mesh-ancestor
82847309|NCT01305148|Warfarin|warfarin|mesh-list
82847310|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
82847311|NCT01305226|Streptokinase|streptokinase|mesh-list
82847312|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82847313|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82847314|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847315|NCT01308268|Ivermectin|ivermectin|mesh-list
82847316|NCT01308268|Albendazole|albendazole|mesh-list
82847317|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82847318|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847319|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
82847320|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
82847321|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82847322|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82847323|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
82847324|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
82847325|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
82847326|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847327|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847328|NCT01308346|Everolimus|everolimus|mesh-list
82847329|NCT01308346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82847330|NCT01308346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847331|NCT01308346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847332|NCT01308346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847333|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847334|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
82847335|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847336|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847337|NCT05694130|Prednisolone|prednisolone|mesh-list
82847338|NCT05694130|Tacrolimus|tacrolimus|mesh-list
82847339|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847340|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
82847341|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847342|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82847343|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847344|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847345|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847346|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
82847347|NCT05694130|Hormones|hormones|mesh-ancestor
82847348|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847349|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82847350|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847351|NCT00419159|Everolimus|everolimus|mesh-list
82847352|NCT00419159|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82847353|NCT00419159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847354|NCT00419159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847355|NCT00419159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847356|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847357|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
82847358|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847359|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847360|NCT03717064|Pitavastatin|pitavastatin|mesh-list
82847361|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82847362|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82847363|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82847364|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
82847365|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847366|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847367|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82847368|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
82847369|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
82847370|NCT02113163|Metformin|metformin|mesh-list
82847371|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
82847372|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82847373|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847374|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82847375|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82847376|NCT00413153|Ritonavir|ritonavir|mesh-list
82847377|NCT00413153|Lopinavir|lopinavir|mesh-list
82847378|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82847379|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82847380|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82847381|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
82847382|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847383|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847384|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82847385|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82847386|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
82847387|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847388|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82847389|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82847390|NCT02107937|Paclitaxel|paclitaxel|mesh-list
82847391|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82847392|NCT02107937|Carboplatin|carboplatin|mesh-list
82847393|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82847394|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847395|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
82847396|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
82847397|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
82847398|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847399|NCT01312402|Brinzolamide|brinzolamide|mesh-list
82847400|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82847401|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847402|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847403|NCT05693428|Propofol|propofol|mesh-list
82847404|NCT05693428|Sevoflurane|sevoflurane|mesh-list
82847405|NCT05693428|Isoflurane|isoflurane|mesh-list
82847406|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82847407|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847408|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847409|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82847410|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
82847411|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
82847412|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82847413|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82847414|NCT01035281|Nabilone|nabilone|mesh-list
82847415|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
82847416|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
82847417|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847418|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847419|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82847420|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82847421|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82847422|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847423|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82847424|NCT01561066|Octreotide|octreotide|mesh-list
82847425|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82847426|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82847427|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82847428|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847429|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
82847430|NCT01561066|Coagulants|coagulants|mesh-ancestor
82847431|NCT00419003|Lamotrigine|lamotrigine|mesh-list
82847432|NCT00419003|Ketamine|ketamine|mesh-list
82847433|NCT00419003|Riluzole|riluzole|mesh-list
82847434|NCT00419003|Analgesics|analgesics|mesh-ancestor
82847435|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
82847436|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847437|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847438|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82847439|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82847440|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
82847441|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
82847442|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847443|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82847444|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82847445|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847446|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847447|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
82847448|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82847449|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847450|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82847451|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82847452|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82847453|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82847454|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82847455|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82847456|NCT00419003|Protective Agents|protective agents|mesh-ancestor
82847457|NCT00418691|Methylphenidate|methylphenidate|mesh-list
82847459|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82847460|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847461|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82847462|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82847463|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847464|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847465|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
82847466|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847467|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82847468|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82847469|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82847470|NCT03781258|Warfarin|warfarin|mesh-list
82847471|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
82847472|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82847473|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82847474|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82847475|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847476|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847477|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82847478|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82847479|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82847480|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
82847481|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847482|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847483|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82847484|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82847485|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
82847486|NCT01308658|Ritonavir|ritonavir|mesh-list
82847487|NCT01308658|Darunavir|darunavir|mesh-list
82847488|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82847489|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82847490|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
82847491|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847492|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847493|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82847494|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82847495|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
82847496|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847497|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82847498|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82847499|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82847500|NCT03777514|Hematinics|hematinics|mesh-ancestor
82847501|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82847502|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82847503|NCT03777124|Carboplatin|carboplatin|mesh-list
82847504|NCT03777124|Pemetrexed|pemetrexed|mesh-list
82847505|NCT03777124|Apatinib|apatinib|mesh-list
82847506|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847507|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847508|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847509|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82847510|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847511|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847512|NCT00418379|Immunomodulating Agents|immunomodulating agents|mesh-list
82847513|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
82847514|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847515|NCT03780556|Lornoxicam|lornoxicam|mesh-list
82847516|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82847517|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82847518|NCT03780556|Analgesics|analgesics|mesh-ancestor
82847519|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
82847520|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847521|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847522|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847523|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847524|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
82847525|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82847526|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82847527|NCT00418145|Prednisolone|prednisolone|mesh-list
82847528|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
82847529|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82847530|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
82847532|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
82847533|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
82847534|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847535|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847536|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82847537|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
82847539|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847540|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82847541|NCT00418145|Protective Agents|protective agents|mesh-ancestor
82847542|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82847543|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847544|NCT03780634|Sorafenib|sorafenib|mesh-list
82847545|NCT03780634|Antibodies|antibodies|mesh-list
82847546|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
82847547|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
82847548|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847549|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847550|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847551|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847552|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847553|NCT03777280|Cobalt|cobalt|mesh-list
82847554|NCT03777280|Chromium|chromium|mesh-list
82847555|NCT03777280|Trace Elements|trace elements|mesh-ancestor
82847556|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
82847557|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847558|NCT02043587|Leucovorin|leucovorin|mesh-list
82847559|NCT02043587|Cytarabine|cytarabine|mesh-list
82847560|NCT02043587|Prednisone|prednisone|mesh-list
82847561|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
82847562|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82847563|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82847564|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82847565|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
82847566|NCT02043587|Rituximab|rituximab|mesh-list
82847567|NCT02043587|Methotrexate|methotrexate|mesh-list
82847568|NCT02043587|Etoposide|etoposide|mesh-list
82847569|NCT02043587|Vincristine|vincristine|mesh-list
82847570|NCT02043587|Daunorubicin|daunorubicin|mesh-list
82847571|NCT02043587|Asparaginase|asparaginase|mesh-list
82847572|NCT02043587|Dasatinib|dasatinib|mesh-list
82847573|NCT02043587|Pegaspargase|pegaspargase|mesh-list
82847574|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847575|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
82847576|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847577|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847578|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82847579|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
82847580|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847581|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847582|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82847583|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82847584|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847585|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
82847586|NCT02043587|Hormones|hormones|mesh-ancestor
82847587|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847588|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82847589|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82847590|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
82847591|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82847592|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82847593|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
82847594|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
82847595|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847596|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82847597|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847598|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82847599|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82847600|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82847601|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
82847602|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847604|NCT02043587|Protective Agents|protective agents|mesh-ancestor
82847605|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
82847606|NCT02043587|Vitamins|vitamins|mesh-ancestor
82847607|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
82847610|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
82847611|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82847612|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847613|NCT01561222|Calcitriol|calcitriol|mesh-list
82847614|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82847615|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847616|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82847617|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847618|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847619|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82847620|NCT01561222|Vitamins|vitamins|mesh-ancestor
82847621|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
82847622|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82847623|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
82847624|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
82847625|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82847626|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82847627|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
82847628|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847629|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847630|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847631|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
82847632|NCT01039025|Melphalan|melphalan|mesh-list
82847633|NCT01039025|Topotecan|topotecan|mesh-list
82847634|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847635|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
82847636|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847637|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847638|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82847639|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
82847640|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847641|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847642|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82847643|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82847644|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82847645|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847646|NCT03779776|Vitamins|vitamins|mesh-list
82847647|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
82847648|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847649|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82847650|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847651|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847652|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847653|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847654|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82847655|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82847656|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847657|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
82847658|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847659|NCT01317784|Antibodies|antibodies|mesh-list
82847660|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
82847661|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
82847662|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
82847663|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847664|NCT03779464|Gemcitabine|gemcitabine|mesh-list
82847665|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82847666|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
82847667|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847668|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847669|NCT01309126|Cetuximab|cetuximab|mesh-list
82847670|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82847671|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847672|NCT03784378|Agerafenib|agerafenib|mesh-list
82847673|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847674|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847675|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847676|NCT01314898|Spironolactone|spironolactone|mesh-list
82847677|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82847678|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
82847679|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847680|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847681|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82847682|NCT01314898|Diuretics|diuretics|mesh-ancestor
82847683|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
82847684|NCT01315912|Letrozole|letrozole|mesh-list
82847685|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847686|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82847687|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82847688|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847689|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847690|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82847691|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
82847692|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847693|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847694|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
82847695|NCT03778450|Analgesics|analgesics|mesh-list
82847696|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
82847697|NCT03778450|Narcotics|narcotics|mesh-ancestor
82847698|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847699|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847700|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
82847701|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847702|NCT03776500|Macozinone|macozinone|mesh-list
82847703|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
82847704|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82847705|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847706|NCT03778138|Pemetrexed|pemetrexed|mesh-list
82847707|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847708|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847709|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847710|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82847711|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847712|NCT03783754|Amlodipine|amlodipine|mesh-list
82847713|NCT03783754|Telmisartan|telmisartan|mesh-list
82847714|NCT03783754|Indapamide|indapamide|mesh-list
82847715|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82847716|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82847717|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847718|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847719|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82847720|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847721|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
83444111|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847722|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82847723|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82847724|NCT03783754|Diuretics|diuretics|mesh-ancestor
82847725|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
82847726|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82847727|NCT01309438|Erythromycin|erythromycin|mesh-list
82847728|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
82847729|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82847730|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
82847731|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
82847732|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82847733|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
82847734|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82847735|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
82847736|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847737|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847738|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
82847739|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82847740|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847741|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82847742|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82847743|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
82847744|NCT03776032|Hematinics|hematinics|mesh-ancestor
82847745|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
82847746|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847747|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
82847748|NCT03775876|Propofol|propofol|mesh-list
82847749|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82847750|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847751|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847752|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82847753|NCT03775876|Analgesics|analgesics|mesh-ancestor
82847755|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847756|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82847757|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82847759|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
82847760|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847761|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847762|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82847763|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
82847764|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
82847765|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82847766|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
82847767|NCT01320514|Coagulants|coagulants|mesh-ancestor
82847768|NCT03773536|Artesunate|artesunate|mesh-list
82847769|NCT03773536|Primaquine|primaquine|mesh-list
82847770|NCT03773536|Amodiaquine|amodiaquine|mesh-list
82847771|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
82847772|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82847773|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82847774|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847775|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847776|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
82847777|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
82847778|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82847779|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
82847780|NCT01320592|Paclitaxel|paclitaxel|mesh-list
82847781|NCT01320592|Palbociclib|palbociclib|mesh-list
82847782|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82847783|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847784|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
82847785|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
82847786|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
82847787|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847788|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847789|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847790|NCT03783676|Remifentanil|remifentanil|mesh-list
82847791|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82847792|NCT03783676|Narcotics|narcotics|mesh-ancestor
82847793|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847794|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847795|NCT03783676|Analgesics|analgesics|mesh-ancestor
82847796|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
82847797|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847798|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82847799|NCT03783520|Eusol|eusol|mesh-list
82847800|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
82847801|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847802|NCT01320982|Aspirin|aspirin|mesh-list
82847803|NCT01320982|Minocycline|minocycline|mesh-list
82847804|NCT01320982|Pramipexole|pramipexole|mesh-list
82847805|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82847806|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82847807|NCT01320982|Analgesics|analgesics|mesh-ancestor
82847808|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
82847809|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847810|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847811|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847812|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82847813|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82847814|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82847815|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847816|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82847817|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82847819|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
82847820|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82847821|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847822|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
82847823|NCT01320982|Protective Agents|protective agents|mesh-ancestor
82847824|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82847825|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82847826|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
82847827|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
82847828|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847829|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
82847830|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82847832|NCT01321138|Morphine|morphine|mesh-list
82847833|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82847834|NCT01321138|Narcotics|narcotics|mesh-ancestor
82847835|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847836|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847837|NCT01321138|Analgesics|analgesics|mesh-ancestor
82847838|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
82847839|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847840|NCT04628572|Ceftazidime|ceftazidime|mesh-list
82847841|NCT04628572|Avibactam|avibactam|mesh-list
82847842|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
82847843|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82847844|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847845|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82847846|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847847|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847848|NCT03772990|Calcium|calcium|mesh-list
82847849|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82847850|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847851|NCT03782662|Itraconazole|itraconazole|mesh-list
82847852|NCT03782662|Rifampin|rifampin|mesh-list
82847853|NCT03782662|Verapamil|verapamil|mesh-list
82847854|NCT03782662|Midazolam|midazolam|mesh-list
82847855|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82847856|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82847857|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847858|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847859|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82847860|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82847861|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82847862|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82847863|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
82847864|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
82847865|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
82847866|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
82847867|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847868|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847869|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
82847870|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847871|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82847872|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82847873|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847874|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82847875|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
82847876|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847877|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82847878|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82847879|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
82847880|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82847881|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
82847882|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847883|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82847884|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82847885|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82847886|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82847887|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82847888|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82847889|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82847890|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82847891|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847892|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82847893|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
82847894|NCT01309984|Propofol|propofol|mesh-list
82847895|NCT01309984|Fospropofol|fospropofol|mesh-list
82847896|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82847897|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847898|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847899|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82847900|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
82847901|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
82847902|NCT03772054|Propofol|propofol|mesh-list
82847903|NCT03772054|Sevoflurane|sevoflurane|mesh-list
82847904|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82847905|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847906|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847907|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82847908|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
82847910|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82847911|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82847912|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
82847913|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82847914|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847915|NCT03771820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82847916|NCT03771820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847917|NCT05531890|Betamethasone|betamethasone|mesh-list
82847918|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
82847919|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82847920|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
82847921|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82847922|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82847923|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82847924|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
82847925|NCT05531890|Hormones|hormones|mesh-ancestor
82847926|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82847927|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847928|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82847929|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
82847930|NCT00123474|Dasatinib|dasatinib|mesh-list
82847931|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847932|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847933|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847934|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847935|NCT00142298|Telbivudine|telbivudine|mesh-list
82847936|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
82847937|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82847938|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82847939|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847940|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847941|NCT03774706|Misoprostol|misoprostol|mesh-list
82847942|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
82847943|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82847944|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82847945|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847946|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
82847947|NCT03774706|Coagulants|coagulants|mesh-ancestor
82847948|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82847949|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
82847950|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82847951|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847952|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82847953|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82847954|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
82847955|NCT03967496|Metformin|metformin|mesh-list
82847956|NCT03967496|Amlodipine|amlodipine|mesh-list
82847957|NCT03967496|Lisinopril|lisinopril|mesh-list
82847958|NCT03967496|Bisoprolol|bisoprolol|mesh-list
82847959|NCT03967496|Hydralazine|hydralazine|mesh-list
82847960|NCT03967496|Anesthetics|anesthetics|mesh-list
82847961|NCT03967496|Atorvastatin|atorvastatin|mesh-list
82847962|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82847963|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847964|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82847965|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82847966|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82847967|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
82847968|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847969|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82847970|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82847971|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847972|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82847973|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82847974|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82847975|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82847976|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
82847977|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82847978|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
82847980|NCT03967496|Protective Agents|protective agents|mesh-ancestor
82847981|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
82847982|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
82847983|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82847984|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82847985|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82847986|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82847987|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
82847988|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82847989|NCT00412061|Everolimus|everolimus|mesh-list
82847990|NCT00412061|Octreotide|octreotide|mesh-list
82847991|NCT00412061|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82847992|NCT00412061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82847993|NCT00412061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82847994|NCT00412061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82847995|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82847996|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
82847997|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82847998|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82847999|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848000|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82848001|NCT03964350|Ethanol|ethanol|mesh-list
82848002|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82848003|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848004|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848005|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848006|NCT01310452|Insulin|insulin|mesh-list
82848007|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82848008|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
82848009|NCT01310452|Protamines|protamines|mesh-list
82848010|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848011|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848012|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
82848013|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848014|NCT01310452|Coagulants|coagulants|mesh-ancestor
82848015|NCT01035671|Vitamin E|vitamin e|mesh-list
82848016|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
82848017|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
82848018|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82848019|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
82848020|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848021|NCT01035671|Protective Agents|protective agents|mesh-ancestor
82848022|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848023|NCT01035671|Vitamins|vitamins|mesh-ancestor
82848024|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
82848025|NCT04560868|Nicotine|nicotine|mesh-list
82848026|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82848027|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
82848028|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848029|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848030|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82848031|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82848032|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
82848033|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848034|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848035|NCT03769714|Bupivacaine|bupivacaine|mesh-list
82848036|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
82848037|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
82848038|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848039|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848040|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
82848041|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848042|NCT03769402|Citric Acid|citric acid|mesh-list
82848043|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
82848044|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
82848045|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82848046|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
82848047|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
82848048|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848049|NCT00411671|Sorafenib|sorafenib|mesh-list
82848050|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848051|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848052|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848053|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848054|NCT01035983|Frovatriptan|frovatriptan|mesh-list
82848057|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848058|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848059|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848060|NCT03770806|Acetaminophen|acetaminophen|mesh-list
82848061|NCT03770806|Celecoxib|celecoxib|mesh-list
82848062|NCT03770806|Oxycodone|oxycodone|mesh-list
82848063|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82848064|NCT03770806|Analgesics|analgesics|mesh-ancestor
82848065|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
82848066|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848067|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848068|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
82848069|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82848070|NCT03770806|Narcotics|narcotics|mesh-ancestor
82848071|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848072|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82848073|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848074|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848075|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82848076|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82848077|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848078|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848079|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
82848080|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82848081|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82848082|NCT01039103|Prednisolone|prednisolone|mesh-list
82848083|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
82848084|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82848085|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
82848086|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848087|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
82848088|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
82848089|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848090|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83444132|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
82848091|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848092|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
82848093|NCT01039103|Hormones|hormones|mesh-ancestor
82848094|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848095|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82848096|NCT01039103|Protective Agents|protective agents|mesh-ancestor
82848097|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82848098|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848099|NCT01039181|Vitamin D|vitamin d|mesh-list
82848100|NCT01039181|Calcitriol|calcitriol|mesh-list
82848101|NCT01039181|Vitamins|vitamins|mesh-ancestor
82848102|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
82848103|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848104|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82848105|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82848106|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82848107|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82848108|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848109|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82848110|NCT03770026|Clomiphene|clomiphene|mesh-list
82848111|NCT03770026|Enclomiphene|enclomiphene|mesh-list
82848112|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
82848113|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82848114|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
82848115|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848116|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848117|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82848118|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
82848119|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82848120|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82848121|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82848122|NCT03769870|Atorvastatin|atorvastatin|mesh-list
82848123|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82848124|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82848125|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
82848126|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848127|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82848128|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82848130|NCT01589081|Nicotine|nicotine|mesh-list
82848131|NCT01589081|Progesterone|progesterone|mesh-list
82848132|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82848133|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
82848134|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848135|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848136|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82848137|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82848138|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
82848139|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848140|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848141|NCT01589081|Progestins|progestins|mesh-ancestor
82848142|NCT01589081|Hormones|hormones|mesh-ancestor
82848143|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848144|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82848145|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848146|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848147|NCT01567540|Incretins|incretins|mesh-ancestor
82848148|NCT01567540|Hormones|hormones|mesh-ancestor
82848149|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848150|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82848151|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
82848152|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848153|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848154|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82848155|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
82848156|NCT01036841|Coagulants|coagulants|mesh-ancestor
82848157|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82848158|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
82848159|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848160|NCT03709576|Azacitidine|azacitidine|mesh-list
82848161|NCT03709576|Pevonedistat|pevonedistat|mesh-list
82848162|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848163|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
82848164|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848165|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848166|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848167|NCT00122460|Cisplatin|cisplatin|mesh-list
82848168|NCT00122460|Carboplatin|carboplatin|mesh-list
82848169|NCT00122460|Fluorouracil|fluorouracil|mesh-list
82848170|NCT00122460|Cetuximab|cetuximab|mesh-list
82848171|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848172|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
82848173|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848174|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848175|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848176|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
82848177|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848178|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848179|NCT03763396|Ketoconazole|ketoconazole|mesh-list
82848180|NCT03763396|Posaconazole|posaconazole|mesh-list
82848181|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
82848182|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848183|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82848184|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82848185|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848186|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848187|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82848188|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
82848189|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848190|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848191|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82848192|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82848193|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82848194|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82848195|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
82848196|NCT01320436|Curcumin|curcumin|mesh-list
82848197|NCT01320436|Mesalamine|mesalamine|mesh-list
82848198|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82848199|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82848200|NCT01320436|Analgesics|analgesics|mesh-ancestor
82848201|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
82848203|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848204|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848205|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848206|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848207|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848208|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848209|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
82848210|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82848211|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848212|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
82848213|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848214|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848215|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848216|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848217|NCT03763084|Acetaminophen|acetaminophen|mesh-list
82848218|NCT03763084|Sufentanil|sufentanil|mesh-list
82848219|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82848220|NCT03763084|Analgesics|analgesics|mesh-ancestor
82848221|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
82848222|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848223|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848224|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
82848225|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82848226|NCT03763084|Narcotics|narcotics|mesh-ancestor
82848227|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848228|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82848229|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82848230|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
82848231|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
82848232|NCT01567618|Docetaxel|docetaxel|mesh-list
82848233|NCT01567618|Fluorouracil|fluorouracil|mesh-list
82848234|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848235|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
82848236|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
82848237|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
82848238|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848239|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
82848240|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848241|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848242|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
82848243|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848244|NCT04771078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
82848245|NCT04771078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848246|NCT04771078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848247|NCT03762928|Efavirenz|efavirenz|mesh-list
82848248|NCT03762928|Midazolam|midazolam|mesh-list
82848249|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82848250|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82848251|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848252|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848253|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82848254|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82848255|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82848256|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82848257|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
82848258|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
82848259|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
82848260|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
82848261|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848262|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848263|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82848264|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82848265|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848266|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
82848267|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848268|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82848269|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82848270|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82848271|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82848273|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82848274|NCT01561456|Docetaxel|docetaxel|mesh-list
82848275|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848276|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
82848277|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
82848278|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
82848279|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848280|NCT00137436|Prednisone|prednisone|mesh-list
82848281|NCT00137436|Docetaxel|docetaxel|mesh-list
82848282|NCT00137436|Sunitinib|sunitinib|mesh-list
82848283|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848284|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
82848285|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
82848286|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
82848287|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848288|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848289|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
82848290|NCT00137436|Hormones|hormones|mesh-ancestor
82848291|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848292|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848293|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82848294|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82848295|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82848296|NCT00137436|Growth Substances|growth substances|mesh-ancestor
82848297|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
82848298|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848299|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848300|NCT03762538|Propofol|propofol|mesh-list
82848301|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82848302|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848303|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848304|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82848305|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
82848306|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
82848307|NCT03762382|Tenofovir|tenofovir|mesh-list
82848308|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
82848309|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
82848310|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848311|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82848312|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82848313|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848314|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848315|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82848316|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82848317|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82848318|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
82848319|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82848320|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848321|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82848322|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82848323|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82848324|NCT03767920|Dexamethasone|dexamethasone|mesh-list
82848325|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
82848326|NCT03767920|Bupivacaine|bupivacaine|mesh-list
82848327|NCT03767920|BB 1101|bb 1101|mesh-list
82848328|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848329|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
82848330|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
82848331|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848332|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848333|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848334|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
82848335|NCT03767920|Hormones|hormones|mesh-ancestor
82848336|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848337|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82848338|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848339|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
82848340|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848341|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848342|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
82848343|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
82848344|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848345|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
82848346|NCT03834623|Nivolumab|nivolumab|mesh-list
82848347|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848348|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848349|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82848350|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848353|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
82848354|NCT03762148|Iron|iron|mesh-list
82848355|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
82848356|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848357|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
82848358|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848359|NCT03762148|Protective Agents|protective agents|mesh-ancestor
82848360|NCT03762148|Trace Elements|trace elements|mesh-ancestor
82848361|NCT01589159|Capecitabine|capecitabine|mesh-list
82848362|NCT01589159|Etoposide|etoposide|mesh-list
82848363|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848364|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
82848365|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848366|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848367|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82848368|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82848369|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82848370|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848371|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82848372|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848373|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
82848374|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848375|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848376|NCT03937895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82848377|NCT03937895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848378|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
82848379|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82848380|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848381|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848382|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82848383|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82848384|NCT03625648|Protective Agents|protective agents|mesh-ancestor
82848385|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848386|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
82848387|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82848388|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
82848389|NCT03767296|Phenylephrine|phenylephrine|mesh-list
82848390|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
82848391|NCT03767296|Ephedrine|ephedrine|mesh-list
82848392|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
82848393|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82848394|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
82848395|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
82848396|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848397|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848398|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
82848399|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82848400|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
82848401|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
82848402|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82848403|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82848404|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82848405|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
82848406|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848407|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848408|NCT03767296|Protective Agents|protective agents|mesh-ancestor
82848409|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82848410|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82848411|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82848412|NCT00410813|Dasatinib|dasatinib|mesh-list
82848413|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848414|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848415|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848416|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848417|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
82848418|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82848419|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848420|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848421|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82848422|NCT03760978|Analgesics|analgesics|mesh-ancestor
82848423|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
82848424|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848425|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82848427|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82848428|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
82848429|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848430|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848431|NCT03766984|Diclofenac|diclofenac|mesh-list
82848432|NCT03766984|Tramadol|tramadol|mesh-list
82848433|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82848434|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82848435|NCT03766984|Analgesics|analgesics|mesh-ancestor
82848436|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
82848437|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848438|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848439|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848440|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848441|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82848442|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848443|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848444|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82848445|NCT03766984|Narcotics|narcotics|mesh-ancestor
82848446|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848447|NCT00405821|Acyclovir|acyclovir|mesh-list
82848448|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
82848449|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848450|NCT03928600|Misoprostol|misoprostol|mesh-list
82848451|NCT03928600|Dinoprostone|dinoprostone|mesh-list
82848452|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82848453|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
82848454|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82848455|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848456|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82848457|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848458|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
82848459|NCT03924856|Gemcitabine|gemcitabine|mesh-list
82848460|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
82848461|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848462|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848463|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
82848464|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848465|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848466|NCT03924856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82848467|NCT03760822|Paclitaxel|paclitaxel|mesh-list
82848468|NCT03760822|Ramucirumab|ramucirumab|mesh-list
82848469|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82848470|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848471|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
82848472|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
82848473|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
82848474|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848475|NCT01322152|Capecitabine|capecitabine|mesh-list
82848476|NCT01322152|Irinotecan|irinotecan|mesh-list
82848477|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848478|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
82848479|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848480|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848481|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82848482|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82848483|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848484|NCT01446016|Paclitaxel|paclitaxel|mesh-list
82848485|NCT01446016|Docetaxel|docetaxel|mesh-list
82848486|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82848487|NCT01446016|Taxane|taxane|mesh-list
82848488|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82848489|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848490|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
82848491|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
82848492|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
82848493|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848494|NCT00137046|Insulin|insulin|mesh-list
82848495|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82848496|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848497|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848499|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848500|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848502|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848503|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
82848504|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82848505|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82848506|NCT03760354|Prednisolone|prednisolone|mesh-list
82848507|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
82848508|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82848509|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
82848510|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848511|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
82848512|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
82848513|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848514|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848515|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848516|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
82848517|NCT03760354|Hormones|hormones|mesh-ancestor
82848518|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848519|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82848520|NCT03760354|Protective Agents|protective agents|mesh-ancestor
82848521|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82848522|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848523|NCT03760276|Voriconazole|voriconazole|mesh-list
82848524|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
82848525|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848526|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82848527|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82848528|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848529|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848530|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82848531|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
82848532|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848533|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848534|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82848535|NCT03766594|Folic Acid|folic acid|mesh-list
82848536|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
82848537|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848538|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
82848539|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82848540|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82848541|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848542|NCT03766594|Urological Agents|urological agents|mesh-ancestor
82848543|NCT03766594|Hematinics|hematinics|mesh-ancestor
82848544|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
82848545|NCT03766594|Vitamins|vitamins|mesh-ancestor
82848546|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
82848547|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848548|NCT03923374|Buprenorphine|buprenorphine|mesh-list
82848549|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82848550|NCT03923374|Narcotics|narcotics|mesh-ancestor
82848551|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848552|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848553|NCT03923374|Analgesics|analgesics|mesh-ancestor
82848554|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
82848555|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848556|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82848557|NCT00122382|Methotrexate|methotrexate|mesh-list
82848558|NCT00122382|Abatacept|abatacept|mesh-list
82848559|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82848560|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
82848561|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82848562|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848563|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848564|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
82848565|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848566|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848567|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
82848568|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848569|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82848570|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848571|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
82848572|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848573|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82848574|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82848575|NCT00122382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848576|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
82848577|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
82848578|NCT01028716|Fludarabine|fludarabine|mesh-list
82848579|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
82848580|NCT01028716|Tacrolimus|tacrolimus|mesh-list
82848581|NCT01028716|Lenograstim|lenograstim|mesh-list
82848582|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848583|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
82848584|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848585|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848586|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82848587|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
82848588|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848589|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848590|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82848591|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82848592|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
82848593|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82848594|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82848595|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848596|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82848597|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82848598|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
82848599|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82848600|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848601|NCT02531724|Simendan|simendan|mesh-list
82848602|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82848603|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
82848604|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82848605|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82848606|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848607|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848608|NCT02531724|Protective Agents|protective agents|mesh-ancestor
82848609|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848610|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82848611|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82848612|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848613|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848614|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82848615|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82848616|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848617|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
82848618|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848619|NCT00106704|Pioglitazone|pioglitazone|mesh-list
82848620|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82848621|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848622|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848623|NCT00106704|Incretins|incretins|mesh-ancestor
82848624|NCT00106704|Hormones|hormones|mesh-ancestor
82848625|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848626|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82848627|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
82848628|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848629|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848630|NCT03759886|Metronidazole|metronidazole|mesh-list
82848631|NCT03759886|Paromomycin|paromomycin|mesh-list
82848632|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848633|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82848634|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82848635|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82848636|NCT01081158|Ritonavir|ritonavir|mesh-list
82848637|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82848638|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
82848639|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82848640|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82848641|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
82848642|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848643|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848644|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82848645|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82848646|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
82848648|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82848650|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
82848651|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848652|NCT00105066|Metformin|metformin|mesh-list
82848653|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848654|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848655|NCT01322308|Pioglitazone|pioglitazone|mesh-list
82848656|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848657|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848658|NCT05208268|Rabeprazole|rabeprazole|mesh-list
82848659|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82848660|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848661|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82848662|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848663|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848664|NCT03165292|Topotecan|topotecan|mesh-list
82848665|NCT03165292|Thiotepa|thiotepa|mesh-list
82848666|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82848667|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82848668|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848669|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848670|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848671|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82848672|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
82848673|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82848674|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848675|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
82848676|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848677|NCT03759262|Vitamin D|vitamin d|mesh-list
82848678|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
82848679|NCT03759262|Vitamins|vitamins|mesh-ancestor
82848680|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
82848681|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848682|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82848683|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82848684|NCT00135330|Exenatide|exenatide|mesh-list
82848685|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
82848686|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848687|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848688|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82848689|NCT00135330|Incretins|incretins|mesh-ancestor
82848690|NCT00135330|Hormones|hormones|mesh-ancestor
82848691|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82848692|NCT01076478|Cilostazol|cilostazol|mesh-list
82848693|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82848694|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
82848695|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848696|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848697|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82848698|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
82848699|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82848700|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82848701|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848702|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82848703|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
82848704|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82848705|NCT01076478|Protective Agents|protective agents|mesh-ancestor
82848706|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82848707|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82848708|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848709|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
82848710|NCT01076556|Rituximab|rituximab|mesh-list
82848711|NCT01076556|Alvocidib|alvocidib|mesh-list
82848712|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82848713|NCT01076556|Antibodies|antibodies|mesh-list
82848714|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
82848715|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82848716|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848717|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
82848718|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848719|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848720|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82848721|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
82848722|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848723|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848724|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82848725|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
82848726|NCT01076556|Growth Substances|growth substances|mesh-ancestor
82848727|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848728|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848729|NCT03965442|Esmolol|esmolol|mesh-list
82848730|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82848731|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82848732|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82848733|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
82848734|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848735|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848736|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848737|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
82848738|NCT00134082|Rituximab|rituximab|mesh-list
82848739|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848740|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
82848741|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848742|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848743|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82848744|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
82848745|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848746|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848747|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82848748|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848749|NCT03765346|Oxycodone|oxycodone|mesh-list
82848750|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82848751|NCT03765346|Narcotics|narcotics|mesh-ancestor
82848752|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848753|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848754|NCT03765346|Analgesics|analgesics|mesh-ancestor
82848755|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
82848756|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848757|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
82848758|NCT01078818|Trace Elements|trace elements|mesh-ancestor
82848759|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
82848760|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848761|NCT01079052|Famotidine|famotidine|mesh-list
82848762|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82848763|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848764|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82848765|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
82848766|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
82848767|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848768|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848769|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848770|NCT01326468|Sirolimus|sirolimus|mesh-list
82848771|NCT01326468|Cisplatin|cisplatin|mesh-list
82848772|NCT01326468|Cetuximab|cetuximab|mesh-list
82848773|NCT01326468|Temsirolimus|temsirolimus|mesh-list
82848774|NCT01326468|MTOR Inhibitors|mtor inhibitors|mesh-list
82848775|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848776|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848777|NCT01326468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848778|NCT01326468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848779|NCT01326468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848780|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848781|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
82848782|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848783|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82848784|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848785|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82848786|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
82848787|NCT01076634|Insulin|insulin|mesh-list
82848788|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82848789|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
82848790|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848791|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848792|NCT00132678|Risperidone|risperidone|mesh-list
82848793|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82848794|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
82848795|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848796|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848797|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848798|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82848799|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82848800|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848802|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82848803|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
82848804|NCT01081548|Atorvastatin|atorvastatin|mesh-list
82848805|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82848806|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82848807|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
82848808|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848809|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82848810|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82848811|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848812|NCT00101400|Sorafenib|sorafenib|mesh-list
82848813|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848814|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848815|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848816|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848817|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
82848818|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82848819|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848820|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848821|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82848822|NCT01076790|Analgesics|analgesics|mesh-ancestor
82848823|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
82848824|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848825|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82848826|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82848827|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82848828|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
82848829|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848830|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848831|NCT01582932|Calcipotriene|calcipotriene|mesh-list
82848832|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
82848833|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
82848834|NCT03965286|Ledipasvir|ledipasvir|mesh-list
82848835|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83444149|NCT02368431|Zonisamide|zonisamide|mesh-list
82848836|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
82848837|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848838|NCT01079286|Sirolimus|sirolimus|mesh-list
82848839|NCT01079286|Nelfinavir|nelfinavir|mesh-list
82848840|NCT01079286|Temsirolimus|temsirolimus|mesh-list
82848841|NCT01079286|MTOR Inhibitors|mtor inhibitors|mesh-list
82848842|NCT01079286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848843|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848844|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848845|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848846|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
82848847|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848848|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848849|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82848850|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848851|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82848852|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
82848853|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82848854|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82848855|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
82848856|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82848857|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82848858|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
82848859|NCT01081704|Ustekinumab|ustekinumab|mesh-list
82848860|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
82848861|NCT00141518|Levodopa|levodopa|mesh-list
82848862|NCT00141518|Carbidopa|carbidopa|mesh-list
82848863|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82848864|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82848865|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82848866|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
82848867|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848868|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848869|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848870|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82848871|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848872|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82848873|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
82848874|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
82848875|NCT01075880|Interferons|interferons|mesh-list
82848877|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
82848878|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848879|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
82848880|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848881|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
82848882|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848883|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82848884|NCT00098748|Maraviroc|maraviroc|mesh-list
82848885|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82848886|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82848887|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848888|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82848889|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82848890|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
82848891|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82848892|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82848893|NCT00130520|Bevacizumab|bevacizumab|mesh-list
82848894|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82848895|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848896|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848897|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82848898|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82848899|NCT00130520|Growth Substances|growth substances|mesh-ancestor
82848900|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848901|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
82848902|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848903|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848904|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848905|NCT00130442|Dacarbazine|dacarbazine|mesh-list
82848906|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82848907|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
82848908|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848909|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848910|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
82848911|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
82848912|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82848913|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
82848914|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848915|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82848916|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82848917|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82848918|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82848919|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848920|NCT00253370|Cisplatin|cisplatin|mesh-list
82848921|NCT00253370|Docetaxel|docetaxel|mesh-list
82848922|NCT00253370|Sorafenib|sorafenib|mesh-list
82848923|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848924|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
82848925|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
82848926|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
82848927|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848928|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82848929|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82848930|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
82848931|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
82848932|NCT00140426|Risperidone|risperidone|mesh-list
82848933|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82848934|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
82848935|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848936|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848937|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848938|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82848939|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82848940|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82848941|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82848942|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82848943|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
82848944|NCT03966560|Timolol|timolol|mesh-list
82848945|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82848946|NCT03966560|Bimatoprost|bimatoprost|mesh-list
82848947|NCT03966560|Travoprost|travoprost|mesh-list
82848948|NCT03966560|Dorzolamide|dorzolamide|mesh-list
82848949|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82848950|NCT03966560|Latanoprost|latanoprost|mesh-list
82848951|NCT03966560|Brinzolamide|brinzolamide|mesh-list
82848954|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848955|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82848956|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82848957|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
82848958|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82848959|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848960|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82848961|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82848962|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82848963|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82848964|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82848965|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82848966|NCT01072058|Adalimumab|adalimumab|mesh-list
82848967|NCT01072058|Infliximab|infliximab|mesh-list
82848968|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
82848969|NCT01072058|Etanercept|etanercept|mesh-list
82848970|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82848971|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848972|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
82848973|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82848974|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82848975|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82848976|NCT01072058|Analgesics|analgesics|mesh-ancestor
82848977|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
82848978|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82848979|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848980|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848981|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
82848982|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
82848983|NCT00121134|Bevacizumab|bevacizumab|mesh-list
82848984|NCT00121134|Capecitabine|capecitabine|mesh-list
82848985|NCT00121134|Methotrexate|methotrexate|mesh-list
82848986|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82848987|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
82848988|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82848989|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82848990|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82848991|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
82848992|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82848993|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82848994|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82848995|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82848996|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82848997|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82848998|NCT00121134|Growth Substances|growth substances|mesh-ancestor
82848999|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
82849000|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849001|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
82849002|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82849003|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
82849004|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82849005|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
82849006|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849007|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82849008|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82849009|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
82849010|NCT03966378|Calcium|calcium|mesh-list
82849011|NCT03966378|Caseins|caseins|mesh-list
82849012|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82849013|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849014|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
82849015|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
82849016|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849017|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82849018|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849019|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
82849020|NCT03966378|Protective Agents|protective agents|mesh-ancestor
82849021|NCT02657434|Carboplatin|carboplatin|mesh-list
82849022|NCT02657434|Pemetrexed|pemetrexed|mesh-list
82849023|NCT02657434|Atezolizumab|atezolizumab|mesh-list
82849024|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849025|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849026|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849028|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82849029|NCT02657434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82849030|NCT02657434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82849031|NCT02652052|Dasatinib|dasatinib|mesh-list
82849032|NCT02652052|Quercetin|quercetin|mesh-list
82849033|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849034|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82849035|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849036|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849037|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
82849038|NCT02652052|Protective Agents|protective agents|mesh-ancestor
82849039|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849040|NCT00119262|Tamoxifen|tamoxifen|mesh-list
82849041|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
82849042|NCT00119262|Bevacizumab|bevacizumab|mesh-list
82849043|NCT00119262|Doxorubicin|doxorubicin|mesh-list
82849044|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82849045|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82849046|NCT00119262|Antibodies|antibodies|mesh-list
82849047|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
82849048|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82849049|NCT00119262|Lenograstim|lenograstim|mesh-list
82849050|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82849051|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849052|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849053|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849054|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
82849055|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849056|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82849057|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82849058|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
82849059|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82849060|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82849061|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82849062|NCT00119262|Growth Substances|growth substances|mesh-ancestor
82849063|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
82849064|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82849065|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82849066|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82849067|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849068|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82849069|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82849070|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
82849071|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849072|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82849073|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82849074|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82849075|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82849076|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82849077|NCT00131664|Metformin|metformin|mesh-list
82849078|NCT00131664|Glimepiride|glimepiride|mesh-list
82849079|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
82849080|NCT00131664|Maleic acid|maleic acid|mesh-list
82849081|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82849082|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849083|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849084|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849085|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82849086|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849087|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
82849088|NCT05050318|Vaccines|vaccines|mesh-list
82849089|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
82849090|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849091|NCT03778996|Sirolimus|sirolimus|mesh-list
82849092|NCT03778996|Phenytoin|phenytoin|mesh-list
82849093|NCT03778996|Methoxsalen|methoxsalen|mesh-list
82849094|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
82849095|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82849096|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849097|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82849098|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849099|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
82849100|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849102|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849103|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849104|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849105|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
82849106|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82849107|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82849108|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82849109|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82849110|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82849111|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82849112|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
82849113|NCT03764722|Simendan|simendan|mesh-list
82849114|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82849115|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
82849116|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82849117|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82849118|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849119|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849120|NCT03764722|Protective Agents|protective agents|mesh-ancestor
82849121|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849122|NCT05024734|Gemcitabine|gemcitabine|mesh-list
82849123|NCT05024734|Docetaxel|docetaxel|mesh-list
82849124|NCT05024734|Epirubicin|epirubicin|mesh-list
82849125|NCT05024734|Mitomycins|mitomycins|mesh-list
82849126|NCT05024734|Mitomycin|mitomycin|mesh-list
82849127|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849128|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
82849129|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849130|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849131|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
82849132|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
82849133|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
82849134|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82849135|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82849136|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82849137|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849138|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
82849139|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82849140|NCT03699124|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82849141|NCT03699124|Antiviral Agents|antiviral agents|mesh-ancestor
82849142|NCT03699124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849143|NCT03756298|Capecitabine|capecitabine|mesh-list
82849144|NCT03756298|Atezolizumab|atezolizumab|mesh-list
82849145|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849146|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
82849147|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849148|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849149|NCT03756298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82849150|NCT03756298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82849151|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
82849152|NCT03756220|Thiamine|thiamine|mesh-list
82849153|NCT03756220|Vitamins|vitamins|mesh-ancestor
82849154|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
82849155|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849156|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
82849157|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849158|NCT03756220|Protective Agents|protective agents|mesh-ancestor
82849159|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
82849160|NCT04980040|Alogliptin|alogliptin|mesh-list
82849161|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82849162|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849163|NCT04980040|Incretins|incretins|mesh-ancestor
82849164|NCT04980040|Hormones|hormones|mesh-ancestor
82849165|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849166|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82849167|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
82849168|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849169|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849170|NCT04647916|Camptothecin|camptothecin|mesh-list
82849171|NCT04647916|Irinotecan|irinotecan|mesh-list
82849172|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
82849173|NCT04647916|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
82849174|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
82849175|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849176|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82849177|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849178|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82849179|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82849180|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849181|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849183|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
82849184|NCT00131352|Protective Agents|protective agents|mesh-ancestor
82849185|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849186|NCT00136916|Insulin|insulin|mesh-list
82849187|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82849188|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82849189|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849190|NCT04633564|Bevacizumab|bevacizumab|mesh-list
82849191|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82849192|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849193|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82849194|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82849195|NCT04633564|Growth Substances|growth substances|mesh-ancestor
82849196|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849197|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
82849198|NCT03756064|Carboplatin|carboplatin|mesh-list
82849199|NCT03756064|Docetaxel|docetaxel|mesh-list
82849200|NCT03756064|Trastuzumab|trastuzumab|mesh-list
82849201|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849202|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
82849203|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
82849204|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
82849205|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849206|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82849207|NCT04607980|Ustekinumab|ustekinumab|mesh-list
82849208|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
82849209|NCT04953910|Decitabine|decitabine|mesh-list
82849210|NCT04953910|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82849211|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849212|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
82849213|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849214|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849215|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849216|NCT03764020|Melatonin|melatonin|mesh-list
82849217|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
82849218|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849219|NCT03764020|Protective Agents|protective agents|mesh-ancestor
82849220|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849221|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849222|NCT00135512|Bupropion|bupropion|mesh-list
82849223|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82849224|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
82849225|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82849226|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82849227|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82849228|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82849229|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849230|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
82849231|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849232|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849233|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82849234|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82849235|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849236|NCT00130728|Bevacizumab|bevacizumab|mesh-list
82849237|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82849238|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82849239|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849240|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82849241|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82849242|NCT00130728|Growth Substances|growth substances|mesh-ancestor
82849243|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849244|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
82849245|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82849246|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849247|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849249|NCT00129974|Pemetrexed|pemetrexed|mesh-list
82849250|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849251|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
82849252|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849253|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849254|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849255|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82849256|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82849257|NCT03966326|Fentanyl|fentanyl|mesh-list
82849258|NCT03966326|Anesthetics|anesthetics|mesh-list
82849259|NCT03966326|Sevoflurane|sevoflurane|mesh-list
82849260|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849261|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849262|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82849263|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82849264|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
82849265|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82849266|NCT03966326|Narcotics|narcotics|mesh-ancestor
82849267|NCT03966326|Analgesics|analgesics|mesh-ancestor
82849268|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
82849269|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849270|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82849271|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82849272|NCT00119106|Tenofovir|tenofovir|mesh-list
82849273|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
82849274|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849275|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83444166|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
82849276|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82849277|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849278|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849279|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82849280|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82849281|NCT03758014|Lomustine|lomustine|mesh-list
82849282|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82849283|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
82849284|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849285|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849286|NCT00135356|Ritonavir|ritonavir|mesh-list
82849287|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82849288|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
82849289|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82849290|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
82849291|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82849292|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849293|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849294|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82849295|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82849296|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
82849297|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849298|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82849299|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82849300|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82849301|NCT00118716|Fluticasone|fluticasone|mesh-list
82849303|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82849304|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82849305|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82849306|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
82849307|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849308|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849309|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82849310|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
82849311|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
82849312|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82849313|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82849314|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82849315|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82849316|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
82849317|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849318|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849319|NCT04907032|Mirabegron|mirabegron|mesh-list
82849320|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82849321|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82849323|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
82849324|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849325|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849326|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849327|NCT04907032|Urological Agents|urological agents|mesh-ancestor
82849328|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
82849329|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82849330|NCT03966950|Melatonin|melatonin|mesh-list
82849331|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
82849332|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849333|NCT03966950|Protective Agents|protective agents|mesh-ancestor
82849334|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849335|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849336|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
82849337|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82849338|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82849339|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849340|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82849341|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82849342|NCT01076582|Desogestrel|desogestrel|mesh-list
82849343|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82849344|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82849345|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82849346|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
82849347|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83444169|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849348|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849349|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82849350|NCT01076582|Estrogens|estrogens|mesh-ancestor
82849351|NCT01076582|Hormones|hormones|mesh-ancestor
82849352|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849353|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82849354|NCT01076582|Progestins|progestins|mesh-ancestor
82849355|NCT01081938|Insulin|insulin|mesh-list
82849356|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82849357|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
82849358|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
82849359|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82849360|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849361|NCT01082796|Glipizide|glipizide|mesh-list
82849362|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82849363|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849364|NCT03763786|Cetrorelix|cetrorelix|mesh-list
82849365|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82849366|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
82849367|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82849368|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849369|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
82849370|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849371|NCT01079364|Insulin|insulin|mesh-list
82849372|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82849373|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
82849374|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
82849375|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
82849376|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82849377|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82849378|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849379|NCT01077752|Acetaminophen|acetaminophen|mesh-list
82849380|NCT01077752|Lidocaine|lidocaine|mesh-list
82849381|NCT01077752|Morphine|morphine|mesh-list
82849382|NCT01077752|Ropivacaine|ropivacaine|mesh-list
82849383|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
82849384|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
82849385|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849386|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849387|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
82849388|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849389|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82849390|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82849391|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82849392|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82849393|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849394|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82849395|NCT01077752|Narcotics|narcotics|mesh-ancestor
82849396|NCT01077752|Analgesics|analgesics|mesh-ancestor
82849401|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
82849402|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82849403|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82849404|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82849405|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82849406|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849407|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
82849408|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849409|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849410|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82849411|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82849412|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849414|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82849415|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849416|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
82849417|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82849418|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
82849419|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849420|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849421|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82849422|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
82849423|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82849424|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
82849425|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849426|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849427|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82849428|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
82849429|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
82849430|NCT03963648|Protective Agents|protective agents|mesh-ancestor
82849431|NCT04899232|Antithrombins|antithrombins|mesh-list
82849432|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
82849433|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82849434|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
82849435|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849436|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849437|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
82849442|NCT03757858|Antibodies|antibodies|mesh-list
82849443|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
82849444|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849445|NCT01079676|Lenograstim|lenograstim|mesh-list
82849446|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82849447|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
82849448|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849449|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82849450|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82849451|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82849452|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849453|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849454|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82849455|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82849456|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82849457|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82849458|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
82849459|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849460|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849461|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82849462|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82849463|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
82849464|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82849465|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82849466|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
82849467|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
82849468|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849469|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849470|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
82849471|NCT04555096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82849472|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
82849473|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849474|NCT04555096|Protective Agents|protective agents|mesh-ancestor
82849475|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849476|NCT00097500|Metformin|metformin|mesh-list
82849477|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
82849478|NCT00097500|Exenatide|exenatide|mesh-list
82849479|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82849480|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849481|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82849482|NCT00097500|Incretins|incretins|mesh-ancestor
82849483|NCT00097500|Hormones|hormones|mesh-ancestor
82849484|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849485|NCT01082484|Treprostinil|treprostinil|mesh-list
82849486|NCT01082484|Iloprost|iloprost|mesh-list
82849487|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82849488|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82849489|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
82849491|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
82849492|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82849493|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
82849494|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
82849495|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
82849496|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849497|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849498|NCT03754816|Anesthetics|anesthetics|mesh-list
82849499|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
82849500|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849501|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849502|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
82849503|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
82849504|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849505|NCT04542694|Favipiravir|favipiravir|mesh-list
82849506|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
82849507|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849508|NCT03965208|Heparin|heparin|mesh-list
82849509|NCT03965208|Calcium heparin|calcium heparin|mesh-list
82849510|NCT03965208|Bivalirudin|bivalirudin|mesh-list
82849511|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
82849512|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82849513|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82849514|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849515|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
82849516|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82849517|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
82849518|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849519|NCT01083264|Gestodene|gestodene|mesh-list
82849520|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82849521|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82849522|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82849523|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
82849524|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82849525|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849526|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82849527|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82849528|NCT01083264|Progestins|progestins|mesh-ancestor
82849529|NCT01083264|Hormones|hormones|mesh-ancestor
82849530|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849531|NCT00129116|Vaccines|vaccines|mesh-list
82849532|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
82849533|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849534|NCT00117156|Rituximab|rituximab|mesh-list
82849535|NCT00117156|Fludarabine|fludarabine|mesh-list
82849536|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82849537|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849538|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
82849539|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849540|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82849541|NCT01083420|Minocycline|minocycline|mesh-list
82849542|NCT01083420|Dexamethasone|dexamethasone|mesh-list
82849543|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82849544|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
82849545|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
82849546|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849547|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849548|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82849549|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
82849550|NCT01083420|Hormones|hormones|mesh-ancestor
82849551|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849552|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82849553|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849554|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82849555|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849556|NCT00096954|Omalizumab|omalizumab|mesh-list
82849557|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82849558|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82849559|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
82849560|NCT00096486|Everolimus|everolimus|mesh-list
82849561|NCT00096486|Gefitinib|gefitinib|mesh-list
82849562|NCT00096486|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82849563|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82849564|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849565|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849566|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849567|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
82849568|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849569|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849570|NCT00116844|Valacyclovir|valacyclovir|mesh-list
82849571|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
82849572|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849573|NCT03963336|Acetazolamide|acetazolamide|mesh-list
82849574|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
82849575|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82849576|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849577|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849578|NCT03963336|Diuretics|diuretics|mesh-ancestor
82849579|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
82849580|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849581|NCT00132314|Risperidone|risperidone|mesh-list
82849582|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
82849583|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82849584|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
82849585|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849586|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849587|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849588|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82849589|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849590|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82849591|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82849592|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
82849594|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
82849595|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849596|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
82849597|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849598|NCT04537234|Vaccines|vaccines|mesh-list
82849599|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
82849600|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849601|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82849602|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
82849603|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
82849604|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82849605|NCT04537078|Cetrorelix|cetrorelix|mesh-list
82849606|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82849607|NCT04537078|Progesterone|progesterone|mesh-list
82849608|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
82849609|NCT04537078|Estradiol|estradiol|mesh-list
82849610|NCT04537078|Progestins|progestins|mesh-ancestor
82849611|NCT04537078|Hormones|hormones|mesh-ancestor
82849612|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849613|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849614|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82849615|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82849616|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
82849617|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82849618|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82849619|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849620|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82849621|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
82849622|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
82849623|NCT04537078|Estrogens|estrogens|mesh-ancestor
82849624|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
82849625|NCT04532164|Clotrimazole|clotrimazole|mesh-list
82849626|NCT04532164|Miconazole|miconazole|mesh-list
82849627|NCT04532164|Butenafine|butenafine|mesh-list
82849628|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849629|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82849630|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82849631|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82849632|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849633|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849634|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82849635|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
82849636|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849637|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849638|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82849639|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82849640|NCT04531540|Butenafine|butenafine|mesh-list
82849641|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
82849642|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849643|NCT04799782|Mirtazapine|mirtazapine|mesh-list
82849644|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
82849645|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82849646|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82849647|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
82849648|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
82849649|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849650|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849651|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849652|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82849653|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83444173|NCT02369211|Acetaminophen|acetaminophen|mesh-list
82849654|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849655|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82849656|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82849657|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82849658|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
82849659|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82849660|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82849661|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
82849662|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82849663|NCT04790812|Acetaminophen|acetaminophen|mesh-list
82849664|NCT04790812|Celecoxib|celecoxib|mesh-list
82849665|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82849666|NCT04790812|Analgesics|analgesics|mesh-ancestor
82849667|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
82849668|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849669|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849670|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
82849671|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82849672|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82849673|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82849674|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82849675|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82849676|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849677|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849678|NCT03697252|Xanomeline|xanomeline|mesh-list
82849679|NCT03697252|Trospium chloride|trospium chloride|mesh-list
82849680|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
82849681|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
82849682|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849683|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849684|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82849685|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82849686|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
82849687|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849688|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849689|NCT03697252|Urological Agents|urological agents|mesh-ancestor
82849690|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82849691|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82849692|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82849693|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82849694|NCT03701074|Acetaminophen|acetaminophen|mesh-list
82849695|NCT03701074|Ibuprofen|ibuprofen|mesh-list
82849696|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82849697|NCT03701074|Analgesics|analgesics|mesh-ancestor
82849698|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
82849699|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849700|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849702|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82849703|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82849704|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82849705|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82849706|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849707|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849708|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
82849709|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82849710|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82849711|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82849712|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
82849713|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849714|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82849715|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82849716|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849717|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82849718|NCT03757156|Aspirin|aspirin|mesh-list
82849719|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82849720|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82849721|NCT03757156|Analgesics|analgesics|mesh-ancestor
82849722|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
82849723|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849724|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849725|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82849726|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82849727|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82849728|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82849729|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849730|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82849731|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82849732|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849733|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
82849734|NCT03750916|Docetaxel|docetaxel|mesh-list
82849735|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849736|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
82849737|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
82849738|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
82849739|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849740|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82849741|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82849742|NCT03750760|Atorvastatin|atorvastatin|mesh-list
82849743|NCT03750760|Ezetimibe|ezetimibe|mesh-list
82849744|NCT03750760|Alirocumab|alirocumab|mesh-list
82849745|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82849746|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82849747|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
82849748|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849749|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82849750|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82849751|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849752|NCT03750760|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82849753|NCT03750760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82849754|NCT03750760|Protease Inhibitors|protease inhibitors|mesh-ancestor
82849755|NCT01076894|Anesthetics|anesthetics|mesh-list
82849756|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849757|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849758|NCT00130832|Vaccines|vaccines|mesh-list
82849759|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
82849760|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849761|NCT00096018|Thalidomide|thalidomide|mesh-list
82849762|NCT00096018|Fludarabine|fludarabine|mesh-list
82849763|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
82849764|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849765|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849766|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
82849767|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849768|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849769|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
82849770|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849771|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
82849772|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82849773|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849774|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82849775|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82849776|NCT00096018|Growth Substances|growth substances|mesh-ancestor
82849777|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
82849779|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
82849780|NCT01079754|Narcotics|narcotics|mesh-ancestor
82849781|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849782|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849783|NCT01079754|Analgesics|analgesics|mesh-ancestor
82849784|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
82849785|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849786|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
82849787|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
82849788|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849789|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
82849790|NCT01322776|Fludarabine|fludarabine|mesh-list
82849791|NCT01322776|Bortezomib|bortezomib|mesh-list
82849792|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849793|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
82849794|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849796|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82849797|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
82849798|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849799|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849800|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82849801|NCT00128102|Vorinostat|vorinostat|mesh-list
82849802|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849803|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82849804|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849805|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849806|NCT03965858|Esketamine|esketamine|mesh-list
82849807|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
82849808|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82849809|NCT04668274|Resveratrol|resveratrol|mesh-list
82849810|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
82849811|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849812|NCT04668274|Protective Agents|protective agents|mesh-ancestor
82849813|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849814|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849815|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82849816|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
82849817|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849818|NCT04406194|Favipiravir|favipiravir|mesh-list
82849819|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
82849820|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849821|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
82849822|NCT03822884|Hematinics|hematinics|mesh-ancestor
82849823|NCT03822416|Nicotine|nicotine|mesh-list
82849824|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82849825|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
82849826|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849827|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849828|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82849829|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82849830|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
82849831|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849832|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849833|NCT04405570|Molnupiravir|molnupiravir|mesh-list
82849834|NCT04405570|Antiviral Agents|antiviral agents|mesh-ancestor
82849835|NCT04405570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849836|NCT00127712|Amiodarone|amiodarone|mesh-list
82849837|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82849838|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
82849839|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82849840|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82849841|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849842|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82849843|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82849844|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82849845|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849846|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82849847|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82849848|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82849849|NCT01082744|Sufentanil|sufentanil|mesh-list
82849850|NCT01082744|Ropivacaine|ropivacaine|mesh-list
82849865|NCT00096356|Tocopherols|tocopherols|mesh-list
82849866|NCT00096356|Tocotrienols|tocotrienols|mesh-list
82849867|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
82849868|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
82849869|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849870|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
82849871|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849872|NCT00096356|Protective Agents|protective agents|mesh-ancestor
82849873|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
82849874|NCT03749590|Analgesics|analgesics|mesh-ancestor
82849875|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
82849876|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849877|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849878|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
82849879|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849880|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82849881|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
82849882|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82849883|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82849884|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849885|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82849886|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
82849887|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82849900|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
82849901|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82849902|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82849903|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849904|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82849905|NCT01076816|Analgesics|analgesics|mesh-ancestor
82849906|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
82849907|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82849908|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82849909|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82849910|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82849911|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
82849912|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82849913|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849914|NCT03777982|Prednisone|prednisone|mesh-list
82849915|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
82849916|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82849917|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
82849918|NCT03777982|Hormones|hormones|mesh-ancestor
82849919|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82849920|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849921|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82849922|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849923|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82849924|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849925|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849926|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
82849927|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82849928|NCT03749356|Tacrolimus|tacrolimus|mesh-list
82849929|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849930|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
82849931|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849932|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82849933|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849934|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849935|NCT04358068|Azithromycin|azithromycin|mesh-list
82849936|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
82849937|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82849938|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82849939|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
82849940|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82849941|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82849942|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849943|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849944|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82849945|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
82849946|NCT00096278|Leucovorin|leucovorin|mesh-list
82849947|NCT00096278|Folic Acid|folic acid|mesh-list
82849948|NCT00096278|Bevacizumab|bevacizumab|mesh-list
82849949|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82849950|NCT00096278|Fluorouracil|fluorouracil|mesh-list
82849951|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
82849952|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
82849953|NCT00096278|Antibodies|antibodies|mesh-list
82849954|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
82849955|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82849956|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
82849957|NCT00096278|Calcium|calcium|mesh-list
82849958|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
82849959|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83444202|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
82849960|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82849961|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82849962|NCT00096278|Growth Substances|growth substances|mesh-ancestor
82849963|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82849964|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
82849965|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
82849966|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82849967|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82849968|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
82849969|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849970|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849971|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82849972|NCT00096278|Antidotes|antidotes|mesh-ancestor
82849973|NCT00096278|Protective Agents|protective agents|mesh-ancestor
82849974|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
82849975|NCT00096278|Vitamins|vitamins|mesh-ancestor
82849976|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
82849977|NCT00096278|Hematinics|hematinics|mesh-ancestor
82849978|NCT00095940|Lapatinib|lapatinib|mesh-list
82849979|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849980|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82849981|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82849982|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849983|NCT00114218|Gemcitabine|gemcitabine|mesh-list
82849984|NCT00114218|Docetaxel|docetaxel|mesh-list
82849985|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849986|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
82849987|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849988|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849989|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
82849990|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
82849991|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
82849992|NCT01077986|Capecitabine|capecitabine|mesh-list
82849993|NCT01077986|Cetuximab|cetuximab|mesh-list
82849994|NCT01077986|Everolimus|everolimus|mesh-list
82849995|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82849996|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
82849997|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82849998|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82849999|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850000|NCT01077986|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82850001|NCT01077986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850002|NCT01077986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850004|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
82850005|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850006|NCT03963024|Treosulfan|treosulfan|mesh-list
82850007|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82850008|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
82850009|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850010|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850011|NCT01082718|Artesunate|artesunate|mesh-list
82850012|NCT01082718|Mefloquine|mefloquine|mesh-list
82850013|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
82850014|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82850015|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82850016|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850017|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850018|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
82850019|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
82850020|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82850021|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
82850022|NCT04380142|Levodopa|levodopa|mesh-list
82850023|NCT04380142|Carbidopa|carbidopa|mesh-list
82850024|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82850025|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82850026|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
82850027|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850028|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850029|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850030|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82850031|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850032|NCT04336228|Dexetimide|dexetimide|mesh-list
82850033|NCT04336228|Citalopram|citalopram|mesh-list
82850034|NCT04336228|Escitalopram|escitalopram|mesh-list
82850035|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850036|NCT04336228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82850037|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82850038|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82850039|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850040|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850041|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
82850042|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82850043|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82850044|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
82850045|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
82850046|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850047|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82850048|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82850049|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
82850050|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82850051|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
82850052|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82850053|NCT03917446|Propofol|propofol|mesh-list
82850054|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82850055|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850056|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850057|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82850058|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
82850059|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
82850060|NCT04332874|Dactinomycin|dactinomycin|mesh-list
82850061|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
82850062|NCT04332874|Melphalan|melphalan|mesh-list
82850063|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850064|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850065|NCT04332874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82850066|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850067|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82850068|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
82850069|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82850070|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850071|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
82850072|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850073|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850074|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850075|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82850076|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82850077|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850078|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82850080|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
82850081|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
82850082|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850083|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850084|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
82850085|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850086|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82850087|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82850088|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82850089|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82850090|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850091|NCT04171414|Adalimumab|adalimumab|mesh-list
82850092|NCT04171414|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82850093|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850094|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850095|NCT04167670|Amoxicillin|amoxicillin|mesh-list
82850096|NCT04167670|Clarithromycin|clarithromycin|mesh-list
82850097|NCT04167670|Lansoprazole|lansoprazole|mesh-list
82850098|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
82850099|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850100|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850101|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82850102|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850103|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850104|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82850105|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82850106|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82850107|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850108|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82850109|NCT00113516|Paclitaxel|paclitaxel|mesh-list
82850110|NCT00113516|Carboplatin|carboplatin|mesh-list
82850111|NCT00113516|Sunitinib|sunitinib|mesh-list
82850112|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82850113|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850114|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
82850115|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
82850116|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
82850117|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850118|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82850119|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82850120|NCT00113516|Growth Substances|growth substances|mesh-ancestor
82850121|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850122|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
82850123|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850124|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850125|NCT04142242|Vaccines|vaccines|mesh-list
82850126|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
82850127|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850128|NCT03251326|Propranolol|propranolol|mesh-list
82850129|NCT03251326|Nabilone|nabilone|mesh-list
82850130|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82850131|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82850132|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
82850133|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850134|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850135|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850136|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82850137|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82850138|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
82850139|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
82850140|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
82850141|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850142|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850143|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82850144|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82850145|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850146|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82850147|NCT04140292|Vitamin D|vitamin d|mesh-list
82850148|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
82850149|NCT04140292|Vitamins|vitamins|mesh-ancestor
82850150|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
82850151|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850152|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82850153|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82850154|NCT00127166|Fluticasone|fluticasone|mesh-list
82850155|NCT00127166|Xhance|xhance|mesh-list
82850156|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82850157|NCT00127166|Montelukast|montelukast|mesh-list
82850158|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850159|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82850160|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
82850161|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850162|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850163|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82850164|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
82850165|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850166|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82850167|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82850168|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82850169|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82850170|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
82850171|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850172|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850173|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82850174|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
82850175|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82850176|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82850177|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82850178|NCT00125138|Metylperon|metylperon|mesh-list
82850179|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82850180|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82850181|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850182|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850183|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82850184|NCT04132336|Naproxen|naproxen|mesh-list
82850185|NCT04132336|Caffeine|caffeine|mesh-list
82850186|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82850187|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850188|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82850189|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850190|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850191|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82850192|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82850193|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
82850194|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850195|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850196|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850197|NCT04132336|Analgesics|analgesics|mesh-ancestor
82850198|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
82850199|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850200|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850201|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850202|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
82850203|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82850204|NCT04131556|Maribavir|maribavir|mesh-list
82850205|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
82850206|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850207|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82850208|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
82850209|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
82850210|NCT03691948|Narcotics|narcotics|mesh-ancestor
82850211|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850212|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850213|NCT03691948|Analgesics|analgesics|mesh-ancestor
82850214|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
82850215|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850216|NCT04124926|Lansoprazole|lansoprazole|mesh-list
82850217|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
82850218|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82850219|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850220|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82850221|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850222|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850223|NCT03746158|Curcumin|curcumin|mesh-list
82850224|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850225|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850226|NCT03746158|Analgesics|analgesics|mesh-ancestor
82850227|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
82850229|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850230|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850231|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850232|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850233|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850234|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850235|NCT03747094|Fentanyl|fentanyl|mesh-list
82850236|NCT03747094|Ketamine|ketamine|mesh-list
82850237|NCT03747094|Analgesics|analgesics|mesh-ancestor
82850238|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
82850239|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850240|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850241|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82850242|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82850243|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
82850244|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
82850245|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850246|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82850247|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82850248|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850249|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850250|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82850251|NCT03747094|Narcotics|narcotics|mesh-ancestor
82850252|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82850253|NCT04105972|Ivacaftor|ivacaftor|mesh-list
82850254|NCT04105972|Elexacaftor|elexacaftor|mesh-list
82850255|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82850256|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82850257|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850258|NCT00124982|Abatacept|abatacept|mesh-list
82850259|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
82850260|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82850261|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850262|NCT00124982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850263|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850264|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850265|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
82850266|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850267|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
82850268|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850269|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850270|NCT04090528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82850271|NCT04090528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850272|NCT04249336|Listerine|listerine|mesh-list
82850273|NCT04249336|Calcium|calcium|mesh-list
82850274|NCT04249336|Fluorides|fluorides|mesh-list
82850275|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
82850276|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82850277|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850278|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
82850279|NCT04249336|Protective Agents|protective agents|mesh-ancestor
82850280|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82850281|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850282|NCT03752476|Lactams|lactams|mesh-list
82850283|NCT03752476|beta-Lactams|beta-lactams|mesh-list
82850284|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850285|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850286|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82850287|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82850288|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
82850289|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
82850290|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850291|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
82850292|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850293|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850294|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850295|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850296|NCT01078142|Sirolimus|sirolimus|mesh-list
82850297|NCT01078142|Rituximab|rituximab|mesh-list
82850298|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82850299|NCT01078142|Temsirolimus|temsirolimus|mesh-list
82850300|NCT01078142|MTOR Inhibitors|mtor inhibitors|mesh-list
82850301|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850302|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850303|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
82850304|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850305|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850306|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82850307|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
82850308|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850309|NCT01078142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850310|NCT01078142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850311|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850312|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850313|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850314|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82850315|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
82850316|NCT04060654|Buprenorphine|buprenorphine|mesh-list
82850317|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82850318|NCT04060654|Narcotics|narcotics|mesh-ancestor
82850319|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850320|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850321|NCT04060654|Analgesics|analgesics|mesh-ancestor
82850322|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
82850323|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850324|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82850325|NCT00096200|Paclitaxel|paclitaxel|mesh-list
82850326|NCT00096200|Carboplatin|carboplatin|mesh-list
82850327|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82850328|NCT00096200|Sorafenib|sorafenib|mesh-list
82850329|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82850330|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850331|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
82850332|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
82850333|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
82850334|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850335|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850336|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850337|NCT00096044|Rituximab|rituximab|mesh-list
82850338|NCT00096044|Lenalidomide|lenalidomide|mesh-list
82850339|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850340|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850341|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
82850342|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850343|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850344|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82850345|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82850346|NCT00096044|Growth Substances|growth substances|mesh-ancestor
82850347|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
82850348|NCT03963128|Vitamin D|vitamin d|mesh-list
82850350|NCT03963128|Vitamins|vitamins|mesh-ancestor
82850351|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
82850352|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850353|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82850354|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82850355|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
82850356|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82850357|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
82850358|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850359|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82850360|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82850361|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82850362|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850363|NCT01083290|Spironolactone|spironolactone|mesh-list
82850364|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82850365|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
82850366|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82850367|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850368|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82850369|NCT01083290|Diuretics|diuretics|mesh-ancestor
82850370|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
82850371|NCT01326650|Vitamin D|vitamin d|mesh-list
82850372|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
82850373|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
82850374|NCT01326650|Vitamins|vitamins|mesh-list
82850375|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82850376|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
82850377|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850378|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82850379|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82850380|NCT03689374|Insulin|insulin|mesh-list
82850381|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82850382|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
82850383|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
82850384|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82850385|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850386|NCT00113360|Everolimus|everolimus|mesh-list
82850387|NCT00113360|Octreotide|octreotide|mesh-list
82850388|NCT00113360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82850389|NCT00113360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850390|NCT00113360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850391|NCT00113360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850392|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850393|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
82850394|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850395|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850396|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850397|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82850398|NCT03745300|Atorvastatin|atorvastatin|mesh-list
82850399|NCT03745300|Simvastatin|simvastatin|mesh-list
82850400|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82850401|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82850402|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
82850403|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850404|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83444214|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850405|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82850406|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850407|NCT00112736|Sirolimus|sirolimus|mesh-list
82850408|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82850409|NCT00112736|Temsirolimus|temsirolimus|mesh-list
82850410|NCT00112736|MTOR Inhibitors|mtor inhibitors|mesh-list
82850411|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850412|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850413|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850414|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850415|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850416|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
82850417|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850418|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850419|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850420|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82850421|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
82850422|NCT04052620|Diclofenac|diclofenac|mesh-list
82850423|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850424|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850426|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
82850427|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850428|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850429|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850430|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850431|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82850432|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850433|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850434|NCT00112580|Ipilimumab|ipilimumab|mesh-list
82850435|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850436|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850437|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82850438|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850439|NCT04238650|Bevacizumab|bevacizumab|mesh-list
82850440|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850441|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850442|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82850443|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82850444|NCT04238650|Growth Substances|growth substances|mesh-ancestor
82850445|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850446|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
82850447|NCT04049578|Balovaptan|balovaptan|mesh-list
82850448|NCT04049578|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82850449|NCT04049578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850450|NCT04049578|Natriuretic Agents|natriuretic agents|mesh-ancestor
82850451|NCT04049578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850459|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850460|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850461|NCT04237792|Analgesics|analgesics|mesh-ancestor
82850462|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
82850463|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850464|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82850465|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82850466|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82850467|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
82850468|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850469|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850470|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82850471|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
82850472|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
82850473|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
82850474|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82850475|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82850476|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850477|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
82850478|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850479|NCT04489732|Interferons|interferons|mesh-list
82850480|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
82850481|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850482|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
82850483|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850484|NCT03744988|Androgens|androgens|mesh-list
82850485|NCT03744988|Hormones|hormones|mesh-ancestor
82850486|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82850487|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850488|NCT03746782|Thrombin|thrombin|mesh-list
82850489|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
82850490|NCT03746782|Coagulants|coagulants|mesh-ancestor
82850491|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
82850492|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82850493|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82850494|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850495|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
82850496|NCT04024228|Vaccines|vaccines|mesh-list
82850497|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
82850498|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850499|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
82850500|NCT04024228|Coagulants|coagulants|mesh-ancestor
82850501|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
82850502|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82850503|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850504|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
82850505|NCT04018612|Acetaminophen|acetaminophen|mesh-list
82850506|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850508|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
82850509|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850510|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850511|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
82850512|NCT04207840|Epinephrine|epinephrine|mesh-list
82850513|NCT04207840|Racepinephrine|racepinephrine|mesh-list
82850514|NCT04207840|Albuterol|albuterol|mesh-list
82850515|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
82850516|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82850517|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82850518|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
82850519|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850520|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850521|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850522|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82850524|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
82850525|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850526|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82850527|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
82850528|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
82850529|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
82850530|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82850531|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
82850532|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82850533|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82850534|NCT04195828|Paclitaxel|paclitaxel|mesh-list
82850535|NCT04195828|Apatinib|apatinib|mesh-list
82850536|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82850537|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850538|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
82850539|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
82850540|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
82850541|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850542|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850543|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850544|NCT03744364|Misoprostol|misoprostol|mesh-list
82850545|NCT03744364|Dinoprostone|dinoprostone|mesh-list
82850546|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82850547|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
82850548|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82850549|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850550|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82850551|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850552|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
82850553|NCT03744208|Antibodies|antibodies|mesh-list
82850554|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82850555|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
82850556|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850557|NCT05069896|Mirikizumab|mirikizumab|mesh-list
82850558|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850559|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850560|NCT05069896|Analgesics|analgesics|mesh-ancestor
82850561|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
82850562|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850563|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850564|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850565|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850566|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82850567|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850568|NCT01562626|Flucytosine|flucytosine|mesh-list
82850569|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
82850570|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850571|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
82850572|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850573|NCT04470622|Aprepitant|aprepitant|mesh-list
82850574|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
82850575|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
82850576|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850577|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850578|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850579|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82850580|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850581|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850582|NCT04465396|Teduglutide|teduglutide|mesh-list
82850583|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850584|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82850585|NCT04465396|Protective Agents|protective agents|mesh-ancestor
82850586|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850588|NCT03996694|Buprenorphine|buprenorphine|mesh-list
82850589|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82850590|NCT03996694|Narcotics|narcotics|mesh-ancestor
82850591|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850592|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850593|NCT03996694|Analgesics|analgesics|mesh-ancestor
82850594|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
82850595|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850596|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82850597|NCT03743896|Capsaicin|capsaicin|mesh-list
82850598|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
82850599|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850600|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
82850601|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850602|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850603|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82850604|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850605|NCT03751228|Deucravacitinib|deucravacitinib|mesh-list
82850606|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850607|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850608|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850609|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850610|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82850611|NCT03656692|Hormones|hormones|mesh-ancestor
82850612|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82850613|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850614|NCT04439266|Crizotinib|crizotinib|mesh-list
82850615|NCT04439266|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82850616|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850617|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850618|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850619|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850620|NCT01329796|Lidocaine|lidocaine|mesh-list
82850621|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
82850622|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
82850623|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850624|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850625|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
82850626|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850627|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83444224|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850628|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82850629|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82850630|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82850631|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850632|NCT04428502|Etanercept|etanercept|mesh-list
82850633|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850634|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850635|NCT04428502|Analgesics|analgesics|mesh-ancestor
82850636|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
82850637|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850638|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850639|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850640|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850641|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850642|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850643|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
82850644|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
82850645|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82850646|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850647|NCT03736330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82850648|NCT03736330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850649|NCT04428424|Etanercept|etanercept|mesh-list
82850650|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850651|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850652|NCT04428424|Analgesics|analgesics|mesh-ancestor
82850653|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
82850654|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850655|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850656|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850657|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850658|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850659|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850660|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
82850661|NCT00095238|Irbesartan|irbesartan|mesh-list
82850662|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82850663|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82850664|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82850665|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850666|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
82850667|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82850668|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850669|NCT01084044|Urinastatin|urinastatin|mesh-list
82850670|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82850673|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850674|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850675|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
82850676|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850677|NCT01090596|Naproxen|naproxen|mesh-list
82850678|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850679|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850680|NCT01090596|Analgesics|analgesics|mesh-ancestor
82850681|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
82850682|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850683|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850684|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850685|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850686|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
82850687|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82850688|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850689|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850690|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82850691|NCT01084122|Hematinics|hematinics|mesh-ancestor
82850692|NCT01084200|Propofol|propofol|mesh-list
82850693|NCT01084200|Sevoflurane|sevoflurane|mesh-list
82850694|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82850695|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850696|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850697|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82850698|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
82850699|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
82850700|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82850701|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82850702|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82850703|NCT00094770|Glipizide|glipizide|mesh-list
82850704|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82850705|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850706|NCT00094770|Incretins|incretins|mesh-ancestor
82850707|NCT00094770|Hormones|hormones|mesh-ancestor
82850708|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82850709|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82850710|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
82850711|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850712|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850713|NCT01087398|Cyclosporine|cyclosporine|mesh-list
82850714|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
82850715|NCT01087398|Busulfan|busulfan|mesh-list
82850716|NCT01087398|Methotrexate|methotrexate|mesh-list
82850717|NCT01087398|Fludarabine|fludarabine|mesh-list
82850718|NCT01087398|Cyclosporins|cyclosporins|mesh-list
82850719|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
82850720|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850721|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
82850722|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850723|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850724|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82850725|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
82850726|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850727|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850728|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82850729|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82850730|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
82850731|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82850732|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82850733|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
82850734|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850735|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850736|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82850737|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82850738|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
82850739|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850740|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82850741|NCT01087476|Doxycycline|doxycycline|mesh-list
82850742|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850743|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850744|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
82850745|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82850746|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82850747|NCT00069108|Leucovorin|leucovorin|mesh-list
82850748|NCT00069108|Capecitabine|capecitabine|mesh-list
82850749|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
82850750|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82850751|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
82850752|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850753|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850754|NCT00069108|Antidotes|antidotes|mesh-ancestor
82850755|NCT00069108|Protective Agents|protective agents|mesh-ancestor
82850756|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850757|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
82850758|NCT00069108|Vitamins|vitamins|mesh-ancestor
82850759|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
82850760|NCT00405587|Vemurafenib|vemurafenib|mesh-list
82850761|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850762|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850763|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850764|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850765|NCT01040429|Clonidine|clonidine|mesh-list
82850766|NCT01040429|Analgesics|analgesics|mesh-ancestor
82850767|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
82850768|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850769|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850770|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82850771|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
82850772|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
82850773|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82850774|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82850775|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82850776|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
82850777|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82850778|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850779|NCT01039883|Albaconazole|albaconazole|mesh-list
82850780|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
82850781|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850782|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
82850783|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
82850784|NCT00405275|Etanercept|etanercept|mesh-list
82850785|NCT00405275|Methotrexate|methotrexate|mesh-list
82850786|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82850787|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
82850788|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82850789|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850790|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82850791|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
82850792|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850793|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850794|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850795|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850796|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82850797|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850798|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
82850799|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850800|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82850801|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
82850802|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82850803|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82850804|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850805|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850806|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850807|NCT00405275|Analgesics|analgesics|mesh-ancestor
82850808|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
82850809|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850810|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850811|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850812|NCT00404651|Vaccines|vaccines|mesh-list
82850813|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
82850814|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850815|NCT00404495|Irinotecan|irinotecan|mesh-list
82850816|NCT00404495|Temozolomide|temozolomide|mesh-list
82850817|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82850818|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82850819|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850820|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850821|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850822|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82850823|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
82850824|NCT00409409|Immunomodulating Agents|immunomodulating agents|mesh-list
82850825|NCT00409409|Immunologic Factors|immunologic factors|mesh-ancestor
82850826|NCT00409409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850827|NCT00409331|Amifostine|amifostine|mesh-list
82850828|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82850829|NCT00409331|Protective Agents|protective agents|mesh-ancestor
82850830|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850831|NCT00362219|Morphine|morphine|mesh-list
82850832|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82850833|NCT00362219|Narcotics|narcotics|mesh-ancestor
82850834|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850835|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850836|NCT00362219|Analgesics|analgesics|mesh-ancestor
82850837|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
82850838|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850839|NCT01040585|Linezolid|linezolid|mesh-list
82850840|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82850841|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850842|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82850843|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850844|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850845|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
82850846|NCT01040195|Methotrexate|methotrexate|mesh-list
82850847|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82850848|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
82850849|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82850850|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850851|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82850852|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
82850853|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850854|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850855|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850856|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850857|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82850858|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850859|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
82850860|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850861|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82850862|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
82850863|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82850864|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82850865|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850866|NCT01040273|Bupivacaine|bupivacaine|mesh-list
82850867|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
82850868|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
82850869|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850870|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850871|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
82850872|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850873|NCT00408629|Adalimumab|adalimumab|mesh-list
82850874|NCT00408629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82850875|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850876|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850877|NCT00408317|Pancrelipase|pancrelipase|mesh-list
82850878|NCT00408317|Pancreatin|pancreatin|mesh-list
82850879|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850880|NCT00112502|Thalidomide|thalidomide|mesh-list
82850881|NCT00112502|Celecoxib|celecoxib|mesh-list
82850882|NCT00112502|Temozolomide|temozolomide|mesh-list
82850883|NCT00112502|Isotretinoin|isotretinoin|mesh-list
82850884|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82850885|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
82850886|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850887|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850888|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82850889|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82850890|NCT00112502|Analgesics|analgesics|mesh-ancestor
82850891|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
82850892|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850893|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850894|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850895|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850896|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82850897|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82850908|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850910|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850911|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850912|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850913|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850914|NCT01083992|Vitamin D|vitamin d|mesh-list
82850915|NCT01083992|Vildagliptin|vildagliptin|mesh-list
82850916|NCT01083992|Vitamins|vitamins|mesh-ancestor
82850917|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
82850918|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850919|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82850920|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82850921|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82850922|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
82850923|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850924|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850925|NCT03822182|Dexamethasone|dexamethasone|mesh-list
82850926|NCT03822182|Bupivacaine|bupivacaine|mesh-list
82850927|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850928|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
82850929|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
82850930|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82850931|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850932|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82850933|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
82850934|NCT03822182|Hormones|hormones|mesh-ancestor
82850935|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82850936|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82850937|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850938|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
82850939|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
82850940|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82850941|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
82850942|NCT01078610|Adalimumab|adalimumab|mesh-list
82850943|NCT01078610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82850944|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82850945|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850946|NCT01080482|Tacrolimus|tacrolimus|mesh-list
82850947|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850948|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
82850949|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850950|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82850951|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850952|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850953|NCT03965624|Ixazomib|ixazomib|mesh-list
82850954|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850955|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
82850956|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850957|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850958|NCT01080560|Cyclosporine|cyclosporine|mesh-list
82850959|NCT01080560|Cyclosporins|cyclosporins|mesh-list
82850960|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850961|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850962|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82850963|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
82850964|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850965|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
82850966|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82850967|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
82850968|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82850969|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82850971|NCT00094328|Bicalutamide|bicalutamide|mesh-list
82850972|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82850973|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850974|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82850975|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82850976|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850977|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850978|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82850979|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
82850980|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82850981|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850982|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
82850984|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82850985|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82850986|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
82850987|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850988|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82850989|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82850990|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850991|NCT00094094|Axitinib|axitinib|mesh-list
82850992|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82850993|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82850994|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82850995|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82850996|NCT03962816|Vaccines|vaccines|mesh-list
82850997|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
82850998|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82850999|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
82851000|NCT01080638|Abciximab|abciximab|mesh-list
82851001|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
82851002|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82851003|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82851004|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
82851005|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851006|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82851007|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851008|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
82851009|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851010|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
82851011|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82851012|NCT01080638|Protective Agents|protective agents|mesh-ancestor
82851013|NCT00110396|Interferons|interferons|mesh-list
82851014|NCT00110396|Interferon-beta|interferon-beta|mesh-list
82851015|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
82851016|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851017|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
82851018|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851019|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
82851020|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851021|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82851022|NCT00093470|Tipifarnib|tipifarnib|mesh-list
82851023|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851024|NCT00407537|Amlodipine|amlodipine|mesh-list
82851025|NCT00407537|Atorvastatin|atorvastatin|mesh-list
82851026|NCT00407537|Calcium|calcium|mesh-list
82851027|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82851028|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851029|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82851030|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82851031|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
82851032|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851033|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82851034|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82851035|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851036|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82851037|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82851038|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82851039|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
82851040|NCT00094458|Infliximab|infliximab|mesh-list
82851041|NCT00094458|Azathioprine|azathioprine|mesh-list
82851042|NCT00094458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82851043|NCT00094458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851044|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
82851045|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82851046|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851047|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
82851048|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851049|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851050|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851051|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851052|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
82851053|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851054|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82851055|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82851056|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851057|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851058|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82851059|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82851060|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851061|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
82851062|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851063|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
82851064|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
82851065|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851066|NCT03961464|Cycloserine|cycloserine|mesh-list
82851067|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82851068|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851069|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82851070|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
82851071|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82851072|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
82851073|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851074|NCT01087554|Sirolimus|sirolimus|mesh-list
82851075|NCT01087554|Everolimus|everolimus|mesh-list
82851076|NCT01087554|MTOR Inhibitors|mtor inhibitors|mesh-list
82851077|NCT01087554|Temsirolimus|temsirolimus|mesh-list
82851078|NCT01087554|Vorinostat|vorinostat|mesh-list
82851079|NCT01087554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851080|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444239|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
82851081|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851082|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851083|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
82851084|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851085|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851086|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82851087|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851088|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82851089|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
82851090|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82851091|NCT01087632|Folic Acid|folic acid|mesh-list
82851092|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
82851093|NCT01087632|Policosanol|policosanol|mesh-list
82851094|NCT01087632|Red yeast rice|red yeast rice|mesh-list
82851095|NCT01087632|Hematinics|hematinics|mesh-ancestor
82851096|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
82851097|NCT01087632|Vitamins|vitamins|mesh-ancestor
82851098|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
82851099|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851100|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82851101|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82851102|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82851103|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
82851104|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851105|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851106|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82851107|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82851108|NCT00394589|Infliximab|infliximab|mesh-list
82851109|NCT00394589|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82851110|NCT00394589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851111|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
82851112|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82851113|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851114|NCT00068406|Cisplatin|cisplatin|mesh-list
82851115|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851116|NCT00403559|Ketoconazole|ketoconazole|mesh-list
82851117|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
82851118|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
82851119|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851120|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82851121|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82851122|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851123|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851124|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82851125|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
82851126|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851127|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851128|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82851129|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82851130|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82851131|NCT00403559|Analgesics|analgesics|mesh-ancestor
82851132|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
82851133|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851134|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851135|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851136|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
82851137|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851138|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
82851139|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82851141|NCT01087710|Antioxidants|antioxidants|mesh-list
82851142|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
82851143|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851144|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851145|NCT01087710|Protective Agents|protective agents|mesh-ancestor
82851146|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82851148|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82851149|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82851150|NCT00403481|Diuretics|diuretics|mesh-ancestor
82851151|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
82851152|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851153|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82851154|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82851155|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851156|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82851157|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82851158|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82851159|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851160|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851161|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851162|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851163|NCT00394433|Bevacizumab|bevacizumab|mesh-list
82851164|NCT00394433|Cisplatin|cisplatin|mesh-list
82851165|NCT00394433|Docetaxel|docetaxel|mesh-list
82851166|NCT00394433|Irinotecan|irinotecan|mesh-list
82851167|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851168|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851169|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851170|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82851171|NCT00394433|Growth Substances|growth substances|mesh-ancestor
82851172|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851173|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851174|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851175|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851176|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851177|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851178|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82851179|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82851180|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851181|NCT00092534|Vaccines|vaccines|mesh-list
82851182|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
82851183|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851184|NCT00068250|Rituximab|rituximab|mesh-list
82851185|NCT00068250|Methotrexate|methotrexate|mesh-list
82851186|NCT00068250|Temozolomide|temozolomide|mesh-list
82851187|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851188|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851191|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851192|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82851193|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
82851194|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82851195|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851196|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
82851197|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851198|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
82851199|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851200|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82851201|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851202|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82851203|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82851204|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
82851205|NCT03957720|Penicillamine|penicillamine|mesh-list
82851206|NCT03957720|Succimer|succimer|mesh-list
82851207|NCT03957720|Antidotes|antidotes|mesh-ancestor
82851208|NCT03957720|Protective Agents|protective agents|mesh-ancestor
82851209|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851210|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
82851211|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
82851212|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851213|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851214|NCT00393029|Aldesleukin|aldesleukin|mesh-list
82851215|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
82851216|NCT00393029|Fludarabine|fludarabine|mesh-list
82851217|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
82851218|NCT00393029|Interleukin-2|interleukin-2|mesh-list
82851219|NCT00393029|Lenograstim|lenograstim|mesh-list
82851220|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851221|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
82851222|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851223|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851224|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82851225|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
82851226|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851227|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851228|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82851229|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851230|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
82851231|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82851232|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82851233|NCT00393029|Analgesics|analgesics|mesh-ancestor
82851234|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
82851235|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851236|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82851237|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82851238|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
82851239|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851240|NCT00402233|Pramipexole|pramipexole|mesh-list
82851241|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
82851242|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851243|NCT00402233|Protective Agents|protective agents|mesh-ancestor
82851244|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851245|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82851246|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82851247|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
82851248|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
82851249|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851250|NCT03993431|Methamphetamine|methamphetamine|mesh-list
82851251|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82851252|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851253|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
82851254|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
82851255|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851256|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
82851257|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851258|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851259|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
82851260|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82851261|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82851262|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82851263|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82851264|NCT00401843|Dexamethasone|dexamethasone|mesh-list
82851265|NCT00401843|Bortezomib|bortezomib|mesh-list
82851266|NCT00401843|Siltuximab|siltuximab|mesh-list
82851267|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851268|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
82851269|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
82851270|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851271|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851272|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82851273|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
82851274|NCT00401843|Hormones|hormones|mesh-ancestor
82851275|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851277|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851278|NCT00401531|Vaccines|vaccines|mesh-list
82851279|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82851280|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
82851281|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851282|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
82851283|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82851284|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851285|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
82851286|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851287|NCT00400517|Thalidomide|thalidomide|mesh-list
82851288|NCT00400517|Sargramostim|sargramostim|mesh-list
82851289|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851290|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
82851291|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851292|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
82851293|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82851294|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851295|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851296|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82851297|NCT00400517|Growth Substances|growth substances|mesh-ancestor
82851298|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851299|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851300|NCT01044095|Vaccines|vaccines|mesh-list
82851301|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
83444249|NCT02039115|Prednisone|prednisone|mesh-list
82851302|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851303|NCT00392171|Temozolomide|temozolomide|mesh-list
82851304|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82851305|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
82851306|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851307|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851308|NCT00091832|Denosumab|denosumab|mesh-list
82851309|NCT00091832|Diphosphonates|diphosphonates|mesh-list
82851310|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82851311|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851312|NCT00391391|Vaccines|vaccines|mesh-list
82851313|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
82851314|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851315|NCT01044251|Frovatriptan|frovatriptan|mesh-list
82851316|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82851317|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
82851318|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851319|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851320|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851321|NCT01044329|Triamcinolone|triamcinolone|mesh-list
82851322|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82851323|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82851324|NCT01044329|Bevacizumab|bevacizumab|mesh-list
82851325|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82851326|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851327|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851328|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851329|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82851330|NCT01044329|Growth Substances|growth substances|mesh-ancestor
82851331|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851332|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851333|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851334|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
82851335|NCT01044329|Hormones|hormones|mesh-ancestor
82851336|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851337|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851340|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851341|NCT00091442|Docetaxel|docetaxel|mesh-list
82851342|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82851343|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851344|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851345|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851346|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851347|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851348|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82851349|NCT00390689|Pramipexole|pramipexole|mesh-list
82851350|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
82851351|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851353|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851354|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82851355|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82851356|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
82851357|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
82851358|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851359|NCT01079078|Acetaminophen|acetaminophen|mesh-list
82851360|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82851361|NCT01079078|Analgesics|analgesics|mesh-ancestor
82851362|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
82851363|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851364|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851365|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
82851366|NCT00390455|Fulvestrant|fulvestrant|mesh-list
82851367|NCT00390455|Lapatinib|lapatinib|mesh-list
82851368|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82851369|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851370|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82851371|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82851372|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
82851373|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851374|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851375|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851376|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444251|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
82851377|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851378|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82851379|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82851380|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851381|NCT01583114|Perindopril|perindopril|mesh-list
82851382|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82851383|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
82851384|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851385|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851386|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82851387|NCT01079312|Fentanyl|fentanyl|mesh-list
82851388|NCT01079312|Remifentanil|remifentanil|mesh-list
82851389|NCT01079312|Propofol|propofol|mesh-list
82851390|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82851391|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82851392|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851393|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82851394|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
82851395|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
82851396|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82851397|NCT01079312|Narcotics|narcotics|mesh-ancestor
82851398|NCT01079312|Analgesics|analgesics|mesh-ancestor
82851399|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
82851400|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851401|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82851402|NCT01044485|Docetaxel|docetaxel|mesh-list
82851403|NCT01044485|Lapatinib|lapatinib|mesh-list
82851404|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851405|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851406|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851407|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851408|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851409|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851410|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851411|NCT00119678|Prednisone|prednisone|mesh-list
82851412|NCT00119678|Abatacept|abatacept|mesh-list
82851414|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
82851415|NCT00119678|Hormones|hormones|mesh-ancestor
82851416|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851417|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851418|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82851419|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851420|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82851421|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851422|NCT00119678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851423|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851424|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
82851425|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851426|NCT00110084|Paclitaxel|paclitaxel|mesh-list
82851427|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82851428|NCT00110084|Gemcitabine|gemcitabine|mesh-list
82851429|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82851430|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851431|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851432|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851433|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851434|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851435|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851436|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
82851437|NCT00390221|Daclizumab|daclizumab|mesh-list
82851438|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851439|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
82851440|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851441|NCT00389831|Rotigotine|rotigotine|mesh-list
82851442|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
82851443|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
82851444|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851445|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851446|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851447|NCT00389519|Ramipril|ramipril|mesh-list
82851448|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82851449|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
83444493|NCT05568797|Vaccines|vaccines|mesh-list
82851450|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851451|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851452|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82851453|NCT00389441|Axitinib|axitinib|mesh-list
82851454|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851455|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851456|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851457|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851458|NCT00118898|Ritonavir|ritonavir|mesh-list
82851459|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82851460|NCT00118898|Tenofovir|tenofovir|mesh-list
82851461|NCT00118898|Lamivudine|lamivudine|mesh-list
82851462|NCT00118898|Emtricitabine|emtricitabine|mesh-list
82851463|NCT00118898|Abacavir|abacavir|mesh-list
82851464|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82851465|NCT00118898|Efavirenz|efavirenz|mesh-list
83444780|NCT05416073|Esketamine|esketamine|mesh-list
82851466|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
82851467|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83444853|NCT02979015|Alirocumab|alirocumab|mesh-list
82851468|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82851469|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
82851470|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83444996|NCT04724447|Valganciclovir|valganciclovir|mesh-list
82851471|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851472|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82851473|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82851474|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
82851475|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851476|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82851477|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82851478|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82851479|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82851480|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82851481|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82851482|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82851483|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82851484|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82851485|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
82851486|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
82851487|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82851488|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
82851489|NCT01085552|Hematinics|hematinics|mesh-ancestor
82851490|NCT01085708|Rabeprazole|rabeprazole|mesh-list
82851491|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82851492|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82851493|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82851494|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851495|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851496|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82851497|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82851498|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82851499|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
82851500|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851501|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851502|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851503|NCT00090584|Urological Agents|urological agents|mesh-ancestor
82851504|NCT01079624|Glucagon|glucagon|mesh-list
82851505|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82851506|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82851507|NCT01079624|Hormones|hormones|mesh-ancestor
82851508|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851509|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851510|NCT01079624|Incretins|incretins|mesh-ancestor
82851511|NCT01086020|Atorvastatin|atorvastatin|mesh-list
82851512|NCT01086020|Ezetimibe|ezetimibe|mesh-list
83445483|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
82851513|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82851514|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82851515|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
82851516|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851517|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82851518|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82851519|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851520|NCT03670810|Lasmiditan|lasmiditan|mesh-list
82851521|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82851522|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
83445696|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
82851523|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851524|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851525|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851526|NCT01086254|Gemcitabine|gemcitabine|mesh-list
82851527|NCT01086254|Iniparib|iniparib|mesh-list
83445841|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851528|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851529|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851530|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
82851531|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83446061|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851532|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82851533|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851534|NCT01086332|Nelfinavir|nelfinavir|mesh-list
82851535|NCT01086332|Gemcitabine|gemcitabine|mesh-list
82851536|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851537|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
83446205|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82851538|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851539|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851540|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82851541|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82851542|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
82851543|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851544|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82851545|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82851546|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
83446433|NCT02697292|Antibodies|antibodies|mesh-list
82851547|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851548|NCT01811368|Cyclosporine|cyclosporine|mesh-list
82851549|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
82851550|NCT01811368|Rituximab|rituximab|mesh-list
82851551|NCT01811368|Cyclosporins|cyclosporins|mesh-list
82851552|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
82851553|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82851554|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
82851555|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851556|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851557|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
82851558|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851559|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851560|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851561|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851562|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851563|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
82851564|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851565|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
82851566|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82851567|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82851568|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83446564|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
82851569|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
82851570|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82851571|NCT00089648|Sunitinib|sunitinib|mesh-list
82851572|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851573|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851574|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83446744|NCT00887575|Paclitaxel|paclitaxel|mesh-list
82851575|NCT00089648|Growth Substances|growth substances|mesh-ancestor
82851576|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851577|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851578|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851579|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851580|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851581|NCT01079702|Capecitabine|capecitabine|mesh-list
82851582|NCT01079702|Everolimus|everolimus|mesh-list
82851583|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851584|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
82851585|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851586|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851587|NCT01079702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82851588|NCT01079702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851589|NCT01079702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851590|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851591|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
82851592|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851593|NCT00118040|Genistein|genistein|mesh-list
82851594|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82851595|NCT00118040|Protective Agents|protective agents|mesh-ancestor
82851596|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851597|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851598|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851599|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851600|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851601|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
82851602|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82851603|NCT00118040|Estrogens|estrogens|mesh-ancestor
82851604|NCT00118040|Hormones|hormones|mesh-ancestor
82851605|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851606|NCT03961958|Propofol|propofol|mesh-list
82851607|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82851608|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82851609|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851610|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82851611|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
82851612|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
82851613|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82851614|NCT00389207|Nevirapine|nevirapine|mesh-list
82851615|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82851616|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82851617|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
82851618|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851619|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851620|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82851621|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82851622|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
82851623|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83447113|NCT00363610|Pegaspargase|pegaspargase|mesh-list
82851624|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82851625|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82851626|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82851627|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82851628|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82851629|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
82851630|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82851631|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83447262|NCT01834183|Tivozanib|tivozanib|mesh-list
82851632|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82851633|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83447400|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82851634|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851635|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
82851636|NCT00085202|Vincristine|vincristine|mesh-list
82851638|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
82851639|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851640|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851641|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82851642|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
83447613|NCT02494180|Meperidine|meperidine|mesh-list
82851643|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851644|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851645|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83447691|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
82851646|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83447763|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
82851647|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851648|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851649|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851650|NCT00388583|Vaccines|vaccines|mesh-list
82851651|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
82851652|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851653|NCT00117572|Docetaxel|docetaxel|mesh-list
82851654|NCT00117572|Fluorouracil|fluorouracil|mesh-list
82851655|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
82851656|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851657|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851658|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851659|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851660|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851661|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
82851662|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851663|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851664|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
82851665|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851666|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
82851667|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851668|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82851669|NCT00388505|Tobramycin|tobramycin|mesh-list
83448045|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
82851670|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82851671|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851672|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
82851673|NCT00388349|Carmustine|carmustine|mesh-list
82851674|NCT00388349|Gemcitabine|gemcitabine|mesh-list
82851675|NCT00388349|Etoposide|etoposide|mesh-list
82851676|NCT00388349|Vinorelbine|vinorelbine|mesh-list
82851677|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851678|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
82851679|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448190|NCT00913003|Lidocaine|lidocaine|mesh-list
82851680|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851681|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82851682|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
82851683|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851684|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851685|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82851686|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851687|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
82851688|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82851689|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82851690|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82851691|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851692|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
83448559|NCT02425306|Poly ICLC|poly iclc|mesh-list
82851693|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851694|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851695|NCT00117338|Montelukast|montelukast|mesh-list
82851696|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82851697|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
82851698|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82851699|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
82851700|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83448785|NCT00880997|Doxazosin|doxazosin|mesh-list
82851701|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83448934|NCT04295850|Aspirin|aspirin|mesh-list
82851702|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82851703|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83448997|NCT03751709|Blinatumomab|blinatumomab|mesh-list
82851704|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851705|NCT00388037|Sunitinib|sunitinib|mesh-list
82851706|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83449144|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
82851707|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851708|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82851709|NCT00388037|Growth Substances|growth substances|mesh-ancestor
82851710|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83449293|NCT05720559|Folic Acid|folic acid|mesh-list
82851711|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851712|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851713|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83449436|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82851714|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851716|NCT00387881|Sumatriptan|sumatriptan|mesh-list
82851717|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82851718|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82851719|NCT00387881|Analgesics|analgesics|mesh-ancestor
82851720|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
82851721|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851722|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851723|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851724|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851725|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
82851726|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82851727|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851728|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851729|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82851730|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82851731|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82851732|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
82851733|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851734|NCT00084656|Ipilimumab|ipilimumab|mesh-list
82851735|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851736|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851737|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82851738|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851739|NCT00387647|Azacitidine|azacitidine|mesh-list
82851740|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851741|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
82851742|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83449939|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82851743|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851744|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851745|NCT00386009|Tadalafil|tadalafil|mesh-list
82851746|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
82851747|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82851748|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82851749|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851750|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851751|NCT00386009|Urological Agents|urological agents|mesh-ancestor
82851752|NCT01045889|Prednisone|prednisone|mesh-list
82851753|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
82851754|NCT01045889|Melphalan|melphalan|mesh-list
82851755|NCT01045889|Rituximab|rituximab|mesh-list
82851756|NCT01045889|Etoposide|etoposide|mesh-list
83450494|NCT01834235|Paclitaxel|paclitaxel|mesh-list
82851757|NCT01045889|Vincristine|vincristine|mesh-list
82851758|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851759|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
82851760|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851761|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851762|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82851763|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
83450669|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83450817|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851764|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851765|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851766|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82851767|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851768|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851769|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
82851770|NCT01045889|Hormones|hormones|mesh-ancestor
82851771|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851772|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83451179|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
82851773|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82851774|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83451255|NCT01721525|Ribavirin|ribavirin|mesh-list
82851775|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82851776|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851777|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851778|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851779|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851780|NCT00373685|Celecoxib|celecoxib|mesh-list
82851781|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82851782|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82851783|NCT00373685|Analgesics|analgesics|mesh-ancestor
82851784|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
82851785|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851786|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851787|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851788|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851789|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82851790|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82851791|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851792|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851793|NCT00373529|Clofarabine|clofarabine|mesh-list
82851794|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851795|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
82851796|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851797|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851798|NCT00373295|Baclofen|baclofen|mesh-list
83451545|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
82851799|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82851800|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851801|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82851802|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851803|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82851804|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
82851805|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
82851806|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851807|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851808|NCT00385541|Morphine|morphine|mesh-list
82851809|NCT00385541|Hydromorphone|hydromorphone|mesh-list
82851810|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82851811|NCT00385541|Narcotics|narcotics|mesh-ancestor
82851812|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82851813|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851814|NCT00385541|Analgesics|analgesics|mesh-ancestor
82851815|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
82851816|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851817|NCT01046045|Everolimus|everolimus|mesh-list
82851818|NCT01046045|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82851819|NCT01046045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82851820|NCT01046045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851821|NCT01046045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851822|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851823|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
82851824|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851825|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851826|NCT01044719|Meropenem|meropenem|mesh-list
82851827|NCT01044719|Tobramycin|tobramycin|mesh-list
82851828|NCT01044719|Ceftazidime|ceftazidime|mesh-list
82851829|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82851830|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851831|NCT01045109|Vitamin D|vitamin d|mesh-list
82851832|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
82851833|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
82851834|NCT01045109|Vitamins|vitamins|mesh-list
82851835|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
82851836|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452031|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
82851837|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83452172|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
83452247|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851838|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82851839|NCT00094302|Spironolactone|spironolactone|mesh-list
82851840|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
82851841|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
82851842|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851843|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851844|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82851845|NCT00094302|Diuretics|diuretics|mesh-ancestor
82851846|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
82851847|NCT00372905|Rituximab|rituximab|mesh-list
82851848|NCT00372905|Bortezomib|bortezomib|mesh-list
82851849|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82851850|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851851|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851852|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
82851853|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851854|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851855|NCT00384839|Azacitidine|azacitidine|mesh-list
82851856|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851857|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
83452679|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82851858|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851859|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851860|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851863|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851864|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851865|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82851867|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851868|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851869|NCT00384293|Niacin|niacin|mesh-list
82851870|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82851871|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
82851872|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851873|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82851874|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
82851875|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
82851876|NCT00384293|Vitamins|vitamins|mesh-ancestor
82851877|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
82851878|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851879|NCT01087866|Metformin|metformin|mesh-list
82851880|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82851881|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851882|NCT01090830|Paclitaxel|paclitaxel|mesh-list
82851883|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82851884|NCT01090830|Bevacizumab|bevacizumab|mesh-list
82851885|NCT01090830|Carboplatin|carboplatin|mesh-list
82851886|NCT01090830|Belinostat|belinostat|mesh-list
82851887|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82851888|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851889|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851890|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851891|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851892|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851893|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851894|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851895|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82851896|NCT01090830|Growth Substances|growth substances|mesh-ancestor
82851897|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851898|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851899|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82851900|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851901|NCT01084824|Cantharidin|cantharidin|mesh-list
82851902|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851903|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851904|NCT01088022|Dexamethasone|dexamethasone|mesh-list
82851905|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
82851906|NCT01088022|Aprepitant|aprepitant|mesh-list
82851907|NCT01088022|Palonosetron|palonosetron|mesh-list
82851908|NCT01088022|BB 1101|bb 1101|mesh-list
82851909|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851910|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
82851911|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
83452751|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82851912|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851913|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851914|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82851915|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
82851916|NCT01088022|Hormones|hormones|mesh-ancestor
82851917|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82851918|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82851919|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851920|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
82851921|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851922|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851923|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82851924|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82851925|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82851926|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82851927|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
82851928|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
82851929|NCT00067002|Melphalan|melphalan|mesh-list
82851930|NCT00067002|Thiotepa|thiotepa|mesh-list
82851931|NCT00067002|Rituximab|rituximab|mesh-list
82851932|NCT00067002|Fludarabine|fludarabine|mesh-list
82851933|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
82851934|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851935|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
82851936|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851938|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82851939|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
82851940|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851941|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851942|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82851943|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851944|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82851945|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
82851946|NCT03961698|Paclitaxel|paclitaxel|mesh-list
82851947|NCT03961698|Bevacizumab|bevacizumab|mesh-list
82851948|NCT03961698|Atezolizumab|atezolizumab|mesh-list
82851949|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82851950|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82851951|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
82851952|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
82851953|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
82851954|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851955|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82851956|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82851957|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82851958|NCT03961698|Growth Substances|growth substances|mesh-ancestor
82851959|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851960|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
82851961|NCT03961698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82851962|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82851963|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82851964|NCT01084902|Latanoprost|latanoprost|mesh-list
82851965|NCT01084902|Brinzolamide|brinzolamide|mesh-list
82851966|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82851967|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82851968|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82851969|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851970|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851971|NCT01084980|Tacrolimus|tacrolimus|mesh-list
82851972|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82851973|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
82851974|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851975|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82851976|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82851977|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82851978|NCT01085058|Lenograstim|lenograstim|mesh-list
82851979|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82851980|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
82851981|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851982|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
82851983|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82851984|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
82851985|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82851986|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851987|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82851988|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82851989|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82851990|NCT01088256|Etoricoxib|etoricoxib|mesh-list
82851991|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82851992|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82851993|NCT01088256|Analgesics|analgesics|mesh-ancestor
82851994|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
82851995|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82851996|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82851997|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82851998|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82851999|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82852000|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82852001|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852002|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852003|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
82852004|NCT01326858|Ketotifen|ketotifen|mesh-list
82852005|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82852006|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82852007|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82852008|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82852010|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
82852011|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852012|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852013|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852014|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852015|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82852016|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82852017|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82852018|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
82852019|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
82852020|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852021|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852022|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
82852023|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
82852024|NCT00091572|Temozolomide|temozolomide|mesh-list
82852025|NCT00091572|Dacarbazine|dacarbazine|mesh-list
82852026|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82852027|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
82852028|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852029|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852030|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
82852031|NCT01091220|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82852032|NCT01091220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852033|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852034|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
82852035|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852036|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852037|NCT00084266|Vancomycin|vancomycin|mesh-list
82852038|NCT00084266|Linezolid|linezolid|mesh-list
82852039|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852040|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852041|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82852042|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852043|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852044|NCT01086878|Trimethoprim|trimethoprim|mesh-list
82852045|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82852046|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
82852047|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82852048|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852049|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
82852050|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82852051|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82852052|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82852053|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852054|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852055|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82852056|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82852057|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82852058|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852059|NCT01086956|Sufentanil|sufentanil|mesh-list
82852060|NCT01086956|Ropivacaine|ropivacaine|mesh-list
82852061|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
82852062|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
82852063|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82852064|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852065|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
82852066|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852067|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82852068|NCT01086956|Narcotics|narcotics|mesh-ancestor
82852069|NCT01086956|Analgesics|analgesics|mesh-ancestor
82852070|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82852071|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82852072|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
82852073|NCT00091026|Bevacizumab|bevacizumab|mesh-list
82852074|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82852075|NCT00091026|Cetuximab|cetuximab|mesh-list
82852076|NCT00091026|Gemcitabine|gemcitabine|mesh-list
82852077|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82852078|NCT00091026|Antibodies|antibodies|mesh-list
82852079|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
82852080|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82852081|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852082|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82852083|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82852086|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
82852087|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
82852088|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852089|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
82852090|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852091|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852092|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852093|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82852094|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852095|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852096|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852097|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852098|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
82852099|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82852100|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
82852101|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82852102|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
82852103|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852104|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
82852105|NCT00100178|Daclizumab|daclizumab|mesh-list
82852106|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82852107|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852108|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82852109|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
82852110|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852111|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852112|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852113|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852114|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852115|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
82852116|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852117|NCT00099632|Ritonavir|ritonavir|mesh-list
82852118|NCT00099632|Lopinavir|lopinavir|mesh-list
82852119|NCT00099632|Tenofovir|tenofovir|mesh-list
82852120|NCT00099632|Lamivudine|lamivudine|mesh-list
82852121|NCT00099632|Emtricitabine|emtricitabine|mesh-list
82852122|NCT00099632|Zidovudine|zidovudine|mesh-list
82852123|NCT00099632|Nevirapine|nevirapine|mesh-list
82852124|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82852125|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82852126|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82852127|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82852128|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
82852129|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852130|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852131|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82852132|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82852133|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
82852134|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852135|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82852136|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82852137|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82852138|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82852139|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
82852140|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82852141|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82852142|NCT01087190|Isoniazid|isoniazid|mesh-list
82852143|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
82852144|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852145|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852146|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82852147|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82852148|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
82852149|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852150|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82852151|NCT01090466|Sirolimus|sirolimus|mesh-list
82852152|NCT01090466|Gemcitabine|gemcitabine|mesh-list
82852153|NCT01090466|Temsirolimus|temsirolimus|mesh-list
82852154|NCT01090466|MTOR Inhibitors|mtor inhibitors|mesh-list
82852155|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852156|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852158|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852159|NCT01090466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852160|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852161|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852162|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
82852163|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852164|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852165|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852166|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82852167|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
82852168|NCT04116398|Dexamethasone|dexamethasone|mesh-list
82852169|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852170|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
82852171|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
82852172|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852173|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852174|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82852175|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
82852176|NCT04116398|Hormones|hormones|mesh-ancestor
82852177|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852178|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82852179|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852180|NCT00098774|Leucovorin|leucovorin|mesh-list
82852181|NCT00098774|Cytarabine|cytarabine|mesh-list
82852182|NCT00098774|Rituximab|rituximab|mesh-list
82852183|NCT00098774|Methotrexate|methotrexate|mesh-list
82852184|NCT00098774|Etoposide|etoposide|mesh-list
82852185|NCT00098774|Temozolomide|temozolomide|mesh-list
82852186|NCT00098774|Calcium|calcium|mesh-list
82852187|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
82852188|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82852189|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852190|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
82852191|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852192|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852193|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82852194|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82852195|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
82852196|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82852197|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852199|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852200|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
82852201|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852202|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82852203|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852204|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83452779|NCT02959359|Ribavirin|ribavirin|mesh-list
82852205|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82852206|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82852207|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82852208|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
82852209|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852210|NCT00098774|Antidotes|antidotes|mesh-ancestor
82852211|NCT00098774|Protective Agents|protective agents|mesh-ancestor
82852212|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
82852213|NCT00098774|Vitamins|vitamins|mesh-ancestor
82852214|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
82852215|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82852216|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
82852217|NCT01081652|Progesterone|progesterone|mesh-list
82852218|NCT01081652|Progestins|progestins|mesh-ancestor
82852219|NCT01081652|Hormones|hormones|mesh-ancestor
82852220|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852221|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852222|NCT01087580|Prednisone|prednisone|mesh-list
82852223|NCT01087580|Docetaxel|docetaxel|mesh-list
82852224|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852225|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
82852226|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
82852227|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
82852228|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852229|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852230|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
82852231|NCT01087580|Hormones|hormones|mesh-ancestor
82852232|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852233|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852234|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82852236|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82852237|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852238|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82852239|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82852240|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852241|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
82852242|NCT01081730|Ustekinumab|ustekinumab|mesh-list
82852243|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
82852244|NCT01090700|Simeprevir|simeprevir|mesh-list
82852245|NCT01090700|Dexetimide|dexetimide|mesh-list
82852246|NCT01090700|Citalopram|citalopram|mesh-list
82852247|NCT01090700|Escitalopram|escitalopram|mesh-list
82852248|NCT01090700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82852249|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82852250|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82852251|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852252|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852253|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
82852254|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852255|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82852256|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82852257|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
82852258|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
82852259|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852260|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82852261|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82852262|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
82852263|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82852264|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
82852265|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82852266|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
82852267|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852268|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
82852269|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852270|NCT03957902|Aspirin|aspirin|mesh-list
82852271|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82852272|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82852273|NCT03957902|Analgesics|analgesics|mesh-ancestor
82852274|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
82852275|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852276|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852277|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852278|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852279|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82852280|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82852281|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852282|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82852283|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82852284|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852285|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
82852286|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82852287|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
82852288|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852289|NCT01046435|Amoxicillin|amoxicillin|mesh-list
82852290|NCT01046435|Metronidazole|metronidazole|mesh-list
82852291|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852292|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852293|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82852294|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82852295|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
82852296|NCT00858364|Hematinics|hematinics|mesh-ancestor
82852297|NCT00382733|Topotecan|topotecan|mesh-list
82852298|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82852299|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82852300|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852301|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852302|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852303|NCT03992885|Pemetrexed|pemetrexed|mesh-list
82852304|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852305|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852306|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852307|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82852309|NCT03739294|Fluticasone|fluticasone|mesh-list
82852311|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852312|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82852313|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
82852314|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852315|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852316|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82852317|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
82852318|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
82852319|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82852320|NCT03732508|Fluorouracil|fluorouracil|mesh-list
82852321|NCT03732508|Irinotecan|irinotecan|mesh-list
82852322|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
82852323|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852324|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852325|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852326|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852327|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
82852328|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852329|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82852330|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82852331|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852332|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82852333|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
82852334|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852335|NCT00112437|Vitamin D|vitamin d|mesh-list
82852336|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
82852337|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
82852338|NCT00112437|Calcium|calcium|mesh-list
82852339|NCT00112437|Vitamins|vitamins|mesh-ancestor
82852340|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
82852341|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852342|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82852343|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82852344|NCT00112437|Antacids|antacids|mesh-ancestor
82852345|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852346|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82852347|NCT03653416|Bupivacaine|bupivacaine|mesh-list
82852348|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
82852349|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
82852350|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82852351|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852352|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
82852353|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852354|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
82852355|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82852356|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
82852357|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852358|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
82852359|NCT01076673|Protective Agents|protective agents|mesh-ancestor
82852360|NCT00119379|Tenofovir|tenofovir|mesh-list
82852361|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
82852362|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852363|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82852364|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82852365|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852366|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852367|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82852368|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82852369|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
82852370|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82852371|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852372|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82852373|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
82852374|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852375|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852376|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852377|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852378|NCT01079481|Everolimus|everolimus|mesh-list
82852379|NCT01079481|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82852380|NCT01079481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852381|NCT01079481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852382|NCT01079481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852384|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
82852385|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852386|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852387|NCT03964779|Antibodies|antibodies|mesh-list
82852388|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
82852389|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
82852390|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852391|NCT00131937|Sorafenib|sorafenib|mesh-list
82852392|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852393|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852394|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852395|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852396|NCT01079559|Tobramycin|tobramycin|mesh-list
82852397|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852398|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852399|NCT00131469|Teriparatide|teriparatide|mesh-list
82852400|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82852401|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852402|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82852403|NCT00372593|Cytarabine|cytarabine|mesh-list
82852404|NCT00372593|Etoposide|etoposide|mesh-list
82852405|NCT00372593|Daunorubicin|daunorubicin|mesh-list
82852406|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
82852407|NCT00372593|Asparaginase|asparaginase|mesh-list
82852408|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
82852409|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82852410|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852411|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82852412|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82852413|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852414|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852415|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852416|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
82852417|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
82852418|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852419|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852420|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
82852421|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852422|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82852423|NCT00372593|Analgesics|analgesics|mesh-ancestor
82852424|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
82852425|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852426|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82852427|NCT00372593|Immunotoxins|immunotoxins|mesh-ancestor
82852428|NCT00372593|Immunoconjugates|immunoconjugates|mesh-ancestor
82852429|NCT01324583|Prednisolone|prednisolone|mesh-list
82852430|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852431|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
82852432|NCT01324583|Hormones|hormones|mesh-ancestor
82852433|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852434|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852435|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82852436|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852437|NCT00382109|Sirolimus|sirolimus|mesh-list
82852438|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
82852439|NCT00382109|Thiotepa|thiotepa|mesh-list
82852440|NCT00382109|Methotrexate|methotrexate|mesh-list
82852441|NCT00382109|Tacrolimus|tacrolimus|mesh-list
82852442|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852443|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
82852444|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852445|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852446|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82852447|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
82852448|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852449|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852450|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82852451|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82852452|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
82852453|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82852454|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852455|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
82852456|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
82852457|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852458|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82852459|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82852460|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82852461|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852462|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852463|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82852464|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
82852465|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
82852466|NCT00381797|Bevacizumab|bevacizumab|mesh-list
82852467|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82852468|NCT00381797|Irinotecan|irinotecan|mesh-list
82852469|NCT00381797|Camptothecin|camptothecin|mesh-list
82852470|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
82852471|NCT00381797|Antibodies|antibodies|mesh-list
82852472|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
82852473|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82852474|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
82852475|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82852476|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852477|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82852478|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82852479|NCT00381797|Growth Substances|growth substances|mesh-ancestor
82852480|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852481|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
82852482|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
82852483|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82852484|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82852485|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852486|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852487|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82852488|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82852489|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
82852490|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
82852491|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852492|NCT03665038|Brexanolone|brexanolone|mesh-list
82852493|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
82852494|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852495|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852496|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852497|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
82852498|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
82852499|NCT03664024|Carboplatin|carboplatin|mesh-list
82852500|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
82852501|NCT03664024|Pemetrexed|pemetrexed|mesh-list
82852502|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852503|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82852504|NCT03664024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82852505|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852506|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852507|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82852508|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82852509|NCT00381641|Sunitinib|sunitinib|mesh-list
82852510|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852511|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82852512|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82852513|NCT00381641|Growth Substances|growth substances|mesh-ancestor
82852514|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852515|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
82852516|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852517|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852518|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852519|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
82852520|NCT03624946|Antibodies|antibodies|mesh-list
82852521|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
82852522|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82852523|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82852524|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
82852525|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
82852526|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852527|NCT03735082|Paclitaxel|paclitaxel|mesh-list
82852528|NCT03735082|Carboplatin|carboplatin|mesh-list
82852529|NCT03735082|Apatinib|apatinib|mesh-list
82852530|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82852531|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852532|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
82852533|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
82852534|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
82852535|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852536|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852538|NCT00381095|Pregabalin|pregabalin|mesh-list
82852539|NCT00381095|Analgesics|analgesics|mesh-ancestor
82852540|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
82852541|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852542|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852543|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
82852544|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82852545|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82852546|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852547|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82852548|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82852549|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82852550|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82852551|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82852552|NCT03737656|Progesterone|progesterone|mesh-list
82852553|NCT03737656|Progestins|progestins|mesh-ancestor
82852554|NCT03737656|Hormones|hormones|mesh-ancestor
82852555|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852556|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852557|NCT00112047|Tenofovir|tenofovir|mesh-list
82852558|NCT00112047|Lamivudine|lamivudine|mesh-list
82852559|NCT00112047|Emtricitabine|emtricitabine|mesh-list
82852560|NCT00112047|Zidovudine|zidovudine|mesh-list
82852561|NCT00112047|Efavirenz|efavirenz|mesh-list
82852562|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82852563|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
82852564|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852565|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82852566|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82852567|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852568|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852569|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82852570|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82852571|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
82852572|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82852573|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82852574|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82852575|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82852576|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82852577|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82852578|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82852579|NCT03658876|Hematinics|hematinics|mesh-ancestor
82852580|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
82852581|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82852582|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852583|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
82852584|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852585|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852586|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852587|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852588|NCT03734614|Aspirin|aspirin|mesh-list
82852589|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82852590|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82852591|NCT03734614|Analgesics|analgesics|mesh-ancestor
82852592|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
82852593|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852594|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852595|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852596|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852597|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82852598|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82852599|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852600|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82852601|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82852602|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852603|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
82852604|NCT00380393|Vaccines|vaccines|mesh-list
82852605|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
82852606|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852607|NCT00380081|Zolpidem|zolpidem|mesh-list
82852608|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82852609|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82852610|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82852611|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852612|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82852613|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
82852614|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
82852615|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852616|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852617|NCT03579940|Lasmiditan|lasmiditan|mesh-list
82852618|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82852619|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
82852620|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852621|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852622|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852623|NCT03732040|Fluorides|fluorides|mesh-list
82852624|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
82852625|NCT03732040|Protective Agents|protective agents|mesh-ancestor
82852626|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852627|NCT00098306|Maraviroc|maraviroc|mesh-list
82852628|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82852629|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82852630|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852631|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82852632|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82852633|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
82852634|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852635|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82852636|NCT03615040|Astegolimab|astegolimab|mesh-list
82852637|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82852638|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852639|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
82852640|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852641|NCT01090778|Hormones|hormones|mesh-list
82852642|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852643|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852644|NCT00068588|Capecitabine|capecitabine|mesh-list
82852645|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852646|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
82852647|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852648|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852649|NCT01088282|Dipivefrin|dipivefrin|mesh-list
82852650|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82852651|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
82852652|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852653|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852654|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852655|NCT03963752|Megestrol|megestrol|mesh-list
82852656|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
82852657|NCT03963752|Leuprolide|leuprolide|mesh-list
82852658|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82852659|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82852660|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82852661|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
82852662|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82852663|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852664|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82852665|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82852666|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82852667|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852668|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
82852669|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82852670|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82852671|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
82852672|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
82852673|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
82852674|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852675|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852676|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852677|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
82852678|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
82852679|NCT01310296|Lofexidine|lofexidine|mesh-list
82852680|NCT01310296|Clonidine|clonidine|mesh-list
82852681|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82852682|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82852683|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852684|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
82852685|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852686|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82852687|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82852688|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82852689|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
82852690|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852691|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852692|NCT01310296|Analgesics|analgesics|mesh-ancestor
82852693|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
82852694|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
82852695|NCT03734068|Doxorubicin|doxorubicin|mesh-list
82852696|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82852697|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852698|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82852699|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82852700|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852701|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852702|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
82852703|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852704|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82852705|NCT03575806|Estrogens|estrogens|mesh-ancestor
82852706|NCT03575806|Hormones|hormones|mesh-ancestor
82852707|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852708|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82852709|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852710|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
82852711|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
82852712|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852713|NCT03729310|Triamcinolone|triamcinolone|mesh-list
82852714|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852715|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
82852716|NCT03729310|Hormones|hormones|mesh-ancestor
82852717|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852718|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852719|NCT03731494|Nickel|nickel|mesh-list
82852720|NCT03731494|Trace Elements|trace elements|mesh-ancestor
82852721|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
82852722|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852723|NCT00111813|Bortezomib|bortezomib|mesh-list
82852724|NCT00111813|Vorinostat|vorinostat|mesh-list
82852725|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852726|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82852727|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852728|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852729|NCT00118287|Etanercept|etanercept|mesh-list
82852730|NCT00118287|Azacitidine|azacitidine|mesh-list
82852731|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852732|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
82852733|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852734|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852735|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852736|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82852737|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82852738|NCT00118287|Analgesics|analgesics|mesh-ancestor
82852739|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
82852740|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852741|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852742|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852743|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852744|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82852745|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852746|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
82852747|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
82852748|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
82852749|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82852750|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852751|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852752|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
82852753|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82852754|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82852755|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852756|NCT01079715|Propranolol|propranolol|mesh-list
82852757|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82852758|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82852759|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
82852760|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852761|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852762|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852763|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82852764|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82852765|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
82852766|NCT00130689|Cetuximab|cetuximab|mesh-list
82852767|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82852768|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852769|NCT01326585|Dexamethasone|dexamethasone|mesh-list
82852770|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
82852771|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82852772|NCT01326585|BB 1101|bb 1101|mesh-list
82852773|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852774|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
82852775|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
82852776|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852777|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852778|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82852779|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
82852780|NCT01326585|Hormones|hormones|mesh-ancestor
82852781|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852782|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82852783|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852784|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
82852785|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852786|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852787|NCT03964935|Minocycline|minocycline|mesh-list
82852788|NCT03964935|Lycopene|lycopene|mesh-list
82852789|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852790|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852791|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852792|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
83452806|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852793|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852794|NCT03964935|Protective Agents|protective agents|mesh-ancestor
82852795|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852796|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82852797|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82852798|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852800|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
82852801|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852802|NCT00117507|Deferasirox|deferasirox|mesh-list
82852803|NCT00117507|Chelating Agents|chelating agents|mesh-list
82852804|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82852805|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
82852806|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852807|NCT03621046|Zolpidem|zolpidem|mesh-list
82852808|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82852809|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82852810|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82852811|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852812|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82852813|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
82852814|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
82852815|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852816|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852817|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
82852818|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82852819|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852820|NCT03603496|Nicotine|nicotine|mesh-list
82852821|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82852822|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
82852823|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852824|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852825|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82852826|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82852827|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
82852828|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852829|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852830|NCT00096135|Leucovorin|leucovorin|mesh-list
82852831|NCT00096135|Cytarabine|cytarabine|mesh-list
82852832|NCT00096135|Dexamethasone|dexamethasone|mesh-list
82852833|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
82852834|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82852835|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82852836|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82852837|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
82852838|NCT00096135|Methotrexate|methotrexate|mesh-list
82852839|NCT00096135|Etoposide|etoposide|mesh-list
82852840|NCT00096135|Vincristine|vincristine|mesh-list
82852841|NCT00096135|Daunorubicin|daunorubicin|mesh-list
82852842|NCT00096135|Asparaginase|asparaginase|mesh-list
82852843|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
82852844|NCT00096135|Pegaspargase|pegaspargase|mesh-list
82852845|NCT00096135|Lenograstim|lenograstim|mesh-list
82852846|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
82852847|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82852848|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
82852849|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852850|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82852851|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82852852|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
82852853|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852854|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852855|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82852856|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82852857|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
82852858|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
82852859|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852860|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82852861|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
82852862|NCT00096135|Hormones|hormones|mesh-ancestor
82852863|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852864|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83452807|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82852865|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82852866|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
82852867|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82852868|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82852869|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
82852870|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
82852871|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852872|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82852873|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82852874|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82852875|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82852876|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82852877|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
82852878|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852879|NCT00096135|Antidotes|antidotes|mesh-ancestor
82852880|NCT00096135|Protective Agents|protective agents|mesh-ancestor
82852881|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
82852882|NCT00096135|Vitamins|vitamins|mesh-ancestor
82852883|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
82852884|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82852885|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
82852886|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
82852887|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
82852888|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82852889|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82852890|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82852891|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82852892|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82852893|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852894|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852895|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
82852896|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852897|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82852898|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82852899|NCT00116649|Imiquimod|imiquimod|mesh-list
82852900|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82852901|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
82852902|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852903|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852904|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
82852905|NCT01080651|Voriconazole|voriconazole|mesh-list
82852906|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
82852907|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852908|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82852909|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82852910|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852911|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852912|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82852913|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
82852914|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852915|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852916|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82852917|NCT01080729|Hormones|hormones|mesh-list
82852918|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82852919|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852920|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852921|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
82852922|NCT03962907|Mupirocin|mupirocin|mesh-list
82852923|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82852924|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852925|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
82852926|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852927|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82852928|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852929|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852930|NCT00083889|Interferons|interferons|mesh-list
82852931|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
82852932|NCT00083889|Sunitinib|sunitinib|mesh-list
82852933|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852934|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
82852935|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852936|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
82852937|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852938|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82852939|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82852940|NCT00083889|Growth Substances|growth substances|mesh-ancestor
82852941|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
82852942|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82852943|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852944|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852945|NCT03639532|Tacrine|tacrine|mesh-list
82852946|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82852947|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852948|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852949|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
82852950|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82852951|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852952|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82852953|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
82852954|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852955|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
82852956|NCT03571516|Teduglutide|teduglutide|mesh-list
82852957|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82852958|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82852959|NCT03571516|Protective Agents|protective agents|mesh-ancestor
82852960|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852961|NCT03600376|Dantrolene|dantrolene|mesh-list
82852962|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82852963|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852964|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82852965|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82852966|NCT03961659|Metformin|metformin|mesh-list
82852967|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
82852968|NCT03961659|Acarbose|acarbose|mesh-list
82852969|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82852970|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852971|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82852972|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852973|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82852974|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82852975|NCT03599362|Nivolumab|nivolumab|mesh-list
82852976|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82852977|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82852978|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82852979|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82852980|NCT03741309|Calcium|calcium|mesh-list
82852981|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82852982|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852983|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
82852984|NCT00082407|Exenatide|exenatide|mesh-list
82852985|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
82852987|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82852988|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82852989|NCT00082407|Incretins|incretins|mesh-ancestor
82852990|NCT00082407|Hormones|hormones|mesh-ancestor
82852991|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82852992|NCT01080963|Daptomycin|daptomycin|mesh-list
82852993|NCT01080963|Cefuroxime|cefuroxime|mesh-list
82852994|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
82852995|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82852996|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82852997|NCT01083381|Risperidone|risperidone|mesh-list
82852998|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82852999|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
82853000|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853001|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853002|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853003|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82853004|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82853005|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853006|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82853007|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82853008|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
82853009|NCT01087359|Melatonin|melatonin|mesh-list
82853010|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
82853011|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853012|NCT01087359|Protective Agents|protective agents|mesh-ancestor
83452812|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82853013|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853014|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853015|NCT01087437|Calcium|calcium|mesh-list
82853016|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82853017|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853018|NCT01083537|Paclitaxel|paclitaxel|mesh-list
82853019|NCT01083537|Cisplatin|cisplatin|mesh-list
82853020|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82853021|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853022|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853023|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853024|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853025|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853026|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
82853027|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
82853028|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
82853029|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
82853030|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853031|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
82853032|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82853033|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82853034|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853035|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82853036|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
82853037|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853038|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82853039|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
82853040|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
82853041|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
82853042|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82853043|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82853044|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82853045|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82853046|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853047|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
82853048|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853049|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853050|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82853051|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853052|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
82853053|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
82853054|NCT03569098|Coagulants|coagulants|mesh-ancestor
82853055|NCT03727282|Dobutamine|dobutamine|mesh-list
82853056|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82853057|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
82853058|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
82853059|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853060|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853061|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82853063|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82853064|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
82853065|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853066|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853067|NCT03727282|Protective Agents|protective agents|mesh-ancestor
82853068|NCT03568942|Gepotidacin|gepotidacin|mesh-list
82853069|NCT03568942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82853070|NCT03568942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853071|NCT03568942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853072|NCT03568942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853073|NCT00110019|Paclitaxel|paclitaxel|mesh-list
82853074|NCT00110019|Carboplatin|carboplatin|mesh-list
82853075|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82853076|NCT00110019|Sorafenib|sorafenib|mesh-list
82853077|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82853078|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853079|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853080|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853081|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853082|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853083|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82853084|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083874|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083875|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83083876|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83083877|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83083878|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83083879|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
83083880|NCT02475746|Itraconazole|itraconazole|mesh-list
83083881|NCT02475746|PF-06372865|pf-06372865|mesh-list
83083882|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
83083883|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083884|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83083885|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83083886|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083887|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083888|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83083889|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
83083890|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083891|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083892|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83083893|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
83083894|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
83083895|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083896|NCT05715164|Nicotine|nicotine|mesh-list
83083897|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83083898|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
83083899|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083900|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083901|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83083902|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83083903|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
83083904|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083905|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083906|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
83083907|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83083908|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
83083909|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83083910|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083911|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83083912|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83083913|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83083914|NCT02480894|Maraviroc|maraviroc|mesh-list
83083915|NCT02480894|Fostemsavir|fostemsavir|mesh-list
83083916|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83083917|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83083918|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083919|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83083920|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83083921|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
83083922|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853093|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
82853094|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853095|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853096|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853097|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853098|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82853099|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853100|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853101|NCT00095979|Epothilones|epothilones|mesh-list
82853102|NCT00095979|Epothilone B|epothilone b|mesh-list
82853103|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853104|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853105|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853106|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853107|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853108|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82853109|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82853110|NCT01087593|Estradiol|estradiol|mesh-list
82853111|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82853112|NCT01087593|Estrogens|estrogens|mesh-ancestor
82853113|NCT01087593|Hormones|hormones|mesh-ancestor
82853114|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853115|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853116|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82853117|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
82853118|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82853119|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82853120|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
82853121|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82853122|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853123|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82853124|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82853125|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853126|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853127|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853128|NCT01087749|Losartan|losartan|mesh-list
82853129|NCT01087749|Propranolol|propranolol|mesh-list
82853130|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82853131|NCT01087749|Eprosartan|eprosartan|mesh-list
82853132|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82853133|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82853134|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82853135|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82853136|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853137|NCT01087749|Diuretics|diuretics|mesh-ancestor
82853138|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
82853139|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853140|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82853141|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82853142|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82853143|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82853144|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
82853145|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853146|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
82853147|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
82853154|NCT00108069|Tamoxifen|tamoxifen|mesh-list
82853155|NCT00108069|Bortezomib|bortezomib|mesh-list
82853156|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853157|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82853158|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
82853159|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853160|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853161|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82853162|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82853163|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82853164|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82853165|NCT00079274|Leucovorin|leucovorin|mesh-list
82853166|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82853167|NCT00079274|Cetuximab|cetuximab|mesh-list
82853168|NCT00079274|Fluorouracil|fluorouracil|mesh-list
82853169|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
82853170|NCT00079274|Irinotecan|irinotecan|mesh-list
82853171|NCT00079274|Antibodies|antibodies|mesh-list
82853172|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
82853173|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82853174|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
82853175|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
83452830|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
82853176|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853177|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853178|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
82853179|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853180|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82853181|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82853182|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82853183|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82853184|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853185|NCT00079274|Antidotes|antidotes|mesh-ancestor
82853186|NCT00079274|Protective Agents|protective agents|mesh-ancestor
82853187|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
82853188|NCT00079274|Vitamins|vitamins|mesh-ancestor
82853189|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
82853190|NCT01081964|Levofloxacin|levofloxacin|mesh-list
82853191|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
82853192|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82853193|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853194|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82853195|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82853196|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82853197|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853198|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853199|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853200|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82853201|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82853202|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82853203|NCT00079040|Bevacizumab|bevacizumab|mesh-list
82853204|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82853205|NCT00079040|Etoposide|etoposide|mesh-list
82853206|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
82853207|NCT00079040|Antibodies|antibodies|mesh-list
82853208|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
82853209|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82853210|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853211|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853212|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853214|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853215|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853216|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
82853217|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82853218|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82853219|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82853220|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853221|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853222|NCT01088516|Ritonavir|ritonavir|mesh-list
82853223|NCT01088516|Lopinavir|lopinavir|mesh-list
82853224|NCT01088516|Zidovudine|zidovudine|mesh-list
82853225|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82853226|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82853227|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
82853228|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853229|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853230|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82853231|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82853232|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
82853233|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853234|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82853235|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82853236|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
82853237|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82853238|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82853239|NCT00078806|Etanercept|etanercept|mesh-list
82853240|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82853241|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853242|NCT00078806|Analgesics|analgesics|mesh-ancestor
82853243|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
82853244|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853245|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853246|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853247|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853248|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82853249|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82853250|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
82853251|NCT00078338|Interferons|interferons|mesh-list
82853252|NCT00078338|Interferon-beta|interferon-beta|mesh-list
82853253|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
82853254|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
82853255|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
82853256|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853257|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
82853258|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853259|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
82853260|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853261|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82853262|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82853263|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853264|NCT01088594|Pioglitazone|pioglitazone|mesh-list
82853265|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
82853266|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82853267|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853268|NCT01082120|Pioglitazone|pioglitazone|mesh-list
82853269|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82853270|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853271|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82853272|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82853273|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
82853274|NCT03808298|Balovaptan|balovaptan|mesh-list
82853275|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82853276|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82853277|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853278|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82853279|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82853280|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853281|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853282|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853283|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82853284|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
82853285|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82853286|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853287|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82853288|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82853289|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82853290|NCT03808298|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82853291|NCT03808298|Natriuretic Agents|natriuretic agents|mesh-ancestor
82853292|NCT03961334|Aspirin|aspirin|mesh-list
82853293|NCT03961334|Dabigatran|dabigatran|mesh-list
82853294|NCT03961334|Apixaban|apixaban|mesh-list
82853295|NCT03961334|Edoxaban|edoxaban|mesh-list
82853296|NCT03961334|Clopidogrel|clopidogrel|mesh-list
82853297|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82853298|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853299|NCT03961334|Analgesics|analgesics|mesh-ancestor
82853300|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
82853301|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853302|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853303|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853304|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853305|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82853306|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82853307|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853308|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82853309|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82853310|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853312|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82853313|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82853314|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82853315|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
82853316|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853317|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
82853318|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82853319|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
82853320|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
82853321|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82853322|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82853323|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
82853324|NCT00077636|Ribavirin|ribavirin|mesh-list
82853325|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
82853326|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853327|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
82853328|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853329|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
82853330|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853331|NCT01082198|Vaccines|vaccines|mesh-list
82853332|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
82853333|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
82853334|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853335|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82853336|NCT01088750|Prednisolone|prednisolone|mesh-list
82853337|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
82853338|NCT01088750|Vinblastine|vinblastine|mesh-list
82853339|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82853340|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
82853341|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853342|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853343|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82853344|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
82853345|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853346|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853347|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82853348|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853349|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
82853350|NCT01088750|Hormones|hormones|mesh-ancestor
82853351|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853352|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82853353|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82853354|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853355|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853356|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853357|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
82853358|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
82853359|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82853360|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82853361|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853362|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853364|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82853365|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82853366|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82853367|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853368|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853369|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82853370|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82853371|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82853372|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82853373|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
82853374|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853375|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853376|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82853377|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82853378|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
82853379|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82853380|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82853381|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
82853382|NCT01088906|Pemetrexed|pemetrexed|mesh-list
82853383|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853384|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853386|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82853387|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82853388|NCT00095199|Docetaxel|docetaxel|mesh-list
82853389|NCT00095199|Pemetrexed|pemetrexed|mesh-list
82853390|NCT00095199|Cetuximab|cetuximab|mesh-list
82853391|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853392|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853393|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853394|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853395|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853396|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853397|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82853398|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82853399|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82853400|NCT00075764|Fulvestrant|fulvestrant|mesh-list
82853401|NCT00075764|Anastrozole|anastrozole|mesh-list
82853402|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82853403|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853404|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82853405|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82853406|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
82853407|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853408|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853409|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82853410|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82853411|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853412|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853413|NCT03567616|Dexamethasone|dexamethasone|mesh-list
82853414|NCT03567616|Venetoclax|venetoclax|mesh-list
82853415|NCT03567616|Pomalidomide|pomalidomide|mesh-list
82853416|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853417|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
82853418|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
82853419|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853420|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853421|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82853422|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
82853423|NCT03567616|Hormones|hormones|mesh-ancestor
82853424|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853425|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82853426|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853427|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
82853428|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853429|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853430|NCT03567616|Growth Substances|growth substances|mesh-ancestor
82853431|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853432|NCT03567382|Tenofovir|tenofovir|mesh-list
82853433|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
82853434|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853435|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82853436|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82853437|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853438|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853439|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82853440|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82853441|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82853442|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82853443|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82853444|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82853445|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82853446|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
82853447|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853448|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853449|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853450|NCT03730714|Epinephrine|epinephrine|mesh-list
82853451|NCT03730714|Racepinephrine|racepinephrine|mesh-list
82853452|NCT03730714|Morphine|morphine|mesh-list
82853453|NCT03730714|Anesthetics|anesthetics|mesh-list
82853454|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
82853455|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
82853456|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82853457|NCT03730714|Narcotics|narcotics|mesh-ancestor
82853458|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853460|NCT03730714|Analgesics|analgesics|mesh-ancestor
82853461|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
82853462|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853463|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82853464|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82853465|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
82853466|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853467|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853468|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82853469|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82853470|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
82853471|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82853472|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
82853473|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
82853474|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
82853475|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82853476|NCT00106353|Temsirolimus|temsirolimus|mesh-list
82853477|NCT00106353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82853478|NCT00106353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82853479|NCT00106353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853480|NCT00106353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853481|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82853482|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
82853483|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853484|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853485|NCT01087983|Metformin|metformin|mesh-list
82853486|NCT01087983|Sirolimus|sirolimus|mesh-list
82853487|NCT01087983|Lapatinib|lapatinib|mesh-list
82853488|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82853489|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853490|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82853491|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853492|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82853493|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853494|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
82853495|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82853496|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
82853497|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82853498|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853499|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853500|NCT00080301|Capecitabine|capecitabine|mesh-list
82853501|NCT00080301|Epothilones|epothilones|mesh-list
82853502|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82853503|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
82853504|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853505|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853506|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853507|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853508|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853509|NCT03961503|Vancomycin|vancomycin|mesh-list
82853510|NCT03961503|Daptomycin|daptomycin|mesh-list
82853511|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82853512|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853513|NCT00079677|Modafinil|modafinil|mesh-list
82853514|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82853515|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853516|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82853517|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82853518|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83452877|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82853519|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853520|NCT01081353|Aspirin|aspirin|mesh-list
82853521|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82853522|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853523|NCT01081353|Analgesics|analgesics|mesh-ancestor
82853524|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
82853525|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853526|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853527|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853528|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853529|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82853530|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82853531|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853532|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82853534|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853535|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
82853536|NCT00095121|Lamivudine|lamivudine|mesh-list
82853537|NCT00095121|Adefovir|adefovir|mesh-list
82853538|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82853539|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82853540|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82853541|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853542|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853543|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
82853544|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853545|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82853546|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82853547|NCT01081431|Lenalidomide|lenalidomide|mesh-list
82853548|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
82853549|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853550|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853551|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853552|NCT01081431|Growth Substances|growth substances|mesh-ancestor
82853553|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853554|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853555|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
82853556|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82853557|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
82853558|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853559|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853560|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853561|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
82853562|NCT01084473|Morphine|morphine|mesh-list
82853563|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82853564|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853565|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853566|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853567|NCT01084473|Analgesics|analgesics|mesh-ancestor
82853568|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
82853569|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853570|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82853571|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82853572|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82853573|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
82853574|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853575|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853576|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82853577|NCT01084473|Narcotics|narcotics|mesh-ancestor
82853578|NCT01088373|Lenalidomide|lenalidomide|mesh-list
82853579|NCT01088373|Azacitidine|azacitidine|mesh-list
82853580|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
82853581|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853582|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853583|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853584|NCT01088373|Growth Substances|growth substances|mesh-ancestor
82853585|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853586|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853587|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82853588|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
82853589|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853590|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853591|NCT01088451|Insulin|insulin|mesh-list
82853592|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82853593|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853594|NCT00075218|Sunitinib|sunitinib|mesh-list
82853595|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853596|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853597|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853598|NCT00075218|Growth Substances|growth substances|mesh-ancestor
82853599|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853600|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853601|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82853602|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853603|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853604|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
82853605|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82853606|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82853607|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853608|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
82853609|NCT01089140|Coagulants|coagulants|mesh-ancestor
82853610|NCT00094653|Ipilimumab|ipilimumab|mesh-list
82853611|NCT00094653|Vaccines|vaccines|mesh-list
82853612|NCT00094653|Antibodies|antibodies|mesh-list
82853613|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82853614|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
82853615|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853616|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82853617|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853618|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82853619|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853620|NCT00104247|Verapamil|verapamil|mesh-list
82853621|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82853622|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82853623|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82853624|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853625|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82853626|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853627|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
82853628|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82853629|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
82853630|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853631|NCT05665348|Bevacizumab|bevacizumab|mesh-list
82853632|NCT05665348|Ipilimumab|ipilimumab|mesh-list
82853633|NCT05665348|Atezolizumab|atezolizumab|mesh-list
82853634|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82853635|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82853636|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853637|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853638|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853639|NCT05665348|Growth Substances|growth substances|mesh-ancestor
82853640|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853641|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853642|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82853643|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853644|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
82853645|NCT03726736|Docetaxel|docetaxel|mesh-list
82853646|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853647|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853648|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853649|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853650|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853651|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82853652|NCT03591406|Hematinics|hematinics|mesh-ancestor
82853653|NCT03726580|Propofol|propofol|mesh-list
82853654|NCT03726580|Sevoflurane|sevoflurane|mesh-list
82853655|NCT03726580|Isoflurane|isoflurane|mesh-list
82853656|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82853657|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853658|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853659|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82853660|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
82853661|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
82853662|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82853663|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82853664|NCT03730558|Aflibercept|aflibercept|mesh-list
82853665|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853666|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853667|NCT03730558|Growth Substances|growth substances|mesh-ancestor
82853668|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853669|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853670|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853671|NCT03588910|Acetaminophen|acetaminophen|mesh-list
82853672|NCT03588910|Ibuprofen|ibuprofen|mesh-list
82853673|NCT03588910|Oxycodone|oxycodone|mesh-list
82853674|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853675|NCT03588910|Analgesics|analgesics|mesh-ancestor
82853676|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
82853677|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853678|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853679|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
82853680|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82853681|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853682|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853683|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82853684|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853685|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853686|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82853687|NCT03588910|Narcotics|narcotics|mesh-ancestor
82853688|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853689|NCT03730402|Bupivacaine|bupivacaine|mesh-list
82853690|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
82853691|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
82853692|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853693|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853694|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
82853695|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853696|NCT00103857|Metformin|metformin|mesh-list
82853697|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82853698|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82853699|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853700|NCT00103857|Incretins|incretins|mesh-ancestor
82853701|NCT00103857|Hormones|hormones|mesh-ancestor
82853702|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853703|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82853704|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
82853705|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853706|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853707|NCT03587584|Bupivacaine|bupivacaine|mesh-list
82853708|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
82853709|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
82853710|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853711|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853712|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
82853713|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853714|NCT03586726|Rifampin|rifampin|mesh-list
82853715|NCT03586726|Balovaptan|balovaptan|mesh-list
82853716|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82853717|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
82853718|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82853719|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853720|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
82853721|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82853722|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853723|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853724|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82853725|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82853726|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82853727|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82853728|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82853729|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82853730|NCT03586726|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82853731|NCT03586726|Natriuretic Agents|natriuretic agents|mesh-ancestor
82853732|NCT03586726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853733|NCT03725878|Folic Acid|folic acid|mesh-list
82853734|NCT03725878|Hematinics|hematinics|mesh-ancestor
82853735|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
82853736|NCT03725878|Vitamins|vitamins|mesh-ancestor
82853737|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
82853738|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853740|NCT03721900|Analgesics|analgesics|mesh-ancestor
82853741|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
82853742|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853743|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853744|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82853745|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82853746|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
82853747|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
82853748|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853749|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82853750|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82853751|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853752|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853753|NCT03585712|Norgestrel|norgestrel|mesh-list
82853754|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82853755|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82853756|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82853758|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82853759|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853760|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82853761|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82853762|NCT01082510|Tegafur|tegafur|mesh-list
82853763|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82853764|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
82853765|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853766|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853767|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82853768|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82853769|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82853770|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
82853771|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853772|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853773|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853774|NCT03583372|Urological Agents|urological agents|mesh-ancestor
82853775|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
82853776|NCT01091324|Silymarin|silymarin|mesh-list
82853777|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
82853778|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
82853779|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82853780|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82853781|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853782|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853783|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853784|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
82853785|NCT01091324|Protective Agents|protective agents|mesh-ancestor
82853786|NCT05782608|Ibuprofen|ibuprofen|mesh-list
82853787|NCT05782608|Ketorolac|ketorolac|mesh-list
82853788|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82853789|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853790|NCT05782608|Analgesics|analgesics|mesh-ancestor
82853791|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
82853792|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853793|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853794|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853795|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853796|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82853797|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853798|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853799|NCT05782426|Paclitaxel|paclitaxel|mesh-list
82853800|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82853801|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853802|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
82853803|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
82853804|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
82853805|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853806|NCT05782348|Listerine|listerine|mesh-list
82853807|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
82853808|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
82853809|NCT05782348|Protective Agents|protective agents|mesh-ancestor
82853810|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83452884|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
82853811|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82853812|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853814|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82853815|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853816|NCT05782192|Incretins|incretins|mesh-ancestor
82853817|NCT05782192|Hormones|hormones|mesh-ancestor
82853818|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853819|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82853820|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
82853821|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853822|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853823|NCT05781997|Mydriatics|mydriatics|mesh-list
82853824|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
82853825|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853826|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853827|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
82853828|NCT05781854|Bupivacaine|bupivacaine|mesh-list
82853829|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
82853830|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
82853831|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853832|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853833|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
82853834|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853835|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82853836|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853838|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82853839|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82853840|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82853841|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
82853842|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853843|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853844|NCT05781685|Testosterone|testosterone|mesh-list
82853845|NCT05781685|Androgens|androgens|mesh-ancestor
82853846|NCT05781685|Hormones|hormones|mesh-ancestor
82853847|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82853848|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853849|NCT05781633|Bevacizumab|bevacizumab|mesh-list
82853850|NCT05781633|Etoposide|etoposide|mesh-list
82853851|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82853852|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853853|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853854|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853855|NCT05781633|Growth Substances|growth substances|mesh-ancestor
82853856|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853857|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853858|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82853859|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82853860|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82853861|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853862|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853863|NCT05781620|Vitamin D|vitamin d|mesh-list
82853864|NCT05781620|Vitamins|vitamins|mesh-ancestor
82853865|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
82853866|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853867|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82853868|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
82853869|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82853870|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
82853871|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853872|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
82853873|NCT05781529|Protective Agents|protective agents|mesh-ancestor
82853874|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
82853875|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82853876|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
82853877|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853878|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853879|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82853880|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
82853881|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853882|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853883|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82853884|NCT05869812|Calcium, Dietary|calcium, dietary|mesh-list
82853885|NCT05869812|Calcium|calcium|mesh-list
82853886|NCT05869812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82853887|NCT05869812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853888|NCT05869812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82853890|NCT05869760|Antioxidants|antioxidants|mesh-ancestor
82853891|NCT05869760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853892|NCT05869760|Protective Agents|protective agents|mesh-ancestor
82853893|NCT05869760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853894|NCT05869591|Apixaban|apixaban|mesh-list
82853895|NCT05869591|Edoxaban|edoxaban|mesh-list
82853896|NCT05869591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82853897|NCT05869591|Antithrombins|antithrombins|mesh-ancestor
82853898|NCT05869591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82853899|NCT05869591|Protease Inhibitors|protease inhibitors|mesh-ancestor
82853900|NCT05869591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853901|NCT05869591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853902|NCT05869591|Anticoagulants|anticoagulants|mesh-ancestor
82853903|NCT05869578|Anesthetics|anesthetics|mesh-list
82853904|NCT05869578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853905|NCT05869578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853907|NCT05869227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82853908|NCT05869227|Antimetabolites|antimetabolites|mesh-ancestor
82853909|NCT05869227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853910|NCT05869227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853911|NCT05869201|Vaccines|vaccines|mesh-list
82853912|NCT05869201|Immunologic Factors|immunologic factors|mesh-ancestor
82853913|NCT05869201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853914|NCT05869136|Hyaluronic Acid|hyaluronic acid|mesh-list
82853915|NCT05869136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82853916|NCT05869136|Immunologic Factors|immunologic factors|mesh-ancestor
82853917|NCT05869136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853918|NCT05869136|Viscosupplements|viscosupplements|mesh-ancestor
82853919|NCT05869136|Protective Agents|protective agents|mesh-ancestor
82853920|NCT05869097|Trifluridine|trifluridine|mesh-list
82853921|NCT05869097|Bevacizumab|bevacizumab|mesh-list
82853922|NCT05869097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82853923|NCT05869097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853924|NCT05869097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82853925|NCT05869097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82853926|NCT05869097|Growth Substances|growth substances|mesh-ancestor
82853927|NCT05869097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853928|NCT05869097|Growth Inhibitors|growth inhibitors|mesh-ancestor
82853929|NCT05869097|Antimetabolites|antimetabolites|mesh-ancestor
82853930|NCT05869097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853931|NCT05869097|Antiviral Agents|antiviral agents|mesh-ancestor
82853932|NCT05869097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82853933|NCT05868993|Ropivacaine|ropivacaine|mesh-list
82853934|NCT05868993|Anesthetics, Local|anesthetics, local|mesh-ancestor
82853935|NCT05868993|Anesthetics|anesthetics|mesh-ancestor
82853936|NCT05868993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853937|NCT05868993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853938|NCT05868993|Sensory System Agents|sensory system agents|mesh-ancestor
82853939|NCT05868993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853940|NCT05868967|Fexuprazan|fexuprazan|mesh-list
82853941|NCT05868967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82853942|NCT05868720|Risperidone|risperidone|mesh-list
82853943|NCT05868720|Aripiprazole|aripiprazole|mesh-list
82853944|NCT05868720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82853945|NCT05868720|Serotonin Agents|serotonin agents|mesh-ancestor
82853946|NCT05868720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82853947|NCT05868720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853948|NCT05868720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853949|NCT05868720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82853950|NCT05868720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82853951|NCT05868720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853952|NCT05868720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82853953|NCT05868720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82853954|NCT05868720|Dopamine Agents|dopamine agents|mesh-ancestor
83452895|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853955|NCT05868720|Antidepressive Agents|antidepressive agents|mesh-ancestor
82853956|NCT05868720|Dopamine Agonists|dopamine agonists|mesh-ancestor
82853957|NCT05868720|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82853958|NCT05868720|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82853959|NCT05868720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82853960|NCT05868720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82853961|NCT05868577|Anesthetics|anesthetics|mesh-list
82853962|NCT05868577|Anesthetics, Local|anesthetics, local|mesh-list
82853963|NCT05868577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82853964|NCT05868577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853965|NCT05868577|Sensory System Agents|sensory system agents|mesh-ancestor
82853966|NCT05868577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853967|NCT05868525|Aspirin|aspirin|mesh-list
82853968|NCT05868525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82853969|NCT05868525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82853970|NCT05868525|Analgesics|analgesics|mesh-ancestor
82853971|NCT05868525|Sensory System Agents|sensory system agents|mesh-ancestor
82853972|NCT05868525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82853973|NCT05868525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853974|NCT05868525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82853975|NCT05868525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853976|NCT05868525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82853977|NCT05868525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82853978|NCT05868525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853979|NCT05868525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82853980|NCT05868525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82853981|NCT05868525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82853982|NCT05868525|Antipyretics|antipyretics|mesh-ancestor
82853983|NCT05868395|Rituximab|rituximab|mesh-list
82853984|NCT05868395|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82853985|NCT05868395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82853986|NCT05868395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82853987|NCT05868395|Immunologic Factors|immunologic factors|mesh-ancestor
82853988|NCT05868395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82853989|NCT05868395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82853990|NCT05868395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82853991|NCT05868395|Alkylating Agents|alkylating agents|mesh-ancestor
82853992|NCT05868395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853993|NCT05868317|Fluorouracil|fluorouracil|mesh-list
82853994|NCT05868317|Irinotecan|irinotecan|mesh-list
82853995|NCT05868317|Folfirinox|folfirinox|mesh-list
82853996|NCT05868317|Oxaliplatin|oxaliplatin|mesh-list
82853997|NCT05868317|Antimetabolites|antimetabolites|mesh-ancestor
82853998|NCT05868317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82853999|NCT05868317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82854000|NCT05868317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854001|NCT05868317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82854002|NCT05868317|Immunologic Factors|immunologic factors|mesh-ancestor
82854003|NCT05868317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854004|NCT05868317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82854005|NCT05868317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82854006|NCT05868317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854007|NCT05868200|Listerine|listerine|mesh-list
82854008|NCT05868200|Sodium Fluoride|sodium fluoride|mesh-list
82854009|NCT05868200|Cariostatic Agents|cariostatic agents|mesh-ancestor
82854010|NCT05868200|Protective Agents|protective agents|mesh-ancestor
82854011|NCT05868200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854012|NCT05868200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82854013|NCT05868200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854014|NCT05868122|Acetaminophen|acetaminophen|mesh-list
82854015|NCT05868122|Naproxen|naproxen|mesh-list
82854016|NCT05868122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854017|NCT05868122|Analgesics|analgesics|mesh-ancestor
82854018|NCT05868122|Sensory System Agents|sensory system agents|mesh-ancestor
82854019|NCT05868122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854020|NCT05868122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854021|NCT05868122|Antipyretics|antipyretics|mesh-ancestor
82854022|NCT05868122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82854023|NCT05868122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82854024|NCT05868122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854025|NCT05868122|Gout Suppressants|gout suppressants|mesh-ancestor
82854026|NCT05868122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82854027|NCT05868122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854028|NCT05868122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854029|NCT05868109|Nitric Oxide|nitric oxide|mesh-list
82854030|NCT05868109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82854031|NCT05868109|Autonomic Agents|autonomic agents|mesh-ancestor
82854032|NCT05868109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854033|NCT05868109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854034|NCT05868109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82854035|NCT05868109|Respiratory System Agents|respiratory system agents|mesh-ancestor
82854036|NCT05868109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82854037|NCT05868109|Antioxidants|antioxidants|mesh-ancestor
82854038|NCT05868109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854039|NCT05868109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854040|NCT05868109|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82854041|NCT05868109|Vasodilator Agents|vasodilator agents|mesh-ancestor
82854042|NCT05868109|Gasotransmitters|gasotransmitters|mesh-ancestor
82854043|NCT05868109|Protective Agents|protective agents|mesh-ancestor
82854044|NCT05867550|Rifaximin|rifaximin|mesh-list
82854045|NCT05867550|Amitriptyline|amitriptyline|mesh-list
82854046|NCT05867550|Mebeverine|mebeverine|mesh-list
82854047|NCT05867550|Psyllium|psyllium|mesh-list
82854048|NCT05867550|Calcium polycarbophil|calcium polycarbophil|mesh-list
82854049|NCT05867550|Alverine|alverine|mesh-list
82854050|NCT05867550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82854051|NCT05867550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854052|NCT05867550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82854053|NCT05867550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82854054|NCT05867550|Antidepressive Agents|antidepressive agents|mesh-ancestor
82854055|NCT05867550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82854056|NCT05867550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854057|NCT05867550|Analgesics|analgesics|mesh-ancestor
82854058|NCT05867550|Sensory System Agents|sensory system agents|mesh-ancestor
82854059|NCT05867550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854060|NCT05867550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854061|NCT05867550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82854062|NCT05867550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82854063|NCT05867550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82854064|NCT05867550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854065|NCT05867550|Adrenergic Agents|adrenergic agents|mesh-ancestor
82854066|NCT05867550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854067|NCT05867550|Cathartics|cathartics|mesh-ancestor
82854068|NCT05867550|Antidiarrheals|antidiarrheals|mesh-ancestor
82854069|NCT05867550|Anticonvulsants|anticonvulsants|mesh-ancestor
82854070|NCT05867550|Parasympatholytics|parasympatholytics|mesh-ancestor
82854071|NCT05867550|Autonomic Agents|autonomic agents|mesh-ancestor
82854072|NCT05867472|Sevoflurane|sevoflurane|mesh-list
82854073|NCT05867472|Isoflurane|isoflurane|mesh-list
82854074|NCT05867472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82854075|NCT05867472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82854076|NCT05867472|Anesthetics, General|anesthetics, general|mesh-ancestor
82854077|NCT05867472|Anesthetics|anesthetics|mesh-ancestor
82854078|NCT05867472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854079|NCT05867472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854080|NCT05867342|Lidocaine|lidocaine|mesh-list
82854081|NCT05867342|Epinephrine|epinephrine|mesh-list
82854082|NCT05867342|Racepinephrine|racepinephrine|mesh-list
82854083|NCT05867342|Epinephryl borate|epinephryl borate|mesh-list
82854084|NCT05867342|Anesthetics, Local|anesthetics, local|mesh-ancestor
82854085|NCT05867342|Anesthetics|anesthetics|mesh-ancestor
82854086|NCT05867342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854087|NCT05867342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854088|NCT05867342|Sensory System Agents|sensory system agents|mesh-ancestor
82854089|NCT05867342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854090|NCT05867342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82854091|NCT05867342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82854092|NCT05867342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82854093|NCT05867342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82854094|NCT05867342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854095|NCT05867342|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82854096|NCT05867342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82854097|NCT05867342|Adrenergic Agents|adrenergic agents|mesh-ancestor
82854098|NCT05867342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854099|NCT05867342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82854100|NCT05867342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82854101|NCT05867342|Autonomic Agents|autonomic agents|mesh-ancestor
82854102|NCT05867342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82854103|NCT05867342|Respiratory System Agents|respiratory system agents|mesh-ancestor
82854104|NCT05867342|Mydriatics|mydriatics|mesh-ancestor
82854105|NCT05867342|Sympathomimetics|sympathomimetics|mesh-ancestor
82854106|NCT05867342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82854107|NCT05865080|Ketamine|ketamine|mesh-list
82854108|NCT05865080|Analgesics|analgesics|mesh-ancestor
82854109|NCT05865080|Sensory System Agents|sensory system agents|mesh-ancestor
82854110|NCT05865080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854111|NCT05865080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854112|NCT05865080|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82854113|NCT05865080|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82854114|NCT05865080|Anesthetics, General|anesthetics, general|mesh-ancestor
82854115|NCT05865080|Anesthetics|anesthetics|mesh-ancestor
82854116|NCT05865080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854117|NCT05865080|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82854118|NCT05865080|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82854119|NCT05865080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854120|NCT05865080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854121|NCT05863286|Botulinum Toxins|botulinum toxins|mesh-list
82854122|NCT05863286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82854123|NCT05863286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82854124|NCT05863286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82854125|NCT05863286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82854126|NCT05863286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854127|NCT05863286|Cholinergic Agents|cholinergic agents|mesh-ancestor
82854128|NCT05863286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854129|NCT05863286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854130|NCT05863286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82854131|NCT05863286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854132|NCT05851768|Dexmedetomidine|dexmedetomidine|mesh-list
82854133|NCT05851768|Bupivacaine|bupivacaine|mesh-list
82854134|NCT05851768|Anesthetics, Local|anesthetics, local|mesh-ancestor
82854135|NCT05851768|Anesthetics|anesthetics|mesh-ancestor
82854136|NCT05851768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854137|NCT05851768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854138|NCT05851768|Sensory System Agents|sensory system agents|mesh-ancestor
82854139|NCT05851768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854140|NCT05851768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82854141|NCT05851768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854142|NCT05851768|Analgesics|analgesics|mesh-ancestor
82854143|NCT05851768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82854144|NCT05851768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82854145|NCT05851768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82854146|NCT05851768|Adrenergic Agents|adrenergic agents|mesh-ancestor
82854147|NCT05851768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854148|NCT05851768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854149|NCT05768373|Fluorides|fluorides|mesh-list
82854150|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
82854151|NCT05768373|Protective Agents|protective agents|mesh-ancestor
82854152|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854153|NCT05737693|Midazolam|midazolam|mesh-list
82854154|NCT05737693|Ketamine|ketamine|mesh-list
82854155|NCT05737693|Analgesics|analgesics|mesh-ancestor
82854156|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
82854157|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854158|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854159|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82854160|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82854161|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
82854162|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
82854163|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854164|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82854165|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82854166|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854167|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854168|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82854169|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82854170|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82854171|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82854172|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82854173|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
82854174|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
82854175|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82854176|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82854177|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
82854178|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854179|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854180|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854181|NCT05733624|Cyclosporine|cyclosporine|mesh-list
82854182|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82854183|NCT05733624|Cyclosporins|cyclosporins|mesh-list
82854184|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854185|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854186|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82854187|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
82854188|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854190|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854191|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
82854192|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854193|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82854194|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82854195|NCT05717049|Theophylline|theophylline|mesh-list
82854196|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82854197|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
82854198|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854199|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854200|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82854201|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
82854202|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82854203|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854204|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854205|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
82854207|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82854208|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
82854209|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854210|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
82854211|NCT05664217|Antithrombins|antithrombins|mesh-list
82854212|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82854213|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
82854214|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854215|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854216|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
82854217|NCT05648110|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
82854218|NCT05648110|Antiviral Agents|antiviral agents|mesh-ancestor
82854219|NCT05648110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854220|NCT05647551|Lidocaine|lidocaine|mesh-list
82854221|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82854222|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
82854223|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
82854224|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854225|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854226|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
82854227|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854228|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82854229|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82854230|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82854231|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82854232|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854233|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82854234|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82854235|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
82854236|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854237|NCT05645900|Vaccines|vaccines|mesh-list
82854238|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
82854239|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854240|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82854241|NCT05642572|Osimertinib|osimertinib|mesh-list
82854242|NCT05642572|Ramucirumab|ramucirumab|mesh-list
82854243|NCT05642572|Antibodies|antibodies|mesh-list
82854244|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
82854245|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82854246|NCT05642572|Lexatumumab|lexatumumab|mesh-list
82854247|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
82854248|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854249|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854250|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854251|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854252|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854253|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
82854254|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854255|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854256|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854257|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854258|NCT05614089|Insulin|insulin|mesh-list
82854259|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82854260|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
82854261|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82854262|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854263|NCT05609578|Carboplatin|carboplatin|mesh-list
82854264|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
82854266|NCT05609578|Adagrasib|adagrasib|mesh-list
82854267|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854268|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854269|NCT05609578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854270|NCT05609578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854271|NCT05609578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854272|NCT05609578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82854273|NCT05609578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82854274|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
82854275|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854276|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854277|NCT05539365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854278|NCT05539365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854279|NCT05526755|Osimertinib|osimertinib|mesh-list
82854285|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82854286|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82854287|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854288|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854289|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82854290|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82854291|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82854292|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82854293|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
82854295|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
82854296|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
82854297|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854298|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854299|NCT05447702|Paclitaxel|paclitaxel|mesh-list
82854300|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
82854301|NCT05447702|Apatinib|apatinib|mesh-list
82854302|NCT05447702|Epirubicin|epirubicin|mesh-list
82854303|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82854304|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854305|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
82854306|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
82854307|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
82854308|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854309|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82854310|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
82854311|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854312|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854313|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82854314|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
82854315|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82854316|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854317|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854318|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82854319|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82854320|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82854321|NCT05418010|Natalizumab|natalizumab|mesh-list
82854322|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
82854323|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854324|NCT05413369|Metformin|metformin|mesh-list
82854325|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
82854326|NCT05413369|Lixisenatide|lixisenatide|mesh-list
82854327|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82854328|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82854329|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854330|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854331|NCT05391971|Bupivacaine|bupivacaine|mesh-list
82854332|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
82854333|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
82854334|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854335|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854336|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
82854337|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854338|NCT05374512|Paclitaxel|paclitaxel|mesh-list
82854339|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82854340|NCT05374512|Carboplatin|carboplatin|mesh-list
82854341|NCT05374512|Capecitabine|capecitabine|mesh-list
82854342|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82854343|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854344|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
82854345|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
82854347|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854348|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82854349|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
82854370|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82854371|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82854372|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
82854373|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
82854374|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82854375|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
82854376|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
82854377|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
82854378|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854379|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854381|NCT05286801|Atezolizumab|atezolizumab|mesh-list
82854382|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82854383|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82854384|NCT05286801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854385|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854386|NCT05286801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854387|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854388|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
82854389|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854390|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82854391|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
82854392|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
82854393|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854394|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
82854395|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854396|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
82854397|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854398|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854399|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82854400|NCT05266469|Ofatumumab|ofatumumab|mesh-list
82854401|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
82854402|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854403|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
82854404|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854405|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
82854406|NCT05222529|Bromides|bromides|mesh-list
82854407|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
82854408|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82854409|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82854410|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82854411|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
82854412|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854413|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854414|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854415|NCT05186779|Progestins|progestins|mesh-list
82854416|NCT05186779|Hormones|hormones|mesh-ancestor
82854417|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82854418|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854419|NCT05178550|Heparin|heparin|mesh-list
82854420|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
82854421|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82854422|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82854423|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854432|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854433|NCT05085782|Propranolol|propranolol|mesh-list
82854434|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82854435|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82854436|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
82854437|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854438|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854439|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854440|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82854441|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82854442|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
82854443|NCT05063565|Durvalumab|durvalumab|mesh-list
82854444|NCT05063565|Tremelimumab|tremelimumab|mesh-list
82854445|NCT05063565|Immunomodulating Agents|immunomodulating agents|mesh-list
82854446|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
82854447|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854448|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854450|NCT05047172|Aspirin|aspirin|mesh-list
82854451|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
82854452|NCT05047172|Clopidogrel|clopidogrel|mesh-list
82854453|NCT05047172|Ticagrelor|ticagrelor|mesh-list
82854454|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82854455|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854456|NCT05047172|Analgesics|analgesics|mesh-ancestor
82854457|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
82854458|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854459|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854460|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82854461|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854462|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82854463|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82854464|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854465|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82854466|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82854467|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854468|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
82854469|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82854470|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82854471|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82854472|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
82854473|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854474|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82854475|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
82854476|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82854477|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
82854478|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
82854479|NCT05011123|Vaccines|vaccines|mesh-list
82854480|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
82854481|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854482|NCT04908449|Bupivacaine|bupivacaine|mesh-list
82854483|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
82854484|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
82854485|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854486|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854487|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
82854488|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854489|NCT04829383|Bevacizumab|bevacizumab|mesh-list
82854490|NCT04829383|Atezolizumab|atezolizumab|mesh-list
82854491|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854492|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854493|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82854494|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82854495|NCT04829383|Growth Substances|growth substances|mesh-ancestor
82854496|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854497|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
82854498|NCT04829383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854499|NCT04829383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854500|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
82854501|NCT04821375|Estrogens|estrogens|mesh-list
82854502|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82854503|NCT04821375|Hormones|hormones|mesh-ancestor
82854504|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82854505|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854506|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82854507|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82854508|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
82854509|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82854510|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82854511|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
82854512|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854513|NCT04788745|Trimetazidine|trimetazidine|mesh-list
82854514|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
82854515|NCT04781387|REP 3123|rep 3123|mesh-list
82854516|NCT04781387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82854517|NCT04781387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854518|NCT04732195|Pilocarpine|pilocarpine|mesh-list
82854519|NCT04732195|Miotics|miotics|mesh-ancestor
82854520|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
82854521|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854522|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854523|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82854524|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82854525|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
82854526|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854527|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854528|NCT04704921|Ranibizumab|ranibizumab|mesh-list
82854529|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82854530|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82854531|NCT04704921|Growth Substances|growth substances|mesh-ancestor
82854532|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854533|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
82854534|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854535|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
82854536|NCT04703426|Sargramostim|sargramostim|mesh-list
82854537|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854538|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854539|NCT04703426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854540|NCT04703426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854541|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
82854542|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854543|NCT04699838|Carboplatin|carboplatin|mesh-list
82854544|NCT04699838|Etoposide|etoposide|mesh-list
82854545|NCT04699838|Durvalumab|durvalumab|mesh-list
82854546|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854547|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82854548|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82854549|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82854550|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854551|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854552|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854553|NCT04681482|Apixaban|apixaban|mesh-list
82854554|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82854555|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
82854556|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82854557|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
82854558|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83452934|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854559|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854560|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
82854561|NCT04676477|Osimertinib|osimertinib|mesh-list
82854562|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
82854563|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82854564|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854565|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854566|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854567|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854568|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
82854569|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854570|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854571|NCT04644068|Paclitaxel|paclitaxel|mesh-list
82854572|NCT04644068|Carboplatin|carboplatin|mesh-list
82854573|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82854574|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854575|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
82854576|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
82854577|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083923|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82854583|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854584|NCT04635644|Analgesics|analgesics|mesh-ancestor
82854585|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
82854586|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854587|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82854589|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
82854590|NCT04631601|Hormones|hormones|mesh-ancestor
82854591|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82854592|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854593|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854594|NCT04631601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854595|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854596|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
82854597|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
82854603|NCT04580277|Tofacitinib|tofacitinib|mesh-list
82854604|NCT04580277|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82854605|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854606|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476466|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854607|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854608|NCT04571229|Mifamurtide|mifamurtide|mesh-list
82854609|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82854610|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
82854611|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854612|NCT04535713|Gemcitabine|gemcitabine|mesh-list
82854613|NCT04535713|Docetaxel|docetaxel|mesh-list
82854614|NCT04535713|Doxorubicin|doxorubicin|mesh-list
82854615|NCT04535713|Nivolumab|nivolumab|mesh-list
82854616|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82854617|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
82854618|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854619|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854620|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
82854621|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
82854622|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
82854623|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82854624|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82854625|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82854626|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854627|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854628|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854629|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
82854630|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82854631|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854632|NCT04526132|Analgesics|analgesics|mesh-ancestor
83452937|NCT00952081|Clevidipine|clevidipine|mesh-list
82854633|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
82854634|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854635|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854636|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82854637|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854638|NCT04514653|Ranibizumab|ranibizumab|mesh-list
82854639|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82854640|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82854641|NCT04514653|Growth Substances|growth substances|mesh-ancestor
82854642|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854643|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
82854644|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854645|NCT04513925|Atezolizumab|atezolizumab|mesh-list
82854646|NCT04513925|Durvalumab|durvalumab|mesh-list
82854647|NCT04513925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854648|NCT04513925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854649|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854650|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854651|NCT04507438|Donepezil|donepezil|mesh-list
82854652|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82854654|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854655|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
82854656|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854657|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854658|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
82854659|NCT04505670|Donepezil|donepezil|mesh-list
82854660|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
82854661|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82854662|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854663|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854664|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
82854665|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854666|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854667|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
82854668|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
82854669|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
82854670|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82854671|NCT04505670|Protective Agents|protective agents|mesh-ancestor
82854672|NCT04493320|Levodopa|levodopa|mesh-list
82854673|NCT04493320|Carbidopa|carbidopa|mesh-list
82854674|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82854675|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82854676|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82854677|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
82854678|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854679|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854680|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854681|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82854682|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854683|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82854684|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
82854685|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
82854686|NCT04435600|Ustekinumab|ustekinumab|mesh-list
82854687|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
82854688|NCT04431635|Rituximab|rituximab|mesh-list
82854689|NCT04431635|Nivolumab|nivolumab|mesh-list
82854690|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854691|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854692|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
82854693|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854694|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854695|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854696|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854697|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
82854698|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854699|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854700|NCT04417166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854701|NCT04417166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854702|NCT04270747|Aflibercept|aflibercept|mesh-list
82854703|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82854704|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82854705|NCT04270747|Growth Substances|growth substances|mesh-ancestor
82854706|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854707|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
82854708|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854709|NCT04225598|Buprenorphine|buprenorphine|mesh-list
82854710|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82854711|NCT04225598|Narcotics|narcotics|mesh-ancestor
82854712|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854713|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854714|NCT04225598|Analgesics|analgesics|mesh-ancestor
82854715|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
82854716|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854717|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82854718|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82854719|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82854720|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82854721|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82854722|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854723|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854724|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854726|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
82854727|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82854728|NCT04189744|Metronidazole|metronidazole|mesh-list
82854729|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
82854730|NCT04189744|Piperaquine|piperaquine|mesh-list
82854731|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
82854732|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82854733|NCT04189744|Artenimol|artenimol|mesh-list
82854734|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854735|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82854736|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82854737|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82854738|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
82854739|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82854740|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854741|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854742|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82854743|NCT04175470|Tocotrienols|tocotrienols|mesh-list
82854744|NCT04175470|Vitamin E|vitamin e|mesh-list
82854745|NCT04175470|Tocopherols|tocopherols|mesh-list
82854746|NCT04175470|Bevacizumab|bevacizumab|mesh-list
82854747|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854748|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854749|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82854750|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82854751|NCT04175470|Growth Substances|growth substances|mesh-ancestor
82854752|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854753|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
82854754|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
82854755|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854756|NCT04175470|Protective Agents|protective agents|mesh-ancestor
82854757|NCT04175470|Vitamins|vitamins|mesh-ancestor
82854758|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
82854759|NCT04165330|Nivolumab|nivolumab|mesh-list
82854760|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854761|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854762|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854763|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854764|NCT04149574|Nivolumab|nivolumab|mesh-list
82854765|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
82854766|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854767|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854768|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854769|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854770|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82854771|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
82854772|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854773|NCT04115878|Oxybutynin|oxybutynin|mesh-list
82854774|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82854775|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82854776|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82854777|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82854778|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854779|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
82854780|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854781|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854782|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
82854783|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
82854784|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854785|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82854786|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82854787|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
82854788|NCT04115878|Urological Agents|urological agents|mesh-ancestor
82854789|NCT03965130|Glucagon|glucagon|mesh-list
82854790|NCT03965130|Hormones|hormones|mesh-ancestor
82854791|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82854792|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854793|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82854794|NCT03900884|Letrozole|letrozole|mesh-list
82854795|NCT03900884|Venetoclax|venetoclax|mesh-list
82854796|NCT03900884|Palbociclib|palbociclib|mesh-list
82854797|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854798|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82854799|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82854800|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854801|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854802|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82854803|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
82854804|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82854805|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854806|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854808|NCT03878524|Leucovorin|leucovorin|mesh-list
82854809|NCT03878524|Vitamin A|vitamin a|mesh-list
82854810|NCT03878524|Sirolimus|sirolimus|mesh-list
82854811|NCT03878524|Celecoxib|celecoxib|mesh-list
82854812|NCT03878524|Paclitaxel|paclitaxel|mesh-list
82854813|NCT03878524|Maytansine|maytansine|mesh-list
82854814|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82854815|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82854816|NCT03878524|Bevacizumab|bevacizumab|mesh-list
82854817|NCT03878524|Carboplatin|carboplatin|mesh-list
82854818|NCT03878524|Doxorubicin|doxorubicin|mesh-list
82854819|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82854820|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
82854821|NCT03878524|Fluorouracil|fluorouracil|mesh-list
82854822|NCT03878524|Capecitabine|capecitabine|mesh-list
82854823|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
82854824|NCT03878524|Nivolumab|nivolumab|mesh-list
82854825|NCT03878524|Trastuzumab|trastuzumab|mesh-list
82854826|NCT03878524|Everolimus|everolimus|mesh-list
82854827|NCT03878524|Bortezomib|bortezomib|mesh-list
82854828|NCT03878524|Ipilimumab|ipilimumab|mesh-list
82854829|NCT03878524|Sorafenib|sorafenib|mesh-list
82854830|NCT03878524|Temsirolimus|temsirolimus|mesh-list
82854831|NCT03878524|Durvalumab|durvalumab|mesh-list
82854832|NCT03878524|Sunitinib|sunitinib|mesh-list
82854833|NCT03878524|Daunorubicin|daunorubicin|mesh-list
82854834|NCT03878524|Venetoclax|venetoclax|mesh-list
82854835|NCT03878524|Dasatinib|dasatinib|mesh-list
82854836|NCT03878524|Lenvatinib|lenvatinib|mesh-list
82854837|NCT03878524|Olaparib|olaparib|mesh-list
82854838|NCT03878524|Palbociclib|palbociclib|mesh-list
82854839|NCT03878524|Pertuzumab|pertuzumab|mesh-list
82854840|NCT03878524|Vorinostat|vorinostat|mesh-list
82854841|NCT03878524|Trametinib|trametinib|mesh-list
82854842|NCT03878524|Tretinoin|tretinoin|mesh-list
82854843|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
82854844|NCT03878524|Bicalutamide|bicalutamide|mesh-list
82854845|NCT03878524|Afatinib|afatinib|mesh-list
82854846|NCT03878524|Vemurafenib|vemurafenib|mesh-list
82854847|NCT03878524|Dabrafenib|dabrafenib|mesh-list
82854848|NCT03878524|Panobinostat|panobinostat|mesh-list
82854849|NCT03878524|Ponatinib|ponatinib|mesh-list
82854850|NCT03878524|Idelalisib|idelalisib|mesh-list
82854851|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82854852|NCT03878524|MTOR Inhibitors|mtor inhibitors|mesh-list
82854853|NCT03878524|Losartan|losartan|mesh-list
82854854|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
82854855|NCT03878524|Antibodies|antibodies|mesh-list
82854856|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
82854857|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82854858|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82854859|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
82854860|NCT03878524|Entrectinib|entrectinib|mesh-list
82854861|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
82854862|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
82854863|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82854864|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854865|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
82854866|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
82854867|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
82854868|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854869|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82854870|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82854871|NCT03878524|Growth Substances|growth substances|mesh-ancestor
82854872|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854873|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
82854874|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
82854875|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
82854876|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82854877|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82854878|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82854879|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854880|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854881|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
82854882|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82854883|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82854884|NCT03878524|Antidotes|antidotes|mesh-ancestor
82854885|NCT03878524|Protective Agents|protective agents|mesh-ancestor
82854886|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
82854887|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82854888|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82854889|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82854890|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
82854891|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82854892|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854893|NCT03878524|Analgesics|analgesics|mesh-ancestor
82854894|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
82854895|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854896|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82854897|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854898|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82854899|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82854900|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82854901|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82854902|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82854903|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82854904|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82854905|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82854906|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
82854907|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
82854908|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
82854909|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82854910|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
82854911|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
82854912|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82854913|NCT03878524|Immunotoxins|immunotoxins|mesh-ancestor
82854914|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82854915|NCT03761030|Levodopa|levodopa|mesh-list
82854916|NCT03761030|Carbidopa|carbidopa|mesh-list
82854917|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82854918|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82854919|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82854920|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
82854921|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854922|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854923|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854924|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82854925|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854926|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82854927|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
82854928|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
82854929|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
82854930|NCT03742505|Vitamin D|vitamin d|mesh-list
82854931|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82854932|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854933|NCT03742505|Vitamins|vitamins|mesh-ancestor
82854934|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
82854935|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82854936|NCT03663205|Cisplatin|cisplatin|mesh-list
82854937|NCT03663205|Carboplatin|carboplatin|mesh-list
82854938|NCT03663205|Pemetrexed|pemetrexed|mesh-list
82854939|NCT03663205|Tislelizumab|tislelizumab|mesh-list
82854940|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854941|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854942|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854943|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82854944|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82854945|NCT03663205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854946|NCT03638999|Ketorolac|ketorolac|mesh-list
82854947|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82854948|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82854949|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854950|NCT03638999|Analgesics|analgesics|mesh-ancestor
82854951|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
82854952|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82854953|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854954|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82854955|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82854956|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82854957|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854958|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854959|NCT03600883|Sotorasib|sotorasib|mesh-list
82854960|NCT03600883|Midazolam|midazolam|mesh-list
82854961|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82854962|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82854963|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82854964|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854965|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82854966|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82854967|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82854968|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82854969|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
82854970|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
82854971|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
82854972|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
82854973|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854974|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854975|NCT03600883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854976|NCT03600883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854977|NCT03600883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854978|NCT03575793|Nivolumab|nivolumab|mesh-list
82854979|NCT03575793|Ipilimumab|ipilimumab|mesh-list
82854980|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82854981|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82854982|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82854983|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82854984|NCT03572088|Terlipressin|terlipressin|mesh-list
82854985|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82854986|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82854987|NCT03560934|Dronabinol|dronabinol|mesh-list
82854988|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
82854989|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82854990|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82854991|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82854992|NCT03560934|Analgesics|analgesics|mesh-ancestor
82854993|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
82854994|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83452971|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82854995|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82854996|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82854997|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82854998|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855000|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855001|NCT03527472|Memantine|memantine|mesh-list
82855002|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82855003|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82855004|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
82855005|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855006|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855007|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855008|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82855009|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82855010|NCT03483012|Atezolizumab|atezolizumab|mesh-list
82855011|NCT03483012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855012|NCT03483012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855013|NCT03483012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855014|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855015|NCT03477396|Estrogens|estrogens|mesh-list
82855016|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82855017|NCT03477396|Hormones|hormones|mesh-ancestor
82855018|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855019|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855020|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82855021|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855022|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855023|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82855024|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
82855025|NCT03388788|CGP 12177|cgp 12177|mesh-list
82855026|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82855027|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82855028|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
82855029|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855030|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855031|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855032|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82855033|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82855034|NCT03289962|Atezolizumab|atezolizumab|mesh-list
82855035|NCT03289962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855036|NCT03289962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855037|NCT03289962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855038|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855039|NCT03283761|Leucovorin|leucovorin|mesh-list
82855040|NCT03283761|Paclitaxel|paclitaxel|mesh-list
82855041|NCT03283761|Fluorouracil|fluorouracil|mesh-list
82855042|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
82855043|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855044|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855045|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855046|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855047|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855048|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855049|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
82855050|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855051|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855052|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
82855053|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855054|NCT03283761|Antidotes|antidotes|mesh-ancestor
82855055|NCT03283761|Protective Agents|protective agents|mesh-ancestor
82855056|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
82855057|NCT03283761|Vitamins|vitamins|mesh-ancestor
82855058|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
82855059|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82855060|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82855061|NCT03240081|Estradiol|estradiol|mesh-list
82855062|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82855063|NCT03240081|Estrogens|estrogens|mesh-ancestor
82855064|NCT03240081|Hormones|hormones|mesh-ancestor
83452973|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
82855065|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855066|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855067|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82855068|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
82855069|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82855070|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82855072|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855073|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82855074|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
82855075|NCT03097120|Estrogens|estrogens|mesh-list
82855076|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82855077|NCT03097120|Hormones|hormones|mesh-ancestor
82855078|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855079|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855080|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82855081|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82855082|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82855083|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
82855084|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82855085|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82855086|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82855087|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82855088|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855089|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855090|NCT03056755|Letrozole|letrozole|mesh-list
82855091|NCT03056755|Fulvestrant|fulvestrant|mesh-list
82855092|NCT03056755|Leuprolide|leuprolide|mesh-list
82855093|NCT03056755|Goserelin|goserelin|mesh-list
82855094|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855095|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82855096|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82855097|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855098|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855099|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82855100|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
82855101|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855102|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855103|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855104|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82855105|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82855106|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
82855107|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82855108|NCT03003520|Prednisone|prednisone|mesh-list
82855109|NCT03003520|Prednisolone|prednisolone|mesh-list
82855110|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
82855111|NCT03003520|Rituximab|rituximab|mesh-list
82855112|NCT03003520|Doxorubicin|doxorubicin|mesh-list
82855113|NCT03003520|Vincristine|vincristine|mesh-list
82855114|NCT03003520|Lenalidomide|lenalidomide|mesh-list
82855115|NCT03003520|Durvalumab|durvalumab|mesh-list
82855116|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855117|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
82855118|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855119|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82855120|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82855121|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
82855122|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855123|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855124|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82855125|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855126|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82855127|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82855128|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82855129|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855130|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82855131|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
82855132|NCT03003520|Hormones|hormones|mesh-ancestor
82855133|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855134|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855135|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855136|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855137|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855138|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855139|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82855140|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82855141|NCT03003520|Growth Substances|growth substances|mesh-ancestor
82855142|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
82855143|NCT02989597|Dexamethasone|dexamethasone|mesh-list
82855144|NCT02989597|Sufentanil|sufentanil|mesh-list
82855145|NCT02989597|Ketamine|ketamine|mesh-list
82855146|NCT02989597|Remifentanil|remifentanil|mesh-list
82855147|NCT02989597|Methadone|methadone|mesh-list
82855148|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82855149|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
82855150|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
82855151|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855152|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855153|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82855154|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
82855155|NCT02989597|Hormones|hormones|mesh-ancestor
82855156|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855157|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855158|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855159|NCT02989597|Analgesics|analgesics|mesh-ancestor
82855160|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
82855161|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82855162|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82855163|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
82855164|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
82855165|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855166|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82855167|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82855168|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855169|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855170|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82855171|NCT02989597|Narcotics|narcotics|mesh-ancestor
82855172|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82855173|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
82855174|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
82855175|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82855176|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82855177|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82855178|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82855179|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855180|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855181|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855182|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82855183|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
82855184|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82855185|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
82855186|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
82855187|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855188|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
82855189|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855190|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82855191|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82855192|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
82855193|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855194|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855195|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83452980|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82855196|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855197|NCT02768701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855198|NCT02621944|Melatonin|melatonin|mesh-list
82855199|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
82855200|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855201|NCT02621944|Protective Agents|protective agents|mesh-ancestor
82855202|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855203|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855204|NCT02620046|Vedolizumab|vedolizumab|mesh-list
82855205|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82855206|NCT02586025|Docetaxel|docetaxel|mesh-list
82855207|NCT02586025|Trastuzumab|trastuzumab|mesh-list
82855208|NCT02586025|Pertuzumab|pertuzumab|mesh-list
82855209|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855210|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855211|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855212|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855213|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855214|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855215|NCT02465164|Oxytocin|oxytocin|mesh-list
82855216|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
82855217|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82855218|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855220|NCT02446600|Carboplatin|carboplatin|mesh-list
82855221|NCT02446600|Gemcitabine|gemcitabine|mesh-list
82855222|NCT02446600|Doxorubicin|doxorubicin|mesh-list
82855223|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82855224|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82855225|NCT02446600|Olaparib|olaparib|mesh-list
82855226|NCT02446600|Cediranib|cediranib|mesh-list
82855227|NCT02446600|Maleic acid|maleic acid|mesh-list
82855228|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855229|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855230|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855231|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855232|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855233|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855234|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855235|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
82855236|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82855237|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82855238|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82855239|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855240|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82855241|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82855242|NCT02094261|Osimertinib|osimertinib|mesh-list
82855243|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855244|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82855245|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855246|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855247|NCT01955512|Clopidogrel|clopidogrel|mesh-list
82855248|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82855249|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82855250|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82855251|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82855252|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
82855253|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855254|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855255|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855256|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
82855257|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
82855258|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855259|NCT00227617|Leucovorin|leucovorin|mesh-list
82855260|NCT00227617|Bevacizumab|bevacizumab|mesh-list
82855261|NCT00227617|Fluorouracil|fluorouracil|mesh-list
82855262|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
82855263|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855264|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855265|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82855266|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82855267|NCT00227617|Growth Substances|growth substances|mesh-ancestor
82855268|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855269|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
82855270|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
82855271|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855272|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855273|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855274|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
82855275|NCT00227617|Antidotes|antidotes|mesh-ancestor
82855276|NCT00227617|Protective Agents|protective agents|mesh-ancestor
82855277|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
82855278|NCT00227617|Vitamins|vitamins|mesh-ancestor
82855279|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
82855280|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
82855281|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82855282|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
82855283|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855284|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
82855285|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82855286|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
82855287|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855288|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855289|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82855290|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
82855291|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82855292|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
82855293|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855294|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855295|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82855296|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
82855297|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
82855298|NCT05703191|Protective Agents|protective agents|mesh-ancestor
82855299|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82855300|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82855301|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
82855302|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855303|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82855304|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855305|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82855306|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855308|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82855309|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82855310|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855311|NCT05649059|Cannabidiol|cannabidiol|mesh-list
82855312|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
82855313|NCT05639686|Remifentanil|remifentanil|mesh-list
82855314|NCT05639686|Anesthetics|anesthetics|mesh-list
82855315|NCT05639686|Propofol|propofol|mesh-list
82855316|NCT05639686|Isoflurane|isoflurane|mesh-list
82855317|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
82855318|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855319|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855320|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82855321|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82855322|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
82855323|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82855324|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82855325|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855326|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
82855327|NCT05639686|Coagulants|coagulants|mesh-ancestor
82855328|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82855329|NCT05639686|Narcotics|narcotics|mesh-ancestor
82855330|NCT05639686|Analgesics|analgesics|mesh-ancestor
82855331|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
82855332|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855333|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82855334|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82855335|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82855336|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
82855337|NCT05590234|Bupivacaine|bupivacaine|mesh-list
82855338|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
82855340|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855341|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855342|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
82855343|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855344|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82855345|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82855346|NCT05590234|Analgesics|analgesics|mesh-ancestor
82855347|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82855348|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82855349|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82855350|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
82855351|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855352|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855353|NCT05586074|Cytarabine|cytarabine|mesh-list
82855354|NCT05586074|Fludarabine|fludarabine|mesh-list
82855355|NCT05586074|Azacitidine|azacitidine|mesh-list
82855356|NCT05586074|Decitabine|decitabine|mesh-list
82855357|NCT05586074|Idarubicin|idarubicin|mesh-list
82855358|NCT05586074|Lenograstim|lenograstim|mesh-list
82855359|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855360|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855361|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
82855362|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855363|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855364|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
82855365|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855366|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
82855367|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855368|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855369|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82855370|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82855371|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82855372|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82855373|NCT05568615|Edaravone|edaravone|mesh-list
82855374|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82855375|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
82855376|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855377|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82855378|NCT05568615|Protective Agents|protective agents|mesh-ancestor
82855379|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855380|NCT05541146|Paclitaxel|paclitaxel|mesh-list
82855381|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855382|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855383|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855384|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855385|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855386|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855387|NCT05532358|Midazolam|midazolam|mesh-list
82855388|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
82855389|NCT05532358|Caffeine|caffeine|mesh-list
82855390|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82855391|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82855392|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855393|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855394|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82855395|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82855396|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82855397|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82855398|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
82855399|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
82855400|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
82855401|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
82855402|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855403|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855404|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82855405|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82855406|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855407|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82855408|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82855409|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
82855410|NCT05532358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82855411|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82855412|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82855414|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82855415|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
82855416|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82855417|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82855418|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82855419|NCT05525416|Propranolol|propranolol|mesh-list
82855420|NCT05525416|Nitroprusside|nitroprusside|mesh-list
82855421|NCT05525416|Phentolamine|phentolamine|mesh-list
82855422|NCT05525416|Phenylephrine|phenylephrine|mesh-list
82855423|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
82855424|NCT05525416|Norepinephrine|norepinephrine|mesh-list
82855425|NCT05525416|Synephrine|synephrine|mesh-list
82855426|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82855427|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82855428|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
82855429|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855430|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855431|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855432|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82855433|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82855434|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
82855435|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82855436|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
82855437|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
82855438|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855439|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
82855440|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82855441|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
82855442|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
82855443|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82855444|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82855445|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82855446|NCT05525416|Protective Agents|protective agents|mesh-ancestor
82855447|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82855448|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82855449|NCT05491512|Carboplatin|carboplatin|mesh-list
82855450|NCT05491512|Fluorouracil|fluorouracil|mesh-list
82855451|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855452|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
82855453|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855454|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855455|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855456|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
82855457|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855458|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
82855459|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855460|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
82855461|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
82855462|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82855463|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
82855464|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
82855465|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855466|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855467|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82855468|NCT05432518|Everolimus|everolimus|mesh-list
82855469|NCT05432518|Dasatinib|dasatinib|mesh-list
82855470|NCT05432518|Olaparib|olaparib|mesh-list
82855471|NCT05432518|Palbociclib|palbociclib|mesh-list
82855472|NCT05432518|Afatinib|afatinib|mesh-list
82855473|NCT05432518|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82855474|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82855475|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855476|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855477|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855478|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
82855479|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855480|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855481|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82855482|NCT05412706|Niraparib|niraparib|mesh-list
82855483|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82855484|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855485|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855486|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855487|NCT05403385|Carboplatin|carboplatin|mesh-list
82855488|NCT05403385|Pemetrexed|pemetrexed|mesh-list
82855490|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855491|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855492|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82855493|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82855494|NCT05394740|Leucovorin|leucovorin|mesh-list
82855495|NCT05394740|Fluorouracil|fluorouracil|mesh-list
82855496|NCT05394740|Capecitabine|capecitabine|mesh-list
82855497|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
82855498|NCT05394740|Nivolumab|nivolumab|mesh-list
82855499|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
83452994|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82855500|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855501|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855502|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855503|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855504|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
82855505|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855506|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855507|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855508|NCT05394740|Antidotes|antidotes|mesh-ancestor
82855509|NCT05394740|Protective Agents|protective agents|mesh-ancestor
82855510|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
82855511|NCT05394740|Vitamins|vitamins|mesh-ancestor
82855512|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
82855513|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82855514|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82855515|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855516|NCT05273996|Bupropion|bupropion|mesh-list
82855517|NCT05273996|Sertraline|sertraline|mesh-list
82855518|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82855519|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82855520|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
82855521|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82855522|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82855523|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82855524|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82855525|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855526|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
82855527|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855528|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855529|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82855530|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82855531|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855532|NCT05273996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82855533|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
82855534|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82855535|NCT05264025|Fexofenadine|fexofenadine|mesh-list
82855536|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82855537|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82855538|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82855539|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
82855540|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
82855541|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855542|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855543|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855544|NCT05262244|Bevacizumab|bevacizumab|mesh-list
82855545|NCT05262244|Vedolizumab|vedolizumab|mesh-list
82855546|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855547|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855548|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82855549|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82855550|NCT05262244|Growth Substances|growth substances|mesh-ancestor
82855551|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855552|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
82855553|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82855554|NCT05244213|Paclitaxel|paclitaxel|mesh-list
82855555|NCT05244213|Carboplatin|carboplatin|mesh-list
82855556|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855557|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855558|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855559|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855560|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855561|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855571|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82855572|NCT05231148|Calcium|calcium|mesh-list
82855573|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82855574|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855575|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855576|NCT05219487|Risdiplam|risdiplam|mesh-list
82855577|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82855578|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855579|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855580|NCT05169112|Leuprolide|leuprolide|mesh-list
82855581|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82855582|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
82855583|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82855584|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855585|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855586|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855587|NCT05137184|Fentanyl|fentanyl|mesh-list
82855588|NCT05137184|Morphine|morphine|mesh-list
82855589|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
82855590|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82855591|NCT05137184|Narcotics|narcotics|mesh-ancestor
82855592|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855593|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855594|NCT05137184|Analgesics|analgesics|mesh-ancestor
82855595|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
82855596|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855597|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82855598|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82855599|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
82855600|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
82855601|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82855602|NCT05128734|Temozolomide|temozolomide|mesh-list
82855603|NCT05128734|Olaparib|olaparib|mesh-list
82855604|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82855605|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
82855606|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855607|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855608|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82855609|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855610|NCT05097209|Cisplatin|cisplatin|mesh-list
82855611|NCT05097209|Gemcitabine|gemcitabine|mesh-list
82855612|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855613|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855614|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
82855615|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855624|NCT05069038|Palbociclib|palbociclib|mesh-list
82855625|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855626|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82855627|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855628|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855629|NCT05067998|Vitamins|vitamins|mesh-list
82855630|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
82855631|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855632|NCT05065411|Everolimus|everolimus|mesh-list
82855633|NCT05065411|Fulvestrant|fulvestrant|mesh-list
82855634|NCT05065411|Exemestane|exemestane|mesh-list
82855635|NCT05065411|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82855636|NCT05065411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82855637|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855638|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855639|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855640|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
82855641|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855642|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855643|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855644|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82855645|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82855646|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
82855647|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855648|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82855649|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82855650|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
82855651|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82855652|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855654|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
82855655|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
82855656|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855657|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855658|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
82855659|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855660|NCT05001776|PENTA|penta|mesh-list
82855661|NCT05001776|Fondaparinux|fondaparinux|mesh-list
82855662|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82855663|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
82855664|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82855665|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
82855666|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855667|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855668|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
82855669|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82855670|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82855671|NCT04991974|Buprenorphine|buprenorphine|mesh-list
82855672|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82855673|NCT04991974|Naloxone|naloxone|mesh-list
82855674|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82855675|NCT04991974|Narcotics|narcotics|mesh-ancestor
82855676|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855677|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855678|NCT04991974|Analgesics|analgesics|mesh-ancestor
82855679|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
82855680|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855681|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82855682|NCT04977479|Vaccines|vaccines|mesh-list
82855683|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
82855684|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855685|NCT04971473|Hormones|hormones|mesh-list
82855686|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855687|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855688|NCT04943588|Antibodies|antibodies|mesh-list
82855689|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
82855690|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
82855691|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855692|NCT04917692|Empagliflozin|empagliflozin|mesh-list
82855693|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82855694|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855695|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82855696|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855697|NCT04915248|Dexamethasone|dexamethasone|mesh-list
82855698|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
82855699|NCT04915248|Bortezomib|bortezomib|mesh-list
82855700|NCT04915248|Daratumumab|daratumumab|mesh-list
82855701|NCT04915248|BB 1101|bb 1101|mesh-list
82855702|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82855703|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82855704|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
82855705|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
82855706|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855707|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855708|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82855709|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
82855710|NCT04915248|Hormones|hormones|mesh-ancestor
82855711|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855712|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855714|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
82855715|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855716|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855717|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
82855718|NCT04893785|Temozolomide|temozolomide|mesh-list
82855719|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82855720|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
82855721|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855722|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855723|NCT04881747|Lasmiditan|lasmiditan|mesh-list
82855724|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82855725|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
82855726|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855727|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855728|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855729|NCT04862949|Bevacizumab|bevacizumab|mesh-list
82855730|NCT04862949|Atezolizumab|atezolizumab|mesh-list
82855731|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855732|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855733|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82855734|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82855735|NCT04862949|Growth Substances|growth substances|mesh-ancestor
82855736|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855737|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
82855738|NCT04862949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855739|NCT04862949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855740|NCT04862663|Fulvestrant|fulvestrant|mesh-list
82855741|NCT04862663|Palbociclib|palbociclib|mesh-list
82855742|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82855743|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855744|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82855745|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82855746|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
82855747|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855748|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855749|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82855750|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855751|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855752|NCT04848974|Cytarabine|cytarabine|mesh-list
82855753|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
82855754|NCT04848974|Cladribine|cladribine|mesh-list
82855755|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855756|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
82855757|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855758|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855759|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
82855760|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855761|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855762|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
82855763|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855764|NCT04840823|Enoxacin|enoxacin|mesh-list
82855765|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82855766|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855767|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82855768|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82855769|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855770|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855771|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855772|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82855773|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82855774|NCT04825704|Bupivacaine|bupivacaine|mesh-list
82855775|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
82855776|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
82855777|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855778|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855779|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
82855780|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855781|NCT04781959|Lenograstim|lenograstim|mesh-list
82855782|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82855783|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
82855784|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855786|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855787|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855788|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855789|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855790|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855791|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855792|NCT04712903|Carboplatin|carboplatin|mesh-list
82855794|NCT04712903|Durvalumab|durvalumab|mesh-list
82855795|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855796|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855797|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82855798|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82855799|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855800|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855801|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855802|NCT04677049|Niacin|niacin|mesh-list
82855803|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
82855804|NCT04677049|Vitamins|vitamins|mesh-ancestor
82855805|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
82855806|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855807|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
82855808|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82855809|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
83453005|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82855810|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855811|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82855812|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
82855813|NCT04652245|Fluticasone|fluticasone|mesh-list
82855814|NCT04652245|Xhance|xhance|mesh-list
82855815|NCT04652245|Azelastine|azelastine|mesh-list
82855816|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82855817|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82855818|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
82855819|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855820|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855821|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82855822|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
82855823|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
82855824|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82855825|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82855826|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82855827|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855828|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82855829|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82855830|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
82855831|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
82855832|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82855833|NCT04642287|Fluorouracil|fluorouracil|mesh-list
82855834|NCT04642287|Calcipotriene|calcipotriene|mesh-list
82855835|NCT04642287|Petrolatum|petrolatum|mesh-list
82855836|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
82855837|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855838|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855839|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855840|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855841|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
82855842|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855843|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
82855845|NCT04635735|Ipilimumab|ipilimumab|mesh-list
82855846|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855847|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855848|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855849|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855850|NCT04595513|Sirolimus|sirolimus|mesh-list
82855851|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82855852|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855853|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82855854|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855855|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
82855856|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855857|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
82855858|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855859|NCT04564339|Ravulizumab|ravulizumab|mesh-list
83083924|NCT02474654|Ketorolac|ketorolac|mesh-list
82855860|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82855861|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855862|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
82855863|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855864|NCT04543110|Durvalumab|durvalumab|mesh-list
82855865|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855866|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855867|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
82855868|NCT04487652|Vitamins|vitamins|mesh-ancestor
82855869|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
82855870|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855871|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
82855872|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855873|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855874|NCT04454489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855875|NCT04454489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855876|NCT04447183|Iodine|iodine|mesh-list
82855877|NCT04447183|Hormones|hormones|mesh-list
82855878|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82855879|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855880|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82855881|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855882|NCT04447183|Trace Elements|trace elements|mesh-ancestor
82855883|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
82855884|NCT04429334|Nangibotide|nangibotide|mesh-list
82855885|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82855886|NCT04421820|Leucovorin|leucovorin|mesh-list
82855887|NCT04421820|Fluorouracil|fluorouracil|mesh-list
82855888|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
82855889|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
82855890|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855891|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855892|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855893|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855894|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
82855895|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855896|NCT04421820|Antidotes|antidotes|mesh-ancestor
82855897|NCT04421820|Protective Agents|protective agents|mesh-ancestor
82855898|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
82855899|NCT04421820|Vitamins|vitamins|mesh-ancestor
82855900|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
82855901|NCT04408443|Vitamin D|vitamin d|mesh-list
82855902|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
82855903|NCT04408443|Vitamins|vitamins|mesh-ancestor
82855904|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
82855905|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855906|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82855907|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82855908|NCT04405739|Molnupiravir|molnupiravir|mesh-list
82855909|NCT04405739|Antiviral Agents|antiviral agents|mesh-ancestor
82855910|NCT04405739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82855911|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
82855912|NCT04396457|Pemetrexed|pemetrexed|mesh-list
82855913|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855914|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855915|NCT04396457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855916|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855918|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82855919|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82855920|NCT04377204|Lidocaine|lidocaine|mesh-list
82855921|NCT04377204|Bupivacaine|bupivacaine|mesh-list
82855922|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
82855923|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
82855924|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855925|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855926|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
82855927|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855928|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82855929|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82855930|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82855931|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82855932|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855933|NCT04349267|Nivolumab|nivolumab|mesh-list
82855934|NCT04349267|Cetuximab|cetuximab|mesh-list
82855935|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83083925|NCT02474654|Epinephrine|epinephrine|mesh-list
82855936|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855937|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855938|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855939|NCT04346589|Antibodies|antibodies|mesh-list
82855940|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
82855941|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82855942|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
82855943|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855944|NCT04331067|Paclitaxel|paclitaxel|mesh-list
82855945|NCT04331067|Carboplatin|carboplatin|mesh-list
82855946|NCT04331067|Nivolumab|nivolumab|mesh-list
82855947|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82855948|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855949|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
82855950|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
82855951|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
82855952|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855953|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82855954|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82855955|NCT04329221|Calcitriol|calcitriol|mesh-list
82855956|NCT04329221|Fluorouracil|fluorouracil|mesh-list
82855957|NCT04329221|Calcipotriene|calcipotriene|mesh-list
82855958|NCT04329221|Petrolatum|petrolatum|mesh-list
82855959|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
83453008|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855960|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855961|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82855962|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855963|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82855964|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
82855965|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855966|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
82855967|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82855968|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82855969|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82855970|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82855971|NCT04329221|Vitamins|vitamins|mesh-ancestor
82855972|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
82855973|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82855974|NCT04329221|Emollients|emollients|mesh-ancestor
82855975|NCT04324840|Temozolomide|temozolomide|mesh-list
82855976|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82855977|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
82855978|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855979|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82855980|NCT04316013|Lidocaine|lidocaine|mesh-list
82855981|NCT04316013|Propofol|propofol|mesh-list
82855982|NCT04316013|Sevoflurane|sevoflurane|mesh-list
82855983|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
82855984|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
82855985|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82855986|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82855987|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
82855988|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82855989|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82855990|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82855991|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82855992|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82855993|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82855994|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82855995|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82855996|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
82855997|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82855998|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82856000|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82856001|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
82856002|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856003|NCT04312594|Expectorants|expectorants|mesh-ancestor
82856004|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
82856005|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82856006|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
82856007|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856008|NCT04312594|Protective Agents|protective agents|mesh-ancestor
82856009|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856010|NCT04312594|Antidotes|antidotes|mesh-ancestor
83083926|NCT02474654|Racepinephrine|racepinephrine|mesh-list
82856011|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
82856012|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
82856013|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82856014|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856015|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856016|NCT04264897|Metformin|metformin|mesh-list
82856017|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82856018|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856019|NCT04225026|Manganese|manganese|mesh-list
82856020|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
82856021|NCT04225026|Trace Elements|trace elements|mesh-ancestor
82856022|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
82856023|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856024|NCT04225026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82856025|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
82856026|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856027|NCT04225026|Protective Agents|protective agents|mesh-ancestor
82856028|NCT04177108|Paclitaxel|paclitaxel|mesh-list
82856029|NCT04177108|Atezolizumab|atezolizumab|mesh-list
82856030|NCT04177108|Ipatasertib|ipatasertib|mesh-list
82856031|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82856032|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83453009|NCT00961441|Levetiracetam|levetiracetam|mesh-list
82856033|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856034|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856035|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
82856036|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
82856037|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856038|NCT04177108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856039|NCT04177108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856040|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
82856041|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856042|NCT04177108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856043|NCT04177108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856044|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
82856045|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82856046|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82856047|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856048|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
82856049|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
82856050|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856051|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82856052|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82856053|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82856054|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82856055|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856056|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82856057|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856058|NCT04111627|Analgesics|analgesics|mesh-ancestor
82856059|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
82856060|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856061|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
82856062|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82856063|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
82856064|NCT04090710|Nivolumab|nivolumab|mesh-list
82856065|NCT04090710|Ipilimumab|ipilimumab|mesh-list
82856066|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856067|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856068|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856069|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856070|NCT04069312|Azithromycin|azithromycin|mesh-list
82856071|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82856072|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856073|NCT04032080|Prexasertib|prexasertib|mesh-list
82856074|NCT04032080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856075|NCT04032080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856076|NCT04032080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856077|NCT03983954|Durvalumab|durvalumab|mesh-list
82856078|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
82856079|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82856080|NCT03983954|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
82856081|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
82856082|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856083|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856084|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
82856085|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856087|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82856088|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
82856089|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82856090|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856091|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
82856092|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82856093|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856094|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856095|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82856096|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82856097|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82856098|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82856099|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82856100|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82856101|NCT03955978|Dostarlimab|dostarlimab|mesh-list
82856102|NCT03955978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856103|NCT03940352|Venetoclax|venetoclax|mesh-list
82856104|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856105|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
82856106|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
82856107|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856108|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
82856109|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856110|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856111|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82856112|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
82856113|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856114|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856115|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82856116|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856117|NCT03918499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856118|NCT03914443|Cisplatin|cisplatin|mesh-list
82856119|NCT03914443|Docetaxel|docetaxel|mesh-list
82856120|NCT03914443|Fluorouracil|fluorouracil|mesh-list
82856121|NCT03914443|Nivolumab|nivolumab|mesh-list
82856122|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856123|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856124|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
82856125|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
82856126|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856127|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
82856128|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856129|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856130|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
82856131|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856132|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856133|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856134|NCT03815890|Nivolumab|nivolumab|mesh-list
82856135|NCT03815890|Ipilimumab|ipilimumab|mesh-list
82856136|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856137|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856138|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83476467|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856139|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856140|NCT03794583|Treprostinil|treprostinil|mesh-list
82856141|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82856142|NCT03777657|Capecitabine|capecitabine|mesh-list
82856143|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
82856144|NCT03777657|Tislelizumab|tislelizumab|mesh-list
82856145|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856146|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856147|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
82856148|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856149|NCT03777657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856150|NCT03711474|Dexamethasone|dexamethasone|mesh-list
82856151|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856152|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
82856153|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
82856154|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856155|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856156|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856157|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
82856158|NCT03711474|Hormones|hormones|mesh-ancestor
82856159|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856160|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82856161|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856163|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82856164|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856165|NCT03482024|Incretins|incretins|mesh-ancestor
82856166|NCT03482024|Hormones|hormones|mesh-ancestor
82856167|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856168|NCT03423199|Tamoxifen|tamoxifen|mesh-list
82856169|NCT03423199|Goserelin|goserelin|mesh-list
82856170|NCT03423199|Palbociclib|palbociclib|mesh-list
82856171|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82856172|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
83453012|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
82856173|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856174|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856175|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82856176|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856177|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82856178|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82856179|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82856180|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856181|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856182|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856183|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
82856184|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82856185|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82856186|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856187|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
82856188|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
82856189|NCT03418532|Osimertinib|osimertinib|mesh-list
82856190|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856191|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856192|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856193|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856194|NCT03417401|Plasminogen|plasminogen|mesh-list
82856195|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82856196|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82856197|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82856198|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856199|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
82856200|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856201|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856202|NCT03391973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856203|NCT03391973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856204|NCT03322631|Tirzepatide|tirzepatide|mesh-list
82856205|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82856206|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856207|NCT03322631|Incretins|incretins|mesh-ancestor
82856208|NCT03322631|Hormones|hormones|mesh-ancestor
82856209|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856210|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
82856211|NCT03290612|Vitamins|vitamins|mesh-ancestor
82856212|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
82856213|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856214|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
82856215|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856216|NCT03290612|Protective Agents|protective agents|mesh-ancestor
82856217|NCT03161522|Fluorouracil|fluorouracil|mesh-list
82856218|NCT03161522|Capecitabine|capecitabine|mesh-list
82856219|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
82856220|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856221|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856222|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856223|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856224|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
82856225|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856226|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82856227|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856228|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856229|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82856230|NCT03057795|Nivolumab|nivolumab|mesh-list
82856231|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82856232|NCT03057795|Antibodies|antibodies|mesh-list
82856233|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
82856240|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856242|NCT03018704|Topiramate|topiramate|mesh-list
82856243|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
82856244|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82856245|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856246|NCT02978612|Capecitabine|capecitabine|mesh-list
82856247|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856248|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
83453021|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856249|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856250|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856251|NCT02970500|Methylphenidate|methylphenidate|mesh-list
82856252|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82856253|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856254|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82856255|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82856256|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82856257|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856258|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
82856259|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82856260|NCT02951130|Milrinone|milrinone|mesh-list
82856261|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82856262|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82856263|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
82856264|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82856265|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82856266|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856267|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856268|NCT02951130|Protective Agents|protective agents|mesh-ancestor
82856269|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856270|NCT02810743|Olaparib|olaparib|mesh-list
82856271|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82856272|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856273|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856274|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856275|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
82856276|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856277|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856278|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856279|NCT02617407|Listerine|listerine|mesh-list
82856280|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
82856281|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
82856282|NCT02617407|Protective Agents|protective agents|mesh-ancestor
82856283|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856284|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82856285|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856286|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
82856287|NCT02537509|Vitamin D|vitamin d|mesh-list
82856288|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82856289|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856290|NCT02537509|Vitamins|vitamins|mesh-ancestor
82856291|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
82856292|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82856293|NCT02490878|Bevacizumab|bevacizumab|mesh-list
82856294|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856295|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856296|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82856297|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82856298|NCT02490878|Growth Substances|growth substances|mesh-ancestor
82856299|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856300|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
82856327|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856328|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82856329|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856330|NCT02262325|Etoposide|etoposide|mesh-list
82856331|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
82856332|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856333|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82856334|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82856335|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82856336|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856337|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856338|NCT02205762|Cytarabine|cytarabine|mesh-list
82856339|NCT02205762|Prednisone|prednisone|mesh-list
82856340|NCT02205762|Indomethacin|indomethacin|mesh-list
82856341|NCT02205762|Methotrexate|methotrexate|mesh-list
82856342|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
82856343|NCT02205762|Vinblastine|vinblastine|mesh-list
82856344|NCT02205762|Cladribine|cladribine|mesh-list
82856345|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
82856346|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82856347|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
82856348|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82856349|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856350|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
82856351|NCT02205762|Hormones|hormones|mesh-ancestor
82856352|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856353|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856354|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82856355|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856356|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82856357|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
82856358|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82856359|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856360|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
82856361|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856362|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
82856363|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856364|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82856365|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856366|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
82856367|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856368|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82856369|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
82856370|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856371|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82856372|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856373|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
82856374|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
82856375|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82856376|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82856377|NCT02205762|Analgesics|analgesics|mesh-ancestor
82856378|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
82856379|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856380|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
82856381|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
82856382|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82856383|NCT01996267|Paclitaxel|paclitaxel|mesh-list
82856384|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
82856385|NCT01996267|Carboplatin|carboplatin|mesh-list
82856387|NCT01996267|Trastuzumab|trastuzumab|mesh-list
82856388|NCT01996267|Pertuzumab|pertuzumab|mesh-list
82856389|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82856390|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856391|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856392|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
82856393|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
82856394|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856395|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856396|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
82856397|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856398|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856399|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82856400|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
82856401|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82856402|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
82856403|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856404|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856405|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
82856406|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82856407|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
82856408|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856409|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
82856410|NCT01934218|Protective Agents|protective agents|mesh-ancestor
82856411|NCT01898117|Paclitaxel|paclitaxel|mesh-list
82856412|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82856413|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
82856414|NCT01898117|Carboplatin|carboplatin|mesh-list
82856415|NCT01898117|Atezolizumab|atezolizumab|mesh-list
82856416|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82856417|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82856418|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856419|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856420|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
82856421|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
82856422|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856423|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856424|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
82856425|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856426|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856427|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82856428|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
82856429|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82856430|NCT01898117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856431|NCT01898117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856432|NCT01623167|Cyclosporine|cyclosporine|mesh-list
82856433|NCT01623167|Cyclosporins|cyclosporins|mesh-list
82856434|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82856435|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856436|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856437|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856438|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
82856439|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856440|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
82856441|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856442|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
82856443|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856444|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82856445|NCT01597388|Fulvestrant|fulvestrant|mesh-list
82856446|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82856447|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856448|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82856449|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82856450|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
82856451|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856452|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856453|NCT01233635|Losartan|losartan|mesh-list
82856454|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82856455|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82856456|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82856457|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82856458|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856459|NCT00385606|Rofecoxib|rofecoxib|mesh-list
82856460|NCT00385606|Gemcitabine|gemcitabine|mesh-list
82856461|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856462|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856463|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
82856464|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856465|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82856466|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82856467|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856468|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82856469|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82856470|NCT00385606|Analgesics|analgesics|mesh-ancestor
82856471|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
82856472|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856473|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856474|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856475|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856477|NCT03721744|Gemcitabine|gemcitabine|mesh-list
82856478|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82856479|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856480|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856481|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
82856482|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
82856483|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856484|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856485|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
82856486|NCT01589354|Ropivacaine|ropivacaine|mesh-list
82856487|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
82856488|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
82856489|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82856490|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856491|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
82856492|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856493|NCT01583660|Acetaminophen|acetaminophen|mesh-list
82856494|NCT01583660|Celecoxib|celecoxib|mesh-list
82856495|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82856496|NCT01583660|Oxycodone|oxycodone|mesh-list
82856497|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82856498|NCT01583660|Analgesics|analgesics|mesh-ancestor
82856499|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
82856500|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856501|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856502|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
82856503|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82856504|NCT01583660|Narcotics|narcotics|mesh-ancestor
82856505|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82856506|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82856507|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856508|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856509|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82856510|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82856511|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856512|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856513|NCT03960866|Phentolamine|phentolamine|mesh-list
82856514|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82856515|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82856516|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82856517|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82856518|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
82856519|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82856520|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856521|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856522|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82856523|NCT01089218|Amoxicillin|amoxicillin|mesh-list
82856524|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
82856525|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
82856526|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82856527|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82856528|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856529|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82856530|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856531|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856532|NCT03957668|Lactulose|lactulose|mesh-list
82856533|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82856534|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856535|NCT03957668|Laxatives|laxatives|mesh-ancestor
82856536|NCT01089452|Amlodipine|amlodipine|mesh-list
82856537|NCT01089452|Olmesartan|olmesartan|mesh-list
82856538|NCT01089452|Perindopril|perindopril|mesh-list
82856539|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82856540|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82856541|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82856542|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856543|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82856544|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856545|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
82856546|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82856547|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82856548|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82856549|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
82856550|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856551|NCT04880980|Itraconazole|itraconazole|mesh-list
82856552|NCT04880980|Terbinafine|terbinafine|mesh-list
82856553|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
82856554|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856555|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82856556|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82856557|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856558|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856559|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82856560|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
82856561|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856562|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856563|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82856564|NCT01583504|Anesthetics|anesthetics|mesh-list
82856565|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
82856566|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82856567|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856568|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
82856569|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856570|NCT01583036|Digoxin|digoxin|mesh-list
82856571|NCT01583036|Ezogabine|ezogabine|mesh-list
82856572|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82856573|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82856574|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856575|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856576|NCT01583036|Protective Agents|protective agents|mesh-ancestor
82856577|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856578|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
82856579|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82856580|NCT01091792|Bevacizumab|bevacizumab|mesh-list
82856581|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856582|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856583|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82856584|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82856585|NCT01091792|Growth Substances|growth substances|mesh-ancestor
82856586|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856587|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
82856588|NCT03510910|Acetaminophen|acetaminophen|mesh-list
82856589|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82856590|NCT03510910|Analgesics|analgesics|mesh-ancestor
82856591|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
82856592|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856593|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856594|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
82856595|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
82856596|NCT01091870|Citric Acid|citric acid|mesh-list
82856597|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
82856598|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
82856599|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82856600|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
82856601|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
82856602|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856603|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
82856604|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82856605|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82856606|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856607|NCT01091870|Urological Agents|urological agents|mesh-ancestor
82856608|NCT03509350|Vitamins|vitamins|mesh-list
82856609|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
82856610|NCT03509350|Thiamine|thiamine|mesh-list
82856611|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
82856612|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82856613|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82856614|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82856615|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
82856616|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856617|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856618|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
82856619|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856620|NCT03509350|Protective Agents|protective agents|mesh-ancestor
82856621|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
82856622|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82856624|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
82856625|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82856626|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
82856627|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856628|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856629|NCT03478696|Budesonide|budesonide|mesh-list
82856630|NCT03478696|Albuterol|albuterol|mesh-list
82856631|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
82856632|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
82856633|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82856634|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856635|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82856636|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
82856637|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856638|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856639|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82856640|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
82856641|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
82856642|NCT03478696|Hormones|hormones|mesh-ancestor
82856643|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856644|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82856645|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82856646|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82856647|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
82856648|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82856649|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856650|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
82856651|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82856652|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
82856653|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
82856654|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82856655|NCT00072176|Sirolimus|sirolimus|mesh-list
82856656|NCT00072176|Temsirolimus|temsirolimus|mesh-list
82856657|NCT00072176|MTOR Inhibitors|mtor inhibitors|mesh-list
82856658|NCT00072176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856659|NCT00072176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856660|NCT00072176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856661|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856662|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
82856663|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856664|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856665|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82856666|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856667|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82856668|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
82856669|NCT00071396|Rituximab|rituximab|mesh-list
82856670|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
82856671|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856672|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856673|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
82856674|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856675|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856676|NCT03472534|Diacerein|diacerein|mesh-list
82856677|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856678|NCT03725020|Fluorides|fluorides|mesh-list
82856679|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
82856680|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
82856681|NCT03725020|Protective Agents|protective agents|mesh-ancestor
82856682|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856683|NCT03721432|Pregabalin|pregabalin|mesh-list
82856684|NCT03721432|Analgesics|analgesics|mesh-ancestor
82856685|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
82856687|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856689|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82856690|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82856691|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856692|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82856693|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82856694|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82856695|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82856696|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82856697|NCT03469336|Betamethasone|betamethasone|mesh-list
82856698|NCT03469336|Calcipotriene|calcipotriene|mesh-list
82856699|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856700|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
82856701|NCT03469336|Hormones|hormones|mesh-ancestor
82856702|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856703|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856704|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82856705|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
82856706|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
82856707|NCT03719560|Cytarabine|cytarabine|mesh-list
82856708|NCT03719560|Methotrexate|methotrexate|mesh-list
82856709|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82856710|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
82856711|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82856712|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856713|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856714|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
82856715|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856716|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856717|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
82856718|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856719|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82856720|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856721|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
82856722|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856723|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82856724|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
82856725|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856726|NCT03469258|Pancrelipase|pancrelipase|mesh-list
82856727|NCT03469258|Pancreatin|pancreatin|mesh-list
82856728|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856729|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
82856730|NCT00066170|Modafinil|modafinil|mesh-list
82856731|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82856732|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856733|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82856734|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82856735|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82856736|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856737|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82856738|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82856739|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
82856740|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
82856741|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82856742|NCT00065468|Interferons|interferons|mesh-list
82856743|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
82856744|NCT00065468|Sirolimus|sirolimus|mesh-list
82856745|NCT00065468|Temsirolimus|temsirolimus|mesh-list
82856746|NCT00065468|MTOR Inhibitors|mtor inhibitors|mesh-list
82856747|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856748|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
82856749|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856750|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
82856751|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856752|NCT00065468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856753|NCT00065468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856754|NCT00065468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856755|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856756|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82856757|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82856758|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
82856760|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856761|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856762|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856763|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856764|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82856765|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82856766|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856767|NCT00094107|Axitinib|axitinib|mesh-list
82856768|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856769|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856770|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856771|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856772|NCT00102063|Aripiprazole|aripiprazole|mesh-list
82856773|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
82856774|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82856775|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82856776|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82856777|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82856778|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856779|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
82856780|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
82856781|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82856782|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856783|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82856784|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82856785|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
82856786|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82856787|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82856788|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82856789|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82856790|NCT00065156|Lenalidomide|lenalidomide|mesh-list
82856791|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
82856792|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856793|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82856794|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82856795|NCT00065156|Growth Substances|growth substances|mesh-ancestor
82856796|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
82856797|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856799|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
82856800|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
82856801|NCT01094210|Protective Agents|protective agents|mesh-ancestor
82856802|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856803|NCT01094444|Vitamin K|vitamin k|mesh-list
82856804|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
82856805|NCT01094444|Vitamins|vitamins|mesh-ancestor
82856806|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
82856807|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856808|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82856809|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82856810|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856811|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
82856812|NCT01094444|Coagulants|coagulants|mesh-ancestor
82856813|NCT00078819|Etanercept|etanercept|mesh-list
82856814|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82856815|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82856816|NCT00078819|Analgesics|analgesics|mesh-ancestor
82856817|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
82856818|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856819|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856820|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856821|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856822|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856823|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856824|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
82856825|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82856826|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82856827|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856828|NCT00098865|Thalidomide|thalidomide|mesh-list
82856829|NCT00098865|Temozolomide|temozolomide|mesh-list
82856830|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82856831|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
82856832|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856833|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856834|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856835|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
82856836|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856837|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
82856838|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82856839|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856840|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82856841|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82856842|NCT00098865|Growth Substances|growth substances|mesh-ancestor
82856843|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
82856844|NCT00098787|Leucovorin|leucovorin|mesh-list
82856845|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
82856846|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
82856847|NCT00098787|Bevacizumab|bevacizumab|mesh-list
82856848|NCT00098787|Fluorouracil|fluorouracil|mesh-list
82856849|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
82856850|NCT00098787|Irinotecan|irinotecan|mesh-list
82856851|NCT00098787|Camptothecin|camptothecin|mesh-list
82856852|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
82856853|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856854|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856855|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82856856|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82856857|NCT00098787|Growth Substances|growth substances|mesh-ancestor
82856858|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856859|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
82856860|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
82856861|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856862|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82856863|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856864|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
82856865|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82856866|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82856867|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856868|NCT00098787|Antidotes|antidotes|mesh-ancestor
82856869|NCT00098787|Protective Agents|protective agents|mesh-ancestor
82856870|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
82856872|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
82856873|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82856874|NCT01084863|Paclitaxel|paclitaxel|mesh-list
82856875|NCT01084863|Trastuzumab|trastuzumab|mesh-list
82856876|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82856877|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856878|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
82856879|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
82856880|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
82856881|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856882|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856883|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
82856884|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82856885|NCT03719404|Eusol|eusol|mesh-list
82856886|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82856887|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856888|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
82856889|NCT03720886|Teriparatide|teriparatide|mesh-list
82856890|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82856891|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856892|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82856893|NCT00077649|Ribavirin|ribavirin|mesh-list
82856894|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82856895|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
82856896|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
82856897|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82856898|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
82856899|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856900|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
82856901|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856902|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
82856903|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856904|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856905|NCT00038948|Cyclosporine|cyclosporine|mesh-list
82856906|NCT00038948|Sirolimus|sirolimus|mesh-list
82856907|NCT00038948|Tacrolimus|tacrolimus|mesh-list
82856908|NCT00038948|Cyclosporins|cyclosporins|mesh-list
82856909|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82856910|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
82856911|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856912|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82856914|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856915|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
82856916|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82856917|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
82856918|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82856919|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82856920|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82856921|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856922|NCT01096940|Simvastatin|simvastatin|mesh-list
82856923|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82856924|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82856925|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
82856926|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453051|NCT04358497|Ibuprofen|ibuprofen|mesh-list
82856927|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82856928|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82856929|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856930|NCT02530424|Trastuzumab|trastuzumab|mesh-list
82856931|NCT02530424|Pertuzumab|pertuzumab|mesh-list
82856932|NCT02530424|Fulvestrant|fulvestrant|mesh-list
82856933|NCT02530424|Palbociclib|palbociclib|mesh-list
82856934|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856935|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856936|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82856937|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82856938|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82856939|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
82856940|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856941|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856942|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82856943|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856944|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856945|NCT01088763|Dexamethasone|dexamethasone|mesh-list
82856946|NCT01088763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82856947|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856948|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
82856949|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
82856950|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856951|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856952|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856953|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
82856954|NCT01088763|Hormones|hormones|mesh-ancestor
82856955|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856956|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82856957|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856958|NCT01088763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82856959|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856960|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856961|NCT01094600|Secretin|secretin|mesh-list
82856962|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82856963|NCT01094600|Hormones|hormones|mesh-ancestor
82856964|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82856965|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856966|NCT01097252|Cisplatin|cisplatin|mesh-list
82856967|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856968|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
82856969|NCT02530502|Temozolomide|temozolomide|mesh-list
82856970|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82856971|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82856972|NCT02530502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82856973|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856974|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82856975|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
82856976|NCT00054704|Riluzole|riluzole|mesh-list
82856977|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
82856978|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82856979|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82856980|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82856981|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856982|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82856983|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82856984|NCT00054704|Protective Agents|protective agents|mesh-ancestor
82856986|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82856987|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82856988|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
82856989|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82856990|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82856991|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82856992|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82856993|NCT03956966|Dexamethasone|dexamethasone|mesh-list
82856994|NCT03956966|Bupivacaine|bupivacaine|mesh-list
82856995|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82856996|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
82856997|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
82856998|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82856999|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857000|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857001|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
82857003|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857004|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82857005|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857006|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
82857007|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
82857008|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857009|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
82857010|NCT00031694|Paclitaxel|paclitaxel|mesh-list
82857011|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
82857012|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82857013|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857014|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857015|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857016|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857017|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857018|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82857019|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
82857020|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857021|NCT03953066|Melatonin|melatonin|mesh-list
82857022|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
82857023|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857024|NCT03953066|Protective Agents|protective agents|mesh-ancestor
82857025|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857026|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857027|NCT00093795|Paclitaxel|paclitaxel|mesh-list
82857028|NCT00093795|Docetaxel|docetaxel|mesh-list
82857029|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
82857030|NCT00093795|Gemcitabine|gemcitabine|mesh-list
82857031|NCT00093795|Doxorubicin|doxorubicin|mesh-list
82857032|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82857033|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857034|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857035|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857036|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857037|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857038|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857039|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
82857040|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857041|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857042|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82857043|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
82857044|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82857045|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82857046|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
82857047|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82857048|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82857049|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82857050|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857051|NCT01092806|Tacrolimus|tacrolimus|mesh-list
82857052|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857053|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
82857054|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857055|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82857056|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857057|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857059|NCT01094912|Narcotics|narcotics|mesh-ancestor
82857060|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857061|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857062|NCT01094912|Analgesics|analgesics|mesh-ancestor
82857063|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
82857064|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857065|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
82857066|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
82857067|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857068|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
82857069|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857070|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857071|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82857072|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
83453056|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
82857073|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857074|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857075|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82857076|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82857077|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82857078|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
82857079|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82857080|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857081|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857082|NCT03802994|Vaccines|vaccines|mesh-list
82857083|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82857084|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
82857085|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857086|NCT01088919|Pioglitazone|pioglitazone|mesh-list
82857087|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
82857088|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82857089|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857090|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82857091|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857092|NCT03802916|Deferiprone|deferiprone|mesh-list
82857093|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82857094|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
82857095|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
82857096|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857097|NCT03720340|Oprelvekin|oprelvekin|mesh-list
82857098|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857099|NCT01094990|Dexamethasone|dexamethasone|mesh-list
82857100|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857101|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
82857102|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
82857103|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857104|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857105|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857106|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
82857107|NCT01094990|Hormones|hormones|mesh-ancestor
82857108|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857109|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82857110|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857111|NCT01584050|Folic Acid|folic acid|mesh-list
82857112|NCT01584050|Hematinics|hematinics|mesh-ancestor
82857113|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
82857114|NCT01584050|Vitamins|vitamins|mesh-ancestor
82857115|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
82857116|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857117|NCT03952832|Leflunomide|leflunomide|mesh-list
82857118|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857119|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857120|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857121|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
82857122|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857123|NCT01311076|Insulin|insulin|mesh-list
82857124|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82857125|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
82857126|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82857127|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857128|NCT01098344|Gemcitabine|gemcitabine|mesh-list
82857129|NCT01098344|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
82857130|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82857131|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
82857133|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857134|NCT01098344|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82857135|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857136|NCT01098656|Lenalidomide|lenalidomide|mesh-list
82857137|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
82857138|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857139|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82857140|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82857141|NCT01098656|Growth Substances|growth substances|mesh-ancestor
82857142|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
82857143|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857144|NCT00076011|Mitogens|mitogens|mesh-list
82857145|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
82857146|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857147|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857148|NCT00076011|Growth Substances|growth substances|mesh-ancestor
82857149|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857150|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
82857151|NCT03465436|Lasmiditan|lasmiditan|mesh-list
82857152|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82857153|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857154|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82857155|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82857156|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857157|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857158|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857159|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857160|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82857161|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
82857162|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857163|NCT01098890|Plasminogen|plasminogen|mesh-list
82857164|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82857165|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82857166|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82857167|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857168|NCT00053846|Buspirone|buspirone|mesh-list
82857169|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82857170|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82857171|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857172|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857173|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82857174|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82857175|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
82857176|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857177|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857178|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
82857179|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82857180|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82857181|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82857182|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857183|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
82857184|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857185|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82857186|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857187|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857188|NCT03489304|Zaleplon|zaleplon|mesh-list
82857189|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
82857190|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82857191|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857192|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857193|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
82857194|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
82857195|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857196|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857197|NCT03718624|Paclitaxel|paclitaxel|mesh-list
82857198|NCT03718624|Apatinib|apatinib|mesh-list
82857199|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82857200|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857201|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857202|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857203|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083927|NCT02474654|Fentanyl|fentanyl|mesh-list
82857204|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857205|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82857206|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857207|NCT03543358|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
82857208|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
82857209|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
82857210|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857211|NCT03485950|Meropenem|meropenem|mesh-list
82857212|NCT03485950|Tazobactam|tazobactam|mesh-list
82857213|NCT03485950|Piperacillin|piperacillin|mesh-list
82857214|NCT03485950|Cefepime|cefepime|mesh-list
82857215|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82857216|NCT03485950|Ceftolozane|ceftolozane|mesh-list
82857217|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82857218|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857219|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82857220|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857221|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857222|NCT00060944|Dexamethasone|dexamethasone|mesh-list
82857223|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
82857224|NCT00060944|Trabectedin|trabectedin|mesh-list
82857225|NCT00060944|BB 1101|bb 1101|mesh-list
82857226|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857227|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
82857228|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
82857229|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857230|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857231|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857232|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
82857234|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857235|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82857236|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857237|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
82857238|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857239|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857240|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82857241|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
82857242|NCT03956732|Vitamin D|vitamin d|mesh-list
82857243|NCT03956732|Caseins|caseins|mesh-list
82857244|NCT03956732|Vitamins|vitamins|mesh-ancestor
82857245|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
82857246|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857247|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82857248|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
82857249|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
82857250|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857251|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
82857252|NCT01093274|Cathartics|cathartics|mesh-ancestor
82857253|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857254|NCT01584206|Ezetimibe|ezetimibe|mesh-list
82857255|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82857256|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82857257|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
82857258|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857259|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82857260|NCT03541252|Cisplatin|cisplatin|mesh-list
82857261|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857262|NCT00031460|Acyclovir|acyclovir|mesh-list
82857263|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
82857264|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857265|NCT03540160|Serlopitant|serlopitant|mesh-list
82857266|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82857267|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857268|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857269|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857270|NCT01095302|Docetaxel|docetaxel|mesh-list
82857271|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857272|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857273|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857274|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857275|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857276|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82857277|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
82857278|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82857279|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82857280|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
82857281|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857282|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857284|NCT03457636|Adapalene|adapalene|mesh-list
82857285|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
82857286|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82857287|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82857288|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857289|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
82857290|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82857291|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82857292|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
82857293|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82857294|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82857295|NCT03457636|Analgesics|analgesics|mesh-ancestor
82857296|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
82857297|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857298|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857299|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857300|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857301|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
82857302|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
82857303|NCT01099436|Docetaxel|docetaxel|mesh-list
82857304|NCT01099436|Doxorubicin|doxorubicin|mesh-list
82857305|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82857306|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857307|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
82857308|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857309|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857310|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82857311|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
82857312|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857313|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857314|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82857315|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857316|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857317|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857318|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82857319|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82857320|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82857321|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857322|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82857323|NCT01099592|Citalopram|citalopram|mesh-list
82857324|NCT01099592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82857325|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82857326|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82857327|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857328|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857329|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
82857330|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857331|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82857332|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
82857333|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82857334|NCT01099748|Methadone|methadone|mesh-list
82857335|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82857336|NCT01099748|Narcotics|narcotics|mesh-ancestor
82857337|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857338|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857339|NCT01099748|Analgesics|analgesics|mesh-ancestor
82857340|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
82857341|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857342|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
82857343|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
82857344|NCT03481816|Vaccines|vaccines|mesh-list
82857345|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
82857346|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857347|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
82857348|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82857349|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
82857350|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857351|NCT03956888|Expectorants|expectorants|mesh-ancestor
82857352|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
82857353|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82857354|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
82857355|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857357|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857358|NCT03956888|Antidotes|antidotes|mesh-ancestor
82857359|NCT03955406|Anesthetics|anesthetics|mesh-list
82857360|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857361|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857362|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
82857363|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
82857364|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
82857365|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83453068|NCT02851108|Methylene Blue|methylene blue|mesh-list
82857366|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82857367|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857368|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857369|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857370|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82857371|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
82857372|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857373|NCT00050960|Paclitaxel|paclitaxel|mesh-list
82857374|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82857375|NCT00050960|Carboplatin|carboplatin|mesh-list
82857376|NCT00050960|Bexarotene|bexarotene|mesh-list
82857377|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82857378|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857379|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857380|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857381|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857382|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857383|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
82857384|NCT00097773|Tobramycin|tobramycin|mesh-list
82857385|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82857386|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857387|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82857388|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82857389|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857390|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857391|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857392|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82857393|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82857394|NCT03480022|Liraglutide|liraglutide|mesh-list
82857395|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82857396|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857397|NCT03480022|Incretins|incretins|mesh-ancestor
82857398|NCT03480022|Hormones|hormones|mesh-ancestor
82857399|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857400|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
82857401|NCT01093820|Hematinics|hematinics|mesh-ancestor
82857402|NCT00049322|Bevacizumab|bevacizumab|mesh-list
82857403|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857404|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857405|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82857406|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82857407|NCT00049322|Growth Substances|growth substances|mesh-ancestor
82857408|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857409|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
82857410|NCT00008138|Paclitaxel|paclitaxel|mesh-list
82857411|NCT00008138|Carboplatin|carboplatin|mesh-list
82857412|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82857413|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857414|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857415|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857416|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857417|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857418|NCT03436732|LMB-100|lmb-100|mesh-list
82857419|NCT03436732|Immunoconjugates|immunoconjugates|mesh-ancestor
82857420|NCT03436732|Immunologic Factors|immunologic factors|mesh-ancestor
82857421|NCT03436732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857422|NCT01100060|Azithromycin|azithromycin|mesh-list
82857423|NCT01100060|Chloroquine|chloroquine|mesh-list
82857424|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82857425|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82857426|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857427|NCT01100060|Amebicides|amebicides|mesh-ancestor
82857428|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82857429|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82857430|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
82857431|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857432|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82857433|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82857434|NCT01100060|Analgesics|analgesics|mesh-ancestor
82857435|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
82857436|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857437|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857438|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857439|NCT01100060|Filaricides|filaricides|mesh-ancestor
82857440|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
82857441|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
82857442|NCT01100216|Nicotine|nicotine|mesh-list
82857443|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82857444|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
82857445|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857446|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857447|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82857448|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82857449|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
82857450|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857451|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857452|NCT01100294|Vaccines|vaccines|mesh-list
82857453|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
82857454|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857455|NCT03436420|Calcium|calcium|mesh-list
82857456|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82857457|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857459|NCT01100372|Doxorubicin|doxorubicin|mesh-list
82857460|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82857461|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82857462|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
82857463|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857464|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857465|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82857466|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82857467|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82857468|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857469|NCT00027560|Cyclosporine|cyclosporine|mesh-list
82857470|NCT00027560|Fludarabine|fludarabine|mesh-list
82857471|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
82857472|NCT00027560|Melphalan|melphalan|mesh-list
82857473|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
82857474|NCT00027560|Cyclosporins|cyclosporins|mesh-list
82857475|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857476|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82857477|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
82857478|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857479|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857480|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
82857481|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857482|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857483|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
82857484|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857485|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
82857486|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857487|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82857488|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82857489|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
82857490|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82857491|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857492|NCT02529878|Paclitaxel|paclitaxel|mesh-list
82857493|NCT02529878|Apatinib|apatinib|mesh-list
82857494|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82857495|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857496|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857497|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857498|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857499|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857500|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82857501|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857502|NCT03451006|Metformin|metformin|mesh-list
82857503|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82857504|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857505|NCT05625854|Cocaine|cocaine|mesh-list
82857506|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
82857507|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
82857509|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857510|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
82857511|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857512|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82857513|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82857514|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82857515|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82857516|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857517|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
82857518|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857519|NCT01327118|Dinoprost|dinoprost|mesh-list
82857520|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
82857521|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82857522|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
82857523|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82857524|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857525|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
82857526|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
82857527|NCT03449758|Chloroquine|chloroquine|mesh-list
82857528|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
82857529|NCT03449758|Methotrexate|methotrexate|mesh-list
82857530|NCT03449758|Azathioprine|azathioprine|mesh-list
82857531|NCT03449758|Leflunomide|leflunomide|mesh-list
82857532|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82857533|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
82857534|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82857535|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857536|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82857537|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
82857538|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857539|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857540|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
82857541|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857542|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82857543|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857544|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
82857545|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857546|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82857547|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
82857548|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82857549|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82857550|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857552|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82857553|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82857554|NCT03449758|Analgesics|analgesics|mesh-ancestor
82857555|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
82857556|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857557|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857558|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857559|NCT03449446|Firsocostat|firsocostat|mesh-list
82857560|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857561|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857562|NCT03716596|Antibodies|antibodies|mesh-list
82857563|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
82857564|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857565|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
82857566|NCT05650840|Calcium|calcium|mesh-list
82857567|NCT05650840|Charcoal|charcoal|mesh-list
82857568|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82857569|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857570|NCT05650840|Antacids|antacids|mesh-ancestor
82857571|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857572|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857573|NCT05650840|Antidotes|antidotes|mesh-ancestor
82857574|NCT05650840|Protective Agents|protective agents|mesh-ancestor
82857575|NCT03722914|Benzonatate|benzonatate|mesh-list
82857576|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
82857577|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
82857578|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
82857579|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82857580|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82857581|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857583|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857584|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857585|NCT03444766|Nivolumab|nivolumab|mesh-list
82857586|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857587|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857588|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82857589|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857590|NCT03526432|Bevacizumab|bevacizumab|mesh-list
82857591|NCT03526432|Atezolizumab|atezolizumab|mesh-list
82857592|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857593|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857594|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82857595|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82857596|NCT03526432|Growth Substances|growth substances|mesh-ancestor
82857597|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857598|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
82857599|NCT03526432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82857600|NCT03526432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857601|NCT01310842|Nicotine|nicotine|mesh-list
82857602|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82857603|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
82857604|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857605|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857606|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82857607|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82857608|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
82857609|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857610|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857612|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82857613|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857614|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82857615|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82857616|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82857617|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82857618|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857619|NCT03717688|Incretins|incretins|mesh-ancestor
82857620|NCT03717688|Hormones|hormones|mesh-ancestor
82857621|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857622|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
82857623|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857624|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857625|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82857626|NCT02953678|Prednisone|prednisone|mesh-list
82857627|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
82857628|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82857629|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82857630|NCT02953678|Prednisolone|prednisolone|mesh-list
82857631|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
82857632|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82857633|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
82857634|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857635|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
82857636|NCT02953678|Hormones|hormones|mesh-ancestor
82857637|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857638|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857639|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82857640|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857641|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
82857642|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
82857643|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857644|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857645|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82857646|NCT02953678|Protective Agents|protective agents|mesh-ancestor
82857647|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
82857648|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
82857649|NCT00090753|Hematinics|hematinics|mesh-ancestor
82857650|NCT00048932|Abatacept|abatacept|mesh-list
82857651|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82857652|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857653|NCT00048932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857654|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857655|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857656|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
82857657|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857658|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857659|NCT00073983|Gemcitabine|gemcitabine|mesh-list
82857660|NCT00073983|Docetaxel|docetaxel|mesh-list
82857661|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82857662|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
82857663|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857664|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857665|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857666|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857667|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857668|NCT02952820|Lemborexant|lemborexant|mesh-list
82857669|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82857670|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857671|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857672|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82857673|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82857674|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857675|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857676|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
82857677|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857678|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
82857679|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
82857680|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82857681|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
82857682|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82857683|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857684|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82857685|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82857686|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82857687|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82857688|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857690|NCT01085487|Coagulants|coagulants|mesh-ancestor
82857691|NCT01089309|Spironolactone|spironolactone|mesh-list
82857692|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82857693|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
82857694|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857695|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857696|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82857697|NCT01089309|Diuretics|diuretics|mesh-ancestor
82857698|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
82857699|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
82857700|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
82857701|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
82857702|NCT01085721|Ephedrine|ephedrine|mesh-list
82857703|NCT01085721|Guaifenesin|guaifenesin|mesh-list
82857704|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82857705|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82857706|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82857707|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
82857708|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857709|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857710|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82857711|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
82857712|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
82857713|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82857714|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82857715|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
82857716|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
82857717|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857718|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857719|NCT01085721|Expectorants|expectorants|mesh-ancestor
82857720|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82857721|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82857722|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
82857723|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82857724|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82857725|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
82857726|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
82857727|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
82857728|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
82857729|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82857730|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
82857731|NCT00006392|Vitamins|vitamins|mesh-list
82857732|NCT00006392|Vitamin E|vitamin e|mesh-list
82857733|NCT00006392|Tocopherols|tocopherols|mesh-list
82857734|NCT00006392|Tocotrienols|tocotrienols|mesh-list
82857735|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
82857736|NCT00006392|Selenium|selenium|mesh-list
82857737|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
82857738|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857739|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
82857740|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857741|NCT00006392|Protective Agents|protective agents|mesh-ancestor
82857742|NCT00006392|Trace Elements|trace elements|mesh-ancestor
82857743|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82857744|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82857745|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82857746|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82857747|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857748|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857749|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857750|NCT01089621|Analgesics|analgesics|mesh-ancestor
82857751|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
82857752|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857753|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
82857754|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82857755|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
82857756|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82857757|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82857758|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82857759|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82857760|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857761|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857762|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857763|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
82857764|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82857765|NCT00379769|Metformin|metformin|mesh-list
82857766|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
82857767|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82857768|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857769|NCT00006164|Ribavirin|ribavirin|mesh-list
82857770|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82857771|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
82857772|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
82857773|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857774|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
82857775|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857776|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
82857777|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857778|NCT00378599|Interferons|interferons|mesh-list
82857779|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
82857780|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
82857781|NCT00378599|Ribavirin|ribavirin|mesh-list
82857782|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82857783|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857784|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
82857785|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857786|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
82857787|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857788|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
82857789|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857790|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82857791|NCT01046981|Metronidazole|metronidazole|mesh-list
82857792|NCT01046981|Cefazolin|cefazolin|mesh-list
82857793|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82857794|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857795|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
82857796|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82857797|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82857798|NCT00378209|Dexamethasone|dexamethasone|mesh-list
82857799|NCT00378209|Lenalidomide|lenalidomide|mesh-list
82857800|NCT00378209|Bortezomib|bortezomib|mesh-list
82857801|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857802|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
82857803|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
82857804|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857805|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857806|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857807|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
82857808|NCT00378209|Hormones|hormones|mesh-ancestor
82857809|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857810|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82857811|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857812|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
82857813|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82857814|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82857815|NCT00378209|Growth Substances|growth substances|mesh-ancestor
82857816|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
82857817|NCT01047059|Bevacizumab|bevacizumab|mesh-list
82857818|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82857819|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857820|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857821|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82857822|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82857823|NCT01047059|Growth Substances|growth substances|mesh-ancestor
82857824|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857825|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
82857826|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82857827|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857828|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857829|NCT00377819|Denosumab|denosumab|mesh-list
82857830|NCT00377819|Alendronate|alendronate|mesh-list
82857831|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82857832|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857834|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857835|NCT01047215|Aripiprazole|aripiprazole|mesh-list
82857836|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82857837|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
82857838|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82857839|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82857840|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82857841|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82857842|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857843|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
82857844|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
82857845|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857846|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857847|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82857848|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82857849|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
82857850|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82857851|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82857852|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82857853|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82857854|NCT03715582|Trimetazidine|trimetazidine|mesh-list
82857855|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
82857856|NCT00376961|Prednisone|prednisone|mesh-list
82857857|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
82857858|NCT00376961|Rituximab|rituximab|mesh-list
82857859|NCT00376961|Doxorubicin|doxorubicin|mesh-list
82857860|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82857861|NCT00376961|Vincristine|vincristine|mesh-list
82857862|NCT00376961|Bortezomib|bortezomib|mesh-list
82857863|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857864|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
82857865|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857866|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857867|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82857868|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
82857869|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857870|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857871|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82857872|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857873|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82857874|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82857875|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82857876|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857877|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857878|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
82857879|NCT00376961|Hormones|hormones|mesh-ancestor
82857880|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857881|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82857882|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82857883|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
82857884|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
82857885|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
82857887|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82857888|NCT00376259|Telbivudine|telbivudine|mesh-list
82857889|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
82857890|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857891|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82857892|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82857893|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857894|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857895|NCT03715348|Thrombin|thrombin|mesh-list
82857896|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
82857897|NCT03715348|Coagulants|coagulants|mesh-ancestor
82857898|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
82857899|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
82857900|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82857901|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82857902|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857903|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857904|NCT00365105|Vitamin D|vitamin d|mesh-list
82857905|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
82857906|NCT00365105|Calcium|calcium|mesh-list
82857907|NCT00365105|Vitamins|vitamins|mesh-ancestor
82857908|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
82857909|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857911|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82857912|NCT01049633|Aspirin|aspirin|mesh-list
82857913|NCT01049633|Sirolimus|sirolimus|mesh-list
82857914|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82857915|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
82857916|NCT01049633|Clotrimazole|clotrimazole|mesh-list
82857917|NCT01049633|Miconazole|miconazole|mesh-list
82857918|NCT01049633|Trimethoprim|trimethoprim|mesh-list
82857919|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
82857920|NCT01049633|Valganciclovir|valganciclovir|mesh-list
82857921|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
82857922|NCT01049633|Heparin|heparin|mesh-list
82857923|NCT01049633|Enoxaparin|enoxaparin|mesh-list
82857924|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
82857925|NCT01049633|Tacrolimus|tacrolimus|mesh-list
82857926|NCT01049633|Basiliximab|basiliximab|mesh-list
82857927|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82857928|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82857929|NCT01049633|Analgesics|analgesics|mesh-ancestor
82857930|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
82857931|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82857932|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857933|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857934|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857935|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82857936|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82857937|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857938|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82857939|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82857940|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82857941|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
82857942|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857943|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
82857944|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82857945|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82857946|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82857947|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857948|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
82857949|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82857950|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82857951|NCT01049633|Protective Agents|protective agents|mesh-ancestor
82857952|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
82857953|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82857954|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
82857955|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82857956|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
82857957|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82857958|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82857959|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82857960|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82857961|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82857962|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82857963|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82857964|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82857965|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82857966|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
82857967|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82857968|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82857969|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82857970|NCT00399893|Octreotide|octreotide|mesh-list
82857971|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82857972|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82857973|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857974|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
82857975|NCT01049711|Hematinics|hematinics|mesh-ancestor
82857976|NCT00048542|Adalimumab|adalimumab|mesh-list
82857977|NCT00048542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82857978|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82857979|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857980|NCT03814590|Vaccines|vaccines|mesh-list
82857981|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
82857982|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857983|NCT01583244|Abatacept|abatacept|mesh-list
82857984|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82857985|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82857986|NCT01583244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82857987|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82857988|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82857989|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
82857990|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857991|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82857992|NCT01085526|Immunomodulating Agents|immunomodulating agents|mesh-list
82857993|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
82857994|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857995|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
82857996|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82857997|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82857998|NCT01102946|Ranibizumab|ranibizumab|mesh-list
82857999|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82858000|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82858001|NCT01102946|Growth Substances|growth substances|mesh-ancestor
82858002|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858003|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
82858004|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858005|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82858006|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
82858007|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858008|NCT01101386|Voriconazole|voriconazole|mesh-list
82858009|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
82858010|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858011|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82858012|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82858013|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858014|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858015|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82858016|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
82858017|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858018|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858019|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82858020|NCT00005906|Octreotide|octreotide|mesh-list
82858021|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858022|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82858023|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858024|NCT01103336|Nicorandil|nicorandil|mesh-list
82858025|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82858026|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82858027|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
82858028|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
82858029|NCT01103336|Vitamins|vitamins|mesh-ancestor
82858030|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
82858031|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858032|NCT03950960|Itraconazole|itraconazole|mesh-list
82858033|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
82858034|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858035|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82858036|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82858038|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858039|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82858040|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
82858041|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858042|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858043|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82858044|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
82858045|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82858046|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82858047|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858048|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
82858049|NCT03954860|Coagulants|coagulants|mesh-ancestor
82858050|NCT00066690|Tamoxifen|tamoxifen|mesh-list
82858051|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82858052|NCT00066690|Exemestane|exemestane|mesh-list
82858053|NCT00066690|Tryptophan|tryptophan|mesh-list
82858054|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858055|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858056|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858057|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82858058|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
82858059|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82858060|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858061|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82858062|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82858063|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82858064|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82858065|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82858066|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858067|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
82858068|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82858069|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
82858070|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82858071|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82858072|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82858073|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
82858074|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82858075|NCT03409276|Vaccines|vaccines|mesh-list
82858076|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
82858077|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858078|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
82858079|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82858080|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82858081|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82858082|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
82858083|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
82858084|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858085|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858086|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858087|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
82858088|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
82858089|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858090|NCT00004088|Pamidronate|pamidronate|mesh-list
82858091|NCT00004088|Interferons|interferons|mesh-list
82858092|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
82858093|NCT00004088|Thalidomide|thalidomide|mesh-list
82858094|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
82858095|NCT00004088|Melphalan|melphalan|mesh-list
82858096|NCT00004088|Busulfan|busulfan|mesh-list
82858097|NCT00004088|Lenograstim|lenograstim|mesh-list
82858098|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82858099|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
82858100|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858101|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858102|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82858103|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
82858104|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858105|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858106|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82858107|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
82858108|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858109|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82858110|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
82858111|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82858112|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82858113|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82858114|NCT00004088|Growth Substances|growth substances|mesh-ancestor
82858115|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
82858116|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82858118|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82858119|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858120|NCT03439072|Hormones|hormones|mesh-ancestor
82858121|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858122|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858123|NCT03439072|Incretins|incretins|mesh-ancestor
82858124|NCT00078312|Modafinil|modafinil|mesh-list
82858125|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82858126|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858127|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82858128|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82858129|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82858130|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858131|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82858132|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858133|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82858135|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858136|NCT00003896|Paclitaxel|paclitaxel|mesh-list
82858137|NCT00003896|Doxorubicin|doxorubicin|mesh-list
82858138|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82858139|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82858140|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858141|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
82858142|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
82858143|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
82858144|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858145|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82858146|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82858147|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82858148|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858149|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82858150|NCT03712540|Rifampin|rifampin|mesh-list
82858151|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82858152|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
82858153|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82858154|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858155|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
82858156|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82858157|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858158|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858159|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82858160|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82858161|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82858162|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82858163|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82858164|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82858165|NCT05472220|Carboplatin|carboplatin|mesh-list
82858166|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
82858167|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858168|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858169|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858170|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
82858171|NCT00003782|Docetaxel|docetaxel|mesh-list
82858172|NCT00003782|Doxorubicin|doxorubicin|mesh-list
82858173|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82858174|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
82858175|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858176|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858177|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82858178|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
82858179|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858180|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858181|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82858182|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
82858183|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
82858184|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
82858185|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82858186|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82858187|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82858188|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858190|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858191|NCT03714490|Capecitabine|capecitabine|mesh-list
82858192|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
82858193|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82858194|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
82858195|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858196|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858197|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
82858198|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858199|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858200|NCT03407170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82858201|NCT03407170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858202|NCT01103648|Simvastatin|simvastatin|mesh-list
82858203|NCT01103648|Ezetimibe|ezetimibe|mesh-list
82858204|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
82858205|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82858206|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82858207|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
82858208|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858209|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82858210|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858211|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
82858212|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82858213|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858214|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858215|NCT03406858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82858216|NCT03406858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858217|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
82858218|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858219|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82858220|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82858221|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
82858222|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858223|NCT01095926|Doxorubicin|doxorubicin|mesh-list
82858224|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82858225|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858226|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82858227|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82858228|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858229|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858230|NCT00003656|Interferons|interferons|mesh-list
82858231|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
82858232|NCT00003656|Tretinoin|tretinoin|mesh-list
82858233|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858234|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
82858235|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858236|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
82858237|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858238|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
82858239|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
82858240|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
82858241|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858242|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
82858243|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858244|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858245|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82858246|NCT03948620|Penicillins|penicillins|mesh-list
82858247|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82858248|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858249|NCT03416374|Dexamethasone|dexamethasone|mesh-list
82858250|NCT03416374|Lenalidomide|lenalidomide|mesh-list
82858251|NCT03416374|Bortezomib|bortezomib|mesh-list
82858252|NCT03416374|Ixazomib|ixazomib|mesh-list
82858253|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858254|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
82858255|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
82858256|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858257|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858258|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858259|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
82858260|NCT03416374|Hormones|hormones|mesh-ancestor
82858261|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858262|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82858263|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858264|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
82858265|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82858266|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82858267|NCT03416374|Growth Substances|growth substances|mesh-ancestor
82858268|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
82858269|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
82858270|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858271|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858272|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
82858273|NCT00077766|Hematinics|hematinics|mesh-ancestor
82858274|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
82858275|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
82858276|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82858277|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858278|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858279|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
82858280|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82858281|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858282|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858283|NCT03388138|Ketotifen|ketotifen|mesh-list
82858284|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
82858285|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
82858286|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82858287|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
82858288|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
82858289|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858290|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858291|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858292|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82858293|NCT01101620|Simendan|simendan|mesh-list
82858294|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82858295|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
82858296|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82858297|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82858298|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858299|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858300|NCT01101620|Protective Agents|protective agents|mesh-ancestor
82858301|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858302|NCT02952898|Diclofenac|diclofenac|mesh-list
82858303|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82858304|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82858305|NCT02952898|Analgesics|analgesics|mesh-ancestor
82858306|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
82858307|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858308|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858309|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858310|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858311|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82858312|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858313|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858314|NCT01101698|Vitamin D|vitamin d|mesh-list
82858315|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
82858316|NCT01101698|Vitamins|vitamins|mesh-list
82858317|NCT01101698|Vitamin K|vitamin k|mesh-list
82858318|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
82858319|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
82858320|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858321|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82858322|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82858323|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82858324|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82858325|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858326|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
82858327|NCT01101698|Coagulants|coagulants|mesh-ancestor
82858328|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
82858329|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858330|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82858331|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858332|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858334|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
82858335|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82858336|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82858337|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858338|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
82858339|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82858340|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82858341|NCT03387046|Prednisolone|prednisolone|mesh-list
82858342|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
82858343|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82858344|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
82858345|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858346|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
82858347|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
82858348|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858349|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858350|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858351|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
82858352|NCT03387046|Hormones|hormones|mesh-ancestor
82858353|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858354|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82858355|NCT03387046|Protective Agents|protective agents|mesh-ancestor
82858356|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82858357|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858358|NCT01101776|Interferons|interferons|mesh-list
82858359|NCT01101776|Interferon-beta|interferon-beta|mesh-list
82858360|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
82858361|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858362|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
82858363|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858364|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
82858365|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858366|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82858367|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82858368|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858369|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82858370|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858371|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858372|NCT03353740|Edetic Acid|edetic acid|mesh-list
82858373|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82858374|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
82858375|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
82858376|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858377|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
82858378|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82858379|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82858380|NCT04814602|Proglumide|proglumide|mesh-list
82858381|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82858382|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858383|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
82858384|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82858385|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82858386|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858387|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
82858388|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
82858389|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82858390|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82858391|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858392|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82858393|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858394|NCT00399035|Leucovorin|leucovorin|mesh-list
82858395|NCT00399035|Fluorouracil|fluorouracil|mesh-list
82858396|NCT00399035|Capecitabine|capecitabine|mesh-list
82858397|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
82858398|NCT00399035|Cediranib|cediranib|mesh-list
82858399|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
82858400|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
82858401|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858402|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82858403|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858404|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82858405|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
82858406|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858407|NCT00399035|Antidotes|antidotes|mesh-ancestor
82858408|NCT00399035|Protective Agents|protective agents|mesh-ancestor
82858409|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
82858410|NCT00399035|Vitamins|vitamins|mesh-ancestor
82858411|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
82858412|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82858413|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858414|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82858415|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858416|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858417|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82858418|NCT00073749|Immunotoxins|immunotoxins|mesh-ancestor
82858419|NCT00073749|Immunoconjugates|immunoconjugates|mesh-ancestor
82858420|NCT00073749|Immunologic Factors|immunologic factors|mesh-ancestor
82858421|NCT00073749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858422|NCT03960801|Remifentanil|remifentanil|mesh-list
82858423|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82858424|NCT03960801|Narcotics|narcotics|mesh-ancestor
82858425|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858426|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858427|NCT03960801|Analgesics|analgesics|mesh-ancestor
82858428|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
82858429|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858430|NCT01583439|Ritonavir|ritonavir|mesh-list
82858431|NCT01583439|Lopinavir|lopinavir|mesh-list
82858432|NCT01583439|Tenofovir|tenofovir|mesh-list
82858433|NCT01583439|Lamivudine|lamivudine|mesh-list
82858434|NCT01583439|Emtricitabine|emtricitabine|mesh-list
82858435|NCT01583439|Zidovudine|zidovudine|mesh-list
82858436|NCT01583439|Efavirenz|efavirenz|mesh-list
82858437|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82858438|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82858439|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82858440|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
82858441|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858442|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858443|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82858444|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
82858445|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858446|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82858447|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82858448|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82858449|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82858450|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
82858451|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82858452|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82858453|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82858454|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82858455|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82858456|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
82858457|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
82858458|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858459|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82858460|NCT00398567|Trastuzumab|trastuzumab|mesh-list
82858461|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858462|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858463|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82858464|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82858465|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82858466|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858467|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858468|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82858469|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82858470|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82858471|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82858472|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
82858473|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858474|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858475|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82858476|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82858477|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
82858478|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82858479|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82858480|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
82858481|NCT05842213|Golimumab|golimumab|mesh-list
82858483|NCT05842213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82858484|NCT05842213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858485|NCT05842213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82858486|NCT05842213|Immunologic Factors|immunologic factors|mesh-ancestor
82858487|NCT05842213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858488|NCT05842174|Hydroxychloroquine|hydroxychloroquine|mesh-list
82858489|NCT05842174|Ethiodized Oil|ethiodized oil|mesh-list
82858490|NCT05842174|Antimalarials|antimalarials|mesh-ancestor
82858491|NCT05842174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82858492|NCT05842174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82858493|NCT05842174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858494|NCT05842174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858495|NCT05842174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858496|NCT05842174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858497|NCT05842174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858498|NCT05842096|Antibodies|antibodies|mesh-list
82858499|NCT05842096|Immunologic Factors|immunologic factors|mesh-ancestor
82858500|NCT05842096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858501|NCT05842044|Acetaminophen|acetaminophen|mesh-list
82858502|NCT05842044|Ibuprofen|ibuprofen|mesh-list
82858503|NCT05842044|Ketorolac|ketorolac|mesh-list
82858504|NCT05842044|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82858505|NCT05842044|Oxycodone|oxycodone|mesh-list
82858506|NCT05842044|Hydromorphone|hydromorphone|mesh-list
82858507|NCT05842044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82858508|NCT05842044|Analgesics|analgesics|mesh-ancestor
82858509|NCT05842044|Sensory System Agents|sensory system agents|mesh-ancestor
82858510|NCT05842044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390040|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
82858511|NCT05842044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858512|NCT05842044|Antipyretics|antipyretics|mesh-ancestor
83391326|NCT02634606|Vitamin E|vitamin e|mesh-list
83391469|NCT03584087|Terlipressin|terlipressin|mesh-list
83391556|NCT05331144|Losartan|losartan|mesh-list
83391919|NCT01672229|Bortezomib|bortezomib|mesh-list
83392071|NCT03033147|Amoxicillin|amoxicillin|mesh-list
83392289|NCT01014351|Everolimus|everolimus|mesh-list
83392749|NCT02246049|Leucovorin|leucovorin|mesh-list
83392834|NCT03769025|Narcotics|narcotics|mesh-ancestor
83392983|NCT03729011|Propofol|propofol|mesh-list
83393056|NCT05176548|Paraproteins|paraproteins|mesh-list
83393208|NCT04626024|Dasatinib|dasatinib|mesh-list
83393351|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393501|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83393584|NCT04436250|Ketamine|ketamine|mesh-list
83394101|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394329|NCT05498181|Valsartan|valsartan|mesh-list
83394402|NCT05427981|Buprenorphine|buprenorphine|mesh-list
83395526|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
83395756|NCT04061512|Dexamethasone|dexamethasone|mesh-list
83396894|NCT04999449|Scopolamine|scopolamine|mesh-list
83398090|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398243|NCT03084419|Abatacept|abatacept|mesh-list
83398469|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83398549|NCT01150461|Losartan|losartan|mesh-list
83481865|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83399593|NCT01176461|Nivolumab|nivolumab|mesh-list
83400040|NCT04124497|Dexamethasone|dexamethasone|mesh-list
83400420|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
83400568|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83481866|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83401201|NCT01924481|Caffeine|caffeine|mesh-list
83481867|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
83401558|NCT05793892|Lidocaine|lidocaine|mesh-list
83401626|NCT05793060|Protease Inhibitors|protease inhibitors|mesh-ancestor
83401849|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83402157|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83481869|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83402683|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
83402991|NCT04961970|Leucovorin|leucovorin|mesh-list
83481870|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
83403661|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83404264|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83404612|NCT04907838|BQ 788|bq 788|mesh-list
83404792|NCT05873218|Ephedrine|ephedrine|mesh-list
83405317|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83405614|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
83405919|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83406293|NCT05908851|Analgesics|analgesics|mesh-ancestor
83407565|NCT05347212|Nivolumab|nivolumab|mesh-list
83408313|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
83408687|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83409066|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
83409143|NCT03794999|Benralizumab|benralizumab|mesh-list
83409675|NCT03215719|Cisplatin|cisplatin|mesh-list
83409860|NCT03027388|LB100|lb100|mesh-list
83409977|NCT02877303|Vincristine|vincristine|mesh-list
83410518|NCT01955460|Analgesics|analgesics|mesh-ancestor
83410910|NCT00588770|Bevacizumab|bevacizumab|mesh-list
83410973|NCT00359684|Cysteamine|cysteamine|mesh-list
83411570|NCT01384539|Vitamins|vitamins|mesh-ancestor
83411795|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
83412021|NCT01894711|Trastuzumab|trastuzumab|mesh-list
83412246|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
83412471|NCT01421797|Dexamethasone|dexamethasone|mesh-list
83412616|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
83412689|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
83412916|NCT03046758|Fosfomycin|fosfomycin|mesh-list
83413215|NCT04877106|Hormones|hormones|mesh-ancestor
83414494|NCT04857450|Analgesics|analgesics|mesh-ancestor
83481871|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83481872|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83415484|NCT01488279|Incretins|incretins|mesh-ancestor
83415857|NCT03060473|Azithromycin|azithromycin|mesh-list
83415934|NCT02169089|Diuretics|diuretics|mesh-ancestor
83416089|NCT01501929|Metoprolol|metoprolol|mesh-list
83416307|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
83416387|NCT01576809|Expectorants|expectorants|mesh-ancestor
83416531|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
83416914|NCT00212147|Analgesics|analgesics|mesh-ancestor
83417213|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
83417609|NCT02763137|Carbidopa|carbidopa|mesh-list
83417750|NCT01148849|Margetuximab|margetuximab|mesh-list
83418046|NCT01532349|Vitamins|vitamins|mesh-ancestor
83418197|NCT04813848|Protective Agents|protective agents|mesh-ancestor
83418423|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
83418653|NCT05401227|Ketamine|ketamine|mesh-list
83481873|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83481874|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
83419104|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
83420007|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
83420526|NCT03431987|Ethanol|ethanol|mesh-list
82858653|NCT05841121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858654|NCT05841121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82858655|NCT05841121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858656|NCT05841056|Amiodarone|amiodarone|mesh-list
82858657|NCT05841056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82858658|NCT05841056|Vasodilator Agents|vasodilator agents|mesh-ancestor
82858659|NCT05841056|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82858660|NCT05841056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82858661|NCT05841056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858662|NCT05841056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82858663|NCT05841056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82858664|NCT05841056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82858665|NCT05841056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858666|NCT05841056|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82858667|NCT05841056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82858668|NCT05841056|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82858669|NCT05841043|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82858670|NCT05841043|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82858671|NCT05840952|Itraconazole|itraconazole|mesh-list
82858672|NCT05840952|Carbamazepine|carbamazepine|mesh-list
82858673|NCT05840952|Midazolam|midazolam|mesh-list
82858674|NCT05840952|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82858675|NCT05840952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82858676|NCT05840952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858677|NCT05840952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858678|NCT05840952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82858679|NCT05840952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82858680|NCT05840952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82858681|NCT05840952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82858682|NCT05840952|Anesthetics, General|anesthetics, general|mesh-ancestor
82858683|NCT05840952|Anesthetics|anesthetics|mesh-ancestor
82858684|NCT05840952|GABA Modulators|gaba modulators|mesh-ancestor
82858685|NCT05840952|GABA Agents|gaba agents|mesh-ancestor
82858686|NCT05840952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858687|NCT05840952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858688|NCT05840952|Antifungal Agents|antifungal agents|mesh-ancestor
82858689|NCT05840952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858690|NCT05840952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82858691|NCT05840952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82858692|NCT05840952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858693|NCT05840952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82858694|NCT05840952|Hormone Antagonists|hormone antagonists|mesh-ancestor
82858695|NCT05840952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858696|NCT05840952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82858697|NCT05840952|Anticonvulsants|anticonvulsants|mesh-ancestor
82858698|NCT05840952|Antimanic Agents|antimanic agents|mesh-ancestor
82858699|NCT05840952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82858700|NCT05840952|Analgesics|analgesics|mesh-ancestor
82858701|NCT05840952|Sensory System Agents|sensory system agents|mesh-ancestor
82858702|NCT05840952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858703|NCT05840952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82858704|NCT05840952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82858705|NCT05840952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82858706|NCT05840952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82858708|NCT05840913|Carticaine|carticaine|mesh-list
82858709|NCT05840913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82858710|NCT05840913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82858711|NCT05840913|Adrenergic Agents|adrenergic agents|mesh-ancestor
82858712|NCT05840913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858713|NCT05840913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858714|NCT05840913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858715|NCT05840913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82858716|NCT05840913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82858717|NCT05840913|Autonomic Agents|autonomic agents|mesh-ancestor
82858718|NCT05840913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858719|NCT05840913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82858720|NCT05840913|Respiratory System Agents|respiratory system agents|mesh-ancestor
82858721|NCT05840913|Mydriatics|mydriatics|mesh-ancestor
82858722|NCT05840913|Sympathomimetics|sympathomimetics|mesh-ancestor
82858723|NCT05840913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82858724|NCT05840913|Anesthetics, Local|anesthetics, local|mesh-ancestor
82858725|NCT05840913|Anesthetics|anesthetics|mesh-ancestor
82858726|NCT05840913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858727|NCT05840913|Sensory System Agents|sensory system agents|mesh-ancestor
82858728|NCT05840861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82858729|NCT05840861|Vortioxetine|vortioxetine|mesh-list
82858730|NCT05840861|Antidepressive Agents|antidepressive agents|mesh-ancestor
82858731|NCT05840861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82858732|NCT05840861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82858733|NCT05840861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82858734|NCT05840861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858735|NCT05840861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858736|NCT05840861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82858737|NCT05840861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82858738|NCT05840861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82858739|NCT05840861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82858740|NCT05840861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858741|NCT05840861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858742|NCT05840861|Serotonin Agents|serotonin agents|mesh-ancestor
82858743|NCT05840861|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82858744|NCT05840861|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82858745|NCT05840861|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82858746|NCT05840861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82858747|NCT05840822|Cannabidiol|cannabidiol|mesh-list
82858748|NCT05840822|Anticonvulsants|anticonvulsants|mesh-ancestor
82858749|NCT05840796|Caseins|caseins|mesh-list
82858750|NCT05840796|Chelating Agents|chelating agents|mesh-ancestor
82858751|NCT05840796|Sequestering Agents|sequestering agents|mesh-ancestor
82858752|NCT05840796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858753|NCT05840770|Cemiplimab|cemiplimab|mesh-list
82858754|NCT05840770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858755|NCT05840770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858756|NCT05840068|Metformin|metformin|mesh-list
82858757|NCT05840068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82858758|NCT05840068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858759|NCT05834569|Acetaminophen|acetaminophen|mesh-list
82858760|NCT05834569|Ibuprofen|ibuprofen|mesh-list
82858761|NCT05834569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82858762|NCT05834569|Analgesics|analgesics|mesh-ancestor
82858763|NCT05834569|Sensory System Agents|sensory system agents|mesh-ancestor
82858764|NCT05834569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858765|NCT05834569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858766|NCT05834569|Antipyretics|antipyretics|mesh-ancestor
82858767|NCT05834569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82858768|NCT05834569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858769|NCT05834569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858770|NCT05834569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82858771|NCT05834569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858772|NCT05834569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858773|NCT05834023|Lidocaine|lidocaine|mesh-list
82858774|NCT05834023|Bupivacaine|bupivacaine|mesh-list
82858775|NCT05834023|Anesthetics, Local|anesthetics, local|mesh-ancestor
82858776|NCT05834023|Anesthetics|anesthetics|mesh-ancestor
82858777|NCT05834023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858778|NCT05834023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858779|NCT05834023|Sensory System Agents|sensory system agents|mesh-ancestor
82858780|NCT05834023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858781|NCT05834023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82858819|NCT05804708|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82858820|NCT05788328|Dabigatran|dabigatran|mesh-list
82858821|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82858822|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82858823|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82858824|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
82858825|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858826|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82858827|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82858828|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858829|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
82858830|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82858831|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
82858832|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
82858833|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
82858834|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82858835|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82858836|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858837|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
82858838|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
82858839|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
82858840|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82858841|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858842|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82858843|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858844|NCT05782816|Oxytocin|oxytocin|mesh-list
82858845|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
82858846|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82858847|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858848|NCT05768932|Paclitaxel|paclitaxel|mesh-list
82858849|NCT05768932|Carboplatin|carboplatin|mesh-list
82858850|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82858851|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858852|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
82858853|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
82858854|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
82858855|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858856|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82858857|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858859|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
82858860|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
82858861|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858862|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858863|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
82858864|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858865|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
82858866|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858867|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858868|NCT05653882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82858869|NCT05653882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858870|NCT05637398|Colchicine|colchicine|mesh-list
82858871|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
82858872|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858873|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
82858874|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
82858875|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
82858876|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858877|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858878|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
82858879|NCT05633602|Ramucirumab|ramucirumab|mesh-list
82858880|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858881|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858882|NCT05633602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82858883|NCT05633602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858884|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
82858885|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82858886|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82858887|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82858888|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82858889|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858890|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
82858891|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858892|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858893|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82858894|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858895|NCT05583071|Rituximab|rituximab|mesh-list
82858896|NCT05583071|Methotrexate|methotrexate|mesh-list
82858897|NCT05583071|Lenalidomide|lenalidomide|mesh-list
82858898|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858899|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858900|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
82858901|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858902|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82858903|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82858904|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
82858905|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82858906|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82858907|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
82858908|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858909|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
82858910|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858911|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82858912|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82858913|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82858914|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82858915|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82858916|NCT05583071|Growth Substances|growth substances|mesh-ancestor
82858917|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
82858918|NCT05552222|Dexamethasone|dexamethasone|mesh-list
82858919|NCT05552222|Lenalidomide|lenalidomide|mesh-list
82858920|NCT05552222|Daratumumab|daratumumab|mesh-list
82858921|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858922|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
82858923|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
82858924|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858925|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858926|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858927|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
82858929|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858931|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858932|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
82858933|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82858934|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82858935|NCT05552222|Growth Substances|growth substances|mesh-ancestor
82858936|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
82858937|NCT05515575|Niraparib|niraparib|mesh-list
82858938|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82858939|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858940|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858941|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858942|NCT05443971|Durvalumab|durvalumab|mesh-list
82858943|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
82858944|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82858945|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
82858946|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858947|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858948|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
82858949|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858950|NCT05417113|Bupivacaine|bupivacaine|mesh-list
82858951|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
82858952|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
82858953|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82858954|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858955|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
82858956|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858957|NCT05411094|Durvalumab|durvalumab|mesh-list
82858958|NCT05411094|Olaparib|olaparib|mesh-list
82858959|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82858960|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
82858961|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82858962|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
82858963|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82858964|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858965|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
82858966|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858967|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82858968|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858969|NCT05405166|Dexamethasone|dexamethasone|mesh-list
82858970|NCT05405166|Pomalidomide|pomalidomide|mesh-list
82858971|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82858972|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82858973|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
82858974|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
82858975|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82858976|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858977|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82858978|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
82858979|NCT05405166|Hormones|hormones|mesh-ancestor
82858980|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82858981|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82858982|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82858983|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
82858984|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82858985|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82858986|NCT05405166|Growth Substances|growth substances|mesh-ancestor
82858987|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
82858988|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82858989|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82858990|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82858991|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
82858992|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
82858993|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82858994|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82858995|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
82858996|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82858997|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82858998|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82858999|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
82859000|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
82859001|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859002|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
82859003|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82859004|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
82859005|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
82859006|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82859007|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82859008|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82859009|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82859010|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859011|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
82859012|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859013|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859014|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82859015|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859016|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
82859017|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82859018|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82859019|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82859020|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82859021|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859022|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
82859023|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859024|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859025|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82859026|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859027|NCT05249569|Avelumab|avelumab|mesh-list
82859028|NCT05249569|Bavituximab|bavituximab|mesh-list
82859029|NCT05249569|Axitinib|axitinib|mesh-list
82859030|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859031|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859032|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82859033|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859034|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859035|NCT05245071|Maytansine|maytansine|mesh-list
82859036|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859037|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859038|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859039|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859040|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859041|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859042|NCT05212662|Cysteamine|cysteamine|mesh-list
82859043|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
82859044|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859045|NCT05198830|Cisplatin|cisplatin|mesh-list
82859046|NCT05198830|Pemetrexed|pemetrexed|mesh-list
82859047|NCT05198830|Durvalumab|durvalumab|mesh-list
82859048|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
82859049|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859050|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
82859051|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859052|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859053|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859054|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82859055|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82859056|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859057|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
82859058|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859059|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
82859060|NCT05182073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82859061|NCT05182073|Fludarabine|fludarabine|mesh-list
82859062|NCT05182073|Daratumumab|daratumumab|mesh-list
82859063|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859064|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82859066|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859067|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82859068|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82859069|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
82859070|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859071|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859072|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82859073|NCT05180318|Ketamine|ketamine|mesh-list
82859074|NCT05180318|Esketamine|esketamine|mesh-list
82859075|NCT05180318|Analgesics|analgesics|mesh-ancestor
82859076|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
82859077|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859078|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859079|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82859080|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82859081|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
82859082|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
82859083|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859084|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82859085|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82859086|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859087|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859088|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
82859089|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82859090|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82859091|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82859092|NCT05096663|Vitamins|vitamins|mesh-list
82859093|NCT05096663|Folic Acid|folic acid|mesh-list
82859094|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
82859095|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
82859096|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
82859097|NCT05096663|Dexamethasone|dexamethasone|mesh-list
82859098|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
82859099|NCT05096663|Gemcitabine|gemcitabine|mesh-list
82859100|NCT05096663|Docetaxel|docetaxel|mesh-list
82859101|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
82859102|NCT05096663|Pemetrexed|pemetrexed|mesh-list
82859103|NCT05096663|Ramucirumab|ramucirumab|mesh-list
82859104|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82859105|NCT05096663|Antibodies|antibodies|mesh-list
82859106|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
82859107|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859108|NCT05096663|Lexatumumab|lexatumumab|mesh-list
82859109|NCT05096663|BB 1101|bb 1101|mesh-list
82859110|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
82859111|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859112|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
82859113|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82859114|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
82859115|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
82859116|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859117|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82859118|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
82859119|NCT05096663|Hormones|hormones|mesh-ancestor
82859120|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82859121|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82859122|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859123|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
82859124|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859125|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859126|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859127|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
82859128|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859129|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859130|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859131|NCT05096663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859132|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82859133|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82859134|NCT05096663|Hematinics|hematinics|mesh-ancestor
82859135|NCT05072314|Lidocaine|lidocaine|mesh-list
82859136|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
82859137|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
82859138|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859139|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859140|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
82859141|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859143|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82859144|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82859145|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82859146|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859147|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
82859148|NCT05061420|Cetuximab|cetuximab|mesh-list
82859149|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859150|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859151|NCT05061420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859152|NCT05061420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859153|NCT05053503|Lofexidine|lofexidine|mesh-list
82859154|NCT05053503|Naltrexone|naltrexone|mesh-list
82859156|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82859157|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859158|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
82859159|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859160|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82859161|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82859162|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82859163|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82859164|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
82859165|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859166|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859167|NCT05040360|Capecitabine|capecitabine|mesh-list
82859168|NCT05040360|Temozolomide|temozolomide|mesh-list
82859169|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859170|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
82859171|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859172|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859173|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82859174|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
82859175|NCT05009082|Paclitaxel|paclitaxel|mesh-list
82859176|NCT05009082|Bevacizumab|bevacizumab|mesh-list
82859177|NCT05009082|Carboplatin|carboplatin|mesh-list
82859178|NCT05009082|Niraparib|niraparib|mesh-list
82859179|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859180|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859181|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859182|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859183|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859184|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859185|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859186|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82859187|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82859188|NCT05009082|Growth Substances|growth substances|mesh-ancestor
82859189|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859190|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
82859191|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82859192|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859193|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82859194|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859195|NCT04989283|Paclitaxel|paclitaxel|mesh-list
82859196|NCT04989283|Etoposide|etoposide|mesh-list
82859197|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
82859198|NCT04989283|Cisplatin|cisplatin|mesh-list
82859199|NCT04989283|Carboplatin|carboplatin|mesh-list
82859200|NCT04989283|Pemetrexed|pemetrexed|mesh-list
82859201|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82859202|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
82859203|NCT04989283|Atezolizumab|atezolizumab|mesh-list
82859204|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859205|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859206|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859207|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859208|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859209|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859210|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859211|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82859212|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859213|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859214|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82859215|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82859216|NCT04989283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859217|NCT04989283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859218|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
82859219|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859220|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
82859221|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
82859222|NCT04982796|Psilocybin|psilocybin|mesh-list
82859223|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
82859224|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859225|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82859226|NCT04970576|Warfarin|warfarin|mesh-list
82859227|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
82859228|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
82859229|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82859230|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
82859231|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82859232|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
82859233|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859234|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859235|NCT04941911|Octreotide|octreotide|mesh-list
82859236|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82859237|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82859238|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859239|NCT04936230|Atezolizumab|atezolizumab|mesh-list
82859240|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859241|NCT04936230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859242|NCT04936230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859243|NCT04936230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859244|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859245|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
82859246|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859247|NCT04887285|Anesthetics|anesthetics|mesh-list
82859248|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
82859249|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859250|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859251|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
82859252|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859253|NCT04871529|Carboplatin|carboplatin|mesh-list
82859254|NCT04871529|Gemcitabine|gemcitabine|mesh-list
82859255|NCT04871529|Avelumab|avelumab|mesh-list
82859256|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
82859257|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
82859258|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859259|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859260|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859261|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
82859262|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859263|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
82859264|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859265|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859266|NCT04858490|Diazepam|diazepam|mesh-list
82859267|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82859268|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
82859269|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
82859270|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
82859271|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859272|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859273|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82859274|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82859275|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859276|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82859277|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82859278|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82859279|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82859280|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82859281|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82859282|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
82859283|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
82859284|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
82859285|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
82859286|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859287|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859288|NCT04858009|Paclitaxel|paclitaxel|mesh-list
82859289|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82859290|NCT04858009|Cisplatin|cisplatin|mesh-list
82859291|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859292|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859293|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859295|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859296|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859297|NCT04790032|Cangrelor|cangrelor|mesh-list
82859298|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82859299|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82859300|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82859301|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82859302|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
82859303|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859304|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859305|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859319|NCT04739800|Maleic acid|maleic acid|mesh-list
82859320|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
82859321|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859322|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
82859323|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859324|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859325|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859326|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859327|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859328|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859329|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82859330|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82859331|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859332|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859333|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859334|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
82859335|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859336|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82859337|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82859338|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82859349|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
82859350|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
82859351|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
82859352|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
82859353|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859354|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859355|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859356|NCT04659603|Gemcitabine|gemcitabine|mesh-list
82859357|NCT04659603|Maytansine|maytansine|mesh-list
82859358|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859359|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
82859360|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859361|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859362|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859363|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859364|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859365|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859366|NCT04643002|Dexamethasone|dexamethasone|mesh-list
82859367|NCT04643002|Pomalidomide|pomalidomide|mesh-list
82859368|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82859369|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
82859370|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
82859371|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859372|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859373|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82859374|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
82859375|NCT04643002|Hormones|hormones|mesh-ancestor
82859376|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82859377|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82859378|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859379|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
82859380|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82859381|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82859382|NCT04643002|Growth Substances|growth substances|mesh-ancestor
82859383|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
82859384|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
82859385|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82859386|NCT04629729|Fludarabine|fludarabine|mesh-list
82859387|NCT04629729|Interleukin-2|interleukin-2|mesh-list
82859388|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82859389|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
82859390|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859391|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82859392|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82859393|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
82859394|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859395|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859396|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82859397|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82859398|NCT04629729|Analgesics|analgesics|mesh-ancestor
82859399|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
82859400|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859401|NCT04599075|Insulin|insulin|mesh-list
82859402|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82859403|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82859404|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859405|NCT04574583|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82859406|NCT04574583|Antiviral Agents|antiviral agents|mesh-ancestor
82859407|NCT04574583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859408|NCT04567784|Cannabidiol|cannabidiol|mesh-list
82859409|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
82859410|NCT04544202|Trametinib|trametinib|mesh-list
82859411|NCT04544202|Dabrafenib|dabrafenib|mesh-list
82859412|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859413|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82859414|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859415|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859416|NCT04523363|Metformin|metformin|mesh-list
82859417|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82859418|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859419|NCT04516447|Paclitaxel|paclitaxel|mesh-list
82859420|NCT04516447|Carboplatin|carboplatin|mesh-list
82859421|NCT04516447|Gemcitabine|gemcitabine|mesh-list
82859422|NCT04516447|Doxorubicin|doxorubicin|mesh-list
82859423|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82859424|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859425|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859426|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859427|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859428|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859429|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859430|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859431|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
82859432|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82859433|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82859434|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859435|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859436|NCT04511013|Nivolumab|nivolumab|mesh-list
82859437|NCT04511013|Ipilimumab|ipilimumab|mesh-list
82859438|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859439|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859440|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859441|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859442|NCT04495894|Ketorolac|ketorolac|mesh-list
82859443|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82859444|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82859445|NCT04495894|Analgesics|analgesics|mesh-ancestor
82859446|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
82859447|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859448|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859449|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82859450|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82859451|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82859452|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859453|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859454|NCT04489433|Trametinib|trametinib|mesh-list
82859455|NCT04489433|Dabrafenib|dabrafenib|mesh-list
82859456|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859457|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82859471|NCT04458909|Nivolumab|nivolumab|mesh-list
82859472|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859473|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859474|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
82859475|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859476|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859477|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859478|NCT04370054|Factor VIII|factor viii|mesh-list
82859479|NCT04370054|Coagulants|coagulants|mesh-ancestor
82859480|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
82859482|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
82859483|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859484|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859485|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859486|NCT04348747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859487|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859488|NCT04283500|Buprenorphine|buprenorphine|mesh-list
82859489|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82859490|NCT04283500|Naloxone|naloxone|mesh-list
82859491|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82859492|NCT04283500|Narcotics|narcotics|mesh-ancestor
82859493|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859494|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859495|NCT04283500|Analgesics|analgesics|mesh-ancestor
82859496|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
82859497|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859498|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82859499|NCT04278573|Vitamin D|vitamin d|mesh-list
82859500|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
82859501|NCT04278573|Vitamins|vitamins|mesh-ancestor
82859502|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
82859503|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859504|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82859505|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82859506|NCT04223791|Islatravir|islatravir|mesh-list
82859507|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
82859508|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859509|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859510|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859511|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82859512|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82859513|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82859514|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
82859515|NCT04205968|Leucovorin|leucovorin|mesh-list
82859516|NCT04205968|Folic Acid|folic acid|mesh-list
82859517|NCT04205968|Paclitaxel|paclitaxel|mesh-list
82859518|NCT04205968|Camptothecin|camptothecin|mesh-list
82859519|NCT04205968|Fluorouracil|fluorouracil|mesh-list
82859520|NCT04205968|Irinotecan|irinotecan|mesh-list
82859521|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82859522|NCT04205968|Ramucirumab|ramucirumab|mesh-list
83083928|NCT02474654|Bupivacaine|bupivacaine|mesh-list
82859523|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82859525|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
82859526|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859527|NCT04205968|Lexatumumab|lexatumumab|mesh-list
82859528|NCT04205968|Calcium|calcium|mesh-list
82859529|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
82859530|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859531|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859532|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859533|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859534|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859535|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859536|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
82859537|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859538|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82859539|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82859540|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
82859541|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859542|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82859543|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82859544|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859545|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859546|NCT04205968|Antidotes|antidotes|mesh-ancestor
82859547|NCT04205968|Protective Agents|protective agents|mesh-ancestor
82859548|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
82859549|NCT04205968|Vitamins|vitamins|mesh-ancestor
82859550|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
82859551|NCT04205968|Hematinics|hematinics|mesh-ancestor
82859552|NCT04205812|Paclitaxel|paclitaxel|mesh-list
82859553|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82859554|NCT04205812|Carboplatin|carboplatin|mesh-list
82859555|NCT04205812|Pemetrexed|pemetrexed|mesh-list
82859556|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859557|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859558|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859559|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859560|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859561|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859562|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859563|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82859564|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82859565|NCT04191421|Spartalizumab|spartalizumab|mesh-list
82859566|NCT04191421|Siltuximab|siltuximab|mesh-list
82859567|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859568|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859569|NCT04191421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859570|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859571|NCT04071457|Lenalidomide|lenalidomide|mesh-list
82859572|NCT04071457|Daratumumab|daratumumab|mesh-list
82859573|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
82859574|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859575|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82859576|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82859577|NCT04071457|Growth Substances|growth substances|mesh-ancestor
82859578|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
82859579|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859580|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82859581|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
82859582|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859583|NCT03982030|Dalbavancin|dalbavancin|mesh-list
82859584|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82859585|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859586|NCT03939104|Artesunate|artesunate|mesh-list
82859587|NCT03939104|Lumefantrine|lumefantrine|mesh-list
82859588|NCT03939104|Artemether|artemether|mesh-list
82859589|NCT03939104|Piperaquine|piperaquine|mesh-list
82859590|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82859591|NCT03939104|Amodiaquine|amodiaquine|mesh-list
82859592|NCT03939104|Mefloquine|mefloquine|mesh-list
82859593|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
82859594|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82859595|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82859596|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859597|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859598|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
82859599|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
83083929|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
82859600|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82859601|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
82859602|NCT03918850|Buprenorphine|buprenorphine|mesh-list
82859603|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82859604|NCT03918850|Narcotics|narcotics|mesh-ancestor
82859605|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859606|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859607|NCT03918850|Analgesics|analgesics|mesh-ancestor
82859608|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
82859609|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859610|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82859611|NCT03917914|Bisoprolol|bisoprolol|mesh-list
82859612|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82859613|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
82859614|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
82859615|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859616|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859617|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82859618|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82859619|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82859620|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
82859621|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859622|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859623|NCT03915067|Botulinum Toxins|botulinum toxins|mesh-list
82859624|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82859625|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82859626|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82859627|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82859628|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859629|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
82859630|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859631|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859632|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82859633|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859634|NCT03911466|Buprenorphine|buprenorphine|mesh-list
82859635|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82859636|NCT03911466|Narcotics|narcotics|mesh-ancestor
82859637|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859638|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859639|NCT03911466|Analgesics|analgesics|mesh-ancestor
82859640|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
82859641|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859642|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82859643|NCT03903133|Vitamin E|vitamin e|mesh-list
82859644|NCT03903133|Antioxidants|antioxidants|mesh-list
82859645|NCT03903133|Vitamins|vitamins|mesh-ancestor
82859646|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
82859647|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859648|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859649|NCT03903133|Protective Agents|protective agents|mesh-ancestor
82859650|NCT03859024|Acetaminophen|acetaminophen|mesh-list
82859651|NCT03859024|Dexamethasone|dexamethasone|mesh-list
82859652|NCT03859024|Ibuprofen|ibuprofen|mesh-list
82859653|NCT03859024|Celecoxib|celecoxib|mesh-list
82859654|NCT03859024|Oxycodone|oxycodone|mesh-list
82859655|NCT03859024|Gabapentin|gabapentin|mesh-list
82859656|NCT03859024|Bupivacaine|bupivacaine|mesh-list
82859657|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82859658|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
82859659|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
82859660|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859661|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859662|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82859663|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
82859664|NCT03859024|Hormones|hormones|mesh-ancestor
82859665|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82859666|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82859667|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859668|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
82859669|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
82859670|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859671|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
82859672|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82859673|NCT03859024|Analgesics|analgesics|mesh-ancestor
82859674|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
82859675|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82859676|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82859715|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
82859716|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859717|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859718|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
82859719|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859720|NCT03798626|Leucovorin|leucovorin|mesh-list
82859721|NCT03798626|Paclitaxel|paclitaxel|mesh-list
82859722|NCT03798626|Bevacizumab|bevacizumab|mesh-list
82859723|NCT03798626|Fluorouracil|fluorouracil|mesh-list
82859724|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
82859725|NCT03798626|Irinotecan|irinotecan|mesh-list
82859726|NCT03798626|Ramucirumab|ramucirumab|mesh-list
82859727|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
82859728|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859729|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859730|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859731|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859732|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859733|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859734|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859735|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82859736|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82859737|NCT03798626|Growth Substances|growth substances|mesh-ancestor
82859738|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859739|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
82859740|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
82859741|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859742|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82859743|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
82859744|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82859745|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859746|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859747|NCT03798626|Antidotes|antidotes|mesh-ancestor
82859748|NCT03798626|Protective Agents|protective agents|mesh-ancestor
82859749|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
82859751|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
82859752|NCT03768414|Paclitaxel|paclitaxel|mesh-list
82859753|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82859754|NCT03768414|Cisplatin|cisplatin|mesh-list
82859755|NCT03768414|Gemcitabine|gemcitabine|mesh-list
82859756|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859757|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859758|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859759|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859760|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859761|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859762|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859763|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
82859764|NCT03743766|Nivolumab|nivolumab|mesh-list
82859765|NCT03743766|Relatlimab|relatlimab|mesh-list
82859766|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859767|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859768|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859769|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859770|NCT03727633|Idarubicin|idarubicin|mesh-list
82859771|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
82859772|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82859773|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859774|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82859775|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859776|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859777|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859778|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
82859779|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859780|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859781|NCT03698019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859782|NCT03698019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859783|NCT03694002|Paclitaxel|paclitaxel|mesh-list
82859784|NCT03694002|Carboplatin|carboplatin|mesh-list
82859785|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82859786|NCT03694002|Ramucirumab|ramucirumab|mesh-list
82859787|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82859788|NCT03694002|Antibodies|antibodies|mesh-list
82859789|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
82859790|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859791|NCT03694002|Lexatumumab|lexatumumab|mesh-list
82859792|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859793|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859794|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859795|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859796|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859797|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859798|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
82859799|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859800|NCT03678025|Prednisone|prednisone|mesh-list
82859801|NCT03678025|Cortisone|cortisone|mesh-list
82859802|NCT03678025|Docetaxel|docetaxel|mesh-list
82859803|NCT03678025|Leuprolide|leuprolide|mesh-list
82859804|NCT03678025|Goserelin|goserelin|mesh-list
82859805|NCT03678025|Bicalutamide|bicalutamide|mesh-list
82859806|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82859807|NCT03678025|Flutamide|flutamide|mesh-list
82859808|NCT03678025|Nilutamide|nilutamide|mesh-list
82859809|NCT03678025|Tryptophan|tryptophan|mesh-list
82859810|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859811|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859812|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859813|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859814|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859815|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82859816|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
82859817|NCT03678025|Hormones|hormones|mesh-ancestor
82859818|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82859819|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859820|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82859821|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82859822|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
82859823|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82859824|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
82859825|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
82859826|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
82859827|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82859828|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
82859829|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82859830|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82859831|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
82859832|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82859834|NCT03648892|Fallypride|fallypride|mesh-list
82859835|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82859836|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82859837|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859838|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859839|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82859840|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82859841|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
82859842|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859843|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859844|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82859845|NCT03623321|Pimavanserin|pimavanserin|mesh-list
82859846|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82859847|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82859848|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82859849|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82859850|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859851|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859852|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82859853|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82859854|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82859855|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
82859856|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82859857|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859858|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
82859859|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859860|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859861|NCT03602586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859862|NCT03602586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859863|NCT03528642|Temozolomide|temozolomide|mesh-list
82859864|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82859865|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
82859866|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859867|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859868|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
82859869|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859870|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859871|NCT03447314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859872|NCT03447314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859873|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
82859874|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
82859875|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859876|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82859877|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82859878|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82859879|NCT03365882|Trastuzumab|trastuzumab|mesh-list
82859880|NCT03365882|Cetuximab|cetuximab|mesh-list
82859881|NCT03365882|Pertuzumab|pertuzumab|mesh-list
82859882|NCT03365882|Irinotecan|irinotecan|mesh-list
82859883|NCT03365882|Camptothecin|camptothecin|mesh-list
82859884|NCT03365882|Antibodies|antibodies|mesh-list
82859885|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
82859886|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859887|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
82859888|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859889|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859890|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82859891|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859892|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859893|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859894|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82859895|NCT03364530|Gemcitabine|gemcitabine|mesh-list
82859896|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
82859897|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859898|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
82859899|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859900|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859901|NCT03289910|Carboplatin|carboplatin|mesh-list
82859902|NCT03289910|Topotecan|topotecan|mesh-list
82859903|NCT03289910|Veliparib|veliparib|mesh-list
82859904|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859905|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82859906|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82859907|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859909|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82859910|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
82859911|NCT03253133|Oxycodone|oxycodone|mesh-list
82859912|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859913|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82859914|NCT03253133|Narcotics|narcotics|mesh-ancestor
82859915|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82859916|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859917|NCT03253133|Analgesics|analgesics|mesh-ancestor
82859918|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
82859919|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82859920|NCT03252756|Cannabidiol|cannabidiol|mesh-list
82859921|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
82859922|NCT03228537|Cisplatin|cisplatin|mesh-list
82859923|NCT03228537|Pemetrexed|pemetrexed|mesh-list
82859924|NCT03228537|Atezolizumab|atezolizumab|mesh-list
82859925|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82859926|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859927|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859928|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859929|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82859930|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82859931|NCT03228537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859932|NCT03228537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859933|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
82859934|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859935|NCT03225417|Sirolimus|sirolimus|mesh-list
82859936|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
82859937|NCT03225417|Ixazomib|ixazomib|mesh-list
82859938|NCT03225417|Tacrolimus|tacrolimus|mesh-list
82859939|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82859940|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82859941|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
82859942|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859943|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82859944|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82859945|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
82859946|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859947|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859948|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82859949|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82859950|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859951|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82859952|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859953|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82859954|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
82859955|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
82859956|NCT03218826|Docetaxel|docetaxel|mesh-list
82859957|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859958|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
82859959|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
82859960|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
82859961|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859962|NCT03092674|Cytarabine|cytarabine|mesh-list
82859963|NCT03092674|Nivolumab|nivolumab|mesh-list
82859964|NCT03092674|Azacitidine|azacitidine|mesh-list
82859965|NCT03092674|Decitabine|decitabine|mesh-list
82859966|NCT03092674|Midostaurin|midostaurin|mesh-list
82859967|NCT03092674|Staurosporine|staurosporine|mesh-list
82859968|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82859969|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82859970|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82859971|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82859972|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82859973|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
82859974|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
82859975|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82859976|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82859977|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
82859978|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859979|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82859980|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82859981|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82859982|NCT03091660|Vaccines|vaccines|mesh-list
82859983|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
82859985|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859986|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82859987|NCT03091595|Drospirenone|drospirenone|mesh-list
82859988|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82859989|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82859990|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82859991|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82859992|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
82859993|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82859994|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82859995|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82859996|NCT03091595|Estrogens|estrogens|mesh-ancestor
82859997|NCT03091595|Hormones|hormones|mesh-ancestor
82859998|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82859999|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82860000|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
82860001|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82860002|NCT03091595|Diuretics|diuretics|mesh-ancestor
82860003|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
82860004|NCT03055013|Nivolumab|nivolumab|mesh-list
82860005|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860006|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860007|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82860008|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860009|NCT02966756|Venetoclax|venetoclax|mesh-list
82860010|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860011|NCT02844816|Atezolizumab|atezolizumab|mesh-list
82860012|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82860013|NCT02844816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82860014|NCT02844816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860015|NCT02844816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860016|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860017|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
82860018|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860019|NCT02822378|Vitamin D|vitamin d|mesh-list
82860020|NCT02822378|Calcium|calcium|mesh-list
82860021|NCT02822378|Vitamins|vitamins|mesh-ancestor
82860022|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
82860023|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860024|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82860025|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82860026|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
82860027|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860028|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860029|NCT02775851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82860030|NCT02775851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860031|NCT02677922|Azacitidine|azacitidine|mesh-list
82860032|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860033|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
82860034|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860035|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860036|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860037|NCT02642042|Docetaxel|docetaxel|mesh-list
82860038|NCT02642042|Trametinib|trametinib|mesh-list
82860039|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860040|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860041|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860042|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860043|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860044|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860045|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860046|NCT02595931|Irinotecan|irinotecan|mesh-list
82860047|NCT02595931|Camptothecin|camptothecin|mesh-list
82860048|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82860049|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860050|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860051|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860052|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860053|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860054|NCT02577406|Cytarabine|cytarabine|mesh-list
82860055|NCT02577406|Azacitidine|azacitidine|mesh-list
82860056|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860057|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
82860058|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860059|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860061|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860062|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860063|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
82860064|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860065|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860066|NCT02567422|Cisplatin|cisplatin|mesh-list
82860067|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860068|NCT02498600|Nivolumab|nivolumab|mesh-list
82860069|NCT02498600|Ipilimumab|ipilimumab|mesh-list
82860070|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860071|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860072|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82860073|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860074|NCT02193191|Plerixafor|plerixafor|mesh-list
82860075|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82860076|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82860077|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
82860078|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860079|NCT02073994|Ivosidenib|ivosidenib|mesh-list
82860080|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860081|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860082|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860083|NCT02059265|Dasatinib|dasatinib|mesh-list
82860084|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860085|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860086|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860087|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860088|NCT01925131|Prednisone|prednisone|mesh-list
82860089|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
82860090|NCT01925131|Vincristine|vincristine|mesh-list
82860091|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82860092|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860093|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
82860094|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860095|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860096|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860097|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
82860098|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860099|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860100|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860101|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860102|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
82860103|NCT01925131|Hormones|hormones|mesh-ancestor
82860104|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860105|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82860106|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860107|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860108|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860109|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860110|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860111|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82860112|NCT01925131|Immunotoxins|immunotoxins|mesh-ancestor
82860113|NCT01925131|Immunoconjugates|immunoconjugates|mesh-ancestor
82860114|NCT01809691|Bicalutamide|bicalutamide|mesh-list
82860115|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
82860116|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
82860117|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860118|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860119|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860120|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82860121|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860122|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860123|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860124|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860125|NCT01708941|Interferons|interferons|mesh-list
82860126|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
82860127|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
82860128|NCT01708941|Ipilimumab|ipilimumab|mesh-list
82860129|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860130|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
82860131|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083930|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
83510371|NCT05736419|Rituximab|rituximab|mesh-list
82860132|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860134|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860135|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
82860136|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860137|NCT01698918|Dexamethasone|dexamethasone|mesh-list
82860138|NCT01698918|Everolimus|everolimus|mesh-list
82860139|NCT01698918|Letrozole|letrozole|mesh-list
82860140|NCT01698918|Exemestane|exemestane|mesh-list
82860141|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860142|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
82860143|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
82860144|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860145|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860146|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82860147|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
82860148|NCT01698918|Hormones|hormones|mesh-ancestor
82860149|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860150|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82860151|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860152|NCT01698918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82860153|NCT01698918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860154|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860155|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860156|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860157|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
82860158|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82860159|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82860160|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82860161|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
82860162|NCT01674140|Tamoxifen|tamoxifen|mesh-list
82860163|NCT01674140|Everolimus|everolimus|mesh-list
82860164|NCT01674140|Letrozole|letrozole|mesh-list
82860165|NCT01674140|Anastrozole|anastrozole|mesh-list
82860166|NCT01674140|Leuprolide|leuprolide|mesh-list
82860167|NCT01674140|Exemestane|exemestane|mesh-list
82860168|NCT01674140|Goserelin|goserelin|mesh-list
82860169|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860170|NCT01674140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82860171|NCT01674140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860172|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860173|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860174|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
82860175|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860176|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860177|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82860178|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82860179|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82860180|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
83453178|NCT04364321|Clonazepam|clonazepam|mesh-list
82860181|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860182|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82860183|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82860184|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82860185|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82860186|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82860187|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
82860188|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82860189|NCT01574274|Pegaspargase|pegaspargase|mesh-list
82860190|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860191|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
82860192|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
82860193|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82860194|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82860195|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860196|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860197|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860198|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860199|NCT01275677|Paclitaxel|paclitaxel|mesh-list
82860200|NCT01275677|Docetaxel|docetaxel|mesh-list
82860201|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
82860202|NCT01275677|Doxorubicin|doxorubicin|mesh-list
82860203|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82860204|NCT01275677|Trastuzumab|trastuzumab|mesh-list
82860205|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82860206|NCT01275677|Daunorubicin|daunorubicin|mesh-list
82860207|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83083931|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
82860208|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82860209|NCT01275677|Antibodies|antibodies|mesh-list
82860210|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
82860211|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82860212|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860213|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860214|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860215|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860216|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860217|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860218|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860219|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
82860220|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860221|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860222|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860223|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
82860224|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860225|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82860226|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860227|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860228|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860229|NCT01169337|Lenalidomide|lenalidomide|mesh-list
82860230|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
82860231|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860232|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82860233|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82860234|NCT01169337|Growth Substances|growth substances|mesh-ancestor
82860235|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
82860236|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860237|NCT00840177|Cytarabine|cytarabine|mesh-list
82860238|NCT00840177|Idarubicin|idarubicin|mesh-list
82860239|NCT00840177|Pravastatin|pravastatin|mesh-list
82860240|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860241|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
82860242|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860243|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860244|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
82860245|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860246|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860247|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
82860248|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860249|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82860250|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860251|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860252|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860253|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82860254|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82860255|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82860256|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82860257|NCT00588991|Carboplatin|carboplatin|mesh-list
82860258|NCT00588991|Topotecan|topotecan|mesh-list
82860259|NCT00588991|Veliparib|veliparib|mesh-list
82860260|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860261|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82860262|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860263|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860264|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860265|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82860266|NCT01347580|Ticagrelor|ticagrelor|mesh-list
82860267|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82860268|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82860269|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82860270|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82860271|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
82860272|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860273|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860274|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860275|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
82860276|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82860277|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860278|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860279|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860280|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860281|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860282|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860283|NCT03352414|Alvimopan|alvimopan|mesh-list
82860284|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82860285|NCT00364793|Emtricitabine|emtricitabine|mesh-list
82860286|NCT00364793|Efavirenz|efavirenz|mesh-list
82860287|NCT00364793|Didanosine|didanosine|mesh-list
82860288|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
82860289|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860290|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82860291|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82860292|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860293|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860294|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82860295|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82860296|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82860297|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82860298|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82860299|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82860300|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82860301|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82860302|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
82860303|NCT03351478|Empagliflozin|empagliflozin|mesh-list
82860304|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82860305|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82860306|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860307|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82860308|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860309|NCT00363545|Vaccines|vaccines|mesh-list
82860310|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
82860311|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860312|NCT03351244|BI 409306|bi 409306|mesh-list
82860313|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82860314|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860315|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860316|NCT03386032|Desonide|desonide|mesh-list
82860317|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860318|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
82860319|NCT00077610|Hematinics|hematinics|mesh-ancestor
82860320|NCT00066222|Etoposide|etoposide|mesh-list
82860321|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860322|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860323|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860324|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860325|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860326|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860327|NCT00397943|Vaccines|vaccines|mesh-list
82860328|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
82860329|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860330|NCT00066066|Amoxicillin|amoxicillin|mesh-list
82860331|NCT00066066|Metronidazole|metronidazole|mesh-list
82860332|NCT00066066|Doxycycline|doxycycline|mesh-list
82860333|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82860334|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860335|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82860336|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82860337|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
82860338|NCT00363467|Busulfan|busulfan|mesh-list
82860339|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
82860340|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860341|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860342|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
82860343|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860344|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860345|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860346|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860347|NCT00397631|Pioglitazone|pioglitazone|mesh-list
82860348|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82860349|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82860350|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860351|NCT00397631|Incretins|incretins|mesh-ancestor
82860352|NCT00397631|Hormones|hormones|mesh-ancestor
82860353|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860354|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82860355|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
82860357|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860359|NCT00077376|Trastuzumab|trastuzumab|mesh-list
82860360|NCT00077376|Epothilone B|epothilone b|mesh-list
82860361|NCT00077376|Epothilones|epothilones|mesh-list
82860362|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860363|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860364|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860365|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860366|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860367|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860368|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
82860369|NCT01088724|Rituximab|rituximab|mesh-list
82860370|NCT01088724|Doxorubicin|doxorubicin|mesh-list
82860371|NCT01088724|Fludarabine|fludarabine|mesh-list
82860372|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860373|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
82860374|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860375|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860376|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860377|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
82860378|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860379|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860380|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860381|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860382|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82860383|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860384|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860385|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860386|NCT03957174|Rivastigmine|rivastigmine|mesh-list
82860387|NCT03957174|Reboxetine|reboxetine|mesh-list
82860388|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82860389|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860390|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860391|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
82860392|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860393|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860394|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82860395|NCT03957174|Protective Agents|protective agents|mesh-ancestor
82860396|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
82860397|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82860398|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82860399|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82860400|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82860401|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
82860402|NCT03406156|Venetoclax|venetoclax|mesh-list
82860403|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82860404|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
82860405|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860406|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860407|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
82860408|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860409|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860410|NCT00363311|Dutasteride|dutasteride|mesh-list
82860411|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82860412|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82860413|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860414|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860415|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
82860416|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860417|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860418|NCT00362609|Pantoprazole|pantoprazole|mesh-list
82860419|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82860420|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82860421|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82860422|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860423|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860424|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
82860425|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
82860426|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860427|NCT02534753|Protective Agents|protective agents|mesh-ancestor
82860428|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860429|NCT02534753|Vitamins|vitamins|mesh-ancestor
82860430|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
82860431|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
82860432|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82860433|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860434|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82860435|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
82860436|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82860437|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860438|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860439|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860440|NCT00362297|Valacyclovir|valacyclovir|mesh-list
82860441|NCT00362297|Acyclovir|acyclovir|mesh-list
82860442|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
82860443|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860444|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
82860445|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860446|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
82860447|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
82860448|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860449|NCT00090402|Protective Agents|protective agents|mesh-ancestor
82860450|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860451|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
82860452|NCT00090402|Vitamins|vitamins|mesh-ancestor
82860453|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
82860454|NCT00361283|Atorvastatin|atorvastatin|mesh-list
82860455|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82860456|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82860457|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
82860458|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860459|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82860460|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82860461|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860462|NCT00077064|Captopril|captopril|mesh-list
82860463|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82860464|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
82860465|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453191|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82860466|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860467|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82860468|NCT00396383|Plerixafor|plerixafor|mesh-list
82860469|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82860470|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82860471|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
82860472|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860473|NCT02534363|Aripiprazole|aripiprazole|mesh-list
82860474|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82860475|NCT02534363|Ziprasidone|ziprasidone|mesh-list
82860476|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
82860477|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82860478|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82860479|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82860480|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82860481|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860482|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
82860483|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
82860484|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860485|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860486|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82860487|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82860488|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
82860489|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82860490|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82860491|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82860492|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82860493|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
82860494|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82860495|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860496|NCT01088958|Micronutrients|micronutrients|mesh-list
82860497|NCT01088958|Trace Elements|trace elements|mesh-list
82860498|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860499|NCT03404518|Acetaminophen|acetaminophen|mesh-list
82860500|NCT03404518|Ibuprofen|ibuprofen|mesh-list
82860501|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82860502|NCT03404518|Hydrocodone|hydrocodone|mesh-list
82860503|NCT03404518|Narcotics|narcotics|mesh-list
82860504|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82860507|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860508|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860509|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
82860510|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82860511|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860513|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82860514|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860515|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860516|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82860517|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82860518|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
82860519|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
82860520|NCT03404206|Ibuprofen|ibuprofen|mesh-list
82860521|NCT03404206|Naproxen|naproxen|mesh-list
82860522|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82860523|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82860524|NCT03404206|Analgesics|analgesics|mesh-ancestor
82860525|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
82860526|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860527|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860528|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860529|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860530|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82860531|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860532|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860533|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
82860534|NCT00394901|Pregabalin|pregabalin|mesh-list
82860535|NCT00394901|Analgesics|analgesics|mesh-ancestor
82860536|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
82860537|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860538|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860539|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
82860540|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82860541|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82860542|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860543|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82860544|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82860545|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82860546|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82860547|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82860548|NCT03349060|Abrocitinib|abrocitinib|mesh-list
82860549|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860550|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860551|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860552|NCT03348904|Paclitaxel|paclitaxel|mesh-list
82860553|NCT03348904|Carboplatin|carboplatin|mesh-list
82860554|NCT03348904|Gemcitabine|gemcitabine|mesh-list
82860555|NCT03348904|Nivolumab|nivolumab|mesh-list
82860556|NCT03348904|Pemetrexed|pemetrexed|mesh-list
82860557|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860558|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860559|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860560|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860561|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860562|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860563|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860564|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
82860565|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860566|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82860567|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860568|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82860569|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82860570|NCT00359021|Etravirine|etravirine|mesh-list
82860571|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82860572|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82860573|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860574|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860575|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
82860576|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860586|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860587|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
82860588|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860589|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860590|NCT01052597|Curcumin|curcumin|mesh-list
82860591|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82860592|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82860593|NCT01052597|Analgesics|analgesics|mesh-ancestor
82860595|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860596|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860597|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860598|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860599|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860600|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860601|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860602|NCT01051115|Dasatinib|dasatinib|mesh-list
82860603|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860604|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860605|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860606|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860607|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
82860608|NCT00076752|Promethazine|promethazine|mesh-list
82860609|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
82860610|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
82860611|NCT00076752|Rituximab|rituximab|mesh-list
82860612|NCT00076752|Fludarabine|fludarabine|mesh-list
82860613|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
82860614|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860615|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
82860616|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860617|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860618|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860619|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
82860620|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860621|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860622|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860623|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860624|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860625|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
82860626|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860627|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
82860628|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
82860629|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860630|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82860631|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
82860632|NCT00076752|Hormones|hormones|mesh-ancestor
82860633|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860634|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82860635|NCT00076752|Protective Agents|protective agents|mesh-ancestor
82860636|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82860637|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82860638|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82860639|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
82860640|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
82860641|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
82860642|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82860643|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
82860644|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
82860645|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860646|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82860647|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
82860648|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
82860649|NCT03384940|Trastuzumab|trastuzumab|mesh-list
82860650|NCT03384940|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82860651|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860653|NCT03384940|Immunoconjugates|immunoconjugates|mesh-ancestor
82860654|NCT03384940|Immunologic Factors|immunologic factors|mesh-ancestor
82860655|NCT03384940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860656|NCT00075582|Dactinomycin|dactinomycin|mesh-list
82860657|NCT00075582|Cactinomycin|cactinomycin|mesh-list
82860658|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
82860659|NCT00075582|Vincristine|vincristine|mesh-list
82860660|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860661|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
82860662|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860663|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860664|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860665|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
82860666|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860667|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860668|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860669|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860670|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860671|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860672|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860673|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82860674|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860675|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82860676|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82860677|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860678|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82860680|NCT00063258|Carboplatin|carboplatin|mesh-list
82860681|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82860682|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860683|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860684|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860685|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860686|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860687|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860688|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82860689|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860690|NCT00088530|Prednisone|prednisone|mesh-list
82860691|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
82860692|NCT00088530|Rituximab|rituximab|mesh-list
82860693|NCT00088530|Gemcitabine|gemcitabine|mesh-list
82860694|NCT00088530|Etoposide|etoposide|mesh-list
82860695|NCT00088530|Vincristine|vincristine|mesh-list
82860696|NCT00088530|Vinorelbine|vinorelbine|mesh-list
82860697|NCT00088530|Pixantrone|pixantrone|mesh-list
82860698|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860699|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
82860700|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860701|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860702|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860703|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
82860704|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860705|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860706|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860707|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860708|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860709|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
82860710|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860711|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
82860712|NCT00088530|Hormones|hormones|mesh-ancestor
82860713|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860714|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82860715|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860716|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860717|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860718|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860719|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860720|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860721|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860722|NCT00359801|Insulin|insulin|mesh-list
82860723|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82860724|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82860725|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860726|NCT03990701|Metomidate|metomidate|mesh-list
82860727|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82860728|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82860729|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860731|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
82860732|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82860733|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82860734|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82860735|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860736|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82860737|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82860738|NCT01051271|Midazolam|midazolam|mesh-list
82860739|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82860740|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82860741|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82860742|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860743|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82860744|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82860745|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82860747|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
82860748|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
82860749|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
82860750|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
82860751|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860752|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860753|NCT01051427|Hemostatics|hemostatics|mesh-list
82860754|NCT01051427|Surgiflo|surgiflo|mesh-list
82860755|NCT01051427|Coagulants|coagulants|mesh-ancestor
82860756|NCT01052909|Glimepiride|glimepiride|mesh-list
82860757|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82860758|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82860759|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860760|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860761|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
82860762|NCT00045032|Trastuzumab|trastuzumab|mesh-list
82860763|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860764|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860765|NCT01052987|Tranilast|tranilast|mesh-list
82860766|NCT01052987|Allopurinol|allopurinol|mesh-list
82860767|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
82860768|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860769|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860770|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
82860771|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860772|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82860773|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
82860774|NCT01052987|Protective Agents|protective agents|mesh-ancestor
82860775|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860776|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82860777|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82860778|NCT01052987|Analgesics|analgesics|mesh-ancestor
82860779|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
82860780|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860781|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860782|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82860783|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82860784|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82860785|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82860786|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
82860787|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
82860788|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860789|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82860790|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82860791|NCT02533973|Calcipotriene|calcipotriene|mesh-list
82860792|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
82860793|NCT01053065|Atorvastatin|atorvastatin|mesh-list
82860794|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
82860795|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
82860796|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82860797|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82860798|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
82860799|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860800|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82860801|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82860802|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860803|NCT01051583|Bevacizumab|bevacizumab|mesh-list
82860804|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860805|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860806|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82860807|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82860808|NCT01051583|Growth Substances|growth substances|mesh-ancestor
82860809|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860810|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
82860812|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82860813|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860814|NCT03950804|Eculizumab|eculizumab|mesh-list
82860815|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82860816|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860817|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
82860818|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860819|NCT00356915|Itraconazole|itraconazole|mesh-list
82860820|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
82860821|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
82860822|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860824|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82860825|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860826|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860827|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82860828|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
82860829|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860830|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860831|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82860832|NCT00356759|Warfarin|warfarin|mesh-list
82860833|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
82860834|NCT00356603|Sumatriptan|sumatriptan|mesh-list
82860835|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82860836|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82860837|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82860838|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
82860839|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860840|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860841|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860842|NCT01052051|Vitamin D|vitamin d|mesh-list
82860843|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
82860844|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
82860845|NCT01052051|Calcium|calcium|mesh-list
82860846|NCT01052051|Vitamins|vitamins|mesh-ancestor
82860847|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
82860848|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860849|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83453206|NCT05528913|Benralizumab|benralizumab|mesh-list
82860850|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82860851|NCT01052051|Antacids|antacids|mesh-ancestor
82860852|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860853|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82860854|NCT00002558|Paclitaxel|paclitaxel|mesh-list
82860855|NCT00002558|Etoposide|etoposide|mesh-list
82860856|NCT00002558|Carboplatin|carboplatin|mesh-list
82860857|NCT00002558|Ifosfamide|ifosfamide|mesh-list
82860858|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82860859|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860860|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
82860861|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
82860862|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860863|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860864|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860865|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860866|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860867|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860868|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
82860869|NCT00001880|Cyclosporine|cyclosporine|mesh-list
82860870|NCT00001880|Methotrexate|methotrexate|mesh-list
82860871|NCT00001880|Cyclosporins|cyclosporins|mesh-list
82860872|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82860873|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
82860874|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82860875|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860876|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860877|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
82860878|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860879|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860880|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
82860881|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860882|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82860883|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860884|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
82860885|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860886|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82860887|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
82860888|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860889|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82860890|NCT01096472|Octenidine|octenidine|mesh-list
82860891|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860892|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82860893|NCT05627648|Mitogens|mitogens|mesh-list
82860894|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
82860895|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860896|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
82860897|NCT05296772|Antibodies|antibodies|mesh-list
82860898|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
82860899|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
82860900|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860901|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860902|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860903|NCT05296772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82860904|NCT05296772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860905|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
82860906|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82860907|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82860908|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860909|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82860910|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82860911|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
82860912|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860913|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860914|NCT01104896|Nicotine|nicotine|mesh-list
82860915|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82860916|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
82860917|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860918|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860919|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82860920|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82860921|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
82860922|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860923|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860924|NCT00043550|Sertraline|sertraline|mesh-list
82860925|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82860926|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
82860927|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82860928|NCT00043550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82860929|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82860930|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82860931|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860932|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82860933|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
82860934|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860935|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82860936|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82860937|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
82860938|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860939|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82860940|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860941|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
82860942|NCT01102244|Hormones|hormones|mesh-ancestor
82860943|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860944|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860945|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82860946|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82860947|NCT01105208|Cephalexin|cephalexin|mesh-list
82860948|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82860949|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860950|NCT01105286|Vitamin D|vitamin d|mesh-list
82860952|NCT01105286|Vitamins|vitamins|mesh-ancestor
82860953|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
82860954|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860955|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82860956|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
82860957|NCT00041132|Leucovorin|leucovorin|mesh-list
82860958|NCT00041132|Cytarabine|cytarabine|mesh-list
82860959|NCT00041132|Dexamethasone|dexamethasone|mesh-list
82860960|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
82860961|NCT00041132|Rituximab|rituximab|mesh-list
82860962|NCT00041132|Doxorubicin|doxorubicin|mesh-list
82860963|NCT00041132|Methotrexate|methotrexate|mesh-list
82860964|NCT00041132|Vincristine|vincristine|mesh-list
82860965|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
82860966|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82860967|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
82860968|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82860969|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82860970|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82860971|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
82860972|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82860973|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82860974|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82860975|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82860976|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82860977|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
82860978|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
82860979|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82860980|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82860981|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
82860982|NCT00041132|Hormones|hormones|mesh-ancestor
82860983|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82860984|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82860985|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82860986|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82860987|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82860988|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82860989|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82860990|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
82860991|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82860992|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82860993|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
82860994|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
82860995|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82860996|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82860997|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
82860998|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82860999|NCT00041132|Antidotes|antidotes|mesh-ancestor
82861000|NCT00041132|Protective Agents|protective agents|mesh-ancestor
82861001|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
82861002|NCT00041132|Vitamins|vitamins|mesh-ancestor
82861003|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
82861004|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82861005|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
82861006|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
82861007|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
82861008|NCT00040664|Ritonavir|ritonavir|mesh-list
82861009|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
82861010|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82861011|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82861012|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
82861013|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861014|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861015|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82861016|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82861017|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
82861018|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861019|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82861020|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82861021|NCT02952586|Avelumab|avelumab|mesh-list
82861022|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861023|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861024|NCT05098574|Drospirenone|drospirenone|mesh-list
82861025|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82861026|NCT05098574|Estradiol|estradiol|mesh-list
82861027|NCT05098574|Estrogens|estrogens|mesh-ancestor
82861028|NCT05098574|Hormones|hormones|mesh-ancestor
82861029|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861030|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861031|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82861032|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
82861033|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82861034|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82861035|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82861036|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82861037|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82861038|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
82861039|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82861040|NCT05098574|Diuretics|diuretics|mesh-ancestor
82861041|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
82861042|NCT01096706|Aspirin|aspirin|mesh-list
82861043|NCT01096706|Fluconazole|fluconazole|mesh-list
82861044|NCT01096706|Substance P|substance p|mesh-list
82861045|NCT01096706|Neurokinin A|neurokinin a|mesh-list
82861046|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82861047|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82861048|NCT01096706|Analgesics|analgesics|mesh-ancestor
83510372|NCT05736419|Fludarabine|fludarabine|mesh-list
82861050|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861051|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861052|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861053|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82861054|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82861055|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82861056|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861057|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82861058|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82861059|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861060|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
82861061|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
82861062|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861063|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82861064|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82861065|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82861066|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
82861067|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861068|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82861069|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82861070|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861071|NCT01102478|Losartan|losartan|mesh-list
82861072|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82861073|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82861074|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82861075|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82861076|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82861077|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861078|NCT01102478|Diuretics|diuretics|mesh-ancestor
82861079|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
82861080|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861081|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82861082|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82861083|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82861084|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82861085|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
82861086|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861087|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82861088|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861089|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82861090|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861091|NCT03384316|Vaccines|vaccines|mesh-list
82861092|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
82861093|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861094|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
82861095|NCT03994172|Vitamin D|vitamin d|mesh-list
82861096|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
82861097|NCT03994172|Teriparatide|teriparatide|mesh-list
82861098|NCT03994172|Citric Acid|citric acid|mesh-list
82861099|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
82861100|NCT03994172|Calcium|calcium|mesh-list
82861101|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
82861102|NCT03994172|Cinacalcet|cinacalcet|mesh-list
82861104|NCT03994172|Vitamins|vitamins|mesh-ancestor
82861105|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
82861106|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861107|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82861108|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82861109|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
82861110|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82861111|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
82861112|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
82861113|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861114|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861115|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82861116|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
82861117|NCT01105832|Teriparatide|teriparatide|mesh-list
82861118|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82861119|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861120|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82861121|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82861122|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
82861123|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82861124|NCT00356525|Carboplatin|carboplatin|mesh-list
82861125|NCT00356525|Gemcitabine|gemcitabine|mesh-list
82861126|NCT00356525|Pemetrexed|pemetrexed|mesh-list
82861127|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861128|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82861129|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
82861130|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861131|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861132|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82861133|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82861134|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
82861135|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861136|NCT01052129|Naproxen|naproxen|mesh-list
82861137|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82861138|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82861139|NCT01052129|Analgesics|analgesics|mesh-ancestor
82861140|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
82861141|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861142|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861143|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861144|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82861145|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
82861146|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82861147|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861148|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861149|NCT01053377|Oseltamivir|oseltamivir|mesh-list
82861150|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
82861151|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861152|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861153|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861154|NCT03991559|Manganese|manganese|mesh-list
82861155|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82861156|NCT03991559|Antibodies|antibodies|mesh-list
82861157|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
82861158|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
82861159|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861160|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861161|NCT03991559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861162|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861163|NCT03991559|Trace Elements|trace elements|mesh-ancestor
82861164|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
82861165|NCT03949634|Paclitaxel|paclitaxel|mesh-list
82861166|NCT03949634|Docetaxel|docetaxel|mesh-list
82861167|NCT03949634|Doxorubicin|doxorubicin|mesh-list
82861168|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82861169|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861170|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
82861171|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
82861172|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
82861173|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861174|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82861175|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82861176|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82861177|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861178|NCT01108874|Metaraminol|metaraminol|mesh-list
82861179|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
82861180|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
82861181|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861182|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861183|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82861184|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82861185|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82861186|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82861187|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
82861188|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861189|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861190|NCT03383614|Emodepside|emodepside|mesh-list
82861191|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82861192|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861193|NCT03403036|Brodalumab|brodalumab|mesh-list
82861194|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
82861195|NCT00356135|Clopidogrel|clopidogrel|mesh-list
82861196|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82861197|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82861198|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82861199|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82861200|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82861201|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
82861202|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861203|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861204|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861205|NCT01052363|Bevacizumab|bevacizumab|mesh-list
82861206|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861207|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861208|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82861209|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82861210|NCT01052363|Growth Substances|growth substances|mesh-ancestor
82861211|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861212|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
82861213|NCT01053611|Remifentanil|remifentanil|mesh-list
82861214|NCT01053611|Propofol|propofol|mesh-list
82861215|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83453217|NCT02959125|Micronutrients|micronutrients|mesh-list
82861216|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861217|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861218|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82861219|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
82861220|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
82861221|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82861222|NCT01053611|Narcotics|narcotics|mesh-ancestor
82861223|NCT01053611|Analgesics|analgesics|mesh-ancestor
82861224|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
82861225|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861226|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
82861227|NCT00350519|Hematinics|hematinics|mesh-ancestor
82861228|NCT01053689|Glimepiride|glimepiride|mesh-list
82861229|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82861230|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82861231|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861232|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861233|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
82861234|NCT01111448|Sirolimus|sirolimus|mesh-list
82861235|NCT01111448|Temsirolimus|temsirolimus|mesh-list
82861236|NCT01111448|MTOR Inhibitors|mtor inhibitors|mesh-list
82861237|NCT01111448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82861238|NCT01111448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861239|NCT01111448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861240|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861241|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
82861242|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861243|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861244|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82861245|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861246|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82861247|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
82861248|NCT03382912|Nivolumab|nivolumab|mesh-list
82861249|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861250|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861251|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82861252|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861254|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82861255|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861256|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82861257|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861258|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
82861259|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861260|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
82861261|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861262|NCT00350207|Bromides|bromides|mesh-list
82861263|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
82861264|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82861265|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82861266|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
82861267|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861268|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861269|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82861270|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
82861271|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
82861272|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82861273|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
82861274|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861275|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861276|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82861278|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82861279|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
82861280|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
82861281|NCT03946826|Halometasone|halometasone|mesh-list
82861282|NCT03946826|Petrolatum|petrolatum|mesh-list
82861283|NCT03946826|Emollients|emollients|mesh-ancestor
82861284|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
82861285|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861286|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
82861287|NCT03946826|Hormones|hormones|mesh-ancestor
82861288|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83453220|NCT02972554|Propranolol|propranolol|mesh-list
82861289|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861290|NCT01311622|Warfarin|warfarin|mesh-list
82861291|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
82861292|NCT00349973|Dipyridamole|dipyridamole|mesh-list
82861293|NCT00349973|Olanzapine|olanzapine|mesh-list
82861294|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
82861295|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
82861296|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861297|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861298|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82861299|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82861300|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82861301|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861302|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82861303|NCT00349973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82861304|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82861305|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82861306|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861307|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861308|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
82861309|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82861310|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861311|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82861312|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
82861313|NCT01111682|Mannitol|mannitol|mesh-list
82861314|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82861315|NCT01111682|Diuretics|diuretics|mesh-ancestor
82861316|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
82861317|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861318|NCT04464122|Somatostatin|somatostatin|mesh-list
82861319|NCT04464122|Hormones|hormones|mesh-ancestor
82861320|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861321|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861322|NCT01111994|Clindamycin|clindamycin|mesh-list
82861323|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
82861324|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
82861325|NCT01111994|Tretinoin|tretinoin|mesh-list
82861326|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82861327|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861328|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82861329|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861330|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861331|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861332|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
82861333|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
82861335|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861336|NCT03944252|Cetuximab|cetuximab|mesh-list
82861337|NCT03944252|Avelumab|avelumab|mesh-list
82861338|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861339|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861340|NCT01209026|Fluticasone|fluticasone|mesh-list
82861341|NCT01209026|Xhance|xhance|mesh-list
82861342|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
82861343|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82861344|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861345|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82861346|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
82861347|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861348|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861349|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82861350|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
82861351|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
82861352|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82861353|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82861354|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861355|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82861356|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82861357|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861358|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861359|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861360|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82861361|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
82861362|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82861363|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82861364|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82861365|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82861366|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82861367|NCT01107470|Hormones|hormones|mesh-ancestor
82861368|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861369|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861370|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82861371|NCT01109264|Chlorambucil|chlorambucil|mesh-list
82861372|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82861373|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
82861374|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861375|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861376|NCT01311700|Metoprolol|metoprolol|mesh-list
82861377|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82861378|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82861379|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
82861380|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
82861381|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861382|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861383|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82861384|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82861385|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82861386|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
82861387|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861388|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861389|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
82861390|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
82861391|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82861392|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82861393|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861394|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861395|NCT01107782|Urological Agents|urological agents|mesh-ancestor
82861396|NCT01107938|Esomeprazole|esomeprazole|mesh-list
82861397|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82861398|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82861399|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82861400|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861401|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861402|NCT02950558|Ropivacaine|ropivacaine|mesh-list
82861403|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
82861404|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
82861405|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861406|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861407|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
82861408|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861409|NCT02791334|Ramucirumab|ramucirumab|mesh-list
82861410|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861411|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
82861412|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82861413|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
82861414|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861415|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861416|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82861417|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
82861418|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
82861419|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82861420|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
82861421|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861422|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861423|NCT05497726|Bevacizumab|bevacizumab|mesh-list
82861424|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861425|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861426|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82861427|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82861428|NCT05497726|Growth Substances|growth substances|mesh-ancestor
82861429|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861430|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
82861431|NCT01209416|Acipimox|acipimox|mesh-list
82861432|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82861433|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
82861434|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861435|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82861436|NCT00349349|Ofatumumab|ofatumumab|mesh-list
82861437|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861438|NCT01112462|Acetaminophen|acetaminophen|mesh-list
82861439|NCT01112462|Phenylephrine|phenylephrine|mesh-list
82861440|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
82861441|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82861442|NCT01112462|Analgesics|analgesics|mesh-ancestor
82861443|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
82861444|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861445|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861446|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
82861447|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82861448|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
82861449|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
82861450|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
82861451|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82861452|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
82861453|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
82861454|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82861455|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82861456|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82861457|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
82861458|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861459|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861460|NCT01112462|Protective Agents|protective agents|mesh-ancestor
82861461|NCT02950480|Zafirlukast|zafirlukast|mesh-list
82861462|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82861463|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
82861464|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82861465|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
82861466|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861467|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861468|NCT01109030|Pioglitazone|pioglitazone|mesh-list
82861469|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
82861470|NCT01109030|Dexetimide|dexetimide|mesh-list
82861471|NCT01109030|Citalopram|citalopram|mesh-list
82861472|NCT01109030|Escitalopram|escitalopram|mesh-list
82861473|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82861474|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861475|NCT01109030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82861476|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82861477|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82861478|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861479|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861480|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
82861481|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82861482|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
82861483|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82861484|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82861485|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82861486|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
82861487|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
82861488|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861489|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82861490|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82861491|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
82861492|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82861493|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82861494|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861495|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82861496|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82861497|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
82861499|NCT05494528|Entecavir|entecavir|mesh-list
82861500|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
82861501|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861502|NCT03987815|Nivolumab|nivolumab|mesh-list
82861503|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861504|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861505|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82861506|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861507|NCT00348881|Vaccines|vaccines|mesh-list
82861508|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
82861509|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861510|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
82861511|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82861512|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82861513|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861514|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
82861515|NCT02257580|Coagulants|coagulants|mesh-ancestor
82861516|NCT01055795|Bevacizumab|bevacizumab|mesh-list
82861517|NCT01055795|Everolimus|everolimus|mesh-list
82861518|NCT01055795|Panobinostat|panobinostat|mesh-list
82861519|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861520|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861521|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82861522|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82861523|NCT01055795|Growth Substances|growth substances|mesh-ancestor
82861524|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861525|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
82861526|NCT01055795|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82861527|NCT01055795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82861528|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861529|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861530|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861531|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
82861532|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82861533|NCT03943784|Propranolol|propranolol|mesh-list
82861534|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82861535|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82861536|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
82861537|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861538|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861539|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861540|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82861541|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82861542|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
82861543|NCT00347009|Adefovir|adefovir|mesh-list
82861544|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82861545|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
82861546|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861547|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82861548|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82861549|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861550|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861551|NCT01209650|Afatinib|afatinib|mesh-list
82861552|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861554|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861555|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861556|NCT01947140|Romidepsin|romidepsin|mesh-list
82861557|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82861558|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861559|NCT01947140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82861560|NCT01947140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861561|NCT01947140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861562|NCT00346775|Beclomethasone|beclomethasone|mesh-list
82861563|NCT00346775|Flunisolide|flunisolide|mesh-list
82861564|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861565|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
82861566|NCT00346775|Hormones|hormones|mesh-ancestor
82861567|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861568|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861569|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82861570|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
82861571|NCT01108562|Lidocaine|lidocaine|mesh-list
82861572|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
82861573|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
82861574|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861575|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861576|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
82861577|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861578|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83453233|NCT05316129|Hormones|hormones|mesh-list
82861579|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82861580|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82861581|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82861582|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861584|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82861585|NCT01112540|Narcotics|narcotics|mesh-ancestor
82861586|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861587|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861588|NCT01112540|Analgesics|analgesics|mesh-ancestor
82861589|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
82861590|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861591|NCT03400852|Cosyntropin|cosyntropin|mesh-list
82861592|NCT03400852|Hormones|hormones|mesh-ancestor
82861593|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861594|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861595|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
82861596|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
82861597|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861598|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
82861599|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
82861600|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861601|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861602|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
82861603|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
82861604|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861605|NCT01056497|Protective Agents|protective agents|mesh-ancestor
82861606|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861607|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
82861608|NCT01056497|Vitamins|vitamins|mesh-ancestor
82861609|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
82861610|NCT03398356|Metformin|metformin|mesh-list
82861611|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82861612|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861613|NCT00346151|Sirolimus|sirolimus|mesh-list
82861614|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
82861615|NCT00346151|Abatacept|abatacept|mesh-list
82861616|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
82861617|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82861618|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
82861619|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
82861620|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82861621|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861622|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82861623|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861624|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
82861625|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861626|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
82861634|NCT00346151|Hormones|hormones|mesh-ancestor
82861635|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861636|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82861637|NCT00346151|Protective Agents|protective agents|mesh-ancestor
82861638|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82861639|NCT00346151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861640|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82861641|NCT03940976|Afatinib|afatinib|mesh-list
82861642|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861643|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82861644|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861645|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861646|NCT01109498|Cyclosporine|cyclosporine|mesh-list
82861647|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
82861648|NCT01109498|Cyclosporins|cyclosporins|mesh-list
82861649|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861650|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861651|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861652|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
82861653|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861654|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
82861655|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861656|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
82861657|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82861658|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82861659|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83453237|NCT00359151|Celecoxib|celecoxib|mesh-list
82861660|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861661|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82861662|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
82861663|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82861664|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
82861665|NCT00130286|Hormones|hormones|mesh-list
82861666|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861667|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861668|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82861669|NCT03940664|Formaldehyde|formaldehyde|mesh-list
82861670|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
82861671|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861672|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
82861673|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
82861674|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82861675|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
82861676|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
82861677|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861678|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861679|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82861680|NCT03941990|Analgesics|analgesics|mesh-ancestor
82861681|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
82861682|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861683|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
82861684|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861685|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861686|NCT03374488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82861687|NCT03374488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861688|NCT01209728|Ethanol|ethanol|mesh-list
82861689|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82861690|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861691|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861692|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861693|NCT00076310|Cisplatin|cisplatin|mesh-list
82861702|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861704|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
82861705|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861706|NCT01211912|Acetaminophen|acetaminophen|mesh-list
82861707|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82861708|NCT01211912|Analgesics|analgesics|mesh-ancestor
82861709|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
82861710|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861711|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861712|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
82861713|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
82861714|NCT03943472|Fludarabine|fludarabine|mesh-list
82861715|NCT03943472|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
82861716|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861717|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
82861718|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861719|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82861720|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82861721|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
82861722|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861723|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861724|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82861725|NCT03943472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861726|NCT01114490|Anacetrapib|anacetrapib|mesh-list
82861727|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82861728|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82861729|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
82861730|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861731|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82861732|NCT01209806|Simethicone|simethicone|mesh-list
82861733|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
82861734|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82861735|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
82861736|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
82861737|NCT01209806|TEMPO|tempo|mesh-list
82861738|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
82861739|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861740|NCT01209806|Emollients|emollients|mesh-ancestor
82861741|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
82861742|NCT01209806|Antacids|antacids|mesh-ancestor
82861743|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82861744|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82861745|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
82861746|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861747|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
82861748|NCT01209806|Protective Agents|protective agents|mesh-ancestor
82861750|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82861751|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861752|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82861753|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861754|NCT01109654|Cetrorelix|cetrorelix|mesh-list
82861755|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82861756|NCT01109654|Hormones|hormones|mesh-ancestor
82861757|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861758|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861759|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82861760|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
82861761|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82861762|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
82861763|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
82861764|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
82861765|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82861766|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82861767|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861768|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861769|NCT01054001|Urological Agents|urological agents|mesh-ancestor
82861770|NCT01057355|Ethanol|ethanol|mesh-list
82861771|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82861772|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861773|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861774|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861775|NCT01057511|Progesterone|progesterone|mesh-list
82861776|NCT01057511|Progestins|progestins|mesh-ancestor
82861777|NCT01057511|Hormones|hormones|mesh-ancestor
82861778|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861779|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861780|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
82861781|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861782|NCT01210040|Folic Acid|folic acid|mesh-list
82861783|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
82861784|NCT01210040|Hematinics|hematinics|mesh-ancestor
82861785|NCT01210040|Vitamins|vitamins|mesh-ancestor
82861786|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
82861787|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861788|NCT01054313|Sirolimus|sirolimus|mesh-list
82861789|NCT01054313|Prednisone|prednisone|mesh-list
82861790|NCT01054313|Docetaxel|docetaxel|mesh-list
82861791|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861792|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
82861793|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
82861794|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
82861795|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861796|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861797|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
82861798|NCT01054313|Hormones|hormones|mesh-ancestor
82861799|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861800|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861801|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82861802|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82861803|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861804|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82861805|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
82861806|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82861807|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
82861808|NCT01114958|Cisplatin|cisplatin|mesh-list
82861809|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861810|NCT03742115|Dexamethasone|dexamethasone|mesh-list
82861811|NCT03742115|Etoposide|etoposide|mesh-list
82861812|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
82861813|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861814|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
82861815|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
82861816|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861817|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861818|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82861819|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
82861820|NCT03742115|Hormones|hormones|mesh-ancestor
83133543|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861821|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861822|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82861823|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861824|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82861826|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82861827|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861828|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861829|NCT01115036|Panobinostat|panobinostat|mesh-list
82861830|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861831|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82861832|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861833|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861834|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82861835|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82861836|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82861837|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82861838|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861839|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
82861840|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861841|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861843|NCT03942068|Apatinib|apatinib|mesh-list
82861844|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82861845|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82861846|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861847|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
82861848|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
82861849|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
82861850|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861851|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82861852|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861853|NCT01112852|Terlipressin|terlipressin|mesh-list
82861854|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82861855|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82861856|NCT01112852|Somatostatin|somatostatin|mesh-list
82861857|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82861858|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861859|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861860|NCT01112852|Hormones|hormones|mesh-ancestor
82861861|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861862|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861863|NCT01054469|Ropivacaine|ropivacaine|mesh-list
82861864|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
82861865|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
82861866|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861867|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861868|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
82861869|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861870|NCT03940430|Lactoferrin|lactoferrin|mesh-list
82861871|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82861872|NCT00355121|Vaccines|vaccines|mesh-list
82861873|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
82861874|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861875|NCT02533349|Pantoprazole|pantoprazole|mesh-list
82861876|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82861877|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82861878|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82861879|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861880|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861881|NCT01115426|Losartan|losartan|mesh-list
82861882|NCT01115426|Ramipril|ramipril|mesh-list
82861883|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82861884|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82861885|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82861886|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82861887|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453240|NCT00359151|Analgesics|analgesics|mesh-ancestor
82861888|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82861889|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
82861890|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861891|NCT03942458|Clopidogrel|clopidogrel|mesh-list
82861892|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82861893|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82861895|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82861897|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82861898|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861899|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861901|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
82861902|NCT01115504|Vitamins|vitamins|mesh-ancestor
82861903|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
82861904|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861905|NCT00343889|Vaccines|vaccines|mesh-list
82861906|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
82861907|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861908|NCT03939884|Diclofenac|diclofenac|mesh-list
82861909|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82861910|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82861911|NCT03939884|Analgesics|analgesics|mesh-ancestor
82861912|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
82861913|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861914|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861915|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861916|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82861917|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82861918|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82861919|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861920|NCT01054547|Anesthetics|anesthetics|mesh-list
82861921|NCT01054547|Ropivacaine|ropivacaine|mesh-list
82861922|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861923|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861924|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
82861925|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
82861926|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861927|NCT01115894|Naltrexone|naltrexone|mesh-list
82861928|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82861929|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82861930|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861931|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
82861932|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861933|NCT01115972|Valsartan|valsartan|mesh-list
82861934|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82861935|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82861936|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82861937|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861938|NCT01116050|Misoprostol|misoprostol|mesh-list
82861939|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82861940|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
82861941|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82861942|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861943|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82861944|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82861945|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
82861946|NCT01054781|Rituximab|rituximab|mesh-list
82861947|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82861948|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861949|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
82861950|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861951|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82861952|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
82861953|NCT01311778|Fentanyl|fentanyl|mesh-list
82861954|NCT01311778|Cannabidiol|cannabidiol|mesh-list
82861955|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82861956|NCT01311778|Narcotics|narcotics|mesh-ancestor
82861957|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82861958|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861959|NCT01311778|Analgesics|analgesics|mesh-ancestor
82861960|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
82861961|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82861962|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82861963|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82861964|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
82861965|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
82861966|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
82861967|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
82861968|NCT00354341|Hematinics|hematinics|mesh-ancestor
82861969|NCT03708718|Prednisolone|prednisolone|mesh-list
82861970|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82861972|NCT03708718|Hormones|hormones|mesh-ancestor
82861973|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82861974|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861975|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82861976|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861977|NCT00354107|Cytarabine|cytarabine|mesh-list
82861978|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
82861979|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82861980|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82861981|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82861982|NCT00354107|Carboplatin|carboplatin|mesh-list
82861983|NCT00354107|Methotrexate|methotrexate|mesh-list
82861984|NCT00354107|Etoposide|etoposide|mesh-list
82861985|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
82861986|NCT00354107|Ifosfamide|ifosfamide|mesh-list
82861987|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82861988|NCT00354107|Antibodies|antibodies|mesh-list
82861989|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82861990|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
82861991|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82861992|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82861993|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82861994|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
82861995|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82861996|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82861997|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
82861998|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82861999|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
82862000|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862001|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82862002|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862003|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862004|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82862005|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82862006|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82862007|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82862008|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
82862009|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862010|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862011|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82862012|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
82862013|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82862014|NCT00354107|Immunotoxins|immunotoxins|mesh-ancestor
82862015|NCT00354107|Immunoconjugates|immunoconjugates|mesh-ancestor
82862016|NCT00354029|Ketamine|ketamine|mesh-list
82862017|NCT00354029|Analgesics|analgesics|mesh-ancestor
82862018|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
82862019|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862020|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862021|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82862022|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82862023|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
82862024|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
82862025|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862026|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82862027|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82862028|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862029|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862030|NCT00353873|Fluticasone|fluticasone|mesh-list
82862031|NCT00353873|Xhance|xhance|mesh-list
82862032|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82862033|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862034|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82862035|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
82862036|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862037|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862038|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82862039|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
82862040|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
82862041|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82862042|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82862043|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82862044|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82862045|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
82862047|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862048|NCT01058057|Atorvastatin|atorvastatin|mesh-list
82862049|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82862050|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82862051|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
82862052|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862053|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82862054|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82862055|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862056|NCT03796676|Abrocitinib|abrocitinib|mesh-list
82862057|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82862058|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862059|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862060|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
82862061|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82862062|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82862063|NCT00339833|Analgesics|analgesics|mesh-ancestor
82862064|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
82862065|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862066|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862067|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862068|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862069|NCT01058291|Apomorphine|apomorphine|mesh-list
82862070|NCT01058291|Emetics|emetics|mesh-ancestor
82862071|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862072|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
82862073|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862074|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862075|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
82862076|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
82862077|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862078|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862079|NCT01055249|Ibuprofen|ibuprofen|mesh-list
82862080|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
82862081|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82862082|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82862083|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82862084|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82862085|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82862086|NCT01055249|Analgesics|analgesics|mesh-ancestor
82862087|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
82862088|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862089|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862090|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862091|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862092|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82862093|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862094|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862095|NCT01055327|Lamotrigine|lamotrigine|mesh-list
82862096|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
82862097|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82862098|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862099|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862100|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82862101|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862102|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82862103|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82862104|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862105|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862106|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82862107|NCT03793556|Omeprazole|omeprazole|mesh-list
82862108|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82862109|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862110|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82862111|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862112|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862113|NCT01113164|Ondansetron|ondansetron|mesh-list
82862114|NCT01113164|Sertraline|sertraline|mesh-list
82862115|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
82862116|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
82862117|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510373|NCT05736419|Bortezomib|bortezomib|mesh-list
82862119|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862120|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
82862121|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
82862122|NCT01113164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82862123|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82862124|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
82862125|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862126|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862127|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
82862128|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862129|NCT01113164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82862130|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82862131|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862132|NCT01210430|Vitamins|vitamins|mesh-list
82862133|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
82862134|NCT01210430|Losartan|losartan|mesh-list
82862135|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
82862136|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862137|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82862138|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82862139|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82862140|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82862141|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862142|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
82862143|NCT01210430|Protective Agents|protective agents|mesh-ancestor
82862145|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
82862146|NCT01210742|Protective Agents|protective agents|mesh-ancestor
82862147|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862148|NCT01116128|Prednisone|prednisone|mesh-list
82862149|NCT01116128|Melphalan|melphalan|mesh-list
82862150|NCT01116128|Dasatinib|dasatinib|mesh-list
82862151|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862152|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
82862153|NCT01116128|Hormones|hormones|mesh-ancestor
82862154|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862155|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862156|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82862157|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862158|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82862159|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
82862160|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862161|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82862162|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862163|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
82862164|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82862165|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862166|NCT03390166|Vaccines|vaccines|mesh-list
82862167|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
82862168|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862169|NCT01116206|Prucalopride|prucalopride|mesh-list
82862170|NCT01116206|Laxatives|laxatives|mesh-ancestor
82862171|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862172|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82862173|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82862174|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
82862175|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862176|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862177|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862178|NCT01210976|Simendan|simendan|mesh-list
82862179|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82862180|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862181|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82862182|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82862183|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862184|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862185|NCT01210976|Protective Agents|protective agents|mesh-ancestor
82862186|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862187|NCT03828539|Topiramate|topiramate|mesh-list
82862188|NCT03828539|Erenumab|erenumab|mesh-list
82862189|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82862190|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
82862191|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82862192|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862193|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82862194|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862196|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
82862197|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862198|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
82862200|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82862201|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
82862202|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82862203|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862204|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
82862205|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862206|NCT03336502|Posaconazole|posaconazole|mesh-list
82862207|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
82862208|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862209|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82862210|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82862211|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82862212|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82862213|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82862214|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862215|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862216|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82862217|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
82862218|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862219|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862220|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
82862221|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82862222|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82862223|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
82862224|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862225|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82862226|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82862227|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862228|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862229|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
82862230|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862231|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82862232|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82862233|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862234|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862235|NCT01055405|Urological Agents|urological agents|mesh-ancestor
82862236|NCT01055483|Panobinostat|panobinostat|mesh-list
82862237|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862238|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82862239|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862240|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862241|NCT03370510|Oxytocin|oxytocin|mesh-list
82862242|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
82862243|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82862244|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862245|NCT03985865|Quinine|quinine|mesh-list
82862246|NCT03985865|Denatonium|denatonium|mesh-list
82862247|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
82862248|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82862249|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82862250|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862251|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82862252|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862253|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82862254|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862255|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82862256|NCT03985865|Analgesics|analgesics|mesh-ancestor
82862257|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
82862258|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
82862259|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862260|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
82862261|NCT01116596|Acetaminophen|acetaminophen|mesh-list
82862262|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82862263|NCT01116596|Analgesics|analgesics|mesh-ancestor
82862264|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
82862265|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862266|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862267|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
82862268|NCT00351611|Pregabalin|pregabalin|mesh-list
82862270|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
82862271|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862272|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862273|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
82862274|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82862275|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862276|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862277|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82862278|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82862279|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82862280|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862281|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862282|NCT01211210|Fluorouracil|fluorouracil|mesh-list
82862283|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
82862284|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
82862285|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862286|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82862287|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862288|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862289|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
82862290|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862291|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
82862292|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82862293|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862294|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862295|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862296|NCT01208012|Liraglutide|liraglutide|mesh-list
82862297|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82862298|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862299|NCT01208012|Incretins|incretins|mesh-ancestor
82862300|NCT01208012|Hormones|hormones|mesh-ancestor
82862301|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862302|NCT03939806|Oxytocin|oxytocin|mesh-list
82862303|NCT03939806|Carbetocin|carbetocin|mesh-list
82862304|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
82862305|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82862306|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862307|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
82862308|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82862309|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862310|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82862311|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
82862312|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862313|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862314|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862315|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862316|NCT00337727|Dexamethasone|dexamethasone|mesh-list
82862317|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
82862318|NCT00337727|Ondansetron|ondansetron|mesh-list
82862319|NCT00337727|Aprepitant|aprepitant|mesh-list
82862320|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
82862321|NCT00337727|BB 1101|bb 1101|mesh-list
82862322|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862323|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
82862324|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
82862325|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862326|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862327|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862328|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
82862329|NCT00337727|Hormones|hormones|mesh-ancestor
82862330|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862331|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82862332|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862333|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
82862334|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862335|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862336|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
82862337|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
82862338|NCT00337727|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82862339|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82862340|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
82862341|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862342|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82862343|NCT03987893|Lactulose|lactulose|mesh-list
82862347|NCT01208480|Carboplatin|carboplatin|mesh-list
82862348|NCT01208480|Docetaxel|docetaxel|mesh-list
82862349|NCT01208480|Bevacizumab|bevacizumab|mesh-list
82862350|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862351|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
82862352|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
82862353|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
82862354|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862355|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82862356|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82862357|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82862358|NCT01208480|Growth Substances|growth substances|mesh-ancestor
82862359|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862360|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
82862364|NCT04774120|Propofol|propofol|mesh-list
82862365|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82862366|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862367|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862368|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82862369|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
82862370|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
82862371|NCT01117220|Ziprasidone|ziprasidone|mesh-list
82862372|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82862373|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
82862374|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862375|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862376|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862377|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82862378|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82862379|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862380|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862381|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82862382|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
82862383|NCT05236972|Capecitabine|capecitabine|mesh-list
82862384|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
82862385|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82862386|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
82862387|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862388|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862389|NCT01114100|Sertraline|sertraline|mesh-list
82862390|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
82862391|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862392|NCT01114100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82862393|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82862394|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862395|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862396|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862397|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
82862398|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862399|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82862400|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862401|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82862402|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82862403|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862404|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862405|NCT01110590|Urological Agents|urological agents|mesh-ancestor
82862406|NCT01117298|Tadalafil|tadalafil|mesh-list
82862407|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862408|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82862409|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82862410|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862411|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862412|NCT01117298|Urological Agents|urological agents|mesh-ancestor
82862413|NCT01117376|Erythromycin|erythromycin|mesh-list
82862414|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
82862415|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82862416|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
82862417|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
82862418|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862420|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862421|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82862422|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862423|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862424|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82862425|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862426|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
82862427|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862428|NCT01213238|Bevacizumab|bevacizumab|mesh-list
82862429|NCT01213238|Capecitabine|capecitabine|mesh-list
82862430|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
82862431|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82862432|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862433|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82862434|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82862435|NCT01213238|Growth Substances|growth substances|mesh-ancestor
82862436|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862437|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
82862438|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82862439|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
82862440|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862441|NCT01110824|Carvedilol|carvedilol|mesh-list
82862442|NCT01110824|Enalapril|enalapril|mesh-list
82862443|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82862444|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82862445|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
82862446|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862447|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862448|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862449|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82862450|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
82862451|NCT01110824|Protective Agents|protective agents|mesh-ancestor
82862452|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82862453|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862454|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82862455|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862456|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82862457|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82862458|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82862459|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
82862460|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862461|NCT03936140|Iloprost|iloprost|mesh-list
82862462|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82862463|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862464|NCT01117610|Ropivacaine|ropivacaine|mesh-list
82862465|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
82862466|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
82862467|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862468|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862469|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
82862470|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862471|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
82862472|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82862473|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862474|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862475|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82862476|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862477|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82862478|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
82862479|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82862480|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862481|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82862482|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
82862483|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862484|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862485|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862486|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862487|NCT03368170|Mesdopetam|mesdopetam|mesh-list
82862488|NCT03368170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82862489|NCT03368170|Dopamine Agents|dopamine agents|mesh-ancestor
82862490|NCT03368170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862500|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
82862501|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862502|NCT01121822|Vaccines|vaccines|mesh-list
82862503|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
82862504|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862505|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
82862506|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82862507|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82862508|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862509|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
82862510|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
82862511|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82862512|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862513|NCT01216046|Ivacaftor|ivacaftor|mesh-list
82862514|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82862515|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862516|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862517|NCT01216124|Docetaxel|docetaxel|mesh-list
82862518|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
82862519|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862520|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
82862521|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
82862522|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
82862523|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862524|NCT01219010|Siltuximab|siltuximab|mesh-list
82862525|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862526|NCT01118234|Rituximab|rituximab|mesh-list
82862527|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82862528|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862529|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
82862530|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862531|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862532|NCT00324155|Ipilimumab|ipilimumab|mesh-list
82862533|NCT00324155|Dacarbazine|dacarbazine|mesh-list
82862534|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82862535|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862536|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82862537|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862538|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82862539|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
82862540|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
82862541|NCT03937544|Fludarabine|fludarabine|mesh-list
82862542|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862543|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
82862544|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862545|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862546|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82862547|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
82862548|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862549|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862550|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82862551|NCT01122056|Interferons|interferons|mesh-list
82862552|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
82862553|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862554|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
82862555|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862556|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82862557|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
82862558|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862559|NCT01219088|Morphine|morphine|mesh-list
82862560|NCT01219088|Bupivacaine|bupivacaine|mesh-list
82862561|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
82862562|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
82862563|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862564|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862565|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
82862566|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862567|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82862568|NCT01219088|Narcotics|narcotics|mesh-ancestor
82862569|NCT01219088|Analgesics|analgesics|mesh-ancestor
82862570|NCT01122134|Artesunate|artesunate|mesh-list
82862571|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
82862572|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82862573|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82862574|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862575|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862576|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
82862577|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
82862578|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82862579|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
82862580|NCT01118702|Methylphenidate|methylphenidate|mesh-list
82862581|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82862582|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862583|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82862584|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82862585|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862586|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862587|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
82862588|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862589|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
82862590|NCT01118936|Antacids|antacids|mesh-ancestor
82862591|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862592|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862593|NCT01119014|Aripiprazole|aripiprazole|mesh-list
82862594|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82862595|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
82862596|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862597|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82862598|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82862599|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862600|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862601|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
82862602|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
82862603|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862604|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862605|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82862606|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82862607|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
82862608|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82862609|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82862610|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82862611|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82862612|NCT01219244|Resveratrol|resveratrol|mesh-list
82862613|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
82862614|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862615|NCT01219244|Protective Agents|protective agents|mesh-ancestor
82862616|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862617|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862618|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82862619|NCT01119482|Vaccines|vaccines|mesh-list
82862620|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
82862621|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862622|NCT01119638|Risperidone|risperidone|mesh-list
82862623|NCT01119638|Escitalopram|escitalopram|mesh-list
82862624|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82862625|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
82862626|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862627|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862628|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862629|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82862630|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82862631|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862632|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82862633|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82862634|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
82862635|NCT01119638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82862636|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82862637|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862638|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82862639|NCT03338998|Siponimod|siponimod|mesh-list
82862640|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82862641|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862642|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862643|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
82862644|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862645|NCT03935984|Calcitonin|calcitonin|mesh-list
82862646|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
82862647|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82862648|NCT03935984|Katacalcin|katacalcin|mesh-list
82862649|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82862650|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862651|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82862652|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862653|NCT01219400|Vildagliptin|vildagliptin|mesh-list
82862654|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82862655|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862656|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82862657|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
82862658|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862659|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862661|NCT01124630|Fluorouracil|fluorouracil|mesh-list
82862662|NCT01124630|Irinotecan|irinotecan|mesh-list
82862663|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
82862664|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862665|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82862666|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862667|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862668|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
82862669|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862670|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82862671|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82862672|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862673|NCT01124630|Antidotes|antidotes|mesh-ancestor
82862674|NCT01124630|Protective Agents|protective agents|mesh-ancestor
82862675|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
82862676|NCT01124630|Vitamins|vitamins|mesh-ancestor
82862677|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
82862678|NCT05683054|Adalimumab|adalimumab|mesh-list
82862679|NCT05683054|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82862680|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862681|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862682|NCT01120106|Simendan|simendan|mesh-list
82862683|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82862684|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862685|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82862686|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82862687|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862688|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862689|NCT01120106|Protective Agents|protective agents|mesh-ancestor
82862690|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862692|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
82862693|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862694|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
82862695|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
82862696|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
82862697|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862698|NCT01216826|Everolimus|everolimus|mesh-list
82862699|NCT01216826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82862700|NCT01216826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82862701|NCT01216826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862702|NCT01216826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862703|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862704|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
82862705|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862706|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862707|NCT01120340|Mesalamine|mesalamine|mesh-list
82862708|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82862709|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82862710|NCT01120340|Analgesics|analgesics|mesh-ancestor
82862711|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
82862712|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862713|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862714|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862715|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862716|NCT01214408|Pantoprazole|pantoprazole|mesh-list
82862717|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82862718|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862719|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82862720|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862721|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862722|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
82862723|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82862724|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82862725|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
82862726|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862727|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82862728|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82862729|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862730|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862731|NCT01216904|Nicotine|nicotine|mesh-list
82862732|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82862733|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
82862734|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862735|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862736|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82862737|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82862738|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
82862739|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862740|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862741|NCT01125020|Gemcitabine|gemcitabine|mesh-list
82862742|NCT01125020|Doxorubicin|doxorubicin|mesh-list
82862743|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
82862744|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862745|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82862746|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
82862747|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862748|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82862749|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82862750|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82862751|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862752|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
82862753|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862754|NCT01125254|Amlodipine|amlodipine|mesh-list
82862755|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82862756|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82862757|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862758|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862759|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82862760|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862761|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862762|NCT03710434|Lansoprazole|lansoprazole|mesh-list
82862763|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
82862764|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82862765|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862766|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82862767|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862768|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862769|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82862770|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
82862771|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82862772|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82862773|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862774|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862775|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
82862776|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862777|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82862778|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82862779|NCT05682586|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
82862780|NCT05682586|Antiviral Agents|antiviral agents|mesh-ancestor
82862781|NCT05682586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862782|NCT01217138|Epinephrine|epinephrine|mesh-list
82862783|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82862784|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82862785|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
82862786|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862787|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862788|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862789|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82862790|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82862791|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
82862792|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862793|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82862794|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
82862795|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
82862796|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
82862797|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82862798|NCT03710356|Danazol|danazol|mesh-list
82862799|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82862800|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
82862801|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862802|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862803|NCT01217294|Morphine|morphine|mesh-list
82862804|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82862805|NCT01217294|Narcotics|narcotics|mesh-ancestor
82862806|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82862807|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862808|NCT01217294|Analgesics|analgesics|mesh-ancestor
82862809|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
82862810|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862811|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
82862812|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82862813|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862814|NCT03361228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82862815|NCT03361228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862816|NCT01121042|Ondansetron|ondansetron|mesh-list
82862817|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
82862818|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
82862819|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862820|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862821|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862822|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
82862823|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
82862824|NCT01121042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82862825|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82862826|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
82862827|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82862828|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862829|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
82862830|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82862831|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862832|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82862833|NCT01217450|Cetuximab|cetuximab|mesh-list
82862834|NCT01217450|Antibodies|antibodies|mesh-list
82862835|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
82862836|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82862837|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
82862838|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862839|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862840|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82862841|NCT01219556|Olmesartan|olmesartan|mesh-list
82862842|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82862843|NCT01219556|Diuretics|diuretics|mesh-ancestor
82862844|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
82862845|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862846|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82862847|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82862848|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862849|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82862850|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82862851|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
82862852|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82862853|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862854|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82862855|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862856|NCT01121276|Insulin|insulin|mesh-list
82862857|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82862858|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
82862859|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
82862860|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82862861|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82862862|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862863|NCT05175508|Azacitidine|azacitidine|mesh-list
82862864|NCT05175508|Tretinoin|tretinoin|mesh-list
82862865|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82862866|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
82862867|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862868|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862869|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862870|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
82862871|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
82862872|NCT01125410|Clindamycin|clindamycin|mesh-list
82862873|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
82862874|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
82862875|NCT01125410|Dequalinium|dequalinium|mesh-list
82862876|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862877|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862878|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82862879|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83510374|NCT05736419|Tacrolimus|tacrolimus|mesh-list
82862880|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862881|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82862882|NCT01328834|Tacrolimus|tacrolimus|mesh-list
82862883|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82862884|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
82862885|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862886|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82862887|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862888|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862889|NCT01121354|Cefazolin|cefazolin|mesh-list
82862890|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862891|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862892|NCT01122602|Aspirin|aspirin|mesh-list
82862893|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82862894|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82862895|NCT01122602|Analgesics|analgesics|mesh-ancestor
82862896|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
82862897|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862898|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862899|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862900|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862901|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82862902|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82862903|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862904|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82862905|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82862906|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862907|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
82862908|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82862909|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82862910|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862911|NCT03359590|Incretins|incretins|mesh-ancestor
82862912|NCT03359590|Hormones|hormones|mesh-ancestor
82862913|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862915|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
82862916|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862917|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862918|NCT01219712|Simendan|simendan|mesh-list
82862919|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82862920|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
82862921|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82862922|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82862923|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862924|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862925|NCT01219712|Protective Agents|protective agents|mesh-ancestor
82862926|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862927|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82862928|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82862929|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862930|NCT03936062|Incretins|incretins|mesh-ancestor
82862931|NCT03936062|Hormones|hormones|mesh-ancestor
82862932|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82862933|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82862934|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
82862935|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862936|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862937|NCT01215266|Sorafenib|sorafenib|mesh-list
82862938|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862939|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82862940|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862941|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862942|NCT05682196|Rituximab|rituximab|mesh-list
82862943|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82862944|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862945|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
82862946|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862947|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862948|NCT03936374|Omeprazole|omeprazole|mesh-list
82862949|NCT03936374|Linrodostat|linrodostat|mesh-list
82862950|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82862951|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82862952|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82862953|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133544|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862954|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862955|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82862956|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
82862957|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82862958|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
82862959|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82862960|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862961|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82862962|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82862963|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862964|NCT01215578|Sunitinib|sunitinib|mesh-list
82862965|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862966|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82862967|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82862968|NCT01215578|Growth Substances|growth substances|mesh-ancestor
82862969|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862970|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
82862971|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82862972|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862973|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862974|NCT01120418|Besifloxacin|besifloxacin|mesh-list
82862975|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82862976|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82862977|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82862978|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82862979|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862980|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862981|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82862982|NCT05577988|Aspirin|aspirin|mesh-list
82862983|NCT05577988|Clopidogrel|clopidogrel|mesh-list
82862984|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82862985|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82862987|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
82862988|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82862989|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82862990|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82862991|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82862992|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82862993|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82862994|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82862995|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82862996|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82862997|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82862999|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82863000|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82863001|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82863002|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
82863003|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863004|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
82863005|NCT01222052|Docetaxel|docetaxel|mesh-list
82863006|NCT01222052|Fluorouracil|fluorouracil|mesh-list
82863007|NCT01222052|Epirubicin|epirubicin|mesh-list
82863008|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82863009|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
82863010|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863011|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863012|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82863013|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
82863014|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863015|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863016|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82863017|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
82863018|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
82863019|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
82863020|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
82863021|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82863022|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82863023|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82863024|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82863025|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863026|NCT03710044|Cyclosporine|cyclosporine|mesh-list
82863027|NCT03710044|Cyclosporins|cyclosporins|mesh-list
82863028|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863029|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863030|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82863031|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
82863032|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863033|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
82863034|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863035|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
82863036|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863037|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82863038|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
82863039|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
82863041|NCT03706300|Guaifenesin|guaifenesin|mesh-list
82863042|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82863043|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82863044|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
82863045|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863046|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863047|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82863048|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
82863049|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
82863050|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82863051|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82863052|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
82863053|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
82863054|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863055|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863056|NCT03706300|Expectorants|expectorants|mesh-ancestor
82863057|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82863058|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82863059|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
82863060|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82863061|NCT05155540|Plasminogen|plasminogen|mesh-list
82863062|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82863063|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82863064|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82863065|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863066|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82863067|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863068|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
82863070|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82863071|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863072|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82863073|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82863074|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863075|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863076|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863077|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863078|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82863079|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82863080|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82863081|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
82863082|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863083|NCT03706222|Grazoprevir|grazoprevir|mesh-list
82863084|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82863085|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
82863086|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863087|NCT01222676|Gemcitabine|gemcitabine|mesh-list
82863088|NCT01222676|Sorafenib|sorafenib|mesh-list
82863089|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82863090|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863091|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82863092|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
82863093|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863094|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82863095|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863096|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82863097|NCT05681728|Paclitaxel|paclitaxel|mesh-list
82863098|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
82863099|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
82863100|NCT05681728|Epirubicin|epirubicin|mesh-list
82863101|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82863102|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863103|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
82863104|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
82863106|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863107|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82863108|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
82863109|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863110|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863111|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82863112|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
82863113|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82863114|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82863115|NCT05681728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82863116|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82863117|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82863118|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82863119|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863120|NCT03931928|Tamoxifen|tamoxifen|mesh-list
82863121|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82863122|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
82863123|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863124|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863125|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82863126|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863127|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82863128|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82863129|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82863130|NCT01220102|Adapalene|adapalene|mesh-list
82863131|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82863132|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83083932|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863134|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863136|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
82863137|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863138|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863139|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863140|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863141|NCT05133310|Simvastatin|simvastatin|mesh-list
82863142|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82863143|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82863144|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
82863145|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863146|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82863147|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82863148|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863149|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
82863150|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82863151|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863152|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863153|NCT01222910|Valacyclovir|valacyclovir|mesh-list
82863154|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
82863155|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863156|NCT04533568|Ibuprofen|ibuprofen|mesh-list
82863157|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
82863158|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82863159|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863160|NCT04533568|Analgesics|analgesics|mesh-ancestor
82863161|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
82863162|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863163|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863164|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863165|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863166|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82863167|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863168|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863169|NCT03932864|Plerixafor|plerixafor|mesh-list
82863170|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82863171|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82863172|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
82863173|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863174|NCT05268562|Ketamine|ketamine|mesh-list
82863175|NCT05268562|Propofol|propofol|mesh-list
82863176|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82863177|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510375|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
82863178|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863179|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82863180|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
82863181|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
82863182|NCT05268562|Analgesics|analgesics|mesh-ancestor
82863183|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
82863184|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863185|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82863186|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82863187|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82863188|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863189|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863190|NCT05245552|Vaccines|vaccines|mesh-list
82863191|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
82863192|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863193|NCT01312324|Docetaxel|docetaxel|mesh-list
82863194|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863195|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
82863196|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
82863197|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
82863198|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863199|NCT05482516|Bevacizumab|bevacizumab|mesh-list
82863200|NCT05482516|Atezolizumab|atezolizumab|mesh-list
83453298|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82863201|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82863202|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863203|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82863204|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82863205|NCT05482516|Growth Substances|growth substances|mesh-ancestor
82863207|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
82863208|NCT05482516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82863209|NCT05482516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863210|NCT01127594|Temozolomide|temozolomide|mesh-list
82863211|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82863212|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
82863213|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863214|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863215|NCT01127672|Betamethasone|betamethasone|mesh-list
82863216|NCT01127672|Lidocaine|lidocaine|mesh-list
82863217|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863218|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
82863219|NCT01127672|Hormones|hormones|mesh-ancestor
82863220|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863221|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863222|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82863223|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
82863224|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
82863225|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
82863226|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863227|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
82863228|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863229|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82863230|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82863231|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82863232|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82863233|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863234|NCT01220258|Azithromycin|azithromycin|mesh-list
82863235|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82863236|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82863237|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82863238|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863239|NCT01223534|Isoniazid|isoniazid|mesh-list
82863240|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
82863241|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82863242|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863243|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82863244|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82863245|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
82863246|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863247|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82863248|NCT01223612|Ranibizumab|ranibizumab|mesh-list
82863249|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82863250|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82863251|NCT01223612|Growth Substances|growth substances|mesh-ancestor
82863252|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863253|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
82863254|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863255|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82863256|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82863257|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863258|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82863259|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
82863260|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863261|NCT02946580|Naloxegol|naloxegol|mesh-list
82863262|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82863263|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863264|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
82863265|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863266|NCT01223690|Clarithromycin|clarithromycin|mesh-list
82863267|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83453303|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
82863268|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863269|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82863270|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863271|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863272|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82863273|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82863274|NCT05381350|Vaccines|vaccines|mesh-list
82863275|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
82863276|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863277|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
82863278|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
82863279|NCT01223768|Vitamins|vitamins|mesh-ancestor
82863280|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
82863281|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863282|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
82863283|NCT01126112|Panitumumab|panitumumab|mesh-list
82863284|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82863285|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863286|NCT05024032|Tirzepatide|tirzepatide|mesh-list
82863287|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82863288|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863289|NCT05024032|Incretins|incretins|mesh-ancestor
82863290|NCT05024032|Hormones|hormones|mesh-ancestor
82863291|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863292|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
82863293|NCT01123538|Progesterone|progesterone|mesh-list
82863294|NCT01123538|Progestins|progestins|mesh-ancestor
82863295|NCT01123538|Hormones|hormones|mesh-ancestor
82863296|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863297|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863298|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
82863299|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
82863300|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82863301|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82863302|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82863303|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
82863304|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82863305|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82863306|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82863307|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
82863308|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82863309|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863310|NCT01220570|Sirolimus|sirolimus|mesh-list
82863311|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82863312|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82863313|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863314|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82863315|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863316|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
82863317|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82863318|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
82863319|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863320|NCT04682860|Scopolamine|scopolamine|mesh-list
82863321|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82863322|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82863323|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
82863324|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
82863325|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863326|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863327|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863328|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
82863329|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82863330|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
82863331|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863332|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863333|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82863334|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
82863335|NCT01127906|Oxycodone|oxycodone|mesh-list
82863336|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82863337|NCT01127906|Narcotics|narcotics|mesh-ancestor
82863338|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863339|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863340|NCT01127906|Analgesics|analgesics|mesh-ancestor
82863341|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
82863342|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863343|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82863344|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
82863345|NCT01127984|Coagulants|coagulants|mesh-ancestor
82863346|NCT01220648|Interferons|interferons|mesh-list
82863347|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
82863348|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863349|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
82863350|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863351|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
82863352|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863353|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82863355|NCT01218386|Estradiol|estradiol|mesh-list
82863356|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82863357|NCT01218386|Estrogens|estrogens|mesh-ancestor
82863358|NCT01218386|Hormones|hormones|mesh-ancestor
82863359|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863360|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863361|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82863362|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
82863363|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82863364|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82863365|NCT03933098|Vaccines|vaccines|mesh-list
82863366|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
82863367|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863368|NCT05111314|Edetic Acid|edetic acid|mesh-list
82863369|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82863370|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
82863371|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
82863372|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863373|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
82863374|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82863375|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82863376|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
82863377|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82863378|NCT01224392|Capecitabine|capecitabine|mesh-list
82863379|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82863380|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
82863381|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863382|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863383|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
82863384|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82863385|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863386|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863387|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863388|NCT01224470|Analgesics|analgesics|mesh-ancestor
82863389|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
82863390|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863391|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82863392|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82863393|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82863394|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
82863395|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863396|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863397|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82863398|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82863399|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
82863400|NCT03740516|Apremilast|apremilast|mesh-list
82863401|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82863402|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863403|NCT03740516|Analgesics|analgesics|mesh-ancestor
82863404|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
82863405|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863406|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863407|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863408|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863409|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82863410|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82863411|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863412|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863413|NCT03933956|Empagliflozin|empagliflozin|mesh-list
82863414|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83453311|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
82863415|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863416|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82863417|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863418|NCT01218620|Tolbutamide|tolbutamide|mesh-list
82863419|NCT01218620|Rifampin|rifampin|mesh-list
82863420|NCT01218620|Ketoconazole|ketoconazole|mesh-list
82863421|NCT01218620|Midazolam|midazolam|mesh-list
82863422|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
82863423|NCT01218620|Omeprazole|omeprazole|mesh-list
82863424|NCT01218620|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82863425|NCT01218620|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82863426|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82863427|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82863428|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863429|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863430|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82863431|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82863432|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82863433|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82863434|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
82863436|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
82863437|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
82863438|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863439|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863440|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82863441|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863442|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82863443|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863444|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82863445|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
82863446|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82863447|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863448|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
82863449|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82863450|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82863451|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82863452|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82863453|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82863454|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82863455|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82863456|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
82863457|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82863458|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82863459|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82863460|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
82863461|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863462|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82863463|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
82863464|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
82863465|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82863466|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82863467|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82863468|NCT00323297|Bosentan|bosentan|mesh-list
82863469|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
82863470|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863471|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
82863472|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82863473|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82863474|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863475|NCT00323297|Urological Agents|urological agents|mesh-ancestor
82863476|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82863477|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82863478|NCT01218698|Losartan|losartan|mesh-list
82863479|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82863480|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82863481|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82863482|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82863483|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863484|NCT01224860|Losartan|losartan|mesh-list
82863485|NCT01224860|Telmisartan|telmisartan|mesh-list
82863486|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82863487|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82863488|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82863489|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82863490|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863491|NCT00323063|Gemcitabine|gemcitabine|mesh-list
82863492|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
82863493|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82863494|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
82863495|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863496|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863497|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82863506|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863507|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82863508|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863509|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863510|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82863512|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82863513|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863514|NCT01225094|Analgesics|analgesics|mesh-ancestor
82863515|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
82863516|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863517|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863518|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863519|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863520|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863521|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863522|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863523|NCT03930212|Progesterone|progesterone|mesh-list
82863524|NCT03930212|Progestins|progestins|mesh-ancestor
82863525|NCT03930212|Hormones|hormones|mesh-ancestor
82863526|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863527|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863528|NCT00322049|Vaccines|vaccines|mesh-list
82863529|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
82863530|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863531|NCT01124240|Temozolomide|temozolomide|mesh-list
82863532|NCT01124240|Procarbazine|procarbazine|mesh-list
82863533|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82863534|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
82863535|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863536|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863537|NCT01124318|Lactulose|lactulose|mesh-list
82863538|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863539|NCT01221116|Simendan|simendan|mesh-list
82863540|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82863541|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
82863542|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82863543|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82863544|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863545|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863546|NCT01221116|Protective Agents|protective agents|mesh-ancestor
82863547|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863548|NCT03929744|Midazolam|midazolam|mesh-list
82863549|NCT03929744|Atorvastatin|atorvastatin|mesh-list
82863550|NCT03929744|Simvastatin|simvastatin|mesh-list
82863551|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82863552|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82863553|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863554|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863555|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82863556|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82863557|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82863558|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82863559|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
82863560|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
82863561|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
82863562|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
82863563|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863564|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863565|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82863566|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82863567|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
82863568|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82863569|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82863570|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863571|NCT01225406|Tenofovir|tenofovir|mesh-list
82863572|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
82863573|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863574|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82863575|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82863576|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863577|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863578|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82863579|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82863580|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
82863581|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863582|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82863583|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863584|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863585|NCT01225484|Ropivacaine|ropivacaine|mesh-list
82863586|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
82863587|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
82863588|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863589|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863590|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
82863591|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863592|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82863593|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82863594|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82863595|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82863596|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863597|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
82863598|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863599|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863600|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82863601|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863602|NCT01128998|Sorafenib|sorafenib|mesh-list
82863603|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863604|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82863605|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863606|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863607|NCT00321893|Budesonide|budesonide|mesh-list
82863608|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863609|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82863610|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
82863611|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863612|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863613|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82863614|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
82863615|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
82863616|NCT00321893|Hormones|hormones|mesh-ancestor
82863617|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863618|NCT01225874|Cytarabine|cytarabine|mesh-list
82863619|NCT01225874|Dexamethasone|dexamethasone|mesh-list
82863620|NCT01225874|Prednisone|prednisone|mesh-list
82863621|NCT01225874|Methotrexate|methotrexate|mesh-list
82863622|NCT01225874|Vincristine|vincristine|mesh-list
82863623|NCT01225874|Daunorubicin|daunorubicin|mesh-list
82863624|NCT01225874|Asparaginase|asparaginase|mesh-list
82863625|NCT01225874|Pegaspargase|pegaspargase|mesh-list
82863626|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863627|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
82863628|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
82863629|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863630|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863631|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863632|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
82863633|NCT01225874|Hormones|hormones|mesh-ancestor
82863634|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863635|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82863636|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863637|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82863638|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
82863639|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82863640|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82863641|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
82863642|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863643|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
82863644|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863645|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82863646|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82863647|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
82863648|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863649|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82863650|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
82863651|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863652|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82863653|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
82863654|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
82863655|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
82863656|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82863657|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82863658|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82863660|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82863661|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863662|NCT00371345|Dasatinib|dasatinib|mesh-list
82863663|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863664|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82863665|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863666|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863667|NCT01226186|Morphine|morphine|mesh-list
82863668|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82863669|NCT01226186|Narcotics|narcotics|mesh-ancestor
82863670|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863671|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863672|NCT01226186|Analgesics|analgesics|mesh-ancestor
82863673|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
82863674|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863675|NCT01228214|Aspirin|aspirin|mesh-list
82863676|NCT01228214|Amiloride|amiloride|mesh-list
82863677|NCT01228214|Clopidogrel|clopidogrel|mesh-list
82863678|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82863679|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863680|NCT01228214|Analgesics|analgesics|mesh-ancestor
82863681|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
82863682|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863683|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863684|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863685|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863686|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82863687|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82863688|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863689|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82863690|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82863691|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863692|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
82863693|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82863694|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82863695|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82863696|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
82863697|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863698|NCT01228214|Diuretics|diuretics|mesh-ancestor
82863699|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
82863700|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82863701|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82863702|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82863703|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82863704|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82863705|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
82863706|NCT00321737|Lansoprazole|lansoprazole|mesh-list
82863707|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82863708|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863709|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82863710|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863711|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863712|NCT03928262|Benralizumab|benralizumab|mesh-list
82863713|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82863714|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
82863715|NCT03740438|Chrysarobin|chrysarobin|mesh-list
82863721|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863722|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863723|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863725|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82863726|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863727|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82863728|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
82863729|NCT02309645|Coagulants|coagulants|mesh-ancestor
82863730|NCT01047995|Ritonavir|ritonavir|mesh-list
82863731|NCT01047995|Darunavir|darunavir|mesh-list
82863732|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
82863733|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82863734|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82863735|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
82863736|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863737|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863738|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82863739|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82863740|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
82863741|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863742|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82863743|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82863744|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82863745|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82863746|NCT01129310|Capecitabine|capecitabine|mesh-list
82863747|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
82863748|NCT01129310|Irinotecan|irinotecan|mesh-list
82863749|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82863750|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
82863751|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863752|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863753|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82863754|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82863755|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863756|NCT01129388|Omeprazole|omeprazole|mesh-list
82863757|NCT01129388|Clopidogrel|clopidogrel|mesh-list
82863758|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82863759|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82863760|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82863761|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82863762|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
82863763|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863764|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863765|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863766|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82863767|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863768|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82863769|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863770|NCT01228292|Heparin|heparin|mesh-list
82863771|NCT01228292|Calcium heparin|calcium heparin|mesh-list
82863772|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
82863773|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82863774|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82863775|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863776|NCT03924596|Boswellic acid|boswellic acid|mesh-list
82863777|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82863778|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863779|NCT03924596|Analgesics|analgesics|mesh-ancestor
82863780|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
82863781|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863782|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863783|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863784|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82863785|NCT00320801|Buprenorphine|buprenorphine|mesh-list
82863787|NCT00320801|Narcotics|narcotics|mesh-ancestor
82863788|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863789|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863790|NCT00320801|Analgesics|analgesics|mesh-ancestor
82863791|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
82863792|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863793|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82863794|NCT01127204|Lamivudine|lamivudine|mesh-list
82863795|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82863796|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82863797|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863798|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863799|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
82863800|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863801|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82863802|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82863803|NCT01228370|Silodosin|silodosin|mesh-list
82863804|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82863805|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82863806|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82863807|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
82863808|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863809|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863810|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863811|NCT01228370|Urological Agents|urological agents|mesh-ancestor
82863812|NCT01221740|Milnacipran|milnacipran|mesh-list
82863813|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
82863814|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82863815|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82863816|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82863817|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863818|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863819|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863820|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82863821|NCT01221740|Analgesics|analgesics|mesh-ancestor
82863822|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
82863823|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863824|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
82863825|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82863826|NCT00320489|Olanzapine|olanzapine|mesh-list
82863827|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
82863828|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
82863829|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863830|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863831|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863832|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82863833|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82863834|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863835|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82863836|NCT00320489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82863837|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82863838|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82863839|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863840|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863841|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
82863842|NCT01127282|Vitamins|vitamins|mesh-list
82863843|NCT01127282|Vitamin A|vitamin a|mesh-list
82863844|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
82863845|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863846|NCT01127360|Bevacizumab|bevacizumab|mesh-list
82863847|NCT01127360|Ranibizumab|ranibizumab|mesh-list
82863848|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82863849|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863850|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82863851|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82863852|NCT01127360|Growth Substances|growth substances|mesh-ancestor
82863853|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863854|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
82863855|NCT01228604|Methylphenidate|methylphenidate|mesh-list
82863856|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82863857|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863858|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82863860|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82863861|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863862|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
82863863|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863864|NCT01228682|Tolvaptan|tolvaptan|mesh-list
82863865|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82863866|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863867|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
82863868|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863869|NCT01221896|Choline|choline|mesh-list
82863870|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
82863871|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82863872|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
82863873|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863874|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863875|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82863876|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
82863877|NCT03923114|Exenatide|exenatide|mesh-list
82863878|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82863879|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863880|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82863881|NCT03923114|Incretins|incretins|mesh-ancestor
82863882|NCT03923114|Hormones|hormones|mesh-ancestor
82863883|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863884|NCT00320411|Lapatinib|lapatinib|mesh-list
82863885|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863886|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82863887|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863888|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863889|NCT01132040|Primidone|primidone|mesh-list
82863890|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
82863891|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
82863892|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
82863893|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863894|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863895|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863896|NCT01226966|Liraglutide|liraglutide|mesh-list
82863897|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82863898|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863899|NCT01226966|Incretins|incretins|mesh-ancestor
82863900|NCT01226966|Hormones|hormones|mesh-ancestor
82863901|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863902|NCT03923036|Cetuximab|cetuximab|mesh-list
82863903|NCT03923036|Panitumumab|panitumumab|mesh-list
82863904|NCT03923036|Aflibercept|aflibercept|mesh-list
82863905|NCT03923036|Capecitabine|capecitabine|mesh-list
82863906|NCT03923036|Irinotecan|irinotecan|mesh-list
82863907|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
82863908|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82863909|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82863910|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82863911|NCT03923036|Growth Substances|growth substances|mesh-ancestor
82863912|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863913|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
82863914|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82863915|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
82863916|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863917|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82863918|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82863919|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863920|NCT01129856|Dexamethasone|dexamethasone|mesh-list
82863921|NCT01129856|Citric Acid|citric acid|mesh-list
82863922|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
82863923|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82863924|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82863925|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82863926|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82863927|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
82863928|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
82863929|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863930|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863931|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863932|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
82863933|NCT01129856|Hormones|hormones|mesh-ancestor
82863934|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82863935|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82863936|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82863937|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
82863938|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82863939|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
82863940|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
82863941|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863943|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
82863945|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82863946|NCT01129934|Narcotics|narcotics|mesh-ancestor
82863947|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863948|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863949|NCT01129934|Analgesics|analgesics|mesh-ancestor
82863950|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
82863951|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863952|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
82863953|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
82863954|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82863955|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
82863956|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
82863957|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863958|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863959|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82863960|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82863961|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82863962|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
82863963|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
82863964|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
82863965|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
82863966|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82863967|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
82863968|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82863969|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
82863970|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82863971|NCT01131572|Expectorants|expectorants|mesh-ancestor
82863972|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
82863973|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82863974|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
82863975|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863976|NCT01131572|Protective Agents|protective agents|mesh-ancestor
82863977|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863978|NCT01131572|Antidotes|antidotes|mesh-ancestor
82863979|NCT01132196|Valproic Acid|valproic acid|mesh-list
82863980|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
82863981|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82863982|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82863983|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
82863984|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863985|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863986|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
82863987|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82863988|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82863989|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82863990|NCT01228994|Baclofen|baclofen|mesh-list
82863991|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82863992|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82863993|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82863994|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82863995|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82863996|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
82863997|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
82863998|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82863999|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864000|NCT03927170|Metformin|metformin|mesh-list
82864001|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82864002|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864003|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864004|NCT03927170|Incretins|incretins|mesh-ancestor
82864005|NCT03927170|Hormones|hormones|mesh-ancestor
82864006|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864007|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82864008|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
82864009|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864010|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864012|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82864013|NCT01227200|Narcotics|narcotics|mesh-ancestor
82864014|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864015|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864016|NCT01227200|Analgesics|analgesics|mesh-ancestor
82864017|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
82864018|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864019|NCT01227356|Interferons|interferons|mesh-list
82864020|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
82864021|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864022|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
82864023|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864024|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864025|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864026|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864027|NCT01132352|Levetiracetam|levetiracetam|mesh-list
82864028|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
82864029|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
82864030|NCT01131728|Naproxen|naproxen|mesh-list
82864031|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
82864032|NCT01131728|Ephedrine|ephedrine|mesh-list
82864033|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82864034|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82864035|NCT01131728|Analgesics|analgesics|mesh-ancestor
82864036|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
82864037|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864038|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864039|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864040|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864041|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
82864042|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82864043|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864044|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864045|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82864046|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
82864047|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82864048|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
82864049|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
82864050|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82864051|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82864052|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
82864053|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
82864054|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864055|NCT01132586|Cytarabine|cytarabine|mesh-list
82864056|NCT01132586|Lenalidomide|lenalidomide|mesh-list
82864057|NCT01132586|Idarubicin|idarubicin|mesh-list
82864058|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82864059|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
82864060|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864061|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864062|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
82864063|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864064|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82864065|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
82864066|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864067|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82864068|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82864069|NCT01132586|Growth Substances|growth substances|mesh-ancestor
82864070|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
82864071|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82864072|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82864073|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82864074|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864075|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
82864076|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
82864077|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864078|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864079|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
82864080|NCT01227590|Ritonavir|ritonavir|mesh-list
82864081|NCT01227590|Lopinavir|lopinavir|mesh-list
82864082|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82864083|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82864084|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
82864085|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864086|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864087|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82864088|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82864089|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
82864090|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864091|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82864092|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82864094|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864095|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864096|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82864097|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864098|NCT03926780|Warfarin|warfarin|mesh-list
82864099|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
82864100|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
82864101|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82864102|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
82864103|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82864104|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
82864105|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864106|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864107|NCT03919448|Bevacizumab|bevacizumab|mesh-list
82864108|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864109|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864110|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82864111|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82864112|NCT03919448|Growth Substances|growth substances|mesh-ancestor
82864113|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864114|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
82864115|NCT03926936|Fulvestrant|fulvestrant|mesh-list
82864116|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82864117|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864118|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82864119|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82864120|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
82864121|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864122|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864123|NCT03920618|Tenofovir|tenofovir|mesh-list
82864124|NCT03920618|Entecavir|entecavir|mesh-list
82864125|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
82864126|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864127|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82864128|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82864129|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864130|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864131|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82864132|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82864133|NCT01131806|Fluticasone|fluticasone|mesh-list
82864134|NCT01131806|Xhance|xhance|mesh-list
82864135|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82864136|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82864137|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864138|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82864139|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
82864140|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864141|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864142|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82864143|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
82864144|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
82864145|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82864146|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82864147|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82864148|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82864149|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
82864150|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864151|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864152|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
82864153|NCT01131806|Hormones|hormones|mesh-ancestor
82864154|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864155|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
82864156|NCT01229930|Paclitaxel|paclitaxel|mesh-list
82864157|NCT01229930|Carboplatin|carboplatin|mesh-list
82864158|NCT01229930|Cediranib|cediranib|mesh-list
82864159|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82864160|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864161|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
82864162|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
82864163|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
82864164|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864165|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864166|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864168|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82864169|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82864170|NCT03805100|Growth Substances|growth substances|mesh-ancestor
82864171|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864172|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
82864173|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864174|NCT03920150|Vitamin D|vitamin d|mesh-list
82864175|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
82864176|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
82864177|NCT03920150|Vitamins|vitamins|mesh-list
82864178|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
82864179|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864180|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82864181|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82864182|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
82864183|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82864184|NCT01130324|Telavancin|telavancin|mesh-list
82864185|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82864186|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864187|NCT01229774|Diclofenac|diclofenac|mesh-list
82864188|NCT01229774|Etoricoxib|etoricoxib|mesh-list
82864189|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82864190|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82864191|NCT01229774|Analgesics|analgesics|mesh-ancestor
82864192|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
82864193|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864194|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864195|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864196|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864197|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82864198|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864199|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864200|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82864201|NCT03918590|Nepafenac|nepafenac|mesh-list
82864202|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82864203|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82864204|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82864205|NCT03918590|Analgesics|analgesics|mesh-ancestor
82864206|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
82864207|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864208|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864209|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864210|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864211|NCT03918590|Laxatives|laxatives|mesh-ancestor
82864212|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864213|NCT00320255|Apixaban|apixaban|mesh-list
82864214|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82864215|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
82864216|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82864217|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
82864218|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864219|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864220|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
82864221|NCT01231802|Leucovorin|leucovorin|mesh-list
82864222|NCT01231802|Fluorouracil|fluorouracil|mesh-list
82864223|NCT01231802|Capecitabine|capecitabine|mesh-list
82864224|NCT01231802|Eniluracil|eniluracil|mesh-list
82864225|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
82864226|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864227|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82864228|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864229|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82864230|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
82864231|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864232|NCT01231802|Antidotes|antidotes|mesh-ancestor
82864233|NCT01231802|Protective Agents|protective agents|mesh-ancestor
82864234|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
82864235|NCT01231802|Vitamins|vitamins|mesh-ancestor
82864236|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
82864238|NCT01329614|Nicotine|nicotine|mesh-list
82864239|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82864240|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
82864241|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864242|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864243|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82864244|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82864245|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864246|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864247|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864248|NCT01231880|Piperaquine|piperaquine|mesh-list
82864249|NCT01231880|Artenimol|artenimol|mesh-list
82864250|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
82864251|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82864252|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82864253|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864254|NCT01232036|Metformin|metformin|mesh-list
82864255|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864256|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864257|NCT01130636|Oseltamivir|oseltamivir|mesh-list
82864258|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
82864259|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864260|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864261|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864262|NCT03926156|Warfarin|warfarin|mesh-list
82864263|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
82864264|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
82864265|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82864266|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
82864267|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82864268|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
82864269|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864270|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864271|NCT01134536|Tapentadol|tapentadol|mesh-list
82864272|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82864273|NCT01134536|Narcotics|narcotics|mesh-ancestor
82864274|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864275|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864276|NCT01134536|Analgesics|analgesics|mesh-ancestor
82864277|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
82864278|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864279|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82864280|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82864281|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82864282|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864283|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
82864284|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864285|NCT01134692|Norfloxacin|norfloxacin|mesh-list
82864286|NCT01134692|Propranolol|propranolol|mesh-list
82864287|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82864288|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82864289|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
82864290|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864291|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864292|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864293|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82864294|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82864295|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
82864296|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82864297|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864298|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82864299|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82864300|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864301|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864302|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82864303|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82864304|NCT01134848|Morphine|morphine|mesh-list
82864305|NCT01134848|Secretin|secretin|mesh-list
82864306|NCT01134848|Neostigmine|neostigmine|mesh-list
82864307|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82864308|NCT01134848|Narcotics|narcotics|mesh-ancestor
82864309|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864310|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864311|NCT01134848|Analgesics|analgesics|mesh-ancestor
82864312|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
82864313|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864314|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82864315|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864316|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864317|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864318|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864319|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82864320|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
82864321|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864322|NCT01134848|Hormones|hormones|mesh-ancestor
82864323|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864324|NCT03926000|Pregabalin|pregabalin|mesh-list
82864325|NCT03926000|Analgesics|analgesics|mesh-ancestor
82864326|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
82864327|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864328|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864329|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
82864330|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82864331|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82864332|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864333|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82864334|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82864335|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82864336|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864337|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82864338|NCT01134926|Misoprostol|misoprostol|mesh-list
82864339|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82864340|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
82864341|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82864342|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864343|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82864344|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864345|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
82864346|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
82864347|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82864348|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82864349|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864350|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
82864351|NCT01228136|Coagulants|coagulants|mesh-ancestor
82864352|NCT03140176|Sunitinib|sunitinib|mesh-list
82864353|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864354|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82864355|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82864356|NCT03140176|Growth Substances|growth substances|mesh-ancestor
82864357|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864358|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
82864359|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864360|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864361|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864362|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
82864363|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
82864364|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864365|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
82864366|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82864367|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82864368|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82864369|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82864370|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864371|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864372|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864373|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864374|NCT01230476|Cetuximab|cetuximab|mesh-list
82864375|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864376|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864377|NCT01135472|Esomeprazole|esomeprazole|mesh-list
82864378|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82864379|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864380|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82864381|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864382|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864383|NCT01133210|Maraviroc|maraviroc|mesh-list
82864384|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82864385|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82864386|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864388|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82864389|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
82864390|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864391|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82864392|NCT01135550|Dexamethasone|dexamethasone|mesh-list
82864393|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
82864394|NCT01135550|BB 1101|bb 1101|mesh-list
82864395|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864396|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
82864397|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
82864398|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864399|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864400|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864401|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
82864402|NCT01135550|Hormones|hormones|mesh-ancestor
82864403|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864404|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82864405|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864406|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
82864407|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864408|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864409|NCT05401370|Methylene Blue|methylene blue|mesh-list
82864410|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864411|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864412|NCT01131026|Amoxicillin|amoxicillin|mesh-list
82864413|NCT01131026|Levofloxacin|levofloxacin|mesh-list
82864414|NCT01131026|Lansoprazole|lansoprazole|mesh-list
82864415|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
82864416|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82864417|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864418|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82864419|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82864420|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82864421|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864422|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864423|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864424|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82864425|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82864426|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82864427|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864428|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82864429|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82864430|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82864431|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864432|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
82864433|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
82864434|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82864435|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864436|NCT01133366|Warfarin|warfarin|mesh-list
82864437|NCT01133366|Mipomersen|mipomersen|mesh-list
82864438|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
82864439|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82864440|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82864441|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
82864442|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864443|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82864444|NCT01232270|Propofol|propofol|mesh-list
82864445|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82864446|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864447|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864448|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82864449|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
82864450|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
82864451|NCT05400902|Apatinib|apatinib|mesh-list
82864452|NCT05400902|Tislelizumab|tislelizumab|mesh-list
82864453|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864454|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864455|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864456|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864457|NCT05400902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864458|NCT01233206|Metformin|metformin|mesh-list
82864459|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864460|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864461|NCT00369941|Tenofovir|tenofovir|mesh-list
82864462|NCT00369941|Emtricitabine|emtricitabine|mesh-list
82864473|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82864474|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82864475|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82864476|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82864477|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82864478|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82864479|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82864480|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82864481|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82864483|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82864484|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82864485|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133545|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
82864486|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864487|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
82864488|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864489|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864490|NCT01133444|Urological Agents|urological agents|mesh-ancestor
82864491|NCT01137656|Acetylcholine|acetylcholine|mesh-list
82864492|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
82864493|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82864494|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864495|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864496|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864497|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864498|NCT00369785|Donepezil|donepezil|mesh-list
82864499|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82864500|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864501|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864502|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864503|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864504|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864505|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
82864506|NCT05476562|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82864507|NCT05476562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864508|NCT05476562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864509|NCT05476562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864510|NCT01136252|Adalimumab|adalimumab|mesh-list
82864511|NCT01136252|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82864512|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864513|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864514|NCT05597462|Minocycline|minocycline|mesh-list
82864515|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82864516|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864517|NCT00369707|Rituximab|rituximab|mesh-list
82864518|NCT00369707|Bortezomib|bortezomib|mesh-list
82864519|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864520|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864521|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
82864522|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864523|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864539|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82864540|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864541|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864542|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864543|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864544|NCT01233362|Vaccines|vaccines|mesh-list
82864545|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
82864546|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864547|NCT01136642|Nicotine|nicotine|mesh-list
82864548|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82864549|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
82864550|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864551|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864552|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82864553|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82864554|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864555|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864556|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864557|NCT00369629|Gemcitabine|gemcitabine|mesh-list
82864558|NCT00369629|Pemetrexed|pemetrexed|mesh-list
82864559|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82864560|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
82864561|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864562|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864563|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864564|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82864565|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82864566|NCT01133600|Vancomycin|vancomycin|mesh-list
82864567|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82864568|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864569|NCT01133912|Paclitaxel|paclitaxel|mesh-list
82864570|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82864571|NCT01133912|Gemcitabine|gemcitabine|mesh-list
82864572|NCT01133912|Lapatinib|lapatinib|mesh-list
82864573|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82864574|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864575|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
82864576|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
82864577|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
82864578|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864579|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82864580|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
82864581|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864582|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864583|NCT05320094|Sorbitol|sorbitol|mesh-list
82864584|NCT05320094|Charcoal|charcoal|mesh-list
82864585|NCT05320094|Antidotes|antidotes|mesh-ancestor
82864586|NCT05320094|Protective Agents|protective agents|mesh-ancestor
82864587|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864588|NCT05320094|Cathartics|cathartics|mesh-ancestor
82864589|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864590|NCT01233752|Morphine|morphine|mesh-list
82864591|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82864592|NCT01233752|Narcotics|narcotics|mesh-ancestor
82864593|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864594|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864595|NCT01233752|Analgesics|analgesics|mesh-ancestor
82864596|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
82864597|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864598|NCT01140620|Ketamine|ketamine|mesh-list
82864599|NCT01140620|Risperidone|risperidone|mesh-list
82864600|NCT01140620|Analgesics|analgesics|mesh-ancestor
82864601|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
82864602|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864603|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864604|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82864605|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82864606|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
82864607|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
82864608|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864609|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82864610|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82864612|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864613|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82864614|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
82864615|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82864616|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82864617|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82864618|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82864619|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
82864620|NCT03917186|Sevoflurane|sevoflurane|mesh-list
82864621|NCT03917186|Desflurane|desflurane|mesh-list
82864622|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82864623|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82864624|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
82864625|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
82864626|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864627|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864628|NCT04713098|Coal Tar|coal tar|mesh-list
82864629|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
82864630|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
82864631|NCT04630730|Gemcitabine|gemcitabine|mesh-list
82864632|NCT04630730|Atezolizumab|atezolizumab|mesh-list
82864633|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
82864634|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864635|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82864636|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
82864637|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864638|NCT04630730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82864639|NCT04630730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864640|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82864641|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
82864642|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864643|NCT01140932|Prednisolone|prednisolone|mesh-list
82864644|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82864645|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
82864646|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82864647|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
82864648|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82864649|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
82864650|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864651|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
82864652|NCT01140932|Hormones|hormones|mesh-ancestor
83133546|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864653|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864654|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864655|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82864656|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864657|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
82864658|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
82864659|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864660|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864661|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82864662|NCT01140932|Protective Agents|protective agents|mesh-ancestor
82864663|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
82864665|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864666|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82864667|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82864668|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864669|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864670|NCT04582448|Insulin|insulin|mesh-list
82864671|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864672|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864673|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
82864674|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864675|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864676|NCT05280314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82864677|NCT05280314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864678|NCT01139138|Irinotecan|irinotecan|mesh-list
82864679|NCT01139138|Everolimus|everolimus|mesh-list
82864680|NCT01139138|Panitumumab|panitumumab|mesh-list
82864681|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82864682|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82864683|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864684|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864685|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864686|NCT01139138|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82864687|NCT01139138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864688|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82864689|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
82864690|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864691|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864692|NCT01134224|Insulin|insulin|mesh-list
82864693|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82864694|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
82864695|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
82864696|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82864697|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
82864698|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82864699|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
82864700|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864701|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864702|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82864703|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82864704|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864705|NCT01231490|Naproxen|naproxen|mesh-list
82864706|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82864707|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82864708|NCT01231490|Analgesics|analgesics|mesh-ancestor
82864709|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
82864710|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864711|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864712|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82864713|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864714|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
82864715|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82864716|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864717|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864718|NCT01141244|Sirolimus|sirolimus|mesh-list
82864719|NCT01141244|Irinotecan|irinotecan|mesh-list
82864720|NCT01141244|Temozolomide|temozolomide|mesh-list
82864721|NCT01141244|Temsirolimus|temsirolimus|mesh-list
82864722|NCT01141244|MTOR Inhibitors|mtor inhibitors|mesh-list
82864723|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82864724|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82864725|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864726|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864727|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864728|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82864729|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
82864730|NCT01141244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864731|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82864732|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
82864733|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864734|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82864735|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864736|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82864737|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
82864738|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82864739|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82864740|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82864741|NCT04003636|Cisplatin|cisplatin|mesh-list
82864742|NCT04003636|Gemcitabine|gemcitabine|mesh-list
82864743|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
82864744|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864745|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82864746|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
82864747|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864748|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864749|NCT04003636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82864750|NCT01141556|Selenium|selenium|mesh-list
82864751|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
82864752|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864753|NCT01141556|Protective Agents|protective agents|mesh-ancestor
82864754|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864755|NCT01141556|Trace Elements|trace elements|mesh-ancestor
82864756|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
82864757|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82864758|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
82864759|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82864760|NCT03638440|Naloxegol|naloxegol|mesh-list
82864761|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82864762|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864763|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
82864764|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864766|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864767|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864768|NCT02439658|Sotalol|sotalol|mesh-list
82864769|NCT02439658|Dofetilide|dofetilide|mesh-list
82864770|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82864771|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82864772|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
82864773|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864774|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864775|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864776|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82864777|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
82864778|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
82864779|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864780|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82864781|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82864782|NCT05191394|Antibodies|antibodies|mesh-list
82864783|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
82864784|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864785|NCT04895098|Ezetimibe|ezetimibe|mesh-list
82864786|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82864787|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82864788|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82864789|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
82864790|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864791|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82864792|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864793|NCT00318461|Metformin|metformin|mesh-list
82864794|NCT00318461|Liraglutide|liraglutide|mesh-list
82864795|NCT00318461|Glimepiride|glimepiride|mesh-list
82864796|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864797|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864798|NCT00318461|Incretins|incretins|mesh-ancestor
82864799|NCT00318461|Hormones|hormones|mesh-ancestor
82864800|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82864801|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82864802|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82864803|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
82864804|NCT02243878|Ranibizumab|ranibizumab|mesh-list
82864805|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82864806|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82864807|NCT02243878|Growth Substances|growth substances|mesh-ancestor
82864808|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864809|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
82864810|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864811|NCT04734652|Tenofovir|tenofovir|mesh-list
82864812|NCT04734652|Lamivudine|lamivudine|mesh-list
82864813|NCT04734652|Dolutegravir|dolutegravir|mesh-list
82864814|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
82864815|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864816|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82864817|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82864818|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864819|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864820|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82864821|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82864822|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82864823|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82864824|NCT01142258|Trazodone|trazodone|mesh-list
82864825|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82864826|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82864827|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864828|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864829|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82864830|NCT01142258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82864831|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82864832|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82864833|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864834|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864835|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
82864837|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
82864838|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
82864839|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82864840|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864841|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82864842|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864843|NCT01139840|Vitamin D|vitamin d|mesh-list
82864844|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
82864845|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
82864846|NCT01139840|Vitamins|vitamins|mesh-list
82864847|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
82864848|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864849|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82864850|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82864851|NCT02945410|Vitamin D|vitamin d|mesh-list
82864852|NCT02945410|Calcium|calcium|mesh-list
82864853|NCT02945410|Vitamins|vitamins|mesh-ancestor
82864854|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
82864855|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864856|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82864857|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82864858|NCT03727724|Cetuximab|cetuximab|mesh-list
82864859|NCT03727724|Afatinib|afatinib|mesh-list
82864860|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864861|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864862|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864863|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864864|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864865|NCT05032508|Lidocaine|lidocaine|mesh-list
82864866|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
82864867|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
82864868|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864869|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864870|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
82864871|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864872|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82864873|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82864874|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82864875|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83453398|NCT01007071|Hormones|hormones|mesh-list
82864876|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864877|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
82864878|NCT01140074|Astringents|astringents|mesh-ancestor
82864879|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864880|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
82864882|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
82864883|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82864884|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
82864885|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
82864886|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
82864887|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864888|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864889|NCT01142414|Fluorouracil|fluorouracil|mesh-list
82864890|NCT01142414|Panitumumab|panitumumab|mesh-list
82864891|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864892|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
82864893|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864894|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82864895|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82864896|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
82864897|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864898|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864899|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
82864900|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864901|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864902|NCT02267603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82864903|NCT02267603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864904|NCT01236482|Oxytocin|oxytocin|mesh-list
82864905|NCT01236482|Ergonovine|ergonovine|mesh-list
82864906|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
82864907|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82864908|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864909|NCT01142492|Interferons|interferons|mesh-list
82864911|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
82864912|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864913|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
82864914|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82864915|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
82864916|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864917|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82864918|NCT03958474|Remifentanil|remifentanil|mesh-list
82864919|NCT03958474|Oxycodone|oxycodone|mesh-list
82864920|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82864921|NCT03958474|Narcotics|narcotics|mesh-ancestor
82864922|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82864923|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864924|NCT03958474|Analgesics|analgesics|mesh-ancestor
82864925|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
82864926|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864927|NCT04956692|Paclitaxel|paclitaxel|mesh-list
82864928|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82864929|NCT04956692|Carboplatin|carboplatin|mesh-list
82864930|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
82864931|NCT04956692|Pemetrexed|pemetrexed|mesh-list
82864932|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82864933|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864934|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
82864935|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
82864936|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
82864937|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864938|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864939|NCT04956692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82864940|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864941|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82864942|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82864943|NCT01234142|Varenicline|varenicline|mesh-list
82864944|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82864945|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82864946|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864947|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864948|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864949|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864950|NCT01140308|Ubiquinone|ubiquinone|mesh-list
82864951|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
82864952|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
82864953|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864954|NCT01140308|Vitamins|vitamins|mesh-ancestor
82864955|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
82864956|NCT01142648|Neostigmine|neostigmine|mesh-list
82864957|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82864958|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864959|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864960|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864961|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82864962|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864963|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82864964|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
82864965|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864966|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82864967|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82864968|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82864970|NCT02143726|Sorafenib|sorafenib|mesh-list
82864971|NCT02143726|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82864972|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864973|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864974|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82864975|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82864976|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
82864977|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864978|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864979|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
82864980|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864981|NCT02088112|Durvalumab|durvalumab|mesh-list
82864982|NCT02088112|Gefitinib|gefitinib|mesh-list
82864983|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82864984|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82864985|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82864986|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82864988|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
82864989|NCT01144910|Miotics|miotics|mesh-ancestor
82864990|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
82864991|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82864992|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82864993|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82864994|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
82864995|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
82864996|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82864997|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82864998|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
82864999|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865000|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865001|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82865002|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82865003|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865004|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82865005|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82865006|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865007|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865008|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
82865009|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865010|NCT05308342|Hormones|hormones|mesh-list
82865011|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82865012|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865013|NCT03332212|Empagliflozin|empagliflozin|mesh-list
82865014|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82865015|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865016|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82865017|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865018|NCT01144988|Bevacizumab|bevacizumab|mesh-list
82865019|NCT01144988|Irinotecan|irinotecan|mesh-list
82865020|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865021|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865022|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82865023|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82865024|NCT01144988|Growth Substances|growth substances|mesh-ancestor
82865025|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865026|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
82865027|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82865028|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82865029|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865030|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865031|NCT03331666|Evolocumab|evolocumab|mesh-list
82865032|NCT03331666|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82865033|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82865034|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82865035|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
82865036|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865037|NCT03331666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82865038|NCT03331666|Protease Inhibitors|protease inhibitors|mesh-ancestor
82865039|NCT03331666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865040|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82865041|NCT04828538|Vitamin D|vitamin d|mesh-list
82865042|NCT04828538|Vitamins|vitamins|mesh-list
82865043|NCT04828538|Folic Acid|folic acid|mesh-list
82865044|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
82865045|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
82865046|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865047|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82865048|NCT04828538|Hematinics|hematinics|mesh-ancestor
82865049|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82865050|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82865051|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
82865052|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865053|NCT03638206|Immunomodulating Agents|immunomodulating agents|mesh-list
82865054|NCT03638206|Immunologic Factors|immunologic factors|mesh-ancestor
82865055|NCT03638206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865056|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
82865057|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82865058|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865060|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82865061|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
82865062|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865063|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865064|NCT01234454|Olanzapine|olanzapine|mesh-list
82865065|NCT01234454|Risperidone|risperidone|mesh-list
82865066|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82865067|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
82865068|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865069|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865070|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865071|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82865072|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82865073|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865074|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865075|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82865076|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
82865077|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
82865078|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
82865079|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865080|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82865081|NCT01234454|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82865082|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82865083|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865084|NCT01145456|Gemcitabine|gemcitabine|mesh-list
82865085|NCT01145456|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82865086|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865087|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
82865088|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865089|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865090|NCT01145456|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82865091|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865092|NCT04939636|Vitamin D|vitamin d|mesh-list
82865093|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
82865094|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
82865095|NCT04939636|Vitamins|vitamins|mesh-list
82865096|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
82865097|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865098|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82865099|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82865100|NCT01238276|Cefazolin|cefazolin|mesh-list
82865101|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82865102|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865103|NCT01145534|Glyburide|glyburide|mesh-list
82865104|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82865105|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865106|NCT01145612|Losartan|losartan|mesh-list
82865107|NCT01145612|Atenolol|atenolol|mesh-list
82865108|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82865109|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82865110|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82865111|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82865112|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865113|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
82865114|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
82865115|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865116|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865117|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82865118|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82865119|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82865120|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
82865121|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865122|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
82865123|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82865124|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
82865125|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865127|NCT01143584|Cabergoline|cabergoline|mesh-list
82865128|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
82865129|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82865130|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
82865131|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
82865133|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865135|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865136|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865137|NCT01143584|Protective Agents|protective agents|mesh-ancestor
82865138|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82865139|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82865140|NCT01145846|Cytarabine|cytarabine|mesh-list
82865141|NCT01145846|Daunorubicin|daunorubicin|mesh-list
82865142|NCT01145846|Idarubicin|idarubicin|mesh-list
82865143|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865144|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
82865145|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865146|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865147|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
82865148|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865149|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865150|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
82865151|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865152|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82865153|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82865154|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82865155|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865156|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
82865157|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865158|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865159|NCT03134456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82865160|NCT03134456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865161|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82865162|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
82865163|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865164|NCT05173688|Propofol|propofol|mesh-list
82865165|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865166|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865167|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865168|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865169|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
82865170|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
82865171|NCT01146548|Fluoxetine|fluoxetine|mesh-list
82865172|NCT01146548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82865173|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82865174|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865175|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865176|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865177|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
82865178|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865179|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82865180|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
82865181|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865182|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82865183|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82865184|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865185|NCT03478930|Omalizumab|omalizumab|mesh-list
82865186|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82865187|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82865188|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
82865189|NCT01312714|Vitamin D|vitamin d|mesh-list
82865190|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
82865191|NCT01312714|Vitamins|vitamins|mesh-ancestor
82865192|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
82865193|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865194|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82865195|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82865196|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
82865197|NCT04188028|Paroxetine|paroxetine|mesh-list
82865198|NCT04188028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82865199|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82865200|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865201|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865202|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865203|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
82865209|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82865210|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865211|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
82865212|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
82865213|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82865214|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82865215|NCT01312792|Ampicillin|ampicillin|mesh-list
82865216|NCT01312792|Cephradine|cephradine|mesh-list
82865217|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82865218|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865219|NCT03523000|Fentanyl|fentanyl|mesh-list
82865220|NCT03523000|Bupivacaine|bupivacaine|mesh-list
82865221|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
82865222|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
82865223|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865224|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865225|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
82865226|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865227|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82865228|NCT03523000|Narcotics|narcotics|mesh-ancestor
82865229|NCT03523000|Analgesics|analgesics|mesh-ancestor
82865230|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82865231|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865232|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
82865233|NCT04705480|Pregabalin|pregabalin|mesh-list
82865234|NCT04705480|Gabapentin|gabapentin|mesh-list
82865235|NCT04705480|Analgesics|analgesics|mesh-ancestor
82865236|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
82865237|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865238|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865239|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
82865240|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82865241|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865242|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865243|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82865244|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82865245|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82865246|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865247|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865248|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82865249|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82865250|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865251|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
82865252|NCT01238978|Vildagliptin|vildagliptin|mesh-list
82865253|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82865254|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865255|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82865256|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
82865257|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865258|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865259|NCT00318149|Vaccines|vaccines|mesh-list
82865260|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
82865261|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865262|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82865263|NCT04648696|Vancomycin|vancomycin|mesh-list
82865264|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82865265|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865266|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
82865267|NCT01236716|Paclitaxel|paclitaxel|mesh-list
82865268|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82865269|NCT01236716|Carboplatin|carboplatin|mesh-list
82865270|NCT01236716|Gemcitabine|gemcitabine|mesh-list
82865271|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82865272|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865273|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
82865274|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
82865275|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
82865276|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865277|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865278|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
82865279|NCT04154800|Itraconazole|itraconazole|mesh-list
82865280|NCT04154800|Diltiazem|diltiazem|mesh-list
82865281|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
82865282|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865283|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82865284|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82865285|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865286|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865287|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82865288|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
82865289|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82865290|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865291|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82865292|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82865293|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82865294|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865295|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82865296|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
82865297|NCT01048229|Pramipexole|pramipexole|mesh-list
82865298|NCT01048229|Rasagiline|rasagiline|mesh-list
82865299|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
82865300|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865301|NCT01048229|Protective Agents|protective agents|mesh-ancestor
82865302|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865303|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82865304|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82865305|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
82865306|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
82865307|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865308|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82865309|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865310|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82865311|NCT01048307|Polihexanide|polihexanide|mesh-list
82865312|NCT01048307|Betaine|betaine|mesh-list
82865313|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82865314|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82865315|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
82865316|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82865317|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
82865318|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865319|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82865320|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
82865321|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865322|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82865323|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82865324|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865325|NCT04017832|Incretins|incretins|mesh-ancestor
82865326|NCT04017832|Hormones|hormones|mesh-ancestor
82865327|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82865328|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82865329|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
82865330|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865331|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865332|NCT02049905|Gemcitabine|gemcitabine|mesh-list
82865333|NCT02049905|Docetaxel|docetaxel|mesh-list
82865334|NCT02049905|Doxorubicin|doxorubicin|mesh-list
82865335|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82865336|NCT02049905|Ifosfamide|ifosfamide|mesh-list
82865337|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
82865338|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865340|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865341|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865342|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
82865343|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
82865344|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
82865345|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82865346|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82865347|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82865348|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865355|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
82865356|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
82865357|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82865358|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82865359|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865360|NCT01239368|Sirolimus|sirolimus|mesh-list
82865361|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
82865362|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865363|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82865364|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865365|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82865366|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865367|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
82865368|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865369|NCT01146002|Guanfacine|guanfacine|mesh-list
82865370|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82865371|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82865372|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82865373|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82865374|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
82865375|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865376|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865377|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865378|NCT01146626|Vitamin D|vitamin d|mesh-list
82865379|NCT01146626|Ribavirin|ribavirin|mesh-list
82865380|NCT01146626|Vitamins|vitamins|mesh-ancestor
82865381|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
82865382|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865383|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82865384|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
82865385|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865386|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
82865387|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865388|NCT02924324|Propofol|propofol|mesh-list
82865389|NCT02924324|Ropivacaine|ropivacaine|mesh-list
82865390|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865391|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865392|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865393|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865394|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
82865395|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
82865396|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
82865397|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
82865398|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865399|NCT03518606|Durvalumab|durvalumab|mesh-list
82865400|NCT03518606|Vinorelbine|vinorelbine|mesh-list
82865401|NCT03518606|Tremelimumab|tremelimumab|mesh-list
82865402|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865403|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865404|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82865405|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
82865406|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
82865407|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
82865408|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865409|NCT05137574|Ketamine|ketamine|mesh-list
82865410|NCT05137574|Propofol|propofol|mesh-list
82865411|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865412|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865413|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865414|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865415|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
82865416|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
82865417|NCT05137574|Analgesics|analgesics|mesh-ancestor
82865418|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
82865419|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865428|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865429|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865430|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82865431|NCT01236950|Listerine|listerine|mesh-list
82865432|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82865433|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865434|NCT04971746|Pirfenidone|pirfenidone|mesh-list
82865435|NCT04971746|Nintedanib|nintedanib|mesh-list
82865436|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865437|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82865438|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865439|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865440|NCT04971746|Analgesics|analgesics|mesh-ancestor
82865441|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
82865442|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865443|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865444|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82865445|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82865446|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82865447|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865448|NCT00369161|Everolimus|everolimus|mesh-list
82865449|NCT00369161|Tacrolimus|tacrolimus|mesh-list
82865450|NCT00369161|Basiliximab|basiliximab|mesh-list
82865451|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865452|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
82865453|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865454|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82865455|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865456|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865457|NCT00369161|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82865458|NCT00369161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82865459|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865460|NCT01143974|Pemetrexed|pemetrexed|mesh-list
82865461|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865462|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865463|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865464|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82865465|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82865466|NCT00337571|Aripiprazole|aripiprazole|mesh-list
82865467|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
82865468|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865469|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82865470|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82865471|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865472|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865473|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
82865474|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
82865475|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865476|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865477|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82865478|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82865479|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
82865480|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82865481|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82865482|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82865483|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82865484|NCT01247870|Metformin|metformin|mesh-list
82865485|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82865486|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865487|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
82865488|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82865489|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865490|NCT03985319|Esomeprazole|esomeprazole|mesh-list
82865491|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82865492|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82865493|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82865494|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865495|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865496|NCT01237028|Calcitriol|calcitriol|mesh-list
82865497|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82865498|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865499|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82865500|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865501|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865502|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82865503|NCT01237028|Vitamins|vitamins|mesh-ancestor
82865504|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
82865505|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82865506|NCT01240850|Prednisone|prednisone|mesh-list
82865507|NCT01240850|Methotrexate|methotrexate|mesh-list
82865508|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82865509|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
82865510|NCT01240850|Hormones|hormones|mesh-ancestor
82865511|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82865512|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865513|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82865514|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865515|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82865516|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
82865517|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82865518|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865519|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
82865520|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865521|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
82865522|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865523|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82865524|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865525|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
82865526|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865527|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82865528|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
82865529|NCT04813016|Tramadol|tramadol|mesh-list
82865530|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865531|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865532|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865533|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82865534|NCT04813016|Analgesics|analgesics|mesh-ancestor
82865535|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
82865536|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865537|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82865538|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82865539|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82865540|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
82865541|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865542|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865543|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82865544|NCT04813016|Narcotics|narcotics|mesh-ancestor
82865545|NCT00368927|Sulindac|sulindac|mesh-list
82865546|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82865547|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82865548|NCT00368927|Analgesics|analgesics|mesh-ancestor
82865549|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
82865550|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865551|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865552|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82865553|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865554|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865555|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82865556|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865557|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865558|NCT01242410|Silicon|silicon|mesh-list
82865562|NCT02655692|Ketamine|ketamine|mesh-list
82865563|NCT02655692|Analgesics|analgesics|mesh-ancestor
82865564|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
82865565|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865566|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865567|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82865568|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865569|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
82865570|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
82865571|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865572|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82865573|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82865574|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865575|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865576|NCT01237262|Adalimumab|adalimumab|mesh-list
82865577|NCT01237262|Infliximab|infliximab|mesh-list
82865578|NCT01237262|Etanercept|etanercept|mesh-list
82865579|NCT01237262|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82865581|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865582|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
82865583|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82865584|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82865585|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82865586|NCT01237262|Analgesics|analgesics|mesh-ancestor
82865587|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
82865588|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865589|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865590|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865591|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
82865592|NCT01329770|Vitamins|vitamins|mesh-list
82865593|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
82865594|NCT01329770|Vitamin E|vitamin e|mesh-list
82865595|NCT01329770|Tocopherols|tocopherols|mesh-list
82865596|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
82865597|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
82865598|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865599|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
82865600|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865601|NCT01329770|Protective Agents|protective agents|mesh-ancestor
82865602|NCT00316589|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82865603|NCT00316589|Antiviral Agents|antiviral agents|mesh-ancestor
82865604|NCT00316589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865605|NCT01048385|Ubiquinone|ubiquinone|mesh-list
82865606|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
82865607|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
82865608|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865609|NCT01048385|Vitamins|vitamins|mesh-ancestor
82865610|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
82865611|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82865612|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865613|NCT03916250|Petrolatum|petrolatum|mesh-list
82865614|NCT03916250|PF-06700841|pf-06700841|mesh-list
82865615|NCT03916250|Emollients|emollients|mesh-ancestor
82865616|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
82865617|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82865618|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865619|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865620|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
82865621|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82865622|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865623|NCT03916406|Midazolam|midazolam|mesh-list
82865624|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82865625|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865626|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865627|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865628|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82865629|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82865630|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865631|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865632|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
82865642|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865643|NCT00316277|Analgesics|analgesics|mesh-ancestor
83453432|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
82865644|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
82865645|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865646|NCT01249352|Fluorouracil|fluorouracil|mesh-list
82865647|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
82865648|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865649|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
82865650|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865651|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865652|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865653|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
82865654|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865655|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865656|NCT03912974|Escitalopram|escitalopram|mesh-list
82865657|NCT03912974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82865658|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82865659|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865660|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865661|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865662|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
83510526|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82865663|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865664|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82865665|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82865666|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82865667|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865668|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865669|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
82865670|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865671|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865673|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82865674|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82865675|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
82865676|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865677|NCT00316199|Paclitaxel|paclitaxel|mesh-list
82865678|NCT00316199|Gemcitabine|gemcitabine|mesh-list
82865679|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82865680|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865681|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
82865682|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
82865683|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
82865684|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865685|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865686|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
82865687|NCT01147718|Digoxin|digoxin|mesh-list
82865688|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
82865689|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82865690|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82865691|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865692|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865693|NCT01147718|Protective Agents|protective agents|mesh-ancestor
82865695|NCT01147718|Incretins|incretins|mesh-ancestor
82865696|NCT01147718|Hormones|hormones|mesh-ancestor
82865697|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82865698|NCT03913052|Viscosupplements|viscosupplements|mesh-list
82865699|NCT03913052|Protective Agents|protective agents|mesh-ancestor
82865700|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865701|NCT03915938|Ketamine|ketamine|mesh-list
82865702|NCT03915938|Analgesics|analgesics|mesh-ancestor
82865703|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
82865704|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865705|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865706|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82865707|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865708|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
82865709|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
82865710|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865711|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82865712|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82865713|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865714|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865715|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82865716|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
82865717|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865718|NCT01251458|Temsirolimus|temsirolimus|mesh-list
82865719|NCT01251458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82865720|NCT01251458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82865721|NCT01251458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865722|NCT01251458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865723|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865724|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
82865725|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865726|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865727|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
82865728|NCT03912740|Remifentanil|remifentanil|mesh-list
82865729|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865730|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865731|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865732|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82865733|NCT03912740|Analgesics|analgesics|mesh-ancestor
82865734|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
82865735|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865736|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82865737|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82865738|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82865739|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
82865740|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865741|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865742|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82865744|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82865745|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82865746|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82865747|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
82865748|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865749|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82865750|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82865751|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865752|NCT01144754|Rituximab|rituximab|mesh-list
82865753|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865754|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865755|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
82865756|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865757|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865758|NCT01144832|Ebastine|ebastine|mesh-list
82865759|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82865760|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
82865761|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
82865762|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865763|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865764|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865765|NCT01251848|Ritonavir|ritonavir|mesh-list
82865766|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
82865767|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82865768|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82865769|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
82865770|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865771|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865773|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82865774|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
82865775|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865776|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82865777|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82865778|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82865779|NCT01251926|Bevacizumab|bevacizumab|mesh-list
82865780|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865781|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865782|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82865783|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82865784|NCT01251926|Growth Substances|growth substances|mesh-ancestor
82865785|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865786|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
82865787|NCT03911648|Lidocaine|lidocaine|mesh-list
82865788|NCT03911648|Bupivacaine|bupivacaine|mesh-list
82865789|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
82865790|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
82865791|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865792|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865793|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
82865794|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865795|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82865796|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82865797|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82865798|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865799|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865800|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82865801|NCT01237730|Cefuroxime|cefuroxime|mesh-list
82865802|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
82865803|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865804|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82865805|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865806|NCT01252160|Capsaicin|capsaicin|mesh-list
82865807|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
82865808|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
82865809|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
82865810|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865811|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865812|NCT00337103|Capecitabine|capecitabine|mesh-list
82865814|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
82865815|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865816|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865817|NCT03911570|Acetaminophen|acetaminophen|mesh-list
82865818|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82865819|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82865820|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82865821|NCT03911570|Analgesics|analgesics|mesh-ancestor
82865822|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
82865823|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865824|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865825|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
82865826|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865827|NCT01250366|Ribavirin|ribavirin|mesh-list
82865828|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
82865829|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865830|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
82865831|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865832|NCT00075504|Gemcitabine|gemcitabine|mesh-list
82865833|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865834|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
82865835|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865836|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865837|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
82865838|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82865839|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82865840|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
82865842|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865843|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865844|NCT01092624|Urological Agents|urological agents|mesh-ancestor
82865845|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
82865847|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82865848|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865849|NCT02889796|Adalimumab|adalimumab|mesh-list
82865850|NCT02889796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82865851|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82865852|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865853|NCT01237808|Cytarabine|cytarabine|mesh-list
82865854|NCT01237808|Etoposide|etoposide|mesh-list
82865855|NCT01237808|Tretinoin|tretinoin|mesh-list
82865856|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82865857|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865858|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82865859|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82865860|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865861|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865862|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865863|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
82865864|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
82865865|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82865866|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865867|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
82865868|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865869|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
82865870|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
82865871|NCT03910634|Carboplatin|carboplatin|mesh-list
82865872|NCT03910634|Fluorouracil|fluorouracil|mesh-list
82865873|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865874|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
82865875|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865876|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82865877|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82865878|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
82865879|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865880|NCT03910712|Trastuzumab|trastuzumab|mesh-list
82865881|NCT03910712|Letrozole|letrozole|mesh-list
82865882|NCT03910712|Anastrozole|anastrozole|mesh-list
82865883|NCT03910712|Exemestane|exemestane|mesh-list
82865884|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82865885|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865886|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865887|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82865888|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133547|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82865889|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865891|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
82865892|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82865893|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865894|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82865895|NCT03910556|Propofol|propofol|mesh-list
82865896|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82865897|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865898|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865899|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82865900|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
82865901|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
82865902|NCT03659578|Thymalfasin|thymalfasin|mesh-list
82865903|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82865904|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
82865905|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865906|NCT03877354|Anesthetics|anesthetics|mesh-list
82865907|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865908|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865909|NCT02889562|Warfarin|warfarin|mesh-list
82865910|NCT02889562|Apixaban|apixaban|mesh-list
82865911|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
82865912|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82865913|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
82865914|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82865915|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
82865924|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865925|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865926|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82865927|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82865928|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82865929|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82865930|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82865931|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
82865932|NCT03914690|Hematinics|hematinics|mesh-ancestor
82865933|NCT03914534|Valproic Acid|valproic acid|mesh-list
82865934|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
82865935|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865936|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865937|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
82865938|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865939|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865940|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
82865941|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82865942|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865943|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865944|NCT03910088|Acetaminophen|acetaminophen|mesh-list
82865945|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
82865946|NCT03910088|Diclofenac|diclofenac|mesh-list
82865947|NCT03910088|Pregabalin|pregabalin|mesh-list
82865948|NCT03910088|Caffeine|caffeine|mesh-list
82865949|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82865950|NCT03910088|Analgesics|analgesics|mesh-ancestor
82865951|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
82865952|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82865953|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865954|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
82865955|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
82865956|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82865957|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82865958|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865959|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82865960|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82865961|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82865962|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82865963|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82865964|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82865965|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82865966|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82865967|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82865968|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82865969|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82865970|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
82865971|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865972|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82865973|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82865974|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82865975|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82865976|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82865977|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865978|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82865981|NCT03610438|Immunologic Factors|immunologic factors|mesh-ancestor
82865982|NCT03610438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865983|NCT03908372|Docetaxel|docetaxel|mesh-list
82865984|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82865985|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
82865986|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
82865987|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
82865988|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865989|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82865990|NCT05617664|Mirabegron|mirabegron|mesh-list
82865991|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82865992|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82865993|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82865994|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
82865995|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82865996|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82865997|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82865998|NCT05617664|Urological Agents|urological agents|mesh-ancestor
82865999|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
82866000|NCT05617664|Coagulants|coagulants|mesh-ancestor
82866001|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82866002|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
82866003|NCT03909776|Cisplatin|cisplatin|mesh-list
82866004|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866005|NCT01148264|Olanzapine|olanzapine|mesh-list
82866006|NCT01148264|Metoclopramide|metoclopramide|mesh-list
82866007|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
82866008|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
82866009|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866010|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866011|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82866012|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82866013|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82866014|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866015|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866016|NCT01148264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82866017|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82866018|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866019|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866020|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866021|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
82866022|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82866023|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82866024|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
82866025|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82866026|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82866027|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866028|NCT00086580|Vidarabine|vidarabine|mesh-list
82866029|NCT00086580|Fludarabine|fludarabine|mesh-list
82866030|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
82866031|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
82866032|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866033|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82866034|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
82866035|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866036|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82866037|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
82866038|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866039|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
82866040|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866041|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866042|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
82866043|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
82866044|NCT03908528|Doxorubicin|doxorubicin|mesh-list
82866045|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82866046|NCT03908528|Paclitaxel|paclitaxel|mesh-list
82866047|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82866048|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82866049|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
82866051|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866052|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82866053|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
82866055|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866056|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82866057|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82866058|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82866059|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82866060|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866061|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82866062|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
82866063|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
82866064|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
82866065|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
82866066|NCT03908528|Protective Agents|protective agents|mesh-ancestor
82866067|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
82866068|NCT03908528|Vitamins|vitamins|mesh-ancestor
82866069|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
82866070|NCT03903458|Nivolumab|nivolumab|mesh-list
82866071|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866072|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866073|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82866074|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866075|NCT00086502|Metformin|metformin|mesh-list
82866076|NCT00086502|Pioglitazone|pioglitazone|mesh-list
82866077|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82866078|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82866079|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866080|NCT00086502|Incretins|incretins|mesh-ancestor
82866081|NCT00086502|Hormones|hormones|mesh-ancestor
82866082|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866083|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82866084|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
82866085|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866086|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866087|NCT03903302|Valproic Acid|valproic acid|mesh-list
82866088|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
82866089|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866090|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866091|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
82866092|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866093|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866094|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
82866095|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82866096|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866097|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866098|NCT03636542|Bupivacaine|bupivacaine|mesh-list
82866099|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
82866100|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
82866101|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866102|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866103|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
82866104|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866105|NCT00086190|Paroxetine|paroxetine|mesh-list
82866106|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82866107|NCT00086190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82866108|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82866109|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866110|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866111|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866112|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
82866113|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866114|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82866115|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
82866116|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866117|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82866118|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82866119|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866120|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82866121|NCT03275350|Naltrexone|naltrexone|mesh-list
82866122|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82866123|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82866125|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
82866126|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866127|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82866129|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866130|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866131|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
82866132|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866133|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866134|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82866135|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82866136|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866137|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
82866138|NCT03557242|Aspirin|aspirin|mesh-list
82866139|NCT03557242|Warfarin|warfarin|mesh-list
82866140|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82866141|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82866142|NCT03557242|Analgesics|analgesics|mesh-ancestor
82866143|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
82866144|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866145|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866146|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82866147|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866148|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82866149|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82866150|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866151|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82866152|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82866153|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866154|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
82866155|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
82866156|NCT04774666|Antibodies|antibodies|mesh-list
82866157|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
82866158|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866159|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82866160|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82866161|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82866162|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866163|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866164|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866165|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82866166|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82866167|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
82866168|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866169|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866170|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82866171|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82866172|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
82866173|NCT03898466|Fluticasone|fluticasone|mesh-list
82866174|NCT03898466|Xhance|xhance|mesh-list
82866175|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82866176|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82866177|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
82866178|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866179|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866180|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82866181|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
82866182|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
82866183|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82866184|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
82866185|NCT02527772|Leucovorin|leucovorin|mesh-list
82866186|NCT02527772|Gemcitabine|gemcitabine|mesh-list
82866187|NCT02527772|Fluorouracil|fluorouracil|mesh-list
82866188|NCT02527772|Doxorubicin|doxorubicin|mesh-list
82866189|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82866190|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
82866191|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82866192|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
82866193|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866194|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866195|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82866196|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82866197|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82866198|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866199|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82866200|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
82866201|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866202|NCT02527772|Antidotes|antidotes|mesh-ancestor
82866203|NCT02527772|Protective Agents|protective agents|mesh-ancestor
82866204|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
82866205|NCT02527772|Vitamins|vitamins|mesh-ancestor
82866206|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
82866207|NCT03273946|Fluticasone|fluticasone|mesh-list
82866208|NCT03273946|Xhance|xhance|mesh-list
82866209|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82866210|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82866211|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
82866212|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866213|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866214|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82866215|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
82866216|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
82866217|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82866218|NCT00660218|Paclitaxel|paclitaxel|mesh-list
82866219|NCT00660218|Cetuximab|cetuximab|mesh-list
82866220|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
82866221|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82866222|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866223|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
82866224|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
82866225|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
82866226|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866227|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866228|NCT00314951|Vancomycin|vancomycin|mesh-list
82866229|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
82866230|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82866231|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866232|NCT00085644|Adalimumab|adalimumab|mesh-list
82866233|NCT00085644|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82866234|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82866235|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866236|NCT01257074|Acyclovir|acyclovir|mesh-list
82866237|NCT01257074|Penciclovir|penciclovir|mesh-list
82866238|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
82866239|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866240|NCT04597918|Faricimab|faricimab|mesh-list
82866241|NCT04597918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82866242|NCT04597918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82866243|NCT04597918|Growth Substances|growth substances|mesh-ancestor
82866244|NCT04597918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866245|NCT04597918|Growth Inhibitors|growth inhibitors|mesh-ancestor
82866246|NCT04597918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866247|NCT01149278|Benzocaine|benzocaine|mesh-list
82866248|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
82866249|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
82866250|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866251|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866252|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
82866253|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866254|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82866255|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
82866256|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82866257|NCT03902522|Leronlimab|leronlimab|mesh-list
82866258|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82866259|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82866260|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866261|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82866262|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82866263|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
82866264|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866265|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
82866266|NCT01092858|Testosterone|testosterone|mesh-list
82866267|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
82866268|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
82866269|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82866270|NCT01092858|Androgens|androgens|mesh-ancestor
82866271|NCT01092858|Hormones|hormones|mesh-ancestor
82866272|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866273|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866274|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82866275|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866276|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
82866277|NCT00314327|Risperidone|risperidone|mesh-list
82866278|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82866279|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
82866280|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866281|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866282|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866283|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82866284|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82866285|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866286|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866287|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82866288|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
82866289|NCT03897452|Fentanyl|fentanyl|mesh-list
82866290|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82866291|NCT03897452|Narcotics|narcotics|mesh-ancestor
82866292|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866293|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866294|NCT03897452|Analgesics|analgesics|mesh-ancestor
82866295|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
82866296|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866297|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82866298|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82866299|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
82866300|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
82866301|NCT01151072|Insulin|insulin|mesh-list
82866302|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82866303|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866304|NCT01257386|Mesalamine|mesalamine|mesh-list
82866305|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82866306|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82866307|NCT01257386|Analgesics|analgesics|mesh-ancestor
82866308|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
82866309|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866310|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866311|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82866312|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866313|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82866314|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82866315|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82866316|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866317|NCT01257464|Incretins|incretins|mesh-ancestor
82866318|NCT01257464|Hormones|hormones|mesh-ancestor
82866319|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866320|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
82866321|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866322|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866323|NCT01255046|Donepezil|donepezil|mesh-list
82866324|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82866325|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866326|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866327|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
82866328|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866329|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866330|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
82866331|NCT01149356|Exemestane|exemestane|mesh-list
82866332|NCT01149356|Goserelin|goserelin|mesh-list
82866333|NCT01149356|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82866334|NCT01149356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82866335|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866336|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82866337|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82866338|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866339|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866340|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82866341|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
82866342|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866343|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866344|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82866345|NCT01148576|Vitamin E|vitamin e|mesh-list
82866346|NCT01148576|Entecavir|entecavir|mesh-list
82866347|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
82866348|NCT01148576|Vitamins|vitamins|mesh-ancestor
82866349|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
82866350|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866351|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
82866352|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866353|NCT01148576|Protective Agents|protective agents|mesh-ancestor
82866355|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866356|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82866357|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
82866358|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82866359|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82866360|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
82866361|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82866362|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82866363|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
82866364|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82866365|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82866367|NCT03905486|Analgesics|analgesics|mesh-ancestor
82866368|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
82866369|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866370|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866371|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
82866372|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82866373|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866374|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866375|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82866376|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82866377|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82866378|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866379|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866380|NCT03901118|Paclitaxel|paclitaxel|mesh-list
82866381|NCT03901118|Etoposide|etoposide|mesh-list
82866382|NCT03901118|Chiauranib|chiauranib|mesh-list
82866383|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82866384|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866385|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
82866386|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
82866387|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
82866388|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866389|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82866390|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82866391|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866392|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82866393|NCT03895892|Caffeine|caffeine|mesh-list
82866394|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82866395|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866396|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82866397|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866398|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866399|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82866400|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82866401|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
82866402|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866403|NCT01151306|Simvastatin|simvastatin|mesh-list
82866404|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82866405|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82866406|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
82866407|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866408|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82866409|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82866410|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866411|NCT05570786|Gestrinone|gestrinone|mesh-list
82866412|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82866413|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82866414|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82866415|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
82866416|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82866417|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866418|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82866419|NCT05570786|Progestins|progestins|mesh-ancestor
82866420|NCT05570786|Hormones|hormones|mesh-ancestor
82866421|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866422|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
82866423|NCT03895970|Lenvatinib|lenvatinib|mesh-list
82866424|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866425|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866426|NCT03895970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82866436|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
82866437|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866438|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
82866439|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866440|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
82866441|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866442|NCT03905564|Pyridoxine|pyridoxine|mesh-list
82866443|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
82866444|NCT03905564|Doxylamine|doxylamine|mesh-list
82866445|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
82866446|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
82866447|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
82866448|NCT03905564|Vitamins|vitamins|mesh-ancestor
82866449|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
82866450|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866451|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
82866452|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
82866453|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866454|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82866455|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82866456|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
82866457|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
82866458|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866459|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866460|NCT01151384|Docetaxel|docetaxel|mesh-list
82866461|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866462|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
82866463|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
82866464|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
82866465|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866466|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
82866467|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82866468|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82866469|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866470|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
82866471|NCT01258010|Coagulants|coagulants|mesh-ancestor
82866472|NCT00314249|Milnacipran|milnacipran|mesh-list
82866473|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
82866474|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82866475|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82866476|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866477|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866478|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866479|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866480|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82866481|NCT00314249|Analgesics|analgesics|mesh-ancestor
82866482|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
82866483|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866484|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
82866485|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866486|NCT03905018|Tadalafil|tadalafil|mesh-list
82866517|NCT03900026|Protease Inhibitors|protease inhibitors|mesh-ancestor
82866518|NCT03900026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866519|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82866520|NCT01149668|Abexinostat|abexinostat|mesh-list
82866521|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82866522|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866523|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866524|NCT01149746|Tamsulosin|tamsulosin|mesh-list
82866525|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82866526|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82866527|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82866529|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866530|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866531|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866532|NCT01149746|Urological Agents|urological agents|mesh-ancestor
82866533|NCT01149824|Salvinorin A|salvinorin a|mesh-list
82866534|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
82866535|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866536|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866537|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
82866538|NCT01149902|Docetaxel|docetaxel|mesh-list
82866539|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82866540|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
82866541|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866542|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866543|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82866544|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
82866545|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866546|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866547|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82866548|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
82866549|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
82866550|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
82866551|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
82866552|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
82866553|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
82866554|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82866555|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
82866556|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
82866557|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866558|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866559|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866560|NCT01149980|Dexetimide|dexetimide|mesh-list
82866561|NCT01149980|Citalopram|citalopram|mesh-list
82866562|NCT01149980|Escitalopram|escitalopram|mesh-list
82866563|NCT01149980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82866564|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82866565|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866566|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866567|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866568|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
82866569|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866570|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82866571|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
82866572|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82866573|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82866574|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82866575|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
82866576|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
82866577|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866578|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82866579|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82866580|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
82866581|NCT01258322|Pioglitazone|pioglitazone|mesh-list
82866582|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82866583|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866584|NCT01255358|Dexamethasone|dexamethasone|mesh-list
82866585|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
82866586|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82866587|NCT01255358|BB 1101|bb 1101|mesh-list
82866588|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82866589|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
82866590|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
82866591|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866592|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866593|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82866594|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
82866595|NCT01255358|Hormones|hormones|mesh-ancestor
82866596|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866597|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82866598|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866599|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
82866600|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866601|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866603|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
82866604|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
82866605|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
82866606|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866607|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866608|NCT03893864|Ubiquinone|ubiquinone|mesh-list
82866609|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
82866610|NCT03893864|Antioxidants|antioxidants|mesh-list
82866611|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866612|NCT03893864|Protective Agents|protective agents|mesh-ancestor
82866613|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866614|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
82866615|NCT03893864|Vitamins|vitamins|mesh-ancestor
82866616|NCT03899324|Bumetanide|bumetanide|mesh-list
82866617|NCT03899324|Diuretics|diuretics|mesh-ancestor
82866618|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
82866619|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866620|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82866621|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866622|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866623|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82866624|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82866625|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
82866626|NCT01258634|Leucovorin|leucovorin|mesh-list
82866627|NCT01258634|Doxorubicin|doxorubicin|mesh-list
82866628|NCT01258634|Etoposide|etoposide|mesh-list
82866629|NCT01258634|Ifosfamide|ifosfamide|mesh-list
82866630|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
82866631|NCT01258634|Razoxane|razoxane|mesh-list
82866632|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866633|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82866634|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82866635|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82866636|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866637|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866638|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82866639|NCT01258634|Antidotes|antidotes|mesh-ancestor
82866640|NCT01258634|Protective Agents|protective agents|mesh-ancestor
82866641|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866642|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
82866643|NCT01258634|Vitamins|vitamins|mesh-ancestor
82866644|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
82866645|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82866646|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
82866647|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82866648|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
82866649|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
82866650|NCT01258712|Methotrexate|methotrexate|mesh-list
82866651|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82866652|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
82866653|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82866654|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866655|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82866656|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
82866657|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866658|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866659|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
82866660|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866661|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82866662|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82866663|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
82866664|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866665|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82866666|NCT01258868|Celecoxib|celecoxib|mesh-list
82866667|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82866668|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82866669|NCT01258868|Analgesics|analgesics|mesh-ancestor
82866670|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
82866671|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866672|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866673|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82866674|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866675|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82866676|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82866677|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866682|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82866683|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82866685|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
82866686|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866687|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
82866688|NCT03892928|Propofol|propofol|mesh-list
82866689|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82866690|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866691|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866692|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82866693|NCT03892928|Analgesics|analgesics|mesh-ancestor
82866694|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
82866695|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866696|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82866697|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82866698|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82866700|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866701|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866702|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82866703|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
82866704|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
82866705|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
82866706|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82866707|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866708|NCT03341806|Avelumab|avelumab|mesh-list
82866709|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866710|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866711|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
82866712|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82866713|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866714|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866715|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
82866716|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82866717|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866718|NCT01149122|Gemcitabine|gemcitabine|mesh-list
82866719|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
82866720|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82866721|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82866722|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
82866723|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866724|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866725|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82866726|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866727|NCT01152398|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82866728|NCT01152398|Antiviral Agents|antiviral agents|mesh-ancestor
82866729|NCT01152398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866730|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82866731|NCT03892148|Furosemide|furosemide|mesh-list
82866732|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82866733|NCT03892148|Diuretics|diuretics|mesh-ancestor
82866734|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
82866735|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866736|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82866737|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866738|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866739|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82866740|NCT01152476|Remifentanil|remifentanil|mesh-list
82866741|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82866742|NCT01152476|Narcotics|narcotics|mesh-ancestor
82866743|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866744|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866745|NCT01152476|Analgesics|analgesics|mesh-ancestor
82866755|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
82866756|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866757|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866758|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
82866759|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866760|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82866761|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82866762|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82866763|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866764|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866765|NCT01259336|Itraconazole|itraconazole|mesh-list
82866766|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
82866767|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866768|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82866769|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82866770|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866771|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866772|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82866773|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
82866774|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866775|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866776|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82866777|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
82866778|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866779|NCT03314662|Vaccines|vaccines|mesh-list
82866780|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
82866781|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
82866782|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866783|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82866784|NCT01152710|Capecitabine|capecitabine|mesh-list
82866785|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82866786|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
82866787|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866788|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866789|NCT03271528|Lacosamide|lacosamide|mesh-list
82866790|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
82866791|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82866792|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82866793|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866794|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866797|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82866798|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
82866799|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866800|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866801|NCT04480372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82866802|NCT04480372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866803|NCT04462276|Atezolizumab|atezolizumab|mesh-list
82866804|NCT04462276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82866805|NCT04462276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866806|NCT04462276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866807|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866808|NCT03890510|Anesthetics|anesthetics|mesh-list
82866809|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866810|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866811|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82866812|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82866813|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866814|NCT01153568|Vitamin D|vitamin d|mesh-list
82866815|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
82866816|NCT01153568|Vitamins|vitamins|mesh-ancestor
82866817|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
82866818|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866819|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82866820|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82866821|NCT03889808|Antitoxins|antitoxins|mesh-list
82866822|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
82866823|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866824|NCT03890042|Dienogest|dienogest|mesh-list
82866825|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82866826|NCT03890042|Gestodene|gestodene|mesh-list
82866827|NCT03890042|Femovan|femovan|mesh-list
82866828|NCT03890042|Estradiol|estradiol|mesh-list
82866829|NCT03890042|Estrogens|estrogens|mesh-ancestor
82866830|NCT03890042|Hormones|hormones|mesh-ancestor
82866831|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866832|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866833|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82866834|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
82866835|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82866836|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82866837|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82866838|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82866839|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82866840|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
82866841|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82866842|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866843|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82866844|NCT03890042|Progestins|progestins|mesh-ancestor
82866845|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82866846|NCT01153802|Dopamine|dopamine|mesh-list
82866847|NCT01153802|Norepinephrine|norepinephrine|mesh-list
82866848|NCT01153802|Serotonin|serotonin|mesh-list
82866849|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
82866850|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82866851|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82866852|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
82866853|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866854|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866855|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
82866856|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
82866857|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866858|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82866859|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82866860|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
82866861|NCT01153802|Protective Agents|protective agents|mesh-ancestor
82866862|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82866863|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
82866864|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
82866865|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82866866|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866867|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
82866869|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
82866870|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866871|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866872|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
82866873|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866874|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82866875|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
82866876|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82866877|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82866878|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866879|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82866880|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
82866881|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82866882|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82866883|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82866884|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82866885|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
82866886|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866887|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82866888|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82866889|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866890|NCT01259804|Immunomodulating Agents|immunomodulating agents|mesh-list
82866891|NCT01259804|Immunologic Factors|immunologic factors|mesh-ancestor
82866892|NCT01259804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866893|NCT01153880|Mupirocin|mupirocin|mesh-list
82866894|NCT01153880|Retapamulin|retapamulin|mesh-list
82866895|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82866896|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866897|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82866898|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866899|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866900|NCT01260506|Bevacizumab|bevacizumab|mesh-list
82866901|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82866902|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866903|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82866904|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82866905|NCT01260506|Growth Substances|growth substances|mesh-ancestor
82866906|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866907|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
82866908|NCT03884972|Venetoclax|venetoclax|mesh-list
82866909|NCT03884972|Trabectedin|trabectedin|mesh-list
82866910|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866911|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82866912|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
82866913|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866914|NCT01154114|Darapladib|darapladib|mesh-list
82866915|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
82866916|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866917|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866918|NCT01157312|Citric Acid|citric acid|mesh-list
82866919|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
82866920|NCT01157312|Clomiphene|clomiphene|mesh-list
82866921|NCT01157312|Enclomiphene|enclomiphene|mesh-list
82866922|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
82866923|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
82866924|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82866925|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
82866926|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
82866927|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866928|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82866929|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
82866930|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82866931|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866932|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82866933|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
82866934|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82866935|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82866936|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82866937|NCT01157546|Lidocaine|lidocaine|mesh-list
82866938|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
82866939|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
82866940|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82866941|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866942|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
82866943|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82866950|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82866951|NCT01263860|Ribavirin|ribavirin|mesh-list
82866952|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82866953|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
82866954|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
82866955|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866956|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
82866957|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866958|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
82866959|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866960|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
82866961|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866962|NCT01154348|Metformin|metformin|mesh-list
82866963|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82866964|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82866965|NCT00075270|Paclitaxel|paclitaxel|mesh-list
82866966|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82866967|NCT00075270|Lapatinib|lapatinib|mesh-list
82866968|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82866969|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866970|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
82866971|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
82866972|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
82866973|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866974|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82866975|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866976|NCT01264094|Clevudine|clevudine|mesh-list
82866977|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
82866978|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866979|NCT03884348|Amoxicillin|amoxicillin|mesh-list
82866980|NCT03884348|Metronidazole|metronidazole|mesh-list
82866981|NCT03884348|Clarithromycin|clarithromycin|mesh-list
82866982|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82866983|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82866984|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82866985|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82866986|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82866987|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82866988|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82866989|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866990|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82866991|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82866992|NCT01154426|Gemcitabine|gemcitabine|mesh-list
82866993|NCT01154426|Veliparib|veliparib|mesh-list
82866994|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82866995|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
82866996|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82866997|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82866998|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82866999|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867000|NCT01589744|Hemostatics|hemostatics|mesh-list
82867001|NCT01589744|Coagulants|coagulants|mesh-ancestor
82867002|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
82867003|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82867004|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82867005|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
82867006|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867007|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867008|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82867009|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867010|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82867011|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
82867019|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867020|NCT03880916|Analgesics|analgesics|mesh-ancestor
82867021|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
82867022|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867023|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
82867024|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82867025|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
82867026|NCT01155908|Amlodipine|amlodipine|mesh-list
82867027|NCT01155908|Benazepril|benazepril|mesh-list
82867028|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82867029|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82867030|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83453485|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867031|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867032|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82867033|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867034|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
82867035|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82867036|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
82867037|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867038|NCT03880448|Metronidazole|metronidazole|mesh-list
82867039|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867040|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82867041|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82867042|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82867043|NCT03298984|Cytarabine|cytarabine|mesh-list
82867044|NCT03298984|Daunorubicin|daunorubicin|mesh-list
82867045|NCT03298984|Alvocidib|alvocidib|mesh-list
82867046|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82867047|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
82867048|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867049|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867050|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
82867051|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867052|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867053|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
82867054|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867055|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82867056|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82867057|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82867058|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867059|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
82867060|NCT03298984|Growth Substances|growth substances|mesh-ancestor
82867061|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867062|NCT03887858|Tamsulosin|tamsulosin|mesh-list
82867063|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82867064|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82867065|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82867066|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
82867067|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867068|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867069|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867070|NCT03887858|Urological Agents|urological agents|mesh-ancestor
82867071|NCT02940574|Oxytocin|oxytocin|mesh-list
82867072|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
82867073|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82867074|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867075|NCT01264328|Paclitaxel|paclitaxel|mesh-list
82867076|NCT01264328|Panitumumab|panitumumab|mesh-list
82867077|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82867080|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
82867081|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
82867082|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867083|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82867084|NCT01157858|Everolimus|everolimus|mesh-list
82867085|NCT01157858|Octreotide|octreotide|mesh-list
82867086|NCT01157858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82867087|NCT01157858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867088|NCT01157858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867089|NCT01157858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867090|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867091|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
82867092|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83511123|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867093|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867094|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867095|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82867096|NCT01157936|Allopurinol|allopurinol|mesh-list
82867097|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
82867098|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867099|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867100|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
82867101|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82867102|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82867103|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
82867104|NCT01157936|Protective Agents|protective agents|mesh-ancestor
82867105|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867106|NCT01264484|Imidacloprid|imidacloprid|mesh-list
82867107|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
82867108|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867109|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867110|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867111|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
82867112|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82867113|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82867114|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867115|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
82867116|NCT01260818|Coagulants|coagulants|mesh-ancestor
82867117|NCT01262612|Cediranib|cediranib|mesh-list
82867118|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867119|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867120|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867121|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867122|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82867123|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
82867124|NCT01158014|Coagulants|coagulants|mesh-ancestor
82867125|NCT03884036|Vitamin D|vitamin d|mesh-list
82867126|NCT03884036|Vitamins|vitamins|mesh-ancestor
82867127|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
82867128|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867129|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82867130|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82867131|NCT01158170|Gefitinib|gefitinib|mesh-list
82867132|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867133|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867134|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867135|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867136|NCT01260974|Caspofungin|caspofungin|mesh-list
82867137|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
82867138|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867139|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867140|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867141|NCT01264640|Aspirin|aspirin|mesh-list
82867142|NCT01264640|Clopidogrel|clopidogrel|mesh-list
82867143|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82867144|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82867145|NCT01264640|Analgesics|analgesics|mesh-ancestor
82867146|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
82867147|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867148|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867149|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82867150|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82867151|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82867152|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82867153|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867154|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82867155|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82867156|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867157|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
82867158|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82867159|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82867160|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82867161|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
82867162|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867163|NCT01155986|Lidocaine|lidocaine|mesh-list
82867164|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
82867165|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
82867166|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867167|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867168|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
82867169|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867170|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82867171|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82867172|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82867173|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867174|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867175|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82867176|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82867177|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
82867178|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867179|NCT01261130|Antacids|antacids|mesh-ancestor
82867180|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867181|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867182|NCT01158248|Panitumumab|panitumumab|mesh-list
82867183|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867184|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82867185|NCT01264874|Vitamin D|vitamin d|mesh-list
82867186|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
82867187|NCT01264874|Vitamins|vitamins|mesh-ancestor
82867188|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
82867189|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867190|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82867191|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82867192|NCT01262924|Vaccines|vaccines|mesh-list
82867193|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
82867194|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867195|NCT01158560|Vitamin D|vitamin d|mesh-list
82867196|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
82867197|NCT01158560|Vitamins|vitamins|mesh-ancestor
82867198|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
82867199|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867200|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82867201|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82867202|NCT03879746|Paroxetine|paroxetine|mesh-list
82867203|NCT03879746|Tamsulosin|tamsulosin|mesh-list
82867204|NCT03879746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82867205|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867206|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867207|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867208|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867209|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
82867210|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867211|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82867212|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
82867213|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82867214|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82867215|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82867216|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867217|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82867218|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82867219|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82867220|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
82867221|NCT03879746|Urological Agents|urological agents|mesh-ancestor
82867222|NCT03879590|Budesonide|budesonide|mesh-list
82867223|NCT03879590|Doxofylline|doxofylline|mesh-list
82867224|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82867225|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82867227|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867228|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867229|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82867230|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867231|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
82867232|NCT03879590|Hormones|hormones|mesh-ancestor
82867233|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82867234|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
82867235|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82867236|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867237|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867238|NCT01265108|Iron|iron|mesh-list
82867239|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82867240|NCT01265108|Trace Elements|trace elements|mesh-ancestor
82867241|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
82867242|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867243|NCT01265108|Hematinics|hematinics|mesh-ancestor
82867245|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
82867246|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
82867247|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867248|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867249|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
82867250|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867251|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82867252|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82867253|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82867254|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867255|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867256|NCT01263002|Adefovir|adefovir|mesh-list
82867257|NCT01263002|Clevudine|clevudine|mesh-list
82867258|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
82867259|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867260|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82867261|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82867262|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867263|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867264|NCT01261286|Verapamil|verapamil|mesh-list
82867265|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82867266|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82867267|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867268|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867269|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82867270|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867271|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
82867272|NCT01263080|Folic Acid|folic acid|mesh-list
82867273|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
82867274|NCT01263080|Mirtazapine|mirtazapine|mesh-list
82867275|NCT01263080|Vitamins|vitamins|mesh-ancestor
82867276|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
82867277|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867278|NCT01263080|Hematinics|hematinics|mesh-ancestor
82867279|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
82867280|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82867281|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82867282|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
82867283|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
82867284|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867285|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867286|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82867287|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82867288|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867289|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82867290|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82867291|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82867292|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
82867293|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82867294|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82867295|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
82867296|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82867297|NCT01263158|Oxytocin|oxytocin|mesh-list
82867298|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
82867299|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82867300|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867302|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82867303|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
82867304|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867305|NCT03879356|Expectorants|expectorants|mesh-ancestor
82867306|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867307|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82867308|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
82867309|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867310|NCT03879356|Protective Agents|protective agents|mesh-ancestor
82867311|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867312|NCT03879356|Antidotes|antidotes|mesh-ancestor
82867313|NCT01159418|Paclitaxel|paclitaxel|mesh-list
82867314|NCT01159418|Carboplatin|carboplatin|mesh-list
82867315|NCT01159418|Panobinostat|panobinostat|mesh-list
82867316|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82867317|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867318|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
82867320|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
82867321|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867322|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82867323|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867324|NCT03886766|Efavirenz|efavirenz|mesh-list
82867325|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82867326|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82867327|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867328|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867329|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
82867330|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867331|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82867332|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82867333|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82867334|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82867335|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82867336|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82867337|NCT01265342|Beclomethasone|beclomethasone|mesh-list
82867338|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82867339|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
82867340|NCT01265342|Hormones|hormones|mesh-ancestor
82867341|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82867342|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867343|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82867344|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867345|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
82867346|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82867347|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
82867348|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867349|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
82867350|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867351|NCT01265576|Etodolac|etodolac|mesh-list
82867352|NCT01265576|Sorafenib|sorafenib|mesh-list
82867353|NCT01265576|Propranolol|propranolol|mesh-list
82867354|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867355|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867356|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867357|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867358|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82867359|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82867360|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
82867361|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867362|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867363|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82867364|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82867365|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
82867366|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82867367|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82867368|NCT01265576|Analgesics|analgesics|mesh-ancestor
82867369|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
82867370|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867371|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82867372|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82867373|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82867374|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82867376|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82867377|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867378|NCT01159652|Zaleplon|zaleplon|mesh-list
82867379|NCT01159652|Zolpidem|zolpidem|mesh-list
82867380|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82867381|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82867382|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867383|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867384|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82867385|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
82867386|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
82867387|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867388|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867389|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
82867390|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
82867391|NCT01261832|Cilostazol|cilostazol|mesh-list
82867392|NCT01261832|Clopidogrel|clopidogrel|mesh-list
83511124|NCT03194373|Carboplatin|carboplatin|mesh-list
82867393|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82867394|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82867395|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82867396|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82867397|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
82867398|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867399|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867400|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867401|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82867402|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
82867403|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867404|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82867405|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867406|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82867407|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82867408|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
82867409|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82867410|NCT01261832|Protective Agents|protective agents|mesh-ancestor
82867411|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82867412|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82867413|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867414|NCT01265810|Calcium|calcium|mesh-list
82867415|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82867416|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867417|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
82867418|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82867419|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
82867420|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867421|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867422|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82867423|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867424|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82867425|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
82867426|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867427|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867428|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82867429|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
82867430|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
82867431|NCT01265888|Protective Agents|protective agents|mesh-ancestor
82867432|NCT01155206|Glucagon|glucagon|mesh-list
82867433|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82867434|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867435|NCT01155206|Hormones|hormones|mesh-ancestor
82867436|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82867437|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867438|NCT01155206|Incretins|incretins|mesh-ancestor
82867439|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
82867440|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
82867441|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
82867442|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867443|NCT03878888|Bupivacaine|bupivacaine|mesh-list
82867444|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
82867445|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
82867446|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867447|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867448|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
82867450|NCT03882710|Metoprolol|metoprolol|mesh-list
82867451|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82867452|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82867453|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
82867454|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
82867455|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867456|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867457|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82867458|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82867459|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82867460|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
82867461|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867462|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867463|NCT01161836|Iniparib|iniparib|mesh-list
82867464|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82867465|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83511125|NCT03194373|Palbociclib|palbociclib|mesh-list
82867466|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867467|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867468|NCT01266434|Simvastatin|simvastatin|mesh-list
82867469|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82867470|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82867471|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
82867472|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867473|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82867474|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82867475|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867477|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867478|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
82867479|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
82867480|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
82867481|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867482|NCT01160042|Metformin|metformin|mesh-list
82867483|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82867484|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867485|NCT03882788|Fentanyl|fentanyl|mesh-list
82867486|NCT03882788|Isoflurane|isoflurane|mesh-list
82867487|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82867488|NCT03882788|Narcotics|narcotics|mesh-ancestor
82867489|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867490|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867491|NCT03882788|Analgesics|analgesics|mesh-ancestor
82867492|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
82867493|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867494|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82867495|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82867496|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
82867497|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
82867498|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82867499|NCT01156688|Misoprostol|misoprostol|mesh-list
82867500|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82867501|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
82867502|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82867503|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867504|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82867505|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867506|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
82867507|NCT03876704|Vitamins|vitamins|mesh-list
82867508|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
82867509|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867510|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
82867511|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
82867512|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867513|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82867514|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867515|NCT03878264|Cortisone|cortisone|mesh-list
82867516|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82867517|NCT03882164|Tacrolimus|tacrolimus|mesh-list
82867518|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867519|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
82867520|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867521|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82867522|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867523|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867525|NCT01160276|Colchicine|colchicine|mesh-list
82867526|NCT01160276|Tacrolimus|tacrolimus|mesh-list
82867527|NCT01160276|Cyclosporins|cyclosporins|mesh-list
82867528|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867529|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
82867530|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867531|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82867532|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453511|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82867533|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867534|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
82867535|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867536|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
82867537|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82867538|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
82867539|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
82867540|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
82867541|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
82867542|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511426|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867543|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82867544|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82867545|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867546|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82867547|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867548|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867549|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867551|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867552|NCT01160432|Methadone|methadone|mesh-list
82867553|NCT01160432|Naloxone|naloxone|mesh-list
82867554|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82867555|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867556|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
82867557|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867558|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82867559|NCT01160432|Narcotics|narcotics|mesh-ancestor
82867560|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867561|NCT01160432|Analgesics|analgesics|mesh-ancestor
82867562|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
82867563|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867564|NCT03877718|Promethazine|promethazine|mesh-list
82867565|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
82867566|NCT03877718|Sumatriptan|sumatriptan|mesh-list
82867567|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82867568|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82867569|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82867570|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
82867571|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867572|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867573|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867574|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
82867575|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
82867576|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82867577|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
82867578|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
82867579|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82867580|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82867581|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82867582|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867583|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
82867584|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
82867585|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
82867586|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867587|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
82867588|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
82867589|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867590|NCT01267058|Vaccines|vaccines|mesh-list
82867591|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
82867592|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867593|NCT02526914|Vasopressins|vasopressins|mesh-list
82867594|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
82867595|NCT02526914|Oxytocin|oxytocin|mesh-list
82867596|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
82867597|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82867598|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867599|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
82867600|NCT02526914|Coagulants|coagulants|mesh-ancestor
82867601|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82867602|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82867603|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
82867604|NCT03876938|Olanzapine|olanzapine|mesh-list
82867605|NCT03876938|Aprepitant|aprepitant|mesh-list
82867606|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
82867607|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
82867608|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867609|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867610|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867611|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82867612|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82867613|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867614|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82867615|NCT03876938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82867616|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867617|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482765|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82867618|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867619|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867620|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
82867621|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82867622|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
82867623|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
82867624|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82867625|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82867626|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867627|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867628|NCT03882008|Abatacept|abatacept|mesh-list
82867629|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82867630|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867631|NCT03882008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82867632|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867633|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867634|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
82867635|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867636|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82867637|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
82867638|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82867639|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
82867640|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867641|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
82867642|NCT01267214|Protective Agents|protective agents|mesh-ancestor
82867643|NCT01156922|Rituximab|rituximab|mesh-list
82867644|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82867645|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867646|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
82867647|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867648|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82867649|NCT03877874|Terbutaline|terbutaline|mesh-list
82867650|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82867651|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
82867652|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867653|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867654|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82867655|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
82867656|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
82867657|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
82867658|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82867659|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82867660|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82867661|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82867662|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
82867663|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867664|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867665|NCT01160588|Sertraline|sertraline|mesh-list
82867666|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
82867667|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82867668|NCT01160588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82867669|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867670|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867671|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867672|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867673|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
82867683|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867685|NCT03877562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82867686|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867687|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867688|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867689|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867690|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
82867691|NCT01160666|Belimumab|belimumab|mesh-list
82867692|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867693|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
82867694|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867695|NCT03876548|Iodine|iodine|mesh-list
82867696|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
82867697|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82867698|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867699|NCT03876548|Trace Elements|trace elements|mesh-ancestor
82867700|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
82867702|NCT03760250|Imiquimod|imiquimod|mesh-list
82867703|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82867704|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
82867705|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867706|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867707|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
82867708|NCT01157000|Canagliflozin|canagliflozin|mesh-list
82867709|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82867710|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867711|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82867712|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867713|NCT01160900|Bivalirudin|bivalirudin|mesh-list
82867714|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82867715|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82867716|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
82867717|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82867718|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
82867719|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867720|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867721|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
82867722|NCT01160978|Simvastatin|simvastatin|mesh-list
82867723|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82867724|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82867725|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
82867726|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867727|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82867728|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82867729|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867730|NCT01161134|Meloxicam|meloxicam|mesh-list
82867731|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82867732|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82867733|NCT01161134|Analgesics|analgesics|mesh-ancestor
82867734|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
82867735|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867736|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867737|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82867738|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82867740|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82867741|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867742|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867743|NCT01268384|Gemcitabine|gemcitabine|mesh-list
82867744|NCT01268384|Capecitabine|capecitabine|mesh-list
82867745|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82867746|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
82867747|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867748|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867749|NCT01269476|Fluorides|fluorides|mesh-list
82867750|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
82867751|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
82867752|NCT01269476|Protective Agents|protective agents|mesh-ancestor
82867753|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867754|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82867755|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867756|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867757|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
82867758|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867759|NCT01267604|Inositol|inositol|mesh-list
82867760|NCT01267604|Melatonin|melatonin|mesh-list
82867761|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
82867762|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867763|NCT01267604|Protective Agents|protective agents|mesh-ancestor
82867764|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867765|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867766|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
82867767|NCT01267604|Vitamins|vitamins|mesh-ancestor
82867768|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
82867769|NCT01161368|Vinorelbine|vinorelbine|mesh-list
82867770|NCT01161368|Lapatinib|lapatinib|mesh-list
82867771|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82867772|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867773|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
82867774|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
82867775|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
82867776|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867777|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867778|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867779|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
82867780|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82867781|NCT01280162|Piperaquine|piperaquine|mesh-list
82867782|NCT01280162|Artenimol|artenimol|mesh-list
82867783|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
82867784|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82867785|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82867786|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867787|NCT01167062|Tamsulosin|tamsulosin|mesh-list
82867788|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82867789|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82867790|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82867791|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
82867792|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867793|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867794|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867795|NCT01167062|Urological Agents|urological agents|mesh-ancestor
82867796|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82867797|NCT01280240|Hematinics|hematinics|mesh-ancestor
82867798|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
82867799|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82867800|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867801|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82867802|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867803|NCT03874364|Lidocaine|lidocaine|mesh-list
82867804|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
82867805|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
82867806|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867807|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867808|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
82867809|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867810|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82867811|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82867812|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82867813|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867814|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867815|NCT01163396|Leucovorin|leucovorin|mesh-list
82867816|NCT01163396|Bevacizumab|bevacizumab|mesh-list
82867817|NCT01163396|Fluorouracil|fluorouracil|mesh-list
82867818|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
82867819|NCT01163396|Irinotecan|irinotecan|mesh-list
82867820|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82867821|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867822|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82867823|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82867824|NCT01163396|Growth Substances|growth substances|mesh-ancestor
82867825|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867826|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
82867827|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
82867828|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867829|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82867830|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867831|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
82867832|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82867833|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82867834|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867835|NCT01163396|Antidotes|antidotes|mesh-ancestor
82867836|NCT01163396|Protective Agents|protective agents|mesh-ancestor
82867837|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
82867838|NCT01163396|Vitamins|vitamins|mesh-ancestor
82867839|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
82867840|NCT01269788|Fluoxetine|fluoxetine|mesh-list
82867841|NCT01269788|Omeprazole|omeprazole|mesh-list
82867842|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82867843|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867844|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82867845|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867846|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867847|NCT01269788|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82867848|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867849|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867850|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867851|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
82867852|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867853|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82867854|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
82867855|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82867856|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82867857|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82867858|NCT01163630|Esomeprazole|esomeprazole|mesh-list
82867859|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82867860|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867861|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82867862|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867863|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867864|NCT03874130|Scopolamine|scopolamine|mesh-list
82867865|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82867866|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82867867|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
82867868|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
82867869|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867870|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867871|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867872|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
82867873|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82867874|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
82867875|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867876|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867877|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82867878|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
82867879|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82867880|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82867881|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82867882|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867883|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867884|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867885|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867886|NCT01269866|Analgesics|analgesics|mesh-ancestor
82867887|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
82867888|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867889|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
82867890|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82867891|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
82867892|NCT05387642|Pramoxine|pramoxine|mesh-list
82867893|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
82867894|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
82867895|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82867896|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867897|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
82867898|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867899|NCT03871322|Vitamin D|vitamin d|mesh-list
82867900|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
82867901|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
82867902|NCT03871322|Vitamins|vitamins|mesh-list
82867903|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
82867904|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867905|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82867906|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82867907|NCT00313781|Prednisone|prednisone|mesh-list
82867908|NCT00313781|Docetaxel|docetaxel|mesh-list
82867909|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867910|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
82867911|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
82867912|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
82867913|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867914|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82867915|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
82867916|NCT00313781|Hormones|hormones|mesh-ancestor
82867917|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82867918|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867919|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82867920|NCT03871478|Lidocaine|lidocaine|mesh-list
82867921|NCT03871478|Bupivacaine|bupivacaine|mesh-list
82867922|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
82867923|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
82867924|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482766|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
82867925|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867926|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
82867927|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82867928|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82867929|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82867930|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82867931|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82867932|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867933|NCT01281566|Cisapride|cisapride|mesh-list
82867934|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82867935|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82867936|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82867937|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
82867938|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82867939|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867940|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867941|NCT00368537|Ampicillin|ampicillin|mesh-list
82867942|NCT00368537|Tigecycline|tigecycline|mesh-list
82867943|NCT00368537|Sulbactam|sulbactam|mesh-list
82867944|NCT00368537|Sultamicillin|sultamicillin|mesh-list
82867945|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82867946|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867947|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82867948|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867949|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867950|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82867951|NCT01165580|Valganciclovir|valganciclovir|mesh-list
82867952|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
82867953|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82867954|NCT01048619|ON 01910|on 01910|mesh-list
82867955|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867956|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867957|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867958|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867959|NCT01281800|Gemcitabine|gemcitabine|mesh-list
82867960|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82867961|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
83083933|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867962|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867964|NCT03982121|Nivolumab|nivolumab|mesh-list
82867965|NCT03982121|Ipilimumab|ipilimumab|mesh-list
82867966|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82867967|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867968|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82867969|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867970|NCT01167530|Everolimus|everolimus|mesh-list
82867971|NCT01167530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82867972|NCT01167530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867973|NCT01167530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867974|NCT01167530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867975|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867976|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
82867977|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867978|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867979|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
82867980|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82867981|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82867982|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867983|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
82867984|NCT01167764|Coagulants|coagulants|mesh-ancestor
82867985|NCT01164176|Everolimus|everolimus|mesh-list
82867986|NCT01164176|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82867987|NCT01164176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82867988|NCT01164176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82867989|NCT01164176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82867990|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82867991|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
82867992|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867993|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82867994|NCT00313313|Metformin|metformin|mesh-list
82867995|NCT00313313|Saxagliptin|saxagliptin|mesh-list
82867996|NCT00313313|Glyburide|glyburide|mesh-list
82867997|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82867998|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82867999|NCT00313313|Incretins|incretins|mesh-ancestor
82868000|NCT00313313|Hormones|hormones|mesh-ancestor
82868001|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868002|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82868003|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868004|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868005|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868006|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
82868007|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
82868008|NCT01167920|Diuretics|diuretics|mesh-list
82868009|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82868010|NCT01167920|Renin Inhibitors|renin inhibitors|mesh-list
82868011|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82868012|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868013|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
82868014|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868015|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868016|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868017|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82868018|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868019|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
82868020|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
82868021|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
82868022|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868023|NCT01268930|Hemostatics|hemostatics|mesh-list
82868024|NCT01268930|Coagulants|coagulants|mesh-ancestor
82868025|NCT02526758|Budesonide|budesonide|mesh-list
82868026|NCT02526758|Beclomethasone|beclomethasone|mesh-list
82868027|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
82868028|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868029|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82868030|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
82868031|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868032|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868033|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82868034|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
82868035|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
82868036|NCT02526758|Hormones|hormones|mesh-ancestor
82868037|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868038|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82868039|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82868040|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82868041|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
82868042|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868043|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868045|NCT01281878|Pyridoxal|pyridoxal|mesh-list
82868046|NCT01281878|Pyridoxine|pyridoxine|mesh-list
82868047|NCT01281878|Vitamins|vitamins|mesh-ancestor
82868048|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
82868049|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868050|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
82868051|NCT01164488|Ritonavir|ritonavir|mesh-list
82868052|NCT01164488|Ketoconazole|ketoconazole|mesh-list
82868053|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82868054|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82868055|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868056|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868057|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868058|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82868059|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82868060|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
82868061|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868062|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82868063|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82868064|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
82868065|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82868066|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82868067|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
82868068|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868069|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868070|NCT00312845|Rituximab|rituximab|mesh-list
82868071|NCT00312845|Bortezomib|bortezomib|mesh-list
82868072|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868073|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868074|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
82868075|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868076|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868077|NCT01168544|Vitamin D|vitamin d|mesh-list
82868078|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
82868079|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
82868080|NCT01168544|Vitamins|vitamins|mesh-list
82868081|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
82868082|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868083|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82868084|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82868085|NCT00368069|Levetiracetam|levetiracetam|mesh-list
82868086|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
82868087|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
82868088|NCT01165814|Naproxen|naproxen|mesh-list
82868089|NCT01165814|Tramadol|tramadol|mesh-list
82868090|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82868091|NCT01165814|Narcotics|narcotics|mesh-ancestor
82868092|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868093|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868094|NCT01165814|Analgesics|analgesics|mesh-ancestor
82868095|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
82868096|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868097|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82868098|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82868099|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868100|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868101|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
82868102|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82868103|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868104|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868105|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
82868106|NCT00367991|Hematinics|hematinics|mesh-ancestor
82868107|NCT00367835|Guanfacine|guanfacine|mesh-list
82868108|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82868109|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82868110|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82868111|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82868112|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
82868113|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868114|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868115|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868117|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82868118|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
82868119|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
82868120|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868121|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868122|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868123|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82868124|NCT03874832|Analgesics|analgesics|mesh-ancestor
82868125|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
82868126|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868127|NCT01164800|Trandolapril|trandolapril|mesh-list
82868128|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82868129|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868130|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868131|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868132|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82868133|NCT01169012|Clofarabine|clofarabine|mesh-list
82868134|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82868135|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
82868136|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868137|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868138|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82868139|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82868140|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868141|NCT01169090|Incretins|incretins|mesh-ancestor
82868142|NCT01169090|Hormones|hormones|mesh-ancestor
82868143|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868144|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82868145|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868146|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868147|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868148|NCT01282502|Midostaurin|midostaurin|mesh-list
82868149|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868150|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82868151|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868152|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868153|NCT01269242|Bindarit|bindarit|mesh-list
82868154|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868155|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82868156|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868157|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868158|NCT01169792|Tamoxifen|tamoxifen|mesh-list
82868159|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82868160|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
82868161|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868162|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868163|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82868164|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868165|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82868166|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82868167|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82868168|NCT01169402|Fluconazole|fluconazole|mesh-list
82868169|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
82868170|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868171|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82868172|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82868173|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868174|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868175|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82868176|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
82868177|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868178|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868179|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82868180|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82868181|NCT01274780|Ritonavir|ritonavir|mesh-list
82868182|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82868187|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82868188|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868189|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868190|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868192|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82868193|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
82868194|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868195|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82868196|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82868197|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82868198|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82868199|NCT01169870|Paclitaxel|paclitaxel|mesh-list
82868200|NCT01169870|genexol-PM|genexol-pm|mesh-list
82868201|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82868202|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868203|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
82868204|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
82868205|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
82868206|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868207|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82868208|NCT01165970|Laxatives|laxatives|mesh-ancestor
82868209|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868210|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82868211|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82868212|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82868213|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868214|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868215|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868216|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868217|NCT01166048|Analgesics|analgesics|mesh-ancestor
82868218|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
82868219|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868220|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
82868221|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82868222|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
82868223|NCT03869762|Denosumab|denosumab|mesh-list
82868224|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82868225|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868226|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83511645|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
82868227|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868228|NCT01283048|Bevacizumab|bevacizumab|mesh-list
82868229|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868230|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868231|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82868232|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82868233|NCT01283048|Growth Substances|growth substances|mesh-ancestor
82868234|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868235|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
82868236|NCT03873740|Vaccines|vaccines|mesh-list
82868237|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
82868238|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868239|NCT01172756|Riociguat|riociguat|mesh-list
82868240|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
82868241|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868242|NCT02525822|Tazarotene|tazarotene|mesh-list
82868243|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
82868244|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
82868245|NCT01172912|Dexamethasone|dexamethasone|mesh-list
82868246|NCT01172912|Carboplatin|carboplatin|mesh-list
82868247|NCT01172912|Etoposide|etoposide|mesh-list
82868248|NCT01172912|Ifosfamide|ifosfamide|mesh-list
82868249|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868250|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
82868251|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
82868252|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868253|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868254|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868255|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
82868256|NCT01172912|Hormones|hormones|mesh-ancestor
82868257|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868258|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82868259|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868260|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82868261|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82868262|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82868263|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868264|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868265|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82868266|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
82868267|NCT01283204|Leucovorin|leucovorin|mesh-list
82868268|NCT01283204|Paclitaxel|paclitaxel|mesh-list
82868269|NCT01283204|Docetaxel|docetaxel|mesh-list
82868270|NCT01283204|Cisplatin|cisplatin|mesh-list
82868271|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
82868272|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
82868273|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82868274|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868275|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
82868276|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
82868277|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
82868278|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868279|NCT01283204|Antidotes|antidotes|mesh-ancestor
82868280|NCT01283204|Protective Agents|protective agents|mesh-ancestor
82868281|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868282|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
82868283|NCT01283204|Vitamins|vitamins|mesh-ancestor
82868284|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
82868285|NCT03869528|Lidocaine|lidocaine|mesh-list
82868286|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
82868287|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
82868288|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868289|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868290|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
82868291|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868292|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82868293|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82868294|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82868295|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868296|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868297|NCT01283360|Tenofovir|tenofovir|mesh-list
82868298|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
82868299|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868300|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82868301|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82868302|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868303|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868304|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82868305|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82868306|NCT01173068|Ertapenem|ertapenem|mesh-list
82868307|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82868308|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868309|NCT03267940|Atezolizumab|atezolizumab|mesh-list
82868310|NCT03267940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82868311|NCT03267940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868312|NCT03267940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868313|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868314|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
82868315|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868316|NCT01170104|Sorafenib|sorafenib|mesh-list
82868317|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868318|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82868319|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868320|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868321|NCT01284764|Mosapride|mosapride|mesh-list
82868322|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868323|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82868324|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
82868325|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868326|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868327|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868328|NCT01170182|Omeprazole|omeprazole|mesh-list
82868329|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82868330|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868331|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82868332|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868333|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868334|NCT01170260|Ethanol|ethanol|mesh-list
82868335|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82868336|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868337|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868338|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868339|NCT00312377|Docetaxel|docetaxel|mesh-list
82868340|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868341|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
82868342|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
82868343|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
82868344|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868345|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
82868346|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82868347|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868348|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82868349|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82868350|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868351|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868352|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868353|NCT01580891|Naftifine|naftifine|mesh-list
82868354|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
82868355|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868356|NCT01059383|Esomeprazole|esomeprazole|mesh-list
82868357|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82868358|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868359|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82868360|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868361|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868362|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82868363|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868364|NCT01166594|Bevacizumab|bevacizumab|mesh-list
82868365|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868366|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868367|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82868368|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82868369|NCT01166594|Growth Substances|growth substances|mesh-ancestor
82868370|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868371|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
82868372|NCT01170338|Varenicline|varenicline|mesh-list
82868373|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82868374|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82868375|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
82868376|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83511721|NCT02385110|Methotrexate|methotrexate|mesh-list
82868377|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868378|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868379|NCT00312221|Oxycodone|oxycodone|mesh-list
82868380|NCT00312221|Buprenorphine|buprenorphine|mesh-list
82868381|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82868382|NCT00312221|Narcotics|narcotics|mesh-ancestor
82868383|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868384|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868385|NCT00312221|Analgesics|analgesics|mesh-ancestor
82868386|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
82868387|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868388|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82868389|NCT03872570|Phenylephrine|phenylephrine|mesh-list
82868390|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
82868391|NCT03872570|Norepinephrine|norepinephrine|mesh-list
82868392|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82868393|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
82868394|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
82868395|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868396|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868397|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
82868398|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82868399|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
82868400|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
82868401|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82868402|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82868403|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82868404|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
82868405|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868406|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868407|NCT03872570|Protective Agents|protective agents|mesh-ancestor
82868408|NCT01173926|Insulin|insulin|mesh-list
82868409|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82868410|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
82868411|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
83453546|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868412|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82868413|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82868414|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868415|NCT03349268|Xenon|xenon|mesh-list
82868416|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82868417|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
82868418|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
82868419|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868420|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868421|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
82868422|NCT01170494|Vitamin D|vitamin d|mesh-list
82868423|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
82868424|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82868425|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868426|NCT01170494|Vitamins|vitamins|mesh-ancestor
82868427|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
82868428|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82868429|NCT01587326|Escitalopram|escitalopram|mesh-list
82868430|NCT01587326|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82868431|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82868432|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868433|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868434|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868435|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
82868436|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868437|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82868438|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82868439|NCT03294538|Estradiol|estradiol|mesh-list
82868440|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82868441|NCT03294538|Estrogens|estrogens|mesh-ancestor
82868442|NCT03294538|Hormones|hormones|mesh-ancestor
82868443|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868444|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868445|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82868446|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
82868447|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82868448|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82868449|NCT03872336|Labetalol|labetalol|mesh-list
82868450|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82868451|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82868452|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
82868453|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868454|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868455|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868456|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82868457|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
82868458|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
82868459|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868460|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82868461|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82868462|NCT02987530|Tenofovir|tenofovir|mesh-list
82868463|NCT02987530|Emtricitabine|emtricitabine|mesh-list
82868464|NCT02987530|Dolutegravir|dolutegravir|mesh-list
82868465|NCT02987530|Darunavir|darunavir|mesh-list
82868466|NCT02987530|Cobicistat|cobicistat|mesh-list
82868467|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
82868468|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
82868469|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868470|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82868471|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82868472|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868473|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868474|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82868475|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82868476|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82868477|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82868478|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82868479|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82868480|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868481|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82868482|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82868483|NCT03865550|Ketamine|ketamine|mesh-list
82868484|NCT03865550|Analgesics|analgesics|mesh-ancestor
82868485|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
82868486|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868487|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868488|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82868489|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82868490|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
82868491|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
82868492|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868493|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82868494|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82868495|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868496|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868497|NCT02965690|Cimetidine|cimetidine|mesh-list
82868498|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82868499|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868500|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82868501|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
82868502|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
82868503|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868504|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868505|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868506|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82868507|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82868508|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868509|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
82868510|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868511|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82868512|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82868513|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868514|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868515|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
82868516|NCT01285466|Paclitaxel|paclitaxel|mesh-list
82868517|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82868518|NCT01285466|Trastuzumab|trastuzumab|mesh-list
82868519|NCT01285466|Dactolisib|dactolisib|mesh-list
82868520|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82868521|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868522|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
82868523|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
82868524|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
82868525|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868526|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868527|NCT01285544|Atorvastatin|atorvastatin|mesh-list
82868528|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82868529|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82868530|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
82868531|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868532|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82868533|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82868534|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868535|NCT01174394|Fluoxetine|fluoxetine|mesh-list
82868536|NCT01174394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82868537|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82868538|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868539|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868540|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868541|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
82868542|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868543|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82868544|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
82868545|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82868546|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82868547|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82868548|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868549|NCT01174472|Paclitaxel|paclitaxel|mesh-list
82868550|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82868551|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868552|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
82868553|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
82868554|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
82868555|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868556|NCT00335153|Levodopa|levodopa|mesh-list
82868557|NCT00335153|Carbidopa|carbidopa|mesh-list
82868558|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82868559|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82868560|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82868561|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
82868562|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868563|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868564|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868565|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82868566|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868567|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82868568|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
82868569|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
82868570|NCT01170806|Orlistat|orlistat|mesh-list
82868571|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868572|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868573|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82868574|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82868575|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
82868576|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82868577|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
82868578|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
82868579|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868580|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868581|NCT01280006|Celecoxib|celecoxib|mesh-list
82868582|NCT01280006|Indomethacin|indomethacin|mesh-list
82868583|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82868584|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82868585|NCT01280006|Analgesics|analgesics|mesh-ancestor
82868586|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
82868587|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868588|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868589|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868590|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868591|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82868592|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82868593|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868594|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868595|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
82868596|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
82868597|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82868598|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82868599|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868600|NCT03865160|Atropine|atropine|mesh-list
82868601|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82868602|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82868603|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82868604|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82868605|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82868606|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
82868607|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868608|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868609|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82868610|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
82868611|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
82868612|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
82868613|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82868614|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82868615|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
82868616|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868617|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868618|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
82868619|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82868620|NCT01059461|Protective Agents|protective agents|mesh-ancestor
82868621|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868622|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
82868623|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82868624|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
82868625|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868626|NCT01286246|Progesterone|progesterone|mesh-list
82868627|NCT01286246|Progestins|progestins|mesh-ancestor
82868628|NCT01286246|Hormones|hormones|mesh-ancestor
82868629|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868631|NCT03981887|Nafithromycin|nafithromycin|mesh-list
82868632|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82868633|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868634|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82868635|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868636|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868637|NCT01063127|Insulin|insulin|mesh-list
82868638|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82868639|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868640|NCT03865004|Acetaminophen|acetaminophen|mesh-list
82868641|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
82868642|NCT03865004|Morphine|morphine|mesh-list
82868643|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82868644|NCT03865004|Narcotics|narcotics|mesh-ancestor
82868645|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868646|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868647|NCT03865004|Analgesics|analgesics|mesh-ancestor
82868648|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
82868649|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868650|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82868651|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
82868652|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82868653|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868654|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868655|NCT00334295|Fulvestrant|fulvestrant|mesh-list
82868656|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82868657|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868658|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82868659|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82868660|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
82868661|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868662|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868663|NCT01285778|Panitumumab|panitumumab|mesh-list
82868664|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868665|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868666|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
82868667|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82868668|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
82868669|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868670|NCT01063205|Expectorants|expectorants|mesh-ancestor
82868671|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
82868672|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82868673|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
82868674|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868675|NCT01063205|Protective Agents|protective agents|mesh-ancestor
82868676|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868677|NCT01063205|Antidotes|antidotes|mesh-ancestor
82868678|NCT01175096|Everolimus|everolimus|mesh-list
82868679|NCT01175096|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82868680|NCT01175096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82868681|NCT01175096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868682|NCT01175096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868683|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82868684|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
82868685|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868686|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868687|NCT01285934|Insulin|insulin|mesh-list
82868688|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82868689|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868690|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
82868691|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82868692|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82868693|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868694|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
82868695|NCT01060163|Coagulants|coagulants|mesh-ancestor
82868696|NCT01063439|Cytarabine|cytarabine|mesh-list
82868697|NCT01063439|Etoposide|etoposide|mesh-list
82868698|NCT01063439|Melphalan|melphalan|mesh-list
82868699|NCT01063439|Busulfan|busulfan|mesh-list
82868700|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82868701|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868702|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82868703|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82868707|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
82868708|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
82868709|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868710|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82868711|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
82868712|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868713|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82868714|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
82868715|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82868716|NCT05275270|Oxytocin|oxytocin|mesh-list
82868717|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
82868718|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82868719|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868720|NCT02884648|Bevacizumab|bevacizumab|mesh-list
82868721|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868722|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868723|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82868724|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82868725|NCT02884648|Growth Substances|growth substances|mesh-ancestor
82868726|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868727|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
82868732|NCT03868202|Estradiol|estradiol|mesh-list
82868733|NCT03868202|Progesterone|progesterone|mesh-list
82868734|NCT03868202|Estrogens|estrogens|mesh-ancestor
82868735|NCT03868202|Hormones|hormones|mesh-ancestor
82868736|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868737|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868738|NCT03868202|Progestins|progestins|mesh-ancestor
82868739|NCT00311363|Gabapentin|gabapentin|mesh-list
82868740|NCT00311363|Analgesics|analgesics|mesh-ancestor
82868741|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
82868742|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868743|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868744|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
82868745|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82868746|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82868747|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868748|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82868749|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82868750|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82868751|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868752|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868753|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
82868754|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82868755|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82868756|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82868757|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82868758|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82868759|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82868760|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
82868762|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82868763|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868764|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82868765|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
82868766|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868767|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868768|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868769|NCT00310817|Vaccines|vaccines|mesh-list
82868770|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
82868771|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868772|NCT03783286|Ivacaftor|ivacaftor|mesh-list
82868773|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82868774|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868775|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868776|NCT03863366|Prucalopride|prucalopride|mesh-list
82868777|NCT03863366|Laxatives|laxatives|mesh-ancestor
82868778|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868779|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82868780|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82868781|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
82868782|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868783|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868784|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868785|NCT01175486|Pioglitazone|pioglitazone|mesh-list
82868786|NCT01175486|Acarbose|acarbose|mesh-list
82868787|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82868788|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868789|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82868790|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868791|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868792|NCT01177904|Progesterone|progesterone|mesh-list
82868793|NCT01177904|Progestins|progestins|mesh-ancestor
82868794|NCT01177904|Hormones|hormones|mesh-ancestor
82868795|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868796|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868797|NCT02940886|Iron|iron|mesh-list
82868798|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82868799|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82868800|NCT02940886|Trace Elements|trace elements|mesh-ancestor
82868801|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
82868802|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868803|NCT02940886|Hematinics|hematinics|mesh-ancestor
82868804|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
82868805|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82868806|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82868807|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868808|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868809|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82868810|NCT05216614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82868811|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82868812|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868813|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868814|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82868815|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
82868816|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82868817|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
82868818|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82868819|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82868820|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868821|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82868822|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82868823|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82868824|NCT03860636|Estradiol|estradiol|mesh-list
82868825|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82868826|NCT03860636|Progesterone|progesterone|mesh-list
82868827|NCT03860636|Estrogens|estrogens|mesh-ancestor
82868828|NCT03860636|Hormones|hormones|mesh-ancestor
82868829|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868830|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868831|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82868832|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
82868833|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82868834|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82868835|NCT03860636|Progestins|progestins|mesh-ancestor
82868836|NCT03860480|Bupivacaine|bupivacaine|mesh-list
82868837|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
82868838|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
82868839|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868840|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868841|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
82868842|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868843|NCT03285646|Fasinumab|fasinumab|mesh-list
82868844|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82868845|NCT03285646|Analgesics|analgesics|mesh-ancestor
82868846|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
82868847|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868848|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868849|NCT03860012|Folic Acid|folic acid|mesh-list
82868850|NCT03860012|Hematinics|hematinics|mesh-ancestor
82868851|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
82868852|NCT03860012|Vitamins|vitamins|mesh-ancestor
82868853|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
82868854|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868855|NCT03859934|Melatonin|melatonin|mesh-list
82868856|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
82868857|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868858|NCT03859934|Protective Agents|protective agents|mesh-ancestor
82868859|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868860|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82868861|NCT01178372|Lactulose|lactulose|mesh-list
82868862|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868863|NCT01178450|Cinacalcet|cinacalcet|mesh-list
82868864|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82868865|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868866|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82868867|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
82868868|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868869|NCT00074490|Prednisone|prednisone|mesh-list
82868870|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
82868871|NCT00074490|Rituximab|rituximab|mesh-list
82868872|NCT00074490|Doxorubicin|doxorubicin|mesh-list
82868873|NCT00074490|Fludarabine|fludarabine|mesh-list
82868874|NCT00074490|Etoposide|etoposide|mesh-list
82868875|NCT00074490|Vincristine|vincristine|mesh-list
82868876|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82868877|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
82868878|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868879|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868880|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82868881|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
82868882|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868883|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82868884|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82868885|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82868886|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82868887|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82868888|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82868889|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868890|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868891|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
82868892|NCT00074490|Hormones|hormones|mesh-ancestor
82868893|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868894|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82868895|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82868896|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
82868897|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
82868898|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
82868899|NCT03859856|Hormones|hormones|mesh-list
82868900|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868901|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868902|NCT01094028|Oxytocin|oxytocin|mesh-list
82868903|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
82868904|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82868905|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868906|NCT01288508|Psyllium|psyllium|mesh-list
82868907|NCT01288508|Cathartics|cathartics|mesh-ancestor
82868908|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82868909|NCT01175954|Lacosamide|lacosamide|mesh-list
82868910|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
82868911|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82868912|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82868913|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82868914|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868915|NCT01288664|Tacrolimus|tacrolimus|mesh-list
82868916|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82868917|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
82868918|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868919|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82868920|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868921|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868922|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
82868923|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868924|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868925|NCT02525276|Hormones|hormones|mesh-list
82868926|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868927|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868929|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82868930|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82868931|NCT01172444|Analgesics|analgesics|mesh-ancestor
82868932|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
82868933|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868934|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868935|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868936|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82868937|NCT01288742|Simeprevir|simeprevir|mesh-list
82868938|NCT01288742|Digoxin|digoxin|mesh-list
82868939|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82868940|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82868941|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82868942|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
82868943|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868944|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82868945|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82868946|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82868947|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82868948|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82868949|NCT01288742|Protective Agents|protective agents|mesh-ancestor
82868950|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868951|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
82868952|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868953|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
82868954|NCT01178996|Ribavirin|ribavirin|mesh-list
82868955|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82868956|NCT01178996|Thymalfasin|thymalfasin|mesh-list
82868957|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
82868958|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868959|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
82868960|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868961|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82868962|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
82868963|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868964|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
82868965|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82868966|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
82868967|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82868968|NCT03862586|Expectorants|expectorants|mesh-ancestor
82868969|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
82868970|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82868971|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
82868972|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82868973|NCT03862586|Protective Agents|protective agents|mesh-ancestor
82868974|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868975|NCT03862586|Antidotes|antidotes|mesh-ancestor
82868976|NCT01180946|Vitamin D|vitamin d|mesh-list
82868977|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
82868978|NCT01180946|Vitamins|vitamins|mesh-ancestor
82868979|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
82868980|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868981|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82868982|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82868983|NCT01179152|Budesonide|budesonide|mesh-list
82868984|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
82868985|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82868986|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82868988|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82868989|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82868990|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82868991|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
82868992|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
82868993|NCT01179152|Hormones|hormones|mesh-ancestor
82868994|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82868995|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82868996|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82868997|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82868998|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
82868999|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869000|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869001|NCT01179230|Dipyridamole|dipyridamole|mesh-list
82869002|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82869003|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869005|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82869006|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869007|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
82869008|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82869009|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
82869010|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82869011|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869012|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82869013|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82869014|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82869015|NCT01179308|Anesthetics|anesthetics|mesh-list
82869016|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869017|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869018|NCT03088826|Acetaminophen|acetaminophen|mesh-list
82869019|NCT03088826|Morphine|morphine|mesh-list
82869020|NCT03088826|Oxycodone|oxycodone|mesh-list
82869021|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82869022|NCT03088826|Narcotics|narcotics|mesh-ancestor
82869023|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869024|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869025|NCT03088826|Analgesics|analgesics|mesh-ancestor
82869026|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
82869027|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869028|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82869029|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
82869030|NCT00367133|Triamcinolone|triamcinolone|mesh-list
82869031|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82869032|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82869033|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82869034|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869035|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
82869036|NCT00367133|Hormones|hormones|mesh-ancestor
82869037|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869038|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869039|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869040|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
82869041|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869042|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869043|NCT01179464|Simvastatin|simvastatin|mesh-list
82869044|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82869045|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82869046|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
82869047|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869048|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82869049|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82869050|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869051|NCT01179620|Certoparin|certoparin|mesh-list
82869052|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
82869053|NCT01288820|Artesunate|artesunate|mesh-list
82869054|NCT01288820|Piperaquine|piperaquine|mesh-list
82869055|NCT01288820|Primaquine|primaquine|mesh-list
82869056|NCT01288820|Amodiaquine|amodiaquine|mesh-list
82869057|NCT01288820|Artenimol|artenimol|mesh-list
82869058|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
82869059|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82869060|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82869061|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869062|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869063|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
82869064|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
82869065|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82869066|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
82869067|NCT00367055|Metformin|metformin|mesh-list
82869068|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
82869069|NCT00367055|Gliclazide|gliclazide|mesh-list
82869070|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869071|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869072|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
82869073|NCT00057330|Vaccines|vaccines|mesh-list
82869074|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
82869075|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
82869076|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869077|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82869078|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82869079|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869080|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
82869081|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869082|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
82869083|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82869084|NCT00057330|Protective Agents|protective agents|mesh-ancestor
82869085|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82869086|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869087|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869088|NCT03283696|Doxorubicin|doxorubicin|mesh-list
82869089|NCT03283696|Ifosfamide|ifosfamide|mesh-list
82869090|NCT03283696|Olaratumab|olaratumab|mesh-list
82869091|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82869092|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869093|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82869094|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82869095|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869096|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869097|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82869098|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
82869099|NCT01176344|Vitamin D|vitamin d|mesh-list
82869100|NCT01176344|Vitamins|vitamins|mesh-ancestor
82869101|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
82869102|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869103|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82869104|NCT02530788|Selenium|selenium|mesh-list
82869105|NCT02530788|Selenious Acid|selenious acid|mesh-list
82869106|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
82869107|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
82869108|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869109|NCT02530788|Protective Agents|protective agents|mesh-ancestor
82869110|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869111|NCT02530788|Trace Elements|trace elements|mesh-ancestor
82869112|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
82869113|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
82869114|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82869115|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869116|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869117|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869118|NCT01089192|Metformin|metformin|mesh-list
82869119|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869120|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869121|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
82869122|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82869123|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869124|NCT02564380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82869125|NCT02564380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869126|NCT01093092|Calcitriol|calcitriol|mesh-list
82869127|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
82869128|NCT01093092|Gemcitabine|gemcitabine|mesh-list
82869129|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869130|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82869131|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
82869132|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869133|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82869134|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869135|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82869136|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869137|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82869138|NCT01093092|Vitamins|vitamins|mesh-ancestor
82869140|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82869141|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
82869142|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869143|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869144|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869145|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869146|NCT01179776|Iloprost|iloprost|mesh-list
82869147|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82869148|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869149|NCT00062010|Interferons|interferons|mesh-list
82869150|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
82869151|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
82869152|NCT00062010|Paclitaxel|paclitaxel|mesh-list
82869153|NCT00062010|Tretinoin|tretinoin|mesh-list
82869154|NCT00062010|Isotretinoin|isotretinoin|mesh-list
82869155|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82869156|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869157|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
82869158|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
82869159|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
82869160|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869161|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
82869162|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869163|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
82869164|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869165|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
82869166|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
82869167|NCT01181414|Amiodarone|amiodarone|mesh-list
82869168|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82869169|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82869170|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
82869171|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869172|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869173|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869174|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82869175|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869176|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82869177|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869178|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82869179|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82869180|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82869181|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869182|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82869183|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82869184|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82869185|NCT01094340|Thalidomide|thalidomide|mesh-list
82869186|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869187|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
82869188|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869189|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
82869190|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82869191|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869192|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82869193|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82869194|NCT01094340|Growth Substances|growth substances|mesh-ancestor
82869195|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
82869196|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869197|NCT00056862|Ribavirin|ribavirin|mesh-list
82869198|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82869199|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
82869200|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
82869201|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869202|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
82869203|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869204|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
82869205|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869206|NCT01289132|Candesartan|candesartan|mesh-list
82869207|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
82869208|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82869209|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82869210|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82869211|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82869212|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869214|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82869215|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869216|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869217|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82869218|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869219|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869220|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
82869221|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82869222|NCT01181570|Adalimumab|adalimumab|mesh-list
82869223|NCT01181570|Mannitol|mannitol|mesh-list
82869224|NCT01181570|Citric Acid|citric acid|mesh-list
82869225|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
82869226|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
82869227|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82869228|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
82869229|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
82869230|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869231|NCT01181570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82869232|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869233|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869234|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82869235|NCT01181570|Diuretics|diuretics|mesh-ancestor
82869236|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
82869237|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869238|NCT05200312|Prednisone|prednisone|mesh-list
82869239|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
82869240|NCT05200312|Rituximab|rituximab|mesh-list
82869241|NCT05200312|Doxorubicin|doxorubicin|mesh-list
82869242|NCT05200312|Vincristine|vincristine|mesh-list
82869243|NCT05200312|Lenalidomide|lenalidomide|mesh-list
82869244|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
82869245|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869246|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
82869247|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869248|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869249|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82869250|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
82869251|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869252|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869253|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82869254|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82869255|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82869256|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82869257|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82869258|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869259|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869260|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
82869261|NCT05200312|Hormones|hormones|mesh-ancestor
82869262|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869263|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82869264|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82869265|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
82869266|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
82869267|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
82869268|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82869269|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82869270|NCT05200312|Growth Substances|growth substances|mesh-ancestor
82869271|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
82869272|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869273|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
82869274|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82869275|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869276|NCT02940730|Dalbavancin|dalbavancin|mesh-list
82869277|NCT02940730|Teicoplanin|teicoplanin|mesh-list
82869278|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82869279|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869280|NCT01587638|Metoprolol|metoprolol|mesh-list
82869281|NCT01587638|Atenolol|atenolol|mesh-list
82869282|NCT01587638|Carvedilol|carvedilol|mesh-list
82869283|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
82869284|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82869285|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82869286|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
83453588|NCT05593341|Narcotics|narcotics|mesh-ancestor
82869287|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
82869288|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83511722|NCT02385110|Etoposide|etoposide|mesh-list
82869289|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869290|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82869291|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82869292|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
82869293|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869294|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869295|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
82869296|NCT01587638|Protective Agents|protective agents|mesh-ancestor
82869297|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82869298|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869299|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82869300|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869301|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82869302|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82869303|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
82869304|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82869305|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82869306|NCT01287338|Analgesics|analgesics|mesh-ancestor
82869307|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
82869308|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869309|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869310|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869311|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869312|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82869313|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82869314|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82869315|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
82869316|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
82869317|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869318|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869319|NCT01180322|Cytarabine|cytarabine|mesh-list
82869320|NCT01180322|Etoposide|etoposide|mesh-list
82869321|NCT01180322|Idarubicin|idarubicin|mesh-list
82869322|NCT01180322|Azacitidine|azacitidine|mesh-list
82869323|NCT01180322|Lenograstim|lenograstim|mesh-list
82869324|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82869325|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869326|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82869327|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82869328|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869329|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869330|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82869331|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
82869332|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
82869333|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869334|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869335|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
82869336|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869337|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82869338|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82869339|NCT01287494|Sertraline|sertraline|mesh-list
82869340|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
82869341|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82869342|NCT01287494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82869343|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82869344|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869345|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869346|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869347|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
82869348|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869349|NCT02524964|Tanshinone|tanshinone|mesh-list
82869350|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869351|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82869352|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82869353|NCT02524964|Analgesics|analgesics|mesh-ancestor
82869354|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
82869355|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869356|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869357|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869358|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869359|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
82869360|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82869361|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869362|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869363|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
82869364|NCT02639702|Clozapine|clozapine|mesh-list
82869365|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82869366|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
82869367|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869368|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869369|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869370|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82869371|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82869372|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869373|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82869374|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
82869375|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
82869376|NCT01289756|Clarithromycin|clarithromycin|mesh-list
82869377|NCT01289756|Paroxetine|paroxetine|mesh-list
82869378|NCT01289756|Clomiphene|clomiphene|mesh-list
82869379|NCT01289756|Enclomiphene|enclomiphene|mesh-list
82869380|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
82869381|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82869382|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869386|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82869387|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82869388|NCT01289756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82869389|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82869390|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869391|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869392|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
82869393|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869394|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82869395|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
82869396|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82869397|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82869398|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82869399|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
82869400|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869401|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82869402|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
82869403|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82869404|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82869405|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82869406|NCT01181882|Aspirin|aspirin|mesh-list
82869407|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82869408|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82869409|NCT01181882|Analgesics|analgesics|mesh-ancestor
82869410|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
82869411|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869412|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869413|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869414|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869415|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82869416|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82869417|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869418|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82869419|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82869420|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869421|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
82869422|NCT01181960|Risperidone|risperidone|mesh-list
82869423|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82869424|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
82869425|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82869426|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
82869427|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453591|NCT05593341|Analgesics|analgesics|mesh-ancestor
82869428|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869429|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869430|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82869431|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869432|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82869433|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82869434|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
82869435|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82869436|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82869437|NCT03858062|Insulin|insulin|mesh-list
82869438|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82869439|NCT03858062|Pancrelipase|pancrelipase|mesh-list
82869440|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869441|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869442|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82869446|NCT03307252|Metformin|metformin|mesh-list
82869447|NCT03307252|Rifampin|rifampin|mesh-list
82869448|NCT03307252|Probenecid|probenecid|mesh-list
82869449|NCT03307252|Digoxin|digoxin|mesh-list
82869450|NCT03307252|Verapamil|verapamil|mesh-list
82869451|NCT03307252|Furosemide|furosemide|mesh-list
82869452|NCT03307252|Cimetidine|cimetidine|mesh-list
82869453|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82869454|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869455|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869456|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82869457|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82869458|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
82869459|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869460|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82869461|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82869462|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869463|NCT03307252|Diuretics|diuretics|mesh-ancestor
82869464|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
82869465|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82869466|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869467|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82869468|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
82869469|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82869470|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869471|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
82869472|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82869473|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82869474|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82869475|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82869476|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82869477|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82869478|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82869479|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82869480|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82869481|NCT03307252|Protective Agents|protective agents|mesh-ancestor
82869482|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82869483|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82869484|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869485|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
82869486|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
82869487|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869488|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82869489|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82869490|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82869491|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
82869492|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
82869493|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869494|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82869495|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82869496|NCT03307174|Fentanyl|fentanyl|mesh-list
82869497|NCT03307174|Bupivacaine|bupivacaine|mesh-list
82869498|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
82869499|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
82869500|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869501|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869502|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
82869503|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869504|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82869505|NCT03307174|Narcotics|narcotics|mesh-ancestor
82869506|NCT03307174|Analgesics|analgesics|mesh-ancestor
82869507|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82869508|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82869509|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
82869510|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
82869511|NCT03448978|Fludarabine|fludarabine|mesh-list
82869512|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869513|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
82869514|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869515|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83511723|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
82869516|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82869517|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
82869518|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869519|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869520|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82869521|NCT01290926|Sorafenib|sorafenib|mesh-list
82869522|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869523|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869524|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869525|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869526|NCT01185158|Gefitinib|gefitinib|mesh-list
82869527|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869528|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869529|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083934|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
82869532|NCT01185236|Simvastatin|simvastatin|mesh-list
82869533|NCT01185236|Ezetimibe|ezetimibe|mesh-list
82869534|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82869535|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82869536|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
82869537|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869538|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82869539|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82869540|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869541|NCT02524652|Ropivacaine|ropivacaine|mesh-list
82869542|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
82869543|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
82869544|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869545|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869546|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
82869547|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869548|NCT01182272|Sorafenib|sorafenib|mesh-list
82869549|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869550|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869551|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869552|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869553|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82869554|NCT01185470|Morphine|morphine|mesh-list
82869555|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82869556|NCT01185470|Narcotics|narcotics|mesh-ancestor
82869557|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869558|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869559|NCT01185470|Analgesics|analgesics|mesh-ancestor
82869560|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
82869561|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869562|NCT00056160|Dexamethasone|dexamethasone|mesh-list
82869563|NCT00056160|Lenalidomide|lenalidomide|mesh-list
82869564|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869565|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
82869566|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
82869567|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869568|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869569|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82869570|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
82869571|NCT00056160|Hormones|hormones|mesh-ancestor
82869572|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869573|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82869574|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869575|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
82869576|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82869577|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82869578|NCT00056160|Growth Substances|growth substances|mesh-ancestor
82869579|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
82869580|NCT01290146|Simendan|simendan|mesh-list
82869581|NCT01290146|Diuretics|diuretics|mesh-list
82869582|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
82869583|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869584|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82869585|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869586|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82869587|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82869588|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869589|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869590|NCT01290146|Protective Agents|protective agents|mesh-ancestor
82869591|NCT00061932|Irinotecan|irinotecan|mesh-list
82869593|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82869594|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82869595|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869596|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869597|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869598|NCT03856970|Glyburide|glyburide|mesh-list
82869599|NCT03856970|Digoxin|digoxin|mesh-list
82869600|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82869601|NCT03856970|Norethindrone|norethindrone|mesh-list
82869602|NCT03856970|Estradiol|estradiol|mesh-list
82869603|NCT03856970|Estrogens|estrogens|mesh-ancestor
82869604|NCT03856970|Hormones|hormones|mesh-ancestor
82869605|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869607|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82869608|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
82869609|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82869610|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82869611|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82869612|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82869613|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82869614|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82869615|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869616|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869617|NCT03856970|Protective Agents|protective agents|mesh-ancestor
82869618|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869619|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82869620|NCT01089348|Metronidazole|metronidazole|mesh-list
82869621|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869622|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82869623|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82869624|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82869625|NCT01291316|Clonazepam|clonazepam|mesh-list
82869626|NCT01291316|Clobazam|clobazam|mesh-list
82869627|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82869628|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82869629|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82869630|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
82869631|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869632|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869633|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869634|NCT01291316|Urological Agents|urological agents|mesh-ancestor
82869635|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
82869636|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
82869637|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
82869638|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82869639|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82869640|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869641|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82869642|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82869643|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
82869644|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
82869645|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82869646|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
82869647|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869648|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869649|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82869650|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
82869651|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82869652|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
82869653|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869654|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869655|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82869656|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
82869657|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
82869658|NCT00060840|Protective Agents|protective agents|mesh-ancestor
82869659|NCT01185860|Ritonavir|ritonavir|mesh-list
82869660|NCT01185860|Ribavirin|ribavirin|mesh-list
82869661|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82869662|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82869663|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82869664|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
82869665|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869666|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869667|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82869668|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82869669|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
82869671|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82869672|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82869673|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
82869674|NCT01290302|Azacitidine|azacitidine|mesh-list
82869675|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82869676|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
82869677|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869678|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869679|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869680|NCT01089660|Vaccines|vaccines|mesh-list
82869681|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
82869682|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869683|NCT01182662|Cyclosporine|cyclosporine|mesh-list
82869684|NCT01182662|Cyclosporins|cyclosporins|mesh-list
82869685|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869686|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869687|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869688|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
82869689|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869690|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
82869691|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869692|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
82869693|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869694|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82869695|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82869696|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82869697|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82869698|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
82869699|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869700|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82869701|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82869702|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869703|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82869704|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82869705|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82869706|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
82869707|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82869708|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82869709|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82869710|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869711|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869712|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
82869713|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869714|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869715|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82869716|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869717|NCT03854942|Naltrexone|naltrexone|mesh-list
82869718|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82869719|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82869720|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869721|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
82869722|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869723|NCT03278626|Paclitaxel|paclitaxel|mesh-list
82869724|NCT03278626|Carboplatin|carboplatin|mesh-list
82869725|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82869726|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869727|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
82869728|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
82869729|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
82869730|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869731|NCT01186094|Sirolimus|sirolimus|mesh-list
82869732|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82869733|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869734|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82869735|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869736|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
82869737|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869738|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
82869739|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869740|NCT01287806|Urinastatin|urinastatin|mesh-list
82869741|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82869742|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82869743|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
82869744|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869745|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869746|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82869747|NCT01186172|Ethanol|ethanol|mesh-list
82869748|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869749|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82869750|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869751|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869752|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
82869753|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82869755|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869756|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869758|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82869759|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82869760|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
82869761|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869762|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869763|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869764|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82869765|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
82869766|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869767|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82869768|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
82869769|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
82869770|NCT01177514|Gabapentin|gabapentin|mesh-list
82869771|NCT01177514|Analgesics|analgesics|mesh-ancestor
82869772|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
82869773|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869774|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869775|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
82869776|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82869777|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82869778|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869779|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82869780|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82869781|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82869782|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82869783|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869784|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
82869785|NCT00073008|Lapatinib|lapatinib|mesh-list
82869786|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869787|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869788|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869789|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869790|NCT01182974|Acetaminophen|acetaminophen|mesh-list
82869791|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82869792|NCT01182974|Analgesics|analgesics|mesh-ancestor
82869793|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
82869794|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869795|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869796|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
82869797|NCT03856502|Dexamethasone|dexamethasone|mesh-list
82869798|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
82869799|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
82869800|NCT03856502|BB 1101|bb 1101|mesh-list
82869801|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869802|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
82869803|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
82869804|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869805|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869806|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82869807|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
82869808|NCT03856502|Hormones|hormones|mesh-ancestor
82869809|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869810|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82869811|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869812|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
82869813|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869814|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869815|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
82869816|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
82869817|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869818|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
82869819|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82869820|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82869821|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869822|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869823|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82869824|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82869825|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869826|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
82869828|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82869829|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82869830|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
82869831|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869832|NCT01093638|Insulin|insulin|mesh-list
82869833|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869834|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869835|NCT01287962|Apatinib|apatinib|mesh-list
82869836|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869837|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869838|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869839|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869840|NCT00058422|Prednisone|prednisone|mesh-list
82869841|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
82869842|NCT00058422|Rituximab|rituximab|mesh-list
82869843|NCT00058422|Doxorubicin|doxorubicin|mesh-list
82869844|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82869845|NCT00058422|Vincristine|vincristine|mesh-list
82869846|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
82869847|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82869848|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82869849|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
82869850|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869851|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869852|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82869853|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
82869854|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869855|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869856|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82869857|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82869858|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82869859|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82869860|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82869861|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869862|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869863|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
82869864|NCT00058422|Hormones|hormones|mesh-ancestor
82869865|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82869866|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82869867|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82869868|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
82869869|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
82869870|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
82869871|NCT00058422|Hematinics|hematinics|mesh-ancestor
82869872|NCT01094964|Interferons|interferons|mesh-list
82869873|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
82869874|NCT01094964|Epirubicin|epirubicin|mesh-list
82869875|NCT01094964|Mitomycins|mitomycins|mesh-list
82869876|NCT01094964|Mitomycin|mitomycin|mesh-list
82869877|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869878|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
82869879|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869880|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
82869881|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869882|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82869883|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82869884|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82869885|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869886|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869887|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
82869888|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82869889|NCT01291472|Ketorolac|ketorolac|mesh-list
82869890|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82869891|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82869892|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82869893|NCT01291472|Analgesics|analgesics|mesh-ancestor
82869894|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
82869895|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82869896|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869897|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82869898|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82869899|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82869900|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869901|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869903|NCT02530632|Sevoflurane|sevoflurane|mesh-list
82869904|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
82869905|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82869906|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869907|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82869908|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82869909|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
82869910|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82869911|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82869913|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869914|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
82869915|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
82869916|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
82869917|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869918|NCT00072384|Carboplatin|carboplatin|mesh-list
82869919|NCT00072384|Etoposide|etoposide|mesh-list
82869920|NCT00072384|Vincristine|vincristine|mesh-list
82869921|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
82869922|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869923|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82869924|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82869925|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82869926|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869927|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869928|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
82869929|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
82869930|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
82869931|NCT01183442|Vitamin D|vitamin d|mesh-list
82869932|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
82869933|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
82869934|NCT01183442|Vitamins|vitamins|mesh-list
82869935|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
82869936|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869937|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82869938|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82869939|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
82869940|NCT01187108|Acetazolamide|acetazolamide|mesh-list
82869941|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82869942|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
82869943|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82869944|NCT01187108|Expectorants|expectorants|mesh-ancestor
82869945|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
82869946|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82869947|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
83453615|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
82869948|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869949|NCT01187108|Protective Agents|protective agents|mesh-ancestor
82869950|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869951|NCT01187108|Antidotes|antidotes|mesh-ancestor
82869952|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
82869953|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82869954|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869955|NCT01187108|Diuretics|diuretics|mesh-ancestor
82869956|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
82869957|NCT01187888|Rasagiline|rasagiline|mesh-list
82869958|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82869959|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869960|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869961|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82869962|NCT01187888|Protective Agents|protective agents|mesh-ancestor
82869963|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869964|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
82869965|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82869966|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869967|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82869968|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869969|NCT00054132|Bevacizumab|bevacizumab|mesh-list
82869970|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82869971|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82869972|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
82869973|NCT00054132|Antibodies|antibodies|mesh-list
82869974|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
82869975|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82869976|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
82869977|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869978|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82869981|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869982|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
82869983|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
82869984|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82869985|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869986|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869987|NCT01187264|Methotrexate|methotrexate|mesh-list
82869988|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82869989|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
82869990|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82869991|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82869992|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82869993|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
82869994|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82869995|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82869996|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
82869997|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82869998|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82869999|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870000|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
82870001|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870002|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82870003|NCT01183676|Valproic Acid|valproic acid|mesh-list
82870004|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
82870005|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870006|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870007|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
82870008|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870009|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870010|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
82870011|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82870012|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870013|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82870014|NCT03856112|Dexamethasone|dexamethasone|mesh-list
82870015|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
82870016|NCT03856112|Venetoclax|venetoclax|mesh-list
82870017|NCT03856112|Ixazomib|ixazomib|mesh-list
82870018|NCT03856112|Ichthammol|ichthammol|mesh-list
82870019|NCT03856112|BB 1101|bb 1101|mesh-list
82870020|NCT03856112|Glycine|glycine|mesh-list
82870021|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870022|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
82870023|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
82870024|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870025|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870026|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870027|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
82870028|NCT03856112|Hormones|hormones|mesh-ancestor
82870029|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870030|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870031|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870032|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870033|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
82870034|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870035|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
82870036|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870037|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
82870038|NCT01290380|Vadimezan|vadimezan|mesh-list
82870039|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870040|NCT00071760|Ritonavir|ritonavir|mesh-list
82870041|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
82870042|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82870043|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82870044|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
82870045|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870046|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870047|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82870048|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82870049|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
82870050|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870051|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83511798|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
82870052|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82870107|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870108|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82870109|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
82870110|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870111|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870112|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82870113|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870114|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
82870115|NCT05234684|Hormones|hormones|mesh-ancestor
82870116|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870117|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870118|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82870119|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
82870120|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
82870121|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
82870122|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82870123|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82870124|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82870125|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82870126|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870127|NCT03853538|Petrolatum|petrolatum|mesh-list
82870128|NCT03853538|Emollients|emollients|mesh-ancestor
82870129|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
82870130|NCT03853304|Folic Acid|folic acid|mesh-list
82870131|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
82870132|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
82870134|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
82870135|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870136|NCT03853304|Hematinics|hematinics|mesh-ancestor
82870137|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
82870138|NCT01290458|Vitamins|vitamins|mesh-list
82870139|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
82870140|NCT01290458|Vitamin E|vitamin e|mesh-list
82870141|NCT01290458|Tocopherols|tocopherols|mesh-list
82870142|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
82870143|NCT01290458|Antioxidants|antioxidants|mesh-list
82870144|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
82870145|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870146|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870147|NCT01290458|Protective Agents|protective agents|mesh-ancestor
82870148|NCT01184144|Pioglitazone|pioglitazone|mesh-list
82870149|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82870150|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870151|NCT01291628|Copper|copper|mesh-list
82870152|NCT01291628|Trace Elements|trace elements|mesh-ancestor
82870153|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
82870154|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870155|NCT00053898|Tamoxifen|tamoxifen|mesh-list
82870156|NCT00053898|Anastrozole|anastrozole|mesh-list
82870157|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870158|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82870159|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
82870160|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870161|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870162|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870163|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870164|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82870165|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82870166|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82870167|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82870168|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82870169|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870170|NCT01293734|Budesonide|budesonide|mesh-list
82870171|NCT01293734|Theophylline|theophylline|mesh-list
82870172|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870173|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82870174|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
82870175|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870176|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870177|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82870178|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
82870179|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
82870180|NCT01293734|Hormones|hormones|mesh-ancestor
82870181|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870182|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82870183|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870184|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870185|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
82870186|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82870187|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82870188|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
82870189|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870190|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82870191|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82870192|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
82870193|NCT01188278|Dasatinib|dasatinib|mesh-list
82870194|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870195|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82870196|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870197|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870198|NCT01184378|Caseins|caseins|mesh-list
82870199|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
82870200|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
82870201|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870202|NCT03852602|Analgesics|analgesics|mesh-list
82870203|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
82870204|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870205|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870206|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82870208|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82870210|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
82870211|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
82870212|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82870213|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
82870214|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82870215|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
82870216|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870217|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
82870218|NCT02459392|Protective Agents|protective agents|mesh-ancestor
82870219|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870220|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
82870221|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
82870222|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870223|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870224|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
82870225|NCT02459392|Hormones|hormones|mesh-ancestor
83453623|NCT00932321|Estradiol|estradiol|mesh-list
83453625|NCT00932321|Estrogens|estrogens|mesh-ancestor
82870226|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870227|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82870228|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870229|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870230|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
82870231|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82870232|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82870233|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82870234|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
82870235|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870236|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870237|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870238|NCT03852446|Tryptophan|tryptophan|mesh-list
82870239|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82870240|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
82870241|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82870242|NCT05117710|Ebselen|ebselen|mesh-list
82870243|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82870244|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82870245|NCT05117710|Analgesics|analgesics|mesh-ancestor
82870246|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
82870247|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870248|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870249|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870250|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870251|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82870252|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870253|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
82870254|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870255|NCT05117710|Protective Agents|protective agents|mesh-ancestor
82870256|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82870257|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870258|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82870259|NCT03637582|Lidocaine|lidocaine|mesh-list
82870260|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
82870261|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
82870262|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870263|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870264|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
82870265|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870266|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82870267|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82870268|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82870269|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82870270|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870271|NCT00053352|Etoposide|etoposide|mesh-list
82870272|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
82870273|NCT00053352|Bleomycin|bleomycin|mesh-list
82870274|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870275|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82870276|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82870277|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82870278|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870279|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870284|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870285|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870287|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82870288|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
82870289|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870290|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870291|NCT05571202|Anesthetics|anesthetics|mesh-list
82870292|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870293|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870294|NCT03245398|Mebendazole|mebendazole|mesh-list
82870295|NCT03245398|Piperazine|piperazine|mesh-list
82870296|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
82870297|NCT03245398|DMP 777|dmp 777|mesh-list
82870298|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
82870299|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
82870300|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83453626|NCT00932321|Hormones|hormones|mesh-ancestor
82870301|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870302|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
82870303|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
82870304|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
82870305|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870306|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870307|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870308|NCT01291940|Petrolatum|petrolatum|mesh-list
82870309|NCT01291940|Emollients|emollients|mesh-ancestor
82870310|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
82870311|NCT03244618|Fluorides|fluorides|mesh-list
82870312|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
82870313|NCT03244618|Protective Agents|protective agents|mesh-ancestor
82870314|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870315|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
82870316|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
82870317|NCT05571046|Hormones|hormones|mesh-ancestor
82870318|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870319|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870320|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870321|NCT03849404|Adalimumab|adalimumab|mesh-list
82870322|NCT03849404|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82870323|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870324|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870325|NCT00051636|Vitamin D|vitamin d|mesh-list
82870326|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
82870327|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
82870328|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
82870329|NCT00051636|Calcium|calcium|mesh-list
82870330|NCT00051636|Vitamins|vitamins|mesh-ancestor
82870331|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
82870332|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870333|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82870334|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82870335|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82870336|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82870337|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870338|NCT01294826|Cetuximab|cetuximab|mesh-list
82870339|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82870340|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870341|NCT03847922|Lidocaine|lidocaine|mesh-list
82870342|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
82870343|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
82870344|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
82870345|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870346|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870347|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
82870348|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870349|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82870350|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82870351|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82870355|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
82870356|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82870357|NCT03847922|Analgesics|analgesics|mesh-ancestor
82870358|NCT01194284|Mifamurtide|mifamurtide|mesh-list
82870359|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82870360|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
82870361|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870362|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82870363|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
82870364|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870365|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
82870366|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870367|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
82870368|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82870369|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82870370|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870371|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
82870372|NCT01191554|Coagulants|coagulants|mesh-ancestor
82870373|NCT01296464|Carbidopa|carbidopa|mesh-list
82870374|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82870375|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82870376|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
82870377|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453630|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
82870378|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870379|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870380|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82870381|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870382|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
82870383|NCT00038142|Doxorubicin|doxorubicin|mesh-list
82870384|NCT00038142|Vincristine|vincristine|mesh-list
82870385|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
82870386|NCT00038142|Razoxane|razoxane|mesh-list
82870387|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870388|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
82870389|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870390|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870391|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82870392|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
82870393|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870394|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870395|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82870396|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82870397|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82870398|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82870399|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870400|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82870401|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
82870402|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
82870403|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
82870404|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82870405|NCT00038142|Protective Agents|protective agents|mesh-ancestor
82870406|NCT00366899|Vaccines|vaccines|mesh-list
82870407|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82870408|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
82870409|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870410|NCT03847376|Rilpivirine|rilpivirine|mesh-list
82870411|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82870412|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82870413|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870414|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870415|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
82870416|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870417|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82870418|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82870419|NCT01090128|Paclitaxel|paclitaxel|mesh-list
82870420|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
82870421|NCT01090128|Doxorubicin|doxorubicin|mesh-list
82870422|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82870423|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82870424|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870425|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
82870426|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
82870427|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
82870428|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870429|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870430|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
82870431|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870432|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870433|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82870434|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
82870435|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82870436|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82870437|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82870438|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82870439|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870441|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82870442|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82870443|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82870444|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
82870445|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870446|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
82870447|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870448|NCT01090206|Vitamin D|vitamin d|mesh-list
82870449|NCT01090206|Calcium|calcium|mesh-list
82870450|NCT01090206|Vitamins|vitamins|mesh-ancestor
82870451|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
82870452|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870453|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82870454|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82870455|NCT04728646|Dexamethasone|dexamethasone|mesh-list
82870456|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870457|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
82870458|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
82870459|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870460|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870461|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870462|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
82870463|NCT04728646|Hormones|hormones|mesh-ancestor
82870464|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870465|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870466|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870467|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82870468|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
82870469|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870470|NCT01295138|Lactulose|lactulose|mesh-list
82870471|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870472|NCT01188824|Cilostazol|cilostazol|mesh-list
82870473|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82870474|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
82870475|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870476|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870477|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82870478|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
82870479|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82870480|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82870481|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870482|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82870483|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
82870484|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82870485|NCT01188824|Protective Agents|protective agents|mesh-ancestor
82870486|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82870487|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82870488|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870489|NCT01060475|Tacrolimus|tacrolimus|mesh-list
82870490|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870491|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
82870492|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870493|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82870494|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870495|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870496|NCT01060631|Propofol|propofol|mesh-list
82870497|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82870498|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870500|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82870501|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
82870502|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
82870503|NCT03254134|Warfarin|warfarin|mesh-list
82870504|NCT03254134|Dabigatran|dabigatran|mesh-list
82870505|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
82870506|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
82870507|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82870508|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
82870509|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870510|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870511|NCT03953196|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82870512|NCT03953196|Antiviral Agents|antiviral agents|mesh-ancestor
82870513|NCT03953196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870514|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
82870515|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
82870516|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
82870517|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82870518|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82870519|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870520|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
82870521|NCT01295294|Coagulants|coagulants|mesh-ancestor
82870522|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82870523|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
82870524|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82870525|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870526|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82870527|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82870528|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82870529|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82870530|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82870531|NCT01295294|Analgesics|analgesics|mesh-ancestor
82870532|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
82870533|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870534|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870535|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870536|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82870537|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870538|NCT01191710|Progesterone|progesterone|mesh-list
82870539|NCT01191710|Progestins|progestins|mesh-ancestor
82870540|NCT01191710|Hormones|hormones|mesh-ancestor
82870541|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870542|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870543|NCT04367740|Antibodies|antibodies|mesh-list
82870544|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
82870545|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
82870546|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870547|NCT03852056|Fluorides|fluorides|mesh-list
82870548|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
82870549|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
82870550|NCT03852056|Protective Agents|protective agents|mesh-ancestor
82870551|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870552|NCT03242434|Mannitol|mannitol|mesh-list
82870553|NCT03242434|Lactulose|lactulose|mesh-list
82870554|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82870555|NCT03242434|Diuretics|diuretics|mesh-ancestor
82870556|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
82870557|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870558|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870559|NCT04222426|Atezolizumab|atezolizumab|mesh-list
82870560|NCT04222426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82870561|NCT04222426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870562|NCT04222426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82870563|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870564|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
82870565|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
82870566|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82870567|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82870568|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870569|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870570|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870571|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870572|NCT01295372|Risperidone|risperidone|mesh-list
82870573|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82870574|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
82870575|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870576|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870577|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870578|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82870579|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82870580|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870581|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82870582|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82870583|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
82870584|NCT05283278|Lactoferrin|lactoferrin|mesh-list
82870585|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870586|NCT05179018|Autoantibodies|autoantibodies|mesh-list
82870587|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
82870588|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870589|NCT01295450|Vitamins|vitamins|mesh-list
82870590|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
82870591|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870592|NCT01297010|Dexamethasone|dexamethasone|mesh-list
82870593|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
82870594|NCT01297010|BB 1101|bb 1101|mesh-list
82870595|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870596|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
82870597|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
82870598|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870599|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870600|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870601|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
82870602|NCT01297010|Hormones|hormones|mesh-ancestor
82870603|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870604|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870605|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870606|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
82870607|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870608|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870609|NCT03851432|Metformin|metformin|mesh-list
82870610|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82870611|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870612|NCT01192490|Lidocaine|lidocaine|mesh-list
82870613|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
82870614|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
82870615|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870616|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870617|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
82870618|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870619|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82870620|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82870621|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82870622|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82870623|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870624|NCT01295606|Cefazolin|cefazolin|mesh-list
82870625|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82870626|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870627|NCT01192724|Aspirin|aspirin|mesh-list
82870628|NCT01192724|Cilostazol|cilostazol|mesh-list
82870629|NCT01192724|Clopidogrel|clopidogrel|mesh-list
82870630|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82870631|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82870632|NCT01192724|Analgesics|analgesics|mesh-ancestor
82870633|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
82870634|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870635|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870636|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870637|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82870638|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82870639|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82870640|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870641|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82870642|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82870643|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870644|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
82870645|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82870646|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82870647|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82870648|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
82870649|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870652|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82870653|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
82870655|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82870656|NCT01192724|Protective Agents|protective agents|mesh-ancestor
82870657|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82870658|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82870659|NCT01192802|Albendazole|albendazole|mesh-list
82870660|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
82870661|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82870662|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870663|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
82870664|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82870665|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82870666|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
82870667|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
82870668|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
82870669|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870670|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870671|NCT01292720|Vitamin D|vitamin d|mesh-list
82870672|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
82870673|NCT01292720|Vitamins|vitamins|mesh-ancestor
82870674|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
82870675|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870676|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82870677|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82870678|NCT05671172|Bupivacaine|bupivacaine|mesh-list
82870679|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
82870680|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
82870681|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870682|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870683|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
82870684|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870685|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82870686|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82870687|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870688|NCT02939014|Immunotoxins|immunotoxins|mesh-ancestor
82870689|NCT02939014|Immunoconjugates|immunoconjugates|mesh-ancestor
82870690|NCT02939014|Immunologic Factors|immunologic factors|mesh-ancestor
82870691|NCT02939014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870692|NCT05177926|Tenofovir|tenofovir|mesh-list
82870693|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
82870694|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870695|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82870696|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82870697|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870698|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870699|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82870700|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82870701|NCT01193192|Vitamins|vitamins|mesh-list
82870702|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
82870703|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870704|NCT01193270|Vitamin E|vitamin e|mesh-list
82870705|NCT01193270|Vitamins|vitamins|mesh-ancestor
82870706|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
82870707|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870708|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
82870709|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870710|NCT01193270|Protective Agents|protective agents|mesh-ancestor
82870711|NCT01189214|Memantine|memantine|mesh-list
82870712|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82870713|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82870714|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
82870715|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870716|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870717|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870718|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82870719|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82870720|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82870721|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
82870722|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82870723|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
82870725|NCT01193504|Prednisolone|prednisolone|mesh-list
82870726|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82870727|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
82870728|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870730|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
82870731|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870732|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870733|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870734|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
82870735|NCT01193504|Hormones|hormones|mesh-ancestor
82870736|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870737|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82870738|NCT01193504|Protective Agents|protective agents|mesh-ancestor
82870739|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870740|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870741|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82870742|NCT03848780|Desflurane|desflurane|mesh-list
82870743|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82870744|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
82870745|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
82870746|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82870747|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870748|NCT05599802|Vaccines|vaccines|mesh-list
82870749|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
82870750|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870751|NCT00051558|Alendronate|alendronate|mesh-list
82870752|NCT00051558|Teriparatide|teriparatide|mesh-list
82870753|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82870754|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870755|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82870756|NCT03848234|Estradiol|estradiol|mesh-list
82870757|NCT03848234|Estrogens|estrogens|mesh-ancestor
82870758|NCT03848234|Hormones|hormones|mesh-ancestor
82870759|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870760|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870761|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82870762|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870763|NCT01195298|Bevacizumab|bevacizumab|mesh-list
82870764|NCT01195298|Capecitabine|capecitabine|mesh-list
82870765|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82870766|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870767|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82870768|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82870769|NCT01195298|Growth Substances|growth substances|mesh-ancestor
82870770|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870771|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
82870772|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82870773|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
82870774|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870775|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82870776|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82870777|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
82870778|NCT01296074|Hormones|hormones|mesh-ancestor
82870779|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870780|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870781|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82870782|NCT01296074|Protective Agents|protective agents|mesh-ancestor
82870783|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870784|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870785|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
82870786|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
82870787|NCT01189448|Spiramycin|spiramycin|mesh-list
82870788|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
82870789|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82870790|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82870791|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870792|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82870793|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870794|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870795|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82870796|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
82870797|NCT01195376|Dactolisib|dactolisib|mesh-list
82870798|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870799|NCT01189526|Ranibizumab|ranibizumab|mesh-list
82870800|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82870801|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82870802|NCT01189526|Growth Substances|growth substances|mesh-ancestor
82870803|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870804|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
82870805|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870806|NCT01296230|Hormones|hormones|mesh-list
82870807|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870808|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870809|NCT01580696|Molgramostim|molgramostim|mesh-list
82870810|NCT01580696|Vaccines|vaccines|mesh-list
82870811|NCT01580696|Sargramostim|sargramostim|mesh-list
82870812|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
82870813|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870814|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870815|NCT01197014|Losartan|losartan|mesh-list
82870816|NCT01197014|Amlodipine|amlodipine|mesh-list
82870817|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82870818|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82870819|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82870820|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870821|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82870822|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870823|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
82870824|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82870825|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82870826|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82870827|NCT01195454|Insulin|insulin|mesh-list
82870828|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82870829|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
82870830|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82870831|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870832|NCT01197170|Bevacizumab|bevacizumab|mesh-list
82870833|NCT01197170|Everolimus|everolimus|mesh-list
82870834|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82870835|NCT01197170|Sorafenib|sorafenib|mesh-list
82870836|NCT01197170|Anastrozole|anastrozole|mesh-list
82870837|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82870838|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870839|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82870840|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82870841|NCT01197170|Growth Substances|growth substances|mesh-ancestor
82870842|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870843|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
82870844|NCT01197170|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82870845|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82870846|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870847|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870848|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870849|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
82870850|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82870851|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82870852|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82870853|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82870854|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
82870855|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82870856|NCT05516966|Dulaglutide|dulaglutide|mesh-list
82870857|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82870858|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870859|NCT01195766|Ofatumumab|ofatumumab|mesh-list
82870860|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870861|NCT03850886|Niacinamide|niacinamide|mesh-list
82870862|NCT03850886|Niacin|niacin|mesh-list
82870863|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
82870864|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82870865|NCT03850886|Vitamins|vitamins|mesh-ancestor
82870866|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
82870867|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870868|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
82870869|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82870870|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
82870871|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870872|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82870873|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
82870874|NCT03251482|Apixaban|apixaban|mesh-list
82870875|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82870877|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82870878|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
82870879|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870880|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870881|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
82870882|NCT03732248|Sirolimus|sirolimus|mesh-list
82870883|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82870884|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870885|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82870886|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870887|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
82870888|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870889|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
82870890|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870891|NCT00310037|Bortezomib|bortezomib|mesh-list
82870892|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870893|NCT01196234|Paclitaxel|paclitaxel|mesh-list
82870894|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82870895|NCT01196234|Carboplatin|carboplatin|mesh-list
82870896|NCT01196234|Gefitinib|gefitinib|mesh-list
82870897|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82870898|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870899|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
82870900|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
82870901|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
82870902|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870903|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82870904|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870905|NCT03992261|Halobetasol|halobetasol|mesh-list
82870906|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82870907|NCT05292404|Alirocumab|alirocumab|mesh-list
82870908|NCT05292404|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82870909|NCT05292404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82870910|NCT05292404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82870911|NCT05292404|Antimetabolites|antimetabolites|mesh-ancestor
82870912|NCT05292404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870913|NCT05292404|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82870914|NCT05292404|Protease Inhibitors|protease inhibitors|mesh-ancestor
82870915|NCT05292404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870916|NCT05292404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82870917|NCT00309959|Paclitaxel|paclitaxel|mesh-list
82870918|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82870919|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82870920|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870921|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
82870922|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
82870923|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
82870924|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870925|NCT03238924|Oxytocin|oxytocin|mesh-list
82870926|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
82870927|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82870928|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870929|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
82870930|NCT01190384|Antioxidants|antioxidants|mesh-list
82870931|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870932|NCT01190384|Protective Agents|protective agents|mesh-ancestor
82870933|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870934|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82870935|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870936|NCT02532413|Entecavir|entecavir|mesh-list
82870937|NCT02532413|Poly I-C|poly i-c|mesh-list
82870938|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
82870939|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82870940|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
82870941|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
82870942|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870943|NCT01190462|Cetuximab|cetuximab|mesh-list
82870944|NCT01190462|Simvastatin|simvastatin|mesh-list
82870945|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82870946|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82870947|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82870948|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82870949|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
82870950|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870951|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82870952|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82870954|NCT01198106|Cinnarizine|cinnarizine|mesh-list
82870955|NCT01198106|Scopolamine|scopolamine|mesh-list
82870956|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82870957|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82870958|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
82870959|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
83512171|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
82870960|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870961|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870962|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82870963|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
82870964|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82870965|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
82870966|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870967|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83453650|NCT00932477|Glycerol|glycerol|mesh-list
82870968|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82870969|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
82870970|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82870971|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82870972|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82870973|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82870974|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
82870975|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
82870976|NCT02918500|Nicotine|nicotine|mesh-list
82870977|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82870978|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
82870979|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82870980|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870981|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82870982|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82870983|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
82870984|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82870985|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870986|NCT03850652|Iron|iron|mesh-list
82870987|NCT03850652|Trace Elements|trace elements|mesh-ancestor
82870988|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
82870989|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82870990|NCT01198184|Sirolimus|sirolimus|mesh-list
82870991|NCT01198184|Temsirolimus|temsirolimus|mesh-list
82870992|NCT01198184|MTOR Inhibitors|mtor inhibitors|mesh-list
82870993|NCT01198184|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82870994|NCT01198184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82870995|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82870996|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82870997|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82870998|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
82870999|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871000|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871001|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871002|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871003|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82871004|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
82871005|NCT01198184|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82871006|NCT00333359|Gabapentin|gabapentin|mesh-list
82871007|NCT00333359|Analgesics|analgesics|mesh-ancestor
82871008|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
82871009|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871010|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871011|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
82871012|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82871013|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82871014|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871015|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82871016|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82871017|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82871018|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871019|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871020|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
82871021|NCT03246724|Midazolam|midazolam|mesh-list
82871022|NCT03246724|Triazolam|triazolam|mesh-list
82871023|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82871024|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82871025|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871026|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871028|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82871029|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82871030|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82871031|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
82871032|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
82871033|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
82871034|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
82871035|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871036|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871037|NCT01196546|Metformin|metformin|mesh-list
82871038|NCT01196546|Vildagliptin|vildagliptin|mesh-list
82871039|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871040|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871041|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82871042|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
82871043|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871044|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871045|NCT01293266|Propofol|propofol|mesh-list
82871046|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82871047|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871048|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871049|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82871050|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
82871051|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
82871052|NCT03948646|Bromides|bromides|mesh-list
82871053|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
82871054|NCT01198340|Ropivacaine|ropivacaine|mesh-list
82871055|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
82871056|NCT01198340|Anesthetics|anesthetics|mesh-list
82871057|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871058|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871059|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
82871060|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871061|NCT01347112|Varenicline|varenicline|mesh-list
82871062|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82871063|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82871064|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
82871065|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871066|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871067|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871068|NCT00308711|Misoprostol|misoprostol|mesh-list
82871069|NCT00308711|Dinoprostone|dinoprostone|mesh-list
82871070|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82871071|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
82871072|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82871073|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871074|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82871075|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82871076|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
82871077|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82871078|NCT04057456|Nabilone|nabilone|mesh-list
82871079|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
82871080|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
82871081|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871082|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871083|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82871084|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82871085|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82871086|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871087|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82871088|NCT01198496|Losartan|losartan|mesh-list
82871089|NCT01198496|Amlodipine|amlodipine|mesh-list
82871090|NCT01198496|Valsartan|valsartan|mesh-list
82871091|NCT01198496|Telmisartan|telmisartan|mesh-list
82871092|NCT01198496|Candesartan|candesartan|mesh-list
82871093|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
82871094|NCT01198496|Olmesartan|olmesartan|mesh-list
82871095|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82871096|NCT01198496|Spironolactone|spironolactone|mesh-list
82871097|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82871098|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82871099|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871100|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871101|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82871102|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871103|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
82871104|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82871105|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82871106|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82871107|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82871108|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
82871109|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871110|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82871111|NCT01198496|Diuretics|diuretics|mesh-ancestor
82871112|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
82871113|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
82871114|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82871115|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
82871116|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871117|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871118|NCT03719326|Paclitaxel|paclitaxel|mesh-list
82871119|NCT03719326|Doxorubicin|doxorubicin|mesh-list
82871120|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82871121|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82871122|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82871123|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871124|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
82871125|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
82871126|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
82871127|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871128|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82871129|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82871130|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82871131|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871132|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
82871133|NCT03846284|Bupivacaine|bupivacaine|mesh-list
82871134|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
82871135|NCT03846284|Anesthetics|anesthetics|mesh-list
82871136|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
82871137|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871138|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871139|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
82871140|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871141|NCT03846284|Analgesics|analgesics|mesh-ancestor
82871142|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82871143|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
82871144|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82871145|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871146|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871147|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82871148|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
82871149|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82871150|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
82871151|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82871152|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871153|NCT01066169|Lactitol|lactitol|mesh-list
82871154|NCT01066169|Cathartics|cathartics|mesh-ancestor
82871155|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82871156|NCT05572060|Metformin|metformin|mesh-list
82871157|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871158|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871159|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
82871160|NCT05431244|Gemcitabine|gemcitabine|mesh-list
82871161|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82871162|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
82871163|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871164|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871165|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871166|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
82871167|NCT01199432|Fluorouracil|fluorouracil|mesh-list
82871168|NCT01199432|Epirubicin|epirubicin|mesh-list
82871169|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871170|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
82871171|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871172|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871173|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82871174|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
82871175|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871176|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871178|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
82871179|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82871180|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82871181|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82871182|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82871183|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871185|NCT05064020|Emtricitabine|emtricitabine|mesh-list
83453667|NCT00358371|Floxacillin|floxacillin|mesh-list
82871186|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82871187|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
82871188|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871189|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82871190|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82871191|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871192|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871193|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82871194|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82871195|NCT05058560|Tislelizumab|tislelizumab|mesh-list
82871196|NCT05058560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871197|NCT05058560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871198|NCT01293422|Rifampin|rifampin|mesh-list
82871199|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82871200|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
82871201|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871202|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871203|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
82871204|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82871205|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871206|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871207|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82871208|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82871209|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82871210|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82871211|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82871212|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82871213|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82871214|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
82871215|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871216|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871217|NCT01566734|Cefazolin|cefazolin|mesh-list
82871218|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871219|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871220|NCT00050778|Interferons|interferons|mesh-list
82871221|NCT00050778|Interferon-beta|interferon-beta|mesh-list
82871222|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
82871223|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
82871224|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871225|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
82871226|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871227|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871228|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
82871229|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871230|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82871231|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82871232|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
82871233|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82871234|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
82871235|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82871236|NCT00050622|Methylphenidate|methylphenidate|mesh-list
82871237|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82871238|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871239|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82871240|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82871241|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871242|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871243|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
82871244|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871245|NCT00308087|Rituximab|rituximab|mesh-list
82871246|NCT00308087|Molgramostim|molgramostim|mesh-list
82871247|NCT00308087|Sargramostim|sargramostim|mesh-list
82871248|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871249|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871251|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871252|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871253|NCT04942184|Complement Factor H|complement factor h|mesh-list
82871254|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82871255|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871256|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
82871257|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871258|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
82871259|NCT00307931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82871260|NCT00307931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871261|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871263|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871264|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871265|NCT01097148|Atracurium|atracurium|mesh-list
82871266|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82871267|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82871268|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82871269|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871270|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871271|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82871272|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82871273|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
82871274|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871275|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871276|NCT01199276|Sevoflurane|sevoflurane|mesh-list
82871277|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82871278|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82871279|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
82871280|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
82871281|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871282|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871283|NCT01202084|Fluticasone|fluticasone|mesh-list
82871284|NCT01202084|Xhance|xhance|mesh-list
82871285|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
82871286|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871287|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82871288|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
82871289|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871290|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871291|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82871292|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
82871293|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
82871294|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82871295|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82871296|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82871297|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82871298|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
82871299|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871300|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871301|NCT04133792|Simvastatin|simvastatin|mesh-list
82871302|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82871303|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82871304|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
82871305|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871306|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82871307|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82871308|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871309|NCT01202240|Ketoconazole|ketoconazole|mesh-list
82871310|NCT01202240|Tofacitinib|tofacitinib|mesh-list
82871311|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
82871312|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871313|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82871314|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82871315|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871316|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871317|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82871318|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
82871319|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871320|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871321|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82871323|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82871324|NCT01204112|Rifampin|rifampin|mesh-list
82871325|NCT01204112|Tofacitinib|tofacitinib|mesh-list
82871326|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82871327|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
82871328|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871329|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871330|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
82871331|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82871332|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871333|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871334|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82871335|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82871336|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82871337|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82871338|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82871339|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82871340|NCT01204112|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82871341|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82871342|NCT01204190|Gestodene|gestodene|mesh-list
82871343|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82871344|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82871345|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82871346|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
82871347|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82871348|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871349|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82871350|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82871351|NCT01204190|Progestins|progestins|mesh-ancestor
82871352|NCT01204190|Hormones|hormones|mesh-ancestor
82871353|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871354|NCT01204268|Sevoflurane|sevoflurane|mesh-list
82871355|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82871356|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82871357|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
82871358|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
82871359|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871360|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871361|NCT02965898|Vitamin D|vitamin d|mesh-list
82871362|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
82871363|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
82871364|NCT02965898|Vitamins|vitamins|mesh-list
82871365|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
82871366|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871367|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82871368|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82871369|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
82871370|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
82871371|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82871372|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871373|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871374|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871375|NCT03844178|Tetracaine|tetracaine|mesh-list
82871376|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
82871377|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
82871378|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871379|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871380|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
82871381|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871382|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82871383|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
82871384|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871385|NCT00307151|Ritonavir|ritonavir|mesh-list
82871386|NCT00307151|Lopinavir|lopinavir|mesh-list
82871387|NCT00307151|Lamivudine|lamivudine|mesh-list
82871388|NCT00307151|Zidovudine|zidovudine|mesh-list
82871389|NCT00307151|Nevirapine|nevirapine|mesh-list
82871390|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82871391|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82871392|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
82871393|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871394|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871395|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82871397|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
82871398|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871399|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82871400|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82871401|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82871402|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82871403|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
82871404|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82871405|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82871406|NCT03981029|Folic Acid|folic acid|mesh-list
82871407|NCT03981029|Hematinics|hematinics|mesh-ancestor
82871408|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
82871409|NCT03981029|Vitamins|vitamins|mesh-ancestor
82871410|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
82871411|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871412|NCT02654132|Dexamethasone|dexamethasone|mesh-list
82871413|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
82871414|NCT02654132|Pomalidomide|pomalidomide|mesh-list
82871415|NCT02654132|Elotuzumab|elotuzumab|mesh-list
82871416|NCT02654132|BB 1101|bb 1101|mesh-list
82871417|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871418|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
82871419|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
82871420|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871421|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871422|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82871423|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
82871424|NCT02654132|Hormones|hormones|mesh-ancestor
82871425|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871426|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82871427|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871428|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
82871429|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871430|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871431|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
82871432|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82871433|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82871434|NCT02654132|Growth Substances|growth substances|mesh-ancestor
82871435|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
82871436|NCT01064141|Vaccines|vaccines|mesh-list
82871437|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
82871438|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871439|NCT03837470|Furosemide|furosemide|mesh-list
82871440|NCT03837470|Diuretics|diuretics|mesh-ancestor
82871441|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
82871442|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871443|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82871444|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871445|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871446|NCT05307874|Aldesleukin|aldesleukin|mesh-list
82871447|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871448|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82871449|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82871450|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
82871451|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871452|NCT01199900|Prednisone|prednisone|mesh-list
82871453|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871454|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
82871455|NCT01199900|Hormones|hormones|mesh-ancestor
82871456|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871457|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871458|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82871459|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871460|NCT01200056|Atorvastatin|atorvastatin|mesh-list
82871461|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82871462|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82871463|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
82871464|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871465|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82871466|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82871467|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871468|NCT03841526|Glucagon|glucagon|mesh-list
82871469|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82871470|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82871472|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871473|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871474|NCT03841526|Incretins|incretins|mesh-ancestor
82871475|NCT01200212|Bevacizumab|bevacizumab|mesh-list
82871476|NCT01200212|Taxane|taxane|mesh-list
82871477|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871478|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871479|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82871480|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82871481|NCT01200212|Growth Substances|growth substances|mesh-ancestor
82871482|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871483|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
82871484|NCT03978845|Lidocaine|lidocaine|mesh-list
82871485|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
82871486|NCT03978845|Anesthetics|anesthetics|mesh-list
82871487|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871488|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871489|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
82871490|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871491|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82871492|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82871493|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82871494|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871495|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871497|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871498|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871499|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82871500|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871501|NCT01204580|Metformin|metformin|mesh-list
82871502|NCT01204580|Glimepiride|glimepiride|mesh-list
82871503|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871504|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871505|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82871506|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871507|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
82871508|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
82871509|NCT03850366|Bortezomib|bortezomib|mesh-list
82871510|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871511|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
82871512|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871513|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871514|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82871515|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
82871516|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871517|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871518|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82871519|NCT05181592|Luspatercept|luspatercept|mesh-list
82871520|NCT05181592|Hematinics|hematinics|mesh-ancestor
82871521|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82871522|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82871523|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82871524|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82871525|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
82871526|NCT03229486|Neostigmine|neostigmine|mesh-list
82871527|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82871528|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871529|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871530|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
82871531|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871532|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871533|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82871534|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
82871535|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871536|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82871537|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82871538|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82871539|NCT05153668|Everolimus|everolimus|mesh-list
82871540|NCT05153668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82871541|NCT05153668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82871542|NCT05153668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871543|NCT05153668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871544|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871546|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871547|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871548|NCT03833570|Melatonin|melatonin|mesh-list
82871549|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
82871550|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871551|NCT03833570|Protective Agents|protective agents|mesh-ancestor
82871552|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871553|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871554|NCT01779050|Paclitaxel|paclitaxel|mesh-list
82871555|NCT01779050|Docetaxel|docetaxel|mesh-list
82871556|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
82871557|NCT01779050|Carboplatin|carboplatin|mesh-list
82871558|NCT01779050|Doxorubicin|doxorubicin|mesh-list
82871559|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82871560|NCT01779050|Fluorouracil|fluorouracil|mesh-list
82871561|NCT01779050|Trastuzumab|trastuzumab|mesh-list
82871562|NCT01779050|Epirubicin|epirubicin|mesh-list
82871563|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82871564|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871565|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
82871566|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
82871567|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
82871568|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871569|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871570|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
82871571|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871572|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871573|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82871574|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
82871575|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82871576|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82871577|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82871578|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82871579|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871580|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
82871581|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82871582|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871583|NCT03841136|Etoposide|etoposide|mesh-list
82871584|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82871585|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871586|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82871587|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82871588|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871589|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871590|NCT05669768|Tamoxifen|tamoxifen|mesh-list
82871591|NCT05669768|Pamiparib|pamiparib|mesh-list
82871592|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82871593|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
82871594|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871595|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871596|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82871597|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871598|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82871599|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82871600|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82871601|NCT05669768|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82871602|NCT05669768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871603|NCT05669768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871604|NCT00306527|Vaccines|vaccines|mesh-list
82871605|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
82871606|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871607|NCT01066247|Midazolam|midazolam|mesh-list
82871608|NCT01066247|Morphine|morphine|mesh-list
82871609|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82871610|NCT01066247|Narcotics|narcotics|mesh-ancestor
82871611|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871612|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871613|NCT01066247|Analgesics|analgesics|mesh-ancestor
82871614|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
82871615|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871616|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82871617|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82871618|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82871619|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82871620|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82871621|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82871622|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
82871623|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
82871624|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
82871625|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
82871626|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871627|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871628|NCT00306293|Valacyclovir|valacyclovir|mesh-list
82871629|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
82871630|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871631|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
82871632|NCT03980951|Narcotics|narcotics|mesh-ancestor
82871633|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871634|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871635|NCT03980951|Analgesics|analgesics|mesh-ancestor
82871636|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
82871637|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871638|NCT02532491|Risperidone|risperidone|mesh-list
82871639|NCT02532491|Aripiprazole|aripiprazole|mesh-list
82871640|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82871641|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
82871642|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871643|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871644|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871645|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82871646|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82871647|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871648|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82871649|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82871650|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
82871651|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
82871652|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
82871653|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82871654|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82871655|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82871656|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82871657|NCT01066403|Pergolide|pergolide|mesh-list
82871658|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
82871659|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
82871660|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871661|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871662|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871663|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82871664|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82871665|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871666|NCT00294671|Diflunisal|diflunisal|mesh-list
82871667|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82871668|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82871669|NCT00294671|Analgesics|analgesics|mesh-ancestor
82871670|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
82871671|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871672|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871673|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871674|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871675|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82871676|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871677|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871678|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82871679|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82871680|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871681|NCT03980249|Carvedilol|carvedilol|mesh-list
82871682|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82871683|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82871684|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
82871685|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871686|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871687|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871688|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82871689|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
82871690|NCT03980249|Protective Agents|protective agents|mesh-ancestor
82871691|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82871692|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871693|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82871694|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
82871695|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82871696|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82871697|NCT01495598|Pomalidomide|pomalidomide|mesh-list
82871698|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
82871699|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871700|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82871701|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82871702|NCT01495598|Growth Substances|growth substances|mesh-ancestor
82871703|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
82871704|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871705|NCT01297166|Calcitriol|calcitriol|mesh-list
82871706|NCT01297166|Calcipotriene|calcipotriene|mesh-list
82871707|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
82871708|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82871709|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871710|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82871711|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871712|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871713|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82871714|NCT01297166|Vitamins|vitamins|mesh-ancestor
82871715|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
82871716|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82871717|NCT01202474|Insulin|insulin|mesh-list
82871718|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82871719|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
82871720|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
82871721|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871722|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871723|NCT05667818|Norfloxacin|norfloxacin|mesh-list
82871724|NCT05667818|Amlodipine|amlodipine|mesh-list
82871725|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82871726|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82871727|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871728|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871729|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82871730|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871731|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
82871732|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871733|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871734|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82871735|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82871736|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871737|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871738|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82871739|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82871740|NCT01205204|Clonidine|clonidine|mesh-list
82871741|NCT01205204|Fentanyl|fentanyl|mesh-list
82871742|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82871743|NCT01205204|Narcotics|narcotics|mesh-ancestor
82871744|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871745|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871746|NCT01205204|Analgesics|analgesics|mesh-ancestor
82871747|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
82871748|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871749|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82871750|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82871751|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
82871752|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
82871753|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82871754|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
82871755|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
82871756|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82871757|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82871758|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82871759|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
82871760|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871761|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871762|NCT01205282|Pioglitazone|pioglitazone|mesh-list
82871763|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871764|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871765|NCT03902912|Prednisolone|prednisolone|mesh-list
82871766|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871767|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
82871768|NCT03902912|Hormones|hormones|mesh-ancestor
82871769|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871770|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871771|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82871772|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871773|NCT01205360|Fentanyl|fentanyl|mesh-list
82871774|NCT01205360|Bupivacaine|bupivacaine|mesh-list
82871775|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
82871776|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
82871777|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871778|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871779|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
82871780|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871781|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82871782|NCT01205360|Narcotics|narcotics|mesh-ancestor
82871783|NCT01205360|Analgesics|analgesics|mesh-ancestor
82871784|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82871785|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82871786|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
82871787|NCT01200914|Heparin|heparin|mesh-list
82871788|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
82871789|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82871790|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82871791|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871793|NCT01205516|Methadone|methadone|mesh-list
82871794|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82871795|NCT01205516|Narcotics|narcotics|mesh-ancestor
82871796|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82871797|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871798|NCT01205516|Analgesics|analgesics|mesh-ancestor
82871799|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
82871800|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871801|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
82871802|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
82871803|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
82871804|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82871805|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82871806|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82871807|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82871808|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871809|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
82871810|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871811|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871812|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82871813|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871814|NCT01201070|Antithrombins|antithrombins|mesh-list
82871815|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
82871816|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82871817|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
82871818|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871819|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871820|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
82871821|NCT01205672|Metformin|metformin|mesh-list
82871822|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871823|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871824|NCT03817970|Ondansetron|ondansetron|mesh-list
82871825|NCT03817970|Palonosetron|palonosetron|mesh-list
82871826|NCT03817970|Granisetron|granisetron|mesh-list
82871827|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
82871828|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
82871829|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871830|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871831|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82871832|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
82871833|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
82871834|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82871835|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82871836|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
82871837|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82871838|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871839|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
82871840|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
82871841|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871842|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871843|NCT03457948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82871844|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871845|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82871846|NCT01205750|Insulin|insulin|mesh-list
82871847|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82871848|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871849|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871850|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
82871851|NCT03012386|Citric Acid|citric acid|mesh-list
82871852|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
82871853|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
82871854|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82871855|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
82871856|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
82871857|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871858|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
82871859|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82871860|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82871861|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871862|NCT03012386|Urological Agents|urological agents|mesh-ancestor
82871863|NCT01202552|Vaccines|vaccines|mesh-list
82871864|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
82871865|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871866|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82871867|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
82871868|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82871869|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82871870|NCT01205984|Prednisolone|prednisolone|mesh-list
82871871|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
82871872|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82871873|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
82871874|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871875|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
82871876|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
82871877|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82871878|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871879|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82871880|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
82871881|NCT01205984|Hormones|hormones|mesh-ancestor
82871882|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871883|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82871884|NCT01205984|Protective Agents|protective agents|mesh-ancestor
82871885|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82871886|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871887|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871888|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871889|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82871890|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871891|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871892|NCT01297946|Hormones|hormones|mesh-list
82871893|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871894|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871895|NCT03211858|Insulin|insulin|mesh-list
82871896|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82871897|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
82871898|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
82871899|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
82871900|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82871901|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82871902|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871903|NCT01298180|Hormones|hormones|mesh-list
82871904|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82871905|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871906|NCT03211156|Amoxicillin|amoxicillin|mesh-list
82871907|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871908|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871909|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
82871910|NCT01298336|Clarithromycin|clarithromycin|mesh-list
82871911|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82871912|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871913|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82871914|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82871915|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871916|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871917|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871918|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82871919|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82871921|NCT04472494|Abatacept|abatacept|mesh-list
82871922|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82871923|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871924|NCT04472494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871925|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871926|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871927|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
82871928|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871929|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871930|NCT04568200|Paclitaxel|paclitaxel|mesh-list
82871931|NCT04568200|Carboplatin|carboplatin|mesh-list
82871932|NCT04568200|Durvalumab|durvalumab|mesh-list
82871933|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82871934|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871935|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
82871936|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
82871937|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
82871938|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83512324|NCT01744574|Progestins|progestins|mesh-ancestor
82871939|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871940|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
82871941|NCT03236506|Grazoprevir|grazoprevir|mesh-list
82871942|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82871943|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
82871944|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871945|NCT01298882|Diacerein|diacerein|mesh-list
82871946|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82871947|NCT01206530|Leucovorin|leucovorin|mesh-list
82871948|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
82871949|NCT01206530|Bevacizumab|bevacizumab|mesh-list
82871950|NCT01206530|Fluorouracil|fluorouracil|mesh-list
82871951|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
82871952|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871953|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871954|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82871955|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82871956|NCT01206530|Growth Substances|growth substances|mesh-ancestor
82871957|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871958|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
82871959|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
82871960|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871961|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82871962|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82871963|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
82871964|NCT01206530|Antidotes|antidotes|mesh-ancestor
82871965|NCT01206530|Protective Agents|protective agents|mesh-ancestor
82871966|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
82871967|NCT01206530|Vitamins|vitamins|mesh-ancestor
82871968|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
82871969|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
82871970|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82871971|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82871972|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82871973|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82871974|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82871975|NCT03209518|Leuprolide|leuprolide|mesh-list
82871976|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82871977|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
82871978|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82871979|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871980|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82871981|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871982|NCT05282420|Ranibizumab|ranibizumab|mesh-list
82871983|NCT05282420|Aflibercept|aflibercept|mesh-list
82871984|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82871985|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82871986|NCT05282420|Growth Substances|growth substances|mesh-ancestor
82871987|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82871988|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
82871989|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871990|NCT00304031|Temozolomide|temozolomide|mesh-list
82871991|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82871992|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
82871993|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82871994|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82871995|NCT01567124|Moxonidine|moxonidine|mesh-list
82871996|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82871997|NCT03617666|Avelumab|avelumab|mesh-list
82871998|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82871999|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872000|NCT01299194|Atorvastatin|atorvastatin|mesh-list
82872001|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82872002|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82872003|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
82872004|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872005|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82872006|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82872007|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872008|NCT03827408|Midazolam|midazolam|mesh-list
82872009|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
82872010|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82872011|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872012|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872013|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872014|NCT03827408|Analgesics|analgesics|mesh-ancestor
82872015|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
83512325|NCT01744574|Hormones|hormones|mesh-ancestor
82872016|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872017|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82872018|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82872019|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82872020|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
82872021|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872022|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872023|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82872024|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82872025|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82872026|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82872027|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82872028|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
82872029|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
82872030|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
82872031|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
82872032|NCT03556904|Docetaxel|docetaxel|mesh-list
82872033|NCT03556904|Hormones|hormones|mesh-list
82872034|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872035|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872036|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872037|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872038|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872039|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872040|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872041|NCT00332189|Verapamil|verapamil|mesh-list
82872042|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82872043|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82872044|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82872045|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872046|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82872047|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872048|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
82872049|NCT01206998|Progesterone|progesterone|mesh-list
82872050|NCT01206998|Progestins|progestins|mesh-ancestor
82872051|NCT01206998|Hormones|hormones|mesh-ancestor
82872052|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872053|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872054|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82872055|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82872056|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82872057|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82872058|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872059|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872060|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872061|NCT00331799|Analgesics|analgesics|mesh-ancestor
82872062|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
82872063|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872064|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
82872065|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82872066|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
82872067|NCT03826940|Lovastatin|lovastatin|mesh-list
82872068|NCT03826940|L 647318|l 647318|mesh-list
82872069|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
82872070|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82872071|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82872072|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
82872073|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872074|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82872075|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82872076|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872077|NCT01201694|Curcumin|curcumin|mesh-list
82872078|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82872079|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872080|NCT01201694|Analgesics|analgesics|mesh-ancestor
82872081|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
82872082|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872083|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872084|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872085|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872086|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872087|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872088|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872090|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82872091|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872092|NCT00303719|Cyclosporine|cyclosporine|mesh-list
82872093|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
82872094|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
82872095|NCT00303719|Fludarabine|fludarabine|mesh-list
82872096|NCT00303719|Cyclosporins|cyclosporins|mesh-list
82872097|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82872098|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872099|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
82872100|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872101|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872102|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82872103|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
82872104|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872105|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872106|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82872107|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872108|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
82872109|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872110|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
82872111|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82872112|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82872113|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82872114|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
82872115|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82872116|NCT01207310|Nicotine|nicotine|mesh-list
82872117|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82872118|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
82872119|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872120|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872121|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82872122|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82872123|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
83453693|NCT05582499|Carboplatin|carboplatin|mesh-list
82872124|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872125|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872126|NCT00331409|Everolimus|everolimus|mesh-list
82872127|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
82872128|NCT00331409|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82872129|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82872130|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872131|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872132|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872133|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
82872134|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872135|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872136|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82872137|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82872138|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82872139|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
82872140|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872141|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82872142|NCT01064921|Vorinostat|vorinostat|mesh-list
82872143|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872144|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82872146|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872147|NCT01299662|Poly ICLC|poly iclc|mesh-list
82872148|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
82872149|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
82872150|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872151|NCT00303485|Vitamin D|vitamin d|mesh-list
82872152|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
82872153|NCT00303485|Calcium|calcium|mesh-list
82872154|NCT00303485|Vitamins|vitamins|mesh-ancestor
82872155|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
82872156|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872157|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82872158|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82872159|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
82872160|NCT03983915|Remifentanil|remifentanil|mesh-list
82872161|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82872162|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872163|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872164|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872165|NCT03983915|Analgesics|analgesics|mesh-ancestor
82872166|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
82872167|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872168|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82872169|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82872170|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82872171|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
82872172|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872173|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872174|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82872175|NCT03983915|Narcotics|narcotics|mesh-ancestor
82872176|NCT01300754|Lidocaine|lidocaine|mesh-list
82872177|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
82872178|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
82872179|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872180|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872181|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
82872182|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872183|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82872184|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82872185|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83453726|NCT02881996|Ketorolac|ketorolac|mesh-list
82872186|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82872187|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872188|NCT00303953|Belinostat|belinostat|mesh-list
82872189|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872190|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82872191|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872192|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872193|NCT03840122|Anesthetics|anesthetics|mesh-list
82872194|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
82872195|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872196|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872197|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
82872198|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872199|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
82872200|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82872201|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
82872202|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872203|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
82872204|NCT03723590|Protective Agents|protective agents|mesh-ancestor
82872205|NCT04343872|Metformin|metformin|mesh-list
82872206|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82872207|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872208|NCT01314274|Bevacizumab|bevacizumab|mesh-list
82872209|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82872210|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872211|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82872212|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82872213|NCT01314274|Growth Substances|growth substances|mesh-ancestor
82872214|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872215|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
82872216|NCT02935894|Ibuprofen|ibuprofen|mesh-list
82872217|NCT02935894|Pilocarpine|pilocarpine|mesh-list
82872218|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82872219|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872221|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
82872222|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872223|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872224|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872225|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872226|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82872227|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872228|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872229|NCT02935894|Miotics|miotics|mesh-ancestor
82872230|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
82872231|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82872232|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82872233|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
82872234|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872235|NCT03224182|Apaziquone|apaziquone|mesh-list
82872236|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872237|NCT03821480|Fluconazole|fluconazole|mesh-list
82872238|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
82872239|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872240|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83512399|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
82872241|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82872242|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872243|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872244|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82872245|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
82872246|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872247|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872248|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82872249|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82872250|NCT01203488|Vitamin A|vitamin a|mesh-list
82872251|NCT01203488|Vitamins|vitamins|mesh-ancestor
82872252|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
82872253|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872254|NCT03697720|Naproxen|naproxen|mesh-list
82872255|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82872256|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872257|NCT03697720|Analgesics|analgesics|mesh-ancestor
82872258|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
82872259|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872260|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872261|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872262|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872263|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
82872264|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82872265|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872266|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872267|NCT01314352|Desloratadine|desloratadine|mesh-list
82872268|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82872269|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
82872270|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872271|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872272|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872273|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82872274|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82872275|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
82872276|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
82872277|NCT03818282|Paclitaxel|paclitaxel|mesh-list
82872278|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82872279|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872280|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872281|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872282|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872283|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872284|NCT01300364|Citalopram|citalopram|mesh-list
82872285|NCT01300364|Reboxetine|reboxetine|mesh-list
82872286|NCT01300364|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82872287|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82872288|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82872289|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872290|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872291|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
82872292|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872293|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82872294|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
82872296|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82872297|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
82872298|NCT03221842|Complement C1s|complement c1s|mesh-list
82872299|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82872300|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
82872301|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
82872302|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872303|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82872304|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872305|NCT05622890|Maytansine|maytansine|mesh-list
82872306|NCT05622890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
82872307|NCT05622890|Immunoconjugates|immunoconjugates|mesh-ancestor
82872308|NCT05622890|Immunologic Factors|immunologic factors|mesh-ancestor
82872309|NCT05622890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872310|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82872311|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872312|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872313|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872314|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872315|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872316|NCT00303329|Deferasirox|deferasirox|mesh-list
82872317|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82872318|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
82872319|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
82872320|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872321|NCT01300988|Aprepitant|aprepitant|mesh-list
82872322|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
82872323|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
82872324|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
82872325|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872326|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872327|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872328|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82872329|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872330|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872331|NCT01064999|Capecitabine|capecitabine|mesh-list
82872332|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
82872333|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82872334|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
82872335|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872336|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872337|NCT03818048|Propofol|propofol|mesh-list
82872338|NCT03818048|Sevoflurane|sevoflurane|mesh-list
82872339|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82872340|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872341|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872342|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82872343|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
82872344|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
82872345|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82872346|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82872347|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
82872348|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82872349|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82872350|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872351|NCT00329849|Vaccines|vaccines|mesh-list
82872352|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
82872353|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872354|NCT05655806|Aminophylline|aminophylline|mesh-list
82872355|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82872356|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
82872357|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872358|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872359|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82872360|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
82872361|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82872362|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82872363|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872364|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872365|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82872367|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
82872368|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872369|NCT05655806|Protective Agents|protective agents|mesh-ancestor
82872370|NCT01300676|Estradiol|estradiol|mesh-list
82872371|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
82872372|NCT01300676|Estrogens|estrogens|mesh-ancestor
82872373|NCT01300676|Hormones|hormones|mesh-ancestor
82872374|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872375|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872376|NCT01300676|Progestins|progestins|mesh-ancestor
82872377|NCT03113968|Ketamine|ketamine|mesh-list
82872378|NCT03113968|Analgesics|analgesics|mesh-ancestor
82872379|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
82872380|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872381|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872382|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82872383|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82872384|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
82872385|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
82872386|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872387|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82872388|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82872389|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83512475|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
82872390|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872391|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
82872392|NCT00329303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82872393|NCT00329303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872394|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872395|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
82872396|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872397|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872398|NCT03806816|Melatonin|melatonin|mesh-list
82872399|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
83453735|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872400|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872401|NCT03806816|Protective Agents|protective agents|mesh-ancestor
82872402|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872403|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872404|NCT01301222|Octreotide|octreotide|mesh-list
82872405|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872406|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82872407|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872408|NCT02532569|Vaccines|vaccines|mesh-list
82872409|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
82872410|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872411|NCT01302002|Metformin|metformin|mesh-list
82872412|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82872413|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872414|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82872415|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
82872416|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
82872417|NCT03814616|Artesunate|artesunate|mesh-list
82872418|NCT03814616|Pyronaridine|pyronaridine|mesh-list
82872419|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
82872420|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82872421|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82872422|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872423|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872424|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
82872425|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
82872426|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82872427|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
82872428|NCT00302159|Temozolomide|temozolomide|mesh-list
82872429|NCT00302159|Valproic Acid|valproic acid|mesh-list
82872430|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82872431|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
82872432|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872433|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872434|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
82872435|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872436|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
82872437|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872438|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872439|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
82872440|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82872441|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872443|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
82872444|NCT03814226|Growth Substances|growth substances|mesh-ancestor
82872445|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872446|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
82872447|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872448|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872449|NCT00302081|Ribavirin|ribavirin|mesh-list
82872450|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82872451|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
82872452|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
82872453|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872454|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
82872455|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872456|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
82872457|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872458|NCT00302003|Cytarabine|cytarabine|mesh-list
82872459|NCT00302003|Dexamethasone|dexamethasone|mesh-list
82872460|NCT00302003|Prednisone|prednisone|mesh-list
82872461|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
82872462|NCT00302003|Ifosfamide|ifosfamide|mesh-list
82872463|NCT00302003|Doxorubicin|doxorubicin|mesh-list
82872464|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82872465|NCT00302003|Etoposide|etoposide|mesh-list
82872466|NCT00302003|Vincristine|vincristine|mesh-list
82872467|NCT00302003|Vinorelbine|vinorelbine|mesh-list
82872468|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
82872469|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872470|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
82872471|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872472|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872473|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82872474|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
83453737|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872475|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872476|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872477|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82872478|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872479|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
82872480|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
82872481|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872482|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872483|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
82872484|NCT00302003|Hormones|hormones|mesh-ancestor
82872485|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872486|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82872487|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82872488|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82872489|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82872490|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872491|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82872492|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82872493|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
82872494|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
82872495|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872496|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872497|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872498|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872499|NCT00036270|Tamoxifen|tamoxifen|mesh-list
82872500|NCT00036270|Exemestane|exemestane|mesh-list
82872501|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82872502|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
82872503|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872504|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872505|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82872506|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872507|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82872508|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82872509|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82872510|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82872511|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82872512|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872513|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872514|NCT01097382|Zolpidem|zolpidem|mesh-list
82872515|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82872516|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82872536|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
82872537|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872538|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872539|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82872540|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872541|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82872542|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82872543|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82872544|NCT00301067|Vitamins|vitamins|mesh-ancestor
82872545|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
82872546|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82872547|NCT03979859|Nafithromycin|nafithromycin|mesh-list
82872548|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82872549|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872550|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82872551|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872552|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872553|NCT03955458|Bupivacaine|bupivacaine|mesh-list
82872554|NCT03955458|Ropivacaine|ropivacaine|mesh-list
82872555|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
82872556|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
82872557|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872558|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872559|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
82872560|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872561|NCT00007020|Cholic Acids|cholic acids|mesh-list
82872562|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872563|NCT00300755|Pantoprazole|pantoprazole|mesh-list
83453740|NCT04367831|Calcium heparin|calcium heparin|mesh-list
82872564|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82872565|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872566|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82872567|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872568|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872569|NCT00033540|Gemcitabine|gemcitabine|mesh-list
82872570|NCT00033540|Capecitabine|capecitabine|mesh-list
82872571|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82872572|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
82872573|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872574|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872575|NCT00300365|Aspirin|aspirin|mesh-list
82872576|NCT00300365|Niacin|niacin|mesh-list
82872577|NCT00300365|Pioglitazone|pioglitazone|mesh-list
82872578|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82872579|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872580|NCT00300365|Analgesics|analgesics|mesh-ancestor
82872581|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
82872582|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872583|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872584|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872585|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872586|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82872587|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82872588|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872589|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82872591|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872592|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
82872593|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82872594|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82872595|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
82872596|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82872597|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
82872598|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
82872599|NCT00300365|Vitamins|vitamins|mesh-ancestor
82872600|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
82872601|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82872602|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872603|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
82872604|NCT00048048|Hematinics|hematinics|mesh-ancestor
82872605|NCT03953118|Azithromycin|azithromycin|mesh-list
82872606|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82872607|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872608|NCT01101204|Metformin|metformin|mesh-list
82872609|NCT01101204|Simvastatin|simvastatin|mesh-list
82872610|NCT01101204|Fenofibrate|fenofibrate|mesh-list
82872611|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82872612|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872613|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82872614|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82872615|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
82872616|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872617|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82872618|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82872619|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872620|NCT01095822|Valsartan|valsartan|mesh-list
82872621|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82872622|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82872623|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82872624|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872625|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
82872626|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82872627|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82872628|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872629|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
82872630|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872631|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872632|NCT00300053|Lenograstim|lenograstim|mesh-list
82872633|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82872634|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
82872635|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872636|NCT01098084|Decitabine|decitabine|mesh-list
82872637|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82872638|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
82872639|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872640|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872641|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872642|NCT03952572|Prednisone|prednisone|mesh-list
82872643|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
82872644|NCT03952572|Doxorubicin|doxorubicin|mesh-list
82872645|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82872646|NCT03952572|Vincristine|vincristine|mesh-list
82872647|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872648|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
82872649|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872650|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872651|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82872652|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
82872653|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872654|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872655|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82872656|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82872657|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82872658|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82872659|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872660|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872661|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
82872662|NCT03952572|Hormones|hormones|mesh-ancestor
82872663|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872664|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82872665|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82872666|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872667|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872668|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872670|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872671|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82872672|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872673|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872674|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
82872675|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82872676|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82872677|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872678|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82872679|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82872680|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
82872681|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872682|NCT00326885|Catumaxomab|catumaxomab|mesh-list
82872683|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872684|NCT00326495|Cetuximab|cetuximab|mesh-list
82872685|NCT00326495|Sorafenib|sorafenib|mesh-list
82872686|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82872687|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872688|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82872689|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872690|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872691|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
82872692|NCT00326417|Fludarabine|fludarabine|mesh-list
82872693|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872694|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
82872695|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872696|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872697|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82872698|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
82872699|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872700|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872701|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82872702|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82872703|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82872704|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
82872705|NCT01060787|Hormones|hormones|mesh-ancestor
82872706|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872707|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872708|NCT01065467|Panobinostat|panobinostat|mesh-list
82872709|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872710|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82872711|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872712|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872713|NCT01065545|Clofarabine|clofarabine|mesh-list
82872714|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82872715|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
82872716|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872717|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872719|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
82872720|NCT03979469|Ketamine|ketamine|mesh-list
82872721|NCT03979469|Remifentanil|remifentanil|mesh-list
82872722|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82872723|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872724|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872725|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872726|NCT03979469|Analgesics|analgesics|mesh-ancestor
82872727|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
82872728|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872729|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82872730|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82872731|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82872732|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
82872733|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872734|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872735|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82872736|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82872737|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
82872738|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
82872739|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82872740|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82872742|NCT03979469|Narcotics|narcotics|mesh-ancestor
82872743|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82872744|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
82872745|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82872746|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872747|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872748|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872749|NCT01065701|Analgesics|analgesics|mesh-ancestor
82872750|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
82872751|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872752|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82872753|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82872754|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82872755|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
82872756|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872757|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872758|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
82872759|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872760|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
82872761|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872762|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872763|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82872764|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
82872765|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
82872766|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
82872767|NCT01065857|Citric Acid|citric acid|mesh-list
82872768|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
82872769|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
82872770|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82872771|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
82872772|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
82872773|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872774|NCT01065857|Cathartics|cathartics|mesh-ancestor
82872775|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872776|NCT01065857|Antacids|antacids|mesh-ancestor
82872777|NCT00297479|Nicotine|nicotine|mesh-list
82872778|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82872779|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
82872780|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872781|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872782|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82872783|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82872784|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
82872785|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453748|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82872786|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872787|NCT00688870|Vaccines|vaccines|mesh-list
82872788|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82872789|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
82872790|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872791|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
82872792|NCT02532335|Cathartics|cathartics|mesh-ancestor
82872793|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872794|NCT03216226|Glucagon|glucagon|mesh-list
82872795|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82872796|NCT03216226|Hormones|hormones|mesh-ancestor
82872797|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872798|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872799|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
82872800|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
82872801|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872802|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82872803|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872804|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872805|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
82872806|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82872807|NCT00290693|Docetaxel|docetaxel|mesh-list
82872808|NCT00290693|Capecitabine|capecitabine|mesh-list
82872809|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872810|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872811|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872812|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872813|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872815|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
82872816|NCT00274469|Fulvestrant|fulvestrant|mesh-list
82872817|NCT00274469|Anastrozole|anastrozole|mesh-list
82872818|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82872819|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872820|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82872821|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82872822|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
82872823|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872824|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872825|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82872826|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82872827|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872828|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872829|NCT01556776|Lenalidomide|lenalidomide|mesh-list
82872830|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
82872831|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872832|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82872833|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82872834|NCT01556776|Growth Substances|growth substances|mesh-ancestor
82872835|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
82872836|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872837|NCT05180422|Sotorasib|sotorasib|mesh-list
82872838|NCT05180422|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82872839|NCT05180422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872840|NCT05180422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82872841|NCT05180422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872842|NCT02422498|Cisplatin|cisplatin|mesh-list
82872843|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872844|NCT01314976|Metronidazole|metronidazole|mesh-list
82872845|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872846|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82872847|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82872848|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82872849|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
82872850|NCT02379520|Nivolumab|nivolumab|mesh-list
82872851|NCT02379520|Fludarabine|fludarabine|mesh-list
82872852|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872853|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
82872854|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872855|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82872856|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82872857|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
82872858|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872859|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872860|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82872861|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82872862|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82872863|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
82872864|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82872865|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82872866|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872867|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82872868|NCT01973452|Analgesics|analgesics|mesh-ancestor
82872869|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
82872870|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82872871|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82872872|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82872873|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82872874|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
82872875|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82872876|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872877|NCT04504942|Leronlimab|leronlimab|mesh-list
82872878|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82872879|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82872880|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872881|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82872882|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82872883|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
82872884|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872885|NCT01882816|Doxorubicin|doxorubicin|mesh-list
82872886|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82872888|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82872889|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82872890|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872891|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872893|NCT00272987|Trastuzumab|trastuzumab|mesh-list
82872894|NCT00272987|Lapatinib|lapatinib|mesh-list
82872895|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82872896|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872897|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872898|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872899|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872900|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872901|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82872902|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82872903|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872904|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82872905|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872906|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82872907|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872908|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872909|NCT01070927|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82872910|NCT01070927|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82872911|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872912|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872913|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82872914|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872915|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82872916|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
82872917|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872918|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
82872919|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872920|NCT01730950|Bevacizumab|bevacizumab|mesh-list
82872921|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82872922|NCT01730950|Antibodies|antibodies|mesh-list
82872923|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
82872924|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82872925|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872926|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82872927|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82872928|NCT01730950|Growth Substances|growth substances|mesh-ancestor
82872929|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872930|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
82872931|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
82872932|NCT00271505|Bevacizumab|bevacizumab|mesh-list
82872933|NCT00271505|Carboplatin|carboplatin|mesh-list
82872934|NCT00271505|Docetaxel|docetaxel|mesh-list
82872935|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82872936|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82714431|NCT02557581|Terbutaline|terbutaline|mesh-list
82872937|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82872938|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82872939|NCT00271505|Growth Substances|growth substances|mesh-ancestor
82872940|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872941|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
82872942|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
82872943|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
82872944|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
82872945|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872946|NCT01642186|Everolimus|everolimus|mesh-list
82872947|NCT01642186|Letrozole|letrozole|mesh-list
82872948|NCT01642186|Leuprolide|leuprolide|mesh-list
82872949|NCT01642186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82872950|NCT01642186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82872951|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872952|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872953|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872954|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
82872955|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872956|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872957|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82872958|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82872960|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
82872961|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82872962|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82872963|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
82872964|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82872965|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82872966|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
82872967|NCT00423514|Melphalan|melphalan|mesh-list
82872968|NCT00423514|Thiotepa|thiotepa|mesh-list
82872969|NCT00423514|Clofarabine|clofarabine|mesh-list
82872970|NCT00423514|Tacrolimus|tacrolimus|mesh-list
82872971|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
82872972|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872973|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82872974|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82872975|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82872976|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82872977|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82872978|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82872979|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82872980|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
82872981|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82872982|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872983|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82872984|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
82872985|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82872986|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82872987|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
82872988|NCT00120952|Cobalt|cobalt|mesh-list
82872989|NCT00120952|Chromium|chromium|mesh-list
82872990|NCT00120952|Trace Elements|trace elements|mesh-ancestor
82872991|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
82872992|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82872993|NCT00289991|Itraconazole|itraconazole|mesh-list
82872994|NCT00289991|Voriconazole|voriconazole|mesh-list
82872995|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
82872996|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82872997|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82872998|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82872999|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873000|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873001|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82873002|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
82873003|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873004|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873005|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82873006|NCT00270413|Sunitinib|sunitinib|mesh-list
82873007|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873008|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82873009|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82873010|NCT00270413|Growth Substances|growth substances|mesh-ancestor
82873011|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873012|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
82873013|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873014|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873015|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873016|NCT00270257|Buprenorphine|buprenorphine|mesh-list
82873017|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82873018|NCT00270257|Naloxone|naloxone|mesh-list
82873019|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82873020|NCT00270257|Narcotics|narcotics|mesh-ancestor
82873021|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873022|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873023|NCT00270257|Analgesics|analgesics|mesh-ancestor
82873024|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
82873025|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873026|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82873027|NCT00269399|Vancomycin|vancomycin|mesh-list
82873028|NCT00269399|Rifaximin|rifaximin|mesh-list
82873029|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82873030|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873031|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873032|NCT00269087|Fluticasone|fluticasone|mesh-list
82873033|NCT00269087|Xhance|xhance|mesh-list
82873034|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82873035|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873036|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82873038|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873039|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873040|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82873041|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
82873042|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
82873043|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82873044|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82873045|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82873046|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82873047|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
82873048|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873049|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873050|NCT00288587|Diuretics|diuretics|mesh-list
82873051|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
82873052|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
82873053|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873054|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873055|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873056|NCT00268463|Capecitabine|capecitabine|mesh-list
82873057|NCT00268463|Floxuridine|floxuridine|mesh-list
82873058|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
82873059|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82873060|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
82873061|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873062|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873063|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
82873064|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82873065|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82873066|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82873067|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873068|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873069|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
82873070|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873071|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873072|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82873073|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873074|NCT01071005|Leuprolide|leuprolide|mesh-list
82873075|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82873076|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
82873077|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82873078|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873079|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82873080|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873081|NCT03976037|Misoprostol|misoprostol|mesh-list
82873082|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82873083|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
82873084|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82873085|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873086|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82873087|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873088|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
82873089|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
82873090|NCT00265889|Melphalan|melphalan|mesh-list
82873091|NCT00265889|Busulfan|busulfan|mesh-list
82873092|NCT00265889|Etoposide|etoposide|mesh-list
82873093|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82873094|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
82873095|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873096|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873097|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82873098|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
82873099|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873100|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873101|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82873102|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82873103|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82873104|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82873105|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873106|NCT02795182|Tislelizumab|tislelizumab|mesh-list
82873107|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
82873110|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873111|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873112|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873113|NCT01333696|Pemetrexed|pemetrexed|mesh-list
82873114|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873115|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873116|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873117|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82873118|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82873119|NCT01333774|Acarbose|acarbose|mesh-list
82873120|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82873121|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873122|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873123|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873124|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873125|NCT01333852|Metformin|metformin|mesh-list
82873126|NCT01333852|Paclitaxel|paclitaxel|mesh-list
82873127|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82873128|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873129|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
82873130|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
82873131|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
82873132|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873133|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873134|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873135|NCT03365362|Varenicline|varenicline|mesh-list
82873136|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82873137|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82873138|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
82873139|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873140|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873141|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873142|NCT03206788|Losartan|losartan|mesh-list
82873143|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82873144|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873145|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82873146|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82873147|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873148|NCT03205150|Licogliflozin|licogliflozin|mesh-list
82873149|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82873150|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873151|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873152|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873153|NCT04936984|Abaloparatide|abaloparatide|mesh-list
82873154|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
82873155|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82873156|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873157|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82873158|NCT02931838|Deucravacitinib|deucravacitinib|mesh-list
82873159|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
82873160|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873161|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873162|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873163|NCT03201562|Tropicamide|tropicamide|mesh-list
82873164|NCT03201562|Aceclidine|aceclidine|mesh-list
82873165|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
82873166|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
82873167|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873168|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873169|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82873170|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82873171|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
82873172|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873173|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873174|NCT03201562|Miotics|miotics|mesh-ancestor
82873175|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82873176|NCT03290950|Dexamethasone|dexamethasone|mesh-list
82873177|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
82873178|NCT03290950|Lenalidomide|lenalidomide|mesh-list
82873180|NCT03290950|BB 1101|bb 1101|mesh-list
82873181|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873182|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
82873183|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
82873184|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873185|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873186|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873187|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
82873188|NCT03290950|Hormones|hormones|mesh-ancestor
82873189|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873190|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82873191|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873192|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
82873193|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873194|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873195|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
82873196|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82873197|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82873198|NCT03290950|Growth Substances|growth substances|mesh-ancestor
82873199|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
82873200|NCT03200860|Empagliflozin|empagliflozin|mesh-list
82873201|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82873202|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873203|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873204|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873205|NCT01314508|Mecasermin|mecasermin|mesh-list
82873206|NCT01314508|Growth Substances|growth substances|mesh-ancestor
82873207|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873208|NCT03268954|Azacitidine|azacitidine|mesh-list
82873209|NCT03268954|Pevonedistat|pevonedistat|mesh-list
82873210|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82873211|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
82873212|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873213|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873214|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873215|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
82873216|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
82873217|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82873218|NCT01314586|Estrogens|estrogens|mesh-ancestor
82873219|NCT01314586|Hormones|hormones|mesh-ancestor
82873220|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873221|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873222|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
82873223|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82873224|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
82873225|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873226|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873227|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82873228|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
82873229|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873230|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873231|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82873232|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
82873233|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873234|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873235|NCT03184558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82873236|NCT03184558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873237|NCT03180736|Dexamethasone|dexamethasone|mesh-list
82873238|NCT03180736|Daratumumab|daratumumab|mesh-list
82873239|NCT03180736|Pomalidomide|pomalidomide|mesh-list
82873240|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873241|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
82873242|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
82873243|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873244|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873245|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873246|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
82873247|NCT03180736|Hormones|hormones|mesh-ancestor
82873248|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873249|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82873250|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873251|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
82873252|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82873253|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82873254|NCT03180736|Growth Substances|growth substances|mesh-ancestor
82873255|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
82873257|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873258|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873259|NCT03093922|Gemcitabine|gemcitabine|mesh-list
82873260|NCT03093922|Atezolizumab|atezolizumab|mesh-list
82873261|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873262|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82873263|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
82873264|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873265|NCT03093922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82873266|NCT03093922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873267|NCT03175198|Dabigatran|dabigatran|mesh-list
82873268|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
82873269|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82873270|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
82873271|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873272|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873273|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
82873274|NCT03087448|Trametinib|trametinib|mesh-list
82873275|NCT03087448|Ceritinib|ceritinib|mesh-list
82873276|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873277|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873278|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83453783|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82873279|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873280|NCT03175120|Insulin|insulin|mesh-list
82873281|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82873282|NCT03175120|Liraglutide|liraglutide|mesh-list
82873283|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
82873284|NCT03175120|Xultophy|xultophy|mesh-list
82873285|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873286|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873287|NCT03175120|Incretins|incretins|mesh-ancestor
82873288|NCT03175120|Hormones|hormones|mesh-ancestor
82873289|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873290|NCT03054766|Ranibizumab|ranibizumab|mesh-list
82873291|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82873292|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82873293|NCT03054766|Growth Substances|growth substances|mesh-ancestor
82873294|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873295|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
82873296|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873297|NCT05118724|Atezolizumab|atezolizumab|mesh-list
82873298|NCT05118724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82873299|NCT05118724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873300|NCT05118724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873301|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873302|NCT03036748|Amiloride|amiloride|mesh-list
82873303|NCT03036748|Diuretics|diuretics|mesh-ancestor
82873304|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
82873305|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873306|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82873307|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82873308|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873309|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873310|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82873311|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82873312|NCT03167242|Lumefantrine|lumefantrine|mesh-list
82873313|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82873314|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
82873315|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82873316|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82873317|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873319|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
82873320|NCT03636178|Growth Substances|growth substances|mesh-ancestor
82873321|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873322|NCT01952782|Naloxone|naloxone|mesh-list
82873323|NCT01952782|Hormones|hormones|mesh-list
82873324|NCT01952782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873325|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873326|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82873327|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
82873328|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873330|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82873331|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873332|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
82873333|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
82873334|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873335|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873336|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82873337|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82873338|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82873339|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
82873340|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873341|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873342|NCT01330810|Curcumin|curcumin|mesh-list
82873343|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82873344|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82873345|NCT01330810|Analgesics|analgesics|mesh-ancestor
82873346|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
82873347|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873348|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873349|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873350|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873351|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873352|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873353|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873354|NCT01331122|Droxidopa|droxidopa|mesh-list
82873355|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82873356|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82873357|NCT01320280|Afatinib|afatinib|mesh-list
82873358|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873359|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873360|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873361|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873362|NCT01331434|Exemestane|exemestane|mesh-list
82873363|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873364|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82873365|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82873366|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873367|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873368|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82873369|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
82873370|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873371|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873372|NCT01331590|Dexamethasone|dexamethasone|mesh-list
82873373|NCT01331590|Etoposide|etoposide|mesh-list
82873374|NCT01331590|Ifosfamide|ifosfamide|mesh-list
82873375|NCT01331590|Lenograstim|lenograstim|mesh-list
82873376|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873377|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
82873378|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
82873379|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873380|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873381|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873382|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
82873383|NCT01331590|Hormones|hormones|mesh-ancestor
82873384|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873385|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82873386|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873387|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82873388|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82873389|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82873390|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873391|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873392|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82873393|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
82873394|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82873395|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
82873396|NCT01331902|Nicorandil|nicorandil|mesh-list
82873397|NCT01331902|Adenosine|adenosine|mesh-list
82873398|NCT01331902|Analgesics|analgesics|mesh-ancestor
82873399|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
82873400|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873401|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873402|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82873403|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
82873404|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82873405|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
82873406|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
82873407|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873408|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873409|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873410|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
82873411|NCT01331902|Vitamins|vitamins|mesh-ancestor
82873412|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
82873413|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82873414|NCT04245748|Escitalopram|escitalopram|mesh-list
82873415|NCT04245748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82873416|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82873417|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873418|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873419|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873420|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
82873421|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873422|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873423|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
82873424|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82873425|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82873426|NCT04245748|Analgesics|analgesics|mesh-ancestor
82873427|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
82873428|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
82873429|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82873430|NCT04245436|Escitalopram|escitalopram|mesh-list
82873431|NCT04245436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82873432|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82873433|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873434|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873435|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873436|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
82873437|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873438|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873439|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
82873440|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82873441|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82873442|NCT04245436|Analgesics|analgesics|mesh-ancestor
82873443|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
82873444|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
82873445|NCT01332370|Metformin|metformin|mesh-list
82873446|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82873447|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
82873448|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873449|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873450|NCT01332370|Incretins|incretins|mesh-ancestor
82873451|NCT01332370|Hormones|hormones|mesh-ancestor
82873452|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873453|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82873454|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
82873455|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873456|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873457|NCT01332448|Orlistat|orlistat|mesh-list
82873458|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873459|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873460|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82873461|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82873462|NCT04484428|Menthol|menthol|mesh-list
82873463|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
82873464|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
82873465|NCT01332604|Bevacizumab|bevacizumab|mesh-list
82873466|NCT01332604|Capecitabine|capecitabine|mesh-list
82873467|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873468|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873469|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82873470|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82873471|NCT01332604|Growth Substances|growth substances|mesh-ancestor
82873472|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873473|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
82873474|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82873475|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
82873477|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
82873478|NCT03445858|Decitabine|decitabine|mesh-list
82873479|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873480|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873481|NCT03445858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82873482|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873483|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82873484|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
82873485|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873486|NCT01333150|Propranolol|propranolol|mesh-list
82873487|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82873488|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82873489|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
82873490|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873491|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873492|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873493|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82873494|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873495|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
82873496|NCT02913664|Losartan|losartan|mesh-list
82873497|NCT02913664|Amlodipine|amlodipine|mesh-list
82873498|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
82873499|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
82873500|NCT02913664|Giapreza|giapreza|mesh-list
82873501|NCT02913664|Calcium|calcium|mesh-list
82873502|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82873503|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
82873504|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82873505|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873506|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873507|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873508|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873509|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
82873510|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82873511|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82873512|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82873513|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82873514|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
82873515|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873516|NCT02818582|Remdesivir|remdesivir|mesh-list
82873517|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
82873518|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873519|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
82873520|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873521|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82873522|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82873523|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873524|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873525|NCT01337440|Incretins|incretins|mesh-ancestor
82873526|NCT01337440|Hormones|hormones|mesh-ancestor
82873527|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873528|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82873529|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
82873530|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873531|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873532|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82873533|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873534|NCT01337518|Androgens|androgens|mesh-list
82873535|NCT01337518|Hormones|hormones|mesh-ancestor
82873536|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873537|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873538|NCT05186194|Vitamin D|vitamin d|mesh-list
82873539|NCT05186194|Calcium|calcium|mesh-list
82873540|NCT05186194|Vitamins|vitamins|mesh-ancestor
82873541|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
82873542|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873543|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82873544|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82873545|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
82873546|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82873547|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82873548|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873550|NCT01338454|Coagulants|coagulants|mesh-ancestor
82873551|NCT02882152|Morphine|morphine|mesh-list
82873552|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82873553|NCT02882152|Narcotics|narcotics|mesh-ancestor
82873554|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873555|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873556|NCT02882152|Analgesics|analgesics|mesh-ancestor
82873557|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
82873558|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873559|NCT05185804|Enoxaparin|enoxaparin|mesh-list
82873560|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
82873561|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
82873562|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82873563|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82873564|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873565|NCT01338844|Inositol|inositol|mesh-list
82873566|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
82873567|NCT01338844|Vitamins|vitamins|mesh-ancestor
82873568|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
82873569|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873570|NCT01338922|Insulin|insulin|mesh-list
82873571|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873572|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873573|NCT01339312|Vaccines|vaccines|mesh-list
82873574|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
82873575|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873576|NCT01339468|Tacrolimus|tacrolimus|mesh-list
82873577|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82873578|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
82873579|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873580|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82873581|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873582|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873583|NCT01339624|Ketorolac|ketorolac|mesh-list
82873584|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82873585|NCT01339624|Fentanyl|fentanyl|mesh-list
82873586|NCT01339624|Morphine|morphine|mesh-list
82873587|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82873588|NCT01339624|Narcotics|narcotics|mesh-ancestor
82873589|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873590|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873591|NCT01339624|Analgesics|analgesics|mesh-ancestor
82873592|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
82873593|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873594|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82873595|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82873596|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
82873597|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
82873598|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82873599|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82873600|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873601|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873602|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82873603|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873604|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873605|NCT01340248|Carvedilol|carvedilol|mesh-list
82873606|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82873607|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82873608|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
82873609|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873610|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873611|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873612|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873613|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
82873614|NCT01340248|Protective Agents|protective agents|mesh-ancestor
82873615|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82873616|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873617|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82873618|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
82873619|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82873620|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82873621|NCT01340326|Valsartan|valsartan|mesh-list
82873622|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873623|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82873624|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82873625|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873627|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82873628|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873629|NCT01340950|Tenofovir|tenofovir|mesh-list
82873630|NCT01340950|Lamivudine|lamivudine|mesh-list
82873631|NCT01340950|Zidovudine|zidovudine|mesh-list
82873632|NCT01340950|Efavirenz|efavirenz|mesh-list
82873633|NCT01340950|Nevirapine|nevirapine|mesh-list
82873634|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82873635|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
82873636|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873637|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82873638|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82873639|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873640|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873641|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82873642|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82873643|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
82873644|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82873645|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82873646|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82873647|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82873648|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82873649|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82873650|NCT01341106|Entecavir|entecavir|mesh-list
82873651|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
82873652|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873653|NCT01341184|Rifampin|rifampin|mesh-list
82873654|NCT01341184|Rifabutin|rifabutin|mesh-list
82873655|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82873656|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
82873657|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82873658|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873659|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
82873660|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82873661|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873662|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873663|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82873664|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82873665|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82873666|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82873667|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82873668|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82873669|NCT00285857|Lovastatin|lovastatin|mesh-list
82873670|NCT00285857|L 647318|l 647318|mesh-list
82873671|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
82873672|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82873673|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
82873674|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873675|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82873676|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82873677|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82873678|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873679|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
82873680|NCT01341262|Thalidomide|thalidomide|mesh-list
82873681|NCT01341262|Dexamethasone|dexamethasone|mesh-list
82873682|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
82873683|NCT01341262|Melphalan|melphalan|mesh-list
82873684|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82873685|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
82873686|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873687|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873688|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82873689|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
82873690|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873691|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873692|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82873693|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873694|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
82873695|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
82873696|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873697|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873698|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
82873700|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873701|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82873702|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
82873703|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82873704|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873705|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82873706|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82873707|NCT01341262|Growth Substances|growth substances|mesh-ancestor
82873708|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
82873709|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82873710|NCT01341340|Everolimus|everolimus|mesh-list
82873711|NCT01341340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82873712|NCT01341340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873713|NCT01341340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873714|NCT01341340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873715|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82873716|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
82873717|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873718|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873719|NCT01341496|Celecoxib|celecoxib|mesh-list
82873720|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
82873721|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82873722|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
82873723|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873724|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873725|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82873726|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
82873727|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873728|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873729|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82873730|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82873731|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82873732|NCT01341496|Analgesics|analgesics|mesh-ancestor
82873733|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
82873734|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873735|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873736|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82873737|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82873738|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873739|NCT00284141|Aflibercept|aflibercept|mesh-list
82873740|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82873741|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82873742|NCT00284141|Growth Substances|growth substances|mesh-ancestor
82873743|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873744|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
82873745|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873746|NCT05182138|Zinc|zinc|mesh-list
82873747|NCT05182138|Trace Elements|trace elements|mesh-ancestor
82873748|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
82873749|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873750|NCT04901494|Serotonin|serotonin|mesh-list
82873751|NCT04901494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82873752|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82873753|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
82873754|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873755|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873756|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873757|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82873758|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873759|NCT01315990|Cetuximab|cetuximab|mesh-list
82873760|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873761|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873762|NCT00265343|Olanzapine|olanzapine|mesh-list
82873763|NCT00265343|Asenapine|asenapine|mesh-list
82873764|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
82873765|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
82873766|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873767|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873768|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873769|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82873770|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82873771|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873772|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82873773|NCT00265343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82873774|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82873775|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873776|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873778|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
82873779|NCT01341886|Metformin|metformin|mesh-list
82873780|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873781|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873782|NCT00283595|Hormones|hormones|mesh-list
82873783|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82873784|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873785|NCT01341964|Aspirin|aspirin|mesh-list
82873786|NCT01341964|Clopidogrel|clopidogrel|mesh-list
82873787|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82873788|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82873789|NCT01341964|Analgesics|analgesics|mesh-ancestor
82873790|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
82873791|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873792|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873793|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873794|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873795|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82873796|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82873797|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873798|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82873799|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82873800|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873801|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
82873802|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82873803|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82873804|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82873805|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
82873806|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873807|NCT00265109|Levetiracetam|levetiracetam|mesh-list
82873808|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
82873809|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
82873810|NCT01342198|Erythromycin|erythromycin|mesh-list
82873811|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
82873812|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82873813|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
82873814|NCT01342198|Pregabalin|pregabalin|mesh-list
82873815|NCT01342198|Analgesics|analgesics|mesh-ancestor
82873816|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
82873817|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873818|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873819|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
82873820|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82873821|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873822|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873823|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82873824|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82873825|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82873826|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873827|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82873828|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82873829|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82873830|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82873831|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82873832|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873833|NCT01342744|Metformin|metformin|mesh-list
82873834|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873835|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873836|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
82873837|NCT05150782|Curcumin|curcumin|mesh-list
82873838|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
82873839|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873840|NCT05150782|Protective Agents|protective agents|mesh-ancestor
82873841|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873842|NCT05150782|Vitamins|vitamins|mesh-ancestor
82873843|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
83512778|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
82873844|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82873845|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82873846|NCT05150782|Analgesics|analgesics|mesh-ancestor
82873847|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
82873848|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873849|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82873850|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82873851|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873852|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873853|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
82873854|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
82873855|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82873856|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
82873857|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873858|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82873859|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82873860|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82873861|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873862|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873863|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82873864|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82873865|NCT00283049|Insulin|insulin|mesh-list
82873866|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82873867|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
82873868|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
82873869|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82873870|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873871|NCT00264875|Pregabalin|pregabalin|mesh-list
82873872|NCT00264875|Analgesics|analgesics|mesh-ancestor
82873873|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
82873874|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873875|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873876|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
82873877|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82873878|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873879|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873880|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82873881|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82873882|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82873883|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873884|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82873885|NCT03635398|Midazolam|midazolam|mesh-list
82873886|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82873887|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82873888|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873889|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873890|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82873891|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82873892|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82873893|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82873894|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
82873895|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
82873896|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
82873897|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
82873898|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873899|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873900|NCT03151408|Azacitidine|azacitidine|mesh-list
82873901|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82873902|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
82873903|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873904|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873905|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873906|NCT05226442|Heparin|heparin|mesh-list
82873907|NCT05226442|Calcium heparin|calcium heparin|mesh-list
82873908|NCT05226442|Argatroban|argatroban|mesh-list
82873909|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
82873910|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82873911|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82873912|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873913|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
82873914|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82873915|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
82873916|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873917|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82873918|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
82873919|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873920|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873921|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873922|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873923|NCT05198128|Calcium|calcium|mesh-list
82873924|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82873925|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873926|NCT01316848|Tivozanib|tivozanib|mesh-list
82873927|NCT01316848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873928|NCT01316848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873929|NCT01316848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873930|NCT02121184|Oxytocin|oxytocin|mesh-list
82873931|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
82873932|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82873933|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873934|NCT01485874|Doxorubicin|doxorubicin|mesh-list
82873935|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82873936|NCT01485874|Nintedanib|nintedanib|mesh-list
82873937|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82873938|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873939|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82873940|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82873941|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82873942|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873943|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82873944|NCT05000710|Durvalumab|durvalumab|mesh-list
82873945|NCT05000710|Tremelimumab|tremelimumab|mesh-list
82873946|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82873947|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873948|NCT04786756|Bupivacaine|bupivacaine|mesh-list
82873949|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
82873950|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
82873951|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873952|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873953|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
82873954|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873955|NCT00546754|Losartan|losartan|mesh-list
82873956|NCT00546754|Valsartan|valsartan|mesh-list
82873957|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82873958|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82873959|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82873960|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82873961|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873962|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82873963|NCT00546754|Diuretics|diuretics|mesh-ancestor
82873964|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
82873965|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873966|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82873967|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82873968|NCT04768426|Capecitabine|capecitabine|mesh-list
82873969|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82873970|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
82873971|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873972|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82873973|NCT04473508|Ropivacaine|ropivacaine|mesh-list
82873974|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
82873975|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
82873976|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873977|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873978|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
82873979|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873980|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
82873981|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82873982|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82873983|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82873984|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82873985|NCT04471402|Analgesics|analgesics|mesh-ancestor
82873986|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
82873987|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82873988|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82873989|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82873990|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82873991|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
82873992|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82873993|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82873994|NCT00282347|Acetaminophen|acetaminophen|mesh-list
82873995|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
82873996|NCT00282347|Promethazine|promethazine|mesh-list
82873997|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
82873999|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
82874000|NCT00282347|Rituximab|rituximab|mesh-list
82874001|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874002|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874003|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
82874004|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874005|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874006|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874007|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
82874008|NCT00282347|Hormones|hormones|mesh-ancestor
82874009|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874010|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874011|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82874012|NCT00282347|Analgesics|analgesics|mesh-ancestor
82874013|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
82874014|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874015|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
82874016|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82874017|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82874018|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
82874019|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874020|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874021|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874022|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874023|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
82874024|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
82874025|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874026|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82874027|NCT00282347|Protective Agents|protective agents|mesh-ancestor
82874028|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82874029|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82874030|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874031|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
82874032|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
82874033|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82874034|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
82874035|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
82874036|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874037|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82874038|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
82874039|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
82874040|NCT01334632|Morphine|morphine|mesh-list
82874041|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82874042|NCT01334632|Narcotics|narcotics|mesh-ancestor
82874043|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874044|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874045|NCT01334632|Analgesics|analgesics|mesh-ancestor
82874046|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
82874047|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874048|NCT00405964|Desloratadine|desloratadine|mesh-list
82874049|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82874050|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
82874051|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874052|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874053|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874054|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82874055|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82874056|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
82874057|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
82874058|NCT00264797|Methylphenidate|methylphenidate|mesh-list
82874059|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82874060|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874061|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82874062|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82874063|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82874064|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874065|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
82874066|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874067|NCT03148756|Dalbavancin|dalbavancin|mesh-list
82874068|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874069|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874070|NCT01343680|Heparin|heparin|mesh-list
82874071|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
82874072|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82874074|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874075|NCT00281957|Sirolimus|sirolimus|mesh-list
82874076|NCT00281957|Sorafenib|sorafenib|mesh-list
82874077|NCT00281957|Temsirolimus|temsirolimus|mesh-list
82874078|NCT00281957|Tipifarnib|tipifarnib|mesh-list
82874079|NCT00281957|MTOR Inhibitors|mtor inhibitors|mesh-list
82874080|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874081|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874082|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874083|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874084|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874085|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
82874086|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874087|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874088|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874089|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82874090|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
82874091|NCT01071161|Azithromycin|azithromycin|mesh-list
82874092|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874093|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874094|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
82874095|NCT01070225|Propranolol|propranolol|mesh-list
82874096|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874097|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82874098|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82874099|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
82874100|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874101|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874102|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874103|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82874104|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82874105|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
82874106|NCT01070615|Prucalopride|prucalopride|mesh-list
82874107|NCT01070615|Laxatives|laxatives|mesh-ancestor
82874108|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874109|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82874110|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82874111|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
82874112|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874113|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874114|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874115|NCT00262925|Leucovorin|leucovorin|mesh-list
82874116|NCT00262925|Dexamethasone|dexamethasone|mesh-list
82874117|NCT00262925|Methotrexate|methotrexate|mesh-list
82874118|NCT00262925|Vincristine|vincristine|mesh-list
82874119|NCT00262925|Asparaginase|asparaginase|mesh-list
82874120|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
82874121|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
82874122|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82874123|NCT00262925|Antibodies|antibodies|mesh-list
82874124|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
82874125|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82874126|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
82874127|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
82874128|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874129|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874130|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
82874131|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
82874132|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874133|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874134|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
82874135|NCT00262925|Hormones|hormones|mesh-ancestor
82874136|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874137|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874138|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874139|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82874140|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
82874141|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82874142|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82874143|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
82874144|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874145|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
82874146|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874147|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82874148|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874149|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874150|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82874152|NCT00262925|Protective Agents|protective agents|mesh-ancestor
82874153|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
82874155|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
82874156|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874157|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
82874158|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
82874159|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
82874160|NCT01581515|Everolimus|everolimus|mesh-list
82874161|NCT01581515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82874162|NCT01581515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874163|NCT01581515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874164|NCT01581515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874165|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874166|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
82874167|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874168|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874169|NCT03720470|Abrocitinib|abrocitinib|mesh-list
82874170|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874171|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874172|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874173|NCT00262847|Paclitaxel|paclitaxel|mesh-list
82874174|NCT00262847|Bevacizumab|bevacizumab|mesh-list
82874175|NCT00262847|Carboplatin|carboplatin|mesh-list
82874176|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82874177|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82874178|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
82874179|NCT00262847|Antibodies|antibodies|mesh-list
82874180|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
82874181|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82874182|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
82874183|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874184|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874185|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
82874186|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
82874187|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
82874188|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874189|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82874190|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82874191|NCT00262847|Growth Substances|growth substances|mesh-ancestor
82874192|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874193|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
82874194|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
82874195|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
82874196|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874197|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874198|NCT05329532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82874199|NCT05329532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874200|NCT01303640|Everolimus|everolimus|mesh-list
82874201|NCT01303640|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82874202|NCT01303640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874203|NCT01303640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874204|NCT01303640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874205|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874206|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
82874207|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874208|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874209|NCT03817268|Capecitabine|capecitabine|mesh-list
82874210|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82874211|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
82874212|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874213|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874214|NCT00280397|Lenvatinib|lenvatinib|mesh-list
82874215|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874216|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874217|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874218|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874219|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
82874220|NCT03817112|Propofol|propofol|mesh-list
82874221|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82874222|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874223|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874225|NCT03817112|Analgesics|analgesics|mesh-ancestor
82874226|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
82874227|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874228|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82874229|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82874230|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82874231|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
82874232|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874233|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874234|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82874235|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
82874236|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
82874237|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82874238|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82874239|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874240|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
82874241|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874242|NCT03814148|Indapamide|indapamide|mesh-list
82874243|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82874244|NCT03814148|Diuretics|diuretics|mesh-ancestor
82874245|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
82874246|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874247|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82874248|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82874249|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874250|NCT00279305|Rituximab|rituximab|mesh-list
82874251|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874252|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874253|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
82874254|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874255|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874256|NCT04224272|Fulvestrant|fulvestrant|mesh-list
82874257|NCT04224272|Palbociclib|palbociclib|mesh-list
82874258|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874259|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874260|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82874261|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82874262|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
82874263|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874264|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874265|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874266|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874267|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874268|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
82874269|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82874270|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
82874271|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874272|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
82874273|NCT03800810|Protective Agents|protective agents|mesh-ancestor
82874274|NCT03974867|Prednisone|prednisone|mesh-list
82874275|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
82874276|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82874277|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82874278|NCT03974867|Prednisolone|prednisolone|mesh-list
82874279|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
82874280|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82874281|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
82874282|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874283|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
82874284|NCT03974867|Hormones|hormones|mesh-ancestor
82874285|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874286|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83453832|NCT00359697|Mannitol|mannitol|mesh-list
82874287|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874288|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874289|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
82874290|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
82874291|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874292|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874293|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82874294|NCT03974867|Protective Agents|protective agents|mesh-ancestor
82874295|NCT03799406|Vitamin D|vitamin d|mesh-list
82874296|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
82874297|NCT03799406|Vitamins|vitamins|mesh-ancestor
82874298|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
82874299|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874300|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82874301|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82874302|NCT03799172|Echinocandins|echinocandins|mesh-list
82874303|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
82874304|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874305|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
82874306|NCT03799094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82874307|NCT03799094|Vitamins|vitamins|mesh-ancestor
82874308|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
82874309|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874310|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
82874311|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874312|NCT03799094|Protective Agents|protective agents|mesh-ancestor
82874313|NCT03799094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874314|NCT03799094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874315|NCT00277355|Minocycline|minocycline|mesh-list
82874316|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874317|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874318|NCT05593094|Trastuzumab|trastuzumab|mesh-list
82874319|NCT05593094|Pertuzumab|pertuzumab|mesh-list
82874320|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82874321|NCT05593094|Maytansine|maytansine|mesh-list
82874322|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874323|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874324|NCT05593094|Immunotoxins|immunotoxins|mesh-ancestor
82874325|NCT05593094|Immunoconjugates|immunoconjugates|mesh-ancestor
82874326|NCT05593094|Immunologic Factors|immunologic factors|mesh-ancestor
82874327|NCT05593094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874328|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
82874329|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
82874330|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
82874331|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874332|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874333|NCT00262223|Sertraline|sertraline|mesh-list
82874334|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
82874335|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82874336|NCT00262223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82874337|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82874338|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82874339|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874340|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874341|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
82874342|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874343|NCT05575700|Ibuprofen|ibuprofen|mesh-list
82874344|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82874345|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82874346|NCT05575700|Analgesics|analgesics|mesh-ancestor
82874347|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
82874348|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874349|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874350|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874351|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874352|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82874353|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874354|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874355|NCT00276419|Diclofenac|diclofenac|mesh-list
82874356|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82874357|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82874358|NCT00276419|Analgesics|analgesics|mesh-ancestor
82874359|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
82874360|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874361|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874362|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874363|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874364|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82874365|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874366|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874367|NCT03798392|Anesthetics|anesthetics|mesh-list
82874368|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874369|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874370|NCT03816020|Niacinamide|niacinamide|mesh-list
82874372|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
82874373|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
82874374|NCT03816020|Vitamins|vitamins|mesh-ancestor
82874375|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
82874376|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874377|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82874378|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
82874379|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874380|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82874381|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
82874382|NCT03815864|Antibodies|antibodies|mesh-list
82874383|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
82874384|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
82874385|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874386|NCT04151342|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82874387|NCT04151342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874388|NCT04151342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874389|NCT04151342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874390|NCT03815942|Nivolumab|nivolumab|mesh-list
82874391|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874392|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874393|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82874394|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874395|NCT01303874|Etanercept|etanercept|mesh-list
82874396|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82874397|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82874398|NCT01303874|Analgesics|analgesics|mesh-ancestor
82874399|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
82874400|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874401|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874402|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874403|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874404|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874405|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874406|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
82874407|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82874408|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
82874409|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82874410|NCT04140266|Tenofovir|tenofovir|mesh-list
82874411|NCT04140266|Emtricitabine|emtricitabine|mesh-list
82874412|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82874413|NCT04140266|Dapivirine|dapivirine|mesh-list
82874414|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
82874415|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874416|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82874417|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82874418|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874419|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874420|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82874421|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82874422|NCT04109924|Trifluridine|trifluridine|mesh-list
82874423|NCT04109924|Bevacizumab|bevacizumab|mesh-list
82874424|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82874425|NCT04109924|Irinotecan|irinotecan|mesh-list
82874426|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
82874427|NCT04109924|Antibodies|antibodies|mesh-list
82874428|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
82874429|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82874430|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874431|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82874432|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82874433|NCT04109924|Growth Substances|growth substances|mesh-ancestor
82874434|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874435|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
82874436|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
82874437|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82874438|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82874439|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874440|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874441|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
82874442|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
82874443|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874444|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874445|NCT04070768|Venetoclax|venetoclax|mesh-list
82874446|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
82874447|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874448|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874449|NCT04070768|Immunotoxins|immunotoxins|mesh-ancestor
82874450|NCT04070768|Immunoconjugates|immunoconjugates|mesh-ancestor
82874451|NCT04070768|Immunologic Factors|immunologic factors|mesh-ancestor
82874452|NCT04070768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874454|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
82874455|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874456|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874457|NCT01303952|Eculizumab|eculizumab|mesh-list
82874458|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82874459|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874460|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
82874461|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874462|NCT03970616|Durvalumab|durvalumab|mesh-list
82874463|NCT03970616|Tivozanib|tivozanib|mesh-list
82874464|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874465|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874466|NCT03970616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874467|NCT03970616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874468|NCT03970616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874469|NCT03815474|Epirubicin|epirubicin|mesh-list
82874470|NCT03815474|Ifosfamide|ifosfamide|mesh-list
82874471|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82874472|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874473|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82874474|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82874475|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874476|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874477|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82874478|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
82874479|NCT01302158|Glimepiride|glimepiride|mesh-list
82874480|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
82874481|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82874482|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82874483|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874484|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874485|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
82874486|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82874487|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874488|NCT01302236|Eplerenone|eplerenone|mesh-list
82874489|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82874490|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
82874491|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874492|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874493|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82874494|NCT01302236|Diuretics|diuretics|mesh-ancestor
82874495|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
82874496|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82874497|NCT01304264|Maleic acid|maleic acid|mesh-list
82874498|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874499|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874500|NCT01304342|Fentanyl|fentanyl|mesh-list
82874501|NCT01304342|Remifentanil|remifentanil|mesh-list
82874502|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82874503|NCT01304342|Narcotics|narcotics|mesh-ancestor
82874504|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874505|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874506|NCT01304342|Analgesics|analgesics|mesh-ancestor
82874507|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
82874508|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874509|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82874510|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82874511|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
82874512|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
82874513|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82874514|NCT03653546|Gefitinib|gefitinib|mesh-list
82874515|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874516|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874517|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874518|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874519|NCT03812354|Nicotine|nicotine|mesh-list
82874520|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82874521|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
82874522|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874523|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874524|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82874527|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874528|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874529|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82874532|NCT03796364|Endostar protein|endostar protein|mesh-list
82874533|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82874534|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82874535|NCT03796364|Growth Substances|growth substances|mesh-ancestor
82874536|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874537|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
82874538|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874539|NCT03795584|Hemostatics|hemostatics|mesh-list
82874540|NCT03795584|Coagulants|coagulants|mesh-ancestor
82874541|NCT03792776|Lidocaine|lidocaine|mesh-list
82874542|NCT03792776|Anesthetics|anesthetics|mesh-list
82874543|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
82874544|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874545|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874546|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
82874547|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874548|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82874549|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82874550|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82874551|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82874552|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874553|NCT03795272|Rucaparib|rucaparib|mesh-list
82874554|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82874555|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874556|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874557|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874558|NCT00980954|Paclitaxel|paclitaxel|mesh-list
82874559|NCT00980954|Carboplatin|carboplatin|mesh-list
82874560|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874561|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874562|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
82874563|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
82874564|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
82874565|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874566|NCT00956930|Doxorubicin|doxorubicin|mesh-list
82874567|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82874568|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82874569|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874570|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82874571|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82874572|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874573|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874574|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82874575|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82874576|NCT00080756|Estradiol|estradiol|mesh-list
82874577|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82874578|NCT00080756|Testosterone|testosterone|mesh-list
82874579|NCT00080756|Deslorelin|deslorelin|mesh-list
82874580|NCT00080756|Estrogens|estrogens|mesh-ancestor
82874581|NCT00080756|Hormones|hormones|mesh-ancestor
82874582|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874583|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874584|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82874585|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
82874586|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82874587|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82874588|NCT00080756|Androgens|androgens|mesh-ancestor
82874589|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874590|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874591|NCT03792620|Daratumumab|daratumumab|mesh-list
82874592|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874593|NCT05027594|Dexamethasone|dexamethasone|mesh-list
82874594|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874595|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
82874596|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
82874597|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874598|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874599|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874601|NCT05027594|Hormones|hormones|mesh-ancestor
82874602|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874603|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874604|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874606|NCT03811418|Trastuzumab|trastuzumab|mesh-list
82874607|NCT03811418|Vinorelbine|vinorelbine|mesh-list
82874608|NCT03811418|Pertuzumab|pertuzumab|mesh-list
82874609|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874610|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
82874611|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
82874612|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
82874613|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874614|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874615|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874616|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
82874617|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
82874618|NCT03794492|Prednisolone|prednisolone|mesh-list
82874619|NCT03794492|Tacrolimus|tacrolimus|mesh-list
82874620|NCT03794492|Basiliximab|basiliximab|mesh-list
82874621|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874622|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
82874623|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874624|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82874625|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874626|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874627|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82874628|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874629|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82874630|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
82874631|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874632|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874633|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874634|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
82874635|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
82874636|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874637|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874638|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
82874639|NCT03794492|Hormones|hormones|mesh-ancestor
82874640|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874641|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82874642|NCT03794492|Protective Agents|protective agents|mesh-ancestor
82874643|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874644|NCT03792152|Warfarin|warfarin|mesh-list
82874645|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
82874646|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
82874647|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82874648|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
82874649|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82874650|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
82874651|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874652|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874653|NCT00262067|Bevacizumab|bevacizumab|mesh-list
82874654|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874655|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874656|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82874657|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82874658|NCT00262067|Growth Substances|growth substances|mesh-ancestor
82874659|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874660|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
82874661|NCT00275561|Fluticasone|fluticasone|mesh-list
82874662|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874663|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82874664|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
82874665|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874666|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874667|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82874668|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
82874669|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
82874670|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82874671|NCT03810872|Paclitaxel|paclitaxel|mesh-list
82874672|NCT03810872|Afatinib|afatinib|mesh-list
82874673|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874677|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
82874678|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874679|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874680|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874682|NCT05569148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82874683|NCT05569148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82874684|NCT05569148|Growth Substances|growth substances|mesh-ancestor
82874685|NCT05569148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874686|NCT05569148|Growth Inhibitors|growth inhibitors|mesh-ancestor
82874687|NCT05569148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874688|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
82874689|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874690|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
82874691|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874692|NCT00274937|Cisplatin|cisplatin|mesh-list
82874693|NCT00274937|Fluorouracil|fluorouracil|mesh-list
82874694|NCT00274937|Amifostine|amifostine|mesh-list
82874695|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874696|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
82874697|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874698|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82874699|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82874700|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
82874701|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874702|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82874703|NCT00274937|Protective Agents|protective agents|mesh-ancestor
82874704|NCT03792074|Paclitaxel|paclitaxel|mesh-list
82874705|NCT03792074|Bevacizumab|bevacizumab|mesh-list
82874706|NCT03792074|Carboplatin|carboplatin|mesh-list
82874707|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874708|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874709|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
82874710|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
82874711|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
82874712|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874713|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82874714|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82874715|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82874716|NCT03792074|Growth Substances|growth substances|mesh-ancestor
82874717|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874718|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
82874719|NCT00251693|Lansoprazole|lansoprazole|mesh-list
82874720|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
82874721|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82874722|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874723|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82874724|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874725|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874726|NCT03791918|Lenvatinib|lenvatinib|mesh-list
82874727|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
82874728|NCT03791918|Antibodies|antibodies|mesh-list
82874729|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
82874730|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
82874731|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874732|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874733|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874734|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874735|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874736|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82874737|NCT03791918|Estrogens|estrogens|mesh-ancestor
82874738|NCT03791918|Hormones|hormones|mesh-ancestor
82874739|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874740|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82874741|NCT00250835|Celecoxib|celecoxib|mesh-list
82874742|NCT00250835|Capecitabine|capecitabine|mesh-list
82874743|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
82874744|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82874745|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
82874746|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874747|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874748|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82874749|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82874751|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
82874752|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874753|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874754|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874755|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874756|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82874757|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82874758|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874759|NCT01303094|Trabectedin|trabectedin|mesh-list
82874760|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82874761|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
82874762|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874763|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874764|NCT04785326|Ustekinumab|ustekinumab|mesh-list
82874765|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
82874766|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
82874767|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
82874768|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82874769|NCT03791762|Protective Agents|protective agents|mesh-ancestor
82874770|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874771|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
82874772|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82874773|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
82874774|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82874775|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874776|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82874777|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82874778|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82874779|NCT03789032|Rabeprazole|rabeprazole|mesh-list
82874780|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82874781|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874782|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82874783|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874784|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874785|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
82874786|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82874787|NCT01306370|Hemostatics|hemostatics|mesh-list
82874788|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82874789|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82874790|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874791|NCT01306370|Coagulants|coagulants|mesh-ancestor
82874792|NCT03716024|Linezolid|linezolid|mesh-list
82874793|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874794|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874795|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82874796|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874797|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874798|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
82874799|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82874800|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
82874801|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874802|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874803|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82874804|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
82874805|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82874806|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82874807|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82874808|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
82874809|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874810|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874811|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
82874812|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
82874813|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82874814|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
82874815|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874816|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
82874817|NCT03791294|Protective Agents|protective agents|mesh-ancestor
82874818|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
82874819|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82874820|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
82874821|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82874822|NCT01567358|Infliximab|infliximab|mesh-list
82874823|NCT01567358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82874824|NCT01567358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874825|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
82874826|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82874827|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874828|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
82874829|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82874830|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874831|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874832|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82874833|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82874834|NCT01308242|Sevelamer|sevelamer|mesh-list
82874835|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
82874836|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
82874837|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874838|NCT01308320|Fentanyl|fentanyl|mesh-list
82874839|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82874840|NCT01308320|Narcotics|narcotics|mesh-ancestor
82874841|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874842|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874843|NCT01308320|Analgesics|analgesics|mesh-ancestor
82874844|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
82874845|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874846|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82874847|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82874848|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
82874849|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
82874850|NCT01306760|Ketamine|ketamine|mesh-list
82874851|NCT01306760|Propofol|propofol|mesh-list
82874852|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82874853|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874854|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874855|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82874856|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
82874857|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
82874858|NCT01306760|Analgesics|analgesics|mesh-ancestor
82874859|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
82874860|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874861|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82874862|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82874863|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82874864|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874865|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874866|NCT03787940|Isoniazid|isoniazid|mesh-list
82874867|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
82874868|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82874869|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874870|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82874871|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82874872|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
82874873|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874874|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82874875|NCT03788018|Lidocaine|lidocaine|mesh-list
82874876|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
82874877|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
82874878|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
82874879|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874880|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874881|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
82874882|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874883|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82874884|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82874885|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82874886|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82874887|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874888|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82874889|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82874890|NCT03788018|Analgesics|analgesics|mesh-ancestor
82874891|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82874892|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82874893|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82874894|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
82874895|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874896|NCT03785756|Ibuprofen|ibuprofen|mesh-list
82874897|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82874898|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82874899|NCT03785756|Analgesics|analgesics|mesh-ancestor
82874900|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
82874901|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874902|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874903|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82874904|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82874905|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82874906|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874907|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874908|NCT03788174|Apatinib|apatinib|mesh-list
83512779|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
82874909|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874910|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82874911|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874912|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874913|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82874914|NCT03787550|Analgesics|analgesics|mesh-list
82874915|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82874916|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874917|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
82874918|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874919|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874920|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874921|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
82874922|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
82874923|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874924|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82874925|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82874926|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
82874927|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874928|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874929|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82874930|NCT03789890|Itraconazole|itraconazole|mesh-list
82874931|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
82874932|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82874933|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82874934|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82874935|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874936|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874937|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82874938|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
82874939|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82874940|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874941|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82874942|NCT01308554|Bupivacaine|bupivacaine|mesh-list
82874943|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
82874944|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
82874945|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874946|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874947|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
82874948|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874949|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
82874950|NCT05693402|Anesthetics|anesthetics|mesh-list
82874951|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82874952|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874953|NCT05693402|Narcotics|narcotics|mesh-ancestor
82874954|NCT05693402|Analgesics|analgesics|mesh-ancestor
82874955|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
82874956|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874957|NCT05694728|Vaccines|vaccines|mesh-list
82874958|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
82874959|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874960|NCT01308632|Irinotecan|irinotecan|mesh-list
82874961|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82874962|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82874963|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874964|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874965|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874966|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
82874967|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82874968|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874969|NCT03785522|Insulin|insulin|mesh-list
82874970|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82874971|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874972|NCT05694416|Etoposide|etoposide|mesh-list
82874973|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82874974|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82874975|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82874976|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82874977|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82874978|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874979|NCT03789422|Cetirizine|cetirizine|mesh-list
82874980|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
82874981|NCT03789422|Levocetirizine|levocetirizine|mesh-list
82874982|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82874983|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82874984|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82874985|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
82874986|NCT03789422|Coagulants|coagulants|mesh-ancestor
82874987|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82874988|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82874989|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
82874990|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
82874991|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82874992|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874993|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82874994|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82874995|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
82874996|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
82874997|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82874998|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82874999|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82875000|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82875001|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
82875002|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875003|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875004|NCT05690048|Vancomycin|vancomycin|mesh-list
82875005|NCT05690048|Bevacizumab|bevacizumab|mesh-list
82875006|NCT05690048|Atezolizumab|atezolizumab|mesh-list
82875007|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875008|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875009|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82875010|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82875011|NCT05690048|Growth Substances|growth substances|mesh-ancestor
82875012|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875013|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
82875014|NCT05690048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82875015|NCT05690048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875016|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875017|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875018|NCT01308086|Leucovorin|leucovorin|mesh-list
82875019|NCT01308086|Fluorouracil|fluorouracil|mesh-list
82875020|NCT01308086|Capecitabine|capecitabine|mesh-list
82875021|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
82875022|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
82875023|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
82875024|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875025|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82875026|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875027|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82875028|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
82875029|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875030|NCT01308086|Antidotes|antidotes|mesh-ancestor
82875031|NCT01308086|Protective Agents|protective agents|mesh-ancestor
82875032|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
82875033|NCT01308086|Vitamins|vitamins|mesh-ancestor
82875034|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
82875035|NCT05443802|Insulin|insulin|mesh-list
82875036|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82875037|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82875038|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875039|NCT01308944|Propranolol|propranolol|mesh-list
82875040|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82875041|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82875042|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875043|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875044|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875045|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875047|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82875048|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
82875049|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
82875050|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82875051|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82875052|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875053|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
82875054|NCT03777488|Coagulants|coagulants|mesh-ancestor
82875055|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
82875056|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82875057|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82875058|NCT03777254|Growth Substances|growth substances|mesh-ancestor
82875059|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875060|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
82875061|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875062|NCT01312298|Bupivacaine|bupivacaine|mesh-list
82875063|NCT01312298|Anesthetics|anesthetics|mesh-list
82875064|NCT01312298|Propofol|propofol|mesh-list
82875065|NCT01312298|Succinylcholine|succinylcholine|mesh-list
82875066|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
82875067|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875068|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875069|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
82875070|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875071|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875072|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875073|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
82875074|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
82875075|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82875076|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82875077|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
82875078|NCT01309022|Sirolimus|sirolimus|mesh-list
82875079|NCT01309022|Tacrolimus|tacrolimus|mesh-list
82875080|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82875081|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
82875082|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875083|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82875084|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875085|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875086|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82875087|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875088|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82875089|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
82875090|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875091|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875092|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
82875093|NCT01560962|Azithromycin|azithromycin|mesh-list
82875094|NCT01560962|Tobramycin|tobramycin|mesh-list
82875095|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
82875096|NCT01560962|Povidone|povidone|mesh-list
82875097|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875098|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875099|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
82875100|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
82875101|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82875102|NCT05401058|Droperidol|droperidol|mesh-list
82875103|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82875104|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
82875105|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
82875106|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875107|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875108|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875109|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82875110|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82875111|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875112|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82875113|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82875114|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82875115|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
82875116|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875117|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875118|NCT03781466|Progesterone|progesterone|mesh-list
82875119|NCT03781466|Progestins|progestins|mesh-ancestor
82875120|NCT03781466|Hormones|hormones|mesh-ancestor
82875121|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875130|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875131|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82875132|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82875133|NCT01309178|Mannitol|mannitol|mesh-list
82875134|NCT01309178|Amitriptyline|amitriptyline|mesh-list
82875135|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82875136|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
82875137|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82875138|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82875139|NCT01309178|Analgesics|analgesics|mesh-ancestor
82875140|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
82875141|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875142|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875143|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82875144|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82875145|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875146|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875147|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875148|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875149|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82875150|NCT01309178|Diuretics|diuretics|mesh-ancestor
82875151|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
82875152|NCT01335334|Metronidazole|metronidazole|mesh-list
82875153|NCT01335334|Tetracycline|tetracycline|mesh-list
82875154|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
82875156|NCT01335334|Bismuth|bismuth|mesh-list
82875157|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875158|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875159|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82875160|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82875161|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82875162|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875163|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82875164|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875165|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875166|NCT01335334|Antacids|antacids|mesh-ancestor
82875167|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82875168|NCT01344304|Aprepitant|aprepitant|mesh-list
82875169|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
82875170|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
82875171|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
82875172|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875173|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875174|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875175|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82875176|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875177|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875178|NCT01320020|Catumaxomab|catumaxomab|mesh-list
82875179|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875180|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82875181|NCT05312762|Chitosan|chitosan|mesh-list
82875182|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82875183|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875184|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
82875185|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875186|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875187|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
82875188|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
82875189|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
82875190|NCT05312762|Coagulants|coagulants|mesh-ancestor
82875191|NCT05312762|Laxatives|laxatives|mesh-ancestor
82875192|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875193|NCT00379288|Fluticasone|fluticasone|mesh-list
82875194|NCT00379288|Xhance|xhance|mesh-list
82875195|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
82875196|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82875197|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82875198|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82875199|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82875200|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
82875201|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875202|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875203|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82875204|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
82875205|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
82875206|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82875207|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82875208|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82875209|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82875210|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875211|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875212|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875213|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
82875214|NCT00379288|Hormones|hormones|mesh-ancestor
82875215|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875216|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
82875217|NCT03784040|Nivolumab|nivolumab|mesh-list
82875218|NCT03784040|Ipilimumab|ipilimumab|mesh-list
82875219|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83513001|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
82875220|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875221|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82875222|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875223|NCT00243503|Trastuzumab|trastuzumab|mesh-list
82875224|NCT00243503|Sunitinib|sunitinib|mesh-list
82875225|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875226|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875227|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82875228|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82875229|NCT00243503|Growth Substances|growth substances|mesh-ancestor
82875230|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875231|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
82875232|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82875233|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875234|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875235|NCT03780686|Dopamine|dopamine|mesh-list
82875236|NCT03780686|Norepinephrine|norepinephrine|mesh-list
82875237|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82875238|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82875239|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875240|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875241|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875242|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875243|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
82875244|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
82875245|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875246|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82875247|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82875248|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
82875249|NCT03780686|Protective Agents|protective agents|mesh-ancestor
82875250|NCT00338260|Atenolol|atenolol|mesh-list
82875251|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875252|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875254|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875255|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
82875256|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875257|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82875258|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82875259|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
82875260|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82875261|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82875262|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82875263|NCT03775928|Capecitabine|capecitabine|mesh-list
82875264|NCT03775928|Apatinib|apatinib|mesh-list
82875265|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82875266|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
82875267|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875268|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875269|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82875270|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875271|NCT03775538|Dopamine|dopamine|mesh-list
82875272|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82875273|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
82875274|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
82875275|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875276|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875277|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
82875278|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875279|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875280|NCT03775538|Protective Agents|protective agents|mesh-ancestor
82875281|NCT00259649|Eletriptan|eletriptan|mesh-list
82875282|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82875283|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
82875284|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875285|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875286|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875287|NCT05668988|Carboplatin|carboplatin|mesh-list
82875288|NCT05668988|Pemetrexed|pemetrexed|mesh-list
82875289|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875290|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875291|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875292|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82875293|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82875294|NCT01320176|Vaccines|vaccines|mesh-list
82875295|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
82875296|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875297|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82875299|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
82875300|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875301|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875302|NCT01309412|Siltuximab|siltuximab|mesh-list
82875303|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875304|NCT00307060|Losartan|losartan|mesh-list
82875305|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82875306|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82875307|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82875308|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82875309|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82875310|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875311|NCT00307060|Diuretics|diuretics|mesh-ancestor
82875312|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
82875313|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875314|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82875315|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875316|NCT01320254|Cisplatin|cisplatin|mesh-list
82875317|NCT01320254|Gemcitabine|gemcitabine|mesh-list
82875318|NCT01320254|Panitumumab|panitumumab|mesh-list
82875319|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82875320|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875321|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82875322|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
82875323|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875324|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875325|NCT00092638|Ezetimibe|ezetimibe|mesh-list
82875327|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875328|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
82875329|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875330|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875331|NCT03783728|Pyridoxine|pyridoxine|mesh-list
82875332|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
82875333|NCT03783728|Isoniazid|isoniazid|mesh-list
82875334|NCT03783728|Rifapentine|rifapentine|mesh-list
82875335|NCT03783728|Vitamins|vitamins|mesh-ancestor
82875336|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
82875337|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875338|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
82875339|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
82875340|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875341|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875342|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82875343|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875344|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
82875345|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875346|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875347|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82875348|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
82875349|NCT03620422|Mannitol|mannitol|mesh-list
82875350|NCT03620422|Albuterol|albuterol|mesh-list
82875351|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82875352|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
82875353|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875354|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875355|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82875356|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
82875357|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
82875358|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82875359|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82875360|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82875361|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82875362|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875363|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83453914|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82875364|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875365|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82875366|NCT03620422|Diuretics|diuretics|mesh-ancestor
82875367|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
82875368|NCT01309490|Ribavirin|ribavirin|mesh-list
82875369|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
82875370|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875371|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
82875372|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875373|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82875374|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82875375|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875376|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
82875377|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875378|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875379|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82875380|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875381|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
82875382|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875383|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875384|NCT03783494|Propofol|propofol|mesh-list
82875385|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875386|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875387|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875388|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875389|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
82875390|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
82875391|NCT03774836|Morphine|morphine|mesh-list
82875392|NCT03774836|Tramadol|tramadol|mesh-list
82875393|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82875394|NCT03774836|Narcotics|narcotics|mesh-ancestor
82875395|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875396|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875397|NCT03774836|Analgesics|analgesics|mesh-ancestor
82875398|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
82875399|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875400|NCT03774680|Cetuximab|cetuximab|mesh-list
82875401|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875404|NCT03783338|Vitamins|vitamins|mesh-ancestor
82875405|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
82875406|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875407|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82875408|NCT03774524|Misoprostol|misoprostol|mesh-list
82875409|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82875410|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
82875411|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82875412|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875413|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82875414|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875415|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
82875416|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
82875417|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
82875418|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82875419|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
82875420|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875421|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82875422|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82875423|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
82875424|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875425|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875426|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82875427|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875428|NCT03773744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82875429|NCT03779516|Lidocaine|lidocaine|mesh-list
82875430|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
82875431|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
82875432|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875433|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875434|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
82875435|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875436|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82875437|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82875438|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82875439|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875440|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875441|NCT03779594|Acetazolamide|acetazolamide|mesh-list
82875442|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
82875443|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82875444|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875445|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875446|NCT03779594|Diuretics|diuretics|mesh-ancestor
82875447|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
83513002|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
82875448|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875449|NCT03779672|Memantine|memantine|mesh-list
82875450|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82875451|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82875452|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
82875453|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875454|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875455|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875456|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82875457|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82875458|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
82875459|NCT03779282|Ketamine|ketamine|mesh-list
82875460|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875461|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875462|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875463|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82875464|NCT03779282|Analgesics|analgesics|mesh-ancestor
82875465|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
82875466|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875467|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82875468|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82875469|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82875470|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875471|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875472|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875473|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82875474|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875476|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
82875477|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82875478|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82875479|NCT03773588|Propofol|propofol|mesh-list
82875480|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875481|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875482|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875483|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875484|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
82875485|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
82875486|NCT03773510|Trabectedin|trabectedin|mesh-list
82875487|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82875488|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
82875489|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875490|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875491|NCT03779360|Clindamycin|clindamycin|mesh-list
82875492|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
82875493|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
82875494|NCT03779360|Erythromycin|erythromycin|mesh-list
82875495|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
82875496|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82875497|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
82875498|NCT03779360|Prednisolone|prednisolone|mesh-list
82875499|NCT03779360|Clobetasol|clobetasol|mesh-list
82875500|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82875501|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
82875502|NCT03779360|Hormones|hormones|mesh-ancestor
82875503|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875504|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875505|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82875506|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875507|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875508|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875509|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875510|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82875511|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875512|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875513|NCT01320878|Iloprost|iloprost|mesh-list
82875514|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82875515|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82875516|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
82875517|NCT01321034|Niacin|niacin|mesh-list
82875518|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875519|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
82875520|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875521|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875522|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
82875523|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
82875524|NCT01321034|Vitamins|vitamins|mesh-ancestor
82875525|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
82875526|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875527|NCT05254184|Nivolumab|nivolumab|mesh-list
82875528|NCT05254184|Ipilimumab|ipilimumab|mesh-list
82875529|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875530|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875531|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82875532|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875533|NCT03773042|Propofol|propofol|mesh-list
82875534|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875535|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875536|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875537|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875538|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
82875539|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
82875540|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82875541|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82875542|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
82875543|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875544|NCT03712280|Rifaximin|rifaximin|mesh-list
82875545|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
82875546|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875547|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875548|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875549|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82875561|NCT04673942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875562|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875563|NCT03772262|Metformin|metformin|mesh-list
82875564|NCT03772262|Furosemide|furosemide|mesh-list
82875565|NCT03772262|Midazolam|midazolam|mesh-list
82875566|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82875567|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82875568|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875569|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82875570|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875571|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875572|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82875573|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82875574|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82875575|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875576|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
82875577|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
82875578|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
82875579|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
82875580|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875581|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875582|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82875583|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875584|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
83453930|NCT03023527|Hormones|hormones|mesh-ancestor
82875585|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875586|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82875587|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875588|NCT03772262|Diuretics|diuretics|mesh-ancestor
82875589|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
82875590|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82875591|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875592|NCT03772106|Propofol|propofol|mesh-list
82875593|NCT03772106|Sevoflurane|sevoflurane|mesh-list
82875594|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875595|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875596|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875597|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875598|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
82875599|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
82875600|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82875601|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82875602|NCT01345240|Vaccines|vaccines|mesh-list
82875603|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
82875604|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875605|NCT03771638|Tenofovir|tenofovir|mesh-list
82875606|NCT03771638|Emtricitabine|emtricitabine|mesh-list
82875607|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
82875608|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875609|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82875610|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82875611|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875612|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875613|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82875614|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82875615|NCT00092560|Ezetimibe|ezetimibe|mesh-list
82875616|NCT00092560|Fenofibrate|fenofibrate|mesh-list
82875617|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82875618|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875619|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
82875620|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875621|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875622|NCT03769064|Methylphenidate|methylphenidate|mesh-list
82875623|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82875624|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875625|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82875626|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82875627|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875628|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875629|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
82875630|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875631|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82875632|NCT00090298|Simvastatin|simvastatin|mesh-list
82875633|NCT00090298|Ezetimibe|ezetimibe|mesh-list
82875634|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82875635|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875636|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
82875637|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875638|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875639|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82875640|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875641|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
82875642|NCT03771092|Hematinics|hematinics|mesh-ancestor
82875643|NCT03768908|Artesunate|artesunate|mesh-list
82875644|NCT03768908|Lumefantrine|lumefantrine|mesh-list
82875645|NCT03768908|Artemether|artemether|mesh-list
82875646|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82875647|NCT03768908|Amodiaquine|amodiaquine|mesh-list
82875648|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
82875649|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82875650|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82875651|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875652|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875653|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
82875654|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
82875655|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82875656|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
82875657|NCT03777878|Oxytocin|oxytocin|mesh-list
82875658|NCT03777878|Carbetocin|carbetocin|mesh-list
82875659|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
82875660|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82875661|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875662|NCT03246958|Nivolumab|nivolumab|mesh-list
82875663|NCT03246958|Ipilimumab|ipilimumab|mesh-list
82875664|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875665|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875666|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82875667|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875668|NCT01321268|Beta Carotene|beta carotene|mesh-list
82875669|NCT01321268|Lycopene|lycopene|mesh-list
82875670|NCT01321268|Resveratrol|resveratrol|mesh-list
82875671|NCT01321268|Carotenoids|carotenoids|mesh-list
82875672|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
82875673|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875674|NCT01321268|Protective Agents|protective agents|mesh-ancestor
82875675|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875676|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875677|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82875678|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82875679|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82875680|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82875681|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875682|NCT01321268|Provitamins|provitamins|mesh-ancestor
82875683|NCT01321268|Vitamins|vitamins|mesh-ancestor
82875684|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
82875685|NCT01335958|DMUC5754A|dmuc5754a|mesh-list
82875686|NCT01335958|Immunoconjugates|immunoconjugates|mesh-ancestor
82875687|NCT01335958|Immunologic Factors|immunologic factors|mesh-ancestor
82875688|NCT01335958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875689|NCT01561274|Bupivacaine|bupivacaine|mesh-list
82875691|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
82875692|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875693|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875694|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
82875695|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875696|NCT02882854|Guanfacine|guanfacine|mesh-list
82875697|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82875698|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82875699|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82875700|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82875701|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875702|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875703|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875704|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875705|NCT03770936|Candesartan|candesartan|mesh-list
82875706|NCT03770936|Ramipril|ramipril|mesh-list
82875707|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82875708|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82875709|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82875710|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875711|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82875712|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
82875713|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875714|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
82875715|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875716|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875717|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82875718|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82875719|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875720|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875721|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83453942|NCT04878627|Cannabidiol|cannabidiol|mesh-list
82875722|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82875723|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82875724|NCT01321346|Cytarabine|cytarabine|mesh-list
82875725|NCT01321346|Panobinostat|panobinostat|mesh-list
82875726|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82875727|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
82875728|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875729|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875730|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
82875731|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875732|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82875733|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
82875734|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875735|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82875736|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875737|NCT04058366|Ivacaftor|ivacaftor|mesh-list
82875738|NCT04058366|Elexacaftor|elexacaftor|mesh-list
82875739|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82875740|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875741|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875742|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
82875743|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82875744|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82875745|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82875746|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875747|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875748|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82875749|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875750|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82875751|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82875752|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875753|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82875754|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82875755|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
82875756|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875757|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
82875758|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82875759|NCT02118610|Analgesics|analgesics|mesh-ancestor
82875760|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
82875761|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875762|NCT01561742|Minocycline|minocycline|mesh-list
82875763|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875764|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875765|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82875766|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875767|NCT01345708|Prednisone|prednisone|mesh-list
82875768|NCT01345708|Rituximab|rituximab|mesh-list
82875769|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875770|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875771|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
82875772|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875773|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82875774|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82875775|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
82875776|NCT01345708|Hormones|hormones|mesh-ancestor
82875777|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875778|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82875779|NCT01345864|Scopolamine|scopolamine|mesh-list
82875780|NCT01345864|Donepezil|donepezil|mesh-list
82875781|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82875782|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82875783|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875784|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875785|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
82875786|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875787|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875788|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
82875789|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82875790|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
82875791|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
82875792|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875793|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82875794|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
82875795|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82875796|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82875797|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
82875798|NCT04320602|Eculizumab|eculizumab|mesh-list
82875799|NCT04320602|Ravulizumab|ravulizumab|mesh-list
82875800|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82875801|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82875802|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
82875803|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875804|NCT03948022|Progesterone|progesterone|mesh-list
82875805|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
82875806|NCT03948022|Progestins|progestins|mesh-ancestor
82875807|NCT03948022|Hormones|hormones|mesh-ancestor
82875808|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875809|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875810|NCT03777644|Morphine|morphine|mesh-list
82875811|NCT03777644|Ropivacaine|ropivacaine|mesh-list
82875812|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82875813|NCT03777644|Narcotics|narcotics|mesh-ancestor
82875814|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875815|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875816|NCT03777644|Analgesics|analgesics|mesh-ancestor
82875817|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
82875818|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875819|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
82875820|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
82875821|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
82875822|NCT04345666|Testosterone|testosterone|mesh-list
82875823|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
82875824|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
82875825|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82875826|NCT04345666|Androgens|androgens|mesh-ancestor
82875827|NCT04345666|Hormones|hormones|mesh-ancestor
82875828|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875829|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875830|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82875831|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875832|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
82875833|NCT01336192|Gemcitabine|gemcitabine|mesh-list
82875834|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82875835|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
82875836|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875837|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875838|NCT04296890|Maytansine|maytansine|mesh-list
82875841|NCT04296890|Immunologic Factors|immunologic factors|mesh-ancestor
82875842|NCT04296890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875843|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82875844|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875845|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
82875846|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
82875847|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
82875848|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875849|NCT04459234|Ketamine|ketamine|mesh-list
82875850|NCT04459234|Analgesics|analgesics|mesh-ancestor
82875851|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
82875852|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875853|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875854|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82875855|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82875856|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
82875857|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
82875858|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875859|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82875860|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82875861|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875862|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875863|NCT01336348|Tirofiban|tirofiban|mesh-list
82875864|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82875865|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82875866|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82875867|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83453950|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
82875868|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875869|NCT01346254|Pioglitazone|pioglitazone|mesh-list
82875870|NCT01346254|Vildagliptin|vildagliptin|mesh-list
82875871|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82875872|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875873|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82875874|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
82875875|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875876|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875877|NCT04592536|Alprazolam|alprazolam|mesh-list
82875878|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82875879|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875880|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875881|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82875882|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82875883|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82875884|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
82875885|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
82875886|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82875887|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875888|NCT01336582|Docetaxel|docetaxel|mesh-list
82875889|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875890|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
82875891|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
82875892|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
82875893|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875894|NCT03149848|Rifabutin|rifabutin|mesh-list
82875895|NCT03149848|Cabotegravir|cabotegravir|mesh-list
82875896|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82875897|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875898|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82875899|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
82875900|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82875901|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82875902|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875903|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875904|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82875905|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82875906|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
82875907|NCT01346800|Ritonavir|ritonavir|mesh-list
82875908|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82875909|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82875910|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82875911|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
82875920|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82875922|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
82875923|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
82875924|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83513003|NCT02239874|Vitamins|vitamins|mesh-list
82875925|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875926|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
82875927|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875928|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82875929|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82875930|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82875931|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82875932|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875933|NCT01336660|Antivenins|antivenins|mesh-list
82875934|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
82875935|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875936|NCT03768518|Exenatide|exenatide|mesh-list
82875937|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82875938|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875939|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82875940|NCT03768518|Incretins|incretins|mesh-ancestor
82875941|NCT03768518|Hormones|hormones|mesh-ancestor
82875942|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875943|NCT04276376|Atezolizumab|atezolizumab|mesh-list
82875944|NCT04276376|Rucaparib|rucaparib|mesh-list
82875945|NCT04276376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82875946|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875947|NCT04276376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875948|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875949|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82875950|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875951|NCT04254692|Bupivacaine|bupivacaine|mesh-list
82875952|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
82875953|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
82875954|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82875955|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875956|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
82875957|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82875958|NCT03770000|Romidepsin|romidepsin|mesh-list
82875959|NCT03770000|Tenalisib|tenalisib|mesh-list
82875960|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82875961|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875962|NCT03770000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82875963|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875964|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875965|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
82875966|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82875967|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82875968|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82875969|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
82875970|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875971|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875972|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82875973|NCT03158272|Nivolumab|nivolumab|mesh-list
82875974|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82875975|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82875976|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82875977|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875978|NCT01431508|Losartan|losartan|mesh-list
82875979|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82875980|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82875981|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82875982|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82875983|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875984|NCT01321502|Famciclovir|famciclovir|mesh-list
82875985|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
82875986|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82875987|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82875988|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82875989|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82875990|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82875991|NCT01347268|Hormones|hormones|mesh-ancestor
82875992|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82875993|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82875994|NCT01347424|Paclitaxel|paclitaxel|mesh-list
82875995|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82875996|NCT01347424|Carboplatin|carboplatin|mesh-list
82875997|NCT01347424|Endostatins|endostatins|mesh-list
82875998|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82875999|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876000|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876001|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876002|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876003|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876004|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82876005|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82876006|NCT01347424|Growth Substances|growth substances|mesh-ancestor
82876007|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876008|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
82876009|NCT01322438|Rifampin|rifampin|mesh-list
82876010|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82876011|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
82876012|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82876013|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876014|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
82876015|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876016|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876017|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876018|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82876019|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82876020|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82876021|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82876022|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82876023|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82876024|NCT00654628|Simvastatin|simvastatin|mesh-list
82876025|NCT00654628|Ezetimibe|ezetimibe|mesh-list
82876026|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82876027|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82876028|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
82876029|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876030|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82876031|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82876032|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876033|NCT00536380|Loratadine|loratadine|mesh-list
82876034|NCT00536380|Desloratadine|desloratadine|mesh-list
82876035|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82876036|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
82876037|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876038|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876039|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876040|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82876041|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82876042|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
82876043|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
82876044|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
82876045|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
82876046|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82876047|NCT01337362|Insulin|insulin|mesh-list
82876048|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82876049|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876050|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876051|NCT03762824|Vaccines|vaccines|mesh-list
82876052|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82876053|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
82876054|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876055|NCT00496834|Losartan|losartan|mesh-list
82876056|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82876057|NCT00496834|Carvedilol|carvedilol|mesh-list
82876058|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82876059|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82876060|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82876061|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82876062|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876063|NCT00496834|Diuretics|diuretics|mesh-ancestor
82876064|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
82876065|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876066|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82876067|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82876068|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82876069|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82876070|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
82876071|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876072|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
82876073|NCT00496834|Protective Agents|protective agents|mesh-ancestor
82876074|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82876075|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82876076|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
82876077|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82876078|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82876079|NCT00189280|Imiquimod|imiquimod|mesh-list
82876080|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82876081|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
82876082|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876083|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876084|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
82876085|NCT01352494|Gemcitabine|gemcitabine|mesh-list
82876086|NCT01352494|Docetaxel|docetaxel|mesh-list
82876087|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82876088|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
82876089|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876090|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876091|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876092|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876093|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876094|NCT01347814|Domperidone|domperidone|mesh-list
82876095|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
82876096|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
82876097|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876098|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876099|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876100|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82876101|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
82876102|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876103|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876104|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
82876105|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82876106|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82876107|NCT01348126|Docetaxel|docetaxel|mesh-list
82876108|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876109|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876110|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876111|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876112|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876113|NCT01348204|Quercetin|quercetin|mesh-list
82876114|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
82876115|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876116|NCT01348204|Protective Agents|protective agents|mesh-ancestor
82876117|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876118|NCT00166504|Atorvastatin|atorvastatin|mesh-list
82876121|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82876122|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82876123|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
82876124|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876125|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82876126|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82876127|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876128|NCT01348282|Rivastigmine|rivastigmine|mesh-list
82876129|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876130|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876131|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876132|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82876133|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
82876134|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876135|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82876136|NCT01348282|Protective Agents|protective agents|mesh-ancestor
82876137|NCT03137992|Bromides|bromides|mesh-list
82876138|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
82876139|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82876140|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
82876141|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876142|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876143|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82876144|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
82876145|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
82876146|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82876147|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
82876148|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876149|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876150|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
82876151|NCT04470778|Famotidine|famotidine|mesh-list
82876152|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82876153|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876154|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82876155|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
82876156|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
82876157|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876158|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876159|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876160|NCT01352572|Milnacipran|milnacipran|mesh-list
82876161|NCT01352572|Mirtazapine|mirtazapine|mesh-list
82876162|NCT01352572|Sertraline|sertraline|mesh-list
82876163|NCT01352572|Fluoxetine|fluoxetine|mesh-list
82876164|NCT01352572|Paroxetine|paroxetine|mesh-list
82876165|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82876166|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
82876167|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
82876168|NCT01352572|Nortriptyline|nortriptyline|mesh-list
82876169|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82876170|NCT01352572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82876171|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82876172|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82876173|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876174|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876175|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
82876176|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876177|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82876178|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82876179|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82876180|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876181|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82876182|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82876183|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
82876184|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
82876185|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82876186|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82876187|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876188|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82876189|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82876190|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82876191|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
82876193|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82876194|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82876195|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876196|NCT01352572|Analgesics|analgesics|mesh-ancestor
82876197|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
82876198|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876199|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82876200|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82876201|NCT01352650|Plerixafor|plerixafor|mesh-list
82876202|NCT01352650|Decitabine|decitabine|mesh-list
82876203|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82876204|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
82876205|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876206|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876207|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876208|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82876209|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82876210|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
82876211|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876212|NCT01352728|Axitinib|axitinib|mesh-list
82876213|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876214|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876215|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876216|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876217|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
82876218|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82876219|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876220|NCT03997448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82876221|NCT03997448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876222|NCT03767660|Sirolimus|sirolimus|mesh-list
82876223|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82876224|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876225|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82876226|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876227|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
82876228|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876229|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
82876230|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876231|NCT03767504|Thymol|thymol|mesh-list
82876232|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876233|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82876234|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
82876235|NCT01343290|Canagliflozin|canagliflozin|mesh-list
82876236|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82876237|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876238|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876239|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876240|NCT03761264|Amoxicillin|amoxicillin|mesh-list
82876241|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
82876242|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876243|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82876244|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876245|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
82876246|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
82876247|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82876248|NCT03761264|Protective Agents|protective agents|mesh-ancestor
82876249|NCT05096312|Zinc|zinc|mesh-list
82876250|NCT05096312|Adapalene|adapalene|mesh-list
82876251|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
82876252|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82876253|NCT05096312|Trace Elements|trace elements|mesh-ancestor
82876254|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
82876255|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876256|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
82876257|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82876258|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876259|NCT05096312|Analgesics|analgesics|mesh-ancestor
82876260|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
82876261|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876262|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876263|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876264|NCT03767036|Ketorolac|ketorolac|mesh-list
82876265|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82876266|NCT03767036|Tramadol|tramadol|mesh-list
82876267|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82876268|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876269|NCT03767036|Analgesics|analgesics|mesh-ancestor
82876270|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
82876271|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876272|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876273|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876274|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876275|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82876276|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876277|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876278|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82876279|NCT03767036|Narcotics|narcotics|mesh-ancestor
82876280|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876281|NCT03758144|Rifaximin|rifaximin|mesh-list
82876282|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82876283|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876284|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876285|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
82876286|NCT03766724|Empagliflozin|empagliflozin|mesh-list
82876287|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82876288|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876289|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876290|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876291|NCT04860518|Dexamethasone|dexamethasone|mesh-list
82876292|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876293|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
82876294|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
82876295|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876296|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876297|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876298|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
82876299|NCT04860518|Hormones|hormones|mesh-ancestor
82876300|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82876301|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82876302|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876303|NCT03110380|Dolutegravir|dolutegravir|mesh-list
82876304|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82876305|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82876306|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82876307|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876308|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876309|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82876310|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82876311|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
82876312|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876313|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82876314|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876315|NCT03757910|Corticosterone|corticosterone|mesh-list
82876316|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876317|NCT01322204|Codeine|codeine|mesh-list
82876318|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82876319|NCT01322204|Narcotics|narcotics|mesh-ancestor
82876320|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876321|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876322|NCT01322204|Analgesics|analgesics|mesh-ancestor
82876323|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
82876324|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876325|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
82876326|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
82876327|NCT03766490|Gefitinib|gefitinib|mesh-list
82876328|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876329|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876330|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876331|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876332|NCT01348984|Fentanyl|fentanyl|mesh-list
82876333|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82876334|NCT01348984|Narcotics|narcotics|mesh-ancestor
82876335|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876336|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876337|NCT01348984|Analgesics|analgesics|mesh-ancestor
82876338|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
82876339|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876340|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82876341|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82876342|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
82876344|NCT01567670|Naloxone|naloxone|mesh-list
82876345|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82876346|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876347|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
82876348|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876349|NCT01349062|Immunomodulating Agents|immunomodulating agents|mesh-list
82876350|NCT01349062|Immunologic Factors|immunologic factors|mesh-ancestor
82876351|NCT01349062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876352|NCT04848662|Budesonide|budesonide|mesh-list
82876353|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876354|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82876355|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
82876356|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876357|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876358|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82876359|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
82876360|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
82876361|NCT04848662|Hormones|hormones|mesh-ancestor
82876362|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82876363|NCT04351256|Durvalumab|durvalumab|mesh-list
82876364|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82876365|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876366|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
82876367|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82876368|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876369|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82876370|NCT03700892|Protective Agents|protective agents|mesh-ancestor
82876371|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876372|NCT01322282|Cetirizine|cetirizine|mesh-list
82876373|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82876374|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82876375|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82876376|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
82876377|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
82876378|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876379|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876380|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876381|NCT03757364|Methotrexate|methotrexate|mesh-list
82876382|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82876383|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
82876384|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82876385|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876386|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82876387|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
82876388|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876389|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876390|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
82876391|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876392|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82876393|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876394|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
82876395|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876396|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876397|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
82876398|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82876399|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876400|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
82876401|NCT04737278|Niacin|niacin|mesh-list
82876402|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
82876403|NCT04737278|Vitamins|vitamins|mesh-ancestor
82876404|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
82876405|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876406|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82876407|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
82876408|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876409|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82876410|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
82876411|NCT03759860|Ranibizumab|ranibizumab|mesh-list
82876412|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82876413|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82876414|NCT03759860|Growth Substances|growth substances|mesh-ancestor
82876415|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876416|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
82876417|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876418|NCT03759782|Tenofovir|tenofovir|mesh-list
82876419|NCT03759782|Ribavirin|ribavirin|mesh-list
82876420|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
82876421|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876422|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82876423|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876424|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876425|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876426|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82876427|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82876428|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
82876429|NCT03757052|Amoxicillin|amoxicillin|mesh-list
82876430|NCT03757052|Penicillins|penicillins|mesh-list
82876431|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82876432|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876433|NCT03765944|Sirolimus|sirolimus|mesh-list
82876434|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82876435|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876436|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82876437|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876438|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
82876439|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876440|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
82876441|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876442|NCT04684394|Aflibercept|aflibercept|mesh-list
82876443|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82876444|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82876445|NCT04684394|Growth Substances|growth substances|mesh-ancestor
82876446|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876447|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
82876448|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876449|NCT03765554|PF-06700841|pf-06700841|mesh-list
82876450|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876451|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876452|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876453|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
82876454|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82876455|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82876456|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876457|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876458|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82876459|NCT04668950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82876460|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82876461|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82876462|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876463|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876464|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
82876465|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82876466|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
82876467|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82876468|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82876469|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876470|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82876471|NCT03078478|Insulin|insulin|mesh-list
82876472|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82876473|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
82876474|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876475|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876476|NCT01349296|Everolimus|everolimus|mesh-list
82876477|NCT01349296|Nintedanib|nintedanib|mesh-list
82876478|NCT01349296|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82876479|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876480|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876481|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876482|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876483|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
82876484|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876485|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876486|NCT03522844|Escitalopram|escitalopram|mesh-list
82876487|NCT03522844|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82876488|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82876489|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82876490|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876493|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876494|NCT00045942|Itraconazole|itraconazole|mesh-list
82876495|NCT00045942|Midostaurin|midostaurin|mesh-list
82876496|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
82876497|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876498|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82876499|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82876500|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876501|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876502|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82876503|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
82876504|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82876505|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876506|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82876507|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876508|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876509|NCT04386616|Astegolimab|astegolimab|mesh-list
82876510|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82876511|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876512|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
82876513|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876514|NCT00045708|Epothilones|epothilones|mesh-list
82876515|NCT00045708|Epothilone B|epothilone b|mesh-list
82876516|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
82876517|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876518|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876519|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876520|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876521|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876522|NCT01349452|Ganciclovir|ganciclovir|mesh-list
82876523|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82876524|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
82876525|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82876526|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82876527|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
82876528|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876529|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876530|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876531|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876532|NCT00045630|Paclitaxel|paclitaxel|mesh-list
82876533|NCT00045630|Carboplatin|carboplatin|mesh-list
82876534|NCT00045630|Gemcitabine|gemcitabine|mesh-list
82876535|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82876536|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876537|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876538|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876539|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876540|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876541|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82876542|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
82876543|NCT01357252|Vildagliptin|vildagliptin|mesh-list
82876544|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876545|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876546|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82876547|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
82876548|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876549|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876550|NCT03465280|Interferons|interferons|mesh-list
82876551|NCT03465280|Acyclovir|acyclovir|mesh-list
82876552|NCT03465280|Cidofovir|cidofovir|mesh-list
82876553|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
82876554|NCT03465280|Artemisinins|artemisinins|mesh-list
82876555|NCT03465280|Artemisinin|artemisinin|mesh-list
82876556|NCT03465280|Celecoxib|celecoxib|mesh-list
82876557|NCT03465280|Methotrexate|methotrexate|mesh-list
82876558|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
82876559|NCT03465280|Isotretinoin|isotretinoin|mesh-list
82876560|NCT03465280|Cimetidine|cimetidine|mesh-list
82876561|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876562|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876563|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82876564|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
82876565|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82876567|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
82876568|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876569|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
82876570|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876571|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82876572|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876573|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
82876574|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876575|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876576|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
82876577|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876578|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82876579|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876580|NCT03465280|Analgesics|analgesics|mesh-ancestor
82876581|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
82876582|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876583|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876584|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82876585|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82876586|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82876587|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876588|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82876589|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
82876590|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
82876591|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876592|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82876593|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82876594|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
82876595|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82876596|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82876597|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82876598|NCT03465280|Protective Agents|protective agents|mesh-ancestor
82876599|NCT01349764|Vitamin D|vitamin d|mesh-list
82876600|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
82876602|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
82876603|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876604|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83453973|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
82876605|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82876606|NCT02924272|Ixazomib|ixazomib|mesh-list
82876607|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876608|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
82876609|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876610|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876611|NCT01353742|Lamivudine|lamivudine|mesh-list
82876612|NCT01353742|Adefovir|adefovir|mesh-list
82876613|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82876614|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82876615|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876616|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876617|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876618|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
82876619|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876620|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82876621|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82876622|NCT00003702|Dactinomycin|dactinomycin|mesh-list
82876623|NCT00003702|Cactinomycin|cactinomycin|mesh-list
82876624|NCT00003702|Methotrexate|methotrexate|mesh-list
82876625|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82876626|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
82876627|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82876628|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876629|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82876630|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
82876631|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876632|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876633|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
82876634|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876635|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82876636|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876637|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
82876638|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876639|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876640|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82876641|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876642|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82876643|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82876644|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
82876645|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
82876646|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82876647|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82876648|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876649|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876650|NCT01350154|Urological Agents|urological agents|mesh-ancestor
82876651|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
82876652|NCT00031590|Lomustine|lomustine|mesh-list
82876653|NCT00031590|Etoposide|etoposide|mesh-list
82876654|NCT00031590|Vincristine|vincristine|mesh-list
82876655|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876656|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
82876657|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876658|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876659|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82876660|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
82876661|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876662|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876663|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82876664|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82876665|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82876666|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82876667|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876668|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876669|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876670|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876671|NCT01318096|Tenofovir|tenofovir|mesh-list
82876672|NCT01318096|Lamivudine|lamivudine|mesh-list
82876673|NCT01318096|Efavirenz|efavirenz|mesh-list
82876674|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
82876675|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
82876676|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876677|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82876678|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82876679|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876680|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876681|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82876682|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82876683|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82876684|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82876685|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82876686|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82876687|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82876688|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82876689|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82876690|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82876691|NCT02530320|Palbociclib|palbociclib|mesh-list
82876692|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876693|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876694|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876695|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876696|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82876697|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82876698|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82876699|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
82876700|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876701|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82876702|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82876703|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876704|NCT00238433|Melphalan|melphalan|mesh-list
82876705|NCT00238433|Busulfan|busulfan|mesh-list
82876706|NCT00238433|Thiotepa|thiotepa|mesh-list
82876707|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
82876708|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876709|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82876710|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
82876711|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876712|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876713|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82876714|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876715|NCT02532023|Curcumin|curcumin|mesh-list
82876716|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82876717|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876718|NCT02532023|Analgesics|analgesics|mesh-ancestor
82876719|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
82876720|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876721|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876722|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876723|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876724|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876725|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876726|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876727|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
82876728|NCT01354522|Docetaxel|docetaxel|mesh-list
82876729|NCT01354522|Doxorubicin|doxorubicin|mesh-list
82876730|NCT01354522|Capecitabine|capecitabine|mesh-list
82876731|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876732|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
82876733|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876734|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876735|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82876736|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
82876737|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876738|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876739|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82876740|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876741|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876742|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876743|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82876744|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82876745|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82876746|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876747|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82876748|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
82876749|NCT00045162|Irinotecan|irinotecan|mesh-list
82876750|NCT00045162|Etoposide|etoposide|mesh-list
82876751|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876752|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82876753|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82876754|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876755|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876756|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82876757|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82876758|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82876759|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82876760|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876761|NCT00238121|Sorafenib|sorafenib|mesh-list
82876762|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876763|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876764|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876765|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876766|NCT01350622|Diclofenac|diclofenac|mesh-list
82876767|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
82876768|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82876769|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876770|NCT01350622|Analgesics|analgesics|mesh-ancestor
82876771|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
82876772|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876773|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876774|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876775|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876776|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82876777|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876778|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876779|NCT01096212|Sevoflurane|sevoflurane|mesh-list
82876780|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82876781|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82876782|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
82876783|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
82876784|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876785|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876786|NCT03139240|Oxycodone|oxycodone|mesh-list
82876787|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82876788|NCT03139240|Narcotics|narcotics|mesh-ancestor
82876789|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876790|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876791|NCT03139240|Analgesics|analgesics|mesh-ancestor
82876792|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
82876793|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876794|NCT01350856|Artesunate|artesunate|mesh-list
82876795|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
82876796|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82876797|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82876798|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876799|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876800|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
82876801|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
82876802|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82876803|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
82876804|NCT03973775|Permethrin|permethrin|mesh-list
82876805|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876806|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876807|NCT01351168|Levodopa|levodopa|mesh-list
82876808|NCT01351168|Zolpidem|zolpidem|mesh-list
82876809|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82876810|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82876811|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
82876812|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876813|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876814|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876815|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82876816|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82876817|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876818|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82876819|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
82876820|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
82876821|NCT01351636|Arotinolol|arotinolol|mesh-list
82876822|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82876823|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82876824|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
82876825|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876826|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876827|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876828|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82876829|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82876830|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82876831|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
82876832|NCT03952260|Anesthetics|anesthetics|mesh-list
82876833|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876834|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876835|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82876836|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82876837|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
82876838|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876839|NCT01351948|Antacids|antacids|mesh-ancestor
82876840|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876841|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876842|NCT01352026|Metformin|metformin|mesh-list
82876843|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876844|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876845|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
82876846|NCT03136198|Diuretics|diuretics|mesh-list
82876847|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
82876848|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
82876849|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876850|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82876851|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876852|NCT01357486|Sorafenib|sorafenib|mesh-list
82876853|NCT01357486|Pravastatin|pravastatin|mesh-list
82876854|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876855|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876856|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876857|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876858|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82876859|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82876860|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
82876861|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82876862|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82876863|NCT01318564|Metformin|metformin|mesh-list
82876864|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876865|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876866|NCT00042432|Cinacalcet|cinacalcet|mesh-list
82876867|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82876868|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876869|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82876870|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
82876871|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82876872|NCT01352338|Prednisone|prednisone|mesh-list
82876873|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
82876874|NCT01352338|Lenalidomide|lenalidomide|mesh-list
82876875|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876876|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
82876877|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876878|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876879|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82876880|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
82876881|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876882|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876883|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82876884|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876885|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
82876886|NCT01352338|Hormones|hormones|mesh-ancestor
82876887|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82876888|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83453991|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
82876889|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82876890|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82876891|NCT01352338|Growth Substances|growth substances|mesh-ancestor
82876892|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
82876893|NCT01542736|Carboplatin|carboplatin|mesh-list
82876894|NCT01542736|Vincristine|vincristine|mesh-list
82876895|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876896|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82876897|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
82876898|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
82876899|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
82876900|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876901|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82876902|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82876903|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82876904|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82876905|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
82876906|NCT01361542|Infliximab|infliximab|mesh-list
82876907|NCT01361542|Etanercept|etanercept|mesh-list
82876908|NCT01361542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82876909|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82876910|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
82876911|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82876912|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82876913|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82876914|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876915|NCT01361542|Analgesics|analgesics|mesh-ancestor
82876916|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
82876917|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876918|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876919|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876920|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
82876921|NCT03950700|Epinephrine|epinephrine|mesh-list
82876922|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82876923|NCT03950700|Bupivacaine|bupivacaine|mesh-list
82876924|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82876925|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
82876926|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
82876927|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82876928|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876929|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
82876930|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876931|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82876932|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82876933|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
82876934|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876935|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876936|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82876937|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82876944|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876945|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82876946|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876947|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876948|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
82876949|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82876950|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82876951|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82876952|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82876953|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876954|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
82876955|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82876956|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876957|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82876958|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876959|NCT00003222|Aldesleukin|aldesleukin|mesh-list
82876960|NCT00003222|Interleukin-2|interleukin-2|mesh-list
82876961|NCT00003222|Sargramostim|sargramostim|mesh-list
82876962|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
82876963|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876964|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82876965|NCT00003222|Analgesics|analgesics|mesh-ancestor
82876966|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
82876967|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82876968|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876969|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
82876970|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82876971|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82876972|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
82876973|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82876974|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82876975|NCT01357876|Metformin|metformin|mesh-list
82876976|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82876977|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876978|NCT02877082|Bortezomib|bortezomib|mesh-list
82876979|NCT02877082|Tacrolimus|tacrolimus|mesh-list
82876980|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
82876981|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82876982|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82876983|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
82876984|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876985|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82876986|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82876987|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876988|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82876989|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82876990|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82876991|NCT03951558|Diuretics|diuretics|mesh-ancestor
82876992|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
82876993|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82876994|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82876995|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82876996|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82876997|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82876998|NCT01362010|Minocycline|minocycline|mesh-list
82876999|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877006|NCT02875366|Ivacaftor|ivacaftor|mesh-list
82877007|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82877008|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877009|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877010|NCT01362400|Docetaxel|docetaxel|mesh-list
82877011|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877012|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
82877013|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
82877014|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
82877015|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877017|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82877018|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
82877019|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877020|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
82877021|NCT00002850|Ofloxacin|ofloxacin|mesh-list
82877022|NCT00002850|Trimethoprim|trimethoprim|mesh-list
82877023|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
82877024|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877025|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877026|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877027|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877028|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877029|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877030|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877031|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82877032|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82877033|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82877034|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
82877035|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82877036|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82877037|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82877038|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82877039|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82877040|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
82877041|NCT04234906|Amiodarone|amiodarone|mesh-list
82877042|NCT04234906|Procainamide|procainamide|mesh-list
82877043|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
82877044|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82877045|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877046|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877047|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82877048|NCT04234906|Analgesics|analgesics|mesh-ancestor
82877049|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
82877050|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877051|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82877052|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82877053|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82877054|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
82877055|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877056|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877057|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
82877058|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82877059|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
82718405|NCT04073160|Durvalumab|durvalumab|mesh-list
82877060|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82877061|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877062|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82877063|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
82877064|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82877065|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
82877066|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82877067|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82877068|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82877069|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82877070|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877071|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82877072|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82877073|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82877074|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82877075|NCT00002766|Cytarabine|cytarabine|mesh-list
82877076|NCT00002766|Dactinomycin|dactinomycin|mesh-list
82877077|NCT00002766|Prednisone|prednisone|mesh-list
82877078|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
82877079|NCT00002766|Carmustine|carmustine|mesh-list
82877080|NCT00002766|Doxorubicin|doxorubicin|mesh-list
82877081|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82877082|NCT00002766|Methotrexate|methotrexate|mesh-list
82877083|NCT00002766|Etoposide|etoposide|mesh-list
82877084|NCT00002766|Vincristine|vincristine|mesh-list
82877085|NCT00002766|Daunorubicin|daunorubicin|mesh-list
82877086|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
82877087|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
82877088|NCT00002766|Pegaspargase|pegaspargase|mesh-list
82877089|NCT00002766|Sargramostim|sargramostim|mesh-list
82877090|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877093|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877094|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82877095|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
82877096|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877097|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877098|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82877099|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82877100|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877101|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877102|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877103|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877104|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
82877105|NCT00002766|Hormones|hormones|mesh-ancestor
82877106|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877107|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82877108|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82877109|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
82877110|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82877111|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82877112|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
82877113|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
82877114|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82877115|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82877116|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82877117|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
82877118|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877119|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
82877120|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
82877121|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
82877122|NCT00002766|Analgesics|analgesics|mesh-ancestor
82877123|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
82877124|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877125|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877126|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82877127|NCT01355380|Iloprost|iloprost|mesh-list
82877128|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82877129|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
82877130|NCT01355614|Infliximab|infliximab|mesh-list
82877131|NCT01355614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82877132|NCT01355614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877133|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
82877134|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82877135|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877136|NCT01584492|Beclomethasone|beclomethasone|mesh-list
82877137|NCT01584492|Albuterol|albuterol|mesh-list
82877139|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82877140|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
82877141|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877142|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877143|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82877144|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
82877145|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82877146|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82877147|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82877148|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
82877149|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877150|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877151|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877152|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
82877153|NCT01584492|Hormones|hormones|mesh-ancestor
82877154|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877155|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
82877156|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82877157|NCT00001962|Daclizumab|daclizumab|mesh-list
82877158|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877159|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
82877160|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877161|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82877162|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82877163|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
82877164|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82877165|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
82877166|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877167|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
82877168|NCT01101984|Protective Agents|protective agents|mesh-ancestor
82877169|NCT01103154|Nadolol|nadolol|mesh-list
82877170|NCT01103154|Carvedilol|carvedilol|mesh-list
82877171|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82877172|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82877173|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
82877174|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877175|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877176|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877177|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82877178|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
82877179|NCT01103154|Protective Agents|protective agents|mesh-ancestor
82877180|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82877181|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877182|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82877183|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
82877184|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82877185|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82877186|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82877187|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
82877188|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
82877189|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877190|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82877191|NCT01100346|Hormones|hormones|mesh-ancestor
82877192|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877193|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877194|NCT01103388|Rituximab|rituximab|mesh-list
82877195|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82877196|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877197|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
82877198|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877199|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877200|NCT01327326|Naltrexone|naltrexone|mesh-list
82877201|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82877202|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82877203|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877204|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
82877205|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877206|NCT03950544|Meropenem|meropenem|mesh-list
82877207|NCT03950544|Fosfomycin|fosfomycin|mesh-list
82877208|NCT03950544|Tigecycline|tigecycline|mesh-list
82877209|NCT03950544|Polymyxins|polymyxins|mesh-list
82877210|NCT03950544|Polymyxin B|polymyxin b|mesh-list
82877211|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877212|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877213|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82877214|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877215|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877216|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
82877217|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877218|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82877219|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877220|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877221|NCT00256997|Risperidone|risperidone|mesh-list
82877222|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
82877223|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82877224|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
82877225|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877226|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877227|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877228|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82877229|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877230|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82877231|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82877232|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
82877233|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
82877234|NCT00027846|Carboplatin|carboplatin|mesh-list
82877235|NCT00027846|Etoposide|etoposide|mesh-list
82877236|NCT00027846|Vincristine|vincristine|mesh-list
82877237|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
82877238|NCT00027846|Lenograstim|lenograstim|mesh-list
82877239|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877240|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
82877241|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877242|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877243|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82877244|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
82877245|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877246|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877247|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82877248|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82877249|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877250|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877251|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877252|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82877253|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
82877254|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
82877255|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
82877256|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
82877257|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
82877258|NCT00027378|Fluoxetine|fluoxetine|mesh-list
82877259|NCT00027378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82877260|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82877261|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877262|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877263|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877264|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
82877265|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877266|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82877267|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
82877268|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82877269|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83454002|NCT02244827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877270|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82877271|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877272|NCT03950154|Bevacizumab|bevacizumab|mesh-list
82877273|NCT03950154|Capecitabine|capecitabine|mesh-list
82877274|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
82877275|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82877276|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877277|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82877278|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82877279|NCT03950154|Growth Substances|growth substances|mesh-ancestor
82877280|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877281|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
82877282|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82877283|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
82877284|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877285|NCT03949062|Rituximab|rituximab|mesh-list
82877286|NCT03949062|Lenalidomide|lenalidomide|mesh-list
82877287|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82877288|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877290|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877291|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877292|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82877293|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82877294|NCT03949062|Growth Substances|growth substances|mesh-ancestor
82877295|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
82877296|NCT00235391|Deferasirox|deferasirox|mesh-list
82877297|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82877298|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
82877299|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
82877300|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877301|NCT01103622|Digoxin|digoxin|mesh-list
82877302|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82877303|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82877304|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877305|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877306|NCT01103622|Protective Agents|protective agents|mesh-ancestor
82877307|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877308|NCT01072955|Heparin|heparin|mesh-list
82877309|NCT01072955|Calcium heparin|calcium heparin|mesh-list
82877310|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
82877311|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82877312|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82877313|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877314|NCT00026208|Prednisone|prednisone|mesh-list
82877315|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
82877316|NCT00026208|Doxorubicin|doxorubicin|mesh-list
82877317|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82877318|NCT00026208|Etoposide|etoposide|mesh-list
82877319|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
82877320|NCT00026208|Vincristine|vincristine|mesh-list
82877321|NCT00026208|Bleomycin|bleomycin|mesh-list
82877322|NCT00026208|Vinblastine|vinblastine|mesh-list
82877323|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877324|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
82877325|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877326|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877327|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82877328|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
82877329|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877330|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877331|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82877332|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82877333|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877334|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877335|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877336|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877337|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
82877338|NCT00026208|Hormones|hormones|mesh-ancestor
82877339|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877340|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82877341|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82877342|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
82877343|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
82877344|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
82877345|NCT00025662|Interleukin-2|interleukin-2|mesh-list
82877346|NCT00025662|Immunotoxins|immunotoxins|mesh-list
82877347|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877348|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82877349|NCT00025662|Analgesics|analgesics|mesh-ancestor
82877350|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
82877351|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877352|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877353|NCT00025662|Immunoconjugates|immunoconjugates|mesh-ancestor
82877354|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
82877355|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
82877356|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82877357|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
82877358|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877359|NCT03759158|Expectorants|expectorants|mesh-ancestor
82877360|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
82877361|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82877362|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
83513004|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
82877363|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877364|NCT03759158|Protective Agents|protective agents|mesh-ancestor
82877365|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877366|NCT03759158|Antidotes|antidotes|mesh-ancestor
82877367|NCT02922764|Carboplatin|carboplatin|mesh-list
82877369|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
82877370|NCT02922764|Pemetrexed|pemetrexed|mesh-list
82877371|NCT02922764|Ipilimumab|ipilimumab|mesh-list
82877372|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877373|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
82877374|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
82877375|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
82877376|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877377|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82877378|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82877379|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877380|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82877381|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82877382|NCT00025506|Thalidomide|thalidomide|mesh-list
82877383|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877384|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
82877385|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877386|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
82877387|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877388|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877389|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82877390|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82877391|NCT00025506|Growth Substances|growth substances|mesh-ancestor
82877392|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
82877394|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
82877395|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877396|NCT03756272|Bupivacaine|bupivacaine|mesh-list
82877397|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
82877398|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
82877399|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877400|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877401|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
82877402|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877403|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82877404|NCT03756116|Epinephrine|epinephrine|mesh-list
82877405|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82877406|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82877407|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
82877408|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877409|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877410|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877411|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82877412|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82877413|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
82877414|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877415|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82877416|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
82877417|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
82877418|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
82877419|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83454006|NCT04359485|Glycolic acid|glycolic acid|mesh-list
82877421|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877422|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82877423|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
82877424|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877425|NCT04640168|Remdesivir|remdesivir|mesh-list
82877426|NCT04640168|Dexamethasone|dexamethasone|mesh-list
82877427|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877428|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
82877429|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
82877430|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877431|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877432|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82877433|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
82877434|NCT04640168|Hormones|hormones|mesh-ancestor
82877435|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877436|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82877437|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877438|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
82877439|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877440|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
82877441|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877442|NCT00022698|Capecitabine|capecitabine|mesh-list
82877443|NCT00022698|Irinotecan|irinotecan|mesh-list
82877444|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82877445|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
82877446|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877447|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877448|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82877449|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877450|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877451|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
82877452|NCT03951402|Tapentadol|tapentadol|mesh-list
82877453|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82877454|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877455|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877456|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877457|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877458|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877459|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877460|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877461|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82877462|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
82877463|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82877464|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877465|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82877466|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82877467|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82877468|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82877470|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877471|NCT03951402|Analgesics|analgesics|mesh-ancestor
82877472|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
82877473|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877474|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82877475|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82877476|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877477|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
82877478|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877479|NCT01100736|Bosentan|bosentan|mesh-list
82877480|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
82877481|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82877482|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82877483|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877484|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
82877485|NCT01584726|Analgesics|analgesics|mesh-ancestor
82877486|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
82877487|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877488|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877489|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
83454008|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
82877490|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877491|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82877492|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
82877493|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82877494|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877495|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877496|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82877497|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
82877498|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82877499|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
82877500|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
82877501|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
82877502|NCT01105494|Hematinics|hematinics|mesh-ancestor
82877503|NCT03949686|Bupivacaine|bupivacaine|mesh-list
82877504|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
82877505|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
82877506|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877507|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877508|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
82877509|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877510|NCT03949842|Fluticasone|fluticasone|mesh-list
82877511|NCT03949842|Xhance|xhance|mesh-list
82877512|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
82877513|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
82877514|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
82877515|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877516|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82877517|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
82877518|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877519|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877520|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82877521|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
82877522|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
82877523|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82877524|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877525|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877526|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82877527|NCT01102608|Ifosfamide|ifosfamide|mesh-list
82877528|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82877529|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
82877530|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877531|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877532|NCT01102686|Leucovorin|leucovorin|mesh-list
82877533|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
82877534|NCT01102686|Antidotes|antidotes|mesh-ancestor
82877535|NCT01102686|Protective Agents|protective agents|mesh-ancestor
82877536|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877537|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
82877538|NCT01102686|Vitamins|vitamins|mesh-ancestor
82877539|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
82877540|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
82877541|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82877542|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82877543|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877544|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82877545|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877546|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877547|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82877548|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82877549|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82877550|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
82877551|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877552|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82877553|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82877554|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877555|NCT04625972|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
82877556|NCT04625972|Antiviral Agents|antiviral agents|mesh-ancestor
82877557|NCT04625972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877558|NCT05626140|Diclofenac|diclofenac|mesh-list
82877559|NCT05626140|Lacosamide|lacosamide|mesh-list
82877560|NCT05626140|Codeine|codeine|mesh-list
82877561|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82877562|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82877563|NCT05626140|Analgesics|analgesics|mesh-ancestor
82877564|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
82877565|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877566|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877567|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877568|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877569|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82877570|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877571|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877572|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
82877573|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82877574|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82877575|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877576|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82877577|NCT05626140|Narcotics|narcotics|mesh-ancestor
82877578|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877579|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
82877580|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
82877581|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82877582|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82877583|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877584|NCT04813614|Lidocaine|lidocaine|mesh-list
82877585|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
82877586|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
82877587|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877588|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877589|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
82877590|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877591|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82877592|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82877593|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82877594|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877595|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877596|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82877597|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
82877598|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82877599|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82877600|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877601|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877602|NCT01106118|Urological Agents|urological agents|mesh-ancestor
82877603|NCT00234065|Aspirin|aspirin|mesh-list
82877604|NCT00234065|Cilostazol|cilostazol|mesh-list
82877605|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82877606|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82877607|NCT00234065|Analgesics|analgesics|mesh-ancestor
82877608|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
82877609|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877610|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877611|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877612|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877613|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82877614|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82877615|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877616|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82877617|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82877618|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877619|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
82877620|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82877621|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
82877622|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82877623|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
82877624|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
82877625|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82877626|NCT00234065|Protective Agents|protective agents|mesh-ancestor
82877627|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82877628|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82877629|NCT01108848|Complement C1s|complement c1s|mesh-list
82877630|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
82877631|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
82877632|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
82877633|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877634|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82877635|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877636|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
82877637|NCT00233987|Melphalan|melphalan|mesh-list
82877638|NCT00233987|Carmustine|carmustine|mesh-list
82877639|NCT00233987|Etoposide|etoposide|mesh-list
82877640|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877641|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
82877642|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877643|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877644|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82877645|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
82877646|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877647|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877648|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82877649|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82877650|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877651|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877652|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877653|NCT01108926|Tenofovir|tenofovir|mesh-list
82877654|NCT01108926|Emtricitabine|emtricitabine|mesh-list
82877655|NCT01108926|Efavirenz|efavirenz|mesh-list
82877656|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82877657|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
82877658|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877659|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82877660|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82877661|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877662|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877663|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82877664|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82877665|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82877666|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82877667|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82877668|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82877669|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82877670|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82877671|NCT05321394|Ritonavir|ritonavir|mesh-list
82877672|NCT05321394|Nirmatrelvir|nirmatrelvir|mesh-list
82877673|NCT05321394|Sotrovimab|sotrovimab|mesh-list
82877674|NCT05321394|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
82877675|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82877676|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82877677|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
82877678|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877679|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877680|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82877681|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82877682|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
82877683|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877684|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82877685|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82877686|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82877687|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
82877688|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877689|NCT00233363|Rebamipide|rebamipide|mesh-list
82877690|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82877691|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82877692|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
82877693|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877694|NCT00233363|Protective Agents|protective agents|mesh-ancestor
82877695|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877696|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877697|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
82877698|NCT01147666|Hematinics|hematinics|mesh-ancestor
82877699|NCT01073111|Sirolimus|sirolimus|mesh-list
82877700|NCT01073111|Everolimus|everolimus|mesh-list
82877701|NCT01073111|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82877702|NCT01073111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82877703|NCT01073111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877704|NCT01073111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877705|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877706|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
82877707|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877708|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877709|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877710|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877711|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82877712|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
82877713|NCT01325987|Vitamin D|vitamin d|mesh-list
82877714|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
82877715|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
82877716|NCT01325987|Vitamins|vitamins|mesh-list
82877717|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
82877718|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877719|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82877720|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82877721|NCT00256295|Gemcitabine|gemcitabine|mesh-list
82877722|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
82877723|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82877724|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
82877725|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877726|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877727|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
82877728|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
82877729|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82877730|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82877731|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877732|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877733|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877734|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877735|NCT01109160|Azithromycin|azithromycin|mesh-list
82877736|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877737|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877738|NCT01363336|Nifedipine|nifedipine|mesh-list
82877739|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82877740|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877741|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877742|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82877743|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877744|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
82877745|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
82877746|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82877747|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
82877748|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82877749|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
82877750|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877751|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
82877752|NCT01363414|Protective Agents|protective agents|mesh-ancestor
82877753|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
82877754|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82877755|NCT02223520|Mupirocin|mupirocin|mesh-list
82877756|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82877757|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877758|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
82877759|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
82877760|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877761|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82877762|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877763|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877764|NCT01356472|Imipenem|imipenem|mesh-list
82877765|NCT01356472|Cilastatin|cilastatin|mesh-list
82877766|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877768|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
82877769|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877770|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877771|NCT02122198|Leuprolide|leuprolide|mesh-list
82877772|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82877773|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
82877774|NCT02122198|Estradiol|estradiol|mesh-list
82877775|NCT02122198|Estrogens|estrogens|mesh-ancestor
82877776|NCT02122198|Hormones|hormones|mesh-ancestor
82877777|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877778|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877779|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82877780|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
82877781|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82877782|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82877783|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82877784|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
82877785|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82877786|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877787|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82877788|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82877789|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82877790|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82877791|NCT01363570|Ranibizumab|ranibizumab|mesh-list
82877792|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82877793|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82877794|NCT01363570|Growth Substances|growth substances|mesh-ancestor
82877795|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877796|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
82877797|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877798|NCT04608500|Minocycline|minocycline|mesh-list
82877799|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877800|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877801|NCT01363648|Choline|choline|mesh-list
82877802|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
82877803|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82877804|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
82877805|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877806|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82877807|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82877808|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
82877809|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
82877810|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877811|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877812|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877813|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877814|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482843|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877815|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877816|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877817|NCT03944070|Ranibizumab|ranibizumab|mesh-list
82877818|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82877819|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82877820|NCT03944070|Growth Substances|growth substances|mesh-ancestor
82877821|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877822|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
82877823|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877824|NCT01363804|Tivozanib|tivozanib|mesh-list
82877825|NCT01363804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82877826|NCT01363804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877827|NCT01363804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877828|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82877830|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82877831|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
82877832|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877833|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877834|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82877835|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82877836|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82877837|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82877838|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877839|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82877840|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82877841|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
82877842|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877844|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82877845|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82877846|NCT05460416|Analgesics|analgesics|mesh-ancestor
82877847|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
82877848|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877849|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877850|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877851|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877852|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82877853|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82877854|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877855|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82877856|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82877857|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877858|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
82877859|NCT01364194|Bupivacaine|bupivacaine|mesh-list
82877860|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
82877861|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
82877862|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877863|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877864|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
82877865|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877866|NCT04575038|Brequinar|brequinar|mesh-list
82877867|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877868|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877869|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877870|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877871|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
82877872|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877873|NCT03066622|Olanzapine|olanzapine|mesh-list
82877874|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
82877875|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
82877876|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877877|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877878|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82877879|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82877880|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82877881|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877882|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82877883|NCT03066622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82877884|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82877885|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82877886|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877887|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877888|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
82877889|NCT01364974|Peficitinib|peficitinib|mesh-list
82877890|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877891|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877892|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877893|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
82877894|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877895|NCT05323214|Fentanyl|fentanyl|mesh-list
82877896|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
82877897|NCT05323214|Analgesics|analgesics|mesh-list
82877898|NCT05323214|Bupivacaine|bupivacaine|mesh-list
82877899|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
82877900|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
82877901|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82877902|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877903|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
82877904|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877905|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82877906|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82877907|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82877908|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82877909|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82877910|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
82877911|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82877912|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877913|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82877914|NCT05323214|Narcotics|narcotics|mesh-ancestor
82877915|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82877916|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82877917|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
82877918|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
82877919|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82877920|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877921|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82877922|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82877923|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877924|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877925|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877926|NCT05366816|Sunitinib|sunitinib|mesh-list
83454023|NCT00361413|Alefacept|alefacept|mesh-list
82877927|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877928|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82877929|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82877930|NCT05366816|Growth Substances|growth substances|mesh-ancestor
82877931|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877932|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
82877933|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82877934|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877935|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877936|NCT02060188|Nivolumab|nivolumab|mesh-list
82877937|NCT02060188|Ipilimumab|ipilimumab|mesh-list
82877938|NCT02060188|Relatlimab|relatlimab|mesh-list
82877939|NCT02060188|Daratumumab|daratumumab|mesh-list
82877940|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82877941|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877942|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82877943|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877944|NCT01356862|Pasireotide|pasireotide|mesh-list
82877945|NCT01356862|Hormones|hormones|mesh-ancestor
82877946|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877947|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877948|NCT03763760|Dexamethasone|dexamethasone|mesh-list
82877949|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82877950|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
82877951|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
82877952|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82877953|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877954|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82877955|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
82877956|NCT03763760|Hormones|hormones|mesh-ancestor
82877957|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82877958|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82877959|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877960|NCT04501952|Remdesivir|remdesivir|mesh-list
82877961|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
83513155|NCT01783574|Hormones|hormones|mesh-ancestor
82877962|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877963|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
82877964|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877965|NCT00321100|Bevacizumab|bevacizumab|mesh-list
82877966|NCT00321100|Cetuximab|cetuximab|mesh-list
82877967|NCT00321100|Capecitabine|capecitabine|mesh-list
82877968|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
82877969|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82877970|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877971|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82877972|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82877973|NCT00321100|Growth Substances|growth substances|mesh-ancestor
82877974|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877975|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
82877976|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82877977|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
82877978|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877979|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82877980|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82877981|NCT01365598|Primaquine|primaquine|mesh-list
82877982|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
82877983|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82877984|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82877985|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877986|NCT01365676|Hypericin|hypericin|mesh-list
82877987|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
82877988|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82877989|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82877990|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
82877991|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82877992|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82877993|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82877994|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82877995|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
82877996|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82877998|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
82877999|NCT03754712|Vitamins|vitamins|mesh-ancestor
82878000|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
82878001|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878002|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82878003|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82878004|NCT01318954|Immunomodulating Agents|immunomodulating agents|mesh-list
82878005|NCT01318954|Immunologic Factors|immunologic factors|mesh-ancestor
82878006|NCT01318954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878007|NCT03754634|Diacerein|diacerein|mesh-list
82878008|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878009|NCT00070018|Prednisone|prednisone|mesh-list
82878010|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
82878011|NCT00070018|Rituximab|rituximab|mesh-list
82878012|NCT00070018|Doxorubicin|doxorubicin|mesh-list
82878013|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82878014|NCT00070018|Vincristine|vincristine|mesh-list
82878015|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82878016|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878017|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
82878018|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878019|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82878020|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82878021|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
82878022|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878023|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878024|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82878025|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82878026|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82878027|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82878028|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82878029|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878030|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878031|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
82878032|NCT00070018|Hormones|hormones|mesh-ancestor
82878033|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878034|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82878035|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82878036|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
82878037|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
82878038|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
82878039|NCT03991988|Montelukast|montelukast|mesh-list
82878040|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82878041|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
82878042|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82878043|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
82878044|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878045|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878046|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82878047|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82878048|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878049|NCT01073189|Fenoldopam|fenoldopam|mesh-list
82878050|NCT01073189|Furosemide|furosemide|mesh-list
82878051|NCT01073189|Diuretics|diuretics|mesh-ancestor
82878052|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
82878053|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878054|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82878055|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878056|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878057|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82878058|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
82878059|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
82878060|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
82878061|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878062|NCT05191186|Immunomodulating Agents|immunomodulating agents|mesh-list
82878063|NCT05191186|Immunologic Factors|immunologic factors|mesh-ancestor
82878064|NCT05191186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878065|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
82878066|NCT03750656|Tamsulosin|tamsulosin|mesh-list
82878067|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82878068|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82878069|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82878070|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
82878071|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878072|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878073|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878074|NCT03750656|Urological Agents|urological agents|mesh-ancestor
82878075|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82878076|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82878077|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82878078|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
82878079|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878080|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82878081|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
82878082|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
82878083|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
82878084|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82878085|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82878086|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
82878087|NCT00229931|Triamcinolone|triamcinolone|mesh-list
82878088|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82878089|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82878090|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82878091|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878092|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
82878093|NCT00229931|Hormones|hormones|mesh-ancestor
82878094|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878095|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878096|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878097|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
82878098|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878099|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878100|NCT03752294|Dabigatran|dabigatran|mesh-list
82878101|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
82878102|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82878103|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
82878104|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878105|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878106|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
82878107|NCT03135028|Cytarabine|cytarabine|mesh-list
82878108|NCT03135028|Daunorubicin|daunorubicin|mesh-list
82878109|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82878110|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
82878111|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878112|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878113|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
82878114|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878115|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878116|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
82878117|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878118|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82878119|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82878120|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82878121|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878122|NCT03752138|Decitabine|decitabine|mesh-list
82878123|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82878124|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
82878125|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878126|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878127|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878128|NCT01370434|Dexamethasone|dexamethasone|mesh-list
82878129|NCT01370434|Doxorubicin|doxorubicin|mesh-list
82878130|NCT01370434|Vincristine|vincristine|mesh-list
82878131|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878132|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
82878133|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
82878134|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878135|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878136|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878137|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
82878138|NCT01370434|Hormones|hormones|mesh-ancestor
83083935|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878139|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878140|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82878141|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878142|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878143|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878144|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82878145|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82878146|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82878147|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82878148|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
82878149|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
82878150|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
82878151|NCT05190952|Dexamethasone|dexamethasone|mesh-list
82878152|NCT05190952|Ketamine|ketamine|mesh-list
82878153|NCT05190952|Bupivacaine|bupivacaine|mesh-list
82878154|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878155|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
82878156|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
82878157|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878158|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878159|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878160|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
82878161|NCT05190952|Hormones|hormones|mesh-ancestor
82878162|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878163|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82878164|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878165|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
82878166|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
82878167|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878168|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
82878169|NCT05190952|Analgesics|analgesics|mesh-ancestor
82878170|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82878171|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82878172|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
82878173|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82878174|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82878175|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878176|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878177|NCT03972683|Atropine|atropine|mesh-list
82878178|NCT03972683|Adenosine|adenosine|mesh-list
82878179|NCT03972683|Nitroprusside|nitroprusside|mesh-list
82878180|NCT03972683|Phenylephrine|phenylephrine|mesh-list
82878181|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
82878182|NCT03972683|Acetylcholine|acetylcholine|mesh-list
82878183|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82878184|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
82878185|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
82878186|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878187|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878188|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
82878189|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82878190|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
82878191|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
82878192|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82878193|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82878194|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82878195|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
82878196|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878197|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878198|NCT03972683|Protective Agents|protective agents|mesh-ancestor
82878199|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82878200|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82878201|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82878202|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82878203|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
82878204|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82878205|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82878206|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
82878207|NCT03972683|Analgesics|analgesics|mesh-ancestor
82878208|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
82878209|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
82878210|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82878211|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
82878212|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
82878213|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82878214|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82878216|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
82878217|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
82878218|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878219|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
82878220|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82878221|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
82878222|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878223|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
82878224|NCT03754010|Protective Agents|protective agents|mesh-ancestor
82878225|NCT00227591|Prednisone|prednisone|mesh-list
82878226|NCT00227591|Lenalidomide|lenalidomide|mesh-list
82878227|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878228|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
82878229|NCT00227591|Hormones|hormones|mesh-ancestor
82878230|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878231|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878232|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82878233|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878234|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
82878235|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82878236|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82878237|NCT00227591|Growth Substances|growth substances|mesh-ancestor
82878238|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
82878239|NCT01358344|Pantoprazole|pantoprazole|mesh-list
82878240|NCT01358344|Vorapaxar|vorapaxar|mesh-list
82878241|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82878242|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878243|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82878244|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878245|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878246|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82878247|NCT01366300|Lidocaine|lidocaine|mesh-list
82878248|NCT01366300|Propofol|propofol|mesh-list
82878249|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
82878250|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
82878251|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878252|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878253|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
82878254|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878255|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82878256|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82878257|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82878258|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878259|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878260|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82878261|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82878262|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
82878263|NCT00226811|Sunitinib|sunitinib|mesh-list
82878264|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878265|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82878266|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82878267|NCT00226811|Growth Substances|growth substances|mesh-ancestor
82878268|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878269|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
82878270|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82878271|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878272|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878273|NCT02951052|Rilpivirine|rilpivirine|mesh-list
82878274|NCT02951052|Cabotegravir|cabotegravir|mesh-list
82878275|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82878276|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82878277|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878278|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878279|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
82878280|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878281|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82878282|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82878283|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82878284|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82878285|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
82878286|NCT05261516|Analgesics|analgesics|mesh-ancestor
82878287|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
82878288|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878289|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878291|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878293|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
82878294|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82878295|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878296|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454033|NCT03062488|Analgesics|analgesics|mesh-ancestor
82878297|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82878298|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
82878299|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82878300|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
82878301|NCT00226655|Hormones|hormones|mesh-ancestor
82878302|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878303|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878304|NCT03691376|Aldesleukin|aldesleukin|mesh-list
82878305|NCT03691376|Melphalan|melphalan|mesh-list
82878306|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
82878307|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82878308|NCT03691376|Interleukin-2|interleukin-2|mesh-list
82878309|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82878310|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
82878311|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878312|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878313|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82878314|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878315|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
82878316|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878317|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82878318|NCT03691376|Analgesics|analgesics|mesh-ancestor
82878319|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
82878320|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878321|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82878322|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82878323|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
82878324|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878325|NCT01371058|Clopidogrel|clopidogrel|mesh-list
82878326|NCT01371058|Policosanol|policosanol|mesh-list
82878327|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82878328|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82878329|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82878330|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82878331|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
82878332|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878333|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878334|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878335|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82878336|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82878337|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
82878338|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82878339|NCT01105338|Lycopene|lycopene|mesh-list
82878340|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878341|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
82878342|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878343|NCT01105338|Protective Agents|protective agents|mesh-ancestor
82878344|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878345|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82878346|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82878347|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878348|NCT03747614|Fluorometholone|fluorometholone|mesh-list
82878349|NCT03747614|Tacrolimus|tacrolimus|mesh-list
82878350|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878351|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
82878352|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878353|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82878354|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878355|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878356|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878357|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
82878358|NCT03747614|Hormones|hormones|mesh-ancestor
82878359|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878360|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82878361|NCT05347004|BI 425809|bi 425809|mesh-list
82878362|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
82878364|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82878365|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
82878366|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878367|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878368|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
82878369|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878370|NCT05190562|Astringents|astringents|mesh-ancestor
82878371|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
82878372|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
82878373|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82878374|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878375|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
82878376|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878377|NCT03747536|Bromides|bromides|mesh-list
82878378|NCT03747536|Ipratropium|ipratropium|mesh-list
82878379|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
82878380|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82878381|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
82878382|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878383|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878384|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82878385|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
82878386|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82878387|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
82878388|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878389|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878390|NCT04734080|Dronabinol|dronabinol|mesh-list
82878391|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
82878392|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878393|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82878394|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82878395|NCT04734080|Analgesics|analgesics|mesh-ancestor
82878396|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
82878397|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878398|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82878399|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82878400|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878401|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878402|NCT04734080|Hormones|hormones|mesh-ancestor
82878403|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878404|NCT01358500|Fentanyl|fentanyl|mesh-list
82878405|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82878406|NCT01358500|Narcotics|narcotics|mesh-ancestor
82878407|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878408|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878409|NCT01358500|Analgesics|analgesics|mesh-ancestor
82878410|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
82878411|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878412|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82878413|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82878414|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
82878415|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
82878416|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
82878417|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
82878418|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878419|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878420|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878421|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
82878422|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
82878423|NCT01208766|Dexamethasone|dexamethasone|mesh-list
82878424|NCT01208766|Prednisone|prednisone|mesh-list
82878425|NCT01208766|Lenalidomide|lenalidomide|mesh-list
82878426|NCT01208766|Bortezomib|bortezomib|mesh-list
82878427|NCT01208766|Melphalan|melphalan|mesh-list
82878428|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878429|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
82878430|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
82878431|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878432|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878433|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878434|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
82878435|NCT01208766|Hormones|hormones|mesh-ancestor
83454039|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
82878436|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878437|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82878438|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878439|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
82878440|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82878441|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82878442|NCT01208766|Growth Substances|growth substances|mesh-ancestor
82878443|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
82878444|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82878445|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
82878446|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878447|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82878448|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878449|NCT03751514|Azithromycin|azithromycin|mesh-list
82878450|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82878451|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878452|NCT03615664|Dexamethasone|dexamethasone|mesh-list
82878453|NCT03615664|Gemcitabine|gemcitabine|mesh-list
82878454|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82878455|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878456|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
82878457|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
82878458|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878459|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878460|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878461|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
82878462|NCT03615664|Hormones|hormones|mesh-ancestor
82878463|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878464|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82878465|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878466|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82878467|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
82878468|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878469|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82878470|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
82878471|NCT03513250|Scopolamine|scopolamine|mesh-list
82878472|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82878473|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82878474|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
82878475|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
82878476|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878477|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878478|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878479|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
82878480|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82878481|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
82878482|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878483|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878484|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82878485|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
82878486|NCT01358812|Panitumumab|panitumumab|mesh-list
82878487|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82878488|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878489|NCT01107522|Temozolomide|temozolomide|mesh-list
82878490|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82878491|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
82878492|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878493|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878494|NCT01371448|Paroxetine|paroxetine|mesh-list
82878495|NCT01371448|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82878496|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82878497|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878498|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878499|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878500|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
82878501|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878502|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82878503|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
82878504|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82878505|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82878506|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82878507|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878508|NCT01371526|Cosyntropin|cosyntropin|mesh-list
82878509|NCT01371526|Hormones|hormones|mesh-ancestor
82878510|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878511|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878513|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82878514|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878515|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82878516|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878517|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878518|NCT01371604|Ribavirin|ribavirin|mesh-list
82878519|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82878520|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
82878521|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878522|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
82878523|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878524|NCT01371682|Ropinirole|ropinirole|mesh-list
82878525|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82878526|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82878527|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
82878528|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
82878529|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878530|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878531|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878532|NCT01107756|Lenograstim|lenograstim|mesh-list
82878533|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82878534|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
82878535|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878536|NCT03127384|Lidocaine|lidocaine|mesh-list
82878537|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
82878538|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
82878539|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878540|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878541|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
82878542|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878543|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82878544|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82878545|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82878546|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878547|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878548|NCT01111656|Interferons|interferons|mesh-list
82878549|NCT01111656|Interferon-beta|interferon-beta|mesh-list
82878550|NCT01111656|Atorvastatin|atorvastatin|mesh-list
82878551|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
82878552|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878553|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
82878554|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878555|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82878556|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82878557|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
82878558|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878559|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82878560|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82878561|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878562|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
82878563|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878564|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82878565|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
82878566|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82878567|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878568|NCT02819752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82878569|NCT02819752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878571|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82878572|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82878573|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
82878574|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878575|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878576|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878577|NCT02523274|Resveratrol|resveratrol|mesh-list
82878578|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
82878579|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878580|NCT02523274|Protective Agents|protective agents|mesh-ancestor
82878581|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878582|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878583|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82878585|NCT02432560|Everolimus|everolimus|mesh-list
82878586|NCT02432560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82878587|NCT02432560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82878588|NCT02432560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878589|NCT02432560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878590|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878591|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
82878592|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878593|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878594|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82878595|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878596|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82878597|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
82878598|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
82878599|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82878600|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878601|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
82878602|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878603|NCT01111734|Expectorants|expectorants|mesh-ancestor
82878604|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
82878605|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82878606|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
82878607|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878608|NCT01111734|Protective Agents|protective agents|mesh-ancestor
82878609|NCT01111734|Antidotes|antidotes|mesh-ancestor
82878610|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82878611|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82878612|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82878613|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878614|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878615|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82878616|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878617|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878618|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
82878619|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878620|NCT01111890|Timolol|timolol|mesh-list
82878621|NCT01111890|Dorzolamide|dorzolamide|mesh-list
82878622|NCT01111890|Brinzolamide|brinzolamide|mesh-list
82878623|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82878624|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82878625|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
82878626|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878627|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878628|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878629|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82878630|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82878631|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82878632|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878633|NCT00745134|Curcumin|curcumin|mesh-list
82878634|NCT00745134|Capecitabine|capecitabine|mesh-list
82878635|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82878636|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
82878637|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878638|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878639|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82878640|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82878641|NCT00745134|Analgesics|analgesics|mesh-ancestor
82878642|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
82878643|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878644|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878645|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878646|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82878647|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878648|NCT01111968|Vaccines|vaccines|mesh-list
82878649|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
82878650|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878651|NCT04398134|Entecavir|entecavir|mesh-list
82878652|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
82878653|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878654|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
82878655|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82878656|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878657|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82878658|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82878660|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878661|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878662|NCT04253262|Rucaparib|rucaparib|mesh-list
82878663|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82878664|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878665|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878666|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878667|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
82878668|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82878669|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82878670|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82878671|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878672|NCT01108302|Oxytocin|oxytocin|mesh-list
82878673|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
82878674|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82878675|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878676|NCT03122860|Lorecivivint|lorecivivint|mesh-list
82878677|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878678|NCT01319188|Ranibizumab|ranibizumab|mesh-list
82878679|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82878680|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82878681|NCT01319188|Growth Substances|growth substances|mesh-ancestor
82878682|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878683|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
82878684|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878685|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
82878686|NCT05167084|Metyrapone|metyrapone|mesh-list
82878687|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878688|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
82878689|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878690|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878691|NCT00867178|Vitamin A|vitamin a|mesh-list
82878692|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
82878693|NCT00867178|Thiotepa|thiotepa|mesh-list
82878694|NCT00867178|Cisplatin|cisplatin|mesh-list
82878695|NCT00867178|Carboplatin|carboplatin|mesh-list
82878696|NCT00867178|Etoposide|etoposide|mesh-list
82878697|NCT00867178|Vincristine|vincristine|mesh-list
82878698|NCT00867178|Vorinostat|vorinostat|mesh-list
82878699|NCT00867178|Tretinoin|tretinoin|mesh-list
82878700|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
82878701|NCT00867178|Isotretinoin|isotretinoin|mesh-list
82878702|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878703|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
82878704|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878705|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82878706|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82878707|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
82878708|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878709|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878710|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82878711|NCT00867178|Vitamins|vitamins|mesh-ancestor
82878712|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
82878713|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82878714|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82878715|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82878716|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878717|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
82878718|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
82878719|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
82878720|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82878721|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
82878722|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
82878724|NCT03945396|Antacids|antacids|mesh-ancestor
82878725|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878726|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878727|NCT01109784|Clopidogrel|clopidogrel|mesh-list
82878728|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82878729|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82878730|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82878731|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82878732|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82878733|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
82878734|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083936|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82878735|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878736|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878737|NCT01328340|Methamphetamine|methamphetamine|mesh-list
82878738|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82878739|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878740|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
82878741|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
82878742|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878743|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
82878744|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878745|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878746|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
82878747|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82878748|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82878749|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878750|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82878752|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
82878753|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
82878754|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878755|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878756|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
82878757|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878758|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82878759|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82878760|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82878761|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878762|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878763|NCT00352534|Dactinomycin|dactinomycin|mesh-list
82878764|NCT00352534|Cactinomycin|cactinomycin|mesh-list
82878765|NCT00352534|Doxorubicin|doxorubicin|mesh-list
82878766|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82878767|NCT00352534|Vincristine|vincristine|mesh-list
82878768|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82878769|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878770|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82878771|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82878772|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878773|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878774|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82878775|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
82878776|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
82878777|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
82878778|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82878779|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878780|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82878781|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82878782|NCT01328106|Trametinib|trametinib|mesh-list
82878783|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878784|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82878785|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878786|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878787|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
82878788|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82878789|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878790|NCT03122548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82878791|NCT03122548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878792|NCT03749642|Gabapentin|gabapentin|mesh-list
82878793|NCT03749642|Trazodone|trazodone|mesh-list
82878794|NCT03749642|Analgesics|analgesics|mesh-ancestor
82878795|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
82878796|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878797|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878798|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
82878799|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82878800|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82878801|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878802|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82878803|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82878804|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82878805|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82878806|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878807|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
82878808|NCT03749642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82878809|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82878810|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878811|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
82878812|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82878813|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
82878814|NCT03751358|Anesthetics|anesthetics|mesh-list
82878815|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
82878816|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878817|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878818|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
82878819|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878820|NCT04097028|Trifluridine|trifluridine|mesh-list
82878821|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
82878822|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878823|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
82878824|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878825|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
82878826|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878827|NCT05193292|Trastuzumab|trastuzumab|mesh-list
82878828|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82878829|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878830|NCT05193214|Antibodies|antibodies|mesh-list
82878831|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82878832|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
82878833|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878834|NCT02529774|Leucovorin|leucovorin|mesh-list
82878835|NCT02529774|Dexamethasone|dexamethasone|mesh-list
82878836|NCT02529774|Capecitabine|capecitabine|mesh-list
82878837|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
82878838|NCT02529774|Fluorouracil|fluorouracil|mesh-list
82878839|NCT02529774|Floxuridine|floxuridine|mesh-list
82878840|NCT02529774|Heparin|heparin|mesh-list
82878841|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
82878842|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878843|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
82878844|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
82878845|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878846|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878847|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878848|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
82878849|NCT02529774|Hormones|hormones|mesh-ancestor
82878850|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878851|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82878852|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878853|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82878854|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
82878855|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878856|NCT02529774|Antidotes|antidotes|mesh-ancestor
82878857|NCT02529774|Protective Agents|protective agents|mesh-ancestor
82878858|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
82878859|NCT02529774|Vitamins|vitamins|mesh-ancestor
82878860|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
82878861|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82878862|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
82878863|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
82878864|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82878865|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82878866|NCT04459598|Efavirenz|efavirenz|mesh-list
82878867|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82878868|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82878869|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878870|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878871|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
82878872|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878873|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82878874|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83481786|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
82878875|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82878876|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82878877|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82878878|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82878879|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
82878880|NCT03942354|Linezolid|linezolid|mesh-list
82878881|NCT03942354|Bedaquiline|bedaquiline|mesh-list
82878882|NCT03942354|Clofazimine|clofazimine|mesh-list
82878883|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82878884|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878885|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82878886|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82878887|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878888|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878889|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878890|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82878891|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
82878892|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878893|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
82878894|NCT05165992|Fentanyl|fentanyl|mesh-list
82878895|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82878896|NCT05165992|Narcotics|narcotics|mesh-ancestor
82878897|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878898|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878899|NCT05165992|Analgesics|analgesics|mesh-ancestor
82878900|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
82878901|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878902|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82878903|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82878904|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
82878905|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
82878906|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82878907|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
82878908|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82878909|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878910|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
82878911|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878912|NCT01367626|Letrozole|letrozole|mesh-list
82878913|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878914|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82878915|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82878916|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878917|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878918|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82878919|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
82878920|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82878921|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878922|NCT01112748|Lidocaine|lidocaine|mesh-list
82878923|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
82878924|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
82878925|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878926|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878927|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
82878928|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878929|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82878930|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82878931|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82878932|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878933|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878934|NCT05192902|Anesthetics|anesthetics|mesh-list
82878935|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82878936|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878937|NCT01211808|Diltiazem|diltiazem|mesh-list
82878938|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82878939|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82878940|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82878941|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878942|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82878943|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878944|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
82878945|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82878946|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
82878947|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82878948|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
82878949|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82878950|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878951|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82878952|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82878953|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82878954|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83083937|NCT02474654|Narcotics|narcotics|mesh-ancestor
82878955|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82878956|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
82878957|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82878958|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82878959|NCT05191888|Amoxicillin|amoxicillin|mesh-list
82878960|NCT05191888|Metronidazole|metronidazole|mesh-list
82878961|NCT05191888|Clarithromycin|clarithromycin|mesh-list
82878962|NCT05191888|Rabeprazole|rabeprazole|mesh-list
82878963|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82878964|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82878965|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82878966|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82878967|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82878968|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82878969|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878970|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82878971|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82878972|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82878973|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82878974|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82878975|NCT01112826|Capecitabine|capecitabine|mesh-list
82878976|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82878977|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
82878978|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82878979|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878980|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
82878981|NCT01210014|Astringents|astringents|mesh-ancestor
82878982|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878983|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
82878984|NCT05118256|Pirfenidone|pirfenidone|mesh-list
82878985|NCT05118256|Analgesics|analgesics|mesh-ancestor
82878986|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
82878987|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82878988|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878989|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82878990|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82878991|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82878992|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82878993|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82878994|NCT01114542|Insulin|insulin|mesh-list
82878995|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82878996|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
82878997|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82878998|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82878999|NCT02529540|Methamphetamine|methamphetamine|mesh-list
82879000|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82879001|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879002|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
82879003|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
82879004|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879005|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
82879006|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879007|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879008|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
82879009|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82879010|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82879011|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879012|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82879014|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
82879015|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879016|NCT01359514|Pregabalin|pregabalin|mesh-list
82879017|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
82879018|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82879019|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879020|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879021|NCT01359514|Analgesics|analgesics|mesh-ancestor
82879022|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
82879023|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879024|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
82879025|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879026|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879027|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82879028|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82879029|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879030|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82879031|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82879032|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82879033|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879034|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
82879035|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
82879036|NCT01368016|Nicotine|nicotine|mesh-list
82879037|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82879038|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
82879039|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879040|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879041|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82879042|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82879043|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
82879044|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879045|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879046|NCT01208454|Vitamin A|vitamin a|mesh-list
82879047|NCT01208454|Vorinostat|vorinostat|mesh-list
82879048|NCT01208454|Tretinoin|tretinoin|mesh-list
82879049|NCT01208454|Isotretinoin|isotretinoin|mesh-list
82879050|NCT01208454|Vitamins|vitamins|mesh-ancestor
82879051|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
82879052|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879053|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879054|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82879055|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879056|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879057|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
82879058|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
82879059|NCT01110486|Carboplatin|carboplatin|mesh-list
82879060|NCT01110486|Docetaxel|docetaxel|mesh-list
82879061|NCT01110486|Ilorasertib|ilorasertib|mesh-list
82879062|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879063|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
82879064|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879065|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879066|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879067|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879068|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879069|NCT01372306|Galantamine|galantamine|mesh-list
82879070|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82879071|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879072|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879073|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
82879074|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879075|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879076|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82879077|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
82879078|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879079|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
82879080|NCT01114854|Topiramate|topiramate|mesh-list
82879081|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
82879082|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82879083|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879084|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
82879085|NCT01359670|Tadalafil|tadalafil|mesh-list
82879086|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879087|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82879088|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82879089|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879090|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879091|NCT01359670|Urological Agents|urological agents|mesh-ancestor
82879092|NCT05188768|Mitogens|mitogens|mesh-list
82879093|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879094|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879095|NCT01368328|Chromium|chromium|mesh-list
82879096|NCT01368328|Niacin|niacin|mesh-list
82879097|NCT01368328|Trace Elements|trace elements|mesh-ancestor
82879098|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
82879099|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879100|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82879101|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
82879102|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879103|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82879104|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879105|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
82879107|NCT01110642|Lovastatin|lovastatin|mesh-list
82879108|NCT01110642|L 647318|l 647318|mesh-list
82879109|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
82879110|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82879111|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82879112|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
82879113|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879114|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82879115|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82879116|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879117|NCT02929498|Azacitidine|azacitidine|mesh-list
82879118|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82879119|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
82879120|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879121|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879122|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879123|NCT01359826|Milnacipran|milnacipran|mesh-list
82879124|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
82879125|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82879126|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82879127|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879128|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879129|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879130|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879131|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82879132|NCT01359826|Analgesics|analgesics|mesh-ancestor
82879133|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
82879134|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879135|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
82879136|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82879137|NCT03792672|Ketamine|ketamine|mesh-list
82879138|NCT03792672|Analgesics|analgesics|mesh-ancestor
82879139|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
82879140|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879141|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879142|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82879143|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82879144|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
82879145|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
82879146|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879147|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82879148|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82879149|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879150|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879151|NCT01372540|Filanesib|filanesib|mesh-list
82879152|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879153|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879154|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879155|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879156|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
82879157|NCT01113138|Analgesics|analgesics|mesh-ancestor
82879158|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
82879159|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879160|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879161|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
82879162|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879163|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82879164|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
82879165|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82879166|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879167|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879168|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879169|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
82879170|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82879171|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
82879172|NCT01115322|Tazarotene|tazarotene|mesh-list
82879173|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
82879174|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
82879175|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
82879176|NCT01115322|Vitamins|vitamins|mesh-ancestor
82879177|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
82879178|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879179|NCT01111188|Bortezomib|bortezomib|mesh-list
82879180|NCT01111188|Palbociclib|palbociclib|mesh-list
82879181|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879182|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879183|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879184|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879186|NCT01210482|Temsirolimus|temsirolimus|mesh-list
82879187|NCT01210482|MTOR Inhibitors|mtor inhibitors|mesh-list
82879188|NCT01210482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879189|NCT01210482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879190|NCT01210482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879191|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82879192|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
82879193|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879194|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879195|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82879196|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879197|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82879198|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
82879199|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
82879200|NCT01360060|Analgesics|analgesics|mesh-ancestor
82879201|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
82879202|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879203|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879204|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
82879205|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879206|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82879207|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
82879208|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82879209|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879210|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879211|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879212|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
82879213|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82879214|NCT01210638|Oxymorphone|oxymorphone|mesh-list
82879215|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82879216|NCT01210638|Narcotics|narcotics|mesh-ancestor
82879217|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879218|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879219|NCT01210638|Analgesics|analgesics|mesh-ancestor
82879220|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
82879221|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879222|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82879223|NCT03120676|Atezolizumab|atezolizumab|mesh-list
82879224|NCT03120676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82879225|NCT03120676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879226|NCT03120676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879227|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879228|NCT01115478|Vitamin A|vitamin a|mesh-list
82879229|NCT01115478|Vitamins|vitamins|mesh-ancestor
82879230|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
82879231|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879232|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
82879233|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82879234|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
82879235|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879236|NCT01111422|Expectorants|expectorants|mesh-ancestor
82879237|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
83513229|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
82879238|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82879239|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
82879240|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879241|NCT01111422|Protective Agents|protective agents|mesh-ancestor
82879242|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879243|NCT01111422|Antidotes|antidotes|mesh-ancestor
82879244|NCT01212432|Daptomycin|daptomycin|mesh-list
82879245|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82879246|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879247|NCT01213368|Dronedarone|dronedarone|mesh-list
82879248|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82879249|NCT01369186|Morphine|morphine|mesh-list
82879250|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82879251|NCT01369186|Narcotics|narcotics|mesh-ancestor
82879252|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879253|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879254|NCT01369186|Analgesics|analgesics|mesh-ancestor
82879255|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
82879256|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879257|NCT01115712|Pioglitazone|pioglitazone|mesh-list
82879258|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82879259|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879260|NCT01117662|Rituximab|rituximab|mesh-list
82879261|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879262|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879263|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
82879264|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879265|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82879266|NCT01319266|Hydrocodone|hydrocodone|mesh-list
82879267|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82879268|NCT01319266|Narcotics|narcotics|mesh-ancestor
82879269|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879270|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879271|NCT01319266|Analgesics|analgesics|mesh-ancestor
82879272|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
82879273|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879274|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
82879275|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
82879276|NCT01115790|Prexasertib|prexasertib|mesh-list
82879277|NCT01115790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879278|NCT01115790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879279|NCT01115790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879280|NCT01115946|Enalapril|enalapril|mesh-list
82879281|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82879282|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
82879283|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879284|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879285|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82879286|NCT01113372|Clopidogrel|clopidogrel|mesh-list
82879287|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82879288|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82879289|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82879290|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82879291|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
82879292|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879293|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879294|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879295|NCT03120520|Plecanatide|plecanatide|mesh-list
82879296|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82879297|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
82879298|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879299|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82879300|NCT03941340|Aflutinib|aflutinib|mesh-list
82879301|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879302|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879303|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879304|NCT01372930|Etanercept|etanercept|mesh-list
82879305|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82879306|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82879307|NCT01372930|Analgesics|analgesics|mesh-ancestor
82879308|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
82879309|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879310|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879311|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82879312|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82879313|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82879314|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82879315|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
82879316|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
82879317|NCT01328652|Lansoprazole|lansoprazole|mesh-list
82879318|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82879319|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879320|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879321|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82879322|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82879323|NCT01373008|Beclomethasone|beclomethasone|mesh-list
82879324|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82879325|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
82879326|NCT01373008|Hormones|hormones|mesh-ancestor
82879327|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879328|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879329|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82879330|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
82879331|NCT01116180|Candesartan|candesartan|mesh-list
82879332|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
82879333|NCT01116180|Giapreza|giapreza|mesh-list
82879334|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82879335|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
82879336|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82879337|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82879338|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879339|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82879340|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82879341|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
82879342|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879343|NCT05067166|Ansuvimab|ansuvimab|mesh-list
82879344|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
82879345|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879346|NCT01113528|Aspirin|aspirin|mesh-list
82879347|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82879348|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82879349|NCT01113528|Analgesics|analgesics|mesh-ancestor
82879350|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
82879351|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879352|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879353|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82879354|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82879355|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82879356|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82879357|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879358|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82879359|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82879360|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879361|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
82879362|NCT01369576|Zopiclone|zopiclone|mesh-list
82879363|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82879364|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879365|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879366|NCT01113762|Cimetidine|cimetidine|mesh-list
82879367|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82879368|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82879369|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82879370|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
82879371|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
82879372|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879373|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879374|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879375|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82879376|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82879377|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879378|NCT01212666|Ropivacaine|ropivacaine|mesh-list
82879379|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
82879380|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
82879381|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879382|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879383|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
82879384|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879385|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82879386|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879387|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879388|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879389|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879390|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82879391|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
82879392|NCT01213680|Hematinics|hematinics|mesh-ancestor
82879393|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
82879394|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82879395|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879396|NCT01211496|Methamphetamine|methamphetamine|mesh-list
82879397|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82879398|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879399|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
82879400|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
82879401|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879402|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
82879403|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83083938|NCT02474654|Analgesics|analgesics|mesh-ancestor
82879404|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879406|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82879407|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82879408|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879409|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82879410|NCT01118286|Nifedipine|nifedipine|mesh-list
82879411|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82879412|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879413|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879414|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879415|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879416|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879417|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
82879418|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82879419|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82879420|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
82879421|NCT01585350|Poly ICLC|poly iclc|mesh-list
82879422|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82879423|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
82879424|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879425|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
82879426|NCT03936036|Linagliptin|linagliptin|mesh-list
82879427|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82879428|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879429|NCT03936036|Incretins|incretins|mesh-ancestor
82879430|NCT03936036|Hormones|hormones|mesh-ancestor
82879431|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879432|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82879433|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
82879434|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879435|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879436|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
82879437|NCT01118598|Niacin|niacin|mesh-list
82879438|NCT01118598|Niacinamide|niacinamide|mesh-list
82879439|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
82879440|NCT01118598|Vitamins|vitamins|mesh-ancestor
82879441|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
82879442|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879443|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82879444|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
82879445|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879446|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82879447|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879448|NCT01216020|Cisplatin|cisplatin|mesh-list
82879449|NCT01216020|Cetuximab|cetuximab|mesh-list
82879450|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879451|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879452|NCT01121796|Vitamin D|vitamin d|mesh-list
82879453|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
82879454|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
82879455|NCT01121796|Vitamins|vitamins|mesh-list
82879456|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
82879457|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879458|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82879459|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879460|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82879461|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
82879462|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83513230|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
82879463|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879464|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82879465|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879466|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
82879467|NCT01119144|Calcium|calcium|mesh-list
82879468|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879469|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879470|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82879471|NCT01117038|Amlodipine|amlodipine|mesh-list
82879472|NCT01117038|Enalapril|enalapril|mesh-list
82879473|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82879474|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82879475|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879476|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879477|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879479|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879480|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82879481|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
82879482|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879483|NCT01119534|Camphor|camphor|mesh-list
82879484|NCT01119534|Eucalyptol|eucalyptol|mesh-list
82879485|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
82879486|NCT01119534|Menthol|menthol|mesh-list
82879487|NCT01119534|Guaifenesin|guaifenesin|mesh-list
82879488|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82879489|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
82879490|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
82879491|NCT01119534|Expectorants|expectorants|mesh-ancestor
82879492|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
82879493|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82879494|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82879495|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
82879496|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879497|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879498|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879499|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
82879500|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82879501|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
82879502|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
82879503|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879504|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
82879505|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82879506|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82879507|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879508|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
82879509|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
82879510|NCT01119534|Protective Agents|protective agents|mesh-ancestor
82879511|NCT01117116|Fluticasone|fluticasone|mesh-list
82879512|NCT01117116|Xhance|xhance|mesh-list
82879513|NCT01117116|Budesonide|budesonide|mesh-list
82879514|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
82879515|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82879516|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82879517|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82879518|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
82879519|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879520|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879521|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82879522|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
82879523|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
82879524|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82879525|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
82879526|NCT01117116|Hormones|hormones|mesh-ancestor
82879527|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879528|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82879529|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82879530|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82879531|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
82879532|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879533|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879534|NCT01216488|Lidocaine|lidocaine|mesh-list
82879535|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
82879536|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
82879537|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879538|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879539|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
82879540|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879541|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82879542|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82879543|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82879544|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879545|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879547|NCT01122342|Testosterone|testosterone|mesh-list
82879548|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
82879549|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
82879550|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82879551|NCT01122342|Androgens|androgens|mesh-ancestor
82879552|NCT01122342|Hormones|hormones|mesh-ancestor
82879553|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879554|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879555|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82879556|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879557|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
82879558|NCT01213992|Iron|iron|mesh-list
82879559|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82879560|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
82879561|NCT01213992|Trace Elements|trace elements|mesh-ancestor
82879562|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
82879563|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879564|NCT01213992|Hematinics|hematinics|mesh-ancestor
82879565|NCT03963414|Carboplatin|carboplatin|mesh-list
82879566|NCT03963414|Etoposide|etoposide|mesh-list
82879567|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
82879568|NCT03963414|Durvalumab|durvalumab|mesh-list
82879569|NCT03963414|Tremelimumab|tremelimumab|mesh-list
82879570|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82879571|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879572|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82879573|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82879574|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82879575|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879576|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879577|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879578|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
82879579|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879580|NCT01216644|Leucovorin|leucovorin|mesh-list
82879581|NCT01216644|Docetaxel|docetaxel|mesh-list
82879582|NCT01216644|Fluorouracil|fluorouracil|mesh-list
82879583|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
82879584|NCT01216644|Epirubicin|epirubicin|mesh-list
82879585|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879586|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
82879587|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879588|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879589|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879590|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
82879591|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82879592|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82879593|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
82879594|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879595|NCT01216644|Antidotes|antidotes|mesh-ancestor
82879596|NCT01216644|Protective Agents|protective agents|mesh-ancestor
82879597|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
82879598|NCT01216644|Vitamins|vitamins|mesh-ancestor
82879599|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
82879600|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82879601|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82879602|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82879603|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879604|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
82879605|NCT04816162|Ketamine|ketamine|mesh-list
82879606|NCT04816162|Propofol|propofol|mesh-list
82879607|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82879608|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879609|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879610|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82879611|NCT04816162|Analgesics|analgesics|mesh-ancestor
82879612|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
82879613|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879614|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82879615|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82879616|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82879617|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
82879618|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879619|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879620|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82879621|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
82879622|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
82879623|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82879624|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82879625|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82879626|NCT04959760|Antibodies|antibodies|mesh-list
82879627|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
82879628|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
82879629|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
82879630|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879633|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879634|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879635|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82879636|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82879637|NCT01214226|Protective Agents|protective agents|mesh-ancestor
82879638|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879639|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879640|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82879641|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
82879642|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
82879643|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82879644|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879645|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
83454112|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879646|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879647|NCT01219062|Morphine|morphine|mesh-list
82879648|NCT01219062|Bupivacaine|bupivacaine|mesh-list
82879649|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
82879650|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
82879651|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879652|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879653|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
82879654|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879655|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82879656|NCT01219062|Narcotics|narcotics|mesh-ancestor
82879657|NCT01219062|Analgesics|analgesics|mesh-ancestor
82879658|NCT01120158|Paclitaxel|paclitaxel|mesh-list
82879659|NCT01120158|Bevacizumab|bevacizumab|mesh-list
82879660|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82879661|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879662|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
82879663|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879664|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879665|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879666|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879667|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82879668|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82879669|NCT01120158|Growth Substances|growth substances|mesh-ancestor
82879670|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879671|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
82879672|NCT01373398|Apaziquone|apaziquone|mesh-list
82879673|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879674|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
82879675|NCT01124526|Rituximab|rituximab|mesh-list
82879676|NCT01124526|Fludarabine|fludarabine|mesh-list
82879677|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82879678|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
82879679|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879680|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82879681|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82879682|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
82879683|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879684|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879685|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82879686|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879687|NCT01120314|Otamixaban|otamixaban|mesh-list
82879688|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82879689|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
82879690|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82879691|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
82879692|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879693|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879695|NCT03633994|Heparin|heparin|mesh-list
82879696|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
82879697|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82879698|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82879699|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879700|NCT01328886|Omalizumab|omalizumab|mesh-list
82879701|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82879702|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82879703|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
82879704|NCT01216878|Losartan|losartan|mesh-list
82879705|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82879706|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82879707|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82879708|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82879709|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879710|NCT04624984|Gemcitabine|gemcitabine|mesh-list
82879711|NCT04624984|Doxorubicin|doxorubicin|mesh-list
82879712|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82879713|NCT04624984|Vinorelbine|vinorelbine|mesh-list
82879714|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82879715|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82879716|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
82879717|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879718|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879719|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82879720|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82879721|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82879722|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879723|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82879724|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
82879725|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879726|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879727|NCT04624984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879728|NCT01214382|Sertraline|sertraline|mesh-list
82879729|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
82879730|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82879731|NCT01214382|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82879732|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82879733|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879734|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879735|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879736|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
82879737|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879738|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
82879739|NCT01216956|Niacin|niacin|mesh-list
82879740|NCT01216956|Niacinamide|niacinamide|mesh-list
82879741|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
82879742|NCT01216956|Vitamins|vitamins|mesh-ancestor
82879743|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
82879744|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879745|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82879746|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
82879747|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879748|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82879749|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879750|NCT01217034|Sorafenib|sorafenib|mesh-list
82879751|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
82879752|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879753|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879754|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879755|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879756|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82879757|NCT01217034|Estrogens|estrogens|mesh-ancestor
82879758|NCT01217034|Hormones|hormones|mesh-ancestor
82879759|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879760|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879761|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82879762|NCT01373554|Oltipraz|oltipraz|mesh-list
82879763|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
82879764|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879765|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
82879766|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82879767|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
82879768|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82879769|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82879770|NCT01373554|Protective Agents|protective agents|mesh-ancestor
82879771|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879772|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879773|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82879774|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82879775|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879776|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879777|NCT01319344|Eplerenone|eplerenone|mesh-list
82879778|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82879779|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
82879780|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879781|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879783|NCT01319344|Diuretics|diuretics|mesh-ancestor
82879784|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
82879785|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82879786|NCT01373632|Sirolimus|sirolimus|mesh-list
82879787|NCT01373632|Temsirolimus|temsirolimus|mesh-list
82879788|NCT01373632|MTOR Inhibitors|mtor inhibitors|mesh-list
82879789|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82879790|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879791|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82879792|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879793|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
82879794|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82879795|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
82879796|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879797|NCT01373632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82879798|NCT01373632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879799|NCT01373632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879800|NCT01124760|Ketoconazole|ketoconazole|mesh-list
82879801|NCT01124760|Diltiazem|diltiazem|mesh-list
82879802|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
82879803|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879804|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82879805|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82879806|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879807|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879808|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82879809|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
82879810|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879811|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879812|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82879813|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82879814|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82879815|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879816|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879817|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879818|NCT01214772|Heparin|heparin|mesh-list
82879819|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
82879820|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82879821|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82879822|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879823|NCT01125150|Metformin|metformin|mesh-list
82879824|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82879825|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879826|NCT01373710|Trastuzumab|trastuzumab|mesh-list
82879827|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879828|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879829|NCT03935256|Paclitaxel|paclitaxel|mesh-list
82879830|NCT03935256|Carboplatin|carboplatin|mesh-list
82879831|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82879832|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879833|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
82879834|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879835|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879836|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879837|NCT03869866|Vaccines|vaccines|mesh-list
82879838|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
82879839|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879840|NCT03783702|Acetaminophen|acetaminophen|mesh-list
82879841|NCT03783702|Ibuprofen|ibuprofen|mesh-list
82879842|NCT03783702|Oxycodone|oxycodone|mesh-list
82879843|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82879845|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
82879846|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879847|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879848|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
82879849|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82879850|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82879851|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82879852|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82879853|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879855|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82879856|NCT03783702|Narcotics|narcotics|mesh-ancestor
82879857|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82879858|NCT01319734|Glyburide|glyburide|mesh-list
82879859|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879860|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82879861|NCT01121016|Montelukast|montelukast|mesh-list
82879862|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82879863|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
82879864|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82879865|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
82879866|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879867|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879868|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82879869|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82879870|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879871|NCT03575572|Colchicine|colchicine|mesh-list
82879872|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
82879873|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82879874|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
82879875|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879876|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879877|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879878|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879879|NCT01214928|Vitamin D|vitamin d|mesh-list
82879880|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
82879881|NCT01214928|Vitamins|vitamins|mesh-ancestor
82879882|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
82879883|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879884|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82879885|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82879886|NCT01122966|Bevacizumab|bevacizumab|mesh-list
82879887|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82879888|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879889|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82879890|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82879891|NCT01122966|Growth Substances|growth substances|mesh-ancestor
82879892|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879893|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
82879894|NCT01219686|Pindolol|pindolol|mesh-list
82879895|NCT01219686|Dexetimide|dexetimide|mesh-list
82879896|NCT01219686|Citalopram|citalopram|mesh-list
82879897|NCT01219686|Escitalopram|escitalopram|mesh-list
82879898|NCT01219686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82879899|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82879900|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879901|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879902|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879903|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
82879904|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879905|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82879906|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82879907|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
82879908|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
82879909|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82879910|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82879911|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82879912|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
82879913|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82879914|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
82879915|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82879916|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82879917|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82879918|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
82879919|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82879920|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82879921|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
82879922|NCT01219764|Amoxicillin|amoxicillin|mesh-list
82879923|NCT01219764|Metronidazole|metronidazole|mesh-list
82879924|NCT01219764|Clarithromycin|clarithromycin|mesh-list
82879925|NCT01219764|Rabeprazole|rabeprazole|mesh-list
82879926|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82879927|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879932|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879933|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82879934|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82879935|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82879936|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82879937|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82879938|NCT03936426|Copper|copper|mesh-list
82879939|NCT03936426|Trace Elements|trace elements|mesh-ancestor
82879940|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
82879941|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879942|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
82879943|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82879944|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82879945|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879946|NCT01125696|Ritonavir|ritonavir|mesh-list
82879947|NCT01125696|Lopinavir|lopinavir|mesh-list
82879948|NCT01125696|Tenofovir|tenofovir|mesh-list
82879949|NCT01125696|Lamivudine|lamivudine|mesh-list
82879950|NCT01125696|Zidovudine|zidovudine|mesh-list
82879951|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82879952|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82879953|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
82879954|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879955|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879956|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82879957|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82879958|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
82879959|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82879960|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82879961|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82879962|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82879963|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82879964|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
82879965|NCT03932916|Donepezil|donepezil|mesh-list
82879966|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82879967|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879968|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879969|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
82879970|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82879971|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879972|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
82879973|NCT03116152|Paclitaxel|paclitaxel|mesh-list
82879974|NCT03116152|Irinotecan|irinotecan|mesh-list
82879975|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82879976|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879977|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
82879978|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
82879979|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
82879980|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879981|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82879982|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82879983|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82879984|NCT01123278|Testosterone|testosterone|mesh-list
82879985|NCT01123278|Androgens|androgens|mesh-ancestor
82879986|NCT01123278|Hormones|hormones|mesh-ancestor
82879987|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82879988|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879989|NCT01219920|Leucovorin|leucovorin|mesh-list
82879990|NCT01219920|Irinotecan|irinotecan|mesh-list
82879991|NCT01219920|Antidotes|antidotes|mesh-ancestor
82879992|NCT01219920|Protective Agents|protective agents|mesh-ancestor
82879993|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82879994|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
82879995|NCT01219920|Vitamins|vitamins|mesh-ancestor
82879996|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
82879997|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82879998|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82879999|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82880000|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82880001|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880003|NCT01400776|Estrogens|estrogens|mesh-ancestor
82880004|NCT01400776|Hormones|hormones|mesh-ancestor
82880005|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880006|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880007|NCT01220076|Tamoxifen|tamoxifen|mesh-list
82880008|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82880009|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
82880010|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880011|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880012|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82880013|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880014|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82880015|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82880016|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82880017|NCT01220154|Paclitaxel|paclitaxel|mesh-list
82880018|NCT01220154|Bevacizumab|bevacizumab|mesh-list
82880019|NCT01220154|Carboplatin|carboplatin|mesh-list
83454121|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82880020|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82880021|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880022|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
82880023|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
82880024|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
82880025|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880026|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880027|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82880028|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82880029|NCT01220154|Growth Substances|growth substances|mesh-ancestor
82880030|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880031|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
82880032|NCT01182766|Topiramate|topiramate|mesh-list
82880033|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
82880034|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82880035|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880036|NCT01220232|Lamivudine|lamivudine|mesh-list
82880037|NCT01220232|Abacavir|abacavir|mesh-list
82880038|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
82880039|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82880040|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82880041|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880042|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880043|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
82880044|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880045|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82880046|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82880047|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
82880048|NCT01126008|Docetaxel|docetaxel|mesh-list
82880049|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880050|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
82880051|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
82880052|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
82880053|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880054|NCT03934710|Serotonin|serotonin|mesh-list
82880055|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
82880056|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
82880057|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880058|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880059|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880060|NCT05169424|Fluticasone|fluticasone|mesh-list
82880061|NCT05169424|Xhance|xhance|mesh-list
82880062|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
82880063|NCT05169424|Olodaterol|olodaterol|mesh-list
82880064|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82880065|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82880066|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
82880067|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880068|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880069|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82880070|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
82880071|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
82880072|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82880073|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
82880074|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82721443|NCT03816488|Metformin|metformin|mesh-list
82880075|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
82880076|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880077|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880078|NCT03117010|Dexamethasone|dexamethasone|mesh-list
82880079|NCT03117010|Etoposide|etoposide|mesh-list
82880080|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82880081|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
82880082|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
82880083|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880084|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880085|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82880086|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
82880087|NCT03117010|Hormones|hormones|mesh-ancestor
82880088|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880089|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82880090|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880091|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454123|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
82880092|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880093|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82880094|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82880095|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82880096|NCT01123824|Clopidogrel|clopidogrel|mesh-list
82880097|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82880098|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82880099|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82880100|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82880101|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
82880102|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880103|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880104|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880105|NCT01126086|Otamixaban|otamixaban|mesh-list
82880106|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82880107|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
82880108|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82880109|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
82880110|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880111|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880112|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
82880113|NCT03009838|Letrozole|letrozole|mesh-list
82880114|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880115|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82880116|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82880117|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880118|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880119|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82880120|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
82880121|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880122|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880123|NCT01124058|Heparin|heparin|mesh-list
82880124|NCT01124058|Calcium heparin|calcium heparin|mesh-list
82880125|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82880126|NCT01124058|Tinzaparin|tinzaparin|mesh-list
82880127|NCT01124058|Dalteparin|dalteparin|mesh-list
82880128|NCT01124058|Warfarin|warfarin|mesh-list
82880129|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
82880130|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82880131|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82880132|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880133|NCT01375972|Cisplatin|cisplatin|mesh-list
82880134|NCT01375972|Gemcitabine|gemcitabine|mesh-list
82880135|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880136|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82880137|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
82880138|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880139|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82880140|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
82880141|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880142|NCT01220622|Nimodipine|nimodipine|mesh-list
82880143|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82880144|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82880145|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880146|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880147|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82880148|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880149|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
82880151|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
82880152|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
82880153|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
82880154|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880155|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880156|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
82880157|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880158|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82880159|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82880160|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82880161|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880162|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880163|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82880164|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82880165|NCT05123170|Analgesics|analgesics|mesh-ancestor
82880166|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82880167|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82880168|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82880169|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
82880170|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880172|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82880173|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82880174|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82880175|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
82880176|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880177|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880178|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880179|NCT01215708|Urological Agents|urological agents|mesh-ancestor
82880180|NCT01222026|Vitamin D|vitamin d|mesh-list
82880181|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
82880182|NCT01222026|Vitamins|vitamins|mesh-ancestor
82880183|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
82880184|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880185|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82880186|NCT00225251|Bupropion|bupropion|mesh-list
82880187|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82880188|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
82880189|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82880190|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82880191|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82880192|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880193|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880194|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
82880195|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880196|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880197|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82880198|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82880199|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880200|NCT01376128|Paroxetine|paroxetine|mesh-list
82880201|NCT01376128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82880202|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82880203|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880204|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880205|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880206|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
82880207|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880208|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82880209|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
82880210|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82880211|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82880212|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82880213|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880214|NCT01376206|Fluticasone|fluticasone|mesh-list
82880215|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82880216|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82880217|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
82880218|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880219|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880220|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83513306|NCT04903652|Vinorelbine|vinorelbine|mesh-list
82880221|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
82880222|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
82880223|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82880225|NCT01073501|Analgesics|analgesics|mesh-ancestor
82880226|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
82880227|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880228|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880229|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
82880230|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82880231|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880232|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880233|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82880234|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82880235|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82880236|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880237|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82880238|NCT05005312|Ritonavir|ritonavir|mesh-list
82880239|NCT05005312|Nirmatrelvir|nirmatrelvir|mesh-list
82880240|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82880241|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82880242|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
82880243|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880244|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880245|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82880246|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82880247|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
82880248|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880249|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82880250|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82880251|NCT01222182|Atorvastatin|atorvastatin|mesh-list
82880252|NCT01222182|Simvastatin|simvastatin|mesh-list
82880253|NCT01222182|Pravastatin|pravastatin|mesh-list
82880254|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82880255|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82880256|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
82880257|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880258|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82880259|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82880260|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880261|NCT01218750|Bevacizumab|bevacizumab|mesh-list
82880262|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880263|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880264|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82880265|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82880266|NCT01218750|Growth Substances|growth substances|mesh-ancestor
82880267|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880268|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
82880269|NCT01376284|Dutasteride|dutasteride|mesh-list
82880270|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82880271|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82880272|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880273|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880274|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
82880275|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880276|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880277|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82880278|NCT01376440|Eusol|eusol|mesh-list
82880279|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
82880280|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880281|NCT01329042|Citric Acid|citric acid|mesh-list
82880282|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
82880283|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
82880284|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82880285|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
82880286|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
82880287|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880288|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82880289|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
82880290|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880291|NCT00253643|Protective Agents|protective agents|mesh-ancestor
82880292|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880293|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82880294|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82880295|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880296|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82880297|NCT01222650|Silodosin|silodosin|mesh-list
82880298|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82880299|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82880300|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82880301|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
82880302|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880303|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880304|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880305|NCT01222650|Urological Agents|urological agents|mesh-ancestor
82880306|NCT04856488|Lugol's solution|lugol's solution|mesh-list
82880307|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82880308|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
82880309|NCT04856488|Coagulants|coagulants|mesh-ancestor
82880310|NCT01073579|Vigabatrin|vigabatrin|mesh-list
82880311|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
82880312|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880313|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880314|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
82880315|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880316|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880317|NCT00221195|Thrombin|thrombin|mesh-list
82880318|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
82880319|NCT00221195|Coagulants|coagulants|mesh-ancestor
82880320|NCT04646590|Vaccines|vaccines|mesh-list
82880321|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
82880322|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880323|NCT03931668|Maleic acid|maleic acid|mesh-list
82880324|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880325|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880326|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
82880327|NCT00220805|Antibodies|antibodies|mesh-list
82880328|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
82880329|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82880330|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82880331|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
82880332|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
82880333|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880334|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
82880335|NCT00220727|Antibodies|antibodies|mesh-list
82880336|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
82880337|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82880338|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82880339|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
82880340|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
82880341|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880342|NCT01072097|Atorvastatin|atorvastatin|mesh-list
82880343|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82880344|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82880345|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
82880346|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880347|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82880348|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82880349|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880350|NCT05760430|Bevacizumab|bevacizumab|mesh-list
82880351|NCT05760430|Apatinib|apatinib|mesh-list
82880352|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880353|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880354|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82880355|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82880356|NCT05760430|Growth Substances|growth substances|mesh-ancestor
82880357|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880358|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
82880359|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82880360|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880361|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880362|NCT01221402|Niacin|niacin|mesh-list
82880363|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82880364|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
82880365|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880366|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82880367|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
82880368|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
82880369|NCT01221402|Vitamins|vitamins|mesh-ancestor
82880370|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
82880371|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880372|NCT04214860|Azacitidine|azacitidine|mesh-list
82880374|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82880375|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
82880376|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880377|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880378|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880379|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82880380|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82880381|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82880382|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880383|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880384|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880385|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880386|NCT01127490|Analgesics|analgesics|mesh-ancestor
82880387|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
82880388|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880389|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
82880390|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82880391|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
82880392|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82880393|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
82880394|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82880395|NCT01126866|Bevacizumab|bevacizumab|mesh-list
82880396|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880397|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880398|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82880399|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82880400|NCT01126866|Growth Substances|growth substances|mesh-ancestor
82880401|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880402|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
82880404|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82880405|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82880406|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82880407|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82880408|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880409|NCT03740568|Progesterone|progesterone|mesh-list
82880410|NCT03740568|Progestins|progestins|mesh-ancestor
82880411|NCT03740568|Hormones|hormones|mesh-ancestor
82880412|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880413|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880414|NCT00252239|Plasminogen|plasminogen|mesh-list
82880415|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82880416|NCT00252239|Tenecteplase|tenecteplase|mesh-list
82880417|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82880418|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82880419|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880420|NCT01127022|Choline|choline|mesh-list
82880421|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
82880422|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82880423|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
82880424|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880425|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82880426|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82880427|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
82880428|NCT01221558|Lycopene|lycopene|mesh-list
82880429|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82880430|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
82880431|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880432|NCT01221558|Protective Agents|protective agents|mesh-ancestor
82880433|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880434|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82880435|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82880436|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880437|NCT01221636|Abatacept|abatacept|mesh-list
82880438|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82880439|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880440|NCT01221636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880441|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880442|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82880443|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
82880444|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880447|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82880448|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82880449|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
82880450|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880451|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880452|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82880453|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82880454|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
82880455|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880456|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82880457|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82880458|NCT01127568|Propranolol|propranolol|mesh-list
83454134|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
82880459|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82880460|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82880461|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
82880462|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880463|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880464|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880465|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82880466|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82880467|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
82880468|NCT03932292|Calcium|calcium|mesh-list
82880469|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82880470|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880471|NCT01127100|Fentanyl|fentanyl|mesh-list
82880472|NCT01127100|Gabapentin|gabapentin|mesh-list
82880473|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82880474|NCT01127100|Narcotics|narcotics|mesh-ancestor
82880475|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880476|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880477|NCT01127100|Analgesics|analgesics|mesh-ancestor
82880478|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
82880479|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880480|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82880481|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82880482|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
82880483|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
82880484|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
82880485|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82880486|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82880487|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82880488|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82880489|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82880490|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880491|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880492|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
82880493|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
82880494|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82880495|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880496|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880497|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880498|NCT01221792|Carvedilol|carvedilol|mesh-list
82880499|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82880500|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82880501|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
82880502|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880503|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880504|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880505|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82880506|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
82880507|NCT01221792|Protective Agents|protective agents|mesh-ancestor
82880508|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82880509|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880510|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82880511|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
82880512|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82880513|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82880514|NCT03932526|Apatinib|apatinib|mesh-list
82880515|NCT03932526|Vinorelbine|vinorelbine|mesh-list
82880516|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880517|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82880518|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880519|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880520|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82880521|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
82880522|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
82880523|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
82880525|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
82880526|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
82880527|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
82880528|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
82880529|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880530|NCT01127724|Hematinics|hematinics|mesh-ancestor
82880531|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
82880532|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82880533|NCT03103906|Protective Agents|protective agents|mesh-ancestor
82880534|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880535|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
82880536|NCT05675098|Methylphenidate|methylphenidate|mesh-list
82880537|NCT05675098|Modafinil|modafinil|mesh-list
82880538|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82880539|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880540|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82880541|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82880542|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880543|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880544|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
82880545|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880546|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82880547|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82880548|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82880549|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
82880550|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
82880551|NCT01223742|Vitamins|vitamins|mesh-ancestor
82880552|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
82880553|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880554|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
82880555|NCT01129518|Vaccines|vaccines|mesh-list
82880556|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
82880557|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880558|NCT01223820|Capsaicin|capsaicin|mesh-list
82880559|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
82880560|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
82880561|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
82880562|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880563|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880564|NCT01131234|Cediranib|cediranib|mesh-list
82880565|NCT01131234|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82880566|NCT01131234|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82880567|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880568|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880569|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880570|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82880571|NCT01129596|Donepezil|donepezil|mesh-list
82880572|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82880573|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880574|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880575|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
82880576|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880577|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880578|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
82880579|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
82880580|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880581|NCT01127880|Clindamycin|clindamycin|mesh-list
82880582|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
82880583|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
82880584|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82880585|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880586|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82880587|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880588|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880589|NCT01228344|Lumefantrine|lumefantrine|mesh-list
82880590|NCT01228344|Artemether|artemether|mesh-list
82880591|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82880592|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
82880593|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82880594|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82880595|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880596|NCT03927456|Fulvestrant|fulvestrant|mesh-list
82880597|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82880598|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880599|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82880600|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82880601|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
82880602|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880603|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880604|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82880605|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82880606|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
82880607|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880608|NCT01228422|Interferons|interferons|mesh-list
82880609|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
82880610|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
82880611|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880612|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
82880613|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880614|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
82880615|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880616|NCT01319422|Pomalidomide|pomalidomide|mesh-list
82880617|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
82880618|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880619|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82880620|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82880621|NCT01319422|Growth Substances|growth substances|mesh-ancestor
82880622|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
82880623|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880624|NCT01227174|Propofol|propofol|mesh-list
82880625|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82880626|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880627|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880628|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82880629|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
82880630|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
82880631|NCT05615974|Rituximab|rituximab|mesh-list
82880632|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880633|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880634|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
82880635|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880636|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82880637|NCT03924492|Pregnanolone|pregnanolone|mesh-list
82880638|NCT03924492|Brexanolone|brexanolone|mesh-list
82880639|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
82880640|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880641|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880642|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880643|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
82880644|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
82880645|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
82880646|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880647|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82880648|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82880649|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
82880650|NCT01224366|Vildagliptin|vildagliptin|mesh-list
82880651|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82880652|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880653|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82880654|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
82880655|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880656|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880657|NCT05415826|Dexamethasone|dexamethasone|mesh-list
82880658|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82880659|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
82880660|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
82880661|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880662|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880663|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82880664|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
82880665|NCT05415826|Hormones|hormones|mesh-ancestor
83083939|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82880666|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880667|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82880669|NCT05415748|Tamsulosin|tamsulosin|mesh-list
82880670|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82880671|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82880672|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82880673|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
82880674|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880675|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880676|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880677|NCT05415748|Urological Agents|urological agents|mesh-ancestor
82880678|NCT03774576|Itraconazole|itraconazole|mesh-list
82880679|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
82880680|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880681|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82880682|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82880683|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880684|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880685|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82880686|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
82880687|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880688|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880689|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82880690|NCT05415436|Propofol|propofol|mesh-list
82880691|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82880692|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880693|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880694|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82880695|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
82880696|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
82880697|NCT01227408|Paclitaxel|paclitaxel|mesh-list
82880698|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
82880699|NCT01227408|Doxorubicin|doxorubicin|mesh-list
82880700|NCT01227408|Capecitabine|capecitabine|mesh-list
82880701|NCT01227408|Methotrexate|methotrexate|mesh-list
82880702|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
82880703|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82880704|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880705|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
82880706|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
82880707|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
82880708|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880709|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82880710|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
82880711|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880712|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82880713|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82880714|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
82880715|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82880716|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82880717|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82880718|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82880719|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880720|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82880721|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
82880722|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82880723|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
82880724|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82880725|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
82880726|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82880727|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82880728|NCT03773796|Nabilone|nabilone|mesh-list
82880729|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
82880730|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
82880731|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880732|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880733|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82880734|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82880735|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82880736|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82880737|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82880738|NCT02927938|Cytarabine|cytarabine|mesh-list
82880740|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
82880741|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880742|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880743|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
82880744|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880745|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82880746|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
82880747|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880748|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
82880749|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82880750|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82880751|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880753|NCT05370820|Coagulants|coagulants|mesh-ancestor
82880754|NCT03863860|Fluzoparib|fluzoparib|mesh-list
82880755|NCT03863860|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82880756|NCT03863860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880757|NCT03863860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880758|NCT03863860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880759|NCT03923166|Capecitabine|capecitabine|mesh-list
82880760|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82880761|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
82880762|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880763|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880764|NCT01224756|Tinoridine|tinoridine|mesh-list
82880765|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82880766|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82880767|NCT01224756|Analgesics|analgesics|mesh-ancestor
82880768|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
82880769|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880770|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880771|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82880772|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82880773|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
82880774|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82880775|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880776|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
82880777|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880778|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880779|NCT03222856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82880780|NCT03222856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880781|NCT01130298|Testosterone|testosterone|mesh-list
82880782|NCT01130298|Androgens|androgens|mesh-ancestor
82880783|NCT01130298|Hormones|hormones|mesh-ancestor
82880784|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880785|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880786|NCT01227720|Nicotine|nicotine|mesh-list
82880787|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82880788|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
82880789|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880790|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880791|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82880792|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82880793|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
82880794|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880795|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880796|NCT03175978|Methotrexate|methotrexate|mesh-list
82880797|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880798|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82880799|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
82880800|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82880801|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82880802|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
82880803|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880804|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880805|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
82880806|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880807|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82880808|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82880809|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
82880810|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82880816|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82880818|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880819|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82880820|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
82880821|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880822|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880823|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82880824|NCT01227798|Interferons|interferons|mesh-list
82880825|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
82880826|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880827|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
82880828|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880829|NCT01130376|Aldesleukin|aldesleukin|mesh-list
82880830|NCT01130376|Interleukin-2|interleukin-2|mesh-list
82880831|NCT01130376|Hormones|hormones|mesh-list
82880832|NCT01130376|Sargramostim|sargramostim|mesh-list
82880833|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880834|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880835|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880836|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82880837|NCT01130376|Analgesics|analgesics|mesh-ancestor
82880838|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
82880839|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82880840|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
82880841|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82880842|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82880843|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
82880844|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880845|NCT03740178|Donepezil|donepezil|mesh-list
82880846|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82880847|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880848|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880849|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
82880850|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880851|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880852|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
82880853|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
82880854|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82880855|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
82880856|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880857|NCT01131468|Expectorants|expectorants|mesh-ancestor
82880858|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
82880859|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82880860|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
82880861|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880862|NCT01131468|Protective Agents|protective agents|mesh-ancestor
82880863|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880864|NCT01131468|Antidotes|antidotes|mesh-ancestor
82880865|NCT01225224|Peficitinib|peficitinib|mesh-list
82880866|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880867|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880868|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82880869|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
82880870|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880871|NCT01131546|Amlodipine|amlodipine|mesh-list
82880872|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82880873|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82880874|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82880875|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880876|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82880877|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880878|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
82880879|NCT01225302|Paclitaxel|paclitaxel|mesh-list
82880880|NCT01225302|Carboplatin|carboplatin|mesh-list
82880881|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82880882|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880883|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
82880884|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
82880885|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
82880886|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880887|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
82880888|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
82880889|NCT01229046|Ticarcillin|ticarcillin|mesh-list
82880890|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
82880891|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82880892|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880893|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880894|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880895|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82880896|NCT03921684|Capecitabine|capecitabine|mesh-list
82880897|NCT03921684|Nivolumab|nivolumab|mesh-list
82880898|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82880899|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
82880900|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880901|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880902|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880903|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82880905|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82880906|NCT03929094|Gemcitabine|gemcitabine|mesh-list
82880907|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82880908|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880909|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
82880910|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
82880911|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
82880912|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880913|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82880914|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
82880915|NCT01131702|Ranitidine|ranitidine|mesh-list
82880916|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82880917|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82880918|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82880919|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82880920|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
82880921|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
82880922|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82880923|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880924|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880925|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
82880926|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82880927|NCT03925818|Metronidazole|metronidazole|mesh-list
82880928|NCT03925818|Tetracycline|tetracycline|mesh-list
82880929|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
82880930|NCT03925818|Pantoprazole|pantoprazole|mesh-list
82880931|NCT03925818|Bismuth|bismuth|mesh-list
82880932|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880933|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82880934|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82880935|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82880936|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82880937|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82880938|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82880939|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880940|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880941|NCT03925818|Antacids|antacids|mesh-ancestor
82880942|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82880943|NCT03925740|Listerine|listerine|mesh-list
82880944|NCT03925740|Fluorides|fluorides|mesh-list
82880945|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
82880946|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
82880947|NCT03925740|Protective Agents|protective agents|mesh-ancestor
82880948|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880949|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82880950|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880951|NCT01130688|Zileuton|zileuton|mesh-list
82880952|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82880953|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82880954|NCT01130688|Analgesics|analgesics|mesh-ancestor
82880955|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
82880959|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82880960|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82880961|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880962|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880963|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82880964|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
82880965|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82880966|NCT03925662|Mebendazole|mebendazole|mesh-list
82880967|NCT03925662|Piperazine|piperazine|mesh-list
82880968|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
82880969|NCT03925662|Bevacizumab|bevacizumab|mesh-list
82880970|NCT03925662|DMP 777|dmp 777|mesh-list
82880971|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880972|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880973|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82880974|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82880975|NCT03925662|Growth Substances|growth substances|mesh-ancestor
82880976|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880977|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
82880978|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
82880979|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
82880980|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83513381|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82880981|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82880982|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
82880983|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
82880984|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
82880985|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82880986|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82880988|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82880989|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82880990|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82880991|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82880992|NCT01229202|Growth Substances|growth substances|mesh-ancestor
82880993|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82880994|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
82880995|NCT01229280|Darifenacin|darifenacin|mesh-list
82880996|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
82880997|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
82880998|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
82880999|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881000|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881001|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881002|NCT01229280|Urological Agents|urological agents|mesh-ancestor
82881003|NCT01131780|Ibuprofen|ibuprofen|mesh-list
82881004|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
82881005|NCT01131780|Ephedrine|ephedrine|mesh-list
82881006|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82881007|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82881008|NCT01131780|Analgesics|analgesics|mesh-ancestor
82881009|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
82881010|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881011|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881012|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881013|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881014|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82881015|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881016|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881017|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82881018|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
82881019|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82881020|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
82881021|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
82881022|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82881023|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82881024|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
82881025|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
82881026|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881027|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
82881035|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881036|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82881037|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
82881038|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881039|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881040|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82881041|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82881042|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82881043|NCT01131000|Ibuprofen|ibuprofen|mesh-list
82881044|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82881045|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82881046|NCT01131000|Analgesics|analgesics|mesh-ancestor
82881047|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
82881048|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881049|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881050|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881051|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881052|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82881053|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454153|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
82881054|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881055|NCT01132170|Valproic Acid|valproic acid|mesh-list
82881056|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
82881057|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881058|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881059|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
82881060|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881061|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881062|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
82881063|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82881064|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881065|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82881067|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82881068|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881069|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881070|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881071|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82881072|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881073|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881074|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
82881075|NCT03919812|Vitamin D|vitamin d|mesh-list
82881076|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82881077|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881078|NCT03919812|Vitamins|vitamins|mesh-ancestor
82881079|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
82881080|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82881081|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
82881082|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82881083|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881084|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881085|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881086|NCT01132248|Mefloquine|mefloquine|mesh-list
82881087|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
82881088|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82881089|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82881090|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881091|NCT01229592|Ethanol|ethanol|mesh-list
82881092|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82881093|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881094|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881095|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881096|NCT01131936|Amlodipine|amlodipine|mesh-list
82881097|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82881098|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82881099|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82881100|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881101|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82881102|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881103|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
82881104|NCT01132404|Leuprolide|leuprolide|mesh-list
82881105|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82881106|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
82881107|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881108|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881109|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82881110|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881111|NCT01231854|Cyclosporine|cyclosporine|mesh-list
82881112|NCT01231854|Alitretinoin|alitretinoin|mesh-list
82881113|NCT01231854|Cyclosporins|cyclosporins|mesh-list
82881114|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881115|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881116|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82881117|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
82881118|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881119|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
82881120|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881121|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
82881122|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881123|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82881124|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881125|NCT01132638|Esomeprazole|esomeprazole|mesh-list
82881126|NCT01132638|Pantoprazole|pantoprazole|mesh-list
82881127|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82881128|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881129|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82881130|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881131|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881132|NCT05402124|Aspirin|aspirin|mesh-list
82881133|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82881134|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82881135|NCT05402124|Analgesics|analgesics|mesh-ancestor
82881136|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
82881137|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881138|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881139|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881140|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881141|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82881142|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82881143|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881144|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82881145|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82881146|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881147|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
82881148|NCT01134432|Prednisolone|prednisolone|mesh-list
82881149|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82881150|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
82881151|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82881152|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
82881153|NCT01134432|Rituximab|rituximab|mesh-list
82881154|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82881155|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
82881156|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82881157|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881158|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
82881159|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881160|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881161|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881162|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
82881163|NCT01134432|Hormones|hormones|mesh-ancestor
82881164|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881165|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82881166|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
82881167|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
82881170|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82881171|NCT01134432|Protective Agents|protective agents|mesh-ancestor
82881172|NCT01232010|Mirodenafil|mirodenafil|mesh-list
82881173|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82881174|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82881175|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881176|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881177|NCT01132716|Valacyclovir|valacyclovir|mesh-list
82881178|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
82881179|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881180|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
82881181|NCT05401812|Hormones|hormones|mesh-ancestor
82881182|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881183|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881184|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
82881185|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82881186|NCT01137708|Tofacitinib|tofacitinib|mesh-list
82881187|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82881188|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
82881189|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881190|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881191|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82881192|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82881193|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82881194|NCT01137708|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82881195|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82881196|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881197|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454161|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
82881198|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82881199|NCT01137708|Estrogens|estrogens|mesh-ancestor
82881200|NCT01137708|Hormones|hormones|mesh-ancestor
82881201|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881202|NCT03765138|Pramipexole|pramipexole|mesh-list
82881203|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
82881204|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881205|NCT03765138|Protective Agents|protective agents|mesh-ancestor
82881206|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881207|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82881208|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82881209|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
82881210|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
82881211|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881212|NCT01134666|Cetuximab|cetuximab|mesh-list
82881213|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82881214|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881215|NCT03739788|Deucravacitinib|deucravacitinib|mesh-list
82881216|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
82881217|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82881218|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881219|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881220|NCT01137942|Metronidazole|metronidazole|mesh-list
82881221|NCT01137942|Clarithromycin|clarithromycin|mesh-list
82881222|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82881223|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881224|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881225|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82881226|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82881227|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82881228|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881229|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881230|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82881231|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82881232|NCT01233492|Mannitol|mannitol|mesh-list
82881233|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82881234|NCT01233492|Diuretics|diuretics|mesh-ancestor
82881235|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
82881236|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881237|NCT01135056|Sorafenib|sorafenib|mesh-list
82881238|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881239|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82881240|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881241|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881242|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
82881243|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82881244|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881245|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881246|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82881247|NCT01132794|Analgesics|analgesics|mesh-ancestor
82881248|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
82881249|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881250|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82881251|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82881252|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82881253|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
82881254|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881255|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881256|NCT01135212|Candesartan|candesartan|mesh-list
82881257|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
82881258|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82881259|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82881260|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82881261|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881262|NCT01233570|Tacrolimus|tacrolimus|mesh-list
82881263|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82881264|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
82881265|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881266|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82881267|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881268|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881269|NCT01135290|Petrolatum|petrolatum|mesh-list
82881270|NCT01135290|Emollients|emollients|mesh-ancestor
82881271|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
82881272|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
82881273|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82881274|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881275|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881276|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881277|NCT01135602|Topiramate|topiramate|mesh-list
82881278|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
82881279|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881280|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881281|NCT05308212|Vaccines|vaccines|mesh-list
82881282|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
82881283|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881284|NCT01138488|Insulin|insulin|mesh-list
82881285|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
82881286|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881287|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881288|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
82881289|NCT01135680|Glycerol|glycerol|mesh-list
82881290|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881291|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881292|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82881293|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82881294|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881295|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881296|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881297|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881298|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82881299|NCT01135680|Protective Agents|protective agents|mesh-ancestor
82881300|NCT01135758|Ketamine|ketamine|mesh-list
82881301|NCT01135758|Analgesics|analgesics|mesh-ancestor
82881302|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
82881303|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881304|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881305|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82881306|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82881307|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
82881308|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
82881309|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881310|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82881311|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82881312|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881313|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881314|NCT05401032|Tamsulosin|tamsulosin|mesh-list
82881316|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82881317|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82881318|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
82881319|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881320|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881321|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881322|NCT05401032|Urological Agents|urological agents|mesh-ancestor
82881323|NCT03768726|Ziprasidone|ziprasidone|mesh-list
82881324|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82881325|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
82881326|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881327|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881328|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881329|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82881330|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82881331|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881332|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82881333|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82881334|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
82881335|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
82881336|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82881337|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
82881338|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881339|NCT01138956|Expectorants|expectorants|mesh-ancestor
82881340|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
82881341|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82881342|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
82881343|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881344|NCT01138956|Protective Agents|protective agents|mesh-ancestor
82881345|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881346|NCT01138956|Antidotes|antidotes|mesh-ancestor
82881347|NCT03917940|Glimepiride|glimepiride|mesh-list
82881348|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82881349|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881350|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881351|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82881352|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
82881353|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82881354|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881355|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881356|NCT01232244|Glucagon|glucagon|mesh-list
82881357|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82881358|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881359|NCT01232244|Hormones|hormones|mesh-ancestor
82881360|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881361|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881362|NCT01232244|Incretins|incretins|mesh-ancestor
82881363|NCT03917784|Curcumin|curcumin|mesh-list
82881364|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82881365|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82881367|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
82881368|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881369|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881370|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881371|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881372|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881373|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881374|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881375|NCT01133496|Alendronate|alendronate|mesh-list
82881376|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82881377|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881378|NCT01232400|Esmolol|esmolol|mesh-list
82881379|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82881380|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82881381|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82881382|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
82881383|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881384|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881385|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881386|NCT02528760|Erythromycin|erythromycin|mesh-list
82881387|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
82881388|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82881390|NCT02528760|Metoclopramide|metoclopramide|mesh-list
82881391|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
82881392|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
82881393|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881394|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881395|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881396|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82881397|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82881398|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
82881399|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881400|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881401|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881402|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881403|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82881404|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881405|NCT05594472|Gentamicins|gentamicins|mesh-list
82881406|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881407|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881408|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82881409|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881410|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881411|NCT01136538|Valacyclovir|valacyclovir|mesh-list
82881412|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
82881413|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881414|NCT03917628|Adalimumab|adalimumab|mesh-list
82881415|NCT03917628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82881416|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881417|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881418|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82881419|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881420|NCT01136850|Azithromycin|azithromycin|mesh-list
82881421|NCT01136850|Chloroquine|chloroquine|mesh-list
82881422|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
82881423|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
82881424|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82881425|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881426|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881427|NCT01136850|Amebicides|amebicides|mesh-ancestor
82881428|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82881429|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82881430|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
82881431|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881432|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82881433|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881434|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881435|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82881436|NCT01234116|Tenofovir|tenofovir|mesh-list
82881437|NCT01234116|Emtricitabine|emtricitabine|mesh-list
82881438|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82881439|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
82881440|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881441|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82881442|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82881443|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881444|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881445|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82881446|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82881447|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
82881448|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
82881450|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881451|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
82881452|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82881453|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82881454|NCT01137084|Prednisolone|prednisolone|mesh-list
82881455|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
82881456|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82881457|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
82881458|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881459|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
82881460|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
82881461|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881462|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881463|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881464|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
82881466|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881467|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82881468|NCT01137084|Protective Agents|protective agents|mesh-ancestor
82881469|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82881470|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881471|NCT01133886|Decitabine|decitabine|mesh-list
82881472|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82881473|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
82881474|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881475|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881476|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881477|NCT01140126|UB-421|ub-421|mesh-list
82881478|NCT01140126|Antibodies|antibodies|mesh-list
82881479|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
82881480|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881481|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82881482|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
82881483|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881484|NCT01231074|Metformin|metformin|mesh-list
82881485|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881486|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881487|NCT03917394|Iron|iron|mesh-list
82881488|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82881489|NCT03917394|Trace Elements|trace elements|mesh-ancestor
82881490|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
82881491|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881492|NCT03917394|Hematinics|hematinics|mesh-ancestor
82881493|NCT03769896|Nabilone|nabilone|mesh-list
82881494|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
82881495|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
82881496|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881497|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881498|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881499|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82881500|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82881501|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881502|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82881503|NCT01234194|Remifentanil|remifentanil|mesh-list
82881504|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82881505|NCT01234194|Narcotics|narcotics|mesh-ancestor
82881506|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881507|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881508|NCT01234194|Analgesics|analgesics|mesh-ancestor
82881509|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
82881510|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881511|NCT04913922|Nivolumab|nivolumab|mesh-list
82881512|NCT04913922|Relatlimab|relatlimab|mesh-list
82881513|NCT04913922|Azacitidine|azacitidine|mesh-list
82881514|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82881515|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881516|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82881517|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881518|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82881519|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
82881520|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881521|NCT04910022|Lomustine|lomustine|mesh-list
82881522|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82881523|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
82881524|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881525|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881526|NCT05485662|Listerine|listerine|mesh-list
82881527|NCT05485662|Fluorides|fluorides|mesh-list
82881528|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
82881529|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
82881530|NCT05485662|Protective Agents|protective agents|mesh-ancestor
82881531|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881532|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82881533|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881534|NCT01234272|Morphine|morphine|mesh-list
82881535|NCT01234272|Ropivacaine|ropivacaine|mesh-list
82881536|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82881537|NCT01234272|Narcotics|narcotics|mesh-ancestor
82881538|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881539|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881540|NCT01234272|Analgesics|analgesics|mesh-ancestor
82881541|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
82881542|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881543|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
82881544|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
82881545|NCT01140438|Metformin|metformin|mesh-list
82881546|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82881547|NCT01140438|Repaglinide|repaglinide|mesh-list
82881548|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
82881549|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
82881550|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
82881551|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881552|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881553|NCT01140438|Incretins|incretins|mesh-ancestor
82881554|NCT01140438|Hormones|hormones|mesh-ancestor
82881555|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881556|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82881557|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
82881558|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881559|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881560|NCT01234506|Vitamin D|vitamin d|mesh-list
82881561|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
82881562|NCT01234506|Vitamins|vitamins|mesh-ancestor
82881563|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
82881564|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881565|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82881566|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
82881567|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82881568|NCT01234506|Estrogens|estrogens|mesh-ancestor
82881569|NCT01234506|Hormones|hormones|mesh-ancestor
83454173|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881570|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881571|NCT04751604|Niacinamide|niacinamide|mesh-list
82881572|NCT04751604|Niacin|niacin|mesh-list
82881573|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
82881574|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
82881575|NCT04751604|Vitamins|vitamins|mesh-ancestor
82881576|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
82881577|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881578|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82881579|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
82881580|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881581|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82881582|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
82881583|NCT01231542|Rifampin|rifampin|mesh-list
82881584|NCT01231542|Rifabutin|rifabutin|mesh-list
82881585|NCT01231542|Dolutegravir|dolutegravir|mesh-list
82881586|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82881587|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
82881588|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881589|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881590|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
82881591|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82881592|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881593|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881594|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82881595|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82881596|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82881597|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82881598|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82881599|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82881600|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82881601|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82881603|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82881604|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
82881605|NCT01231698|Esmolol|esmolol|mesh-list
82881606|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82881607|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82881608|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82881609|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
82881610|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881611|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881612|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881613|NCT01142778|Bevacizumab|bevacizumab|mesh-list
82881614|NCT01142778|Trastuzumab|trastuzumab|mesh-list
82881615|NCT01142778|Docetaxel|docetaxel|mesh-list
82881616|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82881617|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881618|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82881638|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82881639|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82881640|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881641|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
82881642|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
82881643|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82881644|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
82881645|NCT04722978|Carboplatin|carboplatin|mesh-list
82881646|NCT04722978|Gemcitabine|gemcitabine|mesh-list
82881647|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82881648|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881649|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82881650|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
82881651|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881652|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881653|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82881654|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82881655|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881656|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82881657|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
82881658|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881659|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881660|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82881661|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82881662|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82881663|NCT01140828|Rabeprazole|rabeprazole|mesh-list
82881664|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82881665|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881666|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82881667|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881668|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881669|NCT01234740|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82881671|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82881672|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881673|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881674|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
82881675|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82881676|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
82881677|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881678|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881679|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82881680|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82881681|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82881682|NCT03720990|Cholic Acids|cholic acids|mesh-list
82881683|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881684|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
82881685|NCT03714594|Saxagliptin|saxagliptin|mesh-list
82881686|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82881687|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881688|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881689|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881690|NCT03714594|Incretins|incretins|mesh-ancestor
82881691|NCT03714594|Hormones|hormones|mesh-ancestor
82881692|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881694|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
82881695|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881696|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
82881697|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82881698|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82881699|NCT04624776|Prednisolone|prednisolone|mesh-list
82881700|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
82881701|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82881702|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
82881703|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881704|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
82881705|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
82881706|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881707|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881708|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881709|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
82881710|NCT04624776|Hormones|hormones|mesh-ancestor
82881711|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881712|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82881713|NCT04624776|Protective Agents|protective agents|mesh-ancestor
82881714|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82881715|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881716|NCT01234896|Nicotine|nicotine|mesh-list
82881717|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82881718|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
82881719|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881720|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881721|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82881722|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82881723|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
82881724|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881725|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881726|NCT01238094|Simvastatin|simvastatin|mesh-list
82881727|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82881728|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82881729|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
82881730|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881731|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82881732|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82881733|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881734|NCT01236612|Chloroquine|chloroquine|mesh-list
82881735|NCT01236612|Proguanil|proguanil|mesh-list
82881736|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
82881737|NCT01236612|Amebicides|amebicides|mesh-ancestor
82881738|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82881739|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82881740|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881741|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
82881742|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881743|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
82881744|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881745|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
82881746|NCT03633630|Antacids|antacids|mesh-ancestor
82881747|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881748|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881749|NCT01234974|Everolimus|everolimus|mesh-list
82881750|NCT01234974|Pasireotide|pasireotide|mesh-list
82881751|NCT01234974|Somatostatin|somatostatin|mesh-list
82881752|NCT01234974|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82881753|NCT01234974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82881754|NCT01234974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881755|NCT01234974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881756|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82881757|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
82881758|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881759|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881760|NCT01234974|Hormones|hormones|mesh-ancestor
82881761|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881762|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
82881763|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82881764|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82881765|NCT01140984|Prednisolone|prednisolone|mesh-list
82881766|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
82881767|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82881768|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
82881769|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881771|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
82881772|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881773|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881774|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881775|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
82881776|NCT01140984|Hormones|hormones|mesh-ancestor
82881777|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881778|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82881779|NCT01140984|Protective Agents|protective agents|mesh-ancestor
82881780|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82881781|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881782|NCT01145430|Doxorubicin|doxorubicin|mesh-list
82881783|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82881784|NCT01145430|Veliparib|veliparib|mesh-list
82881785|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82881786|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881787|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82881788|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82881789|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881790|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881791|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82881792|NCT03389724|Captopril|captopril|mesh-list
82881793|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82881794|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
82881795|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881796|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881797|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82881798|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
82881799|NCT01586052|Hematinics|hematinics|mesh-ancestor
82881800|NCT03684564|Warfarin|warfarin|mesh-list
82881801|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
82881802|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
82881803|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82881804|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
82881805|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82881806|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
82881807|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881808|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881809|NCT05796635|Allantoin|allantoin|mesh-list
82881810|NCT05796635|Dermatologic Agents|dermatologic agents|mesh-ancestor
82881811|NCT05796362|Azithromycin|azithromycin|mesh-list
82881812|NCT05796362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82881813|NCT05796362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881814|NCT05796115|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82881815|NCT05796115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82881816|NCT05796115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881817|NCT05796115|Antitubercular Agents|antitubercular agents|mesh-ancestor
82881818|NCT05795946|Vitamin D|vitamin d|mesh-list
82881819|NCT05795946|Vitamins|vitamins|mesh-ancestor
82881820|NCT05795946|Micronutrients|micronutrients|mesh-ancestor
82881821|NCT05795946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881822|NCT05795946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82881823|NCT05795920|Gemcitabine|gemcitabine|mesh-list
82881824|NCT05795920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82881825|NCT05795920|Antimetabolites|antimetabolites|mesh-ancestor
82881826|NCT05795920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881827|NCT05795920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881828|NCT05849246|Cisplatin|cisplatin|mesh-list
82881829|NCT05849246|Carboplatin|carboplatin|mesh-list
82881830|NCT05849246|Pemetrexed|pemetrexed|mesh-list
82881831|NCT05849246|Maytansine|maytansine|mesh-list
82881832|NCT05849246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881833|NCT05849246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881834|NCT05849246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881835|NCT05849246|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82881836|NCT05849246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82881837|NCT05849246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82881838|NCT05849246|Tubulin Modulators|tubulin modulators|mesh-ancestor
82881839|NCT05849246|Antimitotic Agents|antimitotic agents|mesh-ancestor
82881840|NCT05849246|Mitosis Modulators|mitosis modulators|mesh-ancestor
82881841|NCT05849220|Dapagliflozin|dapagliflozin|mesh-list
82881842|NCT05849220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82881843|NCT05849220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881844|NCT05849220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82881845|NCT05849220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881846|NCT05849090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82881847|NCT05849090|Vancomycin|vancomycin|mesh-list
82881848|NCT05849090|Clindamycin|clindamycin|mesh-list
82881849|NCT05849090|Clindamycin palmitate|clindamycin palmitate|mesh-list
82881850|NCT05849090|Clindamycin phosphate|clindamycin phosphate|mesh-list
82881851|NCT05849090|Cefazolin|cefazolin|mesh-list
82881852|NCT05849090|Ceftriaxone|ceftriaxone|mesh-list
82881853|NCT05849090|Tobramycin|tobramycin|mesh-list
82881854|NCT05849090|Cephalosporins|cephalosporins|mesh-list
82881855|NCT05849090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82881856|NCT05849090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881857|NCT05849090|Antitubercular Agents|antitubercular agents|mesh-ancestor
82881858|NCT05849090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82881859|NCT05849090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881860|NCT05849090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881861|NCT05848947|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
82881862|NCT05848947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82881863|NCT05848947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881864|NCT05848869|Misoprostol|misoprostol|mesh-list
82881865|NCT05848869|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82881866|NCT05848869|Abortifacient Agents|abortifacient agents|mesh-ancestor
82881867|NCT05848869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881868|NCT05848869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881869|NCT05848869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82881870|NCT05848869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82881871|NCT05848869|Oxytocics|oxytocics|mesh-ancestor
82881872|NCT05848765|Prednisone|prednisone|mesh-list
82881873|NCT05848765|Cyclophosphamide|cyclophosphamide|mesh-list
82881874|NCT05848765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82881875|NCT05848765|Rituximab|rituximab|mesh-list
82881876|NCT05848765|Doxorubicin|doxorubicin|mesh-list
82881877|NCT05848765|Vincristine|vincristine|mesh-list
82881878|NCT05848765|Lenalidomide|lenalidomide|mesh-list
82881879|NCT05848765|Obinutuzumab|obinutuzumab|mesh-list
82881880|NCT05848765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82881881|NCT05848765|Immunologic Factors|immunologic factors|mesh-ancestor
82881882|NCT05848765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881883|NCT05848765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881884|NCT05848765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82881885|NCT05848765|Alkylating Agents|alkylating agents|mesh-ancestor
82881886|NCT05848765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881887|NCT05848765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881888|NCT05848765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82881889|NCT05848765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82881890|NCT05848765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82881891|NCT05848765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82881892|NCT05848765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82881893|NCT05848765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881894|NCT05848765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881895|NCT05848765|Glucocorticoids|glucocorticoids|mesh-ancestor
82881896|NCT05848765|Hormones|hormones|mesh-ancestor
82881897|NCT05848765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881898|NCT05848765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82881899|NCT05848765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82881900|NCT05848765|Tubulin Modulators|tubulin modulators|mesh-ancestor
82881901|NCT05848765|Antimitotic Agents|antimitotic agents|mesh-ancestor
82881902|NCT05848765|Mitosis Modulators|mitosis modulators|mesh-ancestor
82881903|NCT05848765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82881904|NCT05848765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82881905|NCT05848765|Growth Substances|growth substances|mesh-ancestor
82881906|NCT05848765|Growth Inhibitors|growth inhibitors|mesh-ancestor
82881907|NCT05848713|Heparin|heparin|mesh-list
82881908|NCT05848713|Anticoagulants|anticoagulants|mesh-ancestor
82881909|NCT05848713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82881910|NCT05848713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82881911|NCT05848713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881912|NCT05848687|Dexamethasone|dexamethasone|mesh-list
82881913|NCT05848687|Methotrexate|methotrexate|mesh-list
82881914|NCT05848687|Bortezomib|bortezomib|mesh-list
82881915|NCT05848687|Asparaginase|asparaginase|mesh-list
82881916|NCT05848687|Mitoxantrone|mitoxantrone|mesh-list
82881917|NCT05848687|Mercaptopurine|mercaptopurine|mesh-list
82881918|NCT05848687|Vorinostat|vorinostat|mesh-list
82881919|NCT05848687|Blinatumomab|blinatumomab|mesh-list
82881920|NCT05848687|Pegaspargase|pegaspargase|mesh-list
82881921|NCT05848687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82881922|NCT05848687|Antiemetics|antiemetics|mesh-ancestor
82881924|NCT05848687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881925|NCT05848687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881928|NCT05848687|Hormones|hormones|mesh-ancestor
82881929|NCT05848687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82881930|NCT05848687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82881931|NCT05848687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82881932|NCT05848687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82881933|NCT05848687|Abortifacient Agents|abortifacient agents|mesh-ancestor
82881934|NCT05848687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82881935|NCT05848687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82881936|NCT05848687|Antimetabolites|antimetabolites|mesh-ancestor
82881937|NCT05848687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881938|NCT05848687|Dermatologic Agents|dermatologic agents|mesh-ancestor
82881939|NCT05848687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881940|NCT05848687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82881941|NCT05848687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82881942|NCT05848687|Immunologic Factors|immunologic factors|mesh-ancestor
82881943|NCT05848687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82881944|NCT05848687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82881945|NCT05848687|Analgesics|analgesics|mesh-ancestor
82881946|NCT05848687|Sensory System Agents|sensory system agents|mesh-ancestor
82881947|NCT05848687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82881948|NCT05848687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82881949|NCT05848687|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82881950|NCT05848635|Morphine|morphine|mesh-list
82881951|NCT05848635|Hydromorphone|hydromorphone|mesh-list
82881952|NCT05848635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82881953|NCT05848635|Narcotics|narcotics|mesh-ancestor
82881954|NCT05848635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881955|NCT05848635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881956|NCT05848635|Analgesics|analgesics|mesh-ancestor
82881957|NCT05848635|Sensory System Agents|sensory system agents|mesh-ancestor
82881958|NCT05848635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881959|NCT05848531|Clonidine|clonidine|mesh-list
82881960|NCT05848531|Analgesics|analgesics|mesh-ancestor
82881961|NCT05848531|Sensory System Agents|sensory system agents|mesh-ancestor
82881962|NCT05848531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881963|NCT05848531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881964|NCT05848531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82881965|NCT05848531|Sympatholytics|sympatholytics|mesh-ancestor
82881966|NCT05848531|Autonomic Agents|autonomic agents|mesh-ancestor
82881967|NCT05848531|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82881968|NCT05848531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82881969|NCT05848531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82881970|NCT05848531|Adrenergic Agents|adrenergic agents|mesh-ancestor
82881971|NCT05848531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881972|NCT05848531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881973|NCT05848505|Dexmedetomidine|dexmedetomidine|mesh-list
82881974|NCT05848505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82881975|NCT05848505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82881976|NCT05848505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82881977|NCT05848505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82881978|NCT05848505|Analgesics|analgesics|mesh-ancestor
82881979|NCT05848505|Sensory System Agents|sensory system agents|mesh-ancestor
82881980|NCT05848505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82881981|NCT05848505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82881982|NCT05848505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82881983|NCT05848505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82881984|NCT05848505|Adrenergic Agents|adrenergic agents|mesh-ancestor
82881985|NCT05848505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82881986|NCT05848505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881987|NCT05848492|Fluconazole|fluconazole|mesh-list
82881988|NCT05848492|Antifungal Agents|antifungal agents|mesh-ancestor
82881989|NCT05848492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82881990|NCT05848492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82881991|NCT05848492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82881992|NCT05848492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82881993|NCT05848492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82881994|NCT05848492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82882003|NCT05848336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882004|NCT05848128|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82882005|NCT05848128|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82882007|NCT05848102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82882008|NCT05848102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882009|NCT05848102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82882010|NCT05848102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882011|NCT05848011|Prednisone|prednisone|mesh-list
82882012|NCT05848011|Docetaxel|docetaxel|mesh-list
82882013|NCT05848011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882014|NCT05848011|Tubulin Modulators|tubulin modulators|mesh-ancestor
82882015|NCT05848011|Antimitotic Agents|antimitotic agents|mesh-ancestor
82882016|NCT05848011|Mitosis Modulators|mitosis modulators|mesh-ancestor
82882017|NCT05848011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882018|NCT05848011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882019|NCT05848011|Glucocorticoids|glucocorticoids|mesh-ancestor
82882020|NCT05848011|Hormones|hormones|mesh-ancestor
82882021|NCT05848011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882022|NCT05848011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882023|NCT05848011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82882024|NCT05847764|Carboplatin|carboplatin|mesh-list
82882025|NCT05847764|Tislelizumab|tislelizumab|mesh-list
82882026|NCT05847764|Aflutinib|aflutinib|mesh-list
82882027|NCT05847764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882028|NCT05847764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882029|NCT05847764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882030|NCT05847764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882031|NCT05847764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882034|NCT05846698|Tibolone|tibolone|mesh-list
82882035|NCT05846698|Androgen Antagonists|androgen antagonists|mesh-ancestor
82882036|NCT05846698|Hormone Antagonists|hormone antagonists|mesh-ancestor
82882037|NCT05846698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882038|NCT05846698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882039|NCT05846698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82882040|NCT05846698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82882041|NCT05846698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882042|NCT05846698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82882043|NCT05846698|Anabolic Agents|anabolic agents|mesh-ancestor
82882044|NCT05846698|Hormones|hormones|mesh-ancestor
82882051|NCT05846568|Immunoglobulins|immunoglobulins|mesh-list
82882052|NCT05846568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82882053|NCT05846568|Antibodies|antibodies|mesh-list
82882054|NCT05846568|Immunologic Factors|immunologic factors|mesh-ancestor
82882055|NCT05846568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882056|NCT05846451|Oxycodone|oxycodone|mesh-list
82882057|NCT05846451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82882058|NCT05846451|Narcotics|narcotics|mesh-ancestor
82882059|NCT05846451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882060|NCT05846451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882061|NCT05846451|Analgesics|analgesics|mesh-ancestor
82882062|NCT05846451|Sensory System Agents|sensory system agents|mesh-ancestor
82882063|NCT05846451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882064|NCT05846399|Amoxicillin|amoxicillin|mesh-list
82882065|NCT05846399|Ciprofloxacin|ciprofloxacin|mesh-list
82882066|NCT05846399|Clindamycin|clindamycin|mesh-list
82882067|NCT05846399|Clindamycin palmitate|clindamycin palmitate|mesh-list
82882068|NCT05846399|Clindamycin phosphate|clindamycin phosphate|mesh-list
82882075|NCT05846399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82882076|NCT05846399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882077|NCT05846399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882078|NCT05846399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882079|NCT05846399|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82882080|NCT05846399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82882081|NCT05846399|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82882082|NCT05846399|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82882083|NCT05846373|Niacin|niacin|mesh-list
82882084|NCT05846373|Niacinamide|niacinamide|mesh-list
82882085|NCT05846373|Nicotinic Acids|nicotinic acids|mesh-list
82882086|NCT05846373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82882087|NCT05846373|Antimetabolites|antimetabolites|mesh-ancestor
82882088|NCT05846373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882089|NCT05846373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82882090|NCT05846373|Vasodilator Agents|vasodilator agents|mesh-ancestor
82882091|NCT05846373|Vitamin B Complex|vitamin b complex|mesh-ancestor
82882092|NCT05846373|Vitamins|vitamins|mesh-ancestor
82882093|NCT05846373|Micronutrients|micronutrients|mesh-ancestor
82723393|NCT00868426|Antidotes|antidotes|mesh-ancestor
82882094|NCT05846373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882095|NCT05846243|Vaccines|vaccines|mesh-list
82882096|NCT05846243|Immunologic Factors|immunologic factors|mesh-ancestor
82882097|NCT05846243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882098|NCT05846139|Chlorhexidine|chlorhexidine|mesh-list
82882099|NCT05846139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82882100|NCT05846139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882101|NCT05846139|Disinfectants|disinfectants|mesh-ancestor
82882102|NCT05845996|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
82882103|NCT05845996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82882104|NCT05845996|Immunologic Factors|immunologic factors|mesh-ancestor
82882105|NCT05845996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882106|NCT05845723|Cyclophosphamide|cyclophosphamide|mesh-list
82882107|NCT05845723|Tofacitinib|tofacitinib|mesh-list
82882108|NCT05845723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882109|NCT05845723|Immunologic Factors|immunologic factors|mesh-ancestor
82882110|NCT05845723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882111|NCT05845723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882112|NCT05845723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83454208|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82882113|NCT05845723|Alkylating Agents|alkylating agents|mesh-ancestor
82882114|NCT05845723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882115|NCT05845723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882116|NCT05845723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82882117|NCT05845723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82882118|NCT05845723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882119|NCT05845723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882120|NCT05845671|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
82882121|NCT05845671|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82882122|NCT05845671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882123|NCT05845671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882124|NCT05845671|Immunologic Factors|immunologic factors|mesh-ancestor
82882125|NCT05845671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882132|NCT05845567|Clarithromycin|clarithromycin|mesh-list
82882133|NCT05845567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82882134|NCT05845567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882135|NCT05845567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82882136|NCT05845567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882137|NCT05845567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882138|NCT05845567|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82882139|NCT05845567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82882140|NCT05845424|Ezetimibe|ezetimibe|mesh-list
82882141|NCT05845424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82882142|NCT05845424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82882143|NCT05845424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82882145|NCT05845424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882146|NCT05845424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82882147|NCT05845424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882148|NCT05845385|Analgesics|analgesics|mesh-list
82882149|NCT05845385|Sensory System Agents|sensory system agents|mesh-ancestor
82882150|NCT05845385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882151|NCT05845385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882152|NCT05845359|Methadone|methadone|mesh-list
82882153|NCT05845359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82882154|NCT05845359|Narcotics|narcotics|mesh-ancestor
82882155|NCT05845359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882156|NCT05845359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882157|NCT05845359|Analgesics|analgesics|mesh-ancestor
82882158|NCT05845359|Sensory System Agents|sensory system agents|mesh-ancestor
82882159|NCT05845359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882160|NCT05845359|Antitussive Agents|antitussive agents|mesh-ancestor
82882161|NCT05845359|Respiratory System Agents|respiratory system agents|mesh-ancestor
82882162|NCT05845268|Tislelizumab|tislelizumab|mesh-list
82882163|NCT05845268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82882164|NCT05845268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882165|NCT05845268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882166|NCT05845268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882167|NCT05845125|Triamcinolone|triamcinolone|mesh-list
82882168|NCT05845125|Bupivacaine|bupivacaine|mesh-list
82882169|NCT05845125|Anesthetics, Local|anesthetics, local|mesh-ancestor
82882170|NCT05845125|Anesthetics|anesthetics|mesh-ancestor
82882171|NCT05845125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882172|NCT05845125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882173|NCT05845125|Sensory System Agents|sensory system agents|mesh-ancestor
82882174|NCT05845125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882175|NCT05845125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882176|NCT05845125|Glucocorticoids|glucocorticoids|mesh-ancestor
82882178|NCT05845125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882179|NCT05844982|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82882180|NCT05844982|Faricimab|faricimab|mesh-list
82882181|NCT05844982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882182|NCT05844982|Glucocorticoids|glucocorticoids|mesh-ancestor
82882183|NCT05844982|Hormones|hormones|mesh-ancestor
82882184|NCT05844982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882185|NCT05844982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882186|NCT05844982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82882187|NCT05844982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82882188|NCT05844982|Growth Substances|growth substances|mesh-ancestor
82882189|NCT05844982|Growth Inhibitors|growth inhibitors|mesh-ancestor
82882190|NCT05844982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882191|NCT05844930|Triamcinolone|triamcinolone|mesh-list
82882192|NCT05844930|Lidocaine|lidocaine|mesh-list
82882193|NCT05844930|Anesthetics, Local|anesthetics, local|mesh-ancestor
82882194|NCT05844930|Anesthetics|anesthetics|mesh-ancestor
82882195|NCT05844930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882196|NCT05844930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882197|NCT05844930|Sensory System Agents|sensory system agents|mesh-ancestor
82882198|NCT05844930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882199|NCT05844930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82882200|NCT05844930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82882201|NCT05844930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82882202|NCT05844930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82882203|NCT05844930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882204|NCT05844930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882205|NCT05844930|Glucocorticoids|glucocorticoids|mesh-ancestor
82882206|NCT05844930|Hormones|hormones|mesh-ancestor
82882207|NCT05844930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882208|NCT05844800|Bupivacaine|bupivacaine|mesh-list
82882209|NCT05844800|Anesthetics, Local|anesthetics, local|mesh-ancestor
82882210|NCT05844800|Anesthetics|anesthetics|mesh-ancestor
82882211|NCT05844800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882212|NCT05844800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882213|NCT05844800|Sensory System Agents|sensory system agents|mesh-ancestor
82882214|NCT05844800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882215|NCT05844683|Chlorhexidine|chlorhexidine|mesh-list
82882216|NCT05844683|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82882218|NCT05844683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882219|NCT05844683|Disinfectants|disinfectants|mesh-ancestor
82882220|NCT05844683|Dermatologic Agents|dermatologic agents|mesh-ancestor
82882221|NCT05844670|Vincristine|vincristine|mesh-list
82882222|NCT05844670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82882223|NCT05844670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882224|NCT05844670|Tubulin Modulators|tubulin modulators|mesh-ancestor
82882225|NCT05844670|Antimitotic Agents|antimitotic agents|mesh-ancestor
82882226|NCT05844670|Mitosis Modulators|mitosis modulators|mesh-ancestor
82882227|NCT05844670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882228|NCT05844657|Ferrous fumarate|ferrous fumarate|mesh-list
82882229|NCT05844657|Trace Elements|trace elements|mesh-ancestor
82882230|NCT05844657|Micronutrients|micronutrients|mesh-ancestor
82882231|NCT05844657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882232|NCT05844553|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82882233|NCT05844553|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82882234|NCT05844553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882235|NCT05844501|Ondansetron|ondansetron|mesh-list
82882236|NCT05844501|Antiemetics|antiemetics|mesh-ancestor
82882237|NCT05844501|Autonomic Agents|autonomic agents|mesh-ancestor
82882238|NCT05844501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882239|NCT05844501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882240|NCT05844501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82882241|NCT05844501|Antipruritics|antipruritics|mesh-ancestor
82882242|NCT05844501|Dermatologic Agents|dermatologic agents|mesh-ancestor
82882243|NCT05844501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82882244|NCT05844501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82882245|NCT05844501|Serotonin Agents|serotonin agents|mesh-ancestor
82882246|NCT05844501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882247|NCT05844501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882248|NCT05844436|Pritelivir|pritelivir|mesh-list
82882249|NCT05844436|Antiviral Agents|antiviral agents|mesh-ancestor
82882250|NCT05844436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882251|NCT05844436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882252|NCT05844436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882254|NCT05844371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882255|NCT05844306|Deoxyglucose|deoxyglucose|mesh-list
82882256|NCT05844306|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82882257|NCT05844306|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82882258|NCT05844306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882259|NCT05844306|Antimetabolites|antimetabolites|mesh-ancestor
82882260|NCT05844306|Antiviral Agents|antiviral agents|mesh-ancestor
82882261|NCT05844306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882262|NCT05844150|Etoposide|etoposide|mesh-list
82882263|NCT05844150|Atezolizumab|atezolizumab|mesh-list
82882264|NCT05844150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82882265|NCT05844150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882266|NCT05844150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82882267|NCT05844150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82882268|NCT05844150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882269|NCT05844150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882270|NCT05844150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82882271|NCT05844150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882272|NCT05844046|Bevacizumab|bevacizumab|mesh-list
82882273|NCT05844046|Durvalumab|durvalumab|mesh-list
82882274|NCT05844046|Tremelimumab|tremelimumab|mesh-list
82882275|NCT05844046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882276|NCT05844046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882277|NCT05844046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82882278|NCT05844046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82882279|NCT05844046|Growth Substances|growth substances|mesh-ancestor
82882280|NCT05844046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882281|NCT05844046|Growth Inhibitors|growth inhibitors|mesh-ancestor
82882282|NCT05843838|Anesthetics|anesthetics|mesh-list
82882283|NCT05843838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882284|NCT05843838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882285|NCT05843812|Magnesium Sulfate|magnesium sulfate|mesh-list
82882286|NCT05843812|Analgesics|analgesics|mesh-ancestor
82882287|NCT05843812|Sensory System Agents|sensory system agents|mesh-ancestor
82882288|NCT05843812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882289|NCT05843812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882290|NCT05843812|Anesthetics|anesthetics|mesh-ancestor
82882291|NCT05843812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882292|NCT05843812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82882293|NCT05843812|Anticonvulsants|anticonvulsants|mesh-ancestor
82882294|NCT05843812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82882295|NCT05843812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82882296|NCT05843812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882297|NCT05843812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82882298|NCT05843812|Tocolytic Agents|tocolytic agents|mesh-ancestor
82882299|NCT05843812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82882300|NCT05843786|Interferons|interferons|mesh-list
82882301|NCT05843786|Interferon-gamma|interferon-gamma|mesh-list
82882302|NCT05843786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882303|NCT05843786|Antiviral Agents|antiviral agents|mesh-ancestor
82882304|NCT05843786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882305|NCT05843643|Upadacitinib|upadacitinib|mesh-list
82882306|NCT05843643|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82882307|NCT05843643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882308|NCT05843643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882309|NCT05843643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882310|NCT05843643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882311|NCT05843617|Vitamins|vitamins|mesh-list
82882312|NCT05843617|Ascorbic Acid|ascorbic acid|mesh-list
82882313|NCT05843617|Micronutrients|micronutrients|mesh-ancestor
82882314|NCT05843617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882315|NCT05843617|Antioxidants|antioxidants|mesh-ancestor
82882316|NCT05843617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882317|NCT05843617|Protective Agents|protective agents|mesh-ancestor
82882318|NCT05843448|Pembrolizumab|pembrolizumab|mesh-list
82882319|NCT05843448|Vaccines|vaccines|mesh-list
82882320|NCT05843448|Immunologic Factors|immunologic factors|mesh-ancestor
82882321|NCT05843448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882322|NCT05843448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882323|NCT05843448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882324|NCT05843448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82882325|NCT05843448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882326|NCT05843383|Propofol|propofol|mesh-list
82882327|NCT05843383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82882328|NCT05843383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882329|NCT05843383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882330|NCT05843383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82882331|NCT05843383|Anesthetics, General|anesthetics, general|mesh-ancestor
82882332|NCT05843383|Anesthetics|anesthetics|mesh-ancestor
82882333|NCT05843344|Dexmedetomidine|dexmedetomidine|mesh-list
82882334|NCT05843344|Morphine|morphine|mesh-list
82882335|NCT05843344|Ropivacaine|ropivacaine|mesh-list
82882336|NCT05843344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82882337|NCT05843344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882338|NCT05843344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882339|NCT05843344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82882340|NCT05843344|Analgesics|analgesics|mesh-ancestor
82882341|NCT05843344|Sensory System Agents|sensory system agents|mesh-ancestor
82882342|NCT05843344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882343|NCT05843344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82882344|NCT05843344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82882345|NCT05843344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82882346|NCT05843344|Adrenergic Agents|adrenergic agents|mesh-ancestor
82882347|NCT05843344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882348|NCT05843344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882349|NCT05843344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82882350|NCT05843344|Narcotics|narcotics|mesh-ancestor
82882351|NCT05843344|Anesthetics, Local|anesthetics, local|mesh-ancestor
82882352|NCT05843344|Anesthetics|anesthetics|mesh-ancestor
82882353|NCT05843292|Carboplatin|carboplatin|mesh-list
82882354|NCT05843292|Taxane|taxane|mesh-list
82882355|NCT05843292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882356|NCT05843253|Everolimus|everolimus|mesh-list
82882357|NCT05843253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82882358|NCT05843253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882359|NCT05843253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882360|NCT05843253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882361|NCT05843253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882362|NCT05843253|Immunologic Factors|immunologic factors|mesh-ancestor
82882363|NCT05843253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882364|NCT05843253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882365|NCT05843188|Leucovorin|leucovorin|mesh-list
82882366|NCT05843188|Hydroxychloroquine|hydroxychloroquine|mesh-list
82882367|NCT05843188|Bevacizumab|bevacizumab|mesh-list
82882368|NCT05843188|Fluorouracil|fluorouracil|mesh-list
82882370|NCT05843188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882371|NCT05843188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882372|NCT05843188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82882373|NCT05843188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82882375|NCT05843188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882376|NCT05843188|Growth Inhibitors|growth inhibitors|mesh-ancestor
82882377|NCT05843188|Antimetabolites|antimetabolites|mesh-ancestor
82882378|NCT05843188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882379|NCT05843188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82882380|NCT05843188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882381|NCT05843188|Immunologic Factors|immunologic factors|mesh-ancestor
82882382|NCT05843188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82882383|NCT05843188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82882384|NCT05843188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882385|NCT05843188|Antidotes|antidotes|mesh-ancestor
82882386|NCT05843188|Protective Agents|protective agents|mesh-ancestor
82882387|NCT05843188|Vitamin B Complex|vitamin b complex|mesh-ancestor
82882388|NCT05843188|Vitamins|vitamins|mesh-ancestor
82882389|NCT05843188|Micronutrients|micronutrients|mesh-ancestor
82882390|NCT05843188|Antimalarials|antimalarials|mesh-ancestor
82882391|NCT05843188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82882392|NCT05843188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82882393|NCT05843188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882394|NCT05843188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882395|NCT05843162|Losartan|losartan|mesh-list
82882396|NCT05843162|Telmisartan|telmisartan|mesh-list
82882397|NCT05843162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82882398|NCT05843162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82882399|NCT05843162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82882400|NCT05843162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82882401|NCT05843162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882402|NCT05842954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82882403|NCT05842954|Antimalarials|antimalarials|mesh-ancestor
82882404|NCT05842954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82882405|NCT05842954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82882406|NCT05842954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882407|NCT05842759|Norepinephrine|norepinephrine|mesh-list
82882408|NCT05842759|Propofol|propofol|mesh-list
82882409|NCT05842759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82882410|NCT05842759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882411|NCT05842759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882412|NCT05842759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82882413|NCT05842759|Anesthetics, General|anesthetics, general|mesh-ancestor
82882414|NCT05842759|Anesthetics|anesthetics|mesh-ancestor
82882415|NCT05842759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82882416|NCT05842759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82882417|NCT05842759|Adrenergic Agents|adrenergic agents|mesh-ancestor
82882418|NCT05842759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882419|NCT05842759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882420|NCT05842759|Sympathomimetics|sympathomimetics|mesh-ancestor
82882421|NCT05842759|Autonomic Agents|autonomic agents|mesh-ancestor
82882422|NCT05842759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882423|NCT05842759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82882424|NCT05842681|Azithromycin|azithromycin|mesh-list
82882425|NCT05842681|Methylprednisolone|methylprednisolone|mesh-list
82882426|NCT05842681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82882427|NCT05842681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82882428|NCT05842681|Prednisolone|prednisolone|mesh-list
82882429|NCT05842681|Prednisolone acetate|prednisolone acetate|mesh-list
82882430|NCT05842681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82882431|NCT05842681|Prednisolone phosphate|prednisolone phosphate|mesh-list
82882432|NCT05842681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882433|NCT05842681|Antiemetics|antiemetics|mesh-ancestor
82882434|NCT05842681|Autonomic Agents|autonomic agents|mesh-ancestor
82882435|NCT05842681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882436|NCT05842681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882437|NCT05842681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82882438|NCT05842681|Glucocorticoids|glucocorticoids|mesh-ancestor
82882439|NCT05842681|Hormones|hormones|mesh-ancestor
82882440|NCT05842681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882441|NCT05842681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82882442|NCT05842681|Protective Agents|protective agents|mesh-ancestor
82882443|NCT05842681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82882445|NCT05842681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82882446|NCT05842681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882447|NCT05842486|Antibodies|antibodies|mesh-list
82882448|NCT05842486|Immunologic Factors|immunologic factors|mesh-ancestor
82882449|NCT05842486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882450|NCT05842330|Methylphenidate|methylphenidate|mesh-list
82882451|NCT05842330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82882452|NCT05842330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882453|NCT05842330|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82882454|NCT05842330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82882455|NCT05842330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82882456|NCT05842330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882457|NCT05842330|Dopamine Agents|dopamine agents|mesh-ancestor
82882458|NCT05842330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882459|NCT05842317|Lenvatinib|lenvatinib|mesh-list
82882460|NCT05842317|Tislelizumab|tislelizumab|mesh-list
82882461|NCT05842317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882462|NCT05842317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882463|NCT05842317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882464|NCT05842317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882465|NCT05842317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882466|NCT05840848|Beta Carotene|beta carotene|mesh-list
82882467|NCT05840848|Carotenoids|carotenoids|mesh-list
82882468|NCT05840848|Antioxidants|antioxidants|mesh-ancestor
82882469|NCT05840848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882470|NCT05840848|Protective Agents|protective agents|mesh-ancestor
82882471|NCT05840848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882472|NCT05840848|Provitamins|provitamins|mesh-ancestor
82882473|NCT05840848|Vitamins|vitamins|mesh-ancestor
82882474|NCT05840848|Micronutrients|micronutrients|mesh-ancestor
82882475|NCT05840835|Tislelizumab|tislelizumab|mesh-list
82882476|NCT05840835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882477|NCT05840835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882478|NCT05840718|Thiamine|thiamine|mesh-list
82882479|NCT05840718|Vitamin B Complex|vitamin b complex|mesh-ancestor
82882480|NCT05840718|Vitamins|vitamins|mesh-ancestor
82882481|NCT05840718|Micronutrients|micronutrients|mesh-ancestor
82882482|NCT05840718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882483|NCT05840562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82882485|NCT05840562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82882486|NCT05840562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82882487|NCT05840562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82882488|NCT05840562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882489|NCT05840562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882490|NCT05840562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882491|NCT05840562|Analgesics|analgesics|mesh-ancestor
82882492|NCT05840562|Sensory System Agents|sensory system agents|mesh-ancestor
82882493|NCT05840562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882494|NCT05840562|Antidepressive Agents|antidepressive agents|mesh-ancestor
82882495|NCT05840562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82882496|NCT05840562|Dopamine Agents|dopamine agents|mesh-ancestor
82882497|NCT05840562|Antipruritics|antipruritics|mesh-ancestor
82882498|NCT05840562|Dermatologic Agents|dermatologic agents|mesh-ancestor
82882499|NCT05840471|Tranexamic Acid|tranexamic acid|mesh-list
82882500|NCT05840471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82882501|NCT05840471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82882502|NCT05840471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882503|NCT05840471|Hemostatics|hemostatics|mesh-ancestor
82882504|NCT05840471|Coagulants|coagulants|mesh-ancestor
82882505|NCT05840289|Rituximab|rituximab|mesh-list
82882506|NCT05840289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882507|NCT05840289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882508|NCT05840289|Immunologic Factors|immunologic factors|mesh-ancestor
82882509|NCT05840289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882510|NCT05840289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882511|NCT05839938|Vitamin D|vitamin d|mesh-list
82882512|NCT05839938|Vitamins|vitamins|mesh-ancestor
82882513|NCT05839938|Micronutrients|micronutrients|mesh-ancestor
82882514|NCT05839938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882515|NCT05839938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82882516|NCT05839756|Budesonide|budesonide|mesh-list
82882517|NCT05839756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882518|NCT05839756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82882520|NCT05839756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882521|NCT05839756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882522|NCT05839756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82882523|NCT05839756|Respiratory System Agents|respiratory system agents|mesh-ancestor
82882524|NCT05839756|Glucocorticoids|glucocorticoids|mesh-ancestor
82882525|NCT05839756|Hormones|hormones|mesh-ancestor
82882526|NCT05839756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882527|NCT05839314|Cyclosporine|cyclosporine|mesh-list
82882528|NCT05839314|Cyclosporins|cyclosporins|mesh-list
82882529|NCT05839314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882530|NCT05839314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882531|NCT05839314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882532|NCT05839314|Immunologic Factors|immunologic factors|mesh-ancestor
82882533|NCT05839314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882534|NCT05839314|Antifungal Agents|antifungal agents|mesh-ancestor
82882535|NCT05839314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882536|NCT05839314|Dermatologic Agents|dermatologic agents|mesh-ancestor
82882537|NCT05839314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882538|NCT05839314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82882539|NCT05837897|Vedolizumab|vedolizumab|mesh-list
82882540|NCT05837897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82882541|NCT05836740|Minocycline|minocycline|mesh-list
82882542|NCT05836740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82882543|NCT05836740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882544|NCT05836571|Nivolumab|nivolumab|mesh-list
82882545|NCT05836571|Ipilimumab|ipilimumab|mesh-list
82882546|NCT05836571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882547|NCT05836571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882548|NCT05836571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82882549|NCT05836571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882550|NCT05836272|Norepinephrine|norepinephrine|mesh-list
82882551|NCT05836272|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82882552|NCT05836272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82882553|NCT05836272|Adrenergic Agents|adrenergic agents|mesh-ancestor
82882554|NCT05836272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882555|NCT05836272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882556|NCT05836272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82723840|NCT00732108|Topiramate|topiramate|mesh-list
82882557|NCT05836272|Sympathomimetics|sympathomimetics|mesh-ancestor
82882558|NCT05836272|Autonomic Agents|autonomic agents|mesh-ancestor
82882559|NCT05836272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882560|NCT05836272|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82882561|NCT05829499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82882562|NCT05829499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82882564|NCT05828095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82882565|NCT05828095|Immunologic Factors|immunologic factors|mesh-ancestor
82882566|NCT05828095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882567|NCT05825573|Vitamin K|vitamin k|mesh-list
82882568|NCT05825573|Anticoagulants|anticoagulants|mesh-list
82882569|NCT05825573|Vitamins|vitamins|mesh-ancestor
82882570|NCT05825573|Micronutrients|micronutrients|mesh-ancestor
82882571|NCT05825573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882572|NCT05825573|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82882573|NCT05825573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82882574|NCT05825573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882575|NCT05825573|Hemostatics|hemostatics|mesh-ancestor
82882576|NCT05825573|Coagulants|coagulants|mesh-ancestor
82882577|NCT05825352|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82882578|NCT05825352|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82882579|NCT05824494|Paclitaxel|paclitaxel|mesh-list
82882580|NCT05824494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82882581|NCT05824494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882582|NCT05824494|Tubulin Modulators|tubulin modulators|mesh-ancestor
82882583|NCT05824494|Antimitotic Agents|antimitotic agents|mesh-ancestor
82882584|NCT05824494|Mitosis Modulators|mitosis modulators|mesh-ancestor
82882585|NCT05824494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882586|NCT05824000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82882587|NCT05824000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82882588|NCT05823961|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82882589|NCT05823961|Hyaluronic Acid|hyaluronic acid|mesh-list
82882590|NCT05823961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82882591|NCT05823961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82882592|NCT05823961|Immunologic Factors|immunologic factors|mesh-ancestor
82882593|NCT05823961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882594|NCT05823961|Viscosupplements|viscosupplements|mesh-ancestor
82882595|NCT05823961|Protective Agents|protective agents|mesh-ancestor
82882596|NCT05823506|Tadalafil|tadalafil|mesh-list
82882597|NCT05823506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
82882598|NCT05823506|Vasodilator Agents|vasodilator agents|mesh-ancestor
82882599|NCT05823506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82882600|NCT05823506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882601|NCT05823506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882602|NCT05823506|Urological Agents|urological agents|mesh-ancestor
82882603|NCT05822817|Propofol|propofol|mesh-list
82882604|NCT05822817|Sevoflurane|sevoflurane|mesh-list
82882605|NCT05822817|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82882606|NCT05822817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882607|NCT05822817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882608|NCT05822817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82882609|NCT05822817|Anesthetics, General|anesthetics, general|mesh-ancestor
82882610|NCT05822817|Anesthetics|anesthetics|mesh-ancestor
82882611|NCT05822817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82882612|NCT05822817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82882613|NCT05822063|Lidocaine|lidocaine|mesh-list
82882614|NCT05822063|Anesthetics, Local|anesthetics, local|mesh-ancestor
82882615|NCT05822063|Anesthetics|anesthetics|mesh-ancestor
82882616|NCT05822063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882617|NCT05822063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882618|NCT05822063|Sensory System Agents|sensory system agents|mesh-ancestor
82882619|NCT05822063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882620|NCT05822063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82882621|NCT05822063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82882622|NCT05822063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82882623|NCT05822063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82882624|NCT05822063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882625|NCT05821075|Prednisolone|prednisolone|mesh-list
82882626|NCT05821075|Cerebrolysin|cerebrolysin|mesh-list
82882627|NCT05821075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882628|NCT05821075|Glucocorticoids|glucocorticoids|mesh-ancestor
82882629|NCT05821075|Hormones|hormones|mesh-ancestor
82882630|NCT05821075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882631|NCT05821075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882632|NCT05821075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82882633|NCT05821075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882634|NCT05821075|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82882635|NCT05821075|Protective Agents|protective agents|mesh-ancestor
82882636|NCT05821075|Nootropic Agents|nootropic agents|mesh-ancestor
82882637|NCT05818852|Moxifloxacin|moxifloxacin|mesh-list
82882638|NCT05818852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83454223|NCT02982395|Ethanol|ethanol|mesh-list
82882639|NCT05818852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82882640|NCT05818852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882641|NCT05818852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82882642|NCT05818852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82882643|NCT05818852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882644|NCT05818852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882645|NCT05818852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882646|NCT05818852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82882647|NCT05818852|Contraceptive Agents|contraceptive agents|mesh-ancestor
82882648|NCT05818852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82882649|NCT05818852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882650|NCT05818852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82882651|NCT05818852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82882652|NCT05818852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82882653|NCT05817903|Nivolumab|nivolumab|mesh-list
82882654|NCT05817903|Axitinib|axitinib|mesh-list
82882655|NCT05817903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882656|NCT05817903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882657|NCT05817903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82882658|NCT05817903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882659|NCT05817903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882660|NCT05817903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882661|NCT05806931|Bevacizumab|bevacizumab|mesh-list
82882662|NCT05806931|Oxaliplatin|oxaliplatin|mesh-list
82882663|NCT05806931|Irinotecan|irinotecan|mesh-list
82882664|NCT05806931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882665|NCT05806931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882666|NCT05806931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82882667|NCT05806931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82882668|NCT05806931|Growth Substances|growth substances|mesh-ancestor
82882670|NCT05806931|Growth Inhibitors|growth inhibitors|mesh-ancestor
82882671|NCT05806931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82882672|NCT05806931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82882673|NCT05806931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882674|NCT05806931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882675|NCT05806346|Tranexamic Acid|tranexamic acid|mesh-list
82882676|NCT05806346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82882677|NCT05806346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82882678|NCT05806346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882679|NCT05806346|Hemostatics|hemostatics|mesh-ancestor
82882680|NCT05806346|Coagulants|coagulants|mesh-ancestor
82882681|NCT05806021|Triamcinolone|triamcinolone|mesh-list
82882682|NCT05806021|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82882683|NCT05806021|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82882684|NCT05806021|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82882685|NCT05806021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882686|NCT05806021|Glucocorticoids|glucocorticoids|mesh-ancestor
82882687|NCT05806021|Hormones|hormones|mesh-ancestor
82882688|NCT05806021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882689|NCT05806021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882690|NCT05806021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882691|NCT05806021|Immunologic Factors|immunologic factors|mesh-ancestor
82882692|NCT05806021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882693|NCT05806021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882694|NCT05805605|Mycophenolic Acid|mycophenolic acid|mesh-list
82882695|NCT05805605|Sirolimus|sirolimus|mesh-list
82882696|NCT05805605|Cyclophosphamide|cyclophosphamide|mesh-list
82882697|NCT05805605|Fludarabine|fludarabine|mesh-list
82882698|NCT05805605|Allopurinol|allopurinol|mesh-list
82882699|NCT05805605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882700|NCT05805605|Immunologic Factors|immunologic factors|mesh-ancestor
82882701|NCT05805605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882702|NCT05805605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882703|NCT05805605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82882704|NCT05805605|Alkylating Agents|alkylating agents|mesh-ancestor
82882705|NCT05805605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882706|NCT05805605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882707|NCT05805605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82882708|NCT05805605|Antimetabolites|antimetabolites|mesh-ancestor
82882709|NCT05805605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82882710|NCT05805605|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82882711|NCT05805605|Antitubercular Agents|antitubercular agents|mesh-ancestor
82882712|NCT05805605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82882713|NCT05805605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882714|NCT05805605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882715|NCT05805605|Antifungal Agents|antifungal agents|mesh-ancestor
82882716|NCT05805605|Gout Suppressants|gout suppressants|mesh-ancestor
82882717|NCT05805605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82882718|NCT05805605|Antioxidants|antioxidants|mesh-ancestor
82882719|NCT05805605|Protective Agents|protective agents|mesh-ancestor
82882720|NCT05805436|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82882721|NCT05805436|Laxatives|laxatives|mesh-ancestor
82882722|NCT05805436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82882724|NCT05805072|Azacitidine|azacitidine|mesh-list
82882725|NCT05805072|Decitabine|decitabine|mesh-list
82882726|NCT05805072|Homoharringtonine|homoharringtonine|mesh-list
82882727|NCT05805072|Aclacinomycins|aclacinomycins|mesh-list
82882728|NCT05805072|Lenograstim|lenograstim|mesh-list
82882729|NCT05805072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82882730|NCT05805072|Antimetabolites|antimetabolites|mesh-ancestor
82882731|NCT05805072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882732|NCT05805072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882733|NCT05805072|Antiviral Agents|antiviral agents|mesh-ancestor
82882734|NCT05805072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882735|NCT05805072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882736|NCT05805072|Immunologic Factors|immunologic factors|mesh-ancestor
82882737|NCT05805072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882738|NCT05805072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882739|NCT05805072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82882740|NCT05805072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82882741|NCT05805072|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82882742|NCT05805072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82882743|NCT05804032|Dexamethasone|dexamethasone|mesh-list
82882744|NCT05804032|Lenalidomide|lenalidomide|mesh-list
82882753|NCT05804032|Glucocorticoids|glucocorticoids|mesh-ancestor
82882754|NCT05804032|Hormones|hormones|mesh-ancestor
82882755|NCT05804032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82882756|NCT05804032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82882757|NCT05804032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882758|NCT05804032|Immunologic Factors|immunologic factors|mesh-ancestor
82882759|NCT05804032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82882760|NCT05804032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82882761|NCT05804032|Growth Substances|growth substances|mesh-ancestor
82882762|NCT05804032|Growth Inhibitors|growth inhibitors|mesh-ancestor
82882763|NCT05803941|177Lu-PSMA-617|177lu-psma-617|mesh-list
82882764|NCT05803941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82882765|NCT05803941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882766|NCT05801913|Vaccines|vaccines|mesh-list
82882767|NCT05801913|Immunologic Factors|immunologic factors|mesh-ancestor
82882768|NCT05801913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882769|NCT05797090|Cardioplegic Solutions|cardioplegic solutions|mesh-list
82882770|NCT05797090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82882771|NCT05795504|Vitamin D|vitamin d|mesh-list
82882772|NCT05795504|Calcium|calcium|mesh-list
82882773|NCT05795504|Vitamins|vitamins|mesh-ancestor
82882774|NCT05795504|Micronutrients|micronutrients|mesh-ancestor
82882775|NCT05795504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882776|NCT05795504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82882777|NCT05795504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82882778|NCT05795101|Trastuzumab|trastuzumab|mesh-list
82882779|NCT05795101|Durvalumab|durvalumab|mesh-list
82882780|NCT05795101|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82882781|NCT05795101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882782|NCT05795101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882783|NCT05795101|Immunoconjugates|immunoconjugates|mesh-ancestor
82882784|NCT05795101|Immunologic Factors|immunologic factors|mesh-ancestor
82882785|NCT05795101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882786|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
82882787|NCT05788016|Narcotics|narcotics|mesh-ancestor
82882788|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882789|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882790|NCT05788016|Analgesics|analgesics|mesh-ancestor
82882791|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
82882792|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882793|NCT05782907|Upadacitinib|upadacitinib|mesh-list
82882794|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82882795|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882796|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882797|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882798|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882816|NCT05772364|Calcium|calcium|mesh-list
82882817|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82882818|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882819|NCT05770180|Vaccines|vaccines|mesh-list
82882820|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
82882821|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882822|NCT05767749|Lidocaine|lidocaine|mesh-list
82882823|NCT05767749|Epinephrine|epinephrine|mesh-list
82882824|NCT05767749|Racepinephrine|racepinephrine|mesh-list
82882825|NCT05767749|Bupivacaine|bupivacaine|mesh-list
82882826|NCT05767749|Ropivacaine|ropivacaine|mesh-list
82882827|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82882828|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
82882829|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
82882830|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
82882831|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882832|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882833|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
82882834|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882835|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82882836|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82882837|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82882838|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82882839|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882840|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82882841|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82882842|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
82882843|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882844|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82882845|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82882846|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
82882847|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82882848|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
82882849|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
82882850|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
82882851|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82882852|NCT05765682|Bupivacaine|bupivacaine|mesh-list
82882853|NCT05765682|Mepivacaine|mepivacaine|mesh-list
82882854|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
82882855|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
82882856|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882857|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882858|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
82882859|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882860|NCT05765604|Vaccines|vaccines|mesh-list
82882861|NCT05765604|Immunologic Factors|immunologic factors|mesh-ancestor
82882862|NCT05765604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882863|NCT05756673|Listerine|listerine|mesh-list
82882864|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82882865|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
82882866|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
82882867|NCT05756673|Protective Agents|protective agents|mesh-ancestor
82882868|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882869|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882870|NCT05753592|Remibrutinib|remibrutinib|mesh-list
82882871|NCT05753592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82882872|NCT05753592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882873|NCT05753592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882874|NCT05739942|Temozolomide|temozolomide|mesh-list
82882875|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82882876|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
83454232|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82882877|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882878|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882879|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
82882880|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82882881|NCT05736224|Protective Agents|protective agents|mesh-ancestor
82882882|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882883|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
82882884|NCT05735431|Fluticasone|fluticasone|mesh-list
82882885|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
82882886|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882887|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82882888|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
82882889|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882890|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882891|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82882892|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
82882893|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
82882894|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82882895|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82882908|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82882909|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
82882910|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882911|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882912|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82882913|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82882914|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
82882915|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882916|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882919|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82882920|NCT05704673|Narcotics|narcotics|mesh-ancestor
82882921|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882922|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882923|NCT05704673|Analgesics|analgesics|mesh-ancestor
82882924|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
82882925|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882926|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
82882927|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82882928|NCT05702671|Antibodies|antibodies|mesh-list
82882929|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
82882930|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882931|NCT05693545|Penicillins|penicillins|mesh-list
82882932|NCT05693545|Penicillin G|penicillin g|mesh-list
82882933|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
82882934|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
82882935|NCT05693545|Penicillin V|penicillin v|mesh-list
82882936|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82882937|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82882938|NCT05683574|Etoricoxib|etoricoxib|mesh-list
82882939|NCT05683574|Amitriptyline|amitriptyline|mesh-list
82882940|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
82882941|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82882942|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82882943|NCT05683574|Analgesics|analgesics|mesh-ancestor
82882944|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
82882945|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882946|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882947|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82882948|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882949|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82882950|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82882951|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82882952|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882953|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82882954|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
82882955|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82882956|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82882957|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82882958|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82882959|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82882960|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82882961|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82882962|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82882963|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
82882964|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82882965|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
82882966|NCT05681780|Nivolumab|nivolumab|mesh-list
82882967|NCT05681780|Fludarabine|fludarabine|mesh-list
82882968|NCT05681780|Interleukin-2|interleukin-2|mesh-list
82882969|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882970|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
82882971|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882973|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82882974|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
82882975|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882976|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882977|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82882978|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82882979|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82882980|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82882981|NCT05681780|Analgesics|analgesics|mesh-ancestor
82882982|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
82882983|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82882984|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
82882985|NCT05678205|Fludarabine|fludarabine|mesh-list
82882986|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82882987|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
82882988|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82882989|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82882990|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82882991|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
82882992|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82882993|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882994|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82882995|NCT05673811|Paclitaxel|paclitaxel|mesh-list
82882996|NCT05673811|Gemcitabine|gemcitabine|mesh-list
82882997|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82882998|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82882999|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
82883000|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
82883001|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
82883002|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883003|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883004|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
82883005|NCT05671562|Lycopene|lycopene|mesh-list
82883006|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883007|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
82883008|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883009|NCT05671562|Protective Agents|protective agents|mesh-ancestor
82883010|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883011|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82883012|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82883013|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883014|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
82883015|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883016|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883017|NCT05669846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883018|NCT05669846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883019|NCT05665699|Allopurinol|allopurinol|mesh-list
82883020|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
82883021|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883022|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883023|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
82883024|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883025|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82883026|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
82883027|NCT05665699|Protective Agents|protective agents|mesh-ancestor
82883028|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883029|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82883030|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82883031|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883032|NCT05654818|Vitamin D|vitamin d|mesh-list
82883033|NCT05654818|Vitamins|vitamins|mesh-ancestor
82883034|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
82883035|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883036|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82883037|NCT05648006|Bevacizumab|bevacizumab|mesh-list
82883038|NCT05648006|Capecitabine|capecitabine|mesh-list
82883039|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883040|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883041|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82883042|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82883043|NCT05648006|Growth Substances|growth substances|mesh-ancestor
82883044|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883046|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82724287|NCT00864526|Ibuprofen|ibuprofen|mesh-list
82883048|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883049|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82883050|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82883051|NCT05645406|Estradiol|estradiol|mesh-list
82883052|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82883053|NCT05645406|Estrogens|estrogens|mesh-ancestor
82883054|NCT05645406|Hormones|hormones|mesh-ancestor
82883055|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883056|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883057|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82883058|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
82883059|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82883060|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82883061|NCT05645393|Estrogens|estrogens|mesh-list
82883062|NCT05645393|Hormones|hormones|mesh-ancestor
82883063|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883064|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883065|NCT05636787|Melphalan|melphalan|mesh-list
82883066|NCT05636787|Treosulfan|treosulfan|mesh-list
82883067|NCT05636787|Busulfan|busulfan|mesh-list
82883068|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82883069|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
82883070|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883071|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883072|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82883073|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82883074|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
82883075|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883076|NCT05634525|Adagrasib|adagrasib|mesh-list
82883077|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883078|NCT05634369|Dexamethasone|dexamethasone|mesh-list
82883079|NCT05634369|Gemcitabine|gemcitabine|mesh-list
82883080|NCT05634369|Docetaxel|docetaxel|mesh-list
82883081|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883082|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
82883083|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
82883084|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883085|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883086|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883087|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
82883088|NCT05634369|Hormones|hormones|mesh-ancestor
82883089|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883090|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82883091|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883092|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883093|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883094|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
82883095|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
82883096|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
82883097|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
82883098|NCT05633667|Paclitaxel|paclitaxel|mesh-list
82883099|NCT05633667|Docetaxel|docetaxel|mesh-list
82883100|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82883101|NCT05633667|Carboplatin|carboplatin|mesh-list
82883102|NCT05633667|Pemetrexed|pemetrexed|mesh-list
82883103|NCT05633667|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
82883104|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82883105|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883106|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
82883107|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
82883108|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
82883109|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883110|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883111|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82883112|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82883113|NCT05633667|Immunoconjugates|immunoconjugates|mesh-ancestor
82883114|NCT05633667|Immunologic Factors|immunologic factors|mesh-ancestor
82883115|NCT05633667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883116|NCT05630859|Vaccines|vaccines|mesh-list
82883117|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
82883118|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883119|NCT05613205|Vaccines|vaccines|mesh-list
82883121|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
82883122|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883123|NCT05613205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82883124|NCT05589181|Buprenorphine|buprenorphine|mesh-list
82883125|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82883126|NCT05589181|Narcotics|narcotics|mesh-ancestor
82883127|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883128|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883129|NCT05589181|Analgesics|analgesics|mesh-ancestor
82883130|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
82883131|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883132|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82883133|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82883134|NCT05584137|Antibodies|antibodies|mesh-list
82883135|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
82883136|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82883137|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
82883138|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883139|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883140|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
82883141|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
82883142|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82883143|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883144|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883145|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883146|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82883147|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82883148|NCT05561673|Vaccines|vaccines|mesh-list
82883149|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
82883150|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883151|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82883152|NCT05561673|Antacids|antacids|mesh-ancestor
82883153|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883154|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883155|NCT05550714|Anesthetics|anesthetics|mesh-list
82883156|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883157|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883158|NCT05542264|Olanzapine|olanzapine|mesh-list
82883159|NCT05542264|Risperidone|risperidone|mesh-list
82883160|NCT05542264|Aripiprazole|aripiprazole|mesh-list
82883161|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82883162|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
82883163|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82883164|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
82883165|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883166|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883167|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883168|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82883169|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883170|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82883171|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82883172|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
82883173|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
82883174|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
82883175|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883176|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883177|NCT05542264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82883178|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82883179|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82883180|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
82883181|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
82883182|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82883183|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82883184|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82883185|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82883186|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
82883187|NCT05523323|Lenvatinib|lenvatinib|mesh-list
82883188|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883189|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883190|NCT05523323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883191|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883192|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82883193|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883194|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
82883195|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82883196|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
82883197|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883198|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883199|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82883200|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
82883202|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
82883203|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883204|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883205|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82883206|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
82883207|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
82883208|NCT05505617|Protective Agents|protective agents|mesh-ancestor
82883209|NCT05487040|Ritonavir|ritonavir|mesh-list
82883210|NCT05487040|Nirmatrelvir|nirmatrelvir|mesh-list
82883211|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82883212|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82883213|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
82883214|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883215|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883216|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82883217|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82883218|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
82883219|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883220|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82883221|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82883222|NCT05484466|Entecavir|entecavir|mesh-list
82883223|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
82883224|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883225|NCT05479045|Nivolumab|nivolumab|mesh-list
82883226|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883227|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883228|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883229|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883230|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
82883231|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82883232|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
82883233|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883234|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82883235|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
82883236|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82883237|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883238|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883239|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82883240|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82883241|NCT05429502|Temozolomide|temozolomide|mesh-list
82883242|NCT05429502|Topotecan|topotecan|mesh-list
82883243|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82883244|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
82883245|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883246|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883247|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82883248|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82883249|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883250|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82883251|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
82883252|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883253|NCT05402111|Olanzapine|olanzapine|mesh-list
82883254|NCT05402111|Risperidone|risperidone|mesh-list
82883255|NCT05402111|Aripiprazole|aripiprazole|mesh-list
82883256|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82883257|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
82883258|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82883259|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
82883260|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883261|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883262|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883263|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82883264|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883265|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82883266|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82883267|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
82883268|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
82883269|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
82883270|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883271|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883272|NCT05402111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82883273|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83513382|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
82883274|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82883276|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
82883277|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82883278|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82883279|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82883280|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82883281|NCT05399550|Balovaptan|balovaptan|mesh-list
82883282|NCT05399550|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82883283|NCT05399550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883284|NCT05399550|Natriuretic Agents|natriuretic agents|mesh-ancestor
82883285|NCT05399550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883286|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82883287|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
82883288|NCT05399173|Coagulants|coagulants|mesh-ancestor
82883289|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82883290|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
82883291|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883292|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
82883293|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883294|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82883295|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883296|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883297|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
82883298|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883299|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883300|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82883301|NCT05388773|Carboplatin|carboplatin|mesh-list
82883302|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883303|NCT05383521|Tinidazole|tinidazole|mesh-list
82883304|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
82883305|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883306|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82883307|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883308|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82883309|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82883310|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82883311|NCT05374538|Sotorasib|sotorasib|mesh-list
82883312|NCT05374538|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883313|NCT05374538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883314|NCT05374538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883315|NCT05374538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883316|NCT05369832|Ozanimod|ozanimod|mesh-list
82883317|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82883318|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883319|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82883320|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
82883321|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883322|NCT05369052|Linezolid|linezolid|mesh-list
82883323|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82883324|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883325|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82883326|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883327|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883328|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
82883329|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883330|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
82883331|NCT05359211|Fludarabine|fludarabine|mesh-list
82883332|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82883333|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
82883334|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883335|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883336|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82883337|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
82883338|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883339|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883350|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
82883351|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883352|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883353|NCT05356741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83513383|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
82883354|NCT05356741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883355|NCT05349474|Metformin|metformin|mesh-list
82883356|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82883357|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883358|NCT05343481|Nivolumab|nivolumab|mesh-list
82883359|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883360|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883361|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883362|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883363|NCT05340764|Infliximab|infliximab|mesh-list
82883364|NCT05340764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82883365|NCT05340764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883366|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
82883367|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883368|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883369|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
82883370|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82883371|NCT05327361|Protective Agents|protective agents|mesh-ancestor
82883372|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883373|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
82883374|NCT05305989|Belumosudil|belumosudil|mesh-list
82883375|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82883376|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883377|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883378|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82883379|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883380|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
82883381|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82883382|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82883383|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883384|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
82883385|NCT05302986|Coagulants|coagulants|mesh-ancestor
82883386|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
82883387|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82883388|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
82883389|NCT05300451|Daratumumab|daratumumab|mesh-list
82883390|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883391|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
82883392|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
82883393|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82883394|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82883395|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883396|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883397|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883398|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883399|NCT05285904|Ofatumumab|ofatumumab|mesh-list
82883400|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883410|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
82883411|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82883412|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883413|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883414|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82883416|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
82883417|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883418|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82883419|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82883420|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82883421|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
82883422|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883423|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883424|NCT05263206|Loratadine|loratadine|mesh-list
82883425|NCT05263206|Fexofenadine|fexofenadine|mesh-list
82883426|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
82883427|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
82883428|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82883429|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82883430|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82883431|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
82883432|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
82883433|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883434|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883435|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883436|NCT05262855|FAPI-46|fapi-46|mesh-list
82883437|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83482844|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883438|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883440|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
82883441|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
82883442|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883443|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883444|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
82883445|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883446|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82883447|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82883448|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82883449|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82883450|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883451|NCT05260528|Cytarabine|cytarabine|mesh-list
82883452|NCT05260528|Idarubicin|idarubicin|mesh-list
82883453|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883454|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
82883455|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883456|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883457|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
82883458|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883459|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82883460|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
82883461|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883462|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82883463|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82883464|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82883465|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883466|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
82883467|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82883468|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82883469|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883470|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
82883471|NCT05248321|Coagulants|coagulants|mesh-ancestor
82883472|NCT05241093|Cytarabine|cytarabine|mesh-list
82883473|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883474|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
82883475|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883476|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883477|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
82883478|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883479|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82883480|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
82883481|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883482|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
82883483|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883484|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883485|NCT05239624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883486|NCT05239624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883487|NCT05233163|Empagliflozin|empagliflozin|mesh-list
82883499|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82883500|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82883501|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
82883502|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883503|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82883504|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82883517|NCT05214911|Loratadine|loratadine|mesh-list
82883518|NCT05214911|Prednisolone|prednisolone|mesh-list
82883519|NCT05214911|Desloratadine|desloratadine|mesh-list
82883520|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883521|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
82883522|NCT05214911|Hormones|hormones|mesh-ancestor
82883523|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883524|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883525|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82883526|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883527|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82883528|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
82883529|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883530|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883531|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82883532|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83482845|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
82883533|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
82883534|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
82883535|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
82883536|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
82883537|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82883538|NCT05213884|Cisplatin|cisplatin|mesh-list
82883539|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883540|NCT05211336|Prednisone|prednisone|mesh-list
82883541|NCT05211336|Lenalidomide|lenalidomide|mesh-list
82883542|NCT05211336|Venetoclax|venetoclax|mesh-list
82883543|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
82883544|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883545|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
82883546|NCT05211336|Hormones|hormones|mesh-ancestor
82883547|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883548|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883549|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82883550|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883551|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
82883552|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82883553|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82883554|NCT05211336|Growth Substances|growth substances|mesh-ancestor
82883555|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
82883556|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883557|NCT05211024|Penicillins|penicillins|mesh-list
82883558|NCT05211024|Penicillin G|penicillin g|mesh-list
82883559|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
82883560|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
82883561|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82883562|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883563|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82883565|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883566|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
82883567|NCT05209984|Topiramate|topiramate|mesh-list
82883568|NCT05209984|Sibutramine|sibutramine|mesh-list
82883569|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
82883570|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82883571|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883572|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
82883573|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82883574|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
82883575|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82883576|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
82883577|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883578|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883579|NCT05204290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883580|NCT05204290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883581|NCT05199311|Dexamethasone|dexamethasone|mesh-list
82883582|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883583|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
82883584|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
82883585|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883586|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883587|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883588|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
82883589|NCT05199311|Hormones|hormones|mesh-ancestor
82883590|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883591|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82883592|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883593|NCT05183854|Vaccines|vaccines|mesh-list
82883594|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82883595|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
82883596|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883597|NCT05179005|Imidacloprid|imidacloprid|mesh-list
82883598|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
82883599|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883600|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883601|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883602|NCT05176951|Treprostinil|treprostinil|mesh-list
82883603|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82883604|NCT05176080|Fulvestrant|fulvestrant|mesh-list
82883605|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82883606|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883607|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82883608|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82883609|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
82883610|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883611|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883612|NCT05165082|Timolol|timolol|mesh-list
82883613|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82883614|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82883615|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883616|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82883617|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82883618|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
82883619|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883620|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883621|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82883622|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82883623|NCT05159531|Tenofovir|tenofovir|mesh-list
82883624|NCT05159531|Emtricitabine|emtricitabine|mesh-list
82883625|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
82883626|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883627|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82883628|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82883629|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883630|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883631|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82883632|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82883633|NCT05141149|Gemcitabine|gemcitabine|mesh-list
82883634|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883635|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
82883636|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883646|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
82883647|NCT05132504|Folfirinox|folfirinox|mesh-list
82883648|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883649|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883650|NCT05132504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883651|NCT05132504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883652|NCT05128071|Progesterone|progesterone|mesh-list
82883653|NCT05128071|Progestins|progestins|mesh-ancestor
82883654|NCT05128071|Hormones|hormones|mesh-ancestor
82883655|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883656|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883666|NCT05121324|Midazolam|midazolam|mesh-list
82883667|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82883668|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82883669|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883670|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883671|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82883672|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82883673|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82883674|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82883675|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
82883676|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
82883677|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
82883678|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
82883679|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883680|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883681|NCT05118672|Acetaminophen|acetaminophen|mesh-list
82883682|NCT05118672|Fexofenadine|fexofenadine|mesh-list
82883683|NCT05118672|Phenylephrine|phenylephrine|mesh-list
82883684|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
82883685|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82883686|NCT05118672|Analgesics|analgesics|mesh-ancestor
82883687|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
82883688|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883689|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883690|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
82883691|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82883692|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
82883693|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
82883694|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
82883695|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82883696|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
82883697|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
82883698|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82883699|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82883700|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82883701|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
82883702|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883703|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883704|NCT05118672|Protective Agents|protective agents|mesh-ancestor
82883705|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82883706|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82883707|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82883708|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
82883709|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
82883711|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
82883712|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82883713|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
82883714|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82883715|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883716|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
82883717|NCT05114096|Hormones|hormones|mesh-ancestor
82883718|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883719|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883720|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82883721|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
82883722|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
82883723|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82883724|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
82883725|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883726|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883727|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82883728|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
82883729|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82883730|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
82883731|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883732|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883733|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82883734|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
82883735|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
82883736|NCT05109611|Protective Agents|protective agents|mesh-ancestor
82883737|NCT05106153|Zolpidem|zolpidem|mesh-list
82883738|NCT05106153|Suvorexant|suvorexant|mesh-list
82883739|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82883740|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82883741|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883742|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883743|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82883744|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
82883745|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
82883746|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883747|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883748|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82883749|NCT05102591|Ketorolac|ketorolac|mesh-list
82883750|NCT05102591|Metoclopramide|metoclopramide|mesh-list
82883751|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82883752|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82883753|NCT05102591|Analgesics|analgesics|mesh-ancestor
82883754|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
82883755|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883756|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883757|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883758|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883759|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82883760|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883761|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883762|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
82883763|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
82883764|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883765|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82883766|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82883767|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
82883768|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883769|NCT05097326|Misoprostol|misoprostol|mesh-list
82883770|NCT05097326|Mifepristone|mifepristone|mesh-list
82883771|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82883772|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
82883773|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82883774|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883775|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82883776|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82883777|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
82883778|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82724967|NCT05740488|Hormones|hormones|mesh-list
82883779|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82883780|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82883781|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82883782|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
82883783|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82883784|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82883785|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
82883786|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883788|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82883789|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82883790|NCT05081492|Antibodies|antibodies|mesh-list
82883791|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
82883792|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
82883793|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883794|NCT05081102|Ibuprofen|ibuprofen|mesh-list
82883795|NCT05081102|Oxycodone|oxycodone|mesh-list
82883796|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82883797|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82883798|NCT05081102|Analgesics|analgesics|mesh-ancestor
82883799|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
82883800|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883801|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883802|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883803|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883804|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82883805|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883806|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883807|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82883808|NCT05081102|Narcotics|narcotics|mesh-ancestor
82883809|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883810|NCT05074992|Ipilimumab|ipilimumab|mesh-list
82883811|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883812|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883813|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883814|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883815|NCT05070403|Afatinib|afatinib|mesh-list
82883816|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883817|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82883818|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883819|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883820|NCT05064085|Capecitabine|capecitabine|mesh-list
82883821|NCT05064085|Cemiplimab|cemiplimab|mesh-list
82883822|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883823|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
82883824|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883825|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883826|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883827|NCT05063656|Gabapentin|gabapentin|mesh-list
82883828|NCT05063656|Analgesics|analgesics|mesh-ancestor
82883829|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
82883830|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883831|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883832|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
82883833|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82883834|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82883835|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883836|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82883837|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82883838|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82883839|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883840|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883841|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
82883842|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82883843|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82883844|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
82883845|NCT05053087|Ropivacaine|ropivacaine|mesh-list
82883846|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
82883847|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
82883848|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883849|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883850|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
82883851|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883852|NCT05047601|Ritonavir|ritonavir|mesh-list
82883853|NCT05047601|Nirmatrelvir|nirmatrelvir|mesh-list
82883854|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82883855|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82883856|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
82883857|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883858|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883859|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82883860|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82883863|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82883864|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82883865|NCT05043506|Palbociclib|palbociclib|mesh-list
82883866|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82883867|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883868|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82883869|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883870|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883871|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82883872|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82883873|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
82883874|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82883875|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883876|NCT05030311|Remibrutinib|remibrutinib|mesh-list
82883877|NCT05030311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82883878|NCT05030311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883879|NCT05030311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883882|NCT05026606|Nivolumab|nivolumab|mesh-list
82883883|NCT05026606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883884|NCT05026606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883885|NCT05026606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883886|NCT05026606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883887|NCT05022329|Vaccines|vaccines|mesh-list
82883888|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
82883889|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883890|NCT05012371|Everolimus|everolimus|mesh-list
82883891|NCT05012371|Lenvatinib|lenvatinib|mesh-list
82883892|NCT05012371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82883893|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82883894|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883895|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883896|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82883897|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
82883898|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883899|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883900|NCT05011760|Amphetamine|amphetamine|mesh-list
82883901|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
82883902|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82883903|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883904|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
82883905|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
82883906|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883907|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
82883908|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82883909|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883910|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
82883911|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82883912|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82883913|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82883914|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82883915|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
82883916|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82883917|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82883918|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82883919|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883920|NCT05006599|Insulin|insulin|mesh-list
82883921|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82883922|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82883923|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883924|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
82883925|NCT05000216|Methotrexate|methotrexate|mesh-list
82883926|NCT05000216|Vaccines|vaccines|mesh-list
82883927|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82883928|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
82883929|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883930|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82883931|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
82883933|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883934|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
82883936|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883937|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
82883938|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883939|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82883940|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883941|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82883942|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82883943|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82883944|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
82883945|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82883946|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883947|NCT04998669|Rituximab|rituximab|mesh-list
82883948|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82883949|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883950|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883951|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
82883952|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883953|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883954|NCT04998604|Omalizumab|omalizumab|mesh-list
82883955|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82883956|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82883957|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
82883958|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
82883959|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883960|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
82883961|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82883962|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82883963|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
82883964|NCT04975919|Decitabine|decitabine|mesh-list
82883965|NCT04975919|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82883966|NCT04975919|Venetoclax|venetoclax|mesh-list
82883967|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82883968|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
82883969|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883970|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883971|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82883972|NCT04972292|Dipyrone|dipyrone|mesh-list
82883973|NCT04972292|Codeine|codeine|mesh-list
82883974|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82883975|NCT04972292|Narcotics|narcotics|mesh-ancestor
82883976|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82883977|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883978|NCT04972292|Analgesics|analgesics|mesh-ancestor
83454343|NCT03020329|Paclitaxel|paclitaxel|mesh-list
82883979|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
82883980|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82883981|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
82883982|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
82883983|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82883984|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82883985|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82883986|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82883987|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
82883988|NCT04958811|Bevacizumab|bevacizumab|mesh-list
82883989|NCT04958811|Atezolizumab|atezolizumab|mesh-list
82883990|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82883991|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82883992|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82883993|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82883994|NCT04958811|Growth Substances|growth substances|mesh-ancestor
82883995|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82883996|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
82883997|NCT04958811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82883998|NCT04958811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82883999|NCT04950530|Emtricitabine|emtricitabine|mesh-list
82884000|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
82884001|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884002|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82884003|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82884004|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884005|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884006|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82884007|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82884011|NCT04937699|Aspirin|aspirin|mesh-list
82884012|NCT04937699|Clopidogrel|clopidogrel|mesh-list
82884013|NCT04937699|Ticagrelor|ticagrelor|mesh-list
82884014|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82884015|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82884016|NCT04937699|Analgesics|analgesics|mesh-ancestor
82884017|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
82884018|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884019|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884020|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884021|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884022|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82884023|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82884024|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884025|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82884026|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82884027|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884028|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
82884029|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82884030|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82884031|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82884032|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
82884033|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884034|NCT04925375|Abatacept|abatacept|mesh-list
82884035|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884036|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884037|NCT04925375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884038|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884039|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82884040|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
82884041|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884042|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884043|NCT04920708|Fulvestrant|fulvestrant|mesh-list
82884044|NCT04920708|Palbociclib|palbociclib|mesh-list
82884045|NCT04920708|Ipatasertib|ipatasertib|mesh-list
82884046|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82884047|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884048|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82884049|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82884050|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
82884051|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884052|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884053|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82884054|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884055|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884056|NCT04908956|Osimertinib|osimertinib|mesh-list
82884057|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884058|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82884059|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884060|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884061|NCT04891068|Azacitidine|azacitidine|mesh-list
82884062|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82884063|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
82884064|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884065|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884066|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884067|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
82884068|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884069|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884070|NCT04885530|Fluticasone|fluticasone|mesh-list
82884072|NCT04885530|Ivermectin|ivermectin|mesh-list
82884073|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
82884074|NCT04885530|Montelukast|montelukast|mesh-list
82884075|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884076|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82884077|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
82884078|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884079|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884080|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82884081|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
82884082|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
82884083|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82884084|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82884085|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
82884086|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884087|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82884088|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82884089|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884090|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884091|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82884092|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884093|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82884094|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82884095|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884096|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82884097|NCT04885530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82884098|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82884099|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82884100|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884101|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
82884102|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82884103|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
82884104|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82884105|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82884106|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82884107|NCT04883645|Imiquimod|imiquimod|mesh-list
82884108|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82884109|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
82884110|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884111|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884112|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
82884113|NCT04880499|Folic Acid|folic acid|mesh-list
82884114|NCT04880499|Riboflavin|riboflavin|mesh-list
82884115|NCT04880499|Vitamins|vitamins|mesh-ancestor
82884116|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
82884117|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884118|NCT04880499|Hematinics|hematinics|mesh-ancestor
82884119|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
82884120|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82884121|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
82884122|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
82884123|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884124|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884125|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82884126|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
82884127|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82884128|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
82884129|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
82884130|NCT04852484|Ketamine|ketamine|mesh-list
82884131|NCT04852484|Morphine|morphine|mesh-list
82884132|NCT04852484|Anesthetics|anesthetics|mesh-list
82884133|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
82884134|NCT04852484|Analgesics|analgesics|mesh-ancestor
82884135|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
82884136|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884137|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884138|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82884139|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82884140|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
82884141|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884142|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82884143|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82884144|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884145|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884146|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82884147|NCT04852484|Narcotics|narcotics|mesh-ancestor
82884148|NCT04848480|Insulin|insulin|mesh-list
82884149|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82884150|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
82884151|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82884152|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884153|NCT04840589|Nivolumab|nivolumab|mesh-list
82884154|NCT04840589|Ipilimumab|ipilimumab|mesh-list
82884155|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884156|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884157|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884158|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884160|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
82884162|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884163|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884164|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
82884165|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884166|NCT04835805|Nivolumab|nivolumab|mesh-list
82884167|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884168|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884169|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884170|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884171|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
82884172|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
82884173|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884174|NCT04827147|Methamphetamine|methamphetamine|mesh-list
82884175|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82884176|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884177|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
82884178|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
82884179|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884180|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
82884181|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884182|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884183|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
82884184|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82884185|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82884186|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82884187|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82884188|NCT04808505|Miglustat|miglustat|mesh-list
82884189|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884190|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884191|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82884192|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82884193|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
82884194|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884195|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82884196|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82884197|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884198|NCT04786873|Clonidine|clonidine|mesh-list
82884199|NCT04786873|Analgesics|analgesics|mesh-ancestor
82884200|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
82884201|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884202|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884203|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82884204|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
82884205|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
82884206|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82884207|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82884208|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82884209|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
82884210|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884211|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884212|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82884213|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82884214|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884215|NCT04771728|Metronidazole|metronidazole|mesh-list
82884216|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884217|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82884218|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82884219|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82884220|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
82884221|NCT04767074|Guaifenesin|guaifenesin|mesh-list
82884222|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82884223|NCT04767074|Expectorants|expectorants|mesh-ancestor
82884224|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
82884225|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82884226|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82884227|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
82884228|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884229|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884230|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884231|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
82725419|NCT00885586|Gabapentin|gabapentin|mesh-list
82884232|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82884233|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
82884234|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
82884235|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884236|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
82884237|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82884238|NCT04764942|Dexamethasone|dexamethasone|mesh-list
82884239|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
82884240|NCT04764942|Pomalidomide|pomalidomide|mesh-list
82884241|NCT04764942|Ichthammol|ichthammol|mesh-list
82884242|NCT04764942|BB 1101|bb 1101|mesh-list
82884243|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884244|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
82884245|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
82884246|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884247|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884248|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82884249|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
82884250|NCT04764942|Hormones|hormones|mesh-ancestor
82884251|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884252|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82884253|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884254|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
82884255|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884256|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884257|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
82884258|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82884259|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82884260|NCT04764942|Growth Substances|growth substances|mesh-ancestor
82884261|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
82884262|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
82884263|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
82884264|NCT04761614|Leucovorin|leucovorin|mesh-list
82884265|NCT04761614|Folic Acid|folic acid|mesh-list
82884266|NCT04761614|Bevacizumab|bevacizumab|mesh-list
82884267|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82884268|NCT04761614|Fluorouracil|fluorouracil|mesh-list
82884269|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
82884270|NCT04761614|Riluzole|riluzole|mesh-list
82884271|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
82884272|NCT04761614|Antibodies|antibodies|mesh-list
82884273|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
82884274|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82884275|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
82884276|NCT04761614|Calcium|calcium|mesh-list
82884277|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
82884278|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884279|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82884280|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82884281|NCT04761614|Growth Substances|growth substances|mesh-ancestor
82884282|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884283|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
82884284|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
82884285|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82884286|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82884287|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
82884288|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884289|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82884290|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82884291|NCT04761614|Antidotes|antidotes|mesh-ancestor
82884292|NCT04761614|Protective Agents|protective agents|mesh-ancestor
82884293|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
82884294|NCT04761614|Vitamins|vitamins|mesh-ancestor
82884295|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
82884296|NCT04761614|Hematinics|hematinics|mesh-ancestor
82884297|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
82884298|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82884299|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82884300|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884301|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82884302|NCT04760860|Prazosin|prazosin|mesh-list
82884303|NCT04760860|Terazosin|terazosin|mesh-list
82884304|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82884305|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82884306|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82884307|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
82884309|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884310|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884311|NCT04760860|Urological Agents|urological agents|mesh-ancestor
82884312|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82884313|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
82884314|NCT04756063|Vitamins|vitamins|mesh-ancestor
82884315|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
82884316|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884317|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
82884318|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884319|NCT04756063|Protective Agents|protective agents|mesh-ancestor
82884320|NCT04749108|Folfirinox|folfirinox|mesh-list
82884321|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884322|NCT04729114|Dexamethasone|dexamethasone|mesh-list
82884323|NCT04729114|Prednisone|prednisone|mesh-list
82884324|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884325|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
82884326|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
82884327|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884328|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884329|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82884330|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
82884331|NCT04729114|Hormones|hormones|mesh-ancestor
82884332|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884333|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82884334|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884335|NCT04710199|Maraviroc|maraviroc|mesh-list
82884336|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82884337|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82884338|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884339|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82884340|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82884341|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
82884342|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884343|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82884344|NCT04700176|Dexamethasone|dexamethasone|mesh-list
82884345|NCT04700176|Daratumumab|daratumumab|mesh-list
82884346|NCT04700176|Pomalidomide|pomalidomide|mesh-list
82884347|NCT04700176|Tretinoin|tretinoin|mesh-list
82884348|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884349|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
82884350|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
82884351|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884352|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884353|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82884354|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
82884355|NCT04700176|Hormones|hormones|mesh-ancestor
82884356|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884357|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82884358|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884359|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
82884360|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82884361|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82884362|NCT04700176|Growth Substances|growth substances|mesh-ancestor
82884363|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
82884364|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
82884365|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
82884366|NCT04699240|Clotrimazole|clotrimazole|mesh-list
82884367|NCT04699240|Miconazole|miconazole|mesh-list
82884368|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82884369|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884370|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
82884371|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82884372|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82884373|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884374|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884375|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82884376|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
82884377|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884378|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884379|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82884380|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82884381|NCT04688658|Nivolumab|nivolumab|mesh-list
82884382|NCT04688658|Axitinib|axitinib|mesh-list
82884383|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884384|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884385|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884386|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482846|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
82884387|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82884388|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884389|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82884390|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
82884391|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884392|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
82884393|NCT04673617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82884394|NCT04673617|Rituximab|rituximab|mesh-list
82884395|NCT04673617|Fludarabine|fludarabine|mesh-list
82884396|NCT04673617|Interleukin-2|interleukin-2|mesh-list
82884397|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82884398|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
82884399|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884400|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884401|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82884402|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
82884403|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884404|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884405|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82884406|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884407|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82884408|NCT04673617|Analgesics|analgesics|mesh-ancestor
82884409|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
82884410|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884411|NCT04666454|Adenosine|adenosine|mesh-list
82884412|NCT04666454|Dipyridamole|dipyridamole|mesh-list
82884413|NCT04666454|Apixaban|apixaban|mesh-list
82884414|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82884415|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
82884416|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82884417|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
82884418|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884419|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884420|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
82884421|NCT04666454|Analgesics|analgesics|mesh-ancestor
82884422|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
82884423|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884424|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884425|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82884426|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
82884427|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82884428|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
82884429|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
82884430|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884431|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82884432|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82884433|NCT04666038|Rituximab|rituximab|mesh-list
82884434|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82884435|NCT04666038|Idelalisib|idelalisib|mesh-list
82884436|NCT04666038|Pirtobrutinib|pirtobrutinib|mesh-list
82884437|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884438|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884439|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
82884440|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884441|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884442|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82884443|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
82884444|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884445|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884446|NCT04666038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82884447|NCT04665856|Carboplatin|carboplatin|mesh-list
82884448|NCT04665856|Etoposide|etoposide|mesh-list
82884449|NCT04665856|Atezolizumab|atezolizumab|mesh-list
82884450|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884451|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82884452|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82884453|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82884454|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884455|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884456|NCT04665856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884457|NCT04665856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884461|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884462|NCT04657640|Iron|iron|mesh-list
82884463|NCT04657640|Trace Elements|trace elements|mesh-list
82884464|NCT04657640|Folic Acid|folic acid|mesh-list
82884465|NCT04657640|Micronutrients|micronutrients|mesh-list
82884466|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
82884467|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884468|NCT04657640|Hematinics|hematinics|mesh-ancestor
82884469|NCT04657640|Vitamins|vitamins|mesh-ancestor
82884470|NCT04650893|Dexamethasone|dexamethasone|mesh-list
82884471|NCT04650893|Ketorolac|ketorolac|mesh-list
82884472|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884473|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
82884474|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
82884475|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884476|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884477|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82884478|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
82884479|NCT04650893|Hormones|hormones|mesh-ancestor
82884480|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884481|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82884482|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884483|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82884484|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82884485|NCT04650893|Analgesics|analgesics|mesh-ancestor
82884486|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
82884487|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884488|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82884489|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884490|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884491|NCT04622813|Acetaminophen|acetaminophen|mesh-list
82884492|NCT04622813|Ketoprofen|ketoprofen|mesh-list
82884493|NCT04622813|Nefopam|nefopam|mesh-list
82884494|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82884495|NCT04622813|Analgesics|analgesics|mesh-ancestor
82884496|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
82884497|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884498|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884499|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
82884500|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82884501|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884502|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884503|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82884504|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884505|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884506|NCT04616963|Tenofovir|tenofovir|mesh-list
82884507|NCT04616963|Emtricitabine|emtricitabine|mesh-list
82884508|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82884509|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
82884510|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884511|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82884512|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82884513|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884514|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884515|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82884516|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82884517|NCT04606394|Albuterol|albuterol|mesh-list
82884518|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82884519|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
82884520|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884521|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884522|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82884523|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
82884524|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
82884525|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82884526|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82884527|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82884528|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82884529|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
82884530|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884531|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884569|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
82884570|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884571|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884572|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82884573|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
82884574|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884575|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884576|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82884577|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82884578|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
82884580|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
82884581|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884582|NCT04579120|Corticosterone|corticosterone|mesh-list
82884583|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884600|NCT04565990|Selexipag|selexipag|mesh-list
82884601|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82884602|NCT04564547|Islatravir|islatravir|mesh-list
82884603|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
82884604|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884605|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884606|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884607|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82884608|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82884624|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884625|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884626|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884627|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884644|NCT04550442|Azacitidine|azacitidine|mesh-list
82884645|NCT04550442|Venetoclax|venetoclax|mesh-list
82884646|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82884647|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
82884648|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884649|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884650|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884651|NCT04543383|Thrombin|thrombin|mesh-list
82884652|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
82884653|NCT04543383|Coagulants|coagulants|mesh-ancestor
82884654|NCT04527900|Paclitaxel|paclitaxel|mesh-list
82884655|NCT04527900|Carboplatin|carboplatin|mesh-list
82884656|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82884657|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884658|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
82884659|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
82884660|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
82884661|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884669|NCT04549168|Lemborexant|lemborexant|mesh-list
82884670|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82884671|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884672|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884673|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82884674|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82884675|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884676|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884677|NCT04509050|Ivacaftor|ivacaftor|mesh-list
82884678|NCT04509050|Elexacaftor|elexacaftor|mesh-list
82884679|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82884680|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82884681|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884682|NCT04499248|Bimatoprost|bimatoprost|mesh-list
82884683|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82884688|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
82884689|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884693|NCT04459117|Acetaminophen|acetaminophen|mesh-list
82884694|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82884695|NCT04459117|Analgesics|analgesics|mesh-ancestor
82884696|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
82884697|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884698|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884699|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
82884700|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
82884701|NCT04456439|Promethazine|promethazine|mesh-list
82884702|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
82884703|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
82884704|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884705|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82884706|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82884707|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884708|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884709|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
82884710|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
82884711|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
82884712|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884713|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
82884714|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
82884715|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82884716|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82884717|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
82884718|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
82884719|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884720|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884721|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82884722|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
82884723|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
82884724|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
82884725|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884726|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
82884727|NCT04445714|Saxagliptin|saxagliptin|mesh-list
82884728|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82884729|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884730|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82884731|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884732|NCT04445714|Incretins|incretins|mesh-ancestor
82884733|NCT04445714|Hormones|hormones|mesh-ancestor
82884734|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884735|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82884736|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
82884737|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884738|NCT04435704|Oxytocin|oxytocin|mesh-list
82884739|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
82884740|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82884741|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884742|NCT04433741|Oxytocin|oxytocin|mesh-list
82884743|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
82884744|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82884745|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884746|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82884747|NCT04431206|Oxytocin|oxytocin|mesh-list
82884748|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
82884749|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82884750|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884751|NCT04427709|Oxytocin|oxytocin|mesh-list
82884752|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
82884753|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82884754|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884755|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
82884756|NCT04415476|Sirolimus|sirolimus|mesh-list
82884757|NCT04415476|Prednisone|prednisone|mesh-list
82884758|NCT04415476|Tacrolimus|tacrolimus|mesh-list
82884759|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884760|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
82884761|NCT04415476|Hormones|hormones|mesh-ancestor
82884762|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884764|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82884765|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884766|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82884768|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82884769|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884770|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884771|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82884772|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82884773|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
82884774|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82884775|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884776|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
82884777|NCT04394624|Pembrolizumab|pembrolizumab|mesh-list
82884778|NCT04394624|Ramucirumab|ramucirumab|mesh-list
82884779|NCT04394624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884780|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884781|NCT04394624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884782|NCT04394624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884783|NCT04389567|Famotidine|famotidine|mesh-list
82884784|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82884785|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82884786|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82884787|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
82884788|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
82884789|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884790|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884791|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884792|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
82884793|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884794|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884795|NCT04386967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884796|NCT04386967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884797|NCT04384367|Naproxen|naproxen|mesh-list
82884798|NCT04384367|Rizatriptan|rizatriptan|mesh-list
82884799|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82884800|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82884801|NCT04384367|Analgesics|analgesics|mesh-ancestor
82884802|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
82884803|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884804|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884805|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884806|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884807|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
82884808|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82884809|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884810|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884811|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82884812|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
82884813|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884814|NCT04378933|Methamphetamine|methamphetamine|mesh-list
82884815|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82884816|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884817|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
82884818|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
82884819|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884820|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
82884821|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884822|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884823|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
82884824|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82884825|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82884826|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82884827|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82884830|NCT04341259|Ipatasertib|ipatasertib|mesh-list
82884831|NCT04341259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884832|NCT04341259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82884833|NCT04341259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884834|NCT04341259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884835|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
82884842|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884843|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
82884844|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
82884845|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
82884846|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884847|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82884848|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884850|NCT04323956|Cortisone|cortisone|mesh-list
82884851|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
82884852|NCT04323956|Rituximab|rituximab|mesh-list
82884853|NCT04323956|Doxorubicin|doxorubicin|mesh-list
82884854|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82884855|NCT04323956|Vincristine|vincristine|mesh-list
82884856|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82884857|NCT04323956|Antibodies|antibodies|mesh-list
82884858|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
82884859|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82884860|NCT04323956|Lenograstim|lenograstim|mesh-list
82884861|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
82884862|NCT04323956|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
82884863|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82884864|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
82884865|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884866|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82884867|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82884868|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
82884869|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884870|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884871|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82884872|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82884873|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82884874|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82884875|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884876|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884877|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
82884879|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884880|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82884881|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82884882|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82884883|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
82884884|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
82884885|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
82884886|NCT04321330|Atezolizumab|atezolizumab|mesh-list
82884887|NCT04321330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884888|NCT04321330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884889|NCT04321330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884890|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884891|NCT04318548|Vaccines|vaccines|mesh-list
82884892|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
82884893|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884894|NCT04315233|Belinostat|belinostat|mesh-list
82884895|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884896|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82884897|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884898|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884899|NCT04313088|Eluxadoline|eluxadoline|mesh-list
82884900|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82884907|NCT04310020|Atezolizumab|atezolizumab|mesh-list
82884908|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82884909|NCT04310020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82884910|NCT04310020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884911|NCT04310020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884918|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82884919|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82884920|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884921|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
82884922|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82884923|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884924|NCT04299373|Ethanol|ethanol|mesh-list
82884925|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82884926|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884927|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884928|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884936|NCT04294264|Trifluridine|trifluridine|mesh-list
82884937|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
82884938|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884939|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
82884940|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884941|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
82884942|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82884943|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
82884944|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82884945|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
82884946|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
82884947|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884948|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884949|NCT04250805|Lidocaine|lidocaine|mesh-list
82884950|NCT04250805|Ropivacaine|ropivacaine|mesh-list
82884951|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
82884952|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
82884953|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884954|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884955|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
82884956|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884957|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82884958|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82884959|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82884960|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82884961|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884962|NCT04233190|Budesonide|budesonide|mesh-list
82884963|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
82884964|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82884965|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
82884966|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82884967|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884968|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82884969|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
82884970|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82884972|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82884973|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
82884974|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82884975|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82884976|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82884977|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
82884978|NCT04233190|Hormones|hormones|mesh-ancestor
82884979|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82884980|NCT04230304|Daratumumab|daratumumab|mesh-list
82884981|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884982|NCT04214834|Morphine|morphine|mesh-list
82884983|NCT04214834|Methadone|methadone|mesh-list
82884984|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82884985|NCT04214834|Narcotics|narcotics|mesh-ancestor
82884986|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82884987|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82884993|NCT04161118|Tisagenlecleucel|tisagenlecleucel|mesh-list
82884994|NCT04161118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82884995|NCT04161118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884996|NCT04154956|Docetaxel|docetaxel|mesh-list
82884997|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82884998|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
82884999|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
82885000|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
82885001|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885002|NCT04134884|Talazoparib|talazoparib|mesh-list
82885003|NCT04134884|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82885004|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82885005|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885006|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885007|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885008|NCT04134884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885009|NCT04134884|Antimetabolites|antimetabolites|mesh-ancestor
82885010|NCT04127578|Sirolimus|sirolimus|mesh-list
82885011|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
82885012|NCT04127578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82885013|NCT04127578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82885014|NCT04127578|Prednisolone|prednisolone|mesh-list
82885015|NCT04127578|Prednisolone acetate|prednisolone acetate|mesh-list
82885016|NCT04127578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82885017|NCT04127578|Prednisolone phosphate|prednisolone phosphate|mesh-list
82885018|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82885019|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885020|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82885021|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885022|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
82885023|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885024|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
82885025|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885026|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885027|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
82885028|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
82885029|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885030|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885031|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
82885032|NCT04127578|Hormones|hormones|mesh-ancestor
82885033|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885034|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82885035|NCT04127578|Protective Agents|protective agents|mesh-ancestor
82885036|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885037|NCT04121260|Daratumumab|daratumumab|mesh-list
82885038|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885039|NCT04119037|Morphine|morphine|mesh-list
82885040|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82885041|NCT04119037|Narcotics|narcotics|mesh-ancestor
82885042|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885043|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885044|NCT04119037|Analgesics|analgesics|mesh-ancestor
82885045|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
82885046|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885047|NCT04117087|Nivolumab|nivolumab|mesh-list
82885048|NCT04117087|Ipilimumab|ipilimumab|mesh-list
82885049|NCT04117087|Poly ICLC|poly iclc|mesh-list
83513459|NCT01812668|Fluorides|fluorides|mesh-list
82885050|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885051|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885052|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885053|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885054|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
82885055|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
82885056|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885061|NCT04106856|Losartan|losartan|mesh-list
82885062|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82885079|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82885080|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
82885081|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
82885082|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885083|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885084|NCT04052568|Psilocybin|psilocybin|mesh-list
82885085|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
82885086|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885087|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82885088|NCT04050670|Tirzepatide|tirzepatide|mesh-list
82885089|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82885090|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885091|NCT04050670|Incretins|incretins|mesh-ancestor
82885092|NCT04050670|Hormones|hormones|mesh-ancestor
82885093|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885094|NCT04049084|Adenosine|adenosine|mesh-list
82885095|NCT04049084|Analgesics|analgesics|mesh-ancestor
82885096|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
82885097|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885098|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885099|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82885100|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
82885101|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82885102|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
82885103|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
82885104|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885105|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885106|NCT04042753|Nivolumab|nivolumab|mesh-list
82885107|NCT04042753|Ipilimumab|ipilimumab|mesh-list
82885108|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885109|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885110|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885111|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885112|NCT04035486|Carboplatin|carboplatin|mesh-list
82885113|NCT04035486|Pemetrexed|pemetrexed|mesh-list
82885114|NCT04035486|Osimertinib|osimertinib|mesh-list
82885115|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885116|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885117|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885118|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82885119|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82885120|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885138|NCT04028050|Carboplatin|carboplatin|mesh-list
82885140|NCT04028050|Atezolizumab|atezolizumab|mesh-list
82885141|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885142|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82885143|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82885144|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82885145|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885146|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885147|NCT04028050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885148|NCT04028050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885149|NCT04022967|Ritonavir|ritonavir|mesh-list
82885150|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82885151|NCT04022967|Tenofovir|tenofovir|mesh-list
82885152|NCT04022967|Lamivudine|lamivudine|mesh-list
82885153|NCT04022967|Dolutegravir|dolutegravir|mesh-list
82885154|NCT04022967|Efavirenz|efavirenz|mesh-list
82885155|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82885156|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82885157|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
82885158|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885159|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885160|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82885161|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82885162|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
82885163|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885164|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82885165|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82885166|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82885167|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82885168|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82885169|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82885170|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82885171|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82885172|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82885173|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82885174|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82885175|NCT04016714|Vaccines|vaccines|mesh-list
83454381|NCT05028153|Azithromycin|azithromycin|mesh-list
82885176|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82885177|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
82885178|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885179|NCT03988530|Scopolamine|scopolamine|mesh-list
82885180|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82885181|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82885182|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
82885183|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
82885184|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885185|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885186|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885187|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
82885188|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82885189|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
82885190|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885191|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885192|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82885193|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
82885194|NCT03984188|Theophylline|theophylline|mesh-list
82885195|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82885196|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
82885197|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885198|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885199|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82885200|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
82885201|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82885202|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885203|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885204|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
82885205|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82885206|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82885207|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
82885208|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885209|NCT03983824|Cytarabine|cytarabine|mesh-list
82885210|NCT03983824|Etoposide|etoposide|mesh-list
82885211|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
82885212|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
82885213|NCT03983824|Peposertib|peposertib|mesh-list
82885214|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82885215|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885216|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82885217|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82885218|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885219|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885220|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885221|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
82885222|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
82885223|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885224|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885225|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
82885226|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885228|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
82885229|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885230|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885231|NCT03980769|Fludarabine|fludarabine|mesh-list
82885232|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
82885233|NCT03980769|Thiotepa|thiotepa|mesh-list
82885234|NCT03980769|Treosulfan|treosulfan|mesh-list
82885235|NCT03980769|Busulfan|busulfan|mesh-list
82885236|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82885237|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
82885238|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885239|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885240|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
82885241|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885242|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885243|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
82885244|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885245|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82885246|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
82885247|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82885248|NCT03978598|Etonogestrel|etonogestrel|mesh-list
82885249|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82885250|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
82885251|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82885252|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885253|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82885254|NCT03972657|Cemiplimab|cemiplimab|mesh-list
82885255|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885256|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885257|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
82885258|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885259|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
82885260|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885261|NCT03948243|Tolbutamide|tolbutamide|mesh-list
82885262|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
82885263|NCT03948243|Alprazolam|alprazolam|mesh-list
82885264|NCT03948243|Caffeine|caffeine|mesh-list
82885265|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82885266|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885267|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82885268|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885269|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885270|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82885271|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82885272|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
82885273|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885274|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
82885275|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
82885276|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82885277|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82885278|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82885279|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885280|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82885281|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82885282|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82885283|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
82885284|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
82885285|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82885286|NCT03948035|Dexamethasone|dexamethasone|mesh-list
82885287|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
82885288|NCT03948035|Lenalidomide|lenalidomide|mesh-list
82885289|NCT03948035|Elotuzumab|elotuzumab|mesh-list
82885290|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885292|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
82885293|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885294|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885295|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885296|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
82885297|NCT03948035|Hormones|hormones|mesh-ancestor
82885298|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885299|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885300|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885301|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
82885302|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82885303|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82885304|NCT03948035|Growth Substances|growth substances|mesh-ancestor
82885305|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
82885306|NCT03946124|Fesoterodine|fesoterodine|mesh-list
82885307|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82885308|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82885309|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
82885310|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885311|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885312|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885313|NCT03946124|Urological Agents|urological agents|mesh-ancestor
82885314|NCT03942224|Dexamethasone|dexamethasone|mesh-list
82885315|NCT03942224|Bortezomib|bortezomib|mesh-list
82885316|NCT03942224|Daratumumab|daratumumab|mesh-list
82885317|NCT03942224|Ixazomib|ixazomib|mesh-list
82885318|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885319|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
82885320|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
82885321|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885322|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885323|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885324|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
82885325|NCT03942224|Hormones|hormones|mesh-ancestor
82885326|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83454384|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82885327|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885328|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885329|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
82885330|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885331|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885332|NCT03938701|Adalimumab|adalimumab|mesh-list
82885333|NCT03938701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82885334|NCT03938701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885335|NCT03938701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82885336|NCT03936933|Goserelin|goserelin|mesh-list
82885337|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885338|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885339|NCT03936218|Goserelin|goserelin|mesh-list
82885340|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885341|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885342|NCT03904693|Tadalafil|tadalafil|mesh-list
82885343|NCT03904693|Macitentan|macitentan|mesh-list
82885344|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
82885345|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82885346|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82885347|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885348|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885349|NCT03904693|Urological Agents|urological agents|mesh-ancestor
82885350|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82885351|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82885352|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82885353|NCT03895099|Desogestrel|desogestrel|mesh-list
82885354|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82885355|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82885356|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82885357|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
82885358|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82885359|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885360|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82885361|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82885362|NCT03895099|Progestins|progestins|mesh-ancestor
82885363|NCT03895099|Hormones|hormones|mesh-ancestor
83083940|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82885364|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885366|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82885367|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82885368|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885369|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885370|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885372|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885373|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
82885374|NCT03861390|Hormones|hormones|mesh-ancestor
82885375|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885376|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885377|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885378|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885379|NCT03818685|Capecitabine|capecitabine|mesh-list
82885380|NCT03818685|Nivolumab|nivolumab|mesh-list
82885381|NCT03818685|Ipilimumab|ipilimumab|mesh-list
82885382|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885383|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
82885384|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885385|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885386|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885387|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885388|NCT03815643|Avelumab|avelumab|mesh-list
82885389|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885390|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885391|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
82885392|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885393|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885394|NCT03815058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885395|NCT03815058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885396|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
82885397|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82885398|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82885399|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885400|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
82885401|NCT03801122|Coagulants|coagulants|mesh-ancestor
82885402|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82885403|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
82885404|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885405|NCT03771677|Interferons|interferons|mesh-list
82885406|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
82885407|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
82885408|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885409|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
82885410|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885411|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
82885412|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885413|NCT03771651|Aspirin|aspirin|mesh-list
82885414|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82885415|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82885416|NCT03771651|Analgesics|analgesics|mesh-ancestor
82885417|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
82885418|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885419|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885420|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885421|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82885422|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82885423|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82885424|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885425|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82885426|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82885427|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885428|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
82885429|NCT03770767|Insulin|insulin|mesh-list
82885430|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82885431|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
82885432|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82885433|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885434|NCT03769155|Nivolumab|nivolumab|mesh-list
82885435|NCT03769155|Ipilimumab|ipilimumab|mesh-list
82885436|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885437|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885438|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885439|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885440|NCT03756896|Dexamethasone|dexamethasone|mesh-list
82885441|NCT03756896|Pomalidomide|pomalidomide|mesh-list
82885442|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885443|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
82885444|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
82885445|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885446|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885447|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885448|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
82885449|NCT03756896|Hormones|hormones|mesh-ancestor
82885450|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885451|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885452|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885453|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
82885454|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82885455|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82885456|NCT03756896|Growth Substances|growth substances|mesh-ancestor
82885457|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
82885458|NCT03747575|Astegolimab|astegolimab|mesh-list
82885459|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82885460|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885461|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
82885462|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885463|NCT03747419|Avelumab|avelumab|mesh-list
82885464|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885465|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885466|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
82885467|NCT03733145|Giapreza|giapreza|mesh-list
82885468|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
82885469|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82885470|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82885471|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
82885472|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885473|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885474|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
82885475|NCT03715972|Acetazolamide|acetazolamide|mesh-list
82885476|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885477|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
82885478|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885479|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885480|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82885481|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
82885482|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82885483|NCT03715972|Diuretics|diuretics|mesh-ancestor
82885484|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
82885485|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885486|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
82885487|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885488|NCT03691714|Cetuximab|cetuximab|mesh-list
82885489|NCT03691714|Durvalumab|durvalumab|mesh-list
82885490|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885491|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885492|NCT03691493|Tamoxifen|tamoxifen|mesh-list
82885493|NCT03691493|Letrozole|letrozole|mesh-list
82885494|NCT03691493|Fulvestrant|fulvestrant|mesh-list
82885495|NCT03691493|Palbociclib|palbociclib|mesh-list
82885496|NCT03691493|Anastrozole|anastrozole|mesh-list
82885497|NCT03691493|Exemestane|exemestane|mesh-list
82885498|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885499|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82885500|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82885501|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885502|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885503|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82885504|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
82885505|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885506|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885507|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885508|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82885509|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82885510|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82885511|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82885512|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885513|NCT03683251|Ranibizumab|ranibizumab|mesh-list
82885515|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82885516|NCT03683251|Growth Substances|growth substances|mesh-ancestor
82885517|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885518|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
82885519|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885520|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
82885521|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885522|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885523|NCT03652064|Dexamethasone|dexamethasone|mesh-list
82885524|NCT03652064|Lenalidomide|lenalidomide|mesh-list
82885525|NCT03652064|Bortezomib|bortezomib|mesh-list
82885526|NCT03652064|Daratumumab|daratumumab|mesh-list
82885527|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885528|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
82885529|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
82885530|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885531|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885532|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885533|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
82885534|NCT03652064|Hormones|hormones|mesh-ancestor
82885535|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885536|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885537|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885538|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
82885539|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82885540|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82885541|NCT03652064|Growth Substances|growth substances|mesh-ancestor
82885542|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
82885543|NCT03634540|Belzutifan|belzutifan|mesh-list
82885544|NCT03634540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885545|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
82885546|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885547|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885548|NCT03631706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885549|NCT03631706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885550|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
82885551|NCT03630081|Meropenem|meropenem|mesh-list
82885552|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82885553|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885554|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82885555|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82885556|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885557|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885558|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885559|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82885560|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82885561|NCT03619876|Adalimumab|adalimumab|mesh-list
82885562|NCT03619876|Abatacept|abatacept|mesh-list
82885563|NCT03619876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82885564|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885565|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82885566|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885567|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885568|NCT03619876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885569|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885570|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885571|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
82885572|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885573|NCT03610971|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82885574|NCT03610971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885575|NCT03610971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885576|NCT03610971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885577|NCT03605901|Methadone|methadone|mesh-list
82885578|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82885579|NCT03605901|Narcotics|narcotics|mesh-ancestor
82885580|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885581|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885582|NCT03605901|Analgesics|analgesics|mesh-ancestor
82885583|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
82885584|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885585|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
82885586|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
82885587|NCT03583255|Dexamethasone|dexamethasone|mesh-list
82885588|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
82885590|NCT03583255|BB 1101|bb 1101|mesh-list
82885591|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885592|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
82885593|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
82885594|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885595|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885596|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885597|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
82885598|NCT03583255|Hormones|hormones|mesh-ancestor
82885599|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885600|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885601|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885602|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
82885603|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885604|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885605|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
82885606|NCT03579771|Paclitaxel|paclitaxel|mesh-list
82885607|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82885608|NCT03579771|Gemcitabine|gemcitabine|mesh-list
82885609|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82885610|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885611|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
82885612|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
82885613|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
82885614|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885615|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885616|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
82885617|NCT03578081|Dexamethasone|dexamethasone|mesh-list
82885618|NCT03578081|Ondansetron|ondansetron|mesh-list
82885619|NCT03578081|Olanzapine|olanzapine|mesh-list
82885621|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
82885622|NCT03578081|Aprepitant|aprepitant|mesh-list
82885623|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885624|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
82885625|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
82885626|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885627|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885628|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885629|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
82885630|NCT03578081|Hormones|hormones|mesh-ancestor
82885631|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885632|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885633|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885634|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
82885635|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
82885636|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82885637|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82885638|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
82885639|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885640|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885641|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82885642|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82885643|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885644|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82885645|NCT03578081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82885646|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82885647|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82885648|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82885649|NCT03568656|Atezolizumab|atezolizumab|mesh-list
82885650|NCT03568656|Olaparib|olaparib|mesh-list
82885651|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
82885652|NCT03568656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885653|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885654|NCT03568656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885655|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885656|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82885657|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885658|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82885659|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
82885660|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885661|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885662|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82885663|NCT03540420|Atezolizumab|atezolizumab|mesh-list
82885664|NCT03540420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885665|NCT03540420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885666|NCT03540420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885667|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885668|NCT03523312|Capecitabine|capecitabine|mesh-list
82885669|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885670|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
82885671|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885672|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885673|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
82885674|NCT03510884|Niacin|niacin|mesh-list
82885675|NCT03510884|Niacinamide|niacinamide|mesh-list
82885676|NCT03510884|Atorvastatin|atorvastatin|mesh-list
82885677|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82885678|NCT03510884|Simvastatin|simvastatin|mesh-list
82885679|NCT03510884|Ezetimibe|ezetimibe|mesh-list
82885680|NCT03510884|Pravastatin|pravastatin|mesh-list
82885681|NCT03510884|Alirocumab|alirocumab|mesh-list
82885682|NCT03510884|Lovastatin|lovastatin|mesh-list
82885683|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
82885684|NCT03510884|Fenofibrate|fenofibrate|mesh-list
82885685|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82885686|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82885687|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
82885688|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885689|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82885690|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82885691|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885692|NCT03510884|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82885693|NCT03510884|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82885694|NCT03510884|Protease Inhibitors|protease inhibitors|mesh-ancestor
82885695|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
82885696|NCT03510884|Vitamins|vitamins|mesh-ancestor
82885697|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
82885698|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885699|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
82885700|NCT03506360|Dexamethasone|dexamethasone|mesh-list
82885701|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
82885702|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
82885703|NCT03506360|Ixazomib|ixazomib|mesh-list
82885704|NCT03506360|Ichthammol|ichthammol|mesh-list
82885705|NCT03506360|BB 1101|bb 1101|mesh-list
82885706|NCT03506360|Glycine|glycine|mesh-list
82885707|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885708|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
82885709|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
82885710|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885711|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885712|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885713|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
82885714|NCT03506360|Hormones|hormones|mesh-ancestor
82885715|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885716|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885717|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885718|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
82885719|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885720|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885721|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885722|NCT03506360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885723|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
82885724|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
82885725|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885726|NCT03497975|Nalbuphine|nalbuphine|mesh-list
82885727|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82885728|NCT03497975|Narcotics|narcotics|mesh-ancestor
82885729|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885730|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885731|NCT03497975|Analgesics|analgesics|mesh-ancestor
82885732|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
82885733|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885734|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82885735|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82885736|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885737|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82885738|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83083941|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
82885747|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885748|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82885749|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885750|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82885751|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82885752|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82885753|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82885754|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82885755|NCT03492177|Selexipag|selexipag|mesh-list
82885756|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82885757|NCT03478514|Palbociclib|palbociclib|mesh-list
82885758|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885759|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885760|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885761|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885762|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
82885763|NCT03456843|Docetaxel|docetaxel|mesh-list
82885764|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
82885765|NCT03456843|Hormones|hormones|mesh-list
82885766|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82885767|NCT03456843|Androgens|androgens|mesh-list
82885768|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
82885769|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885770|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
82885771|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
82885772|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
82885773|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885774|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885775|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885776|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
82885777|NCT03456843|Protective Agents|protective agents|mesh-ancestor
82885778|NCT03456843|Vitamins|vitamins|mesh-ancestor
82885779|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
82885780|NCT03456843|Estrogens|estrogens|mesh-ancestor
82885781|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885782|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
82885783|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
82885792|NCT03455829|Osimertinib|osimertinib|mesh-list
82885793|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885794|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885795|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885796|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885797|NCT03453489|Tryptophan|tryptophan|mesh-list
82885798|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82885799|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
82885800|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82885801|NCT03451851|Etanercept|etanercept|mesh-list
82885802|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82885803|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82885804|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82885805|NCT03451851|Analgesics|analgesics|mesh-ancestor
82885806|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
82885807|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885808|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885809|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885810|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82885811|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885812|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885813|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
82885814|NCT03440190|Methylphenidate|methylphenidate|mesh-list
82885815|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82885816|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885817|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82885818|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82885819|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82885820|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885821|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
82885822|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885823|NCT03439046|Letrozole|letrozole|mesh-list
82885824|NCT03439046|Fulvestrant|fulvestrant|mesh-list
82885825|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885826|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82885827|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82885828|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885829|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885830|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82885831|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
82885832|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885833|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885834|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885835|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82885836|NCT03434262|Gemcitabine|gemcitabine|mesh-list
82885837|NCT03434262|Trametinib|trametinib|mesh-list
82885838|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885839|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
82885840|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885841|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885842|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885843|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885844|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82885845|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82885846|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885847|NCT03422328|Macitentan|macitentan|mesh-list
82885848|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82885849|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82885850|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885851|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82885852|NCT03412565|Dexamethasone|dexamethasone|mesh-list
82885853|NCT03412565|Prednisone|prednisone|mesh-list
82885854|NCT03412565|Lenalidomide|lenalidomide|mesh-list
82885855|NCT03412565|Bortezomib|bortezomib|mesh-list
82885856|NCT03412565|Melphalan|melphalan|mesh-list
82885857|NCT03412565|Daratumumab|daratumumab|mesh-list
82885858|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885860|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
82885861|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885862|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885863|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885864|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
82885865|NCT03412565|Hormones|hormones|mesh-ancestor
82885866|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885867|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885868|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885869|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
82885870|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82885871|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82885872|NCT03412565|Growth Substances|growth substances|mesh-ancestor
82885873|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
82885874|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82885875|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
82885876|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885877|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82885878|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885879|NCT03408587|Ipilimumab|ipilimumab|mesh-list
82885880|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885881|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885882|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885883|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885884|NCT03387553|Immunomodulating Agents|immunomodulating agents|mesh-list
82885885|NCT03387553|Immunologic Factors|immunologic factors|mesh-ancestor
82885886|NCT03387553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885888|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
82885889|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82885890|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82885891|NCT03370276|Nivolumab|nivolumab|mesh-list
82885892|NCT03370276|Cetuximab|cetuximab|mesh-list
82885893|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885894|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885895|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885896|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885897|NCT03340506|Trametinib|trametinib|mesh-list
82885898|NCT03340506|Dabrafenib|dabrafenib|mesh-list
82885899|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885900|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82885901|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885902|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885903|NCT03331341|Doxorubicin|doxorubicin|mesh-list
82885904|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82885905|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
82885906|NCT03331341|Dacarbazine|dacarbazine|mesh-list
82885907|NCT03331341|Vinblastine|vinblastine|mesh-list
82885908|NCT03331341|Imidazole|imidazole|mesh-list
82885909|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82885910|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885911|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82885912|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82885913|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82885914|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885915|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885916|NCT03331341|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885917|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82885918|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
82885919|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82885920|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
82885921|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
82885922|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
82885923|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
82885924|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885925|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885926|NCT03319745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885927|NCT03319745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885928|NCT03314636|Dexamethasone|dexamethasone|mesh-list
82885929|NCT03314636|Lenalidomide|lenalidomide|mesh-list
82885930|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82885931|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
82885932|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
82885933|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82885934|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885935|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82885936|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
82885937|NCT03314636|Hormones|hormones|mesh-ancestor
82885938|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885939|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885940|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885941|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
82885942|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82885943|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82885944|NCT03314636|Growth Substances|growth substances|mesh-ancestor
82885945|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
82885946|NCT03310541|Fulvestrant|fulvestrant|mesh-list
82885947|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82885948|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885949|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82885950|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82885951|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
82885952|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82885953|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885954|NCT03279861|Valsartan|valsartan|mesh-list
82885955|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82885956|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82885957|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82885958|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82885959|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885960|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
82885961|NCT03277729|Fludarabine|fludarabine|mesh-list
82885962|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
82885963|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82885964|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
82885965|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885966|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82885967|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82885968|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
82885969|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885970|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885971|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82885972|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82885973|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
82885974|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82885975|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
82885976|NCT03255174|Coagulants|coagulants|mesh-ancestor
82885977|NCT03250832|Bevacizumab|bevacizumab|mesh-list
82885978|NCT03250832|Dostarlimab|dostarlimab|mesh-list
82885979|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885980|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885981|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82885982|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82885983|NCT03250832|Growth Substances|growth substances|mesh-ancestor
82885984|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885985|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
82885987|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82885988|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82885989|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
82885990|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
82885991|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82885992|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82885993|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82885994|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
82885995|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
82885996|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82885997|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82885998|NCT03236935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82885999|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886000|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886001|NCT03234972|Dexamethasone|dexamethasone|mesh-list
82886002|NCT03234972|Bortezomib|bortezomib|mesh-list
82886003|NCT03234972|Daratumumab|daratumumab|mesh-list
82886004|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886005|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
82886006|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
82886007|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886008|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886009|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886010|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
82886012|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886013|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886014|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886015|NCT03232073|Ponesimod|ponesimod|mesh-list
82886016|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82886017|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886018|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886019|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
82886020|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886021|NCT03230838|Meropenem|meropenem|mesh-list
82886022|NCT03230838|Tazobactam|tazobactam|mesh-list
82886023|NCT03230838|Ceftolozane|ceftolozane|mesh-list
82886024|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
82886025|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82886026|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886027|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82886028|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886029|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886030|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82886031|NCT03218488|Ustekinumab|ustekinumab|mesh-list
82886032|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
82886033|NCT03217812|Prednisone|prednisone|mesh-list
82886034|NCT03217812|Bortezomib|bortezomib|mesh-list
82886035|NCT03217812|Melphalan|melphalan|mesh-list
82886036|NCT03217812|Daratumumab|daratumumab|mesh-list
82886037|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886038|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
82886039|NCT03217812|Hormones|hormones|mesh-ancestor
82886040|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886041|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886042|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886043|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886044|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886045|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
82886046|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886047|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82886048|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886049|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
82886050|NCT03217136|Metronidazole|metronidazole|mesh-list
82886051|NCT03217136|Meropenem|meropenem|mesh-list
82886052|NCT03217136|Tazobactam|tazobactam|mesh-list
82886053|NCT03217136|Ceftolozane|ceftolozane|mesh-list
82886054|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
82886055|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886056|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82886057|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82886058|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82886059|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82886060|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886061|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886062|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82886063|NCT03201965|Dexamethasone|dexamethasone|mesh-list
82886064|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
82886065|NCT03201965|Bortezomib|bortezomib|mesh-list
82886066|NCT03201965|Daratumumab|daratumumab|mesh-list
82886067|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886068|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
82886069|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886070|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886071|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886072|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
82886073|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886074|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886075|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82886076|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886077|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
82886078|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
82886079|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886080|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886081|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
82886082|NCT03201965|Hormones|hormones|mesh-ancestor
82886083|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886084|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886085|NCT03201939|Lisinopril|lisinopril|mesh-list
82886086|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82886087|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
82886088|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886089|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886090|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82886091|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82886092|NCT03201939|Protective Agents|protective agents|mesh-ancestor
82886093|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886094|NCT03179761|Vaccines|vaccines|mesh-list
82886095|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
82886096|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886097|NCT03173248|Azacitidine|azacitidine|mesh-list
82886098|NCT03173248|Ivosidenib|ivosidenib|mesh-list
82886099|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886100|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
82886101|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886102|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886103|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886104|NCT03158064|Durvalumab|durvalumab|mesh-list
82886105|NCT03158064|Tremelimumab|tremelimumab|mesh-list
82886106|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886107|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886108|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82886109|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
82886110|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82886112|NCT03122522|Nivolumab|nivolumab|mesh-list
82886113|NCT03122522|Ipilimumab|ipilimumab|mesh-list
82886114|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886115|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886116|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886117|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886118|NCT03090165|Bicalutamide|bicalutamide|mesh-list
82886119|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
82886120|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886121|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886122|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886123|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886124|NCT03087708|Naloxegol|naloxegol|mesh-list
82886125|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82886126|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886127|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
82886128|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886129|NCT03059563|Varenicline|varenicline|mesh-list
82886130|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82886131|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82886132|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
82886133|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82886134|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886135|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886136|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
82886137|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82886138|NCT03057847|Velpatasvir|velpatasvir|mesh-list
82886139|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
82886140|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886141|NCT03056001|Doxorubicin|doxorubicin|mesh-list
82886142|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
82886143|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82886144|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886145|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82886146|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886147|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886148|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886149|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886150|NCT03056001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886151|NCT03043599|Nivolumab|nivolumab|mesh-list
82886152|NCT03043599|Ipilimumab|ipilimumab|mesh-list
82886153|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886154|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886155|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886156|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886157|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
82886158|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82886159|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82886161|NCT03040973|Osimertinib|osimertinib|mesh-list
82886162|NCT03040973|Nazartinib|nazartinib|mesh-list
82886163|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886164|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886165|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886166|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886167|NCT03022773|Carotenoids|carotenoids|mesh-list
82886168|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
82886169|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886170|NCT03022773|Protective Agents|protective agents|mesh-ancestor
82886171|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886172|NCT03017820|Iodine|iodine|mesh-list
82886173|NCT03017820|Interferons|interferons|mesh-list
82886174|NCT03017820|Interferon-beta|interferon-beta|mesh-list
82886175|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
82886176|NCT03017820|Nivolumab|nivolumab|mesh-list
82886177|NCT03017820|Ipilimumab|ipilimumab|mesh-list
82886178|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886179|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
82886180|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886181|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886182|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886183|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
82886184|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886185|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886186|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82886187|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886188|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886189|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
82886190|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886191|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82886192|NCT03017820|Trace Elements|trace elements|mesh-ancestor
82886193|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
82886194|NCT02946463|Eculizumab|eculizumab|mesh-list
82886195|NCT02946463|Ravulizumab|ravulizumab|mesh-list
82886196|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82886197|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886198|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
82886199|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886200|NCT02932410|Macitentan|macitentan|mesh-list
82886201|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82886202|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82886203|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886204|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82886205|NCT02928224|Leucovorin|leucovorin|mesh-list
82886206|NCT02928224|Folic Acid|folic acid|mesh-list
82886207|NCT02928224|Fluorouracil|fluorouracil|mesh-list
82886208|NCT02928224|Irinotecan|irinotecan|mesh-list
82886209|NCT02928224|Cetuximab|cetuximab|mesh-list
82886210|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
82886211|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
82886212|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886213|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886214|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886215|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886216|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
82886217|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886218|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82886219|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886220|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886221|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886222|NCT02928224|Antidotes|antidotes|mesh-ancestor
82886223|NCT02928224|Protective Agents|protective agents|mesh-ancestor
82886224|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
82886225|NCT02928224|Vitamins|vitamins|mesh-ancestor
82886226|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
82886227|NCT02928224|Hematinics|hematinics|mesh-ancestor
82886228|NCT02897375|Carboplatin|carboplatin|mesh-list
82886229|NCT02897375|Palbociclib|palbociclib|mesh-list
82886230|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886231|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886232|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886233|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886234|NCT02891603|Sirolimus|sirolimus|mesh-list
82886235|NCT02891603|Tacrolimus|tacrolimus|mesh-list
82886236|NCT02891603|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82886237|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886238|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
82886239|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886240|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82886241|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886242|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886243|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82886244|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886245|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82886246|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886247|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
82886248|NCT02891603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886249|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
82886250|NCT02875314|Thiotepa|thiotepa|mesh-list
82886251|NCT02875314|Cisplatin|cisplatin|mesh-list
82886252|NCT02875314|Carboplatin|carboplatin|mesh-list
82886253|NCT02875314|Methotrexate|methotrexate|mesh-list
82886254|NCT02875314|Etoposide|etoposide|mesh-list
82886255|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
82886256|NCT02875314|Vincristine|vincristine|mesh-list
82886257|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886258|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
82886259|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886260|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886261|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886262|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
82886263|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886264|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886265|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82886266|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82886267|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
82886268|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82886269|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886270|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
82886271|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
82886272|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886273|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82886274|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82886275|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82886276|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82886277|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886278|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
82886279|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886280|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886281|NCT02872116|Leucovorin|leucovorin|mesh-list
82886282|NCT02872116|Fluorouracil|fluorouracil|mesh-list
82886283|NCT02872116|Capecitabine|capecitabine|mesh-list
82886284|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
82886285|NCT02872116|Nivolumab|nivolumab|mesh-list
82886286|NCT02872116|Ipilimumab|ipilimumab|mesh-list
82886287|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
82886288|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886289|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886290|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886291|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886292|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
82886293|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886294|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886295|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886296|NCT02872116|Antidotes|antidotes|mesh-ancestor
82886297|NCT02872116|Protective Agents|protective agents|mesh-ancestor
82886298|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
82886299|NCT02872116|Vitamins|vitamins|mesh-ancestor
82886300|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
82886301|NCT02860039|Vaccines|vaccines|mesh-list
82886302|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
82886303|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886304|NCT02854436|Niraparib|niraparib|mesh-list
82886305|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82886306|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886307|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886308|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886309|NCT02819024|Alovudine|alovudine|mesh-list
82886310|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
82886311|NCT02819024|Dexamethasone|dexamethasone|mesh-list
82886312|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
82886313|NCT02819024|Ichthammol|ichthammol|mesh-list
82886314|NCT02819024|BB 1101|bb 1101|mesh-list
82886315|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886316|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
82886317|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
82886318|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886319|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886320|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886321|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
82886322|NCT02819024|Hormones|hormones|mesh-ancestor
82886323|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886324|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886325|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886326|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
82886327|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886328|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886329|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
82886330|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
82886331|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886332|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
82886333|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82886334|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82886335|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82886336|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886337|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
82886338|NCT02800785|Metronidazole|metronidazole|mesh-list
82886339|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
82886340|NCT02800785|Levofloxacin|levofloxacin|mesh-list
82886341|NCT02800785|Cefazolin|cefazolin|mesh-list
82886342|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
82886343|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
82886344|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
82886345|NCT02800785|Ertapenem|ertapenem|mesh-list
82886346|NCT02800785|Cefuroxime|cefuroxime|mesh-list
82886347|NCT02800785|Tigecycline|tigecycline|mesh-list
82886348|NCT02800785|Cefotaxime|cefotaxime|mesh-list
82886349|NCT02800785|Cefoxitin|cefoxitin|mesh-list
82886350|NCT02800785|Ticarcillin|ticarcillin|mesh-list
82886351|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
82886352|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82886353|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886354|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82886355|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886356|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886357|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886358|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886359|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82886360|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82886361|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82886362|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82886363|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82886364|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82886365|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82886366|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82886367|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82886368|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82886369|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
82886370|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886371|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886372|NCT02792257|Dronabinol|dronabinol|mesh-list
82886373|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
82886374|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886375|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82886376|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82886377|NCT02792257|Analgesics|analgesics|mesh-ancestor
82886378|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
82886379|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886380|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82886381|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82886382|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82886383|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886384|NCT02792257|Hormones|hormones|mesh-ancestor
82886385|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886386|NCT02782663|Upadacitinib|upadacitinib|mesh-list
82886387|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82886388|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886389|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886390|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886391|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886393|NCT02765854|Lenalidomide|lenalidomide|mesh-list
82886394|NCT02765854|Ixazomib|ixazomib|mesh-list
82886395|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886396|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
82886397|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
82886398|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886399|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886400|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886401|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
82886402|NCT02765854|Hormones|hormones|mesh-ancestor
82886403|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886404|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886405|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886406|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
82886407|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82886408|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82886409|NCT02765854|Growth Substances|growth substances|mesh-ancestor
82886410|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
82886411|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886412|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
82886413|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886414|NCT02761694|Paclitaxel|paclitaxel|mesh-list
82886415|NCT02761694|Fulvestrant|fulvestrant|mesh-list
82886416|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82886417|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886419|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886420|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886421|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886422|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886423|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82886424|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82886425|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886426|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886427|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886428|NCT02760030|Fulvestrant|fulvestrant|mesh-list
82886429|NCT02760030|Palbociclib|palbociclib|mesh-list
82886430|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82886431|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886432|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886433|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82886434|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82886435|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886436|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886437|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886438|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886439|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886440|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886441|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82886442|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
82886443|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886444|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886445|NCT02641093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886446|NCT02641093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886447|NCT02584309|Doxorubicin|doxorubicin|mesh-list
82886448|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82886449|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
82886450|NCT02584309|Razoxane|razoxane|mesh-list
82886451|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82886452|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886453|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82886454|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886455|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886456|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886457|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82886458|NCT02584309|Protective Agents|protective agents|mesh-ancestor
82886459|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886460|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886461|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886462|NCT02578732|Leucovorin|leucovorin|mesh-list
82886463|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
82886464|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886465|NCT02578732|Antidotes|antidotes|mesh-ancestor
82886466|NCT02578732|Protective Agents|protective agents|mesh-ancestor
82886467|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886468|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
82886469|NCT02578732|Vitamins|vitamins|mesh-ancestor
82886470|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
82886471|NCT02525757|Paclitaxel|paclitaxel|mesh-list
82886472|NCT02525757|Carboplatin|carboplatin|mesh-list
82886473|NCT02525757|Atezolizumab|atezolizumab|mesh-list
82886474|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82886475|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886476|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
82886477|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886478|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886479|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886480|NCT02525757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886481|NCT02525757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886482|NCT02519452|Daratumumab|daratumumab|mesh-list
82886483|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886484|NCT02505984|Oxytocin|oxytocin|mesh-list
82886485|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
82886486|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82886487|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886488|NCT02494986|Rilpivirine|rilpivirine|mesh-list
82886489|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82886490|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82886491|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886492|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886494|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886495|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82886496|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82886497|NCT02489318|Androgens|androgens|mesh-list
82886498|NCT02489318|Hormones|hormones|mesh-ancestor
82886499|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886500|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886501|NCT02486718|Gemcitabine|gemcitabine|mesh-list
82886502|NCT02486718|Docetaxel|docetaxel|mesh-list
82886503|NCT02486718|Pemetrexed|pemetrexed|mesh-list
82886504|NCT02486718|Atezolizumab|atezolizumab|mesh-list
82886505|NCT02486718|Vinorelbine|vinorelbine|mesh-list
82886506|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886507|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886508|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
82886509|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886510|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
82886511|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886512|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886513|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886514|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82886515|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82886516|NCT02486718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886517|NCT02486718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886518|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82886519|NCT02477280|Methylphenidate|methylphenidate|mesh-list
82886520|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82886521|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886522|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82886523|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82886524|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82886525|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886526|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
82886527|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82886528|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82886529|NCT02438722|Cetuximab|cetuximab|mesh-list
82886530|NCT02438722|Afatinib|afatinib|mesh-list
82886531|NCT02438722|Antibodies|antibodies|mesh-list
82886532|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
82886533|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82886534|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
82886535|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886536|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886537|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886538|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886539|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886540|NCT02435212|Deferasirox|deferasirox|mesh-list
82886541|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82886542|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
82886543|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
82886544|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886545|NCT02426658|Pemetrexed|pemetrexed|mesh-list
82886546|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886547|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886548|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886549|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82886550|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82886551|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
82886552|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82886553|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
82886554|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82886555|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886556|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82886557|NCT02403323|Etrolizumab|etrolizumab|mesh-list
82886558|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886559|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
82886560|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886561|NCT02368665|Amlodipine|amlodipine|mesh-list
82886562|NCT02368665|Candesartan|candesartan|mesh-list
82886563|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
82886564|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82886565|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82886566|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82886567|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886568|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82886569|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886571|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82886572|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82886573|NCT02368652|Amlodipine|amlodipine|mesh-list
82886574|NCT02368652|Candesartan|candesartan|mesh-list
82886575|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
82886576|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82886577|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82886578|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82886579|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886580|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82886581|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886582|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
83454435|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
82886583|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82886584|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82886585|NCT02365597|Metformin|metformin|mesh-list
82886586|NCT02365597|Midazolam|midazolam|mesh-list
82886587|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82886588|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886589|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82886590|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82886591|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82886592|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82886593|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82886594|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82886595|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82886596|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
82886597|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
82886598|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
82886599|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
82886600|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82886601|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886602|NCT02354014|Bedaquiline|bedaquiline|mesh-list
82886603|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
82886604|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
82886605|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82886606|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886607|NCT02339922|Rituximab|rituximab|mesh-list
82886608|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82886609|NCT02339922|Ixazomib|ixazomib|mesh-list
82886610|NCT02339922|Antibodies|antibodies|mesh-list
82886611|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
82886612|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82886613|NCT02339922|Glycine|glycine|mesh-list
82886614|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
82886615|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886616|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886617|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886618|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886619|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
82886620|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886621|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
82886622|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82886623|NCT02332577|Amoxicillin|amoxicillin|mesh-list
82886624|NCT02332577|Pristinamycin|pristinamycin|mesh-list
82886625|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82886626|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886627|NCT02330926|Ibuprofen|ibuprofen|mesh-list
82886628|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82886629|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82886630|NCT02330926|Analgesics|analgesics|mesh-ancestor
82886631|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
82886632|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886633|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886634|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886635|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886636|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82886637|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886638|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886639|NCT02312245|Paclitaxel|paclitaxel|mesh-list
82886640|NCT02312245|Bevacizumab|bevacizumab|mesh-list
82886642|NCT02312245|Doxorubicin|doxorubicin|mesh-list
82886643|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82886644|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82886645|NCT02312245|Topotecan|topotecan|mesh-list
82886646|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82886647|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
82886648|NCT02312245|Antibodies|antibodies|mesh-list
82886649|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
82886650|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82886651|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
82886652|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82886653|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886654|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
82886655|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886656|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886657|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886658|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82886659|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82886660|NCT02312245|Growth Substances|growth substances|mesh-ancestor
82886661|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886662|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
82886663|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
82886664|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886665|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
82886666|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82886667|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82886668|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886669|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886670|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82886671|NCT02297438|Letrozole|letrozole|mesh-list
82886672|NCT02297438|Palbociclib|palbociclib|mesh-list
82886673|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886674|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82886675|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82886676|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886677|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886678|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82886679|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886680|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886681|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886682|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886683|NCT02297139|Dasatinib|dasatinib|mesh-list
82886684|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886685|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886686|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886687|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886688|NCT02277444|Golimumab|golimumab|mesh-list
82886689|NCT02277444|Methotrexate|methotrexate|mesh-list
82886690|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82886691|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
82886692|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82886693|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886694|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886695|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
82886696|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886697|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886698|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
82886699|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886700|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82886701|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886702|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
82886703|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886704|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82886705|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82886706|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886707|NCT02257736|Prednisone|prednisone|mesh-list
82886708|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
82886709|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886710|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
82886711|NCT02257736|Hormones|hormones|mesh-ancestor
82886712|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886713|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886714|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886716|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82886717|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886718|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886719|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886720|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82886721|NCT02252172|Dexamethasone|dexamethasone|mesh-list
82886722|NCT02252172|Lenalidomide|lenalidomide|mesh-list
82886723|NCT02252172|Daratumumab|daratumumab|mesh-list
82886724|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82886725|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886726|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
82886727|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
82886728|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886729|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886730|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886731|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
82886732|NCT02252172|Hormones|hormones|mesh-ancestor
82886733|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886734|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886735|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886736|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
82886737|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82886738|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82886739|NCT02252172|Growth Substances|growth substances|mesh-ancestor
82886740|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
82886741|NCT02195479|Dexamethasone|dexamethasone|mesh-list
82886742|NCT02195479|Prednisone|prednisone|mesh-list
82886743|NCT02195479|Melphalan|melphalan|mesh-list
82886744|NCT02195479|Bortezomib|bortezomib|mesh-list
82886745|NCT02195479|Daratumumab|daratumumab|mesh-list
82886746|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82886747|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886748|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
82886749|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
82886750|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886751|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886752|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886753|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
82886754|NCT02195479|Hormones|hormones|mesh-ancestor
82886755|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886756|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886757|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886758|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886759|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
82886760|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886761|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82886762|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886763|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
82886764|NCT02137759|Temozolomide|temozolomide|mesh-list
82886765|NCT02137759|Belinostat|belinostat|mesh-list
82886766|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886767|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
82886768|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886769|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886770|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82886771|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886773|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
82886774|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886775|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
82886776|NCT02123758|Hormones|hormones|mesh-ancestor
82886777|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886778|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886779|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886780|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886781|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82886782|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886783|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886784|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886785|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82886786|NCT02115295|Cytarabine|cytarabine|mesh-list
82886787|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
82886788|NCT02115295|Venetoclax|venetoclax|mesh-list
82886789|NCT02115295|Idarubicin|idarubicin|mesh-list
82886792|NCT02115295|Staurosporine|staurosporine|mesh-list
82886793|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886794|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
82886795|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886796|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886797|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
82886798|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886799|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886800|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
82886801|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886802|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82886803|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82886804|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886805|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886806|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886807|NCT02090998|Lidocaine|lidocaine|mesh-list
82886808|NCT02090998|Amitriptyline|amitriptyline|mesh-list
82886809|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
82886810|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
82886811|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82886812|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886813|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
82886814|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886815|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82886816|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82886817|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82886818|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82886819|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886820|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82886821|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
82886822|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82886823|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82886824|NCT02090998|Analgesics|analgesics|mesh-ancestor
82886825|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82886826|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82886827|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
82886828|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82886829|NCT02076009|Dexamethasone|dexamethasone|mesh-list
82886830|NCT02076009|Lenalidomide|lenalidomide|mesh-list
82886831|NCT02076009|Daratumumab|daratumumab|mesh-list
82886832|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886833|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
82886834|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
82886835|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886836|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886837|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82886838|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
82886839|NCT02076009|Hormones|hormones|mesh-ancestor
82886840|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886841|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886842|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83454469|NCT03073876|Donepezil|donepezil|mesh-list
82886843|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
82886844|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82886845|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82886846|NCT02076009|Growth Substances|growth substances|mesh-ancestor
82886847|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
82886848|NCT02043678|Prednisone|prednisone|mesh-list
82886849|NCT02043678|Prednisolone|prednisolone|mesh-list
82886850|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82886851|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886852|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
82886853|NCT02043678|Hormones|hormones|mesh-ancestor
82886854|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886855|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886856|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886857|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886858|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
82886859|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886860|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886861|NCT02043665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82886862|NCT02043665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886863|NCT01989585|Trametinib|trametinib|mesh-list
82886866|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886867|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886868|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886869|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886870|NCT01974440|Prednisone|prednisone|mesh-list
82886871|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
82886872|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82886873|NCT01974440|Rituximab|rituximab|mesh-list
82886874|NCT01974440|Doxorubicin|doxorubicin|mesh-list
82886875|NCT01974440|Vincristine|vincristine|mesh-list
82886876|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886877|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
82886878|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886879|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886880|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886881|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
82886882|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886883|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886884|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82886885|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886886|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82886887|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82886888|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886889|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886890|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886891|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
82886892|NCT01974440|Hormones|hormones|mesh-ancestor
82886893|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886894|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886895|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82886896|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
82886897|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886898|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886899|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
82886900|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82886901|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
82886902|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82886903|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886904|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82886905|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82886906|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82886907|NCT01959139|Leucovorin|leucovorin|mesh-list
82886908|NCT01959139|Fluorouracil|fluorouracil|mesh-list
82886909|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
82886910|NCT01959139|Irinotecan|irinotecan|mesh-list
82886911|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
82886912|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886913|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
82886914|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454485|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886915|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82886916|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886917|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82886918|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
82886919|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82886920|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82886921|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886922|NCT01959139|Antidotes|antidotes|mesh-ancestor
82886923|NCT01959139|Protective Agents|protective agents|mesh-ancestor
82886924|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
82886925|NCT01959139|Vitamins|vitamins|mesh-ancestor
82886926|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
82886927|NCT01912651|Cephalexin|cephalexin|mesh-list
82886928|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82886929|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82886930|NCT01912625|Paclitaxel|paclitaxel|mesh-list
82886931|NCT01912625|Carboplatin|carboplatin|mesh-list
82886932|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82886933|NCT01912625|Trametinib|trametinib|mesh-list
82886934|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82886935|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886936|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
82886937|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
82886938|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
82886939|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886940|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82886941|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886942|NCT01817166|Vitamin D|vitamin d|mesh-list
82886943|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
82886944|NCT01817166|Vitamins|vitamins|mesh-ancestor
82886945|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
82886946|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886947|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82886948|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82886949|NCT01814813|Bevacizumab|bevacizumab|mesh-list
82886950|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886951|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886952|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82886953|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82886954|NCT01814813|Growth Substances|growth substances|mesh-ancestor
82886955|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886956|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
82886957|NCT01792687|Prednisone|prednisone|mesh-list
82886958|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
82886959|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886960|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
82886961|NCT01792687|Hormones|hormones|mesh-ancestor
82886962|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82886963|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886964|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82886965|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886966|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82886967|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886968|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886969|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
82886970|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82886971|NCT01776840|Rituximab|rituximab|mesh-list
82886972|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82886973|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82886974|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82886975|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
82886976|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886977|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886978|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82886979|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
82886980|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886981|NCT01720836|Poly ICLC|poly iclc|mesh-list
82886982|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
82886983|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
82886984|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886985|NCT01667120|Ketorolac|ketorolac|mesh-list
82886986|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82886987|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82886988|NCT01667120|Analgesics|analgesics|mesh-ancestor
82886989|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
82886990|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82886991|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82886992|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82886993|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82886994|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82886995|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82886996|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82886997|NCT01642251|Cisplatin|cisplatin|mesh-list
82886998|NCT01642251|Etoposide|etoposide|mesh-list
82886999|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
82887000|NCT01642251|Veliparib|veliparib|mesh-list
82887001|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
82887002|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887003|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82887004|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82887005|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82887006|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887007|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887008|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82887009|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
82887010|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
82887011|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
82887012|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
82887013|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
82887014|NCT01615029|Dexamethasone|dexamethasone|mesh-list
82887015|NCT01615029|Lenalidomide|lenalidomide|mesh-list
82887016|NCT01615029|Daratumumab|daratumumab|mesh-list
82887017|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82887018|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887019|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
82887020|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
82887021|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887022|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887023|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82887024|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
82887025|NCT01615029|Hormones|hormones|mesh-ancestor
82887026|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887027|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82887028|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887029|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
82887030|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82887031|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82887032|NCT01615029|Growth Substances|growth substances|mesh-ancestor
82887033|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
82887034|NCT01606137|Nabiximols|nabiximols|mesh-list
82887035|NCT01606137|Analgesics|analgesics|mesh-ancestor
82887036|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
82887037|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887038|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887039|NCT01532518|MEN 11420|men 11420|mesh-list
82887040|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82887041|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
82887042|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887043|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887044|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82887045|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
82887046|NCT01489813|Genistein|genistein|mesh-list
82887047|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82887048|NCT01489813|Protective Agents|protective agents|mesh-ancestor
82887049|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887050|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887051|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82887052|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887053|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887054|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
82887055|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82887056|NCT01489813|Estrogens|estrogens|mesh-ancestor
82887057|NCT01489813|Hormones|hormones|mesh-ancestor
83454490|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887058|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887059|NCT01420874|Leucovorin|leucovorin|mesh-list
82887060|NCT01420874|Fluorouracil|fluorouracil|mesh-list
82887061|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
82887062|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
82887063|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887064|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82887065|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887066|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887067|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
82887068|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887069|NCT01420874|Antidotes|antidotes|mesh-ancestor
82887070|NCT01420874|Protective Agents|protective agents|mesh-ancestor
82887071|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
82887072|NCT01420874|Vitamins|vitamins|mesh-ancestor
82887073|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
82887074|NCT01405521|Vaccines|vaccines|mesh-list
82887075|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
82887076|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887077|NCT01314118|Prednisone|prednisone|mesh-list
82887078|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
82887079|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887080|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
82887081|NCT01314118|Hormones|hormones|mesh-ancestor
82887082|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887083|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887084|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82887085|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887086|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82887087|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887088|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887089|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
82887090|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82887091|NCT01093326|Ponesimod|ponesimod|mesh-list
82887092|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82887093|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887095|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
82887096|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887097|NCT01027000|Sirolimus|sirolimus|mesh-list
82887098|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
82887099|NCT01027000|Busulfan|busulfan|mesh-list
82887100|NCT01027000|Rituximab|rituximab|mesh-list
82887101|NCT01027000|Methotrexate|methotrexate|mesh-list
82887102|NCT01027000|Fludarabine|fludarabine|mesh-list
82887103|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
82887104|NCT01027000|Tacrolimus|tacrolimus|mesh-list
82887105|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887106|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
82887107|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887108|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887109|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82887110|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
82887111|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887112|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887113|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82887114|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887115|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82887116|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
82887117|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82887118|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82887119|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
82887120|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
82887121|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887122|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82887123|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82887124|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82887125|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887126|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887127|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82887128|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
82887129|NCT00980538|Etravirine|etravirine|mesh-list
82887130|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82887131|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82887132|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887133|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887134|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
82887135|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887136|NCT00861068|Lacosamide|lacosamide|mesh-list
82887137|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
82887138|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82887139|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82887140|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82887141|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887142|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
82887143|NCT00844285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82887144|NCT00844285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887145|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887146|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
82887147|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887148|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887149|NCT00841789|Etanercept|etanercept|mesh-list
82887150|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82887151|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82887152|NCT00841789|Analgesics|analgesics|mesh-ancestor
82887153|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
82887154|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887155|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887156|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887157|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887158|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82887159|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887160|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
82887161|NCT00711646|Nabiximols|nabiximols|mesh-list
82887162|NCT00711646|Analgesics|analgesics|mesh-ancestor
82887163|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
82887164|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887165|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887166|NCT00702468|Nabiximols|nabiximols|mesh-list
82887167|NCT00702468|Analgesics|analgesics|mesh-ancestor
82887168|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
82887169|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887170|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887171|NCT00681538|Nabiximols|nabiximols|mesh-list
82887172|NCT00681538|Analgesics|analgesics|mesh-ancestor
82887173|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
82887174|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887175|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887176|NCT00634634|Sorafenib|sorafenib|mesh-list
82887177|NCT00634634|Letrozole|letrozole|mesh-list
82887178|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887179|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82887180|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887181|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887182|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82887183|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82887184|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82887185|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
82887186|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887187|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887188|NCT00606346|Infliximab|infliximab|mesh-list
82887189|NCT00606346|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82887190|NCT00606346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887191|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
82887192|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82887193|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887194|NCT00497029|Fluorides|fluorides|mesh-list
82887195|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
82887196|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
82887197|NCT00497029|Protective Agents|protective agents|mesh-ancestor
82887198|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887199|NCT00455351|Vorinostat|vorinostat|mesh-list
82887200|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887201|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82887202|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887203|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887204|NCT00379340|Dactinomycin|dactinomycin|mesh-list
82887205|NCT00379340|Cactinomycin|cactinomycin|mesh-list
82887206|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
82887207|NCT00379340|Doxorubicin|doxorubicin|mesh-list
82887208|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82887209|NCT00379340|Etoposide|etoposide|mesh-list
82887210|NCT00379340|Vincristine|vincristine|mesh-list
82887211|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
82887212|NCT00379340|Podophyllotoxin|podophyllotoxin|mesh-list
82887213|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887214|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
82887215|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887216|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887217|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82887218|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
82887219|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887220|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887221|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82887222|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82887223|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82887224|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82887225|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887226|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82887227|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
82887228|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
82887229|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
82887230|NCT00379340|Keratolytic Agents|keratolytic agents|mesh-ancestor
82887231|NCT00379340|Dermatologic Agents|dermatologic agents|mesh-ancestor
82887232|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887233|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887234|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82887235|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82887236|NCT00301808|Docetaxel|docetaxel|mesh-list
82887237|NCT00301808|Pemetrexed|pemetrexed|mesh-list
82887238|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887239|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
82887240|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
82887241|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
82887242|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887244|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82887245|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82887247|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82887248|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82887249|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887250|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
82887251|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887252|NCT00138801|Doxycycline|doxycycline|mesh-list
82887253|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
82887254|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887255|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887256|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
82887257|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82887258|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82887259|NCT05795478|Pregabalin|pregabalin|mesh-list
82887260|NCT05795478|Oxycodone|oxycodone|mesh-list
82887261|NCT05795478|Analgesics|analgesics|mesh-ancestor
82887262|NCT05795478|Sensory System Agents|sensory system agents|mesh-ancestor
82887263|NCT05795478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887264|NCT05795478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887265|NCT05795478|Anticonvulsants|anticonvulsants|mesh-ancestor
82887266|NCT05795478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82887267|NCT05795478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82887268|NCT05795478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887269|NCT05795478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82887270|NCT05795478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82887271|NCT05795478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82887272|NCT05795478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887273|NCT05795478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887274|NCT05795478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82887275|NCT05795478|Narcotics|narcotics|mesh-ancestor
82887276|NCT05795413|Bupivacaine|bupivacaine|mesh-list
82887277|NCT05795413|Anesthetics, Local|anesthetics, local|mesh-ancestor
82887278|NCT05795413|Anesthetics|anesthetics|mesh-ancestor
82887279|NCT05795413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887280|NCT05795413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887281|NCT05795413|Sensory System Agents|sensory system agents|mesh-ancestor
82887282|NCT05795413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887283|NCT05795400|Dapagliflozin|dapagliflozin|mesh-list
82887284|NCT05795400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82887285|NCT05795400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887286|NCT05795400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82887287|NCT05795400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887288|NCT05795283|Dexetimide|dexetimide|mesh-list
82887289|NCT05795283|Citalopram|citalopram|mesh-list
82887290|NCT05795283|Escitalopram|escitalopram|mesh-list
82887291|NCT05795283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82887292|NCT05795283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82887293|NCT05795283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82887294|NCT05795283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887295|NCT05795283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887296|NCT05795283|Serotonin Agents|serotonin agents|mesh-ancestor
82887297|NCT05795283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887298|NCT05795283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82887299|NCT05795283|Antidepressive Agents|antidepressive agents|mesh-ancestor
82887300|NCT05795283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887301|NCT05795283|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82887302|NCT05795283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82887303|NCT05795283|Parasympatholytics|parasympatholytics|mesh-ancestor
82887304|NCT05795283|Autonomic Agents|autonomic agents|mesh-ancestor
82887305|NCT05795283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887306|NCT05795283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82887307|NCT05795283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82887308|NCT05795283|Cholinergic Agents|cholinergic agents|mesh-ancestor
82887310|NCT05795244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887311|NCT05795244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887312|NCT05795244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82887313|NCT05795244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887314|NCT05795062|Warfarin|warfarin|mesh-list
82887315|NCT05795062|Apixaban|apixaban|mesh-list
82887316|NCT05795062|Anticoagulants|anticoagulants|mesh-ancestor
82887317|NCT05795062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82887318|NCT05795062|Antithrombins|antithrombins|mesh-ancestor
82887319|NCT05795062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82887320|NCT05795062|Protease Inhibitors|protease inhibitors|mesh-ancestor
82887321|NCT05795062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887322|NCT05795062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887323|NCT05794997|Propranolol|propranolol|mesh-list
82887325|NCT05794997|Sotalol|sotalol|mesh-list
82887326|NCT05794997|Carvedilol|carvedilol|mesh-list
82887327|NCT05794997|Bisoprolol|bisoprolol|mesh-list
82887328|NCT05794997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82887329|NCT05794997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82887330|NCT05794997|Adrenergic Agents|adrenergic agents|mesh-ancestor
82887331|NCT05794997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887332|NCT05794997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887333|NCT05794997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887334|NCT05794997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82887335|NCT05794997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82887336|NCT05794997|Vasodilator Agents|vasodilator agents|mesh-ancestor
82887337|NCT05794997|Antioxidants|antioxidants|mesh-ancestor
82887338|NCT05794997|Protective Agents|protective agents|mesh-ancestor
82887339|NCT05794997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82887340|NCT05794997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82887341|NCT05794997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82887342|NCT05794997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82887343|NCT05794997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82887344|NCT05794997|Sympatholytics|sympatholytics|mesh-ancestor
82887345|NCT05794997|Autonomic Agents|autonomic agents|mesh-ancestor
82887346|NCT05794997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887347|NCT05794997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82887348|NCT05794919|Calcium, Dietary|calcium, dietary|mesh-list
82887349|NCT05794919|Phenol|phenol|mesh-list
82887350|NCT05794919|Calcium|calcium|mesh-list
82887351|NCT05794919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82887352|NCT05794919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887353|NCT05794919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82887354|NCT05794919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82887355|NCT05794919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887356|NCT05794919|Disinfectants|disinfectants|mesh-ancestor
82887357|NCT05794919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82887358|NCT05794919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82887359|NCT05794828|Bupivacaine|bupivacaine|mesh-list
82887360|NCT05794828|Anesthetics, Local|anesthetics, local|mesh-ancestor
82887361|NCT05794828|Anesthetics|anesthetics|mesh-ancestor
82887362|NCT05794828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887363|NCT05794828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887364|NCT05794828|Sensory System Agents|sensory system agents|mesh-ancestor
82887365|NCT05794828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887366|NCT05794659|Paclitaxel|paclitaxel|mesh-list
82887367|NCT05794659|Carboplatin|carboplatin|mesh-list
82887368|NCT05794659|Molgramostim|molgramostim|mesh-list
82887369|NCT05794659|Sargramostim|sargramostim|mesh-list
82887370|NCT05794659|Immunologic Factors|immunologic factors|mesh-ancestor
82887371|NCT05794659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887372|NCT05794659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82887373|NCT05794659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887374|NCT05794659|Tubulin Modulators|tubulin modulators|mesh-ancestor
82887375|NCT05794659|Antimitotic Agents|antimitotic agents|mesh-ancestor
82887376|NCT05794659|Mitosis Modulators|mitosis modulators|mesh-ancestor
82887377|NCT05794659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887378|NCT05794425|Cyclosporine|cyclosporine|mesh-list
82887379|NCT05794425|Cyclosporins|cyclosporins|mesh-list
82887380|NCT05794425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887381|NCT05794425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887382|NCT05794425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887383|NCT05794425|Immunologic Factors|immunologic factors|mesh-ancestor
83513460|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
82887384|NCT05794425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887385|NCT05794425|Antifungal Agents|antifungal agents|mesh-ancestor
82887386|NCT05794425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887387|NCT05794425|Dermatologic Agents|dermatologic agents|mesh-ancestor
82887388|NCT05794425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887389|NCT05794425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82887390|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
82887391|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887392|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887393|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
82887394|NCT05726097|Prucalopride|prucalopride|mesh-list
82887395|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
82887396|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
82887397|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887398|NCT05726097|Protective Agents|protective agents|mesh-ancestor
82887399|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887400|NCT05726097|Vitamins|vitamins|mesh-ancestor
82887401|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
82887402|NCT05726097|Laxatives|laxatives|mesh-ancestor
82887403|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82887404|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82887405|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82887406|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
82887407|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887408|NCT05726097|Cathartics|cathartics|mesh-ancestor
82887409|NCT05724329|Dasatinib|dasatinib|mesh-list
82887410|NCT05724329|Tislelizumab|tislelizumab|mesh-list
82887411|NCT05724329|Quercetin|quercetin|mesh-list
82887412|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887413|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82887414|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887415|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887416|NCT05724329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887417|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
82887418|NCT05724329|Protective Agents|protective agents|mesh-ancestor
82887419|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887420|NCT05712343|Valacyclovir|valacyclovir|mesh-list
82887421|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
82887422|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887423|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
82887424|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887425|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82887426|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82887427|NCT05703425|Analgesics|analgesics|mesh-ancestor
82887428|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
82887429|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887430|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887431|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887432|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887433|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82887434|NCT05700630|Vorinostat|vorinostat|mesh-list
82887435|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887436|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82887437|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887438|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887439|NCT05690503|Ketamine|ketamine|mesh-list
82887440|NCT05690503|Analgesics|analgesics|mesh-ancestor
82887441|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
82887442|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887443|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887444|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82887445|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82887446|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
82887447|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
82887448|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887449|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82887450|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82887451|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887452|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887453|NCT05667662|Itraconazole|itraconazole|mesh-list
82887454|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
82887455|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887456|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82887457|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82887458|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887459|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887460|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82887461|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
82887462|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887463|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887464|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82887465|NCT05667285|Sirolimus|sirolimus|mesh-list
82887466|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887467|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887468|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82887469|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887470|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
82887471|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887472|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
82887473|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887474|NCT05663515|Insulin|insulin|mesh-list
82887475|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82887476|NCT05663515|Exenatide|exenatide|mesh-list
82887477|NCT05663515|Biguanides|biguanides|mesh-list
82887478|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
82887479|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82887480|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887481|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82887482|NCT05663515|Incretins|incretins|mesh-ancestor
82887483|NCT05663515|Hormones|hormones|mesh-ancestor
82887484|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887485|NCT05624606|Vaccines|vaccines|mesh-list
82887486|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
82887487|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887488|NCT05608070|Oxytocin|oxytocin|mesh-list
82887489|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
82887490|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82887491|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887492|NCT05600062|Racecadotril|racecadotril|mesh-list
82887493|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
82887494|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82887495|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
82887496|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887497|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887498|NCT05588648|Vactosertib|vactosertib|mesh-list
83454509|NCT00985543|Ritonavir|ritonavir|mesh-list
82887499|NCT05588648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82887500|NCT05588648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887501|NCT05588648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887502|NCT05571267|Bevacizumab|bevacizumab|mesh-list
82887503|NCT05571267|Ranibizumab|ranibizumab|mesh-list
82887504|NCT05571267|Aflibercept|aflibercept|mesh-list
82887505|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887506|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887507|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82887508|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82887509|NCT05571267|Growth Substances|growth substances|mesh-ancestor
82887510|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887511|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
82887512|NCT05550194|Valacyclovir|valacyclovir|mesh-list
82887513|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
82887514|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887515|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
82887516|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
82887517|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887518|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887519|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82887520|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
82887521|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887522|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887523|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82887524|NCT05426486|Carboplatin|carboplatin|mesh-list
82887525|NCT05426486|Docetaxel|docetaxel|mesh-list
82887526|NCT05426486|Trastuzumab|trastuzumab|mesh-list
82887527|NCT05426486|Pertuzumab|pertuzumab|mesh-list
82887528|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887529|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
82887530|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
82887531|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
82887532|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887533|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887534|NCT05399290|Doxycycline|doxycycline|mesh-list
82887535|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887536|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887537|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
82887538|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82887539|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82887540|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
82887541|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82887542|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887543|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887544|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82887545|NCT05389852|Analgesics|analgesics|mesh-ancestor
82887546|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
82887547|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887548|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82887549|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82887550|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82887551|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
82887552|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887553|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887554|NCT05386914|Sirolimus|sirolimus|mesh-list
82887555|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887556|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887557|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82887558|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887559|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
82887560|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887561|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
82887562|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887563|NCT05383495|Midazolam|midazolam|mesh-list
82887564|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
82887565|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
82887566|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82887567|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887568|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887569|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82887570|NCT05383495|Analgesics|analgesics|mesh-ancestor
82887571|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
82887572|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887573|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82887574|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82887575|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82887576|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
82887577|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887578|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887579|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82887580|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82887581|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82887582|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887583|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82887584|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
82887585|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
82887586|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
82887587|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
82887588|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82887589|NCT05352828|Nivolumab|nivolumab|mesh-list
82887590|NCT05352828|Fludarabine|fludarabine|mesh-list
82887591|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82887592|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887593|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887594|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82887595|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887596|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82887597|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
82887598|NCT05318469|Ivermectin|ivermectin|mesh-list
82887599|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82887600|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887601|NCT05318248|Clonidine|clonidine|mesh-list
82887602|NCT05318248|Analgesics|analgesics|mesh-ancestor
82887603|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
82887604|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887605|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887606|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82887607|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
82887608|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
82887609|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82887610|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82887611|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82887612|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
82887613|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887614|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887615|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
82887616|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
82887617|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887618|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887619|NCT05287256|Dronabinol|dronabinol|mesh-list
82887620|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
82887621|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887622|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887623|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82887625|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
82887626|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887627|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82887628|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82887629|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887630|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887631|NCT05287256|Hormones|hormones|mesh-ancestor
82887632|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887633|NCT05219266|Midostaurin|midostaurin|mesh-list
82887634|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887635|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82887636|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887637|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887638|NCT05204862|Antibodies|antibodies|mesh-list
82887639|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
82887640|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887641|NCT05193851|Ricolinostat|ricolinostat|mesh-list
82887642|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887643|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82887644|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887645|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887646|NCT05193318|Ketamine|ketamine|mesh-list
82887647|NCT05193318|Analgesics|analgesics|mesh-ancestor
82887648|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
82887649|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887650|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887651|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82887652|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82887653|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
82887654|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
82887655|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887656|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82887657|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82887658|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887659|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887660|NCT05163041|Nivolumab|nivolumab|mesh-list
82887661|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887662|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887663|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82887664|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887665|NCT05138575|Empagliflozin|empagliflozin|mesh-list
82887666|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82887667|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887668|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82887669|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887670|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
82887671|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82887672|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
82887673|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887674|NCT05122559|Expectorants|expectorants|mesh-ancestor
82887675|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
82887676|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82887677|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
82887678|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887679|NCT05122559|Protective Agents|protective agents|mesh-ancestor
82887680|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887681|NCT05122559|Antidotes|antidotes|mesh-ancestor
82887682|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
82887683|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82887684|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
82887685|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82887686|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
82887687|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887688|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887689|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
82887690|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82887691|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82887692|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
82887693|NCT05054725|Sotorasib|sotorasib|mesh-list
82887695|NCT05054725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887696|NCT05054725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887697|NCT05054725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887699|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
82887700|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
82887701|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
82887702|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
82887703|NCT05047211|Hematinics|hematinics|mesh-ancestor
82887704|NCT05046522|Palmidrol|palmidrol|mesh-list
82887705|NCT05046522|Analgesics|analgesics|mesh-ancestor
82887706|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
82887707|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83454516|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82887708|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887709|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82887710|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82887711|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887712|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887713|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
82887714|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887715|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82887716|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82887717|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887718|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887719|NCT05046522|Hormones|hormones|mesh-ancestor
82887720|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887721|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
82887722|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887723|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887724|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82887725|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82887726|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887727|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887728|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887729|NCT04915482|Antibodies|antibodies|mesh-list
82887730|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
82887731|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887732|NCT04897971|Antibodies|antibodies|mesh-list
82887733|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
82887734|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887735|NCT04857827|Timolol|timolol|mesh-list
82887736|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82887737|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82887738|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887739|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82887740|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82887741|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
82887742|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887743|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887744|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82887745|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82887746|NCT04796584|Antibodies|antibodies|mesh-list
82887747|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
82887748|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887749|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82887750|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
82887751|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887752|NCT04712539|Oseltamivir|oseltamivir|mesh-list
82887753|NCT04712539|Baloxavir|baloxavir|mesh-list
82887754|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
82887755|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887756|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887757|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887758|NCT04688931|Mitomycins|mitomycins|mesh-list
82887759|NCT04688931|Mitomycin|mitomycin|mesh-list
82887760|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82887761|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887762|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
83482847|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887763|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887764|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82887765|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887766|NCT04630769|Interleukin-2|interleukin-2|mesh-list
82887767|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887771|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887772|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887773|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
82887774|NCT04622007|Pemetrexed|pemetrexed|mesh-list
82887775|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887776|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887777|NCT04622007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82887778|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887779|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887780|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82887781|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82887784|NCT04543188|Midazolam|midazolam|mesh-list
82887785|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82887786|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82887787|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82887788|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887789|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82887790|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82887791|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887792|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82887793|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
82887794|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
82887795|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
82887796|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
82887797|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887798|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887799|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82887800|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
82887801|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887802|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
82887803|NCT04499950|Naltrexone|naltrexone|mesh-list
82887804|NCT04499950|Bupropion|bupropion|mesh-list
82887805|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82887806|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82887807|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887808|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
82887809|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887810|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82887811|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
82887812|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887813|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82887814|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82887815|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82887816|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887817|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
82887818|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887819|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82887820|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82887821|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887822|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82887823|NCT04477512|Prednisone|prednisone|mesh-list
82887824|NCT04477512|Nivolumab|nivolumab|mesh-list
82887825|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
82887826|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887827|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
82887828|NCT04477512|Hormones|hormones|mesh-ancestor
82887829|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82887830|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887831|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82887832|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887833|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887834|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82887835|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887836|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82887837|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887838|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
82887839|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82887840|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82887841|NCT04459273|FAPI-46|fapi-46|mesh-list
82887842|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82887843|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887844|NCT04457232|FAPI-46|fapi-46|mesh-list
82887845|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82887846|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887847|NCT04407247|Infliximab|infliximab|mesh-list
82887848|NCT04407247|Vedolizumab|vedolizumab|mesh-list
82887849|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
82887850|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
82887851|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
82887852|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887853|NCT04407247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82887854|NCT04407247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82887855|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
82887856|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82887857|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82887858|NCT04349124|Nifedipine|nifedipine|mesh-list
82887859|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82887860|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82887861|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887862|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82887863|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887864|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
82887865|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
82887866|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82887867|NCT04348292|Sirolimus|sirolimus|mesh-list
82887868|NCT04348292|Durvalumab|durvalumab|mesh-list
82887869|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
82887870|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82887871|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
82887872|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887873|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887874|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82887875|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887876|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
82887877|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887878|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
82887879|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887880|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82887881|NCT04316676|Regadenoson|regadenoson|mesh-list
82887882|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82887883|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82887884|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
82887885|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
82887886|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887887|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887888|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887889|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
82887890|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82887891|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
82887892|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887893|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82887894|NCT04147494|Edetic Acid|edetic acid|mesh-list
82887895|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82887896|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82887897|NCT04147494|FAPI-46|fapi-46|mesh-list
82887898|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
82887899|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
82887900|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887901|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
82887902|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82887903|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82887904|NCT04138706|Vancomycin|vancomycin|mesh-list
82887905|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82887906|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82887907|NCT03991403|Paclitaxel|paclitaxel|mesh-list
82887908|NCT03991403|Bevacizumab|bevacizumab|mesh-list
82887909|NCT03991403|Carboplatin|carboplatin|mesh-list
82887910|NCT03991403|Pemetrexed|pemetrexed|mesh-list
82887911|NCT03991403|Atezolizumab|atezolizumab|mesh-list
82887912|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82887913|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887914|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
82887915|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
82887916|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83083942|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83454545|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82887920|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82887921|NCT03991403|Growth Substances|growth substances|mesh-ancestor
82887922|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887923|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
82887924|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887925|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82887926|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82887927|NCT03991403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82887928|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
82887929|NCT03930680|Razoxane|razoxane|mesh-list
82887930|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82887931|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82887932|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82887933|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82887934|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887935|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887936|NCT03930680|Protective Agents|protective agents|mesh-ancestor
82887937|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887938|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
82887939|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
82887940|NCT03900754|Oxytocin|oxytocin|mesh-list
82887941|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
82887942|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82887943|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887944|NCT03897439|Bupropion|bupropion|mesh-list
82887945|NCT03897439|Nicotine|nicotine|mesh-list
82887946|NCT03897439|Varenicline|varenicline|mesh-list
82887947|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82887948|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
82887949|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82887950|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887951|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82887952|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82887953|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
82887954|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82887955|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887956|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82887957|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
82887958|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82887959|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82887960|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82887961|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82887962|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
82887963|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82887964|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82887965|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887966|NCT03830164|Vitamins|vitamins|mesh-list
82887967|NCT03830164|Vitamin E|vitamin e|mesh-list
82887968|NCT03830164|Tocopherols|tocopherols|mesh-list
82887969|NCT03830164|Tocotrienols|tocotrienols|mesh-list
82887970|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
82887971|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
82887972|NCT03830164|Atorvastatin|atorvastatin|mesh-list
82887973|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
82887974|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82887975|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82887976|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82887977|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
82887978|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887979|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82887980|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82887981|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82887982|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
82887983|NCT03830164|Protective Agents|protective agents|mesh-ancestor
82887984|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82887985|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82887986|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82887987|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
82887988|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82887996|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82887997|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
83454548|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82887998|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82887999|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888000|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888001|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888002|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
82888003|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888004|NCT03784326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82888005|NCT03784326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888007|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82888008|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82888009|NCT03777436|Analgesics|analgesics|mesh-ancestor
82888010|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
82888011|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888012|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888013|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888014|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888015|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82888016|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82888017|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888018|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888019|NCT03773302|Gemcitabine|gemcitabine|mesh-list
82888020|NCT03773302|Infigratinib|infigratinib|mesh-list
82888021|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888022|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888023|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
82888024|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888025|NCT03701763|Apremilast|apremilast|mesh-list
82888026|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82888027|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82888028|NCT03701763|Analgesics|analgesics|mesh-ancestor
82888029|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
82888030|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888031|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888032|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888033|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888034|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82888035|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82888036|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888037|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888038|NCT03673462|Vaccines|vaccines|mesh-list
82888039|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
82888040|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888041|NCT03649880|Misonidazole|misonidazole|mesh-list
82888042|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888043|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82888044|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82888045|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888046|NCT03592992|Morphine|morphine|mesh-list
82888047|NCT03592992|Hydromorphone|hydromorphone|mesh-list
82888048|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82888049|NCT03592992|Narcotics|narcotics|mesh-ancestor
82888050|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888051|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888052|NCT03592992|Analgesics|analgesics|mesh-ancestor
82888053|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
82888054|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888055|NCT03447808|Daratumumab|daratumumab|mesh-list
82888056|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888057|NCT03386240|Triclosan|triclosan|mesh-list
82888058|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82888059|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888060|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82888061|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82888062|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
82888063|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888064|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82888065|NCT03366766|Cisplatin|cisplatin|mesh-list
82888066|NCT03366766|Gemcitabine|gemcitabine|mesh-list
82888067|NCT03366766|Nivolumab|nivolumab|mesh-list
82888068|NCT03366766|Pemetrexed|pemetrexed|mesh-list
82888069|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888070|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888071|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
82888072|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888073|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888074|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82888075|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82729007|NCT00932386|Analgesics|analgesics|mesh-ancestor
82888076|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82888077|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82888078|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
82888079|NCT03308448|Hematinics|hematinics|mesh-ancestor
82888081|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
82888082|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888083|NCT03254927|Cetuximab|cetuximab|mesh-list
82888084|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888085|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888086|NCT03039036|Misoprostol|misoprostol|mesh-list
82888087|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82888088|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
82888089|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82888090|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888091|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82888092|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82888093|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
82888094|NCT03025880|Gemcitabine|gemcitabine|mesh-list
82888095|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
82888096|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888097|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
82888098|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888099|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888100|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888101|NCT03025880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82888102|NCT02962297|Vitamin E|vitamin e|mesh-list
82888103|NCT02962297|Vitamins|vitamins|mesh-ancestor
82888104|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
82888105|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888106|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
82888107|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888108|NCT02962297|Protective Agents|protective agents|mesh-ancestor
82888109|NCT02939742|Betamethasone|betamethasone|mesh-list
82888110|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888111|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
82888112|NCT02939742|Hormones|hormones|mesh-ancestor
82888113|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888114|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888115|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82888116|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
82888117|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
82888118|NCT02693535|Nivolumab|nivolumab|mesh-list
82888119|NCT02693535|Trastuzumab|trastuzumab|mesh-list
82888120|NCT02693535|Ipilimumab|ipilimumab|mesh-list
82888121|NCT02693535|Atezolizumab|atezolizumab|mesh-list
82888122|NCT02693535|Pertuzumab|pertuzumab|mesh-list
82888123|NCT02693535|Sunitinib|sunitinib|mesh-list
82888124|NCT02693535|Olaparib|olaparib|mesh-list
82888125|NCT02693535|Palbociclib|palbociclib|mesh-list
82888126|NCT02693535|Temsirolimus|temsirolimus|mesh-list
82888127|NCT02693535|Vemurafenib|vemurafenib|mesh-list
82888128|NCT02693535|Talazoparib|talazoparib|mesh-list
82888129|NCT02693535|Tucatinib|tucatinib|mesh-list
82888130|NCT02693535|Futibatinib|futibatinib|mesh-list
82888131|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82888132|NCT02693535|Entrectinib|entrectinib|mesh-list
82888133|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888134|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888135|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82888136|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888137|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
82888138|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888139|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82888140|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82888141|NCT02693535|Growth Substances|growth substances|mesh-ancestor
82888142|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
82888143|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888144|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888145|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82888147|NCT02693535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888148|NCT02678572|Melphalan|melphalan|mesh-list
82888149|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82888150|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
82888151|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888152|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888153|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82888154|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888155|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
82888156|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888157|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82888159|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
82888160|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82888161|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
82888162|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
82888163|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888164|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888165|NCT02518555|Vaccines|vaccines|mesh-list
82888166|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
82888167|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888168|NCT02027376|Docetaxel|docetaxel|mesh-list
82888169|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888170|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
82888171|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
82888172|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
82888173|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888174|NCT02005289|Lenalidomide|lenalidomide|mesh-list
82888175|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
82888176|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888177|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82888178|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82888179|NCT02005289|Growth Substances|growth substances|mesh-ancestor
82888180|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
82888181|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888182|NCT01924533|Paclitaxel|paclitaxel|mesh-list
82888183|NCT01924533|Olaparib|olaparib|mesh-list
82888184|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82888185|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888186|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
82888187|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
82888188|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
82888189|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888190|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82888191|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888192|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
82888193|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82888194|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82888195|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888196|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
82888197|NCT01683955|Coagulants|coagulants|mesh-ancestor
82888198|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
82888199|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888200|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888201|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82888202|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82888203|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888204|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888205|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888206|NCT01453088|Bortezomib|bortezomib|mesh-list
82888207|NCT01453088|Melphalan|melphalan|mesh-list
82888208|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888209|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82888210|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
82888211|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888212|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82888213|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888214|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
82888215|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888216|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82888217|NCT01345175|Metronidazole|metronidazole|mesh-list
82888218|NCT01345175|Rifaximin|rifaximin|mesh-list
82888219|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82888221|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
82888222|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82888223|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82888224|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82888226|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
82888227|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888228|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888229|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888230|NCT01257139|Docetaxel|docetaxel|mesh-list
82888231|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888232|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
82888233|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
82888234|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
82888235|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888237|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888238|NCT01046825|Leucovorin|leucovorin|mesh-list
82888239|NCT01046825|Folic Acid|folic acid|mesh-list
82888240|NCT01046825|Cytarabine|cytarabine|mesh-list
82888241|NCT01046825|Prednisone|prednisone|mesh-list
82888242|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
82888243|NCT01046825|Doxorubicin|doxorubicin|mesh-list
82888244|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82888245|NCT01046825|Rituximab|rituximab|mesh-list
82888246|NCT01046825|Rasburicase|rasburicase|mesh-list
82888247|NCT01046825|Lenograstim|lenograstim|mesh-list
82888248|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
82888249|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888250|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
82888251|NCT01046825|Hormones|hormones|mesh-ancestor
82888252|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888253|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888254|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82888255|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888256|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82888257|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
82888258|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888259|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888260|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82888261|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
82888262|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888263|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82888264|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82888265|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82888266|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82888267|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888268|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888269|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888270|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
82888271|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
82888272|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888273|NCT01046825|Antidotes|antidotes|mesh-ancestor
82888274|NCT01046825|Protective Agents|protective agents|mesh-ancestor
82888275|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
82888276|NCT01046825|Vitamins|vitamins|mesh-ancestor
82888277|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
82888278|NCT01046825|Hematinics|hematinics|mesh-ancestor
82888279|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
82888280|NCT00936936|Carboplatin|carboplatin|mesh-list
82888281|NCT00936936|Gemcitabine|gemcitabine|mesh-list
82888282|NCT00936936|Docetaxel|docetaxel|mesh-list
82888283|NCT00936936|Etoposide|etoposide|mesh-list
82888284|NCT00936936|Melphalan|melphalan|mesh-list
82888285|NCT00936936|Ifosfamide|ifosfamide|mesh-list
82888286|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888287|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888288|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
82888289|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888290|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
82888291|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
82888292|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
82888293|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82888294|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82888295|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82888296|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888297|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82888299|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82888300|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888301|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
82888302|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888303|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
82888304|NCT04478292|Cisplatin|cisplatin|mesh-list
82888305|NCT04478292|Carboplatin|carboplatin|mesh-list
82888306|NCT04478292|Doxorubicin|doxorubicin|mesh-list
82888307|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82888308|NCT04478292|Fluorouracil|fluorouracil|mesh-list
82888309|NCT04478292|Irinotecan|irinotecan|mesh-list
82888310|NCT04478292|Vincristine|vincristine|mesh-list
82888311|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888312|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82888313|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82888314|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82888315|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888316|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888317|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
82888318|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888319|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888320|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
82888321|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888322|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82888323|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82888324|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
82888325|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
82888326|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
82888327|NCT04478292|Antidotes|antidotes|mesh-ancestor
82888328|NCT04478292|Protective Agents|protective agents|mesh-ancestor
82888329|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
82888330|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
82888331|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888332|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888333|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
82888334|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
82888335|NCT01141296|Fenofibrate|fenofibrate|mesh-list
82888336|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82888337|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
82888338|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888339|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82888340|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
82888341|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82888342|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888343|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
82888344|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888345|NCT01238406|Pancrelipase|pancrelipase|mesh-list
82888346|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82888347|NCT03724890|Avelumab|avelumab|mesh-list
82888348|NCT03724890|Peposertib|peposertib|mesh-list
82888349|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888350|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888351|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888352|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888353|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888354|NCT01141452|Fluticasone|fluticasone|mesh-list
82888355|NCT01141452|Xhance|xhance|mesh-list
82888356|NCT01141452|Beclomethasone|beclomethasone|mesh-list
82888357|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888358|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82888359|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
82888360|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888361|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888362|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82888363|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
82888364|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
82888365|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82888366|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
82888367|NCT01141452|Hormones|hormones|mesh-ancestor
83454571|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888368|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888369|NCT00219557|Gemcitabine|gemcitabine|mesh-list
82888370|NCT00219557|Axitinib|axitinib|mesh-list
82888371|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888372|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
82888373|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888374|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888375|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888376|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888377|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
82888378|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82888379|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82888380|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
82888381|NCT05282940|Estradiol|estradiol|mesh-list
82888382|NCT05282940|Estrogens|estrogens|mesh-ancestor
82888383|NCT05282940|Hormones|hormones|mesh-ancestor
82888384|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888385|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888386|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82888387|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
82888388|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82888389|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82888390|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82888391|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82888392|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82888393|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82888394|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
82888395|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82888396|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82888397|NCT01238562|Lenograstim|lenograstim|mesh-list
82888398|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82888399|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
82888400|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888401|NCT01329666|Vitamin D|vitamin d|mesh-list
82888402|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
82888403|NCT01329666|Vitamins|vitamins|mesh-ancestor
82888404|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
82888405|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888406|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82888407|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82888408|NCT05255484|Antibodies|antibodies|mesh-list
82888409|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
82888410|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888411|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
82888412|NCT01141998|Vitamin D|vitamin d|mesh-list
82888413|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
82888414|NCT01141998|Calcium|calcium|mesh-list
82888415|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82888416|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888417|NCT01141998|Vitamins|vitamins|mesh-ancestor
82888418|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
82888419|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82888420|NCT01238718|Lidocaine|lidocaine|mesh-list
82888421|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
82888422|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
82888423|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888424|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888425|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
82888426|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888427|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82888428|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82888429|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82888430|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82888431|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888432|NCT01238796|Telavancin|telavancin|mesh-list
82888433|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888434|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888435|NCT01143948|Insulin|insulin|mesh-list
82888436|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82888437|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82888438|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888439|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
82888440|NCT01145976|Fludarabine|fludarabine|mesh-list
82888441|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
82888442|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82888443|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888444|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
82888445|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888446|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888447|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82888448|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
82888449|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888457|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888458|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888460|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
82888461|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
82888462|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82888463|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82888464|NCT01144260|Bafetinib|bafetinib|mesh-list
82888465|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888466|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888467|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888468|NCT01239498|Lidocaine|lidocaine|mesh-list
82888469|NCT01239498|Epinephrine|epinephrine|mesh-list
82888470|NCT01239498|Racepinephrine|racepinephrine|mesh-list
82888471|NCT01239498|Anesthetics|anesthetics|mesh-list
82888472|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
82888473|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
82888474|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888475|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888476|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
82888477|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888478|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82888479|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82888480|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82888481|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82888482|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888483|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82888484|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82888485|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
82888486|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888487|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82888488|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82888489|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
82888490|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82888491|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
82888492|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
82888493|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
82888494|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82888495|NCT00251927|Esomeprazole|esomeprazole|mesh-list
82888496|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82888497|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82888498|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82888499|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888500|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888502|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82888503|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
82888504|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82888505|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
82888506|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888507|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888508|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888509|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82888510|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82888511|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82888512|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
82888513|NCT03971201|Sorafenib|sorafenib|mesh-list
82888514|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888515|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888516|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888517|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888533|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888534|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82888536|NCT03971279|Hormones|hormones|mesh-ancestor
82888537|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888538|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82888539|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888540|NCT01329744|Mecasermin|mecasermin|mesh-list
82888541|NCT01329744|Growth Substances|growth substances|mesh-ancestor
82888542|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888543|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
82888544|NCT00165503|Pemetrexed|pemetrexed|mesh-list
82888545|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888546|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888547|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888548|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82888549|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82888550|NCT00165503|Antidotes|antidotes|mesh-ancestor
82888551|NCT00165503|Protective Agents|protective agents|mesh-ancestor
82888552|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888553|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
82888554|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
82888555|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888556|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888557|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
82888558|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
82888559|NCT01144650|Dapsone|dapsone|mesh-list
82888560|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888561|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
82888562|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82888563|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82888564|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82888565|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888566|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888567|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
82888568|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888583|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82888584|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82888585|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
82888586|NCT03970577|Prednisone|prednisone|mesh-list
82888587|NCT03970577|Rituximab|rituximab|mesh-list
82888588|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888589|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888590|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
82888591|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888592|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888593|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888594|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
82888595|NCT03970577|Hormones|hormones|mesh-ancestor
82888596|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888597|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82888598|NCT01073813|Minocycline|minocycline|mesh-list
82888599|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888600|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888601|NCT03823391|Adalimumab|adalimumab|mesh-list
82888602|NCT03823391|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82888603|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82888604|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888605|NCT00161213|Gemcitabine|gemcitabine|mesh-list
82888606|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
82888607|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888608|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
82888609|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888610|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888611|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888612|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888613|NCT01075529|Fluoxetine|fluoxetine|mesh-list
82888614|NCT01075529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82888615|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82888616|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82888617|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888618|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888619|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
82888620|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888621|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82888622|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
82888623|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82888624|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82888625|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82888626|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888627|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
82888628|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82888629|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888630|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888631|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82888632|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82888633|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888634|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888635|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888636|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82888637|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
82888638|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82888639|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888640|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82888641|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82888642|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82888643|NCT00209027|Aripiprazole|aripiprazole|mesh-list
82888644|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
82888645|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82888646|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82888647|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82888648|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888649|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888650|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
82888651|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
82888652|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888653|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888654|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82888655|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82888656|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
82888657|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82888658|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82888659|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82888660|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82888661|NCT00160667|Brivaracetam|brivaracetam|mesh-list
82888662|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
82888663|NCT00206375|Hormones|hormones|mesh-list
82888664|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888665|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888666|NCT00160199|Progesterone|progesterone|mesh-list
82888667|NCT00160199|Progestins|progestins|mesh-ancestor
82888669|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888670|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888671|NCT00157157|Factor VIII|factor viii|mesh-list
82888672|NCT00157157|Coagulants|coagulants|mesh-ancestor
82888673|NCT00203411|Bevacizumab|bevacizumab|mesh-list
82888674|NCT00203411|Capecitabine|capecitabine|mesh-list
82888675|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888676|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888677|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82888678|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82888679|NCT00203411|Growth Substances|growth substances|mesh-ancestor
82888680|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888681|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
82888682|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888683|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
82888684|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888685|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
82888686|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
82888687|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82888688|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
82888689|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888690|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888691|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888692|NCT00201851|Tamoxifen|tamoxifen|mesh-list
82888693|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82888694|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
82888695|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888696|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888697|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82888698|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888699|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82888700|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82888701|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82888702|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
82888703|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82888704|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888705|NCT01074281|Enalapril|enalapril|mesh-list
82888706|NCT01074281|Enalaprilat|enalaprilat|mesh-list
82888707|NCT01074281|Nitrendipine|nitrendipine|mesh-list
82888708|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888709|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888710|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82888711|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
82888712|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82888713|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82888714|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82888715|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82888716|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888717|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
82888718|NCT03129100|Ixekizumab|ixekizumab|mesh-list
82888719|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
82888720|NCT03100006|Nivolumab|nivolumab|mesh-list
82888721|NCT03100006|Oregovomab|oregovomab|mesh-list
82888722|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888723|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888724|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82888725|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888727|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
82888728|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82888729|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888730|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888731|NCT05149768|Immunotoxins|immunotoxins|mesh-ancestor
82888732|NCT05149768|Immunoconjugates|immunoconjugates|mesh-ancestor
82888733|NCT05149768|Immunologic Factors|immunologic factors|mesh-ancestor
82888734|NCT05149768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888735|NCT00883480|Gemcitabine|gemcitabine|mesh-list
82888736|NCT00883480|Docetaxel|docetaxel|mesh-list
82888737|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82888738|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888739|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888740|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
82888741|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888744|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
82888745|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888746|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888747|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
82888748|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82888749|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888750|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82888751|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888752|NCT03097588|Palonosetron|palonosetron|mesh-list
82888753|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
82888754|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
82888755|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888756|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888757|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82888758|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82888759|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82888760|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
82888761|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888762|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888763|NCT05418244|Ondansetron|ondansetron|mesh-list
82888764|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
82888765|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
82888766|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888767|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888768|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82888769|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
82888770|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
82888771|NCT05418244|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82888772|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82888773|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
82888774|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888775|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888776|NCT05418166|Evolocumab|evolocumab|mesh-list
82888777|NCT05418166|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82888778|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82888779|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82888780|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
82888781|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888782|NCT05418166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82888783|NCT05418166|Protease Inhibitors|protease inhibitors|mesh-ancestor
82888784|NCT05418166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888785|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82888786|NCT01631214|Alendronate|alendronate|mesh-list
82888787|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82888788|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82888789|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888790|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
82888791|NCT01567774|Atorvastatin|atorvastatin|mesh-list
82888792|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82888793|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82888794|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82888795|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
82888796|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888797|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82888798|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82888799|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888800|NCT04663750|Aflibercept|aflibercept|mesh-list
82888801|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82888802|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82888803|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82888804|NCT04663750|Growth Substances|growth substances|mesh-ancestor
82888805|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888806|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
82888807|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888808|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82888809|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82888810|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888811|NCT01567930|Sirolimus|sirolimus|mesh-list
82888812|NCT01567930|Temsirolimus|temsirolimus|mesh-list
82888813|NCT01567930|MTOR Inhibitors|mtor inhibitors|mesh-list
82888814|NCT01567930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82888815|NCT01567930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888816|NCT01567930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888817|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888818|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
82888819|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888820|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888821|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888822|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888823|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82888824|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
82888825|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
82888827|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454600|NCT04771156|Ketorolac|ketorolac|mesh-list
82888828|NCT04604548|Protective Agents|protective agents|mesh-ancestor
82888829|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888830|NCT01142622|Ropivacaine|ropivacaine|mesh-list
82888831|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
82888832|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
82888833|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888834|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888835|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
82888836|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888837|NCT01142700|Ribavirin|ribavirin|mesh-list
82888838|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82888839|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
82888840|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888841|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
82888842|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888843|NCT01144728|Metformin|metformin|mesh-list
82888844|NCT01144728|Glimepiride|glimepiride|mesh-list
82888845|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82888846|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888847|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82888848|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888849|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
82888850|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
82888851|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82888852|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
82888853|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888854|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
82888855|NCT01239810|Protective Agents|protective agents|mesh-ancestor
82888856|NCT01239888|Tibolone|tibolone|mesh-list
82888857|NCT01239888|Oxytocin|oxytocin|mesh-list
82888858|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
82888859|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82888860|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888861|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
82888862|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
82888863|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888864|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82888865|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82888866|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888867|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82888868|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
82888869|NCT01239888|Hormones|hormones|mesh-ancestor
82888870|NCT01318486|Heparin|heparin|mesh-list
82888871|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
82888872|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82888873|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82888874|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888875|NCT03436108|Bisphenol A|bisphenol a|mesh-list
82888876|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82888877|NCT03436108|Estrogens|estrogens|mesh-ancestor
82888878|NCT03436108|Hormones|hormones|mesh-ancestor
82888879|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82888880|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888881|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82888882|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
82888883|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888884|NCT03436108|Protective Agents|protective agents|mesh-ancestor
82888885|NCT02870218|Nicotine|nicotine|mesh-list
82888886|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82888887|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
82888888|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888889|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888890|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82888891|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82888892|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
82888893|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888894|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888895|NCT02614690|Calpastatin|calpastatin|mesh-list
82888896|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83454603|NCT04771156|Analgesics|analgesics|mesh-ancestor
82888897|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
82888898|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888899|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888900|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82888901|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82888902|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888903|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888904|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
82888905|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888906|NCT00468130|Aripiprazole|aripiprazole|mesh-list
82888907|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
82888908|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82888909|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82888910|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82888911|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888912|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888913|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
82888914|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
82888915|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82888916|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888917|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82888918|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82888919|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
82888920|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82888921|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82888922|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82888923|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82888924|NCT05196256|Sufentanil|sufentanil|mesh-list
82888925|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
82888926|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82888927|NCT05196256|Narcotics|narcotics|mesh-ancestor
82888928|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888929|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888930|NCT05196256|Analgesics|analgesics|mesh-ancestor
82888931|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
82888932|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888933|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82888934|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82888935|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
82888936|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
82888937|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
82888938|NCT01375348|Remifentanil|remifentanil|mesh-list
82888939|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82888940|NCT01375348|Narcotics|narcotics|mesh-ancestor
82888941|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888942|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888943|NCT01375348|Analgesics|analgesics|mesh-ancestor
82888944|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
82888945|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888946|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
82888947|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
82888948|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82888949|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
82888950|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888951|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888952|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82888953|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
82888954|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888955|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888956|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82888957|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82888958|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82888959|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
82888960|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888961|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888962|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888963|NCT05194852|Anesthetics|anesthetics|mesh-list
82888964|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
82888965|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82888966|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888967|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
82888968|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82888970|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82888971|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82888972|NCT05193838|Allopurinol|allopurinol|mesh-list
82888973|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
82888974|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888975|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82888976|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
82888977|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82888978|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82888979|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
82888980|NCT05193838|Protective Agents|protective agents|mesh-ancestor
82888981|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82888982|NCT05193604|Paclitaxel|paclitaxel|mesh-list
82888983|NCT05193604|Gemcitabine|gemcitabine|mesh-list
82888984|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82888985|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82888986|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
82888987|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
82888988|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
82888989|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82888990|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82888991|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
82888992|NCT01375816|Leucovorin|leucovorin|mesh-list
82888993|NCT01375816|Bevacizumab|bevacizumab|mesh-list
82888994|NCT01375816|Fluorouracil|fluorouracil|mesh-list
82888995|NCT01375816|Irinotecan|irinotecan|mesh-list
82888996|NCT01375816|Calcium|calcium|mesh-list
82888997|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
82888998|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82888999|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889000|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889001|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889002|NCT01375816|Growth Substances|growth substances|mesh-ancestor
82889003|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889004|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889005|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82889006|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
82889007|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889008|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82889009|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82889010|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
82889011|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82889012|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82889013|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889014|NCT01375816|Antidotes|antidotes|mesh-ancestor
82889015|NCT01375816|Protective Agents|protective agents|mesh-ancestor
82889016|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
82889017|NCT01375816|Vitamins|vitamins|mesh-ancestor
82889018|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
82889019|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
82889020|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82889021|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82889022|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889023|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
82889024|NCT03632824|Coagulants|coagulants|mesh-ancestor
82889025|NCT00911820|Bevacizumab|bevacizumab|mesh-list
82889026|NCT00911820|Cisplatin|cisplatin|mesh-list
82889027|NCT00911820|Docetaxel|docetaxel|mesh-list
82889028|NCT00911820|Irinotecan|irinotecan|mesh-list
82889029|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889030|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889031|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889032|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889033|NCT00911820|Growth Substances|growth substances|mesh-ancestor
82889034|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889035|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889036|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
82889037|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
82889038|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
82889039|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889040|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82889042|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889043|NCT05348122|Dulaglutide|dulaglutide|mesh-list
82889044|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82889045|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82889046|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889047|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
82889048|NCT05125276|Aspirin|aspirin|mesh-list
82889049|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82889050|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889051|NCT05125276|Analgesics|analgesics|mesh-ancestor
82889052|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
82889053|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889054|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889055|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889056|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889057|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82889058|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82889059|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889060|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82889061|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82889062|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889063|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
82889064|NCT05054842|Metformin|metformin|mesh-list
82889065|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82889066|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889067|NCT05038618|Somatomedin B|somatomedin b|mesh-list
82889068|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82889069|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82889070|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
82889071|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889072|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889073|NCT01244880|Ketamine|ketamine|mesh-list
82889074|NCT01244880|Analgesics|analgesics|mesh-ancestor
82889075|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
82889076|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889077|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889078|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82889079|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82889080|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
82889081|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
82889082|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889083|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82889084|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82889085|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889086|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889087|NCT01244958|Rituximab|rituximab|mesh-list
82889088|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889089|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889090|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
82889091|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889092|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889093|NCT00246324|Interferons|interferons|mesh-list
82889094|NCT00246324|Interferon-beta|interferon-beta|mesh-list
82889095|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
82889096|NCT00246324|Doxycycline|doxycycline|mesh-list
82889097|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889098|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
82889099|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889100|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82889101|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
82889102|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82889103|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82889104|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
82889105|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889106|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82889108|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82889109|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889110|NCT01245660|Lapatinib|lapatinib|mesh-list
82889111|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889112|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82889113|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889114|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889115|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
82889116|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889117|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82889118|NCT03913806|Bevacizumab|bevacizumab|mesh-list
82889119|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889120|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889121|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889122|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889123|NCT03913806|Growth Substances|growth substances|mesh-ancestor
82889124|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889125|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889126|NCT01250808|Dexamethasone|dexamethasone|mesh-list
82889127|NCT01250808|Bortezomib|bortezomib|mesh-list
82889128|NCT01250808|Melphalan|melphalan|mesh-list
82889129|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889130|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
82889131|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
82889132|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889133|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889134|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889135|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
82889136|NCT01250808|Hormones|hormones|mesh-ancestor
82889137|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889138|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82889139|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889140|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82889141|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
82889142|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889143|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82889144|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82889145|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
82889146|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
82889147|NCT01146678|Lixisenatide|lixisenatide|mesh-list
82889148|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82889149|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889150|NCT05429866|Nivolumab|nivolumab|mesh-list
82889151|NCT05429866|Atezolizumab|atezolizumab|mesh-list
82889152|NCT05429866|Durvalumab|durvalumab|mesh-list
82889153|NCT05429866|Avelumab|avelumab|mesh-list
82889154|NCT05429866|Cemiplimab|cemiplimab|mesh-list
82889155|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82889156|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889157|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889158|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889159|NCT04778982|Fulvestrant|fulvestrant|mesh-list
82889160|NCT04778982|Palbociclib|palbociclib|mesh-list
82889161|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82889162|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889163|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82889164|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82889165|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
82889166|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889167|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889168|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82889169|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889170|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889171|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82889172|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
82889173|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
82889174|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
82889175|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889176|NCT03632590|Analgesics|analgesics|mesh-ancestor
82889177|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
82889178|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889179|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889180|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
82889181|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889182|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82889183|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
82889184|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82889185|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889186|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82889187|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
82889188|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889189|NCT03632590|Cathartics|cathartics|mesh-ancestor
82889190|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889192|NCT05376670|Gentamicins|gentamicins|mesh-list
82889193|NCT05376670|Tobramycin|tobramycin|mesh-list
82889194|NCT05376670|Amikacin|amikacin|mesh-list
82889195|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82889196|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889197|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82889198|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889199|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889200|NCT01242774|Panobinostat|panobinostat|mesh-list
82889201|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889202|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82889203|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889204|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889205|NCT01243086|Dexamethasone|dexamethasone|mesh-list
82889206|NCT01243086|Ranibizumab|ranibizumab|mesh-list
82889207|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889208|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
82889209|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
82889210|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889211|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889212|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889213|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
82889214|NCT01243086|Hormones|hormones|mesh-ancestor
82889215|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889216|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82889217|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889218|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889219|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889220|NCT01243086|Growth Substances|growth substances|mesh-ancestor
82889221|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889222|NCT03908814|Antibodies|antibodies|mesh-list
82889223|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
82889224|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889225|NCT01253382|Ecallantide|ecallantide|mesh-list
82889226|NCT01253382|Analgesics|analgesics|mesh-ancestor
82889227|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
82889228|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889229|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889230|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82889231|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889232|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889233|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889234|NCT01148160|Voriconazole|voriconazole|mesh-list
82889235|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
82889236|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889237|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82889238|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82889239|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889240|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889241|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82889242|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
82889243|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889244|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889245|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82889246|NCT01147692|Simvastatin|simvastatin|mesh-list
82889247|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
82889248|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82889249|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82889250|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
82889251|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889252|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83454631|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
82889253|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82889254|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889255|NCT01147692|Incretins|incretins|mesh-ancestor
82889256|NCT01147692|Hormones|hormones|mesh-ancestor
82889257|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889258|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889259|NCT03913182|Apatinib|apatinib|mesh-list
82889260|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889261|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82889262|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889263|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889264|NCT02713386|Paclitaxel|paclitaxel|mesh-list
82889265|NCT02713386|Carboplatin|carboplatin|mesh-list
82889266|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82889267|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82889268|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889269|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
82889270|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
82889271|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
82889272|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889273|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
82889274|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82889275|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
82889276|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889277|NCT01967238|Vaccines|vaccines|mesh-list
82889278|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
82889279|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889280|NCT05616000|Folic Acid|folic acid|mesh-list
82889281|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
82889282|NCT05616000|Hematinics|hematinics|mesh-ancestor
82889283|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
82889284|NCT05616000|Vitamins|vitamins|mesh-ancestor
82889285|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
82889286|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889287|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
82889288|NCT03912402|Paclitaxel|paclitaxel|mesh-list
82889289|NCT03912402|Bevacizumab|bevacizumab|mesh-list
82889290|NCT03912402|Carboplatin|carboplatin|mesh-list
82889291|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82889292|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889293|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
82889294|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
82889295|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
82889296|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889297|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889298|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889299|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889300|NCT03912402|Growth Substances|growth substances|mesh-ancestor
82889301|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889302|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889303|NCT01147770|Progesterone|progesterone|mesh-list
82889304|NCT01147770|Progestins|progestins|mesh-ancestor
82889305|NCT01147770|Hormones|hormones|mesh-ancestor
82889306|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889307|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889308|NCT01148316|Fluoxetine|fluoxetine|mesh-list
82889309|NCT01148316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82889310|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82889311|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889312|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889313|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889314|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
82889315|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889316|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82889317|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
82889318|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82889319|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82889320|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82889321|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889322|NCT01249638|Bevacizumab|bevacizumab|mesh-list
82889323|NCT01249638|Capecitabine|capecitabine|mesh-list
82889324|NCT01249638|Irinotecan|irinotecan|mesh-list
82889325|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889326|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889327|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889328|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889329|NCT01249638|Growth Substances|growth substances|mesh-ancestor
82889330|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889331|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889332|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82889333|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
82889334|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889335|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82889336|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82889337|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889338|NCT03907098|Endostar protein|endostar protein|mesh-list
82889339|NCT03907098|Endostatins|endostatins|mesh-list
83083943|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82889340|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889341|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889342|NCT03907098|Growth Substances|growth substances|mesh-ancestor
82889343|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889344|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889345|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889346|NCT01251822|Prucalopride|prucalopride|mesh-list
82889347|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82889348|NCT01251822|Laxatives|laxatives|mesh-ancestor
82889349|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889350|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82889351|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82889352|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
82889353|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889354|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889355|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889356|NCT01253694|Ranibizumab|ranibizumab|mesh-list
82889357|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889358|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889359|NCT01253694|Growth Substances|growth substances|mesh-ancestor
82889360|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889361|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889362|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889363|NCT01148004|Ritonavir|ritonavir|mesh-list
82889364|NCT01148004|Lopinavir|lopinavir|mesh-list
82889365|NCT01148004|Fenofibrate|fenofibrate|mesh-list
82889366|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82889367|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82889368|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
82889369|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889370|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889371|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82889372|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82889373|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
82889374|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889375|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82889376|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82889377|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82889378|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
82889379|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82889380|NCT01252056|Cilostazol|cilostazol|mesh-list
82889381|NCT01252056|Probucol|probucol|mesh-list
82889382|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82889383|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
82889384|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889385|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889386|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82889387|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
82889388|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82889389|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82889390|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889391|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82889392|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
82889393|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82889394|NCT01252056|Protective Agents|protective agents|mesh-ancestor
82889395|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82889396|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82889397|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889398|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82889399|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82889400|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
82889401|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82889402|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
82889403|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
82889405|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82889406|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82889407|NCT01148472|Escitalopram|escitalopram|mesh-list
82889408|NCT01148472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82889409|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82889410|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889411|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889412|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889413|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
82889414|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889416|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
82889417|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82889418|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82889420|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
82889421|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
82889422|NCT01147146|Fentanyl|fentanyl|mesh-list
82889423|NCT01147146|Midazolam|midazolam|mesh-list
82889424|NCT01147146|Bupivacaine|bupivacaine|mesh-list
82889425|NCT01147146|Propofol|propofol|mesh-list
82889426|NCT01147146|Atracurium|atracurium|mesh-list
82889427|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
82889428|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
82889429|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889430|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889431|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
82889432|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889433|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82889434|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82889435|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
82889436|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82889437|NCT01147146|Narcotics|narcotics|mesh-ancestor
82889438|NCT01147146|Analgesics|analgesics|mesh-ancestor
82889439|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82889440|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82889441|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82889442|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82889443|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
82889444|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
82889445|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889446|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889447|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82889448|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82889449|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82889450|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82889451|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82889452|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
82889453|NCT01250340|Aspirin|aspirin|mesh-list
82889454|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82889455|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889456|NCT01250340|Analgesics|analgesics|mesh-ancestor
82889457|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
82889458|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889459|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889460|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889461|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889462|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82889463|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82889464|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889465|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82889466|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82889467|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889468|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
82889469|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
82889470|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889471|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889472|NCT01250652|Cetirizine|cetirizine|mesh-list
82889473|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
82889474|NCT01250652|Levocetirizine|levocetirizine|mesh-list
82889475|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82889476|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82889477|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
82889478|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
82889479|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889480|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889481|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889482|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82889483|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
82889484|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
82889485|NCT01253928|Pioglitazone|pioglitazone|mesh-list
82889486|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82889487|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889488|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
82889489|NCT01252524|Psyllium|psyllium|mesh-list
82889490|NCT01252524|Calcium|calcium|mesh-list
82889491|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82889492|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889493|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
82889494|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889495|NCT01252524|Cathartics|cathartics|mesh-ancestor
82889497|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
82889498|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889499|NCT01254006|Thiamine|thiamine|mesh-list
82889500|NCT01254006|Vitamins|vitamins|mesh-ancestor
82889501|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
82889502|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889503|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
82889504|NCT03914118|Modafinil|modafinil|mesh-list
82889505|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82889506|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889507|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82889508|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82889509|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82889510|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889511|NCT02528136|Oxytocin|oxytocin|mesh-list
82889512|NCT02528136|Carbetocin|carbetocin|mesh-list
82889513|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
82889514|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889515|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889516|NCT01252680|Vaccines|vaccines|mesh-list
82889517|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
82889518|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889519|NCT01252758|Albuterol|albuterol|mesh-list
82889520|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82889521|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
82889522|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889523|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889524|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82889525|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
82889526|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
82889527|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889528|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82889529|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82889530|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82889531|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
82889532|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889533|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889534|NCT03913884|Mitogens|mitogens|mesh-list
82889535|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
82889536|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889537|NCT01147224|Ciclesonide|ciclesonide|mesh-list
82889538|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
82889539|NCT01147224|Hormones|hormones|mesh-ancestor
82889540|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889541|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889542|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82889543|NCT03913650|Bupivacaine|bupivacaine|mesh-list
82889544|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
82889545|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
82889546|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889547|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889548|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
82889549|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889550|NCT02874742|Dexamethasone|dexamethasone|mesh-list
82889551|NCT02874742|Lenalidomide|lenalidomide|mesh-list
82889552|NCT02874742|Bortezomib|bortezomib|mesh-list
82889553|NCT02874742|Daratumumab|daratumumab|mesh-list
82889554|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889555|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
82889556|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
82889557|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889558|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889559|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889561|NCT02874742|Hormones|hormones|mesh-ancestor
82889562|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889563|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82889564|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889565|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
82889566|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889569|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889570|NCT01149174|Mitomycins|mitomycins|mesh-list
82889571|NCT01149174|Mitomycin|mitomycin|mesh-list
82889572|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82889573|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889574|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
82889575|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889576|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82889577|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889578|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82889579|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82889580|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889581|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889582|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
82889583|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889584|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889585|NCT01148628|Everolimus|everolimus|mesh-list
82889586|NCT01148628|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82889587|NCT01148628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82889588|NCT01148628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889589|NCT01148628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889590|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82889591|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
82889592|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889593|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889594|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82889595|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
82889596|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889597|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82889598|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82889599|NCT03909594|Ketamine|ketamine|mesh-list
82889600|NCT03909594|Bupivacaine|bupivacaine|mesh-list
82889601|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
82889602|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
82889603|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889604|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889605|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
82889606|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889607|NCT03909594|Analgesics|analgesics|mesh-ancestor
82889608|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82889609|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82889610|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
82889611|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82889612|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82889613|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889614|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889615|NCT04492072|Misoprostol|misoprostol|mesh-list
82889616|NCT04492072|Oxytocin|oxytocin|mesh-list
82889617|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
82889618|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889619|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889620|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82889621|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
82889622|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82889623|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889624|NCT04181008|Amiloride|amiloride|mesh-list
82889625|NCT04181008|Diuretics|diuretics|mesh-ancestor
82889626|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
82889627|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889628|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82889629|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82889630|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889631|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889632|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82889633|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82889634|NCT04160494|Atezolizumab|atezolizumab|mesh-list
82889635|NCT04160494|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
82889636|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
82889637|NCT04160494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82889638|NCT04160494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889639|NCT04160494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889640|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889641|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
82889642|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889643|NCT03629340|Metformin|metformin|mesh-list
82889644|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82889645|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889646|NCT03904836|Tobramycin|tobramycin|mesh-list
82889647|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82889648|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889649|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82889650|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82889651|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889652|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889653|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82889654|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889655|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889656|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
82889657|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889658|NCT03904680|Vitamin D|vitamin d|mesh-list
82889659|NCT03904680|Methotrexate|methotrexate|mesh-list
82889660|NCT03904680|Vitamins|vitamins|mesh-ancestor
82889661|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
82889662|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889663|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82889664|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82889665|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
82889666|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889667|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82889668|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
82889669|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889670|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889671|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
82889672|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889673|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82889674|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82889675|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
82889676|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889677|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82889678|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82889679|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82889680|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82889681|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889682|NCT01256268|Paclitaxel|paclitaxel|mesh-list
82889683|NCT01256268|Carboplatin|carboplatin|mesh-list
82889684|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82889685|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889686|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
82889687|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
82889688|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
82889689|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889690|NCT03902106|Albuterol|albuterol|mesh-list
82889691|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82889692|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
82889693|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889694|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889695|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82889696|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
82889697|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
82889698|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889699|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82889700|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82889701|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82889702|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
82889703|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889704|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889705|NCT03902340|Analgesics|analgesics|mesh-list
82889706|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
82889707|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889708|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889709|NCT01149330|Adapalene|adapalene|mesh-list
82889710|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82889711|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889712|NCT01149330|Analgesics|analgesics|mesh-ancestor
82889713|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
82889714|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889715|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889716|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889717|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889718|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
82889719|NCT03984214|Dronabinol|dronabinol|mesh-list
82889720|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
82889721|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889722|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82889723|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889724|NCT03984214|Analgesics|analgesics|mesh-ancestor
82889725|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
82889726|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889727|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82889728|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82889729|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889730|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889731|NCT03984214|Hormones|hormones|mesh-ancestor
82889732|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889733|NCT01150344|Artemether|artemether|mesh-list
82889734|NCT01150344|Atovaquone|atovaquone|mesh-list
82889735|NCT01150344|Proguanil|proguanil|mesh-list
82889736|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
82889737|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
82889738|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82889739|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82889740|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889741|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889742|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889743|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
82889744|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82889745|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
82889746|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
82889747|NCT05125224|Calcium|calcium|mesh-list
82889748|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82889749|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889750|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82889751|NCT05125224|Diuretics|diuretics|mesh-ancestor
82889752|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
82889753|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82889754|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889755|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889756|NCT01256580|Dexamethasone|dexamethasone|mesh-list
82889757|NCT01256580|Bevacizumab|bevacizumab|mesh-list
82889758|NCT01256580|Verteporfin|verteporfin|mesh-list
82889759|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82889760|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889761|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889762|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889763|NCT01256580|Growth Substances|growth substances|mesh-ancestor
82889764|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889765|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889766|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889767|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
82889768|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
82889769|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889770|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82889771|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
82889772|NCT01256580|Hormones|hormones|mesh-ancestor
82889773|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889774|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82889775|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82889776|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
82889777|NCT03901716|Fentanyl|fentanyl|mesh-list
82889778|NCT03901716|Midazolam|midazolam|mesh-list
82889779|NCT03901716|Sufentanil|sufentanil|mesh-list
82889780|NCT03901716|Remifentanil|remifentanil|mesh-list
82889781|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82889782|NCT03901716|Narcotics|narcotics|mesh-ancestor
82889783|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889784|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889785|NCT03901716|Analgesics|analgesics|mesh-ancestor
82889786|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
82889787|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889788|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82889790|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
82889791|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
82889792|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82889793|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82889794|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82889795|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82889796|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
82889797|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
82889798|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889799|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889800|NCT04113538|Aflibercept|aflibercept|mesh-list
82889801|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889802|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889803|NCT04113538|Growth Substances|growth substances|mesh-ancestor
82889804|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889805|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889806|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889807|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82889808|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889809|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889810|NCT03922750|Insulin|insulin|mesh-list
82889811|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82889812|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
82889813|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82889814|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889815|NCT03898128|Immunotoxins|immunotoxins|mesh-list
82889816|NCT03898128|Immunoconjugates|immunoconjugates|mesh-ancestor
82889817|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
82889818|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889819|NCT01149408|Decitabine|decitabine|mesh-list
82889820|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82889821|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
82889822|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889823|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889824|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889825|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82889826|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82889827|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889828|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889829|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
82889830|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889831|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889832|NCT01149018|Dronabinol|dronabinol|mesh-list
82889833|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
82889834|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889835|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82889836|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889837|NCT01149018|Analgesics|analgesics|mesh-ancestor
82889838|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
82889839|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889840|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83454653|NCT03087604|Epinephrine|epinephrine|mesh-list
82889841|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82889842|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889843|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889844|NCT01149018|Hormones|hormones|mesh-ancestor
82889845|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889846|NCT03904056|Ranibizumab|ranibizumab|mesh-list
82889847|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82889848|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82889849|NCT03904056|Growth Substances|growth substances|mesh-ancestor
82889850|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889851|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
82889852|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889853|NCT03897660|Vitamins|vitamins|mesh-list
82889854|NCT03897660|Vitamin K|vitamin k|mesh-list
82889855|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
82889856|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
82889857|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889858|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82889859|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82889860|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889861|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
82889863|NCT03901170|Letrozole|letrozole|mesh-list
82889864|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889865|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82889866|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82889867|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889868|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889869|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82889870|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
82889871|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889872|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889873|NCT03900858|Isoniazid|isoniazid|mesh-list
82889874|NCT03900858|Rifapentine|rifapentine|mesh-list
82889875|NCT03900858|Rifampin|rifampin|mesh-list
82889876|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
82889877|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82889878|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82889879|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82889880|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82889881|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
82889882|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889883|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82889884|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82889885|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
82889886|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82889887|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889888|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82889889|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82889890|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82889891|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82889892|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82889893|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82889894|NCT01149564|Ibuprofen|ibuprofen|mesh-list
82889895|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82889896|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889897|NCT01149564|Analgesics|analgesics|mesh-ancestor
82889898|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
82889899|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889900|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889901|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889902|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889903|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82889904|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889905|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889906|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
82889907|NCT02527746|Epirubicin|epirubicin|mesh-list
82889908|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82889909|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
82889910|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889911|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889912|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82889913|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
82889914|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889915|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889916|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82889917|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82889918|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82889919|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82889920|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889921|NCT01586286|Nifedipine|nifedipine|mesh-list
82889922|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82889923|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889924|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889925|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82889926|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889927|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
82889928|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
82889929|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82889930|NCT01257048|Budesonide|budesonide|mesh-list
82889931|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
82889932|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889933|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82730806|NCT02546349|Hormones|hormones|mesh-ancestor
82889935|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83083944|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
82889936|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889937|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82889938|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
82889939|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
82889941|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82889942|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82889943|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82889944|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82889945|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
82889946|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889947|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889948|NCT01258296|Fentanyl|fentanyl|mesh-list
82889949|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82889950|NCT01258296|Narcotics|narcotics|mesh-ancestor
82889951|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889952|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889953|NCT01258296|Analgesics|analgesics|mesh-ancestor
82889954|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
82889955|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889956|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82889957|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82889958|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
82889959|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
82889960|NCT01257126|Diclofenac|diclofenac|mesh-list
82889961|NCT01257126|Nimesulide|nimesulide|mesh-list
82889962|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82889963|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82889964|NCT01257126|Analgesics|analgesics|mesh-ancestor
82889965|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
82889966|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82889967|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889968|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82889969|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82889970|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82889971|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889972|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889973|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
82889974|NCT02527824|Irinotecan|irinotecan|mesh-list
82889975|NCT02527824|Tegafur|tegafur|mesh-list
82889976|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82889977|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82889978|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82889979|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889980|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889981|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82889982|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
82889983|NCT01586208|Phenytoin|phenytoin|mesh-list
82889984|NCT01586208|Valproic Acid|valproic acid|mesh-list
82889985|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
82889986|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82889987|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82889988|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
82889989|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82889990|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82889991|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
82889992|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82889993|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82889994|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82889995|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82889996|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82889997|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82889998|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82889999|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82890000|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82890001|NCT03893526|Valsartan|valsartan|mesh-list
82890002|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82890003|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82890004|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890005|NCT03893526|Incretins|incretins|mesh-ancestor
82890006|NCT03893526|Hormones|hormones|mesh-ancestor
83482925|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890007|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890008|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82890009|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
82890011|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890012|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82890013|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82890014|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82890015|NCT01149798|Cisplatin|cisplatin|mesh-list
82890016|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82890017|NCT01149798|Paclitaxel|paclitaxel|mesh-list
82890018|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890019|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82890020|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890021|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890022|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
82890023|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890024|NCT01257360|Panitumumab|panitumumab|mesh-list
82890025|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82890026|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890027|NCT01258452|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
82890028|NCT01258452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82890029|NCT01258452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890030|NCT01258452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890031|NCT01257516|Pregabalin|pregabalin|mesh-list
82890032|NCT01257516|Analgesics|analgesics|mesh-ancestor
82890033|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
82890034|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890035|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890036|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
82890037|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82890038|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82890039|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890040|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82890041|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82890042|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82890043|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890044|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82890045|NCT01149954|Ibuprofen|ibuprofen|mesh-list
82890046|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82890047|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890048|NCT01149954|Analgesics|analgesics|mesh-ancestor
82890049|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
82890050|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890051|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890052|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890053|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82890054|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82890055|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454658|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
82890056|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890057|NCT03899610|Durvalumab|durvalumab|mesh-list
82890058|NCT03899610|Tremelimumab|tremelimumab|mesh-list
82890059|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82890060|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890061|NCT02527668|Vitamin D|vitamin d|mesh-list
82890062|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
82890063|NCT02527668|Calcifediol|calcifediol|mesh-list
82890064|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82890065|NCT02527668|Vitamins|vitamins|mesh-ancestor
82890066|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
82890067|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890068|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82890069|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82890070|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
82890071|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
82890072|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
82890073|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890074|NCT03896256|Ketamine|ketamine|mesh-list
82890075|NCT03896256|Analgesics|analgesics|mesh-ancestor
82890076|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
82890077|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890078|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890079|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82890080|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82890081|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
82890082|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
82890083|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890084|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82890085|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82890086|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890087|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890088|NCT03893136|Leflunomide|leflunomide|mesh-list
82890089|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890090|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890091|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890092|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
82890093|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890094|NCT01258530|Oseltamivir|oseltamivir|mesh-list
82890095|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
82890096|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890097|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890098|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890100|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
82890101|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890102|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
82890103|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890104|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
82890105|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
82890106|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
82890107|NCT01257672|Ondansetron|ondansetron|mesh-list
82890108|NCT01257672|Domperidone|domperidone|mesh-list
82890109|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
82890110|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
82890111|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890112|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890113|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890114|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
82890115|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
82890116|NCT01257672|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82890117|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82890118|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
82890119|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890120|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890121|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82890122|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
82890123|NCT01258686|Silymarin|silymarin|mesh-list
82890124|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
82890125|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890126|NCT01258686|Protective Agents|protective agents|mesh-ancestor
82890127|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890128|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82890129|NCT01258764|Lisinopril|lisinopril|mesh-list
82890130|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82890131|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82890132|NCT01258764|Diuretics|diuretics|mesh-ancestor
82890133|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
82890134|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890135|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82890136|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82890137|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890138|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
82890139|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890140|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82890141|NCT01258764|Protective Agents|protective agents|mesh-ancestor
82890142|NCT03895788|Niraparib|niraparib|mesh-list
82890143|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82890144|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890145|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890146|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890147|NCT01257828|Riluzole|riluzole|mesh-list
82890148|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
82890149|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82890150|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82890151|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890152|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890153|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890154|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82890155|NCT01257828|Protective Agents|protective agents|mesh-ancestor
82890157|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82890159|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
82890160|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890161|NCT03892902|Zopiclone|zopiclone|mesh-list
82890162|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82890163|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890164|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890165|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
82890166|NCT03892668|Oxytocin|oxytocin|mesh-list
82890167|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
82890168|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82890169|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890170|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82890171|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82890172|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890173|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
82890174|NCT03892668|Coagulants|coagulants|mesh-ancestor
82890175|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82890176|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82890177|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82890178|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890179|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890180|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82890181|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82890182|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82890183|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
82890184|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890185|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890186|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82890187|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82890188|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
82890189|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
82890190|NCT03898752|Vitamins|vitamins|mesh-ancestor
82890191|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
82890192|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890193|NCT01255644|Valganciclovir|valganciclovir|mesh-list
82890194|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
82890195|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890196|NCT01255800|Cetuximab|cetuximab|mesh-list
82890197|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82890198|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890199|NCT01257906|Tretinoin|tretinoin|mesh-list
82890200|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890201|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
82890202|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
82890203|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
82890204|NCT03892512|Esmolol|esmolol|mesh-list
82890205|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82890206|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890207|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890208|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890209|NCT03892512|Analgesics|analgesics|mesh-ancestor
82890210|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
82890211|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890212|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82890213|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82890214|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82890215|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
82890216|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890217|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890218|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82890219|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82890220|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82890221|NCT01255878|Gabapentin|gabapentin|mesh-list
82890222|NCT01255878|Analgesics|analgesics|mesh-ancestor
82890223|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
82890224|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890225|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890226|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
82890227|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82890228|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82890229|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890230|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82890231|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82890232|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82890233|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890234|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890235|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
82890237|NCT01255956|Paclitaxel|paclitaxel|mesh-list
82890238|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82890239|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890240|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890241|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890242|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
82890243|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890244|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82890245|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890246|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82890247|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
82890248|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890249|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
82890250|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890251|NCT03892434|Dexamethasone|dexamethasone|mesh-list
82890252|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
82890253|NCT03892434|Bevacizumab|bevacizumab|mesh-list
82890254|NCT03892434|BB 1101|bb 1101|mesh-list
82890255|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82890256|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890257|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82890258|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82890259|NCT03892434|Growth Substances|growth substances|mesh-ancestor
82890260|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890261|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
82890262|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890263|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
82890264|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
82890265|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890266|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890267|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
82890268|NCT03892434|Hormones|hormones|mesh-ancestor
82890269|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890270|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890271|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
82890272|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890273|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890274|NCT03889626|Capecitabine|capecitabine|mesh-list
82890275|NCT03889626|Apatinib|apatinib|mesh-list
82890276|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82890277|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
82890278|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890279|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890280|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82890281|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890282|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
82890283|NCT03892122|Propofol|propofol|mesh-list
82890284|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82890285|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890286|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890287|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890288|NCT03892122|Analgesics|analgesics|mesh-ancestor
82890289|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
82890290|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890291|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82890292|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82890293|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82890294|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
82890295|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890296|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890297|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82890298|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
82890299|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
82890300|NCT01589562|Megestrol|megestrol|mesh-list
82890301|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
82890302|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82890303|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82890304|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82890305|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
83513461|NCT01812668|Protective Agents|protective agents|mesh-ancestor
82890307|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890308|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82890309|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82890310|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890311|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890312|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
82890313|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82890315|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82890316|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890317|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82890318|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
82890319|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82890320|NCT01259934|Interferons|interferons|mesh-list
82890321|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
82890322|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
82890323|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890324|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
82890325|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890326|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
82890327|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890328|NCT01153386|Treprostinil|treprostinil|mesh-list
82890329|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82890330|NCT01260012|Praziquantel|praziquantel|mesh-list
82890331|NCT01260012|Antioxidants|antioxidants|mesh-list
82890332|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890333|NCT01260012|Protective Agents|protective agents|mesh-ancestor
82890334|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890335|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
82890336|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82890337|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890338|NCT03888924|Vaccines|vaccines|mesh-list
82890339|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
82890340|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
82890341|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890342|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82890343|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82890344|NCT01151592|Hematinics|hematinics|mesh-ancestor
82890345|NCT01151670|Pioglitazone|pioglitazone|mesh-list
82890346|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82890347|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890348|NCT03888846|Colchicine|colchicine|mesh-list
82890349|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
82890350|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
82890351|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82890352|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890353|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890354|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
82890355|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890356|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890357|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82890358|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890359|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82890360|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82890361|NCT03888846|Protective Agents|protective agents|mesh-ancestor
82890362|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890363|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
82890364|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82890365|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
82890366|NCT03891420|Galidesivir|galidesivir|mesh-list
82890367|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
82890368|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890369|NCT01153542|Ivacaftor|ivacaftor|mesh-list
82890370|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82890371|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82890372|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890373|NCT01152606|Trastuzumab|trastuzumab|mesh-list
82890374|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82890375|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890376|NCT01153854|Racecadotril|racecadotril|mesh-list
82890377|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
82890378|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890379|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
82890380|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890381|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890382|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82890383|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82890384|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890385|NCT01260246|Incretins|incretins|mesh-ancestor
82890386|NCT01260246|Hormones|hormones|mesh-ancestor
82890387|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890388|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82890389|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
82890390|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890391|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890392|NCT03888534|Ixazomib|ixazomib|mesh-list
82890393|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890394|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
82890395|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890396|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890397|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
82890398|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82890399|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890400|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890401|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890402|NCT03885804|Analgesics|analgesics|mesh-ancestor
82890403|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
82890404|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890405|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82890406|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82890407|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82890408|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
82890409|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890410|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890411|NCT03885258|Melatonin|melatonin|mesh-list
82890412|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
82890413|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890414|NCT03885258|Protective Agents|protective agents|mesh-ancestor
82890415|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890416|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890417|NCT01262196|Chrysarobin|chrysarobin|mesh-list
82890418|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82890419|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890420|NCT01262196|Analgesics|analgesics|mesh-ancestor
82890421|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
82890422|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890423|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890424|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890425|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82890426|NCT03885180|Warfarin|warfarin|mesh-list
82890427|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
82890428|NCT03888144|Ketorolac|ketorolac|mesh-list
82890429|NCT03888144|Oxycodone|oxycodone|mesh-list
82890430|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82890431|NCT03888144|Narcotics|narcotics|mesh-ancestor
82890432|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890433|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890434|NCT03888144|Analgesics|analgesics|mesh-ancestor
82890435|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
82890436|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890437|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82890438|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890439|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890440|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82890441|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82890442|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890443|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890444|NCT03890406|Rocuronium|rocuronium|mesh-list
82890445|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82890446|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82890447|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82890448|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890449|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890450|NCT01154400|Caseins|caseins|mesh-list
82890451|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
82890452|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
82890453|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890454|NCT01152840|Everolimus|everolimus|mesh-list
82890455|NCT01152840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82890457|NCT01152840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890458|NCT01152840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890459|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890460|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
82890461|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890462|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890464|NCT01262274|Tegafur|tegafur|mesh-list
82890465|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890466|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890467|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82890468|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82890469|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890470|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890471|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82890472|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
82890473|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890474|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890475|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82890476|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
82890477|NCT01260558|Sirolimus|sirolimus|mesh-list
82890478|NCT01260558|Temsirolimus|temsirolimus|mesh-list
82890479|NCT01260558|MTOR Inhibitors|mtor inhibitors|mesh-list
82890480|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82890481|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890482|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82890483|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890484|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
82890485|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890486|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
82890487|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890488|NCT01260558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82890489|NCT01260558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890490|NCT01260558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890491|NCT01260714|Etoposide|etoposide|mesh-list
82890492|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
82890493|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
82890494|NCT01260714|Azacitidine|azacitidine|mesh-list
82890495|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
82890496|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82890497|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890498|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82890499|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82890500|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890501|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890502|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82890503|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
82890504|NCT01260714|Analgesics|analgesics|mesh-ancestor
82890505|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
82890506|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890507|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890508|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
82890509|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
82890510|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890511|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890512|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
82890513|NCT03890094|Sufentanil|sufentanil|mesh-list
82890514|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82890515|NCT03890094|Narcotics|narcotics|mesh-ancestor
82890516|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890517|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890518|NCT03890094|Analgesics|analgesics|mesh-ancestor
82890519|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
82890520|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890521|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82890522|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82890523|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
82890524|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
82890525|NCT03887754|Risperidone|risperidone|mesh-list
82890526|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82890527|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
82890528|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890529|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890530|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890531|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82731401|NCT00849615|Leucovorin|leucovorin|mesh-list
82890532|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82890533|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890534|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82890535|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82890536|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
82890537|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
82890538|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
82890539|NCT01262586|Glimepiride|glimepiride|mesh-list
82890540|NCT01262586|Vildagliptin|vildagliptin|mesh-list
82890541|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82890542|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82890543|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890544|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890545|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
82890546|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82890547|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
82890548|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890549|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890550|NCT01157052|Capecitabine|capecitabine|mesh-list
82890551|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
82890552|NCT01157052|Calcium|calcium|mesh-list
82890553|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82890554|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890555|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82890556|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
82890557|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890558|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890559|NCT03887130|Paclitaxel|paclitaxel|mesh-list
82890560|NCT03887130|Vinorelbine|vinorelbine|mesh-list
82890561|NCT03887130|Docetaxel|docetaxel|mesh-list
82890562|NCT03887130|Gemcitabine|gemcitabine|mesh-list
82890563|NCT03887130|Capecitabine|capecitabine|mesh-list
82890564|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82890565|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890566|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890567|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890568|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
83454676|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82890569|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890570|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82890571|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
82890572|NCT01155960|Anastrozole|anastrozole|mesh-list
82890573|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890574|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890575|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82890576|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82890577|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890578|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890579|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82890580|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
82890581|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890582|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890583|NCT03883776|Octreotide|octreotide|mesh-list
82890584|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
82890585|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890586|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890587|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890588|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82890589|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890590|NCT03886896|Lidocaine|lidocaine|mesh-list
82890591|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
82890592|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
82890593|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890594|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890595|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
82890596|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890597|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82890598|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82890599|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82890600|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82890601|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890602|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82890603|NCT03881904|Gestodene|gestodene|mesh-list
82890604|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82890605|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82890606|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82890607|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
82890608|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82890609|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890610|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82890611|NCT03881904|Estrogens|estrogens|mesh-ancestor
82890612|NCT03881904|Hormones|hormones|mesh-ancestor
82890613|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890614|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82890615|NCT03881904|Progestins|progestins|mesh-ancestor
82890616|NCT01262742|Carbetocin|carbetocin|mesh-list
82890617|NCT01262742|Oxytocin|oxytocin|mesh-list
82890618|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
82890619|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82890620|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890621|NCT01261416|Levetiracetam|levetiracetam|mesh-list
82890622|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
82890623|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
82890624|NCT03617172|Misoprostol|misoprostol|mesh-list
82890625|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82890626|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
82890627|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82890628|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890629|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82890630|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890631|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
82890632|NCT01154790|Naproxen|naproxen|mesh-list
82890633|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82890634|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890635|NCT01154790|Analgesics|analgesics|mesh-ancestor
82890636|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
82890637|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890638|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890639|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890640|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82890641|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
82890642|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82890643|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890644|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890645|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
82890646|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
82890647|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890648|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82890649|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
82890650|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890651|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
82890652|NCT01263288|Vitamin D|vitamin d|mesh-list
82890653|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82890654|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890655|NCT01263288|Vitamins|vitamins|mesh-ancestor
82890656|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
82890657|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82890658|NCT01263834|Bevacizumab|bevacizumab|mesh-list
82890659|NCT01263834|Mitomycins|mitomycins|mesh-list
82890660|NCT01263834|Mitomycin|mitomycin|mesh-list
82890661|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82890662|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890663|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82890664|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82890665|NCT01263834|Growth Substances|growth substances|mesh-ancestor
82890666|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890667|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
82890668|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82890669|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
82890670|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890671|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82890672|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890673|NCT01263366|Norepinephrine|norepinephrine|mesh-list
82890674|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82890675|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82890676|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
82890677|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890678|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890679|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890680|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
82890682|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890683|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82890685|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890686|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890687|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82890688|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82890689|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890690|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890691|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82890692|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
82890693|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890694|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890696|NCT01156350|Busulfan|busulfan|mesh-list
82890697|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890698|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890699|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890700|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
82890701|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890702|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
82890703|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82890704|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82890705|NCT03886662|LB100|lb100|mesh-list
82890706|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890707|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890708|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890709|NCT01155258|Sirolimus|sirolimus|mesh-list
82890710|NCT01155258|Vinorelbine|vinorelbine|mesh-list
82890711|NCT01155258|Temsirolimus|temsirolimus|mesh-list
82890712|NCT01155258|MTOR Inhibitors|mtor inhibitors|mesh-list
83454683|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
82890713|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82890714|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890715|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82890716|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890717|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
82890718|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890719|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
82890720|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890721|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82890722|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890723|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890724|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
82890725|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890726|NCT01155258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82890727|NCT01155258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890728|NCT01156584|Flucytosine|flucytosine|mesh-list
82890729|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
82890730|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890731|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
82890732|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890733|NCT03879174|Tamoxifen|tamoxifen|mesh-list
82890734|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
82890735|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82890736|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890737|NCT03879174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82890738|NCT03879174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890739|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82890740|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
82890741|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890742|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890743|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890744|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82890745|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82890746|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82890747|NCT01159548|Promethazine|promethazine|mesh-list
82890748|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
82890749|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
82890750|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
82890751|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82890752|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
82890753|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
82890754|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890755|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82731630|NCT00942838|Cisplatin|cisplatin|mesh-list
82890756|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890757|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82890758|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82890759|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82890760|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890761|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
82890762|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
82890763|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
82890764|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890765|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
82890766|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
82890767|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890768|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82890769|NCT01156740|Amoxicillin|amoxicillin|mesh-list
82890770|NCT01156740|Penicillins|penicillins|mesh-list
82890771|NCT01156740|beta-Lactams|beta-lactams|mesh-list
82890772|NCT01156740|Penicillin G|penicillin g|mesh-list
82890773|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
82890774|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
82890775|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890776|NCT03880968|Etanercept|etanercept|mesh-list
82890777|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82890778|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890779|NCT03880968|Analgesics|analgesics|mesh-ancestor
82890780|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
82890781|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890782|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890783|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890784|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82890785|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890786|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890787|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
82890788|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
82890789|NCT03880734|Vitamin D|vitamin d|mesh-list
82890790|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82890791|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890792|NCT03880734|Vitamins|vitamins|mesh-ancestor
82890793|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
82890794|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82890795|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
82890796|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82890797|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
82890798|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82890799|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890800|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82890801|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82890802|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82890803|NCT01265940|Vinblastine|vinblastine|mesh-list
82890804|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82890805|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890806|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890807|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890808|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
82890809|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890810|NCT01264302|Finasteride|finasteride|mesh-list
82890811|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82890812|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82890813|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890814|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890815|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
82890816|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890817|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890818|NCT01264302|Urological Agents|urological agents|mesh-ancestor
82890819|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82890820|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
82890821|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890822|NCT01161654|Naratriptan|naratriptan|mesh-list
82890823|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82890824|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82890825|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82890826|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
82890827|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890828|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890829|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890830|NCT01266174|Eltoprazine|eltoprazine|mesh-list
82890831|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82890832|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
82890833|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890834|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890835|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890836|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
82890837|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82890838|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82890839|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890840|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82890841|NCT01266252|Analgesics|analgesics|mesh-ancestor
82890842|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
82890843|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890844|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82890845|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82890846|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82890847|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
82890848|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890849|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890850|NCT01266486|Metformin|metformin|mesh-list
82890851|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82890852|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890853|NCT01161888|Imiquimod|imiquimod|mesh-list
82890854|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82890855|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
82890856|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890857|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890858|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
82890859|NCT03759366|Eculizumab|eculizumab|mesh-list
82890860|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82890861|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82890862|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
82890863|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890864|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
82890865|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82890866|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890867|NCT03759600|Niraparib|niraparib|mesh-list
82890868|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82890869|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890870|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890871|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890872|NCT01161966|Zonisamide|zonisamide|mesh-list
82890873|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
82890874|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82890875|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82890876|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890877|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82890878|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890879|NCT01158144|Paclitaxel|paclitaxel|mesh-list
82890880|NCT01158144|Carboplatin|carboplatin|mesh-list
82890881|NCT01158144|Endostar protein|endostar protein|mesh-list
82890882|NCT01158144|Endostatins|endostatins|mesh-list
82890883|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82890884|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890885|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
82890886|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
82890887|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
82890888|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890889|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82890890|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82890891|NCT01158144|Growth Substances|growth substances|mesh-ancestor
82890892|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890893|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
82890894|NCT01264536|Lactoferrin|lactoferrin|mesh-list
82890895|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890896|NCT01160172|Vaccines|vaccines|mesh-list
82890897|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
82890898|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890899|NCT03878784|Sumatriptan|sumatriptan|mesh-list
82890900|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82890901|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82890907|NCT01266720|Gemcitabine|gemcitabine|mesh-list
82890908|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82890909|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
83513614|NCT03509883|Apixaban|apixaban|mesh-list
82890910|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890911|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890912|NCT01589952|Interferons|interferons|mesh-list
82890913|NCT01589952|Entecavir|entecavir|mesh-list
82890914|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890915|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
82890916|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82890917|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
82890918|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82890919|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82890920|NCT03876444|Prednisolone|prednisolone|mesh-list
82890921|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
82890922|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82890923|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
82890924|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890925|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
82890926|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
82890927|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890928|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890929|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890930|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
82890931|NCT03876444|Hormones|hormones|mesh-ancestor
82890932|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890933|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82890934|NCT03876444|Protective Agents|protective agents|mesh-ancestor
82890935|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890936|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890937|NCT01264692|Amlodipine|amlodipine|mesh-list
82890938|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82890939|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82890940|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82890941|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890942|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82890943|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890944|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
82890945|NCT01160328|Leuprolide|leuprolide|mesh-list
82890946|NCT01160328|Testosterone|testosterone|mesh-list
82890947|NCT01160328|Androgens|androgens|mesh-ancestor
82890948|NCT01160328|Hormones|hormones|mesh-ancestor
82890949|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890950|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890951|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890952|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890953|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82890954|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
82890955|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82890961|NCT01162746|Dexamethasone|dexamethasone|mesh-list
82890962|NCT01162746|Ranibizumab|ranibizumab|mesh-list
82890963|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82890964|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
82890965|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
82890966|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890967|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890968|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82890969|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
82890970|NCT01162746|Hormones|hormones|mesh-ancestor
82890971|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82890972|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82890973|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82890974|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82890975|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82890976|NCT01162746|Growth Substances|growth substances|mesh-ancestor
82890977|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
82890978|NCT01268202|Pravastatin|pravastatin|mesh-list
82890979|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82890980|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82890981|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
82890982|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890983|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82890984|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82890985|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82890986|NCT01162824|Adenosine|adenosine|mesh-list
82890987|NCT01162824|Acetylcholine|acetylcholine|mesh-list
82890988|NCT01162824|Analgesics|analgesics|mesh-ancestor
82890989|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
82890990|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82890991|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82890992|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82890993|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
82890994|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82890995|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
82890996|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
82890997|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82890998|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82890999|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82891000|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
82891001|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82891003|NCT01265004|Coagulants|coagulants|mesh-ancestor
82891004|NCT01162902|Candesartan|candesartan|mesh-list
82891005|NCT01162902|Bisoprolol|bisoprolol|mesh-list
82891006|NCT01162902|Diltiazem|diltiazem|mesh-list
82891007|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82891008|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82891009|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82891010|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891011|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
82891012|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
82891013|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891014|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891015|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82891016|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82891017|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82891018|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
82891019|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891020|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82891021|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82891022|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82891023|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
82891024|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82891025|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82891026|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82891027|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
82891028|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891029|NCT02526888|Diltiazem|diltiazem|mesh-list
82891030|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82891031|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82891032|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82891033|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891034|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82891035|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891036|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
82891037|NCT01158612|Hormones|hormones|mesh-list
82891038|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891039|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891040|NCT03877692|Labetalol|labetalol|mesh-list
82891041|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82891042|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82891043|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
82891044|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891045|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891046|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891047|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82891048|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
82891049|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
82891050|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891051|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82891052|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82891053|NCT01158846|Bivalirudin|bivalirudin|mesh-list
82891054|NCT01158846|Abciximab|abciximab|mesh-list
82891055|NCT01158846|Clopidogrel|clopidogrel|mesh-list
82891056|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82891057|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82891058|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82891059|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82891060|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82891061|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
82731929|NCT00855153|Cycloserine|cycloserine|mesh-list
82891062|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891063|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891064|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891065|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
82891066|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82891067|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
82891068|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891069|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
82891070|NCT01268670|Ibuprofen|ibuprofen|mesh-list
82891071|NCT01268670|Oxycodone|oxycodone|mesh-list
82891072|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82891073|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82891074|NCT01268670|Analgesics|analgesics|mesh-ancestor
82891075|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
82891076|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891077|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891078|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82891079|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891080|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82891081|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891082|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891083|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82891084|NCT01268670|Narcotics|narcotics|mesh-ancestor
82891085|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891086|NCT01160718|Fulvestrant|fulvestrant|mesh-list
82891087|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82891088|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891089|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82891090|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82891091|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
82891092|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891093|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891094|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
82891095|NCT01159080|Tacrolimus|tacrolimus|mesh-list
82891096|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891097|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
82891098|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891099|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82891100|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891101|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891102|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82891103|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891104|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82891105|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
82891106|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82891107|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891108|NCT01160952|Itraconazole|itraconazole|mesh-list
82891109|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
82891110|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891111|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82891112|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82891113|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891114|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891115|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82891116|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
82891117|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891118|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891119|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82891120|NCT01159158|Nateglinide|nateglinide|mesh-list
82891121|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891122|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891123|NCT01161108|Melatonin|melatonin|mesh-list
82891124|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
82891125|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891126|NCT01161108|Protective Agents|protective agents|mesh-ancestor
82891127|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891128|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891129|NCT01161186|Paclitaxel|paclitaxel|mesh-list
82891130|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82891131|NCT01161186|Gemcitabine|gemcitabine|mesh-list
82891132|NCT01161186|Capecitabine|capecitabine|mesh-list
82891133|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82891134|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891135|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
82891136|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
82891137|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
82891138|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891139|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891140|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
82891141|NCT01159236|Paclitaxel|paclitaxel|mesh-list
82891142|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
82891143|NCT01159236|Bevacizumab|bevacizumab|mesh-list
82891144|NCT01159236|Doxorubicin|doxorubicin|mesh-list
82891145|NCT01159236|Fluorouracil|fluorouracil|mesh-list
82891146|NCT01159236|Epirubicin|epirubicin|mesh-list
82891147|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82891148|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891149|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
82891150|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
82891151|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
82891152|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891153|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891154|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
82891155|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891156|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891157|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82891158|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
82891159|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82891160|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891161|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82891162|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82891163|NCT01159236|Growth Substances|growth substances|mesh-ancestor
82891164|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
82891165|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82891166|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82891167|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82891168|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891169|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
82891170|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891171|NCT01267344|Gemcitabine|gemcitabine|mesh-list
82891172|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
82891173|NCT01267344|Cetuximab|cetuximab|mesh-list
82891174|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891175|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
82891176|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891177|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891178|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891179|NCT03879564|Ketamine|ketamine|mesh-list
82891180|NCT03879564|Analgesics|analgesics|mesh-ancestor
82891181|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
82891182|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891183|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891184|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82891185|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82891186|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
82891187|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
82891188|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891189|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82891190|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82891191|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891192|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891193|NCT01581840|Panitumumab|panitumumab|mesh-list
82891194|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891195|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891196|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
82891197|NCT03879486|Formaldehyde|formaldehyde|mesh-list
82891199|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
82891200|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
82891201|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82891202|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891203|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
82891204|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
82891205|NCT01269294|Simeprevir|simeprevir|mesh-list
82891206|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82891207|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82891208|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891209|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82891210|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82891211|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83454703|NCT05386459|Interferons|interferons|mesh-list
82891212|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891213|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891214|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82891215|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
82891216|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82891217|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891218|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82891219|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82891220|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82891221|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
82891222|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
82891223|NCT01163994|Doxycycline|doxycycline|mesh-list
82891224|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
82891225|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82891226|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891227|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
82891228|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82891229|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82891230|NCT01267734|Everolimus|everolimus|mesh-list
82891231|NCT01267734|Clopidogrel|clopidogrel|mesh-list
82891232|NCT01267734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82891233|NCT01267734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82891234|NCT01267734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891235|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891236|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891237|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
82891238|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891239|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891240|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82891241|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82891242|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82891243|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82891244|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
82891245|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891246|NCT01164306|Nicotine|nicotine|mesh-list
82891247|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82891248|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
82891249|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891250|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891251|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82891252|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82891253|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
82891254|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891255|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891256|NCT01269450|Progesterone|progesterone|mesh-list
82891257|NCT01269450|Progestins|progestins|mesh-ancestor
82891258|NCT01269450|Hormones|hormones|mesh-ancestor
82891259|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891260|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891261|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
82891262|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
82891263|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82891264|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
82891265|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891266|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891267|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82891268|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
82891269|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82891270|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
82891271|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891272|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891274|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
82891275|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
82891276|NCT01269528|Protective Agents|protective agents|mesh-ancestor
82891277|NCT01269528|Miotics|miotics|mesh-ancestor
82891278|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82891279|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
82891280|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82891281|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82891282|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
82891283|NCT01268904|Valproic Acid|valproic acid|mesh-list
82891284|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
82891285|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891286|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891287|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
82891288|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891289|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891290|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
82891291|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82891292|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891293|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82891294|NCT01269606|Insulin|insulin|mesh-list
82891295|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82891296|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
82891297|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
82891298|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82891299|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891300|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891301|NCT03872232|Telmisartan|telmisartan|mesh-list
82891302|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82891303|NCT03872232|Ezetimibe|ezetimibe|mesh-list
82891304|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82891305|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82891306|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
82891307|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891308|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82891309|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82891310|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891311|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82891312|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82891313|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82891314|NCT01280214|Triamcinolone|triamcinolone|mesh-list
82891315|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82891316|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
82891317|NCT01280214|Hormones|hormones|mesh-ancestor
82891318|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891319|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891320|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82891321|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891322|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82891323|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82891324|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82891325|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
82891326|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891327|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82891328|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82891329|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891330|NCT01269684|Everolimus|everolimus|mesh-list
82891331|NCT01269684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82891332|NCT01269684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82891333|NCT01269684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891334|NCT01269684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891335|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891336|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
82891337|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891338|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891339|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82891340|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
82891341|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82891342|NCT01280526|Romidepsin|romidepsin|mesh-list
82891343|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82891344|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891345|NCT01280526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82891346|NCT01280526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891347|NCT01280526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891349|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82891350|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
82891351|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891352|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891353|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82891354|NCT01269138|Thrombin|thrombin|mesh-list
82891355|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
82891356|NCT01269138|Coagulants|coagulants|mesh-ancestor
82891357|NCT02526810|Insulin|insulin|mesh-list
82891358|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82891359|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
82891360|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
82891361|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891362|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891363|NCT01280682|Rituximab|rituximab|mesh-list
82891364|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891365|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891366|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
82891367|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891368|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891370|NCT01269216|Irinotecan|irinotecan|mesh-list
82891371|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82891372|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82891373|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891374|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891375|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891376|NCT01269216|Antidotes|antidotes|mesh-ancestor
82891377|NCT01269216|Protective Agents|protective agents|mesh-ancestor
82891378|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891379|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
82891380|NCT01269216|Vitamins|vitamins|mesh-ancestor
82891381|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
82891382|NCT03874806|Ropivacaine|ropivacaine|mesh-list
82891383|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82891384|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
82891385|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
82891386|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891387|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891388|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
82891389|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891390|NCT01165476|Treprostinil|treprostinil|mesh-list
82891391|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82891392|NCT01169922|Ethanol|ethanol|mesh-list
82891393|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82891394|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891395|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891396|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891397|NCT01283100|Dolutegravir|dolutegravir|mesh-list
82891398|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82891399|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82891400|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891401|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891402|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82891403|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82891404|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
82891405|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891406|NCT01269996|Metformin|metformin|mesh-list
82891407|NCT01269996|Gliclazide|gliclazide|mesh-list
82891408|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891409|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891410|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82891411|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82891412|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891413|NCT01281150|Paclitaxel|paclitaxel|mesh-list
82891414|NCT01281150|Carboplatin|carboplatin|mesh-list
82891415|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82891416|NCT01281150|Veliparib|veliparib|mesh-list
82891417|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82891418|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891419|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
82891420|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
82891421|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
82891422|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891423|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82891425|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
82891426|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82891427|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
82891428|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891429|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
82891430|NCT03871218|Protective Agents|protective agents|mesh-ancestor
82891431|NCT01281228|Exenatide|exenatide|mesh-list
82891432|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891433|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891434|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82891435|NCT01281228|Incretins|incretins|mesh-ancestor
82891436|NCT01281228|Hormones|hormones|mesh-ancestor
82891437|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891438|NCT01283256|Zonisamide|zonisamide|mesh-list
82891439|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
82891440|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83513615|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82891441|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82891442|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891443|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82891444|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891445|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
82891446|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82891447|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82891448|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891449|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
82891450|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
82891451|NCT03874260|Fenofibrate|fenofibrate|mesh-list
82891452|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82891453|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
82891454|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891455|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82891456|NCT01281540|Cisapride|cisapride|mesh-list
82891457|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82891458|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82891459|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82891460|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
82891461|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891462|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891463|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891464|NCT03874026|Cetuximab|cetuximab|mesh-list
82891465|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891466|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891467|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
82891468|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82891469|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891470|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891471|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82891472|NCT01283412|Analgesics|analgesics|mesh-ancestor
82891473|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
82891474|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891475|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82891476|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82891477|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82891478|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
82891479|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891480|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891481|NCT01271478|Telmisartan|telmisartan|mesh-list
82891482|NCT01271478|Captopril|captopril|mesh-list
82891483|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82891484|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82891485|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82891486|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891487|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82891488|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
82891489|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891490|NCT03871062|Anesthetics|anesthetics|mesh-list
82891491|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891492|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891493|NCT01281696|Bevacizumab|bevacizumab|mesh-list
82891494|NCT01281696|Methotrexate|methotrexate|mesh-list
82891495|NCT01281696|Etoposide|etoposide|mesh-list
82891496|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891497|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891498|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82891499|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82891500|NCT01281696|Growth Substances|growth substances|mesh-ancestor
82891501|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891502|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
82891503|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82891504|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
82891505|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82891506|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891507|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
82891508|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891509|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
82891510|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891511|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82891512|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891513|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
82891514|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891515|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82891516|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82891517|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82891518|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82891520|NCT05835713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82891521|NCT05835713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891522|NCT05835713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891523|NCT05835713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82891524|NCT05835713|Anesthetics, General|anesthetics, general|mesh-ancestor
82891526|NCT05835479|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82891527|NCT05835479|Rezafungin|rezafungin|mesh-list
82891528|NCT05835479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82891529|NCT05835479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891530|NCT05835479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82891531|NCT05835479|Antimalarials|antimalarials|mesh-ancestor
82891532|NCT05835479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82891533|NCT05835479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82891534|NCT05835479|Antifungal Agents|antifungal agents|mesh-ancestor
82891535|NCT05835284|Silicon|silicon|mesh-list
82891536|NCT05835284|Trace Elements|trace elements|mesh-ancestor
82891537|NCT05835284|Micronutrients|micronutrients|mesh-ancestor
82891538|NCT05835284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891539|NCT05835089|Estradiol|estradiol|mesh-list
82891540|NCT05835089|Testosterone|testosterone|mesh-list
82891541|NCT05835089|Estrogens|estrogens|mesh-ancestor
82891542|NCT05835089|Hormones|hormones|mesh-ancestor
82891543|NCT05835089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891544|NCT05835089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891545|NCT05835089|Androgens|androgens|mesh-ancestor
82891546|NCT05835011|Decitabine|decitabine|mesh-list
82891547|NCT05835011|Magrolimab|magrolimab|mesh-list
82891548|NCT05835011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891549|NCT05835011|Antimetabolites|antimetabolites|mesh-ancestor
82891550|NCT05835011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891551|NCT05835011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891552|NCT05835011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891553|NCT05835011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891554|NCT05834868|Insulin Lispro|insulin lispro|mesh-list
82891555|NCT05834868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891556|NCT05834868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891557|NCT05834855|Rituximab|rituximab|mesh-list
82891558|NCT05834855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891559|NCT05834855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891560|NCT05834855|Immunologic Factors|immunologic factors|mesh-ancestor
82891561|NCT05834855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891562|NCT05834855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891563|NCT05834777|Icatibant|icatibant|mesh-list
82891564|NCT05834777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82891565|NCT05834777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82891566|NCT05834777|Analgesics|analgesics|mesh-ancestor
82891567|NCT05834777|Sensory System Agents|sensory system agents|mesh-ancestor
82891568|NCT05834777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891569|NCT05834777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891570|NCT05834777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82891571|NCT05834777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891572|NCT05834777|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
82891573|NCT05834777|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
82891574|NCT05834777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891575|NCT05834777|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82891577|NCT05834777|Immunologic Factors|immunologic factors|mesh-ancestor
82891578|NCT05834764|Maleic acid|maleic acid|mesh-list
82891579|NCT05834764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891580|NCT05834764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891581|NCT05834738|Atrasentan|atrasentan|mesh-list
82891582|NCT05834738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891583|NCT05834738|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82891584|NCT05834738|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82891585|NCT05834738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891586|NCT05834647|Lidocaine|lidocaine|mesh-list
82891587|NCT05834647|Prilocaine|prilocaine|mesh-list
82891588|NCT05834647|Anesthetics, Local|anesthetics, local|mesh-ancestor
82891589|NCT05834647|Anesthetics|anesthetics|mesh-ancestor
82891590|NCT05834647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891591|NCT05834647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891592|NCT05834647|Sensory System Agents|sensory system agents|mesh-ancestor
82891593|NCT05834647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891594|NCT05834647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82891595|NCT05834647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82891596|NCT05834647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82891597|NCT05834647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82891598|NCT05834647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891599|NCT05834582|Paclitaxel|paclitaxel|mesh-list
82891600|NCT05834582|Cyclophosphamide|cyclophosphamide|mesh-list
82891601|NCT05834582|Epirubicin|epirubicin|mesh-list
82891602|NCT05834582|Fluzoparib|fluzoparib|mesh-list
82891603|NCT05834582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82891604|NCT05834582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891605|NCT05834582|Tubulin Modulators|tubulin modulators|mesh-ancestor
82891606|NCT05834582|Antimitotic Agents|antimitotic agents|mesh-ancestor
82891607|NCT05834582|Mitosis Modulators|mitosis modulators|mesh-ancestor
82891608|NCT05834582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891609|NCT05834582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891610|NCT05834582|Immunologic Factors|immunologic factors|mesh-ancestor
82891611|NCT05834582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891612|NCT05834582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891613|NCT05834582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82891614|NCT05834582|Alkylating Agents|alkylating agents|mesh-ancestor
82891615|NCT05834582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82891616|NCT05834582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82891617|NCT05834582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82891618|NCT05834582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82891619|NCT05834582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891620|NCT05834582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82891621|NCT05834543|Paclitaxel|paclitaxel|mesh-list
82891622|NCT05834543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82891623|NCT05834543|Cisplatin|cisplatin|mesh-list
82891624|NCT05834543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82891625|NCT05834543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891626|NCT05834543|Tubulin Modulators|tubulin modulators|mesh-ancestor
82891627|NCT05834543|Antimitotic Agents|antimitotic agents|mesh-ancestor
82891628|NCT05834543|Mitosis Modulators|mitosis modulators|mesh-ancestor
82891629|NCT05834543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891630|NCT05834517|Hyaluronic Acid|hyaluronic acid|mesh-list
82891631|NCT05834517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82891632|NCT05834517|Immunologic Factors|immunologic factors|mesh-ancestor
82891633|NCT05834517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891634|NCT05834517|Viscosupplements|viscosupplements|mesh-ancestor
82891635|NCT05834517|Protective Agents|protective agents|mesh-ancestor
82891636|NCT05834478|Fallypride|fallypride|mesh-list
82891637|NCT05834478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82891638|NCT05834478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82891639|NCT05834478|Dopamine Agents|dopamine agents|mesh-ancestor
82891640|NCT05834478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891641|NCT05834478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83454742|NCT04889547|Dexamethasone|dexamethasone|mesh-list
82891642|NCT05834478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891643|NCT05834361|Carboprost|carboprost|mesh-list
82891644|NCT05834361|Carboprost tromethamine|carboprost tromethamine|mesh-list
82891645|NCT05834361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82891646|NCT05834361|Abortifacient Agents|abortifacient agents|mesh-ancestor
82891647|NCT05834361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82891648|NCT05834361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891649|NCT05834361|Oxytocics|oxytocics|mesh-ancestor
82891650|NCT05834348|Docetaxel|docetaxel|mesh-list
82891651|NCT05834348|Bevacizumab|bevacizumab|mesh-list
82891652|NCT05834348|Carboplatin|carboplatin|mesh-list
82891653|NCT05834348|Pembrolizumab|pembrolizumab|mesh-list
82891654|NCT05834348|Nivolumab|nivolumab|mesh-list
82891655|NCT05834348|Atezolizumab|atezolizumab|mesh-list
82891656|NCT05834348|Gefitinib|gefitinib|mesh-list
82891657|NCT05834348|Osimertinib|osimertinib|mesh-list
82891658|NCT05834348|Afatinib|afatinib|mesh-list
82891659|NCT05834348|Crizotinib|crizotinib|mesh-list
82891660|NCT05834348|Ceritinib|ceritinib|mesh-list
82891661|NCT05834348|Entrectinib|entrectinib|mesh-list
82891662|NCT05834348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891663|NCT05834348|Tubulin Modulators|tubulin modulators|mesh-ancestor
82891664|NCT05834348|Antimitotic Agents|antimitotic agents|mesh-ancestor
82891665|NCT05834348|Mitosis Modulators|mitosis modulators|mesh-ancestor
82891666|NCT05834348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891667|NCT05834348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891668|NCT05834348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82891669|NCT05834348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82891670|NCT05834348|Growth Substances|growth substances|mesh-ancestor
82891671|NCT05834348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891672|NCT05834348|Growth Inhibitors|growth inhibitors|mesh-ancestor
82891673|NCT05834348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82891674|NCT05834348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82891675|NCT05834348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891676|NCT05834270|Tamsulosin|tamsulosin|mesh-list
82891677|NCT05834270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82891678|NCT05834270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82891679|NCT05834270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82891680|NCT05834270|Adrenergic Agents|adrenergic agents|mesh-ancestor
82891681|NCT05834270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891682|NCT05834270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891683|NCT05834270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891684|NCT05834270|Urological Agents|urological agents|mesh-ancestor
82891685|NCT05834244|Azacitidine|azacitidine|mesh-list
82891686|NCT05834244|Venetoclax|venetoclax|mesh-list
82891687|NCT05834244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891688|NCT05834244|Antimetabolites|antimetabolites|mesh-ancestor
82891689|NCT05834244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891690|NCT05834244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891691|NCT05834244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891692|NCT05834231|Memantine|memantine|mesh-list
82891693|NCT05834231|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82891694|NCT05834231|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82891695|NCT05834231|Dopamine Agents|dopamine agents|mesh-ancestor
82891696|NCT05834231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891697|NCT05834231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891698|NCT05834231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891699|NCT05834231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82891700|NCT05834231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82891701|NCT05833958|Metformin|metformin|mesh-list
82891702|NCT05833958|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82891703|NCT05833958|Dapagliflozin|dapagliflozin|mesh-list
82891704|NCT05833958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891705|NCT05833958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891706|NCT05833958|Incretins|incretins|mesh-ancestor
82891707|NCT05833958|Hormones|hormones|mesh-ancestor
82891708|NCT05833958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891709|NCT05833958|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82891710|NCT05833958|Protease Inhibitors|protease inhibitors|mesh-ancestor
82891711|NCT05833958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891712|NCT05833958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891713|NCT05833958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82891714|NCT05833776|Fentanyl|fentanyl|mesh-list
82891715|NCT05833776|Bupivacaine|bupivacaine|mesh-list
82891716|NCT05833776|Anesthetics, Local|anesthetics, local|mesh-ancestor
82891717|NCT05833776|Anesthetics|anesthetics|mesh-ancestor
82891718|NCT05833776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891719|NCT05833776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891720|NCT05833776|Sensory System Agents|sensory system agents|mesh-ancestor
82891721|NCT05833776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891722|NCT05833776|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82891723|NCT05833776|Narcotics|narcotics|mesh-ancestor
82891724|NCT05833776|Analgesics|analgesics|mesh-ancestor
82891725|NCT05833776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82891726|NCT05833776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82891727|NCT05833776|Anesthetics, General|anesthetics, general|mesh-ancestor
82891728|NCT05832047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82891729|NCT05830162|Amoxicillin|amoxicillin|mesh-list
82891730|NCT05830162|Clavulanic Acids|clavulanic acids|mesh-list
82891731|NCT05830162|Clavulanic Acid|clavulanic acid|mesh-list
82891732|NCT05830162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82891733|NCT05830162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891734|NCT05830162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891735|NCT05830162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891736|NCT05830162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82891737|NCT05829707|Diclofenac|diclofenac|mesh-list
82891738|NCT05829707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82891739|NCT05829707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82891740|NCT05829707|Anesthetics|anesthetics|mesh-list
82891741|NCT05829707|Levobupivacaine|levobupivacaine|mesh-list
82891742|NCT05829707|Anesthetics, Local|anesthetics, local|mesh-list
82891743|NCT05829707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891744|NCT05829707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891745|NCT05829707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82891746|NCT05829707|Analgesics|analgesics|mesh-ancestor
82891747|NCT05829707|Sensory System Agents|sensory system agents|mesh-ancestor
82891748|NCT05829707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891749|NCT05829707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891750|NCT05829707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82891751|NCT05829707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891752|NCT05829707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891753|NCT05823948|Insulin|insulin|mesh-list
82891754|NCT05823948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891755|NCT05823948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891756|NCT05819918|Calcifediol|calcifediol|mesh-list
82891757|NCT05819918|Vitamins|vitamins|mesh-ancestor
82891758|NCT05819918|Micronutrients|micronutrients|mesh-ancestor
82891759|NCT05819918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891760|NCT05819918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82891761|NCT05810883|Insulin|insulin|mesh-list
82891762|NCT05810883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83454759|NCT00989911|Bosentan|bosentan|mesh-list
82891763|NCT05810883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891764|NCT05807074|Tranexamic Acid|tranexamic acid|mesh-list
82891765|NCT05807074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82891766|NCT05807074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82891767|NCT05807074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891768|NCT05807074|Hemostatics|hemostatics|mesh-ancestor
82891769|NCT05807074|Coagulants|coagulants|mesh-ancestor
82891770|NCT05804162|Moxifloxacin|moxifloxacin|mesh-list
82891771|NCT05804162|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82891772|NCT05804162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82891773|NCT05804162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891774|NCT05804162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82891775|NCT05804162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82891776|NCT05804162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891777|NCT05804162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891778|NCT05804162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891779|NCT05804162|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82891780|NCT05804162|Contraceptive Agents|contraceptive agents|mesh-ancestor
82891781|NCT05804162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82891782|NCT05804162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891783|NCT05804162|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82891784|NCT05804162|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82891785|NCT05804162|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82891786|NCT05789303|Dexamethasone|dexamethasone|mesh-list
82891787|NCT05789303|Pomalidomide|pomalidomide|mesh-list
82891788|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82891789|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
82891790|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
82891791|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891792|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891793|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82891794|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
82891795|NCT05789303|Hormones|hormones|mesh-ancestor
82891796|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891797|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82891798|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891799|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
82891800|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82891801|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82891802|NCT05789303|Growth Substances|growth substances|mesh-ancestor
82891803|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
82891804|NCT05775380|Pioglitazone|pioglitazone|mesh-list
82891805|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891806|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891807|NCT05772273|Azacitidine|azacitidine|mesh-list
82891808|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891809|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
82891810|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891811|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891812|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891813|NCT05753098|Sildenafil Citrate|sildenafil citrate|mesh-list
82891814|NCT05753098|Clomiphene|clomiphene|mesh-list
82891815|NCT05753098|Enclomiphene|enclomiphene|mesh-list
82891816|NCT05753098|Zuclomiphene|zuclomiphene|mesh-list
82891817|NCT05753098|Estrogens|estrogens|mesh-list
82891818|NCT05753098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891819|NCT05753098|Vasodilator Agents|vasodilator agents|mesh-ancestor
82891820|NCT05753098|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82891821|NCT05753098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82891822|NCT05753098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891823|NCT05753098|Urological Agents|urological agents|mesh-ancestor
82891825|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891826|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891827|NCT05753098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82891828|NCT05753098|Hormone Antagonists|hormone antagonists|mesh-ancestor
82891829|NCT05753098|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82891830|NCT05753098|Fertility Agents|fertility agents|mesh-ancestor
82891831|NCT05753098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82891832|NCT05753098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82891833|NCT05753098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82891834|NCT05726292|Androgens|androgens|mesh-list
82891835|NCT05726292|Hormones|hormones|mesh-ancestor
82891836|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82891837|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891838|NCT05723562|Dostarlimab|dostarlimab|mesh-list
82891839|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891840|NCT05699811|Paclitaxel|paclitaxel|mesh-list
82891841|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
82891842|NCT05699811|Tislelizumab|tislelizumab|mesh-list
82891843|NCT05699811|Antibodies|antibodies|mesh-list
82891844|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82891845|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82891846|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891847|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
82891848|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
82891849|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
82891850|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891851|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891852|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
82891853|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891854|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891855|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82891856|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
82891857|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82891858|NCT05699811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891859|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
82891860|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
82891861|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891862|NCT05692843|Cyclosporine|cyclosporine|mesh-list
82891863|NCT05692843|Cyclosporins|cyclosporins|mesh-list
82891864|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891865|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891866|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891867|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
82891868|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891869|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
82891870|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891871|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
82891872|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891873|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82891874|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82891875|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891876|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82891877|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891878|NCT05660616|Gemcitabine|gemcitabine|mesh-list
82891879|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891880|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
82891881|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891882|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891883|NCT05659810|Gabapentin|gabapentin|mesh-list
82891884|NCT05659810|Analgesics|analgesics|mesh-ancestor
82891885|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
82891886|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891887|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891888|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
82891889|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82891890|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82732760|NCT04685876|Bupivacaine|bupivacaine|mesh-list
82891891|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82891892|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82891893|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82891894|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82891895|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82891896|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891897|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
82891898|NCT05658497|Interferons|interferons|mesh-list
83454786|NCT04706806|Acetic Acid|acetic acid|mesh-list
82891899|NCT05658497|Interferon-beta|interferon-beta|mesh-list
82891900|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
82891901|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82891902|NCT05658497|Natalizumab|natalizumab|mesh-list
82891903|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891904|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
82891905|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891906|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
82891907|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891908|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82891909|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
82891910|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891911|NCT05645757|Ertapenem|ertapenem|mesh-list
82891912|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82891913|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891914|NCT05625347|Aspirin|aspirin|mesh-list
82891915|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82891916|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82891917|NCT05625347|Analgesics|analgesics|mesh-ancestor
82891918|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
82891919|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891920|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891921|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82891922|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891923|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82891924|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82891925|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891926|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82891927|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82891928|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891929|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
82891930|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
82891931|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82891932|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891933|NCT05619913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82891934|NCT05619913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891935|NCT05602194|Asparaginase|asparaginase|mesh-list
82891936|NCT05602194|Pegaspargase|pegaspargase|mesh-list
82891937|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891938|NCT05594680|Methotrexate|methotrexate|mesh-list
82891939|NCT05594680|Cilostazol|cilostazol|mesh-list
82891940|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82891941|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
82891942|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82891943|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891944|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82891945|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
82891946|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891947|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891948|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
82891949|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891951|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891952|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
82891953|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891954|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82891955|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82891956|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
82891957|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82891958|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82891959|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
82891960|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82891961|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82891962|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82891963|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
82891964|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82891965|NCT05594680|Protective Agents|protective agents|mesh-ancestor
82891966|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82891967|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82891968|NCT05594563|Eflornithine|eflornithine|mesh-list
82891969|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82891970|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82891971|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82891972|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82891973|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82891974|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
82891975|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82891976|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82891977|NCT05569044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82891978|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82891979|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
82891980|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891981|NCT05557643|Psilocybin|psilocybin|mesh-list
82891982|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
82891983|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891984|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82891985|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
82891986|NCT05488457|Oxytocin|oxytocin|mesh-list
82891987|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
82891988|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82891989|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891990|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
82891991|NCT05470283|Fludarabine|fludarabine|mesh-list
82891992|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
82891993|NCT05470283|Furosemide|furosemide|mesh-list
82891994|NCT05470283|Acetazolamide|acetazolamide|mesh-list
82891995|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82891996|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
82891997|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82891998|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82891999|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892000|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
82892001|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892002|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892003|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892004|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892005|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
82892006|NCT05470283|Diuretics|diuretics|mesh-ancestor
82892007|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
82892008|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82892009|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82892010|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
82892011|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82892012|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892013|NCT05422534|Ubiquinone|ubiquinone|mesh-list
82892014|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
82892015|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892016|NCT05404945|Doxorubicin|doxorubicin|mesh-list
82892017|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
82892018|NCT05404945|Dacarbazine|dacarbazine|mesh-list
82892019|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82892020|NCT05404945|Vinblastine|vinblastine|mesh-list
82892021|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82892022|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892023|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82892024|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82892025|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892026|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892028|NCT05404945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892029|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892030|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
82892031|NCT05404945|Immunotoxins|immunotoxins|mesh-ancestor
82892032|NCT05404945|Immunoconjugates|immunoconjugates|mesh-ancestor
82892033|NCT05404945|Immunologic Factors|immunologic factors|mesh-ancestor
82892034|NCT05404945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892035|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82892036|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
82892037|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
82892038|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
82892039|NCT05365451|Metformin|metformin|mesh-list
82892040|NCT05365451|Probenecid|probenecid|mesh-list
82892041|NCT05365451|Furosemide|furosemide|mesh-list
82892042|NCT05365451|Cimetidine|cimetidine|mesh-list
82892043|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82892044|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892045|NCT05365451|Diuretics|diuretics|mesh-ancestor
82892046|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
82892047|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82892048|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83454789|NCT02975583|Vorapaxar|vorapaxar|mesh-list
82892049|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892050|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
82892051|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
82892052|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892053|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82892054|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892055|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82892056|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
82892057|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
82892058|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892059|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82892060|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82892061|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892062|NCT05325593|Dexamethasone|dexamethasone|mesh-list
82892063|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
82892064|NCT05325593|BB 1101|bb 1101|mesh-list
82892065|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892066|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
82892067|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
82892068|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892069|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892070|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892071|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
82892072|NCT05325593|Hormones|hormones|mesh-ancestor
82892073|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892074|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892075|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892076|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
82892077|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892078|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892079|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
82892080|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
82892081|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82892082|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82892083|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892084|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82892085|NCT05321121|Analgesics|analgesics|mesh-ancestor
82892086|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
82892087|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892088|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82892089|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82892090|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82892091|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892092|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892093|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892094|NCT05315713|Atezolizumab|atezolizumab|mesh-list
82892095|NCT05315713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892096|NCT05315713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892097|NCT05315713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892098|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892099|NCT05310734|Benzyl Alcohol|benzyl alcohol|mesh-list
82892100|NCT05310734|Anesthetics, Local|anesthetics, local|mesh-ancestor
82892101|NCT05310734|Anesthetics|anesthetics|mesh-ancestor
82892102|NCT05310734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82892103|NCT05310734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892104|NCT05310734|Sensory System Agents|sensory system agents|mesh-ancestor
82892105|NCT05310734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892106|NCT05284552|Tinzaparin|tinzaparin|mesh-list
82892107|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82892108|NCT05284552|Dalteparin|dalteparin|mesh-list
82892109|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
82892110|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82892111|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82892112|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892113|NCT05281614|Etanercept|etanercept|mesh-list
82892114|NCT05281614|Vedolizumab|vedolizumab|mesh-list
82892115|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82892116|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82892117|NCT05281614|Analgesics|analgesics|mesh-ancestor
82892118|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
83454792|NCT03953235|Ipilimumab|ipilimumab|mesh-list
82892119|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892120|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892121|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892122|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892123|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892124|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892125|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
82892126|NCT05267470|Paclitaxel|paclitaxel|mesh-list
82892127|NCT05267470|Docetaxel|docetaxel|mesh-list
82892128|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82892129|NCT05267470|Carboplatin|carboplatin|mesh-list
82892130|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
82892131|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
82892132|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82892133|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892134|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82892135|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82892136|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82892137|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892138|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892139|NCT05267470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892140|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
82892141|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
82892142|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
82892143|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
82892144|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892145|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892146|NCT05215574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892147|NCT05215574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892148|NCT05215418|Topiramate|topiramate|mesh-list
82892149|NCT05215418|Phentermine|phentermine|mesh-list
82892150|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
82892151|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82892152|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892153|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82892154|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
82892155|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82892156|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
82892157|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
82892158|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892159|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892160|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892161|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892162|NCT05203510|Treprostinil|treprostinil|mesh-list
82892163|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82892164|NCT05185089|Maleic acid|maleic acid|mesh-list
82892165|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892166|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892167|NCT05053737|Atezolizumab|atezolizumab|mesh-list
82892168|NCT05053737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892169|NCT05053737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892170|NCT05053737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892171|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892172|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
82892173|NCT05041153|Lenvatinib|lenvatinib|mesh-list
82892174|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892176|NCT05041153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892177|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892178|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82892179|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892181|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82892182|NCT05019703|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892183|NCT05019703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892184|NCT05019703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892185|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892186|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
82892187|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892188|NCT04994808|Fludarabine|fludarabine|mesh-list
82892189|NCT04994808|Clofarabine|clofarabine|mesh-list
82892190|NCT04994808|Treosulfan|treosulfan|mesh-list
82892191|NCT04994808|Busulfan|busulfan|mesh-list
82892192|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892193|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892194|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
82892195|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892196|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892197|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
82892198|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892199|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892200|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
82892201|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892202|NCT04955938|Ivosidenib|ivosidenib|mesh-list
82892203|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892204|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892205|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892206|NCT04907851|Denosumab|denosumab|mesh-list
82892207|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
82892208|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892209|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892210|NCT04907851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892211|NCT04907851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892212|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82892213|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892214|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
82892215|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892216|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82892217|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892218|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892219|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
82892220|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892221|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892222|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82892223|NCT04872608|Letrozole|letrozole|mesh-list
82892224|NCT04872608|Palbociclib|palbociclib|mesh-list
82892225|NCT04872608|Onapristone|onapristone|mesh-list
82892226|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892227|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82892228|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82892229|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892230|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892231|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82892232|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
82892233|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892234|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892235|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82892236|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82892237|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
82892238|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82892239|NCT04869501|Atezolizumab|atezolizumab|mesh-list
82892240|NCT04869501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892241|NCT04869501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892242|NCT04869501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892243|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892244|NCT04831398|Melatonin|melatonin|mesh-list
82892245|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
82892246|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892247|NCT04831398|Protective Agents|protective agents|mesh-ancestor
82892248|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892249|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82892250|NCT04826484|Bupivacaine|bupivacaine|mesh-list
82892251|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
82892252|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
82892253|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82892254|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892255|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
82892256|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892257|NCT04818216|Niacinamide|niacinamide|mesh-list
82892258|NCT04818216|Niacin|niacin|mesh-list
82892259|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
82892260|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
82892261|NCT04818216|Vitamins|vitamins|mesh-ancestor
82892262|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
82892263|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892264|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82892265|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
83454797|NCT03402945|Vancomycin|vancomycin|mesh-list
82892266|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892267|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82892268|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
82892269|NCT04801849|Vitamin E|vitamin e|mesh-list
82892270|NCT04801849|Tocopherols|tocopherols|mesh-list
82892271|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
82892273|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
82892274|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892275|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
82892276|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892277|NCT04801849|Protective Agents|protective agents|mesh-ancestor
82892278|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82892279|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
82892280|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892281|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892282|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
82892283|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892284|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892285|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82892286|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82892287|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82892288|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892289|NCT04635839|Heparin|heparin|mesh-list
82892290|NCT04635839|Calcium heparin|calcium heparin|mesh-list
82892291|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
82892292|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82892293|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82892294|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892295|NCT04610671|Nivolumab|nivolumab|mesh-list
82892296|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892297|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892298|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892299|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892300|NCT04591275|Denosumab|denosumab|mesh-list
82892301|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82892302|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892303|NCT04560179|Tobramycin|tobramycin|mesh-list
82892304|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82892305|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82892306|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82892307|NCT04543591|Ravulizumab|ravulizumab|mesh-list
82892308|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82892309|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892310|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
82892311|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892312|NCT04536337|Entecavir|entecavir|mesh-list
82892313|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
82892314|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82892315|NCT04525014|Irinotecan|irinotecan|mesh-list
82892316|NCT04525014|Temozolomide|temozolomide|mesh-list
82892317|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82892318|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82892319|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892320|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892321|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892323|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
82892325|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82892326|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892327|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892328|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892329|NCT04512365|Dronabinol|dronabinol|mesh-list
82892330|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
82892331|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892332|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892333|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82892334|NCT04512365|Analgesics|analgesics|mesh-ancestor
82892335|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
82892336|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892337|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82892338|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82892339|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892340|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892341|NCT04512365|Hormones|hormones|mesh-ancestor
82892342|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892343|NCT04464798|Rituximab|rituximab|mesh-list
82892344|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
82892345|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892346|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892347|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
82892348|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892349|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892350|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82892351|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
82892352|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892353|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892354|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
82892355|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892356|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892357|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82892358|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82892359|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82892360|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892361|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
82892362|NCT04441034|Convulsants|convulsants|mesh-list
82892363|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
82892364|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892365|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82892366|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892367|NCT04438824|Palbociclib|palbociclib|mesh-list
82892368|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892369|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82892370|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892371|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892373|NCT04361708|Docetaxel|docetaxel|mesh-list
82892374|NCT04361708|Fluorouracil|fluorouracil|mesh-list
82892375|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
82892376|NCT04361708|Irinotecan|irinotecan|mesh-list
82892377|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892378|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
82892379|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
82892380|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
82892381|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892382|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
82892383|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892384|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892385|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
82892386|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892387|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82892388|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82892389|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892390|NCT04361708|Antidotes|antidotes|mesh-ancestor
82892391|NCT04361708|Protective Agents|protective agents|mesh-ancestor
82892392|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
82892393|NCT04361708|Vitamins|vitamins|mesh-ancestor
82892394|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
82892395|NCT04348006|Dexamethasone|dexamethasone|mesh-list
82892398|NCT04348006|Bortezomib|bortezomib|mesh-list
82892399|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892400|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
82892401|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892402|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892403|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892404|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
82892405|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892406|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892407|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892408|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892409|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
82892410|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
82892411|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892412|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892413|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
82892414|NCT04348006|Hormones|hormones|mesh-ancestor
82892415|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892416|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892417|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82892418|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82892419|NCT04348006|Growth Substances|growth substances|mesh-ancestor
82892420|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
82892421|NCT04313972|Naltrexone|naltrexone|mesh-list
82892422|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82892423|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82892424|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892425|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
82892426|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892427|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
82892428|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82892429|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82892430|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892431|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
82892432|NCT04304625|Coagulants|coagulants|mesh-ancestor
82892433|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
82892434|NCT04295863|Nivolumab|nivolumab|mesh-list
82892435|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892436|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892437|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892438|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892439|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
82892440|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892441|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892442|NCT04231526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892443|NCT04231526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892444|NCT04201873|Poly I-C|poly i-c|mesh-list
82892445|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
82892446|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82892447|NCT04201873|Vaccines|vaccines|mesh-list
82892448|NCT04201873|Poly ICLC|poly iclc|mesh-list
82892449|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
82892450|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892451|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892452|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892453|NCT04201873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892454|NCT04201873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892455|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
82892456|NCT04201873|Laxatives|laxatives|mesh-ancestor
82892457|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892458|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
82892459|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82892460|NCT04107077|Mitomycins|mitomycins|mesh-list
82892461|NCT04107077|Mitomycin|mitomycin|mesh-list
82892462|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892463|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82892464|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
82892465|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892466|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82892467|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892468|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
82892469|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892470|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892471|NCT04089904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892472|NCT04089904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892473|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
82892474|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892475|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892476|NCT03873883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892477|NCT03873883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892478|NCT03850574|Venetoclax|venetoclax|mesh-list
82892479|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892480|NCT03785678|Tenecteplase|tenecteplase|mesh-list
82892481|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82892482|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82892483|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892484|NCT03783403|Rituximab|rituximab|mesh-list
82892485|NCT03783403|Cetuximab|cetuximab|mesh-list
82892486|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892487|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892488|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
82892489|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892490|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892491|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
82892492|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892493|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892494|NCT03757689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892495|NCT03757689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892496|NCT03729804|Dexamethasone|dexamethasone|mesh-list
82892497|NCT03729804|Lenalidomide|lenalidomide|mesh-list
82892498|NCT03729804|Bortezomib|bortezomib|mesh-list
82892499|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892501|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
82892502|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892503|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892504|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892505|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
82892506|NCT03729804|Hormones|hormones|mesh-ancestor
82892507|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892508|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892509|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892510|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
82892511|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82892512|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82892513|NCT03729804|Growth Substances|growth substances|mesh-ancestor
82892514|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
82892515|NCT03697564|Gemcitabine|gemcitabine|mesh-list
82892516|NCT03697564|Nivolumab|nivolumab|mesh-list
82892517|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892518|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
82892519|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892520|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892521|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892522|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892523|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
82892524|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892525|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892526|NCT03595683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892527|NCT03595683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892528|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82892529|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82892530|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
82892531|NCT03571321|Cytarabine|cytarabine|mesh-list
82892532|NCT03571321|Dexamethasone|dexamethasone|mesh-list
82892533|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
82892534|NCT03571321|Rituximab|rituximab|mesh-list
82892535|NCT03571321|Doxorubicin|doxorubicin|mesh-list
82892536|NCT03571321|Methotrexate|methotrexate|mesh-list
82892537|NCT03571321|Vincristine|vincristine|mesh-list
82892538|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
82892539|NCT03571321|Pegaspargase|pegaspargase|mesh-list
82892540|NCT03571321|Thioguanine|thioguanine|mesh-list
82892541|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892542|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
82892543|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892544|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892545|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892546|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
82892547|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892548|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892549|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892550|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892551|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892552|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
82892553|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
82892554|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892555|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892556|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
82892557|NCT03571321|Hormones|hormones|mesh-ancestor
82892558|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892559|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892560|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82892561|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82892562|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82892563|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892564|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82892565|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
82892566|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82892567|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892568|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
82892569|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
82892570|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82892571|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82892572|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
82892573|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82892574|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82892575|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
82892576|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
82892577|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
82892578|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
82892579|NCT03565445|Nivolumab|nivolumab|mesh-list
82892580|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892581|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892582|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892583|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892584|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
82892585|NCT03516812|Olaparib|olaparib|mesh-list
82892586|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82892587|NCT03516812|Testosterone|testosterone|mesh-list
82892588|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
82892589|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
82892590|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82892591|NCT03516812|Androgens|androgens|mesh-ancestor
82892592|NCT03516812|Hormones|hormones|mesh-ancestor
82892593|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892594|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892595|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892596|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892597|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
82892598|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892599|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892600|NCT03500445|Dexamethasone|dexamethasone|mesh-list
82892601|NCT03500445|Lenalidomide|lenalidomide|mesh-list
82892602|NCT03500445|Daratumumab|daratumumab|mesh-list
82892603|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892604|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
82892605|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
82892606|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892607|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892608|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892609|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
82892610|NCT03500445|Hormones|hormones|mesh-ancestor
82892611|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892612|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892613|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892614|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
82892615|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82892616|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82892617|NCT03500445|Growth Substances|growth substances|mesh-ancestor
82892618|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
82892619|NCT03494530|Edoxaban|edoxaban|mesh-list
82892620|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82892622|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82892623|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
82892624|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892625|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892626|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
82892627|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82892628|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
82892629|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892630|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892631|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
82892632|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892633|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892634|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82892635|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82892636|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82892637|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892638|NCT03466736|Flutemetamol|flutemetamol|mesh-list
82892639|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82892640|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892641|NCT03423264|Gabapentin|gabapentin|mesh-list
82892642|NCT03423264|Analgesics|analgesics|mesh-ancestor
82892643|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
82892644|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892645|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892646|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
82892647|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82892648|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82892649|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82892650|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892651|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82892652|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82892653|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892654|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892655|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
82892656|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82892657|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
82892658|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892659|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892660|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
82892661|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892662|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892663|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82892664|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82892665|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82892666|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892667|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
82892668|NCT03225547|Mifepristone|mifepristone|mesh-list
82892669|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892670|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892671|NCT03225547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892672|NCT03225547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892673|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82892674|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
82892675|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82892676|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892677|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82892678|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82892679|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82892680|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
82892681|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82892682|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82892683|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
82892684|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892685|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
82892686|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82892687|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82892688|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82892689|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
82892690|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892691|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82892692|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
82892693|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892694|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892695|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82892696|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82892697|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82892698|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892699|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
82892700|NCT03107182|Promethazine|promethazine|mesh-list
82892701|NCT03107182|Dexamethasone|dexamethasone|mesh-list
82892702|NCT03107182|Paclitaxel|paclitaxel|mesh-list
82892703|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82892704|NCT03107182|Carboplatin|carboplatin|mesh-list
82892705|NCT03107182|Nivolumab|nivolumab|mesh-list
82892706|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
82892707|NCT03107182|Famotidine|famotidine|mesh-list
82892708|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82892709|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892710|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
82892711|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
82892712|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
82892713|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892714|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892715|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
82892716|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
82892717|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892718|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892719|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892720|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
82892721|NCT03107182|Hormones|hormones|mesh-ancestor
82892722|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83513616|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
82892723|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892724|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892725|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892726|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
82892727|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892728|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82892729|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82892730|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82892731|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82892732|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
82892733|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
82892734|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
82892735|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82892736|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
82892737|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
82892738|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892739|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82892740|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
82892741|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
82892742|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82892743|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82892744|NCT03037385|Pralsetinib|pralsetinib|mesh-list
82892745|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892746|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
82892747|NCT02990533|Testosterone|testosterone|mesh-list
82892748|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
82892749|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
82892750|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82892751|NCT02990533|Androgens|androgens|mesh-ancestor
82892752|NCT02990533|Hormones|hormones|mesh-ancestor
82892753|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892754|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892755|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892756|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892757|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
82892758|NCT02969837|Dexamethasone|dexamethasone|mesh-list
82892759|NCT02969837|Lenalidomide|lenalidomide|mesh-list
82892760|NCT02969837|Elotuzumab|elotuzumab|mesh-list
82892761|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892762|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
82892763|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
82892764|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892765|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892766|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892767|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
82892768|NCT02969837|Hormones|hormones|mesh-ancestor
82892769|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892770|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892771|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892772|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
82892773|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82892774|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82892775|NCT02969837|Growth Substances|growth substances|mesh-ancestor
82892776|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
82892777|NCT02776917|Paclitaxel|paclitaxel|mesh-list
82892778|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82892779|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892780|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
82892781|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
82892782|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
82892783|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892784|NCT02751255|Tretinoin|tretinoin|mesh-list
82892785|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892786|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
82892787|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
82892788|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
82892789|NCT02707666|Pemetrexed|pemetrexed|mesh-list
82892790|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892791|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892792|NCT02707666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892793|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892794|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892795|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82892796|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82892797|NCT02668770|Ipilimumab|ipilimumab|mesh-list
82892798|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892799|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892800|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892801|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892802|NCT02659293|Dexamethasone|dexamethasone|mesh-list
82892803|NCT02659293|Lenalidomide|lenalidomide|mesh-list
82892804|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892805|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
82892806|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
82892807|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892808|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892809|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892810|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
82892811|NCT02659293|Hormones|hormones|mesh-ancestor
82892812|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892813|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892814|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892815|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
82892816|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82892817|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82892818|NCT02659293|Growth Substances|growth substances|mesh-ancestor
82892819|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
82892820|NCT02656511|Tenofovir|tenofovir|mesh-list
82892821|NCT02656511|Emtricitabine|emtricitabine|mesh-list
82892822|NCT02656511|Dolutegravir|dolutegravir|mesh-list
82892823|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
82892824|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82892825|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82892826|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82892827|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892828|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892829|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82892830|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82892831|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82892832|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82892833|NCT02613169|Isoniazid|isoniazid|mesh-list
82892834|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
82892835|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82892836|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82892837|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82892838|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82892839|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
82892840|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892841|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82892842|NCT02572323|Tesamorelin|tesamorelin|mesh-list
82892843|NCT02572323|Growth Substances|growth substances|mesh-ancestor
82892844|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892845|NCT02513186|Dexamethasone|dexamethasone|mesh-list
82892846|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
82892847|NCT02513186|Lenalidomide|lenalidomide|mesh-list
82892848|NCT02513186|Bortezomib|bortezomib|mesh-list
82892849|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892850|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
82892851|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892852|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892853|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892854|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
82892855|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892856|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892857|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892858|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892859|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
82892860|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
82892861|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892862|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892863|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
82892864|NCT02513186|Hormones|hormones|mesh-ancestor
82892865|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892866|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892867|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82892868|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82892869|NCT02513186|Growth Substances|growth substances|mesh-ancestor
82892870|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
82892871|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
82892872|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892873|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
82892874|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892875|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892876|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892877|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
82892878|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892879|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892880|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892881|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
82892882|NCT02431988|Fludarabine|fludarabine|mesh-list
82892883|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892884|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
82892885|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892886|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82892887|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892888|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
82892889|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892890|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892891|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892892|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
82892893|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892894|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892895|NCT02399371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82892896|NCT02399371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892897|NCT02389517|Dexamethasone|dexamethasone|mesh-list
82892898|NCT02389517|Lenalidomide|lenalidomide|mesh-list
82892899|NCT02389517|Ixazomib|ixazomib|mesh-list
82892900|NCT02389517|Glycine|glycine|mesh-list
82892901|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
82892902|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82892903|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
82892904|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
82892905|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82892906|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892907|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82892908|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
82892909|NCT02389517|Hormones|hormones|mesh-ancestor
82892910|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82892911|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82892912|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892913|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
82892914|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82892915|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82892916|NCT02389517|Growth Substances|growth substances|mesh-ancestor
82892917|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
82892918|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892919|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
82892920|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892921|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
82892922|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892923|NCT02366819|Leucovorin|leucovorin|mesh-list
82892924|NCT02366819|Fluorouracil|fluorouracil|mesh-list
82892925|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
82892926|NCT02366819|Irinotecan|irinotecan|mesh-list
82892927|NCT02366819|Calcium|calcium|mesh-list
82892928|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
82892929|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82892930|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892931|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
82892932|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892933|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892934|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892935|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892936|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
82892937|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82892938|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82892939|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892940|NCT02366819|Antidotes|antidotes|mesh-ancestor
82892941|NCT02366819|Protective Agents|protective agents|mesh-ancestor
82892942|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
82892943|NCT02366819|Vitamins|vitamins|mesh-ancestor
82892944|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
82892945|NCT02352948|Gemcitabine|gemcitabine|mesh-list
82892946|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82892947|NCT02352948|Durvalumab|durvalumab|mesh-list
82892948|NCT02352948|Vinorelbine|vinorelbine|mesh-list
82892949|NCT02352948|Tremelimumab|tremelimumab|mesh-list
82892950|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82892951|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892952|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
82892953|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892954|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892955|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82892956|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892957|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82892958|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
82892959|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892960|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82892961|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
82892962|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
82892963|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
82892964|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
82892965|NCT02333162|Fludarabine|fludarabine|mesh-list
82892966|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
82892967|NCT02333162|Melphalan|melphalan|mesh-list
82892968|NCT02333162|Tacrolimus|tacrolimus|mesh-list
82892969|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82892970|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82892971|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
82892972|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892973|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82892974|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
82892975|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892976|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82892977|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892978|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82892979|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82892980|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
82892981|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82892982|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82892983|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82892984|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
82892985|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82892986|NCT02281838|Enalapril|enalapril|mesh-list
82892987|NCT02281838|Labetalol|labetalol|mesh-list
82892988|NCT02281838|Hydralazine|hydralazine|mesh-list
82892989|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82892990|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
82892991|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82892992|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82892993|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82892994|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82892995|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82892996|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
82892997|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82892998|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82892999|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
82893000|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
82893001|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893002|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82893003|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82893004|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
82893005|NCT02213913|Prednisone|prednisone|mesh-list
82893006|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
82893007|NCT02213913|Rituximab|rituximab|mesh-list
82893008|NCT02213913|Doxorubicin|doxorubicin|mesh-list
82893009|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82893010|NCT02213913|Etoposide|etoposide|mesh-list
82893011|NCT02213913|Vincristine|vincristine|mesh-list
82893012|NCT02213913|Lenalidomide|lenalidomide|mesh-list
82893013|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
82893014|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893015|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
82893016|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893017|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82893018|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82893019|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
82893020|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893021|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893022|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82893023|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893024|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82893025|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82893026|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82893027|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893028|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893029|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
82893031|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893032|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893033|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893034|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893035|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893036|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893037|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893038|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893039|NCT02213913|Growth Substances|growth substances|mesh-ancestor
82893040|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893041|NCT02122172|Afatinib|afatinib|mesh-list
82893042|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893043|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82893044|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893045|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893046|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82893047|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
82893048|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893049|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893050|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
82893051|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893052|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893053|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82893054|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82893055|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82893056|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
82893057|NCT01847326|Paclitaxel|paclitaxel|mesh-list
82893058|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82893059|NCT01847326|Carboplatin|carboplatin|mesh-list
82893060|NCT01847326|Fluorouracil|fluorouracil|mesh-list
82893061|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
82893062|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893063|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893064|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893065|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893066|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893067|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893068|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
82893069|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893070|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893071|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
82893072|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893073|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
82893074|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893075|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893077|NCT01665794|Daratumumab|daratumumab|mesh-list
82893078|NCT01665794|Pomalidomide|pomalidomide|mesh-list
82893079|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893080|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
82893081|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
82893082|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893083|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893084|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893085|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
82893086|NCT01665794|Hormones|hormones|mesh-ancestor
82893087|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893088|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893089|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893090|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
82893091|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893092|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893093|NCT01665794|Growth Substances|growth substances|mesh-ancestor
82893094|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893095|NCT01592370|Dexamethasone|dexamethasone|mesh-list
82893096|NCT01592370|Nivolumab|nivolumab|mesh-list
82893097|NCT01592370|Ipilimumab|ipilimumab|mesh-list
82893098|NCT01592370|Daratumumab|daratumumab|mesh-list
82893099|NCT01592370|Pomalidomide|pomalidomide|mesh-list
82893100|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893101|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
82893102|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
82893103|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893104|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893105|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893106|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
82893108|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893109|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893110|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893111|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893112|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82893113|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893114|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
82893115|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893116|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893117|NCT01592370|Growth Substances|growth substances|mesh-ancestor
82893118|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893119|NCT01526096|Plerixafor|plerixafor|mesh-list
82893120|NCT01526096|Melphalan|melphalan|mesh-list
82893121|NCT01526096|Basiliximab|basiliximab|mesh-list
82893122|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82893123|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
82893124|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893125|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893126|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82893127|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893128|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
82893129|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893130|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82893131|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82893132|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
82893133|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893134|NCT01369212|Tenofovir|tenofovir|mesh-list
82893135|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82893136|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
82893137|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893138|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82893139|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893140|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893141|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893142|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82893143|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82893144|NCT00800215|Lacosamide|lacosamide|mesh-list
82893145|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
82893146|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82893147|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82893148|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82893149|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893150|NCT00669734|Metronidazole|metronidazole|mesh-list
82893151|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
82893152|NCT00669734|Vaccines|vaccines|mesh-list
82893153|NCT00669734|Sargramostim|sargramostim|mesh-list
82893154|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
82893155|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893156|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893157|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893158|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82893159|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82893160|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82893161|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
82893162|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893163|NCT00669734|Protective Agents|protective agents|mesh-ancestor
82893164|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
82893165|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893166|NCT00669734|Growth Substances|growth substances|mesh-ancestor
82893167|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82893168|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893169|NCT00337649|Trastuzumab|trastuzumab|mesh-list
82893170|NCT00337649|Epothilones|epothilones|mesh-list
82893171|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
82893172|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893173|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893174|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893175|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893176|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
83513693|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82893177|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893178|NCT00071084|Zanolimumab|zanolimumab|mesh-list
82893179|NCT00071084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82893180|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893181|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893182|NCT00071084|Immunologic Factors|immunologic factors|mesh-ancestor
82893183|NCT00071084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893184|NCT00042406|Zanolimumab|zanolimumab|mesh-list
82893185|NCT00042406|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82893186|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893187|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893188|NCT00042406|Immunologic Factors|immunologic factors|mesh-ancestor
82893189|NCT00042406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893190|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
82893191|NCT01170078|Hematinics|hematinics|mesh-ancestor
82893192|NCT01283646|Vitamins|vitamins|mesh-list
82893193|NCT01283646|Folic Acid|folic acid|mesh-list
82893194|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
82893195|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
82893196|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893197|NCT01283646|Hematinics|hematinics|mesh-ancestor
82893198|NCT01283724|Dienogest|dienogest|mesh-list
82893199|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82893200|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
82893201|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82893202|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83454847|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
82893203|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82893204|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82893205|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82893206|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82893207|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
82893208|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893209|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893210|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893211|NCT01586442|Eplerenone|eplerenone|mesh-list
82893212|NCT01586442|Spironolactone|spironolactone|mesh-list
82893213|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82893214|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
82893215|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893216|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893217|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82893218|NCT01586442|Diuretics|diuretics|mesh-ancestor
82893219|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
82893220|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82893221|NCT01587066|Valproic Acid|valproic acid|mesh-list
82893222|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82893223|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
82893224|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893225|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82893226|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82893227|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893228|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893229|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
82893230|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893231|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893233|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893234|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
82893235|NCT01587144|Lucanthone|lucanthone|mesh-list
82893236|NCT01587144|Temozolomide|temozolomide|mesh-list
82893237|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82893238|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
82893239|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893240|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893241|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
82893242|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82893243|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
82893244|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82893245|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893246|NCT01587222|Octreotide|octreotide|mesh-list
82893247|NCT01587222|Midodrine|midodrine|mesh-list
82893248|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893249|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893250|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893251|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
82893252|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
82893253|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893254|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893255|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82893256|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82893257|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82893258|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82893259|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
82893260|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893261|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893263|NCT01167738|Gemcitabine|gemcitabine|mesh-list
82893264|NCT01167738|Capecitabine|capecitabine|mesh-list
82893265|NCT01167738|Epirubicin|epirubicin|mesh-list
82893266|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893267|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893268|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
82893269|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893270|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82893271|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893272|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82893273|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82893274|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82893275|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893276|NCT01167816|Azacitidine|azacitidine|mesh-list
82893277|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893278|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
82893279|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893280|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893281|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893282|NCT01167894|Simvastatin|simvastatin|mesh-list
82893283|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82893284|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82893285|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
82893286|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893287|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82893288|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82893289|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893290|NCT03870828|Dimercaprol|dimercaprol|mesh-list
82893291|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
82893292|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
82893293|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893294|NCT03870594|Chrysarobin|chrysarobin|mesh-list
82893295|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82893296|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82893297|NCT03870594|Analgesics|analgesics|mesh-ancestor
82893298|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
82893299|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893300|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893301|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893302|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82893303|NCT01165866|Ondansetron|ondansetron|mesh-list
82893304|NCT01165866|Metoclopramide|metoclopramide|mesh-list
82893305|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
82893306|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
82893307|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893308|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893309|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893310|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
82893311|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
82893312|NCT01165866|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82893313|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82893314|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
82893315|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893316|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893317|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82893318|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82893319|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
82893320|NCT01170468|Vitamin D|vitamin d|mesh-list
82893321|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
82893322|NCT01170468|Vitamins|vitamins|mesh-ancestor
82893323|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
82893324|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893325|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82893326|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82893327|NCT01273584|Metformin|metformin|mesh-list
82893328|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82893329|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893331|NCT01281852|Cisplatin|cisplatin|mesh-list
82893332|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82893333|NCT01281852|Veliparib|veliparib|mesh-list
82893334|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893335|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893336|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893337|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893338|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893339|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893340|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82893341|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893342|NCT01168440|Sunitinib|sunitinib|mesh-list
82893343|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893344|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893345|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893346|NCT01168440|Growth Substances|growth substances|mesh-ancestor
82893347|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893348|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893349|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82893350|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893351|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893352|NCT01170780|Dexamethasone|dexamethasone|mesh-list
82893353|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893354|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
82893355|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
82893356|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893357|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893358|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893359|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
82893360|NCT01170780|Hormones|hormones|mesh-ancestor
82893361|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893362|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893363|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893364|NCT01165944|Pramlintide|pramlintide|mesh-list
82893365|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82893366|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893367|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82893368|NCT01170858|Icodextrin|icodextrin|mesh-list
82893369|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
82893370|NCT01171092|Bortezomib|bortezomib|mesh-list
82893371|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893372|NCT03753204|Furosemide|furosemide|mesh-list
82893373|NCT03753204|Diuretics|diuretics|mesh-ancestor
82893374|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
82893375|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893376|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82893377|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82893378|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893380|NCT01171170|Bevacizumab|bevacizumab|mesh-list
82893381|NCT01171170|Carboplatin|carboplatin|mesh-list
82893382|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82893383|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
82893384|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893385|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893386|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893387|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893388|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893389|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893390|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893391|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893392|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893393|NCT01171170|Growth Substances|growth substances|mesh-ancestor
82893394|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893395|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893396|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
82893397|NCT01166100|Fluoxetine|fluoxetine|mesh-list
82893398|NCT01166100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82893399|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82893400|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82893401|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893402|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893403|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
82893404|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893405|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82893406|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
82893407|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893408|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82893409|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82893410|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893411|NCT01277016|Melphalan|melphalan|mesh-list
82893412|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82893413|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
82893414|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893415|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893416|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82893417|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893418|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
82893419|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893420|NCT01171326|Minocycline|minocycline|mesh-list
82893421|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82893422|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893423|NCT01171482|Fluorouracil|fluorouracil|mesh-list
82893424|NCT01171482|Sorafenib|sorafenib|mesh-list
82893425|NCT01171482|Mitomycins|mitomycins|mesh-list
82893426|NCT01171482|Mitomycin|mitomycin|mesh-list
82893427|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
82893428|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893429|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893430|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893431|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893432|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
82893433|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893434|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82893435|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893436|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82893437|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
82893438|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893439|NCT01282398|Simvastatin|simvastatin|mesh-list
82893440|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82893441|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82893442|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
82893443|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893444|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82893445|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82893446|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893447|NCT01169142|Vitamin D|vitamin d|mesh-list
82893448|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
82893450|NCT01169142|Vitamins|vitamins|mesh-list
82893451|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
82893452|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893453|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82893454|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82893455|NCT01169298|Lenalidomide|lenalidomide|mesh-list
82893456|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
82893457|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893458|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893459|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893460|NCT01169298|Growth Substances|growth substances|mesh-ancestor
82893461|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893462|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893463|NCT01277484|Decitabine|decitabine|mesh-list
82893464|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893465|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
82893466|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893467|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893468|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893469|NCT01282632|Olanzapine|olanzapine|mesh-list
82893470|NCT01282632|Risperidone|risperidone|mesh-list
82893471|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82893472|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
82893473|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893474|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893475|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893476|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82893477|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82893478|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893479|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893480|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82893481|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
82893482|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
82893483|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
82893484|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893485|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893486|NCT01282632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82893487|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82893488|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82893489|NCT01172028|Docetaxel|docetaxel|mesh-list
82893490|NCT01172028|Pemetrexed|pemetrexed|mesh-list
82893491|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893492|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893493|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893494|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893495|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893496|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893497|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82893498|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893499|NCT01278186|Paclitaxel|paclitaxel|mesh-list
82893500|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893501|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893502|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893503|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893504|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893505|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893506|NCT01169688|Phenylephrine|phenylephrine|mesh-list
82893507|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
82893508|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
82893509|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82893510|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
82893511|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
82893512|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893513|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893514|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
82893515|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82893516|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
82893517|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
82893518|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82893519|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82893520|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82893521|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
82893522|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893523|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893524|NCT01169688|Protective Agents|protective agents|mesh-ancestor
82893525|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
82893526|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82893527|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82893528|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
82893529|NCT01278264|Ropivacaine|ropivacaine|mesh-list
82893530|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
82893531|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
82893532|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893533|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893534|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
82893535|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893536|NCT01172652|Ziprasidone|ziprasidone|mesh-list
82893537|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82893538|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
82893539|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893540|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893541|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893542|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82893543|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82893544|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893545|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893546|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82893547|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
82893548|NCT02526030|Aripiprazole|aripiprazole|mesh-list
82893549|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82893550|NCT02526030|Ziprasidone|ziprasidone|mesh-list
82893551|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
82893552|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893553|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82893554|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82893555|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893556|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893557|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
82893558|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
82893559|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893560|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893561|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82893562|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82893563|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
82893564|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82893565|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82893566|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82893567|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82893568|NCT03867240|Gabapentin|gabapentin|mesh-list
82893569|NCT03867240|Analgesics|analgesics|mesh-ancestor
82893570|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
82893571|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893572|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893573|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
82893574|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82893575|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82893576|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893577|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893578|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82893579|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82893580|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893581|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893582|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
82893583|NCT01172964|Flucytosine|flucytosine|mesh-list
82893584|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
82893585|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893586|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
82893587|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893588|NCT03866928|Stiripentol|stiripentol|mesh-list
82893589|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
82893590|NCT01172496|Treprostinil|treprostinil|mesh-list
82893591|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82893592|NCT01178034|Warfarin|warfarin|mesh-list
82893593|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
82893594|NCT01288170|Tobramycin|tobramycin|mesh-list
82893595|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82893596|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893597|NCT01178112|Carboplatin|carboplatin|mesh-list
82893598|NCT01178112|Trientine|trientine|mesh-list
82893599|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893600|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
82893602|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893603|NCT01175460|Nedaplatin|nedaplatin|mesh-list
82893604|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893605|NCT01175538|Lactulose|lactulose|mesh-list
82893606|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893607|NCT01288326|Liraglutide|liraglutide|mesh-list
82893608|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82893609|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893610|NCT01288326|Incretins|incretins|mesh-ancestor
82893611|NCT01288326|Hormones|hormones|mesh-ancestor
82893612|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893613|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
82893614|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82893615|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82893616|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82893617|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82893618|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
82893619|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893620|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82893621|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82893622|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893623|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893624|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82893625|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893626|NCT03435640|Nivolumab|nivolumab|mesh-list
82893627|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893628|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893629|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82893630|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893631|NCT01175772|Celecoxib|celecoxib|mesh-list
82893632|NCT01175772|Methotrexate|methotrexate|mesh-list
82893633|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
82893634|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82893635|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
82893636|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82893637|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893638|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893639|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
82893640|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893641|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893642|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
82893643|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893644|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82893645|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893646|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
82893647|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82893648|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893649|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82893650|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82893651|NCT01175772|Analgesics|analgesics|mesh-ancestor
82893652|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
82893653|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893654|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893655|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82893656|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82893657|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82893658|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
82893659|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82893660|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82893661|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82893662|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82893663|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893664|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893665|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893666|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82893667|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82893668|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82893669|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
82893670|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893671|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893672|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82893673|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82893674|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
82893675|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82893676|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82893677|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
82893678|NCT01536964|Morphine|morphine|mesh-list
82893679|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82893680|NCT01536964|Narcotics|narcotics|mesh-ancestor
82893681|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893682|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893683|NCT01536964|Analgesics|analgesics|mesh-ancestor
82893684|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
82893685|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893686|NCT01288404|Fluorometholone|fluorometholone|mesh-list
82893687|NCT01288404|Bevacizumab|bevacizumab|mesh-list
82893688|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893689|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893690|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893691|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893692|NCT01288404|Growth Substances|growth substances|mesh-ancestor
82893693|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893694|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893695|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893696|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
82893697|NCT01288404|Hormones|hormones|mesh-ancestor
82893698|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893699|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82893700|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
82893701|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82893702|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82893703|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
83482926|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893704|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893705|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82893706|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82893707|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82893708|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82893709|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82893710|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893711|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82893712|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893713|NCT01286688|Terbinafine|terbinafine|mesh-list
82893714|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
82893715|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893716|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893717|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893718|NCT01286766|Cisplatin|cisplatin|mesh-list
82893719|NCT01286766|Docetaxel|docetaxel|mesh-list
82893720|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893721|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893722|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893723|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893724|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893725|NCT02525484|Pirfenidone|pirfenidone|mesh-list
82893726|NCT02525484|Analgesics|analgesics|mesh-ancestor
82893727|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
82893728|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893729|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893730|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82893731|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82893732|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893733|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82893734|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893735|NCT01173978|Prednisolone|prednisolone|mesh-list
82893736|NCT01173978|Hormones|hormones|mesh-list
82893737|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893738|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893739|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893740|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
82893741|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82893742|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893743|NCT01174056|Pioglitazone|pioglitazone|mesh-list
82893744|NCT01174056|Zileuton|zileuton|mesh-list
82893745|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
82893746|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82893747|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893748|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82893749|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82893751|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
82893752|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893753|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893754|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82893755|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82893756|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893757|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893758|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82893759|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
82893760|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893761|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893762|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
82893763|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893764|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82893765|NCT01174212|Vancomycin|vancomycin|mesh-list
82893766|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82893767|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893768|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
82893769|NCT01174290|Haloperidol|haloperidol|mesh-list
82893770|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
82893771|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
82893772|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
82893773|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893774|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893775|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893776|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82893777|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82734635|NCT00611559|PENTA|penta|mesh-list
82893778|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893779|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82893780|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82893781|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
82893782|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893783|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893784|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82893785|NCT03862404|Epinephrine|epinephrine|mesh-list
82893786|NCT03862404|Bupivacaine|bupivacaine|mesh-list
82893787|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
82893788|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
82893789|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893790|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893791|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
82893792|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893793|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82893794|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82893795|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
82893796|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893797|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893798|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82893799|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82893800|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
82893801|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82893802|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
82893803|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
82893804|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
82893805|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82893806|NCT03865680|Fluorides|fluorides|mesh-list
82893807|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
82893808|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
82893809|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
82893810|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893811|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
82893812|NCT03865680|Protective Agents|protective agents|mesh-ancestor
82893813|NCT01288716|Baclofen|baclofen|mesh-list
82893814|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82893815|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893816|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82893817|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893818|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82893819|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
82893820|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
82893821|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893822|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893824|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82893825|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82893826|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82893827|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
82893828|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893829|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893830|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893831|NCT01285596|Urological Agents|urological agents|mesh-ancestor
82893832|NCT00655876|Paclitaxel|paclitaxel|mesh-list
82893833|NCT00655876|Cetuximab|cetuximab|mesh-list
82893834|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893835|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893836|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893837|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893838|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893839|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893840|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893841|NCT01176318|Erdosteine|erdosteine|mesh-list
82893842|NCT01176318|Expectorants|expectorants|mesh-ancestor
82893843|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
82893844|NCT01178658|Cytarabine|cytarabine|mesh-list
82893845|NCT01178658|Etoposide|etoposide|mesh-list
82893846|NCT01178658|Melphalan|melphalan|mesh-list
82893847|NCT01178658|Busulfan|busulfan|mesh-list
82893848|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893849|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893850|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82893851|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82893852|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893853|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893854|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893855|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
82893856|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
82893857|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893858|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893859|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
82893860|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893861|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82893862|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
82893863|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82893864|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82893865|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893866|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82893867|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82893868|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82893869|NCT01174524|Gestodene|gestodene|mesh-list
82893870|NCT01174524|Femovan|femovan|mesh-list
82893871|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
82893872|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
82893873|NCT01174524|Estradiol|estradiol|mesh-list
82893874|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82893875|NCT01174524|Estrogens|estrogens|mesh-ancestor
82893876|NCT01174524|Hormones|hormones|mesh-ancestor
82893877|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82893878|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893879|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82893880|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82893881|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82893882|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82893883|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82893884|NCT01174524|Progestins|progestins|mesh-ancestor
82893885|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82893886|NCT02525172|Rituximab|rituximab|mesh-list
82893887|NCT02525172|Methotrexate|methotrexate|mesh-list
82893888|NCT02525172|Bortezomib|bortezomib|mesh-list
82893889|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
82893890|NCT02525172|Antibodies|antibodies|mesh-list
82893891|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
82893892|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82893893|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82893894|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893895|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893896|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
82893897|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893899|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82893900|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
82893901|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82893902|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893903|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
82893904|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893905|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
82893906|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893907|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82893908|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893909|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82893910|NCT00047008|Cisplatin|cisplatin|mesh-list
82893911|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893912|NCT01285674|Cisplatin|cisplatin|mesh-list
82893913|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893914|NCT03859362|Ertapenem|ertapenem|mesh-list
82893915|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82893916|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893917|NCT05598580|Lenalidomide|lenalidomide|mesh-list
82893918|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
82893919|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893920|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82893921|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82893922|NCT05598580|Growth Substances|growth substances|mesh-ancestor
82893923|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
82893924|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893925|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82893926|NCT01287546|Trametinib|trametinib|mesh-list
82893927|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893928|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82893929|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82893930|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893931|NCT03182166|Golimumab|golimumab|mesh-list
82893932|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82893933|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82893934|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82893935|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
82893936|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893937|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
82893938|NCT03193216|Antacids|antacids|mesh-ancestor
82893939|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893940|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893941|NCT03864978|Rifaximin|rifaximin|mesh-list
82893942|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82893943|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893944|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82893945|NCT01568788|Vaccines|vaccines|mesh-list
82893946|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
82893947|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893948|NCT01287624|Paclitaxel|paclitaxel|mesh-list
82893949|NCT01287624|Gemcitabine|gemcitabine|mesh-list
82893950|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82893951|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893952|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
82893953|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
82893954|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
82893955|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893956|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82893957|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
82893958|NCT05597800|Nivolumab|nivolumab|mesh-list
82893959|NCT05597800|Ipilimumab|ipilimumab|mesh-list
82893960|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82893961|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893962|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82893963|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893964|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
82893965|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
82893966|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82893967|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
82893968|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82893969|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
82893970|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893971|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82893972|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
82893973|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82893974|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82893975|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893976|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82893977|NCT01179438|Analgesics|analgesics|mesh-ancestor
82893978|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
82893979|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893980|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82893981|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82893982|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82893983|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
82893984|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82893985|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893986|NCT03864666|Cilostazol|cilostazol|mesh-list
82893987|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82893988|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
82893989|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82893990|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82893991|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82893992|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
82893993|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82893994|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82893995|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82893996|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82893997|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
82893998|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82893999|NCT03864666|Protective Agents|protective agents|mesh-ancestor
82894000|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82894001|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82894002|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894003|NCT03858972|Capecitabine|capecitabine|mesh-list
82894004|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82894005|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
82894006|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894007|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894008|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
82894009|NCT03091348|Testosterone|testosterone|mesh-list
82894010|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
82894011|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
82894012|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82894013|NCT03091348|Androgens|androgens|mesh-ancestor
82894014|NCT03091348|Hormones|hormones|mesh-ancestor
82894015|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82894016|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894017|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82894018|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894019|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
82894020|NCT02525016|Lidocaine|lidocaine|mesh-list
82894021|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
82894022|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
82894023|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894024|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894025|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
82894026|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894027|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82894028|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82894029|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82894030|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82894031|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894032|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82894033|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
82894034|NCT01179594|Entecavir|entecavir|mesh-list
82894035|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
82894036|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894037|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
82894038|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894039|NCT03751098|Phenylephrine|phenylephrine|mesh-list
82894040|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
82894041|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82894042|NCT03751098|Tropicamide|tropicamide|mesh-list
82894043|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82894044|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82894045|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
82894046|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
82894048|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894049|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
82894050|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82894051|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
82894052|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
82894053|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82894054|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82894055|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82894056|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
82894057|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894058|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894059|NCT03751098|Protective Agents|protective agents|mesh-ancestor
82894060|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82894061|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82894062|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894063|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82894064|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
82894065|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894066|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894067|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82894068|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894069|NCT01288794|Furosemide|furosemide|mesh-list
82894070|NCT01288794|Diuretics|diuretics|mesh-list
82894071|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
82894072|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894073|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82894074|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82894075|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894076|NCT01288872|Praziquantel|praziquantel|mesh-list
82894077|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
82894078|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82894079|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894080|NCT03864588|Ropivacaine|ropivacaine|mesh-list
82894081|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
82894083|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894084|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894085|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
82894086|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894087|NCT01288950|Vitamin D|vitamin d|mesh-list
82894088|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
82894089|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
82894090|NCT01288950|Vitamins|vitamins|mesh-list
82894091|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
82894092|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894093|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82894094|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82894095|NCT01174914|Tenofovir|tenofovir|mesh-list
82894096|NCT01174914|Lamivudine|lamivudine|mesh-list
82894097|NCT01174914|Emtricitabine|emtricitabine|mesh-list
82894098|NCT01174914|Efavirenz|efavirenz|mesh-list
82894099|NCT01174914|Lopinavir|lopinavir|mesh-list
82894100|NCT01174914|Nevirapine|nevirapine|mesh-list
82894101|NCT01174914|Stavudine|stavudine|mesh-list
82894102|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
82894103|NCT01174914|Naltrexone|naltrexone|mesh-list
82894104|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
82894105|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894106|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82894107|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82894108|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894109|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894110|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82894111|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82894112|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82894113|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82894114|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894115|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
82894116|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894117|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82894118|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82894119|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82894120|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82894121|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82894122|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82894123|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82894124|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82894125|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
82894126|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82894127|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
82894128|NCT05548426|Linezolid|linezolid|mesh-list
82894129|NCT05548426|Penicillins|penicillins|mesh-list
82894130|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894131|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894132|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82894133|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894134|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894135|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
82894136|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82894137|NCT01177176|Bupropion|bupropion|mesh-list
82894138|NCT01177176|Nicotine|nicotine|mesh-list
82894139|NCT01177176|Varenicline|varenicline|mesh-list
82894140|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82894141|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
82894142|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894143|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894144|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82894145|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82894146|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894147|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894148|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894149|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82894150|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
82894151|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82894152|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82894153|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82894154|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82894155|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
82894156|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82894157|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82894158|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894159|NCT01287780|Gentamicins|gentamicins|mesh-list
82894160|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894161|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894162|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82894163|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894164|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894165|NCT01179828|Oxycodone|oxycodone|mesh-list
82894166|NCT01179828|Clobazam|clobazam|mesh-list
82894167|NCT01179828|Imipramine|imipramine|mesh-list
82894168|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82894169|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82894170|NCT01179828|Narcotics|narcotics|mesh-ancestor
82894171|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894172|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894173|NCT01179828|Analgesics|analgesics|mesh-ancestor
82894174|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
82894175|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894176|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82894177|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82894178|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894179|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894180|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894181|NCT01179828|Urological Agents|urological agents|mesh-ancestor
82894182|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82894183|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
82894184|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82894185|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83454923|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
82894186|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82894187|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82894188|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
82894189|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
82894190|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82894191|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82894192|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82894193|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
82894194|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
82894195|NCT01180062|Latanoprost|latanoprost|mesh-list
82894196|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82894199|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894200|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894201|NCT03858582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82894202|NCT03858582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894203|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
82894204|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82894205|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82894206|NCT01177566|Analgesics|analgesics|mesh-ancestor
82894207|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
82894208|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894209|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894210|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894211|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894212|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
82894213|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82894214|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
82894215|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82894216|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894217|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894218|NCT01181154|Rituximab|rituximab|mesh-list
82894219|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894220|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894221|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
82894222|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894223|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894224|NCT03101566|Gemcitabine|gemcitabine|mesh-list
82894225|NCT03101566|Nivolumab|nivolumab|mesh-list
82894226|NCT03101566|Ipilimumab|ipilimumab|mesh-list
82894227|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894228|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82894229|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
82894230|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894231|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894232|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82894233|NCT01289496|Interferons|interferons|mesh-list
82894234|NCT01289496|Ribavirin|ribavirin|mesh-list
82894235|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
82894236|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
82894237|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82894238|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894239|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
82894240|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894241|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
82894242|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894243|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
82894244|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894245|NCT01181232|Zolpidem|zolpidem|mesh-list
82894246|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82894247|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82894248|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894249|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894250|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82894251|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
82894252|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
82894253|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894254|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894255|NCT01181310|Scopolamine|scopolamine|mesh-list
82894256|NCT01181310|Donepezil|donepezil|mesh-list
82894257|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82894258|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82894259|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894260|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894261|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894262|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894263|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894264|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
82894265|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82894266|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
82894267|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
82894268|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894269|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82894270|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
82894271|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82894272|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82894273|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
82894274|NCT02525250|Lenalidomide|lenalidomide|mesh-list
82894275|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
82894276|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894277|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82894278|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82894279|NCT02525250|Growth Substances|growth substances|mesh-ancestor
82894280|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
82894281|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894282|NCT01288092|Dactolisib|dactolisib|mesh-list
82894283|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894284|NCT01290744|Clofazimine|clofazimine|mesh-list
82894285|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894286|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
82894287|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894288|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894289|NCT01181388|Tirofiban|tirofiban|mesh-list
82894290|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82894291|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82894292|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894293|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82894294|NCT01181544|Heparin|heparin|mesh-list
82894295|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
82894296|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82894297|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82894298|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894299|NCT01184664|Nicotine|nicotine|mesh-list
82894300|NCT01184664|Varenicline|varenicline|mesh-list
82894301|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82894302|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
82894303|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894304|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894305|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82894306|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82894307|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894308|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894309|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894310|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82894311|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894312|NCT01184820|Factor VIII|factor viii|mesh-list
82894313|NCT01184820|Coagulants|coagulants|mesh-ancestor
82894314|NCT03858270|Memantine|memantine|mesh-list
82894315|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82894316|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82894317|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
82894318|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894319|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894320|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894321|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82894322|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82894323|NCT01289730|Etanercept|etanercept|mesh-list
82894324|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82894325|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82894326|NCT01289730|Analgesics|analgesics|mesh-ancestor
82894327|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
82894328|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894329|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894330|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894331|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894332|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82894333|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82894334|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
82894335|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
82894336|NCT01290900|Ceftazidime|ceftazidime|mesh-list
82894337|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82894338|NCT01290900|Avibactam|avibactam|mesh-list
82894339|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894340|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894341|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82894342|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82894343|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894344|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894345|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894346|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82894347|NCT03855306|Glyburide|glyburide|mesh-list
82894349|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894350|NCT03855384|Cisplatin|cisplatin|mesh-list
82894351|NCT03855384|Carboplatin|carboplatin|mesh-list
82894352|NCT03855384|Fluorouracil|fluorouracil|mesh-list
82894353|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894354|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
82894355|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894356|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82894357|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82894358|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
82894359|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894360|NCT01181934|Nicotine|nicotine|mesh-list
82894361|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82894362|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
82894363|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894364|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894365|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82894366|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82894367|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894368|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894369|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894370|NCT01187862|Efavirenz|efavirenz|mesh-list
82894371|NCT01187862|Losartan|losartan|mesh-list
82894372|NCT01187862|Metoprolol|metoprolol|mesh-list
82894373|NCT01187862|Midazolam|midazolam|mesh-list
82894374|NCT01187862|Caffeine|caffeine|mesh-list
82894375|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
82894376|NCT01187862|Omeprazole|omeprazole|mesh-list
82894377|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82894378|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82894379|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894380|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894381|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82894382|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82894383|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82894384|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82894385|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
82894386|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
82894387|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
82894388|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
82894389|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894390|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894391|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82894392|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82894393|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82894394|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82894395|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82894396|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82894397|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894398|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82894399|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82894400|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
82894401|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82894402|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82894403|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82894404|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82894405|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82894406|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
82894407|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894408|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82894409|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82894410|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82894411|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82894412|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82894413|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82894414|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
82894415|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
82894416|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894417|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82894418|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82894419|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82894420|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
82894421|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82894430|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
82894431|NCT01185444|Protective Agents|protective agents|mesh-ancestor
82894432|NCT03857334|Cortivazol|cortivazol|mesh-list
82894433|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894434|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
82894435|NCT01185678|Desogestrel|desogestrel|mesh-list
82894436|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
82894437|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82894438|NCT01185678|Progestins|progestins|mesh-list
82894439|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82894440|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894441|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82894442|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82894443|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82894444|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82894445|NCT01185678|Hormones|hormones|mesh-ancestor
82894446|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82894447|NCT01188174|Clofarabine|clofarabine|mesh-list
82894448|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82894449|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
82894450|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894451|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894452|NCT01588002|Ritonavir|ritonavir|mesh-list
82894453|NCT01588002|Efavirenz|efavirenz|mesh-list
82894454|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82894455|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82894456|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
82894457|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894458|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894459|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82894460|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82894461|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
82894462|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894463|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82894464|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82894465|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82894466|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82894467|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82894468|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82894469|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82894470|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82894471|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82894472|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
82894473|NCT01291212|Testosterone|testosterone|mesh-list
82894474|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
82894475|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
82894476|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82894477|NCT01291212|Androgens|androgens|mesh-ancestor
82894478|NCT01291212|Hormones|hormones|mesh-ancestor
82894479|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82894480|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894481|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82894482|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894483|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
82894484|NCT01182168|Gemcitabine|gemcitabine|mesh-list
82894485|NCT01182168|Everolimus|everolimus|mesh-list
82894486|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894487|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82894488|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
82894489|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894490|NCT01182168|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82894491|NCT01182168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82894492|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894493|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82894494|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
82894495|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894496|NCT01182246|Genistein|genistein|mesh-list
82894497|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82894498|NCT01182246|Protective Agents|protective agents|mesh-ancestor
82894499|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894500|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894501|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82894502|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894503|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894504|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
82894505|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82894506|NCT01182246|Estrogens|estrogens|mesh-ancestor
82894507|NCT01182246|Hormones|hormones|mesh-ancestor
82894508|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82894509|NCT01588626|Ticagrelor|ticagrelor|mesh-list
82894510|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82894511|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82894512|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82894513|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82894514|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
82894515|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894516|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894517|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894518|NCT01290120|Rituximab|rituximab|mesh-list
82894519|NCT01290120|Doxorubicin|doxorubicin|mesh-list
82894520|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894521|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894522|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
82894523|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894524|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894525|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82894526|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82894527|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82894528|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894529|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894530|NCT01290198|Fluconazole|fluconazole|mesh-list
82894531|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
82894532|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
82894533|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894534|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82894535|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82894536|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894537|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894538|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82894539|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
83133548|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82894540|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82894541|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894542|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82894543|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82894545|NCT01290276|Methylphenidate|methylphenidate|mesh-list
82894546|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
82894547|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
82894548|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894549|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894550|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82894551|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
82894552|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
82894553|NCT01290276|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82894554|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82894555|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
82894556|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894557|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894558|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82894559|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82894560|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82894561|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82894562|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
82894563|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
82894564|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
82894565|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82894566|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82894567|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894568|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894569|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894570|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894571|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82894572|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894573|NCT01182636|Adapalene|adapalene|mesh-list
82894574|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82894575|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82894576|NCT01182636|Analgesics|analgesics|mesh-ancestor
82894577|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
82894578|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894579|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894580|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894581|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894582|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
82894583|NCT01290354|Lapatinib|lapatinib|mesh-list
82894584|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894585|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82894586|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894587|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894588|NCT01188408|Docetaxel|docetaxel|mesh-list
82894589|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894590|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
82894591|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
82894592|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
82894593|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894594|NCT01186146|Aspirin|aspirin|mesh-list
82894595|NCT01186146|Clopidogrel|clopidogrel|mesh-list
82894596|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82894597|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82894598|NCT01186146|Analgesics|analgesics|mesh-ancestor
82894599|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
82894600|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894601|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894602|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894603|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894604|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82894605|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82894606|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894607|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82894608|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82894609|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894610|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
82894611|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82894612|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82894613|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82894614|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
82894615|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894616|NCT01186224|Plerixafor|plerixafor|mesh-list
82894617|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82894618|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82894619|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
82894620|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894621|NCT01183494|Irinotecan|irinotecan|mesh-list
82894622|NCT01183494|Bevacizumab|bevacizumab|mesh-list
82894623|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82894624|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83454941|NCT00990769|Anesthetics|anesthetics|mesh-list
82894625|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894626|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894627|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894628|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894629|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82894630|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82894631|NCT01183494|Growth Substances|growth substances|mesh-ancestor
82894632|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894633|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
82894634|NCT01183572|Iron|iron|mesh-list
82894635|NCT01183572|Folic Acid|folic acid|mesh-list
82894636|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
82894637|NCT01183572|Trace Elements|trace elements|mesh-ancestor
82894638|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
82894639|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894640|NCT01183572|Hematinics|hematinics|mesh-ancestor
82894641|NCT01183572|Vitamins|vitamins|mesh-ancestor
82894642|NCT03856242|Tamsulosin|tamsulosin|mesh-list
82894643|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82894644|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82894645|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82894646|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
82894647|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894648|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894649|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894650|NCT03856242|Urological Agents|urological agents|mesh-ancestor
82894651|NCT01291524|Pregabalin|pregabalin|mesh-list
82894652|NCT01291524|Analgesics|analgesics|mesh-ancestor
82894653|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
82894654|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894655|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894656|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
82894657|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82894658|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82894659|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894660|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82894661|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82894662|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82894663|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894664|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82894665|NCT01183806|Rivastigmine|rivastigmine|mesh-list
82894666|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82894667|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894668|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894669|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894670|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894671|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894672|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82894673|NCT01183806|Protective Agents|protective agents|mesh-ancestor
82894674|NCT01188954|Doxycycline|doxycycline|mesh-list
82894675|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894676|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894677|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
82894678|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82894679|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82894680|NCT01183962|Vitamin D|vitamin d|mesh-list
82894681|NCT01183962|Vitamins|vitamins|mesh-ancestor
82894682|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
82894683|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894684|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82894685|NCT01187238|Cisplatin|cisplatin|mesh-list
82894686|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894687|NCT01588314|Gabapentin|gabapentin|mesh-list
82894688|NCT01588314|Analgesics|analgesics|mesh-ancestor
82894689|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
83513694|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
82894690|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894691|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894692|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
83454947|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
82894693|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82894694|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82894695|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894696|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82894697|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82894698|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82894699|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894700|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894701|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
82894703|NCT01290432|Melatonin|melatonin|mesh-list
82894704|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
82894705|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894706|NCT01290432|Protective Agents|protective agents|mesh-ancestor
82894707|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894708|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82894709|NCT01290432|Hematinics|hematinics|mesh-ancestor
82894710|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
82894711|NCT01290432|Vitamins|vitamins|mesh-ancestor
82894712|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
82894713|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
82894714|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82894715|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
82894716|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894717|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
82894718|NCT01290510|Protective Agents|protective agents|mesh-ancestor
82894719|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
82894720|NCT01184196|Povidone|povidone|mesh-list
82894721|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
82894722|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
82894723|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82894724|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894725|NCT01292460|Timolol|timolol|mesh-list
82894726|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82894727|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82894728|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
82894729|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894730|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894731|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894732|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82894733|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82894734|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
82894735|NCT01292694|Losartan|losartan|mesh-list
82894736|NCT01292694|Captopril|captopril|mesh-list
82894737|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82894738|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82894739|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82894740|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82894741|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894742|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82894743|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
82894744|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894745|NCT03851562|Alprostadil|alprostadil|mesh-list
82894746|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82894747|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
82894748|NCT03851562|Urological Agents|urological agents|mesh-ancestor
82894749|NCT01293630|Paclitaxel|paclitaxel|mesh-list
82894750|NCT01293630|Carboplatin|carboplatin|mesh-list
82894751|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82894752|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894753|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
82894754|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
82894755|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
82894756|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894757|NCT01191060|Lenalidomide|lenalidomide|mesh-list
82894758|NCT01191060|Bortezomib|bortezomib|mesh-list
82894759|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
82894760|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894761|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82894762|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82894763|NCT01191060|Growth Substances|growth substances|mesh-ancestor
82894764|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
82735604|NCT00608205|Fluorouracil|fluorouracil|mesh-list
82894765|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894766|NCT01291602|Avibactam|avibactam|mesh-list
82894767|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82894768|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894769|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894770|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894771|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894772|NCT03851172|Ketorolac|ketorolac|mesh-list
82894773|NCT03851172|Nepafenac|nepafenac|mesh-list
82894774|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
82894775|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82894776|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82894777|NCT03851172|Analgesics|analgesics|mesh-ancestor
82894778|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
82894779|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894780|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894781|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894782|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894783|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82894784|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894785|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894786|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
82894787|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
82894788|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
82894789|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82894790|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82894791|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894792|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894793|NCT03853512|Petrolatum|petrolatum|mesh-list
82894794|NCT03853512|Emollients|emollients|mesh-ancestor
82894795|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
82894796|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
82894797|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82894798|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894799|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
82894800|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82894801|NCT03853200|Acetic Acid|acetic acid|mesh-list
82894802|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
82894803|NCT03853200|Edetic Acid|edetic acid|mesh-list
82894804|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
82894805|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82894806|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894807|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
82894808|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
82894809|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
82894810|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82894811|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
82894812|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
82894813|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894814|NCT03853200|Antidotes|antidotes|mesh-ancestor
82894815|NCT03853200|Protective Agents|protective agents|mesh-ancestor
82894816|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894817|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82894818|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82894819|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
82894820|NCT01293942|Bevacizumab|bevacizumab|mesh-list
82894821|NCT01293942|Capecitabine|capecitabine|mesh-list
82894822|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
82894823|NCT01293942|Irinotecan|irinotecan|mesh-list
82894824|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894825|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894826|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82894827|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82894828|NCT01293942|Growth Substances|growth substances|mesh-ancestor
82894829|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894830|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
82894831|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82894832|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
82894833|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894834|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82894835|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82894836|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894837|NCT01189656|Vaccines|vaccines|mesh-list
82894838|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
82894839|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894840|NCT01581138|Ribavirin|ribavirin|mesh-list
82894841|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
82894842|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894843|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
82894844|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82894845|NCT01191216|Docetaxel|docetaxel|mesh-list
82894846|NCT01191216|Tryptophan|tryptophan|mesh-list
82894847|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894848|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
82894849|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
82894850|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
82894851|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894852|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82894853|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
82894854|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82894855|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
82894856|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
82894857|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894858|NCT01294176|Protective Agents|protective agents|mesh-ancestor
82894859|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894860|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
82894861|NCT01294176|Vitamins|vitamins|mesh-ancestor
82894862|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
82894863|NCT03847818|Carboplatin|carboplatin|mesh-list
82894866|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894867|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
82894868|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
82894869|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
82894870|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894871|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894872|NCT01294410|Antibodies|antibodies|mesh-list
82894873|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
82894874|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
82894875|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894876|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
82894877|NCT01191450|Amiloride|amiloride|mesh-list
82894878|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82894879|NCT01191450|Diuretics|diuretics|mesh-ancestor
82894880|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
82894881|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894882|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82894883|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82894884|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894885|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82894886|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82894887|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82894888|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82894889|NCT01194336|Huperzine A|huperzine a|mesh-list
82894890|NCT01194336|Donepezil|donepezil|mesh-list
82894891|NCT01194336|Galantamine|galantamine|mesh-list
82894892|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82894893|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894894|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894895|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894896|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894897|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894898|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
82894899|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82894900|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
82894901|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82894902|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82894903|NCT01194336|Protective Agents|protective agents|mesh-ancestor
82894904|NCT02660710|Rituximab|rituximab|mesh-list
82894905|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894906|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894907|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
82894908|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894909|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82894910|NCT01294878|Omalizumab|omalizumab|mesh-list
82894911|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82894912|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82894913|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
82894914|NCT01296438|Insulin|insulin|mesh-list
82894915|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82894916|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
82894917|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
82894918|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82894919|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82894920|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894921|NCT03847272|Prednisone|prednisone|mesh-list
82894922|NCT03847272|Ustekinumab|ustekinumab|mesh-list
82894923|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894924|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
82894925|NCT03847272|Hormones|hormones|mesh-ancestor
82894926|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82894927|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894928|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82894929|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894930|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
82894931|NCT03850626|Immunomodulating Agents|immunomodulating agents|mesh-list
82894932|NCT03850626|Immunologic Factors|immunologic factors|mesh-ancestor
82894933|NCT03850626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894934|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82894935|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82894936|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
82894937|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82894938|NCT01294956|Laxatives|laxatives|mesh-ancestor
82894939|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82894940|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
82894941|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82894942|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894943|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
82894944|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894945|NCT01190358|Protective Agents|protective agents|mesh-ancestor
82894946|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894947|NCT01293162|Folic Acid|folic acid|mesh-list
82894948|NCT01293162|Policosanol|policosanol|mesh-list
82894949|NCT01293162|Hematinics|hematinics|mesh-ancestor
82894950|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
82894951|NCT01293162|Vitamins|vitamins|mesh-ancestor
82894952|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
82894953|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894954|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82894955|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82894956|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
82894957|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894958|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82894959|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82894960|NCT01190670|Tacrolimus|tacrolimus|mesh-list
82894961|NCT01190670|Peficitinib|peficitinib|mesh-list
82894962|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82894963|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
82894964|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894965|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82894966|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894967|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894968|NCT01194882|Insulin|insulin|mesh-list
82894969|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82894970|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82894971|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894972|NCT01191684|Vaccines|vaccines|mesh-list
82894973|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
82894974|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894975|NCT02659540|Nivolumab|nivolumab|mesh-list
82894976|NCT02659540|Ipilimumab|ipilimumab|mesh-list
82894977|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82894978|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82894979|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82894980|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894981|NCT01295268|Emu Oil|emu oil|mesh-list
82894982|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82894983|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
82894984|NCT01383694|Piperine|piperine|mesh-list
83454961|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
82894985|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82894986|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894987|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894988|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
82894989|NCT01191918|Donepezil|donepezil|mesh-list
82894990|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82894991|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82894992|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82894993|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
82894994|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82894995|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82894996|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
83513771|NCT03357393|Morphine|morphine|mesh-list
82894997|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
82894998|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82894999|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
82895000|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82895001|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895002|NCT03850314|Glycine|glycine|mesh-list
82895003|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
82895004|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895005|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895006|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895007|NCT01097746|Paclitaxel|paclitaxel|mesh-list
82895008|NCT01097746|Bevacizumab|bevacizumab|mesh-list
82895009|NCT01097746|Carboplatin|carboplatin|mesh-list
82895010|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82895011|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82895012|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
82895013|NCT01097746|Antibodies|antibodies|mesh-list
82895014|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
82895015|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82895017|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82895018|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895019|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
82895020|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
82895021|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
82895022|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895023|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82895024|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82895025|NCT01097746|Growth Substances|growth substances|mesh-ancestor
82895026|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895027|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
82895028|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
82895029|NCT01190748|Galantamine|galantamine|mesh-list
82895030|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82895031|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895032|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895033|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
82895034|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895035|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895036|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82895037|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
82895038|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895039|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
82895040|NCT01383538|Leucovorin|leucovorin|mesh-list
82895041|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
82895042|NCT01383538|Irinotecan|irinotecan|mesh-list
82895043|NCT01383538|Folfirinox|folfirinox|mesh-list
82895044|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895045|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82895046|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82895047|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895048|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895049|NCT01383538|Antidotes|antidotes|mesh-ancestor
82895050|NCT01383538|Protective Agents|protective agents|mesh-ancestor
82895051|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895052|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
82895053|NCT01383538|Vitamins|vitamins|mesh-ancestor
82895054|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
82895055|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
82895056|NCT01383460|Lenograstim|lenograstim|mesh-list
82895057|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82895058|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
82895059|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895060|NCT01383460|Hematinics|hematinics|mesh-ancestor
82895061|NCT01192230|Docetaxel|docetaxel|mesh-list
82895062|NCT01192230|Endostatins|endostatins|mesh-list
82895063|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895064|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
82895065|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
82895066|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
82895067|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895068|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82895069|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82895070|NCT01192230|Growth Substances|growth substances|mesh-ancestor
82895071|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895072|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
82895073|NCT05416840|Amlodipine|amlodipine|mesh-list
82895074|NCT05416840|Clonidine|clonidine|mesh-list
82895075|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82895076|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82895077|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895078|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895079|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82895080|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895081|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
82895082|NCT05416840|Analgesics|analgesics|mesh-ancestor
82895083|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
82895084|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895085|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
82895086|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
82895087|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82895088|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82895089|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82895090|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
82895091|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895092|NCT01192308|Tamoxifen|tamoxifen|mesh-list
82895093|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82895094|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
82895095|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895096|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895097|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82895098|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895099|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82895100|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82895101|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82895102|NCT01190982|Paclitaxel|paclitaxel|mesh-list
82895103|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82895104|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895105|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
82895106|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
82895107|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
82895108|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895109|NCT04170556|Nivolumab|nivolumab|mesh-list
82895110|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895111|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895112|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82895113|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895114|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82895115|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
82895116|NCT01196754|Sevoflurane|sevoflurane|mesh-list
82895117|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82895118|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82895119|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
82895120|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
82895121|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895122|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895123|NCT01295502|Paclitaxel|paclitaxel|mesh-list
82895124|NCT01295502|Cisplatin|cisplatin|mesh-list
82895125|NCT01295502|Carboplatin|carboplatin|mesh-list
82895126|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82895127|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82895128|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895129|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
82895130|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
82895131|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
82895132|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895133|NCT05207644|Letrozole|letrozole|mesh-list
82895134|NCT05207644|Misoprostol|misoprostol|mesh-list
82895135|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895136|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82895137|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82895138|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895139|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895140|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82895141|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
82895142|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895143|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895144|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82895145|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
82895146|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82895147|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82895148|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895149|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
82895150|NCT03846102|Acetaminophen|acetaminophen|mesh-list
82895151|NCT03846102|Morphine|morphine|mesh-list
82895152|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
82895153|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82895154|NCT03846102|Narcotics|narcotics|mesh-ancestor
82895155|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895156|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895157|NCT03846102|Analgesics|analgesics|mesh-ancestor
82895158|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
82895159|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895160|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895161|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
82895162|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
82895163|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
82895164|NCT01383148|Paclitaxel|paclitaxel|mesh-list
82895165|NCT01383148|Cisplatin|cisplatin|mesh-list
82895166|NCT01383148|Carboplatin|carboplatin|mesh-list
82895167|NCT01383148|Gemcitabine|gemcitabine|mesh-list
82895169|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82895170|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895171|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
82895172|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
82895173|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
82895174|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895175|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82895176|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
82895177|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895178|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82895179|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82895181|NCT01192854|Clevudine|clevudine|mesh-list
82895182|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
82895183|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895184|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82895185|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82895186|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895187|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895188|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
82895189|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82895190|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895191|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
82895192|NCT01195428|Simvastatin|simvastatin|mesh-list
82895193|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82895194|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82895195|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
82895196|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895197|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82895198|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82895199|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895200|NCT03439462|Sirolimus|sirolimus|mesh-list
82895201|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895202|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895203|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895204|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895205|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82895206|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
82895207|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82895208|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
82895209|NCT01193166|Olanzapine|olanzapine|mesh-list
82895210|NCT01193166|Risperidone|risperidone|mesh-list
82895211|NCT01193166|Aripiprazole|aripiprazole|mesh-list
82895212|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82895213|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82895214|NCT01193166|Perphenazine|perphenazine|mesh-list
82895215|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82895216|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
82895217|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895218|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895219|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895220|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82895221|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82895222|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895223|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82895224|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82895225|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
82895226|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
82895227|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
82895228|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895229|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895230|NCT01193166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82895231|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82895232|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895233|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
82895234|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
82895235|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82895236|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82895237|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82895238|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82895239|NCT01197144|Adalimumab|adalimumab|mesh-list
82895240|NCT01197144|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82895241|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895242|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895243|NCT01193400|Cytarabine|cytarabine|mesh-list
82895244|NCT01193400|Clofarabine|clofarabine|mesh-list
82895245|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82895246|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
82895247|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895248|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895249|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
82895250|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895251|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82895252|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
82895253|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895254|NCT03904888|Anesthetics|anesthetics|mesh-list
82895255|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
82895256|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895257|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895258|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
82895259|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895260|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82895261|NCT01193478|Ledipasvir|ledipasvir|mesh-list
82895262|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
82895263|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895264|NCT03726268|Fentanyl|fentanyl|mesh-list
82895265|NCT03726268|Sufentanil|sufentanil|mesh-list
82895266|NCT03726268|Morphine|morphine|mesh-list
82895267|NCT03726268|Methadone|methadone|mesh-list
82895268|NCT03726268|Hydromorphone|hydromorphone|mesh-list
82895269|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82895270|NCT03726268|Narcotics|narcotics|mesh-ancestor
82895271|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895272|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895273|NCT03726268|Analgesics|analgesics|mesh-ancestor
82895274|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
82895275|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895276|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82895277|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82895278|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
82895279|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
82895280|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
82895281|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
82895282|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
82895283|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
82895284|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82895285|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82895286|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895287|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895288|NCT01295736|Urological Agents|urological agents|mesh-ancestor
82895289|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
82895290|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
82895291|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82895292|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82895293|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895294|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895295|NCT03733470|Urological Agents|urological agents|mesh-ancestor
82895296|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82895297|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82895298|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895299|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
82895300|NCT04731376|Testosterone|testosterone|mesh-list
82895301|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
82895302|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
82895303|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82895304|NCT04731376|Androgens|androgens|mesh-ancestor
82895305|NCT04731376|Hormones|hormones|mesh-ancestor
82895306|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895307|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895308|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82895309|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895310|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
82895311|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82895312|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895313|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895314|NCT01196208|Immunotoxins|immunotoxins|mesh-ancestor
82895315|NCT01196208|Immunoconjugates|immunoconjugates|mesh-ancestor
82895316|NCT01196208|Immunologic Factors|immunologic factors|mesh-ancestor
82895317|NCT01196208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895318|NCT01295892|Estrogens|estrogens|mesh-list
82895319|NCT01295892|Hormones|hormones|mesh-ancestor
83455010|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82895320|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895321|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895322|NCT03018418|Mitomycins|mitomycins|mesh-list
82895323|NCT03018418|Mitomycin|mitomycin|mesh-list
82895324|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82895325|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895326|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
82895327|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895328|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82895329|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895330|NCT01296204|Antibodies|antibodies|mesh-list
82895331|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
82895332|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895333|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82895334|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
82895335|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82895336|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82895337|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82895338|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895339|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895340|NCT05670678|Lactoferrin|lactoferrin|mesh-list
82895341|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895342|NCT02914366|Ambroxol|ambroxol|mesh-list
82895343|NCT02914366|Expectorants|expectorants|mesh-ancestor
82895344|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
82895345|NCT03846180|Octreotide|octreotide|mesh-list
82895346|NCT03846180|Terlipressin|terlipressin|mesh-list
82895347|NCT03846180|Somatostatin|somatostatin|mesh-list
82895348|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895349|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82895350|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895351|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82895352|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82895353|NCT03846180|Hormones|hormones|mesh-ancestor
82895354|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895355|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895356|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
82895357|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
82895358|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
82895359|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895360|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895361|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
82895362|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895363|NCT02729116|Ertapenem|ertapenem|mesh-list
82895364|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
82895365|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895366|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895367|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82895368|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82895369|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895370|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895371|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895372|NCT02627092|Copper|copper|mesh-list
82895373|NCT02627092|Trace Elements|trace elements|mesh-ancestor
82895374|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
82895375|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895376|NCT05289648|Niraparib|niraparib|mesh-list
82895377|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82895378|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895379|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895380|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895381|NCT01199562|Valganciclovir|valganciclovir|mesh-list
82895382|NCT01199562|Ganciclovir|ganciclovir|mesh-list
82895383|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82895384|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
82895385|NCT01199562|Foscarnet|foscarnet|mesh-list
82895386|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
82895387|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895388|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82895389|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895390|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895391|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82895392|NCT03845322|Curcumin|curcumin|mesh-list
82895393|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82895394|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895396|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
82895397|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895398|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895399|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895400|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895401|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895402|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895403|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895404|NCT03844932|Cyclosporine|cyclosporine|mesh-list
82895405|NCT03844932|Cyclosporins|cyclosporins|mesh-list
82895406|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895407|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895408|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82895409|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
82895410|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895411|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
82895412|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895413|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
82895414|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895415|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82895416|NCT03726996|Desipramine|desipramine|mesh-list
82895417|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82895418|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
82895419|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82895420|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895421|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895422|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82895423|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82895424|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895425|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
82895426|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895427|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895428|NCT01202058|Sirolimus|sirolimus|mesh-list
82895429|NCT01202058|Everolimus|everolimus|mesh-list
82895430|NCT01202058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82895431|NCT01202058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82895432|NCT01202058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895433|NCT01202058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895434|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82895435|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
82895436|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895437|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895438|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895439|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895440|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82895441|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
82895442|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
82895443|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895444|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
82895445|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
82895446|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
82895447|NCT03842046|Phenylephrine|phenylephrine|mesh-list
82895448|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
82895449|NCT03842046|Norepinephrine|norepinephrine|mesh-list
82895450|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82895451|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
82895452|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
82895453|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895454|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895455|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
82895456|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82895457|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
82895458|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
82895459|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82895460|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82895461|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82895462|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
82895463|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895464|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895465|NCT03842046|Protective Agents|protective agents|mesh-ancestor
82895466|NCT01198236|Itraconazole|itraconazole|mesh-list
82895467|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
82895468|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895469|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82895470|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82895471|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895472|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895473|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82895474|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
82895475|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895476|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895477|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82895478|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82895479|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
82895480|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895481|NCT04091490|Nivolumab|nivolumab|mesh-list
82895482|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895483|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895484|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82895485|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895486|NCT05184816|Deferoxamine|deferoxamine|mesh-list
82895487|NCT05184816|Siderophores|siderophores|mesh-ancestor
82895488|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82895489|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
82895490|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
82895491|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895492|NCT03841890|Tolnaftate|tolnaftate|mesh-list
82895493|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
82895494|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895495|NCT01200108|Budesonide|budesonide|mesh-list
82895496|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895497|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82895498|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
82895499|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895500|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895501|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82895502|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
82895503|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
82895504|NCT01200108|Hormones|hormones|mesh-ancestor
82895505|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895506|NCT01200186|Progestins|progestins|mesh-list
82895507|NCT01200186|Hormones|hormones|mesh-ancestor
82895508|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895509|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895510|NCT03841812|Propofol|propofol|mesh-list
82895511|NCT03841812|Sevoflurane|sevoflurane|mesh-list
82895512|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82895513|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895514|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895515|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82895516|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
82895517|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
82895518|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82895519|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82895520|NCT03882970|Tirzepatide|tirzepatide|mesh-list
82895521|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82895522|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895523|NCT03882970|Incretins|incretins|mesh-ancestor
82895524|NCT03882970|Hormones|hormones|mesh-ancestor
82895525|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895526|NCT05111808|Methylene Blue|methylene blue|mesh-list
82895527|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895528|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895529|NCT01198392|Cisplatin|cisplatin|mesh-list
82895530|NCT01198392|Tegafur|tegafur|mesh-list
82895531|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895532|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82895533|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
82895534|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895535|NCT01200264|Apremilast|apremilast|mesh-list
82895536|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82895537|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895538|NCT01200264|Analgesics|analgesics|mesh-ancestor
82895539|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
82895540|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895541|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895542|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895543|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895545|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82895546|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895547|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895548|NCT04799236|Amphotericin B|amphotericin b|mesh-list
82895549|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82895550|NCT04799236|Miltefosine|miltefosine|mesh-list
82895551|NCT04799236|Amebicides|amebicides|mesh-ancestor
82895552|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82895553|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82895554|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895555|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895556|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
82895557|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895558|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
82895559|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82895560|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895561|NCT03630952|Aflibercept|aflibercept|mesh-list
82895562|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82895563|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82895564|NCT03630952|Growth Substances|growth substances|mesh-ancestor
82895565|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895566|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
82895567|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895568|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82895569|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
82895570|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82895571|NCT01200654|Linezolid|linezolid|mesh-list
82895572|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895573|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895574|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82895575|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895576|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895577|NCT01200732|Tadalafil|tadalafil|mesh-list
82895578|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
82895579|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82895580|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82895581|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895582|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895583|NCT01200732|Urological Agents|urological agents|mesh-ancestor
82895584|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
82895585|NCT01198860|Tenofovir|tenofovir|mesh-list
82895586|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
82895587|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895588|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82895589|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82895590|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895591|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895592|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82895593|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82895594|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
82895595|NCT01198860|Protective Agents|protective agents|mesh-ancestor
82895596|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895597|NCT01198860|Vitamins|vitamins|mesh-ancestor
82895598|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
82895599|NCT01198938|Melatonin|melatonin|mesh-list
82895600|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
82895601|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895602|NCT01198938|Protective Agents|protective agents|mesh-ancestor
82895603|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895604|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895605|NCT01201044|Gemcitabine|gemcitabine|mesh-list
82895606|NCT01201044|Nedaplatin|nedaplatin|mesh-list
82895607|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82895608|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
82895609|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895610|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895611|NCT03843060|Itraconazole|itraconazole|mesh-list
82895612|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
82895613|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895614|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82895615|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82895616|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895617|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895619|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
82895620|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895621|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895622|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82895623|NCT04427904|Lidocaine|lidocaine|mesh-list
82895624|NCT04427904|Epinephrine|epinephrine|mesh-list
82895625|NCT04427904|Racepinephrine|racepinephrine|mesh-list
82895626|NCT04427904|Bupivacaine|bupivacaine|mesh-list
82895627|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
82895628|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
82895629|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
82895630|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895631|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895632|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
82895633|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895634|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82895635|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82895636|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82895637|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895638|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895639|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82895640|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82895641|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
82895642|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895643|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82895644|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82895645|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
82895646|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82895647|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
82895648|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
82895649|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
82895650|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82895651|NCT03792516|Artesunate|artesunate|mesh-list
82895652|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
82895653|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82895654|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82895655|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895656|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895657|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
82895658|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
82895659|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82895660|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
82895661|NCT01201122|Mesalamine|mesalamine|mesh-list
83455043|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895662|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82895663|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895664|NCT01201122|Analgesics|analgesics|mesh-ancestor
82895665|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
82895666|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895667|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895668|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895669|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895670|NCT03674112|Trastuzumab|trastuzumab|mesh-list
82895671|NCT03674112|Pertuzumab|pertuzumab|mesh-list
82895672|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895673|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895674|NCT03668808|Insulin|insulin|mesh-list
82895675|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82895676|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
82895677|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
82895678|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82895679|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895680|NCT05281926|Nivolumab|nivolumab|mesh-list
82895681|NCT05281926|Poly ICLC|poly iclc|mesh-list
82895682|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895683|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895684|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82895685|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895686|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
82895687|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
82895688|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895689|NCT03844776|Acetaminophen|acetaminophen|mesh-list
82895690|NCT03844776|Amoxicillin|amoxicillin|mesh-list
82895691|NCT03844776|Metronidazole|metronidazole|mesh-list
82895692|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82895693|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
82895694|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895695|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895696|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82895697|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
82895698|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895699|NCT03844776|Analgesics|analgesics|mesh-ancestor
82895700|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
82895701|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895702|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895703|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
82895704|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82895705|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82895706|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82895707|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895708|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895709|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
82895710|NCT01566942|Irinotecan|irinotecan|mesh-list
82895711|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895712|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82895713|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82895714|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895715|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895716|NCT01201278|Insulin|insulin|mesh-list
82895717|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82895718|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
82895719|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82895720|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895721|NCT05667948|Immunomodulating Agents|immunomodulating agents|mesh-list
82895722|NCT05667948|Immunologic Factors|immunologic factors|mesh-ancestor
82895723|NCT05667948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895724|NCT01199328|Aspirin|aspirin|mesh-list
82895725|NCT01199328|Esomeprazole|esomeprazole|mesh-list
82895726|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82895727|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895728|NCT01199328|Analgesics|analgesics|mesh-ancestor
82895729|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
82895730|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895731|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895732|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895733|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895734|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82895735|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82895736|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895737|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82895738|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82895739|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895740|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
82895741|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82895742|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895743|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82895744|NCT02982954|Nivolumab|nivolumab|mesh-list
82895745|NCT02982954|Ipilimumab|ipilimumab|mesh-list
82895746|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895747|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895748|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82895749|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895750|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
82895751|NCT01203228|Busulfan|busulfan|mesh-list
82895752|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
82895753|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82895754|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
82895755|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895756|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895757|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82895758|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
82895759|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895760|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895761|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82895762|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82895763|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
82895764|NCT01203696|Amlodipine|amlodipine|mesh-list
82895765|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82895766|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82895767|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895768|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895770|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895771|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
82895772|NCT01203306|Bevacizumab|bevacizumab|mesh-list
82895773|NCT01203306|Capecitabine|capecitabine|mesh-list
82895774|NCT01203306|Octreotide|octreotide|mesh-list
82895775|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895776|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895777|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82895778|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82895779|NCT01203306|Growth Substances|growth substances|mesh-ancestor
82895780|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895781|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
82895782|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82895783|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
82895784|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895785|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895786|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82895787|NCT01203384|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
82895788|NCT01203384|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82895789|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895790|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895791|NCT03724968|Nivolumab|nivolumab|mesh-list
82895792|NCT03724968|Ipilimumab|ipilimumab|mesh-list
82895793|NCT03724968|Relatlimab|relatlimab|mesh-list
82895794|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895795|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895796|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82895797|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895798|NCT01204086|Fluoxetine|fluoxetine|mesh-list
82895799|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82895800|NCT01204086|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82895801|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82895802|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895803|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895804|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82895805|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
82895806|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895807|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82895808|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
82895809|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82895810|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82895811|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82895812|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895813|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82895814|NCT01201902|Vaccines|vaccines|mesh-list
82895815|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
82895816|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895817|NCT01204164|Dexamethasone|dexamethasone|mesh-list
82895818|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895819|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
82895820|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
82895821|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895822|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895823|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895824|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
82895825|NCT01204164|Hormones|hormones|mesh-ancestor
82895826|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895827|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82895828|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895829|NCT01206036|Sirolimus|sirolimus|mesh-list
82895830|NCT01206036|Docetaxel|docetaxel|mesh-list
82895831|NCT01206036|Temsirolimus|temsirolimus|mesh-list
82895832|NCT01206036|MTOR Inhibitors|mtor inhibitors|mesh-list
82895833|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895834|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
82895835|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
82895836|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
82895837|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895838|NCT01206036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82895839|NCT01206036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895841|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
82895842|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895843|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895844|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895845|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82895846|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
82895847|NCT01204320|Paclitaxel|paclitaxel|mesh-list
82895848|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82895849|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82895850|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895851|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
82895852|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
82895853|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
82895854|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895855|NCT03722238|Ibuprofen|ibuprofen|mesh-list
82895856|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82895857|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895858|NCT03722238|Analgesics|analgesics|mesh-ancestor
82895859|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
82895860|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895861|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895862|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895863|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83455057|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82895864|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82895865|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895866|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895867|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82895868|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82895869|NCT01203618|Farletuzumab|farletuzumab|mesh-list
82895870|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895871|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
82895872|NCT01206270|Castor Oil|castor oil|mesh-list
82895873|NCT01206270|Testosterone|testosterone|mesh-list
82895874|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
82895875|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
82895876|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82895877|NCT01206270|Androgens|androgens|mesh-ancestor
82895878|NCT01206270|Hormones|hormones|mesh-ancestor
82895879|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895880|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895881|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82895882|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895883|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
82895884|NCT01206270|Cathartics|cathartics|mesh-ancestor
82895885|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895886|NCT01298310|Lidocaine|lidocaine|mesh-list
82895887|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
82895888|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
82895889|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895890|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895891|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
82895892|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895893|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82895894|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82895895|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82895896|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895897|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895898|NCT01298466|Pregabalin|pregabalin|mesh-list
82895899|NCT01298466|Analgesics|analgesics|mesh-ancestor
82895900|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
82895901|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895902|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895903|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
82895904|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82895905|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82895906|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895907|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82895908|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82895909|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82895910|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895911|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82895912|NCT01206348|Minocycline|minocycline|mesh-list
82895913|NCT01206348|Clindamycin|clindamycin|mesh-list
82895914|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
82895915|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
82895916|NCT01206348|Tretinoin|tretinoin|mesh-list
82895917|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82895918|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82895919|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895920|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82895921|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895922|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895923|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
82895924|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895925|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
82895926|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
82895927|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895928|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895929|NCT05669352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82895930|NCT05669352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895931|NCT01204476|Everolimus|everolimus|mesh-list
82895932|NCT01204476|Octreotide|octreotide|mesh-list
82895933|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82895934|NCT01204476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82895935|NCT01204476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82895936|NCT01204476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895937|NCT01204476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895938|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82895939|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
82895940|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895941|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895942|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82895943|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82895944|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82895945|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82895946|NCT04630210|Atezolizumab|atezolizumab|mesh-list
82895947|NCT04630210|Letrozole|letrozole|mesh-list
82895948|NCT04630210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82895949|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895950|NCT04630210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82895951|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895952|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82895953|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82895954|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895955|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82895956|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
82895957|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82895958|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895959|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
82895960|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
82895961|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82895962|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82895963|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895964|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895965|NCT01382368|Urological Agents|urological agents|mesh-ancestor
82895966|NCT04546828|Gemcitabine|gemcitabine|mesh-list
82895967|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82895968|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82895969|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
82895970|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895971|NCT01382134|Aspirin|aspirin|mesh-list
82895972|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82895973|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82895974|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82895975|NCT01382134|Analgesics|analgesics|mesh-ancestor
82895976|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
82895977|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895978|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895979|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82895980|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82895981|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82895982|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82895983|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82895984|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82895985|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82895986|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82895987|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
82895988|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
82895989|NCT01382134|Coagulants|coagulants|mesh-ancestor
82895990|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82895991|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
82895993|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
82895994|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
82895995|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82895996|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82895997|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
82895998|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82895999|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82896000|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82896001|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82896002|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82896003|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896005|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
82896006|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896007|NCT02410980|Tretinoin|tretinoin|mesh-list
82896008|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896009|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
82896010|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
82896011|NCT01298934|Panobinostat|panobinostat|mesh-list
82896012|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896013|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82896014|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896015|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896016|NCT01300962|Capecitabine|capecitabine|mesh-list
82896017|NCT01300962|Trastuzumab|trastuzumab|mesh-list
82896018|NCT01300962|Lapatinib|lapatinib|mesh-list
82896019|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896020|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
82896021|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896022|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896023|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896024|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82896025|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896026|NCT01299012|Liraglutide|liraglutide|mesh-list
82896027|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82896028|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896029|NCT01299012|Incretins|incretins|mesh-ancestor
82896030|NCT01299012|Hormones|hormones|mesh-ancestor
82896031|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896032|NCT02155920|Everolimus|everolimus|mesh-list
82896033|NCT02155920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82896034|NCT02155920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82896035|NCT02155920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896036|NCT02155920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896037|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896038|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
82896039|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896040|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896041|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
82896042|NCT01301040|Docetaxel|docetaxel|mesh-list
82896043|NCT01301040|Epirubicin|epirubicin|mesh-list
82896044|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896045|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
82896046|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896047|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896048|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82896049|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
82896050|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896051|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896052|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82896053|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
82896054|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
82896055|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
82896056|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82896057|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82736890|NCT01052311|Niacin|niacin|mesh-list
82896058|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82896059|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896060|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
82896061|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
82896062|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896063|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
82896064|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896065|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896066|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82896067|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
82896068|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896069|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896070|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82896071|NCT01206972|Enoxaparin|enoxaparin|mesh-list
82896072|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
82896073|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82896074|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
82896075|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82896076|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
82896077|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896078|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896079|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
82896080|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82896081|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82896082|NCT03817476|BI 425809|bi 425809|mesh-list
82896083|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
82896084|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
82896085|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
82896086|NCT02918292|Fludarabine|fludarabine|mesh-list
82896087|NCT02918292|Tacrolimus|tacrolimus|mesh-list
82896088|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
82896089|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82896090|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896091|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
82896092|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896093|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896094|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82896095|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
82896096|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896097|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896098|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82896099|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82896100|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896101|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82896102|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82896103|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
82896104|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82896105|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896106|NCT01207128|Voriconazole|voriconazole|mesh-list
82896107|NCT01207128|Micafungin|micafungin|mesh-list
82896108|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
82896109|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896110|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82896111|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82896112|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896113|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896114|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82896115|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
82896116|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896117|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896118|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82896119|NCT01299558|Fluticasone|fluticasone|mesh-list
82896120|NCT01299558|Xhance|xhance|mesh-list
82896121|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896122|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82896123|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
82896124|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896125|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896126|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82896127|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
82896128|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
82896129|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82896130|NCT01207206|Ketamine|ketamine|mesh-list
82896131|NCT01207206|Analgesics|analgesics|mesh-ancestor
82896132|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
83513772|NCT03357393|Propofol|propofol|mesh-list
82896133|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896134|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896135|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82896136|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82896137|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
82896138|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
82896140|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82896141|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82896142|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896143|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896145|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
82896146|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
82896147|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896148|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
82896149|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896150|NCT05602818|Alprazolam|alprazolam|mesh-list
82896151|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82896152|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896153|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896154|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82896155|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82896156|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82896157|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
82896158|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
82896159|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896160|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896161|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
82896162|NCT01205022|Leucovorin|leucovorin|mesh-list
82896163|NCT01205022|Bevacizumab|bevacizumab|mesh-list
82896164|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82896165|NCT01205022|Fluorouracil|fluorouracil|mesh-list
82896166|NCT01205022|Irinotecan|irinotecan|mesh-list
82896167|NCT01205022|Camptothecin|camptothecin|mesh-list
82896168|NCT01205022|Antibodies|antibodies|mesh-list
82896169|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
82896170|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82896171|NCT01205022|Calcium|calcium|mesh-list
82896172|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
82896173|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896174|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82896175|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82896176|NCT01205022|Growth Substances|growth substances|mesh-ancestor
82896177|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896178|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
82896179|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
82896180|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82896181|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82896182|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
82896183|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896184|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896185|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896186|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82896187|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82896188|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896189|NCT01205022|Antidotes|antidotes|mesh-ancestor
82896190|NCT01205022|Protective Agents|protective agents|mesh-ancestor
83455100|NCT00993655|Paclitaxel|paclitaxel|mesh-list
82896191|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
82896192|NCT01205022|Vitamins|vitamins|mesh-ancestor
82896193|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
82896194|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82896195|NCT01205178|Chloroquine|chloroquine|mesh-list
82896196|NCT01205178|Primaquine|primaquine|mesh-list
82896197|NCT01205178|Tafenoquine|tafenoquine|mesh-list
82896198|NCT01205178|Amebicides|amebicides|mesh-ancestor
82896199|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82896200|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82896201|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896202|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
82896203|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896204|NCT01205256|Methadone|methadone|mesh-list
82896205|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82896206|NCT01205256|Narcotics|narcotics|mesh-ancestor
82896207|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896208|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896209|NCT01205256|Analgesics|analgesics|mesh-ancestor
82896210|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
82896211|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896212|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
82896213|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
82896214|NCT03823482|Lidocaine|lidocaine|mesh-list
82896215|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
82896216|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
82896217|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896218|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896219|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
82896220|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896221|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82896222|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82896223|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82896224|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82896225|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896226|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82896227|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82896228|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896229|NCT03816072|Phenylephrine|phenylephrine|mesh-list
82896230|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
82896231|NCT03816072|Propofol|propofol|mesh-list
82896232|NCT03816072|Sevoflurane|sevoflurane|mesh-list
82896233|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82896234|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896235|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896236|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82896237|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
82896238|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
82896239|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82896240|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82896241|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82896242|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
82896243|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
82896244|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896245|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
82896246|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82896247|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
82896248|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
82896249|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82896250|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82896251|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82896252|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
82896253|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896254|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896255|NCT03816072|Protective Agents|protective agents|mesh-ancestor
82896256|NCT01299948|Prednisolone|prednisolone|mesh-list
82896257|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896258|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
82896259|NCT01299948|Hormones|hormones|mesh-ancestor
82896260|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896261|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896262|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82896263|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896264|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
82896265|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896266|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896267|NCT01297452|Paclitaxel|paclitaxel|mesh-list
82896268|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82896269|NCT01297452|Carboplatin|carboplatin|mesh-list
82896270|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82896271|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896272|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
82896273|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
82896274|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
82896275|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896276|NCT01301586|Doxycycline|doxycycline|mesh-list
82896277|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82896278|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896279|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
82896280|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82896281|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82896282|NCT03815838|Fallypride|fallypride|mesh-list
82896283|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82896284|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82896285|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
82896286|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896287|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896288|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896290|NCT01205724|Coagulants|coagulants|mesh-ancestor
82896291|NCT01301820|Lenalidomide|lenalidomide|mesh-list
82896292|NCT01301820|Azacitidine|azacitidine|mesh-list
82896293|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
82896294|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896295|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82896296|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82896297|NCT01301820|Growth Substances|growth substances|mesh-ancestor
82896298|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
82896299|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896300|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896301|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
82896302|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896303|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896304|NCT01297686|Dexamethasone|dexamethasone|mesh-list
82896305|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896306|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
82896307|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
82896308|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896309|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896310|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896311|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
82896312|NCT01297686|Hormones|hormones|mesh-ancestor
82896313|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896314|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82896315|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896316|NCT01205880|Calcitriol|calcitriol|mesh-list
82896317|NCT01205880|Clobetasol|clobetasol|mesh-list
82896318|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82896319|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896320|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82896321|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82896322|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896323|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82896324|NCT01205880|Vitamins|vitamins|mesh-ancestor
82896325|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
82896326|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82896327|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896328|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
82896329|NCT01205880|Hormones|hormones|mesh-ancestor
82896330|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896331|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
82896332|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82896333|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82896334|NCT01205958|Analgesics|analgesics|mesh-ancestor
82896335|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
82896336|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896337|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896338|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896339|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896340|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
82896341|NCT01297842|Meropenem|meropenem|mesh-list
82896342|NCT01297842|Imipenem|imipenem|mesh-list
82896343|NCT01297842|Ertapenem|ertapenem|mesh-list
82896344|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82896345|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896346|NCT01297998|Cisplatin|cisplatin|mesh-list
82896347|NCT01297998|Gemcitabine|gemcitabine|mesh-list
82896348|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896349|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896350|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
82896351|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896352|NCT01298076|Dexamethasone|dexamethasone|mesh-list
82896353|NCT01298076|Bevacizumab|bevacizumab|mesh-list
82896354|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896355|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896356|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82896357|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82896358|NCT01298076|Growth Substances|growth substances|mesh-ancestor
82896359|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896360|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
82896361|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896362|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
82896363|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
82896365|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896366|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
82896367|NCT01298076|Hormones|hormones|mesh-ancestor
82896368|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896369|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82896370|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
82896371|NCT03819348|Clotrimazole|clotrimazole|mesh-list
82896372|NCT03819348|Miconazole|miconazole|mesh-list
82896373|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896374|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82896375|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82896376|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82896377|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896378|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896379|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82896380|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
82896381|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896382|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896383|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82896384|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82896385|NCT01560390|Ketamine|ketamine|mesh-list
82896386|NCT01560390|Analgesics|analgesics|mesh-ancestor
82896387|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
82896388|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896389|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896390|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82896391|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82896392|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
82896393|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
82896394|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896395|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82896396|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82896397|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896398|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896399|NCT03807882|Clozapine|clozapine|mesh-list
82896400|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82896401|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
82896402|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896403|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896404|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896405|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82896406|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82896407|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896408|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82896409|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
82896410|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
82896411|NCT03796572|Ropivacaine|ropivacaine|mesh-list
82896412|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
82896413|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
82896414|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896415|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896416|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
82896417|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896418|NCT01304472|Clopidogrel|clopidogrel|mesh-list
82896419|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82896420|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82896421|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82896422|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82896423|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82896424|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
82896425|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896426|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896427|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896428|NCT03795792|Curcumin|curcumin|mesh-list
82896429|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82896430|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82896431|NCT03795792|Analgesics|analgesics|mesh-ancestor
82896432|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
82896433|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896434|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896436|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896437|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896438|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896439|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896440|NCT01303536|Ondansetron|ondansetron|mesh-list
82896441|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
82896442|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
82896443|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896444|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896445|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896446|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
82896447|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
82896448|NCT01303536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82896449|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82896450|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
82896451|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896452|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896453|NCT01303614|Lidocaine|lidocaine|mesh-list
82896454|NCT01303614|Prilocaine|prilocaine|mesh-list
82896455|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82896456|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
82896457|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
82896458|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896459|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896460|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
82896461|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896462|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82896463|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82896464|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82896465|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82896466|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896467|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82896468|NCT03347838|Nivolumab|nivolumab|mesh-list
82896469|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896470|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896471|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82896472|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896473|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
82896474|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82896475|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
82896476|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
82896477|NCT03802422|Vitamins|vitamins|mesh-ancestor
82896478|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
82896479|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896480|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
82896481|NCT03802422|Hematinics|hematinics|mesh-ancestor
82896482|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
82896483|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82896484|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
82896485|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896486|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
82896487|NCT03801564|Protective Agents|protective agents|mesh-ancestor
82896488|NCT03813186|Decitabine|decitabine|mesh-list
82896489|NCT03813186|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82896490|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896491|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
82896492|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896493|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896494|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896495|NCT03293784|Infliximab|infliximab|mesh-list
82896496|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
82896497|NCT03293784|Nivolumab|nivolumab|mesh-list
82896498|NCT03293784|Ipilimumab|ipilimumab|mesh-list
82896499|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896500|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896501|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82896502|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896503|NCT03293784|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82896504|NCT03293784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896505|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
82896506|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896507|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896508|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896509|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
82896510|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896511|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
82896512|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82896513|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896514|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
82896515|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82896516|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896517|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82896518|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896519|NCT03799536|Sotalol|sotalol|mesh-list
82896520|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82896521|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82896522|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
82896523|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896524|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896525|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896526|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82896527|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
82896528|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
82896529|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896530|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
82896531|NCT03229278|Nivolumab|nivolumab|mesh-list
82896532|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82896533|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896534|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896535|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82896536|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896537|NCT03812796|Avelumab|avelumab|mesh-list
82896538|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896539|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896540|NCT05759104|Adalimumab|adalimumab|mesh-list
82896541|NCT05759104|Infliximab|infliximab|mesh-list
82896542|NCT05759104|Ustekinumab|ustekinumab|mesh-list
82896543|NCT05759104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82896544|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896545|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896546|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
82896547|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896548|NCT01384240|Proflavine|proflavine|mesh-list
82896549|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82896550|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896551|NCT01381510|Finasteride|finasteride|mesh-list
82896552|NCT01381510|Dutasteride|dutasteride|mesh-list
82896553|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
82896554|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82896555|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896556|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896557|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
82896558|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896559|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896560|NCT01381510|Urological Agents|urological agents|mesh-ancestor
82896561|NCT04258072|Vactosertib|vactosertib|mesh-list
82896562|NCT04258072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82896563|NCT04258072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896564|NCT04258072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896565|NCT02984800|Anesthetics|anesthetics|mesh-list
82896566|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896567|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896568|NCT04188730|Lofexidine|lofexidine|mesh-list
82896569|NCT04188730|Clonidine|clonidine|mesh-list
82896570|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82896571|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82896572|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896573|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
82896574|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896575|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82896576|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82896577|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82896578|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
82896579|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896580|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896581|NCT04188730|Analgesics|analgesics|mesh-ancestor
82896582|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
82896583|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
82896585|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
82896586|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896587|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896588|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896589|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896590|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
82896591|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896592|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896593|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
82896594|NCT01381354|Riboflavin|riboflavin|mesh-list
82896595|NCT01381354|Thiamine|thiamine|mesh-list
82896596|NCT01381354|Niacinamide|niacinamide|mesh-list
82896598|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
82896599|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
82896600|NCT01381354|Ubiquinone|ubiquinone|mesh-list
82896601|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
82896602|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
82896603|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82896604|NCT01381354|Vitamins|vitamins|mesh-ancestor
82896605|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
82896606|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896607|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
82896608|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896609|NCT01381354|Expectorants|expectorants|mesh-ancestor
82896610|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
82896611|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82896612|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
82896613|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896614|NCT01381354|Protective Agents|protective agents|mesh-ancestor
82896615|NCT01381354|Antidotes|antidotes|mesh-ancestor
82896616|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
82896617|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82896618|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
82896619|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82896620|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
82896621|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82896622|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
82896623|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82896624|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
82896625|NCT01381276|Beta Carotene|beta carotene|mesh-list
82896626|NCT01381276|Vitamin A|vitamin a|mesh-list
82896627|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
82896628|NCT01381276|Carotenoids|carotenoids|mesh-list
82896629|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
82896630|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896631|NCT01381276|Protective Agents|protective agents|mesh-ancestor
82896632|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896633|NCT01381276|Provitamins|provitamins|mesh-ancestor
82896634|NCT01381276|Vitamins|vitamins|mesh-ancestor
82896635|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
82896636|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82896637|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896638|NCT02661022|Dexamethasone|dexamethasone|mesh-list
82896639|NCT02661022|Pomalidomide|pomalidomide|mesh-list
82896640|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896641|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
82896642|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
82896643|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896644|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896645|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896646|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
82896647|NCT02661022|Hormones|hormones|mesh-ancestor
83455163|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896648|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896649|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82896650|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896651|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
82896652|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82896653|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82896654|NCT02661022|Growth Substances|growth substances|mesh-ancestor
82896655|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
82896656|NCT01569256|Cabergoline|cabergoline|mesh-list
82896657|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82896658|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82896659|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
82896660|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
82896661|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896662|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896663|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896665|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896666|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896667|NCT01380808|Capecitabine|capecitabine|mesh-list
83513847|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896668|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896669|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
82896670|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896671|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896672|NCT03799224|Decitabine|decitabine|mesh-list
82896673|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896674|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
82896675|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896676|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896677|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896678|NCT03798912|Octreotide|octreotide|mesh-list
82896679|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896680|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82896681|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896682|NCT03798834|Anesthetics|anesthetics|mesh-list
82896683|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896684|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896685|NCT03812562|Nivolumab|nivolumab|mesh-list
82896686|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896687|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896688|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82896689|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896690|NCT01304784|Paclitaxel|paclitaxel|mesh-list
82896691|NCT01304784|Docetaxel|docetaxel|mesh-list
82896692|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82896693|NCT01304784|Capecitabine|capecitabine|mesh-list
82896694|NCT01304784|Trastuzumab|trastuzumab|mesh-list
82896695|NCT01304784|Lapatinib|lapatinib|mesh-list
82896696|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82896697|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82896698|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896699|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
82896700|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
82896701|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
82896702|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896703|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82896704|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
82896705|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896706|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82896707|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896708|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
82896709|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896710|NCT03798600|Caspofungin|caspofungin|mesh-list
82896711|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
82896712|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896713|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896714|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896715|NCT03798522|Nalbuphine|nalbuphine|mesh-list
82896716|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82896717|NCT03798522|Narcotics|narcotics|mesh-ancestor
82896718|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896719|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896720|NCT03798522|Analgesics|analgesics|mesh-ancestor
82896721|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
82896722|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896723|NCT01308034|Sunitinib|sunitinib|mesh-list
82896724|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896725|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82896726|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82896727|NCT01308034|Growth Substances|growth substances|mesh-ancestor
82896728|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896729|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
82896730|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82896731|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896732|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896733|NCT01302210|Mupirocin|mupirocin|mesh-list
82896734|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82896735|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896736|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82896737|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896738|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896740|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
82896741|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82896742|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896743|NCT00005044|Bicalutamide|bicalutamide|mesh-list
82896745|NCT00005044|Hormones|hormones|mesh-list
82896746|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82896747|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896748|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896749|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
82896750|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
82896751|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896752|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82896753|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82896754|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82896755|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82896756|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82896757|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896758|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896759|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896760|NCT03794154|Analgesics|analgesics|mesh-ancestor
82896761|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
82896762|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896763|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
82896764|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82896765|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
82896766|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
82896767|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
82896768|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82896769|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896770|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896771|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
82896772|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82896773|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896774|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896775|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
82896776|NCT02722668|Sirolimus|sirolimus|mesh-list
82896777|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
82896778|NCT02722668|Fludarabine|fludarabine|mesh-list
82896779|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82896780|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82896781|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
82896782|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896783|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896784|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82896785|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
82896786|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896787|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896788|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82896789|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82896790|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82896791|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
82896792|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82896793|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896794|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896795|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
82896796|NCT01303926|Paclitaxel|paclitaxel|mesh-list
82896797|NCT01303926|Bevacizumab|bevacizumab|mesh-list
82896798|NCT01303926|Carboplatin|carboplatin|mesh-list
82896799|NCT01303926|Pemetrexed|pemetrexed|mesh-list
82896800|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82896801|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896802|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
82896803|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
82896804|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
82896805|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896806|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896807|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82896808|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82896809|NCT01303926|Growth Substances|growth substances|mesh-ancestor
82896810|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896811|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
82896812|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896813|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82896814|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82896815|NCT03084796|Bromides|bromides|mesh-list
82896816|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
82896817|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82896819|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896820|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896821|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82896822|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
82896823|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
82896824|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82896825|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
82896826|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896827|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896828|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
82896829|NCT03717012|Nintedanib|nintedanib|mesh-list
82896830|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896831|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82896832|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896833|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896834|NCT01302756|Folic Acid|folic acid|mesh-list
82896835|NCT01302756|Hematinics|hematinics|mesh-ancestor
82896836|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
82896837|NCT01302756|Vitamins|vitamins|mesh-ancestor
82896838|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
82896839|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896840|NCT04893252|Durvalumab|durvalumab|mesh-list
82896841|NCT04893252|Vactosertib|vactosertib|mesh-list
82896842|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82896843|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896844|NCT04893252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82896845|NCT04893252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896846|NCT04893252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896847|NCT03797508|Progesterone|progesterone|mesh-list
82896848|NCT03797508|Progestins|progestins|mesh-ancestor
82896849|NCT03797508|Hormones|hormones|mesh-ancestor
82896850|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896851|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896852|NCT01380496|Doxycycline|doxycycline|mesh-list
82896853|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82896854|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896855|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
82896856|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82896857|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82896858|NCT01304316|Phenylephrine|phenylephrine|mesh-list
82896859|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
82896860|NCT01304316|Tetracaine|tetracaine|mesh-list
82896861|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
82896862|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
82896863|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896864|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896865|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
82896866|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896867|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82896868|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82896869|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
82896870|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896871|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896872|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
82896873|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
82896874|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
82896875|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82896876|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
82896877|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82896878|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
82896879|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82896880|NCT01304316|Protective Agents|protective agents|mesh-ancestor
82896881|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82896882|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82896883|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82896884|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82896885|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896886|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896887|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896888|NCT03792828|Analgesics|analgesics|mesh-ancestor
82896889|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
82896890|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896891|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
82896892|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82896893|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
82896894|NCT01379326|Mebendazole|mebendazole|mesh-list
82896895|NCT01379326|Piperazine|piperazine|mesh-list
82896896|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
82896897|NCT01379326|DMP 777|dmp 777|mesh-list
82896898|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
82896899|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
82896900|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82896901|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896902|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
82896903|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
82896904|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
82896905|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896906|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896907|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896908|NCT01560546|Testosterone|testosterone|mesh-list
82896909|NCT01560546|Androgens|androgens|mesh-ancestor
82896910|NCT01560546|Hormones|hormones|mesh-ancestor
82896911|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82896912|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896913|NCT03792984|Vitamin D|vitamin d|mesh-list
82896914|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
82896915|NCT03792984|Metformin|metformin|mesh-list
82896916|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
82896917|NCT03792984|Calcium|calcium|mesh-list
82896918|NCT03792984|Vitamins|vitamins|mesh-ancestor
82896919|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
82896920|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896921|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82896922|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82896923|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82896924|NCT03792984|Antacids|antacids|mesh-ancestor
82896925|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455220|NCT00421863|Analgesics|analgesics|mesh-ancestor
82896926|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896927|NCT03792906|Norepinephrine|norepinephrine|mesh-list
82896928|NCT03792906|Bupivacaine|bupivacaine|mesh-list
82896929|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
82896930|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
82896931|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896932|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896933|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
82896934|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896935|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82896936|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82896937|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
82896938|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82896939|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896940|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
82896941|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
82896942|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82896943|NCT03078556|Lamivudine|lamivudine|mesh-list
82896944|NCT03078556|Dolutegravir|dolutegravir|mesh-list
82896945|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82896946|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82896947|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896948|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896949|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
82896950|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82896951|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82896952|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82896953|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82896954|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82896955|NCT03949894|Tolvaptan|tolvaptan|mesh-list
82896956|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82896957|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896958|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
82896959|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896960|NCT03714672|Diclofenac|diclofenac|mesh-list
82896961|NCT03714672|Tramadol|tramadol|mesh-list
82896962|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82896963|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82896964|NCT03714672|Analgesics|analgesics|mesh-ancestor
82896967|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896968|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82896969|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82896970|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82896971|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896972|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896973|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82896974|NCT03714672|Narcotics|narcotics|mesh-ancestor
82896975|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896976|NCT03083470|Paclitaxel|paclitaxel|mesh-list
82896977|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82896978|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896979|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82896980|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82896981|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82896982|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82896983|NCT01377610|Naltrexone|naltrexone|mesh-list
82896984|NCT01377610|Buprenorphine|buprenorphine|mesh-list
82896985|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82896986|NCT01377610|Narcotics|narcotics|mesh-ancestor
82896987|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82896988|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82896989|NCT01377610|Analgesics|analgesics|mesh-ancestor
82896990|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
82896991|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82896992|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82896993|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82896994|NCT03811080|Fexuprazan|fexuprazan|mesh-list
82896995|NCT03811080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82896996|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82896997|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82896998|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82896999|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897000|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82897001|NCT03810976|Gemcitabine|gemcitabine|mesh-list
82897002|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82897003|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
82897004|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897005|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897006|NCT05405244|Bromocriptine|bromocriptine|mesh-list
82897007|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897008|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82897009|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82897010|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
82897011|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82897012|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
82897013|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
82897014|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897015|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897016|NCT03788694|Ketamine|ketamine|mesh-list
82897017|NCT03788694|Analgesics|analgesics|mesh-ancestor
82897018|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
82897019|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897020|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897021|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82897022|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897023|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
82897024|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
82897025|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897026|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82897027|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82897028|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897029|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897030|NCT03789006|Interleukin-2|interleukin-2|mesh-list
82897031|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
82897032|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82897033|NCT03789006|Antibodies|antibodies|mesh-list
82897034|NCT03789006|Basiliximab|basiliximab|mesh-list
82897035|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
82897036|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82897037|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
82897038|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897040|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82897041|NCT03789006|Analgesics|analgesics|mesh-ancestor
82897042|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
82897043|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897044|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897045|NCT01306266|Rizatriptan|rizatriptan|mesh-list
82897046|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82897047|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
82897048|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897049|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897050|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897052|NCT03516214|Nazartinib|nazartinib|mesh-list
82897053|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897054|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82897055|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897056|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897057|NCT03630796|Sevoflurane|sevoflurane|mesh-list
82897058|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82897059|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82897060|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
82897061|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
82897062|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897063|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897064|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82897065|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897066|NCT01096966|Bupivacaine|bupivacaine|mesh-list
82897067|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
82897068|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
82897069|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897070|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897071|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
82897072|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897073|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
82897074|NCT01379560|Dinoprost|dinoprost|mesh-list
82897075|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82897076|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82897077|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
82897078|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82897079|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897080|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
82897081|NCT01379482|Paclitaxel|paclitaxel|mesh-list
82897082|NCT01379482|Docetaxel|docetaxel|mesh-list
82897083|NCT01379482|Cisplatin|cisplatin|mesh-list
82897084|NCT01379482|Doxorubicin|doxorubicin|mesh-list
82897085|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
82897086|NCT01379482|Irinotecan|irinotecan|mesh-list
82897087|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82897088|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897089|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
82897090|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
82897091|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
82897092|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897093|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82897094|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82897095|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82897096|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897097|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82897098|NCT05624424|Sufentanil|sufentanil|mesh-list
82897099|NCT05624424|Remifentanil|remifentanil|mesh-list
82897100|NCT05624424|Propofol|propofol|mesh-list
82897101|NCT05624424|Sevoflurane|sevoflurane|mesh-list
82897102|NCT05624424|Cisatracurium|cisatracurium|mesh-list
82897103|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82897104|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897105|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897106|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897107|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
82897108|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
82897109|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82897110|NCT05624424|Narcotics|narcotics|mesh-ancestor
82897111|NCT05624424|Analgesics|analgesics|mesh-ancestor
82897112|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
82897113|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897114|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82897115|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82897116|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82897117|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82897118|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82897119|NCT05461690|Niraparib|niraparib|mesh-list
82897120|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82897121|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897122|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897123|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897124|NCT05456230|Midazolam|midazolam|mesh-list
82897125|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82897126|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82897127|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897128|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897129|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82897130|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82897131|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897132|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897133|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
82897134|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
82897135|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
82897136|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
82897137|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897138|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897139|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82897140|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
82897141|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897142|NCT05404048|Atezolizumab|atezolizumab|mesh-list
82897143|NCT05404048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82897144|NCT05404048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897145|NCT05404048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897146|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897147|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82897148|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897149|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82897150|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897151|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897152|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
82897153|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82897154|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897155|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897156|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82897157|NCT03788538|Analgesics|analgesics|mesh-ancestor
82897158|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
82897159|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897160|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82897161|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82897162|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82897163|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
82897164|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897165|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897166|NCT05342584|Cytarabine|cytarabine|mesh-list
82897167|NCT05342584|Daunorubicin|daunorubicin|mesh-list
82897168|NCT05342584|Venetoclax|venetoclax|mesh-list
82897169|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82897170|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
82897171|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897172|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897173|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
82897174|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897175|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897176|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
82897177|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897178|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82897179|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82897180|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82897181|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897182|NCT05320120|Esketamine|esketamine|mesh-list
82897183|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
82897184|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897185|NCT03077698|Megestrol|megestrol|mesh-list
82897186|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
82897187|NCT03077698|Progestins|progestins|mesh-list
82897188|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
82897189|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82897199|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
82897200|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82897202|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82897203|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
82897204|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
82897205|NCT01377220|Choline|choline|mesh-list
82897206|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
82897207|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82897208|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
82897209|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897210|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82897211|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82897212|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
82897213|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
82897214|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82897215|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
82897216|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897217|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897218|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82897219|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
82897220|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82897221|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
82897222|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897223|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897224|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82897225|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
82897226|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
82897227|NCT03079102|Protective Agents|protective agents|mesh-ancestor
82897228|NCT03791424|Midazolam|midazolam|mesh-list
82897229|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82897230|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82897231|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897232|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897233|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82897234|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82897235|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897236|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897237|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
82897238|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
82897239|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
82897240|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
82897241|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897242|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897243|NCT03787992|Gefitinib|gefitinib|mesh-list
82897244|NCT03787992|Aflutinib|aflutinib|mesh-list
82897245|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897246|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82897247|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897248|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897249|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
82897250|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897251|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897252|NCT02434354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82897253|NCT02434354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897266|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82897267|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897268|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82897269|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897270|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897271|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82897272|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82897273|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
82897274|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897275|NCT01308528|Enoxaparin|enoxaparin|mesh-list
82897276|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
82897277|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
82897278|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82897279|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82897280|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897281|NCT04839328|Hemay005|hemay005|mesh-list
82897282|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
82897283|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82897284|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82897285|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897286|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897287|NCT03785496|Spartalizumab|spartalizumab|mesh-list
82897288|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82897289|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897290|NCT03785496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897291|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897292|NCT01307202|Gabapentin|gabapentin|mesh-list
82897293|NCT01307202|Analgesics|analgesics|mesh-ancestor
82897294|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
82897295|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897296|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897297|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
82897298|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82897299|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82897300|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897301|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897302|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82897303|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82897304|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897305|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897306|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
82897307|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
82897308|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897309|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897310|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82897311|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897313|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
82897314|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897315|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
82897316|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897317|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897318|NCT04637386|Anesthetics|anesthetics|mesh-list
82897319|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
82897320|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897321|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897322|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
82897323|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897324|NCT01308684|Bevacizumab|bevacizumab|mesh-list
82897325|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897326|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897327|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82897328|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82897329|NCT01308684|Growth Substances|growth substances|mesh-ancestor
82897330|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897331|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
82897332|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
82897333|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82897334|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897335|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897336|NCT03790566|Bupivacaine|bupivacaine|mesh-list
82897338|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
82897339|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897340|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897341|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
82897342|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897343|NCT04436224|Fentanyl|fentanyl|mesh-list
82897344|NCT04436224|Hydromorphone|hydromorphone|mesh-list
82897345|NCT04436224|Butorphanol|butorphanol|mesh-list
82897346|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82897347|NCT04436224|Narcotics|narcotics|mesh-ancestor
82897348|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897349|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897350|NCT04436224|Analgesics|analgesics|mesh-ancestor
82897351|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
82897352|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897353|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82897354|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897355|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
82897356|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
82897357|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
82897358|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
82897359|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82897360|NCT03785184|Dexamethasone|dexamethasone|mesh-list
82897361|NCT03785184|Lenalidomide|lenalidomide|mesh-list
82897362|NCT03785184|Venetoclax|venetoclax|mesh-list
82897363|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82897364|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
82897365|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
82897366|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897367|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897368|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82897369|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
82897371|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82897372|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82897373|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897374|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
82897375|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82897376|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82897377|NCT03785184|Growth Substances|growth substances|mesh-ancestor
82897378|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
82897379|NCT03784794|Thrombin|thrombin|mesh-list
82897380|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
82897381|NCT03784794|Coagulants|coagulants|mesh-ancestor
82897382|NCT01378546|Amifampridine|amifampridine|mesh-list
82897383|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82897384|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897385|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897386|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82897387|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897388|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897389|NCT05688384|Alfentanil|alfentanil|mesh-list
82897390|NCT05688384|Propofol|propofol|mesh-list
82897391|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82897392|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897393|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897394|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897395|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
82897396|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
82897397|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82897398|NCT05688384|Narcotics|narcotics|mesh-ancestor
82897399|NCT05688384|Analgesics|analgesics|mesh-ancestor
82897400|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
82897401|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897402|NCT01307592|Rituximab|rituximab|mesh-list
82897403|NCT01307592|Gemcitabine|gemcitabine|mesh-list
82897404|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
82897405|NCT01307592|Lenalidomide|lenalidomide|mesh-list
82897406|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897407|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897408|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
82897409|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897410|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82897411|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82897412|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
82897413|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897415|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82897417|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
82897418|NCT03790020|Bupivacaine|bupivacaine|mesh-list
82897419|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
82897420|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
82897421|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897422|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897423|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
82897424|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897425|NCT03075826|Guadecitabine|guadecitabine|mesh-list
82897426|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897427|NCT01378156|Vaccines|vaccines|mesh-list
82897428|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
82897429|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897430|NCT04108234|Ketamine|ketamine|mesh-list
82897431|NCT04108234|Analgesics|analgesics|mesh-ancestor
82897432|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
82897433|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897434|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897435|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82897436|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897437|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
82897438|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
82897439|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897440|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82897441|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82897442|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897443|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897444|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82897445|NCT03687814|Laxatives|laxatives|mesh-ancestor
82897446|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82897447|NCT05763550|Pregabalin|pregabalin|mesh-list
82897448|NCT05763550|Analgesics|analgesics|mesh-ancestor
82897449|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
82897450|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897451|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897452|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
82897453|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82897454|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897455|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897456|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82897457|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82897458|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82897459|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897460|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897461|NCT03783936|Leucovorin|leucovorin|mesh-list
82897462|NCT03783936|Fluorouracil|fluorouracil|mesh-list
82897463|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
82897464|NCT03783936|Trastuzumab|trastuzumab|mesh-list
82897465|NCT03783936|Avelumab|avelumab|mesh-list
82897466|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
82897467|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897468|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82897469|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897470|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897471|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
82897472|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897473|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897474|NCT03783936|Antidotes|antidotes|mesh-ancestor
82897475|NCT03783936|Protective Agents|protective agents|mesh-ancestor
82897476|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
82897477|NCT03783936|Vitamins|vitamins|mesh-ancestor
82897478|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
82897479|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
82897480|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82897481|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897482|NCT03781596|Fluticasone|fluticasone|mesh-list
82897483|NCT03781596|Omeprazole|omeprazole|mesh-list
82897484|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82897485|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82897486|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
82897487|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897488|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897489|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82897490|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
82897491|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
82897492|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82897493|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82897494|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82897495|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82897496|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897497|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897499|NCT03781674|Progestins|progestins|mesh-ancestor
82897500|NCT03781674|Hormones|hormones|mesh-ancestor
82897501|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82897502|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897503|NCT03786120|Zolpidem|zolpidem|mesh-list
82897504|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82897505|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82897506|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897507|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897508|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82897509|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
82897510|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
82897511|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897512|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897513|NCT01561014|Fluorouracil|fluorouracil|mesh-list
82897514|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
82897515|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82897516|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82897517|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
82897518|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897519|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82897520|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897521|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897522|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
82897523|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83513923|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
82897524|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82897525|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897526|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82897527|NCT01561092|Escitalopram|escitalopram|mesh-list
82897528|NCT01561092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82897529|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82897530|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897531|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897532|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897533|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
82897534|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897535|NCT05494866|Cobicistat|cobicistat|mesh-list
82897536|NCT05494866|Paclitaxel|paclitaxel|mesh-list
82897537|NCT05494866|Gemcitabine|gemcitabine|mesh-list
82897538|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82897539|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897540|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
82897541|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
82897542|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
82897543|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897544|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82897545|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82897546|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
82897547|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897548|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82897549|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82897550|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897551|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82897552|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
82897553|NCT01316874|Valrubicin|valrubicin|mesh-list
82897554|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897555|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82897556|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82897557|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897558|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897559|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82897560|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82897561|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82897562|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897563|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897564|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897565|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897566|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
82897567|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897568|NCT01309620|Zinc|zinc|mesh-list
82897569|NCT01309620|Trace Elements|trace elements|mesh-ancestor
82897570|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
82897571|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897572|NCT03783312|Acetaminophen|acetaminophen|mesh-list
82897573|NCT03783312|Ibuprofen|ibuprofen|mesh-list
82897574|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82897575|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82897576|NCT03783312|Analgesics|analgesics|mesh-ancestor
82897577|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
82897578|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897579|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897580|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82897581|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82897582|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82897583|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897584|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897585|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
82897586|NCT03776916|Simethicone|simethicone|mesh-list
82897587|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
82897588|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897589|NCT03776916|Emollients|emollients|mesh-ancestor
82897590|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
82897591|NCT01560702|Epinephrine|epinephrine|mesh-list
82897592|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82897593|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82897594|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
82897595|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897596|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897597|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897598|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82897599|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82897600|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
82897601|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897602|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82897603|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
82897604|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
82897605|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
82897606|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82897607|NCT03776838|Fentanyl|fentanyl|mesh-list
82897608|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82897609|NCT03776838|Narcotics|narcotics|mesh-ancestor
82897610|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897611|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897612|NCT03776838|Analgesics|analgesics|mesh-ancestor
82897613|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
82897614|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897615|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82897616|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897617|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
82897618|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
82897619|NCT03781050|Sirolimus|sirolimus|mesh-list
82897620|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82897621|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897622|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82897623|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897624|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
82897625|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897626|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
82897627|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897628|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
82897629|NCT02865850|Hematinics|hematinics|mesh-ancestor
82897630|NCT01309698|Inositol|inositol|mesh-list
82897631|NCT01309698|Vildagliptin|vildagliptin|mesh-list
82897632|NCT01309698|Voglibose|voglibose|mesh-list
82897633|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82897634|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897635|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82897636|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
82897637|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897638|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897640|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
82897641|NCT01309698|Vitamins|vitamins|mesh-ancestor
82897642|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
82897643|NCT01142284|Cilostazol|cilostazol|mesh-list
82897644|NCT01142284|Probucol|probucol|mesh-list
82897645|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82897646|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
82897647|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897648|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897649|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82897650|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
82897651|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82897652|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82897653|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897654|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82897655|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
82897656|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82897657|NCT01142284|Protective Agents|protective agents|mesh-ancestor
82897658|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82897659|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82897660|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897661|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82897662|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82897663|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
82897664|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82897665|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
82897666|NCT01309776|Tianeptine|tianeptine|mesh-list
82897667|NCT01309776|Escitalopram|escitalopram|mesh-list
82897668|NCT01309776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82897669|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82897670|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897671|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897672|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897673|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
82897674|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897675|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
82897676|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897677|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82897679|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
82897680|NCT01309854|Pioglitazone|pioglitazone|mesh-list
82897681|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82897682|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897683|NCT03780192|Sirolimus|sirolimus|mesh-list
82897684|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82897685|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897686|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82897687|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897688|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
82897689|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897690|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
82897691|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897692|NCT05305560|Ivermectin|ivermectin|mesh-list
82897693|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82897694|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897695|NCT03776448|Charcoal|charcoal|mesh-list
82897696|NCT03776448|Antidotes|antidotes|mesh-ancestor
82897697|NCT03776448|Protective Agents|protective agents|mesh-ancestor
82897698|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897699|NCT03780270|Fluorides|fluorides|mesh-list
82897700|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
82897701|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
82897702|NCT03780270|Protective Agents|protective agents|mesh-ancestor
82897703|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897704|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
82897705|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897706|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897707|NCT03072160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82897708|NCT03072160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897709|NCT05517486|Bupivacaine|bupivacaine|mesh-list
82897710|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
82897711|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
82897712|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897713|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897714|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
82897720|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82897722|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897723|NCT01314066|Bevacizumab|bevacizumab|mesh-list
82897724|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897725|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897726|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82897727|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82897728|NCT01314066|Growth Substances|growth substances|mesh-ancestor
82897729|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897730|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
82897731|NCT01314300|Lidocaine|lidocaine|mesh-list
82897732|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
82897733|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
82897734|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897735|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897736|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
82897737|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897738|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82897739|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82897740|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82897741|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897742|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897743|NCT05762536|Docetaxel|docetaxel|mesh-list
82897744|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897745|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
82897746|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
82897747|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
82897748|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897749|NCT03776058|Cinacalcet|cinacalcet|mesh-list
82897750|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82897751|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897752|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82897753|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
82897754|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82897755|NCT05202496|Calcitriol|calcitriol|mesh-list
82897756|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82897757|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897758|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82897759|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897760|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897761|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82897763|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
82897764|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82897765|NCT03779568|Bupivacaine|bupivacaine|mesh-list
82897766|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
82897767|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
82897768|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897769|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897770|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
82897771|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897772|NCT05201560|Fentanyl|fentanyl|mesh-list
82897773|NCT05201560|Butorphanol|butorphanol|mesh-list
82897774|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82897775|NCT05201560|Narcotics|narcotics|mesh-ancestor
82897776|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897777|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897778|NCT05201560|Analgesics|analgesics|mesh-ancestor
82897779|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
82897780|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897781|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82897782|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82897784|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
82897785|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
82897786|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
82897787|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82897788|NCT05201326|Bevacizumab|bevacizumab|mesh-list
82897789|NCT05201326|Irinotecan|irinotecan|mesh-list
82897790|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82897791|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897792|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82897793|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82897794|NCT05201326|Growth Substances|growth substances|mesh-ancestor
82897795|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897796|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
82897797|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82897798|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82897799|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897800|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897801|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
82897802|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82897803|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897804|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897805|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82897806|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897807|NCT01561404|Everolimus|everolimus|mesh-list
82897808|NCT01561404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82897809|NCT01561404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82897810|NCT01561404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897811|NCT01561404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897812|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897813|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
82897814|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897815|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897816|NCT03775902|Nicorandil|nicorandil|mesh-list
82897817|NCT03775902|Glimepiride|glimepiride|mesh-list
82897818|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82897819|NCT03775902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82897820|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897821|NCT03775902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897822|NCT03775902|Immunologic Factors|immunologic factors|mesh-ancestor
82897823|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82897824|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
82897825|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
82897826|NCT03775902|Vitamins|vitamins|mesh-ancestor
82897827|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
82897828|NCT03775590|Acetic Acid|acetic acid|mesh-list
82897829|NCT03775590|Retinol acetate|retinol acetate|mesh-list
82897830|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82897831|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897832|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82897833|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
82897834|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897835|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82897836|NCT03775590|Protective Agents|protective agents|mesh-ancestor
82897837|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897838|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
82897839|NCT03775746|Clopidogrel|clopidogrel|mesh-list
82897840|NCT03775746|Ticagrelor|ticagrelor|mesh-list
82897841|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82897842|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82897843|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82897844|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82897845|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
82897846|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897847|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897848|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897849|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82897850|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
82897851|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82897852|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
82897853|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897854|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
82897855|NCT03779178|Landiolol|landiolol|mesh-list
82897856|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82897857|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82897858|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
82897859|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897860|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897861|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897862|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82897864|NCT03779100|Antibodies|antibodies|mesh-list
82897865|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
82897866|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
82897867|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897868|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897869|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82897870|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897871|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897872|NCT05711212|Xanthohumol|xanthohumol|mesh-list
82897873|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897874|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82897875|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82897876|NCT05711212|Growth Substances|growth substances|mesh-ancestor
82897877|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897878|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
82897879|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
82897880|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82897881|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
82897882|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82897883|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82897884|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897885|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
82897886|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
82897887|NCT03775356|Anesthetics|anesthetics|mesh-list
82897888|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897889|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897890|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
82897891|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
82897892|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82897893|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82897894|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82897895|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897896|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
82897897|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
82897898|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
82897899|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897900|NCT05211622|Protective Agents|protective agents|mesh-ancestor
82897901|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897902|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
82897903|NCT05211622|Vitamins|vitamins|mesh-ancestor
82897904|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
82897905|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82897906|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
82897907|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82897908|NCT05191264|Analgesics|analgesics|mesh-list
82897909|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
82897910|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897911|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897912|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
82897913|NCT03778008|Gentamicins|gentamicins|mesh-list
82897914|NCT03778008|Dexamethasone|dexamethasone|mesh-list
82897915|NCT03778008|Lidocaine|lidocaine|mesh-list
82897916|NCT03778008|Mitogens|mitogens|mesh-list
82897917|NCT03778008|Vitamins|vitamins|mesh-ancestor
82897918|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
82897919|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897920|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82897921|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
82897922|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
82897923|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897924|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82897925|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
82897926|NCT03778008|Hormones|hormones|mesh-ancestor
82897927|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82897928|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82897929|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897930|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
82897931|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
82897932|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82897933|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
82897934|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82897935|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82897936|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82897937|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82897938|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897939|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
82897940|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
82897941|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82897942|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897943|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82897944|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82897945|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
82897947|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82897948|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
82897949|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82897950|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455361|NCT04736524|Antibodies|antibodies|mesh-list
82897951|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82897952|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
82897953|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
82897954|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82897955|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82897956|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
82897957|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
82897958|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82897959|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82897960|NCT03777930|Thalidomide|thalidomide|mesh-list
82897961|NCT03777930|Megestrol|megestrol|mesh-list
82897962|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
82897963|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82897964|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
82897965|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897966|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
82897967|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82897968|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82897969|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82897970|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82897971|NCT03777930|Growth Substances|growth substances|mesh-ancestor
82897972|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
82897973|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82897974|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82897975|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82897976|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82897977|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
82897978|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82897979|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82897980|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82897981|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82897982|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
82897983|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82897984|NCT03777696|Misoprostol|misoprostol|mesh-list
82897985|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82897986|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
82897987|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82897988|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897989|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82897990|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82897991|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
82897992|NCT04581148|Antibodies|antibodies|mesh-list
82897993|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
82897994|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
82897995|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82897996|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
82897997|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
82897998|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82897999|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82898000|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
82898001|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898002|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898003|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898004|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898005|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82898006|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898007|NCT03774108|Metformin|metformin|mesh-list
82898008|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82898009|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898010|NCT03438526|Melatonin|melatonin|mesh-list
82898030|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
82898031|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82898032|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82898033|NCT02575144|Growth Substances|growth substances|mesh-ancestor
82898034|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83455378|NCT03618537|Hormones|hormones|mesh-ancestor
82898035|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82898036|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898037|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82898038|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898039|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898040|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82898041|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82898063|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
82898064|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82898065|NCT03768882|Analgesics|analgesics|mesh-ancestor
82898066|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
82898067|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898068|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898069|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
82898070|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82898071|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898072|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898073|NCT02574286|Vitamin D|vitamin d|mesh-list
82898074|NCT02574286|Vitamins|vitamins|mesh-ancestor
82898075|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
82898076|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898077|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82898078|NCT01321944|Nicotine|nicotine|mesh-list
82898079|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82898080|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
82898081|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898082|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898083|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82898084|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82898085|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
82898086|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898087|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898089|NCT03771846|Gemcitabine|gemcitabine|mesh-list
82898090|NCT03771846|Fluorouracil|fluorouracil|mesh-list
82898091|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
82898092|NCT03771846|Irinotecan|irinotecan|mesh-list
82898093|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82898094|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
82898095|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898096|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898097|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83455385|NCT03410446|Ketamine|ketamine|mesh-list
82898098|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
82898099|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898100|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82898101|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82898102|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898103|NCT03771846|Antidotes|antidotes|mesh-ancestor
82898104|NCT03771846|Protective Agents|protective agents|mesh-ancestor
82898105|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
82898106|NCT03771846|Vitamins|vitamins|mesh-ancestor
82898107|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
82898108|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82898109|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82898110|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898111|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
82898112|NCT03771768|Triamcinolone|triamcinolone|mesh-list
82898113|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82898114|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82898115|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82898116|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898117|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
82898118|NCT03771768|Hormones|hormones|mesh-ancestor
82898119|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898120|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898121|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898122|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
82898123|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898124|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898125|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
82898126|NCT04393350|Lenvatinib|lenvatinib|mesh-list
82898127|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82898128|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898129|NCT04393350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82898130|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898131|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82898132|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898133|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
82898134|NCT03768258|Anastrozole|anastrozole|mesh-list
82898135|NCT03768258|Testosterone|testosterone|mesh-list
82898136|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
82898137|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
82898138|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82898139|NCT03768258|Androgens|androgens|mesh-ancestor
82898140|NCT03768258|Hormones|hormones|mesh-ancestor
82898141|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898142|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898143|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82898144|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898145|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
82898146|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82898147|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82898148|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898149|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898150|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82898151|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
82898152|NCT03771222|Decitabine|decitabine|mesh-list
82898153|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82898154|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
82898155|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898156|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898157|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898158|NCT03771066|Bisphenol A|bisphenol a|mesh-list
82898159|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82898160|NCT03771066|Estrogens|estrogens|mesh-ancestor
82898161|NCT03771066|Hormones|hormones|mesh-ancestor
82898162|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898164|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82898165|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
82898166|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898167|NCT03771066|Protective Agents|protective agents|mesh-ancestor
82898168|NCT04478838|Olanzapine|olanzapine|mesh-list
82898169|NCT04478838|Risperidone|risperidone|mesh-list
82898170|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82898171|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
82898172|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898173|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898174|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898175|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82898176|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82898177|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898178|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82898179|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82898180|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
82898181|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
82898182|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
82898183|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898184|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82898185|NCT04478838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82898186|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82898187|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898188|NCT03768024|Hydromorphone|hydromorphone|mesh-list
82898189|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82898190|NCT03768024|Narcotics|narcotics|mesh-ancestor
82898191|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898192|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898193|NCT03768024|Analgesics|analgesics|mesh-ancestor
82898194|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
82898195|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898196|NCT03999684|Tretinoin|tretinoin|mesh-list
82898197|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898198|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
82898199|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
82898200|NCT02083354|Trametinib|trametinib|mesh-list
82898201|NCT02083354|Dabrafenib|dabrafenib|mesh-list
82898202|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898203|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82898204|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898205|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898206|NCT01399918|Bevacizumab|bevacizumab|mesh-list
82898207|NCT01399918|Everolimus|everolimus|mesh-list
82898208|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82898209|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898210|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82898211|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82898212|NCT01399918|Growth Substances|growth substances|mesh-ancestor
82898213|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898214|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
82898215|NCT01399918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82898216|NCT01399918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82898217|NCT01399918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898218|NCT01399918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898219|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898220|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
82898221|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
82898222|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82898223|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
82898224|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898225|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
82898226|NCT03761472|Protective Agents|protective agents|mesh-ancestor
82898227|NCT03767322|Allopurinol|allopurinol|mesh-list
82898228|NCT03767322|Febuxostat|febuxostat|mesh-list
82898229|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
82898230|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898231|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898232|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
82898233|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898234|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82898235|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
82898236|NCT03767322|Protective Agents|protective agents|mesh-ancestor
82898237|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898238|NCT03761004|Levodopa|levodopa|mesh-list
82898239|NCT03761004|Carbidopa|carbidopa|mesh-list
82898240|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82898241|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82898242|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82898243|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
82898244|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898245|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898246|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898247|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82898248|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898249|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82898250|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
82898251|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
82898252|NCT03770208|Lidocaine|lidocaine|mesh-list
82898253|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
82898254|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
82898255|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898256|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898257|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
82898258|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898259|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82898260|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82898261|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82898262|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898263|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898264|NCT03766854|Insulin|insulin|mesh-list
82898265|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82898266|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
82898267|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82898268|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898269|NCT01322100|Bleomycin|bleomycin|mesh-list
82898270|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83455447|NCT03577431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82898271|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898272|NCT03760848|Midazolam|midazolam|mesh-list
82898273|NCT03760848|Atorvastatin|atorvastatin|mesh-list
82898274|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82898275|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82898276|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898277|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898278|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82898279|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82898280|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82898281|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82898282|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
82898283|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
82898284|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
82898285|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
82898286|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898287|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898288|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82898289|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82898290|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
82898291|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82898292|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82898293|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898294|NCT01567488|Everolimus|everolimus|mesh-list
82898295|NCT01567488|Octreotide|octreotide|mesh-list
82898296|NCT01567488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82898297|NCT01567488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82898298|NCT01567488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898299|NCT01567488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898300|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898301|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
82898302|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898303|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898304|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82898305|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82898306|NCT03760770|Riboflavin|riboflavin|mesh-list
82898307|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
82898308|NCT03760770|Vitamins|vitamins|mesh-ancestor
82898309|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
82898310|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898311|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82898312|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
82898314|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82898315|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898316|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82898317|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82898318|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898319|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898320|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898321|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82898322|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82898323|NCT01322178|Cetuximab|cetuximab|mesh-list
82898324|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82898325|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898326|NCT03760614|Entinostat|entinostat|mesh-list
82898327|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898328|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82898329|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898330|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898331|NCT00112840|Bevacizumab|bevacizumab|mesh-list
82898332|NCT00112840|Temsirolimus|temsirolimus|mesh-list
82898333|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82898334|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898335|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82898336|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82898337|NCT00112840|Growth Substances|growth substances|mesh-ancestor
82898338|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83455477|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
82898339|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
82898340|NCT00112840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898341|NCT00112840|Immunologic Factors|immunologic factors|mesh-ancestor
82898342|NCT00112840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82898343|NCT00112840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82898344|NCT00112840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898345|NCT00112840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898346|NCT03769818|Dexamethasone|dexamethasone|mesh-list
82898347|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
82898348|NCT03769818|Bupivacaine|bupivacaine|mesh-list
82898349|NCT03769818|BB 1101|bb 1101|mesh-list
82898350|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898351|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
82898352|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
82898353|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898354|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898355|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82898356|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
82898357|NCT03769818|Hormones|hormones|mesh-ancestor
82898358|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898359|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82898360|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898361|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
82898362|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898363|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898364|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
82898365|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
82898366|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898367|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
82898368|NCT05223244|Triamcinolone|triamcinolone|mesh-list
82898369|NCT05223244|Heparin|heparin|mesh-list
82898370|NCT05223244|Bupivacaine|bupivacaine|mesh-list
82898371|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82898372|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
82898373|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
82898374|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898375|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898376|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
82898377|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898378|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
82898379|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82898380|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82898381|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898382|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898383|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
82898384|NCT05223244|Hormones|hormones|mesh-ancestor
82898385|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898386|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82898387|NCT05223244|Protective Agents|protective agents|mesh-ancestor
82898388|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82898389|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
82898390|NCT05223010|Sevoflurane|sevoflurane|mesh-list
82898391|NCT05223010|Melatonin|melatonin|mesh-list
82898392|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82898393|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82898394|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82898395|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
82898396|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
82898397|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898398|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898399|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
82898400|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898401|NCT05223010|Protective Agents|protective agents|mesh-ancestor
82898402|NCT03760302|Analgesics|analgesics|mesh-list
82898403|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82898404|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
82898405|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898406|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898407|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898408|NCT03766074|Vitamin D|vitamin d|mesh-list
82898409|NCT03766074|Vitamins|vitamins|mesh-ancestor
82898410|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
82898411|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898412|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82898413|NCT05219656|Cyclosporine|cyclosporine|mesh-list
82898414|NCT05219656|Cyclosporins|cyclosporins|mesh-list
82898415|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898416|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898417|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898418|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
82898419|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898420|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
82898421|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898422|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
82898423|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898424|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82898425|NCT05168644|Niclosamide|niclosamide|mesh-list
82898426|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
82898427|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82898428|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
82898429|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82898430|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898431|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
82898432|NCT05645536|Tamoxifen|tamoxifen|mesh-list
82898433|NCT05645536|Letrozole|letrozole|mesh-list
82898434|NCT05645536|Anastrozole|anastrozole|mesh-list
82898435|NCT05645536|Exemestane|exemestane|mesh-list
82898436|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898437|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82898438|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82898439|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898440|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898441|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82898442|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
82898443|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898444|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898445|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82898446|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82898447|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82898448|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82898449|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
82898450|NCT05412888|Ubiquinone|ubiquinone|mesh-list
82898451|NCT05412888|Vitamins|vitamins|mesh-ancestor
82898452|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
82898453|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898454|NCT05558410|Acetaminophen|acetaminophen|mesh-list
82898455|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82898456|NCT05558410|Analgesics|analgesics|mesh-ancestor
82898457|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
82898458|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898459|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898460|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
82898461|NCT05087212|Plerixafor|plerixafor|mesh-list
82898462|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82898463|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82898464|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
82898465|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898467|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898468|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
82898469|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898470|NCT01321788|Tinzaparin|tinzaparin|mesh-list
82898471|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82898472|NCT01321788|Dalteparin|dalteparin|mesh-list
82898473|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
82898474|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82898475|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82898476|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898477|NCT05053828|Clopidogrel|clopidogrel|mesh-list
82898478|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
82898479|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82898480|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82898481|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82898482|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
82898483|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898484|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898485|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898486|NCT03120780|Fentanyl|fentanyl|mesh-list
82898487|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82898488|NCT03120780|Narcotics|narcotics|mesh-ancestor
82898489|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898490|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898491|NCT03120780|Analgesics|analgesics|mesh-ancestor
82898492|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
82898493|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898494|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82898495|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82898496|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
82898497|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
82898498|NCT04920838|Acetaminophen|acetaminophen|mesh-list
82898499|NCT04920838|Ciclesonide|ciclesonide|mesh-list
82898500|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
82898501|NCT04920838|Budesonide|budesonide|mesh-list
82898502|NCT04920838|Telmisartan|telmisartan|mesh-list
82898503|NCT04920838|Fluoxetine|fluoxetine|mesh-list
82898504|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82898505|NCT04920838|Analgesics|analgesics|mesh-ancestor
82898506|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
82898507|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898508|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898509|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
82898510|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898511|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82898512|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
82898513|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82898514|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
82898515|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
82898516|NCT04920838|Hormones|hormones|mesh-ancestor
82898517|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898518|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82898519|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82898520|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82898521|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898522|NCT04920838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82898523|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82898524|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898525|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898526|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
82898527|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82898528|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
82898529|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82898530|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82898531|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82898532|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898533|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82898534|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898535|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82898536|NCT03764280|Insulin|insulin|mesh-list
82898537|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
82898538|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82898539|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898541|NCT05133804|Reboxetine|reboxetine|mesh-list
82898542|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82898543|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898544|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82898545|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82898546|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898547|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898548|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
82898549|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898550|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
82898551|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82898552|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82898553|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
82898554|NCT03764202|Sufentanil|sufentanil|mesh-list
82898555|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82898556|NCT03764202|Narcotics|narcotics|mesh-ancestor
82898557|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898558|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898559|NCT03764202|Analgesics|analgesics|mesh-ancestor
82898561|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898562|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82898563|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82898564|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
82898565|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
82898566|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
82898567|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
82898568|NCT05115630|Melphalan|melphalan|mesh-list
82898569|NCT05115630|Fludarabine|fludarabine|mesh-list
82898570|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
82898571|NCT05115630|Tacrolimus|tacrolimus|mesh-list
82898572|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898573|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
82898574|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898575|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898576|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82898577|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
82898578|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898579|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898580|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82898581|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82898582|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
82898583|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82898584|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898585|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82898586|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82898587|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
82898588|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82898589|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898590|NCT04678492|Amoxicillin|amoxicillin|mesh-list
82898591|NCT04678492|Tetracycline|tetracycline|mesh-list
82898592|NCT04678492|Furazolidone|furazolidone|mesh-list
82898593|NCT04678492|Esomeprazole|esomeprazole|mesh-list
82898594|NCT04678492|Bismuth|bismuth|mesh-list
82898595|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82898596|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898597|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82898598|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82898599|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82898600|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898601|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898602|NCT04678492|Antacids|antacids|mesh-ancestor
82898603|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82898604|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82898605|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82898606|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82898607|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82898608|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82898609|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82898610|NCT03176784|Nicotine|nicotine|mesh-list
82898611|NCT03176784|Varenicline|varenicline|mesh-list
82898612|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82898613|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
82898614|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898615|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898617|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82898618|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
82898619|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898620|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898621|NCT05091528|Capecitabine|capecitabine|mesh-list
82898622|NCT05091528|Trastuzumab|trastuzumab|mesh-list
82898623|NCT05091528|Tucatinib|tucatinib|mesh-list
82898624|NCT05091528|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82898625|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82898626|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
82898627|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898628|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898629|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82898630|NCT05091528|Immunoconjugates|immunoconjugates|mesh-ancestor
82898631|NCT05091528|Immunologic Factors|immunologic factors|mesh-ancestor
82898632|NCT05091528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898633|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82898634|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898635|NCT04236258|Enalapril|enalapril|mesh-list
82898636|NCT04236258|Nifedipine|nifedipine|mesh-list
82898637|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82898638|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898639|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898640|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82898641|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898642|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
82898643|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
82898644|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82898645|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82898646|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
82898647|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898648|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82898649|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82898650|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
82898651|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82898652|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898653|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898654|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
82898655|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898656|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82898657|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
82898658|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82898659|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898660|NCT03049618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82898661|NCT03049618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898662|NCT05536102|Doxorubicin|doxorubicin|mesh-list
82898663|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82898664|NCT05536102|Capecitabine|capecitabine|mesh-list
82898665|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
82898666|NCT05536102|Tislelizumab|tislelizumab|mesh-list
82898667|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82898668|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898669|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82898670|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82898671|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898672|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898673|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82898674|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
82898675|NCT05536102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82898676|NCT04493164|Cytarabine|cytarabine|mesh-list
82898677|NCT04493164|Daunorubicin|daunorubicin|mesh-list
82898678|NCT04493164|Ivosidenib|ivosidenib|mesh-list
82898679|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82898680|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
82898681|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898682|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898683|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
82898684|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898685|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898686|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
82898687|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898688|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82898689|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82898690|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82898691|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898692|NCT05524714|Xanthohumol|xanthohumol|mesh-list
82898693|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898694|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82898695|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82898696|NCT05524714|Growth Substances|growth substances|mesh-ancestor
82898697|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898698|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
82898699|NCT05692804|Protein S|protein s|mesh-list
82898700|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
82898701|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
82898702|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82898703|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
82898704|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898705|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898706|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82898707|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
82898708|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
82898709|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82898710|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
82898711|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898712|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898713|NCT05692570|Ritonavir|ritonavir|mesh-list
82898714|NCT05692570|Cobicistat|cobicistat|mesh-list
82898715|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82898716|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82898717|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
82898718|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898719|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898720|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82898721|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82898722|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
82898723|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898724|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82898725|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82898726|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
82898727|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82898728|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898729|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83455604|NCT03485547|Venetoclax|venetoclax|mesh-list
82898730|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
82898731|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898732|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898733|NCT05422612|Fluoxetine|fluoxetine|mesh-list
82898734|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
82898735|NCT05422612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82898736|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82898737|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898738|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898739|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898740|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
82898741|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898742|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82898743|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
82898744|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82898745|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82898746|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82898747|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898748|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82898749|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82898750|NCT05689450|Amikacin|amikacin|mesh-list
82898751|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82898752|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898753|NCT05417308|Minoxidil|minoxidil|mesh-list
82898754|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82898755|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
82898756|NCT04650542|Paroxetine|paroxetine|mesh-list
82898757|NCT04650542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82898758|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82898759|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82898760|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898761|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898763|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898764|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82898765|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
82898766|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82898767|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82898768|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82898769|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898770|NCT04621058|Vitamin D|vitamin d|mesh-list
82898771|NCT04621058|Vitamins|vitamins|mesh-list
82898772|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
82898773|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898774|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82898775|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
82898776|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
82898777|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82898778|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82898779|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898780|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898781|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898782|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898783|NCT04451330|Doxycycline|doxycycline|mesh-list
82898784|NCT04451330|Trifarotene|trifarotene|mesh-list
82898785|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83455623|NCT03192826|Dipivefrin|dipivefrin|mesh-list
82898786|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898787|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
82898788|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82898789|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82898790|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
82898791|NCT02493426|Oxytocin|oxytocin|mesh-list
82898792|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
82898793|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82898794|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898795|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
82898796|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82898797|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82898798|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82898799|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898800|NCT03763734|Dexamethasone|dexamethasone|mesh-list
82898801|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898802|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
82898803|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
82898804|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898805|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898806|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82898807|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
82898808|NCT03763734|Hormones|hormones|mesh-ancestor
82898809|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898810|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82898811|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898812|NCT05063136|Capecitabine|capecitabine|mesh-list
82898813|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82898814|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
82898815|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898816|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898817|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82898818|NCT03756324|Cefdinir|cefdinir|mesh-list
82898819|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82898820|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898821|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
82898822|NCT03751202|Fluticasone|fluticasone|mesh-list
82898823|NCT03751202|Xhance|xhance|mesh-list
82898824|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82898825|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82898826|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898827|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82898828|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
82898829|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898830|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898831|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82898832|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
82898833|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
82898834|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82898835|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82898836|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82898837|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82898840|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898841|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
82898842|NCT03751202|Hormones|hormones|mesh-ancestor
83455638|NCT03287674|Nivolumab|nivolumab|mesh-list
82898843|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898844|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
82898845|NCT03749408|Mannitol|mannitol|mesh-list
82898846|NCT03749408|Bupivacaine|bupivacaine|mesh-list
82898847|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
82898848|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
82898849|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898850|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898851|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
82898852|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898853|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82898854|NCT03749408|Diuretics|diuretics|mesh-ancestor
82898855|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
82898856|NCT04387136|Sufentanil|sufentanil|mesh-list
82898857|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82898858|NCT04387136|Narcotics|narcotics|mesh-ancestor
82898859|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82898860|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898861|NCT04387136|Analgesics|analgesics|mesh-ancestor
82898862|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
82898863|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83513924|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898864|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82898865|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82898866|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
82898868|NCT04252586|Cannabidiol|cannabidiol|mesh-list
82898869|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
82898870|NCT04507776|Etanercept|etanercept|mesh-list
82898871|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82898872|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82898873|NCT04507776|Analgesics|analgesics|mesh-ancestor
82898874|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
82898875|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82898876|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898877|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82898878|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898879|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82898880|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898881|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
82898882|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
82898883|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82898884|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
82898885|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82898886|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
82898887|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898888|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898889|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
82898890|NCT03756246|Vaccines|vaccines|mesh-list
82898891|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
82898892|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898893|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
82898894|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82898895|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
82898896|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898897|NCT05460858|Expectorants|expectorants|mesh-ancestor
82898898|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
82898899|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82898900|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
82898901|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898902|NCT05460858|Protective Agents|protective agents|mesh-ancestor
82898903|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898904|NCT05460858|Antidotes|antidotes|mesh-ancestor
82898905|NCT05359224|Clopidogrel|clopidogrel|mesh-list
82898906|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82898907|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82898908|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82898909|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83455660|NCT00634244|Cytarabine|cytarabine|mesh-list
82898910|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82898911|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
82898912|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898914|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898915|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
82898916|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
82898917|NCT03756090|Paclitaxel|paclitaxel|mesh-list
82898918|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
82898919|NCT03756090|Epirubicin|epirubicin|mesh-list
82898920|NCT03756090|Palbociclib|palbociclib|mesh-list
82898921|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82898922|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82898923|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
82898924|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
82898925|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
82898926|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898927|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82898928|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
82898929|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898930|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898931|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82898932|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
82898933|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82898934|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82898935|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82898936|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82898937|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898938|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82898939|NCT04605588|Ribavirin|ribavirin|mesh-list
82898940|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
82898941|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
82898942|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
82898943|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898944|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
82898945|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898946|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
82898947|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82898948|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82898949|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898950|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82898951|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
82898952|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82898953|NCT03752736|Protective Agents|protective agents|mesh-ancestor
82898954|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898955|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
82898956|NCT03752658|Tenofovir|tenofovir|mesh-list
82898957|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
82898958|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898959|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82898960|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82898961|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898962|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898963|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82898964|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82898965|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
82898966|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82898967|NCT03755778|Itraconazole|itraconazole|mesh-list
82898968|NCT03755778|Rifampin|rifampin|mesh-list
82898969|NCT03755778|Quinidine|quinidine|mesh-list
82898970|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
82898971|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82898972|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82898973|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82898974|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82898975|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82898976|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82898977|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
82898978|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82898979|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82898980|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82898981|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82898982|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
82898983|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82898984|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
82898985|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82898987|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82898988|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82898989|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82898990|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82898991|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82898992|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82898993|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82898994|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
82898995|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82898996|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82898997|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
82898998|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82898999|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82899000|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82899001|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82899002|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
82899003|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82899004|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82899005|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899006|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82899007|NCT03779074|Amoxicillin|amoxicillin|mesh-list
82899008|NCT03779074|Metronidazole|metronidazole|mesh-list
82899009|NCT03779074|Clarithromycin|clarithromycin|mesh-list
82899010|NCT03779074|Tetracycline|tetracycline|mesh-list
82899011|NCT03779074|Rabeprazole|rabeprazole|mesh-list
82899012|NCT03779074|Bismuth|bismuth|mesh-list
82899013|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899014|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899015|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82899016|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82899017|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82899018|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899019|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899020|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82899021|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82899022|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82899023|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82899024|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82899025|NCT03779074|Antacids|antacids|mesh-ancestor
82899026|NCT03755700|Vitamin E|vitamin e|mesh-list
82899027|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
82899028|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82899029|NCT03755700|Vitamins|vitamins|mesh-ancestor
82899030|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
82899031|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899032|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
82899033|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899034|NCT03755700|Protective Agents|protective agents|mesh-ancestor
82899035|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
82899036|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899037|NCT03755700|Expectorants|expectorants|mesh-ancestor
82899038|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
82899039|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82899040|NCT03755700|Antidotes|antidotes|mesh-ancestor
82899041|NCT03757650|Amoxicillin|amoxicillin|mesh-list
82899042|NCT03757650|Clarithromycin|clarithromycin|mesh-list
82899043|NCT03757650|Omeprazole|omeprazole|mesh-list
82899044|NCT03757650|Bismuth|bismuth|mesh-list
82899045|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
82899046|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899047|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899048|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82899049|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82899050|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82899051|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899052|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899053|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82899054|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82899055|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82899056|NCT03757650|Antacids|antacids|mesh-ancestor
82899057|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
82899058|NCT04432376|Miconazole|miconazole|mesh-list
82899059|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
82899060|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899061|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82899062|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82899063|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899064|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899065|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82899066|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
82899067|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82899068|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899069|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82899070|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82899071|NCT05180968|Dronabinol|dronabinol|mesh-list
82899072|NCT05180968|Nabilone|nabilone|mesh-list
82899073|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
82899074|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
82899075|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899076|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899077|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82899078|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82899079|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82899080|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899081|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899082|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
82899083|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899084|NCT05180968|Analgesics|analgesics|mesh-ancestor
82899085|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
82899086|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82899087|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82899088|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899089|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899090|NCT05180968|Hormones|hormones|mesh-ancestor
82899091|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82899092|NCT03693404|Ketorolac|ketorolac|mesh-list
82899093|NCT03693404|Morphine|morphine|mesh-list
82899094|NCT03693404|Bupivacaine|bupivacaine|mesh-list
82899095|NCT03693404|Anesthetics|anesthetics|mesh-list
83455705|NCT03421210|Nicotine|nicotine|mesh-list
82899096|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
82899097|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
82899098|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899099|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899100|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
82899101|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899102|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82899103|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899104|NCT03693404|Analgesics|analgesics|mesh-ancestor
82899105|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899106|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899107|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82899108|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899109|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899110|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82899111|NCT03693404|Narcotics|narcotics|mesh-ancestor
82899112|NCT04219358|Imiquimod|imiquimod|mesh-list
82899113|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
82899114|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82899115|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
82899116|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899117|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899118|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
82899119|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82899120|NCT04219358|Protective Agents|protective agents|mesh-ancestor
82899121|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
82899122|NCT04218110|Ethanol|ethanol|mesh-list
82899123|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
82899124|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82899125|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82899126|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899127|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899128|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899129|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
82899130|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
82899131|NCT05154994|Durvalumab|durvalumab|mesh-list
82899132|NCT05154994|Ipilimumab|ipilimumab|mesh-list
82899133|NCT05154994|Tremelimumab|tremelimumab|mesh-list
82899134|NCT05154994|Belinostat|belinostat|mesh-list
82899135|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
82899136|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82899137|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
82899138|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899139|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899140|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
82899141|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899142|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82899143|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899144|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82899145|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899146|NCT03752190|Cosyntropin|cosyntropin|mesh-list
82899147|NCT03752190|Hormones|hormones|mesh-ancestor
82899148|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82899149|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899150|NCT04210310|Oxytocin|oxytocin|mesh-list
82899151|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
82899152|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82899153|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899154|NCT03755466|Tofacitinib|tofacitinib|mesh-list
82899155|NCT03755466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82899156|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82899157|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83455713|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899158|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899159|NCT03755310|Suvorexant|suvorexant|mesh-list
82899160|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82899161|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82899162|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899163|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899164|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82899165|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899166|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899167|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
82899168|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
82899169|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82899170|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82899171|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899172|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899173|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899174|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899175|NCT03668392|Asparaginase|asparaginase|mesh-list
82899176|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899177|NCT04176016|Edetic Acid|edetic acid|mesh-list
82899178|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
82899179|NCT04176016|Antidotes|antidotes|mesh-ancestor
82899180|NCT04176016|Protective Agents|protective agents|mesh-ancestor
82899181|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899182|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
82899183|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
82899184|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899185|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82899186|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
82899187|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82899188|NCT03695094|Lamotrigine|lamotrigine|mesh-list
82899189|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
82899190|NCT03695094|Levetiracetam|levetiracetam|mesh-list
82899191|NCT03695094|Brivaracetam|brivaracetam|mesh-list
82899192|NCT03695094|Padsevonil|padsevonil|mesh-list
82899193|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
82899194|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
82899195|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82899196|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899197|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899198|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82899199|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899200|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82899201|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82899202|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899203|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899204|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82899205|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82899206|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82899207|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82899208|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
82899209|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899210|NCT04495374|Pregabalin|pregabalin|mesh-list
82899211|NCT04495374|Analgesics|analgesics|mesh-ancestor
82899212|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
82899214|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899215|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
82899216|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82899217|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899218|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899219|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82899220|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82899221|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82899222|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899223|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899224|NCT03752112|Penicillins|penicillins|mesh-list
82899225|NCT03752112|Cefixime|cefixime|mesh-list
82899226|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
82899227|NCT03752112|Penicillin G|penicillin g|mesh-list
82899228|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
82899229|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899230|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899231|NCT04324606|Acetaminophen|acetaminophen|mesh-list
82899232|NCT04324606|Vaccines|vaccines|mesh-list
82899233|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
82899234|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899235|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899236|NCT04324606|Analgesics|analgesics|mesh-ancestor
82899237|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
82899238|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899239|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
82899240|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82899241|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82899242|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899243|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899244|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
82899245|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899246|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
82899247|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82899248|NCT04168190|Vaccines|vaccines|mesh-list
82899249|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82899250|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
82899251|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899252|NCT03939520|Pirfenidone|pirfenidone|mesh-list
82899253|NCT03939520|Nintedanib|nintedanib|mesh-list
82899254|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899255|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82899256|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899257|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899258|NCT03939520|Analgesics|analgesics|mesh-ancestor
82899259|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
82899260|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899261|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899262|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82899263|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899264|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899265|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899266|NCT03529942|FX006|fx006|mesh-list
82899267|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899268|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
82899269|NCT03529942|Hormones|hormones|mesh-ancestor
82899270|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82899271|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899272|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899273|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
82899274|NCT03501940|Fluorides|fluorides|mesh-list
82899275|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
82899276|NCT03501940|Protective Agents|protective agents|mesh-ancestor
82899277|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899278|NCT03754842|Niacinamide|niacinamide|mesh-list
82899279|NCT03754842|Niacin|niacin|mesh-list
82899280|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
82899281|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
82899282|NCT03754842|Vitamins|vitamins|mesh-ancestor
82899283|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
82899284|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899285|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82899286|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
82899287|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899288|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82899289|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
82899290|NCT01562210|Olaparib|olaparib|mesh-list
82899291|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899292|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82899293|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899294|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899295|NCT04189952|Rituximab|rituximab|mesh-list
82899296|NCT04189952|Carboplatin|carboplatin|mesh-list
82899297|NCT04189952|Etoposide|etoposide|mesh-list
82899298|NCT04189952|Ifosfamide|ifosfamide|mesh-list
82899299|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
82899300|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899301|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899302|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
82899303|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899304|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899305|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82899306|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82899307|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82899308|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899309|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899310|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82899311|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
82899312|NCT04716426|Tetracycline|tetracycline|mesh-list
82899313|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899314|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899315|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82899316|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899317|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899318|NCT05761756|Caffeine|caffeine|mesh-list
82899319|NCT05761756|Methylphenidate|methylphenidate|mesh-list
82899320|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82899321|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899322|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82899323|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899324|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899325|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82899326|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82899327|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
82899328|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899329|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82899330|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82899331|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899332|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
82899333|NCT04164758|Pimavanserin|pimavanserin|mesh-list
82899334|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82899335|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
82899336|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899337|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82899338|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82899339|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899340|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899341|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82899342|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82899343|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82899344|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82899345|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
82899346|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899347|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899348|NCT03754686|Acetaminophen|acetaminophen|mesh-list
82899349|NCT03754686|Oseltamivir|oseltamivir|mesh-list
82899350|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899351|NCT03754686|Analgesics|analgesics|mesh-ancestor
82899352|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
82899353|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899354|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899355|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
82899356|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
82899357|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899358|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899359|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899360|NCT05200884|Lidocaine|lidocaine|mesh-list
82899361|NCT05200884|Carticaine|carticaine|mesh-list
82899362|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
82899363|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
82899364|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899365|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899366|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
82899367|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899368|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82899369|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82899370|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82899371|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899372|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899373|NCT03746444|Anesthetics|anesthetics|mesh-list
82899374|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899375|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899376|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
82899377|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82899379|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
82899380|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82899381|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
83455729|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
82899382|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899383|NCT03748940|Mirikizumab|mirikizumab|mesh-list
82899384|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82899385|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899386|NCT03748940|Analgesics|analgesics|mesh-ancestor
82899387|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
82899388|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899389|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899390|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899391|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899392|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82899393|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82899394|NCT04177862|Fentanyl|fentanyl|mesh-list
82899395|NCT04177862|Sufentanil|sufentanil|mesh-list
82899396|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82899397|NCT04177862|Narcotics|narcotics|mesh-ancestor
82899398|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899399|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899400|NCT04177862|Analgesics|analgesics|mesh-ancestor
82899401|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
82899402|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899403|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82899404|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82899405|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
82899406|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
82899407|NCT03746366|Corticosterone|corticosterone|mesh-list
82899408|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899409|NCT04157738|Insulin|insulin|mesh-list
82899410|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82899411|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
82899412|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
82899413|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82899414|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899415|NCT04156646|Balovaptan|balovaptan|mesh-list
82899416|NCT04156646|Esomeprazole|esomeprazole|mesh-list
82899417|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82899418|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82899419|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82899420|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899421|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899422|NCT04156646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82899423|NCT04156646|Natriuretic Agents|natriuretic agents|mesh-ancestor
82899424|NCT04156646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899425|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
82899426|NCT04676412|Lenvatinib|lenvatinib|mesh-list
82899427|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899428|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899429|NCT04676412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82899430|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899431|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82899432|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899433|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82899434|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82899435|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82899436|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899437|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899438|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899439|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82899440|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82899441|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
82899442|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899443|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899444|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82899445|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82899446|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
82899447|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82899448|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899449|NCT04537806|Pregnanolone|pregnanolone|mesh-list
82899450|NCT04537806|Brexanolone|brexanolone|mesh-list
82899451|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
82899452|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899453|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899454|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
82899455|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899456|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899457|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
82899458|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
82899459|NCT03744806|Bevacizumab|bevacizumab|mesh-list
82899460|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899461|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899462|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82899463|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82899464|NCT03744806|Growth Substances|growth substances|mesh-ancestor
82899465|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899466|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
82899467|NCT04531098|Vaccines|vaccines|mesh-list
82899468|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
82899469|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899470|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
82899471|NCT04529850|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82899472|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
82899473|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899474|NCT04529850|Protective Agents|protective agents|mesh-ancestor
82899475|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899476|NCT04225676|Tisagenlecleucel|tisagenlecleucel|mesh-list
82899477|NCT04225676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899478|NCT04225676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899480|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82899481|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82899482|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82899483|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82899484|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
82899485|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899486|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899487|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899488|NCT04139018|Timolol|timolol|mesh-list
82899489|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82899490|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82899491|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
82899492|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899493|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899494|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899495|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82899496|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82899497|NCT05206318|Cysteamine|cysteamine|mesh-list
82899498|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
82899499|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899500|NCT04136444|Padsevonil|padsevonil|mesh-list
82899501|NCT04136444|Anticonvulsants|anticonvulsants|mesh-ancestor
82899502|NCT05027048|Calcium|calcium|mesh-list
82899503|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82899504|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899505|NCT03751332|Tacrolimus|tacrolimus|mesh-list
82899506|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899507|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
82899508|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899509|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82899510|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899511|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899512|NCT04425252|Brequinar|brequinar|mesh-list
82899513|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899514|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899515|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899516|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899517|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
82899518|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899519|NCT04003610|Carboplatin|carboplatin|mesh-list
82899520|NCT04003610|Gemcitabine|gemcitabine|mesh-list
82899521|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
82899522|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899523|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82899524|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
82899525|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899526|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899527|NCT04003610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82899528|NCT03744104|Vaccines|vaccines|mesh-list
82899529|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
82899530|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899531|NCT03999554|Vaccines|vaccines|mesh-list
82899532|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
82899533|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899534|NCT05280626|Prednisolone|prednisolone|mesh-list
82899535|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82899536|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
82899537|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82899538|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
82899539|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
82899540|NCT05280626|Rituximab|rituximab|mesh-list
82899541|NCT05280626|Doxorubicin|doxorubicin|mesh-list
82899542|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82899543|NCT05280626|Vincristine|vincristine|mesh-list
82899544|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82899545|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
82899546|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899547|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
82899548|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899549|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899550|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82899551|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
82899552|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899553|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899554|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82899555|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899556|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82899557|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82899558|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82899559|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899560|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899561|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
82899563|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82899564|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82899565|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
82899566|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
82899567|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899568|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82899569|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82899570|NCT05280626|Protective Agents|protective agents|mesh-ancestor
82899571|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82899572|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
82899573|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
82899574|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
82899575|NCT04526574|Vaccines|vaccines|mesh-list
82899576|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82899577|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
82899578|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899579|NCT03993392|Buprenorphine|buprenorphine|mesh-list
82899580|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82899581|NCT03993392|Narcotics|narcotics|mesh-ancestor
82899582|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899583|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899584|NCT03993392|Analgesics|analgesics|mesh-ancestor
82899585|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
82899586|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899587|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82899588|NCT04145258|Aspirin|aspirin|mesh-list
82899589|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82899590|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899591|NCT04145258|Analgesics|analgesics|mesh-ancestor
82899592|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
82899593|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899594|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899595|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899596|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899597|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82899598|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82899599|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899600|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82899601|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82899602|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899603|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
82899604|NCT03751176|Leucovorin|leucovorin|mesh-list
82899605|NCT03751176|Folic Acid|folic acid|mesh-list
82899606|NCT03751176|Fluorouracil|fluorouracil|mesh-list
82899607|NCT03751176|Irinotecan|irinotecan|mesh-list
82899608|NCT03751176|Panitumumab|panitumumab|mesh-list
82899609|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
82899610|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
82899611|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899612|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82899613|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899614|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899615|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
82899616|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899617|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82899618|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82899619|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899620|NCT03751176|Antidotes|antidotes|mesh-ancestor
83455788|NCT00633932|Esomeprazole|esomeprazole|mesh-list
82899621|NCT03751176|Protective Agents|protective agents|mesh-ancestor
82899622|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
82899623|NCT03751176|Vitamins|vitamins|mesh-ancestor
82899624|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
82899625|NCT03751176|Hematinics|hematinics|mesh-ancestor
82899626|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899627|NCT04377308|Fluoxetine|fluoxetine|mesh-list
82899628|NCT04377308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82899629|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82899630|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899631|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899632|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899633|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
82899634|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899635|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82899636|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
82899637|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899638|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82899639|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82899640|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899641|NCT03743870|Bupivacaine|bupivacaine|mesh-list
82899642|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
82899643|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
82899644|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
82899645|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899646|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899647|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
82899648|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899649|NCT03988088|Lasmiditan|lasmiditan|mesh-list
82899650|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82899651|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
82899652|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899653|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899654|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899655|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
82899656|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
82899657|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899658|NCT03069352|Cytarabine|cytarabine|mesh-list
82899659|NCT03069352|Venetoclax|venetoclax|mesh-list
82899660|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82899661|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
82899662|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899663|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899673|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899675|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82899676|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82899677|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82899678|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899679|NCT05204056|Epinephrine|epinephrine|mesh-list
82899680|NCT05204056|Morphine|morphine|mesh-list
82899681|NCT05204056|Ropivacaine|ropivacaine|mesh-list
82899682|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
82899683|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82899684|NCT05204056|Narcotics|narcotics|mesh-ancestor
82899685|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899686|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899687|NCT05204056|Analgesics|analgesics|mesh-ancestor
82899688|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
82899689|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899690|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
82899691|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
82899692|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82899693|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82899694|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899695|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
82899696|NCT05204056|Coagulants|coagulants|mesh-ancestor
82899697|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82899698|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82899699|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
82899700|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899701|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82899702|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82899703|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
82899704|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82899705|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
82899706|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
82899707|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
82899708|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82899709|NCT05203744|Tafenoquine|tafenoquine|mesh-list
82899710|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
82899711|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82899712|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82899713|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899714|NCT03987074|Firsocostat|firsocostat|mesh-list
82899715|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899716|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899717|NCT05761366|PSMA-BCH|psma-bch|mesh-list
82899718|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82899719|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899720|NCT05302466|Silicon|silicon|mesh-list
82899721|NCT05302466|Trace Elements|trace elements|mesh-ancestor
82899722|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
82899723|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899724|NCT05203588|Vitamin D|vitamin d|mesh-list
82899725|NCT05203588|Denosumab|denosumab|mesh-list
82899726|NCT05203588|Calcium|calcium|mesh-list
82899727|NCT05203588|Vitamins|vitamins|mesh-ancestor
82899728|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
82899729|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899730|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82899731|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82899732|NCT05203354|Acitretin|acitretin|mesh-list
82899738|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82899739|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899741|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
82899742|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
82899743|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
82899744|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899745|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899746|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82899747|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82899748|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82899749|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899750|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899751|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82899752|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
82899753|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899754|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899755|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82899756|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
82899757|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
82899758|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899759|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899760|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82899761|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82899762|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82899763|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82899764|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899765|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899766|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899767|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
82899768|NCT05180032|Denosumab|denosumab|mesh-list
82899769|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82899770|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899771|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
82899772|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899773|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899774|NCT05761132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83455808|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899775|NCT05761132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899776|NCT04411680|Sargramostim|sargramostim|mesh-list
82899777|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
82899778|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899779|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
82899780|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
82899781|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
82899782|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82899783|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82899784|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899785|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899786|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899787|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899788|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82899789|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899790|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82899791|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899792|NCT05760976|Cisatracurium|cisatracurium|mesh-list
82899793|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82899794|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82899795|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899796|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899797|NCT05324358|Ketorolac|ketorolac|mesh-list
82899798|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82899799|NCT05324358|Morphine|morphine|mesh-list
82899800|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82899801|NCT05324358|Narcotics|narcotics|mesh-ancestor
82899802|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899803|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899805|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
82899806|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899807|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82899808|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82899809|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899810|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899811|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82899812|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899813|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899814|NCT05384496|Nivolumab|nivolumab|mesh-list
82899815|NCT05384496|Ipilimumab|ipilimumab|mesh-list
82899816|NCT05384496|Axitinib|axitinib|mesh-list
82899817|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899818|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899819|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82899820|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899821|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82899822|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899823|NCT03747978|Amlodipine|amlodipine|mesh-list
82899824|NCT03747978|Perindopril|perindopril|mesh-list
82899825|NCT03747978|Indapamide|indapamide|mesh-list
82899826|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
82899827|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82899828|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82899829|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899830|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899831|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82899832|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899833|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
82899834|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82899835|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
82899836|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899837|NCT03747978|Diuretics|diuretics|mesh-ancestor
82899838|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
82899839|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82899840|NCT04603846|Paclitaxel|paclitaxel|mesh-list
82899841|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82899842|NCT04603846|Antibodies|antibodies|mesh-list
82899843|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82899844|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899845|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
82899846|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
82899847|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
82899848|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899849|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
82899850|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899851|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
82899852|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82899853|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82899854|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82899855|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82899856|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899857|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
82899858|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899859|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899860|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82899861|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899862|NCT04578106|Trastuzumab|trastuzumab|mesh-list
82899863|NCT04578106|Pertuzumab|pertuzumab|mesh-list
82899864|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899865|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899866|NCT04472182|Calcium|calcium|mesh-list
82899867|NCT04472182|Fluorides|fluorides|mesh-list
82899868|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
82899869|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82899870|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899871|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
82899872|NCT04472182|Protective Agents|protective agents|mesh-ancestor
82899873|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
82899874|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899875|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899876|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82899878|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899879|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899880|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899881|NCT05759416|Melatonin|melatonin|mesh-list
82899882|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
82899883|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899884|NCT05759416|Protective Agents|protective agents|mesh-ancestor
82899885|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899886|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899887|NCT03746340|Propofol|propofol|mesh-list
82899888|NCT03746340|Sevoflurane|sevoflurane|mesh-list
82899889|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82899890|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899891|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899892|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82899893|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
82899894|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
82899895|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82899896|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82899897|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
82899898|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
82899899|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82899900|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899901|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899902|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
82899903|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82899904|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899905|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899906|NCT04161144|Sirolimus|sirolimus|mesh-list
82899907|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82899908|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899909|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82899910|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83455822|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
82899911|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
82899912|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899913|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
82899914|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899915|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82899916|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899917|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899918|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
82899919|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899920|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899921|NCT04764630|Naloxone|naloxone|mesh-list
82899922|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82899923|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899924|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
82899925|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899926|NCT04153188|Phenylephrine|phenylephrine|mesh-list
82899927|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
82899928|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82899929|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82899930|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
82899931|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82899932|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899933|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899934|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
82899935|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
82899936|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899937|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
82899938|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82899939|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
82899940|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82899941|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
82899942|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82899943|NCT04153188|Protective Agents|protective agents|mesh-ancestor
82899944|NCT03611010|Atorvastatin|atorvastatin|mesh-list
82899945|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82899946|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82899947|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
82899948|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899949|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82899950|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82899951|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899952|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
82899954|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82899955|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82899956|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
82899957|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899958|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82899959|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82899960|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
82899961|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899962|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899963|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82899964|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82899965|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82899966|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82899967|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899968|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
82899970|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
82899971|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899972|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
82899973|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899974|NCT04357782|Protective Agents|protective agents|mesh-ancestor
82899975|NCT03980522|Rilonacept|rilonacept|mesh-list
82899976|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82899977|NCT04400682|Favipiravir|favipiravir|mesh-list
82899978|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
82899979|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82899980|NCT03066778|Carboplatin|carboplatin|mesh-list
82899981|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
82899982|NCT03066778|Etoposide|etoposide|mesh-list
82899983|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82899984|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82899985|NCT03066778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82899986|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82899987|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82899988|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82899989|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82899990|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82899991|NCT04136548|Fentanyl|fentanyl|mesh-list
82899992|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82899993|NCT04136548|Narcotics|narcotics|mesh-ancestor
82899994|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82899995|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82899996|NCT04136548|Analgesics|analgesics|mesh-ancestor
82899997|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
82899998|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82899999|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82900000|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82900001|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
82900002|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
82900003|NCT04347954|Iodine|iodine|mesh-list
82900004|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
82900005|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
82900006|NCT04347954|Povidone|povidone|mesh-list
82900007|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82900008|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900009|NCT04347954|Trace Elements|trace elements|mesh-ancestor
82900010|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
82900011|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900012|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
82900013|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
82900014|NCT01565200|Trastuzumab|trastuzumab|mesh-list
82900015|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82900016|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900017|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900018|NCT01565200|Immunotoxins|immunotoxins|mesh-ancestor
82900019|NCT01565200|Immunoconjugates|immunoconjugates|mesh-ancestor
82900020|NCT01565200|Immunologic Factors|immunologic factors|mesh-ancestor
82900021|NCT01565200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900022|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
82900023|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
82900024|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
82900025|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900026|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
82900029|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900030|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900031|NCT03065530|Analgesics|analgesics|mesh-ancestor
82900032|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
82900033|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900034|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82900035|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82900036|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82900037|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
82900038|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900039|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900040|NCT03979820|Phenelzine|phenelzine|mesh-list
82900041|NCT03979820|Tyramine|tyramine|mesh-list
82900042|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
82900043|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82900044|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82900045|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900046|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900047|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
82900048|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
82900049|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900050|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900051|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82900052|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82900053|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82900054|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
82900055|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900056|NCT03647488|Docetaxel|docetaxel|mesh-list
82900057|NCT03647488|Spartalizumab|spartalizumab|mesh-list
82900058|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900059|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
82900060|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
82900061|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
82900062|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900063|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82900064|NCT03647488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900065|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
82900066|NCT03693950|Hematinics|hematinics|mesh-ancestor
82900067|NCT03579160|Timolol|timolol|mesh-list
82900068|NCT03579160|Petrolatum|petrolatum|mesh-list
82900069|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82900070|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82900071|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
82900072|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900073|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900074|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900075|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82900076|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82900077|NCT03579160|Emollients|emollients|mesh-ancestor
82900078|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
82900079|NCT04109456|Atezolizumab|atezolizumab|mesh-list
82900080|NCT04109456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82900081|NCT04109456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900082|NCT04109456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900083|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900084|NCT04109222|Vaccines|vaccines|mesh-list
82900085|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
82900086|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900087|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
82900088|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82900089|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82900090|NCT03745664|Prednisolone|prednisolone|mesh-list
82900091|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
82900092|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82900093|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
82900094|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900095|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
82900096|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
82900097|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900098|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900099|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900100|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
82900102|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900103|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82900104|NCT03745664|Protective Agents|protective agents|mesh-ancestor
82900105|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82900106|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900107|NCT03447262|Ivacaftor|ivacaftor|mesh-list
82900109|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82900110|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82900111|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900112|NCT04094870|Sertraline|sertraline|mesh-list
82900113|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
82900114|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82900115|NCT04094870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82900116|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82900117|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82900118|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900119|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900120|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
82900121|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900122|NCT04399356|Niclosamide|niclosamide|mesh-list
82900123|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
82900124|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82900125|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
82900126|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82900127|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900128|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
82900129|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
82900130|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82900131|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
82900132|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900133|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900134|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82900135|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
82900136|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
82900137|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82900138|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
82900139|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900140|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900141|NCT04118166|Nivolumab|nivolumab|mesh-list
82900142|NCT04118166|Ipilimumab|ipilimumab|mesh-list
82900143|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900144|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900145|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82900146|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900147|NCT04346628|Favipiravir|favipiravir|mesh-list
82900148|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
82900149|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900150|NCT03681470|Dapsone|dapsone|mesh-list
82900151|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900152|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
82900153|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82900154|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82900155|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82900156|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900157|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900158|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
82900159|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82900160|NCT02414750|Vemurafenib|vemurafenib|mesh-list
82900161|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900162|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82900163|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900164|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900165|NCT04343976|Interferons|interferons|mesh-list
82900166|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900167|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
82900168|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900169|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
82900170|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900171|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900172|NCT03322540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82900173|NCT03322540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900175|NCT02909452|Entinostat|entinostat|mesh-list
82900176|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900177|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900178|NCT02909452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82900179|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900180|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82900181|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900182|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82900183|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
82900184|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900185|NCT01935466|Pioglitazone|pioglitazone|mesh-list
82900186|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82900187|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900188|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
82900189|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
82900190|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82900191|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82900192|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900193|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900194|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900195|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900196|NCT04399122|Acetaminophen|acetaminophen|mesh-list
82900197|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82900198|NCT04399122|Oxycodone|oxycodone|mesh-list
82900199|NCT04399122|Codeine|codeine|mesh-list
82900200|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900201|NCT04399122|Analgesics|analgesics|mesh-ancestor
82900202|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
82900203|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900204|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900205|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
82900206|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82900207|NCT04399122|Narcotics|narcotics|mesh-ancestor
82900208|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900209|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
82900210|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
82900211|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82900212|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900213|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900214|NCT00826462|Triamcinolone|triamcinolone|mesh-list
82900215|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82900216|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82900217|NCT00826462|Naproxen|naproxen|mesh-list
82900218|NCT00826462|Lidocaine|lidocaine|mesh-list
82900219|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82900220|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
82900221|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
82900222|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900223|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900224|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
82900225|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900226|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82900227|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82900228|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82900229|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82900230|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900231|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900232|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
82900233|NCT00826462|Hormones|hormones|mesh-ancestor
82900234|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900235|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82900236|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
82900237|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900238|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82900239|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900240|NCT00826462|Analgesics|analgesics|mesh-ancestor
82900241|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900242|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
82900243|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82900244|NCT04398732|Etanercept|etanercept|mesh-list
82900245|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82900246|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900247|NCT04398732|Analgesics|analgesics|mesh-ancestor
82900248|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
82900249|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900250|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900253|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900254|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82900255|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
82900256|NCT04322682|Colchicine|colchicine|mesh-list
82900257|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
82900258|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900259|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
82900260|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
82900261|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
82900262|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900263|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900264|NCT04322526|Naltrexone|naltrexone|mesh-list
82900265|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82900266|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82900267|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900268|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
82900269|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900270|NCT05743036|Cetuximab|cetuximab|mesh-list
82900271|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900272|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900273|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
82900274|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82900275|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
82900276|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900277|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
82900278|NCT04115358|Protective Agents|protective agents|mesh-ancestor
82900279|NCT05668884|Gemcitabine|gemcitabine|mesh-list
82900280|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
82900281|NCT05668884|Tislelizumab|tislelizumab|mesh-list
82900282|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82900283|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
82900284|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900285|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900286|NCT05668884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900287|NCT05187208|Niraparib|niraparib|mesh-list
82900288|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82900289|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900290|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900291|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900292|NCT05081206|Propofol|propofol|mesh-list
82900293|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82900294|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900295|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900296|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82900297|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
82900298|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
82900299|NCT04105998|Oxytocin|oxytocin|mesh-list
82900300|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
82900301|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82900302|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900303|NCT04690192|Gemcitabine|gemcitabine|mesh-list
82900304|NCT04690192|Melphalan|melphalan|mesh-list
82900305|NCT04690192|Busulfan|busulfan|mesh-list
82900306|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82900307|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
82900308|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900309|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900310|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82900311|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
82900312|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82900313|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82900314|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
82900315|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900316|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
82900317|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
82900318|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900319|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
82900320|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900321|NCT04543968|Protective Agents|protective agents|mesh-ancestor
83455869|NCT00633152|Cephalosporins|cephalosporins|mesh-list
82900322|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900323|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82900325|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
82900326|NCT04368910|Artesunate|artesunate|mesh-list
82900327|NCT04368910|Chloroquine|chloroquine|mesh-list
82900328|NCT04368910|Pyronaridine|pyronaridine|mesh-list
82900329|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
82900330|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82900331|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82900332|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900333|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900334|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
82900335|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
82900336|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82900337|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
82900338|NCT04368910|Amebicides|amebicides|mesh-ancestor
82900339|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900340|NCT04249258|Dobutamine|dobutamine|mesh-list
82900341|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82900342|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
82900343|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
82900344|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900345|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900346|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82900347|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82900348|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82900349|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
82900350|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900351|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900352|NCT04249258|Protective Agents|protective agents|mesh-ancestor
82900353|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
82900354|NCT03938584|Vitamins|vitamins|mesh-ancestor
82900355|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
82900356|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900357|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
82900358|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900359|NCT03938584|Protective Agents|protective agents|mesh-ancestor
82900360|NCT03269344|Gabapentin|gabapentin|mesh-list
82900361|NCT03269344|Analgesics|analgesics|mesh-ancestor
82900362|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
82900363|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900364|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900365|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
82900366|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82900367|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82900368|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900369|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82900370|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82900371|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82900372|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900373|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900374|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
82900375|NCT04389840|Heparin|heparin|mesh-list
82900376|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
82900377|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82900378|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82900379|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900380|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
82900381|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900382|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
82900383|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900384|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900385|NCT02933944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82900386|NCT02933944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900387|NCT04307940|Acetaminophen|acetaminophen|mesh-list
82900388|NCT04307940|Naproxen|naproxen|mesh-list
82900389|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82900390|NCT04307940|Hydrocodone|hydrocodone|mesh-list
82900391|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900392|NCT04307940|Analgesics|analgesics|mesh-ancestor
82900393|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
82900394|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900395|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900396|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
82900397|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82900398|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900399|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900400|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
82900401|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82900402|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900403|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900404|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82900405|NCT04307940|Narcotics|narcotics|mesh-ancestor
82900406|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900407|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
82900408|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
82900409|NCT02717416|Hemostatics|hemostatics|mesh-list
82900410|NCT02717416|Coagulants|coagulants|mesh-ancestor
82900412|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
82900413|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82900414|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
82900415|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900416|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900417|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82900418|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
82900419|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900420|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900421|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82900422|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82900423|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900424|NCT02054104|Analgesics|analgesics|mesh-ancestor
82900425|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
82900426|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900427|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900428|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82900429|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82900430|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900431|NCT04331704|Tenofovir|tenofovir|mesh-list
82900432|NCT04331704|Emtricitabine|emtricitabine|mesh-list
82900433|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
82900434|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900435|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82900436|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82900437|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900438|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900439|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82900440|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82900441|NCT04229290|Dolutegravir|dolutegravir|mesh-list
82900442|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82900443|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82900444|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900445|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900446|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82900447|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82900448|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
82900449|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900450|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
82900451|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82900452|NCT04181476|Protective Agents|protective agents|mesh-ancestor
82900453|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900454|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
82900455|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83455885|NCT03304054|Amifampridine|amifampridine|mesh-list
82900456|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82900457|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900458|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900459|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82900460|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82900461|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900462|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
82900463|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900464|NCT03854110|Gemcitabine|gemcitabine|mesh-list
82900465|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82900466|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
82900467|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900468|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900469|NCT04292730|Remdesivir|remdesivir|mesh-list
82900470|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
82900471|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900472|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
82900473|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900508|NCT02728648|Narcotics|narcotics|mesh-ancestor
82900509|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900510|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900511|NCT02728648|Analgesics|analgesics|mesh-ancestor
82900512|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
82900513|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900514|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82900515|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
82900516|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
82900517|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900518|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900519|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
82900520|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900521|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82900522|NCT01971970|Adalimumab|adalimumab|mesh-list
82900523|NCT01971970|Infliximab|infliximab|mesh-list
82900524|NCT01971970|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82900525|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900526|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900527|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
82900528|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900529|NCT01161394|Pioglitazone|pioglitazone|mesh-list
82900530|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82900531|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900532|NCT04079790|Gepotidacin|gepotidacin|mesh-list
82900533|NCT04079790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82900534|NCT04079790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900535|NCT04079790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900536|NCT04079790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900537|NCT03749226|Aztreonam|aztreonam|mesh-list
82900538|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82900539|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900540|NCT04259346|Ixekizumab|ixekizumab|mesh-list
82900541|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
82900542|NCT03748836|ALPN-101|alpn-101|mesh-list
82900543|NCT03748836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82900544|NCT03748836|Immunologic Factors|immunologic factors|mesh-ancestor
82900545|NCT03748836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900546|NCT03745404|Lidocaine|lidocaine|mesh-list
82900547|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
82900548|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
82900549|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900550|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900551|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
82900552|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900553|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82900554|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82900555|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82900556|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82900557|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900558|NCT01348100|Iloperidone|iloperidone|mesh-list
82900559|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82900560|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82900561|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900562|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900563|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82900564|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
82900565|NCT03673670|Olodaterol|olodaterol|mesh-list
82900566|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82900567|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
82900568|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900569|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900570|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82900571|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
82900572|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
82900573|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82900574|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
82900575|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900576|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900577|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
82900578|NCT04369742|Calcium|calcium|mesh-list
82900579|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82900580|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900581|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900582|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
82900583|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82900584|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82900585|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900586|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900587|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900588|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
82900589|NCT03745586|Hormones|hormones|mesh-ancestor
82900590|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900591|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900592|NCT03055936|Levodopa|levodopa|mesh-list
82900593|NCT03055936|Carbidopa|carbidopa|mesh-list
82900594|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82900595|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82900596|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
82900597|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900598|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900599|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900600|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82900601|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900602|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
82900603|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
82900604|NCT05215366|Coagulants|coagulants|mesh-ancestor
82900605|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82900606|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82900607|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
82900608|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900609|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82900610|NCT03891524|Enoxaparin|enoxaparin|mesh-list
82900611|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
82900612|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82900613|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82900614|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900615|NCT04695652|Somatomedin B|somatomedin b|mesh-list
82900616|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82900617|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82900618|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
82900619|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900620|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900621|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
82900622|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82900624|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900625|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
82900626|NCT04489108|Coagulants|coagulants|mesh-ancestor
82900627|NCT03771586|Ketamine|ketamine|mesh-list
82900628|NCT03771586|Analgesics|analgesics|mesh-ancestor
82900629|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
82900630|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900631|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900632|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82900633|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82900634|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
82900635|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
82900636|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900637|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82900638|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82900639|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900640|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900641|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
82900642|NCT02335060|Dronabinol|dronabinol|mesh-list
82900643|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82900644|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
82900645|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900646|NCT02335060|Expectorants|expectorants|mesh-ancestor
82900647|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
82900648|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82900649|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
82900650|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900651|NCT02335060|Protective Agents|protective agents|mesh-ancestor
82900652|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900653|NCT02335060|Antidotes|antidotes|mesh-ancestor
82900654|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
82900655|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82900656|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900657|NCT02335060|Analgesics|analgesics|mesh-ancestor
82900658|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
82900659|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900660|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82900661|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82900662|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900663|NCT02335060|Hormones|hormones|mesh-ancestor
82900664|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900665|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
82900666|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900667|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
82900668|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900669|NCT04075604|Nivolumab|nivolumab|mesh-list
82900670|NCT04075604|Palbociclib|palbociclib|mesh-list
82900671|NCT04075604|Anastrozole|anastrozole|mesh-list
82900672|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900673|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900674|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82900675|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900676|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82900677|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900678|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82900679|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82900680|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82900681|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82900682|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
82900683|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900684|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900685|NCT01765400|Clopidogrel|clopidogrel|mesh-list
82900686|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82900687|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82900688|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82900689|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82900690|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82900691|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
82900692|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900693|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900694|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900695|NCT05217238|Remifentanil|remifentanil|mesh-list
82900696|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82900697|NCT05217238|Narcotics|narcotics|mesh-ancestor
82900698|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900699|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900700|NCT05217238|Analgesics|analgesics|mesh-ancestor
82900701|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
82900702|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900703|NCT05217160|Morphine|morphine|mesh-list
82900704|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82900705|NCT05217160|Narcotics|narcotics|mesh-ancestor
82900706|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900707|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900708|NCT05217160|Analgesics|analgesics|mesh-ancestor
82900709|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
82900710|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900711|NCT01495676|Cisplatin|cisplatin|mesh-list
82900712|NCT01495676|Gemcitabine|gemcitabine|mesh-list
82900713|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900714|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82900715|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
82900716|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900717|NCT05662228|Lorazepam|lorazepam|mesh-list
82900718|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
82900719|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82900720|NCT05662228|Antibodies|antibodies|mesh-list
82900721|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
82900722|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82900723|NCT05662228|Tofacitinib|tofacitinib|mesh-list
82900724|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
82900725|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900726|NCT05662228|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82900727|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82900728|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900729|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900730|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
82900731|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
82900732|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
82900733|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900734|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900735|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82900736|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900737|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82900738|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82900739|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82900740|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
82900741|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
82900742|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900743|NCT05052970|Dexamethasone|dexamethasone|mesh-list
82900744|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
82900745|NCT05052970|Bortezomib|bortezomib|mesh-list
82900746|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
82900747|NCT05052970|BB 1101|bb 1101|mesh-list
82900748|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900749|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
82900750|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
82900751|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900752|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900753|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900754|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
82900755|NCT05052970|Hormones|hormones|mesh-ancestor
82900756|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900757|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82900758|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900759|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
82900760|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900761|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900762|NCT05052970|Analgesics|analgesics|mesh-ancestor
82900763|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
82900764|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82900765|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82900766|NCT04903210|Niacinamide|niacinamide|mesh-list
82900767|NCT04903210|Niacin|niacin|mesh-list
82900768|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
82900769|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
82900770|NCT04903210|Vitamins|vitamins|mesh-ancestor
82900771|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
82900772|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900773|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82900774|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
82900775|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900776|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82900777|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
82900778|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
82900779|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82900780|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82900781|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
82900782|NCT04719208|Listerine|listerine|mesh-list
82900783|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82900784|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82900785|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900786|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
82900787|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
82900788|NCT04701190|Norepinephrine|norepinephrine|mesh-list
82900789|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900790|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82900791|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82900792|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
82900793|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82900794|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900795|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
82900796|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
82900797|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900798|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82900799|NCT04496362|Heparin|heparin|mesh-list
82900800|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
82900801|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82900802|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82900803|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900804|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
82900805|NCT04423588|Lansoprazole|lansoprazole|mesh-list
82900806|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82900807|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900808|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82900809|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900810|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900811|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
82900812|NCT04090684|Celecoxib|celecoxib|mesh-list
82900813|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82900814|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900815|NCT04090684|Analgesics|analgesics|mesh-ancestor
82900816|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
82900817|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900818|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900819|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900820|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900821|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82900822|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82900823|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900824|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900825|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82900826|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900827|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82900828|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82900829|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900830|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82900831|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82900833|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
82900834|NCT04963816|Bupivacaine|bupivacaine|mesh-list
82900835|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82900836|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82900837|NCT04963816|BB 1101|bb 1101|mesh-list
82900838|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900839|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
82900840|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
82900841|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900842|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900843|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900844|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
82900845|NCT04963816|Hormones|hormones|mesh-ancestor
82900846|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900847|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82900848|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900849|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
82900850|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900851|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900853|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
82900854|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900855|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
82900856|NCT04933240|Tamoxifen|tamoxifen|mesh-list
82900857|NCT04933240|Estradiol|estradiol|mesh-list
82900858|NCT04933240|Estrogens|estrogens|mesh-ancestor
82900859|NCT04933240|Hormones|hormones|mesh-ancestor
82900860|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900861|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900862|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82900863|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
82900864|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82900865|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900866|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82900867|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82900868|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82900869|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
82900870|NCT01317940|Vitamin D|vitamin d|mesh-list
82900871|NCT01317940|Calcitriol|calcitriol|mesh-list
82900872|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
82900873|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
82900874|NCT01317940|Calcium|calcium|mesh-list
82900875|NCT01317940|Vitamins|vitamins|mesh-ancestor
82900876|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
82900877|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900878|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82900879|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82900880|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900881|NCT01317940|Antacids|antacids|mesh-ancestor
82900882|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900883|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82900884|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82900885|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82900886|NCT05706688|Anesthetics|anesthetics|mesh-list
82900887|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900888|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900889|NCT05706454|Ramatroban|ramatroban|mesh-list
82900890|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82900891|NCT01317550|Minocycline|minocycline|mesh-list
82900892|NCT01317550|Modafinil|modafinil|mesh-list
82900893|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82900894|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900895|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83455933|NCT03105518|Acetaminophen|acetaminophen|mesh-list
82900896|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900897|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82900898|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82900899|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82900900|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900901|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
82900902|NCT01317472|Lansoprazole|lansoprazole|mesh-list
82900903|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82900904|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900905|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82900906|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900907|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900908|NCT01345630|Ritonavir|ritonavir|mesh-list
82900909|NCT01345630|Darunavir|darunavir|mesh-list
82900910|NCT01345630|Tenofovir|tenofovir|mesh-list
82900911|NCT01345630|Emtricitabine|emtricitabine|mesh-list
82900912|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82900913|NCT01345630|Maraviroc|maraviroc|mesh-list
82900914|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82900915|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82900916|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
82900917|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900918|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900919|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82900920|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82900921|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
82900922|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900923|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82900924|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82900926|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82900927|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82900928|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82900929|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82900930|NCT03693612|Paclitaxel|paclitaxel|mesh-list
82900931|NCT03693612|Docetaxel|docetaxel|mesh-list
82900932|NCT03693612|Cetuximab|cetuximab|mesh-list
82900933|NCT03693612|Tremelimumab|tremelimumab|mesh-list
82900934|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82900935|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900936|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
82900937|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
82900938|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
82900939|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900940|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82900941|NCT03746652|Dexamethasone|dexamethasone|mesh-list
82900942|NCT03746652|Daratumumab|daratumumab|mesh-list
82900943|NCT03746652|Ixazomib|ixazomib|mesh-list
82900944|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900945|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
82900946|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
82900947|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900948|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900949|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82900950|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
82900951|NCT03746652|Hormones|hormones|mesh-ancestor
82900952|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82900953|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82900954|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82900955|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
82900956|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900957|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900958|NCT01562808|Aripiprazole|aripiprazole|mesh-list
82900959|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
82900960|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82900961|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82900962|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82900963|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82900964|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900965|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
82900966|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
82900967|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133549|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82900968|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900969|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82900970|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82900971|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
82900972|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82900973|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82900974|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82900975|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82900976|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
82900977|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82900978|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
82900979|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900980|NCT04067492|Diclofenac|diclofenac|mesh-list
82900981|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82900982|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82900983|NCT04067492|Analgesics|analgesics|mesh-ancestor
82900984|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
82900985|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82900986|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82900987|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82900988|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82900989|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82900990|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82900991|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82900992|NCT04186806|Muramidase|muramidase|mesh-list
82900993|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82900994|NCT03748446|Xenon|xenon|mesh-list
82900995|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82900996|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
82900997|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
82900998|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901000|NCT04036110|Vitamins|vitamins|mesh-list
82901001|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
82901002|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
82901003|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901004|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
82901005|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901006|NCT04036110|Protective Agents|protective agents|mesh-ancestor
82901007|NCT03053050|Selonsertib|selonsertib|mesh-list
82901008|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901009|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901010|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901011|NCT04369950|Lidocaine|lidocaine|mesh-list
82901012|NCT04369950|Epinephrine|epinephrine|mesh-list
82901013|NCT04369950|Morphine|morphine|mesh-list
82901014|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
82901015|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
82901016|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
82901017|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901018|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901019|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
82901020|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901021|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82901022|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82901023|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82901024|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901025|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901026|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82901027|NCT04369950|Narcotics|narcotics|mesh-ancestor
82901028|NCT04369950|Analgesics|analgesics|mesh-ancestor
82901029|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82901030|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82901031|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
82901032|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901033|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82901034|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82901035|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
82901036|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82901037|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
82901038|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
82901039|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
82901040|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82901041|NCT02955602|Seladelpar|seladelpar|mesh-list
82901042|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82901043|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
82901044|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901045|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82901046|NCT03748290|Pregabalin|pregabalin|mesh-list
82901047|NCT03748290|Analgesics|analgesics|mesh-ancestor
82901048|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
82901049|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901050|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901051|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
82901052|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82901053|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901054|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901055|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901056|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82901057|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82901058|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901059|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82901060|NCT05651074|Omeprazole|omeprazole|mesh-list
82901061|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82901062|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82901063|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82901064|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901065|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901066|NCT03738956|Tofacitinib|tofacitinib|mesh-list
82901067|NCT03738956|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82901068|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901069|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901070|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901071|NCT03738800|Trifarotene|trifarotene|mesh-list
82901072|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
82901073|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
82901075|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901076|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901077|NCT05609656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82901078|NCT05609656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901079|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901080|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901082|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82901083|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901084|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82901085|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82901086|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901087|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901088|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901089|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
82901090|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
82901091|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82901092|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
82901093|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
82901094|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83455955|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
82901095|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901096|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82901097|NCT05598424|Hormones|hormones|mesh-ancestor
82901098|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901099|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82901100|NCT05598424|Protective Agents|protective agents|mesh-ancestor
82901101|NCT05501860|Carticaine|carticaine|mesh-list
82901102|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
82901103|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
82901104|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901105|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901106|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
82901107|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901108|NCT03738176|Triamcinolone|triamcinolone|mesh-list
82901109|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82901110|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
82901111|NCT03738176|Hormones|hormones|mesh-ancestor
82901112|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901113|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901114|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82901115|NCT03051100|Atorvastatin|atorvastatin|mesh-list
82901116|NCT03051100|Ezetimibe|ezetimibe|mesh-list
82901117|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82901118|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82901119|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
83514074|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
82901120|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901122|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82901123|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901124|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82901125|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901126|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82901127|NCT05280028|Tibolone|tibolone|mesh-list
82901128|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82901129|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82901130|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
82901131|NCT05280028|Estradiol|estradiol|mesh-list
82901132|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82901133|NCT05280028|Estrogens|estrogens|mesh-ancestor
82901134|NCT05280028|Hormones|hormones|mesh-ancestor
82901135|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901136|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901137|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82901138|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
82901139|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82901140|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82901141|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82901142|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82901143|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82901144|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82901145|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901146|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901147|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
82901148|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901149|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82901150|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82901151|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
82901152|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82901153|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901154|NCT01343368|Leuprolide|leuprolide|mesh-list
82901155|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82901156|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
82901157|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82901158|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901159|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901160|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901161|NCT02955212|Upadacitinib|upadacitinib|mesh-list
82901162|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82901163|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901164|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901165|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901166|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82901167|NCT03050398|Letrozole|letrozole|mesh-list
82901168|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901169|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82901170|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82901171|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901172|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901173|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82901174|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901175|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901176|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901177|NCT03626506|Amlodipine|amlodipine|mesh-list
82901178|NCT03626506|Indapamide|indapamide|mesh-list
82901179|NCT03626506|Spironolactone|spironolactone|mesh-list
82901180|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82901181|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82901182|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901183|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901184|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901185|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901186|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
82901187|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82901188|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901189|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901190|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82901191|NCT03626506|Diuretics|diuretics|mesh-ancestor
82901192|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
82901193|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82901194|NCT03737708|Adalimumab|adalimumab|mesh-list
82901195|NCT03737708|Methotrexate|methotrexate|mesh-list
82901196|NCT03737708|Abatacept|abatacept|mesh-list
82901197|NCT03737708|Tacrolimus|tacrolimus|mesh-list
82901198|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82901199|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
82901200|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82901201|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901202|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82901203|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
82901204|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901205|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901206|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
82901207|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901208|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82901209|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901210|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
82901211|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82901212|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82901213|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82901214|NCT03737708|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82901215|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82901216|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82901217|NCT03737708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901218|NCT05517928|Omeprazole|omeprazole|mesh-list
82901219|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82901221|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82901222|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901223|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901224|NCT04052204|Avelumab|avelumab|mesh-list
82901225|NCT04052204|Talazoparib|talazoparib|mesh-list
82901226|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901227|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901228|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82901229|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901230|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901231|NCT04050722|Listerine|listerine|mesh-list
82901232|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
82901233|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
82901234|NCT04050722|Protective Agents|protective agents|mesh-ancestor
82901235|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901236|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82901237|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901238|NCT04049552|Sirolimus|sirolimus|mesh-list
82901239|NCT04049552|Temsirolimus|temsirolimus|mesh-list
82901240|NCT04049552|MTOR Inhibitors|mtor inhibitors|mesh-list
82901241|NCT04049552|Petrolatum|petrolatum|mesh-list
82901242|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82901243|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901244|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82901245|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901246|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
82901247|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901248|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
82901249|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901250|NCT04049552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901251|NCT04049552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901252|NCT04049552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901253|NCT04049552|Emollients|emollients|mesh-ancestor
82901254|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
82901255|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
82901256|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
82901257|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901258|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901259|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901260|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
82901261|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
82901262|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82901263|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82901264|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82901265|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82901266|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82901267|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
82901268|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901269|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901270|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901271|NCT03047980|Sirolimus|sirolimus|mesh-list
82901272|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82901273|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901274|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82901275|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901276|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
82901277|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901278|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
82901279|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901280|NCT04022980|Nivolumab|nivolumab|mesh-list
82901281|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901282|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901283|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82901284|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901285|NCT03876028|Tisagenlecleucel|tisagenlecleucel|mesh-list
82901286|NCT03876028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901287|NCT03876028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901288|NCT03732482|Temozolomide|temozolomide|mesh-list
82901289|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82901290|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
82901291|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901292|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901293|NCT04047446|Dexamethasone|dexamethasone|mesh-list
82901294|NCT04047446|Bupivacaine|bupivacaine|mesh-list
82901295|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82901296|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
82901297|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
82901298|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901299|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901300|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82901301|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
82901302|NCT04047446|Hormones|hormones|mesh-ancestor
82901303|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901304|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901305|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901306|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
82901307|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
82901308|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901309|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
82901310|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
82901311|NCT02782546|Tacrolimus|tacrolimus|mesh-list
82901312|NCT02782546|Lenograstim|lenograstim|mesh-list
82901313|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901314|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
82901315|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901316|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82901317|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901318|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901319|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82901320|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901321|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82901322|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
82901323|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82901324|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901325|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82901326|NCT03629054|Metformin|metformin|mesh-list
82901327|NCT03629054|Empagliflozin|empagliflozin|mesh-list
82901328|NCT03629054|Linagliptin|linagliptin|mesh-list
82901329|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82901330|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901331|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82901332|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901333|NCT03629054|Incretins|incretins|mesh-ancestor
82901334|NCT03629054|Hormones|hormones|mesh-ancestor
82901335|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901336|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82901337|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
82901338|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901339|NCT02754856|Durvalumab|durvalumab|mesh-list
82901340|NCT02754856|Ipilimumab|ipilimumab|mesh-list
82901341|NCT02754856|Tremelimumab|tremelimumab|mesh-list
82901342|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
82901343|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82901344|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
82901345|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901346|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901347|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
82901348|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901349|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82901350|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901351|NCT02573896|Lenalidomide|lenalidomide|mesh-list
82901352|NCT02573896|Dinutuximab|dinutuximab|mesh-list
82901353|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
82901354|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901355|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82901356|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82901357|NCT02573896|Growth Substances|growth substances|mesh-ancestor
82901358|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
82901359|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901360|NCT03045328|Venetoclax|venetoclax|mesh-list
82901361|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901362|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82901363|NCT02154490|Nivolumab|nivolumab|mesh-list
82901364|NCT02154490|Ipilimumab|ipilimumab|mesh-list
82901365|NCT02154490|Durvalumab|durvalumab|mesh-list
82901366|NCT02154490|Rilotumumab|rilotumumab|mesh-list
82901367|NCT02154490|Docetaxel|docetaxel|mesh-list
82901368|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82901369|NCT02154490|Palbociclib|palbociclib|mesh-list
82901370|NCT02154490|Tremelimumab|tremelimumab|mesh-list
82901372|NCT02154490|Antibodies|antibodies|mesh-list
82901373|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
82901374|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82901375|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
82901376|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
82901377|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901378|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901379|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
82901380|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
82901381|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
82901382|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901383|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82901384|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901385|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901386|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82901387|NCT01512316|Cycloserine|cycloserine|mesh-list
82901388|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82901389|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901390|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82901391|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
82901392|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82901393|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
82901394|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901395|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
82901396|NCT01286272|Bortezomib|bortezomib|mesh-list
82901397|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82901398|NCT01286272|Ofatumumab|ofatumumab|mesh-list
82901399|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82901400|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82901401|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901402|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82901403|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
82901404|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901405|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82901406|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
82901407|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
82901408|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901409|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
82901410|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901411|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82901412|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
82901413|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901414|NCT01048138|Biperiden|biperiden|mesh-list
82901415|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
82901416|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82901417|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82901418|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
82901419|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
82901420|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901421|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901422|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82901423|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82901424|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
82901425|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901426|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901427|NCT00972478|Prednisone|prednisone|mesh-list
82901428|NCT00972478|Cortisone|cortisone|mesh-list
82901429|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
82901430|NCT00972478|Rituximab|rituximab|mesh-list
82901431|NCT00972478|Doxorubicin|doxorubicin|mesh-list
82901432|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82901433|NCT00972478|Vincristine|vincristine|mesh-list
82901434|NCT00972478|Vorinostat|vorinostat|mesh-list
82901435|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82901436|NCT00972478|Antibodies|antibodies|mesh-list
82901437|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
82901438|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82901439|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901440|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
82901441|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901442|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82901443|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82901444|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
82901445|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901446|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901447|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82901448|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82901449|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82901450|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82901451|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901452|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82901454|NCT00972478|Hormones|hormones|mesh-ancestor
82901455|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901456|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901457|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82901458|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
82901459|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
82901460|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
82901461|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82901462|NCT00823342|Tenofovir|tenofovir|mesh-list
82901463|NCT00823342|Clevudine|clevudine|mesh-list
82901464|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
82901465|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901466|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82901467|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82901468|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901469|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901470|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82901471|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82901472|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
82901473|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82901474|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
82901475|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901476|NCT01082445|Expectorants|expectorants|mesh-ancestor
82901477|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
82901478|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82901479|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
82901480|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901481|NCT01082445|Protective Agents|protective agents|mesh-ancestor
82901482|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901483|NCT01082445|Antidotes|antidotes|mesh-ancestor
82901484|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82901485|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82901486|NCT01085877|Estradiol|estradiol|mesh-list
82901487|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82901488|NCT01085877|Estrogens|estrogens|mesh-ancestor
82901489|NCT01085877|Hormones|hormones|mesh-ancestor
82901490|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901491|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901492|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82901493|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
82901494|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82901495|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82901496|NCT01089855|Carbamazepine|carbamazepine|mesh-list
82901497|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
82901498|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
82901499|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82901500|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901501|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901502|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82901503|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82901504|NCT01089855|Analgesics|analgesics|mesh-ancestor
82901505|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
82901506|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901507|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82901508|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901509|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901510|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82901511|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82901512|NCT04132960|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82901513|NCT04132960|Immunoconjugates|immunoconjugates|mesh-ancestor
82901514|NCT04132960|Immunologic Factors|immunologic factors|mesh-ancestor
82901515|NCT04132960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901516|NCT03980314|Nivolumab|nivolumab|mesh-list
82901517|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901518|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901519|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82901520|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901521|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
82901522|NCT03674320|Testosterone|testosterone|mesh-list
82901523|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
82901524|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
82901525|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82901526|NCT03674320|Androgens|androgens|mesh-ancestor
82901527|NCT03674320|Hormones|hormones|mesh-ancestor
82901528|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901529|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901530|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901531|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901532|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
82901533|NCT05457946|Vaccines|vaccines|mesh-list
82901534|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
82901535|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901536|NCT03625960|Cantharidin|cantharidin|mesh-list
82901537|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901538|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901539|NCT03042910|Talazoparib|talazoparib|mesh-list
82901540|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82901541|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901542|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901543|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901544|NCT03243838|Apatinib|apatinib|mesh-list
82901545|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901546|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901547|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901548|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901549|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
82901550|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82901551|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901552|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82901553|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82901554|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
82901555|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901556|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
82901557|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901558|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901559|NCT02980666|Teduglutide|teduglutide|mesh-list
82901560|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82901561|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82901562|NCT02980666|Protective Agents|protective agents|mesh-ancestor
82901563|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901564|NCT02962102|Calcitriol|calcitriol|mesh-list
82901565|NCT02962102|Calcifediol|calcifediol|mesh-list
82901566|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901567|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901568|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82901569|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901570|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901571|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82901572|NCT02962102|Vitamins|vitamins|mesh-ancestor
82901573|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
83514229|NCT05745038|Zaleplon|zaleplon|mesh-list
82901574|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82901575|NCT02947750|Folic Acid|folic acid|mesh-list
82901576|NCT02947750|Hematinics|hematinics|mesh-ancestor
82901577|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
82901578|NCT02947750|Vitamins|vitamins|mesh-ancestor
82901579|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
82901580|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901581|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
82901582|NCT02630368|Avelumab|avelumab|mesh-list
82901583|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901584|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
82901585|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901586|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82901587|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82901588|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
82901589|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901590|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901591|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82901592|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901593|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82901594|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901595|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901596|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
82901597|NCT05244460|Promethazine|promethazine|mesh-list
82901598|NCT05244460|Droperidol|droperidol|mesh-list
82901599|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82901600|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82901601|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901602|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901603|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
82901604|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
82901605|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
82901606|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901607|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
82901608|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
82901609|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82901610|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82901611|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
82901612|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
82901613|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901614|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901615|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82901616|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
82901617|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
82901618|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82901619|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82901620|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82901621|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82901622|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82901623|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82901624|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
82901625|NCT00096993|Gemcitabine|gemcitabine|mesh-list
82901626|NCT00096993|Pertuzumab|pertuzumab|mesh-list
82901627|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82901628|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
82901629|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901630|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901631|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901632|NCT05172700|Pirtobrutinib|pirtobrutinib|mesh-list
82901633|NCT05172700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901634|NCT05172700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901635|NCT05172700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901636|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
82901637|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901638|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901639|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901640|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901641|NCT03040024|Ketamine|ketamine|mesh-list
82901642|NCT03040024|Analgesics|analgesics|mesh-ancestor
82901643|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
82901644|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901645|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901646|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82901647|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82901648|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
82901649|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
82901650|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901651|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82901652|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82901653|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901654|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901655|NCT05053126|Pregabalin|pregabalin|mesh-list
82901656|NCT05053126|Oxycodone|oxycodone|mesh-list
82901657|NCT05053126|Analgesics|analgesics|mesh-ancestor
82901658|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
82901659|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901660|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901661|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
82901662|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82901663|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901664|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901665|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901666|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82901667|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82901668|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901669|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82901670|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82901671|NCT05053126|Narcotics|narcotics|mesh-ancestor
82901673|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901674|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901675|NCT03038620|Liraglutide|liraglutide|mesh-list
82901676|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82901677|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901678|NCT03038620|Incretins|incretins|mesh-ancestor
82901679|NCT03038620|Hormones|hormones|mesh-ancestor
82901680|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901681|NCT02032810|Ipilimumab|ipilimumab|mesh-list
82901682|NCT02032810|Panobinostat|panobinostat|mesh-list
82901683|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82901684|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901685|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82901686|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901687|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82901688|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901689|NCT01415674|Afatinib|afatinib|mesh-list
82901690|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901691|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901692|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901693|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901694|NCT01350934|Vitamin D|vitamin d|mesh-list
82901695|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
82901696|NCT01350934|Alendronate|alendronate|mesh-list
82901697|NCT01350934|Calcitriol|calcitriol|mesh-list
82901698|NCT01350934|Calcium|calcium|mesh-list
82901699|NCT01350934|Vitamins|vitamins|mesh-ancestor
82901700|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
82901701|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901702|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901703|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82901704|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82901705|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901706|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901707|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82901708|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82901709|NCT01146418|Hormones|hormones|mesh-ancestor
82901710|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901711|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901712|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
82901713|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82901714|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901715|NCT00745108|Tibolone|tibolone|mesh-list
82901716|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901717|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901718|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901719|NCT00745108|Hormones|hormones|mesh-ancestor
82901720|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901721|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
82901722|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901723|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82901724|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82901725|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
82901726|NCT00725374|Tibolone|tibolone|mesh-list
82901727|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
82901728|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901729|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901730|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901731|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82901732|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901733|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901734|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82901735|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
82901736|NCT00725374|Hormones|hormones|mesh-ancestor
82901737|NCT03622580|Aflibercept|aflibercept|mesh-list
82901738|NCT03622580|Faricimab|faricimab|mesh-list
82901739|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82901740|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82901741|NCT03622580|Growth Substances|growth substances|mesh-ancestor
82901742|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901743|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
82901744|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901745|NCT00461032|Montelukast|montelukast|mesh-list
82901746|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82901748|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82901749|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901750|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901751|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901752|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82901753|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82901754|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901755|NCT00446056|Ketotifen|ketotifen|mesh-list
82901756|NCT00446056|Montelukast|montelukast|mesh-list
82901757|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901758|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901759|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901760|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
82901761|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82901762|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82901763|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901764|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901765|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82901766|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82901767|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
82901768|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
82901769|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82901770|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
82901771|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
82901772|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82901773|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82901774|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901775|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82901776|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901777|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901778|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82901779|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82901780|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82901781|NCT00092092|Budesonide|budesonide|mesh-list
82901782|NCT00092092|Montelukast|montelukast|mesh-list
82901783|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82901784|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82901785|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
82901786|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901787|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901788|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82901789|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
82901790|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
82901791|NCT00092092|Hormones|hormones|mesh-ancestor
82901792|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901793|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82901794|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901795|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82901796|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83514230|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
82901797|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901798|NCT00092014|Vitamin D|vitamin d|mesh-list
82901799|NCT00092014|Alendronate|alendronate|mesh-list
82901800|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
82901801|NCT00092014|Calcium|calcium|mesh-list
82901802|NCT00092014|Vitamins|vitamins|mesh-ancestor
82901803|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
82901804|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901805|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901806|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82901807|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82901808|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901809|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901810|NCT00090142|Montelukast|montelukast|mesh-list
82901811|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82901812|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
82901813|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82901814|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901815|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901816|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901817|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82901818|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82901819|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901821|NCT00043108|Carboplatin|carboplatin|mesh-list
82901822|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82901823|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901824|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
82901825|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
82901826|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
82901827|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901828|NCT04985266|Tamoxifen|tamoxifen|mesh-list
82901829|NCT04985266|Letrozole|letrozole|mesh-list
82901830|NCT04985266|Fulvestrant|fulvestrant|mesh-list
82901831|NCT04985266|Palbociclib|palbociclib|mesh-list
82901832|NCT04985266|Anastrozole|anastrozole|mesh-list
82901833|NCT04985266|Exemestane|exemestane|mesh-list
82901834|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901835|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82901836|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82901837|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901838|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901839|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82901840|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
82901841|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82901842|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901843|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82901844|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82901845|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82901846|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82901847|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82901848|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901849|NCT03619408|Antacids|antacids|mesh-list
82901850|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901851|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82901852|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
82901853|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82901854|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
82901855|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901856|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901857|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
82901858|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901859|NCT03620708|Nicotine|nicotine|mesh-list
82901860|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82901861|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
82901862|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901863|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901864|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82901865|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82901866|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
82901867|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901868|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901869|NCT03654326|Naproxen|naproxen|mesh-list
83514603|NCT04167189|Lidocaine|lidocaine|mesh-list
82901870|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82901871|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82901872|NCT03654326|Analgesics|analgesics|mesh-ancestor
82901873|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
82901874|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901875|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901876|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82901877|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82901878|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
82901879|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82901880|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901881|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901882|NCT03735446|Cytarabine|cytarabine|mesh-list
82901883|NCT03735446|Etoposide|etoposide|mesh-list
82901884|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
82901885|NCT03735446|Prexasertib|prexasertib|mesh-list
82901886|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82901887|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901888|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82901889|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82901890|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901891|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901892|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82901893|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
82901894|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
82901895|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901896|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901897|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
82901898|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901899|NCT03735446|Analgesics|analgesics|mesh-ancestor
82901900|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
82901901|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901902|NCT03735446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901903|NCT03735368|Pregabalin|pregabalin|mesh-list
82901904|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
82901905|NCT03735368|Benoxinate|benoxinate|mesh-list
82901906|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
82901907|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82901908|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901909|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82901910|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82901911|NCT03735368|Analgesics|analgesics|mesh-ancestor
82901912|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
82901913|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82901914|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82901915|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82901916|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82901917|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
82901918|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901919|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901920|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
82901921|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82901922|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82901923|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82901924|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82901925|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82901926|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82901927|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
82901928|NCT00071799|Cytarabine|cytarabine|mesh-list
82901929|NCT00071799|Azacitidine|azacitidine|mesh-list
82901930|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82901931|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
82901932|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901933|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901934|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
82901935|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901936|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82901937|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
82901938|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901939|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901940|NCT03615482|Vaccines|vaccines|mesh-list
82901941|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
82901942|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901943|NCT03652610|Vaccines|vaccines|mesh-list
82901944|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
82901945|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901946|NCT03615404|Molgramostim|molgramostim|mesh-list
82901947|NCT03615404|Sargramostim|sargramostim|mesh-list
82901948|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
82901949|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901950|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901951|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
82901952|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82901953|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
82901954|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901955|NCT03730064|Expectorants|expectorants|mesh-ancestor
82901956|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
82901957|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82901958|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
82901959|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901960|NCT03730064|Protective Agents|protective agents|mesh-ancestor
82901961|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901962|NCT03730064|Antidotes|antidotes|mesh-ancestor
82901963|NCT03580382|Trametinib|trametinib|mesh-list
82901964|NCT03580382|Antibodies|antibodies|mesh-list
82901965|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
82901966|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901967|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901968|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82901969|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901970|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901971|NCT03577730|Caffeine|caffeine|mesh-list
82901972|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
82901973|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901974|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82901975|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82901976|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82901977|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82901978|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82901979|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82901980|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
82901981|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82901982|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
82901983|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82901984|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901985|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
82901986|NCT03735134|Colchicine|colchicine|mesh-list
82901987|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
82901988|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82901989|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
82901990|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
82901991|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
82901992|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82901993|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82901994|NCT03608774|Azithromycin|azithromycin|mesh-list
82901995|NCT03608774|Doxycycline|doxycycline|mesh-list
82901996|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82901997|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82901998|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
82901999|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82902000|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82902001|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
82902002|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82902003|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82902004|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82902005|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902006|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
82902007|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
82902008|NCT03729674|Infliximab|infliximab|mesh-list
82902009|NCT03729674|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82902010|NCT03729674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902011|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
82902012|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902013|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902014|NCT03731468|Dexamethasone|dexamethasone|mesh-list
82902015|NCT03731468|Anesthetics|anesthetics|mesh-list
82902016|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
82902017|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902018|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
82902019|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
82902020|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902021|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902022|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902023|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
82902024|NCT03731468|Hormones|hormones|mesh-ancestor
82902025|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82902026|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82902027|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902028|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902029|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
82902030|NCT03600428|Vaccines|vaccines|mesh-list
82902031|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
82902032|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902033|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82902034|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82902035|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82902036|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
82902037|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902038|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902039|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902040|NCT03575702|Urological Agents|urological agents|mesh-ancestor
82902041|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
82902042|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82902043|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902044|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902045|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902046|NCT03639896|Analgesics|analgesics|mesh-ancestor
82902047|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
82902048|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902049|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82902050|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82902051|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82902052|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
82902053|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902054|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902055|NCT03573908|Linaclotide|linaclotide|mesh-list
82902056|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82902057|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
82902058|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902059|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902060|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82902061|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82902062|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902063|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902064|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902065|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902066|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902067|NCT03729284|Analgesics|analgesics|mesh-ancestor
82902068|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
82902069|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902070|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
82902071|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902072|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
82902073|NCT03729128|Memantine|memantine|mesh-list
82902074|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
82902075|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82902076|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82902077|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
82902078|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902079|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902080|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902081|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82902082|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82902083|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
82902084|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
82902085|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
82902086|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
82902087|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902088|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902089|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902090|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
82902091|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
82902092|NCT03728894|Midazolam|midazolam|mesh-list
82902093|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
82902094|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82902095|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82902096|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902097|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902098|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82902099|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82902100|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902101|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82902102|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
82902103|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
82902104|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
82902105|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
82902106|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902107|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902108|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
82902109|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
82902110|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82902111|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
82902112|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
82902113|NCT03730766|Amoxicillin|amoxicillin|mesh-list
82902114|NCT03730766|Metronidazole|metronidazole|mesh-list
82902115|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
82902116|NCT03730766|Esomeprazole|esomeprazole|mesh-list
82902117|NCT03730766|Bismuth|bismuth|mesh-list
82902118|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902119|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82902120|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902121|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82902122|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82902123|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82902124|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902125|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82902126|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902127|NCT03730766|Antacids|antacids|mesh-ancestor
82902128|NCT03730766|Diuretics|diuretics|mesh-ancestor
82902129|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
82902130|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902131|NCT03730766|Expectorants|expectorants|mesh-ancestor
82902132|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
82902133|NCT00071487|Belimumab|belimumab|mesh-list
82902134|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82902135|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
82902136|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902137|NCT03962283|Rifaximin|rifaximin|mesh-list
82902138|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82902139|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902140|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902141|NCT03591146|Ropivacaine|ropivacaine|mesh-list
82902142|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
82902143|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
82902144|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902145|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902146|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
82902147|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902148|NCT00096447|Lapatinib|lapatinib|mesh-list
82902149|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902150|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82902151|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902152|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902153|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82902154|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82902155|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902156|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902157|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902158|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902159|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902160|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82902161|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
82902162|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902163|NCT00070941|Escitalopram|escitalopram|mesh-list
82902164|NCT00070941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82902165|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902166|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902167|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902168|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902169|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
82902170|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902171|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
82902172|NCT00070707|Albuterol|albuterol|mesh-list
82902173|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82902174|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
82902175|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902176|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902177|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82902178|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
82902179|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
82902180|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902181|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82902182|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82902183|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82902184|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
82902185|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902186|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902187|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902188|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
82902189|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82902190|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
82902191|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83083945|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902193|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82902194|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902195|NCT00070317|Methylene Blue|methylene blue|mesh-list
82902196|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
82902197|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902198|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902199|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82902200|NCT01086345|Bevacizumab|bevacizumab|mesh-list
82902201|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82902202|NCT01086345|Irinotecan|irinotecan|mesh-list
82902203|NCT01086345|Camptothecin|camptothecin|mesh-list
82902204|NCT01086345|Antibodies|antibodies|mesh-list
82902205|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
82902206|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82902207|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902208|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82902209|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82902210|NCT01086345|Growth Substances|growth substances|mesh-ancestor
82902211|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902212|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
82902213|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
82902214|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82902215|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82902216|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902217|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902218|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82902219|NCT01089933|Anesthetics|anesthetics|mesh-list
82902220|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
82902221|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902222|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902223|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
82902224|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902225|NCT03960411|Doxycycline|doxycycline|mesh-list
82902226|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82902227|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902228|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
82902229|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83456114|NCT01926158|Denosumab|denosumab|mesh-list
82902230|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82902231|NCT01090167|Clofarabine|clofarabine|mesh-list
82902232|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82902233|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
82902234|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902235|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902236|NCT03587636|Bupivacaine|bupivacaine|mesh-list
82902237|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
82902238|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
82902239|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902240|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902241|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
82902242|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902243|NCT03053362|Vortioxetine|vortioxetine|mesh-list
82902244|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
82902245|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902246|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82902247|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82902248|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902249|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902250|NCT03053362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82902251|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902252|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902253|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902254|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902255|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
82902256|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82902257|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82902258|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82902259|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82902260|NCT03733652|Interferons|interferons|mesh-list
82902261|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
82902262|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
82902263|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902264|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
82902265|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902266|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
82902267|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902268|NCT03572582|Nivolumab|nivolumab|mesh-list
82902269|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82902270|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902271|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82902272|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902273|NCT03586544|Albuterol|albuterol|mesh-list
82902274|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82902275|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
82902276|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902277|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902278|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82902279|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
82902280|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
82902281|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902282|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82902283|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82902284|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82902285|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
82902286|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902287|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902288|NCT03737448|Trimetazidine|trimetazidine|mesh-list
82902289|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
82902290|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82902291|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82902292|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902293|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902294|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902295|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902296|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902297|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
82902298|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902299|NCT03728192|Camptothecin|camptothecin|mesh-list
82902300|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82902301|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902302|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82902303|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82902304|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902305|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902306|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82902307|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82902308|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
82902309|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902310|NCT03589768|Antacids|antacids|mesh-ancestor
82902311|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902312|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902313|NCT03733340|Imipenem|imipenem|mesh-list
82902314|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82902315|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902316|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
82902317|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82902318|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902319|NCT05137600|Clarithromycin|clarithromycin|mesh-list
82902320|NCT05137600|Midazolam|midazolam|mesh-list
82902321|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82902322|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82902323|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902324|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902325|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82902326|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82902327|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902328|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82902329|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
82902330|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
82902331|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
82902332|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
82902333|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902334|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902335|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82902336|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902337|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82902338|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902339|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82902340|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82902341|NCT02906332|Dexamethasone|dexamethasone|mesh-list
82902342|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
82902343|NCT02906332|Lenalidomide|lenalidomide|mesh-list
82902344|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902345|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
82902346|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
82902347|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902348|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902349|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902350|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
82902351|NCT02906332|Hormones|hormones|mesh-ancestor
82902352|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82902353|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82902354|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902355|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82902356|NCT02906332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82902357|NCT02906332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902358|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
82902359|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82902360|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82902361|NCT02906332|Growth Substances|growth substances|mesh-ancestor
82902362|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
82902363|NCT00089505|Ritonavir|ritonavir|mesh-list
82902364|NCT00089505|Lopinavir|lopinavir|mesh-list
82902365|NCT00089505|Tenofovir|tenofovir|mesh-list
82902366|NCT00089505|Emtricitabine|emtricitabine|mesh-list
82902367|NCT00089505|Nevirapine|nevirapine|mesh-list
82902368|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82902369|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82902370|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82902371|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
82902372|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902373|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902374|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82902375|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82902376|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
82902377|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902378|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82902379|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82902380|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82902381|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82902382|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82902383|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82902384|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82902385|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82902386|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82902387|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
82902388|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902389|NCT04009824|Antacids|antacids|mesh-ancestor
82902390|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902391|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902392|NCT05041426|Valganciclovir|valganciclovir|mesh-list
82902393|NCT05041426|Letermovir|letermovir|mesh-list
82902394|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
82902395|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902396|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82902397|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902398|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902399|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902400|NCT04987372|Lidocaine|lidocaine|mesh-list
82902401|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
82902402|NCT04987372|Pregabalin|pregabalin|mesh-list
82902403|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
82902404|NCT04987372|Ketamine|ketamine|mesh-list
82902405|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
82902406|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
82902407|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902408|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902409|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
82902410|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902411|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82902412|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82902413|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82902414|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902415|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902417|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902418|NCT04987372|Analgesics|analgesics|mesh-ancestor
82902419|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82902420|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82902421|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82902422|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
82902423|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902424|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82902425|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82902426|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
82902427|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82902428|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82902429|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
82902430|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82902431|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82902432|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82902433|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82902434|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902435|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
82902436|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902437|NCT03555890|Cetirizine|cetirizine|mesh-list
82902438|NCT03555890|Levocetirizine|levocetirizine|mesh-list
82902439|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82902440|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82902441|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
82902442|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
82902443|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902444|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902445|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902446|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82902447|NCT04905862|Antipyretics|antipyretics|mesh-list
82902448|NCT04905862|Analgesics|analgesics|mesh-list
82902449|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
82902450|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902451|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902452|NCT03630120|Sorafenib|sorafenib|mesh-list
82902453|NCT03630120|Lenvatinib|lenvatinib|mesh-list
82902454|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902455|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82902456|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902457|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902458|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
82902459|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
82902460|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902461|NCT03744702|Protective Agents|protective agents|mesh-ancestor
82902462|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902463|NCT03744702|Vitamins|vitamins|mesh-ancestor
82902464|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
82902465|NCT04004442|Avelumab|avelumab|mesh-list
82902466|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82902467|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902468|NCT03736980|Psilocybin|psilocybin|mesh-list
82902469|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
82902470|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902471|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902472|NCT03727646|Niacinamide|niacinamide|mesh-list
82902473|NCT03727646|Niacin|niacin|mesh-list
82902474|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
82902475|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
82902476|NCT03727646|Vitamins|vitamins|mesh-ancestor
82902477|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
82902478|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902479|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82902480|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
82902481|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902482|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82902483|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
82902484|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
82902485|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
82902486|NCT05666336|Prednisone|prednisone|mesh-list
82902487|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
82902488|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
82902489|NCT05666336|Tacrolimus|tacrolimus|mesh-list
82902490|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82902491|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
82902492|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902493|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902494|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82902495|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
82902496|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902497|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902498|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82902499|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902500|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
82902501|NCT05666336|Hormones|hormones|mesh-ancestor
82902502|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82902503|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82902504|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82902505|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902506|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82902507|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82902508|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
82902509|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82902510|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902511|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
82902512|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
82902513|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902514|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902515|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82902516|NCT05666336|Protective Agents|protective agents|mesh-ancestor
82902517|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
82902518|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82902519|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82902520|NCT03554486|Insulin|insulin|mesh-list
82902521|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82902522|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
82902523|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
82902524|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82902525|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82902526|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902527|NCT03554018|Acetaminophen|acetaminophen|mesh-list
82902528|NCT03554018|Ibuprofen|ibuprofen|mesh-list
82902529|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902530|NCT03554018|Analgesics|analgesics|mesh-ancestor
82902531|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
82902532|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902533|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902534|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
82902535|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82902536|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902537|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902538|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82902539|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902540|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902541|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
82902542|NCT05462938|Propofol|propofol|mesh-list
82902543|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82902544|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902545|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902546|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902547|NCT05462938|Analgesics|analgesics|mesh-ancestor
82902548|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
82902549|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902550|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82902551|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82902552|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82902553|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
82902554|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902555|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902556|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82902557|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
82902558|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
82902559|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
82902560|NCT04787692|Narcotics|narcotics|mesh-ancestor
82902561|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902562|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902563|NCT04787692|Analgesics|analgesics|mesh-ancestor
82902564|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
82902565|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902567|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82902568|NCT05462548|Hematinics|hematinics|mesh-ancestor
82902569|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
82902570|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902571|NCT03408340|Fentanyl|fentanyl|mesh-list
82902572|NCT03408340|Ketamine|ketamine|mesh-list
82902573|NCT03408340|Propofol|propofol|mesh-list
82902574|NCT03408340|Sevoflurane|sevoflurane|mesh-list
82902575|NCT03408340|Rocuronium|rocuronium|mesh-list
82902576|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
82902577|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902578|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902579|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
82902580|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902581|NCT03408340|Analgesics|analgesics|mesh-ancestor
82902582|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82902583|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82902584|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
82902585|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82902586|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82902587|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902588|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902589|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82902590|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82902591|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82902592|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82902593|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82902594|NCT03408340|Narcotics|narcotics|mesh-ancestor
82902595|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82902596|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82902597|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82902598|NCT03570554|Acetaminophen|acetaminophen|mesh-list
82902599|NCT03570554|Celecoxib|celecoxib|mesh-list
82902600|NCT03570554|Naproxen|naproxen|mesh-list
82902601|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902602|NCT03570554|Analgesics|analgesics|mesh-ancestor
82902603|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
82902604|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902605|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902606|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
82902607|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82902608|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902609|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902610|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82902611|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82902612|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902613|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902614|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
82902615|NCT04004208|Aflibercept|aflibercept|mesh-list
82902616|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82902617|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82902618|NCT04004208|Growth Substances|growth substances|mesh-ancestor
82902619|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902620|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
82902621|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902622|NCT03727412|Naproxen|naproxen|mesh-list
82902623|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82902624|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902626|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
82902627|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902628|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902629|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902630|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902631|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
82902632|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82902633|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902634|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902635|NCT03643952|Daptomycin|daptomycin|mesh-list
82902636|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82902637|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902638|NCT03035032|Leuprolide|leuprolide|mesh-list
82902639|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82902640|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
82902641|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902642|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902643|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82902644|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902646|NCT03629184|Baloxavir|baloxavir|mesh-list
82902647|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
82902648|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902649|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902650|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902651|NCT03725228|Lidocaine|lidocaine|mesh-list
82902652|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
82902653|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
82902654|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
82902655|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902656|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902657|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
82902658|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902659|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82902660|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82902661|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82902662|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902663|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902664|NCT03725228|Analgesics|analgesics|mesh-ancestor
82902665|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
82902666|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82902667|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82902668|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
82902669|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902670|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
82902671|NCT03724838|Esomeprazole|esomeprazole|mesh-list
82902672|NCT03724838|Citric Acid|citric acid|mesh-list
82902673|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
82902674|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
82902675|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82902676|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
82902677|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
82902678|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902679|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
82902680|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82902681|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82902682|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902683|NCT03724838|Urological Agents|urological agents|mesh-ancestor
82902684|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82902685|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82902686|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82902687|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
82902688|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902689|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
82902690|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82902691|NCT03727100|Clonidine|clonidine|mesh-list
82902692|NCT03727100|Analgesics|analgesics|mesh-ancestor
82902693|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
82902694|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902695|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902696|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82902697|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
82902698|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
82743366|NCT00678392|Sorafenib|sorafenib|mesh-list
82902699|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82902700|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82902701|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82902702|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
82902703|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902704|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902705|NCT03358030|Riboflavin|riboflavin|mesh-list
82902706|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
82902707|NCT03358030|Vitamins|vitamins|mesh-ancestor
82902708|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
82902709|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902710|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82902711|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
82902712|NCT03566810|Metformin|metformin|mesh-list
82902713|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82902714|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902715|NCT03628716|Atezolizumab|atezolizumab|mesh-list
82902716|NCT03628716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82902717|NCT03628716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902718|NCT03628716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82902719|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902721|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
82902722|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902723|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82902724|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82902725|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902726|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902727|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82902728|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
82902729|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82902730|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902731|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82902732|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82902733|NCT00088413|Molgramostim|molgramostim|mesh-list
82902734|NCT00088413|Sargramostim|sargramostim|mesh-list
82902735|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
82902736|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902737|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902738|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
82902739|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82902740|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82902741|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
82902742|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902743|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902744|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902745|NCT03787654|Urological Agents|urological agents|mesh-ancestor
82902746|NCT00086385|Bupropion|bupropion|mesh-list
82902747|NCT00086385|Nicotine|nicotine|mesh-list
82902748|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82902749|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
82902750|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902751|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902752|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82902753|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82902754|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
82902755|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902756|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902757|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82902758|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
82902759|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902760|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82902761|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902762|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902763|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
82902764|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82902765|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82902766|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902767|NCT03993288|Iron|iron|mesh-list
82902768|NCT03993288|Trace Elements|trace elements|mesh-ancestor
82902769|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
82902770|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902771|NCT05093608|Bevacizumab|bevacizumab|mesh-list
82902772|NCT05093608|Atezolizumab|atezolizumab|mesh-list
83514604|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
82902773|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82902774|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902775|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82902776|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82902777|NCT05093608|Growth Substances|growth substances|mesh-ancestor
82902778|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902779|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
82902780|NCT05093608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82902781|NCT05093608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902782|NCT03991494|Pamiparib|pamiparib|mesh-list
82902783|NCT03991494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82902784|NCT03991494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902785|NCT03991494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902786|NCT03991494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902787|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
82902788|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902789|NCT03383770|Anesthetics|anesthetics|mesh-list
82902790|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902791|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902792|NCT00086307|Pramipexole|pramipexole|mesh-list
82902793|NCT00086307|Escitalopram|escitalopram|mesh-list
82902794|NCT00086307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82902795|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902796|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902797|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902798|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902799|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
82902800|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902801|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82902802|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82902803|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
82902804|NCT00086307|Protective Agents|protective agents|mesh-ancestor
82902805|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
82902806|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
82902807|NCT01086579|Paclitaxel|paclitaxel|mesh-list
82902808|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82902809|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82902810|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902811|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
82902812|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
82902813|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
82902814|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902815|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
82902816|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
82902817|NCT03743922|Vitamin D|vitamin d|mesh-list
82902818|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82902819|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902820|NCT03743922|Vitamins|vitamins|mesh-ancestor
82902821|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
82902822|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82902823|NCT03988842|Heparin|heparin|mesh-list
82902824|NCT03988842|Calcium heparin|calcium heparin|mesh-list
82902825|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82902826|NCT03988842|Plasminogen|plasminogen|mesh-list
82902827|NCT03988842|Apixaban|apixaban|mesh-list
82902828|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
82902829|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82902830|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82902831|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902832|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82902833|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
82902834|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82902835|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
82902836|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902837|NCT02668822|Ibuprofen|ibuprofen|mesh-list
82902838|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82902839|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902840|NCT02668822|Analgesics|analgesics|mesh-ancestor
82902841|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
82902842|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902843|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902844|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902845|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902846|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82902847|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902848|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902850|NCT04112589|Fludarabine|fludarabine|mesh-list
82902851|NCT04112589|Idarubicin|idarubicin|mesh-list
82902852|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902853|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82902854|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
82902855|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902856|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82902857|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
82902858|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902859|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
82902860|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902861|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82902862|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82902863|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82902864|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902865|NCT03547154|Interferons|interferons|mesh-list
82902868|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82902869|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902870|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
82902871|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82902872|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
82902873|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902874|NCT02275546|NuvaRing|nuvaring|mesh-list
82902875|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82902876|NCT02275546|Desogestrel|desogestrel|mesh-list
82902877|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82902878|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
82902879|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902880|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902881|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82902882|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82902883|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82902884|NCT02275546|Estrogens|estrogens|mesh-ancestor
82902885|NCT02275546|Hormones|hormones|mesh-ancestor
82902886|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82902887|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82902888|NCT02275546|Progestins|progestins|mesh-ancestor
82902889|NCT00057837|Cisplatin|cisplatin|mesh-list
82902890|NCT00057837|Irinotecan|irinotecan|mesh-list
82902891|NCT00057837|Etoposide|etoposide|mesh-list
82902892|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
82902893|NCT00057837|Topotecan|topotecan|mesh-list
82902894|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
82902895|NCT00057837|Camptothecin|camptothecin|mesh-list
82902896|NCT00057837|Lenograstim|lenograstim|mesh-list
82902897|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902898|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82902899|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82902900|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902901|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902902|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82902903|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82902904|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82902905|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
82902906|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902907|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
82902908|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
82902909|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
82902910|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
82902911|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
82902912|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82902913|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82902914|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902915|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82902916|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82902917|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902918|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902919|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
82902920|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82902921|NCT01096797|Sevoflurane|sevoflurane|mesh-list
82902922|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82902923|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82902924|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
82902925|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
82902926|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902927|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902928|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
82902929|NCT00068601|Goserelin|goserelin|mesh-list
82902930|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82902931|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
82902932|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902933|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902934|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82902935|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
82902936|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902937|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902938|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82902939|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82902941|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
82902942|NCT01670656|Etonogestrel|etonogestrel|mesh-list
82902943|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82902944|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902945|NCT01670656|Analgesics|analgesics|mesh-ancestor
82902946|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
82902947|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902948|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902949|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82902950|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82902951|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82902952|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902953|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902954|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902955|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82902956|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82902957|NCT03621696|Cisplatin|cisplatin|mesh-list
82902958|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902959|NCT00068445|Lamotrigine|lamotrigine|mesh-list
82902960|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
82902961|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82902962|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902963|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902964|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82902965|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902966|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82902967|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82902968|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82902969|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82902970|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82902971|NCT03033784|Oxytocin|oxytocin|mesh-list
82902972|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
82902973|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82902974|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902975|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
82902976|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82902977|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82902978|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902979|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902980|NCT02926690|OTS167|ots167|mesh-list
82902981|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82902982|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82902983|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902984|NCT03652818|Acetaminophen|acetaminophen|mesh-list
82902985|NCT03652818|Pregabalin|pregabalin|mesh-list
82902986|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82902987|NCT03652818|Analgesics|analgesics|mesh-ancestor
82902988|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
82902989|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82902990|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82902991|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
82902992|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
82902993|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82902994|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82902995|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82902996|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82902997|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82902998|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82902999|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903000|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82903001|NCT03723824|Grazoprevir|grazoprevir|mesh-list
82903002|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82903003|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
82903004|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903005|NCT00620464|Etonogestrel|etonogestrel|mesh-list
82903006|NCT00620464|Desogestrel|desogestrel|mesh-list
82903007|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82903008|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
82903009|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82903010|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903011|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82903012|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82903013|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83456233|NCT04433845|Psilocybin|psilocybin|mesh-list
82903028|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82903029|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82903030|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82903032|NCT00413764|Norethindrone|norethindrone|mesh-list
82903033|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
82903034|NCT00413764|Estradiol|estradiol|mesh-list
82903035|NCT00413764|Estrogens|estrogens|mesh-ancestor
82903036|NCT00413764|Hormones|hormones|mesh-ancestor
82903037|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903038|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903039|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82903040|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
82903041|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82903042|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82903043|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82903044|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82903045|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82903046|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
82903047|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
82903048|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82903049|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82903050|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903051|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82903052|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
82903053|NCT03726788|Triamcinolone|triamcinolone|mesh-list
82903054|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82903055|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82903056|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
82903057|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82903058|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82903059|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82903060|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82903061|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82903062|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903063|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
82903064|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903065|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903066|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82903067|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903068|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903069|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
82903070|NCT03726788|Hormones|hormones|mesh-ancestor
82903071|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903073|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
82903074|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903075|NCT03735264|Docetaxel|docetaxel|mesh-list
82903076|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903077|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
82903078|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
82903079|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
82903080|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903081|NCT03560258|Vaccines|vaccines|mesh-list
82903082|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
82903083|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903084|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
82903085|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82903086|NCT02759380|Estrogens|estrogens|mesh-ancestor
82903087|NCT02759380|Hormones|hormones|mesh-ancestor
82903088|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903089|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903090|NCT02707042|Amoxicillin|amoxicillin|mesh-list
82903091|NCT02707042|Azithromycin|azithromycin|mesh-list
82903092|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903093|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903094|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
82903095|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82903096|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
82903097|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903098|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82903099|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82903100|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82903101|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903102|NCT03615924|Ticagrelor|ticagrelor|mesh-list
82903103|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82903104|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82903105|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82903106|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82903107|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
82903108|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903109|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903110|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903111|NCT05576038|Tryptophan|tryptophan|mesh-list
82903112|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82903113|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
82903114|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82903115|NCT04660240|Sirolimus|sirolimus|mesh-list
82903116|NCT04660240|Temsirolimus|temsirolimus|mesh-list
82903117|NCT04660240|MTOR Inhibitors|mtor inhibitors|mesh-list
82903118|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903119|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903120|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82903121|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903122|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
82903123|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82903124|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
82903125|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903126|NCT04660240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82903127|NCT04660240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903128|NCT04660240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903129|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82903130|NCT03033394|Penicillins|penicillins|mesh-list
82903131|NCT03033394|Lactams|lactams|mesh-list
82903132|NCT03033394|beta-Lactams|beta-lactams|mesh-list
82903133|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903134|NCT03639428|Midazolam|midazolam|mesh-list
82903135|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82903136|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82903137|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903138|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903139|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82903140|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82903141|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82903142|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82903143|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
82903144|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
82903145|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
82903146|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
82903147|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903148|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903150|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
82903151|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
82903152|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903153|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903154|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
82903155|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903156|NCT05528848|Fentanyl|fentanyl|mesh-list
82903157|NCT05528848|Carfentanil|carfentanil|mesh-list
82903158|NCT05528848|Naloxone|naloxone|mesh-list
82903159|NCT05528848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82903160|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903161|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
82903162|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903163|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82903164|NCT05528848|Narcotics|narcotics|mesh-ancestor
82903165|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903166|NCT05528848|Analgesics|analgesics|mesh-ancestor
82903167|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82903168|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82903169|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
82903170|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
82903172|NCT04561648|Calcium heparin|calcium heparin|mesh-list
82903173|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
82903174|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82903175|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82903176|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903177|NCT03981822|Cantharidin|cantharidin|mesh-list
82903178|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903179|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903180|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
82903181|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82903182|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903183|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82903184|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903185|NCT05506930|Morphine|morphine|mesh-list
82903186|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82903187|NCT05506930|Narcotics|narcotics|mesh-ancestor
82903188|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903189|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903190|NCT05506930|Analgesics|analgesics|mesh-ancestor
82903191|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
82903192|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903193|NCT05464264|Ketamine|ketamine|mesh-list
82903194|NCT05464264|Analgesics|analgesics|mesh-ancestor
82903195|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
82903196|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903197|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903198|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82903199|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82903200|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
82903201|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
82903202|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903203|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82903204|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82903205|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903206|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903207|NCT01310738|Amphotericin B|amphotericin b|mesh-list
82903208|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82903209|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
82903210|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
82903211|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
82903212|NCT01310738|Amebicides|amebicides|mesh-ancestor
82903213|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82903214|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82903215|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903216|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903217|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
82903218|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82903219|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903220|NCT03704506|Amoxicillin|amoxicillin|mesh-list
82903221|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903222|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903229|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903230|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82903231|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
82903232|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903233|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82903234|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
82903235|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903236|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82903237|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
82903238|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82903239|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
82903240|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82903241|NCT03682302|Bupivacaine|bupivacaine|mesh-list
82903242|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
82903243|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
82903244|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903245|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903246|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
82903247|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903249|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82903250|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903251|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82903252|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82903253|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82903254|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903255|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
82903256|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82903257|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
82903258|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82903259|NCT03320434|Prednisolone|prednisolone|mesh-list
82903260|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82903261|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
82903262|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903263|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
82903264|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
82903265|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903266|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903267|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903268|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
82903269|NCT03320434|Hormones|hormones|mesh-ancestor
82903270|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903271|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82903272|NCT03320434|Protective Agents|protective agents|mesh-ancestor
82903273|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82903274|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903275|NCT02892734|Nivolumab|nivolumab|mesh-list
82903276|NCT02892734|Ipilimumab|ipilimumab|mesh-list
82903277|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82903278|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903279|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82903280|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903281|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
82903282|NCT05231590|Paraproteins|paraproteins|mesh-list
82903283|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
82903284|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903285|NCT00055497|Adalimumab|adalimumab|mesh-list
82903286|NCT00055497|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82903287|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903288|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82903289|NCT03726398|Macitentan|macitentan|mesh-list
82903290|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82903291|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82903292|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903294|NCT04050592|Estradiol|estradiol|mesh-list
82903295|NCT04050592|Estrogens|estrogens|mesh-ancestor
82903296|NCT04050592|Hormones|hormones|mesh-ancestor
82903297|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903298|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903299|NCT03726242|Cromakalim|cromakalim|mesh-list
82903300|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82903301|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82903302|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
82903303|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903304|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903305|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82903306|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
82903307|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
82903308|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
82903309|NCT03731988|Lidocaine|lidocaine|mesh-list
82903310|NCT03731988|Prilocaine|prilocaine|mesh-list
82903311|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82903312|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
82903313|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
82903314|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903315|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903316|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
82903317|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903318|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82903319|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82903320|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82903321|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133550|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82903322|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903323|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82903324|NCT01094457|Aspirin|aspirin|mesh-list
82903325|NCT01094457|Cilostazol|cilostazol|mesh-list
82903326|NCT01094457|Clopidogrel|clopidogrel|mesh-list
82903327|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82903328|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82903329|NCT01094457|Analgesics|analgesics|mesh-ancestor
82903330|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
82903331|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903332|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903333|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903334|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82903335|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82903336|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82903337|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903338|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82903339|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82903340|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903341|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
82903342|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82903343|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82903344|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82903345|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
82903346|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903347|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82903348|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
82903349|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82903350|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
82903351|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
82903352|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82903353|NCT01094457|Protective Agents|protective agents|mesh-ancestor
82903354|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82903355|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82903356|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
82903357|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82903358|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82903359|NCT03701698|Prednisolone|prednisolone|mesh-list
82903360|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
82903361|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82903362|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
82903363|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903364|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
82903365|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
82903366|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903368|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903370|NCT03701698|Hormones|hormones|mesh-ancestor
82903371|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903372|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82903373|NCT03701698|Protective Agents|protective agents|mesh-ancestor
83456263|NCT01920542|Analgesics|analgesics|mesh-ancestor
82903374|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82903375|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903376|NCT03734562|Amiodarone|amiodarone|mesh-list
82903377|NCT03734562|Sotalol|sotalol|mesh-list
82903378|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82903379|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
82903380|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82903381|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82903382|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903383|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82903384|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82903385|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82903386|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903387|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82903388|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82903389|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82903390|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82903391|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82903392|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
82903393|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903394|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903395|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
82903396|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
82903397|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903398|NCT03034096|Propofol|propofol|mesh-list
82903399|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82903400|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903401|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903402|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82903403|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
82903404|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
82903405|NCT03722498|Leucovorin|leucovorin|mesh-list
82903406|NCT03722498|Fluorouracil|fluorouracil|mesh-list
82903407|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
82903408|NCT03722498|Sorafenib|sorafenib|mesh-list
82903409|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
82903410|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903411|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82903412|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903413|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82903414|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
82903415|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903416|NCT03722498|Antidotes|antidotes|mesh-ancestor
82903417|NCT03722498|Protective Agents|protective agents|mesh-ancestor
82903418|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
82903419|NCT03722498|Vitamins|vitamins|mesh-ancestor
82903420|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
82903421|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82903422|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903423|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
82903424|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903425|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82903426|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903427|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903428|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
82903429|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82903430|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903431|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82903432|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903433|NCT03807843|Vaccines|vaccines|mesh-list
82903434|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
82903435|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903436|NCT01094535|Secretin|secretin|mesh-list
82903437|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903438|NCT01094535|Hormones|hormones|mesh-ancestor
82903439|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903456|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83456279|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
82903457|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82903458|NCT02843074|Growth Substances|growth substances|mesh-ancestor
82903459|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
82903466|NCT00038103|Celecoxib|celecoxib|mesh-list
82903467|NCT00038103|Exemestane|exemestane|mesh-list
82903468|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82903469|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82903470|NCT00038103|Analgesics|analgesics|mesh-ancestor
82903471|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
82903472|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903473|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903474|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903475|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82903476|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82903477|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82903478|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903479|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903480|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903481|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82903482|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82903483|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82903484|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
82903485|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903486|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
82903487|NCT03678870|Narcotics|narcotics|mesh-ancestor
82903488|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903489|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903490|NCT03678870|Analgesics|analgesics|mesh-ancestor
82903491|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
82903492|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903493|NCT03032380|Meropenem|meropenem|mesh-list
82903494|NCT03032380|Linezolid|linezolid|mesh-list
82903495|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903496|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903497|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82903498|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903506|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903507|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903508|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82903509|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903510|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903512|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
82903513|NCT03479216|Bupivacaine|bupivacaine|mesh-list
82903514|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
82903515|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
82903516|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903517|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903518|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
82903519|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903520|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82903521|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82903522|NCT03479216|Analgesics|analgesics|mesh-ancestor
82903523|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82903524|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82903525|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82903526|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
82903527|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903528|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903529|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82903530|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
82903531|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82903532|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456286|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82903533|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82903534|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
82903535|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82903544|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
82903545|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82903546|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903547|NCT03717038|Trifluridine|trifluridine|mesh-list
82903548|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
82903549|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903550|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
82903551|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903552|NCT00143182|Olanzapine|olanzapine|mesh-list
82903553|NCT00143182|Asenapine|asenapine|mesh-list
82903554|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
82903555|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
82903556|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903557|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903558|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903559|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82903560|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82903561|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903562|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82903563|NCT00143182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82903564|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82903565|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82903566|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903567|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903568|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
82903569|NCT03677934|Ranibizumab|ranibizumab|mesh-list
82903570|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82903571|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82903572|NCT03677934|Growth Substances|growth substances|mesh-ancestor
82903573|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903574|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
82903575|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903576|NCT03435692|Acetaminophen|acetaminophen|mesh-list
82903577|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
82903578|NCT03435692|Promethazine|promethazine|mesh-list
82903579|NCT03435692|Fentanyl|fentanyl|mesh-list
82903580|NCT03435692|Morphine|morphine|mesh-list
82903581|NCT03435692|Oxycodone|oxycodone|mesh-list
82903582|NCT03435692|Lorazepam|lorazepam|mesh-list
82903583|NCT03435692|Ondansetron|ondansetron|mesh-list
82903584|NCT03435692|Ropivacaine|ropivacaine|mesh-list
82903585|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82903586|NCT03435692|Narcotics|narcotics|mesh-ancestor
82903587|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903588|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903589|NCT03435692|Analgesics|analgesics|mesh-ancestor
82903590|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
82903591|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903592|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
82903593|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
82903594|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82903595|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82903596|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
82903597|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82903598|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
82903599|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
82903600|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
82903601|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903602|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
82903603|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
82903604|NCT03435692|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82903605|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82903606|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
82903607|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903608|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903609|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82903610|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82903611|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82903612|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
82903613|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
82903614|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82903615|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
82903616|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82903617|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82903618|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82903619|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
82903620|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
82903621|NCT03705442|Loperamide|loperamide|mesh-list
82903622|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
82903623|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82903624|NCT04817410|Naltrexone|naltrexone|mesh-list
82903625|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82903626|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82903627|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903628|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
82903629|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903630|NCT03673956|Vancomycin|vancomycin|mesh-list
82903631|NCT03673956|Levofloxacin|levofloxacin|mesh-list
82903632|NCT03673956|Tobramycin|tobramycin|mesh-list
82903633|NCT03673956|Mupirocin|mupirocin|mesh-list
82903634|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903635|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903636|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82903637|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82903638|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82903639|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903640|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903641|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903642|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82903643|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82903644|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82903645|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
82903646|NCT03716804|Cefuroxime|cefuroxime|mesh-list
82903647|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
82903648|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
82903649|NCT03716804|Cefixime|cefixime|mesh-list
82903650|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903651|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903652|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82903653|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82903655|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903656|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903657|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82903658|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82903659|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82903660|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82903661|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82903662|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83514605|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
82903663|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82903664|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
82903665|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903666|NCT03733860|Alprostadil|alprostadil|mesh-list
82903667|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82903668|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
82903669|NCT03733860|Urological Agents|urological agents|mesh-ancestor
82903670|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
82903671|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82903672|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903673|NCT01310244|Paclitaxel|paclitaxel|mesh-list
82903674|NCT01310244|Carboplatin|carboplatin|mesh-list
82903675|NCT01310244|Belinostat|belinostat|mesh-list
82903676|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82903677|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903678|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
82903679|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
82903680|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
82903681|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903682|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82903683|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903684|NCT03672006|Heparin|heparin|mesh-list
82903685|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82903686|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
82903687|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82903688|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82903689|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903690|NCT03621072|Fluconazole|fluconazole|mesh-list
82903691|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
82903692|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903693|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82903694|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82903695|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903696|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903697|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82903698|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
82903699|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903700|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903701|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82903702|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82903703|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82903704|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
82903705|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903706|NCT01311050|Bevacizumab|bevacizumab|mesh-list
82903707|NCT01311050|Capecitabine|capecitabine|mesh-list
82903708|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
82903709|NCT01311050|Irinotecan|irinotecan|mesh-list
82903710|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82903711|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903712|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82903713|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82903714|NCT01311050|Growth Substances|growth substances|mesh-ancestor
82903715|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903716|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
82903717|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82903718|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
82903719|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903720|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82903721|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82903722|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903723|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
82903724|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82903725|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
82903726|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903727|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82903728|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82903729|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
82903730|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903731|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903732|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82903733|NCT03702946|Oxytocin|oxytocin|mesh-list
82903734|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
82903735|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82903736|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903738|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82903739|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82903740|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82903741|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
82903742|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903743|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903744|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903745|NCT04491526|Urological Agents|urological agents|mesh-ancestor
82903746|NCT04484350|Enalapril|enalapril|mesh-list
82903747|NCT04484350|Labetalol|labetalol|mesh-list
82903748|NCT04484350|Hydralazine|hydralazine|mesh-list
82903749|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82903750|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
82903751|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903752|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903753|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82903754|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82903755|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82903756|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
82903757|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903758|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903759|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
82903760|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
82903761|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903762|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82903763|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82903764|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
82903765|NCT03699904|Valacyclovir|valacyclovir|mesh-list
82903766|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
82903767|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903768|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
82903769|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
82903770|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82903771|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903772|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903773|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
82903774|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82903775|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82903776|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903777|NCT03696940|Atorvastatin|atorvastatin|mesh-list
82903778|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82903779|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82903780|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
82903781|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903782|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82903783|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82903784|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903785|NCT03731442|Paclitaxel|paclitaxel|mesh-list
82903786|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82903787|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903788|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
82903789|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
82903790|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
82903791|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903792|NCT03702400|Phenylephrine|phenylephrine|mesh-list
82903793|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
82903794|NCT03702400|Norepinephrine|norepinephrine|mesh-list
82903795|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82903796|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
82903797|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
82903798|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903799|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903800|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
82903801|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82903802|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
82903803|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
82903804|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82903805|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82903806|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82903807|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
82903808|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903809|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903810|NCT03702400|Protective Agents|protective agents|mesh-ancestor
82903813|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903814|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
82903815|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903816|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
82903817|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82903818|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82903819|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903820|NCT03598140|Urological Agents|urological agents|mesh-ancestor
82903821|NCT04457596|Trastuzumab|trastuzumab|mesh-list
82903822|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82903823|NCT04457596|Maytansine|maytansine|mesh-list
82903824|NCT04457596|Tucatinib|tucatinib|mesh-list
82903825|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82903826|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903827|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82903828|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
82903829|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
82903830|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
82903831|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903832|NCT04457596|Immunotoxins|immunotoxins|mesh-ancestor
82903833|NCT04457596|Immunoconjugates|immunoconjugates|mesh-ancestor
82903834|NCT04457596|Immunologic Factors|immunologic factors|mesh-ancestor
82903835|NCT04457596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903836|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82903837|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903838|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
82903839|NCT03644550|LMB-100|lmb-100|mesh-list
82903840|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82903841|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903842|NCT03644550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82903843|NCT03644550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903844|NCT03644550|Immunoconjugates|immunoconjugates|mesh-ancestor
82903845|NCT03644550|Immunologic Factors|immunologic factors|mesh-ancestor
82903846|NCT03644550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903847|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
82903848|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82903849|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903850|NCT05668650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82903851|NCT05668650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903852|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
82903853|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82903854|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903855|NCT00054717|Ritonavir|ritonavir|mesh-list
82903856|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
82903857|NCT00054717|Tipranavir|tipranavir|mesh-list
82903858|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
82903859|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82903860|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903861|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903862|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82903863|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82903864|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
82903865|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903866|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82903867|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82903868|NCT03430856|Insulin|insulin|mesh-list
82903869|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82903870|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
82903871|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82903872|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903873|NCT01097265|Capecitabine|capecitabine|mesh-list
82903874|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
82903875|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82903877|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903878|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903879|NCT03731286|Caffeine|caffeine|mesh-list
82903880|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82903881|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903882|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82903883|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903884|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903885|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82903886|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82903887|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
82903888|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903890|NCT00066807|Epirubicin|epirubicin|mesh-list
82903891|NCT00066807|Exemestane|exemestane|mesh-list
82903892|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82903893|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82903894|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903895|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82903896|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82903897|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903898|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903899|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82903900|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
82903901|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903902|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903903|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82903904|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82903905|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82903906|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82903907|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82903908|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82903909|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
82903910|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82903911|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
82903912|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82903913|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82903914|NCT03619330|Liraglutide|liraglutide|mesh-list
82903915|NCT03619330|Testosterone|testosterone|mesh-list
82903916|NCT03619330|Androgens|androgens|mesh-ancestor
82903917|NCT03619330|Hormones|hormones|mesh-ancestor
82903918|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82903919|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903920|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82903921|NCT03619330|Incretins|incretins|mesh-ancestor
82903922|NCT04457284|Nivolumab|nivolumab|mesh-list
82903923|NCT04457284|Temozolomide|temozolomide|mesh-list
82903924|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903925|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82903926|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83456333|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82903927|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903928|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82903929|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
82903930|NCT00054639|Rituximab|rituximab|mesh-list
82903931|NCT00054639|Oblimersen|oblimersen|mesh-list
82903932|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82903933|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903934|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
82903935|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903936|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82903937|NCT02530359|Pirfenidone|pirfenidone|mesh-list
82903938|NCT02530359|Analgesics|analgesics|mesh-ancestor
82903939|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
82903940|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903941|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903942|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82903943|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82903944|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903945|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82903946|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903947|NCT03428360|Diazepam|diazepam|mesh-list
82903948|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82903961|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82903962|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82903963|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
82903965|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
82903966|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
82903967|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903968|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903969|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
82903970|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
82903971|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82903972|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82744554|NCT00776828|Cilostazol|cilostazol|mesh-list
82903973|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903974|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
82903975|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
82903976|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
82903977|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82903978|NCT04867928|Azacitidine|azacitidine|mesh-list
82903979|NCT04867928|Venetoclax|venetoclax|mesh-list
82903980|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82903981|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
82903982|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82903983|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82903984|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82903985|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
82903986|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82903987|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82903988|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82903989|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
82903990|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82903991|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82903992|NCT03698734|Analgesics|analgesics|mesh-ancestor
82903993|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
82903994|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82903995|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82903996|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82903997|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82903998|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82903999|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
82904000|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904001|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82904002|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
82904016|NCT04070157|Lofexidine|lofexidine|mesh-list
82904017|NCT04070157|Clonidine|clonidine|mesh-list
82904018|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82904019|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82904020|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904021|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
82904022|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904023|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82904024|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82904026|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
82904027|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904028|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904029|NCT04070157|Analgesics|analgesics|mesh-ancestor
82904030|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
82904031|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
82904032|NCT01091337|Albuterol|albuterol|mesh-list
82904033|NCT01091337|Procaterol|procaterol|mesh-list
82904034|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82904035|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
82904036|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904037|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904038|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82904039|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
82904040|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
82904041|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82904042|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82904043|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82904044|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82904045|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
82904046|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904047|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904048|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
82904049|NCT03955809|Ketamine|ketamine|mesh-list
82904050|NCT03955809|Analgesics|analgesics|mesh-ancestor
82904051|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
82904052|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904053|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904054|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82904055|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82904056|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
82904057|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
82904058|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904059|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82904060|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82904061|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83514680|NCT03862755|Heparin|heparin|mesh-list
82904062|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904063|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
82904064|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
82904065|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904066|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82904067|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904068|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904069|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
82904070|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904071|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82904072|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904073|NCT03953001|Lidocaine|lidocaine|mesh-list
82904074|NCT03953001|Epinephrine|epinephrine|mesh-list
82904075|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
82904076|NCT03953001|Anesthetics|anesthetics|mesh-list
82904077|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83456384|NCT01057381|Morphine|morphine|mesh-list
82904078|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904079|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
82904080|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904081|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82904082|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82904083|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82904084|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904085|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904086|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82904087|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82904088|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
82904089|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904090|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82904091|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82904092|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
82904093|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82904094|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
82904095|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
82904096|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
82904097|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82904098|NCT01094769|Moxonidine|moxonidine|mesh-list
82904099|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82904100|NCT01091415|Calcium|calcium|mesh-list
82904101|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82904102|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904103|NCT00032487|Metformin|metformin|mesh-list
82904104|NCT00032487|Glimepiride|glimepiride|mesh-list
82904105|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
82904106|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82904107|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904108|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82904109|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904110|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
82904111|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
82904112|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82904113|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904114|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82904115|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82904116|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904117|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904118|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904119|NCT03692416|Prednisone|prednisone|mesh-list
82904120|NCT03692416|Ibuprofen|ibuprofen|mesh-list
82904121|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82904122|NCT03692416|Methotrexate|methotrexate|mesh-list
82904123|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904124|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
82904125|NCT03692416|Hormones|hormones|mesh-ancestor
82904126|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904127|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904128|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82904129|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904130|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82904131|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
82904132|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82904133|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82904134|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
82904135|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904136|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
82904137|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904138|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82904139|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904140|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
82904141|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904142|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82904143|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82904144|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82904146|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
82904147|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904148|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82904149|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82904150|NCT03692416|Protective Agents|protective agents|mesh-ancestor
82904151|NCT03594552|Baclofen|baclofen|mesh-list
82904152|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82904153|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904154|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82904155|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904156|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82904157|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
82904158|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
82904159|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904160|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904161|NCT03641508|Dexamethasone|dexamethasone|mesh-list
82904162|NCT03641508|Triamcinolone|triamcinolone|mesh-list
82904163|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904164|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
82904165|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
82904166|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904167|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904168|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904169|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
82904170|NCT03641508|Hormones|hormones|mesh-ancestor
82904171|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904172|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82904173|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904177|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904178|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82904179|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904180|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904181|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82904182|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
82904183|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904184|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904185|NCT00066573|Anastrozole|anastrozole|mesh-list
82904186|NCT00066573|Exemestane|exemestane|mesh-list
82904187|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82904188|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904189|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82904190|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82904191|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904192|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904193|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82904194|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
82904195|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904196|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904197|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
82904198|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82904199|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904200|NCT01091571|Dipyridamole|dipyridamole|mesh-list
82904201|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82904202|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904203|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904204|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82904205|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
82904206|NCT01091649|Ritonavir|ritonavir|mesh-list
82904207|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82904208|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82904209|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
82904210|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904211|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904212|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82904213|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82904214|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
82904215|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83456398|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82904216|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82904217|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82904218|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
82904219|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82904220|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82904221|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82904222|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904223|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904224|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
82904225|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904226|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904227|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82904228|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904230|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904231|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82904232|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
82904233|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904234|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904235|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82904236|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
82904237|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
82904238|NCT03421730|Hormones|hormones|mesh-ancestor
82904239|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904240|NCT01094925|Gabapentin|gabapentin|mesh-list
82904241|NCT01094925|Analgesics|analgesics|mesh-ancestor
82904242|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
82904243|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904244|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904246|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82904247|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82904248|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904249|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82904250|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82904251|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82904252|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904253|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904254|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
82904255|NCT03718676|Pemetrexed|pemetrexed|mesh-list
82904256|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904257|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904258|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904259|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82904260|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82904261|NCT00054327|Cytarabine|cytarabine|mesh-list
82904262|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
82904263|NCT00054327|Busulfan|busulfan|mesh-list
82904264|NCT00054327|Etoposide|etoposide|mesh-list
82904265|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
82904266|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904267|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
82904268|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904269|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904270|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82904271|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
82904272|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904273|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904274|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82904275|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82904276|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82904277|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82904278|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904279|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82904280|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
82904281|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
82904282|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904283|NCT03029650|Scopolamine|scopolamine|mesh-list
82904284|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82904285|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82904286|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
82904287|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
82904288|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904289|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904290|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904291|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
82904292|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82904293|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
82904294|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904295|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904296|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82904297|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
82904298|NCT03462680|Niacin|niacin|mesh-list
82904299|NCT03462680|Vitamins|vitamins|mesh-ancestor
82904300|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
82904301|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904302|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
82904303|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82904304|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
82904305|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904306|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82904307|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
82904308|NCT03692026|Melatonin|melatonin|mesh-list
82904309|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
82904310|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
82904311|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904312|NCT03692026|Protective Agents|protective agents|mesh-ancestor
82904313|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904314|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904315|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82904316|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
82904317|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
82904318|NCT03624322|Olanzapine|olanzapine|mesh-list
82904319|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
82904320|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
82904321|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904322|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904323|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904324|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82904325|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82904326|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904327|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82904328|NCT03624322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82904329|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82904330|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904331|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904332|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904333|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
82904334|NCT01097811|Erythromycin|erythromycin|mesh-list
82904335|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
82904336|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82904337|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
82904338|NCT01097811|Neomycin|neomycin|mesh-list
82904339|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82904340|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904341|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904342|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82904343|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904344|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904345|NCT03418922|Nivolumab|nivolumab|mesh-list
82904346|NCT03418922|Lenvatinib|lenvatinib|mesh-list
82904347|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82904348|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904349|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82904350|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904351|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82904352|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904353|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
82904354|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82904355|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
82904356|NCT03957291|Povidone|povidone|mesh-list
82904357|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82904358|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904359|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
82904360|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
82904361|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
82904362|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
82904363|NCT04044976|Caffeine|caffeine|mesh-list
82904364|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
83456407|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
82904365|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904366|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82904367|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904368|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82904369|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904370|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82904371|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82904372|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
82904373|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904374|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82904375|NCT03691636|Lifitegrast|lifitegrast|mesh-list
82904376|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82904377|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
82904378|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
82904379|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
82904380|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
82904381|NCT03956121|Analgesics|analgesics|mesh-ancestor
82904382|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
82904383|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904384|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904385|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
82904386|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904387|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82904388|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
82904389|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82904390|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904391|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904392|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82904393|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
82904394|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82904395|NCT03636906|Vaccines|vaccines|mesh-list
82904396|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
82904397|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904398|NCT03028870|Naproxen|naproxen|mesh-list
82904399|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82904400|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82904401|NCT03028870|Analgesics|analgesics|mesh-ancestor
82904402|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
82904403|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904404|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904405|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904406|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904407|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
82904408|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82904409|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904410|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904411|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
82904412|NCT01098201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82904413|NCT01098201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904414|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904415|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
82904416|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904417|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904418|NCT01092039|Lactoferrin|lactoferrin|mesh-list
82904419|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904420|NCT03663582|Teduglutide|teduglutide|mesh-list
82904421|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904422|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82904423|NCT03663582|Protective Agents|protective agents|mesh-ancestor
82904424|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904425|NCT01098357|Becaplermin|becaplermin|mesh-list
82904426|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
82904427|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
82904428|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82904429|NCT01098357|Growth Substances|growth substances|mesh-ancestor
82904430|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904431|NCT03730740|Lenalidomide|lenalidomide|mesh-list
82904432|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
82904433|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904434|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82904435|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82904436|NCT03730740|Growth Substances|growth substances|mesh-ancestor
82904437|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
82904438|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904439|NCT01098513|Dolutegravir|dolutegravir|mesh-list
82904440|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82904441|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82904442|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904443|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904444|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82904445|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82904446|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
82904447|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904448|NCT03693976|Xylometazoline|xylometazoline|mesh-list
82904449|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
82904450|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82904451|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
82904452|NCT03730584|Ropivacaine|ropivacaine|mesh-list
82904453|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
82904454|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
82904455|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904456|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904457|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
82904458|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904459|NCT03502616|Tofacitinib|tofacitinib|mesh-list
82904460|NCT03502616|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82904461|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82904462|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904463|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904464|NCT04003012|Lidocaine|lidocaine|mesh-list
82904465|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
82904466|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
82904467|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904468|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904469|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
82904470|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904471|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82904473|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82904474|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904475|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904476|NCT05666076|Bupivacaine|bupivacaine|mesh-list
82904477|NCT05666076|Prilocaine|prilocaine|mesh-list
82904478|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
82904479|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
82904480|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904481|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904482|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
82904483|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904484|NCT03028012|Dexamethasone|dexamethasone|mesh-list
82904485|NCT03028012|Ketorolac|ketorolac|mesh-list
82904486|NCT03028012|Lidocaine|lidocaine|mesh-list
82904487|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904488|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
82904489|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
82904490|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904491|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904492|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904493|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
82904494|NCT03028012|Hormones|hormones|mesh-ancestor
82904495|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904496|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82904497|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904498|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
82904499|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
82904500|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904501|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
82904502|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82904503|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82904504|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82904505|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456414|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904506|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904507|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82904508|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82904509|NCT03028012|Analgesics|analgesics|mesh-ancestor
82904510|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904511|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82904512|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904513|NCT03634800|Nivolumab|nivolumab|mesh-list
82904514|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82904515|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904516|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82904517|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904518|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
82904519|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82904520|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904521|NCT02955186|Saracatinib|saracatinib|mesh-list
82904522|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904523|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904524|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904525|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82904526|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82904527|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82904528|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
82904529|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904530|NCT03690778|Metformin|metformin|mesh-list
82904531|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82904532|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82904533|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904534|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82904535|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82904536|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
82904537|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904538|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82904539|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82904540|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904541|NCT03715634|Buprenorphine|buprenorphine|mesh-list
82904542|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82904543|NCT03715634|Narcotics|narcotics|mesh-ancestor
82904544|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904545|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904546|NCT03715634|Analgesics|analgesics|mesh-ancestor
82904547|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
82904548|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904549|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82904551|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82904552|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904553|NCT04158934|Factor VIII|factor viii|mesh-list
82904554|NCT04158934|BAX 855|bax 855|mesh-list
82904555|NCT04158934|Coagulants|coagulants|mesh-ancestor
82904556|NCT03715556|Amiodarone|amiodarone|mesh-list
82904557|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82904558|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
82904559|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82904560|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904561|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904562|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82904563|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82904564|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82904565|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904566|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82904567|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82904568|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82904569|NCT03715478|Dexamethasone|dexamethasone|mesh-list
82904570|NCT03715478|Pomalidomide|pomalidomide|mesh-list
82904571|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904572|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
82904573|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
82904574|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904575|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904576|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904577|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
82904578|NCT03715478|Hormones|hormones|mesh-ancestor
82904579|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904580|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82904581|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904582|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
82904583|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82904584|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82904585|NCT03715478|Growth Substances|growth substances|mesh-ancestor
82904586|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
82904587|NCT03730038|Pitavastatin|pitavastatin|mesh-list
82904588|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82904589|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82904590|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82904591|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
82904592|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904593|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904594|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82904595|NCT03725904|Progesterone|progesterone|mesh-list
82904596|NCT03725904|Progestins|progestins|mesh-ancestor
82904597|NCT03725904|Hormones|hormones|mesh-ancestor
82904598|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904599|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904600|NCT03730272|Analgesics|analgesics|mesh-list
82904601|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
82904602|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904603|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904604|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
82904605|NCT03585504|Etonogestrel|etonogestrel|mesh-list
82904606|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82904607|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904608|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82904609|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82904610|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
82904611|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82904612|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904613|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904614|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82904615|NCT03690622|Analgesics|analgesics|mesh-ancestor
82904616|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
82904617|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904620|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82904621|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
82904622|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904623|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904625|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82904626|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904627|NCT03687268|Naloxone|naloxone|mesh-list
82904628|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82904629|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904630|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
82904631|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904632|NCT03576066|Tenofovir|tenofovir|mesh-list
82904633|NCT03576066|Entecavir|entecavir|mesh-list
82904634|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
82904635|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904636|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82904637|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82904638|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904639|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904640|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82904641|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82904642|NCT03639480|Amlodipine|amlodipine|mesh-list
82904643|NCT03639480|Valsartan|valsartan|mesh-list
82904644|NCT03639480|Atorvastatin|atorvastatin|mesh-list
82904645|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82904646|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82904647|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
82904648|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904649|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82904650|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82904651|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904652|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82904653|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82904654|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904655|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82904656|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904657|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
82904658|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82904659|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82904660|NCT03689998|Melatonin|melatonin|mesh-list
82904661|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
82904662|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904663|NCT03689998|Protective Agents|protective agents|mesh-ancestor
82904664|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904665|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904666|NCT03948178|Simendan|simendan|mesh-list
82904667|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82904668|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
82904669|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82904670|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82904671|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904672|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904673|NCT03948178|Protective Agents|protective agents|mesh-ancestor
82904674|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904675|NCT03687034|Temozolomide|temozolomide|mesh-list
82904676|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82904677|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
82904678|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904679|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904680|NCT03520920|Rituximab|rituximab|mesh-list
82904681|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
82904682|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82904683|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904684|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
82904685|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904686|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904687|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82904688|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904689|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904690|NCT03686878|Lifitegrast|lifitegrast|mesh-list
82904691|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82904692|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82904693|NCT03682198|Phenylephrine|phenylephrine|mesh-list
82904694|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
82904695|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82904696|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
82904697|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
82904698|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904699|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904700|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
82904701|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82904702|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
82904703|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
82904704|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82904705|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82904706|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82904707|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
82904708|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904709|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904710|NCT03682198|Protective Agents|protective agents|mesh-ancestor
82904711|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
82904712|NCT02953340|Docetaxel|docetaxel|mesh-list
82904713|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904714|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
82904715|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904716|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904717|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82904718|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
82904719|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904720|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904721|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82904722|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
82904723|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
82904724|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
82904725|NCT03554772|Celecoxib|celecoxib|mesh-list
82904726|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82904727|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82904728|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82904729|NCT03554772|Analgesics|analgesics|mesh-ancestor
82904730|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
82904731|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904732|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904733|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904734|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904735|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82904736|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82904737|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904738|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904739|NCT03624010|Simendan|simendan|mesh-list
82904740|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82904741|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
82904742|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82904743|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82904744|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904745|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904746|NCT03624010|Protective Agents|protective agents|mesh-ancestor
82904747|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904748|NCT03686722|Metformin|metformin|mesh-list
82904749|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82904750|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904751|NCT04629976|Tenofovir|tenofovir|mesh-list
82904752|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
82904753|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904754|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82904755|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82904756|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904757|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904758|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82904759|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82904760|NCT03728946|Bupivacaine|bupivacaine|mesh-list
82904761|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
82904762|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
82904763|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904764|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904766|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904767|NCT03553758|Ketamine|ketamine|mesh-list
82904768|NCT03553758|Analgesics|analgesics|mesh-ancestor
82904769|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
82904770|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904771|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904772|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82904773|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82904774|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
82904775|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
82904776|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904777|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82904778|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82904779|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904780|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904781|NCT02954354|Oseltamivir|oseltamivir|mesh-list
82904782|NCT02954354|Baloxavir|baloxavir|mesh-list
82904783|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
82904784|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904785|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904786|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904787|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
82904788|NCT03519516|Levofloxacin|levofloxacin|mesh-list
82904789|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82904790|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82904791|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82904792|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904793|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82904794|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82904795|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904796|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904797|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904798|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82904799|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82904800|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82904801|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
82904802|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
82904803|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904804|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904805|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904806|NCT03519204|Lidocaine|lidocaine|mesh-list
82904807|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
82904808|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
82904809|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904810|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904811|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
82904812|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904813|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82904814|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82904815|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82904816|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82904817|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904819|NCT03624166|Anesthetics|anesthetics|mesh-list
82904820|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
82904821|NCT03624166|Analgesics|analgesics|mesh-ancestor
82904822|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
82904823|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904824|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904825|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82904826|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82904827|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904828|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82904829|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82904830|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82904831|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904832|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
82904833|NCT03518112|Leucovorin|leucovorin|mesh-list
82904834|NCT03518112|Folic Acid|folic acid|mesh-list
82904835|NCT03518112|Cytarabine|cytarabine|mesh-list
82904836|NCT03518112|Dexamethasone|dexamethasone|mesh-list
82904837|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
82904838|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
82904839|NCT03518112|Rituximab|rituximab|mesh-list
82904840|NCT03518112|Methotrexate|methotrexate|mesh-list
82904841|NCT03518112|Vincristine|vincristine|mesh-list
82904842|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
82904843|NCT03518112|Blinatumomab|blinatumomab|mesh-list
82904844|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82904845|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
82904846|NCT03518112|Antibodies|antibodies|mesh-list
82904847|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
82904848|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82904849|NCT03518112|Lenograstim|lenograstim|mesh-list
83456441|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
82904850|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82904851|NCT03518112|BB 1101|bb 1101|mesh-list
82904852|NCT03518112|Calcium|calcium|mesh-list
82904853|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
82904854|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904855|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
82904856|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904857|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904858|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82904859|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
82904860|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904861|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904862|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82904863|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904864|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
82904865|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
82904866|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904867|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904868|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
82904869|NCT03518112|Hormones|hormones|mesh-ancestor
82904870|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904871|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82904872|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
82904873|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904874|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82904875|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82904876|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82904877|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
82904878|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82904879|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82904880|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
82904881|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
82904882|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82904883|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82904884|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
82904885|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82904886|NCT03518112|Antidotes|antidotes|mesh-ancestor
82904887|NCT03518112|Protective Agents|protective agents|mesh-ancestor
82904888|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
82904889|NCT03518112|Vitamins|vitamins|mesh-ancestor
82904890|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
82904891|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82904892|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82904893|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
82904894|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
82904895|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
82904896|NCT03518112|Hematinics|hematinics|mesh-ancestor
82904897|NCT03686254|Bevacizumab|bevacizumab|mesh-list
82904898|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82904899|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904900|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82904901|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82904902|NCT03686254|Growth Substances|growth substances|mesh-ancestor
82904903|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904904|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
82904905|NCT03679780|Nitroprusside|nitroprusside|mesh-list
82904906|NCT03679780|BQ 788|bq 788|mesh-list
82904907|NCT03679780|Nitroarginine|nitroarginine|mesh-list
82904908|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
82904909|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82904910|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
82904911|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82904912|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904913|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82904914|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82904915|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904917|NCT03659734|Narcotics|narcotics|mesh-ancestor
82904918|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904919|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904920|NCT03659734|Analgesics|analgesics|mesh-ancestor
83456456|NCT04347980|Hormones|hormones|mesh-ancestor
82904921|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
82904922|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904923|NCT03680716|Ropivacaine|ropivacaine|mesh-list
82904924|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
82904925|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
82904926|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82904927|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904928|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
82904929|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904930|NCT03680638|Allopurinol|allopurinol|mesh-list
82904931|NCT03680638|Tempol|tempol|mesh-list
82904932|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
82904933|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904934|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82904935|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
82904936|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82904937|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82904938|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
82904939|NCT03680638|Protective Agents|protective agents|mesh-ancestor
82904940|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904941|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82904942|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82904943|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82904944|NCT03680560|Trastuzumab|trastuzumab|mesh-list
82904945|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82904946|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904947|NCT03444298|Vitamin E|vitamin e|mesh-list
82904948|NCT03444298|Tocopherols|tocopherols|mesh-list
82904949|NCT03444298|Tocotrienols|tocotrienols|mesh-list
82904950|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
82904951|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
82904952|NCT03444298|Vitamins|vitamins|mesh-ancestor
82904953|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
82904954|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904955|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
82904956|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904957|NCT03444298|Protective Agents|protective agents|mesh-ancestor
82904958|NCT03640312|Candesartan|candesartan|mesh-list
82904959|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82904960|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82904961|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82904962|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904963|NCT03639610|Dexamethasone|dexamethasone|mesh-list
82904964|NCT03639610|Melphalan|melphalan|mesh-list
82904965|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82904966|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
82904967|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
82904968|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904969|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904970|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82904971|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
82904972|NCT03639610|Hormones|hormones|mesh-ancestor
82904973|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82904974|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82904975|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82904976|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82904977|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
82904978|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82904979|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82904980|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82904981|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
82904982|NCT03680404|Allopurinol|allopurinol|mesh-list
82904983|NCT03680404|Phenylephrine|phenylephrine|mesh-list
82904984|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
82904985|NCT03680404|Tempol|tempol|mesh-list
82904986|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82904987|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
82904988|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
82904989|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82904990|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82904991|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
82904993|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
82904994|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
82904995|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82904996|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82904997|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82904998|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
82904999|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905000|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905001|NCT03680404|Protective Agents|protective agents|mesh-ancestor
82905002|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
82905003|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905004|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
82905005|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905006|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82905007|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
82905008|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82905009|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82905010|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82905011|NCT03685630|Brivaracetam|brivaracetam|mesh-list
82905012|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
82905013|NCT02954406|Rituximab|rituximab|mesh-list
82905014|NCT02954406|Gemcitabine|gemcitabine|mesh-list
82905015|NCT02954406|Lenalidomide|lenalidomide|mesh-list
82905016|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82905017|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82905018|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905019|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
82905020|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905021|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905022|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82905023|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
82905024|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905025|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82905026|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82905027|NCT02954406|Growth Substances|growth substances|mesh-ancestor
82905028|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
82905029|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82905030|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
82905031|NCT01310478|Endostatins|endostatins|mesh-list
82905032|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82905033|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82905034|NCT01310478|Growth Substances|growth substances|mesh-ancestor
82905035|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905036|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
82905037|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905038|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
82905039|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82905040|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
82905041|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905042|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
82905043|NCT03728244|Protective Agents|protective agents|mesh-ancestor
82905044|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82905045|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
82905046|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82905047|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
82905048|NCT03721614|Sirolimus|sirolimus|mesh-list
82905049|NCT03721614|Everolimus|everolimus|mesh-list
82905050|NCT03721614|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82905051|NCT03721614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82905052|NCT03721614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905053|NCT03721614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905054|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905055|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
82905056|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905057|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905058|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905059|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905060|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905061|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
82905062|NCT03727620|Amoxicillin|amoxicillin|mesh-list
82905063|NCT03727620|Metronidazole|metronidazole|mesh-list
82905064|NCT03727620|Doxycycline|doxycycline|mesh-list
82905065|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905066|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905067|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82905069|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
82905070|NCT03727464|Propofol|propofol|mesh-list
82905071|NCT03727464|Sevoflurane|sevoflurane|mesh-list
82905072|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82905073|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905074|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905075|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82905076|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
82905077|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
82905078|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82905079|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82905080|NCT03508830|Bupivacaine|bupivacaine|mesh-list
82905081|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
82905082|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
82905083|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905084|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905085|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
82905086|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905087|NCT03381274|Osimertinib|osimertinib|mesh-list
82905088|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905089|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82905090|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905091|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905092|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82905093|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82905094|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
82905095|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82905096|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
82905097|NCT03724578|Fluorides|fluorides|mesh-list
82905098|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
82905099|NCT03724578|Protective Agents|protective agents|mesh-ancestor
82905100|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905101|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905102|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905103|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
82905104|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905105|NCT03721380|Methadone|methadone|mesh-list
82905106|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82905107|NCT03721380|Narcotics|narcotics|mesh-ancestor
82905108|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905109|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905110|NCT03721380|Analgesics|analgesics|mesh-ancestor
82905111|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
82905112|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905113|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
82905114|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
82905115|NCT03568500|Olanzapine|olanzapine|mesh-list
82905116|NCT03568500|Risperidone|risperidone|mesh-list
82905117|NCT03568500|Aripiprazole|aripiprazole|mesh-list
82905118|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82905119|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82905120|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
82905121|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905122|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905123|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905124|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82905125|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82905126|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905127|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82905128|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82905129|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
82905130|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
82905131|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
82905132|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905133|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905134|NCT03568500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82905135|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82905136|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82905137|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
82905138|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
82905139|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82905140|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82905141|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82905142|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82905144|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82905145|NCT03910738|Testosterone|testosterone|mesh-list
82905146|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
82905147|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
82905148|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82905149|NCT03910738|Androgens|androgens|mesh-ancestor
82905151|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905152|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905153|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82905154|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905155|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
82905156|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82905157|NCT03685084|Piperacillin|piperacillin|mesh-list
82905158|NCT03685084|Cefepime|cefepime|mesh-list
82905159|NCT03685084|Lactams|lactams|mesh-list
82905160|NCT03685084|beta-Lactams|beta-lactams|mesh-list
82905161|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
82905162|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82905163|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905164|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
82905165|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82905166|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905167|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905168|NCT03724266|Chitosan|chitosan|mesh-list
82905169|NCT03724266|Calcium|calcium|mesh-list
82905170|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82905171|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905172|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82905173|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82905174|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
82905175|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905176|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82905177|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
82905178|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
82905179|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
82905180|NCT03724266|Coagulants|coagulants|mesh-ancestor
82905181|NCT03679390|Ketamine|ketamine|mesh-list
82905182|NCT03679390|Analgesics|analgesics|mesh-ancestor
82905183|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
82905184|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905185|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905186|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82905187|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82905188|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
82905189|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
82905190|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905191|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82905192|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82905193|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905194|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905195|NCT03684772|Digoxin|digoxin|mesh-list
82905196|NCT03684772|Furosemide|furosemide|mesh-list
82905197|NCT03684772|Diuretics|diuretics|mesh-ancestor
82905198|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
82905199|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83514982|NCT00377793|Urological Agents|urological agents|mesh-ancestor
82905200|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82905201|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82905202|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905203|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82905204|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82905205|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905206|NCT03684772|Protective Agents|protective agents|mesh-ancestor
82905207|NCT03676114|Ketamine|ketamine|mesh-list
82905208|NCT03676114|Analgesics|analgesics|mesh-ancestor
82905209|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
82905210|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83456472|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82905211|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905212|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82905213|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82905214|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
82905215|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
82905216|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905217|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82905218|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82905219|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905220|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905221|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
82905222|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905223|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
82905224|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82905225|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82905226|NCT03025828|Hormones|hormones|mesh-ancestor
82905227|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905228|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905229|NCT03568630|Chrysarobin|chrysarobin|mesh-list
82905230|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82905231|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82905232|NCT03568630|Analgesics|analgesics|mesh-ancestor
82905233|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
82905234|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905235|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905236|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905237|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905238|NCT03546816|Serlopitant|serlopitant|mesh-list
82905239|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82905240|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905241|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905242|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905243|NCT03675802|Misoprostol|misoprostol|mesh-list
82905244|NCT03675802|Dinoprostone|dinoprostone|mesh-list
82905245|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82905246|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
82905247|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82905248|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905249|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82905250|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905251|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
82905252|NCT03678610|Ionomycin|ionomycin|mesh-list
82905253|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
82905254|NCT03678610|Ionophores|ionophores|mesh-ancestor
82905255|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82905256|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905257|NCT03675646|Morphine|morphine|mesh-list
82905258|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82905259|NCT03675646|Narcotics|narcotics|mesh-ancestor
82905260|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905261|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905262|NCT03675646|Analgesics|analgesics|mesh-ancestor
82905263|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
82905264|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905265|NCT03678532|Midazolam|midazolam|mesh-list
82905266|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82905267|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82905268|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905269|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905270|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82905271|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82905272|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82905273|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82905274|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
82905275|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
82905276|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
82905277|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
82905278|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905279|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905280|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
82905281|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905282|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905283|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82905284|NCT03678142|Vancomycin|vancomycin|mesh-list
82905285|NCT03678142|Imipenem|imipenem|mesh-list
82905286|NCT03678142|Floxacillin|floxacillin|mesh-list
82905287|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905288|NCT03522298|GDC-0084|gdc-0084|mesh-list
82905289|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905290|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905291|NCT03674866|Insulin|insulin|mesh-list
82905292|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905293|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905296|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905297|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905298|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905299|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82905300|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82905301|NCT03683914|Dinoprostone|dinoprostone|mesh-list
82905302|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
82905303|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82905304|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905305|NCT03448406|Empagliflozin|empagliflozin|mesh-list
82905306|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82905307|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905308|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905309|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905310|NCT00064701|Cyclosporine|cyclosporine|mesh-list
82905311|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
82905312|NCT00064701|Tacrolimus|tacrolimus|mesh-list
82905313|NCT00064701|Cyclosporins|cyclosporins|mesh-list
82905314|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905315|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
82905316|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905317|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82905318|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905319|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905320|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
82905321|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905322|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
82905323|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905324|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905325|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905326|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82905327|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
82905328|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905329|NCT00064077|Paclitaxel|paclitaxel|mesh-list
82905330|NCT00064077|Vinorelbine|vinorelbine|mesh-list
82905331|NCT00064077|Cisplatin|cisplatin|mesh-list
82905332|NCT00064077|Gemcitabine|gemcitabine|mesh-list
82905333|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82905334|NCT00064077|Topotecan|topotecan|mesh-list
82905335|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905336|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905337|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905338|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905339|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905340|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905341|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82905342|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
82905343|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82905344|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82905345|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905346|NCT03674008|Propofol|propofol|mesh-list
82905347|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82905348|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905349|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905350|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82905351|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
82905352|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
82905353|NCT00063999|Paclitaxel|paclitaxel|mesh-list
82905354|NCT00063999|Cisplatin|cisplatin|mesh-list
82905355|NCT00063999|Carboplatin|carboplatin|mesh-list
82905356|NCT00063999|Doxorubicin|doxorubicin|mesh-list
82905357|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82905358|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82905359|NCT00063999|Lenograstim|lenograstim|mesh-list
82905360|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905361|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905362|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905363|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905364|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905365|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905366|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905367|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82905368|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82905369|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905370|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82905371|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
82905372|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905373|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
82905374|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82905375|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905376|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905377|NCT02878798|Topiramate|topiramate|mesh-list
82905378|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
82905379|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905380|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905381|NCT03673384|Fluticasone|fluticasone|mesh-list
82905383|NCT03673384|Histamine|histamine|mesh-list
82905384|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905385|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82905386|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
82905387|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905388|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905389|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82905390|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
82905391|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
82905392|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82905393|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
82905394|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
82905395|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905396|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905397|NCT02915302|Vaccines|vaccines|mesh-list
82905398|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
82905399|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905400|NCT03023878|Dexamethasone|dexamethasone|mesh-list
82905401|NCT03023878|Blinatumomab|blinatumomab|mesh-list
82905402|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905403|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
82905404|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
82905405|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905406|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905407|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905408|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
82905409|NCT03023878|Hormones|hormones|mesh-ancestor
82905410|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905411|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82905412|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905413|NCT03670888|Rituximab|rituximab|mesh-list
82905414|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82905415|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905416|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
82905417|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905418|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905419|NCT03023722|Maytansine|maytansine|mesh-list
82905420|NCT03023722|Anetumab ravtansine|anetumab ravtansine|mesh-list
82905421|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905422|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905423|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905424|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905425|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905426|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905427|NCT03023722|Immunoconjugates|immunoconjugates|mesh-ancestor
82905428|NCT03023722|Immunologic Factors|immunologic factors|mesh-ancestor
82905429|NCT03023722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905430|NCT03623230|Bupivacaine|bupivacaine|mesh-list
82905431|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82905432|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
82905433|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
82905434|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905435|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905436|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
82905437|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905438|NCT02624596|Midazolam|midazolam|mesh-list
82905439|NCT02624596|Ketamine|ketamine|mesh-list
82905440|NCT02624596|Analgesics|analgesics|mesh-ancestor
82905441|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
82905442|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905443|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905444|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82905445|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82905446|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
82905447|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
82905448|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905449|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82905450|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82905451|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905452|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905453|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82905454|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82905455|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82905456|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82905457|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82905458|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
82905459|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
82905460|NCT03669562|Alprostadil|alprostadil|mesh-list
82905461|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82905462|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
82905463|NCT03669562|Urological Agents|urological agents|mesh-ancestor
82905464|NCT03669484|Fentanyl|fentanyl|mesh-list
82905465|NCT03669484|Bromides|bromides|mesh-list
82905466|NCT03669484|Propofol|propofol|mesh-list
82905467|NCT03669484|Rocuronium|rocuronium|mesh-list
82905468|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82905469|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905470|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905471|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82905472|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
82905473|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
82905474|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82905475|NCT03669484|Narcotics|narcotics|mesh-ancestor
82905476|NCT03669484|Analgesics|analgesics|mesh-ancestor
82905477|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
82905478|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905479|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82905480|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
82905481|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82905482|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82905483|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82905484|NCT02159404|Immunomodulating Agents|immunomodulating agents|mesh-list
82905485|NCT02159404|Immunologic Factors|immunologic factors|mesh-ancestor
82905486|NCT02159404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905487|NCT01979536|Cytarabine|cytarabine|mesh-list
82905488|NCT01979536|Dexamethasone|dexamethasone|mesh-list
82905489|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
82905490|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
82905491|NCT01979536|Ifosfamide|ifosfamide|mesh-list
82905492|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
82905493|NCT01979536|Doxorubicin|doxorubicin|mesh-list
82905494|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82905495|NCT01979536|Methotrexate|methotrexate|mesh-list
82905496|NCT01979536|Etoposide|etoposide|mesh-list
82905497|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
82905498|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82905499|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
82905500|NCT01979536|Crizotinib|crizotinib|mesh-list
82905501|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82905502|NCT01979536|Antibodies|antibodies|mesh-list
82905503|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
82905504|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82905505|NCT01979536|BB 1101|bb 1101|mesh-list
82905506|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
82905507|NCT01979536|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82905508|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905509|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
82905510|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905511|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905512|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82905513|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
82905514|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905515|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905516|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82905517|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905519|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
82905520|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905521|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905522|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
82905523|NCT01979536|Hormones|hormones|mesh-ancestor
82905524|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905525|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82905526|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
82905527|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905528|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905529|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82905530|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82905531|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82905532|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
82905533|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82905534|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82905535|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
82905536|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
82905537|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82905538|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82905539|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905540|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
82905541|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905542|NCT01979536|Immunotoxins|immunotoxins|mesh-ancestor
82905543|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
82905544|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905545|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905546|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905547|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82905548|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
82905549|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905550|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905551|NCT03668860|Dexamethasone|dexamethasone|mesh-list
82905552|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
82905553|NCT03668860|Betamethasone|betamethasone|mesh-list
82905554|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
82905555|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82905556|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
82905557|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
82905558|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82905559|NCT03668860|BB 1101|bb 1101|mesh-list
82905560|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905561|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
82905562|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
82905563|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905564|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905565|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905566|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
82905567|NCT03668860|Hormones|hormones|mesh-ancestor
82905568|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905569|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82905570|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905571|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
82905572|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905573|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905574|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82905575|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
82905576|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82905577|NCT00062751|Sirolimus|sirolimus|mesh-list
82905578|NCT00062751|Letrozole|letrozole|mesh-list
82905579|NCT00062751|Temsirolimus|temsirolimus|mesh-list
82905580|NCT00062751|MTOR Inhibitors|mtor inhibitors|mesh-list
82905581|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905582|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82905583|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82905584|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905585|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905586|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82905587|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
82905588|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905589|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905590|NCT00062751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82905591|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905592|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
82905593|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905594|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905595|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905596|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
82905597|NCT00945724|Cytarabine|cytarabine|mesh-list
82905598|NCT00945724|Prednisolone|prednisolone|mesh-list
82905599|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
82905600|NCT00945724|Rituximab|rituximab|mesh-list
82905601|NCT00945724|Doxorubicin|doxorubicin|mesh-list
82905602|NCT00945724|Methotrexate|methotrexate|mesh-list
82905605|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
82905606|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905607|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905608|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82905609|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
82905610|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905611|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905612|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82905613|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82905614|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905615|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82905616|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82905617|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905618|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82905619|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
82905620|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82905621|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82905622|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
82905623|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
82905624|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82905625|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82905626|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
82905627|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905628|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905629|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905630|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905631|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905632|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905633|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
82905634|NCT00945724|Hormones|hormones|mesh-ancestor
82905635|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905636|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82905637|NCT00258310|Capecitabine|capecitabine|mesh-list
82905638|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82905639|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
82905640|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905641|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905642|NCT00062439|Docetaxel|docetaxel|mesh-list
82905643|NCT00062439|Etoposide|etoposide|mesh-list
82905644|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905645|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905646|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905647|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905648|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905649|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905650|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83456491|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
82905651|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82905652|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905653|NCT01099059|Amantadine|amantadine|mesh-list
82905654|NCT01099059|Methylphenidate|methylphenidate|mesh-list
82905655|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82905656|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905657|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82905658|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82905659|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82905660|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905661|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
82905662|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905663|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82905664|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82905665|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
82905666|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905667|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82905668|NCT01099059|Analgesics|analgesics|mesh-ancestor
82905669|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
82905670|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905671|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
82905672|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905673|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82905674|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905675|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905677|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
82905678|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905679|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
82905680|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82905681|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905682|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
82905684|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82905685|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82905686|NCT00031551|Analgesics|analgesics|mesh-ancestor
82905687|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
82905688|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905689|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905690|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905691|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905692|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905693|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905694|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
82905695|NCT01099137|Vildagliptin|vildagliptin|mesh-list
82905696|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905697|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905698|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82905699|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
82905700|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905701|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905702|NCT01092975|Phenylephrine|phenylephrine|mesh-list
82905703|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
82905704|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82905705|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
82905706|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
82905707|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905708|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905709|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
82905710|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82905711|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
82905712|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
82905713|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82905714|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82905715|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82905716|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
82905717|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905718|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905719|NCT01092975|Protective Agents|protective agents|mesh-ancestor
82905720|NCT01584297|Ketoconazole|ketoconazole|mesh-list
82905721|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
82905722|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905723|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82905724|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82905725|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905726|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905727|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82905728|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
82905729|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905730|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905731|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82905732|NCT00049257|Paclitaxel|paclitaxel|mesh-list
82905733|NCT00049257|Carboplatin|carboplatin|mesh-list
82905734|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905735|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905736|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905737|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905738|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905739|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905740|NCT03951987|Charcoal|charcoal|mesh-list
82905741|NCT03951987|Antidotes|antidotes|mesh-ancestor
82905742|NCT03951987|Protective Agents|protective agents|mesh-ancestor
82905743|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905744|NCT03668470|Dulaglutide|dulaglutide|mesh-list
82905745|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905746|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905747|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
82905749|NCT03020992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905750|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905751|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
82905752|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905753|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905754|NCT03020914|Methamphetamine|methamphetamine|mesh-list
82905755|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82905756|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905757|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
82905758|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
82905759|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905760|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
82905761|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905762|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905763|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
82905764|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82905765|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82905766|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82905767|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82905768|NCT03018340|Pimavanserin|pimavanserin|mesh-list
82905769|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82905770|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82905771|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82905772|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82905773|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905774|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905775|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82905776|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82905777|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82905778|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
82905779|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905780|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905781|NCT00048165|Cyclosporine|cyclosporine|mesh-list
82905782|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
82905783|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
82905784|NCT00048165|Cyclosporins|cyclosporins|mesh-list
82905785|NCT00048165|Daclizumab|daclizumab|mesh-list
82905786|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905787|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905788|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905789|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
82905790|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905791|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
82905792|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905793|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
82905794|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905795|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82905796|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905797|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905798|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82905799|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
82905800|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905801|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82905802|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
82905803|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
82905804|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905805|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905806|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
82905807|NCT00048165|Hormones|hormones|mesh-ancestor
82905808|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905809|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82905810|NCT00048165|Protective Agents|protective agents|mesh-ancestor
82905811|NCT01099527|Capecitabine|capecitabine|mesh-list
82905812|NCT01099527|Everolimus|everolimus|mesh-list
82905813|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82905814|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
82905815|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905816|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905817|NCT01099527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82905818|NCT01099527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82905819|NCT01099527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905820|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905821|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
82905823|NCT01093365|Varenicline|varenicline|mesh-list
82905824|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82905825|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82905826|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
82905827|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905828|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905829|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905830|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
82905831|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82905832|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
82905833|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905834|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
82905835|NCT03955497|Protective Agents|protective agents|mesh-ancestor
82905836|NCT01099605|Bupivacaine|bupivacaine|mesh-list
82905837|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
82905838|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
82905839|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905840|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905841|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
82905842|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905843|NCT00059787|Paclitaxel|paclitaxel|mesh-list
82905844|NCT00059787|Carboplatin|carboplatin|mesh-list
82905845|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82905846|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82905847|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905848|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905849|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905850|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905851|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905852|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82905853|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905854|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
82905855|NCT01099839|Miglitol|miglitol|mesh-list
82905856|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82905857|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905858|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905859|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456514|NCT02255799|Donepezil|donepezil|mesh-list
82905860|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905861|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82905862|NCT00058539|Pertuzumab|pertuzumab|mesh-list
82905863|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82905864|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905865|NCT03956823|Amlodipine|amlodipine|mesh-list
82905866|NCT03956823|Telmisartan|telmisartan|mesh-list
82905867|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82905868|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82905869|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82905870|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905871|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82905872|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905873|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
82905874|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82905875|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82905876|NCT03015532|Bupivacaine|bupivacaine|mesh-list
82905877|NCT03015532|Ropivacaine|ropivacaine|mesh-list
82905878|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
82905879|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
82905880|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905881|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905882|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
82905883|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905884|NCT03954873|Glucagon|glucagon|mesh-list
82905885|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82905886|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905887|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82905888|NCT03954873|Hormones|hormones|mesh-ancestor
83482927|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905889|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905890|NCT03954873|Incretins|incretins|mesh-ancestor
82905891|NCT03951831|Docetaxel|docetaxel|mesh-list
82905892|NCT03951831|Leuprolide|leuprolide|mesh-list
82905893|NCT03951831|Cemiplimab|cemiplimab|mesh-list
82905894|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905895|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905896|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905897|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905898|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905899|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82905900|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
82905901|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82905902|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905903|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82905904|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82905905|NCT03954639|Bupivacaine|bupivacaine|mesh-list
82905906|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
82905907|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
82905908|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905909|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905910|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
82905911|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82905913|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82905914|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
82905915|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905916|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905917|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82905918|NCT03015220|Dulaglutide|dulaglutide|mesh-list
82905919|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905920|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905921|NCT00022659|Bevacizumab|bevacizumab|mesh-list
82905922|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82905923|NCT00022659|Antibodies|antibodies|mesh-list
82905924|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
82905925|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82905926|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905927|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82905928|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82905929|NCT00022659|Growth Substances|growth substances|mesh-ancestor
82905930|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905931|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
82905932|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
82905933|NCT03018106|Estrogens|estrogens|mesh-list
82905934|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82905935|NCT03018106|Hormones|hormones|mesh-ancestor
82905936|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905937|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905938|NCT03018028|Liraglutide|liraglutide|mesh-list
82905939|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905940|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905941|NCT03018028|Incretins|incretins|mesh-ancestor
82905942|NCT03018028|Hormones|hormones|mesh-ancestor
82905943|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905944|NCT03667222|Minocycline|minocycline|mesh-list
82905945|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82905946|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82905947|NCT03667300|Linagliptin|linagliptin|mesh-list
82905948|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82905949|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905950|NCT03667300|Incretins|incretins|mesh-ancestor
82905951|NCT03667300|Hormones|hormones|mesh-ancestor
82905952|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82905953|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82905954|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
82905955|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905956|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905957|NCT03667066|Clopidogrel|clopidogrel|mesh-list
82905958|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82905959|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82905960|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82905961|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82905962|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
82905963|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905964|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905965|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905966|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
82905967|NCT00021255|Carboplatin|carboplatin|mesh-list
82905968|NCT00021255|Docetaxel|docetaxel|mesh-list
82905969|NCT00021255|Doxorubicin|doxorubicin|mesh-list
82905971|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82905972|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
82905973|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905974|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82905975|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82905976|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
82905977|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82905978|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82905979|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82905980|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
82905981|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
82905982|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
82905983|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82905984|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82905985|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82905986|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82905987|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82905988|NCT03012334|Alprazolam|alprazolam|mesh-list
82905989|NCT03012334|Lasmiditan|lasmiditan|mesh-list
82905990|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82905991|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82905992|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82905993|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82905994|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82905995|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82905996|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
82905997|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
82905998|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82905999|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906000|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82906001|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
82906002|NCT03951285|Niacinamide|niacinamide|mesh-list
82906003|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
82906004|NCT03951285|Vitamins|vitamins|mesh-ancestor
82906005|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
82906006|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906007|NCT04571944|Suvorexant|suvorexant|mesh-list
82906008|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82906009|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82906010|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906011|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906012|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82906013|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906014|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906015|NCT04052932|Allopurinol|allopurinol|mesh-list
82906016|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
82906017|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906018|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906019|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
82906020|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906021|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82906022|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
82906023|NCT04052932|Protective Agents|protective agents|mesh-ancestor
82906024|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906025|NCT03006562|Heparin|heparin|mesh-list
82906026|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
82906027|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82906028|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82906029|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906030|NCT03666208|Sirolimus|sirolimus|mesh-list
82906031|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906032|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906033|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82906034|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906035|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
82906036|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82906037|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
82906038|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906039|NCT03007966|Clonidine|clonidine|mesh-list
82906041|NCT03007966|Bupivacaine|bupivacaine|mesh-list
82906042|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
82906043|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
82906044|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906045|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906046|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
82906047|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906048|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82906049|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82906050|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
82906051|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906052|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906053|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82906054|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82906055|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
82906056|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82906057|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
82906058|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
82906059|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
82906060|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82906061|NCT03007966|Analgesics|analgesics|mesh-ancestor
82906062|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82906063|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
82906064|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82906065|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82906066|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82906067|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
82906068|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906069|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82906070|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82906071|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
83456524|NCT02226159|Lidocaine|lidocaine|mesh-list
82906072|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
82906073|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906074|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906075|NCT03541044|Nicotine|nicotine|mesh-list
82906076|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82906077|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
82906078|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906079|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906080|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82906081|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82906082|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
82906083|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906084|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906085|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
82906086|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82906087|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906088|NCT03540030|Acetaminophen|acetaminophen|mesh-list
82906089|NCT03540030|Celecoxib|celecoxib|mesh-list
82906090|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82906091|NCT03540030|Lidocaine|lidocaine|mesh-list
82906092|NCT03540030|Gabapentin|gabapentin|mesh-list
82906093|NCT03540030|Propofol|propofol|mesh-list
82906094|NCT03540030|Sevoflurane|sevoflurane|mesh-list
82906095|NCT03540030|Desflurane|desflurane|mesh-list
82906096|NCT03540030|Rocuronium|rocuronium|mesh-list
82906097|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
82906098|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
82906099|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
82906100|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906101|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906102|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
82906103|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906104|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82906105|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82906106|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82906107|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82906108|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906109|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82906110|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82906111|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
82906112|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906113|NCT03540030|Analgesics|analgesics|mesh-ancestor
82906114|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
82906115|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82906116|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82906117|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82906118|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906119|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906120|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82906121|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82906124|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82906125|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82906126|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82906127|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82906128|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82906129|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906130|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
82906131|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82906132|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82906133|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82906134|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82906135|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82906136|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
82906137|NCT00008385|Selenium|selenium|mesh-list
82906138|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
82906139|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906140|NCT00008385|Protective Agents|protective agents|mesh-ancestor
82906141|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906142|NCT00008385|Trace Elements|trace elements|mesh-ancestor
82906143|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
82906144|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
82906145|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
82906146|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82906147|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
82906148|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906149|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906150|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82906151|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
82906152|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906153|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906154|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82906155|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906156|NCT03003676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82906157|NCT03665740|Resveratrol|resveratrol|mesh-list
82906158|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
82906159|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906160|NCT03665740|Protective Agents|protective agents|mesh-ancestor
82906161|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906162|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906163|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82906164|NCT03665350|Insulin|insulin|mesh-list
82906165|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906166|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906167|NCT03665428|Bismuth|bismuth|mesh-list
82906168|NCT03665428|Antacids|antacids|mesh-ancestor
82906169|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906170|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82906171|NCT03669328|Anesthetics|anesthetics|mesh-list
82906172|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906173|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906174|NCT02912650|Acetaminophen|acetaminophen|mesh-list
82906175|NCT02912650|Ibuprofen|ibuprofen|mesh-list
82906176|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906177|NCT02912650|Analgesics|analgesics|mesh-ancestor
82906178|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
82906179|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906180|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906181|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
82906182|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82906183|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906184|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906185|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82906186|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906187|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906188|NCT03002038|Rituximab|rituximab|mesh-list
82906189|NCT03002038|Azathioprine|azathioprine|mesh-list
82906190|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906191|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906192|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
82906193|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906194|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906195|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
82906196|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906198|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82906199|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
82906200|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82906201|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906202|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906203|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82906204|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82906205|NCT03664414|Protective Agents|protective agents|mesh-ancestor
82906206|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906207|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
82906208|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82906209|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
82906210|NCT02911948|Insulin|insulin|mesh-list
82906211|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82906212|NCT02911948|Liraglutide|liraglutide|mesh-list
82906213|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
82906214|NCT02911948|Xultophy|xultophy|mesh-list
82906215|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906216|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906217|NCT02911948|Incretins|incretins|mesh-ancestor
82906218|NCT02911948|Hormones|hormones|mesh-ancestor
82906219|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906220|NCT03622918|Rifampin|rifampin|mesh-list
82906221|NCT03622918|Colistin|colistin|mesh-list
82906222|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82906223|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
82906224|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906225|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906226|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
82906227|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82906228|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906229|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906230|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82906231|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82906232|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82906233|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82906234|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82906235|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82906236|NCT03487666|Capecitabine|capecitabine|mesh-list
82906237|NCT03487666|Nivolumab|nivolumab|mesh-list
82906238|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82906239|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
82906240|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906241|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906242|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906243|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82906244|NCT03376672|Dexamethasone|dexamethasone|mesh-list
82906245|NCT03376672|Lenalidomide|lenalidomide|mesh-list
82906246|NCT03376672|Ixazomib|ixazomib|mesh-list
82906247|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906248|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
82906249|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
82906250|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906251|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906252|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82906253|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
82906254|NCT03376672|Hormones|hormones|mesh-ancestor
82906255|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906256|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82906257|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906258|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
82906259|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82906260|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82906261|NCT03376672|Growth Substances|growth substances|mesh-ancestor
82906262|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
82906263|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
82906264|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906265|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906266|NCT03367312|Xenon|xenon|mesh-list
82906267|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82906268|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
82906269|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
82906271|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906273|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906274|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906275|NCT00046839|Celecoxib|celecoxib|mesh-list
82906276|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
82906277|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82906278|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906279|NCT00046839|Analgesics|analgesics|mesh-ancestor
82906280|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
82906281|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906282|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906283|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906284|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906285|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82906286|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906287|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906288|NCT00006903|Fulvestrant|fulvestrant|mesh-list
82906289|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82906290|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906291|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82906292|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82906293|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
82906294|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906295|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906296|NCT03951597|Gemcitabine|gemcitabine|mesh-list
82906297|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
82906298|NCT03951597|Lenvatinib|lenvatinib|mesh-list
82906299|NCT03951597|Antibodies|antibodies|mesh-list
82906300|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
82906301|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906302|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82906303|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
82906304|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906305|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906306|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82906307|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906308|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
82906309|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906310|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906311|NCT01101009|Amlodipine|amlodipine|mesh-list
82906312|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82906313|NCT01101009|Olmesartan|olmesartan|mesh-list
82906314|NCT01101009|Perindopril|perindopril|mesh-list
82906315|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82906316|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82906317|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82906318|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906319|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82906320|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906321|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
82906322|NCT01101009|Diuretics|diuretics|mesh-ancestor
82906323|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
82906324|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82906325|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82906326|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82906327|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82906328|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
82906329|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906330|NCT02996500|Tofacitinib|tofacitinib|mesh-list
82906331|NCT02996500|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82906332|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82906333|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906334|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906335|NCT00006489|Naltrexone|naltrexone|mesh-list
82906336|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82906337|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82906338|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906339|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
82906340|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906341|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
82906346|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906348|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82906349|NCT00025233|Antibodies|antibodies|mesh-list
82906350|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
82906351|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82906352|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906353|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82906354|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82906355|NCT00025233|Growth Substances|growth substances|mesh-ancestor
82906356|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906357|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
82906358|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
82906359|NCT00025155|Epothilones|epothilones|mesh-list
82906360|NCT00025155|Epothilone B|epothilone b|mesh-list
82906361|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
82906362|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
82906363|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
82906364|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906365|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906366|NCT02998996|Endocine|endocine|mesh-list
82906367|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82906368|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
82906369|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906370|NCT03663478|Ropivacaine|ropivacaine|mesh-list
82906371|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
82906372|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
82906373|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906374|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906375|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
82906376|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906377|NCT02994940|Acetaminophen|acetaminophen|mesh-list
82906378|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906379|NCT02994940|Analgesics|analgesics|mesh-ancestor
82906380|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
82906381|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906382|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906383|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
82906384|NCT04053322|Durvalumab|durvalumab|mesh-list
82906385|NCT04053322|Fulvestrant|fulvestrant|mesh-list
82906386|NCT04053322|Olaparib|olaparib|mesh-list
82906387|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906388|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906389|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82906390|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82906391|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82906392|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
82906393|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906394|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906395|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82906396|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906397|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906398|NCT02994394|Tolvaptan|tolvaptan|mesh-list
82906399|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83456563|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82906400|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906401|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
82906402|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906403|NCT01063270|Rifampin|rifampin|mesh-list
82906404|NCT01063270|Clindamycin|clindamycin|mesh-list
82906405|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
82906406|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
82906407|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82906408|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
82906409|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906410|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906411|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
82906412|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82906413|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906424|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82906425|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906426|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
82906427|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
82906428|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
82906429|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906430|NCT01069900|Amoxicillin|amoxicillin|mesh-list
82906431|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
82906432|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
82906433|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
82906434|NCT01069900|Ertapenem|ertapenem|mesh-list
83482928|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
82906435|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82906436|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82906437|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906438|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906439|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82906440|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82906441|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906442|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906443|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906444|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82906445|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
82906446|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82906447|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906448|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82906449|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82906450|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82906451|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82906452|NCT00006237|Interferons|interferons|mesh-list
82906453|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
82906454|NCT00006237|Aldesleukin|aldesleukin|mesh-list
82906455|NCT00006237|Interleukin-2|interleukin-2|mesh-list
82906456|NCT00006237|Dacarbazine|dacarbazine|mesh-list
82906457|NCT00006237|Vinblastine|vinblastine|mesh-list
82906458|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906459|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
82906460|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906461|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
82906462|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906463|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906464|NCT00006237|Analgesics|analgesics|mesh-ancestor
82906465|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
82906466|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906467|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82906468|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82906469|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82906470|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
82906471|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906472|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82906473|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
82906474|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
82906475|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
82906476|NCT04056754|Prednisone|prednisone|mesh-list
82906477|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
82906478|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906479|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
82906481|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906482|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906483|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82906484|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906485|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82906486|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906487|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906488|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
82906489|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82906490|NCT04056442|Cannabidiol|cannabidiol|mesh-list
82906491|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
82906492|NCT03661684|Prednisone|prednisone|mesh-list
82906493|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906494|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
82906495|NCT03661684|Hormones|hormones|mesh-ancestor
82906496|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906497|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906498|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82906499|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906500|NCT02993926|Leuprolide|leuprolide|mesh-list
82906501|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82906502|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
82906503|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82906504|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906505|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82906506|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906507|NCT04055506|Ritonavir|ritonavir|mesh-list
82906508|NCT04055506|Deucravacitinib|deucravacitinib|mesh-list
82906509|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82906510|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82906511|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
82906512|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906513|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906514|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82906515|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82906516|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
82906517|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906518|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82906519|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82906520|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
82906521|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82906522|NCT02993224|Deferasirox|deferasirox|mesh-list
82906523|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82906524|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
82906525|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
82906526|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906527|NCT02992132|Pimavanserin|pimavanserin|mesh-list
82906528|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82906529|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82906530|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82906531|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82906532|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906533|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906534|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82906535|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82906536|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82906537|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
82906538|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906539|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906540|NCT03444584|Metformin|metformin|mesh-list
82906541|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906542|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906543|NCT03717740|Esomeprazole|esomeprazole|mesh-list
82906544|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82906545|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82906546|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82906547|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906548|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906549|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
82906550|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82906551|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83456587|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906552|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906553|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82906554|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906555|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82906557|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82906558|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
82906559|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906560|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906561|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82906562|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82906563|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
82906564|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906565|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906566|NCT03494816|Axitinib|axitinib|mesh-list
82906567|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906568|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82906569|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906570|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906571|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
82906572|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
82906573|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82906574|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906575|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906576|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
82906577|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82906578|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906579|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906580|NCT03713762|Lidocaine|lidocaine|mesh-list
82906581|NCT03713762|Fentanyl|fentanyl|mesh-list
82906582|NCT03713762|Bupivacaine|bupivacaine|mesh-list
82906583|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
82906584|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
82906585|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906586|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906587|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
82906588|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906589|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82906590|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82906591|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82906592|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82906593|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906594|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82906595|NCT03713762|Narcotics|narcotics|mesh-ancestor
82906596|NCT03713762|Analgesics|analgesics|mesh-ancestor
82906597|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82906598|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82906599|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
82906600|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82906601|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82906602|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
82906603|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906604|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82906605|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906606|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906607|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906608|NCT02991040|Lidocaine|lidocaine|mesh-list
82906609|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
82906610|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
82906611|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906612|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906613|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
82906614|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906615|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82906616|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82906617|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82906618|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82906619|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906620|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
82906621|NCT03660436|Deucravacitinib|deucravacitinib|mesh-list
82906622|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82906624|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82906625|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
82906626|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906627|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906628|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906629|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906630|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
82906631|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82906632|NCT03662620|Amlodipine|amlodipine|mesh-list
82906633|NCT03662620|Telmisartan|telmisartan|mesh-list
82906634|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
82906635|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82906636|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82906637|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82906638|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906639|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82906640|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906641|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
82906642|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82906643|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82906644|NCT03662620|Diuretics|diuretics|mesh-ancestor
82906645|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
82906646|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82906647|NCT03415178|Atorvastatin|atorvastatin|mesh-list
82906648|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82906649|NCT03415178|Alirocumab|alirocumab|mesh-list
82906650|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82906651|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82906652|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
82906653|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906654|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82906655|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82906656|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906657|NCT03415178|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82906659|NCT03415178|Protease Inhibitors|protease inhibitors|mesh-ancestor
82906660|NCT01068730|Metformin|metformin|mesh-list
82906661|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906662|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906663|NCT01068652|Insulin|insulin|mesh-list
82906664|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82906665|NCT01068652|Metformin|metformin|mesh-list
82906666|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
82906667|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
82906668|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82906669|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
82906670|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
82906671|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82906672|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906673|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906674|NCT03658720|Ibuprofen|ibuprofen|mesh-list
82906675|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82906676|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906677|NCT03658720|Analgesics|analgesics|mesh-ancestor
82906678|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
82906679|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906680|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906681|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906682|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906683|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82906684|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906685|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906686|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
82906687|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82906688|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82906689|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906690|NCT03658330|Naltrexone|naltrexone|mesh-list
82906691|NCT03658330|Ketamine|ketamine|mesh-list
82906692|NCT03658330|Analgesics|analgesics|mesh-ancestor
82906693|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
82906694|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906695|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906696|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82906697|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82906698|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
82906699|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
82906700|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906701|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82906702|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82906703|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906704|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906705|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82906706|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82906707|NCT02920528|Ketamine|ketamine|mesh-list
82906708|NCT02920528|Analgesics|analgesics|mesh-ancestor
82906709|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
82906710|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906711|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906712|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82906713|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82906714|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
82906715|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
82906716|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906717|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82906718|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82906719|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906720|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906721|NCT01068418|Vitamin D|vitamin d|mesh-list
82906722|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
82906723|NCT01068418|Vitamins|vitamins|mesh-ancestor
82906724|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
82906725|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906726|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82906727|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82906728|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
82906729|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906730|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906731|NCT03657550|Niacin|niacin|mesh-list
82906732|NCT03657550|Amlodipine|amlodipine|mesh-list
82906733|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82906734|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82906735|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82906736|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906737|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82906738|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906739|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
82906740|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82906741|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
82906742|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82906743|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
82906744|NCT03657550|Vitamins|vitamins|mesh-ancestor
82906745|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
82906746|NCT02920450|Paclitaxel|paclitaxel|mesh-list
82906747|NCT02920450|Carboplatin|carboplatin|mesh-list
82906748|NCT02920450|Gedatolisib|gedatolisib|mesh-list
82906749|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82906750|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906751|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
82906752|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
82906753|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
82906754|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906755|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82906756|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906757|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
82906758|NCT03622450|Levofloxacin|levofloxacin|mesh-list
82906759|NCT03622450|Gentamicins|gentamicins|mesh-list
82906760|NCT03622450|Meropenem|meropenem|mesh-list
82906761|NCT03622450|Amikacin|amikacin|mesh-list
82906762|NCT03622450|Colistin|colistin|mesh-list
82906763|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906764|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906765|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82906766|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82906767|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906768|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906769|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906770|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82906771|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82906772|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82906773|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82906774|NCT03657862|Fluorides|fluorides|mesh-list
82906775|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
82906776|NCT03657862|Protective Agents|protective agents|mesh-ancestor
82906777|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906778|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
82906779|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906780|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906781|NCT02730130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82906782|NCT02730130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906783|NCT02919436|Tamsulosin|tamsulosin|mesh-list
82906784|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82906785|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82906786|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82906787|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
82906788|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906789|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906790|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906791|NCT02919436|Urological Agents|urological agents|mesh-ancestor
82906792|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
82906793|NCT03657472|Atorvastatin|atorvastatin|mesh-list
82906794|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82906795|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82906796|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
82906797|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906798|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82906799|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82906800|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906801|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82906802|NCT04440358|Carboplatin|carboplatin|mesh-list
82906803|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906804|NCT04438330|Nickel|nickel|mesh-list
82906805|NCT04438330|Trace Elements|trace elements|mesh-ancestor
82906806|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
83482929|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
82906807|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906808|NCT03803475|Edetic Acid|edetic acid|mesh-list
82906809|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82906810|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
82906811|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
82906812|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906813|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
82906814|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82906815|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82906816|NCT02682004|Serotonin|serotonin|mesh-list
82906817|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82906818|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
82906819|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906820|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906821|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906822|NCT00005937|Cyclosporine|cyclosporine|mesh-list
82906823|NCT00005937|Cyclosporins|cyclosporins|mesh-list
82906824|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82906825|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906826|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906827|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82906828|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
82906829|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906830|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
82906831|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906832|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
82906833|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906834|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82906835|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
82906836|NCT01096329|Testosterone|testosterone|mesh-list
82906837|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
82906838|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
82906839|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82906840|NCT01096329|Androgens|androgens|mesh-ancestor
82906841|NCT01096329|Hormones|hormones|mesh-ancestor
82906842|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906843|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906844|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82906845|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906846|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
82906848|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82906849|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82906850|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906851|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
82906852|NCT02908516|Coagulants|coagulants|mesh-ancestor
82906853|NCT03717350|Meropenem|meropenem|mesh-list
82906854|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906855|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906856|NCT03713372|Antibodies|antibodies|mesh-list
82906857|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82906858|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
82906859|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906860|NCT03656614|Neostigmine|neostigmine|mesh-list
82906861|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82906862|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906863|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906864|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
82906865|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906866|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906867|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82906868|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
82906869|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906870|NCT02906644|Nicotine|nicotine|mesh-list
82906871|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82906872|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
82906873|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906874|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906875|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82906876|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82906877|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
82906878|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906879|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906880|NCT02982772|Nicotine|nicotine|mesh-list
82906881|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82906882|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
82906883|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906884|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906885|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82906886|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82906887|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
82906888|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906889|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906890|NCT03713216|Morphine|morphine|mesh-list
82906891|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82906892|NCT03713216|Narcotics|narcotics|mesh-ancestor
82906893|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82906894|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906895|NCT03713216|Analgesics|analgesics|mesh-ancestor
82906896|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
82906897|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906898|NCT02098954|Gemcitabine|gemcitabine|mesh-list
82906899|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82906900|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82906901|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
82906902|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906903|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83456603|NCT03242590|Androgens|androgens|mesh-ancestor
82906904|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82906905|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906906|NCT03655834|Pemetrexed|pemetrexed|mesh-list
82906907|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906908|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906909|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906910|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82906911|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82906912|NCT03488108|Minoxidil|minoxidil|mesh-list
82906913|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82906914|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
82906915|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
82906916|NCT03712670|Aflibercept|aflibercept|mesh-list
82906917|NCT03712670|Carotenoids|carotenoids|mesh-list
82906918|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82906919|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82906920|NCT03712670|Growth Substances|growth substances|mesh-ancestor
82906921|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906922|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
82906923|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906924|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
82906925|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906926|NCT03712670|Protective Agents|protective agents|mesh-ancestor
82906927|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82906928|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82906929|NCT03712670|Analgesics|analgesics|mesh-ancestor
82906930|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
82906931|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82906932|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82906933|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906934|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
82906935|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
82906936|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82906937|NCT03486392|Liraglutide|liraglutide|mesh-list
82906938|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82906939|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906940|NCT03486392|Incretins|incretins|mesh-ancestor
82906941|NCT03486392|Hormones|hormones|mesh-ancestor
82906942|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82906943|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
82906944|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
82906945|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
82906946|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906947|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82906948|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82906949|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82906950|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
82906951|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906952|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906953|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82906954|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82906955|NCT02981524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82906956|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
82906957|NCT04297150|Apixaban|apixaban|mesh-list
82906958|NCT04297150|Edoxaban|edoxaban|mesh-list
82906959|NCT04297150|Dabigatran|dabigatran|mesh-list
82906960|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82906961|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
82906962|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82906963|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
82906964|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906965|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906966|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
82906967|NCT03486314|Rifampin|rifampin|mesh-list
82906968|NCT03486314|Paclitaxel|paclitaxel|mesh-list
82906969|NCT03486314|Docetaxel|docetaxel|mesh-list
82906970|NCT03486314|Carboplatin|carboplatin|mesh-list
82906971|NCT03486314|Pevonedistat|pevonedistat|mesh-list
82906972|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82906973|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82906974|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
82906975|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
82906976|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
83456613|NCT03345160|Immunomodulating Agents|immunomodulating agents|mesh-list
82906977|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906978|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82906979|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
82906980|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82906981|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82906982|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
82906983|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82906984|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82906985|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82906986|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82906987|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82906988|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82906989|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82906990|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82906991|NCT02975206|Serlopitant|serlopitant|mesh-list
82906992|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82906993|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82906994|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82906995|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82906996|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82906997|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82906998|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
82906999|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82907000|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82907001|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82907002|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907003|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907004|NCT02980042|Rituximab|rituximab|mesh-list
82907005|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
82907006|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907007|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907008|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
82907009|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907010|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907011|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
82907012|NCT01066000|Hematinics|hematinics|mesh-ancestor
82907013|NCT01065844|Nelfinavir|nelfinavir|mesh-list
82907014|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82907015|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82907016|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
82907017|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907018|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907019|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82907020|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82907021|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
82907022|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907023|NCT00004635|Thalidomide|thalidomide|mesh-list
82907024|NCT00004635|Leuprolide|leuprolide|mesh-list
82907025|NCT00004635|Goserelin|goserelin|mesh-list
82907026|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82907027|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
82907028|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907029|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
82907030|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82907031|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907032|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82907033|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82907034|NCT00004635|Growth Substances|growth substances|mesh-ancestor
82907035|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
82907036|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907037|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82907038|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
82907039|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82907040|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907041|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
82907042|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82907043|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
82907044|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907045|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907046|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82907047|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
82907048|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907049|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907050|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82907052|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82907053|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82907054|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82907055|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82907056|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907057|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
82907058|NCT01103115|Vitamin D|vitamin d|mesh-list
82907059|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
82907060|NCT01103115|Calcium|calcium|mesh-list
82907061|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82907062|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907063|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82907064|NCT01103115|Vitamins|vitamins|mesh-ancestor
82907065|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
82907066|NCT01103115|Antacids|antacids|mesh-ancestor
82907067|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907068|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907069|NCT01103193|Remifentanil|remifentanil|mesh-list
82907070|NCT01103193|Sevoflurane|sevoflurane|mesh-list
82907071|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82907072|NCT01103193|Narcotics|narcotics|mesh-ancestor
82907073|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907075|NCT01103193|Analgesics|analgesics|mesh-ancestor
82907076|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
82907077|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907078|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82907079|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82907080|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
82907081|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
82907083|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82907084|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82907085|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82907086|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82907087|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82907088|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
82907089|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907090|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907091|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82907092|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
82907093|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
82907094|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
82907095|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82907096|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82907097|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
82907098|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907099|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907100|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
82907101|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82907102|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
82907103|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82907104|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907105|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82907106|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82907107|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82907108|NCT00003645|Leuprolide|leuprolide|mesh-list
82907109|NCT00003645|Goserelin|goserelin|mesh-list
82907110|NCT00003645|Flutamide|flutamide|mesh-list
82907111|NCT00003645|Bicalutamide|bicalutamide|mesh-list
82907112|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82907113|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
82907114|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82907115|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907116|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907117|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907118|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
82907119|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
82907120|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907121|NCT02918968|Flutamide|flutamide|mesh-list
82907122|NCT02918968|Androgens|androgens|mesh-list
82907123|NCT02918968|Hormones|hormones|mesh-ancestor
82907124|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907125|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907126|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
82907127|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
82907128|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907129|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907130|NCT01065766|Metformin|metformin|mesh-list
82907131|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82907132|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82907133|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907134|NCT01065766|Incretins|incretins|mesh-ancestor
82907135|NCT01065766|Hormones|hormones|mesh-ancestor
82907136|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907137|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82907138|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
82907139|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907140|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907141|NCT03653260|Lidocaine|lidocaine|mesh-list
82907142|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
82907143|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
82907144|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907145|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907146|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
82907147|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907149|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82907150|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82907151|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82907152|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907153|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82907154|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82907155|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82907156|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907157|NCT04054960|Levodopa|levodopa|mesh-list
82907158|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82907159|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82907160|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
82907161|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907162|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907163|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907164|NCT00042939|Docetaxel|docetaxel|mesh-list
82907165|NCT00042939|Irinotecan|irinotecan|mesh-list
82907166|NCT00042939|Cetuximab|cetuximab|mesh-list
82907167|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907168|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
82907169|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
82907170|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
82907171|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907172|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82907173|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82907174|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907175|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907176|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
82907177|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82907178|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83456635|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907179|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907180|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
82907181|NCT04055194|Coagulants|coagulants|mesh-ancestor
82907182|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
82907183|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907184|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
82907185|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907186|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907187|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82907188|NCT02530047|Interferons|interferons|mesh-list
82907189|NCT02530047|Interferon-beta|interferon-beta|mesh-list
82907190|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907191|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
82907192|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907193|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
82907194|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907195|NCT02529969|Curcumin|curcumin|mesh-list
82907196|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82907197|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82907198|NCT02529969|Analgesics|analgesics|mesh-ancestor
82907199|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
82907200|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907201|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907202|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82907203|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907204|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907205|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907206|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907207|NCT01584687|Omalizumab|omalizumab|mesh-list
82907208|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82907209|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82907210|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
82907211|NCT01101789|Triclosan|triclosan|mesh-list
82907212|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82907213|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907214|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82907215|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82907216|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
82907217|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907218|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82907219|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
82907220|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907222|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82907223|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82907224|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
82907225|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907226|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82907227|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82907228|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907229|NCT04054024|Erenumab|erenumab|mesh-list
82907230|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82907231|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907232|NCT04054024|Analgesics|analgesics|mesh-ancestor
82907233|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
82907234|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907235|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907236|NCT00002931|Paclitaxel|paclitaxel|mesh-list
82907237|NCT00002931|Etoposide|etoposide|mesh-list
82907238|NCT00002931|Carboplatin|carboplatin|mesh-list
82907239|NCT00002931|Ifosfamide|ifosfamide|mesh-list
82907240|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82907241|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907242|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
82907243|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
82907244|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83456641|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
82907245|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907246|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82907247|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82907248|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907249|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82907250|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
82907251|NCT02918266|Scopolamine|scopolamine|mesh-list
82907252|NCT02918266|Donepezil|donepezil|mesh-list
82907253|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82907254|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82907255|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907256|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907257|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
82907258|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907259|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907260|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
82907261|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82907262|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
82907264|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907265|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907266|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
82907267|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82907268|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82907269|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
82907270|NCT00041067|Docetaxel|docetaxel|mesh-list
82907271|NCT00041067|Trastuzumab|trastuzumab|mesh-list
82907272|NCT00041067|Vinorelbine|vinorelbine|mesh-list
82907273|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907274|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
82907275|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
82907276|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
82907277|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907278|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907279|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82907280|NCT01063036|Tenofovir|tenofovir|mesh-list
82907281|NCT01063036|Entecavir|entecavir|mesh-list
82907282|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
82907283|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907284|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82907285|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82907286|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907287|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907288|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82907289|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82907290|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
82907291|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82907292|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82907293|NCT03652480|Prednisolone|prednisolone|mesh-list
82907294|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
82907295|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82907296|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
82907297|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82907298|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
82907299|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
82907300|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907301|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907302|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907303|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
82907304|NCT03652480|Hormones|hormones|mesh-ancestor
82907305|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907306|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82907307|NCT03652480|Protective Agents|protective agents|mesh-ancestor
82907308|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907309|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907310|NCT03622060|Nicardipine|nicardipine|mesh-list
82907311|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
82907312|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
82907313|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82907314|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82907315|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82907316|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83456651|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
82907317|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82907318|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907319|NCT00040365|Amifostine|amifostine|mesh-list
82907320|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82907321|NCT00040365|Protective Agents|protective agents|mesh-ancestor
82907322|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907323|NCT02974114|Acetaminophen|acetaminophen|mesh-list
82907324|NCT02974114|Caffeine|caffeine|mesh-list
82907325|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82907326|NCT02974114|Analgesics|analgesics|mesh-ancestor
82907327|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
82907328|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907329|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907330|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
82907331|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82907332|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82907333|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907334|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907335|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82907336|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82907337|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
82907338|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907339|NCT00001959|Pirfenidone|pirfenidone|mesh-list
82907340|NCT00001959|Analgesics|analgesics|mesh-ancestor
82907341|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
82907342|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907343|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907344|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82907345|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82907346|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82907347|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907348|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907349|NCT03950505|Pioglitazone|pioglitazone|mesh-list
82907350|NCT03950505|Alogliptin|alogliptin|mesh-list
82907351|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82907352|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907353|NCT03950505|Incretins|incretins|mesh-ancestor
82907354|NCT03950505|Hormones|hormones|mesh-ancestor
82907355|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907356|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82907357|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
82907358|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907359|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907360|NCT00001941|Daclizumab|daclizumab|mesh-list
82907361|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82907362|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
82907363|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907364|NCT01061866|Thalidomide|thalidomide|mesh-list
82907365|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82907366|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
82907367|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907368|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
82907369|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82907370|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907371|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82907372|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82907373|NCT01061866|Growth Substances|growth substances|mesh-ancestor
82907374|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
82907375|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907376|NCT03652714|Anesthetics|anesthetics|mesh-list
82907377|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
82907378|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907379|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907380|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
82907381|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907382|NCT03948477|Pantoprazole|pantoprazole|mesh-list
82907383|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82907384|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907385|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82907386|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907387|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907388|NCT03953781|Levetiracetam|levetiracetam|mesh-list
82907389|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
82907390|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
82907391|NCT01103817|Vitamin D|vitamin d|mesh-list
82907392|NCT01103817|Vitamins|vitamins|mesh-ancestor
82907393|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
82907394|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907395|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82907396|NCT01102101|Remifentanil|remifentanil|mesh-list
82907397|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82907398|NCT01102101|Narcotics|narcotics|mesh-ancestor
82907399|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907400|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907401|NCT01102101|Analgesics|analgesics|mesh-ancestor
82907402|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
82907403|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907404|NCT03950271|Capecitabine|capecitabine|mesh-list
82907405|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
82907406|NCT03950271|Trastuzumab|trastuzumab|mesh-list
82907407|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82907408|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
82907409|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907410|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907411|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907412|NCT01102335|Telbivudine|telbivudine|mesh-list
82907413|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
82907414|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907415|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82907416|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907417|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907418|NCT02973100|Dulaglutide|dulaglutide|mesh-list
82907419|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82907420|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907421|NCT01105611|Ritonavir|ritonavir|mesh-list
82907422|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82907423|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
82907424|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82907425|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82907426|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
82907427|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907428|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907429|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82907430|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82907431|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
82907432|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907433|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82907434|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82907435|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82907436|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82907437|NCT05497557|Sotorasib|sotorasib|mesh-list
82907438|NCT05497557|Omeprazole|omeprazole|mesh-list
82907439|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82907440|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907441|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82907442|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907443|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907444|NCT05497557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82907445|NCT05497557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907446|NCT05497557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907447|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82907448|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82907449|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
82907450|NCT05415267|Vaccines|vaccines|mesh-list
82907451|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
82907452|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907453|NCT01482286|Metformin|metformin|mesh-list
82907454|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82907455|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907456|NCT03651934|Iron|iron|mesh-list
82907457|NCT03651934|Selenium|selenium|mesh-list
82907458|NCT03651934|Trace Elements|trace elements|mesh-ancestor
82907459|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
82907460|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907461|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
82907462|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907463|NCT03651934|Protective Agents|protective agents|mesh-ancestor
82907464|NCT02972632|Vortioxetine|vortioxetine|mesh-list
82907465|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
82907466|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82907467|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82907468|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82907469|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907470|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907471|NCT02972632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82907472|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82907473|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82907474|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907475|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907476|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
82907477|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82907478|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82907479|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82907480|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82907481|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
82907482|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
82907483|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
82907484|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907485|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907486|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
82907487|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907488|NCT01327521|Cisplatin|cisplatin|mesh-list
82907490|NCT01327521|Doxorubicin|doxorubicin|mesh-list
82907491|NCT01327521|Fluorouracil|fluorouracil|mesh-list
82907492|NCT01327521|Epirubicin|epirubicin|mesh-list
82907493|NCT01327521|Mitomycins|mitomycins|mesh-list
82907494|NCT01327521|Mitomycin|mitomycin|mesh-list
82907495|NCT01327521|Maleic acid|maleic acid|mesh-list
82907496|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907497|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82907498|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
82907499|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907500|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82907501|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82907502|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82907503|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907504|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82907505|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
82907506|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907507|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
82907508|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82907509|NCT04899921|Nivolumab|nivolumab|mesh-list
82907510|NCT04899921|Ipilimumab|ipilimumab|mesh-list
82907511|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907512|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907513|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82907514|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907515|NCT01104519|Niacin|niacin|mesh-list
82907516|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
82907517|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82907518|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
82907519|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907520|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82907521|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
82907522|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
82907523|NCT01104519|Vitamins|vitamins|mesh-ancestor
82907524|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
82907525|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907526|NCT03944733|Iron|iron|mesh-list
82907527|NCT03944733|Trace Elements|trace elements|mesh-ancestor
82907528|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
82907529|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907530|NCT01060384|Lenalidomide|lenalidomide|mesh-list
82907531|NCT01060384|Ofatumumab|ofatumumab|mesh-list
82907532|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
82907533|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907534|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82907535|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82907536|NCT01060384|Growth Substances|growth substances|mesh-ancestor
82907537|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
82907538|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907539|NCT01060150|Methylphenidate|methylphenidate|mesh-list
82907540|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82907541|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907542|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82907543|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82907544|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82907545|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907546|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
82907547|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907548|NCT03863223|Docetaxel|docetaxel|mesh-list
82907549|NCT03863223|Trastuzumab|trastuzumab|mesh-list
82907550|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907551|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
82907552|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
82907553|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
82907554|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907555|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907556|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
82907557|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
82907558|NCT02970292|Pimavanserin|pimavanserin|mesh-list
82907559|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82907560|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82907561|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82907562|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82907563|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907564|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907565|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82907566|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82907567|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82907568|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
82907569|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907570|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907571|NCT03944655|Anesthetics|anesthetics|mesh-list
82907572|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907573|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907574|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
82907575|NCT05276895|Quercetin|quercetin|mesh-list
82907576|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
82907577|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907578|NCT05276895|Protective Agents|protective agents|mesh-ancestor
82907579|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907580|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82907581|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
82907582|NCT02971228|Glucagon|glucagon|mesh-list
82907583|NCT02971228|Pancrelipase|pancrelipase|mesh-list
82907584|NCT02971228|Pancreatin|pancreatin|mesh-list
82907585|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82907586|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82907587|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907588|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907589|NCT02971228|Hormones|hormones|mesh-ancestor
82907590|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907591|NCT02971228|Incretins|incretins|mesh-ancestor
82907592|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82907593|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82907594|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
82907595|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82907596|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82907597|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907598|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
82907599|NCT03741075|Coagulants|coagulants|mesh-ancestor
82907600|NCT01328223|Sorafenib|sorafenib|mesh-list
82907603|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907604|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907605|NCT01104987|Alendronate|alendronate|mesh-list
83456672|NCT05136157|Insulin|insulin|mesh-list
82907606|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82907607|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907608|NCT01106235|Aldesleukin|aldesleukin|mesh-list
82907609|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
82907610|NCT01106235|Interleukin-2|interleukin-2|mesh-list
82907611|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82907612|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
82907613|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907614|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907615|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82907616|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
82907617|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907618|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907619|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82907620|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82907621|NCT01106235|Analgesics|analgesics|mesh-ancestor
82907622|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
82907623|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907624|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82907625|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82907626|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
82907627|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907628|NCT02969590|Leuprolide|leuprolide|mesh-list
82907629|NCT02969590|Norethindrone|norethindrone|mesh-list
82907630|NCT02969590|Estradiol|estradiol|mesh-list
82907631|NCT02969590|Estrogens|estrogens|mesh-list
82907632|NCT02969590|Progesterone|progesterone|mesh-list
82907633|NCT02969590|Progestins|progestins|mesh-list
82907634|NCT02969590|Hormones|hormones|mesh-ancestor
82907635|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907636|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907637|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82907638|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
82907639|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82907640|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82907641|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82907642|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
82907643|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907644|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907645|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82907646|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82907647|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82907649|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
82907650|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
82907651|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907652|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907653|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
82907654|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907655|NCT04053400|Ketamine|ketamine|mesh-list
82907656|NCT04053400|Analgesics|analgesics|mesh-ancestor
82907657|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
82907658|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907659|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907660|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82907661|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82907662|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
82907663|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
82907664|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907665|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82907666|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82907667|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907668|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907669|NCT03345849|Upadacitinib|upadacitinib|mesh-list
82907670|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82907671|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82907672|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907673|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907674|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907675|NCT01109043|Bisoprolol|bisoprolol|mesh-list
82907676|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82907677|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
82907678|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
82907679|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907680|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456673|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82907681|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82907682|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82907683|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82907684|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
82907685|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907686|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907687|NCT01109121|Allopurinol|allopurinol|mesh-list
82907688|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
82907689|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907690|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907691|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
82907692|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907693|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82907694|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
82907695|NCT01109121|Protective Agents|protective agents|mesh-ancestor
82907696|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907697|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
82907698|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82907699|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82907700|NCT01106547|Prednisolone|prednisolone|mesh-list
82907701|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
82907702|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82907703|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
82907704|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82907705|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
82907706|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
82907707|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907708|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907709|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907710|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
82907711|NCT01106547|Hormones|hormones|mesh-ancestor
82907712|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907713|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82907714|NCT01106547|Protective Agents|protective agents|mesh-ancestor
82907715|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907716|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907717|NCT01105299|Anastrozole|anastrozole|mesh-list
82907718|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907719|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907720|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82907721|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82907722|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907723|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907724|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82907725|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
82907726|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907727|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907728|NCT03947229|Clopidogrel|clopidogrel|mesh-list
82907729|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82907730|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82907731|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82907732|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82907733|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
82907734|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907735|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907736|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907737|NCT03011307|Oxytocin|oxytocin|mesh-list
82907738|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
82907739|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82907740|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907741|NCT01327755|Selenium|selenium|mesh-list
82907742|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
82907743|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907744|NCT01327755|Protective Agents|protective agents|mesh-ancestor
82907745|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907746|NCT01327755|Trace Elements|trace elements|mesh-ancestor
82907747|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
82907748|NCT01848639|Spironolactone|spironolactone|mesh-list
82907749|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82907750|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
82907751|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907752|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907753|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82907754|NCT01848639|Diuretics|diuretics|mesh-ancestor
82907755|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
82907756|NCT04537923|Insulin|insulin|mesh-list
82907757|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82907758|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
82907759|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
82907760|NCT04537923|Tirzepatide|tirzepatide|mesh-list
82907761|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82907762|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907763|NCT04537923|Incretins|incretins|mesh-ancestor
82907764|NCT04537923|Hormones|hormones|mesh-ancestor
82907765|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907766|NCT04523493|Lenvatinib|lenvatinib|mesh-list
82907767|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907768|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82907769|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907770|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907771|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
82907772|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82907773|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
82907774|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82907775|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907776|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82907777|NCT01118793|Clopidogrel|clopidogrel|mesh-list
82907778|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82907779|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82907780|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82907781|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82907782|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
82907783|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907784|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907785|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907786|NCT00127335|Atorvastatin|atorvastatin|mesh-list
82907787|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82907788|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82907789|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
82907790|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907791|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82907792|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82907793|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907794|NCT01109511|Oxycodone|oxycodone|mesh-list
82907795|NCT01109511|Naloxone|naloxone|mesh-list
82907796|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82907797|NCT01109511|Narcotics|narcotics|mesh-ancestor
82907798|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907799|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907800|NCT01109511|Analgesics|analgesics|mesh-ancestor
82907801|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
82907802|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907803|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82907804|NCT01112085|Ranibizumab|ranibizumab|mesh-list
82907805|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82907806|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82907807|NCT01112085|Growth Substances|growth substances|mesh-ancestor
82907808|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907809|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
82907810|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907811|NCT01328301|Methamphetamine|methamphetamine|mesh-list
82907812|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82907813|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907814|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
82907815|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
82907816|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907817|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
82907818|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907819|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907820|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
82907821|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82907822|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82907823|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82907824|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82907825|NCT01328457|Paromomycin|paromomycin|mesh-list
82907826|NCT01328457|Neomycin|neomycin|mesh-list
82907827|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82907828|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907829|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82907830|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82907831|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82907832|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907833|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907834|NCT01109823|Levofloxacin|levofloxacin|mesh-list
82907835|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82907836|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907837|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82907838|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82907839|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82907840|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907841|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907842|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907843|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82907844|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82907845|NCT03943407|Imiquimod|imiquimod|mesh-list
82907846|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
82907847|NCT03943407|Doxepin|doxepin|mesh-list
82907848|NCT03943407|Menthol|menthol|mesh-list
82907849|NCT03943407|Histamine|histamine|mesh-list
82907850|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
82907851|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
82907852|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
82907853|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
82907854|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907855|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907856|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907857|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82907858|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
82907859|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907860|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
82907861|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82907862|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82907863|NCT03943407|Protective Agents|protective agents|mesh-ancestor
82907864|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82907865|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83514983|NCT04027803|Eculizumab|eculizumab|mesh-list
82907866|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907867|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82907868|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
82907869|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82907870|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
82907871|NCT01209351|Teduglutide|teduglutide|mesh-list
82907872|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907873|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82907874|NCT01209351|Protective Agents|protective agents|mesh-ancestor
82907875|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907876|NCT02529579|Gemcitabine|gemcitabine|mesh-list
82907877|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82907878|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
82907879|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907880|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907881|NCT01209429|Hormones|hormones|mesh-list
82907882|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907883|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907884|NCT01110291|Docetaxel|docetaxel|mesh-list
82907885|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907886|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
82907887|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
82907888|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
82907889|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907890|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82907891|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
82907892|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82907893|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82907894|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907895|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907897|NCT01107639|Docetaxel|docetaxel|mesh-list
82907898|NCT01107639|Cetuximab|cetuximab|mesh-list
82907899|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907900|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
82907901|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
82907902|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
82907903|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907904|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907905|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
82907906|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82907907|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82907908|NCT03942861|Prednisolone|prednisolone|mesh-list
82907909|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
82907910|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82907911|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
82907912|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82907913|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
82907914|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
82907915|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907916|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907917|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907918|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
82907919|NCT03942861|Hormones|hormones|mesh-ancestor
82907920|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907921|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82907922|NCT03942861|Protective Agents|protective agents|mesh-ancestor
82907923|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907924|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907925|NCT01107951|Dexamethasone|dexamethasone|mesh-list
82907926|NCT01107951|Rituximab|rituximab|mesh-list
82907927|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907928|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907929|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
82907930|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907931|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82907932|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82907933|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
82907934|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
82907935|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82907936|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82907937|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
82907938|NCT01107951|Hormones|hormones|mesh-ancestor
82907939|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82907940|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82907941|NCT01108029|Memantine|memantine|mesh-list
82907942|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82907943|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82907944|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
82907945|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82907946|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907947|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907948|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82907949|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82907951|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907952|NCT01110603|Paclitaxel|paclitaxel|mesh-list
82907953|NCT01110603|Carboplatin|carboplatin|mesh-list
82907954|NCT01110603|Doxorubicin|doxorubicin|mesh-list
82907955|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82907956|NCT01110603|Niraparib|niraparib|mesh-list
83456694|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
82907957|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82907958|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907959|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
82907960|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
82907961|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
82907962|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907963|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82907964|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82907965|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82907966|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82907967|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82907968|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
82907969|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907970|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907971|NCT04258683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82907972|NCT04258683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907973|NCT01112787|Tazarotene|tazarotene|mesh-list
82907974|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
82907975|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
82907976|NCT01108107|Capecitabine|capecitabine|mesh-list
82907977|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
82907978|NCT01108107|Panitumumab|panitumumab|mesh-list
82907979|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82907980|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
82907981|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82907982|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82907983|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82907984|NCT01111227|Propofol|propofol|mesh-list
82907985|NCT01111227|Isoflurane|isoflurane|mesh-list
82907986|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82907987|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82907988|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907989|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82907990|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
82907991|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
82907992|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82907993|NCT01111383|Tobramycin|tobramycin|mesh-list
82907994|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82907995|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82907996|NCT01208649|Exenatide|exenatide|mesh-list
82907997|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82907998|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82907999|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82908000|NCT01208649|Incretins|incretins|mesh-ancestor
82908001|NCT01208649|Hormones|hormones|mesh-ancestor
82908002|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908003|NCT01211847|Diazoxide|diazoxide|mesh-list
82908004|NCT01211847|Choline|choline|mesh-list
82908005|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
82908006|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82908007|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
82908008|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908009|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908010|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82908011|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
82908012|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82908013|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
82908014|NCT01210287|Lamivudine|lamivudine|mesh-list
82908015|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82908016|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82908017|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908018|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908019|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
82908020|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908021|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82908022|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82908023|NCT01211925|Aspirin|aspirin|mesh-list
82908024|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82908025|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82908026|NCT01211925|Analgesics|analgesics|mesh-ancestor
82908027|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
82908028|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908029|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908030|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82908031|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82908032|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82908033|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82908034|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908035|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82908036|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82908037|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908038|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
82908039|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
82908040|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82908041|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82908042|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82908043|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
82908044|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908045|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82908046|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82908048|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908049|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82908050|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82908051|NCT01328145|Aspirin|aspirin|mesh-list
82908052|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82908053|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82908054|NCT01328145|Analgesics|analgesics|mesh-ancestor
82908055|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
82908056|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908057|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908058|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82908059|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82908060|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82908061|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82908062|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908063|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82908064|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82908065|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908066|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
82908067|NCT01210521|Vitamin D|vitamin d|mesh-list
82908068|NCT01210521|Vitamins|vitamins|mesh-ancestor
82908069|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
82908070|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908071|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82908072|NCT01210599|Pamidronate|pamidronate|mesh-list
82908073|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82908074|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908075|NCT03944889|Capsaicin|capsaicin|mesh-list
82908076|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
82908077|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
82908078|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
82908079|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908080|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908081|NCT01210677|Prednisone|prednisone|mesh-list
82908082|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82908083|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
82908084|NCT01210677|Hormones|hormones|mesh-ancestor
82908085|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908086|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908087|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82908088|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908089|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
82908090|NCT01210755|Dabigatran|dabigatran|mesh-list
82908091|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82908092|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
82908093|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82908094|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
82908095|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908096|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908097|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
82908098|NCT01210911|Metformin|metformin|mesh-list
82908099|NCT01210911|Gemcitabine|gemcitabine|mesh-list
82908100|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82908101|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82908102|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
82908103|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908104|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908105|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82908106|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908107|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908108|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908109|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
82908110|NCT01115049|Hexetidine|hexetidine|mesh-list
82908111|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82908112|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908113|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
82908114|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
82908115|NCT03941535|Vitamin K|vitamin k|mesh-list
82908116|NCT03941535|Vitamins|vitamins|mesh-ancestor
82908117|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
82908118|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908119|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82908120|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82908121|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908122|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
82908123|NCT03941535|Coagulants|coagulants|mesh-ancestor
82908124|NCT01115127|Inositol|inositol|mesh-list
82908125|NCT01115127|Melatonin|melatonin|mesh-list
82908126|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
82908127|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908128|NCT01115127|Protective Agents|protective agents|mesh-ancestor
82908129|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908130|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908131|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
82908132|NCT01115127|Vitamins|vitamins|mesh-ancestor
82908133|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
82908134|NCT01211223|Amoxicillin|amoxicillin|mesh-list
82908135|NCT01211223|Metronidazole|metronidazole|mesh-list
82908136|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908137|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908138|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82908139|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908140|NCT01113489|Beclomethasone|beclomethasone|mesh-list
82908141|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82908142|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
82908143|NCT01113489|Hormones|hormones|mesh-ancestor
82908144|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908145|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908146|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82908147|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
82908148|NCT01115439|Artesunate|artesunate|mesh-list
82908149|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
82908150|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
82908151|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82908152|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
82908153|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82908154|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908155|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908156|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908157|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
82908158|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
82908159|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82908160|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
82908161|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82908162|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908163|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908164|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82908165|NCT01212315|Triclosan|triclosan|mesh-list
82908166|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82908167|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908168|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82908169|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82908170|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
82908171|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908172|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82908173|NCT03938259|Fentanyl|fentanyl|mesh-list
82908174|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82908175|NCT03938259|Narcotics|narcotics|mesh-ancestor
82908176|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908177|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908178|NCT03938259|Analgesics|analgesics|mesh-ancestor
82908179|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
82908180|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908181|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82908182|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82908183|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
82908184|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
82908185|NCT03939663|Misoprostol|misoprostol|mesh-list
82908186|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82908187|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
82908188|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82908189|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908190|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82908191|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908192|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
82908193|NCT01213407|Temozolomide|temozolomide|mesh-list
82908194|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82908195|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
82908196|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908197|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908198|NCT01211457|Decitabine|decitabine|mesh-list
82908199|NCT01211457|Venetoclax|venetoclax|mesh-list
82908200|NCT01211457|Sapacitabine|sapacitabine|mesh-list
82908201|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82908202|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
82908203|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908204|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908205|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908206|NCT01213563|Insulin|insulin|mesh-list
82908207|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82908208|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
82908209|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
82908210|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82908211|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908212|NCT01115985|Atorvastatin|atorvastatin|mesh-list
82908213|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82908214|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82908215|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
82908216|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908217|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82908218|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82908219|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908220|NCT01116063|Iloprost|iloprost|mesh-list
82908221|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82908222|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
82908223|NCT01116219|Bevacizumab|bevacizumab|mesh-list
82908224|NCT01116219|Pemetrexed|pemetrexed|mesh-list
82908225|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82908226|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82908227|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908228|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82908229|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82908230|NCT01116219|Growth Substances|growth substances|mesh-ancestor
82908231|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908232|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
82908233|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908234|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908235|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82908236|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82908237|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908238|NCT01213719|Betaine|betaine|mesh-list
82908239|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908240|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
82908241|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82908242|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
82908243|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908244|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82908245|NCT01114191|Ketoconazole|ketoconazole|mesh-list
82908246|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
82908247|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908248|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82908249|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82908250|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908251|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908252|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82908253|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
82908254|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908255|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908256|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82908257|NCT01211691|Antibodies|antibodies|mesh-list
82908258|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82908259|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
82908260|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908261|NCT03937869|Secnidazole|secnidazole|mesh-list
82908262|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82908263|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908264|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908265|NCT01116531|Pregabalin|pregabalin|mesh-list
82908266|NCT01116531|Tramadol|tramadol|mesh-list
82908267|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82908268|NCT01116531|Analgesics|analgesics|mesh-ancestor
82908269|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
82908270|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908271|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908272|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
82908273|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82908274|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82908275|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908276|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82908277|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82908278|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82908279|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908280|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82908281|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82908282|NCT01116531|Narcotics|narcotics|mesh-ancestor
82908283|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82908284|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82908285|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908286|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
82908287|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
82908288|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
82908289|NCT03939975|Nivolumab|nivolumab|mesh-list
82908290|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82908291|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908292|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82908293|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908294|NCT01116609|Epinephrine|epinephrine|mesh-list
82908295|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82908296|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82908297|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
82908298|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908299|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908300|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908301|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82908302|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82908303|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
82908304|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908305|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82908306|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
82908307|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
82908308|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
82908309|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82908310|NCT01118403|Ampicillin|ampicillin|mesh-list
82908311|NCT01118403|Sulbactam|sulbactam|mesh-list
82908312|NCT01118403|Sultamicillin|sultamicillin|mesh-list
82908313|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908314|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908315|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82908316|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908317|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908318|NCT01121835|Insulin|insulin|mesh-list
82908319|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82908320|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
82908321|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
82908322|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82908323|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908324|NCT03788967|Ertapenem|ertapenem|mesh-list
82908325|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908326|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908327|NCT01118559|Darexaban|darexaban|mesh-list
82908328|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82908329|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
82908330|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82908331|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
82908332|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908333|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908334|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
82908335|NCT01216293|Esomeprazole|esomeprazole|mesh-list
82908336|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
82908337|NCT01216293|Lansoprazole|lansoprazole|mesh-list
82908338|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82908339|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908340|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82908341|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908342|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908343|NCT01216371|Sunitinib|sunitinib|mesh-list
82908344|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908345|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82908346|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82908347|NCT01216371|Growth Substances|growth substances|mesh-ancestor
82908348|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908349|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
82908350|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908352|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908353|NCT01118871|Ritonavir|ritonavir|mesh-list
82908354|NCT01118871|Darunavir|darunavir|mesh-list
82908355|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82908356|NCT01118871|Etravirine|etravirine|mesh-list
82908357|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82908358|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82908359|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
82908360|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908361|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908362|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82908363|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82908364|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
82908365|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908366|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82908367|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82908368|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82908369|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82908370|NCT01216449|Citalopram|citalopram|mesh-list
82908371|NCT01216449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82908372|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82908373|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82908374|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908375|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908376|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
82908377|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908378|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82908379|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
82908380|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82908381|NCT03937401|Oxytocin|oxytocin|mesh-list
82908382|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
82908383|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82908384|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908385|NCT03939273|Metronidazole|metronidazole|mesh-list
82908386|NCT03939273|Vancomycin|vancomycin|mesh-list
82908387|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
82908388|NCT03939273|Fluconazole|fluconazole|mesh-list
82908389|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908390|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908391|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82908392|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908393|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82908394|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82908395|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83456714|NCT02153541|Analgesics|analgesics|mesh-ancestor
82908396|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908397|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908398|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83515060|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
82908399|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82908400|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
82908401|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82908402|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82908403|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
82908404|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908405|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908406|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82908407|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82908408|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
82908409|NCT01213017|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82908410|NCT01213017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82908411|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82908412|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
82908413|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908414|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82908415|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
82908416|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82908417|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82908418|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908419|NCT01216605|Oxytocin|oxytocin|mesh-list
82908420|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
82908421|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82908422|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908423|NCT01213095|Rituximab|rituximab|mesh-list
82908424|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82908425|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908426|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
82908427|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908428|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82908429|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
82908430|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82908431|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
82908432|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908433|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
82908434|NCT03938883|Protective Agents|protective agents|mesh-ancestor
82908435|NCT01216839|Everolimus|everolimus|mesh-list
82908436|NCT01216839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82908437|NCT01216839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908438|NCT01216839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908439|NCT01216839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908440|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82908441|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
82908442|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908443|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908444|NCT01119651|Tazarotene|tazarotene|mesh-list
82908445|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
82908446|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
82908447|NCT03971877|Polymyxins|polymyxins|mesh-list
82908448|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908449|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908450|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
82908451|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908452|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908453|NCT01119885|Fentanyl|fentanyl|mesh-list
82908454|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82908455|NCT01119885|Narcotics|narcotics|mesh-ancestor
82908456|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908457|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908458|NCT01119885|Analgesics|analgesics|mesh-ancestor
82908459|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
82908460|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908461|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82908462|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82908463|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
82908464|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
82908465|NCT03935217|Secnidazole|secnidazole|mesh-list
82908466|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82908467|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908468|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908469|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
82908470|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908471|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
82908472|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83515061|NCT00377481|Hematinics|hematinics|mesh-ancestor
82908473|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82908474|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908475|NCT01219023|Urological Agents|urological agents|mesh-ancestor
82908476|NCT01124487|Insulin|insulin|mesh-list
82908477|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82908478|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908479|NCT01120119|Calcitriol|calcitriol|mesh-list
82908480|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82908481|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908482|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82908483|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82908484|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908485|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82908486|NCT01120119|Vitamins|vitamins|mesh-ancestor
82908487|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
82908488|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82908489|NCT01219101|Citric Acid|citric acid|mesh-list
82908490|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
82908491|NCT01219101|Clomiphene|clomiphene|mesh-list
82908492|NCT01219101|Enclomiphene|enclomiphene|mesh-list
82908493|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
82908494|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
82908495|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82908496|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
82908497|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
82908498|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908499|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82908501|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908502|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908503|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82908504|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
82908505|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82908506|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82908507|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82908508|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82908509|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908510|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908511|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908512|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908514|NCT01122615|Sunitinib|sunitinib|mesh-list
82908515|NCT01122615|Temsirolimus|temsirolimus|mesh-list
82908516|NCT01122615|MTOR Inhibitors|mtor inhibitors|mesh-list
82908517|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908518|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82908519|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82908520|NCT01122615|Growth Substances|growth substances|mesh-ancestor
82908521|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908522|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
82908523|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908524|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908525|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908526|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82908527|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
82908528|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908529|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908530|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82908531|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
82908532|NCT01217697|Prednisone|prednisone|mesh-list
82908533|NCT01217697|Prednisolone|prednisolone|mesh-list
82908534|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
82908535|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82908536|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
82908537|NCT01217697|Hormones|hormones|mesh-ancestor
82908538|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908539|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908540|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82908541|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908542|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82908543|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908544|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908545|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
82908546|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82908547|NCT01214343|Sorafenib|sorafenib|mesh-list
82908548|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908549|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908551|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908552|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82908553|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
82908554|NCT01124799|Simeprevir|simeprevir|mesh-list
82908555|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908556|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908557|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82908558|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82908559|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908560|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908561|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908562|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82908563|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82908564|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
82908565|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
82908566|NCT01124877|Ziprasidone|ziprasidone|mesh-list
82908567|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82908568|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
82908569|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908570|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908571|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908573|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82908574|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908575|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82908576|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82908577|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
82908578|NCT01219413|Perindopril|perindopril|mesh-list
82908579|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82908580|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
82908581|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908582|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908583|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82908584|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
82908585|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
82908586|NCT03783039|Coagulants|coagulants|mesh-ancestor
82908587|NCT03933501|Amoxicillin|amoxicillin|mesh-list
82908588|NCT03933501|Metronidazole|metronidazole|mesh-list
82908589|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908590|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908591|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82908592|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908593|NCT01122771|Amphotericin B|amphotericin b|mesh-list
82908594|NCT01122771|Paromomycin|paromomycin|mesh-list
82908595|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82908596|NCT01122771|Miltefosine|miltefosine|mesh-list
82908597|NCT01122771|Amebicides|amebicides|mesh-ancestor
82908598|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82908599|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82908600|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908601|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908602|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
82908603|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908604|NCT01125033|Vitamins|vitamins|mesh-list
82908605|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
82908606|NCT01125033|Vitamin E|vitamin e|mesh-list
82908607|NCT01125033|Tocopherols|tocopherols|mesh-list
82908608|NCT01125033|Tocotrienols|tocotrienols|mesh-list
82908609|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
82908610|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
82908611|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908612|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
82908613|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908614|NCT01125033|Protective Agents|protective agents|mesh-ancestor
82908615|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82908616|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82908617|NCT01120665|Estradiol|estradiol|mesh-list
82908618|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82908619|NCT01120665|Hormones|hormones|mesh-ancestor
82908620|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908621|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908622|NCT01120665|Estrogens|estrogens|mesh-ancestor
82908623|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82908624|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
82908625|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82908626|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82908627|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
82908629|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908630|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908631|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908632|NCT01125423|Milnacipran|milnacipran|mesh-list
82908633|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
82908634|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82908635|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82908636|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82908637|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908638|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908639|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908640|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82908641|NCT01125423|Analgesics|analgesics|mesh-ancestor
82908642|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
82908643|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908644|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
82908645|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82908646|NCT01219569|Propofol|propofol|mesh-list
82908647|NCT01219569|Sevoflurane|sevoflurane|mesh-list
82908648|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82908650|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908651|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82908652|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
82908653|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
82908654|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82908655|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82908656|NCT03933345|Naloxone|naloxone|mesh-list
82908657|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82908658|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908659|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
82908660|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908661|NCT01121055|Lorazepam|lorazepam|mesh-list
82908662|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
82908663|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
82908664|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
82908665|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908666|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908667|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908668|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82908669|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908670|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82908671|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82908672|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82908673|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
82908674|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
82908675|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908676|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908677|NCT01121133|Rifampin|rifampin|mesh-list
82908678|NCT01121133|Navitoclax|navitoclax|mesh-list
82908679|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82908680|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
82908681|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908682|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908683|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
82908684|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82908685|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908686|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908687|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82908688|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82908689|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82908690|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82908691|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82908692|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82908693|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908694|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
82908695|NCT01214889|Vaccines|vaccines|mesh-list
82908696|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
82908697|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908698|NCT01123317|Oxytocin|oxytocin|mesh-list
82908699|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
82908700|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82908701|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908702|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
82908703|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82908704|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908705|NCT01123473|Fluorouracil|fluorouracil|mesh-list
82908706|NCT01123473|Capecitabine|capecitabine|mesh-list
82908707|NCT01123473|Epirubicin|epirubicin|mesh-list
82908708|NCT01123473|Lapatinib|lapatinib|mesh-list
82908709|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908710|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
82908711|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908712|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82908713|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82908714|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
82908715|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908716|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82908717|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82908718|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82908719|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908720|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908721|NCT01123551|Morphine|morphine|mesh-list
82908722|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82908723|NCT01123551|Narcotics|narcotics|mesh-ancestor
82908725|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908726|NCT01123551|Analgesics|analgesics|mesh-ancestor
82908727|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
82908728|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908729|NCT01125657|Darexaban|darexaban|mesh-list
82908730|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82908731|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
82908732|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82908733|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
82908734|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908735|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908736|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
82908737|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
82908738|NCT03934203|BI 409306|bi 409306|mesh-list
82908739|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908740|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908741|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82908742|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82908743|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908744|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908745|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908746|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82908747|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
82908748|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82908749|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82908750|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908751|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
82908752|NCT03934047|Coagulants|coagulants|mesh-ancestor
82908753|NCT01218711|Losartan|losartan|mesh-list
82908754|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82908755|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82908756|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82908757|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82908758|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82908759|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908760|NCT01218711|Diuretics|diuretics|mesh-ancestor
82908761|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
82908762|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908763|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82908764|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82908765|NCT01125891|Gemcitabine|gemcitabine|mesh-list
82908766|NCT01125891|ON 01910|on 01910|mesh-list
82908767|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82908768|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
82908769|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908770|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908771|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82908772|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908773|NCT01124253|Endostatins|endostatins|mesh-list
82908774|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82908775|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82908776|NCT01124253|Growth Substances|growth substances|mesh-ancestor
82908777|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908778|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
82908779|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908780|NCT01215669|Vaccines|vaccines|mesh-list
82908781|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
82908782|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908783|NCT01222221|Temozolomide|temozolomide|mesh-list
82908784|NCT01222221|Sargramostim|sargramostim|mesh-list
82908785|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82908786|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
82908787|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908788|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908789|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
82908790|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908791|NCT01220661|Cefotetan|cefotetan|mesh-list
82908792|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908793|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908794|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
82908795|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82908796|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908797|NCT02903914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82908798|NCT02903914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908799|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
82908800|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82908801|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82908802|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
82908803|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908804|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908805|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82908806|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82908807|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
82908808|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908809|NCT03928353|Ticagrelor|ticagrelor|mesh-list
82908810|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82908811|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82908812|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82908813|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82908814|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
82908815|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908816|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908817|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908818|NCT03931863|Ondansetron|ondansetron|mesh-list
82908819|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
82908820|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
82908821|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908822|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83456744|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
82908823|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908824|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
82908825|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
82908826|NCT03931863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82908827|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82908828|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
82908829|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908830|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908831|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82908832|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82908833|NCT01226355|Sirolimus|sirolimus|mesh-list
82908834|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908835|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908836|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82908837|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908838|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
82908839|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82908840|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
82908841|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908842|NCT01129089|Micronutrients|micronutrients|mesh-list
82908843|NCT01129089|Trace Elements|trace elements|mesh-list
82908844|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908845|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
82908846|NCT01129323|Fludarabine|fludarabine|mesh-list
82908847|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
82908848|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82908849|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
82908850|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908851|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82908852|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82908853|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
82908854|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908855|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908856|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82908858|NCT01221129|Trace Elements|trace elements|mesh-ancestor
82908859|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
82908860|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908861|NCT01222923|Risperidone|risperidone|mesh-list
82908862|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82908863|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
82908864|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908865|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908866|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908867|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82908868|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82908869|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908870|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82908871|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82908872|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
82908874|NCT01223079|Hormones|hormones|mesh-ancestor
82908875|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908876|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908877|NCT03648970|Pravastatin|pravastatin|mesh-list
82908878|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82908879|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82908880|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
82908881|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908882|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82908883|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82908884|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908885|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
82908886|NCT03927963|Propofol|propofol|mesh-list
82908887|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82908888|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908889|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908890|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82908891|NCT03927963|Analgesics|analgesics|mesh-ancestor
82908892|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
82908893|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908894|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82908895|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82908896|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82908897|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
82908898|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908899|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908900|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82908901|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
82908902|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
82908903|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82908904|NCT01127529|Protein C|protein c|mesh-list
82908905|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
82908906|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82908907|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82908908|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908909|NCT01226667|Pregabalin|pregabalin|mesh-list
82908910|NCT01226667|Analgesics|analgesics|mesh-ancestor
82908911|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
82908912|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908913|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908914|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
82908915|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82908916|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82908917|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908918|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82908919|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82908920|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82908921|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908922|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82908923|NCT03927807|Misoprostol|misoprostol|mesh-list
82908924|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82908925|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
82908926|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82908927|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908928|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82908929|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908930|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
82908932|NCT05284942|Prednisone|prednisone|mesh-list
82908933|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82908934|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
82908935|NCT05284942|Hormones|hormones|mesh-ancestor
82908936|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82908937|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908938|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82908939|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908940|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82908941|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82908942|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
82908943|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82908944|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908945|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908946|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908948|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
82908949|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
82908950|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908951|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908952|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
82908953|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908954|NCT01129479|Galantamine|galantamine|mesh-list
82908955|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82908956|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908957|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908958|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
82908959|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82908960|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908961|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82908962|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
82908963|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82908964|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
82908965|NCT03647956|Bevacizumab|bevacizumab|mesh-list
82908966|NCT03647956|Atezolizumab|atezolizumab|mesh-list
82908967|NCT03647956|Carboplatin|carboplatin|mesh-list
82908968|NCT03647956|Pemetrexed|pemetrexed|mesh-list
82908969|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82908970|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82908971|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82908972|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82908973|NCT03647956|Growth Substances|growth substances|mesh-ancestor
82908974|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908975|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
82908976|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82908977|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82908978|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82908979|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82908980|NCT03647956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82908981|NCT01221675|Antibodies|antibodies|mesh-list
82908982|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
82908983|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908984|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
82908985|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82908986|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
82908987|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
82908988|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82908989|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82908990|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82908991|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82908992|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82908993|NCT02968576|Tenofovir|tenofovir|mesh-list
82908994|NCT02968576|Emtricitabine|emtricitabine|mesh-list
82908995|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82908996|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
82908997|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82908998|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82908999|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82909000|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909001|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909002|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82909003|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82909004|NCT01127217|Losartan|losartan|mesh-list
82909005|NCT01127217|Amlodipine|amlodipine|mesh-list
82909006|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82909007|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82909008|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909009|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909010|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82909011|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909013|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82909014|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82909015|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82909016|NCT01226901|Niraparib|niraparib|mesh-list
82909017|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82909018|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909020|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909021|NCT03648658|Acetaminophen|acetaminophen|mesh-list
82909022|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909023|NCT03648658|Analgesics|analgesics|mesh-ancestor
82909024|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
82909025|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909026|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909027|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
82909028|NCT03931239|Vaccines|vaccines|mesh-list
82909029|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
82909030|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909031|NCT03927495|Paclitaxel|paclitaxel|mesh-list
82909032|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82909033|NCT03927495|Cisplatin|cisplatin|mesh-list
82909034|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82909035|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909036|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
82909037|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
82909038|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
82909039|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909040|NCT02966002|Aspirin|aspirin|mesh-list
82909041|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82909042|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909043|NCT02966002|Analgesics|analgesics|mesh-ancestor
82909044|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
82909045|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909046|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909047|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909048|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909049|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82909050|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82909051|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909052|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82909053|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82909054|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909055|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
82909056|NCT01127295|Tamoxifen|tamoxifen|mesh-list
82909057|NCT01127295|Letrozole|letrozole|mesh-list
82909058|NCT01127295|Anastrozole|anastrozole|mesh-list
82909059|NCT01127295|Exemestane|exemestane|mesh-list
82909060|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909061|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82909062|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82909063|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909064|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909065|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82909066|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
82909067|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909068|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909069|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82909070|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82909071|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82909072|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82909073|NCT01129713|Esomeprazole|esomeprazole|mesh-list
82909074|NCT01129713|Omeprazole|omeprazole|mesh-list
82909075|NCT01129713|Lansoprazole|lansoprazole|mesh-list
82909076|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82909077|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82909078|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82909079|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482930|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909080|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909081|NCT01221831|Dienogest|dienogest|mesh-list
82909082|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82909083|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82909084|NCT01221831|Estradiol|estradiol|mesh-list
82909085|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82909086|NCT01221831|Estrogens|estrogens|mesh-ancestor
82909087|NCT01221831|Hormones|hormones|mesh-ancestor
82909088|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909089|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909090|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82909091|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
82909092|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82909094|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82909095|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82909096|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82909097|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
82909098|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82909099|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909100|NCT03931317|Timolol|timolol|mesh-list
82909101|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909102|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82909103|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82909104|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
82909105|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909106|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909107|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82909108|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82909109|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
82909110|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82909111|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82909112|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909113|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
82909114|NCT01221909|Coagulants|coagulants|mesh-ancestor
82909115|NCT02900092|Ganaxolone|ganaxolone|mesh-list
82909116|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
82909117|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909118|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909119|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909120|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
82909121|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
82909122|NCT01130025|Tinzaparin|tinzaparin|mesh-list
82909123|NCT01130025|Warfarin|warfarin|mesh-list
82909124|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
82909125|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82909126|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82909127|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909129|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
82909130|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82909131|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909132|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
82909133|NCT03925155|Trace Elements|trace elements|mesh-ancestor
82909134|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
82909135|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909136|NCT01131195|Paclitaxel|paclitaxel|mesh-list
82909137|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
82909138|NCT01131195|Bevacizumab|bevacizumab|mesh-list
82909139|NCT01131195|Capecitabine|capecitabine|mesh-list
82909140|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82909141|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909142|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
82909143|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
82909144|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
82909145|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909146|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82909147|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
82909148|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909149|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909150|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82909151|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
82909152|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82909153|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82909154|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82909155|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82909156|NCT01131195|Growth Substances|growth substances|mesh-ancestor
82909157|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
82909158|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82909159|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
82909160|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
82909161|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
82909162|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909163|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82909164|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909165|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909166|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
82909167|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82909169|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909170|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909171|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82909172|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82909173|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82909174|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
82909175|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909176|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82909177|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82909178|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909179|NCT01228227|Atorvastatin|atorvastatin|mesh-list
82909180|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82909181|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82909182|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82909183|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
82909184|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909185|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82909186|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82909187|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909188|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
82909189|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909190|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82909191|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909192|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909193|NCT03740373|Budesonide|budesonide|mesh-list
82909194|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
82909195|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
82909196|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909197|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82909198|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
82909199|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909200|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909201|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82909202|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
82909203|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
82909204|NCT03740373|Hormones|hormones|mesh-ancestor
82909205|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909206|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82909207|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82909208|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82909209|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
82909210|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909211|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909212|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82909213|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82909214|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82909215|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
82909216|NCT01228305|Acetaminophen|acetaminophen|mesh-list
82909217|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909218|NCT01228305|Analgesics|analgesics|mesh-ancestor
82909219|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
82909220|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909221|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909222|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
82909223|NCT02902120|Grazoprevir|grazoprevir|mesh-list
82909224|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
82909225|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909226|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
82909227|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
82909228|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909229|NCT01131273|Buprenorphine|buprenorphine|mesh-list
82909230|NCT01131273|Methadone|methadone|mesh-list
82909231|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82909232|NCT01131273|Naloxone|naloxone|mesh-list
82909233|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82909234|NCT01131273|Narcotics|narcotics|mesh-ancestor
82909235|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909236|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909237|NCT01131273|Analgesics|analgesics|mesh-ancestor
82909238|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
82909239|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909240|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82909241|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
82909242|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
82909245|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82909246|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82909247|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
82909248|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909249|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909250|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909251|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
82909252|NCT01130181|Vitamin D|vitamin d|mesh-list
82909253|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82909254|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909255|NCT01130181|Vitamins|vitamins|mesh-ancestor
82909256|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
82909257|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82909258|NCT03621514|Lidocaine|lidocaine|mesh-list
82909259|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
82909260|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
82909261|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909262|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909263|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
82909264|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909265|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82909266|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82909267|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82909268|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909269|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909270|NCT01127841|Rituximab|rituximab|mesh-list
82909271|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82909272|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82909273|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909274|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
82909275|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909276|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909277|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82909278|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
82909279|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909280|NCT01227603|Candesartan|candesartan|mesh-list
82909281|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
82909282|NCT01227603|Nifedipine|nifedipine|mesh-list
82909283|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82909284|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82909285|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82909286|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909287|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82909288|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909289|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82909290|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909291|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
82909292|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
82909293|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82909294|NCT01130259|Iniparib|iniparib|mesh-list
82909295|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82909296|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909297|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909298|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909299|NCT01585623|Metoprolol|metoprolol|mesh-list
82909300|NCT01585623|Midazolam|midazolam|mesh-list
82909301|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82909302|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82909303|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909304|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909305|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82909306|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82909307|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82909308|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82909309|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
82909310|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
82909311|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
82909312|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
82909313|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909314|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909316|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82909317|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
82909318|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
82909319|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909320|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82909321|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82909322|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82909323|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
82909324|NCT03926559|Morphine|morphine|mesh-list
82909325|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82909326|NCT03926559|Narcotics|narcotics|mesh-ancestor
82909327|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909328|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909329|NCT03926559|Analgesics|analgesics|mesh-ancestor
82909330|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
82909331|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909332|NCT01228617|Nicotine|nicotine|mesh-list
82909333|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82909334|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
82909335|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909336|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909337|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82909338|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82909339|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
82909340|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909341|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909342|NCT01227759|Tyrothricin|tyrothricin|mesh-list
82909343|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82909344|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909345|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82909346|NCT03923829|Zinc|zinc|mesh-list
82909347|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
82909348|NCT03923829|Trace Elements|trace elements|mesh-ancestor
82909349|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
82909350|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909351|NCT03923829|Astringents|astringents|mesh-ancestor
82909352|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
82909353|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
82909354|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82909355|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
82909356|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909357|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909358|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
82909359|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909360|NCT03923751|Anesthetics|anesthetics|mesh-list
82909361|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909362|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909363|NCT03923361|Propofol|propofol|mesh-list
82909364|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82909365|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909366|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909367|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82909368|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
82909369|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
82909370|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82909371|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
82909372|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909373|NCT03740295|Protective Agents|protective agents|mesh-ancestor
82909374|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909375|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82909376|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82909377|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909378|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82909379|NCT02965378|Docetaxel|docetaxel|mesh-list
82909380|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909381|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
82909382|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
82909383|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
82909384|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909385|NCT01224093|Rituximab|rituximab|mesh-list
82909386|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82909387|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909388|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
82909389|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909390|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909392|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82909393|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909394|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
82909395|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909396|NCT03922815|Fentanyl|fentanyl|mesh-list
82909397|NCT03922815|Propofol|propofol|mesh-list
82909398|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82909399|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909400|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909401|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82909402|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
82909403|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
82909404|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82909405|NCT03922815|Narcotics|narcotics|mesh-ancestor
82909406|NCT03922815|Analgesics|analgesics|mesh-ancestor
82909407|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
82909408|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909409|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82909410|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
82909411|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909412|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82909413|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909414|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
82909415|NCT01227915|Hormones|hormones|mesh-ancestor
82909416|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909417|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909418|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82909419|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82909420|NCT01224405|Docetaxel|docetaxel|mesh-list
82909421|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909422|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
82909423|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
82909424|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
82909425|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909426|NCT02899156|Flumazenil|flumazenil|mesh-list
82909427|NCT02899156|Antidotes|antidotes|mesh-ancestor
82909428|NCT02899156|Protective Agents|protective agents|mesh-ancestor
82909429|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909430|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
82909431|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
82909432|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909433|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909434|NCT01131429|Cisplatin|cisplatin|mesh-list
82909435|NCT01131429|Docetaxel|docetaxel|mesh-list
82909436|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82909437|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909438|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
82909439|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
82909440|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
82909441|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909442|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82909443|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909444|NCT03645304|Ropivacaine|ropivacaine|mesh-list
82909445|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
82909446|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
82909447|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909448|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909449|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
82909450|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909451|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
82909452|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
82909453|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
82909454|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909455|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
82909456|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82909457|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82909458|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82909459|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909460|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909461|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
82909462|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909463|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909464|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82909466|NCT03646006|Bupivacaine|bupivacaine|mesh-list
82909467|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
82909468|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
82909469|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909470|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909471|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
82909472|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909473|NCT03854344|Lidocaine|lidocaine|mesh-list
82909474|NCT03854344|Bupivacaine|bupivacaine|mesh-list
82909475|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
82909476|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
82909477|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909478|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909479|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
82909480|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909481|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82909482|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82909483|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82909484|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909485|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909486|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82909487|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909488|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
82909489|NCT03609424|Spartalizumab|spartalizumab|mesh-list
82909490|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909491|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82909492|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909493|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909494|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82909495|NCT03609424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82909496|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82909497|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82909498|NCT03644446|Bisoprolol|bisoprolol|mesh-list
82909499|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82909500|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
82909501|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
82909502|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909503|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909504|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82909505|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82909506|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82909507|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
82909508|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909509|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909510|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
82909511|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909512|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
82909513|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82909514|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
82909515|NCT05283850|Calcium|calcium|mesh-list
82909516|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82909517|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909518|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82909519|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
82909520|NCT03925779|Remifentanil|remifentanil|mesh-list
82909521|NCT03925779|Propofol|propofol|mesh-list
82909522|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82909523|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909524|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909525|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909526|NCT03925779|Analgesics|analgesics|mesh-ancestor
82909527|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
82909528|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909529|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82909530|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82909531|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82909532|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
82909533|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909534|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909535|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82909536|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
82909539|NCT03925779|Narcotics|narcotics|mesh-ancestor
82909540|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82909541|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
82909542|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909543|NCT03925701|Metformin|metformin|mesh-list
82909544|NCT03925701|Vildagliptin|vildagliptin|mesh-list
82909545|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82909546|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909547|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82909548|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
82909549|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909550|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909551|NCT01224717|Teriparatide|teriparatide|mesh-list
82909552|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82909553|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909554|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82909555|NCT03925233|Tamoxifen|tamoxifen|mesh-list
82909556|NCT03925233|Toremifene|toremifene|mesh-list
82909557|NCT03925233|Vinorelbine|vinorelbine|mesh-list
82909558|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
82909559|NCT03925233|Bevacizumab|bevacizumab|mesh-list
82909560|NCT03925233|Carboplatin|carboplatin|mesh-list
82909561|NCT03925233|Gemcitabine|gemcitabine|mesh-list
82909562|NCT03925233|Doxorubicin|doxorubicin|mesh-list
82909563|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82909564|NCT03925233|Fluorouracil|fluorouracil|mesh-list
82909565|NCT03925233|Capecitabine|capecitabine|mesh-list
82909566|NCT03925233|Methotrexate|methotrexate|mesh-list
82909567|NCT03925233|Trastuzumab|trastuzumab|mesh-list
82909568|NCT03925233|Letrozole|letrozole|mesh-list
82909569|NCT03925233|Apatinib|apatinib|mesh-list
82909570|NCT03925233|Epirubicin|epirubicin|mesh-list
82909571|NCT03925233|Fulvestrant|fulvestrant|mesh-list
82909572|NCT03925233|Olaparib|olaparib|mesh-list
82909573|NCT03925233|Anastrozole|anastrozole|mesh-list
82909574|NCT03925233|Exemestane|exemestane|mesh-list
82909575|NCT03925233|Endostatins|endostatins|mesh-list
82909576|NCT03925233|Pirarubicin|pirarubicin|mesh-list
82909577|NCT03925233|Citric Acid|citric acid|mesh-list
82909578|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
82909579|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82909580|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909581|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
82909582|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
82909583|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
82909584|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909585|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82909586|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
82909587|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909588|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909589|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82909590|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
82909591|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82909592|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82909593|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82909594|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82909595|NCT03925233|Growth Substances|growth substances|mesh-ancestor
82909596|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
82909597|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82909598|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
82909599|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82909600|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82909601|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82909602|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909603|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82909604|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
82909605|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82909606|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
82909607|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82909608|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82909609|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
82909610|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82909611|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
82909612|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
82909613|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82909614|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82909615|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82750111|NCT00954135|Sorafenib|sorafenib|mesh-list
82909616|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
82909617|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909618|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82909619|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82909620|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82909621|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82909622|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82909623|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82909624|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82909627|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82909628|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
82909629|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909630|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909631|NCT01345162|Ketorolac|ketorolac|mesh-list
82909632|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82909633|NCT01345162|Tramadol|tramadol|mesh-list
82909634|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82909635|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909636|NCT01345162|Analgesics|analgesics|mesh-ancestor
82909637|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
83456767|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
82909638|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909639|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909640|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909641|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909642|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82909643|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909644|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909645|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82909646|NCT01345162|Narcotics|narcotics|mesh-ancestor
82909647|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909648|NCT01131039|Bevacizumab|bevacizumab|mesh-list
82909649|NCT01131039|Gemcitabine|gemcitabine|mesh-list
82909650|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82909651|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909652|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82909653|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82909654|NCT01131039|Growth Substances|growth substances|mesh-ancestor
82909655|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909656|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
82909657|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82909658|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
82909659|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909660|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
82909661|NCT01229085|Salicylates|salicylates|mesh-list
82909662|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909663|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
82909664|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
82909665|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
82909666|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82909667|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909668|NCT01229085|Analgesics|analgesics|mesh-ancestor
82909669|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
82909670|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909671|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909672|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909673|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909674|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82909675|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909676|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909677|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82909678|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909679|NCT03643666|Dexamethasone|dexamethasone|mesh-list
82909680|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
82909681|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909682|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
82909683|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
82909684|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909685|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909686|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82909687|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
82909688|NCT03643666|Hormones|hormones|mesh-ancestor
83083946|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909689|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909690|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82909691|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909692|NCT03643666|Analgesics|analgesics|mesh-ancestor
82909693|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
82909694|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
82909695|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909696|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82909697|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
82909698|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82909699|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909700|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909701|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82909702|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
82909703|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82909704|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
82909705|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82909706|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
82909707|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909708|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
82909709|NCT03643588|Protective Agents|protective agents|mesh-ancestor
82909710|NCT01224951|Beclomethasone|beclomethasone|mesh-list
82909711|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909712|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
82909713|NCT01224951|Hormones|hormones|mesh-ancestor
82909714|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909715|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909716|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82909717|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
82909718|NCT03641404|Ergothioneine|ergothioneine|mesh-list
82909719|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
82909720|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909721|NCT03641404|Protective Agents|protective agents|mesh-ancestor
82909722|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909723|NCT01131741|Epinephrine|epinephrine|mesh-list
82909724|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82909725|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82909726|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
82909727|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909728|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909729|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909730|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82909731|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82909732|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
82909733|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909734|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82909735|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
82909736|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
82909737|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
82909738|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82909739|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82909740|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909741|NCT03921567|Lidocaine|lidocaine|mesh-list
82909742|NCT03921567|Ketamine|ketamine|mesh-list
82909743|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
82909744|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
82909745|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909746|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909747|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
82909748|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909749|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82909750|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82909751|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82909752|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909753|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909754|NCT03921567|Analgesics|analgesics|mesh-ancestor
82909755|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82909756|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82909757|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
82909758|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82909759|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82909760|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909761|NCT01229241|Anesthetics|anesthetics|mesh-list
82909762|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
82909763|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82909764|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909766|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909767|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
82909769|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
82909770|NCT05252884|Calcium|calcium|mesh-list
82909771|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82909772|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909773|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82909774|NCT05252884|Antacids|antacids|mesh-ancestor
82909775|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909776|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82909777|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82909778|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909779|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82909780|NCT05252884|Vitamins|vitamins|mesh-ancestor
82909781|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
82909782|NCT03921177|Micronutrients|micronutrients|mesh-list
82909783|NCT03921177|Trace Elements|trace elements|mesh-list
82909784|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909785|NCT01229319|Imiquimod|imiquimod|mesh-list
82909786|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82909787|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
82909788|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909789|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909790|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
82909791|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
82909792|NCT03921099|Vitamins|vitamins|mesh-ancestor
82909793|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
82909794|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909795|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
82909796|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909797|NCT03921099|Protective Agents|protective agents|mesh-ancestor
82909798|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82909799|NCT02962648|Hematinics|hematinics|mesh-ancestor
82909800|NCT03920631|Nivolumab|nivolumab|mesh-list
82909801|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82909802|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909803|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82909804|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909805|NCT03930069|Vasopressins|vasopressins|mesh-list
82909806|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
82909807|NCT03930069|Misoprostol|misoprostol|mesh-list
82909808|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82909809|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
82909810|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82909811|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909812|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82909813|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82909814|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
82909815|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
82909816|NCT03930069|Coagulants|coagulants|mesh-ancestor
82909817|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82909818|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82909819|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
82909820|NCT01132443|Clindamycin|clindamycin|mesh-list
82909821|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
82909822|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
82909823|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82909824|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82909825|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909826|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82909827|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909828|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909829|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
82909830|NCT01132521|Urinastatin|urinastatin|mesh-list
82909831|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
82909832|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82909833|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
82909834|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909835|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909836|NCT01132599|Choline|choline|mesh-list
82909837|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
82909838|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82909839|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
82909840|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909841|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82909842|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82909843|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
82909844|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
82909845|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82909846|NCT03929835|Protective Agents|protective agents|mesh-ancestor
82909847|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909848|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
82909849|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82909850|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82909851|NCT01132677|Prednisolone|prednisolone|mesh-list
82909852|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
82909853|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82909854|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
82909855|NCT01132677|Hylan|hylan|mesh-list
82909856|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909857|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
82909858|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
82909859|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909860|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909861|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82909862|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
82909863|NCT01132677|Hormones|hormones|mesh-ancestor
82909864|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82909865|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82909866|NCT01132677|Protective Agents|protective agents|mesh-ancestor
82909867|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82909868|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909869|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
82909870|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
82909871|NCT02961790|Oxybutynin|oxybutynin|mesh-list
82909872|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
82909873|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
82909874|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909875|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909876|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82909877|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82909878|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
82909879|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909880|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909881|NCT02961790|Urological Agents|urological agents|mesh-ancestor
82909882|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82909883|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909884|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82909885|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82909886|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82909887|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909888|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909889|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82909890|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909891|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909892|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
82909893|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909894|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
82909895|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82909896|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
82909897|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909898|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
82909899|NCT03920553|Protective Agents|protective agents|mesh-ancestor
82909900|NCT03643900|Indomethacin|indomethacin|mesh-list
82909901|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82909902|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909903|NCT03643900|Analgesics|analgesics|mesh-ancestor
82909904|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
82909905|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909906|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909907|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909908|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909909|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
82909910|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
82909911|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82909912|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82909913|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909914|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909915|NCT03919383|Lenvatinib|lenvatinib|mesh-list
82909916|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909917|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82909918|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909919|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909920|NCT01131897|Levetiracetam|levetiracetam|mesh-list
82909921|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
82909922|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
82909923|NCT01225419|Plerixafor|plerixafor|mesh-list
82909924|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82909925|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82909926|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
82909927|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909928|NCT03919461|Etodolac|etodolac|mesh-list
82909929|NCT03919461|Propranolol|propranolol|mesh-list
82909930|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82909931|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82909932|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
82909933|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909934|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909935|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909936|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82909937|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82909938|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
82909939|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82909940|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82909941|NCT03919461|Analgesics|analgesics|mesh-ancestor
82909942|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
82909943|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82909944|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82909945|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82909946|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82909947|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82909948|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909949|NCT02528877|Sirolimus|sirolimus|mesh-list
82909950|NCT02528877|Fludarabine|fludarabine|mesh-list
82909951|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
82909952|NCT02528877|Melphalan|melphalan|mesh-list
82909953|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
82909954|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82909955|NCT02528877|Tacrolimus|tacrolimus|mesh-list
82909956|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82909957|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82909958|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
82909959|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909960|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82909961|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
82909962|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82909963|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82909964|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909965|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82909966|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82909967|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82909968|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
82909969|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82909970|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
82909971|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82909972|NCT03918993|Tadalafil|tadalafil|mesh-list
82909973|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
82909974|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82909975|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82909976|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82909977|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909978|NCT03918993|Urological Agents|urological agents|mesh-ancestor
82909979|NCT03920475|Sertraline|sertraline|mesh-list
82909980|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82909981|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
82909982|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82909983|NCT03920475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82909984|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82909985|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909986|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82909987|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82909988|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
82909989|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083947|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82909991|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82909992|NCT03920319|Bupropion|bupropion|mesh-list
82909993|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82909994|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
82909995|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82909996|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82909997|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82909998|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82909999|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910000|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
82910001|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910002|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910003|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82910004|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82910005|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910006|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
82910007|NCT03920397|Vitamin D|vitamin d|mesh-list
82910008|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82910009|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910010|NCT03920397|Vitamins|vitamins|mesh-ancestor
82910011|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
82910012|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82910013|NCT01131975|Lamotrigine|lamotrigine|mesh-list
82910014|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
82910015|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82910016|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910017|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910018|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82910019|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910020|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82910021|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82910022|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910023|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82910024|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82910025|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
82910026|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910027|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910028|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82910029|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82910030|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910031|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910032|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910033|NCT01128699|Bevacizumab|bevacizumab|mesh-list
82910034|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910035|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910036|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82910037|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82910038|NCT01128699|Growth Substances|growth substances|mesh-ancestor
82910039|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910040|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
82910041|NCT01329627|Paclitaxel|paclitaxel|mesh-list
82910042|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82910043|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
82910044|NCT01329627|Doxorubicin|doxorubicin|mesh-list
82910045|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82910046|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82910047|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910048|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910049|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910050|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910051|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910052|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910053|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
82910054|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910055|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82910056|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82910057|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
82910058|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82910059|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82910060|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82910062|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910063|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
82910064|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
82910065|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82910066|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82910067|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910068|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910069|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910070|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82910072|NCT01132911|Vorinostat|vorinostat|mesh-list
82910073|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910074|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82910075|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910076|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910077|NCT01132989|Lenalidomide|lenalidomide|mesh-list
82910078|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
82910079|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910080|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82910081|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82910082|NCT01132989|Growth Substances|growth substances|mesh-ancestor
82910083|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
82910084|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910085|NCT01225653|Latanoprost|latanoprost|mesh-list
82910086|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82910087|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82910088|NCT01134861|Cisplatin|cisplatin|mesh-list
82910089|NCT01134861|Etoposide|etoposide|mesh-list
82910090|NCT01134861|Vinblastine|vinblastine|mesh-list
82910091|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910092|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82910093|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82910094|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82910095|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910096|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910097|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910098|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910099|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910100|NCT01133223|Plasminogen|plasminogen|mesh-list
82910101|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82910102|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82910103|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82910104|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910105|NCT01233219|Morphine|morphine|mesh-list
82910106|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82910107|NCT01233219|Narcotics|narcotics|mesh-ancestor
82910108|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910109|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910110|NCT01233219|Analgesics|analgesics|mesh-ancestor
82910111|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
82910112|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910113|NCT02960854|Nivolumab|nivolumab|mesh-list
82910114|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910115|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910116|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82910117|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910118|NCT01133301|Naltrexone|naltrexone|mesh-list
82910119|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82910120|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82910121|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910122|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
82910123|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910124|NCT03918135|Acetaminophen|acetaminophen|mesh-list
82910125|NCT03918135|Ibuprofen|ibuprofen|mesh-list
82910126|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82910127|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82910128|NCT03918135|Analgesics|analgesics|mesh-ancestor
82910129|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
82910130|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910131|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910132|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82910133|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82910134|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82910135|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910136|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910137|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
82910138|NCT05480475|Dabigatran|dabigatran|mesh-list
82910139|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82910140|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82910141|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82910142|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
82910143|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910144|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82910145|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82910146|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910147|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
82910148|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82910149|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
82910150|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
82910151|NCT03642184|Empagliflozin|empagliflozin|mesh-list
82910152|NCT03642184|Linagliptin|linagliptin|mesh-list
82910153|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82910154|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910155|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82910156|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910157|NCT03642184|Incretins|incretins|mesh-ancestor
82910158|NCT03642184|Hormones|hormones|mesh-ancestor
82910159|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910160|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82910161|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
82910162|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910163|NCT01137591|Acetaminophen|acetaminophen|mesh-list
82910164|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
82910165|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82910166|NCT01137591|Analgesics|analgesics|mesh-ancestor
82910167|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
82910168|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910169|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910170|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
82910171|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
82910172|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910173|NCT01137591|Expectorants|expectorants|mesh-ancestor
82910174|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
82910175|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82910176|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
82910177|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910178|NCT01137591|Protective Agents|protective agents|mesh-ancestor
82910179|NCT01133457|Finasteride|finasteride|mesh-list
82910180|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82910181|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82910182|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910183|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910184|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
82910185|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910186|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910187|NCT01133457|Urological Agents|urological agents|mesh-ancestor
82910188|NCT01135563|Sirolimus|sirolimus|mesh-list
82910189|NCT01135563|Vinblastine|vinblastine|mesh-list
82910190|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910191|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910192|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82910193|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910194|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
82910195|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910196|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
82910197|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910198|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910199|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82910200|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910201|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910202|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910203|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
82910204|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82910205|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82910206|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82910207|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910208|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910209|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
82910210|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910211|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910213|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910214|NCT03764631|Empagliflozin|empagliflozin|mesh-list
82910215|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82910216|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82910217|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910218|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82910219|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910220|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
82910221|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910223|NCT01135641|Rituximab|rituximab|mesh-list
82910224|NCT01135641|Cyclosporins|cyclosporins|mesh-list
82910225|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910226|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910227|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
82910228|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910229|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82910230|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910231|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910232|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910233|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
82910234|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910235|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
82910236|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82910237|NCT03640156|Oxytocin|oxytocin|mesh-list
82910238|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
82910239|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82910240|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910241|NCT01230723|Everolimus|everolimus|mesh-list
82910242|NCT01230723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82910243|NCT01230723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82910244|NCT01230723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910245|NCT01230723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910246|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910247|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
82910248|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910249|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910250|NCT05401071|Rifapentine|rifapentine|mesh-list
82910251|NCT05401071|Rifampin|rifampin|mesh-list
82910252|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82910253|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
82910254|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910255|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910256|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
82910257|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82910258|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910259|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910260|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82910261|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82910262|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82910263|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83456821|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
82910264|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82910265|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82910266|NCT01135953|Cycloserine|cycloserine|mesh-list
82910267|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82910268|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910269|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82910270|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
82910271|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910272|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
82910273|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910274|NCT01136031|Paclitaxel|paclitaxel|mesh-list
82910275|NCT01136031|Irinotecan|irinotecan|mesh-list
82910276|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82910277|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910278|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910279|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910280|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910281|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910282|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82910283|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82910284|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910285|NCT05400915|Paclitaxel|paclitaxel|mesh-list
82910286|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82910287|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910288|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910289|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910290|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910291|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910292|NCT01137903|Amoxicillin|amoxicillin|mesh-list
82910293|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
82910294|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
82910295|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
82910296|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82910297|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82910298|NCT01137903|Trimethoprim|trimethoprim|mesh-list
82910299|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
82910300|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910301|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910302|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82910303|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82910304|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910305|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910306|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910307|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82910308|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82910309|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82910310|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
82910311|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82910312|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82910313|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82910314|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82910315|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82910316|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82910317|NCT03739671|Vitamin D|vitamin d|mesh-list
82910318|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
82910319|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
82910320|NCT03739671|Vitamins|vitamins|mesh-list
82910321|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
82910322|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910323|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82910324|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82910325|NCT01233453|Umirolimus|umirolimus|mesh-list
82910326|NCT01233453|Everolimus|everolimus|mesh-list
82910327|NCT01233453|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82910328|NCT01233453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82910329|NCT01233453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910330|NCT01233453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910331|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910332|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
82910333|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910334|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910335|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82910336|NCT01133925|Sirolimus|sirolimus|mesh-list
82910337|NCT01133925|Paclitaxel|paclitaxel|mesh-list
82910338|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82910339|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910340|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910341|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910342|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910343|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910344|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910345|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910346|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82910347|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
82910348|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910349|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
82910350|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910351|NCT01232439|Aticaprant|aticaprant|mesh-list
82910352|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910353|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
82910354|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910355|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82910356|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
82910357|NCT01138137|Paclitaxel|paclitaxel|mesh-list
82910358|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82910359|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82910360|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910361|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910362|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910363|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910364|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910365|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
82910366|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910367|NCT01138137|Expectorants|expectorants|mesh-ancestor
82910368|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
82910369|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82910370|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
82910371|NCT01138137|Protective Agents|protective agents|mesh-ancestor
82910372|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910373|NCT01138137|Antidotes|antidotes|mesh-ancestor
82910374|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
82910375|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
82910376|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
82910377|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910378|NCT01231113|Artesunate|artesunate|mesh-list
82910379|NCT01231113|Piperaquine|piperaquine|mesh-list
82910380|NCT01231113|Amodiaquine|amodiaquine|mesh-list
82910381|NCT01231113|Artenimol|artenimol|mesh-list
82910382|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
82910383|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82910384|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82910385|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910386|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910387|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
82910388|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
82910389|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82910390|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
82910391|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
82910392|NCT01136421|Bromides|bromides|mesh-list
82910393|NCT01136421|Ipratropium|ipratropium|mesh-list
82910394|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
82910395|NCT01136421|Analgesics|analgesics|mesh-ancestor
82910396|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
82910397|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910398|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910399|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
82910400|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910401|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82910402|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82910403|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910404|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910405|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82910406|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
82910407|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82910408|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82910409|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
82910410|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82910411|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
82910412|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82910413|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
82910414|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910415|NCT01136499|Panobinostat|panobinostat|mesh-list
82910416|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910417|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82910418|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910419|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910420|NCT01231191|Acetaminophen|acetaminophen|mesh-list
82910421|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82910422|NCT01231191|Analgesics|analgesics|mesh-ancestor
82910423|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
82910424|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910425|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910426|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
82910427|NCT01138449|Vitamin A|vitamin a|mesh-list
82910428|NCT01138449|Vitamins|vitamins|mesh-ancestor
82910429|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
82910430|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910431|NCT05402865|Denosumab|denosumab|mesh-list
82910432|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82910433|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910434|NCT01138605|Ritonavir|ritonavir|mesh-list
82910435|NCT01138605|Darunavir|darunavir|mesh-list
82910436|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82910437|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82910438|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
82910439|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910440|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910441|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82910442|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82910443|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
82910444|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910445|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82910446|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82910447|NCT01138683|Diuretics|diuretics|mesh-list
82910448|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
82910449|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910450|NCT04767243|Methamphetamine|methamphetamine|mesh-list
82910451|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82910452|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910453|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
82910454|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
82910455|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910456|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
83456846|NCT01075087|Ropivacaine|ropivacaine|mesh-list
82910457|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910458|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910459|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
82910460|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82910461|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82910462|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910463|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82910464|NCT01138839|Dexamethasone|dexamethasone|mesh-list
82910465|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82910466|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
82910467|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
82910468|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910469|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910470|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82910471|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
82910472|NCT01138839|Hormones|hormones|mesh-ancestor
82910473|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910474|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82910475|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910476|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82910477|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82910478|NCT01234701|Liver Extracts|liver extracts|mesh-list
82910479|NCT01234701|Hematinics|hematinics|mesh-ancestor
82910480|NCT05280717|Sotrovimab|sotrovimab|mesh-list
82910481|NCT05280717|Antiviral Agents|antiviral agents|mesh-ancestor
82910482|NCT05280717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910483|NCT04721613|Melatonin|melatonin|mesh-list
82910484|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
82910485|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910486|NCT04721613|Protective Agents|protective agents|mesh-ancestor
82910487|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910488|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910489|NCT05275179|Posaconazole|posaconazole|mesh-list
82910490|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
82910491|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910492|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82910493|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82910494|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82910495|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82910496|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82910497|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910498|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910499|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82910500|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
82910501|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910502|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910503|NCT01139151|Cytarabine|cytarabine|mesh-list
82910504|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82910505|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
82910506|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910507|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910508|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
82910509|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910510|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910511|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
82910512|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910513|NCT01234857|Sirolimus|sirolimus|mesh-list
82910514|NCT01234857|Exemestane|exemestane|mesh-list
82910515|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82910516|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910517|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83515062|NCT00377559|Docetaxel|docetaxel|mesh-list
82910518|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82910519|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910520|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910521|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82910522|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
82910523|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910524|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910525|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910526|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910527|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82910528|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
82910529|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910530|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
82910531|NCT01233843|Carboplatin|carboplatin|mesh-list
82910532|NCT01233843|Fluorouracil|fluorouracil|mesh-list
82910533|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910534|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
82910535|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910536|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82910537|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910538|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
82910539|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910540|NCT01234935|Gemcitabine|gemcitabine|mesh-list
82910541|NCT01234935|Dasatinib|dasatinib|mesh-list
82910542|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82910543|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
82910544|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910545|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910546|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82910547|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910548|NCT03674541|Bromides|bromides|mesh-list
82910549|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82910550|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
82910551|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82910552|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910553|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910554|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
82910555|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910556|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910557|NCT01235013|Maraviroc|maraviroc|mesh-list
82910558|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82910559|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82910560|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910561|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82910562|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82910563|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
82910564|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910565|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82910566|NCT01236495|Morphine|morphine|mesh-list
82910567|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82910568|NCT01236495|Narcotics|narcotics|mesh-ancestor
82910569|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910570|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910571|NCT01236495|Analgesics|analgesics|mesh-ancestor
82910572|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
82910573|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910574|NCT01143129|Dexamethasone|dexamethasone|mesh-list
82910575|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82910576|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
82910577|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
82910578|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910579|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910580|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82910581|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
82910582|NCT01143129|Hormones|hormones|mesh-ancestor
82910583|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910584|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82910585|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910588|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
82910589|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
82910590|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
82910591|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910592|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910593|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82910594|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82910596|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910597|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82910598|NCT01139463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82910599|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82910600|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910601|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910602|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910603|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
82910604|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82910605|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
82910606|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82910607|NCT03640468|Lidocaine|lidocaine|mesh-list
82910608|NCT03640468|Midazolam|midazolam|mesh-list
82910609|NCT03640468|Ketamine|ketamine|mesh-list
82910610|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
82910611|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
82910612|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910613|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910614|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
82910615|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910616|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82910617|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82910618|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82910619|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910620|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910621|NCT03640468|Analgesics|analgesics|mesh-ancestor
82910622|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82910623|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82910624|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
82910625|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82910626|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82910627|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910628|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82910629|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82910630|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82910631|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82910632|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82910633|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
82910634|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
82910635|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
82910636|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
82910637|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82910638|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910639|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910640|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82910641|NCT03640390|Analgesics|analgesics|mesh-ancestor
82910642|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
82910643|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910644|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82910645|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82910646|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82910647|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
82910648|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910649|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910650|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
82910651|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82910652|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
82910653|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82910654|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910655|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82910656|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
82910657|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82910658|NCT03618472|Metformin|metformin|mesh-list
82910659|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82910660|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910661|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
82910662|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910663|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910665|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82910666|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82910667|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82910668|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
82910669|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
82910670|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910671|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910672|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910673|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82910674|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82910675|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910677|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910678|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910679|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82910680|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910681|NCT01336972|Tolvaptan|tolvaptan|mesh-list
82910682|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82910683|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910684|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
82910685|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910686|NCT03537508|Vaccines|vaccines|mesh-list
82910687|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
82910688|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910689|NCT03618082|Desflurane|desflurane|mesh-list
82910690|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82910691|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
82910692|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
82910693|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910694|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910695|NCT01236651|Drotaverin|drotaverin|mesh-list
82910696|NCT01236651|Meperidine|meperidine|mesh-list
82910697|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82910698|NCT01236651|Narcotics|narcotics|mesh-ancestor
82910699|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910700|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910701|NCT01236651|Analgesics|analgesics|mesh-ancestor
82910702|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
82910703|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910704|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82910705|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
82910706|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
82910707|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
82910708|NCT04484025|Ebselen|ebselen|mesh-list
82910709|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82910710|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82910711|NCT04484025|Analgesics|analgesics|mesh-ancestor
82910712|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
82910713|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910714|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910715|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82910716|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82910717|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82910718|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82910719|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
82910720|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910721|NCT04484025|Protective Agents|protective agents|mesh-ancestor
82910722|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82910723|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910724|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82910725|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
82910726|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82910727|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82910728|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82910729|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910730|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910731|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
82910732|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910733|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910735|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910736|NCT03616288|Thiamine|thiamine|mesh-list
82910737|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
82910738|NCT03616288|Vitamins|vitamins|mesh-ancestor
82910739|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
82910740|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910741|NCT02873338|Cytarabine|cytarabine|mesh-list
82910742|NCT02873338|Idarubicin|idarubicin|mesh-list
82910743|NCT02873338|Heparin|heparin|mesh-list
82910744|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82910745|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
82910746|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910747|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910748|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
82910749|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910750|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910751|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
82910752|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910753|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
82910754|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82910755|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82910756|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82910757|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82910758|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82910759|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910760|NCT03616132|Sirolimus|sirolimus|mesh-list
82910761|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910762|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910763|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82910764|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910765|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
82910766|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82910767|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
82910768|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910769|NCT02872012|Lidocaine|lidocaine|mesh-list
82910770|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
82910771|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
82910772|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910773|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910774|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
82910775|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910776|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82910777|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82910778|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82910779|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82910780|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910781|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
82910782|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910783|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910784|NCT03617224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82910785|NCT03617224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910786|NCT03615430|Anesthetics|anesthetics|mesh-list
82910787|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
82910788|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910789|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910790|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
82910791|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910792|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
82910793|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82910794|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82910795|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82910796|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82910797|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82910798|NCT03613792|Fentanyl|fentanyl|mesh-list
82910799|NCT03613792|Midazolam|midazolam|mesh-list
82910800|NCT03613792|Ketamine|ketamine|mesh-list
82910801|NCT03613792|Remifentanil|remifentanil|mesh-list
82910802|NCT03613792|Analgesics|analgesics|mesh-ancestor
82910803|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
82910804|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910805|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910806|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82910807|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82910808|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
82910809|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
82910811|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82910812|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82910813|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910814|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910815|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82910816|NCT03613792|Narcotics|narcotics|mesh-ancestor
82910817|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82910818|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82910819|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82910820|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82910821|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82910822|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
82910823|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
82910824|NCT04837768|Progesterone|progesterone|mesh-list
82910825|NCT04837768|Progestins|progestins|mesh-ancestor
82910826|NCT04837768|Hormones|hormones|mesh-ancestor
82910827|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910828|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910829|NCT02869438|Benralizumab|benralizumab|mesh-list
82910830|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82910831|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
82910832|NCT02868892|Pemetrexed|pemetrexed|mesh-list
82910833|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910834|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910835|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910836|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82910837|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82910838|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
82910839|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82910840|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910841|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910842|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82910843|NCT03613558|Analgesics|analgesics|mesh-ancestor
82910844|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
82910845|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910846|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82910847|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82910848|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82910849|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
82910850|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82910851|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910852|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
82910853|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910854|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910855|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82910856|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82910857|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910858|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910859|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910860|NCT03310125|Colchicine|colchicine|mesh-list
82910861|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
82910862|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82910863|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
82910864|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
82910865|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
82910866|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910867|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910868|NCT03613168|Trastuzumab|trastuzumab|mesh-list
82910869|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910870|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910871|NCT01141881|Bevacizumab|bevacizumab|mesh-list
82910872|NCT01141881|Plasminogen|plasminogen|mesh-list
82910873|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82910874|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910875|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910876|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82910877|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82910878|NCT01141881|Growth Substances|growth substances|mesh-ancestor
82910879|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910880|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
82910881|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82910882|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82910883|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910884|NCT04707430|Progesterone|progesterone|mesh-list
82910885|NCT04707430|Progestins|progestins|mesh-ancestor
82910886|NCT04707430|Hormones|hormones|mesh-ancestor
82910887|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910888|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910889|NCT03611920|Tetracycline|tetracycline|mesh-list
82910890|NCT03611920|Dexamethasone|dexamethasone|mesh-list
82910891|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82910892|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
82910893|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
82910894|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910895|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910896|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82910897|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
82910898|NCT03611920|Hormones|hormones|mesh-ancestor
82910899|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910900|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82910901|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910902|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82910903|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910904|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82910905|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910906|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910907|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82910908|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82910909|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
82910910|NCT02936752|Entinostat|entinostat|mesh-list
82910911|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82910912|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910913|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82910914|NCT02936752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82910915|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910916|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82910917|NCT05383534|Propofol|propofol|mesh-list
82910918|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82910919|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910920|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910921|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82910922|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
82910923|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
82910924|NCT01235325|Vitamin K|vitamin k|mesh-list
82910925|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
82910926|NCT01235325|Vitamins|vitamins|mesh-ancestor
82910927|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
82910928|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910929|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82910930|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82910931|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910932|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
82910933|NCT01235325|Coagulants|coagulants|mesh-ancestor
82910934|NCT01140009|Vaccines|vaccines|mesh-list
82910935|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
82910936|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910937|NCT01235637|Sufentanil|sufentanil|mesh-list
82910938|NCT01235637|Alfentanil|alfentanil|mesh-list
82910939|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82910940|NCT01235637|Narcotics|narcotics|mesh-ancestor
82910941|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82910942|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910943|NCT01235637|Analgesics|analgesics|mesh-ancestor
82910944|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
82910945|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82910946|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82910947|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82910948|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
82910949|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
82910950|NCT01143831|Vitamins|vitamins|mesh-list
82910951|NCT01143831|Vitamin K|vitamin k|mesh-list
82910952|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
82910953|NCT01143831|Menatetrenone|menatetrenone|mesh-list
82910954|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
82910955|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910956|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82910957|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82910958|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910959|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
82910960|NCT01143831|Coagulants|coagulants|mesh-ancestor
82910962|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
82910964|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82910965|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910966|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82910967|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
82910968|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910969|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
82910970|NCT01144065|Testosterone|testosterone|mesh-list
82910971|NCT01144065|Androgens|androgens|mesh-ancestor
82910972|NCT01144065|Hormones|hormones|mesh-ancestor
82910973|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910974|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910975|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82910976|NCT01142505|Mannitol|mannitol|mesh-list
82910977|NCT01142505|Montelukast|montelukast|mesh-list
82910978|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82910979|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
82910980|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82910981|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
82910982|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82910983|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82910984|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82910985|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82910986|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910987|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82910988|NCT01142505|Diuretics|diuretics|mesh-ancestor
82910989|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
82910990|NCT01236963|Listerine|listerine|mesh-list
82910991|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82910992|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82910993|NCT02908672|Atezolizumab|atezolizumab|mesh-list
82910994|NCT02908672|Vemurafenib|vemurafenib|mesh-list
82910995|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82910996|NCT02908672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82910997|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82910998|NCT02908672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82910999|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911000|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
82911001|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911002|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911003|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911004|NCT02572167|Nivolumab|nivolumab|mesh-list
82911005|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82911006|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82911007|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911008|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82911009|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911010|NCT02572167|Immunotoxins|immunotoxins|mesh-ancestor
82911011|NCT02572167|Immunoconjugates|immunoconjugates|mesh-ancestor
82911012|NCT02572167|Immunologic Factors|immunologic factors|mesh-ancestor
82911013|NCT02572167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911014|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
82911015|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82911016|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
82911017|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82911018|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911019|NCT01336738|Incretins|incretins|mesh-ancestor
82911020|NCT01336738|Hormones|hormones|mesh-ancestor
82911021|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911022|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82911023|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
82911024|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911025|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911026|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
82911027|NCT01336738|Vitamins|vitamins|mesh-ancestor
82911028|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
82911029|NCT01140399|Dopamine|dopamine|mesh-list
82911030|NCT01140399|Furosemide|furosemide|mesh-list
82911031|NCT01140399|Diuretics|diuretics|mesh-ancestor
82911032|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
82911033|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911034|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82911035|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911036|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911037|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82911039|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
82911040|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911041|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
82911042|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911043|NCT01140399|Protective Agents|protective agents|mesh-ancestor
82911044|NCT02410317|Morphine|morphine|mesh-list
82911045|NCT02410317|Ropivacaine|ropivacaine|mesh-list
82911046|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82911047|NCT02410317|Narcotics|narcotics|mesh-ancestor
82911048|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911049|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911051|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
82911052|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911053|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
82911054|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
82911055|NCT02258451|Everolimus|everolimus|mesh-list
82911056|NCT02258451|Exemestane|exemestane|mesh-list
82911057|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82911058|NCT02258451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82911059|NCT02258451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911060|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911061|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911062|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911063|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
82911064|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911065|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911066|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82911067|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82911068|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82911069|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
82911070|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911071|NCT01237119|Liraglutide|liraglutide|mesh-list
82911072|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82911073|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911074|NCT01237119|Incretins|incretins|mesh-ancestor
82911075|NCT01237119|Hormones|hormones|mesh-ancestor
82911076|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911077|NCT03760263|Tacrolimus|tacrolimus|mesh-list
82911078|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911079|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
82911080|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911081|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82911082|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911083|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911084|NCT01237275|Sertraline|sertraline|mesh-list
82911085|NCT01237275|Fluoxetine|fluoxetine|mesh-list
82911086|NCT01237275|Paroxetine|paroxetine|mesh-list
82911087|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
82911088|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82911089|NCT01237275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82911090|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82911091|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911092|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911093|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911094|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
82911095|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911096|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82911097|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82911098|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82911099|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911100|NCT04867785|Dulaglutide|dulaglutide|mesh-list
82911101|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82911102|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911103|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
82911104|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82911105|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82911106|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82911107|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911109|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
82911110|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911111|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911112|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82911113|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911114|NCT02033434|Ketamine|ketamine|mesh-list
82911115|NCT02033434|Analgesics|analgesics|mesh-ancestor
82911116|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
82911117|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911118|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911119|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82911120|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82911121|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
82911122|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
82911123|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911124|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82911125|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82911126|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911127|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911128|NCT02033512|Hormones|hormones|mesh-list
82911129|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911130|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911131|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
82911132|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911133|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911134|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911135|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911136|NCT02860546|Nivolumab|nivolumab|mesh-list
82911137|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82911138|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911139|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82911140|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911141|NCT01982955|Carboplatin|carboplatin|mesh-list
82911142|NCT01982955|Pemetrexed|pemetrexed|mesh-list
82911143|NCT01982955|Gefitinib|gefitinib|mesh-list
82911144|NCT01982955|Tepotinib|tepotinib|mesh-list
82911145|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911146|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911147|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911148|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82911149|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82911150|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911151|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
82911152|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82911153|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
82911154|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911155|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
82911156|NCT01144533|Protective Agents|protective agents|mesh-ancestor
82911157|NCT01238055|Docetaxel|docetaxel|mesh-list
82911158|NCT01238055|Sunitinib|sunitinib|mesh-list
82911159|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911160|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
82911161|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
82911162|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
82911163|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911164|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82911165|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82911166|NCT01238055|Growth Substances|growth substances|mesh-ancestor
82911167|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911168|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
82911169|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911170|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911171|NCT01144923|Gabapentin|gabapentin|mesh-list
82911172|NCT01144923|Nortriptyline|nortriptyline|mesh-list
82911173|NCT01144923|Analgesics|analgesics|mesh-ancestor
82911174|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
82911175|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911176|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911177|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
82911178|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82911179|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82911180|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911181|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82911182|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82911183|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82911184|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911185|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911186|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
82911187|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82911188|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
82911189|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82911190|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82911191|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911192|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911193|NCT01329783|Maraviroc|maraviroc|mesh-list
82911194|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82911195|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82911196|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911197|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82911198|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82911199|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
82911200|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911201|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82911202|NCT01238133|Paclitaxel|paclitaxel|mesh-list
82911203|NCT01238133|Carboplatin|carboplatin|mesh-list
82911204|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82911205|NCT01238133|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82911206|NCT01238133|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82911207|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82911208|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911209|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
82911210|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
82911211|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
82911212|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911213|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911214|NCT01145079|Sirolimus|sirolimus|mesh-list
82911215|NCT01145079|Everolimus|everolimus|mesh-list
82911216|NCT01145079|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82911217|NCT01145079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911218|NCT01145079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911219|NCT01145079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911220|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911221|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
82911222|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911223|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911224|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82911225|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911226|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82911227|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
82911228|NCT01146483|Pantoprazole|pantoprazole|mesh-list
82911229|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82911230|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82911231|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82911232|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
82911233|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911234|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82911235|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82911236|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911237|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82911238|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911239|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82911240|NCT00396279|Vitamin D|vitamin d|mesh-list
82911241|NCT00396279|Denosumab|denosumab|mesh-list
82911242|NCT00396279|Calcium|calcium|mesh-list
82911243|NCT00396279|Vitamins|vitamins|mesh-ancestor
82911244|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
82911245|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911246|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82911247|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82911248|NCT01238367|Factor VIII|factor viii|mesh-list
82911249|NCT01238367|Coagulants|coagulants|mesh-ancestor
82911250|NCT01347866|Irinotecan|irinotecan|mesh-list
82911251|NCT01347866|Gedatolisib|gedatolisib|mesh-list
82911252|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82911253|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82911254|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911255|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911256|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911257|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911258|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
82911259|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
82911260|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82911261|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911262|NCT05470868|Naphazoline|naphazoline|mesh-list
82911263|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82911264|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82911265|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911266|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911267|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911268|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911269|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
82911270|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82911271|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
82911272|NCT03485222|Empagliflozin|empagliflozin|mesh-list
82911273|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82911274|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911275|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82911276|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911277|NCT01347554|Everolimus|everolimus|mesh-list
82911278|NCT01347554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82911279|NCT01347554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911280|NCT01347554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911281|NCT01347554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911282|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911283|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
82911284|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911285|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911286|NCT05567354|Oxycodone|oxycodone|mesh-list
82911287|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82911288|NCT05567354|Narcotics|narcotics|mesh-ancestor
83456928|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
82911289|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911290|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911291|NCT05567354|Analgesics|analgesics|mesh-ancestor
82911292|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
82911293|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911294|NCT03482882|Pimavanserin|pimavanserin|mesh-list
82911295|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82911296|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82911297|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82911298|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82911299|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911300|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911301|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82911302|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82911303|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82911304|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
82911305|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911306|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911307|NCT03480932|Interferons|interferons|mesh-list
82911308|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
82911309|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
82911310|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82911311|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
82911312|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911313|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
82911314|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911315|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
82911316|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911317|NCT03387020|Everolimus|everolimus|mesh-list
82911318|NCT03387020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82911319|NCT03387020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911320|NCT03387020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911321|NCT03387020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911322|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911323|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
82911324|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911325|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911326|NCT03386474|Aflibercept|aflibercept|mesh-list
82911327|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82911328|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82911329|NCT03386474|Growth Substances|growth substances|mesh-ancestor
82911330|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911331|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
82911332|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911333|NCT03405818|Tavaborole|tavaborole|mesh-list
82911334|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
82911335|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911336|NCT03403634|Interferons|interferons|mesh-list
82911337|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
82911338|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
82911339|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
82911340|NCT03403634|Celecoxib|celecoxib|mesh-list
82911341|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
82911342|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911343|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
82911344|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911345|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
82911346|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911347|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82911348|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82911349|NCT03403634|Analgesics|analgesics|mesh-ancestor
82911350|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
82911351|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911352|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911353|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82911354|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82911355|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82911356|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911357|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911358|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82911359|NCT02863354|Aflibercept|aflibercept|mesh-list
82911360|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82911361|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82911362|NCT02863354|Growth Substances|growth substances|mesh-ancestor
82911363|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911364|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
82911365|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911367|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82911368|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911369|NCT02862730|Pancrelipase|pancrelipase|mesh-list
82911370|NCT02862730|Pancreatin|pancreatin|mesh-list
82911371|NCT02862730|Hormones|hormones|mesh-list
82911372|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911373|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911374|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911375|NCT03401450|Bupivacaine|bupivacaine|mesh-list
82911376|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
82911377|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
82911378|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911379|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911380|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
82911381|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911382|NCT03609970|Vitamin D|vitamin d|mesh-list
82911383|NCT03609970|Vitamins|vitamins|mesh-ancestor
82911384|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
82911385|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911386|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82911387|NCT03610282|Propofol|propofol|mesh-list
82911388|NCT03610282|Methylphenidate|methylphenidate|mesh-list
82911389|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82911390|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911391|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911392|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82911393|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
82911394|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
82911395|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82911396|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82911397|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82911398|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911399|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911400|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
82911401|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911402|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
82911403|NCT02862574|Methotrexate|methotrexate|mesh-list
82911404|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82911406|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82911407|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911408|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82911409|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
82911410|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911411|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911412|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
82911413|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911414|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82911415|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911416|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
82911417|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82911418|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82911419|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911420|NCT05383300|Oxytocin|oxytocin|mesh-list
82911421|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
82911422|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82911423|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82751918|NCT00865176|Eplerenone|eplerenone|mesh-list
82911424|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82911425|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82911426|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911428|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
82911429|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911430|NCT03609892|Amoxicillin|amoxicillin|mesh-list
82911431|NCT03609892|Tetracycline|tetracycline|mesh-list
82911432|NCT03609892|Furazolidone|furazolidone|mesh-list
82911433|NCT03609892|Esomeprazole|esomeprazole|mesh-list
82911434|NCT03609892|Bismuth|bismuth|mesh-list
82911435|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82911436|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911437|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82911438|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911439|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82911440|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911441|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911442|NCT03609892|Antacids|antacids|mesh-ancestor
82911443|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82911444|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82911445|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82911446|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82911447|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82911448|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82911449|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82911450|NCT03609814|Fludarabine|fludarabine|mesh-list
82911451|NCT03609814|Clofarabine|clofarabine|mesh-list
82911452|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911453|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82911454|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
82911455|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911456|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
82911457|NCT02457598|Idelalisib|idelalisib|mesh-list
82911458|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82911459|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911460|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911461|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911462|NCT02859142|Nicotine|nicotine|mesh-list
82911463|NCT02859142|Varenicline|varenicline|mesh-list
82911464|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82911465|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
82911466|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911467|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911468|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82911469|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82911470|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
82911471|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911472|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911473|NCT03351608|Atropine|atropine|mesh-list
82911474|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
82911475|NCT03351608|Neostigmine|neostigmine|mesh-list
82911476|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82911477|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82911478|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82911479|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
82911480|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911481|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911482|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82911483|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
82911485|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
82911486|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82911487|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82911488|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
82911489|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911490|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911491|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82911492|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911493|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82911494|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82911495|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82911496|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
82911497|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911498|NCT03382418|Antacids|antacids|mesh-ancestor
82911499|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911500|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911501|NCT03382262|Triamcinolone|triamcinolone|mesh-list
82911502|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82911503|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82911504|NCT03382262|FX006|fx006|mesh-list
82911505|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82911506|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911507|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
82911508|NCT03382262|Hormones|hormones|mesh-ancestor
82911509|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911510|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911511|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911512|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
82911513|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911514|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911515|NCT02236936|Cetuximab|cetuximab|mesh-list
82911516|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911517|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82911518|NCT03638960|Bupivacaine|bupivacaine|mesh-list
82911519|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
82911520|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
82911521|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911522|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911523|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
82911524|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911525|NCT02259790|Amlodipine|amlodipine|mesh-list
82911526|NCT02259790|Telmisartan|telmisartan|mesh-list
82911527|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
82911528|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82911529|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82911530|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911531|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911532|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82911533|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911534|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
82911535|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82911536|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82911537|NCT02857270|Paclitaxel|paclitaxel|mesh-list
82911538|NCT02857270|Gemcitabine|gemcitabine|mesh-list
82911539|NCT02857270|Cetuximab|cetuximab|mesh-list
82911540|NCT02857270|Midazolam|midazolam|mesh-list
82911541|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82911542|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911543|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
82911544|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
82911545|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
82911546|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911547|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82911548|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
82911549|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82911550|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82911551|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911552|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911553|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82911554|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82911555|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82911556|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82911557|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
82911558|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
82911559|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
82911560|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
82911561|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911562|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82911563|NCT03609190|Ketamine|ketamine|mesh-list
82911564|NCT03609190|Analgesics|analgesics|mesh-ancestor
82911565|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
82911566|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911567|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911568|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82911569|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82911570|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
82911571|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
82911572|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911573|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82911574|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82911575|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911576|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911578|NCT02856880|Trace Elements|trace elements|mesh-ancestor
82911579|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
82911580|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911581|NCT02856802|Sumatriptan|sumatriptan|mesh-list
82911582|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82911583|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82911584|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82911585|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
82911586|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911587|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911588|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911589|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
82911590|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82911591|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
82911592|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911593|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
82911594|NCT03381248|Protective Agents|protective agents|mesh-ancestor
82911595|NCT02024230|Warfarin|warfarin|mesh-list
82911596|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
82911597|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
82911598|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82911599|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
82911600|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82911601|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
82911602|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911603|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911604|NCT03380390|Phenylephrine|phenylephrine|mesh-list
82911605|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
82911606|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82911607|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82911608|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911609|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911610|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911611|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911612|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
82911613|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
82911614|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911615|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
82911616|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82911617|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
82911618|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82911619|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
82911620|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82911621|NCT03380390|Protective Agents|protective agents|mesh-ancestor
82911622|NCT01935778|Docetaxel|docetaxel|mesh-list
82911623|NCT01935778|Capecitabine|capecitabine|mesh-list
82911624|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
82911625|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911626|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
82911627|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
82911628|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
82911629|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911630|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82911631|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
82911632|NCT02034292|Aspirin|aspirin|mesh-list
82911633|NCT02034292|Clopidogrel|clopidogrel|mesh-list
82911634|NCT02034292|APD791|apd791|mesh-list
82911635|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82911636|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82911637|NCT02034292|Analgesics|analgesics|mesh-ancestor
82911638|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
82911639|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911640|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911641|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911642|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82911643|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82911644|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82911645|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911646|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82911647|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82911648|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911649|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
82911650|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82911651|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82911652|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82911653|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
82911654|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911655|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82911656|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82911657|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
82911658|NCT01758328|Fludarabine|fludarabine|mesh-list
82911659|NCT01758328|Melphalan|melphalan|mesh-list
82911660|NCT01758328|Busulfan|busulfan|mesh-list
82911661|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82911662|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911663|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911664|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911665|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
82911666|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911667|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82911668|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
82911669|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82911670|NCT04125550|Propofol|propofol|mesh-list
82911671|NCT04125550|Sevoflurane|sevoflurane|mesh-list
82911672|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82911673|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911674|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911675|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82911676|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
82911677|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
82911678|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82911679|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82911680|NCT02237326|Acetic Acid|acetic acid|mesh-list
82911681|NCT02237326|Retinol acetate|retinol acetate|mesh-list
82911682|NCT02237326|Lugol's solution|lugol's solution|mesh-list
82911683|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82911684|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911685|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82911686|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
82911687|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911688|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82911689|NCT02237326|Protective Agents|protective agents|mesh-ancestor
82911690|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911691|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
82911692|NCT02237326|Coagulants|coagulants|mesh-ancestor
82911693|NCT02034604|Tamsulosin|tamsulosin|mesh-list
82911694|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82911695|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82911696|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82911697|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911698|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911699|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911700|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911701|NCT02034604|Urological Agents|urological agents|mesh-ancestor
82911702|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
82911703|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82911704|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82911705|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911706|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911707|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911708|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911709|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
82911710|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
82911711|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911712|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
82911713|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82911714|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
82911715|NCT02035072|Gemcitabine|gemcitabine|mesh-list
82911716|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
82911717|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82911718|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
82911719|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911720|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911721|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
82911722|NCT00358215|Hematinics|hematinics|mesh-ancestor
82911723|NCT03605758|Ivermectin|ivermectin|mesh-list
82911724|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82911725|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911726|NCT03605056|Dexamethasone|dexamethasone|mesh-list
82911727|NCT03605056|Lenalidomide|lenalidomide|mesh-list
82911728|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911729|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
82911730|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
82911731|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911732|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911733|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911734|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
82911735|NCT03605056|Hormones|hormones|mesh-ancestor
82911736|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911737|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82911738|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911739|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
82911740|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82911741|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82911742|NCT03605056|Growth Substances|growth substances|mesh-ancestor
82911743|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
82911744|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
82911745|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82911746|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911747|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82911748|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
82911749|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82911750|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911751|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911752|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911753|NCT03604744|Psilocybin|psilocybin|mesh-list
82911754|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
82911755|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911756|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82911757|NCT03604354|Pregabalin|pregabalin|mesh-list
82911758|NCT03604354|Tapentadol|tapentadol|mesh-list
82911759|NCT03604354|Analgesics|analgesics|mesh-ancestor
82911760|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
82911761|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911762|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911763|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
82911764|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82911765|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911766|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911767|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82911768|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82911769|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82911770|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911771|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82911772|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82911773|NCT03604354|Narcotics|narcotics|mesh-ancestor
82911774|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82911775|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82911776|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911777|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911778|NCT03603418|Dexamethasone|dexamethasone|mesh-list
82911779|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
82911780|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82911781|NCT03603418|BB 1101|bb 1101|mesh-list
82911782|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911783|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
82911784|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
82911785|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911786|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911787|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911789|NCT03603418|Hormones|hormones|mesh-ancestor
82911790|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911791|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82911792|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911793|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
82911794|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911795|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911796|NCT02034838|Ritonavir|ritonavir|mesh-list
82911797|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82911798|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82911799|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82911800|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
82911801|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911802|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911803|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82911804|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82911806|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911807|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82911808|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82911809|NCT03287908|Dexamethasone|dexamethasone|mesh-list
82911810|NCT03287908|Pomalidomide|pomalidomide|mesh-list
82911811|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911812|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
82911813|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
82911814|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911815|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911816|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911817|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
82911818|NCT03287908|Hormones|hormones|mesh-ancestor
82911819|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911820|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82911821|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911822|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
82911823|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82911824|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82911825|NCT03287908|Growth Substances|growth substances|mesh-ancestor
82911826|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
82911827|NCT02852434|Lidocaine|lidocaine|mesh-list
82911828|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
82911829|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
82911830|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911831|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911832|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
82911833|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911834|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82911835|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82911836|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82911837|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911838|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911839|NCT03606928|Leucovorin|leucovorin|mesh-list
82911840|NCT03606928|Docetaxel|docetaxel|mesh-list
82911841|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
82911842|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911843|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
82911844|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
82911845|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
82911846|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911847|NCT03606928|Antidotes|antidotes|mesh-ancestor
82911848|NCT03606928|Protective Agents|protective agents|mesh-ancestor
82911849|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911850|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
82911851|NCT03606928|Vitamins|vitamins|mesh-ancestor
82911852|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
82911853|NCT02903368|Prednisone|prednisone|mesh-list
82911854|NCT02903368|Leuprolide|leuprolide|mesh-list
82911855|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
82911856|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911857|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
82911858|NCT02903368|Hormones|hormones|mesh-ancestor
82911859|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911860|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911861|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82911862|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911863|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82911864|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
82911865|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82911866|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82911867|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911868|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911869|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
82911870|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82911871|NCT03602248|Methamphetamine|methamphetamine|mesh-list
82911872|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82911873|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911874|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
82911875|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
82911876|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911877|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
82911878|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911879|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911880|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911881|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82911882|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82911883|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82911884|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82911885|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82911887|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82911888|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911889|NCT03602638|Incretins|incretins|mesh-ancestor
82911890|NCT03602638|Hormones|hormones|mesh-ancestor
82911891|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911892|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82911893|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
82911894|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911895|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911896|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82911897|NCT02237560|Camphor|camphor|mesh-list
82911898|NCT02237560|Salicylates|salicylates|mesh-list
82911899|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
82911900|NCT02237560|Menthol|menthol|mesh-list
82911901|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82911902|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82911903|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
82911904|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
82911905|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82911906|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82911907|NCT02237560|Analgesics|analgesics|mesh-ancestor
82911908|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
82911909|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911910|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911911|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911912|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82911913|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82911914|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911915|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911916|NCT03601624|Dexamethasone|dexamethasone|mesh-list
82911917|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
82911918|NCT03601624|Pomalidomide|pomalidomide|mesh-list
82911919|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82911920|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
82911921|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911922|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82911923|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82911924|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
82911925|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911926|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911927|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82911928|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82911929|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
82911930|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
82911931|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911932|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911933|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
82911935|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82911936|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82911937|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82911938|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82911939|NCT03601624|Growth Substances|growth substances|mesh-ancestor
82911940|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
82911941|NCT03899428|Sorafenib|sorafenib|mesh-list
82911942|NCT03899428|Durvalumab|durvalumab|mesh-list
82911943|NCT03899428|Lenvatinib|lenvatinib|mesh-list
82911944|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911945|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82911946|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911947|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911948|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82911949|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
82911950|NCT02238418|Vitamin D|vitamin d|mesh-list
82911951|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82911952|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911953|NCT02238418|Vitamins|vitamins|mesh-ancestor
82911954|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
82911955|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82911956|NCT02850016|Romidepsin|romidepsin|mesh-list
82911957|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82911958|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82911959|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82911960|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82911961|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911962|NCT02849704|Pancrelipase|pancrelipase|mesh-list
82911963|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82911964|NCT03600766|Mirabegron|mirabegron|mesh-list
82911965|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82911966|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82911967|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82911968|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
82911969|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82911970|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82911971|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911972|NCT03600766|Urological Agents|urological agents|mesh-ancestor
82911973|NCT03600454|Anesthetics|anesthetics|mesh-list
82911974|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911975|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911976|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
82911977|NCT03594604|Norethindrone|norethindrone|mesh-list
82911978|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
82911979|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
82911980|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82911981|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82911982|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911983|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82911984|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82911985|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82911986|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82911987|NCT02689258|Bupivacaine|bupivacaine|mesh-list
82911988|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
82911989|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
82911990|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82911991|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911992|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
82911993|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911994|NCT02238184|Ipratropium|ipratropium|mesh-list
82911995|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82911996|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
82911997|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82911998|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82911999|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82912000|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912001|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82912002|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
82912003|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912004|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912005|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
82912006|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
82912007|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82912009|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82912010|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82912011|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
82912012|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82912014|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82912015|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
82912016|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82912017|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912018|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82912019|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912020|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
82912021|NCT02721082|Nicotine|nicotine|mesh-list
82912022|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82912023|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
82912024|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912025|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912026|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82912027|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82912028|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
82912029|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912030|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912031|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82912032|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82912033|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
82912034|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912035|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912036|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82912037|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912038|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82912039|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82912040|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82912041|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
82912042|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912043|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912045|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912046|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912047|NCT02238262|Telmisartan|telmisartan|mesh-list
82912048|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82912049|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82912050|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82912051|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912052|NCT03577834|Acetic Acid|acetic acid|mesh-list
82912053|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82912054|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912055|NCT03707678|Albuterol|albuterol|mesh-list
82912056|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82912057|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
82912058|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912059|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912060|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82912061|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912062|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
82912063|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82912064|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82912065|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82912066|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82912067|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
82912068|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912069|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912070|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
82912071|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82912072|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912073|NCT04773002|Anesthetics|anesthetics|mesh-list
82912074|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912075|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912076|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82912077|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82912078|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912079|NCT02849080|Incretins|incretins|mesh-ancestor
82912080|NCT02849080|Hormones|hormones|mesh-ancestor
82912081|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912082|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82912083|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
82912084|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912085|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912086|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
82912088|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
82912089|NCT03346070|Neostigmine|neostigmine|mesh-list
82912090|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82912091|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82912092|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82912093|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912094|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912095|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82912096|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912097|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912098|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
82912099|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912100|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82912101|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
82912102|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82912103|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82912104|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82912105|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82912107|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82912108|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912109|NCT02238340|Ketoprofen|ketoprofen|mesh-list
82912110|NCT02238340|Morphine|morphine|mesh-list
82912111|NCT02238340|Oxycodone|oxycodone|mesh-list
82912112|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82912113|NCT02238340|Narcotics|narcotics|mesh-ancestor
82912114|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912115|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912116|NCT02238340|Analgesics|analgesics|mesh-ancestor
82912117|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
82912118|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912119|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82912120|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82912121|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912122|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912123|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82912124|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912125|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912126|NCT03577132|Atezolizumab|atezolizumab|mesh-list
82912127|NCT03577132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82912128|NCT03577132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912129|NCT03577132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912130|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912131|NCT05194124|alpha-MSH|alpha-msh|mesh-list
82912132|NCT05194124|Hormones|hormones|mesh-ancestor
82912133|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912134|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912135|NCT02250664|Nicotine|nicotine|mesh-list
82912136|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82912137|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
82912138|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912139|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912140|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82912141|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82912142|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
82912143|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912144|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912145|NCT02239276|Stiripentol|stiripentol|mesh-list
82912146|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
82912147|NCT03576820|Lidocaine|lidocaine|mesh-list
82912148|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82912149|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
82912150|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
82912151|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912152|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912153|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
82912154|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912156|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82912157|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82912158|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82912159|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912160|NCT03579082|Decitabine|decitabine|mesh-list
82912161|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82912162|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
82912163|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912164|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912165|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912166|NCT03579004|Paclitaxel|paclitaxel|mesh-list
82912167|NCT03579004|Fluorouracil|fluorouracil|mesh-list
82912168|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82912169|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912170|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
82912171|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
82912172|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
82912173|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912174|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
82912175|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82912176|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82912177|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
82912178|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912179|NCT03576508|Lidocaine|lidocaine|mesh-list
82912180|NCT03576508|Epinephrine|epinephrine|mesh-list
82912181|NCT03576508|Capsaicin|capsaicin|mesh-list
82912182|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
82912183|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
82912184|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912185|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912186|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
82912187|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912188|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82912189|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82912190|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82912191|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82912192|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912193|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82912194|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82912195|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
82912196|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912197|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82912198|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82912199|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
82912200|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82912201|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912202|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
82912203|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
82912204|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82912205|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
82912206|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912207|NCT02646982|Candesartan|candesartan|mesh-list
82912208|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82912209|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82912210|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82912211|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912212|NCT03576040|Edotreotide|edotreotide|mesh-list
82912213|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82912214|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912215|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
82912216|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82912217|NCT03574246|Benzydamine|benzydamine|mesh-list
82912218|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82912219|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912220|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
82912221|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912222|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912223|NCT02239900|Ipilimumab|ipilimumab|mesh-list
82912224|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912225|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912226|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82912227|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912230|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912231|NCT03573934|Hormones|hormones|mesh-ancestor
82912232|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912233|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912234|NCT03573934|Incretins|incretins|mesh-ancestor
82912235|NCT02229136|Prednisolone|prednisolone|mesh-list
82912236|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
82912237|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912238|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
82912239|NCT02229136|Hormones|hormones|mesh-ancestor
82912240|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912241|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912242|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912243|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912244|NCT02523898|Metformin|metformin|mesh-list
82912245|NCT02523898|Clomiphene|clomiphene|mesh-list
82912246|NCT02523898|Enclomiphene|enclomiphene|mesh-list
82912247|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
82912248|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82912249|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912250|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82912251|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
82912252|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912253|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82912254|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
82912255|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82912256|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82912257|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82912258|NCT02845336|Celecoxib|celecoxib|mesh-list
82912259|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
82912260|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82912261|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82912262|NCT02845336|Analgesics|analgesics|mesh-ancestor
82912263|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
82912264|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912265|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912266|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912267|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912268|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82912269|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82912270|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912271|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912272|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82912273|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82912274|NCT02244502|Paclitaxel|paclitaxel|mesh-list
82912275|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82912276|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912277|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
82912278|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
82912279|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
82912280|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912281|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
82912282|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82912283|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82912284|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912285|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82912286|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82912287|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
82912288|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912289|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912290|NCT02951156|Rituximab|rituximab|mesh-list
82912291|NCT02951156|Avelumab|avelumab|mesh-list
82912292|NCT02951156|Gemcitabine|gemcitabine|mesh-list
82912293|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
82912294|NCT02951156|Azacitidine|azacitidine|mesh-list
82912295|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82912296|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912297|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912298|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
82912299|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912300|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912301|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82912302|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
82912303|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912304|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912305|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82912306|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
82912307|NCT03571594|Octreotide|octreotide|mesh-list
82912308|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912309|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912310|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912311|NCT03571438|Sirolimus|sirolimus|mesh-list
82912312|NCT03571438|Sunitinib|sunitinib|mesh-list
82912313|NCT03571438|Temsirolimus|temsirolimus|mesh-list
82912314|NCT03571438|MTOR Inhibitors|mtor inhibitors|mesh-list
82912315|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912316|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82912317|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82912318|NCT03571438|Growth Substances|growth substances|mesh-ancestor
82912319|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912320|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
82912321|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82912322|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912323|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912324|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82752826|NCT05147493|Bortezomib|bortezomib|mesh-list
82912325|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
82912326|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82912327|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912328|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82912329|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
82912330|NCT01874860|Doxycycline|doxycycline|mesh-list
82912331|NCT01874860|Clindamycin|clindamycin|mesh-list
82912332|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
82912333|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
82912334|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
82912335|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
82912336|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82912337|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82912338|NCT01874860|Prednisolone|prednisolone|mesh-list
82912339|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
82912340|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
82912341|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82912342|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
82912343|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912344|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82912345|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912346|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
82912347|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82912348|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82912349|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
82912350|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
82912351|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912352|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912353|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912354|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
82912355|NCT01874860|Hormones|hormones|mesh-ancestor
82912356|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912357|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82912358|NCT01874860|Protective Agents|protective agents|mesh-ancestor
82912359|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912360|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912361|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82912362|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912363|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912364|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82912365|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912366|NCT03570346|Hemay005|hemay005|mesh-list
82912367|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912368|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82912369|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82912370|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912371|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912372|NCT03571126|Olanzapine|olanzapine|mesh-list
82912373|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
82912374|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
82912375|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912376|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912377|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912378|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82912380|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912381|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82912382|NCT03571126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82912383|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82912384|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82912385|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457048|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
82912386|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912387|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
82912389|NCT03570112|Velpatasvir|velpatasvir|mesh-list
82912390|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
82912391|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912392|NCT03572686|Dexamethasone|dexamethasone|mesh-list
82912393|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
82912394|NCT03572686|Ropivacaine|ropivacaine|mesh-list
82912395|NCT03572686|BB 1101|bb 1101|mesh-list
82912396|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912397|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
82912398|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
82912399|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912400|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912401|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912402|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
82912403|NCT03572686|Hormones|hormones|mesh-ancestor
82912404|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912405|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912406|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912407|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
82912408|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912409|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912410|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
82912411|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
82912412|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912413|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
82912414|NCT02523820|Fluticasone|fluticasone|mesh-list
82912415|NCT02523820|Xhance|xhance|mesh-list
82912416|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912417|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82912418|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
82912419|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912420|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912421|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82912422|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912423|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912424|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82912425|NCT03369704|Omalizumab|omalizumab|mesh-list
82912426|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82912427|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82912428|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912429|NCT03709160|Bumetanide|bumetanide|mesh-list
82912430|NCT03709160|Diuretics|diuretics|mesh-ancestor
82912431|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
82912432|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912433|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82912434|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82912435|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912436|NCT05332496|Bevacizumab|bevacizumab|mesh-list
82912437|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82912438|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912439|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912440|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82912441|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82912442|NCT05332496|Growth Substances|growth substances|mesh-ancestor
82912443|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912444|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
82912445|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912446|NCT03567304|Rilpivirine|rilpivirine|mesh-list
82912447|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82912448|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82912449|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912450|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912451|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
82912453|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82912454|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82912455|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
82912456|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912457|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82912458|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912459|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912460|NCT03566914|Tadalafil|tadalafil|mesh-list
82912461|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
82912462|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82912463|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82912464|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912465|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912466|NCT03566914|Urological Agents|urological agents|mesh-ancestor
82912467|NCT03366428|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82912468|NCT03366428|Immunoconjugates|immunoconjugates|mesh-ancestor
82912469|NCT03366428|Immunologic Factors|immunologic factors|mesh-ancestor
82912470|NCT03366428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912471|NCT03709082|Trastuzumab|trastuzumab|mesh-list
82912472|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82912473|NCT03709082|Letrozole|letrozole|mesh-list
82912474|NCT03709082|Palbociclib|palbociclib|mesh-list
82912475|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912476|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912477|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82912478|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82912479|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912480|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912481|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82912482|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
82912483|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912484|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912485|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82912486|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
82912487|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
82912488|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
82912489|NCT03709082|Immunotoxins|immunotoxins|mesh-ancestor
82912490|NCT03709082|Immunoconjugates|immunoconjugates|mesh-ancestor
82912491|NCT03709082|Immunologic Factors|immunologic factors|mesh-ancestor
82912492|NCT02839876|Acetaminophen|acetaminophen|mesh-list
82912493|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82912494|NCT02839876|Analgesics|analgesics|mesh-ancestor
82912495|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
82912496|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912497|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912498|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
82912499|NCT01312064|Rituximab|rituximab|mesh-list
82912500|NCT01312064|Everolimus|everolimus|mesh-list
82912501|NCT01312064|Tacrolimus|tacrolimus|mesh-list
82912502|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
82912503|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912504|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912505|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
82912506|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912507|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912508|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82912509|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82912510|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912511|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912512|NCT01312064|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82912513|NCT01312064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82912514|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
82912515|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
82912516|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
82912517|NCT03566134|DA-8010|da-8010|mesh-list
82912518|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82912519|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82912520|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
82912521|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912522|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912523|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912524|NCT03566134|Urological Agents|urological agents|mesh-ancestor
82912525|NCT03101722|Huperzine A|huperzine a|mesh-list
82912526|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
82912527|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457060|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
82912528|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912529|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
82912530|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912531|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912532|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82912533|NCT03101722|Protective Agents|protective agents|mesh-ancestor
82912535|NCT03088852|Cathartics|cathartics|mesh-ancestor
82912536|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912537|NCT03568474|Fluorides|fluorides|mesh-list
82912538|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
82912539|NCT03568474|Protective Agents|protective agents|mesh-ancestor
82912540|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912541|NCT03345836|Upadacitinib|upadacitinib|mesh-list
82912542|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82912543|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82912544|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912545|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912546|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912547|NCT03708926|Abaloparatide|abaloparatide|mesh-list
82912548|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82912549|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912550|NCT03567928|Propofol|propofol|mesh-list
82912551|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82912552|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912553|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912554|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82912555|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
82912556|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
82912557|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82912558|NCT03565354|Hematinics|hematinics|mesh-ancestor
82912559|NCT03363776|Nivolumab|nivolumab|mesh-list
82912560|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912561|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912562|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82912563|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912564|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
82912565|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82912566|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82912567|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912568|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
82912569|NCT03565276|Coagulants|coagulants|mesh-ancestor
82912570|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
82912571|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82912572|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
82912573|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912574|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912575|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912576|NCT03708848|Metronidazole|metronidazole|mesh-list
82912577|NCT03708848|Clarithromycin|clarithromycin|mesh-list
82912578|NCT03708848|Levofloxacin|levofloxacin|mesh-list
82912579|NCT03708848|Tetracycline|tetracycline|mesh-list
82912580|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
82912581|NCT03708848|Esomeprazole|esomeprazole|mesh-list
82912582|NCT03708848|Bismuth|bismuth|mesh-list
82912583|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912584|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912585|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82912586|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82912587|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82912588|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82912589|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912590|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82912591|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912592|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82912593|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82912594|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82912595|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82912596|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82912597|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82912598|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912599|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82912600|NCT03708848|Antacids|antacids|mesh-ancestor
82912601|NCT03708848|Diuretics|diuretics|mesh-ancestor
82912602|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
82912603|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912605|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912606|NCT03564652|Azithromycin|azithromycin|mesh-list
82912607|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82912608|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912609|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82912610|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82912611|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82912612|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82912613|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
82912614|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82912615|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82912616|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912617|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
82912618|NCT03710330|Coagulants|coagulants|mesh-ancestor
82912619|NCT03710252|Ritonavir|ritonavir|mesh-list
82912620|NCT03710252|Ribavirin|ribavirin|mesh-list
82912621|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82912622|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82912623|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
82912624|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912625|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912626|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82912627|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82912628|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
82912629|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912630|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82912631|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82912632|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
82912633|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
82912634|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912635|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912636|NCT03705884|Prednisolone|prednisolone|mesh-list
82912637|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912638|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
82912639|NCT03705884|Hormones|hormones|mesh-ancestor
82912640|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912641|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912642|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912643|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912644|NCT03359174|Tretinoin|tretinoin|mesh-list
82912645|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912646|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
82912647|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912648|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
82912649|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82912650|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82912651|NCT03564106|Prednisolone|prednisolone|mesh-list
82912652|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
82912653|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82912654|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
82912655|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912656|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
82912657|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
82912658|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912659|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912660|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912661|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
82912662|NCT03564106|Hormones|hormones|mesh-ancestor
82912663|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912664|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82912665|NCT03564106|Protective Agents|protective agents|mesh-ancestor
82912666|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912667|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912668|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
82912669|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912670|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
82912671|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
82912672|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912673|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
82912674|NCT00093015|Hematinics|hematinics|mesh-ancestor
82912675|NCT01145703|Vitamin D|vitamin d|mesh-list
82912676|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
82912677|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
82912678|NCT01145703|Vitamins|vitamins|mesh-list
82912680|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912681|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82912682|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82912683|NCT05137587|Ketamine|ketamine|mesh-list
82912684|NCT05137587|Propofol|propofol|mesh-list
82912685|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82912686|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912687|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912688|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82912689|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
82912690|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
82912691|NCT05137587|Analgesics|analgesics|mesh-ancestor
82912692|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
82912693|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912694|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82912695|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82912696|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82912697|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912698|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912699|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
82912700|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82912701|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
82912702|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82912703|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
82912704|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912705|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912706|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
82912707|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82912708|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
82912709|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82912710|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82912711|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82912712|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912713|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912714|NCT03913455|Carboplatin|carboplatin|mesh-list
82912715|NCT03913455|Guadecitabine|guadecitabine|mesh-list
82912716|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912717|NCT03358472|Carboplatin|carboplatin|mesh-list
82912718|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
82912719|NCT03358472|Fluorouracil|fluorouracil|mesh-list
82912720|NCT03358472|Cetuximab|cetuximab|mesh-list
82912721|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912722|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912723|NCT03358472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82912724|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912725|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
82912726|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82912727|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82912728|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
82912729|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912730|NCT01238523|Calpastatin|calpastatin|mesh-list
82912731|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82912732|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
82912733|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912734|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912735|NCT03708536|Bevacizumab|bevacizumab|mesh-list
82912736|NCT03708536|Capecitabine|capecitabine|mesh-list
82912737|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912738|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912739|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82912740|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82912741|NCT03708536|Growth Substances|growth substances|mesh-ancestor
82912742|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912743|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
82912744|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82912745|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
82912746|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912747|NCT03705728|Remifentanil|remifentanil|mesh-list
82912748|NCT03705728|Propofol|propofol|mesh-list
82912749|NCT03705728|Sevoflurane|sevoflurane|mesh-list
82912750|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82912751|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912752|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912754|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
82912756|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82912757|NCT03705728|Narcotics|narcotics|mesh-ancestor
82912758|NCT03705728|Analgesics|analgesics|mesh-ancestor
82912759|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
82912760|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912761|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82912762|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82912763|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
82912764|NCT05177666|Trastuzumab|trastuzumab|mesh-list
82912765|NCT05177666|Pertuzumab|pertuzumab|mesh-list
82912766|NCT05177666|Vemurafenib|vemurafenib|mesh-list
82912767|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82912768|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912769|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82912770|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912771|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912772|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
82912773|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82912774|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
82912775|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
82912776|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82912777|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
82912778|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912779|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912780|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82912781|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
82912782|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912783|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912784|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82912785|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912787|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
82912788|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912789|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82912790|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
82912791|NCT03342638|Hormones|hormones|mesh-ancestor
82912792|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82912793|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82912794|NCT03342638|Protective Agents|protective agents|mesh-ancestor
82912795|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82912796|NCT01246323|Fentanyl|fentanyl|mesh-list
82912797|NCT01246323|Morphine|morphine|mesh-list
82912798|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
82912799|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912800|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912801|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82912802|NCT01246323|Narcotics|narcotics|mesh-ancestor
82912803|NCT01246323|Analgesics|analgesics|mesh-ancestor
82912804|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
82912805|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912806|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82912807|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82912808|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
82912809|NCT05160363|Piperaquine|piperaquine|mesh-list
82912810|NCT05160363|Pyronaridine|pyronaridine|mesh-list
82912811|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
82912812|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82912813|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82912814|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912815|NCT05177276|Irinotecan|irinotecan|mesh-list
82912816|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82912817|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82912818|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912819|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912820|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912821|NCT02528175|Capecitabine|capecitabine|mesh-list
82912822|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82912823|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
82912824|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912825|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912826|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
82912827|NCT03708458|Indomethacin|indomethacin|mesh-list
82912828|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82912829|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
82912830|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912831|NCT03708458|Expectorants|expectorants|mesh-ancestor
82912832|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912833|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82912834|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
82912835|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912836|NCT03708458|Protective Agents|protective agents|mesh-ancestor
82912837|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912838|NCT03708458|Antidotes|antidotes|mesh-ancestor
82912839|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82912840|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82912841|NCT03708458|Analgesics|analgesics|mesh-ancestor
82912842|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
82912843|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912844|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912845|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912846|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
82912847|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
82912848|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82912849|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82912850|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912851|NCT05625555|Midazolam|midazolam|mesh-list
82912852|NCT05625555|Ketamine|ketamine|mesh-list
82912853|NCT05625555|Analgesics|analgesics|mesh-ancestor
82912854|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
82912855|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912856|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912857|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82912858|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82912859|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
82912860|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
82912861|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82912862|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82912863|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82912864|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912865|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912866|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82912867|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82912868|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82912869|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82912870|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82912871|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
82912872|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
82912873|NCT01251471|Escitalopram|escitalopram|mesh-list
82912874|NCT01251471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82912875|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82912876|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82912877|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912878|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912879|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
82912880|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912881|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
82912882|NCT01247805|Citric Acid|citric acid|mesh-list
82912883|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
82912884|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
82912885|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82912886|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
82912887|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
82912888|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912889|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
82912890|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82912891|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82912892|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912893|NCT01247805|Urological Agents|urological agents|mesh-ancestor
82912894|NCT05631717|Aldesleukin|aldesleukin|mesh-list
82912895|NCT05631717|Interleukin-2|interleukin-2|mesh-list
82912896|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912897|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82912898|NCT05631717|Analgesics|analgesics|mesh-ancestor
82912899|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
82912900|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912901|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912902|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82912903|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82912904|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
82912918|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912920|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912921|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
82912922|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82912923|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82912924|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82912925|NCT01251627|Decitabine|decitabine|mesh-list
82912926|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82912927|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
82912928|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912929|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82912930|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912931|NCT01146093|Pravastatin|pravastatin|mesh-list
82912932|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82912933|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82912934|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
82912935|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912936|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82912937|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82912938|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912939|NCT02452983|Sertraline|sertraline|mesh-list
82912940|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
82912941|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82912942|NCT02452983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82912943|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82912944|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82912945|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912946|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82912947|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
82912948|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912949|NCT03911817|Midodrine|midodrine|mesh-list
82912950|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
82912951|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
82912952|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912953|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912954|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82912955|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82912956|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82912970|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82912971|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
82912972|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
82912973|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82912974|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82912975|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912976|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82912977|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82912978|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82912979|NCT04880655|Bacitracin|bacitracin|mesh-list
82912980|NCT04880655|Petrolatum|petrolatum|mesh-list
82912981|NCT04880655|Emollients|emollients|mesh-ancestor
82912982|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
82912983|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82912984|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82912985|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82912986|NCT04865835|Metformin|metformin|mesh-list
82912987|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82912988|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912989|NCT03911271|Atropine|atropine|mesh-list
82912990|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82912991|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82912992|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82912993|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
82912994|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82912995|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82912996|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82912997|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
82912998|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
82912999|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
82913000|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82913001|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82913002|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
82913003|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913004|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913005|NCT01248195|Olanzapine|olanzapine|mesh-list
82913006|NCT01248195|Clozapine|clozapine|mesh-list
82913007|NCT01248195|Amisulpride|amisulpride|mesh-list
82913008|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
82913009|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
82913010|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913011|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913012|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913013|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82913014|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913015|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913016|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913017|NCT01248195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82913018|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82913019|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913020|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913021|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913023|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82913024|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
82913025|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
82913026|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82913027|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
82913028|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82913029|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
82913030|NCT03910803|Brodalumab|brodalumab|mesh-list
82913031|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
82913032|NCT03910647|Pantoprazole|pantoprazole|mesh-list
82913033|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82913034|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913035|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82913036|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913037|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913038|NCT03709940|Methylphenidate|methylphenidate|mesh-list
82913039|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82913040|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913041|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82913042|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82913043|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913044|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913045|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
82913046|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913047|NCT05681312|Amoxicillin|amoxicillin|mesh-list
82913048|NCT05681312|Metronidazole|metronidazole|mesh-list
82913049|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913050|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913051|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82913052|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82913053|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
82913054|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82913055|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913056|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
82913057|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82913058|NCT01147029|Growth Substances|growth substances|mesh-ancestor
82913059|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913060|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
82913061|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913062|NCT01239459|Teriflunomide|teriflunomide|mesh-list
82913063|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
82913064|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82913065|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913066|NCT01239459|Analgesics|analgesics|mesh-ancestor
82913067|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
82913068|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913069|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913070|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913071|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913072|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913073|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
82913074|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82913075|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82913076|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
82913077|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913078|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82913079|NCT03915561|Parecoxib|parecoxib|mesh-list
82913080|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82913081|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82913082|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913083|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913084|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82913085|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913086|NCT03915561|Analgesics|analgesics|mesh-ancestor
82913087|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
82913088|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913089|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913090|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913091|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913092|NCT01148277|Fentanyl|fentanyl|mesh-list
82913093|NCT01148277|Midazolam|midazolam|mesh-list
82913094|NCT01148277|Propofol|propofol|mesh-list
82913095|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82913096|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913097|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913098|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82913099|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
82913100|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
82913101|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82913102|NCT01148277|Narcotics|narcotics|mesh-ancestor
82913103|NCT01148277|Analgesics|analgesics|mesh-ancestor
82913104|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
82913105|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913106|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82913107|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82913108|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913109|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913110|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
82913111|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
82913112|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913113|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913114|NCT03907371|Donepezil|donepezil|mesh-list
82913115|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82913116|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913117|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913118|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
82913119|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913120|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913121|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
82913123|NCT03908619|Omeprazole|omeprazole|mesh-list
82913124|NCT03908619|Rabeprazole|rabeprazole|mesh-list
82913125|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82913126|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913127|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82913128|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913129|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913130|NCT01358734|Lenalidomide|lenalidomide|mesh-list
82913131|NCT01358734|Azacitidine|azacitidine|mesh-list
82913132|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
82913133|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913134|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82913135|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82913136|NCT01358734|Growth Substances|growth substances|mesh-ancestor
82913137|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
82913138|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913139|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82913140|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
82913141|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913142|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913143|NCT03907215|Citalopram|citalopram|mesh-list
82913144|NCT03907215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82913145|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82913146|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913147|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913148|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913149|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
82913150|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913151|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82913152|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
82913153|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913154|NCT05335954|Norepinephrine|norepinephrine|mesh-list
82913155|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82913156|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82913157|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913158|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913159|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913160|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913161|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
82913162|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
82913163|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913164|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82913165|NCT01250457|Timolol|timolol|mesh-list
82913166|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82913167|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82913168|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913169|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913170|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913171|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913172|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82913173|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82913174|NCT03902925|Lidocaine|lidocaine|mesh-list
82913175|NCT03902925|Ropivacaine|ropivacaine|mesh-list
82913176|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
82913177|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
82913178|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913179|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913180|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
82913181|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913182|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82913183|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82913184|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82913185|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913186|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913187|NCT01250535|Warfarin|warfarin|mesh-list
82913188|NCT01250535|Lovastatin|lovastatin|mesh-list
82913189|NCT01250535|L 647318|l 647318|mesh-list
82753650|NCT00861042|Lacosamide|lacosamide|mesh-list
82913190|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
82913191|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
82913192|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82913193|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82913194|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
83457106|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913195|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913196|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82913197|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82913198|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913199|NCT02527941|Metronidazole|metronidazole|mesh-list
82913200|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913201|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913202|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82913203|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82913204|NCT03906669|Tamoxifen|tamoxifen|mesh-list
82913205|NCT03906669|Letrozole|letrozole|mesh-list
82913206|NCT03906669|Progesterone|progesterone|mesh-list
82913207|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913208|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82913209|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82913210|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913211|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913212|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82913213|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
82913214|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82913215|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913216|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82913217|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82913218|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82913219|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82913220|NCT03906669|Progestins|progestins|mesh-ancestor
82913221|NCT03906669|Hormones|hormones|mesh-ancestor
82913222|NCT01254825|Ropivacaine|ropivacaine|mesh-list
82913223|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
82913224|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
82913225|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913226|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913227|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
82913228|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913229|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
82913230|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82913231|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82913232|NCT03906123|Protective Agents|protective agents|mesh-ancestor
82913233|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913234|NCT01341652|Molgramostim|molgramostim|mesh-list
82913235|NCT01341652|Sargramostim|sargramostim|mesh-list
82913236|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
82913237|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913238|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913239|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
82913240|NCT03563794|Vildagliptin|vildagliptin|mesh-list
82913241|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82913242|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913243|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82913244|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
82913245|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913246|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913247|NCT03905967|Lenvatinib|lenvatinib|mesh-list
82913248|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913249|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82913250|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913251|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913252|NCT03563950|Rifampin|rifampin|mesh-list
82913253|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82913254|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
82913255|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913256|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913257|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
82913258|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82913259|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913260|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913261|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82913262|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82913263|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82913264|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82913265|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82913266|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82913267|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
82913268|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82913269|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913270|NCT03914235|Lidocaine|lidocaine|mesh-list
82913271|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
82913272|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
82913273|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913274|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913275|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
82913276|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913277|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82913278|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82913279|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82913280|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913281|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913282|NCT01148667|Caseins|caseins|mesh-list
82913283|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
82913284|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
82913285|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913286|NCT01254123|Exenatide|exenatide|mesh-list
82913287|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82913288|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913289|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82913290|NCT01254123|Incretins|incretins|mesh-ancestor
82913291|NCT01254123|Hormones|hormones|mesh-ancestor
82913292|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82913293|NCT03898635|Linezolid|linezolid|mesh-list
82913294|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913295|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913296|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82913297|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913298|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913299|NCT05116917|Nivolumab|nivolumab|mesh-list
82913300|NCT05116917|Ipilimumab|ipilimumab|mesh-list
82913301|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82913302|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913303|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82913304|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913305|NCT02528019|Glimepiride|glimepiride|mesh-list
82913306|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82913307|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82913308|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82913309|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913310|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913311|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
82913312|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913313|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
82913314|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82913315|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
82913316|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913317|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913318|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82913319|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
82913320|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82913321|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
82913322|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913323|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913324|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82913325|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
82913326|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
82913327|NCT01255215|Protective Agents|protective agents|mesh-ancestor
82913328|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
82913329|NCT02527785|Irinotecan|irinotecan|mesh-list
82913330|NCT02527785|Tegafur|tegafur|mesh-list
82913331|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913332|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82913333|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82913334|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913335|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913336|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82913337|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
82913339|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82913340|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913341|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
82913342|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913343|NCT01256541|Lactulose|lactulose|mesh-list
82913344|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913345|NCT03904719|Vorolanib|vorolanib|mesh-list
82913346|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82913347|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913348|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913349|NCT01148901|Infliximab|infliximab|mesh-list
82913350|NCT01148901|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82913351|NCT01148901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913352|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
82913353|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913354|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913355|NCT01150617|Insulin|insulin|mesh-list
82913356|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82913357|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
82913358|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82913359|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
82913360|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913361|NCT01256619|Desogestrel|desogestrel|mesh-list
82913362|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82913363|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82913364|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82913365|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
82913366|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82913367|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913368|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82913369|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82913370|NCT01256619|Progestins|progestins|mesh-ancestor
82913371|NCT01256619|Hormones|hormones|mesh-ancestor
82913372|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82913373|NCT03898011|Lamotrigine|lamotrigine|mesh-list
82913374|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
82913375|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82913376|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913377|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913378|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82913379|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913380|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82913381|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913382|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913383|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913384|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82913385|NCT01254513|Prednisone|prednisone|mesh-list
82913386|NCT01254513|Docetaxel|docetaxel|mesh-list
82913387|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913388|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
82913389|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
82913390|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
82913391|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913393|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
82913394|NCT01254513|Hormones|hormones|mesh-ancestor
82913395|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82913396|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913397|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82913398|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82913399|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83457122|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
82913400|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913401|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
82913402|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
82913403|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82913404|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
82913405|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913406|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913407|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82913408|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913409|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82913410|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
82913411|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913412|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913414|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913415|NCT01255371|Lopinavir|lopinavir|mesh-list
82913416|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82913417|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82913418|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82913419|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
82913420|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913421|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913422|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82913423|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82913424|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
82913425|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913426|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82913427|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82913428|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
82913429|NCT03903783|Cefotaxime|cefotaxime|mesh-list
82913430|NCT03903783|Cefoxitin|cefoxitin|mesh-list
82913431|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913432|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913433|NCT03899337|Prednisolone|prednisolone|mesh-list
82913434|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
82913435|NCT03899337|Rituximab|rituximab|mesh-list
82913436|NCT03899337|Doxorubicin|doxorubicin|mesh-list
82913437|NCT03899337|Vincristine|vincristine|mesh-list
82913438|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
82913439|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913440|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
82913441|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913442|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913443|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82913444|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
82913445|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913446|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913447|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82913448|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82913449|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82913450|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82913451|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82913452|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913453|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82913454|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
82913455|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
82913456|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
82913457|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913458|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
82913459|NCT03899337|Hormones|hormones|mesh-ancestor
82913460|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82913461|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82913462|NCT01586169|Azithromycin|azithromycin|mesh-list
82913463|NCT01586169|Ivermectin|ivermectin|mesh-list
82913464|NCT01586169|Albendazole|albendazole|mesh-list
82913465|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913466|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913468|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
82913469|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
82913470|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82913471|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82913472|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
82913473|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
82913474|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
82913475|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913476|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913477|NCT01256775|Aspirin|aspirin|mesh-list
82913478|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
82913479|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82913480|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913481|NCT01256775|Analgesics|analgesics|mesh-ancestor
82913482|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
82913483|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913484|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913485|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913486|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913487|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82913488|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83482931|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913489|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913490|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82913491|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82913492|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
82913493|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913494|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82913495|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
82913496|NCT03899571|Oseltamivir|oseltamivir|mesh-list
82913497|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
82913498|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913499|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913500|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913501|NCT01257009|Atorvastatin|atorvastatin|mesh-list
82913502|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82913503|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82913504|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
82913505|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913506|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82913507|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82913508|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913509|NCT01255527|Bortezomib|bortezomib|mesh-list
82913510|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913511|NCT01151787|Amitriptyline|amitriptyline|mesh-list
82913512|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
82913513|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82913514|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
82913515|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913516|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82913517|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913518|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82913519|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913520|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913521|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913522|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913523|NCT01151787|Analgesics|analgesics|mesh-ancestor
82913524|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
82913525|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82913526|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82913527|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913528|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913529|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913530|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913531|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
82913532|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82913533|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913534|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913535|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913536|NCT01151865|Analgesics|analgesics|mesh-ancestor
82913537|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
82913538|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913539|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82913540|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82913541|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82913542|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913543|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913544|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913545|NCT03893097|Artesunate|artesunate|mesh-list
82913546|NCT03893097|Mefloquine|mefloquine|mesh-list
82913547|NCT03893097|Praziquantel|praziquantel|mesh-list
82913548|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
82913549|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82913550|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82913551|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913552|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913553|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
82913554|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
82913555|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82913556|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
82913557|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
82913558|NCT01258491|Niacin|niacin|mesh-list
82913559|NCT01258491|Niacinamide|niacinamide|mesh-list
82913560|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
82913561|NCT01258491|Vitamins|vitamins|mesh-ancestor
82913562|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
82913563|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913564|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82913565|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
82913566|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913567|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82913568|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
82913569|NCT01257165|Ethanol|ethanol|mesh-list
82913570|NCT01257165|Zopiclone|zopiclone|mesh-list
82913571|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82913572|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913573|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913574|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913575|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82913576|NCT01151943|Anesthetics|anesthetics|mesh-list
82913577|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
82913578|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913579|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913580|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
82913581|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913582|NCT01256151|Alprazolam|alprazolam|mesh-list
82913583|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82913584|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913585|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913586|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82913587|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913588|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913589|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
82913590|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
82913591|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913592|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913593|NCT01259973|Haloperidol|haloperidol|mesh-list
82913594|NCT01259973|Risperidone|risperidone|mesh-list
82913595|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
82913596|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82913597|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
82913598|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913599|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913600|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913601|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82913602|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913603|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913604|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913605|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82913606|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
82913607|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
82913608|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
82913609|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913610|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913611|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82913612|NCT01257243|Potassium iodate|potassium iodate|mesh-list
82913613|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
82913614|NCT01257243|Guaifenesin|guaifenesin|mesh-list
82913615|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82913616|NCT01257243|Expectorants|expectorants|mesh-ancestor
82913617|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
82913620|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913621|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913622|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913623|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913624|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
82913625|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82913626|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
82913627|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
82913628|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913629|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
82913630|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82913631|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
82913632|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913633|NCT01258569|Alvimopan|alvimopan|mesh-list
82913634|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913635|NCT01257399|Mesalamine|mesalamine|mesh-list
82913636|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82913637|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913638|NCT01257399|Analgesics|analgesics|mesh-ancestor
82913639|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
82913640|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913641|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913642|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913643|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913644|NCT01258959|Anesthetics|anesthetics|mesh-list
82913645|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
82913646|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913647|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913648|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
82913649|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913650|NCT01153659|Esomeprazole|esomeprazole|mesh-list
82913651|NCT01153659|Rabeprazole|rabeprazole|mesh-list
82913652|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82913653|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913654|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82913655|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913656|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913657|NCT01260129|Silodosin|silodosin|mesh-list
82913658|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82913659|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82913660|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82913661|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913662|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913663|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913664|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913665|NCT01260129|Urological Agents|urological agents|mesh-ancestor
82913666|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82913667|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
82913668|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82913669|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82913670|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913671|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913672|NCT01260285|Urological Agents|urological agents|mesh-ancestor
82913673|NCT03888729|Velpatasvir|velpatasvir|mesh-list
82913674|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
82913675|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913676|NCT01151241|Anesthetics|anesthetics|mesh-list
82913677|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
82913678|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913679|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913680|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
82913681|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913682|NCT02949362|Teduglutide|teduglutide|mesh-list
82913683|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82913684|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82913685|NCT02949362|Protective Agents|protective agents|mesh-ancestor
82913686|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913687|NCT03896217|Simvastatin|simvastatin|mesh-list
82913688|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82913689|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82913690|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
82913691|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913692|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82913693|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82913694|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913696|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
82913697|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913698|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913699|NCT03892161|Ritonavir|ritonavir|mesh-list
82913700|NCT03892161|Darunavir|darunavir|mesh-list
82913701|NCT03892161|Rifampin|rifampin|mesh-list
82913702|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82913703|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82913704|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
82913705|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913706|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913707|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82913708|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82913709|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
82913710|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913711|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82913712|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82913713|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82913714|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
82913715|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913716|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
83515063|NCT00377559|Doxorubicin|doxorubicin|mesh-list
82913717|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82913718|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82913719|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82913720|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82913721|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82913722|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82913723|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82913724|NCT01154361|Cortisone|cortisone|mesh-list
82913725|NCT01154361|Icatibant|icatibant|mesh-list
82913726|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913727|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82913728|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913729|NCT01154361|Analgesics|analgesics|mesh-ancestor
82913730|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
82913731|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913732|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913733|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913734|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
82913735|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
82913736|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913737|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82913738|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913739|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
82913740|NCT01260519|Heparin|heparin|mesh-list
82913741|NCT01260519|Calcium heparin|calcium heparin|mesh-list
82913742|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
82913743|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82913744|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82913745|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913746|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
82913747|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82913748|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82913749|NCT03891615|Niraparib|niraparib|mesh-list
82913750|NCT03891615|Osimertinib|osimertinib|mesh-list
82913751|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82913752|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913753|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913754|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913755|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82913756|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
82913757|NCT02947022|Zinc|zinc|mesh-list
82913758|NCT02947022|Edetic Acid|edetic acid|mesh-list
82913759|NCT02947022|Calcium|calcium|mesh-list
82913760|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
82913761|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82913762|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913763|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82913764|NCT02947022|Trace Elements|trace elements|mesh-ancestor
82913765|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
82913766|NCT02947022|Antidotes|antidotes|mesh-ancestor
82913767|NCT02947022|Protective Agents|protective agents|mesh-ancestor
82913768|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
82913769|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
82913770|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913771|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82913772|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
82913773|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82913774|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
82913775|NCT01259193|Sorafenib|sorafenib|mesh-list
82913776|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913777|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82913778|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913779|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913780|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82913781|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913782|NCT05182892|Dopamine|dopamine|mesh-list
82913783|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
82913784|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82913785|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
82913786|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
82913787|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913788|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913789|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
82913790|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913791|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913792|NCT05182892|Protective Agents|protective agents|mesh-ancestor
82913793|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
82913794|NCT01312376|Bevacizumab|bevacizumab|mesh-list
82913795|NCT01312376|Fludarabine|fludarabine|mesh-list
82913796|NCT01312376|Vaccines|vaccines|mesh-list
82913797|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
82913798|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913799|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913800|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913801|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82913802|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
82913803|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913804|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913805|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82913806|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82913807|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82913808|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82913809|NCT01312376|Growth Substances|growth substances|mesh-ancestor
82913810|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
82913811|NCT01260675|Buprenorphine|buprenorphine|mesh-list
82913812|NCT01260675|Naloxone|naloxone|mesh-list
82913813|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82913814|NCT01260675|Narcotics|narcotics|mesh-ancestor
82913815|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913816|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913817|NCT01260675|Analgesics|analgesics|mesh-ancestor
82913818|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
82913819|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913820|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82913821|NCT03887871|Tamsulosin|tamsulosin|mesh-list
82913822|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82913823|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82913824|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82913825|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913826|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913827|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913828|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913829|NCT03887871|Urological Agents|urological agents|mesh-ancestor
82913830|NCT03708146|Zamicastat|zamicastat|mesh-list
82913831|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913832|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913833|NCT01260753|Fluticasone|fluticasone|mesh-list
82913834|NCT01260753|Xhance|xhance|mesh-list
82913835|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913836|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82913837|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
82913838|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913839|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913840|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82913842|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
82913843|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82913844|NCT03895671|Azacitidine|azacitidine|mesh-list
82913845|NCT03895671|Ponatinib|ponatinib|mesh-list
82913846|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82913847|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
82913848|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913849|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913850|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913851|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82913852|NCT01152723|Nicotine|nicotine|mesh-list
82913853|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82913854|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
82913855|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913856|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913857|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82913858|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82913859|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
82913860|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913861|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913862|NCT01261065|Carvedilol|carvedilol|mesh-list
82913863|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82913864|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82913865|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
82913866|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913867|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913868|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913869|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82913870|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
82913871|NCT01261065|Protective Agents|protective agents|mesh-ancestor
82913872|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82913873|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82913874|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82913875|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
82913876|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82913877|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82913878|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
82913879|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
82913880|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913881|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913882|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913883|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
82913884|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913885|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913886|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913887|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
82913888|NCT03338972|Fludarabine|fludarabine|mesh-list
82913889|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913890|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
82913891|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913892|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913893|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82913894|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
82913895|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913896|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913897|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82913898|NCT01151397|Vitamin D|vitamin d|mesh-list
82913899|NCT01151397|Ribavirin|ribavirin|mesh-list
82913900|NCT01151397|Vitamins|vitamins|mesh-ancestor
82913901|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
83457153|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
82913902|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913903|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82913904|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
82913905|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913906|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
82913907|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913908|NCT01152801|Everolimus|everolimus|mesh-list
82913909|NCT01152801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82913910|NCT01152801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82913911|NCT01152801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913912|NCT01152801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913913|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82913914|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
82913915|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913916|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913918|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
82913919|NCT03887169|Vitamins|vitamins|mesh-ancestor
82913920|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
82913921|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913922|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
82913923|NCT03887169|Hematinics|hematinics|mesh-ancestor
82913924|NCT03886779|Nepafenac|nepafenac|mesh-list
82913925|NCT03886779|Bromfenac|bromfenac|mesh-list
82913926|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82913927|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913928|NCT03886779|Analgesics|analgesics|mesh-ancestor
82913929|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
82913930|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913931|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913932|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913933|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913934|NCT03887013|Trimetazidine|trimetazidine|mesh-list
82913935|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
82913936|NCT01261299|Carboplatin|carboplatin|mesh-list
82913937|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913938|NCT01154829|Aripiprazole|aripiprazole|mesh-list
82913939|NCT01154829|Amisulpride|amisulpride|mesh-list
82913940|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
82913941|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82913942|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82913943|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82913944|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913945|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913946|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
82913948|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82913949|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913950|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82913951|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82913952|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
82913953|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82913954|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82913955|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82913956|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82913957|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82913958|NCT01153191|Gentamicins|gentamicins|mesh-list
82913959|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82913960|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913961|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82913962|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913963|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913964|NCT01259817|Aspirin|aspirin|mesh-list
82913965|NCT01259817|Interferons|interferons|mesh-list
82913966|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
82913967|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
82913968|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82913969|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82913970|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
82913971|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82913972|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82913973|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82913974|NCT01259817|Analgesics|analgesics|mesh-ancestor
82913975|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
82913976|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913977|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913978|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82913979|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82913980|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82913981|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82913982|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82913983|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82913984|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82913985|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82913986|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
82913987|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
82913988|NCT01261689|Sufentanil|sufentanil|mesh-list
82913989|NCT01261689|Dsuvia|dsuvia|mesh-list
82913990|NCT01261689|Ropivacaine|ropivacaine|mesh-list
82913991|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
82913993|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82913994|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82913995|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
82913996|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82913997|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82913999|NCT01261689|Analgesics|analgesics|mesh-ancestor
82914000|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82914001|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82914002|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
82914003|NCT01154907|Praziquantel|praziquantel|mesh-list
82914004|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
82914005|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82914006|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914007|NCT01261923|Alitretinoin|alitretinoin|mesh-list
82914008|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914009|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
82914010|NCT01157247|Fentanyl|fentanyl|mesh-list
82914011|NCT01157247|Anesthetics|anesthetics|mesh-list
82914012|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
82914013|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82914014|NCT01157247|Narcotics|narcotics|mesh-ancestor
82914015|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914016|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914017|NCT01157247|Analgesics|analgesics|mesh-ancestor
82914018|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
82914019|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914020|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82914021|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82914022|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
82914023|NCT03881787|Cetuximab|cetuximab|mesh-list
82914024|NCT03881787|Antibodies|antibodies|mesh-list
82914025|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82914026|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
82914027|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914028|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82914029|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914031|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82914032|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914033|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914034|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82914035|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914036|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
82914037|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
82914038|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82914039|NCT03894189|Theophylline|theophylline|mesh-list
82914040|NCT03894189|Doxapram|doxapram|mesh-list
82914041|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82914042|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
82914043|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914044|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914045|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82914046|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
82914047|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82914048|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914049|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457165|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
82914050|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
82914051|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82914052|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82914053|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
82914054|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914055|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82914056|NCT03886311|Nivolumab|nivolumab|mesh-list
82914057|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82914058|NCT03886311|Trabectedin|trabectedin|mesh-list
82914059|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82914060|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914061|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82914062|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914063|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82914064|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
82914065|NCT01155453|Trametinib|trametinib|mesh-list
82914066|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914069|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914070|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82914071|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
82914072|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914073|NCT03885219|Paclitaxel|paclitaxel|mesh-list
82914074|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82914075|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914076|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
82914077|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
82914078|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
82914079|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914080|NCT01157559|Ziprasidone|ziprasidone|mesh-list
82914081|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82914082|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
82914083|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914084|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914085|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914086|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82914087|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82914088|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914089|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914090|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82914091|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
82914092|NCT01263951|Everolimus|everolimus|mesh-list
82914093|NCT01263951|Sorafenib|sorafenib|mesh-list
82914094|NCT01263951|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82914095|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914096|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914097|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914098|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914099|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
82914100|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914101|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914102|NCT01265433|Molgramostim|molgramostim|mesh-list
82914103|NCT01265433|Sargramostim|sargramostim|mesh-list
82914104|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82914105|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
82914106|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914107|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914108|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82914109|NCT01265589|Vitamin A|vitamin a|mesh-list
82914110|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82914111|NCT01265589|Vitamins|vitamins|mesh-ancestor
82914112|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
82914113|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914114|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
82914115|NCT01159587|Factor VIII|factor viii|mesh-list
82914116|NCT01159587|Coagulants|coagulants|mesh-ancestor
82914117|NCT03885297|Liraglutide|liraglutide|mesh-list
82914118|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82914119|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914120|NCT03885297|Incretins|incretins|mesh-ancestor
82914121|NCT03885297|Hormones|hormones|mesh-ancestor
82914122|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914123|NCT01159821|Paroxetine|paroxetine|mesh-list
82914124|NCT01159821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82914125|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82914126|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914127|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914128|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914129|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
82914130|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914131|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82914132|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
82914133|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914134|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82914135|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82914136|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914137|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
82914138|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
82914139|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82914140|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914141|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82914142|NCT03885141|Zolpidem|zolpidem|mesh-list
82914143|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82914144|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82914145|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914146|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914147|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82914148|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
82914149|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
82914150|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914151|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914152|NCT03879057|Antibodies|antibodies|mesh-list
82914153|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82914154|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
82914155|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914156|NCT01266057|Sirolimus|sirolimus|mesh-list
82914157|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
82914158|NCT01266057|Vorinostat|vorinostat|mesh-list
82914159|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82914160|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914161|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82914162|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914163|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
82914164|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914165|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
82914166|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914167|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914168|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914169|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
82914170|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82914171|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82914172|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82914173|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82914174|NCT01266213|Fulvestrant|fulvestrant|mesh-list
82914175|NCT01266213|Anastrozole|anastrozole|mesh-list
82914176|NCT01266213|Goserelin|goserelin|mesh-list
83515064|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82914177|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82914178|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914179|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82914180|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82914181|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
82914182|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914183|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914184|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82914185|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82914186|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914187|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914188|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
82914189|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82914190|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82914191|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
82914192|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914193|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914194|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914195|NCT01262391|Urological Agents|urological agents|mesh-ancestor
82914196|NCT03880695|Doxorubicin|doxorubicin|mesh-list
82914197|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82914198|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82914199|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914200|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82914201|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82914202|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914203|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914204|NCT01155765|Clopidogrel|clopidogrel|mesh-list
82914205|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82914206|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82914207|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82914208|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82914209|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82914210|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
82914211|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914212|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914213|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914214|NCT01264341|Sirolimus|sirolimus|mesh-list
82914215|NCT01264341|Bevacizumab|bevacizumab|mesh-list
82914216|NCT01264341|Temsirolimus|temsirolimus|mesh-list
82914217|NCT01264341|MTOR Inhibitors|mtor inhibitors|mesh-list
82914218|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82914219|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914220|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82914221|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82914222|NCT01264341|Growth Substances|growth substances|mesh-ancestor
82914223|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914224|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
82914225|NCT01264341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914226|NCT01264341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914227|NCT01264341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914228|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914229|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
82914230|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82914231|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914232|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82914233|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
82914234|NCT01264497|Tesamorelin|tesamorelin|mesh-list
82914235|NCT01264497|Growth Substances|growth substances|mesh-ancestor
82914236|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914237|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
82914238|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
82914239|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914240|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914241|NCT01262469|Capecitabine|capecitabine|mesh-list
82914242|NCT01262469|Lapatinib|lapatinib|mesh-list
82914243|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82914244|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
82914245|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914246|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914247|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914248|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914249|NCT01155921|Risperidone|risperidone|mesh-list
82914250|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82914251|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
82914252|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914253|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914254|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914255|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82914256|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82914257|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914258|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914259|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82914260|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
82914261|NCT03884127|Orlistat|orlistat|mesh-list
82914262|NCT03884127|Ezetimibe|ezetimibe|mesh-list
82914263|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82914264|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82914265|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
82914266|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914267|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82914268|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914269|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82914270|NCT01158105|Bortezomib|bortezomib|mesh-list
82914271|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914272|NCT03337490|Ivermectin|ivermectin|mesh-list
82914273|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82914274|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914275|NCT01158183|Interferons|interferons|mesh-list
82914276|NCT01158183|Interferon-beta|interferon-beta|mesh-list
82914277|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
82914278|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914279|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
82914280|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914281|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
82914282|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914283|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82914284|NCT01264575|Epinephrine|epinephrine|mesh-list
82914285|NCT01264575|Racepinephrine|racepinephrine|mesh-list
82914286|NCT01264575|Bupivacaine|bupivacaine|mesh-list
82914287|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
82914288|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
82914289|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
82914290|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914291|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914292|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
82914293|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914294|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82914295|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82914296|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
82914297|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914298|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914299|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82914300|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82914301|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
82914302|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82914303|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
82914304|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
82914305|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
82914306|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82914307|NCT04992260|Vaccines|vaccines|mesh-list
82914308|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
82914309|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914310|NCT01266681|Amiodarone|amiodarone|mesh-list
82914311|NCT01266681|Dronedarone|dronedarone|mesh-list
82914312|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82914313|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
82914314|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82914315|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914316|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914317|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82914318|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82914319|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82914320|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914321|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82914322|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82914323|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82914324|NCT03638648|Capecitabine|capecitabine|mesh-list
82914325|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82914326|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
82914327|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914328|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914329|NCT01266759|NuvaRing|nuvaring|mesh-list
82914330|NCT01266759|Norethindrone|norethindrone|mesh-list
82914331|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
82914332|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82914333|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
82914334|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82914335|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914336|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82914337|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82914338|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82914339|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82914340|NCT03512223|Dexamethasone|dexamethasone|mesh-list
82914341|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82914342|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
82914343|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
82914344|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914345|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914346|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914347|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
82914348|NCT03512223|Hormones|hormones|mesh-ancestor
82914349|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914350|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82914351|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914352|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
82914353|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
82914354|NCT03878667|Calcium|calcium|mesh-list
82914355|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82914356|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914357|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82914358|NCT03878667|Antacids|antacids|mesh-ancestor
82914359|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914360|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914361|NCT01264653|Epinephrine|epinephrine|mesh-list
82914362|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82914363|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82914364|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
82914365|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914367|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914368|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82914369|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82914370|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
82914371|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914372|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82914373|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
82914374|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
82914375|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
82914376|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82914377|NCT01266837|Everolimus|everolimus|mesh-list
82914378|NCT01266837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82914379|NCT01266837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914380|NCT01266837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914381|NCT01266837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914382|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914383|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
82914384|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914385|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914386|NCT01264731|Imiquimod|imiquimod|mesh-list
82914387|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82914388|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
83457186|NCT00376012|Ethambutol|ethambutol|mesh-list
82914389|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914390|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914391|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
82914392|NCT03879837|Fluticasone|fluticasone|mesh-list
82914393|NCT03879837|Xhance|xhance|mesh-list
82914394|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82914395|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82914396|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
82914397|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914398|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914399|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82914400|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
82914401|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
82914402|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82914403|NCT05308628|Complement C3|complement c3|mesh-list
82914404|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
82914405|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914406|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
82914407|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82914408|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914409|NCT01158729|Antithrombins|antithrombins|mesh-list
82914410|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
82914411|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82914412|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
82914413|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914414|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914415|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
82914416|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
82914418|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
82914419|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82914420|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
82914421|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914422|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914423|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82914424|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
82914425|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
82914426|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
82914427|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914428|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82914429|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82914430|NCT05303324|Growth Substances|growth substances|mesh-ancestor
82914431|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914432|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
82914433|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914434|NCT01262859|Bevacizumab|bevacizumab|mesh-list
82914435|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82914436|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914437|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82914438|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82914439|NCT01262859|Growth Substances|growth substances|mesh-ancestor
82914440|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914442|NCT02527083|Ketamine|ketamine|mesh-list
82914443|NCT02527083|Remifentanil|remifentanil|mesh-list
82914444|NCT02527083|Propofol|propofol|mesh-list
82914445|NCT02527083|Sevoflurane|sevoflurane|mesh-list
82914446|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82914447|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914448|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914449|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82914450|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
82914451|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
82914452|NCT02527083|Analgesics|analgesics|mesh-ancestor
82914453|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
82914454|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914455|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82914456|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82914457|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82914458|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914459|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914460|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82914461|NCT02527083|Narcotics|narcotics|mesh-ancestor
82914462|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82914463|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82914464|NCT05156684|Zinc|zinc|mesh-list
82914465|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
82914466|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
82914467|NCT05156684|Trace Elements|trace elements|mesh-ancestor
82914468|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
82914469|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914470|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82914471|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914472|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914473|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82914474|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82914475|NCT05156684|Protective Agents|protective agents|mesh-ancestor
82914476|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
82914477|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82914478|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
82914479|NCT05156684|Astringents|astringents|mesh-ancestor
82914480|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
82914481|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
82914482|NCT03883347|Remifentanil|remifentanil|mesh-list
82914483|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82914484|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914485|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914486|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914487|NCT03883347|Analgesics|analgesics|mesh-ancestor
82914488|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
82914489|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914490|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82914491|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82914492|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82914493|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
82914494|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914495|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914496|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82914497|NCT03883347|Narcotics|narcotics|mesh-ancestor
82914498|NCT01159275|Lopinavir|lopinavir|mesh-list
82914499|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82914500|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82914501|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
82914502|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914503|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914504|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82914505|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82914506|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
82914507|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914508|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82914509|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82914510|NCT01159353|Insulin|insulin|mesh-list
82914511|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82914512|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
82914513|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
82914514|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82914515|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914516|NCT02943668|Deferasirox|deferasirox|mesh-list
82914517|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82914519|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
82914520|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914521|NCT01265199|Cytarabine|cytarabine|mesh-list
82914522|NCT01265199|Daunorubicin|daunorubicin|mesh-list
82914523|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82914524|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
82914525|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914526|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914527|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
82914528|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914529|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914530|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
82914531|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914532|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82914533|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82914534|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82914535|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914536|NCT01263171|Leucovorin|leucovorin|mesh-list
82914537|NCT01263171|Fluorouracil|fluorouracil|mesh-list
82914538|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
82914539|NCT01263171|Calcium|calcium|mesh-list
82914540|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
82914541|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82914542|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914543|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
82914544|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914545|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82914546|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914547|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914548|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
82914549|NCT01263171|Antidotes|antidotes|mesh-ancestor
82914550|NCT01263171|Protective Agents|protective agents|mesh-ancestor
82914551|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
82914552|NCT01263171|Vitamins|vitamins|mesh-ancestor
82914553|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
82914554|NCT01156233|Anesthetics|anesthetics|mesh-list
82914555|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914556|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914557|NCT03883269|Ethanol|ethanol|mesh-list
82914558|NCT03883269|Clindamycin|clindamycin|mesh-list
82914559|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
82914560|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
82914561|NCT03883269|Erythromycin|erythromycin|mesh-list
82914562|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
82914563|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82914564|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
82914565|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82914566|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914567|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914568|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914569|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82914570|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82914571|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914572|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914573|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914574|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
82914575|NCT01267305|PENTA|penta|mesh-list
82914576|NCT01267305|Nadroparin|nadroparin|mesh-list
82914577|NCT01267305|Fondaparinux|fondaparinux|mesh-list
82914578|NCT01267305|Calcium|calcium|mesh-list
82914579|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82914580|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914581|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82914582|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82914583|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
82914584|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82914585|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
82914586|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914587|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914588|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
82914589|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82914590|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82914591|NCT02891408|Fenofibrate|fenofibrate|mesh-list
82914592|NCT02891408|Firsocostat|firsocostat|mesh-list
82914593|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82914594|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
82914595|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914596|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82914597|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914598|NCT01160991|Olanzapine|olanzapine|mesh-list
82914599|NCT01160991|Amisulpride|amisulpride|mesh-list
82914600|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
82914601|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
82914602|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914603|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914604|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914605|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82914606|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82914607|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914608|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914609|NCT01160991|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82914610|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82914611|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914612|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914613|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914614|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
82914615|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82914616|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
82914617|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82914618|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
82914619|NCT05498480|Nivolumab|nivolumab|mesh-list
82914620|NCT05498480|Relatlimab|relatlimab|mesh-list
82914621|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82914622|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914623|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82914624|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914625|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
82914626|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82914627|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82914628|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914629|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914630|NCT01161147|Meloxicam|meloxicam|mesh-list
82914631|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82914632|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914633|NCT01161147|Analgesics|analgesics|mesh-ancestor
82914634|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
82914635|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914636|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914637|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82914638|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82914639|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82914640|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82914641|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914642|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914643|NCT01161927|Nizatidine|nizatidine|mesh-list
82914644|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82914645|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914646|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82914647|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
82914648|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
82914649|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914650|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914651|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914652|NCT01267383|Sertraline|sertraline|mesh-list
82914653|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
82914654|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914655|NCT01267383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82914656|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82914657|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914658|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914659|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914660|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
82914661|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914662|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
82914663|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82914664|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
82914665|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
82914666|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914667|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914668|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914669|NCT03283670|Analgesics|analgesics|mesh-ancestor
82914670|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
82914671|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914672|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
82914673|NCT03110432|Niacin|niacin|mesh-list
82914674|NCT03110432|Ezetimibe|ezetimibe|mesh-list
82914675|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
82914676|NCT03110432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
82914677|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82914678|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82914679|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
82914680|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914681|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82914682|NCT03110432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82914683|NCT03110432|Protease Inhibitors|protease inhibitors|mesh-ancestor
82914684|NCT03110432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914685|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
82914686|NCT03110432|Vitamins|vitamins|mesh-ancestor
82914687|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
82914688|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914689|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
82914690|NCT03205358|Vaccines|vaccines|mesh-list
82914691|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
82914692|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914693|NCT01358578|Etanercept|etanercept|mesh-list
82914694|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82914695|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914696|NCT01358578|Analgesics|analgesics|mesh-ancestor
82914697|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
82914698|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914699|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914700|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82914701|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82914702|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914703|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914704|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
82914705|NCT01161459|Prednisone|prednisone|mesh-list
82914706|NCT01161459|Tacrolimus|tacrolimus|mesh-list
82914708|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
82914709|NCT01161459|Hormones|hormones|mesh-ancestor
82914710|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914711|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914712|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82914713|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914714|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914715|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
82914716|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82914717|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914718|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914719|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
82914720|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
82914721|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
82914722|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914723|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914724|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
82914725|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914726|NCT03882099|Vitamin D|vitamin d|mesh-list
82914727|NCT03882099|Vitamins|vitamins|mesh-ancestor
82914728|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
82914729|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914730|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82914731|NCT01268163|Docetaxel|docetaxel|mesh-list
82914732|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914733|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
82914734|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
82914735|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
82914736|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914737|NCT04745780|Inositol|inositol|mesh-list
82914738|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
82914739|NCT04745780|Vitamins|vitamins|mesh-ancestor
82914740|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
82914741|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914742|NCT02833948|Aspirin|aspirin|mesh-list
82914744|NCT02833948|Clopidogrel|clopidogrel|mesh-list
82914745|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82914746|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82914747|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82914748|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82914749|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
82914750|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914751|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914752|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914753|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82914754|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
82914755|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82914756|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
82914757|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914758|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
82914759|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82914760|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914761|NCT02833948|Analgesics|analgesics|mesh-ancestor
82914762|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
82914763|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914764|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82914765|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82914766|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82914767|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82914768|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82914769|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
82914770|NCT02527005|Azithromycin|azithromycin|mesh-list
82914771|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
82914772|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
82914773|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82914774|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82914775|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914776|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
82914777|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82914778|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82914779|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82914780|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914781|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914782|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82914783|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
82914784|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914785|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914786|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914787|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914788|NCT02404688|Ethanol|ethanol|mesh-list
82914789|NCT02404688|Dronabinol|dronabinol|mesh-list
82914790|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82914791|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914792|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914793|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914794|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
82914795|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914796|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914797|NCT02404688|Analgesics|analgesics|mesh-ancestor
82914798|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
82914799|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914800|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82914801|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82914802|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914803|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914804|NCT02404688|Hormones|hormones|mesh-ancestor
82914805|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914806|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
82914807|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82914808|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
82914809|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914810|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
82914811|NCT04704518|Protective Agents|protective agents|mesh-ancestor
82914812|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
82914813|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914814|NCT01162941|Prednisolone|prednisolone|mesh-list
82914815|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82914816|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
82914817|NCT01162941|Hormones|hormones|mesh-ancestor
82914818|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914819|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914820|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82914821|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914822|NCT00161044|Galantamine|galantamine|mesh-list
82914823|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82914824|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914825|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914826|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
82914827|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914828|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914829|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82914830|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
82914831|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914832|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
82914833|NCT01156779|Exenatide|exenatide|mesh-list
82914834|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82914835|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914836|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82914837|NCT01156779|Incretins|incretins|mesh-ancestor
82914838|NCT01156779|Hormones|hormones|mesh-ancestor
82914839|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914840|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
82914841|NCT01156857|Progestins|progestins|mesh-list
82914842|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82914843|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
82914844|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82914845|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914846|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82914847|NCT01156857|Hormones|hormones|mesh-ancestor
82914848|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82914849|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
82914850|NCT01269333|Omeprazole|omeprazole|mesh-list
82914851|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82914852|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82914853|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82914854|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914855|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914856|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82914857|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82914858|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914859|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914860|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914861|NCT01269333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82914862|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82914863|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914864|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914865|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
82914866|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82914867|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
82914868|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82914869|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82914870|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82914871|NCT01269411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82914872|NCT01269411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82914873|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914874|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914875|NCT03882255|Propranolol|propranolol|mesh-list
82914876|NCT03882255|Ponesimod|ponesimod|mesh-list
82914877|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82914878|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82914879|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
82914880|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914881|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914882|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914883|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82914884|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82914885|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
82914886|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82914887|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82914888|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
82914889|NCT05433272|Vaccines|vaccines|mesh-list
82914890|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
82914891|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914892|NCT01268631|Pregabalin|pregabalin|mesh-list
82914893|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82914894|NCT01268631|Analgesics|analgesics|mesh-ancestor
82914895|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
82914896|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914897|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914898|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
82914899|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82914900|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914901|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914902|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82914903|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82914904|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82914905|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914906|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914907|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82914908|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82914909|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914910|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
82914911|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
82914912|NCT05430230|Naproxen|naproxen|mesh-list
82914913|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82914914|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82914915|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914916|NCT05430230|Analgesics|analgesics|mesh-ancestor
82914917|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
82914918|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914919|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914920|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82914921|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
82914922|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82914923|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914924|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914925|NCT01268709|Doxepin|doxepin|mesh-list
82914926|NCT01268709|Nortriptyline|nortriptyline|mesh-list
82914927|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82914928|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
82914929|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914930|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82914931|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82914932|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82914933|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914934|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
82914935|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914936|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914937|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82914938|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82914939|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914940|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
82914941|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
82914942|NCT03881943|Aspirin|aspirin|mesh-list
82914943|NCT03881943|Ticagrelor|ticagrelor|mesh-list
82914944|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82914945|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82914946|NCT03881943|Analgesics|analgesics|mesh-ancestor
82914947|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
82914948|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82914949|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914950|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82914951|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82914952|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82914953|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82914954|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914955|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82914956|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82914957|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914958|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
82914959|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82914960|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83457235|NCT01084759|Androgens|androgens|mesh-ancestor
82914961|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82914962|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
82914963|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914964|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82914965|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82914966|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82914967|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82914968|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82914969|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
82914970|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914971|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914972|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914973|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82914974|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82914975|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
82914976|NCT04722848|Blinatumomab|blinatumomab|mesh-list
82914977|NCT04722848|Ponatinib|ponatinib|mesh-list
82914978|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82914979|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82914980|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82914981|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914982|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82914983|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82914984|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914985|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82914986|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82914987|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82914988|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82914989|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82914990|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82914991|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82914992|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82914993|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
82914994|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82914995|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82914996|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82914997|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82914998|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
82914999|NCT05363384|Metformin|metformin|mesh-list
82915000|NCT05363384|Alogliptin|alogliptin|mesh-list
82915001|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82915002|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915003|NCT05363384|Incretins|incretins|mesh-ancestor
82915004|NCT05363384|Hormones|hormones|mesh-ancestor
82915005|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915006|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82915007|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
82915008|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915009|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915010|NCT01165125|Ketoconazole|ketoconazole|mesh-list
82915011|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
82915012|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915013|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82915014|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82915015|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915016|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915017|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82915018|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
82915019|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915020|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915021|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82915022|NCT01163799|Alefacept|alefacept|mesh-list
82915023|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915024|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
82915025|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915026|NCT02274662|Cyclosporine|cyclosporine|mesh-list
82915027|NCT02274662|Tacrolimus|tacrolimus|mesh-list
82915028|NCT02274662|Cyclosporins|cyclosporins|mesh-list
82915029|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82915030|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
82915031|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915032|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
82915033|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915034|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82915035|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915036|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915037|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
82915038|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915039|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915040|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915041|NCT02891174|Acetaminophen|acetaminophen|mesh-list
82915043|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82915044|NCT02891174|Analgesics|analgesics|mesh-ancestor
82915045|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
82915046|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915047|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915048|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
82915049|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82915050|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915051|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915052|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82915053|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915054|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915055|NCT01280175|Charcoal|charcoal|mesh-list
82915056|NCT01280175|Antidotes|antidotes|mesh-ancestor
82915057|NCT01280175|Protective Agents|protective agents|mesh-ancestor
82915058|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915059|NCT01588431|Bevacizumab|bevacizumab|mesh-list
82915060|NCT01588431|Cetuximab|cetuximab|mesh-list
82915061|NCT01588431|Cisplatin|cisplatin|mesh-list
82915062|NCT01588431|Docetaxel|docetaxel|mesh-list
82915063|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82915064|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915065|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82915066|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82915067|NCT01588431|Growth Substances|growth substances|mesh-ancestor
82915068|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915069|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
82915070|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
82915071|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
82915072|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
82915073|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915074|NCT01583283|Dexamethasone|dexamethasone|mesh-list
82915075|NCT01583283|Lenalidomide|lenalidomide|mesh-list
82915076|NCT01583283|Ricolinostat|ricolinostat|mesh-list
83515140|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915077|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82915078|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915079|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
82915080|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
82915081|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915082|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915083|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82915084|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
82915085|NCT01583283|Hormones|hormones|mesh-ancestor
82915086|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915087|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82915088|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915089|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
82915090|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82915091|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82915092|NCT01583283|Growth Substances|growth substances|mesh-ancestor
82915093|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
82915094|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915095|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915096|NCT02076620|Doxorubicin|doxorubicin|mesh-list
82915097|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915098|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915099|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82915100|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82915101|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915102|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915103|NCT01270737|Daidzein|daidzein|mesh-list
82915104|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
82915105|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82915106|NCT01270737|Estrogens|estrogens|mesh-ancestor
82915107|NCT01270737|Hormones|hormones|mesh-ancestor
82915108|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915109|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915110|NCT01270815|Pregabalin|pregabalin|mesh-list
82915112|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
82915113|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915114|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915115|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
82915116|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82915117|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82915118|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915119|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82915120|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82915121|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82915122|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915123|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82915124|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82915125|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82915126|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
82915127|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915128|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82915129|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915130|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82915131|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915132|NCT03330236|Anesthetics|anesthetics|mesh-list
82915133|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915134|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915135|NCT02831764|Tenofovir|tenofovir|mesh-list
82915136|NCT02831764|Lamivudine|lamivudine|mesh-list
82915137|NCT02831764|Emtricitabine|emtricitabine|mesh-list
82915138|NCT02831764|Dolutegravir|dolutegravir|mesh-list
82915139|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
82915140|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915141|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82915142|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82915143|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915144|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915145|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82915146|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82915147|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82915148|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82915149|NCT01271361|Sirolimus|sirolimus|mesh-list
82915150|NCT01271361|Umirolimus|umirolimus|mesh-list
82915151|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915152|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915153|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
82915154|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915155|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82915156|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915157|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915158|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915159|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
82915160|NCT03638726|Atropine|atropine|mesh-list
82915161|NCT03638726|Phenylephrine|phenylephrine|mesh-list
82915162|NCT03638726|Epinephrine|epinephrine|mesh-list
82915163|NCT03638726|Racepinephrine|racepinephrine|mesh-list
82915164|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
82915165|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
82915166|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
82915167|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82915168|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82915169|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
82915170|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457248|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82915171|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915172|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915173|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82915174|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82915175|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
82915176|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915177|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82915178|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
82915179|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
82915180|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
82915181|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82915182|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82915183|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
82915184|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82915185|NCT03638726|Protective Agents|protective agents|mesh-ancestor
82915186|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82915187|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82915188|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
82915189|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82915190|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82915191|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
82915192|NCT01164189|Bevacizumab|bevacizumab|mesh-list
82915193|NCT01164189|Temozolomide|temozolomide|mesh-list
82915194|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82915195|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915196|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82915197|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82915198|NCT01164189|Growth Substances|growth substances|mesh-ancestor
82915199|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915200|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
82915201|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82915202|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
82915203|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915204|NCT01164267|Everolimus|everolimus|mesh-list
82915205|NCT01164267|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82915206|NCT01164267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915207|NCT01164267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915208|NCT01164267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915209|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915210|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
82915211|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915212|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915213|NCT01164345|Plerixafor|plerixafor|mesh-list
82915214|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82915215|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82915216|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
82915217|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915218|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
82915219|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82915220|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82915221|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82915222|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82915223|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
82915224|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915225|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915226|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915227|NCT02259868|Ritonavir|ritonavir|mesh-list
82915228|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82915229|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82915230|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
82915231|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915232|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915233|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82915234|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82915235|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
82915236|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915237|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82915238|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82915239|NCT01167231|Acarbose|acarbose|mesh-list
83457253|NCT01110421|Doripenem|doripenem|mesh-list
82915240|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82915241|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915242|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915243|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82915244|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915245|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82915246|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82915247|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
82915248|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915249|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915250|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915251|NCT00135226|Aspirin|aspirin|mesh-list
82915252|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82915253|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82915254|NCT00135226|Analgesics|analgesics|mesh-ancestor
82915255|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
82915256|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915257|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915258|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915259|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915261|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82915262|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915263|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82915264|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82915265|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915266|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
82915267|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
82915268|NCT01587261|Vitamins|vitamins|mesh-ancestor
82915269|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
82915270|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915271|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
82915272|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915273|NCT01587261|Protective Agents|protective agents|mesh-ancestor
82915274|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
82915275|NCT01269021|Prednisone|prednisone|mesh-list
82915276|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915277|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
82915278|NCT01269021|Hormones|hormones|mesh-ancestor
82915279|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915280|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915281|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82915282|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915283|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915284|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82915285|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
82915286|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82915287|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915288|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915289|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915290|NCT01269099|Fentanyl|fentanyl|mesh-list
82915291|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915292|NCT01269099|Narcotics|narcotics|mesh-ancestor
82915293|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915294|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915295|NCT01269099|Analgesics|analgesics|mesh-ancestor
82915296|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
82915297|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915298|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82915299|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82915300|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
82915301|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
82915302|NCT01164813|Nabumetone|nabumetone|mesh-list
82915303|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82915304|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82915305|NCT01164813|Analgesics|analgesics|mesh-ancestor
82915306|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
82915307|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915308|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915309|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915310|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915311|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82915312|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82915313|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915314|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915315|NCT01165905|Gemcitabine|gemcitabine|mesh-list
82915317|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82915318|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
82915319|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915320|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915321|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915322|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915323|NCT01339000|Vaccines|vaccines|mesh-list
82915324|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82915325|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
82915326|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915327|NCT01269255|Cisplatin|cisplatin|mesh-list
82915328|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915329|NCT03563170|Leucovorin|leucovorin|mesh-list
82915330|NCT03563170|Paclitaxel|paclitaxel|mesh-list
82915331|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
82915332|NCT03563170|Fluorouracil|fluorouracil|mesh-list
82915333|NCT03563170|Capecitabine|capecitabine|mesh-list
82915334|NCT03563170|Cetuximab|cetuximab|mesh-list
82915335|NCT03563170|Sorafenib|sorafenib|mesh-list
82915336|NCT03563170|Avelumab|avelumab|mesh-list
82915337|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82915338|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915339|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
82915340|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
82915341|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
82915342|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915343|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915344|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
82915345|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915346|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915347|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82915348|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
82915349|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82915350|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
82915351|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82915352|NCT03563170|Antidotes|antidotes|mesh-ancestor
82915353|NCT03563170|Protective Agents|protective agents|mesh-ancestor
82915354|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
82915355|NCT03563170|Vitamins|vitamins|mesh-ancestor
82915356|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
82915357|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82915358|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915359|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915360|NCT01281111|Aspirin|aspirin|mesh-list
82915361|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82915362|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82915363|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82915364|NCT01281111|Analgesics|analgesics|mesh-ancestor
82915365|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
82915366|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915367|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915368|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915369|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915370|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82915371|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82915372|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915373|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82915374|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82915375|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915376|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
82915377|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915378|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915379|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
82915380|NCT03869931|Fenofibrate|fenofibrate|mesh-list
82915381|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82915382|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
82915383|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915384|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82915385|NCT04876066|Ketamine|ketamine|mesh-list
82915386|NCT04876066|Analgesics|analgesics|mesh-ancestor
82915387|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
82915388|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915389|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915390|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82915391|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82915392|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
82915393|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
82915394|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915395|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82915396|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82915397|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915398|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915399|NCT01169805|Ondansetron|ondansetron|mesh-list
82915400|NCT01169805|Palonosetron|palonosetron|mesh-list
82915401|NCT01169805|Ramosetron|ramosetron|mesh-list
82915402|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
82915403|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
82915404|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915405|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915406|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82915407|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
82915408|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915409|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82915410|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82915411|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
82915412|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915413|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915414|NCT01283061|Zafirlukast|zafirlukast|mesh-list
82915415|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82915416|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
82915417|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82915418|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
82915419|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915420|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915421|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82915422|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915423|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
82915424|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915425|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
82915426|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82915427|NCT01167465|Protective Agents|protective agents|mesh-ancestor
82915428|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915429|NCT01283217|Cisplatin|cisplatin|mesh-list
82915430|NCT01283217|Docetaxel|docetaxel|mesh-list
82915431|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915432|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
82915433|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
82915434|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
82915435|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915436|NCT01276431|Buprenorphine|buprenorphine|mesh-list
82915437|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915438|NCT01276431|Narcotics|narcotics|mesh-ancestor
82915439|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915440|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915441|NCT01276431|Analgesics|analgesics|mesh-ancestor
82915442|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
82915443|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915444|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82915445|NCT01281579|Canagliflozin|canagliflozin|mesh-list
82915446|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82915447|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915448|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82915449|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915450|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82915451|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82915452|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915453|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915454|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
82915455|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915457|NCT01166451|Trace Elements|trace elements|mesh-ancestor
82915458|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
82915459|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915460|NCT02526615|Metformin|metformin|mesh-list
82915461|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
82915462|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82915463|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915464|NCT01283763|Imiquimod|imiquimod|mesh-list
82915465|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82915466|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
82915467|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915468|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915469|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
82915470|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
82915471|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915472|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915473|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82915474|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
82915475|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82915476|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915477|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915478|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915479|NCT03872661|Bevacizumab|bevacizumab|mesh-list
82915480|NCT03872661|Carboplatin|carboplatin|mesh-list
82915481|NCT03872661|Pemetrexed|pemetrexed|mesh-list
82915482|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82915483|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915484|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82915485|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82915486|NCT03872661|Growth Substances|growth substances|mesh-ancestor
82915487|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915489|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915490|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915491|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82915492|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82915493|NCT01167699|Oxycodone|oxycodone|mesh-list
82915494|NCT01167699|Naloxone|naloxone|mesh-list
82915495|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915496|NCT01167699|Narcotics|narcotics|mesh-ancestor
82915497|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915498|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915499|NCT01167699|Analgesics|analgesics|mesh-ancestor
82915500|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
82915501|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915502|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82915503|NCT02526303|Nadroparin|nadroparin|mesh-list
82915504|NCT02526303|Warfarin|warfarin|mesh-list
82915505|NCT02526303|Calcium|calcium|mesh-list
82915506|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82915507|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915508|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
82915509|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82915510|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82915511|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915512|NCT03869073|Evolocumab|evolocumab|mesh-list
82915513|NCT03869073|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82915514|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82915515|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82915516|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
82915517|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915518|NCT03869073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82915519|NCT03869073|Protease Inhibitors|protease inhibitors|mesh-ancestor
82915520|NCT03869073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915521|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82915522|NCT01587495|Ertapenem|ertapenem|mesh-list
82915523|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82915524|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915525|NCT01170351|Cyclosporine|cyclosporine|mesh-list
82915526|NCT01170351|Cyclosporins|cyclosporins|mesh-list
82915527|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915528|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915529|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915530|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
82915531|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915532|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
82915533|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915534|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915535|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915536|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82915537|NCT01170429|Procaterol|procaterol|mesh-list
82915538|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82915539|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
82915540|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915541|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915542|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82915543|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
82915544|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
82915545|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82915546|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82915547|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82915548|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
82915549|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915550|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915551|NCT01170507|Vitamin D|vitamin d|mesh-list
82915552|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
82915553|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
82915554|NCT01170507|Vitamins|vitamins|mesh-list
82915555|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
82915556|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915557|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82915558|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82915559|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82915560|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82915561|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82915562|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
82915563|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915564|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82915565|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82915566|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915567|NCT01170819|Dinoprostone|dinoprostone|mesh-list
82915568|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
82915569|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82915570|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915571|NCT03868137|Ibuprofen|ibuprofen|mesh-list
82915572|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82915573|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82915574|NCT03868137|Analgesics|analgesics|mesh-ancestor
82915575|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
82915576|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915577|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915578|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915579|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82915580|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82915581|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915582|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915583|NCT01283919|Pantoprazole|pantoprazole|mesh-list
82915584|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82915585|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82915586|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82915587|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915588|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915589|NCT01167933|Simvastatin|simvastatin|mesh-list
82915590|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82915591|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82915592|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
82915593|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915594|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82915595|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82915596|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915597|NCT01168011|ON 01910|on 01910|mesh-list
82915598|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915599|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915600|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915601|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915602|NCT01171209|Interferons|interferons|mesh-list
82915603|NCT01171209|Interferon-beta|interferon-beta|mesh-list
82915604|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
82915605|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
82915606|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915607|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
82915608|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915609|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
82915610|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915611|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82915612|NCT01166685|Everolimus|everolimus|mesh-list
82915613|NCT01166685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82915614|NCT01166685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915615|NCT01166685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915616|NCT01166685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915617|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915618|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
82915619|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915620|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915621|NCT03870711|Lidocaine|lidocaine|mesh-list
82915622|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
82915623|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
82915624|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915625|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915626|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
82915627|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915628|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82915629|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82915630|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82915631|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82915632|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915633|NCT03872505|Paclitaxel|paclitaxel|mesh-list
82915634|NCT03872505|Carboplatin|carboplatin|mesh-list
82915635|NCT03872505|Durvalumab|durvalumab|mesh-list
82915636|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82915638|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
82915639|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
82915640|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
82915641|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915642|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82915643|NCT01171365|Ciclesonide|ciclesonide|mesh-list
82915644|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
82915645|NCT01171365|Hormones|hormones|mesh-ancestor
82915646|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915647|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915648|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82915649|NCT01281891|Morphine|morphine|mesh-list
82915650|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915651|NCT01281891|Narcotics|narcotics|mesh-ancestor
82915652|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915653|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915654|NCT01281891|Analgesics|analgesics|mesh-ancestor
82915655|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
82915656|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915657|NCT01282047|Lenalidomide|lenalidomide|mesh-list
82915658|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
82915659|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915660|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82915661|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82915662|NCT01282047|Growth Substances|growth substances|mesh-ancestor
82915663|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
82915664|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915665|NCT02525991|Loxapine|loxapine|mesh-list
82915666|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82915667|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82915668|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915669|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915670|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82915671|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82915672|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
82915673|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915674|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915675|NCT01171755|Gemcitabine|gemcitabine|mesh-list
82915676|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82915677|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
82915678|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915679|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915680|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
82915681|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82915682|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
82915683|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915684|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915685|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82915686|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
82915687|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82915688|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
82915689|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915690|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915691|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82915692|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
82915693|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
82915694|NCT01172691|Protective Agents|protective agents|mesh-ancestor
82915695|NCT01171833|Sevoflurane|sevoflurane|mesh-list
82915696|NCT01171833|Desflurane|desflurane|mesh-list
82915697|NCT01171833|Isoflurane|isoflurane|mesh-list
82915698|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82915699|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82915700|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
82915701|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
82915702|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915703|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915704|NCT01172769|Sirolimus|sirolimus|mesh-list
82915705|NCT01172769|Temsirolimus|temsirolimus|mesh-list
82915706|NCT01172769|MTOR Inhibitors|mtor inhibitors|mesh-list
82915707|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
82915708|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915709|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915710|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82915711|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
82915712|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915713|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915714|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82915715|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82915716|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915717|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
82915719|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915720|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915721|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915722|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915723|NCT01171911|Nicardipine|nicardipine|mesh-list
82915724|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
82915725|NCT01171911|Esmolol|esmolol|mesh-list
82915726|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82915727|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915728|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82915729|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82915730|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82915731|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
82915732|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915733|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915734|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82915735|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82915736|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
82915737|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
82915738|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82915739|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
82915740|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915741|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915742|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82915743|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
82915744|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
82915745|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82915746|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
82915747|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915748|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915749|NCT01173003|Misoprostol|misoprostol|mesh-list
82915750|NCT01173003|Mifepristone|mifepristone|mesh-list
82915751|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82915752|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
82915753|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82915754|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915755|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82915756|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82915757|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
82915758|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82915759|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82915760|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82915761|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82915762|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
82915763|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82915764|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82915765|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
82915766|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915767|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
82915768|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82915769|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82915770|NCT03435003|Dexamethasone|dexamethasone|mesh-list
82915771|NCT03435003|Fentanyl|fentanyl|mesh-list
82915772|NCT03435003|Scopolamine|scopolamine|mesh-list
82915773|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
82915774|NCT03435003|Ondansetron|ondansetron|mesh-list
82915775|NCT03435003|Aprepitant|aprepitant|mesh-list
82915776|NCT03435003|Metoclopramide|metoclopramide|mesh-list
82915777|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
82915778|NCT03435003|Propofol|propofol|mesh-list
82915779|NCT03435003|Sevoflurane|sevoflurane|mesh-list
82915780|NCT03435003|Desflurane|desflurane|mesh-list
82915781|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82915782|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915783|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
82915784|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
82915785|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915786|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915788|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
82915789|NCT03435003|Hormones|hormones|mesh-ancestor
82915790|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915791|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82915792|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915793|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
82915794|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915795|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82915796|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82915797|NCT03435003|Analgesics|analgesics|mesh-ancestor
82915798|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
82915799|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82915800|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82915801|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82915802|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
82915803|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915804|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915805|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82915806|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
82915807|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915808|NCT03435003|Narcotics|narcotics|mesh-ancestor
82915809|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82915810|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82915811|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82915812|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
82915813|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
82915814|NCT03435003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82915815|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82915816|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
82915817|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82915818|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82915819|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82915820|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
82915821|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
82915822|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82915823|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
82915824|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82915825|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
82915826|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82915827|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82915828|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82915829|NCT01172223|Paclitaxel|paclitaxel|mesh-list
82915830|NCT01172223|Doxorubicin|doxorubicin|mesh-list
82915831|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82915832|NCT01172223|Lapatinib|lapatinib|mesh-list
82915833|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82915834|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915835|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
82915836|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
82915837|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
82915838|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915839|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915840|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82915841|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82915842|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915843|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915845|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82915846|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915847|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82915848|NCT03866733|Narcotics|narcotics|mesh-list
82915849|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915850|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915851|NCT03866733|Analgesics|analgesics|mesh-ancestor
82915852|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
82915853|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915854|NCT01168791|Doxorubicin|doxorubicin|mesh-list
82915855|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82915856|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
82915857|NCT01168791|Ifosfamide|ifosfamide|mesh-list
82915858|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915859|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915860|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82915861|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82915867|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82915868|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82915869|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82915870|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
82915871|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915872|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915873|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915874|NCT01284309|Urological Agents|urological agents|mesh-ancestor
82915875|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82915876|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
82915877|NCT01169025|Fentanyl|fentanyl|mesh-list
82915878|NCT01169025|Ketamine|ketamine|mesh-list
82915879|NCT01169025|Analgesics|analgesics|mesh-ancestor
82915880|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
82915881|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915882|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915883|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82915884|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82915885|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
82915886|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
82915887|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915888|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82915889|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82915890|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915891|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915892|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915893|NCT01169025|Narcotics|narcotics|mesh-ancestor
82915894|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82915895|NCT01582347|Buprenorphine|buprenorphine|mesh-list
82915896|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82915897|NCT01582347|Naloxone|naloxone|mesh-list
82915898|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82915899|NCT01582347|Narcotics|narcotics|mesh-ancestor
82915900|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915901|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915902|NCT01582347|Analgesics|analgesics|mesh-ancestor
82915903|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
82915904|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915905|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82915906|NCT01336634|Trametinib|trametinib|mesh-list
82915907|NCT01336634|Dabrafenib|dabrafenib|mesh-list
82915908|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915909|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915910|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915911|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915912|NCT01284855|Antivenins|antivenins|mesh-list
82915913|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
82915914|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915915|NCT05316116|Siltuximab|siltuximab|mesh-list
82915916|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915917|NCT00785798|Doxorubicin|doxorubicin|mesh-list
82915918|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82915919|NCT00785798|Vorinostat|vorinostat|mesh-list
82915920|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82915921|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915922|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82915923|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82915924|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915925|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915926|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82915927|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
82915928|NCT01175109|Panobinostat|panobinostat|mesh-list
82915929|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915930|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82915931|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915933|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82915934|NCT01282515|Clobetasol|clobetasol|mesh-list
82915935|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82915936|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
82915937|NCT01282515|Hormones|hormones|mesh-ancestor
82915938|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82915939|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915940|NCT04732910|Ivacaftor|ivacaftor|mesh-list
82915941|NCT04732910|Elexacaftor|elexacaftor|mesh-list
82915942|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82915943|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82915944|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915945|NCT03329846|Nivolumab|nivolumab|mesh-list
82915946|NCT03329846|Linrodostat|linrodostat|mesh-list
82915947|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82915948|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915949|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82915950|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915951|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82915952|NCT04020848|Melatonin|melatonin|mesh-list
82915953|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
82915954|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915955|NCT04020848|Protective Agents|protective agents|mesh-ancestor
82915956|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915957|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82915958|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82915959|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82915960|NCT01355302|Capecitabine|capecitabine|mesh-list
82915961|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82915962|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82915963|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
82915964|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915965|NCT01355068|Phenytoin|phenytoin|mesh-list
82915966|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
82915967|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82915968|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82915969|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82915970|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915971|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82915972|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82915973|NCT03562780|Acetaminophen|acetaminophen|mesh-list
82915974|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82915975|NCT03562780|Analgesics|analgesics|mesh-ancestor
82915976|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
82915977|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915978|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915979|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
82915980|NCT02259946|Bromides|bromides|mesh-list
82915981|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
82915982|NCT02259946|Olodaterol|olodaterol|mesh-list
82915983|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82915984|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
82915985|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915986|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82915987|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82915988|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
82915989|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
82915990|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82915991|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
82915992|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82915993|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82915994|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
82915995|NCT03756129|Ketamine|ketamine|mesh-list
82915996|NCT03756129|Analgesics|analgesics|mesh-ancestor
82915997|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
82915998|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82915999|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916000|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82916001|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82916002|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
82916003|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
82916004|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916005|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82916006|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82916007|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916008|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916009|NCT03863691|Amisulpride|amisulpride|mesh-list
82916010|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82916011|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82916012|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916013|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916014|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916015|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82916016|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
82916017|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916018|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916019|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82916020|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
82916021|NCT02822794|Ribavirin|ribavirin|mesh-list
82916022|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
82916023|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82916024|NCT02822794|Velpatasvir|velpatasvir|mesh-list
82916025|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
82916026|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916027|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
82916028|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916029|NCT01173315|Vitamins|vitamins|mesh-list
83457306|NCT05620589|Tetracycline|tetracycline|mesh-list
82916030|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
82916031|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916032|NCT01173549|Canagliflozin|canagliflozin|mesh-list
82916033|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82916034|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916035|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82916036|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916037|NCT01338298|Aripiprazole|aripiprazole|mesh-list
82916038|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
82916039|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916040|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82916041|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82916042|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916043|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916044|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
82916045|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
82916046|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916047|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916048|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82916049|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82916050|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
82916051|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82916052|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82916053|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82916054|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82916055|NCT01169415|Dexamethasone|dexamethasone|mesh-list
82916056|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
82916057|NCT01169415|BB 1101|bb 1101|mesh-list
82916058|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916059|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
82916060|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
82916061|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916062|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916063|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82916064|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
82916065|NCT01169415|Hormones|hormones|mesh-ancestor
82916066|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916067|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82916068|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916069|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
82916070|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916071|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916072|NCT01173627|Fentanyl|fentanyl|mesh-list
82916073|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82916074|NCT01173627|Narcotics|narcotics|mesh-ancestor
82916075|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916076|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916077|NCT01173627|Analgesics|analgesics|mesh-ancestor
82916078|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
82916079|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916080|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82916081|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82916082|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
82916083|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
82916084|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
82916085|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82916086|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916087|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916088|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82916089|NCT01169571|Analgesics|analgesics|mesh-ancestor
82916090|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
82916091|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916092|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82916093|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82916094|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82916095|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
82916096|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916097|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916098|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
82916099|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82916100|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
82916101|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916102|NCT01354132|Expectorants|expectorants|mesh-ancestor
83457310|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916103|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
82916104|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82916105|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
82916106|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916107|NCT01354132|Protective Agents|protective agents|mesh-ancestor
82916108|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916109|NCT01354132|Antidotes|antidotes|mesh-ancestor
82916110|NCT05707936|Heparin|heparin|mesh-list
82916111|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
82916112|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82916113|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82916114|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916115|NCT03863613|Progesterone|progesterone|mesh-list
82916116|NCT03863613|Progestins|progestins|mesh-ancestor
82916117|NCT03863613|Hormones|hormones|mesh-ancestor
82916118|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916119|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916120|NCT01372150|Fluoxetine|fluoxetine|mesh-list
82916121|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82916122|NCT01372150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82916123|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82916124|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82916125|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916126|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916127|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
82916128|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916129|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82916130|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
82916131|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916132|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82916133|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82916134|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916135|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82916136|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82916137|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916138|NCT01175577|Carotenoids|carotenoids|mesh-list
82916139|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
82916140|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916141|NCT01175577|Protective Agents|protective agents|mesh-ancestor
82916142|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916143|NCT01175733|Panitumumab|panitumumab|mesh-list
82916144|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82916145|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916146|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
82916147|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82916148|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916149|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916150|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82916151|NCT02035930|Analgesics|analgesics|mesh-ancestor
82916153|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916154|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82916155|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82916156|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82916157|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
82916158|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916159|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916160|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82916161|NCT01173939|Pravastatin|pravastatin|mesh-list
82916162|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82916163|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82916164|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
82916165|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916166|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82916167|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82916168|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916170|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
82916171|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82916172|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916173|NCT01174017|Trace Elements|trace elements|mesh-ancestor
82916174|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
82916175|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916176|NCT01288131|Cyclosporine|cyclosporine|mesh-list
82916177|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
82916178|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
82916179|NCT01288131|Cyclosporins|cyclosporins|mesh-list
82916180|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82916181|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
82916182|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916183|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916184|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916185|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
82916186|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916187|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916188|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82916189|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916190|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
82916191|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916192|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
82916193|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82916194|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82916195|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82916196|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
82916197|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82916198|NCT02525211|Ropivacaine|ropivacaine|mesh-list
82916199|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
82916200|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
82916201|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916202|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916203|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
82916204|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916205|NCT03865563|Gemcitabine|gemcitabine|mesh-list
82916206|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
82916207|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82916208|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
82916209|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916210|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916211|NCT01178151|Everolimus|everolimus|mesh-list
82916212|NCT01178151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82916213|NCT01178151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82916214|NCT01178151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515141|NCT04004481|Narcotics|narcotics|mesh-ancestor
82916215|NCT01178151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916216|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82916217|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
82916218|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916219|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916220|NCT03862287|Lidocaine|lidocaine|mesh-list
82916221|NCT03862287|Bupivacaine|bupivacaine|mesh-list
82916222|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
82916223|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
82916224|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916225|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916226|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
82916227|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916228|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82916229|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82916230|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83457316|NCT05620589|Antacids|antacids|mesh-ancestor
82916231|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82916232|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916233|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82916234|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82916235|NCT03749109|Quinagolide|quinagolide|mesh-list
82916236|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
82916237|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
82916238|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916239|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916240|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916241|NCT01287351|Fluticasone|fluticasone|mesh-list
82916242|NCT01287351|Xhance|xhance|mesh-list
82916243|NCT01287351|Beclomethasone|beclomethasone|mesh-list
82916244|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916245|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82916246|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
82916247|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916248|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916249|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82916250|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
82916251|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
82916252|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82916253|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
82916254|NCT01287351|Hormones|hormones|mesh-ancestor
82916255|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916256|NCT03864783|Curcumin|curcumin|mesh-list
82916257|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82916258|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82916259|NCT03864783|Analgesics|analgesics|mesh-ancestor
82916260|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
82916261|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916262|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916263|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916264|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916265|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916266|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916267|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916268|NCT01287507|Lactoferrin|lactoferrin|mesh-list
82916269|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916270|NCT03864705|Metformin|metformin|mesh-list
82916271|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82916272|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916273|NCT01287663|Permethrin|permethrin|mesh-list
82916274|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916275|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916276|NCT01176669|Apatinib|apatinib|mesh-list
82916277|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916278|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82916279|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916280|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916281|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
82916282|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82916283|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
82916284|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916285|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916286|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82916287|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
82916288|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82916289|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82916290|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82916291|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
82916292|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916293|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916294|NCT01174953|Finasteride|finasteride|mesh-list
82916295|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82916296|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82916297|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916298|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916299|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
82916300|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916301|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916302|NCT01174953|Urological Agents|urological agents|mesh-ancestor
82916303|NCT01286103|Canagliflozin|canagliflozin|mesh-list
82916304|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82916305|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916306|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82916307|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916308|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
82916309|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
82916310|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82916311|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
82916312|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916313|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916314|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82916315|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
82916316|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
82916317|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82916318|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
82916319|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916320|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916321|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82916322|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82916323|NCT03863925|Propofol|propofol|mesh-list
82916324|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82916325|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916326|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916327|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82916328|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
82916329|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
82916330|NCT01178697|Triamcinolone|triamcinolone|mesh-list
82916331|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82916332|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82916333|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82916334|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916335|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
82916336|NCT01178697|Hormones|hormones|mesh-ancestor
82916337|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916338|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916339|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82916340|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
82916341|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916342|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916343|NCT03329690|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82916344|NCT03329690|Immunoconjugates|immunoconjugates|mesh-ancestor
82916345|NCT03329690|Immunologic Factors|immunologic factors|mesh-ancestor
82916346|NCT03329690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916347|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
82916348|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
82916349|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
82916350|NCT03328832|Thrombin|thrombin|mesh-list
82916351|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82916352|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82916353|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916354|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
82916355|NCT03328832|Coagulants|coagulants|mesh-ancestor
82916356|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82916357|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
82916358|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82916359|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
82916360|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916361|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
82916362|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
82916363|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916364|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82916365|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82916366|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82916367|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916368|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916369|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82916370|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916371|NCT02942576|Warfarin|warfarin|mesh-list
82916372|NCT02942576|Edoxaban|edoxaban|mesh-list
82916373|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
82916374|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
82916375|NCT02942576|Fluindione|fluindione|mesh-list
82916377|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82916378|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
82916379|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82916380|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
82916381|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916382|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916383|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
82916384|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82916385|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916386|NCT02036008|Liver Extracts|liver extracts|mesh-list
82916387|NCT02036008|Hematinics|hematinics|mesh-ancestor
82916388|NCT02819440|Tadalafil|tadalafil|mesh-list
82916389|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
82916390|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82916391|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82916392|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916393|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916394|NCT02819440|Urological Agents|urological agents|mesh-ancestor
82916395|NCT03562468|Niacinamide|niacinamide|mesh-list
82916396|NCT03562468|Niacin|niacin|mesh-list
82916397|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
82916398|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
82916399|NCT03562468|Vitamins|vitamins|mesh-ancestor
82916400|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
82916401|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916402|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82916403|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
82916404|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916405|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82916406|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
82916407|NCT02036164|Paclitaxel|paclitaxel|mesh-list
82916408|NCT02036164|Cisplatin|cisplatin|mesh-list
82916409|NCT02036164|Carboplatin|carboplatin|mesh-list
82916410|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82916411|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916412|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
82916413|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
82916414|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
82916415|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916416|NCT02818036|Naltrexone|naltrexone|mesh-list
82916417|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82916418|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82916419|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916420|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
82916421|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916422|NCT01287741|Prednisone|prednisone|mesh-list
82916423|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
82916424|NCT01287741|Rituximab|rituximab|mesh-list
82916425|NCT01287741|Doxorubicin|doxorubicin|mesh-list
82916426|NCT01287741|Vincristine|vincristine|mesh-list
82916427|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
82916428|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82916429|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
82916430|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916431|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916432|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916433|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
82916434|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916435|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916436|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82916437|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82916438|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82916439|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82916440|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82916441|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916442|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916443|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
82916445|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916446|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82916447|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82916448|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
82916449|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
82916450|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
82916451|NCT01180959|Bevacizumab|bevacizumab|mesh-list
82916452|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82916453|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82916454|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916455|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82916456|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82916457|NCT01180959|Growth Substances|growth substances|mesh-ancestor
82916458|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916459|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
82916460|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82916461|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916462|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916463|NCT01177371|Cyclosporine|cyclosporine|mesh-list
82916464|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
82916465|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82916466|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82916467|NCT01177371|Prednisolone|prednisolone|mesh-list
82916468|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
82916469|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
82916470|NCT01177371|Busulfan|busulfan|mesh-list
82916471|NCT01177371|Methotrexate|methotrexate|mesh-list
82916472|NCT01177371|Cyclosporins|cyclosporins|mesh-list
82916473|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82916474|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
82916475|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82916476|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
82916477|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916478|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916479|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916480|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
82916481|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916482|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916483|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82916484|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82916485|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
82916486|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82916487|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82916488|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
82916489|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
82916490|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916491|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82916492|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82916493|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
82916494|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916495|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82916496|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916497|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
82916498|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
82916499|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916500|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82916501|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
82916502|NCT01177371|Hormones|hormones|mesh-ancestor
82916503|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916504|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82916505|NCT01177371|Protective Agents|protective agents|mesh-ancestor
82916506|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82916507|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
82916508|NCT01178931|Progesterone|progesterone|mesh-list
82916509|NCT01178931|Progestins|progestins|mesh-ancestor
82916510|NCT01178931|Hormones|hormones|mesh-ancestor
83457343|NCT04355429|Captopril|captopril|mesh-list
82916511|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916512|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916513|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
82916514|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82916515|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
82916516|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916517|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916519|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916520|NCT01181193|Vitamin D|vitamin d|mesh-list
82916521|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
82916522|NCT01181193|Temozolomide|temozolomide|mesh-list
82916523|NCT01181193|Vitamins|vitamins|mesh-ancestor
82916524|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
82916525|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916526|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82916527|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916528|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
82916529|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916530|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916531|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82916532|NCT01177683|Doxorubicin|doxorubicin|mesh-list
82916533|NCT01177683|Bortezomib|bortezomib|mesh-list
82916534|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82916535|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82916536|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916537|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82916538|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82916539|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916540|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916541|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916542|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
82916543|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
82916544|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916545|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916546|NCT03855579|Simendan|simendan|mesh-list
82916547|NCT03855579|Milrinone|milrinone|mesh-list
82916548|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82916549|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
82916550|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82916551|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82916552|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916553|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916554|NCT03855579|Protective Agents|protective agents|mesh-ancestor
82916555|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916556|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82916557|NCT03855423|Tocotrienols|tocotrienols|mesh-list
82916558|NCT03855423|Vitamin E|vitamin e|mesh-list
82916559|NCT03855423|Tocopherols|tocopherols|mesh-list
82916560|NCT03855423|Tocovid|tocovid|mesh-list
82916561|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
82916562|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916563|NCT03855423|Protective Agents|protective agents|mesh-ancestor
82916564|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916565|NCT03855423|Vitamins|vitamins|mesh-ancestor
82916566|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
82916567|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82916568|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82916569|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82916570|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
82916571|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916572|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916573|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916574|NCT01181505|Urological Agents|urological agents|mesh-ancestor
82916575|NCT01290783|Irinotecan|irinotecan|mesh-list
82916576|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82916577|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82916578|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916579|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916580|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916581|NCT03857763|Paclitaxel|paclitaxel|mesh-list
82916582|NCT03857763|Apatinib|apatinib|mesh-list
82916583|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82916584|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916585|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
82916586|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
82916587|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
82916588|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916589|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82916590|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916591|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
82916592|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82916593|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916594|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916595|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82916597|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
82916598|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916599|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82916600|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82916601|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82916602|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
82916603|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916604|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916605|NCT01185015|Nicorandil|nicorandil|mesh-list
82916606|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82916607|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82916608|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
82916609|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
82916610|NCT01185015|Vitamins|vitamins|mesh-ancestor
82916611|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
82916612|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916613|NCT01289925|Selenium|selenium|mesh-list
82916614|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
82916615|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916616|NCT01289925|Protective Agents|protective agents|mesh-ancestor
82916617|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916618|NCT01289925|Trace Elements|trace elements|mesh-ancestor
82916619|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
82916620|NCT01290939|Bevacizumab|bevacizumab|mesh-list
82916621|NCT01290939|Lomustine|lomustine|mesh-list
82916622|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82916623|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916624|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82916625|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82916626|NCT01290939|Growth Substances|growth substances|mesh-ancestor
82916627|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916628|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
82916629|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916630|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
82916631|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916632|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
82916633|NCT01288755|Rilpivirine|rilpivirine|mesh-list
82916634|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82916635|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82916636|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
82916637|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916638|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82916639|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82916640|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916641|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916642|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82916643|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82916644|NCT01290003|Tazobactam|tazobactam|mesh-list
82916645|NCT01290003|Piperacillin|piperacillin|mesh-list
82916646|NCT01290003|Amikacin|amikacin|mesh-list
82916647|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82916648|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82916649|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916650|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82916651|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916652|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916653|NCT01291095|Cisplatin|cisplatin|mesh-list
82916654|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916655|NCT03739203|Cariprazine|cariprazine|mesh-list
82916656|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
82916657|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916658|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82916659|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82916660|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916661|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916662|NCT01185405|Voriconazole|voriconazole|mesh-list
82916663|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
82916664|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916665|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82916666|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82916667|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916668|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916669|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82916670|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
82916671|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916672|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916673|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82916674|NCT01182129|Nicotine|nicotine|mesh-list
82916675|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82916676|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
82916677|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916678|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916679|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82916680|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82916681|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
82916682|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916683|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916684|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
82916686|NCT01587729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82916687|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916688|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82916689|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
82916690|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916691|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916692|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916693|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82916694|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82916695|NCT03855267|Propofol|propofol|mesh-list
82916696|NCT03855267|Etomidate|etomidate|mesh-list
82916697|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82916698|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916699|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916700|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82916701|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
82916702|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
82916703|NCT01185873|Ritonavir|ritonavir|mesh-list
82916704|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82916705|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82916706|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
82916707|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916708|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916709|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82916710|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82916711|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
82916712|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916713|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82916714|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82916715|NCT01182597|Pantoprazole|pantoprazole|mesh-list
82916716|NCT01182597|Lansoprazole|lansoprazole|mesh-list
82916717|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
82916718|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82916719|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82916720|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82916721|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916722|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916723|NCT01185951|Polidocanol|polidocanol|mesh-list
82916724|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82916725|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82916726|NCT01186029|Aprepitant|aprepitant|mesh-list
82916727|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
82916728|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
82916729|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916730|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916731|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82916732|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82916733|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916734|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916735|NCT01587807|Dimercaprol|dimercaprol|mesh-list
82916736|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
82916737|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
82916738|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916739|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
82916740|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916741|NCT01180179|Lansoprazole|lansoprazole|mesh-list
82916742|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
82916743|NCT01180179|Famotidine|famotidine|mesh-list
82916744|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82916745|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82916746|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82916747|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916748|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916749|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82916750|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
82916751|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
82916752|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916754|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82916755|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916756|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
82916757|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916758|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916760|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82916761|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82916762|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82916763|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916764|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916765|NCT03854409|Aripiprazole|aripiprazole|mesh-list
82916766|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
82916767|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916768|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82916769|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82916770|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916771|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916772|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
82916773|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
82916774|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916775|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916776|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82916777|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82916778|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
83457380|NCT02245529|Tamsulosin|tamsulosin|mesh-list
82916779|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82916780|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82916781|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82916782|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82916783|NCT01186653|Fluticasone|fluticasone|mesh-list
82916784|NCT01186653|Budesonide|budesonide|mesh-list
82916785|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
82916786|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82916787|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82916788|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916789|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82916790|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
82916791|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916792|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916793|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82916794|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
82916795|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
82916796|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82916797|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
82916798|NCT01186653|Hormones|hormones|mesh-ancestor
82916799|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916800|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82916801|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82916802|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82916803|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
82916804|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916805|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916806|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
82916807|NCT01186731|Docetaxel|docetaxel|mesh-list
82916808|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916809|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
82916810|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
82916811|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
82916812|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916813|NCT01186887|Celecoxib|celecoxib|mesh-list
82916814|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82916815|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82916816|NCT01186887|Analgesics|analgesics|mesh-ancestor
82916817|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
82916818|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916819|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916820|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82916821|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916822|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82916823|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82916824|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916825|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916827|NCT01180413|Amlodipine|amlodipine|mesh-list
82916828|NCT01180413|Ramipril|ramipril|mesh-list
82916829|NCT01180413|Lercanidipine|lercanidipine|mesh-list
82916830|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82916831|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82916832|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82916833|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916834|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82916835|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916836|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
82916837|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82916838|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82916839|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82916840|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82916841|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
82916842|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916843|NCT03858387|Meropenem|meropenem|mesh-list
82916844|NCT03858387|Imipenem|imipenem|mesh-list
82916845|NCT03858387|Cilastatin|cilastatin|mesh-list
82916846|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82916847|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916848|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
82916849|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457389|NCT00947765|Prednisolone|prednisolone|mesh-list
82916850|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916851|NCT01289301|Cyclosporine|cyclosporine|mesh-list
82916852|NCT01289301|Sirolimus|sirolimus|mesh-list
82916853|NCT01289301|Everolimus|everolimus|mesh-list
82916854|NCT01289301|MTOR Inhibitors|mtor inhibitors|mesh-list
82916855|NCT01289301|Temsirolimus|temsirolimus|mesh-list
82916856|NCT01289301|Tacrolimus|tacrolimus|mesh-list
82916857|NCT01289301|Cyclosporins|cyclosporins|mesh-list
82916858|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82916859|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82916860|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
82916861|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916862|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916863|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916864|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
82916865|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916866|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
82916867|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916868|NCT01289301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82916869|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916870|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82916871|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82916872|NCT02524899|Guanfacine|guanfacine|mesh-list
82916873|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82916874|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82916875|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82916876|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82916877|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
82916878|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916879|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916880|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916881|NCT02524821|Metformin|metformin|mesh-list
82916882|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82916883|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916884|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
82916885|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82916886|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916887|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916888|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82916889|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82916890|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
82916891|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82916892|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82916893|NCT03854175|Estradiol|estradiol|mesh-list
82916894|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83482932|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82916895|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916896|NCT03854175|Estrogens|estrogens|mesh-ancestor
82916897|NCT03854175|Hormones|hormones|mesh-ancestor
82916898|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82916899|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916902|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82916903|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82916904|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
82916905|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82916906|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82916907|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916908|NCT03854175|Urological Agents|urological agents|mesh-ancestor
82916909|NCT01183611|Vaccines|vaccines|mesh-list
82916910|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
82916911|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916912|NCT01180569|Lenalidomide|lenalidomide|mesh-list
82916913|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
82916914|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916915|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82916916|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82916917|NCT01180569|Growth Substances|growth substances|mesh-ancestor
82916918|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
82916919|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916920|NCT02942264|Temozolomide|temozolomide|mesh-list
82916921|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82916922|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
82916923|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916924|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916925|NCT01180725|Psyllium|psyllium|mesh-list
82916926|NCT01180725|Cathartics|cathartics|mesh-ancestor
82916927|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82916928|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82916929|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
82916930|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916931|NCT01183767|Protective Agents|protective agents|mesh-ancestor
82916932|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916933|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82916934|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82916935|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916936|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82916937|NCT03853785|Podophyllin|podophyllin|mesh-list
82916938|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82916939|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916940|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
82916941|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
82916942|NCT01290471|U3-1565|u3-1565|mesh-list
82916943|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82916944|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916945|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
82916946|NCT01291563|Bedaquiline|bedaquiline|mesh-list
82916947|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
82916948|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82916949|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82916950|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82916951|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82916952|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82916953|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916954|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916955|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916956|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82916957|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
82916958|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82916959|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916960|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82916961|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82916962|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82916963|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
82916964|NCT01187589|Albuterol|albuterol|mesh-list
82916965|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82916966|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
82916967|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82916968|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916969|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82916970|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
82916971|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
82916972|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82916973|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82916974|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82916975|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82916976|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
82916977|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82916978|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916979|NCT01290549|Rituximab|rituximab|mesh-list
82916980|NCT01290549|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
82916981|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82916982|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916983|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
82916984|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916985|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82916986|NCT01290549|Immunoconjugates|immunoconjugates|mesh-ancestor
82916987|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
82916988|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
82916989|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82916990|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82916991|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82916992|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82916993|NCT04951947|Lenvatinib|lenvatinib|mesh-list
82916994|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82916995|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82916996|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82916997|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82916998|NCT01184391|Valproic Acid|valproic acid|mesh-list
82916999|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
82917000|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917001|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917002|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
82917003|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917004|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917005|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
82917006|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917007|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917008|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917009|NCT02524743|Acetaminophen|acetaminophen|mesh-list
82917010|NCT02524743|Lidocaine|lidocaine|mesh-list
82917011|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
82917012|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
82917013|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917014|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917015|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
82917016|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917017|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82917018|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82917019|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82917020|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82917021|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917022|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917023|NCT02524743|Analgesics|analgesics|mesh-ancestor
82917024|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
82917025|NCT01188057|Alprazolam|alprazolam|mesh-list
82917026|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82917027|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917028|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917029|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82917030|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917031|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917032|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
82917033|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
82917034|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917035|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917036|NCT01291641|Cilostazol|cilostazol|mesh-list
82917037|NCT01291641|Probucol|probucol|mesh-list
82917038|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82917039|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82917040|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
82917041|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917042|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917043|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82917044|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
82917045|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82917046|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83083948|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82917048|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82917049|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
82917050|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82917051|NCT01291641|Protective Agents|protective agents|mesh-ancestor
82917052|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82917053|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82917054|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917055|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82917056|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82917057|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
82917058|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82917059|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
82917060|NCT03855501|Calcium|calcium|mesh-list
82917061|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917062|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917063|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82917064|NCT01588587|Vildagliptin|vildagliptin|mesh-list
82917065|NCT01588587|Alogliptin|alogliptin|mesh-list
82917066|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82917067|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917068|NCT01588587|Incretins|incretins|mesh-ancestor
82917069|NCT01588587|Hormones|hormones|mesh-ancestor
83457396|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917070|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917071|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82917072|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
82917073|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917074|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917075|NCT03325712|Midazolam|midazolam|mesh-list
82917076|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82917077|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82917078|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917079|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917080|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82917081|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917082|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917083|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82917084|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
82917085|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
82917086|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
82917087|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
82917088|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917089|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917090|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82917091|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82917092|NCT01293747|Estradiol|estradiol|mesh-list
82917093|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82917094|NCT01293747|Progesterone|progesterone|mesh-list
82917095|NCT01293747|Estrogens|estrogens|mesh-ancestor
82917096|NCT01293747|Hormones|hormones|mesh-ancestor
82917097|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917098|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917099|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82917100|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
82917101|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82917102|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82917103|NCT01293747|Progestins|progestins|mesh-ancestor
82917104|NCT03849729|Phentermine|phentermine|mesh-list
82917105|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82917106|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917107|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
82917108|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82917109|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
82917110|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
82917111|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917112|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
82917113|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917114|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917115|NCT03325556|Pimavanserin|pimavanserin|mesh-list
82917116|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82917117|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82917118|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82917119|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917120|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917122|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917123|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82917124|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82917125|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
82917126|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917127|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917128|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
82917129|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917130|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82917131|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82917132|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917133|NCT03852303|Ivermectin|ivermectin|mesh-list
82917134|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
82917135|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82917136|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917137|NCT01291719|Insulin|insulin|mesh-list
82917138|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82917139|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917140|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
82917141|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82917142|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82917143|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917144|NCT03325166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82917145|NCT03325166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917146|NCT03325166|Hematinics|hematinics|mesh-ancestor
82917147|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82917148|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82917149|NCT03847623|Curcumin|curcumin|mesh-list
82917150|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82917151|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917152|NCT03847623|Analgesics|analgesics|mesh-ancestor
82917153|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
82917154|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917155|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917156|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917157|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82917158|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917159|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917160|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917161|NCT01294059|Milnacipran|milnacipran|mesh-list
82917162|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
82917163|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82917164|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82917165|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82917166|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917167|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917168|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917169|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917170|NCT01294059|Analgesics|analgesics|mesh-ancestor
82917171|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
82917172|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917173|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
82917174|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917175|NCT03847155|Nicotine|nicotine|mesh-list
82917176|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82917177|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
82917178|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917179|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917180|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82917181|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82917182|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
82917183|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917184|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917185|NCT01294215|Nifedipine|nifedipine|mesh-list
82917186|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82917187|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82917188|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917189|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917190|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917191|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
82917192|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
82917193|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82917194|NCT01296555|Letrozole|letrozole|mesh-list
82917195|NCT01296555|Fulvestrant|fulvestrant|mesh-list
82917196|NCT01296555|Midazolam|midazolam|mesh-list
82917197|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82917198|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82917199|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917200|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917201|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82917202|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917203|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917204|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82917205|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
82917206|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
82917207|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
82917208|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
82917209|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917210|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917211|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917212|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82917213|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82917214|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917215|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82917216|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
82917217|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917218|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82917219|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82917220|NCT01294293|Paclitaxel|paclitaxel|mesh-list
82917221|NCT01294293|Doxorubicin|doxorubicin|mesh-list
82917222|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82917223|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82917224|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917225|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
82917226|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
82917227|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
82917228|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917229|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82917230|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82917231|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82917232|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917233|NCT01294605|Edetic Acid|edetic acid|mesh-list
82917234|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
82917235|NCT01294605|Antidotes|antidotes|mesh-ancestor
82917236|NCT01294605|Protective Agents|protective agents|mesh-ancestor
82917237|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917238|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
82917239|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
82917240|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917241|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82917242|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
82917243|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82917244|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
82917245|NCT01294761|Darunavir|darunavir|mesh-list
82917246|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82917247|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82917248|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
82917249|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917250|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82917251|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82917252|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917253|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917254|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82917255|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82917256|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
82917257|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
82917258|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
82917259|NCT03305666|Bupivacaine|bupivacaine|mesh-list
82917260|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
82917261|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
82917262|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917263|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917264|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
82917265|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917266|NCT01194843|Ropivacaine|ropivacaine|mesh-list
82917267|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
82917268|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
82917269|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917270|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917271|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
82917272|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917273|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
82917274|NCT01297023|Vitamin D|vitamin d|mesh-list
82917275|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
82917276|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
82917277|NCT01297023|Vitamins|vitamins|mesh-list
82917278|NCT01297023|Calcium|calcium|mesh-list
82917279|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
82917280|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917281|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917282|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82917283|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
82917284|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82917285|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82917286|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
82917287|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917288|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917289|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82917290|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917291|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82917292|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917293|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917294|NCT04781426|Tenofovir|tenofovir|mesh-list
82917295|NCT04781426|Lamivudine|lamivudine|mesh-list
82917296|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
82917297|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917298|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82917299|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82917300|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917301|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917302|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82917303|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82917304|NCT01292031|Meropenem|meropenem|mesh-list
82917305|NCT01292031|Colistin|colistin|mesh-list
82917306|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82917307|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917308|NCT04633226|Vaccines|vaccines|mesh-list
82917309|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
82917310|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917311|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
82917312|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82917313|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
82917314|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
82917315|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917316|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917317|NCT01188759|Voriconazole|voriconazole|mesh-list
82917318|NCT01188759|Anidulafungin|anidulafungin|mesh-list
82917319|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
82917320|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917321|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82917322|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82917323|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917324|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917325|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82917326|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
82917327|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917328|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917329|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82917330|NCT03904550|Rocuronium|rocuronium|mesh-list
82917331|NCT03904550|Cisatracurium|cisatracurium|mesh-list
82917332|NCT03904550|Neostigmine|neostigmine|mesh-list
82917333|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82917334|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82917335|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82917336|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917337|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917338|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82917339|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917340|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917341|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
82917342|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917343|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82917344|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
82917346|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
82917347|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
82917348|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917349|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
82917350|NCT01292109|Cathartics|cathartics|mesh-ancestor
82917351|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82917352|NCT01191645|Remifentanil|remifentanil|mesh-list
82917353|NCT01191645|Metoclopramide|metoclopramide|mesh-list
82917354|NCT01191645|Naloxone|naloxone|mesh-list
82917355|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82917356|NCT01191645|Narcotics|narcotics|mesh-ancestor
82917357|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917358|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917359|NCT01191645|Analgesics|analgesics|mesh-ancestor
82917360|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
82917361|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917362|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82917363|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
82917364|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
82917365|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82917366|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82917367|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82917368|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
82917369|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917370|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917371|NCT03736785|Insulin|insulin|mesh-list
82917372|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82917373|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917374|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
82917375|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
82917376|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917377|NCT01295151|Adalimumab|adalimumab|mesh-list
82917378|NCT01295151|Infliximab|infliximab|mesh-list
82917379|NCT01295151|Golimumab|golimumab|mesh-list
82917380|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
82917381|NCT01295151|Etanercept|etanercept|mesh-list
82917382|NCT01295151|Rituximab|rituximab|mesh-list
82917383|NCT01295151|Abatacept|abatacept|mesh-list
82917384|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82917385|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917386|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
82917387|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917388|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82917389|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82917390|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917391|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
82917392|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82917393|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82917394|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917395|NCT01295151|Analgesics|analgesics|mesh-ancestor
82917396|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
82917397|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917398|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82917399|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82917400|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917401|NCT01295307|Clofarabine|clofarabine|mesh-list
82917402|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82917403|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
82917404|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917405|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917406|NCT01292343|Listerine|listerine|mesh-list
82917407|NCT01292343|Triclosan|triclosan|mesh-list
82917408|NCT01292343|Fluorides|fluorides|mesh-list
82917409|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
82917410|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
82917411|NCT01292343|Protective Agents|protective agents|mesh-ancestor
82917412|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917413|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82917414|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917415|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82917416|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82917417|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
82917418|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917419|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82917420|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
82917421|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
82917422|NCT01192113|Vitamins|vitamins|mesh-ancestor
82917423|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
82917424|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917425|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
82917426|NCT05671029|Pritelivir|pritelivir|mesh-list
82917427|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82917428|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82917429|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917430|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82917431|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82917432|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917433|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917434|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917435|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82917436|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
82917437|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82917438|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917439|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82917440|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82917441|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82917442|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
82917443|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82917444|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
82917445|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917446|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82917447|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
82917448|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917449|NCT01192503|Rasagiline|rasagiline|mesh-list
82917450|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82917451|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917452|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917453|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82917454|NCT01192503|Protective Agents|protective agents|mesh-ancestor
82917455|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917456|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82917457|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
82917458|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
82917459|NCT03851289|Calcium|calcium|mesh-list
82917460|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917461|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917462|NCT03733899|Anesthetics|anesthetics|mesh-list
82917463|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917464|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917465|NCT01196013|Clofarabine|clofarabine|mesh-list
82917466|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82917467|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
82917468|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917469|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917470|NCT01196169|Vancomycin|vancomycin|mesh-list
82917471|NCT01196169|Daptomycin|daptomycin|mesh-list
82917472|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82917473|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917474|NCT01196481|Carvedilol|carvedilol|mesh-list
82917475|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82917476|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82917477|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
82917478|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917479|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917480|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917481|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82917482|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
82917483|NCT01196481|Protective Agents|protective agents|mesh-ancestor
82917484|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82917485|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82917486|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917487|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
82917488|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82917489|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82917490|NCT05283057|Empagliflozin|empagliflozin|mesh-list
82917491|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82917492|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917493|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82917494|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917495|NCT01193595|Bevacizumab|bevacizumab|mesh-list
82917496|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82917497|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917498|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82917499|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82917500|NCT01193595|Growth Substances|growth substances|mesh-ancestor
82917501|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917502|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
82917504|NCT01196559|Vinorelbine|vinorelbine|mesh-list
82917505|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82917506|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
82917507|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917508|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917509|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82917510|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
82917511|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
82917512|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
82917513|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
82917514|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
82917515|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82917516|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
82917517|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917518|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82917519|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82917520|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82917521|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82917522|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917523|NCT01581177|Albuterol|albuterol|mesh-list
82917524|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82917525|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
82917526|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917527|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917528|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82917529|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
82917530|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
82917531|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82917532|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82917533|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82917534|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82917535|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
82917536|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917537|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917538|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
82917539|NCT01580007|Vitamin D|vitamin d|mesh-list
82917540|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
82917541|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917542|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917543|NCT01580007|Vitamins|vitamins|mesh-ancestor
82917544|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
82917545|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82917546|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917547|NCT01189695|Ritonavir|ritonavir|mesh-list
82917548|NCT01189695|Lopinavir|lopinavir|mesh-list
82917549|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82917550|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82917551|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
82917552|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917553|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917554|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82917555|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82917556|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
82917557|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917558|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82917559|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82917560|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
82917561|NCT01196715|Hematinics|hematinics|mesh-ancestor
82917562|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82917563|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917564|NCT01189773|Ibuprofen|ibuprofen|mesh-list
82917565|NCT01189773|Codeine|codeine|mesh-list
82917566|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82917567|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917568|NCT01189773|Analgesics|analgesics|mesh-ancestor
82917569|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
82917570|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917572|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917573|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82917574|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82917575|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917576|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917577|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82917578|NCT01189773|Narcotics|narcotics|mesh-ancestor
82917579|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917580|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
82917581|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
82917582|NCT01189929|Gemcitabine|gemcitabine|mesh-list
82917583|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82917584|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82917585|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
82917586|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917587|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917589|NCT03845673|Cathartics|cathartics|mesh-ancestor
82917590|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82917591|NCT01190163|Oxytocin|oxytocin|mesh-list
82917592|NCT01190163|Dinoprostone|dinoprostone|mesh-list
82917593|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
82917594|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82917595|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917596|NCT01199445|Vitamin A|vitamin a|mesh-list
82917597|NCT01199445|Vitamins|vitamins|mesh-ancestor
82917598|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
82917599|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917600|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
82917601|NCT01199523|Mirabegron|mirabegron|mesh-list
82917602|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82917603|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917604|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82917605|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82917606|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917607|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917608|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917609|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917610|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82917611|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82917612|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82917613|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
82917614|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917615|NCT01199523|Urological Agents|urological agents|mesh-ancestor
82917616|NCT01190241|Everolimus|everolimus|mesh-list
82917617|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82917618|NCT01190241|Sorafenib|sorafenib|mesh-list
82917619|NCT01190241|Sunitinib|sunitinib|mesh-list
82917620|NCT01190241|Lapatinib|lapatinib|mesh-list
82917621|NCT01190241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82917622|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82917623|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917624|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917625|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82917626|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
82917627|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917628|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917629|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82917630|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82917631|NCT01190241|Growth Substances|growth substances|mesh-ancestor
82917632|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
82917633|NCT01197261|Oxycodone|oxycodone|mesh-list
82917634|NCT01197261|Naloxone|naloxone|mesh-list
82917635|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82917636|NCT01197261|Narcotics|narcotics|mesh-ancestor
82917637|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917638|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917639|NCT01197261|Analgesics|analgesics|mesh-ancestor
82917640|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
82917641|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917642|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82917643|NCT01190553|Amantadine|amantadine|mesh-list
82917644|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82917645|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82917646|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
82917647|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917649|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917650|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917651|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917652|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917653|NCT01190553|Analgesics|analgesics|mesh-ancestor
82917654|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
83482933|NCT00493064|Protective Agents|protective agents|mesh-ancestor
82917655|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917656|NCT01199757|Fluticasone|fluticasone|mesh-list
82917657|NCT01199757|Xhance|xhance|mesh-list
82917658|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
82917659|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917660|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82917661|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
82917662|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917663|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917664|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82917665|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
82917666|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
82917667|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82917668|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
82917669|NCT03302234|Ipilimumab|ipilimumab|mesh-list
82917670|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82917671|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917672|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82917673|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917674|NCT03843879|Lidocaine|lidocaine|mesh-list
82917675|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
82917676|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
82917677|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917678|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917679|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
82917680|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917681|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82917682|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82917683|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82917684|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82917685|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917686|NCT03850587|Celecoxib|celecoxib|mesh-list
82917687|NCT03850587|Tramadol|tramadol|mesh-list
82917688|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82917689|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917690|NCT03850587|Analgesics|analgesics|mesh-ancestor
82917691|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
82917692|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917693|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917694|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917695|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82917696|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82917697|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82917698|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917699|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917700|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82917701|NCT03850587|Narcotics|narcotics|mesh-ancestor
82917702|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917703|NCT01199835|Calcium|calcium|mesh-list
82917704|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917705|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917706|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
82917707|NCT05671497|Cilostazol|cilostazol|mesh-list
82917708|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82917709|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
82917710|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917711|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917712|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82917713|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
82917714|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82917715|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82917716|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917717|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82917718|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
82917719|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82917720|NCT05671497|Protective Agents|protective agents|mesh-ancestor
82917721|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82917722|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82917723|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917724|NCT03915626|Rivastigmine|rivastigmine|mesh-list
82917725|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82917726|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917727|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917728|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
82917729|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917730|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917731|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82917732|NCT03915626|Protective Agents|protective agents|mesh-ancestor
82917733|NCT04491968|Methadone|methadone|mesh-list
82917734|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82917735|NCT04491968|Narcotics|narcotics|mesh-ancestor
82917736|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917737|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917738|NCT04491968|Analgesics|analgesics|mesh-ancestor
82917739|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
82917740|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917741|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
82917742|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
82917743|NCT05668455|Dexamethasone|dexamethasone|mesh-list
82917744|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
82917745|NCT05668455|Povidone|povidone|mesh-list
82917746|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917747|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
82917748|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
82917749|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917750|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917751|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82917752|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
82917753|NCT05668455|Hormones|hormones|mesh-ancestor
82917754|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917755|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82917756|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917757|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
82917758|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
82917759|NCT03313076|Vitamin D|vitamin d|mesh-list
82917760|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
82917761|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
82917762|NCT03313076|Vitamins|vitamins|mesh-list
82917763|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
82917764|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917765|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82917766|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82917767|NCT01191021|Propofol|propofol|mesh-list
82917768|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
82917769|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917770|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917771|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82917772|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82917773|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
82917774|NCT01200537|Norinyl|norinyl|mesh-list
82917775|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
82917776|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
82917777|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82917778|NCT01200537|Estradiol|estradiol|mesh-list
82917779|NCT01200537|Estrogens|estrogens|mesh-ancestor
82917780|NCT01200537|Hormones|hormones|mesh-ancestor
82917781|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917782|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917783|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82917784|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82917785|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82917786|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82917787|NCT01198353|Ziprasidone|ziprasidone|mesh-list
82917788|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82917789|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
82917790|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917791|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917792|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917793|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82917794|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917795|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917796|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917798|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
82917799|NCT01200693|Sirolimus|sirolimus|mesh-list
82917800|NCT01200693|Everolimus|everolimus|mesh-list
82917801|NCT01200693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82917802|NCT01200693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82917803|NCT01200693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917804|NCT01200693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917805|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82917806|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
82917807|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917808|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917809|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82917810|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917811|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82917812|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
82917813|NCT03844581|Propiverine|propiverine|mesh-list
82917814|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
82917815|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
82917816|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917817|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917818|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82917819|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82917820|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
82917821|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917822|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917823|NCT03844581|Urological Agents|urological agents|mesh-ancestor
82917824|NCT01202097|Fluticasone|fluticasone|mesh-list
82917825|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82917826|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82917827|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917828|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82917829|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
82917830|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917831|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917832|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82917833|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
82917834|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
82917835|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82917836|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82917837|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82917838|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82917839|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
82917840|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917841|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917842|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
82917843|NCT01202097|Hormones|hormones|mesh-ancestor
82917844|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917845|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
82917846|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82917847|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82917848|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
82917849|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
82917850|NCT01201005|Hematinics|hematinics|mesh-ancestor
82917851|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
82917852|NCT01201005|Vitamins|vitamins|mesh-ancestor
82917853|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
82917854|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917855|NCT01198665|Prednisolone|prednisolone|mesh-list
82917856|NCT01198665|Doxorubicin|doxorubicin|mesh-list
82917857|NCT01198665|Vincristine|vincristine|mesh-list
82917858|NCT01198665|Everolimus|everolimus|mesh-list
82917859|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82917860|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917861|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82917862|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82917863|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917864|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917865|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82917866|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
82917867|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
82917868|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
82917869|NCT01198665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82917870|NCT01198665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82917871|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82917872|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
82917873|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917874|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917875|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
82917876|NCT01198665|Hormones|hormones|mesh-ancestor
82917877|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917878|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82917879|NCT05030415|Ixekizumab|ixekizumab|mesh-list
82917880|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
82917881|NCT01198821|Gemcitabine|gemcitabine|mesh-list
82917882|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82917883|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
82917884|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917885|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917886|NCT05013801|Hydroquinone|hydroquinone|mesh-list
82917887|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
82917888|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917889|NCT05013801|Protective Agents|protective agents|mesh-ancestor
82917890|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917891|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82917893|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82917894|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82917895|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917896|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917897|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82917898|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82917899|NCT01566669|Analgesics|analgesics|mesh-ancestor
82917900|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
82917901|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917902|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917903|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82917904|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82917905|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
82917906|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82917907|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
82917908|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917909|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82917910|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917911|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82917912|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917913|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917914|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917915|NCT01201161|Ranibizumab|ranibizumab|mesh-list
82917916|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82917917|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82917918|NCT01201161|Growth Substances|growth substances|mesh-ancestor
82917919|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917920|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
82917921|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917922|NCT03841383|Dipyridamole|dipyridamole|mesh-list
82917923|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82917924|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917925|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917926|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82917927|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
82917928|NCT05667987|Lidocaine|lidocaine|mesh-list
82917929|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
82917930|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
82917931|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917932|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917933|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
82917934|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917935|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82917936|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82917937|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82917938|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82917939|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917940|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
82917941|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82917942|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82917943|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
82917944|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917945|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82917947|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917948|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917950|NCT01199367|Lapatinib|lapatinib|mesh-list
82917951|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82917952|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82917953|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82917954|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482934|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82917955|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917956|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82917957|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
82917958|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82917959|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917960|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82917961|NCT01203735|Valproic Acid|valproic acid|mesh-list
82917962|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
82917963|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917964|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917965|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
82917966|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917967|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917968|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
82917969|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82917970|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82917971|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82917972|NCT03842631|Timolol|timolol|mesh-list
82917973|NCT03842631|Maleic acid|maleic acid|mesh-list
82917974|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82917975|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917976|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82917977|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82917978|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
82917979|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917980|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917981|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82917982|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82917983|NCT05669781|Metoclopramide|metoclopramide|mesh-list
82917984|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
82917985|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
82917986|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82917987|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82917988|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82917989|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82917990|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82917991|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
82917992|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82917993|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82917994|NCT01202331|Azithromycin|azithromycin|mesh-list
82917995|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82917996|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82917997|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82917998|NCT01201551|Latanoprost|latanoprost|mesh-list
82917999|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82918000|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82918001|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82918002|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82918003|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82918004|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82918005|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918006|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918007|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918008|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918009|NCT01204125|Paclitaxel|paclitaxel|mesh-list
82918010|NCT01204125|Iniparib|iniparib|mesh-list
82918011|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918012|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918013|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918014|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918015|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918016|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918017|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82918018|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918019|NCT03074240|Anesthetics|anesthetics|mesh-list
82918020|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
82918021|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918022|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918023|NCT03725085|Guaifenesin|guaifenesin|mesh-list
82918024|NCT03725085|Expectorants|expectorants|mesh-ancestor
82918025|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
82918026|NCT03755804|Prednisone|prednisone|mesh-list
82918027|NCT03755804|Prednisolone|prednisolone|mesh-list
82918028|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
82918029|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82918030|NCT03755804|Dacarbazine|dacarbazine|mesh-list
82918031|NCT03755804|Doxorubicin|doxorubicin|mesh-list
82918032|NCT03755804|Etoposide|etoposide|mesh-list
82918033|NCT03755804|Vincristine|vincristine|mesh-list
82918034|NCT03755804|Bleomycin|bleomycin|mesh-list
82918035|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82918036|NCT03755804|Vinblastine|vinblastine|mesh-list
82918037|NCT03755804|Imidazole|imidazole|mesh-list
82918038|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82918039|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
82918040|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918041|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82918042|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82918043|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
82918044|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918045|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918046|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82918047|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82918048|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82918049|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82918050|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918051|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82918052|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
82918053|NCT03755804|Hormones|hormones|mesh-ancestor
82918054|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82918055|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82918056|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918057|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918058|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918059|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918060|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918061|NCT03755804|Immunotoxins|immunotoxins|mesh-ancestor
82918062|NCT03755804|Immunoconjugates|immunoconjugates|mesh-ancestor
82918063|NCT01566825|Amitriptyline|amitriptyline|mesh-list
82918064|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82918065|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
82918066|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82918067|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82918068|NCT01566825|Analgesics|analgesics|mesh-ancestor
82918069|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
82918070|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918071|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918072|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82918073|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82918074|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82918075|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918076|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918077|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918078|NCT03559010|Norgestrel|norgestrel|mesh-list
82918079|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82918080|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82918081|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82918082|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
82918083|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82918084|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918085|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82918086|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82918087|NCT03298412|Blinatumomab|blinatumomab|mesh-list
82918088|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918089|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
82918090|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
82918091|NCT03297398|Androgens|androgens|mesh-list
82918092|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82918093|NCT03297398|Hormones|hormones|mesh-ancestor
82918094|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083949|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
82918095|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918097|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918098|NCT03297398|Protective Agents|protective agents|mesh-ancestor
82918099|NCT03297398|Vitamins|vitamins|mesh-ancestor
82918100|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
82918101|NCT03297398|Estrogens|estrogens|mesh-ancestor
82918102|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82918103|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918104|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
82918105|NCT03293654|Bevacizumab|bevacizumab|mesh-list
82918106|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918107|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918108|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82918109|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82918110|NCT03293654|Growth Substances|growth substances|mesh-ancestor
82918111|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918112|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
82918113|NCT03930615|Letermovir|letermovir|mesh-list
82918114|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82918115|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918116|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918117|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918118|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
82918119|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918120|NCT03838029|Etodolac|etodolac|mesh-list
82918121|NCT03838029|Propranolol|propranolol|mesh-list
82918122|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82918123|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82918124|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918125|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918126|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918127|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918128|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82918129|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82918130|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
82918131|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82918132|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82918133|NCT03838029|Analgesics|analgesics|mesh-ancestor
82918134|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
82918135|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918136|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82918137|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82918138|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82918139|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82918140|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918141|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
82918142|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82918143|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
82918144|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918145|NCT04708340|Protective Agents|protective agents|mesh-ancestor
82918146|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918147|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
82918148|NCT03292640|Tazarotene|tazarotene|mesh-list
82918149|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
82918150|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
82918151|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
82918152|NCT03292640|Vitamins|vitamins|mesh-ancestor
82918153|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
82918154|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918155|NCT01567215|Ethanol|ethanol|mesh-list
82918156|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
82918157|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82918158|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918159|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918160|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918161|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
82918162|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82918163|NCT01202487|Lidocaine|lidocaine|mesh-list
82918164|NCT01202487|Epinephrine|epinephrine|mesh-list
82918165|NCT01202487|Tetracaine|tetracaine|mesh-list
82918166|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
82918167|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
82918168|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918169|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918171|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918172|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82918173|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82918174|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82918175|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82918176|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918177|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82918178|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82918179|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918180|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918181|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82918182|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82918183|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
82918184|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82918185|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
82918186|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
82918187|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
82918188|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82918189|NCT01204437|Paclitaxel|paclitaxel|mesh-list
82918190|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
82918191|NCT01204437|Capecitabine|capecitabine|mesh-list
82918192|NCT01204437|Methotrexate|methotrexate|mesh-list
82918193|NCT01204437|Epirubicin|epirubicin|mesh-list
82918194|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918195|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918196|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918197|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918198|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918199|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918200|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82918201|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
82918202|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918203|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82918204|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82918205|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
82918206|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82918207|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82918208|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
82918209|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82918210|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
82918211|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82918212|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
82918213|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918214|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82918215|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82918216|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82918217|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82918218|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82918219|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
82918220|NCT02633241|Propofol|propofol|mesh-list
82918221|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82918222|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918223|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918224|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82918225|NCT02633241|Analgesics|analgesics|mesh-ancestor
82918226|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
82918227|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918228|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82918229|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82918230|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82918231|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918232|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918233|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918234|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918235|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
82918236|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
82918237|NCT03292016|Apomorphine|apomorphine|mesh-list
82918238|NCT03292016|Emetics|emetics|mesh-ancestor
82918239|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918240|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
82918241|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918243|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
82918244|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
82918245|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918246|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918247|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
82918248|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82918249|NCT01206075|Plerixafor|plerixafor|mesh-list
82918250|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82918251|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82918252|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
82918253|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918254|NCT03289676|Nicotine|nicotine|mesh-list
82918255|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82918256|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
82918257|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918258|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918260|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82918261|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
82918262|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918263|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918264|NCT03834831|Selenium|selenium|mesh-list
82918265|NCT03834831|Ubiquinone|ubiquinone|mesh-list
82918266|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
82918267|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
82918268|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918269|NCT03834831|Protective Agents|protective agents|mesh-ancestor
82918270|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918271|NCT03834831|Trace Elements|trace elements|mesh-ancestor
82918272|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
82918273|NCT03834831|Vitamins|vitamins|mesh-ancestor
82918274|NCT01206153|Metformin|metformin|mesh-list
82918275|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82918276|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918277|NCT01298271|Propranolol|propranolol|mesh-list
82918278|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82918279|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82918280|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918281|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918282|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918283|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918284|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82918285|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82918286|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
82918287|NCT05281965|Tretinoin|tretinoin|mesh-list
82918288|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918289|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
82918290|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
82918291|NCT04251884|Ropivacaine|ropivacaine|mesh-list
82918292|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
82918293|NCT04251884|Anesthetics|anesthetics|mesh-list
82918294|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918295|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918296|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
82918297|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918298|NCT01202799|Diclofenac|diclofenac|mesh-list
82918299|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82918300|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82918301|NCT01202799|Analgesics|analgesics|mesh-ancestor
82918302|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
82918303|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918304|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918305|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82918306|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82918307|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82918308|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918309|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918310|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
82918311|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
82918312|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918313|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918314|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918315|NCT01298505|Fexofenadine|fexofenadine|mesh-list
82918316|NCT01298505|Terfenadine|terfenadine|mesh-list
82918317|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82918319|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82918320|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
82918322|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918323|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918324|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918325|NCT01204593|Insulin|insulin|mesh-list
82918326|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82918327|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
82918328|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
82918329|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82918330|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918331|NCT03310970|Lidocaine|lidocaine|mesh-list
82918332|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
82918333|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
82918334|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918336|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
82918337|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918338|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82918339|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82918340|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82918341|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82918342|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918343|NCT03427814|Pamiparib|pamiparib|mesh-list
82918344|NCT03427814|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82918345|NCT03427814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918346|NCT03427814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918347|NCT03427814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918348|NCT05281419|Triamcinolone|triamcinolone|mesh-list
82918349|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82918350|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82918351|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82918352|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82918353|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
82918354|NCT05281419|Hormones|hormones|mesh-ancestor
82918355|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82918356|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918357|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82918358|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
82918359|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918360|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918361|NCT04427072|Docetaxel|docetaxel|mesh-list
82918362|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918363|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918364|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918365|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918366|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918367|NCT03537651|Ivacaftor|ivacaftor|mesh-list
82918368|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82918369|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82918370|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918371|NCT01203111|Insulin|insulin|mesh-list
82918372|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82918373|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
82918374|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
82918375|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82918376|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918377|NCT02722941|Panobinostat|panobinostat|mesh-list
82918378|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918379|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82918380|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918381|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918382|NCT03420339|Adderall|adderall|mesh-list
82918383|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82918384|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918385|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
82918386|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82918387|NCT01297179|Mirabegron|mirabegron|mesh-list
82918388|NCT01297179|Estradiol|estradiol|mesh-list
82918389|NCT01297179|Estrogens|estrogens|mesh-ancestor
82918390|NCT01297179|Hormones|hormones|mesh-ancestor
82918391|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82918392|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918393|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82918395|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82918396|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82918397|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82918398|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82918399|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82918400|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82918401|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82918402|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82918403|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918404|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918405|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918406|NCT01297179|Urological Agents|urological agents|mesh-ancestor
82918407|NCT01205139|Simeprevir|simeprevir|mesh-list
82918408|NCT01205139|Rilpivirine|rilpivirine|mesh-list
82918409|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
82918410|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918411|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
82918412|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918413|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918414|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82918415|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82918416|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82918417|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82918418|NCT01205217|Paclitaxel|paclitaxel|mesh-list
82918419|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
82918420|NCT01205217|Trastuzumab|trastuzumab|mesh-list
82918421|NCT01205217|Epirubicin|epirubicin|mesh-list
82918422|NCT01205217|Lapatinib|lapatinib|mesh-list
82918423|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918424|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918425|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918426|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918427|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918428|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918429|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82918430|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
82918431|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918432|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82918433|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82918434|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
82918435|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82918436|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918437|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82918438|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82918439|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82918440|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918441|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82918442|NCT01203267|Paclitaxel|paclitaxel|mesh-list
82918443|NCT01203267|Carboplatin|carboplatin|mesh-list
82918444|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918445|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918446|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918447|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918448|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918449|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918450|NCT01207245|Tobramycin|tobramycin|mesh-list
82918451|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82918452|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918453|NCT01297569|Ranibizumab|ranibizumab|mesh-list
82918454|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82918455|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82918456|NCT01297569|Growth Substances|growth substances|mesh-ancestor
82918457|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918458|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
82918459|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918460|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82918461|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
82918462|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918463|NCT01299597|Atorvastatin|atorvastatin|mesh-list
82918464|NCT01299597|Simvastatin|simvastatin|mesh-list
82918465|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82918467|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
82918468|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918469|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82918470|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82918471|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918472|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
82918473|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918474|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918475|NCT03723915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83457509|NCT04355039|Growth Substances|growth substances|mesh-ancestor
82918476|NCT03723915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918477|NCT03840057|Azithromycin|azithromycin|mesh-list
82918478|NCT03840057|Metoclopramide|metoclopramide|mesh-list
82918479|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82918480|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918481|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
82918482|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
82918483|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918484|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918485|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82918486|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82918487|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82918488|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
82918489|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918490|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918492|NCT01297803|Mitomycin|mitomycin|mesh-list
82918493|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82918494|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918495|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
82918496|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918497|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82918498|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918499|NCT03824691|Durvalumab|durvalumab|mesh-list
82918500|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918501|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918502|NCT01299831|Hormones|hormones|mesh-list
82918503|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82918504|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918505|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
82918506|NCT01205997|Fentanyl|fentanyl|mesh-list
82918507|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82918508|NCT01205997|Narcotics|narcotics|mesh-ancestor
82918509|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918510|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918511|NCT01205997|Analgesics|analgesics|mesh-ancestor
82918512|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
82918513|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918514|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82918515|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918516|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
82918517|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
82918518|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82918519|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
82918520|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82918521|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82918522|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918523|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82918524|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
82918525|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82918526|NCT03818997|Paclitaxel|paclitaxel|mesh-list
82918527|NCT03818997|Atezolizumab|atezolizumab|mesh-list
82918528|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918529|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918530|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918531|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918532|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918533|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918534|NCT03818997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82918535|NCT03818997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918536|NCT03818919|Acetaminophen|acetaminophen|mesh-list
82918537|NCT03818919|Celecoxib|celecoxib|mesh-list
82918538|NCT03818919|Ketorolac|ketorolac|mesh-list
82918540|NCT03818919|Diazepam|diazepam|mesh-list
82918541|NCT03818919|Gabapentin|gabapentin|mesh-list
82918542|NCT03818919|Hydrocodone|hydrocodone|mesh-list
82918543|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82918544|NCT03818919|Analgesics|analgesics|mesh-ancestor
82918545|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
82918546|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918547|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918548|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
82918549|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82918550|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82918551|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82918552|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82918553|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82918554|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918555|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918556|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
82918557|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82918558|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82918559|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918560|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82918561|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82918562|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82918563|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918564|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
82918565|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82918567|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
82918568|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
82918569|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82918570|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
82918571|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
82918572|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82918573|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82918574|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82918575|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82918576|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918577|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
82918578|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
82918579|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
82918580|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
82918581|NCT03821493|Itraconazole|itraconazole|mesh-list
82918582|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82918583|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
82918584|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918585|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82918586|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82918587|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918588|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918589|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82918590|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
82918591|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82918592|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918593|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82918594|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
82918595|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82918596|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82918597|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918598|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
82918599|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82918600|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918601|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82918602|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918603|NCT03814629|Vitamins|vitamins|mesh-list
82918604|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
82918605|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918606|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82918607|NCT01585935|SMOFlipid|smoflipid|mesh-list
82918608|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82918609|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82918610|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82918611|NCT01300377|Lidocaine|lidocaine|mesh-list
82918612|NCT01300377|Bupivacaine|bupivacaine|mesh-list
82918613|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
82918614|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
82918615|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918616|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918617|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
82918618|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918619|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82918620|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82918621|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82918622|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82918623|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918624|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
82918625|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82918626|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
82918627|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918628|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
82918629|NCT03814707|Protective Agents|protective agents|mesh-ancestor
82918630|NCT03818295|Praliciguat|praliciguat|mesh-list
82918631|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82918632|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
82918633|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918634|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82918635|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
82918636|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82918637|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
82918639|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82918640|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
82918641|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82918642|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82918643|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918644|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918645|NCT01301313|Protective Agents|protective agents|mesh-ancestor
82918646|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918647|NCT03817359|Remifentanil|remifentanil|mesh-list
82918648|NCT03817359|Propofol|propofol|mesh-list
82918649|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82918650|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918651|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918652|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918653|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
82918654|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
82918655|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82918656|NCT03817359|Narcotics|narcotics|mesh-ancestor
82918657|NCT03817359|Analgesics|analgesics|mesh-ancestor
82918658|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
82918659|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918660|NCT03813927|Vitamin D|vitamin d|mesh-list
82918661|NCT03813927|Vitamins|vitamins|mesh-ancestor
82918662|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
82918663|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918664|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82918665|NCT02819518|Paclitaxel|paclitaxel|mesh-list
82918666|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82918667|NCT02819518|Carboplatin|carboplatin|mesh-list
82918668|NCT02819518|Gemcitabine|gemcitabine|mesh-list
82918669|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
82918670|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918671|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918672|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918673|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918674|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918675|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918676|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82918677|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
82918678|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918679|NCT02819518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82918680|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82918681|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82918682|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
82918683|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
82918684|NCT03813771|Etanercept|etanercept|mesh-list
82918685|NCT03813771|Methotrexate|methotrexate|mesh-list
82918686|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82918687|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
82918688|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82918689|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918690|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82918692|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83457524|NCT03393208|Metformin|metformin|mesh-list
82918693|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918694|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
82918695|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918696|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82918697|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82918698|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
82918699|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82918700|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82918701|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
82918702|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82918703|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82918704|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918705|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82918706|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82918707|NCT03813771|Analgesics|analgesics|mesh-ancestor
82918708|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
82918709|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918710|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82918711|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82918712|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
82918713|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82918714|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82918715|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918716|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
82918717|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
82918718|NCT02036242|Sufentanil|sufentanil|mesh-list
82918719|NCT02036242|Ropivacaine|ropivacaine|mesh-list
82918720|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
82918721|NCT02036242|Anesthetics|anesthetics|mesh-list
82918722|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918723|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918724|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
82918725|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918726|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82918727|NCT02036242|Narcotics|narcotics|mesh-ancestor
82918728|NCT02036242|Analgesics|analgesics|mesh-ancestor
82918729|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82918730|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918731|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
82918732|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
82918733|NCT05281107|Vitamin D|vitamin d|mesh-list
82918734|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
82918735|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
82918736|NCT05281107|Vitamins|vitamins|mesh-list
82918737|NCT05281107|Calcium|calcium|mesh-list
82918738|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
82918739|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918740|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82918741|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82918742|NCT02812186|Rocuronium|rocuronium|mesh-list
83457542|NCT03587428|Zinc|zinc|mesh-list
82918743|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82918744|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82918745|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82918746|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918747|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918748|NCT03310268|Listerine|listerine|mesh-list
82918749|NCT03310268|Fluorides|fluorides|mesh-list
82918750|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
82918751|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
82918752|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
82918753|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
82918754|NCT03310268|Protective Agents|protective agents|mesh-ancestor
82918755|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918756|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82918757|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918758|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82918759|NCT02810392|Insulin|insulin|mesh-list
82918760|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82918761|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82918762|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918763|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
82918764|NCT03805035|Maleic acid|maleic acid|mesh-list
82918765|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
82918766|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82918767|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
82918768|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918769|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918770|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
82918771|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918772|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918773|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
82918774|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
82918775|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82918776|NCT02815540|Cannabidiol|cannabidiol|mesh-list
82918777|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
82918778|NCT03816267|Albuterol|albuterol|mesh-list
82918779|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82918780|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
82918781|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918782|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918783|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82918784|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
82918785|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
82918786|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82918787|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82918788|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82918789|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82918790|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918791|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918792|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918793|NCT03280550|Omalizumab|omalizumab|mesh-list
82918794|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82918795|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82918796|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
82918797|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
82918798|NCT02036554|Everolimus|everolimus|mesh-list
82918799|NCT02036554|Tacrolimus|tacrolimus|mesh-list
82918800|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82918801|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
82918802|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918803|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82918804|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918805|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918806|NCT02036554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82918807|NCT02036554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82918808|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918809|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82918810|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82918811|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
82918812|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82918813|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918814|NCT05577117|Fentanyl|fentanyl|mesh-list
82918815|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
82918816|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82918817|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918818|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918819|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82918820|NCT05577117|Analgesics|analgesics|mesh-ancestor
82918821|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
82918822|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918823|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82918824|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82918825|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82918826|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
82918827|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918828|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918829|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82918830|NCT05577117|Narcotics|narcotics|mesh-ancestor
82918831|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82918832|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918833|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
82918834|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
82918835|NCT03813303|Fentanyl|fentanyl|mesh-list
82918836|NCT03813303|Midazolam|midazolam|mesh-list
82918837|NCT03813303|Propofol|propofol|mesh-list
82918838|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82918839|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918840|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918841|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918842|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
82918843|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
82918845|NCT03813303|Narcotics|narcotics|mesh-ancestor
82918846|NCT03813303|Analgesics|analgesics|mesh-ancestor
82918847|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
82918848|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918849|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82918850|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82918851|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82918852|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82918853|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
82918854|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
82918855|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918856|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918857|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82918858|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82918859|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918860|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82918861|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918862|NCT03637790|Rifampin|rifampin|mesh-list
82918863|NCT03637790|Abrocitinib|abrocitinib|mesh-list
82918864|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82918865|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
82918866|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82918867|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82918868|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
82918869|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82918870|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918871|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918872|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82918873|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82918874|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82918875|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82918876|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82918877|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82918878|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82918879|NCT03813069|Permethrin|permethrin|mesh-list
82918880|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918881|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918882|NCT03276026|Neostigmine|neostigmine|mesh-list
82918883|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82918884|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918885|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918886|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
82918887|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918888|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918889|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82918890|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
82918891|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918892|NCT01303497|Paclitaxel|paclitaxel|mesh-list
82918893|NCT01303497|Bevacizumab|bevacizumab|mesh-list
82918894|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82918895|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918896|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
82918897|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
82918898|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
82918899|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918900|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918901|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82918902|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82918903|NCT01303497|Growth Substances|growth substances|mesh-ancestor
82918904|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918905|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
82918906|NCT01589523|Cholic Acids|cholic acids|mesh-list
82918907|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
82918908|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82918909|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82918910|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
82918911|NCT03804177|Melatonin|melatonin|mesh-list
82918912|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
82918913|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
83457607|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82918914|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918915|NCT03804177|Protective Agents|protective agents|mesh-ancestor
82918916|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918917|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918918|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82918919|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
82918920|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
82918922|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
82918923|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
82918924|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82918925|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82918926|NCT03277352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82918927|NCT03277352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918928|NCT01302093|Racecadotril|racecadotril|mesh-list
82918929|NCT01302093|Thiorphan|thiorphan|mesh-list
82918930|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
82918931|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82918932|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
82918933|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82918934|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918935|NCT03803007|Glenzocimab|glenzocimab|mesh-list
82918936|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
82918937|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
82918938|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82918939|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
82918940|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82918941|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918942|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82918943|NCT02047552|Iron|iron|mesh-list
82918944|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82918945|NCT02047552|Oxandrolone|oxandrolone|mesh-list
82918946|NCT02047552|Trace Elements|trace elements|mesh-ancestor
82918947|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
82918948|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918949|NCT02047552|Hematinics|hematinics|mesh-ancestor
82918950|NCT02047552|Androgens|androgens|mesh-ancestor
82918951|NCT02047552|Hormones|hormones|mesh-ancestor
82918952|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82918953|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
82918954|NCT01303731|Fentanyl|fentanyl|mesh-list
82918955|NCT01303731|Bupivacaine|bupivacaine|mesh-list
82918956|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
82918957|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
82918958|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918959|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918960|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
82918961|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82918962|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82918963|NCT01303731|Narcotics|narcotics|mesh-ancestor
82918964|NCT01303731|Analgesics|analgesics|mesh-ancestor
82918965|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82918966|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82918967|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
82918968|NCT03815487|Insulin|insulin|mesh-list
82918969|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82918970|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82918971|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918972|NCT03815422|Anesthetics|anesthetics|mesh-list
82918973|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82918974|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918975|NCT02260024|Pramipexole|pramipexole|mesh-list
82918976|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
82918977|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918978|NCT02260024|Protective Agents|protective agents|mesh-ancestor
82918979|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918980|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82918981|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82918982|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
82918983|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
82918984|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82918985|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
82918986|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
82918987|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82918988|NCT03800667|Protective Agents|protective agents|mesh-ancestor
82918989|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918990|NCT03800667|Vitamins|vitamins|mesh-ancestor
82918991|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
82918992|NCT01302171|Lenograstim|lenograstim|mesh-list
82918993|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82918994|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
82918995|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82918996|NCT02047630|Latanoprost|latanoprost|mesh-list
82918997|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82918998|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82918999|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82919000|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82919001|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
82919002|NCT03799809|Voriconazole|voriconazole|mesh-list
82919003|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
82919004|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919005|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82919006|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82919007|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919008|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919009|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82919010|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
82919011|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919012|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919013|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82919014|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82919015|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82919016|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82919017|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82919018|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919019|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919020|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919021|NCT03812523|Analgesics|analgesics|mesh-ancestor
82919022|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
82919023|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919024|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
82919025|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82919026|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
82919027|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
82919028|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82919029|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82919030|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
82919031|NCT02049970|Bupivacaine|bupivacaine|mesh-list
82919032|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919033|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
82919034|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919035|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919036|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
82919037|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919038|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82919039|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82919040|NCT02049970|Analgesics|analgesics|mesh-ancestor
82919041|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82919042|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82919043|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82919044|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
82919045|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919046|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919048|NCT02048020|Carboplatin|carboplatin|mesh-list
82919049|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82919050|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919051|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
82919052|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
82919053|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
82919054|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919055|NCT03562390|Irinotecan|irinotecan|mesh-list
82919056|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82919057|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82919058|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919059|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919060|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919061|NCT02048098|Misoprostol|misoprostol|mesh-list
82919062|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82919063|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
82919064|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82919065|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919066|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82919067|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919068|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
82919069|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
82919070|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
82919071|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82919072|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82919073|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919074|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919075|NCT02050360|Urological Agents|urological agents|mesh-ancestor
82919076|NCT02940860|Iron|iron|mesh-list
82919077|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82919078|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82919079|NCT02940860|Trace Elements|trace elements|mesh-ancestor
82919080|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
82919081|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919082|NCT02940860|Hematinics|hematinics|mesh-ancestor
82919083|NCT01303887|Prednisolone|prednisolone|mesh-list
82919084|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
82919085|NCT01303887|Rituximab|rituximab|mesh-list
82919086|NCT01303887|Fludarabine|fludarabine|mesh-list
82919087|NCT01303887|Vincristine|vincristine|mesh-list
82919088|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82919089|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
82919090|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919091|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82919092|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82919093|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
82919094|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919095|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919096|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82919097|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82919098|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82919099|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
82919100|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
82919101|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
82919102|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919103|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
82919104|NCT01303887|Hormones|hormones|mesh-ancestor
82919105|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919106|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919107|NCT02050594|Ipilimumab|ipilimumab|mesh-list
82919108|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82919109|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919110|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82919111|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919112|NCT02806960|Glucagon|glucagon|mesh-list
82919113|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919114|NCT02806960|Hormones|hormones|mesh-ancestor
82919115|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919116|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919117|NCT03718143|Adavosertib|adavosertib|mesh-list
82919118|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919119|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919120|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
82919121|NCT02955134|Antacids|antacids|mesh-ancestor
82919122|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919123|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919124|NCT02048488|Belizatinib|belizatinib|mesh-list
82919125|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82919126|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919127|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919128|NCT02050672|Inositol|inositol|mesh-list
82919129|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
82919130|NCT02050672|Vitamins|vitamins|mesh-ancestor
82919131|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
82919132|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919133|NCT03811366|Prednisone|prednisone|mesh-list
82919134|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919135|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
82919136|NCT03811366|Hormones|hormones|mesh-ancestor
82919137|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919138|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919139|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919140|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919141|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82919142|NCT03274466|Laxatives|laxatives|mesh-ancestor
82919143|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919144|NCT02037802|Fentanyl|fentanyl|mesh-list
82919145|NCT02037802|Meperidine|meperidine|mesh-list
82919146|NCT02037802|Bupivacaine|bupivacaine|mesh-list
82919147|NCT02037802|Propofol|propofol|mesh-list
82919148|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919149|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
82919150|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919151|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919152|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
82919153|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919154|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82919155|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82919156|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
82919157|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82919158|NCT02037802|Narcotics|narcotics|mesh-ancestor
82919159|NCT02037802|Analgesics|analgesics|mesh-ancestor
82919160|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82919161|NCT02051530|Tryptophan|tryptophan|mesh-list
82919162|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82919163|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
82919164|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82919165|NCT03797703|Lidocaine|lidocaine|mesh-list
82919166|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919167|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
82919168|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919169|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919170|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
82919171|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919172|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82919173|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82919174|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82919175|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82919176|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919177|NCT02048644|Beclomethasone|beclomethasone|mesh-list
82919178|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
82919179|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82919180|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
82919181|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919182|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919183|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82919184|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
82919185|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82919186|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82919187|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82919188|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
82919189|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919190|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919191|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919192|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
82919193|NCT02048644|Hormones|hormones|mesh-ancestor
82919194|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919195|NCT02048800|Treosulfan|treosulfan|mesh-list
82919196|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82919197|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
82919198|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919199|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919200|NCT03797625|Cisplatin|cisplatin|mesh-list
82919201|NCT03797625|Irinotecan|irinotecan|mesh-list
82919202|NCT03797625|Endostar protein|endostar protein|mesh-list
82919203|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919204|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82919205|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82919206|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919207|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919208|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82919209|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82919210|NCT03797625|Growth Substances|growth substances|mesh-ancestor
82919211|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919212|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
82919213|NCT02051842|Metadoxine|metadoxine|mesh-list
82919214|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82919215|NCT02806414|Ivermectin|ivermectin|mesh-list
82919216|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82919217|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919219|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82919220|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919221|NCT02049190|Onapristone|onapristone|mesh-list
82919222|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919223|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82919224|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
82919225|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82919226|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919227|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
82919228|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919229|NCT03811509|Denosumab|denosumab|mesh-list
82919230|NCT03811509|Diphosphonates|diphosphonates|mesh-list
82919231|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82919232|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919233|NCT02037412|Clopidogrel|clopidogrel|mesh-list
82919234|NCT02037412|Ticagrelor|ticagrelor|mesh-list
82919235|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82919236|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82919237|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82919238|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82919239|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
82919240|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919241|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919242|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919243|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82919244|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
82919245|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919246|NCT03797079|Bupivacaine|bupivacaine|mesh-list
82919247|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919248|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
82919249|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919250|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919251|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
82919252|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919253|NCT02049268|Ethanol|ethanol|mesh-list
82919254|NCT02049268|Nicotine|nicotine|mesh-list
82919255|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82919256|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
82919257|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919258|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919259|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82919260|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82919261|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
82919262|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919263|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919264|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82919265|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919266|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919267|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
82919268|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
82919269|NCT02049346|Hematinics|hematinics|mesh-ancestor
82919270|NCT03564873|Azacitidine|azacitidine|mesh-list
82919271|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
82919272|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82919273|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
82919274|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919275|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919276|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919277|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82919278|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82919279|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
82919280|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82919281|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82919282|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919283|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
82919284|NCT02806024|Coagulants|coagulants|mesh-ancestor
82919285|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82919286|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919287|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919288|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
82919289|NCT02049580|Thiotepa|thiotepa|mesh-list
82919290|NCT02049580|Fludarabine|fludarabine|mesh-list
82919291|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82919293|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919294|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82919295|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82919296|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
82919297|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919298|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919299|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82919300|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
82919301|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82919302|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919303|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82919304|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82919305|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919306|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919307|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919308|NCT03796533|Posaconazole|posaconazole|mesh-list
82919309|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
82919310|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919311|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82919312|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82919313|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82919314|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82919315|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82919316|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919317|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919318|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82919319|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
82919320|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919322|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
82919323|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82919324|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
82919325|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82919326|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
82919327|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919328|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919329|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
82919330|NCT02049736|Telbivudine|telbivudine|mesh-list
82919331|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
82919332|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919333|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82919334|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919335|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919336|NCT01303029|Gemcitabine|gemcitabine|mesh-list
82919337|NCT01303029|Capecitabine|capecitabine|mesh-list
82919338|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82919339|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82919340|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
82919341|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919342|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919343|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82919344|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919345|NCT02052388|Daptomycin|daptomycin|mesh-list
82919346|NCT02052388|Brilacidin|brilacidin|mesh-list
82919347|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82919348|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919349|NCT01303107|Bupivacaine|bupivacaine|mesh-list
82919350|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919351|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
82919352|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919353|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919354|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
82919355|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919356|NCT03795909|Dexamethasone|dexamethasone|mesh-list
82919357|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919358|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
82919359|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
82919360|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919361|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919362|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919363|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
82919364|NCT03795909|Hormones|hormones|mesh-ancestor
83083950|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82919365|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919366|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919367|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919368|NCT03795597|Melphalan|melphalan|mesh-list
82919369|NCT03795597|Busulfan|busulfan|mesh-list
82919370|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82919371|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
82919372|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919373|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919374|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82919375|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82919376|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
82919377|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919378|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
82919379|NCT02802592|Hematinics|hematinics|mesh-ancestor
82919380|NCT03637972|Nicotine|nicotine|mesh-list
82919381|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82919382|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
82919383|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919384|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919385|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82919386|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82919387|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
82919388|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919389|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919390|NCT03383679|Capecitabine|capecitabine|mesh-list
82919391|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82919392|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
82919393|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919394|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919395|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
82919396|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82919397|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919398|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
82919400|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
82919401|NCT02053402|Vitamins|vitamins|mesh-ancestor
82919402|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
82919403|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919404|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82919405|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82919406|NCT04639011|Norepinephrine|norepinephrine|mesh-list
82919407|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82919408|NCT04639011|Serotonin|serotonin|mesh-list
82919409|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82919410|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82919411|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82919412|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919413|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919414|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919415|NCT04639011|Analgesics|analgesics|mesh-ancestor
82919416|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
82919417|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919418|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
82919419|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82919420|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
82919421|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82919422|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82919423|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
82919424|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
82919425|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
82919426|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82919427|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82919428|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
82919429|NCT02053558|Lidocaine|lidocaine|mesh-list
82919430|NCT02053558|Ropivacaine|ropivacaine|mesh-list
82919431|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919432|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
82919433|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919434|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919435|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
82919436|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919437|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82919438|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82919439|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82919440|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82919441|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919443|NCT03809949|Anesthetics|anesthetics|mesh-list
82919444|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919445|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919446|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82919447|NCT03809949|Narcotics|narcotics|mesh-ancestor
82919448|NCT03809949|Analgesics|analgesics|mesh-ancestor
82919449|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
82919450|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919451|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82919452|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82919453|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
82919454|NCT02052934|Vaccines|vaccines|mesh-list
82919455|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
82919456|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919457|NCT03810261|Vitamin D|vitamin d|mesh-list
82919458|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
82919459|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
82919460|NCT03810261|Vitamins|vitamins|mesh-list
82919461|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
82919462|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919463|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82919464|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82919465|NCT02037724|Iron|iron|mesh-list
82919466|NCT02037724|Trace Elements|trace elements|mesh-ancestor
82919467|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
82919468|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919469|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82919470|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82919471|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919473|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
82919474|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82919475|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
82919476|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82919477|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919478|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919479|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82919480|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919481|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919482|NCT02054182|Vitamin D|vitamin d|mesh-list
82919483|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
82919484|NCT02054182|Vitamins|vitamins|mesh-ancestor
82919485|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
82919486|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919487|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82919488|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82919489|NCT03323151|Ixazomib|ixazomib|mesh-list
82919490|NCT03323151|Glycine|glycine|mesh-list
82919491|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919492|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
82919493|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919494|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919495|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
82919496|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919497|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919498|NCT02803138|Ritonavir|ritonavir|mesh-list
82919499|NCT02803138|Ribavirin|ribavirin|mesh-list
82919500|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82919501|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82919502|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
82919503|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919504|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919505|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82919506|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82919507|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
82919508|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919509|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82919510|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82919511|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
82919512|NCT03795207|Durvalumab|durvalumab|mesh-list
82919513|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82919514|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919515|NCT02056210|Plerixafor|plerixafor|mesh-list
82919516|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82919517|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82919518|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
82919519|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919520|NCT00131235|Azithromycin|azithromycin|mesh-list
82919521|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
82919522|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
82919523|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82919524|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82919525|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919526|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
82919527|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83457666|NCT04744545|Curcumin|curcumin|mesh-list
82919528|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82919529|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82919530|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919531|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919532|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82919533|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
82919534|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82919535|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82919536|NCT03794505|Prednisolone|prednisolone|mesh-list
82919537|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
82919538|NCT03794505|Lidocaine|lidocaine|mesh-list
82919539|NCT03794505|Ropivacaine|ropivacaine|mesh-list
82919540|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82919541|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
82919542|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919543|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
82919544|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919545|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919546|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
82919547|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919548|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82919549|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82919550|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82919551|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82919552|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919553|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919554|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
82919555|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
82919556|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919557|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
82919558|NCT03794505|Hormones|hormones|mesh-ancestor
82919559|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919560|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82919561|NCT03794505|Protective Agents|protective agents|mesh-ancestor
82919562|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919563|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919564|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
82919565|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
82919566|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82919567|NCT05625243|Protective Agents|protective agents|mesh-ancestor
82919568|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919569|NCT03023007|Anesthetics|anesthetics|mesh-list
82919570|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919571|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919572|NCT01304901|Montelukast|montelukast|mesh-list
82919573|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82919574|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
82919575|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82919576|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
82919577|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919578|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919579|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82919580|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82919581|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919582|NCT05624853|Pregabalin|pregabalin|mesh-list
82919583|NCT05624853|Analgesics|analgesics|mesh-ancestor
82919584|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
82919585|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919586|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919587|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
82919588|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82919589|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82919590|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919592|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82919593|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82919594|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919595|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82919596|NCT03794271|Anesthetics|anesthetics|mesh-list
82919597|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919598|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919599|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
82919600|NCT03792321|Testosterone|testosterone|mesh-list
82919601|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
82919602|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
82919603|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82919604|NCT03792321|Androgens|androgens|mesh-ancestor
82919605|NCT03792321|Hormones|hormones|mesh-ancestor
82919606|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919607|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919608|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919609|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919610|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
82919611|NCT01305057|Pyridoxine|pyridoxine|mesh-list
82919612|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
82919613|NCT01305057|Vitamins|vitamins|mesh-ancestor
82919614|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
82919615|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919616|NCT03792009|Bupivacaine|bupivacaine|mesh-list
82919617|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
82919618|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
82919619|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919620|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919621|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
82919622|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919623|NCT01305135|Azacitidine|azacitidine|mesh-list
82919624|NCT01305135|Idarubicin|idarubicin|mesh-list
82919625|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82919626|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
82919627|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919628|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919629|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919630|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82919631|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82919632|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82919633|NCT01305603|Bupivacaine|bupivacaine|mesh-list
82919634|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
82919635|NCT01305603|Anesthetics|anesthetics|mesh-list
82919636|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919637|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919638|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
82919639|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919640|NCT03793725|Apatinib|apatinib|mesh-list
82919641|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919642|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82919643|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919644|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919645|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82919646|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82919647|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
82919648|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
82919649|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919650|NCT02056366|Protective Agents|protective agents|mesh-ancestor
82919651|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919652|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
82919653|NCT02056366|Vitamins|vitamins|mesh-ancestor
82919654|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
82919655|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
82919656|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82919657|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82919658|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919659|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
82919660|NCT02056444|Coagulants|coagulants|mesh-ancestor
82919661|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82919662|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82919663|NCT05624229|Esomeprazole|esomeprazole|mesh-list
82919664|NCT05624229|Omeprazole|omeprazole|mesh-list
82919665|NCT05624229|Rabeprazole|rabeprazole|mesh-list
82919666|NCT05624229|Pantoprazole|pantoprazole|mesh-list
82919668|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82919669|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919670|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919671|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919672|NCT05622370|Brivaracetam|brivaracetam|mesh-list
82919673|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
82919674|NCT03791775|Polidocanol|polidocanol|mesh-list
82919675|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82919676|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82919677|NCT01730937|Sorafenib|sorafenib|mesh-list
82919678|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919679|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82919680|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919681|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919682|NCT03789123|Dienogest|dienogest|mesh-list
82919683|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82919684|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82919685|NCT03789123|Estradiol|estradiol|mesh-list
82919686|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82919687|NCT03789123|Nandrolone|nandrolone|mesh-list
82919688|NCT03789123|Estrogens|estrogens|mesh-ancestor
82919689|NCT03789123|Hormones|hormones|mesh-ancestor
82919690|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919691|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919692|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82919693|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
82919694|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82919695|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82919696|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82919697|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82919698|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82919699|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
82919700|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919701|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919702|NCT03789123|Androgens|androgens|mesh-ancestor
82919703|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
82919705|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
82919706|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82919707|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
82919708|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919709|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919710|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
82919711|NCT03788889|Ketamine|ketamine|mesh-list
82919712|NCT03788889|Lorazepam|lorazepam|mesh-list
82919713|NCT03788889|Phenobarbital|phenobarbital|mesh-list
82919714|NCT03788889|Analgesics|analgesics|mesh-ancestor
82919715|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
82919716|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919717|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919718|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82919719|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82919720|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
82919721|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
82919722|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919723|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82919724|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82919725|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919726|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919727|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
82919728|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
82919729|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
82919730|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919731|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82919732|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82919733|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82919734|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82919735|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
82919736|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
82919737|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82919738|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82919739|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82919740|NCT03788733|Melatonin|melatonin|mesh-list
82919741|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
82919742|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919744|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919745|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919747|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919748|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919749|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919750|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82919751|NCT04753515|Midazolam|midazolam|mesh-list
82919752|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
82919753|NCT04753515|Remifentanil|remifentanil|mesh-list
82919754|NCT04753515|Propofol|propofol|mesh-list
82919755|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82919756|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919757|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919758|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82919759|NCT04753515|Analgesics|analgesics|mesh-ancestor
82919760|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
82919761|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919762|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82919763|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82919764|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82919765|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
82919766|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919767|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919768|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82919769|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
82919770|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
82919771|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82919772|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82919773|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82919774|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82919775|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
82919776|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
82919777|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82919778|NCT04753515|Narcotics|narcotics|mesh-ancestor
82919779|NCT01306461|Timolol|timolol|mesh-list
82919780|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82919781|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82919782|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
82919783|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919784|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919785|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919786|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82919787|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82919788|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
82919789|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82919790|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82919791|NCT01305837|Prednisolone|prednisolone|mesh-list
82919792|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
82919793|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82919794|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
82919795|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919796|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
82919797|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
82919798|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919799|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919800|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919801|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
82919803|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919804|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82919805|NCT01305837|Protective Agents|protective agents|mesh-ancestor
82919806|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919807|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919808|NCT01306773|Oseltamivir|oseltamivir|mesh-list
82919809|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
82919810|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919811|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919812|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919813|NCT03790605|Curcumin|curcumin|mesh-list
82919814|NCT03790605|Iproplatin|iproplatin|mesh-list
82919815|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82919816|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82919817|NCT03790605|Analgesics|analgesics|mesh-ancestor
82919818|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
82919819|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919820|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919821|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919822|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82919823|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919824|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919825|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919826|NCT03787953|Antibodies|antibodies|mesh-list
82919827|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
82919828|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919829|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82919830|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82919831|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
82919832|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82919833|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
82919834|NCT01306851|Coagulants|coagulants|mesh-ancestor
82919835|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
82919836|NCT03790215|Progestins|progestins|mesh-ancestor
82919837|NCT03790215|Hormones|hormones|mesh-ancestor
82919838|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919839|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919840|NCT03790371|Misoprostol|misoprostol|mesh-list
82919841|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82919842|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
82919843|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82919844|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919845|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82919846|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919847|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
82919848|NCT01307475|Adenosine|adenosine|mesh-list
82919849|NCT01307475|Analgesics|analgesics|mesh-ancestor
82919850|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
82919851|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919852|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919853|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82919854|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
82919855|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82760265|NCT05360433|Oxycodone|oxycodone|mesh-list
82919857|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
82919858|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919859|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919860|NCT03787641|Protamines|protamines|mesh-list
82919861|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
82919862|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919863|NCT03787641|Coagulants|coagulants|mesh-ancestor
82919864|NCT03790293|Rituximab|rituximab|mesh-list
82919865|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82919866|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919867|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
82919868|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919869|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82919870|NCT03245450|Irinotecan|irinotecan|mesh-list
82919871|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82919872|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82919873|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919874|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919875|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919876|NCT05694585|Esmolol|esmolol|mesh-list
82919877|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82919878|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82919879|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82919880|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
82919881|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919882|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919883|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919884|NCT03712917|Topiramate|topiramate|mesh-list
82919885|NCT03712917|Flunarizine|flunarizine|mesh-list
82919886|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
82919887|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82919888|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919889|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82919890|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82919891|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919892|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82919894|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
82919895|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
82919896|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919897|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
82919898|NCT03787017|Metformin|metformin|mesh-list
82919899|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82919900|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919901|NCT01307865|Mannitol|mannitol|mesh-list
82919902|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82919903|NCT01307865|Diuretics|diuretics|mesh-ancestor
82919904|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
82919905|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919906|NCT01308177|Ecabet|ecabet|mesh-list
82919907|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919908|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82919909|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919910|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
82919911|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919912|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919913|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82919914|NCT01308177|Protective Agents|protective agents|mesh-ancestor
82919915|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919916|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919917|NCT01308255|Vitamins|vitamins|mesh-list
82919918|NCT01308255|Folic Acid|folic acid|mesh-list
82919919|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
82919920|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82919921|NCT01308255|Infliximab|infliximab|mesh-list
82919922|NCT01308255|Methotrexate|methotrexate|mesh-list
82919923|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
82919924|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919925|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82919926|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
82919927|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82919928|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82919929|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
82919930|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919931|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919932|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
82919933|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919934|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82919935|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82919936|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
82919937|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82919938|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82919939|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82919940|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
82919941|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
82919942|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919943|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919944|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
82919945|NCT01308255|Hormones|hormones|mesh-ancestor
82919946|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919947|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82919948|NCT01308255|Protective Agents|protective agents|mesh-ancestor
82919949|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82919950|NCT01308255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82919951|NCT01308255|Hematinics|hematinics|mesh-ancestor
82919952|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
82919953|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
82919954|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82919955|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82919956|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919957|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
82919958|NCT03782025|Coagulants|coagulants|mesh-ancestor
82919959|NCT03782025|Vitamins|vitamins|mesh-ancestor
82919960|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
82919961|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919962|NCT03781947|Antarelix|antarelix|mesh-list
82919963|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
82919964|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82919965|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919966|NCT03781869|Cisplatin|cisplatin|mesh-list
82919967|NCT03781869|Etoposide|etoposide|mesh-list
82919968|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
82919969|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82919970|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82919971|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82919972|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82919973|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82919974|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919975|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82919976|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82919977|NCT03781635|Ketamine|ketamine|mesh-list
82919978|NCT03781635|Analgesics|analgesics|mesh-ancestor
82919979|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
82919980|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82919981|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82919982|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82919983|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82919984|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
82919985|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
82919986|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82919987|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82919988|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82919989|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82919990|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919991|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
82919992|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82919993|NCT03781011|Choline|choline|mesh-list
82919994|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
82919995|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82919996|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
82919997|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82919998|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82919999|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82920000|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
82920001|NCT03785613|Buprenorphine|buprenorphine|mesh-list
82920002|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82920003|NCT03785613|Narcotics|narcotics|mesh-ancestor
82920004|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920005|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920006|NCT03785613|Analgesics|analgesics|mesh-ancestor
82920007|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
82920008|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920009|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82920010|NCT03785223|Methylphenidate|methylphenidate|mesh-list
82920011|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82920012|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920013|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82920014|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82920015|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920016|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920017|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
82920018|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920019|NCT01308723|Sorafenib|sorafenib|mesh-list
82920020|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82920021|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920022|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920023|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920024|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920025|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
82920026|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920027|NCT01561131|Calcium|calcium|mesh-list
82920028|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920029|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920030|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
82920031|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82920032|NCT03780621|Andrographolide|andrographolide|mesh-list
82920033|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82920034|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82920035|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82920036|NCT03780621|Analgesics|analgesics|mesh-ancestor
82920037|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
82920038|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920039|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920040|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920041|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82920042|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82920043|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920045|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82920047|NCT03785067|Telmisartan|telmisartan|mesh-list
82920048|NCT03785067|Indapamide|indapamide|mesh-list
82920049|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82920050|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82920051|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920052|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920053|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920054|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920055|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
82920056|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82920057|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82920058|NCT03785067|Diuretics|diuretics|mesh-ancestor
82920059|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
82920060|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82920061|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
82920062|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82920063|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82920064|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920065|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
82920066|NCT05688111|Coagulants|coagulants|mesh-ancestor
82920067|NCT02059018|Diclofenac|diclofenac|mesh-list
82920068|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
82920069|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
82920070|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82920071|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82920072|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82920073|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82920074|NCT02059018|Analgesics|analgesics|mesh-ancestor
82920075|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
82920076|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920077|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920078|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82920079|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920080|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920081|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920082|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
82920083|NCT01561209|Amitriptyline|amitriptyline|mesh-list
82920084|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82920085|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
82920086|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82920087|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82920088|NCT01561209|Analgesics|analgesics|mesh-ancestor
82920089|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
82920090|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920091|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920092|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82920093|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82920094|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920095|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920096|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920097|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920098|NCT02800642|Aflibercept|aflibercept|mesh-list
82920099|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82920100|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82920101|NCT02800642|Growth Substances|growth substances|mesh-ancestor
82920102|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920103|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
82920104|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920105|NCT02056600|Metformin|metformin|mesh-list
82920106|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82920107|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920108|NCT02056678|Acetaminophen|acetaminophen|mesh-list
82920109|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82920110|NCT02056678|Analgesics|analgesics|mesh-ancestor
82920111|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
82920112|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920113|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920114|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
82920115|NCT04662567|Acetaminophen|acetaminophen|mesh-list
82920116|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82920117|NCT04662567|Analgesics|analgesics|mesh-ancestor
82920118|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
82920119|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920120|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920121|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
82920122|NCT02799784|Albuterol|albuterol|mesh-list
82920123|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82920124|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
82920125|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920126|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920127|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82920128|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
82920129|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
82920130|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82920131|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82920132|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82920133|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82920134|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920135|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920136|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920137|NCT03779685|Anesthetics|anesthetics|mesh-list
82920138|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920139|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920140|NCT03779451|Progesterone|progesterone|mesh-list
82920141|NCT03779451|Progestins|progestins|mesh-ancestor
82920142|NCT03779451|Hormones|hormones|mesh-ancestor
82920143|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82920144|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920145|NCT02059330|Palbociclib|palbociclib|mesh-list
82920146|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920147|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920148|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920149|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920150|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
82920151|NCT03784443|Ranibizumab|ranibizumab|mesh-list
82920152|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82920153|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82920154|NCT03784443|Growth Substances|growth substances|mesh-ancestor
82920155|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920156|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
82920157|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920158|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82920159|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
82920160|NCT03784443|Hormones|hormones|mesh-ancestor
82920161|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82920162|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
82920163|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920164|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920165|NCT02054806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82920166|NCT02054806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920167|NCT02054884|Paclitaxel|paclitaxel|mesh-list
82920168|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82920169|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82920170|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920171|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
82920172|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
82920173|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
82920174|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920175|NCT01333072|Risperidone|risperidone|mesh-list
82920176|NCT01333072|Aripiprazole|aripiprazole|mesh-list
82920177|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82920178|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
82920179|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920180|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920181|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920182|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82920183|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82920184|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920185|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82920186|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82920187|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
82920188|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
82920189|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
82920190|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82920191|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82920203|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82920204|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920205|NCT02059564|Incretins|incretins|mesh-ancestor
82920206|NCT02059564|Hormones|hormones|mesh-ancestor
82920207|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82920208|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82920209|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
82920210|NCT05622058|Docetaxel|docetaxel|mesh-list
82920211|NCT05622058|Doxorubicin|doxorubicin|mesh-list
82920212|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920213|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
82920214|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920215|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920216|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82920217|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
82920218|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920219|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920220|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82920221|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
82920222|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
82920223|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
82920224|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82920225|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82920226|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82920227|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920228|NCT02055196|Irinotecan|irinotecan|mesh-list
82920229|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82920230|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82920231|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920232|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920233|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920234|NCT02055274|Rotigotine|rotigotine|mesh-list
82920235|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
82920236|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
82920237|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920238|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920239|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920240|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82920241|NCT03783897|Norgestimate|norgestimate|mesh-list
82920242|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
82920243|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
82920244|NCT03783897|Estradiol|estradiol|mesh-list
82920245|NCT03783897|Estrogens|estrogens|mesh-ancestor
82920246|NCT03783897|Hormones|hormones|mesh-ancestor
82920247|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82920248|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920249|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82920250|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82920251|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82920252|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82920253|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82920254|NCT03779061|Propofol|propofol|mesh-list
82920255|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82920256|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920257|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920258|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82920259|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
82920260|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
82920261|NCT01316445|Midazolam|midazolam|mesh-list
82920262|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82920263|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82920264|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920265|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920266|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82920267|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82920268|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82920269|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82920270|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
82920271|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
82920272|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
82920273|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
82920274|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920275|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920276|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82920277|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82920278|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82920279|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920280|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920281|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82920282|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920283|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920284|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
82920285|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920286|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
82920287|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82920288|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920289|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82920290|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82920291|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
82920292|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920293|NCT03778359|Leuprolide|leuprolide|mesh-list
82920294|NCT03778359|Dienogest|dienogest|mesh-list
82920295|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
82920296|NCT03778359|Progestins|progestins|mesh-list
82920297|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82920298|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
82920299|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82920300|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920301|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82920302|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82920303|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82920304|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82920305|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
82920306|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82920307|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920308|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82920309|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82920310|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
82920311|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82920312|NCT03778359|Hormones|hormones|mesh-ancestor
82920313|NCT03560908|Dasatinib|dasatinib|mesh-list
82920314|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920315|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920316|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920317|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920318|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
82920319|NCT02057770|Busulfan|busulfan|mesh-list
82920320|NCT02057770|Fludarabine|fludarabine|mesh-list
82920321|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
82920322|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920323|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
82920324|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920325|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920326|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82920327|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
82920328|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920329|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920330|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82920331|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82920333|NCT05615025|Propofol|propofol|mesh-list
82920334|NCT05615025|Sevoflurane|sevoflurane|mesh-list
82920335|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82920336|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920337|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920338|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82920339|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
82920340|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
82920341|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82920342|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82920343|NCT03778281|Baclofen|baclofen|mesh-list
82920344|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82920345|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920346|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82920347|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920348|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82920349|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
82920350|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
82920351|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920352|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920353|NCT02055586|Alovudine|alovudine|mesh-list
82920354|NCT02055586|Fluorides|fluorides|mesh-list
82920355|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
82920356|NCT02055586|Protective Agents|protective agents|mesh-ancestor
82920357|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920358|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
82920359|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920360|NCT03778593|Leucovorin|leucovorin|mesh-list
82920361|NCT03778593|Fluorouracil|fluorouracil|mesh-list
82920362|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
82920363|NCT03778593|Irinotecan|irinotecan|mesh-list
82920364|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
82920365|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920366|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82920367|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920368|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920369|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
82920370|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920371|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82920372|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82920373|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920374|NCT03778593|Antidotes|antidotes|mesh-ancestor
82920375|NCT03778593|Protective Agents|protective agents|mesh-ancestor
82920376|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
82920377|NCT03778593|Vitamins|vitamins|mesh-ancestor
82920378|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
82920379|NCT02055664|Ropivacaine|ropivacaine|mesh-list
82920380|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
82920381|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
82920382|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920383|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920384|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
82920385|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920386|NCT01309425|Tapentadol|tapentadol|mesh-list
82920387|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82920388|NCT01309425|Narcotics|narcotics|mesh-ancestor
82920389|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920390|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920391|NCT01309425|Analgesics|analgesics|mesh-ancestor
82920392|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
82920393|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920394|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82920395|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83482935|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
82920397|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920398|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920399|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920400|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
82920401|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920402|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920403|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920404|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920405|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
82920406|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82920407|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920408|NCT02057926|Tetracycline|tetracycline|mesh-list
82920409|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82920410|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920411|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82920413|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920414|NCT03777579|Paclitaxel|paclitaxel|mesh-list
82920415|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82920416|NCT03777579|Antibodies|antibodies|mesh-list
82920417|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
82920418|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82920419|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920420|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
82920421|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
82920422|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
82920423|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920424|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
82920425|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920426|NCT02059876|Paclitaxel|paclitaxel|mesh-list
82920427|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82920428|NCT02059876|Carboplatin|carboplatin|mesh-list
82920429|NCT02059876|Trastuzumab|trastuzumab|mesh-list
82920430|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82920431|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920432|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
82920433|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
82920434|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
82920435|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920436|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920437|NCT03777423|Cobalt|cobalt|mesh-list
82920438|NCT03777423|Chromium|chromium|mesh-list
82920439|NCT03777423|Trace Elements|trace elements|mesh-ancestor
82920440|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
82920441|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920442|NCT05654662|Listerine|listerine|mesh-list
82920443|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
82920444|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82920445|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
82920446|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
82920447|NCT05654662|Protective Agents|protective agents|mesh-ancestor
82920448|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920449|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82920450|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920451|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
82920452|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
82920453|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
82920454|NCT03777033|Calcium|calcium|mesh-list
82920455|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920456|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920457|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82920458|NCT02060032|Atorvastatin|atorvastatin|mesh-list
82920459|NCT02060032|Simvastatin|simvastatin|mesh-list
82920460|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82920461|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82920462|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
82920463|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920464|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82920465|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82920466|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920467|NCT03783273|Vitamin D|vitamin d|mesh-list
82920468|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
82920469|NCT03783273|Vitamins|vitamins|mesh-ancestor
82920470|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
82920471|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920472|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82920473|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920474|NCT03777345|Cobalt|cobalt|mesh-list
82920475|NCT03777345|Chromium|chromium|mesh-list
82920476|NCT03777345|Trace Elements|trace elements|mesh-ancestor
82920477|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
82920478|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920479|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
82920480|NCT01318005|Norinyl|norinyl|mesh-list
82920481|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
82920482|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82920483|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920484|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82920485|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82920487|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82920488|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82920489|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82920490|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
82920491|NCT03710889|Abaloparatide|abaloparatide|mesh-list
82920492|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82920493|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920494|NCT02061124|Sevelamer|sevelamer|mesh-list
82920495|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
82920496|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
82920497|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920498|NCT01318941|Ranibizumab|ranibizumab|mesh-list
82920499|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82920500|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82920501|NCT01318941|Growth Substances|growth substances|mesh-ancestor
82920502|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920503|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
82920504|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920505|NCT03560440|Vancomycin|vancomycin|mesh-list
82920506|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82920507|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920508|NCT03776955|Carvedilol|carvedilol|mesh-list
82920509|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82920510|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82920511|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920512|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920513|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920514|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920515|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82920516|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
82920517|NCT03776955|Protective Agents|protective agents|mesh-ancestor
82920518|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82920519|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920520|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920521|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
82920522|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82920523|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82920524|NCT05102721|Avelumab|avelumab|mesh-list
82920525|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920526|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920527|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
82920528|NCT03308942|Niraparib|niraparib|mesh-list
82920529|NCT03308942|Dostarlimab|dostarlimab|mesh-list
82920530|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920531|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920532|NCT03308942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82920533|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920534|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82920535|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920536|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82920537|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82920538|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
82920539|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920540|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920541|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82920542|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
82920543|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82920544|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82920545|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82920546|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920547|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920548|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920549|NCT03308786|Aldesleukin|aldesleukin|mesh-list
82920550|NCT03308786|Interleukin-2|interleukin-2|mesh-list
82920551|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920552|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82920553|NCT03308786|Analgesics|analgesics|mesh-ancestor
82920554|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
82920555|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920556|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920557|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82920558|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82920569|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82920571|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920582|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
82920583|NCT03782805|Vitamin D|vitamin d|mesh-list
82920584|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920585|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920586|NCT03782805|Vitamins|vitamins|mesh-ancestor
82920587|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
82920588|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82920589|NCT03775863|Liver Extracts|liver extracts|mesh-list
82920590|NCT03775863|Hematinics|hematinics|mesh-ancestor
82920591|NCT03274076|Tofacitinib|tofacitinib|mesh-list
82920592|NCT03274076|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82920593|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920594|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920595|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920596|NCT03775707|Lenvatinib|lenvatinib|mesh-list
82920597|NCT03775707|Antibodies|antibodies|mesh-list
82920598|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
82920599|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920600|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920601|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920602|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920603|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920604|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82920605|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920606|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920607|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920608|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920609|NCT02764268|Apatinib|apatinib|mesh-list
82920610|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920611|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920612|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920613|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920614|NCT01320111|Paclitaxel|paclitaxel|mesh-list
82920615|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82920616|NCT01320111|Sorafenib|sorafenib|mesh-list
82920617|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82920618|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920619|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
82920620|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
82920621|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
82920622|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920623|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920624|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920625|NCT01320579|Tacrolimus|tacrolimus|mesh-list
82920626|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920627|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
82920628|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920629|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82920630|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920631|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920632|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
82920633|NCT05669001|Abatacept|abatacept|mesh-list
82920634|NCT05669001|Tacrolimus|tacrolimus|mesh-list
82920635|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82920636|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920637|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
82920638|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920639|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82920640|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920641|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920642|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82920643|NCT05669001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920644|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920645|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920646|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82920647|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82920648|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
82920649|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82920650|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920651|NCT03775395|Sorafenib|sorafenib|mesh-list
82920652|NCT03775395|Lenvatinib|lenvatinib|mesh-list
82920653|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920654|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920655|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920656|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920657|NCT02797522|Acetaminophen|acetaminophen|mesh-list
82920658|NCT02797522|Tenofovir|tenofovir|mesh-list
82920659|NCT02797522|Entecavir|entecavir|mesh-list
82920660|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
82920661|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
82920662|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82920663|NCT02797522|Analgesics|analgesics|mesh-ancestor
82920664|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
82920665|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920666|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920667|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
82920668|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
82920669|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920670|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82920671|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82920672|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920673|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920674|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82920675|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82920676|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
82920677|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920678|NCT03773367|Fluorouracil|fluorouracil|mesh-list
82920679|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
82920680|NCT03773367|Irinotecan|irinotecan|mesh-list
82920681|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
82920682|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920683|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82920684|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920685|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920686|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
82920687|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920688|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82920689|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82920690|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920691|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
82920692|NCT02060656|Rituximab|rituximab|mesh-list
82920693|NCT02060656|Gemcitabine|gemcitabine|mesh-list
82920694|NCT02060656|Lenalidomide|lenalidomide|mesh-list
82920695|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920696|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920697|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
82920698|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920699|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920700|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82920701|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
82920702|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920703|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82920704|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82920705|NCT02060656|Growth Substances|growth substances|mesh-ancestor
82920706|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
82920707|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82920708|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
82920709|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
82920710|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920711|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82920713|NCT02060656|Hormones|hormones|mesh-ancestor
82920714|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82920715|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82920716|NCT02060656|Protective Agents|protective agents|mesh-ancestor
82920717|NCT03774771|Cinacalcet|cinacalcet|mesh-list
82920718|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920719|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920720|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82920721|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
82920722|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82920723|NCT03774693|Fentanyl|fentanyl|mesh-list
82920724|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
82920725|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920726|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920727|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82920728|NCT03774693|Narcotics|narcotics|mesh-ancestor
82920729|NCT03774693|Analgesics|analgesics|mesh-ancestor
82920730|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
82920731|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920732|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82920733|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82920734|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
82920735|NCT03774615|Ferric maltol|ferric maltol|mesh-list
82920736|NCT03774615|Hematinics|hematinics|mesh-ancestor
82920737|NCT01321047|Propofol|propofol|mesh-list
82920738|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82920739|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920740|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920741|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82920742|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
82920743|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
82920744|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
82920745|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82920746|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
82920747|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82920748|NCT01321125|Povidone|povidone|mesh-list
82920749|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920750|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
82920751|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
82920752|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
82920753|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
82920754|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
82920755|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82920756|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
82920757|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920758|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920759|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82920760|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
82920761|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82920762|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
82920763|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920764|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920765|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82920766|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
82920767|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
82920768|NCT03773991|Protective Agents|protective agents|mesh-ancestor
82920769|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
82920770|NCT05435313|Irinotecan|irinotecan|mesh-list
82920771|NCT05435313|Tislelizumab|tislelizumab|mesh-list
82920772|NCT05435313|Raltitrexed|raltitrexed|mesh-list
82920773|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920774|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82920775|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82920776|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920777|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920778|NCT05435313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920779|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82920780|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
82920781|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82920782|NCT05472675|Bupivacaine|bupivacaine|mesh-list
82920783|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
82920784|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
82920785|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
82920786|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920787|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920789|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920790|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82920791|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920792|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920793|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
82920794|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920796|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
82920797|NCT01321905|Vitamins|vitamins|mesh-ancestor
82920798|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
82920799|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920800|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82920801|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920802|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82920803|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
82920804|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920805|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
82920806|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920807|NCT03763227|Ranibizumab|ranibizumab|mesh-list
82920808|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
82920809|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82920810|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82920811|NCT03763227|Growth Substances|growth substances|mesh-ancestor
82920812|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920813|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
82920814|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920815|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920816|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920817|NCT04929548|Maleic acid|maleic acid|mesh-list
82920818|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920819|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920820|NCT04150029|Azacitidine|azacitidine|mesh-list
82920821|NCT04150029|Venetoclax|venetoclax|mesh-list
82920822|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82920823|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
82920824|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920825|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920826|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920827|NCT02060734|Lidocaine|lidocaine|mesh-list
82920828|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
82920829|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
82920830|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83457779|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920831|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920832|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
82920833|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920834|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82920835|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82920836|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82920837|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920838|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920839|NCT03270644|Propranolol|propranolol|mesh-list
82920840|NCT03270644|Lasmiditan|lasmiditan|mesh-list
82920841|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82920842|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82920843|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920844|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920845|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920846|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920847|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82920848|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82920849|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
82920850|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82920851|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
82920852|NCT04535102|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
82920853|NCT04535102|Immunoconjugates|immunoconjugates|mesh-ancestor
82920854|NCT04535102|Immunologic Factors|immunologic factors|mesh-ancestor
82920855|NCT04535102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920856|NCT04529720|Vaccines|vaccines|mesh-list
82920857|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
82920858|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920859|NCT03768609|Cyclosporine|cyclosporine|mesh-list
82920860|NCT03768609|Cyclosporins|cyclosporins|mesh-list
82920861|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920862|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920863|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82920864|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
82920865|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920866|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
82920867|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920868|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
82920869|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920870|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82920871|NCT03269552|Rituximab|rituximab|mesh-list
82920872|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82920873|NCT03269552|Antibodies|antibodies|mesh-list
82920874|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
82920875|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82920876|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
82920877|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920878|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920879|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82920880|NCT03771729|Valsartan|valsartan|mesh-list
82920881|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82920882|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82920883|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82920884|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82920885|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920886|NCT03560362|Epinephrine|epinephrine|mesh-list
82920887|NCT03560362|Bupivacaine|bupivacaine|mesh-list
82920888|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
82920889|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
82920890|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920891|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920892|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
82920893|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920894|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82920895|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82920896|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920897|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920898|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920899|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82920900|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82920901|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
82920902|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82920903|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
82920904|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
82920905|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
82920906|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82920907|NCT03768531|Nivolumab|nivolumab|mesh-list
82920908|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82920909|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82920910|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82920911|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920912|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
82920913|NCT01322061|Vitamins|vitamins|mesh-ancestor
82920914|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
82920915|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920916|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
82920917|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920918|NCT01322061|Protective Agents|protective agents|mesh-ancestor
82920919|NCT02062996|Phenylephrine|phenylephrine|mesh-list
82920920|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
82920921|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82920922|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82920923|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
82920924|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920925|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920926|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920927|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
82920928|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
82920929|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920930|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
82920931|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82920932|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
82920933|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82920934|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
82920935|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82920936|NCT02062996|Protective Agents|protective agents|mesh-ancestor
82920937|NCT03762369|Latanoprost|latanoprost|mesh-list
82920938|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82920939|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82920940|NCT01321515|Famciclovir|famciclovir|mesh-list
82920941|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
82920942|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920943|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82920944|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920945|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920946|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
82920947|NCT02065414|Listerine|listerine|mesh-list
82920948|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82920949|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920950|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
82920951|NCT04233879|Tenofovir|tenofovir|mesh-list
82920952|NCT04233879|Emtricitabine|emtricitabine|mesh-list
82920953|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82920954|NCT04233879|Islatravir|islatravir|mesh-list
82920955|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
82920956|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82920957|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82920958|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82920959|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82920960|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920961|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82920962|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82920963|NCT01370356|Varenicline|varenicline|mesh-list
82920964|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82920965|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82920966|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
82920967|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82920968|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920969|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920970|NCT03792334|Anesthetics|anesthetics|mesh-list
82920971|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920972|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920973|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
82920974|NCT04545411|Volagidemab|volagidemab|mesh-list
83457787|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82920975|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82920976|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920977|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82920978|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920979|NCT02065492|Amlodipine|amlodipine|mesh-list
82920980|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
82920981|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82920982|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920983|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82920984|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82920985|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82920986|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
82920987|NCT02063620|Ketamine|ketamine|mesh-list
82920988|NCT02063620|Analgesics|analgesics|mesh-ancestor
82920989|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
82920990|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82920991|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82920992|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82920993|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82920994|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
82920995|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
82920996|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82920997|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82920998|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82920999|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921000|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921001|NCT03767439|Nivolumab|nivolumab|mesh-list
82921002|NCT03767439|Ipilimumab|ipilimumab|mesh-list
82921003|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82921004|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921005|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82921006|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921007|NCT04539405|Sevoflurane|sevoflurane|mesh-list
82921008|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82921009|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82921010|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
82921011|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
82921012|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921013|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921014|NCT02065804|Bupivacaine|bupivacaine|mesh-list
82921015|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
82921016|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
82921017|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921018|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921019|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
82921020|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921021|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
82921022|NCT02064010|Acamprosate|acamprosate|mesh-list
82921023|NCT02064010|Calcium|calcium|mesh-list
82921024|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82921025|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921026|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82921027|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82921028|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
82921029|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
82921030|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
82921031|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921032|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921033|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
82921034|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921035|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82921036|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921037|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82921038|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921039|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921040|NCT03766893|Naltrexone|naltrexone|mesh-list
82921041|NCT03766893|Buprenorphine|buprenorphine|mesh-list
82921042|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82921043|NCT03766893|Naloxone|naloxone|mesh-list
82921044|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82921045|NCT03766893|Narcotics|narcotics|mesh-ancestor
82921046|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921047|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921048|NCT03766893|Analgesics|analgesics|mesh-ancestor
82921049|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
82921050|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921051|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82921052|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82921053|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
82921054|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82921055|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921056|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921057|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921058|NCT03760809|Analgesics|analgesics|mesh-ancestor
82921059|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
82921060|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921061|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82921062|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82921063|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82921064|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
82921065|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921066|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921067|NCT01370590|Atorvastatin|atorvastatin|mesh-list
82921068|NCT01370590|Ezetimibe|ezetimibe|mesh-list
82921069|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82921070|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82921071|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
82921072|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921073|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82921074|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82921075|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921076|NCT01567683|Imiquimod|imiquimod|mesh-list
82921077|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82921078|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
82921079|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921080|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921081|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
82921082|NCT03766425|Aflibercept|aflibercept|mesh-list
82921083|NCT03766425|Mitomycins|mitomycins|mesh-list
82921084|NCT03766425|Mitomycin|mitomycin|mesh-list
82921085|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82921086|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82921087|NCT03766425|Growth Substances|growth substances|mesh-ancestor
82921088|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921089|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
82921090|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921091|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82921092|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
82921093|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921094|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82921095|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921097|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82921098|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
82921099|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921100|NCT03770637|Glucagon|glucagon|mesh-list
82921101|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82921102|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921103|NCT03770637|Hormones|hormones|mesh-ancestor
82921104|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921105|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921106|NCT03770637|Incretins|incretins|mesh-ancestor
82921107|NCT03766269|Dronabinol|dronabinol|mesh-list
82921108|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
82921109|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921110|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921111|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921112|NCT03766269|Analgesics|analgesics|mesh-ancestor
82921113|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
82921114|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921115|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82921116|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82921117|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921118|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921119|NCT03766269|Hormones|hormones|mesh-ancestor
82921120|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921121|NCT03894891|Docetaxel|docetaxel|mesh-list
82921122|NCT03894891|Nivolumab|nivolumab|mesh-list
82921123|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921124|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
82921125|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
82921126|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
82921127|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921128|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82921129|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82921130|NCT03878979|Nivolumab|nivolumab|mesh-list
82921131|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82921132|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921133|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82921134|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921135|NCT03765645|Tazobactam|tazobactam|mesh-list
82921136|NCT03765645|Piperacillin|piperacillin|mesh-list
82921137|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82921138|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82921139|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921140|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82921141|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921142|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921143|NCT01321671|Pregabalin|pregabalin|mesh-list
82921144|NCT01321671|Analgesics|analgesics|mesh-ancestor
82921145|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
82921146|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921147|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921148|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
82921149|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82921150|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82921151|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921152|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82921153|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82921154|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82921155|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921156|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921157|NCT03770013|Clonidine|clonidine|mesh-list
82921158|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
82921160|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
82921161|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
82921162|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921163|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921164|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
82921165|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921166|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82921167|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921168|NCT03770013|Analgesics|analgesics|mesh-ancestor
82921169|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82921170|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82921171|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82921172|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
82921173|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921174|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921175|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82921176|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
82921177|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
82921179|NCT03769935|Cisplatin|cisplatin|mesh-list
82921180|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82921181|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921182|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82921183|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82921184|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921185|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921186|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
82921187|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82921188|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82921189|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921190|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
82921191|NCT03765021|Coagulants|coagulants|mesh-ancestor
82921192|NCT05418699|Insulin|insulin|mesh-list
82921193|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82921194|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921195|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82921196|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
82921197|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82921198|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
82921199|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921200|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
82921201|NCT03758859|Protective Agents|protective agents|mesh-ancestor
82921202|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82921203|NCT03759093|Thalidomide|thalidomide|mesh-list
82921204|NCT03759093|Dexamethasone|dexamethasone|mesh-list
82921205|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
82921206|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
82921207|NCT03759093|Bortezomib|bortezomib|mesh-list
82921208|NCT03759093|BB 1101|bb 1101|mesh-list
82921209|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82921210|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
82921211|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921212|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921213|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82921214|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
82921215|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921216|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921217|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82921218|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921219|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
82921220|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
82921221|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921222|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921223|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
82921224|NCT03759093|Hormones|hormones|mesh-ancestor
82921225|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921226|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82921227|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
82921228|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921229|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
82921230|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82921231|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921232|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82921233|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82921234|NCT03759093|Growth Substances|growth substances|mesh-ancestor
82921236|NCT03764241|Vitamin K|vitamin k|mesh-list
82921237|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
82921238|NCT03764241|Vitamins|vitamins|mesh-ancestor
82921239|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
82921240|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921241|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82921242|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
82921243|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82921244|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
82921245|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921246|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921247|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
82921248|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82921249|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82921250|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
82921251|NCT03764241|Coagulants|coagulants|mesh-ancestor
82921252|NCT03764163|Xenon|xenon|mesh-list
82921253|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82921254|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
82921255|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
82921256|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921257|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921258|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
82921259|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921260|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
82921261|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921262|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921263|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82921264|NCT01321827|Itraconazole|itraconazole|mesh-list
82921265|NCT01321827|Prednisolone|prednisolone|mesh-list
82921266|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
82921267|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921268|NCT01321827|Hormones|hormones|mesh-ancestor
82921269|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921270|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921271|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82921272|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921273|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
82921274|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921275|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82921276|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82921277|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921278|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921279|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82921280|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
82921281|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82921282|NCT03753477|Amlodipine|amlodipine|mesh-list
82921283|NCT03753477|Olmesartan|olmesartan|mesh-list
82921284|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82921285|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
82921286|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82921287|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82921288|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82921289|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82921290|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921291|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82921292|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921293|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
82921294|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82921295|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82921296|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
82921297|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82921298|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82921299|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921300|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82921301|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82921302|NCT05236647|Morphine|morphine|mesh-list
82921303|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82921304|NCT05236647|Narcotics|narcotics|mesh-ancestor
82921305|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921306|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921307|NCT05236647|Analgesics|analgesics|mesh-ancestor
82921308|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
82921309|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921311|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82921312|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
82921313|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82921314|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921315|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
82921316|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82921317|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83457820|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82921318|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921319|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82921320|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82921321|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83515596|NCT02299206|Protective Agents|protective agents|mesh-ancestor
82921322|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82921323|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82921324|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82921325|NCT04646109|Azithromycin|azithromycin|mesh-list
82921326|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
82921327|NCT04646109|Ivermectin|ivermectin|mesh-list
82921328|NCT04646109|Favipiravir|favipiravir|mesh-list
82921329|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82921330|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921331|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
82921332|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82921333|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82921334|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921335|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921336|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921337|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
82921338|NCT05320107|Ketamine|ketamine|mesh-list
82921339|NCT05320107|Analgesics|analgesics|mesh-ancestor
82921340|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
82921341|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921342|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921343|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82921344|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82921345|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
82921346|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
82921347|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921348|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82921349|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82921350|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921351|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921352|NCT03752931|Celiprolol|celiprolol|mesh-list
82921353|NCT03752931|Diltiazem|diltiazem|mesh-list
82921354|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82921355|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82921356|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82921357|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921358|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82921359|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921360|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
82921361|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82921362|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
82921363|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
82921364|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921365|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82921366|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82921367|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82921368|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
82921369|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921370|NCT05274633|Ravulizumab|ravulizumab|mesh-list
82921371|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82921372|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82921373|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
82921374|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921375|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82921376|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82921377|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82921378|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82921379|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921380|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921381|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82921383|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921384|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
82921385|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921386|NCT02066350|Pancrelipase|pancrelipase|mesh-list
82921387|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921388|NCT02064946|Vitamin D|vitamin d|mesh-list
82921389|NCT02064946|Vitamins|vitamins|mesh-ancestor
82921390|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
82921391|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921392|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82921393|NCT02064556|Amlodipine|amlodipine|mesh-list
82921394|NCT02064556|Candesartan|candesartan|mesh-list
82921395|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82921396|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83515670|NCT03964532|Avelumab|avelumab|mesh-list
82921397|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82921398|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921399|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82921400|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921401|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
82921402|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82921403|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82921404|NCT05041647|Dronabinol|dronabinol|mesh-list
82921405|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
82921406|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921407|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921408|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921409|NCT05041647|Analgesics|analgesics|mesh-ancestor
82921410|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
82921411|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921412|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82921413|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82921414|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921415|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921416|NCT05041647|Hormones|hormones|mesh-ancestor
82921417|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921418|NCT03752229|Diazepam|diazepam|mesh-list
82921419|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82921420|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
82921421|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
82921422|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
82921423|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921424|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921425|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921426|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82921427|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921428|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82921429|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82921430|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82921431|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82921432|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921433|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82921434|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
82921435|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
82921436|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
82921437|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
82921438|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921439|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921440|NCT05359731|Dexamethasone|dexamethasone|mesh-list
82921441|NCT05359731|Bupivacaine|bupivacaine|mesh-list
82921442|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921443|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
82921444|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
82921445|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921446|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921447|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921448|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
82921449|NCT05359731|Hormones|hormones|mesh-ancestor
82921450|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921451|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82921452|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921453|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
82921454|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
82921455|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921456|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
82921457|NCT03695367|Acetaminophen|acetaminophen|mesh-list
82921458|NCT03695367|Ibuprofen|ibuprofen|mesh-list
82921459|NCT03695367|Ketorolac|ketorolac|mesh-list
82921460|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921461|NCT03695367|Analgesics|analgesics|mesh-ancestor
82921462|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
82921463|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921464|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921465|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
82921466|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82921467|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921468|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921469|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82921470|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483014|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921471|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921472|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82921473|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82921474|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
82921475|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921476|NCT03755427|Antacids|antacids|mesh-ancestor
82921477|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921478|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921479|NCT03758079|Gabapentin|gabapentin|mesh-list
82921480|NCT03758079|Doxepin|doxepin|mesh-list
82921481|NCT03758079|Analgesics|analgesics|mesh-ancestor
82921482|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
82921483|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921484|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921485|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
82921486|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82921487|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82921488|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921489|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921490|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82921491|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82921492|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921493|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921494|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
82921495|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82921496|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82921497|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82921498|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
82921499|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
82921500|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
82921501|NCT02067910|Abatacept|abatacept|mesh-list
82921502|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82921503|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921504|NCT02067910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82921505|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921506|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82921507|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
82921508|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921509|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921510|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
82921511|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
82921512|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82921513|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
82921514|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82921515|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
82921516|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921517|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921518|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
82921519|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
82921520|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82921521|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82921522|NCT05280873|Prednisolone|prednisolone|mesh-list
82921523|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
82921524|NCT05280873|Pirfenidone|pirfenidone|mesh-list
82921525|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82921526|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
82921527|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921528|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
82921529|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
82921530|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921531|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921532|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921533|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
82921534|NCT05280873|Hormones|hormones|mesh-ancestor
82921535|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921536|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82921537|NCT05280873|Protective Agents|protective agents|mesh-ancestor
82921538|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82921539|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921540|NCT05280873|Analgesics|analgesics|mesh-ancestor
82921541|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
82921542|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82921543|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921544|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921545|NCT02066818|Lidocaine|lidocaine|mesh-list
82921546|NCT02066818|Tetracaine|tetracaine|mesh-list
82921547|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
82921549|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921550|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921551|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
82921552|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921553|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82921554|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82921555|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82921556|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82921557|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921558|NCT04558125|Heparin|heparin|mesh-list
82921559|NCT04558125|Calcium heparin|calcium heparin|mesh-list
82921560|NCT04558125|Enoxaparin|enoxaparin|mesh-list
82921561|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82921562|NCT04558125|Tinzaparin|tinzaparin|mesh-list
82921563|NCT04558125|Dalteparin|dalteparin|mesh-list
82921564|NCT04558125|Tenecteplase|tenecteplase|mesh-list
82921565|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
82921566|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
82921567|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82921568|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82921569|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921570|NCT05460195|Immunomodulating Agents|immunomodulating agents|mesh-list
82921571|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
82921572|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921573|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
82921574|NCT02793622|Piperaquine|piperaquine|mesh-list
82921575|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
82921576|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82921577|NCT02793622|Artenimol|artenimol|mesh-list
82921578|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
82921579|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82921580|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82921581|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921582|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82921583|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921584|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921585|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82921586|NCT04493931|Rifampin|rifampin|mesh-list
82921587|NCT04493931|Gepotidacin|gepotidacin|mesh-list
82921588|NCT04493931|Digoxin|digoxin|mesh-list
82921589|NCT04493931|Midazolam|midazolam|mesh-list
82921590|NCT04493931|Cimetidine|cimetidine|mesh-list
82921591|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82921592|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82921593|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921594|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921595|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82921596|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82921597|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921598|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82921599|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
82921600|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
82921601|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
82921602|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
82921603|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921604|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921605|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82921606|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
82921607|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82921608|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921609|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
82921610|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82921611|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921612|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82921613|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82921614|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82921615|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82921616|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82921617|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82921618|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82921619|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82921620|NCT04493931|Protective Agents|protective agents|mesh-ancestor
82921621|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82921622|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921623|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82921624|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
82921625|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
82921626|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82921627|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82921628|NCT04493931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82921629|NCT04493931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921630|NCT02260336|Celecoxib|celecoxib|mesh-list
82921631|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82921632|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921633|NCT02260336|Analgesics|analgesics|mesh-ancestor
82921634|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
82921635|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921636|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921637|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921638|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921639|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82921640|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82921641|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921642|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921643|NCT04948203|Sirolimus|sirolimus|mesh-list
82921644|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82921645|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921646|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82921647|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921648|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
82921649|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82921650|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
82921651|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921652|NCT03755193|Diphosphonates|diphosphonates|mesh-list
82921653|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82921654|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921655|NCT03755115|Epirubicin|epirubicin|mesh-list
82921656|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82921657|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921658|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82921659|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82921660|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921661|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921662|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82921663|NCT03755037|Estradiol|estradiol|mesh-list
82921664|NCT03755037|Estrogens|estrogens|mesh-ancestor
82921665|NCT03755037|Hormones|hormones|mesh-ancestor
82921666|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921667|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921668|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82921669|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
82921670|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82921671|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82921672|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82921673|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82921674|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
82921675|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921676|NCT04490499|Vaccines|vaccines|mesh-list
82921677|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
82921678|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921679|NCT01332994|Rituximab|rituximab|mesh-list
82921680|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82921681|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921682|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
82921683|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921686|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82921687|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82921688|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921689|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921690|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82921691|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82921692|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921693|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82921694|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
82921695|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
82921696|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
82921697|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
82921698|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921699|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921700|NCT02068690|BI 425809|bi 425809|mesh-list
82921701|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
82921702|NCT02067442|Acetaminophen|acetaminophen|mesh-list
82921703|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921704|NCT02067442|Analgesics|analgesics|mesh-ancestor
82921705|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
82921706|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921707|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921708|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
82921709|NCT02067520|Hydromorphone|hydromorphone|mesh-list
82921710|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82921711|NCT02067520|Narcotics|narcotics|mesh-ancestor
82921712|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921713|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921714|NCT02067520|Analgesics|analgesics|mesh-ancestor
82921715|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
82921716|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921717|NCT03757923|Metformin|metformin|mesh-list
82921718|NCT03757923|Pioglitazone|pioglitazone|mesh-list
82921719|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82921720|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921721|NCT02071888|Dexamethasone|dexamethasone|mesh-list
82921722|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
82921723|NCT02071888|Pomalidomide|pomalidomide|mesh-list
82921724|NCT02071888|BB 1101|bb 1101|mesh-list
82921725|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921726|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
82921727|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
82921728|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921729|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921730|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921731|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
82921732|NCT02071888|Hormones|hormones|mesh-ancestor
82921733|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921734|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82921735|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921736|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
82921737|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921738|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921739|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
82921740|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82921741|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82921742|NCT02071888|Growth Substances|growth substances|mesh-ancestor
82921743|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
82921744|NCT02071966|Clopidogrel|clopidogrel|mesh-list
82921745|NCT02071966|Ticagrelor|ticagrelor|mesh-list
82921746|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82921747|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82921748|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82921749|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82921750|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
82921751|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921752|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921753|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921754|NCT02072278|Vortioxetine|vortioxetine|mesh-list
82921755|NCT02072278|Escitalopram|escitalopram|mesh-list
82921756|NCT02072278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82921757|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82921758|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82921759|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921761|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
82921762|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921763|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
82921764|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921765|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82921766|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82921767|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921768|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82921769|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82921770|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82921771|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82921772|NCT02072512|Fulvestrant|fulvestrant|mesh-list
82921773|NCT02072512|Anastrozole|anastrozole|mesh-list
82921774|NCT02072512|Goserelin|goserelin|mesh-list
82921775|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82921776|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921777|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82921778|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82921779|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
82921780|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921781|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921782|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82921783|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82921784|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921785|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921786|NCT04534491|Oxybutynin|oxybutynin|mesh-list
82921787|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
82921788|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
82921789|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921790|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921791|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82921792|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82921793|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
82921794|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921795|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921796|NCT04534491|Urological Agents|urological agents|mesh-ancestor
82921797|NCT02069080|Plerixafor|plerixafor|mesh-list
82921798|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82921799|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82921800|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
82921801|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921802|NCT02077348|Hormones|hormones|mesh-list
82921803|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921804|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921805|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
82921806|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82921807|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82921808|NCT03694821|Prednisolone|prednisolone|mesh-list
82921809|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
82921810|NCT03694821|Ketorolac|ketorolac|mesh-list
82921811|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82921812|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82921813|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
82921814|NCT03694821|Hylan|hylan|mesh-list
82921815|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921816|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
82921817|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
82921818|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921819|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921820|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82921821|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
82921822|NCT03694821|Hormones|hormones|mesh-ancestor
82921823|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921824|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82921825|NCT03694821|Protective Agents|protective agents|mesh-ancestor
82921826|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82921827|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921828|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82921829|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921830|NCT03694821|Analgesics|analgesics|mesh-ancestor
82921831|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
82921832|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921833|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82921834|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921835|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921836|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
82921837|NCT02069158|Paclitaxel|paclitaxel|mesh-list
82921838|NCT02069158|Carboplatin|carboplatin|mesh-list
82921839|NCT02069158|Gedatolisib|gedatolisib|mesh-list
82921840|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82921841|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921842|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
82921843|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
82921844|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
82921845|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921846|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82921847|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921848|NCT04531527|Butenafine|butenafine|mesh-list
82921849|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
82921850|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921851|NCT03165994|Paclitaxel|paclitaxel|mesh-list
82921852|NCT03165994|Carboplatin|carboplatin|mesh-list
82921853|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82921854|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921855|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
82921856|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
82921857|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
82921858|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921859|NCT02078440|Bromocriptine|bromocriptine|mesh-list
82921860|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82921861|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82921862|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
82921863|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921864|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921865|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
82921866|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
82921867|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921868|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921869|NCT02070406|Aldesleukin|aldesleukin|mesh-list
82921870|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
82921871|NCT02070406|Fludarabine|fludarabine|mesh-list
82921872|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
82921873|NCT02070406|Interleukin-2|interleukin-2|mesh-list
82921874|NCT02070406|Vaccines|vaccines|mesh-list
82921875|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82921876|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82921877|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
82921878|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921879|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921880|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82921881|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
82921882|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921883|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921884|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82921885|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82921886|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
82921887|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921888|NCT02070406|Analgesics|analgesics|mesh-ancestor
82921889|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
82921890|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921891|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82921892|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82921893|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
82921894|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921895|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82921896|NCT02078596|Valproic Acid|valproic acid|mesh-list
82921897|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
82921898|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921899|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921900|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
82921901|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921902|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921903|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
82921904|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82921905|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921906|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82921907|NCT02070718|Pentazocine|pentazocine|mesh-list
82921908|NCT02070718|Naloxone|naloxone|mesh-list
82921909|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82921911|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
82921912|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921914|NCT02070718|Narcotics|narcotics|mesh-ancestor
82921915|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921916|NCT02070718|Analgesics|analgesics|mesh-ancestor
82921917|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82921918|NCT02070796|Rotigotine|rotigotine|mesh-list
82921919|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
82921920|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
82921921|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921922|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921923|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921924|NCT02079064|Propofol|propofol|mesh-list
82921925|NCT02079064|Desflurane|desflurane|mesh-list
82921926|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82921927|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82921928|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483015|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
82921929|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82921930|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
82921931|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
82921932|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82921933|NCT02079220|Capecitabine|capecitabine|mesh-list
82921934|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
82921935|NCT02079220|Aflibercept|aflibercept|mesh-list
82921936|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82921937|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
82921938|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921939|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921940|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82921941|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82921942|NCT02079220|Growth Substances|growth substances|mesh-ancestor
82921943|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921944|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
82921945|NCT02079298|Fluconazole|fluconazole|mesh-list
82921946|NCT02079298|Ibuprofen|ibuprofen|mesh-list
82921947|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82921948|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82921949|NCT02079298|Analgesics|analgesics|mesh-ancestor
82921950|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
82921951|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921952|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921953|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82921954|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82921955|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82921956|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921957|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921958|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
82921959|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921960|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82921961|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82921962|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82921963|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
82921964|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82921965|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82921966|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82921967|NCT02071342|Everolimus|everolimus|mesh-list
82921968|NCT02071342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82921969|NCT02071342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82921970|NCT02071342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921971|NCT02071342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921972|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82921973|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
82921974|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921975|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921976|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82921977|NCT02080078|Theophylline|theophylline|mesh-list
82921978|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82921979|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82921980|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82921981|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82921982|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82921983|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
82921984|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82921985|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82921986|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82921987|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
82921988|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82921989|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
82921990|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82921991|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82921992|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
82921993|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82921994|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
82921995|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82921996|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82921997|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82921998|NCT03559504|Sevoflurane|sevoflurane|mesh-list
82921999|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82922000|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82922001|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
82922002|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
82922003|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922004|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922005|NCT02080234|Gemcitabine|gemcitabine|mesh-list
82922006|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
82922007|NCT02080234|Asparaginase|asparaginase|mesh-list
82922008|NCT02080234|Pegaspargase|pegaspargase|mesh-list
82922009|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82922010|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
82922011|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922012|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922013|NCT05070039|Antibodies|antibodies|mesh-list
82922014|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
82922015|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922016|NCT05459649|Cyclosporine|cyclosporine|mesh-list
82922017|NCT05459649|Prednisone|prednisone|mesh-list
82922018|NCT05459649|Cyclosporins|cyclosporins|mesh-list
82922019|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922020|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
82922021|NCT05459649|Hormones|hormones|mesh-ancestor
82922022|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922023|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922024|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922025|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922026|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922027|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922028|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922029|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
82922030|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
82922031|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922032|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922033|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922034|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82922035|NCT05050305|Dexamethasone|dexamethasone|mesh-list
82922036|NCT05050305|Pomalidomide|pomalidomide|mesh-list
82922037|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922038|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
82922039|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
82922040|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922041|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922042|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922043|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
82922044|NCT05050305|Hormones|hormones|mesh-ancestor
82922045|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922046|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922047|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922048|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
82922049|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82922050|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82922051|NCT05050305|Growth Substances|growth substances|mesh-ancestor
82922052|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
82922053|NCT04461795|Erenumab|erenumab|mesh-list
82922054|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82922055|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
82922056|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922057|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82922058|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922059|NCT04461795|Analgesics|analgesics|mesh-ancestor
82922060|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
82922061|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922062|NCT04461015|Insulin|insulin|mesh-list
82922063|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82922064|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82922065|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922066|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
82922067|NCT03754179|Trametinib|trametinib|mesh-list
82922068|NCT03754179|Dabrafenib|dabrafenib|mesh-list
82922069|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
82922070|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82922071|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82922072|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922073|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922074|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922075|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922076|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922077|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82922078|NCT03753867|Acitretin|acitretin|mesh-list
82922079|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
82922080|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922082|NCT04439253|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82922083|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82922084|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922085|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922086|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922087|NCT03750669|Folic Acid|folic acid|mesh-list
82922088|NCT03750669|Paclitaxel|paclitaxel|mesh-list
82922089|NCT03750669|Gemcitabine|gemcitabine|mesh-list
82922090|NCT03750669|Fluorouracil|fluorouracil|mesh-list
82922091|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
82922092|NCT03750669|Irinotecan|irinotecan|mesh-list
82922093|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82922094|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922095|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
82922096|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
82922097|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
82922098|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922099|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82922100|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
82922101|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922102|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
82922103|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922104|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82922105|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82922106|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922107|NCT03750669|Hematinics|hematinics|mesh-ancestor
82922108|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
82922109|NCT03750669|Vitamins|vitamins|mesh-ancestor
82922110|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
82922111|NCT03757221|Daratumumab|daratumumab|mesh-list
82922112|NCT03757221|Ixazomib|ixazomib|mesh-list
82922113|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922114|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
82922115|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922116|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922117|NCT03757143|Ethanol|ethanol|mesh-list
82922118|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
82922119|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
82922120|NCT03757143|Povidone|povidone|mesh-list
82922121|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82922122|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922123|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922124|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922125|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
82922126|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
82922127|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
82922128|NCT04428411|Etanercept|etanercept|mesh-list
82922129|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82922130|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82922131|NCT04428411|Analgesics|analgesics|mesh-ancestor
82922132|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
82922133|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922134|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922135|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922136|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922138|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922139|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
82922140|NCT03751059|Dexamethasone|dexamethasone|mesh-list
82922141|NCT03751059|Bromfenac|bromfenac|mesh-list
82922142|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922143|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
82922144|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
82922145|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922146|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922147|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922148|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
82922149|NCT03751059|Hormones|hormones|mesh-ancestor
82922150|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922151|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922152|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922153|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82922154|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82922155|NCT03751059|Analgesics|analgesics|mesh-ancestor
82922156|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
82922157|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922158|NCT04422561|Ivermectin|ivermectin|mesh-list
82922159|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82922160|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922161|NCT03756987|Ropivacaine|ropivacaine|mesh-list
82922162|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
82922163|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
82922164|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922165|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922166|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
82922167|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922169|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
82922170|NCT02072746|Trace Elements|trace elements|mesh-ancestor
82922171|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
82922172|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922173|NCT02072746|Astringents|astringents|mesh-ancestor
82922174|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922175|NCT04940338|Dexamethasone|dexamethasone|mesh-list
82922176|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
82922177|NCT04940338|Bromfenac|bromfenac|mesh-list
82922178|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82922179|NCT04940338|BB 1101|bb 1101|mesh-list
82922180|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922181|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
82922182|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
82922183|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922184|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922185|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922186|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
82922187|NCT04940338|Hormones|hormones|mesh-ancestor
82922188|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922189|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922190|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922191|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
82922192|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922193|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922194|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82922195|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82922196|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82922197|NCT04940338|Analgesics|analgesics|mesh-ancestor
82922198|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
82922199|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922200|NCT02083510|Colchicine|colchicine|mesh-list
82922201|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
82922202|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922203|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
82922204|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
82922205|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
82922206|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922207|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922208|NCT04407507|Ivermectin|ivermectin|mesh-list
82922209|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82922210|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922211|NCT02080624|Sirolimus|sirolimus|mesh-list
82922212|NCT02080624|Temsirolimus|temsirolimus|mesh-list
82922213|NCT02080624|MTOR Inhibitors|mtor inhibitors|mesh-list
82922214|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922216|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82922217|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922218|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
82922219|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922220|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
82922221|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922222|NCT02080624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82922223|NCT02080624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922224|NCT02080624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922225|NCT02080858|Apixaban|apixaban|mesh-list
82922226|NCT02080858|Ticagrelor|ticagrelor|mesh-list
82922227|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82922228|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82922229|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82922230|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82922231|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
82922232|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922233|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922234|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922235|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82922236|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
82922237|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82922238|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
82922239|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922240|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
82922241|NCT02073526|Adalimumab|adalimumab|mesh-list
82922242|NCT02073526|Infliximab|infliximab|mesh-list
82922243|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
82922244|NCT02073526|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82922245|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922246|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922247|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922248|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922249|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922250|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
82922251|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922252|NCT02073916|Paclitaxel|paclitaxel|mesh-list
82922253|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82922254|NCT02073916|Trastuzumab|trastuzumab|mesh-list
82922255|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82922256|NCT02073916|Lapatinib|lapatinib|mesh-list
82922257|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82922258|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922259|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
82922260|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
82922261|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
82922262|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922263|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82922264|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82922265|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922266|NCT02073916|Immunotoxins|immunotoxins|mesh-ancestor
82922267|NCT02073916|Immunoconjugates|immunoconjugates|mesh-ancestor
82922268|NCT02073916|Immunologic Factors|immunologic factors|mesh-ancestor
82922269|NCT02073916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922270|NCT02084368|Bupivacaine|bupivacaine|mesh-list
82922271|NCT02084368|Ropivacaine|ropivacaine|mesh-list
82922272|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
82922273|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
82922274|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922275|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922276|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
82922277|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922278|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
82922279|NCT02084446|Prednisone|prednisone|mesh-list
82922280|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
82922281|NCT02084446|Everolimus|everolimus|mesh-list
82922282|NCT02084446|Tacrolimus|tacrolimus|mesh-list
82922283|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
82922284|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82922285|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922286|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
82922287|NCT02084446|Hormones|hormones|mesh-ancestor
82922288|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922289|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922290|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922292|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922293|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
82922294|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82922295|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922296|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922297|NCT02084446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82922298|NCT02084446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82922299|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82922300|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82922301|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
82922302|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922303|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922304|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
82922305|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
82922306|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922307|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922308|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82922309|NCT02084446|Protective Agents|protective agents|mesh-ancestor
82922311|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922312|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922313|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82922314|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82922315|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922316|NCT02084602|Artesunate|artesunate|mesh-list
82922317|NCT02084602|Mefloquine|mefloquine|mesh-list
82922318|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
82922319|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82922320|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82922321|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922322|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922323|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
82922324|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
82922325|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82922326|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
82922327|NCT02081560|Colistin|colistin|mesh-list
82922328|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922329|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922330|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82922331|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82922332|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82922333|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922334|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922335|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82922336|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82922337|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922338|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
82922339|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922340|NCT02074228|Methylphenidate|methylphenidate|mesh-list
82922341|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82922342|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922343|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82922344|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82922345|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82922346|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922347|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
82922348|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922349|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
82922350|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922351|NCT03558490|Immunomodulating Agents|immunomodulating agents|mesh-list
82922352|NCT03558490|Immunologic Factors|immunologic factors|mesh-ancestor
82922353|NCT03558490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922354|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
82922355|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
82922356|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82922357|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82922358|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922359|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922360|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922361|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922362|NCT02085304|Temozolomide|temozolomide|mesh-list
82922363|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82922364|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
82922365|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922366|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922367|NCT02260414|Tinzaparin|tinzaparin|mesh-list
82922368|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82922369|NCT02260414|Dalteparin|dalteparin|mesh-list
82922370|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
82922371|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82922372|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82922373|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922374|NCT02085538|Palbociclib|palbociclib|mesh-list
82922375|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922376|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82922377|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922378|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922379|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82922380|NCT04169061|Hormones|hormones|mesh-ancestor
82922381|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922382|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922383|NCT01562691|Petrolatum|petrolatum|mesh-list
82922384|NCT01562691|Emollients|emollients|mesh-ancestor
82922385|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922386|NCT04681677|Bevacizumab|bevacizumab|mesh-list
82922387|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82922388|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922389|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82922390|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82922391|NCT04681677|Growth Substances|growth substances|mesh-ancestor
82922392|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922393|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
82922394|NCT02792218|Teriflunomide|teriflunomide|mesh-list
82922395|NCT02792218|Ofatumumab|ofatumumab|mesh-list
82922396|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82922397|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922398|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
82922399|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922400|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82922401|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82922402|NCT02792218|Analgesics|analgesics|mesh-ancestor
82922403|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
82922404|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922405|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922406|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922407|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922408|NCT02075086|Bevacizumab|bevacizumab|mesh-list
82922409|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82922410|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922411|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82922412|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82922413|NCT02075086|Growth Substances|growth substances|mesh-ancestor
82922414|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922415|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
82922416|NCT02082418|Caseins|caseins|mesh-list
82922417|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
82922418|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
82922419|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922420|NCT02082496|Liraglutide|liraglutide|mesh-list
82922421|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82922422|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922423|NCT02082496|Incretins|incretins|mesh-ancestor
82922424|NCT02082496|Hormones|hormones|mesh-ancestor
82922425|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922426|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
82922427|NCT02075242|Tacrolimus|tacrolimus|mesh-list
82922428|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922429|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
82922430|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922431|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82922432|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922433|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922434|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82922435|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922436|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82922437|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
82922438|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922439|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922441|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82922442|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
82922443|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82922444|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922445|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82922446|NCT00153101|Telmisartan|telmisartan|mesh-list
82922447|NCT00153101|Ramipril|ramipril|mesh-list
82922448|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82922449|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82922450|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82922451|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922452|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82922453|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
82922454|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922455|NCT03558412|Decitabine|decitabine|mesh-list
82922456|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82922457|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
82922458|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922459|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922460|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922461|NCT04401579|Remdesivir|remdesivir|mesh-list
82922462|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
82922463|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922464|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
82922465|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922466|NCT03558880|Anesthetics|anesthetics|mesh-list
83483016|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
82922467|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922468|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922469|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
82922470|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82922471|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
82922472|NCT03749733|Megestrol|megestrol|mesh-list
82922473|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82922474|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82922475|NCT03749733|Estradiol|estradiol|mesh-list
82922476|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82922477|NCT03749733|Estrogens|estrogens|mesh-ancestor
82922478|NCT03749733|Hormones|hormones|mesh-ancestor
82922479|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922480|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922481|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82922482|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
82922483|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82922484|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82922485|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82922486|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82922487|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82922488|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922489|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922490|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
82922491|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82922492|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922493|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
82922494|NCT04160091|FX006|fx006|mesh-list
82922495|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922496|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
82922497|NCT04160091|Hormones|hormones|mesh-ancestor
82922498|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922499|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922500|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922501|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
82922502|NCT01582607|Fentanyl|fentanyl|mesh-list
82922503|NCT01582607|Bupivacaine|bupivacaine|mesh-list
82922504|NCT01582607|Ropivacaine|ropivacaine|mesh-list
82922505|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
82922506|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
82922507|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
82922508|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922509|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922510|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
82922511|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922512|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82922513|NCT01582607|Narcotics|narcotics|mesh-ancestor
82922514|NCT01582607|Analgesics|analgesics|mesh-ancestor
82922515|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82922516|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82922517|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
82922518|NCT00149825|Dexetimide|dexetimide|mesh-list
82922519|NCT00149825|Citalopram|citalopram|mesh-list
82922520|NCT00149825|Escitalopram|escitalopram|mesh-list
82922521|NCT00149825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82922522|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82922523|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82922524|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922525|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922526|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
82922527|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922528|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82922529|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82922530|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
82922531|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
82922532|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922533|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82922534|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82922535|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
83457903|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82922536|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82922537|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
82922538|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82922539|NCT02792062|Relugolix|relugolix|mesh-list
82922540|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
82922541|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
82922542|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922543|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922544|NCT05027295|Riboflavin|riboflavin|mesh-list
82922545|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82922546|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82922547|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
82922548|NCT05027295|Vitamins|vitamins|mesh-ancestor
82922549|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
82922550|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922551|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82922552|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922553|NCT02090920|Nifedipine|nifedipine|mesh-list
82922554|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82922555|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82922556|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922557|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82922558|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922559|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
82922560|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
82922561|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82922562|NCT02086474|Bupivacaine|bupivacaine|mesh-list
82922563|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
82922564|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
82922565|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
82922566|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922567|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922568|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
82922569|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922570|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82922571|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
82922572|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
82922573|NCT02086474|Protective Agents|protective agents|mesh-ancestor
82922574|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
82922575|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922576|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922577|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82922578|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82922579|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922580|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922581|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922582|NCT02621398|Paclitaxel|paclitaxel|mesh-list
82922583|NCT02621398|Carboplatin|carboplatin|mesh-list
82922584|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
82922585|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82922586|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82922587|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922588|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
82922589|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
82922590|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
82922591|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922592|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82922593|NCT02621398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82922595|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82922596|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82922597|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922598|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82922599|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
82922600|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
82922601|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922602|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922603|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922604|NCT02091388|Risperidone|risperidone|mesh-list
82922605|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82922606|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
82922607|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83457905|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
82922608|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922609|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922610|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82922611|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82922612|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922613|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82922614|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82922615|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
82922616|NCT02086942|Dexamethasone|dexamethasone|mesh-list
82922617|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
82922618|NCT02086942|Bortezomib|bortezomib|mesh-list
82922619|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922620|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
82922621|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922622|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922623|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82922624|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
82922625|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922626|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922627|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82922628|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922629|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
82922630|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
82922631|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922632|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922633|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
82922634|NCT02086942|Hormones|hormones|mesh-ancestor
82922635|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922636|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922637|NCT02088424|Insulin|insulin|mesh-list
82922638|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82922639|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922640|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82922641|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82922642|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82922643|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82922644|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922645|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
82922646|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922647|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922648|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82922649|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922650|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
82922651|NCT02088502|Theophylline|theophylline|mesh-list
82922652|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82922653|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
82922654|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922655|NCT02088502|Expectorants|expectorants|mesh-ancestor
82922656|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
82922657|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82922658|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
82922659|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922660|NCT02088502|Protective Agents|protective agents|mesh-ancestor
82922661|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922662|NCT02088502|Antidotes|antidotes|mesh-ancestor
82922663|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82922664|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
82922666|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82922667|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82922668|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922669|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
82922670|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82922671|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82922672|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
82922673|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922674|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
82922675|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82922676|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82922677|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
82922678|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922679|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922680|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922681|NCT02087098|Urological Agents|urological agents|mesh-ancestor
82922682|NCT01369342|Ustekinumab|ustekinumab|mesh-list
82922683|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922684|NCT00191477|Gemcitabine|gemcitabine|mesh-list
82922685|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82922686|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
82922687|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922688|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922689|NCT02087332|Torsemide|torsemide|mesh-list
82922690|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82922691|NCT02087332|Diuretics|diuretics|mesh-ancestor
82922692|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
82922693|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83483017|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922694|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82922695|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82922696|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922697|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
82922698|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
82922699|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82922700|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922701|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922702|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82922703|NCT02092012|Analgesics|analgesics|mesh-ancestor
82922704|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
82922705|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922706|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82922707|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82922708|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82922709|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
82922710|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922711|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922712|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82922713|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922714|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922716|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82922717|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
82922718|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922719|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922720|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82922721|NCT00187889|Diuretics|diuretics|mesh-ancestor
82922722|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
82922723|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82922724|NCT02087488|Eszopiclone|eszopiclone|mesh-list
82922725|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82922726|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922727|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922728|NCT02087566|Linezolid|linezolid|mesh-list
82922729|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922730|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922731|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82922732|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922733|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922734|NCT00148109|Cetuximab|cetuximab|mesh-list
82922735|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82922736|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922737|NCT03746223|Rituximab|rituximab|mesh-list
82922738|NCT03746223|Methotrexate|methotrexate|mesh-list
82922739|NCT03746223|Lenalidomide|lenalidomide|mesh-list
82922740|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82922741|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922742|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
82922743|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922744|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922745|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82922746|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
82922747|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82922748|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82922749|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
82922750|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922751|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922752|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922753|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82922754|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922755|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82922756|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82922757|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82922758|NCT03746223|Growth Substances|growth substances|mesh-ancestor
82922759|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
82922760|NCT03969017|Interferons|interferons|mesh-list
82922761|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922762|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
82922763|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922764|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
82922765|NCT04596033|Fludarabine|fludarabine|mesh-list
82763123|NCT00994695|Vaccines|vaccines|mesh-list
82922766|NCT04596033|Interleukin-2|interleukin-2|mesh-list
82922767|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922768|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
82922769|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922770|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922771|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82922772|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
82922773|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922774|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922775|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82922776|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82922777|NCT04596033|Analgesics|analgesics|mesh-ancestor
82922778|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
82922779|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922780|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
82922781|NCT02092558|Cephalosporins|cephalosporins|mesh-list
82922782|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82922783|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922784|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82922785|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
82922786|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
82922787|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82922788|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
82922789|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922790|NCT01074359|Protective Agents|protective agents|mesh-ancestor
82922791|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922792|NCT02087722|Melatonin|melatonin|mesh-list
82922793|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
82922794|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922795|NCT02087722|Protective Agents|protective agents|mesh-ancestor
82922796|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922797|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922798|NCT01326221|Tenofovir|tenofovir|mesh-list
82922799|NCT01326221|Emtricitabine|emtricitabine|mesh-list
82922800|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
82922801|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922802|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82922803|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82922804|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922805|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922806|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82922807|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82922808|NCT04311177|Losartan|losartan|mesh-list
82922809|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82922810|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82922811|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82922813|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922815|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82922816|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
82922817|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922818|NCT01074593|Interferons|interferons|mesh-list
82922819|NCT01074593|Interferon-beta|interferon-beta|mesh-list
82922820|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
82922821|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922822|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
82922823|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922824|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
82922825|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922826|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82922827|NCT02088970|Riboflavin|riboflavin|mesh-list
82922828|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82922829|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922830|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
82922831|NCT02088970|Vitamins|vitamins|mesh-ancestor
82922832|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
82922833|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922834|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82922835|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922836|NCT03968861|Xenon|xenon|mesh-list
82922837|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82922838|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
82922839|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
82922840|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922841|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922842|NCT04292535|Insulin|insulin|mesh-list
82922843|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82922844|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
82922845|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
82922846|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82922847|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82922848|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922849|NCT03747081|Warfarin|warfarin|mesh-list
82922850|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
82922851|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
82922852|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82922853|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
82922854|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82922855|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
82922856|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922857|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922858|NCT01075841|Cetuximab|cetuximab|mesh-list
82922859|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82922860|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922861|NCT01313390|Docetaxel|docetaxel|mesh-list
82922862|NCT01313390|Everolimus|everolimus|mesh-list
82922863|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922864|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
82922865|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
82922866|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
82922867|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922868|NCT01313390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82922869|NCT01313390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82922870|NCT01313390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922871|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922872|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
82922873|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922874|NCT05571332|Cyclosporine|cyclosporine|mesh-list
82922875|NCT05571332|Cyclosporins|cyclosporins|mesh-list
82922876|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922877|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922878|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922879|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
82922880|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922881|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
82922882|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922883|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922884|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922885|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82922886|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82922887|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82922888|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82922889|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922891|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82922892|NCT02089126|Glimepiride|glimepiride|mesh-list
82922893|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82922894|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82922895|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922896|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82922897|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
82922898|NCT05571176|Ketamine|ketamine|mesh-list
82922899|NCT05571176|Esketamine|esketamine|mesh-list
82922900|NCT05571176|Analgesics|analgesics|mesh-ancestor
82922901|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
82922902|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922903|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922904|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82922905|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82922906|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
82922907|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
82922908|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922909|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82922910|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82922911|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922912|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922913|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
82922914|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82922915|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82922916|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82922917|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922918|NCT02095834|Dexamethasone|dexamethasone|mesh-list
82922919|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
82922920|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82922921|NCT02095834|Ichthammol|ichthammol|mesh-list
82922922|NCT02095834|BB 1101|bb 1101|mesh-list
82922923|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82922924|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
82922925|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
82922926|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922927|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922928|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922929|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
82922930|NCT02095834|Hormones|hormones|mesh-ancestor
82922931|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922932|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82922933|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82922934|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82922935|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
82922936|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922937|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
82922938|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922939|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
82922940|NCT03556852|Misoprostol|misoprostol|mesh-list
82922941|NCT03556852|Carbetocin|carbetocin|mesh-list
82922942|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82922943|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
82922944|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82922945|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922946|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82922947|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82922948|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
82922949|NCT02808572|Mitogens|mitogens|mesh-list
82922950|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
82922951|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922952|NCT02093728|Itraconazole|itraconazole|mesh-list
82922953|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
82922954|NCT02093728|Fluconazole|fluconazole|mesh-list
82922955|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
82922956|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922957|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82922958|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82922959|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82922960|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922961|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82922962|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
82922963|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82922964|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922965|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82922966|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82922967|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82922968|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82922969|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
82922970|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922971|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
82922972|NCT02089204|Fluorides|fluorides|mesh-list
82922973|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
82922974|NCT02089204|Protective Agents|protective agents|mesh-ancestor
82922975|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922976|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
82922977|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922978|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
82922979|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82922980|NCT02095990|Hydroquinone|hydroquinone|mesh-list
82922981|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
82922982|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82922983|NCT02095990|Protective Agents|protective agents|mesh-ancestor
82922984|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922985|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82922986|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
82922987|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82922988|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82922989|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82922990|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82922991|NCT02096068|Analgesics|analgesics|mesh-ancestor
82922992|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
82922993|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82922994|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82922995|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82922996|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82922997|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
82922998|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82922999|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923000|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82923001|NCT02089438|Vildagliptin|vildagliptin|mesh-list
82923002|NCT02089438|Saxagliptin|saxagliptin|mesh-list
82923003|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923004|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923005|NCT02089438|Incretins|incretins|mesh-ancestor
82923006|NCT02089438|Hormones|hormones|mesh-ancestor
82923007|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923008|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82923009|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
82923010|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923011|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923012|NCT05471674|Nivolumab|nivolumab|mesh-list
82923013|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82923014|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923015|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82923016|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923017|NCT02096224|Sevoflurane|sevoflurane|mesh-list
82923018|NCT02096224|Desflurane|desflurane|mesh-list
82923019|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82923020|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82923021|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
82923022|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
82923023|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923024|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923025|NCT02096380|Cisplatin|cisplatin|mesh-list
82923026|NCT02096380|Docetaxel|docetaxel|mesh-list
82923027|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923028|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923029|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923030|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923031|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923032|NCT04384107|Vaccines|vaccines|mesh-list
82923033|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82923034|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
82923035|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923037|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82923038|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923039|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82923040|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82923041|NCT02250118|Growth Substances|growth substances|mesh-ancestor
82923042|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923043|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
82923045|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923046|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923047|NCT02096536|Vancomycin|vancomycin|mesh-list
82923048|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923049|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923050|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
82923051|NCT02096614|Fludarabine|fludarabine|mesh-list
82923052|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82923053|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
82923054|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923055|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923056|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82923057|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
82923058|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923059|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923060|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82923061|NCT02094196|Ethanol|ethanol|mesh-list
82923062|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82923063|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923064|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923065|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923066|NCT02094274|Fluticasone|fluticasone|mesh-list
82923068|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82923069|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923070|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82763422|NCT02582177|Miconazole|miconazole|mesh-list
82923071|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
82923072|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923073|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923074|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82923075|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
82923076|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
82923077|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82923078|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82923079|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82923080|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82923081|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
82923082|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923083|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923085|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82923086|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923087|NCT02096926|Analgesics|analgesics|mesh-ancestor
82923088|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
82923089|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923090|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923091|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923092|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923093|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82923094|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923095|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923096|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82923097|NCT02097004|Entecavir|entecavir|mesh-list
82923098|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
82923099|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923100|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
82923101|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923102|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
82923103|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923104|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923105|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82923106|NCT03691779|Ivacaftor|ivacaftor|mesh-list
82923107|NCT03691779|Elexacaftor|elexacaftor|mesh-list
82923108|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82923109|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82923110|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923112|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82923113|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923114|NCT03555994|Liraglutide|liraglutide|mesh-list
82923115|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923116|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923117|NCT03555994|Incretins|incretins|mesh-ancestor
82923118|NCT03555994|Hormones|hormones|mesh-ancestor
82923119|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923120|NCT02095366|Sufentanil|sufentanil|mesh-list
82923121|NCT02095366|Morphine|morphine|mesh-list
82923122|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82923123|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82923124|NCT02095366|Narcotics|narcotics|mesh-ancestor
82923125|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923126|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923127|NCT02095366|Analgesics|analgesics|mesh-ancestor
82923128|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
82923129|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923130|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82923131|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82923132|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
82923133|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
82923134|NCT02097082|Paclitaxel|paclitaxel|mesh-list
82923135|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82923136|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923137|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923138|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923139|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923140|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923141|NCT02097160|Vitamin D|vitamin d|mesh-list
82923142|NCT02097160|Vitamins|vitamins|mesh-ancestor
82923143|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
82923144|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923145|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82923146|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
82923147|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923148|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82923149|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
82923150|NCT02097316|Insulin|insulin|mesh-list
82923151|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923152|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923153|NCT02095522|Colchicine|colchicine|mesh-list
82923154|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
82923155|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923156|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923157|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923158|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923159|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923160|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923161|NCT02097394|Pancreatin|pancreatin|mesh-list
82923162|NCT02097394|Pancrelipase|pancrelipase|mesh-list
82923163|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923164|NCT04123665|Fluorides|fluorides|mesh-list
82923165|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
82923166|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
82923167|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
82923168|NCT04123665|Protective Agents|protective agents|mesh-ancestor
82923169|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923170|NCT02250508|Factor VIII|factor viii|mesh-list
82923171|NCT02250508|Coagulants|coagulants|mesh-ancestor
82923172|NCT03555526|Amoxicillin|amoxicillin|mesh-list
82923173|NCT03555526|Metronidazole|metronidazole|mesh-list
82923174|NCT03555526|Clarithromycin|clarithromycin|mesh-list
82923175|NCT03555526|Levofloxacin|levofloxacin|mesh-list
82923176|NCT03555526|Tetracycline|tetracycline|mesh-list
82923177|NCT03555526|Esomeprazole|esomeprazole|mesh-list
82923178|NCT03555526|Bismuth|bismuth|mesh-list
82923179|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923180|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923181|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82923182|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82923183|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82923184|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923185|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82923186|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923187|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923188|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82923189|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82923190|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82923191|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82923192|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82923193|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82923194|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923195|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82923196|NCT03555526|Antacids|antacids|mesh-ancestor
82923197|NCT02102620|Lidocaine|lidocaine|mesh-list
82923198|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
82923199|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
82923200|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923201|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923202|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
82923203|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923204|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82923205|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82923206|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82923207|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82923208|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923209|NCT02102698|Ecopipam|ecopipam|mesh-list
82923210|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82923211|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82923212|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923213|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923214|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82923215|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82923216|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
82923217|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923218|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923219|NCT02102776|Mitomycins|mitomycins|mesh-list
82923220|NCT02102776|Mitomycin|mitomycin|mesh-list
82923221|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82923222|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923223|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
82923224|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923225|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82923226|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923227|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
82923228|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82923229|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
82923230|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923231|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82923232|NCT02670044|Venetoclax|venetoclax|mesh-list
82923233|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923234|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82923235|NCT02307656|Cobicistat|cobicistat|mesh-list
82923236|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82923237|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82923238|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
82923239|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923240|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923241|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82923242|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82923243|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
82923244|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923245|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82923246|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82923247|NCT04232943|Vaccines|vaccines|mesh-list
82923248|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
82923249|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923250|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
82923251|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82923252|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82923253|NCT02098330|Prednisolone|prednisolone|mesh-list
82923254|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
82923255|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82923256|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
82923257|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923258|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
82923259|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
82923260|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923261|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923262|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923263|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
82923265|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923266|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82923267|NCT02098330|Protective Agents|protective agents|mesh-ancestor
82923268|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82923269|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923270|NCT02103166|Scopolamine|scopolamine|mesh-list
82923271|NCT02103166|Bromides|bromides|mesh-list
82923272|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
82923273|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82923274|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
82923275|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
82923276|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923277|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923278|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923279|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
82923280|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82923281|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
82923282|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923283|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923284|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82923285|NCT02103244|Carboplatin|carboplatin|mesh-list
82923286|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923287|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
82923288|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
82923289|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923290|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923291|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82923292|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82923293|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923294|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923295|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923296|NCT02250820|Pentobarbital|pentobarbital|mesh-list
82923297|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
82923298|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82923299|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923300|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923301|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923302|NCT02250820|Analgesics|analgesics|mesh-ancestor
82923303|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
82923304|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923305|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82923306|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82923307|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82923308|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
82923309|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923310|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923311|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82923312|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
82923313|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
82923315|NCT04292457|Sevoflurane|sevoflurane|mesh-list
82923316|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82923317|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923318|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923319|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82923320|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
82923321|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
82923322|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82923323|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82923324|NCT02100046|Ethosuximide|ethosuximide|mesh-list
82923325|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
82923326|NCT02100202|Turmeric extract|turmeric extract|mesh-list
82923327|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
82923328|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923329|NCT02100202|Protective Agents|protective agents|mesh-ancestor
82923330|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923331|NCT05423392|Lidocaine|lidocaine|mesh-list
82923332|NCT05423392|Carticaine|carticaine|mesh-list
82923333|NCT05423392|Anesthetics|anesthetics|mesh-list
82923334|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
82923335|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923336|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923337|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
82923338|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923339|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82923340|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82923341|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82923342|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82923343|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923344|NCT02103556|Mineral Oil|mineral oil|mesh-list
82923345|NCT02103556|Emollients|emollients|mesh-ancestor
82923346|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
82923348|NCT02099890|Antioxidants|antioxidants|mesh-list
82923349|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82923350|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923351|NCT02099890|Analgesics|analgesics|mesh-ancestor
82923352|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
82923353|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923354|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923355|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923356|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923357|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923358|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923359|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923360|NCT02099890|Protective Agents|protective agents|mesh-ancestor
82923361|NCT03555136|Vortioxetine|vortioxetine|mesh-list
82923362|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
82923363|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82923364|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82923365|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82923366|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923367|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923368|NCT03555136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82923369|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82923370|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82923371|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923372|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923373|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
82923374|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82763715|NCT04276259|Naltrexone|naltrexone|mesh-list
82923375|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82923376|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82923377|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82923378|NCT03554980|Listerine|listerine|mesh-list
82923379|NCT03554980|Fluorides|fluorides|mesh-list
82923380|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
82923381|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
82923382|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
82923383|NCT03554980|Protective Agents|protective agents|mesh-ancestor
82923384|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923385|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82923386|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923387|NCT04230213|Adalimumab|adalimumab|mesh-list
82923388|NCT04230213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82923389|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923390|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923391|NCT03746691|Citalopram|citalopram|mesh-list
82923392|NCT03746691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82923393|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82923394|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82923395|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923396|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923397|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
82923398|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923399|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82923400|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
82923401|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82923402|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82923403|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82923404|NCT03745911|Paclitaxel|paclitaxel|mesh-list
82923405|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82923406|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923407|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923408|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923409|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923410|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083951|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
83083952|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
82923411|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82923412|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82923413|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923415|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923416|NCT03554590|Insulin|insulin|mesh-list
82923417|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923418|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923419|NCT02106286|Bisoprolol|bisoprolol|mesh-list
82923420|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82923421|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
82923422|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
82923423|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83457991|NCT02574078|Docetaxel|docetaxel|mesh-list
82923424|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923425|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82923426|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82923427|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82923428|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
82923429|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923430|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923431|NCT04109391|Trastuzumab|trastuzumab|mesh-list
82923432|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82923433|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923434|NCT02106364|Insulin|insulin|mesh-list
82923435|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82923436|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
82923437|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923438|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923439|NCT04077866|Temozolomide|temozolomide|mesh-list
82923440|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82923441|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
82923442|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923443|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923444|NCT02101138|Pramipexole|pramipexole|mesh-list
82923445|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
83483018|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923446|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923448|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923449|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82923450|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82923451|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
82923452|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
82923453|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923454|NCT04064294|Levodopa|levodopa|mesh-list
82923455|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82923456|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82923457|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
82923458|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923459|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923460|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923461|NCT02106520|Bevacizumab|bevacizumab|mesh-list
82923462|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82923463|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923464|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82923465|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82923466|NCT02106520|Growth Substances|growth substances|mesh-ancestor
82923467|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923468|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
82923469|NCT02101216|Abacavir|abacavir|mesh-list
82923470|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
82923471|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82923472|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82923473|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923474|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923475|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
82923476|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923477|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82923478|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82923479|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
82923480|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82923481|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
82923482|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923484|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82923485|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923486|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923487|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82923488|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82923489|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
82923490|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82923491|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923492|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923493|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82923494|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82923495|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923496|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923497|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923498|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82923499|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
82923500|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82923501|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923502|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82923503|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82923504|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82923505|NCT01562301|Carboplatin|carboplatin|mesh-list
82923506|NCT01562301|Docetaxel|docetaxel|mesh-list
82923507|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923508|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923509|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923510|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923511|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923512|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
82923513|NCT04094883|Vaccines|vaccines|mesh-list
82923514|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
82923515|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923516|NCT02101606|Tenecteplase|tenecteplase|mesh-list
82923517|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82923518|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82923519|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923520|NCT02101840|Oxycodone|oxycodone|mesh-list
82923521|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82923522|NCT02101840|Narcotics|narcotics|mesh-ancestor
82923523|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923524|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923525|NCT02101840|Analgesics|analgesics|mesh-ancestor
82923526|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
82923527|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923528|NCT02107378|Paclitaxel|paclitaxel|mesh-list
82923529|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82923530|NCT02107378|Doxorubicin|doxorubicin|mesh-list
82923531|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82923532|NCT02107378|Topotecan|topotecan|mesh-list
82923533|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82923534|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923535|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923536|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923537|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923538|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923539|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82923540|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82923541|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82923542|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923543|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82923544|NCT02105350|Gemcitabine|gemcitabine|mesh-list
82923545|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
82923546|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82923547|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
82923548|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923549|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923550|NCT02102152|Tobramycin|tobramycin|mesh-list
82923551|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923552|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923553|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
82923554|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82923555|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923556|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
82923557|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923558|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82923559|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82923560|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923562|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923563|NCT02107690|Lidocaine|lidocaine|mesh-list
82923564|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
82923565|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
82923566|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923567|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923568|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
82923569|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923570|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82923571|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82923572|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82923573|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82923574|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923575|NCT05568836|Vitamin D|vitamin d|mesh-list
82923576|NCT05568836|Vitamins|vitamins|mesh-ancestor
82923577|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
82923578|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923579|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82923580|NCT03259490|Metformin|metformin|mesh-list
82923581|NCT03259490|Empagliflozin|empagliflozin|mesh-list
82923582|NCT03259490|Linagliptin|linagliptin|mesh-list
82923583|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923584|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923585|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82923586|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923587|NCT03259490|Incretins|incretins|mesh-ancestor
82923588|NCT03259490|Hormones|hormones|mesh-ancestor
82923589|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923590|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82923591|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
82923592|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923594|NCT02106130|Mosapride|mosapride|mesh-list
82923595|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923596|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82923597|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923598|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
82923599|NCT02106130|Protective Agents|protective agents|mesh-ancestor
82923600|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923601|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923602|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82923603|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
82923604|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923605|NCT02251132|Ritonavir|ritonavir|mesh-list
82923606|NCT02251132|Erythromycin|erythromycin|mesh-list
82923607|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
82923608|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82923609|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
82923610|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82923611|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82923612|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
82923613|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923614|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923615|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82923616|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82923617|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
82923618|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923619|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82923620|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82923621|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923622|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923623|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82923624|NCT01331824|Amrubicin|amrubicin|mesh-list
82923625|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923626|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
82923627|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82923628|NCT05571722|Vancomycin|vancomycin|mesh-list
82923629|NCT05571722|Linezolid|linezolid|mesh-list
82923630|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923631|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923632|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82923633|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923634|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923635|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
82923636|NCT02110654|Montelukast|montelukast|mesh-list
82923637|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82923638|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
82923639|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82923640|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
82923641|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923642|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923643|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82923644|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82923645|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923646|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923647|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
82923648|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82923649|NCT03258710|Tenofovir|tenofovir|mesh-list
82923650|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
82923651|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923652|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82923653|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82923654|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923655|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923656|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82923657|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82923658|NCT02110810|Indomethacin|indomethacin|mesh-list
82923659|NCT02110810|Glycerol|glycerol|mesh-list
82923660|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82923661|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923662|NCT02110810|Analgesics|analgesics|mesh-ancestor
82923663|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
82923664|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923665|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923666|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82764016|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
82923667|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923668|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
82923669|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
82923670|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82923671|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82923672|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923673|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923674|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82923675|NCT02110810|Protective Agents|protective agents|mesh-ancestor
82923676|NCT02107924|Vancomycin|vancomycin|mesh-list
82923677|NCT02107924|Tobramycin|tobramycin|mesh-list
82923678|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923679|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923680|NCT02108002|Vorinostat|vorinostat|mesh-list
82923681|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923682|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82923683|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923684|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923685|NCT02114476|Progestins|progestins|mesh-list
82923686|NCT02114476|Hormones|hormones|mesh-ancestor
82923687|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923688|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923689|NCT02110966|Tramadol|tramadol|mesh-list
82923690|NCT02110966|Mepivacaine|mepivacaine|mesh-list
82923691|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82923692|NCT02110966|Narcotics|narcotics|mesh-ancestor
82923693|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923694|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923695|NCT02110966|Analgesics|analgesics|mesh-ancestor
82923696|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
82923697|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923698|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
82923699|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
82923700|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
82923701|NCT02937740|Testosterone|testosterone|mesh-list
82923702|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
82923703|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
82923704|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82923706|NCT02937740|Hormones|hormones|mesh-ancestor
82923707|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923708|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923709|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82923710|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923711|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
82923712|NCT02111044|Octreotide|octreotide|mesh-list
82923713|NCT02111044|Somatostatin|somatostatin|mesh-list
82923714|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923715|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82923716|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923717|NCT02111044|Hormones|hormones|mesh-ancestor
82923718|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923719|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923720|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
82923721|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923722|NCT02108548|Naproxen|naproxen|mesh-list
82923723|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82923724|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923725|NCT02108548|Analgesics|analgesics|mesh-ancestor
82923726|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
82923727|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923728|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923729|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923730|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923731|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
82923732|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82923733|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923734|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923735|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
82923736|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82923737|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82923738|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
82923739|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
82923740|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923741|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923742|NCT02108626|Nicotine|nicotine|mesh-list
82923743|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82923744|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
82923745|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923746|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923747|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82923748|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82923749|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
82923750|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923751|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923752|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
82923753|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82923754|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923755|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923756|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923757|NCT05431322|Analgesics|analgesics|mesh-ancestor
82923758|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
82923759|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923760|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82923761|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82923762|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82923763|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
82923764|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923765|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923766|NCT03745599|Diclofenac|diclofenac|mesh-list
82923767|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
82923768|NCT03745599|Benzydamine|benzydamine|mesh-list
82923769|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82923770|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923771|NCT03745599|Analgesics|analgesics|mesh-ancestor
82923772|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
82923773|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923774|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923775|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923776|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923777|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82923778|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923779|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923780|NCT02108782|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82923781|NCT02108782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82923782|NCT02108782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923783|NCT02108782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923785|NCT02111434|Androgens|androgens|mesh-ancestor
82923786|NCT02111434|Hormones|hormones|mesh-ancestor
82923787|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923788|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923789|NCT03230864|Olanzapine|olanzapine|mesh-list
82923790|NCT03230864|Risperidone|risperidone|mesh-list
82923791|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82923792|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
82923793|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923794|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923795|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923796|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82923797|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82923798|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923799|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82923800|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82923801|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
82923802|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
82923803|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
82923804|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923805|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923806|NCT03230864|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82923807|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82923808|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82923809|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
82923810|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82923811|NCT02111590|Antibodies|antibodies|mesh-list
82923812|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
82923813|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923814|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82923815|NCT02937350|Calcifediol|calcifediol|mesh-list
82923816|NCT02937350|Vitamins|vitamins|mesh-ancestor
82923817|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
82923818|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923819|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82923820|NCT02109328|Paclitaxel|paclitaxel|mesh-list
82923821|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82923822|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923823|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923824|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923825|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923826|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923827|NCT02115490|Diphosphonates|diphosphonates|mesh-list
82923828|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82923829|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923830|NCT02251288|Vaccines|vaccines|mesh-list
82923831|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
82923832|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923833|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
82923834|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
82923835|NCT02109718|Petrolatum|petrolatum|mesh-list
82923836|NCT02109718|Emollients|emollients|mesh-ancestor
82923837|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
82923838|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82923839|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82923840|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82923841|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82923842|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
82923843|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82923844|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82923845|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923846|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923847|NCT02112214|Bismuth|bismuth|mesh-list
82923848|NCT02112214|Antacids|antacids|mesh-ancestor
82923849|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923850|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923851|NCT02112292|Dronabinol|dronabinol|mesh-list
82923852|NCT02112292|Cannabidiol|cannabidiol|mesh-list
82923853|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
82923854|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
82923855|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923856|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82923857|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923859|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
82923860|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923861|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82923862|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82923863|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923864|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923865|NCT02112292|Hormones|hormones|mesh-ancestor
82923866|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82923867|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
82923868|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82923869|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
82923870|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82923871|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
82923872|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923873|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923874|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
82923875|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
82923876|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82923877|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
82923878|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923879|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923880|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82923881|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
82923882|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
82923883|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82923884|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
82923885|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923886|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923887|NCT02118844|Rocuronium|rocuronium|mesh-list
82923888|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82923889|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82923890|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82923891|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923892|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923893|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
82923894|NCT02116348|Mitogens|mitogens|mesh-list
82923895|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923896|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923897|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82923898|NCT02116348|Protective Agents|protective agents|mesh-ancestor
82923899|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923900|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
82923902|NCT02119000|Cathartics|cathartics|mesh-ancestor
82923903|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923904|NCT02119000|Laxatives|laxatives|mesh-ancestor
82923905|NCT02119234|Beclomethasone|beclomethasone|mesh-list
82923906|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
82923907|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
82923908|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82923909|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
82923910|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923911|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923912|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82923913|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
82923914|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82923915|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82923916|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82923917|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
82923918|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923919|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923920|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82923921|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82923922|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82923923|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
82923924|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923925|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
82923926|NCT02119234|Hormones|hormones|mesh-ancestor
82923927|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83083953|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
82923929|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82923930|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923931|NCT03694197|Alirocumab|alirocumab|mesh-list
82923932|NCT03694197|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82923933|NCT03694197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82923934|NCT03694197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82923935|NCT03694197|Antimetabolites|antimetabolites|mesh-ancestor
82923936|NCT03694197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923937|NCT03694197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82923938|NCT03694197|Protease Inhibitors|protease inhibitors|mesh-ancestor
82923939|NCT03694197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923940|NCT03694197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82923941|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82923942|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
82923943|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923944|NCT04473716|Paclitaxel|paclitaxel|mesh-list
82923945|NCT04473716|Cisplatin|cisplatin|mesh-list
82923946|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82923947|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82923948|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
82923949|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
82923950|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
82923951|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923952|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
82923953|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
82923954|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923955|NCT03919617|Volagidemab|volagidemab|mesh-list
82923956|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82923957|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923958|NCT03748173|Calfactant|calfactant|mesh-list
82923959|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
82923960|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
82923961|NCT03848403|Ixekizumab|ixekizumab|mesh-list
82923962|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
82923963|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82923964|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82923965|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
82923966|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82923967|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82923968|NCT03743883|Aspirin|aspirin|mesh-list
82923969|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82923970|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82923971|NCT03743883|Analgesics|analgesics|mesh-ancestor
82923972|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
82923973|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82923974|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923975|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82923976|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82923977|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82923978|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82923979|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923980|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82923981|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82923982|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82923983|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
82923984|NCT03988803|Memantine|memantine|mesh-list
82923985|NCT03988803|BI 425809|bi 425809|mesh-list
82923986|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82923987|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82923988|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
82923989|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82923990|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82923991|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82923992|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82923993|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82923994|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
82923995|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82923996|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
82923997|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82923998|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82923999|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82924000|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924001|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924002|NCT00180713|Simvastatin|simvastatin|mesh-list
82924004|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82924005|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
82924006|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924007|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82924008|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82924009|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924010|NCT02531477|Propofol|propofol|mesh-list
82924011|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82924012|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924013|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924014|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82924015|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
82924016|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
82924017|NCT04052139|Naltrexone|naltrexone|mesh-list
82924018|NCT04052139|Gabapentin|gabapentin|mesh-list
82924019|NCT04052139|Analgesics|analgesics|mesh-ancestor
82924020|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
82924021|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924022|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924023|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
82924024|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82924025|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82924026|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924027|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82924028|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82924029|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82924030|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924031|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924032|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
82924033|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82924034|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82924035|NCT03743805|Naloxone|naloxone|mesh-list
82924036|NCT03743805|Flumazenil|flumazenil|mesh-list
82924037|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82924038|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924039|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
82924040|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924041|NCT03743805|Antidotes|antidotes|mesh-ancestor
82924042|NCT03743805|Protective Agents|protective agents|mesh-ancestor
82924043|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
82924044|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
82924045|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924046|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924047|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
82924048|NCT03743727|Ledipasvir|ledipasvir|mesh-list
82924049|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82924050|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
82924051|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924052|NCT03981861|Metformin|metformin|mesh-list
82924053|NCT03981861|Spironolactone|spironolactone|mesh-list
82924054|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82924055|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924056|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82924057|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
82924058|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924059|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82924060|NCT03981861|Diuretics|diuretics|mesh-ancestor
82924061|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
82924062|NCT03743649|Lorazepam|lorazepam|mesh-list
82924063|NCT03743649|Haloperidol|haloperidol|mesh-list
82924064|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
82924065|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
82924066|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
82924067|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924068|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924069|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82924070|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82924071|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82924072|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924073|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82924074|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82924075|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
82924076|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924077|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924078|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82924079|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
82924080|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82924081|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82924082|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
82924084|NCT01332266|Cetuximab|cetuximab|mesh-list
82924085|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924086|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924087|NCT03255824|Fentanyl|fentanyl|mesh-list
82924088|NCT03255824|Midazolam|midazolam|mesh-list
82924089|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
82924090|NCT03255824|Propofol|propofol|mesh-list
82924091|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82924092|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924093|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924094|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82924095|NCT03255824|Analgesics|analgesics|mesh-ancestor
82924096|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
82924097|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924098|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82924099|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82924100|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82924101|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
82924102|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924103|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924104|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82924105|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
82924106|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
82924107|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82924108|NCT03255824|Narcotics|narcotics|mesh-ancestor
82924109|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82924110|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82924111|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82924112|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82924113|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
82924114|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
82924115|NCT03238352|Listerine|listerine|mesh-list
82924116|NCT03238352|Fluorides|fluorides|mesh-list
82924117|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
82924118|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
82924119|NCT03238352|Protective Agents|protective agents|mesh-ancestor
82924120|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924121|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82924122|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924123|NCT01222754|Lenalidomide|lenalidomide|mesh-list
82924124|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
82924125|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924126|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82924127|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82924128|NCT01222754|Growth Substances|growth substances|mesh-ancestor
82924129|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
82924130|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924131|NCT03850418|Azacitidine|azacitidine|mesh-list
82924132|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82924133|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
82924134|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924135|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924136|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924137|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
82924138|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82924139|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924140|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
82924141|NCT00180479|Paclitaxel|paclitaxel|mesh-list
82924142|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82924143|NCT00180479|Everolimus|everolimus|mesh-list
82924144|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82924145|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924146|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
82924147|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
82924148|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
82924149|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924150|NCT00180479|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82924151|NCT00180479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82924152|NCT00180479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924153|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924154|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
82924155|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924157|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924158|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924159|NCT05169944|Magrolimab|magrolimab|mesh-list
82924160|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924161|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924162|NCT02955069|Spartalizumab|spartalizumab|mesh-list
82924163|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82924164|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924165|NCT02955069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924166|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924167|NCT03254108|Tolvaptan|tolvaptan|mesh-list
82924168|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82924169|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924170|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
82924171|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924172|NCT02585895|Evolocumab|evolocumab|mesh-list
82924173|NCT02585895|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82924174|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82924175|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82924176|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
82924177|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924178|NCT02585895|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82924179|NCT02585895|Protease Inhibitors|protease inhibitors|mesh-ancestor
82924180|NCT02585895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924181|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82924182|NCT03736161|Methotrexate|methotrexate|mesh-list
82924183|NCT03736161|Tofacitinib|tofacitinib|mesh-list
82924184|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82924185|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
82924186|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82924187|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924188|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82924189|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
82924190|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924191|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924192|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
82924193|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924194|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82924195|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924196|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
82924197|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924198|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82924199|NCT03736161|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82924200|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82924201|NCT03253796|Golimumab|golimumab|mesh-list
83515671|NCT03964532|Talazoparib|talazoparib|mesh-list
82924202|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82924204|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924205|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
82924206|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924207|NCT02956005|Tacrolimus|tacrolimus|mesh-list
82924208|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924209|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
82924210|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924211|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82924212|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924213|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924214|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82924215|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82924216|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82924217|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
82924218|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924219|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924220|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82924221|NCT03253094|Fluconazole|fluconazole|mesh-list
82924222|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
82924223|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
82924224|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924225|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82924226|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82924227|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924228|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924231|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924232|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924233|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82924234|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82924235|NCT05179070|Carvedilol|carvedilol|mesh-list
82924236|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82924237|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82924238|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
82924239|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924240|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924241|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924242|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82924243|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
82924244|NCT05179070|Protective Agents|protective agents|mesh-ancestor
82924245|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82924246|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82924247|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82924248|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
82924249|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82924250|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82924251|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
82924252|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
82924253|NCT03477500|Cladribine|cladribine|mesh-list
82924254|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
82924255|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924256|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
82924257|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924258|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924259|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82924260|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
82924261|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924262|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924263|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82924264|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924265|NCT00179621|Lenalidomide|lenalidomide|mesh-list
82924266|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
82924267|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924268|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82924269|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82924270|NCT00179621|Growth Substances|growth substances|mesh-ancestor
82924271|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
82924272|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924273|NCT04862780|Osimertinib|osimertinib|mesh-list
82924274|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924275|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82924276|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458051|NCT03035045|Acetaminophen|acetaminophen|mesh-list
82924277|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924279|NCT00179309|Sargramostim|sargramostim|mesh-list
82924280|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924281|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
82924282|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
82924283|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
82924284|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924285|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
82924286|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924287|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82924288|NCT00177671|Donepezil|donepezil|mesh-list
82924289|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82924290|NCT00177671|Escitalopram|escitalopram|mesh-list
82924291|NCT00177671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82924292|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82924293|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82924294|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924295|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924296|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
82924297|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924298|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924299|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
82924300|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82924301|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
82924302|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82924303|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82924305|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
82924306|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
82924307|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82924308|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924309|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
82924310|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
82924311|NCT03235154|Velpatasvir|velpatasvir|mesh-list
82924312|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82924313|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
82924314|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924315|NCT03233438|Dalbavancin|dalbavancin|mesh-list
82924316|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82924317|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924318|NCT02251600|Deflazacort|deflazacort|mesh-list
82924319|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924320|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924321|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
82924322|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924323|NCT02113072|Beclomethasone|beclomethasone|mesh-list
82924324|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924325|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
82924326|NCT02113072|Hormones|hormones|mesh-ancestor
82924327|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924328|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924329|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82924330|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
82924331|NCT02113150|Ketamine|ketamine|mesh-list
82924332|NCT02113150|Remifentanil|remifentanil|mesh-list
82924333|NCT02113150|Analgesics|analgesics|mesh-ancestor
82924334|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
82924335|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924336|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924337|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82924338|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82924339|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
82924340|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
82924341|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924342|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82924343|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82924344|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924345|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458057|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
82924346|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82924347|NCT02113150|Narcotics|narcotics|mesh-ancestor
82924348|NCT04647500|Methylphenidate|methylphenidate|mesh-list
82924349|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82924350|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924351|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82924352|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82924353|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82924354|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924355|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
82924356|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924357|NCT03553108|Olaparib|olaparib|mesh-list
82924358|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82924359|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924360|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924361|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924362|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82924363|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
82924364|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82924365|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82924366|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924367|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
82924368|NCT02117128|Coagulants|coagulants|mesh-ancestor
82924369|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
82924370|NCT00175877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82924371|NCT00175877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924372|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924373|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
82924375|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924376|NCT02117362|Ipilimumab|ipilimumab|mesh-list
82924377|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924378|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924379|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82924380|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924381|NCT02113540|Atorvastatin|atorvastatin|mesh-list
82924382|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82924383|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82924384|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
82924385|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924386|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82924387|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82924388|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924389|NCT02123056|Metoprolol|metoprolol|mesh-list
82924390|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82924391|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82924392|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
82924393|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
82924394|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924395|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924396|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82924397|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82924398|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82924399|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
82924400|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924401|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924402|NCT02120092|Clopidogrel|clopidogrel|mesh-list
82924403|NCT02120092|Ticagrelor|ticagrelor|mesh-list
82924404|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82924405|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82924406|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82924407|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82924408|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
82924409|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924410|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924411|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924412|NCT02117596|Sirolimus|sirolimus|mesh-list
82924413|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82924414|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924415|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82924416|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924417|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
82924418|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924419|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
82924420|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924421|NCT02117752|Dapsone|dapsone|mesh-list
82924422|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924423|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
82924424|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82924425|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82924426|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82924427|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924428|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924429|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
82924430|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82924431|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
82924432|NCT02117830|Enclomiphene|enclomiphene|mesh-list
82924433|NCT02117830|Clomiphene|clomiphene|mesh-list
82924434|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
82924435|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82924436|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924437|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82924438|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82924439|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924440|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924441|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924442|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82924443|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924444|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82924445|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
83083954|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82924446|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924448|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
82924449|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82924450|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82924451|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
82924452|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
82924453|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82924454|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924455|NCT03552406|Cetuximab|cetuximab|mesh-list
82924456|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924457|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924458|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
82924459|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82924460|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
82924461|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924462|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
82924463|NCT02123368|Protective Agents|protective agents|mesh-ancestor
82924464|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
82924465|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82924466|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
82924467|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82924468|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
82924469|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924470|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924471|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
82924472|NCT02117986|Colistin|colistin|mesh-list
82924473|NCT02117986|Polymyxins|polymyxins|mesh-list
82924474|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82924475|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924476|NCT02118064|Irinotecan|irinotecan|mesh-list
82924477|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82924478|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82924479|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924480|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924481|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924482|NCT02120872|Simvastatin|simvastatin|mesh-list
82924483|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82924484|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82924485|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
83458070|NCT05512416|Letrozole|letrozole|mesh-list
82924486|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924487|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82924488|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82924489|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924490|NCT03552016|Riboflavin|riboflavin|mesh-list
82924491|NCT03552016|Vitamins|vitamins|mesh-ancestor
82924492|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
82924493|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924494|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
82924495|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82924496|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
82924497|NCT02788474|Nintedanib|nintedanib|mesh-list
82924498|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924499|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82924500|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924501|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924502|NCT02118142|Betaine|betaine|mesh-list
82924503|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82924504|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
82924505|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82924506|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
82924507|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924508|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82924509|NCT02118376|Exenatide|exenatide|mesh-list
82924510|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82924511|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924512|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82924513|NCT02118376|Incretins|incretins|mesh-ancestor
82924514|NCT02118376|Hormones|hormones|mesh-ancestor
82924515|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924516|NCT02124070|Hormones|hormones|mesh-list
82924517|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924518|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924519|NCT02118532|Paclitaxel|paclitaxel|mesh-list
82924520|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82924523|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
82924524|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
82924525|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924526|NCT02118688|Risperidone|risperidone|mesh-list
82924527|NCT02118688|Trazodone|trazodone|mesh-list
82924528|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82924529|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
82924530|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924531|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924532|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924533|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82924534|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82924535|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924536|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82924537|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82924538|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
82924539|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82924540|NCT02118688|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82924541|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82924542|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82924543|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82924544|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
82924545|NCT03248492|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
82924546|NCT03248492|Immunoconjugates|immunoconjugates|mesh-ancestor
82924547|NCT03248492|Immunologic Factors|immunologic factors|mesh-ancestor
82924548|NCT03248492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924549|NCT02126956|Ponesimod|ponesimod|mesh-list
82924550|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82924551|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924552|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924553|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
82924554|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924555|NCT02124148|Leucovorin|leucovorin|mesh-list
82924556|NCT02124148|Fluorouracil|fluorouracil|mesh-list
82924557|NCT02124148|Pemetrexed|pemetrexed|mesh-list
82924558|NCT02124148|Cetuximab|cetuximab|mesh-list
82924559|NCT02124148|Prexasertib|prexasertib|mesh-list
82924560|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924561|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
82924562|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924563|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82924564|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924565|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
82924566|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924567|NCT02124148|Antidotes|antidotes|mesh-ancestor
82924568|NCT02124148|Protective Agents|protective agents|mesh-ancestor
82924569|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
82924570|NCT02124148|Vitamins|vitamins|mesh-ancestor
82924571|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
82924572|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924573|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82924574|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82924575|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924576|NCT02124148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82924577|NCT02124226|Methotrexate|methotrexate|mesh-list
82924578|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82924579|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
82924580|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82924581|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924582|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82924583|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
82924584|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924585|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924586|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
82924587|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924588|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82924589|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924590|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
82924591|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924592|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82924593|NCT02127034|Digoxin|digoxin|mesh-list
82924594|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
82924596|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82924597|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82924598|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924599|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924600|NCT02127034|Protective Agents|protective agents|mesh-ancestor
82924601|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924602|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82924603|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82924604|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
82924605|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924606|NCT02127034|Urological Agents|urological agents|mesh-ancestor
82924607|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82924608|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82924609|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82924610|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
82924611|NCT02787304|Volixibat|volixibat|mesh-list
82924612|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82924613|NCT00574496|Cyclosporine|cyclosporine|mesh-list
82924614|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
82924615|NCT00574496|Prednisone|prednisone|mesh-list
82924616|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
82924617|NCT00574496|Melphalan|melphalan|mesh-list
82924618|NCT00574496|Ifosfamide|ifosfamide|mesh-list
82924619|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
82924620|NCT00574496|Gemcitabine|gemcitabine|mesh-list
82924621|NCT00574496|Methotrexate|methotrexate|mesh-list
82924622|NCT00574496|Fludarabine|fludarabine|mesh-list
82924623|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
82924624|NCT00574496|Vincristine|vincristine|mesh-list
82924625|NCT00574496|Vinorelbine|vinorelbine|mesh-list
82924626|NCT00574496|Procarbazine|procarbazine|mesh-list
82924627|NCT00574496|Cyclosporins|cyclosporins|mesh-list
82924628|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924629|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
82924630|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924631|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924632|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82924633|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
82924634|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924635|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924636|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82924637|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82924638|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
82924639|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924640|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
82924641|NCT00574496|Hormones|hormones|mesh-ancestor
82924642|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924643|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82924644|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82924645|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
82924646|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82924647|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
82924648|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924649|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82924650|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82924651|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82924652|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
82924653|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
82924654|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
82924655|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
82924656|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924657|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82924658|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82924659|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82924660|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
82924661|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82924663|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924664|NCT02932904|Vortioxetine|vortioxetine|mesh-list
82924665|NCT02932904|Paroxetine|paroxetine|mesh-list
82924666|NCT02932904|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82924667|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82924668|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82924669|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924670|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924672|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924673|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82924674|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
82924675|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82924676|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82924677|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82924678|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924679|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82924680|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82924681|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924682|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82924683|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82924684|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82924685|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82924686|NCT02127736|Amitriptyline|amitriptyline|mesh-list
82924687|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82924688|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
82924689|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82924690|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82924691|NCT02127736|Analgesics|analgesics|mesh-ancestor
82924692|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
82924693|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924694|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924695|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82924696|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82924697|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82924698|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924699|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
82924700|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924701|NCT02124850|Nivolumab|nivolumab|mesh-list
82924702|NCT02124850|Cetuximab|cetuximab|mesh-list
82924703|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924704|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924705|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82924706|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924707|NCT02125084|Everolimus|everolimus|mesh-list
82924708|NCT02125084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82924709|NCT02125084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82924710|NCT02125084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924711|NCT02125084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924712|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924713|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
82924714|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924715|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924716|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
82924717|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82924718|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924719|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924720|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82924721|NCT02122510|Analgesics|analgesics|mesh-ancestor
82924722|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
82924723|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924724|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82924725|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82924726|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82924727|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
82924728|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924729|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924731|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82924732|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82924733|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924734|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82924735|NCT02128126|Vaccines|vaccines|mesh-list
82924736|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
82924737|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924738|NCT02128204|Lidocaine|lidocaine|mesh-list
82924739|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
82924740|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
82924741|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924742|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924743|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
82924744|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924745|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82924746|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82924747|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82924748|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82924749|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924750|NCT02128282|Gemcitabine|gemcitabine|mesh-list
82924751|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924752|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82924753|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
83458087|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82924754|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924755|NCT02125630|Hormones|hormones|mesh-list
82924756|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924757|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924758|NCT03551548|Spironolactone|spironolactone|mesh-list
82924759|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82924760|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
82924761|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924762|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924763|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82924764|NCT03551548|Diuretics|diuretics|mesh-ancestor
82924765|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
82924766|NCT02128360|Letrozole|letrozole|mesh-list
82924767|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924768|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82924769|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82924770|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924771|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924772|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82924773|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
82924774|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924775|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924776|NCT02126020|Infliximab|infliximab|mesh-list
82924777|NCT02126020|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82924778|NCT02126020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924779|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
82924780|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82924781|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924782|NCT00688376|Donepezil|donepezil|mesh-list
82924783|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82924784|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924785|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924786|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
82924787|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924788|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924789|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
82924790|NCT02126332|Acetaminophen|acetaminophen|mesh-list
82924791|NCT02126332|Sufentanil|sufentanil|mesh-list
82924792|NCT02126332|Nefopam|nefopam|mesh-list
82924793|NCT02126332|Tramadol|tramadol|mesh-list
82924794|NCT02126332|Ropivacaine|ropivacaine|mesh-list
82924795|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
82924796|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
82924797|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924798|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924799|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
82924800|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924801|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82924803|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
82924804|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82924805|NCT02126332|Narcotics|narcotics|mesh-ancestor
82924806|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82924807|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82924808|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
82924809|NCT02131246|Insulin|insulin|mesh-list
82924810|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82924811|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
82924812|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
82924813|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82924814|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82924815|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924816|NCT02126644|Glycolic acid|glycolic acid|mesh-list
82924817|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
82924820|NCT03550534|Calcium|calcium|mesh-list
82924821|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82924822|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924823|NCT03550534|Antacids|antacids|mesh-ancestor
82924824|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924825|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82924826|NCT02131480|Doxorubicin|doxorubicin|mesh-list
82924827|NCT02131480|Trabectedin|trabectedin|mesh-list
82924828|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82924829|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924830|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82924831|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82924832|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924833|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924834|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82924835|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
82924836|NCT02128906|Docetaxel|docetaxel|mesh-list
82924837|NCT02128906|Cetuximab|cetuximab|mesh-list
82924838|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924839|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
82924840|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
82924841|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
82924842|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924843|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924844|NCT02128984|Antioxidants|antioxidants|mesh-list
82924845|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924846|NCT02128984|Protective Agents|protective agents|mesh-ancestor
82924847|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924848|NCT02252302|Albuterol|albuterol|mesh-list
82924849|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82924850|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
82924851|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924852|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924853|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82924854|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
82924855|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
82924856|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82924857|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82924858|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82924859|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82924860|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
82924861|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82924862|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924863|NCT02252614|Acetaminophen|acetaminophen|mesh-list
82924864|NCT02252614|Naproxen|naproxen|mesh-list
82924865|NCT02252614|Codeine|codeine|mesh-list
82924866|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82924867|NCT02252614|Analgesics|analgesics|mesh-ancestor
82924868|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
82924869|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924870|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924871|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
82924872|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82924873|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924874|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924875|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
82924876|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82924877|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83515821|NCT02379585|Doxorubicin|doxorubicin|mesh-list
82924878|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924879|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82924880|NCT02252614|Narcotics|narcotics|mesh-ancestor
82924881|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924882|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
82924883|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
82924884|NCT02260570|Tolcapone|tolcapone|mesh-list
82924885|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82924886|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82924887|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82924888|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82924889|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924890|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
82924891|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924892|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924893|NCT03681951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82924894|NCT03681951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924896|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
82924897|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82924898|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924899|NCT02132026|Denosumab|denosumab|mesh-list
82924900|NCT02132026|Alendronate|alendronate|mesh-list
82924901|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82924902|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924903|NCT03735771|Bupivacaine|bupivacaine|mesh-list
82924904|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
82924905|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
82924906|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924907|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924908|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
82924909|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924910|NCT02132104|Hormones|hormones|mesh-list
82924911|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924912|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924913|NCT00174785|Dronedarone|dronedarone|mesh-list
82924914|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82924915|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
82924916|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
82924917|NCT03681093|Growth Substances|growth substances|mesh-ancestor
82924918|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924919|NCT00166439|Cytarabine|cytarabine|mesh-list
82924920|NCT00166439|Dexamethasone|dexamethasone|mesh-list
82924921|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
82924922|NCT00166439|Rituximab|rituximab|mesh-list
82924923|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924924|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
82924925|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
82924926|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924927|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924928|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82924929|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
82924930|NCT00166439|Hormones|hormones|mesh-ancestor
82924931|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82924932|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82924933|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924934|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82924935|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
82924936|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924937|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82924938|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
82924939|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82924940|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
82924941|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924942|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924943|NCT01074905|Artesunate|artesunate|mesh-list
82924944|NCT01074905|Chloroquine|chloroquine|mesh-list
82924945|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82924946|NCT01074905|Primaquine|primaquine|mesh-list
82924947|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
82924948|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82924949|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82924950|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82924951|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82924952|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
82924953|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
82924954|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82924955|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
82924956|NCT01074905|Amebicides|amebicides|mesh-ancestor
82924957|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82924958|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82924959|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82924960|NCT01074905|Analgesics|analgesics|mesh-ancestor
82924961|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
82924962|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924963|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924964|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82924965|NCT01074905|Filaricides|filaricides|mesh-ancestor
82924966|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
82924967|NCT03968237|Buprenorphine|buprenorphine|mesh-list
82924968|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82924970|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82924971|NCT03968237|Narcotics|narcotics|mesh-ancestor
82924972|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82924973|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924974|NCT03968237|Analgesics|analgesics|mesh-ancestor
82924975|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
82924976|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82924977|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82924979|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82924980|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82924981|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924982|NCT01367158|Vaccines|vaccines|mesh-list
82924983|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
82924984|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924985|NCT00130637|Daclizumab|daclizumab|mesh-list
82924986|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82924987|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
82924988|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924989|NCT01077479|Metformin|metformin|mesh-list
82924990|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82924991|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82924992|NCT02136784|Morphine|morphine|mesh-list
82924993|NCT02136784|Oxycodone|oxycodone|mesh-list
82924994|NCT02136784|Buprenorphine|buprenorphine|mesh-list
82924995|NCT02136784|Hydromorphone|hydromorphone|mesh-list
82924996|NCT02136784|Hydrocodone|hydrocodone|mesh-list
82924997|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82924998|NCT02136784|Narcotics|narcotics|mesh-ancestor
82924999|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925000|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925001|NCT02136784|Analgesics|analgesics|mesh-ancestor
82925002|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
82925003|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925004|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82925005|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
82925006|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
82925007|NCT02129764|Prednisone|prednisone|mesh-list
82925008|NCT02129764|Allopurinol|allopurinol|mesh-list
82925009|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925010|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
82925011|NCT02129764|Hormones|hormones|mesh-ancestor
82925012|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925013|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925014|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82925015|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925016|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
82925017|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925018|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925019|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
82925020|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925021|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82925022|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
82925023|NCT02129764|Protective Agents|protective agents|mesh-ancestor
82925024|NCT00130247|Rifampin|rifampin|mesh-list
82925025|NCT00130247|Isoniazid|isoniazid|mesh-list
82925026|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
82925027|NCT00130247|Ethambutol|ethambutol|mesh-list
82925028|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82925029|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
82925030|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82925031|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925032|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
82925033|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82765378|NCT00613106|Ibuprofen|ibuprofen|mesh-list
82925034|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925035|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925036|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82925037|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82925038|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82925039|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82925040|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82925041|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82925042|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82925043|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82925044|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
82925045|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82925047|NCT02252926|Lidocaine|lidocaine|mesh-list
82925048|NCT02252926|Morphine|morphine|mesh-list
82925049|NCT02252926|Gabapentin|gabapentin|mesh-list
82925050|NCT02252926|Bupivacaine|bupivacaine|mesh-list
82925051|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
82925052|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
82925053|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925054|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925055|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
82925056|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925057|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82925058|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82925059|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82925060|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82925061|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925062|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82925063|NCT02252926|Narcotics|narcotics|mesh-ancestor
82925064|NCT02252926|Analgesics|analgesics|mesh-ancestor
82925065|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82925066|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
82925067|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
82925068|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82925069|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82925070|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82925071|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82925072|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82925073|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925074|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
82925075|NCT02253004|Cilostazol|cilostazol|mesh-list
82925076|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82925077|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
82925078|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925079|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925080|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82925081|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
82925082|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82925083|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82925084|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925085|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82925086|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
82925087|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82925088|NCT02253004|Protective Agents|protective agents|mesh-ancestor
82925089|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82925090|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82925091|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925092|NCT02252458|Fentanyl|fentanyl|mesh-list
82925093|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82925094|NCT02252458|Narcotics|narcotics|mesh-ancestor
82925095|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925096|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925097|NCT02252458|Analgesics|analgesics|mesh-ancestor
82925098|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
82925099|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925100|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82925101|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82925102|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
82925103|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
82925104|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
82925105|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82925106|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
82925107|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925108|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925109|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
82925110|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925111|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82925112|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82925113|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925114|NCT02132260|Naftifine|naftifine|mesh-list
82925115|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
82925116|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925117|NCT02137564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82925118|NCT02137564|Nirogacestat|nirogacestat|mesh-list
82925119|NCT02137564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925120|NCT02137564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925121|NCT02132416|Acetaminophen|acetaminophen|mesh-list
82925122|NCT02132416|Ibuprofen|ibuprofen|mesh-list
82925123|NCT02132416|Diclofenac|diclofenac|mesh-list
82925124|NCT02132416|Morphine|morphine|mesh-list
82925125|NCT02132416|Oxycodone|oxycodone|mesh-list
82925126|NCT02132416|Tramadol|tramadol|mesh-list
82925127|NCT02132416|Anesthetics|anesthetics|mesh-list
82925128|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925129|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925130|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82925131|NCT02132416|Narcotics|narcotics|mesh-ancestor
82925132|NCT02132416|Analgesics|analgesics|mesh-ancestor
82925133|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
82925134|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925135|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82925136|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82925137|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925138|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925139|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82925140|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925141|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925142|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
82925143|NCT00137423|Sunitinib|sunitinib|mesh-list
82925144|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925145|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82925146|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82925147|NCT00137423|Growth Substances|growth substances|mesh-ancestor
82925148|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925149|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
82925150|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82925151|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925152|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925153|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82925154|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
82925155|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925156|NCT02130700|Seviteronel|seviteronel|mesh-list
82925157|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925158|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82925159|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925160|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925161|NCT02137954|Lidocaine|lidocaine|mesh-list
82925162|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
82925163|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
82925164|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925165|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925166|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
82925167|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925168|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82925169|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82925170|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82925171|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82925172|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925173|NCT02131012|Celecoxib|celecoxib|mesh-list
82925174|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82925175|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82925176|NCT02131012|Analgesics|analgesics|mesh-ancestor
82925177|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
82925178|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458137|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82925179|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925180|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925181|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925182|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82925183|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82925184|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925185|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925187|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
82925188|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
82925189|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925190|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925191|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925192|NCT01561768|Vaccines|vaccines|mesh-list
82925193|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
82925194|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925195|NCT00137111|Cytarabine|cytarabine|mesh-list
82925196|NCT00137111|Dexamethasone|dexamethasone|mesh-list
82925197|NCT00137111|Prednisone|prednisone|mesh-list
82925198|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
82925200|NCT00137111|Methotrexate|methotrexate|mesh-list
82925201|NCT00137111|Etoposide|etoposide|mesh-list
82925202|NCT00137111|Vincristine|vincristine|mesh-list
82925203|NCT00137111|Daunorubicin|daunorubicin|mesh-list
82925204|NCT00137111|Asparaginase|asparaginase|mesh-list
82925205|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
82925206|NCT00137111|Pegaspargase|pegaspargase|mesh-list
82925207|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82925208|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
82925209|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925210|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925211|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82925212|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
82925213|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925214|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925215|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82925216|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925217|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
82925218|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
82925219|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925220|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82925221|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
82925222|NCT00137111|Hormones|hormones|mesh-ancestor
82925223|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925224|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82925225|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82925226|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82925227|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82925228|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925229|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82925230|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
82925231|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82925232|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82925233|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
82925234|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
82925235|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82925236|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82925237|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82925238|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
82925239|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925240|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
82925241|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
82925242|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
82925243|NCT02133118|Pioglitazone|pioglitazone|mesh-list
82925244|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82925245|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925246|NCT02138812|Paclitaxel|paclitaxel|mesh-list
82925247|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82925248|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925249|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
82925250|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
82925251|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83458144|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82925252|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925253|NCT00136955|Irinotecan|irinotecan|mesh-list
82925254|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82925255|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82925256|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925257|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925258|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925259|NCT00135707|Vitamins|vitamins|mesh-list
82925260|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
82925261|NCT00135707|Vitamin E|vitamin e|mesh-list
82925262|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
82925263|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
82925264|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925265|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
82925266|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925267|NCT00135707|Protective Agents|protective agents|mesh-ancestor
82925268|NCT03548818|Interferons|interferons|mesh-list
82925269|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
82925270|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925271|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
82925272|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925274|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82925275|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
82925276|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925277|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925278|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82925279|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
82925280|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82925281|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
82925282|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925283|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
82925284|NCT03548662|Protective Agents|protective agents|mesh-ancestor
82925285|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82925286|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925287|NCT03966209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925288|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925289|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
82925290|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82925291|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
82925292|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925293|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925294|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82925295|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
82925296|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82925297|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
82925298|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925299|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925300|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82925301|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
82925302|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
82925303|NCT02252770|Protective Agents|protective agents|mesh-ancestor
82925304|NCT05578456|Aspirin|aspirin|mesh-list
82925305|NCT05578456|Prednisone|prednisone|mesh-list
82925306|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925307|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
82925308|NCT05578456|Hormones|hormones|mesh-ancestor
82925309|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925310|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925311|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82925312|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925313|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82925314|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82925315|NCT05578456|Analgesics|analgesics|mesh-ancestor
82925316|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
82925317|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925318|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925319|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82925320|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82925321|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925322|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82925323|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82925324|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925325|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
82925326|NCT02133820|Analgesics|analgesics|mesh-list
82925327|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
82925328|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925329|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925330|NCT05578378|Cytarabine|cytarabine|mesh-list
82925331|NCT05578378|Methotrexate|methotrexate|mesh-list
82925332|NCT05578378|Fludarabine|fludarabine|mesh-list
82925333|NCT05578378|Cladribine|cladribine|mesh-list
82925334|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82925335|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
82925336|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82925337|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925338|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82925339|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
82925340|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925341|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925342|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
82925343|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925344|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82925345|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82925346|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
82925347|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925348|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82925349|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
82925350|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925351|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
82925352|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82925353|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925354|NCT02139904|Vinorelbine|vinorelbine|mesh-list
82925355|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82925356|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925357|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
82925358|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
82925359|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
82925360|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925361|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
82925362|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925363|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925364|NCT05578222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82925365|NCT05578222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925366|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
82925367|NCT05201638|Calcium|calcium|mesh-list
82925368|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82925369|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925370|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82925371|NCT00129545|Warfarin|warfarin|mesh-list
82925372|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
82925373|NCT02134288|Everolimus|everolimus|mesh-list
82925374|NCT02134288|Abatacept|abatacept|mesh-list
82925375|NCT02134288|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82925376|NCT02134288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82925377|NCT02134288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925378|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925379|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82925380|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
82925381|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925382|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925383|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82925384|NCT02134288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925385|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925386|NCT00129467|Methylphenidate|methylphenidate|mesh-list
82925387|NCT00129467|Serotonin|serotonin|mesh-list
82925388|NCT00129467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82925389|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82925390|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925391|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82925392|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82925393|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82925394|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925395|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
82925396|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925397|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82925398|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
82925399|NCT00129311|Selegiline|selegiline|mesh-list
82925400|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
82925401|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82925402|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82925403|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82925404|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82925405|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925406|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925407|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82925408|NCT00129311|Protective Agents|protective agents|mesh-ancestor
82925409|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925410|NCT01076621|Norethindrone|norethindrone|mesh-list
82925411|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
82925412|NCT01076621|Estradiol|estradiol|mesh-list
82925413|NCT01076621|Estrogens|estrogens|mesh-ancestor
82925414|NCT01076621|Hormones|hormones|mesh-ancestor
82925415|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925416|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925417|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82925418|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
82925419|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82925420|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82925421|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82925422|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82925423|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82925424|NCT03965819|Acetaminophen|acetaminophen|mesh-list
82925425|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82925426|NCT03965819|Analgesics|analgesics|mesh-ancestor
82925427|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
82925428|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925429|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925430|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
82925431|NCT02134366|Lorazepam|lorazepam|mesh-list
82925432|NCT02134366|Clonazepam|clonazepam|mesh-list
82925433|NCT02134366|Clobazam|clobazam|mesh-list
82925434|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
82925435|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
82925436|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
82925437|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925438|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925439|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82925440|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82925441|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925442|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82925443|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82925444|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82925445|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
82925446|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
82925447|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925448|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925449|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82925450|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
82925451|NCT01077947|Anesthetics|anesthetics|mesh-list
82925452|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925453|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925454|NCT00133991|Leucovorin|leucovorin|mesh-list
82925455|NCT00133991|Cytarabine|cytarabine|mesh-list
82925456|NCT00133991|Prednisone|prednisone|mesh-list
82925457|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
82925458|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
82925459|NCT00133991|Rituximab|rituximab|mesh-list
82925460|NCT00133991|Methotrexate|methotrexate|mesh-list
82925461|NCT00133991|Vincristine|vincristine|mesh-list
82925462|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82925463|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
82925464|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925465|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925466|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82925467|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
82925468|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925469|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925470|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82925471|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925472|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925473|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
82925474|NCT00133991|Hormones|hormones|mesh-ancestor
82925475|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925476|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82925477|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82925478|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
82925479|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82925480|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82925481|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
82925482|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
82925483|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925484|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82925485|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82925486|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
82925487|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925488|NCT00133991|Antidotes|antidotes|mesh-ancestor
82925489|NCT00133991|Protective Agents|protective agents|mesh-ancestor
82925490|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
82925491|NCT00133991|Vitamins|vitamins|mesh-ancestor
82925492|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
82925493|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82925494|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
82925495|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
82925496|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
82925497|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82925498|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
82925499|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925500|NCT02140450|Timolol|timolol|mesh-list
82925501|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82925503|NCT02140450|Acetazolamide|acetazolamide|mesh-list
82925504|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82925505|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82925506|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
82925507|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925508|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925509|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925510|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82925511|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82925512|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82925513|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82925514|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82925515|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82925516|NCT02140450|Diuretics|diuretics|mesh-ancestor
82925517|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
82925518|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
82925519|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82925520|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925521|NCT05577676|Triamcinolone|triamcinolone|mesh-list
82925522|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82925523|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82925524|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82925525|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925526|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
82925527|NCT05577676|Hormones|hormones|mesh-ancestor
82925528|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925529|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925530|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82925531|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
82925532|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925533|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925534|NCT03549832|Ritonavir|ritonavir|mesh-list
82925535|NCT03549832|Ribavirin|ribavirin|mesh-list
82925536|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
82925537|NCT03549832|Simeprevir|simeprevir|mesh-list
82925538|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83458159|NCT05511948|Hydroquinone|hydroquinone|mesh-list
82925539|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82925540|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
82925541|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925542|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925543|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82925544|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82925545|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
82925546|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925547|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82925548|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82925549|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
82925550|NCT02134990|Docetaxel|docetaxel|mesh-list
82925551|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925552|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
82925553|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
82925554|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
82925555|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925556|NCT02135224|Fentanyl|fentanyl|mesh-list
82925557|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82925558|NCT02135224|Narcotics|narcotics|mesh-ancestor
82925559|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925560|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925561|NCT02135224|Analgesics|analgesics|mesh-ancestor
82925562|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
82925563|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925564|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82925565|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82925566|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
82925567|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
82925568|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
82925569|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925570|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925571|NCT05508100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82925572|NCT05508100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925573|NCT02785900|Azacitidine|azacitidine|mesh-list
82925574|NCT02785900|Decitabine|decitabine|mesh-list
82925575|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82925576|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
82925577|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925578|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925579|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925580|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
82925581|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
82925582|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
82925583|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82925584|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925586|NCT02135770|Calcium heparin|calcium heparin|mesh-list
82925587|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
82925588|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82925589|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82925590|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925591|NCT05478850|Anesthetics|anesthetics|mesh-list
82925592|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925593|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925594|NCT05575180|Acetazolamide|acetazolamide|mesh-list
82925595|NCT05575180|Methazolamide|methazolamide|mesh-list
82925596|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
82925597|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82925598|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925599|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925600|NCT05575180|Diuretics|diuretics|mesh-ancestor
82925601|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
82925602|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925603|NCT01560754|Nicotine|nicotine|mesh-list
82925604|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82925605|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
82925606|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925607|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925608|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82925609|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82925610|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
83458165|NCT00952133|Dexamethasone|dexamethasone|mesh-list
82925611|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925612|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925613|NCT03547804|Apatinib|apatinib|mesh-list
82925614|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925615|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82925616|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925617|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925618|NCT02217267|Lidocaine|lidocaine|mesh-list
82925619|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
82925620|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
82925621|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925622|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925623|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
82925624|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925625|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82925626|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82925627|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82925628|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82925629|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925630|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
82925631|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
82925632|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82925633|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925634|NCT03546400|Methylphenidate|methylphenidate|mesh-list
82925635|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82925636|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925637|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82925638|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82925639|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82925640|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925641|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
82925642|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925643|NCT03669861|Abatacept|abatacept|mesh-list
82925644|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82925645|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925646|NCT03669861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925647|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925648|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82925649|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
82925650|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925652|NCT00127127|Vorinostat|vorinostat|mesh-list
82925653|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925654|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82925655|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925656|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925657|NCT00126659|Sorafenib|sorafenib|mesh-list
82925658|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925659|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82925660|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925661|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925662|NCT03669081|Ketorolac|ketorolac|mesh-list
82925663|NCT03669081|Pregabalin|pregabalin|mesh-list
82925664|NCT03669081|Analgesics|analgesics|mesh-ancestor
82925665|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
82925666|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925667|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925668|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
82925669|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82925670|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82925671|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925672|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82925673|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82925674|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82925675|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925676|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82925677|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82925678|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82925679|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925680|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925681|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82925682|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925683|NCT02253940|Ritonavir|ritonavir|mesh-list
82925684|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82925685|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82925686|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
82925687|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925688|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925689|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82925690|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82925691|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
82925692|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925693|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82925694|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82925695|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
82925696|NCT02253550|Simeprevir|simeprevir|mesh-list
82925697|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
82925698|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925699|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
82925700|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925701|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925702|NCT05203432|Atropine|atropine|mesh-list
82925703|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82925704|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82925705|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82925706|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
82925707|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925708|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925709|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82925710|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
82925711|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
82925712|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
82925713|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82925714|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82925715|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
82925716|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925717|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925718|NCT03667053|Glucagon|glucagon|mesh-list
82925719|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82925720|NCT03667053|Hormones|hormones|mesh-ancestor
82925721|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925722|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925723|NCT04589728|Venetoclax|venetoclax|mesh-list
82925725|NCT05557240|Poly I-C|poly i-c|mesh-list
82925726|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82925727|NCT05557240|Vaccines|vaccines|mesh-list
82925728|NCT05557240|Poly ICLC|poly iclc|mesh-list
82925729|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
82925730|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925731|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
82925732|NCT05557240|Laxatives|laxatives|mesh-ancestor
82925733|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82925734|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
82925735|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925736|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
83458190|NCT05042375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82925737|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925738|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925739|NCT03631407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82925740|NCT03631407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925741|NCT03547024|Midazolam|midazolam|mesh-list
82925742|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
82925743|NCT03547024|Omeprazole|omeprazole|mesh-list
82925744|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
82925745|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82925746|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82925747|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
82925748|NCT03547024|Estradiol|estradiol|mesh-list
82925749|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82925750|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82925751|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925752|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925753|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82925754|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82925755|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82925756|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82925757|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
82925758|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
82925759|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
82925760|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
82925761|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925762|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925763|NCT03547024|Estrogens|estrogens|mesh-ancestor
82925764|NCT03547024|Hormones|hormones|mesh-ancestor
82925765|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925766|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82925767|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
82925768|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82925769|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82925770|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82925771|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82925772|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82925773|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925774|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82925775|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82925776|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82925777|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
82925778|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
82925779|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82925780|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82925781|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82925782|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
82925783|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82925784|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82925785|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
82925786|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
82925787|NCT04012996|Meloxicam|meloxicam|mesh-list
82925788|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82925789|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82925790|NCT04012996|Analgesics|analgesics|mesh-ancestor
82925791|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
82925792|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925793|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925794|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925795|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925796|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82925797|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82925798|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925799|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925801|NCT02253784|Bupivacaine|bupivacaine|mesh-list
82925802|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925803|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
82925804|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
82925805|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925806|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925807|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82925808|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
82925809|NCT02253784|Hormones|hormones|mesh-ancestor
82925810|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925811|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82925812|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925813|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
82925814|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
82925815|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925816|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
82925817|NCT03734445|Vitamins|vitamins|mesh-list
82925818|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
82925819|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925820|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82925821|NCT04538092|Analgesics|analgesics|mesh-list
82925822|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925823|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
82925824|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925825|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925826|NCT03546088|Anesthetics|anesthetics|mesh-list
82925827|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925828|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925829|NCT03866980|Carboplatin|carboplatin|mesh-list
82925830|NCT03866980|Pemetrexed|pemetrexed|mesh-list
82925831|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925832|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925833|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925834|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82925835|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82925836|NCT02253862|Ritonavir|ritonavir|mesh-list
82925837|NCT02253862|Tipranavir|tipranavir|mesh-list
82925838|NCT02253862|Tadalafil|tadalafil|mesh-list
82925839|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82925840|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82925841|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
82925842|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925843|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925844|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82925845|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82925846|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
82925847|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82925848|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82925849|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82925850|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
82925851|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82925852|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82925853|NCT02253862|Urological Agents|urological agents|mesh-ancestor
82925854|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82925855|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82925856|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82925857|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925858|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925859|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82925860|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82925861|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82925862|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82925863|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
82925864|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925865|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925866|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82925867|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82925868|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
82925869|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82925870|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82925871|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
82925872|NCT03776656|Allopurinol|allopurinol|mesh-list
82925873|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
82925874|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925875|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925876|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
82925877|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925878|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82925880|NCT03776656|Protective Agents|protective agents|mesh-ancestor
82925881|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925882|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
82925883|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82925884|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
82925885|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925886|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82925887|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82925888|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
82925889|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925890|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925891|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82925892|NCT00126581|Paclitaxel|paclitaxel|mesh-list
82925893|NCT00126581|Carboplatin|carboplatin|mesh-list
82925894|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82925895|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82925896|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82925897|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925898|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
82925899|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
82925900|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
82925901|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925902|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82925903|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82925904|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
82925905|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82925906|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82925907|NCT03704584|Prednisolone|prednisolone|mesh-list
82925908|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
82925909|NCT03704584|Lidocaine|lidocaine|mesh-list
82925910|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82925911|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
82925912|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
82925913|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
82925914|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925915|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925916|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
82925917|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925918|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82925919|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82925920|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82925921|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82925922|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925923|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82925924|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
82925925|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
82925926|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82925927|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
82925928|NCT03704584|Hormones|hormones|mesh-ancestor
82925929|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925930|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82925931|NCT03704584|Protective Agents|protective agents|mesh-ancestor
82925932|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82925933|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925934|NCT03643510|Fulvestrant|fulvestrant|mesh-list
82925935|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82925936|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925937|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82925938|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82925939|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
82925940|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82925941|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925942|NCT03737721|Avelumab|avelumab|mesh-list
82925943|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925944|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925945|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
82925946|NCT03647709|Narcotics|narcotics|mesh-ancestor
82925947|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925948|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925949|NCT03647709|Analgesics|analgesics|mesh-ancestor
82925950|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
82925951|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82925952|NCT03546634|Vaccines|vaccines|mesh-list
82925953|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
82925954|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925955|NCT03661983|Aripiprazole|aripiprazole|mesh-list
82925956|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
82925957|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82925958|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82925959|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82925960|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82925961|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925962|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
82925963|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
82925964|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82925965|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925966|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82925967|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82925968|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
82925969|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82925970|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82925971|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82925972|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82925973|NCT02783170|Vaccines|vaccines|mesh-list
82925974|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
82925975|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83083955|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83083956|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83083957|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83083958|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83083959|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83083960|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083961|NCT02477852|Rifampin|rifampin|mesh-list
83083962|NCT02477852|Isoniazid|isoniazid|mesh-list
83083963|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
83083964|NCT02477852|Ethambutol|ethambutol|mesh-list
83083965|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83083966|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
83083967|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83083968|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83083969|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
83083970|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83083971|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083972|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083973|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83083974|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83083975|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83083976|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83083977|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83083978|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83083979|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83083980|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83083981|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
83083982|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83083983|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83458203|NCT02561832|Olaparib|olaparib|mesh-list
83083984|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83083985|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83083986|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083987|NCT02725268|Paclitaxel|paclitaxel|mesh-list
83083988|NCT02725268|Serabelisib|serabelisib|mesh-list
83083989|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83083990|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83083991|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
83083992|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
83083993|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
83515822|NCT02379585|Trastuzumab|trastuzumab|mesh-list
83083994|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83083995|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83083996|NCT05038592|Decitabine|decitabine|mesh-list
83083997|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83083998|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
83083999|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925983|NCT04307134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925984|NCT02254018|Maytansine|maytansine|mesh-list
82925985|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
82925986|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82925987|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82925988|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
82925989|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
82925990|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
82925991|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82925992|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82925993|NCT02254018|Immunotoxins|immunotoxins|mesh-ancestor
82925994|NCT02254018|Immunoconjugates|immunoconjugates|mesh-ancestor
82925995|NCT02254018|Immunologic Factors|immunologic factors|mesh-ancestor
82925996|NCT02254018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82925997|NCT04249882|Naltrexone|naltrexone|mesh-list
82925998|NCT04249882|Varenicline|varenicline|mesh-list
82925999|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82926000|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82926001|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926002|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
82926003|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926004|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82926005|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82926006|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
82926007|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926008|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926016|NCT03396952|Aspirin|aspirin|mesh-list
82926017|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
82926018|NCT03396952|Ipilimumab|ipilimumab|mesh-list
82926019|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82926020|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926021|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82926022|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926023|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82926024|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82926025|NCT03396952|Analgesics|analgesics|mesh-ancestor
82926026|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
82926027|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926028|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926029|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926030|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926031|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82926032|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82926033|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82926034|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82926035|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926036|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
82926037|NCT03378934|Aspirin|aspirin|mesh-list
82926038|NCT03378934|Clopidogrel|clopidogrel|mesh-list
82926039|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82926040|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82926041|NCT03378934|Analgesics|analgesics|mesh-ancestor
82926042|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
82926043|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926044|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926045|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926046|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926047|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82926048|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82926049|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926050|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82926051|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82926052|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926053|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
82926054|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82926055|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82926056|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82926057|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
82926058|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926059|NCT00126503|Bevacizumab|bevacizumab|mesh-list
82926060|NCT00126503|Sorafenib|sorafenib|mesh-list
82926061|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82926062|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926063|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82926064|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82926065|NCT00126503|Growth Substances|growth substances|mesh-ancestor
82926066|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926067|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
82926068|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926069|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926070|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926071|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82926072|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926073|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926074|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926075|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82926076|NCT00126191|Leucovorin|leucovorin|mesh-list
82926077|NCT00126191|Cytarabine|cytarabine|mesh-list
82926078|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
82926079|NCT00126191|Ifosfamide|ifosfamide|mesh-list
82926080|NCT00126191|Rituximab|rituximab|mesh-list
82926081|NCT00126191|Doxorubicin|doxorubicin|mesh-list
82926082|NCT00126191|Methotrexate|methotrexate|mesh-list
82926083|NCT00126191|Etoposide|etoposide|mesh-list
82926084|NCT00126191|Vincristine|vincristine|mesh-list
82926085|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82926086|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
82926087|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926088|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926089|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82926090|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
82926091|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926092|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926093|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82926094|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82926095|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82926096|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82926097|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82926098|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926099|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82926100|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
82926101|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82926102|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82926103|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
82926104|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
82926105|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82926106|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82926107|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82926108|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
82926109|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926110|NCT00126191|Antidotes|antidotes|mesh-ancestor
82926111|NCT00126191|Protective Agents|protective agents|mesh-ancestor
82926112|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
82926113|NCT00126191|Vitamins|vitamins|mesh-ancestor
82926114|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
82926115|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926116|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926117|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926118|NCT03207958|Belimumab|belimumab|mesh-list
82926119|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82926120|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
82926121|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926122|NCT00124943|Paclitaxel|paclitaxel|mesh-list
82926123|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82926124|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82926125|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926126|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926127|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926128|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926129|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926130|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
82926131|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82926132|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82926133|NCT00124709|Analgesics|analgesics|mesh-ancestor
82926134|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
82926135|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926136|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926137|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926138|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926139|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
82926140|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82926141|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
82926142|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82926143|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926144|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926145|NCT04139434|Azacitidine|azacitidine|mesh-list
82926146|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82926147|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
82926148|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926149|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926150|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926151|NCT04130464|Ketorolac|ketorolac|mesh-list
82926152|NCT04130464|Ropivacaine|ropivacaine|mesh-list
82926153|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
82926154|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
82926155|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926156|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926157|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
82926158|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926159|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82926160|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82926161|NCT04130464|Analgesics|analgesics|mesh-ancestor
82926162|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926163|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926164|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82926165|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926166|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926167|NCT03058354|Propofol|propofol|mesh-list
82926168|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
82926169|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926170|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926171|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82926172|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82926173|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
82926174|NCT02911792|Metformin|metformin|mesh-list
82926175|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
82926176|NCT02911792|Glipizide|glipizide|mesh-list
82926177|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926178|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926179|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82926180|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926181|NCT02143570|Darifenacin|darifenacin|mesh-list
82926182|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82926183|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82926184|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
82926185|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926186|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926187|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926188|NCT02143570|Urological Agents|urological agents|mesh-ancestor
82926189|NCT02143804|Molgramostim|molgramostim|mesh-list
82926190|NCT02143804|Sargramostim|sargramostim|mesh-list
82926191|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
82926192|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926193|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926194|NCT03544996|Insulin|insulin|mesh-list
82926195|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926196|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926197|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82926198|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
82926199|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82926200|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
82926201|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82926202|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926203|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82926204|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82926205|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926207|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82926208|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926209|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926210|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926211|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926212|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926213|NCT02144194|Docetaxel|docetaxel|mesh-list
82926214|NCT02144194|Vinorelbine|vinorelbine|mesh-list
82926215|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926216|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926217|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926218|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926219|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926220|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82926221|NCT02140840|Trametinib|trametinib|mesh-list
82926222|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926223|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926224|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926225|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926226|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
82926227|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926228|NCT00108160|Mupirocin|mupirocin|mesh-list
82926229|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82926230|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926231|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82926232|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926233|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926234|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
82926235|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82926236|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82926237|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
82926238|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926239|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926240|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82926241|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926242|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
82926243|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82926244|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
82926245|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926246|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926247|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82926248|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82926249|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82926250|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
82926251|NCT03545308|Rocuronium|rocuronium|mesh-list
82926252|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82926253|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82926254|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82926255|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926256|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926257|NCT00108082|Atenolol|atenolol|mesh-list
82926258|NCT00108082|Carvedilol|carvedilol|mesh-list
82926259|NCT00108082|Lisinopril|lisinopril|mesh-list
82926260|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82926261|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82926262|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
82926263|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926264|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926265|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926266|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82926267|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
82926268|NCT00108082|Protective Agents|protective agents|mesh-ancestor
82926269|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82926270|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82926271|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82926272|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
82926273|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82926274|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82926275|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82926282|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926283|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82926285|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82926286|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82926287|NCT02144662|Growth Substances|growth substances|mesh-ancestor
82926288|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926289|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
82926290|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926291|NCT02141698|Esomeprazole|esomeprazole|mesh-list
82926292|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82926293|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82926294|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82926295|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926296|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926297|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82926298|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
82926299|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82926300|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
82926301|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82926302|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926303|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82926304|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82926305|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926306|NCT02147938|Tacrolimus|tacrolimus|mesh-list
82926307|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82926308|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
82926309|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926310|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82926311|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926312|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926313|NCT02148016|Levofloxacin|levofloxacin|mesh-list
82926314|NCT02148016|Betamethasone|betamethasone|mesh-list
82926315|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82926316|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926317|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82926318|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82926319|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82926320|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926321|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926322|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926323|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82926324|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82926325|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458238|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
82926326|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
82926327|NCT02148016|Hormones|hormones|mesh-ancestor
82926328|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926329|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926330|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82926331|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926332|NCT02148094|Tenofovir|tenofovir|mesh-list
82926333|NCT02148094|Emtricitabine|emtricitabine|mesh-list
82926334|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82926335|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
82926336|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926337|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82926338|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82926339|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926340|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926341|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82926342|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82926351|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926352|NCT02142010|Paclitaxel|paclitaxel|mesh-list
82926353|NCT02142010|Cisplatin|cisplatin|mesh-list
82926354|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82926355|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926356|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926357|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926358|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926359|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926360|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
82926361|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82926362|NCT05054140|Calcium|calcium|mesh-list
82926363|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82926364|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926365|NCT03543826|Rocuronium|rocuronium|mesh-list
82926366|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82926367|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82926368|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82926369|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926370|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926371|NCT02148640|Infliximab|infliximab|mesh-list
82926372|NCT02148640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82926373|NCT02148640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926374|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
82926375|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82926376|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926377|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82926378|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
82926379|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82926380|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82926381|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82926382|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926383|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926384|NCT02142634|Budesonide|budesonide|mesh-list
82926385|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926386|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82926387|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
82926388|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926389|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926390|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82926391|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926392|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
82926393|NCT02142634|Hormones|hormones|mesh-ancestor
82926394|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926395|NCT02142790|Paclitaxel|paclitaxel|mesh-list
82926396|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82926397|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926398|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926399|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926400|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926401|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926402|NCT02142868|Letrozole|letrozole|mesh-list
82926403|NCT02142868|Palbociclib|palbociclib|mesh-list
82926404|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926405|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82926406|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82926407|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926408|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926409|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82926410|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
82926411|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926412|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926413|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926414|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
82926415|NCT02145520|Analgesics|analgesics|mesh-ancestor
82926416|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
82926417|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926418|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926419|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
82926420|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926421|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82926424|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82926425|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926426|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82926427|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
82926428|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82926429|NCT02145598|Lenalidomide|lenalidomide|mesh-list
82926430|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
82926431|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926432|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82926433|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82926434|NCT02145598|Growth Substances|growth substances|mesh-ancestor
82926435|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
82926436|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926437|NCT02145832|Fluconazole|fluconazole|mesh-list
82926438|NCT02145832|Micafungin|micafungin|mesh-list
82926439|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
82926440|NCT02145832|Clotrimazole|clotrimazole|mesh-list
82926441|NCT02145832|Miconazole|miconazole|mesh-list
82926442|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926443|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82926444|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82926445|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926446|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926447|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82926448|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
82926449|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926450|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926451|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82926452|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82926453|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82926454|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82926455|NCT00104728|Gefitinib|gefitinib|mesh-list
82926456|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926457|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926458|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926459|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926460|NCT02145910|Vemurafenib|vemurafenib|mesh-list
82926461|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926462|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926463|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926464|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926465|NCT02146222|Docetaxel|docetaxel|mesh-list
82926466|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926467|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926468|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926469|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926470|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926471|NCT02146300|Xylometazoline|xylometazoline|mesh-list
82926472|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
82926473|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82926474|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926475|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
82926476|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82926477|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82926478|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926479|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
82926480|NCT02146456|Coagulants|coagulants|mesh-ancestor
82926481|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
82926482|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82926483|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82926484|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926485|NCT02151916|Fluorides|fluorides|mesh-list
82926486|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
82926487|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
82926488|NCT02151916|Protective Agents|protective agents|mesh-ancestor
82926489|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926490|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
82926491|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926492|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926493|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926494|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926496|NCT02152228|Hormones|hormones|mesh-list
82926497|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
82926498|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926499|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926500|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82926501|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82926502|NCT02152306|Amlodipine|amlodipine|mesh-list
82926503|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82926504|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82926505|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82926506|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926507|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82926508|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926509|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
82926510|NCT02261116|Telmisartan|telmisartan|mesh-list
82926511|NCT02261116|Candesartan|candesartan|mesh-list
82926512|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82926513|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82926514|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82926515|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926516|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82926517|NCT02147548|Lorazepam|lorazepam|mesh-list
82926518|NCT02147548|Etifoxine|etifoxine|mesh-list
82926519|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
82926520|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
82926521|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
82926522|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926523|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926524|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82926525|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82926526|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926527|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82926528|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82926529|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82926530|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
82926531|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
82926532|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926533|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926534|NCT00122681|Vaccines|vaccines|mesh-list
82926535|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
82926536|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458264|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926537|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82926538|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926539|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926540|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926541|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926542|NCT05666349|Niraparib|niraparib|mesh-list
82926543|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82926544|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926545|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926546|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926547|NCT03733275|Lidocaine|lidocaine|mesh-list
82926548|NCT03733275|Bupivacaine|bupivacaine|mesh-list
82926549|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
82926550|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
82926551|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926552|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926553|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
82926554|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926555|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82926556|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82926557|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82926558|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82926559|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926560|NCT03542422|Apatinib|apatinib|mesh-list
82926561|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926562|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926563|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926564|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926565|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82926566|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
82926567|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82926569|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
82926570|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926571|NCT03645057|Tacrolimus|tacrolimus|mesh-list
82926572|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82926573|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
82926574|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926575|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82926576|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926577|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926578|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
82926579|NCT04863430|Apatinib|apatinib|mesh-list
82926580|NCT04863430|Tegafur|tegafur|mesh-list
82926581|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926582|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926583|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926584|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926585|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82926586|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
82926587|NCT05665881|Phenylephrine|phenylephrine|mesh-list
82926588|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
82926589|NCT05665881|Norepinephrine|norepinephrine|mesh-list
82926590|NCT05665881|Ephedrine|ephedrine|mesh-list
82926591|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82926592|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
82926593|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
82926594|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926595|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926596|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
82926597|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82926598|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
82926599|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926600|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82926601|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82926602|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82926603|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
82926604|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926605|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926606|NCT05665881|Protective Agents|protective agents|mesh-ancestor
82926607|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83458272|NCT01037881|Analgesics|analgesics|mesh-ancestor
82926608|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
82926609|NCT03643575|Guaifenesin|guaifenesin|mesh-list
82926610|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82926611|NCT03643575|Expectorants|expectorants|mesh-ancestor
82926612|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926613|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82926614|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82926615|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
82926616|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926617|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926618|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926619|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
82926620|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82926621|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
82926622|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
82926623|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926624|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
82926625|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82926626|NCT02768194|Fluorides|fluorides|mesh-list
82926627|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
82926628|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
82926629|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
82926630|NCT02768194|Protective Agents|protective agents|mesh-ancestor
82926631|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926632|NCT02254954|Temozolomide|temozolomide|mesh-list
82926633|NCT02254954|Macitentan|macitentan|mesh-list
82926634|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82926635|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
82926636|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926637|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926638|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82926639|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82926640|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82926641|NCT00130793|Vaccines|vaccines|mesh-list
82926642|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
82926643|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926644|NCT03732105|Apatinib|apatinib|mesh-list
82926645|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
82926646|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926647|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926648|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926649|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926650|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82926651|NCT03732105|Growth Substances|growth substances|mesh-ancestor
82926652|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926653|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
82926654|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
82926655|NCT02154334|Phenylephrine|phenylephrine|mesh-list
82926656|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
82926657|NCT02154334|Esketamine|esketamine|mesh-list
82926658|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926659|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
82926660|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82926661|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
82926662|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82926663|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82926664|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82926665|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
82926666|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926667|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926668|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926669|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
82926670|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
82926671|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926672|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
82926673|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82926674|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926675|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82926676|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
82926677|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82926678|NCT02154334|Protective Agents|protective agents|mesh-ancestor
82926679|NCT01078961|Bortezomib|bortezomib|mesh-list
82926680|NCT01078961|Sorafenib|sorafenib|mesh-list
82926681|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926682|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926683|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926684|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926685|NCT03818399|Buprenorphine|buprenorphine|mesh-list
82926686|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82926687|NCT03818399|Narcotics|narcotics|mesh-ancestor
82926688|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926689|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926690|NCT03818399|Analgesics|analgesics|mesh-ancestor
82926691|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
82926692|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926693|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82926694|NCT02154646|Gemcitabine|gemcitabine|mesh-list
82926695|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82926696|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
82926697|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926698|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926699|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
82926700|NCT03642873|Hydrocodone|hydrocodone|mesh-list
82926701|NCT03642873|Guaifenesin|guaifenesin|mesh-list
82926702|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
82926703|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82926704|NCT03642873|Narcotics|narcotics|mesh-ancestor
82926705|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926706|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926707|NCT03642873|Analgesics|analgesics|mesh-ancestor
82926708|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
82926709|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926710|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
82926711|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926712|NCT03642873|Expectorants|expectorants|mesh-ancestor
82926713|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82926714|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82926715|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
82926716|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926717|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926718|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
82926719|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82926721|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
82926722|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
82926723|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82926724|NCT01079819|BMS 708163|bms 708163|mesh-list
82926725|NCT01079819|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82926726|NCT01079819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926727|NCT01079819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926728|NCT02156596|Ketoprofen|ketoprofen|mesh-list
82926729|NCT02156596|Morphine|morphine|mesh-list
82926730|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82926731|NCT02156596|Narcotics|narcotics|mesh-ancestor
82926732|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926733|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926734|NCT02156596|Analgesics|analgesics|mesh-ancestor
82926735|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
82926736|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926737|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82926738|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82926739|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926740|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926741|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82926742|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926743|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926744|NCT01079117|Morphine|morphine|mesh-list
82926745|NCT01079117|Methadone|methadone|mesh-list
82926746|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82926747|NCT01079117|Narcotics|narcotics|mesh-ancestor
82926748|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926749|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926750|NCT01079117|Analgesics|analgesics|mesh-ancestor
82926751|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
82926752|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926753|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
82926754|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
82926755|NCT03732963|Melatonin|melatonin|mesh-list
82926756|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
82926757|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926758|NCT03732963|Protective Agents|protective agents|mesh-ancestor
82926759|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926760|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926761|NCT03729687|Capecitabine|capecitabine|mesh-list
82926762|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
82926763|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82926764|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
82926765|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926766|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926767|NCT03818321|Methenamine|methenamine|mesh-list
82926768|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
82926769|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
82926770|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82926771|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926772|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82926773|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
82926774|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926775|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926776|NCT04996719|Sirolimus|sirolimus|mesh-list
82926777|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82926778|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926779|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82926780|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926781|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
82926782|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82926783|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
82926784|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926785|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
82926786|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926787|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926788|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
82926789|NCT02770612|Narcotics|narcotics|mesh-ancestor
82926790|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926791|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926792|NCT02770612|Analgesics|analgesics|mesh-ancestor
82926793|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
82926794|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926795|NCT03542110|Alirocumab|alirocumab|mesh-list
82926796|NCT03542110|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82926797|NCT03542110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82926798|NCT03542110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82926799|NCT03542110|Antimetabolites|antimetabolites|mesh-ancestor
82926800|NCT03542110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926801|NCT03542110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82926802|NCT03542110|Protease Inhibitors|protease inhibitors|mesh-ancestor
82926803|NCT03542110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926804|NCT03542110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82926805|NCT03575871|Abrocitinib|abrocitinib|mesh-list
82926806|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926807|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926808|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926809|NCT02155504|Itraconazole|itraconazole|mesh-list
82926810|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
82926811|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926812|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82926813|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82926814|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926815|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926816|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82926817|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
82926818|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926819|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926820|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82926821|NCT03642717|Empagliflozin|empagliflozin|mesh-list
82926822|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83458284|NCT03017807|Antibodies|antibodies|mesh-list
82926823|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926824|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926825|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926826|NCT02766478|Genistein|genistein|mesh-list
82926827|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82926828|NCT02766478|Protective Agents|protective agents|mesh-ancestor
82926829|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926830|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926831|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82926832|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926833|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926834|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
82926835|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82926836|NCT02766478|Estrogens|estrogens|mesh-ancestor
82926837|NCT02766478|Hormones|hormones|mesh-ancestor
82926838|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926839|NCT03729375|Bupivacaine|bupivacaine|mesh-list
82926840|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
82926841|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
82926842|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926843|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926844|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
82926845|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82926846|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82926847|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
82926848|NCT02159326|Riociguat|riociguat|mesh-list
82926849|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
82926850|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926851|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82926852|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
82926853|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82926854|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926855|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82926856|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82926857|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82926858|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82926859|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82926860|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
82926861|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82926862|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82926863|NCT02255266|Liraglutide|liraglutide|mesh-list
82926864|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926865|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926867|NCT02255266|Hormones|hormones|mesh-ancestor
82926868|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926869|NCT00104650|Diphosphonates|diphosphonates|mesh-list
82926870|NCT00104650|Denosumab|denosumab|mesh-list
82926871|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82926872|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926873|NCT02158078|Insulin|insulin|mesh-list
82926874|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926875|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926876|NCT00104416|Lamotrigine|lamotrigine|mesh-list
82926877|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
82926878|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82926879|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82926880|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926881|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82926882|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926883|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82926884|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82926885|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926886|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82926887|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82926888|NCT04817254|Nivolumab|nivolumab|mesh-list
82926889|NCT04817254|Ipilimumab|ipilimumab|mesh-list
82926890|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82926891|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83458287|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
82926892|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82926893|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926894|NCT02149888|Tenofovir|tenofovir|mesh-list
82926895|NCT02149888|Emtricitabine|emtricitabine|mesh-list
82926896|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
82926897|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926898|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82926899|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82926900|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926901|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926902|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82926903|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82926904|NCT03639675|Aflibercept|aflibercept|mesh-list
82926905|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82926906|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82926907|NCT03639675|Growth Substances|growth substances|mesh-ancestor
82926908|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926909|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
82926910|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926911|NCT03543436|Meropenem|meropenem|mesh-list
82926912|NCT03543436|Imipenem|imipenem|mesh-list
82926913|NCT03543436|Temocillin|temocillin|mesh-list
82926914|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82926915|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926916|NCT02149966|Mitapivat|mitapivat|mesh-list
82926917|NCT02149966|Enzyme Activators|enzyme activators|mesh-ancestor
82926918|NCT02149966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926919|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
82926920|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
82926921|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926922|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
82926923|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82926924|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926925|NCT01310361|Amoxicillin|amoxicillin|mesh-list
82926926|NCT01310361|Penicillins|penicillins|mesh-list
82926927|NCT01310361|Penicillin G|penicillin g|mesh-list
82926928|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
82926929|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
82926930|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82926931|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82926932|NCT03541798|Anesthetics|anesthetics|mesh-list
82926933|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82926934|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926935|NCT02150122|Vitamin D|vitamin d|mesh-list
82926936|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
82926937|NCT02150122|Vitamins|vitamins|mesh-ancestor
82926938|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
82926939|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926940|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82926941|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82926942|NCT03728829|Carboplatin|carboplatin|mesh-list
82926943|NCT03728829|Docetaxel|docetaxel|mesh-list
82926944|NCT03728829|Trastuzumab|trastuzumab|mesh-list
82926945|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926946|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
82926947|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
82926948|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
82926949|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926950|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82926951|NCT00121667|Metformin|metformin|mesh-list
82926952|NCT00121667|Pioglitazone|pioglitazone|mesh-list
82926953|NCT00121667|Saxagliptin|saxagliptin|mesh-list
82926954|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926955|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926956|NCT00121667|Incretins|incretins|mesh-ancestor
82926957|NCT00121667|Hormones|hormones|mesh-ancestor
82926958|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926959|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82926960|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
82926961|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926962|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926963|NCT02954601|Insulin|insulin|mesh-list
82926964|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82926965|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82926966|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926967|NCT00121199|Prednisone|prednisone|mesh-list
82926968|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
82926969|NCT00121199|Bevacizumab|bevacizumab|mesh-list
82926970|NCT00121199|Rituximab|rituximab|mesh-list
82926971|NCT00121199|Doxorubicin|doxorubicin|mesh-list
82926972|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82926973|NCT00121199|Vincristine|vincristine|mesh-list
82926974|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82926975|NCT00121199|Antibodies|antibodies|mesh-list
82926976|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
82926977|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82926978|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82926979|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
82926980|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82926981|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82926982|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82926983|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
82926984|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82926985|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82926986|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82926987|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82926988|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82926989|NCT00121199|Growth Substances|growth substances|mesh-ancestor
82926990|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
82926991|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82926992|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82926993|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82926994|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82926995|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82926996|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
82926997|NCT00121199|Hormones|hormones|mesh-ancestor
82926998|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82926999|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82927000|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82927001|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
82927002|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
82927003|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
82927004|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
82927005|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927006|NCT00119015|Fluticasone|fluticasone|mesh-list
82927008|NCT00119015|Montelukast|montelukast|mesh-list
82927009|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927010|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82927011|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
82927012|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927013|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927014|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82927015|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
82927016|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
82927017|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82927018|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82927019|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
82927020|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927021|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82927022|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82927023|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927024|NCT03557307|Benralizumab|benralizumab|mesh-list
82927025|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82927026|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
82927027|NCT01079351|Carbamazepine|carbamazepine|mesh-list
82927028|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
82927029|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
82927030|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82927031|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927032|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927033|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82927034|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927035|NCT01079351|Analgesics|analgesics|mesh-ancestor
82927036|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
82927037|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927038|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82927039|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927040|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927041|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82927042|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82927043|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
82927044|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82927045|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927046|NCT02158624|Ranibizumab|ranibizumab|mesh-list
82927047|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82927048|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82927049|NCT02158624|Growth Substances|growth substances|mesh-ancestor
82927050|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927051|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
82927052|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927053|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
82927054|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927055|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927056|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927057|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927058|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
82927059|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
82927060|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927061|NCT03639519|Protective Agents|protective agents|mesh-ancestor
82927062|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927063|NCT03639519|Vitamins|vitamins|mesh-ancestor
82927064|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
82927065|NCT02158702|Dexamethasone|dexamethasone|mesh-list
82927066|NCT02158702|Pomalidomide|pomalidomide|mesh-list
82927067|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927068|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
82927069|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
82927070|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927071|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927072|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927073|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
82927074|NCT02158702|Hormones|hormones|mesh-ancestor
82927075|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927076|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82927077|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927078|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
82927079|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82927080|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82927081|NCT02158702|Growth Substances|growth substances|mesh-ancestor
82927082|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
82927083|NCT03725709|Anesthetics|anesthetics|mesh-list
82927084|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927085|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927086|NCT01761890|Dasatinib|dasatinib|mesh-list
82927087|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927088|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927089|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927090|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927091|NCT02160028|Anesthetics|anesthetics|mesh-list
82927092|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927093|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927094|NCT03246152|Bevacizumab|bevacizumab|mesh-list
82927095|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927096|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927097|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82927098|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82927099|NCT03246152|Growth Substances|growth substances|mesh-ancestor
82927100|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927101|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
82927102|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
82927103|NCT03541564|Deucravacitinib|deucravacitinib|mesh-list
82927104|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927105|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927106|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82927107|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82927108|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927109|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927110|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927111|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
82927112|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927113|NCT00115349|Deferiprone|deferiprone|mesh-list
82927114|NCT00115349|Deferoxamine|deferoxamine|mesh-list
82927115|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82927116|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
82927117|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
82927118|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927119|NCT00115349|Siderophores|siderophores|mesh-ancestor
82927120|NCT04804696|Paclitaxel|paclitaxel|mesh-list
82927121|NCT04804696|Cisplatin|cisplatin|mesh-list
82927122|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82927123|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927124|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
82927125|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
82927126|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
82927127|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927129|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82927130|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82927131|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927132|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
82927133|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927134|NCT02160106|Vactosertib|vactosertib|mesh-list
82927135|NCT02160106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927136|NCT02160106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927137|NCT02160106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927138|NCT02160184|Pancrelipase|pancrelipase|mesh-list
82927139|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927140|NCT03725553|Vasopressins|vasopressins|mesh-list
82927141|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
82927142|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
82927143|NCT03725553|Coagulants|coagulants|mesh-ancestor
82927144|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82927145|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82927146|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
82927147|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927148|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82927149|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927150|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927151|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927152|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927153|NCT03604341|Dronabinol|dronabinol|mesh-list
82927154|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
82927155|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927156|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82927157|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927158|NCT03604341|Analgesics|analgesics|mesh-ancestor
82927159|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
82927160|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927161|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82927162|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82927163|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927164|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927165|NCT03604341|Hormones|hormones|mesh-ancestor
82927166|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927168|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82927169|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82927170|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927171|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
82927172|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
82927173|NCT03560960|Pramlintide|pramlintide|mesh-list
82927174|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82927175|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927176|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
82927177|NCT01186640|Fludarabine|fludarabine|mesh-list
82927178|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
82927179|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
82927180|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
82927181|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82927182|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
82927183|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927184|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927185|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82927186|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
82927187|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927188|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927189|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82927190|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82927191|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
82927192|NCT01186640|Analgesics|analgesics|mesh-ancestor
82927193|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
82927194|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927195|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82927196|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82927197|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927198|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927199|NCT04949516|Aspirin|aspirin|mesh-list
82927200|NCT04949516|Colchicine|colchicine|mesh-list
82927201|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927202|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927204|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
82927205|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927206|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927207|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927208|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927209|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82927210|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82927211|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927212|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82927213|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82927214|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927215|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
82927216|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
82927217|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
82927218|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
82927219|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
82927220|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927221|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
82927222|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
82927223|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927224|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927225|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927226|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927227|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82927228|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82927229|NCT02778100|Phenylephrine|phenylephrine|mesh-list
82927230|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
82927231|NCT02778100|Glucagon|glucagon|mesh-list
82927232|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927233|NCT02778100|Hormones|hormones|mesh-ancestor
82927234|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927235|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927236|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82927237|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82927238|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
82927239|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927240|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927241|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
82927243|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927244|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
82927245|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82927246|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
82927247|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82927248|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
82927249|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82927250|NCT02778100|Protective Agents|protective agents|mesh-ancestor
82927251|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
82927252|NCT02159248|Gemcitabine|gemcitabine|mesh-list
82927253|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82927254|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
82927255|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927256|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927257|NCT02159248|Analgesics|analgesics|mesh-ancestor
82927258|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
82927259|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927260|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927261|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927262|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927263|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927264|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927265|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82927266|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927267|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82927268|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
82927269|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
82927270|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927271|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82927272|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
82927273|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927274|NCT00118157|Tamoxifen|tamoxifen|mesh-list
82927275|NCT00118157|Lapatinib|lapatinib|mesh-list
82927276|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927277|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82927278|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
82927279|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927280|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927281|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82927282|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927283|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82927284|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82927285|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82927286|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927287|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927289|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927290|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927291|NCT03552549|Interferons|interferons|mesh-list
82927292|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
82927293|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
82927294|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82927295|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927296|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
82927297|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927298|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
82927299|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927300|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
82927301|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927302|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
82927303|NCT02761642|Hematinics|hematinics|mesh-ancestor
82927304|NCT03731403|Fluorides|fluorides|mesh-list
82927305|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
82927306|NCT03731403|Protective Agents|protective agents|mesh-ancestor
82927307|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927308|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
82927309|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927310|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927311|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927312|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927313|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
82927314|NCT03600909|Busulfan|busulfan|mesh-list
82927315|NCT03600909|Fludarabine|fludarabine|mesh-list
82927316|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82927317|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
82927318|NCT03600909|Lenograstim|lenograstim|mesh-list
82927319|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82927320|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
82927321|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927322|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927323|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82927324|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
82927325|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927326|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927327|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82927328|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82927329|NCT03189446|Paclitaxel|paclitaxel|mesh-list
82927330|NCT03189446|Carboplatin|carboplatin|mesh-list
82927331|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82927332|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927333|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
82927334|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
82927335|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
82927336|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927337|NCT03568461|Tisagenlecleucel|tisagenlecleucel|mesh-list
82927338|NCT03568461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927339|NCT03568461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927340|NCT01314482|Minocycline|minocycline|mesh-list
82927341|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927342|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927343|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
82927344|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82927345|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
82927346|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927347|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927348|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82927349|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
82927350|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
82927351|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82927352|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
82927353|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927354|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927355|NCT02895945|Factor VIII|factor viii|mesh-list
82927356|NCT02895945|Coagulants|coagulants|mesh-ancestor
82927357|NCT02777554|Thalidomide|thalidomide|mesh-list
82927358|NCT02777554|Apremilast|apremilast|mesh-list
82927359|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927360|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927361|NCT02777554|Analgesics|analgesics|mesh-ancestor
82927362|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
82927363|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927364|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927365|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927366|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927367|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82927368|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82927369|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927370|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927371|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82927372|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
82927373|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
82927374|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927375|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927376|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82927377|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82927378|NCT02777554|Growth Substances|growth substances|mesh-ancestor
82927379|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
82927380|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927381|NCT03220178|Letrozole|letrozole|mesh-list
82927382|NCT03220178|Fulvestrant|fulvestrant|mesh-list
82927383|NCT03220178|Palbociclib|palbociclib|mesh-list
82927384|NCT03220178|Anastrozole|anastrozole|mesh-list
82927385|NCT03220178|Exemestane|exemestane|mesh-list
82927386|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927387|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82927388|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82927389|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927390|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927391|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82927393|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927394|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927395|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82927396|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82927397|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927398|NCT03032510|Levofloxacin|levofloxacin|mesh-list
82927399|NCT03032510|Ertapenem|ertapenem|mesh-list
83458314|NCT01039207|Rilotumumab|rilotumumab|mesh-list
82927400|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82927401|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927402|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927403|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82927404|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82927405|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927406|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927407|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927408|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82927409|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82927410|NCT03022292|Aflibercept|aflibercept|mesh-list
82927411|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82927412|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82927413|NCT03022292|Growth Substances|growth substances|mesh-ancestor
82927414|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927415|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
82927416|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927417|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
82927418|NCT03599193|Tazarotene|tazarotene|mesh-list
82927419|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
82927420|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
82927421|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
82927422|NCT03599193|Vitamins|vitamins|mesh-ancestor
82927423|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
82927424|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927425|NCT02161354|Buprenorphine|buprenorphine|mesh-list
82927426|NCT02161354|Naloxone|naloxone|mesh-list
82927427|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82927428|NCT02161354|Narcotics|narcotics|mesh-ancestor
82927429|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927430|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927431|NCT02161354|Analgesics|analgesics|mesh-ancestor
82927432|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
82927433|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927434|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82927435|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
82927436|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82927437|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927438|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
82927439|NCT02777242|Testosterone|testosterone|mesh-list
82927440|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
82927441|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
82927442|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82927443|NCT02777242|Androgens|androgens|mesh-ancestor
82927445|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927446|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927447|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82927448|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927449|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
82927450|NCT02163070|Vitamins|vitamins|mesh-list
82927451|NCT02163070|Vitamin E|vitamin e|mesh-list
82927452|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
82927453|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927454|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
82927455|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927456|NCT02163070|Protective Agents|protective agents|mesh-ancestor
82927457|NCT03484520|Venetoclax|venetoclax|mesh-list
82927458|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927459|NCT03566979|Naproxen|naproxen|mesh-list
82927460|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927461|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927462|NCT03566979|Analgesics|analgesics|mesh-ancestor
82927463|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
82927464|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927465|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927466|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927468|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
82927469|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82927470|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927471|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927472|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
82927473|NCT00116831|Glipizide|glipizide|mesh-list
82927474|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82927475|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927476|NCT02784704|Meropenem|meropenem|mesh-list
82927477|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927478|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927479|NCT03540472|Tacrolimus|tacrolimus|mesh-list
82927480|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82927481|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
82927482|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927483|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82927484|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927485|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927486|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82927487|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82927488|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82927489|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
82927490|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927491|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82927492|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82927493|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927494|NCT01310283|Fluorides|fluorides|mesh-list
82927495|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
82927496|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
82927497|NCT01310283|Protective Agents|protective agents|mesh-ancestor
82927498|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927499|NCT02161822|Simvastatin|simvastatin|mesh-list
82927500|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82927501|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82927502|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
82927503|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927504|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82927505|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82927506|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927508|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
82927509|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927510|NCT03724851|Vactosertib|vactosertib|mesh-list
82927511|NCT03724851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82927512|NCT03724851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927513|NCT03724851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927514|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82927515|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82927516|NCT00113399|Paclitaxel|paclitaxel|mesh-list
82927517|NCT00113399|Docetaxel|docetaxel|mesh-list
82927518|NCT00113399|Fluorouracil|fluorouracil|mesh-list
82927519|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82927520|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927521|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
82927522|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
82927523|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
82927524|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927525|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
82927526|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82927527|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82927528|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
82927529|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927530|NCT01326611|Clarithromycin|clarithromycin|mesh-list
82927531|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927532|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927533|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82927534|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927535|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927536|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82927537|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82927538|NCT00113087|Enalapril|enalapril|mesh-list
82927539|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82927540|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
82927541|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927542|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927543|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82927544|NCT00112463|Romidepsin|romidepsin|mesh-list
82927545|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82927546|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927547|NCT00112463|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82927548|NCT00112463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927549|NCT00112463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927550|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
82927551|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
82927552|NCT01083017|Diuretics|diuretics|mesh-ancestor
82927553|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
82927554|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927555|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82927556|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927557|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927558|NCT00112385|Etanercept|etanercept|mesh-list
82927559|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927560|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927561|NCT00112385|Analgesics|analgesics|mesh-ancestor
82927562|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
82927563|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927564|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927565|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927566|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927567|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927568|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82927569|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
82927570|NCT03731169|Voriconazole|voriconazole|mesh-list
82927571|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
82927572|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927573|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82927574|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82927575|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927576|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927577|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82927578|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
82927579|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927580|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927581|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82927583|NCT03731091|Betamethasone|betamethasone|mesh-list
82927584|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
82927585|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82927586|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
82927587|NCT03731091|Calcipotriene|calcipotriene|mesh-list
82927588|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82927589|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927590|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
82927591|NCT03731091|Hormones|hormones|mesh-ancestor
82927592|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82927593|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927594|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82927595|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
82927596|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
82927597|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82927598|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82927599|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927600|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927601|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82927602|NCT03731091|Vitamins|vitamins|mesh-ancestor
82927603|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
82927604|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82927605|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82927606|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
82927607|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927608|NCT03560739|Ofatumumab|ofatumumab|mesh-list
82927609|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82927610|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927611|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
82927612|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927613|NCT01310673|Allopurinol|allopurinol|mesh-list
82927614|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
82927615|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927616|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927617|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
82927618|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927619|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82927621|NCT01310673|Protective Agents|protective agents|mesh-ancestor
82927622|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927623|NCT00101686|Bevacizumab|bevacizumab|mesh-list
82927624|NCT00101686|Capecitabine|capecitabine|mesh-list
82927625|NCT00101686|Irinotecan|irinotecan|mesh-list
82927626|NCT00101686|Fluorouracil|fluorouracil|mesh-list
82927627|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927628|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927629|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82927630|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82927631|NCT00101686|Growth Substances|growth substances|mesh-ancestor
82927632|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927633|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
82927634|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82927635|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
82927636|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927637|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82927638|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82927639|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927640|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82927641|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
82927642|NCT02163616|Misoprostol|misoprostol|mesh-list
82927643|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82927644|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
82927645|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82927646|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927647|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82927648|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927649|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
82927650|NCT00101452|Escitalopram|escitalopram|mesh-list
82927651|NCT00101452|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82927652|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82927653|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927654|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927655|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927656|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
82927657|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927658|NCT02162134|Cefuroxime|cefuroxime|mesh-list
82927659|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
82927660|NCT02162134|Ketorolac|ketorolac|mesh-list
82927661|NCT02162134|Midazolam|midazolam|mesh-list
82927662|NCT02162134|Propofol|propofol|mesh-list
82927663|NCT02162134|Sevoflurane|sevoflurane|mesh-list
82927664|NCT02162134|Atracurium|atracurium|mesh-list
82927665|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82927666|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927667|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927668|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82927669|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
82927670|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
82927671|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82927672|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82927673|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82927674|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82927675|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
82927676|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
82927677|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927678|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927679|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82927680|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82927681|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927682|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927683|NCT02162134|Analgesics|analgesics|mesh-ancestor
82927684|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
82927685|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927686|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927687|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927688|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82927689|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927690|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927691|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927692|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82927693|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82927694|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82927695|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82927696|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82927697|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
82927698|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82927699|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82927700|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927701|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927702|NCT02164006|Immunotoxins|immunotoxins|mesh-ancestor
82927703|NCT02164006|Immunoconjugates|immunoconjugates|mesh-ancestor
82927704|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
82927705|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927706|NCT02167360|Tisagenlecleucel|tisagenlecleucel|mesh-list
82927707|NCT02167360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927708|NCT02167360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927709|NCT03546621|Tenofovir|tenofovir|mesh-list
82927710|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
82927711|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927712|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82927713|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82927714|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927715|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927716|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82927717|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82927718|NCT02761330|Ketamine|ketamine|mesh-list
82927719|NCT02761330|Analgesics|analgesics|mesh-ancestor
82927720|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
82927721|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927722|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927723|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82927724|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82927725|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
82927726|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
82927727|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927728|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82927729|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82927730|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927731|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927732|NCT03730857|Olanzapine|olanzapine|mesh-list
82927733|NCT03730857|Risperidone|risperidone|mesh-list
82927734|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82927735|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
82927736|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82927737|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
82927738|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927739|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927740|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927741|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82927742|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927743|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82927744|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82927745|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
82927746|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
82927747|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
82927748|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927749|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927750|NCT03730857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82927751|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82927752|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927753|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82927754|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82927755|NCT03726177|Aspirin|aspirin|mesh-list
82927756|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927757|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927758|NCT03726177|Analgesics|analgesics|mesh-ancestor
82927759|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
82927760|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927761|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927762|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927763|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927764|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82927765|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82927766|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927767|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82927768|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82927769|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927770|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
82927771|NCT03726099|Amoxicillin|amoxicillin|mesh-list
82927772|NCT03726099|Tetracycline|tetracycline|mesh-list
82927773|NCT03726099|Furazolidone|furazolidone|mesh-list
82927774|NCT03726099|Esomeprazole|esomeprazole|mesh-list
82927775|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927776|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927777|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82927778|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927779|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82927780|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927781|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927782|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82927783|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82927784|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82927785|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82927786|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82927787|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82927788|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82927789|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
82927790|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
82927791|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82927792|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82927793|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927794|NCT03558555|Acetaminophen|acetaminophen|mesh-list
82927795|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927796|NCT03558555|Analgesics|analgesics|mesh-ancestor
82927797|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
82927798|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927799|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927800|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
82927801|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
82927802|NCT03726021|Irinotecan|irinotecan|mesh-list
82927803|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927804|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82927805|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82927806|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927807|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927808|NCT05665023|Bevacizumab|bevacizumab|mesh-list
82927809|NCT05665023|Folfirinox|folfirinox|mesh-list
82927810|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82927811|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927812|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82927813|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82927814|NCT05665023|Growth Substances|growth substances|mesh-ancestor
82927815|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927816|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
82927817|NCT03557931|Olanzapine|olanzapine|mesh-list
82927818|NCT03557931|Risperidone|risperidone|mesh-list
82927819|NCT03557931|Aripiprazole|aripiprazole|mesh-list
82927820|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82927821|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82927822|NCT03557931|Ziprasidone|ziprasidone|mesh-list
82927823|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82927824|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
82927825|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82927826|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
82927827|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927828|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927829|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927830|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82927831|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82927832|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927833|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82927834|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82927835|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
82927836|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
82927837|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
82927838|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927839|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927840|NCT03557931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82927842|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82927843|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
82927844|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
82927845|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82927846|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82927847|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82927848|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82927849|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82927850|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82927851|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82927852|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
82927853|NCT03977675|Ketamine|ketamine|mesh-list
82927854|NCT03977675|Analgesics|analgesics|mesh-ancestor
82927855|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
82927856|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82927857|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927858|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82927859|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82927860|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
82927861|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
82927862|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927863|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82927864|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82927865|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927866|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927867|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
82927868|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
82927869|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82927870|NCT01066559|Protective Agents|protective agents|mesh-ancestor
82927871|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927872|NCT00293813|Denosumab|denosumab|mesh-list
82927873|NCT00293813|Alendronate|alendronate|mesh-list
82927874|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82927875|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927876|NCT00293579|Pemetrexed|pemetrexed|mesh-list
82927877|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927878|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927879|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927880|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82927881|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82927882|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
82927883|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82927884|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
82927885|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927886|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82927887|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927888|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
82927889|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927890|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
82927891|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82927892|NCT00293423|Protective Agents|protective agents|mesh-ancestor
82927893|NCT03521817|Ethanol|ethanol|mesh-list
82927894|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82927895|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927896|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927897|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927898|NCT03538431|Buspirone|buspirone|mesh-list
82927899|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82927900|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82927901|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927902|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927903|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82927904|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82927905|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
82927906|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927907|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927908|NCT03521193|Aspirin|aspirin|mesh-list
82927909|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82927910|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82927911|NCT03521193|Analgesics|analgesics|mesh-ancestor
82927912|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
82927914|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927915|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927916|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927917|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82927918|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82927919|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927920|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82927921|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82927922|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927923|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
82927924|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
82927925|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82927926|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82927927|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
82927928|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927929|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82927930|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82927931|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927932|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927933|NCT03977441|Pramipexole|pramipexole|mesh-list
82927934|NCT03977441|Agomelatine|agomelatine|mesh-list
82927935|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
82927936|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927937|NCT03977441|Protective Agents|protective agents|mesh-ancestor
82927938|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927939|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82927940|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82927941|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
82927942|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
82927943|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82927944|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82927945|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82927946|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82927947|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82927948|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
82927949|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82927950|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927951|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82927952|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
82927953|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82927954|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927955|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927956|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927957|NCT00111917|Infliximab|infliximab|mesh-list
82927958|NCT00111917|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82927959|NCT00111917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82927960|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
82927961|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927962|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927963|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
82927964|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
82927965|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82927966|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82927967|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82927968|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927969|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927970|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82927971|NCT03520569|Octreotide|octreotide|mesh-list
82927972|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82927973|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82927974|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927975|NCT00111839|Pemetrexed|pemetrexed|mesh-list
82927976|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82927977|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927978|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927979|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82927980|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82927981|NCT03723291|Tocopherols|tocopherols|mesh-list
82927982|NCT03723291|Vitamin E|vitamin e|mesh-list
82927983|NCT03723291|Tocotrienols|tocotrienols|mesh-list
82927984|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
82927985|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
82927986|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82927987|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82927988|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82927989|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82927990|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82927991|NCT03723291|Protective Agents|protective agents|mesh-ancestor
82927992|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82927993|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
82927994|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82927995|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
82927996|NCT03723291|Vitamins|vitamins|mesh-ancestor
82927997|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
82927998|NCT00111761|Leucovorin|leucovorin|mesh-list
82927999|NCT00111761|Fluorouracil|fluorouracil|mesh-list
82928000|NCT00111761|Irinotecan|irinotecan|mesh-list
82928001|NCT00111761|Panitumumab|panitumumab|mesh-list
82928002|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
82928003|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928004|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82928005|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928006|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82928007|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
82928008|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928009|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82928010|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82928011|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928012|NCT00111761|Antidotes|antidotes|mesh-ancestor
82928013|NCT00111761|Protective Agents|protective agents|mesh-ancestor
82928014|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
82928015|NCT00111761|Vitamins|vitamins|mesh-ancestor
82928016|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
82928017|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82928018|NCT03519867|Bromides|bromides|mesh-list
82928019|NCT03519867|Rocuronium|rocuronium|mesh-list
82928020|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
82928021|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82928022|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82928023|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82928024|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928025|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928026|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
82928027|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82928028|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928029|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
82928030|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
82928031|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82928032|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82928033|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
82928034|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928035|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82928036|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
82928037|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928038|NCT02164552|Vitamin D|vitamin d|mesh-list
82928039|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
82928040|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
82928041|NCT02164552|Vitamins|vitamins|mesh-list
82928042|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
82928043|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928044|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82928045|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82928046|NCT03723135|Azacitidine|azacitidine|mesh-list
82928047|NCT03723135|Cc-486|cc-486|mesh-list
82928048|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82928049|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
82928050|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928051|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928052|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928053|NCT02762578|Insulin|insulin|mesh-list
82928054|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82928055|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
82928056|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
82928057|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82928058|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
82928059|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928060|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928061|NCT03540628|Thiamine|thiamine|mesh-list
82928062|NCT03540628|Vitamins|vitamins|mesh-ancestor
82928063|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
82928064|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928065|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
82928066|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
82928068|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928069|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928071|NCT02170948|Analgesics|analgesics|mesh-ancestor
82928072|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
82928073|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928074|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82928075|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82928076|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82928077|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
82928078|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928079|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928080|NCT02171026|Amiodarone|amiodarone|mesh-list
82928081|NCT02171026|Dabigatran|dabigatran|mesh-list
82928082|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
82928083|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82928084|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928085|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928086|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928087|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
82928088|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82928089|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
82928090|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82928091|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928092|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82928093|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82928094|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82928095|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82928096|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82928097|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82928098|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
82928099|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82928100|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
82928101|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928102|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
82928103|NCT02165020|Protective Agents|protective agents|mesh-ancestor
82928104|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
82928105|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928106|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928107|NCT03539224|Lamivudine|lamivudine|mesh-list
82928108|NCT03539224|Dolutegravir|dolutegravir|mesh-list
82928109|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82928110|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82928111|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928112|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928113|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
82928114|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928115|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82928116|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82928117|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82928118|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82928119|NCT02171182|Capsaicin|capsaicin|mesh-list
82928120|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
82928121|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
82928122|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
82928123|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928124|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928125|NCT00100828|Irinotecan|irinotecan|mesh-list
82928126|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82928127|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82928128|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928129|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928130|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928131|NCT02165098|Cariprazine|cariprazine|mesh-list
82928132|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82928133|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82928134|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928135|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928136|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82928137|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82928138|NCT02171338|Azithromycin|azithromycin|mesh-list
82928139|NCT02171338|Clarithromycin|clarithromycin|mesh-list
82928141|NCT02171338|Tazobactam|tazobactam|mesh-list
82928142|NCT02171338|Piperacillin|piperacillin|mesh-list
82928143|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82928144|NCT02171338|Penicillin G|penicillin g|mesh-list
82928145|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928146|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82928147|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928148|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928149|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82928150|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82928151|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82928152|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82928153|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928154|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82928155|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82928156|NCT02171416|Rilonacept|rilonacept|mesh-list
82928157|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928158|NCT02171494|Warfarin|warfarin|mesh-list
82928159|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
82928160|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
82928161|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82928162|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82928163|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928164|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82928165|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82928166|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928167|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928168|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928169|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82928170|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
82928171|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82928172|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928173|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82928174|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82928175|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82928176|NCT02171572|Dabigatran|dabigatran|mesh-list
82928177|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
82928178|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82928179|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928180|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928181|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928182|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
82928183|NCT02255578|Clomiphene|clomiphene|mesh-list
82928184|NCT02255578|Enclomiphene|enclomiphene|mesh-list
82928185|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
82928186|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82928187|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
83458360|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928188|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928189|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928190|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82928191|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
82928192|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82928193|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82928194|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82928195|NCT02169154|Diclofenac|diclofenac|mesh-list
82928196|NCT02169154|Menthol|menthol|mesh-list
82928197|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928198|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928199|NCT02169154|Analgesics|analgesics|mesh-ancestor
82928200|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
82928201|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928202|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928203|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928204|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928205|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82928206|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928207|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928208|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
82928209|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
82928210|NCT00100048|Tenofovir|tenofovir|mesh-list
82928211|NCT00100048|Lamivudine|lamivudine|mesh-list
82928212|NCT00100048|Efavirenz|efavirenz|mesh-list
82928213|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
82928214|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
82928216|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82928217|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82928218|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928219|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928220|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82928221|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82928222|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82928223|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82928224|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82928225|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82928226|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82928227|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82928228|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82928229|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82928230|NCT02171650|Afatinib|afatinib|mesh-list
82928231|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928232|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82928233|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928234|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928235|NCT02165566|Insulin|insulin|mesh-list
82928236|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82928237|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
82928238|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928239|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928240|NCT02171728|Afatinib|afatinib|mesh-list
82928241|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928242|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82928243|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928244|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928245|NCT02165644|Nimodipine|nimodipine|mesh-list
82928246|NCT02165644|Acetazolamide|acetazolamide|mesh-list
82928247|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
82928248|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82928249|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928250|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928251|NCT02165644|Diuretics|diuretics|mesh-ancestor
82928252|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
82928253|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928254|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82928255|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82928256|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928257|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82928258|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
82928259|NCT02171806|Olodaterol|olodaterol|mesh-list
82928260|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82928261|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
82928262|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928263|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928264|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82928265|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
82928266|NCT02169544|Abatacept|abatacept|mesh-list
82928267|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82928268|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928269|NCT02169544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82928270|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928271|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82928272|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
82928273|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928274|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928275|NCT02169856|Cefuroxime|cefuroxime|mesh-list
82928276|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
82928277|NCT02169856|Ketorolac|ketorolac|mesh-list
82928278|NCT02169856|Midazolam|midazolam|mesh-list
82928279|NCT02169856|Propofol|propofol|mesh-list
82928280|NCT02169856|Sevoflurane|sevoflurane|mesh-list
82928281|NCT02169856|Atracurium|atracurium|mesh-list
82928282|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82928283|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928284|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928285|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82928286|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
82928287|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
82928288|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82928290|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82928291|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82928292|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
82928293|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
82928294|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928295|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928296|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82928297|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82928298|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928299|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928300|NCT02169856|Analgesics|analgesics|mesh-ancestor
82928301|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
82928302|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928303|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928304|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928305|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82928306|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928307|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82928308|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928309|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82928310|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82928311|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82928312|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82928313|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82928314|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
82928315|NCT02170246|Telmisartan|telmisartan|mesh-list
82928316|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82928317|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82928318|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82928319|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928320|NCT02170324|Exenatide|exenatide|mesh-list
82928321|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928322|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928323|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82928324|NCT02170324|Incretins|incretins|mesh-ancestor
82928325|NCT02170324|Hormones|hormones|mesh-ancestor
82928326|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928327|NCT02170402|Factor VIII|factor viii|mesh-list
82928328|NCT02170402|Coagulants|coagulants|mesh-ancestor
82928329|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82928330|NCT02172196|Empagliflozin|empagliflozin|mesh-list
82928331|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928332|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928333|NCT02172196|Incretins|incretins|mesh-ancestor
82928334|NCT02172196|Hormones|hormones|mesh-ancestor
82928335|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928336|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82928337|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928338|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483019|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82928339|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928340|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82928341|NCT02172274|Empagliflozin|empagliflozin|mesh-list
82928342|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82928343|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928344|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928345|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928346|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
82928347|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82928348|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
82928349|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928350|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928351|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82928352|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
82928353|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
82928354|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82928355|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
82928356|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928357|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928358|NCT02757352|Ixekizumab|ixekizumab|mesh-list
82928359|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
82928360|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
82928361|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82928362|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
82928363|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928364|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928365|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82928366|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
82928367|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
82928368|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82928369|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
82928370|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928371|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928372|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
82928373|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82928374|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
82928375|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928376|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928377|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82928378|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
82928379|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
82928380|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82928381|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
82928382|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928383|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928384|NCT02172586|Losartan|losartan|mesh-list
82928385|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82928386|NCT02172586|Telmisartan|telmisartan|mesh-list
82928387|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82928388|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82928389|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82928390|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82928391|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928392|NCT02172586|Diuretics|diuretics|mesh-ancestor
82928393|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
82928394|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928395|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82928396|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928397|NCT02170636|Pantoprazole|pantoprazole|mesh-list
82928398|NCT02170636|Dabigatran|dabigatran|mesh-list
82928399|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82928400|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82928401|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82928402|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458372|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928403|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928404|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
82928405|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82928406|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928407|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
82928408|NCT02255734|Acyclovir|acyclovir|mesh-list
82928409|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
82928410|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928411|NCT02170792|Ranitidine|ranitidine|mesh-list
82928412|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82928413|NCT02170792|Dabigatran|dabigatran|mesh-list
82928414|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82928415|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82928416|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82928417|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
82928418|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
82928419|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928420|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928421|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928422|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
82928423|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82928424|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928425|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928426|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
82928427|NCT02172976|Gemcitabine|gemcitabine|mesh-list
82928428|NCT02172976|Fluorouracil|fluorouracil|mesh-list
82928429|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
82928430|NCT02172976|Irinotecan|irinotecan|mesh-list
82928431|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82928432|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
82928433|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928434|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928435|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82928436|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
82928437|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928438|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82928439|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82928440|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928441|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
82928442|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
82928443|NCT02173132|Vitamins|vitamins|mesh-ancestor
82928444|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
82928445|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928446|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
82928447|NCT02173288|Furosemide|furosemide|mesh-list
82928448|NCT02173288|Spironolactone|spironolactone|mesh-list
82928449|NCT02173288|Tolvaptan|tolvaptan|mesh-list
82928450|NCT02173288|Midodrine|midodrine|mesh-list
82928451|NCT02173288|Diuretics|diuretics|mesh-ancestor
82928452|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
82928453|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928454|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82928455|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928456|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928457|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82928458|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
82928459|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928460|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82928461|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82928462|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
82928463|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
82928464|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928465|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82928466|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82928467|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82928468|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82928469|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
82928470|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928471|NCT02175394|Linagliptin|linagliptin|mesh-list
82928472|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82928473|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
82928474|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928475|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928476|NCT02175394|Incretins|incretins|mesh-ancestor
82928477|NCT02175394|Hormones|hormones|mesh-ancestor
82928478|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928479|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82928480|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928481|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928482|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928483|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82928484|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
82928485|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82928486|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82928487|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82928488|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82928489|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82928490|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82928491|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
82928492|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82928493|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82928495|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
82928496|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82928497|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928498|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928499|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82928500|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928501|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82928502|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82928503|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928504|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82928505|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82928506|NCT02173756|Morphine|morphine|mesh-list
82928507|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82928508|NCT02173756|Narcotics|narcotics|mesh-ancestor
82928509|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928511|NCT02173756|Analgesics|analgesics|mesh-ancestor
82928512|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
82928513|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928514|NCT00102466|Metformin|metformin|mesh-list
82928515|NCT00102466|Vildagliptin|vildagliptin|mesh-list
82928516|NCT00102466|Gliclazide|gliclazide|mesh-list
82928517|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928518|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928519|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82928520|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928521|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928522|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928523|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82928524|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82928525|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82928526|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928527|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928528|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928529|NCT02173912|Amlodipine|amlodipine|mesh-list
82928530|NCT02173912|Candesartan|candesartan|mesh-list
82928531|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
82928532|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82928533|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82928534|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928535|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928536|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82928537|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928538|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
82928539|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82928540|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82928541|NCT02173990|Aflibercept|aflibercept|mesh-list
82928542|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82928543|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82928544|NCT02173990|Growth Substances|growth substances|mesh-ancestor
82928545|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928546|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
82928547|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928548|NCT02255812|Quinine|quinine|mesh-list
82928549|NCT02255812|Citric Acid|citric acid|mesh-list
82928550|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
82928551|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
82928552|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82928553|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82928554|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928555|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82928556|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928557|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82928558|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928559|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928560|NCT02255812|Analgesics|analgesics|mesh-ancestor
82928561|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
82928563|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82928564|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
82928565|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
82928566|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928567|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
82928568|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82928569|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928570|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928571|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928572|NCT02256280|Neostigmine|neostigmine|mesh-list
82928573|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82928574|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928575|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928576|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
82928577|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928578|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928579|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82928580|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
82928581|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928582|NCT02174068|Acetaminophen|acetaminophen|mesh-list
82928583|NCT02174068|Nefopam|nefopam|mesh-list
82928584|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928585|NCT02174068|Analgesics|analgesics|mesh-ancestor
82928586|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
82928587|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928588|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928589|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
82928590|NCT02179294|Meperidine|meperidine|mesh-list
82928591|NCT02179294|Remifentanil|remifentanil|mesh-list
82928592|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82928593|NCT02179294|Narcotics|narcotics|mesh-ancestor
82928594|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928595|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928596|NCT02179294|Analgesics|analgesics|mesh-ancestor
82928597|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
82928598|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928599|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82928600|NCT02179528|Etoposide|etoposide|mesh-list
82928601|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82928602|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928603|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82928604|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82928605|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928606|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928607|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
82928608|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
82928609|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928610|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928611|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82928612|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
82928613|NCT02182102|Pemetrexed|pemetrexed|mesh-list
82928614|NCT02182102|Nintedanib|nintedanib|mesh-list
82928615|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928616|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928617|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928618|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82928619|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82928620|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82928621|NCT02176720|Fluorides|fluorides|mesh-list
82928622|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
82928623|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
82928624|NCT02176720|Protective Agents|protective agents|mesh-ancestor
82928625|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928626|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
82928627|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928628|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928629|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82928630|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
82928631|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928632|NCT03537196|Ribavirin|ribavirin|mesh-list
82928633|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
82928634|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
82928635|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928636|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
82928637|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928638|NCT02182258|Nintedanib|nintedanib|mesh-list
82928639|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928640|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82928641|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928642|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928643|NCT02182336|Vitamin K|vitamin k|mesh-list
82928644|NCT02182336|Digoxin|digoxin|mesh-list
82928645|NCT02182336|Midazolam|midazolam|mesh-list
82928646|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
82928647|NCT02182336|Caffeine|caffeine|mesh-list
82928648|NCT02182336|Omeprazole|omeprazole|mesh-list
82928649|NCT02182336|Warfarin|warfarin|mesh-list
82928650|NCT02182336|Vitamins|vitamins|mesh-ancestor
82928651|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
82928652|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928653|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82928654|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82928655|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928656|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82928657|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82928658|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82928659|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82928660|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
82928661|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
82928663|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
82928664|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928665|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928666|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
82928667|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82928668|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82928669|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928670|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82928671|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82928672|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
82928673|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82928674|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82928675|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82928676|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82928677|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82928678|NCT02182336|Protective Agents|protective agents|mesh-ancestor
82928679|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82928680|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82928681|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
82928682|NCT02182336|Coagulants|coagulants|mesh-ancestor
82928683|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
82928684|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
82928685|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82928686|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82928687|NCT02182570|Epinastine|epinastine|mesh-list
82928688|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82928689|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
82928690|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
82928691|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928692|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928693|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928694|NCT02182648|Propofol|propofol|mesh-list
82928695|NCT02182648|Etomidate|etomidate|mesh-list
82928696|NCT02182648|Sevoflurane|sevoflurane|mesh-list
82928697|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82928698|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928699|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928700|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82928701|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
82928702|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
82928703|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82928704|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82928705|NCT02179996|Vaccines|vaccines|mesh-list
82928706|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
82928707|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928708|NCT02177344|Bromides|bromides|mesh-list
82928709|NCT02177344|Ipratropium|ipratropium|mesh-list
82928710|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
82928711|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82928712|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
82928713|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928714|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928715|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82928716|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
82928717|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82928718|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
82928719|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928720|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928721|NCT03536494|Mirabegron|mirabegron|mesh-list
82928722|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82928723|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82928724|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82928725|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
82928726|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928727|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928728|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928729|NCT03536494|Urological Agents|urological agents|mesh-ancestor
82928730|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82928731|NCT02177422|Telmisartan|telmisartan|mesh-list
82928732|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82928733|NCT02177422|Diuretics|diuretics|mesh-ancestor
82928734|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
82928735|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928736|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82928737|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928738|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928739|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82928740|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82928742|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928743|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928744|NCT02182960|Analgesics|analgesics|mesh-ancestor
82928745|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
82928746|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928747|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928748|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928749|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928750|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82928751|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928752|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928753|NCT05141968|Vitamin D|vitamin d|mesh-list
82928754|NCT05141968|Vitamins|vitamins|mesh-ancestor
82928755|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
82928756|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928757|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82928758|NCT00110357|Irinotecan|irinotecan|mesh-list
82928759|NCT00110357|Cetuximab|cetuximab|mesh-list
82928760|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82928761|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82928762|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928763|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83458391|NCT03633448|Guaifenesin|guaifenesin|mesh-list
82928764|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82928765|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82928766|NCT02183038|Naproxen|naproxen|mesh-list
82928767|NCT02183038|Meloxicam|meloxicam|mesh-list
82928768|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928769|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928770|NCT02183038|Analgesics|analgesics|mesh-ancestor
82928771|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
82928772|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928773|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928774|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928775|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928776|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
82928777|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82928778|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928779|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928780|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82928781|NCT02752906|Vaccines|vaccines|mesh-list
82928782|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
82928783|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928784|NCT00293033|Fentanyl|fentanyl|mesh-list
82928785|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82928786|NCT00293033|Narcotics|narcotics|mesh-ancestor
82928787|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928788|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928789|NCT00293033|Analgesics|analgesics|mesh-ancestor
82928790|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
82928791|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928792|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82928793|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82928794|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
82928795|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
82928796|NCT02183116|Meloxicam|meloxicam|mesh-list
82928797|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928798|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928799|NCT02183116|Analgesics|analgesics|mesh-ancestor
82928800|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
82928801|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928802|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928803|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928804|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928805|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82928806|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82928807|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928808|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928809|NCT02183194|Paclitaxel|paclitaxel|mesh-list
82928810|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82928812|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
82928813|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
82928814|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
82928815|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928817|NCT02183272|Analgesics|analgesics|mesh-ancestor
82928818|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
82928819|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928820|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928821|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82928822|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82928823|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
82928824|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
82928825|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928826|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82928827|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82928828|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82928829|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928830|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82928831|NCT02177500|Telmisartan|telmisartan|mesh-list
82928832|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
82928833|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82928834|NCT02177500|Diuretics|diuretics|mesh-ancestor
82928835|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
82928836|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928837|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82928838|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82928839|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928840|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82928841|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82928842|NCT02183350|Linagliptin|linagliptin|mesh-list
82928843|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928844|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928845|NCT02183350|Incretins|incretins|mesh-ancestor
82928846|NCT02183350|Hormones|hormones|mesh-ancestor
82928847|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928848|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82928849|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928850|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928851|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928852|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82928853|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
82928854|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82928855|NCT02183428|Glyburide|glyburide|mesh-list
82928856|NCT02183428|Linagliptin|linagliptin|mesh-list
82928857|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928858|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928859|NCT02183428|Incretins|incretins|mesh-ancestor
82928860|NCT02183428|Hormones|hormones|mesh-ancestor
82928861|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928862|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82928863|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928864|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928865|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928866|NCT01080911|Morphine|morphine|mesh-list
82928867|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
82928868|NCT01080911|Narcotics|narcotics|mesh-ancestor
82928869|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82928870|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928871|NCT01080911|Analgesics|analgesics|mesh-ancestor
82928872|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
82928873|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928874|NCT02183506|Metformin|metformin|mesh-list
82928875|NCT02183506|Linagliptin|linagliptin|mesh-list
82928876|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928877|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928878|NCT02183506|Incretins|incretins|mesh-ancestor
82928879|NCT02183506|Hormones|hormones|mesh-ancestor
82928880|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928881|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82928882|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928883|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928884|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928885|NCT02177734|Vaccines|vaccines|mesh-list
82928886|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
82928887|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928888|NCT02183584|Linagliptin|linagliptin|mesh-list
82928889|NCT02183584|Rifampin|rifampin|mesh-list
82928890|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82928891|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928892|NCT02183584|Incretins|incretins|mesh-ancestor
82928893|NCT02183584|Hormones|hormones|mesh-ancestor
82928894|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82928895|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82928896|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928897|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928898|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928899|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82928900|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
82928901|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82928902|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928903|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
82928904|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82928905|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82928906|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82928907|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82928908|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82928909|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82928910|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82928911|NCT03964493|Vancomycin|vancomycin|mesh-list
82928912|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82928913|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928914|NCT01068353|Etanercept|etanercept|mesh-list
82928915|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928916|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928917|NCT01068353|Analgesics|analgesics|mesh-ancestor
82928918|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
82928919|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928920|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928921|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928922|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928923|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82928924|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82928925|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
82928926|NCT01083251|Vitamin D|vitamin d|mesh-list
82928927|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
82928928|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
82928929|NCT01083251|Vitamins|vitamins|mesh-list
82928930|NCT01083251|Entecavir|entecavir|mesh-list
82928931|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
82928932|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928933|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82928934|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82928935|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
82928936|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928937|NCT02184052|Meloxicam|meloxicam|mesh-list
82928938|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928939|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928940|NCT02184052|Analgesics|analgesics|mesh-ancestor
82928941|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
83483020|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
82928942|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928943|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928944|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928945|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928946|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82928947|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82928948|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928949|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928950|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
82928951|NCT01083329|Niacin|niacin|mesh-list
82928952|NCT01083329|Niacinamide|niacinamide|mesh-list
82928953|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
82928954|NCT01083329|Vitamins|vitamins|mesh-ancestor
82928955|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
82928956|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928957|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82928958|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
82928959|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928961|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
82928962|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
82928963|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82928964|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82928965|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928966|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
82928967|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
82928968|NCT02181322|Meloxicam|meloxicam|mesh-list
82928969|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82928970|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82928971|NCT02181322|Analgesics|analgesics|mesh-ancestor
82928972|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
82928973|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82928974|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82928975|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82928976|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82928977|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82928978|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82928979|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928980|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928981|NCT02184286|Nevirapine|nevirapine|mesh-list
82928982|NCT02184286|Saquinavir|saquinavir|mesh-list
82928983|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82928984|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82928985|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82928986|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82928987|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
82928988|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82928989|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82928990|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82928991|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82928992|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82928993|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82928994|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82928995|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
82928996|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82928997|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82928998|NCT02178124|Donepezil|donepezil|mesh-list
82928999|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82929000|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929001|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929002|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
82929003|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929004|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929005|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
82929006|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
82929007|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82929008|NCT02030314|Diuretics|diuretics|mesh-ancestor
82929009|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
82929010|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929011|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82929012|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82929013|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929014|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82929015|NCT02184364|Estrogens|estrogens|mesh-ancestor
82929016|NCT02184364|Hormones|hormones|mesh-ancestor
83483021|NCT03007927|Hormones|hormones|mesh-ancestor
82929017|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929018|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929019|NCT02181478|Cyclosporine|cyclosporine|mesh-list
82929020|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
82929021|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
82929022|NCT02181478|Fludarabine|fludarabine|mesh-list
82929023|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
82929024|NCT02181478|Cyclosporins|cyclosporins|mesh-list
82929025|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82929026|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
82929027|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929028|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929029|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82929030|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
82929031|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929033|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82929034|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82929035|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
82929036|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929037|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
82929038|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929039|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929040|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82929041|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82929042|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82929043|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
82929044|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929045|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
82929046|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82929047|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
82929048|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
82929049|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83458406|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
82929050|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929051|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929052|NCT02755090|Analgesics|analgesics|mesh-ancestor
82929053|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
82929054|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929055|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82929056|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
82929057|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929058|NCT02185690|Carboplatin|carboplatin|mesh-list
82929059|NCT02185690|Pemetrexed|pemetrexed|mesh-list
82929060|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929061|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929062|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929063|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82929064|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82929065|NCT03536806|Canrenone|canrenone|mesh-list
82929066|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82929067|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
82929068|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929069|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929070|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82929071|NCT03536806|Diuretics|diuretics|mesh-ancestor
82929072|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
82929073|NCT00108485|Niacin|niacin|mesh-list
82929074|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82929075|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
82929076|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929077|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82929078|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
82929079|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
82929080|NCT00108485|Vitamins|vitamins|mesh-ancestor
82929081|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
82929082|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929083|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82929084|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929085|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82929086|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929087|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929088|NCT02181946|Fluconazole|fluconazole|mesh-list
82929089|NCT02181946|Nevirapine|nevirapine|mesh-list
82929090|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
82929091|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929092|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82929093|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82929094|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929095|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929096|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82929097|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
82929098|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929099|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929100|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82929101|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82929102|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82929103|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82929106|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82929107|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82929108|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82929109|NCT00107783|Nitisinone|nitisinone|mesh-list
82929110|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929111|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929112|NCT02185768|Idarubicin|idarubicin|mesh-list
82929113|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82929114|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929115|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82929116|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82929117|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929118|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929119|NCT02182024|Dabigatran|dabigatran|mesh-list
82929120|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
83458408|NCT05313958|Cytarabine|cytarabine|mesh-list
82929121|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82929122|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
82929123|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929124|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929125|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
82929126|NCT02185846|Dirithromycin|dirithromycin|mesh-list
82929127|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929128|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929129|NCT02184832|Metformin|metformin|mesh-list
82929130|NCT02184832|Tryptophan|tryptophan|mesh-list
82929131|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929132|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929133|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82929134|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
82929135|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82929136|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
82929137|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
82929138|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82929139|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929140|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929141|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929142|NCT01083797|Analgesics|analgesics|mesh-ancestor
82929143|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
82929144|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929145|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82929146|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82929147|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82929148|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
82929149|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929150|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929151|NCT01083875|Amlexanox|amlexanox|mesh-list
82929152|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82929153|NCT01068977|Bevacizumab|bevacizumab|mesh-list
82929154|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82929155|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82929156|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929157|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82929158|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82929159|NCT01068977|Growth Substances|growth substances|mesh-ancestor
82929160|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929161|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
82929162|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
82929163|NCT02184910|Gastrins|gastrins|mesh-list
82929164|NCT02184910|Hormones|hormones|mesh-ancestor
82929165|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929166|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929167|NCT02185924|Parecoxib|parecoxib|mesh-list
82929168|NCT02185924|Ropivacaine|ropivacaine|mesh-list
82929169|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
82929170|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
82929171|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929172|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929173|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
82929174|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929175|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82929176|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82929177|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929178|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929180|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929181|NCT02185924|Analgesics|analgesics|mesh-ancestor
82929182|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929183|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929184|NCT02185066|Metformin|metformin|mesh-list
82929185|NCT02185066|Atorvastatin|atorvastatin|mesh-list
82929186|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929187|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929188|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82929189|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82929190|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
82929191|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929192|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83458412|NCT05313958|Cladribine|cladribine|mesh-list
82929193|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82929194|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929195|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
82929196|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
82929197|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929198|NCT01069055|Acetaminophen|acetaminophen|mesh-list
82929199|NCT01069055|Lornoxicam|lornoxicam|mesh-list
82929200|NCT01069055|Piroxicam|piroxicam|mesh-list
82929201|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929202|NCT01069055|Analgesics|analgesics|mesh-ancestor
82929203|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
82929204|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929205|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929206|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
82929207|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82929208|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929209|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929210|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82929211|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929212|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929213|NCT01083953|Sevoflurane|sevoflurane|mesh-list
82929214|NCT01083953|Desflurane|desflurane|mesh-list
82929215|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82929216|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82929217|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
82929218|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
82929219|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929220|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929221|NCT02190526|Mesalamine|mesalamine|mesh-list
82929222|NCT02190526|Amitriptyline|amitriptyline|mesh-list
82929223|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82929224|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929225|NCT02190526|Analgesics|analgesics|mesh-ancestor
82929226|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
82929227|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929228|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929229|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929230|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929231|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82929232|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
82929233|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82929234|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82929235|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82929236|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82929237|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929238|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
82929239|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929240|NCT01084031|Propofol|propofol|mesh-list
82929241|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82929242|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929243|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929244|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82929245|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
82929246|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
82929247|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
82929248|NCT02185222|Vitamin D|vitamin d|mesh-list
82929249|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82929250|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929251|NCT02185222|Vitamins|vitamins|mesh-ancestor
82929253|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82929254|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82929255|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
82929256|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82929257|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82929258|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929259|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929260|NCT01084187|Urological Agents|urological agents|mesh-ancestor
82929262|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82929263|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82929264|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458416|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929265|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929266|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82929267|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82929268|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
82929269|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929270|NCT02190760|Dexamethasone|dexamethasone|mesh-list
82929271|NCT02190760|Bupivacaine|bupivacaine|mesh-list
82929272|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929273|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
82929274|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
82929275|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929276|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929277|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82929278|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
82929279|NCT02190760|Hormones|hormones|mesh-ancestor
82929280|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929281|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82929282|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929283|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
82929284|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
82929285|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929286|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
82929287|NCT02190838|Metformin|metformin|mesh-list
82929288|NCT02190838|Dacarbazine|dacarbazine|mesh-list
82929289|NCT02190838|Melatonin|melatonin|mesh-list
82929290|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929291|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929292|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
82929293|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929294|NCT02190838|Protective Agents|protective agents|mesh-ancestor
82929295|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929296|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82929297|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
82929298|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929299|NCT02185456|Metronidazole|metronidazole|mesh-list
82929300|NCT02185456|Miconazole|miconazole|mesh-list
82929301|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929302|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929303|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82929304|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82929305|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
82929306|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82929307|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82929308|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929309|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929310|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82929311|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
82929312|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929313|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929314|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82929315|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82929316|NCT02190994|Prednisone|prednisone|mesh-list
82929317|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
82929318|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929319|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
82929320|NCT02190994|Hormones|hormones|mesh-ancestor
83515823|NCT02379585|Pertuzumab|pertuzumab|mesh-list
82929321|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929322|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929323|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82929324|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929325|NCT02193568|Anesthetics|anesthetics|mesh-list
82929326|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929327|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929328|NCT02191072|Omalizumab|omalizumab|mesh-list
82929329|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82929330|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82929331|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
82929332|NCT02191228|Linagliptin|linagliptin|mesh-list
82929333|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929334|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929335|NCT02191228|Incretins|incretins|mesh-ancestor
82929336|NCT02191228|Hormones|hormones|mesh-ancestor
83458420|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
82929337|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929338|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82929339|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
82929340|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929341|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929342|NCT02186782|Citric Acid|citric acid|mesh-list
82929343|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
82929344|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82929345|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82929346|NCT02186782|Clomiphene|clomiphene|mesh-list
82929347|NCT02186782|Enclomiphene|enclomiphene|mesh-list
82929348|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
82929349|NCT02186782|Estradiol|estradiol|mesh-list
82929350|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82929351|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
82929352|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82929353|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
82929354|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
82929355|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929356|NCT02186782|Estrogens|estrogens|mesh-ancestor
82929357|NCT02186782|Hormones|hormones|mesh-ancestor
82929358|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929359|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929360|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82929361|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
82929362|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82929363|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82929364|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82929365|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
82929366|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82929367|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
82929368|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82929369|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82929370|NCT02187250|Metformin|metformin|mesh-list
82929371|NCT02187250|Liraglutide|liraglutide|mesh-list
82929372|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929373|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929374|NCT02187250|Incretins|incretins|mesh-ancestor
82929375|NCT02187250|Hormones|hormones|mesh-ancestor
82929376|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929377|NCT03535480|Lenograstim|lenograstim|mesh-list
82929378|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82929379|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
82929380|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929381|NCT02187484|Telmisartan|telmisartan|mesh-list
82929382|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82929383|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82929384|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82929385|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929386|NCT02256748|Midazolam|midazolam|mesh-list
82929387|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82929388|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82929389|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929390|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929391|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82929392|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82929393|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82929394|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82929395|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
82929396|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
82929397|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
82929398|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
82929399|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929400|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929402|NCT02187562|Meloxicam|meloxicam|mesh-list
82929403|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82929404|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929405|NCT02187562|Analgesics|analgesics|mesh-ancestor
82929406|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
82929407|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929408|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929409|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83458424|NCT05313958|Analgesics|analgesics|mesh-ancestor
82929410|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929411|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82929412|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82929413|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929414|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82929415|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82929416|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929417|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
82929418|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82929419|NCT02187718|Anesthetics|anesthetics|mesh-list
82929420|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929421|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929422|NCT03535168|Midazolam|midazolam|mesh-list
82929423|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82929424|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82929425|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929426|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929427|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82929428|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82929429|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82929430|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82929431|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
82929432|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
82929433|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
82929434|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
82929435|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929436|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929437|NCT02192320|Dexamethasone|dexamethasone|mesh-list
82929438|NCT02192320|Atorvastatin|atorvastatin|mesh-list
82929439|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929440|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
82929441|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
82929442|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929443|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929444|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82929445|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
82929446|NCT02192320|Hormones|hormones|mesh-ancestor
82929447|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929448|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82929449|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929450|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82929451|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82929452|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
82929453|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929454|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82929455|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82929456|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929457|NCT02187874|Oxytocin|oxytocin|mesh-list
82929458|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
82929459|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82929460|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929461|NCT04870138|Azithromycin|azithromycin|mesh-list
82929462|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
82929463|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
82929464|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929465|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929466|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82929467|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82929468|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929469|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929470|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929471|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82929472|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82929473|NCT02188186|Metformin|metformin|mesh-list
82929474|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82929475|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929476|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929477|NCT02188186|Incretins|incretins|mesh-ancestor
82929478|NCT02188186|Hormones|hormones|mesh-ancestor
83458425|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
82929479|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929480|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82929481|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
82929482|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929483|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929484|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
82929485|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82929486|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929487|NCT02192632|Analgesics|analgesics|mesh-ancestor
82929488|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
82929489|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929490|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929491|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929492|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929493|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929494|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
82929495|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82929496|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82929497|NCT03535090|Prednisolone|prednisolone|mesh-list
82929498|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
82929499|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82929500|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
82929501|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929502|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
82929503|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
82929504|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929505|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929506|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82929507|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
82929508|NCT03535090|Hormones|hormones|mesh-ancestor
82929509|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929510|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82929511|NCT03535090|Protective Agents|protective agents|mesh-ancestor
82929512|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82929513|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929514|NCT03535870|Fluticasone|fluticasone|mesh-list
82929516|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82929517|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82929518|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929519|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82929520|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
82929521|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929522|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929523|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82929524|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
82929525|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929526|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82929527|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82929528|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82929529|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82929530|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
82929531|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929532|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929533|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
82929534|NCT03535870|Hormones|hormones|mesh-ancestor
82929535|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929536|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
82929537|NCT02192710|Midazolam|midazolam|mesh-list
82929538|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82929539|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82929540|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929541|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929542|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82929543|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82929544|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82929545|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82929546|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
82929547|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
83458433|NCT01006655|Hormones|hormones|mesh-ancestor
82929548|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
82929549|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
82929550|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929551|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929553|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929554|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929555|NCT02192944|Chloroquine|chloroquine|mesh-list
82929556|NCT02192944|Piperaquine|piperaquine|mesh-list
82929557|NCT02192944|Artenimol|artenimol|mesh-list
82929558|NCT02192944|Amebicides|amebicides|mesh-ancestor
82929559|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82929560|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82929561|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929562|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
82929563|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929564|NCT02193022|Miltefosine|miltefosine|mesh-list
82929565|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
82929566|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929567|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929568|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82929569|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82929570|NCT02188810|Vaccines|vaccines|mesh-list
82929571|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
82929572|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929573|NCT02188888|Esmolol|esmolol|mesh-list
82929574|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82929575|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82929576|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82929577|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
82929578|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929579|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929580|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929581|NCT02256826|Ritonavir|ritonavir|mesh-list
82929582|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82929583|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82929584|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
82929585|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929586|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929587|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82929588|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82929589|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
82929590|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929591|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82929592|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82929593|NCT03535792|Fentanyl|fentanyl|mesh-list
82929594|NCT03535792|Nalbuphine|nalbuphine|mesh-list
82929595|NCT03535792|Bupivacaine|bupivacaine|mesh-list
82929596|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
82929597|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
82929598|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929599|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929600|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
82929601|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929602|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82929603|NCT03535792|Narcotics|narcotics|mesh-ancestor
82929604|NCT03535792|Analgesics|analgesics|mesh-ancestor
82929605|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82929606|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82929607|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
82929608|NCT02193256|Prazosin|prazosin|mesh-list
82929609|NCT02193256|Varenicline|varenicline|mesh-list
82929610|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82929611|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82929612|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
82929613|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929614|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929615|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929616|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82929617|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82929618|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82929619|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82929620|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
82929621|NCT03535558|Azithromycin|azithromycin|mesh-list
82929622|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
83458439|NCT03633526|VX-659|vx-659|mesh-list
82929623|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82929624|NCT03535558|Trimethoprim|trimethoprim|mesh-list
82929625|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
82929626|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929627|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929629|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
82929630|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82929631|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82929632|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82929633|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929634|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929635|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82929636|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82929637|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82929638|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82929639|NCT02193334|Mitogens|mitogens|mesh-list
82929640|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
82929641|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929642|NCT04247542|Vancomycin|vancomycin|mesh-list
82929643|NCT04247542|Ibezapolstat|ibezapolstat|mesh-list
82929644|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929645|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929646|NCT04247542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82929647|NCT04247542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929648|NCT04247542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929649|NCT02194192|Ephedrine|ephedrine|mesh-list
82929650|NCT02194192|Ondansetron|ondansetron|mesh-list
82929651|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
82929652|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
82929653|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929654|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929655|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82929656|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
82929657|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929658|NCT02194192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82929659|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82929660|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
82929661|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929662|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929663|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82929664|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
82929665|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82929666|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
82929667|NCT02194270|Ambroxol|ambroxol|mesh-list
82929668|NCT02194270|Expectorants|expectorants|mesh-ancestor
82929669|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
82929670|NCT02190058|DS-1971a|ds-1971a|mesh-list
82929671|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82929672|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82929673|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82929674|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929675|NCT02194348|Olcegepant|olcegepant|mesh-list
82929676|NCT02194348|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82929677|NCT02194348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929678|NCT02194348|Analgesics|analgesics|mesh-ancestor
82929679|NCT02194348|Sensory System Agents|sensory system agents|mesh-ancestor
82929680|NCT02194348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929681|NCT02194348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929682|NCT02195908|Antiemetics|antiemetics|mesh-list
82929683|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
82929684|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929685|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929686|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82929687|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
82929688|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82929689|NCT02197000|Protective Agents|protective agents|mesh-ancestor
82929690|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929691|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929692|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
82929693|NCT02196142|Mannitol|mannitol|mesh-list
82929694|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82929695|NCT02196142|Diuretics|diuretics|mesh-ancestor
82929696|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
82929697|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929698|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929699|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82929700|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82929701|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82929702|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929703|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82929704|NCT03534388|Eusol|eusol|mesh-list
82929705|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
82929706|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929707|NCT04308694|Methadone|methadone|mesh-list
82929708|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82929709|NCT04308694|Narcotics|narcotics|mesh-ancestor
82929710|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929711|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929712|NCT04308694|Analgesics|analgesics|mesh-ancestor
82929713|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
82929714|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929715|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
82929716|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
82929717|NCT03534310|Liraglutide|liraglutide|mesh-list
82929718|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929719|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929720|NCT03534310|Incretins|incretins|mesh-ancestor
82929721|NCT03534310|Hormones|hormones|mesh-ancestor
82929722|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929723|NCT02194894|Acetaminophen|acetaminophen|mesh-list
82929724|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82929725|NCT02194894|Analgesics|analgesics|mesh-ancestor
82929726|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
82929727|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929728|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929729|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
82929730|NCT03534622|Delafloxacin|delafloxacin|mesh-list
82929731|NCT03534622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929732|NCT02197702|Vitamin D|vitamin d|mesh-list
82929733|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
82929734|NCT02197702|Vitamins|vitamins|mesh-ancestor
82929735|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
82929736|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929737|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82929738|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82929739|NCT02031016|Fentanyl|fentanyl|mesh-list
82929740|NCT02031016|Remifentanil|remifentanil|mesh-list
82929741|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82929742|NCT02031016|Narcotics|narcotics|mesh-ancestor
82929743|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929744|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929745|NCT02031016|Analgesics|analgesics|mesh-ancestor
82929746|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
82929747|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929748|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82929749|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82929750|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
82929751|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
82929752|NCT00095147|Infliximab|infliximab|mesh-list
82929753|NCT00095147|Methotrexate|methotrexate|mesh-list
82929754|NCT00095147|Abatacept|abatacept|mesh-list
82929755|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82929756|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
82929757|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82929758|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929759|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82929760|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
82929761|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929762|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929763|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929764|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929765|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82929766|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82929767|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
82929768|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929769|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82929770|NCT00095147|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82929771|NCT00095147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929772|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82929773|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82929774|NCT00095147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82929775|NCT02198170|Ketoconazole|ketoconazole|mesh-list
82929776|NCT02198170|Lenvatinib|lenvatinib|mesh-list
82929777|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
82929778|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929779|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82929780|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82929781|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929782|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929783|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82929784|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
82929785|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929786|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929787|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82929788|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929789|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82929790|NCT02198248|Prednisolone|prednisolone|mesh-list
82929791|NCT02198248|Rituximab|rituximab|mesh-list
82929792|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
82929793|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82929794|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929795|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
82929796|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929797|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929798|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82929799|NCT02198248|Hormones|hormones|mesh-ancestor
82929800|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929801|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82929802|NCT01069133|Rifaximin|rifaximin|mesh-list
82929803|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929804|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929805|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82929806|NCT02198326|Olcegepant|olcegepant|mesh-list
82929807|NCT02198326|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82929808|NCT02198326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929809|NCT02198326|Analgesics|analgesics|mesh-ancestor
82929810|NCT02198326|Sensory System Agents|sensory system agents|mesh-ancestor
82929811|NCT02198326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929812|NCT02198326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929813|NCT02198404|Propofol|propofol|mesh-list
82929814|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82929815|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929816|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929817|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82929818|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
82929819|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
82929820|NCT02198482|Cytarabine|cytarabine|mesh-list
82929821|NCT02198482|Daunorubicin|daunorubicin|mesh-list
82929822|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
82929823|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82929824|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
82929825|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929826|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929827|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
82929828|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929829|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82929830|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
82929831|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929832|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82929833|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82929834|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82929835|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929836|NCT02198482|Analgesics|analgesics|mesh-ancestor
82929837|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
82929838|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929839|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
82929840|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929841|NCT02201134|Sevoflurane|sevoflurane|mesh-list
82929842|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82929843|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82929844|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
82929845|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
82929846|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929847|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929848|NCT02201602|Gliclazide|gliclazide|mesh-list
82929849|NCT02201602|Glyburide|glyburide|mesh-list
82929850|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82929851|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929852|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82929853|NCT02201914|Clomiphene|clomiphene|mesh-list
82929855|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
82929856|NCT02201914|Cetrorelix|cetrorelix|mesh-list
82929857|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
82929858|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82929859|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
82929860|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82929861|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929862|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82929863|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82929864|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929865|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82929866|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
82929867|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82929868|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82929869|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
82929870|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82929871|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82929872|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82929873|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82929874|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82929875|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929876|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929877|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82929878|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82929879|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929880|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
82929881|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929882|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
82929883|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82929884|NCT02202304|Thymol|thymol|mesh-list
82929885|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82929886|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929887|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
82929888|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929889|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
82929890|NCT02207452|Albuterol|albuterol|mesh-list
82929891|NCT02207452|Ipratropium|ipratropium|mesh-list
82929892|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82929893|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
82929894|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929895|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929896|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82929897|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
82929898|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
82929899|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82929900|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82929901|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82929902|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82929903|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
82929904|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929905|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929906|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82929907|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
82929908|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
82929909|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82929910|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82929911|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
82929912|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82929913|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82929914|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929915|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
82929916|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929917|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929918|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82929919|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929920|NCT02207920|Vaccines|vaccines|mesh-list
82929921|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
82929922|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929923|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
82929924|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82929925|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82929926|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929927|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
82929930|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
82929931|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
82929932|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929933|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929934|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
82929935|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929936|NCT02199418|Paclitaxel|paclitaxel|mesh-list
82929937|NCT02199418|Cisplatin|cisplatin|mesh-list
82929938|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82929939|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929940|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
82929941|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
82929942|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
82929943|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929944|NCT02208778|Remifentanil|remifentanil|mesh-list
82929945|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82929946|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82929947|NCT02208778|Narcotics|narcotics|mesh-ancestor
82929948|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82929949|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929950|NCT02208778|Analgesics|analgesics|mesh-ancestor
82929951|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
82929952|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82929953|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82929954|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82929955|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82929956|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929957|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82929958|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
82929959|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82929960|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
82929961|NCT02203396|Cyclosporine|cyclosporine|mesh-list
82929962|NCT02203396|Levamisole|levamisole|mesh-list
82929963|NCT02203396|Cyclosporins|cyclosporins|mesh-list
82929964|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
82929965|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929966|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929967|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82929968|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
82929969|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929970|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
82929971|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929972|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929973|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82929974|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82929975|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82929976|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
82929977|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
82929978|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82929979|NCT02203552|Minocycline|minocycline|mesh-list
82929980|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82929981|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82929982|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82929983|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82929984|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
82929985|NCT02200354|Bevacizumab|bevacizumab|mesh-list
82929986|NCT02200354|Pemetrexed|pemetrexed|mesh-list
82929987|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82929988|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82929989|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82929990|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82929991|NCT02200354|Growth Substances|growth substances|mesh-ancestor
82929992|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82929993|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
82929994|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82929995|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82929996|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82929997|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82929998|NCT02204020|Azacitidine|azacitidine|mesh-list
82929999|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82930000|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
82930001|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930003|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930004|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82930005|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82930006|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
82930007|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930008|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930009|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930010|NCT02220634|Regadenoson|regadenoson|mesh-list
82930011|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82930012|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82930013|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
82930014|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
82930015|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930016|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930017|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930018|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
82930019|NCT02204644|Flumatinib|flumatinib|mesh-list
82930020|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930021|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930022|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930023|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930024|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
82930025|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930026|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930027|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930028|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930029|NCT02204878|Parecoxib|parecoxib|mesh-list
82930030|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82930031|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82930032|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930033|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930034|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930035|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930036|NCT02204878|Analgesics|analgesics|mesh-ancestor
82930037|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
82930038|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930039|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930040|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930041|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930042|NCT02205034|Oxytocin|oxytocin|mesh-list
82930043|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
82930044|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82930045|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930046|NCT02210728|Methylphenidate|methylphenidate|mesh-list
82930047|NCT02210728|Amphetamine|amphetamine|mesh-list
82930048|NCT02210728|Adderall|adderall|mesh-list
82930049|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
82930050|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82930051|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930052|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82930053|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82930054|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82930055|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930056|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
82930057|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930058|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
82930059|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
82930060|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930061|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
82930062|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82930063|NCT02220868|Ribavirin|ribavirin|mesh-list
82930064|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
82930065|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82930066|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
82930067|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930068|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
82930069|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930070|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82930071|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82930072|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82930073|NCT02221102|Aspirin|aspirin|mesh-list
82930075|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930076|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930077|NCT02221102|Analgesics|analgesics|mesh-ancestor
82930078|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
82930079|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930080|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930081|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930082|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930083|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82930084|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82930085|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930086|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82930087|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82930088|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930089|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
82930090|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82930091|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
82930092|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82930093|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
82930094|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
82930095|NCT02213302|Midazolam|midazolam|mesh-list
82930096|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82930097|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82930098|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930099|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930100|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82930101|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82930102|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82930103|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82930104|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
82930105|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
82930106|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
82930107|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
82930108|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930109|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930110|NCT02221180|Metformin|metformin|mesh-list
82930111|NCT02221180|Canagliflozin|canagliflozin|mesh-list
82930112|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82930113|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930114|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82930115|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930116|NCT02205112|Levofloxacin|levofloxacin|mesh-list
82930117|NCT02205112|Nemonoxacin|nemonoxacin|mesh-list
82930118|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82930119|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930120|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82930121|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82930122|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82930123|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930124|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930125|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930126|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82930127|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82930128|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82930129|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82930130|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82930131|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
82930132|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930133|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82930134|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82930135|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930136|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
82930137|NCT02257918|Zoliflodacin|zoliflodacin|mesh-list
82930138|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82930139|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930140|NCT02257918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82930141|NCT02257918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82930142|NCT02257918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930143|NCT02257918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930144|NCT02257918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930145|NCT02221414|Metformin|metformin|mesh-list
82930146|NCT02221414|Linagliptin|linagliptin|mesh-list
82930147|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82930148|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930149|NCT02221414|Incretins|incretins|mesh-ancestor
82930150|NCT02221414|Hormones|hormones|mesh-ancestor
82930151|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82930152|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82930153|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
82930154|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930155|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930156|NCT02221492|Plerixafor|plerixafor|mesh-list
82930157|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82930158|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82930159|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
82930160|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930161|NCT05164978|Antibodies|antibodies|mesh-list
82930162|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
82930163|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930164|NCT02221570|Baclofen|baclofen|mesh-list
82930165|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82930166|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930167|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82930168|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930169|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82930170|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
82930171|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
82930172|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930173|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930174|NCT02205502|Lidocaine|lidocaine|mesh-list
82930175|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
82930176|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
82930177|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930178|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930179|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
82930180|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930181|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82930182|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82930183|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82930184|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82930185|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930186|NCT02219698|Acetaminophen|acetaminophen|mesh-list
82930187|NCT02219698|Ibuprofen|ibuprofen|mesh-list
82930188|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930189|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930190|NCT02219698|Analgesics|analgesics|mesh-ancestor
82930191|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
82930192|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930193|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930194|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930195|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930196|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82930197|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930198|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930199|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
82930200|NCT02205580|Sufentanil|sufentanil|mesh-list
82930201|NCT02205580|Dsuvia|dsuvia|mesh-list
82930202|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82930203|NCT02205580|Narcotics|narcotics|mesh-ancestor
82930204|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930205|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930206|NCT02205580|Analgesics|analgesics|mesh-ancestor
82930207|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
82930208|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930209|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82930210|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82930211|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
82930212|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
82930213|NCT02221960|Durvalumab|durvalumab|mesh-list
82930214|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930215|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930216|NCT02220088|Leucovorin|leucovorin|mesh-list
82930217|NCT02220088|Fluorouracil|fluorouracil|mesh-list
82930218|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
82930219|NCT02220088|Sorafenib|sorafenib|mesh-list
82930220|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
82930221|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930222|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82930223|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930225|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
82930226|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930227|NCT02220088|Antidotes|antidotes|mesh-ancestor
82930228|NCT02220088|Protective Agents|protective agents|mesh-ancestor
82930229|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
82930230|NCT02220088|Vitamins|vitamins|mesh-ancestor
82930231|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
82930232|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930233|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930234|NCT02220400|Ketamine|ketamine|mesh-list
82930236|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
82930237|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930238|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930239|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82930240|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82930241|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
82930242|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
82930243|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930244|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82930245|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82930246|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930247|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930249|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930250|NCT02224768|Ipilimumab|ipilimumab|mesh-list
82930251|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930252|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930253|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82930254|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930255|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
82930256|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82930257|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930258|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930259|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930260|NCT05262166|Analgesics|analgesics|mesh-ancestor
82930261|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
82930262|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930263|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82930264|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82930265|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82930266|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
82930267|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930268|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930269|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
82930270|NCT02206204|Selexipag|selexipag|mesh-list
82930271|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82930272|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82930273|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930274|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82930275|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82930276|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930277|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930278|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930279|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82930280|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
82930281|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82930282|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930283|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82930284|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82930285|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82930286|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82930287|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
82930288|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82930289|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82930290|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82930291|NCT02230930|Apomorphine|apomorphine|mesh-list
82930292|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930293|NCT02230930|Emetics|emetics|mesh-ancestor
82930294|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930295|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
82930296|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930301|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930302|NCT02222350|Firuglipel|firuglipel|mesh-list
82930303|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82930304|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930305|NCT02222428|Olodaterol|olodaterol|mesh-list
82930306|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82930307|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
82930308|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930309|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930310|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82930311|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
82930312|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
82930313|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82930314|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
82930315|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930316|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930317|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82930318|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
82930319|NCT02225470|Vinorelbine|vinorelbine|mesh-list
82930320|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82930321|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930322|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82930323|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82930324|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82930325|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930326|NCT02225548|Tadalafil|tadalafil|mesh-list
82930327|NCT02225548|Selegiline|selegiline|mesh-list
82930328|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
82930329|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82930330|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82930331|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930332|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930333|NCT02225548|Urological Agents|urological agents|mesh-ancestor
82930334|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
82930335|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82930336|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82930337|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82930338|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82930339|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82930340|NCT02225548|Protective Agents|protective agents|mesh-ancestor
82930341|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930342|NCT02223052|Azacitidine|azacitidine|mesh-list
82930343|NCT02223052|Cc-486|cc-486|mesh-list
82930344|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82930345|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
82930346|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930347|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930348|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930349|NCT02231632|Vaccines|vaccines|mesh-list
82930350|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
82930351|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930352|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82930353|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82930354|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82930355|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930356|NCT02231788|Amlodipine|amlodipine|mesh-list
82930357|NCT02231788|Telmisartan|telmisartan|mesh-list
82930358|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82930359|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82930360|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82930361|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930362|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82930363|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930364|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
82930365|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82930366|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82930368|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82930369|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82930370|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
82930371|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
82930372|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82930373|NCT02258620|Diuretics|diuretics|mesh-ancestor
82930374|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
82930375|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930376|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82930377|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930378|NCT02223598|Dexamethasone|dexamethasone|mesh-list
82930379|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930380|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
82930381|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
82930382|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930383|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930384|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82930385|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
82930386|NCT02223598|Hormones|hormones|mesh-ancestor
82930387|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82930388|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82930389|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930390|NCT00094835|Paclitaxel|paclitaxel|mesh-list
82930391|NCT00094835|Carboplatin|carboplatin|mesh-list
82930392|NCT00094835|Panitumumab|panitumumab|mesh-list
82930393|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
82930394|NCT00094835|Imetelstat|imetelstat|mesh-list
82930395|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82930396|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930397|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
82930398|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
82930399|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
82930400|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930401|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930402|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930403|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930404|NCT02226328|Fentanyl|fentanyl|mesh-list
82930405|NCT02226328|Midazolam|midazolam|mesh-list
82930406|NCT02226328|Propofol|propofol|mesh-list
82930407|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82930408|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930409|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930410|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82930411|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
82930412|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
82930413|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82930414|NCT02226328|Narcotics|narcotics|mesh-ancestor
82930415|NCT02226328|Analgesics|analgesics|mesh-ancestor
82930416|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
82930417|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930418|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82930419|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82930420|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82930421|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82930422|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
82930423|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
82930424|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930425|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930426|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
82930427|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82930428|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930429|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
82930430|NCT02226484|Quercetin|quercetin|mesh-list
82930431|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
82930432|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930433|NCT02226484|Protective Agents|protective agents|mesh-ancestor
82930434|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930435|NCT04453852|Vaccines|vaccines|mesh-list
82930436|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
82930437|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930438|NCT00094757|Pioglitazone|pioglitazone|mesh-list
82930439|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82930440|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82930441|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930442|NCT00094757|Incretins|incretins|mesh-ancestor
82930443|NCT00094757|Hormones|hormones|mesh-ancestor
83084000|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930444|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82930446|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
82930447|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930448|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930449|NCT02223832|Ponesimod|ponesimod|mesh-list
82930450|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82930451|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930452|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82930453|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
82930454|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930455|NCT02224066|Aspirin|aspirin|mesh-list
82930456|NCT02224066|Clopidogrel|clopidogrel|mesh-list
82930457|NCT02224066|Ticagrelor|ticagrelor|mesh-list
82930458|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930459|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930460|NCT02224066|Analgesics|analgesics|mesh-ancestor
82930461|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
82930462|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83515898|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82930463|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930464|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930465|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930466|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82930467|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82930468|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930469|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82930470|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82930471|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930473|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82930474|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82930475|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82930476|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
82930477|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930478|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82930479|NCT04378114|Acetaminophen|acetaminophen|mesh-list
82930480|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930481|NCT04378114|Analgesics|analgesics|mesh-ancestor
82930482|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
82930483|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930484|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930485|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
82930486|NCT00082433|Capecitabine|capecitabine|mesh-list
82930487|NCT00082433|Epothilones|epothilones|mesh-list
82930488|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82930489|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
82930490|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930491|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930492|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
82930493|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
82930494|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
82930495|NCT00094445|Curcumin|curcumin|mesh-list
82930496|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930497|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930498|NCT00094445|Analgesics|analgesics|mesh-ancestor
82930499|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
82930500|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930501|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930502|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930503|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930504|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930505|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930506|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930507|NCT01081535|Ketorolac|ketorolac|mesh-list
82930508|NCT01081535|Fentanyl|fentanyl|mesh-list
82930509|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82930510|NCT01081535|Narcotics|narcotics|mesh-ancestor
82930511|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930512|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930513|NCT01081535|Analgesics|analgesics|mesh-ancestor
82930514|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
82930515|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930516|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82930517|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82930518|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
82930520|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930521|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930522|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930523|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930524|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82930525|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930526|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930527|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
82930528|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82930529|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
82930530|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
82930531|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930532|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930533|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930534|NCT01087229|Analgesics|analgesics|mesh-ancestor
82930535|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
82930536|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930537|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82930538|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82930539|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82930540|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930541|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82930542|NCT01084577|Laxatives|laxatives|mesh-ancestor
82930543|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82930544|NCT00094055|Axitinib|axitinib|mesh-list
82930545|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930546|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930547|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930548|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930549|NCT02531165|Aspirin|aspirin|mesh-list
82930550|NCT02531165|Heparin|heparin|mesh-list
82930551|NCT02531165|Fentanyl|fentanyl|mesh-list
82930552|NCT02531165|Morphine|morphine|mesh-list
82930553|NCT02531165|Ticagrelor|ticagrelor|mesh-list
82930554|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930555|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930556|NCT02531165|Analgesics|analgesics|mesh-ancestor
82930557|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
82930558|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930559|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930560|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930561|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930562|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82930563|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82930564|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930565|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82930566|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82930567|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930568|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
82930569|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82930570|NCT02531165|Narcotics|narcotics|mesh-ancestor
82930571|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930572|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82930573|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82930574|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
82930575|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
82930576|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
82930577|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82930578|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82930579|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82930580|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
82930581|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930582|NCT00099983|Risperidone|risperidone|mesh-list
82930583|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82930584|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
82930585|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930586|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930587|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930588|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82930589|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82930590|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930591|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82930593|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
82930595|NCT00099359|Zidovudine|zidovudine|mesh-list
82930596|NCT00099359|Nevirapine|nevirapine|mesh-list
82930597|NCT00099359|Nelfinavir|nelfinavir|mesh-list
82930598|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82930599|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82930600|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930601|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930602|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
82930603|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930604|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82930605|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82930606|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
82930607|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82930608|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82930609|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82930610|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82930611|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
82930612|NCT00092417|Vaccines|vaccines|mesh-list
82930613|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
82930614|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930615|NCT00091949|Pioglitazone|pioglitazone|mesh-list
82930616|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82930617|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930618|NCT02258542|Benralizumab|benralizumab|mesh-list
82930619|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82930620|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
82930621|NCT00091793|Denosumab|denosumab|mesh-list
82930622|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82930623|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930624|NCT00098813|Romidepsin|romidepsin|mesh-list
82930625|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82930626|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930627|NCT00098813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82930628|NCT00098813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930629|NCT00098813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930630|NCT01081613|Bevacizumab|bevacizumab|mesh-list
82930631|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
82930632|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930633|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930634|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82930635|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82930636|NCT01081613|Growth Substances|growth substances|mesh-ancestor
82930637|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930638|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
82930639|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82930640|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930641|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
82930642|NCT02227264|Cinacalcet|cinacalcet|mesh-list
82930643|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82930644|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930645|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82930646|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
82930647|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82930648|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82930649|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930650|NCT04772248|Adalimumab|adalimumab|mesh-list
82930651|NCT04772248|Infliximab|infliximab|mesh-list
82930652|NCT04772248|Golimumab|golimumab|mesh-list
82930653|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
82930654|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
82930655|NCT04772248|Etanercept|etanercept|mesh-list
82930656|NCT04772248|Tofacitinib|tofacitinib|mesh-list
82930657|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930658|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930659|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
82930660|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82930661|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82930662|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930663|NCT04772248|Analgesics|analgesics|mesh-ancestor
82930664|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
82930665|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930666|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930667|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82930668|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
82930669|NCT04772248|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82930670|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930671|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930672|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930674|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930675|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82930676|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82930677|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930678|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930679|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82930680|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
82930681|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82930682|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930683|NCT01775644|Bevacizumab|bevacizumab|mesh-list
82930684|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930685|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930686|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83458515|NCT03016793|Puerarin|puerarin|mesh-list
82930687|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82930688|NCT01775644|Growth Substances|growth substances|mesh-ancestor
82930689|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930690|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
82930691|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82930692|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82930693|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82930694|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930695|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930696|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82930697|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82930698|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930699|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
82930700|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930701|NCT04229368|Vitamin D|vitamin d|mesh-list
82930702|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
82930703|NCT04229368|Vitamins|vitamins|mesh-ancestor
82930704|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
82930705|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930706|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82930707|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82930708|NCT00090779|Ritonavir|ritonavir|mesh-list
82930709|NCT00090779|Lopinavir|lopinavir|mesh-list
82930710|NCT00090779|Tenofovir|tenofovir|mesh-list
82930711|NCT00090779|Emtricitabine|emtricitabine|mesh-list
82930712|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82930713|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82930714|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82930715|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
82930716|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930717|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930718|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82930719|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82930720|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
82930721|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930722|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82930723|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82930724|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82930725|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82930726|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82930727|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
82930728|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930729|NCT01081847|Mannitol|mannitol|mesh-list
82930730|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82930731|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
82930732|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82930733|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
82930734|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930735|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82930736|NCT01081847|Diuretics|diuretics|mesh-ancestor
82930737|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
82930738|NCT02224456|Tenofovir|tenofovir|mesh-list
82930739|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
82930740|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930742|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82930743|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930744|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930745|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82930746|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82930747|NCT02224534|Clopidogrel|clopidogrel|mesh-list
82930748|NCT02224534|Ticagrelor|ticagrelor|mesh-list
82930749|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82930750|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82930751|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82930752|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82930753|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
82930754|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930755|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930756|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930757|NCT04174612|Cytarabine|cytarabine|mesh-list
82930758|NCT04174612|Daunorubicin|daunorubicin|mesh-list
82930759|NCT04174612|Midostaurin|midostaurin|mesh-list
82930760|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83458518|NCT03928522|Vancomycin|vancomycin|mesh-list
82930761|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
82930762|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930763|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930764|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
82930765|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930766|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82930767|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
82930768|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930769|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82930770|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82930771|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82930772|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930773|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930775|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82930776|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930777|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930778|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82930779|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82930780|NCT01082003|Protective Agents|protective agents|mesh-ancestor
82930781|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930782|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
82930783|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82930784|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
82930785|NCT01082237|Escitalopram|escitalopram|mesh-list
82930786|NCT01082237|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82930787|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82930788|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82930789|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930790|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930791|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
82930792|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930793|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82930794|NCT02228122|Laxatives|laxatives|mesh-ancestor
82930795|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82930796|NCT01082315|Cetuximab|cetuximab|mesh-list
82930797|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930798|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930799|NCT01082471|Morphine|morphine|mesh-list
82930800|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82930801|NCT01082471|Narcotics|narcotics|mesh-ancestor
82930802|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930803|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930804|NCT01082471|Analgesics|analgesics|mesh-ancestor
82930805|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
82930806|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930807|NCT03553498|Acetaminophen|acetaminophen|mesh-list
82930808|NCT03553498|Hydromorphone|hydromorphone|mesh-list
82930809|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82930810|NCT03553498|Analgesics|analgesics|mesh-ancestor
82930811|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
82930812|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930813|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930814|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
82930815|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82930816|NCT03553498|Narcotics|narcotics|mesh-ancestor
82930817|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930818|NCT01589393|Enoxaparin|enoxaparin|mesh-list
82930819|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
82930820|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82930821|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82930822|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930823|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
82930824|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82930825|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82930826|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82930827|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82930828|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930829|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
82930830|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82930831|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930832|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82930833|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930834|NCT00096941|Pertuzumab|pertuzumab|mesh-list
82930835|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930836|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930837|NCT00096785|Entecavir|entecavir|mesh-list
82930838|NCT00096785|Adefovir|adefovir|mesh-list
82930839|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
82930840|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930841|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82930842|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82930843|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930844|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930845|NCT01326767|Paclitaxel|paclitaxel|mesh-list
82930846|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82930847|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82930848|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930849|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
82930850|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
82930851|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
82930852|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930853|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
82930854|NCT03963479|Pyridoxal|pyridoxal|mesh-list
82930855|NCT03963479|Pyridoxine|pyridoxine|mesh-list
82930856|NCT03963479|Vitamins|vitamins|mesh-ancestor
82930857|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
82930858|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930859|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
82930860|NCT02228512|Prednisone|prednisone|mesh-list
82930861|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
82930862|NCT02228512|Rituximab|rituximab|mesh-list
82930863|NCT02228512|Doxorubicin|doxorubicin|mesh-list
82930864|NCT02228512|Etoposide|etoposide|mesh-list
82930865|NCT02228512|Vincristine|vincristine|mesh-list
82930866|NCT02228512|Pomalidomide|pomalidomide|mesh-list
82930867|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82930868|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
82930869|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930870|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82930871|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82930872|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
82930873|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930874|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930875|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82930876|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82930877|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82930878|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82930879|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82930880|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930881|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82930882|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
82930883|NCT02228512|Hormones|hormones|mesh-ancestor
82930884|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82930885|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82930886|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82930887|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
82930888|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
82930889|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
82930890|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82930891|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82930892|NCT02228512|Growth Substances|growth substances|mesh-ancestor
82930893|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
82930894|NCT01082627|Somatostatin|somatostatin|mesh-list
82930895|NCT01082627|Hormones|hormones|mesh-ancestor
82930896|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82930897|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930898|NCT03515044|Rifaximin|rifaximin|mesh-list
82930899|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82930900|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930901|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82930902|NCT01082705|Lumefantrine|lumefantrine|mesh-list
82930903|NCT01082705|Artemether|artemether|mesh-list
82930904|NCT01082705|Piperaquine|piperaquine|mesh-list
82930905|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82930906|NCT01082705|Artenimol|artenimol|mesh-list
82930907|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
82930908|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82930909|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82930910|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82930911|NCT01582997|Dabrafenib|dabrafenib|mesh-list
82930912|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930913|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930914|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930915|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930916|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
82930917|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930919|NCT01085981|Niacinamide|niacinamide|mesh-list
82930920|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
82930921|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82930922|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
82930923|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930924|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82930925|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
82930926|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
82930927|NCT01085981|Vitamins|vitamins|mesh-ancestor
82930928|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
82930929|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930930|NCT03345082|Ranibizumab|ranibizumab|mesh-list
82930931|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82930932|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82930933|NCT03345082|Growth Substances|growth substances|mesh-ancestor
82930934|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930935|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
82930936|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930937|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
82930938|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
82930939|NCT02228902|Trace Elements|trace elements|mesh-ancestor
82930940|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
82930941|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930942|NCT02228902|Hematinics|hematinics|mesh-ancestor
82930943|NCT03288454|Apixaban|apixaban|mesh-list
82930944|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82930945|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
82930946|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82930947|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
82930948|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930949|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930950|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
82930951|NCT00090545|Sorafenib|sorafenib|mesh-list
82930952|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930953|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82930954|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82930955|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930956|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
82930957|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82930958|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
82930959|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82930960|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82930961|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82930962|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82930963|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82930964|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82930965|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82930966|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82930967|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82930968|NCT02229058|Paclitaxel|paclitaxel|mesh-list
82930969|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82930970|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82930971|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930972|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
82930973|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
82930974|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
82930975|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930976|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
82930977|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82930978|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82930979|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930980|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
82930981|NCT02229292|Coagulants|coagulants|mesh-ancestor
82930982|NCT00070109|Trabectedin|trabectedin|mesh-list
82930983|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82930984|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
82930985|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930986|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930987|NCT00069953|Paclitaxel|paclitaxel|mesh-list
82930988|NCT00069953|Fluorouracil|fluorouracil|mesh-list
82930989|NCT00069953|Lenograstim|lenograstim|mesh-list
82930990|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82930991|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82930992|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
82930993|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
82930994|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83515899|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
82930995|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82930996|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
82930997|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82930998|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82930999|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
82931000|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931001|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82931002|NCT03118570|Vitamin D|vitamin d|mesh-list
82931003|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
82931004|NCT03118570|Calcium|calcium|mesh-list
82931005|NCT03118570|Vitamins|vitamins|mesh-ancestor
82931006|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
82931007|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931008|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82931009|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82931010|NCT02750800|Adalimumab|adalimumab|mesh-list
82931011|NCT02750800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82931012|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931013|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931014|NCT02229760|Ritonavir|ritonavir|mesh-list
82931015|NCT02229760|Tipranavir|tipranavir|mesh-list
82931016|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82931017|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82931018|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
82931019|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931020|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931021|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82931022|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82931023|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
82931024|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931025|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82931026|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82931027|NCT03662542|Golimumab|golimumab|mesh-list
82931028|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82931029|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82931030|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931031|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931032|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
82931033|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931034|NCT01329562|Naproxen|naproxen|mesh-list
82931035|NCT01329562|Sumatriptan|sumatriptan|mesh-list
82931036|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82931037|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82931038|NCT01329562|Analgesics|analgesics|mesh-ancestor
82931039|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
82931040|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931041|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931042|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931043|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931044|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
82931045|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82931047|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931048|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82931049|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82931050|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82931051|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
82931052|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931053|NCT02230228|Vitamin A|vitamin a|mesh-list
82931054|NCT02230228|Retinol acetate|retinol acetate|mesh-list
82931055|NCT02230228|Vitamins|vitamins|mesh-ancestor
82931056|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
82931057|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931058|NCT02230228|Protective Agents|protective agents|mesh-ancestor
82931059|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82931060|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931061|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82931062|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
82931063|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
82931064|NCT01090661|Mipomersen|mipomersen|mesh-list
82931065|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82931066|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931067|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931068|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82931069|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82931070|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931071|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931072|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931073|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82931074|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
82931075|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82931076|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931077|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82931078|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82931079|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82931080|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82931081|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82931082|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
82931083|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82931085|NCT05563480|Gemcitabine|gemcitabine|mesh-list
82931086|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931087|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82931088|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
82931089|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931090|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82931091|NCT05546398|Ezetimibe|ezetimibe|mesh-list
82931092|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82931093|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82931094|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
82931095|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931096|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82931097|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931098|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82931099|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931100|NCT05472766|Anticoagulants|anticoagulants|mesh-list
82931101|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
82931102|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
82931103|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82931104|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
82931105|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931106|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931107|NCT03653026|Upadacitinib|upadacitinib|mesh-list
82931108|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82931109|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82931110|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931111|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931112|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931113|NCT02232724|Choline|choline|mesh-list
82931114|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
82931115|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82931116|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
82931117|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931118|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82931119|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82931120|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
82931121|NCT02234440|Metformin|metformin|mesh-list
82931122|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82931123|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931124|NCT04981678|Buprenorphine|buprenorphine|mesh-list
82931125|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82931126|NCT04981678|Narcotics|narcotics|mesh-ancestor
82931127|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931128|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931129|NCT04981678|Analgesics|analgesics|mesh-ancestor
82931130|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
82931131|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931132|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82931133|NCT02230618|Insulin|insulin|mesh-list
82931134|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
82931135|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82931136|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931137|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
82931138|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82931139|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931140|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931141|NCT04669288|Azithromycin|azithromycin|mesh-list
82931142|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931143|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931144|NCT02262520|Digoxin|digoxin|mesh-list
82931145|NCT02262520|Apixaban|apixaban|mesh-list
82931146|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82931147|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
82931148|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82931149|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
82931150|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931151|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931152|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
82931153|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82931154|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82931155|NCT02262520|Protective Agents|protective agents|mesh-ancestor
82931156|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931157|NCT02233504|Deferasirox|deferasirox|mesh-list
82931158|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82931159|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
82931160|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
82931161|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931162|NCT02262598|Telmisartan|telmisartan|mesh-list
82931163|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82931164|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82931165|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82931166|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82931167|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931168|NCT02262598|Diuretics|diuretics|mesh-ancestor
82931169|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
82931170|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931171|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82931172|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931173|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82931174|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82931175|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82931176|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
82931177|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931178|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82931179|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82931180|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931181|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
82931182|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82931183|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931184|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931185|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82931186|NCT03723538|Analgesics|analgesics|mesh-ancestor
82931187|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
82931188|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931189|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82931190|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82931191|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82931192|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
82931193|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931194|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931196|NCT01337674|Amlodipine|amlodipine|mesh-list
82931197|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82931198|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82931199|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931200|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931201|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82931202|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931203|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
82931204|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82931205|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
82931206|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
82931207|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931208|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82931209|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82931210|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82931211|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
82931212|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931213|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
82931214|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82931215|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
82931216|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82931217|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
82931218|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931219|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931220|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
82931221|NCT02233582|Ibuprofen|ibuprofen|mesh-list
82931222|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82931223|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82931224|NCT02233582|Analgesics|analgesics|mesh-ancestor
82931225|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
82931226|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931227|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931228|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931229|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931230|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82931231|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931232|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931233|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
82931234|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82931235|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82931236|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82931237|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931238|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931239|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
82931240|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931241|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931242|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82931243|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931245|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
82931246|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931247|NCT02750410|Dulaglutide|dulaglutide|mesh-list
82931248|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82931249|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931250|NCT02750332|Nitisinone|nitisinone|mesh-list
82931251|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931252|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931253|NCT02233894|Ipratropium|ipratropium|mesh-list
82931254|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82931255|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
82931256|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931257|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931258|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82931259|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
82931260|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82931261|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
82931262|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931263|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931264|NCT02233972|Midazolam|midazolam|mesh-list
82931265|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83084001|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931266|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82931267|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931268|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931269|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82931270|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82931271|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82931272|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82931273|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
82931274|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
82931275|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
82931276|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
82931277|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931278|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931279|NCT02234050|Trabectedin|trabectedin|mesh-list
82931280|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82931281|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
82931282|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931283|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931284|NCT02263066|Factor VIII|factor viii|mesh-list
82931285|NCT02263066|Coagulants|coagulants|mesh-ancestor
82931287|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
82931288|NCT02235532|Protective Agents|protective agents|mesh-ancestor
82931289|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931290|NCT00069095|Leucovorin|leucovorin|mesh-list
82931291|NCT00069095|Bevacizumab|bevacizumab|mesh-list
82931292|NCT00069095|Fluorouracil|fluorouracil|mesh-list
82931293|NCT00069095|Capecitabine|capecitabine|mesh-list
82931294|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
82931295|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82931296|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931297|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82931298|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82931299|NCT00069095|Growth Substances|growth substances|mesh-ancestor
82931300|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931301|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
82931302|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
82931303|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931304|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82931305|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931306|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
82931307|NCT00069095|Antidotes|antidotes|mesh-ancestor
82931308|NCT00069095|Protective Agents|protective agents|mesh-ancestor
82931309|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
82931310|NCT00069095|Vitamins|vitamins|mesh-ancestor
82931311|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
82931312|NCT00086411|Bupropion|bupropion|mesh-list
82931313|NCT00086411|Nicotine|nicotine|mesh-list
82931314|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82931315|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
82931316|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931317|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931318|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82931319|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82931320|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
82931321|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931322|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931323|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82931324|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
82931325|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82931326|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82931327|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82931328|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931329|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
82931330|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82931331|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82931332|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931333|NCT00068393|Gemcitabine|gemcitabine|mesh-list
82931334|NCT00068393|Doxorubicin|doxorubicin|mesh-list
82931335|NCT00068393|Lenograstim|lenograstim|mesh-list
82931336|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82931337|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
82931338|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931339|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931340|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82931341|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82931343|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931344|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82931345|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
82931346|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931347|NCT01086527|Montelukast|montelukast|mesh-list
82931348|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82931349|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
82931350|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82931351|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
82931352|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931353|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931354|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82931355|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82931356|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931357|NCT01093937|Varenicline|varenicline|mesh-list
82931358|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82931359|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82931360|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
82931361|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931362|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931363|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931365|NCT01094015|Prilocaine|prilocaine|mesh-list
82931366|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82931367|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
82931368|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
82931369|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931370|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931371|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
83515974|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
82931372|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931373|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82931374|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82931375|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82931376|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931377|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931378|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82931379|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
82931380|NCT01090895|Vitamins|vitamins|mesh-ancestor
82931381|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
82931382|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931383|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
82931384|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931385|NCT01090895|Protective Agents|protective agents|mesh-ancestor
82931386|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
82931387|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
82931388|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
82931389|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931390|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931391|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
82931392|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931393|NCT01094249|Valproic Acid|valproic acid|mesh-list
82931394|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82931395|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82931396|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82931397|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931398|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931399|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82931400|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82931401|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82931402|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
82931403|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931404|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931405|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82931406|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82931407|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
82931408|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
82931409|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931410|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
82931411|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
82931412|NCT00055601|Paclitaxel|paclitaxel|mesh-list
82931413|NCT00055601|Gemcitabine|gemcitabine|mesh-list
82931414|NCT00055601|Fluorouracil|fluorouracil|mesh-list
82931415|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82931416|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931417|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
82931418|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
82931419|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
82931420|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931421|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82931422|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
82931423|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931424|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
82931425|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931426|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
82931427|NCT01583621|Vitamin D|vitamin d|mesh-list
82931428|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82931429|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931430|NCT01583621|Vitamins|vitamins|mesh-ancestor
82931431|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
82931432|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82931433|NCT03806231|Dinoprostone|dinoprostone|mesh-list
82931434|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
82931435|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82931436|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931437|NCT01091051|Ustekinumab|ustekinumab|mesh-list
82931438|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
82931439|NCT01327079|Methadone|methadone|mesh-list
82931440|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82931441|NCT01327079|Narcotics|narcotics|mesh-ancestor
82931442|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931443|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931444|NCT01327079|Analgesics|analgesics|mesh-ancestor
82931445|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
82931446|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931447|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
82931448|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
82931449|NCT01091207|Sorafenib|sorafenib|mesh-list
82931450|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931451|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82931452|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931453|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931454|NCT00054275|Docetaxel|docetaxel|mesh-list
82931455|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82931456|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931457|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
82931458|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
82931459|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
82931460|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931461|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82931462|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931463|NCT01095185|Simvastatin|simvastatin|mesh-list
82931464|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82931465|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82931466|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
82931467|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931468|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82931469|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82931470|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931471|NCT01583777|Belinostat|belinostat|mesh-list
82931472|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931473|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82931474|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931475|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931476|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
82931477|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82931478|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931479|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931480|NCT00052715|Poly ICLC|poly iclc|mesh-list
82931481|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
82931482|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
83458554|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
82931483|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931484|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
82931485|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931486|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
82931487|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931488|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931489|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82931491|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931492|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931493|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82931494|NCT00051311|Cyclosporine|cyclosporine|mesh-list
82931495|NCT00051311|Prednisone|prednisone|mesh-list
82931496|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
82931497|NCT00051311|Doxorubicin|doxorubicin|mesh-list
82931498|NCT00051311|Methotrexate|methotrexate|mesh-list
82931499|NCT00051311|Fludarabine|fludarabine|mesh-list
82931500|NCT00051311|Etoposide|etoposide|mesh-list
82931501|NCT00051311|Vincristine|vincristine|mesh-list
82931502|NCT00051311|Cyclosporins|cyclosporins|mesh-list
82931503|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931504|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
82931505|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931506|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931507|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82931508|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
82931509|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931510|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931511|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82931512|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82931513|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82931514|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82931515|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931516|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931517|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
82931518|NCT00051311|Hormones|hormones|mesh-ancestor
82931519|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931520|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82931521|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82931522|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
82931523|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82931524|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82931525|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
82931526|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
82931527|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82931528|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82931529|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82931530|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
82931531|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
82931532|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
82931533|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
82931534|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931535|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82931537|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82931538|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82931539|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931540|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931541|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82931542|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931543|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
82931544|NCT00049673|Thalidomide|thalidomide|mesh-list
82931545|NCT00049673|Prednisone|prednisone|mesh-list
82931546|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931547|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
82931548|NCT00049673|Hormones|hormones|mesh-ancestor
82931549|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931550|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931551|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82931552|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931553|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931554|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
82931555|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
82931556|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931557|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931558|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82931559|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82931560|NCT00049673|Growth Substances|growth substances|mesh-ancestor
82931561|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
82931562|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
82931563|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931564|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82931565|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931566|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931567|NCT00066365|Molgramostim|molgramostim|mesh-list
82931568|NCT00066365|Sargramostim|sargramostim|mesh-list
82931569|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
82931570|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931571|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931572|NCT00048581|Abatacept|abatacept|mesh-list
82931573|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82931574|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931575|NCT00048581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82931576|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931577|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931578|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
82931579|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931580|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931581|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
82931582|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82931583|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
82931584|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931585|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931586|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
82931587|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931588|NCT03957629|Interferons|interferons|mesh-list
82931589|NCT03957629|Tenofovir|tenofovir|mesh-list
82931590|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
82931591|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
82931592|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82931593|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931594|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
82931595|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931596|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82931597|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82931598|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931599|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931600|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82931601|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82931602|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
82931603|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931604|NCT00065507|Entecavir|entecavir|mesh-list
82931605|NCT00065507|Adefovir|adefovir|mesh-list
82931606|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
82931607|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931608|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82931609|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82931610|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931611|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931612|NCT01095575|Morphine|morphine|mesh-list
82931613|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82931614|NCT01095575|Narcotics|narcotics|mesh-ancestor
82931615|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82931616|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931617|NCT01095575|Analgesics|analgesics|mesh-ancestor
82931618|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
82931619|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931620|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
82931621|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82931622|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931623|NCT00065429|Immunotoxins|immunotoxins|mesh-ancestor
82931624|NCT00065429|Immunoconjugates|immunoconjugates|mesh-ancestor
82931625|NCT00065429|Immunologic Factors|immunologic factors|mesh-ancestor
82931626|NCT00065429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931627|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82931628|NCT01095731|Acetic Acid|acetic acid|mesh-list
82931629|NCT01095731|Retinol acetate|retinol acetate|mesh-list
82931630|NCT01095731|Glycine|glycine|mesh-list
82931631|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
82931632|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931633|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931634|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931635|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931636|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931637|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82931638|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
82931639|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82931640|NCT01095731|Protective Agents|protective agents|mesh-ancestor
82931641|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931642|NCT01095809|Triamcinolone|triamcinolone|mesh-list
82931643|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82931644|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82931645|NCT01095809|Bevacizumab|bevacizumab|mesh-list
82931646|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82931647|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82931648|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931649|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82931650|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82931651|NCT01095809|Growth Substances|growth substances|mesh-ancestor
82931652|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931653|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
82931654|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931655|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
82931656|NCT01095809|Hormones|hormones|mesh-ancestor
82931657|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931658|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931659|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
82931660|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931661|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931662|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
82931663|NCT00048035|Hematinics|hematinics|mesh-ancestor
82931664|NCT01092221|Allopurinol|allopurinol|mesh-list
82931665|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
82931666|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931667|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931668|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
82931669|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931670|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82931671|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
82931672|NCT01092221|Protective Agents|protective agents|mesh-ancestor
82931673|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931674|NCT00047879|Interferons|interferons|mesh-list
82931675|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
82931676|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
82931677|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82931678|NCT00047879|Thalidomide|thalidomide|mesh-list
82931679|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931680|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
82931681|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931682|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
82931683|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931684|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931685|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
82931686|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931687|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82931688|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82931689|NCT00047879|Growth Substances|growth substances|mesh-ancestor
82931690|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
82931691|NCT00064337|Thalidomide|thalidomide|mesh-list
82931692|NCT00064337|Dexamethasone|dexamethasone|mesh-list
82931693|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
82931694|NCT00064337|Melphalan|melphalan|mesh-list
82931695|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931696|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
82931697|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931698|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931699|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82931700|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
82931701|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931702|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931703|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82931704|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931705|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
82931706|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
82931707|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931708|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82931709|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
82931710|NCT00064337|Hormones|hormones|mesh-ancestor
82931711|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931712|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82931713|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
82931714|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931715|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931716|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82931778|NCT00044213|Antidotes|antidotes|mesh-ancestor
82931779|NCT00044213|Protective Agents|protective agents|mesh-ancestor
82931780|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82931781|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82931782|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
82931783|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82931784|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82931785|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82931786|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
82931787|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82931788|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931789|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82931790|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82931791|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82931792|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82931793|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931794|NCT01096199|Cisplatin|cisplatin|mesh-list
82931795|NCT01096199|Everolimus|everolimus|mesh-list
82931796|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931797|NCT01096199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82931798|NCT01096199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82931799|NCT01096199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931800|NCT01096199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931801|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931802|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
82931803|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931804|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82931805|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82931806|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931807|NCT01096277|Incretins|incretins|mesh-ancestor
82931808|NCT01096277|Hormones|hormones|mesh-ancestor
82931809|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931810|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82931811|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
82931812|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931813|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931814|NCT01096355|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82931815|NCT01096355|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82931816|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931817|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931818|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
82931819|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82931820|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931821|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931822|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82931823|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82931824|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931825|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931826|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931827|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82931828|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
82931829|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82931830|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931831|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82931832|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82931833|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82931834|NCT01092455|Heparin|heparin|mesh-list
82931835|NCT01092455|Calcium heparin|calcium heparin|mesh-list
82931836|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
82931837|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82931838|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82931839|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931840|NCT02264938|Antioxidants|antioxidants|mesh-list
82931841|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931842|NCT02264938|Protective Agents|protective agents|mesh-ancestor
82931843|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931844|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
82931845|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82931846|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931847|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82931848|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931849|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82931850|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
82931851|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
82931852|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82931853|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931854|NCT04235140|Ivacaftor|ivacaftor|mesh-list
82931855|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82931856|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931857|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931858|NCT00043979|Cyclosporine|cyclosporine|mesh-list
82931859|NCT00043979|Sirolimus|sirolimus|mesh-list
82931860|NCT00043979|Prednisone|prednisone|mesh-list
82931861|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
82931862|NCT00043979|Melphalan|melphalan|mesh-list
82931863|NCT00043979|Doxorubicin|doxorubicin|mesh-list
82931864|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82931865|NCT00043979|Fludarabine|fludarabine|mesh-list
82931866|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
82931867|NCT00043979|Etoposide|etoposide|mesh-list
82931868|NCT00043979|Vincristine|vincristine|mesh-list
82931869|NCT00043979|Tacrolimus|tacrolimus|mesh-list
82931870|NCT00043979|Cyclosporins|cyclosporins|mesh-list
82931871|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82931872|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82931873|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
82931874|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931875|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931876|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82931877|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
82931878|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931879|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931880|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82931881|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82931882|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82931883|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82931884|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931885|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931886|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
82931888|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931889|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82931890|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82931891|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
82931892|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82931893|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82931894|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
82931895|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
82931896|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
82931897|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
82931898|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931899|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
82931900|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931901|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82931902|NCT01436032|Ketorolac|ketorolac|mesh-list
82931903|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82931904|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82931905|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82931906|NCT01436032|Analgesics|analgesics|mesh-ancestor
82931907|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
82931908|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82931909|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931910|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931911|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82931912|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82931913|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931914|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931915|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
82931916|NCT01092533|Prednisolone|prednisolone|mesh-list
82931917|NCT01092533|Prednisone|prednisone|mesh-list
82931918|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82931919|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931920|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82931921|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
82931922|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931923|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931924|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931925|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931926|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931927|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
82931928|NCT01092533|Hormones|hormones|mesh-ancestor
82931929|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931930|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931931|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82931932|NCT01431820|Luliconazole|luliconazole|mesh-list
82931933|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82931934|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
82931935|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931936|NCT01425970|Interferons|interferons|mesh-list
82931937|NCT01425970|Ribavirin|ribavirin|mesh-list
82931939|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
82931940|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82931941|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931942|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
82931943|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931944|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
82931945|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931946|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
82931947|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931948|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82931949|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82931950|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931951|NCT01619332|Incretins|incretins|mesh-ancestor
82931952|NCT01619332|Hormones|hormones|mesh-ancestor
82931953|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931954|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82931955|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
82931956|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931957|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931958|NCT01616524|Interferons|interferons|mesh-list
82931959|NCT01616524|Ribavirin|ribavirin|mesh-list
82931960|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
82931961|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
82931962|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82931963|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931964|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
82931965|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931966|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
82931967|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931968|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
83458579|NCT03921190|Anesthetics|anesthetics|mesh-list
82931969|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931970|NCT02265328|Prednisolone|prednisolone|mesh-list
82931971|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82931972|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
82931973|NCT02265328|Hormones|hormones|mesh-ancestor
82931974|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82931975|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82931976|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82931977|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82931978|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
82931979|NCT01422148|Minocycline|minocycline|mesh-list
82931980|NCT01422148|Amiodarone|amiodarone|mesh-list
82931981|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82931982|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82931983|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82931984|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
82931985|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82931986|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82931987|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931988|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82931989|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82931990|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82931991|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931992|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82931993|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82931994|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82931995|NCT01421056|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
82931996|NCT01421056|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82931997|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82931998|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82931999|NCT01416064|Molindone|molindone|mesh-list
82932000|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82932001|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82932002|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932003|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932004|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82932005|NCT01594216|Exemestane|exemestane|mesh-list
82932006|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932007|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82932008|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82932009|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932010|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932011|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82932012|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
82932013|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932014|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932016|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
82932017|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
82932018|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932019|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932020|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
82932021|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932022|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82932023|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82932024|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82932025|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82932026|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932027|NCT02265562|Alprostadil|alprostadil|mesh-list
82932028|NCT02265562|Misoprostol|misoprostol|mesh-list
82932029|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82932030|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
82932031|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82932032|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932033|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82932034|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82932035|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
82932036|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82932037|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
82932038|NCT02265562|Urological Agents|urological agents|mesh-ancestor
82932039|NCT01399684|Leucovorin|leucovorin|mesh-list
82932040|NCT01399684|Folic Acid|folic acid|mesh-list
82932041|NCT01399684|Bevacizumab|bevacizumab|mesh-list
82932042|NCT01399684|Fluorouracil|fluorouracil|mesh-list
82932043|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
82932044|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
82932045|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82932046|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932047|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82932048|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82932049|NCT01399684|Growth Substances|growth substances|mesh-ancestor
82932050|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932051|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
82932052|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
82932053|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932054|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932055|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82932056|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
82932057|NCT01399684|Antidotes|antidotes|mesh-ancestor
82932058|NCT01399684|Protective Agents|protective agents|mesh-ancestor
82932059|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
82932060|NCT01399684|Vitamins|vitamins|mesh-ancestor
82932061|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
82932062|NCT01399684|Hematinics|hematinics|mesh-ancestor
82932063|NCT01397968|Cenobamate|cenobamate|mesh-list
82932064|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
82932065|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82932066|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
82932067|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932068|NCT02265718|Methylphenidate|methylphenidate|mesh-list
82932069|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82932070|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932071|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82932072|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82932073|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82932074|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932075|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
82932076|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932077|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82932078|NCT02266030|Aspirin|aspirin|mesh-list
82932079|NCT02266030|Cilostazol|cilostazol|mesh-list
82932080|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82932081|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82932082|NCT02266030|Analgesics|analgesics|mesh-ancestor
82932083|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
82932084|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932085|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932086|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932088|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82932089|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82932090|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932091|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82932092|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82932093|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932094|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
82932095|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82932096|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
82932097|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82932098|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932099|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
82932100|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82932101|NCT02266030|Protective Agents|protective agents|mesh-ancestor
82932102|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82932103|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82932104|NCT01527916|Donepezil|donepezil|mesh-list
82932105|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82932106|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932107|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932108|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
82932109|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83516499|NCT01533753|Analgesics|analgesics|mesh-ancestor
82932110|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932112|NCT01373086|Eplerenone|eplerenone|mesh-list
82932113|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82932114|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
82932115|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932116|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932117|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82932118|NCT01373086|Diuretics|diuretics|mesh-ancestor
82932119|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
82932120|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82932121|NCT01519804|Paclitaxel|paclitaxel|mesh-list
82932122|NCT01519804|Carboplatin|carboplatin|mesh-list
82932123|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82932124|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932125|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
82932126|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
82932127|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
82932128|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932129|NCT02263924|Tocotrienols|tocotrienols|mesh-list
82932130|NCT02263924|Vitamin E|vitamin e|mesh-list
82932131|NCT02263924|Tocopherols|tocopherols|mesh-list
82932132|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
82932133|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932134|NCT02263924|Protective Agents|protective agents|mesh-ancestor
82932135|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932136|NCT02263924|Vitamins|vitamins|mesh-ancestor
82932137|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
82932138|NCT02264002|Metoprolol|metoprolol|mesh-list
82932139|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82932140|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82932141|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
82932142|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
82932143|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932144|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932145|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83458592|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932146|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82932147|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82932148|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
82932149|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932150|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932151|NCT01517776|Temozolomide|temozolomide|mesh-list
82932152|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82932153|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
82932154|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932155|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932156|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
82932157|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82932158|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932160|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82932161|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
82932162|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932163|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
82932164|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932166|NCT01508026|Nebivolol|nebivolol|mesh-list
82932167|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82932168|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82932169|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82932170|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932171|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
82932172|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82932173|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82932174|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82932175|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
82932176|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932177|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932178|NCT01357642|Epinephrine|epinephrine|mesh-list
82932179|NCT01357642|Racepinephrine|racepinephrine|mesh-list
82932180|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
82932181|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82932182|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82932183|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
82932184|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932185|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932186|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932187|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82932188|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82932189|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
82932190|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932191|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82932192|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932194|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
82932195|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82932196|NCT03135340|Anesthetics|anesthetics|mesh-list
82932197|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932198|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932199|NCT01356160|Ribavirin|ribavirin|mesh-list
82932200|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82932201|NCT01356160|Ledipasvir|ledipasvir|mesh-list
82932202|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
82932203|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932204|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
82932205|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932206|NCT02264158|Telmisartan|telmisartan|mesh-list
82932207|NCT02264158|Lacidipine|lacidipine|mesh-list
82932208|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82932209|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83458631|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
82932210|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82932211|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932212|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82932213|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82932214|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82932215|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932216|NCT02264236|Vaccines|vaccines|mesh-list
82932217|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
82932218|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932219|NCT01476904|Epinephrine|epinephrine|mesh-list
82932220|NCT01476904|Racepinephrine|racepinephrine|mesh-list
82932221|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
82932222|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82932223|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82932224|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
82932225|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932226|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932227|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932228|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82932229|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82932230|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
82932231|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932232|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82932233|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932234|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
82932235|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
82932236|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82932237|NCT01337752|Dexamethasone|dexamethasone|mesh-list
82932238|NCT01337752|Bortezomib|bortezomib|mesh-list
82932239|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82932240|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932241|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
82932242|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
82932243|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932244|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932245|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82932246|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
82932247|NCT01337752|Hormones|hormones|mesh-ancestor
82932248|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932249|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82932250|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932251|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
82932252|NCT01318642|Gemcitabine|gemcitabine|mesh-list
82932253|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932254|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
82932255|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932256|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932257|NCT01318252|Latanoprost|latanoprost|mesh-list
82932258|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82932259|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82932260|NCT01313572|Adenosine|adenosine|mesh-list
82932261|NCT01313572|Analgesics|analgesics|mesh-ancestor
82932262|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
82932263|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932264|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932265|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82932266|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
82932267|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82932268|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
82932269|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
82932270|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932271|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932272|NCT02265484|Rifaximin|rifaximin|mesh-list
82932273|NCT02265484|Bromocriptine|bromocriptine|mesh-list
82932274|NCT02265484|Lactulose|lactulose|mesh-list
82932275|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932276|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932277|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82932278|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82932279|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82932280|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
82932281|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932282|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932283|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
82932284|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
82932285|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932286|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932287|NCT02264626|Remifentanil|remifentanil|mesh-list
82932288|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82932289|NCT02264626|Narcotics|narcotics|mesh-ancestor
82932290|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932291|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932292|NCT02264626|Analgesics|analgesics|mesh-ancestor
82932293|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
82932294|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932295|NCT03993262|Bortezomib|bortezomib|mesh-list
82932296|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932297|NCT02267044|Ropivacaine|ropivacaine|mesh-list
82932298|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
82932299|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
82932300|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932301|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932302|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
82932303|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932304|NCT02267122|Mupirocin|mupirocin|mesh-list
82932305|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932306|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932307|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82932308|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084002|NCT00705536|Insulin|insulin|mesh-list
82932309|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932310|NCT01261312|Guadecitabine|guadecitabine|mesh-list
82932311|NCT01261312|Azacitidine|azacitidine|mesh-list
82932312|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932313|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932314|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
82932315|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932316|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932317|NCT01254370|Travoprost|travoprost|mesh-list
82932318|NCT01254370|Latanoprost|latanoprost|mesh-list
82932319|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82932320|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82932321|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82932322|NCT01254136|Trastuzumab|trastuzumab|mesh-list
82932323|NCT01254136|Vinorelbine|vinorelbine|mesh-list
82932324|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82932325|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932326|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82932327|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
82932328|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
82932329|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
82932330|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932331|NCT02268370|Dasatinib|dasatinib|mesh-list
82932332|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932333|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82932334|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932335|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932336|NCT00039377|Leucovorin|leucovorin|mesh-list
82932337|NCT00039377|Cytarabine|cytarabine|mesh-list
82932338|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
82932339|NCT00039377|Methotrexate|methotrexate|mesh-list
82932340|NCT00039377|Etoposide|etoposide|mesh-list
82932341|NCT00039377|Vincristine|vincristine|mesh-list
82932342|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
82932343|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
82932344|NCT00039377|Tacrolimus|tacrolimus|mesh-list
82932345|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
82932346|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82932347|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
82932348|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932349|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932350|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82932351|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
82932352|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932353|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932354|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82932355|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82932356|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
82932357|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82932358|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932359|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
82932360|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
82932361|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932362|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82932363|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82932364|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82932365|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82932366|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82932367|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
82932368|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932369|NCT00039377|Antidotes|antidotes|mesh-ancestor
82932370|NCT00039377|Protective Agents|protective agents|mesh-ancestor
82932371|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
82932372|NCT00039377|Vitamins|vitamins|mesh-ancestor
82932373|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
82932374|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82932375|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
82932376|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
82932377|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
82932378|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82932379|NCT01096745|Cisplatin|cisplatin|mesh-list
82932380|NCT01096745|Gemcitabine|gemcitabine|mesh-list
82932381|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932382|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932383|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
82932384|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932385|NCT03953729|Ibuprofen|ibuprofen|mesh-list
83084003|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82932386|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82932387|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82932389|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
82932390|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932391|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932392|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932393|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932394|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82932395|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932396|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932397|NCT01097213|Ethanol|ethanol|mesh-list
82932398|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82932399|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932400|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932401|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932402|NCT00154102|Leucovorin|leucovorin|mesh-list
82932403|NCT00154102|Folic Acid|folic acid|mesh-list
82932404|NCT00154102|Fluorouracil|fluorouracil|mesh-list
82932405|NCT00154102|Irinotecan|irinotecan|mesh-list
82932406|NCT00154102|Cetuximab|cetuximab|mesh-list
82932407|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
82932408|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
82932409|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932410|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932411|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932412|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82932413|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
83516799|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
82932414|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932415|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82932416|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82932417|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932418|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82932419|NCT00154102|Antidotes|antidotes|mesh-ancestor
82932420|NCT00154102|Protective Agents|protective agents|mesh-ancestor
82932421|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
82932422|NCT00154102|Vitamins|vitamins|mesh-ancestor
82932423|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
82932424|NCT00154102|Hematinics|hematinics|mesh-ancestor
82932425|NCT01269658|Azithromycin|azithromycin|mesh-list
82932426|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82932427|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82932428|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932429|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932430|NCT01229644|Crenolanib|crenolanib|mesh-list
82932431|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932432|NCT02267980|Ketamine|ketamine|mesh-list
82932433|NCT02267980|Sevoflurane|sevoflurane|mesh-list
82932434|NCT02267980|Analgesics|analgesics|mesh-ancestor
82932435|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
82932436|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932437|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932438|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82932439|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82932440|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
82932441|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
82932442|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932443|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82932444|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82932445|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932446|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932447|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82932448|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82932449|NCT01224262|Vaccines|vaccines|mesh-list
82932450|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
82932451|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932452|NCT01222702|Vancomycin|vancomycin|mesh-list
82932453|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
82932454|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932455|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932456|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82932457|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932458|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932459|NCT01204762|Entecavir|entecavir|mesh-list
82932460|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
82932461|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932462|NCT02236078|Isoniazid|isoniazid|mesh-list
82932464|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932465|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932466|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82932467|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82932468|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
82932469|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932470|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82932471|NCT01198834|Etodolac|etodolac|mesh-list
82932472|NCT01198834|Lidocaine|lidocaine|mesh-list
82932473|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
82932474|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
82932475|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82932476|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932477|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
82932478|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932479|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82932480|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82932481|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82932482|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82932483|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932484|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82932485|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82932486|NCT01198834|Analgesics|analgesics|mesh-ancestor
82932487|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932488|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932489|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82932490|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82932491|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932492|NCT01193140|Temozolomide|temozolomide|mesh-list
82932493|NCT01193140|Veliparib|veliparib|mesh-list
82932494|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82932495|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
82932496|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932497|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932498|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82932499|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932500|NCT01189396|Albuterol|albuterol|mesh-list
82932501|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82932502|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
82932503|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932504|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932505|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82932506|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932507|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
82932508|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82932509|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82932510|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82932511|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82932512|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
82932513|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932514|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932515|NCT05626972|Tenecteplase|tenecteplase|mesh-list
82932516|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82932517|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82932518|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932519|NCT01174732|Albuterol|albuterol|mesh-list
82932520|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82932521|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
82932522|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932523|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932524|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82932525|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932526|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
82932527|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82932528|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82932529|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82932530|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82932531|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
82932532|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932533|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932534|NCT01076764|Heparin|heparin|mesh-list
82932542|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82932544|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
82932545|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82932546|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
82932547|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932548|NCT02269072|Anastrozole|anastrozole|mesh-list
82932549|NCT02269072|Leuprolide|leuprolide|mesh-list
82932550|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82932551|NCT02269072|Testosterone|testosterone|mesh-list
82932552|NCT02269072|Androgens|androgens|mesh-ancestor
82932553|NCT02269072|Hormones|hormones|mesh-ancestor
82932554|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932555|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932556|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82932557|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932558|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82932559|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82932560|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932561|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932562|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82932563|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
82932564|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82932565|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
82932566|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82932567|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
82932568|NCT01071850|Metformin|metformin|mesh-list
82932569|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
82932570|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82932571|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932572|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83483094|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932573|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932574|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
82932575|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82932576|NCT01037062|Entecavir|entecavir|mesh-list
82932577|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
82932578|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932579|NCT01167166|ON 01910|on 01910|mesh-list
82932580|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932581|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82932582|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458651|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82932583|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932584|NCT01035502|Idarubicin|idarubicin|mesh-list
82932585|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82932586|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932587|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82932588|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82932589|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932590|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932591|NCT01030432|Ribavirin|ribavirin|mesh-list
82932592|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82932593|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
82932594|NCT01030432|Asunaprevir|asunaprevir|mesh-list
82932595|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
82932596|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932597|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
82932598|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932599|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
82932600|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932601|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
82932602|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932603|NCT02269462|Efavirenz|efavirenz|mesh-list
82932604|NCT02269462|Nevirapine|nevirapine|mesh-list
82932605|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82932606|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82932607|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932608|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932609|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
82932610|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932611|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82932612|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82932613|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82932614|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82932615|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82932616|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82932617|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82932618|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82932619|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82932620|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82932621|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932622|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
82932623|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
82932624|NCT02269540|Sertraline|sertraline|mesh-list
82932625|NCT02269540|Citalopram|citalopram|mesh-list
82932626|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82932627|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
82932628|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932629|NCT02269540|Expectorants|expectorants|mesh-ancestor
82932630|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932631|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82932632|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
82932633|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932634|NCT02269540|Protective Agents|protective agents|mesh-ancestor
82932635|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932636|NCT02269540|Antidotes|antidotes|mesh-ancestor
82932637|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
82932638|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82932639|NCT02269540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82932640|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82932641|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82932642|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932643|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
82932644|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82932645|NCT01023880|Delanzomib|delanzomib|mesh-list
82932646|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
82932647|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
82932648|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932649|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932650|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
82932651|NCT02650804|Gemcitabine|gemcitabine|mesh-list
82932652|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932653|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
82932654|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932655|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932656|NCT02650804|Vitamins|vitamins|mesh-ancestor
82932657|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
82932658|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932659|NCT02269696|Metoprolol|metoprolol|mesh-list
82932660|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82932661|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82932662|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
82932663|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
82932664|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932665|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932666|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82932667|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82932668|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82932669|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
82932670|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932671|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932672|NCT03135184|Coal Tar|coal tar|mesh-list
82932673|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
82932674|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
82932675|NCT05613400|Simvastatin|simvastatin|mesh-list
82932676|NCT05613400|Ezetimibe|ezetimibe|mesh-list
82932677|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82932678|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82932679|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
82932680|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932681|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82932682|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82932683|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932684|NCT02261662|Ribavirin|ribavirin|mesh-list
82932685|NCT02261662|Betamethasone|betamethasone|mesh-list
82932686|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
82932687|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932688|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
82932689|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932690|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932691|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
82932692|NCT02261662|Hormones|hormones|mesh-ancestor
82932693|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932694|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932695|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82932696|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932697|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
82932698|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932699|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932700|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82932701|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82932702|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932703|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932704|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932705|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82932706|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82932707|NCT00035555|Cyclosporine|cyclosporine|mesh-list
82932708|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
82932709|NCT00035555|Abatacept|abatacept|mesh-list
82932710|NCT00035555|Cyclosporins|cyclosporins|mesh-list
82932711|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932712|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932713|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82932714|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
82932715|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932716|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
82932717|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932718|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
82932719|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932720|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82932721|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82932722|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932723|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82932724|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
82932725|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932726|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82932727|NCT00035555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82932728|NCT01093157|Hormones|hormones|mesh-list
82932729|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82932730|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932731|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932732|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
82932733|NCT01093235|Bevacizumab|bevacizumab|mesh-list
82932734|NCT01093235|Docetaxel|docetaxel|mesh-list
82932735|NCT01093235|Fluorouracil|fluorouracil|mesh-list
82932736|NCT01093235|Epirubicin|epirubicin|mesh-list
82932737|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82932738|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
82932739|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932740|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932741|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82932742|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
82932743|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932744|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932745|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82932746|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82932747|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82932748|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82932749|NCT01093235|Growth Substances|growth substances|mesh-ancestor
82932750|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
82932751|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
82932752|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
82932753|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
82932754|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
82932755|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82932756|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82932757|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82932758|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82932759|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932760|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
82932761|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82932762|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932763|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82932764|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932765|NCT01088009|Lamivudine|lamivudine|mesh-list
82932766|NCT01088009|Adefovir|adefovir|mesh-list
82932767|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82932768|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82932769|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932770|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932771|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
82932772|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932773|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82932774|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82932775|NCT03894046|Imipenem|imipenem|mesh-list
82932776|NCT03894046|Colistin|colistin|mesh-list
82932777|NCT03894046|Sulbactam|sulbactam|mesh-list
82932778|NCT03894046|Durlobactam|durlobactam|mesh-list
82932779|NCT03894046|Cilastatin|cilastatin|mesh-list
82932780|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932781|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932782|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
82932783|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932784|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932785|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82932786|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
82932787|NCT04475614|Vitamins|vitamins|mesh-ancestor
82932788|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
82932789|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932790|NCT01143064|Progesterone|progesterone|mesh-list
82932791|NCT01143064|Progestins|progestins|mesh-ancestor
82932792|NCT01143064|Hormones|hormones|mesh-ancestor
82932793|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932794|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932795|NCT00033371|Eflornithine|eflornithine|mesh-list
82932796|NCT00033371|Celecoxib|celecoxib|mesh-list
82932797|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82932798|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82932800|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
82932801|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932802|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932803|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932804|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932805|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82932806|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82932807|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932808|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932809|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932810|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82932811|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82932812|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82932813|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932814|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
82932815|NCT01001338|Allopurinol|allopurinol|mesh-list
82932816|NCT01001338|Lesinurad|lesinurad|mesh-list
82932817|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
82932818|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932819|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932820|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
82932821|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932822|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82932823|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
82932824|NCT01001338|Protective Agents|protective agents|mesh-ancestor
82932825|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932826|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
82932827|NCT03952715|Ibuprofen|ibuprofen|mesh-list
82932828|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82932829|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82932830|NCT03952715|Analgesics|analgesics|mesh-ancestor
82932831|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
82932832|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932833|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932834|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932835|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932836|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82932837|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932838|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932839|NCT01137526|Donepezil|donepezil|mesh-list
82932840|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82932841|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932842|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932843|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
82932844|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932845|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932846|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
82932847|NCT00993382|Amiodarone|amiodarone|mesh-list
82932848|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82932849|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
82932850|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82932851|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82932852|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932853|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82932854|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82932855|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82932856|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932857|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82932858|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82932859|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82932860|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
82932861|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82932862|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82932863|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82932864|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932865|NCT05628610|Paclitaxel|paclitaxel|mesh-list
82932866|NCT05628610|Carboplatin|carboplatin|mesh-list
82932867|NCT05628610|Tislelizumab|tislelizumab|mesh-list
82932868|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82932869|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932870|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
82932871|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
82932872|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
82932873|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932874|NCT05628610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82932875|NCT00079937|Fluticasone|fluticasone|mesh-list
82932876|NCT00079937|Omalizumab|omalizumab|mesh-list
82932877|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82932878|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82932879|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
82932880|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932881|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932882|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82932883|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
82932884|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
82932885|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82932886|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82932887|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82932888|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82932889|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82932890|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82932891|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
82932892|NCT03126110|Nivolumab|nivolumab|mesh-list
82932893|NCT03126110|Ipilimumab|ipilimumab|mesh-list
82932894|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82932895|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932896|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82932897|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932898|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
82932899|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82932900|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932901|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82932902|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
82932903|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82932904|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82932905|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932906|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932908|NCT00906334|Glycine|glycine|mesh-list
82932909|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932910|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82932911|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932912|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932913|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
82932914|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932915|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932916|NCT00905164|Topiramate|topiramate|mesh-list
82932917|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
82932918|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82932919|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932920|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
82932921|NCT00978016|Baclofen|baclofen|mesh-list
82932922|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
82932923|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932924|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932925|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82932926|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932927|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82932928|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82932929|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82932930|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
82932931|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
82932932|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932933|NCT01129648|Allopurinol|allopurinol|mesh-list
82932934|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
82932935|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932936|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83458671|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
82932937|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
82932938|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82932939|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82932940|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
82932941|NCT01129648|Protective Agents|protective agents|mesh-ancestor
82932942|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932943|NCT04438720|Nifedipine|nifedipine|mesh-list
82932944|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82932945|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82932946|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932947|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82932948|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932949|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
82932950|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
82932951|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82932953|NCT05464810|Simvastatin|simvastatin|mesh-list
82932954|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82932955|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82932956|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
82932957|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932958|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82932959|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82932960|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82932961|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82932962|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82932963|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82932964|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82932965|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
82932966|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82932967|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932968|NCT03176966|Vitamin E|vitamin e|mesh-list
82932969|NCT03176966|Ropinirole|ropinirole|mesh-list
82932970|NCT03176966|Vitamins|vitamins|mesh-ancestor
82932971|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
82932972|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932973|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
82932974|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932975|NCT03176966|Protective Agents|protective agents|mesh-ancestor
82932976|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82932977|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82932978|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
82932979|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
82932980|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82932981|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
82932982|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
82932983|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
82932984|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82932985|NCT03209570|Protective Agents|protective agents|mesh-ancestor
82932986|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932987|NCT04405102|Ozanimod|ozanimod|mesh-list
82932988|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82932989|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82932990|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82932991|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
82932992|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932993|NCT03209492|Leuprolide|leuprolide|mesh-list
82932994|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82932995|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
82932996|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82932997|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82932998|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82932999|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933000|NCT00894868|Vildagliptin|vildagliptin|mesh-list
82933001|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933002|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933003|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82933004|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
82933005|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933006|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933007|NCT01122784|Vaccines|vaccines|mesh-list
82933008|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
82933009|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933010|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
82933011|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933012|NCT01088165|Adalimumab|adalimumab|mesh-list
82933013|NCT01088165|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82933014|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933015|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82933016|NCT00892762|Travoprost|travoprost|mesh-list
82933017|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82933018|NCT00892762|Latanoprost|latanoprost|mesh-list
82933019|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82933020|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82933021|NCT00890968|Triamcinolone|triamcinolone|mesh-list
82933022|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82933023|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82933024|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82933025|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933026|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
82933027|NCT00890968|Hormones|hormones|mesh-ancestor
82933028|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933029|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933030|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82933031|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
82933032|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933033|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933034|NCT01098383|Acetylcholine|acetylcholine|mesh-list
82933035|NCT01098383|Donepezil|donepezil|mesh-list
82933036|NCT01098383|Choline|choline|mesh-list
82933037|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82933038|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933039|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933040|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
82933041|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933042|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933043|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
82933044|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
82933045|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82933046|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
82933047|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933048|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82933049|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
82933050|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82933051|NCT00890890|BMS 708163|bms 708163|mesh-list
82933052|NCT00890890|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82933053|NCT00890890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084004|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
82933054|NCT00890890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933055|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
82933056|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82933057|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933058|NCT03175172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82933059|NCT03175172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933060|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82933061|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82933062|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
82933063|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82933064|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82933065|NCT01088477|Estradiol|estradiol|mesh-list
82933066|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82933067|NCT01088477|Estrogens|estrogens|mesh-ancestor
82933068|NCT01088477|Hormones|hormones|mesh-ancestor
82933069|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933070|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933071|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82933072|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
82933073|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82933074|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82933075|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
82933076|NCT01088555|Antidotes|antidotes|mesh-ancestor
82933077|NCT01088555|Protective Agents|protective agents|mesh-ancestor
82933078|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933079|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
82933080|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933081|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
82933082|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933083|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933084|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
82933085|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
82933086|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
82933087|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
82933088|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933089|NCT00078767|Sertraline|sertraline|mesh-list
82933090|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
82933091|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933092|NCT00078767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82933093|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82933094|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933095|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933096|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933097|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
82933098|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933100|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
82933101|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933102|NCT00078377|Modafinil|modafinil|mesh-list
82933103|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82933104|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933105|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82933106|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82933107|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82933108|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933109|NCT01107496|Viloxazine|viloxazine|mesh-list
82933110|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82933111|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
82933112|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933113|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82933114|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82933115|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933116|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933117|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
82933118|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933119|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933120|NCT00886600|Losartan|losartan|mesh-list
82933121|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82933122|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82933123|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82933124|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82933125|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83084005|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933126|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933127|NCT00886600|Diuretics|diuretics|mesh-ancestor
82933128|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
82933129|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933130|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82933131|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933132|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
82933133|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82933134|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933135|NCT02591654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82933136|NCT02591654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933137|NCT03134872|Carboplatin|carboplatin|mesh-list
82933138|NCT03134872|Pemetrexed|pemetrexed|mesh-list
82933139|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933140|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933141|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933142|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82933143|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82933144|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82933145|NCT03952481|Lifitegrast|lifitegrast|mesh-list
82933146|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82933147|NCT05135312|Etanercept|etanercept|mesh-list
82933148|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82933149|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82933150|NCT05135312|Analgesics|analgesics|mesh-ancestor
82933151|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
82933152|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933153|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933154|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933155|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82933156|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933157|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82933158|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
82933159|NCT00881452|Citric Acid|citric acid|mesh-list
82933160|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
82933161|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82933162|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
82933163|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
82933164|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933165|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
82933166|NCT03952325|Nivolumab|nivolumab|mesh-list
82933167|NCT03952325|Atezolizumab|atezolizumab|mesh-list
82933168|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82933169|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933170|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82933171|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933172|NCT00948142|Linezolid|linezolid|mesh-list
82933173|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
82933174|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933175|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933176|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82933177|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933178|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933179|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
82933180|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82933181|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933182|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
82933183|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
82933184|NCT00945802|Dexamethasone|dexamethasone|mesh-list
82933185|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
82933186|NCT00945802|BB 1101|bb 1101|mesh-list
82933187|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933188|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
82933189|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
82933190|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933191|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933192|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933193|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
82933194|NCT00945802|Hormones|hormones|mesh-ancestor
82933195|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933196|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933197|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933198|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
82933199|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933200|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933201|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933202|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933203|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82933204|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82933205|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82933206|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82933207|NCT01105624|Azithromycin|azithromycin|mesh-list
82933208|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82933209|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82933210|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933211|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933212|NCT01102660|Naproxen|naproxen|mesh-list
82933213|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82933214|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82933215|NCT01102660|Analgesics|analgesics|mesh-ancestor
82933216|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
82933217|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933218|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933219|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933220|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82933221|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
82933222|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82933223|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933224|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933225|NCT03135106|Itraconazole|itraconazole|mesh-list
82933226|NCT03135106|Fluconazole|fluconazole|mesh-list
82933227|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
82933228|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933229|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82933230|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82933231|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933232|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933233|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82933234|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
82933235|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933236|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933237|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82933238|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82933239|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82933240|NCT00872014|Sorafenib|sorafenib|mesh-list
82933241|NCT00872014|Trebananib|trebananib|mesh-list
82933242|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933243|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82933244|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933245|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933246|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82933247|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82933248|NCT00872014|Growth Substances|growth substances|mesh-ancestor
82933249|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933250|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
82933251|NCT00871936|Metformin|metformin|mesh-list
82933252|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933253|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933254|NCT00870688|Valproic Acid|valproic acid|mesh-list
82933255|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
82933256|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933257|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933258|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
82933259|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933260|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933261|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
82933262|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82933263|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933264|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933265|NCT00870454|Pregabalin|pregabalin|mesh-list
82933266|NCT00870454|Analgesics|analgesics|mesh-ancestor
82933267|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
82933268|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933269|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933270|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
82933271|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82933272|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933273|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933274|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82933276|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82933277|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933278|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933279|NCT05096962|Antibodies|antibodies|mesh-list
82933280|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
82933281|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933282|NCT00869128|Melatonin|melatonin|mesh-list
82933283|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
82933284|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933285|NCT00869128|Protective Agents|protective agents|mesh-ancestor
82933286|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933287|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933288|NCT00945646|Dexamethasone|dexamethasone|mesh-list
82933289|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933290|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
82933291|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
82933292|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933293|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933294|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933295|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
82933296|NCT00945646|Hormones|hormones|mesh-ancestor
82933297|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933298|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933299|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933300|NCT00077675|Vancomycin|vancomycin|mesh-list
82933301|NCT00077675|Penicillins|penicillins|mesh-list
82933302|NCT00077675|Telavancin|telavancin|mesh-list
82933303|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933304|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933305|NCT00934180|Ondansetron|ondansetron|mesh-list
82933306|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
82933307|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
82933308|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933309|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933310|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933311|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
82933312|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
82933313|NCT00934180|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82933314|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82933315|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
82933316|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933317|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933318|NCT02576444|Olaparib|olaparib|mesh-list
82933319|NCT02576444|Adavosertib|adavosertib|mesh-list
83483095|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82933320|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82933321|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933322|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933323|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933324|NCT00929968|Fluticasone|fluticasone|mesh-list
82933325|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933326|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82933327|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
82933328|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933329|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933330|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82933331|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
82933332|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
82933333|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82933334|NCT03957083|Oxytocin|oxytocin|mesh-list
82933335|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
82933336|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82933337|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933338|NCT04945616|Aspirin|aspirin|mesh-list
82933339|NCT04945616|Clopidogrel|clopidogrel|mesh-list
82933340|NCT04945616|Ticagrelor|ticagrelor|mesh-list
82933341|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82933342|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82933343|NCT04945616|Analgesics|analgesics|mesh-ancestor
82933344|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
82933345|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933346|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933347|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933348|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82933349|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82933350|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82933351|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933352|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82933353|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82933354|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933355|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
82933356|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82933357|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82933358|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82933359|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
82933360|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933362|NCT04473820|Prilocaine|prilocaine|mesh-list
82933363|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82933364|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
82933365|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
82933366|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933367|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933368|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
82933369|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933370|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82933371|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82933372|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82933373|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933374|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933375|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82933376|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82933377|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
82933378|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
82933379|NCT05064332|Estradiol|estradiol|mesh-list
82933380|NCT05064332|Estrogens|estrogens|mesh-ancestor
82933381|NCT05064332|Hormones|hormones|mesh-ancestor
82933382|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933383|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933384|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82933385|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82933386|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82933387|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82933388|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
82933389|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82933390|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
82933391|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
82933392|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82933393|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82933394|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933395|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933396|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82933397|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82933398|NCT00849862|Levetiracetam|levetiracetam|mesh-list
82933399|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
82933400|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
82933401|NCT00077207|Carboplatin|carboplatin|mesh-list
82933402|NCT00077207|Vincristine|vincristine|mesh-list
82933403|NCT00077207|Temozolomide|temozolomide|mesh-list
82933404|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933405|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82933406|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
82933407|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
82933408|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
82933409|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933410|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82933411|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
82933412|NCT01099085|Simvastatin|simvastatin|mesh-list
82933413|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82933414|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82933415|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
82933416|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933417|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82933418|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82933419|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933420|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
82933421|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933422|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82933423|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933424|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933425|NCT05095064|Irinotecan|irinotecan|mesh-list
82933426|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82933427|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82933428|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933429|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933430|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933431|NCT03169244|Bupropion|bupropion|mesh-list
82933432|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82933433|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
82933434|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933435|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82933436|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82933437|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933438|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933439|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
82933440|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933441|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933442|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82933443|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82933444|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933445|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82933446|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82933447|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82933448|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82933449|NCT00920764|Atrasentan|atrasentan|mesh-list
82933450|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933451|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82933452|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82933453|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933454|NCT05376046|Thrombin|thrombin|mesh-list
82933455|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
82933456|NCT05376046|Coagulants|coagulants|mesh-ancestor
82933457|NCT03034304|Carboplatin|carboplatin|mesh-list
82933458|NCT03034304|Gemcitabine|gemcitabine|mesh-list
82933459|NCT03034304|Doxorubicin|doxorubicin|mesh-list
82933460|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82933461|NCT03034304|Ifosfamide|ifosfamide|mesh-list
82933462|NCT03034304|Antibodies|antibodies|mesh-list
82933463|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
82933464|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933465|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933466|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82933467|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
82933468|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933469|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82933470|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82933471|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82933472|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933473|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82933474|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
82933476|NCT00914602|Carbidopa|carbidopa|mesh-list
82933477|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82933478|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82933479|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82933480|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
82933481|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933482|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933483|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933484|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82933485|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933486|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82933487|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
82933488|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
82933489|NCT00914290|Baclofen|baclofen|mesh-list
82933490|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82933491|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933492|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82933493|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933494|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82933495|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
82933496|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
82933497|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933498|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933499|NCT00057941|Fulvestrant|fulvestrant|mesh-list
82933500|NCT00057941|Anastrozole|anastrozole|mesh-list
82933501|NCT00057941|Gefitinib|gefitinib|mesh-list
82933502|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933503|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933504|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82933505|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82933506|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
82933507|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933508|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933509|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82933510|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933511|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933512|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82933513|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82933514|NCT03005522|Dexamethasone|dexamethasone|mesh-list
82933515|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933516|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
82933517|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
82933518|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933519|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933520|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933521|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
82933522|NCT03005522|Hormones|hormones|mesh-ancestor
82933523|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933524|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933525|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933526|NCT02998736|Tadalafil|tadalafil|mesh-list
82933527|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
82933528|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82933529|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82933530|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933531|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933532|NCT02998736|Urological Agents|urological agents|mesh-ancestor
82933533|NCT00075881|Bortezomib|bortezomib|mesh-list
82933534|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933535|NCT00838630|Cilostazol|cilostazol|mesh-list
82933536|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82933537|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
82933538|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933539|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933540|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82933541|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
82933542|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82933543|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82933544|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933545|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82933546|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
82933547|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82933548|NCT00838630|Protective Agents|protective agents|mesh-ancestor
82933549|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82933550|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82933551|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933552|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
82933553|NCT02996474|Decitabine|decitabine|mesh-list
82933554|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82933555|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933556|NCT02996474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82933557|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933558|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82933559|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
82933560|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933561|NCT00821002|Latanoprost|latanoprost|mesh-list
82933562|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82933563|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82933564|NCT00820924|Lapatinib|lapatinib|mesh-list
82933565|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933566|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82933567|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933568|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933569|NCT00820300|Latanoprost|latanoprost|mesh-list
82933570|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82933572|NCT00814372|Metformin|metformin|mesh-list
82933573|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933574|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933575|NCT03134638|Carboplatin|carboplatin|mesh-list
82933576|NCT03134638|Fulvestrant|fulvestrant|mesh-list
82933577|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933578|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933579|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82933580|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82933581|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
82933582|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933583|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933584|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
82933585|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933586|NCT04855526|Dronabinol|dronabinol|mesh-list
82933587|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
82933588|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933589|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933590|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82933591|NCT04855526|Analgesics|analgesics|mesh-ancestor
82933592|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
82933593|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933594|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82933595|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82933596|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933597|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933598|NCT04855526|Hormones|hormones|mesh-ancestor
82933599|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933600|NCT03204812|Durvalumab|durvalumab|mesh-list
82933601|NCT03204812|Ipilimumab|ipilimumab|mesh-list
82933602|NCT03204812|Tremelimumab|tremelimumab|mesh-list
82933603|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
82933604|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82933605|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
82933606|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82933607|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933608|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
82933609|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933610|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82933611|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933612|NCT02339090|Hormones|hormones|mesh-list
82933613|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933614|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933615|NCT05442008|Erenumab|erenumab|mesh-list
82933616|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82933617|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933618|NCT05442008|Analgesics|analgesics|mesh-ancestor
82933619|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
82933620|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933621|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933622|NCT03524092|Mirikizumab|mirikizumab|mesh-list
82933623|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82933624|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82933625|NCT03524092|Analgesics|analgesics|mesh-ancestor
82933626|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
82933627|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933628|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933629|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933630|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82933631|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82933632|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933633|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
82933634|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
82933635|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82933636|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933637|NCT03331562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82933638|NCT03331562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933639|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82933640|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933641|NCT03331562|Vitamins|vitamins|mesh-ancestor
82933642|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
82933644|NCT00814294|Insulin|insulin|mesh-list
82933645|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82933646|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933647|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933648|NCT02038634|Betamethasone|betamethasone|mesh-list
82933649|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933650|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
82933651|NCT02038634|Hormones|hormones|mesh-ancestor
82933652|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933653|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933654|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82933655|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
82933656|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82933657|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82933658|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
82933659|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933660|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933661|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82933662|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
82933663|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82933664|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82933665|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82933666|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
82933667|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933668|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933669|NCT03636308|Paclitaxel|paclitaxel|mesh-list
82933670|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82933671|NCT03636308|Gemcitabine|gemcitabine|mesh-list
82933672|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82933673|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933674|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
82933675|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
82933676|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
82933677|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933678|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82933679|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
82933680|NCT00836056|Clindamycin|clindamycin|mesh-list
82933681|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
82933682|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
82933683|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933684|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933685|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82933686|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933687|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933688|NCT00835666|Finasteride|finasteride|mesh-list
82933689|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82933690|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82933691|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933692|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933693|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
82933694|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933695|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933696|NCT00835666|Urological Agents|urological agents|mesh-ancestor
82933697|NCT00835588|Pantoprazole|pantoprazole|mesh-list
82933698|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82933699|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933700|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82933701|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933702|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933703|NCT00713518|Ranibizumab|ranibizumab|mesh-list
82933704|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82933705|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82933706|NCT00713518|Growth Substances|growth substances|mesh-ancestor
82933707|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933708|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
82933709|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933710|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
82933711|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82933712|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
82933713|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933714|NCT00708292|Dexamethasone|dexamethasone|mesh-list
82933715|NCT00708292|Bortezomib|bortezomib|mesh-list
82933716|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933718|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
83458713|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
82933719|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933720|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933721|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933722|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
82933723|NCT00708292|Hormones|hormones|mesh-ancestor
82933724|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933725|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933726|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933727|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
82933728|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82933729|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933730|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933731|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933732|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
82933733|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
82933734|NCT00835354|Cefprozil|cefprozil|mesh-list
82933735|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933736|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933737|NCT04874480|Decitabine|decitabine|mesh-list
82933738|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82933739|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
82933740|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933741|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933742|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933743|NCT00698230|Metformin|metformin|mesh-list
82933744|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933745|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933746|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
82933747|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82933748|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933749|NCT01330472|Alprazolam|alprazolam|mesh-list
82933750|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82933751|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933752|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933753|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82933754|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82933755|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933756|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
82933757|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
82933758|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933759|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933760|NCT00835276|Fexofenadine|fexofenadine|mesh-list
82933761|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82933762|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82933763|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82933764|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
82933765|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
82933766|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933767|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933768|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933769|NCT04718740|Vitamin K|vitamin k|mesh-list
82933770|NCT04718740|Repaglinide|repaglinide|mesh-list
82933771|NCT04718740|Fluzoparib|fluzoparib|mesh-list
82933772|NCT04718740|Midazolam|midazolam|mesh-list
82933773|NCT04718740|Caffeine|caffeine|mesh-list
82933774|NCT04718740|Bupropion|bupropion|mesh-list
82933775|NCT04718740|Omeprazole|omeprazole|mesh-list
82933776|NCT04718740|Warfarin|warfarin|mesh-list
82933777|NCT04718740|Vitamins|vitamins|mesh-ancestor
82933778|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
82933779|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933780|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82933781|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82933782|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933783|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82933784|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82933785|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933786|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82933787|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
82933788|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
82933789|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
82933790|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
82933791|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084006|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933792|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933794|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82933795|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82933796|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933797|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82933798|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82933799|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
82933800|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82933801|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933802|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82933803|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82933804|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
82933805|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82933806|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82933807|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933808|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
82933809|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82933810|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82933811|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82933812|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82933813|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
82933814|NCT04718740|Coagulants|coagulants|mesh-ancestor
82933815|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933816|NCT04718740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82933817|NCT04718740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933818|NCT03344536|Fulvestrant|fulvestrant|mesh-list
82933819|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933820|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933821|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82933822|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82933823|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
82933824|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933825|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933826|NCT01759238|Bevacizumab|bevacizumab|mesh-list
82933827|NCT01759238|Capecitabine|capecitabine|mesh-list
82933828|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82933829|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933830|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82933831|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82933832|NCT01759238|Growth Substances|growth substances|mesh-ancestor
82933833|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933834|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
82933835|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82933836|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
82933837|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933838|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82933839|NCT00835042|Moexipril|moexipril|mesh-list
82933840|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82933841|NCT00835042|Diuretics|diuretics|mesh-ancestor
82933842|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
82933843|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933844|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82933845|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933846|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933847|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82933848|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
82933849|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933850|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82933851|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82933852|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82933853|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933854|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933855|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933856|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458724|NCT03885154|Analgesics|analgesics|mesh-ancestor
82933857|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82933858|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
82933859|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933860|NCT03070522|Prednisone|prednisone|mesh-list
82933861|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933863|NCT03070522|Hormones|hormones|mesh-ancestor
82933864|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82933865|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933866|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82933867|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933868|NCT00834574|Cefdinir|cefdinir|mesh-list
82933869|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933870|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933871|NCT04879966|Infliximab|infliximab|mesh-list
82933872|NCT04879966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82933873|NCT04879966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933874|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
82933875|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82933876|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82933877|NCT00834418|Leflunomide|leflunomide|mesh-list
82933878|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933879|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933880|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82933881|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
82933882|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933883|NCT04621318|Denosumab|denosumab|mesh-list
82933884|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82933885|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933886|NCT00834340|Glimepiride|glimepiride|mesh-list
82933887|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82933888|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933889|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933890|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82933891|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
82933892|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
82933893|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933894|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
82933895|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933896|NCT04473274|Pioglitazone|pioglitazone|mesh-list
82933897|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82933898|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933899|NCT00679588|Enoxaparin|enoxaparin|mesh-list
82933900|NCT00679588|Semuloparin|semuloparin|mesh-list
82933901|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
82933902|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
82933903|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82933904|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82933905|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933906|NCT00151996|Guanfacine|guanfacine|mesh-list
82933907|NCT00151996|Methylphenidate|methylphenidate|mesh-list
82933908|NCT00151996|Amphetamine|amphetamine|mesh-list
82933909|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82933910|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933911|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82933912|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82933913|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82933914|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933915|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
82933916|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933917|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
82933918|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
82933919|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933920|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
82933921|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82933922|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82933923|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82933924|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82933925|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82933926|NCT00830206|Azithromycin|azithromycin|mesh-list
82933927|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82933928|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933929|NCT04464070|Aspirin|aspirin|mesh-list
82933931|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82933932|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82933933|NCT04464070|Analgesics|analgesics|mesh-ancestor
82933934|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
82933935|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82933936|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084007|NCT02474420|Amlodipine|amlodipine|mesh-list
82933937|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82933938|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82933939|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82933940|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82933941|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933942|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82933943|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82933944|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933946|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82933947|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
82933948|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82933949|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
82933950|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
82933951|NCT04464070|Vitamins|vitamins|mesh-ancestor
82933952|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
82933953|NCT00829504|Ropinirole|ropinirole|mesh-list
82933954|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82933955|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82933956|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
82933957|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
82933958|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933959|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933960|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933961|NCT00829426|Alprazolam|alprazolam|mesh-list
82933962|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82933963|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82933964|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933965|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82933966|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82933967|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82933968|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
82933969|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
82933970|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933971|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933972|NCT00152464|Levocetirizine|levocetirizine|mesh-list
82933973|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82933974|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82933975|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
82933976|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
82933977|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933978|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933979|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933980|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
82933981|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82933982|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82933983|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82933984|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82933985|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
82933986|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82933987|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82933988|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82933989|NCT04472806|Endostar protein|endostar protein|mesh-list
82933990|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82933991|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82933992|NCT04472806|Growth Substances|growth substances|mesh-ancestor
82933993|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82933994|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
82933995|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82933996|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
82933997|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
82933998|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82933999|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934000|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934001|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82934002|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
82934003|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82934004|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82934005|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82934006|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82934007|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934008|NCT00770848|Prednisone|prednisone|mesh-list
82934009|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
82934010|NCT00770848|Rilotumumab|rilotumumab|mesh-list
82934011|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82934013|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
82934014|NCT00770848|Hormones|hormones|mesh-ancestor
82934015|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934016|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934017|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82934018|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934019|NCT00770848|Analgesics|analgesics|mesh-ancestor
82934020|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
82934021|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934022|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934023|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934024|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934025|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934026|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934027|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
82934028|NCT00672412|Lamivudine|lamivudine|mesh-list
82934029|NCT00672412|Zidovudine|zidovudine|mesh-list
82934030|NCT00672412|Nevirapine|nevirapine|mesh-list
82934031|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82934032|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82934033|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934034|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934035|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
82934036|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934037|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82934038|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82934039|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
82934040|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82934041|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82934042|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
82934043|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
82934044|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82934045|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82934046|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934047|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934048|NCT01315262|Urological Agents|urological agents|mesh-ancestor
82934049|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
82934050|NCT03197324|Digoxin|digoxin|mesh-list
82934051|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82934052|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82934053|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934054|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934055|NCT03197324|Protective Agents|protective agents|mesh-ancestor
82934056|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934057|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82934058|NCT01330706|Polihexanide|polihexanide|mesh-list
82934059|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
82934060|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934061|NCT01156220|Furosemide|furosemide|mesh-list
82934062|NCT01156220|Diuretics|diuretics|mesh-ancestor
82934063|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
83458743|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934064|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934065|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82934066|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82934067|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934068|NCT03192488|Cetirizine|cetirizine|mesh-list
82934069|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82934070|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82934071|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82934072|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
82934073|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
82934074|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934075|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934076|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934077|NCT01642004|Docetaxel|docetaxel|mesh-list
82934078|NCT01642004|Nivolumab|nivolumab|mesh-list
82934079|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934080|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
82934081|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
82934082|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
82934083|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934084|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934085|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82934086|NCT03907826|Antibodies|antibodies|mesh-list
82934087|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
82934088|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
82934089|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934090|NCT00042289|Ritonavir|ritonavir|mesh-list
82934091|NCT00042289|Lopinavir|lopinavir|mesh-list
82934092|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82934093|NCT00042289|Darunavir|darunavir|mesh-list
82934094|NCT00042289|Nelfinavir|nelfinavir|mesh-list
82934095|NCT00042289|Indinavir|indinavir|mesh-list
82934096|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
82934097|NCT00042289|Amprenavir|amprenavir|mesh-list
82934098|NCT00042289|Tenofovir|tenofovir|mesh-list
82934099|NCT00042289|Emtricitabine|emtricitabine|mesh-list
82934100|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
82934101|NCT00042289|Nevirapine|nevirapine|mesh-list
82934102|NCT00042289|Dolutegravir|dolutegravir|mesh-list
82934103|NCT00042289|Maraviroc|maraviroc|mesh-list
82934104|NCT00042289|Abacavir|abacavir|mesh-list
82934105|NCT00042289|Didanosine|didanosine|mesh-list
82934106|NCT00042289|Cobicistat|cobicistat|mesh-list
82934107|NCT00042289|Rilpivirine|rilpivirine|mesh-list
82934108|NCT00042289|Tipranavir|tipranavir|mesh-list
82934109|NCT00042289|Elvitegravir|elvitegravir|mesh-list
82934110|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
82934111|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
82934112|NCT00042289|Efavirenz|efavirenz|mesh-list
82934113|NCT00042289|Rifampin|rifampin|mesh-list
82934114|NCT00042289|Isoniazid|isoniazid|mesh-list
82934115|NCT00042289|Linezolid|linezolid|mesh-list
82934116|NCT00042289|Cycloserine|cycloserine|mesh-list
82934117|NCT00042289|Amikacin|amikacin|mesh-list
82934118|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
82934119|NCT00042289|Ethambutol|ethambutol|mesh-list
82934120|NCT00042289|Bedaquiline|bedaquiline|mesh-list
82934121|NCT00042289|Etravirine|etravirine|mesh-list
82934122|NCT00042289|Clofazimine|clofazimine|mesh-list
82934123|NCT00042289|Ofloxacin|ofloxacin|mesh-list
82934124|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
82934125|NCT00042289|Ethionamide|ethionamide|mesh-list
82934126|NCT00042289|Kanamycin|kanamycin|mesh-list
82934127|NCT00042289|Capreomycin|capreomycin|mesh-list
82934128|NCT00042289|Prothionamide|prothionamide|mesh-list
82934129|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82934130|NCT00042289|Etonogestrel|etonogestrel|mesh-list
82934131|NCT00042289|Estradiol|estradiol|mesh-list
82934132|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82934133|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82934134|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
82934135|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934136|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934137|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82934138|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82934139|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
82934140|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934141|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82934142|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82934143|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82934144|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82934145|NCT00042289|Estrogens|estrogens|mesh-ancestor
82934146|NCT00042289|Hormones|hormones|mesh-ancestor
82934147|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934148|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934149|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82934150|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
82934151|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82934152|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82934153|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934154|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934155|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934156|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934157|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82934158|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82934159|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82934160|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82934161|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82934162|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82934163|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82934164|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82934165|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82934166|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
82934167|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
82934168|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82934169|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82934170|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82934171|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82934172|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82934173|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82934174|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
82934175|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82934176|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82934177|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82934178|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82934179|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82934180|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82934181|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934182|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82934183|NCT00039871|Ribavirin|ribavirin|mesh-list
82934184|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82934185|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
82934186|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
82934187|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934188|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
82934189|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934190|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
82934191|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934192|NCT01096693|Substance P|substance p|mesh-list
82934193|NCT01096693|Neurokinin A|neurokinin a|mesh-list
82934194|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934195|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934196|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934197|NCT00015457|Amlodipine|amlodipine|mesh-list
82934198|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
82934199|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82934200|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82934201|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934202|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
82934203|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934204|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934205|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82934206|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82934207|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82934208|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
82934209|NCT03564470|Dasatinib|dasatinib|mesh-list
82934210|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934211|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82934212|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934213|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934214|NCT03191396|Liraglutide|liraglutide|mesh-list
82934215|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82934216|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934217|NCT03191396|Incretins|incretins|mesh-ancestor
82934218|NCT03191396|Hormones|hormones|mesh-ancestor
82934219|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934220|NCT03509636|Fluzoparib|fluzoparib|mesh-list
82934221|NCT03509636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82934222|NCT03509636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934223|NCT03509636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934224|NCT03509636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934225|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82934226|NCT00007345|Romidepsin|romidepsin|mesh-list
82934227|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934228|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934229|NCT00007345|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82934230|NCT00007345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934231|NCT00007345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934232|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82934233|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
82934234|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934235|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82934236|NCT00031447|Acyclovir|acyclovir|mesh-list
82934237|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
82934238|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934239|NCT00006721|Prednisone|prednisone|mesh-list
82934240|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
82934241|NCT00006721|Rituximab|rituximab|mesh-list
82934242|NCT00006721|Doxorubicin|doxorubicin|mesh-list
82934243|NCT00006721|Vincristine|vincristine|mesh-list
82934244|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934245|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
82934246|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934247|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934248|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82934249|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
82934250|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934251|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934252|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82934253|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934254|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934255|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934256|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934257|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934258|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934259|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
82934260|NCT00006721|Hormones|hormones|mesh-ancestor
82934261|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934262|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82934263|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82934264|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
82934265|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
82934266|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
82934267|NCT00006289|Neurotropin|neurotropin|mesh-list
82934268|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82934269|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
82934270|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934271|NCT00006289|Analgesics|analgesics|mesh-ancestor
82934272|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
82934273|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934274|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
82934275|NCT05625841|Propolis|propolis|mesh-list
82934276|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934277|NCT01103401|Tobramycin|tobramycin|mesh-list
82934278|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
82934279|NCT01103401|Dexamethasone|dexamethasone|mesh-list
82934280|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
82934281|NCT01103401|Ketorolac|ketorolac|mesh-list
82934282|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82934283|NCT01103401|BB 1101|bb 1101|mesh-list
82934284|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934285|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
82934286|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
82934287|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83458755|NCT00957359|Psilocybin|psilocybin|mesh-list
82934288|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934289|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82934290|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
82934291|NCT01103401|Hormones|hormones|mesh-ancestor
82934292|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934293|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82934294|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934295|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
82934296|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934297|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934298|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82934299|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82934300|NCT01103401|Analgesics|analgesics|mesh-ancestor
83483096|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934301|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
82934302|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934303|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82934304|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934305|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934306|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82934307|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82934308|NCT00005047|Doxorubicin|doxorubicin|mesh-list
82934309|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82934310|NCT00005047|Methotrexate|methotrexate|mesh-list
82934311|NCT00005047|Vinblastine|vinblastine|mesh-list
82934312|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934313|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934314|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934315|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934316|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934317|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934318|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82934319|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
82934320|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82934321|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934322|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82934323|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
82934324|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
82934325|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82934326|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934327|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
82934328|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934329|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82934330|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82934331|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
82934332|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
82934333|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
82934334|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82934335|NCT01103635|Ipilimumab|ipilimumab|mesh-list
82934336|NCT01103635|Tremelimumab|tremelimumab|mesh-list
82934337|NCT01103635|Antibodies|antibodies|mesh-list
82934338|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
82934339|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82934340|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
82934341|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934342|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934343|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82934344|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934345|NCT03949075|Enalapril|enalapril|mesh-list
82934346|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82934347|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
82934348|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934349|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934350|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82934351|NCT01101529|Aprepitant|aprepitant|mesh-list
82934352|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
82934353|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
82934354|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934355|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83458758|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
82934356|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82934357|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82934358|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934359|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934360|NCT00003907|Cisplatin|cisplatin|mesh-list
82934361|NCT00003907|Doxorubicin|doxorubicin|mesh-list
82934362|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82934363|NCT00003907|Mitomycins|mitomycins|mesh-list
82934364|NCT00003907|Mitomycin|mitomycin|mesh-list
82934365|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934366|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934367|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934368|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934369|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934370|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934371|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
82934372|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82934373|NCT01100125|Insulin|insulin|mesh-list
82934374|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82934375|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82934376|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
82934377|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82934378|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934379|NCT01100125|Incretins|incretins|mesh-ancestor
82934380|NCT01100125|Hormones|hormones|mesh-ancestor
82934381|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934382|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82934383|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
82934384|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934385|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934386|NCT01100203|Eplerenone|eplerenone|mesh-list
82934387|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82934388|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
82934389|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934390|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934391|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82934392|NCT01100203|Diuretics|diuretics|mesh-ancestor
82934393|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
82934394|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82934395|NCT03948685|Carvedilol|carvedilol|mesh-list
82934396|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82934397|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82934398|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
82934399|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934400|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934401|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934402|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82934403|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
82934404|NCT03948685|Protective Agents|protective agents|mesh-ancestor
82934405|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82934406|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82934407|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82934408|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
82934409|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82934410|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82934411|NCT01585051|Vitamin D|vitamin d|mesh-list
82934412|NCT01585051|Vitamins|vitamins|mesh-ancestor
82934413|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
82934414|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934415|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82934416|NCT01103791|Docetaxel|docetaxel|mesh-list
82934417|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934418|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
82934419|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
82934420|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
82934421|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934422|NCT03800173|Galidesivir|galidesivir|mesh-list
82934423|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
82934424|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934425|NCT00003631|Cytarabine|cytarabine|mesh-list
82934426|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
82934427|NCT00003631|Melphalan|melphalan|mesh-list
82934428|NCT00003631|Ifosfamide|ifosfamide|mesh-list
82934429|NCT00003631|Carmustine|carmustine|mesh-list
82934430|NCT00003631|Carboplatin|carboplatin|mesh-list
82934431|NCT00003631|Etoposide|etoposide|mesh-list
82934432|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934433|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
82934434|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934435|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934436|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82934437|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
82934438|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934439|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934440|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82934441|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82934442|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934443|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934444|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934445|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82934446|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
82934447|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
82934448|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934449|NCT01101685|Escitalopram|escitalopram|mesh-list
82934450|NCT01101685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82934451|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82934452|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82934453|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934454|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934456|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934457|NCT00030901|Selenium|selenium|mesh-list
82934458|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
82934459|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934460|NCT00030901|Protective Agents|protective agents|mesh-ancestor
82934461|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934462|NCT00030901|Trace Elements|trace elements|mesh-ancestor
82934463|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
82934464|NCT01104259|Vinorelbine|vinorelbine|mesh-list
82934465|NCT01104259|Veliparib|veliparib|mesh-list
82934466|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934467|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82934468|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
82934469|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
82934470|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
82934471|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934472|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82934473|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934474|NCT01104337|Acetaminophen|acetaminophen|mesh-list
82934475|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82934476|NCT01104337|Analgesics|analgesics|mesh-ancestor
82934477|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
82934478|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934479|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934480|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
82934481|NCT01100359|Carboplatin|carboplatin|mesh-list
82934482|NCT01100359|Doxorubicin|doxorubicin|mesh-list
82934483|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82934484|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934485|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934486|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934487|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934488|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934489|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934491|NCT00003199|Aldesleukin|aldesleukin|mesh-list
82934492|NCT00003199|Melphalan|melphalan|mesh-list
82934493|NCT00003199|Busulfan|busulfan|mesh-list
82934494|NCT00003199|Thiotepa|thiotepa|mesh-list
82934495|NCT00003199|Interleukin-2|interleukin-2|mesh-list
82934496|NCT00003199|Sargramostim|sargramostim|mesh-list
82934497|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934498|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82934499|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
82934500|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934501|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82934502|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934503|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
82934504|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934505|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82934506|NCT00003199|Analgesics|analgesics|mesh-ancestor
82934507|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
82934508|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934509|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82934510|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
82934511|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934512|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82934513|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82934514|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82934515|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82934516|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82934517|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82934518|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
82934519|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934520|NCT01327261|Levodopa|levodopa|mesh-list
82934521|NCT01327261|Benserazide|benserazide|mesh-list
82934522|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82934523|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82934524|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
82934525|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934526|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934527|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934528|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934529|NCT01101919|Tofacitinib|tofacitinib|mesh-list
82934530|NCT01101919|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82934531|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82934532|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934533|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934534|NCT03951415|Durvalumab|durvalumab|mesh-list
82934535|NCT03951415|Olaparib|olaparib|mesh-list
82934536|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82934537|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934538|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934539|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934540|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934541|NCT00001849|Edetic Acid|edetic acid|mesh-list
82934542|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
82934543|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934544|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934545|NCT00001849|Antidotes|antidotes|mesh-ancestor
82934546|NCT00001849|Protective Agents|protective agents|mesh-ancestor
82934547|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
82934548|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
82934549|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82934550|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
82934551|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82934552|NCT01104571|Trastuzumab|trastuzumab|mesh-list
82934553|NCT01104571|Lapatinib|lapatinib|mesh-list
82934554|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934555|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934556|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82934557|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934558|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934559|NCT01104649|Riluzole|riluzole|mesh-list
82934560|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
82934561|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82934562|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82934563|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934564|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934565|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934566|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82934567|NCT01104649|Protective Agents|protective agents|mesh-ancestor
82934568|NCT01327729|Interferons|interferons|mesh-list
82934569|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
82934570|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
82934571|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82934572|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934573|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
82934574|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934575|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
82934576|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934577|NCT01342952|Ambrisentan|ambrisentan|mesh-list
82934578|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82934580|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82934581|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934582|NCT01104883|Trace Elements|trace elements|mesh-ancestor
82934583|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
82934584|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934585|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82934586|NCT04371380|Rilpivirine|rilpivirine|mesh-list
82934587|NCT04371380|Cabotegravir|cabotegravir|mesh-list
82934588|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82934589|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82934590|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934591|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934592|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
82934593|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934594|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82934595|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82934596|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82934597|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82934598|NCT01341080|Varenicline|varenicline|mesh-list
82934599|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82934600|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82934601|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
82934602|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934603|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934604|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934605|NCT01333982|Amoxicillin|amoxicillin|mesh-list
82934606|NCT01333982|Gentamicins|gentamicins|mesh-list
82934607|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934608|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934609|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82934610|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934611|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934612|NCT01334060|Vaccines|vaccines|mesh-list
82934613|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
82934614|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934615|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
82934616|NCT04130828|Trace Elements|trace elements|mesh-ancestor
82934617|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
82934618|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934619|NCT01332344|Fluticasone|fluticasone|mesh-list
82934620|NCT01332344|Xhance|xhance|mesh-list
82934621|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82934622|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934623|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82934624|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
82934625|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934626|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934627|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82934628|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
82934629|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
82934630|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82934631|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82934632|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82934633|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82934634|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
82934635|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934636|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934637|NCT01112306|Selexipag|selexipag|mesh-list
82934638|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82934639|NCT01332422|Fluticasone|fluticasone|mesh-list
82934640|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82934641|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82934642|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934643|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82934644|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
82934645|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934646|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934647|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82934648|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
82934649|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
82934650|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82934651|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82934652|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82934653|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82934654|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
82934655|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934656|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934657|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
82934658|NCT01332422|Hormones|hormones|mesh-ancestor
82934659|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934660|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
82934661|NCT03162224|Durvalumab|durvalumab|mesh-list
82934662|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934663|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934664|NCT00904046|Pioglitazone|pioglitazone|mesh-list
82934665|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
82934666|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82934667|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934668|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
82934669|NCT01332734|Analgesics|analgesics|mesh-ancestor
82934670|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
82934671|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934672|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934673|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
82934674|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82934675|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82934676|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
82934677|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82934678|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83516800|NCT04225611|Hormones|hormones|mesh-ancestor
82934679|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934680|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82934681|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
82934682|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82934683|NCT00719888|Cyclosporine|cyclosporine|mesh-list
82934684|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
82934685|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
82934686|NCT00719888|Thiotepa|thiotepa|mesh-list
82934687|NCT00719888|Fludarabine|fludarabine|mesh-list
82934688|NCT00719888|Cyclosporins|cyclosporins|mesh-list
82934689|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934690|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
82934691|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934692|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934693|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82934694|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
82934695|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934696|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934697|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82934698|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934699|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
82934700|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934701|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
82934702|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82934703|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934704|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82934705|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
82934706|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934707|NCT03326492|Antivenins|antivenins|mesh-list
82934708|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
82934709|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934710|NCT01524536|Prednisone|prednisone|mesh-list
82934711|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934712|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
82934713|NCT01524536|Hormones|hormones|mesh-ancestor
82934714|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934715|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934716|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82934717|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934718|NCT00533468|Lidocaine|lidocaine|mesh-list
82934719|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
82934720|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
82934721|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82934722|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934723|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
82934724|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934725|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82934726|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82934727|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82934728|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82934729|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934730|NCT01333124|Gemcitabine|gemcitabine|mesh-list
82934731|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82934732|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
82934733|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934734|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934735|NCT03035630|Sunitinib|sunitinib|mesh-list
82934736|NCT03035630|Avelumab|avelumab|mesh-list
82934737|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934738|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82934739|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82934740|NCT03035630|Growth Substances|growth substances|mesh-ancestor
82934741|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934742|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
82934743|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82934744|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934745|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934746|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934747|NCT00004124|Prednisone|prednisone|mesh-list
82934748|NCT00004124|Goserelin|goserelin|mesh-list
82934749|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
82934750|NCT00004124|Bicalutamide|bicalutamide|mesh-list
82934751|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934752|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
82934753|NCT00004124|Hormones|hormones|mesh-ancestor
82934754|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934755|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934756|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82934757|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934758|NCT00004124|Analgesics|analgesics|mesh-ancestor
82934759|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
82934760|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934761|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934762|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934763|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934764|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934765|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
82934766|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
82934767|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
82934768|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934769|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934770|NCT01334684|Metformin|metformin|mesh-list
82934771|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82934772|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934774|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934775|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82934776|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82934777|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934778|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934779|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82934780|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
82934781|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934782|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934783|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
82934784|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
82934785|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82934786|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
82934787|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934788|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934789|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82934790|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
82934791|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82934792|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82934793|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82934794|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
82934795|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934796|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934797|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934798|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
82934799|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82934800|NCT01335074|Sirolimus|sirolimus|mesh-list
82934801|NCT01335074|Sorafenib|sorafenib|mesh-list
82934802|NCT01335074|Temsirolimus|temsirolimus|mesh-list
82934803|NCT01335074|MTOR Inhibitors|mtor inhibitors|mesh-list
82934804|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934805|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82934806|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934807|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934808|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934809|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
82934810|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934811|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934812|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934813|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934814|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
82934815|NCT01337492|Sorafenib|sorafenib|mesh-list
82934816|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934817|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82934818|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934819|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934820|NCT01337570|Dapivirine|dapivirine|mesh-list
82934821|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82934822|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82934823|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
82934824|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934825|NCT01337804|Omeprazole|omeprazole|mesh-list
82934826|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
82934827|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82934828|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82934829|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82934830|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934831|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934833|NCT01776424|Pantoprazole|pantoprazole|mesh-list
82934834|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
82934835|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82934836|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82934837|NCT01776424|Analgesics|analgesics|mesh-ancestor
82934838|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
82934839|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934840|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934841|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934842|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934843|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82934844|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82934845|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934846|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82934847|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82934848|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934849|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
82934850|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82934851|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
82934852|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82934853|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
82934854|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
82934855|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82934856|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82934857|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82934858|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82934859|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82934860|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
82934861|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934862|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934863|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82934864|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
82934865|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
82934866|NCT00642148|Hormones|hormones|mesh-ancestor
82934867|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82934868|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
82934869|NCT00629980|Azithromycin|azithromycin|mesh-list
82934870|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934871|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934872|NCT00629590|Azithromycin|azithromycin|mesh-list
82934873|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934874|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934875|NCT00626704|Doxorubicin|doxorubicin|mesh-list
82934876|NCT00626704|Conatumumab|conatumumab|mesh-list
82934877|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82934878|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934879|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82934880|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82934881|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934882|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934883|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82934884|NCT00765700|Ketoprofen|ketoprofen|mesh-list
82934885|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82934886|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82934887|NCT00765700|Analgesics|analgesics|mesh-ancestor
82934888|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
82934889|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934890|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934891|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934892|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934893|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82934894|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934895|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934896|NCT02280694|Celecoxib|celecoxib|mesh-list
82934897|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
82934898|NCT02280694|Capecitabine|capecitabine|mesh-list
82934899|NCT02280694|Methotrexate|methotrexate|mesh-list
82934900|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82934901|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
82934902|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934903|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82934904|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82934905|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
82934906|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934907|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82934908|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82934909|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82934910|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
82934911|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82934912|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
82934913|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82934914|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
82934915|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934916|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82934917|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82934918|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82934919|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82934920|NCT02280694|Analgesics|analgesics|mesh-ancestor
82934922|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934923|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82934924|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82934925|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82934926|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
82934927|NCT02280772|Cathartics|cathartics|mesh-ancestor
82934928|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82934929|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
82934930|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
82934931|NCT00799864|Tenofovir|tenofovir|mesh-list
82934932|NCT00799864|Lamivudine|lamivudine|mesh-list
82934933|NCT00799864|Emtricitabine|emtricitabine|mesh-list
82934934|NCT00799864|Zidovudine|zidovudine|mesh-list
82934935|NCT00799864|Abacavir|abacavir|mesh-list
82934936|NCT00799864|Rilpivirine|rilpivirine|mesh-list
82934937|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
82934938|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934939|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82934940|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82934941|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82934942|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934943|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82934944|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82934945|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
82934946|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
82934947|NCT02281006|Antidotes|antidotes|mesh-ancestor
82934948|NCT02281006|Protective Agents|protective agents|mesh-ancestor
82934949|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934950|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
82934951|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934952|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
82934953|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82934954|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934955|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
82934956|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
82934957|NCT00758290|Triclosan|triclosan|mesh-list
82934958|NCT00758290|Fluorides|fluorides|mesh-list
82934959|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
82934960|NCT00758290|Protective Agents|protective agents|mesh-ancestor
82934961|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934962|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82934963|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82934964|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82934965|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82934966|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
82934967|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934968|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82934969|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
82934970|NCT03799627|Glycine|glycine|mesh-list
82934971|NCT03799627|Hematinics|hematinics|mesh-ancestor
82934972|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
82934973|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934974|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934975|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934976|NCT02274142|Methamphetamine|methamphetamine|mesh-list
82934977|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82934978|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934979|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
82934980|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
82934981|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82934982|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
82934983|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934984|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934985|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
82934986|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82934987|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82934988|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83458804|NCT00958919|Endorphins|endorphins|mesh-list
82934989|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82934990|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
82934991|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82934992|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82934993|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82934994|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82934995|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82934996|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
82934997|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82934998|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82934999|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82935000|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935001|NCT02276014|Beta Carotene|beta carotene|mesh-list
82935002|NCT02276014|Carotenoids|carotenoids|mesh-list
82935003|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
82935004|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935005|NCT02276014|Protective Agents|protective agents|mesh-ancestor
82935006|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935007|NCT02276014|Provitamins|provitamins|mesh-ancestor
82935009|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
82935010|NCT01102387|Octenidine|octenidine|mesh-list
82935011|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935012|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82935013|NCT02277808|Amikacin|amikacin|mesh-list
82935014|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935015|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935016|NCT02281240|Oprelvekin|oprelvekin|mesh-list
82935017|NCT02281240|Heparin|heparin|mesh-list
82935018|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
82935019|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82935020|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82935021|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935022|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935023|NCT01102465|Losartan|losartan|mesh-list
82935024|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82935025|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82935026|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82935027|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82935028|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82935029|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935030|NCT01102465|Diuretics|diuretics|mesh-ancestor
82935031|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
82935032|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935033|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82935034|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935035|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
82935036|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82935037|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935038|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
82935039|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
82935040|NCT00749632|Oxybutynin|oxybutynin|mesh-list
82935041|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
82935042|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
82935043|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935044|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935045|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82935046|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82935047|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935048|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935049|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935050|NCT00749632|Urological Agents|urological agents|mesh-ancestor
82935051|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82935052|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935053|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
82935054|NCT01105273|Fludarabine|fludarabine|mesh-list
82935055|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82935056|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935057|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
83458814|NCT04323592|Prednisolone|prednisolone|mesh-list
82935058|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935059|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82935060|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82935061|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
82935062|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935063|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935064|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82935065|NCT05215327|Vaccines|vaccines|mesh-list
82935066|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
82935067|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935068|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82935069|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935070|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82935071|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935072|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935073|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
82935074|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82935075|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82935076|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
82935077|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935078|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935079|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82935080|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
82935081|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
82935082|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82935083|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935084|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935085|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935086|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82935087|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82935088|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82935089|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
82935090|NCT01105351|Folic Acid|folic acid|mesh-list
82935091|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
82935092|NCT01105351|Hematinics|hematinics|mesh-ancestor
82935093|NCT01105351|Vitamins|vitamins|mesh-ancestor
82935094|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
82935095|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935096|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
82935097|NCT00662506|Temozolomide|temozolomide|mesh-list
82935098|NCT00662506|Cediranib|cediranib|mesh-list
82935099|NCT00662506|Maleic acid|maleic acid|mesh-list
82935100|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82935101|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82935102|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
82935103|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935104|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935105|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935106|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82935107|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82935108|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
82935109|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
82935110|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935111|NCT03947125|Buprenorphine|buprenorphine|mesh-list
82935112|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82935113|NCT03947125|Narcotics|narcotics|mesh-ancestor
82935114|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935115|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935116|NCT03947125|Analgesics|analgesics|mesh-ancestor
82935117|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
82935118|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935119|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82935120|NCT00658762|Paroxetine|paroxetine|mesh-list
82935121|NCT00658762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82935122|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82935123|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935124|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935125|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935126|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
82935127|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935128|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82935129|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
82935130|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82935131|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82935132|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82935133|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935134|NCT00658372|Paroxetine|paroxetine|mesh-list
82935135|NCT00658372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82935136|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82935137|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935138|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935139|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935140|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
82935141|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935142|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82935143|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
82935144|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82935145|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82935147|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935148|NCT03946657|Anesthetics|anesthetics|mesh-list
82935149|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
82935150|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935151|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935152|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
82935153|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
82935154|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82935155|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935156|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935157|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82935158|NCT01106053|Pramipexole|pramipexole|mesh-list
82935159|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
82935160|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935161|NCT01106053|Protective Agents|protective agents|mesh-ancestor
82935162|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935163|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82935164|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82935165|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
82935166|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
82935167|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935168|NCT00616330|Clindamycin|clindamycin|mesh-list
82935169|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
82935170|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
82935171|NCT00616330|Butoconazole|butoconazole|mesh-list
82935172|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935173|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935174|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82935175|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935176|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935177|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
82935178|NCT00612820|Fluticasone|fluticasone|mesh-list
82935179|NCT00612820|Xhance|xhance|mesh-list
82935180|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
82935181|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935182|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82935183|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
82935184|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935185|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935186|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82935187|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
82935188|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
82935189|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82935190|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82935191|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82935192|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935193|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935194|NCT00612742|Testosterone|testosterone|mesh-list
82935195|NCT00612742|Androgens|androgens|mesh-ancestor
82935196|NCT00612742|Hormones|hormones|mesh-ancestor
82935197|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935198|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935199|NCT05016895|Azithromycin|azithromycin|mesh-list
83458825|NCT04323592|Hormones|hormones|mesh-ancestor
82935200|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935201|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935202|NCT01106131|Pioglitazone|pioglitazone|mesh-list
82935203|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82935204|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935205|NCT00612118|Azelastine|azelastine|mesh-list
82935206|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
82935207|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82935208|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
82935209|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935210|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935211|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82935212|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
82935213|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82935214|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935215|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935216|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82935217|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82935218|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82935219|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
82935220|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
82935221|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935222|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82935223|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82935224|NCT00743002|Metformin|metformin|mesh-list
82935225|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82935226|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935227|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82935228|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935229|NCT01102699|Lenograstim|lenograstim|mesh-list
82935230|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82935231|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
82935232|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935233|NCT00603616|Rifaximin|rifaximin|mesh-list
82935234|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935235|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935236|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82935237|NCT02280070|Leucovorin|leucovorin|mesh-list
82935238|NCT02280070|Fluorouracil|fluorouracil|mesh-list
82935239|NCT02280070|Tegafur|tegafur|mesh-list
82935240|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
82935241|NCT02280070|Antibodies|antibodies|mesh-list
82935242|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
82935243|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
82935244|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
82935245|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935246|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
82935247|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935248|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82935249|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935250|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935251|NCT02280070|Antidotes|antidotes|mesh-ancestor
82935252|NCT02280070|Protective Agents|protective agents|mesh-ancestor
82935253|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
82935254|NCT02280070|Vitamins|vitamins|mesh-ancestor
82935255|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
82935256|NCT01108783|Desloratadine|desloratadine|mesh-list
82935257|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82935258|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935259|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935260|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935261|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935262|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82935263|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82935264|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
82935265|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
82935266|NCT02743780|MGV354|mgv354|mesh-list
82935267|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
82935268|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935269|NCT02280148|Propofol|propofol|mesh-list
82935270|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
82935271|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935272|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935273|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82935274|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82935275|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
82935276|NCT00602602|Bevacizumab|bevacizumab|mesh-list
82935277|NCT00602602|Gemcitabine|gemcitabine|mesh-list
82935278|NCT00602602|Fluorouracil|fluorouracil|mesh-list
82935279|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
82935280|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82935281|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935282|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82935283|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82935284|NCT00602602|Growth Substances|growth substances|mesh-ancestor
82935285|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935286|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
82935287|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82935288|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
82935289|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935290|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935291|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
82935292|NCT04177654|Albendazole|albendazole|mesh-list
82935293|NCT04177654|Mebendazole|mebendazole|mesh-list
82935294|NCT04177654|Benzimidazole|benzimidazole|mesh-list
82935295|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
82935296|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82935297|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935298|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
82935299|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82935300|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82935301|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
82935302|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
82935303|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
82935304|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935305|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935306|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
82935307|NCT02281396|Vaccines|vaccines|mesh-list
82935308|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
82935309|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935310|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82935311|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935312|NCT04471480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82935313|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935314|NCT02880956|Tilavonemab|tilavonemab|mesh-list
82935315|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
82935316|NCT01111513|Analgesics|analgesics|mesh-list
82935317|NCT01111513|Ropivacaine|ropivacaine|mesh-list
82935318|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
82935319|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
82935320|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935321|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935322|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
82935323|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935324|NCT01111591|Celecoxib|celecoxib|mesh-list
82935325|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
82935326|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82935327|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82935328|NCT01111591|Analgesics|analgesics|mesh-ancestor
82935329|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
82935330|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935331|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935332|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935333|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82935334|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82935335|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935336|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935337|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
83458840|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
82935338|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82935339|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82935340|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935341|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
82935342|NCT01111669|Coagulants|coagulants|mesh-ancestor
82935343|NCT01108939|Antimalarials|antimalarials|mesh-list
82935344|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82935345|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82935346|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935347|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82935348|NCT00654706|Sertindole|sertindole|mesh-list
82935349|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
82935350|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82935351|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82935352|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82935353|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935354|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935355|NCT03944473|Neostigmine|neostigmine|mesh-list
82935356|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82935357|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935358|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935359|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935360|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935361|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935362|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82935363|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
82935364|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935365|NCT03944317|Azithromycin|azithromycin|mesh-list
82935366|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
82935367|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
82935368|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82935369|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935370|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935372|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82935373|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82935374|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82935375|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935376|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935377|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82935378|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
82935379|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82935380|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
82935381|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935382|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
82935383|NCT02280538|Protective Agents|protective agents|mesh-ancestor
82935384|NCT01111747|Mitogens|mitogens|mesh-list
82935385|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
82935386|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935387|NCT02281708|Cisplatin|cisplatin|mesh-list
82935388|NCT02281708|Vinorelbine|vinorelbine|mesh-list
82935389|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935390|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82935391|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
82935392|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
82935393|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
82935394|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935395|NCT01111903|Lenalidomide|lenalidomide|mesh-list
82935396|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
82935397|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935398|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82935399|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82935400|NCT01111903|Growth Substances|growth substances|mesh-ancestor
82935401|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
82935402|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935403|NCT02280616|Budesonide|budesonide|mesh-list
82935404|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935405|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82935406|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
82935407|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935408|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935409|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82935410|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
82935411|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
82935412|NCT02280616|Hormones|hormones|mesh-ancestor
82935413|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935414|NCT01111981|Clobetasol|clobetasol|mesh-list
82935415|NCT01111981|Emollients|emollients|mesh-list
82935416|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935417|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
82935418|NCT01111981|Hormones|hormones|mesh-ancestor
82935419|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935420|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935421|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
82935422|NCT02283424|Carboplatin|carboplatin|mesh-list
82935423|NCT02283424|Docetaxel|docetaxel|mesh-list
82935424|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935425|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
82935426|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
82935427|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
82935428|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935429|NCT03942601|Sirolimus|sirolimus|mesh-list
82935430|NCT03942601|Dexamethasone|dexamethasone|mesh-list
82935431|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
82935432|NCT03942601|Temsirolimus|temsirolimus|mesh-list
82935433|NCT03942601|MTOR Inhibitors|mtor inhibitors|mesh-list
82935434|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82935435|NCT03942601|BB 1101|bb 1101|mesh-list
82935436|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935437|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
82935438|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
82935439|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935440|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935441|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82935442|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
82935443|NCT03942601|Hormones|hormones|mesh-ancestor
82935444|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935445|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82935446|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935448|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935449|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935450|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935451|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
82935452|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935453|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935454|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82935455|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
82935456|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
82935457|NCT00598312|Leuprolide|leuprolide|mesh-list
82935458|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82935459|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
82935460|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82935461|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935462|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82935463|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935464|NCT00595426|Warfarin|warfarin|mesh-list
82935465|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
82935466|NCT01112137|Clopidogrel|clopidogrel|mesh-list
82935467|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82935468|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82935469|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82935470|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82935471|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
82935472|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935473|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935474|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935475|NCT02282098|Colchicine|colchicine|mesh-list
82935476|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
82935477|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82935478|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
82935479|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
82935480|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
83458847|NCT01047241|Narcotics|narcotics|mesh-ancestor
82935481|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935482|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935483|NCT01208935|Nicotine|nicotine|mesh-list
82935484|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82935485|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
82935486|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935487|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935488|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82935489|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82935490|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935491|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935492|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935493|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82935494|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82935495|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82935496|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935497|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935498|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935499|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935500|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82935501|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
82935502|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82935503|NCT01107067|Testosterone|testosterone|mesh-list
82935504|NCT01107067|Androgens|androgens|mesh-ancestor
82935505|NCT01107067|Hormones|hormones|mesh-ancestor
82935506|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935507|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935508|NCT02282176|Azithromycin|azithromycin|mesh-list
82935509|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935510|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935511|NCT00580216|Biotin|biotin|mesh-list
82935512|NCT00580216|Warfarin|warfarin|mesh-list
82935513|NCT00580216|Idraparinux|idraparinux|mesh-list
82935514|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
82935515|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
82935516|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82935517|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
82935518|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82935519|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
82935520|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935521|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935522|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
82935523|NCT00580216|Vitamins|vitamins|mesh-ancestor
82935524|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
82935525|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935526|NCT01107145|Artesunate|artesunate|mesh-list
82935527|NCT01107145|Chloroquine|chloroquine|mesh-list
82935528|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82935529|NCT01107145|Lumefantrine|lumefantrine|mesh-list
82935530|NCT01107145|Artemether|artemether|mesh-list
82935531|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82935532|NCT01107145|Mefloquine|mefloquine|mesh-list
82935533|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
82935534|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82935535|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82935536|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935537|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935538|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
82935539|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
82935540|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82935541|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
82935542|NCT01107145|Amebicides|amebicides|mesh-ancestor
82935543|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82935544|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82935545|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82935546|NCT01107145|Analgesics|analgesics|mesh-ancestor
82935547|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
82935548|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935549|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935550|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935551|NCT01107145|Filaricides|filaricides|mesh-ancestor
82935552|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
82935553|NCT03944005|Anesthetics|anesthetics|mesh-list
82935554|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935555|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935556|NCT01209403|Insulin|insulin|mesh-list
82935557|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
82935558|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82935559|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935560|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
82935561|NCT01112215|Azathioprine|azathioprine|mesh-list
82935562|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82935563|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935564|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82935565|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
82935566|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935567|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935568|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935569|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935570|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
82935571|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82935572|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935573|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
82935574|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935575|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82935576|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82935577|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82935578|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935579|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
82935580|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82935581|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935582|NCT02286544|Atorvastatin|atorvastatin|mesh-list
82935583|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82935584|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82935585|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
82935586|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935587|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83516951|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
82935588|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82935589|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935590|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82935591|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935592|NCT00384904|Ritonavir|ritonavir|mesh-list
82935593|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82935594|NCT00384904|Tenofovir|tenofovir|mesh-list
82935595|NCT00384904|Famotidine|famotidine|mesh-list
82935596|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82935597|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82935598|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
82935599|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935600|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935601|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82935602|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82935603|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
82935604|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935605|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82935606|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82935607|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82935608|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82935609|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82935610|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82935611|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82935612|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
82935613|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
82935614|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935615|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935616|NCT01335386|Glycerol|glycerol|mesh-list
82935617|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82935618|NCT01335386|Protective Agents|protective agents|mesh-ancestor
82935619|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935620|NCT00383578|Metformin|metformin|mesh-list
82935621|NCT00383578|Vildagliptin|vildagliptin|mesh-list
83458861|NCT03655444|Nivolumab|nivolumab|mesh-list
82935622|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82935623|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935624|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82935625|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
82935626|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935627|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935628|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82935629|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82935630|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
82935631|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935632|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935633|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82935634|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82935635|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82935636|NCT02286622|Deflazacort|deflazacort|mesh-list
82935637|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935638|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935639|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
82935640|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935641|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82935642|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82935643|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82935644|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935645|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935646|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935647|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935648|NCT00564226|Urological Agents|urological agents|mesh-ancestor
82935649|NCT03635684|Acetaminophen|acetaminophen|mesh-list
82935650|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82935651|NCT03635684|Analgesics|analgesics|mesh-ancestor
82935652|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
82935653|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935654|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935655|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
82935656|NCT00092690|Atorvastatin|atorvastatin|mesh-list
82935657|NCT00092690|Simvastatin|simvastatin|mesh-list
82935658|NCT00092690|Ezetimibe|ezetimibe|mesh-list
82935659|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82935660|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82935661|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
82935662|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935663|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82935664|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82935665|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935667|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935668|NCT01338896|Rotigotine|rotigotine|mesh-list
82935669|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
82935670|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
82935671|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935672|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935674|NCT05185544|Pemetrexed|pemetrexed|mesh-list
82935675|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935676|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935677|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935678|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82935679|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82935680|NCT00382096|Metformin|metformin|mesh-list
82935681|NCT00382096|Vildagliptin|vildagliptin|mesh-list
82935682|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82935683|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935684|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82935685|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
82935686|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935687|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935688|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
82935689|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935690|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
82935691|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935692|NCT00379990|Prednisolone|prednisolone|mesh-list
82935693|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935694|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
82935695|NCT00379990|Hormones|hormones|mesh-ancestor
82935696|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935697|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935698|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82935699|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935700|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82935701|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
82935702|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935703|NCT01341938|Nicotine|nicotine|mesh-list
82935704|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82935705|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
82935706|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935707|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935708|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82935709|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82935710|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935711|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935712|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935713|NCT02284048|Ticagrelor|ticagrelor|mesh-list
82935714|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82935715|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82935716|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82935717|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82935718|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
82935719|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935720|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935721|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935722|NCT00374296|Mocetinostat|mocetinostat|mesh-list
82935723|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82935724|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935725|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935726|NCT00547066|Veltuzumab|veltuzumab|mesh-list
82935727|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935728|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
82935729|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82935730|NCT01315496|Antibodies|antibodies|mesh-list
82935731|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
82935732|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
82935733|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935734|NCT00544960|Docetaxel|docetaxel|mesh-list
82935735|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935736|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
82935737|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
82935738|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
82935739|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935740|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82935741|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82935742|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82935743|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935744|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935745|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
82935746|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935747|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935748|NCT00468442|Sirolimus|sirolimus|mesh-list
82935749|NCT00468442|Rituximab|rituximab|mesh-list
82935750|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82935751|NCT00468442|Daclizumab|daclizumab|mesh-list
82935752|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82935753|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935754|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
82935755|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935756|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82935757|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82935758|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82935759|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82935760|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
82935761|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935762|NCT01339442|Fulvestrant|fulvestrant|mesh-list
82935763|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82935764|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935765|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82935766|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82935767|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
82935768|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935769|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935770|NCT02286934|Carvedilol|carvedilol|mesh-list
82935771|NCT02286934|Isoproterenol|isoproterenol|mesh-list
82935772|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82935773|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82935774|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
82935775|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935776|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935777|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935778|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82935779|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
82935780|NCT02286934|Protective Agents|protective agents|mesh-ancestor
82935781|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82935782|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935783|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82935784|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
82935785|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82935786|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82935787|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82935788|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82935789|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82935790|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
82935791|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935792|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82935793|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
82935794|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82935795|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
82935796|NCT02282410|Factor VIII|factor viii|mesh-list
82935797|NCT02282410|Coagulants|coagulants|mesh-ancestor
82935798|NCT00092612|Ezetimibe|ezetimibe|mesh-list
82935799|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82935800|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82935801|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
82935802|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935803|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82935804|NCT00540358|Carboplatin|carboplatin|mesh-list
82935805|NCT00540358|Gemcitabine|gemcitabine|mesh-list
82935806|NCT00540358|Iniparib|iniparib|mesh-list
82935807|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935808|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82935809|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
82935810|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935811|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82935812|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935813|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
82935814|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
82935815|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82935816|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
82935817|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935818|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82935819|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82935820|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82935821|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82935822|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935824|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
82935825|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
82935826|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935827|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935828|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
82935829|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935830|NCT04470544|Camostat|camostat|mesh-list
82935831|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
82935832|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935833|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935834|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82935835|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82935836|NCT00535366|Fluticasone|fluticasone|mesh-list
82935837|NCT00535366|Ciclesonide|ciclesonide|mesh-list
82935838|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
82935839|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82935840|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82935841|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82935842|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
82935843|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935844|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935845|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82935846|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
82935847|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
82935848|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82935849|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
82935850|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82935851|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
82935852|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935853|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935854|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82935855|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82935856|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82935857|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
82935858|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
82935859|NCT00535366|Hormones|hormones|mesh-ancestor
82935860|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82935861|NCT00369070|Paclitaxel|paclitaxel|mesh-list
82935862|NCT00369070|Bevacizumab|bevacizumab|mesh-list
82935863|NCT00369070|Carboplatin|carboplatin|mesh-list
82935864|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
82935865|NCT00369070|Imetelstat|imetelstat|mesh-list
82935866|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82935867|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935868|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
82935869|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
82935870|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
82935871|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935872|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82935873|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82935874|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82935875|NCT00369070|Growth Substances|growth substances|mesh-ancestor
82935876|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935877|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
82935878|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82935879|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935880|NCT02284204|Midazolam|midazolam|mesh-list
82935881|NCT02284204|Ketamine|ketamine|mesh-list
82935882|NCT02284204|Sevoflurane|sevoflurane|mesh-list
82935883|NCT02284204|Analgesics|analgesics|mesh-ancestor
82935884|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
82935885|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935886|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935887|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83516952|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
82935888|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82935889|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
82935890|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
82935891|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935892|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82935893|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82935894|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935895|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935896|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82935897|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82935899|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82935900|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82935901|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
82935902|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
82935903|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82935904|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82935905|NCT01352416|Ranolazine|ranolazine|mesh-list
82935906|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82935907|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935908|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935909|NCT00531622|Escitalopram|escitalopram|mesh-list
82935910|NCT00531622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82935911|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82935912|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935913|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935914|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935915|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
82935916|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935917|NCT00364546|Tapentadol|tapentadol|mesh-list
82935918|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82935919|NCT00364546|Narcotics|narcotics|mesh-ancestor
82935920|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935921|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935922|NCT00364546|Analgesics|analgesics|mesh-ancestor
82935923|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
82935924|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935925|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82935926|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82935927|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935928|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935929|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
82935930|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935931|NCT00361582|Tapentadol|tapentadol|mesh-list
82935932|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82935933|NCT00361582|Narcotics|narcotics|mesh-ancestor
82935934|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935935|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935936|NCT00361582|Analgesics|analgesics|mesh-ancestor
82935937|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
82935938|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935939|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82935940|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82935941|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935942|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935943|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
82935944|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82935945|NCT00450970|Satraplatin|satraplatin|mesh-list
82935946|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935947|NCT02282800|Vitamin D|vitamin d|mesh-list
82935948|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
82935949|NCT02282800|Vitamins|vitamins|mesh-ancestor
82935950|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
82935951|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935952|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82935953|NCT05208034|Methotrexate|methotrexate|mesh-list
82935954|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82935955|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
82935956|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82935957|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935958|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82935959|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
82935960|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935961|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82935962|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
82935963|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935964|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82935965|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82935966|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
82935967|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82935968|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82935969|NCT02284282|Lidocaine|lidocaine|mesh-list
82935970|NCT02284282|Morphine|morphine|mesh-list
82935971|NCT02284282|Bupivacaine|bupivacaine|mesh-list
82935972|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
82935973|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
82935974|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82935975|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935976|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
82935977|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935978|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82935979|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82935980|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82935981|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82935982|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935983|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82935984|NCT02284282|Narcotics|narcotics|mesh-ancestor
82935985|NCT02284282|Analgesics|analgesics|mesh-ancestor
82935986|NCT00359086|Mocetinostat|mocetinostat|mesh-list
82935987|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82935988|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82935989|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82935990|NCT03133780|Midazolam|midazolam|mesh-list
82935991|NCT03133780|Ketamine|ketamine|mesh-list
82935992|NCT03133780|Analgesics|analgesics|mesh-ancestor
82935993|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
82935994|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82935995|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82935996|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82935997|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82935998|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
82935999|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
82936000|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936001|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82936002|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82936003|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936004|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936005|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82936006|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82936007|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82936008|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82936009|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82936010|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
82936011|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
82936012|NCT02282956|Droperidol|droperidol|mesh-list
82936013|NCT02282956|Morphine|morphine|mesh-list
82936014|NCT02282956|Ropivacaine|ropivacaine|mesh-list
82936015|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82936016|NCT02282956|Narcotics|narcotics|mesh-ancestor
82936017|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936018|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936019|NCT02282956|Analgesics|analgesics|mesh-ancestor
82936020|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
82936021|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936022|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936023|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
82936024|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82936025|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
82936026|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
82936027|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82936028|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82936029|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82936030|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82936031|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82936032|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82936033|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
82936034|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936035|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936036|NCT02287558|Pomalidomide|pomalidomide|mesh-list
82936037|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
82936038|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936039|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82936040|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82936041|NCT02287558|Growth Substances|growth substances|mesh-ancestor
82936042|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
82936043|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936044|NCT04470076|Carboplatin|carboplatin|mesh-list
82936045|NCT04470076|Gemcitabine|gemcitabine|mesh-list
82936046|NCT04470076|Pemetrexed|pemetrexed|mesh-list
82936047|NCT04470076|Afatinib|afatinib|mesh-list
82936048|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936049|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936050|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
82936051|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936052|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936053|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82936054|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82936055|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82936056|NCT00445198|Navitoclax|navitoclax|mesh-list
82936057|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936058|NCT00345748|Abatacept|abatacept|mesh-list
82936059|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82936060|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936061|NCT00345748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82936062|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936063|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936064|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
82936065|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936066|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82936067|NCT00439738|Amlodipine|amlodipine|mesh-list
82936068|NCT00439738|Valsartan|valsartan|mesh-list
82936069|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82936070|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936071|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82936072|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82936073|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936074|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82936075|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936076|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
82936077|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82936078|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82936079|NCT00439738|Diuretics|diuretics|mesh-ancestor
82936080|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
82936081|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82936082|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
82936083|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82936084|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936085|NCT00523042|Insulin|insulin|mesh-list
82936086|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82936087|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
82936088|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936089|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936090|NCT00338104|Insulin|insulin|mesh-list
82936091|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82936092|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
82936093|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936094|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936095|NCT00519142|Mitiglinide|mitiglinide|mesh-list
82936096|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936097|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936098|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
82936099|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82936100|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936101|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936102|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82936103|NCT02284672|Analgesics|analgesics|mesh-ancestor
82936104|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
82936105|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936106|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82936107|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82936108|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82936109|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
82936110|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936111|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936112|NCT02283190|Asparaginase|asparaginase|mesh-list
82936113|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936114|NCT00333502|Camptothecin|camptothecin|mesh-list
82936115|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82936116|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936117|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82936118|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82936119|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936120|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936121|NCT00332956|Vaccines|vaccines|mesh-list
82936122|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
82936123|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936124|NCT00324220|Mocetinostat|mocetinostat|mesh-list
82936125|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82936126|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936127|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936128|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82936129|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82936130|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936131|NCT00417118|Escitalopram|escitalopram|mesh-list
82936132|NCT00417118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82936133|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82936134|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82936135|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936136|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936137|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
82936138|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936139|NCT02883452|Infliximab|infliximab|mesh-list
82936140|NCT02883452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82936141|NCT02883452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936142|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
82936143|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82936144|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82936145|NCT00508066|Bupivacaine|bupivacaine|mesh-list
82936146|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936147|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
82936148|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936149|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936150|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
82936151|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936152|NCT01336010|Ribavirin|ribavirin|mesh-list
82936153|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82936154|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
82936155|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936156|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
82936157|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936158|NCT02207504|Crizotinib|crizotinib|mesh-list
82936159|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936160|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82936161|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936162|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936163|NCT01342016|Prednisone|prednisone|mesh-list
82936164|NCT01342016|Tacrolimus|tacrolimus|mesh-list
82936165|NCT01342016|Leflunomide|leflunomide|mesh-list
82936166|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936167|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
82936168|NCT01342016|Hormones|hormones|mesh-ancestor
82936169|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936170|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936171|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82936172|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936173|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936174|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
82936175|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82936176|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936177|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936178|NCT01336166|Vaccines|vaccines|mesh-list
82936179|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
82936180|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936181|NCT04470310|Pioglitazone|pioglitazone|mesh-list
82936182|NCT04470310|Glimepiride|glimepiride|mesh-list
82936183|NCT04470310|Alogliptin|alogliptin|mesh-list
82936184|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936185|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936186|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82936187|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936188|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
82936189|NCT04470310|Incretins|incretins|mesh-ancestor
82936190|NCT04470310|Hormones|hormones|mesh-ancestor
82936191|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936192|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82936193|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
82936194|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936195|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936203|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936204|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936205|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
82936206|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936207|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936208|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
82936209|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936210|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
82936211|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82936212|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82936213|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82936214|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936215|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
82936216|NCT00412828|Immunoconjugates|immunoconjugates|mesh-ancestor
82936217|NCT00412828|Immunologic Factors|immunologic factors|mesh-ancestor
82936218|NCT00412828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936219|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82936220|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936221|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
82936223|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82936224|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82936225|NCT00315640|Growth Substances|growth substances|mesh-ancestor
82936226|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936227|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
82936228|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936229|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936230|NCT00411892|Insulin|insulin|mesh-list
82936231|NCT00411892|Pioglitazone|pioglitazone|mesh-list
82936232|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82936233|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936234|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936235|NCT01336322|Metformin|metformin|mesh-list
82936236|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82936237|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936238|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936239|NCT01336322|Incretins|incretins|mesh-ancestor
82936240|NCT01336322|Hormones|hormones|mesh-ancestor
82936241|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936242|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82936243|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
82936244|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936245|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936246|NCT01339676|Vitamin D|vitamin d|mesh-list
82936247|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
82936248|NCT01339676|Vitamins|vitamins|mesh-ancestor
82936249|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
82936250|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936251|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82936252|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82936253|NCT01339754|Trabectedin|trabectedin|mesh-list
82936254|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82936255|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
83458905|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82936256|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936257|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936258|NCT00313768|Paclitaxel|paclitaxel|mesh-list
82936259|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82936260|NCT00313768|Bevacizumab|bevacizumab|mesh-list
82936261|NCT00313768|Carboplatin|carboplatin|mesh-list
82936262|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82936263|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936264|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
82936265|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
82936266|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
82936267|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936268|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82936269|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82936270|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82936271|NCT00313768|Growth Substances|growth substances|mesh-ancestor
82936272|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936273|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
82936274|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
82936276|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936277|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
82936278|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936279|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82936280|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82936281|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
82936282|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936283|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936284|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82936285|NCT00406588|Levodopa|levodopa|mesh-list
82936286|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82936287|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82936288|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
82936289|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936290|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936291|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936292|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
82936293|NCT01342328|Propofol|propofol|mesh-list
82936294|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82936295|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936296|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936297|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82936298|NCT01342328|Analgesics|analgesics|mesh-ancestor
82936299|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
82936300|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936301|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82936302|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82936303|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82936304|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
82936305|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936306|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936307|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82936308|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
82936309|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
82936310|NCT00313222|Bosentan|bosentan|mesh-list
82936311|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936312|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82936313|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936314|NCT05184530|Evolocumab|evolocumab|mesh-list
82936315|NCT05184530|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82936316|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82936317|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82936318|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
82936319|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936320|NCT05184530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82936321|NCT05184530|Protease Inhibitors|protease inhibitors|mesh-ancestor
82936322|NCT05184530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936323|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82936324|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82936325|NCT05184374|Hormones|hormones|mesh-ancestor
82936326|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936327|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936328|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82936329|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936330|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
82936331|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936332|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936333|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
82936334|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936335|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82936336|NCT01342562|Anesthetics|anesthetics|mesh-list
82936337|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936338|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936339|NCT00116116|Lamivudine|lamivudine|mesh-list
82936350|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82936351|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82936352|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82774742|NCT00964080|Leucovorin|leucovorin|mesh-list
82936353|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82936354|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82936355|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82936357|NCT02287870|Lidocaine|lidocaine|mesh-list
82936358|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
82936359|NCT02287870|Procaine|procaine|mesh-list
82936360|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936361|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
82936362|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936363|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936364|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
82936365|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936366|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82936367|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82936368|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82936369|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82936370|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936371|NCT01340456|Rifampin|rifampin|mesh-list
82936372|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82936373|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
82936374|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82936375|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936376|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
82936377|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82936378|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936379|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936380|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82936381|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82936382|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82936383|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82936384|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82936385|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82936386|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82936387|NCT00110422|Irbesartan|irbesartan|mesh-list
82936388|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936389|NCT00110422|Diuretics|diuretics|mesh-ancestor
82936390|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
82936391|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936392|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82936393|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82936394|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936395|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82936397|NCT00305656|Cediranib|cediranib|mesh-list
82936398|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936399|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936400|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936401|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82936402|NCT02284984|Rituximab|rituximab|mesh-list
82936403|NCT02284984|Belimumab|belimumab|mesh-list
82936404|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83458917|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
82936405|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936406|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
82936407|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936408|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82936409|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936410|NCT00305188|Leucovorin|leucovorin|mesh-list
82936411|NCT00305188|Fluorouracil|fluorouracil|mesh-list
82936412|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
82936413|NCT00305188|Xaliproden|xaliproden|mesh-list
82936414|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
82936415|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936416|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936417|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936418|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936419|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
82936420|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936421|NCT00305188|Antidotes|antidotes|mesh-ancestor
82936422|NCT00305188|Protective Agents|protective agents|mesh-ancestor
82936423|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
82936424|NCT00305188|Vitamins|vitamins|mesh-ancestor
82936425|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
82936426|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82936427|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82936428|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
82936429|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936430|NCT00297310|Tacrolimus|tacrolimus|mesh-list
82936431|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936432|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
82936433|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936434|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82936435|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936436|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936437|NCT00095290|Ramipril|ramipril|mesh-list
82936438|NCT00095290|Irbesartan|irbesartan|mesh-list
82936439|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82936440|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
82936441|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936442|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936443|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936444|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82936445|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82936446|NCT01340846|Ketoconazole|ketoconazole|mesh-list
82936447|NCT01340846|Dabrafenib|dabrafenib|mesh-list
82936448|NCT01340846|Warfarin|warfarin|mesh-list
82936449|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
82936450|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
82936451|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
82936452|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936453|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82936454|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82936455|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936456|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936457|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82936458|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
82936459|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936460|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936461|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82936462|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936463|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82936464|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82936465|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
82936466|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82936467|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82936468|NCT01342874|Inositol|inositol|mesh-list
82936469|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
82936470|NCT01342874|Vitamins|vitamins|mesh-ancestor
82936479|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936480|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936482|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82936483|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
82936484|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936485|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936486|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936487|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82936488|NCT02603809|Protective Agents|protective agents|mesh-ancestor
82936489|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936490|NCT01341158|Interferons|interferons|mesh-list
82936491|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936492|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
82936493|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936494|NCT00393952|Fluticasone|fluticasone|mesh-list
82936495|NCT00393952|Xhance|xhance|mesh-list
82936496|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
82936497|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936498|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82936499|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
82936500|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936501|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936502|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82936503|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
82936504|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
82936505|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82936506|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82936507|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82936508|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82936509|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
82936510|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936511|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936512|NCT02285374|Tenofovir|tenofovir|mesh-list
82936513|NCT02285374|Emtricitabine|emtricitabine|mesh-list
82936514|NCT02285374|Efavirenz|efavirenz|mesh-list
82936515|NCT02285374|Dolutegravir|dolutegravir|mesh-list
82936516|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82936517|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
82936518|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936519|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82936520|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82936521|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936522|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936524|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82936525|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82936526|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82936527|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82936528|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82936529|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82936530|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82936531|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82936532|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82936533|NCT01112449|Selenium|selenium|mesh-list
82936534|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
82936535|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936536|NCT01112449|Protective Agents|protective agents|mesh-ancestor
82936537|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936538|NCT01112449|Trace Elements|trace elements|mesh-ancestor
82936539|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
82936540|NCT01341392|Amlodipine|amlodipine|mesh-list
82936541|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936542|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82936543|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82936544|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936545|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82936546|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936547|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
82936548|NCT04390958|Paclitaxel|paclitaxel|mesh-list
82936549|NCT04390958|Capecitabine|capecitabine|mesh-list
82936550|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82936551|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936552|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
82936553|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
82936554|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
82936555|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936556|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936557|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
82936558|NCT03943459|Atorvastatin|atorvastatin|mesh-list
82936559|NCT03943459|Quercetin|quercetin|mesh-list
82936560|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82936561|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82936562|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
82936563|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936564|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82936565|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82936566|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936567|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
82936568|NCT03943459|Protective Agents|protective agents|mesh-ancestor
82936569|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936570|NCT04832438|Carboplatin|carboplatin|mesh-list
82936571|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936572|NCT05182970|Metformin|metformin|mesh-list
82936573|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936574|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936575|NCT01315886|Fentanyl|fentanyl|mesh-list
82936576|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82936577|NCT01315886|Narcotics|narcotics|mesh-ancestor
82936578|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936579|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936580|NCT01315886|Analgesics|analgesics|mesh-ancestor
82936581|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
82936582|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936583|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82936584|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82936585|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
82936586|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
82936587|NCT00065728|Anecortave|anecortave|mesh-list
82936588|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82936589|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82936590|NCT00065728|Growth Substances|growth substances|mesh-ancestor
82936591|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936592|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
82936593|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936594|NCT00064714|Exenatide|exenatide|mesh-list
82936595|NCT00064714|Daclizumab|daclizumab|mesh-list
82936596|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82936597|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936598|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936599|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82936600|NCT00064714|Incretins|incretins|mesh-ancestor
82936601|NCT00064714|Hormones|hormones|mesh-ancestor
82936602|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936603|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
82936604|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
82936605|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82936606|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82936607|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82936608|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82936609|NCT01109485|Analgesics|analgesics|mesh-ancestor
82936610|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
82936611|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936612|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936613|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936614|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82936615|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82936616|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82936617|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82936618|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
82936619|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
82936620|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936621|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936622|NCT00292396|Antibodies|antibodies|mesh-list
82936623|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82936624|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
82936625|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936626|NCT03942289|Norepinephrine|norepinephrine|mesh-list
82936627|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82936628|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82936629|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
82936630|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936631|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936632|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936633|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
82936634|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
82936635|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936636|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82936637|NCT00284128|Losartan|losartan|mesh-list
82936638|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82936639|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936640|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82936641|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82936642|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936643|NCT00035542|Metformin|metformin|mesh-list
82936644|NCT00035542|Glyburide|glyburide|mesh-list
82936645|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82936646|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936647|NCT01209715|Fluticasone|fluticasone|mesh-list
82936648|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82936649|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82936650|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936651|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82936652|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
82936653|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936654|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936655|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82936656|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
82936657|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
82936658|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82936659|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82936660|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82936661|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82936662|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
82936663|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936664|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936665|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
82936667|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936668|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
82936670|NCT03740893|Olaparib|olaparib|mesh-list
82936671|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82936672|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936673|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82936674|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936675|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936676|NCT00005788|Aldesleukin|aldesleukin|mesh-list
82936677|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936678|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82936679|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82936680|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
82936681|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936682|NCT03945955|Melatonin|melatonin|mesh-list
82936683|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
82936684|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936685|NCT03945955|Protective Agents|protective agents|mesh-ancestor
82936686|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936687|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936688|NCT00005608|Leucovorin|leucovorin|mesh-list
82936689|NCT00005608|Tegafur|tegafur|mesh-list
82936690|NCT00005608|Calcium|calcium|mesh-list
82936691|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
82936692|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82936693|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936694|NCT00005608|Antidotes|antidotes|mesh-ancestor
82936695|NCT00005608|Protective Agents|protective agents|mesh-ancestor
82936696|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
82936697|NCT00005608|Vitamins|vitamins|mesh-ancestor
82936698|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
82936699|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936700|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
82936701|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936702|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936703|NCT02288338|Atorvastatin|atorvastatin|mesh-list
82936704|NCT02288338|Ezetimibe|ezetimibe|mesh-list
82936705|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82936706|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82936707|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
82936708|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936709|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82936710|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82936711|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936712|NCT00388960|Etoposide|etoposide|mesh-list
82936713|NCT00388960|Amrubicin|amrubicin|mesh-list
82936714|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936715|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82936716|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82936717|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82936718|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936719|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936720|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
82936721|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936722|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
82936723|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936724|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936725|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
82936726|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936727|NCT00004912|Megestrol|megestrol|mesh-list
82936728|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
82936729|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82936730|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82936731|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82936732|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
82936733|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82936734|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936735|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82936736|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82936737|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82936738|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936739|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
82936740|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82936741|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
82936743|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82936744|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82936745|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82936746|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936747|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936748|NCT00267592|Temozolomide|temozolomide|mesh-list
82936749|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82936750|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
82936751|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936752|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936753|NCT00267280|Atorvastatin|atorvastatin|mesh-list
82936754|NCT00267280|Simvastatin|simvastatin|mesh-list
82936755|NCT00267280|Torcetrapib|torcetrapib|mesh-list
82936756|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82936757|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82936758|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
82936759|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936760|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82936761|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82936762|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936763|NCT03530488|Lidocaine|lidocaine|mesh-list
82936764|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936765|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
82936766|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936767|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936768|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
82936769|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936770|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82936771|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82936772|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82936773|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82936774|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936775|NCT00262990|Doxorubicin|doxorubicin|mesh-list
82936776|NCT00262990|Epothilone B|epothilone b|mesh-list
82936777|NCT00262990|Epothilones|epothilones|mesh-list
82936778|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82936779|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936780|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82936781|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82936782|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936783|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936784|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
82936785|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
82936786|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
82936787|NCT01110031|Ofatumumab|ofatumumab|mesh-list
82936788|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936789|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82936790|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
82936791|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936792|NCT01210339|Esomeprazole|esomeprazole|mesh-list
82936793|NCT01210339|Clopidogrel|clopidogrel|mesh-list
82936794|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82936795|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82936796|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82936797|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82936798|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
82936799|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936800|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936801|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936802|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82936803|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82936804|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82936805|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936806|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82936807|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82936808|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936809|NCT03147248|Infliximab|infliximab|mesh-list
82936810|NCT03147248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82775186|NCT04009772|Cefuroxime|cefuroxime|mesh-list
82936811|NCT03147248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936812|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
82936813|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82936814|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82936815|NCT00250822|Gemcitabine|gemcitabine|mesh-list
82936816|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
82936817|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936818|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
82936819|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936820|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936821|NCT00004096|Carboplatin|carboplatin|mesh-list
82936822|NCT00004096|Vinorelbine|vinorelbine|mesh-list
82936823|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936824|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83458956|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
82936825|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
82936826|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
82936827|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
82936828|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936830|NCT00002224|Stavudine|stavudine|mesh-list
82936831|NCT00002224|Nelfinavir|nelfinavir|mesh-list
82936832|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
82936833|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936834|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82936835|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82936836|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936837|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
82936838|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936839|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82936840|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82936841|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82936842|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82936843|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
82936844|NCT01207921|Lenalidomide|lenalidomide|mesh-list
82936845|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
82936846|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936847|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82936848|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82936849|NCT01207921|Growth Substances|growth substances|mesh-ancestor
82936850|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
82936851|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936852|NCT01108393|Agomelatine|agomelatine|mesh-list
82936853|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82936854|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936855|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936856|NCT01113229|Misoprostol|misoprostol|mesh-list
82936857|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82936858|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
82936859|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82936860|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936861|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82936862|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82936863|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
82936864|NCT03530176|Listerine|listerine|mesh-list
82936865|NCT03530176|Fluorides|fluorides|mesh-list
82936866|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
82936867|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
82936868|NCT03530176|Protective Agents|protective agents|mesh-ancestor
82936869|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936870|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82936871|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936872|NCT03151304|Azacitidine|azacitidine|mesh-list
82936873|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936874|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
82936875|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936876|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936877|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936878|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
82936879|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
82936880|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82936881|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936882|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936883|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
82936884|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82936885|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936886|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936888|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82936889|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82936890|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
82936891|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
82936892|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936893|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936894|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936895|NCT03942991|Mepivacaine|mepivacaine|mesh-list
82936897|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936898|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
82936899|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936900|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936901|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
82936902|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936903|NCT00162292|Methotrexate|methotrexate|mesh-list
82936904|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82936905|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
82936906|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82936907|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936908|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936909|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
82936910|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936911|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936912|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
82936913|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936914|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82936915|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936916|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
82936917|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82936918|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82936919|NCT00135382|Efavirenz|efavirenz|mesh-list
82936920|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82936921|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82936922|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936923|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936924|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
82936925|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936926|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82936927|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82936928|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82936929|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82936930|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82936931|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82936932|NCT03531970|Dexamethasone|dexamethasone|mesh-list
82936933|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
82936934|NCT03531970|Lidocaine|lidocaine|mesh-list
82936935|NCT03531970|Epinephrine|epinephrine|mesh-list
82936936|NCT03531970|BB 1101|bb 1101|mesh-list
82936937|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82936938|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
82936939|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
82936940|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936941|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936942|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82936943|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
82936944|NCT03531970|Hormones|hormones|mesh-ancestor
82936945|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82936946|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82936947|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936948|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
82936949|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936950|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936951|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
82936952|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
82936953|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82936954|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
82936955|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82936956|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82936957|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82936958|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82936959|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82936960|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82936961|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
82936962|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82936963|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82936964|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82936965|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82936966|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
82936968|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
82936969|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82936970|NCT05726110|Cytarabine|cytarabine|mesh-list
82936971|NCT05726110|Daunorubicin|daunorubicin|mesh-list
82936972|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
82936973|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
82936974|NCT05726110|Lenograstim|lenograstim|mesh-list
82936975|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82936976|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
82936977|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82936978|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82936979|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
82936980|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82936981|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82936982|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
82936983|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936984|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82936985|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82936986|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82936987|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82936988|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82936989|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82936990|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82936991|NCT01211821|Metoprolol|metoprolol|mesh-list
82936992|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82936993|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82936994|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
82936995|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
82936996|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82936997|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82936998|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82936999|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82937000|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82937001|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
82937002|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937003|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937004|NCT03527836|Lidocaine|lidocaine|mesh-list
82937005|NCT03527836|Bupivacaine|bupivacaine|mesh-list
82937006|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
82937007|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
82937008|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937009|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937010|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
82937011|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937012|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82937013|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82937014|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82937015|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82937016|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937017|NCT05724862|Anesthetics|anesthetics|mesh-list
82937018|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937019|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937020|NCT03940651|Anesthetics|anesthetics|mesh-list
82937021|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
82937022|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937023|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937024|NCT03152552|Empagliflozin|empagliflozin|mesh-list
82937025|NCT03152552|Licogliflozin|licogliflozin|mesh-list
82937026|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82937027|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937028|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82937029|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937030|NCT01211275|Cisplatin|cisplatin|mesh-list
82937031|NCT01211275|Pemetrexed|pemetrexed|mesh-list
82937032|NCT01211275|Axitinib|axitinib|mesh-list
82937033|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937034|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83517255|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
82937035|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937036|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82937037|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82937038|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937039|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82937040|NCT03529084|Gefitinib|gefitinib|mesh-list
82937042|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937043|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937044|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937045|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937046|NCT03942757|Bilirubin|bilirubin|mesh-list
82937047|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
82937048|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937049|NCT03942757|Protective Agents|protective agents|mesh-ancestor
82937050|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937051|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82937052|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937053|NCT01208701|Atorvastatin|atorvastatin|mesh-list
82937054|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82937055|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82937056|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
82937057|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937058|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82937059|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82937060|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937061|NCT03528772|Minoxidil|minoxidil|mesh-list
82937062|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
82937063|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82937064|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
82937065|NCT01316744|Ketamine|ketamine|mesh-list
82937066|NCT01316744|Analgesics|analgesics|mesh-ancestor
82937067|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
82937068|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937069|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937070|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82937071|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82937072|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
82937073|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
82937074|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937075|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82937076|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82937077|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937078|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937079|NCT01213381|Carboplatin|carboplatin|mesh-list
82937080|NCT01213381|Gemcitabine|gemcitabine|mesh-list
82937081|NCT01213381|Iniparib|iniparib|mesh-list
82937082|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937083|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82937084|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
82937085|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937086|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82937087|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937088|NCT01316978|Ibuprofen|ibuprofen|mesh-list
82937089|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82937090|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82937091|NCT01316978|Analgesics|analgesics|mesh-ancestor
82937092|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
82937093|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937094|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937095|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937096|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937097|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82937098|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937099|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937100|NCT01317212|Carboplatin|carboplatin|mesh-list
82937101|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937102|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
82937103|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82937104|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937105|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82937106|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937107|NCT01211509|Montelukast|montelukast|mesh-list
82937108|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82937109|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
82937110|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82937111|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
82937112|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937113|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937114|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82937115|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82937116|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937118|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937119|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937120|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937121|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937122|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
82937123|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82937124|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937125|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937126|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937127|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
82937128|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82937129|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
82937130|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937131|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
82937132|NCT04441528|Protective Agents|protective agents|mesh-ancestor
82937133|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
82937134|NCT01344512|Ceftazidime|ceftazidime|mesh-list
82937135|NCT01344512|Voriconazole|voriconazole|mesh-list
82937136|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82937137|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937138|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82937139|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82937140|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937141|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937142|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937143|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82937144|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82937145|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
82937146|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82937147|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82937148|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
82937149|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937150|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937151|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82937152|NCT05064488|Metformin|metformin|mesh-list
82937153|NCT05064488|Digoxin|digoxin|mesh-list
82937154|NCT05064488|Sumatriptan|sumatriptan|mesh-list
82937155|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82937156|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82937157|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937158|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82937159|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82937160|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
82937161|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937162|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82937163|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82937164|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937165|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82937166|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82937167|NCT05064488|Protective Agents|protective agents|mesh-ancestor
82937168|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82937169|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82937170|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82937171|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
82937172|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937173|NCT01344590|Ethanol|ethanol|mesh-list
82937174|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82937175|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937176|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937177|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937178|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
82937179|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937180|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937181|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937182|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937184|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82937185|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937187|NCT01212133|Hormones|hormones|mesh-ancestor
82937188|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937189|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
82937190|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
82937191|NCT04269356|Antacids|antacids|mesh-ancestor
82937192|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937193|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82937194|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82937195|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
82937196|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937197|NCT01118065|Everolimus|everolimus|mesh-list
82937198|NCT01118065|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82937199|NCT01118065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937200|NCT01118065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937201|NCT01118065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937202|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937203|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
82937204|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937205|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937206|NCT03528616|Propranolol|propranolol|mesh-list
82937207|NCT03528616|Digoxin|digoxin|mesh-list
82937208|NCT03528616|Adenosine|adenosine|mesh-list
82937209|NCT03528616|Amiodarone|amiodarone|mesh-list
82937210|NCT03528616|Flecainide|flecainide|mesh-list
82937211|NCT03528616|Procainamide|procainamide|mesh-list
82937212|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82937213|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82937214|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
82937215|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937216|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937217|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937218|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82937219|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82937220|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
82937221|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82937222|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937223|NCT03528616|Protective Agents|protective agents|mesh-ancestor
82937224|NCT03528616|Analgesics|analgesics|mesh-ancestor
82937225|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
82937226|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937227|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82937228|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
82937229|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
82937230|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82937231|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82937232|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82937233|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82937234|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82937235|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82937236|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82937237|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82937238|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82937239|NCT02529631|Orlistat|orlistat|mesh-list
82937240|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937241|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937242|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82937243|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82937244|NCT04469062|Mirikizumab|mirikizumab|mesh-list
82937245|NCT04469062|Vedolizumab|vedolizumab|mesh-list
82937246|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82937247|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82937248|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82937249|NCT04469062|Analgesics|analgesics|mesh-ancestor
82937250|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
82937251|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937252|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937253|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937254|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937255|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82937256|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
82937257|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82937258|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937259|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
82937260|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82937261|NCT03145766|Antibodies|antibodies|mesh-list
82937262|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
82937263|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937264|NCT01115179|Propofol|propofol|mesh-list
82937265|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82937266|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82937267|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937268|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937269|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82937270|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
82937271|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
82937272|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82937273|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82937274|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82937275|NCT04468438|Estrogens|estrogens|mesh-list
82937276|NCT04468438|Hormones|hormones|mesh-ancestor
82937277|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937278|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937279|NCT04468282|Vigabatrin|vigabatrin|mesh-list
82937280|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
82937281|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937282|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937283|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
82937284|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937285|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937286|NCT01121731|Interferons|interferons|mesh-list
82937287|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
82937288|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937289|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
82937290|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937291|NCT01215799|Bafetinib|bafetinib|mesh-list
82937292|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937293|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937294|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937295|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
82937296|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937297|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937298|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937299|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937300|NCT03527134|Amantadine|amantadine|mesh-list
82937301|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82937302|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82937303|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
82937304|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937305|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
82937306|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937307|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937308|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937309|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82937310|NCT03527134|Analgesics|analgesics|mesh-ancestor
82937311|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
82937312|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937313|NCT01213693|Fluticasone|fluticasone|mesh-list
82937314|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82937315|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937316|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82937317|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
82937318|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937319|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937320|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82937321|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
82937322|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
82937323|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82937324|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82937325|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82937326|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82937327|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
82937328|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937329|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937330|NCT01213849|Fluticasone|fluticasone|mesh-list
82937331|NCT01213849|Xhance|xhance|mesh-list
82937332|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937333|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82937334|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
82937335|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937337|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82937338|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
82937339|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
82937340|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82937341|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
82937342|NCT01121809|Etravirine|etravirine|mesh-list
82937343|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82937344|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82937345|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
82937346|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937347|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82937348|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82937349|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937350|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937351|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82937352|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82937353|NCT03937687|Caffeine|caffeine|mesh-list
82937354|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82937355|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937356|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82937357|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937358|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937359|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82937360|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82937361|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
82937362|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937363|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82937364|NCT05110144|Amitriptyline|amitriptyline|mesh-list
82937365|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82937366|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82937367|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82937368|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937369|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937370|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937371|NCT05110144|Analgesics|analgesics|mesh-ancestor
82937372|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
82937373|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937374|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
82937375|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82937376|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
82937377|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82937378|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82937379|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82937380|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
82937381|NCT01212367|Interferons|interferons|mesh-list
82937382|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
82937383|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
82937384|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
82937385|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937386|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
82937387|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937388|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
82937389|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937390|NCT01216111|Paclitaxel|paclitaxel|mesh-list
82937391|NCT01216111|Docetaxel|docetaxel|mesh-list
82937392|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
82937393|NCT01216111|Fluorouracil|fluorouracil|mesh-list
82937394|NCT01216111|Epirubicin|epirubicin|mesh-list
82937395|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82937396|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937397|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
82937398|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
82937399|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
82937400|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937401|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937402|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
82937403|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937404|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937405|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82937406|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
82937407|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82937408|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
82937409|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82937410|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82937411|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82937412|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82937413|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937415|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
82937416|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82937417|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82937418|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82937419|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937420|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937421|NCT01216345|Gemcitabine|gemcitabine|mesh-list
82937422|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
82937423|NCT01216345|Cetuximab|cetuximab|mesh-list
82937424|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82937425|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
82937426|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937427|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937428|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937429|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
82937430|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
82937431|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
82937432|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82937433|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82937434|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937435|NCT01212523|Propofol|propofol|mesh-list
82937436|NCT01212523|Isoflurane|isoflurane|mesh-list
82937437|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82937438|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937439|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937440|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82937441|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
82937442|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
82937443|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82937444|NCT01122121|Leuprolide|leuprolide|mesh-list
82937445|NCT01122121|Flutamide|flutamide|mesh-list
82937446|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82937447|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
82937448|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82937449|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937450|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82937451|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937452|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
82937453|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
82937454|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937455|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82937456|NCT01115725|Hormones|hormones|mesh-ancestor
83459003|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
82937457|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937458|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937459|NCT01122199|Everolimus|everolimus|mesh-list
82937460|NCT01122199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82937461|NCT01122199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937462|NCT01122199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937463|NCT01122199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937464|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937465|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
82937466|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937467|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937468|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
82937469|NCT01118923|Antacids|antacids|mesh-ancestor
82937470|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937471|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82937472|NCT01119079|Anesthetics|anesthetics|mesh-list
82937473|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937474|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937475|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
82937476|NCT04503616|Abatacept|abatacept|mesh-list
82937477|NCT04503616|Tacrolimus|tacrolimus|mesh-list
82937478|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937479|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
82937480|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937481|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937482|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82937483|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
82937484|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937485|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937486|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82937487|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82937488|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937489|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82937490|NCT04503616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937492|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
82937493|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937494|NCT01120015|Diacerein|diacerein|mesh-list
82937495|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937496|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
82937497|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
82937498|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937499|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937500|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
82937501|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
82937502|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937503|NCT01216579|Mannitol|mannitol|mesh-list
82937504|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82937505|NCT01216579|Diuretics|diuretics|mesh-ancestor
82937506|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
82937507|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937508|NCT03528070|Tranilast|tranilast|mesh-list
82937509|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82937510|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82937511|NCT03528070|Analgesics|analgesics|mesh-ancestor
82937512|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
82937513|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937514|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937515|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937516|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937517|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82937518|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82937519|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937520|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82937521|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82937522|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
82937523|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
82937524|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937525|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82937526|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82937527|NCT03935815|Ropivacaine|ropivacaine|mesh-list
82937528|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
82937529|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
82937530|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937531|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937532|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
82937533|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937534|NCT01216657|Sunitinib|sunitinib|mesh-list
82937535|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937536|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82937537|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82937538|NCT01216657|Growth Substances|growth substances|mesh-ancestor
82937539|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937540|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
82937541|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937542|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937543|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937544|NCT04400188|Temozolomide|temozolomide|mesh-list
82937545|NCT04400188|Fluzoparib|fluzoparib|mesh-list
82937546|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82937547|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
82937548|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937549|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937550|NCT04400188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82937551|NCT04400188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937552|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82937553|NCT04163458|Menotropins|menotropins|mesh-list
82937554|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82937555|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
82937556|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82937557|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937558|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
82937560|NCT04902040|Atezolizumab|atezolizumab|mesh-list
82937562|NCT04902040|Avelumab|avelumab|mesh-list
82937563|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
82937564|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82937565|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
82937566|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937567|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937568|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82937569|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937570|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
82937571|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937572|NCT01115959|Valproic Acid|valproic acid|mesh-list
82937573|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
82937574|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937575|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937576|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
82937577|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937578|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937579|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
82937580|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82937581|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937582|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82937583|NCT03936907|Nabiximols|nabiximols|mesh-list
82937584|NCT03936907|Analgesics|analgesics|mesh-ancestor
82937585|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
82937586|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937587|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937588|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
82937589|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937590|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937591|NCT01217203|Lenalidomide|lenalidomide|mesh-list
82937592|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
82937593|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937594|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82937595|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82937596|NCT01217203|Growth Substances|growth substances|mesh-ancestor
82937597|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
82937598|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937599|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
82937600|NCT01120171|Doxorubicin|doxorubicin|mesh-list
82937601|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82937602|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937603|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
82937604|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937605|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937606|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82937607|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
82937608|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937609|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937610|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82937611|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82937612|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82937613|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82937614|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937615|NCT01116193|Dexamethasone|dexamethasone|mesh-list
82937616|NCT01116193|Lenalidomide|lenalidomide|mesh-list
82937617|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937618|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
82937619|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
82937620|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937621|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937622|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82937623|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
82937624|NCT01116193|Hormones|hormones|mesh-ancestor
82937625|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937626|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82937627|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937628|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
82937629|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82937630|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82937631|NCT01116193|Growth Substances|growth substances|mesh-ancestor
82937632|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
82937633|NCT01120327|Amlodipine|amlodipine|mesh-list
82937634|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82937635|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82937636|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82937637|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937638|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82937639|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937640|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
82937641|NCT01116271|Irinotecan|irinotecan|mesh-list
82937642|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82937643|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82937644|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937645|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937646|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937647|NCT01217359|Interferons|interferons|mesh-list
82937648|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
82937649|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
82937650|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937651|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
82937652|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937653|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
82937654|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937655|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
82937656|NCT03225664|Trametinib|trametinib|mesh-list
82937657|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937658|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937659|NCT03225664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82937660|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937661|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937662|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937663|NCT01212679|Mitogens|mitogens|mesh-list
82937664|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
82937665|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937666|NCT03193684|Empagliflozin|empagliflozin|mesh-list
82937667|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82937668|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937669|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82937670|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937671|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
82937672|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82937673|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937674|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937675|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82937676|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82937677|NCT04339270|Azithromycin|azithromycin|mesh-list
82937678|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82937679|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937680|NCT01116583|Gabapentin|gabapentin|mesh-list
82937681|NCT01116583|Analgesics|analgesics|mesh-ancestor
82937682|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
82937683|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937684|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937685|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
82937686|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82937687|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82937688|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937689|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82937690|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82937691|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82937692|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937693|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937694|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
82937695|NCT04299490|Analgesics|analgesics|mesh-list
82937696|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937697|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
82937698|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937699|NCT03935347|Vidarabine|vidarabine|mesh-list
82937700|NCT03935347|Aldesleukin|aldesleukin|mesh-list
82937701|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
82937702|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
82937703|NCT03935347|Fludarabine|fludarabine|mesh-list
82937704|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
82937705|NCT03935347|Interleukin-2|interleukin-2|mesh-list
82937706|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
82937707|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
82937708|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937709|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
82937710|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937712|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82937713|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
82937714|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937715|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937716|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82937717|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937718|NCT03935347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82937719|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82937720|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
82937721|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
82937722|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83459035|NCT01167829|Testosterone|testosterone|mesh-list
82937723|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82937724|NCT03935347|Analgesics|analgesics|mesh-ancestor
82937725|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
82937726|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937727|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82937728|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82937729|NCT04467346|Temozolomide|temozolomide|mesh-list
82937730|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82937731|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
82937732|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937733|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937734|NCT03939871|Vinorelbine|vinorelbine|mesh-list
82937735|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82937736|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937737|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
82937738|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
82937739|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
82937740|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937741|NCT01122667|Anacetrapib|anacetrapib|mesh-list
82937742|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82937743|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82937744|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
82937745|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937746|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82937747|NCT01120561|Trastuzumab|trastuzumab|mesh-list
82937748|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82937749|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937750|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937751|NCT01120561|Immunotoxins|immunotoxins|mesh-ancestor
82937752|NCT01120561|Immunoconjugates|immunoconjugates|mesh-ancestor
82937753|NCT01120561|Immunologic Factors|immunologic factors|mesh-ancestor
82937754|NCT01120561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937755|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
82937756|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
82937757|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
82937758|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937759|NCT01217125|Sirolimus|sirolimus|mesh-list
82937760|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82937761|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937762|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82937763|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937764|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
82937765|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937766|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
82937767|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937768|NCT03936517|Prednisolone|prednisolone|mesh-list
82937769|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
82937770|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937771|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
82937772|NCT03936517|Hormones|hormones|mesh-ancestor
82937773|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937774|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937775|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82937776|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937777|NCT03635372|Sucralfate|sucralfate|mesh-list
82937778|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
82937779|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82937780|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82937781|NCT03635372|Antacids|antacids|mesh-ancestor
82937782|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937783|NCT01116817|Ritonavir|ritonavir|mesh-list
82937784|NCT01116817|Lopinavir|lopinavir|mesh-list
82937785|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82937787|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
82937788|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937789|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937790|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82937791|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82937792|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
82937793|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937794|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82937795|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82937796|NCT01120795|Interferons|interferons|mesh-list
82937797|NCT01120795|Ribavirin|ribavirin|mesh-list
82937798|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82937799|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
82937800|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937801|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
82937802|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937803|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
82937804|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937805|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
82937806|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937807|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
82937808|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82937809|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82937810|NCT04467892|Prednisolone|prednisolone|mesh-list
82937811|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
82937812|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82937813|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
82937814|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937815|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
82937816|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
82937817|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937818|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937819|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82937820|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
82937821|NCT04467892|Hormones|hormones|mesh-ancestor
82937822|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937823|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82937824|NCT04467892|Protective Agents|protective agents|mesh-ancestor
82937825|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82937826|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937827|NCT01122979|Insulin|insulin|mesh-list
82937828|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82937829|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
82937830|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
82937831|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
82937832|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
82937833|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
82937834|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82937835|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937836|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
82937837|NCT04179110|Ramucirumab|ramucirumab|mesh-list
82937838|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937839|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937840|NCT04179110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82937841|NCT04179110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937842|NCT01123057|Riboflavin|riboflavin|mesh-list
82937843|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
82937844|NCT01123057|Vitamins|vitamins|mesh-ancestor
82937845|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
82937846|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937847|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82937848|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
82937849|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
82937850|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82937851|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937852|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937853|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82937854|NCT03524950|Analgesics|analgesics|mesh-ancestor
82937855|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
82937856|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937857|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82937858|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82937859|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82937860|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
82937861|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937862|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937863|NCT04714190|Paclitaxel|paclitaxel|mesh-list
82937864|NCT04714190|Irinotecan|irinotecan|mesh-list
82937865|NCT04714190|Apatinib|apatinib|mesh-list
82937866|NCT04714190|Trastuzumab|trastuzumab|mesh-list
82937867|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82937868|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937869|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
82937870|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
82937871|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
82937872|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937873|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82937874|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82937875|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937876|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937877|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937878|NCT03524872|Analgesics|analgesics|mesh-list
82937879|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937880|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
82937881|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937882|NCT04143724|Luspatercept|luspatercept|mesh-list
82937883|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82937884|NCT04143724|Hematinics|hematinics|mesh-ancestor
82937885|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
82937886|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937887|NCT01345370|Temozolomide|temozolomide|mesh-list
82937888|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82937889|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
82937890|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937891|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937892|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
82937893|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82937894|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
82937895|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937896|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
82937897|NCT04702802|Protective Agents|protective agents|mesh-ancestor
82937898|NCT01214941|Itraconazole|itraconazole|mesh-list
82937899|NCT01214941|Ticlopidine|ticlopidine|mesh-list
82937900|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
82937901|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937902|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82937903|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82937904|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937905|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937906|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82937907|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
83459055|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82937908|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937909|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937910|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82937911|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82937912|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82937913|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82937914|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82937915|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82937916|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82937917|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
82937918|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937919|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82937920|NCT05301634|Bupivacaine|bupivacaine|mesh-list
82937921|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
82937922|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
82937923|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82937924|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937925|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
82937926|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82937927|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
82937928|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82937929|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937930|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937931|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82937932|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82937933|NCT01328821|Protective Agents|protective agents|mesh-ancestor
82937934|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937935|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
82937936|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82937937|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
82937938|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
82937939|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82937940|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937941|NCT04082572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82937942|NCT04082572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937943|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82937944|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82937945|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82937946|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82937947|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82937948|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
82937949|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937950|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937951|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937952|NCT04072822|Prednisone|prednisone|mesh-list
82937953|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82937954|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937955|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
82937956|NCT04072822|Hormones|hormones|mesh-ancestor
82937957|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937958|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937959|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82937960|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937961|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82937962|NCT04001894|Clopidogrel|clopidogrel|mesh-list
82937963|NCT04001894|Ticagrelor|ticagrelor|mesh-list
82937964|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82937965|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82937966|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82937967|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82937968|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
82937969|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82937970|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937971|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937972|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
82937973|NCT04066114|Prednisone|prednisone|mesh-list
82937974|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
82937975|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82937976|NCT04066114|Everolimus|everolimus|mesh-list
82937977|NCT04066114|Abatacept|abatacept|mesh-list
82937978|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
82937979|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82937980|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82937981|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
82937982|NCT04066114|Hormones|hormones|mesh-ancestor
82937983|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82937984|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82937985|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82937986|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82937987|NCT04066114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82937988|NCT04066114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82937989|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82937990|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82937991|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82937992|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
82937993|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82937994|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82937995|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
82937996|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82937997|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82937998|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
82937999|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
82938000|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938001|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82938002|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82938003|NCT04066114|Protective Agents|protective agents|mesh-ancestor
82938004|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82938005|NCT04066114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938006|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82938007|NCT01212913|Insulin|insulin|mesh-list
82938009|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
82938010|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
82938011|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
82938012|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82938013|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938014|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938016|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
82938017|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
82938018|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938019|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938020|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
82938021|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938022|NCT01218217|Rifampin|rifampin|mesh-list
82938023|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82938024|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
82938025|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82938026|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938027|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
82938028|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82938029|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938030|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938031|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82938032|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82938033|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82938034|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82938035|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82938036|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82938037|NCT03522532|Zinc|zinc|mesh-list
82938038|NCT03522532|Trace Elements|trace elements|mesh-ancestor
82938039|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
82938040|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938041|NCT01215019|Mannitol|mannitol|mesh-list
82938042|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82938043|NCT01215019|Diuretics|diuretics|mesh-ancestor
82938044|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
82938045|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938046|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
82938047|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
82938048|NCT01215331|Insulin|insulin|mesh-list
82938049|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82938050|NCT01215331|Metformin|metformin|mesh-list
82938051|NCT01215331|Glyburide|glyburide|mesh-list
82938052|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938053|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938054|NCT03526276|Fluorides|fluorides|mesh-list
82938055|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
82938056|NCT03526276|Protective Agents|protective agents|mesh-ancestor
82938057|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938058|NCT04466254|Cetuximab|cetuximab|mesh-list
82938059|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938060|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938061|NCT04466176|Fluticasone|fluticasone|mesh-list
82938062|NCT04466176|Xhance|xhance|mesh-list
82938063|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82938064|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82938065|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938066|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82938067|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
82938068|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938069|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938070|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82938071|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
82938072|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
82938073|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82938074|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82938075|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82938076|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82938077|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
82938078|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938079|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938080|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
82938081|NCT04466176|Hormones|hormones|mesh-ancestor
82938082|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938083|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
82938085|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938086|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
82938087|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
82938088|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
82776449|NCT01323712|Vitamin D|vitamin d|mesh-list
82938089|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938090|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82938091|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
82938092|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82938093|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82938094|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938095|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938096|NCT01215409|Urological Agents|urological agents|mesh-ancestor
82938097|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
82938098|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82938099|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938100|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938101|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82938102|NCT03936205|Analgesics|analgesics|mesh-ancestor
82938103|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
82938104|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938105|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82938106|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82938107|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82938108|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
82938109|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938110|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938111|NCT03936049|Liraglutide|liraglutide|mesh-list
82938112|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82938113|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938114|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938115|NCT03936049|Incretins|incretins|mesh-ancestor
82938116|NCT03936049|Hormones|hormones|mesh-ancestor
82938117|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938118|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
82938119|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938120|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938121|NCT04674020|Erenumab|erenumab|mesh-list
82938122|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82938123|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938124|NCT04674020|Analgesics|analgesics|mesh-ancestor
82938125|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
82938126|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938127|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938128|NCT01123525|Adenosine|adenosine|mesh-list
82938129|NCT01123525|Analgesics|analgesics|mesh-ancestor
82938130|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
82938131|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938132|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938133|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82938134|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
82938135|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82938136|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
82938137|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
82938138|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938139|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938140|NCT01215565|Sunitinib|sunitinib|mesh-list
82938141|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938142|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82938143|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82938144|NCT01215565|Growth Substances|growth substances|mesh-ancestor
82938145|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938146|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
82938147|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82938148|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938149|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938150|NCT01121497|Physostigmine|physostigmine|mesh-list
82938151|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82938152|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938153|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938154|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
82938156|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938157|NCT01121497|Miotics|miotics|mesh-ancestor
82938158|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
82938159|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938160|NCT01213147|Clomiphene|clomiphene|mesh-list
82938161|NCT01213147|Enclomiphene|enclomiphene|mesh-list
82938162|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
82938163|NCT01213147|Buserelin|buserelin|mesh-list
82938164|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82938165|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
82938166|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938167|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938168|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82938169|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
82938170|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938171|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82938172|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82938173|NCT03143816|Insulin|insulin|mesh-list
82938174|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938175|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938176|NCT01117129|Rituximab|rituximab|mesh-list
82938177|NCT01117129|Methotrexate|methotrexate|mesh-list
82938178|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938179|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938180|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
82938181|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938182|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82938183|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82938184|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
82938185|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938186|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82938187|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
82938188|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938189|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
82938190|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938191|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82938192|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82938193|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82938194|NCT03133988|Margetuximab|margetuximab|mesh-list
82938195|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938196|NCT03934411|Tramadol|tramadol|mesh-list
82938197|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82938198|NCT03934411|Narcotics|narcotics|mesh-ancestor
82938199|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938200|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938201|NCT03934411|Analgesics|analgesics|mesh-ancestor
82938202|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
82938203|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938204|NCT01218451|Vaccines|vaccines|mesh-list
82938205|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
82938206|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938207|NCT01346930|Macitentan|macitentan|mesh-list
82938208|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82938209|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82938210|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938211|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82938212|NCT01219153|Letrozole|letrozole|mesh-list
82938213|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
82938214|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82938215|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938216|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82938217|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82938218|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938219|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938220|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82938221|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
82938222|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938223|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938224|NCT01219153|Hormones|hormones|mesh-ancestor
82938225|NCT03526042|Losartan|losartan|mesh-list
82938226|NCT03526042|Enalapril|enalapril|mesh-list
82938227|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82938228|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82938229|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82938230|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82938231|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82938232|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82938233|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938234|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
82938235|NCT01124539|Camptothecin|camptothecin|mesh-list
82938236|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
82938237|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82938238|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938239|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82938240|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82938241|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938242|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938243|NCT03781375|Etanercept|etanercept|mesh-list
82938244|NCT03781375|Methotrexate|methotrexate|mesh-list
82938245|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82938246|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
82938247|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938248|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938249|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82938250|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
82938251|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938252|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938253|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
82938254|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938255|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82938256|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82938257|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
82938258|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82938259|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82938260|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82938261|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82938262|NCT03781375|Analgesics|analgesics|mesh-ancestor
82938263|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
82938264|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938265|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938266|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82938267|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82938268|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82938269|NCT01123915|Protective Agents|protective agents|mesh-ancestor
82938270|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938271|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82938272|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
82938273|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938274|NCT01218529|Lapatinib|lapatinib|mesh-list
82938275|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938276|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82938277|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938278|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938279|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82938280|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938281|NCT01218607|Bosentan|bosentan|mesh-list
82938282|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82938283|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82938284|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938285|NCT03933787|Saxagliptin|saxagliptin|mesh-list
82938286|NCT03933787|Incretins|incretins|mesh-ancestor
82938287|NCT03933787|Hormones|hormones|mesh-ancestor
82938288|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938289|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938290|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82938291|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
82938292|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938293|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938294|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938295|NCT03934333|Budesonide|budesonide|mesh-list
82938296|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938297|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82938298|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
82938299|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938300|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938301|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82938302|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
82938303|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
82938304|NCT03934333|Hormones|hormones|mesh-ancestor
82938305|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938306|NCT01124227|Icodextrin|icodextrin|mesh-list
82938307|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
82938308|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82938309|NCT03931915|Leuprolide|leuprolide|mesh-list
82938310|NCT03931915|Relugolix|relugolix|mesh-list
82938311|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82938312|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
82938313|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938314|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938315|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938316|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938317|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
82938318|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
82938319|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938320|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
82938321|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82938322|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938323|NCT01124383|Lidocaine|lidocaine|mesh-list
82938324|NCT01124383|Ephedrine|ephedrine|mesh-list
82938325|NCT01124383|Midazolam|midazolam|mesh-list
82938326|NCT01124383|Sufentanil|sufentanil|mesh-list
82938327|NCT01124383|Dsuvia|dsuvia|mesh-list
82938328|NCT01124383|Anesthetics|anesthetics|mesh-list
82938329|NCT01124383|Propofol|propofol|mesh-list
82938330|NCT01124383|Sevoflurane|sevoflurane|mesh-list
82938331|NCT01124383|Rocuronium|rocuronium|mesh-list
82938332|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
82938333|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938334|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938335|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
82938336|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938337|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82938338|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82938339|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82938340|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82938341|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938342|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82938343|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82938344|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
82938345|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82938346|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82938347|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82938348|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82938349|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
82938350|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
82938351|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938352|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82938353|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82938354|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82938355|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82938356|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82938357|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82938358|NCT01124383|Narcotics|narcotics|mesh-ancestor
82938359|NCT01124383|Analgesics|analgesics|mesh-ancestor
82938360|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82938361|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
82938362|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
82938363|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82938364|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
82938365|NCT01226017|Oxytocin|oxytocin|mesh-list
82938366|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
82938367|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938368|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938369|NCT01222819|Lenograstim|lenograstim|mesh-list
82938370|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82938371|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
82938372|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938373|NCT01222897|Valacyclovir|valacyclovir|mesh-list
82938374|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
82938375|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938376|NCT03150056|Prednisone|prednisone|mesh-list
82938377|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938378|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
82938379|NCT03150056|Hormones|hormones|mesh-ancestor
82938380|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938381|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938382|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938383|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938384|NCT01329367|Antioxidants|antioxidants|mesh-list
82938385|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938386|NCT01329367|Protective Agents|protective agents|mesh-ancestor
82938387|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938388|NCT01222975|Risperidone|risperidone|mesh-list
82938389|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82938390|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
82938391|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938392|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938393|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938394|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82938395|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82938396|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938397|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82938398|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82938399|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
82938400|NCT01129063|Clopidogrel|clopidogrel|mesh-list
82938401|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82938402|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82938403|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82938404|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82938405|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
82938406|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938407|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938408|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938409|NCT01317368|Ropivacaine|ropivacaine|mesh-list
82938410|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
82938411|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
82938412|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938413|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938414|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
82938415|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938416|NCT01219699|Fulvestrant|fulvestrant|mesh-list
82938417|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938418|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938419|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82938420|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82938421|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
82938422|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938423|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938424|NCT03933319|Doxorubicin|doxorubicin|mesh-list
82938425|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82938426|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82938427|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938428|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82938429|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82938430|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938431|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938432|NCT01223053|Ketoprofen|ketoprofen|mesh-list
82938433|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82938434|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82938435|NCT01223053|Analgesics|analgesics|mesh-ancestor
82938436|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
82938437|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938438|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938439|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938440|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82938441|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82938442|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83459133|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
82938443|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938444|NCT01223131|Insulin|insulin|mesh-list
82938445|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82938446|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
82938447|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
82938448|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
82938449|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
82938450|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938451|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938452|NCT01125553|Insulin|insulin|mesh-list
82938453|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
82938454|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938455|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938456|NCT02640664|Ranibizumab|ranibizumab|mesh-list
82938457|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82938458|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82938459|NCT02640664|Growth Substances|growth substances|mesh-ancestor
82938460|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938461|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
82938462|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938463|NCT01317446|Fluorides|fluorides|mesh-list
82938464|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
82938465|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
82938466|NCT01317446|Protective Agents|protective agents|mesh-ancestor
82938467|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938468|NCT02529241|Delpazolid|delpazolid|mesh-list
82938469|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
82938470|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82938471|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938472|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82938473|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938474|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938475|NCT02456012|Esomeprazole|esomeprazole|mesh-list
82938476|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82938477|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82938478|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82938479|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938480|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938481|NCT00812006|Rizatriptan|rizatriptan|mesh-list
82938482|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82938483|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
82938484|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938485|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938486|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938487|NCT03133234|Osimertinib|osimertinib|mesh-list
82938488|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938489|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82938490|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938491|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938492|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82938493|NCT01125787|Ofatumumab|ofatumumab|mesh-list
82938494|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82938495|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82938496|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
82938497|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938498|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938499|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
82938500|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938501|NCT02457442|Remifentanil|remifentanil|mesh-list
82938502|NCT02457442|Propofol|propofol|mesh-list
82938503|NCT02457442|Sevoflurane|sevoflurane|mesh-list
82938504|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82938505|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938506|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938507|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82938508|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
82938509|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
82938510|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82938511|NCT02457442|Narcotics|narcotics|mesh-ancestor
82938512|NCT02457442|Analgesics|analgesics|mesh-ancestor
82938513|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
82938514|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938515|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82938516|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82938517|NCT03132038|Nivolumab|nivolumab|mesh-list
82938518|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938519|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938520|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82938521|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938522|NCT01129375|Omeprazole|omeprazole|mesh-list
82938523|NCT01129375|Clopidogrel|clopidogrel|mesh-list
82938524|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82938525|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82938526|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82938527|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82938528|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
82938529|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938530|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938531|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938532|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82938533|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82938534|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82938535|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938536|NCT01352702|Dabigatran|dabigatran|mesh-list
82938537|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
82938538|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
82938539|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82938540|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
82938541|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938542|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938543|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
82938544|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
82938545|NCT03525730|Valproic Acid|valproic acid|mesh-list
82938546|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
82938547|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82938548|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82938549|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938550|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82938551|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938552|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938553|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
82938554|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
82938555|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938556|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938557|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
82938558|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82938559|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938560|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82938561|NCT01223443|Paclitaxel|paclitaxel|mesh-list
82938562|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82938563|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938564|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
82938565|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
82938566|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
82938567|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938568|NCT03525652|Vaccines|vaccines|mesh-list
82938569|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
82938570|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938571|NCT02290054|Anesthetics|anesthetics|mesh-list
82938572|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938573|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938574|NCT01347944|Lenalidomide|lenalidomide|mesh-list
82938575|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
82938576|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938577|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82938578|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82938579|NCT01347944|Growth Substances|growth substances|mesh-ancestor
82938580|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
82938581|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938582|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
82938583|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
82938584|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938585|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82938586|NCT01220245|Heparin|heparin|mesh-list
82938587|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
82938588|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82938589|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82938590|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938591|NCT03931135|Dexamethasone|dexamethasone|mesh-list
82938592|NCT03931135|Morphine|morphine|mesh-list
82938593|NCT03931135|Cyclizine|cyclizine|mesh-list
82938594|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938595|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
82938596|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
82938597|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938598|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938599|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82938600|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
82938601|NCT03931135|Hormones|hormones|mesh-ancestor
82938602|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938603|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938604|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938605|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82938606|NCT03931135|Narcotics|narcotics|mesh-ancestor
82938607|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938608|NCT03931135|Analgesics|analgesics|mesh-ancestor
82938609|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
82938610|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82938611|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
82938612|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
82938613|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938614|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938615|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
82938616|NCT01353170|Calcium|calcium|mesh-list
82938617|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82938618|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938619|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82938620|NCT03620318|Crenolanib|crenolanib|mesh-list
82938621|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938622|NCT01125943|Bevacizumab|bevacizumab|mesh-list
82938623|NCT01125943|Nitroprusside|nitroprusside|mesh-list
82938624|NCT01125943|Acetylcholine|acetylcholine|mesh-list
82938625|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938626|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938627|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82938628|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82938629|NCT01125943|Growth Substances|growth substances|mesh-ancestor
82938630|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938631|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
82938632|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82938633|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
82938634|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82938635|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938636|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82938637|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
82938638|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938639|NCT01223755|Sirolimus|sirolimus|mesh-list
82938640|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82938641|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938642|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82938643|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938644|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
82938645|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82938646|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
82938647|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938648|NCT01126177|Interferons|interferons|mesh-list
82938649|NCT01126177|Interferon-beta|interferon-beta|mesh-list
82938650|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
82938651|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938652|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
82938653|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938654|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
82938655|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938656|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82938657|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
82938658|NCT03680092|Methotrexate|methotrexate|mesh-list
82938659|NCT03680092|Abatacept|abatacept|mesh-list
82938660|NCT03680092|Tacrolimus|tacrolimus|mesh-list
82938661|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82938662|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
82938663|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938664|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82938665|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82938666|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
82938667|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938668|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938669|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82938670|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82938671|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
82938672|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938673|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82938674|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
82938675|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
82938676|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938677|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82938678|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82938679|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82938680|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82938681|NCT03680092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938683|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938684|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
82938685|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
82938686|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
82938687|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938688|NCT05790070|Betaine|betaine|mesh-list
82938689|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82938690|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
82938691|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82938692|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
82938693|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938694|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82938695|NCT05790044|Clonidine|clonidine|mesh-list
82938696|NCT05790044|Bupivacaine|bupivacaine|mesh-list
82938697|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
82938698|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
82938699|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938700|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938701|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
82938702|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938703|NCT05790044|Analgesics|analgesics|mesh-ancestor
82938704|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82938705|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
82938706|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
82938707|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82938708|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82938709|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82938710|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
82938711|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938712|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938713|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
82938714|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82938715|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938716|NCT05789667|Lenvatinib|lenvatinib|mesh-list
82938717|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938718|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82938719|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938720|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938721|NCT05789537|Protein C|protein c|mesh-list
82938722|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
82938723|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82938724|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83459164|NCT01126099|Prazosin|prazosin|mesh-list
82938725|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938726|NCT05789524|Protein C|protein c|mesh-list
82938727|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
82938728|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82938729|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82938730|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938731|NCT05789342|Itraconazole|itraconazole|mesh-list
82938732|NCT05789342|Oseltamivir|oseltamivir|mesh-list
82938733|NCT05789342|Digoxin|digoxin|mesh-list
82938734|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82938735|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82938736|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82938737|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
82938738|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938739|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82938740|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82938741|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938742|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
82938743|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938744|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82938745|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82938746|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82938747|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
82938748|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938749|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938750|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82938751|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82938752|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82938753|NCT05789342|Protective Agents|protective agents|mesh-ancestor
82938754|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
82938755|NCT05789186|Fluoxetine|fluoxetine|mesh-list
82938756|NCT05789186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82938757|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82938759|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938760|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938761|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
82938762|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83517409|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
82938763|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82938764|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
82938765|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82938766|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82938767|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82938768|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938769|NCT05789043|Apatinib|apatinib|mesh-list
82938770|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938771|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82938772|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938773|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938774|NCT05789030|Prednisone|prednisone|mesh-list
82938775|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
82938776|NCT05789030|Betamethasone|betamethasone|mesh-list
82938777|NCT05789030|Leflunomide|leflunomide|mesh-list
82938778|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938779|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
82938780|NCT05789030|Hormones|hormones|mesh-ancestor
82938781|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938782|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938783|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938784|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938785|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938786|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938787|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82938788|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
82938789|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82938790|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
82938791|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
82938792|NCT05789017|Prednisone|prednisone|mesh-list
82938793|NCT05789017|Leflunomide|leflunomide|mesh-list
82938794|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938795|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
82938796|NCT05789017|Hormones|hormones|mesh-ancestor
82938797|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938798|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938799|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938800|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938801|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82938802|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82938803|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
82938804|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82938805|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938806|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938807|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938808|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82938809|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
82938810|NCT05788991|Metronidazole|metronidazole|mesh-list
82938811|NCT05788991|Dequalinium|dequalinium|mesh-list
82938812|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938813|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82938814|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82938815|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82938816|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82938817|NCT05788913|Heparin|heparin|mesh-list
82938818|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
82938819|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82938820|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82938821|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938822|NCT05788900|Heparin|heparin|mesh-list
82938823|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
82938824|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82938825|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82938826|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938827|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
82938828|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82938830|NCT05788835|Hormones|hormones|mesh-ancestor
82938831|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938832|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938833|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938834|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938835|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
82938836|NCT05788705|Boswellic acid|boswellic acid|mesh-list
82938837|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82938838|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82938839|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82938840|NCT05788705|Analgesics|analgesics|mesh-ancestor
82938841|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
82938842|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938843|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938844|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82938845|NCT05788679|Azacitidine|azacitidine|mesh-list
82938846|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82938847|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
82938848|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938849|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938850|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938851|NCT05770544|Entrectinib|entrectinib|mesh-list
82938852|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82938853|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938854|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938855|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82938856|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
82938857|NCT05767086|Cetrorelix|cetrorelix|mesh-list
82938858|NCT05767086|Hormones|hormones|mesh-list
82938859|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
82938860|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
82938861|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938862|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938863|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82938864|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82938865|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82938866|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
82938867|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938868|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82938869|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82938870|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82938871|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938872|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938873|NCT05767086|Progestins|progestins|mesh-ancestor
82938874|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82938875|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
82938876|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
82938877|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82938878|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938879|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
82938880|NCT05732077|Dopamine|dopamine|mesh-list
82938881|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82938882|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
82938883|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
82938884|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938885|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938886|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
82938887|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938888|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938889|NCT05732077|Protective Agents|protective agents|mesh-ancestor
82938890|NCT05722886|Trastuzumab|trastuzumab|mesh-list
82938891|NCT05722886|Atezolizumab|atezolizumab|mesh-list
82938892|NCT05722886|Pertuzumab|pertuzumab|mesh-list
82938893|NCT05722886|Vemurafenib|vemurafenib|mesh-list
82938894|NCT05722886|Entrectinib|entrectinib|mesh-list
82938895|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938896|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938897|NCT05722886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82938898|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938899|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82938900|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82938901|NCT05702905|Metformin|metformin|mesh-list
82938902|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82938903|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938904|NCT05697471|Dienogest|dienogest|mesh-list
82938905|NCT05697471|Danazol|danazol|mesh-list
82938906|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82938907|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
82938908|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82938909|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938910|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82938911|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82938912|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83517563|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82938913|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82938914|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
82938915|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82938916|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82938917|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938918|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82938920|NCT05670561|Esketamine|esketamine|mesh-list
82938921|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82938922|NCT05670561|Narcotics|narcotics|mesh-ancestor
82938923|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82938924|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938925|NCT05670561|Analgesics|analgesics|mesh-ancestor
82938926|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
82938927|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938928|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82938929|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82938930|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
82938931|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
82938932|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
82938933|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82938934|NCT05635877|Esmolol|esmolol|mesh-list
82938935|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82938936|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82938937|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82938938|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
82938939|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938940|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938941|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938942|NCT05630183|Paclitaxel|paclitaxel|mesh-list
82938943|NCT05630183|Gemcitabine|gemcitabine|mesh-list
82938944|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82938945|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938946|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
82938947|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
82938948|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
82938949|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938950|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82938951|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
82938952|NCT05629546|Nivolumab|nivolumab|mesh-list
82938953|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82938954|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938955|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82938956|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938957|NCT05603702|Lacosamide|lacosamide|mesh-list
82938958|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
82938959|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82938960|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82938961|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82938962|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938963|NCT05596006|Domperidone|domperidone|mesh-list
82938964|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
82938965|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
82938966|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82938967|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938968|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82938969|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82938970|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
82938971|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82938972|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938973|NCT05587374|Gemcitabine|gemcitabine|mesh-list
82938974|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82938975|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938976|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82938977|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
82938978|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82938979|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
82938980|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938981|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
82938982|NCT05586529|Vitamin D|vitamin d|mesh-list
82938983|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82938984|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82938985|NCT05586529|Vitamins|vitamins|mesh-ancestor
82938986|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
82938987|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82938989|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82938990|NCT05555303|Amikacin|amikacin|mesh-list
82938991|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82938992|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82938993|NCT05549752|Amiodarone|amiodarone|mesh-list
82938994|NCT05549752|Flecainide|flecainide|mesh-list
82938995|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82938996|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82938997|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
82938998|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82938999|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82939000|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939001|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82939002|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82939003|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82939004|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939005|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82939006|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82939007|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82939008|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82939009|NCT05538091|Atezolizumab|atezolizumab|mesh-list
82939010|NCT05538091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939011|NCT05538091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939012|NCT05538091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939013|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939014|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
82939015|NCT05524935|Olaparib|olaparib|mesh-list
82939016|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939017|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939018|NCT05524935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939019|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939020|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82939021|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939022|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
82939023|NCT05515029|Abatacept|abatacept|mesh-list
82939024|NCT05515029|Vedolizumab|vedolizumab|mesh-list
82939025|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82939026|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939027|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
82939028|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939029|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939030|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82939031|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
82939032|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939033|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939034|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82939035|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939036|NCT05515029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939037|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82939038|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939039|NCT05499832|Tenecteplase|tenecteplase|mesh-list
82939040|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82939041|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82939042|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939043|NCT05487755|Tadalafil|tadalafil|mesh-list
82939044|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
82939045|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
82939046|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82939047|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82939048|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939049|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939051|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82939052|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82939053|NCT05487755|Protective Agents|protective agents|mesh-ancestor
82939054|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939055|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82939056|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
82939057|NCT05461755|Tretinoin|tretinoin|mesh-list
82939058|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939059|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
82939060|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
82939061|NCT05461456|Fexofenadine|fexofenadine|mesh-list
82939062|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82939063|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82939064|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82939065|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
82939066|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
82939067|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939068|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939069|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939070|NCT05441930|Levofloxacin|levofloxacin|mesh-list
82939071|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82939072|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939073|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82939074|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82939075|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82939076|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939077|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939078|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939079|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82939080|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82939081|NCT05394727|Insulin|insulin|mesh-list
82939082|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82939083|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82939084|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939085|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
82939086|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82939087|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939088|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82939089|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939090|NCT05350501|Nivolumab|nivolumab|mesh-list
82939091|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939092|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939093|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939094|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939095|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82939096|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82939097|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939098|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
82939099|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82939100|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939101|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82939102|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939103|NCT05267366|Bevacizumab|bevacizumab|mesh-list
82939104|NCT05267366|Carboplatin|carboplatin|mesh-list
82939105|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82939106|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939107|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939108|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82939109|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82939110|NCT05267366|Growth Substances|growth substances|mesh-ancestor
82939111|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939112|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
82939113|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939114|NCT05267288|Afatinib|afatinib|mesh-list
82939115|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939116|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939117|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939118|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939119|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82939120|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939122|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939123|NCT05191667|Paclitaxel|paclitaxel|mesh-list
82939124|NCT05191667|Carboplatin|carboplatin|mesh-list
82939125|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82939126|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939127|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
82939128|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
82939129|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
82939130|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939131|NCT05112263|Cyclosporine|cyclosporine|mesh-list
82939132|NCT05112263|Cyclosporins|cyclosporins|mesh-list
82939133|NCT05112263|Tofacitinib|tofacitinib|mesh-list
82939134|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939135|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939136|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939137|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
82939138|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939139|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
82939140|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939141|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
82939142|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939143|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82939144|NCT05112263|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82939145|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939146|NCT05104281|Osimertinib|osimertinib|mesh-list
82939147|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939148|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939149|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939150|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939151|NCT05103605|Osimertinib|osimertinib|mesh-list
82939152|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939153|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939154|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939155|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939156|NCT05096884|Metoprolol|metoprolol|mesh-list
82939157|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82939158|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82939159|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
82939160|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
82939161|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939162|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939163|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82939164|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82939165|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82939166|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
82939167|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939168|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939169|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82939170|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
82939171|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
82939172|NCT05084378|Povidone|povidone|mesh-list
82939173|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82939174|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939175|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82939176|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
82939177|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
82939178|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
82939179|NCT05072249|Naloxone|naloxone|mesh-list
82939180|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82939181|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939182|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
82939183|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939184|NCT05065918|Ethanol|ethanol|mesh-list
82939185|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82939186|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939187|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82939188|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939189|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
82939190|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82939191|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939192|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939193|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939194|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
82939195|NCT05040984|Mirabegron|mirabegron|mesh-list
82939196|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82939197|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82939198|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
82939199|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939200|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939201|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939202|NCT05040984|Urological Agents|urological agents|mesh-ancestor
82939203|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82939204|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82939205|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82939206|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
82939207|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
82939208|NCT05017272|Narcotics|narcotics|mesh-ancestor
82939209|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82939210|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939211|NCT05017272|Analgesics|analgesics|mesh-ancestor
82939212|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
82939213|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939214|NCT04981912|Rituximab|rituximab|mesh-list
82939215|NCT04981912|Venetoclax|venetoclax|mesh-list
82939216|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939217|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939218|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
82939219|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939220|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939221|NCT04974879|Osimertinib|osimertinib|mesh-list
82939222|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939223|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939224|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939225|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939226|NCT04933058|Acetaminophen|acetaminophen|mesh-list
82939227|NCT04933058|Fentanyl|fentanyl|mesh-list
82939228|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82939229|NCT04933058|Narcotics|narcotics|mesh-ancestor
82939230|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82939231|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939232|NCT04933058|Analgesics|analgesics|mesh-ancestor
82939233|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
82939234|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939235|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82939236|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82939237|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
82939238|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
82939239|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82939240|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
82939241|NCT04918810|Docetaxel|docetaxel|mesh-list
82939242|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939243|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
82939244|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
82939245|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
82939246|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939247|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
82939248|NCT04894864|Anesthetics|anesthetics|mesh-list
82939249|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82939250|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939251|NCT04894864|Narcotics|narcotics|mesh-ancestor
82939252|NCT04894864|Analgesics|analgesics|mesh-ancestor
82939253|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
82939254|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939255|NCT04894435|Vaccines|vaccines|mesh-list
82939256|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
82939257|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939258|NCT04880395|Lamivudine|lamivudine|mesh-list
82939259|NCT04880395|Emtricitabine|emtricitabine|mesh-list
82939260|NCT04880395|Dolutegravir|dolutegravir|mesh-list
82939261|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82939262|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82939263|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939264|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939265|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
82939266|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939267|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82939268|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82939269|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82939270|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82939271|NCT04849013|Ketanserin|ketanserin|mesh-list
82939272|NCT04849013|Mescaline|mescaline|mesh-list
82939273|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82939274|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82939275|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82939276|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
82939277|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939278|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939279|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939280|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
82939281|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82939282|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82939283|NCT04808245|Atezolizumab|atezolizumab|mesh-list
82939284|NCT04808245|Imiquimod|imiquimod|mesh-list
82939285|NCT04808245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939286|NCT04808245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939287|NCT04808245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939288|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939289|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82939290|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
82939291|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939292|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
82939293|NCT04790513|Evolocumab|evolocumab|mesh-list
82939294|NCT04790513|Alirocumab|alirocumab|mesh-list
82939295|NCT04790513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82939296|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82939297|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82939298|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
82939299|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939300|NCT04790513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82939301|NCT04790513|Protease Inhibitors|protease inhibitors|mesh-ancestor
82939302|NCT04790513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939303|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82939304|NCT04777071|Edetic Acid|edetic acid|mesh-list
82939305|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82939306|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
82939307|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
82939308|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939309|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
82939310|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82939311|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82939312|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82939313|NCT04747847|Atorvastatin|atorvastatin|mesh-list
82939314|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82939315|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82939316|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
82939317|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939318|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82939319|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82939320|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939321|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939322|NCT04646837|Paclitaxel|paclitaxel|mesh-list
82939323|NCT04646837|Carboplatin|carboplatin|mesh-list
82939324|NCT04646837|Durvalumab|durvalumab|mesh-list
82939325|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82939326|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939327|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
82939328|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
82939329|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
83459238|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82939330|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939331|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939332|NCT04640636|Midazolam|midazolam|mesh-list
82939333|NCT04640636|Ketamine|ketamine|mesh-list
82939334|NCT04640636|Analgesics|analgesics|mesh-ancestor
82939335|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
82939336|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939337|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939338|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82939339|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82939340|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
82939341|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
82939342|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82939343|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82939344|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82939345|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939346|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939347|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82939363|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82939364|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82939365|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
82939366|NCT04560725|Choline|choline|mesh-list
82939367|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
82939368|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82939369|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
82939370|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939371|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82939372|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82939373|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
82939388|NCT04522284|Capecitabine|capecitabine|mesh-list
82939389|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82939390|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
82939391|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939392|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939393|NCT04492891|Cyclosporine|cyclosporine|mesh-list
82939394|NCT04492891|Cyclosporins|cyclosporins|mesh-list
82939395|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939396|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939397|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939398|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
82939399|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939400|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
82939401|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939402|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
82939403|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939404|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82939405|NCT04489888|Paclitaxel|paclitaxel|mesh-list
82939406|NCT04489888|Carboplatin|carboplatin|mesh-list
82939407|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
82939408|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82939409|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939410|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
82939411|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
82939412|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
82939413|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939414|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939415|NCT04489888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939416|NCT04443309|Lenvatinib|lenvatinib|mesh-list
82939417|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939418|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939419|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939420|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939421|NCT04435834|Propofol|propofol|mesh-list
82939422|NCT04435834|Sevoflurane|sevoflurane|mesh-list
82939423|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82939425|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939426|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82939427|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
82939428|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
82939429|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82939430|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82939431|NCT04431258|Folfirinox|folfirinox|mesh-list
82939432|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939433|NCT04401800|Lenvatinib|lenvatinib|mesh-list
82939434|NCT04401800|Tislelizumab|tislelizumab|mesh-list
82939435|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939436|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939437|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939438|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939439|NCT04401800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939440|NCT04400110|Amoxicillin|amoxicillin|mesh-list
82939441|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
82939442|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
82939443|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82939444|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939445|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939446|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939447|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82939448|NCT04387227|Carboplatin|carboplatin|mesh-list
82939449|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
82939450|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939451|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939452|NCT04387227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939453|NCT04387227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939454|NCT04368078|Lenvatinib|lenvatinib|mesh-list
82939455|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939456|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939457|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939458|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939459|NCT04350463|Nivolumab|nivolumab|mesh-list
82939460|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
82939461|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939462|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939463|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939464|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939465|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939466|NCT04347616|Aldesleukin|aldesleukin|mesh-list
82939467|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939468|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82939469|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82939470|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
82939471|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939472|NCT04338763|Gemcitabine|gemcitabine|mesh-list
82939473|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82939474|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
82939475|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939476|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939477|NCT04329728|Dexamethasone|dexamethasone|mesh-list
82939478|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82939479|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82939480|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
82939481|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
82939482|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939483|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939484|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82939485|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
82939486|NCT04329728|Hormones|hormones|mesh-ancestor
82939487|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82939488|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82939489|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939490|NCT04265950|Vaccines|vaccines|mesh-list
82939491|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
82939492|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939493|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
82939494|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82939495|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939496|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82939497|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939498|NCT04247815|Methotrexate|methotrexate|mesh-list
82939499|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82939500|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
82939501|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82939502|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939503|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82939504|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
82939505|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939506|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939507|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
82939508|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939509|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82939510|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939511|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
82939512|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939513|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82939514|NCT04227522|Rucaparib|rucaparib|mesh-list
82939515|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82939516|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939517|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939518|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939519|NCT04216953|Atezolizumab|atezolizumab|mesh-list
82939520|NCT04216953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939521|NCT04216953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939522|NCT04216953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939523|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939524|NCT04211168|Lenvatinib|lenvatinib|mesh-list
82939525|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939526|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939527|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939528|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939529|NCT04196257|Paclitaxel|paclitaxel|mesh-list
82939530|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82939531|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939532|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
82939533|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
82939534|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
82939535|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939536|NCT04193553|Lenvatinib|lenvatinib|mesh-list
82939537|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939538|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939539|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939540|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939541|NCT04188548|Trastuzumab|trastuzumab|mesh-list
82939542|NCT04188548|Pertuzumab|pertuzumab|mesh-list
82939543|NCT04188548|Everolimus|everolimus|mesh-list
82939544|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82939545|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939546|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939547|NCT04188548|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82939548|NCT04188548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939549|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939550|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939551|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939552|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
82939553|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939554|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82939555|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82939556|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
82939557|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82939558|NCT04183101|Enalapril|enalapril|mesh-list
82939559|NCT04183101|Enalaprilat|enalaprilat|mesh-list
82939560|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82939561|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
82939562|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939563|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939564|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82939565|NCT04165772|Capecitabine|capecitabine|mesh-list
82939566|NCT04165772|Dostarlimab|dostarlimab|mesh-list
82939567|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82939568|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
82939569|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939584|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82939585|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939587|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
82939588|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939589|NCT04073134|Evolocumab|evolocumab|mesh-list
82939590|NCT04073134|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82939591|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82939592|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82939593|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
82939594|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939595|NCT04073134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82939596|NCT04073134|Protease Inhibitors|protease inhibitors|mesh-ancestor
82939597|NCT04073134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939598|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82939599|NCT04034485|Evolocumab|evolocumab|mesh-list
82939600|NCT04034485|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82939601|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82939602|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82939603|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
82939604|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939605|NCT04034485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82939606|NCT04034485|Protease Inhibitors|protease inhibitors|mesh-ancestor
82939607|NCT04034485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939608|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82939609|NCT04010071|Axitinib|axitinib|mesh-list
82939610|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939611|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82939612|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939613|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939629|NCT03988920|Sevelamer|sevelamer|mesh-list
82939630|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
82939631|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
82939632|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939633|NCT03986034|Venetoclax|venetoclax|mesh-list
82939634|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939635|NCT03925402|Ertapenem|ertapenem|mesh-list
82939636|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82939637|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939638|NCT03892577|Immunomodulating Agents|immunomodulating agents|mesh-list
82939639|NCT03892577|Immunologic Factors|immunologic factors|mesh-ancestor
82939640|NCT03892577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939641|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
82939642|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939643|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939644|NCT03875079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83084009|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82939649|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82939650|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82939651|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
82939652|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939653|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939654|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82939655|NCT03769298|Tacrolimus|tacrolimus|mesh-list
82939656|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939657|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
82939658|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939659|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82939660|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939661|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939667|NCT03688451|Rituximab|rituximab|mesh-list
82939668|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939669|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939670|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
82939671|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939672|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939673|NCT03626064|Nicotine|nicotine|mesh-list
82939674|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82939675|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
82939676|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939677|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939678|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82939679|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82939680|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
82939681|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939682|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939683|NCT03613532|Fludarabine|fludarabine|mesh-list
82939684|NCT03613532|Azacitidine|azacitidine|mesh-list
82939685|NCT03613532|Busulfan|busulfan|mesh-list
82939686|NCT03613532|Decitabine|decitabine|mesh-list
82939687|NCT03613532|Venetoclax|venetoclax|mesh-list
82939688|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939689|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82939690|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
82939691|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939692|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939693|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
82939694|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939695|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939696|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
82939697|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82939698|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82939699|NCT03593018|Gemcitabine|gemcitabine|mesh-list
82939700|NCT03593018|Azacitidine|azacitidine|mesh-list
82939701|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82939702|NCT03593018|Romidepsin|romidepsin|mesh-list
82939703|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82939704|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
82939705|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939706|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939707|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939708|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82939709|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
82939710|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82939711|NCT03593018|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82939712|NCT03570099|Naloxone|naloxone|mesh-list
82939713|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82939714|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939715|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
82939716|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939717|NCT03550391|Memantine|memantine|mesh-list
82939718|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82939719|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82939720|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
82939722|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939723|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939724|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82939725|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82939726|NCT03529396|Chloroquine|chloroquine|mesh-list
82939727|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82939728|NCT03529396|Primaquine|primaquine|mesh-list
82939729|NCT03529396|Amebicides|amebicides|mesh-ancestor
82939730|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82939731|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82939732|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939733|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
82939734|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939735|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82939736|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82939737|NCT03529396|Analgesics|analgesics|mesh-ancestor
82939738|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
82939739|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939740|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939741|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82939742|NCT03529396|Filaricides|filaricides|mesh-ancestor
82939743|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
82939744|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
82939745|NCT03515837|Carboplatin|carboplatin|mesh-list
82939746|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
82939747|NCT03515837|Pemetrexed|pemetrexed|mesh-list
82939748|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82939749|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939750|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939751|NCT03515837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939752|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939753|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939754|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82939755|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82939756|NCT03436563|Atezolizumab|atezolizumab|mesh-list
82939757|NCT03436563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939758|NCT03436563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939759|NCT03436563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939760|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939761|NCT03426254|Talazoparib|talazoparib|mesh-list
82939762|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82939763|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939764|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939765|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939766|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82939767|NCT03422536|Cetuximab|cetuximab|mesh-list
82939768|NCT03422536|Antibodies|antibodies|mesh-list
82939769|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
82939770|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82939771|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
82939772|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939773|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939774|NCT03411031|Thalidomide|thalidomide|mesh-list
82939775|NCT03411031|Dexamethasone|dexamethasone|mesh-list
82939776|NCT03411031|Lenalidomide|lenalidomide|mesh-list
82939777|NCT03411031|Elotuzumab|elotuzumab|mesh-list
82939778|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82939779|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
82939780|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
82939781|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939782|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939783|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82939784|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
82939785|NCT03411031|Hormones|hormones|mesh-ancestor
82939786|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82939787|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82939788|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939789|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
82939790|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82939791|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82939792|NCT03411031|Growth Substances|growth substances|mesh-ancestor
82939793|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
82939794|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82939795|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
82939796|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83459286|NCT04498351|Analgesics|analgesics|mesh-ancestor
82939797|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939799|NCT03358017|Atorvastatin|atorvastatin|mesh-list
82939800|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82939801|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82939802|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
82939803|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939804|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82939805|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82939806|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939807|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82939808|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939809|NCT03289351|Tazobactam|tazobactam|mesh-list
82939810|NCT03289351|Piperacillin|piperacillin|mesh-list
82939811|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82939812|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82939813|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939814|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82939815|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939816|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939817|NCT03280667|Denosumab|denosumab|mesh-list
82939818|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
82939819|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939820|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939821|NCT03280667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939822|NCT03280667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939823|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82939824|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939825|NCT03272347|Tenofovir|tenofovir|mesh-list
82939826|NCT03272347|Lamivudine|lamivudine|mesh-list
82939827|NCT03272347|Islatravir|islatravir|mesh-list
82939828|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
82939829|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939830|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82939831|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82939832|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939833|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939834|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82939835|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82939836|NCT03251300|Mirabegron|mirabegron|mesh-list
82939837|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82939838|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82939839|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82939840|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
82939841|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939842|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939843|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939844|NCT03251300|Urological Agents|urological agents|mesh-ancestor
82939845|NCT03228693|Triamcinolone|triamcinolone|mesh-list
82939846|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82939847|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
82939848|NCT03228693|Hormones|hormones|mesh-ancestor
82939849|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82939850|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939851|NCT03201458|Atezolizumab|atezolizumab|mesh-list
82939852|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82939853|NCT03201458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939854|NCT03201458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939855|NCT03201458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939856|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939857|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
82939858|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939859|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82939860|NCT03108690|Meropenem|meropenem|mesh-list
82939861|NCT03108690|Tazobactam|tazobactam|mesh-list
82939862|NCT03108690|Piperacillin|piperacillin|mesh-list
82939863|NCT03108690|Ampicillin|ampicillin|mesh-list
82939864|NCT03108690|Cefuroxime|cefuroxime|mesh-list
82939865|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82939866|NCT03108690|Lactams|lactams|mesh-list
82939867|NCT03108690|beta-Lactams|beta-lactams|mesh-list
82939868|NCT03108690|Penicillin G|penicillin g|mesh-list
82939869|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
82939870|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82939872|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
82939873|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82939874|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939875|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939877|NCT03103152|Vitamin D|vitamin d|mesh-list
82939878|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
82939879|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
82939880|NCT03103152|Vitamins|vitamins|mesh-list
82939881|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
82939882|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939883|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82939884|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82939885|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82939886|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82939887|NCT03103152|Analgesics|analgesics|mesh-ancestor
82939888|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
82939889|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939890|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82939891|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939892|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82939893|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82939894|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939895|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82939896|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82939897|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939898|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
82939899|NCT02988297|RNS60|rns60|mesh-list
82939900|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82939901|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82939902|NCT02988297|Analgesics|analgesics|mesh-ancestor
82939903|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
82939904|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939905|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939906|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82939907|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82939908|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82939909|NCT02937285|Interferons|interferons|mesh-list
82939910|NCT02937285|Interferon-beta|interferon-beta|mesh-list
82939911|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
82939912|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
82939913|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939914|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
82939915|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82939916|NCT02937285|Analgesics|analgesics|mesh-ancestor
82939917|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
82939918|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939919|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939920|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82939921|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82939922|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939923|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939924|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
82939925|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82939926|NCT02878785|Decitabine|decitabine|mesh-list
82939927|NCT02878785|Talazoparib|talazoparib|mesh-list
82939928|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82939929|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
82939930|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939931|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939932|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939933|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82939934|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
82939935|NCT02825576|Neostigmine|neostigmine|mesh-list
82939936|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82939937|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939938|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939939|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
82939940|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82939941|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939942|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82939943|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
82939944|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939945|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82939946|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82939947|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82939948|NCT02719613|Dexamethasone|dexamethasone|mesh-list
82939949|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
82939950|NCT02719613|Nivolumab|nivolumab|mesh-list
82939951|NCT02719613|Lenalidomide|lenalidomide|mesh-list
82939952|NCT02719613|Bortezomib|bortezomib|mesh-list
82939953|NCT02719613|Pomalidomide|pomalidomide|mesh-list
82939954|NCT02719613|Elotuzumab|elotuzumab|mesh-list
82939955|NCT02719613|BB 1101|bb 1101|mesh-list
82939956|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82939957|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
82939958|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
82939959|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82939960|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82939961|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82939962|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
82939963|NCT02719613|Hormones|hormones|mesh-ancestor
82939964|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82939965|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82939966|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939967|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
82939968|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82939969|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939970|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939971|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939972|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
82939973|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82939974|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82939975|NCT02719613|Growth Substances|growth substances|mesh-ancestor
82939976|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
82939977|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82939978|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82939979|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
82939980|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
82939981|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939982|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939983|NCT02603887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82939984|NCT02603887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939985|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
82939986|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
82939987|NCT02475681|Chlorambucil|chlorambucil|mesh-list
82939988|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82939989|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82939990|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82939991|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
82939992|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82939993|NCT02315196|Paclitaxel|paclitaxel|mesh-list
82939994|NCT02315196|Carboplatin|carboplatin|mesh-list
82939995|NCT02315196|Doxorubicin|doxorubicin|mesh-list
82939996|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82939997|NCT02315196|Epirubicin|epirubicin|mesh-list
82939998|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82939999|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940000|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
82940001|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
82940002|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
82940003|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940004|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82940005|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82940006|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82940007|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940008|NCT02273375|Durvalumab|durvalumab|mesh-list
82940009|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940010|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940011|NCT02207712|Ranibizumab|ranibizumab|mesh-list
82940012|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82940013|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82940014|NCT02207712|Growth Substances|growth substances|mesh-ancestor
82940015|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940016|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
82940017|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940018|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82940019|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940020|NCT02133573|Progesterone|progesterone|mesh-list
82940021|NCT02133573|Progestins|progestins|mesh-ancestor
82940022|NCT02133573|Hormones|hormones|mesh-ancestor
82940023|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940024|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940025|NCT01917877|Dexamethasone|dexamethasone|mesh-list
82940026|NCT01917877|Bevacizumab|bevacizumab|mesh-list
82940027|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940028|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940029|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82940030|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82940031|NCT01917877|Growth Substances|growth substances|mesh-ancestor
82940032|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940033|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
82940034|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940035|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
82940036|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
82940037|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940038|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82940039|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
82940040|NCT01917877|Hormones|hormones|mesh-ancestor
82940041|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940042|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82940043|NCT01698840|Vitamin D|vitamin d|mesh-list
82940044|NCT01698840|Vitamins|vitamins|mesh-ancestor
82940045|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
82940046|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940047|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82940048|NCT01570296|Gefitinib|gefitinib|mesh-list
82940049|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940050|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82940051|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940052|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940053|NCT01199575|Rituximab|rituximab|mesh-list
82940054|NCT01199575|Lenalidomide|lenalidomide|mesh-list
82940055|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940056|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940057|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
82940058|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940059|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940060|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82940061|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82940062|NCT01199575|Growth Substances|growth substances|mesh-ancestor
82940063|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
82940064|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
82940065|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940066|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940067|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
82940068|NCT00496873|Rituximab|rituximab|mesh-list
82940069|NCT00496873|Pentostatin|pentostatin|mesh-list
82940070|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82940071|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
82940072|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940073|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940074|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82940075|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
82940076|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940077|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940078|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82940079|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940080|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82940081|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940082|NCT00492778|Cisplatin|cisplatin|mesh-list
82940083|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940084|NCT03931369|Tolvaptan|tolvaptan|mesh-list
82940085|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82940086|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940087|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
82940088|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940089|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
82940090|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940091|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
82940092|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82940093|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
82940094|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82940095|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940096|NCT03721328|Vancomycin|vancomycin|mesh-list
82940097|NCT03721328|Tobramycin|tobramycin|mesh-list
82940098|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82940099|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940100|NCT01220791|Progesterone|progesterone|mesh-list
82940101|NCT01220791|Progestins|progestins|mesh-ancestor
82940102|NCT01220791|Hormones|hormones|mesh-ancestor
82940103|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940104|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940105|NCT01353482|Pemetrexed|pemetrexed|mesh-list
82940106|NCT01353482|Vorinostat|vorinostat|mesh-list
82940107|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940108|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940109|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940110|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82940111|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82940112|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82940113|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
82940114|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82940115|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82940116|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82940117|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940118|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940119|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
82940120|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940121|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940122|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82940123|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940124|NCT01353716|Dolutegravir|dolutegravir|mesh-list
82940125|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82940126|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82940127|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940128|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940129|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82940130|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82940131|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
82940132|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940133|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
82940134|NCT04481672|Analgesics|analgesics|mesh-ancestor
82940135|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
82940136|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940137|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940138|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
82940139|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940140|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82940141|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
82940142|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82940143|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940144|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940145|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940146|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
82940147|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82940148|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82940149|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
82940150|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82940151|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82940152|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82940153|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940154|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940155|NCT04465942|Paclitaxel|paclitaxel|mesh-list
82940156|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
82940157|NCT04465942|Nivolumab|nivolumab|mesh-list
82940158|NCT04465942|Pemetrexed|pemetrexed|mesh-list
82940159|NCT04465942|Atezolizumab|atezolizumab|mesh-list
82940160|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82940161|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940162|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
82940163|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
82940164|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
82940165|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940166|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940167|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82940168|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940169|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82940170|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82940171|NCT01126645|Sorafenib|sorafenib|mesh-list
82940172|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940173|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82940175|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940176|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82940177|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
82940178|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
82940179|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940180|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
82940181|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940182|NCT01329289|Dexamethasone|dexamethasone|mesh-list
82940183|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
82940184|NCT01329289|Bortezomib|bortezomib|mesh-list
82940185|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82940186|NCT01329289|Pasireotide|pasireotide|mesh-list
82940187|NCT01329289|BB 1101|bb 1101|mesh-list
82940188|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940189|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
82940190|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
82940191|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940192|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940193|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82940194|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
82940195|NCT01329289|Hormones|hormones|mesh-ancestor
82940196|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940197|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82940198|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940199|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
82940200|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940201|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940202|NCT02291536|Dronabinol|dronabinol|mesh-list
82940203|NCT02291536|Cannabidiol|cannabidiol|mesh-list
82940204|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
82940205|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
82940206|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940207|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82940208|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82940209|NCT02291536|Analgesics|analgesics|mesh-ancestor
82940210|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
82940211|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940212|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82940213|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82940214|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940215|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940216|NCT02291536|Hormones|hormones|mesh-ancestor
82940217|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940218|NCT01317992|Ibudilast|ibudilast|mesh-list
82940219|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82940220|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
82940221|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940222|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940223|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82940224|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
82940225|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82940226|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940227|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940228|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82940229|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
82940230|NCT03635788|Rilpivirine|rilpivirine|mesh-list
82940231|NCT03635788|Cabotegravir|cabotegravir|mesh-list
82940232|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82940233|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82940234|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940235|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940236|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
82940237|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940238|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82940239|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82940240|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82940241|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82940242|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
82940243|NCT01348412|Raltitrexed|raltitrexed|mesh-list
82940244|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940245|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82940246|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
82940247|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940248|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82940249|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940250|NCT01353794|Sorafenib|sorafenib|mesh-list
82940251|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940252|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82940253|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940254|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940255|NCT01224301|Vaccines|vaccines|mesh-list
82940256|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
82940257|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940258|NCT01221025|Parecoxib|parecoxib|mesh-list
82940259|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82940260|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82940261|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940262|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940263|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82940264|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82940266|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
82940267|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940268|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940269|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940270|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940271|NCT03523390|Avelumab|avelumab|mesh-list
82940272|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940273|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940274|NCT01221103|Dexamethasone|dexamethasone|mesh-list
82940275|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82940276|NCT01221103|Ofatumumab|ofatumumab|mesh-list
82940277|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82940278|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940279|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
82940280|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
82940281|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940282|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940283|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82940284|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
82940285|NCT01221103|Hormones|hormones|mesh-ancestor
82940286|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940287|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82940288|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940289|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82940290|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
82940291|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940292|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
82940293|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
82940294|NCT03706898|Dolutegravir|dolutegravir|mesh-list
82940295|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
82940296|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
82940297|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940298|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82940299|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82940300|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940301|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940302|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82940303|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82940304|NCT03927313|Aspirin|aspirin|mesh-list
82940305|NCT03927313|Rifampin|rifampin|mesh-list
82940306|NCT03927313|Linezolid|linezolid|mesh-list
82940307|NCT03927313|Dexamethasone|dexamethasone|mesh-list
82940308|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940309|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
82940310|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
82940311|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940312|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940313|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82940314|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
82940315|NCT03927313|Hormones|hormones|mesh-ancestor
82940316|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940317|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82940318|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940319|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82940320|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82940321|NCT03927313|Analgesics|analgesics|mesh-ancestor
82940322|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
82940323|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940324|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82940325|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82940326|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940327|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82940328|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82940329|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940331|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82940332|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
82940333|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82940334|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940335|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
82940336|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82940338|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82940339|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82940340|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82940341|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82940342|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82940343|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82940344|NCT01224457|Phenobarbital|phenobarbital|mesh-list
82940345|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
82940346|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82940347|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940348|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940349|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82940350|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82940351|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940352|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940353|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
82940354|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
82940355|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82940356|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82940357|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82940358|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
82940359|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82940360|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
82940361|NCT03133312|Povidone|povidone|mesh-list
82940362|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82940363|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940364|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
82940365|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
82940366|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
82940367|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
82940368|NCT01318148|Caspofungin|caspofungin|mesh-list
82940369|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
82940370|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940371|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940372|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940373|NCT01354262|Vitamin D|vitamin d|mesh-list
82940374|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
82940375|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
82940376|NCT01354262|Vitamins|vitamins|mesh-list
82940377|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
82940378|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940379|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83459316|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
82940380|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940381|NCT01343498|Dactolisib|dactolisib|mesh-list
82940382|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940383|NCT01221337|Heparin|heparin|mesh-list
82940384|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
82940385|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82940386|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82940387|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940388|NCT01354418|Phenylephrine|phenylephrine|mesh-list
82940389|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
82940390|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82940391|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
82940392|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
82940393|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940394|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940395|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
82940396|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82940397|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
82940398|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
82940399|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82940400|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82940401|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82940402|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
82940403|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940404|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940405|NCT01354418|Protective Agents|protective agents|mesh-ancestor
82940406|NCT02818868|Apixaban|apixaban|mesh-list
82940407|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82940408|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
82940409|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82940410|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
82940411|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940413|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
82940414|NCT01224535|Micronutrients|micronutrients|mesh-list
82940415|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940416|NCT02289274|Aceclofenac|aceclofenac|mesh-list
82940417|NCT02289274|Eperisone|eperisone|mesh-list
82940418|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82940419|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82940420|NCT02289274|Analgesics|analgesics|mesh-ancestor
82940421|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
82940422|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940423|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940424|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940425|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940426|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
82940427|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82940428|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940429|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940430|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940431|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82940432|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82940433|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
82940434|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
82940435|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
82940436|NCT01224613|Vaccines|vaccines|mesh-list
82940437|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
82940438|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940439|NCT03930433|Nebivolol|nebivolol|mesh-list
82940440|NCT03930433|Diltiazem|diltiazem|mesh-list
82940441|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82940442|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
82940443|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82940444|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82940445|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82940446|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
82940447|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940448|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940449|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940450|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82940451|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940452|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940453|NCT01224769|Rituximab|rituximab|mesh-list
82940454|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82940455|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940456|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940457|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
82940458|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940459|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940460|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82940461|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
82940462|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940463|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82940464|NCT02289430|Ezetimibe|ezetimibe|mesh-list
82940465|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82940466|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82940467|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
82940468|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940469|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82940470|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82940471|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940473|NCT01224847|Cocaine|cocaine|mesh-list
82940474|NCT01224847|Tetracaine|tetracaine|mesh-list
82940475|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
82940476|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
82940477|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940478|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940479|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
82940480|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940481|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82940482|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82940483|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82940484|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517564|NCT00000885|Nelfinavir|nelfinavir|mesh-list
82940485|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940486|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82940487|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82940488|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82940490|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940491|NCT02289586|Fentanyl|fentanyl|mesh-list
82940492|NCT02289586|Midazolam|midazolam|mesh-list
82940493|NCT02289586|Remifentanil|remifentanil|mesh-list
82940494|NCT02289586|Dezocine|dezocine|mesh-list
82940495|NCT02289586|Propofol|propofol|mesh-list
82940496|NCT02289586|Rocuronium|rocuronium|mesh-list
82940497|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
82940498|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940499|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940500|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82940501|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82940502|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
82940503|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82940504|NCT02289586|Narcotics|narcotics|mesh-ancestor
82940505|NCT02289586|Analgesics|analgesics|mesh-ancestor
82940506|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
82940507|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940508|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82940509|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82940510|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82940511|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82940512|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
82940513|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
82940514|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940515|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940516|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82940517|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82940518|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82940519|NCT03740581|Insulin|insulin|mesh-list
82940520|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82940521|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940522|NCT03874897|Antibodies|antibodies|mesh-list
82940523|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82940524|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
82940525|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940526|NCT01127035|Immunomodulating Agents|immunomodulating agents|mesh-list
82940527|NCT01127035|Immunologic Factors|immunologic factors|mesh-ancestor
82940528|NCT01127035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940529|NCT02294266|Ethanol|ethanol|mesh-list
82940530|NCT02294266|Methamphetamine|methamphetamine|mesh-list
82940531|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82940532|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940533|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940534|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940535|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82940536|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
82940537|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
82940538|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940539|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
82940540|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940541|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940542|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
82940543|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82940544|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82940545|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940546|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82940547|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
82940548|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82940549|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
82940550|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940551|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940552|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82940553|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
82940554|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940555|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940556|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82940558|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
82940559|NCT01130311|Vitamins|vitamins|mesh-ancestor
82940560|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
82778862|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
82940562|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82940563|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940564|NCT03926377|Clobetasol|clobetasol|mesh-list
82940565|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940566|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
82940567|NCT03926377|Hormones|hormones|mesh-ancestor
82940568|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940569|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940570|NCT03132688|Propofol|propofol|mesh-list
82940571|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82940572|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940573|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940574|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82940575|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
82940576|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
82940577|NCT01227811|Darifenacin|darifenacin|mesh-list
82940578|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
82940579|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
82940580|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
82940581|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940582|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940583|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940584|NCT01227811|Urological Agents|urological agents|mesh-ancestor
82940585|NCT01225081|Pioglitazone|pioglitazone|mesh-list
82940586|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
82940587|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82940588|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940589|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82940590|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940591|NCT02298166|Cytarabine|cytarabine|mesh-list
82940592|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
82940593|NCT02298166|Crenolanib|crenolanib|mesh-list
82940594|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82940595|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
82940596|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940597|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940598|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
82940599|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940600|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82940601|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
82940602|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940603|NCT02298166|Analgesics|analgesics|mesh-ancestor
82940604|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
82940605|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940606|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82940607|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82940608|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940609|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
82940610|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82940611|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940612|NCT01221883|Diazepam|diazepam|mesh-list
82940613|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82940614|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
82940615|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
82940616|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
82940617|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940618|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940619|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82940620|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82940621|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940622|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82940623|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82940624|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82940625|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82940626|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82940627|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82940628|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
82940629|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
82940630|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
82940631|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
82940632|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940633|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940634|NCT02294656|Triamcinolone|triamcinolone|mesh-list
82940635|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82940636|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82940637|NCT02294656|Ranibizumab|ranibizumab|mesh-list
82940638|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82940639|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82940640|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82940641|NCT02294656|Growth Substances|growth substances|mesh-ancestor
82940642|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940643|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
82940644|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940645|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940646|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
82940647|NCT02294656|Hormones|hormones|mesh-ancestor
82940648|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940649|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82940650|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
82940651|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940652|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940653|NCT01225237|Ramosetron|ramosetron|mesh-list
82940654|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
82940655|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
82940656|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940657|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940658|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82940659|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82940660|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
82940661|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940662|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940663|NCT03517930|Loratadine|loratadine|mesh-list
82940664|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
82940665|NCT03517930|Ephedrine|ephedrine|mesh-list
82940666|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
82940667|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
82940668|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82940669|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82940670|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82940671|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
82940672|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
82940673|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940674|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940675|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940676|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82940677|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
82940678|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940679|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82940680|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
82940681|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
82940682|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82940683|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82940684|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
82940685|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
82940686|NCT01130467|Methylphenidate|methylphenidate|mesh-list
82940687|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82940688|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82940689|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940690|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82940691|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82940692|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940693|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940694|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
82940695|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940696|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82940697|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
82940698|NCT02295046|Amlodipine|amlodipine|mesh-list
82940699|NCT02295046|Atorvastatin|atorvastatin|mesh-list
82940700|NCT02295046|Calcium|calcium|mesh-list
82940701|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940702|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940703|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82940704|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82940705|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
82940706|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940707|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82940708|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82940709|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940710|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82940711|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82940712|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940713|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
82940714|NCT03517618|Leucovorin|leucovorin|mesh-list
82940715|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940716|NCT03517618|Antidotes|antidotes|mesh-ancestor
82940717|NCT03517618|Protective Agents|protective agents|mesh-ancestor
82940718|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
82940719|NCT03517618|Vitamins|vitamins|mesh-ancestor
82940720|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
82940721|NCT02295124|Oxycodone|oxycodone|mesh-list
82940722|NCT02295124|Hydromorphone|hydromorphone|mesh-list
82940723|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82940724|NCT02295124|Narcotics|narcotics|mesh-ancestor
82940725|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940726|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940727|NCT02295124|Analgesics|analgesics|mesh-ancestor
82940728|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
82940729|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940730|NCT03925051|Denosumab|denosumab|mesh-list
82940731|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82940732|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940733|NCT03514576|Pasireotide|pasireotide|mesh-list
82940734|NCT03514576|Hormones|hormones|mesh-ancestor
82940735|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82940736|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940737|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
82940738|NCT02299024|Narcotics|narcotics|mesh-ancestor
82940739|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940740|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940741|NCT02299024|Analgesics|analgesics|mesh-ancestor
82940742|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
82940743|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940744|NCT03929419|Insulin|insulin|mesh-list
82940745|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82940746|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940747|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82940748|NCT01228279|Icodextrin|icodextrin|mesh-list
82940749|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
82940750|NCT03514342|Ropivacaine|ropivacaine|mesh-list
82940751|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
82940752|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
82940753|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940754|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940755|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
82940756|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940757|NCT01228045|Trastuzumab|trastuzumab|mesh-list
82940758|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940759|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940760|NCT03514030|Antibodies|antibodies|mesh-list
82940761|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
82940762|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940763|NCT03517462|Ivermectin|ivermectin|mesh-list
82940764|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82940765|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940766|NCT03929575|Calcium|calcium|mesh-list
82940767|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940768|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940769|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
82940770|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82940771|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82940772|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82940773|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940774|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940775|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
82940776|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940777|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940778|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82940779|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940780|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82940781|NCT01131247|Ofatumumab|ofatumumab|mesh-list
82940782|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82940783|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82940784|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
82940785|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940786|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940788|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940789|NCT03513874|Metformin|metformin|mesh-list
82940790|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82940791|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940792|NCT01228357|Milnacipran|milnacipran|mesh-list
82940793|NCT01228357|Mirtazapine|mirtazapine|mesh-list
82940794|NCT01228357|Sertraline|sertraline|mesh-list
82940795|NCT01228357|Fluoxetine|fluoxetine|mesh-list
82940796|NCT01228357|Paroxetine|paroxetine|mesh-list
82940797|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82940798|NCT01228357|Nortriptyline|nortriptyline|mesh-list
82940799|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
82940800|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82940801|NCT01228357|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82940802|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82940803|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940804|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940805|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940806|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
82940807|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940808|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82940809|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82940810|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82940811|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940812|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82940813|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82940814|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
82940815|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
82940816|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82940817|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82940818|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940819|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82940820|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82940821|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82940822|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
82940823|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82940824|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82940825|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82940826|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82940827|NCT01228357|Analgesics|analgesics|mesh-ancestor
82940828|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
82940829|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940830|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82940831|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82940832|NCT01130701|Capecitabine|capecitabine|mesh-list
82940833|NCT01130701|Panitumumab|panitumumab|mesh-list
82940834|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82940835|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
82940836|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940837|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940838|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940839|NCT02292550|Ceritinib|ceritinib|mesh-list
82940840|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940841|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82940842|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940843|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940844|NCT03925285|Bevacizumab|bevacizumab|mesh-list
82940845|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940846|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940847|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82940849|NCT03925285|Growth Substances|growth substances|mesh-ancestor
82940850|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940851|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
82940852|NCT04464694|Ranibizumab|ranibizumab|mesh-list
82940853|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82940854|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82940855|NCT04464694|Growth Substances|growth substances|mesh-ancestor
82940856|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940857|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
82940858|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940859|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82940860|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940862|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940863|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940864|NCT03513484|Azacitidine|azacitidine|mesh-list
82940865|NCT03513484|Nintedanib|nintedanib|mesh-list
82940866|NCT03513484|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82940867|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82940868|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
82940869|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940870|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940871|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940872|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82940873|NCT03519724|Neostigmine|neostigmine|mesh-list
82940874|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82940875|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940876|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940877|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
82940878|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940879|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940880|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82940881|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
82940882|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940883|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
82940884|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82940885|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940886|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940887|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
82940888|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940889|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940890|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
82940891|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82940892|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940893|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82940894|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
82940895|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82940896|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82940897|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940898|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940899|NCT01132027|Tacrolimus|tacrolimus|mesh-list
82940900|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82940901|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
82940902|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940903|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82940904|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940905|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940906|NCT03136484|Canagliflozin|canagliflozin|mesh-list
82940907|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82940908|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940909|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82940910|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940911|NCT01132183|Valproic Acid|valproic acid|mesh-list
82940912|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
82940913|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940914|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940915|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
82940916|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940917|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940918|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
82940919|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82940920|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940921|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82940922|NCT03923881|Cetuximab|cetuximab|mesh-list
83459364|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940923|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82940924|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940925|NCT02295748|Deflazacort|deflazacort|mesh-list
82940926|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940927|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82940928|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
82940929|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940930|NCT03923803|Calcitonin|calcitonin|mesh-list
82940931|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
82940932|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82940933|NCT03923803|Katacalcin|katacalcin|mesh-list
82940934|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82940935|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940936|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82940937|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
82940938|NCT02295826|Aspirin|aspirin|mesh-list
82940939|NCT02295826|Dabigatran|dabigatran|mesh-list
82940940|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82940941|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82940942|NCT02295826|Analgesics|analgesics|mesh-ancestor
82940943|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
82940944|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940945|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940946|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82940947|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82940948|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82940949|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82940950|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940951|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82940952|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82940953|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940954|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
82940955|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
82940956|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82940957|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
82940958|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
82940959|NCT01348724|Naloxegol|naloxegol|mesh-list
82940960|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82940961|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940962|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
82940963|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940964|NCT03519022|Cocaine|cocaine|mesh-list
82940965|NCT03519022|Methylphenidate|methylphenidate|mesh-list
82940966|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82940967|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940968|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82940969|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82940970|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82940971|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940972|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
82940973|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82940974|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
82940975|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
82940976|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82940977|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
82940978|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82940979|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82940980|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
82940981|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82940982|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940983|NCT03516526|Natalizumab|natalizumab|mesh-list
82940984|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
82940985|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82940986|NCT02730416|Paclitaxel|paclitaxel|mesh-list
82940987|NCT02730416|Carboplatin|carboplatin|mesh-list
82940988|NCT02730416|Nintedanib|nintedanib|mesh-list
82940989|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82940990|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82940991|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
82940992|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
82940993|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
82940994|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82940995|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82940996|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82940998|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
82940999|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
82941000|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941001|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941002|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
82941003|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941004|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82941005|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
82941006|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82941007|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82941008|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941009|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941011|NCT03923179|Etoposide|etoposide|mesh-list
82941012|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82941013|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941014|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941015|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941016|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941017|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941018|NCT01318460|Simendan|simendan|mesh-list
82941019|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82941020|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
82941021|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82941022|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82941023|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941024|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941025|NCT01318460|Protective Agents|protective agents|mesh-ancestor
82941026|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941027|NCT02299726|Spironolactone|spironolactone|mesh-list
82941028|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82941029|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
82941030|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941031|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941032|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82941033|NCT02299726|Diuretics|diuretics|mesh-ancestor
82941034|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
82941035|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
82941036|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82941037|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82941038|NCT03647852|Prednisolone|prednisolone|mesh-list
82941039|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
82941040|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82941041|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
82941042|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941043|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
82941044|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
82941045|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941046|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941047|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82941048|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
82941049|NCT03647852|Hormones|hormones|mesh-ancestor
82941050|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941051|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82941052|NCT03647852|Protective Agents|protective agents|mesh-ancestor
82941053|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82941054|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941055|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82941056|NCT01354886|Hormones|hormones|mesh-ancestor
82941057|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941058|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941059|NCT02299882|Vancomycin|vancomycin|mesh-list
82941060|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941061|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941062|NCT01355120|Ipilimumab|ipilimumab|mesh-list
82941063|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82941064|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941065|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82941066|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941067|NCT02300038|Lidocaine|lidocaine|mesh-list
82941068|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941070|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941071|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941072|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
82941073|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941074|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82941075|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82941076|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82941077|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941078|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941079|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
82941080|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82941081|NCT01355198|Glycine|glycine|mesh-list
82941082|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
82941083|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941084|NCT01355198|Expectorants|expectorants|mesh-ancestor
82941085|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
82941086|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82941087|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
82941088|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941089|NCT01355198|Protective Agents|protective agents|mesh-ancestor
82941090|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941091|NCT01355198|Antidotes|antidotes|mesh-ancestor
82941092|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
82941093|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941094|NCT01355276|Domperidone|domperidone|mesh-list
82941095|NCT01355276|Cinitapride|cinitapride|mesh-list
82941096|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
82941097|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
82941098|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941099|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941100|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82941101|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82941102|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
82941103|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941104|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941105|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82941106|NCT02589860|Melphalan|melphalan|mesh-list
82941107|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82941108|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
82941109|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941110|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941111|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82941112|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82941113|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
82941114|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941115|NCT01355354|Digoxin|digoxin|mesh-list
82941116|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82941117|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82941118|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941119|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941120|NCT01355354|Protective Agents|protective agents|mesh-ancestor
82941121|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941122|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82941123|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82941124|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82941125|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82941126|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82941127|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
82941128|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941129|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941130|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941131|NCT01349270|Prednisone|prednisone|mesh-list
82941132|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
82941133|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82941134|NCT01349270|Antibodies|antibodies|mesh-list
82941135|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941136|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
82941137|NCT01349270|Hormones|hormones|mesh-ancestor
82941138|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941139|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941140|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82941141|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941142|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
82941143|NCT01132417|Tigecycline|tigecycline|mesh-list
82941144|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941145|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941146|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82941147|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941148|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941149|NCT02300194|Morphine|morphine|mesh-list
82941150|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82941151|NCT02300194|Narcotics|narcotics|mesh-ancestor
82941152|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941153|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941154|NCT02300194|Analgesics|analgesics|mesh-ancestor
82941155|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
82941156|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941157|NCT01225705|Ritonavir|ritonavir|mesh-list
82941158|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82941159|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
82941160|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82941161|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82941162|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
82941163|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941164|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941165|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82941166|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82941167|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
82941168|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941169|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82941170|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82941171|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82941172|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82941173|NCT01128985|Canagliflozin|canagliflozin|mesh-list
83459417|NCT01173211|Vaccines|vaccines|mesh-list
82941174|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82941175|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941176|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82941177|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941178|NCT03922555|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82941179|NCT03922555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82941180|NCT03922555|Antimetabolites|antimetabolites|mesh-ancestor
82941181|NCT03922555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941182|NCT03922555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941183|NCT03512860|Valproic Acid|valproic acid|mesh-list
82941184|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
82941185|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941186|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941187|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
82941188|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941189|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941190|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
82941191|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82941192|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941193|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82941194|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
82941195|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82941196|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941197|NCT02296762|Sirolimus|sirolimus|mesh-list
82941198|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941199|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941200|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82941201|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941202|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
82941203|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82941204|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
82941205|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941206|NCT01132573|Clofarabine|clofarabine|mesh-list
82941207|NCT01132573|Entinostat|entinostat|mesh-list
82941208|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82941209|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82941210|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
82941211|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941212|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941213|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941214|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82941215|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82941216|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941217|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82941218|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82941219|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941220|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941221|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
82941222|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941223|NCT03518320|Gemcitabine|gemcitabine|mesh-list
82941224|NCT03518320|Nivolumab|nivolumab|mesh-list
82941225|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82941226|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
82941227|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941228|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941229|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82941231|NCT01134289|Bupivacaine|bupivacaine|mesh-list
82941232|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
82941233|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941234|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
82941235|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941236|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941237|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
82941238|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949489|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941239|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82941240|NCT02300350|Digoxin|digoxin|mesh-list
82941241|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82941242|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82941243|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941244|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941245|NCT02300350|Protective Agents|protective agents|mesh-ancestor
82941246|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941247|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82941248|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82941249|NCT01349348|Tolvaptan|tolvaptan|mesh-list
82941250|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82941251|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941252|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
82941253|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941254|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
82941255|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
82941256|NCT02300428|Trace Elements|trace elements|mesh-ancestor
82941257|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
82941258|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941259|NCT02300428|Hematinics|hematinics|mesh-ancestor
82941260|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82941261|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82941262|NCT02296996|Trametinib|trametinib|mesh-list
82941263|NCT02296996|Dabrafenib|dabrafenib|mesh-list
82941264|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941265|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82941266|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941267|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941268|NCT01132729|Valacyclovir|valacyclovir|mesh-list
82941269|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
82941270|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941271|NCT02294110|Anesthetics|anesthetics|mesh-list
82941272|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941273|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941274|NCT03512548|Itraconazole|itraconazole|mesh-list
82941275|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
82941276|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941277|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82941278|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82941279|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941280|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941281|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82941282|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
82941283|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941284|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941285|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82941286|NCT03515668|Methylphenidate|methylphenidate|mesh-list
82941287|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82941288|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941289|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82941290|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82941291|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941292|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941294|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941295|NCT01356212|Ketorolac|ketorolac|mesh-list
82941296|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82941297|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82941298|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941299|NCT01356212|Analgesics|analgesics|mesh-ancestor
82941300|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
82941301|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941302|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941303|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941304|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941305|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82941306|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949490|NCT01288261|Paclitaxel|paclitaxel|mesh-list
82941307|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941309|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941310|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
82941311|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941312|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941313|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
82941314|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941315|NCT01356368|Docetaxel|docetaxel|mesh-list
82941316|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941317|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
82941318|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
82941319|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
82941320|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941321|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
82941322|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82941323|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82941324|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941325|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
82941326|NCT02302456|Coagulants|coagulants|mesh-ancestor
82941327|NCT01356524|Progesterone|progesterone|mesh-list
82941328|NCT01356524|Progestins|progestins|mesh-ancestor
82941329|NCT01356524|Hormones|hormones|mesh-ancestor
82941330|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941331|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941332|NCT01232023|Indobufen|indobufen|mesh-list
82941333|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82941334|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82941335|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941336|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941337|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82941338|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941339|NCT01232023|Analgesics|analgesics|mesh-ancestor
82941340|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
82941341|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941342|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941343|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941344|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941345|NCT02300740|Niacinamide|niacinamide|mesh-list
82941346|NCT02300740|Niacin|niacin|mesh-list
82941347|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
82941348|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
82941349|NCT02300740|Vitamins|vitamins|mesh-ancestor
82941350|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
82941351|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941352|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82941353|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
82941354|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941355|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82941356|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
82941357|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82941358|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82941359|NCT02297386|Testosterone|testosterone|mesh-list
82941360|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
82941361|NCT02297386|Androgens|androgens|mesh-ancestor
82941362|NCT02297386|Hormones|hormones|mesh-ancestor
82941363|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941364|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941365|NCT04464616|Anesthetics|anesthetics|mesh-list
82941366|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941367|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941369|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
82941370|NCT01356680|Dacarbazine|dacarbazine|mesh-list
82941371|NCT01356680|Etoposide|etoposide|mesh-list
82941372|NCT01356680|Vincristine|vincristine|mesh-list
82941373|NCT01356680|Doxorubicin|doxorubicin|mesh-list
82941374|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82941375|NCT01356680|Bleomycin|bleomycin|mesh-list
82941376|NCT01356680|Vinblastine|vinblastine|mesh-list
82941377|NCT01356680|Procarbazine|procarbazine|mesh-list
82941378|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82779676|NCT02542293|Paclitaxel|paclitaxel|mesh-list
82941379|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
82941380|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941381|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941382|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82941383|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
82941384|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941385|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941386|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82941387|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941388|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
82941389|NCT01356680|Hormones|hormones|mesh-ancestor
82941390|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941391|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82941392|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82941393|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941394|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941395|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941396|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
82941397|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
82941398|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
82941399|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82941400|NCT04464850|Iron|iron|mesh-list
82941401|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
82941402|NCT04464850|Folic Acid|folic acid|mesh-list
82941403|NCT04464850|Trace Elements|trace elements|mesh-ancestor
82941404|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
82941405|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941406|NCT04464850|Hematinics|hematinics|mesh-ancestor
82941407|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
82941408|NCT04464850|Vitamins|vitamins|mesh-ancestor
82941409|NCT01356758|Adalimumab|adalimumab|mesh-list
82941410|NCT01356758|Infliximab|infliximab|mesh-list
82941411|NCT01356758|Etanercept|etanercept|mesh-list
82941412|NCT01356758|Ustekinumab|ustekinumab|mesh-list
82941413|NCT01356758|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82941414|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941415|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941416|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
82941417|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82941418|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82941419|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941420|NCT01356758|Analgesics|analgesics|mesh-ancestor
82941421|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
82941422|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941423|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941424|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82941425|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
82941426|NCT01134523|Paclitaxel|paclitaxel|mesh-list
82941427|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82941428|NCT01134523|Epirubicin|epirubicin|mesh-list
82941429|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82941430|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941431|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
82941432|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
82941433|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
82941434|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941435|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82941436|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941437|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941438|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941439|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82941440|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
82941441|NCT01349738|Levofloxacin|levofloxacin|mesh-list
82941442|NCT01349738|Ofloxacin|ofloxacin|mesh-list
82941443|NCT01349738|Gentamicins|gentamicins|mesh-list
82941444|NCT01349738|Cefazolin|cefazolin|mesh-list
82941445|NCT01349738|Tobramycin|tobramycin|mesh-list
82941446|NCT01349738|Ampicillin|ampicillin|mesh-list
82941447|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82941448|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
82941449|NCT01349738|Sulbactam|sulbactam|mesh-list
82941450|NCT01349738|Trimethoprim|trimethoprim|mesh-list
82941451|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
82941452|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941453|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941454|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941455|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941456|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941457|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941458|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82941459|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82941460|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82941461|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82941462|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
82941463|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82941464|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82941465|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82941466|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82941467|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82941468|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82941470|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
82941471|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941472|NCT02302768|Protective Agents|protective agents|mesh-ancestor
82941473|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941474|NCT02302768|Trace Elements|trace elements|mesh-ancestor
82941475|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
82941476|NCT03921775|Propofol|propofol|mesh-list
82941477|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82941478|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941479|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941480|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82941481|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
82941482|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
82941483|NCT01356992|Enoxaparin|enoxaparin|mesh-list
82941484|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
82941485|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82941486|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82941487|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941488|NCT01350050|Carticaine|carticaine|mesh-list
82941489|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941490|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
82941491|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941492|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941493|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
82941494|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941495|NCT03918889|Midazolam|midazolam|mesh-list
82941496|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
82941497|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82941498|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941499|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941500|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941501|NCT03918889|Analgesics|analgesics|mesh-ancestor
82941502|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
82941503|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941504|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82941505|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82941506|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82941507|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
82941508|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941509|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941510|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82941511|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82941512|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82941513|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82941514|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82941515|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
82941516|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
82941517|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
82941519|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
82941520|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82941521|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941522|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82941523|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941524|NCT03739801|Irinotecan|irinotecan|mesh-list
82941525|NCT03739801|Ramucirumab|ramucirumab|mesh-list
82941526|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82941527|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941528|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941529|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941530|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941531|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
82941532|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82779832|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
82941533|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941534|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
82941535|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82941536|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82941537|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82941538|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941539|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941540|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
82941541|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941542|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941543|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82941544|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941545|NCT02297854|Valganciclovir|valganciclovir|mesh-list
82941546|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
82941547|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941548|NCT03511768|Octreotide|octreotide|mesh-list
82941549|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
82941550|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82941551|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82941552|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941553|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82941554|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941555|NCT01134991|Minocycline|minocycline|mesh-list
82941556|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941557|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941558|NCT03515200|Cytarabine|cytarabine|mesh-list
82941559|NCT03515200|Dexamethasone|dexamethasone|mesh-list
82941560|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
82941561|NCT03515200|Doxorubicin|doxorubicin|mesh-list
82941562|NCT03515200|Methotrexate|methotrexate|mesh-list
82941563|NCT03515200|Bortezomib|bortezomib|mesh-list
82941564|NCT03515200|Dasatinib|dasatinib|mesh-list
82941565|NCT03515200|Palbociclib|palbociclib|mesh-list
82941566|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941567|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
82941568|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
82941569|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941570|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941571|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82941572|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
82941573|NCT03515200|Hormones|hormones|mesh-ancestor
82941574|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941575|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82941576|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941577|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82941578|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941579|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941580|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941581|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941582|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82941583|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
82941584|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82941585|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82941586|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
82941587|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
82941588|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82941589|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82941590|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
82941591|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941592|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82941595|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82941596|NCT03918265|Tacrolimus|tacrolimus|mesh-list
82941597|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82941598|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
82941599|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941600|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82941601|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941602|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941603|NCT03920839|Paclitaxel|paclitaxel|mesh-list
82941604|NCT03920839|Carboplatin|carboplatin|mesh-list
82941605|NCT03920839|Gemcitabine|gemcitabine|mesh-list
82941606|NCT03920839|Pemetrexed|pemetrexed|mesh-list
82941607|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82941608|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941609|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
82941610|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
82941611|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
82941612|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941613|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82941614|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
82941615|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941616|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82941617|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82941618|NCT02301130|Durvalumab|durvalumab|mesh-list
82941619|NCT02301130|Tremelimumab|tremelimumab|mesh-list
82941620|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
82941621|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82941622|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82941623|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941624|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
82941625|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941626|NCT03920605|Tenofovir|tenofovir|mesh-list
82941627|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82941628|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82941629|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
82941630|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941631|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82941632|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82941633|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941634|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941635|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82941636|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82941637|NCT02301208|Nedaplatin|nedaplatin|mesh-list
82941638|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941639|NCT02298010|Capecitabine|capecitabine|mesh-list
82941640|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
82941641|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82941642|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
82941643|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941644|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941645|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
82941646|NCT01229605|Docetaxel|docetaxel|mesh-list
82941647|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82941648|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
82941649|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941650|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941651|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82941652|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
82941653|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941654|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941655|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82941656|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
82941657|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
82941658|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
82941659|NCT01319006|Glycine|glycine|mesh-list
82941660|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
82941661|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941662|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941663|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941664|NCT01358240|Econazole|econazole|mesh-list
82941665|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
82941666|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941667|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82941668|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82941669|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941670|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941671|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82941672|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
82941673|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82941674|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941675|NCT01131949|Lamotrigine|lamotrigine|mesh-list
82941676|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
82941677|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82941678|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941679|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941680|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82941681|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941682|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82941683|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82941684|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941685|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82941686|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82941687|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
82941688|NCT03511222|Nivolumab|nivolumab|mesh-list
82941689|NCT03511222|Vorolanib|vorolanib|mesh-list
82941690|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82941691|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941692|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82941693|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941694|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82941695|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941696|NCT01230463|Ketorolac|ketorolac|mesh-list
82941697|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82941698|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82941699|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941700|NCT01230463|Analgesics|analgesics|mesh-ancestor
82941701|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
82941702|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941703|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941704|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941705|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941706|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82941707|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941708|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941709|NCT01358396|Chrysarobin|chrysarobin|mesh-list
82941710|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82941711|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941712|NCT01358396|Analgesics|analgesics|mesh-ancestor
82941713|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
82941714|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941715|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941716|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941717|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941718|NCT01135615|Calcium|calcium|mesh-list
82941719|NCT01135615|Sevelamer|sevelamer|mesh-list
82941720|NCT01135615|Calcium acetate|calcium acetate|mesh-list
82941721|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82941722|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941723|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
82941724|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
82941725|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941726|NCT01361516|Anesthetics|anesthetics|mesh-list
82941727|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941728|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941729|NCT03920137|Nicotine|nicotine|mesh-list
82941730|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82941731|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
82949491|NCT01288261|Bavituximab|bavituximab|mesh-list
82941732|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941733|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941734|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82941735|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82941736|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
82941737|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941738|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941739|NCT03132610|Andrographolide|andrographolide|mesh-list
82941740|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941741|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82941742|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941744|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
82941745|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941746|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941747|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941748|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82941749|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82941750|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941751|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
82941752|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82941753|NCT02298088|Clopidogrel|clopidogrel|mesh-list
82941754|NCT02298088|Ticagrelor|ticagrelor|mesh-list
82941755|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82941756|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82941757|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82941758|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82941759|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
82941760|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941761|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941762|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941763|NCT01133119|Bupivacaine|bupivacaine|mesh-list
82941764|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941765|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
82941766|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941767|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941768|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
82941769|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941770|NCT01230541|Udenafil|udenafil|mesh-list
82941771|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82941772|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82941773|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941774|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941775|NCT01229761|Trimethoprim|trimethoprim|mesh-list
82941776|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82941777|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
82941778|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82941779|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941780|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
82941781|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82941782|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82941783|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82941784|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941785|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941786|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82941787|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82941788|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82941789|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941790|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
82941791|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
82941792|NCT03514810|Ketoprofen|ketoprofen|mesh-list
82941793|NCT03514810|Sertraline|sertraline|mesh-list
82941794|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
82941795|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82941796|NCT03514810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82941797|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82941798|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941799|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941800|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941801|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
82941802|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941803|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82941804|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941805|NCT03514810|Analgesics|analgesics|mesh-ancestor
82941806|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
82941807|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941808|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82941809|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82941810|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82941811|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941812|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
82941813|NCT02301676|Propofol|propofol|mesh-list
82941815|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82941816|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941817|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941818|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941819|NCT02301676|Analgesics|analgesics|mesh-ancestor
82941820|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
82941821|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941822|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82941823|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82941824|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82941825|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
82941826|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941827|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941828|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82941829|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
82941830|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
82941831|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82941832|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82941833|NCT01135771|Insulin|insulin|mesh-list
82941834|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82941835|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941836|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
82941837|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82941838|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82941839|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941840|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941841|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
82941842|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941843|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941844|NCT01135927|Insulin|insulin|mesh-list
82941845|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82941846|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
82941847|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82941848|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941849|NCT02301910|Tenecteplase|tenecteplase|mesh-list
82941850|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82941851|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82941852|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941853|NCT01585753|Maraviroc|maraviroc|mesh-list
82941854|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82941855|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82941856|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941857|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82941858|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82941859|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
82941860|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941861|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82941862|NCT01136005|Provitamins|provitamins|mesh-list
82941863|NCT01136005|Vitamins|vitamins|mesh-ancestor
82941864|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
82941865|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941866|NCT03509740|Acetaminophen|acetaminophen|mesh-list
82941867|NCT03509740|Tramadol|tramadol|mesh-list
82941868|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941869|NCT03509740|Analgesics|analgesics|mesh-ancestor
82941870|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
82941871|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941872|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941873|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
82941874|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82941875|NCT03509740|Narcotics|narcotics|mesh-ancestor
82941876|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941877|NCT03918187|Midazolam|midazolam|mesh-list
82941878|NCT03918187|Nalbuphine|nalbuphine|mesh-list
82941879|NCT03918187|Bupivacaine|bupivacaine|mesh-list
82941880|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941881|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
82941882|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941883|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941884|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
82941885|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941886|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82941887|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82941888|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82941889|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82941890|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82941891|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82941892|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
82941893|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
82941894|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
82941895|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941896|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941897|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82941898|NCT03918187|Narcotics|narcotics|mesh-ancestor
82941899|NCT03918187|Analgesics|analgesics|mesh-ancestor
82941900|NCT03507634|Lidocaine|lidocaine|mesh-list
82941901|NCT03507634|Fentanyl|fentanyl|mesh-list
82941902|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
82941903|NCT03507634|Remifentanil|remifentanil|mesh-list
82941904|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
82941905|NCT03507634|Anesthetics|anesthetics|mesh-list
82941906|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941907|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941908|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941909|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
82941910|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941911|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82941912|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82941913|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82941914|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82941915|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941916|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82941917|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82941918|NCT03507634|Analgesics|analgesics|mesh-ancestor
82941919|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82941920|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82941921|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82941922|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
82941923|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82941924|NCT03507634|Narcotics|narcotics|mesh-ancestor
82941925|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82941926|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82941927|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
82941928|NCT03507556|Metronidazole|metronidazole|mesh-list
82941929|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
82941930|NCT03507556|Minocycline|minocycline|mesh-list
82941931|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
82941932|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941933|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941934|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82941935|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82941936|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941937|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941938|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941939|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941940|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941941|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82941942|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82941943|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
82941944|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
82941945|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83459492|NCT03011905|Ropivacaine|ropivacaine|mesh-list
82941946|NCT03507556|Protective Agents|protective agents|mesh-ancestor
82941947|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941948|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
82941949|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82941950|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
82941951|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941952|NCT01232257|Expectorants|expectorants|mesh-ancestor
82941953|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
82941954|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82941956|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941957|NCT01232257|Protective Agents|protective agents|mesh-ancestor
82941958|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941959|NCT01232257|Antidotes|antidotes|mesh-ancestor
82941960|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
82941961|NCT03509662|Thiamine|thiamine|mesh-list
82941962|NCT03509662|Vitamins|vitamins|mesh-ancestor
82941963|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
82941964|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941965|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
82941966|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941967|NCT03509662|Protective Agents|protective agents|mesh-ancestor
82941968|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
82941969|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
82941970|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941971|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941972|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941973|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941974|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941975|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941976|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941977|NCT01133431|Glimepiride|glimepiride|mesh-list
82941978|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82941979|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82941980|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941981|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82941982|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
82941983|NCT05610007|Prilocaine|prilocaine|mesh-list
82941984|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
82941985|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
82941986|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82941987|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82941988|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
82941989|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82941990|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
82941991|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
82941992|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82941993|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82941994|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82941995|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82941996|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82941997|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82941998|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82941999|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942000|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82942001|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82942002|NCT02303782|Azacitidine|azacitidine|mesh-list
82942003|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82942004|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
82942005|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942006|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942007|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942008|NCT01233505|Capecitabine|capecitabine|mesh-list
82942009|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
82942010|NCT01233505|Veliparib|veliparib|mesh-list
82942011|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82942012|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
82942013|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942014|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83459494|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
82942015|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82942016|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942017|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
82942018|NCT04925180|Cyproterone|cyproterone|mesh-list
82942019|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
82942020|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
82942021|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942022|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942023|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942024|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82942025|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
82942026|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82942027|NCT01133509|Vaccines|vaccines|mesh-list
82942028|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
82942029|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942030|NCT02306902|Fenofibrate|fenofibrate|mesh-list
82942031|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82942032|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
82942033|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942034|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82942035|NCT01230697|Sorafenib|sorafenib|mesh-list
82942036|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942037|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82942038|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942039|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942040|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82942041|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
82942042|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82942044|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942045|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942046|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82942047|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
82942048|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82942049|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82942050|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82942051|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
82942052|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942053|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942054|NCT01230775|Anagrelide|anagrelide|mesh-list
82942055|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82942056|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942057|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942058|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82942059|NCT01136317|Omeprazole|omeprazole|mesh-list
82942060|NCT01136317|Rabeprazole|rabeprazole|mesh-list
82942061|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82942062|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942063|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82942064|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942065|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942066|NCT03507244|Dexamethasone|dexamethasone|mesh-list
82942067|NCT03507244|Pemetrexed|pemetrexed|mesh-list
82942068|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942069|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
82942070|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
82942071|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942072|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942073|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942074|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
82942075|NCT03507244|Hormones|hormones|mesh-ancestor
82942076|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942077|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82942078|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942079|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942080|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942081|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82942082|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82942083|NCT01136395|Rituximab|rituximab|mesh-list
82942084|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942085|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942086|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
82942087|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942088|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942089|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
82942090|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82942091|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82942092|NCT02304094|Prednisolone|prednisolone|mesh-list
82942093|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
82942094|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82942095|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
82942096|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942097|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
82942098|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
82942099|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942100|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942101|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942102|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
82942103|NCT02304094|Hormones|hormones|mesh-ancestor
82942104|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942105|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82942106|NCT02304094|Protective Agents|protective agents|mesh-ancestor
82942107|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82942108|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942109|NCT03507166|Trastuzumab|trastuzumab|mesh-list
82942110|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942111|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942113|NCT01233583|Infliximab|infliximab|mesh-list
82942114|NCT01233583|Etanercept|etanercept|mesh-list
82942115|NCT01233583|Acitretin|acitretin|mesh-list
82942116|NCT01233583|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82942117|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942118|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942119|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
82942120|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942121|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942122|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942123|NCT01233583|Analgesics|analgesics|mesh-ancestor
82942124|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
82942125|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942126|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942127|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82942128|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
82942129|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
82942130|NCT02304250|Dexamethasone|dexamethasone|mesh-list
82942131|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942132|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
82942133|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
82942134|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942135|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942136|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942137|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
82942138|NCT02304250|Hormones|hormones|mesh-ancestor
82942139|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942140|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82942141|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942142|NCT01136551|Huperzine A|huperzine a|mesh-list
82942143|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82942144|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942145|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942146|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
82942147|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942148|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942149|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82942150|NCT01136551|Protective Agents|protective agents|mesh-ancestor
82942151|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
82942152|NCT03132142|Capsaicin|capsaicin|mesh-list
82942153|NCT03132142|Menthol|menthol|mesh-list
82942154|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
82942155|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
82942156|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
82942157|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942158|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942159|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82942160|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942161|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82942162|NCT03132142|Protective Agents|protective agents|mesh-ancestor
82942163|NCT01232647|Vitamins|vitamins|mesh-list
82942164|NCT01232647|Vitamin K|vitamin k|mesh-list
82942165|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
82942166|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
82942167|NCT01232647|Menatetrenone|menatetrenone|mesh-list
82942168|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
82942169|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942170|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82942171|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942172|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942173|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
82942174|NCT01232647|Coagulants|coagulants|mesh-ancestor
82942175|NCT03917095|Mesalamine|mesalamine|mesh-list
82942176|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942177|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942178|NCT03917095|Analgesics|analgesics|mesh-ancestor
82942179|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
82942180|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942181|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942182|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942183|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942184|NCT01133743|Thalidomide|thalidomide|mesh-list
82942185|NCT01133743|Dexamethasone|dexamethasone|mesh-list
82942186|NCT01133743|Lenalidomide|lenalidomide|mesh-list
82942187|NCT01133743|Immunomodulating Agents|immunomodulating agents|mesh-list
82942188|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942189|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
82942190|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
82942191|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942192|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942193|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942194|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
82942195|NCT01133743|Hormones|hormones|mesh-ancestor
82942196|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942197|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82942198|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942199|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
82942200|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82942201|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82942202|NCT01133743|Growth Substances|growth substances|mesh-ancestor
82942203|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
82942204|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82942205|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
82942206|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82942207|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942208|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82942209|NCT01138423|Moxonidine|moxonidine|mesh-list
82942210|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82942211|NCT01138423|Diuretics|diuretics|mesh-ancestor
82942212|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
82942213|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942214|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82942215|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82942216|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942217|NCT01136863|Felodipine|felodipine|mesh-list
82942218|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82942219|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82942220|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82942221|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82942222|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942223|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82942224|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942225|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
82942226|NCT03961516|Pancrelipase|pancrelipase|mesh-list
82942227|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942228|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
82942229|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82942230|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82942231|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82942232|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82942233|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942234|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
82942235|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942236|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942237|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82942238|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942239|NCT05553145|Antibodies|antibodies|mesh-list
82942240|NCT05553145|Autoantibodies|autoantibodies|mesh-list
82942241|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
82942242|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942243|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
82942244|NCT03504280|Vitamin D|vitamin d|mesh-list
82942245|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82942246|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942247|NCT03504280|Vitamins|vitamins|mesh-ancestor
82942248|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
82942249|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82942250|NCT03504202|Trimetazidine|trimetazidine|mesh-list
82942251|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
82942252|NCT01136941|Zileuton|zileuton|mesh-list
82942253|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942254|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942255|NCT01136941|Analgesics|analgesics|mesh-ancestor
82942256|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
82942257|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942258|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942259|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942260|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942261|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82942262|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942263|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942264|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82942265|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
82942266|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942268|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
82942269|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942270|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82942271|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82942272|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942273|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942274|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82942275|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82942276|NCT03504046|Pancrelipase|pancrelipase|mesh-list
82942277|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942278|NCT01139203|Lamivudine|lamivudine|mesh-list
82942279|NCT01139203|Adefovir|adefovir|mesh-list
82942280|NCT01139203|Entecavir|entecavir|mesh-list
82942281|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82942282|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83459519|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
82942283|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942284|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942285|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
82942286|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942287|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82942288|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82942289|NCT05187715|Simvastatin|simvastatin|mesh-list
82942290|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82942291|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82942292|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
82942293|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942294|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82942295|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82942296|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942297|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
82942298|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82942299|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942300|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942301|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
82942302|NCT02312440|Coagulants|coagulants|mesh-ancestor
82942303|NCT01137019|Everolimus|everolimus|mesh-list
82942304|NCT01137019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82942305|NCT01137019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82942306|NCT01137019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942307|NCT01137019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942308|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82942309|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
82942310|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942311|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942312|NCT03508804|Lidocaine|lidocaine|mesh-list
82942313|NCT03508804|Prilocaine|prilocaine|mesh-list
82942314|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82942315|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
82942316|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
82942317|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942318|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942319|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
82942320|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942321|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82942322|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82942323|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82942324|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82942325|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942326|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82942327|NCT01231165|Aspirin|aspirin|mesh-list
82942328|NCT01231165|Amiloride|amiloride|mesh-list
82942329|NCT01231165|Clopidogrel|clopidogrel|mesh-list
82942330|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
82942331|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942332|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942333|NCT01231165|Analgesics|analgesics|mesh-ancestor
82942334|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
82942335|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942336|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942337|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942338|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942339|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82942340|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942341|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942342|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82942343|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82942346|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82942347|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82942348|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82942349|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
82942350|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942351|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82942352|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82942353|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
82942354|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82942355|NCT01231165|Diuretics|diuretics|mesh-ancestor
82942356|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
82942357|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82942358|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82942359|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82942360|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82942361|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82942362|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82942363|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82942364|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942365|NCT03503890|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
82942366|NCT03503890|Immunoconjugates|immunoconjugates|mesh-ancestor
82942367|NCT03503890|Immunologic Factors|immunologic factors|mesh-ancestor
82942368|NCT03503890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942369|NCT01233895|Bortezomib|bortezomib|mesh-list
82942370|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942371|NCT05221645|Rituximab|rituximab|mesh-list
82942372|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
82942373|NCT05221645|Carboplatin|carboplatin|mesh-list
82942374|NCT05221645|Etoposide|etoposide|mesh-list
82942375|NCT05221645|Ifosfamide|ifosfamide|mesh-list
82942376|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942377|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942378|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
82942379|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942380|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942381|NCT05221645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82942382|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942383|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82942384|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82942385|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82942386|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942387|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82942388|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
82942389|NCT03506620|Ropivacaine|ropivacaine|mesh-list
82942390|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
82942391|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
82942392|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942393|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942394|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
82942395|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942396|NCT02305030|Opicapone|opicapone|mesh-list
82942397|NCT02305030|Warfarin|warfarin|mesh-list
82942398|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
82942399|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82942400|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942401|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942402|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82942403|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82942404|NCT01139437|Vaccines|vaccines|mesh-list
82942405|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
83517565|NCT00000885|Indinavir|indinavir|mesh-list
82942406|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942407|NCT01137253|Trimethaphan|trimethaphan|mesh-list
82942408|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
82942409|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82942410|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82942411|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
82942412|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
82942413|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942414|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942415|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82942416|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82942417|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
82942418|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942419|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942420|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
82942421|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
82942422|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942423|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942424|NCT03506542|Mitomycins|mitomycins|mesh-list
82942425|NCT03506542|Mitomycin|mitomycin|mesh-list
82942426|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82942427|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942428|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
82942429|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942430|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82942431|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942432|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
82942433|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942434|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942435|NCT02305186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82942436|NCT02305186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942437|NCT02312908|Clonazepam|clonazepam|mesh-list
82942438|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
82942439|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
82942440|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
82942441|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942442|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942443|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942444|NCT02308930|Vitamin D|vitamin d|mesh-list
82942445|NCT02308930|Vitamins|vitamins|mesh-list
82942446|NCT02308930|Vitamin A|vitamin a|mesh-list
82942447|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
82942448|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
82942449|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942450|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
82942451|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942452|NCT02308930|Protective Agents|protective agents|mesh-ancestor
82942453|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82942454|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942455|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82942456|NCT01139671|Remifentanil|remifentanil|mesh-list
82942457|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82942458|NCT01139671|Narcotics|narcotics|mesh-ancestor
82942459|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942460|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942461|NCT01139671|Analgesics|analgesics|mesh-ancestor
82942462|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
82942463|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942464|NCT02313064|CXA-10|cxa-10|mesh-list
82942465|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942466|NCT05088889|Nivolumab|nivolumab|mesh-list
82942467|NCT05088889|Ipilimumab|ipilimumab|mesh-list
82942468|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942469|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942470|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82942471|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942472|NCT01234051|Docetaxel|docetaxel|mesh-list
82942473|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
82942474|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942475|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
82942476|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
82942477|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
82942478|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942479|NCT03341962|Calcium|calcium|mesh-list
82942480|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82942481|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942482|NCT01234597|Insulin|insulin|mesh-list
82942483|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82942484|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
82942485|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
82942486|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82942487|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942488|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
82942489|NCT02313220|Exenatide|exenatide|mesh-list
82942490|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82942491|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942492|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82942493|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942494|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82942496|NCT02313220|Hormones|hormones|mesh-ancestor
82942497|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942498|NCT02309320|Gontivimab|gontivimab|mesh-list
82942499|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
82942500|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942501|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
82942502|NCT01139749|Ciclopirox|ciclopirox|mesh-list
82942503|NCT01139749|Salicylates|salicylates|mesh-list
82942504|NCT01139749|Isotretinoin|isotretinoin|mesh-list
82942505|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
82942506|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942507|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
82942508|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
82942509|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942510|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942511|NCT01139749|Analgesics|analgesics|mesh-ancestor
82942512|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
82942513|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942514|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942515|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942516|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942517|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82942518|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942519|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942520|NCT04748419|Durvalumab|durvalumab|mesh-list
82942521|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942522|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942523|NCT02305810|Everolimus|everolimus|mesh-list
82942524|NCT02305810|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82942525|NCT02305810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82942526|NCT02305810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942527|NCT02305810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942528|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82942529|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
82942530|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942531|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942532|NCT01142869|Cetuximab|cetuximab|mesh-list
82942533|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942534|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942535|NCT01139905|Ritonavir|ritonavir|mesh-list
82942536|NCT01139905|Lopinavir|lopinavir|mesh-list
82942537|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82942538|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82942539|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
82942540|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942541|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942542|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82942543|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82942544|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
82942545|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942546|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82942547|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82942548|NCT05044429|Lidocaine|lidocaine|mesh-list
82942549|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
82942550|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
82942551|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942552|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942553|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
82942554|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942555|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82942556|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82942557|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82942558|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949492|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82942559|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942560|NCT02309554|Nonoxynol|nonoxynol|mesh-list
82942561|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
82942562|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
82942563|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942564|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82942565|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
82942566|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82942567|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82942568|NCT01143025|Ropivacaine|ropivacaine|mesh-list
82942569|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
82942571|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942572|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942573|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
82942574|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942575|NCT03502642|Morphine|morphine|mesh-list
82942576|NCT03502642|Ropivacaine|ropivacaine|mesh-list
82942577|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
82942578|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942579|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942580|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82942581|NCT03502642|Narcotics|narcotics|mesh-ancestor
82942582|NCT03502642|Analgesics|analgesics|mesh-ancestor
82942583|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
82942584|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942585|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
82942586|NCT02306278|Gabapentin|gabapentin|mesh-list
82942587|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942588|NCT02306278|Analgesics|analgesics|mesh-ancestor
82942589|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
82942590|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942591|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
82942592|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82942593|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82942594|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942595|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82942596|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82942597|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82942598|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942599|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942600|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
82942601|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
82942602|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82942603|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942604|NCT02313922|Etanercept|etanercept|mesh-list
82942605|NCT02313922|Methotrexate|methotrexate|mesh-list
82942606|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82942607|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
82942608|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82942609|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942610|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82942611|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
82942612|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942613|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942614|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
82942615|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942616|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82942617|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82942618|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
82942619|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942620|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82942621|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942622|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942623|NCT02313922|Analgesics|analgesics|mesh-ancestor
82942624|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
82942625|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942626|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942627|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942628|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82942629|NCT04629781|Docetaxel|docetaxel|mesh-list
82942630|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942631|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
82942632|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
82942633|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
82942634|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942636|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82942637|NCT03508102|Narcotics|narcotics|mesh-ancestor
82942638|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942639|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942640|NCT03508102|Analgesics|analgesics|mesh-ancestor
82942641|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
82942642|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942643|NCT03505528|Paclitaxel|paclitaxel|mesh-list
82942644|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82942646|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82942647|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942648|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
82942649|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
82942650|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
82942651|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942652|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
82942653|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82942654|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82942655|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942657|NCT01234285|Calcium heparin|calcium heparin|mesh-list
82942658|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
82942659|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82942660|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942661|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942662|NCT02314312|Cyclosporine|cyclosporine|mesh-list
82942663|NCT02314312|Prednisolone|prednisolone|mesh-list
82942664|NCT02314312|Everolimus|everolimus|mesh-list
82942665|NCT02314312|Cyclosporins|cyclosporins|mesh-list
82942666|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942667|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942668|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82942669|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
82942670|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942671|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
82942672|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942673|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
82942674|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942675|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82942676|NCT02314312|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82942677|NCT02314312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82942678|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942679|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942680|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
82942681|NCT02314312|Hormones|hormones|mesh-ancestor
82942682|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942683|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82942684|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
82942685|NCT02316340|Vorinostat|vorinostat|mesh-list
82942686|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
82942687|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82942688|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82942689|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942690|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942691|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942692|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942693|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942694|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82942695|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82942696|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82942697|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
82942698|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942699|NCT02310490|Mannitol|mannitol|mesh-list
82942700|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82942701|NCT02310490|Diuretics|diuretics|mesh-ancestor
82942702|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
82942703|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942704|NCT02316496|Irinotecan|irinotecan|mesh-list
82942705|NCT02316496|Cetuximab|cetuximab|mesh-list
82942706|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82942707|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82942708|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942709|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942710|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942711|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942712|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
82942713|NCT01140529|Haloperidol|haloperidol|mesh-list
82942714|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
82942715|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82942716|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942717|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942718|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942719|NCT01140529|Analgesics|analgesics|mesh-ancestor
82942720|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
82942721|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942722|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82942723|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82942724|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82942725|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
82942726|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942727|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942729|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
82942730|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942731|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82942732|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82942733|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82942734|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82942735|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
82942736|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82942737|NCT01141153|Aspirin|aspirin|mesh-list
82942738|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
82942739|NCT01141153|Clopidogrel|clopidogrel|mesh-list
82942740|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82942741|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82942742|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82942743|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82942744|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
82942745|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942746|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942747|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942748|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942749|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942750|NCT01141153|Analgesics|analgesics|mesh-ancestor
82942751|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
82942752|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942753|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942754|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942755|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82942756|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942757|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82942758|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942759|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
82942760|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
82942761|NCT01235143|Sevoflurane|sevoflurane|mesh-list
82942762|NCT01235143|Desflurane|desflurane|mesh-list
82942763|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82942764|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82942765|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
82942766|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
82942767|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942768|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942769|NCT01238029|Capecitabine|capecitabine|mesh-list
82942770|NCT01238029|Vinorelbine|vinorelbine|mesh-list
82942771|NCT01238029|Lapatinib|lapatinib|mesh-list
82942772|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82942773|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
82942774|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942775|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942776|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82942777|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
82942778|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
82942779|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
82942780|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82942781|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942782|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
82942783|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82942784|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82942785|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942786|NCT03139604|Prednisone|prednisone|mesh-list
82942787|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
82942788|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82942789|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82942790|NCT03139604|Prednisolone|prednisolone|mesh-list
82942791|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
82942792|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82942793|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
82942794|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942795|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
82942796|NCT03139604|Hormones|hormones|mesh-ancestor
82942797|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942798|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942799|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82942800|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942801|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
82942802|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
82942803|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942804|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942805|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82942806|NCT03139604|Protective Agents|protective agents|mesh-ancestor
82942807|NCT01350596|Ibuprofen|ibuprofen|mesh-list
82942808|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942809|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942810|NCT01350596|Analgesics|analgesics|mesh-ancestor
82942811|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
82942812|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942813|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942814|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942815|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942816|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82942817|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942818|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942819|NCT04462588|Metronidazole|metronidazole|mesh-list
82942820|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942821|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82942822|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82942823|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82942824|NCT04462822|Fluticasone|fluticasone|mesh-list
82942825|NCT04462822|Xhance|xhance|mesh-list
82942826|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82942827|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82942828|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942829|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82942830|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
82942831|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942832|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942833|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82942834|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
82942835|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
82942836|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82942837|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82942838|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82942839|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82942840|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
82942841|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942842|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942843|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
82942844|NCT04462822|Hormones|hormones|mesh-ancestor
82942845|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942846|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
82942847|NCT01362218|Aspirin|aspirin|mesh-list
82942848|NCT01362218|Ramipril|ramipril|mesh-list
82942849|NCT01362218|Simvastatin|simvastatin|mesh-list
82942850|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82942851|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82942852|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
82942853|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942854|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82942855|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82942856|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942857|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942858|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942859|NCT01362218|Analgesics|analgesics|mesh-ancestor
82942860|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
82942861|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942862|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942863|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942864|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942865|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82942866|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82942867|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82942868|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82942869|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
82942870|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82942871|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
82942872|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82942873|NCT02316964|Aldesleukin|aldesleukin|mesh-list
82942874|NCT02316964|Decitabine|decitabine|mesh-list
82942875|NCT02316964|Azacitidine|azacitidine|mesh-list
82942876|NCT02316964|Interleukin-2|interleukin-2|mesh-list
82942877|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82942878|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
82942879|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942880|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942881|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942882|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942883|NCT02316964|Analgesics|analgesics|mesh-ancestor
82942884|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
82942885|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942886|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942887|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82942888|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82942889|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
82942890|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942891|NCT02875340|Risperidone|risperidone|mesh-list
82942892|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82942893|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
82942894|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942895|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942896|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942897|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82942898|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82942899|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82942900|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82942901|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82942902|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
82942903|NCT04462666|Etoricoxib|etoricoxib|mesh-list
82942904|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942905|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942906|NCT04462666|Analgesics|analgesics|mesh-ancestor
82942907|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
82942908|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942909|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942910|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942911|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942912|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82942913|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82942914|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942915|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942916|NCT01359020|Acetaminophen|acetaminophen|mesh-list
82942917|NCT01359020|Dipyrone|dipyrone|mesh-list
82942918|NCT01359020|Ibuprofen|ibuprofen|mesh-list
82942919|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82942920|NCT01359020|Analgesics|analgesics|mesh-ancestor
82942921|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
82942922|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942923|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942924|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
82942925|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82942926|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942927|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82942928|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82942929|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942930|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942931|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
82942932|NCT01359098|Dexamethasone|dexamethasone|mesh-list
82942933|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942934|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
82942935|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
82942936|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942937|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942938|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82942939|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
82942940|NCT01359098|Hormones|hormones|mesh-ancestor
82942941|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942942|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82942943|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942944|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942945|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942946|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82942947|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82942948|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82942949|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82942950|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82942951|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82942952|NCT01319240|Insulin|insulin|mesh-list
82942953|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82942954|NCT01319240|Liraglutide|liraglutide|mesh-list
82942955|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
82942956|NCT01319240|Xultophy|xultophy|mesh-list
82942957|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82942958|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942959|NCT01319240|Incretins|incretins|mesh-ancestor
82942960|NCT01319240|Hormones|hormones|mesh-ancestor
82942961|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942962|NCT04463056|Eculizumab|eculizumab|mesh-list
82942963|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82942964|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82942965|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
82942966|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942967|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
82942968|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82942969|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82942970|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942971|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
82942972|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82942973|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942974|NCT03319316|Durvalumab|durvalumab|mesh-list
82942975|NCT03319316|Tremelimumab|tremelimumab|mesh-list
82942976|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82942977|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942978|NCT02316028|Decitabine|decitabine|mesh-list
82942979|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82942980|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
82942981|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82942982|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82942983|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82942984|NCT01359488|Hormones|hormones|mesh-list
82942985|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
82942986|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82942987|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82942988|NCT01141465|Fluticasone|fluticasone|mesh-list
82942989|NCT01141465|Xhance|xhance|mesh-list
82942990|NCT01141465|Budesonide|budesonide|mesh-list
82942991|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
82942992|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82942993|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82942994|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82942995|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82942996|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82942997|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
82942998|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82942999|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943000|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82943001|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
82943002|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
82943003|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82943004|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
82943005|NCT01141465|Hormones|hormones|mesh-ancestor
82943006|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943007|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82943008|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82943009|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82943010|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
82943011|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943012|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943013|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
82943014|NCT01141543|Plerixafor|plerixafor|mesh-list
82943015|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82943016|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82943017|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
82943018|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943019|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82943020|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82943021|NCT03300518|Estradiol|estradiol|mesh-list
82943022|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82943023|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82943025|NCT03300518|Estrogens|estrogens|mesh-ancestor
82943026|NCT03300518|Hormones|hormones|mesh-ancestor
82943027|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943028|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943029|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82943030|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
82943031|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82943032|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82943033|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
82943034|NCT02317198|Clopidogrel|clopidogrel|mesh-list
82943035|NCT02317198|Ticagrelor|ticagrelor|mesh-list
82943036|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82943037|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82943038|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82943039|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82943040|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82943041|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
82943042|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943043|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943044|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943045|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
82943046|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82943047|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
82943048|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943049|NCT01359722|Expectorants|expectorants|mesh-ancestor
82943050|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
82943051|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82943052|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
82943053|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943054|NCT01359722|Protective Agents|protective agents|mesh-ancestor
82943055|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943056|NCT01359722|Antidotes|antidotes|mesh-ancestor
82943057|NCT01238185|Aspirin|aspirin|mesh-list
82943058|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82943059|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82943060|NCT01238185|Analgesics|analgesics|mesh-ancestor
82943061|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
82943062|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943063|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943064|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943065|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82943066|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82943067|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82943068|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943069|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82943070|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82943071|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943072|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
82943073|NCT01143805|Tofacitinib|tofacitinib|mesh-list
82943074|NCT01143805|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82943075|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82943076|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943077|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943078|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
82943079|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943080|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82943081|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943082|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943083|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
82943084|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943085|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943086|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82943087|NCT03498118|Bupivacaine|bupivacaine|mesh-list
82943088|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
82943089|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
82943090|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943091|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943092|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
82943093|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943094|NCT05188742|Mirabegron|mirabegron|mesh-list
82943095|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82943096|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82943097|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82943098|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
82943099|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943100|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943101|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943102|NCT05188742|Urological Agents|urological agents|mesh-ancestor
82943103|NCT02324452|Fluorouracil|fluorouracil|mesh-list
82943104|NCT02324452|Capecitabine|capecitabine|mesh-list
82943105|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
82943106|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943107|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82943108|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943109|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943110|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
82943111|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943112|NCT02321176|Resveratrol|resveratrol|mesh-list
82943113|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
82943114|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943115|NCT02321176|Protective Agents|protective agents|mesh-ancestor
82943116|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943117|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943118|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82943119|NCT01351298|Lidocaine|lidocaine|mesh-list
82943120|NCT01351298|Xylometazoline|xylometazoline|mesh-list
82943121|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
82943122|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
82943123|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83459605|NCT01181323|Vaccines|vaccines|mesh-list
82943124|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943125|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
82943126|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943127|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82943128|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82943129|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82943130|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943131|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943132|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
82943133|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82943134|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
82943135|NCT02324686|Vitamin K|vitamin k|mesh-list
82943136|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
82943137|NCT02324686|Vitamins|vitamins|mesh-ancestor
82943138|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
82943139|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943140|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82943141|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82943142|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943143|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
82943144|NCT02324686|Coagulants|coagulants|mesh-ancestor
82943145|NCT01360034|Indomethacin|indomethacin|mesh-list
82943146|NCT01360034|Nifedipine|nifedipine|mesh-list
82943147|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82943148|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943149|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943150|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82943151|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943152|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
82943153|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
82943154|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82943155|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82943156|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82943157|NCT01360034|Analgesics|analgesics|mesh-ancestor
82943158|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
82943159|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943160|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943161|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82943162|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
82943163|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82943164|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943165|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82943166|NCT01363310|Escitalopram|escitalopram|mesh-list
82943167|NCT01363310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82943168|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82943169|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943170|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943171|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943172|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
82943173|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943174|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
82943175|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82943176|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82943177|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82943178|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943179|NCT01363544|Methylphenidate|methylphenidate|mesh-list
82943180|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82943181|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943182|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82943183|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82943184|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943185|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943186|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
82943187|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943188|NCT03257618|Temozolomide|temozolomide|mesh-list
82943189|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82943190|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
82943191|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943192|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943193|NCT01363778|Tivozanib|tivozanib|mesh-list
82943194|NCT01363778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82943195|NCT01363778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943196|NCT01363778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943197|NCT04175834|Cetirizine|cetirizine|mesh-list
82943198|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
82943199|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
82943200|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82943201|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82943202|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
82943203|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943204|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943205|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943206|NCT02324998|Olaparib|olaparib|mesh-list
82943207|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82943208|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943209|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943210|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943211|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
82943212|NCT03500848|Sirolimus|sirolimus|mesh-list
82943213|NCT03500848|Tacrolimus|tacrolimus|mesh-list
82943214|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943215|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
82943216|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943217|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82943218|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943219|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943220|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82943221|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943222|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82943223|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
82943224|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82943225|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943226|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
82943227|NCT01360190|Fluoxetine|fluoxetine|mesh-list
82943228|NCT01360190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82943229|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82943230|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943231|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943232|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943233|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
82943234|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943235|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82943236|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
82943237|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82943238|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82943239|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82943240|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943241|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
82943242|NCT01363934|Hematinics|hematinics|mesh-ancestor
82943243|NCT03132376|Caseins|caseins|mesh-list
82943244|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
82943245|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
82943246|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943247|NCT01364012|Paclitaxel|paclitaxel|mesh-list
82943248|NCT01364012|Bevacizumab|bevacizumab|mesh-list
82943249|NCT01364012|Carboplatin|carboplatin|mesh-list
82943250|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82943251|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943252|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
82943253|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
82943254|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
82943255|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943256|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943257|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82943258|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82943259|NCT01364012|Growth Substances|growth substances|mesh-ancestor
82943260|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943261|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
82943262|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82943263|NCT02318056|Bacitracin|bacitracin|mesh-list
82943264|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82943265|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943266|NCT02318056|Laxatives|laxatives|mesh-ancestor
82943267|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943268|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82943269|NCT01360424|Teriparatide|teriparatide|mesh-list
82943270|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82943271|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943272|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82943273|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
82943274|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82943275|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943276|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
82943277|NCT01364402|Hematinics|hematinics|mesh-ancestor
82943278|NCT03552380|Nivolumab|nivolumab|mesh-list
82943279|NCT03552380|Ipilimumab|ipilimumab|mesh-list
82943280|NCT03552380|Entinostat|entinostat|mesh-list
82943281|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943282|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943283|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82943284|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943285|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82943286|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943287|NCT02318290|Analgesics|analgesics|mesh-list
82943288|NCT02318290|Narcotics|narcotics|mesh-list
82943289|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
82943290|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943291|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943292|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943293|NCT03467360|Etoposide|etoposide|mesh-list
82943294|NCT03467360|Acetazolamide|acetazolamide|mesh-list
82943295|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82943296|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943297|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82943298|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82943299|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943300|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943301|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
82943302|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82943303|NCT03467360|Diuretics|diuretics|mesh-ancestor
82943304|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
82943305|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943306|NCT03452072|Timolol|timolol|mesh-list
82943307|NCT03452072|Petrolatum|petrolatum|mesh-list
82943308|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82943309|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82943310|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
82943311|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943312|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943313|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943314|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82943315|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82943318|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82943319|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82943320|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82943321|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
82943322|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943323|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943324|NCT03433040|Progestins|progestins|mesh-ancestor
82943325|NCT03433040|Hormones|hormones|mesh-ancestor
82943326|NCT02318446|Folic Acid|folic acid|mesh-list
82943327|NCT02318446|Hematinics|hematinics|mesh-ancestor
82943328|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
82943329|NCT02318446|Vitamins|vitamins|mesh-ancestor
82943330|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
82943331|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943332|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82943333|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82943334|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82943335|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
82943336|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943337|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
82943338|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82943339|NCT01360658|Antibodies|antibodies|mesh-list
82943340|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
82943341|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82943342|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
82943343|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943344|NCT02318758|Ethanol|ethanol|mesh-list
82943345|NCT02318758|Treprostinil|treprostinil|mesh-list
82943346|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82943347|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943348|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943349|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943350|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82943351|NCT02441686|Dexamethasone|dexamethasone|mesh-list
82943352|NCT02441686|Lenalidomide|lenalidomide|mesh-list
82943353|NCT02441686|Bortezomib|bortezomib|mesh-list
82943354|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943355|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
82943356|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
82943357|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943358|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943359|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943360|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
82943361|NCT02441686|Hormones|hormones|mesh-ancestor
82943362|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943363|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82943364|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943365|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
82943366|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82943367|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82943368|NCT02441686|Growth Substances|growth substances|mesh-ancestor
82943369|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
82943370|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
82943371|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
82943372|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943373|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943374|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943375|NCT01352234|Aspirin|aspirin|mesh-list
82943376|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82943377|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82943378|NCT01352234|Analgesics|analgesics|mesh-ancestor
82943379|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
82943380|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943381|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943382|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943383|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82943384|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82943385|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82943386|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943387|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82943388|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82943389|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943390|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
82943391|NCT01364792|Valacyclovir|valacyclovir|mesh-list
82943393|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943394|NCT02318836|Lofexidine|lofexidine|mesh-list
82943395|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82943396|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82943397|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943398|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
82943399|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943400|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82943401|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82943402|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82943403|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
82943404|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943405|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943406|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82943407|NCT01352312|Ofatumumab|ofatumumab|mesh-list
82943408|NCT01352312|Pentostatin|pentostatin|mesh-list
82943409|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82943410|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
82943411|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943412|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943413|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
82943414|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943415|NCT02939209|Hydromorphone|hydromorphone|mesh-list
82943416|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82943417|NCT02939209|Narcotics|narcotics|mesh-ancestor
82943418|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943419|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943420|NCT02939209|Analgesics|analgesics|mesh-ancestor
82943421|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
82943422|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943423|NCT01141855|Varenicline|varenicline|mesh-list
82943424|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82943425|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82943426|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
82943427|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943428|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943429|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943430|NCT01236859|Gabapentin|gabapentin|mesh-list
82943431|NCT01236859|Analgesics|analgesics|mesh-ancestor
82943432|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
82943433|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943434|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943435|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
82943436|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82943437|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82943438|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943439|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82943440|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82943441|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82943442|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943443|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943444|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
82943445|NCT01145365|Anesthetics|anesthetics|mesh-list
82943446|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943447|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943448|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
82943449|NCT01365104|Deferoxamine|deferoxamine|mesh-list
82943450|NCT01365104|Siderophores|siderophores|mesh-ancestor
82943451|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82943452|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
82943453|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
82943454|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943455|NCT03492970|Melatonin|melatonin|mesh-list
82943456|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
82943457|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943458|NCT03492970|Protective Agents|protective agents|mesh-ancestor
82943459|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943460|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943461|NCT01362374|Leucovorin|leucovorin|mesh-list
82943462|NCT01362374|Paclitaxel|paclitaxel|mesh-list
82943463|NCT01362374|Docetaxel|docetaxel|mesh-list
82943464|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
82943465|NCT01362374|Ipatasertib|ipatasertib|mesh-list
82943466|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82943467|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943469|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
82943470|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
82943471|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943472|NCT01362374|Antidotes|antidotes|mesh-ancestor
82943473|NCT01362374|Protective Agents|protective agents|mesh-ancestor
82943474|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943475|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
82943476|NCT01362374|Vitamins|vitamins|mesh-ancestor
82943477|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
82943478|NCT01362374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82943479|NCT01362374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943480|NCT01142011|Belimumab|belimumab|mesh-list
82943481|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943482|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
82943483|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943484|NCT02319460|Thrombin|thrombin|mesh-list
82943485|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
82943486|NCT02319460|Coagulants|coagulants|mesh-ancestor
82943487|NCT04722952|Cytarabine|cytarabine|mesh-list
82943488|NCT04722952|Azacitidine|azacitidine|mesh-list
82943489|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
82943490|NCT04722952|Visilizumab|visilizumab|mesh-list
82943491|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82943492|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
82943493|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943494|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943495|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
82943496|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943497|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943498|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
82943499|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943500|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943501|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82943502|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82943503|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
82943504|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82943505|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
82943506|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943507|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
82943508|NCT01365260|Protective Agents|protective agents|mesh-ancestor
82943509|NCT01235455|Interferons|interferons|mesh-list
82943510|NCT01235455|Interferon-beta|interferon-beta|mesh-list
82943511|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
82943512|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943513|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
82943514|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943515|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
82943516|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943517|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82943518|NCT01145677|Topiramate|topiramate|mesh-list
82943519|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
82943520|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82943521|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943522|NCT02319616|Clobetasol|clobetasol|mesh-list
82943523|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943524|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
82943525|NCT02319616|Hormones|hormones|mesh-ancestor
82943526|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943527|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943528|NCT01142245|Esomeprazole|esomeprazole|mesh-list
82943529|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82943530|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943531|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82943532|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943533|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943534|NCT02319772|Galidesivir|galidesivir|mesh-list
82943535|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
82943536|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943537|NCT03499132|Anesthetics|anesthetics|mesh-list
82943538|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943539|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943540|NCT01142401|Bortezomib|bortezomib|mesh-list
82943541|NCT01142401|Fulvestrant|fulvestrant|mesh-list
82943542|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943543|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82943544|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82943545|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82943546|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
82943547|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943548|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943549|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
82943550|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943551|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943552|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943553|NCT03498820|Remifentanil|remifentanil|mesh-list
82943554|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82943555|NCT03498820|Narcotics|narcotics|mesh-ancestor
82943556|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943557|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943558|NCT03498820|Analgesics|analgesics|mesh-ancestor
82943559|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
82943560|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943562|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
82943563|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
82943564|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
82943565|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943566|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943567|NCT02320084|Nitisinone|nitisinone|mesh-list
82943568|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943569|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943570|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82943571|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
82943572|NCT02320240|Citalopram|citalopram|mesh-list
82943573|NCT02320240|Fluoxetine|fluoxetine|mesh-list
82943574|NCT02320240|Paroxetine|paroxetine|mesh-list
82943575|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82943576|NCT02320240|Sertraline|sertraline|mesh-list
82943577|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82943578|NCT02320240|Escitalopram|escitalopram|mesh-list
82943579|NCT02320240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82943580|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82943581|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943582|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943583|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943584|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
82943585|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943586|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943587|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82943588|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
82943589|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82943590|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82943591|NCT02320240|Analgesics|analgesics|mesh-ancestor
82943592|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
82943593|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
82943594|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82943595|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82943596|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943597|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82943598|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82943599|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943600|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82943601|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82943602|NCT03492736|Melatonin|melatonin|mesh-list
82943603|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
82943604|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943605|NCT03492736|Protective Agents|protective agents|mesh-ancestor
82943606|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943607|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943608|NCT02320474|Aflibercept|aflibercept|mesh-list
82943609|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82943610|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82943611|NCT02320474|Growth Substances|growth substances|mesh-ancestor
82943612|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943613|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
82943614|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943616|NCT03492580|Empagliflozin|empagliflozin|mesh-list
82943617|NCT03492580|Canagliflozin|canagliflozin|mesh-list
82943618|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
82943619|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82943620|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82943621|NCT03492580|Glucagon|glucagon|mesh-list
82943622|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82943623|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943624|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82943625|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943626|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943627|NCT03492580|Hormones|hormones|mesh-ancestor
82943628|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943629|NCT03492580|Incretins|incretins|mesh-ancestor
82943630|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
82943631|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943632|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
82943633|NCT01238965|Leucovorin|leucovorin|mesh-list
82943634|NCT01238965|Fluorouracil|fluorouracil|mesh-list
82943635|NCT01238965|Panobinostat|panobinostat|mesh-list
82943636|NCT01238965|Calcium|calcium|mesh-list
82943637|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
82943638|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82943639|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82943640|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943641|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82943642|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
82943643|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943644|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82943645|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943646|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943647|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
82943648|NCT01238965|Antidotes|antidotes|mesh-ancestor
82943649|NCT01238965|Protective Agents|protective agents|mesh-ancestor
82943650|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
82943651|NCT01238965|Vitamins|vitamins|mesh-ancestor
82943652|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
82943653|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943654|NCT01142557|Interferons|interferons|mesh-list
82943655|NCT01142557|Interferon-beta|interferon-beta|mesh-list
82943656|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
82943657|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943658|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
82943659|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943660|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
82943661|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943662|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82943663|NCT04496908|Misoprostol|misoprostol|mesh-list
82943664|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82943665|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
82943666|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82943667|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943668|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82943669|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943670|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
82943671|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
82943672|NCT01144117|Hematinics|hematinics|mesh-ancestor
82943673|NCT04371640|Sirolimus|sirolimus|mesh-list
82943674|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82943675|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943676|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82943677|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943678|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
82943679|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943680|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
82943681|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943682|NCT04356196|Verapamil|verapamil|mesh-list
82943683|NCT04356196|Bisoprolol|bisoprolol|mesh-list
82943684|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82943685|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82943686|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943687|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943688|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82943689|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943690|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
82943691|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82943692|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
82943693|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
82943694|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943695|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82943696|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82943697|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82943698|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
82943699|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943700|NCT02115139|Ipilimumab|ipilimumab|mesh-list
82943701|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943702|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943703|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82943704|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943705|NCT02047981|Azithromycin|azithromycin|mesh-list
82943706|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82943707|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943708|NCT04802356|Dexamethasone|dexamethasone|mesh-list
82943709|NCT04802356|Lenalidomide|lenalidomide|mesh-list
82943710|NCT04802356|Bortezomib|bortezomib|mesh-list
82943711|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943712|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
82943713|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
82943714|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943715|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943716|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943717|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
82943718|NCT04802356|Hormones|hormones|mesh-ancestor
82943719|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943720|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82943721|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943722|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
82943723|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82943724|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82943725|NCT04802356|Growth Substances|growth substances|mesh-ancestor
82943726|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
82943727|NCT01142635|Bromides|bromides|mesh-list
82943728|NCT01142635|Rocuronium|rocuronium|mesh-list
82943729|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
82943730|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82943731|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82943732|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82943733|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943734|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943735|NCT01144195|Panitumumab|panitumumab|mesh-list
82943736|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943737|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943738|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
82943739|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82943740|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82943741|NCT02528383|Estradiol|estradiol|mesh-list
82943742|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82943743|NCT02528383|Estrogens|estrogens|mesh-ancestor
82943744|NCT02528383|Hormones|hormones|mesh-ancestor
82943745|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943746|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943747|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82943748|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
82943749|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82943750|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82943751|NCT01146067|Rivastigmine|rivastigmine|mesh-list
82943752|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82943753|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943754|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943755|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
82943756|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943757|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943758|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82943759|NCT01146067|Protective Agents|protective agents|mesh-ancestor
82943760|NCT01237249|Dexamethasone|dexamethasone|mesh-list
82943761|NCT01237249|Prednisone|prednisone|mesh-list
82943762|NCT01237249|Melphalan|melphalan|mesh-list
82943763|NCT01237249|Lenalidomide|lenalidomide|mesh-list
82943764|NCT01237249|Bortezomib|bortezomib|mesh-list
82943765|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943766|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
82943767|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
82943768|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943769|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943770|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943771|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
82943772|NCT01237249|Hormones|hormones|mesh-ancestor
82943773|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943774|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82943775|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943776|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82943777|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
82943778|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943779|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82943780|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943781|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
82943782|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82943783|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82943784|NCT01237249|Growth Substances|growth substances|mesh-ancestor
82943785|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
82943786|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
82943787|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82943788|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
82943789|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943790|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943791|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82943792|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
82943793|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82943794|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82943795|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82943796|NCT01244347|Folic Acid|folic acid|mesh-list
82943797|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
82943798|NCT01244347|Hematinics|hematinics|mesh-ancestor
82943799|NCT01244347|Vitamins|vitamins|mesh-ancestor
82943800|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
82943801|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943802|NCT01763827|Ezetimibe|ezetimibe|mesh-list
82943803|NCT01763827|Evolocumab|evolocumab|mesh-list
82943804|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82943805|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82943806|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82943807|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
82943808|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943809|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82943810|NCT01763827|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82943811|NCT01763827|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82943812|NCT01763827|Protease Inhibitors|protease inhibitors|mesh-ancestor
82943813|NCT01763827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943814|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
82943815|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943816|NCT01146145|Ketamine|ketamine|mesh-list
82943817|NCT01146145|Morphine|morphine|mesh-list
82943818|NCT01146145|Analgesics|analgesics|mesh-ancestor
82943819|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
82943820|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943821|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943822|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82943823|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82943824|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
82943825|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
82943826|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943827|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82943828|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82943829|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943830|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943831|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82943832|NCT01146145|Narcotics|narcotics|mesh-ancestor
82943833|NCT01146535|Interferons|interferons|mesh-list
82943834|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
82943835|NCT01146535|Oseltamivir|oseltamivir|mesh-list
82943836|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943837|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
82943838|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943839|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
82943840|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943841|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943842|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943843|NCT01732783|Panitumumab|panitumumab|mesh-list
83517715|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
82943844|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943845|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943847|NCT04355728|Calcium heparin|calcium heparin|mesh-list
82943848|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
82943850|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82943851|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943853|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943854|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943855|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82943856|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943857|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
82943858|NCT02528461|Liver Extracts|liver extracts|mesh-list
82943859|NCT02528461|Hematinics|hematinics|mesh-ancestor
82943860|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
82943861|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82943862|NCT01237483|Cetuximab|cetuximab|mesh-list
82943863|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943864|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943865|NCT01240213|Vitamin D|vitamin d|mesh-list
82943866|NCT01240213|Vitamins|vitamins|mesh-ancestor
82943867|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
82943868|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943869|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82943870|NCT01375777|Ezetimibe|ezetimibe|mesh-list
82943871|NCT01375777|Evolocumab|evolocumab|mesh-list
82943872|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82943873|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82943874|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82943875|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
82943876|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943877|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82943878|NCT01375777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82943879|NCT01375777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82943880|NCT01375777|Protease Inhibitors|protease inhibitors|mesh-ancestor
82943881|NCT01375777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943882|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
82943883|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943884|NCT02431702|Haloperidol|haloperidol|mesh-list
82943885|NCT02431702|Olanzapine|olanzapine|mesh-list
82943886|NCT02431702|Risperidone|risperidone|mesh-list
82943887|NCT02431702|Aripiprazole|aripiprazole|mesh-list
82943888|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82943889|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82943890|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
82943891|NCT02431702|Perphenazine|perphenazine|mesh-list
82943892|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82943893|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
82943894|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943895|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943896|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943897|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82943898|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82943899|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943900|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82943901|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82943902|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
82943903|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
82943904|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
82943905|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943906|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82943907|NCT02431702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82943908|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82943909|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82943910|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
82943911|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
82943912|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82943913|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82943914|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82943915|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82943916|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82943917|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
82943918|NCT01145209|Fludarabine|fludarabine|mesh-list
82943919|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
82943920|NCT01145209|Ofatumumab|ofatumumab|mesh-list
82943921|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943922|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
82943923|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943924|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82943925|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82943926|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
82943927|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943928|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943929|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82943930|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82943931|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
82943932|NCT02086552|Lenalidomide|lenalidomide|mesh-list
82943933|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
82943934|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943935|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83459706|NCT03709459|Doxycycline|doxycycline|mesh-list
82943936|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82943937|NCT02086552|Growth Substances|growth substances|mesh-ancestor
82943938|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
82943939|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943940|NCT02321878|Liraglutide|liraglutide|mesh-list
82943941|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82943942|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943943|NCT02321878|Incretins|incretins|mesh-ancestor
82943944|NCT02321878|Hormones|hormones|mesh-ancestor
82943945|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82943946|NCT03625141|Atezolizumab|atezolizumab|mesh-list
82943947|NCT03625141|Vemurafenib|vemurafenib|mesh-list
82943948|NCT03625141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82943949|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943950|NCT03625141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82943951|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943952|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82943953|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943954|NCT03491410|Aspirin|aspirin|mesh-list
82943955|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82943956|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82943957|NCT03491410|Analgesics|analgesics|mesh-ancestor
82943958|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
82943959|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943960|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943961|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82943962|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82943963|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82943964|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82943965|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943966|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82943967|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82943968|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943969|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
82943970|NCT00876031|Etoposide|etoposide|mesh-list
82943971|NCT00876031|Idarubicin|idarubicin|mesh-list
82943972|NCT00876031|Trofosfamide|trofosfamide|mesh-list
82943973|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82943974|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82943975|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82943976|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82943977|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82943978|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82943979|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82943980|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82943981|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
82943982|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943983|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82943984|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
82943985|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
82943986|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
82943987|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
82943988|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82943989|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82943990|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
82943991|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82943992|NCT01146301|Clopidogrel|clopidogrel|mesh-list
82943993|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82943994|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82943995|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82943996|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82943997|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
82943998|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82943999|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944000|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944002|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82944003|NCT00807859|Capecitabine|capecitabine|mesh-list
82944004|NCT00807859|Trastuzumab|trastuzumab|mesh-list
82944005|NCT00807859|Lapatinib|lapatinib|mesh-list
82944006|NCT00807859|Trebananib|trebananib|mesh-list
82944007|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82944008|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944009|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
82944010|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
82944011|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
82944012|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944013|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82944014|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
82944015|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82944016|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82944017|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944018|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82944019|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82944020|NCT00807859|Growth Substances|growth substances|mesh-ancestor
82944021|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944022|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
82944023|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82944024|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82944025|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82944026|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944027|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
82944028|NCT03491098|Prednisolone|prednisolone|mesh-list
82944029|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82944030|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
82944031|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82944032|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
82944033|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82944034|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
82944035|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944036|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
82944037|NCT03491098|Hormones|hormones|mesh-ancestor
82944038|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944039|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944040|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82944041|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944042|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
82944043|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
82944044|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944045|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944046|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82944047|NCT03491098|Protective Agents|protective agents|mesh-ancestor
82944048|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
82944049|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82944050|NCT02322502|Propofol|propofol|mesh-list
82944051|NCT02322502|Sevoflurane|sevoflurane|mesh-list
82944052|NCT02322502|Desflurane|desflurane|mesh-list
82944053|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82944054|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944055|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944056|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82944057|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
82944058|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
82944059|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82944060|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82944061|NCT02322580|Etanercept|etanercept|mesh-list
82944062|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82944063|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82944064|NCT02322580|Analgesics|analgesics|mesh-ancestor
82944065|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
82944066|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944067|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944068|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944069|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944070|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944071|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944072|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
82944073|NCT03190174|Sirolimus|sirolimus|mesh-list
82944076|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944077|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82944078|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944079|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82944080|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944081|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82944082|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
82944083|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944084|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
82944085|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944086|NCT03490708|Tranilast|tranilast|mesh-list
82944087|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82944088|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82944089|NCT03490708|Analgesics|analgesics|mesh-ancestor
82944090|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
82944091|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944092|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944093|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944094|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944095|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82944096|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944097|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944098|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82944099|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82944100|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
82944101|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
82944102|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944103|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82944104|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82944105|NCT00924326|Vidarabine|vidarabine|mesh-list
82944106|NCT00924326|Aldesleukin|aldesleukin|mesh-list
82944107|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
82944108|NCT00924326|Fludarabine|fludarabine|mesh-list
82944109|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
82944110|NCT00924326|Interleukin-2|interleukin-2|mesh-list
82944111|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944112|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
82944113|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944114|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944115|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82944116|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
82944117|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944118|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944119|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82944120|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82944121|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
82944122|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
82944123|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944124|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82944125|NCT00924326|Analgesics|analgesics|mesh-ancestor
82944126|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
82944127|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944128|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82944129|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82944130|NCT03496870|Levodopa|levodopa|mesh-list
82944131|NCT03496870|Carbidopa|carbidopa|mesh-list
82944132|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82944133|NCT03496870|Opicapone|opicapone|mesh-list
82944134|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82944135|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82944136|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
82944137|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944138|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944139|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944140|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82944141|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944142|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82944143|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
82944144|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
82944145|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82944146|NCT01370096|Epoprostenol|epoprostenol|mesh-list
82944147|NCT01370096|Vasopressins|vasopressins|mesh-list
82944148|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
82944149|NCT01370096|Tezosentan|tezosentan|mesh-list
82944150|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
82944151|NCT01370096|Coagulants|coagulants|mesh-ancestor
82944152|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82944153|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82944154|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
82944155|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944156|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82944157|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82944158|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
82944159|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82944160|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
82944161|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944162|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
82944163|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944164|NCT02875028|Vorapaxar|vorapaxar|mesh-list
82944165|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82944166|NCT01371344|Tacrolimus|tacrolimus|mesh-list
82944167|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944168|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
82944169|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944170|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82944171|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944172|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944173|NCT03631004|Olanzapine|olanzapine|mesh-list
82944174|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
82944175|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
82944176|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944177|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944178|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944179|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82944180|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82944181|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944182|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82944183|NCT03631004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82944184|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82944185|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944186|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944187|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944188|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
82944189|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
82944190|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944191|NCT00943618|Bupropion|bupropion|mesh-list
82944192|NCT00943618|Varenicline|varenicline|mesh-list
82944193|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82944194|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
82944195|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82944196|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82944197|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82944198|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944199|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944200|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
82944201|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944202|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944203|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82944204|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82944205|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944206|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82944207|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82944208|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
82944209|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
82944210|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
82944211|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
82944212|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82944213|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
82944214|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
82944215|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944216|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944217|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944218|NCT02322658|Eszopiclone|eszopiclone|mesh-list
82944219|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82944220|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944221|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944222|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
82944223|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82944224|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
82944225|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82944226|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
82944227|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944228|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944229|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
82944231|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82944232|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944233|NCT02710084|Oxytocin|oxytocin|mesh-list
82944234|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
82944235|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944236|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944237|NCT02849990|Prednisone|prednisone|mesh-list
82944238|NCT02849990|Cortisone|cortisone|mesh-list
82944239|NCT02849990|Indomethacin|indomethacin|mesh-list
82944240|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
82944241|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944242|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
82944243|NCT02849990|Hormones|hormones|mesh-ancestor
82944244|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944245|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944246|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82944247|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944248|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82944249|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944250|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944251|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
82944252|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82944253|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82944254|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82944255|NCT02849990|Analgesics|analgesics|mesh-ancestor
82944256|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
82944257|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944258|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944259|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
82944260|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
82944261|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944262|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82944263|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
82944264|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82944265|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944266|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
82944267|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944268|NCT03490396|Povidone|povidone|mesh-list
82944269|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
82944270|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82944271|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
82944272|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944273|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
82944274|NCT03490396|Protective Agents|protective agents|mesh-ancestor
82944275|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
82944276|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
82944277|NCT05136040|Bupivacaine|bupivacaine|mesh-list
83459744|NCT01927328|Hematinics|hematinics|mesh-ancestor
82944278|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
82944279|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
82944280|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944281|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944282|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
82944283|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944284|NCT03496246|Vitamin D|vitamin d|mesh-list
82944285|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82944286|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
82944287|NCT03496246|Calcifediol|calcifediol|mesh-list
82944288|NCT03496246|Calcium|calcium|mesh-list
82944289|NCT03496246|Vitamins|vitamins|mesh-ancestor
82944290|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
82944291|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944292|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82944293|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82944294|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
82944295|NCT02017964|Carboplatin|carboplatin|mesh-list
82944296|NCT02017964|Methotrexate|methotrexate|mesh-list
82944297|NCT02017964|Etoposide|etoposide|mesh-list
82944298|NCT02017964|Vincristine|vincristine|mesh-list
82944299|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
82944300|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
82944302|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
82944303|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944304|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944305|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82944306|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
82944307|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944308|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944309|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82944310|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82944311|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
82944312|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944313|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82944314|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
82944315|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
82944316|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944317|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82944318|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82944319|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82944320|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82944321|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82944322|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
82944323|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
82944324|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
82944325|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
82944326|NCT05121298|Upadacitinib|upadacitinib|mesh-list
82944327|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82944328|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82944329|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944330|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944331|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944332|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82944333|NCT01956110|Hormones|hormones|mesh-ancestor
82944334|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944335|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944336|NCT03489928|Misoprostol|misoprostol|mesh-list
82944337|NCT03489928|Dinoprostone|dinoprostone|mesh-list
82944338|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82944339|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
82944340|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944341|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944342|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82944343|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944344|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
82944345|NCT02323282|Ropivacaine|ropivacaine|mesh-list
82944346|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
82944347|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
82944348|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944349|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944350|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
82944351|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944352|NCT01802086|Lidocaine|lidocaine|mesh-list
82944353|NCT01802086|Prilocaine|prilocaine|mesh-list
82944354|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82944355|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
82944356|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
82944357|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944358|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944359|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
82944360|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944361|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82944362|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82944363|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82944364|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944365|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944366|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82944367|NCT05347316|Colchicine|colchicine|mesh-list
82944368|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
82944369|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944370|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
82944371|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
82944372|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
83483174|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944373|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944374|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944375|NCT03495466|Anesthetics|anesthetics|mesh-list
82944377|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944378|NCT01372826|Naloxegol|naloxegol|mesh-list
82944379|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82944380|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944381|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
82944382|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944383|NCT01371968|Alfentanil|alfentanil|mesh-list
82944384|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82944385|NCT01371968|Narcotics|narcotics|mesh-ancestor
82944386|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944387|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944388|NCT01371968|Analgesics|analgesics|mesh-ancestor
82944389|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
82944390|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944391|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82944392|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
82944393|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
82944394|NCT04989322|Carboplatin|carboplatin|mesh-list
82944395|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
82944396|NCT04989322|Pemetrexed|pemetrexed|mesh-list
82944397|NCT04989322|Lenvatinib|lenvatinib|mesh-list
82944398|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944399|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82944400|NCT04989322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82944401|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944402|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944403|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82944404|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82944405|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82944406|NCT01367054|Metformin|metformin|mesh-list
82944407|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82944408|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944409|NCT03634514|Hormones|hormones|mesh-list
82944410|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944411|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944412|NCT02323438|Menthol|menthol|mesh-list
82944413|NCT02323438|Nicotine|nicotine|mesh-list
82944414|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82944415|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
82944416|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944417|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944418|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82944419|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82944420|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
82944421|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944422|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944423|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
82944424|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
82944425|NCT01372904|Dexamethasone|dexamethasone|mesh-list
82944426|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
82944427|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82944428|NCT01372904|BB 1101|bb 1101|mesh-list
82944429|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944430|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
82944431|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
82944432|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944433|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944434|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944435|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
82944436|NCT01372904|Hormones|hormones|mesh-ancestor
82944437|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944438|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82944439|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944440|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
82944441|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944442|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944443|NCT01372982|Letrozole|letrozole|mesh-list
82944444|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944445|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82944446|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82944447|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944448|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944449|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82944450|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
82944451|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944452|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944454|NCT02323516|Loperamide|loperamide|mesh-list
82944455|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
82944456|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82944457|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82944458|NCT02323516|Analgesics|analgesics|mesh-ancestor
82944459|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
82944460|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944461|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944462|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944463|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944464|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82944465|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82944466|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944467|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82944468|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82944469|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944470|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
82944471|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944472|NCT01367210|Maraviroc|maraviroc|mesh-list
82944473|NCT01367210|Darunavir|darunavir|mesh-list
82944474|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82944475|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82944476|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82944477|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944478|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82944479|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
82944480|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944481|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82944482|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82944483|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82944484|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
82944485|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944486|NCT02323594|Asunaprevir|asunaprevir|mesh-list
82944487|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
82944488|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944489|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944490|NCT01372280|Galantamine|galantamine|mesh-list
82944491|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82944492|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944493|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944494|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
82944495|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944496|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944497|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82944498|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
82944499|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944500|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
82944501|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
82944502|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82944503|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944504|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82944505|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944506|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
82944507|NCT04742140|Analgesics|analgesics|mesh-ancestor
82944508|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
82944509|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944510|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944511|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
82944512|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944513|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82944514|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
82944515|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82944516|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944517|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944518|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82944519|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
82944520|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944521|NCT04580992|Ajmaline|ajmaline|mesh-list
82944522|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82944523|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83517864|NCT00001023|Rifabutin|rifabutin|mesh-list
82944524|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82944525|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944526|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944527|NCT04590274|Azithromycin|azithromycin|mesh-list
82944528|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
82944529|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82944530|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944531|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
82944532|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82944533|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82944534|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944535|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944536|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944537|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
82944538|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82944539|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944540|NCT04455178|Indapamide|indapamide|mesh-list
82944541|NCT04455178|Spironolactone|spironolactone|mesh-list
82944542|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82944543|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
82944544|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944545|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944546|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82944547|NCT04455178|Diuretics|diuretics|mesh-ancestor
82944548|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
82944549|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82944550|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82944551|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944552|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944553|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
82944554|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82944555|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944556|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
82944557|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944558|NCT02446834|Metformin|metformin|mesh-list
82944559|NCT02446834|Acarbose|acarbose|mesh-list
82944560|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82944561|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944562|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82944563|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944564|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944565|NCT03489616|Pemetrexed|pemetrexed|mesh-list
82944566|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944567|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944568|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944569|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82944570|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82944571|NCT02323906|Sorafenib|sorafenib|mesh-list
82944572|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944573|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82944574|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944575|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944576|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
82944577|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
82944578|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82944579|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82944580|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944581|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944582|NCT01319942|Sorafenib|sorafenib|mesh-list
82944583|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944584|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82944585|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944586|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944587|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
82944588|NCT01373138|Ephedrine|ephedrine|mesh-list
82944589|NCT01373138|Desloratadine|desloratadine|mesh-list
82944590|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82944591|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
82944592|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944593|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944594|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944595|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82944596|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82944597|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
82944598|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
82944599|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82944600|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
82944601|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944602|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82944603|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
82944604|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
82944605|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82944606|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82944607|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
82944608|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
82944609|NCT01373216|Exenatide|exenatide|mesh-list
82944610|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82944611|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944612|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82944613|NCT01373216|Incretins|incretins|mesh-ancestor
82944614|NCT01373216|Hormones|hormones|mesh-ancestor
82944615|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944616|NCT03487354|Misoprostol|misoprostol|mesh-list
82944617|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82944618|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
82944619|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944620|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944621|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82944622|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944623|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
82944624|NCT04461340|Sirolimus|sirolimus|mesh-list
82944625|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82944626|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944627|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82944628|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944629|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
82944630|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944631|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
82944632|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944633|NCT05154968|Mannitol|mannitol|mesh-list
82944634|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82944635|NCT05154968|Diuretics|diuretics|mesh-ancestor
82944636|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
82944637|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944638|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
82944639|NCT01373372|Hormones|hormones|mesh-ancestor
82944640|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944641|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944642|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82944643|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944644|NCT02324296|Cisplatin|cisplatin|mesh-list
82944645|NCT02324296|Etoposide|etoposide|mesh-list
82944646|NCT02324296|Ifosfamide|ifosfamide|mesh-list
82944647|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944648|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82944649|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82944650|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82944651|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944652|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944653|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82944654|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
82944655|NCT03494686|Anesthetics|anesthetics|mesh-list
82944656|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944657|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944658|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
82944659|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
82944660|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944661|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944662|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944663|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
82944664|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
82944665|NCT02565914|Ivacaftor|ivacaftor|mesh-list
82944666|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82944667|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944668|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944669|NCT03881020|Fluorides|fluorides|mesh-list
82944670|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
82944671|NCT03881020|Protective Agents|protective agents|mesh-ancestor
82944672|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944673|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
82944674|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82944675|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944676|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
82944677|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944679|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82944680|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944681|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
82944682|NCT03487042|Bimatoprost|bimatoprost|mesh-list
82944683|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82944684|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82944685|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82944686|NCT03115294|Theophylline|theophylline|mesh-list
82944687|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82944688|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
82944689|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944690|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944691|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82944692|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
82944693|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82944694|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944695|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944696|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
82944697|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82944698|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82944699|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
82944700|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944701|NCT01367756|Citalopram|citalopram|mesh-list
82944702|NCT01367756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82944703|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82944704|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944705|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944706|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944707|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
82944708|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944709|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82944710|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
82944711|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82944712|NCT04624958|Rituximab|rituximab|mesh-list
82944713|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
82944714|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82944715|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944716|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
82944717|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944718|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944719|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82944720|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944721|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944722|NCT03485482|Bisoprolol|bisoprolol|mesh-list
82944723|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82944724|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
82944725|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
82944726|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944727|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944728|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82944729|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82944730|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82944731|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
82944732|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944733|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944734|NCT02946424|Simvastatin|simvastatin|mesh-list
82944735|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82944736|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82944737|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
82944738|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944739|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82944740|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82944741|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944742|NCT00783536|Etanercept|etanercept|mesh-list
82944743|NCT00783536|Methotrexate|methotrexate|mesh-list
82944744|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82944745|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
82944746|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944747|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944748|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82944749|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
82949493|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944750|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944751|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944752|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
82944753|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944754|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82944755|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944756|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
82944757|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944758|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82944759|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82944760|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82944761|NCT00783536|Analgesics|analgesics|mesh-ancestor
82944762|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
82944763|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944764|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944765|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944766|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82944767|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82944768|NCT01367912|Estradiol|estradiol|mesh-list
82944769|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82944770|NCT01367912|Estrogens|estrogens|mesh-ancestor
82944771|NCT01367912|Hormones|hormones|mesh-ancestor
82944772|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944773|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944774|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82944775|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
82944776|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82944777|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82944778|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82944779|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
82944780|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82944781|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944782|NCT03115112|Incretins|incretins|mesh-ancestor
82944783|NCT03115112|Hormones|hormones|mesh-ancestor
82944784|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944785|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82944786|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
82944787|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944788|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944789|NCT01373528|Budesonide|budesonide|mesh-list
82944790|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944791|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82944792|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
82944793|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944794|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944795|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82944796|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
82944797|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
82944798|NCT01373528|Hormones|hormones|mesh-ancestor
82944799|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944800|NCT03634202|Capecitabine|capecitabine|mesh-list
82944801|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82944802|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
82944803|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944804|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944805|NCT05019560|Sevoflurane|sevoflurane|mesh-list
82944806|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82944807|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82944808|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
82944809|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
82944810|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944811|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944812|NCT01373606|Terlipressin|terlipressin|mesh-list
82944813|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82944814|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82944815|NCT01367990|Norepinephrine|norepinephrine|mesh-list
82944816|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82944817|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82944818|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
82944819|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944820|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944821|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944822|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
82944823|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
82944824|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944825|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82944826|NCT03556358|Paclitaxel|paclitaxel|mesh-list
82944827|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
82944828|NCT03556358|Trastuzumab|trastuzumab|mesh-list
82944829|NCT03556358|Epirubicin|epirubicin|mesh-list
82944830|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82944831|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944832|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
82944833|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
82944834|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
82944835|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944836|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944837|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
82944838|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944839|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944840|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82944841|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
82944842|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82944843|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82944844|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82944845|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82944846|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82944847|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944848|NCT01374308|Interferons|interferons|mesh-list
82944849|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
82944850|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
82944851|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82944852|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944853|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
82944854|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944855|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
82944856|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944857|NCT01368068|Tibolone|tibolone|mesh-list
82944858|NCT01368068|Escitalopram|escitalopram|mesh-list
82944859|NCT01368068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82944860|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82944861|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82944862|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944863|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944864|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
82944865|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944866|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
82944867|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
82944868|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944869|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82944870|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82944871|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944872|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82944873|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
82944874|NCT01368068|Hormones|hormones|mesh-ancestor
82944875|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82944876|NCT03228680|Hormones|hormones|mesh-ancestor
82944877|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944878|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944879|NCT01373684|Tenofovir|tenofovir|mesh-list
82944880|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82944881|NCT01373684|Entecavir|entecavir|mesh-list
82944882|NCT01373684|Adefovir|adefovir|mesh-list
82944883|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
82944884|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944885|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82944886|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82944887|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944888|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944889|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82944890|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82944891|NCT04490018|Vaccines|vaccines|mesh-list
82944892|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
82944893|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944895|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
82944898|NCT02891798|Bupivacaine|bupivacaine|mesh-list
82944899|NCT02891798|BB 1101|bb 1101|mesh-list
82944900|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944901|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
82944902|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
82944903|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944904|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944905|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82944906|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
82944907|NCT02891798|Hormones|hormones|mesh-ancestor
82944908|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82944909|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82944910|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944911|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
82944912|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944913|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944914|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
82944915|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
82944916|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944917|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
82944918|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82944919|NCT02891798|Narcotics|narcotics|mesh-ancestor
82944920|NCT02891798|Analgesics|analgesics|mesh-ancestor
82944921|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82944922|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82944923|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
82944924|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82944925|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82944926|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82944927|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
82944928|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944929|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
82944930|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
82944931|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
82944932|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944933|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944934|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
82944935|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944936|NCT01374620|Paclitaxel|paclitaxel|mesh-list
82944937|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82944938|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
82944939|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82944940|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944941|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
82944942|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
82944943|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
82944944|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944945|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82944946|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
82944947|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944948|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944949|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82944950|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
82944951|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82944952|NCT01374698|Aspirin|aspirin|mesh-list
82944953|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82944954|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82944955|NCT01374698|Analgesics|analgesics|mesh-ancestor
82944956|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
82944957|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82944958|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944959|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82944960|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82944961|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82944962|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82944963|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944964|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82944965|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82944966|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82944967|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
82944968|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
82944969|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82944970|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82944971|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944972|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82944973|NCT05197088|Tamsulosin|tamsulosin|mesh-list
82944974|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82944975|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82944976|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82944977|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
82944978|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82944979|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944980|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944981|NCT05197088|Urological Agents|urological agents|mesh-ancestor
82944982|NCT01375088|Propolis|propolis|mesh-list
82944983|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82944984|NCT01368848|Bevacizumab|bevacizumab|mesh-list
82944985|NCT01368848|Docetaxel|docetaxel|mesh-list
82944986|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82944987|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82944988|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82944989|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82944990|NCT01368848|Growth Substances|growth substances|mesh-ancestor
82944991|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82944992|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
82944993|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
82944994|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
82944995|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
82944996|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82944997|NCT03604874|Oxytocin|oxytocin|mesh-list
82944998|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
82944999|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945000|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945001|NCT01369082|Cyclosporine|cyclosporine|mesh-list
82945002|NCT01369082|Sirolimus|sirolimus|mesh-list
82945003|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
82945004|NCT01369082|Tacrolimus|tacrolimus|mesh-list
82945005|NCT01369082|Cyclosporins|cyclosporins|mesh-list
82945006|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82945007|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
82945008|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945009|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82945010|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945011|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945012|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
82945013|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945014|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
82945015|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945016|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82945017|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945018|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82945019|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
82945020|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945021|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
82945022|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82945023|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82945024|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945025|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
82945026|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
82945027|NCT03135262|Rituximab|rituximab|mesh-list
82945028|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
82945029|NCT03135262|Venetoclax|venetoclax|mesh-list
83459822|NCT04558502|Antacids|antacids|mesh-ancestor
82945030|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82945031|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945032|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
82945033|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945034|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945035|NCT01375244|Lisinopril|lisinopril|mesh-list
82945036|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82945037|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
82945038|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945039|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945040|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82945041|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82945042|NCT01375244|Protective Agents|protective agents|mesh-ancestor
82945043|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945044|NCT01375322|Amlodipine|amlodipine|mesh-list
82945045|NCT01375322|Valsartan|valsartan|mesh-list
82945046|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82945047|NCT01375322|Benazepril|benazepril|mesh-list
82945048|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82945049|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82945050|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82945051|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945052|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82945053|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945054|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
82945055|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82945056|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82945057|NCT01375322|Diuretics|diuretics|mesh-ancestor
82945058|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
82945059|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82945060|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82945061|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
82945062|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945063|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
82945064|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945065|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945066|NCT01369238|Analgesics|analgesics|mesh-ancestor
82945067|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
82945068|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945069|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945070|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945071|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945072|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
82945073|NCT03485404|Vitamins|vitamins|mesh-list
82945074|NCT03485404|Folic Acid|folic acid|mesh-list
82945075|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
82945076|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
82945077|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
82945078|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945079|NCT03485404|Hematinics|hematinics|mesh-ancestor
82945080|NCT05195294|Lenvatinib|lenvatinib|mesh-list
82945081|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945082|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82945083|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945084|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945085|NCT03072628|Nicotine|nicotine|mesh-list
82945086|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82945087|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
82945088|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945089|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945090|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82945091|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82945092|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
82945093|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945094|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945095|NCT05195060|Sotrovimab|sotrovimab|mesh-list
82945096|NCT05195060|Molnupiravir|molnupiravir|mesh-list
82945097|NCT05195060|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
82945098|NCT05195060|Antiviral Agents|antiviral agents|mesh-ancestor
82945099|NCT05195060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945100|NCT03535194|Mirikizumab|mirikizumab|mesh-list
82945101|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945102|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945103|NCT03535194|Analgesics|analgesics|mesh-ancestor
82945104|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
82945105|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945106|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945107|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945108|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945109|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82945110|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82945111|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82945112|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82945113|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
82945114|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945115|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945116|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945117|NCT05194904|Ketorolac|ketorolac|mesh-list
82945118|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
82945119|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82945120|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945122|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945123|NCT05194904|Analgesics|analgesics|mesh-ancestor
82945124|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
82945125|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945126|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82945127|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82945128|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82945129|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
82945130|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945131|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945132|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945133|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945134|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945135|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82945136|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945137|NCT01375400|Aspirin|aspirin|mesh-list
82945138|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945139|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945140|NCT01375400|Analgesics|analgesics|mesh-ancestor
82945141|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
82945142|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945143|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945144|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945145|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945146|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82945147|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82945148|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945149|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82945150|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82945151|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945152|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
82945153|NCT01319864|Plerixafor|plerixafor|mesh-list
82945154|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82945155|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82945156|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
82945157|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945158|NCT05194046|Amoxicillin|amoxicillin|mesh-list
82945159|NCT05194046|Clarithromycin|clarithromycin|mesh-list
82945160|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945161|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945162|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82945163|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945164|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945165|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82945166|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82945167|NCT01369472|Carvedilol|carvedilol|mesh-list
82945168|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82945169|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82945170|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
82945171|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945172|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945173|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945174|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82945175|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
82945176|NCT01369472|Protective Agents|protective agents|mesh-ancestor
82945177|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82945178|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82945179|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82945180|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
82945181|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82945182|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82945183|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
82945184|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82945185|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
82945186|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
82945187|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
82945188|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945189|NCT05193734|Coagulants|coagulants|mesh-ancestor
82945190|NCT01375556|Ethanol|ethanol|mesh-list
82945191|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82945192|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945193|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945194|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945196|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945197|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82945198|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945199|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945200|NCT02091934|Dipivefrin|dipivefrin|mesh-list
82945201|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82945202|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
82945203|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945204|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945205|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945206|NCT01375634|Midazolam|midazolam|mesh-list
82945207|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82945208|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82945209|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945210|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945211|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82945212|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82945213|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82945214|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82945215|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
82945216|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
82945217|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
82945218|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
82945219|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945220|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945221|NCT05388448|Amoxicillin|amoxicillin|mesh-list
82945222|NCT05388448|Rifampin|rifampin|mesh-list
82945223|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
82945224|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
82945225|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945226|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945227|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82945228|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
82945229|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
82945230|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82945231|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945232|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945233|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82945234|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82945235|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82945236|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82945237|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82945238|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82945239|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82945240|NCT05108740|Everolimus|everolimus|mesh-list
82945241|NCT05108740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82945242|NCT05108740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82945243|NCT05108740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945244|NCT05108740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945245|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82945246|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
82945247|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945248|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945249|NCT05105750|Aspirin|aspirin|mesh-list
82945250|NCT05105750|Indobufen|indobufen|mesh-list
82945251|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945252|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945253|NCT05105750|Analgesics|analgesics|mesh-ancestor
82945254|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
82945255|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945256|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945257|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945258|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945259|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82945260|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82945261|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945262|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82945263|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82945264|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945265|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
82945266|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82945267|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82945268|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945269|NCT05152264|Analgesics|analgesics|mesh-list
82945270|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
82945271|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83517940|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
82945272|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945273|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
82945274|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945275|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
82945276|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945277|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945278|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82945279|NCT05152186|Disinfectants|disinfectants|mesh-list
82945280|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945281|NCT03485092|Empagliflozin|empagliflozin|mesh-list
82945282|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82945283|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945284|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82945285|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945286|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
82945287|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
82945288|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
82945289|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82945290|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945291|NCT05064800|Ritonavir|ritonavir|mesh-list
82945292|NCT05064800|Nirmatrelvir|nirmatrelvir|mesh-list
82945293|NCT05064800|Dabigatran|dabigatran|mesh-list
82945294|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82945295|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82945296|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
82945297|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945298|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945299|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82945300|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82945301|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
82945302|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945303|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82945304|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82945305|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
82945306|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82945307|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
82945308|NCT01376180|Lamotrigine|lamotrigine|mesh-list
82945309|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
82945310|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82945311|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82945312|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945313|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82945314|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945315|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82945316|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82945317|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945318|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82945319|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82945320|NCT03633734|Folfirinox|folfirinox|mesh-list
82945321|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945322|NCT01376258|Finasteride|finasteride|mesh-list
82945323|NCT01376258|Dutasteride|dutasteride|mesh-list
82945324|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82945325|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82945326|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945327|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945328|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
82945329|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945330|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945331|NCT01376258|Urological Agents|urological agents|mesh-ancestor
82945332|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82945333|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82945334|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82945335|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82945336|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945337|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
82945338|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945339|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945340|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82945342|NCT03531840|Olaparib|olaparib|mesh-list
82945343|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82945344|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945345|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945346|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945347|NCT05151796|Aspirin|aspirin|mesh-list
82945348|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945349|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945350|NCT05151796|Analgesics|analgesics|mesh-ancestor
82945351|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
82945352|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945353|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945354|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945355|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945356|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82945357|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82945358|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945359|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82945360|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82945361|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945362|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
82945363|NCT04460092|Insulin|insulin|mesh-list
82945364|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82945365|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82945366|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945367|NCT03110900|Lorazepam|lorazepam|mesh-list
82945368|NCT03110900|Haloperidol|haloperidol|mesh-list
82945369|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
82945370|NCT03110900|Loxapine|loxapine|mesh-list
82945371|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
82945372|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
82945373|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945374|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945375|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82945376|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82945377|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82945378|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945379|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82945380|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82945381|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
82945382|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945383|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945384|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82945385|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
82945386|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82945387|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82945388|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
82945389|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
82945390|NCT03486184|Cystatins|cystatins|mesh-list
82945391|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82945392|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
82945393|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945394|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945395|NCT03109756|Gaboxadol|gaboxadol|mesh-list
82945396|NCT03109756|Analgesics|analgesics|mesh-ancestor
82945397|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
82945398|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945399|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945400|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
82945401|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
82945402|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
82945403|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945404|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945405|NCT03867734|Aztreonam|aztreonam|mesh-list
82945406|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945407|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945408|NCT05759546|Fulvestrant|fulvestrant|mesh-list
82945409|NCT05759546|Fluzoparib|fluzoparib|mesh-list
82945410|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82945411|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945412|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82945413|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82945414|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
83084010|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82945415|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945416|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945417|NCT05759546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82945418|NCT05759546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945419|NCT05759546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945420|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82945421|NCT05151016|Mifepristone|mifepristone|mesh-list
82945422|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82945423|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
82945424|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945425|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945426|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82945427|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82945428|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82945429|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
82945430|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82945431|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82945432|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
82945433|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945434|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
82945435|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82945436|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82945437|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82945438|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945439|NCT04459312|Antibodies|antibodies|mesh-list
82945440|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
82945441|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945442|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82945443|NCT04871360|Laxatives|laxatives|mesh-ancestor
82945444|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82945445|NCT05153200|Adalimumab|adalimumab|mesh-list
82945446|NCT05153200|Upadacitinib|upadacitinib|mesh-list
82945447|NCT05153200|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82945448|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945449|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945450|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82945451|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82945452|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945453|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945454|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
82945455|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945456|NCT03477136|Vitamin D|vitamin d|mesh-list
82945457|NCT03477136|Vitamins|vitamins|mesh-ancestor
82945458|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
82945459|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945460|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82945461|NCT03552068|Clonidine|clonidine|mesh-list
82945462|NCT03552068|Analgesics|analgesics|mesh-ancestor
82945463|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
82945464|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945465|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945466|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82945467|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
82945468|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
82945469|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82945470|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82945471|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82945472|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
82945473|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945474|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945475|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82945476|NCT00702988|Hormones|hormones|mesh-ancestor
82945477|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945478|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945479|NCT05759312|Metformin|metformin|mesh-list
82945480|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82945481|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945482|NCT03446456|Vasopressins|vasopressins|mesh-list
82945483|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
82945484|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
82945485|NCT03446456|Coagulants|coagulants|mesh-ancestor
82945486|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82945487|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82945488|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
82945490|NCT03396692|Morphine|morphine|mesh-list
82945491|NCT03396692|Ropivacaine|ropivacaine|mesh-list
82945492|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82945493|NCT03396692|Narcotics|narcotics|mesh-ancestor
82945494|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945495|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945496|NCT03396692|Analgesics|analgesics|mesh-ancestor
82945497|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
82945498|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945499|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
82945500|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
82945501|NCT04796948|Leucovorin|leucovorin|mesh-list
82945502|NCT04796948|Fluorouracil|fluorouracil|mesh-list
82945503|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
82945504|NCT04796948|Irinotecan|irinotecan|mesh-list
82945505|NCT04796948|Calcium|calcium|mesh-list
82945506|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
82945507|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82945508|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945509|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
82945510|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945511|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82945512|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945513|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82945514|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
82945515|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82945516|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82945517|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945518|NCT04796948|Antidotes|antidotes|mesh-ancestor
82945519|NCT04796948|Protective Agents|protective agents|mesh-ancestor
82945520|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
82945521|NCT04796948|Vitamins|vitamins|mesh-ancestor
82945522|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
82945523|NCT03480958|Morphine|morphine|mesh-list
82945524|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82945525|NCT03480958|Narcotics|narcotics|mesh-ancestor
82945526|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945527|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945528|NCT03480958|Analgesics|analgesics|mesh-ancestor
82945529|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
82945530|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945531|NCT03495102|Dulaglutide|dulaglutide|mesh-list
82945532|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82945533|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945534|NCT04859608|Eculizumab|eculizumab|mesh-list
82945535|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82945536|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82945537|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
82945538|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945539|NCT04754386|Antibodies|antibodies|mesh-list
82945540|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
82945541|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945542|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82945543|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82945544|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82945545|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945546|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
82945547|NCT03253172|Diuretics|diuretics|mesh-ancestor
82945548|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
82945549|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945550|NCT03253172|Expectorants|expectorants|mesh-ancestor
82945551|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
82945552|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
82945553|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82945554|NCT03480646|Prednisone|prednisone|mesh-list
82945555|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
82945556|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945557|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
82945558|NCT03480646|Hormones|hormones|mesh-ancestor
82945559|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945560|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945561|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82945562|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945563|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945564|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945565|NCT03483142|Misoprostol|misoprostol|mesh-list
82945566|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82945567|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
82945568|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945569|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945570|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82945571|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82945572|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
82945574|NCT03726372|Rocuronium|rocuronium|mesh-list
82945575|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
82945576|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82945577|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82945578|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82945579|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945580|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945581|NCT03104816|Acetaminophen|acetaminophen|mesh-list
82945582|NCT03104816|Hydromorphone|hydromorphone|mesh-list
82945583|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945584|NCT03104816|Analgesics|analgesics|mesh-ancestor
82945585|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
82945586|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945587|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945588|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
82945589|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82945590|NCT03104816|Narcotics|narcotics|mesh-ancestor
82945591|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945592|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
82945593|NCT04720976|Sotorasib|sotorasib|mesh-list
82945594|NCT04720976|Osimertinib|osimertinib|mesh-list
82945595|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82945596|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945597|NCT04720976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82945598|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945599|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82945600|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945601|NCT03480568|Alirocumab|alirocumab|mesh-list
82945602|NCT03480568|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82945603|NCT03480568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82945604|NCT03480568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82945605|NCT03480568|Antimetabolites|antimetabolites|mesh-ancestor
82945606|NCT03480568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945607|NCT03480568|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82945608|NCT03480568|Protease Inhibitors|protease inhibitors|mesh-ancestor
82945609|NCT03480568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945610|NCT03480568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82945611|NCT04707326|Lamivudine|lamivudine|mesh-list
82945612|NCT04707326|Dolutegravir|dolutegravir|mesh-list
82945613|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82945614|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82945615|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945616|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945617|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
82945618|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945619|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82945620|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82945621|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82945622|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82945623|NCT03559062|Ivacaftor|ivacaftor|mesh-list
82945624|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82945625|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82945626|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945627|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
82945628|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82945629|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945630|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82945631|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945632|NCT03726216|Dalbavancin|dalbavancin|mesh-list
82945633|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945634|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945635|NCT00089791|Denosumab|denosumab|mesh-list
82945636|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82945637|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945638|NCT02876510|Aldesleukin|aldesleukin|mesh-list
82945639|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
82945641|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
82945642|NCT02876510|Atezolizumab|atezolizumab|mesh-list
82945643|NCT02876510|Interleukin-2|interleukin-2|mesh-list
82945644|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82945645|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
82945646|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945647|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945648|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82945649|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
82945650|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945651|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945652|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82945653|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82945654|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
82945655|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
82945656|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945657|NCT02876510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82945658|NCT02876510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82945659|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945660|NCT02876510|Analgesics|analgesics|mesh-ancestor
82945661|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
82945662|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945663|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82945664|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82945666|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82945667|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82945668|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82945669|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
82945670|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
82945671|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945672|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945673|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945674|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82945675|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82945676|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945677|NCT02815280|Minocycline|minocycline|mesh-list
82945678|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945679|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945680|NCT03482752|Molgramostim|molgramostim|mesh-list
82945681|NCT03482752|Sargramostim|sargramostim|mesh-list
82945682|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945683|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
82945684|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945685|NCT04729543|Azacitidine|azacitidine|mesh-list
82945686|NCT04729543|Interleukin-2|interleukin-2|mesh-list
82945687|NCT04729543|Valproic Acid|valproic acid|mesh-list
82945688|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82945689|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
82945690|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945691|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945692|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945693|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945694|NCT04729543|Analgesics|analgesics|mesh-ancestor
82945695|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
82945696|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945697|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945698|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
82945699|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
82945700|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945701|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
82945702|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82945703|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945704|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82945705|NCT01310712|Oxybutynin|oxybutynin|mesh-list
82945706|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
82945707|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
82945708|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945709|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945710|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82945711|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82945712|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
82945713|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945714|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945716|NCT02737930|Fluoxetine|fluoxetine|mesh-list
82945717|NCT02737930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82945718|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82945719|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82945720|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945721|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945722|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
82945723|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945724|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82945725|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
82945726|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82945727|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82945728|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82945729|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945730|NCT01242787|Entecavir|entecavir|mesh-list
82945731|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
82945732|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945733|NCT03476356|Clomiphene|clomiphene|mesh-list
82945734|NCT03476356|Enclomiphene|enclomiphene|mesh-list
82945735|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
82945736|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82945737|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
82945738|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945739|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945740|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82945741|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
82945742|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945743|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82945744|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82945745|NCT03723096|Pomalidomide|pomalidomide|mesh-list
82945746|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
82945747|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945748|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82945749|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82945750|NCT03723096|Growth Substances|growth substances|mesh-ancestor
82945751|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
82945752|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945753|NCT02534012|Anesthetics|anesthetics|mesh-list
82945754|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945755|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945756|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
82945757|NCT05626387|Prednisolone|prednisolone|mesh-list
82945758|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82945759|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
82945760|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82945761|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
82945762|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82945763|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
82945764|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82945765|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945766|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82945767|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
82945768|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945769|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945770|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945771|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945772|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945773|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
82945774|NCT05626387|Hormones|hormones|mesh-ancestor
82945775|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945776|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945777|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82945778|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
82945779|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
82945780|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945781|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82945782|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82945783|NCT05626387|Protective Agents|protective agents|mesh-ancestor
82945784|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
82945785|NCT03722940|Analgesics|analgesics|mesh-ancestor
82945786|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
82945787|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945788|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945789|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
82945790|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945791|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82945792|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
82945793|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82945794|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82945795|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945796|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82945797|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
82945798|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945799|NCT01146925|Deferiprone|deferiprone|mesh-list
82945800|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82945801|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
82945802|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
82945803|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945805|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
82945806|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
82945807|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945808|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945809|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945810|NCT03476044|Selenium|selenium|mesh-list
82945811|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
82945812|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945813|NCT03476044|Protective Agents|protective agents|mesh-ancestor
82945814|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945815|NCT03476044|Trace Elements|trace elements|mesh-ancestor
82945816|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
82945817|NCT01250821|Menotropins|menotropins|mesh-list
82945818|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82945819|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
82945820|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945821|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945822|NCT03493698|Midazolam|midazolam|mesh-list
82945823|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82945824|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82945825|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945826|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945827|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82945828|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82945829|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82945830|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82945831|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
82945832|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
82945833|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
82945834|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
82945835|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945836|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945837|NCT01148173|Ifosfamide|ifosfamide|mesh-list
82945838|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82945839|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
82945840|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945841|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945842|NCT01898312|Mifepristone|mifepristone|mesh-list
82945843|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82945844|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
82945845|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945846|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945847|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82945848|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82945849|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82945850|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
82945851|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82945852|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82945853|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
82945854|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945855|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
82945856|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82945857|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82945858|NCT03528174|Pancrelipase|pancrelipase|mesh-list
82945859|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82945860|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
82945861|NCT05756660|Cisplatin|cisplatin|mesh-list
82945862|NCT05756660|Vorinostat|vorinostat|mesh-list
82945864|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82945865|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945866|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945867|NCT05756660|Antidotes|antidotes|mesh-ancestor
82945868|NCT05756660|Protective Agents|protective agents|mesh-ancestor
82945869|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945870|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
82945871|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
82945872|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82945873|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82945874|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
82945875|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
82945876|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
82945877|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945878|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945879|NCT03482440|Analgesics|analgesics|mesh-ancestor
82945880|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
82945881|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945882|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945883|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945884|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945885|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
82945886|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
82945887|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945888|NCT01253473|Budesonide|budesonide|mesh-list
82945889|NCT01253473|Albuterol|albuterol|mesh-list
82945890|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
82945891|NCT01253473|Ipratropium|ipratropium|mesh-list
82945892|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945893|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82945894|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
82945895|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945896|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945897|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82945898|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
82945899|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
82945900|NCT01253473|Hormones|hormones|mesh-ancestor
82945901|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945902|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82945903|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82945904|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82945905|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
82945906|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945907|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945908|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
82945909|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82945910|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82945911|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
82945912|NCT01883804|Methyldopa|methyldopa|mesh-list
82945913|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82945914|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
82945915|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
82945916|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945917|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945918|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82945919|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82945920|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82945921|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
82945922|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945923|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945924|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82945925|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945926|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945927|NCT03475810|Midazolam|midazolam|mesh-list
82945928|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82945929|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82945930|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82945931|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945932|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82945933|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82945934|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82945935|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82945936|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
82945938|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
83459896|NCT04885998|AMG 757|amg 757|mesh-list
82945940|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945941|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945942|NCT03480100|Xylometazoline|xylometazoline|mesh-list
82945943|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
82945944|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82945945|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
82945946|NCT02348203|Aspirin|aspirin|mesh-list
82945947|NCT02348203|Zileuton|zileuton|mesh-list
82945948|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945949|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945950|NCT02348203|Analgesics|analgesics|mesh-ancestor
82945951|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
82945952|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945953|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945954|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945955|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945956|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82945957|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82945958|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945959|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82945960|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82945961|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945962|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
82945963|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82945964|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82945965|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
82945966|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82945967|NCT03493542|Vaccines|vaccines|mesh-list
82945968|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
82945969|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945970|NCT04365088|Deflazacort|deflazacort|mesh-list
82945971|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945972|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82945973|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
82945974|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945975|NCT03482362|Vinorelbine|vinorelbine|mesh-list
82945976|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82945977|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82945978|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
82945979|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
82945980|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
82945981|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945982|NCT04500470|Ketoprofen|ketoprofen|mesh-list
82945983|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82945984|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82945985|NCT04500470|Analgesics|analgesics|mesh-ancestor
82945986|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
82945987|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82945988|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945989|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82945990|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82945991|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82945992|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82945993|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945994|NCT03493386|Glycine|glycine|mesh-list
82945995|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
82945996|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82945997|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82945998|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82945999|NCT04937816|Empagliflozin|empagliflozin|mesh-list
82946000|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82946001|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946002|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82946003|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946004|NCT01366898|Methotrexate|methotrexate|mesh-list
82946005|NCT01366898|Idarubicin|idarubicin|mesh-list
82946006|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82946007|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
82946008|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82946009|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946010|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82946011|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
82946012|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946013|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946014|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
82946015|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946016|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82946017|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946018|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
82946019|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946020|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82946021|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82946022|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82946023|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82946025|NCT01248871|Remifentanil|remifentanil|mesh-list
82946026|NCT01248871|Dsuvia|dsuvia|mesh-list
82946027|NCT01248871|Propofol|propofol|mesh-list
82946028|NCT01248871|Sevoflurane|sevoflurane|mesh-list
82946029|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82946030|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946031|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946032|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82946033|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
82946034|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
82946035|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82946036|NCT01248871|Narcotics|narcotics|mesh-ancestor
82946037|NCT01248871|Analgesics|analgesics|mesh-ancestor
82946038|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
82946039|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946040|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82946041|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82946042|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82946043|NCT01251133|Vaccines|vaccines|mesh-list
82946044|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
82946045|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946046|NCT03720288|Acetazolamide|acetazolamide|mesh-list
82946047|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
82946048|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82946049|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946050|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946051|NCT03720288|Diuretics|diuretics|mesh-ancestor
82946052|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
82946053|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946054|NCT03907813|Bupivacaine|bupivacaine|mesh-list
82946055|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
82946056|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
82946057|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946058|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946059|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
82946060|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946061|NCT00938912|Lacosamide|lacosamide|mesh-list
82946062|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
82946063|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82946064|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82946065|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946066|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946067|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
82946068|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82946069|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82946070|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82946071|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946072|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946073|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
82946074|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946075|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946076|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82946077|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946078|NCT03473340|Pirfenidone|pirfenidone|mesh-list
82946079|NCT03473340|Analgesics|analgesics|mesh-ancestor
82946080|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
82946081|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946082|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946083|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946084|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946087|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946088|NCT01147705|Allopurinol|allopurinol|mesh-list
82946089|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
82946090|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946091|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946092|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
82946093|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946094|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82946095|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
82946096|NCT01147705|Protective Agents|protective agents|mesh-ancestor
82946097|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946098|NCT03907111|Chitosan|chitosan|mesh-list
82946099|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82946100|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82946101|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
82946102|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946103|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82946104|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
82946105|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
82946106|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
82946107|NCT03907111|Coagulants|coagulants|mesh-ancestor
82946108|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
82946109|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
82946110|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946111|NCT03912727|Protective Agents|protective agents|mesh-ancestor
82946112|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946113|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
82946114|NCT03912727|Vitamins|vitamins|mesh-ancestor
82946115|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
82946116|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
82946117|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82946118|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82946119|NCT03661567|Prednisolone|prednisolone|mesh-list
82946120|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
82946121|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82946122|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
82946123|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946124|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
82946125|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
82946126|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946127|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946128|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82946129|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
82946130|NCT03661567|Hormones|hormones|mesh-ancestor
82946131|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82946132|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82946133|NCT03661567|Protective Agents|protective agents|mesh-ancestor
82946134|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82946135|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946136|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
82946137|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946138|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946139|NCT03739138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82946140|NCT03739138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946141|NCT03472326|GS-9131|gs-9131|mesh-list
82946142|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946143|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946144|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82946145|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82946146|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
82946147|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946148|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82946149|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82946150|NCT03472014|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82946151|NCT03472014|Antiviral Agents|antiviral agents|mesh-ancestor
82946152|NCT03472014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946153|NCT04182100|Aspirin|aspirin|mesh-list
82946154|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946155|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946156|NCT04182100|Analgesics|analgesics|mesh-ancestor
82946157|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
82946158|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946159|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946160|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946161|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946162|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82946163|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82946164|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946165|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82946166|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82946167|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946169|NCT03479320|Lidocaine|lidocaine|mesh-list
82946170|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
82946171|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
82946172|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946173|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946174|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
82946175|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946176|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82946177|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82946178|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82946179|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946180|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946181|NCT03912415|Paclitaxel|paclitaxel|mesh-list
82946182|NCT03912415|Bevacizumab|bevacizumab|mesh-list
82946183|NCT03912415|Carboplatin|carboplatin|mesh-list
82946184|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82946185|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946186|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
82946187|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
82946188|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
82946189|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946190|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946191|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82946192|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82946193|NCT03912415|Growth Substances|growth substances|mesh-ancestor
82946194|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946195|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
82946196|NCT03525834|Everolimus|everolimus|mesh-list
82946197|NCT03525834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82946198|NCT03525834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82946199|NCT03525834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946200|NCT03525834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946201|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946202|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
82946203|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946204|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946205|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
82946206|NCT00925652|Bevacizumab|bevacizumab|mesh-list
82946207|NCT00925652|Methotrexate|methotrexate|mesh-list
82946208|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946209|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
82946210|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946211|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946212|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82946213|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
82946214|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946215|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946216|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82946217|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946218|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82946219|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82946220|NCT00925652|Growth Substances|growth substances|mesh-ancestor
82946221|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
82946222|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82946223|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
82946224|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82946225|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82946226|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
82946227|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
82946228|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946229|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82946230|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82946231|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
82946232|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82946233|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946234|NCT03954106|Defibrotide|defibrotide|mesh-list
82946235|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82946236|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82946237|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946238|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82946239|NCT03525444|Ivacaftor|ivacaftor|mesh-list
82946240|NCT03525444|Elexacaftor|elexacaftor|mesh-list
82946241|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82946242|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946243|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946244|NCT01251835|Rifampin|rifampin|mesh-list
82946245|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
82946246|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82946247|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
82946248|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82946249|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946250|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
82946251|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82946252|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946253|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946254|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82946255|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82946256|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82946257|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82946258|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82946259|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82946260|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82946261|NCT03632876|Vitamin A|vitamin a|mesh-list
82946262|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
82946263|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
82946264|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946265|NCT03632876|Protective Agents|protective agents|mesh-ancestor
82946266|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946267|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82946268|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946269|NCT03632876|Vitamins|vitamins|mesh-ancestor
82946270|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
82946271|NCT03914755|Tucatinib|tucatinib|mesh-list
82946272|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946273|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82946274|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946275|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946276|NCT03905317|Bevacizumab|bevacizumab|mesh-list
82946277|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946278|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946279|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82946280|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82946281|NCT03905317|Growth Substances|growth substances|mesh-ancestor
82946282|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946283|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
82946284|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
82946285|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
82946286|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946287|NCT01251991|Psyllium|psyllium|mesh-list
82946288|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
82946289|NCT01251991|Cathartics|cathartics|mesh-ancestor
82946290|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82946291|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
82946292|NCT04458454|Methocarbamol|methocarbamol|mesh-list
82946293|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82946294|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946295|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82946296|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946297|NCT03914677|Mecamylamine|mecamylamine|mesh-list
82946298|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82946299|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
82946300|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
82946301|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946302|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946303|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82946304|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82946305|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
82946306|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946307|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946308|NCT03479086|Topiramate|topiramate|mesh-list
82946309|NCT03479086|Naltrexone|naltrexone|mesh-list
82946310|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82946311|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82946312|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946313|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
82946314|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946315|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
82946316|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82946317|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
82946318|NCT01252069|Progestins|progestins|mesh-list
82946319|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82946320|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
82946321|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82946322|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946323|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82946324|NCT01252069|Hormones|hormones|mesh-ancestor
82946325|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82946326|NCT01252225|Lidocaine|lidocaine|mesh-list
82946327|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
82946328|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
82946329|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946330|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946331|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
82946332|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946333|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82946334|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82946335|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82946336|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946337|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946338|NCT04459702|Ritonavir|ritonavir|mesh-list
82946339|NCT04459702|Lopinavir|lopinavir|mesh-list
82946340|NCT04459702|Azithromycin|azithromycin|mesh-list
82946341|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
82946342|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82946343|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82946344|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
82946345|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946346|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946347|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82946348|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82946349|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
82946350|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946351|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82946352|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82946353|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82946354|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
82946355|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82946356|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82946357|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946358|NCT03574792|Oxycodone|oxycodone|mesh-list
82946359|NCT03574792|Methadone|methadone|mesh-list
82946360|NCT03574792|Gabapentin|gabapentin|mesh-list
82946361|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82946362|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82946363|NCT03574792|Narcotics|narcotics|mesh-ancestor
82949494|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
82946364|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946365|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946366|NCT03574792|Analgesics|analgesics|mesh-ancestor
82946367|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
82946368|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946369|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
82946370|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82946371|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82946372|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82946373|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82946374|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82946375|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946376|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946377|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
82946378|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
82946379|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
82946380|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82946381|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82946382|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946383|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82946384|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
82946385|NCT03904849|Cannabidiol|cannabidiol|mesh-list
82946386|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
82946387|NCT01250743|Vitamins|vitamins|mesh-list
82946388|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
82946389|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
82946390|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946391|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
82946392|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946393|NCT01250743|Protective Agents|protective agents|mesh-ancestor
82946394|NCT01254175|Vaccines|vaccines|mesh-list
82946395|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
82946396|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946397|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
82946398|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82946399|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946400|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946401|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82946402|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
82946403|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946404|NCT03903367|Fentanyl|fentanyl|mesh-list
82946405|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82946406|NCT03903367|Narcotics|narcotics|mesh-ancestor
82946407|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946408|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946409|NCT03903367|Analgesics|analgesics|mesh-ancestor
82946410|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
82946411|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946412|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82946413|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82946414|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
82946415|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
82946416|NCT03486834|Vaccines|vaccines|mesh-list
82946417|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
82946418|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946419|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
82946420|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946421|NCT03177460|Daratumumab|daratumumab|mesh-list
82946422|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946423|NCT03717168|Hormones|hormones|mesh-list
82946424|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82946425|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946426|NCT00708448|Bevacizumab|bevacizumab|mesh-list
82946427|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82946428|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946429|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946430|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82946431|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82946432|NCT00708448|Growth Substances|growth substances|mesh-ancestor
82946433|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83459930|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
82946434|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
82946435|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82946436|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946437|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946438|NCT02892604|Insulin|insulin|mesh-list
82946439|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82946440|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946441|NCT03478306|Melatonin|melatonin|mesh-list
82946442|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
82946443|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946444|NCT03478306|Protective Agents|protective agents|mesh-ancestor
82946445|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946446|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946447|NCT03103100|Lidocaine|lidocaine|mesh-list
82946448|NCT03103100|Bupivacaine|bupivacaine|mesh-list
82946449|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
82946450|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
82946451|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946452|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946453|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
82946454|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946455|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82946456|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82946457|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82946458|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946459|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946460|NCT02940496|Ribavirin|ribavirin|mesh-list
82946461|NCT02940496|Grazoprevir|grazoprevir|mesh-list
82946462|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82946463|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
82946464|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946465|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946466|NCT02940496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82946467|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946468|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
82946469|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
82946470|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946471|NCT03639168|Cisplatin|cisplatin|mesh-list
82946472|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946473|NCT03131050|Scopolamine|scopolamine|mesh-list
82946474|NCT03131050|Escitalopram|escitalopram|mesh-list
82946475|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82946476|NCT03131050|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82946477|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82946478|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946479|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946480|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946481|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
82946482|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946483|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
82946484|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
82946485|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946486|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82946487|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82946488|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
82946489|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82946490|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
82946491|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82946492|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
82946493|NCT03719820|Clopidogrel|clopidogrel|mesh-list
82946494|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82946495|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946496|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946497|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82946498|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946499|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82946500|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82946501|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82946502|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
82946503|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946504|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82946505|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82946506|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
82946507|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82946508|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82946509|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82946510|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82946511|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82946512|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82946513|NCT01254799|Doxycycline|doxycycline|mesh-list
82946514|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82946515|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946516|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
82946517|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82946518|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82946519|NCT05553938|Empagliflozin|empagliflozin|mesh-list
82946520|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82946521|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946522|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82946523|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946524|NCT03718884|Mirikizumab|mirikizumab|mesh-list
82946525|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946526|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946527|NCT03718884|Analgesics|analgesics|mesh-ancestor
82946528|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
82946529|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946530|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946531|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946532|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946533|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82946534|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82946535|NCT03718806|Zoliflodacin|zoliflodacin|mesh-list
82946536|NCT03718806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82946537|NCT03718806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82946538|NCT03718806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946539|NCT03718806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946540|NCT03718806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946541|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
82946542|NCT03716856|Fludarabine|fludarabine|mesh-list
82946543|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946544|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
82946545|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946546|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946547|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82946548|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
82946549|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946550|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946551|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82946552|NCT03910543|Tofacitinib|tofacitinib|mesh-list
82946553|NCT03910543|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82946554|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82946555|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946556|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946558|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
82946559|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946560|NCT03904537|Antibodies|antibodies|mesh-list
82946561|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
82946562|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946563|NCT03904225|Tegafur|tegafur|mesh-list
82946564|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82946565|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
82946566|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946567|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946568|NCT03910231|Tolvaptan|tolvaptan|mesh-list
82946569|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82946570|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946571|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
82946572|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946573|NCT01149109|Temozolomide|temozolomide|mesh-list
82946574|NCT01149109|Lomustine|lomustine|mesh-list
82946575|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82946576|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
82946577|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946578|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946579|NCT05667415|Cisplatin|cisplatin|mesh-list
82946580|NCT05667415|Disulfiram|disulfiram|mesh-list
82946581|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946582|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82946583|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82946584|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946585|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946586|NCT01586143|Acetaminophen|acetaminophen|mesh-list
82946587|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946588|NCT01586143|Analgesics|analgesics|mesh-ancestor
82946589|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
82946590|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946591|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946592|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
82946593|NCT01256359|Docetaxel|docetaxel|mesh-list
82946594|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946595|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
82946596|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
82946597|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
82946598|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946599|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82946600|NCT02527993|Liraglutide|liraglutide|mesh-list
82946601|NCT02527993|Acarbose|acarbose|mesh-list
82946602|NCT02527993|Verapamil|verapamil|mesh-list
82946603|NCT02527993|Pasireotide|pasireotide|mesh-list
82946604|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82946605|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946606|NCT02527993|Incretins|incretins|mesh-ancestor
82946607|NCT02527993|Hormones|hormones|mesh-ancestor
82946608|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82946609|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82946610|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
82946611|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946612|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946613|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82946614|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82946615|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946616|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82946617|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
82946618|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82946619|NCT04927052|Lidocaine|lidocaine|mesh-list
82946620|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
82946621|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
82946622|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946623|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946624|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
82946625|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946626|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82946627|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82946628|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82946629|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946630|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946632|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
82946633|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946634|NCT03900871|Aspirin|aspirin|mesh-list
82946635|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946636|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946637|NCT03900871|Analgesics|analgesics|mesh-ancestor
82946638|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
82946639|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946640|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946641|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946642|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946643|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82946644|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82946645|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946646|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82946647|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82946648|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946649|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
82946650|NCT01149577|Olanzapine|olanzapine|mesh-list
82946651|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
82946652|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
82946653|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946654|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946655|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82946656|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82946657|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82946658|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946659|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82946660|NCT01149577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82946661|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82946662|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946663|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946664|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946665|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
82946666|NCT03894007|Maytansine|maytansine|mesh-list
82946667|NCT03894007|Docetaxel|docetaxel|mesh-list
82946668|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82946669|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
82946670|NCT03894007|Carboplatin|carboplatin|mesh-list
82946671|NCT03894007|Trastuzumab|trastuzumab|mesh-list
82946672|NCT03894007|Atezolizumab|atezolizumab|mesh-list
82946673|NCT03894007|Epirubicin|epirubicin|mesh-list
82946674|NCT03894007|Pertuzumab|pertuzumab|mesh-list
82946675|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82946676|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946677|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
82946678|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
82946679|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
82946680|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946681|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946683|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946684|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946685|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82946686|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
82946687|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82946688|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946689|NCT03894007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82946690|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82946691|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82946692|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82946693|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946694|NCT03894007|Immunotoxins|immunotoxins|mesh-ancestor
82946695|NCT03894007|Immunoconjugates|immunoconjugates|mesh-ancestor
82946696|NCT01150747|Azithromycin|azithromycin|mesh-list
82946697|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
82946698|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82946699|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946700|NCT03893695|Nivolumab|nivolumab|mesh-list
82946701|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946702|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946703|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82946704|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946705|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
82946706|NCT01258309|Ketorolac|ketorolac|mesh-list
82946707|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82946708|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82946709|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82946710|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946711|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946712|NCT01258309|Analgesics|analgesics|mesh-ancestor
82946713|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
82946714|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946715|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946716|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946717|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946718|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82946719|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946720|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946721|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82946722|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82946723|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82946724|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
82946725|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
82946726|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946727|NCT01256905|Modafinil|modafinil|mesh-list
82946728|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82946729|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946730|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82946731|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82946732|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82946733|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946734|NCT01586299|Acetaminophen|acetaminophen|mesh-list
82946735|NCT01586299|Ibuprofen|ibuprofen|mesh-list
82946736|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946737|NCT01586299|Analgesics|analgesics|mesh-ancestor
82946738|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
82946739|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946740|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946741|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
82946742|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946743|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946744|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946745|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82946746|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946747|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946748|NCT02874794|Valsartan|valsartan|mesh-list
82946749|NCT02874794|Enalapril|enalapril|mesh-list
82946750|NCT02874794|Enalaprilat|enalaprilat|mesh-list
82946751|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82946752|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82946753|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82946754|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82946755|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946756|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82946757|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
82946758|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946759|NCT03102710|Lidocaine|lidocaine|mesh-list
82946760|NCT03102710|Capsaicin|capsaicin|mesh-list
82946761|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
82946762|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
82946763|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946764|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946765|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
82946766|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946767|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82946768|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82946769|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82946770|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946771|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946772|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
82946773|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
82946774|NCT01149967|Dexetimide|dexetimide|mesh-list
82946775|NCT01149967|Citalopram|citalopram|mesh-list
82946776|NCT01149967|Escitalopram|escitalopram|mesh-list
82946777|NCT01149967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82946778|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82946779|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83517941|NCT00001065|Amphotericin B|amphotericin b|mesh-list
82946780|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946782|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
82946783|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946784|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82946785|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
82946786|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82946787|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82946788|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82946789|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
82946790|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
82946791|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946792|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82946793|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82946794|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
82946795|NCT05505409|Pirfenidone|pirfenidone|mesh-list
82946796|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
82946797|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82946798|NCT05505409|Hormones|hormones|mesh-ancestor
82946799|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82946800|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946801|NCT05505409|Analgesics|analgesics|mesh-ancestor
82946802|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
82946803|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946804|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946805|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946806|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946807|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946808|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946809|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
82946810|NCT04770740|Vitamin K|vitamin k|mesh-list
82946811|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
82946812|NCT04770740|Menaquinone 7|menaquinone 7|mesh-list
82946813|NCT04770740|Vitamins|vitamins|mesh-ancestor
82946814|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
82946815|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946816|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82946817|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82946818|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946819|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
82946820|NCT04770740|Coagulants|coagulants|mesh-ancestor
82946821|NCT03896971|Cyclosporine|cyclosporine|mesh-list
82946822|NCT03896971|Cyclosporins|cyclosporins|mesh-list
82946823|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946824|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946825|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946826|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
82946827|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946828|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
82946829|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946831|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946832|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82946833|NCT01258777|Golimumab|golimumab|mesh-list
82946834|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82946835|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82946836|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946837|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946838|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
82946839|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946840|NCT03896893|Emollients|emollients|mesh-list
82946841|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
82946842|NCT01257373|Cobalt|cobalt|mesh-list
82946843|NCT01257373|Chromium|chromium|mesh-list
82946844|NCT01257373|Sirolimus|sirolimus|mesh-list
82946845|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82946846|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82946847|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82946848|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946849|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
82946850|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82946851|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
82946852|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946853|NCT01257373|Trace Elements|trace elements|mesh-ancestor
82946854|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
82946855|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
82946856|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82946857|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82946858|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946859|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
82946860|NCT03899233|Coagulants|coagulants|mesh-ancestor
82946861|NCT03101150|Vitamin D|vitamin d|mesh-list
82946862|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
82946863|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
82946864|NCT03101150|Vitamins|vitamins|mesh-list
82946865|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
82946866|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946867|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82946868|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82946869|NCT03899077|Goserelin|goserelin|mesh-list
82946870|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82946871|NCT03899077|Leuprolide|leuprolide|mesh-list
82946872|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82946873|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946874|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
82946875|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82946876|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
82946877|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82946878|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946879|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82946880|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82946881|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
82946882|NCT01255579|Fluticasone|fluticasone|mesh-list
82946883|NCT01255579|Beclomethasone|beclomethasone|mesh-list
82946884|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
82946885|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82946886|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82946887|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946888|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82946889|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
82946890|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946891|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946892|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82946893|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
82946894|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
82946895|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82946896|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82946897|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82946898|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82946899|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
82946900|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82946901|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946902|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
82946903|NCT01255579|Hormones|hormones|mesh-ancestor
82946904|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82946905|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
82946906|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82946908|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82946909|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946910|NCT03101930|Incretins|incretins|mesh-ancestor
82946911|NCT03101930|Hormones|hormones|mesh-ancestor
82946912|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82946913|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82946914|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
82946915|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946916|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946917|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
82946918|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82946919|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82946920|NCT05415254|Calcitriol|calcitriol|mesh-list
82946921|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82946922|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946923|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82946924|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946925|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946926|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82946927|NCT05415254|Vitamins|vitamins|mesh-ancestor
82946928|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
82946929|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82946930|NCT01150201|Losartan|losartan|mesh-list
82946931|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82946932|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83518019|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
82946933|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82946934|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82946935|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946936|NCT01257451|Vildagliptin|vildagliptin|mesh-list
82946937|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82946938|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946939|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82946940|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
82946941|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946942|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946943|NCT01257529|Pregabalin|pregabalin|mesh-list
82946944|NCT01257529|Analgesics|analgesics|mesh-ancestor
82946945|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
82946946|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946947|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946948|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
82946949|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82946950|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946951|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946952|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82946953|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82946954|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82946955|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82946956|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82946957|NCT03896113|Celecoxib|celecoxib|mesh-list
82946958|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82946959|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82946960|NCT03896113|Analgesics|analgesics|mesh-ancestor
82946961|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
82946962|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82946963|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946964|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82946965|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82946966|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82946967|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82946968|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946969|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946970|NCT03100838|Nifedipine|nifedipine|mesh-list
82946971|NCT03100838|Omeprazole|omeprazole|mesh-list
82946972|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
82946973|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82946974|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82946975|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82946976|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82946977|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946978|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82946979|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82946980|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82946981|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946982|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
82946983|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
82946984|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82946985|NCT01260025|Endostatins|endostatins|mesh-list
82946986|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946987|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82946988|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82946989|NCT01260025|Growth Substances|growth substances|mesh-ancestor
82946990|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82946991|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
82946992|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
82946993|NCT03984578|Capecitabine|capecitabine|mesh-list
82946994|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82946995|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82946996|NCT03984578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82946997|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82946998|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82946999|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
82947000|NCT03892525|Atezolizumab|atezolizumab|mesh-list
82947001|NCT03892525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82947002|NCT03892525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947003|NCT03892525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947004|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947005|NCT05418452|Metformin|metformin|mesh-list
82947006|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82947007|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947008|NCT01260103|Temozolomide|temozolomide|mesh-list
82947009|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82947010|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
82947011|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947012|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947013|NCT03480750|Carboplatin|carboplatin|mesh-list
82947014|NCT03480750|Doxorubicin|doxorubicin|mesh-list
82947015|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82947016|NCT03480750|Trientine|trientine|mesh-list
82947017|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947018|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82947019|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82947020|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82947021|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947022|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947023|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
82947024|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
82947025|NCT03892447|Ferulic acid|ferulic acid|mesh-list
82947026|NCT03892447|Dopamine|dopamine|mesh-list
82947027|NCT03892447|Alprostadil|alprostadil|mesh-list
82947028|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82947029|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
82947030|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
82947031|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947032|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947033|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
82947034|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947035|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947036|NCT03892447|Protective Agents|protective agents|mesh-ancestor
82947037|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82947038|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
82947039|NCT03892447|Urological Agents|urological agents|mesh-ancestor
82947040|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947041|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947042|NCT03892447|Analgesics|analgesics|mesh-ancestor
82947043|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
82947044|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947045|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947046|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
82947047|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82947048|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82947049|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82947050|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82947051|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
82947052|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
82947053|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
82947054|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82947055|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82947056|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
82947057|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947058|NCT05250596|Colchicine|colchicine|mesh-list
82947059|NCT05250596|Atorvastatin|atorvastatin|mesh-list
82947060|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82947061|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82947062|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
82947063|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947064|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82947065|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82947066|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947067|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
82947068|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947069|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
82947070|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
82947071|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
82947072|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947073|NCT04788914|Charcoal|charcoal|mesh-list
82947074|NCT04788914|Antidotes|antidotes|mesh-ancestor
82947075|NCT04788914|Protective Agents|protective agents|mesh-ancestor
82947076|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947077|NCT03716622|Clarithromycin|clarithromycin|mesh-list
82947078|NCT03716622|Furazolidone|furazolidone|mesh-list
82947079|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947080|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947081|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82947082|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947083|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947084|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82947085|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82947086|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82947087|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82947088|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82947089|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82947090|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82947091|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82947092|NCT03892213|Benzonidazole|benzonidazole|mesh-list
82947093|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82947094|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
82947095|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947096|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82947097|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82947098|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82947099|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947100|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
82947101|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82947102|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947103|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
82947104|NCT04881032|Temozolomide|temozolomide|mesh-list
82947105|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82947106|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
82947107|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947108|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947109|NCT03891979|Metronidazole|metronidazole|mesh-list
82947110|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
82947111|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
82947112|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947113|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947114|NCT03891979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82947115|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947116|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947117|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947118|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82947119|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82947120|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82947121|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82947122|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947123|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82947124|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82947125|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
82947126|NCT01260415|Panitumumab|panitumumab|mesh-list
82947127|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947128|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947129|NCT04608344|Atorvastatin|atorvastatin|mesh-list
82947130|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82947131|NCT04608344|Pravastatin|pravastatin|mesh-list
82947132|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82947133|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82947134|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
82947135|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947136|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82947137|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82947138|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947139|NCT03891433|Meropenem|meropenem|mesh-list
82947140|NCT03891433|Tazobactam|tazobactam|mesh-list
82947141|NCT03891433|Piperacillin|piperacillin|mesh-list
82947142|NCT03891433|Ertapenem|ertapenem|mesh-list
82947143|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947144|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947145|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82947146|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947147|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947148|NCT03895411|Sotalol|sotalol|mesh-list
82947149|NCT03895411|Propafenone|propafenone|mesh-list
82947150|NCT03895411|Metoprolol|metoprolol|mesh-list
82947151|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82947152|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82947153|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
82947154|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947155|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947156|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947157|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82947158|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
82947159|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
82947160|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947161|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82947162|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82947163|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947164|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82947165|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82947166|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82947167|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
82947168|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947169|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
82947170|NCT03891277|Hematinics|hematinics|mesh-ancestor
82947171|NCT03888157|Liraglutide|liraglutide|mesh-list
82947172|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82947173|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947174|NCT03888157|Incretins|incretins|mesh-ancestor
82947175|NCT03888157|Hormones|hormones|mesh-ancestor
82947176|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82947177|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
82947178|NCT01154491|Hematinics|hematinics|mesh-ancestor
82947179|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82947180|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
82947181|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82947182|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82947183|NCT02527603|Analgesics|analgesics|mesh-ancestor
82947184|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
82947185|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947186|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947187|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947188|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947189|NCT01259479|Satraplatin|satraplatin|mesh-list
82947190|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947191|NCT01260727|Vaccines|vaccines|mesh-list
82947192|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
82947193|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947194|NCT03890809|Deucravacitinib|deucravacitinib|mesh-list
82947195|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
82947196|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82947197|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947198|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947199|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
82947200|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82947201|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82947202|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82947203|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947204|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947205|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
82947206|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947207|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947208|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82947209|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947210|NCT01154569|Azithromycin|azithromycin|mesh-list
82947211|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947212|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947213|NCT03891043|Selenium|selenium|mesh-list
82947214|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
82947215|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947216|NCT03891043|Protective Agents|protective agents|mesh-ancestor
82947217|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947218|NCT03891043|Trace Elements|trace elements|mesh-ancestor
82947219|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
82947220|NCT03890341|Drospirenone|drospirenone|mesh-list
82947221|NCT03890341|Midazolam|midazolam|mesh-list
82947222|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82947223|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
82947224|NCT03890341|Betadex|betadex|mesh-list
82947225|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82947226|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82947227|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82947228|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947229|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82947230|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82947231|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82947232|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82947233|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
82947234|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
82947235|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
82947236|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
82947237|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947238|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947239|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82947240|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82947241|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82947242|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
82947243|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82947244|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82947245|NCT03890341|Estrogens|estrogens|mesh-ancestor
82947247|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82947248|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82947249|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
82947250|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82947251|NCT03890341|Diuretics|diuretics|mesh-ancestor
82947252|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
82947253|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
82947254|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
82947255|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82947256|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82947257|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82947258|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947259|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947260|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
82947261|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947262|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947263|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82947264|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947265|NCT03894085|Paroxetine|paroxetine|mesh-list
82947266|NCT03894085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82947267|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82947268|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947269|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947270|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947271|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
82947272|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947273|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82947274|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
82947275|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82947276|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82947277|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82947278|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947279|NCT01152931|Vitamins|vitamins|mesh-list
82947280|NCT01152931|Vitamin E|vitamin e|mesh-list
82947281|NCT01152931|Tocopherols|tocopherols|mesh-list
82947282|NCT01152931|Tocotrienols|tocotrienols|mesh-list
82947283|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
82947284|NCT01152931|Vitamin A|vitamin a|mesh-list
82947285|NCT01152931|Zinc|zinc|mesh-list
82947286|NCT01152931|Selenium|selenium|mesh-list
82947287|NCT01152931|Artesunate|artesunate|mesh-list
82947288|NCT01152931|Lumefantrine|lumefantrine|mesh-list
82947289|NCT01152931|Artemether|artemether|mesh-list
82947290|NCT01152931|Amodiaquine|amodiaquine|mesh-list
82947291|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
82947292|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
82947293|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947294|NCT01152931|Trace Elements|trace elements|mesh-ancestor
82947295|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
82947296|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947297|NCT01152931|Protective Agents|protective agents|mesh-ancestor
82947298|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
82947299|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82947300|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82947301|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947302|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947303|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
82947304|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
82947305|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82947306|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
82947307|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82947308|NCT01261117|Ibuprofen|ibuprofen|mesh-list
82947309|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947310|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947311|NCT01261117|Analgesics|analgesics|mesh-ancestor
82947312|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
82947313|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947314|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947315|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947316|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947317|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82947318|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947319|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947320|NCT03889717|Vitamin D|vitamin d|mesh-list
82947321|NCT03889717|Vitamins|vitamins|mesh-ancestor
82947322|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
82947323|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947324|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82947325|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
82947326|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82947327|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82947328|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947329|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
82947330|NCT03885895|Coagulants|coagulants|mesh-ancestor
82947331|NCT01154647|Citalopram|citalopram|mesh-list
82947332|NCT01154647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82947333|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82947334|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947335|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947336|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947337|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
82947338|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947339|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82947340|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
82947341|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82947342|NCT01153165|Citalopram|citalopram|mesh-list
82947343|NCT01153165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82947344|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82947345|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947346|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947347|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947348|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
82947349|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947350|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82947351|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
82947352|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82947353|NCT01155505|Lenalidomide|lenalidomide|mesh-list
82947354|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
82947355|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947356|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82947357|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82947358|NCT01155505|Growth Substances|growth substances|mesh-ancestor
82947359|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
82947360|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947361|NCT01153243|Vitamin D|vitamin d|mesh-list
82947362|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
82947363|NCT01153243|Vitamins|vitamins|mesh-ancestor
82947364|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
82947365|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947366|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82947367|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82947368|NCT03432858|Vancomycin|vancomycin|mesh-list
82947369|NCT03432858|Cefazolin|cefazolin|mesh-list
82947370|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947371|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947372|NCT05659914|Durvalumab|durvalumab|mesh-list
82947373|NCT05659914|Olaparib|olaparib|mesh-list
82947374|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947375|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947376|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82947377|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947378|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947379|NCT01154803|Micronutrients|micronutrients|mesh-list
82947380|NCT01154803|Trace Elements|trace elements|mesh-list
82947381|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947382|NCT03885427|Ketamine|ketamine|mesh-list
82947383|NCT03885427|Analgesics|analgesics|mesh-ancestor
82947384|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
82947385|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947386|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947387|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82947388|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82947389|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
82947390|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
82947391|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82947392|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82947393|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82947394|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947395|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947396|NCT03456960|Aspirin|aspirin|mesh-list
82947397|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947398|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947399|NCT03456960|Analgesics|analgesics|mesh-ancestor
82947400|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
82947401|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947402|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947403|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947404|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947405|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82947406|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82947407|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947408|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82947409|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82947410|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947411|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
82947412|NCT03716388|Mesalamine|mesalamine|mesh-list
82947413|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947414|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947415|NCT03716388|Analgesics|analgesics|mesh-ancestor
82947416|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
82947417|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947418|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947419|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947420|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947421|NCT01311336|Loratadine|loratadine|mesh-list
82947422|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
82947423|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
82947424|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82947425|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82947426|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82947427|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
82947428|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
82947429|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947430|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947431|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947434|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
82947435|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82947436|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947437|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
82947438|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947439|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82947440|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82947441|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82947442|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947443|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947444|NCT01261741|Memantine|memantine|mesh-list
82947445|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82947446|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82947447|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
82947448|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947449|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947450|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947451|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82947452|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82947454|NCT01157455|Everolimus|everolimus|mesh-list
82947455|NCT01157455|Heparin|heparin|mesh-list
82947456|NCT01157455|Bivalirudin|bivalirudin|mesh-list
82947457|NCT01157455|Clopidogrel|clopidogrel|mesh-list
82947458|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947459|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947460|NCT01157455|Analgesics|analgesics|mesh-ancestor
82947461|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
82947462|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947463|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947464|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947465|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947466|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82947467|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82947468|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947469|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82947470|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82947471|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947472|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
82947473|NCT01157455|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82947474|NCT01157455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82947475|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82947476|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
82947477|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947478|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82947479|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82947480|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82947481|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
82947482|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947483|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
82947484|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
82947485|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82947486|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
82947487|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82947488|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947489|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947490|NCT03884881|Meropenem|meropenem|mesh-list
82947491|NCT03884881|Imipenem|imipenem|mesh-list
82947492|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947493|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947494|NCT01154881|Insulin|insulin|mesh-list
82947495|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82949495|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
82947496|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947497|NCT03886441|Beclomethasone|beclomethasone|mesh-list
82947498|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947499|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
82947500|NCT03886441|Hormones|hormones|mesh-ancestor
82947501|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82947502|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947503|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82947504|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
82947505|NCT03713346|Caseins|caseins|mesh-list
82947506|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
82947507|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
82947508|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947509|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
82947510|NCT01154959|Rifampin|rifampin|mesh-list
82947511|NCT01154959|Isoniazid|isoniazid|mesh-list
82947512|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
82947513|NCT01154959|Ethambutol|ethambutol|mesh-list
82947514|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947515|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947516|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82947517|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82947518|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947519|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947520|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947521|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82947522|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
82947523|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
82947524|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82947525|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82947526|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82947527|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82947528|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82947529|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82947530|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82947531|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82947532|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82947533|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
82947534|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82947535|NCT03881293|Lidocaine|lidocaine|mesh-list
82947536|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
82947537|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
82947538|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82947539|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947540|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
82947541|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947542|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82947543|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82947544|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82947545|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947546|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947547|NCT01155037|Vaccines|vaccines|mesh-list
82947548|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
82947549|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947550|NCT01261897|Ropivacaine|ropivacaine|mesh-list
82947551|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
82947552|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
82947553|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82947554|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947555|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
82947556|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947557|NCT03448536|Acetaminophen|acetaminophen|mesh-list
82947558|NCT03448536|Naproxen|naproxen|mesh-list
82947559|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947560|NCT03448536|Analgesics|analgesics|mesh-ancestor
82947561|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
82947562|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947563|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947564|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
82947565|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947566|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947567|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947568|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
82947569|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82947570|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947571|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947572|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
82947573|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82947574|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
82947575|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947576|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947577|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82947578|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
82947579|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82947580|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
82947581|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947582|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947583|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82947584|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
82947585|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
82947586|NCT01155115|Protective Agents|protective agents|mesh-ancestor
82947587|NCT03713190|Empagliflozin|empagliflozin|mesh-list
82947588|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82947589|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947590|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82947591|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947592|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
82947593|NCT03718182|Vitamin D|vitamin d|mesh-list
82947594|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82947595|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947596|NCT03718182|Vitamins|vitamins|mesh-ancestor
82947597|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
82947598|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82947599|NCT03881449|Aripiprazole|aripiprazole|mesh-list
82947600|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
82947601|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82947602|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82947603|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82947604|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82947605|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947606|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
82947607|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
82947608|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947609|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947610|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82947611|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82947612|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
82947613|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82947614|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82947615|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82947616|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82947617|NCT03884491|Vortioxetine|vortioxetine|mesh-list
82947618|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
82947619|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82947620|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82947621|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82947622|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82947623|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947624|NCT03884491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82947625|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82947626|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947627|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947628|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947629|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
82947630|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82947631|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82947632|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82947633|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82947634|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82947635|NCT03712956|Doxorubicin|doxorubicin|mesh-list
82947636|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82947637|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947638|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82947639|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82947640|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947641|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947642|NCT03880981|Acetaminophen|acetaminophen|mesh-list
82947643|NCT03880981|Ibuprofen|ibuprofen|mesh-list
82947644|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947645|NCT03880981|Analgesics|analgesics|mesh-ancestor
82947646|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
82947647|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947648|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947649|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
82947650|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947651|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947652|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947653|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82947654|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947655|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947656|NCT03424044|Glucagon|glucagon|mesh-list
82947657|NCT03424044|Pancrelipase|pancrelipase|mesh-list
82947658|NCT03424044|Pancreatin|pancreatin|mesh-list
82947659|NCT03424044|Hormones|hormones|mesh-list
82947660|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82947661|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947662|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82947663|NCT03880903|Albuterol|albuterol|mesh-list
82947664|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82947665|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
82947666|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947667|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947668|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82947669|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
82947670|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
82947671|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82947672|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82947673|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82947674|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82947675|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
82947676|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947677|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947679|NCT01155895|Benazepril|benazepril|mesh-list
82947680|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82947681|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82947682|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947683|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947684|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82947685|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947686|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
82947687|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82947688|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
82947689|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947690|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
82947691|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947692|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947693|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82947694|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82947695|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947696|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947697|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947698|NCT01589809|Niacinamide|niacinamide|mesh-list
82947699|NCT01589809|Niacin|niacin|mesh-list
82947700|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
82947701|NCT01589809|Vitamins|vitamins|mesh-ancestor
82947702|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
82947703|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947704|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
82947705|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82947706|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
82947707|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947708|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82947709|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
82947710|NCT01264237|Etoricoxib|etoricoxib|mesh-list
82947711|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947712|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947713|NCT01264237|Analgesics|analgesics|mesh-ancestor
82947714|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
82947715|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947716|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947717|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947718|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947719|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82947720|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82947721|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947722|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947723|NCT03880825|Metformin|metformin|mesh-list
82947724|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82947725|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947726|NCT01159639|Clopidogrel|clopidogrel|mesh-list
82947727|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82947728|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82947729|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82947731|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
82947732|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947733|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947734|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947735|NCT03880357|Betamethasone|betamethasone|mesh-list
82947736|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
82947737|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82947738|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
82947739|NCT03880357|Calcipotriene|calcipotriene|mesh-list
82947740|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82947741|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947742|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
82947743|NCT03880357|Hormones|hormones|mesh-ancestor
82947744|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82947745|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947746|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82947747|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
82947748|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
82947749|NCT01266031|Bevacizumab|bevacizumab|mesh-list
82947750|NCT01266031|Vorinostat|vorinostat|mesh-list
82947751|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947752|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947753|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82947754|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82947755|NCT01266031|Growth Substances|growth substances|mesh-ancestor
82947756|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947757|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
82947758|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82947759|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947760|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947761|NCT03880045|Vasopressins|vasopressins|mesh-list
82947762|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
82947763|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
82947764|NCT03880045|Coagulants|coagulants|mesh-ancestor
82947765|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82947766|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82947767|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
82949496|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
82947768|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947769|NCT03879889|Nicotine|nicotine|mesh-list
82947770|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82947771|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
82947772|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947773|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947774|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82947775|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82947776|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
82947777|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947778|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947779|NCT01266187|Leucovorin|leucovorin|mesh-list
82947780|NCT01266187|Cetuximab|cetuximab|mesh-list
82947781|NCT01266187|Fluorouracil|fluorouracil|mesh-list
82947782|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
82947783|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947784|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947785|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
82947786|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947787|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82947788|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82947789|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
82947790|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947791|NCT01266187|Antidotes|antidotes|mesh-ancestor
82947792|NCT01266187|Protective Agents|protective agents|mesh-ancestor
82947793|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
82947794|NCT01266187|Vitamins|vitamins|mesh-ancestor
82947795|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
82947796|NCT01586533|Mesalamine|mesalamine|mesh-list
82947797|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947798|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947799|NCT01586533|Analgesics|analgesics|mesh-ancestor
82947800|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
82947801|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947802|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947803|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947804|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947805|NCT03880123|Ixazomib|ixazomib|mesh-list
82947806|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947807|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
82947808|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947809|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947810|NCT01266499|Colistin|colistin|mesh-list
82947811|NCT01266499|Polymyxins|polymyxins|mesh-list
82947812|NCT01266499|Gentamicins|gentamicins|mesh-list
82947813|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947814|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947815|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82947816|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947817|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947818|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
82947819|NCT00075725|Leucovorin|leucovorin|mesh-list
82947820|NCT00075725|Folic Acid|folic acid|mesh-list
82947821|NCT00075725|Cytarabine|cytarabine|mesh-list
82947822|NCT00075725|Dexamethasone|dexamethasone|mesh-list
82947823|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
82947824|NCT00075725|Prednisone|prednisone|mesh-list
82947825|NCT00075725|Cortisone|cortisone|mesh-list
82947826|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
82947827|NCT00075725|Doxorubicin|doxorubicin|mesh-list
82947828|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82947829|NCT00075725|Methotrexate|methotrexate|mesh-list
82947830|NCT00075725|Vincristine|vincristine|mesh-list
82947831|NCT00075725|Daunorubicin|daunorubicin|mesh-list
82947832|NCT00075725|Asparaginase|asparaginase|mesh-list
82947833|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
82947834|NCT00075725|Pegaspargase|pegaspargase|mesh-list
82947835|NCT00075725|Thioguanine|thioguanine|mesh-list
82947836|NCT00075725|BB 1101|bb 1101|mesh-list
82947837|NCT00075725|Calcium|calcium|mesh-list
82947838|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
82947839|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
82947840|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82947841|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
82947842|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947843|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947844|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82947845|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
82947846|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947847|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947848|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82947849|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947850|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
82947851|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
82947852|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947853|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82947854|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
82947855|NCT00075725|Hormones|hormones|mesh-ancestor
82947856|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82947857|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82947858|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
82947859|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82947860|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82947861|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82947862|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82947863|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82947864|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82947865|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82947866|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
82947867|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82947868|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82947869|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
82947870|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
82947871|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82947872|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82947873|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
82947874|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947875|NCT00075725|Antidotes|antidotes|mesh-ancestor
82947876|NCT00075725|Protective Agents|protective agents|mesh-ancestor
82947877|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
82947878|NCT00075725|Vitamins|vitamins|mesh-ancestor
82947879|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
82947880|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82947881|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
82947882|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
82947883|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
82947884|NCT00075725|Hematinics|hematinics|mesh-ancestor
82947885|NCT02953782|Cetuximab|cetuximab|mesh-list
82947886|NCT02953782|Magrolimab|magrolimab|mesh-list
82947887|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947888|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947889|NCT01264783|RNS60|rns60|mesh-list
82947890|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82947891|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82947892|NCT01264783|Analgesics|analgesics|mesh-ancestor
82947893|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
82947894|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947895|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947896|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947897|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82947898|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82947899|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
82947900|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
82947901|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82947902|NCT01160029|Nateglinide|nateglinide|mesh-list
82947903|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82947904|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947907|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82947908|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947909|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
82947910|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
82947911|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
82947912|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947913|NCT01266655|Baclofen|baclofen|mesh-list
82947914|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82947915|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947916|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82947917|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82947918|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82947919|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
82947920|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
82947921|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82947922|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947923|NCT00075023|Thalidomide|thalidomide|mesh-list
82947924|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82947925|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
82947926|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947927|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
82947928|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82947929|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947930|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82947931|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82947932|NCT00075023|Growth Substances|growth substances|mesh-ancestor
82947933|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
82947934|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947935|NCT01100801|Cisplatin|cisplatin|mesh-list
82947936|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
82947937|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947938|NCT01263145|Paclitaxel|paclitaxel|mesh-list
82947939|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82947940|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947941|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
82947942|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
82947943|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
82947944|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947945|NCT03717558|Ivermectin|ivermectin|mesh-list
82947946|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82947947|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947948|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
82947949|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
82947950|NCT00074711|Calcium|calcium|mesh-list
82947951|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82947952|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947953|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82947954|NCT00074711|Antacids|antacids|mesh-ancestor
82947955|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947956|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82947957|NCT03960905|Meropenem|meropenem|mesh-list
82947958|NCT03960905|Ceftazidime|ceftazidime|mesh-list
82947959|NCT03960905|Cefepime|cefepime|mesh-list
82947960|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
82947962|NCT05619120|Mexiletine|mexiletine|mesh-list
82947963|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82947964|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82947965|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82947966|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82947967|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82947968|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
82947969|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82947970|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82947971|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82947972|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82947973|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82947974|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82947975|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
82947976|NCT01265017|Estradiol|estradiol|mesh-list
82947977|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82947978|NCT01265017|Hormones|hormones|mesh-ancestor
82947979|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82947980|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82947981|NCT01265017|Estrogens|estrogens|mesh-ancestor
82947982|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82947983|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
82947984|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82947985|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82947986|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82947987|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82947988|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82947989|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82947990|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82947991|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82947992|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947993|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82947994|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
82947995|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82947996|NCT03879811|Nivolumab|nivolumab|mesh-list
82947997|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82947998|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82947999|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82948000|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948001|NCT01158859|Pregabalin|pregabalin|mesh-list
82948002|NCT01158859|Analgesics|analgesics|mesh-ancestor
82948003|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
82948004|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948005|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948006|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
82948007|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82948008|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82948009|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948010|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82948011|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82948012|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82948013|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948014|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948015|NCT01100021|Doxazosin|doxazosin|mesh-list
82948016|NCT01100021|Tamsulosin|tamsulosin|mesh-list
82948017|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82948018|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82948019|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82948020|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
82948021|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948022|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948023|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948024|NCT01100021|Urological Agents|urological agents|mesh-ancestor
82948025|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82948026|NCT03407430|Pregabalin|pregabalin|mesh-list
82948027|NCT03407430|Analgesics|analgesics|mesh-ancestor
82948028|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
82948029|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948030|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948031|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
82948032|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82948033|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82948034|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948035|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82948036|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82948037|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82948038|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948039|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948040|NCT01266811|Dexamethasone|dexamethasone|mesh-list
82948041|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
82948042|NCT01266811|Bortezomib|bortezomib|mesh-list
82948043|NCT01266811|Siltuximab|siltuximab|mesh-list
82948044|NCT01266811|BB 1101|bb 1101|mesh-list
82948045|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82948046|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
82948047|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
82948048|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948049|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948050|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948051|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
82948052|NCT01266811|Hormones|hormones|mesh-ancestor
82948053|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948054|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82948056|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
82948057|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948058|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948059|NCT01158937|Meropenem|meropenem|mesh-list
82948060|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82948061|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948062|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
82948063|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82948064|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948065|NCT01100177|Sunitinib|sunitinib|mesh-list
82948066|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948067|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948068|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948069|NCT01100177|Growth Substances|growth substances|mesh-ancestor
82948070|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948071|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948072|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82948073|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948074|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948075|NCT01100333|Hormones|hormones|mesh-list
82948076|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82948077|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948078|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948079|NCT01327235|Cisplatin|cisplatin|mesh-list
82948080|NCT01327235|Endostar protein|endostar protein|mesh-list
82948081|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948082|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948083|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948084|NCT01327235|Growth Substances|growth substances|mesh-ancestor
82948085|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948086|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948087|NCT03406260|Lasmiditan|lasmiditan|mesh-list
82948088|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82948089|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
82948090|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948091|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948092|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948093|NCT01089179|Metformin|metformin|mesh-list
82948094|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82948095|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948096|NCT01160185|Paclitaxel|paclitaxel|mesh-list
82948097|NCT01160185|Topotecan|topotecan|mesh-list
82948098|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82948099|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948100|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
82948101|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
82948102|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
82948103|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948104|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82948105|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82948106|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948107|NCT03419364|Niacinamide|niacinamide|mesh-list
82948108|NCT03419364|Niacin|niacin|mesh-list
82948109|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
82948110|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
82948111|NCT03419364|Vitamins|vitamins|mesh-ancestor
82948112|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
82948113|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948114|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82948115|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
82948116|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948117|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82948118|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
82948119|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
82948120|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
82948121|NCT01265173|Cefotaxime|cefotaxime|mesh-list
82948122|NCT01265173|Cefoxitin|cefoxitin|mesh-list
82948123|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82948124|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948125|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82948126|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82948127|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948128|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948129|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83518475|NCT00001569|Cisplatin|cisplatin|mesh-list
82948130|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82948131|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82948133|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948134|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82948135|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948136|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948137|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
82948138|NCT01160341|Testosterone|testosterone|mesh-list
82948139|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
82948140|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
82948141|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82948142|NCT01160341|Androgens|androgens|mesh-ancestor
82948143|NCT01160341|Hormones|hormones|mesh-ancestor
82948144|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948145|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948146|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82948147|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948148|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
82948149|NCT03882775|Heparin|heparin|mesh-list
82948150|NCT03882775|Bivalirudin|bivalirudin|mesh-list
82948151|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
82948152|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82948153|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82948154|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948155|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
82948156|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82948157|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
82948158|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948159|NCT03877705|Listerine|listerine|mesh-list
82948160|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
82948161|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82948162|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948163|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
82948164|NCT03877705|Protective Agents|protective agents|mesh-ancestor
82948165|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948166|NCT01160419|Leucovorin|leucovorin|mesh-list
82948167|NCT01160419|Folic Acid|folic acid|mesh-list
82948168|NCT01160419|Docetaxel|docetaxel|mesh-list
82948169|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
82948170|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
82948171|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948172|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
82948173|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
82948174|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
82948175|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948176|NCT01160419|Antidotes|antidotes|mesh-ancestor
82948177|NCT01160419|Protective Agents|protective agents|mesh-ancestor
82948178|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948179|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
82948180|NCT01160419|Vitamins|vitamins|mesh-ancestor
82948181|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
82948182|NCT01160419|Hematinics|hematinics|mesh-ancestor
82948183|NCT02954172|Paclitaxel|paclitaxel|mesh-list
82948184|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82948185|NCT02954172|Bevacizumab|bevacizumab|mesh-list
82948186|NCT02954172|Carboplatin|carboplatin|mesh-list
82948187|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82948188|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948189|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
82948190|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
82948191|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
82948192|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948193|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82948194|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948195|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948196|NCT02954172|Growth Substances|growth substances|mesh-ancestor
82948197|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948198|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948200|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82948201|NCT02953938|Ranibizumab|ranibizumab|mesh-list
82948202|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948203|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948204|NCT02953938|Growth Substances|growth substances|mesh-ancestor
82948205|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948206|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948207|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948208|NCT01161667|Naratriptan|naratriptan|mesh-list
82948209|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82948210|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82948211|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82948212|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
82948213|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948214|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948215|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948216|NCT02526979|Mirabegron|mirabegron|mesh-list
82948217|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82948218|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82948219|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82948220|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
82948221|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948222|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948223|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948224|NCT02526979|Urological Agents|urological agents|mesh-ancestor
82948225|NCT03882541|Midazolam|midazolam|mesh-list
82948226|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82948227|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82948228|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948229|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948230|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82948231|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82948232|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948233|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82948234|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
82948235|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
82948236|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
82948237|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
82948238|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948239|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948240|NCT01267903|Vaccines|vaccines|mesh-list
82948241|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
82948242|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948243|NCT03576313|Ivermectin|ivermectin|mesh-list
82948244|NCT03576313|Piperaquine|piperaquine|mesh-list
82948245|NCT03576313|Artenimol|artenimol|mesh-list
82948246|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82948247|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948248|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
82948249|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82948250|NCT01161979|Zonisamide|zonisamide|mesh-list
82948251|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
82948252|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82948253|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82948254|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948255|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82948256|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948257|NCT01160731|Etoposide|etoposide|mesh-list
82948258|NCT01160731|Panobinostat|panobinostat|mesh-list
82948259|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
82948260|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948261|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82948262|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82948263|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82948264|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948265|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948266|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82948267|NCT01160965|Ropivacaine|ropivacaine|mesh-list
82948268|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
82948269|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
82948270|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
82948271|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948272|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948273|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
82948274|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948276|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82948277|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948278|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
82948279|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948280|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82948281|NCT01162603|Latanoprost|latanoprost|mesh-list
82948282|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82948283|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82948284|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
82948285|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82948286|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948287|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
82948288|NCT02527213|Antidotes|antidotes|mesh-ancestor
82948289|NCT02527213|Protective Agents|protective agents|mesh-ancestor
82948290|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948291|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
82948292|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948293|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
82948294|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82948295|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948296|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
82948297|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
82948298|NCT01161277|Haloperidol|haloperidol|mesh-list
82948299|NCT01161277|Aripiprazole|aripiprazole|mesh-list
82948300|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
82948301|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
82948302|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948303|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82948304|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82948305|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948306|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948307|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
82948308|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
82948309|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948310|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948311|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82948312|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82948313|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
82948314|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82948315|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82948316|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82948317|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82948318|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
82948319|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
82948320|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948321|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948322|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82948323|NCT01268215|Budesonide|budesonide|mesh-list
82948324|NCT01268215|Calfactant|calfactant|mesh-list
82948325|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82948326|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82948327|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
82948328|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948329|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948330|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82948331|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
82948332|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
82948333|NCT01268215|Hormones|hormones|mesh-ancestor
82948334|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948335|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
82948336|NCT01269307|Ketamine|ketamine|mesh-list
82948337|NCT01269307|Propofol|propofol|mesh-list
82948338|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82948339|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948340|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948341|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82948342|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
82948343|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
82948344|NCT01269307|Analgesics|analgesics|mesh-ancestor
82948345|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
82948346|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948347|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82948348|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82948349|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82948350|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948351|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948352|NCT03874585|Nicotine|nicotine|mesh-list
82948353|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82948354|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
82948355|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948356|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948357|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82948358|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82948359|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
82948360|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948361|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948362|NCT01268371|Everolimus|everolimus|mesh-list
82948363|NCT01268371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82948364|NCT01268371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82948365|NCT01268371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948366|NCT01268371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948367|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82948368|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
82948369|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948370|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948371|NCT01267669|Somatostatin|somatostatin|mesh-list
82948372|NCT01267669|Hormones|hormones|mesh-ancestor
82948373|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948374|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948375|NCT05666869|Esketamine|esketamine|mesh-list
82948376|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
82948377|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948378|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82948379|NCT01164943|Hormones|hormones|mesh-ancestor
82948380|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948381|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948382|NCT01269541|Rifampin|rifampin|mesh-list
82948383|NCT01269541|Mupirocin|mupirocin|mesh-list
82948384|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82948385|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
82948386|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82948387|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948388|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
82948389|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82948390|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948391|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948392|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82948393|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82948394|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82948395|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82948396|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82948397|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82948398|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82948399|NCT03877003|Choline|choline|mesh-list
82948400|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
82948401|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82948402|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
82948403|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948404|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948405|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82948406|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
82948407|NCT01280149|Substance P|substance p|mesh-list
82948408|NCT01280149|Neurokinin A|neurokinin a|mesh-list
82948409|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948410|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948411|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948412|NCT01165255|Bupropion|bupropion|mesh-list
82948413|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
82948414|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82948415|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948416|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82948417|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82948418|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82948419|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948420|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
82948421|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948422|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948423|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82948424|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82948425|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948426|NCT01167049|Capecitabine|capecitabine|mesh-list
82948427|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82948428|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
82948429|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948430|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948431|NCT01311414|Urapidil|urapidil|mesh-list
82948432|NCT01311414|Cafedrine|cafedrine|mesh-list
82948433|NCT01311414|Theodrenaline|theodrenaline|mesh-list
82948434|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82948435|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
82948436|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82948437|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
82948438|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948439|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948440|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948441|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82948442|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82948443|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82948444|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
82948445|NCT03715296|Lenalidomide|lenalidomide|mesh-list
82948446|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
82948447|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948448|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948449|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948450|NCT03715296|Growth Substances|growth substances|mesh-ancestor
82948451|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948452|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948453|NCT01347762|Nabilone|nabilone|mesh-list
82948454|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
82948455|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
82948456|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948457|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948458|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948459|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82948460|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82948461|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948462|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948463|NCT03874273|Crizotinib|crizotinib|mesh-list
82948464|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948465|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82948466|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948467|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948468|NCT05657652|Cytarabine|cytarabine|mesh-list
82948469|NCT05657652|Venetoclax|venetoclax|mesh-list
82948470|NCT05657652|Cladribine|cladribine|mesh-list
82948471|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82948472|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
82948473|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948474|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948475|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
82948476|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948477|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82948478|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
82948479|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948480|NCT01167127|Oxycodone|oxycodone|mesh-list
82948481|NCT01167127|Naloxone|naloxone|mesh-list
82948482|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82948483|NCT01167127|Narcotics|narcotics|mesh-ancestor
82948484|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948485|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948486|NCT01167127|Analgesics|analgesics|mesh-ancestor
82948487|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
82948488|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948489|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82948490|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82948491|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82948492|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
82948493|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948494|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948495|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82948496|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82948497|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82948498|NCT03872011|Vitamins|vitamins|mesh-list
82948499|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
82948500|NCT03872011|Thiamine|thiamine|mesh-list
82948501|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
82948502|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
82948503|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948504|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82948505|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
83483175|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948506|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948507|NCT03872011|Protective Agents|protective agents|mesh-ancestor
82948508|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
82948509|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
82948510|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82948511|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948512|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
82948513|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82948515|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82948516|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948517|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
82948518|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
82948519|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
82948520|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948521|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
82948522|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82948523|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948524|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
82948525|NCT00073307|Sorafenib|sorafenib|mesh-list
82948526|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948527|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82948528|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948529|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948530|NCT01270789|Liraglutide|liraglutide|mesh-list
82948531|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82948532|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948533|NCT01270789|Incretins|incretins|mesh-ancestor
82948534|NCT01270789|Hormones|hormones|mesh-ancestor
82948535|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948536|NCT01164085|Ketorolac|ketorolac|mesh-list
82948537|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82948538|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82948539|NCT01164085|Analgesics|analgesics|mesh-ancestor
82948540|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
82948541|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948542|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948543|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82948544|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82948545|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82948546|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948547|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948548|NCT01271179|Insulin|insulin|mesh-list
82948549|NCT01271179|Allopurinol|allopurinol|mesh-list
82948550|NCT01271179|Adenosine|adenosine|mesh-list
82948551|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82948552|NCT01271179|Analgesics|analgesics|mesh-ancestor
82948553|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
82948554|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948555|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948556|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82948557|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
82948558|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82948559|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
82948560|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
82948561|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948562|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948563|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
82948564|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948565|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
82948566|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82948567|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82948568|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
82948569|NCT01271179|Protective Agents|protective agents|mesh-ancestor
82948570|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82948571|NCT03388164|Dexetimide|dexetimide|mesh-list
82948572|NCT03388164|Citalopram|citalopram|mesh-list
82948573|NCT03388164|Escitalopram|escitalopram|mesh-list
82948574|NCT03388164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82948575|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82948576|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82948577|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948578|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948579|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
82948580|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948581|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82948582|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82948583|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
82948584|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
82948585|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948586|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82948587|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82948588|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
82948589|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82948590|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
82948591|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948592|NCT01268761|Cetrorelix|cetrorelix|mesh-list
82948593|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82948594|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
82948595|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82948596|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948597|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
82948598|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948599|NCT01268839|Efavirenz|efavirenz|mesh-list
82948600|NCT01268839|Rilpivirine|rilpivirine|mesh-list
82948601|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82948602|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82948603|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948604|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948605|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
82948606|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948607|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82948608|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82948609|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82948610|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82948611|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82948612|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82948613|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82948614|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82948615|NCT03403374|Evolocumab|evolocumab|mesh-list
82948616|NCT03403374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82948617|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82948618|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82948619|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
82948620|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948621|NCT03403374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82948622|NCT03403374|Protease Inhibitors|protease inhibitors|mesh-ancestor
82948623|NCT03403374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948624|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82948625|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
82948626|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82948627|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83460064|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948628|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948629|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82948630|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82948631|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
82948632|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948633|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948634|NCT03387462|Tenofovir|tenofovir|mesh-list
82948635|NCT03387462|Emtricitabine|emtricitabine|mesh-list
82948636|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
82948637|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948638|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82948639|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82948640|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948641|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948642|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82948643|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82948644|NCT03756883|Fluticasone|fluticasone|mesh-list
82948646|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82948647|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82948648|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82948649|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82948650|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
82948651|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948652|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948653|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82948654|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
82948655|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
82948656|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82948657|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82948658|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82948659|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82948660|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
82948661|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948662|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948663|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
82948664|NCT03756883|Hormones|hormones|mesh-ancestor
82948665|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948666|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
82948667|NCT01586611|Leucovorin|leucovorin|mesh-list
82948668|NCT01586611|Gemcitabine|gemcitabine|mesh-list
82948669|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
82948670|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82948671|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
82948672|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948673|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948674|NCT01586611|Antidotes|antidotes|mesh-ancestor
82948675|NCT01586611|Protective Agents|protective agents|mesh-ancestor
82948676|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948677|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
82948678|NCT01586611|Vitamins|vitamins|mesh-ancestor
82948679|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
82948680|NCT03386448|Scopolamine|scopolamine|mesh-list
82948681|NCT03386448|Naltrexone|naltrexone|mesh-list
82948682|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82948683|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82948684|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82948685|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948686|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
82948687|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948688|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82948689|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
82948690|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
82948691|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948692|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
82948693|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82948694|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
82948695|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948696|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460083|NCT05510778|Charcoal|charcoal|mesh-list
82948697|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82948698|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
82948699|NCT01280929|Ranibizumab|ranibizumab|mesh-list
82948700|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948701|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948702|NCT01280929|Growth Substances|growth substances|mesh-ancestor
82948703|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948704|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948705|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948706|NCT01268917|Aspirin|aspirin|mesh-list
82948707|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82948708|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82948709|NCT01268917|Analgesics|analgesics|mesh-ancestor
82948710|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
82948711|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948712|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948713|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82948714|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82948715|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82948716|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82948717|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948718|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82948719|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82948720|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948721|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
82948722|NCT01281163|Lapatinib|lapatinib|mesh-list
82948723|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948724|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82948725|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948726|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948727|NCT01268995|Cyclosporine|cyclosporine|mesh-list
82948728|NCT01268995|Tacrolimus|tacrolimus|mesh-list
82948729|NCT01268995|Cyclosporins|cyclosporins|mesh-list
82948730|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82948731|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
82948732|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948733|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82948734|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948735|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948736|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
82948737|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948738|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
82948739|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82948741|NCT00009737|Fluorouracil|fluorouracil|mesh-list
82948742|NCT00009737|Capecitabine|capecitabine|mesh-list
82948743|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
82948744|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948745|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82948746|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948747|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82948748|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
82948749|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948750|NCT00009737|Antidotes|antidotes|mesh-ancestor
82948751|NCT00009737|Protective Agents|protective agents|mesh-ancestor
82948752|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
82948753|NCT00009737|Vitamins|vitamins|mesh-ancestor
82948754|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
82948755|NCT03711240|Leucovorin|leucovorin|mesh-list
82948756|NCT03711240|Bevacizumab|bevacizumab|mesh-list
82948757|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
82948758|NCT03711240|Irinotecan|irinotecan|mesh-list
82948759|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82948760|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948761|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948762|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948763|NCT03711240|Growth Substances|growth substances|mesh-ancestor
82948764|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948765|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948766|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82948767|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82948768|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83460090|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948769|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948770|NCT03711240|Antidotes|antidotes|mesh-ancestor
82948771|NCT03711240|Protective Agents|protective agents|mesh-ancestor
82948772|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
82948773|NCT03711240|Vitamins|vitamins|mesh-ancestor
82948774|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
82948775|NCT01271881|Heparin|heparin|mesh-list
82948776|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
82948777|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82948778|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82948779|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948780|NCT05459844|Octreotide|octreotide|mesh-list
82948781|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
82948782|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948783|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82948784|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948785|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82948786|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948787|NCT03874975|Vitamin D|vitamin d|mesh-list
82948788|NCT03874975|Vitamins|vitamins|mesh-ancestor
82948789|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
82948790|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948791|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82948793|NCT01164709|Bortezomib|bortezomib|mesh-list
82948794|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948795|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82948796|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82948797|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
82948798|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948799|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948800|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82948801|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82948802|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
82948803|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948804|NCT03960671|Midazolam|midazolam|mesh-list
82948805|NCT03960671|Diazepam|diazepam|mesh-list
82948806|NCT03960671|Propofol|propofol|mesh-list
82948807|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82948808|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83483176|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948809|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948810|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82948811|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
82948812|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
82948813|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82948814|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82948815|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82948816|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82948817|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
82948818|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
82948819|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948820|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948821|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
82948822|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
82948823|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
82948824|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948825|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948826|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82948827|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82948828|NCT01281553|Cisapride|cisapride|mesh-list
82948829|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82948830|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948831|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82948832|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
82948833|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948834|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948835|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948836|NCT01164787|Trandolapril|trandolapril|mesh-list
82948837|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82948838|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
82948839|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948840|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948841|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82948842|NCT01269151|Ranibizumab|ranibizumab|mesh-list
82948843|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948844|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948845|NCT01269151|Growth Substances|growth substances|mesh-ancestor
82948846|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948847|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948848|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948849|NCT00028769|Paclitaxel|paclitaxel|mesh-list
82948850|NCT00028769|Etoposide|etoposide|mesh-list
82948851|NCT00028769|Leuprolide|leuprolide|mesh-list
82948852|NCT00028769|Goserelin|goserelin|mesh-list
82948853|NCT00028769|Bicalutamide|bicalutamide|mesh-list
82948854|NCT00028769|Flutamide|flutamide|mesh-list
82948855|NCT00028769|Estramustine|estramustine|mesh-list
82948856|NCT00028769|Nilutamide|nilutamide|mesh-list
82948857|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82948858|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948859|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
82948860|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
82948861|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
82948862|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948863|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82948864|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82948865|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948866|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82948867|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
82948868|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82948869|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948870|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82948871|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
82948872|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
82948873|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82948874|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82948875|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
82948877|NCT01281787|Metoprolol|metoprolol|mesh-list
82948878|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82948879|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82948880|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82948881|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82948882|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948883|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
82948884|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
82948885|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948886|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948887|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82948888|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82948889|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82948890|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
82948891|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948892|NCT02953314|Ivacaftor|ivacaftor|mesh-list
82948893|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82948894|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82948895|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948896|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
82948897|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82948898|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
82948899|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948900|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82948901|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82948902|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
82948903|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948904|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948905|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83460103|NCT02337530|Pemetrexed|pemetrexed|mesh-list
82948906|NCT01273441|Amoxicillin|amoxicillin|mesh-list
82948907|NCT01273441|Metronidazole|metronidazole|mesh-list
82948908|NCT01273441|Clarithromycin|clarithromycin|mesh-list
82948909|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82948910|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948911|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82948912|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82948913|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82948914|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948915|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948916|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82948917|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82948918|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
82948919|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82948920|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82948921|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948922|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
82948923|NCT03714360|Coagulants|coagulants|mesh-ancestor
82948924|NCT01169857|Bortezomib|bortezomib|mesh-list
82948925|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
82948926|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948927|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
82948928|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948929|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948930|NCT01169935|Dextrans|dextrans|mesh-list
82948931|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
82948932|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
82948933|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
82948934|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82948935|NCT01168063|Amoxicillin|amoxicillin|mesh-list
82948936|NCT01168063|Metronidazole|metronidazole|mesh-list
82948937|NCT01168063|Clarithromycin|clarithromycin|mesh-list
82948938|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82948939|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948940|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
82948941|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82948942|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82948943|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82948944|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948945|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948946|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82948947|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82948948|NCT01166035|Lenalidomide|lenalidomide|mesh-list
82948949|NCT01166035|Cetuximab|cetuximab|mesh-list
82948950|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
82948951|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948952|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82948953|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82948954|NCT01166035|Growth Substances|growth substances|mesh-ancestor
82948955|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
82948956|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948957|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82948958|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82948959|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82948960|NCT03869281|Pancrelipase|pancrelipase|mesh-list
82948961|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82948962|NCT01281943|Sirolimus|sirolimus|mesh-list
82948963|NCT01281943|Doxorubicin|doxorubicin|mesh-list
82948964|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82948965|NCT01281943|Temsirolimus|temsirolimus|mesh-list
82948966|NCT01281943|MTOR Inhibitors|mtor inhibitors|mesh-list
82948967|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82948968|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82948969|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82948970|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82948971|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82948972|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948973|NCT01281943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82948974|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82948975|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
82948976|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948977|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82948978|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82948979|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
82948980|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
82948981|NCT03869047|Bupivacaine|bupivacaine|mesh-list
82948982|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
82948983|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
82948984|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82948985|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82948986|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
82948987|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82948988|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82948989|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82948990|NCT03869047|Analgesics|analgesics|mesh-ancestor
82948991|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82948992|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82948993|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82948994|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
82948995|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82948996|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82948997|NCT01168531|Dexamethasone|dexamethasone|mesh-list
82948998|NCT01168531|Pregabalin|pregabalin|mesh-list
82948999|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949000|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
82949001|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
82949002|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949003|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949004|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949005|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
82949006|NCT01168531|Hormones|hormones|mesh-ancestor
82949007|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949008|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82949009|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949010|NCT01168531|Analgesics|analgesics|mesh-ancestor
82949011|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
82949012|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
82949013|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82949014|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949015|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949016|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82949017|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82949018|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82949019|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949020|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82949021|NCT01170169|Omeprazole|omeprazole|mesh-list
82949022|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82949023|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949024|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82949025|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949026|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949027|NCT01587313|Hydralazine|hydralazine|mesh-list
82949028|NCT01587313|Isosorbide|isosorbide|mesh-list
82949029|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82949030|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82949031|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82949032|NCT01587313|Diuretics|diuretics|mesh-ancestor
82949033|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
82949034|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949035|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
82949036|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82949037|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949038|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82949039|NCT01282333|Gemcitabine|gemcitabine|mesh-list
82949040|NCT01282333|Veliparib|veliparib|mesh-list
82949041|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949042|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82949043|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
82949044|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949045|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82949046|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949047|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
82949048|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
82949049|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82949050|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949051|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949052|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
82949053|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82949054|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949055|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949056|NCT03868969|Fosfomycin|fosfomycin|mesh-list
82949057|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82949058|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949059|NCT01311570|Buprenorphine|buprenorphine|mesh-list
82949060|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82949061|NCT01311570|Narcotics|narcotics|mesh-ancestor
82949062|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949063|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949064|NCT01311570|Analgesics|analgesics|mesh-ancestor
82949065|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
82949066|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949067|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82949068|NCT01170325|Valproic Acid|valproic acid|mesh-list
82949069|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
82949070|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949071|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949072|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
82949073|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949074|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949075|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
82949076|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82949077|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949078|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82949079|NCT05542446|Colistin|colistin|mesh-list
82949080|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82949081|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949082|NCT03355326|Glycerol|glycerol|mesh-list
82949083|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82949084|NCT03355326|Protective Agents|protective agents|mesh-ancestor
82949085|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949086|NCT01170637|Ibuprofen|ibuprofen|mesh-list
82949087|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
82949088|NCT01170637|Ephedrine|ephedrine|mesh-list
82949089|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82949090|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82949091|NCT01170637|Analgesics|analgesics|mesh-ancestor
82949092|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
82949093|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949094|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949095|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949096|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949097|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82949098|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949099|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949100|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82949101|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
82949102|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82949103|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
82949104|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
82949105|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82949106|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82949107|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
82949108|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
82949109|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949110|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
83460125|NCT02569242|Paclitaxel|paclitaxel|mesh-list
82949111|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82949112|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949113|NCT03873025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82949114|NCT03873025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949115|NCT02526745|Vaccines|vaccines|mesh-list
82949116|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
82949117|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949118|NCT01169389|Bupivacaine|bupivacaine|mesh-list
82949119|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
82949120|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
82949121|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949122|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949123|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
82949124|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949125|NCT01170871|Pemetrexed|pemetrexed|mesh-list
82949126|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949127|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949128|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949129|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82949130|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82949131|NCT03868111|Sufentanil|sufentanil|mesh-list
82949132|NCT03868111|Remifentanil|remifentanil|mesh-list
82949133|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82949134|NCT03868111|Narcotics|narcotics|mesh-ancestor
82949135|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949136|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949137|NCT03868111|Analgesics|analgesics|mesh-ancestor
82949138|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
82949139|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949140|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82949141|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82949142|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
82949143|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
82949144|NCT01282879|Itraconazole|itraconazole|mesh-list
82949145|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
82949146|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949147|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82949148|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82949149|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949150|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949151|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82949152|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
82949153|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949154|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949155|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82949156|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
82949157|NCT03868033|Denosumab|denosumab|mesh-list
82949158|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82949159|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949160|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
82949161|NCT01166815|Astringents|astringents|mesh-ancestor
82949162|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949163|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
82949164|NCT03751657|Insulin|insulin|mesh-list
82949165|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82949166|NCT03751657|Metformin|metformin|mesh-list
82949167|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
82949168|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82949169|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82949170|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949172|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949173|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949174|NCT03873415|Deucravacitinib|deucravacitinib|mesh-list
82949175|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
82949176|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82949177|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949178|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949179|NCT00025259|Cytarabine|cytarabine|mesh-list
82949180|NCT00025259|Dexamethasone|dexamethasone|mesh-list
82949181|NCT00025259|Prednisone|prednisone|mesh-list
82949182|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
82949183|NCT00025259|Cortisone|cortisone|mesh-list
82949184|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
82949185|NCT00025259|Cisplatin|cisplatin|mesh-list
82949186|NCT00025259|Doxorubicin|doxorubicin|mesh-list
82949187|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82949188|NCT00025259|Etoposide|etoposide|mesh-list
82949189|NCT00025259|Vincristine|vincristine|mesh-list
82949190|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
82949191|NCT00025259|Bleomycin|bleomycin|mesh-list
82949192|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
82949193|NCT00025259|Lenograstim|lenograstim|mesh-list
82949194|NCT00025259|BB 1101|bb 1101|mesh-list
82949195|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82949196|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
82949197|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949198|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949199|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82949200|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
82949201|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949202|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949203|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82949204|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949205|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
82949206|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
82949207|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949208|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949209|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
82949210|NCT00025259|Hormones|hormones|mesh-ancestor
82949211|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949212|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82949213|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82949214|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82949215|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82949216|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949217|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82949218|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82949219|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
82949220|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
82949221|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949222|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82949223|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
82949224|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
82949225|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
82949226|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
82949227|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
82949228|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
82949229|NCT01171651|Sorafenib|sorafenib|mesh-list
82949230|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949231|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82949232|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949233|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949234|NCT03866629|Lifitegrast|lifitegrast|mesh-list
82949235|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82949236|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82949237|NCT01280071|Aminophylline|aminophylline|mesh-list
82949238|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82949239|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
82949240|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949241|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949242|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82949243|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
82949244|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82949245|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82949246|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949247|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949248|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82949250|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
82949251|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949252|NCT01280071|Protective Agents|protective agents|mesh-ancestor
82949253|NCT02526199|Dexamethasone|dexamethasone|mesh-list
82949254|NCT02526199|Epinephrine|epinephrine|mesh-list
82949255|NCT02526199|Bupivacaine|bupivacaine|mesh-list
82949256|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949257|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
82949258|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
82949259|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949260|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949261|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949262|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
82949263|NCT02526199|Hormones|hormones|mesh-ancestor
82949264|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949265|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82949266|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949267|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
82949268|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
82949269|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949270|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
82949271|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82949272|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82949273|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
82949274|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949275|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949276|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82949277|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82949278|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82949279|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
82949280|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
82949281|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
82949282|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82949283|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82949284|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82949285|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82949286|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82949287|NCT03863977|Dexamethasone|dexamethasone|mesh-list
82949288|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
82949289|NCT03863977|Bupivacaine|bupivacaine|mesh-list
82949290|NCT03863977|BB 1101|bb 1101|mesh-list
82949291|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949292|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
82949293|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
82949294|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949295|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949296|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949297|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
82949298|NCT03863977|Hormones|hormones|mesh-ancestor
82949299|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949300|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82949301|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949302|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
82949303|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949304|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949305|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
82949306|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
82949307|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949308|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
82949309|NCT01171807|Dexamethasone|dexamethasone|mesh-list
82949310|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82949311|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949312|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
82949313|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
82949314|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949315|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949316|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949317|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
82949318|NCT01171807|Hormones|hormones|mesh-ancestor
82949319|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949320|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82949321|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949322|NCT05445648|Tislelizumab|tislelizumab|mesh-list
82949323|NCT05445648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82949324|NCT05445648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949325|NCT01171885|Ropivacaine|ropivacaine|mesh-list
82949326|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
82949327|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
82949328|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949329|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949330|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
82949331|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949332|NCT01286233|Metformin|metformin|mesh-list
82949333|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82949334|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949335|NCT01175161|Copper|copper|mesh-list
82949336|NCT01175161|Trace Elements|trace elements|mesh-ancestor
82949337|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
82949338|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949339|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82949340|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82949341|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949342|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
82949343|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82949344|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
82949345|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949346|NCT00024167|Ketoconazole|ketoconazole|mesh-list
82949347|NCT00024167|Dexamethasone|dexamethasone|mesh-list
82949348|NCT00024167|Prednisone|prednisone|mesh-list
82949349|NCT00024167|Estramustine|estramustine|mesh-list
82949350|NCT00024167|Docetaxel|docetaxel|mesh-list
82949351|NCT00024167|Doxorubicin|doxorubicin|mesh-list
82949352|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82949353|NCT00024167|Vinblastine|vinblastine|mesh-list
82949354|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949355|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
82949356|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
82949357|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949358|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949359|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949360|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
82949361|NCT00024167|Hormones|hormones|mesh-ancestor
82949362|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949363|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82949364|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949365|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
82949366|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
82949367|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
82949368|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949369|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82949370|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82949371|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82949372|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949373|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
82949374|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949375|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82949376|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82949377|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82949378|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
82949379|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82949380|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82949381|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82949382|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
82949383|NCT03867097|Iloprost|iloprost|mesh-list
82949384|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82949385|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
82949386|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
82949387|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82949388|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82949389|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949390|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82949391|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82949392|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
82949393|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949394|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
82949395|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82949396|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
82949397|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949398|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82949407|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
82949408|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949409|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
82949410|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82949411|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
82949412|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949413|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
82949414|NCT01284439|Protective Agents|protective agents|mesh-ancestor
82949423|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82949424|NCT01172431|Indapamide|indapamide|mesh-list
82949425|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82949426|NCT01172431|Diuretics|diuretics|mesh-ancestor
82949427|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
82949428|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949429|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82949430|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949431|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949432|NCT01172509|Baclofen|baclofen|mesh-list
82949433|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82949434|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949435|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82949436|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949437|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82949438|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
82949439|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
82949440|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949441|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949442|NCT01089959|Esomeprazole|esomeprazole|mesh-list
82949443|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82949444|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949445|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82949446|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949447|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949448|NCT01090037|Epoprostenol|epoprostenol|mesh-list
82949449|NCT01090037|Beraprost|beraprost|mesh-list
82949450|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82949451|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
82949452|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82949453|NCT01285375|Curcumin|curcumin|mesh-list
82949454|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82949455|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82949456|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82949457|NCT01285375|Analgesics|analgesics|mesh-ancestor
82949458|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
82949459|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949460|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949461|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949462|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949463|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949464|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949465|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949466|NCT05625893|Bevacizumab|bevacizumab|mesh-list
82949467|NCT05625893|Atezolizumab|atezolizumab|mesh-list
82949468|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82949469|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949470|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82949471|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82949472|NCT05625893|Growth Substances|growth substances|mesh-ancestor
82949473|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949474|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
82949475|NCT05625893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82949476|NCT05625893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949477|NCT01178047|Rasagiline|rasagiline|mesh-list
82949478|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82949479|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949505|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
82949506|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82949507|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949508|NCT01285453|Vadimezan|vadimezan|mesh-list
82949509|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949510|NCT01288339|Leucovorin|leucovorin|mesh-list
82949511|NCT01288339|Fluorouracil|fluorouracil|mesh-list
82949512|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
82949513|NCT01288339|Panitumumab|panitumumab|mesh-list
82949514|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
82949515|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949516|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82949517|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949518|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82949519|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
82949520|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949521|NCT01288339|Antidotes|antidotes|mesh-ancestor
82949522|NCT01288339|Protective Agents|protective agents|mesh-ancestor
82949523|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
82949524|NCT01288339|Vitamins|vitamins|mesh-ancestor
82949525|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
82949526|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82949527|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
82949528|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949529|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82949530|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
82949531|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949532|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
82949533|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82949534|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82949535|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82949536|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82949537|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949538|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949539|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
82949540|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949541|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949542|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82949543|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949544|NCT01105481|Amisulpride|amisulpride|mesh-list
82949545|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82949546|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82949547|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949548|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949550|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82949551|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
82949552|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949553|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949554|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82949555|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
82949557|NCT01178203|Tramadol|tramadol|mesh-list
82949558|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82949559|NCT01178203|Narcotics|narcotics|mesh-ancestor
82949560|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949561|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949562|NCT01178203|Analgesics|analgesics|mesh-ancestor
82949563|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
82949564|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949565|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82949566|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82949567|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949568|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949569|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
82949570|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82949571|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949572|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949573|NCT01286701|Terbinafine|terbinafine|mesh-list
82949574|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
82949575|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949576|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220995|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82949577|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949578|NCT00006305|Biguanides|biguanides|mesh-list
82949579|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
82949580|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
82949581|NCT00006305|Calcium|calcium|mesh-list
82949582|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83483177|NCT00556478|Lidocaine|lidocaine|mesh-list
82949583|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82949584|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82949585|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82949586|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949587|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82949588|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82949589|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
82949590|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949591|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949592|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
82949593|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949594|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949595|NCT01284907|Vitamin D|vitamin d|mesh-list
82949596|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
82949597|NCT01284907|Vitamins|vitamins|mesh-ancestor
82949598|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
82949599|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949600|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82949601|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82949602|NCT01286857|Silicon|silicon|mesh-list
82949603|NCT01286857|Trace Elements|trace elements|mesh-ancestor
82949604|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
82949605|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949606|NCT01101269|Lisinopril|lisinopril|mesh-list
82949607|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82949608|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
82949609|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949610|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949611|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82949612|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82949613|NCT01101269|Protective Agents|protective agents|mesh-ancestor
82949614|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949615|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82949616|NCT01103375|Isotretinoin|isotretinoin|mesh-list
82949617|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949618|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82949619|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949620|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949621|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
82949623|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
82949624|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
82949625|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82949626|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82949627|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
82949628|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949629|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82949630|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82949631|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949632|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949633|NCT01285765|Rituximab|rituximab|mesh-list
82949634|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82949635|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949636|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
82949637|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949638|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949639|NCT03864913|Testosterone|testosterone|mesh-list
82949640|NCT03864913|Androgens|androgens|mesh-ancestor
82949641|NCT03864913|Hormones|hormones|mesh-ancestor
82949642|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949643|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949644|NCT03865147|Acetaminophen|acetaminophen|mesh-list
82949645|NCT03865147|Cetrimonium|cetrimonium|mesh-list
82949646|NCT03865147|Ibuprofen|ibuprofen|mesh-list
82949647|NCT03865147|Lidocaine|lidocaine|mesh-list
82949648|NCT03865147|Epinephrine|epinephrine|mesh-list
82949649|NCT03865147|Racepinephrine|racepinephrine|mesh-list
82949650|NCT03865147|Bupivacaine|bupivacaine|mesh-list
82949651|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82949652|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
82949653|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
82949654|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
82949655|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949656|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949657|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
82949658|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949659|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82949660|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82949661|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82949662|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949663|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949664|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82949665|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82949666|NCT03865147|Analgesics|analgesics|mesh-ancestor
82949667|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82949668|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949669|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82949670|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949671|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
82949672|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82949673|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82949674|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
82949675|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949676|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82949677|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82949678|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
82949679|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82949680|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
82949681|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
82949682|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
82949683|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82949684|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82949685|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82949686|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949687|NCT03722823|Tucatinib|tucatinib|mesh-list
82949688|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949689|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82949690|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949691|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949692|NCT03862651|Cangrelor|cangrelor|mesh-list
82949693|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82949694|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82949695|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82949696|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82949698|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949699|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949700|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949702|NCT03349710|Cetuximab|cetuximab|mesh-list
82949703|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949704|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82949705|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82949706|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949707|NCT01288495|Psyllium|psyllium|mesh-list
82949708|NCT01288495|Cathartics|cathartics|mesh-ancestor
82949709|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82949710|NCT01105793|Danazol|danazol|mesh-list
82949711|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82949712|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
82949713|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949714|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949715|NCT04934579|Rituximab|rituximab|mesh-list
82949716|NCT04934579|Methotrexate|methotrexate|mesh-list
82949717|NCT04934579|Lenalidomide|lenalidomide|mesh-list
82949718|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82949719|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949720|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
83460220|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
82949721|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949722|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949723|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82949724|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
82949725|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82949726|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82949727|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
82949728|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949729|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
82949730|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949731|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82949732|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82949733|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82949734|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83483178|NCT00556478|Prilocaine|prilocaine|mesh-list
82949735|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82949736|NCT04934579|Growth Substances|growth substances|mesh-ancestor
82949737|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
82949739|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949740|NCT01103609|Warfarin|warfarin|mesh-list
82949741|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
82949742|NCT03528369|Capsaicin|capsaicin|mesh-list
82949743|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
82949744|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
82949745|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
82949746|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949747|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949748|NCT01288573|Plerixafor|plerixafor|mesh-list
82949749|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82949750|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82949751|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
82949752|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949753|NCT01174693|Clopidogrel|clopidogrel|mesh-list
82949754|NCT01174693|Triflusal|triflusal|mesh-list
82949755|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82949756|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82949757|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82949758|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82949759|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
82949760|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949761|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949762|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949763|NCT00006011|Paclitaxel|paclitaxel|mesh-list
82949764|NCT00006011|Doxorubicin|doxorubicin|mesh-list
82949765|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82949766|NCT00006011|Lenograstim|lenograstim|mesh-list
82949767|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82949768|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949769|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
82949770|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
82949771|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
82949772|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949773|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82949774|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82949775|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82949776|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949777|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82949778|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
82949779|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949781|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82949782|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949783|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
82949784|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949785|NCT03377556|Talazoparib|talazoparib|mesh-list
82949786|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82949787|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949788|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949789|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949790|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
83460225|NCT00977171|Droxidopa|droxidopa|mesh-list
82949791|NCT05625581|Tofacitinib|tofacitinib|mesh-list
82949792|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82949793|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
82949794|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949795|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82949796|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82949797|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
82949798|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949799|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949800|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82949801|NCT05625581|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82949802|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82949803|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949804|NCT05625503|Verapamil|verapamil|mesh-list
82949805|NCT05625503|Nicardipine|nicardipine|mesh-list
82949806|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
82949807|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82949808|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949809|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82949810|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949811|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949812|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
82949813|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82949814|NCT01176175|Progesterone|progesterone|mesh-list
82949815|NCT01176175|Progestins|progestins|mesh-ancestor
82949816|NCT01176175|Hormones|hormones|mesh-ancestor
82949817|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82949818|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949819|NCT05624099|Paclitaxel|paclitaxel|mesh-list
82949820|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82949821|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949822|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
82949823|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
82949824|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
82949825|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949826|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
82949827|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
82949828|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949829|NCT03864523|Pioglitazone|pioglitazone|mesh-list
82949830|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82949831|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949832|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82949833|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
82949834|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949835|NCT03583359|Lidocaine|lidocaine|mesh-list
82949836|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
82949837|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
82949838|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949839|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949840|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
82949841|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949842|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82949843|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82949844|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82949846|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949847|NCT05619887|Fentanyl|fentanyl|mesh-list
82949848|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82949849|NCT05619887|Narcotics|narcotics|mesh-ancestor
82949850|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949851|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949852|NCT05619887|Analgesics|analgesics|mesh-ancestor
82949853|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
82949854|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949855|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82949856|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82949857|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
82949858|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
82949859|NCT01174927|Heroin|heroin|mesh-list
82949860|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82949861|NCT01174927|Narcotics|narcotics|mesh-ancestor
82949862|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949863|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949864|NCT01174927|Analgesics|analgesics|mesh-ancestor
82949865|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
82949866|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949867|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
82949868|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82949869|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949870|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82949871|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82949872|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949873|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949874|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949875|NCT03948737|Tocopherols|tocopherols|mesh-list
82949876|NCT03948737|Vitamin E|vitamin e|mesh-list
82949877|NCT03948737|Tocotrienols|tocotrienols|mesh-list
82949878|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
82949879|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
82949880|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949881|NCT03948737|Protective Agents|protective agents|mesh-ancestor
82949882|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949883|NCT03948737|Vitamins|vitamins|mesh-ancestor
82949884|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
82949885|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
82949886|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82949887|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82949888|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949889|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949890|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
82949891|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949892|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949893|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82949894|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949895|NCT01327859|Donepezil|donepezil|mesh-list
82949896|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82949897|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949898|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949899|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
82949900|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949901|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949902|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
82949903|NCT01176409|Valacyclovir|valacyclovir|mesh-list
82949904|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
82949905|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949906|NCT03480009|Oxycodone|oxycodone|mesh-list
82949907|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
82949908|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82949909|NCT03480009|Narcotics|narcotics|mesh-ancestor
82949910|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82949911|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949912|NCT03480009|Analgesics|analgesics|mesh-ancestor
82949913|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
82949914|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82949915|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
82949916|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
82949917|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82949918|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82949919|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949920|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949922|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949923|NCT01310751|Iloprost|iloprost|mesh-list
82949924|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82949925|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
82949926|NCT01180933|Folic Acid|folic acid|mesh-list
82949927|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
82949928|NCT01180933|Hematinics|hematinics|mesh-ancestor
82949929|NCT01180933|Vitamins|vitamins|mesh-ancestor
82949930|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
82949931|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949932|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
82949933|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82949934|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82949935|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949936|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
82949937|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
82949938|NCT03859141|Vaccines|vaccines|mesh-list
82949939|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
82949940|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949941|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
82949942|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82949943|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
82949944|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949945|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
82949946|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82949947|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82949948|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
82949949|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949950|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82949951|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82949952|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949953|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949954|NCT03711708|Sertraline|sertraline|mesh-list
82949955|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
82949956|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82949957|NCT03711708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82949958|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82949959|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82949960|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949961|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82949962|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
83518550|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
82949963|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949964|NCT01179529|Omalizumab|omalizumab|mesh-list
82949965|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82949966|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82949967|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
82949968|NCT00004859|Thalidomide|thalidomide|mesh-list
82949969|NCT00004859|Paclitaxel|paclitaxel|mesh-list
82949970|NCT00004859|Carboplatin|carboplatin|mesh-list
82949971|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82949972|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82949973|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
82949974|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
82949975|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
82949976|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949977|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82949978|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
82949979|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949980|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
82949981|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82949982|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82949983|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82949984|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82949985|NCT00004859|Growth Substances|growth substances|mesh-ancestor
82949986|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
82949987|NCT03348930|Tolcapone|tolcapone|mesh-list
82949988|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82949989|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82949990|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82949991|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82949992|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82949993|NCT03500211|Lidocaine|lidocaine|mesh-list
82949994|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
82949995|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
83460247|NCT04120922|Calcium|calcium|mesh-list
82949997|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82949998|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
82949999|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950000|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82950001|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82950002|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82950003|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82950004|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950005|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
82950006|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82950007|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950008|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82950009|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950010|NCT04760717|Spironolactone|spironolactone|mesh-list
82950011|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82950012|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
82950013|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82950014|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950015|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82950016|NCT04760717|Diuretics|diuretics|mesh-ancestor
82950017|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
82950018|NCT03478683|Budesonide|budesonide|mesh-list
82950019|NCT03478683|Albuterol|albuterol|mesh-list
82950020|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
82950021|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
82950022|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82950023|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950024|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82950025|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
82950026|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950027|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950028|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82950029|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
82950030|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
82950031|NCT03478683|Hormones|hormones|mesh-ancestor
82950032|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82950033|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82950034|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82950035|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82950036|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
82950037|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950038|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950039|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
82950040|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82950041|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
82950042|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
82950043|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82950044|NCT04744883|Naloxone|naloxone|mesh-list
82950045|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82950046|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950047|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
82950048|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950049|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
82950050|NCT01176799|Doxorubicin|doxorubicin|mesh-list
82950051|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82950052|NCT01176799|Sunitinib|sunitinib|mesh-list
82950053|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950054|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
82950055|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950056|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950057|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950058|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
82950059|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950060|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950061|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82950062|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82950063|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82950064|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82950065|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950066|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82950068|NCT01176799|Growth Substances|growth substances|mesh-ancestor
82950069|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
82950070|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82950071|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
82950072|NCT03861403|Avelumab|avelumab|mesh-list
82950073|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950074|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
82950075|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950076|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950077|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950078|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
82950079|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950080|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950081|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82950082|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950083|NCT03477903|Metoclopramide|metoclopramide|mesh-list
82950084|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
82950085|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
82950086|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950087|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950088|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950089|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82950090|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82950091|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
82950092|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950093|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950094|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
82950095|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82950096|NCT04728425|Antibodies|antibodies|mesh-list
82950097|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
82950098|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82950099|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
82950100|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
82950101|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950102|NCT01181401|Cisplatin|cisplatin|mesh-list
82950103|NCT01181401|Docetaxel|docetaxel|mesh-list
82950104|NCT01181401|Cetuximab|cetuximab|mesh-list
82950105|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950106|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
82950107|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
82950108|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
82950109|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950110|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950111|NCT01287715|Etanercept|etanercept|mesh-list
82950112|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82950113|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82950114|NCT01287715|Analgesics|analgesics|mesh-ancestor
82950115|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
82950116|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950117|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950118|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950119|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950120|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950121|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950122|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
82950123|NCT03474081|Albuterol|albuterol|mesh-list
82950124|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
82950125|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82950126|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
82950127|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950128|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950129|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82950130|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
82950131|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
82950132|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82950133|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
82950134|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950135|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950136|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
82950137|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82950138|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82950139|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82950140|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82950141|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
82950142|NCT03393000|Vitamin A|vitamin a|mesh-list
82950143|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
82950144|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
82950145|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950146|NCT03393000|Protective Agents|protective agents|mesh-ancestor
82950147|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950148|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82950149|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950150|NCT03393000|Vitamins|vitamins|mesh-ancestor
82950151|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
82950152|NCT01311804|Parecoxib|parecoxib|mesh-list
82950153|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82950154|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82950155|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950156|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950157|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82950158|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82950159|NCT01311804|Analgesics|analgesics|mesh-ancestor
82950160|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
82950161|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950162|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950163|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950164|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950165|NCT03370770|Osimertinib|osimertinib|mesh-list
82950166|NCT03370770|Afatinib|afatinib|mesh-list
82950167|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950168|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82950169|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950170|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950171|NCT01180075|Ritonavir|ritonavir|mesh-list
82950172|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82950173|NCT01180075|Tenofovir|tenofovir|mesh-list
82950174|NCT01180075|Emtricitabine|emtricitabine|mesh-list
82950175|NCT01180075|Efavirenz|efavirenz|mesh-list
82950176|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82950177|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82950178|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
82950179|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950180|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950181|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82950182|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82950183|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
82950184|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950185|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83518701|NCT00002343|Rifabutin|rifabutin|mesh-list
82950186|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82950187|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82950188|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82950189|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82950190|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82950191|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82950192|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82950193|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82950194|NCT01311882|Zopiclone|zopiclone|mesh-list
82950195|NCT01311882|Suvorexant|suvorexant|mesh-list
82950196|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82950197|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460273|NCT03828032|Mannitol|mannitol|mesh-list
82950198|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950199|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82950200|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82950201|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950202|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950203|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
82950204|NCT01287793|Tigecycline|tigecycline|mesh-list
82950205|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82950206|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950207|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82950208|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82950209|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950210|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950211|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950212|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82950213|NCT03391284|Acetaminophen|acetaminophen|mesh-list
82950214|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82950215|NCT03391284|Analgesics|analgesics|mesh-ancestor
82950216|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
82950217|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950218|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950220|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
82950221|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950222|NCT03719625|Norepinephrine|norepinephrine|mesh-list
82950223|NCT03719625|Ephedrine|ephedrine|mesh-list
82950224|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82950225|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82950226|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
82950227|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950228|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950229|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950230|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
82950231|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
82950232|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950233|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82950234|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82950235|NCT01289743|Etanercept|etanercept|mesh-list
82950236|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82950237|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82950238|NCT01289743|Analgesics|analgesics|mesh-ancestor
82950239|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
82950240|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950241|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950242|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950243|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950244|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950245|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950246|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
82950247|NCT03390426|Anesthetics|anesthetics|mesh-list
82950248|NCT03390426|Mepivacaine|mepivacaine|mesh-list
82950249|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
82950250|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950251|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950252|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
82950253|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950254|NCT03472521|Gabapentin|gabapentin|mesh-list
82950255|NCT03472521|Analgesics|analgesics|mesh-ancestor
82950256|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
82950257|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950258|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950259|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
82950260|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82950262|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950263|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82950264|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82950265|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82950266|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950267|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950268|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
82950269|NCT02906020|Venglustat|venglustat|mesh-list
82950270|NCT02906020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950271|NCT02906020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950272|NCT01177423|Anesthetics|anesthetics|mesh-list
82950273|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950274|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950275|NCT01180231|Moxonidine|moxonidine|mesh-list
82950276|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82950277|NCT01177501|Topotecan|topotecan|mesh-list
82950278|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82950279|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82950280|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950281|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950282|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950283|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
82950284|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
82950285|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
82950286|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82950287|NCT03478150|Protective Agents|protective agents|mesh-ancestor
82950288|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950289|NCT03499353|Talazoparib|talazoparib|mesh-list
82950290|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82950291|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950292|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950293|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950295|NCT03368664|Acyclovir|acyclovir|mesh-list
82950296|NCT03368664|Interferon-beta|interferon-beta|mesh-list
82950297|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
82950298|NCT03368664|Prednisolone|prednisolone|mesh-list
82950299|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
82950300|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
82950301|NCT03368664|Ranitidine|ranitidine|mesh-list
82950302|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
82950303|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82950304|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950305|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
82950306|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950307|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950308|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
82950309|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
82950310|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950311|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950312|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950313|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
82950314|NCT03368664|Hormones|hormones|mesh-ancestor
82950315|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82950316|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82950317|NCT03368664|Protective Agents|protective agents|mesh-ancestor
82950318|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82950319|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950320|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82950321|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
82950322|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950323|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950324|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82950325|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82950326|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
82950327|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
82950328|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950329|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950330|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82950331|NCT00004259|Carmustine|carmustine|mesh-list
82950332|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950333|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
82950334|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950335|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950336|NCT01177579|Copper|copper|mesh-list
82950337|NCT01177579|Trace Elements|trace elements|mesh-ancestor
82950338|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
82950339|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950340|NCT03722355|Carmustine|carmustine|mesh-list
82950341|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950342|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
82950343|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950344|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950345|NCT03857815|Antibodies|antibodies|mesh-list
82950346|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
82950347|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950348|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82950349|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950350|NCT04682405|Melphalan|melphalan|mesh-list
82950351|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950352|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
82950353|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950354|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950355|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82950356|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950357|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
82950358|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950359|NCT03477994|Clonidine|clonidine|mesh-list
82950360|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
82950361|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82950362|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950363|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950364|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82950365|NCT03477994|Analgesics|analgesics|mesh-ancestor
82950366|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
82950367|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950368|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82950369|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82950370|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82950371|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
82950372|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950373|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950374|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82950375|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
82950376|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
82950377|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82950378|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
82950379|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
82950380|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82950381|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82950382|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
82950383|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950384|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
82950385|NCT04668131|Protective Agents|protective agents|mesh-ancestor
82950387|NCT03857581|Clozapine|clozapine|mesh-list
82950388|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
82950389|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
82950390|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950391|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950392|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950393|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82950394|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82950395|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950396|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82950397|NCT03857581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82950398|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82950399|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82950400|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950401|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950402|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
82950403|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82950404|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
82950405|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
82950406|NCT01103843|Clopidogrel|clopidogrel|mesh-list
82950407|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82950408|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82950409|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82950410|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82950411|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82950412|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
82950414|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950415|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950416|NCT03738865|Glucagon|glucagon|mesh-list
82950417|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82950418|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950419|NCT03738865|Hormones|hormones|mesh-ancestor
83460281|NCT03827876|Calcipotriene|calcipotriene|mesh-list
82950420|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82950421|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950422|NCT03738865|Incretins|incretins|mesh-ancestor
82950423|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82950424|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82950425|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
82950426|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82950427|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
82950428|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950429|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
82950430|NCT03524157|Protective Agents|protective agents|mesh-ancestor
82950431|NCT03719391|Nicotine|nicotine|mesh-list
82950432|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82950433|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
82950434|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950435|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950436|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82950437|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82950438|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
82950439|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950440|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950441|NCT03468543|Memantine|memantine|mesh-list
82950442|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82950443|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82950444|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
82950445|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950446|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950447|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950448|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82950449|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82950450|NCT03467763|Metformin|metformin|mesh-list
82950451|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82950452|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950453|NCT00004031|Prednisone|prednisone|mesh-list
82950454|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
82950455|NCT00004031|Carmustine|carmustine|mesh-list
82950456|NCT00004031|Rituximab|rituximab|mesh-list
82950457|NCT00004031|Doxorubicin|doxorubicin|mesh-list
82950458|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82950459|NCT00004031|Etoposide|etoposide|mesh-list
82950460|NCT00004031|Vincristine|vincristine|mesh-list
82950461|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950462|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
82950463|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950464|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950465|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950466|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
82950467|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950468|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950469|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82950470|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950471|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82950472|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82950473|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82950474|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950475|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950476|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
82950477|NCT00004031|Hormones|hormones|mesh-ancestor
82950478|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82950479|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82950480|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82950481|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
82950482|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
82950483|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
82950484|NCT01184443|Olanzapine|olanzapine|mesh-list
82950485|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
82950486|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
82950487|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950488|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950489|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950490|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82950491|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82950492|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950493|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82950494|NCT01184443|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82950495|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82950496|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82950497|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950498|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950499|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
82950500|NCT01180621|Vaccines|vaccines|mesh-list
82950501|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
82950502|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950503|NCT01290133|Vestipitant|vestipitant|mesh-list
82950504|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82950505|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950506|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950507|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950508|NCT03467217|Losartan|losartan|mesh-list
82950509|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82950510|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82950511|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82950512|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82950513|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950514|NCT00003875|Aldesleukin|aldesleukin|mesh-list
82950515|NCT00003875|Etoposide|etoposide|mesh-list
82950516|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
82950517|NCT00003875|Busulfan|busulfan|mesh-list
82950518|NCT00003875|Interleukin-2|interleukin-2|mesh-list
82950519|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82950520|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950521|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82950522|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82950523|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950524|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950525|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
82950526|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950527|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
82950528|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950529|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950530|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82950531|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82950532|NCT00003875|Analgesics|analgesics|mesh-ancestor
82950533|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
82950534|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950535|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82950536|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82950537|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
82950538|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950539|NCT01327625|Azithromycin|azithromycin|mesh-list
82950540|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82950541|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950543|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
82950544|NCT01290211|Maraviroc|maraviroc|mesh-list
82950545|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82950546|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82950547|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
82950548|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950549|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950550|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82950551|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82950552|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
82950553|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950554|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82950555|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82950556|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82950557|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82950558|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82950559|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82950560|NCT03720873|Gefitinib|gefitinib|mesh-list
82950561|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950562|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82950563|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950564|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950565|NCT01311960|Bevacizumab|bevacizumab|mesh-list
82950566|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82950567|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950568|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950569|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82950570|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82950571|NCT01311960|Growth Substances|growth substances|mesh-ancestor
82950572|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950573|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
82950574|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82950575|NCT03709056|Propofol|propofol|mesh-list
82950576|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82950577|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950578|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950579|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82950580|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
82950581|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
82950582|NCT05663307|Aspirin|aspirin|mesh-list
82950583|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82950584|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82950585|NCT05663307|Analgesics|analgesics|mesh-ancestor
82950586|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
82950587|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950588|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950589|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950590|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950591|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82950592|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82950593|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950594|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82950595|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82950597|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
82950598|NCT01106495|Simvastatin|simvastatin|mesh-list
82950599|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82950600|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82950601|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
82950602|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950603|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82950604|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82950605|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950606|NCT01184833|Interferons|interferons|mesh-list
82950607|NCT01184833|Interferon-beta|interferon-beta|mesh-list
82950608|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
82950609|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950610|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
82950611|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950612|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
82950613|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950614|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82950615|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
82950616|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
82950617|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82950618|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
82950619|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82950620|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82950621|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950622|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82950623|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950624|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950625|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82950626|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
82950627|NCT01185067|Resveratrol|resveratrol|mesh-list
82950628|NCT01185067|Antioxidants|antioxidants|mesh-list
82950629|NCT01185067|Quercetin|quercetin|mesh-list
82950630|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950631|NCT01185067|Protective Agents|protective agents|mesh-ancestor
82950632|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950633|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950634|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82950635|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82950636|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950637|NCT03364686|Biotin|biotin|mesh-list
82950638|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
82950639|NCT03364686|Vitamins|vitamins|mesh-ancestor
82950640|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
82950641|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950642|NCT03437577|Tacrolimus|tacrolimus|mesh-list
82950643|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950644|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
82950645|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950646|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82950647|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950648|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950649|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
82950650|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
82950651|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82950652|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950653|NCT03364608|Albuterol|albuterol|mesh-list
82950654|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82950655|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
82950656|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950657|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950658|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82950659|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
82950660|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
82950661|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82950662|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82950663|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82950664|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82950665|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
82950666|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950667|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950668|NCT03719157|Anesthetics|anesthetics|mesh-list
82950669|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
82950670|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950671|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950672|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
82950673|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950674|NCT01185223|Valganciclovir|valganciclovir|mesh-list
82950675|NCT01185223|Ganciclovir|ganciclovir|mesh-list
82950676|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
82950677|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
82950678|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950679|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82950680|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950681|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950682|NCT03852979|Paclitaxel|paclitaxel|mesh-list
82950683|NCT03852979|Carboplatin|carboplatin|mesh-list
82950684|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82950685|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950686|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
82950687|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
82950688|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
82950689|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950690|NCT01188031|Alprazolam|alprazolam|mesh-list
82950691|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82950692|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950693|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950694|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82950695|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82950696|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82950697|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
82950698|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
82950699|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950700|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950701|NCT01182883|Sirolimus|sirolimus|mesh-list
82950702|NCT01182883|Temsirolimus|temsirolimus|mesh-list
82950703|NCT01182883|MTOR Inhibitors|mtor inhibitors|mesh-list
82950704|NCT01182883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82950705|NCT01182883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950706|NCT01182883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950707|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83460294|NCT03827876|Vitamins|vitamins|mesh-ancestor
82950708|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
82950709|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950710|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950711|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82950712|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950713|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82950714|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
82950715|NCT01188265|Valproic Acid|valproic acid|mesh-list
82950716|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
82950717|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
82950718|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
82950719|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82950720|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82950721|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950722|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950723|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950724|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
82950725|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950726|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
82950727|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
82950728|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82950729|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950730|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82950731|NCT01291069|Tadalafil|tadalafil|mesh-list
82950732|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950733|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
82950734|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82950735|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82950736|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950737|NCT01291069|Urological Agents|urological agents|mesh-ancestor
82950738|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
82950739|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950740|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82950741|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82950742|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950743|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82950745|NCT01588639|Insulin|insulin|mesh-list
82950746|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82950747|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82950748|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950749|NCT02524639|Sirolimus|sirolimus|mesh-list
82950750|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82950751|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950752|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82950753|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950754|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
82950755|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950756|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
82950757|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950758|NCT01185535|Anesthetics|anesthetics|mesh-list
82950759|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950760|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950761|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
82950762|NCT00003659|Rituximab|rituximab|mesh-list
82950763|NCT00003659|Fludarabine|fludarabine|mesh-list
82950764|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
82950765|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950766|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
82950767|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950768|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950769|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82950770|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
82950771|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950772|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950773|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82950774|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950775|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82950776|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
82950777|NCT01101581|Epratuzumab|epratuzumab|mesh-list
82950778|NCT01101581|Veltuzumab|veltuzumab|mesh-list
82950779|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
82950780|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950781|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950782|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
82950783|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
82950784|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950785|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82950786|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82950787|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82950788|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
82950789|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950790|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82950791|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82950792|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950793|NCT03494985|Muramidase|muramidase|mesh-list
82950794|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950795|NCT01185769|Tocotrienols|tocotrienols|mesh-list
82950796|NCT01185769|Vitamin E|vitamin e|mesh-list
82950797|NCT01185769|Tocopherols|tocopherols|mesh-list
82950798|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
82950799|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950800|NCT01185769|Protective Agents|protective agents|mesh-ancestor
82950801|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950802|NCT01185769|Vitamins|vitamins|mesh-ancestor
82950803|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
82950804|NCT01185847|Gemcitabine|gemcitabine|mesh-list
82950805|NCT01185847|Pemetrexed|pemetrexed|mesh-list
82950806|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950807|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82950808|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
82950809|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950810|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950811|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82950812|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82950813|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
82950814|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82950815|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
82950816|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950817|NCT03720483|Expectorants|expectorants|mesh-ancestor
82950818|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
82950819|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82950820|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
82950821|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950822|NCT03720483|Protective Agents|protective agents|mesh-ancestor
82950823|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950824|NCT03720483|Antidotes|antidotes|mesh-ancestor
82950826|NCT01183663|Sirolimus|sirolimus|mesh-list
82950827|NCT01183663|Bevacizumab|bevacizumab|mesh-list
82950828|NCT01183663|Lenalidomide|lenalidomide|mesh-list
82950829|NCT01183663|Fluorouracil|fluorouracil|mesh-list
82950830|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
82950831|NCT01183663|Sorafenib|sorafenib|mesh-list
82950832|NCT01183663|Temsirolimus|temsirolimus|mesh-list
82950833|NCT01183663|MTOR Inhibitors|mtor inhibitors|mesh-list
82950834|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950835|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950836|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82950837|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82950838|NCT01183663|Growth Substances|growth substances|mesh-ancestor
82950839|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950840|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
82950841|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
82950842|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950843|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82950844|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950845|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
82950846|NCT01183663|Antidotes|antidotes|mesh-ancestor
82950847|NCT01183663|Protective Agents|protective agents|mesh-ancestor
82950848|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
82950849|NCT01183663|Vitamins|vitamins|mesh-ancestor
82950850|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
82950851|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82950852|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950853|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82950854|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950855|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82950856|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
82950857|NCT01291927|Pancrelipase|pancrelipase|mesh-list
82950858|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950859|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
82950860|NCT03344172|Paclitaxel|paclitaxel|mesh-list
82950861|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82950862|NCT03344172|Gemcitabine|gemcitabine|mesh-list
82950863|NCT03344172|Avelumab|avelumab|mesh-list
82950864|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82950865|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950866|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
82950867|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
82950868|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
82950869|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950870|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82950871|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
82950872|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
82950873|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82950874|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82950875|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82950876|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950877|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82950878|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950880|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950881|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82950882|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950883|NCT01101659|Ketamine|ketamine|mesh-list
82950884|NCT01101659|Analgesics|analgesics|mesh-ancestor
82950885|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
82950886|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950887|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950888|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82950889|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82950890|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
82950891|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
82950892|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950893|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82950894|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82950895|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950897|NCT03855865|Vortioxetine|vortioxetine|mesh-list
82950898|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
82950899|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82950900|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82950901|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82950902|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82950903|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950904|NCT03855865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82950905|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82950906|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82950907|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950908|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82950909|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
82950910|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82950911|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82950912|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82950913|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82950914|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
82950915|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82950916|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
82950917|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950918|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
82950919|NCT01290367|Protective Agents|protective agents|mesh-ancestor
82950920|NCT03465891|Atezolizumab|atezolizumab|mesh-list
82950921|NCT03465891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83220996|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82950922|NCT03465891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950923|NCT03465891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82950924|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950925|NCT03363906|Dulaglutide|dulaglutide|mesh-list
82950926|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82950927|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82950928|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950929|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
82950930|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
82950931|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
82950932|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82950933|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82950934|NCT03948191|Prednisolone|prednisolone|mesh-list
82950935|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
82950936|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82950937|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
82950938|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
82950939|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82950940|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
82950941|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
82950942|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82950943|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950944|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82950945|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
82950946|NCT03948191|Hormones|hormones|mesh-ancestor
82950947|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82950948|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82950949|NCT03948191|Protective Agents|protective agents|mesh-ancestor
82950950|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82950951|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950952|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82950953|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82950954|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950955|NCT01292083|Azacitidine|azacitidine|mesh-list
82950956|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82950957|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
82950958|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950959|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950960|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950961|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
82950962|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82950963|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82950964|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950965|NCT01292161|Silymarin|silymarin|mesh-list
82950966|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
82950967|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950968|NCT01292161|Protective Agents|protective agents|mesh-ancestor
82950969|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950970|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
82950971|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
82950972|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82950973|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82950974|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950975|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950976|NCT01185925|Urological Agents|urological agents|mesh-ancestor
82950977|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
82950978|NCT01188889|Everolimus|everolimus|mesh-list
82950979|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950980|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82950981|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950982|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950983|NCT01188889|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82950984|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82950985|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
82950986|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950987|NCT01184287|Ranpirnase|ranpirnase|mesh-list
83460315|NCT01608893|Metoprolol|metoprolol|mesh-list
82950988|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82950989|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82950990|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82950991|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82950992|NCT01107431|Chromium|chromium|mesh-list
82950993|NCT01107431|Trace Elements|trace elements|mesh-ancestor
82950994|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
82950995|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82950996|NCT01186159|Parecoxib|parecoxib|mesh-list
82950997|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82950998|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82950999|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951000|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951001|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82951002|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82951003|NCT01186159|Analgesics|analgesics|mesh-ancestor
82951004|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
82951005|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951006|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951007|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82951008|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82951009|NCT01107509|Everolimus|everolimus|mesh-list
82951010|NCT01107509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82951011|NCT01107509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82951012|NCT01107509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951013|NCT01107509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951014|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82951015|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
83518934|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
82951016|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951017|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951019|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82951020|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82951021|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951022|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
82951023|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951024|NCT01104935|Trastuzumab|trastuzumab|mesh-list
82951025|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951026|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951027|NCT01293643|Clindamycin|clindamycin|mesh-list
82951028|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
82951029|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
82951030|NCT01293643|Amphotericin B|amphotericin b|mesh-list
82951031|NCT01293643|Tetracycline|tetracycline|mesh-list
82951032|NCT01293643|Ketoconazole|ketoconazole|mesh-list
82951033|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82951034|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82951035|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951036|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82951037|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951038|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951039|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
82951040|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82951041|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82951042|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82951044|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951045|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951046|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82951047|NCT01293643|Amebicides|amebicides|mesh-ancestor
82951048|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82951049|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82951050|NCT01105013|Clotrimazole|clotrimazole|mesh-list
82951051|NCT01105013|Miconazole|miconazole|mesh-list
82951052|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82951053|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951054|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
82951055|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82951056|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82951057|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220997|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951058|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951059|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82951060|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
82951061|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951062|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951063|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82951064|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82951065|NCT03851731|Naltrexone|naltrexone|mesh-list
82951066|NCT03851731|Naloxone|naloxone|mesh-list
82951067|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82951068|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82951069|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951070|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
82951071|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951072|NCT03707652|Vitamins|vitamins|mesh-list
82951073|NCT03707652|Niacinamide|niacinamide|mesh-list
82951074|NCT03707652|Niacin|niacin|mesh-list
82951075|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
82951076|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
82951077|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
82951078|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951079|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82951080|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
82951081|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951082|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82951083|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
82951084|NCT01588093|Mecasermin|mecasermin|mesh-list
82951085|NCT01588093|Growth Substances|growth substances|mesh-ancestor
82951086|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951087|NCT01186471|Nicotine|nicotine|mesh-list
82951088|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82951089|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
82951090|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951091|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951092|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82951093|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82951094|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
82951095|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951096|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951097|NCT01292551|Bosentan|bosentan|mesh-list
82951098|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82951099|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82951100|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951101|NCT03854383|Isosorbide|isosorbide|mesh-list
82951102|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82951103|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82951104|NCT03854383|Misoprostol|misoprostol|mesh-list
82951105|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82951106|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
82951107|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82951108|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951109|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82951110|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951111|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
82951112|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82951113|NCT03854383|Diuretics|diuretics|mesh-ancestor
82951114|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
82951115|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
82951116|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82951141|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
82951142|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82951143|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
82951144|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951145|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82951146|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82951147|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
82951148|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
82951149|NCT03851341|Metformin|metformin|mesh-list
82951150|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82951151|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82951152|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951153|NCT03851341|Incretins|incretins|mesh-ancestor
82951154|NCT03851341|Hormones|hormones|mesh-ancestor
82951155|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951156|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82951157|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
82951158|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951159|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951160|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
82951161|NCT04788108|Progestins|progestins|mesh-ancestor
82951162|NCT04788108|Hormones|hormones|mesh-ancestor
82951163|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951164|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951210|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951212|NCT02323126|Nivolumab|nivolumab|mesh-list
82951213|NCT02323126|Nazartinib|nazartinib|mesh-list
82951214|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951215|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951216|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82951217|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951218|NCT01291459|Tenofovir|tenofovir|mesh-list
82951219|NCT01291459|Emtricitabine|emtricitabine|mesh-list
82951220|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
82951221|NCT01291459|Maraviroc|maraviroc|mesh-list
82951222|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
82951223|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951224|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82951225|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82951226|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951227|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951228|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82951229|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82951230|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82951231|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82951232|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82951233|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82951234|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82951235|NCT00003377|Paclitaxel|paclitaxel|mesh-list
82951236|NCT00003377|Cisplatin|cisplatin|mesh-list
82951237|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82951238|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951239|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
82951240|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
82951241|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
82951242|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951243|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82951244|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82951245|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
82951246|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951247|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82951248|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82951249|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
82951250|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
82951251|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951252|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951253|NCT01328015|Oxybutynin|oxybutynin|mesh-list
82951254|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
82951255|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
82951256|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
82951257|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951258|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951259|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82951260|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
82951261|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951262|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951263|NCT01328015|Urological Agents|urological agents|mesh-ancestor
82951264|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
82951265|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82951266|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82951267|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
82951268|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220998|NCT02416999|Bevacizumab|bevacizumab|mesh-list
82951269|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82951270|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82951271|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951272|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951273|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82951274|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
82951275|NCT00002651|Goserelin|goserelin|mesh-list
82951276|NCT00002651|Bicalutamide|bicalutamide|mesh-list
82951277|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82951278|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951279|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
82951280|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
82951281|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951282|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951283|NCT03853993|Vaccines|vaccines|mesh-list
82951284|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
82951285|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951286|NCT03473626|Alicaforsen|alicaforsen|mesh-list
82951287|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951288|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82951289|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
82951290|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951291|NCT05154682|Acetaminophen|acetaminophen|mesh-list
82951292|NCT05154682|Naproxen|naproxen|mesh-list
82951293|NCT05154682|Oxycodone|oxycodone|mesh-list
82951294|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82951295|NCT05154682|Analgesics|analgesics|mesh-ancestor
82951296|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
82951297|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951298|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951299|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
82951300|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82951301|NCT05154682|Narcotics|narcotics|mesh-ancestor
82951302|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951303|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82951304|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82951305|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82951306|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
82951307|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82951308|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951309|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951310|NCT04312841|Acetic Acid|acetic acid|mesh-list
82951311|NCT04312841|Letermovir|letermovir|mesh-list
82951312|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82951313|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951314|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951315|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951316|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951317|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82951318|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
82951320|NCT01294735|Niraparib|niraparib|mesh-list
82951321|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82951322|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
82951323|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951324|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951325|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82951326|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951327|NCT03851263|Evolocumab|evolocumab|mesh-list
82951328|NCT03851263|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82951329|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82951330|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82951331|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
82951332|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951333|NCT03851263|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82951334|NCT03851263|Protease Inhibitors|protease inhibitors|mesh-ancestor
82951335|NCT03851263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951336|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82951337|NCT03849235|Glucagon|glucagon|mesh-list
82951338|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951339|NCT03849235|Hormones|hormones|mesh-ancestor
82951340|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951341|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951342|NCT03477448|Bleomycin|bleomycin|mesh-list
82951343|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82951344|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951346|NCT01187485|Testosterone|testosterone|mesh-list
82951347|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
82951348|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
82951349|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82951350|NCT01187485|Androgens|androgens|mesh-ancestor
82951351|NCT01187485|Hormones|hormones|mesh-ancestor
82951352|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951353|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951354|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82951355|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951356|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
82951357|NCT00002597|Leuprolide|leuprolide|mesh-list
82951358|NCT00002597|Goserelin|goserelin|mesh-list
82951359|NCT00002597|Flutamide|flutamide|mesh-list
82951360|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82951361|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
82951362|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82951363|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951364|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82951365|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951366|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
82951367|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
82951368|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951369|NCT03853525|Petrolatum|petrolatum|mesh-list
82951370|NCT03853525|Emollients|emollients|mesh-ancestor
82951371|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
82951372|NCT03716583|Melatonin|melatonin|mesh-list
82951373|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82951374|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
82951375|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951376|NCT03716583|Protective Agents|protective agents|mesh-ancestor
82951377|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951378|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951379|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82951380|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82951381|NCT02738008|Tenofovir|tenofovir|mesh-list
82951382|NCT02738008|Entecavir|entecavir|mesh-list
82951383|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
82951384|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
82951385|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
82951386|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951387|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83519011|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82951388|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82951390|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951391|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82951392|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82951393|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
82951394|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951395|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951396|NCT03720249|Vitamins|vitamins|mesh-list
82951397|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
82951398|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
82951399|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
82951400|NCT03720249|Betaine|betaine|mesh-list
82951401|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
82951402|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951403|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951404|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
82951405|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82951406|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
82951407|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951408|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82951409|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
82951410|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82951411|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82951412|NCT01294969|Analgesics|analgesics|mesh-ancestor
82951413|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
82951414|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951415|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951416|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82951417|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82951418|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82951419|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82951457|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
82951458|NCT02529839|Fludarabine|fludarabine|mesh-list
82951459|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
82951460|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82951461|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
82951462|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951463|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82951464|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82951465|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
82951466|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951467|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951468|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82951469|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951470|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
82951471|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82951472|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
82951473|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951474|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951475|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82951476|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
82951477|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82951478|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
82951479|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951480|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951481|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82951482|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
82951483|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
82951484|NCT03473314|Protective Agents|protective agents|mesh-ancestor
82951485|NCT03945539|Itraconazole|itraconazole|mesh-list
82951486|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
82951487|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
82951488|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951489|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82951490|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82951491|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951492|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951493|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82951494|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
82951495|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951496|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951497|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82951498|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
82951499|NCT01190293|Efavirenz|efavirenz|mesh-list
82951500|NCT01190293|Maraviroc|maraviroc|mesh-list
82951501|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82951502|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82951503|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951504|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951505|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
82951506|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951507|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82951508|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82951509|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82951510|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82951511|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82951512|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82951513|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82951514|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82951515|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82951516|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82951517|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82951518|NCT03945227|Spartalizumab|spartalizumab|mesh-list
82951519|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82951520|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951521|NCT03945227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951522|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951523|NCT01108133|Dexamethasone|dexamethasone|mesh-list
82951524|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82951525|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
82951526|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
82951527|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951528|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951529|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951530|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
82951531|NCT01108133|Hormones|hormones|mesh-ancestor
82951532|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951533|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82951534|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951535|NCT01108289|Oxytocin|oxytocin|mesh-list
82951536|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
82951537|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82951538|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951539|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
82951540|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82951541|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82951542|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951543|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82951544|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82951545|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
82951546|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951547|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951548|NCT03947411|Oseltamivir|oseltamivir|mesh-list
82951549|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
82951550|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951551|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951552|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951553|NCT03257254|Polidocanol|polidocanol|mesh-list
82951554|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82951555|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82951556|NCT01327469|Albendazole|albendazole|mesh-list
82951557|NCT01327469|Mebendazole|mebendazole|mesh-list
82951558|NCT01327469|Piperazine|piperazine|mesh-list
82951559|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
82951560|NCT01327469|Pyrantel|pyrantel|mesh-list
82951561|NCT01327469|Oxantel|oxantel|mesh-list
82951562|NCT01327469|DMP 777|dmp 777|mesh-list
82951563|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
82951564|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82951565|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951566|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
82951567|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82951568|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82951569|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
82951570|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
82951571|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
82951572|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951573|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951574|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
82951575|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951576|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
82951577|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83460362|NCT04759196|Topiramate|topiramate|mesh-list
82951578|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82951579|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951580|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951581|NCT03950141|Apatinib|apatinib|mesh-list
82951582|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951583|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82951584|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951585|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951586|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
82951587|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82951588|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951589|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82951590|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82951591|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951592|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951593|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951594|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82951595|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82951596|NCT03084718|Beclomethasone|beclomethasone|mesh-list
82951597|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82951598|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
82951599|NCT03084718|Hormones|hormones|mesh-ancestor
82951600|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82951601|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951602|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82951603|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
82951604|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
82951605|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951606|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951607|NCT02938624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82951608|NCT02938624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951609|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
82951610|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951611|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951612|NCT03469804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82951613|NCT03469804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951614|NCT03944291|Bupivacaine|bupivacaine|mesh-list
82951615|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
82951616|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
82951617|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951618|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951619|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
82951620|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951621|NCT03067571|Daratumumab|daratumumab|mesh-list
82951622|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951623|NCT01102439|Aspirin|aspirin|mesh-list
82951624|NCT01102439|Clopidogrel|clopidogrel|mesh-list
82951625|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82951626|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82951627|NCT01102439|Analgesics|analgesics|mesh-ancestor
82951628|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
82951629|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951630|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951631|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82951632|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82951633|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82951634|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82951635|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951636|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82951637|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82951638|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951639|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
82951640|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82951641|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82951642|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82951643|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
82951644|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951645|NCT03949985|Hemostatics|hemostatics|mesh-list
82951646|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
82951647|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82951648|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951649|NCT03949985|Coagulants|coagulants|mesh-ancestor
82951650|NCT01584791|Aspirin|aspirin|mesh-list
82951651|NCT01584791|Clopidogrel|clopidogrel|mesh-list
82951652|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82951653|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82951654|NCT01584791|Analgesics|analgesics|mesh-ancestor
82951655|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
82951656|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951657|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951658|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82951659|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82951660|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82951661|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82951662|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951663|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82951664|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82951665|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951666|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
82951667|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82951668|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82951669|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82951670|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
82951671|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951672|NCT04285684|Ketamine|ketamine|mesh-list
82951673|NCT04285684|Analgesics|analgesics|mesh-ancestor
82951674|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
82951675|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951676|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951677|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82951678|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82951679|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
82951680|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
82951681|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951682|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82951683|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82951684|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951685|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951686|NCT01310985|Capecitabine|capecitabine|mesh-list
82951687|NCT01310985|Cetuximab|cetuximab|mesh-list
82951688|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82951689|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
82951690|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951691|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951692|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951693|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
82951694|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82951695|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951696|NCT02492711|Trastuzumab|trastuzumab|mesh-list
82951697|NCT02492711|Margetuximab|margetuximab|mesh-list
82951698|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951699|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951700|NCT03716427|Tolbutamide|tolbutamide|mesh-list
82951701|NCT03716427|Midazolam|midazolam|mesh-list
82951702|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
82951703|NCT03716427|Omeprazole|omeprazole|mesh-list
83460385|NCT03827642|Naloxone|naloxone|mesh-list
82951704|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82951705|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82951706|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951707|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951708|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82951709|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82951710|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82951711|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82951712|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
82951713|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
82951714|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
82951715|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
82951716|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951717|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951718|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82951719|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951721|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951722|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
82951723|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
82951724|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82951725|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82951726|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82951727|NCT01147822|Sunitinib|sunitinib|mesh-list
82951728|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951729|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82951730|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82951731|NCT01147822|Growth Substances|growth substances|mesh-ancestor
82951732|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951733|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
82951734|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82951735|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951736|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951737|NCT03431337|Amoxicillin|amoxicillin|mesh-list
82951738|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82951739|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951740|NCT01293097|Atorvastatin|atorvastatin|mesh-list
82951741|NCT01293097|Pravastatin|pravastatin|mesh-list
82951742|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82951743|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82951744|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
82951745|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951746|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82951747|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82951748|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951749|NCT03516292|Mitogens|mitogens|mesh-list
82951750|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
82951751|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951752|NCT01291615|Gemcitabine|gemcitabine|mesh-list
82951753|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82951754|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
82951755|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951756|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951757|NCT01295047|Atenolol|atenolol|mesh-list
82951758|NCT01295047|Verapamil|verapamil|mesh-list
82951759|NCT01295047|Perindopril|perindopril|mesh-list
82951760|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82951761|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82951762|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
82951763|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
82951764|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951765|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951766|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82951767|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82951768|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82951769|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
82951770|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951771|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951772|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82951773|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220999|NCT02416999|Temozolomide|temozolomide|mesh-list
82951774|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82951775|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
82951776|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82951777|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
82951778|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951779|NCT03472846|Teriparatide|teriparatide|mesh-list
82951780|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82951781|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951782|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82951783|NCT01190371|Artesunate|artesunate|mesh-list
82951784|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
82951785|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82951786|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82951787|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951788|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951789|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
82951790|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
82951791|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82951792|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
82951793|NCT05158426|Propofol|propofol|mesh-list
82951794|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82951795|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951796|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951797|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82951798|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
82951799|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
82951800|NCT03853369|Nifekalant|nifekalant|mesh-list
82951801|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82951802|NCT05158348|Lidocaine|lidocaine|mesh-list
82951803|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
82951804|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
82951805|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
82951806|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951807|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951808|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
82951809|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951810|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82951811|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82951812|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82951813|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82951814|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951815|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82951816|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82951817|NCT05158348|Analgesics|analgesics|mesh-ancestor
82951818|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82951819|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82951820|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82951821|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
82951822|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951823|NCT01187719|Phenytoin|phenytoin|mesh-list
82951824|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
82951825|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82951826|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82951827|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82951828|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951829|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82951830|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82951831|NCT01102595|Bevacizumab|bevacizumab|mesh-list
82951832|NCT01102595|Temozolomide|temozolomide|mesh-list
82951833|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951834|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951835|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82951836|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82951837|NCT01102595|Growth Substances|growth substances|mesh-ancestor
82951838|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951839|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
82951840|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82951841|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
82951842|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951843|NCT03949517|Piperidine|piperidine|mesh-list
82951844|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82951845|NCT03949517|Bombesin|bombesin|mesh-list
82951846|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951847|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82951848|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951849|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951850|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82951851|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82951852|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82951853|NCT03848611|Vorolanib|vorolanib|mesh-list
82951854|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82951855|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951856|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951857|NCT01584947|Bupivacaine|bupivacaine|mesh-list
82951858|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
82951859|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
82951860|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951861|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951862|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
82951863|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951864|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
82951865|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82951866|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951867|NCT01109615|Gemcitabine|gemcitabine|mesh-list
82951868|NCT01109615|Pemetrexed|pemetrexed|mesh-list
82951869|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82951870|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
82951871|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951872|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951873|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951874|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82951875|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82951876|NCT01209065|Ritonavir|ritonavir|mesh-list
82951877|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
82951878|NCT01209065|Dolutegravir|dolutegravir|mesh-list
82951879|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82951880|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82951881|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
82951882|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951883|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951884|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82951885|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82951886|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
82951887|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951888|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82951889|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82951890|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82951891|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82951892|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
82951893|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82951894|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82951895|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951896|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
82951897|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951898|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951899|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
82951900|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951901|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951902|NCT03481725|Coal Tar|coal tar|mesh-list
82951903|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
82951904|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
82951905|NCT03472456|Eugenol|eugenol|mesh-list
82951906|NCT03472456|Carticaine|carticaine|mesh-list
82951907|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
82951908|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
82951909|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951910|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83460400|NCT01022567|Ertapenem|ertapenem|mesh-list
82951911|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
82951912|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951913|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951914|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82951915|NCT01193881|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82951916|NCT01193881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82951917|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951918|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82951919|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951920|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951921|NCT01194037|Interferons|interferons|mesh-list
82951922|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
82951923|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
82951924|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82951925|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82951926|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
82951927|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951928|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
82951929|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951930|NCT03480243|Erythromycin|erythromycin|mesh-list
82951931|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
82951932|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82951933|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
82951934|NCT03480243|Padsevonil|padsevonil|mesh-list
82951935|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82951936|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82951937|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951938|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82951939|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951940|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951942|NCT01109693|Mirtazapine|mirtazapine|mesh-list
82951943|NCT01109693|Sertraline|sertraline|mesh-list
82951944|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
82951945|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82951946|NCT01109693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82951947|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82951948|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82951949|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951950|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951951|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
82951952|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951953|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82951954|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
82951955|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
82951956|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82951957|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82951958|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82951959|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82951960|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82951961|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82951962|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
82951963|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82951964|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82951965|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82951966|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
82951968|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
82951969|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
82951970|NCT01190683|Vitamins|vitamins|mesh-list
82951971|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
82951972|NCT01190683|Calcium|calcium|mesh-list
82951973|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
82951974|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951975|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82951976|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82951977|NCT01190683|Antacids|antacids|mesh-ancestor
83221000|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82951978|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951979|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82951980|NCT01190761|Galantamine|galantamine|mesh-list
82951981|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82951982|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82951983|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82951984|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
82951985|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82951986|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82951987|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82951988|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
82951989|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951990|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
82951991|NCT01209455|Acetaminophen|acetaminophen|mesh-list
82951992|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
82951993|NCT01209455|Ranitidine|ranitidine|mesh-list
82951994|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
82951995|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82951996|NCT01209455|Analgesics|analgesics|mesh-ancestor
82951997|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
82951998|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82951999|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952000|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
82952001|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82952002|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82952003|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82952004|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
82952005|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
82952006|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952007|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952008|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
82952009|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
82952010|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82952011|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82952012|NCT01194115|Metronidazole|metronidazole|mesh-list
82952013|NCT01194115|Cephalexin|cephalexin|mesh-list
82952014|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952015|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952016|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82952017|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82952018|NCT01209533|Iloprost|iloprost|mesh-list
82952019|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82952020|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
82952021|NCT03847363|Anesthetics|anesthetics|mesh-list
82952022|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952023|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952024|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
82952025|NCT01207739|Doxycycline|doxycycline|mesh-list
82952026|NCT01207739|Clarithromycin|clarithromycin|mesh-list
82952027|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
82952028|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82952029|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82952030|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952031|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952032|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952033|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82952034|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952035|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82952036|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82952037|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82952038|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
82952039|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82952040|NCT03847207|Pasireotide|pasireotide|mesh-list
82952041|NCT03847207|Hormones|hormones|mesh-ancestor
82952042|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952043|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952044|NCT01192087|Cetuximab|cetuximab|mesh-list
82952045|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82952046|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952047|NCT03942029|Fluconazole|fluconazole|mesh-list
82952048|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
82952049|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952050|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82952051|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82952052|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952053|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952054|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82952055|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
82952056|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952057|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952058|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82952059|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82952060|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82952061|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82952062|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
82952063|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952064|NCT01192165|Paclitaxel|paclitaxel|mesh-list
82952065|NCT01192165|Docetaxel|docetaxel|mesh-list
82952066|NCT01192165|Carboplatin|carboplatin|mesh-list
82952067|NCT01192165|Pemetrexed|pemetrexed|mesh-list
82952068|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82952069|NCT01192165|Trametinib|trametinib|mesh-list
82952070|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82952071|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952072|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
82952073|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
82952074|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
82952075|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952076|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952077|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82952078|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82952079|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952080|NCT01192243|Carboplatin|carboplatin|mesh-list
82952081|NCT01192243|Pemetrexed|pemetrexed|mesh-list
82952082|NCT01192243|Gefitinib|gefitinib|mesh-list
82952083|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952084|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952085|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952086|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82952087|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82952088|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952089|NCT01209845|Ketamine|ketamine|mesh-list
82952091|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
82952092|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952093|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952094|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82952095|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82952096|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
82952097|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
83519087|NCT00002463|Procarbazine|procarbazine|mesh-list
82952098|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952099|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82952100|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82952101|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952102|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952103|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
82952104|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
82952105|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82952106|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952107|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952108|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
82952109|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82952110|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952111|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952112|NCT01196767|Ropivacaine|ropivacaine|mesh-list
82952113|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
82952114|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
82952115|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952116|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952117|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
82952118|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952119|NCT03451773|Gemcitabine|gemcitabine|mesh-list
82952120|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82952121|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
82952122|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952123|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952124|NCT01112891|Vitamin D|vitamin d|mesh-list
82952125|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
82952126|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
82952127|NCT01112891|Vitamins|vitamins|mesh-list
82952128|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
82952129|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952130|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82952131|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952132|NCT03847441|Vitamin D|vitamin d|mesh-list
82952133|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
82952134|NCT03847441|Calcipotriene|calcipotriene|mesh-list
82952135|NCT03847441|Vitamins|vitamins|mesh-ancestor
82952136|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
82952137|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952138|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82952139|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952140|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
82952141|NCT02529683|NuvaRing|nuvaring|mesh-list
82952142|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82952143|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
82952144|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82952145|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952146|NCT05406895|Lidocaine|lidocaine|mesh-list
82952147|NCT05406895|Epinephrine|epinephrine|mesh-list
82952148|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
82952149|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
82952150|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952151|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952152|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
82952153|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952154|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82952155|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82952156|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82952157|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952158|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952159|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82952160|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82952161|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
82952162|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952163|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82952164|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82952165|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
82952166|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82952167|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
82952169|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
82952170|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82952171|NCT03425253|Lidocaine|lidocaine|mesh-list
82952172|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
82952173|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
82952174|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952175|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952176|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
82952177|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952178|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82952179|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82952180|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82952181|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952182|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952183|NCT03941561|Tegafur|tegafur|mesh-list
82952184|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82952185|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
82952186|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952187|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952188|NCT05403229|Topiramate|topiramate|mesh-list
82952189|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
82952190|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952191|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952192|NCT03424239|Vitamin D|vitamin d|mesh-list
82952193|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
82952194|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
82952195|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
82952196|NCT03424239|Vitamins|vitamins|mesh-list
82952197|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
82952198|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952199|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952200|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82952201|NCT03941795|Axitinib|axitinib|mesh-list
82952202|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952203|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952204|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952205|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952206|NCT01197001|Losartan|losartan|mesh-list
82952207|NCT01197001|Amlodipine|amlodipine|mesh-list
82952208|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82952209|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82952210|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952211|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952212|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952213|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952214|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
82952215|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82952216|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82952217|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82952218|NCT01113047|Amlodipine|amlodipine|mesh-list
82952219|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82952220|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82952221|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952222|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952223|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952224|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952225|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
82952226|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
82952227|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952228|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952229|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82952230|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952231|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952232|NCT01210391|Caseins|caseins|mesh-list
82952233|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
82952234|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
82952235|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952236|NCT03846739|Oxytocin|oxytocin|mesh-list
82952237|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
82952239|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952240|NCT03716115|Budesonide|budesonide|mesh-list
82952241|NCT03716115|Teduglutide|teduglutide|mesh-list
82952242|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82952243|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82952244|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
82952245|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952246|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952247|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83519088|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
82952248|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
82952249|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
82952251|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952252|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82952253|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82952254|NCT03716115|Protective Agents|protective agents|mesh-ancestor
82952255|NCT01113281|Vaccines|vaccines|mesh-list
82952256|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
82952257|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952258|NCT01295593|Cladribine|cladribine|mesh-list
82952259|NCT01295593|Valproic Acid|valproic acid|mesh-list
82952260|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
82952261|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952262|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952263|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
82952264|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952265|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952266|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
82952267|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82952268|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952269|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82952270|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952271|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82952272|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
82952273|NCT03845881|Oxycodone|oxycodone|mesh-list
82952274|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82952275|NCT03845881|Narcotics|narcotics|mesh-ancestor
82952276|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952277|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952278|NCT03845881|Analgesics|analgesics|mesh-ancestor
82952279|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
82952280|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952281|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
82952282|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82952283|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952284|NCT01296997|Calcium|calcium|mesh-list
82952285|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952286|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952287|NCT01114841|Tazarotene|tazarotene|mesh-list
82952288|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
82952289|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
82952290|NCT01113437|Omalizumab|omalizumab|mesh-list
82952291|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82952292|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82952293|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
82952294|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
82952295|NCT01197235|Hematinics|hematinics|mesh-ancestor
82952296|NCT01192789|Amoxicillin|amoxicillin|mesh-list
82952297|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952298|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952299|NCT01211171|Telmisartan|telmisartan|mesh-list
82952300|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82952301|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82952302|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82952303|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952304|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
82952305|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82952306|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82952307|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952308|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
82952309|NCT03846973|Coagulants|coagulants|mesh-ancestor
82952310|NCT01113515|Esmolol|esmolol|mesh-list
82952311|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82952312|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82952313|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82952319|NCT01211327|Dexamethasone|dexamethasone|mesh-list
82952320|NCT01211327|Cyclosporins|cyclosporins|mesh-list
82952321|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82952322|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
82952323|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
82952324|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952325|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952326|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83460429|NCT04120064|Vitamin D|vitamin d|mesh-list
82952327|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
82952328|NCT01211327|Hormones|hormones|mesh-ancestor
82952329|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952330|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82952331|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952332|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952333|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952334|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82952335|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
82952336|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
82952337|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952338|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
82952339|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82952340|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82952342|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952343|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952344|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952345|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952346|NCT01113671|Vitamin E|vitamin e|mesh-list
82952347|NCT01113671|Tocopherols|tocopherols|mesh-list
82952348|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
82952349|NCT01113671|Vitamins|vitamins|mesh-ancestor
82952350|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
82952351|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952352|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
82952353|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952354|NCT01113671|Protective Agents|protective agents|mesh-ancestor
82952355|NCT03943043|Paclitaxel|paclitaxel|mesh-list
82952356|NCT03943043|Gemcitabine|gemcitabine|mesh-list
82952357|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
82952358|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82952359|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952360|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
82952361|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
82952362|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
82952363|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952364|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82952365|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
82952366|NCT01109927|Insulin|insulin|mesh-list
82952367|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952368|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952369|NCT01211795|Ketoprofen|ketoprofen|mesh-list
82952370|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82952371|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82952372|NCT01211795|Analgesics|analgesics|mesh-ancestor
82952373|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
82952374|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952375|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952376|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82952377|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82952378|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82952379|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952380|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952385|NCT01193491|Geldanamycin|geldanamycin|mesh-list
82952386|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82952387|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952388|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
82952389|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952390|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952391|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952392|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82952393|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
82952394|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82952395|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82952396|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82952397|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952398|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952399|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82952400|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82952401|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82952402|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
82952403|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952404|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952405|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82952406|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82952407|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
82952408|NCT01208285|Ivacaftor|ivacaftor|mesh-list
82952409|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82952410|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952411|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952412|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
82952413|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82952414|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
82952415|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
82952416|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952417|NCT01208441|Letrozole|letrozole|mesh-list
82952418|NCT01208441|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82952419|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952420|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82952421|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82952422|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952423|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952424|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82952425|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
82952426|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952427|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952428|NCT01208441|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82952429|NCT03718377|Anesthetics|anesthetics|mesh-list
82952430|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952431|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952432|NCT01197469|Tadalafil|tadalafil|mesh-list
82952433|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
82952434|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82952435|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82952436|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952437|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952438|NCT01197469|Urological Agents|urological agents|mesh-ancestor
82952439|NCT01211561|Selenium|selenium|mesh-list
82952440|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
82952441|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952442|NCT01211561|Protective Agents|protective agents|mesh-ancestor
82952443|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952444|NCT01211561|Trace Elements|trace elements|mesh-ancestor
82952445|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
82952446|NCT05358535|Propofol|propofol|mesh-list
82952447|NCT05358535|Etomidate|etomidate|mesh-list
82952448|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82952449|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952450|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952451|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82952452|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
82952453|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
82952454|NCT01213355|Scopolamine|scopolamine|mesh-list
82952455|NCT01213355|Donepezil|donepezil|mesh-list
82952456|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82952457|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82952458|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952459|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952460|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
82952461|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952462|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952464|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82952465|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
82952466|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
83460450|NCT05505006|Folic Acid|folic acid|mesh-list
82952467|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952468|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82952469|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
82952470|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82952471|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82952472|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
82952473|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
82952474|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82952475|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952476|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952477|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
82952478|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952479|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952480|NCT03848065|Vaccines|vaccines|mesh-list
82952481|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
83519089|NCT00002463|Calcium|calcium|mesh-list
82952482|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952483|NCT01110473|Azacitidine|azacitidine|mesh-list
82952484|NCT01110473|Ilorasertib|ilorasertib|mesh-list
82952485|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82952486|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
82952487|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952488|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952489|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952490|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952491|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
82952492|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82952493|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952494|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952495|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82952496|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82952497|NCT05558761|Protective Agents|protective agents|mesh-ancestor
82952498|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952499|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
82952500|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82952501|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
82952502|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
82952503|NCT03940391|Midazolam|midazolam|mesh-list
82952504|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82952505|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82952506|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952507|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952508|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82952509|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82952510|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82952511|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82952512|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
82952513|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
82952514|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
82952515|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
82952516|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952517|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952518|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
82952519|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
82952520|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82952521|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
82952522|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
82952523|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82952524|NCT03715881|Prednisolone|prednisolone|mesh-list
82952525|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
82952526|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82952527|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
82952528|NCT03715881|Hormones|hormones|mesh-ancestor
82952529|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952530|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952531|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82952532|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952533|NCT03715881|Hematinics|hematinics|mesh-ancestor
82952534|NCT01197781|Verapamil|verapamil|mesh-list
82952535|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82952536|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82952538|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83460457|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
82952539|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952540|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952541|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
82952542|NCT01110551|Vaccines|vaccines|mesh-list
82952543|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
82952544|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952545|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82952546|NCT01296139|Hematinics|hematinics|mesh-ancestor
82952547|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82952548|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82952549|NCT03940469|Dexamethasone|dexamethasone|mesh-list
82952550|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
82952551|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
82952552|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82952553|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
82952554|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
82952555|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952556|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952557|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82952558|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
82952559|NCT03940469|Hormones|hormones|mesh-ancestor
82952560|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952561|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82952562|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952563|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82952564|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952565|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82952566|NCT03940469|Analgesics|analgesics|mesh-ancestor
82952567|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
82952568|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82952569|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82952570|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82952571|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
82952572|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952573|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952574|NCT01110785|Panitumumab|panitumumab|mesh-list
82952575|NCT01110785|Simvastatin|simvastatin|mesh-list
82952576|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82952577|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82952578|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
82952579|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952580|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82952581|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82952582|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952583|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82952584|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952585|NCT03846271|Oxytocin|oxytocin|mesh-list
82952586|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
82952587|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82952588|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952589|NCT01110941|Leucovorin|leucovorin|mesh-list
82952590|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
82952591|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952592|NCT01110941|Antidotes|antidotes|mesh-ancestor
82952593|NCT01110941|Protective Agents|protective agents|mesh-ancestor
82952594|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952595|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
82952596|NCT01110941|Vitamins|vitamins|mesh-ancestor
82952597|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
82952598|NCT03448419|Empagliflozin|empagliflozin|mesh-list
82952599|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82952600|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952601|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952602|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952603|NCT01118039|Sunitinib|sunitinib|mesh-list
82952604|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952605|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82952606|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82952607|NCT01118039|Growth Substances|growth substances|mesh-ancestor
82952608|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952609|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
82952610|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952611|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952612|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952613|NCT01213433|Artesunate|artesunate|mesh-list
82952614|NCT01213433|Amodiaquine|amodiaquine|mesh-list
82952615|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
82952616|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82952617|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82952618|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952619|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952620|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
82952621|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
82952622|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82952623|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
82952624|NCT03848533|Metformin|metformin|mesh-list
82952625|NCT03848533|Melatonin|melatonin|mesh-list
82952626|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952627|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952628|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
82952629|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952630|NCT03848533|Protective Agents|protective agents|mesh-ancestor
82952631|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952632|NCT01111253|Amoxicillin|amoxicillin|mesh-list
82952633|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
82952634|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
82952635|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82952636|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952637|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952638|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82952639|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952640|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952641|NCT01213667|Ranibizumab|ranibizumab|mesh-list
82952642|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82952643|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82952644|NCT01213667|Growth Substances|growth substances|mesh-ancestor
82952645|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952646|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
82952647|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952648|NCT01196065|Memantine|memantine|mesh-list
82952649|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82952650|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82952651|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
82952652|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952653|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952654|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952655|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82952656|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82952657|NCT05258773|Azasetron|azasetron|mesh-list
82952658|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
82952659|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
82952660|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952661|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952662|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82952663|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82952664|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
82952665|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952666|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952667|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82952668|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82952669|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952670|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952671|NCT03845179|Incretins|incretins|mesh-ancestor
82952672|NCT03845179|Hormones|hormones|mesh-ancestor
82952673|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952674|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
82952675|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952676|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952677|NCT03936023|Saxagliptin|saxagliptin|mesh-list
82952678|NCT03936023|Incretins|incretins|mesh-ancestor
82952679|NCT03936023|Hormones|hormones|mesh-ancestor
82952680|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952681|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952682|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82952683|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
82952684|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952685|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952686|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952687|NCT01121705|Interferons|interferons|mesh-list
82952688|NCT01121705|Ribavirin|ribavirin|mesh-list
82952689|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
82952690|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
82952691|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82952692|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952693|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
82952694|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952695|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
82952696|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952697|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
82952698|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952699|NCT01196455|Capecitabine|capecitabine|mesh-list
82952700|NCT01196455|Mitomycins|mitomycins|mesh-list
82952701|NCT01196455|Mitomycin|mitomycin|mesh-list
82952702|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82952703|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
82952704|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952705|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952706|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82952707|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
82952708|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82952709|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952710|NCT03846583|Trastuzumab|trastuzumab|mesh-list
82952711|NCT03846583|Tucatinib|tucatinib|mesh-list
82952712|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82952713|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82952714|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952715|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82952716|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952717|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952718|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82952719|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
82952720|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952721|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952722|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952723|NCT01115543|Calcitriol|calcitriol|mesh-list
82952724|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
82952725|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82952726|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952727|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952728|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82952729|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952730|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952731|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82952732|NCT01115543|Vitamins|vitamins|mesh-ancestor
82952733|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
82952734|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82952735|NCT01216007|Propofol|propofol|mesh-list
82952736|NCT01216007|Sevoflurane|sevoflurane|mesh-list
82952737|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82952738|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952739|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952740|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82952741|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
82952742|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
83460478|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
82952743|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82952744|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82952745|NCT01198249|Losartan|losartan|mesh-list
82952746|NCT01198249|Amlodipine|amlodipine|mesh-list
82952747|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82952748|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82952749|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82952750|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952751|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952752|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82952753|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952754|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
82952755|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82952756|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82952757|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82952758|NCT01198249|Diuretics|diuretics|mesh-ancestor
82952759|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
82952760|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82952761|NCT02529761|Sorafenib|sorafenib|mesh-list
82952762|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952763|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952764|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952765|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952766|NCT03844243|Mitogens|mitogens|mesh-list
82952767|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
82952768|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952769|NCT05479591|Xultophy|xultophy|mesh-list
82952770|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952771|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952772|NCT05479591|Incretins|incretins|mesh-ancestor
82952773|NCT05479591|Hormones|hormones|mesh-ancestor
82952774|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952775|NCT01119209|Ropivacaine|ropivacaine|mesh-list
82952776|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
82952777|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
82952778|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952779|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952780|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
82952781|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952782|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
82952783|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952784|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952785|NCT01116167|Letrozole|letrozole|mesh-list
82952786|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952787|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82952788|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82952789|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952790|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952791|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82952792|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
82952793|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952794|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952795|NCT01119521|Isoniazid|isoniazid|mesh-list
82952796|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
82952797|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952798|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952799|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82952800|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82952801|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
82952802|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952803|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82952804|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
82952805|NCT03939923|Rocuronium|rocuronium|mesh-list
82952806|NCT03939923|Neostigmine|neostigmine|mesh-list
82952807|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82952808|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82952809|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82952810|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952811|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952812|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82952813|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952814|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952815|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
82952816|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952817|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82952818|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
82952819|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82952820|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82952821|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82952822|NCT01119599|Temozolomide|temozolomide|mesh-list
82952823|NCT01119599|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82952824|NCT01119599|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82952825|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82952826|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
82952827|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952828|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952829|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952830|NCT03419403|Temozolomide|temozolomide|mesh-list
82952831|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82952832|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82952833|NCT03419403|ABT-414|abt-414|mesh-list
82952834|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82952835|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
82952836|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952837|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952838|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82952839|NCT03419403|Immunoconjugates|immunoconjugates|mesh-ancestor
82952840|NCT03419403|Immunologic Factors|immunologic factors|mesh-ancestor
82952841|NCT03419403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952842|NCT05156437|Amoxicillin|amoxicillin|mesh-list
82952843|NCT05156437|Vancomycin|vancomycin|mesh-list
82952844|NCT05156437|Levofloxacin|levofloxacin|mesh-list
82952845|NCT05156437|Rifampin|rifampin|mesh-list
82952846|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
82952847|NCT05156437|Linezolid|linezolid|mesh-list
82952848|NCT05156437|Daptomycin|daptomycin|mesh-list
82952849|NCT05156437|Cephalexin|cephalexin|mesh-list
82952850|NCT05156437|Ampicillin|ampicillin|mesh-list
82952851|NCT05156437|Cefepime|cefepime|mesh-list
82952852|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82952853|NCT05156437|Oxacillin|oxacillin|mesh-list
82952854|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
82952855|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952856|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83519090|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
82952857|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82952858|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82952859|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82952860|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952861|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952862|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952863|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82952864|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82952865|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82952866|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
82952867|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
82952868|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82952869|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82952870|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82952871|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82952872|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82952873|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82952874|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82952875|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82952876|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
82952877|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82952878|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
82952879|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952880|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952881|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
82952882|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952883|NCT03715725|Warfarin|warfarin|mesh-list
82952884|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
82952885|NCT03715725|Dabigatran|dabigatran|mesh-list
82952886|NCT03715725|Apixaban|apixaban|mesh-list
82952887|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
82952888|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82952889|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
82952890|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82952891|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
82952892|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952893|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952894|NCT01212653|Golimumab|golimumab|mesh-list
82952895|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82952896|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82952897|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82952898|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
82952899|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952900|NCT01213979|Iron|iron|mesh-list
82952901|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82952902|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
82952903|NCT01213979|Trace Elements|trace elements|mesh-ancestor
82952904|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
82952905|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952906|NCT01213979|Hematinics|hematinics|mesh-ancestor
82952907|NCT05282719|Azacitidine|azacitidine|mesh-list
82952908|NCT05282719|Venetoclax|venetoclax|mesh-list
82952909|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82952910|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
83084011|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952911|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952912|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952913|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952914|NCT01118429|Oxybutynin|oxybutynin|mesh-list
82952915|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
82952916|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
82952917|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952918|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952919|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82952920|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82952921|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
82952922|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82952923|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952924|NCT01118429|Urological Agents|urological agents|mesh-ancestor
82952925|NCT03447249|Ivacaftor|ivacaftor|mesh-list
82952926|NCT03447249|VX-659|vx-659|mesh-list
82952927|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82952928|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82952929|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952930|NCT04156555|Amoxicillin|amoxicillin|mesh-list
82952931|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
82952932|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
82952933|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82952934|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82952935|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82952936|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82952937|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952938|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952939|NCT01200121|Bevacizumab|bevacizumab|mesh-list
82952940|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82952941|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952942|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82952943|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82952944|NCT01200121|Growth Substances|growth substances|mesh-ancestor
82952945|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952946|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
82952947|NCT01214291|Toremifene|toremifene|mesh-list
82952948|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82952949|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952950|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82952951|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82952952|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
82952953|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952954|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952955|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82952956|NCT01116635|Doxorubicin|doxorubicin|mesh-list
82952957|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82952958|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952959|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82952960|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82952961|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952962|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952963|NCT01566799|Metformin|metformin|mesh-list
82952964|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82952965|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952966|NCT04642807|Calpastatin|calpastatin|mesh-list
82952967|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
82952968|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
82952969|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952970|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952971|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
82952972|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82952973|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82952974|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82952975|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82952976|NCT01198639|Remifentanil|remifentanil|mesh-list
82952977|NCT01198639|Propofol|propofol|mesh-list
82952978|NCT01198639|Anesthetics|anesthetics|mesh-list
82952979|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82952980|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82952981|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952982|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82952983|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
82952984|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82952985|NCT01198639|Narcotics|narcotics|mesh-ancestor
82952986|NCT01198639|Analgesics|analgesics|mesh-ancestor
82952987|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
82952988|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952989|NCT01116713|Dexamethasone|dexamethasone|mesh-list
82952990|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82952991|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
82952992|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
82952993|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82952994|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82952995|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82952996|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
82952997|NCT01116713|Hormones|hormones|mesh-ancestor
82952998|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82952999|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82953000|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953001|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
82953002|NCT01202149|Emollients|emollients|mesh-list
82953003|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82953004|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82953005|NCT01202149|Analgesics|analgesics|mesh-ancestor
82953006|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
82953007|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953008|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953009|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953010|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953011|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
82953012|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953013|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
82953014|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82953015|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953016|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953017|NCT01116791|Cisplatin|cisplatin|mesh-list
82953018|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953019|NCT03717909|Valproic Acid|valproic acid|mesh-list
82953020|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
82953021|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953022|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953023|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
82953024|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953025|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953026|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
82953027|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82953028|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953029|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82953030|NCT03940001|Paclitaxel|paclitaxel|mesh-list
82953031|NCT03940001|Carboplatin|carboplatin|mesh-list
82953032|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82953033|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953034|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
82953035|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
82953036|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
82953037|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953038|NCT01120769|Acetaminophen|acetaminophen|mesh-list
82953039|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82953040|NCT01120769|Analgesics|analgesics|mesh-ancestor
82953041|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
82953042|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953043|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953044|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
82953045|NCT03715413|Tamoxifen|tamoxifen|mesh-list
82953046|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82953047|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
82953048|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82953049|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953050|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82953051|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953052|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82953053|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82953054|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82953055|NCT01122251|Valsartan|valsartan|mesh-list
82953056|NCT01122251|Lercanidipine|lercanidipine|mesh-list
82953057|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82953058|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82953059|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82953060|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953061|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82953062|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82953063|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82953064|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953065|NCT04600999|Favipiravir|favipiravir|mesh-list
82953066|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
82953067|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953068|NCT01199029|Prednisone|prednisone|mesh-list
82953069|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953070|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
82953071|NCT01199029|Hormones|hormones|mesh-ancestor
82953072|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82953073|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953074|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82953075|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953076|NCT01200745|Capsaicin|capsaicin|mesh-list
82953077|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
82953078|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
82953079|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
82953080|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953081|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953082|NCT01585415|Aldesleukin|aldesleukin|mesh-list
82953083|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
82953084|NCT01585415|Fludarabine|fludarabine|mesh-list
82953085|NCT01585415|Vemurafenib|vemurafenib|mesh-list
82953086|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953087|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
82953088|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953089|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953090|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82953091|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
82953092|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953093|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953094|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82953095|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82953096|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82953097|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
82953098|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953099|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82953100|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953101|NCT01566643|Metronidazole|metronidazole|mesh-list
82953102|NCT01566643|Rabeprazole|rabeprazole|mesh-list
82953103|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953104|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82953105|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82953106|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82953107|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82953108|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82953109|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82953110|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953111|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953112|NCT03841747|Paclitaxel|paclitaxel|mesh-list
82953113|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
82953114|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82953115|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953116|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
82953117|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
82953118|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
82953119|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953120|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82953121|NCT03841747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82953122|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
82953123|NCT01121237|Hematinics|hematinics|mesh-ancestor
82953124|NCT03841591|Metformin|metformin|mesh-list
82953125|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953126|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953127|NCT05667727|Epinephrine|epinephrine|mesh-list
82953128|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82953129|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82953130|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
82953131|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953132|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953133|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953134|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82953135|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82953143|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82953144|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
82953145|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82953146|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82953147|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82953148|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953149|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953150|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
82953151|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82953152|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
82953153|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953154|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
82953155|NCT01212809|Protective Agents|protective agents|mesh-ancestor
82953156|NCT01214993|Dolutegravir|dolutegravir|mesh-list
82953157|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82953158|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82953159|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953160|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953161|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82953162|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82953163|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
82953164|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953165|NCT03843229|Bufanolides|bufanolides|mesh-list
82953166|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82953167|NCT03843229|Protective Agents|protective agents|mesh-ancestor
82953168|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953169|NCT01212887|Aldesleukin|aldesleukin|mesh-list
82953170|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
82953171|NCT01212887|Fludarabine|fludarabine|mesh-list
82953172|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
82953173|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953174|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
82953175|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953176|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953177|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82953178|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
82953179|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953180|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953181|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82953182|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82953183|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
82953184|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82953185|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82953186|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
82953187|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953188|NCT01215149|Vaccines|vaccines|mesh-list
82953189|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
82953190|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953191|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
82953192|NCT03843307|Immunomodulating Agents|immunomodulating agents|mesh-list
82953193|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953194|NCT04961281|Triamcinolone|triamcinolone|mesh-list
82953195|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
82953196|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82953197|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953198|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953199|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82953200|NCT04961281|Analgesics|analgesics|mesh-ancestor
82953201|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
82953202|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953203|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82953204|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82953206|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
82953207|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953208|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953209|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953210|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
82953211|NCT04961281|Hormones|hormones|mesh-ancestor
82953212|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82953213|NCT01212965|Selenium|selenium|mesh-list
82953214|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
82953215|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953216|NCT01212965|Protective Agents|protective agents|mesh-ancestor
82953217|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953218|NCT01212965|Trace Elements|trace elements|mesh-ancestor
82953219|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
82953220|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
82953221|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82953222|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953223|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953224|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953226|NCT01216709|Trace Elements|trace elements|mesh-ancestor
82953227|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
82953228|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953229|NCT01216787|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82953230|NCT01216787|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82953231|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953232|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953233|NCT05282251|Bupivacaine|bupivacaine|mesh-list
82953234|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
82953235|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
82953236|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953237|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953238|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
82953239|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953240|NCT01199341|Warfarin|warfarin|mesh-list
82953241|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
82953242|NCT01215539|Panitumumab|panitumumab|mesh-list
82953243|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82953244|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953245|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
82953246|NCT01203709|Tacrolimus|tacrolimus|mesh-list
82953247|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953248|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
82953249|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953250|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82953251|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953252|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953253|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82953254|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953255|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82953256|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
82953257|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82953258|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953259|NCT01122407|Trimethaphan|trimethaphan|mesh-list
82953260|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
82953261|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953262|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82953263|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82953264|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
82953265|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
82953266|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953267|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953268|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82953269|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82953270|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
82953271|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953272|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
82953273|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82953274|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
82953275|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82953276|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82953277|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82953278|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953279|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953280|NCT01124435|Celecoxib|celecoxib|mesh-list
82953281|NCT01124435|Carboplatin|carboplatin|mesh-list
82953282|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953283|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82953284|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82953285|NCT01124435|Analgesics|analgesics|mesh-ancestor
82953286|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
82953287|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953288|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953289|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953290|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953291|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82953292|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82953293|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953294|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953295|NCT03294304|Gemcitabine|gemcitabine|mesh-list
82953296|NCT03294304|Nivolumab|nivolumab|mesh-list
82953297|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953298|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82953299|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
82953300|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953301|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82953302|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82953303|NCT01201213|Anesthetics|anesthetics|mesh-list
82953304|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
82953305|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953306|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953307|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
82953308|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953309|NCT03472378|Celecoxib|celecoxib|mesh-list
82953310|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82953311|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82953312|NCT03472378|Analgesics|analgesics|mesh-ancestor
82953313|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
82953314|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953315|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953316|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953317|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953318|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82953319|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82953320|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953321|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953322|NCT03408873|Aripiprazole|aripiprazole|mesh-list
82953323|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
82953324|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82953325|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82953326|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82953327|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953328|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953329|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
82953330|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
82953331|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953332|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953333|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82953334|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82953335|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
82953336|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82953337|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82953338|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82953339|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82953340|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82953341|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82953342|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82953343|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
82953344|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953345|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82953346|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82953347|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953348|NCT03780959|Etanercept|etanercept|mesh-list
82953349|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82953350|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82953351|NCT03780959|Analgesics|analgesics|mesh-ancestor
82953352|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
82953353|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953354|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953355|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953356|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953357|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82953358|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953359|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
82953360|NCT03838783|Insulin|insulin|mesh-list
82953361|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953362|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953363|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
82953364|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
82953365|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
82953366|NCT03408639|Vitamins|vitamins|mesh-ancestor
82953367|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
82953368|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953369|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
82953370|NCT03408639|Hematinics|hematinics|mesh-ancestor
82953371|NCT01219205|Bevacizumab|bevacizumab|mesh-list
82953372|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82953373|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953374|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82953375|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82953376|NCT01219205|Growth Substances|growth substances|mesh-ancestor
82953377|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953378|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
82953379|NCT03810235|Lidocaine|lidocaine|mesh-list
82953380|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
82953381|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
82953382|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953383|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953384|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
82953385|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953386|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83519244|NCT00002487|Dipyridamole|dipyridamole|mesh-list
82953387|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82953388|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82953389|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82953390|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953391|NCT03408483|Epinephrine|epinephrine|mesh-list
82953392|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
82953393|NCT03408483|Bupivacaine|bupivacaine|mesh-list
82953394|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
82953395|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
82953396|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953397|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953398|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
82953399|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953400|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82953401|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82953402|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
82953403|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953404|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953405|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82953406|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82953407|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
82953408|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82953409|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
82953410|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
82953411|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
82953412|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82953413|NCT03408483|Narcotics|narcotics|mesh-ancestor
82953414|NCT03408483|Analgesics|analgesics|mesh-ancestor
82953415|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
82953416|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82953417|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
82953418|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953419|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
82953420|NCT03777917|Protective Agents|protective agents|mesh-ancestor
82953421|NCT03715023|PC-786|pc-786|mesh-list
82953422|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
82953423|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953424|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953425|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953426|NCT03714867|Pregabalin|pregabalin|mesh-list
82953427|NCT03714867|Analgesics|analgesics|mesh-ancestor
82953428|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
82953429|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953430|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953431|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
82953432|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82953433|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82953434|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953435|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82953436|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82953437|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82953438|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953439|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82953440|NCT01204177|Sorafenib|sorafenib|mesh-list
82953441|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953442|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82953443|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953444|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953445|NCT01217099|Azithromycin|azithromycin|mesh-list
82953446|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
82953447|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82953448|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82953449|NCT01217099|Prednisolone|prednisolone|mesh-list
82953450|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
82953451|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82953452|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
82953453|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953454|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
82953455|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
82953456|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953457|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953458|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82953459|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
82953460|NCT01217099|Hormones|hormones|mesh-ancestor
82953461|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83519627|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
82953462|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82953463|NCT01217099|Protective Agents|protective agents|mesh-ancestor
82953464|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82953465|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953466|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82953467|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953469|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82953470|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
82953471|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953472|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953473|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82953474|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
82953475|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82953476|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
82953477|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953478|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953479|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82953480|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
82953481|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
82953482|NCT04305457|Protective Agents|protective agents|mesh-ancestor
82953483|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
82953484|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82953485|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82953486|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
82953487|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953488|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953489|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953490|NCT01122563|Urological Agents|urological agents|mesh-ancestor
82953491|NCT01217177|Everolimus|everolimus|mesh-list
82953492|NCT01217177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82953493|NCT01217177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82953494|NCT01217177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953495|NCT01217177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953496|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953497|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
82953498|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953499|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953500|NCT01204333|Heparin|heparin|mesh-list
82953501|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
82953503|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82953504|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953505|NCT02529059|Tenofovir|tenofovir|mesh-list
82953506|NCT02529059|Emtricitabine|emtricitabine|mesh-list
82953507|NCT02529059|Rilpivirine|rilpivirine|mesh-list
82953508|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
82953509|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953510|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82953511|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82953512|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953513|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953514|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82953515|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82953516|NCT03100058|Licogliflozin|licogliflozin|mesh-list
82953517|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82953518|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953519|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953520|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953521|NCT03933761|Pamiparib|pamiparib|mesh-list
82953522|NCT03933761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82953523|NCT03933761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953524|NCT03933761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953525|NCT03933761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953526|NCT03932123|Vancomycin|vancomycin|mesh-list
82953527|NCT03932123|Meropenem|meropenem|mesh-list
82953528|NCT03932123|Tazobactam|tazobactam|mesh-list
82953529|NCT03932123|Piperacillin|piperacillin|mesh-list
82953530|NCT03932123|Cefotaxime|cefotaxime|mesh-list
82953531|NCT03932123|Cefoxitin|cefoxitin|mesh-list
82953532|NCT03932123|Azlocillin|azlocillin|mesh-list
82953533|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82953534|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953535|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82953536|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953537|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953538|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
82953539|NCT02866279|Etonogestrel|etonogestrel|mesh-list
82953540|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82953541|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953542|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82953543|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82953544|NCT01222169|Propofol|propofol|mesh-list
82953545|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82953546|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953547|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953548|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82953549|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
82953550|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
82953551|NCT02871778|Ivacaftor|ivacaftor|mesh-list
82953552|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82953553|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82953554|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953555|NCT04947592|Fluconazole|fluconazole|mesh-list
82953556|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
82953557|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953558|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82953559|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82953560|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953561|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953562|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82953563|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
82953564|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82953565|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953566|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82953567|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82953568|NCT02735473|Choline|choline|mesh-list
82953569|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
82953570|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82953571|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
82953572|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953573|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82953574|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82953576|NCT05156788|Lenvatinib|lenvatinib|mesh-list
82953577|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953578|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82953579|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953580|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953581|NCT04199767|Insulin|insulin|mesh-list
82953582|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82953583|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
82953584|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953585|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953586|NCT01125059|Methadone|methadone|mesh-list
82953587|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82953588|NCT01125059|Narcotics|narcotics|mesh-ancestor
82953589|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953590|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953591|NCT01125059|Analgesics|analgesics|mesh-ancestor
82953592|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
82953593|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953594|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
82953595|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
82953596|NCT01204411|Artesunate|artesunate|mesh-list
82953597|NCT01204411|Amodiaquine|amodiaquine|mesh-list
82953598|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
82953599|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82953600|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82953601|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953602|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953603|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
82953604|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
82953605|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82953606|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
82953607|NCT01471444|Methotrexate|methotrexate|mesh-list
82953608|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
82953609|NCT01471444|Clofarabine|clofarabine|mesh-list
82953610|NCT01471444|Fludarabine|fludarabine|mesh-list
82953611|NCT01471444|Busulfan|busulfan|mesh-list
82953612|NCT01471444|Tacrolimus|tacrolimus|mesh-list
82953613|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
82953614|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82953615|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82953616|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
82953617|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82953618|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953619|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82953620|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
82953621|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953622|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953623|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
82953624|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953625|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82953626|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953627|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
82953628|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953629|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82953630|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82953631|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
82953632|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82953633|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82953634|NCT05282407|Tenofovir|tenofovir|mesh-list
82953635|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
82953636|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953637|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82953638|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82953639|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953640|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953641|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82953642|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82953643|NCT04209686|Paclitaxel|paclitaxel|mesh-list
82953644|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
82953645|NCT04209686|Olaparib|olaparib|mesh-list
82953646|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82953647|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953648|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
82953649|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
82953650|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
82953651|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953652|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82953653|NCT04209686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82953654|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82953655|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953656|NCT01125215|Capsaicin|capsaicin|mesh-list
82953657|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
82953658|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
82953659|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
82953660|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953661|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953662|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
82953663|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82953664|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
82953665|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953666|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953667|NCT05162872|Niraparib|niraparib|mesh-list
82953668|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82953669|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953670|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953671|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953672|NCT01567111|Metomidate|metomidate|mesh-list
82953673|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82953674|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953675|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953676|NCT03955211|Acetaminophen|acetaminophen|mesh-list
82953677|NCT03955211|Ibuprofen|ibuprofen|mesh-list
82953678|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82953679|NCT03955211|Analgesics|analgesics|mesh-ancestor
82953680|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
82953681|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953682|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953683|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
82953684|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82953685|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953686|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953687|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82953688|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953689|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953690|NCT03933605|Midazolam|midazolam|mesh-list
82953691|NCT03933605|Palonosetron|palonosetron|mesh-list
82953692|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82953693|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82953694|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953695|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953696|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82953697|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82953698|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82953699|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82953700|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
82953701|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
82953702|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
82953703|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
82953704|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953705|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953706|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
82953707|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
82953708|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953709|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82953710|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82953711|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82953712|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
82953713|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
82953714|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82953715|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82953716|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
82953717|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
82953718|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
82953719|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
82953720|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82953721|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953722|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953723|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
82953724|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82953725|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953726|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953727|NCT01311141|Doripenem|doripenem|mesh-list
82953728|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82953729|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953731|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953732|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953733|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82953734|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
82953735|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953736|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953737|NCT03423979|Paclitaxel|paclitaxel|mesh-list
82953738|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82953739|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953740|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
82953741|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
82953742|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
82953743|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953744|NCT03714555|Copper|copper|mesh-list
82953745|NCT03714555|Paclitaxel|paclitaxel|mesh-list
82953746|NCT03714555|Gemcitabine|gemcitabine|mesh-list
82953747|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82953748|NCT03714555|Folfirinox|folfirinox|mesh-list
82953749|NCT03714555|Disulfiram|disulfiram|mesh-list
82953750|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82953751|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953752|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
82953753|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
82953754|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
82953755|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953756|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82953757|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
82953758|NCT03714555|Trace Elements|trace elements|mesh-ancestor
82953759|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
82953760|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953761|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82953762|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82953763|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953764|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
82953765|NCT01125449|Vitamins|vitamins|mesh-ancestor
82953766|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
82953767|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953768|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
82953769|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953770|NCT01125449|Protective Agents|protective agents|mesh-ancestor
82953771|NCT01206049|Bevacizumab|bevacizumab|mesh-list
82953772|NCT01206049|Panitumumab|panitumumab|mesh-list
82953773|NCT01206049|Gemcitabine|gemcitabine|mesh-list
82953774|NCT01206049|Capecitabine|capecitabine|mesh-list
82953775|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
82953776|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82953777|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953778|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82953779|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82953780|NCT01206049|Growth Substances|growth substances|mesh-ancestor
82953781|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953782|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
82953783|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82953784|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
82953785|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953786|NCT03931889|Vitamin D|vitamin d|mesh-list
82953787|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
82953788|NCT03931889|Vitamins|vitamins|mesh-ancestor
82953789|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
82953790|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953791|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82953792|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82953793|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82953794|NCT02953821|Hormones|hormones|mesh-ancestor
82953795|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82953796|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953797|NCT01206205|Lenalidomide|lenalidomide|mesh-list
82953798|NCT01206205|Bortezomib|bortezomib|mesh-list
82953799|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
82953800|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953801|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82953802|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82953803|NCT01206205|Growth Substances|growth substances|mesh-ancestor
82953804|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
82953805|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953807|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82953808|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953809|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
82953810|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953811|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82953812|NCT03472144|Levofloxacin|levofloxacin|mesh-list
82953813|NCT03472144|Ofloxacin|ofloxacin|mesh-list
82953814|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82953815|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953816|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
82953817|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82953818|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82953819|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82953820|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953821|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953822|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953823|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82953824|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82953825|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
82953826|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
82953827|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953828|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82953829|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953830|NCT01219751|Sunitinib|sunitinib|mesh-list
82953831|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953832|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82953833|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82953834|NCT01219751|Growth Substances|growth substances|mesh-ancestor
82953835|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953836|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
82953837|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82953838|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953839|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953840|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
82953841|NCT04823091|Fludarabine|fludarabine|mesh-list
82953842|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953843|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
82953844|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953845|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953846|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82953847|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
82953848|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953849|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953850|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82953851|NCT01125527|Vaccines|vaccines|mesh-list
82953852|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
82953853|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953854|NCT01298401|Gemcitabine|gemcitabine|mesh-list
82953855|NCT01298401|Capecitabine|capecitabine|mesh-list
82953856|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82953857|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
82953858|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953859|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953860|NCT03931343|Epinephrine|epinephrine|mesh-list
82953861|NCT03931343|Racepinephrine|racepinephrine|mesh-list
82953862|NCT03931343|Bupivacaine|bupivacaine|mesh-list
82953863|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
82953864|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
82953865|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
82953866|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82953867|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953868|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
82953869|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82953870|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82953871|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82953872|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
82953873|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953874|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953875|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82953876|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82953877|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
82953878|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82953879|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
82953880|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
82953881|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
82953882|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82953883|NCT04867798|Tenofovir|tenofovir|mesh-list
82953884|NCT04867798|Lamivudine|lamivudine|mesh-list
82953885|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
82953886|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953887|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82953888|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82953889|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953890|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953891|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82953892|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82953893|NCT01122953|Phenytoin|phenytoin|mesh-list
82953894|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
82953895|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82953896|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82953897|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82953898|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953899|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82953900|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82953901|NCT01125683|Donepezil|donepezil|mesh-list
82953902|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82953903|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953904|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953905|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
82953906|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82953907|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953908|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
82953909|NCT01127555|Leucovorin|leucovorin|mesh-list
82953910|NCT01127555|Fluorouracil|fluorouracil|mesh-list
82953911|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
82953912|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
82953913|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953914|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82953915|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953916|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953917|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
82953918|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953919|NCT01127555|Antidotes|antidotes|mesh-ancestor
82953920|NCT01127555|Protective Agents|protective agents|mesh-ancestor
82953921|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
82953922|NCT01127555|Vitamins|vitamins|mesh-ancestor
82953923|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
82953924|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
82953925|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953926|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
82953927|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953928|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82953929|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82953930|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
82953931|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953932|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953933|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82953934|NCT03471988|Voriconazole|voriconazole|mesh-list
82953935|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
82953936|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82953937|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82953938|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82953939|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953940|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953941|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82953942|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
82953943|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82953944|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953945|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82953946|NCT03724981|Dulaglutide|dulaglutide|mesh-list
82953947|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953948|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953949|NCT03442569|Nivolumab|nivolumab|mesh-list
82953950|NCT03442569|Ipilimumab|ipilimumab|mesh-list
82953951|NCT03442569|Panitumumab|panitumumab|mesh-list
82953952|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82953954|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82953955|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953957|NCT01123031|Lansoprazole|lansoprazole|mesh-list
82953958|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
82953959|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82953960|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82953961|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82953962|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953963|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953964|NCT01220063|Irinotecan|irinotecan|mesh-list
82953965|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82953966|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82953967|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953968|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953969|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953970|NCT01298713|Tamoxifen|tamoxifen|mesh-list
82953971|NCT01298713|Everolimus|everolimus|mesh-list
82953972|NCT01298713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82953973|NCT01298713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82953974|NCT01298713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82953975|NCT01298713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953976|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82953977|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
82953978|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953979|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82953980|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82953981|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
82953982|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82953983|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82953984|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82953985|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82953986|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82953987|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
82953988|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82953989|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953990|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82953991|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82953992|NCT01217879|Telmisartan|telmisartan|mesh-list
82953993|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82953994|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82953995|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82953996|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82953997|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
82953998|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82953999|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954000|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
82954001|NCT04249310|Olodaterol|olodaterol|mesh-list
82954002|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82954003|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
82954004|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954005|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954006|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82954007|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
82954008|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
82954009|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82954010|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
82954011|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954012|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954013|NCT05665075|Cytarabine|cytarabine|mesh-list
82954014|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
82954015|NCT05665075|Fludarabine|fludarabine|mesh-list
82954016|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954017|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
82954018|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954019|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954020|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82954021|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
82954022|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954023|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954024|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82954025|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82954026|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
82954027|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
82954028|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954029|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82954030|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
82954032|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954033|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
82954034|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82954035|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954036|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954037|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82954038|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
82954039|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82954040|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
82954041|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
82954042|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954043|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954044|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82954045|NCT03932825|Analgesics|analgesics|mesh-ancestor
82954046|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
82954047|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954048|NCT03932981|Temozolomide|temozolomide|mesh-list
82954049|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82954050|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
82954051|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954052|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954053|NCT01220219|Pregabalin|pregabalin|mesh-list
82954054|NCT01220219|Analgesics|analgesics|mesh-ancestor
82954055|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
82954056|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954057|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954058|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
82954059|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82954060|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954061|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954062|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82954063|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82954064|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82954065|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954066|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82954067|NCT03441789|Betamethasone|betamethasone|mesh-list
82954068|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
82954069|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82954070|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
82954071|NCT03441789|Calcipotriene|calcipotriene|mesh-list
82954072|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82954073|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954074|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
82954076|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954077|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954078|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82954079|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
82954080|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954081|NCT03359005|Vincristine|vincristine|mesh-list
82954082|NCT03359005|Temozolomide|temozolomide|mesh-list
82954083|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82954084|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954085|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
82954086|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
82954087|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
82954088|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954089|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82954090|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
82954091|NCT04321174|Ritonavir|ritonavir|mesh-list
82954092|NCT04321174|Lopinavir|lopinavir|mesh-list
82954093|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82954094|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82954095|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
82954096|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954097|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954098|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82954100|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
82954101|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954102|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82954103|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82954104|NCT01123265|Methotrexate|methotrexate|mesh-list
82954105|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82954106|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
82954107|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82954108|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954109|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82954110|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
82954111|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954112|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954113|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954114|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954115|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82954116|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954117|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
82954118|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954119|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82954120|NCT01204723|Aprepitant|aprepitant|mesh-list
82954121|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
82954122|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
82954123|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
82954124|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954125|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954126|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954127|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82954128|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954129|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954130|NCT01204801|Doxorubicin|doxorubicin|mesh-list
82954131|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82954132|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82954133|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954134|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82954135|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82954136|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954137|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954138|NCT04194814|Betamethasone|betamethasone|mesh-list
82954139|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
82954140|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82954141|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
82954142|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82954143|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954144|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
82954145|NCT04194814|Hormones|hormones|mesh-ancestor
82954146|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954147|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954148|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82954149|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
82954150|NCT03832621|Nivolumab|nivolumab|mesh-list
82954151|NCT03832621|Ipilimumab|ipilimumab|mesh-list
82954152|NCT03832621|Temozolomide|temozolomide|mesh-list
82954153|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82954154|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954155|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82954156|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954157|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82954158|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
82954159|NCT01220375|Plerixafor|plerixafor|mesh-list
82954160|NCT01220375|Vinorelbine|vinorelbine|mesh-list
82954161|NCT01220375|Lenograstim|lenograstim|mesh-list
82954162|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82954163|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
82954164|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954165|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82954166|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954167|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
82954168|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
82954169|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
82954170|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954171|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82954172|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82954173|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
82954174|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954175|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
82954176|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
82954177|NCT01223729|Vitamins|vitamins|mesh-ancestor
82954178|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
83460552|NCT02338076|Petrolatum|petrolatum|mesh-list
82954179|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954180|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
82954181|NCT01126073|Niacin|niacin|mesh-list
82954182|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82954183|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
82954184|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954185|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82954186|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
82954187|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
82954188|NCT01126073|Vitamins|vitamins|mesh-ancestor
82954189|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
82954190|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954191|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
82954192|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82954193|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954194|NCT03287050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82954195|NCT03287050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954196|NCT05470881|Atropine|atropine|mesh-list
82954197|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82954198|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82954199|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82954200|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
82954201|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954202|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954203|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82954204|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
82954205|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
82954206|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
82954207|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82954208|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82954209|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
82954210|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954211|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954212|NCT03130504|Progesterone|progesterone|mesh-list
82954213|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82954214|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82954215|NCT03130504|Progestins|progestins|mesh-ancestor
82954216|NCT03130504|Hormones|hormones|mesh-ancestor
82954217|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954218|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954219|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82954220|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
82954222|NCT03819127|Vildagliptin|vildagliptin|mesh-list
82954223|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82954224|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954225|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82954226|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
82954227|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954228|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954229|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
82954230|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82954231|NCT05607550|Aflutinib|aflutinib|mesh-list
82954232|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82954233|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954234|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954235|NCT01299181|Atorvastatin|atorvastatin|mesh-list
82954236|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82954237|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82954238|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
82954239|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954240|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82954241|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82954242|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954243|NCT03930875|Aspirin|aspirin|mesh-list
82954244|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82954245|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82954246|NCT03930875|Analgesics|analgesics|mesh-ancestor
82954247|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
82954248|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954249|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954250|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954251|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954252|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82954253|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82954254|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954255|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82954256|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82954257|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954258|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
82954259|NCT01206907|Oxymorphone|oxymorphone|mesh-list
82954260|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82954261|NCT01206907|Narcotics|narcotics|mesh-ancestor
82954262|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954263|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954264|NCT01206907|Analgesics|analgesics|mesh-ancestor
82954265|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
82954266|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954267|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82954268|NCT03925246|Nivolumab|nivolumab|mesh-list
82954269|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82954270|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954271|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82954272|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954273|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82954274|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82954275|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82954276|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
82954277|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954278|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82954279|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82954280|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954281|NCT01126229|Resveratrol|resveratrol|mesh-list
82954282|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
82954283|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954284|NCT01126229|Protective Agents|protective agents|mesh-ancestor
82954285|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954286|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954287|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82954288|NCT03474640|Antibodies|antibodies|mesh-list
82954289|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82954290|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
82954291|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954292|NCT01126307|Verapamil|verapamil|mesh-list
82954293|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82954294|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82954295|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954296|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954297|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82954298|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954299|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
82954300|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
82954301|NCT03439137|Hematinics|hematinics|mesh-ancestor
82954303|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954304|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954305|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954306|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82954307|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82954308|NCT03936491|Methylphenidate|methylphenidate|mesh-list
82954309|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82954310|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82954311|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954312|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82954313|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82954314|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954315|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954316|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
82954317|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954318|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82954319|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
82954320|NCT00890617|Prednisone|prednisone|mesh-list
82954321|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954323|NCT00890617|Hormones|hormones|mesh-ancestor
82954324|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954325|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954326|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82954327|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954328|NCT03468946|Caffeine|caffeine|mesh-list
82954329|NCT03468946|Citric Acid|citric acid|mesh-list
82954330|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82954331|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954332|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82954333|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954334|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954335|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82954336|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82954337|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
82954338|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954339|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
82954340|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82954341|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
82954342|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
82954343|NCT01218425|Levodopa|levodopa|mesh-list
82954344|NCT01218425|Carbidopa|carbidopa|mesh-list
82954345|NCT01218425|Domperidone|domperidone|mesh-list
82954346|NCT01218425|Methylphenidate|methylphenidate|mesh-list
82954347|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82954348|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954349|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82954350|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82954351|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954352|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954353|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
82954354|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954355|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82954356|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82954357|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82954358|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954359|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
82954360|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
82954361|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954362|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954363|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82954364|NCT05621005|Rifaximin|rifaximin|mesh-list
82954365|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82954366|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954367|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954368|NCT01224041|Tacrolimus|tacrolimus|mesh-list
82954369|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954370|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
82954371|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954372|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82954373|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954374|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954375|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
82954376|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954377|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954378|NCT01123811|Cetuximab|cetuximab|mesh-list
82954379|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82954380|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954381|NCT01128101|Spironolactone|spironolactone|mesh-list
82954382|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82954383|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
83460564|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
82954384|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954385|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954386|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82954387|NCT01128101|Diuretics|diuretics|mesh-ancestor
82954388|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
82954389|NCT01299415|Vadimezan|vadimezan|mesh-list
82954390|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954391|NCT01123967|Nicotine|nicotine|mesh-list
82954392|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82954393|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
82954394|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954395|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954396|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82954397|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82954398|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
82954399|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954400|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954401|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
82954402|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954403|NCT01126697|Ubiquinone|ubiquinone|mesh-list
82954404|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
82954405|NCT01126697|Lisinopril|lisinopril|mesh-list
82954406|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82954407|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
82954408|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954409|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954410|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82954411|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82954412|NCT01126697|Protective Agents|protective agents|mesh-ancestor
82954413|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954414|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
82954415|NCT01126697|Vitamins|vitamins|mesh-ancestor
82954416|NCT01220843|Sevelamer|sevelamer|mesh-list
82954417|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
82954418|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
82954419|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954420|NCT02804932|Methamphetamine|methamphetamine|mesh-list
82954421|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82954422|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954423|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
82954424|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
82954425|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954426|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
82954427|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954428|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954429|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
82954430|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82954431|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82954432|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954433|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82954434|NCT03468790|Fluticasone|fluticasone|mesh-list
82954435|NCT03468790|Xhance|xhance|mesh-list
82954436|NCT03468790|Budesonide|budesonide|mesh-list
82954437|NCT03468790|Albuterol|albuterol|mesh-list
82954438|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
82954439|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82954440|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83519704|NCT00002571|Protective Agents|protective agents|mesh-ancestor
82954441|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82954442|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954443|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82954445|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954446|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954447|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82954448|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
82954449|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954450|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82954451|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
82954452|NCT03468790|Hormones|hormones|mesh-ancestor
82954453|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954454|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82954455|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82954456|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82954457|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
83476372|NCT01089569|Incretins|incretins|mesh-ancestor
82954458|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954459|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954460|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
82954461|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82954462|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
82954463|NCT01224197|Simeprevir|simeprevir|mesh-list
82954464|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
82954465|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954466|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
82954467|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954468|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954469|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
82954470|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
82954471|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954473|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954474|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
82954475|NCT01224353|Vitamins|vitamins|mesh-ancestor
82954476|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
82954477|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
82954478|NCT01207297|Tacrolimus|tacrolimus|mesh-list
82954479|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954480|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
82954481|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954482|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954483|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82954484|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
82954485|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954486|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954487|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82954488|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82954489|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954490|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
82954491|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82954492|NCT03720847|Estradiol|estradiol|mesh-list
82954493|NCT03720847|Progesterone|progesterone|mesh-list
82954494|NCT03720847|Estrogens|estrogens|mesh-ancestor
82954495|NCT03720847|Hormones|hormones|mesh-ancestor
82954496|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954497|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954498|NCT03720847|Progestins|progestins|mesh-ancestor
82954499|NCT01128257|Alendronate|alendronate|mesh-list
82954500|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
82954501|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82954502|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954503|NCT01205347|Simvastatin|simvastatin|mesh-list
82954504|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82954505|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82954506|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
82954507|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954508|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82954509|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82954510|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954511|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
82954512|NCT01218737|Prednisolone|prednisolone|mesh-list
82954513|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82954514|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
82954515|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82954516|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
82954518|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
82954519|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954520|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
82954521|NCT01218737|Hormones|hormones|mesh-ancestor
82954522|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954523|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954524|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82954525|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954526|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
82954527|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
82954528|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954529|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954530|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82954531|NCT01218737|Protective Agents|protective agents|mesh-ancestor
82954532|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82954533|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954534|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82954535|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82954536|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82954537|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82954538|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954539|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954540|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
82954541|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82954542|NCT01224509|Mifepristone|mifepristone|mesh-list
82954543|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82954544|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
82954545|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82954546|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954547|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82954549|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82954550|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
82954551|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82954552|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82954553|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
82954554|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954555|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
82954556|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82954557|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82954558|NCT01301053|Insulin|insulin|mesh-list
82954559|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82954560|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82954561|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954562|NCT01218581|Letrozole|letrozole|mesh-list
82954563|NCT01218581|Goserelin|goserelin|mesh-list
82954564|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954565|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82954566|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82954567|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954568|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954569|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82954570|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
82954571|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954572|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954573|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82954574|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
82954575|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82954576|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
82954577|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954578|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
82954579|NCT03825133|Protective Agents|protective agents|mesh-ancestor
82954580|NCT03817567|Antibodies|antibodies|mesh-list
82954581|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82954582|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
82954583|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954584|NCT01127009|Cytarabine|cytarabine|mesh-list
82954585|NCT01127009|Etoposide|etoposide|mesh-list
82954586|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
82954587|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
82954588|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
82954589|NCT01127009|Bortezomib|bortezomib|mesh-list
82954590|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82954591|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954592|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82954593|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82954594|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954595|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954596|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82954597|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
82954598|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
82954599|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954600|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954601|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
82954602|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954603|NCT01127009|Analgesics|analgesics|mesh-ancestor
82954604|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
82954605|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954606|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
82954607|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954608|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
82954609|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
82954610|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
82954611|NCT03817411|Capecitabine|capecitabine|mesh-list
82954612|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
82954613|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82954614|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
82954615|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954616|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954617|NCT01205737|Rituximab|rituximab|mesh-list
82954618|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82954619|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954620|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
82954621|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954622|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954623|NCT01218893|Chloroquine|chloroquine|mesh-list
82954624|NCT01218893|Proguanil|proguanil|mesh-list
82954625|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
82954626|NCT01218893|Amebicides|amebicides|mesh-ancestor
82954627|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82954628|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82954629|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954630|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
82954631|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954632|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
82954633|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954634|NCT03824119|Ibuprofen|ibuprofen|mesh-list
82954635|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82954636|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82954637|NCT03824119|Analgesics|analgesics|mesh-ancestor
82954638|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
82954639|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954640|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954641|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954642|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954643|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82954644|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954645|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954646|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
82954647|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82954648|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82954649|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954650|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
82954651|NCT03823417|Coagulants|coagulants|mesh-ancestor
82954652|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
82954653|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954654|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82954655|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954656|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954657|NCT01225913|Fluticasone|fluticasone|mesh-list
82954658|NCT01225913|Xhance|xhance|mesh-list
82954659|NCT01225913|Budesonide|budesonide|mesh-list
82954660|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
82954661|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82954662|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82954663|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82954664|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954665|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82954666|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
82954667|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954669|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82954670|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
82954671|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954672|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82954673|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
82954674|NCT01225913|Hormones|hormones|mesh-ancestor
82954675|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954676|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82954677|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82954678|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82954679|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
82954680|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954681|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954682|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
82954683|NCT01224977|Azithromycin|azithromycin|mesh-list
82954684|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82954685|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954686|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
82954687|NCT01226069|Glycerol|glycerol|mesh-list
82954688|NCT01226069|Analgesics|analgesics|mesh-ancestor
82954689|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
82954690|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954691|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954692|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
82954693|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954694|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82954695|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
82954696|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82954698|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954699|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82954700|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
82954701|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82954702|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82954703|NCT01226069|Protective Agents|protective agents|mesh-ancestor
82954704|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
82954705|NCT03928691|Analgesics|analgesics|mesh-ancestor
82954706|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
82954707|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954708|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954709|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
82954710|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954711|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82954712|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
82954713|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82954714|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954715|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954716|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82954717|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
82954718|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82954719|NCT01297855|Rifampin|rifampin|mesh-list
82954720|NCT01297855|Colistin|colistin|mesh-list
82954721|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82954722|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
82954723|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82954724|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954725|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
82954726|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82954727|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954728|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954729|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82954730|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82954731|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82954732|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82954733|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82954734|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82954735|NCT02631070|Luspatercept|luspatercept|mesh-list
82954736|NCT02631070|Hematinics|hematinics|mesh-ancestor
82954737|NCT01298011|Paclitaxel|paclitaxel|mesh-list
82954738|NCT01298011|Gemcitabine|gemcitabine|mesh-list
82954739|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82954740|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82954741|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954742|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
82954743|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
82954744|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
82954745|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954746|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82954747|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
82954748|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82954749|NCT01221935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
82954750|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
82954751|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82954752|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954753|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954754|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954755|NCT01221935|Serotonin Agents|serotonin agents|mesh-ancestor
82954756|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954757|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
82954758|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82954759|NCT05137678|Glyburide|glyburide|mesh-list
82954760|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82954761|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954762|NCT01226303|Tretinoin|tretinoin|mesh-list
82954763|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954764|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
82954765|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954766|NCT03814759|Cisplatin|cisplatin|mesh-list
82954767|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954768|NCT05101018|Denosumab|denosumab|mesh-list
82954769|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82954770|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954771|NCT03929861|Fluconazole|fluconazole|mesh-list
82954772|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
82954773|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954774|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82954775|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82954776|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954777|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954778|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82954779|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
82954780|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82954781|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954782|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82954783|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82954784|NCT03821623|Niacinamide|niacinamide|mesh-list
82954785|NCT03821623|Niacin|niacin|mesh-list
82954786|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
82954787|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
82954788|NCT03821623|Vitamins|vitamins|mesh-ancestor
82954789|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
82954790|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954791|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82954792|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
82954793|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954794|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82954795|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
82954796|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82954797|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
82954798|NCT03928145|Amiloride|amiloride|mesh-list
82954799|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82954800|NCT03928145|Diuretics|diuretics|mesh-ancestor
82954801|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
82954802|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954803|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82954804|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82954805|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954806|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82954807|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82954808|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82954809|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82954810|NCT01129271|Clopidogrel|clopidogrel|mesh-list
82954811|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82954812|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82954813|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82954814|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82954815|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
82954816|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954817|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954818|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954819|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
82954820|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954821|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82954822|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954823|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954824|NCT00741988|Bevacizumab|bevacizumab|mesh-list
82954825|NCT00741988|Carboplatin|carboplatin|mesh-list
82954826|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82954827|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954828|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82954829|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82954830|NCT00741988|Growth Substances|growth substances|mesh-ancestor
82954831|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954832|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
82954833|NCT01131377|Acetazolamide|acetazolamide|mesh-list
82954834|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
82954835|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82954836|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954837|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954838|NCT01131377|Diuretics|diuretics|mesh-ancestor
82954839|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
82954840|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954841|NCT04457050|Ribavirin|ribavirin|mesh-list
82954844|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
82954845|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954846|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
82954847|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954848|NCT01228409|Acitretin|acitretin|mesh-list
82954849|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
82954850|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954851|NCT03470350|Capecitabine|capecitabine|mesh-list
82954852|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82954853|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
82954854|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954855|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954856|NCT04565392|Famotidine|famotidine|mesh-list
82954857|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82954858|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954859|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82954860|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
82954861|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
82954862|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954863|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954864|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954865|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
82954866|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
82954867|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82954868|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
82954869|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954870|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82954871|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82954872|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82954873|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82954874|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954875|NCT01226771|Ribavirin|ribavirin|mesh-list
82954876|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
82954877|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954878|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
82954879|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954880|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
82954881|NCT03814447|Fludarabine|fludarabine|mesh-list
82954882|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954883|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
82954884|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954885|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954886|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82954887|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
82954888|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954889|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954890|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82954891|NCT01129427|Pantoprazole|pantoprazole|mesh-list
82954892|NCT01129427|Clopidogrel|clopidogrel|mesh-list
82954893|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82954894|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82954895|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82954896|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82954897|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
82954898|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954899|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954900|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954901|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82954902|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954903|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82954904|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954905|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82954906|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
82954907|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954908|NCT03354429|Ticagrelor|ticagrelor|mesh-list
82954909|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82954910|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82954911|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82954912|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82954913|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
82954914|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82954916|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954917|NCT05160298|Ropivacaine|ropivacaine|mesh-list
82954918|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
82954919|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
82954920|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954921|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954922|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
82954923|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954924|NCT05164198|Adalimumab|adalimumab|mesh-list
82954925|NCT05164198|Infliximab|infliximab|mesh-list
82954926|NCT05164198|Golimumab|golimumab|mesh-list
82954927|NCT05164198|Etanercept|etanercept|mesh-list
82954928|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82954929|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82954930|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82954931|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
82954932|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82954933|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82954934|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82954935|NCT05164198|Analgesics|analgesics|mesh-ancestor
82954936|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
82954937|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82954938|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954939|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954940|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
82954941|NCT03740399|Anesthetics|anesthetics|mesh-list
82954942|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954943|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954944|NCT05160220|Psilocybin|psilocybin|mesh-list
82954945|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
82954946|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954947|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82954948|NCT03924245|Olaparib|olaparib|mesh-list
82954949|NCT03924245|Entinostat|entinostat|mesh-list
82954950|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82954951|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954952|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954953|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954954|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82954955|NCT05647447|SR 142801|sr 142801|mesh-list
82954956|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82954957|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82954958|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82954959|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954960|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82954961|NCT01225445|Ramipril|ramipril|mesh-list
82954962|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82954963|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
82954964|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82954965|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954966|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82954967|NCT05555329|Thalidomide|thalidomide|mesh-list
82954968|NCT05555329|Pomalidomide|pomalidomide|mesh-list
82954969|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
82954970|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954971|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82954972|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82954973|NCT05555329|Growth Substances|growth substances|mesh-ancestor
82954974|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
82954975|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954976|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82954977|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
82954978|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82954979|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82954980|NCT05390710|Paclitaxel|paclitaxel|mesh-list
82954981|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82954982|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82954983|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954984|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
82954985|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
82954986|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
82954987|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82954988|NCT01228565|Cetuximab|cetuximab|mesh-list
82954989|NCT01228565|OTD70DERM|otd70derm|mesh-list
82954991|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82954992|NCT01228565|Protective Agents|protective agents|mesh-ancestor
82954993|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82954994|NCT01226849|Rituximab|rituximab|mesh-list
82954995|NCT01226849|Carboplatin|carboplatin|mesh-list
82954996|NCT01226849|Etoposide|etoposide|mesh-list
82954997|NCT01226849|Bortezomib|bortezomib|mesh-list
82954998|NCT01226849|Ifosfamide|ifosfamide|mesh-list
82954999|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955000|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955001|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
82955002|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955003|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955004|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82955005|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82955006|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82955007|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955008|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955009|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82955010|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
82955011|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
82955012|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955013|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955014|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82955015|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82955016|NCT05159674|Analgesics|analgesics|mesh-ancestor
82955017|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
82955018|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460607|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955019|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82955020|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82955021|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82955022|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955023|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955024|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955025|NCT03813979|Dolutegravir|dolutegravir|mesh-list
82955026|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82955027|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82955028|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955029|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955030|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82955031|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82955032|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
82955033|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955034|NCT05555121|Progesterone|progesterone|mesh-list
82955035|NCT05555121|Progestins|progestins|mesh-ancestor
82955036|NCT05555121|Hormones|hormones|mesh-ancestor
82955037|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82955038|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955039|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
82955040|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955041|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955042|NCT05446467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82955043|NCT05446467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955044|NCT05553613|Clopidogrel|clopidogrel|mesh-list
82955045|NCT05553613|Ticagrelor|ticagrelor|mesh-list
82955046|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82955047|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82955048|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82955049|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82955050|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
82955051|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955052|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955053|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955054|NCT03901144|Glycerol|glycerol|mesh-list
82955055|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82955056|NCT03901144|Protective Agents|protective agents|mesh-ancestor
82955057|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955058|NCT01129739|Cyclosporine|cyclosporine|mesh-list
82955059|NCT01129739|Cyclosporins|cyclosporins|mesh-list
82955060|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955061|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955062|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82955063|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
82955064|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955065|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
82955066|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955067|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
82955068|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955069|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82955070|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
82955071|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
82955072|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82955073|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955074|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460626|NCT02972294|Trace Elements|trace elements|mesh-ancestor
82955075|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955076|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955077|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82955078|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955079|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
82955080|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82955081|NCT03384693|Defibrotide|defibrotide|mesh-list
82955082|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82955083|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82955084|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955085|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82955086|NCT05533281|Dexamethasone|dexamethasone|mesh-list
82955087|NCT05533281|Metoclopramide|metoclopramide|mesh-list
82955088|NCT05533281|Tropisetron|tropisetron|mesh-list
82955089|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82955090|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
82955091|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
82955092|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955093|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955094|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955095|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
82955097|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82955098|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82955099|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955100|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82955101|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82955102|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
82955103|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955104|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955105|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82955106|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82955107|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
82955108|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
82955109|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82955110|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955111|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955112|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82955113|NCT03923075|Analgesics|analgesics|mesh-ancestor
82955114|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
82955115|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955116|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82955117|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82955118|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82955119|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955120|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955121|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955122|NCT03923231|Ritonavir|ritonavir|mesh-list
82955123|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82955124|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82955125|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82955126|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
82955127|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955128|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955129|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82955130|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82955131|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
82955132|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955133|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82955134|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82955135|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
82955136|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955138|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82955139|NCT02618980|Hemostatics|hemostatics|mesh-list
82955140|NCT02618980|Coagulants|coagulants|mesh-ancestor
82955141|NCT02613598|Bortezomib|bortezomib|mesh-list
82955142|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955143|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
82955144|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82955145|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
82955146|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82955147|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
82955148|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955149|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955150|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
82955151|NCT01225523|Paclitaxel|paclitaxel|mesh-list
82955152|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82955153|NCT01225523|Cisplatin|cisplatin|mesh-list
82955154|NCT01225523|Fluorouracil|fluorouracil|mesh-list
82955155|NCT01225523|Capecitabine|capecitabine|mesh-list
82955156|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82955157|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955158|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
82955159|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
82955160|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
82955161|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955162|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
82955163|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82955164|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82955165|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
82955166|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955167|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
82955168|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82955169|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
82955170|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955171|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
82955172|NCT03815539|Protective Agents|protective agents|mesh-ancestor
82955173|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
82955174|NCT03922919|Cefotaxime|cefotaxime|mesh-list
82955175|NCT03922919|Cefoxitin|cefoxitin|mesh-list
82955176|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82955177|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955178|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
82955179|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82955180|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955181|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955182|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82955183|NCT03813277|Analgesics|analgesics|mesh-ancestor
82955184|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
82955185|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955186|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82955187|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82955188|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82955189|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955190|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955191|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955192|NCT03815461|Paclitaxel|paclitaxel|mesh-list
82955193|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82955194|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955195|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
82955196|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
82955197|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
82955198|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955199|NCT01285102|Irinotecan|irinotecan|mesh-list
82955200|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82955201|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82955202|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955203|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955204|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955205|NCT03740243|Buprenorphine|buprenorphine|mesh-list
82955206|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82955207|NCT03740243|Naloxone|naloxone|mesh-list
82955208|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82955209|NCT03740243|Narcotics|narcotics|mesh-ancestor
82955210|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955211|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955212|NCT03740243|Analgesics|analgesics|mesh-ancestor
82955213|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
82955214|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955215|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82955216|NCT03813043|Midazolam|midazolam|mesh-list
82955217|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82955218|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83460649|NCT02983214|Cilostazol|cilostazol|mesh-list
82955219|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955220|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955221|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82955222|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82955223|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82955224|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82955225|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
82955226|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
82955227|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
82955228|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
82955229|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955230|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955231|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
82955232|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955233|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955234|NCT03382899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82955235|NCT03382899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955236|NCT03815305|Petrolatum|petrolatum|mesh-list
82955237|NCT03815305|Emollients|emollients|mesh-ancestor
82955238|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
82955239|NCT01560013|Naltrexone|naltrexone|mesh-list
82955240|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82955241|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82955242|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955243|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
82955244|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955245|NCT01302145|Metformin|metformin|mesh-list
82955246|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
82955247|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955248|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955249|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82955250|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955251|NCT01560091|Tamsulosin|tamsulosin|mesh-list
82955252|NCT01560091|Silodosin|silodosin|mesh-list
82955253|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82955254|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82955255|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82955256|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955257|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955258|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955259|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955260|NCT01560091|Urological Agents|urological agents|mesh-ancestor
82955261|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
82955262|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82955263|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955264|NCT03807271|Anesthetics|anesthetics|mesh-list
82955265|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955266|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955267|NCT03812731|Fentanyl|fentanyl|mesh-list
82955268|NCT03812731|Ropivacaine|ropivacaine|mesh-list
82955269|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
82955270|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
82955271|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955272|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955273|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
82955274|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955275|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82955276|NCT03812731|Narcotics|narcotics|mesh-ancestor
82955277|NCT03812731|Analgesics|analgesics|mesh-ancestor
82955278|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82955279|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82955280|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
82955281|NCT03351231|Nivolumab|nivolumab|mesh-list
82955282|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955283|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955284|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82955285|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955286|NCT03922373|Benzonatate|benzonatate|mesh-list
82955287|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
82955288|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
82955290|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955291|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
82955292|NCT03926663|Bupivacaine|bupivacaine|mesh-list
82955293|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
82955294|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
82955295|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955296|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955297|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
82955298|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955299|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82955300|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82955301|NCT03926663|Analgesics|analgesics|mesh-ancestor
82955302|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82955303|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82955304|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82955305|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955306|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955307|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955308|NCT05481775|Immunomodulating Agents|immunomodulating agents|mesh-list
82955309|NCT05481775|Immunologic Factors|immunologic factors|mesh-ancestor
82955310|NCT05481775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955311|NCT05165914|Midazolam|midazolam|mesh-list
82955312|NCT05165914|Anesthetics|anesthetics|mesh-list
82955313|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955314|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955315|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82955316|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82955317|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82955318|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82955319|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82955320|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82955321|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
82955322|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
82955323|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
82955324|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955325|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955326|NCT04420975|Nivolumab|nivolumab|mesh-list
82955327|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955328|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955329|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82955330|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955331|NCT01132157|Propofol|propofol|mesh-list
82955332|NCT01132157|Desflurane|desflurane|mesh-list
82955333|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82955334|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955335|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955336|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82955337|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
82955338|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
82955339|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82955340|NCT05389150|Pregabalin|pregabalin|mesh-list
82955341|NCT05389150|Tramadol|tramadol|mesh-list
82955342|NCT05389150|Analgesics|analgesics|mesh-ancestor
82955343|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
82955344|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955345|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955346|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
83460660|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
82955347|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82955348|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82955349|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955350|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82955351|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82955352|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82955353|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955354|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82955355|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82955357|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82955358|NCT03806101|Abrocitinib|abrocitinib|mesh-list
82955359|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82955360|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82955361|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
82955362|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955363|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82955365|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955366|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82955367|NCT03812419|Esomeprazole|esomeprazole|mesh-list
82955368|NCT03812419|Pantoprazole|pantoprazole|mesh-list
82955369|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82955370|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955371|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82955372|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955373|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955374|NCT01132235|Etanercept|etanercept|mesh-list
82955375|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82955376|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82955377|NCT01132235|Analgesics|analgesics|mesh-ancestor
82955378|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
82955379|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955380|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955381|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82955382|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955383|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955384|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82955385|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
82955386|NCT01131689|Sorafenib|sorafenib|mesh-list
82955387|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955388|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82955389|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955390|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955391|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
82955392|NCT03401229|Benralizumab|benralizumab|mesh-list
82955393|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82955394|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
82955395|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82955396|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82955397|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
82955398|NCT05435053|Nivolumab|nivolumab|mesh-list
82955399|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955400|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955401|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82955402|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955403|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
82955404|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
82955405|NCT05281081|Morphine|morphine|mesh-list
82955406|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
82955407|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82955408|NCT05281081|Narcotics|narcotics|mesh-ancestor
82955409|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955410|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955411|NCT05281081|Analgesics|analgesics|mesh-ancestor
82955412|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
82955413|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955414|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
82955415|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
82955416|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
82955417|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82955418|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82955419|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82955420|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82955421|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955422|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
82955423|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955424|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955425|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82955426|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955427|NCT01303237|Cetuximab|cetuximab|mesh-list
82955428|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955429|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955430|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
82955431|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82955432|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955433|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82955434|NCT01227941|Doxorubicin|doxorubicin|mesh-list
82955435|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82955436|NCT01227941|Niraparib|niraparib|mesh-list
82955437|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82955438|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955439|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82955440|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82955441|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955442|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955443|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82955444|NCT03919565|Tenofovir|tenofovir|mesh-list
82955445|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82955446|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82955447|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
82955448|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955449|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82955450|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82955451|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955452|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955453|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82955454|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82955455|NCT03380091|Vitamin D|vitamin d|mesh-list
82955456|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
82955457|NCT03380091|Metformin|metformin|mesh-list
82955458|NCT03380091|Vitamins|vitamins|mesh-ancestor
82955459|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
82955460|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955461|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955462|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82955463|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82955464|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
82955465|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955466|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955467|NCT03919253|Paclitaxel|paclitaxel|mesh-list
82955468|NCT03919253|Maleic acid|maleic acid|mesh-list
82955469|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82955470|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955471|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
82955472|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
82955473|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
82955474|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955475|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955476|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82955477|NCT05165290|Latanoprost|latanoprost|mesh-list
82955478|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82955479|NCT01132703|Glyburide|glyburide|mesh-list
82955480|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955481|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955482|NCT01377922|Amifampridine|amifampridine|mesh-list
82955483|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82955484|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955485|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955486|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82955487|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82955488|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955489|NCT03919175|Rituximab|rituximab|mesh-list
82955490|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955491|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955492|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
82955493|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955494|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955495|NCT01303471|Remifentanil|remifentanil|mesh-list
82955496|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82955497|NCT01303471|Narcotics|narcotics|mesh-ancestor
82955498|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955499|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955500|NCT01303471|Analgesics|analgesics|mesh-ancestor
82955501|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
82955502|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955503|NCT03804541|Ensartinib|ensartinib|mesh-list
82955504|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955505|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82955506|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955507|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955508|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
82955509|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955510|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955511|NCT03710811|Insulin|insulin|mesh-list
82955512|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955513|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955515|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82955517|NCT01303549|Amebicides|amebicides|mesh-ancestor
82955518|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82955519|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82955520|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955521|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82955522|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
82955523|NCT03796975|Metformin|metformin|mesh-list
82955524|NCT03796975|Pioglitazone|pioglitazone|mesh-list
82955525|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955526|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955527|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82955528|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955529|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82955530|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955531|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955532|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82955533|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955534|NCT05400070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955535|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955536|NCT01302613|Leucovorin|leucovorin|mesh-list
82955537|NCT01302613|Capecitabine|capecitabine|mesh-list
82955538|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
82955539|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82955540|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
82955541|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955542|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955543|NCT01302613|Antidotes|antidotes|mesh-ancestor
82955544|NCT01302613|Protective Agents|protective agents|mesh-ancestor
82955545|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955546|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
82955547|NCT01302613|Vitamins|vitamins|mesh-ancestor
82955548|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
82955549|NCT03803371|Acetaminophen|acetaminophen|mesh-list
82955550|NCT03803371|Tramadol|tramadol|mesh-list
82955551|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82955552|NCT03803371|Analgesics|analgesics|mesh-ancestor
82955553|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
82955554|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955555|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955556|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
82955557|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82955558|NCT03803371|Narcotics|narcotics|mesh-ancestor
82955559|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955560|NCT01130909|Ketamine|ketamine|mesh-list
82955561|NCT01130909|Analgesics|analgesics|mesh-ancestor
82955562|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
82955563|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955564|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955565|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82955566|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82955567|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
82955568|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
82955569|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955570|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82955571|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82955572|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955573|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955574|NCT03918551|Febuxostat|febuxostat|mesh-list
82955575|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
82955576|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955577|NCT04453930|Irinotecan|irinotecan|mesh-list
82955578|NCT04453930|Apatinib|apatinib|mesh-list
82955579|NCT04453930|Antibodies|antibodies|mesh-list
82955580|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
82955581|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955582|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82955583|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82955584|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955585|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955586|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955587|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82955588|NCT03796507|Temozolomide|temozolomide|mesh-list
82955589|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82955590|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
82955591|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955592|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955593|NCT04586062|Plasminogen|plasminogen|mesh-list
82955594|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82955595|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82955596|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955597|NCT01132781|Theophylline|theophylline|mesh-list
82955598|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82955599|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
82955600|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955601|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955602|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82955603|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
82955604|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82955605|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955606|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955607|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
82955608|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82955609|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82955610|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
82955611|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955612|NCT03497767|Osimertinib|osimertinib|mesh-list
82955613|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955614|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82955615|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955616|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955617|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
82955618|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82955619|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82955620|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955621|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
82955622|NCT05397652|Coagulants|coagulants|mesh-ancestor
82955623|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
82955624|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82955625|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
82955626|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955627|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955628|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82955629|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
82955630|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955631|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955632|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82955634|NCT01134341|Folic Acid|folic acid|mesh-list
82955635|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
82955636|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
82955637|NCT01134341|Bexarotene|bexarotene|mesh-list
82955638|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
82955639|NCT01134341|Aminopterin|aminopterin|mesh-list
82955640|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
82955641|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955642|NCT01134341|Hematinics|hematinics|mesh-ancestor
82955643|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955644|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82955645|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955646|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955647|NCT04308304|Donepezil|donepezil|mesh-list
82955648|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82955649|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955650|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955651|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
82955652|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955653|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955654|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
82955655|NCT05397262|Fluorouracil|fluorouracil|mesh-list
82955656|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955657|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
82955658|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955659|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82955660|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82955661|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
82955662|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955663|NCT01230359|Pyridoxine|pyridoxine|mesh-list
82955664|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
82955665|NCT01230359|Vitamins|vitamins|mesh-ancestor
82955666|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
82955667|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955668|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
82955669|NCT05591677|Cycloserine|cycloserine|mesh-list
82955670|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82955671|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955672|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82955673|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
82955674|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82955675|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
82955676|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955677|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
82955678|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955679|NCT03795571|Dexamethasone|dexamethasone|mesh-list
82955680|NCT03795571|Rituximab|rituximab|mesh-list
82955681|NCT03795571|Gemcitabine|gemcitabine|mesh-list
82955682|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
82955683|NCT03795571|Lenalidomide|lenalidomide|mesh-list
82955684|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955685|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955686|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
82955687|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955688|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955689|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82955690|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
82955691|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
82955692|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955693|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955694|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
82955695|NCT03795571|Hormones|hormones|mesh-ancestor
82955696|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82955697|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82955698|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82955699|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
82955700|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955701|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82955702|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82955703|NCT03795571|Growth Substances|growth substances|mesh-ancestor
82955704|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
82955705|NCT04280848|Temozolomide|temozolomide|mesh-list
82955706|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82955707|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
82955708|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955709|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955710|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
82955711|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82955712|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82955713|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955714|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
82955715|NCT03795649|Coagulants|coagulants|mesh-ancestor
82955716|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
82955717|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82955718|NCT04211272|Macitentan|macitentan|mesh-list
82955719|NCT04211272|Riociguat|riociguat|mesh-list
82955720|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82955721|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82955722|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
82955723|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955724|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82955725|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82955726|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955727|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
82955728|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82955729|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82955730|NCT04211272|Urological Agents|urological agents|mesh-ancestor
82955731|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82955732|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82955733|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82955734|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
82955735|NCT05402189|Fentanyl|fentanyl|mesh-list
82955736|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82955737|NCT05402189|Narcotics|narcotics|mesh-ancestor
82955738|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955739|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955740|NCT05402189|Analgesics|analgesics|mesh-ancestor
82955742|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955743|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82955744|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82955745|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
82955746|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
82955747|NCT01304563|Vaccines|vaccines|mesh-list
82955748|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
82955749|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955750|NCT01231997|Udenafil|udenafil|mesh-list
82955751|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82955752|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82955753|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955754|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955755|NCT03795805|Lidocaine|lidocaine|mesh-list
82955756|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
82955757|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
82955758|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955759|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955760|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
82955761|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955762|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82955763|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82955764|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82955765|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82955766|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955767|NCT04072042|Apatinib|apatinib|mesh-list
82955768|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955769|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82955770|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955771|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955772|NCT03799315|Nicotine|nicotine|mesh-list
82955773|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82955774|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
82955775|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955776|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955777|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82955778|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82955779|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
82955780|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955781|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955782|NCT05387200|Alendronate|alendronate|mesh-list
82955783|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82955784|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955785|NCT05386810|Vaccines|vaccines|mesh-list
82955786|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
82955787|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955788|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
82955789|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82955790|NCT04910269|Antibodies|antibodies|mesh-list
82955791|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
82955792|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955793|NCT03442972|Teduglutide|teduglutide|mesh-list
82955794|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955795|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82955796|NCT03442972|Protective Agents|protective agents|mesh-ancestor
82955797|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955798|NCT03921671|Paclitaxel|paclitaxel|mesh-list
82955799|NCT03921671|Carboplatin|carboplatin|mesh-list
82955800|NCT03921671|Ramucirumab|ramucirumab|mesh-list
82955801|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82955802|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955803|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
82955804|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
82955805|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
82955806|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955808|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955809|NCT03369951|Minocycline|minocycline|mesh-list
82955810|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82955811|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955812|NCT01131767|Naproxen|naproxen|mesh-list
82955813|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
82955814|NCT01131767|Ephedrine|ephedrine|mesh-list
82955815|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82955816|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82955817|NCT01131767|Analgesics|analgesics|mesh-ancestor
82955818|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
82955819|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955820|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955821|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82955822|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82955823|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
82955824|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82955825|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955826|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955827|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82955828|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
82955829|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82955830|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
82955831|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
82955832|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82955833|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82955834|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
82955835|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955836|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955837|NCT03795259|Rocuronium|rocuronium|mesh-list
82955838|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82955839|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82955840|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82955841|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955842|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955843|NCT01229189|Vitamin D|vitamin d|mesh-list
82955844|NCT01229189|Vitamins|vitamins|mesh-ancestor
82955845|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
82955846|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955847|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82955848|NCT05481489|Atropine|atropine|mesh-list
82955849|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82955850|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82955851|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82955852|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
82955853|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955854|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955855|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82955856|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
82955857|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
82955858|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
82955859|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82955860|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82955861|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
82955862|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955863|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955864|NCT05341180|Lactulose|lactulose|mesh-list
82955865|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82955866|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82955867|NCT01133483|Fexofenadine|fexofenadine|mesh-list
82955868|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
82955869|NCT01133483|Ephedrine|ephedrine|mesh-list
82955870|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82955871|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
82955872|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955873|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955874|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82955875|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
82955876|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
82955877|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82955878|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82955879|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
82955880|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
82955881|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955882|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955883|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82955884|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82955885|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82955886|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
82955887|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
82955888|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
82955889|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
82955890|NCT05401721|Coagulants|coagulants|mesh-ancestor
82955891|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82955892|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82955893|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
82955894|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955895|NCT01560481|Metformin|metformin|mesh-list
82955896|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83460735|NCT04393220|Nivolumab|nivolumab|mesh-list
82955897|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955898|NCT04795531|Insulin|insulin|mesh-list
82955899|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82955900|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
82955901|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82955902|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955903|NCT05238844|Tenofovir|tenofovir|mesh-list
82955904|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
82955905|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955906|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82955907|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82955908|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955909|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955910|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82955911|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82955912|NCT04785625|Bupivacaine|bupivacaine|mesh-list
82955913|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
82955914|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
82955915|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955916|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955917|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
82955918|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955919|NCT03368859|Leucovorin|leucovorin|mesh-list
82955920|NCT03368859|Bevacizumab|bevacizumab|mesh-list
82955921|NCT03368859|Fluorouracil|fluorouracil|mesh-list
82955922|NCT03368859|Irinotecan|irinotecan|mesh-list
82955923|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82955924|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955925|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82955926|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82955927|NCT03368859|Growth Substances|growth substances|mesh-ancestor
82955928|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955929|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
82955930|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
82955931|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955932|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82955933|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82955934|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
82955935|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82955936|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82955937|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955938|NCT03368859|Antidotes|antidotes|mesh-ancestor
82955939|NCT03368859|Protective Agents|protective agents|mesh-ancestor
82955940|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
82955941|NCT03368859|Vitamins|vitamins|mesh-ancestor
82955942|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
82955943|NCT01134965|Digoxin|digoxin|mesh-list
82955944|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82955945|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82955946|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955947|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955948|NCT01134965|Protective Agents|protective agents|mesh-ancestor
82955949|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955950|NCT03810547|Ketamine|ketamine|mesh-list
82955951|NCT03810547|Propofol|propofol|mesh-list
82955952|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82955953|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82955954|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955955|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82955956|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
82955957|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
82955958|NCT03810547|Analgesics|analgesics|mesh-ancestor
82955959|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
82955960|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82955961|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82955962|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82955963|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82955964|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955965|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955966|NCT03096314|Vitamin D|vitamin d|mesh-list
82955967|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
82955968|NCT03096314|Vitamins|vitamins|mesh-ancestor
82955969|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
82955970|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82955971|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82955972|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82955973|NCT03917459|Enalapril|enalapril|mesh-list
82955974|NCT03917459|Enalaprilat|enalaprilat|mesh-list
82955975|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82955976|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82955977|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
82955978|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82955979|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955980|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82955981|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82955982|NCT03129646|Paromomycin|paromomycin|mesh-list
82955983|NCT03129646|Miltefosine|miltefosine|mesh-list
82955984|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
82955985|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82955986|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82955987|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82955988|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82955989|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
82955990|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82955991|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
82955992|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82955993|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
82955994|NCT03710655|Histamine|histamine|mesh-list
82955995|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
82955996|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
82955997|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82955998|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82955999|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956000|NCT01135199|Pomalidomide|pomalidomide|mesh-list
82956001|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
82956002|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956003|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82956004|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82956005|NCT01135199|Growth Substances|growth substances|mesh-ancestor
82956006|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
82956007|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956008|NCT03917537|Nivolumab|nivolumab|mesh-list
82956009|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956010|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956011|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82956012|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956013|NCT03335163|Topiramate|topiramate|mesh-list
82956014|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
82956015|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82956016|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956017|NCT04749602|Nivolumab|nivolumab|mesh-list
82956018|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956019|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956020|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82956021|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956022|NCT03461302|Coal Tar|coal tar|mesh-list
82956023|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
82956024|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956025|NCT01232075|Letrozole|letrozole|mesh-list
82956026|NCT01232075|Citric Acid|citric acid|mesh-list
82956027|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
82956028|NCT01232075|Clomiphene|clomiphene|mesh-list
82956029|NCT01232075|Enclomiphene|enclomiphene|mesh-list
82956030|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
82956031|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
82956032|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82956033|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
82956034|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
83221001|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956035|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956036|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956037|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82956038|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82956039|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956040|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82956041|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
82956042|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956043|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956044|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82956045|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
82956046|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82956047|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82956048|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82956049|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
82956050|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956051|NCT01131845|Treprostinil|treprostinil|mesh-list
82956052|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82956053|NCT03711422|Afatinib|afatinib|mesh-list
82956054|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956055|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956056|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956057|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956058|NCT03460678|Pemetrexed|pemetrexed|mesh-list
82956059|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82956060|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956061|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956062|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956063|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82956064|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82956065|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956066|NCT03810391|Butorphanol|butorphanol|mesh-list
82956067|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82956068|NCT03810391|Narcotics|narcotics|mesh-ancestor
82956069|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956070|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956071|NCT03810391|Analgesics|analgesics|mesh-ancestor
82956072|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
82956073|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956074|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
82956075|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
82956076|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82956077|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
82956078|NCT01229579|Astringents|astringents|mesh-ancestor
82956079|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956080|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956081|NCT01131923|Amlodipine|amlodipine|mesh-list
82956082|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82956083|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82956084|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82956085|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956086|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82956087|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956088|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
82956089|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
82956090|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
82956091|NCT01230983|Leucovorin|leucovorin|mesh-list
82956092|NCT01230983|Cytarabine|cytarabine|mesh-list
82956093|NCT01230983|Prednisone|prednisone|mesh-list
82956094|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
82956095|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82956096|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82956097|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82956098|NCT01230983|Doxorubicin|doxorubicin|mesh-list
82956099|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82956100|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
82956101|NCT01230983|Methotrexate|methotrexate|mesh-list
82956102|NCT01230983|Vincristine|vincristine|mesh-list
82956103|NCT01230983|Asparaginase|asparaginase|mesh-list
82956104|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
82956105|NCT01230983|Razoxane|razoxane|mesh-list
82956106|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
82956107|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82956108|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956109|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82956110|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82956111|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956112|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956113|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956114|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956115|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
82956116|NCT01230983|Hormones|hormones|mesh-ancestor
82956117|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956118|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82956119|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82956120|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
82956121|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82956122|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956123|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
82956124|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956125|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82956126|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956127|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
82956128|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956129|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82956130|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
82956131|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956132|NCT01230983|Antidotes|antidotes|mesh-ancestor
82956133|NCT01230983|Protective Agents|protective agents|mesh-ancestor
82956134|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
82956135|NCT01230983|Vitamins|vitamins|mesh-ancestor
82956136|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
82956137|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82956138|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
82956139|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
82956140|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
82956141|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82956142|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
82956143|NCT01304797|Trastuzumab|trastuzumab|mesh-list
82956144|NCT01304797|Doxorubicin|doxorubicin|mesh-list
82956145|NCT01304797|Gancotamab|gancotamab|mesh-list
82956146|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
82956147|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956148|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
82956149|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956150|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956151|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82956152|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
82956153|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956154|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956155|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82956156|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956157|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82956158|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82956159|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82956160|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956161|NCT03707535|Infliximab|infliximab|mesh-list
82956162|NCT03707535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82956163|NCT03707535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956164|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956165|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956166|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956167|NCT01133795|Midodrine|midodrine|mesh-list
82956168|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
82956169|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
82956170|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956171|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956172|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82956173|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82956174|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82956175|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82956176|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
82956177|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83460755|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956178|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956179|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
82956180|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
82956181|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82956182|NCT01133873|Narcotics|narcotics|mesh-ancestor
82956183|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956184|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956185|NCT01133873|Analgesics|analgesics|mesh-ancestor
82956186|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
82956187|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956188|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
82956189|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
82956190|NCT01229813|Bevacizumab|bevacizumab|mesh-list
82956191|NCT01229813|Capecitabine|capecitabine|mesh-list
82956192|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82956193|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956194|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956195|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82956196|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82956197|NCT01229813|Growth Substances|growth substances|mesh-ancestor
82956198|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956200|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956201|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
82956202|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956203|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956204|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956205|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
82956206|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
82956207|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956208|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956209|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956210|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956211|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
82956212|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956213|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82956214|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956215|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
82956216|NCT01649947|Paclitaxel|paclitaxel|mesh-list
82956217|NCT01649947|Bevacizumab|bevacizumab|mesh-list
82956218|NCT01649947|Carboplatin|carboplatin|mesh-list
82956219|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82956220|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956221|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
82956222|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
82956223|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
82956224|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956225|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956226|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82956227|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82956228|NCT01649947|Growth Substances|growth substances|mesh-ancestor
82956229|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956230|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
82956231|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
82956232|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82956233|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82956234|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956235|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956236|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956237|NCT03793075|Ketamine|ketamine|mesh-list
82956238|NCT03793075|Propofol|propofol|mesh-list
82956239|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82956240|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956241|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956242|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82956243|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
82956244|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
82956245|NCT03793075|Analgesics|analgesics|mesh-ancestor
82956246|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
82956247|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956248|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82956249|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82956250|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82956251|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956252|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956253|NCT01233167|Clopidogrel|clopidogrel|mesh-list
82956254|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82956255|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82956256|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82956257|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82956258|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
82956259|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956260|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956261|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956262|NCT01304095|Ranolazine|ranolazine|mesh-list
82956263|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82956264|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82956265|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956267|NCT03707457|Ipilimumab|ipilimumab|mesh-list
82956268|NCT03707457|MK-4166|mk-4166|mesh-list
82956269|NCT03707457|Antibodies|antibodies|mesh-list
82956270|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82956271|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
82956273|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956274|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956275|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82956276|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956277|NCT01568294|Pomalidomide|pomalidomide|mesh-list
82956278|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
82956279|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956280|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82956281|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82956282|NCT01568294|Growth Substances|growth substances|mesh-ancestor
82956283|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
82956284|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956285|NCT03422666|Teduglutide|teduglutide|mesh-list
82956286|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956287|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82956288|NCT03422666|Protective Agents|protective agents|mesh-ancestor
82956289|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956290|NCT03453190|Apremilast|apremilast|mesh-list
82956291|NCT03453190|Clobetasol|clobetasol|mesh-list
82956292|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82956293|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82956294|NCT03453190|Analgesics|analgesics|mesh-ancestor
82956295|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
82956296|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956297|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956298|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956299|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956300|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82956301|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82956302|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956303|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956304|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
82956305|NCT03453190|Hormones|hormones|mesh-ancestor
82956306|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956307|NCT01231139|Acetaminophen|acetaminophen|mesh-list
82956308|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82956309|NCT01231139|Analgesics|analgesics|mesh-ancestor
82956310|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
82956311|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956312|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956313|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
82956314|NCT03382574|Denosumab|denosumab|mesh-list
82956315|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82956316|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956317|NCT01137695|Pramlintide|pramlintide|mesh-list
82956318|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
82956319|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82956320|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956321|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
82956322|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82956323|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
82956324|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956325|NCT03451396|Lifitegrast|lifitegrast|mesh-list
82956326|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82956327|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82956328|NCT02528825|Remifentanil|remifentanil|mesh-list
82956329|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82956330|NCT02528825|Narcotics|narcotics|mesh-ancestor
82956331|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956332|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956333|NCT02528825|Analgesics|analgesics|mesh-ancestor
82956334|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
82956335|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956336|NCT01233245|Interferons|interferons|mesh-list
82956337|NCT01233245|Interferon-beta|interferon-beta|mesh-list
82956338|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
82956339|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956340|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
82956341|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956342|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
82956343|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956344|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82956345|NCT03776812|Paclitaxel|paclitaxel|mesh-list
82956346|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82956347|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82956348|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956349|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
82956350|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
82956351|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
82956352|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956353|NCT03361605|Propofol|propofol|mesh-list
82956354|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82956355|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956356|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956357|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82956358|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
82956359|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
82956360|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
82956361|NCT03794167|Melphalan|melphalan|mesh-list
82956362|NCT03794167|Busulfan|busulfan|mesh-list
82956363|NCT03794167|Etoposide|etoposide|mesh-list
82956364|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956365|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
82956366|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956367|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956368|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82956369|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
82956370|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956371|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956372|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82956373|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82956374|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82956375|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82956376|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956377|NCT05332821|Bevacizumab|bevacizumab|mesh-list
82956378|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82956379|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956380|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956381|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82956382|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82956383|NCT05332821|Growth Substances|growth substances|mesh-ancestor
82956384|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956385|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
82956386|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956387|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
82956388|NCT05331651|Tropisetron|tropisetron|mesh-list
82956389|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82956390|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82956391|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82956392|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
82956393|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956394|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956395|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956396|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
82956397|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
82956398|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956399|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956400|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82956401|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82956402|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
82956403|NCT01134185|Prucalopride|prucalopride|mesh-list
82956404|NCT01134185|Laxatives|laxatives|mesh-ancestor
82956405|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956406|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
82956407|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82956408|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
82956409|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956410|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956411|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956412|NCT03829046|Evolocumab|evolocumab|mesh-list
82956413|NCT03829046|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82956414|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82956415|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82956416|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
82956417|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956418|NCT03829046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82956419|NCT03829046|Protease Inhibitors|protease inhibitors|mesh-ancestor
82956420|NCT03829046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956421|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82956423|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956424|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956425|NCT05320588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82956426|NCT05320588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956427|NCT01231529|Dolutegravir|dolutegravir|mesh-list
82956428|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82956429|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82956430|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956431|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956432|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82956433|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82956434|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
82956435|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956436|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82956437|NCT05306704|Calcifediol|calcifediol|mesh-list
82956438|NCT05306704|Vitamins|vitamins|mesh-ancestor
82956439|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
82956440|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956441|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82956442|NCT01231685|Ritonavir|ritonavir|mesh-list
82956443|NCT01231685|Lopinavir|lopinavir|mesh-list
82956444|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82956445|NCT01231685|Darunavir|darunavir|mesh-list
82956446|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
82956447|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
82956448|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
82956449|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82956450|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956451|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956452|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82956453|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82956454|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
82956455|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956456|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82956457|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82956458|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82956459|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82956460|NCT05402735|Uric Acid|uric acid|mesh-list
82956461|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
82956462|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956463|NCT05402735|Protective Agents|protective agents|mesh-ancestor
82956464|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956465|NCT01138085|Trametinib|trametinib|mesh-list
82956466|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956467|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956468|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956469|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956470|NCT05278858|Triamcinolone|triamcinolone|mesh-list
82956471|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956472|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
82956473|NCT05278858|Hormones|hormones|mesh-ancestor
82956474|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956475|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956476|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82956477|NCT03792217|Eusol|eusol|mesh-list
82956478|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
82956479|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956480|NCT03359811|Bupivacaine|bupivacaine|mesh-list
82956481|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
82956482|NCT03359811|Anesthetics|anesthetics|mesh-list
82956483|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956484|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956485|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
82956486|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956487|NCT03728426|Letermovir|letermovir|mesh-list
82956488|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82956489|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956490|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956491|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956492|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
82956493|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956494|NCT01140581|Dronedarone|dronedarone|mesh-list
82956495|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82956496|NCT03792139|Itraconazole|itraconazole|mesh-list
82956497|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
82956498|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956499|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82956500|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82956501|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956502|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956503|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82956504|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
82956505|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956506|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956507|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82956508|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82956509|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
82956510|NCT04664738|Coagulants|coagulants|mesh-ancestor
82956511|NCT03792295|Acetaminophen|acetaminophen|mesh-list
82956513|NCT03792295|Oxycodone|oxycodone|mesh-list
82956514|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82956515|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82956516|NCT03792295|Analgesics|analgesics|mesh-ancestor
82956517|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
82956518|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956519|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956520|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956521|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956522|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82956523|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956524|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956525|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82956526|NCT03792295|Narcotics|narcotics|mesh-ancestor
82956527|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956528|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
82956529|NCT03449056|Albuterol|albuterol|mesh-list
82956530|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82956531|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
82956532|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956533|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956534|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82956535|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
82956536|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
82956537|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82956538|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82956539|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82956540|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82956541|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
82956542|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956543|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956544|NCT01135433|Metformin|metformin|mesh-list
82956545|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
82956546|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82956547|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956548|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82956549|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956550|NCT04745273|Ondansetron|ondansetron|mesh-list
82956551|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
82956552|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
82956553|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956554|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956555|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956556|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
82956557|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956558|NCT04745273|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82956559|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82956560|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
82956561|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956562|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956563|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
82956564|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82956565|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
82956566|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956567|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
82956568|NCT01305187|Protective Agents|protective agents|mesh-ancestor
82956569|NCT01138397|Vaccines|vaccines|mesh-list
82956570|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
82956571|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956572|NCT03448744|Entecavir|entecavir|mesh-list
82956573|NCT03448744|Thymalfasin|thymalfasin|mesh-list
82956574|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
82956575|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956576|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82956577|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
82956578|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956579|NCT03448588|Selenium|selenium|mesh-list
82956580|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
82956581|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956582|NCT03448588|Protective Agents|protective agents|mesh-ancestor
82956583|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956584|NCT03448588|Trace Elements|trace elements|mesh-ancestor
82956585|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
82956586|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
82956587|NCT03797443|Paclitaxel|paclitaxel|mesh-list
82956588|NCT03797443|Gemcitabine|gemcitabine|mesh-list
82956589|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82956590|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956591|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
82956592|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
82956593|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
82956594|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956595|NCT03797443|Vitamins|vitamins|mesh-ancestor
82956596|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
82956597|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956598|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956599|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
82956600|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
82956601|NCT03797443|Protective Agents|protective agents|mesh-ancestor
82956602|NCT01135589|Micafungin|micafungin|mesh-list
82956603|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
82956604|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956605|NCT01915810|Nicotine|nicotine|mesh-list
82956606|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82956607|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
82956608|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956609|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956610|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82956611|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82956612|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
82956613|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956614|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956615|NCT01140737|Axitinib|axitinib|mesh-list
82956616|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956617|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956618|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956619|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956620|NCT05594095|Everolimus|everolimus|mesh-list
82956621|NCT05594095|Fulvestrant|fulvestrant|mesh-list
82956622|NCT05594095|Goserelin|goserelin|mesh-list
82956623|NCT05594095|Fluzoparib|fluzoparib|mesh-list
82956624|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82956625|NCT05594095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82956626|NCT05594095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956627|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956628|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956629|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956630|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
82956631|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956632|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956633|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82956634|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82956635|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82956636|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
82956637|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956638|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82956639|NCT05594095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82956640|NCT04951063|Immunomodulating Agents|immunomodulating agents|mesh-list
82956641|NCT04951063|Immunologic Factors|immunologic factors|mesh-ancestor
82956642|NCT04951063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956643|NCT05624671|Fentanyl|fentanyl|mesh-list
82956644|NCT05624671|Bupivacaine|bupivacaine|mesh-list
82956645|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
82956646|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
82956647|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956648|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956649|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
82956650|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956651|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82956652|NCT05624671|Narcotics|narcotics|mesh-ancestor
82956653|NCT05624671|Analgesics|analgesics|mesh-ancestor
82956654|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82956655|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82956656|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
82956657|NCT03578965|Cefazolin|cefazolin|mesh-list
82956658|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82956659|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956660|NCT03791905|Leucovorin|leucovorin|mesh-list
82956661|NCT03791905|Paclitaxel|paclitaxel|mesh-list
82956662|NCT03791905|Fluorouracil|fluorouracil|mesh-list
82956663|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
82956664|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82956665|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956666|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
82956667|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
82956668|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
82956669|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956670|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
82956671|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956672|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956673|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
82956674|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956675|NCT03791905|Antidotes|antidotes|mesh-ancestor
82956676|NCT03791905|Protective Agents|protective agents|mesh-ancestor
82956677|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
82956678|NCT03791905|Vitamins|vitamins|mesh-ancestor
82956679|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
82956680|NCT01138553|Mifepristone|mifepristone|mesh-list
82956681|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82956682|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
82956683|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82956684|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956685|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82956686|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82956687|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82956688|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
82956689|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82956690|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82956691|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
82956692|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956693|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
82956694|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82956695|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82956696|NCT05171374|Trametinib|trametinib|mesh-list
82956697|NCT05171374|Dabrafenib|dabrafenib|mesh-list
82956698|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956699|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956700|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956701|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956702|NCT03447184|Androgens|androgens|mesh-list
82956703|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82956704|NCT03447184|Hormones|hormones|mesh-ancestor
82956705|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956706|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956707|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82956708|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956709|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956710|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82956711|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
82956712|NCT03739541|Benzonidazole|benzonidazole|mesh-list
82956713|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956714|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
82956715|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956716|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82956717|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82956718|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82956719|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956720|NCT01135667|Clopidogrel|clopidogrel|mesh-list
82956721|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82956722|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82956723|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82956724|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82956725|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82956727|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956728|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956729|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956730|NCT03446872|Leucovorin|leucovorin|mesh-list
82956731|NCT03446872|Fluorouracil|fluorouracil|mesh-list
82956732|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
82956733|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956734|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956735|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956736|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956737|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
82956738|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956739|NCT03446872|Antidotes|antidotes|mesh-ancestor
82956740|NCT03446872|Protective Agents|protective agents|mesh-ancestor
82956741|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
82956742|NCT03446872|Vitamins|vitamins|mesh-ancestor
82956743|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
82956744|NCT03446638|Cytarabine|cytarabine|mesh-list
82956745|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956746|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
82956747|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956748|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956749|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
82956750|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956751|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956752|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
82956753|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956754|NCT05401019|Pramipexole|pramipexole|mesh-list
82956755|NCT05401019|Risperidone|risperidone|mesh-list
82956756|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82956757|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
82956758|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956759|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956760|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956761|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82956762|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82956763|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956764|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82956765|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82956766|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
82956767|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
82956768|NCT05401019|Protective Agents|protective agents|mesh-ancestor
82956769|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82956770|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82956771|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
82956772|NCT03788863|Diflucortolone|diflucortolone|mesh-list
82956773|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
82956774|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956775|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
82956776|NCT03788863|Hormones|hormones|mesh-ancestor
82956777|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956778|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956779|NCT04659161|Xanomeline|xanomeline|mesh-list
82956780|NCT04659161|Trospium chloride|trospium chloride|mesh-list
82956781|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
82956782|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
82956783|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956784|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956785|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82956786|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82956787|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
82956788|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956789|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956790|NCT04659161|Urological Agents|urological agents|mesh-ancestor
82956791|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82956792|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82956793|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82956794|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82956795|NCT03129256|Apatinib|apatinib|mesh-list
82956796|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956797|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82956798|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956799|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956800|NCT05682807|Caffeine|caffeine|mesh-list
82956801|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82956802|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956803|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82956804|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956805|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956806|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82956807|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82956808|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
82956809|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956811|NCT05313009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82956812|NCT05313009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956813|NCT05313009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956814|NCT05313009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956815|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
82956816|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
82956817|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
82956818|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956819|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956820|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
82956821|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956822|NCT05364099|Triamcinolone|triamcinolone|mesh-list
82956823|NCT05364099|Lidocaine|lidocaine|mesh-list
82956824|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
82956825|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
82956826|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956827|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956828|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
82956829|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956830|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82956831|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82956832|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82956833|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82956834|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956835|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956836|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
82956837|NCT05364099|Hormones|hormones|mesh-ancestor
82956838|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956839|NCT03445702|Metformin|metformin|mesh-list
82956840|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82956841|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956842|NCT03445624|Infliximab|infliximab|mesh-list
82956843|NCT03445624|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82956844|NCT03445624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956845|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956846|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956847|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956848|NCT01312077|Morphine|morphine|mesh-list
82956849|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
82956850|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82956851|NCT01312077|Narcotics|narcotics|mesh-ancestor
82956852|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956853|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956854|NCT01312077|Analgesics|analgesics|mesh-ancestor
82956855|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
82956856|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956857|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
82956858|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
82956859|NCT03793309|Vitamin D|vitamin d|mesh-list
82956860|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
82956861|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
82956862|NCT03793309|Vitamins|vitamins|mesh-list
82956863|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
82956864|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956865|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82956866|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82956867|NCT01140893|Exenatide|exenatide|mesh-list
82956868|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82956869|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956870|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82956871|NCT01140893|Incretins|incretins|mesh-ancestor
82956872|NCT01140893|Hormones|hormones|mesh-ancestor
82956873|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956875|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
82956876|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956877|NCT03791827|Cyclosporine|cyclosporine|mesh-list
82956878|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
82956879|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
82956880|NCT03791827|Prednisone|prednisone|mesh-list
82956881|NCT03791827|Prednisolone|prednisolone|mesh-list
82956882|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
82956883|NCT03791827|Rituximab|rituximab|mesh-list
82956884|NCT03791827|Azathioprine|azathioprine|mesh-list
82956885|NCT03791827|Tacrolimus|tacrolimus|mesh-list
82956886|NCT03791827|Cyclosporins|cyclosporins|mesh-list
82956887|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956888|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
82956889|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956890|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956891|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82956892|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
82956893|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956894|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956895|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82956896|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82956897|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956898|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
82956899|NCT03791827|Hormones|hormones|mesh-ancestor
82956900|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956901|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82956902|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82956903|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956904|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
82956905|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956906|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956907|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82956908|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82956909|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
82956910|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82956911|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
82956912|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82956913|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82956914|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
82956915|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956916|NCT03708861|Ritonavir|ritonavir|mesh-list
82956917|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82956918|NCT03708861|Maraviroc|maraviroc|mesh-list
82956919|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82956920|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82956921|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
82956922|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956923|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956924|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82956925|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82956926|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
82956927|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82956928|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82956929|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82956930|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82956931|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82956932|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82956933|NCT04798755|Adalimumab|adalimumab|mesh-list
82956934|NCT04798755|Methotrexate|methotrexate|mesh-list
82956935|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82956936|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
82956937|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82956938|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956939|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82956940|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
82956941|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956942|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956943|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
82956944|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82956945|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82956946|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82956947|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
82956948|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82956949|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82956950|NCT04798755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82956951|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82956953|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82956954|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82956955|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
82956956|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
82956957|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
82956958|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956959|NCT03445078|Selenium|selenium|mesh-list
82956960|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
82956961|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956962|NCT03445078|Protective Agents|protective agents|mesh-ancestor
82956963|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956964|NCT03445078|Trace Elements|trace elements|mesh-ancestor
82956965|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
82956966|NCT01233791|Diazepam|diazepam|mesh-list
82956967|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82956968|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
82956969|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
82956970|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
82956971|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82956972|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956973|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956974|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82956975|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82956976|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82956977|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82956978|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82956979|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82956980|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82956981|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82956982|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
82956983|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
82956984|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
82956985|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
82956986|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82956987|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82956988|NCT01140971|Misoprostol|misoprostol|mesh-list
82956989|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82956990|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
82956991|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82956992|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956993|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82956994|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82956995|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
82956996|NCT01306357|Hormones|hormones|mesh-list
82956997|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82956998|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82956999|NCT03129022|Anesthetics|anesthetics|mesh-list
82957000|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957001|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957002|NCT03342963|Aripiprazole|aripiprazole|mesh-list
82957003|NCT03342963|Sertraline|sertraline|mesh-list
82957004|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
82957005|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82957006|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82957007|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82957008|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957009|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957010|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
82957011|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
82957012|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957013|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957014|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82957015|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82957016|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
82957017|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82957018|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82957019|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82957020|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82957021|NCT03342963|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82957022|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82957023|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82957024|NCT03706755|Norepinephrine|norepinephrine|mesh-list
82957025|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82957026|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82957027|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
82957028|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957029|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957030|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957031|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
82957032|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
82957033|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957034|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82957035|NCT03791515|Calcitonin|calcitonin|mesh-list
82957036|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
82957037|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82957038|NCT03791515|Katacalcin|katacalcin|mesh-list
82957039|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82957040|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957041|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82957042|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
82957043|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
82957044|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
82957045|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957046|NCT04595591|Remifentanil|remifentanil|mesh-list
82957047|NCT04595591|Rocuronium|rocuronium|mesh-list
82957048|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82957049|NCT04595591|Narcotics|narcotics|mesh-ancestor
82957050|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957051|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957052|NCT04595591|Analgesics|analgesics|mesh-ancestor
82957053|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
82957054|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957055|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82957056|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82957057|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82957058|NCT03709953|Apatinib|apatinib|mesh-list
82957059|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957060|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82957061|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957062|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957063|NCT03444142|Exenatide|exenatide|mesh-list
82957064|NCT03444142|Dulaglutide|dulaglutide|mesh-list
82957065|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82957066|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957067|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82957068|NCT03444142|Incretins|incretins|mesh-ancestor
82957069|NCT03444142|Hormones|hormones|mesh-ancestor
82957070|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957071|NCT01305733|Ketorolac|ketorolac|mesh-list
82957072|NCT01305733|Epinephrine|epinephrine|mesh-list
82957073|NCT01305733|Racepinephrine|racepinephrine|mesh-list
82957074|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
82957075|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
82957076|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82957077|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82957078|NCT01305733|Analgesics|analgesics|mesh-ancestor
82957079|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
82957080|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957081|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957082|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82957083|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82957084|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82957085|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957086|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957087|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
82957088|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
82957089|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957090|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82957091|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82957092|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
82957093|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957094|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82957095|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82957096|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
82957097|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82957098|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
82957099|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
82957100|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
82957101|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82957102|NCT05210153|Sertraline|sertraline|mesh-list
83460822|NCT02565186|Lasmiditan|lasmiditan|mesh-list
82957103|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
82957105|NCT05210153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82957106|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82957107|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82957108|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957109|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957110|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
82957111|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957112|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
82957113|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
82957114|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82957115|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82957116|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957117|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82957118|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
82957119|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82957120|NCT04749459|Protective Agents|protective agents|mesh-ancestor
82957121|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957122|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
82957123|NCT04585295|Betaine|betaine|mesh-list
82957124|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957125|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
82957126|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82957127|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
82957128|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957129|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82957130|NCT01136213|Fluoxetine|fluoxetine|mesh-list
82957131|NCT01136213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82957132|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82957133|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82957134|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957135|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957136|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
82957137|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957138|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82957139|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
82957140|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82957141|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82957142|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82957143|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957144|NCT03361176|Triamcinolone|triamcinolone|mesh-list
82957145|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82957146|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82957147|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
82957148|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82957149|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82957150|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
82957151|NCT03361176|Hormones|hormones|mesh-ancestor
82957152|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957153|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957154|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82957155|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
82957156|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957157|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957158|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82957159|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957160|NCT03438214|Vancomycin|vancomycin|mesh-list
82957161|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82957162|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957163|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
82957164|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82957165|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82957166|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957167|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
82957168|NCT01141127|Coagulants|coagulants|mesh-ancestor
82957169|NCT04613206|Vaccines|vaccines|mesh-list
82957170|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
82957171|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957172|NCT03708822|Docetaxel|docetaxel|mesh-list
82957173|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
82957174|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957176|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
82957177|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
82957178|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957179|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957181|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82957182|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957183|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82957184|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82957185|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957186|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957187|NCT01308541|Propofol|propofol|mesh-list
82957188|NCT01308541|Fospropofol|fospropofol|mesh-list
82957189|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82957190|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957191|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957192|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82957193|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
82957194|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
82957195|NCT05679765|Dexamethasone|dexamethasone|mesh-list
82957196|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
82957197|NCT05679765|Lidocaine|lidocaine|mesh-list
82957198|NCT05679765|BB 1101|bb 1101|mesh-list
82957199|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82957200|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
82957201|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
82957202|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957203|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957204|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957205|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
82957206|NCT05679765|Hormones|hormones|mesh-ancestor
82957207|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957208|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82957209|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957210|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
82957211|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957212|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957213|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
82957214|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
82957215|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957216|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
82957217|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82957218|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82957219|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82957220|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82957221|NCT03437980|Propofol|propofol|mesh-list
82957222|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82957223|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957224|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957225|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82957226|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
82957227|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
82957228|NCT05176119|Ketamine|ketamine|mesh-list
82957229|NCT05176119|Nalbuphine|nalbuphine|mesh-list
82957230|NCT05176119|Analgesics|analgesics|mesh-ancestor
82957231|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
82957232|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957233|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957234|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82957235|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82957236|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
82957237|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
82957238|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957239|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82957240|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82957241|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957242|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957243|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82957244|NCT05176119|Narcotics|narcotics|mesh-ancestor
82957245|NCT03437902|Vitamins|vitamins|mesh-list
82957246|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
82957247|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
82957248|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957249|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
82957250|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957252|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
82957254|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
82957255|NCT05283499|Narcotics|narcotics|mesh-ancestor
82957256|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957257|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957258|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
82957259|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957260|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
82957261|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
82957263|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
82957264|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957265|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
82957266|NCT03437824|Hematinics|hematinics|mesh-ancestor
82957267|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
82957268|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
82957269|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82957270|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82957271|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
82957272|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957273|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957274|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957275|NCT01136525|Valacyclovir|valacyclovir|mesh-list
82957276|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
82957277|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957278|NCT05632445|Apixaban|apixaban|mesh-list
82957279|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82957280|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
82957281|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82957282|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
82957283|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957284|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957285|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
82957286|NCT04422652|Bupropion|bupropion|mesh-list
82957287|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82957288|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
82957289|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82957290|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82957291|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82957292|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82957293|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957294|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
82957295|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957296|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957297|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82957298|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82957299|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957300|NCT01235117|Azacitidine|azacitidine|mesh-list
82957301|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82957302|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
82957303|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957304|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957305|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957306|NCT01306591|Bevacizumab|bevacizumab|mesh-list
82957307|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957308|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957309|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82957310|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82957311|NCT01306591|Growth Substances|growth substances|mesh-ancestor
82957312|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957313|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
82957314|NCT03098030|Irinotecan|irinotecan|mesh-list
82957315|NCT03098030|Topotecan|topotecan|mesh-list
82957316|NCT03098030|Dinutuximab|dinutuximab|mesh-list
82957317|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82957318|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82957319|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957320|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957321|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957322|NCT01233947|Fulvestrant|fulvestrant|mesh-list
82957323|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82957324|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957325|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82957327|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
82957328|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957329|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957330|NCT01139645|Esomeprazole|esomeprazole|mesh-list
82957331|NCT01139645|Rabeprazole|rabeprazole|mesh-list
82957332|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82957333|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957334|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82957335|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957336|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957337|NCT03706287|Cisplatin|cisplatin|mesh-list
82957338|NCT03706287|Carboplatin|carboplatin|mesh-list
82957339|NCT03706287|Pemetrexed|pemetrexed|mesh-list
82957340|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957341|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957342|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957343|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82957344|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82957345|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82957346|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957347|NCT05107193|Afatinib|afatinib|mesh-list
82957348|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957349|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82957350|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957351|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957352|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82957353|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82957354|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
82957355|NCT02522650|Amiloride|amiloride|mesh-list
82957356|NCT02522650|Triamterene|triamterene|mesh-list
82957357|NCT02522650|Diuretics|diuretics|mesh-ancestor
82957358|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
82957359|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957360|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82957361|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82957362|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82957363|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957364|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82957365|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82957366|NCT05681871|Folic Acid|folic acid|mesh-list
82957367|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
82957368|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
82957369|NCT05681871|Hematinics|hematinics|mesh-ancestor
82957370|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
82957371|NCT05681871|Vitamins|vitamins|mesh-ancestor
82957372|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
82957373|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957374|NCT05681871|Trace Elements|trace elements|mesh-ancestor
82957375|NCT04455958|Ritonavir|ritonavir|mesh-list
82957376|NCT04455958|Lopinavir|lopinavir|mesh-list
82957377|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82957378|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82957379|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
82957380|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957381|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957382|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82957383|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82957384|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
82957385|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957386|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82957387|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82957388|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
82957389|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957390|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957391|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957392|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82957393|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
82957394|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82957395|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82957396|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82957397|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82957398|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957399|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
82957401|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957402|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82957403|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957404|NCT01378858|Varenicline|varenicline|mesh-list
82957405|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82957406|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82957407|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
82957408|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957409|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957410|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957411|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
82957412|NCT02891850|Tadalafil|tadalafil|mesh-list
82957413|NCT02891850|Riociguat|riociguat|mesh-list
82957414|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
82957415|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82957416|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82957417|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957418|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957419|NCT02891850|Urological Agents|urological agents|mesh-ancestor
82957420|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
82957421|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
82957422|NCT05175027|Povidone|povidone|mesh-list
82957423|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
82957424|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
82957425|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82957426|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957427|NCT05089630|Vaccines|vaccines|mesh-list
82957428|NCT05089630|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
82957429|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
82957430|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957431|NCT05089630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82957432|NCT03707418|Heparin|heparin|mesh-list
82957433|NCT03707418|Calcium heparin|calcium heparin|mesh-list
82957434|NCT03707418|Bivalirudin|bivalirudin|mesh-list
82957435|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
82957436|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82957437|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82957438|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957439|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
82957440|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82957441|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
82957442|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957443|NCT03785041|Tramadol|tramadol|mesh-list
82957444|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
82957445|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82957446|NCT03785041|Narcotics|narcotics|mesh-ancestor
82957447|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957448|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957449|NCT03785041|Analgesics|analgesics|mesh-ancestor
82957450|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
82957451|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957452|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
82957453|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
82957454|NCT03710304|Misoprostol|misoprostol|mesh-list
82957455|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
82957456|NCT03710304|Oxytocin|oxytocin|mesh-list
82957457|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
82957458|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82957459|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957460|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82957461|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82957462|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957463|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
82957464|NCT03710304|Coagulants|coagulants|mesh-ancestor
82957465|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82957466|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
82957467|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82957468|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957469|NCT05605639|Bupivacaine|bupivacaine|mesh-list
82957470|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
82957471|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
82957472|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957473|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957474|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
82957475|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957476|NCT03790345|Vitamins|vitamins|mesh-list
82957477|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
82957482|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957483|NCT05416190|Anticoagulants|anticoagulants|mesh-list
82957484|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
82957485|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
82957486|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957487|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82957488|NCT04454788|Tenecteplase|tenecteplase|mesh-list
82957489|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82957490|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82957491|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957495|NCT04862650|Paclitaxel|paclitaxel|mesh-list
82957496|NCT04862650|Carboplatin|carboplatin|mesh-list
82957497|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82957498|NCT04862650|Cemiplimab|cemiplimab|mesh-list
82957499|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82957500|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957501|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
82957502|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
82957503|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
82957504|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957505|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957506|NCT05163561|Vaccines|vaccines|mesh-list
82957507|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
82957508|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957509|NCT05681403|Cytarabine|cytarabine|mesh-list
82957510|NCT05681403|Carmustine|carmustine|mesh-list
82957511|NCT05681403|Melphalan|melphalan|mesh-list
82957512|NCT05681403|Etoposide|etoposide|mesh-list
82957513|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82957514|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
82957515|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957516|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957517|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82957518|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
82957519|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
82957520|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957521|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82957522|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
82957523|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957524|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82957525|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82957526|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82957527|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957528|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82957529|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82957530|NCT01309009|MEN 11420|men 11420|mesh-list
82957531|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82957532|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
82957533|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957534|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957535|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82957536|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
82957537|NCT03339453|Glucagon|glucagon|mesh-list
82957538|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82957539|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957540|NCT03339453|Hormones|hormones|mesh-ancestor
82957541|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957542|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957543|NCT03339453|Incretins|incretins|mesh-ancestor
82957544|NCT05418686|Colchicine|colchicine|mesh-list
82957545|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
82957546|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82957547|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
82957548|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
82957549|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
82957550|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957551|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957552|NCT01306981|Ranibizumab|ranibizumab|mesh-list
82957553|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82957554|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82957555|NCT01306981|Growth Substances|growth substances|mesh-ancestor
82957556|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957557|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
82957558|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957559|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82957560|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
82957561|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957563|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957565|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
82957566|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957567|NCT03784495|Protective Agents|protective agents|mesh-ancestor
82957568|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957569|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957570|NCT04120246|Acetic Acid|acetic acid|mesh-list
82957571|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82957572|NCT04120246|Trastuzumab|trastuzumab|mesh-list
82957573|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
82957574|NCT04120246|Antibodies|antibodies|mesh-list
82957575|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
82957576|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82957577|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
82957578|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957579|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957580|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82957581|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957582|NCT05659147|Secretin|secretin|mesh-list
82957583|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957584|NCT05659147|Hormones|hormones|mesh-ancestor
82957585|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957586|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957587|NCT05234697|Remifentanil|remifentanil|mesh-list
82957588|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82957589|NCT05234697|Narcotics|narcotics|mesh-ancestor
82957590|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957591|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957592|NCT05234697|Analgesics|analgesics|mesh-ancestor
82957593|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
82957594|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957595|NCT03490760|Durvalumab|durvalumab|mesh-list
82957596|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957597|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957598|NCT02133404|Cinacalcet|cinacalcet|mesh-list
82957599|NCT02133404|ASP7991|asp7991|mesh-list
82957600|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82957601|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957602|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82957603|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
82957604|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957605|NCT01307215|Ropivacaine|ropivacaine|mesh-list
82957606|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
82957607|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
82957608|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957609|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957610|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
82957611|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957612|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
82957613|NCT03761056|Fludarabine|fludarabine|mesh-list
82957614|NCT03761056|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83460850|NCT04274816|Tremelimumab|tremelimumab|mesh-list
82957615|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82957616|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
82957617|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957618|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82957619|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82957620|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
82957621|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957622|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957623|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82957624|NCT03761056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957625|NCT05177601|Cycloserine|cycloserine|mesh-list
82957626|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82957627|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957628|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82957629|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
82957630|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82957631|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
82957632|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957633|NCT03420794|Analgesics|analgesics|mesh-list
82957634|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
82957635|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
82957636|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957637|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957638|NCT01568450|Oxycodone|oxycodone|mesh-list
82957639|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82957640|NCT01568450|Narcotics|narcotics|mesh-ancestor
82957641|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957642|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957643|NCT01568450|Analgesics|analgesics|mesh-ancestor
82957644|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
82957645|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957646|NCT05410496|Tenofovir|tenofovir|mesh-list
82957647|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
82957648|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957649|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82957650|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82957651|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957652|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957653|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82957654|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82957655|NCT03784105|Codeine|codeine|mesh-list
82957656|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82957657|NCT03784105|Narcotics|narcotics|mesh-ancestor
82957658|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957659|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957660|NCT03784105|Analgesics|analgesics|mesh-ancestor
82957661|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
82957662|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957663|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
82957664|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
82957665|NCT03784261|Abatacept|abatacept|mesh-list
82957666|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82957667|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957668|NCT03784261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957669|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957670|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82957671|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
82957672|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957673|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82957674|NCT02989402|Rivastigmine|rivastigmine|mesh-list
82957675|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82957676|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957677|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957678|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
82957679|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957680|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957681|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82957682|NCT02989402|Protective Agents|protective agents|mesh-ancestor
82957683|NCT03783949|Paclitaxel|paclitaxel|mesh-list
82957684|NCT03783949|Carboplatin|carboplatin|mesh-list
82957685|NCT03783949|Gemcitabine|gemcitabine|mesh-list
82957686|NCT03783949|Niraparib|niraparib|mesh-list
82957687|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82957688|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957689|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
82957690|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
82957691|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
82957692|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957693|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82957694|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
82957695|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82957696|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957697|NCT02861950|Bupivacaine|bupivacaine|mesh-list
82957698|NCT02861950|Ropivacaine|ropivacaine|mesh-list
82957699|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
82957700|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
82957701|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957702|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957703|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
82957704|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957705|NCT05681247|Ezetimibe|ezetimibe|mesh-list
82957706|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82957707|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82957708|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
82957709|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957710|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82957711|NCT03787927|Aspirin|aspirin|mesh-list
82957712|NCT03787927|Clopidogrel|clopidogrel|mesh-list
82957713|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82957714|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82957715|NCT03787927|Analgesics|analgesics|mesh-ancestor
82957716|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
82957717|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957718|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957719|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82957720|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82957721|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82957722|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82957723|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957724|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82957725|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82957726|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957727|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
82957728|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82957729|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82957730|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82957731|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
82957732|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957733|NCT00602576|Temozolomide|temozolomide|mesh-list
82957734|NCT00602576|Sorafenib|sorafenib|mesh-list
82957735|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82957736|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
82957737|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957738|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957739|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82957740|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957741|NCT04807972|Folfirinox|folfirinox|mesh-list
82957742|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957743|NCT05694871|Palbociclib|palbociclib|mesh-list
82957744|NCT05694871|Cemiplimab|cemiplimab|mesh-list
82957745|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
82957746|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
82957747|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
82957748|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957749|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957750|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82957751|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957752|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957753|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957754|NCT03359850|Niraparib|niraparib|mesh-list
82957755|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82957756|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957757|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957758|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957759|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
82957760|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
82957761|NCT01306123|Vitamins|vitamins|mesh-ancestor
82957762|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
82957763|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957764|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
82957765|NCT01306123|Hematinics|hematinics|mesh-ancestor
82957766|NCT04803994|Bevacizumab|bevacizumab|mesh-list
82957767|NCT04803994|Atezolizumab|atezolizumab|mesh-list
82957768|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957769|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957770|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82957771|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82957772|NCT04803994|Growth Substances|growth substances|mesh-ancestor
82957773|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957774|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
82957775|NCT04803994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82957776|NCT04803994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957777|NCT03130426|Insulin|insulin|mesh-list
82957778|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82957779|NCT03130426|Metformin|metformin|mesh-list
82957780|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
82957781|NCT03130426|Lixisenatide|lixisenatide|mesh-list
82957782|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82957783|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957785|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82957786|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
82957787|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957788|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957789|NCT03342690|Eplerenone|eplerenone|mesh-list
82957790|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82957791|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
82957792|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957793|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957794|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82957795|NCT03342690|Diuretics|diuretics|mesh-ancestor
82957796|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
82957797|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82957798|NCT03130582|Etoposide|etoposide|mesh-list
82957799|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82957800|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957801|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82957802|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82957803|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957804|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957805|NCT04752540|Olorofim|olorofim|mesh-list
82957806|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
82957807|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957808|NCT04341454|Fexuprazan|fexuprazan|mesh-list
82957809|NCT04341454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957810|NCT03712345|Vilobelimab|vilobelimab|mesh-list
82957811|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82957812|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82957813|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
82957814|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957815|NCT03130348|Dexamethasone|dexamethasone|mesh-list
82957816|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
82957817|NCT03130348|Bortezomib|bortezomib|mesh-list
82957818|NCT03130348|Ichthammol|ichthammol|mesh-list
82957819|NCT03130348|BB 1101|bb 1101|mesh-list
82957820|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82957821|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
82957822|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
82957823|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957824|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957825|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957826|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
82957827|NCT03130348|Hormones|hormones|mesh-ancestor
82957828|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957829|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82957830|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957831|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
82957832|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957833|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957834|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
82957835|NCT01307527|Riboflavin|riboflavin|mesh-list
82957836|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
82957837|NCT01307527|Vitamins|vitamins|mesh-ancestor
82957838|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
82957839|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957840|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82957841|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
82957842|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
82957843|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
82957844|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82957845|NCT03789799|Protective Agents|protective agents|mesh-ancestor
82957846|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957847|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
82957848|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82957849|NCT05439772|Ondansetron|ondansetron|mesh-list
82957850|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
82957851|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
82957852|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957853|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957854|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957855|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
82957856|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
82957857|NCT05439772|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82957858|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82957860|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957861|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957862|NCT05694715|Irinotecan|irinotecan|mesh-list
82957863|NCT05694715|Niraparib|niraparib|mesh-list
82957864|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82957865|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82957866|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957867|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957868|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957869|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82957870|NCT01309399|Teriparatide|teriparatide|mesh-list
82957871|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82957872|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957873|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82957874|NCT03311828|Daratumumab|daratumumab|mesh-list
82957875|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957876|NCT01309477|Tacrolimus|tacrolimus|mesh-list
82957877|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82957878|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
82957879|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957880|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82957881|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957882|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957883|NCT03709992|Tamsulosin|tamsulosin|mesh-list
82957884|NCT03709992|Trospium chloride|trospium chloride|mesh-list
82957885|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82957886|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82957887|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82957888|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
82957889|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957890|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957891|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957892|NCT03709992|Urological Agents|urological agents|mesh-ancestor
82957893|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
82957894|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
82957895|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957896|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82957897|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82957898|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
82957899|NCT05438992|Bupivacaine|bupivacaine|mesh-list
82957900|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
82957901|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
82957902|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83460867|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957903|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957904|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
82957905|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957906|NCT05361486|Primaquine|primaquine|mesh-list
82957907|NCT05361486|Tafenoquine|tafenoquine|mesh-list
82957908|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
82957909|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82957910|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82957911|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957912|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
82957913|NCT03089216|Calcium|calcium|mesh-list
82957914|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82957915|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957916|NCT03089216|Antacids|antacids|mesh-ancestor
82957917|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957918|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957919|NCT03339726|Phenylephrine|phenylephrine|mesh-list
82957920|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
82957921|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82957922|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
82957923|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
82957924|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957925|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957926|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
82957927|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82957928|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
82957929|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
82957930|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82957931|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82957932|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82957933|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
82957934|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957935|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957936|NCT03339726|Protective Agents|protective agents|mesh-ancestor
82957937|NCT03339297|Defibrotide|defibrotide|mesh-list
82957938|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82957939|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82957940|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519705|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
82957941|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82957942|NCT05434624|Midazolam|midazolam|mesh-list
82957943|NCT05434624|Propofol|propofol|mesh-list
82957944|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82957945|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82957946|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957947|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82957948|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
82957949|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
82957950|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82957951|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82957952|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82957953|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82957954|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
82957955|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
82957956|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82957957|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957958|NCT01309633|Bevacizumab|bevacizumab|mesh-list
82957959|NCT01309633|Sunitinib|sunitinib|mesh-list
82957960|NCT01309633|Cisplatin|cisplatin|mesh-list
82957961|NCT01309633|Gemcitabine|gemcitabine|mesh-list
82957962|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82957963|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82957964|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82957965|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82957966|NCT01309633|Growth Substances|growth substances|mesh-ancestor
82957967|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957968|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
82957969|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82957970|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
82957971|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957972|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82957973|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82957974|NCT05215431|Antioxidants|antioxidants|mesh-list
82957975|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82957976|NCT05215431|Protective Agents|protective agents|mesh-ancestor
82957977|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957978|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
82957979|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82957980|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82957981|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
82957982|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82957983|NCT01310647|Estradiol|estradiol|mesh-list
82957984|NCT01310647|Testosterone|testosterone|mesh-list
82957985|NCT01310647|Estrogens|estrogens|mesh-ancestor
82957986|NCT01310647|Hormones|hormones|mesh-ancestor
82957987|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82957988|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957989|NCT01310647|Androgens|androgens|mesh-ancestor
82957990|NCT05560399|Dexamethasone|dexamethasone|mesh-list
82957991|NCT05560399|Elotuzumab|elotuzumab|mesh-list
82957992|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82957993|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
82957994|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
82957995|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82957996|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82957997|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82957998|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
82957999|NCT05560399|Hormones|hormones|mesh-ancestor
82958000|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958001|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82958002|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958003|NCT02949024|Triamcinolone|triamcinolone|mesh-list
82958004|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82958005|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82958006|NCT02949024|Aflibercept|aflibercept|mesh-list
82958007|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82958008|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82958009|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
82958011|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958012|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958013|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958014|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
82958015|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958016|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958017|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83519706|NCT00002571|Vitamins|vitamins|mesh-ancestor
82958018|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82958019|NCT02949024|Growth Substances|growth substances|mesh-ancestor
82958020|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
82958021|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958022|NCT04394481|Dexamethasone|dexamethasone|mesh-list
82958023|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
82958024|NCT04394481|Ropivacaine|ropivacaine|mesh-list
82958025|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82958026|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
82958027|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
82958028|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958029|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958030|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958031|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
82958032|NCT04394481|Hormones|hormones|mesh-ancestor
82958033|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958034|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82958035|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958036|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82958037|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958038|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958039|NCT04394481|Analgesics|analgesics|mesh-ancestor
82958040|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
82958041|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82958042|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82958043|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82958044|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
82958045|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958046|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958047|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
82958048|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
82958049|NCT03782935|Choline|choline|mesh-list
82958050|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
82958051|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82958052|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
82958053|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958054|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958055|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82958056|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
82958057|NCT04370847|Ephedrine|ephedrine|mesh-list
82958058|NCT04370847|Fentanyl|fentanyl|mesh-list
82958059|NCT04370847|Bupivacaine|bupivacaine|mesh-list
82958060|NCT04370847|Oxytocin|oxytocin|mesh-list
82958061|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
82958062|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
82958063|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958064|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958065|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
82958066|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958067|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82958068|NCT04370847|Narcotics|narcotics|mesh-ancestor
82958069|NCT04370847|Analgesics|analgesics|mesh-ancestor
82958070|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82958071|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82958072|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
82958073|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
82958074|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82958075|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82958076|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
82958077|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
82958078|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82958079|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
82958080|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958081|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958082|NCT03708120|Insect Repellents|insect repellents|mesh-list
82958083|NCT03708120|Protective Agents|protective agents|mesh-ancestor
82958084|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958085|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
82958099|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82958100|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82958101|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958102|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
82958103|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958104|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958105|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82958106|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
82958107|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958108|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958109|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82958110|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82958111|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82958112|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82958113|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958114|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82958116|NCT01309789|Hormones|hormones|mesh-ancestor
82958117|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958118|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82958119|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82958120|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958121|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958122|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958123|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958124|NCT01309789|Immunotoxins|immunotoxins|mesh-ancestor
82958125|NCT01309789|Immunoconjugates|immunoconjugates|mesh-ancestor
82958126|NCT03707847|Etoposide|etoposide|mesh-list
82958127|NCT03707847|Crizotinib|crizotinib|mesh-list
82958128|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82958129|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958130|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82958131|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82958132|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958133|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958134|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82958135|NCT03338400|Dexamethasone|dexamethasone|mesh-list
82958136|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82958137|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
82958138|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
82958139|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958140|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958141|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958142|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
82958143|NCT03338400|Hormones|hormones|mesh-ancestor
82958144|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958145|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82958146|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958168|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958169|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
82958170|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958171|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82958172|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82958173|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82958174|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958175|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958176|NCT02620306|Losartan|losartan|mesh-list
82958177|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82958178|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82958179|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82958180|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82958181|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958182|NCT03781843|Lidocaine|lidocaine|mesh-list
82958183|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
82958184|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
82958185|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958186|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958187|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
82958188|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958189|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82958190|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82958191|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82958192|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958193|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958194|NCT05205447|Itraconazole|itraconazole|mesh-list
82958195|NCT05205447|Carbamazepine|carbamazepine|mesh-list
82958196|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
82958197|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958198|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82958199|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82958200|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958201|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958202|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82958203|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
82958204|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958205|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958206|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82958207|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
82958208|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
82958209|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82958210|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958211|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82958212|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958213|NCT05205447|Analgesics|analgesics|mesh-ancestor
82958214|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
82958215|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958216|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82958217|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958218|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82958219|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82958220|NCT03781687|Morphine|morphine|mesh-list
82958221|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82958222|NCT03781687|Narcotics|narcotics|mesh-ancestor
82958223|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958224|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958225|NCT03781687|Analgesics|analgesics|mesh-ancestor
82958226|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
82958227|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958228|NCT03092726|ASP8062|asp8062|mesh-list
82958229|NCT03092726|Analgesics|analgesics|mesh-ancestor
82958230|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
82958231|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958232|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958234|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
82958235|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958236|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958237|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
82958238|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82958239|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
82958240|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82958241|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
82958242|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958243|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958244|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
82958245|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82958246|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
82958247|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
82958248|NCT05126511|Hormones|hormones|mesh-ancestor
82958249|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958250|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958251|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958252|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958253|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82958254|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82958255|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
82958256|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82958257|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
82958258|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82958259|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82958260|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82958261|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958262|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958263|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
82958264|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958265|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958266|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82958267|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958268|NCT03787069|Lidocaine|lidocaine|mesh-list
82958269|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
82958270|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
82958271|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958272|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958273|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
82958274|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958275|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82958276|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82958277|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82958278|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958279|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958280|NCT04447118|Docetaxel|docetaxel|mesh-list
82958281|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958282|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958283|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958284|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958285|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958286|NCT05532319|Lenvatinib|lenvatinib|mesh-list
82958287|NCT05532319|Tislelizumab|tislelizumab|mesh-list
82958288|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958289|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82958290|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958291|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958292|NCT05532319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958293|NCT01553032|Cetuximab|cetuximab|mesh-list
82958294|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958295|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958296|NCT05181124|Naproxen|naproxen|mesh-list
82958297|NCT05181124|Meloxicam|meloxicam|mesh-list
82958298|NCT05181124|Aceclofenac|aceclofenac|mesh-list
82958299|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82958300|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958301|NCT05181124|Analgesics|analgesics|mesh-ancestor
82958302|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
82958303|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958304|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958306|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958307|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
82958308|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82958309|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958310|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958311|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82958312|NCT02897648|Lactams|lactams|mesh-list
82958313|NCT02897648|beta-Lactams|beta-lactams|mesh-list
82958314|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82958315|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958316|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
82958317|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82958318|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958319|NCT04959591|Acetaminophen|acetaminophen|mesh-list
82958320|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958321|NCT04959591|Analgesics|analgesics|mesh-ancestor
82958322|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
82958323|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958324|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958325|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
82958326|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
82958327|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82958328|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82958329|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958330|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
82958331|NCT05598086|Coagulants|coagulants|mesh-ancestor
82958332|NCT00753532|Vitamin E|vitamin e|mesh-list
82958333|NCT00753532|Tocopherols|tocopherols|mesh-list
82958334|NCT00753532|Tocotrienols|tocotrienols|mesh-list
82958335|NCT00753532|Tocovid|tocovid|mesh-list
82958336|NCT00753532|Vitamins|vitamins|mesh-ancestor
82958337|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
82958338|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958339|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
82958340|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958341|NCT00753532|Protective Agents|protective agents|mesh-ancestor
82958342|NCT03632408|Zopiclone|zopiclone|mesh-list
82958343|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82958344|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958345|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958346|NCT01307839|Lidocaine|lidocaine|mesh-list
82958347|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
82958348|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
82958349|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958350|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958351|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
82958352|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958353|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82958354|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82958355|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82958356|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958357|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958358|NCT03777085|Rituximab|rituximab|mesh-list
82958359|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958360|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958361|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
82958362|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958363|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958364|NCT01328548|Vaccines|vaccines|mesh-list
82958365|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
82958366|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958367|NCT04453306|Topiramate|topiramate|mesh-list
82958368|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
82958369|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82958370|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958371|NCT03777163|Vaccines|vaccines|mesh-list
82958372|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
82958373|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958374|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
82958375|NCT03786289|Hematinics|hematinics|mesh-ancestor
82958376|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82958377|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82958378|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958379|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
82958380|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
82958382|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82958383|NCT03337308|Ezetimibe|ezetimibe|mesh-list
82958384|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82958385|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82958386|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
82958387|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958388|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82958389|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958390|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82958391|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958392|NCT03631862|Apatinib|apatinib|mesh-list
82958393|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958394|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82958395|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958396|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958397|NCT03468010|Paclitaxel|paclitaxel|mesh-list
82958398|NCT03468010|Cisplatin|cisplatin|mesh-list
82958399|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82958400|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958401|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958402|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958403|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958404|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958405|NCT03337152|Chloroquine|chloroquine|mesh-list
82958406|NCT03337152|Primaquine|primaquine|mesh-list
82958407|NCT03337152|Amebicides|amebicides|mesh-ancestor
82958408|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82958409|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82958410|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958411|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
82958412|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958413|NCT03467620|Cannabidiol|cannabidiol|mesh-list
82958414|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
82958415|NCT03780205|Methamphetamine|methamphetamine|mesh-list
82958416|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82958417|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958418|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
82958419|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
82958420|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958421|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
82958422|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958423|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958424|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
82958425|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82958426|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82958427|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958428|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82958429|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82958430|NCT04751500|Metronidazole|metronidazole|mesh-list
82958431|NCT04751500|Clindamycin|clindamycin|mesh-list
82958432|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82958433|NCT04751500|Misoprostol|misoprostol|mesh-list
82958434|NCT04751500|Mifepristone|mifepristone|mesh-list
82958435|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958436|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82958437|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82958438|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82958439|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
82958440|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82958441|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958442|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82958443|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958444|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
82958445|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82958446|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958447|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958448|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82958449|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82958450|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82958451|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82958452|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
82958453|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82958454|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82958455|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
82958456|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958457|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
82958458|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82958459|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82958460|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82958461|NCT04305249|Nivolumab|nivolumab|mesh-list
82958462|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958463|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958464|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82958465|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958466|NCT03710161|Vitamin D|vitamin d|mesh-list
82958467|NCT03710161|Vitamins|vitamins|mesh-ancestor
82958468|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
82958469|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958470|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82958471|NCT02719574|Cytarabine|cytarabine|mesh-list
82958472|NCT02719574|Azacitidine|azacitidine|mesh-list
82958473|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82958474|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
82958475|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958476|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958477|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
82958478|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958479|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958480|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
82958481|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958482|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958483|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
82958484|NCT04947501|Ifosfamide|ifosfamide|mesh-list
82958485|NCT04947501|Carboplatin|carboplatin|mesh-list
82958486|NCT04947501|Doxorubicin|doxorubicin|mesh-list
82958487|NCT04947501|Etoposide|etoposide|mesh-list
82958488|NCT04947501|Vincristine|vincristine|mesh-list
82958489|NCT04947501|Topotecan|topotecan|mesh-list
82958490|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958491|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
82958492|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958493|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958494|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82958495|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
82958496|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958497|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958498|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82958499|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82958500|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82958501|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82958502|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958503|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82958504|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958505|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958506|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958507|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82958509|NCT03707808|Ipilimumab|ipilimumab|mesh-list
82958510|NCT03707808|Avelumab|avelumab|mesh-list
82958511|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958512|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958513|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82958514|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958515|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82958516|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82958517|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82958518|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958519|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958520|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
82958521|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958522|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958523|NCT04716634|Tislelizumab|tislelizumab|mesh-list
82958524|NCT04716634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958525|NCT04716634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958526|NCT02761070|Bevacizumab|bevacizumab|mesh-list
82958527|NCT02761070|Temozolomide|temozolomide|mesh-list
82958528|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958529|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958530|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82958532|NCT02761070|Growth Substances|growth substances|mesh-ancestor
82958533|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958534|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
82958535|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82958536|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
82958537|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958539|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82958540|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
82958541|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82958542|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
82958543|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958544|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958545|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82958546|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82958547|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958548|NCT03090152|Bupivacaine|bupivacaine|mesh-list
82958549|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
82958550|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
82958551|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958552|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958553|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
82958554|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958555|NCT03466528|Thiamine|thiamine|mesh-list
82958556|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
82958557|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
82958558|NCT03466528|Vitamins|vitamins|mesh-ancestor
82958559|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
82958560|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958561|NCT03466528|Analgesics|analgesics|mesh-ancestor
82958562|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
82958563|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958564|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
82958565|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958566|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82958567|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
82958568|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83460908|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
82958569|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958570|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958571|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82958572|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
82958573|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82958574|NCT03466216|Octreotide|octreotide|mesh-list
82958575|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958576|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82958577|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958578|NCT03098654|Metformin|metformin|mesh-list
82958579|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82958580|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958581|NCT05175066|Bisoprolol|bisoprolol|mesh-list
82958582|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82958583|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
82958584|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
82958585|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958586|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958587|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82958588|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82958589|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82958590|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
82958591|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958592|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958593|NCT03130114|Azithromycin|azithromycin|mesh-list
82958594|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82958595|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958596|NCT03130270|Apatinib|apatinib|mesh-list
82958597|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958598|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82958599|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958600|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958601|NCT03780361|Aflibercept|aflibercept|mesh-list
82958602|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82958603|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82958604|NCT03780361|Growth Substances|growth substances|mesh-ancestor
82958605|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958606|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
82958607|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958608|NCT05183646|Propagermanium|propagermanium|mesh-list
82958609|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958610|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
82958611|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
82958612|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958614|NCT04943445|Carboplatin|carboplatin|mesh-list
82958615|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
82958616|NCT04943445|Immunomodulating Agents|immunomodulating agents|mesh-list
82958617|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
82958618|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82958619|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958620|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958621|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958622|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958623|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958624|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958625|NCT04943445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82958626|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958627|NCT02522572|Plerixafor|plerixafor|mesh-list
82958628|NCT02522572|Bortezomib|bortezomib|mesh-list
82958629|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958630|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82958631|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82958632|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
82958633|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958634|NCT04602507|Ivermectin|ivermectin|mesh-list
82958635|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82958636|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958637|NCT04657666|Nabiximols|nabiximols|mesh-list
82958638|NCT04657666|Analgesics|analgesics|mesh-ancestor
82958639|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
82958640|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83460916|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958641|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958642|NCT04645966|Acetaminophen|acetaminophen|mesh-list
82958643|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958644|NCT04645966|Analgesics|analgesics|mesh-ancestor
82958645|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
82958646|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958647|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958648|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
82958649|NCT03773809|Vitamin D|vitamin d|mesh-list
82958650|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
82958651|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
82958652|NCT03773809|Vitamins|vitamins|mesh-list
82958653|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
82958654|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958655|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82958656|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82958657|NCT01313611|Rituximab|rituximab|mesh-list
82958658|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82958659|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958660|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958661|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
82958662|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958663|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958664|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82958665|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
82958666|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958667|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82958668|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958669|NCT04534582|Denosumab|denosumab|mesh-list
82958670|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82958671|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958672|NCT03780049|Leucovorin|leucovorin|mesh-list
82958673|NCT03780049|Fluorouracil|fluorouracil|mesh-list
82958674|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
82958675|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
82958676|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958677|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82958678|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958679|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958681|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958682|NCT03780049|Antidotes|antidotes|mesh-ancestor
82958683|NCT03780049|Protective Agents|protective agents|mesh-ancestor
82958684|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
82958685|NCT03780049|Vitamins|vitamins|mesh-ancestor
82958686|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
82958687|NCT04252287|Canagliflozin|canagliflozin|mesh-list
82958688|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82958689|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958690|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82958691|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958692|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
82958693|NCT05681754|Calcium|calcium|mesh-list
82958694|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82958695|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958696|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82958697|NCT03465202|Capecitabine|capecitabine|mesh-list
82958698|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82958699|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
82958700|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958701|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958702|NCT04195958|Omalizumab|omalizumab|mesh-list
82958703|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82958704|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82958705|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
82958706|NCT05540262|Edaravone|edaravone|mesh-list
82958707|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82958708|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
82958709|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958710|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82958711|NCT05540262|Protective Agents|protective agents|mesh-ancestor
82958712|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958713|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
82958714|NCT04245423|Narcotics|narcotics|mesh-ancestor
82958715|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958716|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958717|NCT04245423|Analgesics|analgesics|mesh-ancestor
82958718|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
82958719|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958720|NCT02735200|Vitamin D|vitamin d|mesh-list
82958721|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
82958722|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
82958723|NCT02735200|Vitamins|vitamins|mesh-list
82958724|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
82958725|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958726|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82958727|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82958728|NCT01312311|Docetaxel|docetaxel|mesh-list
82958729|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958730|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958731|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958732|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958733|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958735|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
82958736|NCT03464968|Irinotecan|irinotecan|mesh-list
82958737|NCT03464968|Fluorouracil|fluorouracil|mesh-list
82958738|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
82958739|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958740|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82958741|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82958742|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958743|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958744|NCT03464968|Antidotes|antidotes|mesh-ancestor
82958745|NCT03464968|Protective Agents|protective agents|mesh-ancestor
82958746|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958747|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
82958748|NCT03464968|Vitamins|vitamins|mesh-ancestor
82958749|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
82958750|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
82958751|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82958752|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958753|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
82958754|NCT05073744|Morphine|morphine|mesh-list
82958755|NCT05073744|Nalbuphine|nalbuphine|mesh-list
82958756|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82958758|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958759|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958760|NCT05073744|Analgesics|analgesics|mesh-ancestor
82958761|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
82958762|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958763|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
82958764|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958765|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
82958766|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958767|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958768|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82958769|NCT01312350|Docetaxel|docetaxel|mesh-list
82958770|NCT01312350|Fluorouracil|fluorouracil|mesh-list
82958771|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958772|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958773|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958774|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958775|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958776|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
82958777|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82958778|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958779|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
82958780|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958781|NCT03464656|Antioxidants|antioxidants|mesh-list
82958782|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958783|NCT03464656|Protective Agents|protective agents|mesh-ancestor
82958784|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958785|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
82958786|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82958787|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958788|NCT03705858|Lintuzumab|lintuzumab|mesh-list
82958789|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958790|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958791|NCT05156658|Etonogestrel|etonogestrel|mesh-list
82958792|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82958793|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
82958794|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82958795|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958796|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82958797|NCT03463642|Vitamin D|vitamin d|mesh-list
82958798|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
82958799|NCT03463642|Mineral Oil|mineral oil|mesh-list
82958800|NCT03463642|Vitamins|vitamins|mesh-ancestor
82958801|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
82958802|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958803|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82958804|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82958805|NCT03463642|Emollients|emollients|mesh-ancestor
82958806|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
82958807|NCT03463564|Insulin|insulin|mesh-list
82958808|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82958809|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82958810|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958811|NCT05092386|Vaccines|vaccines|mesh-list
82958812|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
82958813|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958814|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82958815|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
82958816|NCT03463252|Progesterone|progesterone|mesh-list
82958817|NCT03463252|Progestins|progestins|mesh-ancestor
82958818|NCT03463252|Hormones|hormones|mesh-ancestor
82958819|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82958820|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958821|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82958822|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82958823|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82958824|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
82958825|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82958826|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82958827|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82958828|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82958829|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82958830|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958831|NCT05309538|Betahistine|betahistine|mesh-list
82958832|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
82958833|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
82958834|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
82958835|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958836|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958837|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958838|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
82958839|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
82958840|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958841|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82958842|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958843|NCT03011450|Fenofibrate|fenofibrate|mesh-list
82958844|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82958845|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
82958846|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958847|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82958848|NCT03638856|Misoprostol|misoprostol|mesh-list
82958849|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82958850|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
82958851|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82958852|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958853|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82958854|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82958855|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
82958857|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82958858|NCT03705780|Narcotics|narcotics|mesh-ancestor
83460931|NCT03821714|Hormones|hormones|mesh-ancestor
82958859|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82958860|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958861|NCT03705780|Analgesics|analgesics|mesh-ancestor
82958862|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
82958863|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958864|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82958865|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82958866|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
82958867|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
82958868|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
82958869|NCT04976790|Analgesics|analgesics|mesh-ancestor
82958870|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
82958871|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958872|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958873|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82958874|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958875|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82958876|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958877|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82958878|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958879|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958880|NCT04452838|Fesoterodine|fesoterodine|mesh-list
82958881|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82958882|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82958883|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
82958884|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958885|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958886|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958887|NCT04452838|Urological Agents|urological agents|mesh-ancestor
82958888|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
82958889|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82958890|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958891|NCT04188860|Paclitaxel|paclitaxel|mesh-list
82958892|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82958893|NCT04188860|Antibodies|antibodies|mesh-list
82958894|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82958895|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958896|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
82958897|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
82958898|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
82958899|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958900|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
82958901|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958902|NCT05425862|Talazoparib|talazoparib|mesh-list
82958903|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82958904|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958905|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958906|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958907|NCT01383668|Sirolimus|sirolimus|mesh-list
82958908|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
82958909|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82958910|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958911|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82958912|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958913|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
82958914|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958915|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
82958916|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958917|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958918|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
82958919|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82958920|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82958921|NCT01381796|Sumatriptan|sumatriptan|mesh-list
82958922|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82958923|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82958924|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82958925|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
82958926|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958927|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958928|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958929|NCT04375228|Rituximab|rituximab|mesh-list
82958930|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82958931|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958932|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
82958933|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958934|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958935|NCT02521714|Lenalidomide|lenalidomide|mesh-list
82958936|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
82958937|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958938|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82958939|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82958940|NCT02521714|Growth Substances|growth substances|mesh-ancestor
82958941|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
82958942|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958943|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
82958944|NCT02096588|Doxorubicin|doxorubicin|mesh-list
82958945|NCT02096588|Simvastatin|simvastatin|mesh-list
82958946|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82958947|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
82958948|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958949|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82958950|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82958951|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
82958952|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958953|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82958954|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82958955|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82958956|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82958957|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82958958|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958959|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82958960|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82958961|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
82958962|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82958963|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82958964|NCT03768089|Ivacaftor|ivacaftor|mesh-list
82958965|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82958966|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82958967|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958968|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
82958969|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
82958970|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82958971|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82958972|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958973|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
82958974|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
82958975|NCT01381640|Acetaminophen|acetaminophen|mesh-list
82958976|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82958977|NCT01381640|Analgesics|analgesics|mesh-ancestor
82958978|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
82958979|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82958980|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82958995|NCT04483973|Protective Agents|protective agents|mesh-ancestor
82958996|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82958997|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82958998|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82959000|NCT04283890|Ipilimumab|ipilimumab|mesh-list
82959001|NCT04283890|Melphalan|melphalan|mesh-list
82959002|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959003|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959004|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82959005|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959006|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82959007|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
82959008|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82959009|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82959010|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
82959011|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959012|NCT01139723|Bevacizumab|bevacizumab|mesh-list
82959013|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959014|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959015|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82959016|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82959017|NCT01139723|Growth Substances|growth substances|mesh-ancestor
82959018|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959019|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
82959020|NCT05068037|Antiemetics|antiemetics|mesh-list
82959021|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
82959022|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959023|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959024|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82959025|NCT01136759|Tenofovir|tenofovir|mesh-list
82959026|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
82959027|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959028|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82959029|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82959030|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959031|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959032|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82959033|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82959048|NCT01141439|Fluticasone|fluticasone|mesh-list
82959049|NCT01141439|Xhance|xhance|mesh-list
82959050|NCT01141439|Beclomethasone|beclomethasone|mesh-list
82959051|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959052|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82959053|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
82959054|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959055|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959057|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
82959058|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959059|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82959060|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
82959061|NCT01141439|Hormones|hormones|mesh-ancestor
82959062|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959063|NCT05549531|Itraconazole|itraconazole|mesh-list
82959064|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
82959065|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959066|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83519707|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
82959067|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82959068|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959069|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959070|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82959071|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
82959072|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959073|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959074|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82959075|NCT02953834|Insulin|insulin|mesh-list
82959076|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959077|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959078|NCT04452370|Etoposide|etoposide|mesh-list
82959079|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82959080|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959081|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82959082|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82959083|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959084|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959085|NCT03819088|Zinc|zinc|mesh-list
82959086|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
82959087|NCT03819088|Trace Elements|trace elements|mesh-ancestor
82959088|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
82959089|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959090|NCT03819088|Astringents|astringents|mesh-ancestor
82959091|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959092|NCT01232777|Bevacizumab|bevacizumab|mesh-list
82959093|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959094|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959095|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82959096|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82959097|NCT01232777|Growth Substances|growth substances|mesh-ancestor
82959098|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959099|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
82959100|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
82959101|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959102|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959103|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
82959104|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82959105|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959106|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959107|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959108|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
82959109|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82959110|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959111|NCT04921995|Tislelizumab|tislelizumab|mesh-list
82959112|NCT04921995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959113|NCT04921995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959114|NCT03129867|Ticagrelor|ticagrelor|mesh-list
82959115|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82959116|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82959117|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82959118|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82959119|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
82959120|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959121|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959122|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959123|NCT01235273|Hormones|hormones|mesh-list
82959124|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959125|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959126|NCT01140035|Insulin|insulin|mesh-list
82959127|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959129|NCT02525692|TIC10 compound|tic10 compound|mesh-list
82959130|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959131|NCT00872950|Amifampridine|amifampridine|mesh-list
82959132|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82959133|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959134|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959135|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82959136|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959137|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959138|NCT03233217|Vaccines|vaccines|mesh-list
82959139|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
83519708|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
82959140|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959141|NCT01568996|Sulforaphane|sulforaphane|mesh-list
82959142|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82959143|NCT01568996|Protective Agents|protective agents|mesh-ancestor
82959144|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959145|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959146|NCT02943993|Edoxaban|edoxaban|mesh-list
82959147|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82959148|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
82959149|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82959150|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
82959151|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959152|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959153|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
82959154|NCT02620150|Escitalopram|escitalopram|mesh-list
82959155|NCT02620150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82959156|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82959157|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959158|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959159|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959160|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
82959161|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959162|NCT04098302|Dutasteride|dutasteride|mesh-list
83460954|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
82959163|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82959164|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82959165|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959166|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959167|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
82959168|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959169|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959170|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
82959171|NCT05488613|Midostaurin|midostaurin|mesh-list
82959172|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959173|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82959174|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959175|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959176|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82959177|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959178|NCT01137383|Interferons|interferons|mesh-list
82959179|NCT01137383|Ribavirin|ribavirin|mesh-list
82959180|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
82959181|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
82959182|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82959183|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959184|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
82959185|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959186|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
82959187|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959188|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
82959189|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959190|NCT03449836|Fluticasone|fluticasone|mesh-list
82959191|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
82959192|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959193|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82959194|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
82959195|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959196|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959197|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82959198|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
82959199|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959200|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82959201|NCT03449524|CXA-10|cxa-10|mesh-list
82959202|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959203|NCT03961256|Exenatide|exenatide|mesh-list
82959204|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959205|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959206|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82959207|NCT03961256|Incretins|incretins|mesh-ancestor
82959208|NCT03961256|Hormones|hormones|mesh-ancestor
82959209|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959210|NCT03443518|Remifentanil|remifentanil|mesh-list
82959211|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959212|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959213|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82959214|NCT03443518|Narcotics|narcotics|mesh-ancestor
82959215|NCT03443518|Analgesics|analgesics|mesh-ancestor
82959216|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
82959217|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959219|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959220|NCT04330625|Volagidemab|volagidemab|mesh-list
82959221|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959222|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959223|NCT03747497|Linezolid|linezolid|mesh-list
82959224|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82959225|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959226|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82959227|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959228|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959229|NCT03109600|Vaccines|vaccines|mesh-list
82959230|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82959231|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
82959232|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959233|NCT03679013|Acetaminophen|acetaminophen|mesh-list
82959234|NCT03679013|Gabapentin|gabapentin|mesh-list
82959235|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82959236|NCT03679013|Analgesics|analgesics|mesh-ancestor
82959237|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
82959238|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959239|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959240|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
82959241|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
82959242|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82959243|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82959244|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959245|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82959246|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82959247|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82959248|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959249|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959250|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
82959251|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
82959252|NCT01140425|PF 232798|pf 232798|mesh-list
82959253|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82959254|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959255|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82959256|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82959257|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959258|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959259|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959260|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82959261|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82959262|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82959263|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
82959264|NCT04884412|Anesthetics|anesthetics|mesh-list
82959265|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959266|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959267|NCT03991013|Dolutegravir|dolutegravir|mesh-list
82959268|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82959269|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82959270|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959271|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959272|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82959273|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82959274|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
82959275|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959276|NCT03441412|Metoprolol|metoprolol|mesh-list
82959277|NCT03441412|Epinephrine|epinephrine|mesh-list
82959278|NCT03441412|Ticagrelor|ticagrelor|mesh-list
82959279|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82959280|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82959281|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
82959282|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959283|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959284|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959285|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82959286|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82959287|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
82959288|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959289|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82959290|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
82959291|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
82959292|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
82959293|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82959294|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82959295|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82959296|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82959297|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82959298|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
82959299|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82959300|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82959301|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
82959302|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82959303|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83460968|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959304|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82959305|NCT01235819|Insulin|insulin|mesh-list
82959306|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82959307|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82959308|NCT01235819|Exenatide|exenatide|mesh-list
82959309|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82959310|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959311|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959312|NCT01235819|Incretins|incretins|mesh-ancestor
82959313|NCT01235819|Hormones|hormones|mesh-ancestor
82959314|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959315|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
82959316|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959317|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959318|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82959319|NCT05275569|Antiemetics|antiemetics|mesh-list
82959320|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
82959321|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959322|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959323|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82959324|NCT04599933|Pilocarpine|pilocarpine|mesh-list
82959325|NCT04599933|Miotics|miotics|mesh-ancestor
82959326|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
82959327|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959328|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959329|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82959330|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82959331|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
82959332|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959333|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959334|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82959335|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959336|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959337|NCT03440788|Immunotoxins|immunotoxins|mesh-ancestor
82959338|NCT03440788|Immunoconjugates|immunoconjugates|mesh-ancestor
82959339|NCT03440788|Immunologic Factors|immunologic factors|mesh-ancestor
82959340|NCT03440788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959341|NCT02824575|Paclitaxel|paclitaxel|mesh-list
82959342|NCT02824575|Rebastinib|rebastinib|mesh-list
82959343|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82959344|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959345|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
82959346|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
82959347|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
82959348|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959349|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82959350|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959351|NCT03780608|Durvalumab|durvalumab|mesh-list
82959352|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959353|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959354|NCT03631316|Valganciclovir|valganciclovir|mesh-list
82959355|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
82959356|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959357|NCT03608865|Durvalumab|durvalumab|mesh-list
82959358|NCT03608865|Tremelimumab|tremelimumab|mesh-list
82959359|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959360|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959361|NCT03532451|Nivolumab|nivolumab|mesh-list
82959362|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959363|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959364|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82959365|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959366|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
82959367|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82959368|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
82959369|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959371|NCT04704531|Protective Agents|protective agents|mesh-ancestor
82959372|NCT02637531|Nivolumab|nivolumab|mesh-list
82959373|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959374|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959375|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82959376|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959377|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
82959378|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
82959379|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82959380|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
82959381|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
82959382|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959383|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959384|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959385|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
82959386|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959387|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82959388|NCT01380548|Iron|iron|mesh-list
82959389|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82959390|NCT01380548|Trace Elements|trace elements|mesh-ancestor
82959391|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
82959392|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959393|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82959394|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959395|NCT01313247|Acetaminophen|acetaminophen|mesh-list
82959396|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82959397|NCT01313247|Analgesics|analgesics|mesh-ancestor
82959398|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
82959399|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959400|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959401|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
82959402|NCT01142453|Interferons|interferons|mesh-list
82959403|NCT01142453|Interferon-beta|interferon-beta|mesh-list
82959404|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
82959405|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959406|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
82959407|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959408|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
82959409|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959410|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82959411|NCT04701424|Insulin|insulin|mesh-list
82959412|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959413|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959414|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
82959415|NCT03560193|Ethanol|ethanol|mesh-list
82959416|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
82959417|NCT03560193|Povidone|povidone|mesh-list
82959418|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82959419|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959420|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
82959421|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959422|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959423|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
82959424|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
82959425|NCT04451200|Busulfan|busulfan|mesh-list
82959426|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
82959427|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959428|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82959429|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
82959430|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959431|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82959433|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82959434|NCT04678479|Ganaxolone|ganaxolone|mesh-list
82959435|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
82959436|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959437|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959438|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959439|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
82959440|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
82959441|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
82959442|NCT03431831|Naltrexone|naltrexone|mesh-list
82959443|NCT03431831|Bupropion|bupropion|mesh-list
82959444|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82959445|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82959446|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82959447|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959448|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
82959449|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959450|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82959451|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
82959452|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82959453|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82959454|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82959455|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959456|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959457|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
82959458|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959459|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82959460|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82959461|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959462|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82959463|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82959464|NCT03442556|Carboplatin|carboplatin|mesh-list
82959465|NCT03442556|Docetaxel|docetaxel|mesh-list
82959466|NCT03442556|Rucaparib|rucaparib|mesh-list
82959467|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959468|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
82959469|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
82959470|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
82959471|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959472|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82959473|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959474|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
82959475|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
82959476|NCT02251821|Melphalan|melphalan|mesh-list
82959477|NCT02251821|Busulfan|busulfan|mesh-list
82959478|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
82959479|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
82959480|NCT02251821|Methotrexate|methotrexate|mesh-list
82959481|NCT02251821|Fludarabine|fludarabine|mesh-list
82959482|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
82959483|NCT02251821|Tacrolimus|tacrolimus|mesh-list
82959484|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82959485|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
82959486|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959487|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82959488|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82959489|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
82959490|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959491|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959492|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82959493|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82959494|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
82959495|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82959496|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82959497|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
82959498|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959499|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959500|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82959501|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82959502|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82959503|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82959504|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82959505|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
82959506|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82959507|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959508|NCT03784781|Dimercaprol|dimercaprol|mesh-list
82959509|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
82959510|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
82959511|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959512|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
82959513|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82959514|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82959515|NCT03425201|Niraparib|niraparib|mesh-list
82959516|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82959517|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959518|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959519|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959520|NCT03438604|Donepezil|donepezil|mesh-list
82959521|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82959522|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959523|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959524|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
82959525|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959526|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959527|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
82959528|NCT03433378|Tretinoin|tretinoin|mesh-list
82959529|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959530|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
82959531|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959532|NCT03433222|Coal Tar|coal tar|mesh-list
82959533|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
82959534|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959535|NCT05016076|Dexamethasone|dexamethasone|mesh-list
82959536|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959537|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
82959538|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
82959539|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959540|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959541|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82959542|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
82959543|NCT05016076|Hormones|hormones|mesh-ancestor
82959544|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959545|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82959546|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959547|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
82959548|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82959549|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959550|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959551|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82959552|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
82959553|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82959554|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82959555|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959556|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
82959557|NCT03433144|Coagulants|coagulants|mesh-ancestor
82959558|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
82959559|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82959560|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82959561|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82959562|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959563|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959564|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
82959565|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959566|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959567|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82959568|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959569|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82959570|NCT02927834|Prednisone|prednisone|mesh-list
82959571|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959572|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
82959573|NCT02927834|Hormones|hormones|mesh-ancestor
82959574|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959575|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959576|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82959577|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959578|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82959579|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959580|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82959581|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959582|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959583|NCT03170180|Sunitinib|sunitinib|mesh-list
82959584|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
82959585|NCT03170180|Gefitinib|gefitinib|mesh-list
82959586|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959587|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82959588|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82959589|NCT03170180|Growth Substances|growth substances|mesh-ancestor
82959590|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959591|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
83519709|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
82959592|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82959593|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959594|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959595|NCT03319667|Dexamethasone|dexamethasone|mesh-list
82959596|NCT03319667|Lenalidomide|lenalidomide|mesh-list
82959597|NCT03319667|Bortezomib|bortezomib|mesh-list
82959598|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959599|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
82959600|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
82959601|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959602|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959603|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82959604|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
82959605|NCT03319667|Hormones|hormones|mesh-ancestor
82959606|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959607|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82959608|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959609|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
82959610|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82959611|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82959612|NCT03319667|Growth Substances|growth substances|mesh-ancestor
82959613|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
82959614|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
82959615|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959616|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959617|NCT03432676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82959618|NCT03432676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959619|NCT03432598|Paclitaxel|paclitaxel|mesh-list
82959620|NCT03432598|Etoposide|etoposide|mesh-list
82959621|NCT03432598|Carboplatin|carboplatin|mesh-list
82959622|NCT03432598|Gemcitabine|gemcitabine|mesh-list
82959623|NCT03432598|Pemetrexed|pemetrexed|mesh-list
82959624|NCT03432598|Tislelizumab|tislelizumab|mesh-list
82959625|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82959626|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959627|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
82959628|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
82959629|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
82959630|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959631|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82959632|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
82959633|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82959634|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82959635|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959636|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82959637|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82959638|NCT03432598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959639|NCT03432442|Ivermectin|ivermectin|mesh-list
82959640|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82959641|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959642|NCT01964547|Nabiximols|nabiximols|mesh-list
82959643|NCT01964547|Analgesics|analgesics|mesh-ancestor
82959644|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
82959645|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959646|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959647|NCT01380314|Miltefosine|miltefosine|mesh-list
82959648|NCT01380314|Imiquimod|imiquimod|mesh-list
82959649|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82959650|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
83460996|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
82959651|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959652|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959653|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
82959654|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
82959655|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959656|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82959657|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82959659|NCT03110510|Fluorouracil|fluorouracil|mesh-list
82959660|NCT03110510|Irinotecan|irinotecan|mesh-list
82959661|NCT03110510|Calcium|calcium|mesh-list
82959662|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
82959663|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82959664|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959665|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
82959666|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959667|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82959668|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959669|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82959670|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
82959671|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82959672|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82959673|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959674|NCT03110510|Antidotes|antidotes|mesh-ancestor
82959675|NCT03110510|Protective Agents|protective agents|mesh-ancestor
82959676|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
82959677|NCT03110510|Vitamins|vitamins|mesh-ancestor
82959678|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
82959679|NCT01238237|Cetuximab|cetuximab|mesh-list
82959680|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82959681|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959682|NCT03319719|Lidocaine|lidocaine|mesh-list
82959683|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
82959684|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
82959685|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
82959686|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959687|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959688|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
82959689|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959690|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82959691|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82959692|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82959693|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959694|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959695|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82959696|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
82959697|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
82959698|NCT03319719|Protective Agents|protective agents|mesh-ancestor
82959699|NCT03128242|Oxytocin|oxytocin|mesh-list
82959700|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
82959701|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82959702|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959703|NCT01313689|Ofatumumab|ofatumumab|mesh-list
82959704|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959705|NCT03431272|Lifitegrast|lifitegrast|mesh-list
82959706|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82959707|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82959708|NCT02528513|Fentanyl|fentanyl|mesh-list
82959709|NCT02528513|Midazolam|midazolam|mesh-list
82959710|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
82959711|NCT02528513|Propofol|propofol|mesh-list
82959712|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82959713|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959714|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959715|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82959716|NCT02528513|Analgesics|analgesics|mesh-ancestor
82959717|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
82959718|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959719|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82959720|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82959721|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82959722|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
82959723|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959724|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959725|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82959726|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
82959727|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
82959728|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82959729|NCT02528513|Narcotics|narcotics|mesh-ancestor
82959730|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82959731|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82959732|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82959733|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82959734|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
82959736|NCT01320007|Furosemide|furosemide|mesh-list
82959737|NCT01320007|Diuretics|diuretics|mesh-ancestor
82959738|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
82959739|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959740|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82959741|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959742|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959743|NCT03318315|Vaccines|vaccines|mesh-list
82959744|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
82959745|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959746|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
82959747|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82959748|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
82959749|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959750|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959751|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82959752|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
82959753|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82959754|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
82959755|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959756|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959757|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82959758|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
82959759|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
82959760|NCT04460183|Protective Agents|protective agents|mesh-ancestor
82959761|NCT01243697|Desogestrel|desogestrel|mesh-list
82959762|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82959763|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82959764|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82959765|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
82959766|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82959767|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959768|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82959769|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82959770|NCT01243697|Progestins|progestins|mesh-ancestor
82959771|NCT01243697|Hormones|hormones|mesh-ancestor
82959772|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959773|NCT04703101|Leucovorin|leucovorin|mesh-list
82959774|NCT04703101|Fluorouracil|fluorouracil|mesh-list
82959775|NCT04703101|Capecitabine|capecitabine|mesh-list
82959776|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
82959777|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
82959778|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959779|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82959780|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959781|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82959782|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
82959783|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959784|NCT04703101|Antidotes|antidotes|mesh-ancestor
82959785|NCT04703101|Protective Agents|protective agents|mesh-ancestor
82959786|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
82959787|NCT04703101|Vitamins|vitamins|mesh-ancestor
82959788|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
82959789|NCT01145573|Calcium|calcium|mesh-list
82959790|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82959791|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959792|NCT01320709|Piroxicam|piroxicam|mesh-list
82959793|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82959794|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82959795|NCT01320709|Analgesics|analgesics|mesh-ancestor
82959796|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
82959797|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959798|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959799|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959800|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82959801|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82959802|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959803|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959804|NCT01238393|Ranibizumab|ranibizumab|mesh-list
82959805|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82959806|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82959807|NCT01238393|Growth Substances|growth substances|mesh-ancestor
82959808|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959809|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
82959810|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959811|NCT01244399|Inositol|inositol|mesh-list
82959812|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
82959813|NCT01244399|Vitamins|vitamins|mesh-ancestor
82959814|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
82959815|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959816|NCT03776305|Imipenem|imipenem|mesh-list
82959817|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82959818|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959819|NCT01146509|Donepezil|donepezil|mesh-list
82959820|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82959821|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959822|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959823|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
82959824|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959825|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959826|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
82959827|NCT03775993|Hormones|hormones|mesh-list
82959828|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959829|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959830|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
82959831|NCT03316131|Febuxostat|febuxostat|mesh-list
82959832|NCT03316131|Verinurad|verinurad|mesh-list
82959833|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82959834|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959835|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82959836|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959837|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
82959838|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82959839|NCT03779659|Anesthetics|anesthetics|mesh-list
82959840|NCT03779659|Benzocaine|benzocaine|mesh-list
82959841|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
82959842|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959843|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959844|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
82959845|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959846|NCT01145807|Terbinafine|terbinafine|mesh-list
82959847|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
82959848|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959849|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959850|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959851|NCT03898895|Antibodies|antibodies|mesh-list
82959852|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
82959853|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959854|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82959855|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82959856|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
82959857|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959858|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959859|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82959860|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
82959861|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
82959862|NCT01245569|Hormones|hormones|mesh-ancestor
82959863|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959864|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
82959865|NCT01314859|Nifedipine|nifedipine|mesh-list
82959866|NCT01314859|Atosiban|atosiban|mesh-list
82959867|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82959868|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959869|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959870|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82959871|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959872|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
82959873|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
83478383|NCT01229891|Vitamins|vitamins|mesh-list
82959874|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82959875|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
82959876|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82959877|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82959878|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
82959879|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82959880|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82959881|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959882|NCT01238627|Nicotine|nicotine|mesh-list
82959883|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82959884|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
82959885|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959886|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959887|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82959888|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82959889|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
82959890|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959891|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959892|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
82959893|NCT01321021|Promethazine|promethazine|mesh-list
82959894|NCT01321021|Losartan|losartan|mesh-list
82959895|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82959896|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82959897|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82959898|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82959899|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959900|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82959901|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82959902|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82959903|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959904|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
82959905|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
82959906|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
82959907|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959908|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
82959909|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
82959910|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82959911|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82959912|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
82959913|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
82959914|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959915|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82959916|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
82959917|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
82959918|NCT01238705|Metoprolol|metoprolol|mesh-list
82959919|NCT01238705|Felodipine|felodipine|mesh-list
82959920|NCT01238705|Irbesartan|irbesartan|mesh-list
82959921|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82959922|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82959923|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
82959924|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
82959925|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959926|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959927|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82959928|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82959929|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82959930|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
82959931|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82959932|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959933|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82959934|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83461010|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
82959935|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82959936|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82959937|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82959938|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
82959939|NCT03779347|Praziquantel|praziquantel|mesh-list
82959940|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
82959941|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82959942|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959943|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
82959944|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959945|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82959946|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
82959947|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
82959948|NCT01245725|Tirofiban|tirofiban|mesh-list
82959949|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82959950|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82959951|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959952|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82959953|NCT01143545|Celecoxib|celecoxib|mesh-list
82959954|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
82959955|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82959956|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
82959957|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959958|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82959959|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82959961|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959962|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959963|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82959964|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82959965|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82959966|NCT01143545|Analgesics|analgesics|mesh-ancestor
82959967|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
82959968|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959969|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82959970|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82959971|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82959972|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82959973|NCT03779035|Gemcitabine|gemcitabine|mesh-list
82959974|NCT03779035|Capecitabine|capecitabine|mesh-list
82959975|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82959976|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
82959977|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82959978|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82959979|NCT01586117|Amifostine|amifostine|mesh-list
82959980|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82959981|NCT01586117|Protective Agents|protective agents|mesh-ancestor
82959982|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959983|NCT03301415|Valganciclovir|valganciclovir|mesh-list
82959984|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
82959985|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82959986|NCT05449015|Atropine|atropine|mesh-list
82959987|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82959988|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82959989|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82959990|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
82959991|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82959992|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82959993|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82959994|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
82959995|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
82959996|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
82959997|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82959998|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82959999|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
82960000|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960001|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960002|NCT01239017|Fasinumab|fasinumab|mesh-list
82960003|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82960004|NCT01239017|Analgesics|analgesics|mesh-ancestor
82960005|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
82960006|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960007|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960008|NCT02732938|Paclitaxel|paclitaxel|mesh-list
82960009|NCT02732938|Gemcitabine|gemcitabine|mesh-list
82960010|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82960011|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960012|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
82960013|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
82960014|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
82960015|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960016|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960017|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
82960018|NCT03778723|Fentanyl|fentanyl|mesh-list
82960019|NCT03778723|Anesthetics|anesthetics|mesh-list
82960020|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960021|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960022|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82960023|NCT03778723|Narcotics|narcotics|mesh-ancestor
82960024|NCT03778723|Analgesics|analgesics|mesh-ancestor
82960025|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
82960026|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960027|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82960028|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82960029|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
82960030|NCT01245959|Cisplatin|cisplatin|mesh-list
82960031|NCT01245959|Docetaxel|docetaxel|mesh-list
82960032|NCT01245959|Fluorouracil|fluorouracil|mesh-list
82960033|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960034|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
82960057|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82960059|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
82960060|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960061|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960062|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960063|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82960064|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82960065|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
82960066|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960067|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82960068|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
82960069|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
82960070|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
82960071|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82960072|NCT04326478|Azithromycin|azithromycin|mesh-list
82960073|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82960074|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960075|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
82960076|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960077|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82960078|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
82960079|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
82960080|NCT04647721|Protective Agents|protective agents|mesh-ancestor
82960081|NCT03470038|Mitogens|mitogens|mesh-list
82960082|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
82960083|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960084|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
82960085|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960086|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
82960087|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960088|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960089|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82960090|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
82960091|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960092|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960093|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82960094|NCT03778567|Lamivudine|lamivudine|mesh-list
82960095|NCT03778567|Telbivudine|telbivudine|mesh-list
82960096|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82960097|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82960098|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960099|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960100|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
82960101|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960102|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82960103|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82960104|NCT03784066|Durvalumab|durvalumab|mesh-list
82960105|NCT03784066|Tremelimumab|tremelimumab|mesh-list
82960106|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82960107|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960108|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960109|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
82960110|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960112|NCT05168683|Uric Acid|uric acid|mesh-list
82960113|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
82960114|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960115|NCT05168683|Protective Agents|protective agents|mesh-ancestor
82960116|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960117|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
82960118|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960119|NCT03113123|Tenofovir|tenofovir|mesh-list
82960120|NCT03113123|Emtricitabine|emtricitabine|mesh-list
82960121|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82960122|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
82960123|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960124|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82960125|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82960126|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960127|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960128|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82960129|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82960130|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
82960131|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82960132|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960133|NCT01143857|Varenicline|varenicline|mesh-list
82960134|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82960135|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82960136|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
82960137|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960138|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960139|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960140|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
82960141|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
82960142|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
82960143|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82960144|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82960145|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
82960146|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960147|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
82960148|NCT05159284|Protective Agents|protective agents|mesh-ancestor
82960149|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82960150|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82960151|NCT01239173|Propranolol|propranolol|mesh-list
82960152|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82960153|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82960154|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
82960155|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960156|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960157|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960158|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82960159|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82960160|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
82960161|NCT03063203|Decitabine|decitabine|mesh-list
82960162|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960163|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
82960164|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960165|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960166|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960167|NCT03435094|Alendronate|alendronate|mesh-list
82960168|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82960169|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960170|NCT03772483|Anesthetics|anesthetics|mesh-list
82960171|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960172|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960173|NCT01236911|Calcium|calcium|mesh-list
82960174|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82960175|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960176|NCT03772561|Durvalumab|durvalumab|mesh-list
82960177|NCT03772561|Olaparib|olaparib|mesh-list
82960178|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960179|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960180|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82960181|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960182|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960183|NCT01239485|Irinotecan|irinotecan|mesh-list
82960184|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82960185|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82960187|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960188|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960189|NCT01146041|Rivastigmine|rivastigmine|mesh-list
82960190|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82960191|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960192|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960193|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
82960194|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960195|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960196|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82960197|NCT01146041|Protective Agents|protective agents|mesh-ancestor
82960198|NCT04450576|Chrysarobin|chrysarobin|mesh-list
82960199|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82960200|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82960201|NCT04450576|Analgesics|analgesics|mesh-ancestor
82960202|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
82960203|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960204|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960205|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82960206|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960207|NCT03430180|Naloxone|naloxone|mesh-list
82960208|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82960209|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960210|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
82960211|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960212|NCT03777787|Denatonium|denatonium|mesh-list
82960213|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
82960214|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960215|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
82960216|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960217|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
82960218|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960219|NCT03430024|Estrogens|estrogens|mesh-list
82960220|NCT03430024|Hormones|hormones|mesh-ancestor
82960221|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82960222|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960223|NCT03434782|Listerine|listerine|mesh-list
82960224|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82960225|NCT03434782|Fluorides|fluorides|mesh-list
82960226|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
82960227|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
82960228|NCT03434782|Protective Agents|protective agents|mesh-ancestor
82960229|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960230|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82960231|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960232|NCT01320397|Losartan|losartan|mesh-list
82960233|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82960234|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82960235|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82960236|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82960237|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960238|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
82960239|NCT03434704|Clotrimazole|clotrimazole|mesh-list
82960240|NCT03434704|Miconazole|miconazole|mesh-list
82960241|NCT03434704|Fludarabine|fludarabine|mesh-list
82960242|NCT03434704|Thiotepa|thiotepa|mesh-list
82960243|NCT03434704|Treosulfan|treosulfan|mesh-list
82960244|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960245|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960246|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960247|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
82960248|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960249|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82960250|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
82960251|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82960252|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960253|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82960254|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82960255|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82960256|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960257|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82960259|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82960260|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82960261|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82960263|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960264|NCT04779151|Niraparib|niraparib|mesh-list
82960265|NCT04779151|Dostarlimab|dostarlimab|mesh-list
82960266|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82960267|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960268|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960269|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960270|NCT02891226|Mirikizumab|mirikizumab|mesh-list
82960271|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82960272|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82960273|NCT02891226|Analgesics|analgesics|mesh-ancestor
82960274|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
82960275|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960276|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960277|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82960278|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960279|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82960280|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82960281|NCT03654274|Norethindrone|norethindrone|mesh-list
82960282|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
82960283|NCT03654274|Estradiol|estradiol|mesh-list
82960284|NCT03654274|Relugolix|relugolix|mesh-list
82960285|NCT03654274|Estrogens|estrogens|mesh-ancestor
82960286|NCT03654274|Hormones|hormones|mesh-ancestor
82960287|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82960288|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960289|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82960290|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
82960291|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82960292|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82960293|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82960294|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82960295|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82960296|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
82960297|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
82960298|NCT03771781|Empagliflozin|empagliflozin|mesh-list
82960299|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82960300|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960301|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82960302|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960303|NCT04140721|Moxonidine|moxonidine|mesh-list
82960304|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82960305|NCT03224104|Temozolomide|temozolomide|mesh-list
82960306|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82960307|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
82960308|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960309|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960310|NCT01320475|Sufentanil|sufentanil|mesh-list
82960311|NCT01320475|Ketamine|ketamine|mesh-list
82960312|NCT01320475|Analgesics|analgesics|mesh-ancestor
82960313|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
82960314|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960315|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960316|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82960317|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82960318|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
82960319|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
82960320|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960321|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82960322|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82960323|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960324|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960325|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82960326|NCT01320475|Narcotics|narcotics|mesh-ancestor
82960327|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82960328|NCT05177406|Erenumab|erenumab|mesh-list
82960329|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82960330|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960332|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
82960333|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960334|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960335|NCT02521246|Losartan|losartan|mesh-list
82960336|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82960337|NCT02521246|Candesartan|candesartan|mesh-list
82960338|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
82960339|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
82960340|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82960341|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82960342|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82960343|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82960344|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960345|NCT02521246|Diuretics|diuretics|mesh-ancestor
82960346|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
82960347|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960348|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82960349|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82960350|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
82960351|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82960352|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
82960353|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960354|NCT05309070|Expectorants|expectorants|mesh-ancestor
82960355|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
82960356|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82960357|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
82960358|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960359|NCT05309070|Protective Agents|protective agents|mesh-ancestor
82960360|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960361|NCT05309070|Antidotes|antidotes|mesh-ancestor
82960362|NCT04763928|Decitabine|decitabine|mesh-list
82960363|NCT04763928|Venetoclax|venetoclax|mesh-list
82960364|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960365|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
82960366|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960367|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960368|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960369|NCT01567501|Cetirizine|cetirizine|mesh-list
82960370|NCT01567501|Levocetirizine|levocetirizine|mesh-list
82960371|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82960372|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82960373|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
82960374|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
82960375|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960376|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83519710|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
82960377|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960378|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82960380|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
82960381|NCT01321957|Irinotecan|irinotecan|mesh-list
82960382|NCT01321957|Fluorouracil|fluorouracil|mesh-list
82960383|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960384|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960385|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82960386|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82960387|NCT01321957|Growth Substances|growth substances|mesh-ancestor
82960388|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960389|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
82960390|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82960391|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82960392|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960393|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960394|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
82960395|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960396|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960397|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
82960398|NCT05363592|Metformin|metformin|mesh-list
82960399|NCT05363592|Alogliptin|alogliptin|mesh-list
82960400|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82960401|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960402|NCT05363592|Incretins|incretins|mesh-ancestor
82960403|NCT05363592|Hormones|hormones|mesh-ancestor
82960404|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82960405|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82960406|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
82960407|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960408|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960409|NCT03708211|Esomeprazole|esomeprazole|mesh-list
82960410|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82960411|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82960412|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82960413|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960414|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960415|NCT03770923|Montelukast|montelukast|mesh-list
82960416|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82960417|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
82960418|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82960419|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
82960420|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82960421|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960422|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82960423|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82960424|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960425|NCT03433534|Nivolumab|nivolumab|mesh-list
82960426|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960427|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960428|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82960429|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960430|NCT05445895|Clopidogrel|clopidogrel|mesh-list
82960431|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82960432|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82960433|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82960434|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82960435|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
82960436|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960437|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960438|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960439|NCT03367299|Blinatumomab|blinatumomab|mesh-list
82960440|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960441|NCT04449952|Listerine|listerine|mesh-list
82960442|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
82960443|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
82960444|NCT04449952|Protective Agents|protective agents|mesh-ancestor
82960445|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960446|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82960447|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960448|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
82960449|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82960450|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
82960451|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82960452|NCT04449718|Vitamin D|vitamin d|mesh-list
82960453|NCT04449718|Vitamins|vitamins|mesh-ancestor
82960454|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
82960455|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960456|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82960457|NCT03763279|Triclosan|triclosan|mesh-list
82960458|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82960459|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960460|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82960461|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82960462|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
82960463|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960464|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82960465|NCT03638037|Vitamin D|vitamin d|mesh-list
82960466|NCT03638037|Vitamins|vitamins|mesh-ancestor
82960467|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
82960468|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960469|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82960470|NCT03763123|Paclitaxel|paclitaxel|mesh-list
82960471|NCT03763123|Topotecan|topotecan|mesh-list
82960472|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82960473|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960474|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
82960475|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
82960476|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
82960477|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960478|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82960479|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82960480|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960481|NCT03429400|Morphine|morphine|mesh-list
82960482|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82960483|NCT03429400|Narcotics|narcotics|mesh-ancestor
82960484|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960485|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960486|NCT03429400|Analgesics|analgesics|mesh-ancestor
82960487|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
82960488|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960489|NCT03429010|Anesthetics|anesthetics|mesh-list
82960490|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960491|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960492|NCT02944656|Gabapentin|gabapentin|mesh-list
82960493|NCT02944656|Analgesics|analgesics|mesh-ancestor
82960494|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
82960495|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960496|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960497|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
82960498|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82960499|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82960500|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960501|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82960502|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82960503|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82960504|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960505|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960506|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
82960507|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
82960508|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960509|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960510|NCT02713529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82960511|NCT02713529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960512|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
82960513|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
82960514|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82960515|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82960516|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960517|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960518|NCT03763045|Urological Agents|urological agents|mesh-ancestor
82960519|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
82960520|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960521|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
82960522|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82960523|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82960524|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960525|NCT01321489|Urological Agents|urological agents|mesh-ancestor
82960526|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
82960527|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82960528|NCT04800627|Pevonedistat|pevonedistat|mesh-list
82960529|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960530|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960531|NCT04800627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82960532|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960533|NCT05308602|Vaccines|vaccines|mesh-list
82960534|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
82960535|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960536|NCT03768037|Pemetrexed|pemetrexed|mesh-list
82960537|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960538|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960539|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960540|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82960541|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82960542|NCT01146977|Cytarabine|cytarabine|mesh-list
82960543|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960544|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
82960545|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960546|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960547|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
82960548|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960549|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960550|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
82960551|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960552|NCT03762967|Hormones|hormones|mesh-list
82960553|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82960554|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960555|NCT03762889|Anesthetics|anesthetics|mesh-list
82960556|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960557|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960558|NCT03746041|Abaloparatide|abaloparatide|mesh-list
82960559|NCT03746041|Bevacizumab|bevacizumab|mesh-list
82960560|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960561|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960562|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82960563|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82960564|NCT03746041|Growth Substances|growth substances|mesh-ancestor
82960565|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960566|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
82960567|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82960568|NCT01236989|Liver Extracts|liver extracts|mesh-list
82960569|NCT01236989|Hematinics|hematinics|mesh-ancestor
82960570|NCT03423472|Vitamin A|vitamin a|mesh-list
82960571|NCT03423472|Vitamins|vitamins|mesh-ancestor
82960572|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
82960573|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960574|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
82960575|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82960576|NCT01239563|Basiliximab|basiliximab|mesh-list
82960577|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
82960578|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960579|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960580|NCT01321255|Aspirin|aspirin|mesh-list
82960581|NCT01321255|Ramipril|ramipril|mesh-list
82960582|NCT01321255|Simvastatin|simvastatin|mesh-list
82960583|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82960584|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82960585|NCT01321255|Analgesics|analgesics|mesh-ancestor
82960586|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
82960587|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960588|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960589|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82960590|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960591|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82960592|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82960593|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960594|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82960595|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82960596|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960597|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
82960598|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82960599|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82960600|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
82960601|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82960602|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82960603|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82960604|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
82960605|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82960606|NCT01883297|Aldesleukin|aldesleukin|mesh-list
82960607|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
82960608|NCT01883297|Interleukin-2|interleukin-2|mesh-list
82960609|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960610|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
82960611|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960612|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960613|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82960614|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
82960615|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960616|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960617|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82960618|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82960619|NCT01883297|Analgesics|analgesics|mesh-ancestor
82960620|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
82960621|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960622|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82960623|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82960624|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
82960625|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960626|NCT04546581|Remdesivir|remdesivir|mesh-list
82960627|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
82960628|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82960629|NCT04546581|Antibodies|antibodies|mesh-list
82960630|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
82960631|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960632|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
82960633|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960634|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
82960635|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960636|NCT02204254|Doxycycline|doxycycline|mesh-list
82960637|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82960638|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960639|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
82960640|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82960641|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82960642|NCT01321567|Rabeprazole|rabeprazole|mesh-list
82960643|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82960644|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82960645|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82960646|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960647|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960648|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
82960649|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82960650|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960651|NCT05294172|Cisplatin|cisplatin|mesh-list
82960652|NCT05294172|Gemcitabine|gemcitabine|mesh-list
82960653|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960654|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960655|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
82960656|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960657|NCT03164655|Leucovorin|leucovorin|mesh-list
82960658|NCT03164655|Bevacizumab|bevacizumab|mesh-list
82960659|NCT03164655|Cetuximab|cetuximab|mesh-list
82960660|NCT03164655|Panitumumab|panitumumab|mesh-list
82960661|NCT03164655|Fluorouracil|fluorouracil|mesh-list
82960662|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
82960663|NCT03164655|Irinotecan|irinotecan|mesh-list
82960664|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82960665|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960666|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82960667|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82960668|NCT03164655|Growth Substances|growth substances|mesh-ancestor
82960669|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960670|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
82960671|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
82960672|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960673|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82960674|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960675|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
82960676|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82960677|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82960678|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960679|NCT03164655|Antidotes|antidotes|mesh-ancestor
82960680|NCT03164655|Protective Agents|protective agents|mesh-ancestor
82960681|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
82960683|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
82960684|NCT02561273|Prednisone|prednisone|mesh-list
82960685|NCT02561273|Cortisone|cortisone|mesh-list
82960686|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
82960687|NCT02561273|Doxorubicin|doxorubicin|mesh-list
82960688|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82960689|NCT02561273|Etoposide|etoposide|mesh-list
82960690|NCT02561273|Vincristine|vincristine|mesh-list
82960691|NCT02561273|Lenalidomide|lenalidomide|mesh-list
82960692|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
82960693|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
82960694|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960695|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
82960696|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960697|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960698|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82960699|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
82960700|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960701|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960702|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82960703|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82960704|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82960705|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82960706|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960707|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82960709|NCT02561273|Hormones|hormones|mesh-ancestor
82960710|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82960711|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82960712|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82960713|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
82960714|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
82960715|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
82960716|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82960717|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82960718|NCT02561273|Growth Substances|growth substances|mesh-ancestor
82960719|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
82960720|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
82960721|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
82960722|NCT02521012|Vitamin D|vitamin d|mesh-list
82960723|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
82960724|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
82960725|NCT02521012|Vitamins|vitamins|mesh-list
82960726|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
82960727|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960728|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82960729|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82960730|NCT04756128|Colchicine|colchicine|mesh-list
82960731|NCT04756128|Naltrexone|naltrexone|mesh-list
82960732|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82960733|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82960734|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960735|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
82960736|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960737|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
82960738|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82960739|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
82960740|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
82960741|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
82960742|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960743|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960744|NCT03427216|Diazepam|diazepam|mesh-list
82960745|NCT03427216|Baclofen|baclofen|mesh-list
82960746|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82960747|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960748|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82960749|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960750|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82960751|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
82960752|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
82960753|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960754|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960755|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82960756|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
82960757|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
82960758|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
82960759|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82960760|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82960761|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960762|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82960763|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82960764|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82960765|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82960766|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
82960767|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
82960768|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
82960769|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
82960770|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82960771|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960772|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960773|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82960774|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82960775|NCT01144091|Protective Agents|protective agents|mesh-ancestor
82960776|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960777|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
82960778|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82960779|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
82960780|NCT02392559|Evolocumab|evolocumab|mesh-list
82960781|NCT02392559|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82960782|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82960783|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82960784|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
82960785|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960787|NCT02392559|Protease Inhibitors|protease inhibitors|mesh-ancestor
82960788|NCT02392559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960789|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82960790|NCT03332589|Dabrafenib|dabrafenib|mesh-list
82960791|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960792|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82960793|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960794|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960795|NCT03767569|Folic Acid|folic acid|mesh-list
82960796|NCT03767569|Inositol|inositol|mesh-list
82960797|NCT03767569|Hematinics|hematinics|mesh-ancestor
82960798|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
82960799|NCT03767569|Vitamins|vitamins|mesh-ancestor
82960800|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
82960801|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960802|NCT03620916|Morphine|morphine|mesh-list
82960803|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82960804|NCT03620916|Narcotics|narcotics|mesh-ancestor
82960805|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960806|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960807|NCT03620916|Analgesics|analgesics|mesh-ancestor
82960808|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
82960809|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960810|NCT01237067|Carboplatin|carboplatin|mesh-list
82960811|NCT01237067|Olaparib|olaparib|mesh-list
82960812|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960813|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82960814|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960815|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960816|NCT03426982|Heparin|heparin|mesh-list
82960817|NCT03426982|Calcium heparin|calcium heparin|mesh-list
82960818|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
82960819|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82960820|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82960821|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960822|NCT01546948|Methadone|methadone|mesh-list
82960823|NCT01546948|Hydromorphone|hydromorphone|mesh-list
82960824|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82960825|NCT01546948|Narcotics|narcotics|mesh-ancestor
82960826|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960827|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960828|NCT01546948|Analgesics|analgesics|mesh-ancestor
82960829|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
82960830|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960831|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
82960832|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
82960833|NCT00458003|Phenylephrine|phenylephrine|mesh-list
82960834|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
82960835|NCT00458003|Ephedrine|ephedrine|mesh-list
82960836|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82960837|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
82960838|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
82960839|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960840|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960841|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
82960842|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82960843|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
82960844|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
82960845|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82960846|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82960847|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82960848|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
82960849|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960850|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960851|NCT00458003|Protective Agents|protective agents|mesh-ancestor
82960852|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82960853|NCT04599972|Pilocarpine|pilocarpine|mesh-list
82960854|NCT04599972|Miotics|miotics|mesh-ancestor
82960855|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
82960856|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960857|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960858|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82960859|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82960860|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
82960861|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960862|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960864|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82960865|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82960866|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960867|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960868|NCT03008616|Protective Agents|protective agents|mesh-ancestor
82960869|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960870|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
82960871|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82960872|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960873|NCT03426592|Vitamin D|vitamin d|mesh-list
82960874|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
82960875|NCT03426592|Vitamins|vitamins|mesh-ancestor
82960876|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
82960877|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960878|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82960879|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82960880|NCT01567657|Midazolam|midazolam|mesh-list
82960881|NCT01567657|Meperidine|meperidine|mesh-list
82960882|NCT01567657|Propofol|propofol|mesh-list
82960883|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82960884|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960885|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960886|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82960887|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
82960888|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
82960889|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82960890|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82960891|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82960892|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82960893|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
82960894|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
82960895|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960896|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960897|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82960898|NCT01567657|Narcotics|narcotics|mesh-ancestor
82960899|NCT01567657|Analgesics|analgesics|mesh-ancestor
82960900|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
82960901|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960902|NCT03416062|Niacinamide|niacinamide|mesh-list
82960903|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
82960904|NCT03416062|Vitamins|vitamins|mesh-ancestor
82960905|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
82960906|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960907|NCT03761485|Fluorides|fluorides|mesh-list
82960908|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
82960909|NCT03761485|Protective Agents|protective agents|mesh-ancestor
82960910|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960911|NCT03766867|Vortioxetine|vortioxetine|mesh-list
82960912|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
82960913|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82960914|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82960915|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82960916|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960917|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960918|NCT03766867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82960919|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82960920|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82960921|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960922|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960923|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
82960924|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82960925|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82960926|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82960927|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82960928|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
82960929|NCT02061293|Promethazine|promethazine|mesh-list
82960930|NCT02061293|Psilocybin|psilocybin|mesh-list
82960931|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82960932|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82960933|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960934|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960935|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
82960936|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
82960937|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
82960938|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960939|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
82960940|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
82960941|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82960942|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82960943|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
82960944|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
82960945|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82960946|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960947|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82960948|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
82960949|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
82960950|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
82960951|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82960952|NCT03761329|Lidocaine|lidocaine|mesh-list
82960953|NCT03761329|Anesthetics|anesthetics|mesh-list
82960954|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
82960955|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82960956|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960957|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
82960958|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960959|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82960960|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82960961|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82960962|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82960963|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960964|NCT03415906|Valsartan|valsartan|mesh-list
82960965|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82960966|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82960967|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82960968|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82960969|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960970|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
82960971|NCT03415750|Everolimus|everolimus|mesh-list
82960972|NCT03415750|Tacrolimus|tacrolimus|mesh-list
82960973|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82960974|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
82960975|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960976|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82960977|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82960978|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82960979|NCT03415750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82960980|NCT03415750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82960981|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82960982|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82960983|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82960984|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
82960985|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82960986|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82960987|NCT01239719|Clemastine|clemastine|mesh-list
82960988|NCT01239719|Dexamethasone|dexamethasone|mesh-list
82960989|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
82960990|NCT01239719|BB 1101|bb 1101|mesh-list
82960991|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82960992|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
82960993|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
82960994|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82960995|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82960996|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82960997|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
82960998|NCT01239719|Hormones|hormones|mesh-ancestor
82960999|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961000|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82961001|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961002|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
82961003|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961004|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961005|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
82961006|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
82961007|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82961008|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
82961009|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
82961010|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961011|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82961012|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
82961014|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961015|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
82961016|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961017|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961018|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82961019|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
82961020|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961021|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961022|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82961023|NCT03421990|Anesthetics|anesthetics|mesh-list
82961024|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961025|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961026|NCT02913612|Timolol|timolol|mesh-list
82961027|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82961028|NCT02913612|Maleic acid|maleic acid|mesh-list
82961029|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961030|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961031|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82961032|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82961033|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
82961034|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961035|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961036|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82961037|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82961038|NCT03426202|Modafinil|modafinil|mesh-list
82961039|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82961040|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961041|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82961042|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82961043|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82961044|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961045|NCT01248299|Cisplatin|cisplatin|mesh-list
82961046|NCT01248299|Docetaxel|docetaxel|mesh-list
82961047|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
82961048|NCT01248299|Fluorouracil|fluorouracil|mesh-list
82961049|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961050|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
82961051|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
82961052|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
82961053|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961054|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
82961055|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82961056|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961057|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
82961058|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961059|NCT01239875|Vaccines|vaccines|mesh-list
82961060|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82961061|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
82961062|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961063|NCT03415594|Glucagon|glucagon|mesh-list
82961064|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82961065|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82961066|NCT03415594|Hormones|hormones|mesh-ancestor
83221002|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82961067|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961068|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961069|NCT03415594|Incretins|incretins|mesh-ancestor
82961070|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
82961071|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961072|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961073|NCT04219254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82961074|NCT04219254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961075|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
82961076|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
82961077|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82961078|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82961079|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961080|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961081|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961082|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961083|NCT02709954|Ethanol|ethanol|mesh-list
82961084|NCT02709954|Dronabinol|dronabinol|mesh-list
82961085|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82961086|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961087|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961088|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961089|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
82961090|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82961091|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961092|NCT02709954|Analgesics|analgesics|mesh-ancestor
82961093|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
82961094|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961095|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82961096|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82961097|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961098|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961099|NCT02709954|Hormones|hormones|mesh-ancestor
82961100|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961101|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
82961102|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
82961103|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82961104|NCT03620838|Progesterone|progesterone|mesh-list
82961105|NCT03620838|Progestins|progestins|mesh-ancestor
82961106|NCT03620838|Hormones|hormones|mesh-ancestor
82961107|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961108|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961109|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82961110|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82961111|NCT01239953|Paclitaxel|paclitaxel|mesh-list
82961112|NCT01239953|Everolimus|everolimus|mesh-list
82961113|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82961114|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961115|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
82961116|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
82961117|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
82961118|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961119|NCT01239953|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82961120|NCT01239953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82961121|NCT01239953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961122|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961123|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
82961124|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961125|NCT01322191|Morphine|morphine|mesh-list
82961126|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82961127|NCT01322191|Narcotics|narcotics|mesh-ancestor
82961128|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961129|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961130|NCT01322191|Analgesics|analgesics|mesh-ancestor
82961131|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
82961132|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961133|NCT03620760|Aspirin|aspirin|mesh-list
82961134|NCT03620760|Ticagrelor|ticagrelor|mesh-list
82961135|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961136|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961137|NCT03620760|Analgesics|analgesics|mesh-ancestor
82961138|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
82961139|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961140|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961141|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961142|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961143|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82961144|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82961145|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961146|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82961147|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961148|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961149|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
82961150|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82961151|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82961152|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82961153|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
82961154|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961155|NCT03765931|Amoxicillin|amoxicillin|mesh-list
82961156|NCT03765931|Doxycycline|doxycycline|mesh-list
82961157|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82961158|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961159|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
82961160|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82961161|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82961162|NCT01240265|Vitamin D|vitamin d|mesh-list
82961163|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
82961164|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
82961165|NCT01240265|Vitamins|vitamins|mesh-list
82961166|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
82961167|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961168|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82961169|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82961170|NCT02327455|Dobutamine|dobutamine|mesh-list
82961171|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82961172|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
82961173|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
82961174|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961175|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961176|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82961177|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82961178|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82961179|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
82961180|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961181|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961182|NCT02327455|Protective Agents|protective agents|mesh-ancestor
82961183|NCT03638076|Ritonavir|ritonavir|mesh-list
82961184|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82961185|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82961186|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
82961187|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961188|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961189|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82961190|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82961191|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
82961192|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961193|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82961194|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82961195|NCT01329731|Olaflur|olaflur|mesh-list
82961196|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
82961197|NCT01329731|Protective Agents|protective agents|mesh-ancestor
82961198|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961199|NCT03765697|Lidocaine|lidocaine|mesh-list
82961200|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
82961201|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
82961202|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961203|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961204|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
82961205|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83461136|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
82961206|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82961207|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82961208|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82961209|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82961210|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961211|NCT03311841|Rifampin|rifampin|mesh-list
82961212|NCT03311841|Midazolam|midazolam|mesh-list
82961213|NCT03311841|Dabigatran|dabigatran|mesh-list
82961214|NCT03311841|Atorvastatin|atorvastatin|mesh-list
82961215|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82961216|NCT03311841|Pitavastatin|pitavastatin|mesh-list
82961217|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82961218|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82961219|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82961220|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961221|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961222|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82961223|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82961224|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82961225|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82961226|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
82961227|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
82961228|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
82961229|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
82961230|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961231|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961232|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82961233|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82961234|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
82961235|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82961236|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82961237|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961239|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82961240|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
82961241|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
82961242|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82961243|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
82961244|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82961245|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961246|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
82961247|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82961248|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82961249|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82961250|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82961251|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82961252|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82961253|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82961254|NCT01249937|Triamcinolone|triamcinolone|mesh-list
82961255|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82961256|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82961257|NCT01249937|Ranibizumab|ranibizumab|mesh-list
82961258|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82961259|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82961260|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82961261|NCT01249937|Growth Substances|growth substances|mesh-ancestor
82961262|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961263|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
82961264|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961265|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961266|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
82961267|NCT01249937|Hormones|hormones|mesh-ancestor
82961268|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961269|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961270|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
82961271|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961272|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961273|NCT02528201|Celecoxib|celecoxib|mesh-list
82961274|NCT02528201|Diclofenac|diclofenac|mesh-list
83461142|NCT01453946|Hormones|hormones|mesh-ancestor
82961275|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961276|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961277|NCT02528201|Analgesics|analgesics|mesh-ancestor
82961278|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
82961279|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961280|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961281|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961282|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961283|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82961284|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961285|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961286|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961287|NCT03758677|Gemcitabine|gemcitabine|mesh-list
82961288|NCT03758677|Docetaxel|docetaxel|mesh-list
82961289|NCT03758677|Pemetrexed|pemetrexed|mesh-list
82961290|NCT03758677|Apatinib|apatinib|mesh-list
82961291|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82961292|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
82961293|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961294|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961295|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
82961296|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
82961297|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
82961298|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961299|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82961300|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82961301|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82961302|NCT03764683|Suvorexant|suvorexant|mesh-list
82961303|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82961304|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82961305|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961306|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961307|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82961308|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961309|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961310|NCT03414892|Globalagliatin|globalagliatin|mesh-list
82961311|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
82961312|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961314|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961315|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82961316|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
82961317|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961318|NCT03414814|Osimertinib|osimertinib|mesh-list
82961319|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961320|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82961321|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961322|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961323|NCT03421366|Posaconazole|posaconazole|mesh-list
82961324|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
82961325|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961326|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82961327|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82961328|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82961329|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82961330|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82961331|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961332|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961333|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82961334|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
82961335|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961336|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961337|NCT03764605|Metformin|metformin|mesh-list
82961338|NCT03764605|Tolvaptan|tolvaptan|mesh-list
82961339|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82961340|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961341|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82961342|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961343|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
82961344|NCT03764527|Artesunate|artesunate|mesh-list
82961345|NCT03764527|Lumefantrine|lumefantrine|mesh-list
82961346|NCT03764527|Artemether|artemether|mesh-list
82961347|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82961348|NCT03764527|Amodiaquine|amodiaquine|mesh-list
82961349|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
82961350|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82961351|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82961352|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961353|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961354|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
82961355|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
82961356|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82961357|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
82961358|NCT01321801|Pregabalin|pregabalin|mesh-list
82961359|NCT01321801|Analgesics|analgesics|mesh-ancestor
82961360|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
82961361|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961362|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961363|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
82961364|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82961365|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82961366|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961367|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82961368|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82961369|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82961370|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961371|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82961372|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
82961373|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82961374|NCT01155375|Hematinics|hematinics|mesh-ancestor
82961375|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82961376|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82961377|NCT01155375|Trace Elements|trace elements|mesh-ancestor
82961378|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
82961379|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961380|NCT03759301|Cetrorelix|cetrorelix|mesh-list
82961381|NCT03759301|Hormones|hormones|mesh-list
82961382|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961383|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961384|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82961385|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
82961386|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82961387|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
82961388|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
82961389|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82961390|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961391|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
82961392|NCT02260102|Temocillin|temocillin|mesh-list
82961393|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82961394|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961395|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
82961396|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82961397|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961398|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961399|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961400|NCT03425734|Analgesics|analgesics|mesh-ancestor
82961401|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
82961402|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961403|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82961404|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82961405|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82961406|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
83461161|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
82961407|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961408|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961409|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
82961410|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82961411|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
82961412|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
82961413|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961414|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961415|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961416|NCT03420586|Analgesics|analgesics|mesh-ancestor
82961417|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
82961418|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961419|NCT03759067|Clopidogrel|clopidogrel|mesh-list
82961420|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82961421|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82961422|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82961423|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82961424|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
82961425|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961426|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961427|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961428|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
82961429|NCT03425656|Docetaxel|docetaxel|mesh-list
82961430|NCT03425656|Doxorubicin|doxorubicin|mesh-list
82961431|NCT03425656|Trastuzumab|trastuzumab|mesh-list
82961432|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961433|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
82961434|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961435|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961436|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82961437|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
82961438|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961439|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961440|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82961441|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
82961442|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
82961443|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
82961444|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82961445|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82961446|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82961447|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961448|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961449|NCT03413722|Everolimus|everolimus|mesh-list
82961450|NCT03413722|Tacrolimus|tacrolimus|mesh-list
82961451|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961452|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
82961453|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961454|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82961455|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961456|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961457|NCT03413722|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82961458|NCT03413722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82961459|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961460|NCT04843462|Esketamine|esketamine|mesh-list
82961461|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
82961462|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82961463|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
82961464|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82961465|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961466|NCT03413410|Metoprolol|metoprolol|mesh-list
82961467|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82961468|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82961469|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
82961470|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
82961471|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961472|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961473|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82961474|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82961475|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82961476|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
82961477|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961478|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961479|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82961480|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82961481|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
82961482|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961483|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82961484|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82961485|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
82961486|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
82961487|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961488|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961489|NCT03424876|Sunitinib|sunitinib|mesh-list
82961490|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
82961491|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961492|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82961493|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82961494|NCT03424876|Growth Substances|growth substances|mesh-ancestor
82961495|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961496|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
82961497|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82961498|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961499|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961500|NCT03476577|Ibuprofen|ibuprofen|mesh-list
82961501|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961502|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961503|NCT03476577|Analgesics|analgesics|mesh-ancestor
82961504|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
82961505|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961506|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961507|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961508|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961509|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961510|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961511|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961512|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82961514|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961515|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961516|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
82961517|NCT04893915|Fludarabine|fludarabine|mesh-list
82961518|NCT04893915|Interleukin-2|interleukin-2|mesh-list
82961519|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961520|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
82961521|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961522|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961523|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82961524|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
82961525|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961526|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961527|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82961528|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961529|NCT04893915|Analgesics|analgesics|mesh-ancestor
82961530|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
82961531|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961532|NCT03419494|Doxorubicin|doxorubicin|mesh-list
82961533|NCT03419494|Daunorubicin|daunorubicin|mesh-list
82961535|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82961536|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961537|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82961538|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82961539|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961540|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961541|NCT03413020|Amoxicillin|amoxicillin|mesh-list
82961542|NCT03413020|Metronidazole|metronidazole|mesh-list
82961543|NCT03413020|Clarithromycin|clarithromycin|mesh-list
82961544|NCT03413020|Levofloxacin|levofloxacin|mesh-list
82961545|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
82961546|NCT03413020|Esomeprazole|esomeprazole|mesh-list
82961547|NCT03413020|Bismuth|bismuth|mesh-list
82961548|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961549|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82961550|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961551|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82961552|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82961553|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82961554|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82961555|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82961556|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961557|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82961558|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82961559|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82961560|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82961561|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82961562|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82961563|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961564|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82961565|NCT03413020|Antacids|antacids|mesh-ancestor
82961566|NCT03413020|Diuretics|diuretics|mesh-ancestor
82961567|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
82961568|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961569|NCT03413020|Expectorants|expectorants|mesh-ancestor
82961570|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
82961571|NCT03424408|Aspirin|aspirin|mesh-list
82961572|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961573|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961574|NCT03424408|Analgesics|analgesics|mesh-ancestor
82961575|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
82961576|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961577|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961578|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961579|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961580|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82961581|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82961582|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961583|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82961584|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961585|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961586|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
82961587|NCT03305055|Fentanyl|fentanyl|mesh-list
82961588|NCT03305055|Ketamine|ketamine|mesh-list
82961589|NCT03305055|Analgesics|analgesics|mesh-ancestor
82961590|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
82961591|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961592|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961593|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82961594|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82961595|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
82961596|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
82961597|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961598|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82961599|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82961600|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83461194|NCT01456208|Norepinephrine|norepinephrine|mesh-list
82961601|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961602|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82961603|NCT03305055|Narcotics|narcotics|mesh-ancestor
82961604|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82961605|NCT04547985|Naltrexone|naltrexone|mesh-list
82961606|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82961607|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82961608|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961609|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
82961610|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961611|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
82961612|NCT03412552|Analgesics|analgesics|mesh-ancestor
82961613|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
82961614|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961615|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961616|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
82961617|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961618|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82961619|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
82961620|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82961621|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82961622|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961623|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82961624|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
82961625|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82961626|NCT03412474|Acetaminophen|acetaminophen|mesh-list
82961627|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
82961628|NCT03412474|Bupivacaine|bupivacaine|mesh-list
82961629|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
82961630|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
82961631|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961632|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961633|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
82961634|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961635|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82961636|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961637|NCT03412474|Analgesics|analgesics|mesh-ancestor
82961638|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82961639|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82961640|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82961641|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
82961642|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961643|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961644|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
82961645|NCT03273387|Trimetazidine|trimetazidine|mesh-list
82961646|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
82961647|NCT04527003|Cannabidiol|cannabidiol|mesh-list
82961648|NCT04527003|Norethindrone|norethindrone|mesh-list
82961649|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
82961650|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
82961651|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82961652|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82961653|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82961654|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
82961655|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82961656|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961657|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82961658|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82961659|NCT04447612|Gemcitabine|gemcitabine|mesh-list
82961660|NCT04447612|Durvalumab|durvalumab|mesh-list
82961661|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961662|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82961663|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
82961664|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961665|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961666|NCT03418558|Trastuzumab|trastuzumab|mesh-list
82961667|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82961668|NCT03418558|Maytansine|maytansine|mesh-list
82961669|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961670|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961671|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82961672|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
82961673|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
82961674|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
82961675|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961676|NCT03418558|Immunotoxins|immunotoxins|mesh-ancestor
82961677|NCT03418558|Immunoconjugates|immunoconjugates|mesh-ancestor
82961678|NCT03418558|Immunologic Factors|immunologic factors|mesh-ancestor
82961679|NCT03418558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961680|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
82961681|NCT05170828|Sirolimus|sirolimus|mesh-list
82961682|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
82961683|NCT05170828|Busulfan|busulfan|mesh-list
82961684|NCT05170828|Fludarabine|fludarabine|mesh-list
82961686|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
82961687|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961688|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961689|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82961690|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
82961691|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961692|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961693|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82961694|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82961695|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82961696|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
82961697|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82961698|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961699|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961700|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
82961701|NCT03412006|Fulacimstat|fulacimstat|mesh-list
82961702|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961703|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961704|NCT03418246|Calcium|calcium|mesh-list
82961705|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82961706|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961707|NCT03411850|Abatacept|abatacept|mesh-list
82961708|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82961709|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961710|NCT03411850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961711|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961712|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82961713|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
82961714|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961715|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961716|NCT05170594|Bevacizumab|bevacizumab|mesh-list
82961717|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
82961718|NCT05170594|Fluzoparib|fluzoparib|mesh-list
82961719|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961720|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961721|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82961722|NCT05170594|Growth Substances|growth substances|mesh-ancestor
82961723|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961724|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
82961725|NCT05170594|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82961726|NCT05170594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961727|NCT05170594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961728|NCT03410836|Lidocaine|lidocaine|mesh-list
82961729|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
82961730|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
82961731|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961732|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961733|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
82961734|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961735|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82961736|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82961737|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82961738|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82961739|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961740|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
82961741|NCT03273153|Atezolizumab|atezolizumab|mesh-list
82961742|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961743|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961744|NCT03273153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82961745|NCT03273153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961747|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82961748|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
82961749|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
82961750|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961751|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961752|NCT03323034|Irinotecan|irinotecan|mesh-list
82961753|NCT03323034|Temozolomide|temozolomide|mesh-list
82961754|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82961755|NCT03323034|Pevonedistat|pevonedistat|mesh-list
82961756|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82961757|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82961758|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961759|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961760|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82961761|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
82961762|NCT02520934|Miglustat|miglustat|mesh-list
82961763|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961764|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961765|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82961766|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82961767|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
82961768|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961769|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82961770|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82961771|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961772|NCT02749968|Bupivacaine|bupivacaine|mesh-list
82961773|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
82961774|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
82961775|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961776|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961777|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
82961778|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961779|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82961780|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82961781|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961782|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
82961783|NCT03417700|Vitamin D|vitamin d|mesh-list
82961784|NCT03417700|Vitamins|vitamins|mesh-ancestor
82961785|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
82961786|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961787|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82961788|NCT03410524|Simethicone|simethicone|mesh-list
82961789|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
82961790|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961791|NCT03410524|Emollients|emollients|mesh-ancestor
82961792|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
82961793|NCT02713776|Pasireotide|pasireotide|mesh-list
82961794|NCT02713776|Somatostatin|somatostatin|mesh-list
82961795|NCT02713776|Hormones|hormones|mesh-ancestor
82961796|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82961797|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961798|NCT05215990|Metformin|metformin|mesh-list
82961799|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82961800|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961801|NCT03268941|Metoclopramide|metoclopramide|mesh-list
82961802|NCT03268941|Maleic acid|maleic acid|mesh-list
82961803|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961804|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961805|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
82961806|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
82961807|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961808|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961809|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82961810|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82961811|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82961812|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
82961813|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961814|NCT05215834|Remifentanil|remifentanil|mesh-list
82961815|NCT05215834|Propofol|propofol|mesh-list
82961816|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83519787|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
82961817|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961818|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961819|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82961820|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
82961821|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
82961822|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82961823|NCT05215834|Narcotics|narcotics|mesh-ancestor
82961824|NCT05215834|Analgesics|analgesics|mesh-ancestor
82961825|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
82961826|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961827|NCT03394144|Durvalumab|durvalumab|mesh-list
82961828|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961829|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961830|NCT05011149|Ibuprofen|ibuprofen|mesh-list
82961831|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961832|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961833|NCT05011149|Analgesics|analgesics|mesh-ancestor
82961834|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
82961835|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961836|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961837|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961838|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961839|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961840|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961841|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961842|NCT03393988|Fentanyl|fentanyl|mesh-list
82961843|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
82961844|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
82961845|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82961846|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961847|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961848|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961849|NCT03393988|Analgesics|analgesics|mesh-ancestor
82961850|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
82961851|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961852|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82961853|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82961854|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82961855|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
82961856|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961857|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961858|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82961859|NCT03393988|Narcotics|narcotics|mesh-ancestor
82961860|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82961861|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82961862|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
82961863|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
82961864|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
82961865|NCT03410212|Ketorolac|ketorolac|mesh-list
82961866|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82961867|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961868|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961869|NCT03410212|Analgesics|analgesics|mesh-ancestor
82961870|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
82961871|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961872|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961873|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961874|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961875|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961876|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961877|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961878|NCT03397264|Aflibercept|aflibercept|mesh-list
82961879|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82961880|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82961881|NCT03397264|Growth Substances|growth substances|mesh-ancestor
82961882|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961883|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
82961884|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961885|NCT03397186|Trabectedin|trabectedin|mesh-list
82961886|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82961887|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
82961888|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961889|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961890|NCT03393364|Ketorolac|ketorolac|mesh-list
82961891|NCT03393364|Oxycodone|oxycodone|mesh-list
82961892|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82961893|NCT03393364|Narcotics|narcotics|mesh-ancestor
82961894|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961895|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961896|NCT03393364|Analgesics|analgesics|mesh-ancestor
82961897|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
82961898|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961899|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961900|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961901|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961902|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961903|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961904|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961905|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961906|NCT04632706|Ivermectin|ivermectin|mesh-list
82961907|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82961908|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961909|NCT03405454|Durvalumab|durvalumab|mesh-list
82961910|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82961911|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961912|NCT05168176|Dolutegravir|dolutegravir|mesh-list
82961913|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82961914|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82961915|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961916|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961917|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82961918|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82961919|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
82961920|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82961921|NCT04539730|Bupivacaine|bupivacaine|mesh-list
82961922|NCT04539730|Ropivacaine|ropivacaine|mesh-list
82961923|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
82961924|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
82961925|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961926|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961927|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
82961928|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961929|NCT03396484|Methyldopa|methyldopa|mesh-list
82961930|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82961931|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
82961932|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
82961933|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961934|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961935|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82961936|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82961937|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82961938|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
82961939|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961940|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961941|NCT03321396|Calcium|calcium|mesh-list
82961942|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82961943|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961944|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
82961945|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
82961946|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82961947|NCT03321006|Escitalopram|escitalopram|mesh-list
82961948|NCT03321006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82961949|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82961950|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82961951|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961952|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82961953|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
82961954|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961955|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961956|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
82961957|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82961958|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82961959|NCT03321006|Analgesics|analgesics|mesh-ancestor
82961960|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
82961961|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
82961962|NCT04760626|Insulin|insulin|mesh-list
82961963|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82961964|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
82961965|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82961966|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961967|NCT01974609|Acetaminophen|acetaminophen|mesh-list
82961968|NCT01974609|Ibuprofen|ibuprofen|mesh-list
82961969|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
82961970|NCT01974609|Hydrocodone|hydrocodone|mesh-list
82961971|NCT01974609|Narcotics|narcotics|mesh-list
82961972|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82961973|NCT01974609|Analgesics|analgesics|mesh-ancestor
82961974|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
82961975|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82961976|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961977|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
82961978|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82961979|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82961980|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82961981|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82961982|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82961983|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82961985|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82961986|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
82961987|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
82961988|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
82961989|NCT02593123|Molgramostim|molgramostim|mesh-list
82961990|NCT02593123|Lenograstim|lenograstim|mesh-list
82961991|NCT02593123|Sargramostim|sargramostim|mesh-list
82961992|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82961993|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
82961994|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82961995|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82961996|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82961997|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82961998|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
82961999|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82962000|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962001|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962002|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962003|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
82962004|NCT03396250|Promethazine|promethazine|mesh-list
82962005|NCT03396250|Naproxen|naproxen|mesh-list
82962006|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82962007|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962008|NCT03396250|Analgesics|analgesics|mesh-ancestor
82962009|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
82962010|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962011|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962012|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962013|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962014|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
82962015|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82962016|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962017|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962018|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82962019|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82962020|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962021|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
82962022|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
82962023|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
82962024|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
82962025|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82962026|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82962027|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
82962028|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
82962029|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962030|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82962031|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
82962032|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962033|NCT03302559|Vitamin A|vitamin a|mesh-list
82962034|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
82962035|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
82962036|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82962037|NCT03302559|Protective Agents|protective agents|mesh-ancestor
82962038|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962039|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962040|NCT03302559|Vitamins|vitamins|mesh-ancestor
82962041|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
82962042|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
82962043|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962044|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82962045|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962047|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
82962048|NCT03763669|Inositol|inositol|mesh-list
82962049|NCT03763669|Hematinics|hematinics|mesh-ancestor
82962050|NCT03763669|Vitamins|vitamins|mesh-ancestor
82962051|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
82962052|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962053|NCT03302247|Gemcitabine|gemcitabine|mesh-list
82962054|NCT03302247|Nivolumab|nivolumab|mesh-list
82962055|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82962056|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
82962057|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962058|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962059|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962060|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82962061|NCT01758081|Vitamin D|vitamin d|mesh-list
82962062|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
82962063|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
82962064|NCT01758081|Vitamins|vitamins|mesh-list
82962065|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
82962066|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962067|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82962068|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82962069|NCT04363840|Aspirin|aspirin|mesh-list
82962070|NCT04363840|Vitamin D|vitamin d|mesh-list
82962071|NCT04363840|Vitamins|vitamins|mesh-ancestor
82962072|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
82962073|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962074|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82962075|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82962076|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962077|NCT04363840|Analgesics|analgesics|mesh-ancestor
82962078|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
82962079|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962080|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962081|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962082|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82962083|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82962084|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962085|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82962086|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82962087|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962088|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
82962089|NCT04981665|Tislelizumab|tislelizumab|mesh-list
82962090|NCT04981665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962091|NCT04981665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962092|NCT03392740|Lisinopril|lisinopril|mesh-list
82962093|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82962094|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
82962095|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962096|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962097|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82962098|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82962099|NCT03392740|Protective Agents|protective agents|mesh-ancestor
82962100|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962101|NCT04919317|Dexamethasone|dexamethasone|mesh-list
82962102|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962103|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
82962104|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
82962105|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962106|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962107|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82962108|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
82962109|NCT04919317|Hormones|hormones|mesh-ancestor
82962110|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962111|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82962112|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962113|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
82962114|NCT02818023|Vemurafenib|vemurafenib|mesh-list
82962115|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962116|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962117|NCT02818023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82962118|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962119|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82962120|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962121|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82962122|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82962123|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962124|NCT04631536|Folic Acid|folic acid|mesh-list
82962125|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
82962126|NCT04631536|Nicorandil|nicorandil|mesh-list
82962127|NCT04631536|Nebivolol|nebivolol|mesh-list
82962128|NCT04631536|Atorvastatin|atorvastatin|mesh-list
82962129|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82962130|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82962131|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
82962132|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962133|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82962134|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82962135|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962136|NCT04631536|Hematinics|hematinics|mesh-ancestor
82962138|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
82962139|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962140|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82962141|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
82962142|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82962143|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82962144|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82962145|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
82962146|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962147|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82962148|NCT03262233|Nicotine|nicotine|mesh-list
82962149|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82962150|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
82962151|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962152|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962153|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82962154|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82962155|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962156|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962157|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962158|NCT05166538|Clopidogrel|clopidogrel|mesh-list
82962159|NCT05166538|Ticagrelor|ticagrelor|mesh-list
82962160|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82962161|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82962162|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82962163|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82962164|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
82962165|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962166|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962167|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962168|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
82962169|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82962170|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962171|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82962172|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82962173|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962174|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962175|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
82962176|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962177|NCT04666441|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
82962178|NCT04666441|Antiviral Agents|antiviral agents|mesh-ancestor
82962179|NCT04666441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962180|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
82962181|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82962182|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82962183|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82962184|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962185|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962186|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962187|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962188|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962189|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82962190|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962191|NCT04447378|PENTA|penta|mesh-list
82962192|NCT04447378|Fondaparinux|fondaparinux|mesh-list
82962193|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82962194|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
82962195|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82962196|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
82962197|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962198|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962199|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
82962200|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82962201|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82962202|NCT03125980|Capecitabine|capecitabine|mesh-list
82962203|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
82962204|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82962205|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
82962206|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962207|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962208|NCT03399604|Treprostinil|treprostinil|mesh-list
82962209|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82962210|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
82962211|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962212|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82962213|NCT03399526|Calcitriol|calcitriol|mesh-list
82962214|NCT03399526|Betamethasone|betamethasone|mesh-list
82962215|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
82962216|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82962217|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
82962218|NCT03399526|Clobetasol|clobetasol|mesh-list
82962219|NCT03399526|Prednicarbate|prednicarbate|mesh-list
82962220|NCT03399526|Calcipotriene|calcipotriene|mesh-list
82962221|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82962222|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962223|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
82962224|NCT03399526|Hormones|hormones|mesh-ancestor
82962225|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962226|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962227|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82962228|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962229|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962230|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82962231|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82962232|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962233|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962234|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82962235|NCT03399526|Vitamins|vitamins|mesh-ancestor
82962236|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
82962237|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82962238|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82962239|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
82962240|NCT03392272|Coagulants|coagulants|mesh-ancestor
82962241|NCT03905902|Vaccines|vaccines|mesh-list
82962242|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
82962243|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962244|NCT03638310|Gentamicins|gentamicins|mesh-list
82962245|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82962246|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962247|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82962248|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962249|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962250|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
82962251|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
82962252|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962253|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
82962254|NCT03399448|Fludarabine|fludarabine|mesh-list
82962255|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82962256|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
82962257|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962258|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962259|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82962260|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
82962261|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962262|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962263|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82962264|NCT03755947|Venetoclax|venetoclax|mesh-list
82962265|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
82962266|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962267|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962268|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82962269|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82962270|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82962271|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
82962272|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962273|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82962274|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82962275|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962276|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
82962277|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
82962278|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962279|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962280|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962281|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
82962282|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
82962283|NCT01610700|Nabiximols|nabiximols|mesh-list
82962284|NCT01610700|Analgesics|analgesics|mesh-ancestor
82962285|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
82962287|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962288|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
82962289|NCT04632459|Ramucirumab|ramucirumab|mesh-list
82962290|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962291|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962292|NCT04632459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82962293|NCT04632459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962294|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82962295|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82962296|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
82962297|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962298|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962299|NCT03316872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82962300|NCT03316872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962301|NCT03256695|Albuterol|albuterol|mesh-list
82962302|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82962303|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
82962304|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962305|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962306|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82962307|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962308|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
82962309|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82962310|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82962311|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82962312|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82962313|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
82962314|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962315|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962316|NCT04623684|Phenylephrine|phenylephrine|mesh-list
82962317|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
82962318|NCT04623684|Tropicamide|tropicamide|mesh-list
82962319|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82962320|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
82962321|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
82962322|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962323|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962324|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
82962325|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82962326|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
82962327|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962328|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82962329|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82962330|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82962331|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
82962332|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962333|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962334|NCT04623684|Protective Agents|protective agents|mesh-ancestor
82962335|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82962336|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82962337|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962338|NCT03297021|Ondansetron|ondansetron|mesh-list
82962339|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
82962340|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
82962341|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962342|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962343|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82962344|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
82962345|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962346|NCT03297021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82962347|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82962348|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
82962349|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962350|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962351|NCT03752749|Prednisolone|prednisolone|mesh-list
82962352|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962353|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
82962354|NCT03752749|Hormones|hormones|mesh-ancestor
82962355|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962356|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962357|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82962358|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962359|NCT01988571|Atorvastatin|atorvastatin|mesh-list
82962360|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82962361|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82962362|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
82962363|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962364|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82962365|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82962366|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962367|NCT00536172|Escitalopram|escitalopram|mesh-list
82962368|NCT00536172|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82962369|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82962370|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962371|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962372|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962373|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
82962374|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962375|NCT03755557|Budesonide|budesonide|mesh-list
82962376|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962377|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82962378|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
82962379|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962380|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962381|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82962382|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962383|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
82962384|NCT03755557|Hormones|hormones|mesh-ancestor
82962385|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962386|NCT03511599|Cycloserine|cycloserine|mesh-list
82962387|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82962388|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962389|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82962390|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
82962391|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82962392|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
82962393|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962394|NCT01140867|Zonisamide|zonisamide|mesh-list
82962395|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
82962396|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82962397|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962398|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962399|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82962400|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962401|NCT04572997|Apremilast|apremilast|mesh-list
82962402|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82962403|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962404|NCT04572997|Analgesics|analgesics|mesh-ancestor
82962405|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
82962406|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962407|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962408|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962409|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962410|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82962411|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82962412|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962413|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962414|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82962415|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82962416|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962417|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83519865|NCT05806749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962418|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962420|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
82962421|NCT02891070|Coagulants|coagulants|mesh-ancestor
82962422|NCT00381381|Donepezil|donepezil|mesh-list
82962423|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82962424|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461275|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962425|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962426|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962427|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962428|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962429|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
82962430|NCT03637335|Carboplatin|carboplatin|mesh-list
82962431|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962432|NCT02939937|Phenytoin|phenytoin|mesh-list
82962433|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
82962434|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82962435|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82962436|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962437|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962438|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82962439|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82962440|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82962441|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82962442|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962443|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82962444|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
82962445|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962446|NCT02774265|Aspirin|aspirin|mesh-list
82962447|NCT02774265|Heparin|heparin|mesh-list
82962448|NCT02774265|Enoxaparin|enoxaparin|mesh-list
82962449|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82962450|NCT02774265|Tinzaparin|tinzaparin|mesh-list
82962451|NCT02774265|Dalteparin|dalteparin|mesh-list
82962452|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82962453|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962454|NCT02774265|Analgesics|analgesics|mesh-ancestor
82962455|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
82962456|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962457|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962458|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962459|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962460|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82962461|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82962462|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962463|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82962464|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82962465|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962466|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
82962467|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
82962468|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82962469|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82962470|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82962471|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962472|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962473|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82962474|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962475|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962476|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962477|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962478|NCT03755479|Insulin|insulin|mesh-list
82962479|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82962480|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962481|NCT05239390|Dronabinol|dronabinol|mesh-list
82962482|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
82962483|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962484|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82962485|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962486|NCT05239390|Analgesics|analgesics|mesh-ancestor
82962487|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
82962488|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962489|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82962490|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82962491|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962492|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962493|NCT05239390|Hormones|hormones|mesh-ancestor
82962494|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962495|NCT03752437|Heparin|heparin|mesh-list
82962496|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
82962497|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82962498|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82962499|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962500|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
82962501|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82962502|NCT04748341|Benzocaine|benzocaine|mesh-list
82962503|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
82962504|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
82962505|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962506|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962507|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
82962508|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962509|NCT01328002|Milnacipran|milnacipran|mesh-list
82962510|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
82962511|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82962512|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82962513|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962514|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962515|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962516|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962517|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962518|NCT01328002|Analgesics|analgesics|mesh-ancestor
82962519|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
82962520|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962521|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
82962522|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82962523|NCT05239078|Anesthetics|anesthetics|mesh-list
82962524|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
82962525|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962526|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962527|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
82962528|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962529|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82962530|NCT02579265|SMOFlipid|smoflipid|mesh-list
82962531|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
82962532|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82962533|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82962534|NCT05238220|Valganciclovir|valganciclovir|mesh-list
82962535|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
82962536|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962537|NCT04446598|Tadalafil|tadalafil|mesh-list
82962538|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
82962539|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82962540|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82962541|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962542|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962543|NCT04446598|Urological Agents|urological agents|mesh-ancestor
82962544|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
82962545|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82962546|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962547|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962548|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82962549|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962550|NCT03391570|Analgesics|analgesics|mesh-ancestor
82962551|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
82962552|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962553|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962554|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962555|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962556|NCT03755089|Lidocaine|lidocaine|mesh-list
82962557|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
82962558|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
82962559|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962560|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962561|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
82962562|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962563|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83461283|NCT01456364|Ticagrelor|ticagrelor|mesh-list
82962564|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82962566|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962567|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962568|NCT03757117|Hormones|hormones|mesh-list
82962569|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962570|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962571|NCT03752125|Caffeine|caffeine|mesh-list
82962572|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82962573|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962574|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82962575|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962576|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962577|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82962578|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82962579|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
82962580|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962582|NCT03289533|Axitinib|axitinib|mesh-list
82962583|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962584|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962585|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82962586|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962587|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962588|NCT03395002|Fluticasone|fluticasone|mesh-list
82962589|NCT03395002|Xhance|xhance|mesh-list
82962590|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
82962591|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82962592|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962593|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82962594|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
82962595|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962596|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962597|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82962598|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962599|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962600|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82962601|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
82962602|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82962603|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962604|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962605|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962606|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82962607|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82962608|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82962609|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
82962610|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
82962611|NCT05238064|Doxorubicin|doxorubicin|mesh-list
82962612|NCT05238064|Vincristine|vincristine|mesh-list
82962613|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82962614|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
82962615|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962616|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962617|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82962618|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
82962619|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962620|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962621|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82962622|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82962623|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82962624|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82962625|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962626|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82962627|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
82962628|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
82962629|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
82962630|NCT03390790|Lidocaine|lidocaine|mesh-list
82962631|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
82962632|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
82962633|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962634|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962635|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
82962636|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962637|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83520014|NCT05804747|Antithrombins|antithrombins|mesh-ancestor
82962638|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82962639|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82962640|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82962641|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962642|NCT03697993|Levofloxacin|levofloxacin|mesh-list
82962643|NCT03697993|Fosfomycin|fosfomycin|mesh-list
82962644|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82962645|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962646|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82962647|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82962648|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82962649|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962650|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962652|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82962653|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82962654|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
82962655|NCT05393245|Olodaterol|olodaterol|mesh-list
82962656|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
82962657|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
82962658|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82962659|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
82962660|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962661|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962662|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82962663|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962664|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
82962665|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82962666|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962667|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962668|NCT04544995|Niraparib|niraparib|mesh-list
82962669|NCT04544995|Dostarlimab|dostarlimab|mesh-list
82962670|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82962671|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962672|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962673|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962674|NCT03390712|Risperidone|risperidone|mesh-list
82962675|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82962676|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
82962677|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82962678|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
82962679|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962680|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962681|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962682|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82962683|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962684|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82962685|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82962686|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
82962687|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82962688|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82962689|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
82962690|NCT03756727|Vitamins|vitamins|mesh-ancestor
82962691|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
82962692|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962693|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
82962694|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962695|NCT03756727|Protective Agents|protective agents|mesh-ancestor
82962696|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82962697|NCT03398434|Apixaban|apixaban|mesh-list
82962698|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82962699|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
82962700|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82962701|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
82962702|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962703|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962704|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
82962705|NCT03398122|Apatinib|apatinib|mesh-list
83461293|NCT04281420|Niacin|niacin|mesh-list
82962706|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962707|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82962708|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962709|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962710|NCT05459857|Menthol|menthol|mesh-list
82962711|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
82962712|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962713|NCT03394222|Budesonide|budesonide|mesh-list
82962714|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962715|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82962716|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
82962717|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962718|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962719|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82962720|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962721|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
82962722|NCT03394222|Hormones|hormones|mesh-ancestor
82962723|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962737|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962738|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962739|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
82962740|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82962741|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82962742|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
82962743|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962744|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962745|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82962746|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
82962747|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
82962748|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82962749|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962750|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962751|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962752|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
82962753|NCT02813200|Hormones|hormones|mesh-ancestor
82962754|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962755|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
82962756|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82962757|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82962758|NCT03750721|Rifampin|rifampin|mesh-list
82962759|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82962760|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
82962761|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82962762|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962763|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
82962764|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82962765|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962766|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962767|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82962768|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82962769|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82962770|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82962771|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82962772|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82962773|NCT01481272|Leucovorin|leucovorin|mesh-list
82962774|NCT01481272|Cytarabine|cytarabine|mesh-list
82962775|NCT01481272|Methotrexate|methotrexate|mesh-list
82962776|NCT01481272|Etoposide|etoposide|mesh-list
82962777|NCT01481272|Ofatumumab|ofatumumab|mesh-list
82962778|NCT01481272|Lenograstim|lenograstim|mesh-list
82962779|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82962780|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
82962781|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82962782|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962783|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82962784|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
82962785|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962787|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962788|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962789|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82962790|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82962791|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
82962792|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962793|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82962794|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82962795|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82962796|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82962797|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
82962798|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962799|NCT01481272|Antidotes|antidotes|mesh-ancestor
82962800|NCT01481272|Protective Agents|protective agents|mesh-ancestor
82962801|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
82962802|NCT01481272|Vitamins|vitamins|mesh-ancestor
82962803|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
82962804|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82962805|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
82962806|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962807|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962808|NCT04478695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82962809|NCT04478695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962810|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
82962811|NCT02687386|Analgesics|analgesics|mesh-ancestor
82962812|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
82962813|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962814|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962815|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962816|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82962817|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82962818|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962819|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962820|NCT04531813|Butenafine|butenafine|mesh-list
82962821|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
82962822|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962823|NCT01380028|Prednisone|prednisone|mesh-list
82962824|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962825|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
82962826|NCT01380028|Hormones|hormones|mesh-ancestor
82962827|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962828|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962829|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82962830|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962831|NCT01305460|Azacitidine|azacitidine|mesh-list
82962832|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82962833|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
82962834|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962835|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962836|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962838|NCT03754543|Trace Elements|trace elements|mesh-ancestor
82962839|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
82962840|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962841|NCT01199302|Brodalumab|brodalumab|mesh-list
82962842|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
82962843|NCT03754387|Ceftazidime|ceftazidime|mesh-list
82962844|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82962845|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962846|NCT03171480|Isosorbide|isosorbide|mesh-list
82962847|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82962848|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82962849|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82962850|NCT03171480|Diuretics|diuretics|mesh-ancestor
82962851|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
82962852|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962853|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
82962854|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82962855|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962856|NCT04465357|Erenumab|erenumab|mesh-list
82962857|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82962858|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962859|NCT04465357|Analgesics|analgesics|mesh-ancestor
82962860|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
82962861|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962862|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962864|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82962865|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82962866|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
82962867|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
82962868|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962869|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962870|NCT01384058|Simvastatin|simvastatin|mesh-list
82962871|NCT01384058|Ezetimibe|ezetimibe|mesh-list
82962872|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82962873|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82962874|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
82962875|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962876|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82962877|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82962878|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962879|NCT04401384|Pyridoxine|pyridoxine|mesh-list
82962880|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
82962881|NCT04401384|Doxylamine|doxylamine|mesh-list
82962882|NCT04401384|Dicyclomine|dicyclomine|mesh-list
82962883|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
82962884|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
82962885|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962886|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962887|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82962888|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82962889|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
82962890|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
82962891|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962892|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962893|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
82962894|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82962895|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82962896|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
82962897|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
82962898|NCT04401384|Vitamins|vitamins|mesh-ancestor
82962899|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
82962900|NCT03312114|Avelumab|avelumab|mesh-list
82962901|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82962902|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962903|NCT04239222|Ibuprofen|ibuprofen|mesh-list
82962904|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82962905|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962906|NCT04239222|Analgesics|analgesics|mesh-ancestor
82962907|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
82962908|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962909|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962910|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962911|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962912|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82962913|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962914|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962915|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
82962916|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
82962917|NCT02566304|Fludarabine|fludarabine|mesh-list
82962918|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
82962919|NCT02566304|Tacrolimus|tacrolimus|mesh-list
82962920|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82962921|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
82962922|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962923|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962924|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82962925|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
82962926|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962927|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962928|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82962929|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82962930|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
82962931|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962932|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82962933|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962934|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83461299|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
82962935|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82962936|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
82962937|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82962939|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82962940|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962941|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962942|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962943|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
82962944|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82962945|NCT03084536|Acetaminophen|acetaminophen|mesh-list
82962946|NCT03084536|Celecoxib|celecoxib|mesh-list
82962947|NCT03084536|Fentanyl|fentanyl|mesh-list
82962948|NCT03084536|Midazolam|midazolam|mesh-list
82962949|NCT03084536|Gabapentin|gabapentin|mesh-list
82962950|NCT03084536|Bupivacaine|bupivacaine|mesh-list
82962951|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
82962952|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
82962953|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82962954|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962955|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
82962956|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82962957|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82962958|NCT03084536|Narcotics|narcotics|mesh-ancestor
82962959|NCT03084536|Analgesics|analgesics|mesh-ancestor
82962960|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82962961|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82962962|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
82962963|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82962964|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82962965|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82962966|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82962967|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
82962968|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
82962969|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82962970|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962971|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82962972|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
82962973|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82962974|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82962975|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82962976|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82962977|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82962978|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82962979|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
82962980|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82962981|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82962982|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
82962983|NCT03311724|Tirzepatide|tirzepatide|mesh-list
82962984|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82962985|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82962986|NCT03311724|Incretins|incretins|mesh-ancestor
82962987|NCT03311724|Hormones|hormones|mesh-ancestor
82962988|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82962989|NCT05213312|Paclitaxel|paclitaxel|mesh-list
82962990|NCT05213312|Fluorouracil|fluorouracil|mesh-list
82962991|NCT05213312|Nivolumab|nivolumab|mesh-list
82962992|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82962993|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82962994|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
82962995|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
82962996|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
82962997|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82962998|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
82962999|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82963000|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963001|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
82963002|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963003|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963004|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82963005|NCT03311646|Nicotine|nicotine|mesh-list
82963006|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82963007|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
82963008|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963009|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963010|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82963011|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82963012|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
82963013|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963014|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963016|NCT03680274|Vitamins|vitamins|mesh-ancestor
82963017|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
82963018|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963019|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
82963020|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963021|NCT03680274|Protective Agents|protective agents|mesh-ancestor
82963022|NCT03288987|Leucovorin|leucovorin|mesh-list
82963023|NCT03288987|Bevacizumab|bevacizumab|mesh-list
82963024|NCT03288987|Fluorouracil|fluorouracil|mesh-list
82963025|NCT03288987|Irinotecan|irinotecan|mesh-list
82963026|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963027|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963028|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82963029|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82963030|NCT03288987|Growth Substances|growth substances|mesh-ancestor
82963031|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963032|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
82963033|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
82963034|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963035|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82963036|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963037|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
82963038|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82963039|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82963040|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963041|NCT03288987|Antidotes|antidotes|mesh-ancestor
82963042|NCT03288987|Protective Agents|protective agents|mesh-ancestor
82963043|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
82963044|NCT03288987|Vitamins|vitamins|mesh-ancestor
82963045|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
82963046|NCT01379846|Vaccines|vaccines|mesh-list
82963047|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
82963048|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963049|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
82963050|NCT01379300|Dabigatran|dabigatran|mesh-list
82963051|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82963052|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
82963053|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82963054|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
82963055|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963056|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963057|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
82963058|NCT03682224|Epinephrine|epinephrine|mesh-list
82963059|NCT03682224|Bupivacaine|bupivacaine|mesh-list
82963060|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
82963061|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
82963062|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963063|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963064|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
82963065|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963066|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82963067|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82963068|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
82963069|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963070|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963071|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82963072|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82963073|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
82963074|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82963075|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
82963076|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
82963077|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
82963078|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82963079|NCT01383044|Carvedilol|carvedilol|mesh-list
82963080|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82963081|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82963082|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
82963083|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963084|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963085|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963086|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82963087|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
82963088|NCT01383044|Protective Agents|protective agents|mesh-ancestor
82963089|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82963090|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82963091|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82963092|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
82963093|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82963094|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82963095|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
82963096|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82963097|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
82963098|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963099|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963100|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82963101|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
82963102|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82963103|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82963104|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82963105|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
82963106|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483179|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82963107|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963108|NCT03083990|Bevacizumab|bevacizumab|mesh-list
82963109|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963110|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963111|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82963112|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82963113|NCT03083990|Growth Substances|growth substances|mesh-ancestor
82963114|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963115|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
82963116|NCT03252015|Lasmiditan|lasmiditan|mesh-list
82963117|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82963118|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
82963119|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963120|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963121|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963122|NCT01314027|Gemcitabine|gemcitabine|mesh-list
82963123|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
82963124|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82963125|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
82963126|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963127|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963128|NCT03708003|Venetoclax|venetoclax|mesh-list
82963129|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963130|NCT03083132|Modafinil|modafinil|mesh-list
82963131|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82963132|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963133|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82963134|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82963135|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82963136|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963137|NCT04121468|Metformin|metformin|mesh-list
82963138|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82963139|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963140|NCT03648489|Paclitaxel|paclitaxel|mesh-list
82963141|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82963142|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963143|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
82963144|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
82963145|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
82963146|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963147|NCT01382888|Heparin|heparin|mesh-list
82963148|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
82963149|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82963150|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82963151|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963152|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82963153|NCT03249909|Laxatives|laxatives|mesh-ancestor
82963154|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82963155|NCT04809116|Pimavanserin|pimavanserin|mesh-list
82963156|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82963157|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82963158|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82963159|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82963160|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963161|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963163|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82963164|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82963165|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
82963166|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963167|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963168|NCT03077438|Vaccines|vaccines|mesh-list
82963169|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
82963170|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963171|NCT01382732|Oxytocin|oxytocin|mesh-list
82963172|NCT01382732|Carbetocin|carbetocin|mesh-list
82963173|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
82963174|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82963175|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963176|NCT02183870|Crizotinib|crizotinib|mesh-list
82963177|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963178|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82963179|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963180|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963181|NCT03076970|Sumatriptan|sumatriptan|mesh-list
82963182|NCT03076970|Lasmiditan|lasmiditan|mesh-list
82963183|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82963184|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82963185|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82963186|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
82963187|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963188|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963189|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963190|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
82963191|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
82963192|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82963193|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82963194|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963195|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963196|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963197|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963198|NCT04897880|Panobinostat|panobinostat|mesh-list
82963199|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963200|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82963201|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963202|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963203|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
82963204|NCT02890992|Niacin|niacin|mesh-list
82963205|NCT02890992|Niacinamide|niacinamide|mesh-list
82963206|NCT02890992|Ezetimibe|ezetimibe|mesh-list
82963207|NCT02890992|Alirocumab|alirocumab|mesh-list
82963208|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
82963209|NCT02890992|Fenofibrate|fenofibrate|mesh-list
82963210|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82963211|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82963212|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
82963213|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963214|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82963215|NCT02890992|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82963216|NCT02890992|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82963217|NCT02890992|Protease Inhibitors|protease inhibitors|mesh-ancestor
82963218|NCT02890992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963219|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
82963220|NCT02890992|Vitamins|vitamins|mesh-ancestor
82963221|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
82963222|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963223|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
82963224|NCT03603912|Metformin|metformin|mesh-list
82963225|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82963226|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963227|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82963228|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82963229|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82963230|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963231|NCT05274984|Lidocaine|lidocaine|mesh-list
82963232|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
82963233|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
82963234|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963235|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963236|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
82963237|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963238|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82963239|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82963240|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82963241|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82963242|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963243|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
82963244|NCT05274672|Cephalexin|cephalexin|mesh-list
82963245|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82963246|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
82963247|NCT05274672|Trimethoprim|trimethoprim|mesh-list
82963248|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
82963249|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82963250|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963251|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82963252|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82963253|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963254|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963255|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963256|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82963257|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82963258|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82963259|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
82963260|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82963261|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82963262|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82963263|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82963264|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82963265|NCT01379144|Latanoprost|latanoprost|mesh-list
82963266|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82963267|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82963268|NCT01376882|Caffeine|caffeine|mesh-list
82963269|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82963270|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963271|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82963272|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963273|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963274|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82963275|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82963276|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
82963277|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963278|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
82963279|NCT03329196|Hematinics|hematinics|mesh-ancestor
82963280|NCT04656002|Vactosertib|vactosertib|mesh-list
82963281|NCT04656002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82963282|NCT04656002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963283|NCT04656002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963284|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
82963285|NCT01382498|Calcium|calcium|mesh-list
82963286|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82963287|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963288|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
82963289|NCT01382498|Coagulants|coagulants|mesh-ancestor
82963290|NCT05322902|Propofol|propofol|mesh-list
82963291|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82963292|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963293|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963294|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82963295|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
82963296|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
82963297|NCT03476538|Gabapentin|gabapentin|mesh-list
82963298|NCT03476538|Analgesics|analgesics|mesh-ancestor
82963299|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
82963300|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963301|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963302|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
82963303|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82963304|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82963305|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963306|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82963307|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82963308|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82963309|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963310|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963311|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
82963312|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
82963313|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82963314|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82963315|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82963316|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82963317|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963318|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
82963319|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963320|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963321|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82963322|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963323|NCT00000116|Vitamin A|vitamin a|mesh-list
82963324|NCT00000116|Vitamins|vitamins|mesh-ancestor
82963325|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
82963326|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963327|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82963328|NCT05232396|Antibodies|antibodies|mesh-list
82963329|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
82963330|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82963331|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
82963332|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963333|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963335|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82963336|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82963337|NCT05222724|Analgesics|analgesics|mesh-ancestor
82963338|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
82963339|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963340|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963341|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963342|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963343|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82963344|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963345|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963346|NCT01382342|Rasagiline|rasagiline|mesh-list
82963347|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82963348|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963349|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963350|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82963351|NCT01382342|Protective Agents|protective agents|mesh-ancestor
82963352|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963353|NCT03471728|Linaclotide|linaclotide|mesh-list
82963354|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82963355|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
82963356|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963357|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82963358|NCT03630614|Nicotine|nicotine|mesh-list
82963359|NCT03630614|Varenicline|varenicline|mesh-list
82963360|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82963361|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
82963362|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963363|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963364|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82963365|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82963366|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
82963367|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963368|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963369|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82963370|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963371|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
82963372|NCT05060432|Dostarlimab|dostarlimab|mesh-list
82963373|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963374|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963375|NCT05060432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82963376|NCT05060432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963377|NCT01378754|Fospropofol|fospropofol|mesh-list
82963378|NCT01378754|Propofol|propofol|mesh-list
82963379|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82963380|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963381|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963382|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82963383|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
82963384|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
82963385|NCT05764304|Sinomenine|sinomenine|mesh-list
82963386|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
82963387|NCT05764304|Hormones|hormones|mesh-ancestor
82963389|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963390|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963391|NCT03075410|GSK656|gsk656|mesh-list
82963392|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82963393|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963394|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82963395|NCT02826512|Niraparib|niraparib|mesh-list
82963396|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82963397|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963398|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963399|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963400|NCT05391230|Permethrin|permethrin|mesh-list
82963401|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963402|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963403|NCT02731352|Apatinib|apatinib|mesh-list
82963404|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963405|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82963406|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963407|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963408|NCT05132660|Levodopa|levodopa|mesh-list
82963409|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
82963410|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82963411|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82963412|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
82963413|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963414|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963415|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963416|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82963417|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
82963418|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
82963419|NCT05762744|Exenatide|exenatide|mesh-list
82963420|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82963421|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963422|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82963423|NCT05762744|Incretins|incretins|mesh-ancestor
82963424|NCT05762744|Hormones|hormones|mesh-ancestor
82963425|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963426|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
82963427|NCT02257424|Trametinib|trametinib|mesh-list
82963428|NCT02257424|Dabrafenib|dabrafenib|mesh-list
82963429|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
82963430|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82963431|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82963432|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963433|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963434|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963435|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963436|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963437|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82963438|NCT01858922|Cytarabine|cytarabine|mesh-list
82963439|NCT01858922|Dexamethasone|dexamethasone|mesh-list
82963440|NCT01858922|Prednisone|prednisone|mesh-list
82963441|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
82963442|NCT01858922|Cisplatin|cisplatin|mesh-list
82963443|NCT01858922|Doxorubicin|doxorubicin|mesh-list
82963444|NCT01858922|Etoposide|etoposide|mesh-list
82963445|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
82963446|NCT01858922|Vincristine|vincristine|mesh-list
82963447|NCT01858922|Bleomycin|bleomycin|mesh-list
82963448|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963449|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
82963450|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963451|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963452|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82963453|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
82963454|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963455|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963456|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82963457|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963458|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
82963459|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
82963460|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963461|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82963462|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
82963463|NCT01858922|Hormones|hormones|mesh-ancestor
82963464|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963465|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82963466|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963467|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82963468|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82963469|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82963470|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82963471|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82963472|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
82963473|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
82963474|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963475|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
82963476|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
82963477|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
82963478|NCT01378286|Artesunate|artesunate|mesh-list
82963479|NCT01378286|Chloroquine|chloroquine|mesh-list
82963480|NCT01378286|Amodiaquine|amodiaquine|mesh-list
82963481|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
82963482|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82963483|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82963484|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963485|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963486|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
82963487|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
82963488|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82963489|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
82963490|NCT01378286|Amebicides|amebicides|mesh-ancestor
82963491|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963492|NCT01377974|Miltefosine|miltefosine|mesh-list
82963493|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
82963494|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
82963495|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963496|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963497|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82963498|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82963499|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82963500|NCT04929080|Antibodies|antibodies|mesh-list
82963501|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
82963502|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82963503|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
82963504|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
82963505|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963506|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963507|NCT03071276|Cytarabine|cytarabine|mesh-list
82963508|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
82963509|NCT03071276|Methotrexate|methotrexate|mesh-list
82963510|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
82963511|NCT03071276|Fludarabine|fludarabine|mesh-list
82963512|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82963513|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
82963514|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82963515|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963516|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82963517|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
82963518|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963519|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963520|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
82963521|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963522|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82963523|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963524|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
82963525|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963526|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82963527|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
82963528|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963529|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963530|NCT03629600|Indomethacin|indomethacin|mesh-list
82963531|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82963532|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82963533|NCT03629600|Analgesics|analgesics|mesh-ancestor
82963534|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
82963535|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963536|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963537|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963538|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963539|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
82963540|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
82963541|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82963542|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82963543|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963544|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963545|NCT03074162|Diclofenac|diclofenac|mesh-list
82963546|NCT03074162|Capsaicin|capsaicin|mesh-list
82963547|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82963548|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82963549|NCT03074162|Analgesics|analgesics|mesh-ancestor
82963550|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
82963551|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963552|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963553|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963554|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963555|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82963556|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963557|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963558|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
82963559|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
82963560|NCT05069012|Morphine|morphine|mesh-list
82963561|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82963562|NCT05069012|Narcotics|narcotics|mesh-ancestor
82963563|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963564|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963565|NCT05069012|Analgesics|analgesics|mesh-ancestor
82963566|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
82963567|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963568|NCT04065074|FX006|fx006|mesh-list
82963569|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963570|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
82963571|NCT04065074|Hormones|hormones|mesh-ancestor
82963572|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963573|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963574|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963575|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
82963576|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
82963577|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82963578|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963579|NCT02888106|Tenofovir|tenofovir|mesh-list
82963580|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82963581|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
82963582|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
82963583|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963584|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82963585|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82963586|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963587|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963588|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82963589|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82963590|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963591|NCT03793010|FX006|fx006|mesh-list
82963592|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963593|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
82963594|NCT03793010|Hormones|hormones|mesh-ancestor
82963595|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963596|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963597|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963598|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
82963599|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
82963600|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82963601|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
82963602|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82963603|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
82963604|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963605|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963606|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
82963607|NCT03304626|Prednisone|prednisone|mesh-list
82963608|NCT03304626|Budesonide|budesonide|mesh-list
82963609|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963610|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
82963611|NCT03304626|Hormones|hormones|mesh-ancestor
82963612|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963613|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963614|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82963615|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963616|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82963617|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
82963618|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963620|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
82963621|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
82963622|NCT05121714|Caffeine|caffeine|mesh-list
82963623|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82963624|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963625|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82963626|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963627|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963628|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82963629|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82963630|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
83461360|NCT05243862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82963631|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963632|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82963633|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82963634|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963635|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82963636|NCT05121714|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82963637|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82963638|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82963639|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
82963640|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82963641|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
82963642|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82963643|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82963644|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82963646|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82963647|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963648|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963649|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82963650|NCT02958150|Analgesics|analgesics|mesh-ancestor
82963651|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
82963652|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963653|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82963654|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82963655|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82963656|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
82963657|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963658|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963659|NCT04250142|Methamphetamine|methamphetamine|mesh-list
82963660|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82963661|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963662|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
82963663|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
82963664|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963665|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
82963666|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963667|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963668|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
82963669|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82963670|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82963671|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82963672|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82963673|NCT02714322|Adalimumab|adalimumab|mesh-list
82963674|NCT02714322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82963675|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963676|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963677|NCT03267576|Metformin|metformin|mesh-list
82963678|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82963679|NCT03267576|Canagliflozin|canagliflozin|mesh-list
82963680|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82963681|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963682|NCT03267576|Incretins|incretins|mesh-ancestor
82963683|NCT03267576|Hormones|hormones|mesh-ancestor
82963684|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963685|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82963686|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
82963687|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963688|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963689|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82963690|NCT02472912|Adalimumab|adalimumab|mesh-list
82963691|NCT02472912|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82963692|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963693|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963694|NCT02356458|Bortezomib|bortezomib|mesh-list
82963695|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963696|NCT03243630|Menthol|menthol|mesh-list
82963697|NCT03243630|Nicotine|nicotine|mesh-list
82963698|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82963699|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
82963700|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963701|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963702|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82963703|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82963704|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
82963705|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963706|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963707|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
82963708|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
82963709|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
82963710|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963711|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963712|NCT04725331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82963713|NCT04725331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963714|NCT03753685|Ensartinib|ensartinib|mesh-list
82963715|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963716|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82963717|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963718|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963719|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82963720|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82963721|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
82963722|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963723|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963724|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82963725|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82963726|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82963727|NCT02787044|Vaccines|vaccines|mesh-list
82963728|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
82963729|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963730|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
82963731|NCT01345019|Denosumab|denosumab|mesh-list
82963732|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82963733|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963734|NCT03629522|Ondansetron|ondansetron|mesh-list
82963735|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
82963736|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
82963737|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963738|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963739|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82963740|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
82963741|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
82963742|NCT03629522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82963743|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82963744|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
82963745|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963746|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963747|NCT03751111|Naloxone|naloxone|mesh-list
82963748|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82963749|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963750|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
82963751|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963752|NCT05167370|Amifostine|amifostine|mesh-list
82963753|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82963754|NCT05167370|Protective Agents|protective agents|mesh-ancestor
82963755|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963756|NCT01265537|Tacrolimus|tacrolimus|mesh-list
82963757|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963758|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
82963759|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963760|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82963761|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963762|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963763|NCT05763836|Ibuprofen|ibuprofen|mesh-list
82963765|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82963766|NCT05763836|Analgesics|analgesics|mesh-ancestor
82963767|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
82963768|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963769|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963770|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963771|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963772|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82963773|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963774|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963775|NCT01237535|Progesterone|progesterone|mesh-list
82963776|NCT01237535|Estrogens|estrogens|mesh-list
82963777|NCT01237535|Progestins|progestins|mesh-ancestor
82963778|NCT01237535|Hormones|hormones|mesh-ancestor
82963779|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963780|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963781|NCT04396639|Factor VIII|factor viii|mesh-list
82963782|NCT04396639|Coagulants|coagulants|mesh-ancestor
82963783|NCT01146431|Anesthetics|anesthetics|mesh-list
82963784|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963785|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963786|NCT01250249|Vaccines|vaccines|mesh-list
82963787|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
82963788|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
82963789|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963790|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82963791|NCT03747679|Mannitol|mannitol|mesh-list
82963792|NCT03747679|Sorbitol|sorbitol|mesh-list
82963793|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82963794|NCT03747679|Diuretics|diuretics|mesh-ancestor
82963795|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
82963796|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963797|NCT03747679|Cathartics|cathartics|mesh-ancestor
82963798|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82963799|NCT01243385|Metformin|metformin|mesh-list
82963800|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82963801|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963802|NCT01147133|Clopidogrel|clopidogrel|mesh-list
82963803|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82963804|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82963805|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82963806|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82963807|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
82963808|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963809|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963810|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963811|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
82963812|NCT02162420|Fludarabine|fludarabine|mesh-list
82963813|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
82963814|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82963815|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963816|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
82963817|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963818|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963819|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82963820|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
82963821|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963822|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963823|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82963824|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963825|NCT04167085|Doxycycline|doxycycline|mesh-list
82963826|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82963827|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963828|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
82963829|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82963830|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82963831|NCT01147289|Meloxicam|meloxicam|mesh-list
82963832|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82963833|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82963834|NCT01147289|Analgesics|analgesics|mesh-ancestor
82963835|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
82963836|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963837|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963838|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963839|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963840|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82963841|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82963842|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963843|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963844|NCT01237769|Vitamin D|vitamin d|mesh-list
82963845|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
82963846|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
82963847|NCT01237769|Vitamins|vitamins|mesh-list
82963848|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
82963849|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963850|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82963851|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82963852|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82963853|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
82963854|NCT03914963|Coagulants|coagulants|mesh-ancestor
82963855|NCT04162795|Loratadine|loratadine|mesh-list
82963856|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
82963857|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
82963858|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82963859|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82963860|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82963861|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
82963862|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
82963863|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963864|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963865|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963866|NCT01250951|Deferasirox|deferasirox|mesh-list
82963867|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82963868|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
82963869|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
82963870|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963871|NCT03069482|Nicotine|nicotine|mesh-list
82963872|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82963873|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
82963874|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963875|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963876|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82963877|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82963878|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
82963879|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963880|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963881|NCT01250405|Cinacalcet|cinacalcet|mesh-list
82963882|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82963883|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963884|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82963885|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
82963886|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963887|NCT05083910|Misoprostol|misoprostol|mesh-list
82963888|NCT05083910|Oxytocin|oxytocin|mesh-list
82963889|NCT05083910|Carbetocin|carbetocin|mesh-list
82963890|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
82963891|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82963892|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963893|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82963894|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
82963895|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82963896|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82963897|NCT01250561|Valacyclovir|valacyclovir|mesh-list
82963898|NCT01250561|Gabapentin|gabapentin|mesh-list
82963899|NCT01250561|Analgesics|analgesics|mesh-ancestor
82963900|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
82963901|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82963902|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963903|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
82963904|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82963905|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82963906|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82963907|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82963908|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82963909|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82963910|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82963911|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963912|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
82963913|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
82963914|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963916|NCT05055908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82963917|NCT05055908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963918|NCT05055908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963919|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963921|NCT01147523|Spironolactone|spironolactone|mesh-list
82963922|NCT01147523|Vitamins|vitamins|mesh-ancestor
82963923|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
82963924|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963925|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
82963926|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963927|NCT01147523|Protective Agents|protective agents|mesh-ancestor
82963928|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82963929|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
82963930|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963931|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82963932|NCT01147523|Diuretics|diuretics|mesh-ancestor
82963933|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
82963934|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
82963935|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82963936|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
82963937|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963938|NCT01251029|Expectorants|expectorants|mesh-ancestor
82963939|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
82963940|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82963941|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
82963942|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963943|NCT01251029|Protective Agents|protective agents|mesh-ancestor
82963944|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963945|NCT01251029|Antidotes|antidotes|mesh-ancestor
82963946|NCT01251107|Prednisone|prednisone|mesh-list
82963947|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
82963948|NCT01251107|Dacarbazine|dacarbazine|mesh-list
82963949|NCT01251107|Doxorubicin|doxorubicin|mesh-list
82963950|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82963951|NCT01251107|Etoposide|etoposide|mesh-list
82963952|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
82963953|NCT01251107|Vincristine|vincristine|mesh-list
82963954|NCT01251107|Bleomycin|bleomycin|mesh-list
82963955|NCT01251107|Vinblastine|vinblastine|mesh-list
82963956|NCT01251107|Procarbazine|procarbazine|mesh-list
82963957|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82963958|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
82963959|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963960|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963961|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82963962|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
82963963|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82963964|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963965|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82963966|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82963967|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82963968|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82963969|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82963970|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82963971|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
82963972|NCT01251107|Hormones|hormones|mesh-ancestor
82963973|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82963974|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82963975|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82963976|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
82963977|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
82963978|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
82963979|NCT01125176|Thalidomide|thalidomide|mesh-list
82963980|NCT01125176|Rituximab|rituximab|mesh-list
82963981|NCT01125176|Lenalidomide|lenalidomide|mesh-list
82963982|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82963983|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82963984|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
82963985|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963986|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82963987|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82963988|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82963989|NCT01125176|Growth Substances|growth substances|mesh-ancestor
82963990|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
82963992|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
82963993|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82963994|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82963995|NCT00882050|Exenatide|exenatide|mesh-list
82963996|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82963997|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82963998|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82963999|NCT00882050|Incretins|incretins|mesh-ancestor
82964000|NCT00882050|Hormones|hormones|mesh-ancestor
82964001|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964002|NCT03912857|Apatinib|apatinib|mesh-list
82964003|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964004|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82964005|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964006|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964007|NCT04316390|Vitamins|vitamins|mesh-list
82964008|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
82964009|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
82964010|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964011|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
82964012|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964013|NCT04316390|Protective Agents|protective agents|mesh-ancestor
82964014|NCT04892420|Dexamethasone|dexamethasone|mesh-list
82964015|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
82964016|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
82964017|NCT04892420|Bupivacaine|bupivacaine|mesh-list
82964018|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964019|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
82964020|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
82964021|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964022|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964023|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964024|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
82964025|NCT04892420|Hormones|hormones|mesh-ancestor
82964026|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964027|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964028|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964029|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
82964030|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
82964031|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964032|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
82964033|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82964034|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82964035|NCT04892420|Analgesics|analgesics|mesh-ancestor
82964036|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82964037|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82964038|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82964039|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
82964040|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964041|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964042|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82964043|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
82964044|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82964045|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964046|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82964047|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
82964048|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82964049|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82964050|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82964051|NCT01251263|Estradiol|estradiol|mesh-list
83461404|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82964052|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82964053|NCT01251263|Estrogens|estrogens|mesh-ancestor
82964054|NCT01251263|Hormones|hormones|mesh-ancestor
82964055|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964056|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964057|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82964058|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
82964059|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82964060|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82964061|NCT04707534|Dexamethasone|dexamethasone|mesh-list
82964062|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964063|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
82964064|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
82964065|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964067|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964068|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
82964069|NCT04707534|Hormones|hormones|mesh-ancestor
82964070|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964071|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964072|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964073|NCT05761730|Dexamethasone|dexamethasone|mesh-list
82964074|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964075|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
82964076|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
82964077|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964078|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964079|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964080|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
82964081|NCT05761730|Hormones|hormones|mesh-ancestor
82964082|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964083|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964084|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964085|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82964086|NCT04257500|Etonogestrel|etonogestrel|mesh-list
82964087|NCT04257500|NuvaRing|nuvaring|mesh-list
82964088|NCT04257500|Estradiol|estradiol|mesh-list
82964089|NCT04257500|Estrogens|estrogens|mesh-ancestor
82964090|NCT04257500|Hormones|hormones|mesh-ancestor
82964091|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964092|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964093|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82964094|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
82964095|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82964096|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82964097|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82964098|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82964099|NCT04353817|Ivacaftor|ivacaftor|mesh-list
82964100|NCT04353817|Elexacaftor|elexacaftor|mesh-list
82964101|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82964102|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964103|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964104|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
82964105|NCT00159588|Gabapentin|gabapentin|mesh-list
82964106|NCT00159588|Valproic Acid|valproic acid|mesh-list
82964107|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
82964108|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
82964109|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82964110|NCT00159588|Analgesics|analgesics|mesh-ancestor
82964111|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
82964112|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964113|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964114|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
82964115|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82964116|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82964117|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964118|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82964119|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82964120|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82964121|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964122|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964123|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
82964124|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964125|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
82964126|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82964127|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82964128|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
82964129|NCT04166942|Belumosudil|belumosudil|mesh-list
82964130|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82964131|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964132|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964133|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
82964134|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82964135|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82964136|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82964137|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964138|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964139|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
82964140|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964141|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964142|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82964143|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964144|NCT04349917|Methylphenidate|methylphenidate|mesh-list
82964145|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82964146|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964147|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82964148|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82964149|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964150|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964151|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
82964152|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964153|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82964154|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82964155|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82964156|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
82964157|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964158|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82964159|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82964160|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964161|NCT04691856|Acetaminophen|acetaminophen|mesh-list
82964162|NCT04691856|Ibuprofen|ibuprofen|mesh-list
82964163|NCT04691856|Morphine|morphine|mesh-list
82964164|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82964165|NCT04691856|Narcotics|narcotics|mesh-ancestor
82964166|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964167|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964168|NCT04691856|Analgesics|analgesics|mesh-ancestor
82964169|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
82964170|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964171|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82964172|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82964173|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964174|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964175|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82964176|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964177|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964178|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
82964179|NCT03924986|Tislelizumab|tislelizumab|mesh-list
82964180|NCT03924986|Gemcitabine|gemcitabine|mesh-list
82964181|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964182|NCT03924986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82964183|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82964184|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
82964185|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964186|NCT01254929|Frovatriptan|frovatriptan|mesh-list
82964187|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82964188|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
83461414|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
82964189|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964190|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964191|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964192|NCT03300570|Dolcanatide|dolcanatide|mesh-list
82964193|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82964194|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
82964195|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964196|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964197|NCT03853694|Morphine|morphine|mesh-list
82964198|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82964199|NCT03853694|Narcotics|narcotics|mesh-ancestor
82964200|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964201|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964202|NCT03853694|Analgesics|analgesics|mesh-ancestor
82964203|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
82964204|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964205|NCT04154293|Isotretinoin|isotretinoin|mesh-list
82964206|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
82964207|NCT01148147|Adenosine|adenosine|mesh-list
82964208|NCT01148147|Analgesics|analgesics|mesh-ancestor
82964209|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
82964210|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964211|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964212|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82964213|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
82964214|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82964215|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
82964216|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
82964217|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964218|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964219|NCT03902249|Dexamethasone|dexamethasone|mesh-list
82964220|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964221|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
82964222|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
82964223|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964224|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964225|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964226|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
82964227|NCT03902249|Hormones|hormones|mesh-ancestor
82964228|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964229|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964230|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964231|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
82964232|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
82964233|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964234|NCT03908489|Protective Agents|protective agents|mesh-ancestor
82964235|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964236|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82964237|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964238|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82964239|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964240|NCT04342897|Zansecimab|zansecimab|mesh-list
82964241|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
82964242|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964243|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
82964245|NCT03263767|Clofarabine|clofarabine|mesh-list
82964246|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
82964247|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82964248|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
82964249|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964250|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964251|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82964252|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
82964253|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964254|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964255|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82964256|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82964257|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
82964258|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82964259|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964260|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
82964261|NCT03908333|Paclitaxel|paclitaxel|mesh-list
82964262|NCT03908333|Gemcitabine|gemcitabine|mesh-list
82964263|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82964264|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82964265|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964266|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
82964267|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
82964268|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
82964269|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964270|NCT03908333|Vitamins|vitamins|mesh-ancestor
82964271|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
82964272|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964273|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82964274|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
82964275|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
82964276|NCT03908333|Protective Agents|protective agents|mesh-ancestor
82964277|NCT04340557|Losartan|losartan|mesh-list
82964278|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82964279|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82964280|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82964281|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82964282|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964283|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
82964284|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
82964285|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82964286|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82964287|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
82964288|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964289|NCT04549376|Iodine|iodine|mesh-list
82964296|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
82964297|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964298|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
82964299|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
82964300|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
82964301|NCT01149395|Lansoprazole|lansoprazole|mesh-list
82964302|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82964303|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964304|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82964305|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964306|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964307|NCT02527733|Ranibizumab|ranibizumab|mesh-list
82964308|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82964309|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82964310|NCT02527733|Growth Substances|growth substances|mesh-ancestor
82964311|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964312|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
82964313|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964315|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82964316|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964317|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964318|NCT01148303|Etoricoxib|etoricoxib|mesh-list
82964319|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82964320|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82964321|NCT01148303|Analgesics|analgesics|mesh-ancestor
82964322|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
82964323|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964324|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964325|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964326|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964327|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82964328|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82964329|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964330|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964332|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82964333|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82964334|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461433|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
82964335|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82964336|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964343|NCT05205200|Paclitaxel|paclitaxel|mesh-list
82964344|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82964345|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964346|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
82964347|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
82964348|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
82964349|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964350|NCT01149629|Droxidopa|droxidopa|mesh-list
82964351|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82964352|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82964353|NCT05205122|Mitomycins|mitomycins|mesh-list
82964354|NCT05205122|Mitomycin|mitomycin|mesh-list
82964355|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82964356|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964357|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
82964358|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964359|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82964360|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964361|NCT03907163|Dronabinol|dronabinol|mesh-list
82964362|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
82964363|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964364|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82964365|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82964366|NCT03907163|Analgesics|analgesics|mesh-ancestor
82964367|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
82964368|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964369|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82964370|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82964371|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964372|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964374|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964375|NCT01253681|Paclitaxel|paclitaxel|mesh-list
82964376|NCT01253681|Carboplatin|carboplatin|mesh-list
82964377|NCT01253681|Trebananib|trebananib|mesh-list
82964378|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82964379|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964380|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
82964381|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
82964382|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
82964383|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964384|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82964385|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82964386|NCT01253681|Growth Substances|growth substances|mesh-ancestor
82964387|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964388|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
82964389|NCT01149941|Ibuprofen|ibuprofen|mesh-list
82964390|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82964391|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82964392|NCT01149941|Analgesics|analgesics|mesh-ancestor
82964393|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
82964394|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964395|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964396|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964397|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964398|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82964399|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964400|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964401|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
82964402|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964403|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
82964404|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
82964405|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964406|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964407|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964408|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
82964409|NCT01589549|Hormones|hormones|mesh-ancestor
82964410|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964411|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82964412|NCT01589549|Protective Agents|protective agents|mesh-ancestor
82964413|NCT03899675|Caffeine|caffeine|mesh-list
82964414|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82964415|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964416|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82964417|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964418|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964419|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82964420|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82964421|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
82964422|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964423|NCT01562197|Axitinib|axitinib|mesh-list
82964424|NCT01562197|Lomustine|lomustine|mesh-list
82964425|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964426|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82964427|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964428|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964429|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82964430|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
82964431|NCT03905837|Lidocaine|lidocaine|mesh-list
82964432|NCT03905837|Piperidine|piperidine|mesh-list
82964433|NCT03905837|Remifentanil|remifentanil|mesh-list
82964434|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
82964435|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
82964436|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964437|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964439|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964440|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82964441|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82964442|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82964443|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964444|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964445|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82964446|NCT03905837|Narcotics|narcotics|mesh-ancestor
82964447|NCT03905837|Analgesics|analgesics|mesh-ancestor
82964448|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82964449|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82964450|NCT03063632|Interferons|interferons|mesh-list
82964451|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
82964452|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
82964453|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82964454|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964455|NCT03063632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82964456|NCT03063632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964457|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
82964458|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964459|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
82964460|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
82964461|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82964462|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82964463|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964464|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964465|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964466|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964467|NCT01148615|Docetaxel|docetaxel|mesh-list
82964468|NCT01148615|Aflibercept|aflibercept|mesh-list
82964469|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964470|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
82964471|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
82964472|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
82964473|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964474|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82964475|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82964476|NCT01148615|Growth Substances|growth substances|mesh-ancestor
83461441|NCT04066426|Narcotics|narcotics|mesh-ancestor
82964477|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964478|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
82964479|NCT04161248|Dexamethasone|dexamethasone|mesh-list
82964480|NCT04161248|Rituximab|rituximab|mesh-list
82964481|NCT04161248|Gemcitabine|gemcitabine|mesh-list
82964482|NCT04161248|Venetoclax|venetoclax|mesh-list
82964483|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82964484|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964485|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
82964486|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964487|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964488|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964489|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
82964490|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
82964491|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964492|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964493|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
82964494|NCT04161248|Hormones|hormones|mesh-ancestor
82964495|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964496|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964497|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82964498|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
82964499|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964500|NCT03905759|Colchicine|colchicine|mesh-list
82964501|NCT03905759|Amiodarone|amiodarone|mesh-list
82964502|NCT03905759|Dronedarone|dronedarone|mesh-list
82964503|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
82964504|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964505|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
82964506|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
82964507|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
82964508|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964509|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964510|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82964511|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
82964512|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82964513|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964514|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82964515|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82964516|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82964517|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964518|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82964519|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82964520|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82964522|NCT01255475|Hydralazine|hydralazine|mesh-list
82964523|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82964524|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82964525|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964526|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964527|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82964528|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964529|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
82964530|NCT05208398|Warfarin|warfarin|mesh-list
82964531|NCT05208398|Apixaban|apixaban|mesh-list
82964532|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
82964533|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82964534|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
82964535|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82964536|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
82964537|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964538|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964539|NCT05593601|Neomycin|neomycin|mesh-list
82964540|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82964541|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964542|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82964543|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964544|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964545|NCT03629210|Dexamethasone|dexamethasone|mesh-list
82964546|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964547|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
82964548|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
82964549|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964550|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964551|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964552|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
82964553|NCT03629210|Hormones|hormones|mesh-ancestor
82964554|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964555|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964556|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964557|NCT05569811|Letrozole|letrozole|mesh-list
82964558|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
82964559|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964560|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82964561|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82964562|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964563|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964564|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82964565|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
82964566|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964567|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964568|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82964569|NCT03899285|Citalopram|citalopram|mesh-list
82964570|NCT03899285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82964571|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82964572|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964573|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964574|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964575|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
82964576|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964577|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82964578|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
82964579|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82964580|NCT01254071|Tamsulosin|tamsulosin|mesh-list
82964581|NCT01254071|Dutasteride|dutasteride|mesh-list
82964582|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82964583|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82964584|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82964585|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
82964586|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964587|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964588|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964589|NCT01254071|Urological Agents|urological agents|mesh-ancestor
82964590|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82964591|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82964592|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964593|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
82964594|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964595|NCT05761418|Misoprostol|misoprostol|mesh-list
82964596|NCT05761418|Dinoprostone|dinoprostone|mesh-list
82964597|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82964598|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
82964599|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82964600|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964601|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82964602|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964603|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
82964604|NCT05207774|Oxytocin|oxytocin|mesh-list
82964605|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
82964606|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82964607|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964608|NCT02528123|Tobramycin|tobramycin|mesh-list
82964609|NCT02528123|Ofloxacin|ofloxacin|mesh-list
82964610|NCT02528123|Dexamethasone|dexamethasone|mesh-list
82964611|NCT02528123|Benoxinate|benoxinate|mesh-list
82964612|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
82964613|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964614|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
82964615|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
82964616|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964617|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964618|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964619|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
82964620|NCT02528123|Hormones|hormones|mesh-ancestor
82964621|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964622|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964623|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964624|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82964625|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964626|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82964627|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82964628|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82964629|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964630|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964631|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82964632|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82964633|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
82964634|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
82964635|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964636|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
82964637|NCT02527811|Urinastatin|urinastatin|mesh-list
82964638|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
82964639|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82964640|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
82964641|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964642|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964643|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82964644|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82964645|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964646|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
82964647|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
82964648|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82964649|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82964650|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964651|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964652|NCT01254383|Urological Agents|urological agents|mesh-ancestor
82964653|NCT03700970|Bupivacaine|bupivacaine|mesh-list
82964654|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
82964655|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
82964656|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964657|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964658|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
82964659|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964661|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82964662|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82964663|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82964664|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964665|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964666|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
82964667|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964668|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964669|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82964670|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964671|NCT04320745|Testosterone|testosterone|mesh-list
82964672|NCT04320745|Androgens|androgens|mesh-ancestor
82964674|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964675|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964676|NCT01254461|Pravastatin|pravastatin|mesh-list
82964677|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82964678|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82964679|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
82964680|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964681|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82964682|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82964683|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964684|NCT03747523|Vitamin D|vitamin d|mesh-list
82964685|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
82964686|NCT03747523|Vitamins|vitamins|mesh-ancestor
82964687|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
82964688|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964689|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82964690|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82964691|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
82964692|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82964693|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964694|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82964695|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82964696|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964697|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964698|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964699|NCT03063086|Fluticasone|fluticasone|mesh-list
82964700|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82964701|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964702|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82964703|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
82964704|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964705|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964706|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82964707|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
82964708|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
82964709|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82964710|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82964711|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82964712|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82964713|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
82964714|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964715|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964717|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
82964718|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964719|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964720|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
82964721|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82964722|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
82964723|NCT05187338|Ipilimumab|ipilimumab|mesh-list
82964724|NCT05187338|Durvalumab|durvalumab|mesh-list
82964725|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82964726|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964727|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82964728|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964729|NCT03898583|Calcitriol|calcitriol|mesh-list
83461466|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964730|NCT03898583|Betamethasone|betamethasone|mesh-list
82964731|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
82964732|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82964733|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
82964734|NCT03898583|Calcipotriene|calcipotriene|mesh-list
82964735|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82964736|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964737|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
82964738|NCT03898583|Hormones|hormones|mesh-ancestor
82964739|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964740|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964741|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82964742|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
82964743|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
82964744|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82964745|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82964746|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82964747|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964748|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82964749|NCT03898583|Vitamins|vitamins|mesh-ancestor
82964750|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
82964751|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82964752|NCT03898193|Montelukast|montelukast|mesh-list
82964753|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82964754|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
82964755|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82964756|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
82964757|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964758|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964759|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82964760|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82964761|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964762|NCT03321188|Paclitaxel|paclitaxel|mesh-list
82964763|NCT03321188|Carboplatin|carboplatin|mesh-list
82964764|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82964765|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964766|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
82964767|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
82964768|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
82964769|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964770|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82964771|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82964772|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964773|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82964774|NCT01254617|Cetuximab|cetuximab|mesh-list
82964775|NCT01254617|Lenalidomide|lenalidomide|mesh-list
82964776|NCT01254617|Antibodies|antibodies|mesh-list
82964777|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
82964778|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82964779|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
82964780|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964781|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964782|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82964783|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82964784|NCT01254617|Growth Substances|growth substances|mesh-ancestor
82964785|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
82964786|NCT01150331|Levetiracetam|levetiracetam|mesh-list
82964787|NCT01150331|Clonazepam|clonazepam|mesh-list
82964788|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
82964789|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
82964790|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
82964791|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
82964792|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964793|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964794|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964795|NCT03191084|Dronabinol|dronabinol|mesh-list
82964796|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
82964797|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964798|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82964799|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83461493|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964800|NCT03191084|Analgesics|analgesics|mesh-ancestor
82964801|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
82964802|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964803|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82964804|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82964805|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964806|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964808|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964809|NCT01256489|Infliximab|infliximab|mesh-list
82964810|NCT01256489|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82964811|NCT01256489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964812|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
82964813|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964814|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82964815|NCT03746119|Nicotine|nicotine|mesh-list
82964816|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82964817|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
82964818|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964819|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964820|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82964821|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82964822|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
82964823|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82964824|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964825|NCT01149005|Insulin|insulin|mesh-list
82964826|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82964827|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
82964828|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
82964829|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
82964830|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82964831|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964832|NCT03903887|Antibodies|antibodies|mesh-list
82964833|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
82964834|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964835|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82964836|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82964837|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964838|NCT05122130|Melatonin|melatonin|mesh-list
82964839|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
82964840|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964841|NCT05122130|Protective Agents|protective agents|mesh-ancestor
82964842|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964843|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82964844|NCT02898506|Liraglutide|liraglutide|mesh-list
82964845|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82964846|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964847|NCT02898506|Incretins|incretins|mesh-ancestor
82964848|NCT02898506|Hormones|hormones|mesh-ancestor
83483180|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
82964849|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964850|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
82964851|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82964852|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
82964853|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964854|NCT04123405|Expectorants|expectorants|mesh-ancestor
82964855|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
82964856|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82964857|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
82964858|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964859|NCT04123405|Protective Agents|protective agents|mesh-ancestor
82964860|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964861|NCT04123405|Antidotes|antidotes|mesh-ancestor
82964862|NCT02611232|Liraglutide|liraglutide|mesh-list
82964863|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82964864|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964865|NCT02611232|Incretins|incretins|mesh-ancestor
82964866|NCT02611232|Hormones|hormones|mesh-ancestor
82964867|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964868|NCT01150877|Vitamin D|vitamin d|mesh-list
82964869|NCT01150877|Vitamins|vitamins|mesh-ancestor
82964870|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
82964871|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964872|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82964873|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82964874|NCT03893591|Dalteparin|dalteparin|mesh-list
82964875|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
82964876|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82964877|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82964878|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964879|NCT01256801|Interleukin-2|interleukin-2|mesh-list
82964880|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964881|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82964882|NCT01256801|Analgesics|analgesics|mesh-ancestor
82964883|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
82964884|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82964885|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964886|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
82964887|NCT02519738|Triamcinolone|triamcinolone|mesh-list
82964888|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82964889|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964890|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
82964891|NCT02519738|Hormones|hormones|mesh-ancestor
82964892|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964893|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964894|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82964895|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
82964896|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82964897|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964898|NCT03893747|Vaccines|vaccines|mesh-list
82964899|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
82964900|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964901|NCT02343224|Interferons|interferons|mesh-list
82964902|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
82964903|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
82964904|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82964905|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964906|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
82964907|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964908|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
82964909|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964910|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82964911|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82964912|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964913|NCT04314037|Praziquantel|praziquantel|mesh-list
82964914|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
82964915|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82964916|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964917|NCT05737862|Folic Acid|folic acid|mesh-list
82964918|NCT05737862|Hematinics|hematinics|mesh-ancestor
82964919|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
82964920|NCT05737862|Vitamins|vitamins|mesh-ancestor
82964921|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
82964922|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964923|NCT02097680|Letrozole|letrozole|mesh-list
82964924|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964925|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82964926|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82964927|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964928|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964929|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82964930|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
82964931|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964932|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964933|NCT01150955|Resveratrol|resveratrol|mesh-list
82964934|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
82964935|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964936|NCT01150955|Protective Agents|protective agents|mesh-ancestor
82964937|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964938|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964939|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82964940|NCT03897413|Antacids|antacids|mesh-list
82964941|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
82964942|NCT03897413|Calcium|calcium|mesh-list
82964943|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83461499|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82964944|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964945|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964946|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82964947|NCT01258439|Ritonavir|ritonavir|mesh-list
82964948|NCT01258439|Darunavir|darunavir|mesh-list
82964949|NCT01258439|Tenofovir|tenofovir|mesh-list
82964950|NCT01258439|Emtricitabine|emtricitabine|mesh-list
82964951|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
82964952|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82964953|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82964954|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82964955|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
82964956|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964957|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964958|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82964959|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82964961|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964962|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82964963|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82964964|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82964965|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82964966|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82964967|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82964968|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82964969|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82964970|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964971|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964972|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964973|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82964974|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82964975|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82964976|NCT03893045|Hematinics|hematinics|mesh-ancestor
82964977|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82964978|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82964979|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
82964980|NCT01560572|Prednisolone|prednisolone|mesh-list
82964981|NCT01560572|Tacrolimus|tacrolimus|mesh-list
82964982|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82964983|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
82964984|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82964985|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82964986|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82964987|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82964988|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82964989|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
82964990|NCT01560572|Hormones|hormones|mesh-ancestor
82964991|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82964992|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82964993|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82964994|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82964995|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82964996|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
82964997|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82964998|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82964999|NCT05209256|Pemetrexed|pemetrexed|mesh-list
82965000|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965001|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965002|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965003|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82965004|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82965006|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
82965007|NCT05211050|Cromakalim|cromakalim|mesh-list
82965008|NCT05211050|Sumatriptan|sumatriptan|mesh-list
82965009|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82965010|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82965011|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82965012|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
82965013|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965014|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965015|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965016|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82965017|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82965018|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
82965019|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965020|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82965021|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
82965022|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
82965023|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
82965024|NCT03892499|Itraconazole|itraconazole|mesh-list
82965025|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
82965026|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965027|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82965028|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82965029|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965030|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965031|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82965032|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
82965033|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965034|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965035|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82965036|NCT01152047|Oxytocin|oxytocin|mesh-list
82965037|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
82965038|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82965039|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965040|NCT01151267|Anesthetics|anesthetics|mesh-list
82965041|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965042|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965043|NCT01259141|Azithromycin|azithromycin|mesh-list
82965044|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
82965045|NCT01259141|Cephalosporins|cephalosporins|mesh-list
82965046|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965047|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965048|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82965049|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82965050|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965051|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965052|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965053|NCT05210192|Lidocaine|lidocaine|mesh-list
82965054|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
82965055|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
82965056|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965057|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965058|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
82965059|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965060|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82965061|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82965062|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82965063|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82965064|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965065|NCT01152203|Bevacizumab|bevacizumab|mesh-list
82965066|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82965067|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965068|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965069|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82965070|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82965071|NCT01152203|Growth Substances|growth substances|mesh-ancestor
82965072|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965073|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
82965074|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82965075|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
82965076|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965078|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82965079|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82965080|NCT01257815|Growth Substances|growth substances|mesh-ancestor
82965081|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965082|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
82965083|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965084|NCT03892421|Cytarabine|cytarabine|mesh-list
82965085|NCT03892421|Dexamethasone|dexamethasone|mesh-list
82965086|NCT03892421|Rituximab|rituximab|mesh-list
82965087|NCT03892421|Carboplatin|carboplatin|mesh-list
82965088|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965089|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965090|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
82965091|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965092|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965093|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965094|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
82965095|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
82965096|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965097|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82965098|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
82965099|NCT03892421|Hormones|hormones|mesh-ancestor
82965100|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965101|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965102|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82965103|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
82965104|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965105|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
82965106|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965107|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965108|NCT05546567|Niacinamide|niacinamide|mesh-list
82965109|NCT05546567|Niacin|niacin|mesh-list
82965110|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
82965111|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
82965112|NCT05546567|Vitamins|vitamins|mesh-ancestor
82965113|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
82965114|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965115|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82965116|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
82965117|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965118|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82965119|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
82965120|NCT03895229|Empagliflozin|empagliflozin|mesh-list
82965121|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82965122|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965123|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965124|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965125|NCT01257893|Aspirin|aspirin|mesh-list
82965126|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82965127|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82965128|NCT01257893|Analgesics|analgesics|mesh-ancestor
82965129|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
82965130|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965131|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965132|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965133|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965134|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82965135|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82965136|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965137|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82965138|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82965139|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965140|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
82965141|NCT01152593|Mupirocin|mupirocin|mesh-list
82965142|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965143|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965144|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82965145|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965146|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965147|NCT01259219|Rifabutin|rifabutin|mesh-list
82965148|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965149|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965150|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82965151|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
82965153|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
82965154|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82965155|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965156|NCT05667077|Amantadine|amantadine|mesh-list
82965157|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82965158|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82965159|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
82965160|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965161|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
82965162|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965163|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461510|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
82965164|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965165|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82965166|NCT05667077|Analgesics|analgesics|mesh-ancestor
82965167|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
82965168|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965169|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
82965170|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82965171|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82965172|NCT03894839|Glutaral|glutaral|mesh-list
82965173|NCT03894839|Eusol|eusol|mesh-list
82965174|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82965175|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965176|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
82965177|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
82965178|NCT01152749|Nicotine|nicotine|mesh-list
82965179|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82965180|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
82965181|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965182|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965183|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82965185|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
82965186|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965187|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965188|NCT03894683|Melatonin|melatonin|mesh-list
82965189|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
82965190|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965191|NCT03894683|Protective Agents|protective agents|mesh-ancestor
82965192|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965193|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965194|NCT01259531|Silodosin|silodosin|mesh-list
82965195|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82965196|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82965197|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82965198|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
82965199|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965200|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965201|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965202|NCT01259531|Urological Agents|urological agents|mesh-ancestor
82965203|NCT01151735|Complement C1s|complement c1s|mesh-list
82965204|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
82965205|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965206|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82965207|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965208|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965209|NCT03061214|Incretins|incretins|mesh-ancestor
82965210|NCT03061214|Hormones|hormones|mesh-ancestor
82965211|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965212|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82965213|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
82965214|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965215|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965216|NCT01152827|Everolimus|everolimus|mesh-list
82965217|NCT01152827|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82965218|NCT01152827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82965219|NCT01152827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965220|NCT01152827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965221|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965222|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
82965223|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965224|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965225|NCT01153373|Ethanol|ethanol|mesh-list
82965226|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82965227|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965228|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965229|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965230|NCT03889145|Amlodipine|amlodipine|mesh-list
82965231|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82965232|NCT03889145|Telmisartan|telmisartan|mesh-list
82965233|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82965234|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82965235|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82965236|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965237|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82965238|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965239|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
82965240|NCT03889145|Diuretics|diuretics|mesh-ancestor
82965241|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
82965242|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82965243|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82965244|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82965245|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
82965246|NCT03888677|Epirubicin|epirubicin|mesh-list
82965247|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965248|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
82965249|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965250|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965251|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82965252|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
82965253|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965254|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965255|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82965256|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82965257|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82965258|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82965259|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965261|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965262|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965263|NCT01260233|Nicotine|nicotine|mesh-list
82965264|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82965265|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
82965266|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965267|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965268|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82965269|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82965270|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
82965271|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965272|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965273|NCT04435964|Immunomodulating Agents|immunomodulating agents|mesh-list
82965274|NCT04435964|Immunologic Factors|immunologic factors|mesh-ancestor
82965275|NCT04435964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965276|NCT01153919|Interferons|interferons|mesh-list
82965277|NCT01153919|Ribavirin|ribavirin|mesh-list
82965278|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
82965279|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
82965280|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82965281|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965282|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
82965283|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965284|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
82965285|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965286|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
82965287|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965288|NCT03912389|Carboplatin|carboplatin|mesh-list
82965289|NCT03912389|Pemetrexed|pemetrexed|mesh-list
82965290|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965291|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965292|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965293|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82965294|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82965295|NCT01147757|Remifentanil|remifentanil|mesh-list
82965296|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82965297|NCT01147757|Narcotics|narcotics|mesh-ancestor
82965298|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965299|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965300|NCT01147757|Analgesics|analgesics|mesh-ancestor
82965301|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
82965302|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965303|NCT01251809|Pegaspargase|pegaspargase|mesh-list
82965304|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965305|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
82965306|NCT01154387|Tacrolimus|tacrolimus|mesh-list
82965307|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
82965308|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82965309|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965310|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
82965311|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965312|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82965313|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965314|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965315|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82965316|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965317|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82965318|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
82965319|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965320|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965321|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
82965322|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82965323|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965324|NCT01260623|Prednisone|prednisone|mesh-list
82965325|NCT01260623|Prednisolone|prednisolone|mesh-list
82965326|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965327|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
82965328|NCT01260623|Hormones|hormones|mesh-ancestor
82965329|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965330|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965331|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965332|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965333|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82965334|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
82965335|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82965336|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
82965337|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82965338|NCT01260857|Diuretics|diuretics|mesh-ancestor
82965339|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
82965340|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965341|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82965342|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82965343|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965344|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
82965345|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965346|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965347|NCT01153217|Tenofovir|tenofovir|mesh-list
82965348|NCT01153217|Abacavir|abacavir|mesh-list
82965349|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
82965350|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965351|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82965352|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82965353|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965354|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965355|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82965356|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82965357|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
82965358|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82965359|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965360|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82965361|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
82965362|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965363|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965364|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965365|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965366|NCT03889379|Albuterol|albuterol|mesh-list
82965367|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82965368|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
82965369|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965370|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965371|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82965372|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
82965373|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
82965374|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83483181|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
83461521|NCT04272788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82965375|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82965376|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82965377|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82965378|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
82965379|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965380|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965381|NCT01586507|Tramadol|tramadol|mesh-list
82965382|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82965383|NCT01586507|Narcotics|narcotics|mesh-ancestor
82965384|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965385|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965386|NCT01586507|Analgesics|analgesics|mesh-ancestor
82965387|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
82965388|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965389|NCT03910361|Pioglitazone|pioglitazone|mesh-list
82965390|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965391|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965392|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82965393|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
82965394|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82965395|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82965396|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82965397|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
82965398|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82965399|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965400|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82965401|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82965402|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82965403|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965404|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965405|NCT03885947|Fludarabine|fludarabine|mesh-list
82965406|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
82965407|NCT03885947|Thiotepa|thiotepa|mesh-list
82965408|NCT03885947|Valproic Acid|valproic acid|mesh-list
82965409|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965410|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965411|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965412|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
82965413|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965414|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965415|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82965416|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
82965417|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82965418|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
82965419|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965420|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
82965421|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965422|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
82965423|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82965424|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965425|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82965426|NCT01261481|Tolvaptan|tolvaptan|mesh-list
82965427|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82965428|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965429|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
82965430|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965431|NCT01261637|Ropivacaine|ropivacaine|mesh-list
82965432|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
82965433|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
82965434|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965435|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965436|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
82965437|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965438|NCT01262183|Panitumumab|panitumumab|mesh-list
82965439|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965440|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965441|NCT01154933|Exenatide|exenatide|mesh-list
82965442|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965443|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965444|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82965445|NCT01154933|Incretins|incretins|mesh-ancestor
82965446|NCT01154933|Hormones|hormones|mesh-ancestor
83461523|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
82965447|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965448|NCT01155635|Carvedilol|carvedilol|mesh-list
82965449|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82965450|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82965451|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
82965452|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965453|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965454|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965455|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82965456|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
82965457|NCT01155635|Protective Agents|protective agents|mesh-ancestor
82965458|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82965459|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82965460|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82965461|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
82965462|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82965463|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82965464|NCT01155089|Anastrozole|anastrozole|mesh-list
82965465|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965466|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965467|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82965468|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82965469|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965470|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965471|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82965472|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
82965473|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965474|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965475|NCT01155245|Teriparatide|teriparatide|mesh-list
82965476|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82965477|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965478|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82965479|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
82965480|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82965481|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
82965482|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965483|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
82965484|NCT01262417|Protective Agents|protective agents|mesh-ancestor
82965485|NCT01155791|Prednisone|prednisone|mesh-list
82965486|NCT01155791|Docetaxel|docetaxel|mesh-list
82965487|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965488|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
82965489|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
82965490|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
82965491|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965492|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965493|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
82965494|NCT01155791|Hormones|hormones|mesh-ancestor
82965495|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965496|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965497|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965498|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82965499|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82965500|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82965501|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965502|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965503|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82965504|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82965505|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965506|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
82965507|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965508|NCT03881423|Bromides|bromides|mesh-list
82965509|NCT03881423|Rocuronium|rocuronium|mesh-list
82965510|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
82965511|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
82965512|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82965513|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82965514|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965515|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965516|NCT03884465|Treprostinil|treprostinil|mesh-list
82965517|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82965518|NCT01155947|Anastrozole|anastrozole|mesh-list
82965519|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965520|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965521|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82965522|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82965523|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965524|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965525|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82965526|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
82965527|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965528|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965529|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82965530|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82965531|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82965532|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965533|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965534|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82965535|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82965536|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82965537|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
82965538|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965539|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965540|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82965541|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82965542|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
82965544|NCT01264133|Clevudine|clevudine|mesh-list
82965545|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
82965546|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965547|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82965548|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82965549|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965550|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965551|NCT02527577|Ropivacaine|ropivacaine|mesh-list
82965552|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
82965553|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
82965554|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965555|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965556|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
82965557|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965558|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
82965559|NCT03883841|Hematinics|hematinics|mesh-ancestor
82965560|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
82965561|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965562|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965563|NCT03881111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82965564|NCT03881111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965566|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965567|NCT03880877|Leucovorin|leucovorin|mesh-list
82965568|NCT03880877|Antidotes|antidotes|mesh-ancestor
82965569|NCT03880877|Protective Agents|protective agents|mesh-ancestor
82965570|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965571|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
82965572|NCT03880877|Vitamins|vitamins|mesh-ancestor
82965573|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
82965574|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82965575|NCT05666999|Laxatives|laxatives|mesh-ancestor
82965576|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82965577|NCT01262729|Xenon|xenon|mesh-list
82965578|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82965579|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
82965580|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
82965581|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965582|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965583|NCT01264289|Finasteride|finasteride|mesh-list
82965584|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82965585|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82965586|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965587|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83461532|NCT01457690|Protective Agents|protective agents|mesh-ancestor
82965588|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
82965589|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965590|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965591|NCT01264289|Urological Agents|urological agents|mesh-ancestor
82965592|NCT03880487|Oxycodone|oxycodone|mesh-list
82965593|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82965594|NCT03880487|Narcotics|narcotics|mesh-ancestor
82965595|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965596|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965597|NCT03880487|Analgesics|analgesics|mesh-ancestor
82965598|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
82965599|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965600|NCT03880409|Lidocaine|lidocaine|mesh-list
82965601|NCT03880409|Epinephrine|epinephrine|mesh-list
82965602|NCT03880409|Racepinephrine|racepinephrine|mesh-list
82965603|NCT03880409|Carticaine|carticaine|mesh-list
82965604|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
82965605|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
82965606|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
82965607|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965608|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965609|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
82965610|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965611|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82965612|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82965613|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82965614|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82965615|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965616|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82965617|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82965618|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
82965619|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965620|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82965621|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82965622|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
82965623|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82965624|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
82965625|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
82965626|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
82965627|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82965628|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
82965629|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965630|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965631|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82965632|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82965633|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965634|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965635|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965636|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82965637|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82965638|NCT01264367|Interferons|interferons|mesh-list
82965640|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965641|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
82965642|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965643|NCT05097716|Tolbutamide|tolbutamide|mesh-list
82965644|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965645|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965646|NCT01262963|Dabrafenib|dabrafenib|mesh-list
82965647|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965648|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82965649|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965650|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965651|NCT01264445|Vaccines|vaccines|mesh-list
82965652|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
82965653|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965654|NCT01157975|Pioglitazone|pioglitazone|mesh-list
82965655|NCT01157975|Prednisone|prednisone|mesh-list
82965656|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965657|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
82965658|NCT01157975|Hormones|hormones|mesh-ancestor
82965659|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965660|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965661|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965662|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965663|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965664|NCT03060512|Naloxegol|naloxegol|mesh-list
82965665|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82965666|NCT03060512|Laxatives|laxatives|mesh-ancestor
82965667|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82965668|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82965669|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965670|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
82965671|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965672|NCT01263353|Everolimus|everolimus|mesh-list
82965673|NCT01263353|Pasireotide|pasireotide|mesh-list
82965674|NCT01263353|Somatostatin|somatostatin|mesh-list
82965675|NCT01263353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82965676|NCT01263353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82965677|NCT01263353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965678|NCT01263353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965679|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965680|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
82965681|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965682|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965683|NCT01263353|Hormones|hormones|mesh-ancestor
82965684|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965685|NCT01158287|Sorafenib|sorafenib|mesh-list
82965686|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965687|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82965688|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965689|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965690|NCT01158365|Glycerol|glycerol|mesh-list
82965691|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82965692|NCT01158365|Protective Agents|protective agents|mesh-ancestor
82965693|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965694|NCT01156649|Acetaminophen|acetaminophen|mesh-list
82965695|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82965696|NCT01156649|Analgesics|analgesics|mesh-ancestor
82965697|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
82965698|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965699|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965700|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
82965701|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
82965702|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965703|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965704|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82965705|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82965707|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965708|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965709|NCT03879707|Melatonin|melatonin|mesh-list
82965710|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
82965711|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965712|NCT03879707|Protective Agents|protective agents|mesh-ancestor
82965713|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965714|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965715|NCT01265147|Nedaplatin|nedaplatin|mesh-list
82965716|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965717|NCT01159145|Omeprazole|omeprazole|mesh-list
82965718|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82965719|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82965720|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82965721|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965722|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965723|NCT01156883|Cytarabine|cytarabine|mesh-list
82965724|NCT01156883|Dexamethasone|dexamethasone|mesh-list
82965725|NCT01156883|Prednisone|prednisone|mesh-list
82965726|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
82965727|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
82965728|NCT01156883|Ifosfamide|ifosfamide|mesh-list
82965729|NCT01156883|Doxorubicin|doxorubicin|mesh-list
82965730|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82965731|NCT01156883|Methotrexate|methotrexate|mesh-list
82965732|NCT01156883|Vincristine|vincristine|mesh-list
82965733|NCT01156883|Daunorubicin|daunorubicin|mesh-list
82965734|NCT01156883|Asparaginase|asparaginase|mesh-list
82965735|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
82965736|NCT01156883|Thioguanine|thioguanine|mesh-list
82965737|NCT01156883|Vindesine|vindesine|mesh-list
82965738|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965739|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
82965740|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965741|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965742|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82965743|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
82965744|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965745|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965746|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82965747|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965748|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
82965749|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
82965750|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965751|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82965752|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
82965753|NCT01156883|Hormones|hormones|mesh-ancestor
83483182|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82965754|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965755|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965756|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82965757|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82965758|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82965759|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965760|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82965761|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
82965762|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82965763|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82965764|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
82965765|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
82965766|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82965767|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82965768|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
82965769|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965770|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82965771|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
82965772|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
82965773|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
82965774|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82965775|NCT01156883|Protective Agents|protective agents|mesh-ancestor
82965776|NCT01156961|Paclitaxel|paclitaxel|mesh-list
82965777|NCT01156961|Bevacizumab|bevacizumab|mesh-list
82965778|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82965779|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965780|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
82965781|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
82965782|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
82965783|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965784|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965785|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82965786|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82965787|NCT01156961|Growth Substances|growth substances|mesh-ancestor
82965788|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965789|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
82965790|NCT01159301|Sorafenib|sorafenib|mesh-list
82965791|NCT01159301|Entinostat|entinostat|mesh-list
82965792|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82965793|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965794|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82965795|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965796|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965797|NCT01159379|Ertapenem|ertapenem|mesh-list
82965798|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965799|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965800|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82965801|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965802|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965803|NCT01159847|Incretins|incretins|mesh-ancestor
82965804|NCT01159847|Hormones|hormones|mesh-ancestor
82965805|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965806|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82965807|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
82965808|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965809|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965810|NCT02539160|Ticagrelor|ticagrelor|mesh-list
82965811|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82965812|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82965813|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82965814|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82965815|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
82965816|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965817|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965818|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965819|NCT01265927|Trastuzumab|trastuzumab|mesh-list
82965820|NCT01265927|Imetelstat|imetelstat|mesh-list
82965821|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965822|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965823|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965824|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965825|NCT01266005|Entecavir|entecavir|mesh-list
82965826|NCT01266005|Clevudine|clevudine|mesh-list
82965827|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
82965828|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965830|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
82965831|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965832|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
82965833|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965834|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
82965835|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82965836|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82965837|NCT03876899|Analgesics|analgesics|mesh-ancestor
82965838|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
82965839|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965840|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965841|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965842|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965843|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82965844|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
82965845|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965846|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82965847|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
82965848|NCT03241173|Nivolumab|nivolumab|mesh-list
82965849|NCT03241173|Ipilimumab|ipilimumab|mesh-list
82965850|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965851|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965852|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82965853|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965854|NCT03264066|Atezolizumab|atezolizumab|mesh-list
82965855|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82965856|NCT03264066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82965857|NCT03264066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965858|NCT03264066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965859|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965860|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
82965861|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965862|NCT03759041|Vancomycin|vancomycin|mesh-list
82965863|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82965864|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965865|NCT04110145|Linaclotide|linaclotide|mesh-list
82965866|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82965867|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
82965868|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965869|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82965870|NCT02477618|Brexanolone|brexanolone|mesh-list
82965871|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
82965872|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965873|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965874|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965875|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
82965876|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
82965877|NCT01268033|Rituximab|rituximab|mesh-list
82965878|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965879|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965880|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
82965881|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965882|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965883|NCT01162031|Bortezomib|bortezomib|mesh-list
82965884|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965885|NCT02879162|Durvalumab|durvalumab|mesh-list
82965886|NCT02879162|Tremelimumab|tremelimumab|mesh-list
82965887|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82965888|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965889|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
82965890|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965891|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965892|NCT02285504|Brexanolone|brexanolone|mesh-list
82965893|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
82965894|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82965895|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965896|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965897|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
82965898|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
82965899|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
82965900|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965901|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82965902|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965903|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965904|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82965905|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82965906|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
82965907|NCT05158491|Irinotecan|irinotecan|mesh-list
82965908|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82965909|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82965910|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965911|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965912|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965913|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
82965914|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965915|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965916|NCT03876587|Docetaxel|docetaxel|mesh-list
82965917|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965918|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
82965919|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
82965920|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
82965921|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965922|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82965923|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
82965924|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965925|NCT04635423|Vaccines|vaccines|mesh-list
82965926|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
82965927|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965928|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
82965929|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965930|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82965931|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
82965933|NCT03282357|Protective Agents|protective agents|mesh-ancestor
82965934|NCT01162967|Posaconazole|posaconazole|mesh-list
82965935|NCT01162967|Benzonidazole|benzonidazole|mesh-list
82965936|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
82965937|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82965938|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82965939|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82965940|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82965941|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82965942|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82965943|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461555|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
82965944|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965945|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82965946|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
82965947|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965948|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965949|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965950|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
82965951|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82965952|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
82965953|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82965954|NCT04272775|Dexamethasone|dexamethasone|mesh-list
82965955|NCT04272775|Lenalidomide|lenalidomide|mesh-list
82965956|NCT04272775|Ixazomib|ixazomib|mesh-list
82965957|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965958|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
82965959|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
82965960|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82965961|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965962|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82965963|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
82965964|NCT04272775|Hormones|hormones|mesh-ancestor
82965965|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82965966|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82965967|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965968|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
82965969|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82965970|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82965971|NCT04272775|Growth Substances|growth substances|mesh-ancestor
82965972|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
82965973|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
82965974|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82965975|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965976|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
82965977|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82965978|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965979|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
82965980|NCT01163201|Fludarabine|fludarabine|mesh-list
82965981|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82965982|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
82965983|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82965984|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82965985|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82965986|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
82965987|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82965988|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82965989|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82965990|NCT03876041|Dexamethasone|dexamethasone|mesh-list
82965991|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
82965992|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
82965993|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82965994|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82965995|NCT03876041|BB 1101|bb 1101|mesh-list
82965996|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82965997|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
82965998|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
82965999|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966000|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966001|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966002|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
82966003|NCT03876041|Hormones|hormones|mesh-ancestor
82966004|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966005|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82966006|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966009|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966010|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82966011|NCT03876041|Protective Agents|protective agents|mesh-ancestor
82966012|NCT04102345|Zolpidem|zolpidem|mesh-list
82966013|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82966014|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82966015|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966016|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966017|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82966018|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
82966019|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
82966020|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966021|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966022|NCT01163435|Clarithromycin|clarithromycin|mesh-list
82966023|NCT01163435|Levofloxacin|levofloxacin|mesh-list
82966024|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82966025|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966026|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82966027|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966028|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966029|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82966030|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82966031|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82966032|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82966033|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82966034|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966035|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82966036|NCT03299244|Cinacalcet|cinacalcet|mesh-list
82966037|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82966038|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966039|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82966040|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
82966041|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966042|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82966043|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966044|NCT03757715|Dexamethasone|dexamethasone|mesh-list
82966045|NCT03757715|Bupivacaine|bupivacaine|mesh-list
82966046|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966047|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
82966048|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
82966049|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966050|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966051|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966052|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
82966053|NCT03757715|Hormones|hormones|mesh-ancestor
82966054|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966055|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82966056|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966057|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
82966058|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
82966059|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966060|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
82966061|NCT01163825|Mitogens|mitogens|mesh-list
82966062|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
82966063|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966064|NCT01163903|Doxorubicin|doxorubicin|mesh-list
82966065|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82966066|NCT01163903|Pantoprazole|pantoprazole|mesh-list
82966067|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82966068|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83461566|NCT01451294|Phenylephrine|phenylephrine|mesh-list
83461567|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
82966069|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82966070|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82966071|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966072|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966073|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82966074|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966075|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82966076|NCT03759587|Niraparib|niraparib|mesh-list
82966077|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82966078|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966079|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966080|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966081|NCT03745807|Nivolumab|nivolumab|mesh-list
82966082|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966083|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966084|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82966085|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966086|NCT01164059|Haloperidol|haloperidol|mesh-list
82966087|NCT01164059|Olanzapine|olanzapine|mesh-list
82966088|NCT01164059|Aripiprazole|aripiprazole|mesh-list
82966089|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82966090|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
82966091|NCT01164059|Flupenthixol|flupenthixol|mesh-list
82966092|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
82966093|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
82966094|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
82966095|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966096|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966097|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966098|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82966099|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82966100|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966101|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82966102|NCT01164059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82966103|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82966104|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82966105|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966106|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966107|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
82966108|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
82966109|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
82966110|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
82966111|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82966112|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82966113|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82966114|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82966115|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82966116|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82966117|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82966118|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
82966119|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82966120|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966121|NCT03878771|Clobetasol|clobetasol|mesh-list
82966122|NCT03878771|Benzocaine|benzocaine|mesh-list
82966123|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966124|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
82966125|NCT03878771|Hormones|hormones|mesh-ancestor
82966126|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966127|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966128|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
82966129|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
82966130|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966131|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
82966132|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966133|NCT02959918|Sirolimus|sirolimus|mesh-list
82966134|NCT02959918|Temsirolimus|temsirolimus|mesh-list
82966135|NCT02959918|MTOR Inhibitors|mtor inhibitors|mesh-list
82966136|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83461584|NCT01451294|Protective Agents|protective agents|mesh-ancestor
83461587|NCT01187017|Fludarabine|fludarabine|mesh-list
82966137|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966138|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82966139|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966140|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
82966141|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82966142|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
82966143|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966144|NCT02959918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82966145|NCT02959918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966146|NCT02959918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966147|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
82966148|NCT01266707|Vaccines|vaccines|mesh-list
82966149|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
82966150|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966151|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82966152|NCT01266707|Growth Substances|growth substances|mesh-ancestor
82966154|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966155|NCT03263442|Thiamine|thiamine|mesh-list
83461589|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
82966156|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966157|NCT03263442|Vitamins|vitamins|mesh-ancestor
82966158|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
82966159|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966160|NCT01164215|Leucovorin|leucovorin|mesh-list
82966161|NCT01164215|Fluorouracil|fluorouracil|mesh-list
82966162|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
82966163|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
82966164|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966165|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
82966166|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966167|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82966168|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966169|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82966170|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
82966171|NCT01164215|Antidotes|antidotes|mesh-ancestor
82966172|NCT01164215|Protective Agents|protective agents|mesh-ancestor
82966173|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966174|NCT01164215|Vitamins|vitamins|mesh-ancestor
82966175|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
82966176|NCT04245709|Clenbuterol|clenbuterol|mesh-list
82966177|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82966178|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82966179|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
82966180|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966181|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966182|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966183|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82966184|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
82966185|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966186|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82966187|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
82966188|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
82966189|NCT03878693|Fomepizole|fomepizole|mesh-list
82966190|NCT03878693|Antidotes|antidotes|mesh-ancestor
82966191|NCT03878693|Protective Agents|protective agents|mesh-ancestor
82966192|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966193|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966194|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966195|NCT05305495|Empagliflozin|empagliflozin|mesh-list
82966196|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82966197|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966198|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82966199|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966200|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
82966201|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966202|NCT02527109|Nifedipine|nifedipine|mesh-list
82966203|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82966204|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82966205|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966206|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82966207|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966208|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
82966209|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
82966210|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82966211|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82966212|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82966213|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82966214|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
82966215|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966216|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966217|NCT02940522|Progestins|progestins|mesh-ancestor
82966218|NCT02940522|Hormones|hormones|mesh-ancestor
82966219|NCT01266785|Infliximab|infliximab|mesh-list
82966220|NCT01266785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82966221|NCT01266785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966222|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
82966223|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966224|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82966225|NCT03262038|Ondansetron|ondansetron|mesh-list
82966226|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
82966227|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
82966228|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966229|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966231|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
82966232|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
82966233|NCT03262038|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82966234|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82966235|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
82966236|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966237|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966238|NCT03746821|Biotin|biotin|mesh-list
82966239|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966240|NCT03746821|Vitamins|vitamins|mesh-ancestor
82966241|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
82966242|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966243|NCT02472964|Paclitaxel|paclitaxel|mesh-list
82966244|NCT02472964|Docetaxel|docetaxel|mesh-list
82966245|NCT02472964|Trastuzumab|trastuzumab|mesh-list
82966246|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82966247|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966248|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
82966249|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
82966250|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
82966251|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966252|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966253|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82966254|NCT01160315|Norethindrone|norethindrone|mesh-list
82966255|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
82966256|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
82966257|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82966258|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
82966259|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82966260|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966261|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82966262|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82966263|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966264|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82966265|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82966266|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82966267|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
82966268|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
82966269|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966270|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
82966271|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966272|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966273|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
82966274|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82966275|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82966276|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
82966277|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966278|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82966279|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82966280|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966281|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966282|NCT03380728|Ibogaine|ibogaine|mesh-list
82966283|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
82966284|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966285|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82966286|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82966287|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82966288|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966289|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966290|NCT01104922|Cetuximab|cetuximab|mesh-list
82966291|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966292|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966293|NCT01164761|Ramipril|ramipril|mesh-list
82966294|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82966295|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
82966296|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966297|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966298|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82966299|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
82966300|NCT03385096|Melphalan|melphalan|mesh-list
82966301|NCT03385096|Busulfan|busulfan|mesh-list
82966302|NCT03385096|Etoposide|etoposide|mesh-list
82966303|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82966304|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
82966305|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966306|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82966307|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82966308|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
82966309|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966310|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966311|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82966312|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82966313|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82966314|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82966315|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966316|NCT02526875|Amlodipine|amlodipine|mesh-list
82966317|NCT02526875|Telmisartan|telmisartan|mesh-list
82966318|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82966319|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82966320|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82966321|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966322|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82966323|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966324|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
82966325|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82966326|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82966327|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
82966328|NCT04222699|Mupirocin|mupirocin|mesh-list
82966329|NCT04222699|Calcium|calcium|mesh-list
82966330|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82966331|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966332|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82966333|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966334|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
82966335|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82966336|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82966337|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966338|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966339|NCT01269203|Curcumin|curcumin|mesh-list
82966340|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82966341|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82966342|NCT01269203|Analgesics|analgesics|mesh-ancestor
82966343|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
82966344|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966345|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966346|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966347|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82966348|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966349|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966350|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966351|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
82966352|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82966353|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
82966354|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966355|NCT01160627|Expectorants|expectorants|mesh-ancestor
82966356|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
82966357|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82966358|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
82966359|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966360|NCT01160627|Protective Agents|protective agents|mesh-ancestor
82966361|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966362|NCT01160627|Antidotes|antidotes|mesh-ancestor
82966363|NCT04075513|Insulin|insulin|mesh-list
82966364|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82966365|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
82966366|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
82966367|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82966368|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966369|NCT03877679|Triamcinolone|triamcinolone|mesh-list
82966370|NCT03877679|Curcumin|curcumin|mesh-list
82966371|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966372|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
82966373|NCT03877679|Hormones|hormones|mesh-ancestor
82966374|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966375|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966376|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966377|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966378|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82966380|NCT03877679|Analgesics|analgesics|mesh-ancestor
82966381|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
82966382|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966383|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82966384|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966385|NCT03330249|Cisplatin|cisplatin|mesh-list
82966386|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966387|NCT04652206|Paclitaxel|paclitaxel|mesh-list
82966388|NCT04652206|Gemcitabine|gemcitabine|mesh-list
82966389|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82966390|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966391|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
82966392|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
82966393|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
82966394|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966395|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82966396|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
82966397|NCT01269281|Sumatriptan|sumatriptan|mesh-list
82966398|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82966399|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82966400|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82966401|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
82966402|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966403|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966404|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966405|NCT02778204|Maraviroc|maraviroc|mesh-list
82966406|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82966407|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82966408|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966409|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82966410|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82966411|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
82966412|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966413|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82966414|NCT01160705|Docetaxel|docetaxel|mesh-list
82966415|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966416|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
82966417|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
82966418|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
82966419|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966420|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83461599|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
82966421|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
82966422|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82966423|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
82966424|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82966425|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966426|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82966427|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82966428|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966429|NCT03261336|Vitamin D|vitamin d|mesh-list
82966430|NCT03261336|Calcitriol|calcitriol|mesh-list
82966431|NCT03261336|Ketoconazole|ketoconazole|mesh-list
82966432|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
82966433|NCT03261336|Vitamins|vitamins|mesh-ancestor
82966434|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
82966435|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966436|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82966437|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82966438|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966439|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
82966440|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966441|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82966442|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82966443|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966444|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966445|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82966446|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
82966447|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966448|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82966449|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
82966450|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82966451|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82966453|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
82966454|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
82966455|NCT03384862|Vitamins|vitamins|mesh-ancestor
82966456|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
82966457|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966458|NCT03384862|Hematinics|hematinics|mesh-ancestor
82966459|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966460|NCT01269437|Budesonide|budesonide|mesh-list
82966461|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966462|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82966463|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
82966464|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966465|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966466|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82966467|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
82966468|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
82966469|NCT01269437|Hormones|hormones|mesh-ancestor
82966470|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966471|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82966472|NCT04163952|Panitumumab|panitumumab|mesh-list
82966473|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82966474|NCT04163952|Antibodies|antibodies|mesh-list
82966475|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
82966476|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82966477|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
82966478|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966479|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966480|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
82966481|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
82966482|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966483|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
82966484|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966485|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966486|NCT00462748|Atorvastatin|atorvastatin|mesh-list
82966487|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82966488|NCT00462748|Simvastatin|simvastatin|mesh-list
82966489|NCT00462748|Ezetimibe|ezetimibe|mesh-list
82966490|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82966491|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82966492|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
82966493|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966494|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82966495|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82966496|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966497|NCT01161017|Topiramate|topiramate|mesh-list
82966498|NCT01161017|Amitriptyline|amitriptyline|mesh-list
82966499|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
82966500|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82966501|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966502|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82966503|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
82966504|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82966505|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82966506|NCT01161017|Analgesics|analgesics|mesh-ancestor
82966507|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
82966508|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966509|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82966510|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82966511|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82966512|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966513|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
82966514|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966515|NCT03935685|Mirtazapine|mirtazapine|mesh-list
82966516|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
82966517|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82966518|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82966519|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
82966520|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
82966521|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966522|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966523|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966524|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82966525|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82966526|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966527|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82966528|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82966529|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82966530|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
82966531|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82966532|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82966533|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
82966534|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82966535|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82966536|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
82966537|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966538|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82966540|NCT01269515|Etoricoxib|etoricoxib|mesh-list
82966541|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82966542|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82966543|NCT01269515|Analgesics|analgesics|mesh-ancestor
82966544|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
82966545|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966546|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966547|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966548|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82966549|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82966550|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82966551|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966552|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966553|NCT00418834|Atorvastatin|atorvastatin|mesh-list
82966554|NCT00418834|Ezetimibe|ezetimibe|mesh-list
82966555|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82966556|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82966557|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
82966558|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966559|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82966560|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82966561|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966562|NCT01269671|Peppermint oil|peppermint oil|mesh-list
82966563|NCT01269671|Melatonin|melatonin|mesh-list
82966564|NCT01269671|Simethicone|simethicone|mesh-list
82966565|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
82966566|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966567|NCT01269671|Protective Agents|protective agents|mesh-ancestor
82966568|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966569|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966570|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
82966571|NCT01269671|Emollients|emollients|mesh-ancestor
82966572|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
82966573|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
82966574|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
82966575|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966576|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966577|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
82966578|NCT04407286|Vitamin D|vitamin d|mesh-list
82966579|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
82966580|NCT04407286|Vitamins|vitamins|mesh-ancestor
82966581|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
82966582|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966583|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83520091|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82966584|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82966585|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82966586|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
82966587|NCT03276975|Coagulants|coagulants|mesh-ancestor
82966588|NCT03125746|Exemestane|exemestane|mesh-list
82966589|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966590|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82966591|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82966592|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966593|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966594|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82966595|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
82966596|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966597|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966598|NCT03877601|Bevacizumab|bevacizumab|mesh-list
82966599|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966600|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966601|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82966602|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82966603|NCT03877601|Growth Substances|growth substances|mesh-ancestor
82966604|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966605|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
82966606|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82966607|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82966608|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82966609|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
82966610|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966611|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966613|NCT03297216|Hormones|hormones|mesh-ancestor
82966614|NCT03260868|Insulin|insulin|mesh-list
82966615|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82966616|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
82966617|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
82966618|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
82966619|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82966620|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966621|NCT01165385|Cisplatin|cisplatin|mesh-list
82966622|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966623|NCT01267487|Heparin|heparin|mesh-list
82966624|NCT01267487|Calcium heparin|calcium heparin|mesh-list
82966625|NCT01267487|Protamines|protamines|mesh-list
82966626|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
82966627|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82966628|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82966629|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966630|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
82966631|NCT01267487|Coagulants|coagulants|mesh-ancestor
82966632|NCT01267643|Alefacept|alefacept|mesh-list
82966633|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
82966634|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
82966635|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966636|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
82966637|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82966638|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966639|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966640|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82966641|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82966642|NCT01269827|Protective Agents|protective agents|mesh-ancestor
82966643|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966644|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
82966645|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82966646|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
82966647|NCT03388372|Temozolomide|temozolomide|mesh-list
82966648|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
82966649|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82966650|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
82966651|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966652|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966653|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966654|NCT05173246|Paclitaxel|paclitaxel|mesh-list
82966655|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82966656|NCT05173246|Cisplatin|cisplatin|mesh-list
82966657|NCT05173246|Carboplatin|carboplatin|mesh-list
82966658|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82966659|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966660|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
82966661|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
82966662|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
82966663|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966664|NCT01167101|Pantoprazole|pantoprazole|mesh-list
82966665|NCT01167101|Rebamipide|rebamipide|mesh-list
82966666|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82966667|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966668|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82966669|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966670|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966671|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
82966672|NCT01167101|Protective Agents|protective agents|mesh-ancestor
82966673|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966674|NCT05173090|Ropivacaine|ropivacaine|mesh-list
82966675|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
82966676|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
82966677|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966678|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966679|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
82966680|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966682|NCT02526953|Capecitabine|capecitabine|mesh-list
82966683|NCT02526953|Mitomycins|mitomycins|mesh-list
82966684|NCT02526953|Mitomycin|mitomycin|mesh-list
82966685|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82966686|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966687|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
82966688|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
82966689|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
82966690|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966691|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82966692|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
82966693|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82966694|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
82966695|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83461631|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82966696|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966697|NCT03258762|Leucovorin|leucovorin|mesh-list
82966698|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
82966699|NCT03258762|Calcium|calcium|mesh-list
82966700|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
82966701|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82966702|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966703|NCT03258762|Antidotes|antidotes|mesh-ancestor
82966704|NCT03258762|Protective Agents|protective agents|mesh-ancestor
82966705|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966706|NCT03258762|Vitamins|vitamins|mesh-ancestor
82966707|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
82966708|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
82966709|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82966710|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82966711|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966712|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82966713|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966714|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966715|NCT05427669|Leucovorin|leucovorin|mesh-list
82966716|NCT05427669|Fluorouracil|fluorouracil|mesh-list
82966717|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
82966718|NCT05427669|Irinotecan|irinotecan|mesh-list
82966719|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
82966720|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
82966721|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966722|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82966723|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966724|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82966725|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
82966726|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966727|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82966728|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82966729|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966730|NCT05427669|Antidotes|antidotes|mesh-ancestor
82966731|NCT05427669|Protective Agents|protective agents|mesh-ancestor
82966732|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966733|NCT05427669|Vitamins|vitamins|mesh-ancestor
82966734|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
82966735|NCT01270373|Docetaxel|docetaxel|mesh-list
82966736|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966737|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
82966738|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
82966739|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
82966740|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966741|NCT03713086|Vaccines|vaccines|mesh-list
82966742|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
82966743|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966744|NCT01271231|Azithromycin|azithromycin|mesh-list
82966745|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82966746|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966747|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
82966748|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82966749|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
82966750|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966751|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
82966752|NCT03697876|Protective Agents|protective agents|mesh-ancestor
82966753|NCT04526691|Carboplatin|carboplatin|mesh-list
82966754|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
82966755|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966756|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966757|NCT04526691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82966758|NCT04526691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966760|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82966761|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966762|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82966763|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966764|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
82966765|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83461639|NCT01188109|Gemcitabine|gemcitabine|mesh-list
82966766|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
82966767|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966768|NCT03379558|Alirocumab|alirocumab|mesh-list
82966769|NCT03379558|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82966770|NCT03379558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82966771|NCT03379558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82966772|NCT03379558|Antimetabolites|antimetabolites|mesh-ancestor
82966773|NCT03379558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966774|NCT03379558|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82966775|NCT03379558|Protease Inhibitors|protease inhibitors|mesh-ancestor
82966776|NCT03379558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966777|NCT03379558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82966778|NCT01169909|Ranibizumab|ranibizumab|mesh-list
82966779|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82966780|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82966781|NCT01169909|Growth Substances|growth substances|mesh-ancestor
82966782|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966783|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
82966784|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966785|NCT04502589|Disulfiram|disulfiram|mesh-list
82966786|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82966787|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82966788|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966789|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966790|NCT04485039|Tecovirimat|tecovirimat|mesh-list
82966791|NCT04485039|Sevelamer|sevelamer|mesh-list
82966792|NCT04485039|Calcium acetate|calcium acetate|mesh-list
82966793|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
82966794|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
82966795|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966796|NCT04485039|Antiviral Agents|antiviral agents|mesh-ancestor
82966797|NCT04485039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966798|NCT03387904|Irinotecan|irinotecan|mesh-list
82966799|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82966800|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82966801|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966802|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966803|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966804|NCT03291288|Tolbutamide|tolbutamide|mesh-list
82966805|NCT03291288|Midazolam|midazolam|mesh-list
82966806|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82966807|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82966808|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966809|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966810|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82966811|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82966812|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82966813|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82966814|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
82966815|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
82966816|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
82966817|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
82966818|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483183|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966819|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966820|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82966821|NCT05172310|FAPI-46|fapi-46|mesh-list
82966822|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82966823|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966824|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82966825|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82966826|NCT04084626|Lenalidomide|lenalidomide|mesh-list
82966827|NCT04084626|Antibodies|antibodies|mesh-list
82966828|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
82966829|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966830|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82966831|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82966832|NCT04084626|Growth Substances|growth substances|mesh-ancestor
82966833|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
82966834|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966836|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82966837|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82966838|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82966839|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82966840|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82966841|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
82966842|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966843|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966844|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966845|NCT03871517|Aspirin|aspirin|mesh-list
82966846|NCT03871517|Indobufen|indobufen|mesh-list
82966847|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82966848|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82966849|NCT03871517|Analgesics|analgesics|mesh-ancestor
82966850|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
82966851|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966852|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966853|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966854|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82966855|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82966856|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82966857|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966858|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82966859|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82966860|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966861|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
82966862|NCT03387592|Leucovorin|leucovorin|mesh-list
82966863|NCT03387592|Fluorouracil|fluorouracil|mesh-list
82966864|NCT03387592|Capecitabine|capecitabine|mesh-list
82966865|NCT03387592|Temozolomide|temozolomide|mesh-list
82966866|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
82966867|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
82966868|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966869|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82966870|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966871|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82966872|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
82966873|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966874|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82966875|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
82966876|NCT03387592|Antidotes|antidotes|mesh-ancestor
82966877|NCT03387592|Protective Agents|protective agents|mesh-ancestor
82966878|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966879|NCT03387592|Vitamins|vitamins|mesh-ancestor
82966880|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
82966881|NCT04445506|Dexamethasone|dexamethasone|mesh-list
82966882|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82966883|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
82966884|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
82966885|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82966886|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966887|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82966888|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
82966889|NCT04445506|Hormones|hormones|mesh-ancestor
82966890|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966891|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82966892|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966893|NCT03379012|Sunitinib|sunitinib|mesh-list
82966894|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
82966895|NCT03379012|Testosterone|testosterone|mesh-list
82966896|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
82966897|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
82966898|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82966899|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966900|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82966901|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82966902|NCT03379012|Growth Substances|growth substances|mesh-ancestor
82966903|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966904|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
82966905|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82966906|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966907|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966908|NCT03379012|Androgens|androgens|mesh-ancestor
82966909|NCT03379012|Hormones|hormones|mesh-ancestor
82966910|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966911|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82966912|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
82966913|NCT03383302|Nivolumab|nivolumab|mesh-list
82966914|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966915|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966916|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82966917|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966918|NCT03493126|Estradiol|estradiol|mesh-list
82966919|NCT03493126|Estrogens|estrogens|mesh-ancestor
82966920|NCT03493126|Hormones|hormones|mesh-ancestor
82966921|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966922|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966923|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82966924|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82966925|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966926|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82966927|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
82966928|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966929|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
82966930|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82966931|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82966932|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966933|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
82966934|NCT03386656|Coagulants|coagulants|mesh-ancestor
82966935|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82966936|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82966937|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82966938|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82966939|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966940|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82966941|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82966942|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82966943|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
82966944|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82966945|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966946|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82966947|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82966948|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
82966949|NCT01281605|Insulin|insulin|mesh-list
82966950|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82966951|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
82966952|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82966953|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966954|NCT01170143|Trastuzumab|trastuzumab|mesh-list
82966955|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966956|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966957|NCT05171530|Lenvatinib|lenvatinib|mesh-list
82966958|NCT05171530|Taxane|taxane|mesh-list
82966959|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966960|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82966961|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966962|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966963|NCT02936037|Biotin|biotin|mesh-list
82966964|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
82966965|NCT02936037|Vitamins|vitamins|mesh-ancestor
82966966|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
83461654|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
82966967|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966968|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
82966969|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
82966970|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82966971|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966972|NCT04068181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82966973|NCT04068181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966974|NCT01283789|Everolimus|everolimus|mesh-list
82966975|NCT01283789|Lapatinib|lapatinib|mesh-list
82966976|NCT01283789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82966977|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82966978|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966979|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966980|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82966981|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
82966982|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966983|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82966985|NCT03383068|Exenatide|exenatide|mesh-list
82966986|NCT03383068|Acarbose|acarbose|mesh-list
82966987|NCT03383068|Orlistat|orlistat|mesh-list
82966988|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82966989|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82966990|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82966991|NCT03383068|Incretins|incretins|mesh-ancestor
82966992|NCT03383068|Hormones|hormones|mesh-ancestor
82966993|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82966994|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82966995|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82966996|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82966997|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82966998|NCT03378310|Linrodostat|linrodostat|mesh-list
82966999|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967000|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967001|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
82967002|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967003|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967004|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82967005|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
82967006|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967007|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967008|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967009|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967010|NCT04094298|FX006|fx006|mesh-list
82967011|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967012|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
82967013|NCT04094298|Hormones|hormones|mesh-ancestor
82967014|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967015|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967016|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967017|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
82967018|NCT04194151|Propofol|propofol|mesh-list
82967019|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82967020|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967021|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967022|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82967023|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
82967024|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
82967025|NCT01281761|Irinotecan|irinotecan|mesh-list
82967026|NCT01281761|Cetuximab|cetuximab|mesh-list
82967027|NCT01281761|Simvastatin|simvastatin|mesh-list
82967028|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82967029|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82967030|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967031|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967032|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967033|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967034|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82967035|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82967036|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
82967037|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83461672|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82967038|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82967039|NCT04280328|Daratumumab|daratumumab|mesh-list
82967040|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967041|NCT03748147|Misoprostol|misoprostol|mesh-list
82967042|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82967043|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
82967044|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82967045|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967046|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82967047|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967048|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
82967049|NCT01580813|Acipimox|acipimox|mesh-list
82967050|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82967051|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
82967052|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967053|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82967054|NCT04446364|Disinfectants|disinfectants|mesh-list
82967055|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967056|NCT01588535|Benzocaine|benzocaine|mesh-list
82967057|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
82967058|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
82967059|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967060|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967061|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
82967062|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967064|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
82967065|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967066|NCT03441282|Fentanyl|fentanyl|mesh-list
82967067|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82967068|NCT03441282|Narcotics|narcotics|mesh-ancestor
82967069|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967070|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967071|NCT03441282|Analgesics|analgesics|mesh-ancestor
82967072|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
82967073|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967074|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82967075|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82967076|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
82967077|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
82967078|NCT01274273|Interferons|interferons|mesh-list
82967079|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
82967080|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
82967081|NCT01274273|Aldesleukin|aldesleukin|mesh-list
82967082|NCT01274273|Bevacizumab|bevacizumab|mesh-list
82967083|NCT01274273|Interleukin-2|interleukin-2|mesh-list
82967084|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967085|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967086|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82967087|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82967088|NCT01274273|Growth Substances|growth substances|mesh-ancestor
82967089|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967090|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
82967091|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
82967092|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967093|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
82967094|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82967095|NCT01274273|Analgesics|analgesics|mesh-ancestor
82967096|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
82967097|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967098|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82967099|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82967100|NCT04058353|Ivacaftor|ivacaftor|mesh-list
82967101|NCT04058353|Elexacaftor|elexacaftor|mesh-list
82967102|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82967103|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967104|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967105|NCT01167725|Leucovorin|leucovorin|mesh-list
82967106|NCT01167725|Bevacizumab|bevacizumab|mesh-list
82967107|NCT01167725|Cetuximab|cetuximab|mesh-list
82967108|NCT01167725|Fluorouracil|fluorouracil|mesh-list
82967109|NCT01167725|Capecitabine|capecitabine|mesh-list
82967110|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
82967111|NCT01167725|Irinotecan|irinotecan|mesh-list
82967112|NCT01167725|Mitomycins|mitomycins|mesh-list
82967113|NCT01167725|Mitomycin|mitomycin|mesh-list
82967114|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
82967115|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967116|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967117|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82967118|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82967119|NCT01167725|Growth Substances|growth substances|mesh-ancestor
82967120|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967121|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
82967122|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
82967123|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967124|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82967125|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967126|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
82967127|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82967128|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82967129|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967130|NCT01167725|Antidotes|antidotes|mesh-ancestor
82967131|NCT01167725|Protective Agents|protective agents|mesh-ancestor
82967132|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
82967133|NCT01167725|Vitamins|vitamins|mesh-ancestor
82967134|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
82967135|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967136|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
82967137|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82967138|NCT04446130|Decitabine|decitabine|mesh-list
82967139|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82967140|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
82967141|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967142|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967143|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967144|NCT03226275|Amlodipine|amlodipine|mesh-list
82967145|NCT03226275|Bisoprolol|bisoprolol|mesh-list
82967146|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82967147|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82967148|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967149|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967150|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82967151|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967152|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
82967153|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
82967154|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
82967155|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967156|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82967157|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82967158|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82967159|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967160|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967161|NCT03382756|Choline|choline|mesh-list
82967162|NCT03382756|Atorvastatin|atorvastatin|mesh-list
82967163|NCT03382756|Fenofibrate|fenofibrate|mesh-list
82967164|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82967165|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82967166|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
82967167|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967168|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82967169|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82967170|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967171|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
82967172|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967173|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
82967174|NCT01166087|Fluoxetine|fluoxetine|mesh-list
82967175|NCT01166087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82967176|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82967177|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967178|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967179|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967180|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
82967181|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967182|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82967183|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
82967184|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82967185|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82967186|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82967187|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967188|NCT01170767|Bevacizumab|bevacizumab|mesh-list
82967189|NCT01170767|Ranibizumab|ranibizumab|mesh-list
82967190|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967191|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967192|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82967193|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82967194|NCT01170767|Growth Substances|growth substances|mesh-ancestor
82967195|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967196|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
82967197|NCT01170845|Sivelestat|sivelestat|mesh-list
82967198|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82967199|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
82967200|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967201|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967202|NCT01150890|Brodalumab|brodalumab|mesh-list
82967203|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
82967204|NCT01167803|Desflurane|desflurane|mesh-list
82967205|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82967206|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
82967207|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
82967208|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967209|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967210|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82967211|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82967212|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967213|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967214|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82967215|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967216|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967217|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
82967218|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967219|NCT01275911|Remifentanil|remifentanil|mesh-list
82967220|NCT01275911|Esmolol|esmolol|mesh-list
82967221|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82967222|NCT01275911|Narcotics|narcotics|mesh-ancestor
82967223|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967224|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967225|NCT01275911|Analgesics|analgesics|mesh-ancestor
82967226|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
82967227|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967228|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82967229|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82967230|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82967231|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967232|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967233|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967234|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
82967235|NCT01166165|Vitamin D|vitamin d|mesh-list
82967236|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82967237|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967238|NCT01166165|Vitamins|vitamins|mesh-ancestor
82967239|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
82967240|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82967241|NCT03286218|Alprazolam|alprazolam|mesh-list
82967242|NCT03286218|Lasmiditan|lasmiditan|mesh-list
82967243|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82967244|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967245|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967246|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82967247|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82967248|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82967249|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
82967250|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
82967251|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967252|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967253|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82967254|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
82967255|NCT03745261|Fluticasone|fluticasone|mesh-list
82967256|NCT03745261|Xhance|xhance|mesh-list
82967257|NCT03745261|Bromides|bromides|mesh-list
82967258|NCT03745261|Albuterol|albuterol|mesh-list
82967259|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
82967260|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82967261|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82967262|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967263|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82967264|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
82967265|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967266|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967267|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82967268|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
82967269|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
82967270|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82967271|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
82967272|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82967273|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
82967274|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967275|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967276|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82967277|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82967278|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82967279|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967280|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
82967281|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
82967282|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82967283|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
82967284|NCT03745261|Hormones|hormones|mesh-ancestor
82967285|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967286|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
82967287|NCT03744949|Remifentanil|remifentanil|mesh-list
82967288|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82967290|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967291|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967292|NCT03744949|Analgesics|analgesics|mesh-ancestor
82967293|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
82967294|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967295|NCT03870581|Warfarin|warfarin|mesh-list
82967296|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
82967297|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82967298|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967299|NCT04016779|Viloxazine|viloxazine|mesh-list
82967300|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82967301|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
82967302|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82967303|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82967304|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82967305|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967306|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967307|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967308|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967309|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967310|NCT03870503|Misoprostol|misoprostol|mesh-list
82967311|NCT03870503|Oxytocin|oxytocin|mesh-list
82967312|NCT03870503|Carbetocin|carbetocin|mesh-list
82967313|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
82967314|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82967315|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967316|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82967317|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
82967318|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82967319|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967320|NCT02857426|Nivolumab|nivolumab|mesh-list
82967321|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967322|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967323|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82967324|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967325|NCT05181033|Letrozole|letrozole|mesh-list
82967326|NCT05181033|Lenvatinib|lenvatinib|mesh-list
82967327|NCT05181033|Fulvestrant|fulvestrant|mesh-list
82967328|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967329|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82967330|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82967331|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967332|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967333|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82967334|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
82967335|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967336|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967337|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82967338|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82967339|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82967340|NCT05666765|Isotretinoin|isotretinoin|mesh-list
82967341|NCT05666765|Silymarin|silymarin|mesh-list
82967342|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
82967343|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
82967344|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967345|NCT05666765|Protective Agents|protective agents|mesh-ancestor
82967346|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967347|NCT01127256|Carbamazepine|carbamazepine|mesh-list
82967348|NCT01127256|Zonisamide|zonisamide|mesh-list
82967349|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
82967350|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
82967351|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83520245|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
82967352|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967353|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967354|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82967355|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82967356|NCT01127256|Analgesics|analgesics|mesh-ancestor
82967357|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
82967358|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967359|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82967360|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967361|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967362|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82967363|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82967364|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82967365|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82967366|NCT03377842|Leucovorin|leucovorin|mesh-list
82967367|NCT03377842|Apatinib|apatinib|mesh-list
82967368|NCT03377842|Fluorouracil|fluorouracil|mesh-list
82967369|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
82967370|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967371|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82967372|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967373|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967374|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
82967375|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82967376|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967377|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
82967378|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967379|NCT03377842|Antidotes|antidotes|mesh-ancestor
82967380|NCT03377842|Protective Agents|protective agents|mesh-ancestor
82967381|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
82967382|NCT03377842|Vitamins|vitamins|mesh-ancestor
82967383|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
82967384|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82967385|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
82967386|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967387|NCT01277705|Vaccines|vaccines|mesh-list
82967388|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
82967389|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967390|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
82967391|NCT04757337|Doxorubicin|doxorubicin|mesh-list
82967392|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967393|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
82967394|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967395|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967396|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82967397|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
82967398|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967399|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967400|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82967401|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967402|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82967403|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82967404|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967405|NCT03946527|Lanreotide|lanreotide|mesh-list
82967406|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967407|NCT03377608|Tenofovir|tenofovir|mesh-list
82967408|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82967409|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
82967410|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
82967411|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967412|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82967413|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82967414|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967415|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967416|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82967417|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82967418|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82967419|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
82967420|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82967421|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967422|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82967423|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82967424|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82967425|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83520246|NCT05132101|Palbociclib|palbociclib|mesh-list
82967426|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82967427|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82967428|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82967429|NCT01282073|Cyclosporine|cyclosporine|mesh-list
82967430|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
82967431|NCT01282073|Cyclosporins|cyclosporins|mesh-list
82967432|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967433|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967434|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967435|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
83461721|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82967436|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967437|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
82967438|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967439|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
82967440|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967441|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82967442|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967443|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967444|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82967445|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
82967446|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967447|NCT01166477|Ritonavir|ritonavir|mesh-list
82967448|NCT01166477|Lopinavir|lopinavir|mesh-list
82967449|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82967450|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82967451|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
82967452|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967453|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967454|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82967455|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82967456|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
82967457|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967458|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82967459|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82967460|NCT01282151|Cisplatin|cisplatin|mesh-list
82967461|NCT01282151|Pemetrexed|pemetrexed|mesh-list
82967462|NCT01282151|Docetaxel|docetaxel|mesh-list
82967463|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967464|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967465|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967466|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82967467|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82967468|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
82967469|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
82967470|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
82967471|NCT03377218|Iodine|iodine|mesh-list
82967472|NCT03377218|Selenium|selenium|mesh-list
82967473|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
82967474|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82967475|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967476|NCT03377218|Trace Elements|trace elements|mesh-ancestor
82967477|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
82967478|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967479|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
82967480|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967481|NCT03377218|Protective Agents|protective agents|mesh-ancestor
82967482|NCT01168505|Teferrol|teferrol|mesh-list
82967483|NCT01168505|Hematinics|hematinics|mesh-ancestor
82967484|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
82967485|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
82967486|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967487|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967488|NCT03382600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82967489|NCT03382600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967490|NCT04013191|Padsevonil|padsevonil|mesh-list
82967491|NCT04013191|Anticonvulsants|anticonvulsants|mesh-ancestor
82967492|NCT03867929|Vitamin D|vitamin d|mesh-list
82967493|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82967494|NCT03867929|Calcifediol|calcifediol|mesh-list
82967495|NCT03867929|Vitamins|vitamins|mesh-ancestor
82967496|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
82967497|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967498|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82967499|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
82967500|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82967501|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83520397|NCT04587687|Immunotoxins|immunotoxins|mesh-ancestor
82967502|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967503|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82967504|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967505|NCT01171469|Imiquimod|imiquimod|mesh-list
82967506|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82967507|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
82967508|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967509|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967510|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
82967511|NCT02695992|Metoprolol|metoprolol|mesh-list
82967512|NCT02695992|Diltiazem|diltiazem|mesh-list
82967513|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82967514|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82967515|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
82967517|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967518|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967519|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82967520|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82967521|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82967522|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967523|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967524|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967525|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82967526|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967527|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82967528|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
82967529|NCT04050865|Dexamethasone|dexamethasone|mesh-list
82967530|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967531|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
82967532|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
82967533|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967534|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967535|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967536|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
82967537|NCT04050865|Hormones|hormones|mesh-ancestor
82967538|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967539|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82967540|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967541|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
82967542|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
82967543|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82967544|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82967545|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967546|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967547|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967548|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967549|NCT01171547|Daptomycin|daptomycin|mesh-list
82967550|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967551|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967552|NCT04048681|Cocaine|cocaine|mesh-list
82967553|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
82967554|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
82967555|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967556|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967557|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
82967558|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967559|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82967560|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82967561|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82967562|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967563|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967564|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
82967565|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967566|NCT01282385|Simvastatin|simvastatin|mesh-list
82967567|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82967568|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82967569|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
82967570|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967571|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82967572|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82967573|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967574|NCT01166711|Chromium|chromium|mesh-list
82967575|NCT01166711|Paclitaxel|paclitaxel|mesh-list
82967576|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82967577|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82967578|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967579|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
82967580|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
82967581|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
82967582|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967583|NCT01166711|Trace Elements|trace elements|mesh-ancestor
82967584|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
82967585|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967586|NCT01168739|Quercetin|quercetin|mesh-list
82967587|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
82967588|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967589|NCT01168739|Protective Agents|protective agents|mesh-ancestor
82967590|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967591|NCT01171781|Cisplatin|cisplatin|mesh-list
82967592|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967593|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
82967594|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
82967595|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967596|NCT01171859|Doxycycline|doxycycline|mesh-list
82967597|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
82967598|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967599|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967600|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
82967601|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82967602|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82967603|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
82967604|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82967605|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967606|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
82967607|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
82967608|NCT02652468|Rituximab|rituximab|mesh-list
82967609|NCT02652468|Fludarabine|fludarabine|mesh-list
82967610|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
82967611|NCT02652468|Tacrolimus|tacrolimus|mesh-list
82967612|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967613|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
82967614|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967615|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967616|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82967617|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
82967618|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967619|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967620|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82967621|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967622|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82967623|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
82967624|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82967625|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967626|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967627|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82967628|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
82967629|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967630|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967631|NCT04673877|Vancomycin|vancomycin|mesh-list
82967632|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967633|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967634|NCT01166789|Lubiprostone|lubiprostone|mesh-list
82967635|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82967636|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967637|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967638|NCT01314339|Desloratadine|desloratadine|mesh-list
82967639|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82967640|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
82967641|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967642|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967643|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967644|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82967645|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82967646|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
82967647|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
82967648|NCT05179512|Fluticasone|fluticasone|mesh-list
82967649|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
82967650|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82967651|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82967652|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967653|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82967654|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
82967655|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967656|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967657|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82967658|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
82967659|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
82967660|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82967661|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
82967662|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82967663|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
82967664|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967665|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967666|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82967667|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82967668|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82967669|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967670|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
82967671|NCT05179512|Hormones|hormones|mesh-ancestor
82967672|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967673|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
82967674|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82967675|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
82967676|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82967677|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82967678|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967679|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967680|NCT01168817|Urological Agents|urological agents|mesh-ancestor
82967681|NCT01279811|Dopamine|dopamine|mesh-list
82967682|NCT01279811|Norepinephrine|norepinephrine|mesh-list
82967683|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82967684|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82967685|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82967686|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967687|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967688|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967689|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967690|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
82967691|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
82967692|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967693|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82967694|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
82967695|NCT01279811|Protective Agents|protective agents|mesh-ancestor
82967696|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
82967697|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967698|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967699|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82967700|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82967701|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967702|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967703|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967704|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82967705|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82967706|NCT03745105|Dexamethasone|dexamethasone|mesh-list
82967707|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
82967708|NCT03745105|Piroxicam|piroxicam|mesh-list
82967709|NCT03745105|Mepivacaine|mepivacaine|mesh-list
82967710|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
82967711|NCT03745105|BB 1101|bb 1101|mesh-list
82967712|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967713|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
82967714|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
82967715|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967716|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967717|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967718|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
82967719|NCT03745105|Hormones|hormones|mesh-ancestor
82967720|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967721|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82967722|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967723|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
82967724|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
82967725|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967726|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
82967727|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
82967728|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967729|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967730|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82967731|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82967732|NCT03745105|Analgesics|analgesics|mesh-ancestor
82967733|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967734|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82967735|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
82967736|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82967737|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82967738|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82967739|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967740|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967742|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967743|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967744|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82967745|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967746|NCT03744247|Lenvatinib|lenvatinib|mesh-list
82967747|NCT03744247|Antibodies|antibodies|mesh-list
82967748|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
82967749|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
82967750|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967751|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967752|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82967753|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967754|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967755|NCT01282619|Huperzine A|huperzine a|mesh-list
82967756|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82967757|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967758|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967759|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
82967760|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967761|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967762|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82967763|NCT01282619|Protective Agents|protective agents|mesh-ancestor
82967764|NCT01282697|Sirolimus|sirolimus|mesh-list
82967765|NCT01282697|Irinotecan|irinotecan|mesh-list
82967766|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82967767|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82967768|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967769|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967770|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967771|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967772|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967773|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967774|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
82967775|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967776|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
82967777|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83461753|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967778|NCT01169597|Prednisone|prednisone|mesh-list
82967779|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967780|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
82967781|NCT01169597|Hormones|hormones|mesh-ancestor
82967782|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967783|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967784|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82967785|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967786|NCT02527798|Furosemide|furosemide|mesh-list
82967787|NCT02527798|Diuretics|diuretics|mesh-ancestor
82967788|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
82967789|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967790|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82967791|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82967792|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967793|NCT05331911|Propofol|propofol|mesh-list
82967794|NCT05331911|Sevoflurane|sevoflurane|mesh-list
82967795|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82967796|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967797|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967798|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82967799|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
82967800|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
82967801|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82967802|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82967803|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82967804|NCT03857542|Pilocarpine|pilocarpine|mesh-list
82967805|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82967806|NCT03857542|Miotics|miotics|mesh-ancestor
82967807|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
82967808|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967809|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967810|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82967811|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82967812|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
82967813|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967814|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967815|NCT01172717|Panitumumab|panitumumab|mesh-list
82967816|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967817|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967818|NCT03209973|Tislelizumab|tislelizumab|mesh-list
82967819|NCT03209973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82967820|NCT03209973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967821|NCT03751631|Phenylephrine|phenylephrine|mesh-list
82967822|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
82967823|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82967824|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82967825|NCT03751631|Tropicamide|tropicamide|mesh-list
82967826|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82967827|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
82967828|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
82967829|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967830|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967831|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
82967832|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82967833|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
82967834|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
82967835|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82967836|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82967837|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82967838|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
82967839|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967840|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967841|NCT03751631|Protective Agents|protective agents|mesh-ancestor
82967842|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82967843|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82967844|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
82967845|NCT03866681|Sirolimus|sirolimus|mesh-list
82967846|NCT03866681|Warfarin|warfarin|mesh-list
82967847|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967848|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967849|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967850|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967851|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
82967852|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82967853|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
82967854|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967855|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
82967856|NCT03736369|Esomeprazole|esomeprazole|mesh-list
82967857|NCT03736369|Fexuprazan|fexuprazan|mesh-list
82967858|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82967859|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967860|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82967861|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967862|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967863|NCT03867695|Ropivacaine|ropivacaine|mesh-list
82967864|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
82967865|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
82967866|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967867|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967868|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
82967869|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967870|NCT01172171|Melatonin|melatonin|mesh-list
82967871|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
82967872|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967873|NCT01172171|Protective Agents|protective agents|mesh-ancestor
82967874|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967875|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967876|NCT03655717|Ethanol|ethanol|mesh-list
82967877|NCT03655717|Dronabinol|dronabinol|mesh-list
82967878|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82967879|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967880|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967881|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967882|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
82967883|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82967884|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82967885|NCT03655717|Analgesics|analgesics|mesh-ancestor
82967886|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
82967887|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967888|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82967889|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82967890|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967891|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967892|NCT03655717|Hormones|hormones|mesh-ancestor
82967893|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82967894|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
82967895|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82967896|NCT03222531|Velpatasvir|velpatasvir|mesh-list
82967897|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
82967898|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967899|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
82967900|NCT03867071|Hematinics|hematinics|mesh-ancestor
82967901|NCT01284413|Cisplatin|cisplatin|mesh-list
82967902|NCT01284413|Gemcitabine|gemcitabine|mesh-list
82967903|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967904|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82967905|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
82967906|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967907|NCT05152017|Vaccines|vaccines|mesh-list
82967908|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
82967909|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967910|NCT03866993|Paclitaxel|paclitaxel|mesh-list
82967911|NCT03866993|Carboplatin|carboplatin|mesh-list
82967912|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82967913|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967914|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
82967915|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
82967916|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
82967917|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967918|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
82967919|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82967920|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
82967921|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967922|NCT05142735|Expectorants|expectorants|mesh-ancestor
82967923|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
82967924|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82967925|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
82967926|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967927|NCT05142735|Protective Agents|protective agents|mesh-ancestor
82967928|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967929|NCT05142735|Antidotes|antidotes|mesh-ancestor
82967930|NCT01172405|Ibuprofen|ibuprofen|mesh-list
82967931|NCT01172405|Caffeine|caffeine|mesh-list
82967932|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82967933|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82967934|NCT01172405|Analgesics|analgesics|mesh-ancestor
82967935|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
82967936|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82967937|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967938|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82967939|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967940|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82967941|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967942|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967943|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82967944|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82967945|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82967946|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82967947|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
82967948|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967949|NCT04000165|Mitapivat|mitapivat|mesh-list
82967950|NCT04000165|Enzyme Activators|enzyme activators|mesh-ancestor
82967951|NCT04000165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967952|NCT03375424|Vedolizumab|vedolizumab|mesh-list
82967953|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967954|NCT03187197|Dabigatran|dabigatran|mesh-list
82967955|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
82967956|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82967957|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
82967958|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967959|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967960|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
82967961|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
82967962|NCT01284647|Sucralfate|sucralfate|mesh-list
82967963|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82967964|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82967965|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967966|NCT04000009|Pimavanserin|pimavanserin|mesh-list
82967967|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82967968|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82967969|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82967970|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82967971|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82967972|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967973|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82967974|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82967975|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82967976|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
82967977|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82967978|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967980|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
82967981|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967982|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
82967983|NCT01284725|Azathioprine|azathioprine|mesh-list
82967984|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82967985|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82967986|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82967987|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82967988|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
82967989|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82967990|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82967991|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82967992|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82967993|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
82967994|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82967995|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
82967996|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82967997|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82967998|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
82967999|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82968000|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968001|NCT01173107|Colchicine|colchicine|mesh-list
82968002|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
82968003|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968004|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
82968005|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
82968006|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
82968007|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968008|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968009|NCT03744091|Dronabinol|dronabinol|mesh-list
82968010|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
82968011|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968012|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82968013|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82968014|NCT03744091|Analgesics|analgesics|mesh-ancestor
82968015|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
82968016|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968017|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82968018|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82968019|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968020|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968021|NCT03744091|Hormones|hormones|mesh-ancestor
82968022|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82968023|NCT03376594|Loratadine|loratadine|mesh-list
82968024|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
82968025|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
82968026|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82968027|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82968028|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82968029|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
82968030|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
82968031|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968032|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968033|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968034|NCT03381664|Quinidine|quinidine|mesh-list
82968035|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
82968036|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
82968037|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968038|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82968039|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82968040|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968041|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968042|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968043|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82968044|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82968045|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
82968046|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82968047|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
82968048|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82968049|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82968050|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968051|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968052|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82968053|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82968054|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
82968055|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82968056|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82968057|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82968058|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82968059|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82968060|NCT04060758|Latanoprost|latanoprost|mesh-list
82968061|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82968062|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82968063|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82968064|NCT03863405|Metformin|metformin|mesh-list
82968065|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82968066|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968067|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
82968068|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82968069|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968070|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82968071|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82968072|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968073|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968074|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968075|NCT04024891|Phentolamine|phentolamine|mesh-list
82968076|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82968077|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82968078|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82968079|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82968080|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
82968081|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968082|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968083|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968084|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82968085|NCT01178021|Chloroquine|chloroquine|mesh-list
82968086|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
82968087|NCT01178021|Primaquine|primaquine|mesh-list
82968088|NCT01178021|Amebicides|amebicides|mesh-ancestor
82968089|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82968090|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82968091|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968092|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
82968093|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968094|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82968095|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82968096|NCT01178021|Analgesics|analgesics|mesh-ancestor
82968097|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
82968098|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968099|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968100|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968101|NCT01178021|Filaricides|filaricides|mesh-ancestor
82968102|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
82968103|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
82968104|NCT03250182|Budesonide|budesonide|mesh-list
82968105|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
82968106|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
82968107|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968108|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82968109|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
82968110|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968111|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968112|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82968113|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968114|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
82968115|NCT03250182|Hormones|hormones|mesh-ancestor
82968116|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82968117|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82968118|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82968119|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82968120|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
82968121|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968122|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968123|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82968124|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82968125|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82968126|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
82968127|NCT01173263|Propofol|propofol|mesh-list
82968128|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82968129|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968130|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968131|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82968132|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
82968133|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
82968134|NCT03381430|Gefitinib|gefitinib|mesh-list
82968135|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968136|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82968137|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968138|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968139|NCT01288157|Golimumab|golimumab|mesh-list
82968140|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82968141|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82968142|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968143|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968144|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
82968145|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968146|NCT03993379|Ipilimumab|ipilimumab|mesh-list
82968147|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968148|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968149|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968150|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968151|NCT03866447|Vitamin D|vitamin d|mesh-list
82968152|NCT03866447|Adapalene|adapalene|mesh-list
82968153|NCT03866447|Vitamins|vitamins|mesh-ancestor
82968154|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
82968155|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968156|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82968157|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82968158|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82968159|NCT03866447|Analgesics|analgesics|mesh-ancestor
82968160|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
82968161|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968162|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968163|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968164|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
82968165|NCT03370120|Padsevonil|padsevonil|mesh-list
82968166|NCT03370120|Anticonvulsants|anticonvulsants|mesh-ancestor
82968167|NCT01175291|Leucovorin|leucovorin|mesh-list
82968168|NCT01175291|Bevacizumab|bevacizumab|mesh-list
82968169|NCT01175291|Fluorouracil|fluorouracil|mesh-list
82968170|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
82968171|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
82968172|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968173|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968174|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82968175|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82968176|NCT01175291|Growth Substances|growth substances|mesh-ancestor
82968177|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968178|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
82968179|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
83483184|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
82968180|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968181|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82968182|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968183|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
82968184|NCT01175291|Antidotes|antidotes|mesh-ancestor
82968185|NCT01175291|Protective Agents|protective agents|mesh-ancestor
82968186|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
82968187|NCT01175291|Vitamins|vitamins|mesh-ancestor
82968188|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
82968189|NCT03230266|Insulin|insulin|mesh-list
82968190|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82968191|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968192|NCT03732469|Acetaminophen|acetaminophen|mesh-list
82968193|NCT03732469|Fentanyl|fentanyl|mesh-list
82968194|NCT03732469|Propofol|propofol|mesh-list
82968195|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82968196|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968197|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968198|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82968199|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
82968200|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
82968201|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82968202|NCT03732469|Narcotics|narcotics|mesh-ancestor
82968203|NCT03732469|Analgesics|analgesics|mesh-ancestor
82968204|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
82968205|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968206|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82968207|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82968208|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
82968209|NCT03381352|Capecitabine|capecitabine|mesh-list
82968210|NCT03381352|Mitomycins|mitomycins|mesh-list
82968211|NCT03381352|Mitomycin|mitomycin|mesh-list
82968212|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82968213|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
82968214|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968215|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968216|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82968217|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
82968218|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82968219|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968220|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
82968221|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
82968222|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
82968223|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968224|NCT01175525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82968225|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968226|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82968227|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968228|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82968229|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968230|NCT03381118|Cytarabine|cytarabine|mesh-list
82968231|NCT03381118|Nivolumab|nivolumab|mesh-list
82968232|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968233|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968234|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968235|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968236|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82968237|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
82968238|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
82968239|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968240|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968241|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
82968242|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968243|NCT03375112|Bupivacaine|bupivacaine|mesh-list
82968244|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
82968245|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
82968246|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968247|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968248|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
82968249|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968250|NCT02954575|Factor VIII|factor viii|mesh-list
82968251|NCT02954575|Coagulants|coagulants|mesh-ancestor
82968252|NCT02997358|Doxorubicin|doxorubicin|mesh-list
82968253|NCT02997358|Trabectedin|trabectedin|mesh-list
82968254|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82968255|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968256|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82968257|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82968258|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968259|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968260|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82968261|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
82968262|NCT03375034|Clonazepam|clonazepam|mesh-list
82968263|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
82968264|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
82968265|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
82968266|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968267|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968268|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968269|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
82968270|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82968271|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
82968272|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968274|NCT03381040|Protective Agents|protective agents|mesh-ancestor
82968275|NCT03376048|Ropivacaine|ropivacaine|mesh-list
82968276|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
82968277|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
82968278|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968279|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968280|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
82968281|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968282|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
82968283|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
82968284|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82968285|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968286|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82968287|NCT01285037|Gemcitabine|gemcitabine|mesh-list
82968288|NCT01285037|Cetuximab|cetuximab|mesh-list
82968289|NCT01285037|Ramucirumab|ramucirumab|mesh-list
82968290|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968291|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82968292|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
82968293|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968294|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968295|NCT03732391|Carboplatin|carboplatin|mesh-list
82968296|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
82968297|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968298|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968299|NCT03732391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968300|NCT03732391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968301|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
82968302|NCT03374722|Narcotics|narcotics|mesh-ancestor
82968303|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968304|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968305|NCT03374722|Analgesics|analgesics|mesh-ancestor
82968306|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
82968307|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968308|NCT03207243|Fluticasone|fluticasone|mesh-list
82968309|NCT03207243|Xhance|xhance|mesh-list
82968310|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82968311|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968312|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82968313|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
82968314|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968315|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968316|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82968317|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968318|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
82968319|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82968320|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82968321|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82968322|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82968323|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
82968324|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968325|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968326|NCT01285271|Sevoflurane|sevoflurane|mesh-list
82968327|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82968328|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82968329|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
82968330|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
82968331|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968332|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968333|NCT03982069|Vaccines|vaccines|mesh-list
82968334|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
82968335|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968336|NCT03219723|Amoxicillin|amoxicillin|mesh-list
82968337|NCT03219723|Metronidazole|metronidazole|mesh-list
82968338|NCT03219723|Clarithromycin|clarithromycin|mesh-list
82968339|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82968340|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968341|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82968342|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82968343|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82968344|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968345|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968346|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82968347|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82968348|NCT03628417|Bleomycin|bleomycin|mesh-list
82968349|NCT03628417|Calcium|calcium|mesh-list
82968350|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82968351|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968352|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82968353|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968354|NCT03369964|Atezolizumab|atezolizumab|mesh-list
82968355|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
82968356|NCT03369964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968357|NCT03369964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968358|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968359|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968360|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
82968361|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968362|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968363|NCT01173809|Amiodarone|amiodarone|mesh-list
82968364|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82968365|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
82968366|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82968367|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82968368|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968369|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82968370|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82968371|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82968372|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968373|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82968374|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82968375|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82968376|NCT03375580|Metformin|metformin|mesh-list
82968377|NCT03375580|Simvastatin|simvastatin|mesh-list
82968378|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82968379|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968380|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82968381|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82968382|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
82968383|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968384|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82968385|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82968386|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968387|NCT03340896|Docetaxel|docetaxel|mesh-list
82968388|NCT03340896|Fluorouracil|fluorouracil|mesh-list
82968389|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968390|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
82968391|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
82968392|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
82968393|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968394|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
82968395|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82968396|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968397|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
82968398|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968399|NCT03282981|Timolol|timolol|mesh-list
82968400|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82968401|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82968402|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
82968403|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968404|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968405|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968406|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82968407|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82968409|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968410|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
82968411|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968412|NCT01286909|Protective Agents|protective agents|mesh-ancestor
82968413|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968414|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82968415|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82968416|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968417|NCT02954887|Cannabidiol|cannabidiol|mesh-list
82968418|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
82968419|NCT03860129|Sevoflurane|sevoflurane|mesh-list
82968420|NCT03860129|Desflurane|desflurane|mesh-list
82968421|NCT03860129|Isoflurane|isoflurane|mesh-list
82968422|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82968423|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82968424|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
82968425|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
82968426|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968427|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968428|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82968429|NCT03369808|Vaccines|vaccines|mesh-list
82968430|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
82968431|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968432|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82968433|NCT03369808|Antacids|antacids|mesh-ancestor
82968434|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968435|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968436|NCT02525237|Apatinib|apatinib|mesh-list
82968437|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968438|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82968439|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968440|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968441|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
82968442|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968443|NCT03369574|Reslizumab|reslizumab|mesh-list
82968444|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82968445|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968446|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82968447|NCT02651740|Rifaximin|rifaximin|mesh-list
82968448|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82968449|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968450|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968451|NCT03862391|Analgesics|analgesics|mesh-list
82968452|NCT03862391|Antiemetics|antiemetics|mesh-list
82968453|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
82968454|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968455|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968456|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
82968457|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968458|NCT03859583|Capsaicin|capsaicin|mesh-list
82968459|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
82968460|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
82968461|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
82968462|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968463|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968464|NCT03369262|Atosiban|atosiban|mesh-list
82968465|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
82968466|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82968467|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968468|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
82968469|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82968470|NCT03276078|Bromides|bromides|mesh-list
82968471|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
82968472|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82968473|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
82968474|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968475|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968476|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82968477|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968478|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82968479|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82968480|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82968481|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
82968482|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968483|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968484|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
82968485|NCT01288547|Theobromine|theobromine|mesh-list
82968486|NCT01288547|Caffeine|caffeine|mesh-list
82968487|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82968488|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968489|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82968490|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968491|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968492|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82968493|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82968494|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
82968495|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968496|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82968497|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
82968498|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968499|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82968500|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968501|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
82968503|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968504|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968505|NCT04597320|Fentanyl|fentanyl|mesh-list
82968506|NCT04597320|Midazolam|midazolam|mesh-list
82968507|NCT04597320|Esketamine|esketamine|mesh-list
82968508|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82968509|NCT04597320|Narcotics|narcotics|mesh-ancestor
82968510|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968511|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968512|NCT04597320|Analgesics|analgesics|mesh-ancestor
82968513|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
82968514|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968515|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82968516|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82968517|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
82968518|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
82968519|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82968520|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82968521|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82968522|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82968523|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
82968524|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
82968525|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968526|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968527|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
82968528|NCT03373708|Tamoxifen|tamoxifen|mesh-list
82968529|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
82968530|NCT03373708|Docetaxel|docetaxel|mesh-list
82968531|NCT03373708|Letrozole|letrozole|mesh-list
82968532|NCT03373708|Epirubicin|epirubicin|mesh-list
82968533|NCT03373708|Goserelin|goserelin|mesh-list
82968534|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968535|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
82968536|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968537|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968538|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82968539|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
82968540|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968541|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968542|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82968543|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
82968544|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
82968545|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
82968546|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82968547|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82968548|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968549|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82968550|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
82968551|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82968552|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82968553|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82968554|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82968555|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82968556|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82968557|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83520398|NCT04585750|Pembrolizumab|pembrolizumab|mesh-list
82968558|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82968559|NCT03123952|ABT-414|abt-414|mesh-list
82968560|NCT03123952|Immunoconjugates|immunoconjugates|mesh-ancestor
82968561|NCT03123952|Immunologic Factors|immunologic factors|mesh-ancestor
82968562|NCT03123952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968563|NCT02519608|Aspirin|aspirin|mesh-list
82968564|NCT02519608|Clopidogrel|clopidogrel|mesh-list
82968565|NCT02519608|Ticagrelor|ticagrelor|mesh-list
82968566|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82968567|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82968568|NCT02519608|Analgesics|analgesics|mesh-ancestor
82968569|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
82968570|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968571|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968572|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968573|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968574|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82968575|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82968576|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968577|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82968578|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82968579|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968580|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
82968581|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82968582|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82968583|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82968584|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
82968585|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968586|NCT05181852|Pregabalin|pregabalin|mesh-list
82968587|NCT05181852|Analgesics|analgesics|mesh-ancestor
82968588|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
82968589|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968590|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968591|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
82968592|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82968593|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82968594|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968595|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82968596|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82968597|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82968598|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968599|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82968600|NCT04584684|Ethanol|ethanol|mesh-list
82968601|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82968602|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
82968603|NCT04584684|Povidone|povidone|mesh-list
82968604|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82968605|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968606|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968607|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968608|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
82968609|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
82968610|NCT03748823|Ravulizumab|ravulizumab|mesh-list
82968611|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82968612|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968613|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
82968614|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968615|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
82968616|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82968617|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82968618|NCT03124420|Amoxicillin|amoxicillin|mesh-list
82968619|NCT03124420|Clarithromycin|clarithromycin|mesh-list
82968620|NCT03124420|Lansoprazole|lansoprazole|mesh-list
82968621|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
82968622|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82968623|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968624|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82968625|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968626|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968627|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82968628|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82968629|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82968630|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968631|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82968632|NCT03231228|Cefazolin|cefazolin|mesh-list
82968633|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82968634|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968635|NCT03510468|Pyridoxine|pyridoxine|mesh-list
82968636|NCT03510468|Isoniazid|isoniazid|mesh-list
82968637|NCT03510468|Rifapentine|rifapentine|mesh-list
82968638|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
82968639|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82968640|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968641|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82968642|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82968643|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
82968644|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968645|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82968646|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
82968647|NCT03510468|Vitamins|vitamins|mesh-ancestor
82968648|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
82968649|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968650|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82968651|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
82968653|NCT01178645|Etoposide|etoposide|mesh-list
82968654|NCT01178645|Melphalan|melphalan|mesh-list
82968655|NCT01178645|Busulfan|busulfan|mesh-list
82968656|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82968657|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968658|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82968659|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82968660|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968661|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968662|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82968663|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
82968664|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
82968665|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968666|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968667|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
82968668|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968669|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82968670|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
82968671|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82968672|NCT01285505|Alprazolam|alprazolam|mesh-list
82968673|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82968674|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968675|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968676|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82968677|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82968678|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82968679|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
82968680|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
82968681|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968682|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968683|NCT03372850|Esomeprazole|esomeprazole|mesh-list
82968684|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82968685|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968686|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82968687|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968688|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968689|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
82968690|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82968691|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
82968692|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968693|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
82968694|NCT04525066|Protective Agents|protective agents|mesh-ancestor
82968695|NCT03362788|Vitamin K|vitamin k|mesh-list
82968696|NCT03362788|Anticoagulants|anticoagulants|mesh-list
82968697|NCT03362788|Vitamins|vitamins|mesh-ancestor
82968698|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
82968699|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968700|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82968701|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82968702|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968703|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
82968704|NCT03362788|Coagulants|coagulants|mesh-ancestor
82968705|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
82968706|NCT03368794|Narcotics|narcotics|mesh-ancestor
82968707|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968708|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968709|NCT03368794|Analgesics|analgesics|mesh-ancestor
82968710|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
82968711|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968712|NCT03862079|Tazobactam|tazobactam|mesh-list
82968713|NCT03862079|Piperacillin|piperacillin|mesh-list
82968714|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
82968716|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82968717|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968718|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82968719|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968720|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968721|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
82968722|NCT03862079|Ionophores|ionophores|mesh-ancestor
82968723|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82968724|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82968725|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82968726|NCT01179269|Paclitaxel|paclitaxel|mesh-list
82968728|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968729|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
82968730|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
82968731|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
82968732|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968733|NCT00165724|Donepezil|donepezil|mesh-list
82968734|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82968735|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968736|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968737|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
82968738|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968739|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968740|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
82968741|NCT01287455|Vitamin D|vitamin d|mesh-list
82968742|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
82968743|NCT01287455|Vitamins|vitamins|mesh-ancestor
82968744|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
82968745|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968746|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82968747|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82968748|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
82968749|NCT04965090|Lazertinib|lazertinib|mesh-list
82968750|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82968751|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968752|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968753|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968754|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968755|NCT03865511|Osimertinib|osimertinib|mesh-list
82968756|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968757|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82968758|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968759|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968760|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
82968761|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968762|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968763|NCT03498612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968764|NCT03498612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968765|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
82968766|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82968767|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968768|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82968769|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82968770|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
82968771|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82968772|NCT01287689|Antibodies|antibodies|mesh-list
82968773|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
82968774|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
82968775|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968776|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
82968777|NCT01179503|Vitamin D|vitamin d|mesh-list
82968778|NCT01179503|Calcium|calcium|mesh-list
82968779|NCT01179503|Vitamins|vitamins|mesh-ancestor
82968780|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
82968781|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968782|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82968783|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82968784|NCT03117049|Paclitaxel|paclitaxel|mesh-list
82968785|NCT03117049|Bevacizumab|bevacizumab|mesh-list
82968786|NCT03117049|Carboplatin|carboplatin|mesh-list
82968787|NCT03117049|Nivolumab|nivolumab|mesh-list
82968788|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82968789|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968790|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
82968791|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
82968792|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
82968793|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968794|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968795|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82968796|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82968797|NCT03117049|Growth Substances|growth substances|mesh-ancestor
82968798|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968799|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
82968800|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968802|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
82968803|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
82968804|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968805|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968806|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
82968807|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968808|NCT02525081|Ramipril|ramipril|mesh-list
82968809|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82968810|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
82968811|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83461865|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968812|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968813|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82968814|NCT05566548|Bilirubin|bilirubin|mesh-list
82968815|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
82968816|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968817|NCT05566548|Protective Agents|protective agents|mesh-ancestor
82968818|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968819|NCT02525003|Vitamin D|vitamin d|mesh-list
82968820|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
82968821|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
82968822|NCT02525003|Vitamins|vitamins|mesh-list
82968823|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
82968824|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968825|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82968826|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82968827|NCT03464448|Teriflunomide|teriflunomide|mesh-list
82968828|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82968829|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82968830|NCT03464448|Analgesics|analgesics|mesh-ancestor
82968831|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
82968832|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968833|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968834|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968835|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968836|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968837|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
82968838|NCT03362008|Varenicline|varenicline|mesh-list
82968839|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82968840|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82968841|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
82968842|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968843|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968844|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968845|NCT05556798|Nirogacestat|nirogacestat|mesh-list
82968846|NCT05556798|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82968847|NCT05556798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968848|NCT05556798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968849|NCT03123406|Cinacalcet|cinacalcet|mesh-list
82968850|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82968851|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968852|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
82968853|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
82968854|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82968855|NCT01179659|Pantoprazole|pantoprazole|mesh-list
82968856|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82968857|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968858|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82968859|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968860|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968861|NCT04523818|Fluorouracil|fluorouracil|mesh-list
82968862|NCT04523818|Capecitabine|capecitabine|mesh-list
82968863|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
83520474|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
82968864|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968865|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82968866|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968867|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968868|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
82968869|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968870|NCT03361774|Fluorides|fluorides|mesh-list
82968871|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
82968872|NCT03361774|Protective Agents|protective agents|mesh-ancestor
82968873|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968874|NCT04523740|Acetaminophen|acetaminophen|mesh-list
82968876|NCT04523740|Analgesics|analgesics|mesh-ancestor
82968877|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
82968878|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968879|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968880|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
82968881|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
82968882|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82968883|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
82968884|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82968885|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
82968886|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968887|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968888|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
82968889|NCT04523662|Apatinib|apatinib|mesh-list
82968890|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968891|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82968892|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968893|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968894|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
82968895|NCT03371992|Nivolumab|nivolumab|mesh-list
82968896|NCT03371992|Atezolizumab|atezolizumab|mesh-list
82968897|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968898|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968899|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968900|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968901|NCT03682705|Upadacitinib|upadacitinib|mesh-list
82968902|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82968903|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82968904|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968905|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968906|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968907|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
82968908|NCT03361618|Astringents|astringents|mesh-ancestor
82968909|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968910|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
82968911|NCT01314495|Abatacept|abatacept|mesh-list
82968912|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82968913|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968914|NCT01314495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82968915|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968916|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82968917|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
82968918|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968919|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968920|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82968921|NCT03123484|Gefitinib|gefitinib|mesh-list
82968922|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968923|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82968924|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82968925|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968926|NCT03179787|Aripiprazole|aripiprazole|mesh-list
82968927|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
82968928|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82968929|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82968930|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82968931|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968932|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968933|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
82968934|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
82968935|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968936|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968937|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82968938|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82968939|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
82968940|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82968941|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82968942|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82968943|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82968944|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
82968945|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
82968946|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
82968947|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968948|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
82968949|NCT02956057|Protective Agents|protective agents|mesh-ancestor
82968950|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968951|NCT02956057|Vitamins|vitamins|mesh-ancestor
82968952|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
82968953|NCT02956057|Cathartics|cathartics|mesh-ancestor
82968954|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82968955|NCT04526470|Paclitaxel|paclitaxel|mesh-list
82968956|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82968957|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968958|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82968959|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82968960|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82968961|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968962|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
82968963|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82968964|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968965|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
82968966|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82968967|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82968968|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82968969|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
82968970|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82968971|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968972|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968973|NCT04526236|Methadone|methadone|mesh-list
82968974|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82968975|NCT04526236|Narcotics|narcotics|mesh-ancestor
82968976|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82968977|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968978|NCT04526236|Analgesics|analgesics|mesh-ancestor
82968979|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
82968980|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968981|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
82968982|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
82968983|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
82968984|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82968985|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82968986|NCT01179971|Analgesics|analgesics|mesh-ancestor
82968987|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
82968988|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82968989|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82968990|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82968991|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82968992|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82968993|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
82968994|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82968995|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82968996|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
82968997|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
82968998|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82968999|NCT03681691|Estradiol|estradiol|mesh-list
82969000|NCT03681691|Estrogens|estrogens|mesh-ancestor
82969001|NCT03681691|Hormones|hormones|mesh-ancestor
82969002|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969003|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969004|NCT01289171|Glycolic acid|glycolic acid|mesh-list
82969005|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
82969006|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
82969007|NCT03360760|Doxorubicin|doxorubicin|mesh-list
82969008|NCT03360760|Methotrexate|methotrexate|mesh-list
82969009|NCT03360760|Ifosfamide|ifosfamide|mesh-list
82969010|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
82969011|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969012|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82969013|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82969014|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82969015|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83520554|NCT04005690|Onvansertib|onvansertib|mesh-list
82969016|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969017|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82969018|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
82969019|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82969020|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969021|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82969022|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
82969023|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
82969024|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82969026|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
82969027|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969028|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82969029|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82969030|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
82969032|NCT01285661|Warfarin|warfarin|mesh-list
82969033|NCT01285661|Anticoagulants|anticoagulants|mesh-list
82969034|NCT01285661|Vitamins|vitamins|mesh-ancestor
82969035|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
82969036|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969037|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82969038|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82969039|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969040|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
82969041|NCT01285661|Coagulants|coagulants|mesh-ancestor
82969042|NCT03360682|Tenofovir|tenofovir|mesh-list
82969043|NCT03360682|Lamivudine|lamivudine|mesh-list
82969044|NCT03360682|Emtricitabine|emtricitabine|mesh-list
82969045|NCT03360682|Dolutegravir|dolutegravir|mesh-list
82969046|NCT03360682|Abacavir|abacavir|mesh-list
82969047|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
82969048|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969049|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82969050|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82969051|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969052|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969053|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82969054|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82969055|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82969056|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82969057|NCT01180205|Amlodipine|amlodipine|mesh-list
82969058|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82969059|NCT01180205|Telmisartan|telmisartan|mesh-list
82969060|NCT01180205|Olmesartan|olmesartan|mesh-list
82969061|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82969062|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82969063|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82969064|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969065|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969066|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82969067|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969068|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
82969069|NCT01180205|Diuretics|diuretics|mesh-ancestor
82969070|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
82969071|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82969072|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82969073|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82969074|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
82969075|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82969076|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969077|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969078|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
82969079|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969080|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969081|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
82969082|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969083|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969084|NCT03867084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82969085|NCT03867084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969086|NCT03860831|Midazolam|midazolam|mesh-list
82969087|NCT03860831|Ketamine|ketamine|mesh-list
82969088|NCT03860831|Analgesics|analgesics|mesh-ancestor
82969089|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
82969090|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969091|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969092|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82969093|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82969094|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
82969095|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
82969096|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969097|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82969098|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82969099|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969100|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969101|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82969102|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82969103|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82969104|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82969105|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969106|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
82969107|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
82969108|NCT01064479|Cisplatin|cisplatin|mesh-list
82969109|NCT01064479|Carboplatin|carboplatin|mesh-list
82969110|NCT01064479|Docetaxel|docetaxel|mesh-list
82969111|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82969112|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969113|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
82969114|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
82969115|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
82969116|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969117|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82969118|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969119|NCT04218708|Nicotine|nicotine|mesh-list
82969120|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82969121|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
82969122|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969123|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969124|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82969125|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82969126|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
82969127|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969128|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969129|NCT03667326|Aspirin|aspirin|mesh-list
82969130|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82969131|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82969132|NCT03667326|Analgesics|analgesics|mesh-ancestor
82969133|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
82969134|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969135|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969136|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969137|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969138|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82969139|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82969140|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969141|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82969142|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82969143|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969144|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
82969145|NCT04525300|Liraglutide|liraglutide|mesh-list
82969146|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82969147|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969148|NCT04525300|Incretins|incretins|mesh-ancestor
82969149|NCT04525300|Hormones|hormones|mesh-ancestor
82969150|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969151|NCT03865121|Nicotine|nicotine|mesh-list
82969152|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82969153|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
82969154|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969155|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969156|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82969157|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82969158|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
82969159|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969160|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969161|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
82969162|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82969163|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
82969164|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969165|NCT03680911|Expectorants|expectorants|mesh-ancestor
82969166|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969167|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82969169|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969170|NCT03680911|Protective Agents|protective agents|mesh-ancestor
82969171|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969172|NCT03680911|Antidotes|antidotes|mesh-ancestor
82969173|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
82969174|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82969175|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969176|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969177|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82969179|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
82969180|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969181|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82969182|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82969183|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82969184|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
82969185|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969186|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969187|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
82969188|NCT05156814|Progestins|progestins|mesh-ancestor
82969189|NCT05156814|Hormones|hormones|mesh-ancestor
82969190|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969191|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969192|NCT01289483|Fospropofol|fospropofol|mesh-list
82969193|NCT01289483|Propofol|propofol|mesh-list
82969194|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82969195|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969196|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969197|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82969198|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
82969199|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
82969200|NCT03680521|Nivolumab|nivolumab|mesh-list
82969201|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969202|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969203|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82969204|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969205|NCT01289327|Midazolam|midazolam|mesh-list
82969206|NCT01289327|Alfentanil|alfentanil|mesh-list
82969207|NCT01289327|Propofol|propofol|mesh-list
82969208|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82969209|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969210|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969211|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82969212|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
82969213|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
82969214|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82969215|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82969216|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82969217|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969218|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
82969219|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
82969220|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969221|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969222|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82969223|NCT01289327|Narcotics|narcotics|mesh-ancestor
82969224|NCT01289327|Analgesics|analgesics|mesh-ancestor
82969225|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
82969226|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969227|NCT01181063|Budesonide|budesonide|mesh-list
82969228|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
82969229|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969230|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82969231|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
82969232|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969233|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969234|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82969235|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969236|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
82969237|NCT01181063|Hormones|hormones|mesh-ancestor
82969238|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969239|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82969240|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82969241|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82969242|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
82969243|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969244|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969245|NCT02596997|Brincidofovir|brincidofovir|mesh-list
82969246|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
82969247|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969248|NCT03649477|Carbetocin|carbetocin|mesh-list
82969249|NCT03649477|Oxytocin|oxytocin|mesh-list
82969250|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
82969251|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82969252|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969254|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82969255|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
82969256|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969257|NCT01310101|Dexamethasone|dexamethasone|mesh-list
82969258|NCT01310101|Ofatumumab|ofatumumab|mesh-list
82969259|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969260|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
82969261|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
82969262|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969263|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969264|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82969265|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
82969266|NCT01310101|Hormones|hormones|mesh-ancestor
82969267|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969268|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82969269|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969270|NCT03639727|Mannitol|mannitol|mesh-list
82969271|NCT03639727|Citric Acid|citric acid|mesh-list
82969272|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
82969273|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82969274|NCT03639727|Diuretics|diuretics|mesh-ancestor
82969275|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
82969276|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969277|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
82969278|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82969279|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
82969280|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
82969281|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969282|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82969283|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82969284|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969285|NCT04523272|Sunitinib|sunitinib|mesh-list
82969286|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969287|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82969288|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82969289|NCT04523272|Growth Substances|growth substances|mesh-ancestor
82969290|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969291|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
82969292|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82969293|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969294|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969295|NCT01289561|Ethanol|ethanol|mesh-list
82969296|NCT01289561|Quinine|quinine|mesh-list
82969297|NCT01289561|Caffeine|caffeine|mesh-list
82969298|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82969299|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969300|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969301|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969302|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82969303|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82969304|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969305|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969306|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82969307|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82969308|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
82969309|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969310|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
82969311|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82969312|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82969313|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82969314|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82969315|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969316|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82969317|NCT01289561|Analgesics|analgesics|mesh-ancestor
82969318|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
82969319|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
82969320|NCT03855527|Fluorides|fluorides|mesh-list
82969321|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
82969322|NCT03855527|Protective Agents|protective agents|mesh-ancestor
82969323|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969324|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82969325|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969326|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
82969330|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969331|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82969332|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82969333|NCT03677401|Serlopitant|serlopitant|mesh-list
82969334|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82969335|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969336|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969337|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969338|NCT03357874|Clopidogrel|clopidogrel|mesh-list
82969339|NCT03357874|Ticagrelor|ticagrelor|mesh-list
82969340|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82969341|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82969342|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82969343|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82969344|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
82969345|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969346|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969347|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969348|NCT01286051|Ganirelix|ganirelix|mesh-list
82969349|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
82969350|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969351|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969352|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
82969353|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82969354|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82969355|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969356|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969357|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969358|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969359|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
82969360|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969361|NCT02359513|Fluoxetine|fluoxetine|mesh-list
82969362|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
82969363|NCT02359513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82969364|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82969365|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969366|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969367|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969368|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
82969369|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969370|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82969371|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969372|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82969373|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82969374|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969375|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
82969376|NCT01184495|Hematinics|hematinics|mesh-ancestor
82969377|NCT03864575|Celecoxib|celecoxib|mesh-list
82969378|NCT03864575|Nivolumab|nivolumab|mesh-list
82969379|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969380|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969381|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82969382|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969383|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82969384|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82969385|NCT03864575|Analgesics|analgesics|mesh-ancestor
82969386|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
82969387|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969388|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969389|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969390|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969391|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82969392|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82969393|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969394|NCT03357718|Midazolam|midazolam|mesh-list
82969395|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
82969396|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82969397|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969398|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969399|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82969400|NCT03357718|Analgesics|analgesics|mesh-ancestor
82969401|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
82969402|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969403|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82969404|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82969405|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82969406|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
82969407|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969408|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969409|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82969410|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82969411|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82969412|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969413|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82969414|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
82969415|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
82969416|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
82969417|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
82969418|NCT04521400|Interferons|interferons|mesh-list
82969419|NCT04521400|Ritonavir|ritonavir|mesh-list
82969420|NCT04521400|Lopinavir|lopinavir|mesh-list
82969421|NCT04521400|Interferon-beta|interferon-beta|mesh-list
82969422|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
82969423|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969424|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
82969425|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969426|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82969427|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82969428|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
82969429|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969430|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969431|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82969432|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82969433|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82969434|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82969435|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
82969436|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969437|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82969438|NCT03864185|Rituximab|rituximab|mesh-list
82969439|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969440|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969441|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
82969442|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969443|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969444|NCT01185119|Glucagon|glucagon|mesh-list
82969445|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82969446|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82969447|NCT01185119|Hormones|hormones|mesh-ancestor
83461964|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
82969448|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969449|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969450|NCT01185119|Incretins|incretins|mesh-ancestor
82969451|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
82969452|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
82969453|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82969454|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82969455|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969456|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82969457|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
82969458|NCT01185197|Prednisolone|prednisolone|mesh-list
82969459|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82969460|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969461|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82969462|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
82969463|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82969464|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969465|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969466|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969467|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969468|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
82969469|NCT01185197|Hormones|hormones|mesh-ancestor
82969470|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969471|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969472|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82969473|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
82969474|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
82969475|NCT03733873|Coagulants|coagulants|mesh-ancestor
82969476|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82969477|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
82969478|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969479|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82969480|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
82969481|NCT03733639|Coagulants|coagulants|mesh-ancestor
82969482|NCT03733561|Rotigotine|rotigotine|mesh-list
82969483|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
82969484|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
82969485|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969486|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969487|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969488|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
82969489|NCT03358888|Narcotics|narcotics|mesh-ancestor
82969490|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969491|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969492|NCT03358888|Analgesics|analgesics|mesh-ancestor
82969493|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
82969494|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969495|NCT01291121|Ranibizumab|ranibizumab|mesh-list
82969496|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82969497|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82969498|NCT01291121|Growth Substances|growth substances|mesh-ancestor
82969499|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969500|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
82969501|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969502|NCT01187849|Metformin|metformin|mesh-list
82969503|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82969504|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969505|NCT04522882|Insulin|insulin|mesh-list
82969506|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82969507|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969508|NCT03123718|Methotrexate|methotrexate|mesh-list
82969509|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82969510|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
82969511|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82969512|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969513|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82969514|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
82969515|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969516|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969517|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
82969518|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969519|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82969520|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82969521|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
82969522|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969523|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82969524|NCT01185743|Olanzapine|olanzapine|mesh-list
82969525|NCT01185743|Ziprasidone|ziprasidone|mesh-list
82969526|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
82969527|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
82969528|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969529|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969530|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82969531|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82969532|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82969533|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969534|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969535|NCT01185743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82969536|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82969537|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969538|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969539|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969540|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
82969541|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82969542|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82969543|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
82969544|NCT01188005|Vitamins|vitamins|mesh-list
82969546|NCT01188005|Vitamin A|vitamin a|mesh-list
82969547|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
82969548|NCT01188005|Allopurinol|allopurinol|mesh-list
82969549|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82969550|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
82969551|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969552|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
82969553|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969554|NCT01188005|Protective Agents|protective agents|mesh-ancestor
82969555|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
82969556|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969557|NCT01188005|Expectorants|expectorants|mesh-ancestor
82969558|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969559|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82969560|NCT01188005|Antidotes|antidotes|mesh-ancestor
82969561|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
82969562|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969563|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
82969564|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969565|NCT04445194|Vaccines|vaccines|mesh-list
82969566|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
82969567|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969568|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82969569|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
82969570|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82969571|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82969572|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969573|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969574|NCT01291199|Urological Agents|urological agents|mesh-ancestor
82969575|NCT04444726|Betamethasone|betamethasone|mesh-list
82969576|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
82969577|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82969578|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
82969579|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82969580|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969581|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
82969582|NCT04444726|Hormones|hormones|mesh-ancestor
82969583|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969584|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969585|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82969586|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969587|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
82969588|NCT03733327|Busulfan|busulfan|mesh-list
82969589|NCT03733327|Etoposide|etoposide|mesh-list
82969590|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82969591|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
82969592|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969593|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969594|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82969595|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
82969596|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969597|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969598|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82969599|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82969600|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82969601|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82969602|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969603|NCT03733171|Epinephrine|epinephrine|mesh-list
82969604|NCT03733171|Hemostatics|hemostatics|mesh-list
82969605|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82969606|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82969607|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
82969608|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969609|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969610|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969611|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82969612|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82969613|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
82969614|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969615|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82969616|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969617|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
82969618|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
82969619|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82969620|NCT03733171|Coagulants|coagulants|mesh-ancestor
82969621|NCT03207750|Vaccines|vaccines|mesh-list
82969622|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82969623|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
82969624|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969625|NCT01185977|Fluoxetine|fluoxetine|mesh-list
82969626|NCT01185977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82969627|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82969628|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969629|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969630|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969631|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
82969632|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969633|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82969634|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
82969635|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969636|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82969637|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82969638|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969639|NCT03857399|Caspofungin|caspofungin|mesh-list
82969640|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
82969641|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969642|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969643|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969644|NCT04520620|Enoxaparin|enoxaparin|mesh-list
82969645|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
82969646|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82969647|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82969648|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969649|NCT03857711|Amiodarone|amiodarone|mesh-list
82969650|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82969651|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
82969652|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82969653|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969654|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969655|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82969656|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82969657|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82969658|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969659|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82969660|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82969661|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82969662|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82969663|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82969664|NCT03847896|Budesonide|budesonide|mesh-list
82969665|NCT03847896|Albuterol|albuterol|mesh-list
82969666|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969667|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82969668|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
82969669|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969670|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969671|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82969672|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969673|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
82969674|NCT03847896|Hormones|hormones|mesh-ancestor
82969675|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969676|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
82969677|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82969678|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82969679|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82969680|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82969681|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
82969682|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969683|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969684|NCT01186289|Atorvastatin|atorvastatin|mesh-list
82969685|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82969686|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82969687|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
82969688|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969689|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82969690|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82969691|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969692|NCT01291823|Gefitinib|gefitinib|mesh-list
82969693|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969694|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82969695|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969696|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969697|NCT01181765|Infliximab|infliximab|mesh-list
82969698|NCT01181765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82969699|NCT01181765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969700|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
82969701|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82969702|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969703|NCT01186445|Morphine|morphine|mesh-list
82969704|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82969705|NCT01186445|Narcotics|narcotics|mesh-ancestor
82969706|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969707|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969708|NCT01186445|Analgesics|analgesics|mesh-ancestor
82969709|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
82969710|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969711|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
82969712|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82969713|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969714|NCT04520230|Budesonide|budesonide|mesh-list
82969715|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
82969716|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
82969717|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82969718|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969719|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82969720|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
82969721|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969722|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969723|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82969724|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
82969725|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
82969726|NCT04520230|Hormones|hormones|mesh-ancestor
82969727|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969728|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82969729|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82969730|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82969731|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
82969732|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969733|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969734|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
82969735|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82969736|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
82969737|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
82969738|NCT03619837|Velpatasvir|velpatasvir|mesh-list
82969739|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82969740|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
82969741|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969742|NCT03852563|Petrolatum|petrolatum|mesh-list
82969743|NCT03852563|Emollients|emollients|mesh-ancestor
82969744|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
82969745|NCT01188317|Ibuprofen|ibuprofen|mesh-list
82969746|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82969747|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82969748|NCT01188317|Analgesics|analgesics|mesh-ancestor
82969749|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
82969750|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969751|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969752|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969753|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969754|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82969755|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969756|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969757|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
82969758|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969759|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82969760|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969761|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969762|NCT03739021|Ropivacaine|ropivacaine|mesh-list
82969763|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
82969764|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
82969765|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969766|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969767|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
82969768|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969770|NCT03738943|Pyridoxal|pyridoxal|mesh-list
82969771|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
82969772|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
82969773|NCT03738943|Adenosine|adenosine|mesh-list
82969774|NCT03738943|Nitroprusside|nitroprusside|mesh-list
82969775|NCT03738943|Acetylcholine|acetylcholine|mesh-list
82969776|NCT03738943|Vitamins|vitamins|mesh-ancestor
82969777|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
82969778|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969779|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
82969780|NCT03738943|Analgesics|analgesics|mesh-ancestor
82969781|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
82969782|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969783|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82969784|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
82969785|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82969786|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
82969787|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
82969788|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969789|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969790|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82969791|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82969792|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82969793|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
83462075|NCT01472692|Febuxostat|febuxostat|mesh-list
82969794|NCT03178851|Atezolizumab|atezolizumab|mesh-list
82969795|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82969796|NCT03178851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82969797|NCT03178851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969798|NCT03178851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969799|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969800|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
82969801|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969802|NCT01291979|Lidocaine|lidocaine|mesh-list
82969803|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
82969804|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
82969805|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969806|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969807|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
82969808|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969809|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82969810|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82969811|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82969812|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82969813|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969814|NCT04443634|Bupivacaine|bupivacaine|mesh-list
82969815|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
82969816|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
82969817|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969818|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969819|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
82969820|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969821|NCT03643159|Aripiprazole|aripiprazole|mesh-list
82969822|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
82969823|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
82969824|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969825|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82969826|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969827|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969828|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
82969829|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
82969830|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969831|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969832|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82969833|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82969834|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
82969835|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82969836|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82969837|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83462099|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
82969838|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82969839|NCT03205566|Lamivudine|lamivudine|mesh-list
82969840|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
82969841|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82969842|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82969843|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969844|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969845|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
82969846|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969847|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82969848|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82969849|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82969850|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82969851|NCT01181999|Rituximab|rituximab|mesh-list
82969852|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969853|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969854|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
82969855|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969856|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969857|NCT04509232|Fluorides|fluorides|mesh-list
82969858|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
82969859|NCT04509232|Protective Agents|protective agents|mesh-ancestor
82969860|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969861|NCT03732235|Bevacizumab|bevacizumab|mesh-list
82969862|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
82969863|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969864|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969865|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82969866|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82969867|NCT03732235|Growth Substances|growth substances|mesh-ancestor
82969868|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969869|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
82969870|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82969871|NCT03732235|Estrogens|estrogens|mesh-ancestor
82969872|NCT03732235|Hormones|hormones|mesh-ancestor
82969873|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82969874|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82969875|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
82969876|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82969877|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82969878|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
82969879|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969880|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82969881|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82969882|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969883|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969884|NCT01182077|Midazolam|midazolam|mesh-list
82969885|NCT01182077|Peficitinib|peficitinib|mesh-list
82969886|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82969887|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82969888|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462140|NCT04139304|Hormones|hormones|mesh-ancestor
82969889|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969890|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82969891|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82969892|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82969893|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82969894|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
82969895|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
82969896|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
82969897|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
82969898|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82969899|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969900|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969901|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82969902|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
82969903|NCT03618823|Acetaminophen|acetaminophen|mesh-list
82969904|NCT03618823|Ibuprofen|ibuprofen|mesh-list
82969905|NCT03618823|Oxycodone|oxycodone|mesh-list
82969906|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82969907|NCT03618823|Analgesics|analgesics|mesh-ancestor
82969908|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
82969909|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969910|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969911|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
82969912|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82969913|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82969914|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82969915|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82969916|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969917|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969918|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82969919|NCT03618823|Narcotics|narcotics|mesh-ancestor
83520555|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969920|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969921|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82969922|NCT01188707|Belinostat|belinostat|mesh-list
82969923|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969924|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82969925|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969926|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969927|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82969928|NCT03356158|Cetuximab|cetuximab|mesh-list
82969929|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82969930|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969931|NCT03356080|Cytarabine|cytarabine|mesh-list
82969932|NCT03356080|Decitabine|decitabine|mesh-list
82969933|NCT03356080|Tretinoin|tretinoin|mesh-list
82969934|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82969935|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
82969936|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969937|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969938|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
82969939|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969940|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82969941|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
82969942|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969943|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969944|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
82969945|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
82969946|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
82969947|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82969948|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82969949|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
82969950|NCT02937636|Fluorides|fluorides|mesh-list
82969951|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
82969952|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
82969953|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
82969954|NCT02937636|Protective Agents|protective agents|mesh-ancestor
82969955|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969956|NCT03638635|Bupivacaine|bupivacaine|mesh-list
83462152|NCT02936206|Tamoxifen|tamoxifen|mesh-list
82969957|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
82969958|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
82969959|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969960|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969961|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
82969962|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969963|NCT02518516|Atorvastatin|atorvastatin|mesh-list
82969964|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82969965|NCT02518516|Simvastatin|simvastatin|mesh-list
82969966|NCT02518516|Pravastatin|pravastatin|mesh-list
82969967|NCT02518516|Lovastatin|lovastatin|mesh-list
82969968|NCT02518516|L 647318|l 647318|mesh-list
82969969|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
82969970|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82969971|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82969972|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
82969973|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969974|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82969975|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82969976|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82969977|NCT04508686|Capecitabine|capecitabine|mesh-list
82969978|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82969979|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
82969980|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82969981|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82969982|NCT02518438|Tramadol|tramadol|mesh-list
82969983|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82969984|NCT02518438|Narcotics|narcotics|mesh-ancestor
82969985|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969986|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969987|NCT02518438|Analgesics|analgesics|mesh-ancestor
82969988|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
82969989|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82969990|NCT04521556|Morphine|morphine|mesh-list
82969991|NCT04521556|Tramadol|tramadol|mesh-list
82969992|NCT04521556|Anesthetics|anesthetics|mesh-list
82969993|NCT04521556|Ropivacaine|ropivacaine|mesh-list
82969994|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82969995|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82969996|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82969997|NCT04521556|Narcotics|narcotics|mesh-ancestor
82969998|NCT04521556|Analgesics|analgesics|mesh-ancestor
82969999|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
82970000|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970001|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970002|NCT03204279|Palonosetron|palonosetron|mesh-list
82970003|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
82970004|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
82970005|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970006|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970007|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970008|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82970009|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82970010|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
82970011|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970012|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970013|NCT02524301|Diprenorphine|diprenorphine|mesh-list
82970014|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82970015|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970016|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
82970017|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970018|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
82970019|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82970020|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82970021|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970022|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
82970023|NCT03122782|Coagulants|coagulants|mesh-ancestor
82970024|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
82970025|NCT01291433|Tocopherols|tocopherols|mesh-list
82970026|NCT01291433|Vitamin E|vitamin e|mesh-list
82970027|NCT01291433|Tocotrienols|tocotrienols|mesh-list
82970028|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
82970029|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
82970030|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82970031|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970032|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970033|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82970034|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82970035|NCT01291433|Protective Agents|protective agents|mesh-ancestor
82970036|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970037|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
82970038|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82970039|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
82970040|NCT01291433|Vitamins|vitamins|mesh-ancestor
82970041|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
82970042|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82970043|NCT01314144|Bupivacaine|bupivacaine|mesh-list
82970044|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970045|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
82970046|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970047|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970048|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
82970049|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970050|NCT02954653|Cytarabine|cytarabine|mesh-list
82970051|NCT02954653|Azacitidine|azacitidine|mesh-list
82970052|NCT02954653|Decitabine|decitabine|mesh-list
82970053|NCT02954653|Daunorubicin|daunorubicin|mesh-list
82970054|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82970055|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
82970056|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970057|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970058|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
82970059|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970060|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970061|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
82970062|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970063|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970064|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82970065|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82970066|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82970067|NCT04895748|Everolimus|everolimus|mesh-list
82970068|NCT04895748|Spartalizumab|spartalizumab|mesh-list
82970069|NCT04895748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82970070|NCT04895748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82970071|NCT04895748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970072|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970073|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970074|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
82970075|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970076|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970077|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82970078|NCT04895748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970079|NCT04508452|Bevacizumab|bevacizumab|mesh-list
82970080|NCT04508452|Capecitabine|capecitabine|mesh-list
82970081|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
82970082|NCT04508452|Irinotecan|irinotecan|mesh-list
82970083|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970084|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970085|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82970086|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82970087|NCT04508452|Growth Substances|growth substances|mesh-ancestor
82970088|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970089|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
82970090|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82970091|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
82970092|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970093|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82970094|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82970095|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970096|NCT03856853|Pirfenidone|pirfenidone|mesh-list
82970097|NCT03856853|Analgesics|analgesics|mesh-ancestor
82970098|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
82970099|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970100|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970101|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82970102|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82970103|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82970104|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82970105|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970106|NCT03732703|Thalidomide|thalidomide|mesh-list
82970107|NCT03732703|Dexamethasone|dexamethasone|mesh-list
82970108|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
82970109|NCT03732703|Venetoclax|venetoclax|mesh-list
82970110|NCT03732703|Daratumumab|daratumumab|mesh-list
82970111|NCT03732703|Pomalidomide|pomalidomide|mesh-list
82970112|NCT03732703|Ixazomib|ixazomib|mesh-list
82970113|NCT03732703|BB 1101|bb 1101|mesh-list
82970114|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82970115|NCT03732703|Glycine|glycine|mesh-list
82970116|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82970117|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
82970118|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
82970119|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970120|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970121|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970122|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
82970123|NCT03732703|Hormones|hormones|mesh-ancestor
82970124|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82970125|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82970126|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970127|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
82970128|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970129|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970130|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
82970131|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82970132|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82970133|NCT03732703|Growth Substances|growth substances|mesh-ancestor
82970134|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
82970135|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970136|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
82970137|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82970138|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970139|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
82970140|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970141|NCT03636555|Oxytocin|oxytocin|mesh-list
82970142|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
82970143|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82970144|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970145|NCT03123016|Apremilast|apremilast|mesh-list
82970146|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82970147|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82970148|NCT03123016|Analgesics|analgesics|mesh-ancestor
82970149|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
82970150|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970151|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970152|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82970153|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82970154|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82970155|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82970156|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970157|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970159|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970160|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970161|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82970162|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970163|NCT03732001|Docetaxel|docetaxel|mesh-list
82970164|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970165|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
82970166|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
82970167|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
82970168|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970169|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
82970170|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82970171|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82970172|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
82970173|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82970174|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970175|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970176|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
82970177|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970178|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970179|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82970180|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
82970181|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
82970182|NCT01186835|Protective Agents|protective agents|mesh-ancestor
82970183|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82970184|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970185|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
82970186|NCT04812951|Cyclosporine|cyclosporine|mesh-list
82970187|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82970188|NCT04812951|Cyclosporins|cyclosporins|mesh-list
82970189|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970190|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970191|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970192|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
82970193|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970194|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
82970195|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970196|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
82970197|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82970198|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82970199|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82970200|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
82970201|NCT05666089|Calcium|calcium|mesh-list
82970202|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82970203|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82970204|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970205|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
82970206|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970207|NCT05666089|Expectorants|expectorants|mesh-ancestor
82970208|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
82970209|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82970210|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
82970211|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970212|NCT05666089|Protective Agents|protective agents|mesh-ancestor
82970213|NCT05666089|Antidotes|antidotes|mesh-ancestor
82970214|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
82970215|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82970216|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82970217|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
82970218|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970219|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82970220|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82970221|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970222|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970223|NCT04597476|Fucoidan|fucoidan|mesh-list
83462191|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
82970224|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82970225|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970226|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
82970227|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133551|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970228|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82970229|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82970230|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970232|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970233|NCT02730208|Ivacaftor|ivacaftor|mesh-list
82970234|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82970235|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970236|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970237|NCT01291511|Iloperidone|iloperidone|mesh-list
82970238|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82970239|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82970240|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970241|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970242|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82970243|NCT01292213|Dimercaprol|dimercaprol|mesh-list
82970244|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
82970245|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
82970246|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970247|NCT03122938|Lactoferrin|lactoferrin|mesh-list
82970248|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970249|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
82970250|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
82970251|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970252|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970253|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
82970254|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970255|NCT03782532|Prednisone|prednisone|mesh-list
82970256|NCT03782532|Prednisolone|prednisolone|mesh-list
82970257|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82970258|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
82970259|NCT03782532|Hormones|hormones|mesh-ancestor
82970260|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82970261|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970262|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82970263|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970264|NCT03355768|Romidepsin|romidepsin|mesh-list
82970265|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82970266|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970267|NCT03355768|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82970268|NCT03355768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970269|NCT03355768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970270|NCT03349840|Insulin|insulin|mesh-list
82970271|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82970272|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
82970273|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82970274|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970275|NCT03170271|Benralizumab|benralizumab|mesh-list
82970276|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82970277|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
82970278|NCT03355612|Capecitabine|capecitabine|mesh-list
82970279|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
82970280|NCT03355612|Apatinib|apatinib|mesh-list
82970281|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82970282|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
82970283|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970284|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970285|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82970286|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970287|NCT03732547|Poly I-C|poly i-c|mesh-list
82970288|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
82970289|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970290|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
82970291|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
82970292|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970293|NCT04503850|Mirabegron|mirabegron|mesh-list
82970294|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
82970295|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82970296|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82970297|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82970298|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
82970299|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970300|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970301|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970302|NCT04503850|Urological Agents|urological agents|mesh-ancestor
82970303|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82970304|NCT03349684|Metformin|metformin|mesh-list
82970307|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970308|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82970309|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970310|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970311|NCT03856697|Gefitinib|gefitinib|mesh-list
82970312|NCT03856697|Maleic acid|maleic acid|mesh-list
82970313|NCT03856697|Abivertinib|abivertinib|mesh-list
82970314|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970315|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970316|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970317|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82970318|NCT03349606|Amphetamine|amphetamine|mesh-list
82970319|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
82970320|NCT03349606|FLB 457|flb 457|mesh-list
82970321|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82970322|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970323|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
82970324|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
82970325|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970326|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
82970327|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970328|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970329|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
82970330|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82970331|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82970332|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970333|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82970334|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82970335|NCT02843451|Silymarin|silymarin|mesh-list
82970336|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
82970337|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970338|NCT02843451|Protective Agents|protective agents|mesh-ancestor
82970339|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970340|NCT01292525|Tacrolimus|tacrolimus|mesh-list
82970341|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970342|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
82970343|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970344|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82970345|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970346|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970347|NCT01189019|Ranibizumab|ranibizumab|mesh-list
82970348|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82970349|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82970350|NCT01189019|Growth Substances|growth substances|mesh-ancestor
82970351|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970352|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
82970353|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970354|NCT01183247|Sirolimus|sirolimus|mesh-list
82970355|NCT01183247|Prednisone|prednisone|mesh-list
82970356|NCT01183247|Everolimus|everolimus|mesh-list
82970357|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82970358|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
82970359|NCT01183247|Hormones|hormones|mesh-ancestor
82970360|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82970361|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970362|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82970363|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970364|NCT01183247|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82970365|NCT01183247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82970366|NCT01183247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970367|NCT01183247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970368|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970369|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
82970370|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82970371|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970372|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82970373|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
82970374|NCT03349216|Anesthetics|anesthetics|mesh-list
82970375|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133552|NCT02107729|Lidocaine|lidocaine|mesh-list
82970376|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970377|NCT04507750|Apatinib|apatinib|mesh-list
82970378|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970379|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82970380|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970381|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970382|NCT03633331|Letrozole|letrozole|mesh-list
82970383|NCT03633331|Fulvestrant|fulvestrant|mesh-list
82970384|NCT03633331|Palbociclib|palbociclib|mesh-list
82970385|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970386|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82970387|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82970388|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970389|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970390|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82970391|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
82970392|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82970393|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970394|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82970395|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82970396|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82970397|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
82970398|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
82970399|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
82970400|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82970401|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82970402|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970403|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970404|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970405|NCT01187303|Ofatumumab|ofatumumab|mesh-list
82970406|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970407|NCT01187459|Vitamin D|vitamin d|mesh-list
82970408|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
82970409|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
82970410|NCT01187459|Vitamins|vitamins|mesh-list
82970411|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
82970412|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970413|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82970414|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82970415|NCT01187537|Bupivacaine|bupivacaine|mesh-list
82970416|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970417|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
82970418|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970419|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970420|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
82970421|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970422|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82970423|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82970424|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82970425|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82970426|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970427|NCT01290419|Vaccines|vaccines|mesh-list
82970428|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
82970429|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970430|NCT03737773|Methamphetamine|methamphetamine|mesh-list
82970431|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83462214|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82970432|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970433|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
82970434|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
82970435|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970436|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
82970437|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970438|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970439|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
82970440|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82970441|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82970442|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970443|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82970444|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82970445|NCT01060579|Latanoprost|latanoprost|mesh-list
82970446|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82970447|NCT04443946|Sufentanil|sufentanil|mesh-list
82970448|NCT04443946|Propofol|propofol|mesh-list
82970449|NCT04443946|Sevoflurane|sevoflurane|mesh-list
82970450|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82970451|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970452|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970454|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
82970455|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
82970456|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82970457|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82970458|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82970459|NCT04443946|Narcotics|narcotics|mesh-ancestor
82970460|NCT04443946|Analgesics|analgesics|mesh-ancestor
82970461|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
82970462|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970463|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82970464|NCT03729973|Lidocaine|lidocaine|mesh-list
82970465|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
82970466|NCT03729973|Ketamine|ketamine|mesh-list
82970467|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82970468|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970469|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
82970470|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970471|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970472|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
82970473|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970474|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82970475|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82970476|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82970477|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970478|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970479|NCT03729973|Analgesics|analgesics|mesh-ancestor
82970480|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82970481|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82970482|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
82970483|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82970484|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82970485|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970486|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
82970487|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82970488|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82970489|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
82970490|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82970491|NCT01189253|Doxorubicin|doxorubicin|mesh-list
82970492|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82970493|NCT01189253|Trabectedin|trabectedin|mesh-list
82970494|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82970495|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970496|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82970497|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82970498|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970499|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970500|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82970501|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
82970502|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
82970503|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82970504|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
82970505|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970506|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970507|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82970508|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
82970509|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82970510|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
82970511|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970512|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970513|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82970514|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
82970515|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
82970516|NCT04443868|Protective Agents|protective agents|mesh-ancestor
82970517|NCT03851393|Citric Acid|citric acid|mesh-list
82970518|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
82970519|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
82970520|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82970521|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
82970522|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
82970523|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970524|NCT04443556|Tramadol|tramadol|mesh-list
82970525|NCT04443556|Anesthetics|anesthetics|mesh-list
82970526|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
82970527|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970529|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82970530|NCT04443556|Narcotics|narcotics|mesh-ancestor
82970531|NCT04443556|Analgesics|analgesics|mesh-ancestor
82970532|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
82970533|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970534|NCT01187615|Cisplatin|cisplatin|mesh-list
82970535|NCT01187615|Pemetrexed|pemetrexed|mesh-list
82970536|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970537|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970538|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970539|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82970540|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82970541|NCT05375097|Erenumab|erenumab|mesh-list
82970542|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82970543|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970544|NCT05375097|Analgesics|analgesics|mesh-ancestor
82970545|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
82970546|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970547|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970548|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82970549|NCT02752191|Hematinics|hematinics|mesh-ancestor
82970550|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82970551|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82970552|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
82970553|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82970554|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
82970555|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970556|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
82970557|NCT01290497|Protective Agents|protective agents|mesh-ancestor
82970558|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
82970559|NCT04509466|Pegaspargase|pegaspargase|mesh-list
82970560|NCT04509466|Asparaginase|asparaginase|mesh-list
82970561|NCT04509466|Analgesics|analgesics|mesh-ancestor
82970562|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
82970563|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970564|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970565|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970566|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82970567|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82970568|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970569|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970570|NCT03738215|Cariprazine|cariprazine|mesh-list
82970571|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82970572|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82970573|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970574|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970575|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82970576|NCT05352321|Gemcitabine|gemcitabine|mesh-list
82970577|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970578|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82970579|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
82970580|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970581|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82970582|NCT03199911|Erythromycin|erythromycin|mesh-list
82970583|NCT03199911|Bacitracin|bacitracin|mesh-list
82970584|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970585|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970586|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82970587|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970588|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970589|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82970590|NCT02517814|Vitamin D|vitamin d|mesh-list
82970591|NCT02517814|Vitamins|vitamins|mesh-ancestor
82970592|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
82970593|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970594|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82970595|NCT05349201|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
82970596|NCT05349201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970597|NCT05349201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970598|NCT05303727|Cyclosporine|cyclosporine|mesh-list
82970599|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
82970600|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
82970601|NCT05303727|Melphalan|melphalan|mesh-list
82970602|NCT05303727|Busulfan|busulfan|mesh-list
82970603|NCT05303727|Thiotepa|thiotepa|mesh-list
82970605|NCT05303727|Fludarabine|fludarabine|mesh-list
82970606|NCT05303727|Topotecan|topotecan|mesh-list
82970607|NCT05303727|Tacrolimus|tacrolimus|mesh-list
82970608|NCT05303727|Cyclosporins|cyclosporins|mesh-list
82970609|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82970610|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970611|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
82970612|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970613|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82970614|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82970615|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
82970616|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970617|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970618|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82970619|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82970620|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
82970621|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82970622|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82970623|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
82970624|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
82970625|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970626|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82970627|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82970628|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82970629|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
82970630|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970631|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82970632|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82970633|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
82970634|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82970635|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82970636|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82970637|NCT05480800|Vaccines|vaccines|mesh-list
82970638|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
82970639|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970640|NCT04502368|Dimercaprol|dimercaprol|mesh-list
82970641|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
82970642|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
82970643|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970644|NCT04984083|Vitamin K|vitamin k|mesh-list
82970645|NCT04984083|Vitamins|vitamins|mesh-ancestor
82970646|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
82970647|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970648|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82970649|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82970650|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970651|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
82970652|NCT04984083|Coagulants|coagulants|mesh-ancestor
82970653|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82970654|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
82970655|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970656|NCT05224089|Dexamethasone|dexamethasone|mesh-list
82970657|NCT05224089|Epinephrine|epinephrine|mesh-list
82970658|NCT05224089|Bupivacaine|bupivacaine|mesh-list
82970659|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82970660|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
82970661|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
82970662|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970663|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970664|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970665|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
82970666|NCT05224089|Hormones|hormones|mesh-ancestor
82970667|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82970668|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82970669|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970670|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970671|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970673|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970674|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
82970675|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82970676|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82970677|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
82970678|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970679|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82970680|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82970681|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82970682|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
82970683|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
82970684|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
82970685|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82970686|NCT01581203|Interferons|interferons|mesh-list
82970687|NCT01581203|Ribavirin|ribavirin|mesh-list
82970688|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
82970689|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
82970690|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82970691|NCT01581203|Asunaprevir|asunaprevir|mesh-list
82970692|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970693|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
82970694|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970695|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
82970696|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970697|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
82970698|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970699|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
82970700|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970701|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
82970702|NCT03168555|Cathartics|cathartics|mesh-ancestor
82970703|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970704|NCT03235050|Liraglutide|liraglutide|mesh-list
82970705|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82970706|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970707|NCT03235050|Incretins|incretins|mesh-ancestor
82970708|NCT03235050|Hormones|hormones|mesh-ancestor
82970709|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82970710|NCT04933149|Ketamine|ketamine|mesh-list
82970711|NCT04933149|Analgesics|analgesics|mesh-ancestor
82970712|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
82970713|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970714|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970715|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82970716|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82970717|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
82970718|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
82970719|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970720|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82970721|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82970722|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970723|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970724|NCT01189721|Propofol|propofol|mesh-list
82970725|NCT01189721|Sevoflurane|sevoflurane|mesh-list
82970726|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82970727|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970728|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970729|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82970730|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
82970731|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
82970732|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82970733|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82970734|NCT03167619|Durvalumab|durvalumab|mesh-list
82970735|NCT03167619|Olaparib|olaparib|mesh-list
82970736|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970737|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970738|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82970739|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970740|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970741|NCT03198507|Amoxicillin|amoxicillin|mesh-list
82970742|NCT03198507|Rifabutin|rifabutin|mesh-list
82970743|NCT03198507|Omeprazole|omeprazole|mesh-list
82970744|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82970745|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970746|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82970747|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970748|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82970749|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970750|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970751|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82970752|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
82970753|NCT03850769|Paclitaxel|paclitaxel|mesh-list
82970754|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82970755|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970756|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
82970757|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
82970758|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
82970759|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970760|NCT04663464|Abaloparatide|abaloparatide|mesh-list
82970761|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
83462260|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970762|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82970763|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970764|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82970765|NCT01292993|Metformin|metformin|mesh-list
82970766|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82970767|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82970768|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970769|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82970770|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970771|NCT03849833|Vitamin D|vitamin d|mesh-list
82970772|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
82970773|NCT03849833|Vitamins|vitamins|mesh-ancestor
82970774|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
82970775|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970776|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82970777|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82970778|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
82970779|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970780|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970781|NCT03167151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82970782|NCT03167151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970783|NCT04910711|Dolutegravir|dolutegravir|mesh-list
82970784|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82970785|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
82970786|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
82970787|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82970788|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
82970789|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82970790|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970791|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82970792|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82970793|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82970794|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82970795|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82970796|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970797|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970798|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82970799|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82970800|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
82970801|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970802|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82970803|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82970804|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82970805|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970806|NCT01191203|Copper|copper|mesh-list
82970807|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82970808|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
82970809|NCT01191203|Trace Elements|trace elements|mesh-ancestor
82970810|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
82970811|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970812|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82970813|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82970814|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82970815|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
82970816|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82970817|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82970818|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82970819|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83133553|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970820|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82970821|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970822|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
82970823|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82970824|NCT03197883|Protective Agents|protective agents|mesh-ancestor
82970825|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970826|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
82970827|NCT03729505|Lidocaine|lidocaine|mesh-list
82970828|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
82970829|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970830|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
82970831|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970832|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970833|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
82970834|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970835|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82970836|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82970837|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82970838|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970839|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970840|NCT03729505|Analgesics|analgesics|mesh-ancestor
82970841|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
82970842|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82970843|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82970844|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
82970845|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82970846|NCT03234036|Ritonavir|ritonavir|mesh-list
82970847|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
82970848|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82970849|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82970850|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
82970851|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970852|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970853|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82970854|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82970855|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
82970856|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970857|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82970858|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82970859|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
82970860|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82970861|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82970862|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970863|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
82970864|NCT03606109|Coagulants|coagulants|mesh-ancestor
82970865|NCT01191359|Immunomodulating Agents|immunomodulating agents|mesh-list
82970866|NCT01191359|Immunologic Factors|immunologic factors|mesh-ancestor
82970867|NCT01191359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970868|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82970869|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82970870|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82970871|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
82970872|NCT01193855|Dutasteride|dutasteride|mesh-list
82970873|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82970874|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82970875|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970876|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970877|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
82970878|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82970879|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970880|NCT01190345|Bevacizumab|bevacizumab|mesh-list
82970881|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970882|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970883|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82970884|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82970885|NCT01190345|Growth Substances|growth substances|mesh-ancestor
82970886|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970887|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
82970888|NCT02729896|Rituximab|rituximab|mesh-list
82970889|NCT02729896|Atezolizumab|atezolizumab|mesh-list
82970890|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
82970891|NCT02729896|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
82970892|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970893|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970894|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
82970895|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970896|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82970897|NCT02729896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82970898|NCT02729896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970899|NCT02729896|Immunoconjugates|immunoconjugates|mesh-ancestor
82970900|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
82970901|NCT04540380|Rituximab|rituximab|mesh-list
82970902|NCT04540380|Fludarabine|fludarabine|mesh-list
82970903|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82970904|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
82970905|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970906|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82970907|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82970908|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
82970909|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970910|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970911|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82970912|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82970913|NCT04506034|Lidocaine|lidocaine|mesh-list
82970914|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970915|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
82970916|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970917|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970918|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
82970919|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970920|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82970921|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82970922|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82970923|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970924|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970925|NCT01294631|Canagliflozin|canagliflozin|mesh-list
82970926|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82970927|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970928|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82970929|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970930|NCT03849209|Pancrelipase|pancrelipase|mesh-list
82970931|NCT03849209|Pancreatin|pancreatin|mesh-list
82970932|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970933|NCT05342662|Methamphetamine|methamphetamine|mesh-list
82970934|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82970935|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970936|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
82970937|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
82970938|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970939|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
82970940|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970941|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970942|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
82970943|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82970944|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82970945|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82970946|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82970947|NCT03847571|Acetazolamide|acetazolamide|mesh-list
82970948|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
82970949|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82970950|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970951|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970952|NCT03847571|Diuretics|diuretics|mesh-ancestor
82970953|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
82970954|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970955|NCT01293149|Clonidine|clonidine|mesh-list
82970956|NCT01293149|Ropivacaine|ropivacaine|mesh-list
82970957|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
82970958|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
82970959|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970960|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970961|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
82970962|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82970963|NCT01293149|Analgesics|analgesics|mesh-ancestor
82970964|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82970965|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
82970966|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
82970967|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83462283|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82970968|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82970969|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82970970|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
82970971|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970972|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970974|NCT03575065|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82970975|NCT03575065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82970977|NCT03575065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82970978|NCT04454424|Midazolam|midazolam|mesh-list
82970979|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82970980|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82970981|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82970982|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82970983|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82970984|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82970985|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82970986|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82970987|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
82970988|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
82970989|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
82970990|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
82970991|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82970992|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82970993|NCT03348046|Infliximab|infliximab|mesh-list
82970994|NCT03348046|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82970995|NCT03348046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82970996|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
82970997|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82970998|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82970999|NCT05653492|Sulforaphane|sulforaphane|mesh-list
82971000|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82971001|NCT05653492|Protective Agents|protective agents|mesh-ancestor
82971002|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971003|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971004|NCT04505644|Lidocaine|lidocaine|mesh-list
82971005|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
82971006|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
82971007|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971008|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971009|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
82971010|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971011|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82971012|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82971013|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82971014|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82971015|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971016|NCT04505800|Tryptophan|tryptophan|mesh-list
82971017|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82971018|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
82971019|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82971020|NCT05200156|Choline|choline|mesh-list
82971021|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
82971022|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82971023|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
82971024|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971025|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971026|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82971027|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
82971028|NCT03347968|Warfarin|warfarin|mesh-list
82971029|NCT03347968|Esmolol|esmolol|mesh-list
82971030|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
82971031|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82971032|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82971033|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82971034|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971035|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971036|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971037|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971038|NCT01191593|Ropivacaine|ropivacaine|mesh-list
82971039|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
82971040|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
82971041|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971042|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971043|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
82971044|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971045|NCT03347890|Liraglutide|liraglutide|mesh-list
82971046|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971047|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971048|NCT03347890|Incretins|incretins|mesh-ancestor
82971049|NCT03347890|Hormones|hormones|mesh-ancestor
82971050|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971051|NCT01296503|Thalidomide|thalidomide|mesh-list
82971052|NCT01296503|Dexamethasone|dexamethasone|mesh-list
82971053|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
82971054|NCT01296503|BB 1101|bb 1101|mesh-list
82971055|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971056|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
82971057|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
82971058|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971059|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971060|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971061|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
82971062|NCT01296503|Hormones|hormones|mesh-ancestor
82971063|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971064|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971065|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971066|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
82971067|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971068|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971069|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971070|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
82971071|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
82971072|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82971073|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971074|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82971075|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82971076|NCT01296503|Growth Substances|growth substances|mesh-ancestor
82971077|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
82971078|NCT01295099|Triamcinolone|triamcinolone|mesh-list
82971079|NCT01295099|Fluorouracil|fluorouracil|mesh-list
82971080|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
82971081|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971082|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82971083|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971084|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971085|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
82971086|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971087|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971088|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
82971089|NCT01295099|Hormones|hormones|mesh-ancestor
82971090|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971091|NCT01426529|Norepinephrine|norepinephrine|mesh-list
82971092|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
82971093|NCT01426529|Giapreza|giapreza|mesh-list
82971094|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
82971095|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82971096|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82971097|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971098|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971099|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971100|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971101|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
82971102|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
82971103|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971104|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82971105|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82971106|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
82971107|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971108|NCT03122158|Escitalopram|escitalopram|mesh-list
82971109|NCT03122158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82971110|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83462288|NCT02758132|Denosumab|denosumab|mesh-list
82971111|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82971112|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971113|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971114|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
82971115|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971116|NCT02668653|Cytarabine|cytarabine|mesh-list
82971117|NCT02668653|Daunorubicin|daunorubicin|mesh-list
82971118|NCT02668653|Idarubicin|idarubicin|mesh-list
82971119|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82971121|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971122|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971123|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
82971124|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971125|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971126|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
82971127|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971128|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82971129|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82971130|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82971131|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971132|NCT03555565|Metformin|metformin|mesh-list
82971133|NCT03555565|Alogliptin|alogliptin|mesh-list
82971134|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971135|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971136|NCT03555565|Incretins|incretins|mesh-ancestor
82971137|NCT03555565|Hormones|hormones|mesh-ancestor
82971138|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971139|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82971140|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
82971141|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971142|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971143|NCT01190735|Caffeine|caffeine|mesh-list
82971144|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82971145|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971146|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82971147|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971148|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971149|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82971150|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82971151|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
82971152|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971153|NCT05097118|Ketamine|ketamine|mesh-list
82971154|NCT05097118|Bupivacaine|bupivacaine|mesh-list
82971155|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
82971156|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
82971157|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971158|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971159|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
82971160|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971161|NCT05097118|Analgesics|analgesics|mesh-ancestor
82971162|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82971163|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82971164|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
82971165|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82971166|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82971167|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971168|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462298|NCT01891916|Caseins|caseins|mesh-list
82971169|NCT01194791|Dexamethasone|dexamethasone|mesh-list
82971170|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
82971171|NCT01194791|Lenalidomide|lenalidomide|mesh-list
82971172|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971173|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
82971174|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971175|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971176|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82971177|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
82971178|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971179|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971180|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82971181|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971182|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
82971183|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
82971184|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971185|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971186|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
82971187|NCT01194791|Hormones|hormones|mesh-ancestor
82971188|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971189|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971190|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82971191|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82971192|NCT01194791|Growth Substances|growth substances|mesh-ancestor
82971193|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
82971194|NCT03351322|Minoxidil|minoxidil|mesh-list
82971195|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82971196|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
82971197|NCT01296971|Ribavirin|ribavirin|mesh-list
82971198|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82971199|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
82971200|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971201|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
82971202|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971203|NCT01195181|Ribavirin|ribavirin|mesh-list
82971204|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
82971205|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971206|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
82971207|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971208|NCT01197053|Immunomodulating Agents|immunomodulating agents|mesh-list
82971209|NCT01197053|Immunologic Factors|immunologic factors|mesh-ancestor
82971210|NCT01197053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971211|NCT03845699|Fentanyl|fentanyl|mesh-list
82971212|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82971213|NCT03845699|Narcotics|narcotics|mesh-ancestor
82971214|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971215|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971216|NCT03845699|Analgesics|analgesics|mesh-ancestor
82971217|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
82971218|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971219|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82971220|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82971221|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
82971222|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
82971223|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
82971224|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971225|NCT00709618|Vinorelbine|vinorelbine|mesh-list
82971226|NCT00709618|Lapatinib|lapatinib|mesh-list
82971227|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82971228|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971229|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
82971230|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
82971231|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
82971232|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971233|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82971234|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971235|NCT01195259|Metformin|metformin|mesh-list
82971236|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
82971237|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971238|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971239|NCT05584228|Infliximab|infliximab|mesh-list
82971240|NCT05584228|Azathioprine|azathioprine|mesh-list
82971241|NCT05584228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82971242|NCT05584228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971243|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
82971244|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971245|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971246|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
82971247|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971248|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82971249|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971250|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971251|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
82971252|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971253|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82971254|NCT03193047|Evolocumab|evolocumab|mesh-list
82971255|NCT03193047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82971256|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82971257|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82971258|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
82971259|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971260|NCT03193047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82971261|NCT03193047|Protease Inhibitors|protease inhibitors|mesh-ancestor
82971262|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971263|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82971264|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971265|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971266|NCT05597735|Tecovirimat|tecovirimat|mesh-list
82971267|NCT05597735|Antiviral Agents|antiviral agents|mesh-ancestor
82971268|NCT05597735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971269|NCT04504552|Avelumab|avelumab|mesh-list
82971270|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82971271|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971272|NCT03845387|Pramipexole|pramipexole|mesh-list
82971273|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
82971274|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971275|NCT03845387|Protective Agents|protective agents|mesh-ancestor
82971276|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971277|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82971278|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82971279|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
82971281|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971282|NCT01295177|Insulin|insulin|mesh-list
82971283|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82971284|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971285|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971286|NCT02918019|Astegolimab|astegolimab|mesh-list
82971287|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82971288|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971289|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
82971290|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971291|NCT04848454|Vinorelbine|vinorelbine|mesh-list
82971292|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971293|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82971294|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
82971295|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
82971296|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
82971297|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971298|NCT04842292|Heparin|heparin|mesh-list
82971299|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
82971300|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82971301|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82971302|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971303|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
82971304|NCT01191983|Hematinics|hematinics|mesh-ancestor
82971305|NCT03055988|Fluticasone|fluticasone|mesh-list
82971306|NCT03055988|Xhance|xhance|mesh-list
82971307|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
82971308|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82971309|NCT03055988|Olodaterol|olodaterol|mesh-list
82971310|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971311|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82971312|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
82971313|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971314|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971315|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82971316|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
82971317|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
82971318|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82971319|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
82971320|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82971321|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
82971322|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971323|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971324|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82971325|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82971326|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82971327|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971328|NCT03346642|Decitabine|decitabine|mesh-list
82971329|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82971330|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82971331|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
82971332|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971333|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971334|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971335|NCT03346642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82971336|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
82971337|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
82971338|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
82971339|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971340|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82971341|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971342|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971343|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971344|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82971345|NCT04789304|Midazolam|midazolam|mesh-list
82971346|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82971347|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82971348|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971349|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971350|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82971351|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82971352|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82971353|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82971354|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
82971355|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
82971356|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
82971357|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
82971358|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971359|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971360|NCT04780724|Nitrox|nitrox|mesh-list
82971361|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82971362|NCT04780724|Protective Agents|protective agents|mesh-ancestor
82971363|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971364|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
82971365|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82971366|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82971367|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971368|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
82971369|NCT03128866|Coagulants|coagulants|mesh-ancestor
82971370|NCT05583214|Dexamethasone|dexamethasone|mesh-list
82971371|NCT05583214|Ondansetron|ondansetron|mesh-list
82971372|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971373|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
82971374|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
82971375|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971376|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971377|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971378|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
82971379|NCT05583214|Hormones|hormones|mesh-ancestor
82971380|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971381|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971382|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971383|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
82971384|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
82971385|NCT05583214|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82971386|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82971387|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
82971388|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971389|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971390|NCT02871297|Vortioxetine|vortioxetine|mesh-list
82971391|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
82971392|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82971393|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82971394|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82971395|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971396|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971397|NCT02871297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82971398|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82971399|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82971400|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971401|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971402|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
82971403|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82971404|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82971405|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82971406|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82971407|NCT03628430|Lidocaine|lidocaine|mesh-list
82971408|NCT03628430|Epinephrine|epinephrine|mesh-list
82971409|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
82971410|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
82971411|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971412|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971413|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
82971414|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971415|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82971416|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82971417|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82971418|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82971419|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971420|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82971421|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82971422|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971423|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971424|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82971425|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82971427|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82971428|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
82971429|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
82971430|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
82971431|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82971432|NCT03121846|Apatinib|apatinib|mesh-list
82971433|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971434|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82971435|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971436|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971437|NCT03122314|Acetaminophen|acetaminophen|mesh-list
82971438|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
82971439|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82971440|NCT03122314|Analgesics|analgesics|mesh-ancestor
82971441|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
82971442|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971443|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971444|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
82971445|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82971446|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971447|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971448|NCT03554005|Acetaminophen|acetaminophen|mesh-list
82971449|NCT03554005|Interferons|interferons|mesh-list
82971450|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
82971451|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
82971452|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82971453|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971454|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
82971455|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971456|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82971457|NCT03554005|Analgesics|analgesics|mesh-ancestor
82971458|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
82971459|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971460|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971461|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
82971462|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
82971463|NCT00709228|Ribavirin|ribavirin|mesh-list
82971464|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82971465|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
82971466|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971467|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
82971468|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971469|NCT01584557|Tolvaptan|tolvaptan|mesh-list
82971470|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82971471|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971472|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
82971473|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971474|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
82971475|NCT05214872|Calcium|calcium|mesh-list
82971476|NCT05214872|Mitogens|mitogens|mesh-list
82971477|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82971478|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971479|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
82971480|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971481|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
82971482|NCT01195571|Vaccines|vaccines|mesh-list
82971483|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
82971484|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971485|NCT03219372|Pravastatin|pravastatin|mesh-list
82971486|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82971487|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82971488|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
82971489|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971490|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82971491|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82971492|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971493|NCT03304080|Trastuzumab|trastuzumab|mesh-list
82971494|NCT03304080|Pertuzumab|pertuzumab|mesh-list
82971495|NCT03304080|Palbociclib|palbociclib|mesh-list
82971496|NCT03304080|Anastrozole|anastrozole|mesh-list
82971497|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82971498|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971499|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82971500|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971501|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971502|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971503|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82971504|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82971505|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82971506|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
82971507|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971508|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971510|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82971511|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
82971512|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82971513|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971514|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82971515|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
82971516|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971517|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971518|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
82971519|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971520|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82971521|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971522|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
82971523|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971524|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82971525|NCT03628040|Ropivacaine|ropivacaine|mesh-list
82971526|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
82971527|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
82971528|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971529|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971530|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
82971531|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971532|NCT04715763|Telmisartan|telmisartan|mesh-list
82971533|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82971534|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82971535|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82971536|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971537|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
82971538|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82971539|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
82971540|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971541|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971542|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82971543|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
82971544|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82971545|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
82971546|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971547|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971548|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82971549|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
82971550|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
82971551|NCT04338828|Protective Agents|protective agents|mesh-ancestor
82971552|NCT01295567|Dipyridamole|dipyridamole|mesh-list
82971553|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82971554|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971555|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971556|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82971557|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
82971558|NCT01192529|Phentermine|phentermine|mesh-list
82971559|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82971560|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971561|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
82971562|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82971563|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
82971564|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
82971565|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971566|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971567|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971568|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971569|NCT01195649|Sorafenib|sorafenib|mesh-list
82971570|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971571|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82971572|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971573|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83462360|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
82971574|NCT01195727|Apixaban|apixaban|mesh-list
82971576|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
82971577|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82971578|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
82971579|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971580|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971581|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
82971582|NCT04958876|Naltrexone|naltrexone|mesh-list
82971583|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82971584|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82971585|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971586|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
82971587|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971588|NCT01195805|Amiloride|amiloride|mesh-list
82971589|NCT01195805|Spironolactone|spironolactone|mesh-list
82971590|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82971591|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
82971592|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971593|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971594|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82971595|NCT01195805|Diuretics|diuretics|mesh-ancestor
82971596|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
82971597|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82971598|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82971599|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82971600|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971601|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82971602|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
82971603|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82971604|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971605|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
82971606|NCT01791478|Letrozole|letrozole|mesh-list
82971607|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
82971608|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971609|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82971610|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82971611|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971612|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971613|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82971614|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
82971615|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971616|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971617|NCT03845153|Metformin|metformin|mesh-list
82971618|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971619|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971620|NCT00198718|Vitamin A|vitamin a|mesh-list
82971621|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
82971622|NCT00198718|Vitamins|vitamins|mesh-ancestor
82971623|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
82971624|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971625|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
82971626|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971627|NCT00198718|Protective Agents|protective agents|mesh-ancestor
82971628|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82971629|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971630|NCT04500808|Macitentan|macitentan|mesh-list
82971631|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82971632|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82971633|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971634|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82971635|NCT01192763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82971636|NCT01192763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
82971637|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221003|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82971638|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971639|NCT04539548|Prednisolone|prednisolone|mesh-list
82971640|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971641|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
82971642|NCT04539548|Hormones|hormones|mesh-ancestor
82971643|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971644|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971645|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971647|NCT00708916|Apremilast|apremilast|mesh-list
82971648|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82971649|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82971650|NCT00708916|Analgesics|analgesics|mesh-ancestor
82971651|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
82971652|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971653|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971654|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971655|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971656|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82971657|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82971658|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971659|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971660|NCT02352753|Denosumab|denosumab|mesh-list
82971661|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82971662|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971663|NCT04245514|Durvalumab|durvalumab|mesh-list
82971664|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82971665|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971666|NCT02517736|Sorafenib|sorafenib|mesh-list
82971667|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971668|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82971669|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971670|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971671|NCT03727971|Omalizumab|omalizumab|mesh-list
82971672|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82971673|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82971674|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
82971675|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
82971676|NCT03844841|Propofol|propofol|mesh-list
82971677|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82971678|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971679|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971680|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82971681|NCT03844841|Analgesics|analgesics|mesh-ancestor
82971682|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
82971683|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971684|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82971685|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82971686|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82971687|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971688|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971689|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971690|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82971691|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
82971692|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
82971693|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
82971694|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
82971695|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971696|NCT04501900|Clopidogrel|clopidogrel|mesh-list
82971697|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82971698|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82971699|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82971700|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82971701|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
82971702|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971703|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971704|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971705|NCT03637556|Deferasirox|deferasirox|mesh-list
82971706|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82971707|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
82971708|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
82971709|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971710|NCT04641351|Triamcinolone|triamcinolone|mesh-list
82971711|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82971712|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82971713|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82971714|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971715|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
82971716|NCT04641351|Hormones|hormones|mesh-ancestor
82971717|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971718|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971719|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971720|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
82971721|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971722|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971724|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82971725|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
82971726|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971727|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971728|NCT01198223|Nystatin|nystatin|mesh-list
82971729|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82971730|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82971731|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
82971732|NCT01198223|Ionophores|ionophores|mesh-ancestor
82971733|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82971734|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971735|NCT01193465|Anesthetics|anesthetics|mesh-list
82971736|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971737|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971738|NCT03347344|Riluzole|riluzole|mesh-list
82971739|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
82971740|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82971741|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82971742|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971743|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971744|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971745|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82971746|NCT03347344|Protective Agents|protective agents|mesh-ancestor
82971747|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
82971748|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82971749|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971750|NCT04220866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82971751|NCT04220866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971752|NCT03173456|Acetaminophen|acetaminophen|mesh-list
82971753|NCT03173456|Ibuprofen|ibuprofen|mesh-list
82971754|NCT03173456|Oxycodone|oxycodone|mesh-list
82971755|NCT03173456|Hydrocodone|hydrocodone|mesh-list
82971756|NCT03173456|Codeine|codeine|mesh-list
82971757|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82971758|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82971759|NCT03173456|Analgesics|analgesics|mesh-ancestor
82971760|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
82971761|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971762|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971763|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971764|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971765|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82971766|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971767|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971768|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82971769|NCT03173456|Narcotics|narcotics|mesh-ancestor
82971770|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971771|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
82971772|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
82971773|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
82971774|NCT01193621|Haloperidol|haloperidol|mesh-list
82971775|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
82971776|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
82971777|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
82971778|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971779|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971780|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971781|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82971782|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82971783|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971784|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82971785|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82971786|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
82971787|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971788|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971789|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82971790|NCT02517424|Dronabinol|dronabinol|mesh-list
82971791|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
82971792|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971793|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82971794|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82971795|NCT02517424|Analgesics|analgesics|mesh-ancestor
82971796|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
82971797|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971798|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82971799|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82971800|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971801|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971802|NCT02517424|Hormones|hormones|mesh-ancestor
82971803|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971804|NCT01567904|Semuloparin|semuloparin|mesh-list
82971805|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82971806|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82971807|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971808|NCT01196507|Carvedilol|carvedilol|mesh-list
82971809|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82971810|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82971811|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971812|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971813|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971814|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971815|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82971816|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
82971817|NCT01196507|Protective Agents|protective agents|mesh-ancestor
82971818|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82971819|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82971820|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82971821|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
82971822|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82971823|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82971824|NCT05670509|Midazolam|midazolam|mesh-list
82971825|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82971826|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82971827|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971828|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971829|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82971830|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82971831|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82971832|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82971833|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
82971834|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
82971835|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
82971836|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
82971837|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971838|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971839|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
82971840|NCT05282771|Clobetasol|clobetasol|mesh-list
82971841|NCT05282771|Halobetasol|halobetasol|mesh-list
82971842|NCT05282771|Tazarotene|tazarotene|mesh-list
82971843|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
82971844|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
82971845|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
82971846|NCT05282771|Vitamins|vitamins|mesh-ancestor
82971847|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
82971848|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971849|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82971850|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971851|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
82971852|NCT05282771|Hormones|hormones|mesh-ancestor
82971853|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971854|NCT05487833|Insulin|insulin|mesh-list
82971855|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971856|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971857|NCT03600805|Prednisone|prednisone|mesh-list
82971858|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971859|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
82971860|NCT03600805|Hormones|hormones|mesh-ancestor
82971861|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971862|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971863|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971864|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971865|NCT01198379|Aspirin|aspirin|mesh-list
82971866|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82971867|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82971868|NCT01198379|Analgesics|analgesics|mesh-ancestor
82971869|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
82971870|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971871|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971872|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971873|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971874|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82971875|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82971876|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971877|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82971878|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82971879|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971880|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
82971881|NCT03848039|Vaccines|vaccines|mesh-list
82971882|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
82971883|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971884|NCT01296269|Vasopressins|vasopressins|mesh-list
82971885|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
82971886|NCT01296269|Oxytocin|oxytocin|mesh-list
82971887|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
82971888|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82971889|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971890|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
82971891|NCT01296269|Coagulants|coagulants|mesh-ancestor
82971892|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82971893|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82971894|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
82971895|NCT05595772|Mitogens|mitogens|mesh-list
82971896|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
82971897|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971898|NCT03844451|Epinephrine|epinephrine|mesh-list
82971899|NCT03844451|Bupivacaine|bupivacaine|mesh-list
82971900|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
82971901|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
82971902|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82971903|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971904|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
82971905|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971906|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82971907|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82971908|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
82971909|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82971910|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971911|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82971912|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82971913|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
82971914|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82971915|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
82971916|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
82971917|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
82971918|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82971919|NCT03346096|Thiotepa|thiotepa|mesh-list
82971920|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82971921|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
82971922|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971923|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971924|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82971925|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971926|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
82971927|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971928|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
82971929|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82971930|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971931|NCT03386214|Pevonedistat|pevonedistat|mesh-list
82971932|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971933|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971934|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82971935|NCT01198535|Cetuximab|cetuximab|mesh-list
82971936|NCT01198535|Antibodies|antibodies|mesh-list
82971937|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
82971938|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82971939|NCT01198535|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
82971940|NCT01198535|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
82971941|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
82971943|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971944|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971945|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971946|NCT05081219|Insulin|insulin|mesh-list
82971947|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82971948|NCT05081219|Empagliflozin|empagliflozin|mesh-list
82971949|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82971950|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971951|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82971952|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971953|NCT03909334|Osimertinib|osimertinib|mesh-list
82971954|NCT03909334|Ramucirumab|ramucirumab|mesh-list
82971955|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971956|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82971957|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82971958|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971959|NCT03860038|Dexamethasone|dexamethasone|mesh-list
82971960|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971961|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
82971962|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
82971963|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971964|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971965|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971966|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
82971967|NCT03860038|Hormones|hormones|mesh-ancestor
82971968|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971969|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971970|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971971|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
82971972|NCT03844763|Avelumab|avelumab|mesh-list
82971973|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82971974|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
82971975|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971976|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82971977|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82971978|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
82971979|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82971980|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971981|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82971982|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82971983|NCT05016947|Dexamethasone|dexamethasone|mesh-list
82971984|NCT05016947|Venetoclax|venetoclax|mesh-list
82971985|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82971986|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82971987|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
82971988|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
82971989|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82971990|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82971991|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82971992|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
82971993|NCT05016947|Hormones|hormones|mesh-ancestor
82971994|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82971995|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82971996|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82971997|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82971998|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82971999|NCT05016947|Immunotoxins|immunotoxins|mesh-ancestor
82972000|NCT05016947|Immunoconjugates|immunoconjugates|mesh-ancestor
82972001|NCT05016947|Immunologic Factors|immunologic factors|mesh-ancestor
82972002|NCT01198925|Piperacillin|piperacillin|mesh-list
82972003|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972004|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972005|NCT03844139|Glycerol|glycerol|mesh-list
82972006|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82972007|NCT03844139|Protective Agents|protective agents|mesh-ancestor
82972008|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972009|NCT04500496|Isoniazid|isoniazid|mesh-list
82972010|NCT04500496|Dinoprostone|dinoprostone|mesh-list
82972011|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
82972012|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972013|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972014|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
82972015|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972016|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972017|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82972018|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82972019|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
82972020|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972021|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82972023|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972024|NCT04989335|Fludarabine|fludarabine|mesh-list
82972025|NCT04989335|Clofarabine|clofarabine|mesh-list
82972026|NCT04989335|Bisantrene|bisantrene|mesh-list
82972027|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972028|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82972029|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
82972030|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972031|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82972032|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82972033|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
82972034|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
82972035|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972036|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972037|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
82972038|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972039|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
82972040|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
82972041|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
82972042|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972043|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972044|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
82972045|NCT01199159|Pyridoxal|pyridoxal|mesh-list
82972046|NCT01199159|Pyridoxine|pyridoxine|mesh-list
82972047|NCT01199159|Misoprostol|misoprostol|mesh-list
82972048|NCT01199159|Vitamins|vitamins|mesh-ancestor
82972049|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
82972050|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972051|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82972052|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
82972053|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972054|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82972055|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972056|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
82972057|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
82972058|NCT05669963|Lactoferrin|lactoferrin|mesh-list
82972059|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972060|NCT02507440|Lidocaine|lidocaine|mesh-list
82972061|NCT02507440|Propofol|propofol|mesh-list
82972062|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
82972063|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
82972064|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972065|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972066|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
82972067|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972068|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972069|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82972070|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82972071|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972072|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972073|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82972074|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82972075|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
82972076|NCT02507362|Riboflavin|riboflavin|mesh-list
82972077|NCT02507362|Dextrans|dextrans|mesh-list
82972078|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
82972079|NCT02507362|Vitamins|vitamins|mesh-ancestor
82972080|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
82972081|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972082|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82972083|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
82972084|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
82972085|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
82972086|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
82972087|NCT05640830|Paclitaxel|paclitaxel|mesh-list
82972088|NCT05640830|Bevacizumab|bevacizumab|mesh-list
82972089|NCT05640830|Trastuzumab|trastuzumab|mesh-list
82972090|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82972091|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972092|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
82972093|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
82972094|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972095|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972096|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972097|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82972098|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82972099|NCT05640830|Growth Substances|growth substances|mesh-ancestor
82972100|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972101|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
82972103|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82972104|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972105|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
82972106|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972108|NCT03730961|Diuretics|diuretics|mesh-ancestor
82972109|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
82972110|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972111|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82972112|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972113|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972114|NCT01078454|Dexamethasone|dexamethasone|mesh-list
82972115|NCT01078454|Bortezomib|bortezomib|mesh-list
82972116|NCT01078454|Melphalan|melphalan|mesh-list
82972117|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972118|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
82972119|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
82972120|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972121|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972122|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972123|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
82972124|NCT01078454|Hormones|hormones|mesh-ancestor
82972125|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82972126|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82972127|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972128|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82972129|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
82972130|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972131|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82972132|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972133|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
82972134|NCT02968602|Minocycline|minocycline|mesh-list
82972135|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972136|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972137|NCT03345004|Vitamin D|vitamin d|mesh-list
82972138|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
82972139|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
82972140|NCT03345004|Vitamins|vitamins|mesh-list
82972141|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
82972142|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972143|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82972144|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82972145|NCT03034356|Levetiracetam|levetiracetam|mesh-list
82972146|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
82972147|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
82972148|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
82972149|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972150|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972151|NCT03003468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82972152|NCT03003468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972153|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82972154|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972155|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972156|NCT03552523|Pancrelipase|pancrelipase|mesh-list
82972157|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972158|NCT03728101|Dabigatran|dabigatran|mesh-list
82972159|NCT03728101|Simvastatin|simvastatin|mesh-list
82972160|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82972161|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82972162|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
82972163|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972164|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82972165|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82972166|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972167|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
82972168|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82972169|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
82972170|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
82972172|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82972173|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
82972174|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82972175|NCT04170972|Insulin|insulin|mesh-list
82972176|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82972177|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972178|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
82972179|NCT02515864|Dotinurad|dotinurad|mesh-list
82972180|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82972181|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972182|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972183|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82972184|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82972185|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972186|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972187|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972188|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82972189|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
82972190|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972191|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972192|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82972193|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82972194|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82972195|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
82972196|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
82972197|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972198|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
82972199|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
82972200|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
82972201|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972202|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972203|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972204|NCT02892409|Amoxicillin|amoxicillin|mesh-list
82972205|NCT02892409|Clarithromycin|clarithromycin|mesh-list
82972206|NCT02892409|Lansoprazole|lansoprazole|mesh-list
82972207|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
82972208|NCT02892409|Bismuth|bismuth|mesh-list
82972209|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972210|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972211|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82972212|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972213|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972214|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82972215|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82972216|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82972217|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972218|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82972219|NCT02892409|Antacids|antacids|mesh-ancestor
82972220|NCT02507128|Liraglutide|liraglutide|mesh-list
82972221|NCT02507128|Glucagon|glucagon|mesh-list
82972222|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82972223|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82972224|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972225|NCT02507128|Incretins|incretins|mesh-ancestor
82972226|NCT02507128|Hormones|hormones|mesh-ancestor
82972227|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82972228|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972229|NCT03844529|Lidocaine|lidocaine|mesh-list
82972230|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
82972231|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
82972232|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972233|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972234|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
82972235|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972236|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972237|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82972238|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82972239|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972240|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972241|NCT02292758|Bevacizumab|bevacizumab|mesh-list
82972242|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82972243|NCT02292758|Cetuximab|cetuximab|mesh-list
82972244|NCT02292758|Irinotecan|irinotecan|mesh-list
82972245|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
82972246|NCT02292758|Antibodies|antibodies|mesh-list
82972247|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
82972248|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82972249|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
82972250|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972251|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82972252|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82972253|NCT02292758|Growth Substances|growth substances|mesh-ancestor
82972254|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972255|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
82972256|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
82972257|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82972258|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82972259|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972260|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972261|NCT03727867|Mitogens|mitogens|mesh-list
82972262|NCT03727867|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82972263|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972264|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972265|NCT03727867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82972266|NCT03727867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972267|NCT02832648|Selenium|selenium|mesh-list
82972268|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
82972269|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972270|NCT02832648|Protective Agents|protective agents|mesh-ancestor
82972271|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972272|NCT02832648|Trace Elements|trace elements|mesh-ancestor
82972273|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
82972274|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
82972275|NCT04497766|Analgesics|analgesics|mesh-ancestor
82972276|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
82972277|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972278|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972279|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
82972280|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972281|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972282|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
82972283|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82972284|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972285|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972286|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82972287|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
82972288|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972289|NCT03841721|Linezolid|linezolid|mesh-list
82972290|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972291|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972292|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82972293|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972294|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972295|NCT03164057|Cytarabine|cytarabine|mesh-list
82972296|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
82972297|NCT03164057|Methotrexate|methotrexate|mesh-list
82972298|NCT03164057|Azacitidine|azacitidine|mesh-list
82972299|NCT03164057|Decitabine|decitabine|mesh-list
82972300|NCT03164057|Fludarabine|fludarabine|mesh-list
82972301|NCT03164057|Etoposide|etoposide|mesh-list
82972302|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
82972303|NCT03164057|Sorafenib|sorafenib|mesh-list
82972304|NCT03164057|Daunorubicin|daunorubicin|mesh-list
82972305|NCT03164057|Asparaginase|asparaginase|mesh-list
82972306|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
82972307|NCT03164057|Idarubicin|idarubicin|mesh-list
82972308|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
82972309|NCT03164057|Razoxane|razoxane|mesh-list
82972310|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
82972311|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82972312|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
82972313|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972314|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972315|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82972316|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
83133554|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
82972317|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972318|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972319|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
82972320|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972321|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82972322|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972324|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972325|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82972326|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82972327|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82972328|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82972330|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972331|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82972332|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972333|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82972334|NCT03164057|Analgesics|analgesics|mesh-ancestor
82972335|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
82972336|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972337|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82972338|NCT03164057|Protective Agents|protective agents|mesh-ancestor
82972339|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
82972340|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972341|NCT03620526|Iloprost|iloprost|mesh-list
82972342|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82972343|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
82972344|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
82972345|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
82972346|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82972347|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82972348|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972349|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972350|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972351|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972352|NCT03843749|Trastuzumab|trastuzumab|mesh-list
82972353|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972354|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972355|NCT01199783|Vancomycin|vancomycin|mesh-list
82972356|NCT01199783|Daptomycin|daptomycin|mesh-list
82972357|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972358|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972359|NCT03192306|Ethanol|ethanol|mesh-list
82972360|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82972361|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972362|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972363|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972364|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
82972365|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82972366|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
82972367|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972368|NCT03216954|Expectorants|expectorants|mesh-ancestor
83462444|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
82972369|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
82972370|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82972371|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
82972372|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972373|NCT03216954|Protective Agents|protective agents|mesh-ancestor
82972374|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972375|NCT03216954|Antidotes|antidotes|mesh-ancestor
82972376|NCT05669807|Paclitaxel|paclitaxel|mesh-list
82972377|NCT05669807|Irinotecan|irinotecan|mesh-list
82972378|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82972379|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82972380|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972381|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
82972382|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
82972383|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972384|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972385|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82972386|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82972387|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972388|NCT03599089|Acetaminophen|acetaminophen|mesh-list
82972389|NCT03599089|Ketorolac|ketorolac|mesh-list
82972390|NCT03599089|Oxycodone|oxycodone|mesh-list
82972391|NCT03599089|Bupivacaine|bupivacaine|mesh-list
82972392|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
82972393|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
83221004|NCT02416999|Growth Substances|growth substances|mesh-ancestor
82972394|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972395|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972396|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
82972397|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972398|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82972401|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82972402|NCT03599089|Narcotics|narcotics|mesh-ancestor
82972403|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82972404|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972405|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972406|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82972407|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972408|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972409|NCT03597529|Melatonin|melatonin|mesh-list
82972410|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
82972411|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972412|NCT03597529|Protective Agents|protective agents|mesh-ancestor
82972413|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972414|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972415|NCT03991091|Oxytocin|oxytocin|mesh-list
82972416|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
82972417|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972418|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972419|NCT05420454|Paclitaxel|paclitaxel|mesh-list
82972420|NCT05420454|Docetaxel|docetaxel|mesh-list
82972421|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82972422|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
82972423|NCT05420454|Carboplatin|carboplatin|mesh-list
82972424|NCT05420454|Trastuzumab|trastuzumab|mesh-list
82972425|NCT05420454|Epirubicin|epirubicin|mesh-list
82972426|NCT05420454|Pertuzumab|pertuzumab|mesh-list
82972427|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82972428|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972429|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
82972430|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
82972431|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972432|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972433|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972434|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
82972435|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972436|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972437|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82972438|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
82972439|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82972440|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972441|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82972442|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82972443|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82972444|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972445|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
82972446|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
82972447|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972448|NCT04667507|Dexamethasone|dexamethasone|mesh-list
82972449|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972450|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
82972451|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
82972452|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972453|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972454|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972455|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
82972456|NCT04667507|Hormones|hormones|mesh-ancestor
82972457|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82972458|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82972459|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972460|NCT01200251|Bimatoprost|bimatoprost|mesh-list
82972461|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82972462|NCT03597139|Cyclosporine|cyclosporine|mesh-list
82972463|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82972464|NCT03597139|Cyclosporins|cyclosporins|mesh-list
82972465|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972466|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972467|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972468|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
82972469|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972470|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
82972471|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972472|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
82972473|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972474|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82972475|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82972477|NCT01202435|Analgesics|analgesics|mesh-ancestor
82972478|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
82972479|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972480|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972481|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
82972482|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82972483|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972484|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972485|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82972486|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82972487|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82972488|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972489|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82972490|NCT05406102|Propofol|propofol|mesh-list
82972491|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82972492|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972493|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972494|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82972495|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
82972496|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
82972497|NCT01204307|Cisplatin|cisplatin|mesh-list
82972498|NCT01204307|Docetaxel|docetaxel|mesh-list
82972499|NCT01204307|Pemetrexed|pemetrexed|mesh-list
82972500|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972501|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
82972502|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
82972503|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972504|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972505|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972506|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82972507|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82972508|NCT00708214|Letrozole|letrozole|mesh-list
82972509|NCT00708214|Afatinib|afatinib|mesh-list
82972510|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972511|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82972512|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82972513|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972514|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972515|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82972516|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
82972517|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82972518|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972519|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82972520|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
82972521|NCT02506894|Analgesics|analgesics|mesh-ancestor
82972522|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
82972523|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972524|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972525|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
82972526|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972527|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972528|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
82972529|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82972530|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972531|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972532|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82972533|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
82972534|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972535|NCT03909737|Azithromycin|azithromycin|mesh-list
82972536|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972537|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972538|NCT04891250|Ivermectin|ivermectin|mesh-list
82972539|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82972540|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972541|NCT03570697|Evolocumab|evolocumab|mesh-list
82972542|NCT03570697|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82972543|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82972544|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82972545|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
82972546|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972547|NCT03570697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82972548|NCT03570697|Protease Inhibitors|protease inhibitors|mesh-ancestor
82972549|NCT03570697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972550|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82972551|NCT02511574|Progesterone|progesterone|mesh-list
82972552|NCT02511574|Progestins|progestins|mesh-ancestor
82972553|NCT02511574|Hormones|hormones|mesh-ancestor
82972554|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82972555|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972556|NCT01200641|Gabapentin|gabapentin|mesh-list
82972557|NCT01200641|Melatonin|melatonin|mesh-list
82972558|NCT01200641|Analgesics|analgesics|mesh-ancestor
82972559|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
82972560|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972561|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972562|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
82972563|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82972564|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82972565|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972566|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82972567|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82972568|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82972569|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972570|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972571|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
82972572|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
82972573|NCT01200641|Protective Agents|protective agents|mesh-ancestor
82972574|NCT01856270|Amitriptyline|amitriptyline|mesh-list
82972575|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82972576|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
82972577|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82972578|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82972579|NCT01856270|Analgesics|analgesics|mesh-ancestor
82972580|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
82972581|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972582|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972583|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82972584|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82972585|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972586|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972587|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
82972588|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972589|NCT02511340|Flumatinib|flumatinib|mesh-list
82972590|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82972591|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972592|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972593|NCT02506348|Diclofenac|diclofenac|mesh-list
82972594|NCT02506348|Nepafenac|nepafenac|mesh-list
82972595|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82972596|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82972597|NCT02506348|Analgesics|analgesics|mesh-ancestor
82972598|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
82972599|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972600|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972601|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972602|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972603|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82972604|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972605|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972606|NCT01318070|Pioglitazone|pioglitazone|mesh-list
82972607|NCT01318070|Alogliptin|alogliptin|mesh-list
82972608|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82972609|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972610|NCT01318070|Incretins|incretins|mesh-ancestor
82972611|NCT01318070|Hormones|hormones|mesh-ancestor
82972612|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82972613|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82972614|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
82972615|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972616|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972617|NCT01202513|Bimatoprost|bimatoprost|mesh-list
82972618|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82972619|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82972620|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82972621|NCT03835715|Vortioxetine|vortioxetine|mesh-list
82972622|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
82972623|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82972624|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82972625|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82972627|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972628|NCT03835715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82972629|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82972630|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972631|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972632|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972633|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
82972634|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82972635|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82972636|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82972637|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82972638|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
82972639|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82972640|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82972641|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972642|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972643|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
82972644|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972645|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972646|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82972647|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972648|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82972649|NCT03843281|Acetaminophen|acetaminophen|mesh-list
82972650|NCT03843281|Morphine|morphine|mesh-list
82972651|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82972652|NCT03843281|Narcotics|narcotics|mesh-ancestor
82972653|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972654|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972655|NCT03843281|Analgesics|analgesics|mesh-ancestor
82972656|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
82972657|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972658|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82972659|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
82972660|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82972661|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
82972662|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972663|NCT03843515|Nivolumab|nivolumab|mesh-list
82972664|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972665|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972666|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82972667|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972668|NCT00245960|Etanercept|etanercept|mesh-list
82972669|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82972670|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82972671|NCT00245960|Analgesics|analgesics|mesh-ancestor
82972672|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
82972673|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972674|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972675|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972676|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972677|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972678|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972679|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
82972680|NCT04443322|Durvalumab|durvalumab|mesh-list
82972681|NCT04443322|Lenvatinib|lenvatinib|mesh-list
82972682|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82972683|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972684|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972685|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
82972686|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972687|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82972688|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972689|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972690|NCT01202825|Simeprevir|simeprevir|mesh-list
82972691|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
82972692|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972693|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
82972694|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972695|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972696|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82972697|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82972698|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972701|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82972702|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972703|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
82972704|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
82972705|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972706|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972707|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82972708|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
82972709|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
82972710|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82972711|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
82972712|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82972713|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
82972714|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972715|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972716|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
82972717|NCT05218616|Sunitinib|sunitinib|mesh-list
82972718|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972719|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82972720|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82972721|NCT05218616|Growth Substances|growth substances|mesh-ancestor
82972722|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972723|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
82972724|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82972725|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972726|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972727|NCT02505880|Anesthetics|anesthetics|mesh-list
82972728|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
82972729|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972730|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972731|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
82972732|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972733|NCT03215706|Paclitaxel|paclitaxel|mesh-list
82972734|NCT03215706|Carboplatin|carboplatin|mesh-list
82972735|NCT03215706|Nivolumab|nivolumab|mesh-list
82972736|NCT03215706|Pemetrexed|pemetrexed|mesh-list
83462479|NCT01202110|Propranolol|propranolol|mesh-list
82972737|NCT03215706|Ipilimumab|ipilimumab|mesh-list
82972738|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82972739|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972740|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
82972741|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
82972742|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
82972743|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83520779|NCT02624518|Hormones|hormones|mesh-ancestor
82972744|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972745|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82972747|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82972748|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82972749|NCT02510950|Temozolomide|temozolomide|mesh-list
82972750|NCT02510950|Poly ICLC|poly iclc|mesh-list
82972751|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82972752|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
82972753|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972754|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972755|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
82972756|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
82972757|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972758|NCT05221736|Ethanol|ethanol|mesh-list
82972759|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82972760|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972761|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972762|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972763|NCT05651594|Leucovorin|leucovorin|mesh-list
82972764|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
82972765|NCT05651594|Fluorouracil|fluorouracil|mesh-list
82972766|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
82972767|NCT05651594|Propranolol|propranolol|mesh-list
82972768|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972769|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972770|NCT05651594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82972771|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972772|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
82972774|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972775|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
82972776|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972777|NCT05651594|Antidotes|antidotes|mesh-ancestor
82972778|NCT05651594|Protective Agents|protective agents|mesh-ancestor
82972779|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
82972780|NCT05651594|Vitamins|vitamins|mesh-ancestor
82972781|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
82972782|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82972783|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82972784|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
82972785|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972786|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972787|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82972788|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
82972789|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
82972790|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82972791|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972792|NCT04454411|Naltrexone|naltrexone|mesh-list
82972793|NCT04454411|Buprenorphine|buprenorphine|mesh-list
82972794|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82972795|NCT04454411|Narcotics|narcotics|mesh-ancestor
82972796|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972797|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972798|NCT04454411|Analgesics|analgesics|mesh-ancestor
82972799|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
82972800|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972801|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82972802|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82972803|NCT02505568|Infliximab|infliximab|mesh-list
82972804|NCT02505568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82972805|NCT02505568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972806|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
82972807|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972808|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972809|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82972810|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82972811|NCT05217836|Hepcidins|hepcidins|mesh-list
82972812|NCT05217836|Chrysarobin|chrysarobin|mesh-list
82972813|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82972814|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82972815|NCT05217836|Analgesics|analgesics|mesh-ancestor
82972816|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
82972817|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972818|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972819|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972820|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82972821|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972822|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
82972823|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972824|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972825|NCT02514538|Acetaminophen|acetaminophen|mesh-list
82972826|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82972827|NCT02514538|Analgesics|analgesics|mesh-ancestor
82972828|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
82972829|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972830|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972831|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
82972832|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
82972833|NCT05669417|Analgesics|analgesics|mesh-ancestor
82972834|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
82972835|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972836|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972837|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
82972838|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972839|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972840|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
82972841|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82972842|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972843|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972844|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82972845|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
82972846|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972847|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
82972848|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82972849|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972850|NCT03832673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82972851|NCT03832673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972852|NCT02504944|Propranolol|propranolol|mesh-list
82972853|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82972854|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82972855|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82972856|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82972857|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
82972858|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972859|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972860|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972861|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82972862|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82972863|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
82972864|NCT01201499|Morphine|morphine|mesh-list
82972865|NCT01201499|Remifentanil|remifentanil|mesh-list
82972866|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82972867|NCT01201499|Narcotics|narcotics|mesh-ancestor
82972868|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972869|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972870|NCT01201499|Analgesics|analgesics|mesh-ancestor
82972871|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
82972872|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972873|NCT03473639|Capecitabine|capecitabine|mesh-list
82972874|NCT03473639|Entinostat|entinostat|mesh-list
82972875|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82972876|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
82972877|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972878|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972879|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82972880|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972881|NCT03121690|Prednisone|prednisone|mesh-list
82972882|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82972883|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
82972884|NCT03121690|Hormones|hormones|mesh-ancestor
82972885|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82972886|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972887|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82972889|NCT03831269|Azithromycin|azithromycin|mesh-list
82972890|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972891|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972892|NCT02504476|Midazolam|midazolam|mesh-list
82972893|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82972894|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82972895|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972896|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972897|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82972898|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82972899|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82972900|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82972901|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
82972902|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
82972903|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
82972904|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
82972905|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972906|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972907|NCT02504398|Methamphetamine|methamphetamine|mesh-list
82972908|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82972909|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972910|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
82972911|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
82972912|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82972913|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
82972914|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972915|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972916|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
82972917|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82972918|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82972919|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82972920|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82972921|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83462517|NCT02518750|Vincristine|vincristine|mesh-list
82972922|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82972923|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972924|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
82972925|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
82972926|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972927|NCT03830489|Protective Agents|protective agents|mesh-ancestor
82972928|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972929|NCT03830489|Vitamins|vitamins|mesh-ancestor
82972930|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
82972931|NCT02509468|Sirolimus|sirolimus|mesh-list
82972932|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82972933|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972934|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82972935|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972936|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
82972937|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82972938|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
82972939|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972940|NCT03344614|Apatinib|apatinib|mesh-list
82972941|NCT03344614|Raltitrexed|raltitrexed|mesh-list
82972942|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972943|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82972944|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972945|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972946|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82972947|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
82972948|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82972949|NCT01205087|Omeprazole|omeprazole|mesh-list
82972950|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82972951|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972952|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82972953|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972954|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972955|NCT01205243|Abacavir|abacavir|mesh-list
82972956|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82972957|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82972958|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972959|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972960|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
82972961|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82972962|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82972963|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82972964|NCT02504164|Midazolam|midazolam|mesh-list
82972965|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82972966|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82972967|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82972968|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972969|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82972970|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82972971|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82972972|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82972973|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
82972974|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
82972975|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
82972976|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
82972977|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972978|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972979|NCT02509234|Irinotecan|irinotecan|mesh-list
82972980|NCT02509234|Trabectedin|trabectedin|mesh-list
82972981|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82972982|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82972983|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82972984|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972985|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82972986|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82972987|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
82972988|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
82972989|NCT01205321|Bombesin|bombesin|mesh-list
82972990|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82972991|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82972992|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972993|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82972994|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
82972995|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82972996|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82972997|NCT03566485|Atezolizumab|atezolizumab|mesh-list
82972998|NCT03566485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82972999|NCT03566485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973000|NCT03566485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973001|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973002|NCT02513290|Loratadine|loratadine|mesh-list
82973003|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
82973004|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
82973005|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82973006|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82973007|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82973008|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
82973009|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
82973010|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973011|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973012|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973013|NCT02501200|Ezetimibe|ezetimibe|mesh-list
82973014|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82973015|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82973016|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
82973017|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973018|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82973019|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82973020|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973021|NCT02501278|Cisplatin|cisplatin|mesh-list
82973022|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973023|NCT03176238|Everolimus|everolimus|mesh-list
82973024|NCT03176238|Exemestane|exemestane|mesh-list
82973025|NCT03176238|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82973026|NCT03176238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973027|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973028|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973029|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973030|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
82973031|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973032|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973033|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82973034|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82973035|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82973036|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
82973037|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973038|NCT01957332|Trastuzumab|trastuzumab|mesh-list
82973039|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973040|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973041|NCT01205711|Leucovorin|leucovorin|mesh-list
82973042|NCT01205711|Fluorouracil|fluorouracil|mesh-list
82973043|NCT01205711|Irinotecan|irinotecan|mesh-list
82973044|NCT01205711|Calcium|calcium|mesh-list
82973045|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
82973046|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82973047|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973048|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
82973049|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973050|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82973051|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973052|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973053|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
82973054|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82973055|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82973056|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973057|NCT01205711|Antidotes|antidotes|mesh-ancestor
82973058|NCT01205711|Protective Agents|protective agents|mesh-ancestor
82973059|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
82973060|NCT01205711|Vitamins|vitamins|mesh-ancestor
82973061|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
82973062|NCT02508922|Vitamin D|vitamin d|mesh-list
82973063|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
82973064|NCT02508922|Vitamins|vitamins|mesh-ancestor
82973065|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
82973066|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973067|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82973068|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82973069|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
82973070|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973071|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973072|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973073|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973074|NCT03730675|Sorafenib|sorafenib|mesh-list
82973075|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973076|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973077|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973078|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973079|NCT01765140|Amifampridine|amifampridine|mesh-list
82973080|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82973081|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973082|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973083|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82973084|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82973085|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973086|NCT01345682|Methotrexate|methotrexate|mesh-list
82973087|NCT01345682|Afatinib|afatinib|mesh-list
82973088|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82973089|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
82973090|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82973091|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973092|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82973093|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
82973094|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973095|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973096|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
82973097|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973098|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82973099|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973100|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
82973101|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973102|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82973103|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973104|NCT03562117|Gepotidacin|gepotidacin|mesh-list
82973105|NCT03562117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82973106|NCT03562117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973107|NCT03562117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973108|NCT03562117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973109|NCT02503462|Ritonavir|ritonavir|mesh-list
82973110|NCT02503462|Darunavir|darunavir|mesh-list
82973111|NCT02503462|Cobicistat|cobicistat|mesh-list
82973112|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82973113|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82973114|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
82973115|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973116|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973117|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82973118|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82973119|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
82973120|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973121|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82973122|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82973123|NCT03343678|Venetoclax|venetoclax|mesh-list
82973124|NCT03343678|BI 836826|bi 836826|mesh-list
82973125|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973126|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973127|NCT05216822|Racecadotril|racecadotril|mesh-list
82973128|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
83462540|NCT02518750|Hormones|hormones|mesh-ancestor
82973129|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973130|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
82973131|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973132|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973133|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
82973134|NCT04498936|Ledipasvir|ledipasvir|mesh-list
82973135|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82973136|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
82973137|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
82973138|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973139|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82973140|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
82973141|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82973142|NCT03627260|Protective Agents|protective agents|mesh-ancestor
82973143|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973144|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
82973145|NCT05706038|Adalimumab|adalimumab|mesh-list
82973146|NCT05706038|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82973147|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973148|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973149|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
82973152|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973153|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973154|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82973155|NCT05126264|Ibuprofen|ibuprofen|mesh-list
82973156|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82973157|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82973158|NCT05126264|Analgesics|analgesics|mesh-ancestor
82973159|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
82973160|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973161|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973162|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973163|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973164|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82973165|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973166|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973167|NCT03001817|Fenofibrate|fenofibrate|mesh-list
82973168|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82973169|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
82973170|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973171|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82973172|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
82973173|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82973174|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82973175|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973176|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
82973177|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
82973178|NCT03590743|Apixaban|apixaban|mesh-list
82973179|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82973180|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
82973181|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82973182|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
82973183|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973184|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973185|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
82973186|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
82973187|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973188|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973190|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973191|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82973192|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
82973193|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973194|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
82973195|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82973196|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
82973197|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973198|NCT03121222|Expectorants|expectorants|mesh-ancestor
82973199|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
82973200|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82973201|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
82973202|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973203|NCT03121222|Protective Agents|protective agents|mesh-ancestor
82973204|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973205|NCT03121222|Antidotes|antidotes|mesh-ancestor
82973206|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
82973207|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82973208|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82973209|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82973210|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
82973211|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973212|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82973213|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82973214|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973215|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82973216|NCT05705804|Atorvastatin|atorvastatin|mesh-list
82973217|NCT05705804|Pitavastatin|pitavastatin|mesh-list
82973218|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82973219|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82973220|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
82973221|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973222|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82973223|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82973225|NCT03344302|Oxytocin|oxytocin|mesh-list
82973226|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
82973227|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82973228|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973229|NCT03545503|Ketamine|ketamine|mesh-list
82973230|NCT03545503|Etomidate|etomidate|mesh-list
82973231|NCT03545503|Analgesics|analgesics|mesh-ancestor
82973232|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
82973233|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973234|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973235|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82973236|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82973237|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
82973238|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
82973239|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973240|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82973241|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82973242|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973243|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973244|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82973245|NCT01297829|Ibuprofen|ibuprofen|mesh-list
82973246|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82973247|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82973248|NCT01297829|Analgesics|analgesics|mesh-ancestor
82973249|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
82973250|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973251|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973252|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973253|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973254|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82973255|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973256|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973257|NCT03829943|Vitamin D|vitamin d|mesh-list
82973258|NCT03829943|Vitamins|vitamins|mesh-ancestor
82973259|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
82973260|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973261|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82973262|NCT02508142|Scopolamine|scopolamine|mesh-list
82973263|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
82973264|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82973265|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
82973266|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
82973267|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973268|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973269|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973270|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
82973271|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82973272|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
82973273|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973274|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973275|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82973276|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
82973277|NCT02508220|Oxytocin|oxytocin|mesh-list
82973278|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
82973279|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82973280|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973281|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
82973282|NCT01297907|Miotics|miotics|mesh-ancestor
82973283|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
82973284|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973285|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973286|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82973287|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
82973288|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
82973289|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82973290|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82973291|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
82973292|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973293|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973294|NCT02508064|Fostemsavir|fostemsavir|mesh-list
82973295|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82973296|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82973297|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
82973298|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973299|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82973300|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82973301|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973302|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
82973303|NCT05705570|Fludarabine|fludarabine|mesh-list
82973304|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973305|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
82973306|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973307|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973308|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82973309|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
82973310|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973311|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973312|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82973313|NCT05670236|Lidocaine|lidocaine|mesh-list
82973314|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
82973315|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
82973316|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973317|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973318|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
82973319|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973320|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82973321|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82973322|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82973323|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82973324|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973325|NCT03214380|Insulin|insulin|mesh-list
82973326|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82973327|NCT03214380|Metformin|metformin|mesh-list
82973328|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
82973329|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
82973330|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82973331|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82973332|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973333|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973334|NCT04498234|Bupivacaine|bupivacaine|mesh-list
82973335|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
82973336|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
82973337|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973338|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973339|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
82973340|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973341|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
82973342|NCT03343444|Ledipasvir|ledipasvir|mesh-list
82973343|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
82973344|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973345|NCT03819101|Aspirin|aspirin|mesh-list
82973346|NCT03819101|Atorvastatin|atorvastatin|mesh-list
82973347|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82973348|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82973349|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
82973350|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973351|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82973352|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82973353|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973354|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82973355|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82973356|NCT03819101|Analgesics|analgesics|mesh-ancestor
82973357|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
82973358|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973359|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973360|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973361|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973362|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82973363|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82973364|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82973365|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82973366|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
82973367|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82973368|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
82973369|NCT05199324|Cefazolin|cefazolin|mesh-list
82973370|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
82973371|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
82973372|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
82973374|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
82973375|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973376|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82973377|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82973378|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973379|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973380|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973381|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82973382|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82973383|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82973384|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
82973385|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82973386|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82973387|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82973388|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82973389|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82973390|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82973391|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82973392|NCT03343366|Metronidazole|metronidazole|mesh-list
82973393|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973394|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82973395|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82973396|NCT01298297|Morphine|morphine|mesh-list
82973397|NCT01298297|Buprenorphine|buprenorphine|mesh-list
82973398|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82973399|NCT01298297|Narcotics|narcotics|mesh-ancestor
82973400|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973401|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973402|NCT01298297|Analgesics|analgesics|mesh-ancestor
82973403|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
82973404|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973405|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82973406|NCT03818945|Listerine|listerine|mesh-list
82973407|NCT03818945|Fluorides|fluorides|mesh-list
82973408|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
82973409|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
82973410|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
82973411|NCT03818945|Protective Agents|protective agents|mesh-ancestor
82973412|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973413|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82973414|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973415|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
82973416|NCT04300751|Narcotics|narcotics|mesh-ancestor
82973417|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973418|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973419|NCT04300751|Analgesics|analgesics|mesh-ancestor
82973420|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
82973421|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973422|NCT03842423|Anesthetics|anesthetics|mesh-list
82973423|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973424|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973425|NCT03172026|Maraviroc|maraviroc|mesh-list
82973426|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82973427|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82973428|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973429|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82973430|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82973431|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
82973432|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973433|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82973434|NCT01201577|Azithromycin|azithromycin|mesh-list
82973435|NCT01201577|Sulfalene|sulfalene|mesh-list
82973436|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82973437|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973438|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82973439|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
82973440|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82973441|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82973442|NCT04496050|Alprostadil|alprostadil|mesh-list
82973443|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82973444|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
82973445|NCT04496050|Urological Agents|urological agents|mesh-ancestor
82973446|NCT01300793|Rituximab|rituximab|mesh-list
82973447|NCT01300793|Carboplatin|carboplatin|mesh-list
82973448|NCT01300793|Etoposide|etoposide|mesh-list
82973449|NCT01300793|Bortezomib|bortezomib|mesh-list
82973450|NCT01300793|Ifosfamide|ifosfamide|mesh-list
82973452|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973453|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973454|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
82973455|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973456|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973457|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82973458|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82973459|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82973460|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973461|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973462|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82973463|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
82973464|NCT03342040|Bupivacaine|bupivacaine|mesh-list
82973465|NCT03342040|Ropivacaine|ropivacaine|mesh-list
82973466|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
82973467|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
82973468|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973469|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973470|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
82973471|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973472|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
82973473|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82973474|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973475|NCT03336970|Calcium|calcium|mesh-list
82973476|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82973477|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973478|NCT03336814|Terlipressin|terlipressin|mesh-list
82973479|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82973480|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82973481|NCT02495584|Vitamin D|vitamin d|mesh-list
82973482|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
82973483|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
82973484|NCT02495584|Vitamins|vitamins|mesh-list
82973485|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
82973486|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973487|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82973488|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82973489|NCT02495818|Lidocaine|lidocaine|mesh-list
82973490|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
82973491|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
82973492|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973493|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973494|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
82973495|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973496|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82973497|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82973498|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82973499|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82973500|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973501|NCT02495662|Prednisolone|prednisolone|mesh-list
82973502|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82973503|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
82973504|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82973505|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
82973506|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82973507|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
82973508|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973509|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
82973510|NCT02495662|Hormones|hormones|mesh-ancestor
82973511|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973512|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973513|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82973514|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973515|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
82973516|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
82973517|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973518|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973519|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82973520|NCT02495662|Protective Agents|protective agents|mesh-ancestor
82973521|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82973522|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82973523|NCT02496052|Estradiol|estradiol|mesh-list
82973524|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82973525|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
82973526|NCT02496052|Estrogens|estrogens|mesh-ancestor
82973527|NCT02496052|Hormones|hormones|mesh-ancestor
82973528|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973529|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973530|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82973531|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
82973532|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82973533|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82973534|NCT02496052|Progestins|progestins|mesh-ancestor
82973535|NCT01206569|Tacrolimus|tacrolimus|mesh-list
82973536|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973537|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
82973538|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973539|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82973540|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973541|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973542|NCT01206647|Metformin|metformin|mesh-list
82973543|NCT01206647|Saxagliptin|saxagliptin|mesh-list
82973544|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82973545|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973546|NCT01206647|Incretins|incretins|mesh-ancestor
82973547|NCT01206647|Hormones|hormones|mesh-ancestor
82973548|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973549|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82973550|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
82973551|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973552|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973553|NCT03341884|Ipatasertib|ipatasertib|mesh-list
82973554|NCT03341884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973555|NCT03341884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973556|NCT03341884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973557|NCT03341884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973558|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
82973559|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82973560|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
82973561|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973562|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973563|NCT02495272|Oxytocin|oxytocin|mesh-list
82973564|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
82973565|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82973566|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973567|NCT03336346|Efavirenz|efavirenz|mesh-list
82973568|NCT03336346|Dolutegravir|dolutegravir|mesh-list
82973569|NCT03336346|Etonogestrel|etonogestrel|mesh-list
82973570|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82973571|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82973572|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973573|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973574|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
82973575|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973576|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82973577|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82973578|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82973579|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82973580|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82973581|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82973582|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82973583|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82973584|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82973585|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82973586|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82973587|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
82973588|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82973589|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973590|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82973591|NCT03841292|Varenicline|varenicline|mesh-list
82973592|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82973593|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82973594|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
82973595|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973596|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973597|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973598|NCT03814577|Antioxidants|antioxidants|mesh-list
82973599|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973600|NCT03814577|Protective Agents|protective agents|mesh-ancestor
82973601|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973602|NCT03730363|Pentamidine|pentamidine|mesh-list
82973603|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
82973604|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973605|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82973606|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82973607|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82973608|NCT01206803|Ganirelix|ganirelix|mesh-list
82973609|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
82973610|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973611|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973612|NCT03335956|Pioglitazone|pioglitazone|mesh-list
82973613|NCT03335956|Prednisone|prednisone|mesh-list
82973614|NCT03335956|Cortisone|cortisone|mesh-list
82973615|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973616|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
82973617|NCT03335956|Hormones|hormones|mesh-ancestor
82973618|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973619|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973620|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82973621|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973622|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82973623|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
82973624|NCT03817931|Mirabegron|mirabegron|mesh-list
82973625|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
82973626|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
82973627|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
82973628|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
82973629|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82973630|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
82973631|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973632|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973633|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973634|NCT03817931|Urological Agents|urological agents|mesh-ancestor
82973635|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82973636|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
82973637|NCT01206881|Docetaxel|docetaxel|mesh-list
82973638|NCT01206881|Doxorubicin|doxorubicin|mesh-list
82973639|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82973640|NCT01206881|Trastuzumab|trastuzumab|mesh-list
82973641|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973642|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
82973643|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973644|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973645|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82973646|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
82973647|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973648|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973649|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82973650|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
82973651|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
82973652|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
82973653|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82973654|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82973655|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82973656|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973657|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973658|NCT02494804|Temozolomide|temozolomide|mesh-list
82973659|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82973660|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
82973661|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973662|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973663|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82973664|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
82973665|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973666|NCT03814343|Amphotericin B|amphotericin b|mesh-list
82973667|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82973668|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82973669|NCT03814343|Amebicides|amebicides|mesh-ancestor
82973670|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82973671|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82973672|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973673|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82973674|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
82973676|NCT03814343|Protective Agents|protective agents|mesh-ancestor
82973677|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973678|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82973679|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
82973680|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973681|NCT03817541|Propofol|propofol|mesh-list
82973682|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82973683|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973684|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973685|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82973686|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
82973687|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
82973688|NCT03341494|Thalidomide|thalidomide|mesh-list
82973689|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973690|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
82973691|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973692|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
82973693|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82973694|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973695|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82973696|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82973697|NCT03341494|Growth Substances|growth substances|mesh-ancestor
82973698|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
82973699|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973700|NCT03586609|Cytarabine|cytarabine|mesh-list
82973701|NCT03586609|Azacitidine|azacitidine|mesh-list
82973702|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
82973703|NCT03586609|Venetoclax|venetoclax|mesh-list
82973704|NCT03586609|Cladribine|cladribine|mesh-list
82973705|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82973706|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
82973707|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973708|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973709|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
82973710|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973711|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973712|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
82973713|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973714|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973715|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82973716|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
82973717|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973718|NCT03725995|Lidocaine|lidocaine|mesh-list
82973719|NCT03725995|Midazolam|midazolam|mesh-list
82973720|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
82973721|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
82973722|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973723|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973724|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
82973725|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973726|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82973727|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82973728|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82973729|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82973730|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973731|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82973732|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82973733|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82973734|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82973735|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82973736|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82973737|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
82973738|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
82973739|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
82973740|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973741|NCT03341260|Diclofenac|diclofenac|mesh-list
82973742|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82973743|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82973744|NCT03341260|Analgesics|analgesics|mesh-ancestor
82973745|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
82973746|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973747|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973748|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973749|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973750|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82973751|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973752|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973753|NCT03052400|Mifepristone|mifepristone|mesh-list
82973754|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82973755|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
82973756|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82973757|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973758|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82973759|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82973760|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82973761|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
82973762|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82973763|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82973764|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
82973765|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973766|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
82973767|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82973768|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82973769|NCT03341104|Bupivacaine|bupivacaine|mesh-list
82973770|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
82973771|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
82973772|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973773|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973774|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
82973775|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973776|NCT03335098|Thalidomide|thalidomide|mesh-list
82973777|NCT03335098|Dexamethasone|dexamethasone|mesh-list
82973778|NCT03335098|Bortezomib|bortezomib|mesh-list
82973779|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973780|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
82973781|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
82973782|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973783|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973784|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973785|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
82973786|NCT03335098|Hormones|hormones|mesh-ancestor
83133555|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973787|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973788|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82973789|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973790|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973791|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
82973792|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
82973793|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82973794|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973795|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82973796|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82973797|NCT03335098|Growth Substances|growth substances|mesh-ancestor
82973798|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
82973800|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82973801|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82973802|NCT03639571|Analgesics|analgesics|mesh-ancestor
82973803|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
82973804|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973805|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973806|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973807|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973808|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82973809|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973810|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973811|NCT03052322|Adalimumab|adalimumab|mesh-list
82973812|NCT03052322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82973813|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973814|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973815|NCT03722173|Itraconazole|itraconazole|mesh-list
82973816|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
82973817|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82973818|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82973819|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82973820|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973821|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973822|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82973823|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
82973824|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973826|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82973827|NCT03521791|Bromfenac|bromfenac|mesh-list
82973828|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82973829|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82973830|NCT03521791|Analgesics|analgesics|mesh-ancestor
82973831|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
82973832|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973833|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973834|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82973835|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973836|NCT03521635|Pramipexole|pramipexole|mesh-list
82973837|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
82973838|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973839|NCT03521635|Protective Agents|protective agents|mesh-ancestor
82973840|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973841|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82973842|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82973843|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
82973844|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
82973845|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82973846|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
82973847|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82973848|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973849|NCT03813641|Capecitabine|capecitabine|mesh-list
82973850|NCT03813641|Raltitrexed|raltitrexed|mesh-list
82973851|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82973852|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
82973853|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973854|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973855|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82973856|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973857|NCT02492464|Red yeast rice|red yeast rice|mesh-list
82973858|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82973859|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82973860|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82973861|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
82973862|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973863|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973864|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82973865|NCT05255159|Furosemide|furosemide|mesh-list
82973866|NCT05255159|Diuretics|diuretics|mesh-ancestor
82973867|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
82973868|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973869|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82973870|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82973871|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973872|NCT03340558|Atezolizumab|atezolizumab|mesh-list
82973873|NCT03340558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82973874|NCT03340558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973875|NCT03340558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973876|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973877|NCT04905108|Riboflavin|riboflavin|mesh-list
82973878|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
82973879|NCT04905108|Vitamins|vitamins|mesh-ancestor
82973880|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
82973881|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973882|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82973883|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
82973884|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
82973885|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82973886|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
82973887|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973888|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
82973889|NCT04443166|Protective Agents|protective agents|mesh-ancestor
82973890|NCT01560221|Buprenorphine|buprenorphine|mesh-list
82973891|NCT01560221|Methadone|methadone|mesh-list
82973892|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82973893|NCT01560221|Narcotics|narcotics|mesh-ancestor
82973894|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973895|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973896|NCT01560221|Analgesics|analgesics|mesh-ancestor
82973897|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
82973898|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973899|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82973900|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
82973901|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
82973902|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
82973903|NCT03813329|Calcium|calcium|mesh-list
82973904|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82973905|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973906|NCT03813329|Antacids|antacids|mesh-ancestor
82973907|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973908|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973909|NCT03639415|Oxycodone|oxycodone|mesh-list
82973910|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82973911|NCT03639415|Narcotics|narcotics|mesh-ancestor
82973912|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82973913|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973914|NCT03639415|Analgesics|analgesics|mesh-ancestor
82973915|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
83462663|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973916|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973917|NCT02492386|Everolimus|everolimus|mesh-list
82973918|NCT02492386|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82973919|NCT02492386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973920|NCT02492386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973921|NCT02492386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973922|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973923|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
82973924|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973925|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973926|NCT03340168|Bisphenol A|bisphenol a|mesh-list
82973927|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82973928|NCT03340168|Estrogens|estrogens|mesh-ancestor
82973929|NCT03340168|Hormones|hormones|mesh-ancestor
82973930|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82973931|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973932|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82973933|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
82973934|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973935|NCT03340168|Protective Agents|protective agents|mesh-ancestor
82973936|NCT01299701|Vadimezan|vadimezan|mesh-list
82973937|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973938|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82973939|NCT01299779|Laxatives|laxatives|mesh-ancestor
82973940|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973941|NCT03812939|Octreotide|octreotide|mesh-list
82973942|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973943|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82973944|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973945|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
82973946|NCT03339700|Busulfan|busulfan|mesh-list
82973947|NCT03339700|Gemcitabine|gemcitabine|mesh-list
82973948|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973949|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
82973950|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973951|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973952|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82973953|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
82973954|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973955|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973956|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82973957|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82973958|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
82973959|NCT05661149|Insulin|insulin|mesh-list
82973960|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82973961|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973962|NCT01299857|Rituximab|rituximab|mesh-list
82973963|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973964|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973965|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
82973966|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973967|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973968|NCT03478969|Insulin|insulin|mesh-list
82973969|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82973970|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973971|NCT03812783|Sorafenib|sorafenib|mesh-list
82973972|NCT03812783|Folfirinox|folfirinox|mesh-list
82973973|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973974|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82973975|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82973976|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973977|NCT02500498|Abatacept|abatacept|mesh-list
82973978|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82973979|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973980|NCT02500498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82973981|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82973982|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82973983|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
82973984|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973985|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82973986|NCT05644223|Edaravone|edaravone|mesh-list
82973987|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82973988|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
82973989|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82973990|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82973991|NCT05644223|Protective Agents|protective agents|mesh-ancestor
82973992|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973993|NCT02500108|Domperidone|domperidone|mesh-list
82973994|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
82973995|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
82973996|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82973997|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82973998|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82973999|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82974000|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
82974001|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974002|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974003|NCT02499874|Tenofovir|tenofovir|mesh-list
82974004|NCT02499874|Lamivudine|lamivudine|mesh-list
82974005|NCT02499874|Emtricitabine|emtricitabine|mesh-list
82974006|NCT02499874|Zidovudine|zidovudine|mesh-list
82974007|NCT02499874|Efavirenz|efavirenz|mesh-list
82974008|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
82974009|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
82974010|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974011|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82974012|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82974013|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974014|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974015|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82974016|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82974017|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
82974018|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82974019|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82974020|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82974021|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82974022|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82974023|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82974024|NCT02492308|Basiliximab|basiliximab|mesh-list
82974025|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974026|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
82974027|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974028|NCT05865470|Dronabinol|dronabinol|mesh-list
82974029|NCT05865470|Hallucinogens|hallucinogens|mesh-ancestor
82974030|NCT05865470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974031|NCT05865470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82974032|NCT05865470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82974033|NCT05865470|Analgesics|analgesics|mesh-ancestor
82974034|NCT05865470|Sensory System Agents|sensory system agents|mesh-ancestor
82974035|NCT05865470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974036|NCT05865470|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82974037|NCT05865470|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82974038|NCT05865470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974039|NCT05865470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974040|NCT05865470|Hormones|hormones|mesh-ancestor
82974041|NCT05865470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974042|NCT05865431|Zinc Oxide|zinc oxide|mesh-list
82974043|NCT05865431|Avobenzone|avobenzone|mesh-list
82974044|NCT05865431|Dermatologic Agents|dermatologic agents|mesh-ancestor
82974045|NCT05865431|Sunscreening Agents|sunscreening agents|mesh-ancestor
82974046|NCT05865431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82974047|NCT05865431|Protective Agents|protective agents|mesh-ancestor
82974048|NCT05865431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974049|NCT05865288|Oxytocin|oxytocin|mesh-list
82974050|NCT05865288|Oxytocics|oxytocics|mesh-ancestor
82974051|NCT05865288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82974052|NCT05865288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974053|NCT05865132|Palbociclib|palbociclib|mesh-list
82974054|NCT05865132|Afatinib|afatinib|mesh-list
82974055|NCT05865132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974056|NCT05865132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82974057|NCT05865132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974058|NCT05865132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974059|NCT05864885|Minoxidil|minoxidil|mesh-list
82974060|NCT05864885|Latanoprost|latanoprost|mesh-list
82974061|NCT05864885|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82974062|NCT05864885|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82974063|NCT05864885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82974064|NCT05864885|Vasodilator Agents|vasodilator agents|mesh-ancestor
82974065|NCT05864742|Rituximab|rituximab|mesh-list
82974066|NCT05864742|Venetoclax|venetoclax|mesh-list
82974067|NCT05864742|Navitoclax|navitoclax|mesh-list
82974068|NCT05864742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974069|NCT05864742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974070|NCT05864742|Immunologic Factors|immunologic factors|mesh-ancestor
82974071|NCT05864742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974072|NCT05864742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974073|NCT05864677|Cerebrolysin|cerebrolysin|mesh-list
82974074|NCT05864677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82974075|NCT05864677|Protective Agents|protective agents|mesh-ancestor
82974076|NCT05864677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974077|NCT05864677|Nootropic Agents|nootropic agents|mesh-ancestor
82974078|NCT05864664|Anesthetics|anesthetics|mesh-list
82974079|NCT05864664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974080|NCT05864664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974081|NCT05864508|Oxytocin|oxytocin|mesh-list
82974082|NCT05864508|Oxytocics|oxytocics|mesh-ancestor
82974083|NCT05864508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82974084|NCT05864508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974085|NCT05864417|Sunscreening Agents|sunscreening agents|mesh-list
82974086|NCT05864417|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82974087|NCT05864417|Protective Agents|protective agents|mesh-ancestor
82974088|NCT05864417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974089|NCT05864417|Dermatologic Agents|dermatologic agents|mesh-ancestor
82974090|NCT05864209|Bisphenol A|bisphenol a|mesh-list
82974091|NCT05864209|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82974092|NCT05864209|Estrogens|estrogens|mesh-ancestor
82974094|NCT05864209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974095|NCT05864209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974096|NCT05864209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82974097|NCT05864209|Antioxidants|antioxidants|mesh-ancestor
82974098|NCT05864209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974099|NCT05864209|Protective Agents|protective agents|mesh-ancestor
82974100|NCT05864118|Antibodies|antibodies|mesh-list
82974101|NCT05864118|Immunologic Factors|immunologic factors|mesh-ancestor
82974102|NCT05864118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974103|NCT05864053|Ketamine|ketamine|mesh-list
82974104|NCT05864053|Analgesics|analgesics|mesh-ancestor
82974105|NCT05864053|Sensory System Agents|sensory system agents|mesh-ancestor
82974106|NCT05864053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974107|NCT05864053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974108|NCT05864053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82974109|NCT05864053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82974110|NCT05864053|Anesthetics, General|anesthetics, general|mesh-ancestor
82974111|NCT05864053|Anesthetics|anesthetics|mesh-ancestor
82974112|NCT05864053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974113|NCT05864053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82974114|NCT05864053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82974115|NCT05864053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974116|NCT05864053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974117|NCT05863975|Interferons|interferons|mesh-list
82974118|NCT05863975|Interferon-alpha|interferon-alpha|mesh-list
82974119|NCT05863975|Interferon alpha-2|interferon alpha-2|mesh-list
82974120|NCT05863975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974121|NCT05863975|Antiviral Agents|antiviral agents|mesh-ancestor
82974122|NCT05863975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974123|NCT05863975|Immunologic Factors|immunologic factors|mesh-ancestor
82974124|NCT05863975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974125|NCT05863949|Vitamin D|vitamin d|mesh-list
82974126|NCT05863949|Calcium|calcium|mesh-list
82974127|NCT05863949|Vitamins|vitamins|mesh-ancestor
82974128|NCT05863949|Micronutrients|micronutrients|mesh-ancestor
82974129|NCT05863949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974130|NCT05863949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82974131|NCT05863949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82974132|NCT05863936|Methylprednisolone|methylprednisolone|mesh-list
82974133|NCT05863936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82974134|NCT05863936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82974135|NCT05863936|Prednisolone|prednisolone|mesh-list
82974136|NCT05863936|Prednisolone acetate|prednisolone acetate|mesh-list
82974137|NCT05863936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82974138|NCT05863936|Prednisolone phosphate|prednisolone phosphate|mesh-list
82974139|NCT05863936|Belimumab|belimumab|mesh-list
82974140|NCT05863936|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82974141|NCT05863936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974142|NCT05863936|Antiemetics|antiemetics|mesh-ancestor
82974143|NCT05863936|Autonomic Agents|autonomic agents|mesh-ancestor
82974144|NCT05863936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974145|NCT05863936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974146|NCT05863936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82974147|NCT05863936|Glucocorticoids|glucocorticoids|mesh-ancestor
82974148|NCT05863936|Hormones|hormones|mesh-ancestor
82974149|NCT05863936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974150|NCT05863936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82974151|NCT05863936|Protective Agents|protective agents|mesh-ancestor
82974152|NCT05863936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974153|NCT05863936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974154|NCT05863936|Immunologic Factors|immunologic factors|mesh-ancestor
82974155|NCT05863858|Amoxicillin|amoxicillin|mesh-list
82974156|NCT05863858|Moxifloxacin|moxifloxacin|mesh-list
82974157|NCT05863858|Levofloxacin|levofloxacin|mesh-list
82974158|NCT05863858|Ofloxacin|ofloxacin|mesh-list
82974159|NCT05863858|Tinidazole|tinidazole|mesh-list
82974160|NCT05863858|Omeprazole|omeprazole|mesh-list
82974161|NCT05863858|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82974162|NCT05863858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82974163|NCT05863858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974164|NCT05863858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82974165|NCT05863858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82974166|NCT05863858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974167|NCT05863858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974168|NCT05863858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974169|NCT05863858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82974170|NCT05863858|Contraceptive Agents|contraceptive agents|mesh-ancestor
82974171|NCT05863858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82974172|NCT05863858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974173|NCT05863858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82974174|NCT05863858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82974175|NCT05863858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82974176|NCT05863858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82974177|NCT05863858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82974178|NCT05863858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82974179|NCT05863858|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82974180|NCT05863858|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82974181|NCT05863858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82974182|NCT05863858|Alkylating Agents|alkylating agents|mesh-ancestor
82974183|NCT05863858|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82974184|NCT05863858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82974185|NCT05863858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82974187|NCT05863845|Etoposide|etoposide|mesh-list
82974188|NCT05863845|Melphalan|melphalan|mesh-list
82974189|NCT05863845|Venetoclax|venetoclax|mesh-list
82974190|NCT05863845|Carmustine|carmustine|mesh-list
82974191|NCT05863845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82974192|NCT05863845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974193|NCT05863845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82974194|NCT05863845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82974195|NCT05863845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974196|NCT05863845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974197|NCT05863845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82974198|NCT05863845|Antimetabolites|antimetabolites|mesh-ancestor
82974199|NCT05863845|Antiviral Agents|antiviral agents|mesh-ancestor
82974200|NCT05863845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974201|NCT05863845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974202|NCT05863845|Immunologic Factors|immunologic factors|mesh-ancestor
82974203|NCT05863845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974204|NCT05863845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82974205|NCT05863845|Alkylating Agents|alkylating agents|mesh-ancestor
82974206|NCT05863845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82974207|NCT05863832|Metronidazole|metronidazole|mesh-list
82974208|NCT05863832|Ciprofloxacin|ciprofloxacin|mesh-list
82974209|NCT05863832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974210|NCT05863832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82974211|NCT05863832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82974212|NCT05863832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82974213|NCT05863832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82974214|NCT05863832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82974215|NCT05863832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974216|NCT05863832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974217|NCT05863832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974218|NCT05863832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82974219|NCT05863832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82974220|NCT05863585|MEDI9197|medi9197|mesh-list
82974221|NCT05863585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82974222|NCT05863585|Immunologic Factors|immunologic factors|mesh-ancestor
82974223|NCT05863585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974224|NCT05863455|Midazolam|midazolam|mesh-list
82974225|NCT05863455|Sufentanil|sufentanil|mesh-list
82974226|NCT05863455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82974227|NCT05863455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82974228|NCT05863455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974229|NCT05863455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974230|NCT05863455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82974231|NCT05863455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82974232|NCT05863455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82974233|NCT05863455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82974234|NCT05863455|Anesthetics, General|anesthetics, general|mesh-ancestor
82974235|NCT05863455|Anesthetics|anesthetics|mesh-ancestor
82974236|NCT05863455|GABA Modulators|gaba modulators|mesh-ancestor
82974237|NCT05863455|GABA Agents|gaba agents|mesh-ancestor
82974238|NCT05863455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974239|NCT05863455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974240|NCT05863455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82974241|NCT05863455|Narcotics|narcotics|mesh-ancestor
82974242|NCT05863455|Analgesics|analgesics|mesh-ancestor
82974243|NCT05863455|Sensory System Agents|sensory system agents|mesh-ancestor
82974244|NCT05863455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974245|NCT05863442|Eculizumab|eculizumab|mesh-list
82974246|NCT05863442|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82974247|NCT05863442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974248|NCT05863442|Immunologic Factors|immunologic factors|mesh-ancestor
82974249|NCT05863442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974250|NCT05863416|Dexmedetomidine|dexmedetomidine|mesh-list
82974251|NCT05863416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82974252|NCT05863416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974253|NCT05863416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974254|NCT05863416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82974255|NCT05863416|Analgesics|analgesics|mesh-ancestor
82974256|NCT05863416|Sensory System Agents|sensory system agents|mesh-ancestor
82974257|NCT05863416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974258|NCT05863416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82974259|NCT05863416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82974260|NCT05863416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82974261|NCT05863416|Adrenergic Agents|adrenergic agents|mesh-ancestor
82974262|NCT05863416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974263|NCT05863416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974264|NCT05863364|Rifaximin|rifaximin|mesh-list
82974265|NCT05863364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82974266|NCT05863364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974267|NCT05863364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82974268|NCT05863325|Docetaxel|docetaxel|mesh-list
82974269|NCT05863325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974270|NCT05863325|Tubulin Modulators|tubulin modulators|mesh-ancestor
82974271|NCT05863325|Antimitotic Agents|antimitotic agents|mesh-ancestor
82974272|NCT05863325|Mitosis Modulators|mitosis modulators|mesh-ancestor
82974273|NCT05863325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974274|NCT05863312|Temazepam|temazepam|mesh-list
82974275|NCT05863312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82974276|NCT05863312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974277|NCT05863312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974278|NCT05863312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82974279|NCT05863312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82974280|NCT05863312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82974281|NCT05863312|GABA Modulators|gaba modulators|mesh-ancestor
82974282|NCT05863312|GABA Agents|gaba agents|mesh-ancestor
82974283|NCT05863312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974284|NCT05863312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974285|NCT05863273|Apremilast|apremilast|mesh-list
82974286|NCT05863273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82974287|NCT05863273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82974288|NCT05863273|Analgesics|analgesics|mesh-ancestor
82974289|NCT05863273|Sensory System Agents|sensory system agents|mesh-ancestor
82974290|NCT05863273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974291|NCT05863273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974292|NCT05863273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974293|NCT05863273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974294|NCT05863273|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82974295|NCT05863273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82974296|NCT05863273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974297|NCT05863273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974298|NCT05862272|Relugolix|relugolix|mesh-list
82974299|NCT05862272|Androgen Antagonists|androgen antagonists|mesh-ancestor
82974300|NCT05862272|Hormone Antagonists|hormone antagonists|mesh-ancestor
82974301|NCT05862272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974302|NCT05862272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974303|NCT05862233|Cyclosporine|cyclosporine|mesh-list
82974304|NCT05862233|Cyclosporins|cyclosporins|mesh-list
82974305|NCT05862233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974306|NCT05862233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974307|NCT05862233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974308|NCT05862233|Immunologic Factors|immunologic factors|mesh-ancestor
82974309|NCT05862233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974310|NCT05862233|Antifungal Agents|antifungal agents|mesh-ancestor
82974311|NCT05862233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974312|NCT05862233|Dermatologic Agents|dermatologic agents|mesh-ancestor
82974313|NCT05862233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974314|NCT05862233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82974315|NCT05860998|Antibodies|antibodies|mesh-list
82974316|NCT05860998|Immunoglobulin G|immunoglobulin g|mesh-list
82974317|NCT05860998|Immunologic Factors|immunologic factors|mesh-ancestor
82974318|NCT05860998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974319|NCT05860452|Ropivacaine|ropivacaine|mesh-list
82974320|NCT05860452|Anesthetics, Local|anesthetics, local|mesh-ancestor
82974321|NCT05860452|Anesthetics|anesthetics|mesh-ancestor
82974322|NCT05860452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974323|NCT05860452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974324|NCT05860452|Sensory System Agents|sensory system agents|mesh-ancestor
82974325|NCT05860452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974326|NCT05856500|Curcumin|curcumin|mesh-list
82974327|NCT05856500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82974328|NCT05856500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82974329|NCT05856500|Analgesics|analgesics|mesh-ancestor
82974330|NCT05856500|Sensory System Agents|sensory system agents|mesh-ancestor
82974331|NCT05856500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974332|NCT05856500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974333|NCT05856500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974334|NCT05856500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974335|NCT05856500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974336|NCT05856500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974337|NCT05856500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974338|NCT05850520|Aflibercept|aflibercept|mesh-list
83462697|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
82974339|NCT05850520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82974340|NCT05850520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82974341|NCT05850520|Growth Substances|growth substances|mesh-ancestor
82974342|NCT05850520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974343|NCT05850520|Growth Inhibitors|growth inhibitors|mesh-ancestor
82974344|NCT05850520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974345|NCT05849779|Sevoflurane|sevoflurane|mesh-list
82974346|NCT05849779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82974347|NCT05849779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82974348|NCT05849779|Anesthetics, General|anesthetics, general|mesh-ancestor
82974349|NCT05849779|Anesthetics|anesthetics|mesh-ancestor
82974350|NCT05849779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974351|NCT05849779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974352|NCT05847517|Metoprolol|metoprolol|mesh-list
82974353|NCT05847517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82974354|NCT05847517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82974355|NCT05847517|Sympatholytics|sympatholytics|mesh-ancestor
82974356|NCT05847517|Autonomic Agents|autonomic agents|mesh-ancestor
82974357|NCT05847517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974358|NCT05847517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974359|NCT05847517|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82974360|NCT05847517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82974361|NCT05847517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82974362|NCT05847517|Adrenergic Agents|adrenergic agents|mesh-ancestor
82974363|NCT05847517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974364|NCT05847517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974365|NCT05837104|Vitamin B 6|vitamin b 6|mesh-list
82974366|NCT05837104|Pyridoxal|pyridoxal|mesh-list
82974367|NCT05837104|Pyridoxine|pyridoxine|mesh-list
82974368|NCT05837104|Vitamins|vitamins|mesh-ancestor
82974369|NCT05837104|Micronutrients|micronutrients|mesh-ancestor
82974370|NCT05837104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974371|NCT05837104|Vitamin B Complex|vitamin b complex|mesh-ancestor
82974372|NCT05828303|Metformin|metformin|mesh-list
82974373|NCT05828303|Digoxin|digoxin|mesh-list
82974374|NCT05828303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82974375|NCT05828303|Calcium|calcium|mesh-list
82974376|NCT05828303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82974377|NCT05828303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974378|NCT05828303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82974379|NCT05828303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82974380|NCT05828303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82974381|NCT05828303|Antimetabolites|antimetabolites|mesh-ancestor
82974382|NCT05828303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974383|NCT05828303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82974384|NCT05828303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82974385|NCT05828303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974386|NCT05828303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82974387|NCT05828303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82974388|NCT05828303|Protective Agents|protective agents|mesh-ancestor
82974389|NCT05821309|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
82974390|NCT05821309|Glycerol|glycerol|mesh-list
82974391|NCT05821309|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82974392|NCT05821309|Protective Agents|protective agents|mesh-ancestor
82974393|NCT05821309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974394|NCT05821309|Laxatives|laxatives|mesh-ancestor
82974395|NCT05821309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82974396|NCT05801705|Tamoxifen|tamoxifen|mesh-list
82974397|NCT05801705|Toremifene|toremifene|mesh-list
82974398|NCT05801705|Hormones|hormones|mesh-list
82974399|NCT05801705|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82974400|NCT05801705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974401|NCT05801705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974402|NCT05801705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82974403|NCT05801705|Hormone Antagonists|hormone antagonists|mesh-ancestor
82974404|NCT05801705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974405|NCT05801705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974406|NCT05801705|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82974407|NCT05801705|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82974408|NCT05801705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82974409|NCT05801705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82974410|NCT05801705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974411|NCT05801705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974412|NCT05780216|Harmine|harmine|mesh-list
82974413|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
82974414|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974415|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82974416|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82974417|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974418|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974419|NCT05778617|Ambroxol|ambroxol|mesh-list
82974420|NCT05778617|Expectorants|expectorants|mesh-ancestor
82974421|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
82974422|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
82974423|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82974424|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
82974425|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974426|NCT05756153|Cetuximab|cetuximab|mesh-list
82974427|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974428|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974429|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
82974430|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974432|NCT05743777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974433|NCT05743777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974434|NCT05701007|Docetaxel|docetaxel|mesh-list
82974435|NCT05701007|Goserelin|goserelin|mesh-list
82974436|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82974437|NCT05701007|Leuprolide|leuprolide|mesh-list
82974438|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974439|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
82974440|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
82974441|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
82974442|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974443|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974444|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
82974445|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82974446|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
82974447|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82974448|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974449|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82974450|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82974451|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
82974452|NCT05688475|Dexamethasone|dexamethasone|mesh-list
82974453|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974454|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
82974455|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
82974456|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974457|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974458|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82974459|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
82974460|NCT05688475|Hormones|hormones|mesh-ancestor
82974461|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974462|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974463|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974464|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
82974465|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
83520856|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
82974466|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974468|NCT05676203|Androgens|androgens|mesh-list
82974469|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974470|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
82974471|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
82974472|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
82974473|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974474|NCT05676203|Hormones|hormones|mesh-ancestor
82974475|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974476|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974477|NCT05673928|Trastuzumab|trastuzumab|mesh-list
82974478|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82974479|NCT05673928|Maytansine|maytansine|mesh-list
82974480|NCT05673928|Tucatinib|tucatinib|mesh-list
83462708|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
82974481|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974482|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974483|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82974484|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
82974485|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
82974486|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
82974487|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974488|NCT05673928|Immunotoxins|immunotoxins|mesh-ancestor
82974489|NCT05673928|Immunoconjugates|immunoconjugates|mesh-ancestor
82974490|NCT05673928|Immunologic Factors|immunologic factors|mesh-ancestor
82974491|NCT05673928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974492|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82974493|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974494|NCT05659537|Dulaglutide|dulaglutide|mesh-list
82974495|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82974496|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974497|NCT05615779|Levan|levan|mesh-list
82974498|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974499|NCT05615220|Ecopipam|ecopipam|mesh-list
82974500|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82974501|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82974502|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974503|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974504|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82974505|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82974506|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
82974507|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974508|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974509|NCT05591092|Iodine|iodine|mesh-list
82974510|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
82974511|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82974512|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974513|NCT05591092|Trace Elements|trace elements|mesh-ancestor
82974514|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
82974515|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974516|NCT05580003|Moxifloxacin|moxifloxacin|mesh-list
82974517|NCT05580003|Midazolam|midazolam|mesh-list
82974518|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82974519|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82974520|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974521|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974522|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82974523|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82974524|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82974525|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82974526|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
82974527|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
82974528|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
82974529|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
82974530|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82974531|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974532|NCT05580003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82974533|NCT05580003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974534|NCT05580003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82974535|NCT05580003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82974536|NCT05580003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974537|NCT05580003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974538|NCT05562466|Budesonide|budesonide|mesh-list
82974539|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974540|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82974541|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
82974542|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974543|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974544|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82974545|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
82974546|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
82974547|NCT05562466|Hormones|hormones|mesh-ancestor
82974548|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974549|NCT05553834|Cemiplimab|cemiplimab|mesh-list
82974550|NCT05553834|Alirocumab|alirocumab|mesh-list
82974551|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974552|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974553|NCT05553834|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82974554|NCT05553834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82974555|NCT05553834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82974556|NCT05553834|Antimetabolites|antimetabolites|mesh-ancestor
82974557|NCT05553834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974558|NCT05553834|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82974559|NCT05553834|Protease Inhibitors|protease inhibitors|mesh-ancestor
82974560|NCT05553834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974561|NCT05553834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82974562|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82974563|NCT05548283|Lactams|lactams|mesh-list
82974564|NCT05548283|beta-Lactams|beta-lactams|mesh-list
82974565|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974566|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
82974567|NCT05513560|Ibudilast|ibudilast|mesh-list
82974568|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82974569|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974570|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974571|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82974572|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82974573|NCT05513560|Protective Agents|protective agents|mesh-ancestor
82974574|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974575|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
82974576|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82974577|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
82974578|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82974579|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
82974580|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974581|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82974582|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
82974596|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82974597|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82974598|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974599|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974600|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82974601|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974602|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974603|NCT05435547|Dexamethasone|dexamethasone|mesh-list
82974604|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974605|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
82974606|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
82974607|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974608|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974609|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82974610|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
82974611|NCT05435547|Hormones|hormones|mesh-ancestor
82974612|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974613|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974614|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974615|NCT05422131|Clozapine|clozapine|mesh-list
82974616|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82974617|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
82974618|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83462715|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
82974619|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974620|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974621|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82974622|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82974623|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974624|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82974625|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
82974626|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
82974627|NCT05415228|Edetic Acid|edetic acid|mesh-list
82974628|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82974629|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
82974630|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
83133556|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974631|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974632|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
82974633|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82974634|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82974635|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
82974636|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82974637|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82974638|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974639|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
82974640|NCT05357079|Coagulants|coagulants|mesh-ancestor
82974653|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
82974654|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82974655|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82974656|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974657|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
82974658|NCT05326997|Coagulants|coagulants|mesh-ancestor
82974683|NCT05184062|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
82974684|NCT05184062|Antiviral Agents|antiviral agents|mesh-ancestor
82974685|NCT05184062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974687|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974688|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974689|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974690|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974711|NCT05109728|Temozolomide|temozolomide|mesh-list
82974712|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
82974713|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
82974714|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82974715|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
82974716|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974717|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974718|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
82974719|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
82974720|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82974721|NCT05103332|Amlodipine|amlodipine|mesh-list
82974722|NCT05103332|Olmesartan|olmesartan|mesh-list
82974723|NCT05103332|Indapamide|indapamide|mesh-list
82974724|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82974725|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82974726|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82974727|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974728|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82974729|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974732|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82974733|NCT05103332|Diuretics|diuretics|mesh-ancestor
82974734|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
82974735|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82974736|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
82974737|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974738|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974739|NCT05101070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974740|NCT05101070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974741|NCT05098938|Acyclovir|acyclovir|mesh-list
82974742|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
82974743|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974744|NCT05071183|Trametinib|trametinib|mesh-list
82974745|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974746|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83462735|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82974747|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974748|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974749|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
82974750|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974751|NCT05022901|Melphalan|melphalan|mesh-list
82974752|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82974753|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
82974754|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974755|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974756|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82974757|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974758|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
82974759|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974760|NCT05009862|Aspirin|aspirin|mesh-list
82974761|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
82974762|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82974763|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82974764|NCT05009862|Analgesics|analgesics|mesh-ancestor
82974765|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
82974766|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974767|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974768|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974769|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974770|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82974771|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82974772|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974773|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82974774|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82974775|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974776|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
82974777|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82974778|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
82974779|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82974780|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
82974781|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
82974784|NCT04973748|Analgesics, Opioid|analgesics, opioid|mesh-list
82974785|NCT04973748|Narcotics|narcotics|mesh-ancestor
82974786|NCT04973748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974787|NCT04973748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974788|NCT04973748|Analgesics|analgesics|mesh-ancestor
82974789|NCT04973748|Sensory System Agents|sensory system agents|mesh-ancestor
82974790|NCT04973748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82974791|NCT04968054|Propofol|propofol|mesh-list
82974792|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82974793|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974794|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974795|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82974796|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
82974797|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
82974798|NCT04967495|Lenvatinib|lenvatinib|mesh-list
82974799|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
82974800|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974801|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82974802|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974803|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974804|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82974806|NCT04967495|Hormones|hormones|mesh-ancestor
82974807|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974808|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974809|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974810|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
82974811|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974812|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974813|NCT04933721|Berotralstat|berotralstat|mesh-list
82974814|NCT04933721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82974815|NCT04933721|Protease Inhibitors|protease inhibitors|mesh-ancestor
82974816|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974817|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974818|NCT04883528|Valsartan|valsartan|mesh-list
82974819|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82974820|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82974821|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82974822|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82974823|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974824|NCT04828135|Xenon|xenon|mesh-list
82974825|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82974826|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
82974827|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
82974828|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82974829|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974830|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
82974831|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974832|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974833|NCT04815720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974834|NCT04815720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974835|NCT04777851|Pembrolizumab|pembrolizumab|mesh-list
82974836|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974837|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974838|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974839|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974840|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82974841|NCT04773353|Hormones|hormones|mesh-ancestor
82974842|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974843|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974844|NCT04765111|Rituximab|rituximab|mesh-list
82974845|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82974846|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
82974847|NCT04765111|Antibodies|antibodies|mesh-list
82974848|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
82974849|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82974850|NCT04765111|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82974851|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
82974852|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974853|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974854|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974855|NCT04765111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82974856|NCT04765111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974857|NCT04765111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974858|NCT04737889|Rituximab|rituximab|mesh-list
82974859|NCT04737889|Methotrexate|methotrexate|mesh-list
82974860|NCT04737889|Lenalidomide|lenalidomide|mesh-list
82974861|NCT04737889|Temozolomide|temozolomide|mesh-list
82974862|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974863|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974864|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
82974865|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974866|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974867|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82974868|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
82974869|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82974870|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82974871|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
82974872|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974873|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
82974874|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974875|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82974876|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974877|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82974878|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82974879|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82974880|NCT04737889|Growth Substances|growth substances|mesh-ancestor
82974881|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
82974882|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82974883|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
82974885|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82974886|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82974887|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82974888|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82974889|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974890|NCT04679740|Sirolimus|sirolimus|mesh-list
82974891|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82974892|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974893|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82974894|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974895|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
82974896|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974897|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
82974898|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974899|NCT04672291|Poly I-C|poly i-c|mesh-list
82974900|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82974901|NCT04672291|Poly ICLC|poly iclc|mesh-list
82974902|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
82974903|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
82974904|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974905|NCT04672291|Laxatives|laxatives|mesh-ancestor
82974906|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82974907|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
82974908|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82974909|NCT04668365|Prednisone|prednisone|mesh-list
82974910|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
82974911|NCT04668365|Rituximab|rituximab|mesh-list
82974912|NCT04668365|Vincristine|vincristine|mesh-list
82974913|NCT04668365|Epirubicin|epirubicin|mesh-list
82974914|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
82974915|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974916|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
82974917|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974918|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82974919|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82974920|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
82974921|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974922|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974923|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82974924|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974925|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974926|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
82974927|NCT04668365|Hormones|hormones|mesh-ancestor
82974928|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974929|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974930|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82974931|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
82974932|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
82974933|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
82974934|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82974935|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82974936|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82974937|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974938|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82974939|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
82974940|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974941|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974942|NCT04657991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974943|NCT04657991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974944|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
82974945|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974946|NCT04633239|Olaparib|olaparib|mesh-list
83462746|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
82974947|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82974948|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974949|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974950|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974952|NCT04626479|Lenvatinib|lenvatinib|mesh-list
82974953|NCT04626479|Belzutifan|belzutifan|mesh-list
82974954|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974955|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974956|NCT04626479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82974957|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974958|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82974959|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974960|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82974961|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
82974962|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82974963|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
82974964|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82974965|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974966|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82974967|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974968|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974969|NCT04590963|Cetuximab|cetuximab|mesh-list
82974970|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974971|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974972|NCT04496401|Tacrolimus|tacrolimus|mesh-list
82974973|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974974|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
82974975|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974976|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82974977|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82974978|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974979|NCT04433156|Prednisone|prednisone|mesh-list
82974980|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
82974981|NCT04433156|Rituximab|rituximab|mesh-list
82974982|NCT04433156|Bortezomib|bortezomib|mesh-list
82974983|NCT04433156|Epirubicin|epirubicin|mesh-list
82974984|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82974985|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
82974986|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82974987|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83521006|NCT00390793|Doxorubicin|doxorubicin|mesh-list
82974988|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82974989|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
82974990|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82974991|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82974992|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82974993|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82974994|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82974995|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
82974996|NCT04433156|Hormones|hormones|mesh-ancestor
82974997|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82974998|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82974999|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82975000|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82975001|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82975002|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975003|NCT04419519|Venetoclax|venetoclax|mesh-list
82975004|NCT04419519|Antibodies|antibodies|mesh-list
82975005|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82975006|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
82975007|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975008|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975009|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82975010|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975011|NCT04417465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975012|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975013|NCT04416451|Rituximab|rituximab|mesh-list
82975014|NCT04416451|Venetoclax|venetoclax|mesh-list
82975015|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975016|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975017|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
82975018|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975019|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975020|NCT04388176|Compound 21|compound 21|mesh-list
82975021|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975022|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
82975023|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
82975024|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975026|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82975027|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
82975028|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975029|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975030|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82975031|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
82975032|NCT04311489|Diuretics|diuretics|mesh-ancestor
82975033|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
82975034|NCT04305405|Benralizumab|benralizumab|mesh-list
82975035|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82975036|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
82975037|NCT04258488|Vitamin K|vitamin k|mesh-list
82975038|NCT04258488|Warfarin|warfarin|mesh-list
82975039|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
82975040|NCT04258488|Vitamins|vitamins|mesh-ancestor
82975041|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
82975042|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975043|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
82975044|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82975045|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
82975046|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82975047|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
82975048|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975049|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975050|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82975051|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82975052|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
82975053|NCT04258488|Coagulants|coagulants|mesh-ancestor
82975054|NCT04255134|Adalimumab|adalimumab|mesh-list
82975055|NCT04255134|Abatacept|abatacept|mesh-list
82975056|NCT04255134|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82975057|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975058|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975059|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975060|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975061|NCT04255134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975062|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975063|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82975064|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
82975065|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975066|NCT04214626|Prednisone|prednisone|mesh-list
82975067|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
82975068|NCT04214626|Rituximab|rituximab|mesh-list
82975069|NCT04214626|Methotrexate|methotrexate|mesh-list
82975070|NCT04214626|Vincristine|vincristine|mesh-list
82975071|NCT04214626|Lenalidomide|lenalidomide|mesh-list
82975072|NCT04214626|Epirubicin|epirubicin|mesh-list
82975073|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82975074|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
82975075|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975076|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975077|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975078|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
82975079|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975080|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975081|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82975082|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975083|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975084|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
82975085|NCT04214626|Hormones|hormones|mesh-ancestor
82975086|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975087|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82975088|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82975089|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
82975090|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82975091|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82975092|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
82975093|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
82975094|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975095|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82975096|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82975097|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82975098|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
82975099|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
82975100|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
82975101|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82975102|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82975103|NCT04214626|Growth Substances|growth substances|mesh-ancestor
82975104|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975105|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82975106|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82975107|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82975108|NCT04192370|Cannabidiol|cannabidiol|mesh-list
82975109|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
82975110|NCT04180371|Nivolumab|nivolumab|mesh-list
82975111|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975112|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975113|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975114|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975115|NCT04179864|Prednisone|prednisone|mesh-list
82975116|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975117|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
82975118|NCT04179864|Hormones|hormones|mesh-ancestor
82975119|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975120|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975121|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82975122|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975123|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
82975124|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975125|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975126|NCT04165083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975127|NCT04165083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975128|NCT04165070|Paclitaxel|paclitaxel|mesh-list
82975129|NCT04165070|Carboplatin|carboplatin|mesh-list
82975130|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
82975131|NCT04165070|Pemetrexed|pemetrexed|mesh-list
82975132|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82975133|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975134|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
82975135|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
82975136|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
82975137|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975138|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975139|NCT04165070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975140|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975141|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82975142|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82975143|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
82975144|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82975145|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
82975146|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82975147|NCT04152200|Lumasiran|lumasiran|mesh-list
82975148|NCT04152200|Renal Agents|renal agents|mesh-ancestor
82975149|NCT04125472|Lumasiran|lumasiran|mesh-list
82975150|NCT04125472|Renal Agents|renal agents|mesh-ancestor
82975151|NCT04093323|Interferons|interferons|mesh-list
82975152|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
82975153|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
82975154|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
82975155|NCT04093323|Celecoxib|celecoxib|mesh-list
82975156|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82975157|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
82975158|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975159|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
82975160|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975161|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
82975162|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975163|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82975164|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82975165|NCT04093323|Analgesics|analgesics|mesh-ancestor
82975166|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
82975167|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975168|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975169|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975170|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82975171|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82975172|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975173|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975174|NCT04093323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975175|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82975176|NCT04067037|Vincristine|vincristine|mesh-list
82975177|NCT04067037|Epirubicin|epirubicin|mesh-list
82975178|NCT04067037|Dacarbazine|dacarbazine|mesh-list
82975179|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82975180|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975181|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
82975182|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
82975183|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
82975184|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975185|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82975186|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82975187|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82975188|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975189|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975190|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
82975192|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82975193|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975194|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
82975195|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
82975196|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
82975197|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975198|NCT03943537|Insulin|insulin|mesh-list
82975199|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82975200|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975201|NCT03905694|Lumasiran|lumasiran|mesh-list
82975202|NCT03905694|Renal Agents|renal agents|mesh-ancestor
82975203|NCT03776487|Fluorouracil|fluorouracil|mesh-list
82975204|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
82975205|NCT03776487|Nivolumab|nivolumab|mesh-list
82975206|NCT03776487|Ipilimumab|ipilimumab|mesh-list
82975207|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
82975208|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975209|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82975210|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975211|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82975212|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
82975213|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975214|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975215|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975216|NCT03681184|Lumasiran|lumasiran|mesh-list
82975217|NCT03681184|Renal Agents|renal agents|mesh-ancestor
82975218|NCT03668119|Nivolumab|nivolumab|mesh-list
82975219|NCT03668119|Ipilimumab|ipilimumab|mesh-list
82975220|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975221|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975222|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975223|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975224|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
82975225|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975226|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975227|NCT03632941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83221005|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462780|NCT05478954|Amodiaquine|amodiaquine|mesh-list
82975228|NCT03632941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975229|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
82975230|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975231|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975232|NCT03595059|Paclitaxel|paclitaxel|mesh-list
82975233|NCT03595059|Docetaxel|docetaxel|mesh-list
82975234|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82975235|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975236|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
82975237|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
82975238|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
82975239|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975240|NCT03578367|Niacinamide|niacinamide|mesh-list
82975241|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
82975242|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975243|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82975244|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975245|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975246|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
82975247|NCT03578367|Vitamins|vitamins|mesh-ancestor
82975248|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
82975249|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975250|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
82975251|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975252|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975253|NCT03568058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975254|NCT03568058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975255|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
82975256|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975257|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975258|NCT03514017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975259|NCT03514017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975260|NCT03502785|Atezolizumab|atezolizumab|mesh-list
82975261|NCT03502785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975262|NCT03502785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975263|NCT03502785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975264|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975265|NCT03495960|Rituximab|rituximab|mesh-list
82975266|NCT03495960|Methotrexate|methotrexate|mesh-list
82975267|NCT03495960|Lenalidomide|lenalidomide|mesh-list
82975268|NCT03495960|Temozolomide|temozolomide|mesh-list
82975269|NCT03495960|Procarbazine|procarbazine|mesh-list
82975270|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975271|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975272|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
82975273|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975274|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975275|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82975276|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
82975277|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82975278|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82975279|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
82975280|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975281|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
82975282|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975283|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82975284|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82975285|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82975286|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82975287|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82975288|NCT03495960|Growth Substances|growth substances|mesh-ancestor
82975289|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975290|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975291|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
82975292|NCT03491683|Temozolomide|temozolomide|mesh-list
82975293|NCT03491683|Cemiplimab|cemiplimab|mesh-list
82975294|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975295|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
82975296|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975297|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975298|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975299|NCT03351296|Bevacizumab|bevacizumab|mesh-list
82975300|NCT03351296|Capecitabine|capecitabine|mesh-list
82975301|NCT03351296|Temozolomide|temozolomide|mesh-list
82975302|NCT03351296|Streptozocin|streptozocin|mesh-list
82975303|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975304|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975305|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82975306|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82975307|NCT03351296|Growth Substances|growth substances|mesh-ancestor
82975308|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975309|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975310|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82975311|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
82975312|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975313|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975314|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
82975315|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82975316|NCT03345823|Upadacitinib|upadacitinib|mesh-list
82975317|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82975318|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82975319|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975320|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975321|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975322|NCT03338920|Sumatriptan|sumatriptan|mesh-list
82975323|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82975324|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82975325|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82975332|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
82975333|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
82975334|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975335|NCT03138161|Nivolumab|nivolumab|mesh-list
82975336|NCT03138161|Ipilimumab|ipilimumab|mesh-list
82975337|NCT03138161|Trabectedin|trabectedin|mesh-list
82975338|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975339|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975340|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975341|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975342|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975343|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
82975344|NCT03091075|Oxandrolone|oxandrolone|mesh-list
82975345|NCT03091075|Androgens|androgens|mesh-ancestor
82975346|NCT03091075|Hormones|hormones|mesh-ancestor
82975347|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975348|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975349|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
82975350|NCT03031821|Metformin|metformin|mesh-list
82975351|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82975352|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975353|NCT02907359|Guadecitabine|guadecitabine|mesh-list
82975354|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975355|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
82975356|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
82975357|NCT02669173|Bevacizumab|bevacizumab|mesh-list
82975358|NCT02669173|Capecitabine|capecitabine|mesh-list
82975359|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975360|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975361|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82975362|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82975363|NCT02669173|Growth Substances|growth substances|mesh-ancestor
82975364|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975365|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975366|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82975367|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
82975368|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975369|NCT02647437|Levetiracetam|levetiracetam|mesh-list
82975370|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
82975371|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
82975377|NCT02369458|Mitomycins|mitomycins|mesh-list
82975378|NCT02369458|Mitomycin|mitomycin|mesh-list
82975379|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82975380|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975381|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
82975382|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975383|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82975384|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975385|NCT02329080|Cytarabine|cytarabine|mesh-list
82975386|NCT02329080|Rituximab|rituximab|mesh-list
82975387|NCT02329080|Methotrexate|methotrexate|mesh-list
82975388|NCT02329080|Etoposide|etoposide|mesh-list
82975389|NCT02329080|Ifosfamide|ifosfamide|mesh-list
82975390|NCT02329080|Thiotepa|thiotepa|mesh-list
82975391|NCT02329080|Carmustine|carmustine|mesh-list
82975392|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975393|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975394|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
82975395|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975396|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975397|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82975398|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
82975399|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82975400|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82975401|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
82975403|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
82975404|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975405|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82975406|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82975407|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82975408|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82975409|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82975410|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82975411|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
82975412|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975413|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975414|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
82975415|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82975416|NCT02227927|Domperidone|domperidone|mesh-list
82975417|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
82975418|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
82975419|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975420|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975421|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82975422|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82975423|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
82975424|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975425|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975426|NCT02152995|Iodine|iodine|mesh-list
82975427|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
82975428|NCT02152995|Trametinib|trametinib|mesh-list
82975429|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82975430|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975431|NCT02152995|Trace Elements|trace elements|mesh-ancestor
82975432|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
82975433|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975434|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975435|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82975436|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975437|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975438|NCT02117791|Riociguat|riociguat|mesh-list
82975439|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
82975440|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975441|NCT01820910|Doxycycline|doxycycline|mesh-list
82975442|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82975443|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975444|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
82975445|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82975446|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82975447|NCT01808599|Rituximab|rituximab|mesh-list
82975448|NCT01808599|Chlorambucil|chlorambucil|mesh-list
82975449|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975450|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975451|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
82975452|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975453|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975454|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975455|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
82975456|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975457|NCT01704859|Vitamin D|vitamin d|mesh-list
82975458|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
82975459|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
82975460|NCT01704859|Vitamins|vitamins|mesh-list
82975461|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
82975462|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975463|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82975464|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82975465|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
82975466|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
82975467|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975468|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82975469|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82975470|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
82975471|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975472|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975473|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82975474|NCT00071071|Zanolimumab|zanolimumab|mesh-list
82975475|NCT00071071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82975476|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975477|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975478|NCT00071071|Immunologic Factors|immunologic factors|mesh-ancestor
82975479|NCT00071071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975481|NCT05465278|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82975482|NCT05465278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82975483|NCT05465278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82975484|NCT05465278|Antimetabolites|antimetabolites|mesh-ancestor
82975485|NCT05465278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975486|NCT05465278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82975487|NCT05465278|Protease Inhibitors|protease inhibitors|mesh-ancestor
82975488|NCT05465278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975489|NCT05465278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82975490|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
82975491|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
82975492|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82975493|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82975494|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82975495|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975496|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82975497|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82975498|NCT03339544|Celecoxib|celecoxib|mesh-list
82975499|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82975500|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82975501|NCT03339544|Analgesics|analgesics|mesh-ancestor
82975502|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
82975503|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975504|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975505|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975506|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975507|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82975508|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82975509|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975510|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975511|NCT03332602|Vitamins|vitamins|mesh-list
82975512|NCT03332602|Folic Acid|folic acid|mesh-list
82975513|NCT03332602|Vitamin A|vitamin a|mesh-list
82975514|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
82975515|NCT03332602|Fesoterodine|fesoterodine|mesh-list
82975516|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
82975517|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
82975518|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975519|NCT03332602|Hematinics|hematinics|mesh-ancestor
82975520|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
82975521|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82975522|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
82975523|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
82975524|NCT03332602|Protective Agents|protective agents|mesh-ancestor
82975525|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
82975526|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975527|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82975528|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975529|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82975530|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82975531|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
82975532|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975533|NCT03332602|Urological Agents|urological agents|mesh-ancestor
82975535|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82975536|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
82975537|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
82975538|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975539|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975540|NCT03812315|Propolis|propolis|mesh-list
82975541|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975542|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
82975543|NCT03332524|Ibuprofen|ibuprofen|mesh-list
82975544|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82975545|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82975546|NCT03332524|Analgesics|analgesics|mesh-ancestor
82975547|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
82975548|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975549|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975550|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975551|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975552|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82975553|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975554|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975555|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
82975556|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
82975557|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82975558|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
82975559|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
82975560|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975561|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82975562|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
82975563|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
82975564|NCT03812003|Remifentanil|remifentanil|mesh-list
82975565|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82975566|NCT03812003|Narcotics|narcotics|mesh-ancestor
82975567|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975568|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975569|NCT03812003|Analgesics|analgesics|mesh-ancestor
82975570|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
82975571|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975572|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
82975573|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82975574|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82975575|NCT04874610|Prednisolone|prednisolone|mesh-list
82975576|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
82975577|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82975578|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
82975579|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975580|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
82975581|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
82975582|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975583|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975584|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82975585|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
82975586|NCT04874610|Hormones|hormones|mesh-ancestor
82975587|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975588|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82975589|NCT04874610|Protective Agents|protective agents|mesh-ancestor
82975590|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82975591|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975592|NCT03518125|Vaccines|vaccines|mesh-list
82975593|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
82975594|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975595|NCT02492230|Warfarin|warfarin|mesh-list
82975596|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
82975597|NCT03169530|Ethanol|ethanol|mesh-list
82975598|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82975599|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975600|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975601|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975602|NCT03723187|Heparin|heparin|mesh-list
82975603|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
82975604|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82975605|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82975606|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975607|NCT02440230|Anastrozole|anastrozole|mesh-list
82975608|NCT02440230|Exemestane|exemestane|mesh-list
82975609|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82975610|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975611|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82975612|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82975613|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975614|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975615|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82975616|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
82975617|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975618|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975619|NCT03478891|Ansuvimab|ansuvimab|mesh-list
82975620|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
82975621|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975622|NCT00706966|Dutasteride|dutasteride|mesh-list
82975623|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82975624|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82975625|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975626|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975627|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
82975629|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975630|NCT01330524|Triamcinolone|triamcinolone|mesh-list
82975631|NCT01330524|Bevacizumab|bevacizumab|mesh-list
82975632|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975633|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975634|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82975635|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82975636|NCT01330524|Growth Substances|growth substances|mesh-ancestor
82975637|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975638|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975639|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975640|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
82975641|NCT01330524|Hormones|hormones|mesh-ancestor
82975642|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975643|NCT01560065|Folic Acid|folic acid|mesh-list
82975644|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
82975645|NCT01560065|Inositol|inositol|mesh-list
82975646|NCT01560065|Hematinics|hematinics|mesh-ancestor
82975647|NCT01560065|Vitamins|vitamins|mesh-ancestor
82975648|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
82975649|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975650|NCT01302587|Albuterol|albuterol|mesh-list
82975651|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82975652|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
82975653|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975654|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221006|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975655|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82975656|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
82975657|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
82975658|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82975659|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82975660|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82975661|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82975662|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
82975663|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975664|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975665|NCT03723109|Anesthetics|anesthetics|mesh-list
82975666|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975667|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975668|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
82975669|NCT03018288|Temozolomide|temozolomide|mesh-list
82975670|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975671|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975672|NCT03018288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975673|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975674|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82975675|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
82975676|NCT03515941|Leucovorin|leucovorin|mesh-list
82975678|NCT03515941|Capecitabine|capecitabine|mesh-list
82975679|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
82975680|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
82975681|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975682|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82975683|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975684|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82975685|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
82975686|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975687|NCT03515941|Antidotes|antidotes|mesh-ancestor
82975688|NCT03515941|Protective Agents|protective agents|mesh-ancestor
82975689|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
82975690|NCT03515941|Vitamins|vitamins|mesh-ancestor
82975691|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
82975692|NCT02492074|Dronabinol|dronabinol|mesh-list
82975693|NCT02492074|Cannabidiol|cannabidiol|mesh-list
82975694|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
82975695|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
82975696|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975697|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82975698|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82975699|NCT02492074|Analgesics|analgesics|mesh-ancestor
82975700|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
82975701|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975702|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82975703|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82975704|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975705|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975706|NCT02492074|Hormones|hormones|mesh-ancestor
82975707|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975708|NCT03819647|Stiripentol|stiripentol|mesh-list
82975709|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
82975710|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
82975711|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975712|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975713|NCT02498860|Pemetrexed|pemetrexed|mesh-list
82975714|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975715|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975716|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975717|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82975718|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82975719|NCT03011034|Daratumumab|daratumumab|mesh-list
82975720|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83462835|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83462836|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83462837|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82975721|NCT05464966|Insulin|insulin|mesh-list
82975722|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82975723|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975724|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
82975725|NCT03515629|Cemiplimab|cemiplimab|mesh-list
82975726|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82975727|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975728|NCT03515629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82975729|NCT03515629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975730|NCT01302821|Tryptophan|tryptophan|mesh-list
82975731|NCT01302821|Vaccines|vaccines|mesh-list
82975732|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
82975733|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975734|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82975735|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
82975736|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82975737|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
82975738|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
82975739|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975740|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82975741|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82975742|NCT03512353|Dexamethasone|dexamethasone|mesh-list
82975743|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975744|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
82975745|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
82975746|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975747|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975748|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82975749|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
82975750|NCT03512353|Hormones|hormones|mesh-ancestor
82975751|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975752|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82975753|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975754|NCT04959006|Antioxidants|antioxidants|mesh-list
82975755|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975756|NCT04959006|Protective Agents|protective agents|mesh-ancestor
82975757|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975759|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82975760|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975761|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82975762|NCT04851522|Eusol|eusol|mesh-list
82975763|NCT04851522|Petrolatum|petrolatum|mesh-list
82975764|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
82975765|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83462838|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
83462839|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
83462840|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83462841|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82975766|NCT04851522|Emollients|emollients|mesh-ancestor
83462846|NCT05478876|Immunologic Factors|immunologic factors|mesh-ancestor
82975767|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
82975768|NCT03512275|Antibodies|antibodies|mesh-list
82975769|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82975770|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
82975771|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975772|NCT03809897|Nicotine|nicotine|mesh-list
82975773|NCT03809897|Varenicline|varenicline|mesh-list
82975774|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82975775|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
82975776|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975777|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975778|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82975779|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82975780|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
82975781|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975782|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975784|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975785|NCT01560299|Methimazole|methimazole|mesh-list
82975786|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
82975787|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
82975788|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975789|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975790|NCT03337828|Ethanol|ethanol|mesh-list
82975791|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82975792|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975793|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975794|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975795|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
82975796|NCT03510715|Niacin|niacin|mesh-list
82975797|NCT03510715|Niacinamide|niacinamide|mesh-list
82975798|NCT03510715|Atorvastatin|atorvastatin|mesh-list
82975799|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82975800|NCT03510715|Simvastatin|simvastatin|mesh-list
82975801|NCT03510715|Ezetimibe|ezetimibe|mesh-list
82975802|NCT03510715|Pravastatin|pravastatin|mesh-list
82975803|NCT03510715|Alirocumab|alirocumab|mesh-list
82975804|NCT03510715|Lovastatin|lovastatin|mesh-list
82975805|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
82975806|NCT03510715|Fenofibrate|fenofibrate|mesh-list
82975807|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82975808|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82975809|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
82975810|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975811|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82975812|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82975813|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975814|NCT03510715|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82975815|NCT03510715|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82975816|NCT03510715|Protease Inhibitors|protease inhibitors|mesh-ancestor
82975817|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
82975818|NCT03510715|Vitamins|vitamins|mesh-ancestor
82975819|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
82975820|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975821|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
82975822|NCT03815279|Dexamethasone|dexamethasone|mesh-list
82975823|NCT03815279|Lenalidomide|lenalidomide|mesh-list
82975824|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975825|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
82975826|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
82975827|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975828|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975829|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82975830|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
82975831|NCT03815279|Hormones|hormones|mesh-ancestor
82975832|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975833|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82975834|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975835|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
82975836|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82975837|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82975838|NCT03815279|Growth Substances|growth substances|mesh-ancestor
82975839|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975841|NCT03814733|Alprazolam|alprazolam|mesh-list
82975842|NCT03814733|Analgesics|analgesics|mesh-ancestor
82975843|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
82975844|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975845|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975846|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82975847|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82975848|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
82975849|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
82975850|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975851|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82975852|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82975853|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975854|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975855|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82975856|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82975858|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82975859|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
82975860|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
82975861|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
82975862|NCT03721627|Ledipasvir|ledipasvir|mesh-list
82975863|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82975864|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
82975865|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82975866|NCT03811223|Evolocumab|evolocumab|mesh-list
82975867|NCT03811223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82975868|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82975869|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82975870|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
82975871|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975872|NCT03811223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82975873|NCT03811223|Protease Inhibitors|protease inhibitors|mesh-ancestor
82975874|NCT03811223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975875|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82975876|NCT03723031|Misoprostol|misoprostol|mesh-list
82975877|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82975878|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
82975879|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82975880|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975881|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82975882|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82975883|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
82975884|NCT03722875|Apatinib|apatinib|mesh-list
82975885|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975886|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82975887|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975888|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975889|NCT04860713|Aspirin|aspirin|mesh-list
82975890|NCT04860713|Ketamine|ketamine|mesh-list
82975891|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82975892|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82975893|NCT04860713|Analgesics|analgesics|mesh-ancestor
82975894|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
82975895|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975896|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975897|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975898|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975899|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82975900|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82975901|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975902|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82975903|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82975904|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975905|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
82975906|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82975907|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82975908|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
82975909|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
82975910|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975911|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82975912|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82975913|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975914|NCT03528577|Albuterol|albuterol|mesh-list
82975915|NCT03528577|Procaterol|procaterol|mesh-list
82975916|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82975917|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
82975918|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975919|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975920|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82975921|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
82975922|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
82975923|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82975924|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82975925|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82975926|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82975927|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
82975928|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975929|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975930|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
82975931|NCT05432414|Dexamethasone|dexamethasone|mesh-list
82975932|NCT05432414|Bortezomib|bortezomib|mesh-list
82975934|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975935|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
82975936|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
82975937|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975938|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975939|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82975940|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
82975941|NCT05432414|Hormones|hormones|mesh-ancestor
82975942|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82975943|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82975944|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82975945|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
82975946|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82975947|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82975948|NCT05432414|Growth Substances|growth substances|mesh-ancestor
82975949|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
82975950|NCT03796403|Diclofenac|diclofenac|mesh-list
82975951|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82975952|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82975953|NCT03796403|Analgesics|analgesics|mesh-ancestor
82975954|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
83462890|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82975955|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975956|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975957|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82975958|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82975959|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82975960|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82975961|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975962|NCT00706654|Aripiprazole|aripiprazole|mesh-list
82975963|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
82975964|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82975965|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82975966|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82975967|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975968|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975969|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
82975970|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
82975971|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975972|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975973|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82975974|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82975975|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
82975976|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82975977|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82975978|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82975979|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82975980|NCT03471871|Lemborexant|lemborexant|mesh-list
82975981|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82975982|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82975983|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82975984|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82975985|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82975986|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975987|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975988|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
82975989|NCT04313153|Hematinics|hematinics|mesh-ancestor
82975990|NCT03337672|Midazolam|midazolam|mesh-list
82975991|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
82975992|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82975993|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82975994|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82975995|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82975996|NCT03337672|Analgesics|analgesics|mesh-ancestor
82975997|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
82975998|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82975999|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82976000|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82976001|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82976002|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
82976003|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976004|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976005|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82976006|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82976007|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82976008|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82976009|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82976010|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
82976012|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
82976013|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
82976014|NCT03330808|Anesthetics|anesthetics|mesh-list
82976015|NCT03330808|Ropivacaine|ropivacaine|mesh-list
82976016|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976017|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976018|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
82976019|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
82976020|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83462903|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
82976021|NCT01303055|Metformin|metformin|mesh-list
82976022|NCT01303055|Alogliptin|alogliptin|mesh-list
82976023|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82976024|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976025|NCT01303055|Incretins|incretins|mesh-ancestor
82976026|NCT01303055|Hormones|hormones|mesh-ancestor
82976027|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976028|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82976029|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
82976030|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976031|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976032|NCT05474560|Allopurinol|allopurinol|mesh-list
82976033|NCT05474560|Febuxostat|febuxostat|mesh-list
82976034|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
82976035|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976036|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976037|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
82976038|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976039|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82976040|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
82976041|NCT05474560|Protective Agents|protective agents|mesh-ancestor
82976042|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976043|NCT03636048|Bupivacaine|bupivacaine|mesh-list
82976044|NCT03636048|Anesthetics|anesthetics|mesh-list
82976045|NCT03636048|Propofol|propofol|mesh-list
82976046|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
82976047|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976048|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976049|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
82976050|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976051|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82976052|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82976053|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
82976054|NCT03527173|Vaccines|vaccines|mesh-list
82976055|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
82976056|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976057|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
82976058|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82976059|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82976060|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976061|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
82976062|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
82976063|NCT01303601|Olanzapine|olanzapine|mesh-list
82976064|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
82976065|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
82976066|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976067|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976068|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82976069|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82976070|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82976071|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976072|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82976073|NCT01303601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82976074|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82976075|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82976076|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976077|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976078|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
82976079|NCT00707980|Vortioxetine|vortioxetine|mesh-list
82976080|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
82976081|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82976082|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82976084|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976085|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976086|NCT00707980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82976087|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82976088|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82976089|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976090|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976091|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
82976092|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82976093|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82976094|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82976095|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82976096|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82976097|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
82976098|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82976099|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82976100|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
82976101|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976102|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976103|NCT03051620|Alendronate|alendronate|mesh-list
82976104|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82976105|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976106|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
82976107|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82976108|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
82976109|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976110|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
82976111|NCT02861183|Protective Agents|protective agents|mesh-ancestor
82976112|NCT02498002|Lidocaine|lidocaine|mesh-list
82976113|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
82976114|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
82976115|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976116|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976117|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
82976118|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976119|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82976120|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82976121|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82976122|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82976123|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976124|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
82976125|NCT03810209|Analgesics|analgesics|mesh-ancestor
82976126|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
82976127|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976128|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976129|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
82976130|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976131|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82976132|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
82976133|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82976134|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82976135|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976136|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82976137|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
82976138|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82976139|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
82976140|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976141|NCT01303679|Paclitaxel|paclitaxel|mesh-list
82976142|NCT01303679|Bevacizumab|bevacizumab|mesh-list
82976143|NCT01303679|Exemestane|exemestane|mesh-list
82976144|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82976145|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976146|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
82976147|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
82976148|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
82976149|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976150|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976151|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82976152|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82976153|NCT01303679|Growth Substances|growth substances|mesh-ancestor
82976154|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976155|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
82976156|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82976157|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82976158|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976159|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82976160|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
82976161|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976162|NCT03337282|Anesthetics|anesthetics|mesh-list
82976163|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976164|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976166|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82976167|NCT03801707|Velpatasvir|velpatasvir|mesh-list
82976168|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
82976169|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976170|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82976171|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82976172|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976173|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
82976174|NCT04239872|Calcium|calcium|mesh-list
82976175|NCT04239872|Fluorides|fluorides|mesh-list
82976176|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82976177|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976178|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82976179|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
82976180|NCT04239872|Protective Agents|protective agents|mesh-ancestor
82976181|NCT03164772|Durvalumab|durvalumab|mesh-list
82976182|NCT03164772|Tremelimumab|tremelimumab|mesh-list
82976183|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976184|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976185|NCT03801317|Micronutrients|micronutrients|mesh-list
82976186|NCT03801317|Trace Elements|trace elements|mesh-list
82976187|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976188|NCT03337126|Metronidazole|metronidazole|mesh-list
82976189|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976190|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82976191|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82976192|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82976193|NCT04710732|Enoxaparin|enoxaparin|mesh-list
82976194|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
82976195|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
82976196|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82976197|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82976198|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976199|NCT05014334|Amoxicillin|amoxicillin|mesh-list
82976200|NCT05014334|Clarithromycin|clarithromycin|mesh-list
82976201|NCT05014334|Rabeprazole|rabeprazole|mesh-list
82976202|NCT05014334|Bismuth|bismuth|mesh-list
82976203|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82976204|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976205|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82976206|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976207|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976208|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82976209|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82976210|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82976211|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82976212|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82976214|NCT02497378|Dexamethasone|dexamethasone|mesh-list
82976215|NCT02497378|Bortezomib|bortezomib|mesh-list
82976216|NCT02497378|Daratumumab|daratumumab|mesh-list
82976217|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82976218|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
82976219|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
82976220|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976221|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976222|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82976223|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
82976224|NCT02497378|Hormones|hormones|mesh-ancestor
82976225|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976226|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82976227|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976228|NCT02497222|RNS60|rns60|mesh-list
82976229|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82976230|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82976231|NCT02497222|Analgesics|analgesics|mesh-ancestor
82976232|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
82976233|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976234|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976235|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82976236|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976237|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82976238|NCT02491606|Tafenoquine|tafenoquine|mesh-list
82976239|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
82976240|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82976241|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82976242|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976243|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82976244|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82976245|NCT03050450|Lenalidomide|lenalidomide|mesh-list
82976246|NCT03050450|Vorinostat|vorinostat|mesh-list
82976247|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
82976248|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976249|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82976250|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82976251|NCT03050450|Growth Substances|growth substances|mesh-ancestor
82976252|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
82976253|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976254|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82976255|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976256|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976257|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
82976258|NCT03505021|Simendan|simendan|mesh-list
82976259|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82976260|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
82976261|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82976262|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82976263|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976264|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976265|NCT03505021|Protective Agents|protective agents|mesh-ancestor
82976266|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976267|NCT03793283|Insulin|insulin|mesh-list
82976268|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82976269|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82976270|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976271|NCT02496988|Temozolomide|temozolomide|mesh-list
82976272|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82976273|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
82976274|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976275|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976276|NCT03793205|Lenograstim|lenograstim|mesh-list
82976277|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82976278|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
82976279|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976280|NCT03329248|Leucovorin|leucovorin|mesh-list
82976281|NCT03329248|Paclitaxel|paclitaxel|mesh-list
82976282|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
82976283|NCT03329248|Bevacizumab|bevacizumab|mesh-list
82976284|NCT03329248|Fluorouracil|fluorouracil|mesh-list
82976285|NCT03329248|Capecitabine|capecitabine|mesh-list
82976286|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
82976287|NCT03329248|Avelumab|avelumab|mesh-list
82976288|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82976289|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976290|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
82976291|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
82976292|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
82976293|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976294|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976295|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
82976296|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976297|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976298|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82976299|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
82976300|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82976301|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976302|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82976303|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82976304|NCT03329248|Growth Substances|growth substances|mesh-ancestor
82976305|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
82976306|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
82976307|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82976308|NCT03329248|Antidotes|antidotes|mesh-ancestor
82976309|NCT03329248|Protective Agents|protective agents|mesh-ancestor
82976310|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
82976311|NCT03329248|Vitamins|vitamins|mesh-ancestor
82976312|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
82976313|NCT03795311|Bevacizumab|bevacizumab|mesh-list
82976314|NCT03795311|Folfirinox|folfirinox|mesh-list
82976315|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976316|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976317|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82976318|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82976319|NCT03795311|Growth Substances|growth substances|mesh-ancestor
82976320|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976321|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
82976322|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
82976323|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
82976324|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
82976325|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
82976326|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82976327|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82976328|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976329|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976330|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976331|NCT03792971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82976332|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
82976333|NCT03792971|Protective Agents|protective agents|mesh-ancestor
82976334|NCT03328936|Melphalan|melphalan|mesh-list
82976335|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82976336|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
82976337|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976338|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976339|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82976340|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976341|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
82976342|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976343|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82976344|NCT02496754|Hormones|hormones|mesh-ancestor
82976345|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976346|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976347|NCT04887194|Nivolumab|nivolumab|mesh-list
82976348|NCT04887194|Digoxin|digoxin|mesh-list
82976349|NCT04887194|Midazolam|midazolam|mesh-list
82976350|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
82976351|NCT04887194|Warfarin|warfarin|mesh-list
82976352|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82976353|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976354|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976355|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82976356|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976357|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82976358|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82976359|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976360|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976361|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82976362|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82976363|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82976364|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82976365|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
82976366|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
83462934|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976367|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
82976368|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
82976369|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976370|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82976371|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82976372|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
82976373|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82976374|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82976375|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976376|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
82976377|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82976378|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82976379|NCT04887194|Protective Agents|protective agents|mesh-ancestor
82976380|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
82976381|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
82976382|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82976383|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82976385|NCT02496910|Telmisartan|telmisartan|mesh-list
82976386|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
82976387|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
82976388|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82976389|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82976390|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82976391|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976392|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82976393|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976394|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
82976395|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82976396|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82976397|NCT02496910|Diuretics|diuretics|mesh-ancestor
82976398|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
82976399|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82976400|NCT03342352|Carboplatin|carboplatin|mesh-list
82976401|NCT03342352|Fluorouracil|fluorouracil|mesh-list
82976402|NCT03342352|Nivolumab|nivolumab|mesh-list
82976403|NCT03342352|Cetuximab|cetuximab|mesh-list
82976404|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976405|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
82976406|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976407|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82976408|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976409|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
82976410|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976411|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976412|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82976413|NCT03120442|Fentanyl|fentanyl|mesh-list
83462943|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
82976414|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
82976415|NCT03120442|Propofol|propofol|mesh-list
82976416|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82976417|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976418|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976419|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82976420|NCT03120442|Analgesics|analgesics|mesh-ancestor
82976421|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
82976422|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976423|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82976424|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82976425|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82976426|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
82976427|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976428|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976429|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82976430|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
82976431|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
82976432|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82976433|NCT03120442|Narcotics|narcotics|mesh-ancestor
82976434|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82976435|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
82976436|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82976437|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82976438|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82976439|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
82976440|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976441|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976442|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976443|NCT00852696|Urological Agents|urological agents|mesh-ancestor
82976444|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82976445|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82976446|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976447|NCT03324490|Fentanyl|fentanyl|mesh-list
82976448|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
82976449|NCT03324490|Bupivacaine|bupivacaine|mesh-list
82976450|NCT03324490|Anesthetics|anesthetics|mesh-list
82976451|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
82976452|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976453|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976454|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
82976455|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976456|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82976457|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82976464|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976466|NCT03324490|Narcotics|narcotics|mesh-ancestor
82976467|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82976468|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82976469|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
82976470|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
82976471|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82976472|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
82976473|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
82976474|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976475|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976476|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
82976477|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976478|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976479|NCT03274661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82976480|NCT03274661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976481|NCT03798821|Sulfalene|sulfalene|mesh-list
82976482|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976483|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82976484|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
82976485|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82976486|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82976487|NCT03324334|Antibodies|antibodies|mesh-list
82976488|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
82976489|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976490|NCT03792815|Etoposide|etoposide|mesh-list
82976491|NCT03792815|Melphalan|melphalan|mesh-list
82976492|NCT03792815|Busulfan|busulfan|mesh-list
82976493|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82976494|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976495|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82976496|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82976497|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976498|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976499|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82976500|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
82976501|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82976502|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976503|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
82976504|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976505|NCT04381364|Ciclesonide|ciclesonide|mesh-list
82976506|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
82976507|NCT04381364|Hormones|hormones|mesh-ancestor
82976508|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976509|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976510|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82976511|NCT01331382|Resveratrol|resveratrol|mesh-list
82976512|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
82976513|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976514|NCT01331382|Protective Agents|protective agents|mesh-ancestor
82976515|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976516|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976517|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82976518|NCT03794765|Metronidazole|metronidazole|mesh-list
82976519|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
82976520|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976521|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82976522|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82976523|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82976530|NCT02496286|Bevacizumab|bevacizumab|mesh-list
82976531|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976532|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976533|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82976534|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82976535|NCT02496286|Growth Substances|growth substances|mesh-ancestor
82976536|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976537|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
82976538|NCT01489176|Regadenoson|regadenoson|mesh-list
82976539|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
82976540|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82976541|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
82976542|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
82976543|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976544|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976545|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976546|NCT03792503|Pemetrexed|pemetrexed|mesh-list
82976547|NCT03792503|Apatinib|apatinib|mesh-list
82976548|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976549|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976550|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976551|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82976552|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82976553|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82976554|NCT03794843|Nimodipine|nimodipine|mesh-list
82976555|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82976556|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82976557|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82976558|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976559|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82976560|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976561|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
82976562|NCT01333800|Ciclesonide|ciclesonide|mesh-list
82976563|NCT01333800|Beclomethasone|beclomethasone|mesh-list
82976564|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82976565|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
82976566|NCT01333800|Hormones|hormones|mesh-ancestor
82976567|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976568|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976569|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82976570|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
82976571|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82976572|NCT04494100|Lidocaine|lidocaine|mesh-list
82976573|NCT04494100|Epinephrine|epinephrine|mesh-list
82976574|NCT04494100|Ropivacaine|ropivacaine|mesh-list
82976575|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
82976576|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
82976577|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976578|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976579|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
82976580|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976581|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82976582|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82976583|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82976584|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82976585|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976586|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82976587|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82976588|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
82976589|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976590|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82976591|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82976592|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
82976593|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82976594|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
82976595|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
82976596|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
82976597|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82976598|NCT01333878|Abatacept|abatacept|mesh-list
82976599|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82976600|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976601|NCT01333878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976602|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976603|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976604|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
82976605|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976606|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976607|NCT03328312|Atropine|atropine|mesh-list
82976608|NCT03328312|Neostigmine|neostigmine|mesh-list
82976609|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82976610|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82976611|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82976612|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
82976613|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976614|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976615|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82976616|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
82976617|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
82976618|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
82976619|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82976620|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82976621|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
82976622|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976623|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976624|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82976625|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976626|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82976627|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
82976628|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82976629|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82976630|NCT03328234|Paclitaxel|paclitaxel|mesh-list
82976631|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82976632|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82976633|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976634|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
82976635|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
82976636|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
82976637|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976638|NCT04781192|Durvalumab|durvalumab|mesh-list
82976639|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976640|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976641|NCT03323710|Sunitinib|sunitinib|mesh-list
82976642|NCT03323710|Propranolol|propranolol|mesh-list
82976643|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976644|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82976645|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82976646|NCT03323710|Growth Substances|growth substances|mesh-ancestor
82976647|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976648|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
82976649|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82976650|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976651|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976652|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82976653|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82976654|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
82976655|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976656|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82976657|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82976658|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
82976659|NCT03792269|Capecitabine|capecitabine|mesh-list
82976660|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
82976661|NCT03792269|Irinotecan|irinotecan|mesh-list
82976662|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82976663|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
82976664|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976665|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976666|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82976667|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82976668|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976669|NCT02488564|Metformin|metformin|mesh-list
82976670|NCT02488564|Docetaxel|docetaxel|mesh-list
82976671|NCT02488564|Doxorubicin|doxorubicin|mesh-list
82976672|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82976673|NCT02488564|Trastuzumab|trastuzumab|mesh-list
82976674|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82976675|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976676|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976677|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
82976678|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
82976679|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
82976680|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976681|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82976682|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82976683|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82976684|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976685|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976686|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
82976687|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82976688|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
82976689|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976690|NCT02966873|Expectorants|expectorants|mesh-ancestor
82976691|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
82976692|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82976693|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
82976694|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976695|NCT02966873|Protective Agents|protective agents|mesh-ancestor
82976696|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976697|NCT02966873|Antidotes|antidotes|mesh-ancestor
82976698|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
82976699|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976700|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976701|NCT03792347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82976702|NCT03792347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976703|NCT04697186|Amoxicillin|amoxicillin|mesh-list
82976704|NCT04697186|Clarithromycin|clarithromycin|mesh-list
82976705|NCT04697186|Rabeprazole|rabeprazole|mesh-list
82976706|NCT04697186|Bismuth|bismuth|mesh-list
82976707|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82976708|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976709|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82976710|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976711|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976712|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82976713|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82976714|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82976715|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82976716|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82976717|NCT04697186|Antacids|antacids|mesh-ancestor
82976718|NCT02488642|Isosorbide|isosorbide|mesh-list
82976719|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82976720|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82976721|NCT02488642|Misoprostol|misoprostol|mesh-list
82976722|NCT02488642|Oxytocin|oxytocin|mesh-list
82976723|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
82976724|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82976725|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976726|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82976727|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
82976728|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82976729|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82976730|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82976731|NCT02488642|Diuretics|diuretics|mesh-ancestor
82976732|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
82976733|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
82976734|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82976735|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976736|NCT02488486|Remifentanil|remifentanil|mesh-list
82976737|NCT02488486|Propofol|propofol|mesh-list
82976738|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82976739|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976740|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976741|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82976742|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
82976743|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
82976744|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82976745|NCT02488486|Narcotics|narcotics|mesh-ancestor
82976746|NCT02488486|Analgesics|analgesics|mesh-ancestor
82976747|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
82976748|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976749|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
82976750|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976751|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976752|NCT04144517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82976753|NCT04144517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976754|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
82976755|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976756|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
82976757|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976758|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976759|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82976760|NCT03327766|Calcifediol|calcifediol|mesh-list
82976762|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
82976763|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976764|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82976765|NCT03798119|Tenofovir|tenofovir|mesh-list
82976766|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
82976767|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976768|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82976769|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82976770|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976771|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976772|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82976773|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82976774|NCT03794219|Naproxen|naproxen|mesh-list
82976775|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83462990|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976776|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82976777|NCT03794219|Analgesics|analgesics|mesh-ancestor
82976778|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
82976779|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976780|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976781|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82976782|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976783|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
82976784|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82976785|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976786|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976787|NCT01297764|Dexamethasone|dexamethasone|mesh-list
82976788|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
82976789|NCT01297764|Lenalidomide|lenalidomide|mesh-list
82976790|NCT01297764|Vorinostat|vorinostat|mesh-list
82976791|NCT01297764|BB 1101|bb 1101|mesh-list
82976792|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82976793|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
82976794|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
82976795|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976796|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976797|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82976798|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
82976799|NCT01297764|Hormones|hormones|mesh-ancestor
82976800|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976801|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82976802|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976803|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
82976804|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976805|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976806|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
82976807|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82976808|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82976809|NCT01297764|Growth Substances|growth substances|mesh-ancestor
82976810|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
82976811|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82976812|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
82976813|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82976814|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976815|NCT03050060|Nelfinavir|nelfinavir|mesh-list
82976816|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
82976817|NCT03050060|Nivolumab|nivolumab|mesh-list
82976818|NCT03050060|Atezolizumab|atezolizumab|mesh-list
82976819|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82976820|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82976821|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976822|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82976823|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976824|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
82976825|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976826|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82976827|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82976828|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
82976829|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976830|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82976831|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82976832|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
82976833|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976834|NCT01334112|Axitinib|axitinib|mesh-list
82976835|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976836|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82976837|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976838|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976839|NCT03791957|Chrysarobin|chrysarobin|mesh-list
82976840|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82976841|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82976842|NCT03791957|Analgesics|analgesics|mesh-ancestor
82976843|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
82976844|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976845|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976846|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82976847|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976848|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
82976849|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
82976850|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82976851|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82976852|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
82976853|NCT03792113|Coagulants|coagulants|mesh-ancestor
82976854|NCT02491528|Insulin|insulin|mesh-list
82976855|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82976856|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
82976857|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
82976858|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82976859|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82976860|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976861|NCT01304927|Vitamin D|vitamin d|mesh-list
82976862|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
82976863|NCT01304927|Calcium|calcium|mesh-list
82976864|NCT01304927|Vitamins|vitamins|mesh-ancestor
82976865|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
82976866|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976867|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82976868|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82976869|NCT05464940|Caffeine|caffeine|mesh-list
82976870|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82976871|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976872|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82976873|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976874|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976875|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82976876|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82976877|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
82976878|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976879|NCT01305551|Metformin|metformin|mesh-list
82976880|NCT01305551|Saxagliptin|saxagliptin|mesh-list
82976881|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82976882|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976883|NCT01305551|Incretins|incretins|mesh-ancestor
82976884|NCT01305551|Hormones|hormones|mesh-ancestor
82976885|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82976886|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82976887|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
82976888|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976889|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976890|NCT03799757|Bupivacaine|bupivacaine|mesh-list
82976891|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
82976892|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
82976893|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976894|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976895|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
82976896|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976897|NCT03611738|Docetaxel|docetaxel|mesh-list
82976898|NCT03611738|Ceritinib|ceritinib|mesh-list
82976899|NCT03611738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82976900|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976901|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
82976902|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
82976903|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
82976904|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976905|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82976906|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976907|NCT03327454|Etanercept|etanercept|mesh-list
82976908|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82976909|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82976910|NCT03327454|Analgesics|analgesics|mesh-ancestor
82976911|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
82976912|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976913|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976914|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463007|NCT03661320|Gemcitabine|gemcitabine|mesh-list
82976915|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976916|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82976917|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976918|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
82976919|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
82976920|NCT03799913|Fludarabine|fludarabine|mesh-list
82976921|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82976922|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
82976923|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976924|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976925|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82976926|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
82976927|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976928|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976929|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82976930|NCT01304069|Etoricoxib|etoricoxib|mesh-list
82976931|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82976932|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82976933|NCT01304069|Analgesics|analgesics|mesh-ancestor
82976934|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
82976935|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976936|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976937|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82976938|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82976939|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82976940|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82976941|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976942|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976943|NCT05459402|Methadone|methadone|mesh-list
82976944|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82976945|NCT05459402|Narcotics|narcotics|mesh-ancestor
82976946|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976947|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976948|NCT05459402|Analgesics|analgesics|mesh-ancestor
82976949|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
82976950|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976951|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
82976952|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
82976953|NCT03799601|Carboplatin|carboplatin|mesh-list
82976954|NCT03799601|Docetaxel|docetaxel|mesh-list
82976955|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82976956|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
82976957|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
82976958|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
82976959|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976960|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
82976961|NCT03791801|Rocuronium|rocuronium|mesh-list
82976962|NCT03791801|Neostigmine|neostigmine|mesh-list
82976963|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82976964|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82976965|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82976966|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976967|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976968|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82976969|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976970|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976971|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
82976972|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82976973|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82976975|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82976976|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82976977|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82976978|NCT01305083|Udenafil|udenafil|mesh-list
82976979|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82976980|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82976981|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82976982|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976983|NCT03791723|Valsartan|valsartan|mesh-list
82976984|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82976985|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83463011|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
82976986|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82976987|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82976988|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82976989|NCT05452070|Lidocaine|lidocaine|mesh-list
82976990|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
82976991|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
82976992|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82976993|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82976994|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
82976995|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82976996|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82976997|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82976998|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82976999|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977000|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977001|NCT03920657|Deferasirox|deferasirox|mesh-list
82977002|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82977003|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
82977004|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
82977005|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977006|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82977007|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977008|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977009|NCT03501277|Pioglitazone|pioglitazone|mesh-list
82977010|NCT03501277|Alogliptin|alogliptin|mesh-list
82977011|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82977012|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977013|NCT03501277|Incretins|incretins|mesh-ancestor
82977014|NCT03501277|Hormones|hormones|mesh-ancestor
82977015|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82977016|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82977017|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
82977018|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977019|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977020|NCT03797729|Tirofiban|tirofiban|mesh-list
82977021|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82977022|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82977023|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977024|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82977025|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82977026|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82977027|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82977028|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82977029|NCT02487706|Dolutegravir|dolutegravir|mesh-list
82977030|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82977031|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82977032|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977033|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977034|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82977035|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82977036|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
82977037|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977038|NCT04551950|Paclitaxel|paclitaxel|mesh-list
82977039|NCT04551950|Bevacizumab|bevacizumab|mesh-list
82977040|NCT04551950|Carboplatin|carboplatin|mesh-list
82977041|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82977042|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977043|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
82977044|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
82977045|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
82977046|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977047|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977048|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82977049|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82977050|NCT04551950|Growth Substances|growth substances|mesh-ancestor
82977051|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977052|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
82977053|NCT03772925|Belinostat|belinostat|mesh-list
82977054|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82977055|NCT03772925|Pevonedistat|pevonedistat|mesh-list
82977056|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977057|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977058|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82977059|NCT03326752|Nivolumab|nivolumab|mesh-list
82977062|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977063|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977065|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82977066|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
82977067|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977068|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977069|NCT01316900|Bromides|bromides|mesh-list
82977070|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
82977071|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82977072|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
82977073|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977074|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977075|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82977076|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
82977077|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
82977078|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82977079|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
82977080|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977081|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977082|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
82977083|NCT03714815|Macitentan|macitentan|mesh-list
82977084|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82977085|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82977086|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977087|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82977088|NCT02490982|Teriflunomide|teriflunomide|mesh-list
82977089|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82977090|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82977091|NCT02490982|Analgesics|analgesics|mesh-ancestor
82977092|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
82977093|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977094|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977095|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977096|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977097|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977098|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
82977099|NCT03322150|Atropine|atropine|mesh-list
82977100|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
82977101|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82977102|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82977103|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82977104|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
82977105|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977106|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977107|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82977108|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
82977109|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
82977110|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
82977111|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82977112|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82977113|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
82977114|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977115|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977116|NCT00936390|Leuprolide|leuprolide|mesh-list
82977117|NCT00936390|Goserelin|goserelin|mesh-list
82977118|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82977119|NCT00936390|Flutamide|flutamide|mesh-list
82977120|NCT00936390|Bicalutamide|bicalutamide|mesh-list
82977121|NCT00936390|Buserelin|buserelin|mesh-list
82977122|NCT00936390|Androgens|androgens|mesh-list
82977123|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
82977124|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82977125|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
82977126|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82977127|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977128|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82977129|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977130|NCT00936390|Hormones|hormones|mesh-ancestor
82977131|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82977133|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
82977134|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82977135|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
82977136|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82977137|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
82977138|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82977139|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82977140|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977141|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
82977142|NCT03326596|Coagulants|coagulants|mesh-ancestor
82977143|NCT03499873|Nepafenac|nepafenac|mesh-list
82977144|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82977145|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82977146|NCT03499873|Analgesics|analgesics|mesh-ancestor
82977147|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
82977148|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977149|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977150|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977151|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977152|NCT01305707|Diazepam|diazepam|mesh-list
82977153|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82977154|NCT01305707|Lorazepam|lorazepam|mesh-list
82977155|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
82977156|NCT01305707|Dexetimide|dexetimide|mesh-list
82977157|NCT01305707|Olanzapine|olanzapine|mesh-list
82977158|NCT01305707|Risperidone|risperidone|mesh-list
82977159|NCT01305707|Aripiprazole|aripiprazole|mesh-list
82977160|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82977161|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
82977162|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
82977163|NCT01305707|Mirtazapine|mirtazapine|mesh-list
82977164|NCT01305707|Citalopram|citalopram|mesh-list
82977165|NCT01305707|Sertraline|sertraline|mesh-list
82977166|NCT01305707|Fluoxetine|fluoxetine|mesh-list
82977167|NCT01305707|Paroxetine|paroxetine|mesh-list
82977168|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82977169|NCT01305707|Nortriptyline|nortriptyline|mesh-list
82977170|NCT01305707|Imipramine|imipramine|mesh-list
82977171|NCT01305707|Clomipramine|clomipramine|mesh-list
82977172|NCT01305707|Mianserin|mianserin|mesh-list
82977173|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
82977174|NCT01305707|Escitalopram|escitalopram|mesh-list
82977175|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82977176|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
82977177|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977178|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977179|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977180|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82977181|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977182|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82977183|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82977184|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
82977185|NCT01305707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82977186|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82977187|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977188|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82977189|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82977190|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
82977191|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
82977192|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977193|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82977194|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82977195|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
82977196|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82977197|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
82977198|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82977199|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
82977200|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82977201|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82977202|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82977203|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82977204|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82977205|NCT01305707|Analgesics|analgesics|mesh-ancestor
82977206|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
82977207|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82977208|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82977209|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977210|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
82977211|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
82977212|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82977213|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82977214|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
82977215|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
82977216|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82977217|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
82977218|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
82977219|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82977220|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82977221|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82977222|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
82977223|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82977224|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82977225|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82977226|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82977227|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82977228|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
82977229|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
82977230|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82977231|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82977232|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82977233|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
82977234|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977235|NCT03722329|Eculizumab|eculizumab|mesh-list
82977236|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82977237|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977238|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
82977239|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977240|NCT03467971|Metformin|metformin|mesh-list
82977241|NCT03467971|Gliclazide|gliclazide|mesh-list
82977242|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82977243|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977244|NCT03319498|Peppermint oil|peppermint oil|mesh-list
82977245|NCT03319498|Mineral Oil|mineral oil|mesh-list
82977246|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
82977247|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
82977248|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977249|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977250|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82977251|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
82977252|NCT03319498|Emollients|emollients|mesh-ancestor
82977253|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
82977254|NCT03791099|Metronidazole|metronidazole|mesh-list
82977255|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977256|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82977257|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82977258|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82977259|NCT03185000|Immunomodulating Agents|immunomodulating agents|mesh-list
82977260|NCT03185000|Immunologic Factors|immunologic factors|mesh-ancestor
82977261|NCT03185000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977262|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
82977263|NCT03791255|Calcium|calcium|mesh-list
82977264|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82977265|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977266|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82977267|NCT03742349|Spartalizumab|spartalizumab|mesh-list
82977268|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82977269|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977270|NCT03742349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977271|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977272|NCT03326128|Bupropion|bupropion|mesh-list
82977273|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82977274|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
82977275|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82977276|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82977277|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82977278|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977279|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977280|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
82977281|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977282|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977283|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82977284|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82977285|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977286|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82977287|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82977288|NCT03794297|Trametinib|trametinib|mesh-list
82977289|NCT03794297|Dabrafenib|dabrafenib|mesh-list
82977290|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
82977291|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977292|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82977293|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977294|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977295|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82977296|NCT03794297|Protective Agents|protective agents|mesh-ancestor
82977297|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977298|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82977299|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
82977300|NCT03048500|Metformin|metformin|mesh-list
82977301|NCT03048500|Nivolumab|nivolumab|mesh-list
82977302|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82977303|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977304|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977305|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977306|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82977307|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977308|NCT03790787|Empagliflozin|empagliflozin|mesh-list
82977309|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82977310|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977311|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82977312|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977313|NCT01334268|Paclitaxel|paclitaxel|mesh-list
82977314|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82977315|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977316|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
82977317|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
82977318|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
82977319|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977320|NCT04493398|Erythritol|erythritol|mesh-list
82977321|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
82977322|NCT00908076|Lubiprostone|lubiprostone|mesh-list
82977323|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82977324|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977325|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977326|NCT01305317|Atorvastatin|atorvastatin|mesh-list
82977327|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82977328|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82977329|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
82977330|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977331|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82977332|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83463047|NCT00932152|Analgesics|analgesics|mesh-list
82977333|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977334|NCT02613416|Denosumab|denosumab|mesh-list
82977335|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82977336|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977337|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
82977338|NCT03326050|Rifampin|rifampin|mesh-list
82977339|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
82977340|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82977341|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977342|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82977343|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82977344|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977345|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977346|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977347|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82977348|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82977349|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82977350|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
82977351|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
82977352|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82977353|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82977354|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82977355|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82977356|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82977357|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82977359|NCT01334424|Propofol|propofol|mesh-list
82977360|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82977361|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977362|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977363|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82977364|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
82977365|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
82977366|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82977367|NCT05664685|Bismuth|bismuth|mesh-list
82977368|NCT05664685|Antacids|antacids|mesh-ancestor
82977369|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977370|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82977371|NCT03793517|Decitabine|decitabine|mesh-list
82977372|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82977373|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
82977374|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977375|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977376|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977377|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
82977378|NCT02886702|Tazarotene|tazarotene|mesh-list
82977379|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
82977380|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
82977381|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
82977382|NCT02886702|Vitamins|vitamins|mesh-ancestor
82977383|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
82977384|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977385|NCT03498313|Estradiol|estradiol|mesh-list
82977386|NCT03498313|Progesterone|progesterone|mesh-list
82977387|NCT03498313|Estrogens|estrogens|mesh-ancestor
82977388|NCT03498313|Hormones|hormones|mesh-ancestor
82977389|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82977390|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977391|NCT03498313|Progestins|progestins|mesh-ancestor
82977392|NCT03721081|Lidocaine|lidocaine|mesh-list
82977393|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
82977394|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
82977395|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977396|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977397|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
82977398|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977399|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82977400|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82977401|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82977402|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977403|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977404|NCT04493554|Vasopressins|vasopressins|mesh-list
82977405|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
82977406|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
82977407|NCT04493554|Coagulants|coagulants|mesh-ancestor
82977408|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82977409|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82977410|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
82977411|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977412|NCT02601014|Nivolumab|nivolumab|mesh-list
82977413|NCT02601014|Ipilimumab|ipilimumab|mesh-list
82977414|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977415|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977416|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82977417|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977418|NCT01307046|Losartan|losartan|mesh-list
82977419|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82977420|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82977421|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82977422|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82977423|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977424|NCT05419115|Furosemide|furosemide|mesh-list
82977425|NCT05419115|Diuretics|diuretics|mesh-ancestor
82977426|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
82977427|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977428|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82977429|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977430|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977431|NCT02490592|Fluorides|fluorides|mesh-list
82977432|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
82977433|NCT02490592|Protective Agents|protective agents|mesh-ancestor
82977434|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977435|NCT03075462|Apatinib|apatinib|mesh-list
82977436|NCT03075462|Fluzoparib|fluzoparib|mesh-list
82977437|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977438|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82977439|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977440|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977441|NCT03075462|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82977442|NCT01305395|Sirolimus|sirolimus|mesh-list
82977443|NCT01305395|Temsirolimus|temsirolimus|mesh-list
82977444|NCT01305395|MTOR Inhibitors|mtor inhibitors|mesh-list
82977445|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82977446|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977447|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82977448|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977449|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
82977450|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977451|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
82977452|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977453|NCT01305395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82977454|NCT01305395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977455|NCT01305395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977456|NCT02886624|Grazoprevir|grazoprevir|mesh-list
82977457|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82977458|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
82977459|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977460|NCT02487316|Crizotinib|crizotinib|mesh-list
82977461|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977462|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82977463|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977464|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977465|NCT02490436|Cetuximab|cetuximab|mesh-list
82977466|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977467|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977468|NCT03318718|Rocuronium|rocuronium|mesh-list
82977469|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977470|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82977471|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82977472|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82977473|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977474|NCT03325348|Labetalol|labetalol|mesh-list
82977475|NCT03325348|Nifedipine|nifedipine|mesh-list
82977476|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82977477|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977478|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977479|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82977480|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977481|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
82977482|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
82977483|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82977484|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82977485|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82977486|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
82977487|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977488|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82977489|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
82977490|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
82977491|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521007|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82977492|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82977493|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82977494|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
82977495|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
82977496|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
82977497|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977498|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977499|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
82977500|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977501|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
82977502|NCT03325270|Trace Elements|trace elements|mesh-ancestor
82977503|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
82977504|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977505|NCT02963766|Dulaglutide|dulaglutide|mesh-list
82977506|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82977507|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977508|NCT01334502|Prednisone|prednisone|mesh-list
82977509|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
82977510|NCT01334502|Rituximab|rituximab|mesh-list
82977511|NCT01334502|Doxorubicin|doxorubicin|mesh-list
82977512|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82977513|NCT01334502|Vincristine|vincristine|mesh-list
82977514|NCT01334502|Everolimus|everolimus|mesh-list
82977515|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977516|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
82977517|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977518|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977519|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82977520|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
82977521|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977522|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977523|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82977524|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977525|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82977526|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82977527|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82977528|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977529|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977530|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
82977531|NCT01334502|Hormones|hormones|mesh-ancestor
82977532|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82977533|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82977534|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82977535|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
82977536|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
82977537|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
82977538|NCT01334502|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82977539|NCT01334502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82977540|NCT02487082|Melatonin|melatonin|mesh-list
82977541|NCT02487082|Donepezil|donepezil|mesh-list
82977542|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
82977543|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977544|NCT02487082|Protective Agents|protective agents|mesh-ancestor
82977545|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977546|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977547|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82977548|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977549|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
82977550|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977551|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
82977552|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82977553|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82977554|NCT03788681|Estradiol|estradiol|mesh-list
82977555|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82977556|NCT03788681|Estrogens|estrogens|mesh-ancestor
82977557|NCT03788681|Hormones|hormones|mesh-ancestor
82977558|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82977559|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977560|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82977561|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
82977562|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82977563|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82977564|NCT01308203|Niacin|niacin|mesh-list
82977565|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82977566|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
82977567|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977568|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82977569|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
82977570|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
82977571|NCT01308203|Vitamins|vitamins|mesh-ancestor
82977572|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
82977573|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977574|NCT03790085|Olanzapine|olanzapine|mesh-list
82977575|NCT03790085|Risperidone|risperidone|mesh-list
82977576|NCT03790085|Aripiprazole|aripiprazole|mesh-list
82977577|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82977578|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
82977579|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977580|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977581|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977582|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82977583|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82977584|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977586|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82977587|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
82977588|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
82977589|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
82977590|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977591|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82977592|NCT03790085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82977593|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82977594|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977595|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
82977596|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
82977597|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82977598|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82977599|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82977600|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82977601|NCT01306097|Zinc|zinc|mesh-list
82977602|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
82977603|NCT01306097|Trace Elements|trace elements|mesh-ancestor
82977604|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
82977605|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977606|NCT01306097|Astringents|astringents|mesh-ancestor
82977607|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
82977608|NCT03790007|Bupivacaine|bupivacaine|mesh-list
82977609|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
82977610|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
82977611|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977612|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977613|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
82977614|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977615|NCT03789695|Dabigatran|dabigatran|mesh-list
82977616|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
82977617|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82977618|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
82977619|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977620|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977621|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
82977622|NCT00739674|Losartan|losartan|mesh-list
82977623|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82977624|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
82977625|NCT00739674|Calcium|calcium|mesh-list
82977626|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82977627|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977628|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82977629|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82977630|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82977631|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82977632|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977633|NCT00739674|Diuretics|diuretics|mesh-ancestor
82977634|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
82977635|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82977636|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977637|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
82977638|NCT01306409|Hematinics|hematinics|mesh-ancestor
82977639|NCT01331928|Docetaxel|docetaxel|mesh-list
82977640|NCT01331928|Capecitabine|capecitabine|mesh-list
82977641|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
82977642|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977643|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
82977644|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
82977645|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
82977646|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977647|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82977648|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
82977649|NCT01334580|Methadone|methadone|mesh-list
82977650|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82977651|NCT01334580|Narcotics|narcotics|mesh-ancestor
82977652|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977653|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977654|NCT01334580|Analgesics|analgesics|mesh-ancestor
82977655|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
82977656|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977657|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
82977658|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
82977659|NCT02694588|Infliximab|infliximab|mesh-list
82977660|NCT02694588|Vedolizumab|vedolizumab|mesh-list
82977661|NCT02694588|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82977662|NCT02694588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977663|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
82977664|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82977665|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977666|NCT03789539|Vaccines|vaccines|mesh-list
82977667|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
82977668|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977669|NCT00400218|Losartan|losartan|mesh-list
82977670|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82977671|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82977672|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82977673|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83463080|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
82977674|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82977675|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977676|NCT00400218|Diuretics|diuretics|mesh-ancestor
82977677|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
82977678|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977679|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82977680|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82977681|NCT02486848|Minoxidil|minoxidil|mesh-list
82977682|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82977683|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82977684|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
82977685|NCT01306565|Atorvastatin|atorvastatin|mesh-list
82977686|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82977687|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82977688|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
82977689|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977690|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82977691|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82977692|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977693|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
82977694|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977695|NCT03786029|Acetaminophen|acetaminophen|mesh-list
82977696|NCT03786029|Ibuprofen|ibuprofen|mesh-list
82977697|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82977698|NCT03786029|Analgesics|analgesics|mesh-ancestor
82977699|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
82977700|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977701|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977702|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
82977703|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82977704|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977705|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977706|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82977707|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977708|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977709|NCT01334892|Cyclosporine|cyclosporine|mesh-list
82977710|NCT01334892|Cyclosporins|cyclosporins|mesh-list
82977711|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977712|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977713|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977714|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
82977715|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977716|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
82977717|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977718|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
82977719|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977720|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82977721|NCT04730219|Paclitaxel|paclitaxel|mesh-list
82977722|NCT04730219|Tislelizumab|tislelizumab|mesh-list
82977723|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82977724|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977725|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
82977726|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
82977727|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
82977728|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977729|NCT04730219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977730|NCT04492774|Dexamethasone|dexamethasone|mesh-list
82977731|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977732|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
82977733|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
82977734|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977735|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977736|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82977737|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
82977738|NCT04492774|Hormones|hormones|mesh-ancestor
82977739|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82977740|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82977741|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977742|NCT03321292|Aspirin|aspirin|mesh-list
83221007|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82977743|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82977744|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82977745|NCT03321292|Analgesics|analgesics|mesh-ancestor
82977746|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
82977747|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977748|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977749|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977750|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977751|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82977752|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82977753|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977754|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82977755|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82977756|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977757|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
82977758|NCT01306721|Fexofenadine|fexofenadine|mesh-list
82977759|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
82977760|NCT01306721|Ephedrine|ephedrine|mesh-list
82977761|NCT01306721|Terfenadine|terfenadine|mesh-list
82977762|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82977763|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
82977764|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977765|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977766|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82977767|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
82977768|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
82977769|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82977770|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82977771|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
82977772|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
82977773|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977774|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977775|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82977776|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82977777|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82977778|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
82977779|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
82977780|NCT01337466|Fialuridine|fialuridine|mesh-list
82977781|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
82977782|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977783|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82977784|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977785|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977786|NCT02486926|Remifentanil|remifentanil|mesh-list
82977787|NCT02486926|Alfentanil|alfentanil|mesh-list
82977788|NCT02486926|Thiopental|thiopental|mesh-list
82977789|NCT02486926|Sevoflurane|sevoflurane|mesh-list
82977790|NCT02486926|Rocuronium|rocuronium|mesh-list
82977791|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82977792|NCT02486926|Narcotics|narcotics|mesh-ancestor
82977793|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977794|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977795|NCT02486926|Analgesics|analgesics|mesh-ancestor
82977796|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
82977797|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977798|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82977799|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82977800|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
82977801|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
82977802|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82977803|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82977804|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82977805|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82977806|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
82977807|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82977808|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
82977809|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
82977810|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977811|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977812|NCT01335048|Clopidogrel|clopidogrel|mesh-list
82977813|NCT01335048|Atorvastatin|atorvastatin|mesh-list
82977814|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82977815|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82977816|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
82977817|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977818|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82977819|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82977820|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977821|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82977822|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82977823|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82977824|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82977825|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
82977826|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977827|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977828|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
82977829|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82977830|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82977831|NCT01567475|Rituximab|rituximab|mesh-list
82977832|NCT01567475|Everolimus|everolimus|mesh-list
82977833|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82977834|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977835|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
82977836|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977837|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977838|NCT01567475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82977839|NCT01567475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82977840|NCT01567475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977841|NCT01567475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977842|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977843|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
82977844|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82977845|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
82977846|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
82977847|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977848|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977849|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82977850|NCT03435055|Analgesics|analgesics|mesh-ancestor
82977851|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
82977852|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977853|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
82977854|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82977855|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82977856|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82977857|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
82977858|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977859|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977860|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977861|NCT03316066|Ropivacaine|ropivacaine|mesh-list
82977862|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
82977863|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
82977864|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977865|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977866|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
82977867|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977868|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
82977869|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977870|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
82977871|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977872|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977873|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82977874|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
82977875|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977876|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977877|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82977878|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82977879|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82977880|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82977881|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977882|NCT01335360|Nevirapine|nevirapine|mesh-list
82977883|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82977884|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82977885|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977886|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977887|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
82977888|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977889|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82977890|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82977891|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82977892|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82977893|NCT02489266|Aldesleukin|aldesleukin|mesh-list
82977894|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
82977895|NCT02489266|Fludarabine|fludarabine|mesh-list
82977896|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82977897|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
82977898|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977899|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82977900|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82977901|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
82977902|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977903|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977904|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82977905|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82977906|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82977907|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
82977908|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977909|NCT03434119|Insulin|insulin|mesh-list
82977910|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82977911|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
82977912|NCT03434119|Lixisenatide|lixisenatide|mesh-list
82977913|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82977914|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977915|NCT02484352|Oxycodone|oxycodone|mesh-list
82977916|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82977917|NCT02484352|Narcotics|narcotics|mesh-ancestor
82977918|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82977919|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977920|NCT02484352|Analgesics|analgesics|mesh-ancestor
82977921|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
82977922|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977923|NCT01308671|Varenicline|varenicline|mesh-list
82977924|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82977925|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82977926|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
82977927|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977928|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977929|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977930|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
82977931|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82977932|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
82977933|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82977934|NCT03315676|Esomeprazole|esomeprazole|mesh-list
82977935|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82977936|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82977937|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82977938|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977939|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977940|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
82977941|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82977942|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
82977943|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82977944|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977945|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82977946|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
82977947|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
82977948|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82977949|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
82977950|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977951|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977952|NCT02486458|Listerine|listerine|mesh-list
82977953|NCT02486458|Fluorides|fluorides|mesh-list
82977954|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
82977955|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
82977956|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
82977957|NCT02486458|Protective Agents|protective agents|mesh-ancestor
82977958|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977959|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82977960|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977961|NCT01335516|Terlipressin|terlipressin|mesh-list
82977963|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82977964|NCT05694923|Empagliflozin|empagliflozin|mesh-list
82977965|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82977966|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977967|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82977968|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977969|NCT01332396|Lapatinib|lapatinib|mesh-list
82977970|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977971|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82977972|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977973|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977974|NCT03719053|Tenofovir|tenofovir|mesh-list
82977975|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
82977976|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82977977|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82977978|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82977979|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82977980|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977981|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82977982|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82977983|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82977984|NCT03526848|Antibodies|antibodies|mesh-list
82977985|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
82977986|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82977987|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
82977988|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977989|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82977990|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
82977991|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
82977992|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82977993|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82977994|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82977995|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
82977996|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82977997|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82977998|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82977999|NCT01332552|Ritonavir|ritonavir|mesh-list
82978000|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82978001|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82978002|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
82978003|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978004|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978005|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82978006|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82978007|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
82978008|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978009|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82978010|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82978011|NCT03720223|Bupivacaine|bupivacaine|mesh-list
82978012|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
82978013|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
82978014|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978015|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978016|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
82978017|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978018|NCT03160716|Lidocaine|lidocaine|mesh-list
82978019|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
82978020|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
82978021|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978022|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978023|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
82978024|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978025|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82978026|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82978027|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82978028|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978029|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978030|NCT00092664|Simvastatin|simvastatin|mesh-list
82978031|NCT00092664|Ezetimibe|ezetimibe|mesh-list
82978032|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82978033|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82978034|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
82978035|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978037|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82978038|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978039|NCT02483884|Bombesin|bombesin|mesh-list
82978040|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978041|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978042|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978043|NCT03317548|Progesterone|progesterone|mesh-list
82978044|NCT03317548|Progestins|progestins|mesh-ancestor
82978045|NCT03317548|Hormones|hormones|mesh-ancestor
82978046|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978047|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978048|NCT00092586|Ezetimibe|ezetimibe|mesh-list
82978049|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82978050|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82978051|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
82978052|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978053|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82978054|NCT03786887|Nalbuphine|nalbuphine|mesh-list
82978055|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82978056|NCT03786887|Narcotics|narcotics|mesh-ancestor
82978057|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978058|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978059|NCT03786887|Analgesics|analgesics|mesh-ancestor
82978060|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
82978061|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978062|NCT03787043|Metformin|metformin|mesh-list
82978063|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82978064|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978065|NCT00090168|Atorvastatin|atorvastatin|mesh-list
82978066|NCT00090168|Simvastatin|simvastatin|mesh-list
82978067|NCT00090168|Ezetimibe|ezetimibe|mesh-list
82978068|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82978069|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82978070|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
82978071|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978072|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82978073|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82978074|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978075|NCT01332786|Tigecycline|tigecycline|mesh-list
82978076|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82978077|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978078|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82978079|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978080|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978081|NCT01338090|Bevacizumab|bevacizumab|mesh-list
82978082|NCT01338090|Everolimus|everolimus|mesh-list
82978083|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
82978084|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82978085|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978086|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82978087|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82978088|NCT01338090|Growth Substances|growth substances|mesh-ancestor
82978089|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978090|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
82978091|NCT01338090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82978092|NCT01338090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82978093|NCT01338090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978094|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978095|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978096|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
82978097|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82978098|NCT01307969|Lidocaine|lidocaine|mesh-list
82978099|NCT01307969|Epinephrine|epinephrine|mesh-list
82978100|NCT01307969|Racepinephrine|racepinephrine|mesh-list
82978101|NCT01307969|Ropivacaine|ropivacaine|mesh-list
82978102|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
82978103|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
82978104|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
82978105|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978106|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978107|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
82978108|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978109|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82978110|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82978111|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82978112|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978113|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978114|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82978115|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82978116|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
82978117|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978118|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82978119|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82978120|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
82978121|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82978122|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
82978123|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
82978124|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
82978125|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82978126|NCT03786419|Atezolizumab|atezolizumab|mesh-list
82978127|NCT03786419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82978128|NCT03786419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978129|NCT03786419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82978130|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978131|NCT01338324|Simvastatin|simvastatin|mesh-list
82978132|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82978133|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82978134|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
82978135|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978136|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82978137|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82978138|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978140|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82978141|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82978142|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978143|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
82978144|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
82978145|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
82978146|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978147|NCT05694221|Metformin|metformin|mesh-list
82978148|NCT05694221|Digoxin|digoxin|mesh-list
82978149|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82978150|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978151|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82978152|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82978153|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978154|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978155|NCT05694221|Protective Agents|protective agents|mesh-ancestor
82978156|NCT01308047|Bupivacaine|bupivacaine|mesh-list
82978157|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
82978158|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
82978159|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978160|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978161|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
83221008|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
82978162|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978163|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
82978164|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
82978165|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
82978166|NCT03777761|Tucatinib|tucatinib|mesh-list
82978167|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82978168|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978169|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82978170|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82978171|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978172|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463125|NCT01844206|Analgesics|analgesics|mesh-ancestor
82978173|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978174|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82978175|NCT01316861|Acarbose|acarbose|mesh-list
82978176|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
82978177|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978178|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978179|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82978180|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978181|NCT01336218|Rifampin|rifampin|mesh-list
82978182|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82978183|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
82978184|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82978185|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978186|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
82978187|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82978188|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978189|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978190|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82978191|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82978192|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82978193|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82978194|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82978195|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82978196|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82978197|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978198|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82978199|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978200|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
82978201|NCT03776279|Analgesics|analgesics|mesh-ancestor
82978202|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
82978203|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978204|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978205|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978206|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82978207|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82978208|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978209|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978210|NCT01561391|Factor VIII|factor viii|mesh-list
82978211|NCT01561391|Coagulants|coagulants|mesh-ancestor
82978212|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
82978213|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82978214|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978215|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978216|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978217|NCT03775655|Analgesics|analgesics|mesh-ancestor
82978218|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
82978219|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978220|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82978221|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82978222|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82978223|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
82978224|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978225|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978226|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
82978227|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82978228|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978229|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
82978230|NCT03781895|Vitamin D|vitamin d|mesh-list
82978231|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82978232|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978233|NCT03781895|Vitamins|vitamins|mesh-ancestor
82978234|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
82978235|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82978236|NCT00706030|Vinorelbine|vinorelbine|mesh-list
82978237|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82978238|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978239|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
82978240|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
82978241|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
82978242|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978243|NCT03781505|Acetaminophen|acetaminophen|mesh-list
82978244|NCT03781505|Ropivacaine|ropivacaine|mesh-list
82978245|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
82978247|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978248|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978249|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
82978250|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978251|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978252|NCT03781505|Analgesics|analgesics|mesh-ancestor
82978253|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
82978254|NCT03781115|Olanzapine|olanzapine|mesh-list
82978255|NCT03781115|Ziprasidone|ziprasidone|mesh-list
82978256|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
82978257|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
82978258|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978259|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978260|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82978261|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82978262|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82978263|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978264|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82978265|NCT03781115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82978266|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82978267|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978268|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978269|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978270|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
82978271|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82978272|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82978273|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
82978274|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82978275|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
82978276|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82978277|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82978278|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82978279|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978280|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978281|NCT01313429|Celecoxib|celecoxib|mesh-list
82978282|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
82978283|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978284|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
82978285|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978286|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978287|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82978288|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
82978289|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978290|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978291|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82978292|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82978293|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978294|NCT01313429|Analgesics|analgesics|mesh-ancestor
82978295|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
82978296|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978297|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978298|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83463128|NCT03626454|Norepinephrine|norepinephrine|mesh-list
82978299|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82978300|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978301|NCT03488251|Gemcitabine|gemcitabine|mesh-list
82978302|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
82978303|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82978304|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
82978305|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978306|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978307|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
82978308|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82978309|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978310|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82978311|NCT03315520|Cytarabine|cytarabine|mesh-list
82978312|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
82978313|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82978314|NCT03315520|Etoposide|etoposide|mesh-list
82978315|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978316|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
82978317|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978318|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978319|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82978320|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
82978321|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978322|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978323|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82978324|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82978325|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82978326|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82978327|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978328|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82978330|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
82978331|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978332|NCT02483182|Acyclovir|acyclovir|mesh-list
82978333|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
82978334|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978335|NCT01338558|Bevacizumab|bevacizumab|mesh-list
82978336|NCT01338558|Cetuximab|cetuximab|mesh-list
82978337|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82978338|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978339|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82978340|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82978341|NCT01338558|Growth Substances|growth substances|mesh-ancestor
82978342|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978343|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
82978344|NCT03780569|Temozolomide|temozolomide|mesh-list
82978345|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82978346|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
82978347|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978348|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978349|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82978350|NCT03487549|Cantharidin|cantharidin|mesh-list
82978351|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978352|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978353|NCT01313585|Beclomethasone|beclomethasone|mesh-list
82978354|NCT01313585|Albuterol|albuterol|mesh-list
82978355|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82978356|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
82978357|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978358|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978359|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82978360|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
82978361|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
82978362|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82978363|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82978364|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82978365|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82978366|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
82978367|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978368|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978369|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978370|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
82978371|NCT01313585|Hormones|hormones|mesh-ancestor
82978372|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978373|NCT01561235|Hormones|hormones|mesh-list
82978374|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978375|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978376|NCT02485990|Olaparib|olaparib|mesh-list
82978377|NCT02485990|Tremelimumab|tremelimumab|mesh-list
82978378|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82978379|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978380|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978381|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978382|NCT01313819|Amantadine|amantadine|mesh-list
82978383|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82978384|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82978385|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
82978386|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978387|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
82978388|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978389|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978390|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978391|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978392|NCT01313819|Analgesics|analgesics|mesh-ancestor
82978393|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
82978394|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978395|NCT03315442|Caffeine|caffeine|mesh-list
82978396|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82978397|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978398|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82978399|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978400|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978401|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82978402|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82978403|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
82978404|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978405|NCT03464383|Escitalopram|escitalopram|mesh-list
82978406|NCT03464383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82978407|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82978408|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978409|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978410|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978411|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
82978412|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978413|NCT03315364|Paclitaxel|paclitaxel|mesh-list
82978414|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82978415|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82978416|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978417|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
82978418|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
82978419|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
82978420|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978421|NCT03779633|Estradiol|estradiol|mesh-list
82978422|NCT03779633|Estrogens|estrogens|mesh-ancestor
82978423|NCT03779633|Hormones|hormones|mesh-ancestor
82978424|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978425|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978426|NCT03720067|Propranolol|propranolol|mesh-list
82978427|NCT03720067|Carvedilol|carvedilol|mesh-list
82978428|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82978429|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82978430|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82978431|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
82978432|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978433|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82978434|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82978435|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978436|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82978437|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82978438|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
83463139|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82978439|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978440|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978441|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82978442|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82978443|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
82978444|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
82978445|NCT03720067|Protective Agents|protective agents|mesh-ancestor
82978446|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82978447|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978448|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82978449|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82978450|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82978451|NCT01444092|Budesonide|budesonide|mesh-list
82978452|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978453|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82978454|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
82978455|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978456|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978457|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82978458|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
82978459|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
82978460|NCT01444092|Hormones|hormones|mesh-ancestor
82978461|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978462|NCT03719989|Azacitidine|azacitidine|mesh-list
82978463|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82978464|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
82978465|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521008|NCT00390793|Methotrexate|methotrexate|mesh-list
82978466|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978467|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978468|NCT05462470|Liver Extracts|liver extracts|mesh-list
82978469|NCT05462470|Hematinics|hematinics|mesh-ancestor
82978470|NCT03779087|Amoxicillin|amoxicillin|mesh-list
82978471|NCT03779087|Levofloxacin|levofloxacin|mesh-list
82978472|NCT03779087|Ofloxacin|ofloxacin|mesh-list
82978473|NCT03779087|Tetracycline|tetracycline|mesh-list
82978474|NCT03779087|Esomeprazole|esomeprazole|mesh-list
82978475|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82978476|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978477|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82978478|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82978479|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82978480|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978481|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978482|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82978483|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82978484|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82978485|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978486|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82978487|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82978488|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82978489|NCT01265784|Ertapenem|ertapenem|mesh-list
82978490|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82978491|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978492|NCT05692271|Propranolol|propranolol|mesh-list
82978493|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82978494|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82978495|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
82978496|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978497|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978498|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978499|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82978500|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82978501|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
82978502|NCT03774953|Vitamins|vitamins|mesh-list
82978503|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
82978504|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978505|NCT02483026|Vitamin D|vitamin d|mesh-list
82978506|NCT02483026|Vitamins|vitamins|mesh-list
82978507|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
82978508|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978509|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82978510|NCT02483104|Paclitaxel|paclitaxel|mesh-list
82978511|NCT02483104|Carboplatin|carboplatin|mesh-list
82978512|NCT02483104|Veliparib|veliparib|mesh-list
82978513|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82978514|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978515|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
82978516|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
82978517|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
82978518|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978519|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82978520|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978521|NCT00116220|Goserelin|goserelin|mesh-list
82978522|NCT00116220|Flutamide|flutamide|mesh-list
82978523|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978524|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82978525|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978526|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
82978527|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
82978528|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978529|NCT03785015|Aspirin|aspirin|mesh-list
82978530|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82978531|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978532|NCT03785015|Analgesics|analgesics|mesh-ancestor
82978533|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
82978534|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978535|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978536|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978537|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978538|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82978539|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82978540|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978541|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82978542|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82978543|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978545|NCT04867343|Fentanyl|fentanyl|mesh-list
82978546|NCT04867343|Remifentanil|remifentanil|mesh-list
82978547|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82978548|NCT04867343|Narcotics|narcotics|mesh-ancestor
82978549|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978550|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978551|NCT04867343|Analgesics|analgesics|mesh-ancestor
82978552|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
82978553|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978554|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82978555|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82978556|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
82978557|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
82978558|NCT05185518|Insulin|insulin|mesh-list
82978559|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82978560|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978561|NCT03316690|Metformin|metformin|mesh-list
82978562|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82978563|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978564|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
82978565|NCT03315052|Prednisone|prednisone|mesh-list
82978566|NCT03315052|Budesonide|budesonide|mesh-list
82978567|NCT03315052|Tacrolimus|tacrolimus|mesh-list
82978568|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978569|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
82978570|NCT03315052|Hormones|hormones|mesh-ancestor
82978571|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978572|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978573|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82978574|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978575|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978576|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
82978577|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82978578|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978579|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978580|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82978581|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82978582|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
82978583|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82978584|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978585|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82978586|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
82978587|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978588|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82978589|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
82978590|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
82978591|NCT03778619|Rituximab|rituximab|mesh-list
82978592|NCT03778619|Fludarabine|fludarabine|mesh-list
82978593|NCT03778619|Interleukin-2|interleukin-2|mesh-list
82978594|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978595|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
82978596|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978597|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978598|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82978599|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
82978600|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978601|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978602|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82978603|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82978604|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978605|NCT03778619|Analgesics|analgesics|mesh-ancestor
82978606|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
82978607|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978608|NCT05714176|Lactoferrin|lactoferrin|mesh-list
82978609|NCT05714176|Dextrans|dextrans|mesh-list
82978610|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
82978611|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978612|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
82978613|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
82978614|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
82978615|NCT05714176|Hematinics|hematinics|mesh-ancestor
82978616|NCT03156504|Ketamine|ketamine|mesh-list
82978617|NCT03156504|Analgesics|analgesics|mesh-ancestor
82978618|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
82978619|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978620|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978621|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82978622|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82978623|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
82978624|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
82978625|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978626|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82978627|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82978628|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978629|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978630|NCT01333332|Capecitabine|capecitabine|mesh-list
82978631|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82978632|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
82978633|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978634|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978635|NCT03316534|Aspirin|aspirin|mesh-list
82978636|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82978637|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978638|NCT03316534|Analgesics|analgesics|mesh-ancestor
82978639|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
82978640|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978641|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978642|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978643|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978644|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82978645|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82978646|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978647|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82978648|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82978649|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978650|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
82978651|NCT04476420|Betamethasone|betamethasone|mesh-list
83463152|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978652|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
82978653|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82978654|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
82978655|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82978656|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978657|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
82978658|NCT04476420|Hormones|hormones|mesh-ancestor
82978659|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82978660|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978661|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82978662|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
82978663|NCT03778541|Temozolomide|temozolomide|mesh-list
82978664|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82978665|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
82978666|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978667|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978668|NCT02479828|Ropivacaine|ropivacaine|mesh-list
82978669|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
82978670|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
82978671|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978672|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978673|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
82978674|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978675|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
82978676|NCT01320449|Hematinics|hematinics|mesh-ancestor
82978677|NCT03430063|Ipilimumab|ipilimumab|mesh-list
82978678|NCT03430063|Cemiplimab|cemiplimab|mesh-list
82978679|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82978680|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978681|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82978682|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978683|NCT03158220|Vaccines|vaccines|mesh-list
82978684|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
82978685|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978686|NCT01308983|Amiloride|amiloride|mesh-list
82978687|NCT01308983|Diuretics|diuretics|mesh-ancestor
82978688|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
82978689|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978690|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82978691|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82978692|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133557|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
82978693|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978694|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82978695|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82978696|NCT01336842|Pemetrexed|pemetrexed|mesh-list
82978697|NCT01336842|Panobinostat|panobinostat|mesh-list
82978698|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978699|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978700|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978701|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82978702|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82978703|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82978704|NCT05178407|Micronutrients|micronutrients|mesh-list
82978705|NCT05178407|Trace Elements|trace elements|mesh-list
82978706|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978707|NCT01339026|Clopidogrel|clopidogrel|mesh-list
82978708|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82978709|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82978710|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82978711|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82978712|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82978713|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
82978714|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978715|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978716|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978717|NCT03314740|Paclitaxel|paclitaxel|mesh-list
82978718|NCT03314740|Olaparib|olaparib|mesh-list
82978719|NCT03314740|Cediranib|cediranib|mesh-list
82978720|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82978721|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463155|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
82978722|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
82978723|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
82978724|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
82978725|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978726|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82978727|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978728|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82978729|NCT02482636|Vaccines|vaccines|mesh-list
82978730|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82978731|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
82978732|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978733|NCT02482402|Iloprost|iloprost|mesh-list
82978734|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82978735|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
82978736|NCT03774095|Pycnogenols|pycnogenols|mesh-list
82978737|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82978738|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
82978739|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978740|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
82978741|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978742|NCT03774095|Protective Agents|protective agents|mesh-ancestor
82978743|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82978744|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
82978745|NCT01333410|Tacrolimus|tacrolimus|mesh-list
82978746|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978747|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
82978748|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978749|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82978750|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978751|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978752|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978753|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
82978754|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82978755|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
82978756|NCT02482090|Fludarabine|fludarabine|mesh-list
82978757|NCT02482090|Interleukin-2|interleukin-2|mesh-list
82978758|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978759|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
82978760|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978761|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978762|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82978763|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
82978764|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978765|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978766|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82978767|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978768|NCT02482090|Analgesics|analgesics|mesh-ancestor
82978769|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
82978770|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978771|NCT02482324|Ibuprofen|ibuprofen|mesh-list
82978772|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82978773|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978774|NCT02482324|Analgesics|analgesics|mesh-ancestor
82978775|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
82978776|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978777|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978778|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978779|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978780|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82978781|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463159|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978782|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978784|NCT05185284|Favipiravir|favipiravir|mesh-list
82978785|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
82978786|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978787|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
82978788|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978789|NCT03784703|Atorvastatin|atorvastatin|mesh-list
82978790|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82978791|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82978792|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82978793|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
82978794|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978795|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82978796|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82978797|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978798|NCT02724592|Fluorides|fluorides|mesh-list
82978799|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
82978800|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
82978801|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
82978802|NCT02724592|Protective Agents|protective agents|mesh-ancestor
82978803|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978804|NCT02476864|Macitentan|macitentan|mesh-list
82978805|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82978806|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82978807|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978808|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82978809|NCT05451550|Anesthetics|anesthetics|mesh-list
82978810|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82978811|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978812|NCT02476708|Curcumin|curcumin|mesh-list
82978813|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82978814|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978815|NCT02476708|Analgesics|analgesics|mesh-ancestor
82978816|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
82978817|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978818|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978819|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978820|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978821|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978822|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978823|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978824|NCT02479204|Atenolol|atenolol|mesh-list
82978825|NCT02479204|Diltiazem|diltiazem|mesh-list
82978826|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82978827|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82978828|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
82978829|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
82978830|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978831|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978832|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82978833|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82978834|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82978835|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
82978836|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978837|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978838|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82978839|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978840|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82978841|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
82978842|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
82978843|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
82978844|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978845|NCT01339572|Plerixafor|plerixafor|mesh-list
83463173|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82978846|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82978847|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82978848|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
82978849|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978850|NCT04199117|Nicotine|nicotine|mesh-list
82978851|NCT04199117|Varenicline|varenicline|mesh-list
82978852|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82978853|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
82978854|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978855|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978856|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82978857|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82978858|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
82978859|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978860|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978861|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
82978862|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82978863|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
82978864|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978865|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978866|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82978867|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
82978868|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
82978869|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82978870|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
82978871|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978872|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978873|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
82978874|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
82978875|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82978876|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82978877|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978878|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978879|NCT03154476|Urological Agents|urological agents|mesh-ancestor
82978880|NCT03784391|Nifurtimox|nifurtimox|mesh-list
82978881|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82978882|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82978883|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82978884|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978885|NCT02476552|Niraparib|niraparib|mesh-list
82978886|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82978887|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978888|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978889|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978890|NCT01316718|Mesalamine|mesalamine|mesh-list
82978891|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82978892|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82978893|NCT01316718|Analgesics|analgesics|mesh-ancestor
82978894|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
82978895|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82978896|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978897|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82978898|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82978899|NCT01316952|Carvedilol|carvedilol|mesh-list
82978900|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82978901|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
82978902|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
82978903|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82978904|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978905|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978906|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82978907|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
82978908|NCT01316952|Protective Agents|protective agents|mesh-ancestor
82978909|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82978910|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978911|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82978912|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
82978913|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82978914|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82978915|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82978916|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82978917|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978918|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
82978919|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
82978920|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82978921|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
82978922|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82978923|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978924|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82978925|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82978926|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82978927|NCT03768713|Suvorexant|suvorexant|mesh-list
82978928|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82978929|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82978943|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978944|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978945|NCT02481076|Ionophores|ionophores|mesh-ancestor
82978946|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82978947|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
82978961|NCT05713396|Losartan|losartan|mesh-list
82978962|NCT05713396|Quinapril|quinapril|mesh-list
82978963|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82978964|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82978965|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82978966|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82978967|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978968|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82978969|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
82978970|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978971|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
82978972|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
82978973|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978974|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82978975|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82978976|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978977|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
82978978|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82978979|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
82978980|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
82978981|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82978982|NCT02475382|Nivolumab|nivolumab|mesh-list
82978983|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82978984|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82978985|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82978986|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978987|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82978988|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
82978989|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82978990|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
82978991|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978992|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
82978993|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
82978994|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82978995|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
82978996|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82978997|NCT05371288|Protective Agents|protective agents|mesh-ancestor
82978998|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82978999|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
82979000|NCT05371288|Vitamins|vitamins|mesh-ancestor
83463194|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979001|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
82979002|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
82979003|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979004|NCT05371288|Expectorants|expectorants|mesh-ancestor
82979005|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
82979006|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82979007|NCT05371288|Antidotes|antidotes|mesh-ancestor
82979008|NCT02478424|Cyclosporine|cyclosporine|mesh-list
82979009|NCT02478424|Methotrexate|methotrexate|mesh-list
82979010|NCT02478424|Cannabidiol|cannabidiol|mesh-list
82979011|NCT02478424|Cyclosporins|cyclosporins|mesh-list
82979012|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82979013|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
82979014|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82979015|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979016|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82979017|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
82979018|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979019|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979020|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
82979021|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979022|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82979023|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979024|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
82979025|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979026|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82979027|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
82979028|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979029|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82979030|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
82979031|NCT03712787|Tilavonemab|tilavonemab|mesh-list
82979032|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
82979033|NCT02478268|Xenon|xenon|mesh-list
82979034|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82979035|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
82979036|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
82979037|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979038|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979039|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
82979040|NCT04053881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82979041|NCT04053881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979042|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979043|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
82979044|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979045|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979046|NCT03768557|Minocycline|minocycline|mesh-list
82979047|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82979048|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979049|NCT03783845|Amoxicillin|amoxicillin|mesh-list
82979050|NCT03783845|Metronidazole|metronidazole|mesh-list
82979051|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82979052|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979053|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82979054|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82979055|NCT01560689|Budesonide|budesonide|mesh-list
82979056|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
82979057|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979058|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82979059|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
82979060|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979061|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979062|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82979063|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
82979064|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
82979065|NCT01560689|Hormones|hormones|mesh-ancestor
82979066|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979067|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82979068|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82979069|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82979070|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
82979071|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83463203|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83463205|NCT00843310|Hormones|hormones|mesh-ancestor
82979072|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979073|NCT02474914|Octreotide|octreotide|mesh-list
82979074|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82979075|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82979076|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979077|NCT03769103|Osimertinib|osimertinib|mesh-list
82979078|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979079|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979080|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979081|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979083|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
82979084|NCT04998214|Coagulants|coagulants|mesh-ancestor
82979085|NCT01309607|Paclitaxel|paclitaxel|mesh-list
82979086|NCT01309607|Carboplatin|carboplatin|mesh-list
82979087|NCT01309607|Lapatinib|lapatinib|mesh-list
82979088|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82979089|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979090|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
82979091|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
82979092|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
82979093|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979094|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979095|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979096|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
82979097|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82979098|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
82979099|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979100|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
82979101|NCT03783455|Protective Agents|protective agents|mesh-ancestor
82979102|NCT05305066|Adalimumab|adalimumab|mesh-list
82979103|NCT05305066|Golimumab|golimumab|mesh-list
82979104|NCT05305066|Etanercept|etanercept|mesh-list
82979105|NCT05305066|Upadacitinib|upadacitinib|mesh-list
82979106|NCT05305066|Tofacitinib|tofacitinib|mesh-list
82979107|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82979108|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979109|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979110|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82979111|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82979112|NCT05305066|Analgesics|analgesics|mesh-ancestor
82979113|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
82979114|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979115|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979116|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82979117|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979118|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
82979119|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82979120|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979121|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979122|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979123|NCT05251714|Fulvestrant|fulvestrant|mesh-list
82979124|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82979125|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979126|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82979127|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82979128|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
82979129|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979130|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979131|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
82979132|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979133|NCT02477956|Vitamin D|vitamin d|mesh-list
82979134|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
82979135|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
82979136|NCT02477956|Vitamins|vitamins|mesh-list
82979137|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
82979138|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979139|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82979140|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82979141|NCT02472574|Plasminogen|plasminogen|mesh-list
82979142|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82979143|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82979144|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82979145|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979146|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
82979147|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82979148|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979149|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979150|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82979151|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82979152|NCT05708248|Protective Agents|protective agents|mesh-ancestor
82979153|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979154|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
82979155|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82979156|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
82979157|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
82979159|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979160|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82979161|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979162|NCT03772223|Budesonide|budesonide|mesh-list
82979163|NCT03772223|Albuterol|albuterol|mesh-list
82979164|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979165|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82979166|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
82979167|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979168|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979169|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82979170|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
82979171|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
82979172|NCT03772223|Hormones|hormones|mesh-ancestor
82979173|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979174|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
82979175|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82979176|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82979177|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82979178|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82979179|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
82979180|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979181|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979182|NCT03783299|Lumefantrine|lumefantrine|mesh-list
82979183|NCT03783299|Artemether|artemether|mesh-list
82979184|NCT03783299|Primaquine|primaquine|mesh-list
82979185|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82979186|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
82979187|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82979188|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82979189|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979190|NCT03771755|Acetaminophen|acetaminophen|mesh-list
82979191|NCT03771755|Ibuprofen|ibuprofen|mesh-list
82979192|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82979193|NCT03771755|Analgesics|analgesics|mesh-ancestor
82979194|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
82979195|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979196|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979197|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
82979198|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82979199|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979200|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979201|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82979202|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979203|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979204|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82979205|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
82979206|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82979207|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
82979208|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82979209|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979210|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83463219|NCT00809458|Vitamin E|vitamin e|mesh-list
82979211|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82979212|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979213|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
82979214|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979215|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
82979216|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979217|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979218|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82979219|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
82979220|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979221|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979222|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82979223|NCT01309685|Varenicline|varenicline|mesh-list
82979224|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82979225|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82979226|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
82979227|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979228|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979229|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979230|NCT03782987|Itraconazole|itraconazole|mesh-list
82979232|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979233|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82979234|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82979235|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979236|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979237|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82979238|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
82979239|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979240|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979241|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82979242|NCT03972527|Analgesics|analgesics|mesh-list
82979243|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
82979244|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979245|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979247|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82979248|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82979249|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82979250|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979251|NCT03772067|Incretins|incretins|mesh-ancestor
82979252|NCT03772067|Hormones|hormones|mesh-ancestor
82979253|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979254|NCT03783065|Propranolol|propranolol|mesh-list
82979255|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82979256|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82979257|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
82979258|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979259|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979260|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979261|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82979262|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82979263|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
82979264|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
82979265|NCT03766997|Betamethasone|betamethasone|mesh-list
82979266|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
82979267|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979268|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
82979269|NCT03766997|Hormones|hormones|mesh-ancestor
82979270|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979271|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979272|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82979273|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
82979274|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
82979275|NCT03782831|Antibodies|antibodies|mesh-list
82979276|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
82979277|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979278|NCT05539391|Rocuronium|rocuronium|mesh-list
82979279|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82979280|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82979281|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82979282|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979283|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979284|NCT03766607|Paclitaxel|paclitaxel|mesh-list
82979285|NCT03766607|Trastuzumab|trastuzumab|mesh-list
82979286|NCT03766607|Ramucirumab|ramucirumab|mesh-list
82979287|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82979288|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979289|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
82979290|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
82979291|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
82979292|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979293|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979294|NCT01567709|Vorinostat|vorinostat|mesh-list
82979295|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979296|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82979297|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979298|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979299|NCT03765827|Vitamins|vitamins|mesh-list
82979300|NCT03765827|Vitamin E|vitamin e|mesh-list
82979301|NCT03765827|Tocopherols|tocopherols|mesh-list
82979302|NCT03765827|Tocotrienols|tocotrienols|mesh-list
82979303|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
82979304|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
82979305|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979306|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
82979307|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979308|NCT03765827|Protective Agents|protective agents|mesh-ancestor
82979309|NCT03771053|Simvastatin|simvastatin|mesh-list
82979310|NCT03771053|Ezetimibe|ezetimibe|mesh-list
82979311|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82979312|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82979313|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
82979314|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979315|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82979316|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82979317|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979318|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
82979319|NCT03770663|Azathioprine|azathioprine|mesh-list
82979320|NCT03770663|Tacrolimus|tacrolimus|mesh-list
82979321|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979322|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
82979323|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979324|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979325|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82979326|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
82979327|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979328|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979329|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82979330|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82979331|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979332|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
82979333|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82979334|NCT03048422|Tenofovir|tenofovir|mesh-list
82979335|NCT03048422|Emtricitabine|emtricitabine|mesh-list
82979336|NCT03048422|Efavirenz|efavirenz|mesh-list
82979337|NCT03048422|Dolutegravir|dolutegravir|mesh-list
82979338|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82979339|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
82979340|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82979341|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
82979342|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979343|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82979344|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82979345|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979346|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979347|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82979348|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82979349|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82979350|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82979351|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82979352|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82979353|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82979354|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82979355|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82979356|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82979357|NCT01561781|Digoxin|digoxin|mesh-list
82979358|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82979359|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82979360|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979361|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979362|NCT01561781|Protective Agents|protective agents|mesh-ancestor
82979363|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979364|NCT04259255|Edaravone|edaravone|mesh-list
82979365|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82979366|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
82979367|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979368|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82979369|NCT04259255|Protective Agents|protective agents|mesh-ancestor
82979370|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979371|NCT03770039|PF-06700841|pf-06700841|mesh-list
82979372|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979373|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979374|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979375|NCT01321775|Paclitaxel|paclitaxel|mesh-list
82979376|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
82979377|NCT01321775|Bevacizumab|bevacizumab|mesh-list
82979380|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979381|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
82979382|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
82979383|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
82979384|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979385|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979386|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
82979387|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979388|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979389|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82979390|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
82979391|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82979392|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979393|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82979394|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82979396|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
82979397|NCT05514509|Cabotegravir|cabotegravir|mesh-list
82979398|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82979399|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82979400|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979401|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979402|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82979403|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82979404|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
82979405|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979406|NCT03764267|Lidocaine|lidocaine|mesh-list
82979407|NCT03764267|Remifentanil|remifentanil|mesh-list
82979408|NCT03764267|Anesthetics|anesthetics|mesh-list
82979409|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
82979410|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
82979411|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979412|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979413|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
82979414|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979415|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82979416|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82979417|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82979418|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82979419|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979420|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82979421|NCT03764267|Narcotics|narcotics|mesh-ancestor
82979422|NCT03764267|Analgesics|analgesics|mesh-ancestor
82979423|NCT01321931|Nicotine|nicotine|mesh-list
82979424|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82979425|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
82979426|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979427|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979428|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82979429|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82979430|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
82979431|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979432|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979433|NCT03763409|Losartan|losartan|mesh-list
82979434|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82979435|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82979436|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82979437|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82979438|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979439|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82979440|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82979441|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979442|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
82979443|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82979444|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979445|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979446|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82979447|NCT03762785|Analgesics|analgesics|mesh-ancestor
82979448|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
82979449|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979450|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82979451|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82979452|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82979453|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
82979454|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979455|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979456|NCT03758729|Nivolumab|nivolumab|mesh-list
82979457|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979458|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979459|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82979460|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979461|NCT03756623|Metformin|metformin|mesh-list
82979462|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82979463|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979464|NCT03599453|Interferons|interferons|mesh-list
82979465|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
82979466|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
82979467|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
82979468|NCT03599453|Poly I-C|poly i-c|mesh-list
82979469|NCT03599453|Celecoxib|celecoxib|mesh-list
82979470|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
82979471|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
82979472|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
82979473|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
82979474|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979475|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979476|NCT03599453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82979477|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979478|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
82979479|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979480|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
82979481|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979482|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82979483|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82979484|NCT03599453|Analgesics|analgesics|mesh-ancestor
82979485|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
82979486|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979487|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979488|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83463239|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
82979489|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82979490|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82979491|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979492|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
82979493|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82979494|NCT03756233|Remifentanil|remifentanil|mesh-list
82979495|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82979496|NCT03756233|Narcotics|narcotics|mesh-ancestor
82979497|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979498|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979499|NCT03756233|Analgesics|analgesics|mesh-ancestor
82979500|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
82979501|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979502|NCT03758339|Tucatinib|tucatinib|mesh-list
82979503|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979504|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979505|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979506|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979507|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
82979508|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
82979509|NCT03565913|Calcium|calcium|mesh-list
82979510|NCT03565913|Calcium acetate|calcium acetate|mesh-list
82979511|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82979512|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979513|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82979514|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
82979515|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
82979516|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979517|NCT03565913|Cathartics|cathartics|mesh-ancestor
82979518|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82979519|NCT05085665|Ivermectin|ivermectin|mesh-list
82979520|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82979521|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979522|NCT05004077|Amiodarone|amiodarone|mesh-list
82979523|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82979524|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
82979525|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82979526|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82979527|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979528|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82979529|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82979530|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82979531|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979532|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82979533|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82979534|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82979535|NCT03755609|Fentanyl|fentanyl|mesh-list
82979536|NCT03755609|Oxycodone|oxycodone|mesh-list
82979537|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82979538|NCT03755609|Narcotics|narcotics|mesh-ancestor
82979539|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979540|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979541|NCT03755609|Analgesics|analgesics|mesh-ancestor
82979542|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
82979543|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979544|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82979545|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82979546|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
82979547|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
82979548|NCT03760445|Cytarabine|cytarabine|mesh-list
82979549|NCT03760445|Posaconazole|posaconazole|mesh-list
82979550|NCT03760445|Daunorubicin|daunorubicin|mesh-list
82979551|NCT03760445|Idarubicin|idarubicin|mesh-list
82979552|NCT03760445|Midostaurin|midostaurin|mesh-list
82979553|NCT03760445|Midazolam|midazolam|mesh-list
82979554|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82979555|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
82979556|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979557|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979558|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
82979559|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979560|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979561|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
82979562|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979563|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82979564|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82979565|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979566|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82979567|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82979568|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82979569|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82979570|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
82979571|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
82979572|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
82979573|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
82979574|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979575|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82979576|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82979577|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82979578|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979579|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
82979580|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82979581|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82979582|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82979583|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82979584|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82979585|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82979586|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
82979587|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979588|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979589|NCT05460377|Vaccines|vaccines|mesh-list
82979590|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
82979591|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979592|NCT04956575|Vaccines|vaccines|mesh-list
82979593|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
82979594|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979595|NCT05692856|Clenbuterol|clenbuterol|mesh-list
82979596|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82979597|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82979598|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
82979599|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979600|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979601|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979603|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
82979604|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979605|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82979606|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
82979607|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
82979608|NCT04300556|Farletuzumab|farletuzumab|mesh-list
82979609|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979610|NCT03755531|Oxytocin|oxytocin|mesh-list
82979611|NCT03755531|Carbetocin|carbetocin|mesh-list
82979612|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
82979613|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82979614|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979615|NCT04854707|Menotropins|menotropins|mesh-list
82979616|NCT04854707|Hormones|hormones|mesh-list
82979617|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82979618|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979619|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979620|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82979621|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
82979622|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82979623|NCT03215069|Empagliflozin|empagliflozin|mesh-list
82979624|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82979625|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979626|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82979627|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979628|NCT03759353|Lactoferrin|lactoferrin|mesh-list
82979629|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979630|NCT03757559|Hydromorphone|hydromorphone|mesh-list
82979631|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82979632|NCT03757559|Narcotics|narcotics|mesh-ancestor
82979633|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979634|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979635|NCT03757559|Analgesics|analgesics|mesh-ancestor
82979636|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
82979637|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979638|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
82979639|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979640|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979641|NCT05668949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82979642|NCT05668949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979643|NCT05415917|Gemcitabine|gemcitabine|mesh-list
82979644|NCT05415917|Capecitabine|capecitabine|mesh-list
82979645|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82979646|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
82979647|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979648|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979649|NCT02658929|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
82979650|NCT02658929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979651|NCT02658929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979652|NCT04784897|Brilacidin|brilacidin|mesh-list
82979653|NCT04784897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979654|NCT02780804|Entinostat|entinostat|mesh-list
82979655|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979656|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82979657|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979658|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979659|NCT01322711|Atorvastatin|atorvastatin|mesh-list
82979660|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82979661|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82979662|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
82979663|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979664|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82979665|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82979666|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979667|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82979668|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82979669|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979670|NCT03041792|Liraglutide|liraglutide|mesh-list
82979671|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82979672|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979673|NCT03041792|Incretins|incretins|mesh-ancestor
82979674|NCT03041792|Hormones|hormones|mesh-ancestor
82979675|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979676|NCT03753581|Cytarabine|cytarabine|mesh-list
82979677|NCT03753581|Methotrexate|methotrexate|mesh-list
82979678|NCT03753581|Etoposide|etoposide|mesh-list
82979679|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82979680|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
82979681|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979682|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979683|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
82979684|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979685|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979686|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
82979687|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979688|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82979689|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82979690|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82979691|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979692|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83463262|NCT01607320|Clomiphene|clomiphene|mesh-list
82979693|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
82979694|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82979695|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
82979696|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82979697|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979698|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82979699|NCT04507763|Etanercept|etanercept|mesh-list
82979700|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82979701|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82979702|NCT04507763|Analgesics|analgesics|mesh-ancestor
82979703|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
82979704|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979705|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979706|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979707|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979708|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82979709|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979710|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
82979711|NCT00705484|Infliximab|infliximab|mesh-list
82979712|NCT00705484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82979713|NCT00705484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979714|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
82979715|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82979716|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979717|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
82979718|NCT05358626|Antibodies|antibodies|mesh-list
82979719|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
82979720|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
82979721|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979722|NCT03753269|Fasudil|fasudil|mesh-list
82979723|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82979724|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82979725|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979726|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82979727|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979728|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
82979729|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979730|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979731|NCT05459441|Pemetrexed|pemetrexed|mesh-list
82979732|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979733|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979734|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979735|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82979736|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82979737|NCT04523831|Doxycycline|doxycycline|mesh-list
82979738|NCT04523831|Ivermectin|ivermectin|mesh-list
82979739|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82979740|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979741|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
82979742|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82979743|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82979744|NCT05691764|Cyclosporine|cyclosporine|mesh-list
82979745|NCT05691764|Cyclosporins|cyclosporins|mesh-list
82979746|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979747|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979748|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979749|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
82979750|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979751|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
82979753|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
82979754|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979755|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82979756|NCT04707664|Sargramostim|sargramostim|mesh-list
82979757|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
82979758|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979759|NCT01316276|Amikacin|amikacin|mesh-list
82979760|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82979761|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979762|NCT02474290|Sorafenib|sorafenib|mesh-list
82979763|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979764|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979765|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979766|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979767|NCT02474212|Enoxaparin|enoxaparin|mesh-list
82979768|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
82979769|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82979770|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83133558|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979771|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979772|NCT05200286|Olorofim|olorofim|mesh-list
82979773|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
82979774|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979775|NCT02474446|Vitamin D|vitamin d|mesh-list
82979776|NCT02474446|Vitamins|vitamins|mesh-ancestor
82979777|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
82979778|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979779|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82979780|NCT05199818|Palonosetron|palonosetron|mesh-list
82979781|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
82979782|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
82979783|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979784|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979785|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82979786|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82979787|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82979788|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
82979789|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979790|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979791|NCT02474134|Interferons|interferons|mesh-list
82979792|NCT02474134|Interferon-beta|interferon-beta|mesh-list
82979793|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
82979794|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979795|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
82979796|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979797|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
82979798|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979799|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82979800|NCT02473900|Oseltamivir|oseltamivir|mesh-list
82979801|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
82979802|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979803|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979804|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979805|NCT02471950|Isoflurane|isoflurane|mesh-list
82979806|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82979807|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
82979808|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
82979809|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979810|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979811|NCT01322867|Alprazolam|alprazolam|mesh-list
82979812|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82979813|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979814|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979815|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82979816|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82979817|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82979818|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
82979819|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
82979820|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979821|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979822|NCT04624828|Androgens|androgens|mesh-list
82979823|NCT04624828|Hormones|hormones|mesh-ancestor
82979824|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979825|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979826|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82979827|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
82979828|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979829|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
82979830|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979831|NCT02477488|Allopurinol|allopurinol|mesh-list
82979832|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
82979833|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979834|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979835|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
82979836|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979837|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82979838|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
82979839|NCT02477488|Protective Agents|protective agents|mesh-ancestor
82979840|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979841|NCT05163106|Letrozole|letrozole|mesh-list
82979842|NCT05163106|Goserelin|goserelin|mesh-list
82979843|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979844|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82979845|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82979846|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979847|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979848|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82979849|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
82979850|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82979851|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979852|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82979853|NCT02477098|Ropivacaine|ropivacaine|mesh-list
82979854|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
82979855|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
82979856|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979857|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979858|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
82979859|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979860|NCT04518046|Nivolumab|nivolumab|mesh-list
82979861|NCT04518046|Ipilimumab|ipilimumab|mesh-list
82979862|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979863|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979864|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82979865|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979866|NCT05571670|Sirolimus|sirolimus|mesh-list
82979867|NCT05571670|MTOR Inhibitors|mtor inhibitors|mesh-list
82979868|NCT05571670|Temsirolimus|temsirolimus|mesh-list
82979869|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979870|NCT05571670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82979871|NCT05571670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979872|NCT05571670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979873|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979874|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
82979875|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979876|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82979877|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979878|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82979879|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
82979880|NCT02473354|Remifentanil|remifentanil|mesh-list
82979881|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82979882|NCT02473354|Narcotics|narcotics|mesh-ancestor
82979883|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979884|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979885|NCT02473354|Analgesics|analgesics|mesh-ancestor
82979886|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
82979887|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979888|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
82979889|NCT02470858|Asunaprevir|asunaprevir|mesh-list
82979890|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
82979891|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979892|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
82979893|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979894|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979895|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82979896|NCT02473198|Morphine|morphine|mesh-list
82979897|NCT02473198|Bupivacaine|bupivacaine|mesh-list
82979898|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
82979899|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
82979900|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82979901|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979902|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
82979903|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979917|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
82979918|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979919|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979920|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979922|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82979923|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979924|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82979925|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979926|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979940|NCT05336266|Ketorolac|ketorolac|mesh-list
82979941|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82979942|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82979943|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82979944|NCT05336266|Analgesics|analgesics|mesh-ancestor
82979945|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
82979946|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82979947|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979948|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82979949|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979950|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82979951|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979952|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979953|NCT02470780|Rifaximin|rifaximin|mesh-list
82979954|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82979955|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82979956|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82979957|NCT05180292|Carvedilol|carvedilol|mesh-list
82979958|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82979959|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82979960|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
82979961|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82979962|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979963|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979964|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82979965|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
82979966|NCT05180292|Protective Agents|protective agents|mesh-ancestor
82979967|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82979968|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82979969|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82979970|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
82979971|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82979972|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82979973|NCT01315938|Abatacept|abatacept|mesh-list
82979974|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82979975|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979976|NCT01315938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82979977|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979978|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82979979|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
82979980|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979981|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82979982|NCT01339884|Resveratrol|resveratrol|mesh-list
82979983|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
82979984|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979985|NCT01339884|Protective Agents|protective agents|mesh-ancestor
82979986|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82979987|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979988|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82979989|NCT04736394|Epirubicin|epirubicin|mesh-list
82979990|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82979991|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82979992|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82979993|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83481950|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
82979994|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82979995|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82979996|NCT01341834|Everolimus|everolimus|mesh-list
82979997|NCT01341834|Panobinostat|panobinostat|mesh-list
82979998|NCT01341834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82979999|NCT01341834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82980000|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980001|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980002|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82980003|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
82980004|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980005|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980006|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82980007|NCT01340118|Budesonide|budesonide|mesh-list
82980008|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980009|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82980010|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
82980011|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980012|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980013|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82980014|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
82980015|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
82980016|NCT01340118|Hormones|hormones|mesh-ancestor
82980017|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980018|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
82980019|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82980020|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82980021|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82980022|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980023|NCT02470702|Oritavancin|oritavancin|mesh-list
82980024|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82980025|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980026|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82980027|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
82980028|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82980029|NCT04409964|Lidocaine|lidocaine|mesh-list
82980030|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
82980031|NCT04409964|Remifentanil|remifentanil|mesh-list
82980032|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
82980033|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
82980034|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980035|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980036|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
82980037|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980038|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82980039|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82980040|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82980041|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82980042|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980043|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82980044|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980045|NCT04409964|Analgesics|analgesics|mesh-ancestor
82980046|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82980047|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82980048|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82980049|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
82980050|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980051|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82980053|NCT01342146|Hormones|hormones|mesh-list
82980054|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980055|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980056|NCT03212716|Oseltamivir|oseltamivir|mesh-list
82980057|NCT03212716|Diltiazem|diltiazem|mesh-list
82980058|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
82980059|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980060|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980061|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980062|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82980063|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82980064|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82980065|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82980066|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980067|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
82980068|NCT04762836|Cycloserine|cycloserine|mesh-list
82980069|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82980070|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980071|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82980072|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
82980073|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82980074|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
82980075|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980076|NCT00705406|Peramivir|peramivir|mesh-list
82980077|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
82980078|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980079|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980080|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980081|NCT01342224|Gemcitabine|gemcitabine|mesh-list
82980082|NCT01342224|Tadalafil|tadalafil|mesh-list
82980083|NCT01342224|Sargramostim|sargramostim|mesh-list
82980084|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
82980085|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980086|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82980087|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
82980088|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980089|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980090|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
82980091|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82980092|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82980093|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980094|NCT01342224|Urological Agents|urological agents|mesh-ancestor
82980095|NCT03155178|Ethanol|ethanol|mesh-list
82980096|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
82980097|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82980098|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82980099|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980100|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980101|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980102|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
82980103|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
82980105|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82980106|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980107|NCT03310762|Silicon|silicon|mesh-list
82980108|NCT03310762|Trace Elements|trace elements|mesh-ancestor
82980109|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
82980110|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980111|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82980112|NCT03310606|Lactams|lactams|mesh-list
82980113|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980114|NCT01315704|Vitamin D|vitamin d|mesh-list
82980115|NCT01315704|Vitamins|vitamins|mesh-ancestor
82980116|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
82980117|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980118|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82980119|NCT03107884|Metformin|metformin|mesh-list
82980120|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82980121|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980122|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
82980123|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82980124|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
82980125|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980126|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980127|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82980129|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980130|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980131|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82980132|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
82980133|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82980134|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
82980135|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980136|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
82980137|NCT04702776|Protective Agents|protective agents|mesh-ancestor
82980138|NCT03310372|Temozolomide|temozolomide|mesh-list
83463298|NCT01602016|Antidotes|antidotes|mesh-ancestor
82980139|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82980140|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
82980141|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980142|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980143|NCT02980276|Metformin|metformin|mesh-list
82980144|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82980145|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980146|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82980147|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82980148|NCT01342614|Metformin|metformin|mesh-list
82980149|NCT01342614|Fosinopril|fosinopril|mesh-list
82980150|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82980151|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980152|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82980153|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
82980154|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980155|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980156|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82980157|NCT01342692|Lenalidomide|lenalidomide|mesh-list
82980158|NCT01342692|Azacitidine|azacitidine|mesh-list
82980159|NCT01342692|Idarubicin|idarubicin|mesh-list
82980160|NCT01342692|Valproic Acid|valproic acid|mesh-list
82980161|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
82980162|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980163|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82980164|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82980165|NCT01342692|Growth Substances|growth substances|mesh-ancestor
82980166|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
82980167|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980168|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82980169|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
82980170|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980171|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980172|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
82980173|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
82980174|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980175|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
82980176|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82980177|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980178|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82980179|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82980180|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82980181|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82980182|NCT05153772|Octreotide|octreotide|mesh-list
82980183|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82980184|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82980185|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980186|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
82980187|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82980188|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82980189|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82980190|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980191|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
82980192|NCT03310060|Coagulants|coagulants|mesh-ancestor
82980193|NCT02520778|Osimertinib|osimertinib|mesh-list
82980194|NCT02520778|Navitoclax|navitoclax|mesh-list
82980195|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980196|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82980197|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980198|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980199|NCT03740958|Argatroban|argatroban|mesh-list
82980200|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
82980201|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82980202|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
82980203|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980204|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980205|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
82980206|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82980207|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
82980208|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82980209|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
82980210|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463302|NCT01602016|Vitamins|vitamins|mesh-ancestor
82980211|NCT03685188|Sufentanil|sufentanil|mesh-list
82980212|NCT03685188|Oxycodone|oxycodone|mesh-list
82980213|NCT03685188|Dsuvia|dsuvia|mesh-list
82980214|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82980215|NCT03685188|Narcotics|narcotics|mesh-ancestor
82980216|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980217|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980218|NCT03685188|Analgesics|analgesics|mesh-ancestor
82980219|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
82980220|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980221|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82980222|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82980223|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
82980224|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
82980225|NCT02305654|Paclitaxel|paclitaxel|mesh-list
82980226|NCT02305654|Ifosfamide|ifosfamide|mesh-list
82980227|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82980228|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980229|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
82980230|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
82980231|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
82980232|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980233|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82980234|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
82980235|NCT05251584|Gentamicins|gentamicins|mesh-list
82980236|NCT05251584|Mupirocin|mupirocin|mesh-list
82980237|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82980238|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980239|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82980240|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980241|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980242|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
82980243|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82980244|NCT02108860|Abatacept|abatacept|mesh-list
82980245|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82980246|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980247|NCT02108860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980248|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980249|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82980250|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
82980251|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980252|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980253|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82980254|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82980255|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
82980256|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980257|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980258|NCT03309592|Ambrisentan|ambrisentan|mesh-list
82980259|NCT03309592|Tadalafil|tadalafil|mesh-list
82980260|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
82980261|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82980262|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82980263|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980264|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980265|NCT03309592|Urological Agents|urological agents|mesh-ancestor
82980266|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82980267|NCT04641312|Dulaglutide|dulaglutide|mesh-list
82980268|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82980269|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980270|NCT03078192|Xenon|xenon|mesh-list
82980271|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82980272|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
82980273|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
82980274|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980275|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980276|NCT00703846|Ketoconazole|ketoconazole|mesh-list
82980277|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
82980278|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980279|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82980280|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82980281|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980282|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980283|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82980284|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
82980285|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980286|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980287|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82980288|NCT03309436|Clomiphene|clomiphene|mesh-list
82980289|NCT03309436|Enclomiphene|enclomiphene|mesh-list
82980290|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
82980291|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82980292|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
82980293|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980294|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980295|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82980296|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
82980297|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82980298|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82980299|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82980300|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
82980301|NCT05183334|Tramadol|tramadol|mesh-list
82980302|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
82980303|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82980304|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82980305|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980306|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980307|NCT05183334|Urological Agents|urological agents|mesh-ancestor
82980308|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82980309|NCT05183334|Narcotics|narcotics|mesh-ancestor
82980310|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980311|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980312|NCT05183334|Analgesics|analgesics|mesh-ancestor
82980313|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
82980314|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980315|NCT03304444|Bupivacaine|bupivacaine|mesh-list
82980316|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
82980317|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
82980318|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980319|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980320|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
82980321|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980322|NCT03304288|Rituximab|rituximab|mesh-list
82980323|NCT03304288|Tretinoin|tretinoin|mesh-list
82980324|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980325|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980326|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
82980327|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980328|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980329|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
82980330|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
82980331|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82980332|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980334|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82980335|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980336|NCT03308890|Entecavir|entecavir|mesh-list
82980337|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
82980338|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980339|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82980340|NCT03313726|Hormones|hormones|mesh-ancestor
82980341|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980342|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980343|NCT03303976|Vaccines|vaccines|mesh-list
82980344|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82980345|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
82980346|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980347|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
82980348|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82980349|NCT03313414|Velpatasvir|velpatasvir|mesh-list
82980350|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
82980351|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980352|NCT02468518|Vitamin E|vitamin e|mesh-list
82980353|NCT02468518|Vitamins|vitamins|mesh-ancestor
82980354|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
82980355|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980356|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
82980357|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980358|NCT02468518|Protective Agents|protective agents|mesh-ancestor
82980359|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82980360|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
82980361|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
82980362|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980363|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980364|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
82980365|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980366|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82980367|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
82980369|NCT05262322|Edoxaban|edoxaban|mesh-list
82980370|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82980371|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
82980372|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82980373|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
82980374|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980375|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980376|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
82980377|NCT04490980|Butorphanol|butorphanol|mesh-list
82980378|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82980379|NCT04490980|Narcotics|narcotics|mesh-ancestor
82980380|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980381|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980382|NCT04490980|Analgesics|analgesics|mesh-ancestor
82980383|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
82980384|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980385|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
82980386|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
82980387|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82980388|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82980389|NCT03307720|Hormones|hormones|mesh-list
82980390|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980391|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980392|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82980393|NCT04608786|Capecitabine|capecitabine|mesh-list
82980394|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82980395|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
82980396|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980397|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980398|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82980399|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82980400|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82980401|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
82980402|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980403|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980404|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980405|NCT01314872|Urological Agents|urological agents|mesh-ancestor
82980406|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
82980407|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83463327|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
82980408|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82980409|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82980410|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980411|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
82980412|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980413|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980415|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82980416|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980417|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82980418|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82980419|NCT03302650|Norepinephrine|norepinephrine|mesh-list
82980420|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
82980421|NCT03302650|Giapreza|giapreza|mesh-list
82980422|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
82980423|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82980424|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82980425|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
82980426|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980427|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980428|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980430|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
82980431|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980432|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82980433|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82980434|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
82980435|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980436|NCT01343706|BI 409306|bi 409306|mesh-list
82980437|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82980438|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980439|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980440|NCT03312478|Antibodies|antibodies|mesh-list
82980441|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980442|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
82980443|NCT03312244|Bromides|bromides|mesh-list
82980444|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82980445|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
82980446|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82980447|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980448|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980449|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
82980450|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980451|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980452|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
82980453|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82980454|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82980455|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82980456|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82980457|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980458|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
82980459|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980460|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980461|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82980462|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980463|NCT00739050|Simvastatin|simvastatin|mesh-list
82980464|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82980465|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82980466|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
82980467|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980468|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82980469|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82980470|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980471|NCT03302182|Ritonavir|ritonavir|mesh-list
82980472|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82980473|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82980474|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
82980475|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980476|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980477|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82980478|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82980479|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
82980480|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980481|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82980482|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82980483|NCT01343862|Cycloserine|cycloserine|mesh-list
82980484|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82980485|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980486|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82980487|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
82980488|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82980489|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
82980490|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980491|NCT03311932|Hydrocortisone|hydrocortisone|mesh-list
82980492|NCT03311932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980493|NCT00604812|Rizatriptan|rizatriptan|mesh-list
82980494|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82980495|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
82980496|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980497|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980498|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980499|NCT04347408|Antibodies|antibodies|mesh-list
82980500|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
82980501|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980502|NCT03306550|Aspirin|aspirin|mesh-list
82980503|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82980504|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980505|NCT03306550|Analgesics|analgesics|mesh-ancestor
82980506|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
82980507|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980508|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980509|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980510|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980511|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82980512|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82980513|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980514|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82980515|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82980516|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980517|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
82980518|NCT03306472|Letrozole|letrozole|mesh-list
82980519|NCT03306472|Megestrol|megestrol|mesh-list
82980520|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
82980521|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980522|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82980523|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82980524|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980525|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980526|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82980527|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
82980528|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980529|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980530|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82980531|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82980532|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82980533|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
82980534|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82980535|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82980536|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82980537|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82980538|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
82980539|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82980540|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
82980541|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980542|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980543|NCT03311542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82980544|NCT03311542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980545|NCT03311464|Adalimumab|adalimumab|mesh-list
82980546|NCT03311464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82980547|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980548|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980549|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
82980550|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
82980551|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980552|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82980553|NCT02468206|Polidocanol|polidocanol|mesh-list
82980554|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82980555|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82980556|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
82980557|NCT03233854|Fludarabine|fludarabine|mesh-list
82980558|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
82980559|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82980560|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
82980561|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980562|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980563|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82980564|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
82980565|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980566|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980567|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82980568|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82980569|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
82980570|NCT01344174|Lamivudine|lamivudine|mesh-list
82980571|NCT01344174|Dexamethasone|dexamethasone|mesh-list
82980572|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980573|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
82980574|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
82980575|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980576|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980577|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82980579|NCT01344174|Hormones|hormones|mesh-ancestor
82980580|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980581|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82980582|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980583|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82980584|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82980585|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980586|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980587|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
82980588|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980589|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82980590|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82980591|NCT05162274|Lazertinib|lazertinib|mesh-list
82980592|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82980593|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980594|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980595|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
82980596|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
82980597|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
82980598|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980599|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
82980600|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82980601|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82980602|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980603|NCT02468908|Molgramostim|molgramostim|mesh-list
82980604|NCT02468908|Sargramostim|sargramostim|mesh-list
82980605|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
82980606|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980607|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980608|NCT02468128|Nalbuphine|nalbuphine|mesh-list
82980609|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82980610|NCT02468128|Narcotics|narcotics|mesh-ancestor
82980611|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980612|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980613|NCT02468128|Analgesics|analgesics|mesh-ancestor
82980614|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
82980615|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980616|NCT03305536|Vitamin D|vitamin d|mesh-list
82980617|NCT03305536|Vitamins|vitamins|mesh-list
82980618|NCT03305536|Vitamin K|vitamin k|mesh-list
82980619|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
82980620|NCT03305536|Menaquinone 7|menaquinone 7|mesh-list
82980621|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
82980622|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980623|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82980624|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82980625|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82980626|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980627|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
82980628|NCT03305536|Coagulants|coagulants|mesh-ancestor
82980629|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
82980630|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82980631|NCT03210688|Prednisone|prednisone|mesh-list
82980632|NCT03210688|Prednisolone|prednisolone|mesh-list
82980633|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980634|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
82980635|NCT03210688|Hormones|hormones|mesh-ancestor
82980636|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980637|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980638|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82980639|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980640|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82980641|NCT03210688|Vitamins|vitamins|mesh-ancestor
82980642|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
82980643|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
82980644|NCT02467426|Analgesics|analgesics|mesh-ancestor
82980645|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
82980646|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980647|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980648|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980649|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82980650|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82980651|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980652|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980654|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82980655|NCT04296942|Maytansine|maytansine|mesh-list
82980656|NCT04296942|Entinostat|entinostat|mesh-list
82980657|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980658|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463349|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
83463351|NCT03579472|Halichondrin B|halichondrin b|mesh-list
82980659|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82980660|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
82980661|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
82980662|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
82980663|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980664|NCT04296942|Immunotoxins|immunotoxins|mesh-ancestor
82980665|NCT04296942|Immunoconjugates|immunoconjugates|mesh-ancestor
82980666|NCT04296942|Immunologic Factors|immunologic factors|mesh-ancestor
82980667|NCT04296942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980668|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82980669|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980670|NCT01344564|Leuprolide|leuprolide|mesh-list
82980671|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82980672|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
82980673|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82980674|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980675|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82980676|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980677|NCT01344720|Etoricoxib|etoricoxib|mesh-list
82980678|NCT01344720|Oxycodone|oxycodone|mesh-list
82980679|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82980680|NCT01344720|Narcotics|narcotics|mesh-ancestor
82980681|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980682|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980683|NCT01344720|Analgesics|analgesics|mesh-ancestor
82980684|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
82980685|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980686|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82980687|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980688|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980689|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980690|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82980691|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82980692|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980693|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980694|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82980695|NCT03220854|Antibodies|antibodies|mesh-list
82980696|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
82980697|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82980698|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
82980699|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980700|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980701|NCT03305068|Celecoxib|celecoxib|mesh-list
82980702|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82980703|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980704|NCT03305068|Analgesics|analgesics|mesh-ancestor
82980705|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
82980706|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980707|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980708|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980709|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980710|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82980711|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82980712|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980713|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980715|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82980716|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980717|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82980718|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82980719|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980720|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980721|NCT03299998|Anesthetics|anesthetics|mesh-list
82980722|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463387|NCT05482464|Caseins|caseins|mesh-list
82980723|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980724|NCT03735420|Xanthohumol|xanthohumol|mesh-list
82980725|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980743|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82980744|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980746|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
82980747|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980748|NCT02720536|Deferasirox|deferasirox|mesh-list
82980749|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82980750|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
82980751|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
82980752|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980753|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
82980754|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
82980755|NCT03168438|Fludarabine|fludarabine|mesh-list
82980756|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82980757|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
82980758|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980759|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82980760|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82980761|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
82980762|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980763|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980764|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82980765|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980766|NCT03168438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82980767|NCT03299296|Enoxaparin|enoxaparin|mesh-list
82980768|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
82980769|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82980770|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
82980771|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82980772|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
82980773|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980774|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980775|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
82980776|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82980777|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82980778|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
82980779|NCT03137784|Bromides|bromides|mesh-list
82980780|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
82980781|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82980782|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82980783|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82980784|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
82980785|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980786|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980787|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980788|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
82980789|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82980790|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82980791|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
82980792|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82980793|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
82980794|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980795|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980796|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
82980797|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
82980798|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980800|NCT01347996|Histamine|histamine|mesh-list
82980802|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980803|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980804|NCT01347996|Analgesics|analgesics|mesh-ancestor
82980805|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
82980806|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980807|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980808|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
82980809|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
82980810|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980811|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980812|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82980813|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
82980814|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82980815|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
82980816|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980817|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
82980818|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980819|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
82980820|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82980821|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82980822|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980823|NCT02466802|Urological Agents|urological agents|mesh-ancestor
82980824|NCT01348308|Maraviroc|maraviroc|mesh-list
82980825|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82980826|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82980827|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980828|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82980829|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82980830|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
82980831|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980832|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82980833|NCT04074174|Acetaminophen|acetaminophen|mesh-list
82980834|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
82980835|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
82980836|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980837|NCT04074174|Analgesics|analgesics|mesh-ancestor
82980838|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
82980839|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980840|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980841|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
82980842|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82980843|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82980844|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
82980845|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980846|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980847|NCT04752826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82980848|NCT04752826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980849|NCT03620292|Bevacizumab|bevacizumab|mesh-list
82980850|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980851|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980852|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82980853|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82980854|NCT03620292|Growth Substances|growth substances|mesh-ancestor
82980855|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980856|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
82980857|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
82980858|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82980859|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980860|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980861|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980862|NCT01353378|Analgesics|analgesics|mesh-ancestor
82980863|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
82980864|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980865|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82980866|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82980867|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82980868|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
82980869|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980870|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980871|NCT05245006|Antibodies|antibodies|mesh-list
82980872|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
82980873|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
82980874|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980875|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
82980876|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82980877|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82980878|NCT01465334|Prednisolone|prednisolone|mesh-list
82980879|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
82980880|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
82980881|NCT01465334|Ofatumumab|ofatumumab|mesh-list
82980882|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82980883|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
82980884|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82980885|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
82980886|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
82980887|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980888|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980889|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82980890|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
82980891|NCT01465334|Hormones|hormones|mesh-ancestor
82980892|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980893|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82980894|NCT01465334|Protective Agents|protective agents|mesh-ancestor
82980895|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82980896|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980897|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980898|NCT04019262|Temozolomide|temozolomide|mesh-list
82980899|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82980900|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
82980901|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980902|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980903|NCT05549726|Cabotegravir|cabotegravir|mesh-list
82980904|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82980905|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82980906|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980907|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980908|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82980909|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82980910|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
82980911|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980912|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
82980913|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82980914|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980915|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980916|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980917|NCT01353456|Analgesics|analgesics|mesh-ancestor
82980918|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
82980919|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980920|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82980921|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82980922|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82980923|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
82980924|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980925|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980926|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
82980927|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82980928|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980929|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980930|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82980931|NCT04289142|Analgesics|analgesics|mesh-ancestor
82980932|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
82980933|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980934|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82980935|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82980936|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82980937|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
82980938|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980939|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980940|NCT04953962|Nivolumab|nivolumab|mesh-list
82980941|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980942|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82980943|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82980944|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980945|NCT04948814|Vancomycin|vancomycin|mesh-list
82980946|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82980947|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980949|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
82980950|NCT05726734|Amoxicillin|amoxicillin|mesh-list
82980951|NCT05726734|Metronidazole|metronidazole|mesh-list
82980952|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
82980953|NCT05726734|Esomeprazole|esomeprazole|mesh-list
82980955|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980956|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82980957|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82980958|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82980959|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82980960|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82980961|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82980962|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82980963|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82980964|NCT05726734|Antacids|antacids|mesh-ancestor
82980965|NCT05726734|Diuretics|diuretics|mesh-ancestor
82980966|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
82980967|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980968|NCT05726734|Expectorants|expectorants|mesh-ancestor
82980969|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
82980970|NCT01317966|Oprelvekin|oprelvekin|mesh-list
82980971|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82980972|NCT01345734|Liraglutide|liraglutide|mesh-list
82980973|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82980974|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980975|NCT01345734|Incretins|incretins|mesh-ancestor
82980976|NCT01345734|Hormones|hormones|mesh-ancestor
82980977|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82980978|NCT04674670|Naltrexone|naltrexone|mesh-list
82980979|NCT04674670|Bromocriptine|bromocriptine|mesh-list
82980980|NCT04674670|Amisulpride|amisulpride|mesh-list
82980981|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82980982|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82980983|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82980984|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
82980985|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82980986|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82980987|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82980988|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82980989|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82980990|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82980991|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
82980992|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82980993|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82980994|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82980995|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
82980996|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82980997|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82980998|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
82980999|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981000|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
82981001|NCT01318044|Thiopental|thiopental|mesh-list
82981002|NCT01318044|Propofol|propofol|mesh-list
82981003|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82981004|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981005|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981006|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82981007|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
82981008|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
82981009|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
82981010|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
82981011|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
82981012|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981013|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981014|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82981015|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82981016|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82981017|NCT01353846|Estradiol|estradiol|mesh-list
82981018|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82981019|NCT01353846|Progesterone|progesterone|mesh-list
82981020|NCT01353846|Estrogens|estrogens|mesh-ancestor
82981021|NCT01353846|Hormones|hormones|mesh-ancestor
82981022|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981023|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981024|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82981025|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
82981026|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82981027|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82981028|NCT01353846|Progestins|progestins|mesh-ancestor
82981029|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
82981030|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82981031|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981032|NCT01349010|Probucol|probucol|mesh-list
82981033|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82981034|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82981035|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
82981036|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981037|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82981038|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
82981039|NCT01349010|Protective Agents|protective agents|mesh-ancestor
82981040|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981041|NCT05232370|Losartan|losartan|mesh-list
82981042|NCT05232370|Enalapril|enalapril|mesh-list
82981043|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
82981044|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
82981045|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
82981046|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82981047|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82981048|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82981049|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981050|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
82981051|NCT01349088|Niacinamide|niacinamide|mesh-list
82981052|NCT01349088|Capecitabine|capecitabine|mesh-list
82981053|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
82981054|NCT01349088|Imetelstat|imetelstat|mesh-list
82981055|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82981056|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
82981057|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981058|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981059|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82981060|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981061|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
82981062|NCT01349088|Vitamins|vitamins|mesh-ancestor
82981063|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
82981064|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981065|NCT04490434|Celecoxib|celecoxib|mesh-list
82981066|NCT04490434|Naproxen|naproxen|mesh-list
82981067|NCT04490434|Meloxicam|meloxicam|mesh-list
82981068|NCT04490434|Fexuprazan|fexuprazan|mesh-list
82981069|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82981070|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82981071|NCT04490434|Analgesics|analgesics|mesh-ancestor
82981072|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
82981073|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981074|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981075|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981076|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82981077|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82981078|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82981079|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981080|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981081|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
82981082|NCT04490434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82981083|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
82981084|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82981085|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
82981086|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981087|NCT03143166|Telmisartan|telmisartan|mesh-list
82981088|NCT03143166|Dabigatran|dabigatran|mesh-list
82981089|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82981090|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82981091|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82981092|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981093|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
82981094|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82981095|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
82981096|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981097|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
82981098|NCT02466568|Nivolumab|nivolumab|mesh-list
82981099|NCT02466568|Vaccines|vaccines|mesh-list
82981100|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
82981101|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981102|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82981103|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981104|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82981105|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981107|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82981108|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981109|NCT02879994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82981110|NCT02879994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981111|NCT02466022|Fentanyl|fentanyl|mesh-list
82981112|NCT02466022|Midazolam|midazolam|mesh-list
82981113|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
82981114|NCT02466022|Bupivacaine|bupivacaine|mesh-list
82981115|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
82981116|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
82981117|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981118|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981119|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
82981120|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981121|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82981122|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82981123|NCT02466022|Analgesics|analgesics|mesh-ancestor
82981124|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82981125|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82981126|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82981127|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
82981128|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981129|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981130|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82981131|NCT02466022|Narcotics|narcotics|mesh-ancestor
82981132|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82981133|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82981134|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
82981135|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82981136|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981137|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981138|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
82981139|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
82981140|NCT03937596|Cycloserine|cycloserine|mesh-list
82981141|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82981142|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981143|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82981144|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
82981145|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82981146|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
82981147|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981148|NCT04606264|Dexamethasone|dexamethasone|mesh-list
82981149|NCT04606264|Morphine|morphine|mesh-list
82981150|NCT04606264|Hydromorphone|hydromorphone|mesh-list
82981151|NCT04606264|Ondansetron|ondansetron|mesh-list
82981152|NCT04606264|Aprepitant|aprepitant|mesh-list
82981153|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
82981154|NCT04606264|Perphenazine|perphenazine|mesh-list
82981155|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981156|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
82981157|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
82981158|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981159|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981160|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82981161|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
82981162|NCT04606264|Hormones|hormones|mesh-ancestor
82981163|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981164|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82981165|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463424|NCT01475500|Dimercaprol|dimercaprol|mesh-list
82981166|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82981167|NCT04606264|Narcotics|narcotics|mesh-ancestor
82981168|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981169|NCT04606264|Analgesics|analgesics|mesh-ancestor
82981170|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
82981171|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
82981172|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
82981173|NCT04606264|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82981174|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82981175|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
82981176|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981177|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981178|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82981179|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82981180|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981181|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981182|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82981183|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
82981184|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82981185|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
82981186|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
82981188|NCT03578172|Hormones|hormones|mesh-list
82981189|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981190|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981191|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82981192|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
82981193|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82981194|NCT03928158|Valsartan|valsartan|mesh-list
82981195|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82981196|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82981197|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82981198|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82981199|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981200|NCT05174884|Etonogestrel|etonogestrel|mesh-list
82981201|NCT05174884|Desogestrel|desogestrel|mesh-list
82981202|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82981203|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
82981204|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82981205|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981206|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82981207|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82981208|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82981209|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82981210|NCT05174884|Progestins|progestins|mesh-ancestor
82981211|NCT05174884|Hormones|hormones|mesh-ancestor
82981212|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981213|NCT01354158|Droxidopa|droxidopa|mesh-list
82981214|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82981215|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82981216|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82981217|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82981218|NCT02466490|Diuretics|diuretics|mesh-ancestor
82981219|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
82981220|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981221|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82981222|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981223|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981224|NCT04547842|Dexamethasone|dexamethasone|mesh-list
82981225|NCT04547842|Mirtazapine|mirtazapine|mesh-list
82981226|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981227|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
82981228|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
82981229|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981230|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981231|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82981232|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
82981233|NCT04547842|Hormones|hormones|mesh-ancestor
82981234|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981235|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82981236|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981237|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
82981238|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981239|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82981240|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
82981241|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
82981242|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981243|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981244|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82981245|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981246|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981247|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82981248|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82981249|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82981250|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
82981251|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82981252|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82981253|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
82981254|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82981255|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
82981256|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
82981257|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981258|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
82981259|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981260|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981261|NCT00702052|Everolimus|everolimus|mesh-list
82981262|NCT00702052|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82981263|NCT00702052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82981264|NCT00702052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981265|NCT00702052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981266|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981267|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
82981268|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981269|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981270|NCT01354470|Modafinil|modafinil|mesh-list
82981271|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82981272|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981273|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82981274|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82981275|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82981276|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981277|NCT01349556|Tretinoin|tretinoin|mesh-list
82981278|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981279|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
82981280|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
82981281|NCT01354704|Enoxaparin|enoxaparin|mesh-list
82981282|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
82981283|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82981284|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82981285|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981286|NCT01346670|Lovastatin|lovastatin|mesh-list
82981287|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82981288|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82981289|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
82981290|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981291|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82981292|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82981293|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981294|NCT03136068|Digoxin|digoxin|mesh-list
82981295|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82981296|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82981297|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981298|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981299|NCT03136068|Protective Agents|protective agents|mesh-ancestor
82981300|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981301|NCT01350024|Lidocaine|lidocaine|mesh-list
82981302|NCT01350024|Epinephrine|epinephrine|mesh-list
82981303|NCT01350024|Racepinephrine|racepinephrine|mesh-list
82981304|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
82981305|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
82981306|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
82981307|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981308|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981309|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
82981310|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981311|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82981312|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82981313|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82981314|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981315|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981316|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82981317|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82981318|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
82981319|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981320|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82981321|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82981322|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
82981323|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82981324|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
82981326|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
82981327|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82981328|NCT01318590|Triamcinolone|triamcinolone|mesh-list
82981329|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82981330|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82981331|NCT01318590|Bupivacaine|bupivacaine|mesh-list
82981332|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82981333|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
82981334|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
82981335|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981336|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981337|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
82981338|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981339|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981340|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
82981341|NCT01318590|Hormones|hormones|mesh-ancestor
82981342|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981343|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981344|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
82981345|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981346|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981347|NCT01346826|Infliximab|infliximab|mesh-list
82981348|NCT01346826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82981349|NCT01346826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981350|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
82981351|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82981352|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82981353|NCT01354860|Lobeline|lobeline|mesh-list
82981354|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82981355|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
82981356|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981357|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981358|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82981359|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82981360|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
82981361|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981362|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981363|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
82981364|NCT02556606|Midazolam|midazolam|mesh-list
82981365|NCT02556606|Ketamine|ketamine|mesh-list
82981366|NCT02556606|Analgesics|analgesics|mesh-ancestor
82981367|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
82981368|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981369|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981370|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82981371|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82981372|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
82981373|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
82981374|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981375|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82981376|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82981377|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981378|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981379|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82981380|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82981381|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82981382|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981383|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981384|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
82981385|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
82981386|NCT01355562|Interleukin-2|interleukin-2|mesh-list
82981387|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981388|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82981389|NCT01355562|Analgesics|analgesics|mesh-ancestor
82981390|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
82981391|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981392|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981393|NCT01350570|Loperamide|loperamide|mesh-list
82981394|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
82981395|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82981396|NCT01355718|Repaglinide|repaglinide|mesh-list
82981397|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82981398|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981399|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82981400|NCT03377790|Cantharidin|cantharidin|mesh-list
82981402|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981404|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82981405|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981406|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
82981407|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82981408|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82981409|NCT02422368|Prednisolone|prednisolone|mesh-list
82981410|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
82981411|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82981412|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
82981413|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981414|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
82981415|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
82981416|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981417|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981418|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82981419|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
82981420|NCT02422368|Hormones|hormones|mesh-ancestor
82981421|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981422|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82981423|NCT02422368|Protective Agents|protective agents|mesh-ancestor
82981424|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82981425|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981426|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
82981427|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
82981428|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981429|NCT01355952|Protective Agents|protective agents|mesh-ancestor
82981430|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981431|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
82981432|NCT01355952|Vitamins|vitamins|mesh-ancestor
82981433|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
82981434|NCT05720572|Antazoline|antazoline|mesh-list
82981435|NCT05720572|Propafenone|propafenone|mesh-list
82981436|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82981437|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82981438|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82981439|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981440|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981441|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82981442|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
82981443|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
82981444|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981445|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981446|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82981447|NCT05111002|Doxycycline|doxycycline|mesh-list
82981448|NCT05111002|Lefamulin|lefamulin|mesh-list
82981449|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82981450|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981451|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
82981452|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82981453|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82981454|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
82981455|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
82981456|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981457|NCT05716750|Vitamin D|vitamin d|mesh-list
82981458|NCT05716750|Vitamins|vitamins|mesh-ancestor
82981459|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
82981460|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981461|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82981462|NCT01350882|Rituximab|rituximab|mesh-list
82981463|NCT01350882|Citric Acid|citric acid|mesh-list
82981464|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
82981465|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82981466|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981467|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
82981468|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981469|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82981470|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
82981471|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82981472|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
82981473|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
82981474|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981475|NCT01844856|Ertapenem|ertapenem|mesh-list
82981476|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82981477|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981478|NCT00618098|Thrombin|thrombin|mesh-list
82981479|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
82981480|NCT00618098|Coagulants|coagulants|mesh-ancestor
82981481|NCT02464228|Tipifarnib|tipifarnib|mesh-list
82981482|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981483|NCT01351038|Capecitabine|capecitabine|mesh-list
82981484|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
82981485|NCT01351038|Panitumumab|panitumumab|mesh-list
82981486|NCT01351038|Epirubicin|epirubicin|mesh-list
82981487|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82981488|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
82981489|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981490|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981491|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82981492|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82981493|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82981494|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82981495|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981496|NCT02464462|Vitamin D|vitamin d|mesh-list
82981497|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
82981498|NCT02464462|Calcium|calcium|mesh-list
82981499|NCT02464462|Vitamins|vitamins|mesh-ancestor
82981500|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
82981501|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981502|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82981503|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82981504|NCT04270864|Nivolumab|nivolumab|mesh-list
82981505|NCT04270864|Ipilimumab|ipilimumab|mesh-list
82981506|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82981507|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981508|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82981509|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981510|NCT01318668|Vaccines|vaccines|mesh-list
82981511|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
82981512|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981513|NCT01351272|Methylphenidate|methylphenidate|mesh-list
82981514|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82981515|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981516|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82981517|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82981518|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981519|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981520|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
82981521|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981522|NCT01351428|Nifedipine|nifedipine|mesh-list
82981523|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82981524|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981525|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981526|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82981527|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981528|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
82981529|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
82981530|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82981531|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82981532|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82981533|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981534|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
82981535|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
82981536|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981537|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
82981538|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82981539|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981540|NCT01351818|Hormones|hormones|mesh-list
82981541|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981542|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981543|NCT02463994|Atezolizumab|atezolizumab|mesh-list
82981544|NCT02463994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82981545|NCT02463994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981546|NCT02463994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82981547|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981548|NCT04235686|Amphetamine|amphetamine|mesh-list
82981549|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
82981550|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82981551|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981563|NCT02079948|Folic Acid|folic acid|mesh-list
82981564|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
82981565|NCT02079948|Methotrexate|methotrexate|mesh-list
82981566|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82981567|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
82981568|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82981569|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981570|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82981571|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
82981572|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981573|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981574|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
82981575|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981576|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82981577|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981578|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
82981579|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82981580|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82981581|NCT02079948|Hematinics|hematinics|mesh-ancestor
82981582|NCT02079948|Vitamins|vitamins|mesh-ancestor
82981583|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
82981584|NCT01357902|Lamotrigine|lamotrigine|mesh-list
82981585|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
82981586|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82981587|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981588|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981589|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82981590|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981591|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82981592|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981593|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981594|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981595|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82981596|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
82981597|NCT04634409|Sotrovimab|sotrovimab|mesh-list
82981598|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
82981599|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981600|NCT01352130|Ondansetron|ondansetron|mesh-list
82981601|NCT01352130|Granisetron|granisetron|mesh-list
82981602|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
82981603|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
82981604|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
82981605|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981606|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981607|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82981608|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
82981609|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
82981610|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82981611|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
82981612|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981613|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981614|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82981615|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82981616|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981617|NCT00005780|Prednisone|prednisone|mesh-list
82981618|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
82981619|NCT00005780|Doxorubicin|doxorubicin|mesh-list
82981620|NCT00005780|Etoposide|etoposide|mesh-list
82981621|NCT00005780|Vincristine|vincristine|mesh-list
82981622|NCT00005780|Sargramostim|sargramostim|mesh-list
82981623|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981624|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
82981625|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981626|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82981627|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82981628|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
82981629|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981630|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981631|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82981632|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82981633|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82981634|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82981635|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981636|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981637|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
82981638|NCT00005780|Hormones|hormones|mesh-ancestor
83463494|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
82981639|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981640|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82981641|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82981642|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
82981643|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
82981644|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
82981645|NCT01356732|Sufentanil|sufentanil|mesh-list
82981646|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82981647|NCT01356732|Narcotics|narcotics|mesh-ancestor
82981648|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981649|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981650|NCT01356732|Analgesics|analgesics|mesh-ancestor
82981651|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
82981652|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981653|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82981654|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82981655|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
82981656|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
82981657|NCT02463682|Insulin|insulin|mesh-list
82981658|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82981659|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981660|NCT05315648|Anesthetics|anesthetics|mesh-list
82981661|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981662|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981663|NCT01978938|Levofloxacin|levofloxacin|mesh-list
82981664|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82981665|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981666|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82981667|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82981668|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82981669|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981670|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981671|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981672|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82981673|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82981674|NCT02465320|Lidocaine|lidocaine|mesh-list
82981675|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
82981676|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
82981677|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981678|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981679|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
82981681|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82981682|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82981683|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82981684|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981685|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981686|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
82981687|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
82981688|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
82981689|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981690|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981691|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
82981692|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981693|NCT03228186|Docetaxel|docetaxel|mesh-list
82981694|NCT03228186|Pevonedistat|pevonedistat|mesh-list
82981695|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981696|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
82981697|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
82981698|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
82981699|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981700|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981701|NCT04105114|Buspirone|buspirone|mesh-list
82981702|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82981703|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981704|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981705|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981706|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981707|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82981708|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
82981709|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981710|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981711|NCT05573230|Cyclosporine|cyclosporine|mesh-list
82981712|NCT05573230|Midazolam|midazolam|mesh-list
82981713|NCT05573230|Cyclosporins|cyclosporins|mesh-list
82981714|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82981715|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82981716|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981717|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981718|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82981719|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981720|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981721|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82981722|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
82981723|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
82981724|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
82981725|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
82981726|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981727|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981728|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981729|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981730|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
82981731|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
82981732|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981733|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
82981734|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82981735|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82981736|NCT05550142|Vaccines|vaccines|mesh-list
82981737|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
82981738|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981739|NCT04047862|Paclitaxel|paclitaxel|mesh-list
82981740|NCT04047862|Etoposide|etoposide|mesh-list
82981741|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82981742|NCT04047862|Carboplatin|carboplatin|mesh-list
82981743|NCT04047862|Fluorouracil|fluorouracil|mesh-list
82981744|NCT04047862|Capecitabine|capecitabine|mesh-list
82981745|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
82981746|NCT04047862|Pemetrexed|pemetrexed|mesh-list
82981747|NCT04047862|Tislelizumab|tislelizumab|mesh-list
82981748|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82981749|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981750|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
82981751|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
82981752|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
82981753|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981754|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
82981755|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82981756|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981757|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
82981758|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981759|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82981760|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82981761|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981762|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82981763|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82981764|NCT04047862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82981765|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
82981766|NCT00116142|Docetaxel|docetaxel|mesh-list
82981767|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
82981768|NCT00116142|Androgens|androgens|mesh-list
82981769|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82981770|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981771|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
82981772|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
82981773|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
82981774|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981775|NCT00116142|Hormones|hormones|mesh-ancestor
82981776|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981777|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463503|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
82981778|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
82981779|NCT00116142|Protective Agents|protective agents|mesh-ancestor
82981780|NCT00116142|Vitamins|vitamins|mesh-ancestor
82981781|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
82981782|NCT00116142|Estrogens|estrogens|mesh-ancestor
82981783|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82981784|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
82981785|NCT05547256|Vaccines|vaccines|mesh-list
82981786|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
82981787|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981788|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
82981789|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
82981790|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82981791|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82981792|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981793|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981794|NCT01757782|Urological Agents|urological agents|mesh-ancestor
82981795|NCT02023905|Everolimus|everolimus|mesh-list
82981796|NCT02023905|Temozolomide|temozolomide|mesh-list
82981797|NCT02023905|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82981798|NCT02023905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82981799|NCT02023905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981800|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981801|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981802|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
82981803|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981804|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981805|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82981806|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
82981807|NCT01330563|Ketoconazole|ketoconazole|mesh-list
82981808|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
82981809|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981810|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82981811|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82981812|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981813|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981814|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82981815|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
82981816|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981817|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981818|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82981819|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
82981820|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981821|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82981822|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981823|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981824|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
82981825|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
82981826|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981827|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981828|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981829|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
82981831|NCT04897503|Riboflavin|riboflavin|mesh-list
82981832|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
82981833|NCT04897503|Vitamins|vitamins|mesh-ancestor
82981834|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
82981835|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981836|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82981837|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
82981838|NCT01333917|Curcumin|curcumin|mesh-list
82981839|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82981840|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82981841|NCT01333917|Analgesics|analgesics|mesh-ancestor
82981842|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
82981843|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981844|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981845|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981846|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82981847|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981848|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981849|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981850|NCT03129360|Levetiracetam|levetiracetam|mesh-list
82981851|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
82981852|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
82981853|NCT01315275|Ranibizumab|ranibizumab|mesh-list
82981854|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82981855|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82981856|NCT01315275|Growth Substances|growth substances|mesh-ancestor
82981857|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981858|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
82981859|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981860|NCT01319448|Artesunate|artesunate|mesh-list
82981861|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
82981862|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
82981863|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
82981864|NCT01319448|Amodiaquine|amodiaquine|mesh-list
82981865|NCT01319448|Mefloquine|mefloquine|mesh-list
82981866|NCT01319448|Proguanil|proguanil|mesh-list
82981867|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
82981868|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82981869|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82981870|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82981871|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981872|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
82981873|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
82981874|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82981875|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
82981876|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82981877|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981878|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981879|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82981880|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
82981881|NCT04360551|Telmisartan|telmisartan|mesh-list
82981882|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82981883|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82981884|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82981885|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981886|NCT01334073|Everolimus|everolimus|mesh-list
82981887|NCT01334073|Axitinib|axitinib|mesh-list
82981888|NCT01334073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82981889|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82981890|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981891|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981892|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981893|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
82981894|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981895|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981896|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82981897|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82981898|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981899|NCT01928199|Incretins|incretins|mesh-ancestor
82981900|NCT01928199|Hormones|hormones|mesh-ancestor
82981901|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981902|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82981903|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
82981904|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981905|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981906|NCT01845441|Fentanyl|fentanyl|mesh-list
82981907|NCT01845441|Midazolam|midazolam|mesh-list
82981908|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
82981909|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82981910|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981911|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981912|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82981913|NCT01845441|Analgesics|analgesics|mesh-ancestor
82981914|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
82981915|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981916|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82981917|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82981918|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83463519|NCT00634972|Analgesics|analgesics|mesh-ancestor
82981919|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
82981920|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981921|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981922|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82981923|NCT01845441|Narcotics|narcotics|mesh-ancestor
82981924|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82981925|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82981926|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
82981927|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
82981928|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82981929|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82981930|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82981931|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
82981932|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
82981933|NCT03296488|Fentanyl|fentanyl|mesh-list
82981934|NCT03296488|Nalbuphine|nalbuphine|mesh-list
82981935|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82981936|NCT03296488|Narcotics|narcotics|mesh-ancestor
82981937|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981938|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981939|NCT03296488|Analgesics|analgesics|mesh-ancestor
82981940|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
82981941|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981942|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82981943|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82981944|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
82981945|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
82981946|NCT01365936|Menotropins|menotropins|mesh-list
82981947|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82981948|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
82981949|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82981950|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981951|NCT01334151|Insulin|insulin|mesh-list
82981952|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82981953|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
82981954|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82981955|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981956|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82981957|NCT04216017|Lidocaine|lidocaine|mesh-list
82981958|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
82981959|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
82981960|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82981961|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981962|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
82981963|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981964|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82981965|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82981966|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82981967|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981968|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981969|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82981970|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
82981971|NCT04216017|Hormones|hormones|mesh-ancestor
82981972|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82981973|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82981974|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
82981975|NCT03296410|Vaccines|vaccines|mesh-list
82981976|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
82981977|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82981978|NCT05189184|Paclitaxel|paclitaxel|mesh-list
82981979|NCT05189184|Apatinib|apatinib|mesh-list
82981980|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82981981|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82981982|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82981983|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
82981985|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
82981986|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981987|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82981988|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82981989|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
82981990|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82981991|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
82981992|NCT04623099|Escitalopram|escitalopram|mesh-list
82981993|NCT04623099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83463521|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82981994|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82981995|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82981996|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82981997|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82981998|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
82981999|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982000|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82982001|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982002|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
82982003|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982004|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982005|NCT03735290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82982006|NCT03735290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982008|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82982009|NCT03619538|Analgesics|analgesics|mesh-ancestor
82982010|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
82982011|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982012|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982013|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
82982014|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82982015|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
82982016|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82982017|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982018|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82982019|NCT01366326|Bromides|bromides|mesh-list
82982020|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
82982021|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
82982022|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82982023|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982024|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
82982025|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982026|NCT01822275|Temozolomide|temozolomide|mesh-list
82982027|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82982028|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
82982029|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982030|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982031|NCT01331421|Exemestane|exemestane|mesh-list
82982032|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982033|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82982034|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82982035|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982036|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982037|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82982038|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982039|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982040|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982041|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
82982042|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82982043|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82982044|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82982045|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82982046|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
82982047|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82982048|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982049|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82982050|NCT01656434|Estrogens|estrogens|mesh-ancestor
82982051|NCT01656434|Hormones|hormones|mesh-ancestor
82982052|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982053|NCT01656434|Trace Elements|trace elements|mesh-ancestor
82982054|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
82982055|NCT01319214|Propranolol|propranolol|mesh-list
82982056|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82982057|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82982058|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
82982059|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982060|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982061|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982062|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82982063|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82982064|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
82982066|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82982067|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982068|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982069|NCT02461030|Listerine|listerine|mesh-list
82982070|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
82982071|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
82982072|NCT02461030|Protective Agents|protective agents|mesh-ancestor
82982073|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982074|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82982075|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982076|NCT05168618|Atezolizumab|atezolizumab|mesh-list
82982077|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82982078|NCT05168618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82982079|NCT05168618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982080|NCT05168618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982081|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982082|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
82982083|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982084|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82982085|NCT01599494|Progesterone|progesterone|mesh-list
82982086|NCT01599494|Ganirelix|ganirelix|mesh-list
82982087|NCT01599494|Progestins|progestins|mesh-ancestor
82982088|NCT01599494|Hormones|hormones|mesh-ancestor
82982089|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982090|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982091|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82982092|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982093|NCT03295786|Dopamine|dopamine|mesh-list
82982094|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82982095|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
82982096|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
82982097|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982098|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982099|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
82982100|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982101|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982102|NCT03295786|Protective Agents|protective agents|mesh-ancestor
82982103|NCT03194932|Cytarabine|cytarabine|mesh-list
82982104|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
82982105|NCT03194932|Methotrexate|methotrexate|mesh-list
82982106|NCT03194932|Azacitidine|azacitidine|mesh-list
82982107|NCT03194932|Venetoclax|venetoclax|mesh-list
82982108|NCT03194932|Idarubicin|idarubicin|mesh-list
82982109|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82982110|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
82982111|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82982112|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982113|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982114|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
82982115|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982116|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982117|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
82982118|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982119|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82982120|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982121|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
82982122|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982123|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82982124|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
82982125|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982126|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982127|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82982128|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82982129|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82982130|NCT03037580|Treprostinil|treprostinil|mesh-list
82982131|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82982133|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982134|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
82982135|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982136|NCT02978404|Nivolumab|nivolumab|mesh-list
82982137|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982138|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982139|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82982140|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982141|NCT04441918|Antibodies|antibodies|mesh-list
82982142|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82982143|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
82982144|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982145|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
82982146|NCT01331655|Drospirenone|drospirenone|mesh-list
82982147|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82982148|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982149|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982150|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982151|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82982152|NCT01331655|Diuretics|diuretics|mesh-ancestor
82982153|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
82982154|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
82982155|NCT01331655|Vitamins|vitamins|mesh-ancestor
82982156|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
82982157|NCT03289390|Acetaminophen|acetaminophen|mesh-list
82982158|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82982159|NCT03289390|Analgesics|analgesics|mesh-ancestor
82982160|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
82982161|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982162|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982163|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
82982164|NCT03382977|Carmustine|carmustine|mesh-list
82982165|NCT03382977|Lomustine|lomustine|mesh-list
82982166|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82982167|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
82982168|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982169|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982170|NCT00897104|Sumatriptan|sumatriptan|mesh-list
82982171|NCT00897104|Rizatriptan|rizatriptan|mesh-list
82982172|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82982173|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82982174|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82982175|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
82982176|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133559|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82982177|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982178|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982179|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
82982180|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
82982181|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982182|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982183|NCT03295162|Melatonin|melatonin|mesh-list
82982184|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
82982185|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982186|NCT03295162|Protective Agents|protective agents|mesh-ancestor
82982187|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982188|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982189|NCT05237492|Tramadol|tramadol|mesh-list
82982190|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82982191|NCT05237492|Narcotics|narcotics|mesh-ancestor
82982192|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982193|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982194|NCT05237492|Analgesics|analgesics|mesh-ancestor
82982195|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
82982196|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982197|NCT03295084|Capecitabine|capecitabine|mesh-list
82982198|NCT03295084|Irinotecan|irinotecan|mesh-list
82982199|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982200|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
82982201|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982202|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982203|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82982204|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82982205|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982206|NCT04710134|Reslizumab|reslizumab|mesh-list
82982207|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82982208|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
82982210|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
82982211|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982212|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982213|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982214|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
82982215|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
82982216|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82982217|NCT00702806|Ganirelix|ganirelix|mesh-list
82982218|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982219|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982220|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982221|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82982222|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82982223|NCT01336803|Hematinics|hematinics|mesh-ancestor
82982224|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82982225|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82982226|NCT03635931|Mitogens|mitogens|mesh-list
82982227|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
82982228|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982229|NCT01331967|Pioglitazone|pioglitazone|mesh-list
82982230|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82982231|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982232|NCT00696878|Progesterone|progesterone|mesh-list
82982233|NCT00696878|Progestins|progestins|mesh-ancestor
82982234|NCT00696878|Hormones|hormones|mesh-ancestor
82982235|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982236|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982237|NCT04493151|Imipenem|imipenem|mesh-list
82982238|NCT04493151|Relebactam|relebactam|mesh-list
82982239|NCT04493151|Cilastatin|cilastatin|mesh-list
82982240|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82982241|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982242|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
82982243|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982244|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982245|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82982246|NCT00731757|Adalimumab|adalimumab|mesh-list
82982247|NCT00731757|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82982248|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982249|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982250|NCT03108274|Fexofenadine|fexofenadine|mesh-list
82982251|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
82982253|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82982254|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82982255|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982256|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982257|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82982258|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82982259|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82982260|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82982261|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
82982262|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
82982263|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
82982264|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
82982265|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982266|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982267|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82982268|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982269|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82982270|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
82982271|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82982272|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982273|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982274|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82982275|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82982276|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82982277|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
82982278|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
82982279|NCT02278588|Rasagiline|rasagiline|mesh-list
82982280|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
82982281|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463533|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982282|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982284|NCT02278588|Protective Agents|protective agents|mesh-ancestor
82982285|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982286|NCT03288610|Vasopressins|vasopressins|mesh-list
82982287|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
82982288|NCT03288610|Coagulants|coagulants|mesh-ancestor
82982289|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82982290|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82982291|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
82982292|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982293|NCT00696800|Progesterone|progesterone|mesh-list
82982294|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82982295|NCT00696800|Ganirelix|ganirelix|mesh-list
82982296|NCT00696800|Progestins|progestins|mesh-ancestor
82982297|NCT00696800|Hormones|hormones|mesh-ancestor
82982298|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982299|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982300|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982301|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
82982302|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82982303|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982304|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
82982305|NCT03288532|Durvalumab|durvalumab|mesh-list
82982306|NCT03288532|Tremelimumab|tremelimumab|mesh-list
82982307|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982308|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982309|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82982310|NCT00598208|Hormones|hormones|mesh-ancestor
82982311|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982312|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982313|NCT00480662|Alendronate|alendronate|mesh-list
82982314|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82982315|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982316|NCT00398606|Alendronate|alendronate|mesh-list
82982317|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
82982318|NCT00398606|Calcium|calcium|mesh-list
82982319|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82982320|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982321|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982322|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82982323|NCT00398606|Antacids|antacids|mesh-ancestor
82982324|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982326|NCT00395408|Montelukast|montelukast|mesh-list
82982327|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982328|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982329|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
82982330|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82982331|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82982332|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982333|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982334|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82982335|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82982336|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982337|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
82982338|NCT00395408|Hormones|hormones|mesh-ancestor
82982339|NCT02462044|Iodine|iodine|mesh-list
82982340|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
82982341|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82982342|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982343|NCT02462044|Trace Elements|trace elements|mesh-ancestor
82982344|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
82982345|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982346|NCT00289874|Montelukast|montelukast|mesh-list
82982347|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82982348|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
82982349|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82982350|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982351|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982352|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982353|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82982354|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82982355|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982356|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82982357|NCT00245570|Montelukast|montelukast|mesh-list
82982358|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82982359|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
82982360|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982361|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982362|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82982363|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
82982364|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82982365|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82982366|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82982367|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
82982368|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982369|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982370|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82982371|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982372|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982373|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82982374|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82982375|NCT02461888|Dexamethasone|dexamethasone|mesh-list
82982376|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
82982378|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982379|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
82982380|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982381|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982382|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82982383|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
82982384|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982385|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982386|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82982387|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982388|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
82982389|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
82982390|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982391|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982392|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
82982393|NCT02461888|Hormones|hormones|mesh-ancestor
82982394|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982395|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82982396|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
82982397|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982398|NCT00229970|Montelukast|montelukast|mesh-list
82982399|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82982400|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
82982401|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82982402|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982403|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982404|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982405|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82982406|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82982407|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982408|NCT00111722|Rizatriptan|rizatriptan|mesh-list
82982409|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982410|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982411|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982412|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82982413|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
82982414|NCT04626596|Etonogestrel|etonogestrel|mesh-list
82982415|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82982416|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
82982417|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83463547|NCT02550288|Atorvastatin|atorvastatin|mesh-list
82982418|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982419|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82982420|NCT05235100|Apatinib|apatinib|mesh-list
82982421|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982422|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82982423|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982424|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982425|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
82982426|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82982427|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82982428|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82982429|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82982430|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982431|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
82982432|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982433|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982434|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82982435|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982436|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
82982437|NCT00092066|Vitamin D|vitamin d|mesh-list
82982438|NCT00092066|Alendronate|alendronate|mesh-list
82982439|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82982440|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982441|NCT00092066|Vitamins|vitamins|mesh-ancestor
82982442|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
82982443|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82982444|NCT01466686|Temozolomide|temozolomide|mesh-list
82982445|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82982446|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
82982447|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982448|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982449|NCT04091750|Nivolumab|nivolumab|mesh-list
82982450|NCT04091750|Ipilimumab|ipilimumab|mesh-list
82982451|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982452|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982453|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82982454|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982455|NCT01334619|Ropivacaine|ropivacaine|mesh-list
82982456|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
82982457|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
82982458|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982459|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982460|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
82982461|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982462|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
82982463|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982464|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982465|NCT03287128|Immunotoxins|immunotoxins|mesh-ancestor
82982466|NCT03287128|Immunoconjugates|immunoconjugates|mesh-ancestor
82982467|NCT03287128|Immunologic Factors|immunologic factors|mesh-ancestor
82982468|NCT03287128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982469|NCT00457275|Ezetimibe|ezetimibe|mesh-list
83521009|NCT00390793|Vincristine|vincristine|mesh-list
82982471|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82982472|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
82982473|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982474|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82982475|NCT03294070|Amlodipine|amlodipine|mesh-list
82982476|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82982477|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82982478|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82982479|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982480|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82982481|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982482|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
82982483|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
82982484|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
82982485|NCT04479566|Calcium|calcium|mesh-list
82982486|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82982487|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982488|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
82982489|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82982490|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982491|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982492|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
82982493|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82982494|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982495|NCT04479566|Antacids|antacids|mesh-ancestor
82982496|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982497|NCT03293992|Latanoprost|latanoprost|mesh-list
82982498|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82982499|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82982500|NCT01332201|Tacrolimus|tacrolimus|mesh-list
82982501|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982502|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
82982503|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982504|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82982505|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982506|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982507|NCT01332279|Everolimus|everolimus|mesh-list
82982508|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82982509|NCT01332279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82982510|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82982511|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982512|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982513|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982514|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
82982515|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982516|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982517|NCT03298906|Ticlopidine|ticlopidine|mesh-list
82982518|NCT03298906|Esketamine|esketamine|mesh-list
82982519|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
82982520|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82982521|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82982522|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82982523|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982524|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82982525|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82982526|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82982527|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82982528|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
82982529|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982530|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982531|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82982532|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82982533|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982534|NCT03697629|Daratumumab|daratumumab|mesh-list
82982535|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982536|NCT00398541|Losartan|losartan|mesh-list
82982537|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82982538|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82982539|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82982540|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82982541|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83483185|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982542|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463555|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982544|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
82982545|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982546|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82982547|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82982548|NCT03286582|Clobetasol|clobetasol|mesh-list
82982549|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982550|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
82982551|NCT03286582|Hormones|hormones|mesh-ancestor
82982552|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982553|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982554|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82982555|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
82982556|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
82982557|NCT05202002|Hormones|hormones|mesh-ancestor
82982558|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982559|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982560|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982561|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982562|NCT02460640|Morphine|morphine|mesh-list
82982563|NCT02460640|Ropivacaine|ropivacaine|mesh-list
82982564|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82982565|NCT02460640|Narcotics|narcotics|mesh-ancestor
82982566|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982567|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982568|NCT02460640|Analgesics|analgesics|mesh-ancestor
82982569|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
82982570|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982571|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
82982572|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
82982573|NCT03298516|Azacitidine|azacitidine|mesh-list
82982574|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982575|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
82982576|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982577|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982578|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982579|NCT05120960|Osimertinib|osimertinib|mesh-list
82982580|NCT05120960|Tepotinib|tepotinib|mesh-list
82982581|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982582|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82982583|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982584|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982585|NCT05169866|Amiodarone|amiodarone|mesh-list
82982586|NCT05169866|Nifekalant|nifekalant|mesh-list
82982587|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82982588|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
82982589|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82982590|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82982591|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982592|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82982593|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82982594|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82982595|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982596|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82982597|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82982598|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82982599|NCT03843008|Melatonin|melatonin|mesh-list
82982600|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
82982601|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982602|NCT03843008|Protective Agents|protective agents|mesh-ancestor
82982603|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982604|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982605|NCT03285802|Everolimus|everolimus|mesh-list
82982606|NCT03285802|Letrozole|letrozole|mesh-list
82982607|NCT03285802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82982608|NCT03285802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82982609|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982610|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982611|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982612|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
82982613|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982614|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982616|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82982617|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82982618|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
82982619|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982620|NCT05130086|Islatravir|islatravir|mesh-list
82982621|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
82982622|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982623|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982624|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982625|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82982626|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82982627|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82982628|NCT02461186|Piperaquine|piperaquine|mesh-list
82982629|NCT02461186|Artenimol|artenimol|mesh-list
82982630|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
82982631|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82982632|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82982633|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982634|NCT04921670|Infliximab|infliximab|mesh-list
82982635|NCT04921670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82982636|NCT04921670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982637|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
82982638|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982639|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982640|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
82982641|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82982642|NCT03512210|Velpatasvir|velpatasvir|mesh-list
82982643|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
82982644|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982645|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
82982646|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
82982647|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82982648|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
82982649|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982650|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982651|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82982652|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
82982653|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82982654|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82982655|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82982656|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
82982657|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982658|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982659|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982660|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
82982661|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82982662|NCT03292822|Paclitaxel|paclitaxel|mesh-list
82982663|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82982664|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982665|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
82982666|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
82982667|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
82982668|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982669|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
82982670|NCT03297502|Tacrolimus|tacrolimus|mesh-list
82982671|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82982672|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82982673|NCT03297502|Analgesics|analgesics|mesh-ancestor
82982674|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
82982675|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982676|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982677|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982678|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982679|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
82982680|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982681|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
82982682|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82982683|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982684|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982685|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
82982686|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
82982687|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82982688|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83521010|NCT00390793|Daunorubicin|daunorubicin|mesh-list
82982689|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982690|NCT03292744|Vitamins|vitamins|mesh-ancestor
82982691|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
82982692|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82982693|NCT03035942|Dexamethasone|dexamethasone|mesh-list
82982694|NCT03035942|Ondansetron|ondansetron|mesh-list
82982695|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982696|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
82982697|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
82982698|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982699|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982700|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982701|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
82982702|NCT03035942|Hormones|hormones|mesh-ancestor
82982703|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982704|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82982705|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982706|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
82982707|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
82982708|NCT03035942|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82982709|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82982710|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
82982711|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982712|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982713|NCT02820519|Loxapine|loxapine|mesh-list
82982714|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82982715|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82982716|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982717|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982718|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82982719|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82982720|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
82982721|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982722|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982723|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82982724|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82982725|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
82982726|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82982728|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82982729|NCT02616146|Estradiol|estradiol|mesh-list
82982730|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82982731|NCT02616146|Estrogens|estrogens|mesh-ancestor
82982732|NCT02616146|Hormones|hormones|mesh-ancestor
82982733|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982734|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982735|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82982736|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
82982737|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82982738|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82982739|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82982740|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82982741|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82982742|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82982743|NCT01332747|Atorvastatin|atorvastatin|mesh-list
82982744|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82982745|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82982746|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
82982747|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982748|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82982749|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82982750|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982751|NCT03442413|Nicotine|nicotine|mesh-list
83463583|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982752|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82982753|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
82982754|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982755|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982756|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82982757|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82982758|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
82982759|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982760|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982761|NCT01337427|Interferons|interferons|mesh-list
82982762|NCT01337427|Interferon-beta|interferon-beta|mesh-list
82982763|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
82982764|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982765|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
82982766|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982767|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
82982768|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982769|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82982770|NCT02459938|Glucagon|glucagon|mesh-list
82982771|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82982772|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982773|NCT02459938|Hormones|hormones|mesh-ancestor
82982774|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982775|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982776|NCT02459938|Incretins|incretins|mesh-ancestor
82982777|NCT03284164|Tenofovir|tenofovir|mesh-list
82982778|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
82982779|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982780|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82982781|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82982782|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982783|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982784|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82982785|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82982786|NCT01337583|Dapivirine|dapivirine|mesh-list
82982787|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82982788|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82982789|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
82982790|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982791|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
82982792|NCT03107962|Antibodies|antibodies|mesh-list
82982793|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
82982794|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
82982795|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982796|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982797|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982798|NCT03107962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82982799|NCT03107962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982800|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
82982801|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82982802|NCT04891172|Antibodies|antibodies|mesh-list
82982803|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
82982804|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82982805|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
82982806|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982807|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
82982808|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982809|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982810|NCT01335321|Triamcinolone|triamcinolone|mesh-list
82982811|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
82982812|NCT01335321|Hylan|hylan|mesh-list
82982813|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982814|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
82982815|NCT01335321|Hormones|hormones|mesh-ancestor
82982816|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982817|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982818|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
82982819|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
83463592|NCT00000736|Zidovudine|zidovudine|mesh-list
82982820|NCT01335321|Protective Agents|protective agents|mesh-ancestor
82982821|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82982822|NCT01333137|Carboplatin|carboplatin|mesh-list
82982823|NCT01333137|Gemcitabine|gemcitabine|mesh-list
82982824|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982825|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982826|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
82982827|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982828|NCT03282838|Celecoxib|celecoxib|mesh-list
82982829|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82982830|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82982831|NCT03282838|Analgesics|analgesics|mesh-ancestor
82982832|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
82982833|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982834|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982835|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982836|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982837|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82982838|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82982839|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982840|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982841|NCT04431466|Ivermectin|ivermectin|mesh-list
82982842|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82982843|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982845|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82982846|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82982847|NCT03291418|Analgesics|analgesics|mesh-ancestor
82982848|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
82982849|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82982850|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982851|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982852|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982853|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
82982854|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82982855|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982856|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982857|NCT02885181|Methotrexate|methotrexate|mesh-list
82982858|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82982859|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
82982860|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82982861|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982862|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982863|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
82982864|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982865|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982866|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
82982867|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982868|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82982869|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982870|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
82982871|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82982872|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82982873|NCT02459782|Anesthetics|anesthetics|mesh-list
82982874|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982875|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982878|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982879|NCT01315431|Capecitabine|capecitabine|mesh-list
82982880|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982881|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
82982882|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982883|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982884|NCT00092625|Ezetimibe|ezetimibe|mesh-list
82982885|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82982886|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82982887|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
82982888|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982889|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82982890|NCT04135846|Doxazosin|doxazosin|mesh-list
82982891|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83463597|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982892|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82982893|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82982894|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82982895|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
82982896|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82982897|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982898|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982899|NCT01333449|Decitabine|decitabine|mesh-list
82982900|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982901|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
82982902|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982903|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982904|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982905|NCT04853199|Quercetin|quercetin|mesh-list
82982906|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
82982907|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982908|NCT04853199|Protective Agents|protective agents|mesh-ancestor
82982909|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982910|NCT01341717|Metformin|metformin|mesh-list
82982911|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82982912|NCT01341717|Glimepiride|glimepiride|mesh-list
82982913|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82982914|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982915|NCT01341717|Incretins|incretins|mesh-ancestor
82982916|NCT01341717|Hormones|hormones|mesh-ancestor
82982917|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82982918|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82982919|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
82982920|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982921|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982922|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82982923|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982924|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
82982925|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
82982926|NCT03157089|Afatinib|afatinib|mesh-list
82982927|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982928|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982929|NCT03157089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82982930|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982931|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82982932|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982933|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
82982934|NCT01338129|Vitamins|vitamins|mesh-ancestor
82982935|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
82982936|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982937|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
82982938|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982939|NCT01338129|Protective Agents|protective agents|mesh-ancestor
82982940|NCT05181969|Dextrans|dextrans|mesh-list
82982941|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
82982942|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
82982943|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
82982944|NCT00092157|Simvastatin|simvastatin|mesh-list
82982945|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82982946|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82982947|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
82982948|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982949|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82982950|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82982951|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982953|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82982954|NCT05166291|Anesthetics|anesthetics|mesh-list
82982955|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82982956|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982957|NCT01338441|Erythromycin|erythromycin|mesh-list
82982958|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
82982959|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82982960|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
82982961|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82982962|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82982963|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82982964|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82982965|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82982966|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982967|NCT01341951|Lenograstim|lenograstim|mesh-list
82982968|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82982969|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
82982970|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982971|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
82982972|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82982973|NCT02714218|Nivolumab|nivolumab|mesh-list
82982974|NCT02714218|Ipilimumab|ipilimumab|mesh-list
82982975|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82982976|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982977|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82982978|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982979|NCT05185869|Paclitaxel|paclitaxel|mesh-list
82982980|NCT05185869|Gemcitabine|gemcitabine|mesh-list
82982981|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82982982|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982983|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
82982984|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
82982985|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
82982986|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982987|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82982988|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
82982989|NCT01338675|Busulfan|busulfan|mesh-list
82982990|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
82982991|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82982992|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82982993|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
82982994|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82982995|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82982996|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82982997|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82982998|NCT01338753|Bevacizumab|bevacizumab|mesh-list
82982999|NCT01338753|Docetaxel|docetaxel|mesh-list
82983000|NCT01338753|Doxorubicin|doxorubicin|mesh-list
82983001|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983002|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983003|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82983004|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82983005|NCT01338753|Growth Substances|growth substances|mesh-ancestor
82983006|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983007|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
82983008|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
82983009|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
82983010|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
82983011|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983012|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82983013|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82983014|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82983015|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983016|NCT02457286|Metformin|metformin|mesh-list
82983017|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82983018|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983019|NCT01338909|Clopidogrel|clopidogrel|mesh-list
82983020|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82983021|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82983022|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82983023|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82983024|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82983025|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
82983026|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983027|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983028|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983029|NCT03282136|Incretins|incretins|mesh-list
82983030|NCT03282136|Hormones|hormones|mesh-ancestor
82983031|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983032|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983033|NCT03156621|Alirocumab|alirocumab|mesh-list
82983034|NCT03156621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82983035|NCT03156621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82983036|NCT03156621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82983037|NCT03156621|Antimetabolites|antimetabolites|mesh-ancestor
82983038|NCT03156621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983039|NCT03156621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82983040|NCT03156621|Protease Inhibitors|protease inhibitors|mesh-ancestor
82983041|NCT03156621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983042|NCT03156621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82983043|NCT03264586|Lidocaine|lidocaine|mesh-list
82983044|NCT03264586|Prilocaine|prilocaine|mesh-list
82983045|NCT03264586|Mepivacaine|mepivacaine|mesh-list
82983046|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
82983047|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
82983048|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
82983049|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983050|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983051|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
82983052|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983053|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82983054|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82983055|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82983056|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82983057|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983058|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
82983059|NCT01342731|Tigecycline|tigecycline|mesh-list
82983060|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82983061|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983062|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82983063|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983064|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983066|NCT01339065|Analgesics|analgesics|mesh-ancestor
82983067|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
82983068|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983069|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983070|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82983071|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82983072|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
82983073|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
82983074|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983075|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82983076|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82983077|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983078|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983079|NCT02460016|Ziresovir|ziresovir|mesh-list
82983080|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
82983081|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983082|NCT05187507|Theobromine|theobromine|mesh-list
82983083|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82983084|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
82983085|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983086|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983087|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82983088|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
82983089|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983090|NCT01339143|Pioglitazone|pioglitazone|mesh-list
82983091|NCT01339143|Vildagliptin|vildagliptin|mesh-list
82983092|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82983093|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983094|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82983095|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
82983096|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983097|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983099|NCT03264430|Bupivacaine|bupivacaine|mesh-list
82983100|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
82983101|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
82983102|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463611|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82983103|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983104|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
82983105|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983106|NCT03264430|Analgesics|analgesics|mesh-ancestor
82983107|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82983108|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82983109|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
82983110|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82983111|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82983112|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983113|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983114|NCT05250843|Lenvatinib|lenvatinib|mesh-list
82983115|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983116|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82983117|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983118|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983119|NCT03264274|Aflibercept|aflibercept|mesh-list
82983120|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82983121|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82983122|NCT03264274|Growth Substances|growth substances|mesh-ancestor
82983123|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983124|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
82983125|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983126|NCT02457208|Rifampin|rifampin|mesh-list
82983127|NCT02457208|Isoniazid|isoniazid|mesh-list
82983128|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
82983129|NCT02457208|Ethambutol|ethambutol|mesh-list
82983130|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82983131|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
82983132|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82983133|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983134|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
82983135|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82983136|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983137|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983138|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82983139|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82983140|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82983141|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82983142|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82983143|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82983144|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82983145|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82983146|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
82983147|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82983148|NCT02457130|Clopidogrel|clopidogrel|mesh-list
82983149|NCT02457130|Ticagrelor|ticagrelor|mesh-list
82983150|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82983151|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82983152|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82983153|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82983154|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
82983155|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983156|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983157|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983158|NCT01340235|Erythromycin|erythromycin|mesh-list
82983159|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
82983160|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82983161|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
82983162|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82983163|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983164|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82983165|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82983166|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983167|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983168|NCT03263962|Canrenone|canrenone|mesh-list
82983169|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82983170|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
82983171|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983172|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983173|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82983174|NCT03263962|Diuretics|diuretics|mesh-ancestor
82983175|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
82983176|NCT05186649|Warfarin|warfarin|mesh-list
82983177|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
82983178|NCT05184465|Anesthetics|anesthetics|mesh-list
82983179|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983180|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983181|NCT03152019|Tacrolimus|tacrolimus|mesh-list
82983182|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983183|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
82983184|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983185|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82983186|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983187|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983188|NCT04813107|Tislelizumab|tislelizumab|mesh-list
82983189|NCT04813107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983190|NCT04813107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983191|NCT02714062|Topiramate|topiramate|mesh-list
82983192|NCT02714062|Phentermine|phentermine|mesh-list
82983193|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
82983194|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82983195|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983196|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82983197|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
82983198|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82983199|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
82983200|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
82983201|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983202|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
82983203|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983204|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983205|NCT03280342|Topiramate|topiramate|mesh-list
82983206|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
82983207|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82983208|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983209|NCT04965519|Trastuzumab|trastuzumab|mesh-list
82983210|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983211|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983212|NCT03279796|Betamethasone|betamethasone|mesh-list
82983213|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983214|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
82983215|NCT03279796|Hormones|hormones|mesh-ancestor
82983216|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983217|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983218|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82983219|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
82983220|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
82983221|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82983222|NCT02713828|Immunoconjugates|immunoconjugates|mesh-ancestor
82983223|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
82983224|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983225|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983226|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983227|NCT05183997|Verapamil|verapamil|mesh-list
82983228|NCT05183997|Thrombin|thrombin|mesh-list
82983229|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82983230|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82983231|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82983232|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983233|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983234|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983235|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983236|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
82983237|NCT05183997|Coagulants|coagulants|mesh-ancestor
82983238|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
82983239|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983240|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983241|NCT05119101|Analgesics|analgesics|mesh-ancestor
82983242|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
82983243|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983244|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983245|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
82983247|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
82983248|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82983249|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82983250|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983251|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
82983252|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82983253|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
82983254|NCT01340547|Ifosfamide|ifosfamide|mesh-list
82983255|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82983256|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
82983257|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983258|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983259|NCT05183841|Fenoterol|fenoterol|mesh-list
82983260|NCT05183841|Ipratropium|ipratropium|mesh-list
82983261|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
82983262|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
82983263|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983264|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983265|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82983266|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
82983267|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82983268|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
82983269|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983270|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983271|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
82983272|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
82983273|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82983274|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82983275|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82983276|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82983277|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
82983278|NCT03277222|Insulin|insulin|mesh-list
82983279|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82983280|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983281|NCT04931667|Lorecivivint|lorecivivint|mesh-list
82983282|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983283|NCT03262948|Paclitaxel|paclitaxel|mesh-list
82983284|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82983285|NCT03262948|Carboplatin|carboplatin|mesh-list
82983286|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82983287|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983288|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
82983289|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
82983290|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
82983291|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983292|NCT02876328|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82983293|NCT02876328|Antiviral Agents|antiviral agents|mesh-ancestor
82983294|NCT02876328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983295|NCT03276598|Losartan|losartan|mesh-list
82983296|NCT03276598|Amlodipine|amlodipine|mesh-list
82983297|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82983298|NCT03276598|Bisoprolol|bisoprolol|mesh-list
82983299|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82983300|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82983301|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82983302|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983303|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983304|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983305|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983306|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82983307|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82983308|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82983309|NCT03276598|Diuretics|diuretics|mesh-ancestor
82983310|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
82983311|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82983312|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
82983313|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
82983314|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983315|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82983316|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82983317|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82983318|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
82983319|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983320|NCT03262792|Andrographolide|andrographolide|mesh-list
82983321|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983322|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82983323|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983324|NCT03262792|Analgesics|analgesics|mesh-ancestor
82983325|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
82983326|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983327|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983328|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983329|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82983330|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82983331|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983332|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
82983333|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82983334|NCT01359462|Tolvaptan|tolvaptan|mesh-list
82983335|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82983336|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983337|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
82983338|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983339|NCT02875392|Fucoidan|fucoidan|mesh-list
82983340|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82983341|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82983342|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
82983343|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983344|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
82983345|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82983346|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82983347|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983348|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82983349|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82983350|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983351|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983352|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983353|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82983354|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
82983355|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82983356|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983357|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82983358|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82983359|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82983360|NCT03267628|Morphine|morphine|mesh-list
82983361|NCT03267628|Anesthetics|anesthetics|mesh-list
82983362|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
82983363|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82983365|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983366|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983367|NCT03267628|Analgesics|analgesics|mesh-ancestor
82983368|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
82983369|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983370|NCT01359696|Gemcitabine|gemcitabine|mesh-list
82983371|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82983372|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
82983373|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983374|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983375|NCT03268018|Calcium|calcium|mesh-list
82983376|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983377|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983378|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82983379|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82983380|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82983381|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983382|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983383|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82983384|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82983385|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82983386|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
82983387|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983388|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983389|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82983390|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82983391|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
82983392|NCT01367028|Bevacizumab|bevacizumab|mesh-list
82983393|NCT01367028|Trastuzumab|trastuzumab|mesh-list
82983395|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983396|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983397|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82983398|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82983399|NCT01367028|Growth Substances|growth substances|mesh-ancestor
82983400|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983401|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
82983402|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
82983403|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
82983404|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
82983405|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983406|NCT03965962|Vaccines|vaccines|mesh-list
82983407|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
82983408|NCT03965962|Antibodies|antibodies|mesh-list
82983409|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
82983410|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82983411|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82983412|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
82983413|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983414|NCT03273088|Etanercept|etanercept|mesh-list
82983415|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82983416|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983417|NCT03273088|Analgesics|analgesics|mesh-ancestor
82983418|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
82983419|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983420|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983421|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983422|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983423|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82983424|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983425|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
82983426|NCT04235634|Alprostadil|alprostadil|mesh-list
82983427|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82983428|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983429|NCT04235634|Urological Agents|urological agents|mesh-ancestor
82983430|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
82983431|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82983432|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983433|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983434|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983435|NCT03262090|Analgesics|analgesics|mesh-ancestor
82983436|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
82983437|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83521011|NCT00390793|Dasatinib|dasatinib|mesh-list
82983438|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82983439|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82983440|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82983441|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
82983442|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983443|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983444|NCT03151551|Adalimumab|adalimumab|mesh-list
82983445|NCT03151551|Ixekizumab|ixekizumab|mesh-list
82983446|NCT03151551|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82983447|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983448|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983449|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
82983450|NCT03267316|Paclitaxel|paclitaxel|mesh-list
82983451|NCT03267316|Gemcitabine|gemcitabine|mesh-list
82983452|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82983453|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983454|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
82983455|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
82983456|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
82983457|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983458|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82983459|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
82983460|NCT01359930|Naltrexone|naltrexone|mesh-list
82983461|NCT01359930|Bupropion|bupropion|mesh-list
82983462|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82983463|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82983464|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983465|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
82983466|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983467|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82983468|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
82983469|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82983470|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82983471|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82983472|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82983473|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983474|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
82983475|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983476|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82983477|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82983478|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983479|NCT05075512|Fulvestrant|fulvestrant|mesh-list
82983480|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82983481|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983482|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82983483|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82983484|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
82983485|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983486|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983488|NCT01316757|Carboplatin|carboplatin|mesh-list
82983489|NCT01316757|Cetuximab|cetuximab|mesh-list
82983490|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82983491|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82983492|NCT01316757|Antibodies|antibodies|mesh-list
82983493|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
82983494|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82983495|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82983496|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983497|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
82983498|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
82983499|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
82983500|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983501|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
82983502|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983503|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82983504|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983505|NCT05074966|Cetuximab|cetuximab|mesh-list
82983506|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983507|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983508|NCT03266926|Bupivacaine|bupivacaine|mesh-list
82983509|NCT03266926|Estrogens|estrogens|mesh-list
82983510|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
82983511|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
82983512|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
82983513|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983514|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983515|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
82983516|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983517|NCT03266926|Hormones|hormones|mesh-ancestor
83463645|NCT00000772|Ribavirin|ribavirin|mesh-list
82983518|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983519|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
82983520|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82983521|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
82983522|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983523|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983524|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82983525|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
82983526|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82983527|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82983528|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82983529|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
82983530|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983531|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983532|NCT01367418|Sufentanil|sufentanil|mesh-list
82983533|NCT01367418|Morphine|morphine|mesh-list
82983534|NCT01367418|Bupivacaine|bupivacaine|mesh-list
82983535|NCT01367418|Ropivacaine|ropivacaine|mesh-list
82983536|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
82983537|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
82983538|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983539|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983540|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
82983541|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983542|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82983544|NCT01367418|Analgesics|analgesics|mesh-ancestor
82983545|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82983546|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82983547|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
82983548|NCT01360086|Leucovorin|leucovorin|mesh-list
82983549|NCT01360086|Fluorouracil|fluorouracil|mesh-list
82983550|NCT01360086|Cetuximab|cetuximab|mesh-list
82983551|NCT01360086|Calcium|calcium|mesh-list
82983552|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
82983553|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983554|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983555|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983556|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
82983557|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983558|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82983559|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983560|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
82983561|NCT01360086|Antidotes|antidotes|mesh-ancestor
82983562|NCT01360086|Protective Agents|protective agents|mesh-ancestor
82983563|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
82983564|NCT01360086|Vitamins|vitamins|mesh-ancestor
82983565|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
82983566|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983567|NCT02458924|Niacin|niacin|mesh-list
82983568|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82983569|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
82983570|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983571|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82983572|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983573|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
82983574|NCT02458924|Vitamins|vitamins|mesh-ancestor
82983575|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
82983576|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983577|NCT01367496|Naltrexone|naltrexone|mesh-list
82983578|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
82983579|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82983580|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983581|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
82983582|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983583|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82983584|NCT02459158|Arbekacin|arbekacin|mesh-list
82983585|NCT02459158|Dibekacin|dibekacin|mesh-list
82983586|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82983587|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82983588|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983589|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
82983590|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82983591|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983592|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
82983593|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983594|NCT04693689|Vaccines|vaccines|mesh-list
82983595|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
82983596|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983597|NCT03126786|Triamcinolone|triamcinolone|mesh-list
82983598|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82983599|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82983600|NCT03126786|Aflibercept|aflibercept|mesh-list
82983601|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82983602|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983603|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
82983604|NCT03126786|Hormones|hormones|mesh-ancestor
82983605|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983606|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983607|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983608|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
82983609|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983610|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983611|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82983612|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82983613|NCT03126786|Growth Substances|growth substances|mesh-ancestor
82983614|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
82983615|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983616|NCT01367652|Letrozole|letrozole|mesh-list
82983617|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983618|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82983619|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82983620|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983621|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983622|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82983623|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
82983624|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983625|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983626|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82983627|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
82983628|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82983629|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
82983630|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82983631|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983632|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82983633|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82983634|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82983635|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983636|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82983637|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82983638|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82983639|NCT03146403|Vaccines|vaccines|mesh-list
82983640|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
82983641|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983642|NCT01360476|Vitamin D|vitamin d|mesh-list
82983643|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
82983644|NCT01360476|Vitamins|vitamins|mesh-ancestor
82983645|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
82983646|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983647|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82983648|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983649|NCT01317069|Fluorouracil|fluorouracil|mesh-list
82983650|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
82983651|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983652|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82983653|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983654|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983655|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
82983656|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983657|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
82983658|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
82983659|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82983660|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
82983661|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983662|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983663|NCT01317225|Progestins|progestins|mesh-ancestor
82983664|NCT01317225|Hormones|hormones|mesh-ancestor
82983665|NCT01363206|Ipilimumab|ipilimumab|mesh-list
82983666|NCT01363206|Molgramostim|molgramostim|mesh-list
82983667|NCT01363206|Sargramostim|sargramostim|mesh-list
82983668|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983669|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983670|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82983671|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983672|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
82983673|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983674|NCT04962022|Ritonavir|ritonavir|mesh-list
82983675|NCT04962022|Itraconazole|itraconazole|mesh-list
82983676|NCT04962022|Nirmatrelvir|nirmatrelvir|mesh-list
82983677|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82983678|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82983679|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
82983680|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983681|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983682|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82983683|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82983684|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
82983685|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983686|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82983687|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82983688|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
82983689|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82983690|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82983691|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
82983692|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983693|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983695|NCT01344213|Pregabalin|pregabalin|mesh-list
82983696|NCT01344213|Analgesics|analgesics|mesh-ancestor
82983697|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
82983698|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983699|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983700|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
82983701|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82983702|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82983703|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983704|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983705|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82983706|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82983707|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983708|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82983709|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82983710|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983711|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983712|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983713|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82983714|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82983715|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983716|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
82983717|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82983718|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
82983719|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82983720|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
82983721|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983722|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983723|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
82983724|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82983725|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82983726|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82983727|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82983728|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983729|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983730|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983731|NCT01363284|Analgesics|analgesics|mesh-ancestor
82983732|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
82983733|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983734|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
82983735|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82983736|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
82983737|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82983738|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82983739|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983740|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
82983741|NCT01344291|Curcumin|curcumin|mesh-list
82983742|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82983743|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983744|NCT01344291|Analgesics|analgesics|mesh-ancestor
82983745|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
82983746|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983747|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983748|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983749|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983750|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983751|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983752|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983753|NCT01367964|Hormones|hormones|mesh-list
82983754|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82983755|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
82983756|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
82983757|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983758|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983759|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983760|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983761|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
82983762|NCT04326933|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82983763|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983764|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82983765|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983766|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983767|NCT04733560|Bupivacaine|bupivacaine|mesh-list
82983768|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
82983769|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
82983770|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983771|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983772|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
82983773|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983774|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
82983775|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82983776|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
82983777|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983778|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983779|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82983780|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
82983781|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82983782|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
82983783|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983784|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983785|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82983786|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983787|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
82983788|NCT01347957|Protective Agents|protective agents|mesh-ancestor
82983789|NCT04735965|Meperidine|meperidine|mesh-list
82983790|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
82983791|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82983792|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983793|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983794|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983795|NCT04735965|Analgesics|analgesics|mesh-ancestor
82983796|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
82983797|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983798|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83463662|NCT00000778|Isoniazid|isoniazid|mesh-list
83463664|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983799|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82983800|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82983801|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
82983802|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82983803|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983804|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82983805|NCT04735965|Narcotics|narcotics|mesh-ancestor
82983806|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82983807|NCT04291599|Ketorolac|ketorolac|mesh-list
82983808|NCT04291599|Morphine|morphine|mesh-list
82983809|NCT04291599|Hydromorphone|hydromorphone|mesh-list
82983810|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82983811|NCT04291599|Narcotics|narcotics|mesh-ancestor
82983812|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983813|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983814|NCT04291599|Analgesics|analgesics|mesh-ancestor
82983815|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
82983816|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983817|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82983818|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983819|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82983820|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983821|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82983822|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983823|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983824|NCT02456428|Insulin|insulin|mesh-list
82983825|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82983826|NCT02456428|Metformin|metformin|mesh-list
82983827|NCT02456428|Pioglitazone|pioglitazone|mesh-list
82983828|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82983829|NCT02456428|Liraglutide|liraglutide|mesh-list
82983830|NCT02456428|Exenatide|exenatide|mesh-list
82983831|NCT02456428|Glimepiride|glimepiride|mesh-list
82983832|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
82983833|NCT02456428|Vildagliptin|vildagliptin|mesh-list
82983834|NCT02456428|Saxagliptin|saxagliptin|mesh-list
82983835|NCT02456428|Acarbose|acarbose|mesh-list
82983836|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82983837|NCT02456428|Repaglinide|repaglinide|mesh-list
82983838|NCT02456428|Gliclazide|gliclazide|mesh-list
82983839|NCT02456428|Glipizide|glipizide|mesh-list
82983840|NCT02456428|Biguanides|biguanides|mesh-list
82983841|NCT02456428|Tolbutamide|tolbutamide|mesh-list
82983842|NCT02456428|Voglibose|voglibose|mesh-list
82983843|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
82983844|NCT02456428|Nateglinide|nateglinide|mesh-list
82983846|NCT02456428|Meglitinide|meglitinide|mesh-list
82983847|NCT02456428|Troglitazone|troglitazone|mesh-list
82983848|NCT02456428|Acetohexamide|acetohexamide|mesh-list
82983849|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
82983851|NCT02456428|Buformin|buformin|mesh-list
82983852|NCT02456428|Glibornuride|glibornuride|mesh-list
82983853|NCT02456428|Tolazamide|tolazamide|mesh-list
82983854|NCT02456428|Carbutamide|carbutamide|mesh-list
82983855|NCT02456428|Gliquidone|gliquidone|mesh-list
82983856|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82983857|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
82983858|NCT02456428|Incretins|incretins|mesh-list
82983859|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983860|NCT02456428|Hormones|hormones|mesh-ancestor
82983861|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983862|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
82983863|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983864|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983865|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82983866|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82983867|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983868|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
82983869|NCT03259516|Cytarabine|cytarabine|mesh-list
82983870|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
82983871|NCT03259516|Melphalan|melphalan|mesh-list
82983872|NCT03259516|Nivolumab|nivolumab|mesh-list
82983873|NCT03259516|Fludarabine|fludarabine|mesh-list
82983874|NCT03259516|Azacitidine|azacitidine|mesh-list
82983875|NCT03259516|Tretinoin|tretinoin|mesh-list
82983876|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
82983877|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983878|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
82983879|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983880|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983881|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82983882|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
82983883|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983884|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983885|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82983886|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82983887|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82983888|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82983889|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
82983890|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
82983891|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983892|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983893|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983894|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82983895|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82983896|NCT03259516|Urological Agents|urological agents|mesh-ancestor
82983897|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
82983898|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
82983899|NCT01344681|Itraconazole|itraconazole|mesh-list
82983900|NCT01344681|Micafungin|micafungin|mesh-list
82983901|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
82983902|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983903|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82983904|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82983905|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983906|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983907|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82983908|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
82983909|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82983910|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983911|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82983912|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
82983913|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82983914|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983915|NCT03259672|Sevoflurane|sevoflurane|mesh-list
82983916|NCT03259672|Desflurane|desflurane|mesh-list
82983917|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82983918|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82983919|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
82983920|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
82983921|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82983923|NCT03537742|Alirocumab|alirocumab|mesh-list
82983924|NCT03537742|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82983925|NCT03537742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82983926|NCT03537742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82983927|NCT03537742|Antimetabolites|antimetabolites|mesh-ancestor
82983928|NCT03537742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983929|NCT03537742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82983930|NCT03537742|Protease Inhibitors|protease inhibitors|mesh-ancestor
82983931|NCT03537742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983932|NCT03537742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82983933|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
82983934|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82983935|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82983936|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
82983937|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983938|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82983939|NCT02456194|Calcium|calcium|mesh-list
82983940|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82983941|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983942|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983943|NCT03265288|Fenretinide|fenretinide|mesh-list
82983944|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983945|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82983946|NCT03265288|Protective Agents|protective agents|mesh-ancestor
83463679|NCT00000778|Vitamins|vitamins|mesh-ancestor
82983947|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983948|NCT03261310|Acetaminophen|acetaminophen|mesh-list
82983949|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82983950|NCT03261310|Analgesics|analgesics|mesh-ancestor
82983951|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
82983952|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983953|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983954|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
82983955|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
82983956|NCT02456350|Fludarabine|fludarabine|mesh-list
82983957|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983958|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
82983959|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983960|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82983961|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82983962|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
82983963|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983964|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983965|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82983966|NCT01319370|Minoxidil|minoxidil|mesh-list
82983967|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82983968|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
82983969|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
82983970|NCT01363752|Sirolimus|sirolimus|mesh-list
82983971|NCT01363752|Tacrolimus|tacrolimus|mesh-list
82983972|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82983973|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
82983974|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82983975|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82983976|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82983977|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983978|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82983979|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82983980|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82983981|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
82983982|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82983983|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82983984|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
82983985|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82983986|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
82983987|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82983988|NCT01360710|Irbesartan|irbesartan|mesh-list
82983989|NCT01360710|Moxonidine|moxonidine|mesh-list
82983990|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82983991|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82983992|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82983993|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82983994|NCT01360788|Albuterol|albuterol|mesh-list
82983995|NCT01360788|Ipratropium|ipratropium|mesh-list
82983996|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82983997|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
82983998|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82983999|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984000|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82984001|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
82984002|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
82984003|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82984004|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82984005|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82984006|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82984007|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
82984008|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984009|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984010|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82984011|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
82984012|NCT01361022|Brotizolam|brotizolam|mesh-list
82984013|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82984014|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984015|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984016|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82984017|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83463682|NCT00000796|Pyridoxine|pyridoxine|mesh-list
82984018|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82984019|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
82984020|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984021|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82984022|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82984023|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984024|NCT02713204|Aflibercept|aflibercept|mesh-list
82984025|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82984026|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82984027|NCT02713204|Growth Substances|growth substances|mesh-ancestor
82984028|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984029|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
82984030|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984031|NCT03695172|Ropivacaine|ropivacaine|mesh-list
82984032|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
82984033|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
82984034|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984035|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984036|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
82984037|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984038|NCT01364376|Leucovorin|leucovorin|mesh-list
82984039|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
82984040|NCT01364376|Calcium|calcium|mesh-list
82984041|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
82984042|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82984043|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984044|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984045|NCT01364376|Antidotes|antidotes|mesh-ancestor
82984046|NCT01364376|Protective Agents|protective agents|mesh-ancestor
82984047|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
82984049|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
82984050|NCT01348503|Lenalidomide|lenalidomide|mesh-list
82984051|NCT01348503|Sorafenib|sorafenib|mesh-list
82984052|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
82984053|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984054|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82984055|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82984056|NCT01348503|Growth Substances|growth substances|mesh-ancestor
82984057|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
82984058|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984059|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82984060|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984061|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984062|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82984063|NCT01369290|Bupropion|bupropion|mesh-list
82984064|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82984065|NCT01369290|Escitalopram|escitalopram|mesh-list
82984066|NCT01369290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82984067|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82984068|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82984069|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984070|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984071|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
82984072|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984073|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984074|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82984075|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
83463685|NCT00000796|Cycloserine|cycloserine|mesh-list
82984076|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984077|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82984078|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
82984079|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82984080|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82984081|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984082|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82984083|NCT01369290|Analgesics|analgesics|mesh-ancestor
82984084|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
82984085|NCT03533452|Ropivacaine|ropivacaine|mesh-list
82984086|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
82984087|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
82984088|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984089|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984090|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
82984091|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984092|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
82984093|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
82984094|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
82984095|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
82984096|NCT04359147|Yohimbine|yohimbine|mesh-list
82984097|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984098|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
82984099|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
82984100|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984101|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984102|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82984103|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82984104|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82984105|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
82984106|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984107|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984108|NCT04359147|Urological Agents|urological agents|mesh-ancestor
82984109|NCT01369368|Azacitidine|azacitidine|mesh-list
82984110|NCT01369368|Valproic Acid|valproic acid|mesh-list
82984111|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82984112|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
82984113|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984114|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984115|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984116|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
82984117|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
82984118|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984119|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984120|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
82984122|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984123|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984124|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
82984125|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82984126|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984127|NCT04074759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82984128|NCT04074759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984129|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
82984130|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
82984131|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984132|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984133|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
82984134|NCT01369602|Vitamins|vitamins|mesh-ancestor
82984135|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
82984136|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984137|NCT03252496|Ephedrine|ephedrine|mesh-list
82984138|NCT03252496|Fentanyl|fentanyl|mesh-list
82984139|NCT03252496|Bupivacaine|bupivacaine|mesh-list
82984140|NCT03252496|Oxytocin|oxytocin|mesh-list
82984141|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
82984142|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
82984143|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984144|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984145|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
82984146|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984148|NCT03252496|Narcotics|narcotics|mesh-ancestor
82984149|NCT03252496|Analgesics|analgesics|mesh-ancestor
82984150|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82984151|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82984152|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
82984153|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
82984154|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82984155|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82984156|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
82984157|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
82984158|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82984159|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
82984160|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984161|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984162|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
82984163|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
82984164|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984165|NCT03252418|Protective Agents|protective agents|mesh-ancestor
82984166|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984167|NCT03252418|Vitamins|vitamins|mesh-ancestor
82984168|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
82984169|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
82984170|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
82984171|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82984172|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984173|NCT01364688|Vitamins|vitamins|mesh-ancestor
82984174|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
82984175|NCT01370148|Conivaptan|conivaptan|mesh-list
82984176|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82984177|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984178|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
82984179|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984180|NCT04684953|Hormones|hormones|mesh-list
82984181|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984182|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984183|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
82984184|NCT01349127|Vitamin D|vitamin d|mesh-list
82984185|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
82984186|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
82984187|NCT01349127|Vitamins|vitamins|mesh-list
82984188|NCT01349127|Calcium|calcium|mesh-list
82984189|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
82984190|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984191|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82984192|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82984193|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
82984195|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984196|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984197|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82984198|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984199|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
82984200|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
82984201|NCT01349205|Caffeine|caffeine|mesh-list
82984202|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82984203|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984204|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82984205|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984206|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984207|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82984208|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82984209|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
82984210|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984211|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
82984212|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82984213|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82984214|NCT01349205|Protective Agents|protective agents|mesh-ancestor
82984215|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82984216|NCT01349205|Analgesics|analgesics|mesh-ancestor
82984217|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
82984218|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984219|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82984220|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82984221|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82984222|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82984223|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984224|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984225|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984226|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82984227|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
82984228|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984229|NCT03982485|Paclitaxel|paclitaxel|mesh-list
82984230|NCT03982485|Apatinib|apatinib|mesh-list
82984231|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82984232|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984233|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
82984234|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
82984235|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
82984236|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984237|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82984238|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984239|NCT03966339|Hormones|hormones|mesh-list
82984240|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984241|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984242|NCT03251872|Olaparib|olaparib|mesh-list
82984243|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82984244|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984245|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984246|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984247|NCT03160521|Risperidone|risperidone|mesh-list
82984248|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82984249|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
82984250|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984251|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984252|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984253|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82984254|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82984255|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984256|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984257|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82984258|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
82984259|NCT01365000|Naloxegol|naloxegol|mesh-list
82984260|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82984261|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984262|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
82984263|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984264|NCT03147040|Carboplatin|carboplatin|mesh-list
82984265|NCT03147040|Atezolizumab|atezolizumab|mesh-list
82984266|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984267|NCT03147040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82984268|NCT03147040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984269|NCT03147040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82984270|NCT03251170|Fentanyl|fentanyl|mesh-list
82984271|NCT03251170|Midazolam|midazolam|mesh-list
82984272|NCT03251170|Ketamine|ketamine|mesh-list
82984273|NCT03251170|Analgesics|analgesics|mesh-ancestor
82984274|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
82984275|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984276|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984277|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82984278|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82984279|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
82984280|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
82984281|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984282|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82984283|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82984284|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984285|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984286|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82984287|NCT03251170|Narcotics|narcotics|mesh-ancestor
82984288|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82984289|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82984290|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82984291|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82984292|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984293|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
82984294|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
82984295|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
82984296|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
82984297|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
82984298|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984299|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82984300|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82984301|NCT03539601|Analgesics|analgesics|mesh-ancestor
82984302|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
82984303|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984304|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984305|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82984306|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
82984307|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82984308|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
82984309|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82984310|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984311|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984312|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
82984313|NCT02455180|Vitamins|vitamins|mesh-ancestor
82984314|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
82984315|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984316|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
82984317|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984318|NCT02455180|Protective Agents|protective agents|mesh-ancestor
82984319|NCT03514719|Avelumab|avelumab|mesh-list
82984320|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82984321|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82984322|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984323|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
82984324|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984325|NCT01349439|Propranolol|propranolol|mesh-list
82984326|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82984327|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82984328|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
82984329|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984330|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984331|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984332|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82984333|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82984334|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
82984335|NCT03245554|Propranolol|propranolol|mesh-list
82984336|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82984337|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82984338|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
82984339|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984340|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984341|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984342|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82984343|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82984344|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
82984346|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82984347|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
82984348|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984349|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
82984350|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
82984351|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
82984352|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984353|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984354|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
82984355|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984356|NCT03004131|Fluticasone|fluticasone|mesh-list
82984357|NCT03004131|Xhance|xhance|mesh-list
82984358|NCT03004131|Loratadine|loratadine|mesh-list
82984359|NCT03004131|Azelastine|azelastine|mesh-list
82984360|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984361|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82984362|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
82984363|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984364|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984365|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82984366|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
82984367|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
82984368|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82984369|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
82984370|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82984371|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82984372|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
82984373|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
82984374|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984375|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984376|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82984377|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984378|NCT01350063|Troclosene|troclosene|mesh-list
82984379|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
82984380|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82984381|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
82984382|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
82984383|NCT03421041|Dexamethasone|dexamethasone|mesh-list
82984384|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984385|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
82984386|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
82984387|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984388|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984389|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82984390|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
82984391|NCT03421041|Hormones|hormones|mesh-ancestor
82984392|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984393|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82984394|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984395|NCT03244774|Paclitaxel|paclitaxel|mesh-list
82984396|NCT03244774|Fluorouracil|fluorouracil|mesh-list
82984397|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
82984398|NCT03244774|Apatinib|apatinib|mesh-list
82984399|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82984400|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984401|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
82984402|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
82984403|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
82984404|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984405|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
82984406|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82984407|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82984408|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
82984409|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984410|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82984411|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984412|NCT02903823|Baclofen|baclofen|mesh-list
82984413|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82984414|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984415|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82984416|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984417|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82984418|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
82984419|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
82984420|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984421|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984422|NCT03244930|Plerixafor|plerixafor|mesh-list
82984423|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82984424|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82984425|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
82984426|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83463727|NCT00000802|Atovaquone|atovaquone|mesh-list
82984427|NCT02855697|Olaparib|olaparib|mesh-list
82984428|NCT02855697|Cediranib|cediranib|mesh-list
82984429|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82984430|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984431|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984432|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984433|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82984434|NCT03894501|Methadone|methadone|mesh-list
82984435|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82984436|NCT03894501|Narcotics|narcotics|mesh-ancestor
82984437|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984438|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984439|NCT03894501|Analgesics|analgesics|mesh-ancestor
82984440|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
82984441|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984442|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
82984443|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
82984444|NCT01346865|Cilostazol|cilostazol|mesh-list
82984445|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82984446|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
82984447|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984448|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984449|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82984450|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
82984451|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82984452|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82984453|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984454|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82984455|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
82984456|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82984457|NCT01346865|Protective Agents|protective agents|mesh-ancestor
82984458|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82984459|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82984460|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984461|NCT03244462|Methotrexate|methotrexate|mesh-list
82984462|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82984463|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
82984464|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82984465|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984466|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82984467|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
82984468|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984469|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984470|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
82984471|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984472|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82984473|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82984474|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
82984475|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82984476|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82984477|NCT03244540|Acetaminophen|acetaminophen|mesh-list
82984478|NCT03244540|Dipyrone|dipyrone|mesh-list
82984479|NCT03244540|Ketoprofen|ketoprofen|mesh-list
82984480|NCT03244540|Bupivacaine|bupivacaine|mesh-list
82984481|NCT03244540|Ropivacaine|ropivacaine|mesh-list
82984482|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
82984483|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
82984484|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984485|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984486|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
82984487|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984488|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82984489|NCT03244540|Analgesics|analgesics|mesh-ancestor
82984490|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
82984491|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82984492|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984493|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82984494|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82984495|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984496|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984497|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
82984498|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
82984499|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
82984500|NCT02454868|Remifentanil|remifentanil|mesh-list
82984501|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82984502|NCT02454868|Narcotics|narcotics|mesh-ancestor
82984503|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984504|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984505|NCT02454868|Analgesics|analgesics|mesh-ancestor
82984506|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
82984507|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984508|NCT03753087|Empagliflozin|empagliflozin|mesh-list
82984509|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82984510|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984511|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82984512|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984513|NCT02454712|Naltrexone|naltrexone|mesh-list
82984514|NCT02454712|Oxycodone|oxycodone|mesh-list
82984515|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82984516|NCT02454712|Narcotics|narcotics|mesh-ancestor
82984517|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984518|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984519|NCT02454712|Analgesics|analgesics|mesh-ancestor
82984520|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
82984521|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984522|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82984528|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
82984529|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984530|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984531|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83463731|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82984532|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82984533|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984534|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
82984535|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984536|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
82984537|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82984542|NCT01350921|Ticagrelor|ticagrelor|mesh-list
82984543|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82984544|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82984545|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82984546|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82984547|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
82984548|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984549|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984550|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984551|NCT00423579|Simvastatin|simvastatin|mesh-list
82984552|NCT00423579|Ezetimibe|ezetimibe|mesh-list
82984553|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
82984554|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82984555|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82984556|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
82984557|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984558|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82984559|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82984560|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984561|NCT03243604|Hormones|hormones|mesh-list
82984562|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984563|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984564|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82984565|NCT02454556|Hormones|hormones|mesh-ancestor
82984566|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984567|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984568|NCT01352559|Milnacipran|milnacipran|mesh-list
82984569|NCT01352559|Mirtazapine|mirtazapine|mesh-list
82984570|NCT01352559|Sertraline|sertraline|mesh-list
82984571|NCT01352559|Fluoxetine|fluoxetine|mesh-list
82984572|NCT01352559|Paroxetine|paroxetine|mesh-list
82984573|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82984574|NCT01352559|Nortriptyline|nortriptyline|mesh-list
82984575|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
82984576|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984577|NCT01352559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82984578|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82984579|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82984580|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984581|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984582|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
82984583|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984584|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82984585|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82984586|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82984587|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984588|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82984589|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82984590|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
82984591|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
82984592|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82984593|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82984601|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82984602|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82984603|NCT01352559|Analgesics|analgesics|mesh-ancestor
82984604|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
82984605|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984606|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82984607|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82984608|NCT03247972|Evolocumab|evolocumab|mesh-list
82984609|NCT03247972|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82984610|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82984611|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82984612|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
82984613|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984614|NCT03247972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82984615|NCT03247972|Protease Inhibitors|protease inhibitors|mesh-ancestor
82984616|NCT03247972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984617|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82984618|NCT01350609|Candesartan|candesartan|mesh-list
82984619|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
82984620|NCT01350609|Nifedipine|nifedipine|mesh-list
82984621|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82984622|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82984623|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82984624|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984625|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82984626|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82984627|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82984628|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984629|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
82984630|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
82984631|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82984632|NCT03269409|Coal Tar|coal tar|mesh-list
82984633|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
82984634|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
82984643|NCT03778372|Methadone|methadone|mesh-list
82984644|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82984645|NCT03778372|Narcotics|narcotics|mesh-ancestor
82984646|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984647|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984648|NCT03778372|Analgesics|analgesics|mesh-ancestor
82984649|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
82984650|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984651|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
82984652|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
82984653|NCT03246880|Tadalafil|tadalafil|mesh-list
82984654|NCT03246880|Tamsulosin|tamsulosin|mesh-list
82984655|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
82984656|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82984657|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82984658|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984659|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984660|NCT03246880|Urological Agents|urological agents|mesh-ancestor
82984661|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82984662|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82984663|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82984664|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
82984665|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984666|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984668|NCT03257722|Idelalisib|idelalisib|mesh-list
82984669|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82984670|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984671|NCT03257722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82984672|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984673|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984674|NCT03268005|Insulin|insulin|mesh-list
82984675|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82984676|NCT03268005|Metformin|metformin|mesh-list
82984677|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
82984678|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
82984679|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82984680|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82984681|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984682|NCT03239314|Dexamethasone|dexamethasone|mesh-list
82984683|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82984684|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984685|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
82984686|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
82984687|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984688|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984689|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82984690|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
82984691|NCT03239314|Hormones|hormones|mesh-ancestor
82984692|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984693|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82984694|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984695|NCT03241888|Megestrol|megestrol|mesh-list
82984696|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
82984697|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
82984698|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82984699|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
82984700|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82984701|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984702|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82984703|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82984704|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82984705|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82984706|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82984707|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984708|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
82984709|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82984710|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
82984711|NCT02454088|Triamcinolone|triamcinolone|mesh-list
82984712|NCT02454088|Calcium|calcium|mesh-list
82984713|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82984714|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984715|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82984716|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984717|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
82984718|NCT02454088|Hormones|hormones|mesh-ancestor
82984719|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984720|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
82984721|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82984722|NCT02456116|Analgesics|analgesics|mesh-ancestor
82984723|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
82984724|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984725|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984726|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984727|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82984728|NCT03239236|Anesthetics|anesthetics|mesh-list
82984729|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984730|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984731|NCT03257800|Ketamine|ketamine|mesh-list
82984732|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
82984733|NCT03257800|Sevoflurane|sevoflurane|mesh-list
82984734|NCT03257800|Analgesics|analgesics|mesh-ancestor
82984735|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
82984736|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984737|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984738|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82984739|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82984740|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
82984741|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
82984742|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984743|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82984744|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82984745|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984746|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984747|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82984748|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82984749|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82984750|NCT01353339|Levofloxacin|levofloxacin|mesh-list
82984751|NCT01353339|Ofloxacin|ofloxacin|mesh-list
82984752|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82984753|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82984754|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82984755|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82984756|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82984757|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984758|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984759|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984760|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82984761|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82984762|NCT03239080|Denosumab|denosumab|mesh-list
82984763|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82984764|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984765|NCT03149055|Isavuconazole|isavuconazole|mesh-list
82984766|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
82984767|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82984768|NCT01352091|Goserelin|goserelin|mesh-list
82984769|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82984770|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984771|NCT02954523|Dasatinib|dasatinib|mesh-list
82984772|NCT02954523|Osimertinib|osimertinib|mesh-list
82984773|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984774|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82984775|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984776|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984777|NCT04486612|Anesthetics|anesthetics|mesh-list
82984778|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984779|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984780|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
82984781|NCT01353729|Zanamivir|zanamivir|mesh-list
82984782|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82984783|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82984784|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82984785|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82984786|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82984787|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984788|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984789|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463759|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82984790|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82984791|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
82984792|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82984793|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984794|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82984795|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82984796|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82984797|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
82984798|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
82984799|NCT01357317|Calcium|calcium|mesh-list
82984800|NCT01357317|Calcium acetate|calcium acetate|mesh-list
82984801|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82984802|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984803|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82984804|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
82984805|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
83521012|NCT00390793|BB 1101|bb 1101|mesh-list
82984806|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984807|NCT03238612|Clarithromycin|clarithromycin|mesh-list
82984808|NCT03238612|Oseltamivir|oseltamivir|mesh-list
82984809|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
82984810|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82984811|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82984812|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82984813|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984814|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984815|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82984816|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82984817|NCT03137121|Olanzapine|olanzapine|mesh-list
82984818|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
82984819|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
82984820|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984821|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984822|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82984823|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82984824|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82984825|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984826|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984827|NCT03137121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82984828|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82984829|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82984830|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984831|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984832|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
82984833|NCT02453776|Infliximab|infliximab|mesh-list
82984834|NCT02453776|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82984835|NCT02453776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82984836|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
82984837|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82984838|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82984839|NCT03256864|Everolimus|everolimus|mesh-list
82984840|NCT03256864|Tacrolimus|tacrolimus|mesh-list
82984841|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82984842|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
82984843|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984844|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82984845|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984846|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984847|NCT03256864|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82984848|NCT03256864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82984849|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984850|NCT01317849|Vitamins|vitamins|mesh-list
82984851|NCT01317849|Folic Acid|folic acid|mesh-list
82984852|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
82984853|NCT01317849|Pyridoxine|pyridoxine|mesh-list
82984854|NCT01317849|Pyridoxal|pyridoxal|mesh-list
82984855|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
82984856|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
82984857|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
82984858|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984859|NCT01317849|Hematinics|hematinics|mesh-ancestor
82984860|NCT01317927|Belinostat|belinostat|mesh-list
82984861|NCT01317927|Warfarin|warfarin|mesh-list
83463762|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
82984862|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
82984863|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984864|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82984865|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984866|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984867|NCT04251585|Insulin|insulin|mesh-list
82984868|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82984869|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984870|NCT04418427|Aflibercept|aflibercept|mesh-list
82984871|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82984872|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82984873|NCT04418427|Growth Substances|growth substances|mesh-ancestor
82984874|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984875|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
82984876|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984877|NCT02901483|Cisplatin|cisplatin|mesh-list
82984878|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984879|NCT02874651|Apatinib|apatinib|mesh-list
82984880|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984881|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82984882|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521168|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82984883|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984885|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82984886|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984887|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984888|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
82984889|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984890|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984891|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
82984892|NCT04385433|Pravastatin|pravastatin|mesh-list
82984893|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82984894|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82984896|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984897|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82984898|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82984899|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984901|NCT00700570|Capecitabine|capecitabine|mesh-list
82984902|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
82984903|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82984904|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82984905|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82984906|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82984907|NCT00700570|Growth Substances|growth substances|mesh-ancestor
82984908|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984909|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
82984910|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82984911|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
82984912|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984913|NCT02453698|Methylphenidate|methylphenidate|mesh-list
82984914|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82984915|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984916|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82984917|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82984918|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82984919|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984920|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
82984921|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984922|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
82984923|NCT01354275|Hormones|hormones|mesh-ancestor
82984924|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82984925|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984926|NCT01318161|Morphine|morphine|mesh-list
82984927|NCT01318161|Ropivacaine|ropivacaine|mesh-list
82984928|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82984929|NCT01318161|Narcotics|narcotics|mesh-ancestor
82984930|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984931|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984932|NCT01318161|Analgesics|analgesics|mesh-ancestor
82984933|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
82984934|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984935|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
82984936|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
82984937|NCT03255226|Tolvaptan|tolvaptan|mesh-list
82984938|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82984939|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984940|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
82984941|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984942|NCT02455726|Pregabalin|pregabalin|mesh-list
82984943|NCT02455726|Oxycodone|oxycodone|mesh-list
82984944|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
82984945|NCT02455726|Analgesics|analgesics|mesh-ancestor
82984946|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
82984947|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984948|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984949|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
82984950|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82984951|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82984952|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984953|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82984955|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82984956|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984957|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82984958|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82984959|NCT02455726|Narcotics|narcotics|mesh-ancestor
82984960|NCT02455726|Antacids|antacids|mesh-ancestor
82984961|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82984962|NCT04488172|Vitamins|vitamins|mesh-list
82984963|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
82984964|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984965|NCT03239860|Antibodies|antibodies|mesh-list
82984966|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82984967|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
82984968|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984970|NCT04486690|Propofol|propofol|mesh-list
82984971|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82984972|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82984973|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984974|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82984975|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
82984976|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
82984977|NCT04486690|Analgesics|analgesics|mesh-ancestor
82984978|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
82984979|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82984980|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82984981|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82984982|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82984983|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82984984|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984985|NCT03255148|Oxytocin|oxytocin|mesh-list
82984986|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
82984987|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82984988|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82984989|NCT03236818|Bosentan|bosentan|mesh-list
82984990|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
82984991|NCT03236818|Tadalafil|tadalafil|mesh-list
82984992|NCT03236818|Macitentan|macitentan|mesh-list
82984993|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
82984994|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82984995|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82984996|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82984997|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82984998|NCT03236818|Urological Agents|urological agents|mesh-ancestor
82984999|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82985000|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82985001|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
82985002|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82985003|NCT03236974|Fulvestrant|fulvestrant|mesh-list
82985004|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82985005|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83463770|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
82985006|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82985007|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82985008|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
82985009|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985010|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985011|NCT03748043|Lactoferrin|lactoferrin|mesh-list
82985012|NCT03748043|Teferrol|teferrol|mesh-list
82985013|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985014|NCT03748043|Hematinics|hematinics|mesh-ancestor
82985015|NCT03750773|Gabapentin|gabapentin|mesh-list
82985016|NCT03750773|Analgesics|analgesics|mesh-ancestor
82985017|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
82985018|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985019|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985020|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
82985021|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82985022|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82985023|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985024|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82985025|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82985026|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82985027|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985028|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985029|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
82985030|NCT02874924|Sirolimus|sirolimus|mesh-list
82985031|NCT02874924|Temsirolimus|temsirolimus|mesh-list
82985032|NCT02874924|MTOR Inhibitors|mtor inhibitors|mesh-list
82985033|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82985034|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985035|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82985036|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985037|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
82985038|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82985039|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
82985040|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985041|NCT02874924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82985042|NCT02874924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985043|NCT02874924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985044|NCT04425863|Aspirin|aspirin|mesh-list
82985045|NCT04425863|Ivermectin|ivermectin|mesh-list
82985046|NCT04425863|Dexamethasone|dexamethasone|mesh-list
82985047|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
82985048|NCT04425863|Enoxaparin|enoxaparin|mesh-list
82985049|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82985050|NCT04425863|BB 1101|bb 1101|mesh-list
82985051|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985052|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
82985053|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
82985054|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985055|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985056|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985057|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
82985058|NCT04425863|Hormones|hormones|mesh-ancestor
82985059|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985060|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82985061|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985062|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
82985063|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985064|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985065|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985066|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985067|NCT04425863|Analgesics|analgesics|mesh-ancestor
82985068|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
82985069|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985070|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82985071|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82985072|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82985073|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82985074|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
82985075|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
82985076|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82985077|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985078|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
82985079|NCT01370772|Rituximab|rituximab|mesh-list
82985080|NCT01370772|Fludarabine|fludarabine|mesh-list
82985081|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82985082|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
82985083|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985084|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985085|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82985086|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
82985087|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985088|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985089|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82985090|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82985091|NCT01842282|Amlexanox|amlexanox|mesh-list
82985092|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82985093|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
82985094|NCT03234244|Vitamin D|vitamin d|mesh-list
82985095|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
82985096|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985097|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985098|NCT03234244|Vitamins|vitamins|mesh-ancestor
82985099|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
82985100|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82985101|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82985102|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82985103|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
82985104|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985105|NCT03234400|Dapivirine|dapivirine|mesh-list
82985106|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82985107|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82985108|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
82985109|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985110|NCT03254368|ZGN-1061|zgn-1061|mesh-list
82985111|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985112|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985113|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82985114|NCT03236740|Metformin|metformin|mesh-list
82985115|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82985116|NCT03236740|Estradiol|estradiol|mesh-list
82985117|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82985118|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985119|NCT03236740|Estrogens|estrogens|mesh-ancestor
82985120|NCT03236740|Hormones|hormones|mesh-ancestor
82985121|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985122|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82985123|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
82985124|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82985125|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82985126|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82985127|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82985128|NCT02453464|Leucovorin|leucovorin|mesh-list
82985129|NCT02453464|Irinotecan|irinotecan|mesh-list
82985130|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82985131|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82985132|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985133|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985134|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985135|NCT02453464|Antidotes|antidotes|mesh-ancestor
82985136|NCT02453464|Protective Agents|protective agents|mesh-ancestor
82985137|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985138|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
82985139|NCT02453464|Vitamins|vitamins|mesh-ancestor
82985140|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
82985141|NCT03233932|Leuprolide|leuprolide|mesh-list
82985142|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82985143|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
82985144|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82985145|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985146|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82985147|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985148|NCT03236584|Tenofovir|tenofovir|mesh-list
82985149|NCT03236584|Lamivudine|lamivudine|mesh-list
82985150|NCT03236584|Adefovir|adefovir|mesh-list
82985151|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
82985152|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985153|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82985154|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82985155|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985156|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985157|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82985158|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82985159|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82985160|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985161|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82985162|NCT04614168|Glycerol|glycerol|mesh-list
82985163|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985164|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
82985165|NCT04614168|Protective Agents|protective agents|mesh-ancestor
82985166|NCT01365312|Ethanol|ethanol|mesh-list
82985167|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82985168|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985169|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985170|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985171|NCT04495283|Acetaminophen|acetaminophen|mesh-list
82985172|NCT04495283|Pregabalin|pregabalin|mesh-list
82985173|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985174|NCT04495283|Analgesics|analgesics|mesh-ancestor
82985175|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
82985176|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985177|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985178|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
82985179|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
82985180|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82985181|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985182|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985183|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985185|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82985186|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985187|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82985188|NCT03634020|Sirolimus|sirolimus|mesh-list
82985189|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82985190|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985191|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82985192|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985193|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
82985194|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82985195|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
82985196|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985197|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
82985198|NCT03253276|Cathartics|cathartics|mesh-ancestor
82985199|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985200|NCT01372644|Pasireotide|pasireotide|mesh-list
82985201|NCT01372644|Hormones|hormones|mesh-ancestor
83463795|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985202|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985203|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985204|NCT03253198|Bupivacaine|bupivacaine|mesh-list
82985205|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
82985206|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
82985207|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985208|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985209|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
82985210|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985211|NCT04285086|Anagrelide|anagrelide|mesh-list
82985212|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82985213|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82985214|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985215|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82985216|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82985217|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82985218|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
82985219|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985220|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985221|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985222|NCT04234464|Budesonide|budesonide|mesh-list
82985223|NCT04234464|Albuterol|albuterol|mesh-list
82985224|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985225|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82985226|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
82985227|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985228|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985229|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82985230|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
82985231|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
82985232|NCT04234464|Hormones|hormones|mesh-ancestor
82985233|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985234|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
82985235|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82985236|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82985237|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82985238|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82985239|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
82985240|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985241|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985242|NCT03233152|Nivolumab|nivolumab|mesh-list
82985243|NCT03233152|Ipilimumab|ipilimumab|mesh-list
82985244|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82985245|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82985246|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985247|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82985248|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985249|NCT03229096|Apatinib|apatinib|mesh-list
82985250|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985251|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82985252|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985253|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985254|NCT03123588|Anagrelide|anagrelide|mesh-list
82985255|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82985256|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83521244|NCT03003637|Nivolumab|nivolumab|mesh-list
82985257|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985258|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82985259|NCT02452918|Oritavancin|oritavancin|mesh-list
82985260|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82985261|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985262|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
82985263|NCT02821026|Sirolimus|sirolimus|mesh-list
82985264|NCT02821026|Etanercept|etanercept|mesh-list
82985265|NCT02821026|Tacrolimus|tacrolimus|mesh-list
82985266|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
82985267|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82985268|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82985269|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
82985270|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985271|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82985272|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985273|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985274|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82985275|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985276|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82985277|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
82985278|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82985279|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985280|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
82985281|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985282|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985284|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
82985285|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985286|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985287|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985288|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985289|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
82985290|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82985291|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
82985292|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
82985293|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985294|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985295|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985296|NCT03228628|Analgesics|analgesics|mesh-ancestor
82985297|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
82985298|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985299|NCT03232450|Aspirin|aspirin|mesh-list
82985300|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985301|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985302|NCT03232450|Analgesics|analgesics|mesh-ancestor
82985303|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
82985304|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985305|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985306|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985307|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985308|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82985309|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82985310|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985311|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82985312|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82985313|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985314|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
82985315|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
82985316|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82985317|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
82985318|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
82985319|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985320|NCT04948697|Tislelizumab|tislelizumab|mesh-list
82985321|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82985322|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985323|NCT04358549|Favipiravir|favipiravir|mesh-list
82985324|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
82985325|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985326|NCT01562483|Dronabinol|dronabinol|mesh-list
82985327|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
82985328|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985329|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82985330|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985331|NCT01562483|Analgesics|analgesics|mesh-ancestor
82985332|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
82985333|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985334|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82985335|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82985336|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985337|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985338|NCT01562483|Hormones|hormones|mesh-ancestor
82985339|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985340|NCT00700180|Bevacizumab|bevacizumab|mesh-list
82985341|NCT00700180|Carboplatin|carboplatin|mesh-list
83463812|NCT02658890|Nivolumab|nivolumab|mesh-list
82985342|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82985343|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985344|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82985345|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82985346|NCT00700180|Growth Substances|growth substances|mesh-ancestor
82985347|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985348|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
82985349|NCT03222544|Methylene Blue|methylene blue|mesh-list
82985350|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985351|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985352|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
82985353|NCT03228862|Vitamin D|vitamin d|mesh-list
82985354|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985355|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985356|NCT03228862|Vitamins|vitamins|mesh-ancestor
82985357|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
82985358|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82985359|NCT03228238|Vitamins|vitamins|mesh-list
82985360|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
82985361|NCT03228238|Vitamin E|vitamin e|mesh-list
82985362|NCT03228238|Tocopherols|tocopherols|mesh-list
82985363|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
82985364|NCT03228238|Atorvastatin|atorvastatin|mesh-list
82985365|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
82985366|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985367|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985368|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82985369|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82985370|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
82985371|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985372|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82985373|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82985374|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985375|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
82985376|NCT03228238|Protective Agents|protective agents|mesh-ancestor
82985377|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985378|NCT03232216|Vitamin D|vitamin d|mesh-list
82985379|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
82985380|NCT03232216|Vitamins|vitamins|mesh-ancestor
82985381|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
82985382|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985383|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82985384|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985385|NCT03231982|Amlodipine|amlodipine|mesh-list
82985386|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82985387|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82985388|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985389|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985390|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985391|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985392|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
82985393|NCT03222310|Itraconazole|itraconazole|mesh-list
82985394|NCT03222310|Ipatasertib|ipatasertib|mesh-list
82985395|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
82985396|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985397|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82985398|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82985399|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985400|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985401|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82985402|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
82985403|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985404|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985405|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82985407|NCT03222310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82985408|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
82985409|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82985410|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985411|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
82985412|NCT03231436|Bupivacaine|bupivacaine|mesh-list
82985413|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
82985414|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
82985415|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985416|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985417|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
82985418|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985419|NCT02452450|Acetaminophen|acetaminophen|mesh-list
82985420|NCT02452450|Ibuprofen|ibuprofen|mesh-list
82985421|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985422|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985423|NCT02452450|Analgesics|analgesics|mesh-ancestor
82985424|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
82985425|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985426|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985427|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985428|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985429|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82985430|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985431|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985432|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
82985433|NCT01204684|Poly ICLC|poly iclc|mesh-list
82985434|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
82985435|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
82985436|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985437|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
82985438|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82985439|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985440|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985441|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985442|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985443|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82985444|NCT00238420|Paclitaxel|paclitaxel|mesh-list
82985445|NCT00238420|Trastuzumab|trastuzumab|mesh-list
82985446|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82985447|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
82985448|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82985449|NCT00238420|Antibodies|antibodies|mesh-list
82985450|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
82985451|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82985452|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82985453|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985454|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
82985455|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
82985456|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
82985457|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985458|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
82985459|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985460|NCT03221998|Acetaminophen|acetaminophen|mesh-list
82985461|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985462|NCT03221998|Analgesics|analgesics|mesh-ancestor
82985463|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
82985464|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985465|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985466|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
82985467|NCT04492475|Interferons|interferons|mesh-list
82985468|NCT04492475|Interferon-beta|interferon-beta|mesh-list
82985469|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
82985470|NCT04492475|Remdesivir|remdesivir|mesh-list
82985471|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985472|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
82985473|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985474|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
82985475|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985476|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82985477|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
82985478|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985479|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
82985480|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82985481|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
82985482|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985483|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
82985484|NCT04936763|Protective Agents|protective agents|mesh-ancestor
82985485|NCT03226522|Bupropion|bupropion|mesh-list
83463816|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985486|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82985487|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
82985488|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82985489|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82985490|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82985491|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985492|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985493|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
82985494|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985495|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985496|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82985497|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82985498|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985499|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
82985500|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82985501|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985502|NCT03752333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82985503|NCT03752333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985504|NCT03750383|Cyclosporine|cyclosporine|mesh-list
82985505|NCT03750383|Prednisone|prednisone|mesh-list
82985506|NCT03750383|Cyclosporins|cyclosporins|mesh-list
82985507|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985508|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
82985509|NCT03750383|Hormones|hormones|mesh-ancestor
82985510|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985511|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985512|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82985513|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985514|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985515|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985516|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82985517|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
82985518|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
82985519|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985520|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
82985521|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985522|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82985523|NCT03226210|Insulin|insulin|mesh-list
82985524|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
82985525|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82985526|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985527|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82985528|NCT03229954|Hematinics|hematinics|mesh-ancestor
82985529|NCT03220126|Mirikizumab|mirikizumab|mesh-list
82985530|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985531|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985532|NCT03220126|Analgesics|analgesics|mesh-ancestor
82985533|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
82985534|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985535|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985536|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985537|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985538|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82985539|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985540|NCT02452684|Eszopiclone|eszopiclone|mesh-list
82985541|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82985542|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985543|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985544|NCT03119428|Nivolumab|nivolumab|mesh-list
82985545|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82985546|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985547|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82985548|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985549|NCT04345367|Abrocitinib|abrocitinib|mesh-list
82985550|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82985551|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985552|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985553|NCT02452606|Levodopa|levodopa|mesh-list
82985554|NCT02452606|Carbidopa|carbidopa|mesh-list
82985555|NCT02452606|Entacapone|entacapone|mesh-list
82985556|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82985557|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82985558|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
82985559|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985560|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985561|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985562|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
82985563|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985564|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82985565|NCT03225352|Aspirin|aspirin|mesh-list
82985566|NCT03225352|Ibuprofen|ibuprofen|mesh-list
82985567|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985568|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985569|NCT03225352|Analgesics|analgesics|mesh-ancestor
82985570|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
82985572|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985573|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985574|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985575|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82985576|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82985577|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985578|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82985579|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82985580|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985581|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
82985582|NCT03208270|Antithrombins|antithrombins|mesh-list
82985583|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
82985584|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82985585|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
82985586|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985587|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985588|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
82985589|NCT03208426|Amoxicillin|amoxicillin|mesh-list
82985590|NCT03208426|Metronidazole|metronidazole|mesh-list
82985591|NCT03208426|Clarithromycin|clarithromycin|mesh-list
82985592|NCT03208426|Tetracycline|tetracycline|mesh-list
82985593|NCT03208426|Esomeprazole|esomeprazole|mesh-list
82985594|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82985595|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985596|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82985597|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82985598|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82985599|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985600|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82985601|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985602|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985603|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82985604|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82985605|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82985606|NCT03216070|Dasatinib|dasatinib|mesh-list
82985607|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985608|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82985609|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985610|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985611|NCT03215602|Pyrantel|pyrantel|mesh-list
82985612|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
82985613|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
82985614|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
82985615|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82985616|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985617|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
82985618|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82985619|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82985620|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985621|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985622|NCT02450968|Dexamethasone|dexamethasone|mesh-list
82985623|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985624|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
82985625|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
82985626|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985627|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985628|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985629|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
82985630|NCT02450968|Hormones|hormones|mesh-ancestor
82985631|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985632|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82985633|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985634|NCT03749915|Tetracaine|tetracaine|mesh-list
82985635|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
82985636|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
82985637|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985638|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985639|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
82985640|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985641|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
82985642|NCT03119116|Apixaban|apixaban|mesh-list
82985643|NCT03119116|Dabigatran|dabigatran|mesh-list
82985644|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82985645|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
82985646|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82985648|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985649|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985650|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
82985651|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
82985652|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
82985653|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82985654|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82985655|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985656|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985657|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985658|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985659|NCT04403399|Varenicline|varenicline|mesh-list
82985660|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82985661|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82985662|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
82985663|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985664|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985665|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985666|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
82985667|NCT03224572|Vitamins|vitamins|mesh-ancestor
82985668|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
82985669|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985670|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
82985671|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985672|NCT03224572|Protective Agents|protective agents|mesh-ancestor
82985673|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
82985674|NCT02452216|Hematinics|hematinics|mesh-ancestor
82985675|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82985676|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82985677|NCT03207334|Cytarabine|cytarabine|mesh-list
82985678|NCT03207334|Midostaurin|midostaurin|mesh-list
82985679|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82985680|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
82985681|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985682|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985683|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
82985684|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985685|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82985686|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
82985687|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985688|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82985689|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985690|NCT03212950|Insulin|insulin|mesh-list
82985691|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82985692|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
82985693|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
83463829|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
82985694|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82985695|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82985696|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985697|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
82985698|NCT01561937|Warfarin|warfarin|mesh-list
82985699|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
82985700|NCT03210766|Nabilone|nabilone|mesh-list
82985701|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
82985702|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
82985703|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985704|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985705|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985706|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82985707|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82985708|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985709|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82985710|NCT03747341|Fentanyl|fentanyl|mesh-list
82985711|NCT03747341|Oxycodone|oxycodone|mesh-list
82985712|NCT03747341|Buprenorphine|buprenorphine|mesh-list
82985713|NCT03747341|Ondansetron|ondansetron|mesh-list
82985714|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82985715|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82985716|NCT03747341|Narcotics|narcotics|mesh-ancestor
82985717|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985718|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985719|NCT03747341|Analgesics|analgesics|mesh-ancestor
82985720|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
82985721|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985722|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82985724|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
82985725|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
82985726|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82985727|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
82985728|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
82985729|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985730|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
82985731|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
82985732|NCT03747341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82985733|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82985734|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
82985735|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985736|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985737|NCT04401293|Heparin|heparin|mesh-list
82985738|NCT04401293|Enoxaparin|enoxaparin|mesh-list
82985739|NCT04401293|Calcium heparin|calcium heparin|mesh-list
82985740|NCT04401293|Dalteparin|dalteparin|mesh-list
82985741|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
82985742|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
82985743|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82985744|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82985745|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985746|NCT03209908|Tenofovir|tenofovir|mesh-list
82985747|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
82985748|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985749|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82985750|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82985751|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985752|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985753|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82985754|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82985755|NCT04484740|Gepotidacin|gepotidacin|mesh-list
82985756|NCT04484740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82985757|NCT04484740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83463839|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985758|NCT04484740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985759|NCT04484740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985760|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
82985761|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82985762|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
82985763|NCT03224338|Dolutegravir|dolutegravir|mesh-list
82985764|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82985765|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82985766|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985767|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985768|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82985769|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82985770|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
82985771|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985772|NCT04318535|Griseofulvin|griseofulvin|mesh-list
82985773|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
82985774|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985775|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
82985776|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82985777|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
83521245|NCT03003637|Ipilimumab|ipilimumab|mesh-list
82985778|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82985779|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985780|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82985781|NCT03224416|Ethanol|ethanol|mesh-list
82985782|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82985783|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985784|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985785|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985786|NCT01562561|Repaglinide|repaglinide|mesh-list
82985787|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
82985788|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
82985789|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
82985790|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82985791|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985792|NCT03206944|Aspirin|aspirin|mesh-list
82985793|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985794|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985795|NCT03206944|Analgesics|analgesics|mesh-ancestor
82985796|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
82985797|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985798|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985799|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985800|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985801|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82985802|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82985803|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985804|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82985805|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82985806|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985807|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
82985808|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82985809|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82985810|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985811|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985812|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
82985813|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985814|NCT03206554|Ropivacaine|ropivacaine|mesh-list
82985815|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
82985816|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
82985817|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985818|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985819|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
82985820|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985821|NCT03209206|Docetaxel|docetaxel|mesh-list
82985822|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985823|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
82985824|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
82985825|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
82985826|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985827|NCT03223402|Lamivudine|lamivudine|mesh-list
82985828|NCT03223402|Nevirapine|nevirapine|mesh-list
82985829|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82985830|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82985831|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985832|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985833|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
82985834|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985835|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82985836|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82985837|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82985838|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82985839|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82985840|NCT03208972|Menotropins|menotropins|mesh-list
82985841|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82985842|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985843|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82985844|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
82985845|NCT03206866|Antibodies|antibodies|mesh-list
82985846|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
82985847|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985848|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
82985849|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
82985850|NCT02451748|Prednisone|prednisone|mesh-list
82985851|NCT02451748|Triamcinolone|triamcinolone|mesh-list
82985852|NCT02451748|Naproxen|naproxen|mesh-list
82985853|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
82985854|NCT02451748|Methotrexate|methotrexate|mesh-list
82985855|NCT02451748|Leflunomide|leflunomide|mesh-list
82985856|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82985857|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
82985858|NCT02451748|Hormones|hormones|mesh-ancestor
82985859|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82985860|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985861|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82985862|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985863|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82985864|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
82985865|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82985866|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82985867|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
82985868|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985869|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
82985870|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985871|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82985872|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82985873|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
82985874|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985876|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
82985877|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82985878|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82985879|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985880|NCT02451748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82985881|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82985882|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82985883|NCT02451748|Analgesics|analgesics|mesh-ancestor
82985884|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
82985885|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985886|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
83463868|NCT00001768|Antibodies|antibodies|mesh-list
82985887|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82985888|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82985889|NCT03208894|Furosemide|furosemide|mesh-list
82985890|NCT03208894|Diuretics|diuretics|mesh-ancestor
82985891|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
82985892|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985893|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82985894|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985895|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985896|NCT02450656|Docetaxel|docetaxel|mesh-list
82985897|NCT02450656|Afatinib|afatinib|mesh-list
82985898|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82985899|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
82985900|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
82985901|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
82985902|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985903|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82985904|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82985905|NCT03206320|Lidocaine|lidocaine|mesh-list
82985906|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
82985907|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
82985908|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985909|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985910|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
82985911|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985912|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82985913|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82985914|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82985915|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985916|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985917|NCT04448561|Morphine|morphine|mesh-list
82985918|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82985919|NCT04448561|Narcotics|narcotics|mesh-ancestor
82985920|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985921|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985922|NCT04448561|Analgesics|analgesics|mesh-ancestor
82985923|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
82985924|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985925|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
82985926|NCT03206008|Analgesics|analgesics|mesh-ancestor
82985927|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
83521400|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
82985928|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985929|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985930|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
82985931|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985932|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82985933|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
82985934|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82985935|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82985936|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985937|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985938|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
82985939|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82985940|NCT04978259|Remdesivir|remdesivir|mesh-list
82985941|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
82985942|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985943|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
82985944|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82985945|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
82985946|NCT03208582|Diphosphonates|diphosphonates|mesh-list
82985947|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82985949|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985950|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82985951|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985952|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82985953|NCT03200938|Zinc|zinc|mesh-list
82985954|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
82985955|NCT03200938|Trace Elements|trace elements|mesh-ancestor
82985956|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
82985957|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985958|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
82985959|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
82985960|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82985961|NCT03200938|Protective Agents|protective agents|mesh-ancestor
82985962|NCT04297241|Isosorbide|isosorbide|mesh-list
82985963|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
82985964|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
82985965|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82985966|NCT04297241|Diuretics|diuretics|mesh-ancestor
82985967|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
82985968|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985969|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
82985970|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
82985971|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985972|NCT04292171|Gabapentin|gabapentin|mesh-list
82985973|NCT04292171|Analgesics|analgesics|mesh-ancestor
82985974|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
82985975|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82985976|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985977|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
82985978|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82985979|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82985980|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82985981|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82985982|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82985983|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82985984|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82985985|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985986|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
82985987|NCT03200782|Empagliflozin|empagliflozin|mesh-list
82985988|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82985989|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82985990|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82985991|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82985992|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82985993|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82985994|NCT02449954|Ketorolac|ketorolac|mesh-list
82985995|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82985996|NCT02449954|Morphine|morphine|mesh-list
82985997|NCT02449954|Tramadol|tramadol|mesh-list
82985998|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82985999|NCT02449954|Narcotics|narcotics|mesh-ancestor
82986000|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986001|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986002|NCT02449954|Analgesics|analgesics|mesh-ancestor
82986003|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
82986004|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986005|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82986006|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82986007|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986008|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986009|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82986010|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986011|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986012|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
82986013|NCT04393493|Furosemide|furosemide|mesh-list
82986014|NCT04393493|Spironolactone|spironolactone|mesh-list
82986015|NCT04393493|Diuretics|diuretics|mesh-ancestor
82986016|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
82986017|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986018|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82986019|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986020|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986021|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82986023|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986024|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82986025|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82986026|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82986027|NCT02448082|Ichthammol|ichthammol|mesh-list
82986028|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
82986029|NCT03205228|Flupenthixol|flupenthixol|mesh-list
82986030|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
82986031|NCT03205228|Omeprazole|omeprazole|mesh-list
82986032|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82986033|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82986034|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82986035|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986036|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986037|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82986038|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82986039|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986040|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986041|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82986042|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82986043|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
82986044|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986045|NCT03195946|Midazolam|midazolam|mesh-list
82986046|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82986047|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82986048|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986049|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986050|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82986051|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82986052|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82986053|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82986054|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
82986055|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
82986056|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
82986057|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
82986058|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986059|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986060|NCT03204760|Dexamethasone|dexamethasone|mesh-list
82986061|NCT03204760|Prednisolone|prednisolone|mesh-list
82986062|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986063|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
82986064|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
82986065|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986066|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986067|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82986068|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
82986069|NCT03204760|Hormones|hormones|mesh-ancestor
82986070|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986071|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82986072|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986073|NCT03200392|Chromium|chromium|mesh-list
82986074|NCT03200392|Trace Elements|trace elements|mesh-ancestor
82986075|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
82986076|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986077|NCT03200080|Amphetamine|amphetamine|mesh-list
82986078|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
82986079|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82986080|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986081|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
82986082|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
82986083|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986084|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
82986085|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986086|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986087|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
83463889|NCT00020722|Etoposide|etoposide|mesh-list
82986088|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82986089|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82986090|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986091|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82986092|NCT03200236|Nicotine|nicotine|mesh-list
82986093|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82986094|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
82986095|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986096|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986098|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82986099|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
82986100|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986101|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986102|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
82986103|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
82986104|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82986105|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
82986106|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986107|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986108|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82986109|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
82986110|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986111|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986112|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82986113|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82986114|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82986115|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
82986116|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82986117|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986118|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986119|NCT02447380|Docetaxel|docetaxel|mesh-list
82986120|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986121|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
82986122|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
82986123|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
82986124|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986125|NCT02447224|Metronidazole|metronidazole|mesh-list
82986126|NCT02447224|Ertapenem|ertapenem|mesh-list
82986127|NCT02447224|Cefdinir|cefdinir|mesh-list
82986128|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986129|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82986130|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82986131|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82986132|NCT03199690|Rifampin|rifampin|mesh-list
82986133|NCT03199690|Dolutegravir|dolutegravir|mesh-list
82986134|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82986135|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
82986136|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82986137|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986138|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
82986139|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82986140|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986141|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986142|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82986143|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82986144|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82986145|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82986146|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82986147|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82986148|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82986149|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82986150|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82986151|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82986152|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
82986153|NCT03204058|Metformin|metformin|mesh-list
82986154|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82986155|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82986156|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986157|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82986158|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82986159|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
82986160|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986161|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82986162|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82986163|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986164|NCT03203746|Lycopene|lycopene|mesh-list
82986165|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986166|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
82986167|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986168|NCT03203746|Protective Agents|protective agents|mesh-ancestor
82986169|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986170|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82986171|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82986172|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986173|NCT03203668|Choline|choline|mesh-list
82986174|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
82986175|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82986176|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
82986177|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986178|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82986179|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82986180|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
82986181|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
82986182|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82986183|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82986184|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82986185|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986186|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986187|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
82986188|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986189|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986190|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82986191|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986192|NCT03203356|Hormones|hormones|mesh-list
82986193|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986194|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986195|NCT04280705|Remdesivir|remdesivir|mesh-list
82986196|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
82986197|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986198|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
82986199|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986200|NCT03203590|Carboplatin|carboplatin|mesh-list
82986201|NCT03203590|Vinorelbine|vinorelbine|mesh-list
82986202|NCT03203590|Gefitinib|gefitinib|mesh-list
82986203|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986204|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82986205|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
82986206|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
82986207|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
82986208|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986209|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82986210|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986211|NCT02077166|Rituximab|rituximab|mesh-list
82986212|NCT02077166|Lenalidomide|lenalidomide|mesh-list
82986213|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82986214|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986215|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
82986216|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986217|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986218|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82986219|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82986220|NCT02077166|Growth Substances|growth substances|mesh-ancestor
82986221|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
82986222|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
82986223|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
82986224|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82986225|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82986226|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986227|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986228|NCT02450188|Urological Agents|urological agents|mesh-ancestor
82986229|NCT03198676|Poly I-C|poly i-c|mesh-list
82986230|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
82986231|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986232|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
82986233|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
82986234|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986235|NCT04484506|Prednisone|prednisone|mesh-list
82986236|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
82986237|NCT04484506|Etoposide|etoposide|mesh-list
82986238|NCT04484506|Vincristine|vincristine|mesh-list
82986239|NCT04484506|Pegaspargase|pegaspargase|mesh-list
82986240|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82986241|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
82986242|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986243|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986244|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82986245|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
82986246|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986247|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986248|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82986249|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986250|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
82986251|NCT04484506|Hormones|hormones|mesh-ancestor
82986252|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986253|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82986254|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82986255|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82986256|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82986257|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986258|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
82986259|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
82986260|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
82986261|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
82986262|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82986263|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986264|NCT04332653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82986265|NCT04332653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986266|NCT02449564|Sirolimus|sirolimus|mesh-list
82986267|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82986268|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986269|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82986270|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986271|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
82986272|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82986273|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
82986274|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986275|NCT02449720|Ropivacaine|ropivacaine|mesh-list
82986276|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
82986277|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
82986278|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986279|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986280|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
82986281|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986282|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
82986283|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
82986284|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82986285|NCT03194620|Procyanidin|procyanidin|mesh-list
82986286|NCT03194620|Theaflavin|theaflavin|mesh-list
82986287|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
82986288|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986289|NCT03194620|Protective Agents|protective agents|mesh-ancestor
82986290|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986291|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82986292|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82986293|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986294|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82986295|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986296|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
82986297|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986298|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
82986299|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82986300|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82986301|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
82986302|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
82986303|NCT02445976|Seviteronel|seviteronel|mesh-list
82986304|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986305|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82986306|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986307|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986308|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82986309|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82986310|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986312|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82986313|NCT03198208|Narcotics|narcotics|mesh-ancestor
82986314|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986315|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986316|NCT03198208|Analgesics|analgesics|mesh-ancestor
82986317|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
82986318|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986319|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82986320|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82986321|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
82986323|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
82986324|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82986325|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82986326|NCT01044056|NuvaRing|nuvaring|mesh-list
82986327|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
82986328|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
82986329|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82986330|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82986331|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986332|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82986333|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82986334|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82986335|NCT01044056|Estrogens|estrogens|mesh-ancestor
82986336|NCT01044056|Hormones|hormones|mesh-ancestor
82986337|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986338|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82986339|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82986340|NCT01005056|Desogestrel|desogestrel|mesh-list
82986341|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82986342|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82986343|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82986344|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
82986345|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82986346|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986347|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82986348|NCT01005056|Estrogens|estrogens|mesh-ancestor
82986349|NCT01005056|Hormones|hormones|mesh-ancestor
82986350|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986351|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82986352|NCT01005056|Progestins|progestins|mesh-ancestor
82986353|NCT04796714|Aspirin|aspirin|mesh-list
82986354|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82986355|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82986356|NCT04796714|Analgesics|analgesics|mesh-ancestor
82986357|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
82986358|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986359|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986360|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986361|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986362|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82986363|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82986364|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83463921|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
82986365|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82986366|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82986367|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986368|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
82986369|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
82986370|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82986371|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82986372|NCT02445898|Prednisolone|prednisolone|mesh-list
82986373|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
82986374|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82986375|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
82986376|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986377|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
82986378|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
82986379|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986380|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986381|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82986382|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
82986383|NCT02445898|Hormones|hormones|mesh-ancestor
82986384|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986385|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82986386|NCT02445898|Protective Agents|protective agents|mesh-ancestor
82986387|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82986388|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986389|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
82986390|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82986391|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82986392|NCT03198130|Cemiplimab|cemiplimab|mesh-list
82986393|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82986394|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986395|NCT04238780|Fentanyl|fentanyl|mesh-list
82986408|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
82986409|NCT04238663|Bevacizumab|bevacizumab|mesh-list
82986410|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82986411|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986412|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82986413|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82986414|NCT04238663|Growth Substances|growth substances|mesh-ancestor
82986415|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986416|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
82986417|NCT00878462|Asenapine|asenapine|mesh-list
82986418|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82986419|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82986420|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986421|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986422|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82986423|NCT03197818|Budesonide|budesonide|mesh-list
82986424|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
82986425|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986426|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82986427|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
82986428|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986429|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986430|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82986431|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
82986432|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
82986433|NCT03197818|Hormones|hormones|mesh-ancestor
82986434|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986435|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82986436|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82986437|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82986438|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
82986439|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986440|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986441|NCT03442088|Apremilast|apremilast|mesh-list
82986442|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82986443|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82986444|NCT03442088|Analgesics|analgesics|mesh-ancestor
82986445|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
82986446|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986447|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986448|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83463927|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
82986449|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986450|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82986451|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82986452|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986453|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986454|NCT01562405|Dexamethasone|dexamethasone|mesh-list
82986455|NCT01562405|Lenalidomide|lenalidomide|mesh-list
82986456|NCT01562405|Pomalidomide|pomalidomide|mesh-list
82986457|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986458|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
82986459|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
82986460|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986461|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986462|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82986463|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
82986464|NCT01562405|Hormones|hormones|mesh-ancestor
82986465|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986466|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82986467|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986468|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
82986469|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82986470|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82986471|NCT01562405|Growth Substances|growth substances|mesh-ancestor
82986472|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
82986473|NCT03119194|Opicapone|opicapone|mesh-list
82986474|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82986475|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986476|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986477|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82986478|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82986479|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
82986480|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82986481|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82986482|NCT03107338|Analgesics|analgesics|mesh-ancestor
82986483|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
82986484|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986485|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986486|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986487|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986488|NCT05581940|Bupivacaine|bupivacaine|mesh-list
82986489|NCT05581940|Anesthetics|anesthetics|mesh-list
82986490|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
82986491|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986492|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986493|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
82986494|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986495|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
82986496|NCT02445508|Sevelamer|sevelamer|mesh-list
82986497|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
82986498|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
82986499|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986500|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82986501|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82986502|NCT03197584|Leucovorin|leucovorin|mesh-list
82986503|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
82986504|NCT03197584|Bevacizumab|bevacizumab|mesh-list
82986505|NCT03197584|Fluorouracil|fluorouracil|mesh-list
82986506|NCT03197584|Capecitabine|capecitabine|mesh-list
82986507|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
82986508|NCT03197584|Fulvestrant|fulvestrant|mesh-list
82986509|NCT03197584|Avelumab|avelumab|mesh-list
82986510|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986511|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986512|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82986513|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
82986514|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986515|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986516|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82986517|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
82986518|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83463932|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
82986519|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82986520|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82986521|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82986522|NCT03197584|Growth Substances|growth substances|mesh-ancestor
82986523|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
82986524|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
82986525|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82986526|NCT03197584|Antidotes|antidotes|mesh-ancestor
82986527|NCT03197584|Protective Agents|protective agents|mesh-ancestor
82986528|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
82986529|NCT03197584|Vitamins|vitamins|mesh-ancestor
82986530|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
82986531|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82986532|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82986533|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82986534|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
82986535|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986536|NCT03722576|Calcium|calcium|mesh-list
82986537|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82986538|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986539|NCT03416348|Ethanol|ethanol|mesh-list
82986540|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82986541|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986542|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986543|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986544|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
82986545|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82986546|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82986547|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82986548|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986549|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986550|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
82986551|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986552|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986553|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82986554|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986555|NCT02449486|Ropivacaine|ropivacaine|mesh-list
82986556|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
82986557|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
82986558|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986559|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986560|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
82986561|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986562|NCT03202186|Progesterone|progesterone|mesh-list
82986563|NCT03202186|Progestins|progestins|mesh-ancestor
82986564|NCT03202186|Hormones|hormones|mesh-ancestor
82986565|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986566|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986567|NCT03625076|Lidocaine|lidocaine|mesh-list
82986568|NCT03625076|Propofol|propofol|mesh-list
82986569|NCT03625076|Etomidate|etomidate|mesh-list
82986570|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
82986571|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
82986572|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986573|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986574|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
82986575|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986576|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82986577|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82986578|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82986579|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986580|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986581|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82986582|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82986583|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
82986584|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82986585|NCT02445352|Ezetimibe|ezetimibe|mesh-list
82986586|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82986587|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82986588|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
83463936|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82986589|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986590|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82986591|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82986592|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986593|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
82986594|NCT03693989|Difluprednate|difluprednate|mesh-list
82986595|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
82986596|NCT03693989|Hormones|hormones|mesh-ancestor
82986597|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986598|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986599|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986600|NCT04944212|Vitamin D|vitamin d|mesh-list
82986601|NCT04944212|Vitamins|vitamins|mesh-ancestor
82986602|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
82986603|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986604|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82986605|NCT03197740|Donepezil|donepezil|mesh-list
82986606|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82986607|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986608|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986609|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
82986610|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986611|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986612|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
82986613|NCT03201796|Levofloxacin|levofloxacin|mesh-list
82986614|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
82986615|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82986616|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986617|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82986618|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82986619|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82986620|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986621|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986622|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986623|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82986624|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82986625|NCT02727998|Midazolam|midazolam|mesh-list
82986626|NCT02727998|Ketamine|ketamine|mesh-list
82986627|NCT02727998|Analgesics|analgesics|mesh-ancestor
82986628|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
82986629|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986630|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986631|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82986632|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82986633|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
82986634|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
82986635|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986636|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82986637|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82986638|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986639|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986640|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82986641|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82986642|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82986643|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82986644|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82986645|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
82986646|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
82986647|NCT02636270|Mecasermin|mecasermin|mesh-list
82986648|NCT02636270|Growth Substances|growth substances|mesh-ancestor
82986649|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986650|NCT02108990|Acetaminophen|acetaminophen|mesh-list
82986651|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82986652|NCT02108990|Analgesics|analgesics|mesh-ancestor
82986653|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
82986654|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986655|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986656|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
82986657|NCT03194074|Propofol|propofol|mesh-list
82986658|NCT03194074|Desflurane|desflurane|mesh-list
82986659|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82986660|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83463939|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986661|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986662|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82986663|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
82986664|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
82986665|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82986666|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82986667|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82986668|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82986669|NCT04179461|Vitamin D|vitamin d|mesh-list
82986670|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
82986671|NCT04179461|Fluticasone|fluticasone|mesh-list
82986672|NCT04179461|Xhance|xhance|mesh-list
82986673|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
82986674|NCT04179461|Cetirizine|cetirizine|mesh-list
82986675|NCT04179461|Loratadine|loratadine|mesh-list
82986676|NCT04179461|Azithromycin|azithromycin|mesh-list
82986677|NCT04179461|Budesonide|budesonide|mesh-list
82986678|NCT04179461|Beclomethasone|beclomethasone|mesh-list
82986679|NCT04179461|Emollients|emollients|mesh-list
82986680|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
82986681|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
82986682|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82986683|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82986684|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
82986685|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
82986686|NCT04179461|Vitamins|vitamins|mesh-ancestor
82986687|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
82986688|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986689|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82986690|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986691|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82986692|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
82986693|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986694|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82986695|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
82986696|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
82986697|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82986698|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82986699|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
82986700|NCT04179461|Hormones|hormones|mesh-ancestor
82986701|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986702|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82986703|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986704|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82986705|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82986706|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82986707|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
82986708|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986709|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986710|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
82986711|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82986712|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
82986713|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82986714|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
82986715|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
82986716|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
82986717|NCT04844528|Niacinamide|niacinamide|mesh-list
82986718|NCT04844528|Niacin|niacin|mesh-list
82986719|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
82986720|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
82986721|NCT04844528|Vitamins|vitamins|mesh-ancestor
82986722|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
82986723|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986724|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82986725|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
82986726|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986727|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82986728|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
82986729|NCT03196882|Iron|iron|mesh-list
82986730|NCT03196882|Trace Elements|trace elements|mesh-ancestor
82986731|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
82986732|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986733|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
82986734|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82986735|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
82986736|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82986737|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82986738|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986739|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82986740|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986741|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82986742|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986743|NCT01562717|Ibuprofen|ibuprofen|mesh-list
82986744|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82986745|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82986746|NCT01562717|Analgesics|analgesics|mesh-ancestor
82986747|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
82986748|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986749|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986750|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986751|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986752|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82986753|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986754|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986755|NCT03196648|Fluorides|fluorides|mesh-list
82986756|NCT03196648|Antioxidants|antioxidants|mesh-list
82986757|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
82986758|NCT03196648|Protective Agents|protective agents|mesh-ancestor
82986759|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986760|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986761|NCT03625310|Listerine|listerine|mesh-list
82986762|NCT03625310|Fluorides|fluorides|mesh-list
82986763|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
82986764|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
82986765|NCT03625310|Protective Agents|protective agents|mesh-ancestor
82986766|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986767|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82986768|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82986769|NCT05058404|Prednisone|prednisone|mesh-list
82986770|NCT05058404|Rituximab|rituximab|mesh-list
82986771|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82986772|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
82986773|NCT05058404|Vincristine|vincristine|mesh-list
82986774|NCT05058404|Doxorubicin|doxorubicin|mesh-list
82986775|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82986776|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986777|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
82986778|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986779|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986780|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82986781|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
82986782|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986783|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82986784|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82986785|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986786|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
82986787|NCT05058404|Hormones|hormones|mesh-ancestor
82986788|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82986789|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82986790|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82986791|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
82986792|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
82986793|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
82986794|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82986795|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82986796|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82986797|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986798|NCT03118336|Empagliflozin|empagliflozin|mesh-list
82986799|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82986800|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986801|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82986802|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986803|NCT02444572|Enoxaparin|enoxaparin|mesh-list
82986804|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
82986805|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82986806|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82986807|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986808|NCT04165031|Docetaxel|docetaxel|mesh-list
82986809|NCT04165031|Cetuximab|cetuximab|mesh-list
82986810|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82986811|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986812|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
82986813|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
82986814|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
82986815|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986816|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82986817|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82986818|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986819|NCT05480150|Dexetimide|dexetimide|mesh-list
82986820|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82986821|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82986822|NCT05480150|Citalopram|citalopram|mesh-list
82986823|NCT05480150|Escitalopram|escitalopram|mesh-list
82986824|NCT05480150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82986825|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82986826|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986827|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986828|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986829|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
82986830|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986831|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82986832|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82986833|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
82986834|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
82986835|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986836|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82986837|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82986838|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
82986839|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82986840|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
82986841|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82986842|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82986843|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82986844|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986845|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82986846|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82986847|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82986848|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
82986849|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82986850|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82986851|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82986852|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82986853|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
82986854|NCT05464628|Atorvastatin|atorvastatin|mesh-list
82986855|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82986856|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82986857|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
82986858|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986859|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82986860|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82986861|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986862|NCT03193918|Paclitaxel|paclitaxel|mesh-list
82986863|NCT03193918|Ramucirumab|ramucirumab|mesh-list
82986864|NCT03193918|Crenolanib|crenolanib|mesh-list
82986865|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82986866|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986867|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
82986868|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
82986869|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
82986870|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986871|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
82986872|NCT03117790|Morphine|morphine|mesh-list
82986873|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82986874|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986875|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986876|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82986877|NCT03117790|Analgesics|analgesics|mesh-ancestor
82986878|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
82986879|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986880|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82986881|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82986882|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82986883|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
82986884|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986885|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986886|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82986887|NCT03117790|Narcotics|narcotics|mesh-ancestor
82986888|NCT03193372|Azelaic acid|azelaic acid|mesh-list
82986889|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986890|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
82986891|NCT03034772|Timolol|timolol|mesh-list
82986892|NCT03034772|Dorzolamide|dorzolamide|mesh-list
82986893|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
82986894|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82986895|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82986896|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
82986897|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986898|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986899|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986900|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82986901|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82986902|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82986903|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82986904|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82986905|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986906|NCT03193606|Fluorides|fluorides|mesh-list
82986907|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
82986908|NCT03193606|Protective Agents|protective agents|mesh-ancestor
82986909|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986910|NCT02448784|Donepezil|donepezil|mesh-list
82986911|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82986912|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986913|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986914|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
82986915|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986916|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986917|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
82986918|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
82986919|NCT04050488|Astringents|astringents|mesh-ancestor
82986920|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986921|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
82986922|NCT02449252|Prednisone|prednisone|mesh-list
82986923|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
82986924|NCT02449252|Doxorubicin|doxorubicin|mesh-list
82986925|NCT02449252|Vincristine|vincristine|mesh-list
82986926|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82986927|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
82986928|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986929|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82986930|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82986931|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
82986932|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986933|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986934|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82986935|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82986936|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82986937|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82986938|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986939|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82986940|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
82986941|NCT02449252|Hormones|hormones|mesh-ancestor
82986942|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83463962|NCT00000856|Foscarnet|foscarnet|mesh-list
82986943|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82986944|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82986945|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
82986946|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
82986947|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
82986948|NCT04779554|Mitomycins|mitomycins|mesh-list
82986949|NCT04779554|Mitomycin|mitomycin|mesh-list
82986950|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82986951|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82986952|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
82986953|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986954|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82986955|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82986956|NCT02444260|Lidocaine|lidocaine|mesh-list
82986957|NCT02444260|Midazolam|midazolam|mesh-list
82986958|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82986959|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82986960|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82986961|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986962|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82986963|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82986964|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82986965|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82986966|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
82986967|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
82986968|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
82986969|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
82986970|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986971|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986972|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
82986973|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
82986974|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82986975|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82986976|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82986977|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82986978|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986979|NCT03195634|Carvedilol|carvedilol|mesh-list
82986980|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82986981|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82986983|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82986984|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82986985|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82986986|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82986987|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
82986988|NCT03195634|Protective Agents|protective agents|mesh-ancestor
82986989|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82986990|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82986991|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82986992|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
82986993|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82986994|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82986995|NCT02448550|Heparin|heparin|mesh-list
82986996|NCT02448550|Calcium heparin|calcium heparin|mesh-list
82986997|NCT02448550|Bivalirudin|bivalirudin|mesh-list
82986998|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
82986999|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82987000|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82987001|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987003|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82987004|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
82987005|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987006|NCT03701750|Heparin|heparin|mesh-list
82987007|NCT03701750|Enoxaparin|enoxaparin|mesh-list
82987008|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82987009|NCT03701750|Tinzaparin|tinzaparin|mesh-list
82987010|NCT03701750|Dalteparin|dalteparin|mesh-list
82987011|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
82987012|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
82987013|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82987014|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82987015|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987016|NCT03704246|Antibodies|antibodies|mesh-list
82987017|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82987018|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
82987019|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987020|NCT05239910|Tenalisib|tenalisib|mesh-list
82987021|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
82987022|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987023|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987024|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
82987025|NCT03701672|Analgesics|analgesics|mesh-list
82987026|NCT03701672|Narcotics|narcotics|mesh-ancestor
82987027|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987028|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987029|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
82987030|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987031|NCT03624530|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
82987032|NCT03624530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82987033|NCT03624530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987034|NCT03624530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987035|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
82987036|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82987037|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987038|NCT03746249|Lenvatinib|lenvatinib|mesh-list
82987039|NCT03746249|Antibodies|antibodies|mesh-list
82987040|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
82987041|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
82987042|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987043|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987044|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82987045|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987046|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987047|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
82987048|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
82987049|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
82987050|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
82987051|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987052|NCT03698474|Analgesics|analgesics|mesh-ancestor
82987053|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
82987054|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987055|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987056|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
82987057|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987058|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82987059|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
82987060|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82987061|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987062|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82987063|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
82987064|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987065|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
82987066|NCT03698474|Protective Agents|protective agents|mesh-ancestor
82987067|NCT03698474|Vitamins|vitamins|mesh-ancestor
82987068|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
82987069|NCT03698474|Cathartics|cathartics|mesh-ancestor
82987070|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82987071|NCT04709276|Carboplatin|carboplatin|mesh-list
82987072|NCT04709276|Nivolumab|nivolumab|mesh-list
82987073|NCT04709276|Ipilimumab|ipilimumab|mesh-list
82987074|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987075|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82987076|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82987077|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987078|NCT01194622|Fluticasone|fluticasone|mesh-list
82987080|NCT01194622|Azelastine|azelastine|mesh-list
82987081|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987082|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82987083|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
82987084|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987085|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987086|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82987087|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
82987088|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
82987089|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82987090|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82987091|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987092|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987093|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82987094|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82987095|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
82987096|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
82987097|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987098|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82987099|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
82987100|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82987101|NCT02448316|Prednisolone|prednisolone|mesh-list
82987102|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
82987103|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82987104|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
82987105|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987106|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
82987107|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
82987108|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987109|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987110|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82987111|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
82987112|NCT02448316|Hormones|hormones|mesh-ancestor
82987113|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987114|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82987115|NCT02448316|Protective Agents|protective agents|mesh-ancestor
82987116|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82987117|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987118|NCT04564898|Trifluridine|trifluridine|mesh-list
82987119|NCT04564898|Bevacizumab|bevacizumab|mesh-list
82987120|NCT04564898|Capecitabine|capecitabine|mesh-list
82987121|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82987122|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987123|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82987124|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82987125|NCT04564898|Growth Substances|growth substances|mesh-ancestor
82987126|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987127|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
82987128|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82987129|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
82987130|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987131|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
82987132|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987133|NCT02443714|Insulin|insulin|mesh-list
82987134|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82987135|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
82987136|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82987137|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987138|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
82987139|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82987140|NCT03703154|Tacrolimus|tacrolimus|mesh-list
82987141|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82987142|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
82987143|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987144|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82987145|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987146|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987147|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
82987148|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
82987149|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987150|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
82987151|NCT02434276|Coagulants|coagulants|mesh-ancestor
82987152|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
82987153|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82987154|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82987155|NCT03190642|Prednisolone|prednisolone|mesh-list
82987156|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
82987157|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82987158|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
82987159|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987160|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
82987161|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
82987162|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987163|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987164|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82987165|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
82987166|NCT03190642|Hormones|hormones|mesh-ancestor
82987167|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987168|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82987169|NCT03190642|Protective Agents|protective agents|mesh-ancestor
82987170|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82987171|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987172|NCT03702530|Albendazole|albendazole|mesh-list
82987173|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
82987174|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82987175|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987176|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
82987177|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82987178|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82987179|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
82987180|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
82987181|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
82987182|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987183|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987184|NCT02443246|Vitamin D|vitamin d|mesh-list
82987185|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
82987186|NCT02443246|Vitamins|vitamins|mesh-ancestor
82987187|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
82987188|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987189|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82987190|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82987191|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82987192|NCT03031496|Amiloride|amiloride|mesh-list
82987193|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
82987194|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82987195|NCT03031496|Diuretics|diuretics|mesh-ancestor
82987196|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
82987197|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987198|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82987199|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987200|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987201|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
82987202|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82987203|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
82987204|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82987205|NCT03187912|Riboflavin|riboflavin|mesh-list
82987206|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
82987207|NCT03187912|Vitamins|vitamins|mesh-ancestor
82987208|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
82987209|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987211|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
82987212|NCT02443012|Nepafenac|nepafenac|mesh-list
82987213|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987214|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987215|NCT02443012|Analgesics|analgesics|mesh-ancestor
82987216|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
82987217|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987218|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987219|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987220|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987221|NCT04670432|Troxerutin|troxerutin|mesh-list
82987222|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
82987223|NCT03701126|Bupivacaine|bupivacaine|mesh-list
82987224|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
82987225|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
82987226|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987227|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987228|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
82987229|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987230|NCT03702140|Teriparatide|teriparatide|mesh-list
83463976|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987231|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82987232|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987233|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82987234|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82987235|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82987236|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987237|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82987238|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987239|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987240|NCT02433808|Neostigmine|neostigmine|mesh-list
82987241|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82987242|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987243|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987244|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
82987245|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987246|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987247|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82987248|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
82987249|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987250|NCT03701984|Lidocaine|lidocaine|mesh-list
82987251|NCT03701984|Tramadol|tramadol|mesh-list
82987252|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
82987253|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
82987254|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987255|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987256|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
82987257|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987258|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82987259|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82987260|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82987261|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987262|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987263|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82987264|NCT03701984|Narcotics|narcotics|mesh-ancestor
82987265|NCT03701984|Analgesics|analgesics|mesh-ancestor
82987266|NCT04651400|Antithrombins|antithrombins|mesh-list
82987267|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
82987268|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82987269|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
82987270|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987271|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987272|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
82987273|NCT02439190|Aspirin|aspirin|mesh-list
82987274|NCT02439190|Clopidogrel|clopidogrel|mesh-list
82987275|NCT02439190|BMS-986120|bms-986120|mesh-list
82987276|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987277|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987278|NCT02439190|Analgesics|analgesics|mesh-ancestor
82987279|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
82987280|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987281|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987282|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987283|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987284|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82987285|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82987286|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987287|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82987288|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82987289|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987290|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
82987291|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82987292|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82987293|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82987294|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
82987295|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987297|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82987298|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
82987299|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82987300|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987301|NCT04336982|Azacitidine|azacitidine|mesh-list
82987303|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82987304|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
82987305|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987306|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987307|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987308|NCT02439034|Acetaminophen|acetaminophen|mesh-list
82987309|NCT02439034|Ketoprofen|ketoprofen|mesh-list
82987310|NCT02439034|Codeine|codeine|mesh-list
82987311|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987312|NCT02439034|Analgesics|analgesics|mesh-ancestor
82987313|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
82987314|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987315|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987316|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
82987317|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987318|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987319|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987320|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82987321|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987322|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987323|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82987324|NCT02439034|Narcotics|narcotics|mesh-ancestor
82987325|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987326|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
82987327|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
82987328|NCT04483492|Caffeine|caffeine|mesh-list
82987329|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
82987330|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987331|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82987332|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987333|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82987334|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987335|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82987336|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82987337|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
82987338|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987339|NCT03186742|Eplerenone|eplerenone|mesh-list
82987340|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82987341|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
82987342|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987343|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987344|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82987345|NCT03186742|Diuretics|diuretics|mesh-ancestor
82987346|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
82987347|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82987348|NCT03186664|Nabiximols|nabiximols|mesh-list
82987349|NCT03186664|Analgesics|analgesics|mesh-ancestor
82987350|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
82987351|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987352|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987353|NCT02441842|Atenolol|atenolol|mesh-list
82987354|NCT02441842|Lisinopril|lisinopril|mesh-list
82987355|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82987356|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
82987357|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987358|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987359|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82987360|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82987361|NCT02441842|Protective Agents|protective agents|mesh-ancestor
82987362|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987363|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82987364|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
82987365|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
82987366|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987367|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82987368|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82987369|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82987370|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
82987371|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987372|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
82987373|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82987374|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82987375|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987376|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
82987377|NCT02438566|Coagulants|coagulants|mesh-ancestor
82987378|NCT02433652|Vaccines|vaccines|mesh-list
82987379|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
82987380|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987381|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
82987382|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82987383|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
82987384|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987385|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987386|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82987387|NCT02433418|Diclofenac|diclofenac|mesh-list
82987388|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987389|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987390|NCT02433418|Analgesics|analgesics|mesh-ancestor
82987391|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
82987392|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987393|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987394|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987395|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987396|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82987397|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987398|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987399|NCT02433730|Testosterone|testosterone|mesh-list
82987400|NCT02433730|Androgens|androgens|mesh-ancestor
82987401|NCT02433730|Hormones|hormones|mesh-ancestor
82987402|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987403|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987404|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
82987405|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82987406|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
82987407|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82987408|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
82987409|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987410|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987411|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
82987412|NCT02441530|Vitamin D|vitamin d|mesh-list
82987413|NCT02441530|Vitamins|vitamins|mesh-list
82987414|NCT02441530|Vitamin E|vitamin e|mesh-list
82987415|NCT02441530|Ibuprofen|ibuprofen|mesh-list
82987416|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
82987417|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987418|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82987419|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987420|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987421|NCT02441530|Analgesics|analgesics|mesh-ancestor
82987422|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
82987423|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987424|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987425|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987426|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82987427|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987428|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987429|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
82987430|NCT02441530|Protective Agents|protective agents|mesh-ancestor
82987431|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
82987432|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
82987433|NCT02433184|Etanercept|etanercept|mesh-list
82987434|NCT02433184|Methotrexate|methotrexate|mesh-list
82987435|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82987436|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
82987437|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987438|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83463992|NCT02344472|Paclitaxel|paclitaxel|mesh-list
82987439|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82987440|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
82987441|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987442|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987443|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
82987444|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987445|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82987446|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82987447|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
82987448|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987449|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82987450|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
82987451|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82987452|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82987453|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987454|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987455|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987456|NCT02433184|Analgesics|analgesics|mesh-ancestor
82987457|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
82987458|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987459|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987460|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82987461|NCT02438020|Metformin|metformin|mesh-list
82987462|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82987463|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987464|NCT02440750|Dienogest|dienogest|mesh-list
82987465|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
82987466|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82987467|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
82987468|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987469|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987470|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82987471|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82987472|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82987473|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82987474|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
82987475|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987476|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82987477|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987478|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
82987479|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82987480|NCT02432872|Cytarabine|cytarabine|mesh-list
82987481|NCT02432872|Daunorubicin|daunorubicin|mesh-list
82987482|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82987483|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
82987484|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987485|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987486|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
82987487|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987488|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82987489|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
82987490|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987491|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82987492|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82987493|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82987494|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987495|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
82987496|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82987497|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
82987498|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987499|NCT02436928|Vaccines|vaccines|mesh-list
82987500|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
82987501|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987502|NCT02436538|Hormones|hormones|mesh-list
82987503|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987504|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987505|NCT02436694|Dexamethasone|dexamethasone|mesh-list
82987506|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
82987507|NCT02436694|Ropivacaine|ropivacaine|mesh-list
82987508|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
82987509|NCT02436694|Anesthetics|anesthetics|mesh-list
82987510|NCT02436694|BB 1101|bb 1101|mesh-list
82987511|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987512|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
82987513|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
82987514|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987515|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987516|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82987517|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
82987518|NCT02436694|Hormones|hormones|mesh-ancestor
82987519|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987520|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82987521|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987522|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
82987523|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987524|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987525|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987526|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
82987527|NCT03186040|Lacosamide|lacosamide|mesh-list
82987528|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
82987529|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82987530|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82987531|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987532|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987533|NCT02659020|Gemcitabine|gemcitabine|mesh-list
82987534|NCT02659020|Docetaxel|docetaxel|mesh-list
82987535|NCT02659020|Olaratumab|olaratumab|mesh-list
82987536|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82987537|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
82987538|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987539|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987540|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
82987541|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
82987542|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
82987543|NCT03482011|Mirikizumab|mirikizumab|mesh-list
82987544|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987545|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987546|NCT03482011|Analgesics|analgesics|mesh-ancestor
82987547|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
82987548|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987549|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987550|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987551|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987552|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82987553|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82987554|NCT02436226|Citric Acid|citric acid|mesh-list
82987555|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
82987556|NCT02436226|Clomiphene|clomiphene|mesh-list
82987557|NCT02436226|Enclomiphene|enclomiphene|mesh-list
82987558|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
82987559|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82987560|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
82987561|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82987562|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
82987563|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
82987564|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987565|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82987566|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
82987567|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987568|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987569|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82987570|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
82987571|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987572|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82987573|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82987574|NCT01374126|Azithromycin|azithromycin|mesh-list
82987575|NCT01374126|Artesunate|artesunate|mesh-list
82987576|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82987577|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987578|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
82987579|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82987580|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82987581|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987582|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
82987583|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
82987584|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82987585|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
82987586|NCT02584920|Rituximab|rituximab|mesh-list
82987587|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82987588|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987589|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
82987590|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987591|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987592|NCT02431936|Prazosin|prazosin|mesh-list
82987593|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82987594|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82987595|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82987596|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82987597|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
82987598|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987599|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987600|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987601|NCT02440828|Tobramycin|tobramycin|mesh-list
82987602|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82987603|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987604|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82987605|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82987606|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987607|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987608|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82987609|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
82987610|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987611|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987612|NCT03789318|Acetaminophen|acetaminophen|mesh-list
82987613|NCT03789318|Fentanyl|fentanyl|mesh-list
82987614|NCT03789318|Oxycodone|oxycodone|mesh-list
82987615|NCT03789318|Hydromorphone|hydromorphone|mesh-list
82987616|NCT03789318|Bupivacaine|bupivacaine|mesh-list
82987617|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
82987618|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
82987619|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987620|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987621|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
82987622|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987623|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82987624|NCT03789318|Narcotics|narcotics|mesh-ancestor
82987625|NCT03789318|Analgesics|analgesics|mesh-ancestor
82987626|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82987627|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82987628|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
82987629|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987630|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
82987631|NCT04518410|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
82987632|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
82987633|NCT04518410|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
82987634|NCT04518410|Gabexate|gabexate|mesh-list
82987635|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
82987636|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82987637|NCT04518410|Antibodies|antibodies|mesh-list
82987638|NCT04518410|Camostat|camostat|mesh-list
82987639|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
82987640|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987641|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
82987642|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987643|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987644|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82987645|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82987646|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
82987647|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
82987648|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987649|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
82987650|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82987651|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987652|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82987653|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
82987654|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82987655|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83464006|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987656|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987657|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987658|NCT05160090|Bupropion|bupropion|mesh-list
82987659|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82987660|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
82987661|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82987662|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82987663|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82987664|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987665|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987666|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
82987667|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987668|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987669|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82987670|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82987671|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987672|NCT04516616|Paclitaxel|paclitaxel|mesh-list
82987673|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82987674|NCT04516616|Cisplatin|cisplatin|mesh-list
82987675|NCT04516616|Antibodies|antibodies|mesh-list
82987676|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82987677|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83521628|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
82987678|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987679|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
82987680|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
82987681|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
82987682|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987683|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
82987684|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987685|NCT00511134|Eszopiclone|eszopiclone|mesh-list
82987686|NCT00511134|Bupropion|bupropion|mesh-list
82987687|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82987688|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
82987689|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82987690|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82987691|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82987692|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987693|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987694|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
82987695|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987696|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987697|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82987698|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82987699|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987700|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82987701|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987702|NCT05103228|Menotropins|menotropins|mesh-list
82987703|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82987704|NCT05103228|Hormones|hormones|mesh-ancestor
82987705|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987706|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987707|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82987708|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
82987709|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987710|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82987711|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987712|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82987713|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987714|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987715|NCT03190798|Canagliflozin|canagliflozin|mesh-list
82987716|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82987717|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987718|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82987719|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987720|NCT03696290|Aztreonam|aztreonam|mesh-list
83464012|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
82987721|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82987722|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987723|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
82987724|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82987725|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987726|NCT03696212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82987727|NCT03696212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987728|NCT03692546|Bupivacaine|bupivacaine|mesh-list
82987729|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
82987730|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
82987731|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987732|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987733|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
82987734|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987735|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82987736|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
82987737|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987739|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
82987740|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987741|NCT01371474|Paroxetine|paroxetine|mesh-list
82987742|NCT01371474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82987743|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82987744|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987745|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987746|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987747|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
82987748|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987749|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82987750|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
82987751|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82987752|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82987753|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82987754|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987755|NCT03185104|Fluorides|fluorides|mesh-list
82987756|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
82987757|NCT03185104|Protective Agents|protective agents|mesh-ancestor
82987758|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987759|NCT01319994|Metformin|metformin|mesh-list
82987760|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82987761|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987762|NCT02430298|Melatonin|melatonin|mesh-list
82987763|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
82987764|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987765|NCT02430298|Protective Agents|protective agents|mesh-ancestor
82987766|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987767|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987768|NCT03626376|Valacyclovir|valacyclovir|mesh-list
82987769|NCT03626376|Acyclovir|acyclovir|mesh-list
82987770|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82987771|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82987772|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
82987773|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82987774|NCT05007522|Ketotifen|ketotifen|mesh-list
82987775|NCT05007522|Indomethacin|indomethacin|mesh-list
82987776|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987777|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987778|NCT05007522|Analgesics|analgesics|mesh-ancestor
82987779|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
82987780|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987781|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987782|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987783|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987784|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
82987785|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
82987786|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987787|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82987788|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987789|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987790|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
82987791|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
82987792|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82987793|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
82987794|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
82987795|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987796|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82987797|NCT03695822|Mirabegron|mirabegron|mesh-list
82987798|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82987799|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82987800|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82987801|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
82987802|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987803|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987804|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987805|NCT03695822|Urological Agents|urological agents|mesh-ancestor
82987806|NCT03718507|Atropine|atropine|mesh-list
82987807|NCT03718507|Fentanyl|fentanyl|mesh-list
82987808|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82987810|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987811|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987813|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
82987814|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987815|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82987816|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82987817|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
82987818|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
82987819|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82987820|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82987821|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
82987822|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82987823|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
82987824|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
82987825|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
82987826|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82987827|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82987828|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
82987829|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987830|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987832|NCT03695744|Bortezomib|bortezomib|mesh-list
82987833|NCT03695744|Daratumumab|daratumumab|mesh-list
82987834|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987835|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
82987836|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
82987837|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987838|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987839|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82987840|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
82987841|NCT03695744|Hormones|hormones|mesh-ancestor
82987842|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987843|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82987844|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987845|NCT01374282|Penicillamine|penicillamine|mesh-list
82987846|NCT01374282|Antidotes|antidotes|mesh-ancestor
82987847|NCT01374282|Protective Agents|protective agents|mesh-ancestor
82987848|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987849|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
82987850|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
82987851|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987852|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987853|NCT03691922|Epinephrine|epinephrine|mesh-list
82987854|NCT03691922|Racepinephrine|racepinephrine|mesh-list
82987855|NCT03691922|Bupivacaine|bupivacaine|mesh-list
82987856|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
82987857|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
82987858|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
82987859|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987860|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987861|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
82987862|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987863|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82987864|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82987865|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
82987866|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987867|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987868|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82987869|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82987870|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
82987871|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82987872|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
82987873|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
82987874|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
82987875|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82987876|NCT03453151|Anesthetics|anesthetics|mesh-list
82987877|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
82987878|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987879|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987880|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
82987881|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987882|NCT03433248|Empagliflozin|empagliflozin|mesh-list
82987883|NCT03433248|Gliclazide|gliclazide|mesh-list
82987884|NCT03433248|Linagliptin|linagliptin|mesh-list
82987886|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987887|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82987888|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987889|NCT03433248|Incretins|incretins|mesh-ancestor
82987890|NCT03433248|Hormones|hormones|mesh-ancestor
82987891|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987892|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82987893|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
82987894|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987895|NCT03691688|Aspirin|aspirin|mesh-list
82987896|NCT03691688|Clopidogrel|clopidogrel|mesh-list
82987897|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82987898|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987899|NCT03691688|Analgesics|analgesics|mesh-ancestor
82987900|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
82987901|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987902|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987903|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987904|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82987905|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82987906|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82987907|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987908|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82987909|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82987910|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82987911|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
82987912|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82987913|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82987914|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82987915|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
82987916|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987917|NCT02887248|Paclitaxel|paclitaxel|mesh-list
82987918|NCT02887248|Gemcitabine|gemcitabine|mesh-list
82987919|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82987920|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987921|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
82987922|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
82987923|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
82987924|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987925|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82987926|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
82987927|NCT02425462|Dienogest|dienogest|mesh-list
82987928|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82987929|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
82987930|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82987931|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987932|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82987933|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82987934|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82987935|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82987936|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
82987937|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987938|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82987939|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987940|NCT03452527|Aflibercept|aflibercept|mesh-list
82987941|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
82987942|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82987943|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82987944|NCT03452527|Growth Substances|growth substances|mesh-ancestor
82987945|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987946|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
82987947|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82987948|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
82987949|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
82987950|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82987951|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82987952|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987953|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82987954|NCT04878510|Analgesics|analgesics|mesh-ancestor
82987955|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
82987956|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987957|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82987958|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82987959|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82987960|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
82987961|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987962|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987963|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
82987964|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82987965|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
82987966|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987967|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987968|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82987969|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
82987970|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
82987971|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82987972|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
82987973|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987974|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987975|NCT02800824|Budesonide|budesonide|mesh-list
82987976|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987977|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82987978|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
82987979|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987980|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987981|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82987982|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
82987983|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
82987984|NCT02800824|Hormones|hormones|mesh-ancestor
82987985|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82987986|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
82987987|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82987988|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82987989|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82987990|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82987991|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82987992|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82987993|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
82987994|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82987995|NCT03715699|Prednisone|prednisone|mesh-list
82987996|NCT03715699|Leflunomide|leflunomide|mesh-list
82987997|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82987998|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
82987999|NCT03715699|Hormones|hormones|mesh-ancestor
82988000|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988001|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988002|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82988003|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988004|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988005|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988006|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82988007|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
82988008|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
82988009|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82988010|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
82988011|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988012|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988013|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82988014|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
82988015|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82988016|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
82988017|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988018|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988019|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82988020|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
82988021|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
82988022|NCT04776408|Protective Agents|protective agents|mesh-ancestor
82988023|NCT02429596|Lamotrigine|lamotrigine|mesh-list
82988024|NCT02429596|Carbamazepine|carbamazepine|mesh-list
82988025|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
82988026|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82988027|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82988028|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988029|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82988030|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988031|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82988032|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988033|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988034|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988035|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82988036|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
82988037|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82988038|NCT02429596|Analgesics|analgesics|mesh-ancestor
82988039|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
82988040|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988041|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82988042|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82988043|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
82988044|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
82988045|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988046|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988047|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988048|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
82988049|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
82988050|NCT02653092|Heparin|heparin|mesh-list
82988051|NCT02653092|Anticoagulants|anticoagulants|mesh-list
82988052|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82988053|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82988054|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82988055|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988056|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82988057|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82988058|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82988059|NCT03691454|Docetaxel|docetaxel|mesh-list
82988060|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
82988061|NCT03691454|Trastuzumab|trastuzumab|mesh-list
82988062|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988063|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
82988064|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
82988065|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
82988066|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988067|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988068|NCT03718273|Digoxin|digoxin|mesh-list
82988069|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82988070|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82988071|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988072|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988073|NCT03718273|Protective Agents|protective agents|mesh-ancestor
82988074|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988075|NCT02421640|Cisplatin|cisplatin|mesh-list
82988076|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988077|NCT03715387|Bacitracin|bacitracin|mesh-list
82988078|NCT03715387|Polymyxin B|polymyxin b|mesh-list
82988079|NCT03715387|Tacrolimus|tacrolimus|mesh-list
82988080|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82988081|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
82988082|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988083|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82988084|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988085|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988086|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82988087|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988088|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82988089|NCT03715309|Lenalidomide|lenalidomide|mesh-list
82988090|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
82988091|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988092|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82988093|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82988094|NCT03715309|Growth Substances|growth substances|mesh-ancestor
82988095|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
82988096|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988097|NCT03179254|Metformin|metformin|mesh-list
82988098|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988099|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988100|NCT04147715|Dolutegravir|dolutegravir|mesh-list
82988101|NCT04147715|Midazolam|midazolam|mesh-list
82988102|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82988103|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82988104|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988105|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988106|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82988107|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988108|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988109|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988110|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
82988111|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
82988112|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
82988113|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
82988114|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988115|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988116|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82988117|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82988118|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988119|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82988120|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82988121|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
82988122|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988123|NCT02420938|Rituximab|rituximab|mesh-list
82988124|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988125|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988126|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
82988127|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988128|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82988129|NCT02429440|Molgramostim|molgramostim|mesh-list
82988130|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
82988131|NCT02429440|Sargramostim|sargramostim|mesh-list
82988132|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82988133|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
83464053|NCT02627846|Epinephrine|epinephrine|mesh-list
82988134|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988135|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988136|NCT02429518|Miltefosine|miltefosine|mesh-list
82988137|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
82988138|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988139|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988140|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82988141|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82988142|NCT00708526|Anesthetics|anesthetics|mesh-list
82988143|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988144|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988145|NCT03712735|Fentanyl|fentanyl|mesh-list
82988146|NCT03712735|Bupivacaine|bupivacaine|mesh-list
82988147|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
82988148|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
82988149|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988150|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988151|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
82988152|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988153|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82988154|NCT03712735|Narcotics|narcotics|mesh-ancestor
82988155|NCT03712735|Analgesics|analgesics|mesh-ancestor
82988156|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82988157|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988158|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
82988159|NCT03182218|Heparin|heparin|mesh-list
82988160|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82988161|NCT03182218|Tinzaparin|tinzaparin|mesh-list
82988162|NCT03182218|Dalteparin|dalteparin|mesh-list
82988163|NCT03182218|Anticoagulants|anticoagulants|mesh-list
82988164|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82988165|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82988166|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988167|NCT02452554|Maytansine|maytansine|mesh-list
82988168|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
82988169|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82988170|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82988171|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988172|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
82988173|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
82988174|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
82988175|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988176|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988177|NCT02452554|Immunotoxins|immunotoxins|mesh-ancestor
82988178|NCT02452554|Immunoconjugates|immunoconjugates|mesh-ancestor
82988179|NCT02452554|Immunologic Factors|immunologic factors|mesh-ancestor
82988180|NCT02452554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988181|NCT03182296|Exenatide|exenatide|mesh-list
82988182|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988183|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988184|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82988186|NCT03182296|Hormones|hormones|mesh-ancestor
82988187|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988189|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
82988190|NCT03182374|Protective Agents|protective agents|mesh-ancestor
82988191|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988192|NCT01319682|Lidocaine|lidocaine|mesh-list
82988193|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
82988194|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
82988195|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988196|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988197|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
82988198|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988199|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82988200|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82988201|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82988202|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82988203|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988204|NCT04009577|Lemborexant|lemborexant|mesh-list
82988205|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
82988206|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464055|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82988207|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988208|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82988210|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988211|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988212|NCT02176668|Esomeprazole|esomeprazole|mesh-list
82988213|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82988214|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988215|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82988216|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988217|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988218|NCT03712423|Docetaxel|docetaxel|mesh-list
82988219|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988220|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
82988221|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
82988222|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
82988223|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988224|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
82988225|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
82988226|NCT04620252|Citric Acid|citric acid|mesh-list
82988227|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
82988228|NCT04620252|Calcium|calcium|mesh-list
82988229|NCT04620252|Fluorides|fluorides|mesh-list
82988230|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82988231|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988232|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82988233|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
82988234|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82988235|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
82988236|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
82988237|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988238|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
82988239|NCT04620252|Protective Agents|protective agents|mesh-ancestor
82988240|NCT04620252|Antacids|antacids|mesh-ancestor
82988241|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988242|NCT03694886|Caffeine|caffeine|mesh-list
82988243|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82988244|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988245|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82988246|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988247|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988248|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82988249|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82988250|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
82988251|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988252|NCT05602675|Repaglinide|repaglinide|mesh-list
82988253|NCT05602675|Methotrexate|methotrexate|mesh-list
82988254|NCT05602675|Midazolam|midazolam|mesh-list
82988255|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
82988256|NCT05602675|Warfarin|warfarin|mesh-list
82988257|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82988258|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
82988259|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988260|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988261|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82988262|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
82988263|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988264|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988265|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
82988266|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988267|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82988268|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82988269|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
82988270|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82988271|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82988272|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82988273|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82988274|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988275|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82988276|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988277|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988278|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988279|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
82988280|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
82988281|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
82988282|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
82988283|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988284|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
82988285|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
82988286|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
82988287|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82988288|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82988289|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988290|NCT03714685|Firibastat|firibastat|mesh-list
82988291|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82988292|NCT02705716|Fluorides|fluorides|mesh-list
82988293|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
82988294|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
82988295|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
82988296|NCT02705716|Protective Agents|protective agents|mesh-ancestor
82988297|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988298|NCT02429050|Morphine|morphine|mesh-list
82988299|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82988300|NCT02429050|Narcotics|narcotics|mesh-ancestor
82988301|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988302|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988303|NCT02429050|Analgesics|analgesics|mesh-ancestor
82988304|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
82988305|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988306|NCT02417142|Exenatide|exenatide|mesh-list
82988307|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988308|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988309|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82988310|NCT02417142|Incretins|incretins|mesh-ancestor
82988311|NCT02417142|Hormones|hormones|mesh-ancestor
82988312|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988313|NCT04135937|Bupropion|bupropion|mesh-list
82988314|NCT04135937|Nicotine|nicotine|mesh-list
82988315|NCT04135937|Varenicline|varenicline|mesh-list
82988316|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82988317|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
82988318|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988319|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988320|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82988321|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82988322|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
82988323|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988324|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988325|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82988326|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
82988327|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988328|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82988329|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82988330|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82988331|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
82988332|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82988333|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82988334|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988335|NCT01374750|Cyclosporine|cyclosporine|mesh-list
82988336|NCT01374750|Sirolimus|sirolimus|mesh-list
82988337|NCT01374750|Tacrolimus|tacrolimus|mesh-list
82988338|NCT01374750|Cyclosporins|cyclosporins|mesh-list
82988339|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82988340|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
82988341|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988342|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82988343|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988344|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988345|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
82988346|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988347|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
82988348|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82988349|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82988350|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82988351|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988352|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
82988353|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82988354|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
82988355|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988356|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988357|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82988358|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82988359|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82988360|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82988361|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82988362|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82988363|NCT01374828|Analgesics|analgesics|mesh-ancestor
82988364|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
82988365|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988366|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988367|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82988368|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82988369|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82988370|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988371|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988372|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
82988373|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988374|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988375|NCT03634332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82988376|NCT03634332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988377|NCT03744767|Spironolactone|spironolactone|mesh-list
82988378|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82988379|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
82988380|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988381|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988382|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82988383|NCT03744767|Diuretics|diuretics|mesh-ancestor
82988384|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
82988385|NCT02428972|Propofol|propofol|mesh-list
82988386|NCT02428972|Sevoflurane|sevoflurane|mesh-list
82988387|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82988388|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988389|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988390|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988391|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
82988392|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
82988393|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82988394|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82988395|NCT03699332|Labetuzumab|labetuzumab|mesh-list
82988396|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988397|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988398|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82988399|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
82988400|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988401|NCT03178708|Amantadine|amantadine|mesh-list
82988402|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82988403|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82988404|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
82988405|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988406|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
82988407|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988408|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988409|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988410|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82988411|NCT03178708|Analgesics|analgesics|mesh-ancestor
82988412|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
83464078|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
82988413|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988414|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82988415|NCT00787176|Oxytocin|oxytocin|mesh-list
82988416|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
82988417|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988418|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988419|NCT03744689|Bupivacaine|bupivacaine|mesh-list
82988420|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
82988421|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
82988422|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988423|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988424|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
82988425|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988426|NCT02424214|Ionophores|ionophores|mesh-list
82988427|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82988428|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988429|NCT03712111|Norepinephrine|norepinephrine|mesh-list
82988430|NCT03712111|Bupivacaine|bupivacaine|mesh-list
82988431|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
82988432|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
83521629|NCT04343963|Bromides|bromides|mesh-list
82988433|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988434|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988435|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
82988436|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988437|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82988438|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82988439|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
82988440|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988441|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988442|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
82988443|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
82988444|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82988445|NCT02925494|Norethindrone|norethindrone|mesh-list
82988446|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
82988447|NCT02925494|Estradiol|estradiol|mesh-list
82988448|NCT02925494|Estrogens|estrogens|mesh-ancestor
82988449|NCT02925494|Hormones|hormones|mesh-ancestor
82988450|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988451|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988452|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82988453|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
82988454|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988455|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82988456|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82988457|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82988458|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82988459|NCT03717415|Carboplatin|carboplatin|mesh-list
82988460|NCT03717415|Rebastinib|rebastinib|mesh-list
82988461|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988462|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82988463|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988464|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988465|NCT03689894|Rituximab|rituximab|mesh-list
82988466|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988467|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988468|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
82988469|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988470|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82988471|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
82988472|NCT04126343|Padsevonil|padsevonil|mesh-list
82988473|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82988474|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988475|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82988476|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82988477|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988478|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988479|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988480|NCT04126343|Anticonvulsants|anticonvulsants|mesh-ancestor
82988481|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
82988482|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
82988483|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
82988484|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988485|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988486|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
82988487|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988489|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
82988490|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988491|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988492|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
82988493|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988494|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988495|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988496|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82988497|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
82988498|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82988499|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82988500|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988501|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
82988502|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
82988503|NCT03689114|Topiramate|topiramate|mesh-list
82988504|NCT03689114|Lamotrigine|lamotrigine|mesh-list
82988505|NCT03689114|Zonisamide|zonisamide|mesh-list
82988506|NCT03689114|Carbamazepine|carbamazepine|mesh-list
82988507|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
82988508|NCT03689114|Gabapentin|gabapentin|mesh-list
82988509|NCT03689114|Levetiracetam|levetiracetam|mesh-list
82988510|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
82988511|NCT03689114|Valproic Acid|valproic acid|mesh-list
82988512|NCT03689114|Analgesics|analgesics|mesh-ancestor
82988513|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
82988514|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988515|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988516|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82988517|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988518|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988519|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988520|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82988521|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82988522|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988523|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988524|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
82988525|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988526|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
82988527|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82988528|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82988529|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82988530|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82988531|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82988532|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988533|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
82988534|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82988535|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82988536|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82988537|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82988538|NCT04040946|Choline|choline|mesh-list
82988539|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
82988540|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82988541|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
82988542|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988543|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988544|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82988545|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
82988546|NCT02952001|Triamcinolone|triamcinolone|mesh-list
82988547|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82988548|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82988549|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82988550|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82988551|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
82988552|NCT02952001|Hormones|hormones|mesh-ancestor
82988553|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988554|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988555|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82988556|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
82988557|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988558|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988559|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82988560|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988561|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988562|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
82988563|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
82988564|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
82988566|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
82988567|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988568|NCT01311739|Hematinics|hematinics|mesh-ancestor
82988569|NCT05507359|Benzocaine|benzocaine|mesh-list
82988570|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
82988571|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
82988572|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988573|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988574|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
82988575|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988576|NCT04123067|Pioglitazone|pioglitazone|mesh-list
82988577|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988578|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988579|NCT03703050|Nivolumab|nivolumab|mesh-list
82988580|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988581|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988582|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82988583|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988584|NCT03688958|Iodine|iodine|mesh-list
82988585|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
82988586|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82988587|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988588|NCT03688958|Trace Elements|trace elements|mesh-ancestor
82988589|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
82988590|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988591|NCT04117607|Rezafungin|rezafungin|mesh-list
82988592|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
82988593|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988594|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
82988595|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988596|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82988597|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988598|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988599|NCT05192304|Maleic acid|maleic acid|mesh-list
82988600|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988601|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988602|NCT03693872|Dopamine|dopamine|mesh-list
82988603|NCT03693872|Apomorphine|apomorphine|mesh-list
82988604|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
82988605|NCT03693872|Emetics|emetics|mesh-ancestor
82988606|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988607|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
82988608|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988609|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988610|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
82988611|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988612|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988613|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82988614|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
82988615|NCT03693872|Protective Agents|protective agents|mesh-ancestor
82988616|NCT03693638|Fentanyl|fentanyl|mesh-list
82988617|NCT03693638|Bupivacaine|bupivacaine|mesh-list
82988618|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
82988619|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
82988620|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988621|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988622|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
82988623|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988624|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82988625|NCT03693638|Narcotics|narcotics|mesh-ancestor
82988626|NCT03693638|Analgesics|analgesics|mesh-ancestor
83464091|NCT00000880|Cyclosporine|cyclosporine|mesh-list
82988627|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82988628|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988629|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
82988630|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
82988631|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82988632|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
82988633|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988634|NCT01319838|Isotretinoin|isotretinoin|mesh-list
82988635|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
82988636|NCT05191914|Fulvestrant|fulvestrant|mesh-list
82988637|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82988638|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988639|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82988640|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82988641|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
82988642|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988643|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988644|NCT04060394|Prednisone|prednisone|mesh-list
82988645|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82988646|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
82988647|NCT04060394|Hormones|hormones|mesh-ancestor
82988648|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988649|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988650|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82988651|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988652|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
82988653|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988654|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988655|NCT04099277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82988656|NCT04099277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988657|NCT03743987|Pemetrexed|pemetrexed|mesh-list
82988658|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988659|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988660|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988661|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82988662|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82988663|NCT03693326|Spartalizumab|spartalizumab|mesh-list
82988664|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82988665|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988666|NCT03693326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988667|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988668|NCT03988907|Midazolam|midazolam|mesh-list
82988669|NCT03988907|Risdiplam|risdiplam|mesh-list
82988670|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82988671|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82988672|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988673|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988674|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82988675|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988676|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988677|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988678|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
82988679|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
82988680|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
82988681|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
82988682|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988683|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988684|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82988685|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988686|NCT03693248|Paclitaxel|paclitaxel|mesh-list
82988687|NCT03693248|Carboplatin|carboplatin|mesh-list
82988688|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82988689|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988690|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
82988691|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
82988692|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
82988693|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988694|NCT03987191|Insulin|insulin|mesh-list
82988695|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
82988696|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
82988697|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988698|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988699|NCT01373970|Pantoprazole|pantoprazole|mesh-list
82988700|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82988701|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988702|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82988703|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988704|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988705|NCT04050098|Metformin|metformin|mesh-list
82988706|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988707|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988708|NCT03745625|Propofol|propofol|mesh-list
82988709|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82988710|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988711|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988712|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988713|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
82988714|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
82988715|NCT03698630|Dexamethasone|dexamethasone|mesh-list
82988716|NCT03698630|Prednisolone|prednisolone|mesh-list
82988717|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82988718|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
82988719|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82988720|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
82988721|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82988722|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
82988723|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82988724|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
82988725|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
82988726|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988727|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988728|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988729|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
82988731|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988732|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82988733|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988734|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82988735|NCT03698630|Protective Agents|protective agents|mesh-ancestor
82988736|NCT01375452|Letrozole|letrozole|mesh-list
82988737|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988738|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82988739|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82988740|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988741|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988742|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82988743|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
82988744|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988745|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988746|NCT03046836|Oxytocin|oxytocin|mesh-list
82988747|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
82988748|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988749|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988750|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
82988751|NCT03400033|Hematinics|hematinics|mesh-ancestor
82988752|NCT05123820|Midazolam|midazolam|mesh-list
82988753|NCT05123820|Omeprazole|omeprazole|mesh-list
82988754|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82988755|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82988756|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988757|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988758|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82988759|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988760|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988761|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988762|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
82988763|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
82988764|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
82988765|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
82988766|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988767|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988768|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82988769|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988770|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82988771|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988772|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
82988773|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
82988774|NCT02876835|Hematinics|hematinics|mesh-ancestor
82988775|NCT03503318|Risperidone|risperidone|mesh-list
82988776|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82988777|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
82988778|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988779|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988780|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988781|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82988782|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988783|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988784|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988785|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82988786|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
82988787|NCT01375920|Metyrapone|metyrapone|mesh-list
82988788|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
82988789|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988790|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988791|NCT03683108|Resveratrol|resveratrol|mesh-list
82988793|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988795|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988796|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988797|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82988798|NCT05137860|Bortezomib|bortezomib|mesh-list
82988799|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988800|NCT03682952|Alprostadil|alprostadil|mesh-list
82988801|NCT03682952|Beraprost|beraprost|mesh-list
82988802|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82988803|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
82988804|NCT03682952|Urological Agents|urological agents|mesh-ancestor
82988805|NCT03682718|Misoprostol|misoprostol|mesh-list
82988806|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82988807|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
82988808|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988809|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988810|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82988811|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82988812|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
82988813|NCT03682640|Insulin|insulin|mesh-list
82988814|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82988815|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
82988816|NCT03682640|Azithromycin|azithromycin|mesh-list
82988817|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82988818|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988819|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82988820|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988821|NCT04084769|Vaccines|vaccines|mesh-list
82988822|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
82988823|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988824|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
82988825|NCT01376076|Risperidone|risperidone|mesh-list
82988826|NCT01376076|Cariprazine|cariprazine|mesh-list
82988827|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82988828|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82988829|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988830|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82988831|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82988832|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988833|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988834|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988835|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82988836|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
82988837|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82988838|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988839|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82988840|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82988841|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82988842|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82988843|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
82988844|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988845|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82988846|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988847|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988848|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988849|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82988850|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
82988851|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82988852|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82988853|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82988854|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82988855|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988856|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988857|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988858|NCT03395353|Analgesics|analgesics|mesh-ancestor
82988859|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
82988860|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988861|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
82988862|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988863|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
82988864|NCT01376154|Lamivudine|lamivudine|mesh-list
82988865|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82988866|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82988867|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988868|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988869|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
82988870|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988871|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82988872|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82988873|NCT01562951|Adalimumab|adalimumab|mesh-list
82988874|NCT01562951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82988875|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82988876|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82988877|NCT01375842|Atezolizumab|atezolizumab|mesh-list
82988878|NCT01375842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82988879|NCT01375842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988880|NCT01375842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988881|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988882|NCT03682367|Gabapentin|gabapentin|mesh-list
82988883|NCT03682367|Analgesics|analgesics|mesh-ancestor
82988884|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
82988885|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82988886|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988887|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
82988888|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82988889|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988890|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988891|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988892|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82988893|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82988894|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988895|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988896|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
82988898|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82988899|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988900|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82988901|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988902|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988903|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82988904|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82988905|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
82988906|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988907|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
82988908|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82988909|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988910|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988911|NCT03394885|Paclitaxel|paclitaxel|mesh-list
82988912|NCT03394885|Bevacizumab|bevacizumab|mesh-list
82988913|NCT03394885|Carboplatin|carboplatin|mesh-list
82988914|NCT03394885|Atezolizumab|atezolizumab|mesh-list
82988915|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82988916|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988917|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
82988918|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
82988919|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
82988920|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988921|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82988922|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82988923|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82988924|NCT03394885|Growth Substances|growth substances|mesh-ancestor
82988925|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988926|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
82988927|NCT03394885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82988928|NCT01361373|Levodopa|levodopa|mesh-list
82988929|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82988930|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82988931|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
82988932|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988933|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988934|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988935|NCT03677336|Progesterone|progesterone|mesh-list
82988936|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
82988937|NCT03677336|Progestins|progestins|mesh-ancestor
82988938|NCT03677336|Hormones|hormones|mesh-ancestor
82988939|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82988958|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82988959|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82988960|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82988961|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988962|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988963|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82988964|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82988965|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82988966|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82988967|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82988968|NCT05032950|Ritonavir|ritonavir|mesh-list
82988969|NCT05032950|Nirmatrelvir|nirmatrelvir|mesh-list
82988970|NCT05032950|Midazolam|midazolam|mesh-list
82988971|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82988972|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82988973|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82988974|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82988975|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82988976|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82988977|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82988978|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82988979|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
82988980|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
82988981|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
82988982|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
82988983|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82988984|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82988985|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82988986|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82988987|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
82988988|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82988989|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82988990|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82988991|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
82988992|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82988993|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82988994|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82988995|NCT01442649|Leucovorin|leucovorin|mesh-list
82988996|NCT01442649|Folic Acid|folic acid|mesh-list
82988997|NCT01442649|Bevacizumab|bevacizumab|mesh-list
82988999|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
82989000|NCT01442649|Irinotecan|irinotecan|mesh-list
82989001|NCT01442649|Fluorouracil|fluorouracil|mesh-list
82989002|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
82989003|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82989004|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989005|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82989006|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82989007|NCT01442649|Growth Substances|growth substances|mesh-ancestor
82989008|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989009|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
82989010|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82989011|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82989012|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989013|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989014|NCT01442649|Antidotes|antidotes|mesh-ancestor
82989015|NCT01442649|Protective Agents|protective agents|mesh-ancestor
82989016|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
82989017|NCT01442649|Vitamins|vitamins|mesh-ancestor
82989018|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
82989019|NCT01442649|Hematinics|hematinics|mesh-ancestor
82989020|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
82989021|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82989022|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82989023|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
82989024|NCT04995120|Paclitaxel|paclitaxel|mesh-list
82989025|NCT04995120|Cisplatin|cisplatin|mesh-list
82989026|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82989027|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989028|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
82989029|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
82989030|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
82989031|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989032|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
82989033|NCT01376232|Glycine|glycine|mesh-list
82989034|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
82989035|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989036|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989037|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989038|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82989039|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
82989040|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82989041|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82989042|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82989043|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989044|NCT01354665|Interferons|interferons|mesh-list
82989045|NCT01354665|Interferon-beta|interferon-beta|mesh-list
82989046|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
82989047|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989048|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
82989049|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989050|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
82989051|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989052|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82989053|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82989054|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82989055|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82989056|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989057|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
82989058|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989059|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989060|NCT05008575|Fludarabine|fludarabine|mesh-list
82989061|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
82989062|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989063|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989064|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82989065|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
82989066|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989067|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989068|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82989069|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
82989070|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83464123|NCT02780024|Metformin|metformin|mesh-list
82989071|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82989072|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82989073|NCT03111108|Grazoprevir|grazoprevir|mesh-list
82989074|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
82989075|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989076|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82989077|NCT00702520|Hormones|hormones|mesh-list
82989078|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82989079|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989080|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989081|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
82989082|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82989083|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
82989084|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82989085|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82989086|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989087|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989088|NCT05198856|Thalidomide|thalidomide|mesh-list
82989089|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82989090|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
82989091|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989092|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
82989093|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82989094|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989095|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82989096|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82989097|NCT05198856|Growth Substances|growth substances|mesh-ancestor
82989098|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
82989099|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989100|NCT02876601|Defibrotide|defibrotide|mesh-list
82989101|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82989102|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82989103|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989104|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989105|NCT04059536|Aspirin|aspirin|mesh-list
82989106|NCT04059536|Heparin|heparin|mesh-list
82989107|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82989108|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82989109|NCT04059536|Analgesics|analgesics|mesh-ancestor
82989110|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
82989111|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989112|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989113|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989114|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989115|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82989116|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82989117|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989118|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989119|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82989120|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989121|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
82989122|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
82989123|NCT05711628|Carboplatin|carboplatin|mesh-list
82989124|NCT05711628|Gemcitabine|gemcitabine|mesh-list
82989125|NCT05711628|Doxorubicin|doxorubicin|mesh-list
82989126|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82989127|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
82989128|NCT05711628|Etoposide|etoposide|mesh-list
82989129|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
82989130|NCT05711628|Vinorelbine|vinorelbine|mesh-list
82989131|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
82989132|NCT05711628|Ifosfamide|ifosfamide|mesh-list
82989133|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
82989134|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82989135|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
82989136|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82989137|NCT05711628|Antibodies|antibodies|mesh-list
82989138|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
82989139|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82989140|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
82989141|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
82989142|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989143|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989144|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82989145|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
82989146|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989147|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82989148|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82989149|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82989150|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989151|NCT05711628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82989152|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82989153|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
82989154|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
82989155|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
82989156|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82989157|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
82989158|NCT05711628|Immunotoxins|immunotoxins|mesh-ancestor
82989159|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
82989160|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
82989162|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
82989163|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989164|NCT03178396|Protective Agents|protective agents|mesh-ancestor
82989165|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989166|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82989167|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
82989168|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82989169|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
82989170|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989171|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
82989172|NCT03677258|Protective Agents|protective agents|mesh-ancestor
82989173|NCT01361763|Dabigatran|dabigatran|mesh-list
82989174|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
82989175|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82989176|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
82989177|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989178|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989179|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
82989180|NCT02420782|Itraconazole|itraconazole|mesh-list
82989181|NCT02420782|Midazolam|midazolam|mesh-list
82989182|NCT02420782|Pilocarpine|pilocarpine|mesh-list
82989183|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82989184|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82989185|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82989186|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989187|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82989188|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82989189|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82989190|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82989191|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
82989192|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
82989193|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
82989194|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
82989195|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989196|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989197|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
82989198|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989199|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82989200|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82989201|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989202|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82989203|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
82989204|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989205|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82989206|NCT02420782|Miotics|miotics|mesh-ancestor
82989207|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
82989208|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989209|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82989210|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82989211|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
82989212|NCT04054193|Dexamethasone|dexamethasone|mesh-list
82989213|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
82989214|NCT04054193|Aprepitant|aprepitant|mesh-list
82989215|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
82989216|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989217|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
82989218|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
82989219|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989220|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989221|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989222|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
82989223|NCT04054193|Hormones|hormones|mesh-ancestor
82989224|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989225|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989226|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989227|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82989228|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989229|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989230|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82989231|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
82989233|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989234|NCT03682172|Glucagon|glucagon|mesh-list
82989235|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82989236|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989237|NCT03682172|Hormones|hormones|mesh-ancestor
82989238|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989239|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989240|NCT03682172|Incretins|incretins|mesh-ancestor
82989241|NCT03184480|Fluticasone|fluticasone|mesh-list
82989242|NCT03184480|Xhance|xhance|mesh-list
82989243|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989244|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82989245|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
82989246|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989247|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989248|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82989249|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
82989250|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
82989251|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82989252|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
82989253|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82989254|NCT03136107|Protective Agents|protective agents|mesh-ancestor
82989255|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989256|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
82989257|NCT03686774|Memantine|memantine|mesh-list
82989258|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82989259|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82989260|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
82989261|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989262|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989263|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989264|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82989265|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82989266|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
82989267|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82989268|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989269|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82989270|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989271|NCT01562795|Fluorometholone|fluorometholone|mesh-list
82989272|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
82989273|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
82989274|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82989275|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82989276|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
82989277|NCT01562795|Hormones|hormones|mesh-ancestor
82989278|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989279|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989280|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82989281|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
82989282|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
82989283|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82989284|NCT02424136|Antibodies|antibodies|mesh-list
82989285|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
82989286|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989287|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82989288|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
82989289|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989290|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83464133|NCT02564978|Minocycline|minocycline|mesh-list
82989291|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
82989292|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82989293|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
82989294|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989295|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989296|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
82989297|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
82989298|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
82989299|NCT02424136|Protective Agents|protective agents|mesh-ancestor
82989301|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
82989302|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989303|NCT03770676|Protective Agents|protective agents|mesh-ancestor
82989304|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989305|NCT03770676|Trace Elements|trace elements|mesh-ancestor
82989306|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
82989307|NCT01361841|Bimatoprost|bimatoprost|mesh-list
82989308|NCT01361841|Travoprost|travoprost|mesh-list
82989309|NCT01361841|Latanoprost|latanoprost|mesh-list
82989310|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82989311|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82989312|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82989313|NCT02583789|Treprostinil|treprostinil|mesh-list
82989314|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82989315|NCT01355367|Nifedipine|nifedipine|mesh-list
82989316|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82989317|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82989318|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989319|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82989320|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989321|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
82989322|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
82989323|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82989324|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82989325|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
82989326|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989327|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82989328|NCT02427880|Furosemide|furosemide|mesh-list
82989329|NCT02427880|Acetazolamide|acetazolamide|mesh-list
82989330|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82989331|NCT02427880|Diuretics|diuretics|mesh-ancestor
82989332|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
82989333|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989334|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82989335|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82989336|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989337|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82989338|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
82989339|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82989340|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989341|NCT01355445|Irinotecan|irinotecan|mesh-list
82989342|NCT01355445|Vincristine|vincristine|mesh-list
82989343|NCT01355445|Temozolomide|temozolomide|mesh-list
82989344|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82989345|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82989346|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989347|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989348|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989349|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82989350|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
82989351|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
82989352|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
82989353|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82989354|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
82989355|NCT05759442|Metformin|metformin|mesh-list
82989356|NCT05759442|Acetic Acid|acetic acid|mesh-list
82989357|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82989358|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989359|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82989360|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989361|NCT02420080|Brincidofovir|brincidofovir|mesh-list
82989362|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
82989363|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989364|NCT04483258|Sevoflurane|sevoflurane|mesh-list
82989365|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989366|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82989367|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
82989368|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
82989369|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82989370|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989371|NCT01355757|Anesthetics|anesthetics|mesh-list
82989372|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
82989373|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82989374|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989375|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
82989376|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989377|NCT02507505|Anesthetics|anesthetics|mesh-list
82989379|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989380|NCT03181360|Tenecteplase|tenecteplase|mesh-list
82989381|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82989382|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82989383|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989384|NCT04275531|Anesthetics|anesthetics|mesh-list
82989385|NCT04275531|Propofol|propofol|mesh-list
82989386|NCT04275531|Sevoflurane|sevoflurane|mesh-list
82989387|NCT04275531|Isoflurane|isoflurane|mesh-list
82989388|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82989389|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989390|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82989391|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82989392|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
82989393|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989394|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82989395|NCT03689712|Manganese|manganese|mesh-list
82989396|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
82989397|NCT03689712|Trace Elements|trace elements|mesh-ancestor
82989398|NCT03689712|Micronutrients|micronutrients|mesh-ancestor
82989399|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989400|NCT03689712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82989401|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
82989402|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989403|NCT03689712|Protective Agents|protective agents|mesh-ancestor
82989404|NCT01361997|Ethanol|ethanol|mesh-list
82989405|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
82989406|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82989407|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989408|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82989409|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989410|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
82989411|NCT04750824|Afatinib|afatinib|mesh-list
82989412|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989413|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82989414|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989415|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989416|NCT03180970|Lugol's solution|lugol's solution|mesh-list
82989417|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82989418|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
82989419|NCT03180970|Coagulants|coagulants|mesh-ancestor
82989420|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
82989421|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
82989422|NCT03631446|Citric Acid|citric acid|mesh-list
82989423|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
82989424|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
82989425|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82989426|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
82989427|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
82989428|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989429|NCT03631446|Cathartics|cathartics|mesh-ancestor
82989430|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989431|NCT03631446|Antacids|antacids|mesh-ancestor
82989432|NCT01362153|Golimumab|golimumab|mesh-list
83464147|NCT00001864|Atropine|atropine|mesh-list
82989433|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82989434|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82989435|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989436|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82989437|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
82989438|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989439|NCT03184324|Esomeprazole|esomeprazole|mesh-list
82989440|NCT03184324|Fexuprazan|fexuprazan|mesh-list
82989441|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82989442|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989443|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82989444|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989445|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989446|NCT02427334|Dienogest|dienogest|mesh-list
82989447|NCT02427334|Fluoxetine|fluoxetine|mesh-list
82989448|NCT02427334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82989449|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82989450|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82989451|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989452|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989453|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
82989454|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989455|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82989456|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
82989458|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82989459|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82989460|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989461|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82989462|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
82989463|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82989464|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82989465|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82989466|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82989467|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82989468|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
82989469|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989470|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989471|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989472|NCT03620253|Modafinil|modafinil|mesh-list
82989473|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82989474|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989475|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82989476|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82989477|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82989478|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989479|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
82989480|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82989481|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82989482|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
82989483|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989484|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989485|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82989486|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
82989487|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
82989488|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82989489|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
82989490|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989491|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989492|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82989493|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82989494|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82989495|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
82989496|NCT01358253|Cytarabine|cytarabine|mesh-list
82989497|NCT01358253|Dexamethasone|dexamethasone|mesh-list
82989498|NCT01358253|Prednisone|prednisone|mesh-list
82989499|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
82989500|NCT01358253|Rituximab|rituximab|mesh-list
82989501|NCT01358253|Doxorubicin|doxorubicin|mesh-list
82989502|NCT01358253|Methotrexate|methotrexate|mesh-list
82989503|NCT01358253|Vincristine|vincristine|mesh-list
82989504|NCT01358253|Asparaginase|asparaginase|mesh-list
82989505|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
83464149|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82989506|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82989507|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
82989508|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989509|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989510|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82989511|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
82989512|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989513|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989514|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82989515|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82989516|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989517|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
82989518|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
82989519|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989520|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989521|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
82989522|NCT01358253|Hormones|hormones|mesh-ancestor
82989523|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989524|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989525|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82989526|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82989528|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989529|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82989530|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
82989531|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82989532|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82989533|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
82989534|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
82989535|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82989536|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82989537|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
82989538|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989539|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82989540|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
82989541|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
82989542|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
82989544|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
82989545|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989546|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82989547|NCT03180346|Laxatives|laxatives|mesh-ancestor
82989548|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989549|NCT01356225|Ketorolac|ketorolac|mesh-list
82989550|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82989551|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82989552|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82989553|NCT01356225|Analgesics|analgesics|mesh-ancestor
82989554|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
82989555|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989556|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989557|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989558|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989559|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82989560|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989561|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989562|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
82989563|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82989564|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82989565|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989566|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
82989567|NCT02427412|Coagulants|coagulants|mesh-ancestor
82989568|NCT01356303|Docetaxel|docetaxel|mesh-list
82989569|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989570|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
82989571|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
82989572|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
82989573|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989574|NCT02220309|Pramipexole|pramipexole|mesh-list
82989575|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
82989576|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989577|NCT02220309|Protective Agents|protective agents|mesh-ancestor
82989578|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989579|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82989580|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82989581|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
82989582|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
82989583|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989584|NCT02419534|Diltiazem|diltiazem|mesh-list
82989585|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82989586|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82989587|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82989588|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989589|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82989590|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989591|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
82989592|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
82989593|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
82989594|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989595|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82989596|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
82989597|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989598|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989599|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82989600|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82989601|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82989602|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
82989604|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82989605|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
82989606|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82989607|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82989608|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82989609|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
82989610|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989611|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989612|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989613|NCT02423590|Carboplatin|carboplatin|mesh-list
82989614|NCT02423590|Gemcitabine|gemcitabine|mesh-list
82989615|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989616|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82989617|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
82989618|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989619|NCT01362309|Cycloserine|cycloserine|mesh-list
82989620|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82989621|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989622|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82989623|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
82989624|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82989625|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
82989626|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989627|NCT03710863|Vorolanib|vorolanib|mesh-list
82989628|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82989629|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989630|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989631|NCT03178084|Lamivudine|lamivudine|mesh-list
82989632|NCT03178084|Zidovudine|zidovudine|mesh-list
82989633|NCT03178084|Efavirenz|efavirenz|mesh-list
82989634|NCT03178084|Maraviroc|maraviroc|mesh-list
82989635|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82989636|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82989637|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989638|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989639|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
82989640|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989641|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82989642|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82989643|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
82989644|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83464156|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
82989645|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82989646|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82989647|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82989648|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82989649|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82989650|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82989651|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82989652|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
82989653|NCT01356381|Vildagliptin|vildagliptin|mesh-list
82989654|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82989655|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989656|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82989657|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
82989658|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989659|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989660|NCT03117166|Lidocaine|lidocaine|mesh-list
82989661|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
82989662|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
82989663|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82989664|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989665|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
82989666|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989667|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82989668|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82989669|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82989670|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82989671|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989672|NCT03302286|Mannitol|mannitol|mesh-list
82989673|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82989674|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
82989675|NCT03302286|Diuretics|diuretics|mesh-ancestor
82989676|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
82989677|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989678|NCT01356615|Heparin|heparin|mesh-list
82989679|NCT01356615|Calcium heparin|calcium heparin|mesh-list
82989680|NCT01356615|Enoxaparin|enoxaparin|mesh-list
82989681|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82989682|NCT01356615|Tinzaparin|tinzaparin|mesh-list
82989683|NCT01356615|Dalteparin|dalteparin|mesh-list
82989684|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
82989685|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
82989686|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82989687|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82989688|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989689|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
82989690|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
82989691|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82989692|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82989693|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989694|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989695|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989696|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989697|NCT04583592|Gabexate|gabexate|mesh-list
82989698|NCT04583592|Camostat|camostat|mesh-list
82989699|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
82989700|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989701|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989702|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82989703|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82989704|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
82989705|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
82989706|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
82989707|NCT02418988|Estrogens|estrogens|mesh-ancestor
82989708|NCT02418988|Hormones|hormones|mesh-ancestor
82989709|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989710|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989711|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989712|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989713|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
82989714|NCT05005182|Luspatercept|luspatercept|mesh-list
83464163|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
82989715|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
82989716|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989717|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
82989718|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989719|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989720|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82989721|NCT05005182|Hematinics|hematinics|mesh-ancestor
82989722|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
82989723|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989724|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
82989725|NCT01356927|Etonogestrel|etonogestrel|mesh-list
82989726|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82989727|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
82989728|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82989729|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989730|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82989731|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82989732|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989733|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989734|NCT03439670|Prednisone|prednisone|mesh-list
82989735|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989736|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
82989737|NCT03439670|Hormones|hormones|mesh-ancestor
82989738|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989739|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989740|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989741|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989743|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
82989744|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
82989745|NCT02930343|Prednisolone|prednisolone|mesh-list
82989746|NCT02930343|Methotrexate|methotrexate|mesh-list
82989747|NCT02930343|Leflunomide|leflunomide|mesh-list
82989748|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
82989749|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82989750|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
82989751|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82989752|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989753|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82989754|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
82989755|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989756|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989757|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
82989758|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989759|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82989760|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82989761|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
82989762|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989763|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82989764|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989765|NCT02930343|Hormones|hormones|mesh-ancestor
82989766|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989767|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82989768|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989769|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989770|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
82989771|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82989772|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82989773|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989774|NCT02930343|Hematinics|hematinics|mesh-ancestor
82989775|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
82989776|NCT02930343|Vitamins|vitamins|mesh-ancestor
82989777|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
82989778|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82989779|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82989780|NCT02930343|Analgesics|analgesics|mesh-ancestor
82989781|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
82989782|NCT03686618|Secretin|secretin|mesh-list
82989783|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989784|NCT03686618|Hormones|hormones|mesh-ancestor
82989785|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989786|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989787|NCT02426866|Efavirenz|efavirenz|mesh-list
82989788|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82989789|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82989790|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989791|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989792|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
82989793|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82989794|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82989795|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82989796|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82989797|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82989798|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82989799|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82989800|NCT02423824|Liraglutide|liraglutide|mesh-list
82989801|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82989802|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989803|NCT02423824|Incretins|incretins|mesh-ancestor
82989804|NCT02423824|Hormones|hormones|mesh-ancestor
82989805|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989806|NCT01012167|Galantamine|galantamine|mesh-list
82989807|NCT01012167|Oxytocin|oxytocin|mesh-list
82989808|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
82989809|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82989810|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989811|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82989813|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989814|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
82989815|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989816|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82989817|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
82989818|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989819|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
82989820|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
82989821|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989822|NCT05189067|Paclitaxel|paclitaxel|mesh-list
82989823|NCT05189067|Docetaxel|docetaxel|mesh-list
82989824|NCT05189067|Trastuzumab|trastuzumab|mesh-list
82989825|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82989826|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989827|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
82989828|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
82989829|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
82989830|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989831|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82989832|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82989833|NCT02422966|Acetaminophen|acetaminophen|mesh-list
82989834|NCT02422966|Ibuprofen|ibuprofen|mesh-list
82989835|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82989836|NCT02422966|Analgesics|analgesics|mesh-ancestor
82989837|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
82989838|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989839|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989840|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
82989841|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82989842|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989843|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989844|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82989845|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989846|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989847|NCT02422888|Ticagrelor|ticagrelor|mesh-list
82989848|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82989849|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989850|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82989851|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82989852|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82989853|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
82989854|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989855|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989856|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989857|NCT03633552|Temozolomide|temozolomide|mesh-list
82989858|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82989859|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
82989860|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989861|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989862|NCT05760456|Metformin|metformin|mesh-list
82989863|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82989864|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989865|NCT02418130|Inositol|inositol|mesh-list
82989866|NCT02418130|Thiamine|thiamine|mesh-list
82989867|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
82989868|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
82989869|NCT02418130|Vitamins|vitamins|mesh-ancestor
82989870|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
82989871|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989872|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
82989873|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989874|NCT03391765|Tilavonemab|tilavonemab|mesh-list
82989875|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
82989876|NCT02802228|Ifetroban|ifetroban|mesh-list
82989877|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989878|NCT02801448|Sulforaphane|sulforaphane|mesh-list
82989879|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82989880|NCT02801448|Protective Agents|protective agents|mesh-ancestor
82989881|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989882|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989883|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
82989884|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
82989885|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82989886|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989887|NCT03674177|Vaccines|vaccines|mesh-list
82989888|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
82989889|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989890|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
82989891|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989892|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
82989893|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989894|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989895|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82989896|NCT02417896|Spironolactone|spironolactone|mesh-list
82989897|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82989898|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
82989899|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989900|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989901|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82989902|NCT02417896|Diuretics|diuretics|mesh-ancestor
82989903|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
82989904|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
82989905|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82989906|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989907|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
82989908|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82989909|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
82989910|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82989911|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
82989912|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82989913|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82989914|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
82989915|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989916|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
82989917|NCT03116776|Protective Agents|protective agents|mesh-ancestor
82989918|NCT02505204|Clonidine|clonidine|mesh-list
82989919|NCT02505204|Analgesics|analgesics|mesh-ancestor
82989920|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
82989921|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989922|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989923|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82989924|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
82989925|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
82989926|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82989927|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82989928|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82989929|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
82989930|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989931|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989932|NCT04351698|Montelukast|montelukast|mesh-list
82989933|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82989934|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
82989935|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82989936|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
82989937|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82989938|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989939|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82989940|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82989941|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989942|NCT01359423|Cilostazol|cilostazol|mesh-list
82989943|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82989944|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
82989945|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989946|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989947|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82989948|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
82989949|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82989950|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82989951|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989952|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989953|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
82989954|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82989955|NCT01359423|Protective Agents|protective agents|mesh-ancestor
82989956|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82989957|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82989958|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989960|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82989961|NCT01363089|Phenylephrine|phenylephrine|mesh-list
82989962|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
82989963|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82989964|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82989965|NCT01363089|Analgesics|analgesics|mesh-ancestor
82989966|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
82989967|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82989968|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82989969|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82989970|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82989971|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82989972|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989973|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82989974|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82989975|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82989976|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
82989977|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82989978|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
82989979|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
82989980|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
82989981|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82989982|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
82989983|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82989985|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82989986|NCT01363089|Protective Agents|protective agents|mesh-ancestor
82989987|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82989988|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82989989|NCT03361748|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
82989990|NCT03361748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82989991|NCT03361748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989992|NCT03681548|Doxorubicin|doxorubicin|mesh-list
82989993|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82989994|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82989995|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82989996|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82989997|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82989998|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82989999|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990000|NCT02417506|Ibuprofen|ibuprofen|mesh-list
83464179|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990001|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82990002|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82990003|NCT02417506|Analgesics|analgesics|mesh-ancestor
82990004|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
82990005|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990006|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990007|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990008|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990009|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82990010|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990011|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990012|NCT05188911|Prednisone|prednisone|mesh-list
82990013|NCT05188911|Androgens|androgens|mesh-list
82990014|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990015|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
82990016|NCT05188911|Hormones|hormones|mesh-ancestor
82990017|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990018|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990019|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82990020|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990021|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82990022|NCT03676946|Antibodies|antibodies|mesh-list
82990023|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
82990024|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82990025|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
82990026|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990027|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990028|NCT01363167|Vitamin D|vitamin d|mesh-list
82990029|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
82990030|NCT01363167|Vitamins|vitamins|mesh-ancestor
82990031|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
82990032|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990033|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82990034|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82990035|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
82990036|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
82990037|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990038|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990039|NCT02422654|Eliglustat|eliglustat|mesh-list
82990040|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990041|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990042|NCT05188833|Paroxetine|paroxetine|mesh-list
82990043|NCT05188833|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82990044|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82990045|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990046|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990047|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990048|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
82990049|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990050|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82990051|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
82990052|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82990053|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82990054|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82990055|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990056|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
82990058|NCT02426164|Morphine|morphine|mesh-list
82990059|NCT02426164|Bupivacaine|bupivacaine|mesh-list
82990060|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
82990061|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
82990062|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990063|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990064|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
82990065|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990066|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82990067|NCT02426164|Narcotics|narcotics|mesh-ancestor
82990068|NCT02426164|Analgesics|analgesics|mesh-ancestor
82990069|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990070|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
82990071|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
82990072|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990073|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
82990074|NCT02426164|Hormones|hormones|mesh-ancestor
82990075|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990076|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82990077|NCT02426164|Protective Agents|protective agents|mesh-ancestor
82990078|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82990079|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82990080|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
82990081|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990082|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990083|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82990084|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82990085|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82990086|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
82990087|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
82990088|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
82990089|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82990090|NCT03745157|Insulin|insulin|mesh-list
82990091|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
82990092|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82990093|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990094|NCT02426008|Mitogens|mitogens|mesh-list
82990095|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
82990096|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990097|NCT04050371|Tenofovir|tenofovir|mesh-list
82990098|NCT04050371|Emtricitabine|emtricitabine|mesh-list
82990099|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
82990100|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990101|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82990102|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82990103|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990104|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990105|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82990106|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82990107|NCT04447287|Buprenorphine|buprenorphine|mesh-list
82990108|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
82990109|NCT04447287|ASP8062|asp8062|mesh-list
82990110|NCT04447287|Naloxone|naloxone|mesh-list
82990111|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82990112|NCT04447287|Narcotics|narcotics|mesh-ancestor
82990113|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990114|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990115|NCT04447287|Analgesics|analgesics|mesh-ancestor
82990116|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
82990117|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990118|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82990119|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
82990120|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
82990121|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990122|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990123|NCT01879319|Evolocumab|evolocumab|mesh-list
82990124|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82990125|NCT01879319|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82990127|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82990128|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
82990129|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990130|NCT01879319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82990131|NCT01879319|Protease Inhibitors|protease inhibitors|mesh-ancestor
82990132|NCT01879319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990133|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82990134|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
82990135|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990136|NCT04165122|Valacyclovir|valacyclovir|mesh-list
82990137|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
82990138|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990139|NCT02422030|Atorvastatin|atorvastatin|mesh-list
82990140|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
82990141|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82990142|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82990143|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
82990144|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990145|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82990146|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82990147|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990148|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
82990149|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990150|NCT01365897|Modafinil|modafinil|mesh-list
82990151|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82990152|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990153|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
82990154|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82990155|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82990156|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990157|NCT02422108|Denosumab|denosumab|mesh-list
82990158|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82990159|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990160|NCT01359657|Dexamethasone|dexamethasone|mesh-list
82990161|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
82990162|NCT01359657|Lenalidomide|lenalidomide|mesh-list
82990163|NCT01359657|Bortezomib|bortezomib|mesh-list
82990164|NCT01359657|BB 1101|bb 1101|mesh-list
82990165|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82990166|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990167|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
82990168|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
82990169|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990170|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990171|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990172|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
82990173|NCT01359657|Hormones|hormones|mesh-ancestor
82990174|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990175|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82990176|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990177|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
82990178|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990179|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990180|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
82990181|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82990182|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82990183|NCT01359657|Growth Substances|growth substances|mesh-ancestor
82990184|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
82990185|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82990186|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
82990187|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82990188|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82990189|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
82990190|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990191|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
82990192|NCT02417116|Protective Agents|protective agents|mesh-ancestor
82990193|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
82990194|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
82990195|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
82990196|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990197|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990198|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990199|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82990200|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82990201|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990202|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82990203|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82990204|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
82990205|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990206|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990208|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
82990209|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82990210|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83464196|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82990211|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990212|NCT03177850|Diuretics|diuretics|mesh-ancestor
82990213|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
82990214|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990215|NCT03102918|Cannabidiol|cannabidiol|mesh-list
82990216|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
82990217|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
82990218|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82990219|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82990220|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82990221|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990222|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990223|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
82990224|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990225|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990226|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82990227|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990228|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82990229|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
82990230|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82990231|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
82990232|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82990233|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990234|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82990235|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82990236|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990237|NCT03177538|Menotropins|menotropins|mesh-list
82990238|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82990239|NCT03177538|Hormones|hormones|mesh-ancestor
82990240|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990241|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990242|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82990243|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
82990244|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82990245|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
82990246|NCT01363323|Naltrexone|naltrexone|mesh-list
82990247|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
82990248|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82990249|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990250|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82990251|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83464200|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83464201|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
83464202|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464203|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464204|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83464205|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83464206|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
83464207|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
83464208|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464209|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990252|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483186|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82990253|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990254|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990255|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990256|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82990257|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
82990258|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990259|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82990260|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
82990261|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
82990262|NCT03106948|Penicillamine|penicillamine|mesh-list
82990263|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
82990264|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990265|NCT03106948|Protective Agents|protective agents|mesh-ancestor
82990266|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990267|NCT03106948|Vitamins|vitamins|mesh-ancestor
82990268|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
82990269|NCT03106948|Antidotes|antidotes|mesh-ancestor
82990270|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
82990271|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
82990272|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990273|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
82990274|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82990275|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990282|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
82990283|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990284|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990285|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990286|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990287|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82990288|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82990289|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990290|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990291|NCT01363557|Gefitinib|gefitinib|mesh-list
82990292|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990293|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82990294|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990295|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990296|NCT01346475|Valacyclovir|valacyclovir|mesh-list
82990297|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
82990298|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990299|NCT01338636|Ambrisentan|ambrisentan|mesh-list
82990300|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82990301|NCT02416258|Betamethasone|betamethasone|mesh-list
82990302|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
82990303|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
82990304|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
82990305|NCT02416258|Calcipotriene|calcipotriene|mesh-list
82990306|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
82990307|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990308|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
82990309|NCT02416258|Hormones|hormones|mesh-ancestor
82990310|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990311|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990312|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82990313|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
82990314|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
82990315|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
82990316|NCT02410720|Cathartics|cathartics|mesh-ancestor
82990317|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990318|NCT02416570|Clarithromycin|clarithromycin|mesh-list
82990319|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82990320|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990321|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82990322|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990323|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990324|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82990325|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82990326|NCT05328336|Paclitaxel|paclitaxel|mesh-list
82990327|NCT05328336|Tislelizumab|tislelizumab|mesh-list
82990328|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82990329|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990330|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
82990331|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
82990332|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
82990333|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83521630|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
82990334|NCT05328336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82990336|NCT02873754|Nicotine|nicotine|mesh-list
82990337|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82990338|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
82990339|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990340|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990341|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82990342|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82990343|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
82990344|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990345|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990346|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82990348|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82990349|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82990350|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82990351|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990352|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
82990353|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82990354|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82990355|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990356|NCT03669614|Gallium citrate|gallium citrate|mesh-list
82990357|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990358|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82990359|NCT05200260|Niraparib|niraparib|mesh-list
82990360|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
82990361|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990362|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990363|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990364|NCT02416804|Buprenorphine|buprenorphine|mesh-list
82990365|NCT02416804|Tramadol|tramadol|mesh-list
82990366|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82990367|NCT02416804|Narcotics|narcotics|mesh-ancestor
82990368|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990369|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990370|NCT02416804|Analgesics|analgesics|mesh-ancestor
82990371|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
82990372|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990373|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82990374|NCT04792320|Charcoal|charcoal|mesh-list
82990375|NCT04792320|Antidotes|antidotes|mesh-ancestor
82990376|NCT04792320|Protective Agents|protective agents|mesh-ancestor
82990377|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990378|NCT03176758|Anesthetics|anesthetics|mesh-list
82990379|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
82990380|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990381|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990382|NCT03177070|Methylene Blue|methylene blue|mesh-list
82990383|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990384|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990385|NCT03680612|Cefepime|cefepime|mesh-list
82990386|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
82990387|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82990388|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990389|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82990390|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990391|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990392|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
83464216|NCT03252600|Growth Substances|growth substances|mesh-ancestor
82990393|NCT02410096|Miotics|miotics|mesh-ancestor
82990394|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
82990395|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990396|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990397|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82990398|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
82990399|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
82990400|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
82990401|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82990402|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
82990403|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990404|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990405|NCT04046939|Pramipexole|pramipexole|mesh-list
82990406|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
82990407|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990408|NCT04046939|Protective Agents|protective agents|mesh-ancestor
82990409|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990410|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82990411|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82990412|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
82990413|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
82990414|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990415|NCT05188131|Diclofenac|diclofenac|mesh-list
82990416|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82990417|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82990418|NCT05188131|Analgesics|analgesics|mesh-ancestor
82990431|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990432|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990434|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82990435|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82990436|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82990437|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82990438|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82990439|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
82990440|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990441|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990442|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990443|NCT02409862|Oxytocin|oxytocin|mesh-list
82990444|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
82990445|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82990446|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990447|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
82990448|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
82990449|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82990450|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82990451|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990452|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990453|NCT01360671|Urological Agents|urological agents|mesh-ancestor
82990466|NCT02955797|Vaccines|vaccines|mesh-list
82990467|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
82990468|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990469|NCT03680378|Cefepime|cefepime|mesh-list
82990470|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82990471|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990472|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82990473|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
82990474|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82990475|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82990476|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
82990477|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990478|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990479|NCT05418348|Nimodipine|nimodipine|mesh-list
82990480|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82990481|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82990482|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990483|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990484|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82990485|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990486|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
82990487|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
82990488|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82990489|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990490|NCT03010176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82990491|NCT03010176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990492|NCT03176524|Glucagon|glucagon|mesh-list
82990493|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
82990494|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990495|NCT03176524|Hormones|hormones|mesh-ancestor
82990496|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990497|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990498|NCT03176524|Incretins|incretins|mesh-ancestor
82990499|NCT03676088|Mitogens|mitogens|mesh-list
82990500|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
82990501|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990502|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
82990503|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82990504|NCT02414464|Calcium|calcium|mesh-list
82990505|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82990506|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990507|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82990508|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82990509|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990511|NCT03226418|Azacitidine|azacitidine|mesh-list
82990512|NCT03226418|Decitabine|decitabine|mesh-list
82990513|NCT03226418|Daunorubicin|daunorubicin|mesh-list
82990514|NCT03226418|Venetoclax|venetoclax|mesh-list
82990515|NCT03226418|Idarubicin|idarubicin|mesh-list
82990516|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82990517|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
82990518|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990519|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990520|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
82990521|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990522|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82990523|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
82990524|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990525|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990526|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82990527|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82990528|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82990529|NCT04039503|Tirzepatide|tirzepatide|mesh-list
82990530|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82990531|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990532|NCT04039503|Incretins|incretins|mesh-ancestor
82990533|NCT04039503|Hormones|hormones|mesh-ancestor
82990534|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990535|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
82990536|NCT05418114|Analgesics|analgesics|mesh-ancestor
82990537|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
82990538|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990539|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990540|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
82990541|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990542|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82990543|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
82990544|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82990545|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990546|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990547|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82990548|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
82990549|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82990550|NCT05528952|Bevacizumab|bevacizumab|mesh-list
82990551|NCT05528952|Atezolizumab|atezolizumab|mesh-list
82990552|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82990553|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990554|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82990555|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82990556|NCT05528952|Growth Substances|growth substances|mesh-ancestor
82990557|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990558|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
83464232|NCT00000916|Lamivudine|lamivudine|mesh-list
82990559|NCT05528952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82990560|NCT05528952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990561|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
82990562|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82990563|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
82990564|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82990565|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990566|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82990567|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82990568|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82990569|NCT03672812|Liraglutide|liraglutide|mesh-list
82990570|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82990571|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990572|NCT03672812|Incretins|incretins|mesh-ancestor
82990573|NCT03672812|Hormones|hormones|mesh-ancestor
82990574|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990575|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
82990576|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990577|NCT05029726|Clonidine|clonidine|mesh-list
82990578|NCT05029726|Epinephrine|epinephrine|mesh-list
82990579|NCT05029726|Bupivacaine|bupivacaine|mesh-list
82990580|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
82990581|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
82990582|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990583|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990584|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
82990585|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990586|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82990587|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82990588|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
82990589|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990590|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990591|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82990592|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82990593|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
82990594|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82990595|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
82990596|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
82990597|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
82990598|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82990599|NCT05029726|Analgesics|analgesics|mesh-ancestor
82990600|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82990601|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
82990602|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82990603|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
82990604|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82990605|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990606|NCT05007652|Plerixafor|plerixafor|mesh-list
82990607|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82990608|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82990609|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
82990610|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990611|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
82990612|NCT03632772|Mirabegron|mirabegron|mesh-list
82990613|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82990614|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82990615|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
82990616|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990617|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990618|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990619|NCT03632772|Urological Agents|urological agents|mesh-ancestor
82990620|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82990621|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82990622|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82990623|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
82990624|NCT01360749|Lidocaine|lidocaine|mesh-list
82990625|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
82990626|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
82990627|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990628|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990629|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
82990630|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990631|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82990632|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82990633|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82990634|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990635|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990636|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
82990637|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82990638|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82990639|NCT01367301|Paclitaxel|paclitaxel|mesh-list
82990640|NCT01367301|Carboplatin|carboplatin|mesh-list
82990641|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82990643|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
82990644|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
82990645|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
82990646|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990647|NCT03675854|Cefazolin|cefazolin|mesh-list
82990648|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82990649|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990650|NCT01360827|Cisplatin|cisplatin|mesh-list
82990651|NCT01360827|Fluorouracil|fluorouracil|mesh-list
82990652|NCT01360827|Cetuximab|cetuximab|mesh-list
82990653|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990654|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
82990655|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990656|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82990657|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82990658|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
82990659|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990660|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82990661|NCT03171610|Fentanyl|fentanyl|mesh-list
82990662|NCT03171610|Sufentanil|sufentanil|mesh-list
82990663|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82990664|NCT03171610|Narcotics|narcotics|mesh-ancestor
82990665|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990666|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990667|NCT03171610|Analgesics|analgesics|mesh-ancestor
82990668|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
82990669|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990670|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82990671|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82990672|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
82990673|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
82990674|NCT01364181|Udenafil|udenafil|mesh-list
82990675|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82990676|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82990677|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990678|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990679|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
82990680|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82990681|NCT03679442|Antidotes|antidotes|mesh-list
82990682|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990683|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
82990684|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990685|NCT03679442|Expectorants|expectorants|mesh-ancestor
82990686|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
82990687|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82990688|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
82990689|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990690|NCT03679442|Protective Agents|protective agents|mesh-ancestor
82990691|NCT01367535|Naltrexone|naltrexone|mesh-list
82990692|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
82990693|NCT01367535|Paroxetine|paroxetine|mesh-list
82990694|NCT01367535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82990695|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82990696|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990697|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990698|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990699|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
82990700|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990701|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82990702|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
82990703|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82990704|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82990705|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82990706|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990707|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82990708|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
82990709|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990710|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82990711|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
82990712|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
82990713|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82990714|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82990715|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990717|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990718|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990719|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
82990720|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82990721|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990722|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
82990723|NCT04482712|Sirolimus|sirolimus|mesh-list
82990724|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82990725|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990726|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82990727|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990728|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
82990729|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82990730|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
82990731|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990732|NCT02409004|Rifampin|rifampin|mesh-list
82990733|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82990734|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
82990735|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82990736|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990737|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
82990738|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82990739|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990740|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990741|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82990742|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82990743|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82990744|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82990745|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82990746|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82990747|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
82990748|NCT03131895|Lansoprazole|lansoprazole|mesh-list
82990749|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82990750|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990751|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82990752|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990753|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990754|NCT04039919|Padsevonil|padsevonil|mesh-list
82990755|NCT04039919|Anticonvulsants|anticonvulsants|mesh-ancestor
82990756|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
82990757|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82990758|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990759|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
82990760|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990761|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
82990762|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82990763|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990764|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82990765|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990766|NCT01364415|Pasireotide|pasireotide|mesh-list
82990767|NCT01364415|Hormones|hormones|mesh-ancestor
82990768|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990769|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990770|NCT03176446|Anesthetics|anesthetics|mesh-list
82990771|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
82990772|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990773|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990774|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
82990775|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990776|NCT03176212|Milk fat globule|milk fat globule|mesh-list
82990777|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990778|NCT04035473|Paclitaxel|paclitaxel|mesh-list
82990779|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82990780|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990781|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
82990782|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
82990783|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
82990784|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990785|NCT02408926|Vaccines|vaccines|mesh-list
82990786|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
82990787|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990788|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
82990789|NCT00704158|Immunoconjugates|immunoconjugates|mesh-ancestor
82990790|NCT00704158|Immunologic Factors|immunologic factors|mesh-ancestor
82990791|NCT00704158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990792|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82990793|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990794|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
82990795|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82990796|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82990797|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990798|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
82990799|NCT03738527|Coagulants|coagulants|mesh-ancestor
82990801|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82990802|NCT02915978|Narcotics|narcotics|mesh-ancestor
82990803|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990804|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990805|NCT02915978|Analgesics|analgesics|mesh-ancestor
82990806|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
82990807|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990808|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82990809|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82990810|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
82990811|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
82990812|NCT02412904|Menotropins|menotropins|mesh-list
82990813|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82990814|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
82990815|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82990816|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990817|NCT02408302|Midazolam|midazolam|mesh-list
82990818|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82990819|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82990820|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990821|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990822|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82990823|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82990824|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82990825|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82990826|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
82990827|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
82990828|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
82990829|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
82990830|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990831|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990832|NCT02408146|Celecoxib|celecoxib|mesh-list
82990833|NCT02408146|Parecoxib|parecoxib|mesh-list
82990834|NCT02408146|Fentanyl|fentanyl|mesh-list
82990835|NCT02408146|Ondansetron|ondansetron|mesh-list
82990836|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82990837|NCT02408146|Narcotics|narcotics|mesh-ancestor
82990838|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990839|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990840|NCT02408146|Analgesics|analgesics|mesh-ancestor
82990841|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
82990842|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990843|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82990844|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82990845|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
82990846|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
82990847|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990848|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82990849|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82990850|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990851|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990852|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82990853|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82990854|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82990855|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
82990856|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
82990857|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990858|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
82990859|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
82990860|NCT02408146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82990861|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82990862|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
82990863|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82990864|NCT03175666|Leucovorin|leucovorin|mesh-list
82990865|NCT03175666|Paclitaxel|paclitaxel|mesh-list
82990866|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
82990867|NCT03175666|Bevacizumab|bevacizumab|mesh-list
82990883|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82990884|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82990885|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82990886|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82990887|NCT03175666|Growth Substances|growth substances|mesh-ancestor
82990888|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
82990889|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
82990890|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82990891|NCT03175666|Antidotes|antidotes|mesh-ancestor
82990892|NCT03175666|Protective Agents|protective agents|mesh-ancestor
82990893|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
82990894|NCT03175666|Vitamins|vitamins|mesh-ancestor
82990895|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
82990896|NCT03101358|Paclitaxel|paclitaxel|mesh-list
82990897|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82990898|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82990899|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990900|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
82990901|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
82990902|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
82990903|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990904|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
82990905|NCT03171220|Fludarabine|fludarabine|mesh-list
82990906|NCT03171220|Interleukin-2|interleukin-2|mesh-list
82990907|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82990908|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
82990909|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990910|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82990911|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82990912|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
82990913|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990914|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990915|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82990916|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82990917|NCT03171220|Analgesics|analgesics|mesh-ancestor
82990918|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
82990919|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990920|NCT04853004|Antibodies|antibodies|mesh-list
82990921|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
82990922|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990923|NCT03116542|Alovudine|alovudine|mesh-list
82990924|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
82990925|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990926|NCT03170596|Tazarotene|tazarotene|mesh-list
82990927|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
82990928|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
82990943|NCT03173326|Anesthetics|anesthetics|mesh-list
82990944|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990946|NCT03172858|Oxytocin|oxytocin|mesh-list
82990947|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
82990948|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82990949|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990950|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
82990951|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82990952|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82990953|NCT02403856|Prednisolone|prednisolone|mesh-list
82990954|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
82990955|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82990956|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
82990957|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82990958|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
82990959|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
82990960|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990961|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990962|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82990963|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
82990964|NCT02403856|Hormones|hormones|mesh-ancestor
82990965|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82990966|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82990967|NCT02403856|Protective Agents|protective agents|mesh-ancestor
82990968|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82990969|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990970|NCT03170284|Bevacizumab|bevacizumab|mesh-list
82990971|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82990972|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990973|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82990974|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82990975|NCT03170284|Growth Substances|growth substances|mesh-ancestor
82990976|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990977|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
82990978|NCT02407912|Cisplatin|cisplatin|mesh-list
82990979|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82990980|NCT03170050|Lidocaine|lidocaine|mesh-list
82990981|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
82990982|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
82990983|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82990984|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82990985|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
82990986|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82990987|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82990988|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82990989|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82990990|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82990991|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82990992|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82990993|NCT02407834|Eusol|eusol|mesh-list
82990994|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
82990995|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82990996|NCT03169738|Leucovorin|leucovorin|mesh-list
82990997|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
82990998|NCT03169738|Bevacizumab|bevacizumab|mesh-list
82990999|NCT03169738|Fluorouracil|fluorouracil|mesh-list
82991000|NCT03169738|Capecitabine|capecitabine|mesh-list
82991001|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
82991002|NCT03169738|Nivolumab|nivolumab|mesh-list
82991003|NCT03169738|Fulvestrant|fulvestrant|mesh-list
82991004|NCT03169738|Avelumab|avelumab|mesh-list
82991005|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991006|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991007|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82991008|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
82991009|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991010|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82991011|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82991012|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
82991013|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82991014|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991015|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82991016|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82991017|NCT03169738|Growth Substances|growth substances|mesh-ancestor
82991018|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
82991019|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
83464254|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82991020|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82991021|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82991022|NCT03169738|Antidotes|antidotes|mesh-ancestor
82991023|NCT03169738|Protective Agents|protective agents|mesh-ancestor
82991024|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
82991025|NCT03169738|Vitamins|vitamins|mesh-ancestor
82991026|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
82991027|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82991028|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82991029|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82991030|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
82991031|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991032|NCT02407600|Aprepitant|aprepitant|mesh-list
82991033|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
82991034|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
82991035|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
82991036|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991037|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991038|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82991039|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82991040|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991041|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991042|NCT02403544|Capecitabine|capecitabine|mesh-list
82991043|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
82991044|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82991045|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
82991046|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991047|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991048|NCT02411344|Pertuzumab|pertuzumab|mesh-list
82991049|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991050|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991051|NCT03657095|Beraprost|beraprost|mesh-list
82991052|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82991053|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
82991054|NCT02407366|Carboplatin|carboplatin|mesh-list
82991055|NCT02407366|Pemetrexed|pemetrexed|mesh-list
82991056|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991057|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991058|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991059|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82991060|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82991061|NCT03738137|Lidocaine|lidocaine|mesh-list
82991062|NCT03738137|Midazolam|midazolam|mesh-list
82991063|NCT03738137|Sufentanil|sufentanil|mesh-list
82991064|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
82991065|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
82991066|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991067|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991068|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
82991069|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991070|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82991071|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82991072|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82991073|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991074|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991075|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82991076|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82991077|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82991078|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82991079|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82991080|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82991081|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
82991082|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
82991083|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
82991084|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991085|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82991086|NCT03738137|Narcotics|narcotics|mesh-ancestor
82991087|NCT03738137|Analgesics|analgesics|mesh-ancestor
82991088|NCT02407210|Olmesartan|olmesartan|mesh-list
82991089|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82991090|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
82991091|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82991092|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82991093|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82991094|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991095|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
82991096|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82991097|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82991098|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991099|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
82991100|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
82991101|NCT03175042|Chrysarobin|chrysarobin|mesh-list
82991102|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82991103|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991104|NCT03175042|Analgesics|analgesics|mesh-ancestor
82991105|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
82991106|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991107|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991108|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991109|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82991110|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
82991111|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82991112|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991113|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991114|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991115|NCT03738059|Analgesics|analgesics|mesh-ancestor
82991116|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
82991117|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991118|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82991119|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82991120|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82991121|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
82991122|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991123|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991124|NCT05233462|Bupivacaine|bupivacaine|mesh-list
82991125|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
82991126|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
82991127|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991128|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991129|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
82991130|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991131|NCT02700412|Cannabidiol|cannabidiol|mesh-list
82991132|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
82991133|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
82991134|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82991135|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82991136|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82991137|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991138|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991139|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
82991140|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991141|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991142|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82991143|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991144|NCT02288832|Azithromycin|azithromycin|mesh-list
82991145|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82991146|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991147|NCT03116308|Opicapone|opicapone|mesh-list
82991148|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82991149|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991150|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991151|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82991152|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82991153|NCT03665441|Leucovorin|leucovorin|mesh-list
82991154|NCT03665441|Paclitaxel|paclitaxel|mesh-list
82991155|NCT03665441|Gemcitabine|gemcitabine|mesh-list
82991156|NCT03665441|Irinotecan|irinotecan|mesh-list
82991157|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82991158|NCT03665441|Asparaginase|asparaginase|mesh-list
82991159|NCT03665441|Eryaspase|eryaspase|mesh-list
82991160|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82991161|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464271|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
82991162|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
82991163|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
82991164|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
82991165|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991166|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82991167|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
82991168|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991169|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82991170|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82991171|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991172|NCT03665441|Antidotes|antidotes|mesh-ancestor
82991173|NCT03665441|Protective Agents|protective agents|mesh-ancestor
82991174|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
82991176|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
82991177|NCT03169660|Aflibercept|aflibercept|mesh-list
82991178|NCT03169660|Mitogens|mitogens|mesh-list
82991179|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
82991180|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
82991181|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991182|NCT03169660|Growth Substances|growth substances|mesh-ancestor
82991183|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991184|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82991185|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82991186|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
82991187|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991188|NCT02401828|Dolutegravir|dolutegravir|mesh-list
82991189|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82991190|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82991191|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991192|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991193|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82991194|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82991195|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
82991196|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991197|NCT02401594|Enoxaparin|enoxaparin|mesh-list
82991198|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
82991199|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82991200|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
82991201|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82991202|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
82991203|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991204|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991205|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
82991206|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82991207|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82991208|NCT02406508|Sorafenib|sorafenib|mesh-list
82991209|NCT02406508|Melphalan|melphalan|mesh-list
82991210|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991211|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82991212|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991213|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991214|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82991215|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
82991216|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82991217|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82991218|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
82991219|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991220|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
82991221|NCT03662789|Hematinics|hematinics|mesh-ancestor
82991222|NCT04481932|Trastuzumab|trastuzumab|mesh-list
82991223|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991224|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991225|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
82991226|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
82991227|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82991228|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82991229|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991230|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991231|NCT03169582|Urological Agents|urological agents|mesh-ancestor
82991232|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
82991233|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82991234|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82991235|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82991236|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991237|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991238|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
82991239|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991240|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991241|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82991242|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991243|NCT03169504|Fluticasone|fluticasone|mesh-list
82991245|NCT03169504|Bromides|bromides|mesh-list
82991246|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
82991247|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991249|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
82991250|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991251|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991252|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82991253|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
82991254|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
82991255|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82991256|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
82991257|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82991258|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
82991259|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991260|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991261|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
82991262|NCT03169426|Carvedilol|carvedilol|mesh-list
82991263|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
82991264|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82991265|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
82991266|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991267|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991268|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991269|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82991270|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
82991271|NCT03169426|Protective Agents|protective agents|mesh-ancestor
82991272|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82991273|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991274|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82991275|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
82991276|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82991277|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82991278|NCT03580928|Venetoclax|venetoclax|mesh-list
82991279|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
82991280|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
82991281|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991282|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991283|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
82991284|NCT03169348|Ledipasvir|ledipasvir|mesh-list
82991285|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
82991286|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
82991287|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991288|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
82991289|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82991290|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82991291|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991292|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
82991293|NCT03631355|Coagulants|coagulants|mesh-ancestor
82991294|NCT03571568|Rituximab|rituximab|mesh-list
82991295|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991296|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991297|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
82991298|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991299|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82991300|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
82991301|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82991302|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991303|NCT03679052|Clonidine|clonidine|mesh-list
82991304|NCT03679052|Mirtazapine|mirtazapine|mesh-list
82991305|NCT03679052|Analgesics|analgesics|mesh-ancestor
82991306|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
82991307|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991308|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991309|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82991310|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
82991311|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
82991312|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82991313|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82991314|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82991315|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
82991316|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991317|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991318|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
82991319|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82991320|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82991321|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
82991322|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
82991323|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82991324|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82991325|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991326|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82991327|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82991328|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82991329|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82991330|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82991331|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
82991332|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82991333|NCT03540914|Acetazolamide|acetazolamide|mesh-list
82991334|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
82991335|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82991336|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991337|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991338|NCT03540914|Diuretics|diuretics|mesh-ancestor
82991339|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
82991340|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991341|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
82991342|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
82991343|NCT03629249|Growth Substances|growth substances|mesh-ancestor
82991344|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991345|NCT03671174|Aspirin|aspirin|mesh-list
82991346|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
82991347|NCT03671174|Prednisone|prednisone|mesh-list
82991348|NCT03671174|Heparin|heparin|mesh-list
82991349|NCT03671174|Enoxaparin|enoxaparin|mesh-list
82991350|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82991351|NCT03671174|Tinzaparin|tinzaparin|mesh-list
82991352|NCT03671174|Dalteparin|dalteparin|mesh-list
82991353|NCT03671174|Nadroparin|nadroparin|mesh-list
82991354|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991355|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
82991356|NCT03671174|Hormones|hormones|mesh-ancestor
82991357|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991358|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991359|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82991360|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991361|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82991362|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991363|NCT03671174|Analgesics|analgesics|mesh-ancestor
82991364|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
82991365|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991366|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82991367|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82991368|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82991369|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991370|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82991371|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82991372|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991373|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
82991374|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
82991376|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82991377|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82991378|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991379|NCT03172234|Amantadine|amantadine|mesh-list
82991380|NCT03172234|Gabapentin|gabapentin|mesh-list
82991381|NCT03172234|Analgesics|analgesics|mesh-ancestor
82991382|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
82991383|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991384|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991385|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
82991386|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82991387|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82991388|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991389|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82991390|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82991391|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82991392|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991393|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991394|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
82991395|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82991396|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82991397|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
82991398|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991399|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
82991401|NCT03709849|Citric Acid|citric acid|mesh-list
82991402|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
82991403|NCT03709849|Clomiphene|clomiphene|mesh-list
82991404|NCT03709849|Enclomiphene|enclomiphene|mesh-list
82991405|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
82991406|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
82991407|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82991408|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
82991409|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
82991410|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991411|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82991412|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
82991413|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991414|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991415|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82991416|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
82991417|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82991418|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82991419|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82991420|NCT05343325|Paclitaxel|paclitaxel|mesh-list
82991421|NCT05343325|Cisplatin|cisplatin|mesh-list
82991422|NCT05343325|Tislelizumab|tislelizumab|mesh-list
82991423|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82991424|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82991425|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991426|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
82991427|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
82991428|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
82991429|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991430|NCT05343325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991431|NCT03349333|Folic Acid|folic acid|mesh-list
82991432|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
82991433|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
82991434|NCT03349333|Vitamins|vitamins|mesh-ancestor
82991435|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
82991436|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991437|NCT03349333|Hematinics|hematinics|mesh-ancestor
82991438|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
82991439|NCT03365791|Spartalizumab|spartalizumab|mesh-list
82991440|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82991441|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991442|NCT03365791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991443|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991444|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
82991445|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82991446|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
82991447|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
82991448|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991449|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991450|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991451|NCT03365011|Analgesics|analgesics|mesh-ancestor
82991452|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
82991453|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991454|NCT03627767|Abrocitinib|abrocitinib|mesh-list
82991455|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82991456|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991457|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991458|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82991459|NCT03732365|Cefazolin|cefazolin|mesh-list
82991460|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991461|NCT03732287|Anesthetics|anesthetics|mesh-list
82991462|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991463|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991464|NCT02142738|Paclitaxel|paclitaxel|mesh-list
82991465|NCT02142738|Carboplatin|carboplatin|mesh-list
82991466|NCT02142738|Gemcitabine|gemcitabine|mesh-list
82991467|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
82991468|NCT02142738|Pemetrexed|pemetrexed|mesh-list
82991469|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82991470|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991471|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
82991472|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
82991473|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
82991474|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991475|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82991477|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991478|NCT02142738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82991479|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991480|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82991481|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82991482|NCT03617861|Secretin|secretin|mesh-list
82991483|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82991484|NCT03617861|Hormones|hormones|mesh-ancestor
82991485|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991486|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991487|NCT03614975|Vaccines|vaccines|mesh-list
82991488|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
82991489|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991490|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
82991491|NCT03613649|Zoliflodacin|zoliflodacin|mesh-list
82991492|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82991493|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991494|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82991495|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82991496|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991497|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991498|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991499|NCT03096288|Evolocumab|evolocumab|mesh-list
82991500|NCT03096288|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82991501|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82991502|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82991503|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
82991504|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991505|NCT03096288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82991506|NCT03096288|Protease Inhibitors|protease inhibitors|mesh-ancestor
82991507|NCT03096288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991508|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82991509|NCT03731897|Lidocaine|lidocaine|mesh-list
82991510|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
82991511|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
82991512|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991513|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991514|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
82991515|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991516|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82991517|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82991518|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82991519|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991520|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991521|NCT02072148|Cisplatin|cisplatin|mesh-list
82991522|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991523|NCT04456608|Aspirin|aspirin|mesh-list
82991524|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83464294|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
82991525|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991526|NCT04456608|Analgesics|analgesics|mesh-ancestor
82991527|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
82991528|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991529|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991530|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991531|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82991532|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82991533|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82991534|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991535|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82991536|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82991537|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991538|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
82991539|NCT04450212|Vitamin K|vitamin k|mesh-list
82991540|NCT04450212|Vitamins|vitamins|mesh-ancestor
82991541|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
82991542|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991543|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82991544|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82991545|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991546|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
82991547|NCT04450212|Coagulants|coagulants|mesh-ancestor
82991548|NCT05074290|Taxane|taxane|mesh-list
82991549|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991550|NCT03095508|Menthol|menthol|mesh-list
82991552|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
82991553|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
82991554|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
82991555|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82991556|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82991557|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
82991558|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991559|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991560|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
82991561|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82991562|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991563|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991564|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82991565|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82991566|NCT03731741|Protective Agents|protective agents|mesh-ancestor
82991567|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991568|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
82991569|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82991570|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
82991571|NCT03736187|Metronidazole|metronidazole|mesh-list
82991572|NCT03736187|Cephalexin|cephalexin|mesh-list
82991573|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991574|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82991575|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82991576|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82991577|NCT03731429|Lidocaine|lidocaine|mesh-list
82991578|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
82991579|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
82991580|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991581|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991582|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
82991583|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991584|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82991585|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82991586|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82991587|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991588|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991589|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
82991590|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
82991591|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
82991592|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991593|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
82991594|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82991595|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82991596|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464297|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82991597|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
82991598|NCT03653429|Coagulants|coagulants|mesh-ancestor
82991599|NCT03731117|Furosemide|furosemide|mesh-list
82991600|NCT03731117|Diuretics|diuretics|mesh-ancestor
82991601|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
82991602|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991603|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82991604|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991605|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991606|NCT03735251|Metoprolol|metoprolol|mesh-list
82991607|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
82991608|NCT03735251|Diuretics|diuretics|mesh-list
82991609|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
82991610|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991611|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82991612|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82991613|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
82991614|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
82991615|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991616|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
82991617|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82991618|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82991619|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
82991620|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991621|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991622|NCT03098550|Nivolumab|nivolumab|mesh-list
82991623|NCT03098550|Daratumumab|daratumumab|mesh-list
82991624|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991625|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991626|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82991627|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991628|NCT03095118|Daratumumab|daratumumab|mesh-list
82991629|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991630|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
82991631|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991632|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991633|NCT04224480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82991634|NCT04224480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991635|NCT05386758|Molnupiravir|molnupiravir|mesh-list
82991636|NCT05386758|Antiviral Agents|antiviral agents|mesh-ancestor
82991637|NCT05386758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991638|NCT05013216|Poly ICLC|poly iclc|mesh-list
82991639|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
82991640|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
82991641|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991642|NCT03169114|Amikacin|amikacin|mesh-list
82991643|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82991644|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991645|NCT03115762|Bevacizumab|bevacizumab|mesh-list
82991646|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991647|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991648|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82991649|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82991650|NCT03115762|Growth Substances|growth substances|mesh-ancestor
82991651|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991652|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
82991653|NCT03168958|Methadone|methadone|mesh-list
82991654|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82991655|NCT03168958|Narcotics|narcotics|mesh-ancestor
82991656|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991657|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991658|NCT03168958|Analgesics|analgesics|mesh-ancestor
82991659|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
82991660|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991661|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
82991662|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
82991663|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
82991664|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83464305|NCT05480280|Antidotes|antidotes|mesh-ancestor
82991665|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991666|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991667|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991668|NCT03632460|Analgesics|analgesics|mesh-ancestor
82991669|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
82991670|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991671|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82991672|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82991673|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82991674|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
82991675|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991676|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991677|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
82991678|NCT05418660|Nivolumab|nivolumab|mesh-list
82991679|NCT05418660|Atezolizumab|atezolizumab|mesh-list
82991680|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991681|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991682|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82991683|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991684|NCT03364309|Ixekizumab|ixekizumab|mesh-list
82991685|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
82991686|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82991687|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82991688|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991689|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
82991690|NCT05166096|Aspirin|aspirin|mesh-list
82991691|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82991692|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991693|NCT05166096|Analgesics|analgesics|mesh-ancestor
82991694|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
82991695|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991696|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991697|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991698|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82991699|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82991700|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82991701|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991702|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82991703|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82991704|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991706|NCT03168412|Vaccines|vaccines|mesh-list
82991707|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
82991708|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991709|NCT05110638|Luliconazole|luliconazole|mesh-list
82991710|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
82991711|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991712|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
82991713|NCT03700788|Calcium|calcium|mesh-list
82991714|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82991715|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991716|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82991717|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991718|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
82991719|NCT03334903|Gabapentin|gabapentin|mesh-list
82991720|NCT03334903|Analgesics|analgesics|mesh-ancestor
82991721|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
82991722|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991723|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991724|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
82991725|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82991726|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82991727|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991728|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82991729|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82991730|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82991731|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991732|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991733|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
82991734|NCT03168100|Dexamethasone|dexamethasone|mesh-list
82991735|NCT03168100|Lenalidomide|lenalidomide|mesh-list
82991736|NCT03168100|Bortezomib|bortezomib|mesh-list
82991737|NCT03168100|Elotuzumab|elotuzumab|mesh-list
82991738|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991739|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
82991740|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
82991741|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991742|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991743|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82991744|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
82991745|NCT03168100|Hormones|hormones|mesh-ancestor
82991746|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991747|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82991748|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991749|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
82991750|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82991751|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82991752|NCT03168100|Growth Substances|growth substances|mesh-ancestor
82991753|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
82991754|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82991755|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
82991756|NCT03709381|Cosyntropin|cosyntropin|mesh-list
82991757|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
82991758|NCT03709381|Hormones|hormones|mesh-ancestor
82991759|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991760|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991761|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991762|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991763|NCT01353664|Romidepsin|romidepsin|mesh-list
82991764|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82991765|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991766|NCT01353664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82991767|NCT01353664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991768|NCT01353664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991769|NCT02395744|Paclitaxel|paclitaxel|mesh-list
82991770|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82991771|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991772|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
82991773|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
82991775|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991776|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82991777|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82991778|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991779|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
82991780|NCT03168568|Valsartan|valsartan|mesh-list
82991781|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82991782|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82991783|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82991784|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82991785|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991786|NCT02400112|Vancomycin|vancomycin|mesh-list
82991787|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82991788|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991789|NCT02694328|Olanzapine|olanzapine|mesh-list
82991790|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
82991791|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
82991792|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991793|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991794|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82991795|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82991796|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82991797|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991798|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82991799|NCT02694328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82991800|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82991801|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991802|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991803|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991804|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
82991805|NCT02395510|Vortioxetine|vortioxetine|mesh-list
83464311|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
82991806|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
82991807|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82991808|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82991809|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82991810|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991811|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991812|NCT02395510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82991813|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82991814|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991815|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991816|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991817|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
82991818|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82991819|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82991820|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82991821|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82991822|NCT02399800|Triamcinolone|triamcinolone|mesh-list
82991823|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82991824|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82991825|NCT02399800|Bupivacaine|bupivacaine|mesh-list
82991826|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82991827|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
82991828|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
82991829|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991830|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991831|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
82991832|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991833|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82991834|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
82991835|NCT02399800|Hormones|hormones|mesh-ancestor
82991836|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991837|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82991838|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
82991839|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991840|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991841|NCT02399566|Pemetrexed|pemetrexed|mesh-list
82991842|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82991843|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991844|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991845|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991846|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82991847|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82991848|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82991849|NCT03167164|Leucovorin|leucovorin|mesh-list
82991850|NCT03167164|Paclitaxel|paclitaxel|mesh-list
82991851|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
82991852|NCT03167164|Bevacizumab|bevacizumab|mesh-list
82991853|NCT03167164|Fluorouracil|fluorouracil|mesh-list
82991854|NCT03167164|Capecitabine|capecitabine|mesh-list
82991855|NCT03167164|Avelumab|avelumab|mesh-list
82991856|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82991857|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991858|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
82991859|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
82991860|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
82991861|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991862|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82991863|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
82991864|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991865|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82991866|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82991867|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
82991868|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82991869|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991870|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82991871|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82991872|NCT03167164|Growth Substances|growth substances|mesh-ancestor
82991873|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
82991874|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
82991875|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82991876|NCT03167164|Antidotes|antidotes|mesh-ancestor
82991877|NCT03167164|Protective Agents|protective agents|mesh-ancestor
82991878|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
82991879|NCT03167164|Vitamins|vitamins|mesh-ancestor
82991880|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
82991881|NCT03334747|Lumefantrine|lumefantrine|mesh-list
82991882|NCT03334747|Artemether|artemether|mesh-list
82991883|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82991884|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
82991885|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82991886|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82991887|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991888|NCT02394652|Metformin|metformin|mesh-list
82991889|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
82991890|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82991891|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991892|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82991893|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991894|NCT02394496|Fulvestrant|fulvestrant|mesh-list
82991895|NCT02394496|Lapatinib|lapatinib|mesh-list
82991896|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
82991897|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82991898|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991899|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82991900|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82991901|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
82991902|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991903|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991904|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82991905|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82991906|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991907|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82991908|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
82991909|NCT02394418|Propofol|propofol|mesh-list
82991910|NCT02394418|Sevoflurane|sevoflurane|mesh-list
82991911|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82991912|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82991913|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991914|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82991915|NCT02394418|Analgesics|analgesics|mesh-ancestor
82991916|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
82991917|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82991918|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82991919|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82991920|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82991922|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82991923|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991924|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82991925|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
82991926|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
82991927|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82991928|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82991929|NCT02693002|Norethindrone|norethindrone|mesh-list
82991930|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
82991931|NCT02693002|Estradiol|estradiol|mesh-list
82991932|NCT02693002|Estrogens|estrogens|mesh-ancestor
82991933|NCT02693002|Hormones|hormones|mesh-ancestor
82991934|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82991935|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991936|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82991937|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
82991938|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82991939|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82991940|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82991941|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82991942|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82991943|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
82991944|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82991945|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83464323|NCT00000196|Naltrexone|naltrexone|mesh-list
82991946|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991947|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
82991948|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
82991949|NCT03707509|Gemcitabine|gemcitabine|mesh-list
82991950|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991951|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82991952|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
82991953|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991954|NCT03710395|Nifedipine|nifedipine|mesh-list
82991955|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82991956|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82991957|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991958|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82991959|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991960|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
82991961|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
82991962|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82991963|NCT03093870|Capecitabine|capecitabine|mesh-list
82991964|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82991965|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
82991966|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991967|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991968|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
82991969|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
82991970|NCT02394106|Ofatumumab|ofatumumab|mesh-list
82991971|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991972|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
82991973|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
82991974|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
82991975|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82991976|NCT04793646|Expectorants|expectorants|mesh-ancestor
82991977|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
82991978|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
82991979|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
82991980|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991981|NCT04793646|Protective Agents|protective agents|mesh-ancestor
82991982|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991983|NCT04793646|Antidotes|antidotes|mesh-ancestor
82991984|NCT03607890|Nivolumab|nivolumab|mesh-list
82991985|NCT03607890|Relatlimab|relatlimab|mesh-list
82991986|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82991987|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82991988|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82991989|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82991990|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
82991991|NCT02393482|Vitamin D|vitamin d|mesh-list
82991992|NCT02393482|Leuprolide|leuprolide|mesh-list
82991993|NCT02393482|Tibolone|tibolone|mesh-list
82991994|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
82991995|NCT02393482|Hormones|hormones|mesh-list
82991996|NCT02393482|Estradiol|estradiol|mesh-list
82991998|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82991999|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992000|NCT02393482|Estrogens|estrogens|mesh-ancestor
82992001|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82992002|NCT02393482|Antacids|antacids|mesh-ancestor
82992003|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992004|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992005|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82992006|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
82992007|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82992008|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992009|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
82992010|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
82992011|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82992012|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82992013|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
82992014|NCT02393482|Vitamins|vitamins|mesh-ancestor
82992015|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
82992016|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82992017|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
82992018|NCT03346057|Rocuronium|rocuronium|mesh-list
82992019|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
82992020|NCT03346057|Neostigmine|neostigmine|mesh-list
82992021|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82992022|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82992023|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82992024|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992025|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992026|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82992027|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992028|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992029|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
82992030|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992031|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82992032|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
82992033|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82992034|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82992035|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82992036|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
82992037|NCT03166306|Bevacizumab|bevacizumab|mesh-list
82992038|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82992039|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992040|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82992041|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82992042|NCT03166306|Growth Substances|growth substances|mesh-ancestor
82992043|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992044|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
82992045|NCT02398630|Hormones|hormones|mesh-list
82992046|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992047|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992048|NCT02398552|Sunitinib|sunitinib|mesh-list
82992049|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992050|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82992051|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82992052|NCT02398552|Growth Substances|growth substances|mesh-ancestor
82992053|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992054|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
82992055|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82992056|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992057|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992058|NCT03345979|Aripiprazole|aripiprazole|mesh-list
82992059|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
82992060|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
82992061|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
82992062|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82992063|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82992064|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82992065|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992066|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992067|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
82992068|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
82992069|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992071|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82992072|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82992073|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
82992074|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82992075|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82992076|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82992077|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82992078|NCT02696434|Naltrexone|naltrexone|mesh-list
82992079|NCT02696434|Buprenorphine|buprenorphine|mesh-list
82992080|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82992081|NCT02696434|Narcotics|narcotics|mesh-ancestor
82992082|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992083|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992084|NCT02696434|Analgesics|analgesics|mesh-ancestor
82992085|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
82992086|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992087|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82992088|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82992089|NCT03709147|Metformin|metformin|mesh-list
82992090|NCT03709147|Carboplatin|carboplatin|mesh-list
82992091|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
82992092|NCT03709147|Pemetrexed|pemetrexed|mesh-list
82992093|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992094|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82992095|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992096|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82992097|NCT03709147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82992098|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992099|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992100|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82992101|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82992102|NCT02398474|Ropivacaine|ropivacaine|mesh-list
82992103|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
82992104|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
82992105|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992106|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992107|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
82992108|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992109|NCT03710317|Misoprostol|misoprostol|mesh-list
82992110|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
82992111|NCT03710317|Carbetocin|carbetocin|mesh-list
82992112|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82992113|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82992114|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992115|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
82992116|NCT03710317|Coagulants|coagulants|mesh-ancestor
82992117|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82992118|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
82992119|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82992120|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992121|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82992122|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992123|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
82992124|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
82992125|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82992126|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82992127|NCT02392780|Prednisolone|prednisolone|mesh-list
82992128|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
82992129|NCT02392780|Cannabidiol|cannabidiol|mesh-list
82992130|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82992131|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
82992132|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
82992133|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992134|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
82992135|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
83521631|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
82992136|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992137|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992138|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992139|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
82992140|NCT02392780|Hormones|hormones|mesh-ancestor
82992141|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992142|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82992143|NCT02392780|Protective Agents|protective agents|mesh-ancestor
82992144|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82992145|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992146|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
82992147|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992148|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992149|NCT04053478|Phenylephrine|phenylephrine|mesh-list
82992150|NCT04053478|Vasopressins|vasopressins|mesh-list
82992151|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
82992152|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
82992153|NCT04053478|Norepinephrine|norepinephrine|mesh-list
82992154|NCT04053478|Ephedrine|ephedrine|mesh-list
82992155|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82992156|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
82992157|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
82992158|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992159|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992160|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
82992161|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82992162|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
82992163|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
83464332|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992164|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82992165|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82992166|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82992167|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
82992168|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992169|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992170|NCT04053478|Protective Agents|protective agents|mesh-ancestor
82992171|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
82992172|NCT04053478|Coagulants|coagulants|mesh-ancestor
82992173|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
82992174|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
82992175|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82992176|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
82992177|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82992178|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992179|NCT03593915|Azacitidine|azacitidine|mesh-list
82992180|NCT03593915|Decitabine|decitabine|mesh-list
82992181|NCT03593915|Alvocidib|alvocidib|mesh-list
82992182|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82992183|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
82992184|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992185|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992186|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992187|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
82992188|NCT03593915|Growth Substances|growth substances|mesh-ancestor
82992189|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992190|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82992191|NCT02392702|Ivacaftor|ivacaftor|mesh-list
82992192|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82992193|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82992194|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992195|NCT02392468|BI 409306|bi 409306|mesh-list
82992196|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82992197|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992198|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992199|NCT02397928|Carboplatin|carboplatin|mesh-list
82992200|NCT02397928|Pemetrexed|pemetrexed|mesh-list
82992201|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992202|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992203|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992204|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82992205|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82992206|NCT03734627|Acetaminophen|acetaminophen|mesh-list
82992207|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
82992208|NCT03734627|Octreotide|octreotide|mesh-list
82992209|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82992210|NCT03734627|Analgesics|analgesics|mesh-ancestor
82992211|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
83522158|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
82992212|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992213|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992214|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
82992215|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992216|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82992217|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992218|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992219|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82992220|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992221|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82992223|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
82992224|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82992225|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992226|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
82992227|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82992228|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82992229|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
82992230|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
82992231|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
82992232|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992233|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992234|NCT03592277|Vitamins|vitamins|mesh-list
82992235|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
82992236|NCT03592277|Thiamine|thiamine|mesh-list
82992237|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
82992238|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992239|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
82992240|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992241|NCT03592277|Protective Agents|protective agents|mesh-ancestor
82992242|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
82992243|NCT03106402|Bromfenac|bromfenac|mesh-list
82992244|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82992245|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82992246|NCT03106402|Analgesics|analgesics|mesh-ancestor
82992247|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
82992248|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992249|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992250|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992251|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82992252|NCT03734159|Ropivacaine|ropivacaine|mesh-list
82992253|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
82992254|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
82992255|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992256|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992257|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
82992258|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992259|NCT02397382|Midazolam|midazolam|mesh-list
82992260|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
82992261|NCT02397382|Caffeine|caffeine|mesh-list
82992262|NCT02397382|Omeprazole|omeprazole|mesh-list
82992263|NCT02397382|Warfarin|warfarin|mesh-list
82992264|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82992265|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82992266|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992267|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992268|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82992269|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82992270|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82992271|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82992272|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
82992273|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
82992274|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
82992275|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
82992276|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992277|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992278|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
82992279|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82992280|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82992281|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992282|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82992283|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82992284|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
82992285|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82992286|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992287|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82992288|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
82992289|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
82992290|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82992291|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82992292|NCT02697916|Aspirin|aspirin|mesh-list
82992293|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82992294|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82992295|NCT02697916|Analgesics|analgesics|mesh-ancestor
82992296|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
82992297|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992298|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992299|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992300|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82992301|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82992302|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82992303|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992304|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82992305|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82992306|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992307|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
82992308|NCT04762680|Vaccines|vaccines|mesh-list
82992309|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
82992310|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992311|NCT03650387|Lidocaine|lidocaine|mesh-list
82992312|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
82992313|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
82992314|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992315|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992316|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
82992317|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992318|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82992319|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82992320|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82992321|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82992322|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992323|NCT02392156|Factor VIII|factor viii|mesh-list
82992324|NCT02392156|Coagulants|coagulants|mesh-ancestor
82992325|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
82992326|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82992327|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82992328|NCT03359473|GSK2881078|gsk2881078|mesh-list
82992329|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
82992330|NCT03359473|Hormones|hormones|mesh-ancestor
82992331|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992332|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992333|NCT03632304|Anesthetics|anesthetics|mesh-list
82992334|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992335|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992336|NCT02397538|Amlodipine|amlodipine|mesh-list
82992337|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82992338|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82992339|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82992340|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82992341|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992342|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82992343|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992344|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
82992345|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82992346|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82992347|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
82992348|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82992349|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82992350|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992351|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
82992352|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82992353|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992354|NCT03359395|Alfentanil|alfentanil|mesh-list
82992355|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82992356|NCT03359395|Narcotics|narcotics|mesh-ancestor
82992357|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992358|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992359|NCT03359395|Analgesics|analgesics|mesh-ancestor
82992360|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
82992361|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992362|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82992363|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
82992364|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
82992365|NCT03733691|Lenalidomide|lenalidomide|mesh-list
82992366|NCT03733691|Ixazomib|ixazomib|mesh-list
82992367|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
82992368|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992369|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82992370|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82992371|NCT03733691|Growth Substances|growth substances|mesh-ancestor
82992372|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
82992373|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992374|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
82992375|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992376|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992377|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
82992378|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82992379|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
82992380|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992381|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992382|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82992383|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
82992384|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
82992385|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82992386|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
82992387|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992388|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992389|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
82992390|NCT05741632|Levofloxacin|levofloxacin|mesh-list
82992391|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82992392|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82992393|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82992394|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992395|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82992396|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82992397|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992398|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992399|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992400|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82992401|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82992402|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82992403|NCT03093402|Dronabinol|dronabinol|mesh-list
82992404|NCT03093402|Lenabasum|lenabasum|mesh-list
82992405|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82992406|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82992407|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992408|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992409|NCT03093402|Hormones|hormones|mesh-ancestor
82992410|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992411|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992412|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
82992413|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82992414|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82992415|NCT03093402|Analgesics|analgesics|mesh-ancestor
82992416|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
82992417|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992418|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
82992419|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992420|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
82992421|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
82992422|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992423|NCT03733379|Amoxicillin|amoxicillin|mesh-list
82992424|NCT03733379|Metronidazole|metronidazole|mesh-list
82992425|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82992426|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992427|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82992428|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82992429|NCT05733676|Calcium|calcium|mesh-list
82992430|NCT05733676|Fluorides|fluorides|mesh-list
82992431|NCT05733676|Caseins|caseins|mesh-list
82992432|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82992433|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992434|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
82992435|NCT05733676|Protective Agents|protective agents|mesh-ancestor
82992436|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
82992438|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992439|NCT03343639|Serlopitant|serlopitant|mesh-list
82992440|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82992441|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992442|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992443|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992444|NCT04479748|Dexamethasone|dexamethasone|mesh-list
82992445|NCT04479748|Prednisolone|prednisolone|mesh-list
82992446|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82992447|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
82992448|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82992449|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
82992450|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82992451|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
82992452|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992453|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
82992454|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
82992455|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992456|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992457|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992458|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
82992459|NCT04479748|Hormones|hormones|mesh-ancestor
82992460|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992461|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82992462|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992463|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82992464|NCT04479748|Protective Agents|protective agents|mesh-ancestor
82992465|NCT02690974|Valsartan|valsartan|mesh-list
82992466|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82992467|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82992468|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82992469|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82992470|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992471|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82992472|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992473|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82992474|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
82992475|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992476|NCT03584009|Venetoclax|venetoclax|mesh-list
82992477|NCT03584009|Fulvestrant|fulvestrant|mesh-list
82992478|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992479|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82992480|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82992481|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82992482|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
82992483|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992484|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992485|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
82992486|NCT03709927|Fosfomycin|fosfomycin|mesh-list
82992487|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82992488|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992489|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82992490|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82992491|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992492|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992493|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992494|NCT03730181|Isoniazid|isoniazid|mesh-list
82992495|NCT03730181|Rifapentine|rifapentine|mesh-list
82992496|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
82992497|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82992498|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992499|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82992500|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82992501|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
82992502|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992503|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82992504|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82992505|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
82992506|NCT04167462|Deucravacitinib|deucravacitinib|mesh-list
82992507|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992508|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82992509|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992510|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992511|NCT04160520|Morphine|morphine|mesh-list
82992512|NCT04160520|Pramipexole|pramipexole|mesh-list
82992513|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82992514|NCT04160520|Narcotics|narcotics|mesh-ancestor
82992515|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992516|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992517|NCT04160520|Analgesics|analgesics|mesh-ancestor
82992518|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
82992519|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992521|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992522|NCT04160520|Protective Agents|protective agents|mesh-ancestor
82992523|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82992524|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82992525|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
82992526|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
82992527|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992528|NCT03583385|Metformin|metformin|mesh-list
82992529|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82992530|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992531|NCT05288335|Methamphetamine|methamphetamine|mesh-list
82992532|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82992533|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992534|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
82992535|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
82992536|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992537|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
82992538|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992539|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992540|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
82992541|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82992542|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82992543|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82992544|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82992545|NCT04792801|Choline|choline|mesh-list
82992546|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
82992547|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82992548|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
82992549|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992550|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992551|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82992552|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
82992553|NCT05420922|Lenvatinib|lenvatinib|mesh-list
82992554|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
82992555|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992556|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82992557|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992558|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992559|NCT05420922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82992560|NCT03582215|Salicylates|salicylates|mesh-list
82992561|NCT03582215|Avobenzone|avobenzone|mesh-list
82992562|NCT03582215|Homosalate|homosalate|mesh-list
82992563|NCT03582215|Oxybenzone|oxybenzone|mesh-list
82992564|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
82992565|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
82992566|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
82992567|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82992568|NCT03582215|Protective Agents|protective agents|mesh-ancestor
82992569|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992570|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992571|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82992572|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82992573|NCT03582215|Analgesics|analgesics|mesh-ancestor
82992574|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
82992575|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992576|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992577|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82992578|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82992579|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992580|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992581|NCT05175703|Paclitaxel|paclitaxel|mesh-list
82992582|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82992583|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992584|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
82992585|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
82992586|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
82992587|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992589|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82992590|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
82992591|NCT03323346|Disulfiram|disulfiram|mesh-list
82992592|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82992593|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
82992594|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992595|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992596|NCT05628571|Fluorides|fluorides|mesh-list
82992597|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
82992598|NCT05628571|Protective Agents|protective agents|mesh-ancestor
82992599|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992600|NCT05255016|Riboflavin|riboflavin|mesh-list
82992601|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
82992602|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
82992603|NCT05255016|Vitamins|vitamins|mesh-ancestor
82992604|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
82992605|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992606|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
82992607|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992608|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82992609|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82992610|NCT05178888|Palbociclib|palbociclib|mesh-list
82992611|NCT05178888|Adagrasib|adagrasib|mesh-list
82992612|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992613|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82992614|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992615|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992616|NCT03342001|Calcitonin|calcitonin|mesh-list
82992617|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
82992618|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82992619|NCT03342001|Katacalcin|katacalcin|mesh-list
82992620|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82992621|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992622|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82992623|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
82992624|NCT03579719|Itraconazole|itraconazole|mesh-list
82992625|NCT03579719|Balovaptan|balovaptan|mesh-list
82992626|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
82992627|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992628|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82992629|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82992630|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992631|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992632|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82992633|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
82992634|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992635|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992636|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82992637|NCT03579719|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82992638|NCT03579719|Natriuretic Agents|natriuretic agents|mesh-ancestor
82992639|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
82992640|NCT03631602|Clotrimazole|clotrimazole|mesh-list
82992641|NCT03631602|Miconazole|miconazole|mesh-list
82992642|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992643|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82992644|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82992645|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82992646|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992647|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992648|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82992649|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
82992650|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992651|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992652|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82992653|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82992654|NCT02688088|Midazolam|midazolam|mesh-list
82992655|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
82992656|NCT02688088|Caffeine|caffeine|mesh-list
82992657|NCT02688088|Warfarin|warfarin|mesh-list
82992658|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82992659|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82992660|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992661|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992662|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82992663|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82992664|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82992665|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82992666|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
82992668|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
82992669|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
82992670|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992671|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992672|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
82992673|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82992674|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82992675|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992676|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82992677|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82992678|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
82992679|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
82992680|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
82992681|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82992682|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82992683|NCT03641651|Frovatriptan|frovatriptan|mesh-list
82992684|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82992685|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
82992686|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992687|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992688|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992689|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
82992690|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82992691|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992692|NCT05666219|Aminophylline|aminophylline|mesh-list
82992693|NCT05666219|Theophylline|theophylline|mesh-list
82992694|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82992695|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
82992696|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992697|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992698|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82992699|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
82992700|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82992701|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992702|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992703|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
82992704|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82992705|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82992706|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
82992707|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992708|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82992709|NCT05666219|Protective Agents|protective agents|mesh-ancestor
82992710|NCT02949271|Fentanyl|fentanyl|mesh-list
82992711|NCT02949271|Ropivacaine|ropivacaine|mesh-list
82992712|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
82992713|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
82992714|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992715|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992716|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
82992717|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992718|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82992719|NCT02949271|Narcotics|narcotics|mesh-ancestor
82992720|NCT02949271|Analgesics|analgesics|mesh-ancestor
82992721|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82992722|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82992723|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
82992724|NCT03339583|Zopiclone|zopiclone|mesh-list
82992725|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82992726|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992727|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992728|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
82992729|NCT03639779|Antidotes|antidotes|mesh-ancestor
82992730|NCT03639779|Protective Agents|protective agents|mesh-ancestor
82992731|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992732|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
82992733|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992734|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
82992735|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82992736|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992737|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
82992738|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
82992739|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
82992740|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82992741|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82992742|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
82992743|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82992745|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
82992746|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992747|NCT03708133|Nifurtimox|nifurtimox|mesh-list
82992748|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
82992749|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82992750|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82992751|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992752|NCT05075161|Pirfenidone|pirfenidone|mesh-list
82992753|NCT05075161|Analgesics|analgesics|mesh-ancestor
82992754|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
82992755|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992756|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992757|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82992758|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82992759|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992760|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82992761|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992762|NCT05095831|Pancrelipase|pancrelipase|mesh-list
82992763|NCT05095831|Pancreatin|pancreatin|mesh-list
82992764|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992765|NCT03638869|Methadone|methadone|mesh-list
82992766|NCT03638869|D-methadone|d-methadone|mesh-list
82992767|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82992768|NCT03638869|Narcotics|narcotics|mesh-ancestor
82992769|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992770|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992771|NCT03638869|Analgesics|analgesics|mesh-ancestor
82992772|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
82992773|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992774|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
82992775|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
82992776|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82992777|NCT03091920|Praliciguat|praliciguat|mesh-list
82992778|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
82992779|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
82992780|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464401|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
82992781|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992782|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
82992783|NCT03338569|Vitamins|vitamins|mesh-ancestor
82992784|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
82992785|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992786|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
82992787|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992788|NCT03338569|Protective Agents|protective agents|mesh-ancestor
82992789|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
82992790|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82992791|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992792|NCT05053633|Anesthetics|anesthetics|mesh-list
82992793|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992794|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992795|NCT03337477|Insulin|insulin|mesh-list
82992796|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82992797|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82992798|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992799|NCT03707899|Amlodipine|amlodipine|mesh-list
82992800|NCT03707899|Telmisartan|telmisartan|mesh-list
82992801|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
82992802|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82992803|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82992804|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82992805|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82992806|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992807|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82992808|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992809|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
83522378|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82992810|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82992811|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82992812|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
82992813|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82992814|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82992815|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992816|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82992817|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82992818|NCT05490511|Cannabidiol|cannabidiol|mesh-list
82992819|NCT05490511|Tacrolimus|tacrolimus|mesh-list
82992820|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82992821|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
82992822|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992823|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82992824|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992825|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992826|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
82992827|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
82992828|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82992829|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992830|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
82992831|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992832|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992833|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
82992834|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82992835|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82992836|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992837|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
82992838|NCT03706339|Coagulants|coagulants|mesh-ancestor
82992839|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
82992840|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
82992841|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82992842|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82992843|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82992844|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992845|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992846|NCT03639558|Promethazine|promethazine|mesh-list
82992847|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
82992848|NCT03639558|Haloperidol|haloperidol|mesh-list
82992849|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
82992850|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
82992851|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
82992852|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
82992853|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992854|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992855|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992856|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82992857|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82992858|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82992859|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82992860|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82992861|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
82992862|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992863|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992864|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82992865|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
82992866|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992867|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82992868|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
82992869|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
82992870|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82992871|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82992872|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82992873|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
82992874|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
82992875|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
82992876|NCT01353508|Valsartan|valsartan|mesh-list
82992877|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82992878|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82992879|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82992880|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82992881|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992882|NCT01568268|Palonosetron|palonosetron|mesh-list
82992883|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
82992884|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
82992885|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992886|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992887|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992888|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82992889|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82992890|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
82992891|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992892|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992893|NCT04911361|Dexamethasone|dexamethasone|mesh-list
82992894|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82992895|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
82992896|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
82992897|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82992898|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992899|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82992900|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
82992901|NCT04911361|Hormones|hormones|mesh-ancestor
82992902|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82992903|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82992904|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992905|NCT04475731|Ponatinib|ponatinib|mesh-list
82992906|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992907|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82992908|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992909|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992910|NCT03087786|Nicotine|nicotine|mesh-list
82992911|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82992912|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
82992913|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83464406|NCT00000976|Zidovudine|zidovudine|mesh-list
82992914|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992915|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82992916|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82992917|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
82992918|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992919|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992920|NCT03635957|Folic Acid|folic acid|mesh-list
82992921|NCT03635957|Methotrexate|methotrexate|mesh-list
82992922|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82992923|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
82992924|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82992925|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992926|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82992927|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
82992928|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992929|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992930|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
82992931|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992932|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82992933|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82992934|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
82992935|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82992936|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82992937|NCT03635957|Hematinics|hematinics|mesh-ancestor
82992938|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
82992939|NCT03635957|Vitamins|vitamins|mesh-ancestor
82992940|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
82992941|NCT05005507|Tenofovir|tenofovir|mesh-list
82992942|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
82992943|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
82992944|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992945|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82992946|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82992947|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992948|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992949|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82992950|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82992951|NCT04739358|Tepotinib|tepotinib|mesh-list
82992952|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992953|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82992954|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82992955|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992956|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
82992957|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
82992958|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
82992959|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992960|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
82992961|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
82992962|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992963|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82992964|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82992965|NCT02684344|Tamsulosin|tamsulosin|mesh-list
82992966|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82992967|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82992968|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82992969|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
82992970|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82992971|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992972|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992973|NCT02684344|Urological Agents|urological agents|mesh-ancestor
82992974|NCT05199571|Ofatumumab|ofatumumab|mesh-list
82992975|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82992976|NCT03974100|Denosumab|denosumab|mesh-list
82992977|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82992978|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992979|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
82992980|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
82992981|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
82992982|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
82992983|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82992984|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82992985|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82992986|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82992987|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82992988|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82992989|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
82992990|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
82992991|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82992992|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82992993|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82992994|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82992995|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82992996|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82992997|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
82992998|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82992999|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993000|NCT03417882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82993001|NCT03417882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993002|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
82993003|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993004|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993005|NCT01374568|Incretins|incretins|mesh-ancestor
82993006|NCT01374568|Hormones|hormones|mesh-ancestor
82993007|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993008|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
82993009|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
82993010|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993011|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993012|NCT02991456|Ondansetron|ondansetron|mesh-list
82993013|NCT02991456|Rolapitant|rolapitant|mesh-list
82993014|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
82993015|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
82993016|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993017|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993018|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82993019|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
82993020|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
82993021|NCT02991456|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82993022|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82993023|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
82993024|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993025|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993026|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82993027|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
82993028|NCT01312441|Vitamin D|vitamin d|mesh-list
82993029|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82993030|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993031|NCT01312441|Vitamins|vitamins|mesh-ancestor
82993032|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
82993033|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82993034|NCT02682784|Oxytocin|oxytocin|mesh-list
82993036|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82993037|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993038|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
82993039|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
82993040|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82993041|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
82993042|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993043|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
82993044|NCT03705949|Protective Agents|protective agents|mesh-ancestor
82993045|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82993046|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82993047|NCT03162562|Oregovomab|oregovomab|mesh-list
82993048|NCT03162562|Poly ICLC|poly iclc|mesh-list
82993049|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
82993050|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
82993051|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993052|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993053|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993054|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
82993055|NCT03164590|Ketamine|ketamine|mesh-list
82993056|NCT03164590|Bupivacaine|bupivacaine|mesh-list
82993057|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
82993058|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
82993059|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993060|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993061|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
82993062|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993063|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82993064|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82993065|NCT03164590|Analgesics|analgesics|mesh-ancestor
82993066|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82993067|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82993068|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82993069|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
82993070|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993071|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993072|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82993073|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82993074|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
82993075|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82993076|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82993077|NCT05119075|Dopamine|dopamine|mesh-list
82993078|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
82993079|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82993080|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
82993081|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
82993082|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993083|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993084|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
82993085|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993086|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993087|NCT05119075|Protective Agents|protective agents|mesh-ancestor
82993088|NCT03387852|Fluticasone|fluticasone|mesh-list
82993089|NCT03387852|Xhance|xhance|mesh-list
82993090|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82993091|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82993092|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82993093|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993094|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82993095|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
82993096|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993097|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993098|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82993099|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
82993100|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
82993101|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82993102|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82993103|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82993104|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82993105|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
82993106|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993107|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993108|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
82993109|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
82993110|NCT03387852|Hormones|hormones|mesh-ancestor
82993111|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993112|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
82993113|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
82993114|NCT02679274|Testosterone|testosterone|mesh-list
82993115|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
82993116|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
82993117|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82993118|NCT02679274|Androgens|androgens|mesh-ancestor
82993119|NCT02679274|Hormones|hormones|mesh-ancestor
82993120|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993121|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993122|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82993123|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993124|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
82993125|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82993126|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82993127|NCT03620929|Estradiol|estradiol|mesh-list
82993128|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82993129|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
82993130|NCT03620929|Estrogens|estrogens|mesh-ancestor
82993131|NCT03620929|Hormones|hormones|mesh-ancestor
82993132|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993133|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993134|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82993135|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
82993136|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82993137|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82993138|NCT03620929|Progestins|progestins|mesh-ancestor
82993139|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
82993140|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993141|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993142|NCT04969861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82993143|NCT04969861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993144|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82993145|NCT05308849|beta-Lactams|beta-lactams|mesh-list
82993146|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993147|NCT02678416|Acetaminophen|acetaminophen|mesh-list
82993148|NCT02678416|Morphine|morphine|mesh-list
82993149|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82993150|NCT02678416|Narcotics|narcotics|mesh-ancestor
82993151|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993152|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993153|NCT02678416|Analgesics|analgesics|mesh-ancestor
82993154|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
82993155|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993156|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82993157|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
82993158|NCT03164668|Menthol|menthol|mesh-list
82993159|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
82993160|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
82993161|NCT03164512|Cannabidiol|cannabidiol|mesh-list
82993162|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
82993163|NCT02680756|Ferric maltol|ferric maltol|mesh-list
82993164|NCT02680756|Hematinics|hematinics|mesh-ancestor
82993165|NCT03631836|Bevacizumab|bevacizumab|mesh-list
82993166|NCT03631836|Antibodies|antibodies|mesh-list
82993167|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82993168|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993169|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993170|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82993171|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82993172|NCT03631836|Growth Substances|growth substances|mesh-ancestor
82993173|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993174|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
82993175|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
82993176|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82993177|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82993178|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
82993179|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82993180|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
82993181|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993182|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993183|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82993184|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
82993185|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82993186|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82993187|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82993188|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
82993189|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993190|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993191|NCT05422066|Prednisone|prednisone|mesh-list
82993192|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
82993193|NCT05422066|Rituximab|rituximab|mesh-list
82993194|NCT05422066|Doxorubicin|doxorubicin|mesh-list
83464437|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82993195|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82993196|NCT05422066|Vincristine|vincristine|mesh-list
82993197|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993198|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
82993199|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993200|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993201|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82993202|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
82993203|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993204|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993205|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82993206|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993207|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82993208|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82993209|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82993210|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993211|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993213|NCT05422066|Hormones|hormones|mesh-ancestor
82993214|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993215|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82993216|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82993217|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
82993218|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
82993219|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
82993220|NCT03670706|Analgesics|analgesics|mesh-list
82993221|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
82993222|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993223|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993224|NCT03114280|Carboplatin|carboplatin|mesh-list
82993225|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993226|NCT01312363|Rivastigmine|rivastigmine|mesh-list
82993227|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82993228|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993229|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993230|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
82993231|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993232|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993233|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82993234|NCT01312363|Protective Agents|protective agents|mesh-ancestor
82993235|NCT03161678|Clopidogrel|clopidogrel|mesh-list
82993236|NCT03161678|Ticagrelor|ticagrelor|mesh-list
82993237|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82993238|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82993239|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82993240|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82993241|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
82993242|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993243|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993244|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993245|NCT05597280|Rifampin|rifampin|mesh-list
82993246|NCT05597280|Bedaquiline|bedaquiline|mesh-list
82993247|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82993248|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
82993249|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82993250|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993251|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
82993252|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82993253|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993254|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993255|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82993256|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82993257|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82993258|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82993259|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82993260|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82993261|NCT03674606|Aspirin|aspirin|mesh-list
82993262|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82993263|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82993264|NCT03674606|Analgesics|analgesics|mesh-ancestor
82993265|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
82993266|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993267|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993268|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993269|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993270|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82993271|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82993272|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993273|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82993274|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82993275|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993276|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
82993277|NCT02677324|Venetoclax|venetoclax|mesh-list
82993278|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993279|NCT03108846|Escitalopram|escitalopram|mesh-list
82993280|NCT03108846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82993281|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82993282|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82993283|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993284|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993285|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
82993286|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993287|NCT03163966|Methotrexate|methotrexate|mesh-list
82993288|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82993289|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
82993290|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82993291|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993292|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82993293|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
82993294|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993295|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993296|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
82993297|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993298|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82993299|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993300|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
82993301|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993302|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82993303|NCT03678116|Caffeine|caffeine|mesh-list
82993304|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82993305|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993306|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82993307|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993308|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993309|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82993310|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82993311|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
82993312|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993313|NCT03678038|Triamcinolone|triamcinolone|mesh-list
82993314|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82993315|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82993316|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82993317|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993318|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
82993319|NCT03678038|Hormones|hormones|mesh-ancestor
82993320|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993321|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993322|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993323|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
82993324|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993325|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993326|NCT03163420|Diclofenac|diclofenac|mesh-list
82993327|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82993328|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82993329|NCT03163420|Analgesics|analgesics|mesh-ancestor
82993330|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
82993331|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993332|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993333|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993334|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83464447|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
82993335|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82993336|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993337|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993338|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
82993339|NCT04440436|Fludarabine|fludarabine|mesh-list
82993340|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993341|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
82993342|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993343|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993344|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82993345|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
82993346|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993347|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993348|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82993349|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82993350|NCT05405686|Hormones|hormones|mesh-ancestor
82993351|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993352|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993353|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82993354|NCT04711122|Cephalosporins|cephalosporins|mesh-list
82993355|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993356|NCT05272696|Paclitaxel|paclitaxel|mesh-list
82993357|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
82993358|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82993359|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993360|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
82993361|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
82993362|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
82993363|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993364|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993365|NCT05272696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82993366|NCT05563116|Calcium|calcium|mesh-list
82993367|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82993368|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993369|NCT03520946|Ramucirumab|ramucirumab|mesh-list
82993370|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993371|NCT03709758|Cytarabine|cytarabine|mesh-list
82993372|NCT03709758|Daunorubicin|daunorubicin|mesh-list
82993373|NCT03709758|Venetoclax|venetoclax|mesh-list
82993374|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82993375|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
82993376|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993377|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993378|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
82993379|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993380|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993381|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
82993382|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993383|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82993384|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82993385|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82993386|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993387|NCT03674060|Sorafenib|sorafenib|mesh-list
82993388|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993389|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82993390|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993391|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993392|NCT03163576|Niacin|niacin|mesh-list
82993393|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82993394|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
82993395|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993396|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82993397|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
82993398|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
82993399|NCT03163576|Vitamins|vitamins|mesh-ancestor
82993400|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
82993401|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993402|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
82993403|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993404|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993405|NCT03673280|Morphine|morphine|mesh-list
82993406|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82993407|NCT03673280|Narcotics|narcotics|mesh-ancestor
83523057|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
82993408|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993409|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993410|NCT03673280|Analgesics|analgesics|mesh-ancestor
82993411|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
82993412|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993413|NCT05420220|Axitinib|axitinib|mesh-list
82993414|NCT05420220|Antibodies|antibodies|mesh-list
82993415|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
82993416|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993417|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993418|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82993419|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993420|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993421|NCT05383560|Vaccines|vaccines|mesh-list
82993422|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
82993423|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993424|NCT01382004|Azithromycin|azithromycin|mesh-list
82993425|NCT01382004|Penicillins|penicillins|mesh-list
82993426|NCT01382004|Penicillin G|penicillin g|mesh-list
82993427|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
82993428|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
82993429|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82993430|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993431|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
82993432|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82993433|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82993434|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993435|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
82993436|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
82993437|NCT01381848|Doripenem|doripenem|mesh-list
82993438|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82993439|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993440|NCT04546620|Prednisolone|prednisolone|mesh-list
82993441|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82993442|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
82993443|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82993444|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
82993445|NCT04546620|Prednisone|prednisone|mesh-list
82993446|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
82993447|NCT04546620|Rituximab|rituximab|mesh-list
82993448|NCT04546620|Doxorubicin|doxorubicin|mesh-list
82993449|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82993450|NCT04546620|Vincristine|vincristine|mesh-list
82993451|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
82993452|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82993453|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
82993454|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993455|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
82993456|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993457|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993458|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82993459|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
82993460|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993461|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993462|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82993463|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993464|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82993465|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82993466|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82993467|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993468|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82993469|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
82993470|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
82993471|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
82993472|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993473|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
82993474|NCT04546620|Hormones|hormones|mesh-ancestor
83464455|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82993475|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993476|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82993477|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
82993478|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
82993479|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993480|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82993481|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82993482|NCT04546620|Protective Agents|protective agents|mesh-ancestor
82993483|NCT04058210|Ivacaftor|ivacaftor|mesh-list
82993484|NCT04058210|Elexacaftor|elexacaftor|mesh-list
82993485|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
82993486|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82993487|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993488|NCT02250300|Ixazomib|ixazomib|mesh-list
82993489|NCT02250300|Glycine|glycine|mesh-list
82993490|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993491|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
82993492|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993493|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993494|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
82993495|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993496|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993497|NCT03020966|Acetaminophen|acetaminophen|mesh-list
82993498|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82993499|NCT03020966|Analgesics|analgesics|mesh-ancestor
82993500|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
82993501|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993502|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993503|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
82993504|NCT04051268|Vaccines|vaccines|mesh-list
82993505|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
82993506|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993507|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
82993508|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82993509|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82993510|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993511|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
82993512|NCT04595786|Coagulants|coagulants|mesh-ancestor
82993513|NCT02108652|Atezolizumab|atezolizumab|mesh-list
82993514|NCT02108652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82993515|NCT02108652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993516|NCT02108652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993517|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993518|NCT01381614|Bevacizumab|bevacizumab|mesh-list
82993519|NCT01381614|Sunitinib|sunitinib|mesh-list
82993520|NCT01381614|Sorafenib|sorafenib|mesh-list
82993521|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993522|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993523|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82993524|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82993525|NCT01381614|Growth Substances|growth substances|mesh-ancestor
82993526|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993527|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
82993528|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82993529|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993530|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993531|NCT01381536|Belimumab|belimumab|mesh-list
82993532|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993533|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
82993534|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993535|NCT03162406|Vitamin D|vitamin d|mesh-list
82993536|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
82993537|NCT03162406|Vitamins|vitamins|mesh-ancestor
82993538|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
82993539|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993540|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82993541|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82993542|NCT02946385|Vaccines|vaccines|mesh-list
82993543|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
82993544|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993545|NCT05676190|Immunomodulating Agents|immunomodulating agents|mesh-list
82993546|NCT05676190|Immunologic Factors|immunologic factors|mesh-ancestor
82993547|NCT05676190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993548|NCT02694718|Capecitabine|capecitabine|mesh-list
82993549|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
82993550|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82993551|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
82993552|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993553|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993554|NCT05681299|Liraglutide|liraglutide|mesh-list
82993555|NCT05681299|Hormones|hormones|mesh-list
82993556|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993557|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993558|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993559|NCT05681299|Incretins|incretins|mesh-ancestor
82993560|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82993561|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82993563|NCT04908787|Doxorubicin|doxorubicin|mesh-list
82993564|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82993565|NCT04908787|Topotecan|topotecan|mesh-list
82993566|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82993567|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993568|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
82993569|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
82993570|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
82993571|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993572|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82993573|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82993574|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82993575|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993576|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82993578|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82993579|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
82993580|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82993581|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
82993582|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993583|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993584|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
82993585|NCT05681221|Calcium|calcium|mesh-list
82993586|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82993587|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993588|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
82993589|NCT04303507|Chloroquine|chloroquine|mesh-list
82993590|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
82993591|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82993592|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82993593|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993594|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993595|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993596|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993597|NCT04303507|Amebicides|amebicides|mesh-ancestor
82993598|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
82993599|NCT03202537|Lansoprazole|lansoprazole|mesh-list
82993600|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82993601|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82993602|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82993603|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993604|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993605|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
82993606|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993607|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993608|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993609|NCT04138615|Morphine|morphine|mesh-list
82993610|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82993611|NCT04138615|Narcotics|narcotics|mesh-ancestor
82993612|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993613|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993614|NCT04138615|Analgesics|analgesics|mesh-ancestor
82993615|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
83464466|NCT00000232|Analgesics|analgesics|mesh-ancestor
82993616|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993617|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
82993618|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82993619|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993620|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
82993621|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82993622|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993623|NCT03018938|Insulin|insulin|mesh-list
82993624|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82993625|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993626|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993627|NCT04776499|Perphenazine|perphenazine|mesh-list
82993628|NCT04776499|Riociguat|riociguat|mesh-list
82993629|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
82993630|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
82993631|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993632|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82993633|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82993634|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993635|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993636|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82993637|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82993638|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
82993639|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993640|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
82993641|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
82993642|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
82993643|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993644|NCT03668054|Bevacizumab|bevacizumab|mesh-list
82993645|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993646|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993647|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82993654|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993655|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82993656|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993657|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
82993658|NCT03623048|Propolis|propolis|mesh-list
82993659|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82993660|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993661|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
82993662|NCT03016598|Oxytocin|oxytocin|mesh-list
82993663|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
82993664|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82993665|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993672|NCT03017846|Cantharidin|cantharidin|mesh-list
82993673|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993674|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993675|NCT03638401|Morphine|morphine|mesh-list
82993676|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82993677|NCT03638401|Narcotics|narcotics|mesh-ancestor
82993678|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993679|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993680|NCT03638401|Analgesics|analgesics|mesh-ancestor
82993681|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
82993682|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993683|NCT03666650|Edoxaban|edoxaban|mesh-list
82993684|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82993685|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
82993686|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82993687|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
82993688|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993689|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993690|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
82993691|NCT02942485|Metronidazole|metronidazole|mesh-list
82993692|NCT02942485|Tinidazole|tinidazole|mesh-list
82993693|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993694|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82993695|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82993696|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82993697|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
82993698|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993699|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
82993700|NCT03666494|Fentanyl|fentanyl|mesh-list
82993701|NCT03666494|Ketamine|ketamine|mesh-list
82993702|NCT03666494|Propofol|propofol|mesh-list
82993703|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82993704|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993705|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993706|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82993707|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
82993708|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
82993709|NCT03666494|Analgesics|analgesics|mesh-ancestor
82993710|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
82993711|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993712|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82993713|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82993714|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82993715|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993716|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993717|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82993718|NCT03666494|Narcotics|narcotics|mesh-ancestor
82993719|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82993720|NCT03666884|Cyclosporine|cyclosporine|mesh-list
82993721|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82993722|NCT03666884|Cyclosporins|cyclosporins|mesh-list
82993723|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82993724|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993725|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993726|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993727|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
82993728|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993729|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
82993730|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993731|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
82993732|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993733|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82993734|NCT02942407|Warfarin|warfarin|mesh-list
82993735|NCT02942407|Apixaban|apixaban|mesh-list
82993736|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
82993737|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82993738|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
82993739|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82993740|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
82993741|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993742|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993743|NCT02921035|Interferons|interferons|mesh-list
82993744|NCT02921035|Interferon-beta|interferon-beta|mesh-list
82993745|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
82993746|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993747|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
82993748|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993749|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
82993750|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993751|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82993752|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82993753|NCT03006848|Avelumab|avelumab|mesh-list
82993754|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993755|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993756|NCT03667352|Fentanyl|fentanyl|mesh-list
82993757|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82993758|NCT03667352|Narcotics|narcotics|mesh-ancestor
82993759|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993760|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993761|NCT03667352|Analgesics|analgesics|mesh-ancestor
82993762|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
82993763|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993764|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82993765|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82993766|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
82993767|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
82993768|NCT03320941|Licogliflozin|licogliflozin|mesh-list
82993769|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82993770|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993771|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993772|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993773|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
82993774|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82993775|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993776|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993777|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993778|NCT03559699|Mitapivat|mitapivat|mesh-list
82993779|NCT03559699|Enzyme Activators|enzyme activators|mesh-ancestor
82993780|NCT03559699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993781|NCT03557281|GSK656|gsk656|mesh-list
82993782|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82993783|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82993784|NCT02573233|Fluticasone|fluticasone|mesh-list
82993785|NCT02573233|Xhance|xhance|mesh-list
82993786|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
82993787|NCT02573233|Budesonide|budesonide|mesh-list
82993788|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
82993789|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
82993790|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993791|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82993792|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
82993793|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993794|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993795|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82993796|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
82993797|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
82993798|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82993799|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
82993800|NCT02573233|Hormones|hormones|mesh-ancestor
82993801|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993802|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82993803|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82993804|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82993805|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
82993806|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993807|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993809|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82993810|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993811|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82993812|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993813|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
82993814|NCT01569048|Remifentanil|remifentanil|mesh-list
82993815|NCT01569048|Propofol|propofol|mesh-list
82993816|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82993817|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82993818|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993819|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82993820|NCT01569048|Analgesics|analgesics|mesh-ancestor
82993821|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
82993822|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993823|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82993824|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82993825|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82993826|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
82993827|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993828|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993829|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82993830|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
82993831|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
82993832|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82993833|NCT01569048|Narcotics|narcotics|mesh-ancestor
82993834|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82993835|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
82993836|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82993837|NCT01380912|Prednisolone|prednisolone|mesh-list
82993838|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
82993839|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82993840|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
82993841|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993842|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
82993843|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
82993844|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993845|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993846|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82993847|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
82993848|NCT01380912|Hormones|hormones|mesh-ancestor
82993849|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993850|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82993851|NCT01380912|Protective Agents|protective agents|mesh-ancestor
82993852|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82993853|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993854|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82993855|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82993856|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82993857|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82993858|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993859|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993860|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993861|NCT03315793|Analgesics|analgesics|mesh-ancestor
82993862|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
82993863|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993864|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
82993865|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82993866|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
82993867|NCT01569204|Dexamethasone|dexamethasone|mesh-list
82993868|NCT01569204|Prednisone|prednisone|mesh-list
82993869|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
82993870|NCT01569204|Dacarbazine|dacarbazine|mesh-list
82993871|NCT01569204|Doxorubicin|doxorubicin|mesh-list
82993872|NCT01569204|Etoposide|etoposide|mesh-list
82993873|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82993874|NCT01569204|Procarbazine|procarbazine|mesh-list
82993875|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993876|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
82993877|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993878|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82993879|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82993881|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993882|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993883|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82993884|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993885|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
82993886|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
82993887|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993888|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82993889|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
82993890|NCT01569204|Hormones|hormones|mesh-ancestor
82993891|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993892|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82993893|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82993894|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82993895|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82993896|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993897|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82993898|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993899|NCT01569204|Immunotoxins|immunotoxins|mesh-ancestor
82993900|NCT01569204|Immunoconjugates|immunoconjugates|mesh-ancestor
82993901|NCT02676466|Losartan|losartan|mesh-list
82993902|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82993903|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82993904|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82993905|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82993906|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993907|NCT04439890|Carboplatin|carboplatin|mesh-list
82993908|NCT04439890|Pemetrexed|pemetrexed|mesh-list
82993909|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993910|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993911|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993912|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82993913|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83464486|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82993914|NCT03635892|Nivolumab|nivolumab|mesh-list
82993915|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993916|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993917|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82993918|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993919|NCT02324725|Naltrexone|naltrexone|mesh-list
82993920|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82993921|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82993922|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993923|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
82993924|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993925|NCT01380678|Bevacizumab|bevacizumab|mesh-list
82993926|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82993927|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
82993928|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
82993929|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82993930|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993931|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82993932|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82993933|NCT01380678|Growth Substances|growth substances|mesh-ancestor
82993934|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993935|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
82993936|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
82993937|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82993938|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993939|NCT01380600|Molgramostim|molgramostim|mesh-list
82993940|NCT01380600|Sargramostim|sargramostim|mesh-list
82993941|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
82993942|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993943|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993944|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
82993945|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
82993946|NCT03264118|Coagulants|coagulants|mesh-ancestor
82993947|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
82993948|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993949|NCT02674204|Atorvastatin|atorvastatin|mesh-list
82993950|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82993951|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82993952|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
83523135|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
82993953|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993954|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82993955|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82993957|NCT05675644|Drospirenone|drospirenone|mesh-list
82993958|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82993959|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
82993960|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82993961|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993962|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82993963|NCT05675644|Diuretics|diuretics|mesh-ancestor
82993964|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
82993965|NCT05010772|Decitabine|decitabine|mesh-list
82993966|NCT05010772|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
82993967|NCT05010772|Venetoclax|venetoclax|mesh-list
82993968|NCT05010772|Ivosidenib|ivosidenib|mesh-list
82993969|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82993970|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
82993971|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993972|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993973|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993974|NCT02579044|Everolimus|everolimus|mesh-list
82993975|NCT02579044|Lonafarnib|lonafarnib|mesh-list
82993976|NCT02579044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82993977|NCT02579044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82993978|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82993979|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82993980|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82993981|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
82993982|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993983|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82993984|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
82993985|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82993986|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82993987|NCT02464696|Prednisolone|prednisolone|mesh-list
82993988|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
82993989|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82993990|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
82993991|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82993992|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
82993993|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
82993994|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82993995|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82993996|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82993997|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
82993998|NCT02464696|Hormones|hormones|mesh-ancestor
82993999|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994000|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82994001|NCT02464696|Protective Agents|protective agents|mesh-ancestor
82994002|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82994003|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994004|NCT04503694|Nivolumab|nivolumab|mesh-list
82994005|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994006|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994007|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82994008|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994009|NCT03525379|Resveratrol|resveratrol|mesh-list
82994010|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
82994011|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994012|NCT03525379|Protective Agents|protective agents|mesh-ancestor
82994013|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994014|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994015|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82994016|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82994017|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82994018|NCT03476551|Diuretics|diuretics|mesh-ancestor
82994019|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
82994020|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994021|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82994022|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82994023|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994025|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82994026|NCT04702789|Dorzolamide|dorzolamide|mesh-list
82994027|NCT04702789|Latanoprost|latanoprost|mesh-list
82994028|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82994029|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82994030|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
82994031|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994032|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994033|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994034|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82994035|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82994036|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82994037|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82994038|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82994039|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82994040|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82994041|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82994042|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994043|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82994044|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82994045|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994046|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82994047|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994048|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
82994049|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994050|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994051|NCT01380522|Metronidazole|metronidazole|mesh-list
82994052|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994053|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994054|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82994055|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82994056|NCT02913326|Warfarin|warfarin|mesh-list
82994057|NCT02913326|Dabigatran|dabigatran|mesh-list
82994058|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
82994059|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
82994060|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82994061|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
82994062|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994063|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994064|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82994065|NCT03725891|Aspirin|aspirin|mesh-list
82994066|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82994067|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82994068|NCT03725891|Analgesics|analgesics|mesh-ancestor
82994069|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
82994070|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994071|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994072|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82994073|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994074|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82994075|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82994076|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994077|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82994078|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82994079|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994080|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
82994081|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
82994082|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
82994083|NCT03751163|Hydroquinone|hydroquinone|mesh-list
82994084|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82994085|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82994086|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994087|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
82994088|NCT03751163|Coagulants|coagulants|mesh-ancestor
82994089|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82994090|NCT03751163|Protective Agents|protective agents|mesh-ancestor
82994091|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994092|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
82994093|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
82994094|NCT03639545|Metformin|metformin|mesh-list
82994095|NCT03639545|Empagliflozin|empagliflozin|mesh-list
82994096|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82994097|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994098|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82994099|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994100|NCT03181386|Warfarin|warfarin|mesh-list
82994101|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
82994102|NCT03181386|Dabigatran|dabigatran|mesh-list
82994103|NCT03181386|Apixaban|apixaban|mesh-list
82994104|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
82994105|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82994106|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
82994107|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82994108|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
82994109|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994110|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994111|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
82994112|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82994113|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
82994114|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82994115|NCT03639467|Gemcitabine|gemcitabine|mesh-list
82994116|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994117|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82994118|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
82994119|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994120|NCT01382706|Docetaxel|docetaxel|mesh-list
82994121|NCT01382706|Lapatinib|lapatinib|mesh-list
82994122|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994123|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
82994124|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
82994125|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
82994126|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994127|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994128|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994129|NCT03665402|Isoniazid|isoniazid|mesh-list
82994130|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
82994131|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994132|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994133|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82994134|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82994135|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
82994136|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994137|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82994138|NCT01380288|Rivastigmine|rivastigmine|mesh-list
82994139|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82994140|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994141|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994142|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
82994143|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994144|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994145|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82994146|NCT01380288|Protective Agents|protective agents|mesh-ancestor
82994147|NCT03110484|Pemetrexed|pemetrexed|mesh-list
82994148|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82994149|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994150|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994151|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994152|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82994153|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82994154|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994155|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
82994156|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994157|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994158|NCT03110328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82994159|NCT03110328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994160|NCT00002874|Bicalutamide|bicalutamide|mesh-list
82994161|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
82994162|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
82994163|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994164|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994165|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994166|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82994167|NCT03001076|Ezetimibe|ezetimibe|mesh-list
82994168|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82994169|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82994170|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
82994171|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994172|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82994173|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994174|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82994175|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994176|NCT03555305|Insulin|insulin|mesh-list
82994177|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82994178|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
82994179|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82994180|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994181|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82994182|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994183|NCT05422716|Baclofen|baclofen|mesh-list
82994184|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
82994185|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994186|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82994187|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994188|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
82994189|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
82994190|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
82994191|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994192|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994193|NCT03728777|Resveratrol|resveratrol|mesh-list
82994194|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
82994195|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994196|NCT03728777|Protective Agents|protective agents|mesh-ancestor
82994197|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994198|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994199|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82994200|NCT05421936|Osimertinib|osimertinib|mesh-list
82994201|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994202|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994203|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994204|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994205|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82994206|NCT01382472|Simvastatin|simvastatin|mesh-list
82994207|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82994208|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82994209|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
82994210|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994211|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82994212|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82994213|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994214|NCT03725423|Apatinib|apatinib|mesh-list
82994215|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994216|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994217|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994218|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994219|NCT03521141|Nicotine|nicotine|mesh-list
82994220|NCT03521141|Varenicline|varenicline|mesh-list
82994221|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82994222|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
82994223|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994224|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994225|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82994226|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82994227|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
82994228|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994229|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994230|NCT03725267|Melatonin|melatonin|mesh-list
82994231|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
82994232|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994233|NCT03725267|Protective Agents|protective agents|mesh-ancestor
82994234|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994235|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994236|NCT02997176|Talazoparib|talazoparib|mesh-list
82994237|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82994238|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994239|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994240|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994241|NCT03000452|Durvalumab|durvalumab|mesh-list
82994242|NCT03000452|Daratumumab|daratumumab|mesh-list
82994243|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994244|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994245|NCT03664388|Clopidogrel|clopidogrel|mesh-list
82994246|NCT03664388|Ticagrelor|ticagrelor|mesh-list
82994247|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83523285|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
82994248|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82994249|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82994250|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82994251|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
82994252|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994253|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994254|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994255|NCT01373164|Gemcitabine|gemcitabine|mesh-list
82994256|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82994257|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
82994258|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994259|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994260|NCT02999984|Busulfan|busulfan|mesh-list
82994261|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
82994262|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994263|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82994264|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
82994265|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994266|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82994267|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994268|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82994269|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82994270|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
82994271|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994272|NCT03312907|Rituximab|rituximab|mesh-list
82994273|NCT03312907|Belimumab|belimumab|mesh-list
82994274|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82994275|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994276|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994277|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
82994278|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994279|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994280|NCT02999672|Trastuzumab|trastuzumab|mesh-list
82994281|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
82994282|NCT02999672|Maytansine|maytansine|mesh-list
82994283|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994284|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994285|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82994286|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
82994287|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
82994288|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
82994289|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994290|NCT02999672|Immunotoxins|immunotoxins|mesh-ancestor
82994291|NCT02999672|Immunoconjugates|immunoconjugates|mesh-ancestor
82994292|NCT02999672|Immunologic Factors|immunologic factors|mesh-ancestor
82994293|NCT02999672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994294|NCT03664622|Ketamine|ketamine|mesh-list
82994295|NCT03664622|Morphine|morphine|mesh-list
82994296|NCT03664622|Analgesics|analgesics|mesh-ancestor
82994297|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
82994298|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994299|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994300|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82994301|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82994302|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
82994303|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
82994304|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994305|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82994306|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82994307|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994308|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994309|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82994310|NCT03664622|Narcotics|narcotics|mesh-ancestor
82994311|NCT04056182|Lofexidine|lofexidine|mesh-list
82994312|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82994313|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82994314|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994315|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
82994316|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994317|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82994318|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82994319|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82994320|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
82994321|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994322|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994323|NCT03573323|Ixekizumab|ixekizumab|mesh-list
82994324|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
82994325|NCT04058054|Histamine|histamine|mesh-list
82994326|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
82994327|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
82994328|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994329|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464510|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
82994330|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994331|NCT04498286|Antibodies|antibodies|mesh-list
82994332|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
82994333|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994334|NCT01069172|Dipivefrin|dipivefrin|mesh-list
82994335|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82994336|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
82994337|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994338|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994339|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994340|NCT04245280|Ropivacaine|ropivacaine|mesh-list
82994341|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82994342|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
82994343|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
82994344|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994345|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994346|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
82994347|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994348|NCT03724955|Estradiol|estradiol|mesh-list
82994349|NCT03724955|Estrogens|estrogens|mesh-ancestor
82994350|NCT03724955|Hormones|hormones|mesh-ancestor
82994351|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994352|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994353|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
82994354|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
82994355|NCT04220008|Busulfan|busulfan|mesh-list
82994356|NCT04220008|Rituximab|rituximab|mesh-list
82994357|NCT04220008|Gemcitabine|gemcitabine|mesh-list
82994358|NCT04220008|Vorinostat|vorinostat|mesh-list
82994359|NCT04220008|Clofarabine|clofarabine|mesh-list
82994360|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82994361|NCT04220008|Tacrolimus|tacrolimus|mesh-list
82994362|NCT04220008|Antibodies|antibodies|mesh-list
82994363|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
82994364|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82994365|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82994366|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
82994367|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994368|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994369|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82994370|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
82994371|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994372|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994373|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82994374|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82994375|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
82994376|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82994377|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994378|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82994379|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82994380|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
82994381|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994382|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994383|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82994384|NCT03721991|Butyric Acid|butyric acid|mesh-list
82994385|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994386|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994387|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994388|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
82994389|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
82994390|NCT02911688|Vitamin E|vitamin e|mesh-list
82994391|NCT02911688|Tocopherols|tocopherols|mesh-list
82994392|NCT02911688|Tocotrienols|tocotrienols|mesh-list
82994393|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
82994394|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
82994395|NCT02911688|Vitamins|vitamins|mesh-ancestor
82994396|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
82994397|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994398|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
82994399|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994400|NCT02911688|Protective Agents|protective agents|mesh-ancestor
82994401|NCT05580250|Metformin|metformin|mesh-list
82994402|NCT05580250|Simvastatin|simvastatin|mesh-list
82994403|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82994404|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994405|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82994406|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82994407|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
82994408|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994409|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82994410|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82994411|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994412|NCT03431948|Nivolumab|nivolumab|mesh-list
82994413|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994414|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994415|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82994416|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994417|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
82994418|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
82994419|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
82994420|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
82994421|NCT03662516|Estradiol|estradiol|mesh-list
82994422|NCT03662516|Abrocitinib|abrocitinib|mesh-list
82994423|NCT03662516|Estrogens|estrogens|mesh-ancestor
82994424|NCT03662516|Hormones|hormones|mesh-ancestor
82994425|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994426|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994427|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82994428|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82994429|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82994430|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82994431|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82994432|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994433|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994434|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994435|NCT03728465|Nivolumab|nivolumab|mesh-list
82994436|NCT03728465|Ipilimumab|ipilimumab|mesh-list
82994437|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994438|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994439|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82994440|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994441|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
82994442|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82994443|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
82994444|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994445|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82994446|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
82994447|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82994448|NCT02994056|Velpatasvir|velpatasvir|mesh-list
82994449|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
82994450|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994451|NCT03728153|Fluoxetine|fluoxetine|mesh-list
82994452|NCT03728153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82994453|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82994454|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82994455|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994456|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994457|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
82994458|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994459|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82994460|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
82994461|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82994462|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82994463|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82994464|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994465|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
82994466|NCT04056806|Terlipressin|terlipressin|mesh-list
82994467|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994468|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994469|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82994470|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82994471|NCT03305575|Bupivacaine|bupivacaine|mesh-list
82994472|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
82994473|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
82994474|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
82994475|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994476|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994477|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
82994478|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994479|NCT02993822|Maleic acid|maleic acid|mesh-list
82994480|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994481|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994482|NCT02391844|Oxycodone|oxycodone|mesh-list
82994483|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82994484|NCT02391844|Narcotics|narcotics|mesh-ancestor
82994485|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994486|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994487|NCT02391844|Analgesics|analgesics|mesh-ancestor
82994488|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
82994489|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994490|NCT02391688|Fexofenadine|fexofenadine|mesh-list
82994491|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
82994492|NCT02391688|Midazolam|midazolam|mesh-list
82994493|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
82994494|NCT02391688|Caffeine|caffeine|mesh-list
82994495|NCT02391688|Bupropion|bupropion|mesh-list
82994496|NCT02391688|Omeprazole|omeprazole|mesh-list
82994497|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82994498|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82994499|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994500|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994501|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82994502|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82994503|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82994504|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82994505|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
82994506|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
82994507|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
82994508|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
82994509|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994510|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994511|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82994512|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82994513|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994514|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82994515|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82994516|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
82994517|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82994518|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82994519|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82994520|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82994521|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
82994522|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82994523|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82994524|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82994525|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
82994526|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82994527|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82994528|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
82994529|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
82994530|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82994531|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82994532|NCT02391688|Analgesics|analgesics|mesh-ancestor
82994533|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
82994534|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994535|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82994536|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82994537|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82994538|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994539|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82994540|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
82994541|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
82994542|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82994551|NCT01068860|Glyburide|glyburide|mesh-list
82994552|NCT01068860|Glipizide|glipizide|mesh-list
82994554|NCT01068860|Tolbutamide|tolbutamide|mesh-list
82994555|NCT01068860|Acetohexamide|acetohexamide|mesh-list
82994556|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
82994557|NCT01068860|Tolazamide|tolazamide|mesh-list
82994558|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
82994559|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82994560|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82994561|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994562|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82994563|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82994564|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
82994565|NCT04056650|Caffeine|caffeine|mesh-list
82994566|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82994567|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994568|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82994569|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994570|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994571|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82994572|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82994573|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
82994574|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994575|NCT04055480|Insulin|insulin|mesh-list
82994576|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82994577|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
82994578|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
82994579|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82994580|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994581|NCT03158090|Lanreotide|lanreotide|mesh-list
82994582|NCT03158090|Octreotide|octreotide|mesh-list
82994583|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994584|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82994585|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82994586|NCT02670538|Cariprazine|cariprazine|mesh-list
82994587|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82994588|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82994589|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994590|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994591|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82994599|NCT03727763|Cetuximab|cetuximab|mesh-list
82994600|NCT03727763|Vemurafenib|vemurafenib|mesh-list
82994601|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994602|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994603|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994604|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994605|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994606|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
82994607|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
82994608|NCT02991482|Gemcitabine|gemcitabine|mesh-list
82994609|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
82994610|NCT02991482|Vinorelbine|vinorelbine|mesh-list
82994611|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82994612|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
82994613|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994614|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994615|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994616|NCT02991482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82994617|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82994618|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
82994619|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
82994620|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
82994622|NCT02391142|Ropivacaine|ropivacaine|mesh-list
83464531|NCT00000250|Analgesics|analgesics|mesh-ancestor
82994623|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
82994624|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
82994625|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994626|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994627|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
82994628|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994629|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82994630|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82994631|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82994632|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82994633|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994634|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
82994635|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
82994636|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994637|NCT04479202|Bentonite|bentonite|mesh-list
82994638|NCT04479202|Antidotes|antidotes|mesh-ancestor
82994639|NCT04479202|Protective Agents|protective agents|mesh-ancestor
82994640|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994641|NCT01372618|Pasireotide|pasireotide|mesh-list
82994642|NCT01372618|Hormones|hormones|mesh-ancestor
82994643|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994644|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994645|NCT03304873|Retapamulin|retapamulin|mesh-list
82994646|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994647|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994648|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
82994649|NCT04526509|Fludarabine|fludarabine|mesh-list
82994650|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82994651|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
82994652|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994653|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994654|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82994655|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
82994656|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994657|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994658|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82994659|NCT03660020|Anesthetics|anesthetics|mesh-list
82994660|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
82994661|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994662|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994663|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
82994664|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994665|NCT03661892|Dronabinol|dronabinol|mesh-list
82994666|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
82994667|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994668|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82994669|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82994670|NCT03661892|Analgesics|analgesics|mesh-ancestor
82994671|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
82994672|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994673|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
82994674|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
82994675|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994676|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994677|NCT03661892|Hormones|hormones|mesh-ancestor
82994678|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464550|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
82994679|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82994680|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82994681|NCT03658850|Diuretics|diuretics|mesh-ancestor
82994682|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
82994683|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994684|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82994685|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82994686|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994687|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
82994688|NCT03659162|Clotrimazole|clotrimazole|mesh-list
82994689|NCT03659162|Miconazole|miconazole|mesh-list
82994690|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994691|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82994692|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82994693|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82994694|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994695|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994696|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82994697|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
82994698|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994699|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994700|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82994701|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82994702|NCT03659084|Deferasirox|deferasirox|mesh-list
82994703|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82994704|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
82994705|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
82994706|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994707|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82994708|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82994709|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82994710|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
82994711|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994712|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82994713|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82994714|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994715|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
82994716|NCT02921750|Laxatives|laxatives|mesh-ancestor
82994717|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82994718|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82994719|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994720|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
82994721|NCT03622502|Remifentanil|remifentanil|mesh-list
82994722|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82994723|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994724|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994725|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82994726|NCT03622502|Analgesics|analgesics|mesh-ancestor
82994727|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
82994728|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994729|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82994730|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82994731|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82994732|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
82994733|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994734|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994735|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82994736|NCT03622502|Narcotics|narcotics|mesh-ancestor
82994737|NCT04397354|Dexamethasone|dexamethasone|mesh-list
82994738|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
82994740|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82994741|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
82994742|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
82994743|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994744|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994745|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82994746|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
82994747|NCT04397354|Hormones|hormones|mesh-ancestor
83464559|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994748|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994749|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82994750|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994751|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
82994752|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994753|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994754|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
82994755|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82994756|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82994757|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
82994758|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994759|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82994760|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82994761|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994762|NCT01068158|Ivermectin|ivermectin|mesh-list
82994763|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82994764|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994765|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82994766|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
82994767|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994768|NCT01067846|Cycloserine|cycloserine|mesh-list
82994769|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82994770|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994771|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82994772|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
82994773|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994774|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
82994775|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994776|NCT03874234|GSK3186899|gsk3186899|mesh-list
82994777|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994778|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994779|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994780|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
82994781|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994782|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994783|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82994784|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82994785|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994786|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994787|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994788|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
82994789|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82994790|NCT05275777|Paclitaxel|paclitaxel|mesh-list
82994791|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
82994792|NCT05275777|Doxorubicin|doxorubicin|mesh-list
82994793|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82994794|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994795|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
82994796|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
82994797|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
82994798|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994799|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82994800|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
82994801|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994802|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994803|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82994804|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
82994805|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82994806|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82994807|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82994808|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82994809|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994810|NCT05672212|Sufentanil|sufentanil|mesh-list
82994811|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82994812|NCT05672212|Narcotics|narcotics|mesh-ancestor
82994813|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994814|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994815|NCT05672212|Analgesics|analgesics|mesh-ancestor
83464564|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
82994816|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
82994817|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994818|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82994819|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82994820|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
82994821|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
82994822|NCT02390674|Cyclosporine|cyclosporine|mesh-list
82994823|NCT02390674|Cyclosporins|cyclosporins|mesh-list
82994824|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994825|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994826|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82994827|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
82994828|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994829|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
82994830|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994831|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
82994832|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994833|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82994834|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82994835|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994836|NCT02663674|Fluconazole|fluconazole|mesh-list
82994837|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
82994838|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994839|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82994840|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82994841|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994842|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994843|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82994844|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
82994845|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82994846|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994847|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82994848|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82994849|NCT03657212|Zolpidem|zolpidem|mesh-list
82994850|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82994851|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82994852|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994853|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994854|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82994855|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
82994856|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
82994857|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994858|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994859|NCT03310411|Sumatriptan|sumatriptan|mesh-list
82994861|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82994862|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82994863|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82994864|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
82994865|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994866|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994867|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994868|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
82994869|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
82994870|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82994871|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994872|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994873|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
82994874|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82994875|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994876|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994877|NCT02390440|Bupivacaine|bupivacaine|mesh-list
82994878|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
82994879|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
82994880|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82994881|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994882|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
82994883|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994884|NCT03677830|Acetaminophen|acetaminophen|mesh-list
82994885|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82994886|NCT03677830|Analgesics|analgesics|mesh-ancestor
82994887|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
82994888|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994889|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994890|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
82994891|NCT02199691|Vaccines|vaccines|mesh-list
82994892|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
82994893|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994894|NCT05667454|Atropine|atropine|mesh-list
82994895|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82994896|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82994897|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82994898|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
82994899|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994900|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994901|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82994902|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
82994903|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
82994904|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
82994905|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82994906|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82994907|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
82994908|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994909|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994910|NCT02389972|Dasatinib|dasatinib|mesh-list
82994911|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994912|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82994913|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994914|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994915|NCT03502330|Nivolumab|nivolumab|mesh-list
82994916|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82994917|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82994918|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82994919|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994921|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82994922|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82994923|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82994924|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
82994925|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
82994926|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82994927|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994928|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994929|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82994930|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82994931|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994932|NCT02389582|Enoxaparin|enoxaparin|mesh-list
82994933|NCT02389582|Dabigatran|dabigatran|mesh-list
82994934|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
82994935|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82994936|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82994937|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994938|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
82994939|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82994940|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
82994941|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994942|NCT02389426|Bosentan|bosentan|mesh-list
82994943|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82994944|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82994945|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994946|NCT02389348|Artefenomel|artefenomel|mesh-list
82994947|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
82994948|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82994949|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82994950|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994951|NCT02387242|Rifampin|rifampin|mesh-list
82994952|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82994953|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
82994954|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82994955|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994956|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
82994957|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82994958|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994959|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994960|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82994961|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82994962|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82994963|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82994964|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82994965|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82994966|NCT03656588|Iodine|iodine|mesh-list
82994967|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
82994968|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
82994969|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
82994970|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
82994971|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82994972|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82994973|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
82994974|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
82994975|NCT03656588|Trace Elements|trace elements|mesh-ancestor
82994976|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
82994977|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994978|NCT02387086|Aspirin|aspirin|mesh-list
82994979|NCT02387086|Thalidomide|thalidomide|mesh-list
82994980|NCT02387086|Gefitinib|gefitinib|mesh-list
82994981|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82994982|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82994983|NCT02387086|Analgesics|analgesics|mesh-ancestor
82994984|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
82994985|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82994986|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82994987|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82994988|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82994989|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82994990|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82994991|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82994992|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82994993|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82994994|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82994995|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
82994996|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82994997|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
82994998|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
82994999|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995000|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995001|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82995002|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82995003|NCT02387086|Growth Substances|growth substances|mesh-ancestor
82995004|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
82995005|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995006|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82995007|NCT02383030|Fulvestrant|fulvestrant|mesh-list
82995008|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82995009|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995010|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82995011|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82995012|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995013|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995014|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995015|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82995016|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
82995017|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995018|NCT02983604|Fulvestrant|fulvestrant|mesh-list
82995019|NCT02983604|Exemestane|exemestane|mesh-list
82995020|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82995021|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995022|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82995023|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82995024|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995025|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995026|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995027|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82995028|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82995029|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995030|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995031|NCT03656432|Fluorides|fluorides|mesh-list
82995032|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
82995033|NCT03656432|Protective Agents|protective agents|mesh-ancestor
82995034|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995035|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
82995036|NCT02386462|Propofol|propofol|mesh-list
82995037|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82995038|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82995039|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995040|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995041|NCT02386462|Analgesics|analgesics|mesh-ancestor
82995042|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
82995043|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995044|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82995045|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82995046|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82995047|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
82995048|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995049|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995050|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82995051|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
82995052|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
82995053|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
82995054|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
82995055|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995056|NCT02382328|Protective Agents|protective agents|mesh-ancestor
82995057|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995058|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
82995059|NCT02382328|Vitamins|vitamins|mesh-ancestor
82995060|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
82995061|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
82995062|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995063|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995064|NCT02388490|Immunotoxins|immunotoxins|mesh-ancestor
82995065|NCT02388490|Immunoconjugates|immunoconjugates|mesh-ancestor
82995066|NCT02388490|Immunologic Factors|immunologic factors|mesh-ancestor
82995067|NCT02388490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995068|NCT02382094|Bicalutamide|bicalutamide|mesh-list
82995069|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
82995070|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995071|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995072|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995073|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995074|NCT02386150|Vaccines|vaccines|mesh-list
82995075|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
82995076|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995077|NCT02377180|Anesthetics|anesthetics|mesh-list
82995078|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
82995079|NCT02377180|Capsaicin|capsaicin|mesh-list
82995080|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82995081|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995082|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
82995083|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995084|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
82995085|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995086|NCT03656042|Lenograstim|lenograstim|mesh-list
82995087|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82995088|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
82995089|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995090|NCT03655964|Olmesartan|olmesartan|mesh-list
82995091|NCT03655964|Nebivolol|nebivolol|mesh-list
82995092|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
82995093|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82995094|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82995095|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995096|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
82995097|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82995098|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82995099|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82995100|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
82995101|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995102|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995103|NCT02982590|Warfarin|warfarin|mesh-list
82995104|NCT02982590|Apixaban|apixaban|mesh-list
82995105|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
82995106|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82995107|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
82995108|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82995109|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995110|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995111|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995112|NCT02381548|Belinostat|belinostat|mesh-list
82995113|NCT02381548|Adavosertib|adavosertib|mesh-list
82995114|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995115|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995116|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995117|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82995118|NCT02381314|Ipilimumab|ipilimumab|mesh-list
82995119|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995120|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995121|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82995122|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995123|NCT04282018|Tislelizumab|tislelizumab|mesh-list
82995124|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
82995125|NCT04282018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995126|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995127|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82995128|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995129|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995130|NCT02386072|Mirabegron|mirabegron|mesh-list
82995131|NCT02386072|Oxybutynin|oxybutynin|mesh-list
82995132|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
82995133|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82995134|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82995135|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82995136|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
82995137|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995138|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995139|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995140|NCT02386072|Urological Agents|urological agents|mesh-ancestor
82995141|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82995142|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
82995143|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
82995144|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
82995145|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995146|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
82995147|NCT02381470|Amoxicillin|amoxicillin|mesh-list
82995148|NCT02381470|Rifampin|rifampin|mesh-list
82995149|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82995150|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
82995151|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
82995152|NCT02381470|Cefadroxil|cefadroxil|mesh-list
82995153|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995154|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995155|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82995156|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
82995157|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
82995158|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82995159|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995160|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995161|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82995162|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82995163|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82995164|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82995165|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82995166|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82995167|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82995168|NCT02381158|Beclomethasone|beclomethasone|mesh-list
82995169|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995170|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
82995171|NCT02381158|Hormones|hormones|mesh-ancestor
82995172|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995173|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995174|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82995175|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
82995176|NCT02381080|Voriconazole|voriconazole|mesh-list
82995177|NCT02381080|Erythromycin|erythromycin|mesh-list
82995178|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
82995179|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82995180|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
82995181|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
82995182|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995183|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82995184|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82995185|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995186|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995187|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82995188|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995189|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995190|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995191|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82995192|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995193|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995194|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82995195|NCT04694248|Aspirin|aspirin|mesh-list
82995196|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
82995197|NCT04694248|Anticoagulants|anticoagulants|mesh-list
82995198|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995199|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995200|NCT04694248|Analgesics|analgesics|mesh-ancestor
82995201|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
82995202|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995203|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995204|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995205|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995206|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82995207|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82995208|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995209|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82995210|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82995211|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995212|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
82995213|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82995214|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
82995215|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82995216|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995217|NCT02376478|Folic Acid|folic acid|mesh-list
82995218|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
82995219|NCT02376478|Adalimumab|adalimumab|mesh-list
82995220|NCT02376478|Infliximab|infliximab|mesh-list
82995221|NCT02376478|Etanercept|etanercept|mesh-list
82995222|NCT02376478|Methotrexate|methotrexate|mesh-list
82995223|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
82995224|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
82995225|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82995226|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
82995227|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82995228|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995229|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82995230|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
82995231|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995232|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995233|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995234|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995235|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995236|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
82995237|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995238|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82995239|NCT02376478|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82995240|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995241|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995242|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995243|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995244|NCT02376478|Analgesics|analgesics|mesh-ancestor
82995245|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
82995246|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995247|NCT02376478|Hematinics|hematinics|mesh-ancestor
82995248|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
82995249|NCT02376478|Vitamins|vitamins|mesh-ancestor
82995250|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
82995251|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995252|NCT02385448|Dienogest|dienogest|mesh-list
82995253|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
82995254|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
82995255|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
82995256|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
82995257|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82995258|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995259|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
82995260|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82995261|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82995262|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82995263|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995264|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995265|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82995266|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995267|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82995268|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82995269|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
82995270|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82995271|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82995272|NCT02376400|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82995273|NCT02376400|Antiviral Agents|antiviral agents|mesh-ancestor
82995274|NCT02376400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995275|NCT02385058|Mebendazole|mebendazole|mesh-list
82995276|NCT02385058|Piperazine|piperazine|mesh-list
82995277|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
82995278|NCT02385058|DMP 777|dmp 777|mesh-list
82995279|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
82995280|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
82995281|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82995282|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995283|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
82995284|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
82995285|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
82995286|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995287|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995288|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995289|NCT02376088|Methimazole|methimazole|mesh-list
82995290|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
82995291|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995292|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464602|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995293|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995294|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
82995295|NCT03310021|Apixaban|apixaban|mesh-list
82995296|NCT03310021|Edoxaban|edoxaban|mesh-list
82995297|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
82995298|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
82995299|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82995300|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995301|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995302|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995303|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
82995305|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
82995306|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995307|NCT03333109|Analgesics|analgesics|mesh-ancestor
82995308|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
82995309|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995310|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995311|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
82995312|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82995313|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82995314|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
82995315|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
82995316|NCT01312831|Vitamins|vitamins|mesh-ancestor
82995317|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
82995318|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995319|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
82995320|NCT01312831|Hematinics|hematinics|mesh-ancestor
82995321|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
82995322|NCT03296527|Hormones|hormones|mesh-ancestor
82995323|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995324|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995325|NCT04431193|Oxytocin|oxytocin|mesh-list
82995326|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
82995327|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82995328|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995329|NCT03293485|Imipenem|imipenem|mesh-list
82995330|NCT03293485|Relebactam|relebactam|mesh-list
82995331|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
82995332|NCT03293485|Cilastatin|cilastatin|mesh-list
82995333|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995334|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995335|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995336|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995337|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995338|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82995339|NCT03309943|Propranolol|propranolol|mesh-list
82995340|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82995341|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82995342|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
82995343|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995344|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995345|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995346|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82995347|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82995348|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
82995349|NCT01732627|Vaccines|vaccines|mesh-list
82995350|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
82995351|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995352|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82995353|NCT03331315|Celecoxib|celecoxib|mesh-list
82995354|NCT03331315|Ketorolac|ketorolac|mesh-list
82995355|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995356|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995357|NCT03331315|Analgesics|analgesics|mesh-ancestor
82995358|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
82995359|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995360|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995361|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995362|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995363|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82995364|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83464612|NCT00982865|Niacinamide|niacinamide|mesh-list
82995365|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995366|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995367|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
82995368|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
82995369|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995370|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995371|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995372|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
82995373|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
82995374|NCT02661490|Vaccines|vaccines|mesh-list
82995375|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
82995376|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995377|NCT03287791|Azelaic acid|azelaic acid|mesh-list
82995378|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
82995379|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82995380|NCT03287791|Protective Agents|protective agents|mesh-ancestor
82995381|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995382|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995383|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995384|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82995385|NCT03287635|Hormones|hormones|mesh-ancestor
82995386|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995387|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995388|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
82995389|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82995390|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995391|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995392|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
82995393|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82995394|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995395|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
82995396|NCT02385136|Temozolomide|temozolomide|mesh-list
82995397|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82995398|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
82995399|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995400|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995401|NCT04927780|Leucovorin|leucovorin|mesh-list
82995402|NCT04927780|Fluorouracil|fluorouracil|mesh-list
82995403|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
82995404|NCT04927780|Irinotecan|irinotecan|mesh-list
82995405|NCT04927780|Calcium|calcium|mesh-list
82995406|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
82995407|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82995408|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995409|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
82995410|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995411|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82995412|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995413|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995414|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
82995415|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82995416|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82995417|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995418|NCT04927780|Antidotes|antidotes|mesh-ancestor
82995419|NCT04927780|Protective Agents|protective agents|mesh-ancestor
82995420|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
82995421|NCT04927780|Vitamins|vitamins|mesh-ancestor
82995422|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
82995423|NCT02940691|Grazoprevir|grazoprevir|mesh-list
82995424|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82995425|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
82995426|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995427|NCT04949269|Deucravacitinib|deucravacitinib|mesh-list
82995428|NCT04949269|Famotidine|famotidine|mesh-list
82995429|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82995430|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995431|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
82995432|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
82995433|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
82995434|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995435|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995436|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995437|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995438|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82995439|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995440|NCT02379754|Gentamicins|gentamicins|mesh-list
82995442|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995443|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82995444|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995445|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995446|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
82995447|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82995448|NCT01313377|Gemcitabine|gemcitabine|mesh-list
82995449|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
82995450|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82995451|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
82995452|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995453|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995454|NCT02384746|Fulvestrant|fulvestrant|mesh-list
82995455|NCT02384746|Ixazomib|ixazomib|mesh-list
82995456|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82995457|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995458|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
82995459|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82995460|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995461|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995462|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995463|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995464|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995465|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995467|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995468|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82995469|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995470|NCT03113344|Amoxicillin|amoxicillin|mesh-list
82995471|NCT03113344|Azithromycin|azithromycin|mesh-list
82995472|NCT03113344|Meropenem|meropenem|mesh-list
82995473|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
82995474|NCT03113344|Penicillins|penicillins|mesh-list
82995475|NCT03113344|Imipenem|imipenem|mesh-list
82995476|NCT03113344|Erythromycin|erythromycin|mesh-list
82995477|NCT03113344|Ceftazidime|ceftazidime|mesh-list
82995478|NCT03113344|Ampicillin|ampicillin|mesh-list
82995479|NCT03113344|Cephalosporins|cephalosporins|mesh-list
82995480|NCT03113344|Acyclovir|acyclovir|mesh-list
82995481|NCT03113344|Ganciclovir|ganciclovir|mesh-list
82995482|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
82995483|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995484|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995485|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995486|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995487|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995488|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82995489|NCT03113266|Antibodies|antibodies|mesh-list
82995490|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82995491|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
82995492|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995493|NCT02379676|Clopidogrel|clopidogrel|mesh-list
82995494|NCT02379676|Ticagrelor|ticagrelor|mesh-list
82995495|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82995496|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82995497|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82995498|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82995499|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
82995500|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995501|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995502|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995503|NCT04715230|Lorazepam|lorazepam|mesh-list
82995504|NCT04715230|Haloperidol|haloperidol|mesh-list
82995505|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
82995506|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
82995507|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
82995508|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995509|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995510|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995511|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82995512|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83464617|NCT00001054|Valacyclovir|valacyclovir|mesh-list
82995513|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82995514|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82995515|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82995516|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
82995517|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995518|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995519|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82995520|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
82995521|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82995522|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82995523|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
82995524|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
82995525|NCT02378740|Ketamine|ketamine|mesh-list
82995526|NCT02378740|Analgesics|analgesics|mesh-ancestor
82995527|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
82995528|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995529|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995530|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82995531|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82995532|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
82995533|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
82995534|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82995535|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82995536|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82995537|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995538|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995540|NCT01411267|Methotrexate|methotrexate|mesh-list
82995541|NCT01411267|Etoposide|etoposide|mesh-list
82995542|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
82995543|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82995544|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
82995545|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82995546|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995547|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82995548|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
82995549|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995550|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995551|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995552|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995553|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82995554|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995555|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
82995556|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995557|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82995558|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82995559|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82995560|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82995561|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
82995562|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995563|NCT03113110|Empagliflozin|empagliflozin|mesh-list
82995564|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82995565|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995566|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82995567|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995568|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83464625|NCT01226719|Leucovorin|leucovorin|mesh-list
82995569|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995570|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995571|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995572|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82995573|NCT02383888|BI 425809|bi 425809|mesh-list
82995574|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
82995575|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
82995576|NCT03130959|Nivolumab|nivolumab|mesh-list
82995577|NCT03130959|Ipilimumab|ipilimumab|mesh-list
82995578|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995579|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995580|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82995581|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995582|NCT01370031|Charcoal|charcoal|mesh-list
82995583|NCT01370031|Antidotes|antidotes|mesh-ancestor
82995584|NCT01370031|Protective Agents|protective agents|mesh-ancestor
82995585|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995586|NCT02373514|Acetaminophen|acetaminophen|mesh-list
82995587|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
82995588|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995589|NCT02373514|Analgesics|analgesics|mesh-ancestor
82995590|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
82995591|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995592|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995593|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
82995594|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995595|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995596|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995597|NCT01364493|Capecitabine|capecitabine|mesh-list
82995598|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
82995599|NCT01364493|Trastuzumab|trastuzumab|mesh-list
82995600|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82995601|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
82995602|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995603|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995604|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995605|NCT01370187|Montelukast|montelukast|mesh-list
82995606|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82995607|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
82995608|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
82995609|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995610|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995611|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995612|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82995613|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82995614|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995615|NCT04483960|Nafamostat|nafamostat|mesh-list
82995616|NCT04483960|Enoxaparin|enoxaparin|mesh-list
82995617|NCT04483960|Dalteparin|dalteparin|mesh-list
82995618|NCT04483960|Tinzaparin|tinzaparin|mesh-list
82995619|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
82995620|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
82995621|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82995622|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82995623|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995624|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995625|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995626|NCT04483960|Analgesics|analgesics|mesh-ancestor
82995627|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
82995628|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995629|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995630|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995631|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995632|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995633|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995634|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
82995635|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82995636|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
82995637|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995638|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
82995639|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
82995640|NCT01370343|Cyclosporine|cyclosporine|mesh-list
82995641|NCT01370343|Cyclosporins|cyclosporins|mesh-list
82995642|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
82995643|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995644|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995645|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995646|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
82995647|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995648|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
82995649|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995650|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995651|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995652|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82995653|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
82995654|NCT01370343|Vitamins|vitamins|mesh-ancestor
82995655|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
82995656|NCT01368003|Dutasteride|dutasteride|mesh-list
82995657|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
82995658|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82995659|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995660|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995661|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
82995662|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995663|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995664|NCT01364571|Vaccines|vaccines|mesh-list
82995665|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
82995666|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995667|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82995668|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82995669|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995670|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
82995671|NCT03933904|Sirolimus|sirolimus|mesh-list
82995672|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995673|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995674|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82995675|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995676|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
82995677|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995678|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
82995679|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995680|NCT02377648|Everolimus|everolimus|mesh-list
82995681|NCT02377648|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82995682|NCT02377648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82995683|NCT02377648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995684|NCT02377648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995685|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995686|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
82995687|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995688|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995689|NCT02371408|Ribavirin|ribavirin|mesh-list
82995690|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
82995691|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
82995692|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995693|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
82995694|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995695|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
82995696|NCT01364805|Gemcitabine|gemcitabine|mesh-list
82995697|NCT01364805|Vitamins|vitamins|mesh-ancestor
82995698|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
82995699|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995700|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82995701|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
82995702|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995703|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995704|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
82995705|NCT01364805|Protective Agents|protective agents|mesh-ancestor
82995706|NCT01370889|Resveratrol|resveratrol|mesh-list
82995707|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
82995708|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995709|NCT01370889|Protective Agents|protective agents|mesh-ancestor
82995710|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995711|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995712|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82995713|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82995714|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82995715|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995716|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82995717|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995718|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
82995719|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
82995720|NCT04382404|Velpatasvir|velpatasvir|mesh-list
82995721|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
82995722|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995723|NCT02371096|Rituximab|rituximab|mesh-list
82995724|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995725|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995726|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
82995727|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995728|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995729|NCT04420455|Enoximone|enoximone|mesh-list
82995730|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82995731|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
82995732|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82995733|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82995734|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995735|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995736|NCT04420455|Protective Agents|protective agents|mesh-ancestor
82995737|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995738|NCT04381936|Aspirin|aspirin|mesh-list
82995739|NCT04381936|Empagliflozin|empagliflozin|mesh-list
82995740|NCT04381936|Ritonavir|ritonavir|mesh-list
82995742|NCT04381936|Azithromycin|azithromycin|mesh-list
82995743|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
82995744|NCT04381936|Nirmatrelvir|nirmatrelvir|mesh-list
82995745|NCT04381936|Sotrovimab|sotrovimab|mesh-list
82995746|NCT04381936|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
82995747|NCT04381936|Molnupiravir|molnupiravir|mesh-list
82995748|NCT04381936|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
82995749|NCT04381936|Colchicine|colchicine|mesh-list
82995750|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82995751|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
82995752|NCT04381936|Antibodies|antibodies|mesh-list
82995753|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
82995754|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
82995755|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83523286|NCT04342247|Hormones|hormones|mesh-ancestor
82995756|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995757|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995758|NCT04381936|Analgesics|analgesics|mesh-ancestor
82995759|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
82995760|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995761|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995762|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995763|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82995764|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82995765|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995766|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82995767|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82995768|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995769|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
82995770|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82995771|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82995772|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995773|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82995774|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82995775|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
82995776|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995777|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82995778|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82995779|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995780|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
82995781|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82995782|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82995783|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82995784|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82995785|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
82995786|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
82995787|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
82995788|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
82995789|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995790|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995791|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995792|NCT03124407|Capsaicin|capsaicin|mesh-list
82995793|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
82995794|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995795|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
82995796|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995797|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995798|NCT01364961|Resveratrol|resveratrol|mesh-list
82995799|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
82995800|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995801|NCT01364961|Protective Agents|protective agents|mesh-ancestor
82995802|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995803|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995804|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82995805|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
82995806|NCT02370862|Neostigmine|neostigmine|mesh-list
82995807|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
82995808|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995809|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995810|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
82995811|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995812|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995813|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
82995814|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
82995815|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995816|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82995817|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82995818|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82995819|NCT03620578|Nivolumab|nivolumab|mesh-list
82995820|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995821|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995822|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82995823|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995824|NCT02373280|Amoxicillin|amoxicillin|mesh-list
82995825|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
82995826|NCT02373280|Metronidazole|metronidazole|mesh-list
82995827|NCT02373280|Clarithromycin|clarithromycin|mesh-list
82995828|NCT02373280|Esomeprazole|esomeprazole|mesh-list
82995829|NCT02373280|Bismuth|bismuth|mesh-list
82995830|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
82995831|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995832|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995833|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82995834|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82995835|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995836|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995837|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995838|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83464661|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
82995839|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
82995840|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82995841|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995842|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
82995843|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82995844|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82995845|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82995846|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82995847|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82995848|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995849|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82995850|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82995851|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82995852|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82995853|NCT02373280|Antacids|antacids|mesh-ancestor
82995854|NCT02370550|Cyclosporine|cyclosporine|mesh-list
82995855|NCT02370550|Prednisone|prednisone|mesh-list
82995856|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
82995857|NCT02370550|Calcium|calcium|mesh-list
82995858|NCT02370550|Cyclosporins|cyclosporins|mesh-list
82995859|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82995860|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995861|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995862|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
82995863|NCT02370550|Hormones|hormones|mesh-ancestor
82995864|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995865|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82995866|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995867|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995868|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995869|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995870|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
82995871|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
82995872|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995873|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
82995874|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995875|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82995876|NCT02370550|Antacids|antacids|mesh-ancestor
82995877|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995878|NCT02365402|Entecavir|entecavir|mesh-list
82995879|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
82995880|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995881|NCT02364934|Propofol|propofol|mesh-list
82995882|NCT02364934|Sevoflurane|sevoflurane|mesh-list
82995883|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82995884|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82995885|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995886|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82995887|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
82995888|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
82995889|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82995890|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82995891|NCT02372656|Metformin|metformin|mesh-list
82995892|NCT02372656|Simvastatin|simvastatin|mesh-list
82995893|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82995894|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995895|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82995896|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82995897|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
82995898|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995899|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82995900|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82995901|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995902|NCT03123939|Tisagenlecleucel|tisagenlecleucel|mesh-list
82995903|NCT03123939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82995904|NCT03123939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995906|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995907|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995908|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82995909|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995910|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
82995911|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82995912|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
82995913|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995914|NCT02358681|Ketorolac|ketorolac|mesh-list
82995915|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82995916|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995917|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995918|NCT02358681|Analgesics|analgesics|mesh-ancestor
82995919|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
82995920|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995921|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995922|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995923|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995924|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82995925|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995926|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995927|NCT03123861|Gabapentin|gabapentin|mesh-list
82995928|NCT03123861|Analgesics|analgesics|mesh-ancestor
82995929|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
82995930|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995931|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995932|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
82995933|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82995934|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82995935|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82995936|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82995937|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82995938|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82995939|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82995940|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995941|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
82995942|NCT01368783|Ritonavir|ritonavir|mesh-list
82995943|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
82995944|NCT01368783|Tenofovir|tenofovir|mesh-list
82995945|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82995946|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82995947|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
82995948|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995949|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995950|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82995951|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82995952|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
82995953|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995954|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82995955|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82995956|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82995957|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82995958|NCT01509339|Vancomycin|vancomycin|mesh-list
82995959|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82995960|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995961|NCT03123471|Apremilast|apremilast|mesh-list
82995962|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82995963|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82995964|NCT03123471|Analgesics|analgesics|mesh-ancestor
82995965|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
82995966|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995967|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995968|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995969|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82995970|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82995971|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82995972|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82995973|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82995974|NCT02661178|Emodepside|emodepside|mesh-list
82995975|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82995976|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82995977|NCT01365117|Insulin|insulin|mesh-list
82995978|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82995980|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995981|NCT02372812|Dexamethasone|dexamethasone|mesh-list
82995982|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82995983|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
82995984|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
82995985|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995986|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995987|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82995988|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
82995989|NCT02372812|Hormones|hormones|mesh-ancestor
82995990|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82995991|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82995992|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82995993|NCT02365012|Midodrine|midodrine|mesh-list
82995994|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
82995995|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
82995996|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82995997|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82995998|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82995999|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
82996000|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82996001|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82996002|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
82996003|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996004|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996005|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
82996006|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996007|NCT01365351|Hormones|hormones|mesh-list
82996008|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996009|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996010|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
82996011|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82996012|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996013|NCT01372449|Memantine|memantine|mesh-list
82996014|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82996015|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82996016|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
82996017|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996018|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996019|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996020|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82996021|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82996022|NCT04666389|Atorvastatin|atorvastatin|mesh-list
82996023|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82996024|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82996025|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
82996026|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996027|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82996028|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82996029|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996030|NCT02372110|Caffeine|caffeine|mesh-list
82996031|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82996032|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996033|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82996034|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996035|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996036|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82996037|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82996038|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
82996040|NCT02372188|Caffeine|caffeine|mesh-list
82996041|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82996042|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996043|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82996044|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996045|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996046|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82996047|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82996048|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
82996049|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996050|NCT01371435|Paroxetine|paroxetine|mesh-list
83483343|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996051|NCT01371435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82996052|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83464679|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996053|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82996054|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996055|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996056|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
82996057|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996058|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82996059|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
82996060|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82996061|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82996062|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82996063|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996064|NCT01369719|Deferasirox|deferasirox|mesh-list
82996065|NCT01369719|Deferoxamine|deferoxamine|mesh-list
82996066|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82996067|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
82996068|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
82996069|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996070|NCT01369719|Siderophores|siderophores|mesh-ancestor
82996071|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
82996072|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82996073|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
82996074|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996075|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
82996076|NCT02369380|Protective Agents|protective agents|mesh-ancestor
82996077|NCT02038816|Azacitidine|azacitidine|mesh-list
82996078|NCT02038816|Deferasirox|deferasirox|mesh-list
82996079|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996080|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
82996081|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996082|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996083|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996084|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
82996085|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
82996086|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
82996087|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
82996088|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82996089|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996090|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
82996091|NCT02358850|Acetaminophen|acetaminophen|mesh-list
82996092|NCT02358850|Oxycodone|oxycodone|mesh-list
82996093|NCT02358850|Hydromorphone|hydromorphone|mesh-list
82996094|NCT02358850|Hydrocodone|hydrocodone|mesh-list
82996095|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82996096|NCT02358850|Analgesics|analgesics|mesh-ancestor
82996097|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
82996098|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996099|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996100|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
82996101|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82996102|NCT02358850|Narcotics|narcotics|mesh-ancestor
82996103|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996104|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
82996105|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
82996106|NCT02359162|Prednisone|prednisone|mesh-list
82996107|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
82996108|NCT02359162|Gemcitabine|gemcitabine|mesh-list
82996109|NCT02359162|Doxorubicin|doxorubicin|mesh-list
82996110|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
82996111|NCT02359162|Etoposide|etoposide|mesh-list
82996112|NCT02359162|Vincristine|vincristine|mesh-list
82996113|NCT02359162|Pegaspargase|pegaspargase|mesh-list
82996114|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996115|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
82996116|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996117|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996118|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82996119|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
82996120|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996121|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996122|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82996123|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996124|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
82996125|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82996126|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82996127|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82996129|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82996130|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
82996132|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996133|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82996134|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82996135|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
82996136|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
82996137|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
82996138|NCT03634605|Tetracycline|tetracycline|mesh-list
82996139|NCT03634605|Lidocaine|lidocaine|mesh-list
82996140|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
82996141|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
82996142|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996143|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996144|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
82996145|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996146|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82996147|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82996148|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82996149|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82996150|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996151|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996152|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996153|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82996154|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996155|NCT02363764|Dimercaprol|dimercaprol|mesh-list
82996156|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
82996157|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
82996158|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996159|NCT03654794|Tacrolimus|tacrolimus|mesh-list
82996160|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996161|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
82996162|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996163|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82996164|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996165|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996166|NCT03654170|BI 425809|bi 425809|mesh-list
82996167|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
82996168|NCT02369146|UB-421|ub-421|mesh-list
82996169|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996170|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
82996171|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996172|NCT02363452|Lamivudine|lamivudine|mesh-list
82996173|NCT02363452|Zidovudine|zidovudine|mesh-list
82996174|NCT02363452|Abacavir|abacavir|mesh-list
82996175|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
82996176|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82996177|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996178|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996179|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
82996180|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996181|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82996182|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996183|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
82996184|NCT03634137|Afamelanotide|afamelanotide|mesh-list
82996185|NCT03634137|alpha-MSH|alpha-msh|mesh-list
82996186|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
82996187|NCT03634137|Hormones|hormones|mesh-ancestor
82996188|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996189|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996190|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
82996191|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
82996192|NCT02358694|Antibodies|antibodies|mesh-list
82996193|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
82996194|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996195|NCT04473807|Sotalol|sotalol|mesh-list
82996196|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82996197|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82996198|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
82996199|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996200|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996201|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996202|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82996203|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
82996205|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996206|NCT02323659|Interferons|interferons|mesh-list
82996207|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
82996208|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
82996209|NCT02323659|Methotrexate|methotrexate|mesh-list
82996210|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82996211|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
82996212|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82996213|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996214|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996215|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
82996216|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996217|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996218|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
82996219|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996220|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82996221|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996222|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
82996223|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996224|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82996225|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
82996226|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996227|NCT03634059|Apatinib|apatinib|mesh-list
82996228|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996229|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82996230|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996231|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996232|NCT02358304|Calcitonin|calcitonin|mesh-list
82996233|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
82996234|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
82996235|NCT02358304|Katacalcin|katacalcin|mesh-list
82996236|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82996237|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996238|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82996239|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
82996240|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
82996241|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
82996242|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82996243|NCT01316523|Rituximab|rituximab|mesh-list
82996244|NCT01316523|Lenalidomide|lenalidomide|mesh-list
82996245|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996246|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996247|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
82996248|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996249|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996250|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82996251|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82996252|NCT01316523|Growth Substances|growth substances|mesh-ancestor
82996253|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
82996254|NCT02362906|Azithromycin|azithromycin|mesh-list
82996255|NCT02362906|Erythromycin|erythromycin|mesh-list
82996256|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
82996257|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82996258|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
82996259|NCT02362906|Cephalosporins|cephalosporins|mesh-list
82996260|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996261|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996262|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82996263|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82996264|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996265|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996266|NCT04469530|Sirolimus|sirolimus|mesh-list
82996267|NCT04469530|Celecoxib|celecoxib|mesh-list
82996268|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
82996269|NCT04469530|Etoposide|etoposide|mesh-list
82996270|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996271|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
82996272|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996273|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996274|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82996275|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
82996276|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996277|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996278|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83523363|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
82996279|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82996280|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82996281|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82996282|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996283|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996284|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996285|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82996286|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
82996287|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82996288|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82996289|NCT04469530|Analgesics|analgesics|mesh-ancestor
82996290|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
82996291|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996292|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82996293|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
82996294|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82996295|NCT03085914|Leucovorin|leucovorin|mesh-list
82996296|NCT03085914|Paclitaxel|paclitaxel|mesh-list
82996297|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82996298|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
82996299|NCT03085914|Carboplatin|carboplatin|mesh-list
82996300|NCT03085914|Gemcitabine|gemcitabine|mesh-list
82996301|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
82996302|NCT03085914|Fluorouracil|fluorouracil|mesh-list
82996303|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
82996304|NCT03085914|Pemetrexed|pemetrexed|mesh-list
82996305|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82996306|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996307|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
82996308|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
82996309|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
82996310|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996311|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996312|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
82996313|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996314|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996315|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82996316|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
82996317|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82996318|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996319|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
82996320|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996321|NCT03085914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82996322|NCT03085914|Antidotes|antidotes|mesh-ancestor
82996323|NCT03085914|Protective Agents|protective agents|mesh-ancestor
82996324|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
82996325|NCT03085914|Vitamins|vitamins|mesh-ancestor
82996326|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
82996327|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996328|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82996329|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82996330|NCT02467608|Isoniazid|isoniazid|mesh-list
82996331|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
82996332|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996333|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996334|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82996335|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82996336|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
82996337|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996338|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82996339|NCT02368288|Entecavir|entecavir|mesh-list
82996340|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
82996341|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996342|NCT02357524|Oritavancin|oritavancin|mesh-list
82996343|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996344|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996345|NCT02368054|Epinephrine|epinephrine|mesh-list
82996346|NCT02368054|Racepinephrine|racepinephrine|mesh-list
82996347|NCT02368054|Bupivacaine|bupivacaine|mesh-list
82996348|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
82996349|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
82996350|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
82996351|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996352|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996353|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
82996354|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996355|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82996356|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82996357|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
82996358|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996359|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996360|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82996361|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82996363|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82996364|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
82996365|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
82996366|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
82996367|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82996368|NCT02357602|Tenofovir|tenofovir|mesh-list
82996369|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
82996370|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996371|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82996372|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82996373|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996374|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996375|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82996376|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996377|NCT01379196|Azithromycin|azithromycin|mesh-list
82996378|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996379|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996380|NCT01382238|Dolutegravir|dolutegravir|mesh-list
82996381|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82996382|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82996383|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996384|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996385|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82996386|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996387|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
82996388|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996389|NCT03112564|Fentanyl|fentanyl|mesh-list
82996390|NCT03112564|Sevoflurane|sevoflurane|mesh-list
82996391|NCT03112564|Rocuronium|rocuronium|mesh-list
82996392|NCT03112564|Cisatracurium|cisatracurium|mesh-list
82996393|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82996394|NCT03112564|Narcotics|narcotics|mesh-ancestor
82996395|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996396|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996397|NCT03112564|Analgesics|analgesics|mesh-ancestor
82996398|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
82996399|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996400|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82996401|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82996402|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
82996403|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
82996404|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82996405|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82996406|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
82996407|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
82996408|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82996409|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
82996410|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
82996411|NCT01379976|Vitamins|vitamins|mesh-ancestor
82996412|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
82996413|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996414|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
82996415|NCT01379898|Doxazosin|doxazosin|mesh-list
82996416|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
82996417|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82996418|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82996419|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82996420|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82996421|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
82996422|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996423|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996424|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996425|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
82996426|NCT02362516|BI 425809|bi 425809|mesh-list
82996427|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
82996428|NCT02367664|Vaccines|vaccines|mesh-list
82996429|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
82996430|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996431|NCT05421000|Anesthetics|anesthetics|mesh-list
82996432|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996433|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996434|NCT05419362|Avelumab|avelumab|mesh-list
82996435|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996436|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996437|NCT02357212|Adenosine|adenosine|mesh-list
82996438|NCT02357212|Analgesics|analgesics|mesh-ancestor
82996439|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
82996440|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996441|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996442|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82996443|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
82996444|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
82996445|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
82996446|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
82996447|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996448|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996449|NCT01382160|Adalimumab|adalimumab|mesh-list
82996450|NCT01382160|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82996451|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82996452|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996453|NCT00735748|Tramadol|tramadol|mesh-list
82996454|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82996455|NCT00735748|Narcotics|narcotics|mesh-ancestor
82996456|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996457|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996458|NCT00735748|Analgesics|analgesics|mesh-ancestor
82996459|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
82996460|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996461|NCT02367196|Rituximab|rituximab|mesh-list
82996462|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996463|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996464|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
82996465|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996466|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996467|NCT05418504|Anesthetics|anesthetics|mesh-list
82996468|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996469|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996470|NCT03408886|Vancomycin|vancomycin|mesh-list
82996471|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996472|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996473|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
82996474|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82996475|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
82996476|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82996477|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996478|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82996479|NCT04013334|Nivolumab|nivolumab|mesh-list
82996480|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996481|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996482|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82996483|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996484|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82996485|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
82996486|NCT02366884|Clotrimazole|clotrimazole|mesh-list
82996487|NCT02366884|Miconazole|miconazole|mesh-list
82996488|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
82996489|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996490|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82996491|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82996492|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82996493|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996494|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996495|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82996496|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
82996497|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996498|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996499|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82996500|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82996501|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82996502|NCT02361502|Mirabegron|mirabegron|mesh-list
82996503|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
82996504|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82996505|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82996506|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
82996507|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996508|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996509|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996510|NCT02361502|Urological Agents|urological agents|mesh-ancestor
82996512|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82996513|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
82996514|NCT02367118|Hormones|hormones|mesh-ancestor
82996515|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996516|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996517|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82996518|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996519|NCT00979212|Paclitaxel|paclitaxel|mesh-list
82996520|NCT00979212|Carboplatin|carboplatin|mesh-list
82996521|NCT00979212|Panitumumab|panitumumab|mesh-list
82996522|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82996523|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996524|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
82996525|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
82996526|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
82996527|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996528|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996529|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
82996530|NCT02361190|Testosterone|testosterone|mesh-list
82996531|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
82996532|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
82996533|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
82996534|NCT02361190|Androgens|androgens|mesh-ancestor
82996535|NCT02361190|Hormones|hormones|mesh-ancestor
82996536|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996537|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464735|NCT00000274|Flupenthixol|flupenthixol|mesh-list
82996538|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82996539|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996540|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
82996541|NCT02361112|Capecitabine|capecitabine|mesh-list
82996542|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996543|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
82996544|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996545|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996546|NCT02360956|Olmesartan|olmesartan|mesh-list
82996547|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
82996548|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
82996549|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82996550|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82996551|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996552|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
82996553|NCT02360800|Hemostatics|hemostatics|mesh-list
82996554|NCT02360800|Coagulants|coagulants|mesh-ancestor
82996555|NCT03501966|Acetazolamide|acetazolamide|mesh-list
82996556|NCT03501966|Diuretics|diuretics|mesh-list
82996557|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
82996558|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996559|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
82996560|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
82996561|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996562|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996563|NCT02355184|Leronlimab|leronlimab|mesh-list
82996564|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
82996565|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
82996566|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996567|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82996568|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996569|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
82996570|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996571|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
82996572|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82996573|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
82996574|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996575|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
82996576|NCT03477630|Protective Agents|protective agents|mesh-ancestor
82996577|NCT02981342|Gemcitabine|gemcitabine|mesh-list
82996578|NCT02981342|Capecitabine|capecitabine|mesh-list
82996579|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996580|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
82996581|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996582|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996584|NCT02639026|Tremelimumab|tremelimumab|mesh-list
82996585|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996586|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996587|NCT02360644|Vitamin D|vitamin d|mesh-list
82996588|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
82996589|NCT02360644|Vitamins|vitamins|mesh-ancestor
82996590|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
82996591|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996592|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82996593|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82996594|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
82996595|NCT02365948|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82996596|NCT02365948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82996597|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996598|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
82996599|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996600|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996601|NCT02354950|Cabotegravir|cabotegravir|mesh-list
82996602|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82996603|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82996604|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996605|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996606|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82996607|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996608|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
82996609|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996610|NCT02980874|Triamcinolone|triamcinolone|mesh-list
82996611|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82996612|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82996613|NCT02980874|Aflibercept|aflibercept|mesh-list
82996614|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82996615|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82996616|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
82996617|NCT02980874|Hormones|hormones|mesh-ancestor
82996618|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996619|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996620|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996621|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
82996622|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996623|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996624|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82996625|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82996626|NCT02980874|Growth Substances|growth substances|mesh-ancestor
82996627|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
82996628|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996629|NCT02354872|Nicotine|nicotine|mesh-list
82996630|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82996631|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
82996632|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996633|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996634|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82996635|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82996636|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
82996637|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996638|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996639|NCT02354638|Nicotine|nicotine|mesh-list
82996640|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82996641|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
82996642|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996643|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996644|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82996645|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82996646|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
82996647|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996648|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996650|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82996651|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996652|NCT03121014|Methotrexate|methotrexate|mesh-list
82996653|NCT03121014|Fludarabine|fludarabine|mesh-list
82996654|NCT03121014|Busulfan|busulfan|mesh-list
82996655|NCT03121014|Tacrolimus|tacrolimus|mesh-list
82996656|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
82996657|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82996659|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82996660|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996661|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996662|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
82996663|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996664|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996665|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
82996666|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996667|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82996668|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996669|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
82996670|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996671|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82996672|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82996673|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
82996674|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82996675|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82996676|NCT03112642|Anesthetics|anesthetics|mesh-list
82996677|NCT03112642|Bupivacaine|bupivacaine|mesh-list
82996678|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
82996679|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996680|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996681|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
82996682|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996683|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
82996684|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
82996685|NCT01377324|Estradiol|estradiol|mesh-list
82996686|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
82996687|NCT01377324|Estrogens|estrogens|mesh-ancestor
82996688|NCT01377324|Hormones|hormones|mesh-ancestor
82996689|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996690|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996691|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82996692|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
82996693|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82996694|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82996695|NCT02359942|Citric Acid|citric acid|mesh-list
82996696|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
82996697|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
82996698|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82996699|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
82996700|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
82996701|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996702|NCT02354560|Erythromycin|erythromycin|mesh-list
82996703|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
82996704|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
82996705|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
82996706|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82996707|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996708|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82996709|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82996710|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996711|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996712|NCT01378884|Domperidone|domperidone|mesh-list
82996713|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
82996714|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
82996715|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996716|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996717|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82996718|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82996719|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
82996720|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996721|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996722|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
82996723|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82996724|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
82996725|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996726|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996727|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82996728|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
82996729|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
82996730|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82996731|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
82996732|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996733|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996734|NCT05383482|Paclitaxel|paclitaxel|mesh-list
82996735|NCT05383482|Docetaxel|docetaxel|mesh-list
82996736|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82996737|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996738|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
82996739|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
82996740|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
82996741|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996742|NCT02354170|Mifepristone|mifepristone|mesh-list
82996743|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82996744|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
82996745|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82996746|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996747|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82996748|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82996749|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82996750|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
82996751|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82996752|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82996753|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
82996754|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996755|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
82996756|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82996757|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82996758|NCT01377246|Octreotide|octreotide|mesh-list
82996759|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82996760|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82996761|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996762|NCT02353936|Afatinib|afatinib|mesh-list
82996763|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996764|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82996765|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996766|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996767|NCT02353858|Fluorouracil|fluorouracil|mesh-list
82996768|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
82996769|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996770|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82996771|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996772|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82996773|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
82996774|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996775|NCT02353702|Ropivacaine|ropivacaine|mesh-list
82996776|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
82996777|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
82996778|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996779|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996780|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
82996781|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996782|NCT02532660|Dexetimide|dexetimide|mesh-list
82996783|NCT02532660|Citalopram|citalopram|mesh-list
82996784|NCT02532660|Escitalopram|escitalopram|mesh-list
82996785|NCT02532660|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82996786|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82996787|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82996788|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996789|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82996790|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
82996791|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996792|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82996793|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82996794|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
82996795|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
82996796|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996797|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82996798|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82996799|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
82996800|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82996801|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
82996802|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82996803|NCT01377168|Naltrexone|naltrexone|mesh-list
82996804|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82996805|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82996806|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996807|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
82996808|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996809|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
82996810|NCT02892149|Hematinics|hematinics|mesh-ancestor
82996811|NCT02348398|Topotecan|topotecan|mesh-list
82996812|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82996813|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82996814|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996815|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996816|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996817|NCT05278338|Denosumab|denosumab|mesh-list
82996818|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82996819|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996820|NCT03721757|Nivolumab|nivolumab|mesh-list
82996821|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996822|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996823|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82996824|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996825|NCT03727607|Propofol|propofol|mesh-list
82996826|NCT03727607|Desflurane|desflurane|mesh-list
82996827|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82996828|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82996829|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996830|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82996831|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
82996832|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
82996833|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82996834|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
82996835|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
82996836|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82996837|NCT03157804|Plerixafor|plerixafor|mesh-list
82996838|NCT03157804|Lenograstim|lenograstim|mesh-list
82996839|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82996840|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
82996841|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996842|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82996843|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996844|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
82996845|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996846|NCT03157414|Empagliflozin|empagliflozin|mesh-list
82996847|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82996848|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996849|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82996850|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996851|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
82996852|NCT03147196|Bicalutamide|bicalutamide|mesh-list
82996853|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
82996854|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
82996855|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996856|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996857|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996858|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82996859|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82996860|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82996861|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82996862|NCT03153436|Inositol|inositol|mesh-list
82996863|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
82996864|NCT03153436|Vitamins|vitamins|mesh-ancestor
82996865|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
82996866|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996867|NCT03544229|Maleic acid|maleic acid|mesh-list
82996868|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996869|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996870|NCT02351908|Tenofovir|tenofovir|mesh-list
82996871|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
82996872|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82996873|NCT02351908|Dolutegravir|dolutegravir|mesh-list
82996874|NCT02351908|Cobicistat|cobicistat|mesh-list
82996875|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
82996876|NCT02351908|Elvitegravir|elvitegravir|mesh-list
82996877|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
82996878|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83523434|NCT01707043|Calcitriol|calcitriol|mesh-list
82996879|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82996880|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82996881|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996882|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996883|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82996884|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82996885|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82996886|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82996887|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82996888|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82996889|NCT01371240|Secretin|secretin|mesh-list
82996890|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82996891|NCT01371240|Hormones|hormones|mesh-ancestor
82996892|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996893|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996894|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82996895|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83464753|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82996896|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996897|NCT03723941|Etoposide|etoposide|mesh-list
82996898|NCT03723941|Mitotane|mitotane|mesh-list
82996899|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996900|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82996901|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82996902|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82996903|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996904|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996905|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82996906|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
82996907|NCT03721679|Nivolumab|nivolumab|mesh-list
82996908|NCT03721679|Atezolizumab|atezolizumab|mesh-list
82996909|NCT03721679|Durvalumab|durvalumab|mesh-list
82996910|NCT03721679|Poly ICLC|poly iclc|mesh-list
82996911|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996912|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996913|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82996914|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996915|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
82996916|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
82996917|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996918|NCT03639948|Carboplatin|carboplatin|mesh-list
82996919|NCT03639948|Docetaxel|docetaxel|mesh-list
82996920|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
82996921|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996922|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
82996923|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
82996924|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
82996925|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996926|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82996927|NCT03639948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82996928|NCT03968406|Talazoparib|talazoparib|mesh-list
82996929|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82996930|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996931|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996932|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996933|NCT03510455|Infigratinib|infigratinib|mesh-list
82996934|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996935|NCT03509675|Ibuprofen|ibuprofen|mesh-list
82996936|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82996937|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82996938|NCT03509675|Analgesics|analgesics|mesh-ancestor
82996939|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
82996940|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996941|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996943|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996944|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82996945|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996946|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996947|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
82996948|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
82996949|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82996950|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82996951|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82996952|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996953|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996954|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82996955|NCT04852224|Leuprolide|leuprolide|mesh-list
82996956|NCT04852224|Goserelin|goserelin|mesh-list
82996957|NCT04852224|Androgens|androgens|mesh-list
82996958|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82996959|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
82996960|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82996961|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996962|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82996963|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996964|NCT04852224|Hormones|hormones|mesh-ancestor
82996965|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82996966|NCT02353078|Sucralfate|sucralfate|mesh-list
82996967|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82996968|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82996969|NCT03509207|Vorinostat|vorinostat|mesh-list
82996970|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996971|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
82996972|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996973|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996974|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
82996975|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82996976|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
82996977|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82996978|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996979|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82996980|NCT03727295|Idebenone|idebenone|mesh-list
82996981|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
82996982|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996983|NCT03727295|Protective Agents|protective agents|mesh-ancestor
82996984|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996985|NCT01378650|Cilostazol|cilostazol|mesh-list
82996986|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82996987|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
82996988|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82996989|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82996990|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82996991|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
82996992|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82996993|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82996994|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82996995|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82996996|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
82996997|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82996998|NCT01378650|Protective Agents|protective agents|mesh-ancestor
82996999|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82997000|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82997001|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997002|NCT04796922|Rituximab|rituximab|mesh-list
82997003|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
82997004|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997005|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997006|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
82997007|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997008|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997009|NCT03723785|Insulin|insulin|mesh-list
82997010|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82997011|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82997012|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997013|NCT03543137|Nicotine|nicotine|mesh-list
82997014|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82997015|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
82997016|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997017|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997018|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82997019|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82997020|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
82997021|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997022|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997023|NCT03146650|Nivolumab|nivolumab|mesh-list
82997024|NCT03146650|Ipilimumab|ipilimumab|mesh-list
82997025|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997026|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997027|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82997028|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997029|NCT02343484|Ethanol|ethanol|mesh-list
82997030|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82997031|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997032|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997033|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997035|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
82997036|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997037|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83464760|NCT00000286|Nefazodone|nefazodone|mesh-list
82997038|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
82997039|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997040|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997041|NCT03630042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82997042|NCT03630042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997043|NCT03073980|Acetaminophen|acetaminophen|mesh-list
82997044|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82997045|NCT03073980|Analgesics|analgesics|mesh-ancestor
82997046|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
82997047|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997048|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997049|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
82997050|NCT04117932|Ustekinumab|ustekinumab|mesh-list
82997051|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
82997052|NCT03930186|Apremilast|apremilast|mesh-list
82997053|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82997054|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82997055|NCT03930186|Analgesics|analgesics|mesh-ancestor
82997056|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
82997057|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997058|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997059|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82997060|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997061|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
82997062|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82997063|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997064|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997065|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82997066|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82997067|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82997068|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997069|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997070|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997071|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997072|NCT02351440|Analgesics|analgesics|mesh-ancestor
82997073|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
82997074|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997075|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
82997076|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82997077|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
82997078|NCT03504917|Balovaptan|balovaptan|mesh-list
82997079|NCT03504917|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
82997080|NCT03504917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997081|NCT03504917|Natriuretic Agents|natriuretic agents|mesh-ancestor
82997082|NCT03504917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997083|NCT02351128|Lanreotide|lanreotide|mesh-list
82997084|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997085|NCT02343250|Valsartan|valsartan|mesh-list
82997086|NCT02343250|Cilnidipine|cilnidipine|mesh-list
82997087|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82997088|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82997089|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82997090|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997091|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82997092|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997093|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82997094|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997095|NCT03781440|Lidocaine|lidocaine|mesh-list
82997096|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
82997097|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
82997098|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997099|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997100|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
82997101|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997102|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82997103|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82997104|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82997105|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997106|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997107|NCT03565211|Progesterone|progesterone|mesh-list
82997108|NCT03565211|Progestins|progestins|mesh-ancestor
82997109|NCT03565211|Hormones|hormones|mesh-ancestor
82997110|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997111|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997112|NCT03740100|MTOR Inhibitors|mtor inhibitors|mesh-list
82997113|NCT03740100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82997114|NCT03740100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997115|NCT03740100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997116|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997117|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
82997118|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997119|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997120|NCT03723395|Repaglinide|repaglinide|mesh-list
82997121|NCT03723395|Tolbutamide|tolbutamide|mesh-list
82997122|NCT03723395|Itraconazole|itraconazole|mesh-list
82997123|NCT03723395|Rifampin|rifampin|mesh-list
82997124|NCT03723395|Tucatinib|tucatinib|mesh-list
82997125|NCT03723395|Digoxin|digoxin|mesh-list
82997126|NCT03723395|Midazolam|midazolam|mesh-list
82997127|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
82997128|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82997129|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82997130|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997131|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997132|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82997133|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82997134|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82997135|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82997136|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
82997137|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
82997138|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
82997139|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
82997140|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997141|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997142|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
82997143|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997144|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82997145|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82997146|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997147|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82997148|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
82997149|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997150|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82997151|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82997152|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
82997153|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997154|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
82997155|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82997156|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82997157|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82997158|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
82997159|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
82997160|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
82997161|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82997162|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82997163|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82997164|NCT03723395|Protective Agents|protective agents|mesh-ancestor
82997165|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82997166|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997167|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82997168|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82997169|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
82997170|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82997171|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
82997172|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
82997173|NCT03531905|Ezetimibe|ezetimibe|mesh-list
82997174|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82997175|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82997176|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
82997177|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997178|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82997179|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997180|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82997181|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997182|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
82997183|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
82997184|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997185|NCT02346682|Clonazepam|clonazepam|mesh-list
82997186|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
82997187|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82997188|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82997189|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997190|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997191|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997192|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997193|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82997194|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
82997195|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82997196|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
82997197|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
82997198|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
82997199|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82997200|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
82997201|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997202|NCT05764590|Sevelamer|sevelamer|mesh-list
82997203|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
82997204|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
82997205|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997206|NCT05764512|Endorphins|endorphins|mesh-list
82997207|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997208|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997209|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997210|NCT02342392|Ranibizumab|ranibizumab|mesh-list
82997211|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82997212|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82997213|NCT02342392|Growth Substances|growth substances|mesh-ancestor
82997214|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997215|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
82997216|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997217|NCT02342002|Misoprostol|misoprostol|mesh-list
82997218|NCT02342002|Mifepristone|mifepristone|mesh-list
82997219|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82997220|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
82997221|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82997222|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997223|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82997224|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997225|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
82997226|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
82997227|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
82997228|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
82997229|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82997230|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
82997231|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
82997232|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
82997233|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
82997234|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997235|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
82997236|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82997237|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
82997239|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997240|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997241|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82997242|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82997243|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997244|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997245|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997246|NCT02345902|Haloperidol|haloperidol|mesh-list
82997247|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
82997248|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
82997250|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997251|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997252|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997253|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82997254|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82997255|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997256|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82997257|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82997258|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
82997259|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997260|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997261|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82997262|NCT03601806|Thalidomide|thalidomide|mesh-list
82997263|NCT03601806|Pomalidomide|pomalidomide|mesh-list
82997264|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997265|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
82997266|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997267|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
82997268|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997269|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997270|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82997271|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82997272|NCT03601806|Growth Substances|growth substances|mesh-ancestor
82997273|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
82997274|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997275|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
82997276|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
82997277|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
82997278|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82997279|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997280|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997281|NCT02345980|Urological Agents|urological agents|mesh-ancestor
82997282|NCT02345746|Leucovorin|leucovorin|mesh-list
82997283|NCT02345746|Folic Acid|folic acid|mesh-list
82997284|NCT02345746|Fluorouracil|fluorouracil|mesh-list
82997285|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
82997286|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
82997287|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
82997288|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997289|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82997290|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997291|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997292|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
82997293|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997294|NCT02345746|Antidotes|antidotes|mesh-ancestor
82997295|NCT02345746|Protective Agents|protective agents|mesh-ancestor
82997296|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
82997297|NCT02345746|Vitamins|vitamins|mesh-ancestor
82997298|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
82997299|NCT02345746|Hematinics|hematinics|mesh-ancestor
82997300|NCT03794778|Paclitaxel|paclitaxel|mesh-list
82997301|NCT03794778|Carboplatin|carboplatin|mesh-list
82997302|NCT03794778|Doxorubicin|doxorubicin|mesh-list
82997303|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82997304|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82997305|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997306|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
82997307|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
82997308|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
82997309|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83464784|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
82997310|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82997311|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82997312|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82997313|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997314|NCT02341300|Iron|iron|mesh-list
82997315|NCT02341300|Trace Elements|trace elements|mesh-ancestor
82997316|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
82997317|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997318|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82997319|NCT05462496|Metronidazole|metronidazole|mesh-list
82997320|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
82997321|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82997322|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
82997323|NCT05462496|Folfirinox|folfirinox|mesh-list
82997324|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997325|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83523435|NCT01707043|Betamethasone|betamethasone|mesh-list
82997326|NCT05462496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82997327|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997328|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997329|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
82997330|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82997331|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82997332|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82997333|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82997334|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997335|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82997336|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82997337|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
82997338|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82997339|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82997340|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82997341|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82997342|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
82997343|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997344|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997345|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997347|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82997348|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
82997349|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997350|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997351|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82997352|NCT02345590|Diuretics|diuretics|mesh-ancestor
82997353|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
82997354|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82997355|NCT03723083|Thalidomide|thalidomide|mesh-list
82997356|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997357|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
82997358|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997359|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
82997360|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997361|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997362|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82997363|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82997364|NCT03723083|Growth Substances|growth substances|mesh-ancestor
82997365|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
82997366|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997367|NCT03774810|Zolpidem|zolpidem|mesh-list
82997368|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82997369|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82997370|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83464787|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
82997371|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997372|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82997373|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
82997374|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
82997375|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997376|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997377|NCT03562481|Lidocaine|lidocaine|mesh-list
82997378|NCT03562481|Epinephrine|epinephrine|mesh-list
82997379|NCT03562481|Racepinephrine|racepinephrine|mesh-list
82997380|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
82997381|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
82997382|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
82997383|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997384|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997385|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
82997386|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997387|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82997388|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82997389|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82997390|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997391|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997392|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82997393|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82997394|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
82997395|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997396|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82997397|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82997398|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
82997399|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82997400|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
82997401|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
82997402|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
82997403|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82997404|NCT03726593|Artesunate|artesunate|mesh-list
82997405|NCT03726593|Mefloquine|mefloquine|mesh-list
82997406|NCT03726593|Atovaquone|atovaquone|mesh-list
82997407|NCT03726593|Pyronaridine|pyronaridine|mesh-list
82997408|NCT03726593|Proguanil|proguanil|mesh-list
82997409|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
82997410|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
82997411|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82997412|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82997413|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997414|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997415|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
82997416|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
82997417|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
82997418|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
82997419|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997420|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997421|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
82997422|NCT04007224|Oxytocin|oxytocin|mesh-list
82997423|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
82997424|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82997425|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997426|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
82997427|NCT03197064|Aprepitant|aprepitant|mesh-list
82997428|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
82997429|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
82997430|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997431|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997432|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997433|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82997434|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997435|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997436|NCT02345044|Eplerenone|eplerenone|mesh-list
82997437|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82997438|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
82997439|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997440|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83464800|NCT02507336|Growth Substances|growth substances|mesh-ancestor
82997441|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82997442|NCT02345044|Diuretics|diuretics|mesh-ancestor
82997443|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
82997444|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82997445|NCT02349802|Exenatide|exenatide|mesh-list
82997446|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82997447|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997448|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
82997449|NCT02349802|Incretins|incretins|mesh-ancestor
82997450|NCT02349802|Hormones|hormones|mesh-ancestor
82997451|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997452|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
82997453|NCT03145714|Anesthetics|anesthetics|mesh-list
82997454|NCT03145714|Propofol|propofol|mesh-list
82997455|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997456|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997457|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82997458|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82997459|NCT03145714|Analgesics|analgesics|mesh-ancestor
82997460|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
82997461|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997462|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82997463|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82997464|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82997465|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
82997466|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997467|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997468|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82997469|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
82997470|NCT02349958|Doxorubicin|doxorubicin|mesh-list
82997471|NCT02349958|Cisplatin|cisplatin|mesh-list
82997472|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82997473|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997474|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82997475|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82997476|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997477|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997478|NCT04872426|Insulin|insulin|mesh-list
82997479|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82997480|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997481|NCT02344888|Folic Acid|folic acid|mesh-list
82997482|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
82997483|NCT02344888|Prednisolone|prednisolone|mesh-list
82997484|NCT02344888|Citric Acid|citric acid|mesh-list
82997485|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
82997486|NCT02344888|Clomiphene|clomiphene|mesh-list
82997487|NCT02344888|Enclomiphene|enclomiphene|mesh-list
82997488|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
82997489|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
82997490|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
82997491|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
82997492|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
82997493|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997494|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82997495|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
82997496|NCT02344888|Hormones|hormones|mesh-ancestor
82997497|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997498|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997499|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82997500|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997501|NCT02344888|Hematinics|hematinics|mesh-ancestor
82997502|NCT02344888|Vitamins|vitamins|mesh-ancestor
82997503|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
82997504|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82997505|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
82997506|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82997507|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
82997508|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82997509|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
82997510|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
82997511|NCT02921022|Paclitaxel|paclitaxel|mesh-list
82997512|NCT02921022|Gemcitabine|gemcitabine|mesh-list
82997513|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82997514|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997515|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
82997516|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
82997517|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
82997518|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997519|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82997520|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
82997521|NCT03497429|Niraparib|niraparib|mesh-list
82997522|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82997523|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997524|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997525|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997526|NCT03146104|Propofol|propofol|mesh-list
82997527|NCT03146104|Isoflurane|isoflurane|mesh-list
82997528|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82997529|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997530|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997531|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82997532|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
82997533|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
82997534|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82997535|NCT03497039|Diclofenac|diclofenac|mesh-list
82997536|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82997537|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82997538|NCT03497039|Analgesics|analgesics|mesh-ancestor
82997539|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
82997540|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997541|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997542|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82997543|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997544|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82997545|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997546|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997547|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
82997548|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82997549|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82997550|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
82997551|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997552|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997553|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997554|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
82997555|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
82997556|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997557|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
82997558|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82997559|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
82997560|NCT02349490|Hemostatics|hemostatics|mesh-list
82997561|NCT02349490|Coagulants|coagulants|mesh-ancestor
82997562|NCT03720899|Nicotine|nicotine|mesh-list
82997563|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
82997564|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
82997565|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997566|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997567|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82997568|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82997569|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
82997570|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997571|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997572|NCT02340988|Oritavancin|oritavancin|mesh-list
82997573|NCT02340988|Warfarin|warfarin|mesh-list
82997574|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
82997575|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997576|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997577|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
82997578|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997579|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997580|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
82997581|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997582|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997583|NCT03726515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82997584|NCT03726515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997585|NCT05665283|Ensartinib|ensartinib|mesh-list
82997586|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997587|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82997588|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997589|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997590|NCT03071094|Nivolumab|nivolumab|mesh-list
82997591|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997592|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997593|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82997594|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997595|NCT03148990|Vaccines|vaccines|mesh-list
82997596|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
82997597|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997598|NCT04477642|Abatacept|abatacept|mesh-list
82997599|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82997600|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997601|NCT04477642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997602|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997603|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997604|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
82997605|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997606|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997607|NCT02344732|Polymyxins|polymyxins|mesh-list
82997608|NCT02344732|Neomycin|neomycin|mesh-list
82997609|NCT02344732|Polymyxin B|polymyxin b|mesh-list
82997610|NCT02344732|Dexamethasone|dexamethasone|mesh-list
82997611|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82997612|NCT02344732|Homatropine|homatropine|mesh-list
82997613|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82997614|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
82997615|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
82997616|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997617|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997618|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997619|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
82997620|NCT02344732|Hormones|hormones|mesh-ancestor
82997621|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997622|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82997623|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997624|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82997625|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997626|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997627|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82997628|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997629|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997630|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
82997631|NCT03720665|Caffeine|caffeine|mesh-list
82997632|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82997633|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997634|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82997635|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997636|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997637|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82997638|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82997639|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
82997640|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997641|NCT03726281|Nivolumab|nivolumab|mesh-list
82997642|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997643|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997644|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82997645|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997646|NCT02344264|Ropivacaine|ropivacaine|mesh-list
82997647|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
82997648|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
82997649|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997650|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997651|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
82997652|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997653|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
82997654|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
82997655|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
82997656|NCT02339662|Gabapentin|gabapentin|mesh-list
82997657|NCT02339662|Amitriptyline|amitriptyline|mesh-list
82997658|NCT02339662|Analgesics|analgesics|mesh-ancestor
82997659|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
82997660|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997661|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997662|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
82997663|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82997664|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82997665|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997666|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82997667|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82997668|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82997669|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997670|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997671|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
82997672|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
82997673|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
82997674|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82997675|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82997676|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82997677|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997678|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
82997679|NCT02343718|Sirolimus|sirolimus|mesh-list
82997680|NCT02343718|Temsirolimus|temsirolimus|mesh-list
82997681|NCT02343718|MTOR Inhibitors|mtor inhibitors|mesh-list
82997682|NCT02343718|Vinblastine|vinblastine|mesh-list
82997683|NCT02343718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82997684|NCT02343718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997685|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997686|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997687|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
82997688|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997689|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997690|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997691|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997692|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82997693|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
82997694|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82997695|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
82997696|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
82997697|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
82997698|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
82997699|NCT03148522|Mirtazapine|mirtazapine|mesh-list
82997700|NCT03148522|Escitalopram|escitalopram|mesh-list
82997701|NCT03148522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82997702|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82997703|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997704|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997705|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997706|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
82997707|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997708|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997709|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
82997710|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82997711|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
82997712|NCT03148522|Analgesics|analgesics|mesh-ancestor
82997713|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
82997714|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
82997715|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
82997716|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
82997717|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
82997718|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82997719|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82997720|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997721|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82997722|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82997723|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82997724|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
82997725|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82997726|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82997727|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82997728|NCT03148444|Cephalexin|cephalexin|mesh-list
82997729|NCT03148444|Roxithromycin|roxithromycin|mesh-list
82997730|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82997731|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997732|NCT03148132|Bevacizumab|bevacizumab|mesh-list
82997733|NCT03148132|Ranibizumab|ranibizumab|mesh-list
82997734|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997735|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997736|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82997737|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82997738|NCT03148132|Growth Substances|growth substances|mesh-ancestor
82997739|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997740|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
82997741|NCT02339350|Methotrexate|methotrexate|mesh-list
82997742|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82997743|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
82997744|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82997745|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997746|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82997747|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
82997748|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997749|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997750|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
82997751|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997752|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82997753|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997754|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
82997755|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997756|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82997757|NCT05166304|Rebamipide|rebamipide|mesh-list
82997758|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82997759|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997760|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
82997761|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997762|NCT05166304|Protective Agents|protective agents|mesh-ancestor
82997763|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997764|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997765|NCT02339428|Diclofenac|diclofenac|mesh-list
82997766|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82997767|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82997768|NCT02339428|Analgesics|analgesics|mesh-ancestor
82997769|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
82997770|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997771|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997772|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82997773|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997774|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82997775|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997776|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997777|NCT02337322|Ritonavir|ritonavir|mesh-list
82997778|NCT02337322|Darunavir|darunavir|mesh-list
82997779|NCT02337322|Dolutegravir|dolutegravir|mesh-list
82997780|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82997781|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82997782|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
82997783|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997784|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997785|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82997786|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82997787|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
82997788|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997789|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82997790|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82997791|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
82997792|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
82997793|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
82997794|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82997795|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
82997796|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997797|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
82997798|NCT02337166|Protective Agents|protective agents|mesh-ancestor
82997799|NCT03148288|Vitamin D|vitamin d|mesh-list
82997800|NCT03148288|Vitamins|vitamins|mesh-ancestor
82997801|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
82997802|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997803|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82997804|NCT02039362|Tenofovir|tenofovir|mesh-list
82997805|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
82997806|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997807|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82997808|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82997809|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997810|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997811|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82997812|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82997813|NCT02339116|Bevacizumab|bevacizumab|mesh-list
82997814|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
82997815|NCT02339116|Irinotecan|irinotecan|mesh-list
82997816|NCT02339116|Fluorouracil|fluorouracil|mesh-list
82997817|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997818|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997819|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82997820|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82997821|NCT02339116|Growth Substances|growth substances|mesh-ancestor
82997822|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997823|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
82997824|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82997825|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82997826|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997827|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997828|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
82997829|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82997830|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997831|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
82997832|NCT04824274|Fentanyl|fentanyl|mesh-list
82997833|NCT04824274|Morphine|morphine|mesh-list
82997834|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82997835|NCT04824274|Narcotics|narcotics|mesh-ancestor
82997836|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997837|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997838|NCT04824274|Analgesics|analgesics|mesh-ancestor
82997839|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
82997840|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997841|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82997842|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82997843|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
82997844|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
82997845|NCT02509494|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
82997846|NCT02509494|Antiviral Agents|antiviral agents|mesh-ancestor
82997847|NCT02509494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997848|NCT02348788|Chloroquine|chloroquine|mesh-list
82997849|NCT02348788|Lumefantrine|lumefantrine|mesh-list
82997851|NCT02348788|Primaquine|primaquine|mesh-list
82997852|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
82997853|NCT02348788|Amebicides|amebicides|mesh-ancestor
82997854|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82997855|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82997856|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997857|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
82997858|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997859|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
82997860|NCT02338570|Everolimus|everolimus|mesh-list
82997861|NCT02338570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82997862|NCT02338570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82997863|NCT02338570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997864|NCT02338570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997865|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997866|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
82997867|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997868|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997869|NCT02336854|Tacrolimus|tacrolimus|mesh-list
82997870|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997871|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
82997872|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997873|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82997874|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997875|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997876|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
82997877|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
82997878|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82997879|NCT02332174|Rufinamide|rufinamide|mesh-list
82997880|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
82997881|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82997882|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82997883|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997884|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997885|NCT03493451|Tislelizumab|tislelizumab|mesh-list
82997886|NCT03493451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82997887|NCT03493451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997888|NCT03726125|Insulin|insulin|mesh-list
82997889|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
82997890|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
82997891|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82997892|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997893|NCT02336308|Ketamine|ketamine|mesh-list
82997894|NCT02336308|Analgesics|analgesics|mesh-ancestor
82997895|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
82997896|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997897|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997898|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82997899|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82997900|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
82997901|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
82997902|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997903|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82997904|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82997905|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997906|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997907|NCT02336386|Dexamethasone|dexamethasone|mesh-list
82997908|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
82997909|NCT02336386|Doxorubicin|doxorubicin|mesh-list
82997910|NCT02336386|Bortezomib|bortezomib|mesh-list
82997911|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82997912|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
82997913|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997914|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82997915|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82997916|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
82997917|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997918|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997919|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82997920|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82997921|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
82997922|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
83464845|NCT02548650|Vorapaxar|vorapaxar|mesh-list
82997923|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997924|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997925|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
82997926|NCT02336386|Hormones|hormones|mesh-ancestor
83483344|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82997927|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997928|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82997929|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997930|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82997931|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82997932|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82997933|NCT02337712|Etoposide|etoposide|mesh-list
82997934|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997935|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82997936|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82997937|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82997938|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82997939|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997940|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
82997941|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
82997942|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82997943|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
82997944|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997945|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997946|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997947|NCT03492281|Urological Agents|urological agents|mesh-ancestor
82997948|NCT02336152|Anesthetics|anesthetics|mesh-list
82997949|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82997950|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997951|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
82997952|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
82997953|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
82997954|NCT02331862|Prednisolone|prednisolone|mesh-list
82997955|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
82997956|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
82997957|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
82997958|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82997959|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
82997960|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
82997961|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997962|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997963|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997964|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
82997965|NCT02331862|Hormones|hormones|mesh-ancestor
82997966|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82997967|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
82997968|NCT02331862|Protective Agents|protective agents|mesh-ancestor
82997969|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82997970|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997971|NCT03525119|Vaccines|vaccines|mesh-list
82997972|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
82997973|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997974|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
82997975|NCT05230654|Aprepitant|aprepitant|mesh-list
82997976|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
82997977|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
82997978|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82997979|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997980|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82997981|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
82997982|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82997983|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997984|NCT02039518|Gemcitabine|gemcitabine|mesh-list
82997985|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82997986|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
82997987|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997988|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82997989|NCT03722381|Amlodipine|amlodipine|mesh-list
82997990|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82997991|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82997992|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82997993|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82997994|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82997995|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82997996|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
82997997|NCT04352608|Vaccines|vaccines|mesh-list
82997998|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
82997999|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998000|NCT03722303|Cortisone|cortisone|mesh-list
82998001|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998002|NCT03558503|Mitomycins|mitomycins|mesh-list
82998003|NCT03558503|Mitomycin|mitomycin|mesh-list
82998004|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82998005|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998006|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
82998007|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998008|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82998009|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998010|NCT02331706|Interferons|interferons|mesh-list
82998011|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
82998012|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
82998013|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998014|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
82998015|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998016|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
82998017|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998018|NCT04400838|Vaccines|vaccines|mesh-list
82998019|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
82998020|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998021|NCT03489863|Ticagrelor|ticagrelor|mesh-list
82998022|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
82998023|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82998024|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82998025|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82998026|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82998027|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
82998028|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998029|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998030|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998031|NCT04344444|Azithromycin|azithromycin|mesh-list
82998032|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
82998033|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82998034|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998035|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
82998036|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82998037|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82998038|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998039|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998040|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998041|NCT03489551|Haloperidol|haloperidol|mesh-list
82998042|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
82998043|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
82998044|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998045|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998046|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998047|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82998048|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82998049|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998050|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998051|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82998052|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
82998053|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998054|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998055|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82998056|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
82998057|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82998058|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998059|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82998060|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998061|NCT02335684|Methamphetamine|methamphetamine|mesh-list
82998062|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82998063|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998064|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
82998065|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
82998066|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998067|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
82998068|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998069|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998070|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
82998071|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83483345|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998072|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82998073|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998074|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82998075|NCT05198388|Endorphins|endorphins|mesh-list
82998076|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998077|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998078|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998079|NCT04210180|Varenicline|varenicline|mesh-list
82998080|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
82998081|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
82998082|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
82998083|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998084|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998085|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998086|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
82998087|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
82998088|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998089|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82998090|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82998091|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82998092|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998093|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998094|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82998095|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998096|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998097|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
82998098|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998099|NCT03105310|Interferons|interferons|mesh-list
82998100|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
82998101|NCT03105310|Ezetimibe|ezetimibe|mesh-list
82998102|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998103|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
82998104|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998105|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
82998106|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998107|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82998108|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82998109|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
82998110|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998111|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82998112|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
82998113|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82998114|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998115|NCT03144466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82998116|NCT03144466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998117|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
82998118|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82998119|NCT03105466|Tacrolimus|tacrolimus|mesh-list
82998120|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998121|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
82998122|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998123|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
82998124|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998125|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998126|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83464860|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
82998127|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998128|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82998129|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998130|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
82998131|NCT03105466|Hormones|hormones|mesh-ancestor
82998132|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998133|NCT02335372|Acetic Acid|acetic acid|mesh-list
82998134|NCT02335372|Proflavine|proflavine|mesh-list
82998135|NCT02335372|Retinol acetate|retinol acetate|mesh-list
82998136|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82998138|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82998139|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
82998140|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998141|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
82998142|NCT02335372|Protective Agents|protective agents|mesh-ancestor
82998143|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998144|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82998145|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
82998146|NCT03488225|Leucovorin|leucovorin|mesh-list
82998147|NCT03488225|Folic Acid|folic acid|mesh-list
82998149|NCT03488225|Dexamethasone|dexamethasone|mesh-list
82998150|NCT03488225|Prednisone|prednisone|mesh-list
82998151|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
82998152|NCT03488225|Cortisone|cortisone|mesh-list
82998153|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
82998154|NCT03488225|Rituximab|rituximab|mesh-list
82998155|NCT03488225|Doxorubicin|doxorubicin|mesh-list
82998156|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
82998157|NCT03488225|Methotrexate|methotrexate|mesh-list
82998158|NCT03488225|Vincristine|vincristine|mesh-list
82998159|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
82998160|NCT03488225|Ofatumumab|ofatumumab|mesh-list
82998161|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
82998162|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82998163|NCT03488225|Antibodies|antibodies|mesh-list
82998164|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
82998165|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82998166|NCT03488225|BB 1101|bb 1101|mesh-list
82998167|NCT03488225|Calcium|calcium|mesh-list
82998168|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
82998169|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998170|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
82998171|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998172|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998173|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
82998174|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
82998175|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998176|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998177|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82998178|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998179|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
82998180|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
82998181|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998182|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998183|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
82998184|NCT03488225|Hormones|hormones|mesh-ancestor
82998185|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998186|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82998187|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82998188|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82998189|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82998190|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998191|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82998192|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82998193|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82998194|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
82998195|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82998196|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82998197|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
82998198|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
82998199|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82998200|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82998201|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
82998202|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998203|NCT03488225|Antidotes|antidotes|mesh-ancestor
82998204|NCT03488225|Protective Agents|protective agents|mesh-ancestor
82998205|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
82998206|NCT03488225|Vitamins|vitamins|mesh-ancestor
82998207|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
82998208|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82998209|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
82998210|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
82998211|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
82998212|NCT03488225|Hematinics|hematinics|mesh-ancestor
82998213|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
82998214|NCT03488225|Immunotoxins|immunotoxins|mesh-ancestor
82998215|NCT03488225|Immunoconjugates|immunoconjugates|mesh-ancestor
82998216|NCT02334904|Risperidone|risperidone|mesh-list
82998217|NCT02334904|Aripiprazole|aripiprazole|mesh-list
82998218|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82998219|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
82998220|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998221|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998222|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998223|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82998224|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82998225|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998226|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998227|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82998229|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
82998230|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
82998231|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82998232|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82998233|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82998234|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82998235|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82998236|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82998237|NCT03437447|Praziquantel|praziquantel|mesh-list
82998238|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
82998239|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82998240|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998241|NCT03720041|Dexamethasone|dexamethasone|mesh-list
82998242|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
82998243|NCT03720041|Lenalidomide|lenalidomide|mesh-list
82998244|NCT03720041|Ixazomib|ixazomib|mesh-list
82998245|NCT03720041|BB 1101|bb 1101|mesh-list
82998246|NCT03720041|Glycine|glycine|mesh-list
82998247|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998248|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
82998249|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
82998250|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998251|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998252|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998253|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
82998254|NCT03720041|Hormones|hormones|mesh-ancestor
82998255|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998256|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82998257|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998258|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
82998259|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998260|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998261|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
82998262|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82998263|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82998264|NCT03720041|Growth Substances|growth substances|mesh-ancestor
82998265|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
82998266|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
82998267|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998268|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
82998269|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82998270|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
82998271|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084012|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084013|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83084014|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084015|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
83084016|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83084017|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
83084018|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
83084019|NCT02474186|Paclitaxel|paclitaxel|mesh-list
83084020|NCT02474186|Docetaxel|docetaxel|mesh-list
83084021|NCT02474186|Capecitabine|capecitabine|mesh-list
83084022|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83084023|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084024|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
83084025|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
83084026|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
83084027|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084028|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83084029|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
83084030|NCT02477306|Rabeprazole|rabeprazole|mesh-list
83084031|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83084032|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998273|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
82998274|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998275|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82998276|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82998277|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998278|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998279|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82998280|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
82998281|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998282|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998283|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82998284|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
82998286|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82998287|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998288|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998289|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
82998290|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
82998291|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
82998292|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82998293|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
82998294|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82998295|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998296|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
82998297|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82998298|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998299|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
82998300|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
82998301|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
82998302|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998303|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
82998304|NCT05076526|Protective Agents|protective agents|mesh-ancestor
82998305|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
82998306|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82998307|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998308|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
82998309|NCT03143998|Grazoprevir|grazoprevir|mesh-list
82998310|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
82998311|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998312|NCT02334046|Remifentanil|remifentanil|mesh-list
82998313|NCT02334046|Sevoflurane|sevoflurane|mesh-list
82998314|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82998315|NCT02334046|Narcotics|narcotics|mesh-ancestor
82998316|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998317|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998318|NCT02334046|Analgesics|analgesics|mesh-ancestor
82998319|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
82998320|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998321|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82998322|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82998323|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
82998324|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
82998325|NCT02330380|Adalimumab|adalimumab|mesh-list
82998326|NCT02330380|Etanercept|etanercept|mesh-list
82998327|NCT02330380|Methotrexate|methotrexate|mesh-list
82998328|NCT02330380|Ustekinumab|ustekinumab|mesh-list
82998329|NCT02330380|Acitretin|acitretin|mesh-list
82998330|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82998331|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
82998332|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82998333|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998334|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82998335|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
82998336|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998337|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998338|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
82998339|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998340|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82998341|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998342|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
82998343|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998344|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82998345|NCT02330380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82998346|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998347|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82998348|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82998349|NCT02330380|Analgesics|analgesics|mesh-ancestor
82998350|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
82998351|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998352|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998353|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
82998355|NCT04278404|Interferons|interferons|mesh-list
82998356|NCT04278404|Ritonavir|ritonavir|mesh-list
82998357|NCT04278404|Ribavirin|ribavirin|mesh-list
82998358|NCT04278404|Lopinavir|lopinavir|mesh-list
82998359|NCT04278404|Oseltamivir|oseltamivir|mesh-list
82998360|NCT04278404|Remdesivir|remdesivir|mesh-list
82998361|NCT04278404|Azithromycin|azithromycin|mesh-list
82998362|NCT04278404|Clindamycin|clindamycin|mesh-list
82998363|NCT04278404|Meropenem|meropenem|mesh-list
82998364|NCT04278404|Voriconazole|voriconazole|mesh-list
82998365|NCT04278404|Ceftazidime|ceftazidime|mesh-list
82998366|NCT04278404|Fosfomycin|fosfomycin|mesh-list
82998367|NCT04278404|Cefepime|cefepime|mesh-list
82998368|NCT04278404|Cefdinir|cefdinir|mesh-list
82998369|NCT04278404|Dexamethasone|dexamethasone|mesh-list
82998370|NCT04278404|Budesonide|budesonide|mesh-list
82998371|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
82998372|NCT04278404|Colchicine|colchicine|mesh-list
82998373|NCT04278404|Amiodarone|amiodarone|mesh-list
82998374|NCT04278404|Bosentan|bosentan|mesh-list
82998375|NCT04278404|Guanfacine|guanfacine|mesh-list
82998376|NCT04278404|Labetalol|labetalol|mesh-list
82998377|NCT04278404|Nicardipine|nicardipine|mesh-list
82998378|NCT04278404|Nifedipine|nifedipine|mesh-list
82998379|NCT04278404|Milrinone|milrinone|mesh-list
82998380|NCT04278404|Furosemide|furosemide|mesh-list
82998381|NCT04278404|Spironolactone|spironolactone|mesh-list
82998382|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
82998383|NCT04278404|Oxycodone|oxycodone|mesh-list
82998384|NCT04278404|Gabapentin|gabapentin|mesh-list
82998385|NCT04278404|Nalbuphine|nalbuphine|mesh-list
82998386|NCT04278404|Clobazam|clobazam|mesh-list
82998387|NCT04278404|Zolpidem|zolpidem|mesh-list
82998388|NCT04278404|Risperidone|risperidone|mesh-list
82998389|NCT04278404|Amphetamine|amphetamine|mesh-list
82998390|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
82998391|NCT04278404|Sertraline|sertraline|mesh-list
82998392|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
82998393|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
82998394|NCT04278404|Terbutaline|terbutaline|mesh-list
82998395|NCT04278404|Sevelamer|sevelamer|mesh-list
82998396|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998397|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
82998398|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
82998399|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998400|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998401|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998402|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
82998403|NCT04278404|Hormones|hormones|mesh-ancestor
82998404|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83464885|NCT02734004|Growth Substances|growth substances|mesh-ancestor
82998405|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82998406|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998407|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
82998408|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998409|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998410|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82998411|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82998412|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998413|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82998414|NCT04278404|Analgesics|analgesics|mesh-ancestor
82998415|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
82998416|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82998417|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82998418|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82998419|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
82998420|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998421|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
82998422|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998423|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998424|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82998425|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82998426|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82998427|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82998428|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82998429|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82998430|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82998432|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
82998433|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82998434|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82998435|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
82998436|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82998437|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
82998438|NCT04278404|Coagulants|coagulants|mesh-ancestor
82998439|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82998440|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82998441|NCT04278404|Narcotics|narcotics|mesh-ancestor
82998442|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
82998443|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82998444|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82998445|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998446|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82998447|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82998448|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
82998449|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82998450|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
82998451|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82998452|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82998453|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
82998454|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
82998455|NCT04278404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82998456|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82998457|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998458|NCT04278404|Diuretics|diuretics|mesh-ancestor
82998459|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
82998460|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
82998461|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
82998462|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
82998463|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
82998464|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
82998465|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
82998466|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
82998467|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
82998468|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82998469|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82998470|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82998471|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
82998472|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
82998473|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82998474|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
82998475|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82998476|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82998477|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
82998478|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
82998479|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
82998480|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
82998481|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82998482|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
82998483|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82998484|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
82998485|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
82998486|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82998487|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82998488|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
82998489|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82998490|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82998491|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82998492|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
82998493|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
82998494|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
82998495|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82998496|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
82998497|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82998498|NCT04278404|Protective Agents|protective agents|mesh-ancestor
82998499|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82998500|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82998501|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
82998502|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82998503|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82998504|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82998506|NCT02333890|Amebicides|amebicides|mesh-ancestor
82998507|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
82998508|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
82998509|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998510|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
82998511|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998512|NCT02330302|Ropivacaine|ropivacaine|mesh-list
82998513|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
82998514|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
82998515|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998516|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998517|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
82998518|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998519|NCT03143530|Ropivacaine|ropivacaine|mesh-list
82998520|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
82998521|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
82998522|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998523|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998524|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
82998525|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998526|NCT01065818|Telbivudine|telbivudine|mesh-list
82998527|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
82998528|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998529|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82998530|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998531|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998532|NCT03697408|Everolimus|everolimus|mesh-list
82998533|NCT03697408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
82998534|NCT03697408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82998535|NCT03697408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998536|NCT03697408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998537|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998538|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
82998539|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998540|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998541|NCT02318277|Durvalumab|durvalumab|mesh-list
82998542|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82998543|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998544|NCT03143452|Lidocaine|lidocaine|mesh-list
82998545|NCT03143452|Tetracaine|tetracaine|mesh-list
82998546|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82998547|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
82998548|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
82998549|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998550|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998551|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
82998552|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998553|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82998554|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82998555|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82998556|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998557|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998558|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82998559|NCT01063868|Oxycodone|oxycodone|mesh-list
82998560|NCT01063868|Tapentadol|tapentadol|mesh-list
82998561|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82998562|NCT01063868|Narcotics|narcotics|mesh-ancestor
82998563|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998564|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998565|NCT01063868|Analgesics|analgesics|mesh-ancestor
82998566|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
82998567|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998568|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82998569|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82998570|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998571|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998572|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
82998573|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998574|NCT04993924|Cetrorelix|cetrorelix|mesh-list
82998575|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
82998576|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
82998577|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82998578|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998579|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
82998580|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998581|NCT02330068|Citalopram|citalopram|mesh-list
82998582|NCT02330068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82998583|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82998584|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998585|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998586|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998587|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
82998588|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998589|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82998590|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
82998591|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998592|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
82998593|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82998594|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998595|NCT01312857|Panitumumab|panitumumab|mesh-list
82998596|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82998597|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998598|NCT02974010|Cycloserine|cycloserine|mesh-list
82998599|NCT02974010|Ketamine|ketamine|mesh-list
82998600|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
82998601|NCT02974010|Analgesics|analgesics|mesh-ancestor
82998602|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
82998603|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998604|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998605|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82998606|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82998607|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
83464904|NCT00000316|Cocaine|cocaine|mesh-list
82998608|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
82998609|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998610|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82998611|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82998612|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998613|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998614|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
82998615|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998616|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
82998617|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
82998618|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82998619|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
82998620|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82998621|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82998622|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998623|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
82998624|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
82998625|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82998626|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
82998627|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82998628|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82998629|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
82998630|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
82998631|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82998632|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
82998633|NCT01061606|Sirolimus|sirolimus|mesh-list
82998634|NCT01061606|Temsirolimus|temsirolimus|mesh-list
82998635|NCT01061606|MTOR Inhibitors|mtor inhibitors|mesh-list
82998636|NCT01061606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82998637|NCT01061606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998638|NCT01061606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998639|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998640|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
82998641|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998642|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998643|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82998644|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998645|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82998646|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
82998647|NCT04696822|Epinephrine|epinephrine|mesh-list
82998648|NCT04696822|Racepinephrine|racepinephrine|mesh-list
82998649|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
82998650|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82998651|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82998652|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
82998653|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998654|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998655|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998656|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82998657|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82998659|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998660|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82998661|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
82998662|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
82998663|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
82998664|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82998665|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
82998666|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
82998667|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82998668|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998669|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
82998670|NCT02329756|Coagulants|coagulants|mesh-ancestor
82998671|NCT02329288|Triamcinolone|triamcinolone|mesh-list
82998672|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82998673|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82998674|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82998675|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998676|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
82998677|NCT02329288|Hormones|hormones|mesh-ancestor
82998678|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998679|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998680|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998681|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
82998682|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998683|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998684|NCT02329054|Favipiravir|favipiravir|mesh-list
82998685|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
82998686|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998687|NCT03122457|C 1027|c 1027|mesh-list
82998688|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
82998689|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
82998690|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82998691|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998692|NCT04407988|Letrozole|letrozole|mesh-list
82998693|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998694|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
82998695|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
82998696|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998697|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998698|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
82998699|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
82998700|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998701|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998702|NCT02329132|Ranibizumab|ranibizumab|mesh-list
82998703|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82998704|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82998705|NCT02329132|Growth Substances|growth substances|mesh-ancestor
82998706|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998707|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
82998708|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998709|NCT04342078|Vitamin D|vitamin d|mesh-list
82998710|NCT04342078|Vitamins|vitamins|mesh-ancestor
82998711|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
82998712|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998713|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82998714|NCT02332954|Vortioxetine|vortioxetine|mesh-list
82998715|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
82998716|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998717|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82998718|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82998719|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998720|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998721|NCT02332954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82998722|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82998723|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998724|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998725|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998726|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
82998727|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82998728|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82998729|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82998730|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82998732|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82998733|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82998734|NCT01372761|Growth Substances|growth substances|mesh-ancestor
82998735|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998736|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
82998737|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998738|NCT03873675|Hormones|hormones|mesh-list
82998739|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
82998740|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998741|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998742|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82998743|NCT05173857|Paclitaxel|paclitaxel|mesh-list
82998744|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82998745|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998746|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
82998747|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
82998748|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
82998749|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998750|NCT05133297|Tofacitinib|tofacitinib|mesh-list
82998751|NCT05133297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
82998752|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82998753|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998754|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998755|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
82998756|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82998757|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998758|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998759|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82998760|NCT03417999|Analgesics|analgesics|mesh-ancestor
82998761|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
82998762|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998763|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82998764|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82998765|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82998766|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
82998767|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998768|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998769|NCT03142516|Leucovorin|leucovorin|mesh-list
82998770|NCT03142516|Folic Acid|folic acid|mesh-list
82998771|NCT03142516|Fluorouracil|fluorouracil|mesh-list
82998772|NCT03142516|Irinotecan|irinotecan|mesh-list
82998773|NCT03142516|Panitumumab|panitumumab|mesh-list
82998774|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
82998775|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
82998776|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998777|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82998778|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998779|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998780|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
82998781|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998782|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
82998783|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82998784|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998785|NCT03142516|Antidotes|antidotes|mesh-ancestor
82998786|NCT03142516|Protective Agents|protective agents|mesh-ancestor
82998787|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
82998788|NCT03142516|Vitamins|vitamins|mesh-ancestor
82998789|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
82998790|NCT03142516|Hematinics|hematinics|mesh-ancestor
82998791|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82998792|NCT03719729|Rifaximin|rifaximin|mesh-list
82998793|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82998794|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998795|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998796|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
82998797|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
82998798|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
82998799|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998800|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998801|NCT03714113|Antibodies|antibodies|mesh-list
82998802|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
82998803|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998804|NCT03472547|Diacerein|diacerein|mesh-list
82998805|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998806|NCT00799396|Aspirin|aspirin|mesh-list
82998807|NCT00799396|Clopidogrel|clopidogrel|mesh-list
82998808|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82998809|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82998810|NCT00799396|Analgesics|analgesics|mesh-ancestor
82998811|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
82998812|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998813|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998814|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998815|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998816|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83464926|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998817|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83523436|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
82998818|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998819|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82998820|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82998821|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998822|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
82998823|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
82998824|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
82998825|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82998826|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
82998827|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998829|NCT02624128|Valproic Acid|valproic acid|mesh-list
82998830|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998831|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82998832|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
82998833|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998834|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998835|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
82998836|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998837|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998838|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
82998839|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82998840|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998841|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998842|NCT03469349|Actovegin|actovegin|mesh-list
82998843|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82998844|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998845|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82998846|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998847|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
82998848|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998849|NCT03469349|Protective Agents|protective agents|mesh-ancestor
82998850|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
82998851|NCT03467945|Metformin|metformin|mesh-list
82998852|NCT03467945|Gliclazide|gliclazide|mesh-list
82998853|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82998854|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998855|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
82998856|NCT03719261|Eusol|eusol|mesh-list
82998857|NCT03719261|Chitosan|chitosan|mesh-list
82998858|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82998859|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82998860|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
82998861|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998862|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82998863|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
82998864|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
82998865|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
82998866|NCT03719261|Coagulants|coagulants|mesh-ancestor
82998867|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
82998868|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82998869|NCT00069238|Prednisone|prednisone|mesh-list
82998870|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
82998871|NCT00069238|Doxorubicin|doxorubicin|mesh-list
82998872|NCT00069238|Etoposide|etoposide|mesh-list
82998873|NCT00069238|Vincristine|vincristine|mesh-list
82998874|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
82998875|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998876|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
82998877|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998878|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998879|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83362081|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998880|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
82998881|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998882|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998883|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
82998884|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82998885|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82998886|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82998887|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998888|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998889|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
82998890|NCT00069238|Hormones|hormones|mesh-ancestor
82998891|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998892|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82998893|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82998894|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
82998895|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
82998896|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
82998897|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82998898|NCT03639155|Glycine|glycine|mesh-list
82998899|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
82998900|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998901|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998902|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998903|NCT05080348|Ropivacaine|ropivacaine|mesh-list
82998904|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
82998905|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
82998906|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82998907|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998908|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
82998909|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998910|NCT03073200|Etanercept|etanercept|mesh-list
82998911|NCT03073200|Ixekizumab|ixekizumab|mesh-list
82998912|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82998913|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82998914|NCT03073200|Analgesics|analgesics|mesh-ancestor
82998915|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
82998916|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998917|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998918|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998919|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82998920|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82998921|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998922|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
82998923|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
82998924|NCT02030860|Gemcitabine|gemcitabine|mesh-list
82998925|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
82998926|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82998927|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
82998928|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998929|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998930|NCT01569984|Bevacizumab|bevacizumab|mesh-list
82998931|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82998932|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998933|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82998934|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82998935|NCT01569984|Growth Substances|growth substances|mesh-ancestor
82998936|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998937|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
82998938|NCT02328118|Triamcinolone|triamcinolone|mesh-list
82998939|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
82998940|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
82998941|NCT02328118|Ranibizumab|ranibizumab|mesh-list
82998942|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
82998943|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82998944|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82998945|NCT02328118|Growth Substances|growth substances|mesh-ancestor
82998946|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998947|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
82998948|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998949|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82998950|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
82998951|NCT02328118|Hormones|hormones|mesh-ancestor
82998952|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82998953|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82998954|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
82998955|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998956|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998957|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
82998958|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82998959|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82998960|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82998961|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998962|NCT05079880|Caffeine|caffeine|mesh-list
82998963|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
82998964|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998965|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82998966|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998967|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
82998969|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
82998970|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
82998971|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
82998972|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998973|NCT03716765|Vitamin D|vitamin d|mesh-list
82998974|NCT03716765|Vitamins|vitamins|mesh-ancestor
82998975|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
82998976|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998977|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82998978|NCT03070002|Denosumab|denosumab|mesh-list
82998979|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82998980|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998981|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
82998982|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
82998983|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
82998984|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
82998985|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82998986|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82998987|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
82998988|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82998989|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82998990|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
82998991|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82998992|NCT02918318|Esketamine|esketamine|mesh-list
82998993|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
82998994|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82998995|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
82998996|NCT04926454|Bupivacaine|bupivacaine|mesh-list
82998997|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
82998998|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
82998999|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999000|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999001|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
82999002|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999003|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82999004|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999005|NCT04926454|Analgesics|analgesics|mesh-ancestor
82999006|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82999007|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82999008|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82999009|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
82999010|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999011|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999012|NCT03652376|Benralizumab|benralizumab|mesh-list
82999013|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82999014|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
82999015|NCT05200143|Nivolumab|nivolumab|mesh-list
82999016|NCT05200143|Ipilimumab|ipilimumab|mesh-list
82999017|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999018|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999019|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82999020|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999021|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
82999022|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82999023|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999024|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
82999025|NCT01372839|Atorvastatin|atorvastatin|mesh-list
82999026|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83362082|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
82999027|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82999028|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
82999029|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999030|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82999031|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
82999032|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999033|NCT01065350|Ketamine|ketamine|mesh-list
82999034|NCT01065350|Propofol|propofol|mesh-list
82999035|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82999036|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999037|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999038|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82999039|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
82999040|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
82999041|NCT01065350|Analgesics|analgesics|mesh-ancestor
82999042|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
82999043|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999044|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82999045|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82999046|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82999047|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999048|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999049|NCT02914977|Daunorubicin|daunorubicin|mesh-list
82999050|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
82999051|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999052|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82999053|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82999054|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999055|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999056|NCT03718715|Metformin|metformin|mesh-list
82999057|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82999058|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999059|NCT05079022|Aflutinib|aflutinib|mesh-list
82999060|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999061|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999062|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999063|NCT05078788|Triamcinolone|triamcinolone|mesh-list
82999064|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999065|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
82999066|NCT05078788|Hormones|hormones|mesh-ancestor
82999067|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82999068|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999069|NCT02032654|Floxacillin|floxacillin|mesh-list
82999070|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82999071|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999072|NCT04734886|Vitamin D|vitamin d|mesh-list
82999073|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
82999074|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
82999075|NCT04734886|Vitamins|vitamins|mesh-list
82999076|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
82999077|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999078|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
82999079|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82999080|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
82999081|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
82999082|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
82999083|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82999084|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
82999085|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82999086|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
82999087|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999088|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999089|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
82999090|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
82999091|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
82999092|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999093|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999094|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
82999095|NCT03114969|Hormones|hormones|mesh-ancestor
83221009|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999096|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82999097|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
82999098|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
82999099|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
82999100|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999101|NCT03144778|Durvalumab|durvalumab|mesh-list
82999102|NCT03144778|Ipilimumab|ipilimumab|mesh-list
82999103|NCT03144778|Tremelimumab|tremelimumab|mesh-list
82999104|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
82999105|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82999106|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
82999107|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999108|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999109|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
82999110|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999111|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82999112|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999113|NCT03142360|Beraprost|beraprost|mesh-list
82999114|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82999115|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
82999116|NCT05124678|Isoniazid|isoniazid|mesh-list
82999117|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
82999118|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82999119|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999120|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
82999121|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82999122|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
82999123|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999124|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82999125|NCT05761860|Oxycodone|oxycodone|mesh-list
82999126|NCT05761860|Oxytocin|oxytocin|mesh-list
82999127|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
82999128|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82999129|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999130|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82999131|NCT05761860|Narcotics|narcotics|mesh-ancestor
82999132|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999133|NCT05761860|Analgesics|analgesics|mesh-ancestor
82999134|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
82999135|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999136|NCT03122145|Capsaicin|capsaicin|mesh-list
82999137|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
82999138|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
82999139|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
82999140|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999141|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999142|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
82999143|NCT05081674|Nivolumab|nivolumab|mesh-list
82999144|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82999145|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999146|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999147|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82999148|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999149|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999150|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999151|NCT05003076|Methamphetamine|methamphetamine|mesh-list
82999152|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
82999153|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999154|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
82999155|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
82999156|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999157|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
82999158|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999159|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999160|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
82999161|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
82999162|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82999163|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999164|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
82999165|NCT03144856|Apatinib|apatinib|mesh-list
82999166|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999167|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999168|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999169|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999170|NCT03141970|Prednisone|prednisone|mesh-list
82999171|NCT03141970|Prednisolone|prednisolone|mesh-list
82999172|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999173|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
82999174|NCT03141970|Hormones|hormones|mesh-ancestor
82999175|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82999176|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999177|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
82999178|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999179|NCT04949022|Insulin|insulin|mesh-list
82999180|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82999181|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999182|NCT02327338|Ibuprofen|ibuprofen|mesh-list
82999183|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82999184|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999185|NCT02327338|Analgesics|analgesics|mesh-ancestor
82999186|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
82999187|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999188|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999189|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999190|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999191|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82999192|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999193|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999194|NCT02327416|Entecavir|entecavir|mesh-list
82999195|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
82999196|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
82999197|NCT02327416|Adefovir|adefovir|mesh-list
82999198|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
82999199|NCT02327416|Molgramostim|molgramostim|mesh-list
82999200|NCT02327416|Sargramostim|sargramostim|mesh-list
82999201|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
82999202|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999203|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
82999204|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999205|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
82999206|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82999207|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999208|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999209|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999210|NCT02926950|Metformin|metformin|mesh-list
82999211|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
82999212|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82999213|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999214|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82999215|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999216|NCT01064414|Canagliflozin|canagliflozin|mesh-list
82999217|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
82999218|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999219|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82999220|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999221|NCT03433703|Lenvatinib|lenvatinib|mesh-list
82999222|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999223|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999224|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999225|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999226|NCT01374633|Sevoflurane|sevoflurane|mesh-list
82999227|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82999228|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
82999229|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
82999230|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
82999231|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999232|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999233|NCT01178814|Lenalidomide|lenalidomide|mesh-list
82999234|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
83221010|NCT02412085|Golimumab|golimumab|mesh-list
82999235|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999236|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82999237|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82999238|NCT01178814|Growth Substances|growth substances|mesh-ancestor
82999239|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
82999240|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999241|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
82999242|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
82999243|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999244|NCT05762484|Clindamycin|clindamycin|mesh-list
82999245|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
82999246|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
82999247|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82999248|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999249|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82999250|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999251|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999252|NCT03462641|Flumazenil|flumazenil|mesh-list
82999253|NCT03462641|Antidotes|antidotes|mesh-ancestor
82999254|NCT03462641|Protective Agents|protective agents|mesh-ancestor
82999255|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999256|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
82999257|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
82999258|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999259|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999260|NCT05201352|Trifluridine|trifluridine|mesh-list
82999261|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
82999262|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999263|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
82999264|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999265|NCT04128956|Aspirin|aspirin|mesh-list
82999266|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82999267|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999268|NCT04128956|Analgesics|analgesics|mesh-ancestor
82999269|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
82999270|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999271|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999272|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999273|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999274|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82999275|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82999276|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999277|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
82999278|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82999279|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999280|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
82999281|NCT05761704|Anticoagulants|anticoagulants|mesh-list
82999282|NCT03652142|Nivolumab|nivolumab|mesh-list
82999283|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999284|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999285|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82999286|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999287|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82999288|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82999289|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999290|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
82999291|NCT04629378|Amoxicillin|amoxicillin|mesh-list
82999292|NCT04629378|Meropenem|meropenem|mesh-list
82999293|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
82999294|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
82999295|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
82999296|NCT04629378|Bedaquiline|bedaquiline|mesh-list
82999297|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
82999298|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82999299|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999300|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
82999301|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999302|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999303|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
82999304|NCT03651674|Olanzapine|olanzapine|mesh-list
82999305|NCT03651674|Clozapine|clozapine|mesh-list
82999306|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
82999307|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
82999308|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999309|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999310|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82999311|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82999312|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82999313|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999314|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82999315|NCT03651674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82999316|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82999317|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999318|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999319|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999320|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
82999321|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82999322|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
82999323|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
82999324|NCT01061840|Molgramostim|molgramostim|mesh-list
82999325|NCT01061840|Vaccines|vaccines|mesh-list
82999326|NCT01061840|Sargramostim|sargramostim|mesh-list
82999327|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
82999328|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999329|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999330|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
82999331|NCT02926638|Rilotumumab|rilotumumab|mesh-list
82999332|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
82999333|NCT02926638|Antibodies|antibodies|mesh-list
82999334|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
82999335|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82999336|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
82999337|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999338|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999339|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999340|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999341|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999343|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82999344|NCT03650582|Hormones|hormones|mesh-ancestor
82999345|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82999346|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999347|NCT02903030|Silicon|silicon|mesh-list
82999348|NCT02903030|Trace Elements|trace elements|mesh-ancestor
82999349|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
82999350|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999351|NCT02969408|Albuterol|albuterol|mesh-list
82999352|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
82999353|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
82999354|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999355|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999356|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
82999357|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
82999358|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
82999359|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82999360|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
82999361|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82999362|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82999363|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
82999364|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999365|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999366|NCT05180214|Ketorolac|ketorolac|mesh-list
82999367|NCT05180214|Bupivacaine|bupivacaine|mesh-list
82999368|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
82999369|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
82999370|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999371|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999372|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
82999373|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999374|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82999375|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999376|NCT05180214|Analgesics|analgesics|mesh-ancestor
82999377|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999378|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999379|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82999380|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999381|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999382|NCT01060124|Fentanyl|fentanyl|mesh-list
82999383|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82999384|NCT01060124|Narcotics|narcotics|mesh-ancestor
82999385|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999386|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999387|NCT01060124|Analgesics|analgesics|mesh-ancestor
82999388|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
82999389|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999390|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82999391|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82999392|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
82999393|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
82999394|NCT03461003|Losartan|losartan|mesh-list
82999395|NCT03461003|Amlodipine|amlodipine|mesh-list
82999396|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
82999397|NCT03461003|Lisinopril|lisinopril|mesh-list
82999398|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82999399|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82999400|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999401|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999402|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82999403|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999404|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
82999405|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82999406|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82999407|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82999408|NCT03461003|Diuretics|diuretics|mesh-ancestor
82999409|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
82999410|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
82999411|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82999412|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
82999413|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999414|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82999415|NCT03461003|Protective Agents|protective agents|mesh-ancestor
82999416|NCT03650348|Atezolizumab|atezolizumab|mesh-list
82999417|NCT03650348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82999418|NCT03650348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999419|NCT03650348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999420|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999421|NCT05761470|Paclitaxel|paclitaxel|mesh-list
82999422|NCT05761470|Fluzoparib|fluzoparib|mesh-list
82999423|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82999424|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999425|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
82999426|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
82999427|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
82999428|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999429|NCT05761470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
82999430|NCT05761470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999431|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
82999432|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
82999433|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
82999434|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82999435|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999436|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
82999437|NCT02904902|Adalimumab|adalimumab|mesh-list
82999438|NCT02904902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
82999439|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999440|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999441|NCT03650270|Phenytoin|phenytoin|mesh-list
82999442|NCT03650270|Midazolam|midazolam|mesh-list
82999443|NCT03650270|Phenobarbital|phenobarbital|mesh-list
82999444|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82999445|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82999446|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999447|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999448|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82999449|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82999450|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82999451|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82999452|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
82999453|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
82999454|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
82999455|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
82999456|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999457|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999458|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
82999459|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82999460|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82999461|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999462|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
82999463|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
82999464|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82999465|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82999466|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
82999467|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
82999468|NCT05285228|Fluorides|fluorides|mesh-list
82999469|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
82999470|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
82999471|NCT05285228|Protective Agents|protective agents|mesh-ancestor
82999472|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999473|NCT04075526|Vancomycin|vancomycin|mesh-list
82999474|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
82999475|NCT04075526|Povidone|povidone|mesh-list
82999476|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82999477|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999478|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
82999479|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
82999480|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82999482|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999483|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999484|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999485|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999486|NCT03650738|Paclitaxel|paclitaxel|mesh-list
82999487|NCT03650738|Carboplatin|carboplatin|mesh-list
82999488|NCT03650738|Apatinib|apatinib|mesh-list
82999489|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82999490|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999491|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
82999492|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
82999493|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
82999494|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999495|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999496|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999497|NCT02904200|Silicon|silicon|mesh-list
82999498|NCT02904200|Trace Elements|trace elements|mesh-ancestor
82999499|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
82999500|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999501|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
82999502|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
82999503|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999504|NCT03621800|Menthol|menthol|mesh-list
82999505|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
82999506|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
82999507|NCT03649334|Ketorolac|ketorolac|mesh-list
82999508|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
82999509|NCT03649334|Fentanyl|fentanyl|mesh-list
82999510|NCT03649334|Ketamine|ketamine|mesh-list
82999511|NCT03649334|Analgesics|analgesics|mesh-ancestor
82999512|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
82999513|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999514|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999515|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82999516|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82999517|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
82999518|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
82999519|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999520|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82999521|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82999522|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999523|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999524|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82999525|NCT03649334|Narcotics|narcotics|mesh-ancestor
82999526|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82999527|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82999528|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999529|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999530|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999531|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82999532|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999533|NCT02901548|Durvalumab|durvalumab|mesh-list
82999534|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999535|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999536|NCT03457727|Omeprazole|omeprazole|mesh-list
82999537|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82999538|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82999539|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82999540|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999541|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999542|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
82999543|NCT05285384|Paraproteins|paraproteins|mesh-list
82999544|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
82999545|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999546|NCT03648554|Dulaglutide|dulaglutide|mesh-list
82999547|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82999548|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999549|NCT03648320|Immunomodulating Agents|immunomodulating agents|mesh-list
82999550|NCT03648320|Immunologic Factors|immunologic factors|mesh-ancestor
82999551|NCT03648320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999552|NCT05284994|Osimertinib|osimertinib|mesh-list
82999553|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999554|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999555|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999556|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999557|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
82999558|NCT03068754|Hormones|hormones|mesh-ancestor
82999559|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82999560|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999561|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
82999562|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
82999563|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
82999565|NCT03430895|Durvalumab|durvalumab|mesh-list
82999566|NCT03430895|Tremelimumab|tremelimumab|mesh-list
82999567|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999568|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999569|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
82999570|NCT05745480|Narcotics|narcotics|mesh-ancestor
82999571|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999572|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999573|NCT05745480|Analgesics|analgesics|mesh-ancestor
82999574|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
82999575|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999576|NCT03452189|Vancomycin|vancomycin|mesh-list
82999577|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82999578|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999579|NCT00603954|Fludarabine|fludarabine|mesh-list
82999580|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
82999581|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82999582|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999583|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82999584|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
82999585|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999586|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82999587|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
82999588|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999589|NCT03427619|Picibanil|picibanil|mesh-list
82999590|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999591|NCT03712475|Pregabalin|pregabalin|mesh-list
82999592|NCT03712475|Analgesics|analgesics|mesh-ancestor
82999593|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
82999594|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999595|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999596|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
82999597|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
82999598|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999599|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999600|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82999601|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
82999602|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82999603|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999604|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82999605|NCT02435433|Ramucirumab|ramucirumab|mesh-list
82999606|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999607|NCT01372371|Vancomycin|vancomycin|mesh-list
82999608|NCT01372371|Gentamicins|gentamicins|mesh-list
82999609|NCT01372371|Cefuroxime|cefuroxime|mesh-list
82999610|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
82999611|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
82999612|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999613|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
82999614|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999615|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999616|NCT03120351|Lidocaine|lidocaine|mesh-list
82999617|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
82999618|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
82999619|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999620|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999621|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
82999622|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999623|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82999624|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82999625|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82999626|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999627|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999628|NCT05165355|Aflutinib|aflutinib|mesh-list
82999629|NCT05165355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999630|NCT05165355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999631|NCT05165355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999632|NCT01374789|Panitumumab|panitumumab|mesh-list
82999633|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999634|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999635|NCT02354703|Ondansetron|ondansetron|mesh-list
82999636|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
82999637|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
82999638|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999639|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999640|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82999641|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
82999642|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
82999643|NCT02354703|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
82999644|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82999645|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
82999646|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999647|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999648|NCT05008887|Fluorouracil|fluorouracil|mesh-list
82999649|NCT05008887|Methotrexate|methotrexate|mesh-list
82999650|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
82999651|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999652|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
82999653|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999654|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82999655|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
82999656|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999657|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
82999658|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
82999659|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82999660|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
82999661|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999662|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82999663|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999664|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82999665|NCT01376193|Naratriptan|naratriptan|mesh-list
82999666|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
82999667|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
82999668|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
82999669|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
82999670|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999671|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999672|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999673|NCT04944771|Rabeprazole|rabeprazole|mesh-list
82999674|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
82999675|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
82999676|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
82999677|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999678|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999679|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
82999680|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
82999681|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
82999682|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999683|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
82999684|NCT05197101|Oxytocin|oxytocin|mesh-list
82999685|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
82999686|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82999687|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999688|NCT01375101|Quercetin|quercetin|mesh-list
82999689|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
82999690|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999691|NCT01375101|Protective Agents|protective agents|mesh-ancestor
82999692|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999693|NCT04865289|Paclitaxel|paclitaxel|mesh-list
82999694|NCT04865289|Carboplatin|carboplatin|mesh-list
82999695|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
82999696|NCT04865289|Lenvatinib|lenvatinib|mesh-list
82999697|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82999698|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999699|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
82999700|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
82999701|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
82999702|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999703|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999704|NCT04865289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
82999705|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999707|NCT03633591|Tolcapone|tolcapone|mesh-list
82999708|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82999709|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82999710|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
82999711|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999712|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999713|NCT01376271|Paroxetine|paroxetine|mesh-list
83523668|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999714|NCT01376271|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
82999715|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
82999716|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999717|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999718|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999719|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
82999720|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999721|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82999722|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
82999723|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82999724|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
82999725|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82999726|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999727|NCT04885881|Lidocaine|lidocaine|mesh-list
82999728|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
82999729|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
82999730|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999731|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999732|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
82999733|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999734|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82999735|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
82999736|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
82999737|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82999738|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999739|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
82999740|NCT04820205|Ketamine|ketamine|mesh-list
82999741|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
82999742|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82999743|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999744|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999745|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999746|NCT04820205|Analgesics|analgesics|mesh-ancestor
82999747|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
82999748|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999749|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82999750|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82999751|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82999752|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
82999753|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999754|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999755|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
82999756|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82999757|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
82999758|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
82999759|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
82999760|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
82999761|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
82999762|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
82999763|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999764|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
82999765|NCT01375335|Dobutamine|dobutamine|mesh-list
82999766|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
82999767|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
82999768|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
82999769|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999770|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999771|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
82999772|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
82999773|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82999774|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
82999775|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999776|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999777|NCT01375335|Protective Agents|protective agents|mesh-ancestor
82999778|NCT01373463|Carboplatin|carboplatin|mesh-list
82999779|NCT01373463|Pemetrexed|pemetrexed|mesh-list
82999780|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999781|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999782|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999783|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
82999784|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
82999785|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
82999786|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82999788|NCT03113409|Buprenorphine|buprenorphine|mesh-list
82999789|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82999790|NCT03113409|Narcotics|narcotics|mesh-ancestor
82999791|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999792|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999793|NCT03113409|Analgesics|analgesics|mesh-ancestor
82999794|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
82999795|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999796|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
82999797|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
82999798|NCT05193747|Anesthetics|anesthetics|mesh-list
82999799|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999800|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999801|NCT03634293|Alirocumab|alirocumab|mesh-list
82999802|NCT03634293|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
82999803|NCT03634293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82999804|NCT03634293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82999805|NCT03634293|Antimetabolites|antimetabolites|mesh-ancestor
82999806|NCT03634293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999807|NCT03634293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
82999808|NCT03634293|Protease Inhibitors|protease inhibitors|mesh-ancestor
82999809|NCT03634293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999810|NCT03634293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82999811|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
82999812|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999813|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999814|NCT03633747|Propranolol|propranolol|mesh-list
82999815|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
82999816|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
82999817|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
82999818|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999819|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999820|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999821|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82999822|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82999823|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
82999824|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
82999825|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
82999826|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
82999827|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
82999828|NCT01373697|Ibuprofen|ibuprofen|mesh-list
82999829|NCT01373697|Ketoprofen|ketoprofen|mesh-list
82999830|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
82999831|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999832|NCT01373697|Analgesics|analgesics|mesh-ancestor
82999833|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
82999834|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999835|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999836|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
82999837|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
82999838|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
82999839|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999840|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999841|NCT01375881|Ritonavir|ritonavir|mesh-list
82999842|NCT01375881|Darunavir|darunavir|mesh-list
82999843|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
82999844|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
82999845|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
82999846|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999847|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999848|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
82999849|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
82999850|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
83362083|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999851|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999852|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
82999853|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
82999854|NCT04690023|Ropivacaine|ropivacaine|mesh-list
82999855|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
82999856|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
82999857|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999858|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999859|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
82999860|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999861|NCT03066804|Valsartan|valsartan|mesh-list
82999862|NCT03066804|Enalapril|enalapril|mesh-list
82999863|NCT03066804|Enalaprilat|enalaprilat|mesh-list
82999864|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
82999865|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
82999866|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
82999867|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
82999868|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999869|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
82999870|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
82999871|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999872|NCT03629262|Sufentanil|sufentanil|mesh-list
82999873|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
82999874|NCT03629262|Dsuvia|dsuvia|mesh-list
82999875|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82999876|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999877|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999878|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
82999879|NCT03629262|Analgesics|analgesics|mesh-ancestor
82999880|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
82999881|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
82999882|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
82999883|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
82999884|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
82999885|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
82999886|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999887|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999888|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
82999889|NCT03629262|Narcotics|narcotics|mesh-ancestor
82999890|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
82999891|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
82999892|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
82999893|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
82999894|NCT05208294|Sulpiride|sulpiride|mesh-list
82999895|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82999896|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82999897|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999898|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999899|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82999900|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
82999901|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
82999902|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
82999903|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999904|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
82999905|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
82999906|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
82999907|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
82999908|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
82999909|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
82999910|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999911|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
82999912|NCT05207904|Paclitaxel|paclitaxel|mesh-list
82999913|NCT05207904|Carboplatin|carboplatin|mesh-list
82999914|NCT05207904|Tislelizumab|tislelizumab|mesh-list
82999915|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
82999916|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999917|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
82999918|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
82999919|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
82999920|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999921|NCT05207904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
82999922|NCT05207514|Ethanol|ethanol|mesh-list
82999923|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
82999924|NCT05207514|Docetaxel|docetaxel|mesh-list
82999939|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
82999940|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
82999941|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999942|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
82999943|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82999944|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999961|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
82999962|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
82999963|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999964|NCT03118947|Pimavanserin|pimavanserin|mesh-list
82999965|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
82999966|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
82999967|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
82999968|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
82999969|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999970|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999971|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
82999972|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
82999973|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
82999974|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
82999975|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83464991|NCT02157974|Incretins|incretins|mesh-ancestor
82999976|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999977|NCT03998319|Tenecteplase|tenecteplase|mesh-list
82999978|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
82999979|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
82999980|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999981|NCT03953079|Sunitinib|sunitinib|mesh-list
82999982|NCT03953079|Aflibercept|aflibercept|mesh-list
82999983|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82999984|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82999985|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
82999986|NCT03953079|Growth Substances|growth substances|mesh-ancestor
82999987|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999988|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
82999989|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
82999990|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82999991|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82999992|NCT03794427|Anesthetics|anesthetics|mesh-list
82999993|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999994|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999995|NCT05759481|Propofol|propofol|mesh-list
82999996|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
82999997|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
82999998|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362084|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82999999|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83000000|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
83000001|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
83000002|NCT03410901|Antibodies|antibodies|mesh-list
83000003|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
83000004|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000005|NCT03357939|Adalimumab|adalimumab|mesh-list
83000006|NCT03357939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83000007|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000008|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000009|NCT03567057|Amantadine|amantadine|mesh-list
83000010|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83000011|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83000012|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
83000013|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000014|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
83000015|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000016|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000017|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000018|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83000019|NCT03567057|Analgesics|analgesics|mesh-ancestor
83000020|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
83000021|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000022|NCT03057600|Paclitaxel|paclitaxel|mesh-list
83000023|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83000024|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000025|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
83000026|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
83000027|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
83000028|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000029|NCT04382937|Ribavirin|ribavirin|mesh-list
83000030|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83000031|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
83000032|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000033|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
83000034|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000035|NCT05206890|Fluzoparib|fluzoparib|mesh-list
83000036|NCT05206890|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83000037|NCT05206890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000038|NCT05206890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000039|NCT05206890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000040|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
83000041|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000042|NCT03107091|Terlipressin|terlipressin|mesh-list
83000043|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83000044|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83000045|NCT03849768|Gefitinib|gefitinib|mesh-list
83000046|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000047|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000048|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000049|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000050|NCT05760261|Midazolam|midazolam|mesh-list
83000051|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83000052|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83000053|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000054|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000055|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83000056|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83000057|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83000058|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83000059|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
83000060|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
83000061|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
83000062|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
83000063|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000064|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000065|NCT03189693|Anesthetics|anesthetics|mesh-list
83000066|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000067|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000068|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
83000069|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000070|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000071|NCT03065400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000072|NCT03065400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000073|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
83000074|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83000075|NCT05734716|Hematinics|hematinics|mesh-ancestor
83000076|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
83000077|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
83000078|NCT05733000|Gemcitabine|gemcitabine|mesh-list
83000079|NCT05733000|Fluorouracil|fluorouracil|mesh-list
83000080|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83000081|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
83000082|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000083|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000084|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000085|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
83000086|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000087|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
83000088|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83000089|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83000090|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000091|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000092|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000093|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
83000094|NCT05733000|Protective Agents|protective agents|mesh-ancestor
83000095|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
83000096|NCT05733000|Vitamins|vitamins|mesh-ancestor
83000097|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
83000098|NCT04879368|Trifluridine|trifluridine|mesh-list
83000099|NCT04879368|Paclitaxel|paclitaxel|mesh-list
83000100|NCT04879368|Docetaxel|docetaxel|mesh-list
83000101|NCT04879368|Nivolumab|nivolumab|mesh-list
83000102|NCT04879368|Irinotecan|irinotecan|mesh-list
83000103|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83000104|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000105|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83000106|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83000107|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83000108|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000109|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000110|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000111|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83000112|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83000113|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000114|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
83000115|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
83000116|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000117|NCT03417180|Remifentanil|remifentanil|mesh-list
83000118|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83000119|NCT03417180|Narcotics|narcotics|mesh-ancestor
83000120|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000121|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000122|NCT03417180|Analgesics|analgesics|mesh-ancestor
83000123|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
83000124|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000125|NCT03085095|Leuprolide|leuprolide|mesh-list
83000126|NCT03085095|Relugolix|relugolix|mesh-list
83000127|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83000128|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
83000129|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83000130|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000131|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000132|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000133|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
83000134|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
83000135|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000136|NCT02891811|Thalidomide|thalidomide|mesh-list
83000137|NCT02891811|Dexamethasone|dexamethasone|mesh-list
83000138|NCT02891811|Lenalidomide|lenalidomide|mesh-list
83000139|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000140|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
83000141|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
83000142|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000143|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000144|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000145|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
83000146|NCT02891811|Hormones|hormones|mesh-ancestor
83000147|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000148|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000149|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000150|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
83000151|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83362085|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83000152|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83000154|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
83000155|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000156|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
83000157|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83000158|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000159|NCT02811783|Naloxone|naloxone|mesh-list
83000160|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83000161|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000162|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
83000163|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000164|NCT02649855|Docetaxel|docetaxel|mesh-list
83000165|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000166|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
83000167|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
83000168|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
83000169|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000170|NCT05720715|Cyclosporine|cyclosporine|mesh-list
83000171|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83000172|NCT05720715|Cyclosporins|cyclosporins|mesh-list
83000173|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000174|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000175|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000176|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
83000177|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000178|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
83000179|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000180|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
83000181|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000182|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83000183|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83000184|NCT02310867|Abatacept|abatacept|mesh-list
83000185|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000186|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000187|NCT02310867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000188|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000189|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465007|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83000190|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
83000191|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000192|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000193|NCT05757219|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83000194|NCT05757219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000195|NCT05757219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000196|NCT03106077|Maytansine|maytansine|mesh-list
83000197|NCT03106077|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83000198|NCT03106077|Immunoconjugates|immunoconjugates|mesh-ancestor
83000199|NCT03106077|Immunologic Factors|immunologic factors|mesh-ancestor
83000200|NCT03106077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000201|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83000202|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000203|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
83000204|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
83000205|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
83000206|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000207|NCT03648008|Morphine|morphine|mesh-list
83000208|NCT03648008|Hydromorphone|hydromorphone|mesh-list
83000209|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83000210|NCT03648008|Narcotics|narcotics|mesh-ancestor
83000211|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000212|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000213|NCT03648008|Analgesics|analgesics|mesh-ancestor
83000214|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
83000215|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000216|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83000217|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83000218|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000219|NCT05253495|Cytarabine|cytarabine|mesh-list
83000220|NCT05253495|Etoposide|etoposide|mesh-list
83000221|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83000222|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000223|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83000224|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83000225|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000226|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000227|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83000229|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
83000230|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000231|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000232|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
83000233|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000234|NCT05054751|Fulvestrant|fulvestrant|mesh-list
83000235|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000236|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000237|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83000238|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83000239|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
83000240|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000241|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000242|NCT00604617|Interferons|interferons|mesh-list
83000243|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
83000244|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000245|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
83000246|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000247|NCT03426995|Cantharidin|cantharidin|mesh-list
83000248|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000249|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000250|NCT05200299|Leucovorin|leucovorin|mesh-list
83000251|NCT05200299|Fluorouracil|fluorouracil|mesh-list
83000252|NCT05200299|Capecitabine|capecitabine|mesh-list
83000253|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
83000254|NCT05200299|Irinotecan|irinotecan|mesh-list
83000255|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
83000256|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
83000257|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000258|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83000259|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000260|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000261|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
83000262|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000263|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83000264|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83000265|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000266|NCT05200299|Antidotes|antidotes|mesh-ancestor
83000267|NCT05200299|Protective Agents|protective agents|mesh-ancestor
83000268|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
83000269|NCT05200299|Vitamins|vitamins|mesh-ancestor
83000270|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
83000272|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000273|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000274|NCT03322566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000275|NCT03322566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000276|NCT03822975|Heparin|heparin|mesh-list
83000277|NCT03822975|Calcium heparin|calcium heparin|mesh-list
83000278|NCT03822975|Bivalirudin|bivalirudin|mesh-list
83000279|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
83000280|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83000281|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83000282|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000283|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
83000284|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83000285|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
83000286|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000287|NCT05732532|Dexamethasone|dexamethasone|mesh-list
83000288|NCT05732532|Lidocaine|lidocaine|mesh-list
83000289|NCT05732532|Bupivacaine|bupivacaine|mesh-list
83000290|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000291|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
83000292|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
83000293|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000294|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000295|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000296|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
83000297|NCT05732532|Hormones|hormones|mesh-ancestor
83000298|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000299|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000300|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000301|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
83000302|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
83000303|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000305|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83000306|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83000307|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83000308|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83000309|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000310|NCT05178225|Ubiquinone|ubiquinone|mesh-list
83000311|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
83000312|NCT05178225|Anticoagulants|anticoagulants|mesh-list
83000313|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
83000314|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000315|NCT05178225|Vitamins|vitamins|mesh-ancestor
83000316|NCT02969018|PF-06700841|pf-06700841|mesh-list
83000317|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000318|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000319|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000320|NCT03255096|Rituximab|rituximab|mesh-list
83000321|NCT03255096|Venetoclax|venetoclax|mesh-list
83000322|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000323|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000324|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
83000325|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000326|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000327|NCT01319721|Mitomycins|mitomycins|mesh-list
83000328|NCT01319721|Mitomycin|mitomycin|mesh-list
83000329|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83000330|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000331|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
83000332|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000333|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83000334|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000335|NCT03792867|Doxorubicin|doxorubicin|mesh-list
83000336|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83000337|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000338|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83000339|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83000340|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000341|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000342|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
83000343|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
83000344|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83000345|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83000346|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000347|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000348|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000349|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000350|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
83000351|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
83000352|NCT05139849|Vasopressins|vasopressins|mesh-list
83000353|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000354|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
83000355|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
83000356|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000357|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000358|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000359|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
83000360|NCT05139849|Hormones|hormones|mesh-ancestor
83000361|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000362|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83000363|NCT05139849|Protective Agents|protective agents|mesh-ancestor
83000364|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
83000365|NCT05139849|Coagulants|coagulants|mesh-ancestor
83000366|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83000367|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83000368|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
83000369|NCT03315741|Pirfenidone|pirfenidone|mesh-list
83000370|NCT03315741|Analgesics|analgesics|mesh-ancestor
83000371|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
83000372|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000373|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000374|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83000375|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83000376|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000377|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000378|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000379|NCT05077449|Fulvestrant|fulvestrant|mesh-list
83362086|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000380|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000381|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000382|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83000383|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83000384|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83000385|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000386|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000387|NCT03632733|Tetracycline|tetracycline|mesh-list
83000388|NCT03632733|Clotrimazole|clotrimazole|mesh-list
83000389|NCT03632733|Miconazole|miconazole|mesh-list
83000390|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83000391|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000392|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83000393|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000394|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000395|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83000396|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
83000397|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83000398|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83000399|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83000400|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
83000401|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000402|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000403|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83000404|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83000405|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83000406|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000407|NCT05305287|Pioglitazone|pioglitazone|mesh-list
83000408|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83000409|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000410|NCT03259425|Nivolumab|nivolumab|mesh-list
83000411|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000412|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000413|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000414|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000415|NCT03061188|Nivolumab|nivolumab|mesh-list
83000416|NCT03061188|Veliparib|veliparib|mesh-list
83000417|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000418|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000419|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83523894|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
83000420|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000421|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83000422|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000423|NCT05588453|Temozolomide|temozolomide|mesh-list
83000424|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83000425|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
83000426|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000427|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000428|NCT05186454|Dexamethasone|dexamethasone|mesh-list
83000430|NCT05186454|Morphine|morphine|mesh-list
83000431|NCT05186454|Bupivacaine|bupivacaine|mesh-list
83000432|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000433|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
83000434|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
83000435|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000436|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000437|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000438|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
83000439|NCT05186454|Hormones|hormones|mesh-ancestor
83000440|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000441|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000442|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000443|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
83000444|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
83000445|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000446|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
83000447|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83000448|NCT05186454|Narcotics|narcotics|mesh-ancestor
83000449|NCT05186454|Analgesics|analgesics|mesh-ancestor
83000450|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83000451|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83000452|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83000453|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83000454|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83000455|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83000456|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
83000457|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
83000458|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
83000459|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000460|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000462|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000463|NCT05162898|Lenvatinib|lenvatinib|mesh-list
83000464|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000465|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000466|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000467|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000468|NCT05113290|Sorafenib|sorafenib|mesh-list
83000469|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000470|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000471|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000472|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000473|NCT03477162|Metformin|metformin|mesh-list
83000474|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83000475|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000476|NCT03461952|Nivolumab|nivolumab|mesh-list
83000477|NCT03461952|Ipilimumab|ipilimumab|mesh-list
83000478|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000479|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000480|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000481|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000482|NCT03619824|Gemcitabine|gemcitabine|mesh-list
83000483|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000484|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83000485|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
83000486|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000487|NCT01759836|Atorvastatin|atorvastatin|mesh-list
83000488|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83000489|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83000490|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
83000491|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000492|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83000493|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83000494|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000495|NCT03447821|Rifamycins|rifamycins|mesh-list
83000496|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
83000497|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83000498|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000499|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000501|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
83000502|NCT05630339|Vitamins|vitamins|mesh-ancestor
83000503|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
83000504|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000505|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83000506|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83000507|NCT04968366|Temozolomide|temozolomide|mesh-list
83000508|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83000509|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
83000510|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000511|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000512|NCT03447353|Acetaminophen|acetaminophen|mesh-list
83000513|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83000514|NCT03447353|Hydrocodone|hydrocodone|mesh-list
83000515|NCT03447353|Alprazolam|alprazolam|mesh-list
83000516|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83000517|NCT03447353|Analgesics|analgesics|mesh-ancestor
83000518|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
83000519|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000520|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000521|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
83000522|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83000523|NCT03447353|Narcotics|narcotics|mesh-ancestor
83000524|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000525|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
83000526|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
83362087|NCT04739410|Ivermectin|ivermectin|mesh-list
83000527|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83000528|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83000529|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83000530|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83000531|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
83000532|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
83000533|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000534|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000535|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83000536|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000537|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000538|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83000539|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83000540|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000541|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83000542|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83000543|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83000544|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000545|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
83000546|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000547|NCT00710970|Tamoxifen|tamoxifen|mesh-list
83000548|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83000549|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83000550|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
83000551|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000552|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000553|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000554|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465021|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
83000555|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83000556|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83000557|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83000558|NCT03421379|Glucagon|glucagon|mesh-list
83000559|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83000560|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000561|NCT03421379|Hormones|hormones|mesh-ancestor
83000562|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000563|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000564|NCT03421379|Incretins|incretins|mesh-ancestor
83000565|NCT03712241|Indomethacin|indomethacin|mesh-list
83000566|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83000567|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83000568|NCT03712241|Analgesics|analgesics|mesh-ancestor
83000569|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
83000570|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000571|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000572|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000573|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000574|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
83000575|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
83000576|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83000577|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83000578|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000579|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000580|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
83000581|NCT02675946|Cetuximab|cetuximab|mesh-list
83000582|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000583|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000584|NCT02675946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000585|NCT02675946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000586|NCT02900378|Valsartan|valsartan|mesh-list
83000587|NCT02900378|Enalapril|enalapril|mesh-list
83000588|NCT02900378|Enalaprilat|enalaprilat|mesh-list
83000589|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83000590|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83000591|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83000592|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83000593|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000594|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83000595|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
83000596|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000597|NCT03058692|Vaccines|vaccines|mesh-list
83362088|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83000599|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000600|NCT03647150|Amoxicillin|amoxicillin|mesh-list
83000601|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83000602|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000603|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
83000604|NCT03056352|Promethazine|promethazine|mesh-list
83000605|NCT03056352|Metoclopramide|metoclopramide|mesh-list
83000606|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83000607|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83000608|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000609|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000610|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
83000611|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
83000612|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
83000613|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000614|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
83000615|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
83000616|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000617|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83000618|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
83000619|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
83000620|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000621|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000622|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83000623|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
83000624|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
83000625|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83000626|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83000627|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
83000628|NCT04360980|Colchicine|colchicine|mesh-list
83000629|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
83000630|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000631|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
83000632|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
83000633|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
83000634|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000635|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000636|NCT03647072|Famotidine|famotidine|mesh-list
83000637|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83000638|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000639|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83000640|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
83000641|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
83000642|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000643|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000644|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000645|NCT05284136|Prednisolone|prednisolone|mesh-list
83000646|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000647|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
83000648|NCT05284136|Hormones|hormones|mesh-ancestor
83000649|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000650|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000651|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000652|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000653|NCT03646916|Dexamethasone|dexamethasone|mesh-list
83000654|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
83000655|NCT03646916|BB 1101|bb 1101|mesh-list
83000656|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000657|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
83000658|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
83000659|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000660|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000661|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000662|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
83000663|NCT03646916|Hormones|hormones|mesh-ancestor
83000664|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000665|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000666|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000667|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
83000668|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000669|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000670|NCT04305756|Enoxaparin|enoxaparin|mesh-list
83000671|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
83000672|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83000673|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83000674|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000675|NCT05283980|Bupivacaine|bupivacaine|mesh-list
83000676|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
83000677|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
83000678|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000679|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000680|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
83000681|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000682|NCT03645980|Sorafenib|sorafenib|mesh-list
83000683|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000684|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000685|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000686|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000687|NCT04315038|Anesthetics|anesthetics|mesh-list
83000688|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000689|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000690|NCT03645200|Apatinib|apatinib|mesh-list
83000691|NCT03645200|Fluzoparib|fluzoparib|mesh-list
83000692|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000693|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000694|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000695|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000696|NCT03645200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83000697|NCT03055338|Risperidone|risperidone|mesh-list
83000698|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83465024|NCT00002002|Antidotes|antidotes|mesh-ancestor
83000699|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
83000700|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000701|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000702|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000703|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83000704|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83000705|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000706|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83000707|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83000708|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
83000709|NCT03645668|Meropenem|meropenem|mesh-list
83000710|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83000711|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000712|NCT04186494|Liraglutide|liraglutide|mesh-list
83000713|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83000714|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000715|NCT04186494|Incretins|incretins|mesh-ancestor
83000716|NCT04186494|Hormones|hormones|mesh-ancestor
83000717|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000718|NCT03712163|Ketotifen|ketotifen|mesh-list
83000719|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
83000720|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
83000721|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83000722|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
83000723|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
83000724|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000725|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000726|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000727|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83000728|NCT01311167|Dexamethasone|dexamethasone|mesh-list
83000729|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000730|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
83000731|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
83000732|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000733|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000734|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000735|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
83000736|NCT01311167|Hormones|hormones|mesh-ancestor
83000737|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000738|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000739|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000740|NCT04233840|Nivolumab|nivolumab|mesh-list
83000741|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000742|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000743|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000744|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000745|NCT02896400|Nicotine|nicotine|mesh-list
83000746|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83000747|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
83362089|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000748|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000749|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000750|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83000751|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83000752|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
83000753|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000754|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000756|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83000757|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83000758|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000759|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83000760|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000761|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
83000762|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000763|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000764|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
83000765|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83000766|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000767|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000768|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83000769|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83000770|NCT05284448|Protective Agents|protective agents|mesh-ancestor
83000771|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000772|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
83000773|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83000774|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
83000775|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
83000776|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000777|NCT03444155|Folic Acid|folic acid|mesh-list
83000778|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
83000779|NCT03444155|Vitamins|vitamins|mesh-ancestor
83000780|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
83000781|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000782|NCT03444155|Hematinics|hematinics|mesh-ancestor
83000783|NCT02898116|Durvalumab|durvalumab|mesh-list
83000784|NCT02898116|Ensartinib|ensartinib|mesh-list
83000785|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000786|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000787|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000788|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000789|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000790|NCT03717701|Metformin|metformin|mesh-list
83000791|NCT03717701|Esomeprazole|esomeprazole|mesh-list
83000792|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83000793|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000794|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83000795|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000796|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83000797|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000798|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000799|NCT03658304|Mitomycins|mitomycins|mesh-list
83000800|NCT03658304|Mitomycin|mitomycin|mesh-list
83000801|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83000802|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000803|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
83000804|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000805|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83000806|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000807|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
83000808|NCT03422159|Thiamine|thiamine|mesh-list
83000809|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
83000810|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83000811|NCT03422159|Vitamins|vitamins|mesh-ancestor
83000812|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
83000813|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000814|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000815|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
83000816|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000817|NCT03422159|Protective Agents|protective agents|mesh-ancestor
83000818|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
83000819|NCT04538040|Tenofovir|tenofovir|mesh-list
83000820|NCT04538040|Emtricitabine|emtricitabine|mesh-list
83000821|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83000822|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
83000823|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000824|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83000825|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83000826|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000827|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000828|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83000829|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83000830|NCT02297412|Minocycline|minocycline|mesh-list
83000831|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83000832|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000833|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
83000834|NCT03644576|Ephedrine|ephedrine|mesh-list
83000835|NCT03644576|Ozanimod|ozanimod|mesh-list
83000836|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83000837|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
83000838|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000839|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000840|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83000841|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
83000842|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
83000843|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83000844|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83000845|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
83000846|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
83000847|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000848|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000849|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83000850|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000851|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
83000852|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83000853|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83000854|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83000855|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83000856|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83000857|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83000858|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83000859|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83000860|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83000861|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000862|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000863|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000864|NCT03418727|Laxatives|laxatives|mesh-ancestor
83000865|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000866|NCT01180374|Dronabinol|dronabinol|mesh-list
83000867|NCT01180374|Cannabidiol|cannabidiol|mesh-list
83000868|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
83000869|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
83000870|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000871|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83000872|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83000873|NCT01180374|Analgesics|analgesics|mesh-ancestor
83000874|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
83000875|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000876|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83000877|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83000878|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83000879|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000880|NCT01180374|Hormones|hormones|mesh-ancestor
83000881|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000882|NCT03418571|Gontivimab|gontivimab|mesh-list
83000883|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
83000884|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83000885|NCT03715517|Morphine|morphine|mesh-list
83000886|NCT03715517|Hydromorphone|hydromorphone|mesh-list
83000887|NCT03715517|Bupivacaine|bupivacaine|mesh-list
83000888|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83000889|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
83000890|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
83000891|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000892|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000893|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
83000894|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000895|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83000896|NCT03715517|Narcotics|narcotics|mesh-ancestor
83000897|NCT03715517|Analgesics|analgesics|mesh-ancestor
83000898|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
83000899|NCT03717467|Analgesics|analgesics|mesh-ancestor
83000900|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
83000901|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000902|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000904|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83000905|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83000906|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
83000907|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83465040|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83000908|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83000909|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000910|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83000911|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
83000912|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83000913|NCT01318122|Pioglitazone|pioglitazone|mesh-list
83000914|NCT01318122|Alogliptin|alogliptin|mesh-list
83000915|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83000916|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000917|NCT01318122|Incretins|incretins|mesh-ancestor
83000918|NCT01318122|Hormones|hormones|mesh-ancestor
83000919|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000920|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83000921|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
83000922|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000923|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000924|NCT02954159|Vedolizumab|vedolizumab|mesh-list
83000925|NCT02954159|Tacrolimus|tacrolimus|mesh-list
83000926|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000927|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
83000928|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000929|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83000930|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000931|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000932|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000933|NCT03737136|Bortezomib|bortezomib|mesh-list
83000934|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000935|NCT03763422|Temozolomide|temozolomide|mesh-list
83000936|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83000937|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
83000938|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000939|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000940|NCT03667716|Nivolumab|nivolumab|mesh-list
83000941|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83000942|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000943|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83000944|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000945|NCT03740334|Dexamethasone|dexamethasone|mesh-list
83000946|NCT03740334|Everolimus|everolimus|mesh-list
83000947|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000948|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
83000949|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
83000950|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000951|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000952|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000953|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
83000954|NCT03740334|Hormones|hormones|mesh-ancestor
83000955|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000956|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000957|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000958|NCT03740334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83000959|NCT03740334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83000960|NCT03740334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83000961|NCT03740334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000962|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000963|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
83000964|NCT03440411|Dexamethasone|dexamethasone|mesh-list
83000965|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
83000966|NCT03440411|Pomalidomide|pomalidomide|mesh-list
83000967|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83000968|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
83000969|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000970|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83000971|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83000972|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
83362090|NCT02691936|Estrogens|estrogens|mesh-list
83000973|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83000974|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83000975|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83000976|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000977|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
83000978|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
83000979|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83000980|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83000981|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
83000982|NCT03440411|Hormones|hormones|mesh-ancestor
83000983|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83000984|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83000985|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83000986|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83000987|NCT03440411|Growth Substances|growth substances|mesh-ancestor
83000988|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
83000989|NCT03714737|Vaccines|vaccines|mesh-list
83000990|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
83000991|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000992|NCT03389555|Vitamins|vitamins|mesh-list
83000993|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
83000994|NCT03389555|Thiamine|thiamine|mesh-list
83000995|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
83000996|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
83000997|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83000998|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83000999|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
83001000|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001001|NCT03389555|Protective Agents|protective agents|mesh-ancestor
83001002|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
83001003|NCT03395639|Heparin|heparin|mesh-list
83001004|NCT03395639|Enoxaparin|enoxaparin|mesh-list
83001005|NCT03395639|Warfarin|warfarin|mesh-list
83001006|NCT03395639|Edoxaban|edoxaban|mesh-list
83001007|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
83001008|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83001009|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83001010|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001011|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83001012|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
83001013|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83001014|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83001015|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001016|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
83001017|NCT03353922|Tolperisone|tolperisone|mesh-list
83001018|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83001019|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
83001020|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83001021|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83001022|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001023|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83001024|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001025|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83001026|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001027|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
83001028|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83001029|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001030|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
83001031|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83001032|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001033|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83001034|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001035|NCT05467553|Tenofovir|tenofovir|mesh-list
83001036|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83001037|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
83001038|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001039|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83001040|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83001041|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001042|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001043|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83001044|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83001045|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83001046|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001047|NCT02942004|Pregnanolone|pregnanolone|mesh-list
83001048|NCT02942004|Brexanolone|brexanolone|mesh-list
83362091|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83001049|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
83001050|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001051|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001052|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001053|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
83001054|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
83001055|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
83001056|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001057|NCT03414983|Leucovorin|leucovorin|mesh-list
83001058|NCT03414983|Bevacizumab|bevacizumab|mesh-list
83001059|NCT03414983|Nivolumab|nivolumab|mesh-list
83001060|NCT03414983|Fluorouracil|fluorouracil|mesh-list
83001061|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
83001062|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83001063|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001064|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83001065|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83001066|NCT03414983|Growth Substances|growth substances|mesh-ancestor
83001067|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001068|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
83001069|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
83001070|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001071|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83001072|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001073|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
83001074|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83001075|NCT03414983|Antidotes|antidotes|mesh-ancestor
83001076|NCT03414983|Protective Agents|protective agents|mesh-ancestor
83001077|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
83001078|NCT03414983|Vitamins|vitamins|mesh-ancestor
83001079|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
83001080|NCT03414359|Lidocaine|lidocaine|mesh-list
83001081|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
83001082|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
83001083|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
83001084|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001085|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001086|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
83001087|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001088|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83001089|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83001090|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83001091|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83001092|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001093|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
83001094|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
83001095|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001096|NCT02583048|Dolutegravir|dolutegravir|mesh-list
83001097|NCT02583048|Bedaquiline|bedaquiline|mesh-list
83001098|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83001099|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83001100|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001101|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001102|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83001103|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83001104|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
83001105|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001106|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
83001107|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83001108|NCT04661137|Dexamethasone|dexamethasone|mesh-list
83001109|NCT04661137|Daratumumab|daratumumab|mesh-list
83001110|NCT04661137|Pomalidomide|pomalidomide|mesh-list
83001111|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001112|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
83001113|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
83001114|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001115|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001116|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001117|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
83001118|NCT04661137|Hormones|hormones|mesh-ancestor
83001119|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001120|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83001121|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001122|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
83001123|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83001124|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83001125|NCT04661137|Growth Substances|growth substances|mesh-ancestor
83001126|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
83001127|NCT03274687|Androgens|androgens|mesh-list
83001128|NCT03274687|Hormones|hormones|mesh-ancestor
83001129|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001130|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001131|NCT02542956|Bupivacaine|bupivacaine|mesh-list
83001132|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
83001133|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
83001134|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001135|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001136|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
83001137|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001138|NCT03274453|Ketamine|ketamine|mesh-list
83001139|NCT03274453|Analgesics|analgesics|mesh-ancestor
83001140|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
83001141|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001142|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001143|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83001144|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83001145|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
83001146|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
83001147|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001148|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83001149|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83001150|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001151|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001152|NCT02313870|Clobetasol|clobetasol|mesh-list
83001153|NCT02313870|Methotrexate|methotrexate|mesh-list
83001154|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83001155|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
83001156|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83001157|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001158|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83001159|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
83001160|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001161|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001162|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
83001163|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001164|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83001165|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001166|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
83001167|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001168|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83001169|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001170|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
83001171|NCT02313870|Hormones|hormones|mesh-ancestor
83523971|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
83001172|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001174|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83001175|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001176|NCT01942122|Analgesics|analgesics|mesh-ancestor
83001177|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
83001178|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001179|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001180|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001181|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001182|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83001183|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001184|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001185|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
83001186|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83001187|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83001188|NCT02236806|Ramipril|ramipril|mesh-list
83001189|NCT02236806|Bisoprolol|bisoprolol|mesh-list
83001190|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83001191|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
83001192|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001193|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001194|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83001195|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
83001196|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
83001197|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001198|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001199|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83001200|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83001201|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83001202|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001203|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001204|NCT01578954|Lenalidomide|lenalidomide|mesh-list
83001205|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
83001206|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001207|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83001208|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83001209|NCT01578954|Growth Substances|growth substances|mesh-ancestor
83001210|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
83001211|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001212|NCT00659646|Levofloxacin|levofloxacin|mesh-list
83001213|NCT00659646|Ofloxacin|ofloxacin|mesh-list
83001214|NCT00659646|Gentamicins|gentamicins|mesh-list
83001215|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83001216|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001217|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83001218|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83001219|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83001220|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001221|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001222|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001223|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83001224|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83001225|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83001226|NCT02236572|Everolimus|everolimus|mesh-list
83001227|NCT02236572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83001228|NCT02236572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83001229|NCT02236572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001230|NCT02236572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001231|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001232|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
83001233|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001234|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001235|NCT03054870|Xenon|xenon|mesh-list
83001236|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83001237|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
83001238|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
83001239|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001240|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001241|NCT03414047|Prexasertib|prexasertib|mesh-list
83001242|NCT03414047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83001243|NCT03414047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523972|NCT02314728|Misoprostol|misoprostol|mesh-list
83001244|NCT03414047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001245|NCT05448677|Bevacizumab|bevacizumab|mesh-list
83001246|NCT05448677|Atezolizumab|atezolizumab|mesh-list
83001247|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83001248|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001249|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83001250|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83001251|NCT05448677|Growth Substances|growth substances|mesh-ancestor
83001252|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001253|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
83001254|NCT05448677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83001255|NCT05448677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001256|NCT05222646|Metoclopramide|metoclopramide|mesh-list
83001257|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
83001258|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
83001259|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83465065|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001260|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001261|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001262|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83001263|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83001264|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
83001265|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001266|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001267|NCT05222334|Bupivacaine|bupivacaine|mesh-list
83001268|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
83001269|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
83001270|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001271|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001272|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
83001273|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001274|NCT04465266|Tolperisone|tolperisone|mesh-list
83001275|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83001276|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001277|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83001278|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001279|NCT04434300|Daptomycin|daptomycin|mesh-list
83001280|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83001281|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001282|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
83001283|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
83001284|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83001285|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83001286|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001287|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001288|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001289|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001290|NCT05178654|Nirmatrelvir|nirmatrelvir|mesh-list
83001291|NCT05178654|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83001292|NCT05178654|Protease Inhibitors|protease inhibitors|mesh-ancestor
83001293|NCT05178654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001294|NCT05178654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001295|NCT05178654|Antiviral Agents|antiviral agents|mesh-ancestor
83001296|NCT05178654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001297|NCT04108962|Benralizumab|benralizumab|mesh-list
83001298|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83001299|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001300|NCT04865796|Lactoferrin|lactoferrin|mesh-list
83001301|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001302|NCT04811118|Docetaxel|docetaxel|mesh-list
83001303|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001304|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83001305|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83001306|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83001307|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001308|NCT05221164|Aspirin|aspirin|mesh-list
83001309|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83001310|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001311|NCT05221164|Analgesics|analgesics|mesh-ancestor
83001312|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
83001313|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001314|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001315|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001316|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001317|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83001318|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83001319|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001320|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83001321|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83001322|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001323|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
83001324|NCT04647084|Lidocaine|lidocaine|mesh-list
83001325|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
83001326|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
83001327|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001328|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001329|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
83001330|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001331|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83001332|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83001333|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83001334|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83001335|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001336|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
83001337|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83001338|NCT03627546|Velpatasvir|velpatasvir|mesh-list
83001339|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
83001340|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001341|NCT04620798|Antibodies|antibodies|mesh-list
83001342|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
83001343|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001344|NCT05220228|Prucalopride|prucalopride|mesh-list
83001345|NCT05220228|Laxatives|laxatives|mesh-ancestor
83001346|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001347|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83362092|NCT02691936|Hormones|hormones|mesh-ancestor
83001348|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83001349|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
83001350|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001351|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001352|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001353|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
83001354|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
83001355|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83001356|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83001357|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001358|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001359|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001360|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001361|NCT04765644|Celecoxib|celecoxib|mesh-list
83001362|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83001363|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001364|NCT04765644|Analgesics|analgesics|mesh-ancestor
83001365|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
83001366|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001367|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001368|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001369|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001370|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83001371|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83001372|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001373|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001374|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
83001375|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83001376|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83001377|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83001378|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83221011|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83001379|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001380|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
83001381|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001382|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001383|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83001384|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001385|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83001386|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83001387|NCT05197374|Estradiol|estradiol|mesh-list
83001388|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83001389|NCT05197374|Estrogens|estrogens|mesh-ancestor
83001390|NCT05197374|Hormones|hormones|mesh-ancestor
83001391|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001392|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001393|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83001394|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
83001395|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83001396|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83001397|NCT02951819|Dexamethasone|dexamethasone|mesh-list
83001398|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
83001399|NCT02951819|Bortezomib|bortezomib|mesh-list
83001400|NCT02951819|Daratumumab|daratumumab|mesh-list
83001401|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001402|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
83001403|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001404|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001405|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83001406|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
83001407|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001408|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001409|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83001410|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001411|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
83001412|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
83001413|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001414|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001415|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
83001416|NCT02951819|Hormones|hormones|mesh-ancestor
83001417|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001418|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83001419|NCT05191290|Heparin|heparin|mesh-list
83001420|NCT05191290|Calcium heparin|calcium heparin|mesh-list
83001421|NCT05191290|Citric Acid|citric acid|mesh-list
83001422|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
83001423|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
83001424|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83001426|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
83001427|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001428|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83001429|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83001430|NCT05627544|Anesthetics|anesthetics|mesh-list
83001431|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001432|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001433|NCT05189028|Gemcitabine|gemcitabine|mesh-list
83001434|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001435|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83001436|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
83001437|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001438|NCT05706870|Clobetasol|clobetasol|mesh-list
83001439|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001440|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
83001441|NCT05706870|Hormones|hormones|mesh-ancestor
83001442|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001443|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001444|NCT03383783|Listerine|listerine|mesh-list
83001445|NCT03383783|Fluorides|fluorides|mesh-list
83001446|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
83001447|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
83001448|NCT03383783|Protective Agents|protective agents|mesh-ancestor
83001449|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001450|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83001451|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001452|NCT03627390|Molybdenum|molybdenum|mesh-list
83001453|NCT03627390|Trace Elements|trace elements|mesh-ancestor
83001454|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
83001455|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001456|NCT03709745|Ranibizumab|ranibizumab|mesh-list
83001457|NCT03709745|Aflibercept|aflibercept|mesh-list
83001458|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83001459|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83001460|NCT03709745|Growth Substances|growth substances|mesh-ancestor
83001461|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001462|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
83001463|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001464|NCT05570526|Melatonin|melatonin|mesh-list
83001465|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
83001466|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001467|NCT05570526|Protective Agents|protective agents|mesh-ancestor
83001468|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001469|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001470|NCT03707639|Apatinib|apatinib|mesh-list
83001471|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001472|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83001473|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001474|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001475|NCT03334721|Gabapentin|gabapentin|mesh-list
83001476|NCT03334721|Analgesics|analgesics|mesh-ancestor
83001477|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
83001478|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001479|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001480|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
83001481|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83001482|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83001483|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001484|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83001485|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83001486|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83001487|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001488|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001489|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
83001490|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
83001491|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83001492|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
83001493|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001494|NCT05706402|Expectorants|expectorants|mesh-ancestor
83001495|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001496|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83001497|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
83001498|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001499|NCT05706402|Protective Agents|protective agents|mesh-ancestor
83001500|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001501|NCT05706402|Antidotes|antidotes|mesh-ancestor
83001502|NCT05706090|Fentanyl|fentanyl|mesh-list
83001503|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
83001504|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001505|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001506|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83001507|NCT05706090|Narcotics|narcotics|mesh-ancestor
83001508|NCT05706090|Analgesics|analgesics|mesh-ancestor
83001509|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
83001510|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001511|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83001512|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83001513|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
83001514|NCT03380429|Albuterol|albuterol|mesh-list
83001515|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83001516|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
83001517|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001518|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001519|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83001520|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001521|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
83001522|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83001523|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83001524|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83001525|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83001526|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001527|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001528|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001529|NCT05096442|Paclitaxel|paclitaxel|mesh-list
83001530|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83001531|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83001532|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001533|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83001534|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83001535|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83001536|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001537|NCT01313143|Esmolol|esmolol|mesh-list
83001538|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83001539|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83001540|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83001541|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001542|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001543|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001544|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001545|NCT05071794|Propofol|propofol|mesh-list
83001546|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83001547|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001548|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001549|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83001550|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
83001551|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
83001552|NCT03280537|Omalizumab|omalizumab|mesh-list
83001553|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83001554|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83001555|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001556|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83001557|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
83001558|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83001559|NCT05029050|Clonidine|clonidine|mesh-list
83001560|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
83001561|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83001562|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001563|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001564|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001565|NCT05029050|Analgesics|analgesics|mesh-ancestor
83001566|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
83001567|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001568|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83001569|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83001570|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83001571|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001572|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001573|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001574|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83001575|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
83001576|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
83001577|NCT04690231|Etoposide|etoposide|mesh-list
83001578|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
83001579|NCT04690231|Apatinib|apatinib|mesh-list
83001580|NCT04690231|Ifosfamide|ifosfamide|mesh-list
83001581|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
83001582|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83001583|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001584|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83001585|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83001586|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001587|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001588|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83001589|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83001590|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
83001591|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83001592|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83465106|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
83001593|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83001594|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
83001595|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001596|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83001597|NCT04998006|Ethanol|ethanol|mesh-list
83001598|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83001599|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001600|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83001601|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001602|NCT04234945|Doxycycline|doxycycline|mesh-list
83001603|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83001604|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001605|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
83001606|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83001607|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83001608|NCT03316807|Vaccines|vaccines|mesh-list
83001609|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
83001610|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001611|NCT03379259|Tislelizumab|tislelizumab|mesh-list
83001612|NCT03379259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83001613|NCT03379259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001614|NCT03328897|Omalizumab|omalizumab|mesh-list
83001615|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83001616|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83001617|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001618|NCT04918758|Sucralfate|sucralfate|mesh-list
83001619|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83001620|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001621|NCT03378635|Glucagon|glucagon|mesh-list
83001622|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001624|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001625|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001626|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83001627|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83001628|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001629|NCT01182727|Analgesics|analgesics|mesh-ancestor
83001630|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
83001631|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001632|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001633|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001634|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001635|NCT03334409|Vitamins|vitamins|mesh-list
83001636|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
83001637|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
83001638|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001639|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
83001640|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001641|NCT03334409|Protective Agents|protective agents|mesh-ancestor
83001642|NCT02891915|Amoxicillin|amoxicillin|mesh-list
83001643|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
83001644|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
83001645|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83001646|NCT02891915|Cefdinir|cefdinir|mesh-list
83001647|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83001648|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001649|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83001650|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001651|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001652|NCT05230368|Decitabine|decitabine|mesh-list
83001653|NCT05230368|Romidepsin|romidepsin|mesh-list
83001654|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83001655|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
83001656|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001657|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001658|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001659|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83001660|NCT05230368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83001661|NCT03046446|FX006|fx006|mesh-list
83001662|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001663|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
83001664|NCT03046446|Hormones|hormones|mesh-ancestor
83001665|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001666|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001667|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001668|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
83001669|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
83001670|NCT03051217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83001671|NCT03051217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001672|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001673|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
83001674|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001675|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001676|NCT05035303|Epinephrine|epinephrine|mesh-list
83001677|NCT05035303|Norepinephrine|norepinephrine|mesh-list
83001678|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83001679|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83001680|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001681|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001682|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001683|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001684|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83001685|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83001686|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
83001687|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001688|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83001689|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001690|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
83001691|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
83001692|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83001693|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83001694|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
83001695|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001696|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
83001698|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001699|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83001700|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
83001701|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83001702|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001703|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001704|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001705|NCT04580394|Oxybutynin|oxybutynin|mesh-list
83001706|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83001707|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83001708|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83001709|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83001710|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001711|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001712|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001713|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001714|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
83001715|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
83001716|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001717|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83001718|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83001719|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
83001720|NCT04580394|Urological Agents|urological agents|mesh-ancestor
83001721|NCT03713580|Venetoclax|venetoclax|mesh-list
83001722|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001723|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83001724|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83001725|NCT04385173|Temozolomide|temozolomide|mesh-list
83362152|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83001726|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83001727|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
83001728|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001729|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001730|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
83001731|NCT03707249|Hematinics|hematinics|mesh-ancestor
83001732|NCT05682911|Simvastatin|simvastatin|mesh-list
83001733|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83001734|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83001735|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
83001736|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001737|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83001738|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83001739|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001740|NCT04625088|Atropine|atropine|mesh-list
83001741|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83001742|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83001743|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83001744|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
83001745|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001746|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001747|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83001748|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001749|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
83001750|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
83001751|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83001752|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83001753|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
83001754|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001755|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001756|NCT03568422|Paclitaxel|paclitaxel|mesh-list
83001757|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83001758|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001759|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
83001760|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
83001761|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
83001762|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001763|NCT03535350|Temozolomide|temozolomide|mesh-list
83001764|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83001765|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
83001766|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001767|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001768|NCT02547493|Abatacept|abatacept|mesh-list
83001769|NCT02547493|Vaccines|vaccines|mesh-list
83001770|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83001771|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
83001772|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001773|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83001774|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001775|NCT02547493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83001776|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001777|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001778|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001779|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
83001780|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83001781|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001782|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
83001783|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
83001784|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001785|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001786|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001787|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
83001788|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
83001789|NCT03257995|Maleic acid|maleic acid|mesh-list
83001790|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001791|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001792|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83001793|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83001794|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
83001795|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001796|NCT03049488|Antacids|antacids|mesh-ancestor
83001797|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001798|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001799|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
83001800|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83001801|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83465114|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001802|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001803|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001804|NCT04484922|Analgesics|analgesics|mesh-ancestor
83001805|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
83001806|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001807|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83001808|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83001809|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83001810|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001811|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001812|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001813|NCT04446390|Listerine|listerine|mesh-list
83001814|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
83001815|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
83001816|NCT04446390|Protective Agents|protective agents|mesh-ancestor
83001817|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001818|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83001819|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001820|NCT02338921|Metformin|metformin|mesh-list
83001821|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83001822|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
83001823|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83001824|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001825|NCT02338921|Incretins|incretins|mesh-ancestor
83001826|NCT02338921|Hormones|hormones|mesh-ancestor
83001827|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83001828|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83001829|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
83001830|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001831|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001832|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83001833|NCT01313845|Amantadine|amantadine|mesh-list
83001834|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83001835|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83001836|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
83001837|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001838|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
83001839|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001840|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001841|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001842|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001843|NCT01313845|Analgesics|analgesics|mesh-ancestor
83001844|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
83001845|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001846|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
83001847|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83001848|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83001849|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
83001850|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001851|NCT04745845|Norepinephrine|norepinephrine|mesh-list
83001852|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83001853|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83001854|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001855|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001856|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001857|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001858|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
83001859|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
83001860|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001861|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83001862|NCT04173247|Mineral Oil|mineral oil|mesh-list
83001863|NCT04173247|Emollients|emollients|mesh-ancestor
83001864|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
83001865|NCT03196986|Bevacizumab|bevacizumab|mesh-list
83001866|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83001867|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001868|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83001869|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83001870|NCT03196986|Growth Substances|growth substances|mesh-ancestor
83001871|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001872|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
83001873|NCT04051632|Insulin|insulin|mesh-list
83362153|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83001874|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83001875|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001876|NCT04423237|Deferasirox|deferasirox|mesh-list
83001877|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83001878|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
83001879|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
83001880|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001881|NCT03043560|Ezogabine|ezogabine|mesh-list
83001882|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
83001883|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83001884|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001885|NCT02145403|Tacrolimus|tacrolimus|mesh-list
83001886|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001887|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
83001888|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001889|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83001890|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001891|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001892|NCT02899988|Mirikizumab|mirikizumab|mesh-list
83001893|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83001894|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001895|NCT02899988|Analgesics|analgesics|mesh-ancestor
83001896|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
83001897|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001898|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001899|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001900|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001901|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83001902|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83001903|NCT03646526|Amitriptyline|amitriptyline|mesh-list
83001904|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83001905|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
83001906|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83001907|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001908|NCT03646526|Analgesics|analgesics|mesh-ancestor
83001909|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
83001910|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001911|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001912|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83001913|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83001914|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83465128|NCT00000334|Buprenorphine|buprenorphine|mesh-list
83001915|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001916|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001917|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001918|NCT03646370|Tenofovir|tenofovir|mesh-list
83001919|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
83001920|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83001921|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83001922|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83001923|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001924|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001925|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83001926|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83001927|NCT03646292|Pioglitazone|pioglitazone|mesh-list
83001928|NCT03646292|Empagliflozin|empagliflozin|mesh-list
83001929|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83001930|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001931|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83001932|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001933|NCT03345407|Albuterol|albuterol|mesh-list
83001934|NCT03345407|Nemiralisib|nemiralisib|mesh-list
83001935|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83001936|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
83001937|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001938|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001939|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83001940|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
83001941|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
83001942|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83001943|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83001944|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83001945|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83001946|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83001947|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83001948|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001949|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83001950|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001951|NCT02537418|Durvalumab|durvalumab|mesh-list
83001952|NCT02537418|Tremelimumab|tremelimumab|mesh-list
83001953|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83001954|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001955|NCT03626298|Niacinamide|niacinamide|mesh-list
83001956|NCT03626298|Niacin|niacin|mesh-list
83001957|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
83001958|NCT03626298|Adapalene|adapalene|mesh-list
83001959|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
83001960|NCT03626298|Vitamins|vitamins|mesh-ancestor
83001961|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
83001962|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001963|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83001964|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
83001965|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001966|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83001967|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
83001968|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83001969|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83001970|NCT03626298|Analgesics|analgesics|mesh-ancestor
83001971|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
83001972|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83001973|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83001974|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001975|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
83001976|NCT03644264|Sevelamer|sevelamer|mesh-list
83001977|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
83001978|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
83001979|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001980|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
83001981|NCT02298348|Sorafenib|sorafenib|mesh-list
83001982|NCT02298348|Topotecan|topotecan|mesh-list
83001983|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83001984|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
83001985|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83001986|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83001987|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83001988|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
83001989|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83001990|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83001991|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83001992|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83001993|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83001994|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83001995|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83001996|NCT03240133|Berotralstat|berotralstat|mesh-list
83001997|NCT03240133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83001998|NCT03240133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83001999|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002000|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002001|NCT03814356|Methylphenidate|methylphenidate|mesh-list
83002002|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83002003|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002004|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83002005|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83002006|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002007|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002008|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
83002009|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002010|NCT03707171|Liraglutide|liraglutide|mesh-list
83002011|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83002012|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002013|NCT03707171|Incretins|incretins|mesh-ancestor
83002014|NCT03707171|Hormones|hormones|mesh-ancestor
83002015|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002016|NCT02030964|Eflornithine|eflornithine|mesh-list
83002017|NCT02030964|Celecoxib|celecoxib|mesh-list
83002018|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
83002019|NCT02030964|Topotecan|topotecan|mesh-list
83002020|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83002021|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
83002022|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362154|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002024|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465132|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465133|NCT00000334|Analgesics|analgesics|mesh-ancestor
83002025|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
83002026|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002027|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002028|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83002029|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83002030|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002031|NCT02030964|Analgesics|analgesics|mesh-ancestor
83002032|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
83002033|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002034|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002035|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83002036|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83002037|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002038|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83002039|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83002040|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83002041|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83002042|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83002043|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002044|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83002045|NCT03372083|Deferasirox|deferasirox|mesh-list
83002046|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83002047|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
83002048|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
83002049|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002050|NCT03044886|Vitamin D|vitamin d|mesh-list
83002051|NCT03044886|Vitamins|vitamins|mesh-ancestor
83002052|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
83002053|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002054|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83002055|NCT02961764|Dalbavancin|dalbavancin|mesh-list
83002056|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83002057|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002058|NCT03371459|Albuterol|albuterol|mesh-list
83002059|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83002060|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
83002061|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002062|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002063|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83002064|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
83002065|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
83002066|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83523973|NCT02314728|Oxytocin|oxytocin|mesh-list
83002067|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83002068|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83002069|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83002070|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002071|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465134|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
83465135|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002072|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002073|NCT03371381|Nivolumab|nivolumab|mesh-list
83002074|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002075|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002076|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83002077|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002078|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
83002079|NCT03044730|Capecitabine|capecitabine|mesh-list
83002080|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002081|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002082|NCT03044730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83002083|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002084|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83002085|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
83002086|NCT03738852|Insulin|insulin|mesh-list
83002087|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83002088|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002089|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83002090|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002091|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002092|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002093|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002094|NCT04783233|Chitosan|chitosan|mesh-list
83002095|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83002096|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83002097|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83002098|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
83002099|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002100|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83002101|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
83002102|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
83002103|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
83002104|NCT04783233|Coagulants|coagulants|mesh-ancestor
83002105|NCT04777539|Natalizumab|natalizumab|mesh-list
83002106|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
83002107|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002108|NCT04664829|Capecitabine|capecitabine|mesh-list
83002109|NCT04664829|Bexarotene|bexarotene|mesh-list
83002110|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83002111|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
83002112|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002113|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002114|NCT02951429|Pirfenidone|pirfenidone|mesh-list
83002115|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
83002116|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
83002117|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83002118|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83002119|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002120|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002121|NCT02951429|Urological Agents|urological agents|mesh-ancestor
83002122|NCT02951429|Analgesics|analgesics|mesh-ancestor
83002123|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
83002124|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002125|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002126|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83002127|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002128|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002129|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002130|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002131|NCT04622709|Furosemide|furosemide|mesh-list
83002132|NCT04622709|Diuretics|diuretics|mesh-list
83002133|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83002134|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
83002135|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002136|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002137|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002138|NCT05423379|Everolimus|everolimus|mesh-list
83002139|NCT05423379|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83002140|NCT05423379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002141|NCT05423379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002142|NCT05423379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002143|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83002144|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
83002145|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002146|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002148|NCT05214807|Hylan|hylan|mesh-list
83002149|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83002150|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83002151|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
83002152|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002153|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83002154|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
83002155|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
83002156|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
83002157|NCT05214807|Coagulants|coagulants|mesh-ancestor
83002158|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
83002159|NCT05214807|Protective Agents|protective agents|mesh-ancestor
83002160|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002161|NCT02454855|Melatonin|melatonin|mesh-list
83002162|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
83002163|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002164|NCT02454855|Protective Agents|protective agents|mesh-ancestor
83002165|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002166|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002167|NCT03343067|Norethindrone|norethindrone|mesh-list
83002168|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
83002169|NCT03343067|Estradiol|estradiol|mesh-list
83002170|NCT03343067|Estrogens|estrogens|mesh-ancestor
83002171|NCT03343067|Hormones|hormones|mesh-ancestor
83084033|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83002172|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002173|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002174|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83002175|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
83002176|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83002177|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83002178|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83002179|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83002180|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83002181|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83002182|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83002183|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002184|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
83002185|NCT04707183|Lidocaine|lidocaine|mesh-list
83002186|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
83002187|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
83002188|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002189|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002190|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
83002191|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002192|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83002193|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83002194|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83465161|NCT00002032|Rifabutin|rifabutin|mesh-list
83002195|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002196|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002197|NCT04703205|Ivermectin|ivermectin|mesh-list
83002198|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83002199|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002200|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
83002201|NCT03706781|Benzydamine|benzydamine|mesh-list
83002202|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83002203|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002204|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002205|NCT03706703|Carboplatin|carboplatin|mesh-list
83002206|NCT03706703|Docetaxel|docetaxel|mesh-list
83002207|NCT03706703|Pemetrexed|pemetrexed|mesh-list
83002208|NCT03706703|Endostar protein|endostar protein|mesh-list
83002209|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002210|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
83002211|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
83002212|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
83002213|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002214|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002215|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83002216|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83002217|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83002218|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83002219|NCT03706703|Growth Substances|growth substances|mesh-ancestor
83002220|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002221|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
83002222|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83002223|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
83002224|NCT03706547|Fludarabine|fludarabine|mesh-list
83002225|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83002226|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
83002227|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002228|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002229|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83002230|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
83002231|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002232|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002233|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83002234|NCT05682209|Octreotide|octreotide|mesh-list
83002235|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83002236|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83002237|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002238|NCT03708497|Misoprostol|misoprostol|mesh-list
83002239|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
83002240|NCT03708497|Carbetocin|carbetocin|mesh-list
83002241|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83002242|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83002243|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002244|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
83002245|NCT03708497|Coagulants|coagulants|mesh-ancestor
83002246|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83002249|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002251|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83002252|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
83002253|NCT04608903|Sulforaphane|sulforaphane|mesh-list
83002254|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83002255|NCT04608903|Protective Agents|protective agents|mesh-ancestor
83002256|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002257|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002258|NCT05681975|Antibodies|antibodies|mesh-list
83002259|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
83002260|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83002261|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
83002262|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
83002263|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002264|NCT05216744|Doxycycline|doxycycline|mesh-list
83002265|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
83002266|NCT05216744|Cefixime|cefixime|mesh-list
83002267|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83002268|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002269|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
83002270|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83002271|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83002272|NCT05681897|Minoxidil|minoxidil|mesh-list
83002273|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83002274|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
83002278|NCT01345058|Lacosamide|lacosamide|mesh-list
83002279|NCT01345058|Levetiracetam|levetiracetam|mesh-list
83002280|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
83002281|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
83002282|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83002283|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83002284|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002285|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002286|NCT01345292|Listerine|listerine|mesh-list
83002287|NCT01345292|Fluorides|fluorides|mesh-list
83002288|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
83002289|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
83002290|NCT01345292|Protective Agents|protective agents|mesh-ancestor
83002291|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002292|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83002293|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002294|NCT03340961|Doxycycline|doxycycline|mesh-list
83002295|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83002296|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002297|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
83002298|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83002299|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83002300|NCT03708341|Melatonin|melatonin|mesh-list
83002301|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
83002302|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002303|NCT03708341|Protective Agents|protective agents|mesh-ancestor
83002304|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002305|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002306|NCT03643874|Albuterol|albuterol|mesh-list
83002307|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83002308|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
83002309|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002310|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002311|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83002312|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
83002313|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
83002314|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83002315|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83002316|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83002317|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83465205|NCT00000376|Desipramine|desipramine|mesh-list
83002318|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002319|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002320|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002321|NCT03254485|Praliciguat|praliciguat|mesh-list
83002322|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83002323|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
83002324|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002325|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83002326|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
83002327|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002328|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002329|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002330|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002331|NCT01068704|Letrozole|letrozole|mesh-list
83002332|NCT01068704|Lapatinib|lapatinib|mesh-list
83002333|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002334|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83002335|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83002336|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002337|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002338|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83002339|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
83002340|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002341|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002342|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002343|NCT03339401|Brincidofovir|brincidofovir|mesh-list
83002344|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
83002345|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002346|NCT05179525|Risperidone|risperidone|mesh-list
83002347|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83002348|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
83002349|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002350|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002351|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002352|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83002353|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83002354|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002355|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83002356|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83002357|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
83002358|NCT03370289|Vaccines|vaccines|mesh-list
83002359|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
83002360|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002361|NCT01344824|Bevacizumab|bevacizumab|mesh-list
83002362|NCT01344824|Carboplatin|carboplatin|mesh-list
83002363|NCT01344824|Pemetrexed|pemetrexed|mesh-list
83002364|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83002365|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002366|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002367|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83002368|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83002369|NCT01344824|Growth Substances|growth substances|mesh-ancestor
83002370|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002371|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
83002372|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83523974|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
83002373|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002374|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83002375|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83002376|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002377|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83002378|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
83002379|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002380|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
83002381|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83002382|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83002383|NCT05137496|Prednisolone|prednisolone|mesh-list
83002384|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
83002385|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83002386|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
83002387|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002388|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
83002389|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
83002390|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002391|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002392|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83002393|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
83002394|NCT05137496|Hormones|hormones|mesh-ancestor
83002395|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002396|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83002397|NCT05137496|Protective Agents|protective agents|mesh-ancestor
83002398|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362155|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002399|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002400|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83002401|NCT02959892|Amphetamine|amphetamine|mesh-list
83002402|NCT02959892|Naxagolide|naxagolide|mesh-list
83002403|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83002404|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002405|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
83002406|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
83002407|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002408|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
83002409|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002410|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002411|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002412|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83002413|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83002414|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002415|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83002416|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
83002417|NCT01661400|Thalidomide|thalidomide|mesh-list
83002418|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
83002419|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83002420|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
83002421|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002422|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002423|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83002424|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
83002425|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002426|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002427|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83002428|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
83002429|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83002430|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002431|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83002432|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83002433|NCT01661400|Growth Substances|growth substances|mesh-ancestor
83002434|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
83002435|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83002436|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83002437|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83002438|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002439|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002440|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83002441|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002442|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002443|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
83002444|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465214|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002445|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
83002446|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83002447|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002448|NCT05179213|Azacitidine|azacitidine|mesh-list
83002449|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83002450|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
83002451|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002452|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002453|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002454|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
83002455|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83002456|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002457|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83002458|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002459|NCT03367793|Metronidazole|metronidazole|mesh-list
83002460|NCT03367793|Methamphetamine|methamphetamine|mesh-list
83002461|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83002462|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002463|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
83002464|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
83002465|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002466|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
83002467|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002468|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002469|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002470|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83002471|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83002472|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002473|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83002474|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002475|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83002476|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83002477|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83002479|NCT05178745|Irinotecan|irinotecan|mesh-list
83002480|NCT05178745|Aflibercept|aflibercept|mesh-list
83002481|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
83002482|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002483|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83002484|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002485|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83002486|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
83002487|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002488|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83002489|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83002490|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002491|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83002492|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83002493|NCT05178745|Growth Substances|growth substances|mesh-ancestor
83002494|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
83002495|NCT05178511|Ensartinib|ensartinib|mesh-list
83002496|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002497|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002498|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002499|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002500|NCT05571163|Sotorasib|sotorasib|mesh-list
83002501|NCT05571163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83002502|NCT05571163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002503|NCT05571163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002504|NCT05571163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465226|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002505|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83002506|NCT03995641|Bupivacaine|bupivacaine|mesh-list
83002507|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
83002508|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
83002509|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002510|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002511|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
83002512|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002513|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002514|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
83002515|NCT03995641|Hormones|hormones|mesh-ancestor
83002516|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002517|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83002518|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
83002519|NCT04105231|Cannabidiol|cannabidiol|mesh-list
83002520|NCT04105231|Risperidone|risperidone|mesh-list
83002521|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83002522|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
83002523|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002524|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002525|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002526|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83002527|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83002528|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002529|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83002530|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83002531|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
83002532|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
83002533|NCT03557749|Dimercaprol|dimercaprol|mesh-list
83002534|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
83002535|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
83002536|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002537|NCT03532555|Zinc|zinc|mesh-list
83002538|NCT03532555|Trace Elements|trace elements|mesh-ancestor
83002539|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
83002540|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002541|NCT03993457|Bupropion|bupropion|mesh-list
83002542|NCT03993457|Escitalopram|escitalopram|mesh-list
83002543|NCT03993457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83002544|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83002545|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83084034|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002546|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002547|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002548|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
83002549|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002550|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83002551|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
83002552|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83002553|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83002554|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
83002555|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83002556|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83002557|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002558|NCT04677439|Flumatinib|flumatinib|mesh-list
83002559|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002560|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002561|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002562|NCT05689710|Inositol|inositol|mesh-list
83002563|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
83002564|NCT05689710|Vitamins|vitamins|mesh-ancestor
83002565|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
83002566|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002567|NCT02777424|Thrombin|thrombin|mesh-list
83002568|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
83002569|NCT02777424|Coagulants|coagulants|mesh-ancestor
83002570|NCT01347073|Glycerol|glycerol|mesh-list
83002571|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83002572|NCT01347073|Protective Agents|protective agents|mesh-ancestor
83002573|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002574|NCT01315236|Amikacin|amikacin|mesh-list
83002575|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83002576|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002577|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83002578|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
83002579|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
83002580|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002581|NCT05627466|Magrolimab|magrolimab|mesh-list
83002582|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002583|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002584|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
83002585|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002586|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002587|NCT03364049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83002588|NCT03364049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002589|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
83002590|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83002591|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002592|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83524496|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
83002593|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002594|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
83002595|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
83002596|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83002597|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83002598|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002599|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002600|NCT03710369|Urological Agents|urological agents|mesh-ancestor
83002601|NCT03706157|Doxorubicin|doxorubicin|mesh-list
83002602|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83002603|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83002604|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002605|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83002606|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83002607|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002608|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002609|NCT03707795|Betamethasone|betamethasone|mesh-list
83002610|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
83002611|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83002612|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
83002613|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
83002614|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
83002615|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83002616|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002617|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
83002618|NCT03707795|Hormones|hormones|mesh-ancestor
83362156|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002619|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002620|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002621|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83002622|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
83002623|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83002624|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
83002625|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002626|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
83002627|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83002628|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002629|NCT05171231|Hemostatics|hemostatics|mesh-list
83002630|NCT05171231|Coagulants|coagulants|mesh-ancestor
83002631|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83002632|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002633|NCT03360071|Immunomodulating Agents|immunomodulating agents|mesh-list
83465248|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
83002634|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
83002635|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002636|NCT05058924|Aspirin|aspirin|mesh-list
83002637|NCT05058924|Heparin|heparin|mesh-list
83002638|NCT05058924|Calcium heparin|calcium heparin|mesh-list
83002639|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83002640|NCT05058924|Tinzaparin|tinzaparin|mesh-list
83002641|NCT05058924|Dalteparin|dalteparin|mesh-list
83002642|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83002643|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002644|NCT05058924|Analgesics|analgesics|mesh-ancestor
83002645|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
83002646|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002647|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002648|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002649|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002650|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83002651|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83002652|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002653|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83002654|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83002655|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002656|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
83002657|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
83002658|NCT05681429|Acetaminophen|acetaminophen|mesh-list
83002659|NCT05681429|Parecoxib|parecoxib|mesh-list
83002660|NCT05681429|Lidocaine|lidocaine|mesh-list
83002661|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
83002662|NCT05681429|Sevoflurane|sevoflurane|mesh-list
83002663|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83002664|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002665|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002666|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002667|NCT05681429|Analgesics|analgesics|mesh-ancestor
83002668|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
83002669|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002670|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83002671|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83002672|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83002673|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002674|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002675|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002676|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
83002677|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83002678|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83002679|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
83002680|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
83002681|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
83002682|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83002683|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83002684|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83002685|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002686|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83002687|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83002688|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002689|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83002690|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002691|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002692|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
83002693|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83002694|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83002695|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002696|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
83002698|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83002699|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465259|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
83002700|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
83002701|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002702|NCT02949011|Oseltamivir|oseltamivir|mesh-list
83002703|NCT02949011|Baloxavir|baloxavir|mesh-list
83002704|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
83002705|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002706|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002707|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002708|NCT03705533|Telmisartan|telmisartan|mesh-list
83002709|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83002710|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83002711|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83002712|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002713|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
83002714|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
83002715|NCT03357341|Albuterol|albuterol|mesh-list
83002716|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83002717|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
83002718|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002719|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002720|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83002721|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
83002722|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
83002723|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83002724|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83002725|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83002726|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83002727|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002728|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002729|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002730|NCT05177237|Endostar protein|endostar protein|mesh-list
83002731|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83002732|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83002733|NCT05177237|Growth Substances|growth substances|mesh-ancestor
83002734|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002735|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
83002736|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002737|NCT05176925|Tislelizumab|tislelizumab|mesh-list
83002738|NCT05176925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002739|NCT05176925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002740|NCT05147376|Curcumin|curcumin|mesh-list
83002741|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83002742|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002744|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
83002745|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002746|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002747|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002748|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002749|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002750|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002751|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002752|NCT05175131|Mebeverine|mebeverine|mesh-list
83002753|NCT05175131|Simethicone|simethicone|mesh-list
83002754|NCT05175131|Alverine|alverine|mesh-list
83002755|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
83002756|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002757|NCT05175131|Emollients|emollients|mesh-ancestor
83002758|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
83002759|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
83002760|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
83002761|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
83002762|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002763|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002764|NCT04507373|Simvastatin|simvastatin|mesh-list
83002765|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83002766|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83002767|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
83002768|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002769|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83002770|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83002771|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002772|NCT01312337|Gefitinib|gefitinib|mesh-list
83465267|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83002773|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002774|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83002775|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002776|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002777|NCT05229653|Ketamine|ketamine|mesh-list
83002778|NCT05229653|Analgesics|analgesics|mesh-ancestor
83002779|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
83002780|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002781|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002782|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83002783|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83002784|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
83002785|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
83002786|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002787|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83002788|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83002789|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002790|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002791|NCT05551949|Estradiol|estradiol|mesh-list
83002792|NCT05551949|Estrogens|estrogens|mesh-ancestor
83002793|NCT05551949|Hormones|hormones|mesh-ancestor
83002794|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002795|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002796|NCT05541497|Varenicline|varenicline|mesh-list
83002797|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83002798|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83002799|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
83002800|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002801|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002802|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002803|NCT05283954|Ivermectin|ivermectin|mesh-list
83002804|NCT05283954|Albendazole|albendazole|mesh-list
83002805|NCT05283954|Prednisolone|prednisolone|mesh-list
83002806|NCT05283954|Fluoxetine|fluoxetine|mesh-list
83002807|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002808|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002809|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
83002810|NCT05283954|Hormones|hormones|mesh-ancestor
83002811|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002812|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83002813|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002814|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002815|NCT05283954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83002816|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83002817|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002818|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002819|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
83002820|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83002821|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
83002822|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83002823|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83002824|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83002825|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002826|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83002827|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002828|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
83002829|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
83002830|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83002831|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83002832|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
83002833|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
83002834|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
83002835|NCT01312415|Morphine|morphine|mesh-list
83002836|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
83002837|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83002838|NCT01312415|Narcotics|narcotics|mesh-ancestor
83002839|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002840|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002841|NCT01312415|Analgesics|analgesics|mesh-ancestor
83002842|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
83002843|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002844|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
83002845|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
83002846|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
83002847|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83002848|NCT03036852|Velpatasvir|velpatasvir|mesh-list
83002849|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
83002850|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83002851|NCT01312493|Panitumumab|panitumumab|mesh-list
83002852|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002853|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002854|NCT04313244|Vaccines|vaccines|mesh-list
83002855|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
83002856|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002857|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
83002858|NCT05279898|Ketamine|ketamine|mesh-list
83002859|NCT05279898|Remifentanil|remifentanil|mesh-list
83002860|NCT05279898|Propofol|propofol|mesh-list
83002861|NCT05279898|Ropivacaine|ropivacaine|mesh-list
83002862|NCT05279898|Rocuronium|rocuronium|mesh-list
83002863|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83002864|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002865|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002866|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002867|NCT05279898|Analgesics|analgesics|mesh-ancestor
83002868|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
83002869|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002870|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83002871|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83002872|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83002873|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002874|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002875|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002876|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83002877|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
83002878|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
83002879|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83002880|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83002881|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83002882|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
83002883|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83002884|NCT05279898|Narcotics|narcotics|mesh-ancestor
83002885|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83002886|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83002887|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83002889|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
83002890|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83002891|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002892|NCT05309694|Trace Elements|trace elements|mesh-ancestor
83002893|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
83002894|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
83002895|NCT05268510|Olaparib|olaparib|mesh-list
83002896|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83002897|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002898|NCT05268510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83002899|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002900|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83002901|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002902|NCT05438303|Celecoxib|celecoxib|mesh-list
83002903|NCT05438303|Midazolam|midazolam|mesh-list
83002904|NCT05438303|Omeprazole|omeprazole|mesh-list
83002905|NCT05438303|Dabigatran|dabigatran|mesh-list
83002906|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83002907|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83002908|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002909|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002910|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83002911|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83002912|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83002913|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83002914|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
83002915|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
83002916|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
83002917|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
83362157|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
83002918|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002919|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002920|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83002921|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002922|NCT05438303|Analgesics|analgesics|mesh-ancestor
83002923|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
83002924|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002925|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002926|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83002927|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83002928|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83002929|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002930|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83002931|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83002932|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83002933|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
83002934|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83002935|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
83002936|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
83002938|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
83002939|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002940|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
83002941|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83002942|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002943|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83002944|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002945|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
83002946|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83002947|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83002948|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002949|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002950|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
83002951|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83002952|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002953|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83002954|NCT04906889|Lidocaine|lidocaine|mesh-list
83002955|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
83002956|NCT04906889|Remifentanil|remifentanil|mesh-list
83002957|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
83002958|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
83002959|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002960|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002961|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
83002962|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002963|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83221012|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83002964|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83002965|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83002966|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83524497|NCT04246177|Lenvatinib|lenvatinib|mesh-list
83002967|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002968|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83002969|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83002970|NCT04906889|Analgesics|analgesics|mesh-ancestor
83002971|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83002972|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83002973|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83002974|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
83002975|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83002976|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83002977|NCT04906889|Narcotics|narcotics|mesh-ancestor
83002978|NCT02948777|Evolocumab|evolocumab|mesh-list
83002979|NCT02948777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83002980|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83002981|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83002982|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
83002983|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83002984|NCT02948777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83002985|NCT02948777|Protease Inhibitors|protease inhibitors|mesh-ancestor
83002986|NCT02948777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83002987|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83002988|NCT04868747|Lidocaine|lidocaine|mesh-list
83002989|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
83002990|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
83002991|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83002992|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83002993|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
83002994|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83002995|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83002996|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83002997|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83002998|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83002999|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003000|NCT05330273|Efavirenz|efavirenz|mesh-list
83003001|NCT05330273|Lumefantrine|lumefantrine|mesh-list
83003002|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83003003|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83003004|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003005|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003006|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
83003007|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003008|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83003009|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83003010|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83003011|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83003012|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83003013|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83003014|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
83003015|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83003016|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83003017|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83003018|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
83003019|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003020|NCT04533737|Brodalumab|brodalumab|mesh-list
83003021|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003022|NCT05254847|Capecitabine|capecitabine|mesh-list
83003023|NCT05254847|Lenvatinib|lenvatinib|mesh-list
83003024|NCT05254847|Tislelizumab|tislelizumab|mesh-list
83003025|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83003026|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
83003027|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003028|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003029|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83003030|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465305|NCT00001300|Doxorubicin|doxorubicin|mesh-list
83003031|NCT05254847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003032|NCT05249699|Isoniazid|isoniazid|mesh-list
83003033|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
83003034|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83003035|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003036|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83003037|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83003038|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
83003039|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003040|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83003041|NCT04751669|Trace Elements|trace elements|mesh-list
83003042|NCT04751669|Micronutrients|micronutrients|mesh-list
83003043|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003044|NCT04731233|Triamcinolone|triamcinolone|mesh-list
83003045|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83003046|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83003047|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83003049|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003050|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
83003051|NCT04731233|Hormones|hormones|mesh-ancestor
83003052|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003053|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003054|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83003055|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
83003056|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003057|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003058|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
83003059|NCT04417517|Azacitidine|azacitidine|mesh-list
83003060|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83003061|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
83003062|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003063|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003064|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003065|NCT04695977|Nivolumab|nivolumab|mesh-list
83003066|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003067|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003068|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83362093|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003069|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003070|NCT03093155|Bevacizumab|bevacizumab|mesh-list
83003071|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003072|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003073|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83003074|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83003075|NCT03093155|Growth Substances|growth substances|mesh-ancestor
83003076|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003077|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
83003078|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83003079|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83003080|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83003081|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003082|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003083|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83003084|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003085|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465309|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83003086|NCT03629873|Cytarabine|cytarabine|mesh-list
83003087|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
83003088|NCT03629873|Carmustine|carmustine|mesh-list
83003089|NCT03629873|Etoposide|etoposide|mesh-list
83003090|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83003091|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
83003092|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003093|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83003094|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83003095|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
83003096|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003097|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003098|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83003099|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83003100|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83003101|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83003102|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003103|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83003104|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
83003105|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
83003106|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003107|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
83003108|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83003109|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003110|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003111|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
83003112|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003113|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003114|NCT02899793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83003115|NCT02899793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003116|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
83003117|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
83003118|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83003119|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83003120|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003121|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003122|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003123|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83003124|NCT02864147|Imiquimod|imiquimod|mesh-list
83003125|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83003126|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
83003127|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003128|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003129|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
83003130|NCT04258631|Hydromorphone|hydromorphone|mesh-list
83003131|NCT04258631|Bupivacaine|bupivacaine|mesh-list
83003132|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
83003133|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
83003134|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003135|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003136|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
83003137|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003138|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83003139|NCT04258631|Narcotics|narcotics|mesh-ancestor
83003140|NCT04258631|Analgesics|analgesics|mesh-ancestor
83003141|NCT02931695|Hormones|hormones|mesh-list
83003142|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003143|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003145|NCT03638063|Capsaicin|capsaicin|mesh-list
83003146|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
83003147|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003148|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
83003149|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003150|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003151|NCT03638063|Analgesics|analgesics|mesh-ancestor
83003152|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83003153|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
83003154|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83003155|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
83003156|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
83003157|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003158|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003159|NCT04869371|Prednisone|prednisone|mesh-list
83003160|NCT04869371|Docetaxel|docetaxel|mesh-list
83003161|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83003162|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003163|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
83003164|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
83003165|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
83003166|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003167|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003168|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
83003169|NCT04869371|Hormones|hormones|mesh-ancestor
83003170|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003171|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003172|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83003173|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
83003174|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83003175|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
83003176|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83003177|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83003178|NCT02710331|Ethanol|ethanol|mesh-list
83003179|NCT02710331|Dronabinol|dronabinol|mesh-list
83003180|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83003181|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003182|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003183|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003184|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
83003185|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83003186|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83003187|NCT02710331|Analgesics|analgesics|mesh-ancestor
83003188|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
83003189|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003190|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83003191|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83003192|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003193|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003194|NCT02710331|Hormones|hormones|mesh-ancestor
83003195|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003196|NCT02885753|Leucovorin|leucovorin|mesh-list
83003197|NCT02885753|Folic Acid|folic acid|mesh-list
83003198|NCT02885753|Bevacizumab|bevacizumab|mesh-list
83003199|NCT02885753|Panitumumab|panitumumab|mesh-list
83003200|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
83003201|NCT02885753|Irinotecan|irinotecan|mesh-list
83003202|NCT02885753|Fluorouracil|fluorouracil|mesh-list
83003203|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
83003204|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003205|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003206|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83003207|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83003208|NCT02885753|Growth Substances|growth substances|mesh-ancestor
83003209|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003210|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
83003211|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83003212|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83003213|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003214|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003215|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
83003216|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83003217|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83003218|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
83003219|NCT02885753|Antidotes|antidotes|mesh-ancestor
83003220|NCT02885753|Protective Agents|protective agents|mesh-ancestor
83003221|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
83003222|NCT02885753|Vitamins|vitamins|mesh-ancestor
83003223|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
83003224|NCT02885753|Hematinics|hematinics|mesh-ancestor
83003225|NCT03320057|Mifepristone|mifepristone|mesh-list
83003226|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83003227|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
83003228|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83003229|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003230|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83003231|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83003232|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83003233|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
83003234|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83003235|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83003236|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
83003237|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003238|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
83003239|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83003240|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83003241|NCT04741139|Acetaminophen|acetaminophen|mesh-list
83003242|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
83003243|NCT04741139|Promethazine|promethazine|mesh-list
83003244|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83003245|NCT04741139|Analgesics|analgesics|mesh-ancestor
83003246|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
83003247|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003248|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003249|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
83003250|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83003251|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83003252|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003253|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
83003254|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
83003255|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
83003256|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
83003257|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003258|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83003259|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
83003260|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
83003261|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003262|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003263|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83003264|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
83003265|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003266|NCT02227199|Carboplatin|carboplatin|mesh-list
83003267|NCT02227199|Etoposide|etoposide|mesh-list
83003268|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
83003269|NCT02227199|Ifosfamide|ifosfamide|mesh-list
83003270|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
83003271|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83003272|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
83003273|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83003274|NCT02227199|Antibodies|antibodies|mesh-list
83003275|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
83003276|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83003277|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
83003278|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
83003279|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003280|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003281|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83003282|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83003283|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83003284|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003285|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003286|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83465336|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003287|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
83003288|NCT02227199|Immunotoxins|immunotoxins|mesh-ancestor
83003289|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
83003290|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003291|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83003292|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83003293|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83003294|NCT04853147|Dexamethasone|dexamethasone|mesh-list
83003295|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
83003296|NCT04853147|Palonosetron|palonosetron|mesh-list
83003297|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
83003299|NCT04853147|BB 1101|bb 1101|mesh-list
83003300|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003301|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
83003302|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
83003303|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003304|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003305|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003306|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
83003307|NCT04853147|Hormones|hormones|mesh-ancestor
83003308|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003309|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83003310|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003311|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83003312|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003313|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003314|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83003315|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83003316|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
83003317|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003318|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83003319|NCT03473561|Racecadotril|racecadotril|mesh-list
83003320|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
83003321|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003322|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
83003323|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003324|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003325|NCT04689347|Leucovorin|leucovorin|mesh-list
83003326|NCT04689347|Bevacizumab|bevacizumab|mesh-list
83003327|NCT04689347|Fluorouracil|fluorouracil|mesh-list
83003328|NCT04689347|Irinotecan|irinotecan|mesh-list
83003329|NCT04689347|Temozolomide|temozolomide|mesh-list
83003330|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003331|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003332|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83003333|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83003334|NCT04689347|Growth Substances|growth substances|mesh-ancestor
83003335|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003336|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
83003337|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
83003338|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003339|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83003340|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83003341|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
83003342|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83003343|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83003344|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003345|NCT04689347|Antidotes|antidotes|mesh-ancestor
83003346|NCT04689347|Protective Agents|protective agents|mesh-ancestor
83003347|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
83003348|NCT04689347|Vitamins|vitamins|mesh-ancestor
83003349|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
83003350|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83003351|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
83003352|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83003353|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
83003354|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003355|NCT01268579|Ribavirin|ribavirin|mesh-list
83003356|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
83003357|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003358|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
83003359|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003360|NCT02420795|TIC10 compound|tic10 compound|mesh-list
83003361|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003362|NCT02384759|Aflibercept|aflibercept|mesh-list
83003363|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83003364|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83003365|NCT02384759|Growth Substances|growth substances|mesh-ancestor
83003366|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003367|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
83003368|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003369|NCT05276687|Vancomycin|vancomycin|mesh-list
83003370|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
83003371|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83003372|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362158|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
83003373|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83003374|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
83003375|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83003376|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003377|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83003378|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003379|NCT03332771|Metformin|metformin|mesh-list
83003380|NCT03332771|Glimepiride|glimepiride|mesh-list
83003381|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83003382|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83003383|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003384|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83003385|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83003386|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
83003387|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83003388|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003389|NCT03625830|Paclitaxel|paclitaxel|mesh-list
83003390|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83003391|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003392|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
83003393|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
83003394|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
83003395|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003396|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
83003397|NCT04108104|Prazosin|prazosin|mesh-list
83003398|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83003399|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83003400|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83003401|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83003402|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
83003403|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003404|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003405|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003406|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
83003407|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003408|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003409|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83003410|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
83003411|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
83003412|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83003413|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
83003414|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83003415|NCT05304468|Cisplatin|cisplatin|mesh-list
83465368|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
83003416|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003417|NCT04731480|Propofol|propofol|mesh-list
83003418|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83003419|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003420|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003421|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83003422|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
83003423|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
83003424|NCT03039192|Esketamine|esketamine|mesh-list
83003425|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
83003426|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83003427|NCT03698279|Vaccines|vaccines|mesh-list
83003428|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
83003429|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003430|NCT03038880|Ranibizumab|ranibizumab|mesh-list
83003431|NCT03038880|Faricimab|faricimab|mesh-list
83003432|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83003433|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83003434|NCT03038880|Growth Substances|growth substances|mesh-ancestor
83003435|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003436|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
83003437|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003438|NCT03035916|Anesthetics|anesthetics|mesh-list
83003439|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003440|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003441|NCT01702571|Trastuzumab|trastuzumab|mesh-list
83003442|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83003443|NCT01702571|Maytansine|maytansine|mesh-list
83003444|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003445|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003446|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83003447|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83003448|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83003449|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83003450|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003451|NCT01702571|Immunotoxins|immunotoxins|mesh-ancestor
83003452|NCT01702571|Immunoconjugates|immunoconjugates|mesh-ancestor
83003453|NCT01702571|Immunologic Factors|immunologic factors|mesh-ancestor
83003454|NCT01702571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003455|NCT01578239|Octreotide|octreotide|mesh-list
83003456|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83003457|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003458|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83003459|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003460|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83003461|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003462|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83003463|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003464|NCT03231709|Alogliptin|alogliptin|mesh-list
83003465|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83003466|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003467|NCT03231709|Incretins|incretins|mesh-ancestor
83003468|NCT03231709|Hormones|hormones|mesh-ancestor
83003469|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003470|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83003471|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
83003472|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003473|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003474|NCT01220531|Cyclosporine|cyclosporine|mesh-list
83003475|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
83003476|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
83003477|NCT01220531|Prednisolone|prednisolone|mesh-list
83003478|NCT01220531|Tacrolimus|tacrolimus|mesh-list
83003479|NCT01220531|Cyclosporins|cyclosporins|mesh-list
83003480|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83003481|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
83003482|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83003483|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
83003484|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003485|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83003486|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003487|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003488|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
83003489|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003490|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003491|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83003492|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83003493|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003494|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83003495|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
83003496|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83003497|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003498|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
83003499|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
83003500|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003501|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003502|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
83003503|NCT01220531|Hormones|hormones|mesh-ancestor
83003504|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003505|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83003506|NCT01220531|Protective Agents|protective agents|mesh-ancestor
83003507|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83003508|NCT05255471|Olaparib|olaparib|mesh-list
83003509|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83003510|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003511|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003512|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003513|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
83003514|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003515|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003516|NCT03241927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83003517|NCT03241927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003518|NCT02941523|Carboplatin|carboplatin|mesh-list
83003519|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003520|NCT03666143|Tislelizumab|tislelizumab|mesh-list
83003521|NCT03666143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003522|NCT03666143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003523|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
83003524|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83003525|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83003526|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003527|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83003528|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83003529|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003530|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003531|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003532|NCT00360425|Hematinics|hematinics|mesh-ancestor
83003533|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83003534|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83003535|NCT02938585|Factor VIII|factor viii|mesh-list
83003536|NCT02938585|Coagulants|coagulants|mesh-ancestor
83003537|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83003538|NCT00233597|Hematinics|hematinics|mesh-ancestor
83003539|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83003540|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83003541|NCT04282811|Venetoclax|venetoclax|mesh-list
83003542|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003543|NCT03229759|Octenidine|octenidine|mesh-list
83003544|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003545|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83003546|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
83003547|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003548|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003549|NCT03476681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83003550|NCT03476681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003551|NCT03620825|Indomethacin|indomethacin|mesh-list
83003552|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83003553|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83003554|NCT03620825|Analgesics|analgesics|mesh-ancestor
83003555|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
83003556|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003557|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003558|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003559|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83003560|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
83003561|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
83003562|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83003563|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83003564|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003565|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003566|NCT03527537|Insulin|insulin|mesh-list
83003567|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83003568|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003569|NCT01496118|Panobinostat|panobinostat|mesh-list
83003570|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003571|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83003572|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003573|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003574|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83003575|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83003576|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003577|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003578|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83003579|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003580|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003581|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
83003582|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003583|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
83003584|NCT05014776|Ipilimumab|ipilimumab|mesh-list
83003585|NCT05014776|Tadalafil|tadalafil|mesh-list
83003586|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003587|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003588|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83003589|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003590|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
83003591|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83003592|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83003593|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003594|NCT05014776|Urological Agents|urological agents|mesh-ancestor
83003595|NCT03329573|Paroxetine|paroxetine|mesh-list
83003596|NCT03329573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83003597|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83003598|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003599|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003600|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003601|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
83003602|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003603|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83003604|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
83003605|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83003606|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83003607|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83003608|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003609|NCT00492349|Varenicline|varenicline|mesh-list
83003610|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83003611|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83003612|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
83003613|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003614|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003615|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003616|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83003617|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83003618|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003619|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83003620|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83003621|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003622|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003623|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
83003624|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003625|NCT03308825|Vaccines|vaccines|mesh-list
83003626|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
83003627|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003628|NCT04235855|Liver Extracts|liver extracts|mesh-list
83003629|NCT04235855|Hematinics|hematinics|mesh-ancestor
83003630|NCT03328325|Vaccines|vaccines|mesh-list
83003631|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
83003632|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003633|NCT03476603|Irbesartan|irbesartan|mesh-list
83003634|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83003635|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83003636|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83003637|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003638|NCT03476525|Fluoxetine|fluoxetine|mesh-list
83003639|NCT03476525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83003640|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83003641|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003642|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003643|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003644|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
83003645|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003646|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83003647|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
83003648|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83003649|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83003650|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83003651|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003652|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
83003653|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83003654|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003655|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003656|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83003657|NCT03665545|Poly I-C|poly i-c|mesh-list
83003658|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
83003659|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83003660|NCT03665545|Poly ICLC|poly iclc|mesh-list
83003661|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003662|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003663|NCT03665545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83003664|NCT03665545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003665|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
83362094|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003666|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
83003667|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003668|NCT03665545|Laxatives|laxatives|mesh-ancestor
83003669|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003670|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
83003671|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003672|NCT03305081|Copper|copper|mesh-list
83003673|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
83003674|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83003675|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
83003676|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83003677|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003678|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83003679|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83003680|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83003681|NCT03305081|Trace Elements|trace elements|mesh-ancestor
83003682|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
83003683|NCT04079881|Insulin|insulin|mesh-list
83003684|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83003685|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83003686|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003687|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
83003688|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83003689|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
83003690|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003691|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
83003692|NCT03223909|Protective Agents|protective agents|mesh-ancestor
83003693|NCT03733925|Golimumab|golimumab|mesh-list
83003694|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83003695|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003696|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83003697|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
83003698|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003699|NCT03649711|Aspirin|aspirin|mesh-list
83003700|NCT03649711|Clopidogrel|clopidogrel|mesh-list
83003701|NCT03649711|Ticagrelor|ticagrelor|mesh-list
83003702|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83003703|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83003704|NCT03649711|Analgesics|analgesics|mesh-ancestor
83003705|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
83003706|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003707|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003708|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003709|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83003710|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83003711|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83003712|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003713|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83003714|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83003715|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003716|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
83003717|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83003718|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83003719|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83003720|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
83003721|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003723|NCT03897673|Trace Elements|trace elements|mesh-ancestor
83003724|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
83003725|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003726|NCT03273257|Riociguat|riociguat|mesh-list
83003727|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
83003728|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003729|NCT02553473|Doxycycline|doxycycline|mesh-list
83003730|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83003731|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003732|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
83003733|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83003734|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83003735|NCT04270877|Naltrexone|naltrexone|mesh-list
83003736|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83003737|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83003738|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003739|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
83003740|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003741|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83003742|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83003743|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83003744|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003745|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003746|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003747|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003749|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
83003750|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003751|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
83003752|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83003753|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
83003754|NCT03301649|Ivermectin|ivermectin|mesh-list
83003755|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83003756|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003757|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83003758|NCT01144416|Hormones|hormones|mesh-ancestor
83003759|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003760|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003761|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
83003762|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83003763|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
83003764|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
83003765|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003766|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003767|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003768|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83003769|NCT00335777|Analgesics|analgesics|mesh-ancestor
83003770|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
83003771|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003772|NCT03764137|Panitumumab|panitumumab|mesh-list
83003773|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003774|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003775|NCT02889809|Fluticasone|fluticasone|mesh-list
83003776|NCT02889809|Xhance|xhance|mesh-list
83003777|NCT02889809|Montelukast|montelukast|mesh-list
83003778|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003779|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83003780|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
83003781|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003782|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003783|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83003784|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
83003785|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003786|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83003787|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83003788|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
83003789|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003790|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83003791|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83003792|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003794|NCT03625518|Dinoprostone|dinoprostone|mesh-list
83003795|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
83003796|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83003797|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003798|NCT00972738|Loratadine|loratadine|mesh-list
83003799|NCT00972738|Montelukast|montelukast|mesh-list
83003800|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83003801|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
83003802|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83003803|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
83003804|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003805|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003806|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83003807|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83003808|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003809|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
83003810|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003811|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83003812|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83003813|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83003814|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
83003815|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
83003816|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003817|NCT03452839|Meropenem|meropenem|mesh-list
83362095|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
83465417|NCT01231399|Antidotes|antidotes|mesh-ancestor
83003818|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83003819|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83003820|NCT04701281|Capecitabine|capecitabine|mesh-list
83003821|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83003822|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
83003823|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003824|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003825|NCT03882918|Gaboxadol|gaboxadol|mesh-list
83003826|NCT03882918|Analgesics|analgesics|mesh-ancestor
83003827|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
83003828|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003829|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003830|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
83003831|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
83003832|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
83003833|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003834|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003835|NCT04180397|Furosemide|furosemide|mesh-list
83003836|NCT04180397|Diuretics|diuretics|mesh-ancestor
83003837|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
83003838|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003839|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83003840|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003841|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003842|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
83003843|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83003844|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
83003845|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83003846|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
83003847|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003848|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003849|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
83003850|NCT03295721|Bupivacaine|bupivacaine|mesh-list
83003851|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
83003852|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
83003853|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003854|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003855|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
83003856|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003857|NCT00803790|Vitamin D|vitamin d|mesh-list
83003858|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
83003859|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
83003860|NCT00803790|Alendronate|alendronate|mesh-list
83003861|NCT00803790|Vitamins|vitamins|mesh-list
83003862|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
83003863|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003864|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83003865|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83003866|NCT00442338|Aminophylline|aminophylline|mesh-list
83003867|NCT00442338|Theophylline|theophylline|mesh-list
83003868|NCT00442338|Montelukast|montelukast|mesh-list
83003869|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83003870|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
83003871|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83003872|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
83003873|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003874|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003875|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83003876|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83003877|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003878|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83003879|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
83003880|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003881|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83003882|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83003883|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003884|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83003885|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83003886|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
83003887|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003888|NCT00442338|Protective Agents|protective agents|mesh-ancestor
83003889|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
83003890|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83003891|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83003892|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003893|NCT02316834|Talazoparib|talazoparib|mesh-list
83003894|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83003895|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003896|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003897|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003898|NCT02975934|Docetaxel|docetaxel|mesh-list
83003899|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
83003900|NCT02975934|Rucaparib|rucaparib|mesh-list
83003901|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003902|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
83003903|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
83003904|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
83003905|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003906|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83003907|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003908|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
83003909|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83003910|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003911|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83003912|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83003913|NCT02879136|Methylphenidate|methylphenidate|mesh-list
83003914|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83003915|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83003916|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003917|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83003918|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83003919|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003920|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003921|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
83003922|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003923|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83003924|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
83003925|NCT00250458|Rizatriptan|rizatriptan|mesh-list
83003926|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83003927|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
83003928|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003929|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003930|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003931|NCT01965132|Adalimumab|adalimumab|mesh-list
83003932|NCT01965132|Infliximab|infliximab|mesh-list
83003933|NCT01965132|Golimumab|golimumab|mesh-list
83003934|NCT01965132|Etanercept|etanercept|mesh-list
83003935|NCT01965132|Abatacept|abatacept|mesh-list
83003936|NCT01965132|Upadacitinib|upadacitinib|mesh-list
83003937|NCT01965132|Ustekinumab|ustekinumab|mesh-list
83003938|NCT01965132|Ixekizumab|ixekizumab|mesh-list
83003939|NCT01965132|Tofacitinib|tofacitinib|mesh-list
83003940|NCT01965132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83003941|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003942|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
83003943|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003944|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83003945|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83003946|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83003947|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
83003948|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003949|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83003950|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83003951|NCT01965132|Analgesics|analgesics|mesh-ancestor
83003952|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
83003953|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003954|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83465428|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
83003955|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83003956|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003957|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83003958|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83003959|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003960|NCT01667133|Ponatinib|ponatinib|mesh-list
83003961|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83003962|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83003963|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83003964|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003966|NCT01498770|Risperidone|risperidone|mesh-list
83003967|NCT01498770|Aripiprazole|aripiprazole|mesh-list
83003968|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83003969|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83003970|NCT01498770|Ziprasidone|ziprasidone|mesh-list
83003971|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83003972|NCT01498770|Clozapine|clozapine|mesh-list
83003973|NCT01498770|Asenapine|asenapine|mesh-list
83003974|NCT01498770|Amisulpride|amisulpride|mesh-list
83003975|NCT01498770|Iloperidone|iloperidone|mesh-list
83003976|NCT01498770|Sertindole|sertindole|mesh-list
83003977|NCT01498770|Zotepine|zotepine|mesh-list
83003978|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83003979|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
83003980|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83003981|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83003982|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83003983|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83003984|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83003985|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83003986|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83003987|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83003988|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
83003989|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
83003990|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
83003991|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83003992|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83003993|NCT01498770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83003994|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83003995|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83003996|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
83003997|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
83003998|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83003999|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83004000|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83004001|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83004002|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83004003|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83004004|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83004005|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
83004006|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
83004007|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
83004008|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83004009|NCT00140946|Montelukast|montelukast|mesh-list
83004010|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004011|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004012|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83004013|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83004014|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83004015|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
83004016|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004017|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83004018|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83004019|NCT01267812|Rituximab|rituximab|mesh-list
83004020|NCT01267812|Bortezomib|bortezomib|mesh-list
83004021|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004022|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004023|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
83004024|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004025|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004026|NCT00095004|Rizatriptan|rizatriptan|mesh-list
83004027|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004028|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004029|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004030|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83004031|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
83004032|NCT00967746|Etonogestrel|etonogestrel|mesh-list
83004033|NCT00967746|Desogestrel|desogestrel|mesh-list
83004034|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83004035|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
83004036|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83362096|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83004037|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004038|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83004039|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83004040|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83004041|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83004042|NCT00967746|Progestins|progestins|mesh-ancestor
83004043|NCT00967746|Hormones|hormones|mesh-ancestor
83004044|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004045|NCT00092118|Montelukast|montelukast|mesh-list
83004046|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83004047|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
83004048|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83004049|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
83004050|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004051|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004052|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83004053|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83004054|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004055|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83004056|NCT00920634|Hormones|hormones|mesh-ancestor
83004057|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004058|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004059|NCT00092040|Alendronate|alendronate|mesh-list
83004060|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
83004061|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004062|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004063|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83004064|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83004065|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83004066|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83004067|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
83004068|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004069|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004070|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004071|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004072|NCT05416827|Dexamethasone|dexamethasone|mesh-list
83004073|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004074|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
83004075|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
83004076|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004077|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83465441|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
83004078|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004079|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
83004080|NCT05416827|Hormones|hormones|mesh-ancestor
83004081|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004082|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83004083|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004084|NCT04961619|Trametinib|trametinib|mesh-list
83004085|NCT04961619|Dabrafenib|dabrafenib|mesh-list
83004086|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004087|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004088|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004089|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004090|NCT05076513|Niraparib|niraparib|mesh-list
83004091|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83004092|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004093|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004094|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004095|NCT04979910|Ixekizumab|ixekizumab|mesh-list
83004096|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83004097|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
83004098|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83004099|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004100|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83004101|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004102|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
83004103|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83004104|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83004105|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83004106|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83004107|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004108|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83004109|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004110|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004111|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83004112|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004113|NCT05391126|Irinotecan|irinotecan|mesh-list
83004114|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83004115|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83004116|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004117|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004118|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004119|NCT05418309|Paclitaxel|paclitaxel|mesh-list
83004120|NCT05418309|Tislelizumab|tislelizumab|mesh-list
83004121|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83004122|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004123|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
83004124|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
83004125|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
83004126|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004127|NCT05418309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004128|NCT05137548|Tenofovir|tenofovir|mesh-list
83004129|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
83004130|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004131|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83004132|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83004133|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004134|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004135|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83004136|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83004137|NCT05044611|Amiloride|amiloride|mesh-list
83004138|NCT05044611|Diuretics|diuretics|mesh-ancestor
83004139|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
83004140|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004141|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83004142|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83004143|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83004144|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004145|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83004146|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83004147|NCT05091294|Anesthetics|anesthetics|mesh-list
83004148|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
83004149|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004150|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004151|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
83004152|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004153|NCT04520178|Carbidopa|carbidopa|mesh-list
83004154|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83004155|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83004156|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83004157|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
83004158|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004159|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004161|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83004162|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004163|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83004164|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
83004165|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83004166|NCT04872543|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83004167|NCT04872543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83004168|NCT04872543|Antimetabolites|antimetabolites|mesh-ancestor
83004169|NCT04872543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004170|NCT04872543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004171|NCT05320926|Aspirin|aspirin|mesh-list
83004172|NCT05320926|Clopidogrel|clopidogrel|mesh-list
83004173|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004174|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004175|NCT05320926|Analgesics|analgesics|mesh-ancestor
83004176|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
83004177|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004178|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004179|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004180|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004184|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83004185|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83004186|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004188|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83004189|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83004190|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83004191|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
83004192|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004193|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
83004194|NCT05296512|Lenvatinib|lenvatinib|mesh-list
83004195|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004196|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004197|NCT05296512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83004198|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004199|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004200|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004201|NCT05417997|Clarithromycin|clarithromycin|mesh-list
83004202|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
83004203|NCT05417997|Favipiravir|favipiravir|mesh-list
83004204|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
83004205|NCT05417997|Enoxaparin|enoxaparin|mesh-list
83004206|NCT05417997|Lansoprazole|lansoprazole|mesh-list
83004207|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004208|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
83004209|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
83004210|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004211|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004212|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004213|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
83004214|NCT05417997|Hormones|hormones|mesh-ancestor
83004215|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004216|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83004217|NCT05417997|Protective Agents|protective agents|mesh-ancestor
83004218|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83004219|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004220|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83004221|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004222|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465460|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83004223|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83004224|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83004225|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
83004226|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83004227|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83004228|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83004229|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83004230|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
83004231|NCT03856788|Bupivacaine|bupivacaine|mesh-list
83004232|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
83004233|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
83004234|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004235|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004236|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
83004237|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004238|NCT03242759|Pirfenidone|pirfenidone|mesh-list
83004239|NCT03242759|Nintedanib|nintedanib|mesh-list
83004240|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004241|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004242|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004243|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004244|NCT03242759|Analgesics|analgesics|mesh-ancestor
83004245|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
83004246|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004247|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004248|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004249|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004250|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004251|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004263|NCT03625050|Analgesics|analgesics|mesh-ancestor
83004264|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
83004265|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004266|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004267|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004268|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004269|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83004270|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83004271|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004272|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004273|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83004274|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004275|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83004276|NCT03257813|Timolol|timolol|mesh-list
83004277|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83004278|NCT03257813|Dorzolamide|dorzolamide|mesh-list
83004279|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83004280|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83004281|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
83004282|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004283|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004284|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004285|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83004286|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83004287|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83004288|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83004289|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83004290|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83004291|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004292|NCT03210259|Adalimumab|adalimumab|mesh-list
83004293|NCT03210259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83004294|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004295|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004296|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
83004297|NCT04319757|Fludarabine|fludarabine|mesh-list
83004298|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83004299|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
83004300|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004301|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004302|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83004303|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
83004304|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004305|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004306|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83004307|NCT05180461|Ivermectin|ivermectin|mesh-list
83004308|NCT05180461|Emodepside|emodepside|mesh-list
83004309|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83004310|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004311|NCT02496611|Exenatide|exenatide|mesh-list
83004312|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83004313|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004314|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83004315|NCT02496611|Incretins|incretins|mesh-ancestor
83004316|NCT02496611|Hormones|hormones|mesh-ancestor
83004317|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004318|NCT03636295|Warfarin|warfarin|mesh-list
83004319|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
83004320|NCT03237481|Bupivacaine|bupivacaine|mesh-list
83004321|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
83004322|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
83004323|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004324|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004325|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
83004326|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004327|NCT03704220|Warfarin|warfarin|mesh-list
83004328|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
83004329|NCT03222349|Diazepam|diazepam|mesh-list
83004330|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83004331|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
83004333|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
83004334|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004335|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004336|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004337|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83004338|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004339|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83004340|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83004341|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83004342|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83004343|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83004344|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83004345|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
83004346|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
83004347|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
83004348|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
83004349|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004350|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004351|NCT02927925|Daratumumab|daratumumab|mesh-list
83004352|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004353|NCT03208933|Pirfenidone|pirfenidone|mesh-list
83004354|NCT03208933|Analgesics|analgesics|mesh-ancestor
83004355|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
83004356|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004357|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004358|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004359|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004360|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004361|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004362|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004363|NCT02499120|Cetuximab|cetuximab|mesh-list
83004364|NCT02499120|Palbociclib|palbociclib|mesh-list
83004365|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004366|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004367|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004368|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004369|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004370|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
83004371|NCT01568307|Serotonin|serotonin|mesh-list
83004372|NCT01568307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83004373|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83004374|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83004375|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
83004376|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004377|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004378|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004379|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83004380|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83004381|NCT02415036|Melphalan|melphalan|mesh-list
83004382|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83004383|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
83004384|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004385|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004386|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83004387|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83004388|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
83004389|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004390|NCT04752267|Clevudine|clevudine|mesh-list
83004391|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
83004392|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004393|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
83004394|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83004395|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
83004396|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004397|NCT02117700|Expectorants|expectorants|mesh-ancestor
83004398|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
83004399|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83004400|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
83004401|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004402|NCT02117700|Protective Agents|protective agents|mesh-ancestor
83004403|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004404|NCT02117700|Antidotes|antidotes|mesh-ancestor
83004405|NCT03257267|Cemiplimab|cemiplimab|mesh-list
83004406|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004407|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004408|NCT02932579|Acetaminophen|acetaminophen|mesh-list
83004410|NCT02932579|Oxycodone|oxycodone|mesh-list
83004411|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004412|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362097|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
83004413|NCT02932579|Analgesics|analgesics|mesh-ancestor
83004414|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
83004415|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004416|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004417|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004418|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004419|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83004420|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004421|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004422|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83004423|NCT02932579|Narcotics|narcotics|mesh-ancestor
83004424|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004425|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
83004426|NCT04748757|Annexin A5|annexin a5|mesh-list
83004427|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004428|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004429|NCT03207451|Aspirin|aspirin|mesh-list
83004430|NCT03207451|Clopidogrel|clopidogrel|mesh-list
83004431|NCT03207451|Vorapaxar|vorapaxar|mesh-list
83004432|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004433|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004434|NCT03207451|Analgesics|analgesics|mesh-ancestor
83004435|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
83004436|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004437|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004438|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004439|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004440|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83004441|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83004442|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004443|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83004444|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83004445|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004446|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
83004447|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83004448|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83004449|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83004450|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
83004451|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004452|NCT05089123|Vaccines|vaccines|mesh-list
83004453|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
83004454|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004455|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83004456|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83004457|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004458|NCT02361125|Methylphenidate|methylphenidate|mesh-list
83004459|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83004460|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004461|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83004462|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83004463|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83004464|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004465|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
83004466|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004467|NCT03701256|Atracurium|atracurium|mesh-list
83004468|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83004469|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83004470|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83004471|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004472|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004473|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83004474|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83004475|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
83004476|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004477|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362098|NCT04707742|Povidone|povidone|mesh-list
83004478|NCT04780581|Dexamethasone|dexamethasone|mesh-list
83004479|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
83004480|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83004481|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83004482|NCT04780581|Prednisolone|prednisolone|mesh-list
83004483|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
83004484|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83004485|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
83004486|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004487|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
83004488|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
83004489|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004490|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004491|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004492|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
83004493|NCT04780581|Hormones|hormones|mesh-ancestor
83221013|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83004494|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004495|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83004496|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004497|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83004498|NCT04780581|Protective Agents|protective agents|mesh-ancestor
83004499|NCT01526135|Gemcitabine|gemcitabine|mesh-list
83004500|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83004501|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
83004502|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004503|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004504|NCT05417139|Immunomodulating Agents|immunomodulating agents|mesh-list
83004505|NCT05417139|Immunologic Factors|immunologic factors|mesh-ancestor
83004506|NCT05417139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004507|NCT03701022|Apatinib|apatinib|mesh-list
83004508|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004509|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004510|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004511|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004512|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
83004513|NCT04221165|Narcotics|narcotics|mesh-ancestor
83004514|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004515|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004516|NCT04221165|Analgesics|analgesics|mesh-ancestor
83004517|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
83004518|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004519|NCT03255629|Glucagon|glucagon|mesh-list
83004520|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83004521|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004522|NCT03255629|Hormones|hormones|mesh-ancestor
83004523|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004524|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004525|NCT03255629|Incretins|incretins|mesh-ancestor
83004526|NCT01143779|Telbivudine|telbivudine|mesh-list
83004527|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
83004528|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004529|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83004530|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004531|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004532|NCT03703596|Docetaxel|docetaxel|mesh-list
83004533|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004534|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
83004535|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
83004536|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83004537|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004538|NCT01137773|Insulin|insulin|mesh-list
83004539|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83004540|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83004541|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004542|NCT03698292|Metoclopramide|metoclopramide|mesh-list
83004543|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
83004544|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
83004545|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004546|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004547|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004548|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83004549|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83004550|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
83004551|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004552|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004554|NCT04614909|Olaparib|olaparib|mesh-list
83004555|NCT04614909|Pamiparib|pamiparib|mesh-list
83004556|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83004557|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
83004558|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004559|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004560|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83004561|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004562|NCT04613271|Azithromycin|azithromycin|mesh-list
83004563|NCT04613271|Favipiravir|favipiravir|mesh-list
83004564|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83004565|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004566|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
83004567|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83004568|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004569|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004570|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83004571|NCT03094611|Immunotoxins|immunotoxins|mesh-ancestor
83004572|NCT03094611|Immunoconjugates|immunoconjugates|mesh-ancestor
83004573|NCT03094611|Immunologic Factors|immunologic factors|mesh-ancestor
83004574|NCT03094611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004575|NCT03631953|Trametinib|trametinib|mesh-list
83004576|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004577|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004578|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004579|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004580|NCT01030575|Inositol|inositol|mesh-list
83004581|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
83004582|NCT01030575|Vitamins|vitamins|mesh-ancestor
83004583|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
83004584|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004585|NCT04215471|Antibodies|antibodies|mesh-list
83004586|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
83004587|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
83004588|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004589|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
83004590|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83004591|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83004592|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
83004593|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004594|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004595|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004596|NCT03106987|Olaparib|olaparib|mesh-list
83004597|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83004598|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004599|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004600|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004601|NCT04971109|Tecovirimat|tecovirimat|mesh-list
83004602|NCT04971109|Antiviral Agents|antiviral agents|mesh-ancestor
83004603|NCT04971109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004604|NCT02932267|Adapalene|adapalene|mesh-list
83004605|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004606|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004607|NCT02932267|Analgesics|analgesics|mesh-ancestor
83004608|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
83004609|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004610|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004611|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004612|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004613|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83004614|NCT03217591|Praliciguat|praliciguat|mesh-list
83004615|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83004616|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
83004617|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004618|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004619|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
83004620|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
83004621|NCT03697824|Fludarabine|fludarabine|mesh-list
83004622|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83004623|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
83004624|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004625|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221014|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
83004626|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83004627|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
83004628|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362099|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
83004629|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004630|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83004631|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004632|NCT03697824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83004633|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83004634|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83004635|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004636|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83004637|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004638|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004639|NCT03697746|Acetaminophen|acetaminophen|mesh-list
83004640|NCT03697746|Ibuprofen|ibuprofen|mesh-list
83004641|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83004642|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004643|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004644|NCT03697746|Analgesics|analgesics|mesh-ancestor
83004645|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
83004646|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004647|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004648|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004649|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004650|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83004651|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004652|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004653|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
83004654|NCT03697668|Piperaquine|piperaquine|mesh-list
83004655|NCT03697668|Artenimol|artenimol|mesh-list
83004656|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
83004657|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004658|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004659|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004660|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004661|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
83004662|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83004663|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83004664|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004665|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
83004666|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83004667|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
83004668|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004669|NCT03702738|Expectorants|expectorants|mesh-ancestor
83004670|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
83004671|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83004672|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
83004673|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004674|NCT03702738|Protective Agents|protective agents|mesh-ancestor
83004675|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004676|NCT03702738|Antidotes|antidotes|mesh-ancestor
83004677|NCT03702582|Warfarin|warfarin|mesh-list
83004678|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
83004679|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
83004680|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83004681|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
83004682|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83004683|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
83004684|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004685|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004686|NCT03697044|Irinotecan|irinotecan|mesh-list
83004687|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83004688|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83004689|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004690|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004691|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004692|NCT03699774|Firuglipel|firuglipel|mesh-list
83004693|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83004694|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83004695|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83004696|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
83004697|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004698|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83004699|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83004700|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004701|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83004702|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004704|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83362100|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
83004705|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004706|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004707|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83004708|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
83004709|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
83004710|NCT03702426|Norfloxacin|norfloxacin|mesh-list
83004711|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83004712|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004713|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83004714|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83004715|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004716|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004717|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004718|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83004719|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83004720|NCT00265941|Cetuximab|cetuximab|mesh-list
83004721|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004722|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004723|NCT03699384|Azacitidine|azacitidine|mesh-list
83004724|NCT03699384|Avelumab|avelumab|mesh-list
83004725|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83004726|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
83004727|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004728|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004729|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004730|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004731|NCT05378763|Docetaxel|docetaxel|mesh-list
83004732|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004733|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
83004734|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
83004735|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
83004736|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004737|NCT02937571|Dexamethasone|dexamethasone|mesh-list
83004738|NCT02937571|Lenalidomide|lenalidomide|mesh-list
83004739|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004740|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
83004741|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
83004742|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004743|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004744|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004745|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
83004746|NCT02937571|Hormones|hormones|mesh-ancestor
83004747|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004748|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83004749|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004750|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
83004751|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83004752|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83004753|NCT02937571|Growth Substances|growth substances|mesh-ancestor
83465521|NCT00000454|Nicotine|nicotine|mesh-list
83004754|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
83004755|NCT03201211|Vaccines|vaccines|mesh-list
83004756|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
83004757|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004758|NCT04624945|Thromboplastin|thromboplastin|mesh-list
83004759|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
83004760|NCT04624945|Coagulants|coagulants|mesh-ancestor
83004761|NCT04472949|Carboplatin|carboplatin|mesh-list
83004762|NCT04472949|Etoposide|etoposide|mesh-list
83004763|NCT04472949|Durvalumab|durvalumab|mesh-list
83004764|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004765|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83004766|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83004767|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83004768|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004769|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004770|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004771|NCT03696186|Phenobarbital|phenobarbital|mesh-list
83004772|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
83004773|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83004774|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004775|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004776|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83004777|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83004778|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004779|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004780|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
83004781|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
83004782|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83004783|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83004784|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83004785|NCT03698916|Celecoxib|celecoxib|mesh-list
83004786|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004787|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004788|NCT03698916|Analgesics|analgesics|mesh-ancestor
83004789|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
83004790|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004791|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004792|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004793|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004794|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83004795|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83004796|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004797|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004798|NCT03336333|Rituximab|rituximab|mesh-list
83004799|NCT03336333|Venetoclax|venetoclax|mesh-list
83004800|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83004801|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
83004802|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004803|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004804|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
83004805|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004806|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004807|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83004808|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
83004809|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004810|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83004811|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004812|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
83004813|NCT03695952|Nivolumab|nivolumab|mesh-list
83004814|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83004815|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004816|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004817|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004818|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
83004819|NCT03695640|Analgesics|analgesics|mesh-ancestor
83004820|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
83004821|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004822|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004823|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
83004824|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004825|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83004826|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
83004827|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83004828|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83004829|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004830|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83004831|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
83004832|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83004833|NCT03698682|Levofloxacin|levofloxacin|mesh-list
83004834|NCT03698682|Ofloxacin|ofloxacin|mesh-list
83004835|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83004836|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83004837|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83004838|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83004839|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83004840|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004841|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004842|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004843|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83004844|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83004845|NCT03029832|Atezolizumab|atezolizumab|mesh-list
83004846|NCT03029832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83004847|NCT03029832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004848|NCT03029832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004849|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004850|NCT05598567|Anesthetics|anesthetics|mesh-list
83004851|NCT05598567|Sevoflurane|sevoflurane|mesh-list
83004852|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004853|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004854|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83004855|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83004856|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
83004857|NCT03701880|Bisoprolol|bisoprolol|mesh-list
83004858|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83004859|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
83004860|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
83004861|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004862|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004863|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83004864|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83004865|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83004866|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
83004867|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004868|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004869|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
83004870|NCT03692754|Dexamethasone|dexamethasone|mesh-list
83004871|NCT03692754|Atorvastatin|atorvastatin|mesh-list
83004872|NCT03692754|Calcium|calcium|mesh-list
83004873|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004874|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
83004875|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
83004876|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004877|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004878|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004879|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
83004880|NCT03692754|Hormones|hormones|mesh-ancestor
83004881|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004882|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83004883|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004884|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83004885|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83004886|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83004887|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83004888|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
83004889|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004890|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83004891|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83004892|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004893|NCT04224558|Acetaminophen|acetaminophen|mesh-list
83004894|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
83004895|NCT04224558|Promethazine|promethazine|mesh-list
83004896|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
83004897|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83004898|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
83004899|NCT04224558|Fludarabine|fludarabine|mesh-list
83004900|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
83004901|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83004902|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
83004903|NCT04224558|Antibodies|antibodies|mesh-list
83004904|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
83004905|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83004906|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83004907|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83004908|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
83004909|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004910|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004911|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83004912|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
83004913|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004914|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004915|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83004916|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004917|NCT04224558|Analgesics|analgesics|mesh-ancestor
83004919|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004920|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
83004921|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004922|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
83004923|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
83004924|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004925|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
83004926|NCT04224558|Hormones|hormones|mesh-ancestor
83004927|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362101|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83004928|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83004929|NCT04224558|Protective Agents|protective agents|mesh-ancestor
83004930|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83004931|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83004932|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83004933|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83004934|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
83004935|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
83004936|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83004937|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
83004938|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
83004939|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83004940|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83004941|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
83004942|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
83004943|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
83004944|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
83004945|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004946|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
83004947|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
83004948|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004949|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004950|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83004951|NCT05598411|Hormones|hormones|mesh-ancestor
83004952|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83004953|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83004954|NCT05598411|Protective Agents|protective agents|mesh-ancestor
83004955|NCT03688230|Cetuximab|cetuximab|mesh-list
83004956|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004957|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004958|NCT03694236|Durvalumab|durvalumab|mesh-list
83004959|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83004960|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004961|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
83004962|NCT03692286|Calcium|calcium|mesh-list
83004963|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83004964|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004965|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83004966|NCT03694080|Calcium|calcium|mesh-list
83004967|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83004968|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004969|NCT04207944|Sulindac|sulindac|mesh-list
83004970|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004971|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004972|NCT04207944|Analgesics|analgesics|mesh-ancestor
83004973|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
83004974|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004975|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004976|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83004977|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83004978|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83004979|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83004980|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83004981|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83004982|NCT04203498|Nabiximols|nabiximols|mesh-list
83004983|NCT04203498|Analgesics|analgesics|mesh-ancestor
83004984|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
83004985|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83004986|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004987|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
83004988|NCT03691896|Vitamin D|vitamin d|mesh-list
83004989|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83004990|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83004991|NCT03691896|Vitamins|vitamins|mesh-ancestor
83004992|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
83004993|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83004994|NCT03691818|Ibuprofen|ibuprofen|mesh-list
83004995|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83004996|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83004997|NCT03691818|Analgesics|analgesics|mesh-ancestor
83004998|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
83004999|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005000|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005001|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005002|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005003|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83005005|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005006|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83005007|NCT03687606|Menotropins|menotropins|mesh-list
83005008|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83005009|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005010|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83005011|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
83005012|NCT03691662|Timolol|timolol|mesh-list
83005013|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83005014|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83005015|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005016|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83005017|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83005018|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005019|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005020|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005021|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83005022|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83005023|NCT04059978|Remifentanil|remifentanil|mesh-list
83005024|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83005025|NCT04059978|Narcotics|narcotics|mesh-ancestor
83005026|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005027|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005028|NCT04059978|Analgesics|analgesics|mesh-ancestor
83005029|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
83005030|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005031|NCT03199963|Tamoxifen|tamoxifen|mesh-list
83005032|NCT03199963|Afimoxifene|afimoxifene|mesh-list
83005033|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83005034|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
83005035|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005036|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005037|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83005038|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005039|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83005040|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83005041|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83005042|NCT03636685|Paclitaxel|paclitaxel|mesh-list
83005043|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83005044|NCT03636685|Carboplatin|carboplatin|mesh-list
83005045|NCT03636685|Pemetrexed|pemetrexed|mesh-list
83005046|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83005047|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005048|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
83005049|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
83005050|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
83005051|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005052|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005053|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83005054|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83005055|NCT03257631|Thalidomide|thalidomide|mesh-list
83005056|NCT03257631|Pomalidomide|pomalidomide|mesh-list
83005057|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
83005058|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005059|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83005060|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83005061|NCT03257631|Growth Substances|growth substances|mesh-ancestor
83005062|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
83005063|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005064|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83005065|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
83005066|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83005067|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005068|NCT03883581|Quinidine|quinidine|mesh-list
83005069|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
83005070|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
83005071|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
83005072|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
83005073|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83005074|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83005075|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005076|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005077|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005078|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83005079|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83005080|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005081|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83005082|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
83005083|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83005084|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83005085|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005086|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005087|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83005088|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83005089|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
83005090|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83005091|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83005092|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005093|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83005094|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83005095|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
83005096|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83005097|NCT03824535|Fluorides|fluorides|mesh-list
83005098|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83005099|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005100|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
83005101|NCT03824535|Protective Agents|protective agents|mesh-ancestor
83005102|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005103|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
83005104|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
83005105|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005106|NCT03113643|Azacitidine|azacitidine|mesh-list
83005107|NCT03113643|Venetoclax|venetoclax|mesh-list
83005108|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83005109|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
83005110|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005111|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005112|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005113|NCT03091491|Nivolumab|nivolumab|mesh-list
83005114|NCT03091491|Ipilimumab|ipilimumab|mesh-list
83005115|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005116|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005117|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005118|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005119|NCT05598255|Dexamethasone|dexamethasone|mesh-list
83005120|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
83005121|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005122|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
83005123|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
83005124|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005125|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005126|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83005127|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
83005128|NCT05598255|Hormones|hormones|mesh-ancestor
83005129|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005130|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83005131|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005132|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83005133|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
83005134|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005135|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
83005136|NCT04733235|Progesterone|progesterone|mesh-list
83005137|NCT04733235|Hormones|hormones|mesh-ancestor
83005138|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005139|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005140|NCT04733235|Progestins|progestins|mesh-ancestor
83005141|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
83005142|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83005144|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005145|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83005146|NCT05598177|Analgesics|analgesics|mesh-ancestor
83005147|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
83005148|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005149|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83005150|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83005151|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83005152|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005154|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005155|NCT03740529|Rituximab|rituximab|mesh-list
83005156|NCT03740529|Venetoclax|venetoclax|mesh-list
83005157|NCT03740529|Pirtobrutinib|pirtobrutinib|mesh-list
83005158|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005159|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005160|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
83005161|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005162|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005163|NCT03740529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83005164|NCT03740529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005165|NCT03740529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005166|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
83005167|NCT03029208|Hematinics|hematinics|mesh-ancestor
83005168|NCT05212623|Vaccines|vaccines|mesh-list
83005169|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
83005170|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005171|NCT03693222|Morphine|morphine|mesh-list
83005172|NCT03693222|Tramadol|tramadol|mesh-list
83005173|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83005174|NCT03693222|Narcotics|narcotics|mesh-ancestor
83005175|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005176|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005177|NCT03693222|Analgesics|analgesics|mesh-ancestor
83005178|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
83005179|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005180|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
83005181|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83005182|NCT03693066|Disinfectants|disinfectants|mesh-list
83005183|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83005184|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005185|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
83005186|NCT03631641|Nivolumab|nivolumab|mesh-list
83005187|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005188|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005189|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005190|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005191|NCT03631875|Ketamine|ketamine|mesh-list
83005192|NCT03631875|Propofol|propofol|mesh-list
83005193|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83005194|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005195|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005196|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83005197|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
83005198|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
83005199|NCT03631875|Analgesics|analgesics|mesh-ancestor
83005200|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
83005201|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005202|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83005203|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83005204|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83005205|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005206|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005207|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83005208|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
83005209|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005210|NCT03158805|Liraglutide|liraglutide|mesh-list
83005211|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83005212|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005213|NCT03158805|Incretins|incretins|mesh-ancestor
83005214|NCT03158805|Hormones|hormones|mesh-ancestor
83005215|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005216|NCT03197935|Paclitaxel|paclitaxel|mesh-list
83005217|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
83005218|NCT03197935|Doxorubicin|doxorubicin|mesh-list
83005219|NCT03197935|Atezolizumab|atezolizumab|mesh-list
83005220|NCT03197935|Antibodies|antibodies|mesh-list
83005221|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83005222|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005223|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83005224|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83005225|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83005226|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005227|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83005228|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
83005229|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005230|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005231|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83005232|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
83005233|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83005234|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83005235|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83005236|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83005237|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005238|NCT03197935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005239|NCT03197935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005240|NCT04941261|Vaccines|vaccines|mesh-list
83005241|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
83005242|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005243|NCT05597709|Insulin|insulin|mesh-list
83005244|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83005245|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005246|NCT04863885|Nivolumab|nivolumab|mesh-list
83005247|NCT04863885|Ipilimumab|ipilimumab|mesh-list
83005248|NCT04863885|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83005249|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005250|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005251|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005252|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005253|NCT04863885|Immunoconjugates|immunoconjugates|mesh-ancestor
83005254|NCT04863885|Immunologic Factors|immunologic factors|mesh-ancestor
83005255|NCT04863885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005256|NCT02917629|Pioglitazone|pioglitazone|mesh-list
83005257|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83005258|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005259|NCT05417841|Insulin|insulin|mesh-list
83005260|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83005261|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
83005262|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
83005263|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83005264|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83005265|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005266|NCT03691038|Pregabalin|pregabalin|mesh-list
83005267|NCT03691038|Analgesics|analgesics|mesh-ancestor
83005268|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
83005269|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005270|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005271|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
83005272|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83005273|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005274|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005275|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83005276|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83005277|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83005278|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005279|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83005280|NCT02927847|Nicotine|nicotine|mesh-list
83005281|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83005282|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
83005283|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005284|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005285|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83005286|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83005287|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
83005288|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005289|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005290|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83005291|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
83005292|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83524804|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005293|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005294|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
83005295|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005296|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005297|NCT02886585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005298|NCT02886585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005299|NCT01568853|Norepinephrine|norepinephrine|mesh-list
83005300|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83005301|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83362102|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362103|NCT02680054|Insulin|insulin|mesh-list
83005302|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005303|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005304|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005305|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005306|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
83005307|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
83005308|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005309|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83005310|NCT02960438|Quetmolimab|quetmolimab|mesh-list
83005311|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005312|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83005313|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83005314|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005315|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83005316|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83005317|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005318|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005319|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
83005320|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005321|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
83005322|NCT05411991|Acetazolamide|acetazolamide|mesh-list
83005323|NCT05411991|Bumetanide|bumetanide|mesh-list
83005324|NCT05411991|Diuretics|diuretics|mesh-list
83005325|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83005326|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
83005327|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005328|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
83005329|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83005330|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005331|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005332|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83005333|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83005334|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005335|NCT03690414|Atropine|atropine|mesh-list
83005336|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83005337|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83005338|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83005339|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83005340|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83005341|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
83005342|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005343|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005344|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83005345|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
83005346|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
83005347|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
83005348|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83005349|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83005350|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
83005351|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005352|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005353|NCT02959970|Dapsone|dapsone|mesh-list
83005354|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005355|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
83005356|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83005357|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83005358|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83005359|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005360|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005361|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
83005362|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83005363|NCT03681990|Ethanol|ethanol|mesh-list
83005364|NCT03681990|Chlorhexidine|chlorhexidine|mesh-list
83005365|NCT03681990|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83005366|NCT03681990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83005367|NCT03681990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005368|NCT03681990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005369|NCT03681990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005370|NCT03681990|Disinfectants|disinfectants|mesh-ancestor
83005371|NCT03681990|Dermatologic Agents|dermatologic agents|mesh-ancestor
83005372|NCT02740335|Protein C|protein c|mesh-list
83005373|NCT02740335|Protein S|protein s|mesh-list
83005374|NCT02740335|Thrombin|thrombin|mesh-list
83005375|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
83005376|NCT02740335|Coagulants|coagulants|mesh-ancestor
83005377|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
83005378|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83005379|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83005380|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005381|NCT03580369|Omalizumab|omalizumab|mesh-list
83005382|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83005383|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83005384|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
83005385|NCT05351151|Lidocaine|lidocaine|mesh-list
83005386|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
83005387|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
83005388|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005389|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005390|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
83005391|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005392|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83005393|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83005394|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83005395|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005396|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005397|NCT01568931|Coal Tar|coal tar|mesh-list
83005398|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
83005399|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
83005400|NCT04800367|Denosumab|denosumab|mesh-list
83005401|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83005402|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005403|NCT03713658|Risperidone|risperidone|mesh-list
83005404|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83005405|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83005406|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
83005407|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005408|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005409|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005410|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83005411|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83005412|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005413|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83005414|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83005415|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
83005416|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83005417|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83005418|NCT05475717|Alprostadil|alprostadil|mesh-list
83005419|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83005420|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
83005421|NCT05475717|Urological Agents|urological agents|mesh-ancestor
83005422|NCT05133687|Bupivacaine|bupivacaine|mesh-list
83005423|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
83005424|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
83005425|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005426|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005427|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
83005428|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005429|NCT03685032|Dexamethasone|dexamethasone|mesh-list
83005430|NCT03685032|Ondansetron|ondansetron|mesh-list
83005431|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005432|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
83005433|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
83005434|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005435|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005436|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83005437|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
83005438|NCT03685032|Hormones|hormones|mesh-ancestor
83005439|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005440|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83005441|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005442|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
83005443|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
83005444|NCT03685032|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83005445|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83005446|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
83005447|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005448|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005449|NCT02451111|Rituximab|rituximab|mesh-list
83005450|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362104|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
83362105|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83005451|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005452|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
83005453|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005454|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005455|NCT03689010|Azelaic acid|azelaic acid|mesh-list
83005456|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005457|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
83005458|NCT05451771|Dexamethasone|dexamethasone|mesh-list
83005459|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
83005460|NCT05451771|Venetoclax|venetoclax|mesh-list
83005461|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83005462|NCT05451771|Daratumumab|daratumumab|mesh-list
83005463|NCT05451771|Pomalidomide|pomalidomide|mesh-list
83005464|NCT05451771|Ixazomib|ixazomib|mesh-list
83005465|NCT05451771|BB 1101|bb 1101|mesh-list
83005466|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005467|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
83005468|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
83005469|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005470|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005471|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83005472|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
83005473|NCT05451771|Hormones|hormones|mesh-ancestor
83005474|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005475|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83005476|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005477|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
83005478|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005479|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005480|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83005481|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
83005482|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
83005483|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83005484|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83005485|NCT05451771|Growth Substances|growth substances|mesh-ancestor
83005486|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
83005487|NCT03680976|CXA-10|cxa-10|mesh-list
83005488|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005489|NCT05387343|Vaccines|vaccines|mesh-list
83005490|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
83005491|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005492|NCT04220775|Atezolizumab|atezolizumab|mesh-list
83005493|NCT04220775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005494|NCT04220775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005495|NCT04220775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005496|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005497|NCT01381887|Canagliflozin|canagliflozin|mesh-list
83005498|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83005499|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005500|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83005501|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005502|NCT04877379|Ceftibuten|ceftibuten|mesh-list
83005503|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83005504|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005505|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
83005506|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005507|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005508|NCT03684330|Vitamin D|vitamin d|mesh-list
83005509|NCT03684330|Vitamins|vitamins|mesh-ancestor
83005510|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
83005511|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005512|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83005513|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
83005514|NCT03688464|Promethazine|promethazine|mesh-list
83005515|NCT03688464|Melatonin|melatonin|mesh-list
83005516|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
83005517|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005518|NCT03688464|Protective Agents|protective agents|mesh-ancestor
83005519|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005520|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005521|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83005522|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83005523|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
83005524|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
83005525|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
83005526|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005527|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
83005528|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
83005529|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83005530|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83005531|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
83005532|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
83005533|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005534|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83005535|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
83005536|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83005537|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
83005538|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83005539|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005540|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
83005541|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
83005542|NCT01381809|Hematinics|hematinics|mesh-ancestor
83005543|NCT03677466|Tenecteplase|tenecteplase|mesh-list
83005544|NCT03677466|Streptokinase|streptokinase|mesh-list
83005545|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83005546|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83005547|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005548|NCT03447132|Fulvestrant|fulvestrant|mesh-list
83005549|NCT03447132|Goserelin|goserelin|mesh-list
83005550|NCT03447132|Palbociclib|palbociclib|mesh-list
83005551|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83005552|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005553|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83005554|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83005555|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
83005556|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005557|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005558|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83005559|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005560|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005561|NCT04133623|Ibuprofen|ibuprofen|mesh-list
83005562|NCT04133623|Ketorolac|ketorolac|mesh-list
83005563|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83005564|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83005565|NCT04133623|Analgesics|analgesics|mesh-ancestor
83005566|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
83005567|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005568|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005569|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005570|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005571|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83005572|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005573|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005574|NCT03425838|Letrozole|letrozole|mesh-list
83005575|NCT03425838|Fulvestrant|fulvestrant|mesh-list
83005576|NCT03425838|Palbociclib|palbociclib|mesh-list
83005577|NCT03425838|Anastrozole|anastrozole|mesh-list
83005578|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83005579|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005580|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83005581|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005582|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005583|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83005584|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
83005585|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005586|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005587|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83005588|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83005589|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83005590|NCT03188185|Naltrexone|naltrexone|mesh-list
83005591|NCT03188185|Buprenorphine|buprenorphine|mesh-list
83005592|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83005593|NCT03188185|Narcotics|narcotics|mesh-ancestor
83005594|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005595|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005596|NCT03188185|Analgesics|analgesics|mesh-ancestor
83005597|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
83005598|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005599|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83005600|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83005601|NCT03679182|Olanzapine|olanzapine|mesh-list
83005602|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
83005603|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
83005604|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005605|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005606|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83005607|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83005608|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83005609|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005610|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83005611|NCT03679182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83005612|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83005613|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005614|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005615|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005616|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
83005617|NCT03184987|Albuterol|albuterol|mesh-list
83005618|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83005619|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
83005620|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005621|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005622|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83005623|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
83005624|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
83005625|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83005626|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83005627|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83005628|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83005629|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005630|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005631|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005632|NCT03193333|Timolol|timolol|mesh-list
83005633|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83005634|NCT03193333|Dorzolamide|dorzolamide|mesh-list
83005635|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83005636|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83005637|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83005638|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83005639|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005640|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005641|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005642|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005643|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83005644|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83005645|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83005646|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83005647|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83005648|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83005649|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005650|NCT03026166|Nivolumab|nivolumab|mesh-list
83005651|NCT03026166|Ipilimumab|ipilimumab|mesh-list
83005652|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83005653|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005654|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005655|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005656|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005657|NCT03026166|Immunoconjugates|immunoconjugates|mesh-ancestor
83005658|NCT03026166|Immunologic Factors|immunologic factors|mesh-ancestor
83005659|NCT03026166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005660|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
83005661|NCT03345576|Testosterone|testosterone|mesh-list
83005662|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
83005663|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
83005664|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83005665|NCT03345576|Androgens|androgens|mesh-ancestor
83005666|NCT03345576|Hormones|hormones|mesh-ancestor
83483423|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83005667|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83005668|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005669|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83005670|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005671|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
83005672|NCT03573648|Palbociclib|palbociclib|mesh-list
83005673|NCT03573648|Avelumab|avelumab|mesh-list
83005674|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005675|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83005676|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362106|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005677|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005678|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005679|NCT03026088|Bisoprolol|bisoprolol|mesh-list
83005680|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83005681|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
83005682|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
83005683|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005684|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005685|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83005686|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83005687|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83005688|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005689|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005690|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005691|NCT03328884|Irinotecan|irinotecan|mesh-list
83005692|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83005693|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83005694|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005695|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005696|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005697|NCT03678792|Morphine|morphine|mesh-list
83005698|NCT03678792|Buprenorphine|buprenorphine|mesh-list
83005699|NCT03678792|Tramadol|tramadol|mesh-list
83005700|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83005701|NCT03678792|Naloxone|naloxone|mesh-list
83005702|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83005703|NCT03678792|Narcotics|narcotics|mesh-ancestor
83005704|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005705|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005706|NCT03678792|Analgesics|analgesics|mesh-ancestor
83005707|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
83005708|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005709|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83005710|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83005711|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83005712|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83005713|NCT03181789|Interleukin-12|interleukin-12|mesh-list
83005714|NCT03181789|Vaccines|vaccines|mesh-list
83005715|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
83005716|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005717|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83005718|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83005719|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83005720|NCT03181789|Growth Substances|growth substances|mesh-ancestor
83005721|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
83005722|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005723|NCT03678090|Plasminogen|plasminogen|mesh-list
83005724|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83005725|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83005726|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83005727|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005728|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83005729|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83005730|NCT03678012|Hematinics|hematinics|mesh-ancestor
83005731|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83005732|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83005733|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83005734|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005735|NCT03259074|Adalimumab|adalimumab|mesh-list
83005736|NCT03259074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83005737|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005738|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005739|NCT03676296|Puerarin|puerarin|mesh-list
83005740|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
83005741|NCT03676140|Azithromycin|azithromycin|mesh-list
83005743|NCT03676140|Albendazole|albendazole|mesh-list
83005744|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
83005745|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83005746|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005747|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83005748|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
83005749|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
83005750|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83005751|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83005752|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83005753|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83362107|NCT00367978|Amlodipine|amlodipine|mesh-list
83005754|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83005755|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005756|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005757|NCT03676140|Filaricides|filaricides|mesh-ancestor
83005758|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
83005759|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83005760|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005761|NCT03504774|Immunomodulating Agents|immunomodulating agents|mesh-list
83005762|NCT03504774|Immunologic Factors|immunologic factors|mesh-ancestor
83005763|NCT03504774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005764|NCT04059198|Tenofovir|tenofovir|mesh-list
83005765|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
83005766|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005767|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83005768|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83005769|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005770|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005771|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83005772|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83005773|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
83005774|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005775|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005776|NCT04058964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83005777|NCT04058964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005778|NCT03246906|Cyclosporine|cyclosporine|mesh-list
83005779|NCT03246906|Sirolimus|sirolimus|mesh-list
83005780|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
83005781|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
83005782|NCT03246906|Cyclosporins|cyclosporins|mesh-list
83005783|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83005784|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
83005785|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005786|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005787|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83005788|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
83005789|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005790|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005791|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83005792|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005793|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
83005794|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005795|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
83005796|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83005797|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83005798|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83005799|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
83005800|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83005802|NCT03675594|Chromium|chromium|mesh-list
83005803|NCT03675594|Trace Elements|trace elements|mesh-ancestor
83005804|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
83005805|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005806|NCT03671538|Pemetrexed|pemetrexed|mesh-list
83005807|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005808|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005809|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005810|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83005811|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83005812|NCT05420467|Paclitaxel|paclitaxel|mesh-list
83005813|NCT05420467|Docetaxel|docetaxel|mesh-list
83005814|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83005815|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
83005816|NCT05420467|Carboplatin|carboplatin|mesh-list
83005817|NCT05420467|Trastuzumab|trastuzumab|mesh-list
83005818|NCT05420467|Epirubicin|epirubicin|mesh-list
83005819|NCT05420467|Pertuzumab|pertuzumab|mesh-list
83005820|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83005821|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005822|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
83005823|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
83005824|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
83005825|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005826|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83005827|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
83005828|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005829|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005830|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83362109|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83362110|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83362111|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362112|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362113|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83362114|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362115|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
83362116|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83362117|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
83362118|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005831|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
83005832|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83005833|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005834|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83005835|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83005836|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83005837|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005838|NCT03022578|Lomustine|lomustine|mesh-list
83005839|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83005840|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
83005841|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005842|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005843|NCT03671070|Epinephrine|epinephrine|mesh-list
83005844|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83005845|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83005846|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005847|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005848|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005849|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005850|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83005851|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83005852|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
83005853|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005854|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83005855|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
83005856|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
83005857|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
83005858|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83005859|NCT03670758|Protein S|protein s|mesh-list
83005860|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
83005861|NCT03674658|Propafenone|propafenone|mesh-list
83005862|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83005863|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83005864|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83005865|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005866|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005867|NCT03623256|Fentanyl|fentanyl|mesh-list
83005868|NCT03623256|Bupivacaine|bupivacaine|mesh-list
83005869|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
83005870|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
83005871|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005872|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005873|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
83005874|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005875|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83005876|NCT03623256|Narcotics|narcotics|mesh-ancestor
83005877|NCT03623256|Analgesics|analgesics|mesh-ancestor
83005878|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83005879|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83005880|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
83005881|NCT03082014|Losartan|losartan|mesh-list
83005882|NCT03082014|Atenolol|atenolol|mesh-list
83005883|NCT03082014|Amlodipine|amlodipine|mesh-list
83005884|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83005885|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83005886|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83005887|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005888|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83005889|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005890|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
83005891|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83005892|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83005893|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83005894|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
83005895|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
83005896|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005897|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83005898|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83005899|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83005900|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005901|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005902|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
83005903|NCT03670212|Yohimbine|yohimbine|mesh-list
83005904|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83005905|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
83005906|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
83005907|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83005908|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005909|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83005910|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83005911|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83005912|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
83005913|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005914|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005915|NCT03670212|Urological Agents|urological agents|mesh-ancestor
83005916|NCT03165955|Paclitaxel|paclitaxel|mesh-list
83005917|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83005918|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005919|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83005920|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83005921|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83005922|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005923|NCT05263921|Ritonavir|ritonavir|mesh-list
83005924|NCT05263921|Nirmatrelvir|nirmatrelvir|mesh-list
83005925|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83005926|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83005927|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
83005928|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005929|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005930|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83005931|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83005932|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
83005933|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83005934|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83005935|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83005936|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83005937|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005938|NCT03673332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005939|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005940|NCT02400216|Cholic Acids|cholic acids|mesh-list
83005941|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83005942|NCT03048084|Levetiracetam|levetiracetam|mesh-list
83005943|NCT03048084|Valproic Acid|valproic acid|mesh-list
83005944|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
83005945|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
83005946|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005947|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005948|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
83005949|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83005950|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005951|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
83005952|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83005953|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83005954|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83005955|NCT02329860|Apatinib|apatinib|mesh-list
83005956|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005957|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83005958|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005959|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005960|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
83005961|NCT02251548|Rituximab|rituximab|mesh-list
83005962|NCT02251548|Fludarabine|fludarabine|mesh-list
83005963|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83005964|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
83005965|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005966|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005967|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83005968|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
83005969|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005970|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005971|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83005972|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83005973|NCT03165721|Guadecitabine|guadecitabine|mesh-list
83005974|NCT03165721|Azacitidine|azacitidine|mesh-list
83005975|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005976|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83005977|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
83005978|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005979|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005980|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
83005981|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
83005982|NCT02224872|Fludarabine|fludarabine|mesh-list
83005983|NCT02224872|Tacrolimus|tacrolimus|mesh-list
83005984|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
83005985|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83005986|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
83005987|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83005988|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83005989|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83005990|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
83005991|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83005992|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83005993|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83005994|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83005995|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83005996|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83005997|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83005998|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
83005999|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83006000|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006001|NCT02187198|Buprenorphine|buprenorphine|mesh-list
83006002|NCT02187198|Naloxone|naloxone|mesh-list
83006003|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83006004|NCT02187198|Narcotics|narcotics|mesh-ancestor
83006005|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006006|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006007|NCT02187198|Analgesics|analgesics|mesh-ancestor
83006008|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
83006009|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006010|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83006011|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
83006012|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83006013|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006014|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006015|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006016|NCT04969705|Analgesics|analgesics|mesh-ancestor
83006017|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
83006018|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006019|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83006020|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83006021|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83006022|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
83006023|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006024|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006025|NCT03676374|Prucalopride|prucalopride|mesh-list
83006026|NCT03676374|Laxatives|laxatives|mesh-ancestor
83006027|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006028|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83006029|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83006030|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
83006031|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006032|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006033|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006034|NCT02085408|Cytarabine|cytarabine|mesh-list
83006035|NCT02085408|Decitabine|decitabine|mesh-list
83006036|NCT02085408|Clofarabine|clofarabine|mesh-list
83006037|NCT02085408|Azacitidine|azacitidine|mesh-list
83006038|NCT02085408|Daunorubicin|daunorubicin|mesh-list
83006039|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83006040|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
83006041|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006042|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006043|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
83362119|NCT00368056|Eszopiclone|eszopiclone|mesh-list
83006044|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006045|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006046|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
83006047|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006048|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83006049|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83006050|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83006051|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006052|NCT01829958|Prednisone|prednisone|mesh-list
83006053|NCT01829958|Rituximab|rituximab|mesh-list
83006054|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83006055|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006056|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
83006057|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006058|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006059|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006060|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
83006061|NCT01829958|Hormones|hormones|mesh-ancestor
83006062|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006063|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83006064|NCT03021642|Tepotinib|tepotinib|mesh-list
83006065|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006066|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
83006067|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
83006068|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83006069|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83006070|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
83006071|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006072|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83006073|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
83006074|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006075|NCT03023046|Prednisone|prednisone|mesh-list
83006076|NCT03023046|Cortisone|cortisone|mesh-list
83006077|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
83006078|NCT03023046|Rituximab|rituximab|mesh-list
83006079|NCT03023046|Doxorubicin|doxorubicin|mesh-list
83006080|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83006081|NCT03023046|Etoposide|etoposide|mesh-list
83006082|NCT03023046|Vincristine|vincristine|mesh-list
83006083|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
83006084|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
83006085|NCT03023046|Daunorubicin|daunorubicin|mesh-list
83006086|NCT03023046|Dasatinib|dasatinib|mesh-list
83006087|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
83006088|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83006089|NCT03023046|Antibodies|antibodies|mesh-list
83006090|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
83006091|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83006092|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006093|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
83006094|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006095|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006096|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83006097|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
83006098|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006099|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006100|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83006101|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83006102|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83006103|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83006104|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006105|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006106|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
83006107|NCT03023046|Hormones|hormones|mesh-ancestor
83006108|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006109|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83006110|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83006111|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006112|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006113|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006114|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83006115|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
83006116|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006117|NCT03668262|Atracurium|atracurium|mesh-list
83006118|NCT03668262|Cisatracurium|cisatracurium|mesh-list
83362120|NCT00368056|Zopiclone|zopiclone|mesh-list
83006119|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83006120|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83006121|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83006122|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006123|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006124|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83006125|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83006126|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
83006127|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006128|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006129|NCT03668964|Vitamin D|vitamin d|mesh-list
83006130|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
83006131|NCT03668964|Vitamins|vitamins|mesh-list
83006132|NCT03668964|Vitamin E|vitamin e|mesh-list
83006133|NCT03668964|Tocopherols|tocopherols|mesh-list
83006134|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
83006135|NCT03668964|Vitamin A|vitamin a|mesh-list
83006136|NCT03668964|Riboflavin|riboflavin|mesh-list
83006137|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
83006138|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
83006139|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006140|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83006141|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83006142|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
83006143|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006144|NCT03668964|Protective Agents|protective agents|mesh-ancestor
83006145|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83006146|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006147|NCT03668730|Paclitaxel|paclitaxel|mesh-list
83006148|NCT03668730|Fluorouracil|fluorouracil|mesh-list
83006149|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83006150|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006151|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006152|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006153|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006154|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006155|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
83006156|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83006157|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006158|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
83006159|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006160|NCT03021018|Lorazepam|lorazepam|mesh-list
83006161|NCT03021018|Brivaracetam|brivaracetam|mesh-list
83006162|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
83006163|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
83006164|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
83006165|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006166|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006167|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006168|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83006169|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006170|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83006171|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83006172|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83006173|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
83006174|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
83006175|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006176|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006177|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
83006178|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83006179|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83006180|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006181|NCT02509507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83006182|NCT02509507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006183|NCT03175549|Apremilast|apremilast|mesh-list
83006184|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83006185|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006186|NCT03175549|Analgesics|analgesics|mesh-ancestor
83006187|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
83006188|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006189|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006190|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006191|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006192|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83006193|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83006194|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006195|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006196|NCT01314937|Mebendazole|mebendazole|mesh-list
83006197|NCT01314937|Piperazine|piperazine|mesh-list
83006198|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
83006199|NCT01314937|DMP 777|dmp 777|mesh-list
83006200|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
83006201|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
83006202|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83006203|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006204|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006205|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006206|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006207|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006208|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006209|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006210|NCT04718155|Atorvastatin|atorvastatin|mesh-list
83006211|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83006212|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83006213|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
83006214|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006215|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83006216|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83006217|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006218|NCT04668859|Midodrine|midodrine|mesh-list
83006219|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
83006220|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
83006221|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006222|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006223|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83006224|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83006225|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83006226|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83006227|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
83006228|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006229|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006230|NCT04648969|Hormones|hormones|mesh-list
83006231|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006232|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006233|NCT02924688|Fluticasone|fluticasone|mesh-list
83006234|NCT02924688|Albuterol|albuterol|mesh-list
83006235|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83006236|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83006237|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006238|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83006239|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
83006240|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006241|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006242|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83006243|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
83006244|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006245|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83006246|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83006247|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83006248|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83006249|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
83006250|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006251|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006252|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
83006253|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83006254|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
83006255|NCT02924688|Hormones|hormones|mesh-ancestor
83006256|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006257|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
83006258|NCT03668418|Camptothecin|camptothecin|mesh-list
83006259|NCT03668418|Docetaxel|docetaxel|mesh-list
83006260|NCT03668418|Gemcitabine|gemcitabine|mesh-list
83006261|NCT03668418|Fluorouracil|fluorouracil|mesh-list
83006262|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
83006263|NCT03668418|Irinotecan|irinotecan|mesh-list
83006264|NCT03668418|Epirubicin|epirubicin|mesh-list
83006265|NCT03668418|Taxane|taxane|mesh-list
83006266|NCT03668418|Antimetabolites|antimetabolites|mesh-list
83006267|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83006268|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006269|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006270|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006271|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006272|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83465737|NCT00000574|Ibuprofen|ibuprofen|mesh-list
83006273|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83006274|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006275|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
83006276|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006277|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83006278|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83006279|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006280|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83006281|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83006282|NCT03011892|Triamcinolone|triamcinolone|mesh-list
83006283|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006284|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
83006285|NCT03011892|Hormones|hormones|mesh-ancestor
83006286|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006287|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006288|NCT02125513|Paclitaxel|paclitaxel|mesh-list
83006289|NCT02125513|Carboplatin|carboplatin|mesh-list
83006290|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83006291|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006292|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006293|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006294|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006295|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006296|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
83006297|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83006298|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006299|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
83006300|NCT03666546|Methamphetamine|methamphetamine|mesh-list
83006301|NCT03666546|Lactulose|lactulose|mesh-list
83006302|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006303|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83006304|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006305|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
83006306|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
83006307|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006308|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
83006309|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006310|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006311|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83006312|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83006313|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83006314|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83006315|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83006316|NCT03012828|Moxidectin|moxidectin|mesh-list
83006317|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
83006318|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83006319|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006320|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
83006321|NCT03666390|Midazolam|midazolam|mesh-list
83006322|NCT03666390|Ketamine|ketamine|mesh-list
83006323|NCT03666390|Analgesics|analgesics|mesh-ancestor
83006324|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
83006325|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006326|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006327|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83006328|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83006329|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
83006330|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
83006331|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006332|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83006333|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83006334|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006335|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006336|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83006337|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83465740|NCT00000574|Analgesics|analgesics|mesh-ancestor
83006338|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83006339|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83006340|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83006341|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
83006342|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
83006343|NCT03003390|Enoxaparin|enoxaparin|mesh-list
83006344|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
83006345|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83006346|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83006347|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006348|NCT03003000|Ibuprofen|ibuprofen|mesh-list
83006349|NCT03003000|Caffeine|caffeine|mesh-list
83006350|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83006351|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006352|NCT03003000|Analgesics|analgesics|mesh-ancestor
83006353|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
83006354|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006355|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006356|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006357|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006358|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83006359|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006360|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006361|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83006362|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83006363|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83006364|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83006365|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
83006366|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006367|NCT03665766|Cycloserine|cycloserine|mesh-list
83006368|NCT03665766|Tacrolimus|tacrolimus|mesh-list
83006369|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006370|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
83006371|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006372|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83006373|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006374|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006375|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83006376|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006377|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83006378|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
83006379|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83006380|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
83006381|NCT03546894|Ceritinib|ceritinib|mesh-list
83006382|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006383|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83006384|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006385|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006386|NCT03637361|Methadone|methadone|mesh-list
83006387|NCT03637361|D-methadone|d-methadone|mesh-list
83006388|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83006389|NCT03637361|Narcotics|narcotics|mesh-ancestor
83006390|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006391|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006392|NCT03637361|Analgesics|analgesics|mesh-ancestor
83006393|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
83006394|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006395|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
83006396|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
83006397|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006398|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
83006399|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006400|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83006401|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006402|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006403|NCT03254459|Morphine|morphine|mesh-list
83006404|NCT03254459|Oxycodone|oxycodone|mesh-list
83006405|NCT03254459|Buprenorphine|buprenorphine|mesh-list
83006406|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83006407|NCT03254459|Narcotics|narcotics|mesh-ancestor
83006408|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006409|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006410|NCT03254459|Analgesics|analgesics|mesh-ancestor
83006411|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
83006412|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006413|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83006414|NCT03620591|Lidocaine|lidocaine|mesh-list
83006415|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83006416|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
83006417|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006418|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006419|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
83006420|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006421|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83006422|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83006423|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83006424|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83006425|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006426|NCT05178953|Zinc|zinc|mesh-list
83006427|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
83006428|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
83006429|NCT05178953|Trace Elements|trace elements|mesh-ancestor
83006430|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
83006431|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006432|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83006433|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006434|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006435|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83006436|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83006437|NCT05178953|Protective Agents|protective agents|mesh-ancestor
83006438|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
83006439|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83006440|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
83006441|NCT05178953|Astringents|astringents|mesh-ancestor
83006442|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006443|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
83006444|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83006445|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006446|NCT03251963|Enoxaparin|enoxaparin|mesh-list
83006447|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
83006448|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
83006449|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83006450|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83006451|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006452|NCT03287219|Methylene Blue|methylene blue|mesh-list
83006453|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006454|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006455|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
83006456|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83006457|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006458|NCT05572229|Lenalidomide|lenalidomide|mesh-list
83006459|NCT05572229|Daratumumab|daratumumab|mesh-list
83006460|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
83006461|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006462|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83006463|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83006464|NCT05572229|Growth Substances|growth substances|mesh-ancestor
83006465|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
83006466|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006467|NCT03249935|Azithromycin|azithromycin|mesh-list
83006468|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83006469|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006470|NCT03622073|Misoprostol|misoprostol|mesh-list
83006471|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83006472|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
83006473|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83006474|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006475|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83006476|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006477|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
83006478|NCT03000348|Cysteamine|cysteamine|mesh-list
83006479|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83006480|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006481|NCT03664986|Bupivacaine|bupivacaine|mesh-list
83006482|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
83006483|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
83006484|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006485|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006486|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
83006487|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006488|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
83006489|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83006490|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006491|NCT03492918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83006492|NCT03492918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006493|NCT03247673|Bevacizumab|bevacizumab|mesh-list
83006494|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83006495|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006496|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83006497|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83006498|NCT03247673|Growth Substances|growth substances|mesh-ancestor
83006499|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006500|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
83006502|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83006503|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006504|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006505|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
83006506|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006507|NCT03664908|Antibodies|antibodies|mesh-list
83006508|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
83006509|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006510|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83006511|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83006512|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
83006513|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006514|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83006515|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83006516|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
83006517|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
83006518|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006519|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006520|NCT03664440|Nevirapine|nevirapine|mesh-list
83006521|NCT03664440|Rilpivirine|rilpivirine|mesh-list
83006522|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83006523|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83006524|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006525|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006526|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
83006527|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006528|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83006529|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83006530|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83006531|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83006532|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83006533|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83006534|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006535|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
83006536|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
83006537|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83006538|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83006539|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
83006540|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006541|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006542|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006543|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006544|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83006545|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006546|NCT03240575|Fluticasone|fluticasone|mesh-list
83006547|NCT03240575|Xhance|xhance|mesh-list
83006548|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
83006549|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83006550|NCT03240575|Olodaterol|olodaterol|mesh-list
83006551|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006552|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83006553|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
83006554|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006555|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006556|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83006557|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
83006558|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006559|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83006560|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
83006561|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83006562|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
83006563|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006564|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006565|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83006566|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83006567|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83006568|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
83006569|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
83006570|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83006571|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006572|NCT04034225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83006573|NCT04034225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006575|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83006576|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83006577|NCT03690947|Growth Substances|growth substances|mesh-ancestor
83006578|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006579|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
83006580|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006581|NCT02999178|Nintedanib|nintedanib|mesh-list
83006582|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006583|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83006584|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006585|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006586|NCT02999100|Oxytocin|oxytocin|mesh-list
83006587|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
83006588|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83006589|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006590|NCT02749370|Etanercept|etanercept|mesh-list
83006591|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83006592|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006593|NCT02749370|Analgesics|analgesics|mesh-ancestor
83006594|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
83006595|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006596|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006597|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006598|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006599|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006600|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006601|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
83006602|NCT03618758|Paclitaxel|paclitaxel|mesh-list
83006603|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83006604|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006605|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006606|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006607|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006608|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006609|NCT03617900|Acetaminophen|acetaminophen|mesh-list
83006610|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006611|NCT03617900|Analgesics|analgesics|mesh-ancestor
83006612|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
83006613|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006614|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006615|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
83006616|NCT05384366|Paclitaxel|paclitaxel|mesh-list
83006617|NCT05384366|Carboplatin|carboplatin|mesh-list
83006618|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83006619|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83465761|NCT00001450|Paclitaxel|paclitaxel|mesh-list
83006620|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006621|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006622|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006623|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006624|NCT03616808|Hemostatics|hemostatics|mesh-list
83006625|NCT03616808|Coagulants|coagulants|mesh-ancestor
83006626|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
83006627|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83006628|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006629|NCT03617510|Analgesics|analgesics|mesh-ancestor
83006630|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
83006631|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006632|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006633|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006634|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006635|NCT03617432|Prednisone|prednisone|mesh-list
83006636|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
83006637|NCT03617432|Doxorubicin|doxorubicin|mesh-list
83006638|NCT03617432|Etoposide|etoposide|mesh-list
83006639|NCT03617432|Vincristine|vincristine|mesh-list
83006640|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006641|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
83006642|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006643|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006644|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83006645|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
83006646|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006647|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006648|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83006649|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83006650|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83006651|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83006652|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006653|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006654|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
83006656|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006657|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83006658|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83006659|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83006660|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83006661|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83006662|NCT02996682|Ribavirin|ribavirin|mesh-list
83006663|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83006664|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
83006665|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006666|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
83006667|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006668|NCT02873702|Lansoprazole|lansoprazole|mesh-list
83006669|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
83006670|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83006671|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006672|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83006673|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006674|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006675|NCT03616262|Lidocaine|lidocaine|mesh-list
83006676|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
83006677|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
83006678|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006679|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006680|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
83006681|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006682|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83006683|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83006684|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83006685|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83006686|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006687|NCT03615950|Vitamin D|vitamin d|mesh-list
83006688|NCT03615950|Vitamins|vitamins|mesh-ancestor
83006689|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
83006690|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006691|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83006692|NCT02911116|Ustekinumab|ustekinumab|mesh-list
83465771|NCT00000580|Antibodies|antibodies|mesh-list
83006693|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006694|NCT03664050|Letrozole|letrozole|mesh-list
83006695|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006696|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83006697|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83006698|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006699|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006700|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83006701|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83006702|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006703|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006704|NCT04055844|Decitabine|decitabine|mesh-list
83006705|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83006706|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
83006707|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006708|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006709|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006710|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83006711|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83006712|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006713|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83006714|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006715|NCT04494438|Rituximab|rituximab|mesh-list
83006716|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83006717|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006718|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
83006719|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006720|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006721|NCT04057482|Dequalinium|dequalinium|mesh-list
83006722|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83006723|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006724|NCT03662412|Sirolimus|sirolimus|mesh-list
83006725|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83006726|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006727|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83006728|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006729|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
83006730|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83006731|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
83006732|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006733|NCT02870972|Berotralstat|berotralstat|mesh-list
83006734|NCT02870972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83006735|NCT02870972|Protease Inhibitors|protease inhibitors|mesh-ancestor
83006736|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006737|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006739|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83006740|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
83006741|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
83006742|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83006743|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006744|NCT03662958|Leuprolide|leuprolide|mesh-list
83006745|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83006746|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
83006747|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83006748|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006749|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83006750|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006751|NCT03231371|Adenosine|adenosine|mesh-list
83006752|NCT03231371|Analgesics|analgesics|mesh-ancestor
83006753|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
83006754|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006755|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006756|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83006757|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
83006758|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83006759|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
83006760|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
83006761|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006762|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006763|NCT03663114|Lenvatinib|lenvatinib|mesh-list
83465776|NCT00002116|Cidofovir|cidofovir|mesh-list
83006764|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006765|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83006766|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006767|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006768|NCT03526679|Lenvatinib|lenvatinib|mesh-list
83006769|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006770|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83006771|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006772|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006773|NCT04057326|Pancreatin|pancreatin|mesh-list
83006774|NCT04057326|Pancrelipase|pancrelipase|mesh-list
83006775|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006776|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83006777|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83006778|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83006779|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
83006780|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006781|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006782|NCT05384210|Gabapentin|gabapentin|mesh-list
83006783|NCT05384210|Milnacipran|milnacipran|mesh-list
83006784|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
83006785|NCT05384210|Analgesics|analgesics|mesh-ancestor
83006786|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
83006787|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006788|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006789|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
83006790|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83006791|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83006792|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006793|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83006794|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83006795|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83006796|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006797|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006798|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
83006799|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83006800|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83006801|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83006802|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006803|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
83006805|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83006806|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
83006807|NCT02032394|Povidone|povidone|mesh-list
83006808|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83006809|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006810|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
83006811|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
83006812|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
83006813|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
83006814|NCT03239483|Dapivirine|dapivirine|mesh-list
83006815|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83006816|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83006817|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
83006818|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006819|NCT01068912|Favipiravir|favipiravir|mesh-list
83006820|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
83006821|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006822|NCT04056702|Ivacaftor|ivacaftor|mesh-list
83006823|NCT04056702|Elexacaftor|elexacaftor|mesh-list
83006824|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83006825|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83006826|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006827|NCT03662100|Mirikizumab|mirikizumab|mesh-list
83006828|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83006829|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006830|NCT03662100|Analgesics|analgesics|mesh-ancestor
83006831|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
83006832|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006833|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006834|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006835|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006836|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83006837|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006838|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
82711802|NCT00742911|Copper|copper|mesh-list
83006839|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83006840|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006841|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006842|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006843|NCT03612440|Analgesics|analgesics|mesh-ancestor
83006844|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
83006845|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006846|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83006847|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83006848|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83006849|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
83006850|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006851|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006852|NCT03662724|Venetoclax|venetoclax|mesh-list
83006853|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006854|NCT03662568|Ritonavir|ritonavir|mesh-list
83006855|NCT03662568|Tenofovir|tenofovir|mesh-list
83006856|NCT03662568|Entecavir|entecavir|mesh-list
83006857|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83006858|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83006859|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
83006860|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006861|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006862|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83006863|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83006864|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
83006865|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006866|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83006867|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83006868|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83006869|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83006870|NCT02993250|Simeprevir|simeprevir|mesh-list
83006871|NCT02993250|Odalasvir|odalasvir|mesh-list
83006872|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
83006873|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006874|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
83006875|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006876|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006877|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83006878|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83006879|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83006880|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83006881|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006882|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
83006883|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006884|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006885|NCT05383820|Ketorolac|ketorolac|mesh-list
83006886|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83006887|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83006888|NCT05383820|Analgesics|analgesics|mesh-ancestor
83006889|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
83006890|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006891|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006892|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006893|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83006894|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83006895|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006896|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006897|NCT03611504|Hemostatics|hemostatics|mesh-list
83006898|NCT03611504|Coagulants|coagulants|mesh-ancestor
83006899|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83006900|NCT02954510|Hematinics|hematinics|mesh-ancestor
83006901|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83006902|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83006903|NCT02032784|Octreotide|octreotide|mesh-list
83006904|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006905|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83006906|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006907|NCT03611426|Thrombin|thrombin|mesh-list
83006908|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
83006909|NCT03611426|Coagulants|coagulants|mesh-ancestor
83006910|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83006911|NCT03658746|Amoxicillin|amoxicillin|mesh-list
83006912|NCT03658746|Metronidazole|metronidazole|mesh-list
83006913|NCT03658746|Clarithromycin|clarithromycin|mesh-list
83006914|NCT03658746|Levofloxacin|levofloxacin|mesh-list
83006915|NCT03658746|Ofloxacin|ofloxacin|mesh-list
83006916|NCT03658746|Tetracycline|tetracycline|mesh-list
83006917|NCT03658746|Tinidazole|tinidazole|mesh-list
83006918|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83006919|NCT03658746|Furazolidone|furazolidone|mesh-list
83006920|NCT03658746|Bismuth|bismuth|mesh-list
83006921|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83006922|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83006923|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
83006924|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83006925|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83006926|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83006927|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006928|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006929|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83006930|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83006931|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83006932|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83006933|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83006934|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006935|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83006936|NCT03658746|Antacids|antacids|mesh-ancestor
83006937|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006938|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83006939|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83006940|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83006941|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
83006942|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
83006943|NCT02990910|Narcotics|narcotics|mesh-ancestor
83006944|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83006945|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006946|NCT02990910|Analgesics|analgesics|mesh-ancestor
83006947|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
83006948|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006949|NCT04056000|Caffeine|caffeine|mesh-list
83483424|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006950|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83006951|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006952|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83006953|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006954|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006955|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83006957|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
83006958|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83006959|NCT03611348|Latanoprost|latanoprost|mesh-list
83006960|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83006961|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83006962|NCT02033018|Aflibercept|aflibercept|mesh-list
83006963|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83006964|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83006965|NCT02033018|Growth Substances|growth substances|mesh-ancestor
83006966|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006967|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
83006968|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006969|NCT03155100|Dexamethasone|dexamethasone|mesh-list
83006970|NCT03155100|Elotuzumab|elotuzumab|mesh-list
83006971|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83006972|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006973|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
83006974|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
83006975|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006976|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006977|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006978|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
83006979|NCT03155100|Hormones|hormones|mesh-ancestor
83006980|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006981|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83006982|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83006983|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
83006984|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006985|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006986|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
83006987|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83006988|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83006989|NCT03658590|Dexamethasone|dexamethasone|mesh-list
83006990|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83006991|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
83006992|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
83006993|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83006994|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83006995|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83006996|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
83006997|NCT03658590|Hormones|hormones|mesh-ancestor
83006998|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83006999|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83007000|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007001|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
83007002|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
83007003|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83007004|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83007005|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007006|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007007|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007008|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007009|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
83007010|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007011|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83007012|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83007013|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007014|NCT03941093|Leucovorin|leucovorin|mesh-list
83007015|NCT03941093|Paclitaxel|paclitaxel|mesh-list
83007016|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83007017|NCT03941093|Gemcitabine|gemcitabine|mesh-list
83007018|NCT03941093|Irinotecan|irinotecan|mesh-list
83007019|NCT03941093|Fluorouracil|fluorouracil|mesh-list
83007020|NCT03941093|Folfirinox|folfirinox|mesh-list
83007021|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
83007022|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83007023|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007024|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
83007025|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
83007026|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
83007027|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007028|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83007029|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
83007030|NCT03941093|Antidotes|antidotes|mesh-ancestor
83007031|NCT03941093|Protective Agents|protective agents|mesh-ancestor
83007032|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007033|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
83007034|NCT03941093|Vitamins|vitamins|mesh-ancestor
83007035|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
83007036|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83007037|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83007038|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007039|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83007040|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
83007041|NCT03917381|Docetaxel|docetaxel|mesh-list
83007042|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
83007043|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007044|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
83007045|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
83007046|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
83007047|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007048|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007049|NCT03917381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83007050|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83007051|NCT02033408|Amoxicillin|amoxicillin|mesh-list
83007052|NCT02033408|Metronidazole|metronidazole|mesh-list
83007053|NCT02033408|Vancomycin|vancomycin|mesh-list
83007054|NCT02033408|Doxycycline|doxycycline|mesh-list
83007055|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
83007056|NCT02033408|Gentamicins|gentamicins|mesh-list
83007057|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007058|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83007059|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83007060|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
83007061|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83007062|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83007063|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007064|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007065|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007066|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83007067|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83007068|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83007069|NCT03610880|Yimitasvir|yimitasvir|mesh-list
83007070|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
83007071|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007072|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
83007073|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83007074|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83007075|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83007076|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83007077|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007078|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
83007079|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007080|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007081|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83007082|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007083|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83007084|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83007085|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007086|NCT02560298|Paclitaxel|paclitaxel|mesh-list
83007087|NCT02560298|Cisplatin|cisplatin|mesh-list
83007088|NCT02560298|Carboplatin|carboplatin|mesh-list
83007089|NCT02560298|Fluorouracil|fluorouracil|mesh-list
83007090|NCT02560298|Capecitabine|capecitabine|mesh-list
83007091|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83007092|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83007093|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007094|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
83007095|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
83007096|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
83007097|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007098|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
83007099|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83007100|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83007101|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
83007102|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007103|NCT01330615|Lidocaine|lidocaine|mesh-list
83007104|NCT01330615|Prilocaine|prilocaine|mesh-list
83007105|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83007106|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
83007107|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
83007108|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007109|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007110|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
83007111|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007112|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83007113|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83007114|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83007115|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83007116|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007117|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83007118|NCT05034029|Metformin|metformin|mesh-list
83007119|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83007120|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007121|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83007122|NCT03237065|Hematinics|hematinics|mesh-ancestor
83007123|NCT03620461|Gemcitabine|gemcitabine|mesh-list
83007124|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83007125|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83007126|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
83221015|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007127|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007128|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007129|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
83007130|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83007131|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83007132|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
83007133|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007134|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007135|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007136|NCT01314781|Urological Agents|urological agents|mesh-ancestor
83007137|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83007138|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83007139|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83007140|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83007141|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007142|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83007143|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007144|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007145|NCT04377451|Metformin|metformin|mesh-list
83007146|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83007147|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007148|NCT02863328|Empagliflozin|empagliflozin|mesh-list
83007149|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83007150|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007151|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83007152|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007153|NCT03040141|Oseltamivir|oseltamivir|mesh-list
83007154|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
83007155|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007156|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007157|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007158|NCT02937701|Infliximab|infliximab|mesh-list
83007159|NCT02937701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83007160|NCT02937701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007161|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007162|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007163|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007164|NCT05186623|Ustekinumab|ustekinumab|mesh-list
83007165|NCT05186623|Vedolizumab|vedolizumab|mesh-list
83007166|NCT05186623|Tofacitinib|tofacitinib|mesh-list
83007167|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83007168|NCT05186623|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83007169|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83007170|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007171|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007172|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007173|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
83007174|NCT04602845|Fentanyl|fentanyl|mesh-list
83007175|NCT04602845|Midazolam|midazolam|mesh-list
83007176|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83007177|NCT04602845|Narcotics|narcotics|mesh-ancestor
83007178|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007179|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007180|NCT04602845|Analgesics|analgesics|mesh-ancestor
83007181|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
83007182|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007183|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83007184|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83007185|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
83007186|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
83007187|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83007188|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83007189|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83007190|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83007191|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
83007192|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
83007193|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007194|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007195|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83007196|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83007197|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007198|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007199|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83007200|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007201|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
83007202|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83007203|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007204|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83007205|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83007206|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007207|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007208|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007209|NCT03168919|Temozolomide|temozolomide|mesh-list
83007210|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83007211|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
83007212|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007213|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007214|NCT03205163|Factor VIII|factor viii|mesh-list
83007215|NCT03205163|Coagulants|coagulants|mesh-ancestor
83007216|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
83007217|NCT03638947|Povidone|povidone|mesh-list
83007218|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
83007219|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
83007220|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83007221|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007222|NCT03502681|Avelumab|avelumab|mesh-list
83007223|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007224|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007225|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
83007226|NCT04938817|Lenvatinib|lenvatinib|mesh-list
83007227|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007228|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007229|NCT04938817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83007230|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007231|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83007232|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007233|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
83007234|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83007235|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
83007236|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83007237|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007238|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83007239|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83007241|NCT03636373|Triamcinolone|triamcinolone|mesh-list
83007242|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83007243|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83007244|NCT03636373|Etanercept|etanercept|mesh-list
83007245|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83007246|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007247|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
83007248|NCT03636373|Hormones|hormones|mesh-ancestor
83007249|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83007250|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007251|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83007252|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
83007253|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007254|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007255|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362122|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007256|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83007257|NCT03636373|Analgesics|analgesics|mesh-ancestor
83007258|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
83007259|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007260|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007261|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007263|NCT04485325|Tofacitinib|tofacitinib|mesh-list
83007264|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83007265|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83007266|NCT04485325|Analgesics|analgesics|mesh-ancestor
83007267|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
83007268|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007269|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007270|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007271|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007272|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007273|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83007274|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
83007275|NCT04485325|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83007276|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83007277|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007278|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007279|NCT03610178|Insulin|insulin|mesh-list
83007280|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83007281|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83007282|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007283|NCT02033798|Tamsulosin|tamsulosin|mesh-list
83007284|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83007285|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83007286|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83007287|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
83007288|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007289|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007290|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007291|NCT02033798|Urological Agents|urological agents|mesh-ancestor
83007292|NCT02887183|Valsartan|valsartan|mesh-list
83007293|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83007294|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83007295|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83007296|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83007297|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007298|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
83007299|NCT03660306|Anesthetics|anesthetics|mesh-list
83007300|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007301|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007302|NCT03660306|Narcotics|narcotics|mesh-ancestor
83007303|NCT03660306|Analgesics|analgesics|mesh-ancestor
83007304|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
83007305|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007306|NCT01067352|Hormones|hormones|mesh-list
83007307|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83007308|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007309|NCT02920242|Rifaximin|rifaximin|mesh-list
83007310|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83007311|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007312|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007313|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83007314|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83007315|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83007316|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83007317|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007318|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007319|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
83007320|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007321|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83007322|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83007323|NCT03203447|Triamcinolone|triamcinolone|mesh-list
83007324|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83007325|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83007326|NCT03203447|Bevacizumab|bevacizumab|mesh-list
83007327|NCT03203447|Ranibizumab|ranibizumab|mesh-list
83007328|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83007329|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007330|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007331|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83007332|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83007333|NCT03203447|Growth Substances|growth substances|mesh-ancestor
83007334|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007335|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
83007336|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007337|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
83007339|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83007340|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83007341|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
83007342|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007343|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007344|NCT01068678|Insulin|insulin|mesh-list
83007345|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83007346|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
83007347|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83007348|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007349|NCT03202511|Tenofovir|tenofovir|mesh-list
83007350|NCT03202511|Emtricitabine|emtricitabine|mesh-list
83007351|NCT03202511|Probenecid|probenecid|mesh-list
83007352|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
83007353|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007354|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83007355|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83007356|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83525102|NCT02241655|Anesthetics|anesthetics|mesh-list
83007357|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007359|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83007360|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
83007361|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
83007362|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007363|NCT03637049|Midazolam|midazolam|mesh-list
83007364|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83007365|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83007366|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007367|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007368|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83007369|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83007370|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83007371|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83007372|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
83007373|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
83007374|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
83007375|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
83007376|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007377|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007378|NCT03636971|Mannitol|mannitol|mesh-list
83007379|NCT03636971|Sorbitol|sorbitol|mesh-list
83007380|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
83007381|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83007382|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
83007383|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007384|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
83007385|NCT03636971|Protective Agents|protective agents|mesh-ancestor
83007386|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83007387|NCT03636971|Diuretics|diuretics|mesh-ancestor
83007388|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
83007389|NCT03636971|Cathartics|cathartics|mesh-ancestor
83007390|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007391|NCT03610100|Gemcitabine|gemcitabine|mesh-list
83007392|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83007393|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
83007394|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007395|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007396|NCT03657966|Paclitaxel|paclitaxel|mesh-list
83007397|NCT03657966|Carboplatin|carboplatin|mesh-list
83007398|NCT03657966|Gemcitabine|gemcitabine|mesh-list
83007399|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83007400|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007401|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
83007402|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
83007403|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
83007404|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007405|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83007406|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
83007407|NCT03659292|Anesthetics|anesthetics|mesh-list
83007408|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007409|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007410|NCT03659058|Colchicine|colchicine|mesh-list
83007411|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83007412|NCT03659058|Antioxidants|antioxidants|mesh-list
83007413|NCT03659058|Silymarin|silymarin|mesh-list
83007414|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
83007415|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007416|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
83007417|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
83007418|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
83007419|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007420|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007421|NCT03659058|Protective Agents|protective agents|mesh-ancestor
83007422|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007423|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83007424|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007425|NCT03635905|Gabapentin|gabapentin|mesh-list
83007426|NCT03635905|Analgesics|analgesics|mesh-ancestor
83007427|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
83007428|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007429|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007430|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
83007431|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83007432|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83007433|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007434|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83007435|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83007436|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83007437|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007438|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007439|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
83007440|NCT02960113|Scopolamine|scopolamine|mesh-list
83007441|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83007442|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83007443|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
83007444|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
83007445|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007446|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007447|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007448|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
83007449|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83007450|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
83007451|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007452|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007453|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83007454|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
83007455|NCT04458324|Buspirone|buspirone|mesh-list
83007456|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83007457|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83007458|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221016|NCT01679405|Cisplatin|cisplatin|mesh-list
83007459|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007460|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83007461|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83007462|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
83007463|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007464|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007465|NCT03657420|Dexamethasone|dexamethasone|mesh-list
83007466|NCT03657420|Pomalidomide|pomalidomide|mesh-list
83007467|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007468|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
83007469|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
83007470|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007471|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007472|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007473|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
83007474|NCT03657420|Hormones|hormones|mesh-ancestor
83007475|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83007476|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83007477|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007478|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
83007479|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83007480|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83007481|NCT03657420|Growth Substances|growth substances|mesh-ancestor
83007482|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
83007483|NCT02984982|Anticoagulants|anticoagulants|mesh-list
83007484|NCT02984982|Atorvastatin|atorvastatin|mesh-list
83007485|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83007486|NCT02984982|Ezetimibe|ezetimibe|mesh-list
83007487|NCT02984982|Alirocumab|alirocumab|mesh-list
83007488|NCT02984982|Fenofibrate|fenofibrate|mesh-list
83007489|NCT02984982|Bezafibrate|bezafibrate|mesh-list
83007490|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83007491|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83007492|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
83007493|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007494|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83007495|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83007496|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007497|NCT02984982|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83007498|NCT02984982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83007499|NCT02984982|Protease Inhibitors|protease inhibitors|mesh-ancestor
83007500|NCT03656484|Metronidazole|metronidazole|mesh-list
83007501|NCT03656484|Tetracycline|tetracycline|mesh-list
83007502|NCT03656484|Melatonin|melatonin|mesh-list
83007503|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
83007504|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007505|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83007506|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83007507|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83007508|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
83007509|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007510|NCT03656484|Protective Agents|protective agents|mesh-ancestor
83007511|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007512|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007513|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83007514|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
83007515|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
83007516|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83007517|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007518|NCT04309578|Capecitabine|capecitabine|mesh-list
83007519|NCT04309578|Trastuzumab|trastuzumab|mesh-list
83007520|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007521|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83007522|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
83007523|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007524|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007525|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
83007526|NCT03656952|PF-06700841|pf-06700841|mesh-list
83007527|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83007528|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007529|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83007530|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83007531|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007532|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007533|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007534|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83007535|NCT02981472|Vitamin K|vitamin k|mesh-list
83007536|NCT02981472|Heparin|heparin|mesh-list
83007537|NCT02981472|Enoxaparin|enoxaparin|mesh-list
83007538|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83007539|NCT02981472|Tinzaparin|tinzaparin|mesh-list
83007540|NCT02981472|Dalteparin|dalteparin|mesh-list
83007541|NCT02981472|Warfarin|warfarin|mesh-list
83007542|NCT02981472|Apixaban|apixaban|mesh-list
83007543|NCT02981472|Vitamins|vitamins|mesh-ancestor
83007544|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
83007545|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007546|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
83007547|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83007548|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83007549|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007550|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83007551|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
83007552|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83007553|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
83007554|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007555|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83007556|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
83007557|NCT02981472|Coagulants|coagulants|mesh-ancestor
83007558|NCT03656172|Chrysarobin|chrysarobin|mesh-list
83007559|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83007560|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83007561|NCT03656172|Analgesics|analgesics|mesh-ancestor
83007562|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
83007563|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007564|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007565|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007566|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83007567|NCT03656094|Docetaxel|docetaxel|mesh-list
83007568|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
83007569|NCT03656094|Pemetrexed|pemetrexed|mesh-list
83007570|NCT03656094|Vinorelbine|vinorelbine|mesh-list
83007571|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007572|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
83007573|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
83007574|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
83483500|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007575|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007576|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007577|NCT03656094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83007578|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007579|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83007580|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83007581|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83007583|NCT04298034|Nifedipine|nifedipine|mesh-list
83007584|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83007585|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83007586|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007587|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83007588|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007589|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
83465855|NCT00002122|Rifabutin|rifabutin|mesh-list
83007590|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
83007591|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83007592|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83007593|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83007594|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
83007595|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83007596|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83007597|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
83007598|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
83007599|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007600|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83007601|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83007602|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83007603|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
83007604|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007605|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007606|NCT02982720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83007607|NCT02982720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007608|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
83007609|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007610|NCT00849667|Carboplatin|carboplatin|mesh-list
83007611|NCT00849667|Taxane|taxane|mesh-list
83007612|NCT00849667|Farletuzumab|farletuzumab|mesh-list
83007613|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007614|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83007615|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
83007616|NCT03201419|Coagulants|coagulants|mesh-ancestor
83007617|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83007618|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
83007619|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007620|NCT01764633|Evolocumab|evolocumab|mesh-list
83007621|NCT01764633|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83007622|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83007623|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83007624|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
83007625|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007626|NCT01764633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83007627|NCT01764633|Protease Inhibitors|protease inhibitors|mesh-ancestor
83007628|NCT01764633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007629|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83007630|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83007631|NCT02924389|Dolutegravir|dolutegravir|mesh-list
83007632|NCT02924389|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
83007633|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83007634|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83007635|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007636|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007637|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
83007638|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83007639|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83007640|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83007641|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83007642|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83007643|NCT01315093|Heparin|heparin|mesh-list
83007644|NCT01315093|Calcium heparin|calcium heparin|mesh-list
83007645|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83007646|NCT01315093|Tinzaparin|tinzaparin|mesh-list
83007647|NCT01315093|Dalteparin|dalteparin|mesh-list
83007648|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
83007649|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83007650|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83007651|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007652|NCT01331707|Everolimus|everolimus|mesh-list
83007653|NCT01331707|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83007654|NCT01331707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83007655|NCT01331707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007656|NCT01331707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007657|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83007658|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
83007659|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007660|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007661|NCT02956447|Hormones|hormones|mesh-list
83007662|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83007663|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007664|NCT03953807|Dexamethasone|dexamethasone|mesh-list
83007665|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83007666|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
83007667|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
83007668|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007669|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007670|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83007671|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
83007672|NCT03953807|Hormones|hormones|mesh-ancestor
83007673|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83007674|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83007675|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007676|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
83007677|NCT03662711|Olodaterol|olodaterol|mesh-list
83007678|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
83007679|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007680|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007681|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83007682|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
83007683|NCT02923531|Nivolumab|nivolumab|mesh-list
83007684|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007685|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007686|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83007687|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007688|NCT02934503|Carboplatin|carboplatin|mesh-list
83007689|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
83007690|NCT02934503|Etoposide|etoposide|mesh-list
83007691|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83007692|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83007693|NCT02934503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83007694|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83007695|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83007696|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83007697|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83007698|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83007699|NCT04563247|Antibodies|antibodies|mesh-list
83007700|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
83007701|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007702|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
83007703|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83007704|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83007705|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83007706|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83007707|NCT01314209|Analgesics|analgesics|mesh-ancestor
83007708|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
83007709|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83007710|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83084062|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084063|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084064|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
83084065|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084066|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084067|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
83084068|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084069|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83084070|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83084071|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83084072|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084073|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
83084074|NCT02472626|Protective Agents|protective agents|mesh-ancestor
83084075|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
83084076|NCT02472626|Vitamins|vitamins|mesh-ancestor
83084077|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
83084078|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
83084079|NCT02472392|Melphalan|melphalan|mesh-list
83084080|NCT02472392|Busulfan|busulfan|mesh-list
83084081|NCT02472392|Fludarabine|fludarabine|mesh-list
83084082|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
83084083|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83084084|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084085|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
83084086|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084087|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084088|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83084089|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
83084090|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084091|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084092|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83084093|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
83084094|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83084095|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084096|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
83084097|NCT02472080|Gemcitabine|gemcitabine|mesh-list
83084098|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
83084099|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83084100|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
83084101|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084102|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084103|NCT02473562|Varenicline|varenicline|mesh-list
83084104|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83084105|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83084106|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
83084107|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084108|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084109|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084110|NCT02724020|Everolimus|everolimus|mesh-list
83084111|NCT02724020|Serabelisib|serabelisib|mesh-list
83084112|NCT02724020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83084113|NCT02724020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83084114|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084115|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084116|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084117|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
83084118|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084119|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084120|NCT02660034|Tislelizumab|tislelizumab|mesh-list
83084121|NCT02660034|Pamiparib|pamiparib|mesh-list
83084122|NCT02660034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084123|NCT02660034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084124|NCT02660034|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83084125|NCT02660034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084126|NCT02660034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084127|NCT02816736|Valsartan|valsartan|mesh-list
83084128|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83084129|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83084130|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83084131|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83084132|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084133|NCT02477072|Heparin|heparin|mesh-list
83084134|NCT02477072|Calcium heparin|calcium heparin|mesh-list
83084135|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
83084136|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83084137|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83084138|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084139|NCT05103410|Aripiprazole|aripiprazole|mesh-list
83084140|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
83084141|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83084142|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83084143|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83084144|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084145|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084146|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
83084147|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
83084148|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084149|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084150|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83084151|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83084152|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
83084153|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83084154|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83084155|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83084156|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83084157|NCT02472236|Digoxin|digoxin|mesh-list
83084158|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83084159|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83084160|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084161|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084162|NCT02472236|Protective Agents|protective agents|mesh-ancestor
83084163|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084164|NCT03108872|Anticoagulants|anticoagulants|mesh-list
83084165|NCT02194491|AS2471907|as2471907|mesh-list
83084166|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83084167|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084168|NCT03487770|Aripiprazole|aripiprazole|mesh-list
83084169|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83084170|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
83084171|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83084172|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83084173|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83084174|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084175|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084176|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
83084177|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
83084178|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084179|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084180|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83084181|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83084182|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
83084183|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83084184|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83084185|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83084186|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83084187|NCT02473328|Ritonavir|ritonavir|mesh-list
83084188|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83084189|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83084190|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83084191|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
83084192|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084193|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084194|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084195|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084196|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
83084197|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084198|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83084199|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83084200|NCT02473406|Thymalfasin|thymalfasin|mesh-list
83084201|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83084202|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
83084203|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084204|NCT02473094|Metformin|metformin|mesh-list
83084205|NCT02473094|Capecitabine|capecitabine|mesh-list
83084206|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83084207|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084208|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83084209|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
83084210|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084211|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084213|NCT03492138|Ixazomib|ixazomib|mesh-list
83084214|NCT03492138|TIC10 compound|tic10 compound|mesh-list
83084215|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084216|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
83084217|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
83084218|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084219|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084220|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084221|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
83084222|NCT03492138|Hormones|hormones|mesh-ancestor
83084223|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084224|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83084225|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084226|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
83084227|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084228|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084229|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83084230|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
83084231|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084232|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
83084233|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084234|NCT03131700|Bevacizumab|bevacizumab|mesh-list
83084235|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084236|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084237|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83084238|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83084239|NCT03131700|Growth Substances|growth substances|mesh-ancestor
83084240|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084241|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084242|NCT04730258|Azacitidine|azacitidine|mesh-list
83084243|NCT04730258|Decitabine|decitabine|mesh-list
83084244|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83084245|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
83084246|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084247|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084248|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084249|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
83084250|NCT04706936|Fludarabine|fludarabine|mesh-list
83084251|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084252|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
83084253|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084254|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084255|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83084256|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
83084257|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084258|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084259|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83084260|NCT02194881|Ivacaftor|ivacaftor|mesh-list
83084261|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83084262|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83084263|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084264|NCT02194179|Nevirapine|nevirapine|mesh-list
83084265|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83084266|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83084267|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084268|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084269|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
83084270|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084271|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084272|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084273|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83084274|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83084275|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83084276|NCT02194257|Ambroxol|ambroxol|mesh-list
83084277|NCT02194257|Expectorants|expectorants|mesh-ancestor
83084278|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
83084279|NCT02195115|Amitriptyline|amitriptyline|mesh-list
83084280|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83084281|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
83084282|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83084283|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83084284|NCT02195115|Analgesics|analgesics|mesh-ancestor
83084285|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
83084286|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084287|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084288|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83084289|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83084290|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83084291|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084292|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
83084293|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084294|NCT02194335|Olcegepant|olcegepant|mesh-list
83084295|NCT02194335|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83084296|NCT02194335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084297|NCT02194335|Analgesics|analgesics|mesh-ancestor
83084298|NCT02194335|Sensory System Agents|sensory system agents|mesh-ancestor
83084299|NCT02194335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084300|NCT02194335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084301|NCT02195973|Paclitaxel|paclitaxel|mesh-list
83084302|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83084303|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084304|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
83084305|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
83084306|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
83084307|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084308|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83084309|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
83084310|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084311|NCT02195271|Melatonin|melatonin|mesh-list
83084312|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
83084313|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084314|NCT02195271|Protective Agents|protective agents|mesh-ancestor
83084315|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084316|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084317|NCT02196285|Vaccines|vaccines|mesh-list
83084318|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
83084319|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084320|NCT04229979|Cytarabine|cytarabine|mesh-list
83084321|NCT04229979|Azacitidine|azacitidine|mesh-list
83084322|NCT04229979|Decitabine|decitabine|mesh-list
83084323|NCT04229979|Venetoclax|venetoclax|mesh-list
83084324|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83084325|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
83084326|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084327|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084328|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
83084329|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084330|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084331|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
83084332|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084333|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084334|NCT02196441|Bupivacaine|bupivacaine|mesh-list
83084335|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
83084336|NCT02196441|Tetracaine|tetracaine|mesh-list
83084337|NCT02196441|Anesthetics|anesthetics|mesh-list
83084338|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084339|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084340|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
83084341|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084342|NCT02195661|Melatonin|melatonin|mesh-list
83084343|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
83465906|NCT00000628|Zidovudine|zidovudine|mesh-list
83084344|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
83084345|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084346|NCT02195661|Protective Agents|protective agents|mesh-ancestor
83084347|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084348|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084349|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83084350|NCT03534297|Dapansutrile|dapansutrile|mesh-list
83084351|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084352|NCT02195817|Nalmefene|nalmefene|mesh-list
83084353|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83084354|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084355|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
83084356|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084357|NCT02197143|Esomeprazole|esomeprazole|mesh-list
83084358|NCT02197143|Ranitidine|ranitidine|mesh-list
83084359|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83084360|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83084361|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084362|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83084363|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084364|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084365|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83084366|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
83084367|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
83084368|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084369|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084370|NCT02096874|Bevacizumab|bevacizumab|mesh-list
83084371|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084372|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084373|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83084374|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83084375|NCT02096874|Growth Substances|growth substances|mesh-ancestor
83084376|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084377|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084378|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
83084379|NCT02198547|Ropivacaine|ropivacaine|mesh-list
83084380|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
83084381|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
83084382|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084383|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084384|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
83084385|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084386|NCT02198547|Analgesics|analgesics|mesh-ancestor
83084387|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83084388|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
83084389|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83084390|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83084391|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084392|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83084393|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
83084394|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83084395|NCT01024608|Beclomethasone|beclomethasone|mesh-list
83084396|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084397|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
83084398|NCT01024608|Hormones|hormones|mesh-ancestor
83084399|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084400|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084401|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83084402|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
83084403|NCT03489798|Alprostadil|alprostadil|mesh-list
83084404|NCT03489798|Misoprostol|misoprostol|mesh-list
83084405|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83084406|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
83084407|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83084408|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084409|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83084410|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084411|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
83084412|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83084413|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
83084414|NCT03489798|Urological Agents|urological agents|mesh-ancestor
83084415|NCT02031081|Prucalopride|prucalopride|mesh-list
83084416|NCT02031081|Laxatives|laxatives|mesh-ancestor
83084417|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83221017|NCT01679405|Gemcitabine|gemcitabine|mesh-list
83084418|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83084419|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83084420|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
83084421|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084422|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084423|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084424|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
83084425|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
83084426|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83084427|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084428|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084429|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
83084430|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83084431|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084432|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084433|NCT02199171|Carboplatin|carboplatin|mesh-list
83084434|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084435|NCT00910650|Aldesleukin|aldesleukin|mesh-list
83084436|NCT00910650|Interleukin-2|interleukin-2|mesh-list
83084437|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084438|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83084439|NCT00910650|Analgesics|analgesics|mesh-ancestor
83084440|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
83084441|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084442|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084443|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084444|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084445|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
83084446|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084447|NCT02199327|Interferons|interferons|mesh-list
83084448|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
83084449|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
83084450|NCT02199327|Mitomycins|mitomycins|mesh-list
83084451|NCT02199327|Mitomycin|mitomycin|mesh-list
83084452|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084453|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
83084454|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084455|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
83084456|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084457|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83084458|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
83084459|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084460|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83084461|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084462|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
83084463|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
83084464|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83084465|NCT02198001|Amoxicillin|amoxicillin|mesh-list
83084466|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
83084467|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
83084468|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83084469|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084470|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83084471|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084472|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084473|NCT05116800|Gemcitabine|gemcitabine|mesh-list
83084474|NCT05116800|Docetaxel|docetaxel|mesh-list
83084475|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83084476|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
83084477|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084478|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084479|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
83084480|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
83084481|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
83084482|NCT04078737|Aspirin|aspirin|mesh-list
83084483|NCT04078737|Clopidogrel|clopidogrel|mesh-list
83084484|NCT04078737|Ticagrelor|ticagrelor|mesh-list
83084485|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83084486|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83084487|NCT04078737|Analgesics|analgesics|mesh-ancestor
83084488|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
83084489|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084490|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084491|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084492|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084493|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83084494|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83084495|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084496|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83084497|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83084498|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084499|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
83084500|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83084501|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83084502|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83084503|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
83084504|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084505|NCT03491904|Fasinumab|fasinumab|mesh-list
83084506|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83084507|NCT03491904|Analgesics|analgesics|mesh-ancestor
83084508|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
83084509|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084510|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084511|NCT02199951|Piperaquine|piperaquine|mesh-list
83084513|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
83084514|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83084515|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83084516|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084517|NCT03533361|Lenvatinib|lenvatinib|mesh-list
83084518|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084519|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83084520|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084521|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084522|NCT01433328|Lidocaine|lidocaine|mesh-list
83084523|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
83084524|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
83084525|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084526|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084527|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
83084528|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084529|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83084530|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83084531|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83084532|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83084533|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084534|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83084535|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83084536|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
83084537|NCT02200185|Morphine|morphine|mesh-list
83084538|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83084539|NCT02200185|Narcotics|narcotics|mesh-ancestor
83084540|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084541|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084542|NCT02200185|Analgesics|analgesics|mesh-ancestor
83084543|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
83084544|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084545|NCT02201043|Thalidomide|thalidomide|mesh-list
83084546|NCT02201043|Tolnaftate|tolnaftate|mesh-list
83084547|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084548|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
83084549|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084550|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
83084551|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83084552|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084553|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83084554|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83084555|NCT02201043|Growth Substances|growth substances|mesh-ancestor
83084556|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084557|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084558|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
83084559|NCT02201121|Phenylephrine|phenylephrine|mesh-list
83084560|NCT02201121|Dopamine|dopamine|mesh-list
83084561|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
83084562|NCT02201121|Ephedrine|ephedrine|mesh-list
83084563|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83084564|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
83084565|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
83084566|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084567|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084568|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
83084569|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83084570|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
83084571|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83084572|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83084573|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83084574|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83084575|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83084576|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084577|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084578|NCT02201121|Protective Agents|protective agents|mesh-ancestor
83084579|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83084580|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
83084581|NCT02200575|Telmisartan|telmisartan|mesh-list
83084582|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83084583|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83084584|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83084585|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084586|NCT02201199|Insulin|insulin|mesh-list
83084587|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83084588|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
83084589|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83084590|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084591|NCT02200653|Losartan|losartan|mesh-list
83084592|NCT02200653|Telmisartan|telmisartan|mesh-list
83084593|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83084594|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83084595|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83084596|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83084597|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084598|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83084599|NCT03999411|Nicotine|nicotine|mesh-list
83084600|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
83084601|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084602|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83084603|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
83084604|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084605|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084606|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83084607|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83084608|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
83084609|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084610|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084611|NCT05261997|Metformin|metformin|mesh-list
83084612|NCT05261997|Acarbose|acarbose|mesh-list
83084613|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83084614|NCT05261997|Pancreatin|pancreatin|mesh-list
83084615|NCT05261997|Pancrelipase|pancrelipase|mesh-list
83084616|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084617|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83084618|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084619|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084620|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084621|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
83084622|NCT02206425|Dexamethasone|dexamethasone|mesh-list
83084623|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
83084624|NCT02206425|Prednisone|prednisone|mesh-list
83084625|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
83084626|NCT02206425|Melphalan|melphalan|mesh-list
83084627|NCT02206425|Doxorubicin|doxorubicin|mesh-list
83084628|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83084629|NCT02206425|Lenalidomide|lenalidomide|mesh-list
83084630|NCT02206425|Pomalidomide|pomalidomide|mesh-list
83084631|NCT02206425|BB 1101|bb 1101|mesh-list
83084632|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084633|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
83084634|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084635|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084636|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83084637|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
83084638|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084639|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084640|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83084641|NCT02206425|Vitamins|vitamins|mesh-ancestor
83084642|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
83084643|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084644|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
83084645|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
83084646|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084647|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084649|NCT02206425|Hormones|hormones|mesh-ancestor
83084650|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084651|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83084652|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
83084653|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084654|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83084655|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83084656|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83084657|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83084658|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83084659|NCT02206425|Growth Substances|growth substances|mesh-ancestor
83084660|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084661|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
83084662|NCT02206425|Protective Agents|protective agents|mesh-ancestor
83084663|NCT02201667|Aspirin|aspirin|mesh-list
83084664|NCT02201667|Clopidogrel|clopidogrel|mesh-list
83084665|NCT02201667|Ticagrelor|ticagrelor|mesh-list
83084666|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83084667|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83084668|NCT02201667|Analgesics|analgesics|mesh-ancestor
83084669|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
83084670|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084671|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084672|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084673|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084674|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83084675|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83084676|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084677|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83084678|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83084679|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084680|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
83084681|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83084682|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83084683|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83084684|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
83084685|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084686|NCT02206503|Dexamethasone|dexamethasone|mesh-list
83084687|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
83084688|NCT02206503|Lenalidomide|lenalidomide|mesh-list
83084689|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084690|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
83084691|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084692|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084693|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83084694|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
83084695|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084696|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084697|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83084698|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084699|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
83084700|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
83084701|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084702|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084703|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
83084704|NCT02206503|Hormones|hormones|mesh-ancestor
83084705|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084706|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83084707|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83084708|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83084709|NCT02206503|Growth Substances|growth substances|mesh-ancestor
83084710|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084711|NCT02206659|Telmisartan|telmisartan|mesh-list
83084712|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83084713|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83084714|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83084715|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084716|NCT02206737|Nicotine|nicotine|mesh-list
83084717|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83084718|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
83084719|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084720|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084721|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83084722|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83084723|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
83084724|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084725|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084726|NCT03533127|Bevacizumab|bevacizumab|mesh-list
83084727|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084728|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084729|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83084730|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83084731|NCT03533127|Growth Substances|growth substances|mesh-ancestor
83084732|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084733|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084734|NCT02207361|Paclitaxel|paclitaxel|mesh-list
83084735|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83084736|NCT02207361|Carboplatin|carboplatin|mesh-list
83084737|NCT02207361|Epirubicin|epirubicin|mesh-list
83084738|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83084739|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084740|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
83084741|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
83084742|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
83084743|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084744|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83084745|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83084746|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83084747|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084748|NCT02207439|Nelfinavir|nelfinavir|mesh-list
83084749|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83084750|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83084751|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
83084752|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084753|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084754|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084755|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084756|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
83084757|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084758|NCT02202525|Telmisartan|telmisartan|mesh-list
83084759|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83084760|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83084761|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83084762|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084763|NCT02202603|Teriparatide|teriparatide|mesh-list
83084764|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83084765|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084766|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83084767|NCT02202993|Mibefradil|mibefradil|mesh-list
83084768|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83084769|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83084770|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83084771|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084772|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83084773|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084774|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83084775|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83084776|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83084777|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084778|NCT02190357|Rifaximin|rifaximin|mesh-list
83084779|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83084780|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084781|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084782|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
83084783|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83084784|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
83084785|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
83084786|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83084787|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83084788|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084789|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83084790|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83084791|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83084792|NCT02257671|Estrogens|estrogens|mesh-ancestor
83084793|NCT02257671|Hormones|hormones|mesh-ancestor
83084794|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084795|NCT01460160|Dasatinib|dasatinib|mesh-list
83084796|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084797|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83084798|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084799|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084800|NCT02203227|Turmeric extract|turmeric extract|mesh-list
83084801|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
83084802|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084803|NCT02203227|Protective Agents|protective agents|mesh-ancestor
83084804|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084805|NCT01170702|Ropivacaine|ropivacaine|mesh-list
83084806|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
83084807|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
83084808|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084809|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084810|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
83084811|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084813|NCT02203461|Lopinavir|lopinavir|mesh-list
83084814|NCT02203461|Darunavir|darunavir|mesh-list
83084815|NCT02203461|Tenofovir|tenofovir|mesh-list
83084816|NCT02203461|Emtricitabine|emtricitabine|mesh-list
83084817|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83084818|NCT02203461|Cobicistat|cobicistat|mesh-list
83084819|NCT02203461|Elvitegravir|elvitegravir|mesh-list
83084820|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83084821|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83084822|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
83084823|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084824|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084825|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084826|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084827|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
83084828|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084829|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83084830|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83084831|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83084832|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83084833|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83084834|NCT02191059|Docetaxel|docetaxel|mesh-list
83084835|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084836|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83084837|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83084838|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83084839|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084840|NCT02191215|Nevirapine|nevirapine|mesh-list
83084841|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83084842|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83084843|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084844|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084845|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
83084846|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084847|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084848|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084849|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83084850|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83084851|NCT02209155|Verapamil|verapamil|mesh-list
83084852|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83084853|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83084854|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83084855|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084856|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83084857|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084858|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
83084859|NCT03485118|Rituximab|rituximab|mesh-list
83084860|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084861|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084862|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
83084863|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084864|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084865|NCT02191293|Nevirapine|nevirapine|mesh-list
83084866|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83084867|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83084868|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084869|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084870|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
83084871|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084872|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084873|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084874|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83084875|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83084876|NCT02880540|Fentanyl|fentanyl|mesh-list
83084877|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
83084878|NCT02880540|Morphine|morphine|mesh-list
83084879|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83084880|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084881|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084882|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83084883|NCT02880540|Analgesics|analgesics|mesh-ancestor
83084884|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
83084885|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084886|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83084887|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83084888|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83084889|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
83084890|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83084891|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084892|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83084893|NCT02880540|Narcotics|narcotics|mesh-ancestor
83084894|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83084895|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83084896|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
83084897|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
83084898|NCT02191371|Propofol|propofol|mesh-list
83084899|NCT02191371|Desflurane|desflurane|mesh-list
83084900|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83084901|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83084902|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084903|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83084904|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
83084905|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
83084906|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83084907|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
83084908|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084909|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084910|NCT03532737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83084911|NCT03532737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084912|NCT02741388|Cytarabine|cytarabine|mesh-list
83084913|NCT02741388|Dexamethasone|dexamethasone|mesh-list
83084914|NCT02741388|Rituximab|rituximab|mesh-list
83084915|NCT02741388|Gemcitabine|gemcitabine|mesh-list
83084916|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
83084917|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084918|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084919|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
83084920|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084921|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084922|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084923|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
83084924|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
83084925|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084926|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83084927|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
83084928|NCT02741388|Hormones|hormones|mesh-ancestor
83084929|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83084930|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83084931|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83084932|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
83084933|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084934|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
83084935|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084936|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83084937|NCT02191527|Chrysarobin|chrysarobin|mesh-list
83084938|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83084939|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83084940|NCT02191527|Analgesics|analgesics|mesh-ancestor
83084941|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
83084942|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83084943|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084944|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83084945|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83084946|NCT03484962|Antibodies|antibodies|mesh-list
83084947|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83084948|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
83084949|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084950|NCT01331616|Bevacizumab|bevacizumab|mesh-list
83084951|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83084952|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084953|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83084954|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83084955|NCT01331616|Growth Substances|growth substances|mesh-ancestor
83084956|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084957|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
83084958|NCT02209701|Porfiromycin|porfiromycin|mesh-list
83084959|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83084960|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084962|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
83084963|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83084964|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83084965|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83084966|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084967|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084968|NCT02204397|Ustekinumab|ustekinumab|mesh-list
83084969|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
83084970|NCT02192229|Vitamin D|vitamin d|mesh-list
83084971|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
83084972|NCT02192229|Vitamins|vitamins|mesh-ancestor
83084973|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
83084974|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83084975|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83084976|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83084977|NCT02192463|Nevirapine|nevirapine|mesh-list
83084978|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83084979|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83084980|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83084981|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83084982|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
83084983|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084984|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83084985|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83084986|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83084987|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83084988|NCT02204475|Interferons|interferons|mesh-list
83084989|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83084990|NCT02204475|Grazoprevir|grazoprevir|mesh-list
83084991|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83084992|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83084993|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
83084994|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084995|NCT02210169|Vancomycin|vancomycin|mesh-list
83084996|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83084997|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83084998|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
83084999|NCT02210949|Hematinics|hematinics|mesh-ancestor
83085000|NCT02204553|Panobinostat|panobinostat|mesh-list
83085001|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085002|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83085003|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483501|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085004|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085006|NCT01109004|Lenalidomide|lenalidomide|mesh-list
83085007|NCT01109004|Bortezomib|bortezomib|mesh-list
83085008|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83085009|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
83085010|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
83085011|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085012|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085013|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085014|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
83085015|NCT01109004|Hormones|hormones|mesh-ancestor
83085016|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085017|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83085018|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085019|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
83085020|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83085021|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83085022|NCT01109004|Growth Substances|growth substances|mesh-ancestor
83085023|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
83085024|NCT02211729|Azithromycin|azithromycin|mesh-list
83085025|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
83085026|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
83085027|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83085028|NCT02211729|Amodiaquine|amodiaquine|mesh-list
83085029|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085030|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085031|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
83085032|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83085033|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83085034|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83085035|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085036|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085037|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83085039|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
83085040|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
83085041|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085042|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085043|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
83085044|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085045|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83085046|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83085047|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83085048|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085049|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085050|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
83085051|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83085052|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085053|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085054|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
83085055|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085056|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085057|NCT03484650|Lidocaine|lidocaine|mesh-list
83085058|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
83085059|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
83085060|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085061|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085062|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
83085063|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085064|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83085065|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83085066|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83085067|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085068|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085069|NCT02192697|Naquotinib|naquotinib|mesh-list
83085070|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085071|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83085072|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085073|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085074|NCT05153928|Norethindrone|norethindrone|mesh-list
83085075|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
83525180|NCT01769209|Asparaginase|asparaginase|mesh-list
83085076|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83085077|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83085078|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83085079|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
83085080|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83085081|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085082|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83085083|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83085084|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
83085085|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085086|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085087|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83085088|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83085089|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085090|NCT02192853|Incretins|incretins|mesh-ancestor
83085091|NCT02192853|Hormones|hormones|mesh-ancestor
83085092|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085093|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83085094|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
83085095|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085096|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085097|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
83085098|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085099|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
83085100|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
83085101|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
83085102|NCT04574154|Anesthetics|anesthetics|mesh-list
83085103|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085104|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085105|NCT03484416|Vitamin D|vitamin d|mesh-list
83085106|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
83085107|NCT03484416|Calcium|calcium|mesh-list
83085108|NCT03484416|Vitamins|vitamins|mesh-ancestor
83085109|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
83085110|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085111|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83085112|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83085113|NCT03484416|Antacids|antacids|mesh-ancestor
83085114|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085115|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085116|NCT02205255|Azithromycin|azithromycin|mesh-list
83221018|NCT01679405|Afatinib|afatinib|mesh-list
83085117|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085118|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085119|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
83085120|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085121|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
83085122|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085123|NCT03476772|Nalbuphine|nalbuphine|mesh-list
83085124|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83085125|NCT03476772|Narcotics|narcotics|mesh-ancestor
83085126|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085127|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085128|NCT03476772|Analgesics|analgesics|mesh-ancestor
83085129|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
83085130|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085131|NCT03535233|Triamcinolone|triamcinolone|mesh-list
83085132|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83085133|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83085134|NCT03535233|Clobetasol|clobetasol|mesh-list
83085135|NCT03535233|Minoxidil|minoxidil|mesh-list
83085136|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83085137|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83085138|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
83085139|NCT03535233|Hormones|hormones|mesh-ancestor
83085140|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085141|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085142|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085143|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
83085144|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085145|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085146|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83085147|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
83085148|NCT02205489|Cetirizine|cetirizine|mesh-list
83085149|NCT02205489|Acyclovir|acyclovir|mesh-list
83085150|NCT02205489|Ibuprofen|ibuprofen|mesh-list
83085151|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
83085152|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83085153|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83085154|NCT02205489|Prednisolone|prednisolone|mesh-list
83085155|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
83085156|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
83085157|NCT02205489|Esomeprazole|esomeprazole|mesh-list
83085158|NCT02205489|Ranitidine|ranitidine|mesh-list
83085159|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83085160|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
83085161|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83085162|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83085163|NCT02205489|Analgesics|analgesics|mesh-ancestor
83085164|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
83085165|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085166|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085167|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83085168|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085169|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83085170|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085171|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085172|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
83085173|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
83085174|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085175|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
83085176|NCT02205489|Hormones|hormones|mesh-ancestor
83085177|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085178|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83085179|NCT02205489|Protective Agents|protective agents|mesh-ancestor
83085180|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83085181|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085182|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83085183|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83085184|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085185|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
83085186|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085188|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83085189|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83085190|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
83085191|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
83085192|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085193|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83085194|NCT02523846|Morphine|morphine|mesh-list
83085195|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83085196|NCT02523846|Narcotics|narcotics|mesh-ancestor
83085197|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085198|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085199|NCT02523846|Analgesics|analgesics|mesh-ancestor
83085200|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
83085201|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085202|NCT03484260|Testosterone|testosterone|mesh-list
83085203|NCT03484260|Androgens|androgens|mesh-ancestor
83085204|NCT03484260|Hormones|hormones|mesh-ancestor
83085205|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085206|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085207|NCT05195775|Tadalafil|tadalafil|mesh-list
83085208|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
83085209|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83085210|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83085211|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085212|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085213|NCT05195775|Urological Agents|urological agents|mesh-ancestor
83085214|NCT03480906|Latanoprost|latanoprost|mesh-list
83085215|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83085216|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83085217|NCT05262465|Azacitidine|azacitidine|mesh-list
83085218|NCT05262465|Venetoclax|venetoclax|mesh-list
83085219|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83085220|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
83085221|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085222|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085223|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085224|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
83085225|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83085226|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
83085227|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085228|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
83085229|NCT02220621|Protective Agents|protective agents|mesh-ancestor
83085230|NCT04370418|Fluorouracil|fluorouracil|mesh-list
83085231|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
83085232|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085233|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83085234|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085235|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085236|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
83085237|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085238|NCT02220777|Omeprazole|omeprazole|mesh-list
83085239|NCT02220777|ASP8477|asp8477|mesh-list
83085240|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83085241|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085242|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83085243|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085244|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085245|NCT03476616|Valsartan|valsartan|mesh-list
83085246|NCT03476616|Eplerenone|eplerenone|mesh-list
83085247|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83085248|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83085249|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83085250|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085251|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83085252|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
83085253|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085254|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085255|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83085256|NCT03476616|Diuretics|diuretics|mesh-ancestor
83085257|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
83085258|NCT02205879|Pregabalin|pregabalin|mesh-list
83085259|NCT02205879|Analgesics|analgesics|mesh-ancestor
83085260|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
83085261|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085262|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085263|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
83085264|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83085265|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085266|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085267|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83085268|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83085269|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83085270|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085271|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83085272|NCT03483948|Azacitidine|azacitidine|mesh-list
83085273|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83085274|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
83085275|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085276|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085277|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085278|NCT03483870|Morphine|morphine|mesh-list
83085279|NCT03483870|Granisetron|granisetron|mesh-list
83085280|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83085281|NCT03483870|Narcotics|narcotics|mesh-ancestor
83085282|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085283|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085284|NCT03483870|Analgesics|analgesics|mesh-ancestor
83085285|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
83085286|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085287|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
83085288|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
83085289|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085290|NCT03483870|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83085291|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83085292|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
83085293|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085294|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085295|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
83085296|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83085297|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085298|NCT03480516|Fluorides|fluorides|mesh-list
83085299|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
83085300|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
83085301|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
83085302|NCT03480516|Protective Agents|protective agents|mesh-ancestor
83085303|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085305|NCT02221401|Linagliptin|linagliptin|mesh-list
83085306|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83085307|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085308|NCT02221401|Incretins|incretins|mesh-ancestor
83085309|NCT02221401|Hormones|hormones|mesh-ancestor
83085310|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085311|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83085312|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
83085313|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085314|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085315|NCT03483636|Lemborexant|lemborexant|mesh-list
83085316|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83085317|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085318|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085319|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83085320|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83085321|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085322|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085323|NCT02221479|Plerixafor|plerixafor|mesh-list
83085324|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83085325|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83085326|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
83085327|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085328|NCT02221635|Risperidone|risperidone|mesh-list
83085329|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83085330|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
83085331|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085332|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085333|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085334|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83085335|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83085336|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085337|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83085338|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83085339|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
83085340|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
83085341|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
83085342|NCT03480360|Fludarabine|fludarabine|mesh-list
83085343|NCT03480360|Tacrolimus|tacrolimus|mesh-list
83085344|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085345|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
83085346|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085347|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085348|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83085349|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
83085350|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085351|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085352|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83085353|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83085354|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085355|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83085356|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83085357|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
83085358|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085359|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085360|NCT02723864|Veliparib|veliparib|mesh-list
83085361|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085362|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83085363|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085364|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085365|NCT02471690|Oritavancin|oritavancin|mesh-list
83085366|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085367|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085368|NCT02225067|Calcium|calcium|mesh-list
83085369|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83085370|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085371|NCT03475758|Goserelin|goserelin|mesh-list
83085372|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83085373|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085374|NCT02231385|Acetic Acid|acetic acid|mesh-list
83085375|NCT02231385|Retinol acetate|retinol acetate|mesh-list
83085376|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085377|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085378|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83085379|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
83085380|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085381|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83085382|NCT02231385|Protective Agents|protective agents|mesh-ancestor
83085383|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085384|NCT02523768|Basiliximab|basiliximab|mesh-list
83085385|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085386|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
83085387|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085388|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83085389|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
83085390|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83085391|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085392|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
83085393|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83085394|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085395|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085396|NCT03203642|XL647|xl647|mesh-list
83085397|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085398|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83085399|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085400|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085401|NCT03475680|Gentamicins|gentamicins|mesh-list
83085402|NCT03475680|Ornidazole|ornidazole|mesh-list
83085403|NCT03475680|Sennosides|sennosides|mesh-list
83085404|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085405|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085406|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83085407|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83465969|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
83085408|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085409|NCT03475680|Laxatives|laxatives|mesh-ancestor
83085410|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085411|NCT03475680|Amebicides|amebicides|mesh-ancestor
83085412|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83085413|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83085414|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83085415|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83085416|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83085418|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83085419|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085420|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
83085421|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83085422|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83085423|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83085424|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085425|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085426|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
83085427|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085428|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085429|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83085430|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085431|NCT02471846|Atezolizumab|atezolizumab|mesh-list
83085432|NCT02471846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83085433|NCT02471846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085434|NCT02471846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085435|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085436|NCT02472782|Teriparatide|teriparatide|mesh-list
83085437|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83085438|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085439|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83085440|NCT02258607|Trametinib|trametinib|mesh-list
83085441|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83085442|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085443|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83085444|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085445|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085446|NCT03792750|Nivolumab|nivolumab|mesh-list
83085447|NCT03792750|Linrodostat|linrodostat|mesh-list
83085448|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085449|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085450|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83525181|NCT01769209|Pegaspargase|pegaspargase|mesh-list
83085451|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085452|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085453|NCT02258763|Amoxicillin|amoxicillin|mesh-list
83085454|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
83085455|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
83085456|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83085457|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085458|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085459|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83085460|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085461|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085462|NCT02469974|Busulfan|busulfan|mesh-list
83085463|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
83085464|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085465|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
83085466|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085467|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085468|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83085469|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085470|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83085471|NCT02231931|Metformin|metformin|mesh-list
83085472|NCT02231931|Digoxin|digoxin|mesh-list
83085473|NCT02231931|Furosemide|furosemide|mesh-list
83085474|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83085475|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83085476|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085477|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83085478|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83085479|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
83085480|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085481|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83085482|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83085483|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085484|NCT02231931|Diuretics|diuretics|mesh-ancestor
83085485|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
83085486|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83085487|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085488|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83085489|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83085490|NCT02231931|Protective Agents|protective agents|mesh-ancestor
83085491|NCT03131622|Coal Tar|coal tar|mesh-list
83085492|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
83085493|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
83085494|NCT03482544|Pregabalin|pregabalin|mesh-list
83085495|NCT03482544|Analgesics|analgesics|mesh-ancestor
83085496|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
83085497|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085498|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085499|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
83085500|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83085501|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085502|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085503|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83085504|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83085505|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83085506|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085507|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83085508|NCT02750709|Nitisinone|nitisinone|mesh-list
83085509|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085510|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085511|NCT02222649|Vitamin D|vitamin d|mesh-list
83085512|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
83085513|NCT02222649|Vitamins|vitamins|mesh-ancestor
83085514|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
83085515|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085516|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83085517|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83085518|NCT02222727|Donepezil|donepezil|mesh-list
83085519|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83085520|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085521|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085522|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
83085523|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085524|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085525|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
83085526|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
83085527|NCT02723786|Azathioprine|azathioprine|mesh-list
83085528|NCT02723786|Tacrolimus|tacrolimus|mesh-list
83085529|NCT02723786|Basiliximab|basiliximab|mesh-list
83085530|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085531|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
83085532|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085533|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83085534|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085535|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085536|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83085537|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085538|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83085539|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
83085540|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83465983|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
83085541|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085542|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
83085543|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83085544|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085545|NCT03310736|Hepcidins|hepcidins|mesh-list
83085546|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085547|NCT02226783|Omeprazole|omeprazole|mesh-list
83085548|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83085549|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085550|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83085551|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085552|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085553|NCT03482232|Acetaminophen|acetaminophen|mesh-list
83085554|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83085555|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83085556|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
83085557|NCT03482232|Ibuprofen|ibuprofen|mesh-list
83085558|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83085559|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83085560|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
83085561|NCT03482232|Expectorants|expectorants|mesh-list
83085562|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
83085563|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83085564|NCT03482232|Analgesics|analgesics|mesh-ancestor
83085565|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
83085566|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085567|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085568|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085569|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83085570|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085571|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085572|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
83085573|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
83085574|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83085575|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
83085576|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83085577|NCT04542200|Antibodies|antibodies|mesh-list
83085578|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
83085579|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085580|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
83085581|NCT02227173|Digoxin|digoxin|mesh-list
83085582|NCT02227173|Montelukast|montelukast|mesh-list
83085583|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83085584|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
83085585|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83085586|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
83085587|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085588|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085589|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83085590|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83085591|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085592|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83085593|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83085594|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085595|NCT02227173|Protective Agents|protective agents|mesh-ancestor
83085596|NCT02227173|Analgesics|analgesics|mesh-ancestor
83085597|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
83085598|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085599|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83085600|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83085601|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83085602|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085603|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83085604|NCT02469740|Clopidogrel|clopidogrel|mesh-list
83085605|NCT02469740|Ticagrelor|ticagrelor|mesh-list
83085606|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83085607|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83085608|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83085609|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83085610|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
83085611|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085612|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085613|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085614|NCT04432220|Apixaban|apixaban|mesh-list
83085615|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83085616|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
83085617|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83085618|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
83085619|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085620|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085621|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
83085622|NCT03520842|Methotrexate|methotrexate|mesh-list
83085623|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83085624|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
83085625|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83085626|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085627|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83085628|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
83085629|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085630|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085631|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
83085632|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085633|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83085634|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085635|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
83085636|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085637|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83085638|NCT04405622|Gemcitabine|gemcitabine|mesh-list
83085639|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83085640|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
83085641|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085642|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085643|NCT03481998|Letrozole|letrozole|mesh-list
83085644|NCT03481998|Fulvestrant|fulvestrant|mesh-list
83085645|NCT03481998|Anastrozole|anastrozole|mesh-list
83085646|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085647|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83085648|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83085649|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085650|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085651|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83085652|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
83085653|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085654|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085655|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83085656|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83085657|NCT02723084|Ribavirin|ribavirin|mesh-list
83085658|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
83085659|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
83085660|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085661|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
83085662|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085663|NCT02750943|Fluorides|fluorides|mesh-list
83085664|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
83085665|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
83085666|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
83085667|NCT02750943|Protective Agents|protective agents|mesh-ancestor
83085668|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085669|NCT03481920|Avelumab|avelumab|mesh-list
83085670|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085671|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085672|NCT02227797|Voriconazole|voriconazole|mesh-list
83085673|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
83085674|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085675|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83085676|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83085677|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085678|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085679|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83085680|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
83085681|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085682|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085683|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83085684|NCT05784311|Metronidazole|metronidazole|mesh-list
83085685|NCT05784311|Cefuroxime|cefuroxime|mesh-list
83085686|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
83085687|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085688|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83085689|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83085690|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83085691|NCT05783921|Paclitaxel|paclitaxel|mesh-list
83085692|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83085693|NCT05783921|Cisplatin|cisplatin|mesh-list
83085694|NCT05783921|Carboplatin|carboplatin|mesh-list
83085695|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83085696|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085697|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83085698|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83085699|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83085700|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085701|NCT05783778|Testosterone|testosterone|mesh-list
83085702|NCT05783778|Androgens|androgens|mesh-ancestor
83085703|NCT05783778|Hormones|hormones|mesh-ancestor
83085704|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085705|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085706|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83085707|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085708|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
83085709|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83085710|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83085711|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085712|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
83085713|NCT05783648|Coagulants|coagulants|mesh-ancestor
83085714|NCT05783609|Rituximab|rituximab|mesh-list
83085715|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085716|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085717|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
83085718|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085719|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085720|NCT05783557|Clevidipine|clevidipine|mesh-list
83085721|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83085722|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83085723|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085724|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83085725|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085726|NCT05783544|Interferons|interferons|mesh-list
83085727|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
83085728|NCT05783544|Interleukin-4|interleukin-4|mesh-list
83085729|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085730|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
83085731|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085732|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83085733|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
83085734|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085735|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085736|NCT05783518|Propofol|propofol|mesh-list
83085737|NCT05783518|Desflurane|desflurane|mesh-list
83085738|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83085739|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085740|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085741|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83085742|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
83085743|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
83085744|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83085745|NCT05783492|Ketamine|ketamine|mesh-list
83085746|NCT05783492|Analgesics|analgesics|mesh-ancestor
83085747|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
83085748|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085749|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085750|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83085751|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83085752|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
83085753|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
83085754|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085755|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83085756|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83085757|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83465993|NCT00000658|Hormones|hormones|mesh-ancestor
83085758|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085759|NCT05783479|Estradiol|estradiol|mesh-list
83085760|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
83085761|NCT05783479|Estrogens|estrogens|mesh-ancestor
83085762|NCT05783479|Hormones|hormones|mesh-ancestor
83085763|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085764|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085765|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83085766|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
83085767|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
83085768|NCT05783479|Protective Agents|protective agents|mesh-ancestor
83085769|NCT05783453|Emollients|emollients|mesh-list
83085770|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
83085771|NCT05782933|Rituximab|rituximab|mesh-list
83085772|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085773|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085774|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
83085775|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085776|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085777|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
83085778|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83085779|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
83085780|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085781|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
83085782|NCT05782920|Protective Agents|protective agents|mesh-ancestor
83085783|NCT05782881|Glucagon|glucagon|mesh-list
83085784|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83085785|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83085786|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83085787|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085788|NCT05782881|Hormones|hormones|mesh-ancestor
83085789|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83085790|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085791|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085792|NCT05782881|Incretins|incretins|mesh-ancestor
83085793|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
83085794|NCT05782777|Ezetimibe|ezetimibe|mesh-list
83085795|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83085796|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83085797|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83085798|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
83085799|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085800|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83085801|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085802|NCT05782764|Endostar protein|endostar protein|mesh-list
83085803|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83085804|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83085805|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83085806|NCT05782764|Growth Substances|growth substances|mesh-ancestor
83085807|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085808|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
83085809|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085810|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085811|NCT05782764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085812|NCT05782751|Mitogens|mitogens|mesh-list
83085813|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83085814|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085815|NCT05781074|Lenvatinib|lenvatinib|mesh-list
83085816|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085817|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83085818|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085819|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085820|NCT05780541|Remdesivir|remdesivir|mesh-list
83085821|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
83085822|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085823|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
83085824|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085825|NCT05780463|Remdesivir|remdesivir|mesh-list
83085826|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
83085827|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085828|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
83085829|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085830|NCT05780281|Remdesivir|remdesivir|mesh-list
83085831|NCT05780281|Sotrovimab|sotrovimab|mesh-list
83085832|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
83085833|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085834|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
83085835|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085836|NCT05780268|Remdesivir|remdesivir|mesh-list
83085837|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
83085838|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
83085839|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085840|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
83085841|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085842|NCT05779657|Midazolam|midazolam|mesh-list
83085843|NCT05779657|Ketamine|ketamine|mesh-list
83085844|NCT05779657|Analgesics|analgesics|mesh-ancestor
83085845|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
83085846|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085847|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085848|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83085849|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83085850|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
83085851|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
83085852|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085853|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83085854|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83085855|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085856|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085857|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83085858|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83085859|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83085860|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83085861|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83085862|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
83085863|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
83085864|NCT05774054|Norepinephrine|norepinephrine|mesh-list
83085865|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83085866|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83085867|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
83085868|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085869|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085870|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085871|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
83085872|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
83085873|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085874|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83085875|NCT05751148|Bupivacaine|bupivacaine|mesh-list
83085876|NCT05751148|Prilocaine|prilocaine|mesh-list
83085877|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
83085878|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
83085879|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085880|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085881|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
83085882|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085883|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
83085884|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
83085885|NCT05703971|Atezolizumab|atezolizumab|mesh-list
83085886|NCT05703971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83085887|NCT05703971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085888|NCT05703971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085889|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085890|NCT05703074|Niacinamide|niacinamide|mesh-list
83085891|NCT05703074|Niacin|niacin|mesh-list
83085892|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
83085893|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
83085894|NCT05703074|Vitamins|vitamins|mesh-ancestor
83085895|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
83085896|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085897|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83085898|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
83085899|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085900|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83085901|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
83085902|NCT05701865|Ethanol|ethanol|mesh-list
83085903|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83085904|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085905|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085906|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83485772|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
83085907|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
83085908|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83085909|NCT05674721|Ibuprofen|ibuprofen|mesh-list
83085910|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83085911|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83085912|NCT05674721|Analgesics|analgesics|mesh-ancestor
83085913|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
83085914|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085915|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085916|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83085917|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085918|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83085919|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085920|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085921|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
83085922|NCT05664464|Temozolomide|temozolomide|mesh-list
83085923|NCT05664464|Gabapentin|gabapentin|mesh-list
83085924|NCT05664464|Memantine|memantine|mesh-list
83085925|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83085926|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
83085927|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085928|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085929|NCT05664464|Analgesics|analgesics|mesh-ancestor
83085930|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
83085931|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83085932|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085933|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
83085934|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83085935|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83085936|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085937|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83085938|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83085939|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83085940|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83085941|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
83085942|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83085943|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83085944|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
83085945|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085946|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83085947|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83085948|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83085949|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085950|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83085951|NCT05657457|Tenecteplase|tenecteplase|mesh-list
83085952|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83085953|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83085954|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085955|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83085956|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
83085957|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83085958|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085959|NCT05635344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83085960|NCT05635344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085961|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
83085962|NCT05630989|Mitogens|mitogens|mesh-list
83085963|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
83085964|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83085965|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83085966|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085967|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085968|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085969|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83085970|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
83085971|NCT05626530|Letermovir|letermovir|mesh-list
83085972|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83085973|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83085974|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085975|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085976|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
83085977|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83085978|NCT05601674|Anesthetics|anesthetics|mesh-list
83085979|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83085980|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085981|NCT05567835|Leucovorin|leucovorin|mesh-list
83085982|NCT05567835|Docetaxel|docetaxel|mesh-list
83085983|NCT05567835|Fluorouracil|fluorouracil|mesh-list
83085984|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
83085985|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83085986|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83085987|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83085988|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83085989|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83085990|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
83085991|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83085992|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83085993|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
83085994|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83085995|NCT05567835|Antidotes|antidotes|mesh-ancestor
83085996|NCT05567835|Protective Agents|protective agents|mesh-ancestor
83085997|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
83085998|NCT05567835|Vitamins|vitamins|mesh-ancestor
83085999|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
83086000|NCT05563961|Acetaminophen|acetaminophen|mesh-list
83086001|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83086002|NCT05563961|Analgesics|analgesics|mesh-ancestor
83086003|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
83086004|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086005|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086006|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
83086007|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83086008|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83086009|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086010|NCT05551104|Labetalol|labetalol|mesh-list
83086011|NCT05551104|Nifedipine|nifedipine|mesh-list
83086012|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83086013|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83086014|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086015|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83086016|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086017|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
83086018|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
83086019|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83086020|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83086021|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83086022|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
83086023|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086024|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83086025|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
83086026|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
83086027|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086028|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83086029|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83086030|NCT05527314|Fentanyl|fentanyl|mesh-list
83086031|NCT05527314|Remifentanil|remifentanil|mesh-list
83086032|NCT05527314|Sevoflurane|sevoflurane|mesh-list
83086033|NCT05527314|Cisatracurium|cisatracurium|mesh-list
83086034|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83086035|NCT05527314|Narcotics|narcotics|mesh-ancestor
83086036|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086037|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086038|NCT05527314|Analgesics|analgesics|mesh-ancestor
83086039|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
83086040|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086041|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83086042|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83086043|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
83086044|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
83086045|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83086046|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83086047|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83086048|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83086049|NCT05517122|Niacinamide|niacinamide|mesh-list
83086050|NCT05517122|Niacin|niacin|mesh-list
83086051|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
83086052|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
83086053|NCT05517122|Vitamins|vitamins|mesh-ancestor
83086054|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
83086055|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086056|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83086057|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
83086058|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086059|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83086060|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
83086061|NCT05484505|Nicotine|nicotine|mesh-list
83086062|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83086063|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
83086064|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086065|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086066|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83086067|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83086068|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
83086069|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086070|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086071|NCT05478161|Fexofenadine|fexofenadine|mesh-list
83086072|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83086073|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83086074|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83086075|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
83086076|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
83086077|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086078|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086079|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086080|NCT05476822|Antibodies|antibodies|mesh-list
83086081|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
83086082|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086083|NCT05473364|Acetazolamide|acetazolamide|mesh-list
83086084|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
83086085|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83086086|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086087|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086088|NCT05473364|Diuretics|diuretics|mesh-ancestor
83086089|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
83086090|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086092|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
83086093|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086094|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086095|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086096|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086097|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
83086098|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086099|NCT05393804|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
83086100|NCT05393804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086101|NCT05393804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086102|NCT05392608|Fulvestrant|fulvestrant|mesh-list
83086103|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83086104|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086105|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83086106|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83086107|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
83086108|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086109|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086110|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
83086111|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83086112|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
83086113|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83086114|NCT05351346|Prednisone|prednisone|mesh-list
83086115|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
83086116|NCT05351346|Rituximab|rituximab|mesh-list
83086117|NCT05351346|Doxorubicin|doxorubicin|mesh-list
83086118|NCT05351346|Vincristine|vincristine|mesh-list
83086119|NCT05351346|Lenalidomide|lenalidomide|mesh-list
83086120|NCT05351346|Decitabine|decitabine|mesh-list
83086121|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086122|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
83086123|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086124|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83086125|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83086126|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
83086127|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086128|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086129|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83086130|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086131|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086132|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83086133|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086134|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086135|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83086136|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
83086137|NCT05351346|Hormones|hormones|mesh-ancestor
83086138|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086139|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83086140|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086141|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086142|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086143|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086144|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83086145|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83086146|NCT05351346|Growth Substances|growth substances|mesh-ancestor
83086147|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
83086148|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086149|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
83086150|NCT05323019|Ketamine|ketamine|mesh-list
83086151|NCT05323019|Esketamine|esketamine|mesh-list
83086152|NCT05323019|Analgesics|analgesics|mesh-ancestor
83086153|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
83086154|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086155|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086156|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83086157|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83086158|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
83086159|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
83086160|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086161|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83086162|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83086163|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086164|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086165|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
83086166|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83086167|NCT05280743|Oxycodone|oxycodone|mesh-list
83086168|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83086169|NCT05280743|Narcotics|narcotics|mesh-ancestor
83086170|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086171|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086172|NCT05280743|Analgesics|analgesics|mesh-ancestor
83086173|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
83086174|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086175|NCT05276258|Bupivacaine|bupivacaine|mesh-list
83086176|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
83086177|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
83086178|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086179|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086180|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
83086181|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086182|NCT05233982|Olaparib|olaparib|mesh-list
83086183|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83086184|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086185|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086186|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086187|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83086188|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
83086189|NCT05199493|Giapreza|giapreza|mesh-list
83086190|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
83086191|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83086192|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83086193|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
83086194|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086195|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086196|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83086197|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
83086198|NCT05169658|Antibodies|antibodies|mesh-list
83086199|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
83086200|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83086201|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83086202|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
83086203|NCT05169658|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83086204|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
83086205|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086206|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086207|NCT05141305|Clopidogrel|clopidogrel|mesh-list
83086208|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086209|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086210|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83086211|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83086212|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83086213|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83086214|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
83086215|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086216|NCT05112536|Paclitaxel|paclitaxel|mesh-list
83086217|NCT05112536|Carboplatin|carboplatin|mesh-list
83086218|NCT05112536|Doxorubicin|doxorubicin|mesh-list
83086219|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
83086220|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086221|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086222|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086223|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086224|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086225|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086226|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086227|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83086228|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086229|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086230|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086231|NCT05112536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086232|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
83086233|NCT05109455|Procyanidin|procyanidin|mesh-list
83086234|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
83086235|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086236|NCT05109455|Protective Agents|protective agents|mesh-ancestor
83086237|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086238|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83086239|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83086240|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086241|NCT05098028|Rifaximin|rifaximin|mesh-list
83086242|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83086243|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086244|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83086245|NCT05079360|Everolimus|everolimus|mesh-list
83086246|NCT05079360|Exemestane|exemestane|mesh-list
83086247|NCT05079360|Estrogens|estrogens|mesh-list
83086248|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
83086249|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
83086250|NCT05079360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83086251|NCT05079360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83086252|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086253|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086254|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086255|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
83086256|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086257|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086258|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83086259|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83086260|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83086261|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
83086262|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086263|NCT05079360|Hormones|hormones|mesh-ancestor
83086264|NCT05078060|Vaccines|vaccines|mesh-list
83086265|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
83086266|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086267|NCT05075980|Cisplatin|cisplatin|mesh-list
83086268|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086269|NCT05063786|Capecitabine|capecitabine|mesh-list
83086270|NCT05063786|Trastuzumab|trastuzumab|mesh-list
83086271|NCT05063786|Vinorelbine|vinorelbine|mesh-list
83086272|NCT05063786|Fulvestrant|fulvestrant|mesh-list
83086273|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086274|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
83086275|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086276|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086277|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086278|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086279|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086280|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086281|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086282|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83086283|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83086284|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83086285|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
83086286|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086287|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086288|NCT05035836|Tamoxifen|tamoxifen|mesh-list
83086289|NCT05035836|Letrozole|letrozole|mesh-list
83086290|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086291|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83086292|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83086293|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086294|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086295|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83086296|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
83086297|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086298|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086299|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83086300|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83086301|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83086302|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83086303|NCT05012787|Vaccines|vaccines|mesh-list
83086304|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83086305|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
83086306|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086307|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83086308|NCT05005260|Bupivacaine|bupivacaine|mesh-list
83086309|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
83086310|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
83086311|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086312|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086313|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
83086314|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086316|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
83086317|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83086318|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
83086319|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086320|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086321|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83086322|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83086323|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
83086324|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83086325|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83086326|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086327|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086328|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
83086329|NCT04926181|Androgens|androgens|mesh-list
83086330|NCT04926181|Hormones|hormones|mesh-ancestor
83086331|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086332|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086333|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
83086334|NCT04918927|Favipiravir|favipiravir|mesh-list
83086335|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83086336|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086337|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
83086338|NCT04907825|Warfarin|warfarin|mesh-list
83086339|NCT04907825|Anticoagulants|anticoagulants|mesh-list
83086340|NCT04907084|Fenofibrate|fenofibrate|mesh-list
83086341|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83086342|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
83086343|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086344|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83086345|NCT04893356|Dacarbazine|dacarbazine|mesh-list
83086346|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83086347|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
83086348|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086349|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086350|NCT04857983|Memantine|memantine|mesh-list
83086351|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83086352|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83086353|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
83086354|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086355|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086356|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086357|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83086358|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83086359|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
83086360|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086361|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086362|NCT04777708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086363|NCT04777708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086364|NCT04763512|Caseins|caseins|mesh-list
83086365|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
83086366|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
83086367|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086368|NCT04730349|Nivolumab|nivolumab|mesh-list
83086369|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086370|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086371|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086372|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086373|NCT04602117|Paclitaxel|paclitaxel|mesh-list
83086374|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83086375|NCT04602117|Trastuzumab|trastuzumab|mesh-list
83086376|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086377|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086378|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086379|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086380|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086381|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086382|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086383|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
83086384|NCT04601857|Futibatinib|futibatinib|mesh-list
83086385|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086388|NCT04601857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086390|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086391|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83086392|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83086393|NCT04590508|Growth Substances|growth substances|mesh-ancestor
83086394|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086395|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
83086399|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
83086401|NCT04541355|Antidotes|antidotes|mesh-list
83086402|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086403|NCT04541355|Protective Agents|protective agents|mesh-ancestor
83086404|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086405|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
83086406|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086407|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
83086408|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83086409|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086410|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
83086411|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
83086412|NCT04517396|Fenofibrate|fenofibrate|mesh-list
83086413|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
83086414|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83086415|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
83086416|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086417|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83086418|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83086419|NCT04501978|Remdesivir|remdesivir|mesh-list
83086420|NCT04501978|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83086421|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
83086422|NCT04501978|Sotrovimab|sotrovimab|mesh-list
83086423|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
83086424|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086425|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
83086426|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086427|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83086428|NCT04382352|Trastuzumab|trastuzumab|mesh-list
83086429|NCT04382352|Antibodies|antibodies|mesh-list
83086430|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
83086431|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83086432|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
83086433|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086434|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086435|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
83086436|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086437|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086438|NCT04354246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086439|NCT04354246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086440|NCT04353492|Ofatumumab|ofatumumab|mesh-list
83086441|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086442|NCT04311424|Tirzepatide|tirzepatide|mesh-list
83086443|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83086444|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086445|NCT04311424|Incretins|incretins|mesh-ancestor
83086446|NCT04311424|Hormones|hormones|mesh-ancestor
83086447|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086448|NCT04301765|Testosterone|testosterone|mesh-list
83086449|NCT04301765|Androgens|androgens|mesh-ancestor
83086450|NCT04301765|Hormones|hormones|mesh-ancestor
83086451|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086452|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086453|NCT04296396|Oxycodone|oxycodone|mesh-list
83086454|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83086455|NCT04296396|Narcotics|narcotics|mesh-ancestor
83086456|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086457|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086458|NCT04296396|Analgesics|analgesics|mesh-ancestor
83086459|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
83086460|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086461|NCT04291456|Minocycline|minocycline|mesh-list
83086462|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83086463|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086464|NCT04266977|Dexamethasone|dexamethasone|mesh-list
83086465|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83086466|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
83086467|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
83086468|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086469|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086470|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83086471|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
83086472|NCT04266977|Hormones|hormones|mesh-ancestor
83086473|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086474|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83086475|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086476|NCT04195945|Cytarabine|cytarabine|mesh-list
83086477|NCT04195945|Daunorubicin|daunorubicin|mesh-list
83086478|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
83086479|NCT04195945|Cladribine|cladribine|mesh-list
83086480|NCT04195945|Lenograstim|lenograstim|mesh-list
83086481|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086482|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
83086483|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086484|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086485|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
83086486|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086487|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086488|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
83086489|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086490|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086491|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83086492|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086493|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086494|NCT04195945|Analgesics|analgesics|mesh-ancestor
83086495|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
83086496|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086497|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83086498|NCT04172922|Sirolimus|sirolimus|mesh-list
83086499|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83086500|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086501|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086502|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086503|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
83086504|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086505|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
83086506|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086507|NCT04139772|Docetaxel|docetaxel|mesh-list
83086508|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
83086509|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086510|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086511|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086512|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086513|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086514|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83086515|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086516|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83086517|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086518|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086519|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83086520|NCT04136353|Hormones|hormones|mesh-list
83086521|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83086522|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086523|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086524|NCT04094688|Vitamin D|vitamin d|mesh-list
83086525|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
83086526|NCT04094688|Leucovorin|leucovorin|mesh-list
83086527|NCT04094688|Bevacizumab|bevacizumab|mesh-list
83086528|NCT04094688|Fluorouracil|fluorouracil|mesh-list
83086529|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
83086530|NCT04094688|Irinotecan|irinotecan|mesh-list
83086531|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
83086532|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086533|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086534|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83086535|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83086536|NCT04094688|Growth Substances|growth substances|mesh-ancestor
83086537|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086538|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
83086539|NCT04094688|Vitamins|vitamins|mesh-ancestor
83086540|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
83086541|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83086542|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83086543|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
83086544|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086545|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086546|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086547|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
83086548|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83086549|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086550|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086551|NCT04094688|Antidotes|antidotes|mesh-ancestor
83086552|NCT04094688|Protective Agents|protective agents|mesh-ancestor
83086553|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
83086554|NCT04091204|Olaparib|olaparib|mesh-list
83086555|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83086556|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086557|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086558|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086559|NCT04028245|Spartalizumab|spartalizumab|mesh-list
83086560|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086561|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086562|NCT04028245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086563|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086564|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83086565|NCT04017650|Nivolumab|nivolumab|mesh-list
83086566|NCT04017650|Cetuximab|cetuximab|mesh-list
83086567|NCT04017650|Antibodies|antibodies|mesh-list
83086568|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
83086569|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83086570|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
83086571|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086572|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086573|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086574|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086575|NCT03975114|Durvalumab|durvalumab|mesh-list
83086576|NCT03975114|Tremelimumab|tremelimumab|mesh-list
83086577|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086578|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086579|NCT03955783|Venetoclax|venetoclax|mesh-list
83086580|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086581|NCT03942120|Ustekinumab|ustekinumab|mesh-list
83086582|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
83086583|NCT03940742|Tirzepatide|tirzepatide|mesh-list
83086584|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83086585|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086586|NCT03940742|Incretins|incretins|mesh-ancestor
83086587|NCT03940742|Hormones|hormones|mesh-ancestor
83086588|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086589|NCT03893240|Antibodies|antibodies|mesh-list
83086590|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
83086591|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
83086592|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086593|NCT03878199|Cytarabine|cytarabine|mesh-list
83086594|NCT03878199|Daunorubicin|daunorubicin|mesh-list
83086595|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83086596|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086597|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
83086598|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086599|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086600|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
83086601|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086602|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086603|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
83086604|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086605|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086606|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83086607|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086608|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086609|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83086610|NCT03875274|Morphine|morphine|mesh-list
83086611|NCT03875274|Ropivacaine|ropivacaine|mesh-list
83086612|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83086613|NCT03875274|Narcotics|narcotics|mesh-ancestor
83086614|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086615|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086616|NCT03875274|Analgesics|analgesics|mesh-ancestor
83086617|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
83086618|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086619|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
83086620|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
83086621|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
83086622|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086623|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086624|NCT03775850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086625|NCT03775850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086627|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83086628|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086629|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83086630|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086631|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
83086632|NCT03732664|Nivolumab|nivolumab|mesh-list
83086633|NCT03732664|Durvalumab|durvalumab|mesh-list
83086634|NCT03732664|Tislelizumab|tislelizumab|mesh-list
83086635|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086636|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086637|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086638|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086639|NCT03620032|Vinorelbine|vinorelbine|mesh-list
83086640|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
83086641|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086642|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086643|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086644|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086645|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086646|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086647|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086648|NCT03410784|Paclitaxel|paclitaxel|mesh-list
83086649|NCT03410784|Carboplatin|carboplatin|mesh-list
83086650|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
83086651|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086652|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086653|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086654|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086655|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086656|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086657|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086658|NCT03410784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086659|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
83086660|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
83086661|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086662|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
83086663|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83086664|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83086665|NCT03355482|Prednisolone|prednisolone|mesh-list
83086666|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
83086667|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83086668|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
83086669|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83086670|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
83086671|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
83086672|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086673|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086674|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83086675|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
83086676|NCT03355482|Hormones|hormones|mesh-ancestor
83086677|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086678|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83086679|NCT03355482|Protective Agents|protective agents|mesh-ancestor
83086680|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83086681|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086682|NCT03340064|Levetiracetam|levetiracetam|mesh-list
83086683|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
83086684|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
83086685|NCT03326921|Vidarabine|vidarabine|mesh-list
83086686|NCT03326921|Fludarabine|fludarabine|mesh-list
83086687|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
83086688|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086689|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086690|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
83086691|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086692|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086693|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
83086694|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086695|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
83086696|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086697|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83086698|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086699|NCT03310619|Nivolumab|nivolumab|mesh-list
83086700|NCT03310619|Durvalumab|durvalumab|mesh-list
83086701|NCT03310619|Relatlimab|relatlimab|mesh-list
83086702|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086703|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086704|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086705|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086706|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
83086707|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
83086708|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086709|NCT03093064|Natalizumab|natalizumab|mesh-list
83086710|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
83086711|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086712|NCT03060577|Evolocumab|evolocumab|mesh-list
83086713|NCT03060577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83086714|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83086715|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83086716|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
83086717|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086718|NCT03060577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83086719|NCT03060577|Protease Inhibitors|protease inhibitors|mesh-ancestor
83086720|NCT03060577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086721|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83086722|NCT02797275|Albuterol|albuterol|mesh-list
83086723|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83086724|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
83086725|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086726|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086727|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83086728|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
83086729|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
83086730|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83086731|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83086732|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83086733|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83086734|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
83086735|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086736|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086737|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
83086738|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086739|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
83086740|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086741|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83086742|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83086743|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
83086744|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086745|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086746|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83086747|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
83086748|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086749|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086750|NCT02787005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086751|NCT02787005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086752|NCT02734290|Paclitaxel|paclitaxel|mesh-list
83086753|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
83086754|NCT02734290|Capecitabine|capecitabine|mesh-list
83086755|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086756|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086757|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086758|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086759|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086760|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086761|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086762|NCT02734290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086763|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086764|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
83086765|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
83086766|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086767|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086768|NCT02673333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086769|NCT02673333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086770|NCT02633189|Bevacizumab|bevacizumab|mesh-list
83086771|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83086772|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086773|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086774|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83086775|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83086776|NCT02633189|Growth Substances|growth substances|mesh-ancestor
83086777|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086778|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
83086779|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83086780|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086781|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086782|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83086783|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83086784|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83086785|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086786|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086788|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086789|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83086790|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83086791|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
83086792|NCT02601313|Fludarabine|fludarabine|mesh-list
83086793|NCT02601313|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83086794|NCT02601313|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
83086795|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086796|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
83086797|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086798|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83086799|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83086800|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
83086801|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086802|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086803|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83086804|NCT02601313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086805|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
83086806|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83086807|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086808|NCT02514083|Fludarabine|fludarabine|mesh-list
83086809|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086810|NCT02500576|Aldesleukin|aldesleukin|mesh-list
83086811|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
83086812|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
83086813|NCT02500576|Fludarabine|fludarabine|mesh-list
83086814|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
83086815|NCT02500576|Interleukin-2|interleukin-2|mesh-list
83086816|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086817|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
83086818|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086819|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83086820|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83086821|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
83086822|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086823|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086824|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83086825|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086826|NCT02500576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086827|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086828|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
83086829|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83086830|NCT02500576|Analgesics|analgesics|mesh-ancestor
83086831|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
83086832|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83086833|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83086834|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83086835|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
83086836|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086837|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
83086838|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83086839|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83086840|NCT02214381|Paclitaxel|paclitaxel|mesh-list
83086841|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
83086842|NCT02214381|Doxorubicin|doxorubicin|mesh-list
83086843|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086844|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086845|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086846|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086847|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086848|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086849|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086850|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
83086851|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086852|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83086853|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83086854|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
83086855|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83086856|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086857|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83086858|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086859|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086861|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83086862|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
83086863|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086864|NCT02061761|Nivolumab|nivolumab|mesh-list
83086865|NCT02061761|Relatlimab|relatlimab|mesh-list
83086866|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086867|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086868|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83086869|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086870|NCT01927068|Paclitaxel|paclitaxel|mesh-list
83086871|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086872|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086873|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086874|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086875|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086876|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086877|NCT01898104|Capecitabine|capecitabine|mesh-list
83086878|NCT01898104|Valproic Acid|valproic acid|mesh-list
83086879|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086880|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
83086881|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086882|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086883|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
83086884|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086885|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
83086886|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83086887|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086888|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
83086889|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83086890|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83086891|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83086892|NCT01817452|Paclitaxel|paclitaxel|mesh-list
83086893|NCT01817452|Trastuzumab|trastuzumab|mesh-list
83086894|NCT01817452|Pertuzumab|pertuzumab|mesh-list
83086895|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086896|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086897|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086898|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086899|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086900|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086901|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086902|NCT01815242|Paclitaxel|paclitaxel|mesh-list
83086903|NCT01815242|Carboplatin|carboplatin|mesh-list
83086904|NCT01815242|Gemcitabine|gemcitabine|mesh-list
83086905|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086906|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086907|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086908|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086909|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086910|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086911|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086912|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
83086913|NCT01802749|Paclitaxel|paclitaxel|mesh-list
83086914|NCT01802749|Bevacizumab|bevacizumab|mesh-list
83086915|NCT01802749|Carboplatin|carboplatin|mesh-list
83086916|NCT01802749|Gemcitabine|gemcitabine|mesh-list
83086917|NCT01802749|Doxorubicin|doxorubicin|mesh-list
83086918|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83086919|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086920|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086921|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086922|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086923|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086924|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086925|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086926|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83086927|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83086928|NCT01802749|Growth Substances|growth substances|mesh-ancestor
83086929|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086930|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
83086931|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086932|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
83086933|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086934|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83086935|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086936|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086937|NCT01801904|Panitumumab|panitumumab|mesh-list
83086938|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086939|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086940|NCT01779206|Paclitaxel|paclitaxel|mesh-list
83086941|NCT01779206|Docetaxel|docetaxel|mesh-list
83086942|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
83086943|NCT01779206|Epirubicin|epirubicin|mesh-list
83086944|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086945|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086946|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086947|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086948|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83086949|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086950|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83086951|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
83086952|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086953|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83086954|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83086955|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
83086956|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83086957|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83086958|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83086959|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83086960|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086961|NCT01745965|Trastuzumab|trastuzumab|mesh-list
83086962|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086963|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086964|NCT01706120|Paclitaxel|paclitaxel|mesh-list
83086965|NCT01706120|Bevacizumab|bevacizumab|mesh-list
83086966|NCT01706120|Carboplatin|carboplatin|mesh-list
83086967|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83086968|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086969|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
83086970|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
83086971|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
83221019|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086972|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086973|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83086974|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83086975|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83086976|NCT01706120|Growth Substances|growth substances|mesh-ancestor
83086977|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086978|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
83086979|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
83086980|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83086981|NCT01682941|Estrogens|estrogens|mesh-ancestor
83086982|NCT01682941|Hormones|hormones|mesh-ancestor
83086983|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83086984|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83086985|NCT01656551|Gemcitabine|gemcitabine|mesh-list
83086986|NCT01656551|Pemetrexed|pemetrexed|mesh-list
83086987|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83086988|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83086989|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
83389673|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83086990|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83086991|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83086992|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83086993|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83086994|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
83086995|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
83086996|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83086997|NCT01649674|Cathartics|cathartics|mesh-ancestor
83086998|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83086999|NCT01628211|Leucovorin|leucovorin|mesh-list
83087000|NCT01628211|Folic Acid|folic acid|mesh-list
83087001|NCT01628211|Fluorouracil|fluorouracil|mesh-list
83087002|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
83087003|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
83087004|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
83087005|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087006|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83087007|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087008|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83087009|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
83087010|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087011|NCT01628211|Antidotes|antidotes|mesh-ancestor
83087012|NCT01628211|Protective Agents|protective agents|mesh-ancestor
83087013|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
83087014|NCT01628211|Vitamins|vitamins|mesh-ancestor
83087015|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
83087016|NCT01628211|Hematinics|hematinics|mesh-ancestor
83087017|NCT01593488|Cytarabine|cytarabine|mesh-list
83087018|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83087019|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
83087020|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087021|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087022|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
83087023|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087024|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83087025|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
83087026|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087027|NCT01405586|Gemcitabine|gemcitabine|mesh-list
83087028|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087029|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83087030|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
83087031|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087032|NCT01309230|Immunomodulating Agents|immunomodulating agents|mesh-list
83087033|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
83087034|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087035|NCT01238692|Rituximab|rituximab|mesh-list
83087036|NCT01238692|Panobinostat|panobinostat|mesh-list
83087037|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087038|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087039|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
83087040|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087041|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83087042|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83087043|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087044|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087045|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
83087046|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83087047|NCT01209871|Antibodies|antibodies|mesh-list
83087048|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
83087049|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087050|NCT01042379|Metformin|metformin|mesh-list
83087051|NCT01042379|Paclitaxel|paclitaxel|mesh-list
83087052|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83087053|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83087054|NCT01042379|Carboplatin|carboplatin|mesh-list
83087055|NCT01042379|Doxorubicin|doxorubicin|mesh-list
83087056|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
83087057|NCT01042379|Trastuzumab|trastuzumab|mesh-list
83087058|NCT01042379|Irinotecan|irinotecan|mesh-list
83087059|NCT01042379|Durvalumab|durvalumab|mesh-list
83087060|NCT01042379|Letrozole|letrozole|mesh-list
83087061|NCT01042379|Olaparib|olaparib|mesh-list
83087062|NCT01042379|Pertuzumab|pertuzumab|mesh-list
83087063|NCT01042379|Veliparib|veliparib|mesh-list
83087064|NCT01042379|Cemiplimab|cemiplimab|mesh-list
83087065|NCT01042379|Talazoparib|talazoparib|mesh-list
83087066|NCT01042379|Dostarlimab|dostarlimab|mesh-list
83087067|NCT01042379|Trebananib|trebananib|mesh-list
83087068|NCT01042379|Tucatinib|tucatinib|mesh-list
83087069|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83087070|NCT01042379|SGN-LIV1A|sgn-liv1a|mesh-list
83389674|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83087071|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83087072|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087073|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
83087074|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
83087075|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
83483502|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83087076|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087077|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83087078|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087079|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83087080|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83087081|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83087082|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087083|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087084|NCT01042379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83087085|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83087086|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
83087087|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83087088|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83087089|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83087090|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
83087091|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087092|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83087093|NCT01042379|Immunotoxins|immunotoxins|mesh-ancestor
83087094|NCT01042379|Immunoconjugates|immunoconjugates|mesh-ancestor
83087095|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83087096|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83087097|NCT01042379|Growth Substances|growth substances|mesh-ancestor
83087098|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
83087099|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83087100|NCT00996983|Ziconotide|ziconotide|mesh-list
83087101|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83087102|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83087103|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087104|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83087105|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087106|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83087107|NCT00996983|Protective Agents|protective agents|mesh-ancestor
83087108|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83087109|NCT00996983|Analgesics|analgesics|mesh-ancestor
83087110|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
83087111|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087112|NCT00660842|Paclitaxel|paclitaxel|mesh-list
83087113|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83087114|NCT00660842|Carboplatin|carboplatin|mesh-list
83087115|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83087116|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087117|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
83087118|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
83087119|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
83087120|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087121|NCT00657878|Paclitaxel|paclitaxel|mesh-list
83087122|NCT00657878|Carboplatin|carboplatin|mesh-list
83087123|NCT00657878|Gemcitabine|gemcitabine|mesh-list
83087124|NCT00657878|Doxorubicin|doxorubicin|mesh-list
83087125|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83087126|NCT00657878|Topotecan|topotecan|mesh-list
83087127|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83087128|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087129|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
83087130|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
83087131|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
83087132|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087133|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83087134|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
83087135|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83087136|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83087137|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83087138|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087139|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83087140|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
83087141|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83087142|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83087143|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83389675|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
83087144|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087146|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087147|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087148|NCT00526396|Cisplatin|cisplatin|mesh-list
83087149|NCT00526396|Etoposide|etoposide|mesh-list
83087150|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
83087151|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087152|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83087153|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83087154|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83087155|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087156|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087157|NCT00431704|Carboplatin|carboplatin|mesh-list
83087158|NCT00431704|Trastuzumab|trastuzumab|mesh-list
83087159|NCT00431704|Vinorelbine|vinorelbine|mesh-list
83087160|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087161|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087162|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83087163|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
83087164|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
83087165|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83087166|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087167|NCT00412022|Tamoxifen|tamoxifen|mesh-list
83087168|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
83087169|NCT00412022|Letrozole|letrozole|mesh-list
83087170|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83087171|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087172|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83087173|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83087174|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087175|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087176|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83087177|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
83087178|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087179|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087180|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83087181|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83087182|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83087183|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83087184|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
83087185|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83087186|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
83087187|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83087188|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83087189|NCT03474510|Bupivacaine|bupivacaine|mesh-list
83087190|NCT03474510|Ropivacaine|ropivacaine|mesh-list
83087191|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
83087192|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
83087193|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087194|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087195|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
83087196|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087197|NCT02470832|Itraconazole|itraconazole|mesh-list
83087198|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
83087199|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087200|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83087201|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83087202|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087203|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087204|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83087205|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
83087206|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83525256|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
83087207|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087208|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83087210|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83087211|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
83087212|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087213|NCT05258682|Expectorants|expectorants|mesh-ancestor
83087214|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
83087215|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83087216|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
83087217|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087218|NCT05258682|Protective Agents|protective agents|mesh-ancestor
83087219|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087220|NCT05258682|Antidotes|antidotes|mesh-ancestor
83087221|NCT02228031|Oxytocin|oxytocin|mesh-list
83087222|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
83087223|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83087224|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087225|NCT04458948|Azithromycin|azithromycin|mesh-list
83087226|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
83087227|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83087228|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087229|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
83087230|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83087231|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83087232|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087233|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087234|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83087235|NCT02232399|Simendan|simendan|mesh-list
83087236|NCT02232399|Milrinone|milrinone|mesh-list
83087237|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83087238|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
83087239|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83087240|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83087241|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087242|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087243|NCT02232399|Protective Agents|protective agents|mesh-ancestor
83087244|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087245|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83087246|NCT00704522|Ribavirin|ribavirin|mesh-list
83087247|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83087248|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
83087249|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087250|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
83087251|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087252|NCT04458558|Mifepristone|mifepristone|mesh-list
83087253|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83087254|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
83087255|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83087256|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087257|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83087258|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83087259|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83087260|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
83087261|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83087262|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83087263|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
83087264|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087265|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
83087266|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83087267|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83087268|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
83087269|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
83087270|NCT03930498|Antibodies|antibodies|mesh-list
83087271|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
83087272|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
83087273|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087274|NCT03817554|Dopamine|dopamine|mesh-list
83087275|NCT03817554|Pramipexole|pramipexole|mesh-list
83087276|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
83087277|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
83087278|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087279|NCT03817554|Protective Agents|protective agents|mesh-ancestor
83087280|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087281|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83087282|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83087283|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
83087284|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087285|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83087286|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
83087287|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
83087288|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087289|NCT02223819|Crizotinib|crizotinib|mesh-list
83087290|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087291|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83087292|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087293|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087294|NCT03474198|Levofloxacin|levofloxacin|mesh-list
83087295|NCT03474198|Rifampin|rifampin|mesh-list
83087296|NCT03474198|Isoniazid|isoniazid|mesh-list
83087297|NCT03474198|Linezolid|linezolid|mesh-list
83087298|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
83087299|NCT03474198|Ethambutol|ethambutol|mesh-list
83087300|NCT03474198|Rifapentine|rifapentine|mesh-list
83087301|NCT03474198|Bedaquiline|bedaquiline|mesh-list
83087302|NCT03474198|Clofazimine|clofazimine|mesh-list
83087303|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83087304|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087305|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83087306|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83087307|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83087308|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087309|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087310|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087311|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83087312|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83087313|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83087314|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
83087315|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
83087316|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83087317|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83087318|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83087319|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83087320|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83087321|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83087322|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83087323|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83087324|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83087325|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
83087326|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83087327|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83087328|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087329|NCT02723630|Lenvatinib|lenvatinib|mesh-list
83087330|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087331|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83087332|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087333|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087334|NCT02866227|TOL-463|tol-463|mesh-list
83087335|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087336|NCT05258136|Antibodies|antibodies|mesh-list
83087337|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83087338|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
83087339|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087340|NCT04356326|Aspirin|aspirin|mesh-list
83087341|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83087342|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83087343|NCT04356326|Analgesics|analgesics|mesh-ancestor
83087344|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
83087345|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087346|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087347|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087348|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83087349|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83087350|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83087351|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087352|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83087353|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83087354|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087355|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
83087356|NCT02224131|Aspirin|aspirin|mesh-list
83087357|NCT02224131|Clopidogrel|clopidogrel|mesh-list
83087358|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83087359|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83087360|NCT02224131|Analgesics|analgesics|mesh-ancestor
83087361|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
83087362|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087363|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087364|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087365|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83087366|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83087367|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83087368|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087369|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83087370|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83087371|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087372|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
83087373|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83087374|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83087375|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83087376|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
83087377|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087378|NCT02068586|Sunitinib|sunitinib|mesh-list
83087379|NCT02068586|Valproic Acid|valproic acid|mesh-list
83087380|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087381|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83087382|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83087383|NCT02068586|Growth Substances|growth substances|mesh-ancestor
83087384|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087385|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
83087386|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83087387|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087388|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087389|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
83087390|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
83087391|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087392|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
83087393|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83087394|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087395|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83087396|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83087397|NCT03473964|Hormones|hormones|mesh-ancestor
83087398|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087399|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087400|NCT03309644|Iodine|iodine|mesh-list
82715946|NCT00427999|Hormones|hormones|mesh-ancestor
83087401|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83087402|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087403|NCT03309644|Trace Elements|trace elements|mesh-ancestor
83087404|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
83087405|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087406|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
83087407|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
83087408|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83087409|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83087410|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087411|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83087412|NCT02008292|Physostigmine|physostigmine|mesh-list
83087413|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83087414|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087415|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087416|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
83087417|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087418|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087419|NCT02008292|Miotics|miotics|mesh-ancestor
83087420|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
83087421|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087422|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83087423|NCT03477864|Ipilimumab|ipilimumab|mesh-list
83087424|NCT03477864|Cemiplimab|cemiplimab|mesh-list
83087425|NCT03477864|Antibodies|antibodies|mesh-list
83087426|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
83087427|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83087428|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
83087429|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087430|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087431|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83087432|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087433|NCT02229045|Paclitaxel|paclitaxel|mesh-list
83087434|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83087435|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83087436|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087437|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
83087438|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
83087439|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
83087440|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087441|NCT02229123|Levetiracetam|levetiracetam|mesh-list
83087442|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
83087443|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
83087444|NCT02229201|Propofol|propofol|mesh-list
83087445|NCT02229201|Sevoflurane|sevoflurane|mesh-list
83087446|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83087447|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087448|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087449|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83087450|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
83087451|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
83087452|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83087453|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83087454|NCT02224443|Fentanyl|fentanyl|mesh-list
83087455|NCT02224443|Midazolam|midazolam|mesh-list
83087456|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
83087457|NCT02224443|Remifentanil|remifentanil|mesh-list
83087458|NCT02224443|Propofol|propofol|mesh-list
83087459|NCT02224443|Etomidate|etomidate|mesh-list
83087460|NCT02224443|Sevoflurane|sevoflurane|mesh-list
83087461|NCT02224443|Atracurium|atracurium|mesh-list
83087462|NCT02224443|Cisatracurium|cisatracurium|mesh-list
83087463|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83087464|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087465|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087466|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83087467|NCT02224443|Analgesics|analgesics|mesh-ancestor
83087468|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
83087469|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087470|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83087471|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83087472|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83087473|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
83087474|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087475|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087476|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83087477|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
83087478|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
83087479|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83087480|NCT02224443|Narcotics|narcotics|mesh-ancestor
83087481|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83087482|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83087483|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83087484|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83087485|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
83087486|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
83087487|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83087488|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83087489|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83087490|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83087491|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83087492|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83087493|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83087494|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
83087495|NCT05183126|Paclitaxel|paclitaxel|mesh-list
83087496|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83087497|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83087498|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087499|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
83087500|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
83087501|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
83087502|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087503|NCT01944800|Ticagrelor|ticagrelor|mesh-list
83087504|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83087505|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83087506|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83087507|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83087508|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83087509|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
83087510|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087511|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087512|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087513|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83087514|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83087515|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83087516|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087517|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087518|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83087519|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83087520|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087521|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
83087522|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087523|NCT02470676|Progesterone|progesterone|mesh-list
83087524|NCT02470676|Progestins|progestins|mesh-ancestor
83087525|NCT02470676|Hormones|hormones|mesh-ancestor
83087526|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087527|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087528|NCT01933724|Prednisone|prednisone|mesh-list
83087529|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
83087530|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087531|NCT01933724|Hormones|hormones|mesh-ancestor
83087532|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087533|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087534|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83087535|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087536|NCT02229747|Diclofenac|diclofenac|mesh-list
83087537|NCT02229747|Meloxicam|meloxicam|mesh-list
83087538|NCT02229747|Nimesulide|nimesulide|mesh-list
83087539|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83087540|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83087541|NCT02229747|Analgesics|analgesics|mesh-ancestor
83087542|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
83087543|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087544|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087545|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087546|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83087547|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83087548|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087549|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087550|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83087551|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83087552|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
83087553|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087554|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83087555|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
83087556|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087557|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087558|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83087559|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83087560|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83087561|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
83087562|NCT03030222|Empagliflozin|empagliflozin|mesh-list
83087563|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83087564|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087565|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83087566|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087567|NCT02232945|Oseltamivir|oseltamivir|mesh-list
83087568|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
83087569|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087570|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087571|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087572|NCT02546622|Factor VIII|factor viii|mesh-list
83087573|NCT02546622|Coagulants|coagulants|mesh-ancestor
83087574|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83087575|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83087576|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83087577|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83087578|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087579|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087580|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087582|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
83087583|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087584|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
83087585|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83087587|NCT03309566|Tenofovir|tenofovir|mesh-list
83087588|NCT03309566|Emtricitabine|emtricitabine|mesh-list
83087589|NCT03309566|Efavirenz|efavirenz|mesh-list
83087590|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
83087591|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087592|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83087593|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83087594|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087595|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087596|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83087597|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83087598|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83087599|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83087600|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83087601|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83087602|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83087603|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83087604|NCT00735657|Iodine|iodine|mesh-list
83087605|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83087606|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087607|NCT00735657|Trace Elements|trace elements|mesh-ancestor
83087608|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
83087609|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087610|NCT04030143|Aripiprazole|aripiprazole|mesh-list
83087611|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
83087612|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83087613|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83087614|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83087615|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087616|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087617|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
83087618|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
83087619|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087620|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087621|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83087622|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83087623|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
83087624|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83087625|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83087626|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83087627|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83087628|NCT02470442|Sevoflurane|sevoflurane|mesh-list
83087629|NCT02470442|Desflurane|desflurane|mesh-list
83087630|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83087631|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83087632|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
83087633|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
83087634|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087635|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087636|NCT01329939|Montelukast|montelukast|mesh-list
83087637|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83087638|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
83087639|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83087640|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
83087641|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087642|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087643|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83087644|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83087645|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087646|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
83087647|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
83087648|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83087649|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
83087650|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087655|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83087656|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83087657|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83087658|NCT02230371|Granisetron|granisetron|mesh-list
83087659|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
83087660|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
83087661|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087662|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087663|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087664|NCT02230371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83087665|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83087666|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
83087667|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087668|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087669|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
83087670|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83087671|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
83087672|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087673|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
83087674|NCT03313934|Protective Agents|protective agents|mesh-ancestor
83087675|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
83087676|NCT03313856|Antacids|antacids|mesh-ancestor
83087677|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087678|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087679|NCT05137626|Digoxin|digoxin|mesh-list
83087680|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83087681|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83087682|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087683|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087684|NCT05137626|Protective Agents|protective agents|mesh-ancestor
83087685|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087690|NCT02233023|Dopamine|dopamine|mesh-list
83087691|NCT02233023|Pramipexole|pramipexole|mesh-list
83087692|NCT02233023|Bromocriptine|bromocriptine|mesh-list
83087693|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
83087694|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
83087695|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087696|NCT02233023|Protective Agents|protective agents|mesh-ancestor
83087697|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087698|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83087699|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83087700|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
83087701|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087702|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83087703|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
83087704|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
83087705|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087706|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
83087707|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087708|NCT03710642|Prazosin|prazosin|mesh-list
83087709|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83087710|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83087711|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83087712|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83087713|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83087714|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087715|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087716|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087717|NCT02259309|Misoprostol|misoprostol|mesh-list
83087718|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83087719|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
83087720|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83087721|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087722|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83087723|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087724|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
83087725|NCT04459026|Ropivacaine|ropivacaine|mesh-list
83087726|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
83087727|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
83087728|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83525558|NCT01796665|Clindamycin|clindamycin|mesh-list
83087729|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087730|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
83087731|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087732|NCT03473418|Ketoconazole|ketoconazole|mesh-list
83087733|NCT03473418|Terconazole|terconazole|mesh-list
83087734|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
83087735|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087736|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83087737|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83087738|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087739|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087740|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83087741|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
83087742|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087743|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087744|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83087745|NCT04282278|Apatinib|apatinib|mesh-list
83087746|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087747|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83087748|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087749|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087750|NCT00705224|Interferons|interferons|mesh-list
83087751|NCT00705224|Ribavirin|ribavirin|mesh-list
83087752|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087753|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
83087754|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087755|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
83087756|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087757|NCT02457156|Octreotide|octreotide|mesh-list
83087758|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087759|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83087760|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087761|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
83087762|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
83087763|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087764|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
83087765|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
83087766|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087767|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087768|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087769|NCT02523300|Hormones|hormones|mesh-ancestor
83087770|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087771|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83087772|NCT02523300|Protective Agents|protective agents|mesh-ancestor
83087773|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
83087774|NCT02325960|Exenatide|exenatide|mesh-list
83087775|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83087776|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087777|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83087778|NCT02325960|Incretins|incretins|mesh-ancestor
83087779|NCT02325960|Hormones|hormones|mesh-ancestor
83087780|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087781|NCT05265650|Nivolumab|nivolumab|mesh-list
83087782|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087783|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087784|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83087785|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087786|NCT02234349|Pancrelipase|pancrelipase|mesh-list
83087787|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087788|NCT04458636|Prednisolone|prednisolone|mesh-list
83087789|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087790|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
83087791|NCT04458636|Hormones|hormones|mesh-ancestor
83087792|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087793|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087794|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83087795|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087796|NCT03304652|Zaleplon|zaleplon|mesh-list
83087797|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
83087798|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83087799|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087800|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087801|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
83087802|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
83087803|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087804|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087805|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83087806|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83087807|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
83087808|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
83087809|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83087810|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087811|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087812|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83087813|NCT02523144|Analgesics|analgesics|mesh-ancestor
83087814|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
83087815|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087816|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83087817|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83087818|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83087819|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
83087820|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087821|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087822|NCT03856047|Liraglutide|liraglutide|mesh-list
83087823|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83087824|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087825|NCT03856047|Incretins|incretins|mesh-ancestor
83087826|NCT03856047|Hormones|hormones|mesh-ancestor
83087827|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087828|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83087829|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83087830|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087831|NCT00704132|Incretins|incretins|mesh-ancestor
83087832|NCT00704132|Hormones|hormones|mesh-ancestor
83087833|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087834|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83087835|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
83087836|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087837|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087838|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
83087839|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83087840|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
83087841|NCT03840837|Rivastigmine|rivastigmine|mesh-list
83087842|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83087843|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087844|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087845|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
83087846|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087847|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087848|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83087849|NCT03840837|Protective Agents|protective agents|mesh-ancestor
83087850|NCT03527238|Tacrolimus|tacrolimus|mesh-list
83087851|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83087852|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
83087853|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087854|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83087855|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087856|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087857|NCT03832179|Dexamethasone|dexamethasone|mesh-list
83087858|NCT03832179|Bevacizumab|bevacizumab|mesh-list
83087859|NCT03832179|Ranibizumab|ranibizumab|mesh-list
83087860|NCT03832179|Aflibercept|aflibercept|mesh-list
83087861|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087862|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087863|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83087864|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83087865|NCT03832179|Growth Substances|growth substances|mesh-ancestor
83087866|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087867|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
83087868|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087869|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
83087870|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
83087871|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087872|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087873|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
83087874|NCT03832179|Hormones|hormones|mesh-ancestor
83087875|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087876|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83087877|NCT03123783|Nivolumab|nivolumab|mesh-list
83087878|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087879|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087880|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83087881|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087882|NCT05154396|Loperamide|loperamide|mesh-list
83087883|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
83087884|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087885|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83087886|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
83087887|NCT04740645|Coagulants|coagulants|mesh-ancestor
83087888|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83087889|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
83087890|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087891|NCT04735185|Anesthetics|anesthetics|mesh-list
83087892|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
83087893|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83087894|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087895|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
83087896|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087897|NCT02802813|Piperaquine|piperaquine|mesh-list
83087898|NCT02802813|Primaquine|primaquine|mesh-list
83087899|NCT02802813|Artenimol|artenimol|mesh-list
83087900|NCT02802813|Artemisinins|artemisinins|mesh-list
83087901|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
83087902|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83087903|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83087904|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83087905|NCT05134584|Lactulose|lactulose|mesh-list
83087906|NCT05134584|Linaclotide|linaclotide|mesh-list
83087907|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087908|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83087909|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
83087910|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087911|NCT05633277|Polidocanol|polidocanol|mesh-list
82716474|NCT02578550|Tenofovir|tenofovir|mesh-list
83087912|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83087913|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83087914|NCT04692831|Pertuzumab|pertuzumab|mesh-list
83087915|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087916|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087917|NCT03312140|Choline|choline|mesh-list
83087918|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
83087919|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83087920|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
83087921|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087922|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087923|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83087924|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
83087925|NCT02233179|Calpastatin|calpastatin|mesh-list
83087926|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83087927|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
83087928|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087929|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087930|NCT04596657|Vitamin D|vitamin d|mesh-list
83087931|NCT04596657|Vitamins|vitamins|mesh-ancestor
83087932|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
83087933|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087934|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83087935|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83087936|NCT03311984|Dalteparin|dalteparin|mesh-list
83087937|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
83087938|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83087939|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83087940|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087941|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
83087942|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83087943|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
83087944|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087945|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
83087946|NCT03311906|Protective Agents|protective agents|mesh-ancestor
83087947|NCT04554459|Ponatinib|ponatinib|mesh-list
83087948|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087949|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83087950|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087951|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087952|NCT03311750|Panitumumab|panitumumab|mesh-list
83525559|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
83087953|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087954|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087955|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
83087956|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83087957|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087958|NCT03311672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83087959|NCT03311672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087960|NCT03311516|Insulin|insulin|mesh-list
83087961|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83087962|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83087963|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087964|NCT04528329|Dexamethasone|dexamethasone|mesh-list
83087965|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
83087966|NCT04528329|BB 1101|bb 1101|mesh-list
83087967|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83087968|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
83087969|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
83087970|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087971|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087972|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83087973|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
83087974|NCT04528329|Hormones|hormones|mesh-ancestor
83087975|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087976|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83087977|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087978|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
83087979|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83087980|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087981|NCT02811939|Dronabinol|dronabinol|mesh-list
83087982|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
83087983|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83087984|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83087985|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83087986|NCT02811939|Analgesics|analgesics|mesh-ancestor
83087987|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
83087988|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83087989|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83087990|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83087991|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83087992|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83087993|NCT02811939|Hormones|hormones|mesh-ancestor
83087994|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83087995|NCT01329549|Carboplatin|carboplatin|mesh-list
83087996|NCT01329549|Nintedanib|nintedanib|mesh-list
83087997|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83087998|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83087999|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088000|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088001|NCT02234739|Voriconazole|voriconazole|mesh-list
83088002|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
83088003|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088004|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83088005|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83088006|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088007|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088008|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83088009|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
83088010|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088011|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088012|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83088013|NCT02736474|Naltrexone|naltrexone|mesh-list
83088014|NCT02736474|Bupropion|bupropion|mesh-list
83088015|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83088016|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83088017|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088018|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
83088019|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088020|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83088021|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
83088022|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83088023|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83088024|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83088025|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088038|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
83088039|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088040|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83088041|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83088042|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83088043|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088044|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088045|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83088046|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83088047|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088048|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088049|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83088050|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83088051|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
83088052|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83088053|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
83088054|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
83088055|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
83088056|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83088057|NCT03712371|Chitosan|chitosan|mesh-list
83088058|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83088059|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83088060|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
83088061|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088062|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83088063|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
83088064|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
83088065|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
83088066|NCT03712371|Coagulants|coagulants|mesh-ancestor
83088067|NCT03472950|Ranolazine|ranolazine|mesh-list
83088068|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83088069|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088070|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088083|NCT03706521|Lorecivivint|lorecivivint|mesh-list
83088084|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83088085|NCT02259543|Tetracycline|tetracycline|mesh-list
83088086|NCT02259543|Citric Acid|citric acid|mesh-list
83088087|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
83088088|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83088089|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088090|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83088091|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088092|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088093|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
83088094|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83088095|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
83088096|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
83088097|NCT03301454|Paclitaxel|paclitaxel|mesh-list
83088098|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088099|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088100|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088102|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088103|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088104|NCT04343235|Labetalol|labetalol|mesh-list
83088105|NCT04343235|Furosemide|furosemide|mesh-list
83088106|NCT04343235|Diuretics|diuretics|mesh-ancestor
83088107|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
83088108|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088109|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83088110|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088111|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088112|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83088113|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83088114|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088115|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088116|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83088117|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
83088118|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
83088119|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088120|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83088121|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83088122|NCT05727410|Docetaxel|docetaxel|mesh-list
83088123|NCT05727410|Nivolumab|nivolumab|mesh-list
83088124|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088125|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088126|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088127|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088128|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088129|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83088130|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83088131|NCT02467010|Dexamethasone|dexamethasone|mesh-list
83088132|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
83088133|NCT02467010|Bortezomib|bortezomib|mesh-list
83088134|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83088135|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
83088136|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088137|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83088138|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83088139|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
83088140|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088141|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088142|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83088143|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83088144|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
83088145|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
83088146|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088147|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088148|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
83088149|NCT02467010|Hormones|hormones|mesh-ancestor
83088150|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088151|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83088152|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83088153|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83088154|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83088155|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088156|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088157|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088158|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088159|NCT02232555|Analgesics|analgesics|mesh-ancestor
83088160|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
83088161|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088162|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
83088163|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83088164|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
83088165|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83088166|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83088167|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83088168|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088169|NCT00702650|Testosterone|testosterone|mesh-list
83088170|NCT00702650|Androgens|androgens|mesh-ancestor
83088171|NCT00702650|Hormones|hormones|mesh-ancestor
83088172|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088173|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088174|NCT03230916|Relebactam|relebactam|mesh-list
83088175|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83088176|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088177|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088178|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83088179|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088180|NCT04210713|Minocycline|minocycline|mesh-list
83088181|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83088182|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088183|NCT01337115|Ropivacaine|ropivacaine|mesh-list
83088184|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
83088185|NCT01337115|Anesthetics|anesthetics|mesh-list
83088186|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088187|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088188|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
83088189|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088190|NCT03761784|Tretinoin|tretinoin|mesh-list
83088191|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83088192|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83088193|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088194|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
83088195|NCT03300440|Vitamins|vitamins|mesh-list
83088197|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
83088198|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
83088199|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088201|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83088202|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
83088203|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088204|NCT02467556|Morphine|morphine|mesh-list
83088205|NCT02467556|Memantine|memantine|mesh-list
83088206|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83088207|NCT02467556|Narcotics|narcotics|mesh-ancestor
83088208|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088209|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088210|NCT02467556|Analgesics|analgesics|mesh-ancestor
83088211|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
83088212|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088213|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83088214|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83088215|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
83088216|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088217|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088218|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83088219|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83088220|NCT02262585|Telmisartan|telmisartan|mesh-list
83088221|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83088222|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83088223|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83088224|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088225|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83088226|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
83088227|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83088228|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83088229|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83088230|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
83088231|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83088232|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088233|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83088234|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83088235|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83088236|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83088237|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088238|NCT02602353|Loxoprofen|loxoprofen|mesh-list
83088239|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83088240|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83088241|NCT02602353|Analgesics|analgesics|mesh-ancestor
83088242|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
83088243|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088244|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088245|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83088246|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83088247|NCT04983498|Ondansetron|ondansetron|mesh-list
83088248|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
83088249|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
83088250|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088251|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088252|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088253|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
83088254|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
83088255|NCT04983498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83088256|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83088257|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
83088258|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088259|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088260|NCT03300362|Vaccines|vaccines|mesh-list
83088261|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
83088262|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088263|NCT02467400|Propranolol|propranolol|mesh-list
83088264|NCT02467400|Atenolol|atenolol|mesh-list
83088265|NCT02467400|Nebivolol|nebivolol|mesh-list
83088266|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83088267|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83088268|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088269|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088270|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088271|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088272|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83088273|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83088274|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
83088275|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
83088276|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
83088277|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088278|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83088279|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83088280|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83088281|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83088282|NCT04002141|Letrozole|letrozole|mesh-list
83088283|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088284|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83088285|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83088286|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088287|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088288|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83088289|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
83088290|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088291|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088292|NCT03308708|Norepinephrine|norepinephrine|mesh-list
83088293|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83088294|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83088295|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088296|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088297|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088298|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088299|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
83088300|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
83088301|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088302|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83088303|NCT02262741|Durvalumab|durvalumab|mesh-list
83088304|NCT02262741|Tremelimumab|tremelimumab|mesh-list
83088305|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83088306|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088307|NCT00250341|Beclomethasone|beclomethasone|mesh-list
83088308|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83088309|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83088310|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
83088311|NCT00250341|Hormones|hormones|mesh-ancestor
83088312|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088313|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088314|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83088315|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
83088316|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83088317|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
83088318|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088319|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
83088320|NCT05156970|Carboplatin|carboplatin|mesh-list
83088321|NCT05156970|Docetaxel|docetaxel|mesh-list
83088322|NCT05156970|Apatinib|apatinib|mesh-list
83088323|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088324|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088325|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088326|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088327|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088328|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83088329|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088331|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83088332|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
83088333|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088334|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088335|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83088336|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
83088337|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83088338|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
83088339|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088340|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088341|NCT02234037|Decitabine|decitabine|mesh-list
83088342|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83088343|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
83088344|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088345|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088346|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088347|NCT02234193|Lidocaine|lidocaine|mesh-list
83088348|NCT02234193|Epinephrine|epinephrine|mesh-list
83088349|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
83088351|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088352|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088353|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
83088354|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088355|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83088356|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83088357|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83088358|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088359|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088360|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83088361|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83088362|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088363|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088364|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83088365|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83088366|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
83088367|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83088368|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
83088369|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
83088370|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
83088371|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83088372|NCT04476459|Apatinib|apatinib|mesh-list
83088373|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088374|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83088375|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088376|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088377|NCT02262897|Paclitaxel|paclitaxel|mesh-list
83088378|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83088379|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088380|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088381|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088382|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088383|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088384|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088385|NCT02723006|Nivolumab|nivolumab|mesh-list
83088386|NCT02723006|Ipilimumab|ipilimumab|mesh-list
83088387|NCT02723006|Vedolizumab|vedolizumab|mesh-list
83088388|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83088389|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088390|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83088391|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088392|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088393|NCT03308552|Paclitaxel|paclitaxel|mesh-list
83088394|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83088395|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088396|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088397|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088399|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088400|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088401|NCT03308084|Dexamethasone|dexamethasone|mesh-list
83088402|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
83088403|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83088404|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83088405|NCT03308084|Prednisolone|prednisolone|mesh-list
83088406|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
83088407|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83088408|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
83088409|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83088410|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
83088411|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
83088412|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088413|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088414|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088415|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
83088416|NCT03308084|Hormones|hormones|mesh-ancestor
83088417|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088418|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83088419|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088420|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83088421|NCT03308084|Protective Agents|protective agents|mesh-ancestor
83088422|NCT00702962|Carboplatin|carboplatin|mesh-list
83088423|NCT00702962|Etoposide|etoposide|mesh-list
83088424|NCT00702962|Vorinostat|vorinostat|mesh-list
83088425|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088426|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088427|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83088428|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83088429|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088430|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088431|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83088433|NCT01379508|Telbivudine|telbivudine|mesh-list
83088434|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
83088435|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088436|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83088437|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83088438|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088439|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088440|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83088441|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83088442|NCT05162430|Propofol|propofol|mesh-list
83088443|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83088444|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088445|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088446|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83088447|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
83088448|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
83088449|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
83088450|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83088451|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088452|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088453|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83088454|NCT05031026|Analgesics|analgesics|mesh-ancestor
83088455|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
83088456|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088457|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83088458|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83088459|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83088460|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088461|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088462|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088463|NCT02264769|Carbetocin|carbetocin|mesh-list
83088464|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
83088465|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83088466|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088467|NCT02264847|Clomiphene|clomiphene|mesh-list
83088468|NCT02264847|Enclomiphene|enclomiphene|mesh-list
83088469|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
83088470|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83088471|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83088472|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
83088478|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83088480|NCT04965506|Dulaglutide|dulaglutide|mesh-list
83088481|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83088482|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088483|NCT03469128|Sertraline|sertraline|mesh-list
83088484|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
83088485|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83088486|NCT03469128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83088487|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83088488|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088489|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088490|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088491|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
83088492|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088493|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
83088494|NCT05161572|Tegafur|tegafur|mesh-list
83088495|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088496|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83088497|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
83088498|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088499|NCT03472170|Lactoferrin|lactoferrin|mesh-list
83088500|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088501|NCT04156698|Docetaxel|docetaxel|mesh-list
83088502|NCT04156698|Capecitabine|capecitabine|mesh-list
83088503|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088504|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088505|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088506|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088507|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088508|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83088509|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
83088510|NCT03108326|Infliximab|infliximab|mesh-list
83088511|NCT03108326|Ustekinumab|ustekinumab|mesh-list
83088512|NCT03108326|Vedolizumab|vedolizumab|mesh-list
83088513|NCT03108326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83088514|NCT03108326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83088515|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83088516|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83088517|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088518|NCT04964024|Antibodies|antibodies|mesh-list
83088519|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
83088520|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088528|NCT02466542|Esmolol|esmolol|mesh-list
83088529|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83088530|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83088531|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83088532|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088533|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088534|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088535|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088536|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
83088537|NCT05067270|Treprostinil|treprostinil|mesh-list
83088538|NCT05067270|Citric Acid|citric acid|mesh-list
83088539|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
83088540|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
83088541|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83088542|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
83088543|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
83088544|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088545|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83088546|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088547|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83088548|NCT01437735|Montelukast|montelukast|mesh-list
83088549|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83088550|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83088551|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83088552|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
83088553|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088554|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088555|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83088556|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83088557|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088558|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
83088559|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83088560|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088561|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088562|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83088563|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83088564|NCT03470610|Estradiol|estradiol|mesh-list
83088565|NCT03470610|Progesterone|progesterone|mesh-list
83088566|NCT03470610|Estrogens|estrogens|mesh-ancestor
83088567|NCT03470610|Hormones|hormones|mesh-ancestor
83088568|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088569|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088570|NCT03470610|Progestins|progestins|mesh-ancestor
83088571|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
83088572|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83088573|NCT03307148|Paclitaxel|paclitaxel|mesh-list
83088574|NCT03307148|Gemcitabine|gemcitabine|mesh-list
83088575|NCT03307148|Tretinoin|tretinoin|mesh-list
83088576|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088577|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088578|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088579|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088580|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088581|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088582|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83088583|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
83088584|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
83088585|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
83088586|NCT03984591|Eplerenone|eplerenone|mesh-list
83088587|NCT03984591|Spironolactone|spironolactone|mesh-list
83088588|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83088589|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
83088590|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088591|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088592|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83088594|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
83088595|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83088596|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83088597|NCT03470532|Epinephrine|epinephrine|mesh-list
83088598|NCT03470532|Racepinephrine|racepinephrine|mesh-list
83088599|NCT03470532|Mepivacaine|mepivacaine|mesh-list
83088600|NCT03470532|Carticaine|carticaine|mesh-list
83088601|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
83088602|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83088603|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83088604|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088605|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088606|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088607|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088608|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83088609|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83088610|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
83088611|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088612|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83088613|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
83088614|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
83088615|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
83088616|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83088617|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
83088618|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
83088619|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088620|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
83088621|NCT02502669|Finasteride|finasteride|mesh-list
83088622|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83088623|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83088624|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088625|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088626|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
83088627|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088628|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088629|NCT02502669|Urological Agents|urological agents|mesh-ancestor
83088630|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83088631|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
83088632|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
83088634|NCT03306836|Calcium heparin|calcium heparin|mesh-list
83088635|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
83088636|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83088637|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83088638|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088639|NCT04487145|Piperaquine|piperaquine|mesh-list
83088640|NCT04487145|Artenimol|artenimol|mesh-list
83088641|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
83088642|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83088643|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83088644|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088645|NCT04780568|Osimertinib|osimertinib|mesh-list
83088646|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088647|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83088648|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088649|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088650|NCT00709956|Iloprost|iloprost|mesh-list
83088651|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83088652|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
83088653|NCT02268201|Tacrolimus|tacrolimus|mesh-list
83088654|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83088655|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
83088656|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088657|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83088658|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088659|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088660|NCT03306602|Z 350|z 350|mesh-list
83088661|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83088662|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83088663|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088664|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088665|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
83088666|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088667|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088668|NCT02268279|Solithromycin|solithromycin|mesh-list
83088669|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83088670|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088671|NCT02268357|Propranolol|propranolol|mesh-list
83088672|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83088673|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83088674|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83088675|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088676|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088677|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088678|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83088679|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83088680|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
83088681|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
83088682|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088683|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83088684|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088685|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088686|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
83088687|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
83088688|NCT02466464|Coagulants|coagulants|mesh-ancestor
83088689|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
83088690|NCT01423149|Combretastatin|combretastatin|mesh-list
83088691|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088692|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088693|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088694|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088695|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088696|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088697|NCT03470454|Linagliptin|linagliptin|mesh-list
83088698|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83088699|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088700|NCT03470454|Incretins|incretins|mesh-ancestor
83088701|NCT03470454|Hormones|hormones|mesh-ancestor
83088702|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088703|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83088704|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
83088705|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088706|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088707|NCT03130842|Midazolam|midazolam|mesh-list
83088708|NCT03130842|Alprazolam|alprazolam|mesh-list
83088709|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83088710|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83088711|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088712|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088713|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83088714|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83088715|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83088716|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83088717|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
83088718|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
83088719|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
83088720|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
83088721|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088722|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088723|NCT03130764|Durvalumab|durvalumab|mesh-list
83088724|NCT03130764|Tremelimumab|tremelimumab|mesh-list
83088725|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83088726|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088727|NCT01234779|Olanzapine|olanzapine|mesh-list
83088728|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
83088729|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
83088730|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088731|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088732|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088733|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83088734|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83088735|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088736|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83088737|NCT01234779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83525560|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
83088738|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83088739|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088740|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088741|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088742|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
83088744|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
83088745|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
83088746|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
83088747|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088748|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088749|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
83088750|NCT03306368|Narcotics|narcotics|mesh-ancestor
83088751|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088752|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088753|NCT03306368|Analgesics|analgesics|mesh-ancestor
83088754|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
83088755|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088756|NCT02840136|Meropenem|meropenem|mesh-list
83088757|NCT02840136|Tazobactam|tazobactam|mesh-list
83088758|NCT02840136|Piperacillin|piperacillin|mesh-list
83088759|NCT02840136|Ceftazidime|ceftazidime|mesh-list
83088760|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83088761|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83088762|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088763|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83088764|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088765|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088766|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83088767|NCT03306290|Cefoxitin|cefoxitin|mesh-list
83088768|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088769|NCT01616199|Vemurafenib|vemurafenib|mesh-list
83088770|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088771|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83088772|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088773|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088774|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
83088775|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83088776|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83088777|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83088778|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088779|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088780|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
83088781|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088782|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088783|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83088784|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088785|NCT04506138|Paclitaxel|paclitaxel|mesh-list
83088786|NCT04506138|Carboplatin|carboplatin|mesh-list
83088787|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088788|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088789|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088790|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088791|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088792|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088793|NCT01407003|Licogliflozin|licogliflozin|mesh-list
83088794|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83088795|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088796|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83088797|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088798|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83088799|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
83088800|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088801|NCT01232595|Vancomycin|vancomycin|mesh-list
83088802|NCT01232595|LFF571|lff571|mesh-list
83088803|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83088804|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088805|NCT01231347|Gemcitabine|gemcitabine|mesh-list
83088806|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83088807|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83088808|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
83088809|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088810|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088811|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
83088812|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088813|NCT01230957|Vaccines|vaccines|mesh-list
83088814|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
83088815|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088816|NCT01228383|Vaccines|vaccines|mesh-list
83088817|NCT01228383|Antibodies|antibodies|mesh-list
83088818|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83088819|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
83088820|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
83088821|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83088822|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83088823|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
83088824|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088825|NCT03305978|Ivermectin|ivermectin|mesh-list
83088826|NCT03305978|Selamectin|selamectin|mesh-list
83088827|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83088828|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088829|NCT01594983|Fenofibrate|fenofibrate|mesh-list
83088830|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83088831|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
83088832|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088833|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83088834|NCT03305510|Vitamin D|vitamin d|mesh-list
83088835|NCT03305510|Vitamins|vitamins|mesh-ancestor
83088836|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
83088837|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088838|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83088839|NCT01224795|Peramivir|peramivir|mesh-list
83088840|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
83088841|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088842|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088843|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088844|NCT01402401|Trastuzumab|trastuzumab|mesh-list
83088845|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83088846|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088847|NCT02720510|Dexamethasone|dexamethasone|mesh-list
83088848|NCT02720510|Lenalidomide|lenalidomide|mesh-list
83088849|NCT02720510|Bortezomib|bortezomib|mesh-list
83088850|NCT02720510|Panobinostat|panobinostat|mesh-list
83088851|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83088852|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
83088853|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
83088854|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088855|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088856|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088857|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
83088858|NCT02720510|Hormones|hormones|mesh-ancestor
83088859|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088860|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83088861|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088862|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
83088863|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83088864|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83088865|NCT02720510|Growth Substances|growth substances|mesh-ancestor
83088866|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
83088867|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83088868|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088869|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088870|NCT01220271|Temozolomide|temozolomide|mesh-list
83088871|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83088872|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
83088873|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088874|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088875|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
83088876|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83088877|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
83088878|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83088879|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
83088880|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088881|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088882|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
83088883|NCT01205061|Lidocaine|lidocaine|mesh-list
83088884|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
83088885|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
83088886|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088887|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088888|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
83088889|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088890|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83088891|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83088892|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83088893|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088894|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088896|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83088897|NCT01204749|Trebananib|trebananib|mesh-list
83088898|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83088899|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83088900|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088901|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83088902|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83088903|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83088904|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088905|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83088906|NCT01204749|Growth Substances|growth substances|mesh-ancestor
83088907|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088908|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
83088909|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83088910|NCT02466698|Metronidazole|metronidazole|mesh-list
83088911|NCT02466698|Vancomycin|vancomycin|mesh-list
83088912|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83088913|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83088914|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088915|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
83088916|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83088917|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83088918|NCT02466698|Laxatives|laxatives|mesh-ancestor
83088919|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83088920|NCT02720198|Milnacipran|milnacipran|mesh-list
83088921|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83088922|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
83088923|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
83088924|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83088925|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83088927|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83088928|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088929|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83088930|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83088931|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83088932|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088933|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83088934|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83088935|NCT02720198|Analgesics|analgesics|mesh-ancestor
83088936|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
83088937|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83088938|NCT01193361|Interferons|interferons|mesh-list
83088939|NCT01193361|Ribavirin|ribavirin|mesh-list
83088940|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
83088941|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
83088942|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83088943|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088944|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
83088945|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088946|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
83088947|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088948|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
83088949|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088950|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83088951|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83088952|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088953|NCT02263677|Incretins|incretins|mesh-ancestor
83088954|NCT02263677|Hormones|hormones|mesh-ancestor
83088955|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83088956|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83088957|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
83088958|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088959|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088960|NCT01390545|Veltuzumab|veltuzumab|mesh-list
83088961|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088962|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83088963|NCT01591473|Poly I-C|poly i-c|mesh-list
83088964|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
83088965|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088966|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
83088967|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
83088968|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83088969|NCT01192035|Ritonavir|ritonavir|mesh-list
83088970|NCT01192035|Lopinavir|lopinavir|mesh-list
83088971|NCT01192035|Nevirapine|nevirapine|mesh-list
83088972|NCT01192035|Efavirenz|efavirenz|mesh-list
83088973|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83088974|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83088975|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
83088976|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83088977|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83088978|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83088979|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83088980|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
83088981|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088982|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83088983|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83088984|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83088985|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83088986|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83088987|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83088988|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83088989|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83088990|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83088991|NCT01384383|Ledipasvir|ledipasvir|mesh-list
83088992|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
83088993|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83088994|NCT01557777|Navitoclax|navitoclax|mesh-list
83088995|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088996|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
83088997|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83088998|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83088999|NCT02268825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83089000|NCT02268825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089001|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83089002|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83089003|NCT02268903|Furosemide|furosemide|mesh-list
83089004|NCT02268903|Diuretics|diuretics|mesh-list
83089005|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
83089006|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089007|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83089008|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83089009|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089010|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83089011|NCT01369095|Escitalopram|escitalopram|mesh-list
83089012|NCT01369095|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83089013|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83089014|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83089015|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089016|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089017|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
83089018|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089019|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089020|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
83089021|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83089022|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83089023|NCT01369095|Analgesics|analgesics|mesh-ancestor
83089024|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
83089025|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
83089026|NCT02266173|Pertuzumab|pertuzumab|mesh-list
83089027|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089028|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089029|NCT01168713|Levofloxacin|levofloxacin|mesh-list
83089030|NCT01168713|Solithromycin|solithromycin|mesh-list
83089031|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83089032|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089033|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83089034|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83089035|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83089036|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089037|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089038|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089039|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83089040|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83089041|NCT02269293|Paclitaxel|paclitaxel|mesh-list
83089042|NCT02269293|Carboplatin|carboplatin|mesh-list
83089043|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83089044|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089045|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
83089046|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
83089047|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
83089048|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089049|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83089050|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
83089051|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089052|NCT01366131|Paclitaxel|paclitaxel|mesh-list
83089053|NCT01366131|Bevacizumab|bevacizumab|mesh-list
83089054|NCT01366131|Carboplatin|carboplatin|mesh-list
83089055|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83089056|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089057|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
83089058|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
83089059|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
83089060|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089061|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089062|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83089063|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83089064|NCT01366131|Growth Substances|growth substances|mesh-ancestor
83089065|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089066|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
83089067|NCT01365195|Ketamine|ketamine|mesh-list
83089068|NCT01365195|Analgesics|analgesics|mesh-ancestor
83089069|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
83089070|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089071|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089072|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83089073|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83089074|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
83089075|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
83089076|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83089077|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83089078|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83089079|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089080|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089081|NCT02269449|Hemostatics|hemostatics|mesh-list
83089082|NCT02269449|Coagulants|coagulants|mesh-ancestor
83089083|NCT01160601|Paclitaxel|paclitaxel|mesh-list
83089084|NCT01160601|Carboplatin|carboplatin|mesh-list
83089085|NCT01160601|Bavituximab|bavituximab|mesh-list
83089086|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83089087|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089088|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
83089089|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
83089090|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
83089091|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089092|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089093|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
83089094|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83089095|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
83089096|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089097|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089098|NCT01356849|Atrasentan|atrasentan|mesh-list
83089099|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089100|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83089101|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83089102|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089103|NCT02266485|Pravastatin|pravastatin|mesh-list
83089104|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83089105|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83089106|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
82717615|NCT00782717|Prednisolone|prednisolone|mesh-list
83089107|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089108|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83089109|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83089111|NCT02263989|Telmisartan|telmisartan|mesh-list
83089112|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83089113|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83089114|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83089115|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089116|NCT01516203|Rifampin|rifampin|mesh-list
83089117|NCT01516203|Isoniazid|isoniazid|mesh-list
83089118|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
83089119|NCT01516203|Ethambutol|ethambutol|mesh-list
83089120|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83089121|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
83089122|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83089123|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089124|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
83089125|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83089126|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089127|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089128|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83089129|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83089130|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83089131|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83089132|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83089133|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83089134|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83089135|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83089136|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
83089137|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83089138|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
83089139|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
83089140|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089141|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089142|NCT00703118|Ribavirin|ribavirin|mesh-list
83089143|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
83089144|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83089145|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
83089146|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089147|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
83089148|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089149|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089150|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
83089152|NCT01510119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83089153|NCT01510119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83089154|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089155|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089156|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089157|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
83089158|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089159|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089160|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
83089161|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83089162|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83089163|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089164|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089165|NCT01150695|Vaccines|vaccines|mesh-list
83089166|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
83089167|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089168|NCT01302249|Timolol|timolol|mesh-list
83089169|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83089170|NCT01302249|Latanoprost|latanoprost|mesh-list
83089171|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83089172|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089173|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83089174|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83089175|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83089176|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089177|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089178|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83089179|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83089180|NCT02261636|Mesalamine|mesalamine|mesh-list
83089181|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83089182|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089183|NCT02261636|Analgesics|analgesics|mesh-ancestor
83089184|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
83089185|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089186|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089187|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089188|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089189|NCT05191706|Dexamethasone|dexamethasone|mesh-list
83089190|NCT05191706|Prednisolone|prednisolone|mesh-list
83089191|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83089192|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
83089193|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83089194|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
83089195|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83089196|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
83089197|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089198|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
83089199|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
83089200|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089201|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089202|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089203|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
83089204|NCT05191706|Hormones|hormones|mesh-ancestor
83089205|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83089206|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83089207|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089208|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83089209|NCT05191706|Protective Agents|protective agents|mesh-ancestor
83089210|NCT01493505|Paclitaxel|paclitaxel|mesh-list
83089211|NCT01493505|Carboplatin|carboplatin|mesh-list
83089212|NCT01493505|Trebananib|trebananib|mesh-list
83089214|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089215|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
83089216|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
83089217|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
83089218|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089219|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83089220|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83089221|NCT01493505|Growth Substances|growth substances|mesh-ancestor
83089222|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089223|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
83089224|NCT01301157|Calcipotriene|calcipotriene|mesh-list
83089225|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
83089226|NCT02264145|Norflurane|norflurane|mesh-list
83089227|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83089228|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
83089229|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83089230|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089231|NCT05157464|Losartan|losartan|mesh-list
83089232|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83089233|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83089234|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83089235|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83089236|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089237|NCT02264301|Puerarin|puerarin|mesh-list
83089238|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
83089239|NCT02267109|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83089240|NCT02267109|Antiviral Agents|antiviral agents|mesh-ancestor
83089241|NCT02267109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089242|NCT04476069|Ibuprofen|ibuprofen|mesh-list
83089243|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83089244|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089245|NCT04476069|Analgesics|analgesics|mesh-ancestor
83089246|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
83089247|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089248|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089249|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089250|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089251|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83089252|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089253|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089254|NCT01480479|Temozolomide|temozolomide|mesh-list
83089255|NCT01480479|Molgramostim|molgramostim|mesh-list
83089256|NCT01480479|Rindopepimut|rindopepimut|mesh-list
83089257|NCT01480479|Sargramostim|sargramostim|mesh-list
83089258|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83089259|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
83089260|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089261|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089262|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
83089263|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089264|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089265|NCT01116141|Folic Acid|folic acid|mesh-list
83089266|NCT01116141|Methotrexate|methotrexate|mesh-list
83089267|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83089268|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
83089269|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83089270|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089271|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83089272|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
83089273|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089274|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089275|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
83089276|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089277|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83089278|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089279|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
83089280|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089281|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83089282|NCT01116141|Hematinics|hematinics|mesh-ancestor
83089283|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
83089284|NCT01116141|Vitamins|vitamins|mesh-ancestor
83089285|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
83089286|NCT01280565|Dacarbazine|dacarbazine|mesh-list
83089287|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83089288|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
83089289|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089290|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089291|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
83089292|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83089293|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089294|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83089295|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
83089296|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83089297|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089298|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089299|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089300|NCT01113957|Doxorubicin|doxorubicin|mesh-list
83089301|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83089302|NCT01113957|Temozolomide|temozolomide|mesh-list
83089303|NCT01113957|Veliparib|veliparib|mesh-list
83089304|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83089305|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089306|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83089307|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83089308|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089309|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089310|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83089311|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
83089312|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83089313|NCT01111773|Lidocaine|lidocaine|mesh-list
83089314|NCT01111773|Tetracaine|tetracaine|mesh-list
83089315|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
83089316|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
83089317|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83089318|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089319|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
83089320|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089321|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83089322|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83525561|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83089323|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83089324|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83089325|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089326|NCT01280331|Morphine|morphine|mesh-list
83089327|NCT01280331|Oxycodone|oxycodone|mesh-list
83089328|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83089329|NCT01280331|Narcotics|narcotics|mesh-ancestor
83089330|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83089331|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089332|NCT01280331|Analgesics|analgesics|mesh-ancestor
83089333|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
83089334|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089335|NCT01266525|Donepezil|donepezil|mesh-list
83089336|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83089337|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089338|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089339|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
83089340|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089341|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089342|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
83089343|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
83089344|NCT01265901|Sunitinib|sunitinib|mesh-list
83089345|NCT01265901|Molgramostim|molgramostim|mesh-list
83089346|NCT01265901|Sargramostim|sargramostim|mesh-list
83089347|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
83089348|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089349|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089350|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089351|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83089352|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
83089353|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089354|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089355|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83089356|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83089357|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83089358|NCT01265901|Growth Substances|growth substances|mesh-ancestor
83089359|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
83089360|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83089361|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089363|NCT05231382|Fluorouracil|fluorouracil|mesh-list
83089364|NCT05231382|Raltitrexed|raltitrexed|mesh-list
83089365|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
83089366|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
83089367|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089368|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83089369|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089370|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089371|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
83089372|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089373|NCT05231382|Antidotes|antidotes|mesh-ancestor
83089374|NCT05231382|Protective Agents|protective agents|mesh-ancestor
83089375|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
83089376|NCT05231382|Vitamins|vitamins|mesh-ancestor
83089377|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
83089378|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83089379|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089380|NCT01262235|TKM-080301|tkm-080301|mesh-list
83089381|NCT01262235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83089382|NCT01262235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089383|NCT01262235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089384|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83089385|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
83089386|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089387|NCT01460511|Epinephrine|epinephrine|mesh-list
83089388|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83089389|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83089390|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83089391|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089392|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089393|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089394|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83089395|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83089396|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
83089397|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089398|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83089399|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
83089400|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
83089401|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
83089402|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83089403|NCT03135171|Trastuzumab|trastuzumab|mesh-list
83089404|NCT03135171|Pertuzumab|pertuzumab|mesh-list
83089405|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089406|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089407|NCT01449591|Metronidazole|metronidazole|mesh-list
83089408|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089409|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83089410|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83089411|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83089412|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83089413|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83089414|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089415|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83089416|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089417|NCT01444365|Analgesics|analgesics|mesh-ancestor
83089418|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
83089419|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089420|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089421|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089422|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089423|NCT01098435|ALKS-33|alks-33|mesh-list
83089424|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83089425|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089426|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
83089427|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089428|NCT00909597|Pioglitazone|pioglitazone|mesh-list
83089429|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83089430|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83089431|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089432|NCT00909597|Incretins|incretins|mesh-ancestor
83089433|NCT00909597|Hormones|hormones|mesh-ancestor
83089434|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83089435|NCT01077297|Tezosentan|tezosentan|mesh-list
83089436|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
83089437|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
83089438|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089440|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83089441|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83089442|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83089443|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83089444|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83089445|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
83089446|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089447|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089448|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83089449|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
83089450|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
83089451|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
83089452|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83089453|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83089454|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
83089455|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089456|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089457|NCT02718326|Aflibercept|aflibercept|mesh-list
83089458|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83089459|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83089460|NCT02718326|Growth Substances|growth substances|mesh-ancestor
83089461|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089462|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
83089463|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089464|NCT03691584|Dimercaprol|dimercaprol|mesh-list
83089465|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
83089466|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
83089467|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089468|NCT04655144|Dexamethasone|dexamethasone|mesh-list
83089469|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089470|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
83089471|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
83089472|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089473|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089474|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089475|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
83089476|NCT04655144|Hormones|hormones|mesh-ancestor
83089477|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83089478|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83089479|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089480|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83089482|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089483|NCT03600714|Interferons|interferons|mesh-list
83089484|NCT03600714|Ritonavir|ritonavir|mesh-list
83089485|NCT03600714|Lonafarnib|lonafarnib|mesh-list
83089486|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089487|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
83089488|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089489|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83089490|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83089491|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
83089492|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089493|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089494|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83089495|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83089496|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83089497|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83089498|NCT04590326|Cemiplimab|cemiplimab|mesh-list
83089499|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089500|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089501|NCT05163366|Ketamine|ketamine|mesh-list
83089502|NCT05163366|Morphine|morphine|mesh-list
83089503|NCT05163366|Analgesics|analgesics|mesh-ancestor
83089504|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
83089505|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089506|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089507|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83089508|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83089509|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
83089510|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
83089511|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83089512|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83089513|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83089514|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089515|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089516|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83089517|NCT05163366|Narcotics|narcotics|mesh-ancestor
83089518|NCT00900783|Valacyclovir|valacyclovir|mesh-list
83089519|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
83089520|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089521|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83089522|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83089523|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089524|NCT01035879|Incretins|incretins|mesh-ancestor
83089525|NCT01035879|Hormones|hormones|mesh-ancestor
83089526|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83089527|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83089528|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
83089529|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089530|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089531|NCT04978298|Phenelzine|phenelzine|mesh-list
83089532|NCT04978298|Ozanimod|ozanimod|mesh-list
83089533|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83089534|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089535|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089536|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
83089537|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089538|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
83089539|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83089540|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83089541|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089542|NCT01029873|Cisplatin|cisplatin|mesh-list
83089543|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089544|NCT01024101|Paclitaxel|paclitaxel|mesh-list
83089545|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83089546|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089547|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
83089548|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
83089549|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
83089550|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089551|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
83089552|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089553|NCT00818571|Vildagliptin|vildagliptin|mesh-list
83089554|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83089555|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089556|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83089557|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
83089558|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089559|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089560|NCT00818493|Acetaminophen|acetaminophen|mesh-list
83089561|NCT00818493|Morphine|morphine|mesh-list
83089562|NCT00818493|Oxycodone|oxycodone|mesh-list
83089563|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83089564|NCT00818493|Narcotics|narcotics|mesh-ancestor
83089565|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83089566|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089567|NCT00818493|Analgesics|analgesics|mesh-ancestor
83089568|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
83089569|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089570|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089571|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
83089572|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83089573|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83089574|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83089575|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83089576|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83089577|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089578|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83089579|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089580|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089581|NCT00892203|Sumatriptan|sumatriptan|mesh-list
83089582|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83089583|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83089584|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83089585|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
83089586|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089587|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089588|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089589|NCT00810147|BMS 708163|bms 708163|mesh-list
83089590|NCT00810147|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83089591|NCT00810147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089592|NCT00810147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089593|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
83089594|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089595|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089596|NCT04375956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83089597|NCT04375956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089598|NCT04495478|Ramucirumab|ramucirumab|mesh-list
83089599|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83089600|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089601|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
83089602|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089603|NCT04487444|Thymalfasin|thymalfasin|mesh-list
83089604|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83089605|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
83089606|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089607|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
83089608|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089609|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089610|NCT02717156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83089611|NCT02717156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089612|NCT00884715|Octreotide|octreotide|mesh-list
83089613|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089614|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83089615|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089616|NCT03603080|Metformin|metformin|mesh-list
83089617|NCT03603080|Topiramate|topiramate|mesh-list
83089618|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
83089619|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83089620|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089621|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
83089622|NCT01019187|Modafinil|modafinil|mesh-list
83089623|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83089624|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089625|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83089626|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83089627|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83089628|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089629|NCT05088876|Acetaminophen|acetaminophen|mesh-list
83089630|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089631|NCT05088876|Analgesics|analgesics|mesh-ancestor
83089632|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
83089633|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089634|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089635|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
83089636|NCT05084508|Vaccines|vaccines|mesh-list
83089637|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83089638|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
83089639|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089640|NCT01018875|Donepezil|donepezil|mesh-list
83089641|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83089642|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089643|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089644|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
83089645|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089646|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089647|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
83089648|NCT05390736|Vitamin D|vitamin d|mesh-list
83089649|NCT05390736|Vitamins|vitamins|mesh-ancestor
83089650|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
83089651|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089652|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83089653|NCT00806403|Reteplase|reteplase|mesh-list
83089654|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83089655|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83089656|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089657|NCT01007721|Fluticasone|fluticasone|mesh-list
83089658|NCT01007721|Xhance|xhance|mesh-list
83089659|NCT01007721|Montelukast|montelukast|mesh-list
83089660|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089661|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83089662|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
83089663|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089664|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089665|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83089666|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
83089667|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
83089668|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83089669|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83089670|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
83089671|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83089672|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83089673|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83089674|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089675|NCT00701558|Gemcitabine|gemcitabine|mesh-list
83089676|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83089677|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83089678|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
83089679|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089680|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089681|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83089682|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089683|NCT03233828|Aldesleukin|aldesleukin|mesh-list
83089684|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089685|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83089686|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83089687|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
83089688|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089689|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
83089691|NCT03882177|Pyridoxine|pyridoxine|mesh-list
83089692|NCT03882177|Pravastatin|pravastatin|mesh-list
83089693|NCT03882177|Vitamins|vitamins|mesh-ancestor
83089694|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
83089695|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089696|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
83089697|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83089698|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83089699|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
83089700|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089701|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83089702|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83089703|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089704|NCT01007097|Glimepiride|glimepiride|mesh-list
83089705|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83089706|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83089707|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089708|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089709|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
83089710|NCT01663402|Alirocumab|alirocumab|mesh-list
83089711|NCT01663402|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83089712|NCT01663402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83089713|NCT01663402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83089714|NCT01663402|Antimetabolites|antimetabolites|mesh-ancestor
83089715|NCT01663402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089716|NCT01663402|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83089717|NCT01663402|Protease Inhibitors|protease inhibitors|mesh-ancestor
83089718|NCT01663402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089719|NCT01663402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83089720|NCT05115903|Adalimumab|adalimumab|mesh-list
83089721|NCT05115903|Infliximab|infliximab|mesh-list
83089722|NCT05115903|Golimumab|golimumab|mesh-list
83089723|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
83089724|NCT05115903|Etanercept|etanercept|mesh-list
83089725|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83089726|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83089727|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089728|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089729|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83089730|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089731|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83089732|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089733|NCT05115903|Analgesics|analgesics|mesh-ancestor
83089734|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
83089735|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089736|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089737|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089738|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
83089740|NCT03695250|Linrodostat|linrodostat|mesh-list
83089741|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089742|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089743|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83089744|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089745|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089746|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
83089747|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83089748|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83089749|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83089750|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83089751|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089752|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
83089753|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089754|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089755|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83089756|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089757|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83089758|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
83089760|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
83089761|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089762|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
83089763|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089764|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
83089765|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089766|NCT03192566|Acetaminophen|acetaminophen|mesh-list
83089767|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089768|NCT03192566|Analgesics|analgesics|mesh-ancestor
82718273|NCT01034683|Leucovorin|leucovorin|mesh-list
83089769|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
83089770|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089771|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089772|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
83089773|NCT03296930|Ritonavir|ritonavir|mesh-list
83089774|NCT03296930|Ribavirin|ribavirin|mesh-list
83089775|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
83089776|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83089777|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83089778|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
83089779|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089780|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089781|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83089782|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83089783|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
83089784|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089785|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83089786|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83089787|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
83089788|NCT04607772|Rituximab|rituximab|mesh-list
83089789|NCT04607772|Gemcitabine|gemcitabine|mesh-list
83089790|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
83089791|NCT04607772|Lenalidomide|lenalidomide|mesh-list
83089792|NCT04607772|Venetoclax|venetoclax|mesh-list
83089793|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83089794|NCT04607772|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83089795|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089796|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089797|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
83089798|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089799|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089800|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83089801|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
83089802|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089803|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83089804|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83089805|NCT04607772|Growth Substances|growth substances|mesh-ancestor
83089806|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
83089807|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83089808|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
83089809|NCT04607772|Immunoconjugates|immunoconjugates|mesh-ancestor
83089810|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
83089812|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089813|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83089814|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089815|NCT00859521|Levetiracetam|levetiracetam|mesh-list
83089816|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
83089817|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
83089818|NCT05398770|Vitamin D|vitamin d|mesh-list
83089819|NCT05398770|Vitamins|vitamins|mesh-ancestor
83089820|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
83089821|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089822|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83089823|NCT03033914|Doxorubicin|doxorubicin|mesh-list
83089824|NCT03033914|Bleomycin|bleomycin|mesh-list
83089825|NCT03033914|Nivolumab|nivolumab|mesh-list
83089826|NCT03033914|Dacarbazine|dacarbazine|mesh-list
83089827|NCT03033914|Vinblastine|vinblastine|mesh-list
83089828|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83089829|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089830|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83089831|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83089832|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089833|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089834|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83089835|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83089836|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83089837|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
83089838|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83089839|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
83089840|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
83089841|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
83089842|NCT00843687|Risperidone|risperidone|mesh-list
83089843|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83089844|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
83089845|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089846|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089847|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089848|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83089849|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83089850|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83089851|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83089852|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83089853|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
83089854|NCT04642131|Caffeine|caffeine|mesh-list
83089855|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83089856|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089857|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83089858|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089859|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089860|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83089861|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83089862|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
83089863|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089864|NCT01001715|Fasinumab|fasinumab|mesh-list
83089865|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83089866|NCT01001715|Analgesics|analgesics|mesh-ancestor
83089867|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
83089868|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089869|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089870|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83089871|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83089872|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83089873|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83089874|NCT00789633|Gemcitabine|gemcitabine|mesh-list
83089875|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83089876|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
83089877|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089878|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089879|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
83089880|NCT00788541|Anecortave|anecortave|mesh-list
83089881|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83089882|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83089883|NCT00788541|Growth Substances|growth substances|mesh-ancestor
83089884|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089885|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
83089886|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089887|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089888|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83089889|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83089890|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83089891|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83089892|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83089893|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
83089894|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089895|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83089896|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
83089897|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089898|NCT02320292|Rituximab|rituximab|mesh-list
83089899|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83089900|NCT02320292|Antibodies|antibodies|mesh-list
83089901|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
83089902|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83089903|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
83089904|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089905|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089906|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83089907|NCT05514483|Ondansetron|ondansetron|mesh-list
83089908|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
83089909|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
83089910|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089911|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089912|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089913|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
83089914|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
83089915|NCT05514483|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83089916|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83089917|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
83089918|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089919|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089920|NCT00841815|Amlodipine|amlodipine|mesh-list
83089921|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83089922|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83089923|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83089924|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089925|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83089926|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089927|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
83089928|NCT03296306|Cisplatin|cisplatin|mesh-list
83089930|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
83089931|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83089932|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83089933|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83089934|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
83089935|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089936|NCT04440280|Expectorants|expectorants|mesh-ancestor
83089937|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
83089938|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83089939|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
83089940|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089941|NCT04440280|Protective Agents|protective agents|mesh-ancestor
83089942|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089943|NCT04440280|Antidotes|antidotes|mesh-ancestor
83089944|NCT00841659|Paroxetine|paroxetine|mesh-list
83089945|NCT00841659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83089946|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83089947|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83089948|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089949|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83089950|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
83089951|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089952|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83089953|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
83089954|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83089955|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83089956|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83089957|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089958|NCT04061252|Brodalumab|brodalumab|mesh-list
83089959|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
83089960|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
83089961|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83089962|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089963|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83089964|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089965|NCT01001091|Dexamethasone|dexamethasone|mesh-list
83089966|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83089967|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83089968|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83089969|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
83089970|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
83089971|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83089972|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089973|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83089974|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
83089975|NCT01001091|Hormones|hormones|mesh-ancestor
83089976|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83089977|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83089978|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83089979|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
83089980|NCT05076682|Efavirenz|efavirenz|mesh-list
83089981|NCT05076682|Choline|choline|mesh-list
83089982|NCT05076682|Antibodies|antibodies|mesh-list
83089983|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
83089984|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83089985|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83089986|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83089987|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83089988|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83089989|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
83089990|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83089991|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83089992|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83089993|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83089994|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83089995|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83089996|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83089997|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
83089998|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83089999|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
83090000|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83090001|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83090002|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
83090003|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83090004|NCT05076682|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83090005|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090006|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83090007|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
83090008|NCT00840879|Meloxicam|meloxicam|mesh-list
83090009|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83090010|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83090011|NCT00840879|Analgesics|analgesics|mesh-ancestor
83090012|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
83090013|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090014|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090015|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090016|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090017|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83090018|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83090019|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090020|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090021|NCT02163434|Gabapentin|gabapentin|mesh-list
83090022|NCT02163434|Metoclopramide|metoclopramide|mesh-list
83090023|NCT02163434|Analgesics|analgesics|mesh-ancestor
83090024|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
83090025|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090026|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090027|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
83090028|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83090029|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83090030|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090031|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090032|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83090033|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83090034|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090035|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090036|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
83090037|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
83090038|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
83090039|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83090040|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83090041|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83090042|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
83090044|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090045|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83090046|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83090047|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83090048|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090049|NCT00840411|Clarithromycin|clarithromycin|mesh-list
83090050|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090051|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090052|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83090053|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090054|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090055|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83090056|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83090057|NCT00840099|Amoxicillin|amoxicillin|mesh-list
83090058|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
83090059|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
83090060|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83090061|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090062|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090063|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83090064|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090065|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090066|NCT03108248|Doxorubicin|doxorubicin|mesh-list
83090067|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
83090068|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83090069|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83090070|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090071|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83090072|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83090073|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090074|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090075|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
83090077|NCT00836901|Amoxicillin|amoxicillin|mesh-list
83090078|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83090079|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
83090080|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
83090081|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090082|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090083|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83090084|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090085|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090086|NCT04460560|Terlipressin|terlipressin|mesh-list
83090087|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83090088|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83090089|NCT04537689|Cyclosporine|cyclosporine|mesh-list
83090090|NCT04537689|Methotrexate|methotrexate|mesh-list
83090092|NCT04537689|Acitretin|acitretin|mesh-list
83090093|NCT04537689|Cyclosporins|cyclosporins|mesh-list
83090094|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83090095|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
83090096|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83090097|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090098|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83090099|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
83090100|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090101|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090102|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
83090103|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090104|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83090105|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090106|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
83090107|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090108|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83090109|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
83090110|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090111|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83090112|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
83090114|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
83090115|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
83090116|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090117|NCT03295760|Vitamins|vitamins|mesh-ancestor
83090118|NCT05563012|Capecitabine|capecitabine|mesh-list
83090119|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
83090120|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83090121|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
83090122|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090123|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090124|NCT04501653|Methylphenidate|methylphenidate|mesh-list
83090125|NCT04501653|Psilocybin|psilocybin|mesh-list
83090126|NCT04501653|Psilocin|psilocin|mesh-list
83090127|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83090128|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090129|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83090130|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83090131|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090132|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090133|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
83090134|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090135|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
83090136|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090137|NCT04730206|Molnupiravir|molnupiravir|mesh-list
83090138|NCT04730206|Camostat|camostat|mesh-list
83090139|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
83090140|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090141|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090142|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83090143|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83090144|NCT04730206|Antiviral Agents|antiviral agents|mesh-ancestor
83090145|NCT04730206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090146|NCT00990327|Adenosine|adenosine|mesh-list
83090147|NCT00990327|Analgesics|analgesics|mesh-ancestor
83090148|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
83090149|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090150|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090151|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83090152|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
83090153|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83090154|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
83090155|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
83090156|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090157|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090158|NCT03050814|Leucovorin|leucovorin|mesh-list
83090159|NCT03050814|Bevacizumab|bevacizumab|mesh-list
83090160|NCT03050814|Avelumab|avelumab|mesh-list
83090161|NCT03050814|Fluorouracil|fluorouracil|mesh-list
83090162|NCT03050814|Capecitabine|capecitabine|mesh-list
83090163|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
83090164|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83090165|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090166|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83090167|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83090168|NCT03050814|Growth Substances|growth substances|mesh-ancestor
83090169|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090170|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
83090171|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
83090172|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090173|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83090174|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090175|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
83090176|NCT03050814|Antidotes|antidotes|mesh-ancestor
83090177|NCT03050814|Protective Agents|protective agents|mesh-ancestor
83090178|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
83090179|NCT03050814|Vitamins|vitamins|mesh-ancestor
83090180|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
83090181|NCT02462174|Ketamine|ketamine|mesh-list
83090182|NCT02462174|Bupivacaine|bupivacaine|mesh-list
83090183|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
83090184|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
83090185|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090186|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090187|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
83090188|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090190|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83090191|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83090192|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
83090193|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83090194|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83090195|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090196|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090197|NCT02564146|Paclitaxel|paclitaxel|mesh-list
83090198|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83090199|NCT02564146|Gemcitabine|gemcitabine|mesh-list
83090200|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83090201|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090202|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83090203|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83090204|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83090205|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090206|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83090207|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
83090208|NCT00981357|Naproxen|naproxen|mesh-list
83090209|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83090210|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83090211|NCT00981357|Analgesics|analgesics|mesh-ancestor
83090212|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
83090213|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090214|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090215|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090216|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090217|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
83090218|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83090219|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090220|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090221|NCT02462252|Cyclosporine|cyclosporine|mesh-list
83090222|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
83090223|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83090224|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83090225|NCT02462252|Cyclosporins|cyclosporins|mesh-list
83090226|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83090227|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090228|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090229|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090230|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
83090231|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090232|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
83090233|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090234|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
83090235|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090236|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83090237|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090238|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
83090239|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
83090240|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090241|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83090242|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
83090243|NCT02462252|Hormones|hormones|mesh-ancestor
83090244|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090245|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83090246|NCT02462252|Protective Agents|protective agents|mesh-ancestor
83090247|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83090248|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090249|NCT03130452|Amoxicillin|amoxicillin|mesh-list
83090250|NCT03130452|Metronidazole|metronidazole|mesh-list
83090251|NCT03130452|Clarithromycin|clarithromycin|mesh-list
83090252|NCT03130452|Lansoprazole|lansoprazole|mesh-list
83090253|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
83090254|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090255|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090256|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83090257|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83090258|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83090259|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090260|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090261|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83090262|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83090263|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83090264|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83090265|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83090266|NCT00979251|Oseltamivir|oseltamivir|mesh-list
83090267|NCT00979251|Amantadine|amantadine|mesh-list
83090268|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
83090269|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090270|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090271|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090272|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83090273|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83090274|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
83090275|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090276|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090277|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83090278|NCT00979251|Analgesics|analgesics|mesh-ancestor
83090279|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
83090280|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090281|NCT04551352|Adalimumab|adalimumab|mesh-list
83090282|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
83090283|NCT04551352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83090284|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090285|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090286|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83090287|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090288|NCT05398224|Rituximab|rituximab|mesh-list
83090289|NCT05398224|Methotrexate|methotrexate|mesh-list
83090290|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
83090291|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83090292|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090293|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
83090294|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090295|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090296|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83090297|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
83090298|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83090299|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83090300|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
83090301|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090302|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
83090303|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090304|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83090305|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090306|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83090307|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83090309|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83090310|NCT04542304|Diuretics|diuretics|mesh-ancestor
83090311|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
83090312|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090313|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83090314|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090315|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090316|NCT02463110|Sertraline|sertraline|mesh-list
83090317|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
83090318|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090319|NCT02463110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83090320|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83090321|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090322|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090323|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090324|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
83090325|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090326|NCT04495257|Nivolumab|nivolumab|mesh-list
83090327|NCT04495257|Ipilimumab|ipilimumab|mesh-list
83090328|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83090329|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090330|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83090331|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090332|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
83090333|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83090334|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090335|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090336|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83090337|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83090338|NCT05502952|Protective Agents|protective agents|mesh-ancestor
83090339|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090340|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
83090341|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83090343|NCT05457855|Fluticasone|fluticasone|mesh-list
83090344|NCT05457855|Montelukast|montelukast|mesh-list
83090345|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090346|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83090347|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
83090348|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090349|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090350|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83090351|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
83090352|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
83090353|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83090354|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83090355|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
83090356|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090357|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83090358|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83090359|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090360|NCT03910244|Pomalidomide|pomalidomide|mesh-list
83090361|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
83090362|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090363|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83090364|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83090365|NCT03910244|Growth Substances|growth substances|mesh-ancestor
83090366|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
83090367|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090368|NCT05497804|Dexamethasone|dexamethasone|mesh-list
83090369|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
83090370|NCT05497804|Lenalidomide|lenalidomide|mesh-list
83090371|NCT05497804|Daratumumab|daratumumab|mesh-list
83090372|NCT05497804|Ichthammol|ichthammol|mesh-list
83090373|NCT05497804|BB 1101|bb 1101|mesh-list
83090374|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090375|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
83090376|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
83090377|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090378|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090379|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83090380|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
83090381|NCT05497804|Hormones|hormones|mesh-ancestor
83090382|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090383|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83090384|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090385|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
83090386|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090387|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090388|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
83090389|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83090390|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83090391|NCT05497804|Growth Substances|growth substances|mesh-ancestor
83090392|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
83090393|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
83090394|NCT00835575|Mirtazapine|mirtazapine|mesh-list
83090395|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
83090396|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090397|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83090398|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
83090399|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
83090400|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090401|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090402|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090403|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83090404|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83090405|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090406|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83090407|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83090408|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83090409|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
83090410|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83090411|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83090412|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
83090413|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83090414|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83090415|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090416|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83090417|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090418|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090419|NCT03295214|Acetaminophen|acetaminophen|mesh-list
83090420|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83090421|NCT03295214|Analgesics|analgesics|mesh-ancestor
83090422|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
83090423|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090424|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090425|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
83090426|NCT04604704|Niacinamide|niacinamide|mesh-list
83090427|NCT04604704|Naltrexone|naltrexone|mesh-list
83090428|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83090429|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83090430|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090431|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
83090432|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090433|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
83090434|NCT04604704|Vitamins|vitamins|mesh-ancestor
83090435|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
83090436|NCT00776373|Cytarabine|cytarabine|mesh-list
83090437|NCT00776373|Sirolimus|sirolimus|mesh-list
83090438|NCT00776373|Etoposide|etoposide|mesh-list
83090439|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83090440|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090441|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83090442|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83090443|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090444|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090445|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83090446|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
83090447|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
83090448|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090449|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090450|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
83090451|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090452|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090453|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83090454|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
83090456|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83090457|NCT00772785|Narcotics|narcotics|mesh-ancestor
83090458|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090459|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090460|NCT00772785|Analgesics|analgesics|mesh-ancestor
83090461|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
83090462|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090463|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83090464|NCT02461706|Cannabidiol|cannabidiol|mesh-list
83090465|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
83090466|NCT05497570|Tenoxicam|tenoxicam|mesh-list
83090467|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83090468|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83090469|NCT05497570|Analgesics|analgesics|mesh-ancestor
83090470|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
83090471|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090472|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090473|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090474|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090475|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83090476|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090477|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090478|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83090479|NCT00963885|Lactams|lactams|mesh-list
83090480|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
83090481|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
82719093|NCT05554133|Proflavine|proflavine|mesh-list
83090482|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090483|NCT05497492|Lidocaine|lidocaine|mesh-list
83090484|NCT05497492|Sufentanil|sufentanil|mesh-list
83090485|NCT05497492|Propofol|propofol|mesh-list
83090486|NCT05497492|Esketamine|esketamine|mesh-list
83090487|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
83090488|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
83090489|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090490|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090491|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
83090492|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090493|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83090494|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83090495|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83090496|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090497|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090498|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83090499|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83090500|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
83090501|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83090502|NCT05497492|Narcotics|narcotics|mesh-ancestor
83090503|NCT05497492|Analgesics|analgesics|mesh-ancestor
83090504|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83090505|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
83090506|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090507|NCT00835497|Metformin|metformin|mesh-list
83090508|NCT00835497|Glipizide|glipizide|mesh-list
83090509|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83090510|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090511|NCT04279054|Morphine|morphine|mesh-list
83090512|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83090513|NCT04279054|Narcotics|narcotics|mesh-ancestor
83090514|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090515|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090516|NCT04279054|Analgesics|analgesics|mesh-ancestor
83090517|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
83090518|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090519|NCT05005689|Fluorides|fluorides|mesh-list
83090520|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
83090521|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090522|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
83090523|NCT05005689|Protective Agents|protective agents|mesh-ancestor
83090524|NCT00763503|Calcitriol|calcitriol|mesh-list
83090525|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83090526|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090527|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83090528|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090529|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090530|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83090531|NCT00763503|Vitamins|vitamins|mesh-ancestor
83090532|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
83090533|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83090534|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83090535|NCT00761709|Latanoprost|latanoprost|mesh-list
83090536|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83090537|NCT00760539|Timolol|timolol|mesh-list
83090538|NCT00760539|Travoprost|travoprost|mesh-list
83090539|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83090540|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83090541|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83090542|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83090543|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
83090544|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090545|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090546|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090547|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83090548|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83090549|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83090550|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83090551|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
83090552|NCT00759135|Finasteride|finasteride|mesh-list
83090553|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83090554|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83090555|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090556|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090557|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
83090558|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090559|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090560|NCT00759135|Urological Agents|urological agents|mesh-ancestor
83090562|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
83090563|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83090564|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090565|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090566|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83090567|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090568|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83090569|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83090570|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090571|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090572|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83090573|NCT02639910|Venetoclax|venetoclax|mesh-list
83090574|NCT02639910|Idelalisib|idelalisib|mesh-list
83090575|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090576|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090577|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090578|NCT04454580|Azacitidine|azacitidine|mesh-list
83090579|NCT04454580|Decitabine|decitabine|mesh-list
83090580|NCT04454580|Venetoclax|venetoclax|mesh-list
83090581|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83090582|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
83090583|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090584|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090585|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090586|NCT00948909|Donepezil|donepezil|mesh-list
83090587|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83090588|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090589|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090590|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
83090591|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090592|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090593|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
83090594|NCT02522910|Docetaxel|docetaxel|mesh-list
83090595|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090596|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83090597|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83090598|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83090599|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090600|NCT00948753|Maraviroc|maraviroc|mesh-list
83090601|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83090602|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83090603|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090604|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83090605|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83090606|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
83090607|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090608|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83090609|NCT05397834|Fluticasone|fluticasone|mesh-list
83090610|NCT05397834|Xhance|xhance|mesh-list
83090611|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090612|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83090613|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
83090614|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090615|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090616|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83090617|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
83090618|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83090619|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83090620|NCT03134547|Sevoflurane|sevoflurane|mesh-list
83090621|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83090622|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83090623|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
83090624|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
83090625|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090626|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090627|NCT01963208|Ganaxolone|ganaxolone|mesh-list
83090628|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
83090629|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090630|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090631|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090632|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
83090633|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
83090634|NCT00834873|Carvedilol|carvedilol|mesh-list
83090635|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83090636|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83090637|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
83090638|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090639|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090640|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090641|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83090642|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
83090643|NCT00834873|Protective Agents|protective agents|mesh-ancestor
83090644|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83090645|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090646|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83090647|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
83090648|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83090649|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83090650|NCT01377480|Posaconazole|posaconazole|mesh-list
83090651|NCT01377480|Benzonidazole|benzonidazole|mesh-list
83090652|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
83090653|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090654|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83090655|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83090656|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83090657|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83090658|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83090659|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090660|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090661|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83090662|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
83090663|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090664|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090665|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090666|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
83090668|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83090669|NCT04263909|Narcotics|narcotics|mesh-ancestor
83090670|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090671|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090672|NCT04263909|Analgesics|analgesics|mesh-ancestor
83090673|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
83090674|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090675|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83090676|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83090677|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
83090678|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
83090679|NCT01421264|Gabapentin|gabapentin|mesh-list
83090680|NCT01421264|Analgesics|analgesics|mesh-ancestor
83090681|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
83090682|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090683|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090684|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
83090685|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83090686|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83090687|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090688|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090689|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83090690|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83090691|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090692|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090693|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
83090694|NCT04415840|Acetic Acid|acetic acid|mesh-list
83090695|NCT04415840|Retinol acetate|retinol acetate|mesh-list
83090696|NCT04415840|Lugol's solution|lugol's solution|mesh-list
83090697|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090698|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090699|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83090700|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
83090701|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090702|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83090703|NCT04415840|Protective Agents|protective agents|mesh-ancestor
83090704|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090705|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
83090706|NCT04415840|Coagulants|coagulants|mesh-ancestor
83090707|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
83090708|NCT04488614|Estrogens|estrogens|mesh-list
83090709|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83090710|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090711|NCT04488614|Hormones|hormones|mesh-ancestor
83090712|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090713|NCT00834795|Carvedilol|carvedilol|mesh-list
83090714|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83090715|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83090716|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83090717|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090718|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090719|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090720|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83090721|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
83090722|NCT00834795|Protective Agents|protective agents|mesh-ancestor
83090723|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83090724|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090725|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83090726|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
83090727|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83090728|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83090729|NCT00834717|Granisetron|granisetron|mesh-list
83090730|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
83090731|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
83090732|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090733|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090734|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83090735|NCT00834717|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83090736|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83090737|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
83090738|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090739|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090740|NCT00834639|Valproic Acid|valproic acid|mesh-list
83090741|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
83090742|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090743|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090744|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
83090745|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090746|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090747|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
83090748|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83090749|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090750|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090751|NCT00834561|Lamotrigine|lamotrigine|mesh-list
83090752|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
83090753|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83090754|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090755|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090756|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83090757|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090758|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83090759|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83090760|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090761|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090762|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83090763|NCT00754221|Reboxetine|reboxetine|mesh-list
83090764|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
83090765|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090766|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83090767|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83090768|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090769|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090770|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
83090771|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090772|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090773|NCT00834405|Leflunomide|leflunomide|mesh-list
83090774|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090775|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090776|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090777|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
83090778|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090779|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83090780|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83090781|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83090782|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83090783|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090784|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090785|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090786|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83090787|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
83090788|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83090789|NCT00751803|Eletriptan|eletriptan|mesh-list
83090790|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83090791|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
83090792|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090793|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090794|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090795|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83090796|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
83090797|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090798|NCT05402397|Losartan|losartan|mesh-list
83090799|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83090800|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83090801|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83090802|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83090803|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090804|NCT00833937|Zolpidem|zolpidem|mesh-list
83090805|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83090806|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83090807|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090808|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090809|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83090810|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
83090811|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
83090812|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83090813|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090814|NCT00831051|Morphine|morphine|mesh-list
83090815|NCT00831051|Oxycodone|oxycodone|mesh-list
83090816|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83090817|NCT00831051|Narcotics|narcotics|mesh-ancestor
83090818|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090819|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090820|NCT00831051|Analgesics|analgesics|mesh-ancestor
83090821|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
83090822|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090823|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
83090824|NCT00750633|Dexamethasone|dexamethasone|mesh-list
83090825|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83090826|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83090827|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090828|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
83090829|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
83090830|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090831|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090832|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83090833|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
83090834|NCT00750633|Hormones|hormones|mesh-ancestor
83090835|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090836|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83090837|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090838|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090839|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090840|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83090841|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83090842|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090843|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090844|NCT00750243|Naproxen|naproxen|mesh-list
83090845|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83090846|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83090847|NCT00750243|Analgesics|analgesics|mesh-ancestor
83090848|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
83090849|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090850|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090851|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83090852|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090853|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
83090854|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83090855|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090856|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090857|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
83090858|NCT00924170|Fludarabine|fludarabine|mesh-list
83090859|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090860|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
83090861|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090862|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090863|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83090864|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
83090865|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090866|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090867|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83090868|NCT04809285|Insulin|insulin|mesh-list
83090869|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83090870|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090871|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
83090872|NCT00920985|Gestodene|gestodene|mesh-list
83090873|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
83090874|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83090875|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090876|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83090877|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83090878|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83090879|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83090880|NCT00920985|Progestins|progestins|mesh-ancestor
83090881|NCT00920985|Hormones|hormones|mesh-ancestor
83090882|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83090883|NCT05388747|Cefuroxime|cefuroxime|mesh-list
83090884|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
83090885|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83090886|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090887|NCT00828321|Ramipril|ramipril|mesh-list
83090888|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83090889|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
83090890|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090891|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090892|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83090893|NCT01352715|Ritonavir|ritonavir|mesh-list
83090894|NCT01352715|Lopinavir|lopinavir|mesh-list
83090895|NCT01352715|Tenofovir|tenofovir|mesh-list
83090896|NCT01352715|Lamivudine|lamivudine|mesh-list
83090897|NCT01352715|Emtricitabine|emtricitabine|mesh-list
83090898|NCT01352715|Zidovudine|zidovudine|mesh-list
83090899|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
83090900|NCT01352715|Abacavir|abacavir|mesh-list
83090901|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83090902|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
83090903|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83090904|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83090905|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
83090906|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090907|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090908|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83090909|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83090910|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
83090911|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83090912|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83090913|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83090914|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83090915|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83090916|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
83090917|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83090918|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83090919|NCT00743925|Atorvastatin|atorvastatin|mesh-list
83090920|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
83090921|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83090922|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83090923|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
83090924|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090925|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83090926|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83090927|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83090928|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83090929|NCT04221945|Cisplatin|cisplatin|mesh-list
83090931|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090932|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83090933|NCT04221945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83090934|NCT04221945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090935|NCT00738387|Docetaxel|docetaxel|mesh-list
83090936|NCT00738387|Vadimezan|vadimezan|mesh-list
83090937|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090938|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
83090939|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
83090940|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83090941|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090942|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
83090943|NCT03710421|Fludarabine|fludarabine|mesh-list
83090944|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83090945|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
83090946|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090947|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83090948|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83090949|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
83090950|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090951|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090952|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83090953|NCT00645177|Paclitaxel|paclitaxel|mesh-list
83090954|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83090955|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090956|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83090957|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83090958|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83090959|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090960|NCT00643383|Acetaminophen|acetaminophen|mesh-list
83090961|NCT00643383|Tramadol|tramadol|mesh-list
83090962|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83090963|NCT00643383|Analgesics|analgesics|mesh-ancestor
83090964|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
83090965|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090966|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090967|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
83090968|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83090969|NCT00643383|Narcotics|narcotics|mesh-ancestor
83090970|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090971|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83090972|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
83090973|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090974|NCT04285450|Vitamin K|vitamin k|mesh-list
83090975|NCT04285450|Vitamins|vitamins|mesh-ancestor
83090976|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
83090977|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090978|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83090979|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83090980|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83090981|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
83090982|NCT04285450|Coagulants|coagulants|mesh-ancestor
83090983|NCT05497102|Lenalidomide|lenalidomide|mesh-list
83090984|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
83090985|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090986|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
82719671|NCT04727996|Tislelizumab|tislelizumab|mesh-list
83090987|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83090988|NCT05497102|Growth Substances|growth substances|mesh-ancestor
83090989|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83090990|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83090991|NCT04017442|Morphine|morphine|mesh-list
83090992|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83090993|NCT04017442|Narcotics|narcotics|mesh-ancestor
83090994|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83090995|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83090996|NCT04017442|Analgesics|analgesics|mesh-ancestor
83090997|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
83090998|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83090999|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83091000|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83091001|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091002|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
83091003|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83091004|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83091005|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091006|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
83091007|NCT05490160|Coagulants|coagulants|mesh-ancestor
83091008|NCT05495620|Dexamethasone|dexamethasone|mesh-list
83091009|NCT05495620|Lenalidomide|lenalidomide|mesh-list
83091010|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091011|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
83091012|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
83091013|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091014|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091015|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091016|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
83091017|NCT05495620|Hormones|hormones|mesh-ancestor
83091018|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091019|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091020|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091021|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
83091022|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83091023|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83091024|NCT05495620|Growth Substances|growth substances|mesh-ancestor
83091025|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
83091026|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
83091027|NCT05490082|Mirabegron|mirabegron|mesh-list
83091028|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83091029|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83091030|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
83091031|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091032|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091033|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091034|NCT05490082|Urological Agents|urological agents|mesh-ancestor
83091035|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83091036|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83091037|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83091038|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091039|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
83091040|NCT02559310|Linezolid|linezolid|mesh-list
83091041|NCT02559310|Lefamulin|lefamulin|mesh-list
83091042|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83091043|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091044|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83091045|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83091046|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091047|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091048|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091049|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83091050|NCT05489926|Pamiparib|pamiparib|mesh-list
83091051|NCT05489926|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83091052|NCT05489926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091053|NCT05489926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091054|NCT05489926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091055|NCT05489848|Paclitaxel|paclitaxel|mesh-list
83091056|NCT05489848|Carboplatin|carboplatin|mesh-list
83091057|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83091058|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091059|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
83091060|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
83091061|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
83091062|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091063|NCT03517449|Paclitaxel|paclitaxel|mesh-list
83091064|NCT03517449|Doxorubicin|doxorubicin|mesh-list
83091065|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
83091066|NCT03517449|Lenvatinib|lenvatinib|mesh-list
83091067|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83091068|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091069|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83091070|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83091071|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83091072|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091073|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83091074|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83091075|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83091076|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091077|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091078|NCT03517449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83091079|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83091080|NCT05489692|Leucovorin|leucovorin|mesh-list
83091081|NCT05489692|Fluorouracil|fluorouracil|mesh-list
83091082|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
83091083|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83091084|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
83091085|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091086|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83091087|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091088|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091089|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
83091090|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091091|NCT05489692|Antidotes|antidotes|mesh-ancestor
83091092|NCT05489692|Protective Agents|protective agents|mesh-ancestor
83091093|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
83091094|NCT05489692|Vitamins|vitamins|mesh-ancestor
83091095|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
83091096|NCT05489692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091097|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83091098|NCT00721695|Mydriatics|mydriatics|mesh-list
83091099|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
83091100|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091101|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091102|NCT00625833|Reboxetine|reboxetine|mesh-list
83091103|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
83091104|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83091105|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83091106|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83091107|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091108|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091109|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091110|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091111|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091112|NCT00670358|Prednisone|prednisone|mesh-list
83091113|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
83091114|NCT00670358|Rituximab|rituximab|mesh-list
83091115|NCT00670358|Doxorubicin|doxorubicin|mesh-list
83091116|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83091117|NCT00670358|Vincristine|vincristine|mesh-list
83091118|NCT00670358|Lenalidomide|lenalidomide|mesh-list
83091119|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091120|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
83091121|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091122|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091123|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83091124|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
83091125|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091126|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091127|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83091128|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091129|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83091130|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83091131|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83091132|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091133|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091134|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
83091135|NCT00670358|Hormones|hormones|mesh-ancestor
83091136|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091137|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091138|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83091139|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83091140|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83091141|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83091142|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83091143|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83091144|NCT00670358|Growth Substances|growth substances|mesh-ancestor
83091145|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
83091146|NCT03299036|Doxorubicin|doxorubicin|mesh-list
83091147|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83091148|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091149|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83091150|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83091151|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091152|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091153|NCT03290846|Secretin|secretin|mesh-list
83091154|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091155|NCT03290846|Hormones|hormones|mesh-ancestor
83389676|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091156|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091157|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091159|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83091160|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091161|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83091162|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091163|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
83091164|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091165|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
83091166|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091167|NCT04488926|Palmidrol|palmidrol|mesh-list
83091168|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83091169|NCT04488926|Analgesics|analgesics|mesh-ancestor
83091170|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
83091171|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091172|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091173|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83466296|NCT00002182|Megestrol|megestrol|mesh-list
83091174|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091175|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091176|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
83091177|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091178|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83091179|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83091180|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091181|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091182|NCT04488926|Hormones|hormones|mesh-ancestor
83091183|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091184|NCT04328714|Interferons|interferons|mesh-list
83091185|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
83091186|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091187|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
83091188|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091189|NCT03290456|Prednisone|prednisone|mesh-list
83091190|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091191|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
83091192|NCT03290456|Hormones|hormones|mesh-ancestor
83091193|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091194|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091195|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091196|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091197|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
83091198|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83091199|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
83091200|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83091201|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
83091202|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091203|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091204|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
83091205|NCT03298646|Diclofenac|diclofenac|mesh-list
83091206|NCT03298646|Lidocaine|lidocaine|mesh-list
83091207|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
83091208|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
83091209|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091210|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091211|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
83091212|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091213|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83091214|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83091215|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83091216|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091217|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091218|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83091219|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83091220|NCT03298646|Analgesics|analgesics|mesh-ancestor
83091221|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091222|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091223|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83091224|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091225|NCT02460692|Dronabinol|dronabinol|mesh-list
83091226|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
83091227|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091228|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83091229|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83091230|NCT02460692|Analgesics|analgesics|mesh-ancestor
83091231|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
83091232|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091233|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83091234|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83091235|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091236|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091237|NCT02460692|Hormones|hormones|mesh-ancestor
83091238|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091239|NCT05494060|Capecitabine|capecitabine|mesh-list
83091240|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
83091241|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83091242|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
83091243|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091244|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091245|NCT05488990|Calcitriol|calcitriol|mesh-list
83091246|NCT05488990|Calcipotriene|calcipotriene|mesh-list
83091247|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
83091248|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83091249|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091250|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83091251|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091252|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091253|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83091254|NCT05488990|Vitamins|vitamins|mesh-ancestor
83091255|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
83091256|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83091257|NCT02715284|Dostarlimab|dostarlimab|mesh-list
83091258|NCT02715284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091259|NCT03289520|Clopidogrel|clopidogrel|mesh-list
83091260|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83091261|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83091262|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83091263|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83091264|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
83091265|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091266|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091267|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091268|NCT03293108|Vitamin D|vitamin d|mesh-list
83091269|NCT03293108|Denosumab|denosumab|mesh-list
83091270|NCT03293108|Calcium|calcium|mesh-list
83091271|NCT03293108|Vitamins|vitamins|mesh-ancestor
83091272|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
83091273|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091274|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83091275|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83091276|NCT03292796|Bimatoprost|bimatoprost|mesh-list
83091277|NCT03292796|Latanoprost|latanoprost|mesh-list
83091278|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83091279|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83091280|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83091281|NCT03288896|Ethanol|ethanol|mesh-list
83091282|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83091283|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091284|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091285|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091286|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
83091287|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
83091288|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091289|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83091290|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091291|NCT03292172|Atezolizumab|atezolizumab|mesh-list
83091292|NCT03292172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83091293|NCT03292172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091294|NCT03292172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091295|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091296|NCT02461004|Ezetimibe|ezetimibe|mesh-list
83091297|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83091298|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83091299|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
83091300|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091301|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83091303|NCT03288428|Nalbuphine|nalbuphine|mesh-list
83091304|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83091305|NCT03288428|Narcotics|narcotics|mesh-ancestor
83091306|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091307|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091308|NCT03288428|Analgesics|analgesics|mesh-ancestor
83091309|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
83091310|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091311|NCT03288350|Avelumab|avelumab|mesh-list
83091312|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091313|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091314|NCT00003224|Vaccines|vaccines|mesh-list
83091315|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
83091316|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
83091317|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091318|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83091319|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83091320|NCT03288038|Ezetimibe|ezetimibe|mesh-list
83091321|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83091322|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83091323|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
83091324|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091325|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83091326|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83091327|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091328|NCT03287882|Micronutrients|micronutrients|mesh-list
83091329|NCT03287882|Trace Elements|trace elements|mesh-list
83091330|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091331|NCT03291314|Avelumab|avelumab|mesh-list
83091332|NCT03291314|Axitinib|axitinib|mesh-list
83091333|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091334|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091335|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83091336|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091337|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091338|NCT03291158|Minocycline|minocycline|mesh-list
83091339|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83091340|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091341|NCT03283202|Prednisone|prednisone|mesh-list
83091342|NCT03283202|Prednisolone|prednisolone|mesh-list
83091343|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
83091344|NCT03283202|Rituximab|rituximab|mesh-list
83091345|NCT03283202|Vincristine|vincristine|mesh-list
83091346|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091347|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
83091348|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091349|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091350|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83091351|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
83091352|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091353|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091354|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83091355|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091356|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091357|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
83091358|NCT03283202|Hormones|hormones|mesh-ancestor
83091359|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091360|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091361|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83091362|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
83091363|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
83091364|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
83091365|NCT03283046|Dexamethasone|dexamethasone|mesh-list
83091366|NCT03283046|Nivolumab|nivolumab|mesh-list
83091367|NCT03283046|Lenalidomide|lenalidomide|mesh-list
83091368|NCT03283046|Ipilimumab|ipilimumab|mesh-list
83091369|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091370|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
83091371|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
83091372|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091373|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091374|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091375|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
83091376|NCT03283046|Hormones|hormones|mesh-ancestor
83091377|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091378|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091379|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091380|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091381|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83091382|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091383|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
83091384|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83091385|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83091386|NCT03283046|Growth Substances|growth substances|mesh-ancestor
83091387|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
83091388|NCT03287180|Buprenorphine|buprenorphine|mesh-list
83091389|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83091390|NCT03287180|Naloxone|naloxone|mesh-list
83091391|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83091392|NCT03287180|Narcotics|narcotics|mesh-ancestor
83091393|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091394|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091395|NCT03287180|Analgesics|analgesics|mesh-ancestor
83091396|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
83091397|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091398|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83091399|NCT02460146|CXA-10|cxa-10|mesh-list
83091400|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091401|NCT02460302|Progesterone|progesterone|mesh-list
83091402|NCT02460302|Progestins|progestins|mesh-ancestor
83091403|NCT02460302|Hormones|hormones|mesh-ancestor
83091404|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091405|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091406|NCT03282188|Sargramostim|sargramostim|mesh-list
83091407|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
83091408|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091409|NCT03384212|Cytarabine|cytarabine|mesh-list
83091410|NCT03384212|Fludarabine|fludarabine|mesh-list
83091411|NCT03384212|Busulfan|busulfan|mesh-list
83091412|NCT03384212|Cladribine|cladribine|mesh-list
83091413|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091414|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83091415|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
83091416|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091417|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091418|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
83091419|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091420|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
83091421|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091422|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
83091423|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83091424|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83091425|NCT02460068|Nivolumab|nivolumab|mesh-list
83091426|NCT02460068|Ipilimumab|ipilimumab|mesh-list
83091427|NCT02460068|Fotemustine|fotemustine|mesh-list
83091428|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091429|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091430|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83091431|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091432|NCT03286244|Paclitaxel|paclitaxel|mesh-list
83091433|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83091434|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091435|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
83091436|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
83091437|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
83091438|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091439|NCT03282110|Citalopram|citalopram|mesh-list
83091440|NCT03282110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83091441|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83091442|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091443|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091444|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091445|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
83091446|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091447|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83091448|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
83091449|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83091450|NCT03269786|Bilirubin|bilirubin|mesh-list
83091451|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
83091452|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091453|NCT03269786|Protective Agents|protective agents|mesh-ancestor
83091454|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091455|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
83091456|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
83091457|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
83091458|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091459|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091460|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
83091461|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83091462|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83091463|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
83091464|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091465|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091466|NCT03269318|Theophylline|theophylline|mesh-list
83091467|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83091468|NCT03269318|Montelukast|montelukast|mesh-list
83091469|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83091470|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
83091471|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091472|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091473|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83091474|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
83091475|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83091476|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83091477|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83091478|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091479|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091480|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091481|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83091482|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
83091483|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091484|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83091485|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83091486|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83091487|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091488|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
83091489|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83091490|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83091491|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
83091493|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83091494|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
83091495|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83091496|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
83091497|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091498|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091499|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
83091500|NCT04186598|Nifedipine|nifedipine|mesh-list
83091501|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83091502|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091503|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091504|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83091505|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091506|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
83091507|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
83091508|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83091509|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83091510|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83091511|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83091512|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091513|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091514|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83091515|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091516|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091517|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
83091518|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091519|NCT03107858|Dopamine|dopamine|mesh-list
83091520|NCT03107858|Norepinephrine|norepinephrine|mesh-list
83091521|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83091522|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83091523|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091524|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091525|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091526|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091528|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
83091529|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091530|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83091531|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83091532|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
83091533|NCT03107858|Protective Agents|protective agents|mesh-ancestor
83091534|NCT03269162|Docetaxel|docetaxel|mesh-list
83091535|NCT03269162|Pemetrexed|pemetrexed|mesh-list
83091536|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091537|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
83091538|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
83091539|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
83091540|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091541|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091542|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83091543|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83091544|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
83091545|NCT03284294|Vitamin D|vitamin d|mesh-list
83091546|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83091547|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091548|NCT03284294|Vitamins|vitamins|mesh-ancestor
83091549|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
83091550|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83091551|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
83091552|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83091553|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091554|NCT03268226|Beclomethasone|beclomethasone|mesh-list
83091555|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
83091556|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
83091557|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83091558|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
83091559|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83525641|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091560|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091561|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83091562|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
83091563|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83091564|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83091565|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83091566|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091567|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091568|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091569|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83091570|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83091571|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83091572|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
83091573|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091574|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
83091575|NCT03268226|Hormones|hormones|mesh-ancestor
83091576|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091577|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
83091578|NCT02737475|Nivolumab|nivolumab|mesh-list
83091579|NCT02737475|Ipilimumab|ipilimumab|mesh-list
83091580|NCT02737475|Vaccines|vaccines|mesh-list
83091581|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
83091582|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091583|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091584|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091585|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83091586|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
83091587|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091588|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091589|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83091590|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091591|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83091592|NCT02457806|Phenylephrine|phenylephrine|mesh-list
83091593|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
83091594|NCT02457806|Tetracaine|tetracaine|mesh-list
83091595|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
83091596|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
83091597|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091598|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091599|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
83091600|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091601|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83091602|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83091603|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091604|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091605|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091606|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
83091607|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
83091608|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
83091609|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83091610|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
83091611|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83091612|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
83091613|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83091614|NCT02457806|Protective Agents|protective agents|mesh-ancestor
83091615|NCT02459756|Citric Acid|citric acid|mesh-list
83091616|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
83091617|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091618|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
83091619|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83091620|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
83091621|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
83091622|NCT02557672|Thrombin|thrombin|mesh-list
83091623|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
83091624|NCT02557672|Coagulants|coagulants|mesh-ancestor
83091625|NCT02458274|Dimercaprol|dimercaprol|mesh-list
83091626|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
83091627|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
83091628|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091629|NCT02632175|Adalimumab|adalimumab|mesh-list
83091630|NCT02632175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83091631|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091632|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091633|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
83091634|NCT02458196|Prednisone|prednisone|mesh-list
83091635|NCT02458196|Prednisolone|prednisolone|mesh-list
83091636|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091637|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
83091638|NCT02458196|Hormones|hormones|mesh-ancestor
83091639|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091640|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091641|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091642|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091643|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83091644|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83091645|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
83091646|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83091647|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091648|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091649|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091650|NCT05207735|Capecitabine|capecitabine|mesh-list
83091651|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83091652|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
83091653|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091654|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091655|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
83091656|NCT03264638|Cyproterone|cyproterone|mesh-list
83091657|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83091658|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
83091659|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
83091660|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091661|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091662|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091663|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83091664|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
83091665|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83091666|NCT04502381|Amphotericin B|amphotericin b|mesh-list
83091667|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83091668|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
83091669|NCT04502381|Amebicides|amebicides|mesh-ancestor
83091670|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83091671|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83091672|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091673|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83091674|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
83091675|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83091676|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091677|NCT03264794|Gefitinib|gefitinib|mesh-list
83091678|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091679|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83091680|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091681|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091682|NCT02925923|Clopidogrel|clopidogrel|mesh-list
83091683|NCT02925923|Ticagrelor|ticagrelor|mesh-list
83091684|NCT02925923|Eptifibatide|eptifibatide|mesh-list
83091685|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83091686|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83091687|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83091688|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83091689|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
83091690|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091691|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091692|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091693|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83091694|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
83091695|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83091696|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83091697|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83091698|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091699|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091700|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
83091701|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091702|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091703|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83091704|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091705|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83091706|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83091707|NCT03280316|Urological Agents|urological agents|mesh-ancestor
83091708|NCT02410343|Hormones|hormones|mesh-list
83133560|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83091709|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091710|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091711|NCT05234840|Triamcinolone|triamcinolone|mesh-list
83091712|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091713|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
83091714|NCT05234840|Hormones|hormones|mesh-ancestor
83091715|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091716|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091717|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
83091718|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83091719|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83091720|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091721|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83091722|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83091723|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091724|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091725|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091726|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83091727|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
83091728|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83091729|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091730|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83091731|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83091732|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83091733|NCT03434379|Bevacizumab|bevacizumab|mesh-list
83091734|NCT03434379|Atezolizumab|atezolizumab|mesh-list
83091735|NCT03434379|Sorafenib|sorafenib|mesh-list
83091736|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091737|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091738|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83091739|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83091740|NCT03434379|Growth Substances|growth substances|mesh-ancestor
83091741|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091742|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
83091743|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83091744|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091745|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091746|NCT03434379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83091747|NCT02459288|Clopidogrel|clopidogrel|mesh-list
83091748|NCT02459288|Ticagrelor|ticagrelor|mesh-list
83091749|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83389677|NCT02080637|Ambrisentan|ambrisentan|mesh-list
83091750|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83091751|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83091752|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83091753|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
83091754|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091755|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091756|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091757|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
83091758|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
83091759|NCT00734253|Vitamins|vitamins|mesh-ancestor
83091760|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
83091761|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091762|NCT00730665|Esomeprazole|esomeprazole|mesh-list
83091763|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83091764|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091765|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83091766|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091767|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091768|NCT00714597|Enoxaparin|enoxaparin|mesh-list
83091769|NCT00714597|Semuloparin|semuloparin|mesh-list
83091770|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
83091771|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
83091772|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83091773|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83091774|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091775|NCT03265886|Bupivacaine|bupivacaine|mesh-list
83091776|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
83091777|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
83091778|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091779|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091780|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
83091781|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091782|NCT00728091|Satavaptan|satavaptan|mesh-list
83091783|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83091784|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091785|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
83091786|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091787|NCT03275090|SMOFlipid|smoflipid|mesh-list
83091788|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83091789|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83091790|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83091791|NCT03382821|Dexamethasone|dexamethasone|mesh-list
83091792|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
83091793|NCT03382821|Triamcinolone|triamcinolone|mesh-list
83091794|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83091795|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83091796|NCT03382821|Lidocaine|lidocaine|mesh-list
83091797|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83091798|NCT03382821|BB 1101|bb 1101|mesh-list
83091799|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83091800|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091801|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
83091802|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
83091803|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091804|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091805|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091806|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
83091807|NCT03382821|Hormones|hormones|mesh-ancestor
83091808|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091809|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091810|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091811|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
83091812|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091813|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091814|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
83091815|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
83091816|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091817|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
83091818|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83091819|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83091820|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83091821|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83091822|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091823|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
83091825|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
83091826|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
83091827|NCT00711555|Dexamethasone|dexamethasone|mesh-list
83091828|NCT00711555|Ondansetron|ondansetron|mesh-list
83091829|NCT00711555|Aprepitant|aprepitant|mesh-list
83091830|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091831|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
83091832|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
83091833|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091834|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091835|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091836|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
83091837|NCT00711555|Hormones|hormones|mesh-ancestor
83091838|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091839|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091840|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091841|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
83091842|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
83091843|NCT00711555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83091844|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83091845|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
83091846|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091847|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091848|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83091849|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
83091850|NCT02280993|Dexamethasone|dexamethasone|mesh-list
83091851|NCT02280993|Cisplatin|cisplatin|mesh-list
83091852|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83091853|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091854|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
83091855|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
83091856|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091857|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091858|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091859|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
83091861|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091862|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091863|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091864|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091865|NCT02280993|Immunotoxins|immunotoxins|mesh-ancestor
83091866|NCT02280993|Immunoconjugates|immunoconjugates|mesh-ancestor
83091867|NCT02280993|Immunologic Factors|immunologic factors|mesh-ancestor
83091868|NCT05488522|Bevacizumab|bevacizumab|mesh-list
83091869|NCT05488522|Atezolizumab|atezolizumab|mesh-list
83091870|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83091871|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091872|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83091873|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83091874|NCT05488522|Growth Substances|growth substances|mesh-ancestor
83091875|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091876|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
83091877|NCT05488522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83091878|NCT05488522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091879|NCT05492968|Phenylephrine|phenylephrine|mesh-list
83091880|NCT05492968|Epinephrine|epinephrine|mesh-list
83091881|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
83091882|NCT05492968|Norepinephrine|norepinephrine|mesh-list
83091883|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83091884|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83091885|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091886|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091887|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091888|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091889|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83091890|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83091891|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
83091892|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091893|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83091894|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
83091895|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
83091896|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
83091897|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83091898|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83091899|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
83091900|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83091901|NCT05492968|Protective Agents|protective agents|mesh-ancestor
83091902|NCT02457026|Triamcinolone|triamcinolone|mesh-list
83091903|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83091904|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83091905|NCT02457026|Aflibercept|aflibercept|mesh-list
83091906|NCT02457026|Verteporfin|verteporfin|mesh-list
83091907|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83091908|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091909|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
83091910|NCT02457026|Hormones|hormones|mesh-ancestor
83091911|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091912|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091913|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091914|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
83091915|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83091916|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091917|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83091918|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83091919|NCT02457026|Growth Substances|growth substances|mesh-ancestor
83091920|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
83091921|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091922|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83091923|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83091924|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
83091925|NCT03919526|Fludarabine|fludarabine|mesh-list
83091926|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091927|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
83091928|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091929|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091930|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83091931|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
83091932|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091933|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091935|NCT05492812|Melatonin|melatonin|mesh-list
83091936|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
83091937|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
83091938|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
83091939|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091940|NCT05492812|Protective Agents|protective agents|mesh-ancestor
83091941|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091942|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091943|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
83091944|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
83091945|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83091946|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
83091947|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
83091948|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091949|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83091950|NCT02458118|Secretin|secretin|mesh-list
83091951|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091952|NCT02458118|Hormones|hormones|mesh-ancestor
83091953|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091954|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091955|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
83091956|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83091957|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091958|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091959|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83091960|NCT05487742|Analgesics|analgesics|mesh-ancestor
83091961|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
83091962|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091963|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83091964|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83091965|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83091966|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
83091967|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83091968|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091969|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
83091970|NCT02457650|Fludarabine|fludarabine|mesh-list
83091971|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83091972|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
83091973|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091974|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83091975|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83091976|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
83091977|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83091978|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091979|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83091980|NCT02456948|Minocycline|minocycline|mesh-list
83091981|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83091982|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83091983|NCT05487508|Dexamethasone|dexamethasone|mesh-list
83091984|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83091985|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
83091986|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
83091987|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83091988|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83091989|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83091990|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
83091991|NCT05487508|Hormones|hormones|mesh-ancestor
83091992|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83091993|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83091994|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83091995|NCT02713490|Bupivacaine|bupivacaine|mesh-list
83091996|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
83091997|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
83091998|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83091999|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092000|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
83092001|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092002|NCT03787628|Cannabidiol|cannabidiol|mesh-list
83092003|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
83092004|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
83092005|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83092006|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092007|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83092008|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092010|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83092011|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
83092012|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092013|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092014|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092015|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83092016|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83092017|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092018|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83092019|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83092020|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
83092021|NCT05387954|Anticoagulants|anticoagulants|mesh-list
83092022|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
83092023|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
83092024|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83092025|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
83092026|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092027|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092028|NCT03262688|Bupivacaine|bupivacaine|mesh-list
83092029|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092030|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
83092031|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092032|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092033|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
83092034|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092035|NCT05486884|Benzocaine|benzocaine|mesh-list
83092036|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092037|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
83092038|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092039|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092040|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
83092041|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092042|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83092043|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83092044|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092045|NCT05485402|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83092046|NCT05485402|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
83092047|NCT05485402|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
83092048|NCT05485402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092049|NCT05485402|Antioxidants|antioxidants|mesh-ancestor
83092050|NCT05485402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092051|NCT05485402|Protective Agents|protective agents|mesh-ancestor
83092052|NCT05485402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092053|NCT05485402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83092054|NCT05485402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83092055|NCT05485402|Disinfectants|disinfectants|mesh-ancestor
83092056|NCT05485402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83092058|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092059|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
83092060|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092061|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092062|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
83092063|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092064|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83092065|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466390|NCT05571644|Antidotes|antidotes|mesh-ancestor
83092066|NCT05486650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83092067|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092068|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
83092069|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83092070|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092071|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83092072|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
83092073|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83092074|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
83092075|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83092076|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
83092077|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092078|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092079|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
83092080|NCT02458742|Morphine|morphine|mesh-list
83092081|NCT02458742|Bupivacaine|bupivacaine|mesh-list
83092082|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092083|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
83092084|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092085|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092086|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
83092087|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092088|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83092089|NCT02458742|Narcotics|narcotics|mesh-ancestor
83092090|NCT02458742|Analgesics|analgesics|mesh-ancestor
83092091|NCT02403310|Cytarabine|cytarabine|mesh-list
83092092|NCT02403310|Daunorubicin|daunorubicin|mesh-list
83092093|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092094|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
83092095|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092096|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092097|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
83092098|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092099|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092100|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
83092101|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092102|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83092103|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83092104|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83092105|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092106|NCT01665274|Capecitabine|capecitabine|mesh-list
83092107|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
83092108|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092109|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
83092110|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092111|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092112|NCT05387876|Vitamin D|vitamin d|mesh-list
83092113|NCT05387876|Vitamins|vitamins|mesh-ancestor
83092114|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
83092115|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092116|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83092117|NCT04560166|Irinotecan|irinotecan|mesh-list
83092118|NCT04560166|Temozolomide|temozolomide|mesh-list
83092119|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83092120|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83092121|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092122|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092123|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092124|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83092125|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
83092127|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
83092128|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092129|NCT02456714|Folfirinox|folfirinox|mesh-list
83092130|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092131|NCT03258866|Rituximab|rituximab|mesh-list
83092132|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83092133|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092134|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
83092135|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092136|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092137|NCT03258476|Guanfacine|guanfacine|mesh-list
83092138|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83092139|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83092140|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83092141|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83092142|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
83092143|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092144|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092145|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092146|NCT05484154|Protein C|protein c|mesh-list
83092147|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
83092148|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83092149|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83092150|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092151|NCT03258398|Avelumab|avelumab|mesh-list
83092152|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83092153|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092154|NCT03261596|Mebendazole|mebendazole|mesh-list
83092155|NCT03261596|Piperazine|piperazine|mesh-list
83092156|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
83092157|NCT03261596|DMP 777|dmp 777|mesh-list
83092158|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
83092159|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
83092160|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83092161|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092162|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
83092163|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
83092164|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83092165|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092166|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092167|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092168|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83092170|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092171|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
83092172|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83092173|NCT03772574|Nicotine|nicotine|mesh-list
83092174|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83092175|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
83092176|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092177|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092178|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83092179|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83092180|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
83092181|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092182|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092183|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83092184|NCT02456558|Deferiprone|deferiprone|mesh-list
83092185|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83092186|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
83092187|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
83092188|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092189|NCT03798080|Insulin|insulin|mesh-list
83092190|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83092191|NCT03798080|Metformin|metformin|mesh-list
83092192|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
83092193|NCT03798080|Lixisenatide|lixisenatide|mesh-list
83092194|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83092195|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092196|NCT03257930|Ethanol|ethanol|mesh-list
83092197|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83092198|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466402|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
83092199|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092200|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092201|NCT03257852|Methotrexate|methotrexate|mesh-list
83092202|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83092204|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83092205|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092206|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092207|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
83092208|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092209|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092210|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83092211|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092212|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83092213|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092214|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
83092215|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092216|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83092217|NCT05498896|Paclitaxel|paclitaxel|mesh-list
83092218|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
83092219|NCT05498896|Doxorubicin|doxorubicin|mesh-list
83092220|NCT05498896|Atezolizumab|atezolizumab|mesh-list
83092221|NCT05498896|Ipatasertib|ipatasertib|mesh-list
83092222|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83092223|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092224|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
83092225|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
83092226|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
83092227|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092228|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092229|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
83092230|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092231|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092232|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83092233|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
83092234|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83092235|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83092236|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83092237|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83092238|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092239|NCT05498896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83092240|NCT05498896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83092241|NCT05498896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83092242|NCT02743221|Trifluridine|trifluridine|mesh-list
83092243|NCT02743221|Bevacizumab|bevacizumab|mesh-list
83092244|NCT02743221|Capecitabine|capecitabine|mesh-list
83092245|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83092246|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092247|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83092248|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83092249|NCT02743221|Growth Substances|growth substances|mesh-ancestor
83092250|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092251|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
83092252|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092253|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
83092254|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092255|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
83092256|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092257|NCT03955887|Dimercaprol|dimercaprol|mesh-list
83092258|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
83092259|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
83092260|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092261|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
83092262|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092263|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
83092264|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83466420|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83092265|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092266|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
83092267|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092268|NCT03370263|Belimumab|belimumab|mesh-list
83092269|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092270|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
83092271|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092272|NCT00692445|Mecamylamine|mecamylamine|mesh-list
83092273|NCT00692445|Dexetimide|dexetimide|mesh-list
83092274|NCT00692445|Citalopram|citalopram|mesh-list
83092275|NCT00692445|Escitalopram|escitalopram|mesh-list
83092276|NCT00692445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83092277|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83092278|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092279|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092280|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092281|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
83092282|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092283|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83092284|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
83092285|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83092286|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83092287|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83092288|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
83092289|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
83092290|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092291|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83092292|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83092293|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83092294|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83092295|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83092296|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83092297|NCT03929757|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83092298|NCT03929757|Antiviral Agents|antiviral agents|mesh-ancestor
83092299|NCT03929757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092300|NCT03256292|Testosterone|testosterone|mesh-list
83092301|NCT03256292|Androgens|androgens|mesh-ancestor
83092302|NCT03256292|Hormones|hormones|mesh-ancestor
83092303|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092304|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092305|NCT04473261|Iodine|iodine|mesh-list
83092306|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
83092307|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83092308|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092309|NCT04473261|Trace Elements|trace elements|mesh-ancestor
83092310|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
83092311|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092313|NCT01358968|Pemetrexed|pemetrexed|mesh-list
83092314|NCT01358968|Desipramine|desipramine|mesh-list
83092315|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092316|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
83092317|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092318|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092319|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092320|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83092321|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83092322|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83092323|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
83092324|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83092325|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83092326|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83092327|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092328|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
83092329|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092330|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092331|NCT02281305|Colchicine|colchicine|mesh-list
83092332|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
83092333|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092334|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
83092335|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
83092336|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
83092337|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092338|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092339|NCT00624351|Epratuzumab|epratuzumab|mesh-list
83092340|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83092341|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092342|NCT03251690|Tenofovir|tenofovir|mesh-list
83092343|NCT03251690|Emtricitabine|emtricitabine|mesh-list
83092344|NCT03251690|Efavirenz|efavirenz|mesh-list
83092345|NCT03251690|Rilpivirine|rilpivirine|mesh-list
83092346|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
83092347|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092348|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83092349|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83092350|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389678|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83092351|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092352|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83092353|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83092354|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83092355|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83092356|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83092357|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83092358|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83092359|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83092361|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83092362|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
83092363|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092364|NCT00687687|Paclitaxel|paclitaxel|mesh-list
83092365|NCT00687687|Carboplatin|carboplatin|mesh-list
83092366|NCT00687687|Iniparib|iniparib|mesh-list
83092367|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83092368|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092369|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
83092370|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
83092371|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
83092372|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092373|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83092374|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092375|NCT00701090|Metformin|metformin|mesh-list
83092376|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83092377|NCT00701090|Glimepiride|glimepiride|mesh-list
83092378|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83092379|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092380|NCT00701090|Incretins|incretins|mesh-ancestor
83092381|NCT00701090|Hormones|hormones|mesh-ancestor
83092382|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092383|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83092384|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
83092385|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092386|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092387|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83092388|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092389|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
83092391|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
83092392|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092393|NCT02283489|Paclitaxel|paclitaxel|mesh-list
83092394|NCT02283489|Endostatins|endostatins|mesh-list
83092395|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83092396|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092397|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83092398|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83092399|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83092400|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092401|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83092402|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83092403|NCT02283489|Growth Substances|growth substances|mesh-ancestor
83092404|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092405|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
83092406|NCT02455232|Lidocaine|lidocaine|mesh-list
83092407|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092408|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
83092409|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092410|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092411|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
83092412|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092413|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83092414|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83092415|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83092416|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092417|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092418|NCT03259958|Donepezil|donepezil|mesh-list
83092419|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83092420|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092421|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092422|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
83092423|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092424|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092425|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
83092426|NCT02923947|Osimertinib|osimertinib|mesh-list
83092427|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092428|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83092429|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092430|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092431|NCT00679731|Methotrexate|methotrexate|mesh-list
83092432|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83092433|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
83092434|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83092435|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092436|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092437|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
83092438|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092439|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092440|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
83092441|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092442|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83092443|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092444|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
83092445|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092446|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83092447|NCT02455856|Itraconazole|itraconazole|mesh-list
83092448|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
83092449|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092450|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83092451|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83092452|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092453|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092454|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83092455|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
83092456|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092457|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092458|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83092459|NCT02283645|Minoxidil|minoxidil|mesh-list
83092460|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83092461|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
83092462|NCT00602745|Fluorouracil|fluorouracil|mesh-list
83092463|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
83092464|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092465|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092466|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092467|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092468|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
83092469|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092470|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
83092471|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83092472|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092473|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092474|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83092475|NCT03251222|Analgesics|analgesics|mesh-ancestor
83092476|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
83092477|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092478|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83466432|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83092479|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83092480|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83092481|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83092482|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092483|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092484|NCT04487834|Simethicone|simethicone|mesh-list
83092485|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
83092486|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092487|NCT04487834|Emollients|emollients|mesh-ancestor
83092488|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
83092489|NCT03250910|Ribavirin|ribavirin|mesh-list
83092490|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
83092491|NCT03250910|Velpatasvir|velpatasvir|mesh-list
83092492|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83092493|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
83092494|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092495|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
83092496|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092497|NCT02283801|Lamotrigine|lamotrigine|mesh-list
83092498|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83092499|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
83092500|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83092501|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092502|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092503|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83092504|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092505|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83092506|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83092507|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092508|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83092509|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83092510|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83092511|NCT02455154|Letrozole|letrozole|mesh-list
83092512|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092513|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83092514|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83092515|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092516|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092517|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83092518|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
83092519|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092520|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092521|NCT03254810|Adalimumab|adalimumab|mesh-list
83092522|NCT03254810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83092523|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83092524|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092525|NCT03255044|Atorvastatin|atorvastatin|mesh-list
83092526|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83092527|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83092528|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83092529|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
83133561|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83092530|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092531|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83092532|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83092533|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092535|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83092536|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092537|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092538|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092539|NCT03245996|Atenolol|atenolol|mesh-list
83092540|NCT03245996|Nebivolol|nebivolol|mesh-list
83092541|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83092542|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83092543|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
83092544|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
83092545|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092546|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092547|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83092548|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83092549|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83092550|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
83092551|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092552|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092553|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
83092554|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83092555|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83092556|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83092557|NCT02281929|Amoxicillin|amoxicillin|mesh-list
83092558|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
83092559|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
83092560|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83092561|NCT02281929|Prednisolone|prednisolone|mesh-list
83092562|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83092563|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092564|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83092565|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
83092566|NCT02281929|Hormones|hormones|mesh-ancestor
83389679|NCT05019690|Paclitaxel|paclitaxel|mesh-list
83389680|NCT05019690|Apatinib|apatinib|mesh-list
83092567|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092568|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092569|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83092570|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092571|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092572|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092573|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83092574|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83092575|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092577|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
83092578|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092579|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83092580|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83092581|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092582|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092583|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83092584|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
83092585|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092586|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092587|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83092588|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83092589|NCT02945852|Apatinib|apatinib|mesh-list
83092590|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092591|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83092592|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092593|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092594|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
83092595|NCT03245528|Giapreza|giapreza|mesh-list
83092596|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83092597|NCT00495885|Volinanserin|volinanserin|mesh-list
83092598|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83092599|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
83092600|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092601|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092602|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092603|NCT03254186|Propranolol|propranolol|mesh-list
83092604|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83092605|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83092606|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
83092607|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092608|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092609|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092610|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83092611|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83092612|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
83092613|NCT00589875|Valacyclovir|valacyclovir|mesh-list
83092614|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
83092615|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092616|NCT03250598|Mitapivat|mitapivat|mesh-list
83092617|NCT03250598|Enzyme Activators|enzyme activators|mesh-ancestor
83092618|NCT03250598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092619|NCT05483062|Fluorides|fluorides|mesh-list
83092620|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
83092621|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
83092622|NCT05483062|Protective Agents|protective agents|mesh-ancestor
83092623|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092624|NCT02282085|Olanzapine|olanzapine|mesh-list
83092625|NCT02282085|Risperidone|risperidone|mesh-list
83092626|NCT02282085|Aripiprazole|aripiprazole|mesh-list
83092627|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83092628|NCT02282085|Ziprasidone|ziprasidone|mesh-list
83092629|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
83092630|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83092631|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83092632|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
83092633|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092634|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092635|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092636|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83092637|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092638|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83092639|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83092640|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
83092641|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
83092642|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
83092643|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092644|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83092645|NCT02282085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83092646|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83092647|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092648|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
83092649|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
83092650|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83092651|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83092652|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83092653|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83092654|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83092655|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83092656|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83092657|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
83092658|NCT03244592|Minocycline|minocycline|mesh-list
83092659|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83092660|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092661|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
83092662|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83092663|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
83092664|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092665|NCT03253328|Expectorants|expectorants|mesh-ancestor
83092666|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
83092667|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83092668|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
83092669|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092670|NCT03253328|Protective Agents|protective agents|mesh-ancestor
83092671|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092672|NCT03253328|Antidotes|antidotes|mesh-ancestor
83092674|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83092675|NCT03253250|Entecavir|entecavir|mesh-list
83092676|NCT03253250|Adefovir|adefovir|mesh-list
83092677|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
83092678|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092679|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83092680|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83092681|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092682|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092683|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83092684|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83092685|NCT03253562|Metformin|metformin|mesh-list
83092686|NCT03253562|Vildagliptin|vildagliptin|mesh-list
83092687|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83092688|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092689|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83092690|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
83092691|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092692|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092693|NCT03250052|Linagliptin|linagliptin|mesh-list
83092694|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83092695|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092696|NCT03250052|Incretins|incretins|mesh-ancestor
83092697|NCT03250052|Hormones|hormones|mesh-ancestor
83092698|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092699|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83092700|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
83092701|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092702|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092703|NCT05478382|Pregabalin|pregabalin|mesh-list
83092704|NCT05478382|Analgesics|analgesics|mesh-ancestor
83092705|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
83092706|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092707|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092708|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
83092709|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83092710|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092711|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092712|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83092713|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83092714|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83092715|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092716|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83092717|NCT03244358|Epalrestat|epalrestat|mesh-list
83092718|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092719|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092720|NCT03249740|Sunitinib|sunitinib|mesh-list
83092721|NCT03249740|Aflibercept|aflibercept|mesh-list
83092722|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092723|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83092724|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83092725|NCT03249740|Growth Substances|growth substances|mesh-ancestor
83092726|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092727|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
83092728|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83092729|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092730|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092731|NCT03057977|Empagliflozin|empagliflozin|mesh-list
83092732|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83092733|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092734|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83092735|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092736|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
83092737|NCT03249506|Empagliflozin|empagliflozin|mesh-list
83092738|NCT03249506|Canagliflozin|canagliflozin|mesh-list
83092739|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83092740|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83092741|NCT03249506|Glucagon|glucagon|mesh-list
83092742|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83092743|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83092744|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092745|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83092746|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092747|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83092748|NCT03249506|Hormones|hormones|mesh-ancestor
83525794|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83092749|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092750|NCT03249506|Incretins|incretins|mesh-ancestor
83092751|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
83092752|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092753|NCT03249662|Bupivacaine|bupivacaine|mesh-list
83092754|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092755|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
83092756|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092757|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092758|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
83092759|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092760|NCT03249428|Nicotine|nicotine|mesh-list
83092761|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83092762|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
83092763|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092764|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092765|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83092766|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83092767|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
83092768|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092769|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092770|NCT03243500|Lidocaine|lidocaine|mesh-list
83092771|NCT03243500|Bupivacaine|bupivacaine|mesh-list
83092772|NCT03243500|Atracurium|atracurium|mesh-list
83092773|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092774|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
83092775|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092776|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092777|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
83092778|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092779|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83092780|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83092781|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83092782|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092783|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092784|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83092785|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83092786|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83092787|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83092788|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83092789|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
83092790|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092791|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
83092792|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83092793|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83092794|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83092795|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092796|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092797|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
83092798|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092799|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092800|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83092801|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092802|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83092803|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83092804|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
83092805|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092806|NCT04486508|Heparin|heparin|mesh-list
83092807|NCT04486508|Calcium heparin|calcium heparin|mesh-list
83092808|NCT04486508|Enoxaparin|enoxaparin|mesh-list
83092809|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
83092810|NCT04486508|Atorvastatin|atorvastatin|mesh-list
83092811|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83092812|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83092813|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83092814|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
83092815|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466463|NCT00002206|Adefovir|adefovir|mesh-list
83092816|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83092817|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092818|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
83092819|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83092820|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83092821|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
83092822|NCT02552212|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83092823|NCT02552212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83092824|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83092825|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
83092826|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092827|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092828|NCT02454764|Interferons|interferons|mesh-list
83092829|NCT02454764|Tenofovir|tenofovir|mesh-list
83092830|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
83092831|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
83092832|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092833|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
83092834|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092835|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83092836|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83092837|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092838|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092839|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83092840|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83092841|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
83092842|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092843|NCT00685919|Carbidopa|carbidopa|mesh-list
83092844|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83092845|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83092846|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
83092847|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092848|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092849|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092850|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83092851|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092852|NCT03243344|Surgiflo|surgiflo|mesh-list
83092853|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
83092854|NCT03243344|Coagulants|coagulants|mesh-ancestor
83092855|NCT03243032|Ibuprofen|ibuprofen|mesh-list
83092856|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83092857|NCT03243032|Anesthetics|anesthetics|mesh-list
83092858|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
83092859|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092860|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092861|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83092862|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83092863|NCT03243032|Analgesics|analgesics|mesh-ancestor
83092864|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
83092865|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092866|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092867|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83092868|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092869|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092870|NCT03249038|Chrysarobin|chrysarobin|mesh-list
83092871|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83092872|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83092873|NCT03249038|Analgesics|analgesics|mesh-ancestor
83092874|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
83092875|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092876|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092877|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83092878|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092879|NCT03061331|Ivacaftor|ivacaftor|mesh-list
83092880|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83092881|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092882|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092883|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83092884|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83092885|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092886|NCT05213585|Ivermectin|ivermectin|mesh-list
83092887|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83092888|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83092889|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
83092890|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83092891|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092892|NCT05482282|Vaccines|vaccines|mesh-list
83092893|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
83092894|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092895|NCT05209529|Durvalumab|durvalumab|mesh-list
83092896|NCT05209529|Olaparib|olaparib|mesh-list
83525870|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
83092897|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83092898|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092899|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83092900|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092901|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092902|NCT04424134|Spironolactone|spironolactone|mesh-list
83092903|NCT04424134|Bromhexine|bromhexine|mesh-list
83092904|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83092905|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
83092906|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83092907|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092908|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83092909|NCT04424134|Diuretics|diuretics|mesh-ancestor
83092910|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
83092911|NCT04424134|Expectorants|expectorants|mesh-ancestor
83092912|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
83092913|NCT04486430|Salicylates|salicylates|mesh-list
83092914|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83092915|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83092916|NCT04486430|Analgesics|analgesics|mesh-ancestor
83092917|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
83092918|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092919|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092920|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83092921|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83092922|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83092923|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092924|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092925|NCT03248726|Bisacodyl|bisacodyl|mesh-list
83092926|NCT03248726|Cathartics|cathartics|mesh-ancestor
83092927|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83092928|NCT03248726|Laxatives|laxatives|mesh-ancestor
83092929|NCT05208827|Vitamin D|vitamin d|mesh-list
83092930|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
83092931|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
83092932|NCT05208827|Vitamins|vitamins|mesh-list
83092933|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
83092934|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092935|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83092936|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83092937|NCT04947059|Gemcitabine|gemcitabine|mesh-list
83092938|NCT04947059|Epirubicin|epirubicin|mesh-list
83092939|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83092940|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
83092941|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092942|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092943|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83092944|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83092945|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83092946|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092947|NCT05481970|Dexamethasone|dexamethasone|mesh-list
83092948|NCT05481970|Lidocaine|lidocaine|mesh-list
83092949|NCT05481970|Fentanyl|fentanyl|mesh-list
83092950|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
83092951|NCT05481970|Ketamine|ketamine|mesh-list
83092952|NCT05481970|Propofol|propofol|mesh-list
83092953|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83092954|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
83092955|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
83092956|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092957|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092958|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83092959|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
83092960|NCT05481970|Hormones|hormones|mesh-ancestor
83092961|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83466469|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83092962|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83092963|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83092964|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83092965|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
83092966|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
83092967|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83092968|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
83092969|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83092970|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83092971|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83526395|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
83092972|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83092973|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83092974|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83092975|NCT05481970|Analgesics|analgesics|mesh-ancestor
83092976|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83092977|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83092978|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83092979|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
83092980|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83092981|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83092982|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
83092983|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83092984|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83092985|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83092986|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83092987|NCT05481970|Narcotics|narcotics|mesh-ancestor
83092988|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83092989|NCT03248648|Ketamine|ketamine|mesh-list
83092990|NCT03248648|Neostigmine|neostigmine|mesh-list
83092991|NCT03248648|Analgesics|analgesics|mesh-ancestor
83092992|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
83092993|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83092994|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83092995|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83092996|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83092997|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
83092998|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
83092999|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093000|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83093001|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83093002|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093003|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093004|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83093005|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093006|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
83093007|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83093008|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
83093009|NCT03241784|Interleukin-2|interleukin-2|mesh-list
83093010|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093011|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093012|NCT03241784|Analgesics|analgesics|mesh-ancestor
83093013|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
83093014|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093015|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093016|NCT03242096|Sirolimus|sirolimus|mesh-list
83093017|NCT03242096|Paclitaxel|paclitaxel|mesh-list
83093018|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83093019|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093020|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
83093021|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
83093022|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
83093023|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093024|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093025|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093026|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83093027|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
83093028|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83093029|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
83093030|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093031|NCT03241472|Letrozole|letrozole|mesh-list
83093032|NCT03241472|Clomiphene|clomiphene|mesh-list
83093033|NCT03241472|Enclomiphene|enclomiphene|mesh-list
83093034|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
83093035|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093036|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093037|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83093038|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83093039|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093040|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83093041|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
83093042|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093043|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093044|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83093045|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
83093046|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83526396|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
83093047|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83093048|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83093049|NCT04313075|Leronlimab|leronlimab|mesh-list
83093050|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83093051|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83093052|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093053|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83093054|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83093055|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
83093056|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093057|NCT03241550|Isavuconazole|isavuconazole|mesh-list
83093058|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
83093059|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093060|NCT03241706|Glucagon|glucagon|mesh-list
83093061|NCT03241706|Somatostatin|somatostatin|mesh-list
83093062|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093063|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093064|NCT03241706|Hormones|hormones|mesh-ancestor
83093065|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093066|NCT03237416|Midazolam|midazolam|mesh-list
83093067|NCT03237416|Dabigatran|dabigatran|mesh-list
83093068|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83093069|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83093070|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093071|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093072|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83093073|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83093074|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83093075|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83093076|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
83093077|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
83093078|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
83093079|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
83093080|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093081|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093082|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
83093083|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83093084|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
83093085|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093086|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
83093087|NCT05211011|Fosfomycin|fosfomycin|mesh-list
83093088|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093089|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093090|NCT03312400|Danazol|danazol|mesh-list
83093091|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83093092|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
83093093|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093094|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093095|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
83093096|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83093097|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83093098|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093099|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
83093100|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093101|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093102|NCT04094519|Digoxin|digoxin|mesh-list
83093103|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83093104|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83093105|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093106|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
83093107|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093108|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093109|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83093110|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093111|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83093112|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83093113|NCT04094519|Protective Agents|protective agents|mesh-ancestor
83093114|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093115|NCT02189798|Imidacloprid|imidacloprid|mesh-list
83093116|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
83093117|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093118|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093119|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093120|NCT03107702|Melatonin|melatonin|mesh-list
83093121|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
83093122|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093123|NCT03107702|Protective Agents|protective agents|mesh-ancestor
83093124|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093125|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093126|NCT02554318|Rifampin|rifampin|mesh-list
83093127|NCT02554318|Isoniazid|isoniazid|mesh-list
83093128|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
83093129|NCT02554318|Ethambutol|ethambutol|mesh-list
83093130|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83093131|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
83093132|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093133|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093134|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
83093135|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83093136|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093137|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093138|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83093139|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83093140|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83093141|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83093142|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83093143|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83093144|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83093145|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093146|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
83093147|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093148|NCT03587662|Gemcitabine|gemcitabine|mesh-list
83093149|NCT03587662|Doxorubicin|doxorubicin|mesh-list
83093150|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83093151|NCT03587662|Daunorubicin|daunorubicin|mesh-list
83093152|NCT03587662|Ixazomib|ixazomib|mesh-list
83093153|NCT03587662|Glycine|glycine|mesh-list
83093154|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83093155|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
83093156|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093157|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093158|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83093159|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83093160|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83093161|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093162|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
83093163|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
83093164|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093165|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093166|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
83093167|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83093168|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
83093169|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093170|NCT03976973|Expectorants|expectorants|mesh-ancestor
83093171|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
83093172|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83093173|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
83093174|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093175|NCT03976973|Protective Agents|protective agents|mesh-ancestor
83093176|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093177|NCT03976973|Antidotes|antidotes|mesh-ancestor
83093178|NCT04066751|Ivacaftor|ivacaftor|mesh-list
83093179|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83093180|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83093181|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093182|NCT02550106|Omalizumab|omalizumab|mesh-list
83093183|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83093184|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83093185|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
83093186|NCT03237260|Vedolizumab|vedolizumab|mesh-list
83093187|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093188|NCT03247400|Atorvastatin|atorvastatin|mesh-list
83093189|NCT03247400|Simvastatin|simvastatin|mesh-list
83093190|NCT03247400|Calcium|calcium|mesh-list
83093191|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83093192|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093193|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83093194|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093195|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
83093196|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093197|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093198|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83093199|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093200|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83093201|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
83093202|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093203|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093204|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83093205|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83093206|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
83093207|NCT02453516|Epinephrine|epinephrine|mesh-list
83093208|NCT02453516|Ropivacaine|ropivacaine|mesh-list
83093209|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
83093210|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
83093211|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093212|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093213|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
83093214|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093215|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83093216|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83093217|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
83093218|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093219|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093220|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83093221|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83093222|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
83093223|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83093224|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
83093225|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
83093226|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
83093227|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83093228|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
83093229|NCT03716609|Citric Acid|citric acid|mesh-list
83093230|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
83093231|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
83093232|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83093233|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
83093234|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
83093235|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093236|NCT03716609|Cathartics|cathartics|mesh-ancestor
83093237|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093238|NCT03709355|Clarithromycin|clarithromycin|mesh-list
83093239|NCT03709355|Rifampin|rifampin|mesh-list
83093240|NCT03709355|Rifabutin|rifabutin|mesh-list
83093241|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
83093242|NCT03709355|Omeprazole|omeprazole|mesh-list
83093243|NCT03709355|Atorvastatin|atorvastatin|mesh-list
83093244|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
83466483|NCT00002212|Bexarotene|bexarotene|mesh-list
83093245|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83093246|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83093247|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83093248|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093249|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
83093250|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093251|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093252|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83093253|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093254|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83093255|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093256|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83093257|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093258|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093259|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83093260|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83093261|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83093262|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83093263|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
83093264|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83093265|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093266|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83093267|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83093268|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83093269|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83093270|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
83093271|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
83093272|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83093273|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83093274|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83093275|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83093276|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83093277|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83093278|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83093279|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83093280|NCT03709355|Estrogens|estrogens|mesh-ancestor
83093281|NCT03709355|Hormones|hormones|mesh-ancestor
83093282|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093283|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83093284|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83093285|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
83093286|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83093287|NCT05209217|Ketamine|ketamine|mesh-list
83093288|NCT05209217|Analgesics|analgesics|mesh-ancestor
83093289|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
83093290|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093291|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093292|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83093293|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83093294|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
83093295|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
83093296|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093297|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83093298|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83093299|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093300|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093301|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83093302|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83093303|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83093304|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093305|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093306|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83093307|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83093308|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83093309|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
83093310|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093311|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093312|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83093313|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83093314|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
83093315|NCT00700622|Insulin|insulin|mesh-list
83093316|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83093317|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
83093318|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
83093319|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83093320|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093321|NCT03628625|Letrozole|letrozole|mesh-list
83093322|NCT03628625|Misoprostol|misoprostol|mesh-list
83093323|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093324|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83093325|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83093326|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093327|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093328|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83093329|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
83093330|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093331|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093332|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83093333|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
83093334|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83093335|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83093336|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093337|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
83093338|NCT02553928|Memantine|memantine|mesh-list
83093339|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83093340|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83093341|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
83093342|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093343|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093344|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093345|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83093346|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83093347|NCT03908255|Vitamins|vitamins|mesh-list
83093348|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
83093349|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093350|NCT03246776|Triclosan|triclosan|mesh-list
83093351|NCT03246776|Halometasone|halometasone|mesh-list
83093352|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83093353|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093354|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83093355|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093356|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
83093357|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093358|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093359|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093360|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83093361|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
83093362|NCT03246776|Hormones|hormones|mesh-ancestor
83093363|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093364|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093365|NCT03246386|Posaconazole|posaconazole|mesh-list
83093366|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
83093367|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093368|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83093369|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83093370|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83093371|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83093372|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83093373|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093374|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093375|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83093376|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
83093377|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093378|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093379|NCT03851081|Vincristine|vincristine|mesh-list
83093380|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83093381|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83093382|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093383|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
83093384|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
83093385|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
83093386|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093387|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83093388|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83093389|NCT03851081|Immunotoxins|immunotoxins|mesh-ancestor
83093390|NCT03851081|Immunoconjugates|immunoconjugates|mesh-ancestor
83093391|NCT03851081|Immunologic Factors|immunologic factors|mesh-ancestor
83093392|NCT03851081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093393|NCT03239600|Methotrexate|methotrexate|mesh-list
83093394|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83093395|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
83093396|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83093397|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093398|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83093399|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
83093400|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093401|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093402|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
83093403|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093404|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83093405|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83093406|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
83093407|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093408|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83093409|NCT02966093|Lenvatinib|lenvatinib|mesh-list
83093410|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093411|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83093412|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093413|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093414|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
83093415|NCT03229616|Busulfan|busulfan|mesh-list
83093416|NCT03229616|Etoposide|etoposide|mesh-list
83093417|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83093418|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
83093419|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093420|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093421|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83093422|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
83093423|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093424|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093425|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83093426|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83093427|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83093428|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83093429|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093430|NCT03234764|Immunomodulating Agents|immunomodulating agents|mesh-list
83093431|NCT03234764|Immunologic Factors|immunologic factors|mesh-ancestor
83093432|NCT03234764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093434|NCT03234842|Carboplatin|carboplatin|mesh-list
83093435|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83093436|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093437|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
83093438|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
83093439|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
83093440|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093441|NCT03229148|Anesthetics|anesthetics|mesh-list
83093442|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093443|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093444|NCT03228992|Ibuprofen|ibuprofen|mesh-list
83093445|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83093446|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093447|NCT03228992|Analgesics|analgesics|mesh-ancestor
83093448|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
83093449|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093450|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093451|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093452|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093453|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83093454|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093455|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093456|NCT02627963|Sorafenib|sorafenib|mesh-list
83093457|NCT02627963|Tivozanib|tivozanib|mesh-list
83093458|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093459|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83093460|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093461|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093462|NCT02452502|Atorvastatin|atorvastatin|mesh-list
83093463|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83093464|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093465|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
83093466|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093467|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093468|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83093469|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093470|NCT03234296|Metronidazole|metronidazole|mesh-list
83093471|NCT03234296|Levofloxacin|levofloxacin|mesh-list
83093472|NCT03234296|Ertapenem|ertapenem|mesh-list
83093473|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093474|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093475|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83093476|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83093477|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83093478|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83093479|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83093480|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093481|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093482|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093483|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83093484|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83093485|NCT03228368|Atezolizumab|atezolizumab|mesh-list
83093486|NCT03228368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83093487|NCT03228368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093488|NCT03228368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83093489|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093490|NCT03665129|Avdoralimab|avdoralimab|mesh-list
83093491|NCT03665129|Durvalumab|durvalumab|mesh-list
83093492|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83093493|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093494|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093495|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
83093496|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093497|NCT03235700|Nicorandil|nicorandil|mesh-list
83093498|NCT03235700|Adenosine|adenosine|mesh-list
83093499|NCT03235700|Analgesics|analgesics|mesh-ancestor
83093500|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
83093501|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093502|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093503|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83093504|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
83093505|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83093506|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
83093507|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
83093508|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093509|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093510|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83093511|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
83093512|NCT03235700|Vitamins|vitamins|mesh-ancestor
83093513|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
83093514|NCT03234062|Choline|choline|mesh-list
83093515|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
83093516|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093517|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
83093518|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093519|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83466503|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
83093520|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093521|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
83093522|NCT05702879|Prednisolone|prednisolone|mesh-list
83093523|NCT05702879|Adalimumab|adalimumab|mesh-list
83093524|NCT05702879|Infliximab|infliximab|mesh-list
83093525|NCT05702879|Etanercept|etanercept|mesh-list
83093526|NCT05702879|Golimumab|golimumab|mesh-list
83093527|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83093528|NCT05702879|Ustekinumab|ustekinumab|mesh-list
83093529|NCT05702879|Vedolizumab|vedolizumab|mesh-list
83093530|NCT05702879|Ozanimod|ozanimod|mesh-list
83093531|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093532|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
83093533|NCT05702879|Hormones|hormones|mesh-ancestor
83093534|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093535|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093536|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83093537|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093538|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093539|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093541|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
83093542|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83093543|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093544|NCT05702879|Analgesics|analgesics|mesh-ancestor
83093545|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
83093546|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83093547|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
83093548|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83093549|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093550|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
83093551|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83093552|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093553|NCT03235778|Analgesics|analgesics|mesh-ancestor
83093554|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
83093555|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093556|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093557|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093558|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093559|NCT04439513|Hemostatics|hemostatics|mesh-list
83093560|NCT04439513|Coagulants|coagulants|mesh-ancestor
83093561|NCT02452970|Gemcitabine|gemcitabine|mesh-list
83093562|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093563|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83093564|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
83093565|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093566|NCT03227900|Lidocaine|lidocaine|mesh-list
83093567|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
83093568|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
83093569|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093570|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093571|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
83093572|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093573|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83093574|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83093575|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83093576|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83093577|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093578|NCT03120182|Aspirin|aspirin|mesh-list
83093579|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83093580|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093581|NCT03120182|Analgesics|analgesics|mesh-ancestor
83093582|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
83093583|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093584|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093585|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093586|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093587|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83093588|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83093589|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093590|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83093591|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83093592|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093593|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
83093594|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
83093595|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83093596|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83093597|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093598|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
83093599|NCT02074436|Coagulants|coagulants|mesh-ancestor
83093600|NCT03227432|Dexamethasone|dexamethasone|mesh-list
83093601|NCT03227432|Nivolumab|nivolumab|mesh-list
83093602|NCT03227432|Pomalidomide|pomalidomide|mesh-list
83093603|NCT03227432|Elotuzumab|elotuzumab|mesh-list
83093604|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093605|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
83093606|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
83093607|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093608|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093609|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093610|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
83093611|NCT03227432|Hormones|hormones|mesh-ancestor
83093612|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093613|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83093614|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093615|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83093616|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83093617|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093618|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
83093619|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83093620|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83093621|NCT03227432|Growth Substances|growth substances|mesh-ancestor
83093622|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
83093623|NCT03222518|Acetaminophen|acetaminophen|mesh-list
83093624|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83093625|NCT03222518|Piroxicam|piroxicam|mesh-list
83093626|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093627|NCT03222518|Analgesics|analgesics|mesh-ancestor
83093628|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
83093629|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093630|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093631|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
83093632|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093633|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093634|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83093635|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093636|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093637|NCT01750281|Docetaxel|docetaxel|mesh-list
83093638|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093639|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83093640|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83093641|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83093642|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093643|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83093644|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83093645|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093647|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
83093648|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093649|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093650|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093651|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093652|NCT03221816|Folic Acid|folic acid|mesh-list
83093653|NCT03221816|Pyridoxine|pyridoxine|mesh-list
83093654|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
83093655|NCT03221816|Hematinics|hematinics|mesh-ancestor
83093656|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
83093657|NCT03221816|Vitamins|vitamins|mesh-ancestor
83093658|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
83093659|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093660|NCT03119636|Levodopa|levodopa|mesh-list
83093661|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83466512|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
83093662|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83093663|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
83093664|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093665|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093666|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093667|NCT03226340|Niacin|niacin|mesh-list
83093668|NCT03226340|Amlodipine|amlodipine|mesh-list
83093669|NCT03226340|Telmisartan|telmisartan|mesh-list
83093670|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
83093671|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83093672|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83093673|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83093674|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093675|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83093676|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093677|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
83093678|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83093679|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83093680|NCT03226340|Diuretics|diuretics|mesh-ancestor
83093681|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
83093682|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83093683|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093684|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
83093685|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093686|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
83093687|NCT03226340|Vitamins|vitamins|mesh-ancestor
83093688|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
83093689|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
83093690|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83093691|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83093692|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
83093693|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093694|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093695|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093696|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
83093697|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
83093698|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093699|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
83093700|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83093701|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83093702|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83093703|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
83093704|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093705|NCT03232034|Calcium|calcium|mesh-list
83093706|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83093707|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093708|NCT03225950|Antibodies|antibodies|mesh-list
83093709|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
83093710|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093711|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
83093712|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83093713|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83093714|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093715|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
83093716|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093717|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093718|NCT03232112|Exenatide|exenatide|mesh-list
83093719|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83093720|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093721|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83093723|NCT03232112|Hormones|hormones|mesh-ancestor
83093724|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093725|NCT03000569|Levodopa|levodopa|mesh-list
83093726|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
83093727|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83093728|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
83093729|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093730|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093731|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093732|NCT02554786|Fluticasone|fluticasone|mesh-list
83093733|NCT02554786|Xhance|xhance|mesh-list
83093734|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
83093735|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83093736|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093737|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83093738|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
83093739|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093740|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093741|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83093742|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
83093743|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
83093744|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83093745|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83093746|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83093747|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83093748|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
83093749|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093750|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093751|NCT05202314|Immunomodulating Agents|immunomodulating agents|mesh-list
83093752|NCT05202314|Immunologic Factors|immunologic factors|mesh-ancestor
83093753|NCT05202314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093754|NCT03225326|Carticaine|carticaine|mesh-list
83093755|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
83093756|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
83093757|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093758|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093759|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
83093760|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093761|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
83093762|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83093763|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093764|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093765|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093766|NCT03220880|Analgesics|analgesics|mesh-ancestor
83093767|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
83093768|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093769|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83093770|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83093771|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83093772|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
83093773|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093774|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093775|NCT02929589|Ibuprofen|ibuprofen|mesh-list
83093776|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
83093777|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83093778|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83093779|NCT02929589|Analgesics|analgesics|mesh-ancestor
83093780|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
83093781|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093782|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093783|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093784|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83093785|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83093786|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093787|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093788|NCT02929589|Narcotics|narcotics|mesh-ancestor
83093789|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093790|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
83093791|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093792|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093793|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83093794|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83093795|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093796|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093797|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093798|NCT02614547|Brexanolone|brexanolone|mesh-list
83093799|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
83466524|NCT00002368|Lamivudine|lamivudine|mesh-list
83093800|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093801|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093802|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093803|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
83093804|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
83093805|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
83093806|NCT04472481|Vitamin D|vitamin d|mesh-list
83093807|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83093808|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093809|NCT04472481|Vitamins|vitamins|mesh-ancestor
83093810|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
83093811|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83093812|NCT01233297|Azithromycin|azithromycin|mesh-list
83093813|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093814|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093815|NCT04681079|Albuterol|albuterol|mesh-list
83093816|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83093817|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
83093818|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093819|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093820|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83093821|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
83093822|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
83093823|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83093824|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83093825|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83093826|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83093827|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
83093828|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093829|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093830|NCT00580125|Aripiprazole|aripiprazole|mesh-list
83093831|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
83093832|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83093833|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83093834|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83093835|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093836|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093837|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
83093838|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
83093839|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093840|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093841|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83093842|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83093843|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
83093844|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83093845|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83093846|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83093847|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83093848|NCT01179009|Clonidine|clonidine|mesh-list
83093849|NCT01179009|Scopolamine|scopolamine|mesh-list
83093850|NCT01179009|Ketamine|ketamine|mesh-list
83093851|NCT01179009|Lorazepam|lorazepam|mesh-list
83093852|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83093853|NCT01179009|Analgesics|analgesics|mesh-ancestor
83093854|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
83093855|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093856|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093857|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83093858|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83093859|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
83093860|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
83093861|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093862|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83093863|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83093864|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83093865|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093866|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83093867|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
83093868|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
83093869|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83093870|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83093871|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83093872|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
83093873|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
83093874|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
83093875|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093876|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83093877|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83093878|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83093879|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83093880|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
83093881|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
83093882|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83093883|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
83093884|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83093885|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
83093886|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83093887|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
83093888|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
83093889|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83093890|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093891|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093892|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83093893|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83093894|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093895|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093896|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093897|NCT00667953|Temozolomide|temozolomide|mesh-list
83093898|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
83093899|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83093900|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
83093901|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093902|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093903|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83093904|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093905|NCT00578955|Azithromycin|azithromycin|mesh-list
83093906|NCT00578955|Dexamethasone|dexamethasone|mesh-list
83093907|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
83093908|NCT00578955|BB 1101|bb 1101|mesh-list
83093909|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093910|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
83093911|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
83093912|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093913|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093914|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093915|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
83093916|NCT00578955|Hormones|hormones|mesh-ancestor
83093917|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093918|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83093919|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093920|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
83093921|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093922|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093923|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093924|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093925|NCT00576537|Immunomodulating Agents|immunomodulating agents|mesh-list
83093926|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
83093927|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093928|NCT02282241|Melatonin|melatonin|mesh-list
83093929|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
83093930|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093931|NCT02282241|Protective Agents|protective agents|mesh-ancestor
83093932|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093933|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83093934|NCT02424851|Thalidomide|thalidomide|mesh-list
83093935|NCT02424851|Dexamethasone|dexamethasone|mesh-list
83093936|NCT02424851|Bortezomib|bortezomib|mesh-list
83093937|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83093938|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83093939|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
83093940|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
83093941|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093942|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093943|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093944|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
83093945|NCT02424851|Hormones|hormones|mesh-ancestor
83093946|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093947|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83093948|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83093949|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83093950|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
83093951|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093952|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83093953|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
83093954|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
83093955|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83093956|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093957|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83093958|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83093959|NCT02424851|Growth Substances|growth substances|mesh-ancestor
83093960|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
83093961|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
83093962|NCT02284035|Lamivudine|lamivudine|mesh-list
83093963|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83093964|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83093965|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
83093966|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83093967|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83093968|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83093969|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093970|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093971|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83093972|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83093973|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83093974|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
83093975|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83093976|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83093977|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093978|NCT00484419|Incretins|incretins|mesh-ancestor
83093979|NCT00484419|Hormones|hormones|mesh-ancestor
83093980|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83093981|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83093982|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
83093983|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83093984|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83093985|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83093986|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83093987|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
83093988|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83093989|NCT02273895|Scopolamine|scopolamine|mesh-list
83093990|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83093991|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83093992|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
83093993|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
83093994|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83093995|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83093996|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83093997|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
83093998|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83093999|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
83094000|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094001|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094002|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83094003|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
83094004|NCT00480831|Paclitaxel|paclitaxel|mesh-list
83094005|NCT00480831|Bevacizumab|bevacizumab|mesh-list
83094006|NCT00480831|Carboplatin|carboplatin|mesh-list
83094007|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83094008|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094009|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
83094010|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
83094011|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
83094012|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094013|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094014|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83094015|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83094016|NCT00480831|Growth Substances|growth substances|mesh-ancestor
83094017|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094018|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83094019|NCT02549092|Levodopa|levodopa|mesh-list
83094020|NCT02549092|Carbidopa|carbidopa|mesh-list
83094021|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83094022|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83094023|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83094024|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
83094025|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094026|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094027|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094028|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83094029|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094030|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83094031|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
83094032|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
83094033|NCT03220256|Lamotrigine|lamotrigine|mesh-list
83094034|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
83094035|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83094036|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094037|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094038|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83094039|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094040|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83094041|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83094042|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094043|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83094044|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83094045|NCT03220490|Timolol|timolol|mesh-list
83094046|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83094047|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83094048|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83094049|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
83094050|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094051|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094052|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094053|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83094054|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83094055|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83094056|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83094057|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83094058|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83094059|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83094060|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83094061|NCT02553772|Laxatives|laxatives|mesh-ancestor
83094062|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094063|NCT03119714|Pemirolast|pemirolast|mesh-list
83094064|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
83094065|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
83094066|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094067|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094068|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094069|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83094070|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
83094071|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094072|NCT05468554|Metformin|metformin|mesh-list
83094073|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83094074|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094075|NCT04617821|Paclitaxel|paclitaxel|mesh-list
83094076|NCT04617821|Gemcitabine|gemcitabine|mesh-list
83094077|NCT04617821|Folfirinox|folfirinox|mesh-list
83094078|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83094079|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094080|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
83094081|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
83094082|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
83094083|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094084|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83094085|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
83094086|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
83094087|NCT03219008|Mirtazapine|mirtazapine|mesh-list
83094088|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
83094089|NCT03219008|Fluoxetine|fluoxetine|mesh-list
83094090|NCT03219008|Bupropion|bupropion|mesh-list
83094091|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
83094092|NCT03219008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83094093|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83094094|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094095|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094096|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094097|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
83094098|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094099|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83094100|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
83094101|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83094102|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83094103|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83094104|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094105|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
83094106|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83094107|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094108|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83094109|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
83094110|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
83094111|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83094112|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83094113|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83094114|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83094115|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
83094116|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83094117|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83094118|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83094119|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83094120|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83094121|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83094122|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
83094123|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83094124|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83094125|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094126|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
83094127|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
83094128|NCT00562497|Prednisone|prednisone|mesh-list
83094129|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
83094130|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83094131|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
83094132|NCT00562497|Hormones|hormones|mesh-ancestor
83094133|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094134|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094135|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83094136|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094137|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
83094138|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
83094139|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094140|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094141|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83094142|NCT00562497|Protective Agents|protective agents|mesh-ancestor
83094143|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
83094144|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094145|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83094146|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83094147|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
83094148|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094149|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094150|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83094151|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83094152|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83094153|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83094154|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83094155|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83094156|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094157|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094158|NCT01503515|Fluconazole|fluconazole|mesh-list
83094159|NCT01503515|Voriconazole|voriconazole|mesh-list
83094160|NCT01503515|Caspofungin|caspofungin|mesh-list
83094161|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
83094162|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094163|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83094164|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83094165|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094166|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094167|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83094168|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
83094169|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094170|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094171|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83094172|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83094173|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83094174|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
83094175|NCT00468273|Antibodies|antibodies|mesh-list
83094176|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
83094177|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83094178|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83094179|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
83094180|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094181|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
83094182|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83094183|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
83094184|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094185|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83094186|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094187|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
83094188|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094189|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
83094190|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83094191|NCT03217916|Protective Agents|protective agents|mesh-ancestor
83094192|NCT00468117|Etanercept|etanercept|mesh-list
83094193|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83094194|NCT00468117|Basiliximab|basiliximab|mesh-list
83094195|NCT00468117|Daclizumab|daclizumab|mesh-list
83094196|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83094197|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83094198|NCT00468117|Analgesics|analgesics|mesh-ancestor
83094199|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
83094200|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094201|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094202|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83094203|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094204|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094205|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094206|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
83094207|NCT00468039|Metformin|metformin|mesh-list
83094208|NCT00468039|Vildagliptin|vildagliptin|mesh-list
83094209|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83094210|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094211|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83094212|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
83094213|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094214|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094215|NCT02742519|Ivacaftor|ivacaftor|mesh-list
83094216|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83094217|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094218|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094219|NCT01375010|Vitamin D|vitamin d|mesh-list
83094220|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
83094221|NCT01375010|Vitamins|vitamins|mesh-list
83094222|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
83094223|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094224|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83094225|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83094226|NCT03231176|Capecitabine|capecitabine|mesh-list
83094227|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83094228|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
83094229|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094230|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094231|NCT00467025|Sorafenib|sorafenib|mesh-list
83094232|NCT00467025|Trebananib|trebananib|mesh-list
83094233|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094234|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83094235|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094236|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094237|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83094238|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83094239|NCT00467025|Growth Substances|growth substances|mesh-ancestor
83094240|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094241|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
83094242|NCT03230786|Metformin|metformin|mesh-list
83094243|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83094244|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094245|NCT02451098|Atorvastatin|atorvastatin|mesh-list
83094246|NCT02451098|Ezetimibe|ezetimibe|mesh-list
83094247|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83094248|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83094249|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
83094250|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094251|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83094252|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83094253|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094254|NCT00546273|Vaccines|vaccines|mesh-list
83094255|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
83094256|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094257|NCT02452112|Lidocaine|lidocaine|mesh-list
83094258|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
83094259|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
83094260|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094261|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094262|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
83094263|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094264|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83094265|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83094266|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83094267|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094268|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094269|NCT00659061|Micronutrients|micronutrients|mesh-list
83094270|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094271|NCT02451956|Paclitaxel|paclitaxel|mesh-list
83094272|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83094273|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094274|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
83094275|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
83094276|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
83094277|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094278|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
83094279|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83094280|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
83094281|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094282|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094283|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83094284|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
83094285|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83094286|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
83221020|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83094287|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094288|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094289|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83094290|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
83094291|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
83094292|NCT02725372|Protective Agents|protective agents|mesh-ancestor
83094294|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83094295|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094296|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094297|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
83094298|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094299|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094300|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
83094301|NCT00539721|Ondansetron|ondansetron|mesh-list
83094302|NCT00539721|Rolapitant|rolapitant|mesh-list
83094303|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
83094304|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
83094305|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094306|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094307|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094308|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
83094309|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
83094310|NCT00539721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83094311|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83094312|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
83094313|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094314|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094315|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83094316|NCT00464061|Volinanserin|volinanserin|mesh-list
83094317|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83094318|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
83094319|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094320|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094321|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094322|NCT03230630|Melatonin|melatonin|mesh-list
83094323|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
83094324|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094325|NCT03230630|Protective Agents|protective agents|mesh-ancestor
83094326|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094327|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094328|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83094329|NCT00460941|Incretins|incretins|mesh-ancestor
83094330|NCT00460941|Hormones|hormones|mesh-ancestor
83094331|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094332|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094333|NCT00460317|Paclitaxel|paclitaxel|mesh-list
83094334|NCT00460317|Carboplatin|carboplatin|mesh-list
83094335|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
83094336|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83094337|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094338|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
83094339|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
83094340|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
83094341|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094342|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83094343|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094344|NCT03213548|Daminozide|daminozide|mesh-list
83094345|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83094346|NCT03213548|Growth Substances|growth substances|mesh-ancestor
83094347|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094348|NCT00534027|Conatumumab|conatumumab|mesh-list
83094349|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094350|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094351|NCT02548078|Vaccines|vaccines|mesh-list
83094352|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
83094353|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094354|NCT00532311|Atorvastatin|atorvastatin|mesh-list
83094355|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83094356|NCT00532311|Simvastatin|simvastatin|mesh-list
83094357|NCT00532311|Pravastatin|pravastatin|mesh-list
83094358|NCT00532311|Lovastatin|lovastatin|mesh-list
83094359|NCT00532311|L 647318|l 647318|mesh-list
83094360|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
83094361|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83094362|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83094363|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83094364|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
83094365|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094366|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83094367|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094368|NCT03230474|Morphine|morphine|mesh-list
83094369|NCT03230474|Naloxone|naloxone|mesh-list
83094370|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83094371|NCT03230474|Narcotics|narcotics|mesh-ancestor
83094372|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094373|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094374|NCT03230474|Analgesics|analgesics|mesh-ancestor
83094375|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
83094376|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094377|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83094378|NCT02671435|Bevacizumab|bevacizumab|mesh-list
83094379|NCT02671435|Cetuximab|cetuximab|mesh-list
83094380|NCT02671435|Durvalumab|durvalumab|mesh-list
83094381|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094382|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094383|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83094384|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83094385|NCT02671435|Growth Substances|growth substances|mesh-ancestor
83094386|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094387|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
83094388|NCT05476354|Amlodipine|amlodipine|mesh-list
83094389|NCT05476354|Irbesartan|irbesartan|mesh-list
83094390|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83094391|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83094392|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094393|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094394|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83094395|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094396|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
83094397|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83094398|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83094399|NCT00529503|Rituximab|rituximab|mesh-list
83094400|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
83094401|NCT00529503|Carboplatin|carboplatin|mesh-list
83094402|NCT00529503|Etoposide|etoposide|mesh-list
83094403|NCT00529503|Ifosfamide|ifosfamide|mesh-list
83094404|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094405|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094406|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
83094407|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094408|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094409|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83094410|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83094411|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83094412|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094413|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094414|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83094415|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
83094416|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83094417|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83094418|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
83094419|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094420|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094421|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83094422|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
83094423|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
83094424|NCT05459194|Hormones|hormones|mesh-ancestor
83094425|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094426|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
83094427|NCT05476198|Anesthetics|anesthetics|mesh-list
83094428|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094429|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094430|NCT02280057|Metformin|metformin|mesh-list
83094431|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83094432|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094433|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83094434|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
83094435|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094437|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
83094438|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094439|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094440|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
83094441|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83094442|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094443|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094444|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83094445|NCT02282787|Analgesics|analgesics|mesh-ancestor
83094446|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
83094447|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094448|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83094449|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83094450|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83094451|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83094452|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094453|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094454|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
83094455|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83094456|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094457|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83094458|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83094459|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094460|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094461|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
83094462|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094463|NCT00458601|Temozolomide|temozolomide|mesh-list
83094464|NCT00458601|Molgramostim|molgramostim|mesh-list
83094465|NCT00458601|Rindopepimut|rindopepimut|mesh-list
83094466|NCT00458601|Sargramostim|sargramostim|mesh-list
83094467|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83094468|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
83094469|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094470|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094471|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
83094472|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094473|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094474|NCT00658047|Methotrexate|methotrexate|mesh-list
83094475|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83094476|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
83094477|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83094478|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094479|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83094480|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
83094481|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094482|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094483|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
83094484|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094485|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83094486|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094487|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
83094488|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094489|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83094490|NCT03230162|Heparin|heparin|mesh-list
83094491|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83094492|NCT03230162|Tinzaparin|tinzaparin|mesh-list
83094493|NCT03230162|Dalteparin|dalteparin|mesh-list
83094494|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
83094495|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
83094496|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83094497|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83221021|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
83094498|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094499|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
83094500|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83094501|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83094502|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094503|NCT03230162|Urological Agents|urological agents|mesh-ancestor
83094504|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
83094505|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094506|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83094507|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094508|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094509|NCT02916433|Octreotide|octreotide|mesh-list
83094510|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094511|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83094512|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094513|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83094514|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094515|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83094516|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094517|NCT04059523|Tretinoin|tretinoin|mesh-list
83094518|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094519|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
83094520|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83094521|NCT00657501|Testosterone|testosterone|mesh-list
83094522|NCT00657501|Androgens|androgens|mesh-ancestor
83094523|NCT00657501|Hormones|hormones|mesh-ancestor
83094524|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094525|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094526|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
83094527|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
83094528|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83094529|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094530|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
83094531|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83094532|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83094533|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83094534|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094535|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094536|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094537|NCT03229694|Bosentan|bosentan|mesh-list
83094538|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
83094539|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83094540|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094541|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83094542|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83094543|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094544|NCT03209648|Itraconazole|itraconazole|mesh-list
83094545|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
83094546|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094547|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83094548|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83094549|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094550|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094551|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83094552|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
83094553|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094554|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094555|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83094556|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
83094557|NCT04058899|Nalbuphine|nalbuphine|mesh-list
83094558|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83094559|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094560|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094561|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83094562|NCT04058899|Analgesics|analgesics|mesh-ancestor
83094563|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
83094564|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094565|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83094566|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83094567|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83094568|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
83094569|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094570|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094571|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83094572|NCT04058899|Narcotics|narcotics|mesh-ancestor
83094573|NCT00657189|Sifalimumab|sifalimumab|mesh-list
83094574|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83094575|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
83094576|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094577|NCT03209180|Carvedilol|carvedilol|mesh-list
83094578|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83094579|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83094580|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
83094581|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094582|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094583|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094584|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83094585|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
83094586|NCT03209180|Protective Agents|protective agents|mesh-ancestor
83094587|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83094588|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094589|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83094590|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
83094591|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83094592|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83094593|NCT03215017|Loperamide|loperamide|mesh-list
83094594|NCT03215017|Sorbitol|sorbitol|mesh-list
83094595|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
83094596|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094597|NCT03215017|Cathartics|cathartics|mesh-ancestor
83094598|NCT02500849|Busulfan|busulfan|mesh-list
83094599|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
83094600|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094601|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094602|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
83094603|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094604|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83094605|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094606|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83094607|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
83094608|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83094609|NCT02280447|Vaccines|vaccines|mesh-list
83094610|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
83094611|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094612|NCT00528333|Cytarabine|cytarabine|mesh-list
83094613|NCT00528333|Lintuzumab|lintuzumab|mesh-list
83094614|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83094615|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
83094616|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094617|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094618|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
83094619|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094620|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094621|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
83094622|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094623|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094624|NCT00526227|Clotrimazole|clotrimazole|mesh-list
83094625|NCT00526227|Miconazole|miconazole|mesh-list
83094626|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83094627|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094628|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
83094629|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83094630|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83094631|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094632|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094633|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83094634|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
83094635|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094636|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094637|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83094638|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83094639|NCT02280603|Minoxidil|minoxidil|mesh-list
83094640|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83094641|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
83094642|NCT00524277|Molgramostim|molgramostim|mesh-list
83094643|NCT00524277|Vaccines|vaccines|mesh-list
83094644|NCT00524277|Sargramostim|sargramostim|mesh-list
83094645|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
83094646|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094647|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094648|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83094649|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83094650|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83094651|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
83094652|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094653|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83094654|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83094655|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094656|NCT00650949|Carboplatin|carboplatin|mesh-list
83094657|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094658|NCT00520923|Olanzapine|olanzapine|mesh-list
83094659|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
83094660|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
83094661|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094662|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094663|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094664|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83094665|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83094666|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094667|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83094668|NCT00520923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83094669|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83094670|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83094671|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094672|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094673|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
83094674|NCT02283177|Cytarabine|cytarabine|mesh-list
83094675|NCT02283177|Daunorubicin|daunorubicin|mesh-list
83094676|NCT02283177|Idarubicin|idarubicin|mesh-list
83094677|NCT02283177|Crenolanib|crenolanib|mesh-list
83094678|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83094679|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
83094680|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094681|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094682|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
83094683|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094684|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094685|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
83094686|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094687|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83094688|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83094689|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83094690|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094691|NCT00514371|Bortezomib|bortezomib|mesh-list
83094692|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094693|NCT03214510|Fentanyl|fentanyl|mesh-list
83094694|NCT03214510|Hydromorphone|hydromorphone|mesh-list
83094695|NCT03214510|Bupivacaine|bupivacaine|mesh-list
83094696|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
83094697|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
83094698|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094699|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094700|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
83094701|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094702|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83094703|NCT03214510|Narcotics|narcotics|mesh-ancestor
83094704|NCT03214510|Analgesics|analgesics|mesh-ancestor
83094705|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83094706|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83094707|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
83094708|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83094709|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094710|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83094711|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83094712|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094713|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83094714|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
83094715|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83094716|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83094717|NCT02286453|Diclofenac|diclofenac|mesh-list
83094718|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83094719|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83094720|NCT02286453|Analgesics|analgesics|mesh-ancestor
83094721|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
83094722|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094723|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094724|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83094725|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094726|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83094727|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094728|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094729|NCT00385515|Meclocycline|meclocycline|mesh-list
83094730|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83094731|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094732|NCT02286609|Deflazacort|deflazacort|mesh-list
83094733|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83094734|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094735|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
83094736|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094737|NCT00508989|Niacin|niacin|mesh-list
83094738|NCT00508989|Acetylcholine|acetylcholine|mesh-list
83094739|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83094740|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
83094741|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094742|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83094743|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
83094744|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
83094745|NCT00508989|Vitamins|vitamins|mesh-ancestor
83094746|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
83094747|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094748|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83094749|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
83094750|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094751|NCT05457868|Albuterol|albuterol|mesh-list
83094752|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83094753|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
83094754|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094755|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094756|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83094757|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
83094758|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
83094759|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83094760|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83094761|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83094762|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83094763|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
83094764|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094765|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094766|NCT03104842|Dexamethasone|dexamethasone|mesh-list
83094767|NCT03104842|Lenalidomide|lenalidomide|mesh-list
83094768|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83094769|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
83094770|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
83094771|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094772|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094773|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094774|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
83094775|NCT03104842|Hormones|hormones|mesh-ancestor
83094776|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094777|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83094778|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094779|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
83094780|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83094781|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83094782|NCT03104842|Growth Substances|growth substances|mesh-ancestor
83094783|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
83094784|NCT00436683|Sevelamer|sevelamer|mesh-list
83094785|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
83094786|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
83094787|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094788|NCT00434811|Sirolimus|sirolimus|mesh-list
83094789|NCT00434811|Etanercept|etanercept|mesh-list
83094790|NCT00434811|Tacrolimus|tacrolimus|mesh-list
83094791|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83094792|NCT00434811|Basiliximab|basiliximab|mesh-list
83094793|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094794|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
83094795|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094796|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83094797|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094798|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094799|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83094800|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094801|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83094802|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094803|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
83094804|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83094805|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83094806|NCT00434811|Analgesics|analgesics|mesh-ancestor
83094807|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
83094808|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094809|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83094810|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094811|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094812|NCT03133845|Fentanyl|fentanyl|mesh-list
83094813|NCT03133845|Midazolam|midazolam|mesh-list
83094814|NCT03133845|Morphine|morphine|mesh-list
83094815|NCT03133845|Anesthetics|anesthetics|mesh-list
83094816|NCT03133845|Propofol|propofol|mesh-list
83094817|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83094818|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094819|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83094820|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83094821|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
83094822|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83094823|NCT03133845|Narcotics|narcotics|mesh-ancestor
83094824|NCT03133845|Analgesics|analgesics|mesh-ancestor
83094825|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
83094826|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83094827|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83094828|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83094829|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83094830|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83094831|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
83094832|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
83094833|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83094834|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094835|NCT00120393|Ritonavir|ritonavir|mesh-list
83094836|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83094837|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83094838|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83094839|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
83094841|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094842|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83094843|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83094844|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
83094845|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094846|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83094847|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83094848|NCT05726019|Colchicine|colchicine|mesh-list
83094849|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
83094850|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094851|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
83094852|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
83094853|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
83094854|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094855|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094856|NCT00116415|Lamivudine|lamivudine|mesh-list
83094857|NCT00116415|Efavirenz|efavirenz|mesh-list
83094858|NCT00116415|Didanosine|didanosine|mesh-list
83094859|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83094860|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83094861|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094862|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094863|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
83094864|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094865|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83094866|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83094867|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83094868|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83094869|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83094870|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83094871|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83094872|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83094873|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
83094874|NCT03207698|Metformin|metformin|mesh-list
83094875|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83094876|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094877|NCT03208712|Atezolizumab|atezolizumab|mesh-list
83094878|NCT03208712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83094879|NCT03208712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094880|NCT03208712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094881|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094882|NCT03201380|Choline|choline|mesh-list
83094883|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
83094884|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83094885|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
83094886|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094887|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83094888|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83094889|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
83094890|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
83094891|NCT03208556|Fludarabine|fludarabine|mesh-list
83094892|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094893|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
83094894|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094895|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83094896|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83094897|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
83094898|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094899|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094900|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83094901|NCT00429429|Immunomodulating Agents|immunomodulating agents|mesh-list
83094902|NCT00429429|Immunologic Factors|immunologic factors|mesh-ancestor
83094903|NCT00429429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094904|NCT03201146|Cisplatin|cisplatin|mesh-list
83094905|NCT03201146|Carboplatin|carboplatin|mesh-list
83094906|NCT03201146|Pemetrexed|pemetrexed|mesh-list
83094907|NCT03201146|Apatinib|apatinib|mesh-list
83094908|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094909|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094910|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094911|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83094912|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83094913|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83094915|NCT00370383|Satraplatin|satraplatin|mesh-list
83094916|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094917|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83094918|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094919|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094920|NCT00367887|Ribavirin|ribavirin|mesh-list
83094921|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
83094922|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83094923|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
83094924|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
83094925|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094926|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
83094927|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83094928|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094929|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
83094930|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094931|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83094932|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83094933|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83094934|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
83094935|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094936|NCT03207308|Vitamin A|vitamin a|mesh-list
83094937|NCT03207308|Vitamins|vitamins|mesh-ancestor
83094938|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
83094939|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094940|NCT00366795|Satavaptan|satavaptan|mesh-list
83094941|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83094942|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094943|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
83094944|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094945|NCT00422019|Rilotumumab|rilotumumab|mesh-list
83094946|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83094947|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094948|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094949|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
83094950|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094951|NCT03207542|Daratumumab|daratumumab|mesh-list
83094952|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094953|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
83094954|NCT00360867|Imetelstat|imetelstat|mesh-list
83094955|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83094956|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094957|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094958|NCT02287389|Mitomycins|mitomycins|mesh-list
83094959|NCT02287389|Mitomycin|mitomycin|mesh-list
83094960|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83094961|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094962|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
83094963|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094964|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83094965|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094966|NCT00057993|Trastuzumab|trastuzumab|mesh-list
83094967|NCT00057993|Exemestane|exemestane|mesh-list
83094968|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83094969|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094970|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83094971|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83094972|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094973|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094974|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83094975|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
83094976|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83094977|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83094978|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
83094979|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
83094980|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83094981|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83094982|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83094983|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094984|NCT02284737|Urological Agents|urological agents|mesh-ancestor
83094985|NCT02448290|Docetaxel|docetaxel|mesh-list
83094986|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83094987|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
83094989|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
83094990|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094991|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83094992|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83094993|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83094994|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83094995|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83094996|NCT00055575|Scopolamine|scopolamine|mesh-list
83094997|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83094998|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83094999|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
83095000|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
83095001|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095002|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095003|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83095004|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
83095005|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83095006|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
83095007|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095008|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095009|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83095010|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
83095011|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
83095012|NCT00051129|Anecortave|anecortave|mesh-list
83095013|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83095014|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83095015|NCT00051129|Growth Substances|growth substances|mesh-ancestor
83095016|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095017|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
83095018|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095019|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095020|NCT03200600|Dexamethasone|dexamethasone|mesh-list
83095021|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
83095022|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
83095023|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83095024|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83095025|NCT03200600|BB 1101|bb 1101|mesh-list
83095026|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095027|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
83095028|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
83095029|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095030|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095031|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83095032|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
83095033|NCT03200600|Hormones|hormones|mesh-ancestor
83095034|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095035|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095036|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095038|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095039|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095040|NCT03200600|Analgesics|analgesics|mesh-ancestor
83095041|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
83095042|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83095043|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83095044|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095045|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83095046|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
83095047|NCT02547454|Hematinics|hematinics|mesh-ancestor
83095048|NCT01491893|Vaccines|vaccines|mesh-list
83095049|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
83095050|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095051|NCT00049959|Verteporfin|verteporfin|mesh-list
83095052|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83095053|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
83095054|NCT03119324|Nimesulide|nimesulide|mesh-list
83095055|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83095056|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83095057|NCT03119324|Analgesics|analgesics|mesh-ancestor
83095058|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
83095059|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095060|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095061|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095062|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095063|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83095064|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095065|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095066|NCT00415623|Amlodipine|amlodipine|mesh-list
83095067|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83095068|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83095069|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83466607|NCT00002386|Indinavir|indinavir|mesh-list
83095070|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095071|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83095072|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095073|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
83095074|NCT03133923|Vaccines|vaccines|mesh-list
83095075|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
83095076|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095077|NCT03134001|Analgesics|analgesics|mesh-list
83095078|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
83095079|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095080|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095081|NCT01969409|Rituximab|rituximab|mesh-list
83095082|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095083|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095084|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
83095085|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095086|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095087|NCT05218577|Selenium|selenium|mesh-list
83095088|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
83095089|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095090|NCT05218577|Protective Agents|protective agents|mesh-ancestor
83095091|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095092|NCT05218577|Trace Elements|trace elements|mesh-ancestor
83095093|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
83095094|NCT00150813|Levetiracetam|levetiracetam|mesh-list
83095095|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
83095096|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
83095097|NCT02712788|Milrinone|milrinone|mesh-list
83095098|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83095099|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83095100|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
83095101|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83095102|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83095103|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095104|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095105|NCT02712788|Protective Agents|protective agents|mesh-ancestor
83095106|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095107|NCT00035529|Abatacept|abatacept|mesh-list
83095108|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83095109|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095110|NCT00035529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095111|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095112|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095113|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
83095114|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095115|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095116|NCT04470609|Vaccines|vaccines|mesh-list
83095117|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
83095118|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095119|NCT00356109|Insulin|insulin|mesh-list
83095120|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83095121|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
83095122|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095123|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095124|NCT03206138|Imiquimod|imiquimod|mesh-list
83095125|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83095126|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
83095127|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095128|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095129|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
83095130|NCT04530305|Upadacitinib|upadacitinib|mesh-list
83095131|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83095132|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83095133|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095134|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095135|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095136|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
83095137|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83095138|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
83095139|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095140|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83095141|NCT00006225|Protective Agents|protective agents|mesh-ancestor
83095142|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
83095143|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095144|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
83095145|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
83095146|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095147|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095148|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
83095149|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83095150|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83095151|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
83095152|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095153|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095154|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095155|NCT04477265|Urological Agents|urological agents|mesh-ancestor
83095156|NCT00353457|Capecitabine|capecitabine|mesh-list
83095157|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
83095158|NCT00353457|Cetuximab|cetuximab|mesh-list
83095159|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095160|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
83095161|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095162|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095163|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095164|NCT00411099|Agomelatine|agomelatine|mesh-list
83095165|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83095166|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095167|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095168|NCT03195530|Propofol|propofol|mesh-list
83095169|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83095170|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095171|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095172|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83095173|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
83095174|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
83095175|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
83095176|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83095177|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83095178|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83095179|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
83095180|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095181|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83095182|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83095183|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095184|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095185|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095186|NCT00406809|Navitoclax|navitoclax|mesh-list
83095187|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095188|NCT03200210|Febuxostat|febuxostat|mesh-list
83095189|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
83095190|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095191|NCT00004899|Etoposide|etoposide|mesh-list
83095192|NCT00004899|Busulfan|busulfan|mesh-list
83095193|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83095194|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095195|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83095196|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83095197|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095198|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095199|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
83095200|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095201|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
83095202|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095203|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83095204|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83095205|NCT03199976|Fluticasone|fluticasone|mesh-list
83095206|NCT03199976|Xhance|xhance|mesh-list
83095207|NCT03199976|Bromides|bromides|mesh-list
83095208|NCT03199976|Albuterol|albuterol|mesh-list
83095209|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
83095210|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095211|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83095212|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
83095213|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095214|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095215|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83095216|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
83095217|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
83095218|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83095219|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
83095220|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83095221|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
83095222|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095223|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095224|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
83095225|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
83095226|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83095227|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83095228|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83095229|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83095230|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
83095232|NCT00369317|Etoposide|etoposide|mesh-list
83095233|NCT00369317|Daunorubicin|daunorubicin|mesh-list
83095234|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
83095235|NCT00369317|Asparaginase|asparaginase|mesh-list
83095236|NCT00369317|Thioguanine|thioguanine|mesh-list
83095237|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83095238|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095239|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83095240|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83095241|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095242|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095243|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095244|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
83095245|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
83095246|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095247|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095248|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
83095249|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095250|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83095251|NCT02447666|Azacitidine|azacitidine|mesh-list
83095252|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095253|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
83095254|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095255|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095256|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095257|NCT04469829|Methotrexate|methotrexate|mesh-list
83095258|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83095259|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
83095260|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83095261|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095262|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095263|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
83095264|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095265|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095266|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
83095267|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095268|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83095269|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095270|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
83095271|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095272|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095274|NCT00405951|Obatoclax|obatoclax|mesh-list
83095275|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095276|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
83095277|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
83095278|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095279|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095280|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095281|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83095282|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83095283|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095284|NCT03669757|Betamethasone|betamethasone|mesh-list
83095285|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
83095286|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83095287|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
83095288|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83095289|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095290|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
83095291|NCT03669757|Hormones|hormones|mesh-ancestor
83095292|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095293|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095294|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83095295|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
83095296|NCT02303821|Cytarabine|cytarabine|mesh-list
83095297|NCT02303821|Dexamethasone|dexamethasone|mesh-list
83095298|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
83095299|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
83095300|NCT02303821|Methotrexate|methotrexate|mesh-list
83095301|NCT02303821|Vincristine|vincristine|mesh-list
83095302|NCT02303821|Daunorubicin|daunorubicin|mesh-list
83095303|NCT02303821|Asparaginase|asparaginase|mesh-list
83095304|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
83095305|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
83095306|NCT02303821|Pegaspargase|pegaspargase|mesh-list
83095307|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095308|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
83095309|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095310|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095311|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83095312|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
83095313|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095314|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095315|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83095316|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095317|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
83095318|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
83095319|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095320|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83095321|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
83095322|NCT02303821|Hormones|hormones|mesh-ancestor
83095323|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095324|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095325|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83095326|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
83095327|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83095328|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095329|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
83095330|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
83095331|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095332|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83095333|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095334|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
83095335|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095336|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83095337|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
83095338|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
83095339|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095340|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83095341|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83095342|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83095343|NCT02303821|Analgesics|analgesics|mesh-ancestor
83095344|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
83095345|NCT03913091|Bupivacaine|bupivacaine|mesh-list
83095346|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
83095347|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
83095348|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095349|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095350|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
83095351|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095352|NCT00330369|Darusentan|darusentan|mesh-list
83095353|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83095354|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095355|NCT03199664|Tacrolimus|tacrolimus|mesh-list
83095356|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095357|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
83095358|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095359|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83095360|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095361|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095363|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095364|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095365|NCT05674643|Acetaminophen|acetaminophen|mesh-list
83095366|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83095367|NCT05674643|Analgesics|analgesics|mesh-ancestor
83095368|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
83095369|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095370|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095371|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
83095372|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
83095373|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095374|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
83095375|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095376|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095377|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095378|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
83095379|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095380|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095381|NCT03179917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83095382|NCT03179917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095383|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
83095384|NCT05216237|Apatinib|apatinib|mesh-list
83095385|NCT05216237|Tegafur|tegafur|mesh-list
83095386|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095387|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83095388|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095389|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095390|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095391|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
83095392|NCT00322257|Insulin|insulin|mesh-list
83095393|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83095394|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
83095395|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
83095396|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095397|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095398|NCT03674671|Ketamine|ketamine|mesh-list
83095399|NCT03674671|Analgesics|analgesics|mesh-ancestor
83095400|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
83095401|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095402|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095403|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83095404|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83095405|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
83095406|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
83095407|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095408|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83095409|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83095410|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095411|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095412|NCT00312975|Tremelimumab|tremelimumab|mesh-list
83095414|NCT03199820|Dinoprostone|dinoprostone|mesh-list
83095415|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
83095416|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83095417|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095418|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83095419|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
83095420|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095421|NCT03199430|Protective Agents|protective agents|mesh-ancestor
83095422|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095423|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83095424|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83095425|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095426|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83095428|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
83095429|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095430|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83095431|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095432|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095433|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095434|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83095435|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83095436|NCT01318499|Nepafenac|nepafenac|mesh-list
83095437|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83095438|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83095439|NCT01318499|Analgesics|analgesics|mesh-ancestor
83095440|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
83095441|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095442|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095443|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095444|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095445|NCT00397293|Topotecan|topotecan|mesh-list
83095446|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83095447|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83095448|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095449|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095450|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095451|NCT03628079|Mebendazole|mebendazole|mesh-list
83095452|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
83095453|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
83095454|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83095455|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095456|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
83095457|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
83095458|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095459|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095460|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095461|NCT03204734|Capecitabine|capecitabine|mesh-list
83095462|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095463|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
83095464|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095465|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095466|NCT00396357|Metformin|metformin|mesh-list
83095467|NCT00396357|Vildagliptin|vildagliptin|mesh-list
83095468|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095469|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095470|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83095471|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
83095472|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095473|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095474|NCT00394563|Tanezumab|tanezumab|mesh-list
83095475|NCT00394563|Analgesics|analgesics|mesh-ancestor
83095476|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
83095477|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095478|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095479|NCT02449538|Everolimus|everolimus|mesh-list
83095480|NCT02449538|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83095481|NCT02449538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83095482|NCT02449538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095483|NCT02449538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095484|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095485|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
83095486|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095487|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095489|NCT02446652|Carboplatin|carboplatin|mesh-list
83095490|NCT02446652|Hydralazine|hydralazine|mesh-list
83095491|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83095492|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095493|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
83095494|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
83466639|NCT02168855|Nicotine|nicotine|mesh-list
83095495|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095496|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095497|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83095498|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
83095499|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83095500|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83095501|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83095502|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095503|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095504|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83095505|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83095506|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83095507|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
83095508|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095509|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095510|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83095511|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83095512|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
83095513|NCT00299325|Rimonabant|rimonabant|mesh-list
83095514|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83095515|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83095516|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83095517|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095518|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095519|NCT00299325|Hormones|hormones|mesh-ancestor
83095520|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095521|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095522|NCT00391209|Insulin|insulin|mesh-list
83095523|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83095524|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095525|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095526|NCT02446574|Paclitaxel|paclitaxel|mesh-list
83095527|NCT02446574|Cisplatin|cisplatin|mesh-list
83095528|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83095529|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095530|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
83095531|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
83095532|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095533|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095534|NCT01775813|Metformin|metformin|mesh-list
83095535|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095536|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095537|NCT00287547|Abatacept|abatacept|mesh-list
83095538|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83095539|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095540|NCT00287547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095541|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095542|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095543|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
83095544|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095545|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095546|NCT03204578|Midazolam|midazolam|mesh-list
83095547|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83095548|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83095549|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095550|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095551|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83095552|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83095553|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83095554|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83095555|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
83095556|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
83095557|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
83095558|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
83095559|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095560|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095561|NCT01694069|Tazobactam|tazobactam|mesh-list
83095562|NCT01694069|Piperacillin|piperacillin|mesh-list
83095563|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83095564|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83095565|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466641|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
83095566|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83095567|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095568|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095569|NCT03204032|Thalidomide|thalidomide|mesh-list
83095570|NCT03204032|Temozolomide|temozolomide|mesh-list
83095571|NCT03204032|Tegafur|tegafur|mesh-list
83095572|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83095573|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
83095574|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095575|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095576|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095577|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
83095578|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095579|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
83095580|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83095581|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095582|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83095583|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83095584|NCT03204032|Growth Substances|growth substances|mesh-ancestor
83095585|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
83095586|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095587|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
83095588|NCT02285751|Aspirin|aspirin|mesh-list
83095589|NCT02285751|Clopidogrel|clopidogrel|mesh-list
83095590|NCT02285751|Ticagrelor|ticagrelor|mesh-list
83095591|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83095592|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83095593|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83095594|NCT02285751|Analgesics|analgesics|mesh-ancestor
83095595|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
83095596|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095597|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095598|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095599|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095600|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83095601|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83095602|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095603|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83095604|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83095605|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095606|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
83095607|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83095608|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83095609|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83095610|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
83095611|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095612|NCT02446730|Clopidogrel|clopidogrel|mesh-list
83095613|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83095614|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83095615|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83095616|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83095617|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
83095618|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095619|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095620|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095621|NCT05114915|Docetaxel|docetaxel|mesh-list
83095622|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095623|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
83095624|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
83095625|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095626|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095627|NCT03532035|Brincidofovir|brincidofovir|mesh-list
83095628|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
83095629|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095631|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095632|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095633|NCT03198338|Bupivacaine|bupivacaine|mesh-list
83095634|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
83095635|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
83095636|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095637|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095638|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
83095639|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095640|NCT05222633|Ranibizumab|ranibizumab|mesh-list
83095641|NCT05222633|Aflibercept|aflibercept|mesh-list
83095642|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83095643|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83095644|NCT05222633|Growth Substances|growth substances|mesh-ancestor
83095645|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095646|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
83095647|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095648|NCT05222243|Calcium|calcium|mesh-list
83095649|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83095650|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095651|NCT04469283|Caffeine|caffeine|mesh-list
83095652|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83095653|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095654|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83095655|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095656|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095657|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83095658|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83095659|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
83095660|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095661|NCT02285829|Bromides|bromides|mesh-list
83095662|NCT02285829|Rocuronium|rocuronium|mesh-list
83095663|NCT02285829|Cisatracurium|cisatracurium|mesh-list
83095664|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
83095665|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83095666|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83095667|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83095668|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095669|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095671|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
83095672|NCT03203408|Protective Agents|protective agents|mesh-ancestor
83095673|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095674|NCT02285985|Saxagliptin|saxagliptin|mesh-list
83095675|NCT02285985|Incretins|incretins|mesh-ancestor
83095676|NCT02285985|Hormones|hormones|mesh-ancestor
83095677|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095678|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095679|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83095680|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
83095681|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095682|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095683|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095684|NCT02445872|Dexamethasone|dexamethasone|mesh-list
83095685|NCT02445872|Aprepitant|aprepitant|mesh-list
83095686|NCT02445872|Palonosetron|palonosetron|mesh-list
83095687|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095688|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
83095689|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
83095690|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095691|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095692|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83095693|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
83095694|NCT02445872|Hormones|hormones|mesh-ancestor
83095695|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095696|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095697|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095698|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83095699|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095700|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095701|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83095702|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83095703|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
83095704|NCT05221775|Lenvatinib|lenvatinib|mesh-list
83095705|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095706|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83095707|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095708|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095709|NCT04700423|Ivermectin|ivermectin|mesh-list
83095710|NCT04700423|Albendazole|albendazole|mesh-list
83095711|NCT04700423|Moxidectin|moxidectin|mesh-list
83095713|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095714|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
83095715|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
83095716|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83095717|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83095718|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
83095719|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
83095720|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
83095721|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095722|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095723|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
83095724|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
83095725|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
83095726|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
83095727|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095728|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
83095729|NCT02445716|Testosterone|testosterone|mesh-list
83095730|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
83095731|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
83095732|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83095733|NCT02445716|Androgens|androgens|mesh-ancestor
83095734|NCT02445716|Hormones|hormones|mesh-ancestor
83095735|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095736|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095737|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095738|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095739|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
83095740|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
83095741|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095742|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095743|NCT03197636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83095744|NCT03197636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095745|NCT05724381|Phenol|phenol|mesh-list
83095746|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83095747|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095748|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
83095749|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83095750|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83095751|NCT03194594|Dexamethasone|dexamethasone|mesh-list
83095752|NCT03194594|Ketamine|ketamine|mesh-list
83095753|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095754|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
83095755|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
83095756|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095757|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095758|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83095759|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
83095760|NCT03194594|Hormones|hormones|mesh-ancestor
83095761|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095762|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095763|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095764|NCT03194594|Analgesics|analgesics|mesh-ancestor
83095765|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
83095766|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83095767|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83095768|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
83095769|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
83095770|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095771|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83095772|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83095773|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095774|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095775|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
83095777|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83095778|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
83095779|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83466649|NCT05751850|Leucovorin|leucovorin|mesh-list
83095780|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83095781|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095782|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83095783|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095784|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83095785|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83095786|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
83095787|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83095788|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83095789|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83095790|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83095791|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095792|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
83095793|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83095794|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095795|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83095796|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095797|NCT00257205|Temozolomide|temozolomide|mesh-list
83095798|NCT00257205|Dacarbazine|dacarbazine|mesh-list
83095799|NCT00257205|Tremelimumab|tremelimumab|mesh-list
83095800|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83095801|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
83095802|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095803|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095804|NCT03194204|Doxycycline|doxycycline|mesh-list
83095805|NCT03194204|Uric Acid|uric acid|mesh-list
83095806|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
83095807|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83095808|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095809|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
83095810|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83095811|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83095812|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
83095813|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095814|NCT03194204|Protective Agents|protective agents|mesh-ancestor
83095815|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095816|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
83095817|NCT04045301|Omalizumab|omalizumab|mesh-list
83095818|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83095819|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
83095820|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095821|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83095822|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83095823|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
83095824|NCT03197480|Aflibercept|aflibercept|mesh-list
83095825|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83095826|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83095827|NCT03197480|Growth Substances|growth substances|mesh-ancestor
83095828|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095829|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
83095830|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095831|NCT00151281|Thalidomide|thalidomide|mesh-list
83095832|NCT00151281|Prednisone|prednisone|mesh-list
83095833|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
83095834|NCT00151281|Rituximab|rituximab|mesh-list
83095835|NCT00151281|Etoposide|etoposide|mesh-list
83095836|NCT00151281|Procarbazine|procarbazine|mesh-list
83095837|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095838|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
83095839|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095841|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83095842|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
83095843|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095844|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095845|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83095846|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095847|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095848|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
83095849|NCT00151281|Hormones|hormones|mesh-ancestor
83095850|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095851|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095852|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83095853|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83095854|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83095855|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095856|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
83095857|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83095858|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095859|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83095860|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83095861|NCT00151281|Growth Substances|growth substances|mesh-ancestor
83095862|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83095864|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095865|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095866|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83095867|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83095868|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
83095869|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095870|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095871|NCT00255099|Etravirine|etravirine|mesh-list
83095872|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83095873|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095874|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095875|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095876|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
83095877|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095878|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
83095879|NCT00231153|Povidone|povidone|mesh-list
83095880|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
83095881|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
83095882|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83095883|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095884|NCT03202784|Berotralstat|berotralstat|mesh-list
83095885|NCT03202784|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83095886|NCT03202784|Protease Inhibitors|protease inhibitors|mesh-ancestor
83095887|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095888|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095889|NCT05220527|Triamcinolone|triamcinolone|mesh-list
83095890|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
83095892|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
83095893|NCT05220527|Hormones|hormones|mesh-ancestor
83095894|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095895|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095896|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
83095897|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83095898|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
83095899|NCT05220527|Protective Agents|protective agents|mesh-ancestor
83095900|NCT03197402|Caseins|caseins|mesh-list
83095901|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
83095902|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
83095903|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095904|NCT05723991|Gemcitabine|gemcitabine|mesh-list
83095905|NCT05723991|Disitamab vedotin|disitamab vedotin|mesh-list
83095906|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095907|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
83095908|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095909|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095910|NCT05723991|Immunoconjugates|immunoconjugates|mesh-ancestor
83095911|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
83095912|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095913|NCT01318109|Metformin|metformin|mesh-list
83095914|NCT01318109|Alogliptin|alogliptin|mesh-list
83095915|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83095916|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095917|NCT01318109|Incretins|incretins|mesh-ancestor
83095918|NCT01318109|Hormones|hormones|mesh-ancestor
83095919|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095920|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83095921|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
83095922|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095923|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095924|NCT05721027|Dexamethasone|dexamethasone|mesh-list
83095925|NCT05721027|Ibuprofen|ibuprofen|mesh-list
83095926|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83095927|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
83095928|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
83095929|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095930|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095931|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83095932|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
83095933|NCT05721027|Hormones|hormones|mesh-ancestor
83095934|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83095935|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83095936|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095937|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83095938|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83095939|NCT05721027|Analgesics|analgesics|mesh-ancestor
83095940|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
83095941|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095942|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83095943|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095944|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095945|NCT05720871|Capsaicin|capsaicin|mesh-list
83095946|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
83095947|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
83095948|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
83095949|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83095950|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095951|NCT05672927|Vaccines|vaccines|mesh-list
83095952|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
83095953|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095954|NCT05636267|Carboplatin|carboplatin|mesh-list
83095955|NCT05636267|Pemetrexed|pemetrexed|mesh-list
83095956|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095957|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095958|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095959|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83095960|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095961|NCT03873311|Cytarabine|cytarabine|mesh-list
83095962|NCT03873311|Azacitidine|azacitidine|mesh-list
83095963|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83095964|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
83095965|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095966|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095967|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
83095968|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83095969|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095970|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
83095971|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095972|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095973|NCT00162279|Abatacept|abatacept|mesh-list
83095974|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83095975|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095976|NCT00162279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83095977|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83095978|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83095979|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
83095980|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83095981|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83095982|NCT00145431|Atorvastatin|atorvastatin|mesh-list
83095983|NCT00145431|Torcetrapib|torcetrapib|mesh-list
83095984|NCT00145431|Fenofibrate|fenofibrate|mesh-list
83095985|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83095986|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83095987|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
83095988|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095989|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83095990|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83095991|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095992|NCT00135369|Lamivudine|lamivudine|mesh-list
83095993|NCT00135369|Efavirenz|efavirenz|mesh-list
83095994|NCT00135369|Stavudine|stavudine|mesh-list
83095995|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83095996|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83095997|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83095998|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83095999|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
83096000|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096001|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83096002|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83096003|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83096004|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83096005|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83096006|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83096007|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83096008|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83096009|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
83096010|NCT03530319|Azithromycin|azithromycin|mesh-list
83096011|NCT03530319|Doxycycline|doxycycline|mesh-list
83096012|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83096013|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096014|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
83096015|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83096016|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83096017|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83096018|NCT05726253|Amoxicillin|amoxicillin|mesh-list
83096019|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096020|NCT02445404|Dexamethasone|dexamethasone|mesh-list
83096021|NCT02445404|Prednisone|prednisone|mesh-list
83096022|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
83096023|NCT02445404|Ifosfamide|ifosfamide|mesh-list
83096024|NCT02445404|Carboplatin|carboplatin|mesh-list
83096025|NCT02445404|Etoposide|etoposide|mesh-list
83096026|NCT02445404|Vincristine|vincristine|mesh-list
83096027|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096028|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
83096029|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096030|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096031|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83096032|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
83096033|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096034|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096035|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83096036|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096037|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
83096038|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
83096039|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096040|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096041|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
83096042|NCT02445404|Hormones|hormones|mesh-ancestor
83096043|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096044|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83096045|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096046|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83096047|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83096048|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83096049|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
83096050|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
83096051|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
83096052|NCT05726175|Disitamab vedotin|disitamab vedotin|mesh-list
83096053|NCT05726175|Immunoconjugates|immunoconjugates|mesh-ancestor
83096054|NCT05726175|Immunologic Factors|immunologic factors|mesh-ancestor
83096055|NCT05726175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096056|NCT03530085|Fludarabine|fludarabine|mesh-list
83096057|NCT03530085|Busulfan|busulfan|mesh-list
83096058|NCT03530085|Decitabine|decitabine|mesh-list
83096059|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096060|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83096061|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
83096062|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096063|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096064|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
83466673|NCT01938248|Aspirin|aspirin|mesh-list
83096065|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096066|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
83096067|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83096068|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83096069|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096070|NCT03196934|Cannabidiol|cannabidiol|mesh-list
83096071|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
83096072|NCT05304351|Vaccines|vaccines|mesh-list
83096073|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
83096074|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096075|NCT03197012|Octreotide|octreotide|mesh-list
83096076|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83096077|NCT03197012|Edotreotide|edotreotide|mesh-list
83096078|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
83096079|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
83096080|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096081|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83096082|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096083|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83096084|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096085|NCT03530007|Ondansetron|ondansetron|mesh-list
83096086|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
83096087|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
83096088|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096089|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096090|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096091|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
83096092|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83096093|NCT03530007|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83096094|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83096095|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
83096096|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096097|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096098|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
83096099|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83096100|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83096101|NCT03529929|Prednisolone|prednisolone|mesh-list
83096102|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
83096103|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83096104|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
83096105|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096106|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
83096107|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
83096108|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096109|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096110|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096111|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
83096112|NCT03529929|Hormones|hormones|mesh-ancestor
83096113|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096114|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83096115|NCT03529929|Protective Agents|protective agents|mesh-ancestor
83096116|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83096117|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096118|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
83096119|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096120|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
83096121|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096122|NCT03525561|Acetazolamide|acetazolamide|mesh-list
83096123|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
83096124|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83096125|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096126|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096127|NCT03525561|Diuretics|diuretics|mesh-ancestor
83096128|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
83096129|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096130|NCT05696691|Ketamine|ketamine|mesh-list
83096131|NCT05696691|Analgesics|analgesics|mesh-ancestor
83096132|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
83096133|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096134|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096135|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83096136|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83096137|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
83096138|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
83096139|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096140|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83096141|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83096142|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096143|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096144|NCT03527355|Vaccines|vaccines|mesh-list
83096145|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
83096146|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096147|NCT05707169|Lidocaine|lidocaine|mesh-list
83096148|NCT05707169|Epinephrine|epinephrine|mesh-list
83096149|NCT05707169|Racepinephrine|racepinephrine|mesh-list
83096150|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
83096151|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
83096152|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
83096153|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
83096154|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096155|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096156|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
83096157|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096158|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83096159|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83096160|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83096161|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096162|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096163|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83096165|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
83096166|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096167|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83096168|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83096169|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
83096170|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83096171|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
83096172|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
83096173|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
83096174|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83096175|NCT05052827|Caseins|caseins|mesh-list
83096176|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
83096177|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
83096178|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096179|NCT02712008|Aflibercept|aflibercept|mesh-list
83096180|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83096181|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83096182|NCT02712008|Growth Substances|growth substances|mesh-ancestor
83096183|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096184|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
83096185|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096186|NCT05130515|Niraparib|niraparib|mesh-list
83096187|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83096188|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096189|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096190|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096191|NCT03193814|Apatinib|apatinib|mesh-list
83096192|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096193|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83096194|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096195|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096196|NCT05706779|Cetuximab|cetuximab|mesh-list
83096197|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83096198|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096199|NCT02450084|Fentanyl|fentanyl|mesh-list
83096200|NCT02450084|Ropivacaine|ropivacaine|mesh-list
83096201|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
83096202|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
83096203|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096204|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096205|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
83096206|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096207|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83096208|NCT02450084|Narcotics|narcotics|mesh-ancestor
83096209|NCT02450084|Analgesics|analgesics|mesh-ancestor
83096210|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83096211|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83096212|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
83096213|NCT03201770|Artesunate|artesunate|mesh-list
83096214|NCT03201770|Pyronaridine|pyronaridine|mesh-list
83096215|NCT03201770|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83096216|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
83096217|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83096218|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83096219|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096220|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096221|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
83096222|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
83096223|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83096224|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
83096225|NCT03626831|Evolocumab|evolocumab|mesh-list
83096226|NCT03626831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83096227|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83096228|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83096229|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
83096230|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096231|NCT03626831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83096232|NCT03626831|Protease Inhibitors|protease inhibitors|mesh-ancestor
83096233|NCT03626831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096234|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83096235|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83096236|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83096237|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096238|NCT04213209|Immunotoxins|immunotoxins|mesh-ancestor
83096239|NCT04213209|Immunoconjugates|immunoconjugates|mesh-ancestor
83096240|NCT04213209|Immunologic Factors|immunologic factors|mesh-ancestor
83096241|NCT04213209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096242|NCT03196466|Topiramate|topiramate|mesh-list
83096243|NCT03196466|Pregabalin|pregabalin|mesh-list
83096244|NCT03196466|Lamotrigine|lamotrigine|mesh-list
83096245|NCT03196466|Zonisamide|zonisamide|mesh-list
83096246|NCT03196466|Lacosamide|lacosamide|mesh-list
83096247|NCT03196466|Carbamazepine|carbamazepine|mesh-list
83096248|NCT03196466|Phenytoin|phenytoin|mesh-list
83096249|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
83096250|NCT03196466|Rufinamide|rufinamide|mesh-list
83096251|NCT03196466|Cannabidiol|cannabidiol|mesh-list
83096252|NCT03196466|Levetiracetam|levetiracetam|mesh-list
83096253|NCT03196466|Valproic Acid|valproic acid|mesh-list
83096254|NCT03196466|Brivaracetam|brivaracetam|mesh-list
83096255|NCT03196466|Phenobarbital|phenobarbital|mesh-list
83096256|NCT03196466|Clobazam|clobazam|mesh-list
83096257|NCT03196466|Ethosuximide|ethosuximide|mesh-list
83096258|NCT03196466|Stiripentol|stiripentol|mesh-list
83096259|NCT03196466|Tiagabine|tiagabine|mesh-list
83096260|NCT03196466|Primidone|primidone|mesh-list
83096261|NCT03196466|Felbamate|felbamate|mesh-list
83096262|NCT03196466|Analgesics|analgesics|mesh-ancestor
83096263|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
83096264|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096265|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096266|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
83096267|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83096268|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096269|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096270|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83096271|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83096272|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83096273|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096274|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83096275|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83096276|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
83096277|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83096278|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83096279|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096280|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
83096281|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096282|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
83096283|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83096284|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83096285|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83096286|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83096287|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83096288|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096289|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83096290|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83096291|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
83096292|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83096293|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83096294|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
83096295|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83096296|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83096297|NCT04188405|Decitabine|decitabine|mesh-list
83096298|NCT04188405|Venetoclax|venetoclax|mesh-list
83096299|NCT04188405|Ponatinib|ponatinib|mesh-list
83096300|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83096301|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
83096302|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096303|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096304|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096305|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83096306|NCT04176393|Ivosidenib|ivosidenib|mesh-list
83096307|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096308|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096309|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096310|NCT02449070|Nicorandil|nicorandil|mesh-list
83096311|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83096312|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83096313|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
83096314|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
83096315|NCT02449070|Vitamins|vitamins|mesh-ancestor
83096316|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
83096317|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096318|NCT03529149|Diltiazem|diltiazem|mesh-list
83096319|NCT03529149|Urapidil|urapidil|mesh-list
83096320|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83096321|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83096322|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096323|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096324|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83096325|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096326|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
83096327|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83096328|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
83096329|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096330|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83096331|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83096332|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83096333|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83096334|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83096335|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
83096336|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096337|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83096338|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
83096339|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096340|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096341|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83096342|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83096343|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096344|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83096345|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
83096346|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83096347|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
83096348|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83096349|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
83096350|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466692|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83096351|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096352|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
83096353|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
83096354|NCT02711306|Cathartics|cathartics|mesh-ancestor
83096355|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096356|NCT03193112|Agomelatine|agomelatine|mesh-list
83096357|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096358|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096359|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096361|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83096362|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096363|NCT03193424|Docetaxel|docetaxel|mesh-list
83096364|NCT03193424|Apatinib|apatinib|mesh-list
83096365|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096366|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
83096367|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
83096368|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
83096369|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096370|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83096371|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096372|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
83096373|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83096374|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83096375|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83096376|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096377|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096378|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
83096379|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096380|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096381|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83096382|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096383|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
83096384|NCT03118076|Ropivacaine|ropivacaine|mesh-list
83096385|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096386|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096387|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096388|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83096389|NCT03118076|Analgesics|analgesics|mesh-ancestor
83096390|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
83096391|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096392|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83096393|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83096394|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83096395|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
83096396|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096397|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096398|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
83096399|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
83096400|NCT03528915|Rifamycins|rifamycins|mesh-list
83096401|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
83096402|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83096403|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096404|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096405|NCT03192878|Infliximab|infliximab|mesh-list
83096406|NCT03192878|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83096407|NCT03192878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096408|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
83096409|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096410|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096411|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
83096412|NCT03241940|Fludarabine|fludarabine|mesh-list
83096413|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
83096414|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096415|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
83096416|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096417|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096418|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83096419|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
83096420|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096421|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096422|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83096423|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83096424|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
83096425|NCT00294320|Imiquimod|imiquimod|mesh-list
83096426|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83096427|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
83096428|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096429|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096430|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
83096431|NCT03526575|Zaleplon|zaleplon|mesh-list
83096432|NCT03526575|Zolpidem|zolpidem|mesh-list
83096433|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83096434|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096435|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096436|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096437|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83096438|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
83096439|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
83096440|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096441|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096442|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
83096443|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
83096444|NCT00189254|Imiquimod|imiquimod|mesh-list
83096445|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83096446|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
83096447|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096448|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096449|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
83096450|NCT03526419|Bupivacaine|bupivacaine|mesh-list
83096451|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
83096452|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
83096453|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096454|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096455|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
83096456|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096457|NCT03192644|Leucovorin|leucovorin|mesh-list
83096458|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
83096459|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
83096460|NCT03192644|Epirubicin|epirubicin|mesh-list
83096461|NCT03192644|Calcium|calcium|mesh-list
83096462|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
83096463|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096464|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83096465|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096466|NCT03192644|Antidotes|antidotes|mesh-ancestor
83096467|NCT03192644|Protective Agents|protective agents|mesh-ancestor
83096468|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
83096469|NCT03192644|Vitamins|vitamins|mesh-ancestor
83096470|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
83096471|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83096472|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83096473|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83096474|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096475|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096476|NCT03110055|Grazoprevir|grazoprevir|mesh-list
83096477|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83096478|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
83096479|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096480|NCT01190852|Fluticasone|fluticasone|mesh-list
83096481|NCT01190852|Azelastine|azelastine|mesh-list
83096482|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096483|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83096484|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
83096485|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096486|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096487|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83096488|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
83096489|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83096490|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83096491|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
82725250|NCT00738192|Dsuvia|dsuvia|mesh-list
83096492|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096493|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096494|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83096495|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83096496|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
83096497|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
83096498|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096499|NCT02710214|Estrogens|estrogens|mesh-list
83096500|NCT02710214|Hormones|hormones|mesh-ancestor
83096501|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096502|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096503|NCT03782415|Temozolomide|temozolomide|mesh-list
83096504|NCT03782415|Ibudilast|ibudilast|mesh-list
83096505|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83096506|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
83096507|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096508|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096509|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83096510|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
83096511|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096512|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096513|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83096514|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
83096515|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83096516|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096517|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83096518|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
83096519|NCT05561205|Methylphenidate|methylphenidate|mesh-list
83096520|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83096521|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096522|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83096523|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83096524|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096525|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096526|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
83096527|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096528|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
83096529|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83096530|NCT03052517|Growth Substances|growth substances|mesh-ancestor
83096531|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096532|NCT02443844|Tamsulosin|tamsulosin|mesh-list
83096533|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83096534|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83096535|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83096536|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
83096537|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096538|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096539|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096540|NCT02443844|Urological Agents|urological agents|mesh-ancestor
83096541|NCT02440100|Midazolam|midazolam|mesh-list
83096542|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83096543|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096544|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096545|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096546|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83096547|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83096548|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83096549|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83096550|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
83096551|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
83096552|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
83096553|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
83096554|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096555|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096556|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
83096557|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
83096558|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096559|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
83096560|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096561|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096562|NCT02439944|Nicotine|nicotine|mesh-list
83096563|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83096564|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
83096565|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096566|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096567|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83096568|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83096569|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83096570|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096571|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096572|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
83096573|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096574|NCT03190616|Apatinib|apatinib|mesh-list
83096575|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096576|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83096577|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096578|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096579|NCT02443922|Metformin|metformin|mesh-list
83096580|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83096581|NCT02443922|Glimepiride|glimepiride|mesh-list
83096582|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83096583|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096584|NCT02443922|Incretins|incretins|mesh-ancestor
83096585|NCT02443922|Hormones|hormones|mesh-ancestor
83096586|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096587|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83096588|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
83096589|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096590|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096591|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83096592|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096594|NCT04799847|Catumaxomab|catumaxomab|mesh-list
83096595|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096596|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
83096597|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83096598|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83096599|NCT02439866|Prednisolone|prednisolone|mesh-list
83096600|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
83096601|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83096602|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
83096603|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096604|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
83096605|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
83096606|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096607|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096608|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096609|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
83096610|NCT02439866|Hormones|hormones|mesh-ancestor
83096611|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096612|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83096613|NCT02439866|Protective Agents|protective agents|mesh-ancestor
83096614|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83096615|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096616|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
83096617|NCT02439788|Fludarabine|fludarabine|mesh-list
83096618|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096619|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
83096620|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096621|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096622|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83096623|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
83096624|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096625|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096626|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83096627|NCT03188510|Mirikizumab|mirikizumab|mesh-list
83096628|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83096629|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83096630|NCT03188510|Analgesics|analgesics|mesh-ancestor
83096631|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
83096632|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096633|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096634|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096635|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096636|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83096637|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096638|NCT03188198|Prednisone|prednisone|mesh-list
83096639|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
83096640|NCT03188198|Rituximab|rituximab|mesh-list
83096641|NCT03188198|Doxorubicin|doxorubicin|mesh-list
83096642|NCT03188198|Etoposide|etoposide|mesh-list
83096643|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
83096644|NCT03188198|Vincristine|vincristine|mesh-list
83096645|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096646|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
83096647|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096648|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096649|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83096650|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
83096651|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096652|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096653|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83096654|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83096655|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83096656|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83096657|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83096658|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096659|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096660|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
83096661|NCT03188198|Hormones|hormones|mesh-ancestor
83096662|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096663|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83096664|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83096665|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
83096666|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
83096667|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
83096668|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
83096669|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83096670|NCT03188276|Ledipasvir|ledipasvir|mesh-list
83096671|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
83096672|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096673|NCT03190304|Enalapril|enalapril|mesh-list
83096674|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83096675|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83096676|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
83096677|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096678|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83096679|NCT02439632|Levofloxacin|levofloxacin|mesh-list
83096680|NCT02439632|Ofloxacin|ofloxacin|mesh-list
83096681|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
83096682|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
83096683|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83096684|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83466742|NCT00002392|Thalidomide|thalidomide|mesh-list
83096685|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83096686|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83096687|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83096688|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096689|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096690|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096691|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83096692|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83096693|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83096694|NCT02443064|Vancomycin|vancomycin|mesh-list
83096695|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83096696|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83096697|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
83096698|NCT02741271|Prednisone|prednisone|mesh-list
83096699|NCT02741271|Prednisolone|prednisolone|mesh-list
83096700|NCT02741271|Albuterol|albuterol|mesh-list
83096701|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096702|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
83096703|NCT02741271|Hormones|hormones|mesh-ancestor
83096704|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096705|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096706|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83096707|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096708|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
83096709|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096710|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83096711|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83096712|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
83096713|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
83096714|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83096715|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83096716|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83096717|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83096718|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
83096719|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096720|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096721|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
83096722|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83096723|NCT02443142|Acetaminophen|acetaminophen|mesh-list
83096724|NCT02443142|Ibuprofen|ibuprofen|mesh-list
83096725|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83096726|NCT02443142|Analgesics|analgesics|mesh-ancestor
83096727|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
83096728|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096729|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096730|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
83096731|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83096732|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096733|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096734|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83096735|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096736|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096737|NCT03524079|Ajmaline|ajmaline|mesh-list
83096738|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83096739|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83096740|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83096741|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096742|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096743|NCT02438852|Ropivacaine|ropivacaine|mesh-list
83096744|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
83096745|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
83096746|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096747|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096748|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
83096749|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096750|NCT02442674|Tolvaptan|tolvaptan|mesh-list
83096751|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83096752|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096753|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
83096754|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096755|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
83096756|NCT02442752|Lansoprazole|lansoprazole|mesh-list
83096757|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83096758|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096759|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83096760|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096761|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096762|NCT02442362|Paclitaxel|paclitaxel|mesh-list
83096763|NCT02442362|Fluorouracil|fluorouracil|mesh-list
83096764|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
83096765|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83096766|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096767|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83096768|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83096769|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83389681|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83096770|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096772|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83096773|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83096774|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
83096775|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096776|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
83096777|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83096778|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096779|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096780|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83096781|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83096782|NCT02433860|Nicotine|nicotine|mesh-list
83096783|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83096784|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
83096785|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096786|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096787|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83096788|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83096789|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
83096790|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096791|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096792|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83096793|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096794|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
83096795|NCT03523455|Hematinics|hematinics|mesh-ancestor
83096796|NCT03189836|Rituximab|rituximab|mesh-list
83096797|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83096798|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096799|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
83096800|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096801|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096802|NCT04466943|Rocuronium|rocuronium|mesh-list
83096803|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83096804|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83096805|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83096806|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527144|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83096807|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096808|NCT03212469|Durvalumab|durvalumab|mesh-list
83096809|NCT03212469|Tremelimumab|tremelimumab|mesh-list
83096810|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83096811|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096812|NCT02442440|Anisodamine|anisodamine|mesh-list
83096813|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83096814|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83096815|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
83096816|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096817|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096818|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096819|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83096820|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83096821|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83096822|NCT02442440|Analgesics|analgesics|mesh-ancestor
83096823|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
83096824|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096825|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096826|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096827|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83096828|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096829|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
83096830|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
83096831|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
83096832|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83096833|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
83096834|NCT02442440|Protective Agents|protective agents|mesh-ancestor
83096835|NCT03187496|Midazolam|midazolam|mesh-list
83096836|NCT03187496|Caffeine|caffeine|mesh-list
83096837|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83096838|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83096839|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096840|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096841|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096842|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83096843|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83096844|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83096845|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83096846|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
83096847|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
83096848|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
83096849|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
83096850|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096851|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096852|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83096853|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83096854|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
83096855|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83096856|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83096857|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096858|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83096859|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83096860|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83096861|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83096862|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
83096863|NCT02438072|Fexofenadine|fexofenadine|mesh-list
83096864|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
83096865|NCT02438072|Midazolam|midazolam|mesh-list
83096866|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
83096867|NCT02438072|Caffeine|caffeine|mesh-list
83096868|NCT02438072|Bupropion|bupropion|mesh-list
83096869|NCT02438072|Omeprazole|omeprazole|mesh-list
83096870|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83096871|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096872|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096873|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096874|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83096875|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83096876|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83096877|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83096878|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
83096879|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
83096880|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
83096881|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
83096882|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096883|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83527145|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
83096884|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83096885|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83096886|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096887|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83096888|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83096889|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
83096890|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83096891|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096892|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83096893|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83096894|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
83096895|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83096896|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83096897|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096898|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
83096899|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83096900|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83096901|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
83096902|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
83096903|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83096904|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83096905|NCT02438072|Analgesics|analgesics|mesh-ancestor
83096906|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
83096907|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096908|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83096909|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83096910|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096911|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83096912|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83096913|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83096914|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83096915|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83096916|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
83096917|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
83096918|NCT03522987|Escitalopram|escitalopram|mesh-list
83096919|NCT03522987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83096920|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83096921|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096922|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096923|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096924|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
83096925|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096926|NCT02433626|Cisplatin|cisplatin|mesh-list
83096927|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096928|NCT02442128|Fentanyl|fentanyl|mesh-list
83096929|NCT02442128|Propofol|propofol|mesh-list
83096930|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096931|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096932|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096933|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83096934|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
83096935|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
83096936|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83096937|NCT02442128|Narcotics|narcotics|mesh-ancestor
83096938|NCT02442128|Analgesics|analgesics|mesh-ancestor
83096939|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
83096940|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096941|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83096942|NCT04465773|Remifentanil|remifentanil|mesh-list
83096943|NCT04465773|Propofol|propofol|mesh-list
83096944|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
83096945|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096946|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096947|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83096948|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83096949|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
83096950|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83096951|NCT04465773|Narcotics|narcotics|mesh-ancestor
83096952|NCT04465773|Analgesics|analgesics|mesh-ancestor
83096953|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
83096954|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096955|NCT02709746|Vortioxetine|vortioxetine|mesh-list
83096956|NCT02709746|Fluoxetine|fluoxetine|mesh-list
83466767|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83096957|NCT02709746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83527146|NCT01644474|Ezetimibe|ezetimibe|mesh-list
83096958|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83096959|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83096960|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83096961|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83096962|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
83096963|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096964|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83096965|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
83096966|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83096967|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83096968|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83096969|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83096970|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83096971|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83096972|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83096973|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83096974|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83096975|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83096976|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83096977|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
83096978|NCT02441894|Promethazine|promethazine|mesh-list
83096979|NCT02441894|Dexamethasone|dexamethasone|mesh-list
83096980|NCT02441894|Prednisolone|prednisolone|mesh-list
83096981|NCT02441894|Ondansetron|ondansetron|mesh-list
83096982|NCT02441894|Metoclopramide|metoclopramide|mesh-list
83096983|NCT02441894|Granisetron|granisetron|mesh-list
83096984|NCT02441894|Ranitidine|ranitidine|mesh-list
83096985|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
83096986|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83096987|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
83096988|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
83096989|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83096990|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83096991|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83096992|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
83096993|NCT02441894|Hormones|hormones|mesh-ancestor
83096994|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83096995|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83096996|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83096997|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
83096998|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
83096999|NCT02441894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83097000|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83097001|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
83097002|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097003|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097004|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83097005|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83097006|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097007|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
83097008|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
83097009|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
83097010|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83097011|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
83097012|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
83097013|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83097014|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83097015|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83097016|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
83097017|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83097018|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83097019|NCT02433704|Cefazolin|cefazolin|mesh-list
83097020|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097021|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097022|NCT05453825|Paclitaxel|paclitaxel|mesh-list
83097023|NCT05453825|Irinotecan|irinotecan|mesh-list
83097024|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83097025|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097026|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83097027|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83097028|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83097029|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097030|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83097031|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83097032|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097033|NCT02441816|Aflibercept|aflibercept|mesh-list
83097034|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83097035|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83097036|NCT02441816|Growth Substances|growth substances|mesh-ancestor
83097037|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097038|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
83097039|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097041|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
83097042|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097043|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097044|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097045|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
83097046|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
83097047|NCT02290431|Dexamethasone|dexamethasone|mesh-list
83097048|NCT02290431|Bortezomib|bortezomib|mesh-list
83097049|NCT02290431|Panobinostat|panobinostat|mesh-list
83097050|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097051|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
83097052|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
83097053|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097054|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097055|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097056|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
83097057|NCT02290431|Hormones|hormones|mesh-ancestor
83097058|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097059|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83097060|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097061|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83097062|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097063|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097064|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
83097065|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83097066|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
83097067|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097068|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83097069|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83097070|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
83097071|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097072|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097073|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83097075|NCT02436980|Tramadol|tramadol|mesh-list
83097076|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83097077|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83097078|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097079|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097080|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83097081|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83097082|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83097083|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83097084|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
83097085|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
83097086|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
83097087|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
83097088|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097089|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466788|NCT01241539|Dabigatran|dabigatran|mesh-list
83097090|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83097091|NCT02436980|Narcotics|narcotics|mesh-ancestor
83097092|NCT02436980|Analgesics|analgesics|mesh-ancestor
83097093|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
83097094|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097095|NCT02436902|Sorafenib|sorafenib|mesh-list
83097096|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
83097097|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097098|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83097099|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097100|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097101|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83097102|NCT02436902|Estrogens|estrogens|mesh-ancestor
83097103|NCT02436902|Hormones|hormones|mesh-ancestor
83097104|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097105|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097106|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83097107|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
83097108|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83097109|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
83097110|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097111|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097112|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83097113|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
83097114|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83097115|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
83097116|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097117|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097118|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83097119|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
83097120|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
83097121|NCT02436512|Protective Agents|protective agents|mesh-ancestor
83097122|NCT04466241|Ritonavir|ritonavir|mesh-list
83097123|NCT04466241|Lopinavir|lopinavir|mesh-list
83097124|NCT04466241|Telmisartan|telmisartan|mesh-list
83097125|NCT04466241|Atorvastatin|atorvastatin|mesh-list
83097126|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83097127|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83097128|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
83097129|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097130|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83097131|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83097132|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097133|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83097134|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83097135|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
83097136|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83097137|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83097138|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
83097139|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097140|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83097141|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83097142|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83097143|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83097144|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83097149|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
83097150|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
83097151|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097152|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097153|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097154|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
83097155|NCT02440880|Hormones|hormones|mesh-ancestor
83097156|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097157|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83097158|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097159|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
83097160|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097161|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097162|NCT03186482|Rifampin|rifampin|mesh-list
83097163|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83097164|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83097165|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
83097166|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097167|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097168|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
83097169|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83097170|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097171|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097172|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83097173|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83097174|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83097175|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83097176|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83097177|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83097178|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
83097179|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83097180|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83097181|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83097182|NCT03522207|Trazodone|trazodone|mesh-list
83097183|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83097184|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83097185|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097186|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097187|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83097188|NCT03522207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83097189|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83097190|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83097191|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097192|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097193|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
83097194|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83097195|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
83097196|NCT03528057|Hemostatics|hemostatics|mesh-list
83097197|NCT03528057|Coagulants|coagulants|mesh-ancestor
83097202|NCT05018273|Atezolizumab|atezolizumab|mesh-list
83097203|NCT05018273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83097204|NCT05018273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097205|NCT05018273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83097206|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097207|NCT02707952|Ritonavir|ritonavir|mesh-list
83097208|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83097209|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83097210|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
83097211|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097212|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097213|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83097214|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83097215|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
83097216|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097217|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83097218|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83097219|NCT02720445|Nicotine|nicotine|mesh-list
83097220|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83097221|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
83097222|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097223|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097224|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83097225|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83097226|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83097227|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097228|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097229|NCT02291211|Cisplatin|cisplatin|mesh-list
83097230|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097231|NCT05392101|Deferasirox|deferasirox|mesh-list
83097232|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83097233|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
83097234|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
83097235|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097236|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83097237|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83097238|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83097239|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83097240|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097241|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097242|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097243|NCT02291367|Analgesics|analgesics|mesh-ancestor
83097244|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
83097245|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097246|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
83097247|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83097248|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
83097249|NCT02440958|Folfirinox|folfirinox|mesh-list
83097250|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097251|NCT02432534|Atorvastatin|atorvastatin|mesh-list
83097252|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83097253|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83097254|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
83097255|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097256|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83097257|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83097258|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097259|NCT02432612|Nabiximols|nabiximols|mesh-list
83097260|NCT02432612|Analgesics|analgesics|mesh-ancestor
83097261|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
83097262|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097263|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097264|NCT05705843|Vancomycin|vancomycin|mesh-list
83097265|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097266|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097267|NCT02436044|Leucovorin|leucovorin|mesh-list
83097268|NCT02436044|Fluorouracil|fluorouracil|mesh-list
83097269|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
83097270|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
83097271|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
83097272|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097273|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83097274|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097275|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83097276|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
83097277|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097278|NCT02436044|Antidotes|antidotes|mesh-ancestor
83097279|NCT02436044|Protective Agents|protective agents|mesh-ancestor
83097280|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
83097281|NCT02436044|Vitamins|vitamins|mesh-ancestor
83097282|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
83097283|NCT02435732|Heparin|heparin|mesh-list
83097284|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
83097285|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83097286|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83097287|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097288|NCT02435654|Olanzapine|olanzapine|mesh-list
83097289|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
83097290|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
83097291|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097292|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097293|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097295|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83097296|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097297|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83097298|NCT02435654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83097299|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83097300|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83097301|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097302|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097303|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
83097304|NCT03191162|Benzonidazole|benzonidazole|mesh-list
83097305|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83097306|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
83097307|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097308|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83097309|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83097310|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83097311|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097312|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
83097313|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83097314|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
83097315|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83097316|NCT05620901|Prednisolone|prednisolone|mesh-list
83097317|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83097318|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
83097319|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097320|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
83097321|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
83097322|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097323|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097324|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097325|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
83097326|NCT05620901|Hormones|hormones|mesh-ancestor
83097327|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097328|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83097329|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097330|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83097331|NCT05620901|Protective Agents|protective agents|mesh-ancestor
83097332|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
83097333|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83097334|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
83097335|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097336|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
83097337|NCT05571527|Protective Agents|protective agents|mesh-ancestor
83097338|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
83097339|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83097340|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83097341|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
83097342|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097343|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097344|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097345|NCT04824599|Ropivacaine|ropivacaine|mesh-list
83097346|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
83097347|NCT04824599|Anesthetics|anesthetics|mesh-list
83097348|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097349|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097350|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
83097351|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097352|NCT05233514|Metformin|metformin|mesh-list
83097353|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83097354|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097355|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83097356|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097357|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097358|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83097359|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097360|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097361|NCT02435186|Paclitaxel|paclitaxel|mesh-list
83097362|NCT02435186|Cisplatin|cisplatin|mesh-list
83097363|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83097364|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097365|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
83097366|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
83097367|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
83097368|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097369|NCT02435108|Crizotinib|crizotinib|mesh-list
83097370|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097371|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83097372|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097373|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097374|NCT02434952|Piperaquine|piperaquine|mesh-list
83097375|NCT02434952|Primaquine|primaquine|mesh-list
83097376|NCT02434952|Artenimol|artenimol|mesh-list
83097377|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
83097378|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83097379|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83097380|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097381|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
83097382|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83097383|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
83097384|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097385|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097386|NCT03626753|Acetaminophen|acetaminophen|mesh-list
83097387|NCT03626753|Piroxicam|piroxicam|mesh-list
83097388|NCT03626753|Nefopam|nefopam|mesh-list
83097389|NCT03626753|Proroxan|proroxan|mesh-list
83097390|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83097391|NCT03626753|Analgesics|analgesics|mesh-ancestor
83097392|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
83097393|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097394|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097395|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
83097396|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83097397|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097398|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83097399|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83097400|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097401|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097402|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83097403|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83097404|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
83097405|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097406|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83097407|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
83097408|NCT02440256|Narcotics|narcotics|mesh-ancestor
83097409|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097410|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097411|NCT02440256|Analgesics|analgesics|mesh-ancestor
83097412|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
83097413|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097414|NCT05157698|Naltrexone|naltrexone|mesh-list
83097415|NCT05157698|Bupropion|bupropion|mesh-list
83097416|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83097417|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83097418|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097419|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
83097420|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097421|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83097422|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
83097423|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83097424|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83097425|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83097426|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83097427|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097428|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
83097429|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097430|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83097431|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83097432|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097433|NCT03185624|Rifaximin|rifaximin|mesh-list
83097434|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097435|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097436|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097437|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
83097438|NCT02707640|Pirfenidone|pirfenidone|mesh-list
83097439|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83097440|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
83097441|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097442|NCT02707640|Expectorants|expectorants|mesh-ancestor
83097443|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
83097444|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83097446|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097447|NCT02707640|Protective Agents|protective agents|mesh-ancestor
83097448|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097449|NCT02707640|Antidotes|antidotes|mesh-ancestor
83097450|NCT02707640|Analgesics|analgesics|mesh-ancestor
83097451|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
83097452|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097453|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83097454|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83097455|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097456|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83097457|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097458|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
83097459|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83097460|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097461|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83097462|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097463|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
83097464|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83097465|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83097466|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83097467|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
83097468|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097469|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097470|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097471|NCT03188978|Atorvastatin|atorvastatin|mesh-list
83097472|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83097473|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83097474|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
83097475|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83466855|NCT01200433|Analgesics|analgesics|mesh-ancestor
83097476|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83097477|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83097478|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097479|NCT02431286|Dexamethasone|dexamethasone|mesh-list
83097480|NCT02431286|Aprepitant|aprepitant|mesh-list
83097481|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097482|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
83097483|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
83097484|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097485|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097486|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097487|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
83097488|NCT02431286|Hormones|hormones|mesh-ancestor
83097489|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83527147|NCT01644474|Alirocumab|alirocumab|mesh-list
83097490|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83097491|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097492|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83097493|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097494|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097495|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83097497|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83097498|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83097499|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
83097500|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097501|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83097502|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097503|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83097504|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097505|NCT02431208|Dexamethasone|dexamethasone|mesh-list
83097506|NCT02431208|Lenalidomide|lenalidomide|mesh-list
83097507|NCT02431208|Atezolizumab|atezolizumab|mesh-list
83097508|NCT02431208|Daratumumab|daratumumab|mesh-list
83097509|NCT02431208|Pomalidomide|pomalidomide|mesh-list
83097510|NCT02431208|Antibodies|antibodies|mesh-list
83097511|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83097512|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
83097513|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097514|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097515|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
83097516|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
83097517|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097518|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097519|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
83097521|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097522|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83097523|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097524|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83097525|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83097526|NCT02431208|Growth Substances|growth substances|mesh-ancestor
83097527|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
83097528|NCT02431208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83097529|NCT02431208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097530|NCT02431208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83097531|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
83097532|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
83097533|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097534|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
83097535|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
83097536|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097537|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097538|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097539|NCT03107078|Hormones|hormones|mesh-ancestor
83097540|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097541|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83097542|NCT03107078|Protective Agents|protective agents|mesh-ancestor
83097543|NCT02430350|Edaravone|edaravone|mesh-list
83097544|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83097545|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
83097546|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097547|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83097548|NCT02430350|Protective Agents|protective agents|mesh-ancestor
83097549|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097550|NCT02429960|Remifentanil|remifentanil|mesh-list
83097551|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83097552|NCT02429960|Narcotics|narcotics|mesh-ancestor
83097553|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097554|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097555|NCT02429960|Analgesics|analgesics|mesh-ancestor
83097556|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
83097557|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097558|NCT02429804|Listerine|listerine|mesh-list
83097559|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
83097560|NCT02429804|Fluorides|fluorides|mesh-list
83097561|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
83097562|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83097563|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
83097564|NCT02429804|Protective Agents|protective agents|mesh-ancestor
83097565|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097566|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83097567|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097568|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83097569|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097570|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
83097571|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
83097572|NCT03185156|Propofol|propofol|mesh-list
83097573|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83097574|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097575|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097576|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83097577|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
83097578|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
83097579|NCT02429726|Cisplatin|cisplatin|mesh-list
83097580|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097581|NCT02429882|Brodalumab|brodalumab|mesh-list
83097582|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
83097583|NCT02430896|Methylphenidate|methylphenidate|mesh-list
83097584|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83097585|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83097586|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097587|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83097588|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83097589|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83097590|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097591|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
83097592|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097593|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83097594|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
83097595|NCT03184844|Thalidomide|thalidomide|mesh-list
83097596|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83097597|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
83097598|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097599|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
83097600|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097601|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097602|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83097603|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83097604|NCT03184844|Growth Substances|growth substances|mesh-ancestor
83097605|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
83097606|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097607|NCT02425202|Ketamine|ketamine|mesh-list
83097608|NCT02425202|Analgesics|analgesics|mesh-ancestor
83097609|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
83097610|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097611|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097612|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83097613|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83097614|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
83097615|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
83097616|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097617|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83097618|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83097619|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097620|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097621|NCT03182504|Meropenem|meropenem|mesh-list
83097622|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097623|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097624|NCT02428946|Bromocriptine|bromocriptine|mesh-list
83097625|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83097626|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83097627|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
83097628|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097629|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097630|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
83097631|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
83097632|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097633|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097634|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83097635|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83527148|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83097636|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097637|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
83097638|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83097639|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83097640|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097641|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
83097642|NCT02428868|Coagulants|coagulants|mesh-ancestor
83097643|NCT03181880|Bromides|bromides|mesh-list
83097644|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
83097645|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83097646|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
83097647|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097648|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097649|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83097650|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
83097651|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83097652|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83097653|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83097654|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
83097655|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097656|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097657|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
83097658|NCT03178994|Ketoconazole|ketoconazole|mesh-list
83097659|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
83097660|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097661|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83097662|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83097663|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097664|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097665|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83097666|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
83097667|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097668|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097669|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83097671|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
83097672|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
83097673|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097674|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097675|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
83097676|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097677|NCT02428322|Vitamin D|vitamin d|mesh-list
83097678|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
83097679|NCT02428322|Vitamins|vitamins|mesh-ancestor
83097680|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
83097681|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097682|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83097683|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83097684|NCT03053063|Selonsertib|selonsertib|mesh-list
83097685|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83097686|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097687|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097688|NCT00702338|Hormones|hormones|mesh-list
83097689|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83097690|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097691|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097692|NCT05484557|Enoxaparin|enoxaparin|mesh-list
83097693|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
83097694|NCT05484557|Apixaban|apixaban|mesh-list
83097695|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
83097696|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83097697|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83097698|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097699|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83097700|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
83097701|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83097702|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
83097703|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097704|NCT02427932|Gentamicins|gentamicins|mesh-list
83097705|NCT02427932|Ampicillin|ampicillin|mesh-list
83097706|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097707|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097708|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83097709|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097710|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097711|NCT03626519|Menthol|menthol|mesh-list
83097712|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
83097713|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83097714|NCT03184766|Ibuprofen|ibuprofen|mesh-list
83097715|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
83097716|NCT03184766|Ephedrine|ephedrine|mesh-list
83097717|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83097718|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83097719|NCT03184766|Analgesics|analgesics|mesh-ancestor
83097720|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
83097721|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097722|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097723|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097724|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83097725|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83097726|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097727|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097728|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83097729|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
83097730|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83097731|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
83097732|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
83097733|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83097734|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83097735|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
83097736|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
83097737|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097738|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83097739|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
83097740|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83097741|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83097742|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83097743|NCT02420834|Laxatives|laxatives|mesh-ancestor
83097744|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097745|NCT02423954|Sirolimus|sirolimus|mesh-list
83097746|NCT02423954|Capecitabine|capecitabine|mesh-list
83097747|NCT02423954|Nivolumab|nivolumab|mesh-list
83097748|NCT02423954|Irinotecan|irinotecan|mesh-list
83097749|NCT02423954|Temsirolimus|temsirolimus|mesh-list
83097750|NCT02423954|MTOR Inhibitors|mtor inhibitors|mesh-list
83097751|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83097752|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
83097753|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097754|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097755|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83097756|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83097757|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83097758|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83097759|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097760|NCT02423954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83097761|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83097762|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
83097763|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097764|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097765|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097766|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83097767|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
83097768|NCT04221503|Niraparib|niraparib|mesh-list
83097769|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83097770|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097771|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097772|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097773|NCT02427308|Miltefosine|miltefosine|mesh-list
83097774|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
83097775|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097776|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097777|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83097778|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83097779|NCT03178292|Levofloxacin|levofloxacin|mesh-list
83097780|NCT03178292|Ofloxacin|ofloxacin|mesh-list
83097781|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83097782|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097783|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097784|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83097785|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83097786|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097787|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097788|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097789|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83097790|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83097792|NCT02427386|Estrogens|estrogens|mesh-list
83097793|NCT02427386|Hormones|hormones|mesh-ancestor
83097794|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097795|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097796|NCT03181178|Micronutrients|micronutrients|mesh-list
83097797|NCT03181178|Trace Elements|trace elements|mesh-list
83097798|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097799|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
83097800|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83097801|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83097802|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83097803|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097804|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
83097805|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097806|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097807|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
83097808|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
83097809|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097810|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83097811|NCT03180944|Lugol's solution|lugol's solution|mesh-list
83097812|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83097813|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
83097814|NCT03180944|Coagulants|coagulants|mesh-ancestor
83097815|NCT04025879|Paclitaxel|paclitaxel|mesh-list
83097816|NCT04025879|Docetaxel|docetaxel|mesh-list
83097817|NCT04025879|Carboplatin|carboplatin|mesh-list
83097818|NCT04025879|Nivolumab|nivolumab|mesh-list
83097819|NCT04025879|Pemetrexed|pemetrexed|mesh-list
83097820|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83097821|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097822|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
83466882|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
83097823|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
83097824|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
83097825|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097826|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83097827|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83097828|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097829|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83097830|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83097831|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
83097832|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83097833|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097834|NCT04322669|Pidotimod|pidotimod|mesh-list
83097835|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83097836|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
83097837|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097838|NCT03180476|Apatinib|apatinib|mesh-list
83097839|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097840|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83097841|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097842|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097843|NCT03180632|Lorazepam|lorazepam|mesh-list
83097844|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
83097845|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
83097846|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
83097847|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097848|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097849|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097850|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83097851|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097852|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83097853|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83097854|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83097855|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
83097856|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
83097857|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097858|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097859|NCT02420132|Ranibizumab|ranibizumab|mesh-list
83097860|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83097861|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83097862|NCT02420132|Growth Substances|growth substances|mesh-ancestor
83097863|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097864|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
83097865|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097866|NCT03183752|Metformin|metformin|mesh-list
83097867|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83097868|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097869|NCT03183674|Oxytocin|oxytocin|mesh-list
83097870|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
83097871|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83097872|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097873|NCT03117530|Minocycline|minocycline|mesh-list
83097874|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83097875|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097876|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
83097877|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83097878|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
83097879|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097880|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
83097881|NCT03889925|Protective Agents|protective agents|mesh-ancestor
83097882|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83097883|NCT05103254|Ezetimibe|ezetimibe|mesh-list
83097884|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83097885|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83097886|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
83097887|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097888|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83097889|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83466894|NCT01924052|Calcitonin|calcitonin|mesh-list
83097890|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83097891|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097892|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
83097893|NCT02426840|Vitamin D|vitamin d|mesh-list
83097894|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
83097895|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
83097896|NCT02426840|Vitamins|vitamins|mesh-list
83097898|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
83097899|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097900|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83097901|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83097902|NCT03178526|Lovastatin|lovastatin|mesh-list
83097903|NCT03178526|L 647318|l 647318|mesh-list
83097904|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
83097905|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83097906|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83097907|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
83097908|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097909|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83097910|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83097911|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097912|NCT03857321|Insulin|insulin|mesh-list
83097913|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83097914|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
83097915|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83097916|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097917|NCT02423642|Heparin|heparin|mesh-list
83097918|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
83097919|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097920|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83097921|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83097922|NCT03180242|Trastuzumab|trastuzumab|mesh-list
83097923|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83097924|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097925|NCT00709904|Semuloparin|semuloparin|mesh-list
83097926|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83097927|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83097928|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83097929|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097930|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
83097931|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
83097932|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83097933|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
83097934|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83097935|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
83097936|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097937|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097938|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
83097939|NCT03183596|Dexamethasone|dexamethasone|mesh-list
83097940|NCT03183596|Bupivacaine|bupivacaine|mesh-list
83097941|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097942|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
83097943|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
83097944|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097945|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097946|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83097947|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
83097948|NCT03183596|Hormones|hormones|mesh-ancestor
83097949|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83097950|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83097951|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097952|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
83097953|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
83097954|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83097955|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
83097956|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
83097957|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83097958|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
83097959|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
83097960|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83097961|NCT03620669|Durvalumab|durvalumab|mesh-list
83097962|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83097963|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83097964|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
83097965|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
83097966|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83097967|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83097968|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097969|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097970|NCT04325243|Urological Agents|urological agents|mesh-ancestor
83097971|NCT02419820|Aspirin|aspirin|mesh-list
83097972|NCT02419820|Clopidogrel|clopidogrel|mesh-list
83097973|NCT02419820|APD791|apd791|mesh-list
83097974|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83097975|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83097976|NCT02419820|Analgesics|analgesics|mesh-ancestor
83097977|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
83097978|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83097979|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83097980|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83097981|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83097982|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83097983|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83097984|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83097985|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83097986|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83097987|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83097988|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
83097989|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83097990|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83097991|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83097992|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
83097993|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83097994|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83097995|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83097996|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
83097997|NCT05692739|Cyclosporine|cyclosporine|mesh-list
83097998|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
83097999|NCT05692739|Cyclosporins|cyclosporins|mesh-list
83098000|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098001|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098002|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098003|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098004|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
83098005|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
83098006|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098007|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
83098008|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098009|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83098010|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83098011|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83098013|NCT02419352|Neostigmine|neostigmine|mesh-list
83098014|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83098015|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83098016|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83098017|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
83098018|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098019|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098020|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83098021|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
83098022|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
83098023|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
83098024|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83098025|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83098026|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
83098027|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098028|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098029|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83098030|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098031|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83098032|NCT03365687|Vitamin D|vitamin d|mesh-list
83098033|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
83098034|NCT03365687|Vitamins|vitamins|mesh-ancestor
83098035|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
83098036|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098037|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83098038|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83098039|NCT02419118|Dexamethasone|dexamethasone|mesh-list
83098040|NCT02419118|Lenalidomide|lenalidomide|mesh-list
83098041|NCT02419118|Daratumumab|daratumumab|mesh-list
83098042|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098043|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
83098044|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
83098045|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098046|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098047|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098048|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
83098049|NCT02419118|Hormones|hormones|mesh-ancestor
83098050|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098051|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098052|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098053|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
83098054|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83098055|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83098056|NCT02419118|Growth Substances|growth substances|mesh-ancestor
83098057|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
83098058|NCT02426294|Pioglitazone|pioglitazone|mesh-list
83098059|NCT02426294|Glimepiride|glimepiride|mesh-list
83098060|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83098061|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098062|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83098063|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098064|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
83098065|NCT02426450|Leucovorin|leucovorin|mesh-list
83098066|NCT02426450|Fluorouracil|fluorouracil|mesh-list
83098067|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
83098068|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
83098069|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098070|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83098071|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098072|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098073|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
83098074|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098075|NCT02426450|Antidotes|antidotes|mesh-ancestor
83098076|NCT02426450|Protective Agents|protective agents|mesh-ancestor
83098077|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
83098078|NCT02426450|Vitamins|vitamins|mesh-ancestor
83098079|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
83098080|NCT02426060|Warfarin|warfarin|mesh-list
83098081|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
83098082|NCT02422784|Vitamin D|vitamin d|mesh-list
83098083|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
83098084|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
83098085|NCT02422784|Vitamins|vitamins|mesh-list
83098086|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
83098087|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098088|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83098089|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83098090|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
83098091|NCT03740009|Estrogens|estrogens|mesh-list
83098092|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83098093|NCT03740009|Hormones|hormones|mesh-ancestor
83098094|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098095|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098096|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83098097|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83098098|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
83098099|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83098100|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
83098101|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83098102|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
83098103|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
83098104|NCT03182894|Azacitidine|azacitidine|mesh-list
83466911|NCT00002254|Alovudine|alovudine|mesh-list
83098105|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83098106|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098107|NCT03182894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83098108|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098109|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83098110|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
83098111|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098112|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83098113|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83098114|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83098115|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
83098116|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098117|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83098118|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83098119|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098120|NCT02423096|Haloperidol|haloperidol|mesh-list
83098121|NCT02423096|Olanzapine|olanzapine|mesh-list
83098122|NCT02423096|Risperidone|risperidone|mesh-list
83098123|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83098124|NCT02423096|Sulpiride|sulpiride|mesh-list
83098125|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83098126|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
83098127|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098128|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098129|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098130|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83098131|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83098132|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098133|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83098134|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83098135|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
83098136|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
83098137|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
83098138|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098139|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098140|NCT02423096|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83098141|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83098142|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83098143|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
83098144|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83098145|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83098146|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
83098147|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83098148|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098149|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098150|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83098151|NCT02423018|Pregabalin|pregabalin|mesh-list
83098152|NCT02423018|Analgesics|analgesics|mesh-ancestor
83098153|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
83098154|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098155|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098156|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
83098157|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83098158|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83098159|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098160|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83098161|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83098162|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83098163|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098164|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83098165|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
83098166|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83098167|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098168|NCT05691959|Calcium|calcium|mesh-list
83098169|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83098170|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098171|NCT02422706|Metronidazole|metronidazole|mesh-list
83098172|NCT02422706|Clarithromycin|clarithromycin|mesh-list
83098173|NCT02422706|Levofloxacin|levofloxacin|mesh-list
83098174|NCT02422706|Ofloxacin|ofloxacin|mesh-list
83098175|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
83098176|NCT02422706|Doxycycline|doxycycline|mesh-list
83098177|NCT02422706|Omeprazole|omeprazole|mesh-list
83098178|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098179|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83098180|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83098181|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83098182|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83098183|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098184|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83098185|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098186|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098187|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83098188|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83098189|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83098190|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83098191|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83098192|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83098193|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098194|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83098195|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
83098196|NCT03058757|Mitomycins|mitomycins|mesh-list
83098197|NCT03058757|Mitomycin|mitomycin|mesh-list
83098198|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83098199|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098200|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
83389682|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83098201|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098202|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83098203|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098205|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83098206|NCT03138889|Carboplatin|carboplatin|mesh-list
83098207|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
83098208|NCT03138889|Pemetrexed|pemetrexed|mesh-list
83098209|NCT03138889|Atezolizumab|atezolizumab|mesh-list
83098210|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83098211|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098212|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
83098213|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
83098214|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
83098215|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098216|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83098217|NCT03138889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83098218|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098219|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83098220|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83098221|NCT01881763|Ketamine|ketamine|mesh-list
83098222|NCT01881763|Methohexital|methohexital|mesh-list
83098223|NCT01881763|Analgesics|analgesics|mesh-ancestor
83098224|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
83098225|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098226|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098227|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83098228|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83098229|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
83098230|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
83098231|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098232|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83098233|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83098234|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098235|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098236|NCT03669601|Gemcitabine|gemcitabine|mesh-list
83098237|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83098238|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
83098239|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098240|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098241|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
83098242|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83098243|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098244|NCT02959463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83098245|NCT02959463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098246|NCT02416388|Cytarabine|cytarabine|mesh-list
83098247|NCT02416388|Cyclosporine|cyclosporine|mesh-list
83098248|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
83098249|NCT02416388|Dexamethasone|dexamethasone|mesh-list
83098250|NCT02416388|Methotrexate|methotrexate|mesh-list
83098251|NCT02416388|Daunorubicin|daunorubicin|mesh-list
83098252|NCT02416388|Venetoclax|venetoclax|mesh-list
83098253|NCT02416388|Idarubicin|idarubicin|mesh-list
83098254|NCT02416388|Cyclosporins|cyclosporins|mesh-list
83098255|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098256|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
83098257|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
83098258|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098259|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098260|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098261|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
83098262|NCT02416388|Hormones|hormones|mesh-ancestor
83098263|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098264|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098265|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098266|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83098267|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
83098268|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83098269|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83098270|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
83098271|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098272|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
83098273|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098274|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83098275|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098276|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
83098277|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098278|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83098279|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
83098280|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098281|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
83098282|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83098283|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83098284|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83098285|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83098286|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83098287|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
83098288|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83098289|NCT02886065|Lenalidomide|lenalidomide|mesh-list
83098291|NCT02886065|Citarinostat|citarinostat|mesh-list
83098292|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
83098293|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098294|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83098295|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83098296|NCT02886065|Growth Substances|growth substances|mesh-ancestor
83098297|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
83098298|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098299|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
83098300|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83098301|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098302|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098303|NCT03392441|Insulin|insulin|mesh-list
83098304|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83098305|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098306|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
83466935|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098307|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098308|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
83098309|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83098310|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83098311|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098312|NCT03177824|Urological Agents|urological agents|mesh-ancestor
83098313|NCT02416232|Trametinib|trametinib|mesh-list
83098314|NCT02416232|Dabrafenib|dabrafenib|mesh-list
83098315|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098316|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83098317|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098318|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098319|NCT04482842|Warfarin|warfarin|mesh-list
83098320|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
83098321|NCT02767661|Capecitabine|capecitabine|mesh-list
83098322|NCT02767661|Letrozole|letrozole|mesh-list
83098323|NCT02767661|Anastrozole|anastrozole|mesh-list
83098325|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83098326|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83098327|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
83098328|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098329|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098330|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83098331|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098332|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83098333|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
83098334|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098335|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098336|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098337|NCT02415920|Oxytocin|oxytocin|mesh-list
83098338|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
83098339|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83098340|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098341|NCT05691491|Temozolomide|temozolomide|mesh-list
83098342|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83098343|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
83098344|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098345|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098346|NCT03389243|Acetaminophen|acetaminophen|mesh-list
83098347|NCT03389243|Dipyrone|dipyrone|mesh-list
83098348|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098349|NCT03389243|Analgesics|analgesics|mesh-ancestor
83098350|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
83098351|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098352|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098353|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
83098354|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098355|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098356|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098357|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
83098358|NCT02421926|Dasatinib|dasatinib|mesh-list
83098359|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098360|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83098361|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098362|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098363|NCT02410460|Lidocaine|lidocaine|mesh-list
83098364|NCT02410460|Clonidine|clonidine|mesh-list
83098365|NCT02410460|Midazolam|midazolam|mesh-list
83098366|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
83098367|NCT02410460|Scopolamine|scopolamine|mesh-list
83098368|NCT02410460|Ketamine|ketamine|mesh-list
83098369|NCT02410460|Ondansetron|ondansetron|mesh-list
83098370|NCT02410460|Metoclopramide|metoclopramide|mesh-list
83098371|NCT02410460|Bupivacaine|bupivacaine|mesh-list
83098372|NCT02410460|Propofol|propofol|mesh-list
83098373|NCT02410460|Sevoflurane|sevoflurane|mesh-list
83098374|NCT02410460|Desflurane|desflurane|mesh-list
83098375|NCT02410460|Famotidine|famotidine|mesh-list
83098376|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83098377|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
83098378|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
83098379|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098380|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098381|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
83098382|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098383|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83098384|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83098385|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83098386|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83098387|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098388|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83098389|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83098390|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
83098391|NCT02410460|Analgesics|analgesics|mesh-ancestor
83098392|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83098393|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83098394|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83098395|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098396|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83098397|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83098398|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83098399|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83098400|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
83098401|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
83098402|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83098403|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83098404|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
83098405|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
83098406|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098407|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
83098408|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83098409|NCT02410460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83098410|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83098411|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
83098412|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83098413|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
83098414|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83098415|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83098416|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83098417|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
83098418|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83098419|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83098420|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
83098421|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83098422|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83098423|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
83098424|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83098425|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83098426|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
83098427|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
83098428|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
83098429|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
83098430|NCT02410226|Anesthetics|anesthetics|mesh-list
83098431|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098432|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098433|NCT03116672|Diclofenac|diclofenac|mesh-list
83098434|NCT03116672|Ketorolac|ketorolac|mesh-list
83098435|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098436|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098437|NCT03116672|Analgesics|analgesics|mesh-ancestor
83098438|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
83098439|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098440|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098441|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098442|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098443|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83098444|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098445|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098446|NCT03174860|Diclofenac|diclofenac|mesh-list
83098447|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098448|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098449|NCT03174860|Analgesics|analgesics|mesh-ancestor
83098450|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
83098451|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098452|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098453|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098454|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098455|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83098456|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098457|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098458|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83098459|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83098460|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098461|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83098462|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098463|NCT02417090|Metformin|metformin|mesh-list
83098464|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83098465|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098466|NCT00703820|Cytarabine|cytarabine|mesh-list
83098467|NCT00703820|Etoposide|etoposide|mesh-list
83098468|NCT00703820|Daunorubicin|daunorubicin|mesh-list
83098469|NCT00703820|Clofarabine|clofarabine|mesh-list
83098470|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83098471|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098472|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83098473|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83098474|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098475|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098476|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83098477|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
83098478|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
83098479|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098480|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098481|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
83098482|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098483|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83098484|NCT03177980|Clonidine|clonidine|mesh-list
83098485|NCT03177980|Fentanyl|fentanyl|mesh-list
83098486|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83098487|NCT03177980|Narcotics|narcotics|mesh-ancestor
83098488|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098489|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098490|NCT03177980|Analgesics|analgesics|mesh-ancestor
83098491|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
83098492|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098493|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83098494|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83098495|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
83098496|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
83098497|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83098498|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
83098499|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
82727209|NCT00697788|Analgesics|analgesics|mesh-ancestor
83098500|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83098501|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83098502|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83098503|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
83098504|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098505|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098507|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098508|NCT02587325|Sirolimus|sirolimus|mesh-list
83098509|NCT02587325|Temsirolimus|temsirolimus|mesh-list
83098510|NCT02587325|MTOR Inhibitors|mtor inhibitors|mesh-list
83098511|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83098512|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098513|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83098514|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098515|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
83098516|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098517|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
83098518|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098519|NCT02587325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83098520|NCT02587325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098521|NCT02587325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098522|NCT02414984|Golimumab|golimumab|mesh-list
83098523|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83098524|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098525|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098526|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
83098527|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098528|NCT02415062|Donepezil|donepezil|mesh-list
83098529|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83098530|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098531|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098532|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
83098533|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098534|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098535|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
83098536|NCT02408978|Naproxen|naproxen|mesh-list
83098537|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098538|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098539|NCT02408978|Analgesics|analgesics|mesh-ancestor
83098540|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
83098541|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098542|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098543|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098544|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098545|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
83098546|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83098547|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098548|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098549|NCT02408744|Pirfenidone|pirfenidone|mesh-list
83098550|NCT02408744|Analgesics|analgesics|mesh-ancestor
83098551|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
83098552|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098553|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098554|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098555|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098556|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098557|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098558|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098560|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
83098561|NCT03174080|Protective Agents|protective agents|mesh-ancestor
83098562|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098563|NCT03116516|Amlodipine|amlodipine|mesh-list
83098564|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83098565|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83098566|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83098567|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83098568|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098569|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83098570|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098571|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
83098572|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83098573|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83098574|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
83098575|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83098576|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83098577|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098578|NCT01564537|Dexamethasone|dexamethasone|mesh-list
83098579|NCT01564537|Lenalidomide|lenalidomide|mesh-list
83098580|NCT01564537|Ixazomib|ixazomib|mesh-list
83098581|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098582|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
83098583|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
83098584|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098585|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098586|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098587|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
83098588|NCT01564537|Hormones|hormones|mesh-ancestor
83098589|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098590|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098591|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098592|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
83098593|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83098594|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83098595|NCT01564537|Growth Substances|growth substances|mesh-ancestor
83098596|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
83098597|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
83098598|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098599|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098600|NCT02446457|Rituximab|rituximab|mesh-list
83098601|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83098602|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
83098603|NCT02446457|Lenalidomide|lenalidomide|mesh-list
83098604|NCT02446457|Antibodies|antibodies|mesh-list
83098605|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
83098606|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83098607|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
83098608|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098609|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098610|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098611|NCT02446457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83098612|NCT02446457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098613|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83098614|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83098615|NCT02446457|Growth Substances|growth substances|mesh-ancestor
83098616|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
83098617|NCT03174236|Metronidazole|metronidazole|mesh-list
83098618|NCT03174236|Gentamicins|gentamicins|mesh-list
83098619|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
83098620|NCT03174236|Penicillins|penicillins|mesh-list
83098621|NCT03174236|Penicillin G|penicillin g|mesh-list
83098622|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83098623|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
83098624|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098625|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83098626|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83098627|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83098628|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83098629|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098630|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098631|NCT03172052|Streptokinase|streptokinase|mesh-list
83098633|NCT03172052|Protective Agents|protective agents|mesh-ancestor
83098634|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098635|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83098636|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83098637|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098638|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
83098639|NCT03171818|Hematinics|hematinics|mesh-ancestor
83098640|NCT02408354|Glycerol|glycerol|mesh-list
83098641|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83098642|NCT02408354|Protective Agents|protective agents|mesh-ancestor
83098643|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098644|NCT03176264|Bevacizumab|bevacizumab|mesh-list
83098645|NCT03176264|Spartalizumab|spartalizumab|mesh-list
83098646|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83098647|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098648|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83098649|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83098650|NCT03176264|Growth Substances|growth substances|mesh-ancestor
83098651|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098652|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
83098653|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83098654|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098655|NCT02406170|Paclitaxel|paclitaxel|mesh-list
83098656|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83098657|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098658|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
83098659|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
83098660|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
83098661|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098662|NCT02413658|Phenytoin|phenytoin|mesh-list
83098663|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
83098664|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83098665|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83098666|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83098667|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098668|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83098669|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83098670|NCT02406014|Diclofenac|diclofenac|mesh-list
83098671|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098672|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098673|NCT02406014|Analgesics|analgesics|mesh-ancestor
83098674|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
83098675|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098676|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098677|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098678|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098679|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83098680|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098681|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098682|NCT02406092|Prednisone|prednisone|mesh-list
83098683|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
83098684|NCT02406092|Rituximab|rituximab|mesh-list
83098685|NCT02406092|Doxorubicin|doxorubicin|mesh-list
83098686|NCT02406092|Fludarabine|fludarabine|mesh-list
83098687|NCT02406092|Vincristine|vincristine|mesh-list
83098688|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098689|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
83098690|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098691|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098692|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83098693|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
83098694|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098695|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098696|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83098697|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83098698|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83098699|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83098700|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83098701|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098703|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
83098704|NCT02406092|Hormones|hormones|mesh-ancestor
83466991|NCT01459484|Cisplatin|cisplatin|mesh-list
83098705|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098706|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098707|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83098708|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
83098709|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
83098710|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
83098711|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
83098712|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
83098713|NCT02405858|Prednisolone|prednisolone|mesh-list
83098714|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
83098715|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098716|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
83098717|NCT02405858|Hormones|hormones|mesh-ancestor
83098718|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098719|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098720|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098721|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098722|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83098723|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098724|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098725|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
83098726|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83098727|NCT03171740|Midazolam|midazolam|mesh-list
83098728|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
83098729|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83098730|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83098731|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098732|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098733|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098734|NCT03171740|Analgesics|analgesics|mesh-ancestor
83098735|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
83098736|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098737|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83098738|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83098739|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83098740|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
83098741|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098742|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098743|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83098744|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83098745|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83098746|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83098747|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83098748|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
83098749|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
83098750|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
83098751|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
83098752|NCT03176186|Xenon|xenon|mesh-list
83098753|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83098754|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
83098755|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
83098756|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098757|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098758|NCT04482764|Valproic Acid|valproic acid|mesh-list
83098759|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
83098760|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098761|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098762|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
83098763|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098764|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098765|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
83098766|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83098767|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098768|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83098769|NCT02408042|Rituximab|rituximab|mesh-list
83098770|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
83098771|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83098772|NCT02408042|Carboplatin|carboplatin|mesh-list
83098773|NCT02408042|Etoposide|etoposide|mesh-list
83098774|NCT02408042|Ifosfamide|ifosfamide|mesh-list
83098775|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83098776|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098777|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
83098778|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098779|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098780|NCT02408042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83098781|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098782|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83098783|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83098784|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83098785|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098786|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83098787|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
83098789|NCT02408042|Immunoconjugates|immunoconjugates|mesh-ancestor
83098790|NCT03172988|Dexamethasone|dexamethasone|mesh-list
83098791|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
83098792|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
83098793|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83098794|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83098795|NCT03172988|BB 1101|bb 1101|mesh-list
83098796|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098797|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
83098798|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
83098799|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098800|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098801|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098802|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
83098803|NCT03172988|Hormones|hormones|mesh-ancestor
83098804|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098805|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098806|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098807|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
83098808|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098809|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098810|NCT03172988|Analgesics|analgesics|mesh-ancestor
83098811|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
83098812|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098813|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098814|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098815|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83098816|NCT03042611|Apatinib|apatinib|mesh-list
83098817|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098818|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83098819|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098820|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098821|NCT03171584|Itraconazole|itraconazole|mesh-list
83098822|NCT03171584|Fluconazole|fluconazole|mesh-list
83098823|NCT03171584|Terbinafine|terbinafine|mesh-list
83098824|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
83098825|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098826|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83098827|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83098828|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098829|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098830|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83098831|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
83098832|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098833|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098834|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83098835|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83098836|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83098837|NCT02950259|Indomethacin|indomethacin|mesh-list
83098838|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
83098839|NCT02950259|Omeprazole|omeprazole|mesh-list
83098840|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83098841|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
83098842|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098843|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098844|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83098845|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
83098846|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098847|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098848|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83098849|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83098850|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098851|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83098852|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098853|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098854|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098855|NCT02950259|Analgesics|analgesics|mesh-ancestor
83098856|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
83098857|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098858|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098859|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
83098860|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
83098861|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83098862|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83098863|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
83098864|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83098865|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
83098866|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83098867|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098868|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83098869|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83098870|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83098871|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83098872|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83098873|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83098874|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
83098875|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83098876|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098877|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098879|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098880|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83098881|NCT02407340|Oxytocin|oxytocin|mesh-list
83098882|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
83098883|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83098884|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098885|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83098886|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098887|NCT02405156|Letrozole|letrozole|mesh-list
83098888|NCT02405156|Misoprostol|misoprostol|mesh-list
83098889|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098890|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83098891|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83098892|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098893|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098894|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83098895|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
83098896|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098897|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098898|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83098899|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
83098900|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83098901|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83098902|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83098903|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
83098904|NCT02411942|Adapalene|adapalene|mesh-list
83098905|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83098906|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83098907|NCT02411942|Analgesics|analgesics|mesh-ancestor
83098908|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
83098909|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83098910|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098911|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83098912|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83098913|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
83098914|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83098915|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83098916|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098917|NCT02406950|Incretins|incretins|mesh-ancestor
83098918|NCT02406950|Hormones|hormones|mesh-ancestor
83098919|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098920|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83098921|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
83098922|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098923|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098924|NCT02406872|Propofol|propofol|mesh-list
83098925|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83098926|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098927|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098928|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83098929|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
83098930|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
83098931|NCT03172676|Amoxicillin|amoxicillin|mesh-list
83098932|NCT03172676|Clarithromycin|clarithromycin|mesh-list
83098933|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83098934|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83098935|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098936|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83098937|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098938|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098939|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83098940|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83098941|NCT02404844|Tamoxifen|tamoxifen|mesh-list
83098942|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83098943|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
83098944|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098945|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098946|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83098947|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098948|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83098949|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83098950|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83098951|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
83098952|NCT04482296|Astringents|astringents|mesh-ancestor
83098953|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098954|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
83098956|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83098957|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098958|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83098959|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098960|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
83098961|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83098962|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
83098963|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098964|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
83098965|NCT02404454|Protective Agents|protective agents|mesh-ancestor
83098966|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
83098967|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83098968|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098969|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
83098970|NCT02411786|Molgramostim|molgramostim|mesh-list
83098971|NCT02411786|Sargramostim|sargramostim|mesh-list
83098972|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
83098973|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098974|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098975|NCT02404376|Exenatide|exenatide|mesh-list
83098976|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83098977|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098978|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83098979|NCT02404376|Incretins|incretins|mesh-ancestor
83098980|NCT02404376|Hormones|hormones|mesh-ancestor
83098981|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83098982|NCT04466085|Vaccines|vaccines|mesh-list
83098983|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
83098984|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098985|NCT03517995|Sulforaphane|sulforaphane|mesh-list
83098986|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83098987|NCT03517995|Protective Agents|protective agents|mesh-ancestor
83098988|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83098989|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83098990|NCT02411630|Tenofovir|tenofovir|mesh-list
83098991|NCT02411630|Emtricitabine|emtricitabine|mesh-list
83098992|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
83098993|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83098994|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83098995|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83098996|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83098997|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83098998|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83098999|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83099000|NCT02411318|Ethanol|ethanol|mesh-list
83099001|NCT02411318|Caffeine|caffeine|mesh-list
83099002|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83099003|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099004|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83099005|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099006|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099007|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83099008|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83099009|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
83099010|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099011|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83099012|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099013|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099015|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
83099016|NCT03133299|Vitamins|vitamins|mesh-ancestor
83099017|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
83099018|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099019|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83099020|NCT03133299|Hormones|hormones|mesh-ancestor
83099021|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099022|NCT04465695|Interferons|interferons|mesh-list
83099023|NCT04465695|Interferon-beta|interferon-beta|mesh-list
83099024|NCT04465695|Clofazimine|clofazimine|mesh-list
83099025|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
83099026|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099027|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
83099028|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099029|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
83099030|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099031|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83099032|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099033|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
83099034|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83099036|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
83099037|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099038|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83099039|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83099040|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099041|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099042|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83099043|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83099044|NCT04465851|Curcumin|curcumin|mesh-list
83099045|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83099046|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099047|NCT04465851|Analgesics|analgesics|mesh-ancestor
83099048|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
83099049|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099050|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099051|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099052|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099053|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099054|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099055|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099056|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
83099057|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83099058|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099059|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
83099060|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
83099061|NCT02404142|Atracurium|atracurium|mesh-list
83099062|NCT02404142|Curare|curare|mesh-list
83099063|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83099064|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83099065|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83099066|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099067|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099068|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83099069|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83099070|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
83099071|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099072|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099073|NCT03522051|Calcium|calcium|mesh-list
83099074|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83099075|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099076|NCT03171974|Dexamethasone|dexamethasone|mesh-list
83099078|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
83099079|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
83099080|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099081|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099082|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83099083|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
83099084|NCT03171974|Hormones|hormones|mesh-ancestor
83099085|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099086|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83099087|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099088|NCT02292069|Amlodipine|amlodipine|mesh-list
83099089|NCT02292069|Atorvastatin|atorvastatin|mesh-list
83099090|NCT02292069|Calcium|calcium|mesh-list
83099091|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83099092|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099093|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83099094|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83099095|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
83099096|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099097|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83099098|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83099099|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099100|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83099101|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83099102|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83099103|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
83099104|NCT02404064|Metronidazole|metronidazole|mesh-list
83099106|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099107|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83099108|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83099109|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83099110|NCT02294643|Aspirin|aspirin|mesh-list
83099111|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
83099112|NCT02294643|Clopidogrel|clopidogrel|mesh-list
83099113|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83099114|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099115|NCT02294643|Analgesics|analgesics|mesh-ancestor
83099116|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
83099117|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099118|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099119|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099120|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099121|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83099122|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83099123|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099124|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83099125|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83099126|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099127|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
83099128|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83099129|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83099130|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83099131|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
83099132|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099133|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83099134|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
83099135|NCT02410694|Thalidomide|thalidomide|mesh-list
83099136|NCT02410694|Dexamethasone|dexamethasone|mesh-list
83099137|NCT02410694|Ixazomib|ixazomib|mesh-list
83099138|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099139|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
83099140|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
83099141|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099142|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099143|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83099144|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
83099145|NCT02410694|Hormones|hormones|mesh-ancestor
83099146|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099147|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83099148|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099149|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83099150|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
83099151|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
83099152|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83099153|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099154|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83099155|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83099156|NCT02410694|Growth Substances|growth substances|mesh-ancestor
83099157|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
83099158|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
83099159|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099160|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099161|NCT03521895|Aflibercept|aflibercept|mesh-list
83099162|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83099163|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83099164|NCT03521895|Growth Substances|growth substances|mesh-ancestor
83099165|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099166|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
83099167|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099168|NCT02401880|Empagliflozin|empagliflozin|mesh-list
83099169|NCT02401880|Linagliptin|linagliptin|mesh-list
83099170|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83099171|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099172|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099173|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099174|NCT02401880|Incretins|incretins|mesh-ancestor
83099175|NCT02401880|Hormones|hormones|mesh-ancestor
83099176|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099177|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83099178|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
83099179|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099181|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83099182|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83099183|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099184|NCT03170726|Analgesics|analgesics|mesh-ancestor
83099185|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
83099186|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099187|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099188|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099189|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099190|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83099191|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099192|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099193|NCT03175016|Irinotecan|irinotecan|mesh-list
83099194|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83099195|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83099196|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099197|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099198|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099199|NCT03174938|Flutemetamol|flutemetamol|mesh-list
83099200|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83099201|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099202|NCT03520257|Apatinib|apatinib|mesh-list
83099203|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099204|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83099205|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099206|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099208|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
83099209|NCT02292303|Trace Elements|trace elements|mesh-ancestor
83099210|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
83099211|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099212|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
83099213|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
83099214|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83099215|NCT02292303|Protective Agents|protective agents|mesh-ancestor
83099216|NCT02294955|Amiodarone|amiodarone|mesh-list
83099217|NCT02294955|Sotalol|sotalol|mesh-list
83099218|NCT02294955|Flecainide|flecainide|mesh-list
83099219|NCT02294955|Dronedarone|dronedarone|mesh-list
83099220|NCT02294955|Propafenone|propafenone|mesh-list
83099221|NCT02294955|Disopyramide|disopyramide|mesh-list
83099222|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83099223|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
83099224|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83099225|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83099226|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099227|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83527297|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099228|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83099229|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83099231|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83099232|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83099233|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83099234|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83099235|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83099236|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099237|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099238|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099239|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
83099240|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
83099241|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099242|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83099243|NCT02396888|Insulin|insulin|mesh-list
83099244|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099245|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099246|NCT03517683|Methamphetamine|methamphetamine|mesh-list
83099247|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83099248|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099249|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
83099250|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
83099251|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099252|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
83099253|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099254|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099255|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099256|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83099257|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83099258|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83099259|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83099260|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
83099261|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83099263|NCT00801489|Fludarabine|fludarabine|mesh-list
83099264|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
83099265|NCT00801489|Decitabine|decitabine|mesh-list
83099266|NCT00801489|Idarubicin|idarubicin|mesh-list
83099267|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
83099268|NCT00801489|Calicheamicins|calicheamicins|mesh-list
83099269|NCT00801489|Lenograstim|lenograstim|mesh-list
83099270|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099271|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83099272|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
83099273|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099274|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83099275|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
83099276|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099277|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
83099278|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099279|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83099280|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099281|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83099282|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83099283|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83099284|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099285|NCT00801489|Immunotoxins|immunotoxins|mesh-ancestor
83099286|NCT00801489|Immunoconjugates|immunoconjugates|mesh-ancestor
83099287|NCT02164643|Flutemetamol|flutemetamol|mesh-list
83099288|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83099289|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099290|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83099291|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83099292|NCT02292459|Laxatives|laxatives|mesh-ancestor
83099293|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83099294|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83099295|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
83099296|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83099297|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83099298|NCT03170336|Amiloride|amiloride|mesh-list
83099299|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83099300|NCT03170336|Diuretics|diuretics|mesh-ancestor
83099301|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
83099302|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83527298|NCT00551161|Memantine|memantine|mesh-list
83099303|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83099304|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83099305|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099306|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83099307|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83099308|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83099309|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83099310|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83099311|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83099312|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83099313|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099314|NCT02295189|Triamcinolone|triamcinolone|mesh-list
83099315|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83099316|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83099318|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83099319|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83099320|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099321|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
83099322|NCT02295189|Hormones|hormones|mesh-ancestor
83099323|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099324|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099325|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83099326|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
83099327|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099328|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099329|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83099330|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099332|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
83099333|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099334|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099335|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83099336|NCT04055012|Metformin|metformin|mesh-list
83099337|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099338|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099339|NCT03519633|Neostigmine|neostigmine|mesh-list
83099340|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83099341|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099342|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099343|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
83099344|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099345|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099346|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83099347|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
83099348|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099349|NCT02289027|Vaccines|vaccines|mesh-list
83099350|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
83099351|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099352|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
83099353|NCT02396030|Analgesics|analgesics|mesh-ancestor
83099354|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
83099355|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099356|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099357|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
83099358|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099359|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83099360|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
83099361|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83099362|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83099363|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099364|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83099365|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
83099366|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099367|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
83099368|NCT02289261|Morphine|morphine|mesh-list
83099369|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83099370|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099371|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099372|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099373|NCT02289261|Analgesics|analgesics|mesh-ancestor
83099374|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
83099375|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83527299|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83099376|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83099377|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83099378|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83099379|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099380|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099381|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099382|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83099383|NCT02289261|Narcotics|narcotics|mesh-ancestor
83099384|NCT03168074|Lenvatinib|lenvatinib|mesh-list
83099385|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099386|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83099387|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099388|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099389|NCT02396108|Paclitaxel|paclitaxel|mesh-list
83099390|NCT02396108|Carboplatin|carboplatin|mesh-list
83099391|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83099392|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099393|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
83099394|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
83099395|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
83099396|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099397|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
83099398|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83099399|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83099400|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099401|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
83099402|NCT02403596|Coagulants|coagulants|mesh-ancestor
83099403|NCT02289495|Ritonavir|ritonavir|mesh-list
83099404|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
83099405|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83099406|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83099407|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
83099408|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099409|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099410|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83099411|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83099412|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
83099413|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099414|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83099415|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83099416|NCT01774721|Gefitinib|gefitinib|mesh-list
83099417|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099418|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83099419|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099420|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099421|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83099422|NCT02395952|Laxatives|laxatives|mesh-ancestor
83099423|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83099424|NCT03516903|Folic Acid|folic acid|mesh-list
83099425|NCT03516903|Methotrexate|methotrexate|mesh-list
83099426|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83099427|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
83099428|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099429|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099430|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83099431|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
83099432|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099433|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099434|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83099435|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099436|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83099437|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83099438|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
83099439|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099440|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83099441|NCT03516903|Hematinics|hematinics|mesh-ancestor
83099442|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
83099443|NCT03516903|Vitamins|vitamins|mesh-ancestor
83099444|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
83099445|NCT03516747|Hormones|hormones|mesh-list
83099446|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
83099447|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099448|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099449|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83099450|NCT03516669|Amoxicillin|amoxicillin|mesh-list
83099451|NCT03516669|Clarithromycin|clarithromycin|mesh-list
83099452|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83099453|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099454|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83099455|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099456|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099457|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83099458|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83099459|NCT02289807|Cisplatin|cisplatin|mesh-list
83099460|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099461|NCT02298153|Atezolizumab|atezolizumab|mesh-list
83099462|NCT02298153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83099463|NCT02298153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099464|NCT02298153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099465|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099466|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83099467|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
83099468|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099469|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
83099470|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099471|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099473|NCT02296047|Albuterol|albuterol|mesh-list
83099474|NCT02296047|Ipratropium|ipratropium|mesh-list
83099475|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
83099476|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83099477|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
83099478|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099479|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099480|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83099481|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83099482|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
83099483|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099484|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83099485|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83099486|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83099487|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099488|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099489|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099490|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83099491|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
83099492|NCT02293785|Oxycodone|oxycodone|mesh-list
83099493|NCT02293785|Naloxone|naloxone|mesh-list
83099494|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83099495|NCT02293785|Narcotics|narcotics|mesh-ancestor
83099496|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099497|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099498|NCT02293785|Analgesics|analgesics|mesh-ancestor
83099499|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
83099500|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099501|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83099502|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
83099503|NCT01162109|Astringents|astringents|mesh-ancestor
83099504|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099505|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
83099506|NCT02296203|Irinotecan|irinotecan|mesh-list
83099507|NCT02296203|Cetuximab|cetuximab|mesh-list
83099508|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83099509|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83099510|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099511|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099512|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099513|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099514|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
83099515|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83099516|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099517|NCT02296281|Pirfenidone|pirfenidone|mesh-list
83099518|NCT02296281|Analgesics|analgesics|mesh-ancestor
83099519|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
83099520|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099521|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099522|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83099523|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099524|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099525|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099526|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099527|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83099528|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83099529|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83099530|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
83099531|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099532|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83099533|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83099534|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099535|NCT03513549|Loxapine|loxapine|mesh-list
83099536|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83099537|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83099538|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099539|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099540|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83099541|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83099542|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
83099543|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099544|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099545|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83099546|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099547|NCT03513393|Velpatasvir|velpatasvir|mesh-list
83099548|NCT03513393|Omeprazole|omeprazole|mesh-list
83099549|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83099550|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83099551|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83099552|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099553|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099554|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
83099555|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099556|NCT02299401|Misoprostol|misoprostol|mesh-list
83099557|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83099558|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
83099559|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099560|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099561|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83099562|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83099563|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
83099564|NCT02699450|Ranibizumab|ranibizumab|mesh-list
83099565|NCT02699450|Faricimab|faricimab|mesh-list
83099566|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83099567|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83099568|NCT02699450|Growth Substances|growth substances|mesh-ancestor
83099569|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099570|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
83099571|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099572|NCT02299557|Phenylephrine|phenylephrine|mesh-list
83099573|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
83099574|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83099575|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83099576|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099577|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099578|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099579|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099580|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
83099581|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
83099582|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099583|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
83099584|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83099585|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
83099586|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83099587|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
83099588|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83099589|NCT02299557|Protective Agents|protective agents|mesh-ancestor
83099590|NCT02302989|Ranibizumab|ranibizumab|mesh-list
83099591|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83099592|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83099593|NCT02302989|Growth Substances|growth substances|mesh-ancestor
83099594|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099595|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
83099596|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099597|NCT02296671|Leucovorin|leucovorin|mesh-list
83099598|NCT02296671|Fluorouracil|fluorouracil|mesh-list
83099599|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
83099600|NCT02296671|Pemetrexed|pemetrexed|mesh-list
83099601|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
83099602|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099603|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83099604|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099605|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83099606|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
83099607|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099608|NCT02296671|Antidotes|antidotes|mesh-ancestor
83099609|NCT02296671|Protective Agents|protective agents|mesh-ancestor
83099610|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
83099611|NCT02296671|Vitamins|vitamins|mesh-ancestor
83099612|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
83099613|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099614|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83099615|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83099616|NCT02296749|Sirolimus|sirolimus|mesh-list
83099617|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83099618|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099619|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83099620|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099621|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
83099622|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83099623|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
83099624|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099625|NCT04481750|Edaravone|edaravone|mesh-list
83099626|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83099627|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
83099628|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099629|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83099630|NCT04481750|Protective Agents|protective agents|mesh-ancestor
83467044|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
83099631|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099632|NCT02303223|Propofol|propofol|mesh-list
83099633|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83099634|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099635|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099636|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83099637|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
83099638|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
83099639|NCT03168698|Oxytocin|oxytocin|mesh-list
83099640|NCT03168698|Carbetocin|carbetocin|mesh-list
83099641|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
83099642|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099643|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099644|NCT04464135|Acetic Acid|acetic acid|mesh-list
83099645|NCT04464135|Retinol acetate|retinol acetate|mesh-list
83099646|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83099647|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099648|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83099649|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
83099650|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099651|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83099652|NCT04464135|Protective Agents|protective agents|mesh-ancestor
83099653|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099654|NCT03510351|Tazobactam|tazobactam|mesh-list
83099655|NCT03510351|Ceftolozane|ceftolozane|mesh-list
83099656|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83099657|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83099658|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099659|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83099660|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099661|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099662|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83099663|NCT02403284|Liraglutide|liraglutide|mesh-list
83099664|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099665|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099666|NCT02403284|Incretins|incretins|mesh-ancestor
83099667|NCT02403284|Hormones|hormones|mesh-ancestor
83099668|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099669|NCT02400866|Olanzapine|olanzapine|mesh-list
83099670|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
83099671|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
83099672|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099673|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099674|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83099675|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83099676|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83099677|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099678|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83099679|NCT02400866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83099680|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83099681|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83099682|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099683|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099684|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
83099685|NCT02400788|Sorafenib|sorafenib|mesh-list
83099686|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099687|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83099688|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099689|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099690|NCT02403128|Aflibercept|aflibercept|mesh-list
83099691|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83099692|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83099693|NCT02403128|Growth Substances|growth substances|mesh-ancestor
83099694|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099695|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
83099696|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099697|NCT02297217|Paclitaxel|paclitaxel|mesh-list
83099698|NCT02297217|Carboplatin|carboplatin|mesh-list
83099699|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83099700|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099701|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83099702|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83099703|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83099704|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099705|NCT03515577|Edetic Acid|edetic acid|mesh-list
83099706|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83099707|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
83099708|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
83099709|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099710|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
83099711|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83099712|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83099713|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
83099714|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83099715|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099716|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099717|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099718|NCT02300649|Analgesics|analgesics|mesh-ancestor
83099719|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
83099720|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099721|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83099722|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83099723|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83099724|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099725|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099726|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099727|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83099728|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83099729|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
83099730|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099731|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099732|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83099733|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83099734|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83099735|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099736|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83099737|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099738|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099740|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83099741|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83099742|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83099743|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099744|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099745|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099746|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099747|NCT02303769|Urological Agents|urological agents|mesh-ancestor
83099748|NCT02303847|Ketamine|ketamine|mesh-list
83099749|NCT02303847|Analgesics|analgesics|mesh-ancestor
83527375|NCT04801043|Cilastatin|cilastatin|mesh-list
83099751|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099752|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099753|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83099754|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83099755|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
83099756|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
83099757|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099758|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83099759|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83099760|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099761|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099762|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83099763|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
83099764|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83099765|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83099766|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83099767|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099768|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099769|NCT03511833|Ketamine|ketamine|mesh-list
83099770|NCT03511833|Morphine|morphine|mesh-list
83099771|NCT03511833|Analgesics|analgesics|mesh-ancestor
83099772|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
83099773|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099774|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099775|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83099776|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83099777|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
83099778|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
83099779|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099780|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83099781|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83099782|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099783|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099784|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83099785|NCT03511833|Narcotics|narcotics|mesh-ancestor
83099786|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83099787|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099788|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099789|NCT02696798|Ixekizumab|ixekizumab|mesh-list
83099790|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83099791|NCT02304081|Saxagliptin|saxagliptin|mesh-list
83099792|NCT02304081|Incretins|incretins|mesh-ancestor
83099793|NCT02304081|Hormones|hormones|mesh-ancestor
83099794|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099795|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099796|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83099797|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
83099798|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099799|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099800|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099801|NCT02304237|Progesterone|progesterone|mesh-list
83099802|NCT02304237|Progestins|progestins|mesh-ancestor
83099803|NCT02304237|Hormones|hormones|mesh-ancestor
83099804|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099805|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099806|NCT03515187|Bromides|bromides|mesh-list
83099807|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83099808|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83099809|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
83099810|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
83099811|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83099812|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
83099813|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099814|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
83099815|NCT03515187|Protective Agents|protective agents|mesh-ancestor
83099816|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
83099817|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83099818|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099819|NCT02395016|Gemcitabine|gemcitabine|mesh-list
83099820|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
83099821|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83099822|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
83467064|NCT00002428|Vaccines|vaccines|mesh-list
83133562|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83099823|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099824|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099825|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099826|NCT04480268|Paclitaxel|paclitaxel|mesh-list
83099827|NCT04480268|Gemcitabine|gemcitabine|mesh-list
83099828|NCT04480268|Capecitabine|capecitabine|mesh-list
83099829|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83099830|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099831|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
83099832|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
83099833|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
83099834|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099835|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83099836|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
83099837|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83099838|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
83099839|NCT03510975|Coagulants|coagulants|mesh-ancestor
83099840|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83099841|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
83099842|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099843|NCT03169790|Leucovorin|leucovorin|mesh-list
83099844|NCT03169790|Paclitaxel|paclitaxel|mesh-list
83099845|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
83099846|NCT03169790|Bevacizumab|bevacizumab|mesh-list
83099847|NCT03169790|Rituximab|rituximab|mesh-list
83099848|NCT03169790|Fluorouracil|fluorouracil|mesh-list
83099849|NCT03169790|Capecitabine|capecitabine|mesh-list
83099850|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
83099852|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83099853|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099854|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
83099855|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
83099856|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
83099857|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099858|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83099859|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
83099860|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099861|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099862|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83099863|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
83099864|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83099865|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099866|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83099867|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83099868|NCT03169790|Growth Substances|growth substances|mesh-ancestor
83099869|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83099870|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
83099871|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83099872|NCT03169790|Antidotes|antidotes|mesh-ancestor
83099873|NCT03169790|Protective Agents|protective agents|mesh-ancestor
83099874|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
83099875|NCT03169790|Vitamins|vitamins|mesh-ancestor
83099876|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
83099877|NCT02304393|Atezolizumab|atezolizumab|mesh-list
83099878|NCT02304393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83099879|NCT02304393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099880|NCT02304393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099881|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099882|NCT02402972|Leucovorin|leucovorin|mesh-list
83099883|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
83099884|NCT02402972|Floxuridine|floxuridine|mesh-list
83099885|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
83099886|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099887|NCT02402972|Antidotes|antidotes|mesh-ancestor
83099888|NCT02402972|Protective Agents|protective agents|mesh-ancestor
83099889|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099890|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
83099891|NCT02402972|Vitamins|vitamins|mesh-ancestor
83099892|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
83099893|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83099894|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
83099895|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099896|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
83099897|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099898|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83099899|NCT02394470|Protective Agents|protective agents|mesh-ancestor
83099900|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099901|NCT02304627|Insulin|insulin|mesh-list
83099902|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099903|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099904|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
83099905|NCT02394158|Metformin|metformin|mesh-list
83099906|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099907|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099908|NCT03508635|Prednisone|prednisone|mesh-list
83099909|NCT03508635|Cortisone|cortisone|mesh-list
83099910|NCT03508635|Mifepristone|mifepristone|mesh-list
83099911|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099912|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
83099913|NCT03508635|Hormones|hormones|mesh-ancestor
83099914|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099915|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099916|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83099917|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099918|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83099919|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
83099920|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099921|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83099922|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83099923|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83099924|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
83099925|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83099926|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83099927|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
83099928|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
83099929|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83099930|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83099932|NCT04481282|Danazol|danazol|mesh-list
83099933|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83099934|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
83099935|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099936|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099937|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83099938|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
83099939|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
83099940|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
83099941|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099942|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83099943|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83099944|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83099945|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
83099946|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099947|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099948|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83099949|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
83099950|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099951|NCT02541604|Atezolizumab|atezolizumab|mesh-list
83099952|NCT02541604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83099953|NCT02541604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099954|NCT02541604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83099955|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83099956|NCT02393846|Ketoprofen|ketoprofen|mesh-list
83099957|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83099958|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83099959|NCT02393846|Analgesics|analgesics|mesh-ancestor
83099960|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
83099961|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83099962|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099963|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099964|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83099965|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83099966|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83099967|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099968|NCT02302209|Oxytocin|oxytocin|mesh-list
83099969|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
83099970|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83099971|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099972|NCT02394002|Propofol|propofol|mesh-list
83099973|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83099974|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83099975|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099976|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83099977|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
83099978|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
83099979|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83099980|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83099981|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83099982|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
83099983|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83099984|NCT02402348|Metformin|metformin|mesh-list
83099985|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83099986|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099987|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83099988|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83099989|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
83099990|NCT02399462|Hormones|hormones|mesh-ancestor
83099991|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83099992|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83099993|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83099994|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83099995|NCT02305173|Dexamethasone|dexamethasone|mesh-list
83099996|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83099997|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
83099998|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
83099999|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100000|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100001|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83100002|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
83100003|NCT02305173|Hormones|hormones|mesh-ancestor
83100004|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100005|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83100006|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100008|NCT03505047|Trace Elements|trace elements|mesh-ancestor
83100009|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
83100010|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100011|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
83100012|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100013|NCT02305485|Everolimus|everolimus|mesh-list
83100014|NCT02305485|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83100015|NCT02305485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83100016|NCT02305485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100017|NCT02305485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100018|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83100019|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
83100020|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100021|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100022|NCT02311569|Mirabegron|mirabegron|mesh-list
83100023|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83100024|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83100025|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83100026|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
83100027|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100028|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100029|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100030|NCT02311569|Urological Agents|urological agents|mesh-ancestor
83100031|NCT02393456|Oxytocin|oxytocin|mesh-list
83100032|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
83100033|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83100034|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100035|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
83100036|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83100037|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83100038|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100039|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83100040|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83100041|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
83100042|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100043|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100044|NCT02306733|Oxytocin|oxytocin|mesh-list
83100045|NCT02306733|Ergonovine|ergonovine|mesh-list
83100046|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
83100047|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83100048|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100049|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83100050|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
83100051|NCT03507465|Capecitabine|capecitabine|mesh-list
83100053|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100054|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
83100055|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100056|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100057|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83100058|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83100059|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100060|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83100061|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
83100062|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100063|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100064|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
83100065|NCT05476042|Hematinics|hematinics|mesh-ancestor
83100066|NCT03507387|Phenylephrine|phenylephrine|mesh-list
83100067|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
83100068|NCT03507387|Bupivacaine|bupivacaine|mesh-list
83100069|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
83100070|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
83100071|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100072|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100073|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
83100074|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100075|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83100076|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
83100077|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
83100078|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
83100079|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83100080|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
83100081|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83100082|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83100083|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83100084|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83100085|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
83100086|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100087|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100088|NCT03507387|Protective Agents|protective agents|mesh-ancestor
83100090|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100091|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83100092|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83100093|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100094|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100095|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83100096|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
83100097|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100098|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100099|NCT02694536|Gemcitabine|gemcitabine|mesh-list
83100100|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83100101|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100102|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
83100103|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100104|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100105|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83100106|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100107|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
83100108|NCT02312037|Antibodies|antibodies|mesh-list
83100109|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
83100110|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
83100111|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100112|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100113|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100114|NCT02312037|Immunotoxins|immunotoxins|mesh-ancestor
83100115|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
83100116|NCT03167918|Metformin|metformin|mesh-list
83100117|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
83100118|NCT03167918|Calcium|calcium|mesh-list
83100119|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83100120|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100121|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83100122|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83100123|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
83100124|NCT03167918|Coagulants|coagulants|mesh-ancestor
83100125|NCT05745818|Colchicine|colchicine|mesh-list
83100126|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
83100127|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100128|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
83100129|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
83100130|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
83100131|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100132|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100133|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
83100134|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83100135|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83100136|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100137|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
83100138|NCT02393300|Coagulants|coagulants|mesh-ancestor
83100139|NCT03106610|Nivolumab|nivolumab|mesh-list
83100140|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100141|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100142|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83100143|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100144|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83100145|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83100146|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100147|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83100148|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83100149|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83100150|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
83100151|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100152|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83100153|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83100154|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83100155|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83100156|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83100157|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100158|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83100159|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100160|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83100161|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
83100162|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
83100163|NCT02312115|Furosemide|furosemide|mesh-list
83100164|NCT02312115|Diuretics|diuretics|mesh-ancestor
83100165|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
83100166|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100167|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83100168|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83100169|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100170|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83100171|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83100172|NCT03026140|Celecoxib|celecoxib|mesh-list
83100173|NCT03026140|Nivolumab|nivolumab|mesh-list
83100174|NCT03026140|Ipilimumab|ipilimumab|mesh-list
83100175|NCT03026140|Relatlimab|relatlimab|mesh-list
83100176|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100177|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100178|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83100179|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100180|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83100181|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83100182|NCT03026140|Analgesics|analgesics|mesh-ancestor
83100183|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
83100184|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100185|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100186|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100187|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100188|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83100189|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83100190|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100191|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
83100192|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
83100193|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83100194|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
83100195|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83100196|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100197|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
83100198|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
83100199|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100200|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100201|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83100202|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
83100204|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100205|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83100206|NCT02398994|Protective Agents|protective agents|mesh-ancestor
83100207|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
83100208|NCT02306889|Fenofibrate|fenofibrate|mesh-list
83100209|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83100210|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
83100211|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100212|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83100213|NCT02393144|Meperidine|meperidine|mesh-list
83100214|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
83100215|NCT02393144|Analgesics|analgesics|mesh-list
83100216|NCT02393144|Oxytocin|oxytocin|mesh-list
83100217|NCT02393144|Dinoprostone|dinoprostone|mesh-list
83100218|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
83100219|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83100220|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100221|NCT02393144|Narcotics|narcotics|mesh-ancestor
83100222|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100223|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
82728930|NCT00931450|Sunitinib|sunitinib|mesh-list
83100224|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100225|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83100227|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
83100228|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83100229|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83100230|NCT02306031|Analgesics|analgesics|mesh-ancestor
83100231|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
83100232|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100233|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100234|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100235|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100236|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83100237|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100238|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100239|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83100240|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83100241|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83100242|NCT02392910|Hematinics|hematinics|mesh-ancestor
83100243|NCT02307045|Nicotine|nicotine|mesh-list
83100244|NCT02307045|Varenicline|varenicline|mesh-list
83100245|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83100246|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
83100247|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100248|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100249|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83100250|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83100251|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
83100252|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100253|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100254|NCT03167372|Imidacloprid|imidacloprid|mesh-list
83100255|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
83100256|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100257|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100258|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100259|NCT03504345|Progesterone|progesterone|mesh-list
83100260|NCT03504345|Progestins|progestins|mesh-ancestor
83100261|NCT03504345|Hormones|hormones|mesh-ancestor
83100262|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100263|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100264|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
83100265|NCT02307201|Analgesics|analgesics|mesh-ancestor
83100266|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
83100267|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100268|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100269|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
83100270|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100271|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83100272|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
83100273|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83100274|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83100275|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100276|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83100277|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
83100278|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83100279|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
83100280|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83100281|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100282|NCT03167216|Cetirizine|cetirizine|mesh-list
83100283|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
83100284|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83100285|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83100286|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83100287|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
83100288|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
83100289|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100290|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100291|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100292|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83100293|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
83100294|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100295|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83100296|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
83100297|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
83100298|NCT02393066|Propofol|propofol|mesh-list
83100300|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100301|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100302|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83100303|NCT02393066|Analgesics|analgesics|mesh-ancestor
83100304|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
83100305|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100306|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83100307|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83100308|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83100309|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
83100310|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100311|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100312|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83100313|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
83100314|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
83100315|NCT02398838|Misoprostol|misoprostol|mesh-list
83100316|NCT02398838|Mifepristone|mifepristone|mesh-list
83100317|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83100318|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
83100319|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83100320|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100321|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83100322|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83100323|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
83100324|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83100325|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83100326|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83100327|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83100328|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
83100329|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83100330|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83100331|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
83100332|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100333|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
83100334|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83100335|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83100336|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
83100337|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
83100338|NCT02398682|Protective Agents|protective agents|mesh-ancestor
83100339|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100340|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83100341|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
83100342|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100343|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100344|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83100345|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100346|NCT03504033|Desflurane|desflurane|mesh-list
83100347|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83100348|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
83100349|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
83100350|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100351|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100352|NCT03132519|Remifentanil|remifentanil|mesh-list
83100353|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83100354|NCT03132519|Narcotics|narcotics|mesh-ancestor
83100355|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100356|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100357|NCT03132519|Analgesics|analgesics|mesh-ancestor
83100358|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
83100359|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100360|NCT02398448|Allopurinol|allopurinol|mesh-list
83100361|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
83100362|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100363|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100364|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
83100365|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100366|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83100367|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
83100368|NCT02398448|Protective Agents|protective agents|mesh-ancestor
83100369|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100370|NCT02392520|Cetrorelix|cetrorelix|mesh-list
83100371|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83100372|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
83100373|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83100374|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100375|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
83100376|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100378|NCT02316249|Hormones|hormones|mesh-ancestor
83100379|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100380|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100381|NCT02316249|Estrogens|estrogens|mesh-ancestor
83100382|NCT02696096|Buprenorphine|buprenorphine|mesh-list
83100383|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83100384|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83100385|NCT02696096|Narcotics|narcotics|mesh-ancestor
83100386|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100387|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100388|NCT02696096|Analgesics|analgesics|mesh-ancestor
83100389|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
83100390|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100391|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83100392|NCT02316327|Bevacizumab|bevacizumab|mesh-list
83100393|NCT02316327|Gemcitabine|gemcitabine|mesh-list
83100394|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100395|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100396|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83100397|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83100398|NCT02316327|Growth Substances|growth substances|mesh-ancestor
83100399|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100400|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83100401|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100402|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
83100403|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100404|NCT02695628|Misonidazole|misonidazole|mesh-list
83100405|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100406|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83100407|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83100408|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83100409|NCT02392364|Aflibercept|aflibercept|mesh-list
83100410|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83100411|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83100412|NCT02392364|Growth Substances|growth substances|mesh-ancestor
83100413|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100414|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
83100415|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100416|NCT02392676|Olaparib|olaparib|mesh-list
83100417|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83100418|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100419|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100420|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100421|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83100422|NCT03106298|Hematinics|hematinics|mesh-ancestor
83100423|NCT02307591|Amiodarone|amiodarone|mesh-list
83100424|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83100425|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
83100426|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83100427|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83100428|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100429|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83100430|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83100431|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83100432|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100433|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83467157|NCT01421810|Hormones|hormones|mesh-ancestor
83100434|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83100435|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83100436|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
83100437|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100438|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100439|NCT03506997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83100440|NCT03506997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100441|NCT02398136|Midazolam|midazolam|mesh-list
83100442|NCT02398136|Ketamine|ketamine|mesh-list
83100443|NCT02398136|Analgesics|analgesics|mesh-ancestor
83100444|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
83100445|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100446|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100447|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83100448|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83100449|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
83100450|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
83100451|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100452|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83100453|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83100454|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100455|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100456|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83100457|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83100458|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83100459|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83100460|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83100461|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
83100462|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
83100463|NCT05745584|Mirabegron|mirabegron|mesh-list
83100464|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83100465|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83100466|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83100467|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83100468|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83100469|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100470|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100471|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100472|NCT05745584|Urological Agents|urological agents|mesh-ancestor
83100473|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
83100474|NCT02312661|Metformin|metformin|mesh-list
83100475|NCT02312661|Paclitaxel|paclitaxel|mesh-list
83100476|NCT02312661|Carboplatin|carboplatin|mesh-list
83100477|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83100478|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100479|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
83100480|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
83100481|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
83100482|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100483|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83100484|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100485|NCT02398058|Olaparib|olaparib|mesh-list
83100486|NCT02398058|Trabectedin|trabectedin|mesh-list
83100487|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83100488|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100489|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100490|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100491|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83100492|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
83100493|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
83100494|NCT03501615|Immunotoxins|immunotoxins|mesh-ancestor
83100495|NCT03501615|Immunoconjugates|immunoconjugates|mesh-ancestor
83100496|NCT03501615|Immunologic Factors|immunologic factors|mesh-ancestor
83100497|NCT03501615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100498|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100499|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
83100500|NCT05745350|Etoposide|etoposide|mesh-list
83100501|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100502|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83527603|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
83100503|NCT05745350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83100504|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100505|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83100506|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83100507|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83100508|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100509|NCT03506919|Allopurinol|allopurinol|mesh-list
83100510|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
83100511|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100512|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100513|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
83100514|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100515|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83100516|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
83100517|NCT03506919|Protective Agents|protective agents|mesh-ancestor
83100518|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100519|NCT02545504|Leucovorin|leucovorin|mesh-list
83100520|NCT02545504|Fluorouracil|fluorouracil|mesh-list
83100521|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
83100522|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
83100523|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100524|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100525|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100526|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83100527|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
83100528|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100529|NCT02545504|Antidotes|antidotes|mesh-ancestor
83100530|NCT02545504|Protective Agents|protective agents|mesh-ancestor
83100531|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
83100533|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
83100534|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
83100535|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83100536|NCT03506841|Protective Agents|protective agents|mesh-ancestor
83100537|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100538|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
83100539|NCT02397512|Lactulose|lactulose|mesh-list
83100540|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83100541|NCT02313051|Everolimus|everolimus|mesh-list
83100542|NCT02313051|Letrozole|letrozole|mesh-list
83100543|NCT02313051|Goserelin|goserelin|mesh-list
83100544|NCT02313051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83100545|NCT02313051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83100546|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100547|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100548|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83100549|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
83100550|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100551|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100552|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83100553|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83100554|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83100555|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
83100556|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100557|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83100558|NCT02397590|Atorvastatin|atorvastatin|mesh-list
83100559|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83100560|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83100561|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
83100562|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100563|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83100564|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83100565|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100566|NCT02397356|Ketamine|ketamine|mesh-list
83100567|NCT02397356|Analgesics|analgesics|mesh-ancestor
83100568|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
83100569|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100570|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100571|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83100572|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83100573|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
83100574|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
83100575|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100576|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83100577|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83100578|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100579|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100580|NCT02307825|Azithromycin|azithromycin|mesh-list
83100581|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83100582|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83100583|NCT02540668|Warfarin|warfarin|mesh-list
83100584|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
83100585|NCT03506763|Diclofenac|diclofenac|mesh-list
83100586|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83100587|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83100588|NCT03506763|Analgesics|analgesics|mesh-ancestor
83100589|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
83100590|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100591|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100592|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100593|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100594|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83100595|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100596|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100598|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83100599|NCT02441439|Trace Elements|trace elements|mesh-ancestor
83100600|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
83100601|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100602|NCT02441439|Hematinics|hematinics|mesh-ancestor
83100603|NCT02308137|Domperidone|domperidone|mesh-list
83100604|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100605|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
83100606|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
83100607|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100608|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100609|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83100610|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83100611|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
83100612|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100613|NCT03501459|Rituximab|rituximab|mesh-list
83100614|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100615|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100616|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
83100617|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100618|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100619|NCT02317263|Testosterone|testosterone|mesh-list
83100620|NCT02317263|Androgens|androgens|mesh-ancestor
83100621|NCT02317263|Hormones|hormones|mesh-ancestor
83100622|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100623|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100624|NCT02317341|Midazolam|midazolam|mesh-list
83100625|NCT02317341|Ketamine|ketamine|mesh-list
83100626|NCT02317341|Analgesics|analgesics|mesh-ancestor
83100627|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
83100628|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100629|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100630|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83100631|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83100632|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
83100633|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
83100634|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100635|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83100636|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83100637|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100638|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100639|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83100640|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83100641|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83100642|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83100643|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83100644|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
83100645|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
83100646|NCT02339740|Vitamins|vitamins|mesh-list
83100647|NCT02339740|Vitamin A|vitamin a|mesh-list
83100648|NCT02339740|Cytarabine|cytarabine|mesh-list
83100649|NCT02339740|Dexamethasone|dexamethasone|mesh-list
83100650|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
83100651|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
83100652|NCT02339740|Idarubicin|idarubicin|mesh-list
83100653|NCT02339740|Tretinoin|tretinoin|mesh-list
83100654|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
83100655|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
83100656|NCT02339740|BB 1101|bb 1101|mesh-list
83100657|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
83100658|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100659|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100660|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
83100661|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
83100662|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100663|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83100664|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
83100665|NCT02339740|Hormones|hormones|mesh-ancestor
83100666|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100667|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83100668|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100669|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
83100670|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100671|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100672|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100673|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
83100675|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83100676|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83100677|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
83100678|NCT02339740|Analgesics|analgesics|mesh-ancestor
83100679|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
83100680|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83100681|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83100682|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83100683|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
83100684|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
83100685|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
83100686|NCT02339740|Protective Agents|protective agents|mesh-ancestor
83100687|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83100688|NCT02317419|Paclitaxel|paclitaxel|mesh-list
83100689|NCT02317419|Gemcitabine|gemcitabine|mesh-list
83100690|NCT02317419|LMB-100|lmb-100|mesh-list
83100691|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83100692|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100693|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
83100694|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
83100695|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
83100696|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100697|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100698|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
83100699|NCT02317419|Immunoconjugates|immunoconjugates|mesh-ancestor
83100700|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
83100701|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100702|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83100703|NCT02957968|Paclitaxel|paclitaxel|mesh-list
83100704|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
83100705|NCT02957968|Carboplatin|carboplatin|mesh-list
83100706|NCT02957968|Doxorubicin|doxorubicin|mesh-list
83100707|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
83100708|NCT02957968|Decitabine|decitabine|mesh-list
83100709|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83100710|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100711|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
83100712|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
83467177|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
83100713|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
83100714|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100715|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83100716|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
83100717|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100718|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100719|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83100720|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
83100721|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83100722|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83100723|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83100724|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83100725|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100726|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100727|NCT02957968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83100728|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100729|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
83100730|NCT05452174|Mirtazapine|mirtazapine|mesh-list
83100731|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
83100732|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83100733|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83100734|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
83100735|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
83100736|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100737|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100738|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100739|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83100740|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83100741|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100742|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83100743|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83100744|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83100745|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
83100746|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83100747|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83100748|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
83100749|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83100751|NCT03943888|Neostigmine|neostigmine|mesh-list
83100752|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83100753|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83100754|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83100755|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
83100756|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100757|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100758|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83100759|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
83100760|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
83100761|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
83100762|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83100763|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83100764|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
83100765|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100766|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100767|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83100768|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100769|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83100770|NCT03502551|Ketamine|ketamine|mesh-list
83100771|NCT03502551|Analgesics|analgesics|mesh-ancestor
83100772|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
83100773|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100774|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100775|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83100776|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83100777|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
83100778|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
83100779|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100780|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83100781|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83100782|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100783|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100784|NCT02314377|Bevacizumab|bevacizumab|mesh-list
83100785|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100786|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100787|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83100788|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83100789|NCT02314377|Growth Substances|growth substances|mesh-ancestor
83100790|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100791|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
83100792|NCT02942290|Azacitidine|azacitidine|mesh-list
83100793|NCT02942290|Venetoclax|venetoclax|mesh-list
83100794|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83100795|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
83100796|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100797|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100798|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100799|NCT02540356|Antibodies|antibodies|mesh-list
83100800|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
83100801|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
83100802|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100803|NCT05463094|Metformin|metformin|mesh-list
83100804|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83100805|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100806|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
83100807|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100808|NCT05461378|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83100809|NCT05461378|Antiviral Agents|antiviral agents|mesh-ancestor
83100810|NCT05461378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83100811|NCT02392130|Clobetasol|clobetasol|mesh-list
83100812|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100813|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
83100814|NCT02392130|Hormones|hormones|mesh-ancestor
83100815|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100816|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100817|NCT05356091|Sevoflurane|sevoflurane|mesh-list
83100818|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83100819|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83100820|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
83100821|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
83100822|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100823|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100824|NCT05351021|Metformin|metformin|mesh-list
83100825|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83100826|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100827|NCT02688764|Calcium|calcium|mesh-list
83100828|NCT02688764|Calcium acetate|calcium acetate|mesh-list
83100829|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83100830|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100831|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
83100832|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
83100833|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100834|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
83100835|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100836|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100837|NCT02688608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83100838|NCT02688608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100839|NCT02688530|Dexamethasone|dexamethasone|mesh-list
83100840|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
83100841|NCT02688530|BB 1101|bb 1101|mesh-list
83100842|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100843|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
83100844|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
83100845|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100846|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100847|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83100848|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
83100849|NCT02688530|Hormones|hormones|mesh-ancestor
83100850|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83100851|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83100852|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100853|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
83100854|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100855|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100856|NCT05744804|Aspirin|aspirin|mesh-list
83100857|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
83100858|NCT05744804|Clopidogrel|clopidogrel|mesh-list
83100859|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83100860|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83100861|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83100862|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83100863|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
83100864|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100865|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100866|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100867|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83100868|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
83100869|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83100870|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
83100871|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100872|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
83100873|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83100874|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83100875|NCT05744804|Analgesics|analgesics|mesh-ancestor
83100876|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
83100877|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100878|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83100879|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83100880|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83100881|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83100882|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83100883|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
83100884|NCT05744726|Bone wax|bone wax|mesh-list
83100885|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
83100886|NCT05744726|Coagulants|coagulants|mesh-ancestor
83100887|NCT02467270|Ponatinib|ponatinib|mesh-list
83100888|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100889|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83100890|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100891|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100892|NCT05150795|Pregabalin|pregabalin|mesh-list
83100893|NCT05150795|Fentanyl|fentanyl|mesh-list
83100894|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83100895|NCT05150795|Narcotics|narcotics|mesh-ancestor
83100896|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100897|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100898|NCT05150795|Analgesics|analgesics|mesh-ancestor
83100899|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
83100900|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100901|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83100902|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83100903|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
83100904|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
83100905|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
83100906|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83100907|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83100908|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100909|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83100910|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83100911|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83100912|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83100913|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
83100914|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
83100915|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83100916|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83100917|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83100918|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100919|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100920|NCT02533570|Immunotoxins|immunotoxins|mesh-ancestor
83100921|NCT02533570|Immunoconjugates|immunoconjugates|mesh-ancestor
83100922|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
83100923|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100924|NCT02268448|Clonidine|clonidine|mesh-list
83100925|NCT02268448|Naltrexone|naltrexone|mesh-list
83100926|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83100927|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83100928|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100929|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
83100930|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83100931|NCT02268448|Analgesics|analgesics|mesh-ancestor
83100932|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83100933|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
83100934|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
83100935|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83100936|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83100937|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83100938|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
83100939|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83100940|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100941|NCT05744570|Anesthetics|anesthetics|mesh-list
83100942|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83100943|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100944|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
83100945|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83100946|NCT03036839|Ledipasvir|ledipasvir|mesh-list
83100947|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
83100948|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83100949|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83100950|NCT04977791|Antibodies|antibodies|mesh-list
83100951|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83100952|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
83100953|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83100954|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100955|NCT04977791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100956|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100957|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
83100958|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83100959|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100960|NCT04152863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83100961|NCT04152863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100962|NCT03625739|Amoxicillin|amoxicillin|mesh-list
83100963|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
83100964|NCT03625739|Levofloxacin|levofloxacin|mesh-list
83100965|NCT03625739|Isoniazid|isoniazid|mesh-list
83100966|NCT03625739|Cycloserine|cycloserine|mesh-list
83100967|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
83100968|NCT03625739|Imipenem|imipenem|mesh-list
83100969|NCT03625739|Amikacin|amikacin|mesh-list
83100970|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
83100971|NCT03625739|Ethambutol|ethambutol|mesh-list
83100972|NCT03625739|Bedaquiline|bedaquiline|mesh-list
83100973|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83100974|NCT03625739|Clofazimine|clofazimine|mesh-list
83100975|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
83100976|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83100977|NCT03625739|Streptomycin|streptomycin|mesh-list
83100978|NCT03625739|Ethionamide|ethionamide|mesh-list
83100979|NCT03625739|Kanamycin|kanamycin|mesh-list
83100980|NCT03625739|Capreomycin|capreomycin|mesh-list
83100981|NCT03625739|Thioacetazone|thioacetazone|mesh-list
83100982|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
83100983|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83100984|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83100985|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83100986|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83100987|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83100988|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83100989|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83100990|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83100991|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83100992|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83100993|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83100994|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
83100995|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83100996|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83100997|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
83100998|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83100999|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83101000|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101001|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83101002|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83101003|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83101004|NCT03904199|Insulin|insulin|mesh-list
83101005|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83101006|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83101007|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101008|NCT03902951|Leuprolide|leuprolide|mesh-list
83101009|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
83101010|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83101011|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
83101012|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101013|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101014|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101015|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101016|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83101017|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101018|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101019|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101020|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101021|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83101022|NCT01286207|Rizatriptan|rizatriptan|mesh-list
83101023|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83101024|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
83101025|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101026|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101027|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101028|NCT05408026|Dexamethasone|dexamethasone|mesh-list
83101029|NCT05408026|Bortezomib|bortezomib|mesh-list
83101030|NCT05408026|Daratumumab|daratumumab|mesh-list
83101031|NCT05408026|Pomalidomide|pomalidomide|mesh-list
83101032|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101033|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
83101034|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
83101035|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101036|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101037|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101038|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
83101040|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101041|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101042|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101043|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
83101044|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83101045|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83101046|NCT05408026|Growth Substances|growth substances|mesh-ancestor
83101047|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
83101048|NCT02170090|Gemcitabine|gemcitabine|mesh-list
83101049|NCT02170090|Capecitabine|capecitabine|mesh-list
83101050|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101051|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83101052|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
83101053|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101054|NCT04423510|Phenol|phenol|mesh-list
83101055|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83101056|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101057|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
83101058|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83101059|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83101060|NCT00968201|Montelukast|montelukast|mesh-list
83101061|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101062|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101063|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83101064|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101065|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101066|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101067|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83101068|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83101069|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101070|NCT00943397|Montelukast|montelukast|mesh-list
83101071|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101072|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101073|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83101074|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101075|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101076|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101077|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83101078|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83101079|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101080|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
83101081|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101082|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
83101083|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83101084|NCT00702845|Hormones|hormones|mesh-list
83101085|NCT00702845|Progesterone|progesterone|mesh-list
83101086|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83101087|NCT00702845|Ganirelix|ganirelix|mesh-list
83101088|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101089|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101090|NCT00702845|Progestins|progestins|mesh-ancestor
83101091|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101092|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83101093|NCT00647933|Lynestrenol|lynestrenol|mesh-list
83101094|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83101095|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83101096|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83101097|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
83101098|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101099|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101100|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83101101|NCT00647933|Estrogens|estrogens|mesh-ancestor
83101102|NCT00647933|Hormones|hormones|mesh-ancestor
83101103|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101104|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83101105|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
83101106|NCT00641771|Vitamin D|vitamin d|mesh-list
83101107|NCT00641771|Alendronate|alendronate|mesh-list
83101108|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83101109|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101110|NCT00641771|Vitamins|vitamins|mesh-ancestor
83101111|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
83101112|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83101113|NCT00519857|Tibolone|tibolone|mesh-list
83101114|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
83101115|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101116|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101117|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101118|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83101119|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101120|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101121|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83101122|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
83101123|NCT00519857|Hormones|hormones|mesh-ancestor
83101124|NCT00431093|Tibolone|tibolone|mesh-list
83101125|NCT00431093|Estradiol|estradiol|mesh-list
83101126|NCT00431093|Estrogens|estrogens|mesh-ancestor
83101127|NCT00431093|Hormones|hormones|mesh-ancestor
83101128|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101129|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101130|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
83101131|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101132|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83101133|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101134|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101135|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83101136|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
83101137|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
83101138|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101139|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101140|NCT03665597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83101141|NCT03665597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101142|NCT00092963|Rizatriptan|rizatriptan|mesh-list
83101143|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101144|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101145|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101146|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83101147|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
83101148|NCT00092885|Montelukast|montelukast|mesh-list
83101149|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101150|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101151|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83101152|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101153|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101154|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101155|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83101156|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83101157|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101158|NCT03673735|Durvalumab|durvalumab|mesh-list
83101159|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101160|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101161|NCT01272037|Tamoxifen|tamoxifen|mesh-list
83101162|NCT01272037|Letrozole|letrozole|mesh-list
83101163|NCT01272037|Anastrozole|anastrozole|mesh-list
83101164|NCT01272037|Exemestane|exemestane|mesh-list
83101165|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101166|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101167|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83101168|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83101169|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101170|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83101171|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101172|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101173|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101174|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101175|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83101176|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83101177|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83101178|NCT00092105|Montelukast|montelukast|mesh-list
83101179|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101180|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101181|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83101182|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101183|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83527604|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
83101184|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101185|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83101186|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83101187|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101188|NCT00092027|Alendronate|alendronate|mesh-list
83101189|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101190|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83101191|NCT00076973|Montelukast|montelukast|mesh-list
83101192|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101193|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101194|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83101195|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101196|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101197|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101198|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83101199|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83101200|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101201|NCT03565991|Avelumab|avelumab|mesh-list
83101202|NCT03565991|Talazoparib|talazoparib|mesh-list
83101203|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101204|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101205|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83101206|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101207|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101208|NCT02314533|Fenofibrate|fenofibrate|mesh-list
83101209|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83101210|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
83101211|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101212|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83101213|NCT03502395|Lidocaine|lidocaine|mesh-list
83101214|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
83101215|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
83101216|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83101217|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101218|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
83101219|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101220|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83101221|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83101222|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83101223|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83101224|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101225|NCT02318043|Fluticasone|fluticasone|mesh-list
83101226|NCT02318043|Budesonide|budesonide|mesh-list
83101227|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83101228|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83101229|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101230|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83101231|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
83101232|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101233|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101234|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101235|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101236|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83101237|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83101238|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
83101239|NCT02318043|Hormones|hormones|mesh-ancestor
83101240|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101241|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83101242|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83101243|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83101244|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83101245|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101246|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101247|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
83101248|NCT03433313|Trastuzumab|trastuzumab|mesh-list
83101249|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101250|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101251|NCT02318121|Oxytocin|oxytocin|mesh-list
83101252|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
83101253|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83527905|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101254|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101256|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83101257|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101258|NCT05225597|Carbachol|carbachol|mesh-list
83101259|NCT05225597|Epinephrine|epinephrine|mesh-list
83101260|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83101261|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83101262|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
83101263|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101264|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101265|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101266|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83101267|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83101268|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
83101269|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101270|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101271|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101272|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
83101273|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
83101274|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83101275|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83101276|NCT05225597|Miotics|miotics|mesh-ancestor
83101277|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83101278|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
83101279|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83101280|NCT05225597|Analgesics|analgesics|mesh-ancestor
83101281|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
83101282|NCT05225597|Protective Agents|protective agents|mesh-ancestor
83101283|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
83101284|NCT03393845|Fulvestrant|fulvestrant|mesh-list
83101285|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101286|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101287|NCT03393845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83101288|NCT03393845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101289|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101290|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83101291|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83101292|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101293|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101294|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101295|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
83101296|NCT03070327|Lenalidomide|lenalidomide|mesh-list
83101297|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101298|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
83101299|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101300|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83101301|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83101302|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
83101303|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101304|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101305|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83101306|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83101307|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83101308|NCT03070327|Growth Substances|growth substances|mesh-ancestor
83101309|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83101310|NCT00543127|Fulvestrant|fulvestrant|mesh-list
83101311|NCT00543127|Anastrozole|anastrozole|mesh-list
83101312|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101313|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101314|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83101315|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83101316|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
83101317|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101318|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101319|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83101320|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83101321|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101322|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101323|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83101324|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83101325|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101326|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101327|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
83101328|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101329|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101330|NCT03673501|Sunitinib|sunitinib|mesh-list
83101331|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101332|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83101333|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83101334|NCT03673501|Growth Substances|growth substances|mesh-ancestor
83101335|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101336|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
83101337|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83101338|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101339|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101340|NCT02309385|Dexamethasone|dexamethasone|mesh-list
83101341|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
83101342|NCT02309385|Prednisolone|prednisolone|mesh-list
83101343|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83101344|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
83101345|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83101346|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
83101347|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83101348|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
83101349|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83101350|NCT02309385|BB 1101|bb 1101|mesh-list
83101351|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101352|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
83101353|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
83101354|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101355|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101356|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101357|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
83101358|NCT02309385|Hormones|hormones|mesh-ancestor
83101359|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101360|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101361|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101362|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
83101363|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101364|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101365|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83101366|NCT02309385|Protective Agents|protective agents|mesh-ancestor
83101367|NCT02315001|Liraglutide|liraglutide|mesh-list
83101368|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83101369|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101370|NCT02315001|Incretins|incretins|mesh-ancestor
83101371|NCT02315001|Hormones|hormones|mesh-ancestor
83101372|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101373|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83101374|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83101375|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
83101376|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101377|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101378|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
83101379|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101380|NCT03500367|Sirolimus|sirolimus|mesh-list
83101381|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83101382|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101383|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83101384|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101385|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
83101386|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101387|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
83101388|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101389|NCT02318433|Dexamethasone|dexamethasone|mesh-list
83101390|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101391|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
83101392|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
83101393|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101394|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101395|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101396|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
83101397|NCT02318433|Hormones|hormones|mesh-ancestor
83101398|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101399|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101400|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101401|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
83101402|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83101403|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
83101404|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101405|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
83101406|NCT02318511|Protective Agents|protective agents|mesh-ancestor
83101407|NCT02315391|Glycine|glycine|mesh-list
83101408|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
83101409|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101410|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101411|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101412|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
83101413|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83101414|NCT03022981|Velpatasvir|velpatasvir|mesh-list
83101415|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
83101416|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101417|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
83101418|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
83101419|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101421|NCT03502005|Emtricitabine|emtricitabine|mesh-list
83101422|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83101423|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
83101424|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101425|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83101426|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83101427|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101428|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101429|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83101430|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83101431|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83101432|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101433|NCT03669445|Dexamethasone|dexamethasone|mesh-list
83101434|NCT03669445|Lenalidomide|lenalidomide|mesh-list
83101435|NCT03669445|Daratumumab|daratumumab|mesh-list
83101436|NCT03669445|Ixazomib|ixazomib|mesh-list
83101437|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101438|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
83101439|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
83101440|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101441|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101442|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101443|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
83101444|NCT03669445|Hormones|hormones|mesh-ancestor
83101445|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101446|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101447|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101448|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
83101449|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83101450|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83101451|NCT03669445|Growth Substances|growth substances|mesh-ancestor
83101452|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
83101453|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
83101454|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101455|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101456|NCT03500133|Cytarabine|cytarabine|mesh-list
83101457|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
83101458|NCT03500133|Cisplatin|cisplatin|mesh-list
83101459|NCT03500133|Etoposide|etoposide|mesh-list
83101460|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101461|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83101462|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
83101463|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101464|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
83101465|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101466|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101467|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
83101468|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101469|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83101470|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83101471|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83101472|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101473|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101474|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
83101475|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
83101476|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101477|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101478|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
83101479|NCT03500133|Hormones|hormones|mesh-ancestor
83101480|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101481|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83101482|NCT03500133|Protective Agents|protective agents|mesh-ancestor
83101483|NCT04462809|Talazoparib|talazoparib|mesh-list
83101484|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83101485|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101486|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101487|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101488|NCT02320773|Mirabegron|mirabegron|mesh-list
83101489|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83101490|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83101491|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83101492|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
83101493|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101494|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101495|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101496|NCT02320773|Urological Agents|urological agents|mesh-ancestor
83101498|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83101499|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
83101500|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
83101501|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83101502|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101503|NCT04463901|Mitomycins|mitomycins|mesh-list
83101504|NCT04463901|Mitomycin|mitomycin|mesh-list
83101505|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83101506|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101507|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
83101508|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101509|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83101510|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101511|NCT01314443|Vitamin E|vitamin e|mesh-list
83101512|NCT01314443|Tocopherols|tocopherols|mesh-list
83101513|NCT01314443|Tocotrienols|tocotrienols|mesh-list
83101514|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
83101515|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
83101516|NCT01314443|Nicotine|nicotine|mesh-list
83101517|NCT01314443|Vitamins|vitamins|mesh-ancestor
83101518|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
83101519|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101520|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83101521|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
83101522|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101523|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83101524|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83101525|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
83101526|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101527|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101528|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
83101529|NCT01314443|Protective Agents|protective agents|mesh-ancestor
83101530|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83101531|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83101532|NCT03498417|Antibodies|antibodies|mesh-list
83101533|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
83101534|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101535|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
83101536|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101537|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101538|NCT03212651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83101539|NCT03212651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101540|NCT02319135|Cytarabine|cytarabine|mesh-list
83101541|NCT02319135|Fludarabine|fludarabine|mesh-list
83101542|NCT02319135|Lenograstim|lenograstim|mesh-list
83101543|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101544|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83101545|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
83101546|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101547|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101548|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
83101549|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101550|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
83101551|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101552|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83101553|NCT04738097|Clopidogrel|clopidogrel|mesh-list
83101554|NCT04738097|Ticagrelor|ticagrelor|mesh-list
83101555|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83527979|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83101556|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83101557|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83101558|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83101559|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
83101560|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101561|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101562|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101564|NCT03499743|Scopolamine|scopolamine|mesh-list
83101565|NCT03499743|Bromides|bromides|mesh-list
83101566|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83101567|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83101568|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83101569|NCT03499743|Analgesics|analgesics|mesh-ancestor
83101570|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
83101571|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101572|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101573|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101574|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83101575|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83101576|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83101577|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101578|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101579|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
83101580|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83101581|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
83101582|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
83101583|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101584|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
83101585|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83101586|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
83101587|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101588|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83101589|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
83101590|NCT02310087|Vitamin E|vitamin e|mesh-list
83101591|NCT02310087|Vitamins|vitamins|mesh-ancestor
83101592|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
83101593|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101594|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
83101595|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101596|NCT02310087|Protective Agents|protective agents|mesh-ancestor
83101597|NCT02923921|Leucovorin|leucovorin|mesh-list
83101598|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
83101599|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101600|NCT02923921|Antidotes|antidotes|mesh-ancestor
83101601|NCT02923921|Protective Agents|protective agents|mesh-ancestor
83101602|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101603|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
83101604|NCT02923921|Vitamins|vitamins|mesh-ancestor
83467256|NCT01004393|Bromides|bromides|mesh-list
83101605|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
83101606|NCT02310243|Palbociclib|palbociclib|mesh-list
83101607|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101608|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83101609|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101610|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101611|NCT03497715|Ibuprofen|ibuprofen|mesh-list
83101612|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83101613|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83101614|NCT03497715|Analgesics|analgesics|mesh-ancestor
83101615|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
83101616|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101617|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101618|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101619|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83101620|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83101621|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101622|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101623|NCT02321241|Aflibercept|aflibercept|mesh-list
83101624|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83101625|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83101626|NCT02321241|Growth Substances|growth substances|mesh-ancestor
83101627|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101628|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
83101629|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101630|NCT03583307|Sirolimus|sirolimus|mesh-list
83101631|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83101632|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101633|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83101634|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101635|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
83101636|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101637|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
83101638|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101640|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
83101641|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83101642|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
83101643|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101644|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101645|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83101646|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
83101647|NCT02321397|Oxycodone|oxycodone|mesh-list
83101648|NCT02321397|Naloxone|naloxone|mesh-list
83101649|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83101650|NCT02321397|Narcotics|narcotics|mesh-ancestor
83101651|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83101652|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101653|NCT02321397|Analgesics|analgesics|mesh-ancestor
83101654|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
83101655|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101656|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83101657|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
83101658|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83101659|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83101660|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101661|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
83101662|NCT02319915|Coagulants|coagulants|mesh-ancestor
83101663|NCT04898309|Complement C1s|complement c1s|mesh-list
83101664|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83101665|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83101666|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
83101667|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101668|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83101669|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101670|NCT03498963|Dimercaprol|dimercaprol|mesh-list
83101671|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
83101672|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
83101673|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101674|NCT02311101|Mitomycins|mitomycins|mesh-list
83101675|NCT02311101|Mitomycin|mitomycin|mesh-list
83101676|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83101677|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101678|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
83101679|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101680|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83101681|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101682|NCT04620187|Cisplatin|cisplatin|mesh-list
83101683|NCT04620187|Carboplatin|carboplatin|mesh-list
83101684|NCT04620187|Trastuzumab|trastuzumab|mesh-list
83101685|NCT04620187|Maytansine|maytansine|mesh-list
83101686|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101687|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101688|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83101689|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
83101690|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
83101691|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
83101692|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101693|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
83101694|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83101695|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
83101696|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101697|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
83101698|NCT03668665|Protective Agents|protective agents|mesh-ancestor
83101699|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83101700|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
83101701|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83101702|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
83101703|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101704|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101705|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101706|NCT03704909|Epinephrine|epinephrine|mesh-list
83101707|NCT03704909|Racepinephrine|racepinephrine|mesh-list
83101709|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
83101710|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83101711|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83101712|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
83101713|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101714|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101715|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101716|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83101717|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83101718|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
83101719|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101720|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101721|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101722|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
83101723|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
83101724|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83101725|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83101726|NCT03704831|Anesthetics|anesthetics|mesh-list
83101727|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
83101728|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83101729|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101730|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
83101731|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101732|NCT03704675|Vactosertib|vactosertib|mesh-list
83101733|NCT03704675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83101734|NCT03704675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101735|NCT03704675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101736|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
83101737|NCT03494517|Analgesics|analgesics|mesh-ancestor
83101738|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
83101739|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101740|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101741|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
83101742|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83101743|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83101744|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
83101745|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83101746|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83101747|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101748|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83101749|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
83101750|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101751|NCT04912505|Aspirin|aspirin|mesh-list
83101752|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83101753|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83101754|NCT04912505|Analgesics|analgesics|mesh-ancestor
83101755|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
83101756|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101757|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101758|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101759|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83101760|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83101761|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83101762|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101763|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83101764|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83101765|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101766|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
83101767|NCT04912427|Dexamethasone|dexamethasone|mesh-list
83101768|NCT04912427|Bortezomib|bortezomib|mesh-list
83101769|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101770|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
83101771|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
83101772|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101773|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101774|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101775|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
83101776|NCT04912427|Hormones|hormones|mesh-ancestor
83101777|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101778|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101779|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101780|NCT02322645|Eszopiclone|eszopiclone|mesh-list
83101782|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83101783|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101784|NCT04050761|Nivolumab|nivolumab|mesh-list
83101785|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101786|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101787|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83101788|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101789|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83101790|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83101791|NCT03496389|Acetaminophen|acetaminophen|mesh-list
83101792|NCT03496389|Gabapentin|gabapentin|mesh-list
83101793|NCT03496389|Tramadol|tramadol|mesh-list
83101794|NCT03496389|Analgesics|analgesics|mesh-ancestor
83101795|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
83101796|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101797|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101798|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
83101799|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83101801|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83101802|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83101803|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83101804|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83101805|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101806|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101807|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
83101808|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83101809|NCT03496389|Narcotics|narcotics|mesh-ancestor
83467283|NCT00002476|Vincristine|vincristine|mesh-list
83101810|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83101811|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
83101812|NCT03491709|Cetuximab|cetuximab|mesh-list
83101813|NCT03491709|Antibodies|antibodies|mesh-list
83101814|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83101815|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
83101816|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101817|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101818|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101819|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
83101820|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83101821|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83101822|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101823|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
83101824|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101825|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101826|NCT02323191|Atezolizumab|atezolizumab|mesh-list
83101827|NCT02323191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83101828|NCT02323191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101829|NCT02323191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83101830|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101831|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83101832|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
83101833|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101834|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
83101835|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101836|NCT02323347|Progesterone|progesterone|mesh-list
83101837|NCT02323347|Progestins|progestins|mesh-ancestor
83101838|NCT02323347|Hormones|hormones|mesh-ancestor
83101839|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101840|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101841|NCT03495765|Ranibizumab|ranibizumab|mesh-list
83101842|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83101843|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83101844|NCT03495765|Growth Substances|growth substances|mesh-ancestor
83101845|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101846|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
83101847|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101848|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83101849|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101850|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101851|NCT03491475|Ajmaline|ajmaline|mesh-list
83101852|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83101853|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83101854|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83527980|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
83101855|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83101856|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101857|NCT03499119|Erenumab|erenumab|mesh-list
83101858|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83101859|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101860|NCT03499119|Analgesics|analgesics|mesh-ancestor
83101861|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
83101862|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101863|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101864|NCT03328845|Insulin|insulin|mesh-list
83101865|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83101866|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
83101867|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
83101868|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83101869|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101870|NCT02323737|Cisplatin|cisplatin|mesh-list
83101871|NCT02323737|Irinotecan|irinotecan|mesh-list
83101872|NCT02323737|Etoposide|etoposide|mesh-list
83101873|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101874|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83101875|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83101876|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101877|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101878|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83101879|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83101880|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
83101881|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
83101882|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101883|NCT03491085|Amoxicillin|amoxicillin|mesh-list
83101884|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
83101885|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
83101886|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83101887|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83101888|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101889|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83101890|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101891|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101893|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83101894|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83101895|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83101896|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83101897|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
83101898|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101899|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101900|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101901|NCT03148899|Oxytocin|oxytocin|mesh-list
83101902|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
83101903|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101904|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101905|NCT03495063|Caffeine|caffeine|mesh-list
83101906|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83101907|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101908|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83101909|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101910|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101911|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83101912|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83101913|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
83101914|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101915|NCT03490617|Misoprostol|misoprostol|mesh-list
83101916|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83101917|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
83101918|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101919|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101920|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83101921|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83101922|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
83101923|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
83101924|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83101925|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83101926|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101927|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83101928|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83101929|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101930|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101931|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101932|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83101933|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
83101934|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101935|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101936|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83101937|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83101938|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83101939|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
83101940|NCT03490539|Azathioprine|azathioprine|mesh-list
83101941|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83101942|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101943|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83101944|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
83101945|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83101946|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83101947|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101948|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101949|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
83101950|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83101951|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83101952|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
83101953|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101954|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83101956|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83101957|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
83101958|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83101959|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101960|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83101961|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83101962|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
83101963|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101964|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83101965|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83101966|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83101967|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83101968|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83101969|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101970|NCT02143414|Prednisone|prednisone|mesh-list
83101971|NCT02143414|Cortisone|cortisone|mesh-list
83101972|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83101973|NCT02143414|Methotrexate|methotrexate|mesh-list
83101974|NCT02143414|Vincristine|vincristine|mesh-list
83101975|NCT02143414|Dasatinib|dasatinib|mesh-list
83101976|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
83101977|NCT02143414|Blinatumomab|blinatumomab|mesh-list
83101978|NCT02143414|Antibodies|antibodies|mesh-list
83101979|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
83101980|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83101981|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
83101982|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83101983|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
83101984|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83101985|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83101986|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83101987|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
83101988|NCT02143414|Hormones|hormones|mesh-ancestor
83101989|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83101990|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83101991|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83101992|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
83101993|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83101994|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83101995|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
83101996|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83101997|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
83101998|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83101999|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83102000|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102001|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102002|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102003|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83102004|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
83102005|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
83102006|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
83102007|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83102008|NCT04791761|Acetaminophen|acetaminophen|mesh-list
83102009|NCT04791761|Ibuprofen|ibuprofen|mesh-list
83102010|NCT04791761|Oxycodone|oxycodone|mesh-list
83102011|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
83102012|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83102013|NCT04791761|Analgesics|analgesics|mesh-ancestor
83102014|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
83102015|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102016|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102017|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
83102018|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83102019|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102020|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102021|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83102022|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102023|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102024|NCT04791761|Narcotics|narcotics|mesh-ancestor
83102025|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102026|NCT03667963|Lactulose|lactulose|mesh-list
83102027|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83102028|NCT03489837|Dipropizine|dipropizine|mesh-list
83102029|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
83102030|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102031|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83102032|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
83102033|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102034|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102035|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83102036|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102037|NCT03625505|Venetoclax|venetoclax|mesh-list
83102038|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102039|NCT03493269|Midazolam|midazolam|mesh-list
83102040|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83102041|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83102042|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102043|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102044|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83102045|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83102046|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102047|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83102048|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
83102049|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
83102050|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
83102051|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
83102052|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102053|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102054|NCT04257682|Bupivacaine|bupivacaine|mesh-list
83102055|NCT04257682|Ropivacaine|ropivacaine|mesh-list
83102056|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
83102057|NCT04257682|Mepivacaine|mepivacaine|mesh-list
83102058|NCT04257682|Anesthetics|anesthetics|mesh-list
83102059|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102060|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102061|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
83102062|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102063|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
83102064|NCT05426434|Piperaquine|piperaquine|mesh-list
83102065|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
83102066|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83102067|NCT05426434|Artenimol|artenimol|mesh-list
83102068|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
83102069|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83102070|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83102071|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102072|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83102073|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102074|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102075|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83102076|NCT05404906|Azacitidine|azacitidine|mesh-list
83102077|NCT05404906|Venetoclax|venetoclax|mesh-list
83102078|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102079|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
83102080|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102081|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102082|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102083|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83102085|NCT03020407|Epinephrine|epinephrine|mesh-list
83102086|NCT03020407|Norepinephrine|norepinephrine|mesh-list
83102087|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83102088|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102089|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83102090|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83102091|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83102092|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102093|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102094|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102095|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83102096|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83102097|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
83102098|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102100|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102101|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
83102102|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
83102103|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83102104|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
83102105|NCT03020407|Protective Agents|protective agents|mesh-ancestor
83102106|NCT03624959|Itraconazole|itraconazole|mesh-list
83102107|NCT03624959|Rifampin|rifampin|mesh-list
83102108|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
83102109|NCT03624959|Ozanimod|ozanimod|mesh-list
83102110|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
83102111|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102112|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83102113|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83102114|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102115|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102116|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83102117|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
83102118|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102119|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102120|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83102121|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83102122|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
83102123|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83102124|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
83102125|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102126|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83102127|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83102128|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83102129|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83102130|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83102131|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83102132|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83102133|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102134|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
83102135|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83102136|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
83102137|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83102138|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83102139|NCT02536846|Olanzapine|olanzapine|mesh-list
83102140|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
83102141|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
83102142|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102143|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102144|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83102145|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83102146|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83102147|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102148|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102149|NCT02536846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83102150|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83102151|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83102152|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102153|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102154|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
83102155|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83102156|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102157|NCT02293655|Methylphenidate|methylphenidate|mesh-list
83102158|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83102159|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102160|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83102161|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83102162|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83102163|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102164|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
83102165|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102166|NCT04452214|Carboplatin|carboplatin|mesh-list
83102167|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
83102168|NCT04452214|Pemetrexed|pemetrexed|mesh-list
83102169|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102170|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102171|NCT04452214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83102172|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102173|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102174|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83102175|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102176|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83102177|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83102178|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102179|NCT05439460|Phenylephrine|phenylephrine|mesh-list
83102180|NCT05439460|Vasopressins|vasopressins|mesh-list
83102181|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
83102182|NCT05439460|Epinephrine|epinephrine|mesh-list
83102183|NCT05439460|Racepinephrine|racepinephrine|mesh-list
83102184|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
83102185|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
83102186|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83102187|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83102188|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
83102189|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102190|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102191|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102192|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83102193|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83102194|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
83102195|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102196|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83102197|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102198|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
83102199|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
83102200|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83102201|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83102202|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
83102203|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83102204|NCT05439460|Protective Agents|protective agents|mesh-ancestor
83102205|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
83102206|NCT05439460|Coagulants|coagulants|mesh-ancestor
83102207|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83102208|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
83102209|NCT01661140|Methotrexate|methotrexate|mesh-list
83102210|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83102211|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
83102212|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83102213|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102214|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102215|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
83102216|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102217|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102218|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
83102219|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102220|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83102221|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102222|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
83102223|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102224|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102225|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83102226|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83102227|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83102228|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
83102229|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102230|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83102231|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83102232|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102233|NCT05399602|Anesthetics|anesthetics|mesh-list
83102234|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102235|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102236|NCT05397886|Propofol|propofol|mesh-list
83102237|NCT05397886|Flumazenil|flumazenil|mesh-list
83102238|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83102239|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102240|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102241|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83102242|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
83102243|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
83102244|NCT05397886|Antidotes|antidotes|mesh-ancestor
83102245|NCT05397886|Protective Agents|protective agents|mesh-ancestor
83102246|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
83102248|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102249|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102250|NCT05436886|Gabapentin|gabapentin|mesh-list
83102251|NCT05436886|Analgesics|analgesics|mesh-ancestor
83102252|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
83102253|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102254|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102255|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
83102256|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83102257|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83102258|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102259|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102260|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83102261|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83102262|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102263|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102264|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
83102265|NCT01373151|Adalimumab|adalimumab|mesh-list
83102266|NCT01373151|Methotrexate|methotrexate|mesh-list
83102267|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83102268|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
83102269|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83102270|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102271|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102272|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
83102273|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102274|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102275|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
83102276|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102277|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83102278|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102279|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
83102280|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102281|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102282|NCT01373151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83102283|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102284|NCT05436652|Prednisolone|prednisolone|mesh-list
83102285|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83102286|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
83102287|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83102288|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
83102289|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83102290|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
83102291|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102292|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
83102293|NCT05436652|Hormones|hormones|mesh-ancestor
83102294|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102295|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102296|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83102297|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102298|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
83102299|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
83102300|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102301|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83527981|NCT05303987|Propofol|propofol|mesh-list
83102302|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83102303|NCT05436652|Protective Agents|protective agents|mesh-ancestor
83102304|NCT01660906|Dasatinib|dasatinib|mesh-list
83102305|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102306|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83102307|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102308|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102309|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
83102310|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102311|NCT03666949|Anesthetics|anesthetics|mesh-list
83102312|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102313|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102314|NCT00886691|Bevacizumab|bevacizumab|mesh-list
83102315|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83102316|NCT00886691|Everolimus|everolimus|mesh-list
83102317|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
83102318|NCT00886691|Antibodies|antibodies|mesh-list
83102319|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
83102320|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83102321|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
83102322|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102323|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83102324|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83102325|NCT00886691|Growth Substances|growth substances|mesh-ancestor
83102326|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102327|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
83102328|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
83102329|NCT00886691|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83102330|NCT00886691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83102331|NCT00886691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102332|NCT00886691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102333|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102334|NCT00960297|Paclitaxel|paclitaxel|mesh-list
83102335|NCT00960297|Bevacizumab|bevacizumab|mesh-list
83102336|NCT00960297|Carboplatin|carboplatin|mesh-list
83102337|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83102338|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102339|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
83102340|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
83102341|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
83102342|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102343|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102344|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83102345|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83102346|NCT00960297|Growth Substances|growth substances|mesh-ancestor
83102347|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102348|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
83102349|NCT05112861|Bevacizumab|bevacizumab|mesh-list
83102350|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102351|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102352|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83102353|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83102354|NCT05112861|Growth Substances|growth substances|mesh-ancestor
83102355|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102356|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83102357|NCT03012061|Fluticasone|fluticasone|mesh-list
83102358|NCT03012061|Xhance|xhance|mesh-list
83102359|NCT03012061|Albuterol|albuterol|mesh-list
83102360|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102361|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83102362|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
83102363|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102364|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102365|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83102366|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102367|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
83102368|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83102369|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
83102370|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83102371|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83102372|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83102373|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83102374|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83102375|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102376|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102377|NCT00408863|Tibolone|tibolone|mesh-list
83102378|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
83102379|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
83102380|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102381|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102382|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83102383|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83102384|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102385|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83102386|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
83102387|NCT00408863|Hormones|hormones|mesh-ancestor
83102388|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
83102389|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83102390|NCT05085327|Protective Agents|protective agents|mesh-ancestor
83102391|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102392|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
83102393|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83102394|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
83102395|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83102396|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102397|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102398|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102399|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83102400|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83102401|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
83102402|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102403|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102404|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83102405|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83102406|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
83102407|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83102408|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83102409|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83102410|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102411|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102412|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83102413|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83102414|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102415|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
83102416|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102417|NCT03131973|Leucovorin|leucovorin|mesh-list
83102418|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
83102419|NCT03131973|Methotrexate|methotrexate|mesh-list
83102420|NCT03131973|Digoxin|digoxin|mesh-list
83102421|NCT03131973|Midazolam|midazolam|mesh-list
83102422|NCT03131973|Caffeine|caffeine|mesh-list
83102423|NCT03131973|Omeprazole|omeprazole|mesh-list
83102424|NCT03131973|Pravastatin|pravastatin|mesh-list
83102425|NCT03131973|Montelukast|montelukast|mesh-list
83102426|NCT03131973|Branebrutinib|branebrutinib|mesh-list
83102427|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83102428|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
83102429|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83102430|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102431|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102432|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
83102433|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102434|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102435|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
83102436|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102437|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83102438|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102439|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
83102440|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102441|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102442|NCT03131973|Antidotes|antidotes|mesh-ancestor
83102443|NCT03131973|Protective Agents|protective agents|mesh-ancestor
83102444|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
83102445|NCT03131973|Vitamins|vitamins|mesh-ancestor
83102446|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
83102447|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83102448|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83102449|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102450|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83102451|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83102452|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102453|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83102454|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
83102455|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
83102456|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
83102457|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
83102458|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102459|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83102460|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83102461|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83102462|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83102463|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
83102464|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83102465|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83102466|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83102467|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83102468|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102469|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83102470|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
83102471|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102472|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83102473|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83102474|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83102475|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83102476|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83102477|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83102478|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83102479|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83102480|NCT03131973|Analgesics|analgesics|mesh-ancestor
83102481|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
83102482|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102483|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83102484|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83102485|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102486|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83102487|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83102488|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
83102489|NCT05078931|Lenvatinib|lenvatinib|mesh-list
83102490|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102491|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102492|NCT05078931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83102493|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102494|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83102495|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102496|NCT04825197|Poractant alfa|poractant alfa|mesh-list
83102497|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83102498|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102499|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
83102500|NCT04187105|Fludarabine|fludarabine|mesh-list
83102501|NCT04187105|Tacrolimus|tacrolimus|mesh-list
83102502|NCT04187105|Complement Factor H|complement factor h|mesh-list
83102503|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102504|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
83102505|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467345|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
83102506|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102507|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83102508|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
83102509|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102510|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102511|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83102512|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83102513|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102514|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83102515|NCT04703361|Niacin|niacin|mesh-list
83102516|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83102517|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
83102518|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102519|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83102520|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
83102521|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
83102522|NCT04703361|Vitamins|vitamins|mesh-ancestor
83102523|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
83102524|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102525|NCT03010423|Nicorandil|nicorandil|mesh-list
83102526|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83102527|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83102528|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
83102529|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
83102530|NCT03010423|Vitamins|vitamins|mesh-ancestor
83102531|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
83102532|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102533|NCT05576597|Butyric Acid|butyric acid|mesh-list
83102534|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
83102535|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
83102536|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102537|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102538|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102539|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
83102540|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83102541|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102542|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83102543|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102544|NCT03665779|Pyridoxine|pyridoxine|mesh-list
83102545|NCT03665779|Isosorbide|isosorbide|mesh-list
83102546|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83102547|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83102548|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83102549|NCT03665779|Diuretics|diuretics|mesh-ancestor
83102550|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
83102551|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102552|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
83102553|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83102554|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102555|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
83102556|NCT03665779|Vitamins|vitamins|mesh-ancestor
83102557|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
83102558|NCT03703505|Mitapivat|mitapivat|mesh-list
83102559|NCT03703505|Enzyme Activators|enzyme activators|mesh-ancestor
83102560|NCT03703505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102561|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83102562|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102563|NCT04944017|Ketamine|ketamine|mesh-list
83102564|NCT04944017|Analgesics|analgesics|mesh-ancestor
83102565|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
83102566|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102567|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102568|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83102569|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83102570|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
83102571|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
83102572|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102573|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83102574|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83102575|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102576|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102577|NCT03703427|Capecitabine|capecitabine|mesh-list
83102578|NCT03703427|Vinorelbine|vinorelbine|mesh-list
83102579|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102580|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
83102581|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102582|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102583|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83102584|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83102585|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83102586|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83102587|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
83102588|NCT03703349|Analgesics|analgesics|mesh-ancestor
83102589|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
83102590|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102591|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102592|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
83102593|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102594|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83102595|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
83102596|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83102597|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83102598|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102599|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83102600|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
83102601|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83102603|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
83102604|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102605|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102606|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83102607|NCT03008005|Analgesics|analgesics|mesh-ancestor
83102608|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
83102609|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102610|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83102611|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83102612|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102613|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102614|NCT03008005|Hormones|hormones|mesh-ancestor
83102615|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102616|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
83102617|NCT03666325|Cetuximab|cetuximab|mesh-list
83102618|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102619|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102620|NCT03666325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83102621|NCT03666325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102622|NCT02440425|Paclitaxel|paclitaxel|mesh-list
83102623|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
83102624|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83102625|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102626|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
83102627|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
83102628|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
83102629|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102630|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102631|NCT02440425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83102632|NCT04931511|Betamethasone|betamethasone|mesh-list
83102633|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
83102634|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83102635|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
83102636|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83102637|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102638|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
83102639|NCT04931511|Hormones|hormones|mesh-ancestor
83102640|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102641|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102642|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83102643|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102644|NCT04182321|Metformin|metformin|mesh-list
83102645|NCT04182321|Entecavir|entecavir|mesh-list
83102646|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83102647|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102648|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
83102649|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102650|NCT03702959|Betamethasone|betamethasone|mesh-list
83102651|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102652|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
83102653|NCT03702959|Hormones|hormones|mesh-ancestor
83102654|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102655|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102656|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83102657|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102658|NCT04879823|Acetaminophen|acetaminophen|mesh-list
83102659|NCT04879823|Dexamethasone|dexamethasone|mesh-list
83102660|NCT04879823|Ibuprofen|ibuprofen|mesh-list
83102661|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102662|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
83102663|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
83102664|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102665|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102666|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83102667|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
83102668|NCT04879823|Hormones|hormones|mesh-ancestor
83102669|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102670|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83102671|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102672|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83102673|NCT04879823|Analgesics|analgesics|mesh-ancestor
83102674|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
83102675|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
83102676|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83102677|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102678|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83102679|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102680|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102681|NCT03001219|Methotrexate|methotrexate|mesh-list
83102682|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83102683|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
83102684|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83102685|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102686|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102687|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
83102688|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102689|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102690|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83102691|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102692|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83102693|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102694|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
83102695|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83467361|NCT01004939|PENTA|penta|mesh-list
83102696|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102697|NCT03702803|Alprazolam|alprazolam|mesh-list
83102698|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83102699|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102700|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102701|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83102702|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83102703|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102704|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
83102705|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
83102706|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102707|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102708|NCT03487809|Budesonide|budesonide|mesh-list
83102709|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102710|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83102711|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
83102712|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102713|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102714|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83102715|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
83102716|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
83102717|NCT03487809|Hormones|hormones|mesh-ancestor
83102718|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102719|NCT03702647|Ropivacaine|ropivacaine|mesh-list
83102720|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
83102721|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
83102722|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102723|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102724|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
83102725|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102726|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83102727|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83102728|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102729|NCT03000673|Heparin|heparin|mesh-list
83102730|NCT03000673|Enoxaparin|enoxaparin|mesh-list
83102731|NCT03000673|Calcium heparin|calcium heparin|mesh-list
83102732|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
83102733|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83102734|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83102735|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102736|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
83102737|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83102738|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
83102739|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102740|NCT05423249|Protective Agents|protective agents|mesh-ancestor
83102741|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102742|NCT05423249|Vitamins|vitamins|mesh-ancestor
83102743|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
83102744|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
83102745|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83102746|NCT02912455|Canagliflozin|canagliflozin|mesh-list
83102747|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83102748|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102749|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83102750|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102751|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
83102752|NCT03702491|Apatinib|apatinib|mesh-list
83102753|NCT03702491|Tegafur|tegafur|mesh-list
83102754|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102755|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83102756|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102757|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102758|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102759|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
83102760|NCT03663751|Decitabine|decitabine|mesh-list
83102761|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102762|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
83102763|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102764|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102765|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102766|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
83102767|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83102768|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83102769|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102770|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
83102771|NCT04054687|Coagulants|coagulants|mesh-ancestor
83102772|NCT03492489|Cemiplimab|cemiplimab|mesh-list
83102773|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102774|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102775|NCT02531698|Vaccines|vaccines|mesh-list
83102776|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
83102777|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102778|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
83102779|NCT04308837|Promethazine|promethazine|mesh-list
83102780|NCT04308837|Dexamethasone|dexamethasone|mesh-list
83102781|NCT04308837|Paclitaxel|paclitaxel|mesh-list
83102782|NCT04308837|Carboplatin|carboplatin|mesh-list
83102783|NCT04308837|Palonosetron|palonosetron|mesh-list
83102784|NCT04308837|Famotidine|famotidine|mesh-list
83102785|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83102786|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102787|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
83102788|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
83102789|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
83102790|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102791|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102792|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
83102793|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
83102794|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102795|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102796|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83102797|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
83102798|NCT04308837|Hormones|hormones|mesh-ancestor
83102799|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102800|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83102801|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83102802|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83102803|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102804|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
83102805|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
83102806|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
83102807|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83102808|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
83102809|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
83102810|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102811|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83102812|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
83102813|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
83102814|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83102815|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83102816|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
83102817|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83102818|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83102819|NCT04692467|Amlodipine|amlodipine|mesh-list
83102820|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83102821|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83102822|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83102823|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102824|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83528131|NCT02205047|Trastuzumab|trastuzumab|mesh-list
83102825|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102826|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
83102827|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
83102828|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83102829|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83102830|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83102831|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83102832|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102833|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
83102834|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102835|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102836|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83102837|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102838|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
83102839|NCT00403793|Etonogestrel|etonogestrel|mesh-list
83102840|NCT00403793|Testosterone|testosterone|mesh-list
83102841|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
83102842|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
83102843|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83102844|NCT00403793|Androgens|androgens|mesh-ancestor
83102845|NCT00403793|Hormones|hormones|mesh-ancestor
83102846|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83102847|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102848|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83102849|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102850|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
83102851|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83102852|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
83102853|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83102854|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83102855|NCT05597098|Cantharidin|cantharidin|mesh-list
83102856|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102857|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102858|NCT03034577|Neostigmine|neostigmine|mesh-list
83102859|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83102860|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102861|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102862|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
83102863|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102864|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102865|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83102866|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
83102867|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102868|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83102869|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83102870|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83102871|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83102872|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83102873|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102874|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102875|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102876|NCT04364997|Analgesics|analgesics|mesh-ancestor
83102877|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
83102878|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102879|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
83102880|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83102881|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
83102882|NCT05417386|Leucovorin|leucovorin|mesh-list
83102883|NCT05417386|Fluorouracil|fluorouracil|mesh-list
83102884|NCT05417386|Capecitabine|capecitabine|mesh-list
83102885|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
83102886|NCT05417386|Irinotecan|irinotecan|mesh-list
83102887|NCT05417386|Camptothecin|camptothecin|mesh-list
83102888|NCT05417386|Folfirinox|folfirinox|mesh-list
83102889|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
83102890|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102891|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
83102892|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102893|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102894|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102895|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102896|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
83102897|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83102898|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83102899|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102901|NCT05417386|Protective Agents|protective agents|mesh-ancestor
83102902|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
83102903|NCT05417386|Vitamins|vitamins|mesh-ancestor
83102904|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
83102905|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83102906|NCT04005729|Cangrelor|cangrelor|mesh-list
83102907|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83102908|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83102909|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83102910|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83102911|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
83102912|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102913|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102914|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102915|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
83102916|NCT03487107|Yimitasvir|yimitasvir|mesh-list
83102917|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
83102918|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102919|NCT02997163|Talazoparib|talazoparib|mesh-list
83102920|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83102921|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389683|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102922|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102923|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102924|NCT03705065|Bupivacaine|bupivacaine|mesh-list
83102925|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
83102926|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
83102927|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83102928|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102929|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
83102930|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102931|NCT03702023|Acetaminophen|acetaminophen|mesh-list
83102932|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83102933|NCT03702023|Analgesics|analgesics|mesh-ancestor
83102934|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
83102935|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102936|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102937|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
83102938|NCT04259944|Capecitabine|capecitabine|mesh-list
83102939|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102940|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
83102941|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102942|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102943|NCT03698513|Aspirin|aspirin|mesh-list
83102944|NCT03698513|Clopidogrel|clopidogrel|mesh-list
83102945|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83102946|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83102947|NCT03698513|Analgesics|analgesics|mesh-ancestor
83102948|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
83102949|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83102950|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102951|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83102952|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102953|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83102954|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83102955|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102956|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83102957|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83102958|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83102959|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
83102960|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83102961|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83102962|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83102963|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
83102964|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83102965|NCT03698435|Valganciclovir|valganciclovir|mesh-list
83102966|NCT03698435|Ganciclovir|ganciclovir|mesh-list
83102967|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83102968|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
83102969|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102970|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83102971|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483503|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
83467395|NCT01245595|Aminophylline|aminophylline|mesh-list
83102972|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102973|NCT01652092|Vidarabine|vidarabine|mesh-list
83102974|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
83102975|NCT01652092|Melphalan|melphalan|mesh-list
83102976|NCT01652092|Busulfan|busulfan|mesh-list
83102977|NCT01652092|Fludarabine|fludarabine|mesh-list
83102978|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
83102979|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
83102981|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83102982|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
83102983|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83102984|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83102985|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83102986|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
83102987|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83102988|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83102989|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83102990|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83102991|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
83102992|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
83102993|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83102994|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83102995|NCT01652092|Protective Agents|protective agents|mesh-ancestor
83102996|NCT04572815|Interleukin-12|interleukin-12|mesh-list
83102997|NCT04572815|Ustekinumab|ustekinumab|mesh-list
83102998|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
83102999|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
83103000|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
83103001|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103002|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
83103003|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83103004|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83103005|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83103006|NCT04572815|Growth Substances|growth substances|mesh-ancestor
83103007|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83103008|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103009|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83103010|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83103012|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83103013|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103014|NCT03697889|Analgesics|analgesics|mesh-ancestor
83103015|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
83103016|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103017|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103018|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103019|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103020|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
83103021|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83103022|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103023|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103024|NCT03692819|Amoxicillin|amoxicillin|mesh-list
83103025|NCT03692819|Metronidazole|metronidazole|mesh-list
83103026|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83103027|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103028|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83103029|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83103030|NCT00458536|Molgramostim|molgramostim|mesh-list
83103031|NCT00458536|Sargramostim|sargramostim|mesh-list
83103032|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
83103033|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103034|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103035|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83103036|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83103037|NCT05577364|Prednisone|prednisone|mesh-list
83103038|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
83103039|NCT05577364|Doxorubicin|doxorubicin|mesh-list
83103040|NCT05577364|Vincristine|vincristine|mesh-list
83103041|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83103042|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
83103043|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103044|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103045|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83103046|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
83103047|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103048|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103049|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83103050|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83103051|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83103052|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83103053|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103054|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103055|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
83103057|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103058|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83103059|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83103060|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
83103061|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
83103062|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
83103063|NCT03697655|Daratumumab|daratumumab|mesh-list
83103064|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103065|NCT03701321|Dexamethasone|dexamethasone|mesh-list
83103066|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
83103067|NCT03701321|Bortezomib|bortezomib|mesh-list
83103068|NCT03701321|Venetoclax|venetoclax|mesh-list
83103069|NCT03701321|Daratumumab|daratumumab|mesh-list
83103070|NCT03701321|Ichthammol|ichthammol|mesh-list
83103071|NCT03701321|BB 1101|bb 1101|mesh-list
83103072|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103073|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
83103074|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
83103075|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103076|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103077|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103078|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
83103079|NCT03701321|Hormones|hormones|mesh-ancestor
83103080|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103081|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83103082|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103083|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
83103084|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103085|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103086|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
83103087|NCT02526550|Vaccines|vaccines|mesh-list
83103088|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
83103089|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103090|NCT05565352|Ketamine|ketamine|mesh-list
83103091|NCT05565352|Analgesics|analgesics|mesh-ancestor
83103092|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
83103093|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103094|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103095|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83103096|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83103097|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
83103098|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
83103099|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103100|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83103101|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83103102|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103103|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103104|NCT04423276|Donepezil|donepezil|mesh-list
83103105|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83103106|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103107|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103108|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
83103109|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103110|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103111|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
83103112|NCT05564416|Atezolizumab|atezolizumab|mesh-list
83103113|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83103114|NCT05564416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83103115|NCT05564416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103116|NCT05564416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103117|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103118|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
83103119|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103120|NCT03701087|Vitamin D|vitamin d|mesh-list
83103121|NCT03701087|Vitamins|vitamins|mesh-ancestor
83103122|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
83103123|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103124|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83103125|NCT03697265|Pregnanolone|pregnanolone|mesh-list
83103126|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
83103127|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103128|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103129|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83103130|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83103131|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
83103132|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103133|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103134|NCT04513067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83103135|NCT04513067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103136|NCT04336943|Durvalumab|durvalumab|mesh-list
83103137|NCT04336943|Olaparib|olaparib|mesh-list
83103138|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83103139|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
83103140|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83103141|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
83103142|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103143|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103144|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
83103145|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103146|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103147|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103148|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
83103149|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83103150|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83103151|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103152|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
83103153|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83103154|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
83103155|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
83103156|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83103157|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103158|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103159|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
83103160|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83103161|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103162|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103163|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
83103164|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83103165|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83103166|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83103167|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103168|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
83103169|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103170|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103171|NCT03696095|Ropivacaine|ropivacaine|mesh-list
83103172|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
83103173|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
83103174|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103175|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103176|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
83103177|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103179|NCT03700229|Bortezomib|bortezomib|mesh-list
83103180|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103181|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103182|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
83103183|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103184|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103185|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83103186|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83103187|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103188|NCT03695705|Rifaximin|rifaximin|mesh-list
83103189|NCT03695705|Norfloxacin|norfloxacin|mesh-list
83103190|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83103191|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103192|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103193|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83103194|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83103195|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103196|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103197|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103198|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83103199|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83103200|NCT03699839|Vaccines|vaccines|mesh-list
83103201|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
83103202|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103203|NCT04050215|Edetic Acid|edetic acid|mesh-list
83103204|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83103205|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
83103206|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
83103207|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103208|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
83103209|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83103210|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83103211|NCT03691649|Timolol|timolol|mesh-list
83103212|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83103213|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83103214|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103215|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83103216|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83103217|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83103218|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103219|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103220|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83103221|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83103222|NCT03699449|Paclitaxel|paclitaxel|mesh-list
83103223|NCT03699449|Durvalumab|durvalumab|mesh-list
83103224|NCT03699449|Olaparib|olaparib|mesh-list
83103225|NCT03699449|Tremelimumab|tremelimumab|mesh-list
83103226|NCT03699449|Cediranib|cediranib|mesh-list
83103227|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83103228|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83103229|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103230|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83103231|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83103232|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83103233|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103234|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103235|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
83103236|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103237|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83103238|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103239|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83103240|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
83103241|NCT04475939|Niraparib|niraparib|mesh-list
83103242|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103243|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103244|NCT04475939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83103245|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103246|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83103247|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103248|NCT03699293|Aspirin|aspirin|mesh-list
83103249|NCT03699293|Celecoxib|celecoxib|mesh-list
83103250|NCT03699293|Naproxen|naproxen|mesh-list
83103251|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83103252|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103253|NCT03699293|Analgesics|analgesics|mesh-ancestor
83103254|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
83103255|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103256|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103257|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103258|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103259|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83103260|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83103261|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103262|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83103263|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83103264|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103265|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
83103266|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83103267|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
83103268|NCT03029819|Nicotine|nicotine|mesh-list
83103269|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83103270|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
83103271|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103272|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103273|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83103274|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83103275|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
83103276|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483504|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83103277|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103279|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103280|NCT03105830|Analgesics|analgesics|mesh-ancestor
83103281|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
83103282|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103283|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103284|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
83103285|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
83103286|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83103287|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103288|NCT03699215|Simendan|simendan|mesh-list
83103289|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83103290|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
83103291|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83103292|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83103293|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103294|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103295|NCT03699215|Protective Agents|protective agents|mesh-ancestor
83103296|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103297|NCT03694535|Mitomycins|mitomycins|mesh-list
83103298|NCT03694535|Mitomycin|mitomycin|mesh-list
83389684|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83103299|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83103300|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103301|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
83103302|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103303|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83103304|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103305|NCT03115034|Melatonin|melatonin|mesh-list
83103306|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
83103307|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103308|NCT03115034|Protective Agents|protective agents|mesh-ancestor
83103309|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103310|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103311|NCT05525546|Vaccines|vaccines|mesh-list
83103312|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
83103313|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103314|NCT03027557|Denosumab|denosumab|mesh-list
83103315|NCT03027557|Cinacalcet|cinacalcet|mesh-list
83103316|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83103317|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103318|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83103319|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83103320|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
83103321|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103322|NCT03698825|Vactosertib|vactosertib|mesh-list
83103323|NCT03698825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83103324|NCT03698825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103325|NCT03698825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103326|NCT02691572|Acetaminophen|acetaminophen|mesh-list
83103327|NCT02691572|Ketorolac|ketorolac|mesh-list
83103328|NCT02691572|Fentanyl|fentanyl|mesh-list
83103329|NCT02691572|Bupivacaine|bupivacaine|mesh-list
83103330|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
83103331|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
83103332|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103333|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103334|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
83103335|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103336|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83103337|NCT02691572|Narcotics|narcotics|mesh-ancestor
83103338|NCT02691572|Analgesics|analgesics|mesh-ancestor
83103339|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83103340|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83103341|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
83103342|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103343|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
83103344|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83103345|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103346|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103347|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83103348|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103349|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103350|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83103351|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83103353|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
83103354|NCT03693599|Carbetocin|carbetocin|mesh-list
83103355|NCT03693599|Syntometrine|syntometrine|mesh-list
83103356|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
83103357|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83103358|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103359|NCT04277663|Interferons|interferons|mesh-list
83103360|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103361|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
83103362|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103363|NCT04270643|Vitamin D|vitamin d|mesh-list
83103364|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
83103365|NCT04270643|Vitamins|vitamins|mesh-ancestor
83103366|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
83103367|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103368|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83103369|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83103370|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83103371|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83103372|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83103373|NCT02677844|Loperamide|loperamide|mesh-list
83103374|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
83103375|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103376|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
83103377|NCT03687905|Chloroquine|chloroquine|mesh-list
83103378|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
83103379|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83103380|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83103381|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103382|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103383|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103384|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103385|NCT03687905|Amebicides|amebicides|mesh-ancestor
83103386|NCT03687515|Prednisone|prednisone|mesh-list
83103387|NCT03687515|Budesonide|budesonide|mesh-list
83103388|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103389|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
83103390|NCT03687515|Hormones|hormones|mesh-ancestor
83103391|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103392|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103393|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83103394|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103395|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83103396|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
83103397|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103398|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83103399|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
83103400|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83103401|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83103402|NCT02691494|Norethindrone|norethindrone|mesh-list
83103403|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
83103404|NCT02691494|Estradiol|estradiol|mesh-list
83103405|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83103406|NCT02691494|Estrogens|estrogens|mesh-ancestor
83103407|NCT02691494|Hormones|hormones|mesh-ancestor
83103408|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103409|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103410|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83103411|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
83103412|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83103413|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83103414|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83103415|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83103416|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83103417|NCT02682602|Tacrine|tacrine|mesh-list
83103418|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83103419|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103420|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103421|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
83103422|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103423|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103424|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83103425|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
83103426|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103427|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
83103428|NCT03691337|Bupivacaine|bupivacaine|mesh-list
83103429|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83103430|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
83103431|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
83103432|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103433|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103434|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
83103435|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103436|NCT02681510|Nicotine|nicotine|mesh-list
83103437|NCT02681510|Varenicline|varenicline|mesh-list
83103438|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83103439|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
83103440|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103441|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103442|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83103443|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83103444|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
83103445|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103446|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103447|NCT03690323|Paclitaxel|paclitaxel|mesh-list
83103448|NCT03690323|Gemcitabine|gemcitabine|mesh-list
83103449|NCT03690323|Folfirinox|folfirinox|mesh-list
83103450|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83103451|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103452|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
83103453|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
83103454|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
83103455|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103456|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83103457|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
83103458|NCT03682211|Fentanyl|fentanyl|mesh-list
83103459|NCT03682211|Morphine|morphine|mesh-list
83103460|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83103461|NCT03682211|Narcotics|narcotics|mesh-ancestor
83103462|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103463|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103464|NCT03682211|Analgesics|analgesics|mesh-ancestor
83103465|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
83103466|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103467|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83103468|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83103469|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
83103470|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
83103471|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
83103472|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
83103473|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83103474|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83103475|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103476|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103477|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103478|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103479|NCT02690714|Plasminogen|plasminogen|mesh-list
83103480|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83103481|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83103482|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103483|NCT03690167|Mitogens|mitogens|mesh-list
83103484|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
83103485|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103486|NCT03165890|Acetazolamide|acetazolamide|mesh-list
83103487|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
83103488|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83103489|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103490|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103491|NCT03165890|Diuretics|diuretics|mesh-ancestor
83103492|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
83103493|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103494|NCT03681509|Pramipexole|pramipexole|mesh-list
83103495|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
83103496|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103497|NCT03681509|Protective Agents|protective agents|mesh-ancestor
83103498|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103499|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83103500|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83103501|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
83103502|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
83103503|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103504|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
83103505|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
83103506|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83103507|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103508|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103509|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
83103510|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83103511|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103512|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103513|NCT03161210|Anesthetics|anesthetics|mesh-list
83103514|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103515|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103516|NCT01898793|Aldesleukin|aldesleukin|mesh-list
83103517|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
83103518|NCT01898793|Fludarabine|fludarabine|mesh-list
83103519|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
83103520|NCT01898793|Interleukin-2|interleukin-2|mesh-list
83103521|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83103522|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
83103523|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103524|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103525|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83103526|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
83103527|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103528|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103529|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83103530|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83103531|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
83103532|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
83103533|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103534|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103535|NCT01898793|Analgesics|analgesics|mesh-ancestor
83103536|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
83103537|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103538|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83103539|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83103540|NCT03164096|Bupivacaine|bupivacaine|mesh-list
83103541|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
83103542|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
83103543|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103544|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103545|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
83103546|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103547|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
83103548|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83103549|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83103550|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103551|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83103552|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83103553|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103554|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
83103555|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
83103556|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83103557|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103559|NCT03681197|Clomiphene|clomiphene|mesh-list
83103560|NCT03681197|Enclomiphene|enclomiphene|mesh-list
83103561|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
83103562|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83103563|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103564|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83103565|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
83103566|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103567|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83103568|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
83103569|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83103570|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83103571|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83103572|NCT03485703|Azithromycin|azithromycin|mesh-list
83103573|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83103574|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103575|NCT03165344|Prednisone|prednisone|mesh-list
83103576|NCT03165344|Triamcinolone|triamcinolone|mesh-list
83103577|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83103578|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83103579|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
83103580|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83103581|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83103582|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83103583|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
83103584|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83103585|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103586|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
83103587|NCT03165344|Hormones|hormones|mesh-ancestor
83103588|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103589|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103590|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83103591|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103592|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83103593|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
83103594|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103595|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103596|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83103597|NCT03165344|Antacids|antacids|mesh-ancestor
83103598|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103599|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
83103600|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83103601|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83103602|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
83103603|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103604|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103605|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103606|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
83103607|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
83103608|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103609|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
83103610|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83103611|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
83103612|NCT03689465|Cyclosporine|cyclosporine|mesh-list
83103613|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
83103614|NCT03689465|Methotrexate|methotrexate|mesh-list
83103615|NCT03689465|Cyclosporins|cyclosporins|mesh-list
83103616|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83103617|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
83103618|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83103619|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103620|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83103621|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
83103622|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103623|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103624|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
83103625|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103626|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83103627|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83103628|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
83103629|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103630|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83103631|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
83103632|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103633|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83103634|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83103635|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83103636|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
83103637|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83103638|NCT03485625|Acetaminophen|acetaminophen|mesh-list
83103639|NCT03485625|Ketorolac|ketorolac|mesh-list
83103640|NCT03485625|Lidocaine|lidocaine|mesh-list
83103641|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
83103642|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
83103643|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103644|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103645|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
83103646|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103647|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83103648|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83103649|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83103650|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83103651|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103652|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103653|NCT03485625|Analgesics|analgesics|mesh-ancestor
83103654|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
83103655|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83103656|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103657|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103658|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83103659|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103661|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
83103662|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
83103663|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103664|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103665|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
83103666|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103667|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83103668|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83103669|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83103670|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83103671|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103672|NCT03033069|Sertraline|sertraline|mesh-list
83103673|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
83103674|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
83103675|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83103676|NCT03033069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83103677|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83389685|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83103678|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83103679|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103680|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103681|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
83103682|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103683|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
83103684|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
83103685|NCT03685409|Metformin|metformin|mesh-list
83103686|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83103687|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103688|NCT03165500|Midazolam|midazolam|mesh-list
83103689|NCT03165500|Diazepam|diazepam|mesh-list
83103690|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
83103691|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83103692|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83103693|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103694|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103695|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83103696|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83103697|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83103698|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83103699|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
83103700|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
83103701|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
83103702|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
83103703|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103704|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103705|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83103706|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103707|NCT03165500|Analgesics|analgesics|mesh-ancestor
83103708|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
83103709|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103710|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
83103711|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
83103712|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
83103713|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103714|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83103715|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83103716|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
83103717|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83103718|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83103719|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103720|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83103721|NCT03163238|Analgesics|analgesics|mesh-ancestor
83103722|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
83103723|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103724|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83103725|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83103726|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83103727|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
83103728|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103729|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103731|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83103732|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83103733|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103734|NCT03680573|Allopurinol|allopurinol|mesh-list
83103735|NCT03680573|Nitroprusside|nitroprusside|mesh-list
83103736|NCT03680573|Nitroarginine|nitroarginine|mesh-list
83103737|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
83103738|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
83103739|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103740|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103741|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
83103742|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103743|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83103744|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
83103745|NCT03680573|Protective Agents|protective agents|mesh-ancestor
83103746|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103747|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83103748|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
83103749|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83103750|NCT03689075|Tacrolimus|tacrolimus|mesh-list
83103751|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83103752|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
83103753|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103754|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83103755|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103756|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103757|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
83103758|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83103759|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83103761|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
83103762|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83103763|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
83103764|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103765|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
83103766|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
83103767|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103768|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103769|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103770|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
83103771|NCT03680495|Hormones|hormones|mesh-ancestor
83103772|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103773|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83103774|NCT03680495|Protective Agents|protective agents|mesh-ancestor
83103775|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83103776|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103777|NCT03647969|Nivolumab|nivolumab|mesh-list
83103778|NCT03647969|Ipilimumab|ipilimumab|mesh-list
83103779|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103780|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103781|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83103782|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103783|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
83103784|NCT03492255|Prednisone|prednisone|mesh-list
83103785|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
83103786|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
83103787|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83103788|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
83103789|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103790|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103791|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83103792|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
83103793|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103794|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103795|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83103796|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103797|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
83103798|NCT03492255|Hormones|hormones|mesh-ancestor
83103799|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103800|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83103801|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83103802|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83103803|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
83103804|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83103805|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103806|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103807|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
83103808|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
83103809|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103810|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103811|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83103812|NCT03492255|Protective Agents|protective agents|mesh-ancestor
83103813|NCT03684863|Capecitabine|capecitabine|mesh-list
83103814|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83103815|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
83103816|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103817|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103818|NCT03680339|Misoprostol|misoprostol|mesh-list
83103819|NCT03680339|Oxytocin|oxytocin|mesh-list
83103820|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
83103821|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83103822|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103823|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83103824|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
83103825|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83103826|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103827|NCT03680183|Entecavir|entecavir|mesh-list
83103828|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
83103829|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103830|NCT02136069|Infliximab|infliximab|mesh-list
83103831|NCT02136069|Etrolizumab|etrolizumab|mesh-list
83103832|NCT02136069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83103833|NCT02136069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103834|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83103835|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83103836|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103837|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
83103838|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103839|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83103840|NCT02917031|Saxagliptin|saxagliptin|mesh-list
83103841|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83103842|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103843|NCT02917031|Incretins|incretins|mesh-ancestor
83103844|NCT02917031|Hormones|hormones|mesh-ancestor
83103845|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103846|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83103847|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
83103848|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103849|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103850|NCT04460547|Interferons|interferons|mesh-list
83103851|NCT04460547|Interferon-beta|interferon-beta|mesh-list
83103852|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
83103853|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
83103854|NCT04460547|Ivermectin|ivermectin|mesh-list
83103855|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103856|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
83103857|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103858|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
83103859|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83103860|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83103861|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103862|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103863|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83103864|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
83103865|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103866|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83103867|NCT03132051|Triamcinolone|triamcinolone|mesh-list
83103868|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83103869|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83103870|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83103871|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103872|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
83103873|NCT03132051|Hormones|hormones|mesh-ancestor
83103874|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103875|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103876|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83103877|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
83103878|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103879|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103880|NCT03684707|Metformin|metformin|mesh-list
83103881|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83103882|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103883|NCT01018563|Farletuzumab|farletuzumab|mesh-list
83103884|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103885|NCT02528188|Tanezumab|tanezumab|mesh-list
83103886|NCT02528188|Analgesics|analgesics|mesh-ancestor
83103887|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
83103888|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103889|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103890|NCT03684395|Warfarin|warfarin|mesh-list
83103891|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
83103892|NCT03684395|Dabigatran|dabigatran|mesh-list
83103893|NCT03684395|Apixaban|apixaban|mesh-list
83103894|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
83103895|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83103896|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
83103897|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83103898|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83103899|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103900|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103901|NCT04460001|Triamcinolone|triamcinolone|mesh-list
83103902|NCT04460001|Ranibizumab|ranibizumab|mesh-list
83103903|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83103904|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83103905|NCT04460001|Growth Substances|growth substances|mesh-ancestor
83103906|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103907|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83103908|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103909|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103910|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
83103911|NCT04460001|Hormones|hormones|mesh-ancestor
83103912|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103913|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
83103914|NCT03484845|Lactoferrin|lactoferrin|mesh-list
83103915|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83103916|NCT03484845|Trace Elements|trace elements|mesh-ancestor
83103917|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
83103918|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103919|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
83103920|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83103921|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83103922|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103923|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
83103924|NCT03679481|Coagulants|coagulants|mesh-ancestor
83103925|NCT04461249|Travoprost|travoprost|mesh-list
83103926|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83103927|NCT04461249|Latanoprost|latanoprost|mesh-list
83103928|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83103929|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83103930|NCT05151549|Carboplatin|carboplatin|mesh-list
83103931|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103932|NCT05151393|Vitamin D|vitamin d|mesh-list
83103933|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
83103934|NCT05151393|Vitamins|vitamins|mesh-ancestor
83103935|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
83103936|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103937|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83103938|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83103939|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83103940|NCT03484611|Cetrorelix|cetrorelix|mesh-list
83103941|NCT03484611|Menotropins|menotropins|mesh-list
83103942|NCT03484611|Progesterone|progesterone|mesh-list
83103943|NCT03484611|Progestins|progestins|mesh-ancestor
83103944|NCT03484611|Hormones|hormones|mesh-ancestor
83103945|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83103946|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103947|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83103948|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83103949|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
83103950|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
83103951|NCT03679325|Vitamin D|vitamin d|mesh-list
83103952|NCT03679325|Vitamins|vitamins|mesh-ancestor
83103953|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
83103954|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103955|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83103956|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
83103957|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83103958|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83103959|NCT03878927|Immunotoxins|immunotoxins|mesh-ancestor
83103960|NCT03878927|Immunoconjugates|immunoconjugates|mesh-ancestor
83103961|NCT03878927|Immunologic Factors|immunologic factors|mesh-ancestor
83103962|NCT03878927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103963|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
83103964|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83103965|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83103967|NCT03623711|Escitalopram|escitalopram|mesh-list
83103968|NCT03623711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83103969|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83103970|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83103971|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103972|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103973|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
83103974|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103975|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83103976|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83103977|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
83103978|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83103979|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83103980|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
83103981|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83103982|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83103983|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83103984|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83103985|NCT03623711|Analgesics|analgesics|mesh-ancestor
83103986|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
83103987|NCT05368090|Epinephrine|epinephrine|mesh-list
83103988|NCT05368090|Racepinephrine|racepinephrine|mesh-list
83103989|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
83103990|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83103991|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83103992|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
83103993|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83103994|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83103995|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83103996|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83103997|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83103998|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
83103999|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104000|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83104001|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
83104002|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
83104003|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
83104004|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83104005|NCT05382442|Leucovorin|leucovorin|mesh-list
83104006|NCT05382442|Bevacizumab|bevacizumab|mesh-list
83104007|NCT05382442|Fluorouracil|fluorouracil|mesh-list
83104008|NCT05382442|Capecitabine|capecitabine|mesh-list
83104009|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
83104010|NCT05382442|Irinotecan|irinotecan|mesh-list
83104011|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104012|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104013|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83104014|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83104015|NCT05382442|Growth Substances|growth substances|mesh-ancestor
83104016|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104017|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
83104018|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
83104019|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104020|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83104021|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83104022|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
83104023|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83104024|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83104025|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104026|NCT05382442|Antidotes|antidotes|mesh-ancestor
83104027|NCT05382442|Protective Agents|protective agents|mesh-ancestor
83104028|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
83104029|NCT05382442|Vitamins|vitamins|mesh-ancestor
83104030|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
83104031|NCT05362474|Montelukast|montelukast|mesh-list
83104032|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83104033|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
83104034|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83104035|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
83104036|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104037|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104038|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83104039|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83104040|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104041|NCT05542342|Tislelizumab|tislelizumab|mesh-list
83104042|NCT05542342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104043|NCT05542342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104044|NCT05599516|Vaccines|vaccines|mesh-list
83104045|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
83104046|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104047|NCT05380024|Ensartinib|ensartinib|mesh-list
83104048|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104049|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83104050|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104051|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104052|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
83104053|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83104054|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104055|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104056|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104057|NCT04251910|Analgesics|analgesics|mesh-ancestor
83104058|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
83104059|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104060|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83104061|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83104062|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83104063|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
83104064|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104065|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104066|NCT05342194|Gemcitabine|gemcitabine|mesh-list
83104067|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
83104068|NCT05342194|Lenvatinib|lenvatinib|mesh-list
83104069|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104070|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83104071|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
83104072|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104073|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83104074|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104075|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
83104076|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
83104077|NCT03623789|Hemostatics|hemostatics|mesh-list
83104078|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83104079|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83104080|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104081|NCT03623789|Coagulants|coagulants|mesh-ancestor
83104082|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
83104083|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83104084|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83104085|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104086|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83104087|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83104088|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104089|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104090|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
83104091|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83104092|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83104093|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83104094|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104095|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
83104096|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104097|NCT05306548|Triamcinolone|triamcinolone|mesh-list
83104098|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83104099|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83104100|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83104101|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104102|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
83104103|NCT05306548|Hormones|hormones|mesh-ancestor
83104104|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104105|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104106|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83104107|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
83104109|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104110|NCT05306470|Lidocaine|lidocaine|mesh-list
83104111|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
83104112|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
83104113|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
83104114|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104115|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104116|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
83104117|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104118|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83104119|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83104120|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83104121|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83104122|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104123|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83104124|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83104125|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104126|NCT05339386|Xenon|xenon|mesh-list
83104127|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83104128|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
83104129|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
83104130|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389686|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83104141|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104142|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83104143|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83104144|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104145|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104146|NCT05560282|Fenfluramine|fenfluramine|mesh-list
83104147|NCT05560282|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83104148|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83104149|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83104150|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104151|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104152|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
83104153|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104154|NCT03530267|Aflibercept|aflibercept|mesh-list
83104155|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83104156|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83104157|NCT03530267|Growth Substances|growth substances|mesh-ancestor
83104158|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104159|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
83104160|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104161|NCT05338450|Clemastine|clemastine|mesh-list
83104162|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
83104163|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
83104164|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83104165|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
83104166|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
83104167|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83467506|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104168|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104169|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104170|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83104179|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83104180|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83104181|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83104182|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
83104183|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104184|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83104185|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83104186|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104187|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83104188|NCT03676985|Antibodies|antibodies|mesh-list
83104189|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
83104190|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83104191|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
83104192|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104193|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104194|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83104195|NCT05348824|Eusol|eusol|mesh-list
83104196|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
83528132|NCT02205047|Pertuzumab|pertuzumab|mesh-list
83104198|NCT02988401|Insulin|insulin|mesh-list
83104199|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83104200|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104201|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83104202|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
83104203|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104204|NCT05266924|Hormones|hormones|mesh-list
83104205|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83104206|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104207|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104208|NCT05266456|Vaccines|vaccines|mesh-list
83104209|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83104210|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
83104211|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104212|NCT05486416|Propofol|propofol|mesh-list
83104213|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83104214|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104215|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104216|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83104217|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
83104218|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
83104219|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83104220|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
83104221|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104222|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104223|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83104224|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83104225|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83104226|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
83104227|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104228|NCT05294146|Clofazimine|clofazimine|mesh-list
83104229|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104230|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
83104231|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83104232|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104233|NCT05293288|Anesthetics|anesthetics|mesh-list
83104234|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104235|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104236|NCT03484221|Fluorouracil|fluorouracil|mesh-list
83104237|NCT03484221|Capecitabine|capecitabine|mesh-list
83104238|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
83104239|NCT03484221|Irinotecan|irinotecan|mesh-list
83104240|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
83104241|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104242|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83104243|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104244|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83104245|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
83104246|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104247|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83104248|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83104249|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104250|NCT03857139|Nicotine|nicotine|mesh-list
83104251|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83104252|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
83104253|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104254|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104255|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83104256|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83104257|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
83104258|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104259|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104260|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
83104261|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83104262|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104263|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83104264|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83104265|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104266|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104267|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104268|NCT05255770|Benzocaine|benzocaine|mesh-list
83104269|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
83104270|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
83104271|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104272|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104273|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
83104274|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104276|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
83104277|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
83104278|NCT05322538|Vitamins|vitamins|mesh-list
83104279|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83104280|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
83104281|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104282|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83104283|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83104284|NCT04965220|Trametinib|trametinib|mesh-list
83104285|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104286|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83104287|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104288|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104289|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83104290|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104291|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
83104292|NCT05322070|Hormones|hormones|mesh-ancestor
83104293|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104294|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104295|NCT03131037|Valacyclovir|valacyclovir|mesh-list
83104296|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
83104297|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104298|NCT03483753|Vasopressins|vasopressins|mesh-list
83104299|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
83104300|NCT03483753|Norepinephrine|norepinephrine|mesh-list
83104301|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83104302|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83104303|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
83104304|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104305|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104306|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104307|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
83104308|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
83104309|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104310|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83104311|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
83104312|NCT03483753|Coagulants|coagulants|mesh-ancestor
83104313|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83104314|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
83104315|NCT03389477|Cisplatin|cisplatin|mesh-list
83104316|NCT03389477|Cetuximab|cetuximab|mesh-list
83104317|NCT03389477|Palbociclib|palbociclib|mesh-list
83104318|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104319|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104320|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83104321|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104322|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104323|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
83104324|NCT02680574|Hematinics|hematinics|mesh-ancestor
83104325|NCT03672149|Cefazolin|cefazolin|mesh-list
83104326|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83104327|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104328|NCT03672071|Ephedrine|ephedrine|mesh-list
83104329|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
83104330|NCT03672071|Norepinephrine|norepinephrine|mesh-list
83104331|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83104332|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104333|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
83104334|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
83104335|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104336|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83104338|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104339|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104340|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83104341|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83104342|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
83104343|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
83104344|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83104345|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83104346|NCT03480945|Nitroprusside|nitroprusside|mesh-list
83104347|NCT03480945|Serotonin|serotonin|mesh-list
83104348|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83104349|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
83104350|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104351|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104352|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104353|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83104354|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
83104356|NCT03483207|Heparin|heparin|mesh-list
83104357|NCT03483207|Warfarin|warfarin|mesh-list
83104358|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
83104359|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83104360|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83104361|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104362|NCT05132985|Carboplatin|carboplatin|mesh-list
83104363|NCT05132985|Pemetrexed|pemetrexed|mesh-list
83104364|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104365|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104366|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104367|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83104368|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83104369|NCT03739593|Dexamethasone|dexamethasone|mesh-list
83104370|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
83104371|NCT03739593|BB 1101|bb 1101|mesh-list
83104372|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104373|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
83104374|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
83104375|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104376|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104377|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83104378|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
83104379|NCT03739593|Hormones|hormones|mesh-ancestor
83104380|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104381|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83104382|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104383|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
83104384|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104385|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104386|NCT03480867|Temozolomide|temozolomide|mesh-list
83104387|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83104388|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
83104389|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104390|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104391|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
83104392|NCT05254912|Petrolatum|petrolatum|mesh-list
83104393|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83104394|NCT05254912|Protective Agents|protective agents|mesh-ancestor
83104395|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104396|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
83104397|NCT05254912|Emollients|emollients|mesh-ancestor
83104398|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
83104399|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83104400|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104401|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104402|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104403|NCT03480789|Analgesics|analgesics|mesh-ancestor
83104404|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
83104405|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104406|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83104407|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83104408|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83104409|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
83104410|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104411|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104412|NCT05251636|Aflibercept|aflibercept|mesh-list
83104413|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83104414|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83104415|NCT05251636|Growth Substances|growth substances|mesh-ancestor
83104416|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104417|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
83104418|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104419|NCT03475407|Dexamethasone|dexamethasone|mesh-list
83104420|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
83104421|NCT03475407|BB 1101|bb 1101|mesh-list
83104422|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104423|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
83104424|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
83104425|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104426|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104427|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83104428|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
83104429|NCT03475407|Hormones|hormones|mesh-ancestor
83104430|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104431|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83104432|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104433|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
83104434|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104435|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104436|NCT03655197|Doxycycline|doxycycline|mesh-list
83104437|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83104438|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104439|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
83104440|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83104441|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83104442|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
83104443|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83104444|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83104445|NCT05317624|Prednisolone|prednisolone|mesh-list
83104446|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
83104447|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83104448|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
83104449|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104450|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
83104451|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
83104452|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104453|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104454|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83104455|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
83104456|NCT05317624|Hormones|hormones|mesh-ancestor
83104457|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104458|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83104459|NCT05317624|Protective Agents|protective agents|mesh-ancestor
83104460|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83104461|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104462|NCT03475017|Curcumin|curcumin|mesh-list
83104463|NCT03475017|Piperine|piperine|mesh-list
83104464|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83104465|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104466|NCT03475017|Analgesics|analgesics|mesh-ancestor
83104467|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
83104468|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104469|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104470|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104471|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104472|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104473|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104474|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104475|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83104476|NCT02674568|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83104477|NCT02674568|Immunoconjugates|immunoconjugates|mesh-ancestor
83104478|NCT02674568|Immunologic Factors|immunologic factors|mesh-ancestor
83104479|NCT02674568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104480|NCT03474939|Midazolam|midazolam|mesh-list
83104481|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83104482|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83104483|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104484|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104485|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83104486|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83104487|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83104488|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83104489|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
83104490|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
83104491|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
83104492|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
83104493|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104494|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104495|NCT03131583|Colchicine|colchicine|mesh-list
83104496|NCT03131583|Febuxostat|febuxostat|mesh-list
83104497|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
83104498|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104499|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83104500|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83104501|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83104502|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104503|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104504|NCT04672928|Paclitaxel|paclitaxel|mesh-list
83104505|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83104506|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104507|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
83104508|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
83104509|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
83104510|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104511|NCT03480321|Cilostazol|cilostazol|mesh-list
83104512|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83104513|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
83104514|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104515|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104516|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83104517|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
83104518|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83104519|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83104520|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104521|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83104522|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
83104523|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83104524|NCT03480321|Protective Agents|protective agents|mesh-ancestor
83104525|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83104526|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83104527|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104528|NCT04928950|Charcoal|charcoal|mesh-list
83104529|NCT04928950|Antidotes|antidotes|mesh-ancestor
83104530|NCT04928950|Protective Agents|protective agents|mesh-ancestor
83104531|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104532|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83104533|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104534|NCT02986269|Anesthetics|anesthetics|mesh-list
83104535|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104536|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104537|NCT05313256|Lidocaine|lidocaine|mesh-list
83104538|NCT05313256|Epinephrine|epinephrine|mesh-list
83104539|NCT05313256|Racepinephrine|racepinephrine|mesh-list
83104540|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
83104541|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
83104542|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
83104543|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104544|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104545|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
83104546|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104547|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83104548|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83104549|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83104550|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83104551|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104552|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83104553|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83104554|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83104555|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104556|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83104557|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83104558|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
83104559|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83104560|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83104561|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
83104562|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
83104563|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83104564|NCT03474237|Hormones|hormones|mesh-list
83104565|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104566|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104567|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
83104568|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83104569|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104570|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104571|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104572|NCT05276830|Analgesics|analgesics|mesh-ancestor
83104573|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
83104574|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104575|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83104576|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83104577|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83104578|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
83104579|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104580|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104581|NCT03480165|Parecoxib|parecoxib|mesh-list
83104582|NCT03480165|Ropivacaine|ropivacaine|mesh-list
83104583|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
83104584|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
83104585|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104586|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104587|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
83104588|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104589|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83104590|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83104591|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104592|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104593|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83104594|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104595|NCT03480165|Analgesics|analgesics|mesh-ancestor
83104596|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104597|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104598|NCT05311852|Palmidrol|palmidrol|mesh-list
83104599|NCT05311852|Antioxidants|antioxidants|mesh-list
83104600|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104601|NCT05311852|Protective Agents|protective agents|mesh-ancestor
83104602|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104603|NCT05311852|Analgesics|analgesics|mesh-ancestor
83104604|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
83104605|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104606|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83104607|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104608|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104609|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104610|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
83104611|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104612|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83104613|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83104614|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104615|NCT05311852|Hormones|hormones|mesh-ancestor
83104616|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104617|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
83104618|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104619|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
83104620|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104621|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104622|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83104623|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83104624|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83104625|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83104626|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83104627|NCT03671915|Insulin|insulin|mesh-list
83104628|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83104629|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104630|NCT03302195|Heparin|heparin|mesh-list
83104631|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
83104632|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83104633|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83528207|NCT02679911|Ciclopirox|ciclopirox|mesh-list
83104634|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104635|NCT02515773|Metformin|metformin|mesh-list
83104636|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83104637|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104638|NCT05275426|Gemcitabine|gemcitabine|mesh-list
83104639|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83104640|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
83104641|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104642|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104643|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83104644|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
83104645|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83104646|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
83104647|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104648|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
83104649|NCT03114020|Protective Agents|protective agents|mesh-ancestor
83104650|NCT04460079|Lenograstim|lenograstim|mesh-list
83104651|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83104652|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
83104653|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104654|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
83104656|NCT03473691|Immunologic Factors|immunologic factors|mesh-ancestor
83104657|NCT03473691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104658|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104659|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104660|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83104661|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
83104662|NCT03676361|Coagulants|coagulants|mesh-ancestor
83104663|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83104664|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
83104665|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104666|NCT01712763|Goserelin|goserelin|mesh-list
83104667|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83104668|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83104669|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104670|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
83104671|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83104672|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
83104673|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83104674|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104675|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83104676|NCT02827877|Copper|copper|mesh-list
83104677|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83104678|NCT02827877|Trastuzumab|trastuzumab|mesh-list
83104679|NCT02827877|Pertuzumab|pertuzumab|mesh-list
83104680|NCT02827877|Antibodies|antibodies|mesh-list
83104681|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
83104682|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83104683|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
83104684|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104685|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104686|NCT02827877|Trace Elements|trace elements|mesh-ancestor
83104687|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
83104688|NCT05218486|Isotretinoin|isotretinoin|mesh-list
83104689|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
83104690|NCT05216770|Bupivacaine|bupivacaine|mesh-list
83104691|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
83104692|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
83104693|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104694|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104695|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
83104696|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104697|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
83104698|NCT05236036|Temozolomide|temozolomide|mesh-list
83104699|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83104700|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104701|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83104702|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
83104703|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83104704|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104705|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104706|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104707|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83104708|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
83104709|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83104710|NCT02781779|Laxatives|laxatives|mesh-ancestor
83104711|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83104712|NCT05270200|Azacitidine|azacitidine|mesh-list
83104713|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83104714|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
83104715|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104716|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104717|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104719|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104720|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104721|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83104722|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104723|NCT03671057|Midazolam|midazolam|mesh-list
83104724|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83104725|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83104726|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104727|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104728|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83104729|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83104730|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83104731|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83104732|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
83104733|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
83104734|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
83104735|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
83104736|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104737|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104738|NCT03670901|Rituximab|rituximab|mesh-list
83104739|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104740|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104741|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
83104742|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104743|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104744|NCT05166616|Osimertinib|osimertinib|mesh-list
83104745|NCT05166616|Triptolide|triptolide|mesh-list
83104746|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104747|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83104748|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104749|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104750|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83104751|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
83104752|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83104753|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104754|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83104755|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
83104756|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83104757|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83104758|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
83104759|NCT05213728|Vaccines|vaccines|mesh-list
83104760|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
83104761|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104762|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
83104763|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83104764|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104765|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104766|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104767|NCT05165836|Analgesics|analgesics|mesh-ancestor
83104768|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
83104769|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104770|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83104771|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83104772|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83104773|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
83104774|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104775|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104776|NCT05213104|Flecainide|flecainide|mesh-list
83104777|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83104778|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83104779|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83104780|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83104781|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104782|NCT04238416|Lactulose|lactulose|mesh-list
83104783|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83104784|NCT05162014|Empagliflozin|empagliflozin|mesh-list
83104785|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83104786|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83104787|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104788|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104790|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104791|NCT01657162|Alendronate|alendronate|mesh-list
83104792|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83104793|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104794|NCT05209906|Fentanyl|fentanyl|mesh-list
83104795|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83104796|NCT05209906|Narcotics|narcotics|mesh-ancestor
83104797|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104798|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104799|NCT05209906|Analgesics|analgesics|mesh-ancestor
83104800|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
83104801|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104802|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83104803|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83104804|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
83104805|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
83104806|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
83104807|NCT04422184|Diuretics|diuretics|mesh-ancestor
83104808|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
83104809|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104810|NCT04422184|Expectorants|expectorants|mesh-ancestor
83104811|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
83104812|NCT05633810|Aspirin|aspirin|mesh-list
83104813|NCT05633810|Colchicine|colchicine|mesh-list
83104814|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83104815|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104816|NCT05633810|Analgesics|analgesics|mesh-ancestor
83104817|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
83104818|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104819|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104820|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104821|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104822|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83104823|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83104824|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104825|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83104826|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83104827|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104828|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
83104829|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
83104830|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83104831|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83104832|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83104833|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104834|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83104835|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83104836|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83104837|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104838|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104839|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83104840|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83104841|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104842|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
83104843|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104844|NCT05203822|Itraconazole|itraconazole|mesh-list
83104845|NCT05203822|Tepotinib|tepotinib|mesh-list
83104846|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
83104847|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104848|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83104849|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83104850|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104851|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104852|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83104853|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
83104854|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104855|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104856|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83104857|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104858|NCT01373294|Lenalidomide|lenalidomide|mesh-list
83104859|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
83104860|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
83104861|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104862|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83104863|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83104864|NCT01373294|Growth Substances|growth substances|mesh-ancestor
83104865|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
83104866|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104867|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83104868|NCT05220358|Fostemsavir|fostemsavir|mesh-list
83104869|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83104870|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83104871|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
83104872|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104873|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83104874|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83104875|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104876|NCT04422028|Desogestrel|desogestrel|mesh-list
83104877|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83104878|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83104879|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83104880|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
83104881|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83104882|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104883|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83104884|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83104885|NCT04422028|Progestins|progestins|mesh-ancestor
83104887|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83104888|NCT01656304|Bevacizumab|bevacizumab|mesh-list
83104889|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83104890|NCT01656304|Antibodies|antibodies|mesh-list
83104891|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
83104892|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83104893|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104894|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83104895|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83104896|NCT01656304|Growth Substances|growth substances|mesh-ancestor
83104897|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104898|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
83104899|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
83104900|NCT04421872|Anesthetics|anesthetics|mesh-list
83104901|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83104902|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104903|NCT04227028|Bevacizumab|bevacizumab|mesh-list
83104904|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83104905|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
83104906|NCT04227028|Antibodies|antibodies|mesh-list
83104907|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
83104908|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83104909|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
83104910|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104911|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83104912|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83104913|NCT04227028|Growth Substances|growth substances|mesh-ancestor
83104914|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104915|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83104916|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
83104917|NCT03023423|Atezolizumab|atezolizumab|mesh-list
83104918|NCT03023423|Daratumumab|daratumumab|mesh-list
83104919|NCT03023423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83104920|NCT03023423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104921|NCT03023423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104922|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104923|NCT03675191|Orlistat|orlistat|mesh-list
83104924|NCT03675191|Phentermine|phentermine|mesh-list
83104925|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104926|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104927|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83104928|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83104929|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83104930|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104931|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
83104932|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
83104933|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
83104934|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104935|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83104936|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83104937|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83104938|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104939|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104940|NCT03198689|Immunotoxins|immunotoxins|mesh-ancestor
83104941|NCT03198689|Immunoconjugates|immunoconjugates|mesh-ancestor
83104942|NCT03198689|Immunologic Factors|immunologic factors|mesh-ancestor
83104943|NCT03198689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104944|NCT02635061|Nivolumab|nivolumab|mesh-list
83104945|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104946|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104947|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83104948|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104949|NCT05096728|Nifedipine|nifedipine|mesh-list
83104950|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83104951|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83104952|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104953|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83104954|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104955|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
83104956|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
83104957|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83104958|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
83104959|NCT03190265|Nivolumab|nivolumab|mesh-list
83104960|NCT03190265|Ipilimumab|ipilimumab|mesh-list
83104961|NCT03190265|Pancrelipase|pancrelipase|mesh-list
83104962|NCT03190265|Vaccines|vaccines|mesh-list
83104963|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
83104964|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104965|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83104966|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104967|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83104968|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
83104969|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104970|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104971|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83104972|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83104973|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83104974|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83104975|NCT04421716|Ursolic acid|ursolic acid|mesh-list
83104976|NCT04421716|Curcumin|curcumin|mesh-list
83104977|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83104978|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83104979|NCT04421716|Analgesics|analgesics|mesh-ancestor
83104980|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
83104981|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83104982|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104983|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83104984|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83104985|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104986|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83104987|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83104988|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83104989|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83104990|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83104991|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
83104992|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83104993|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83104994|NCT04226950|Interferons|interferons|mesh-list
83104995|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
83104996|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
83104997|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83104998|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83104999|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
83105000|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105001|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
83105002|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105003|NCT05085574|Celecoxib|celecoxib|mesh-list
83105004|NCT05085574|Famotidine|famotidine|mesh-list
83105005|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83105006|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105007|NCT05085574|Analgesics|analgesics|mesh-ancestor
83105008|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
83105009|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83528208|NCT02679911|Amorolfine|amorolfine|mesh-list
83105010|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105011|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105012|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105013|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83105014|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83105015|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105016|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105017|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83105018|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105019|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83105020|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
83105021|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
83105022|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105023|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
83105024|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
83105025|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83105026|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
83105027|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83105028|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83105029|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105030|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83105031|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105032|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105033|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83105034|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83105035|NCT01126749|Gemcitabine|gemcitabine|mesh-list
83105036|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105037|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83105038|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
83105039|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105040|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
83105041|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
83105043|NCT03674411|Busulfan|busulfan|mesh-list
83105044|NCT03674411|Fludarabine|fludarabine|mesh-list
83105045|NCT03674411|Tacrolimus|tacrolimus|mesh-list
83105046|NCT03674411|Lenograstim|lenograstim|mesh-list
83105047|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105048|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
83105049|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105050|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105051|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83105052|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
83105053|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105054|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105055|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83105056|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83105057|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105058|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83105059|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83105060|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
83105061|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83105062|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105063|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83105064|NCT03674333|Folic Acid|folic acid|mesh-list
83105065|NCT03674333|Hematinics|hematinics|mesh-ancestor
83105066|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
83105067|NCT03674333|Vitamins|vitamins|mesh-ancestor
83105068|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
83105069|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105070|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
83105071|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83105072|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83105073|NCT03674099|Prednisolone|prednisolone|mesh-list
83105074|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
83105075|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
83105076|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83105077|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
83105078|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105079|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
83105080|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
83105081|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105082|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105083|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105084|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
83105085|NCT03674099|Hormones|hormones|mesh-ancestor
83105086|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105087|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83105088|NCT03674099|Protective Agents|protective agents|mesh-ancestor
83105089|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83105090|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105091|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83105092|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105093|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105094|NCT05124340|Vaccines|vaccines|mesh-list
83105095|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
83105096|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105097|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
83105098|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105099|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105100|NCT05085028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83105101|NCT05085028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105102|NCT05084404|Guanabenz|guanabenz|mesh-list
83105103|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83105104|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83105105|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83105106|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83105107|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
83105108|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105109|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105110|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105111|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
83105112|NCT03473613|Cabergoline|cabergoline|mesh-list
83105114|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83105115|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105116|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83105117|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83105118|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83105119|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
83105120|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
83105121|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105122|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105123|NCT03670043|Metformin|metformin|mesh-list
83105124|NCT03670043|Psyllium|psyllium|mesh-list
83105125|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83105126|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105127|NCT03670043|Cathartics|cathartics|mesh-ancestor
83105128|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105129|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
83105130|NCT01701986|Rituximab|rituximab|mesh-list
83105131|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83105132|NCT01701986|Gemcitabine|gemcitabine|mesh-list
83105133|NCT01701986|Busulfan|busulfan|mesh-list
83105134|NCT01701986|Clofarabine|clofarabine|mesh-list
83105135|NCT01701986|Antibodies|antibodies|mesh-list
83105136|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
83105137|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83105138|NCT01701986|Tacrolimus|tacrolimus|mesh-list
83467605|NCT00002524|Vitamins|vitamins|mesh-ancestor
83105139|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
83105140|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83105141|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
83105142|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105143|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105144|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105145|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83105146|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
83105147|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105148|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105149|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83105150|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105151|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83105152|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83105153|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
83105154|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83105155|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105156|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
83105157|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83105158|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83105159|NCT05561660|Aspirin|aspirin|mesh-list
83105160|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83105161|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105162|NCT05561660|Analgesics|analgesics|mesh-ancestor
83105163|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
83105164|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105165|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105166|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105167|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105168|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83105169|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83105170|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105171|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83105172|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83105173|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105174|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
83105175|NCT03042819|Doxorubicin|doxorubicin|mesh-list
83105176|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83467628|NCT00002536|Vincristine|vincristine|mesh-list
83105177|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105178|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83105179|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83105180|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105181|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105182|NCT02832687|Acetaminophen|acetaminophen|mesh-list
83105183|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105184|NCT02832687|Analgesics|analgesics|mesh-ancestor
83105185|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
83105186|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105187|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105188|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
83105189|NCT04372017|Vitamin D|vitamin d|mesh-list
83105190|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
83105191|NCT04372017|Vitamins|vitamins|mesh-ancestor
83105192|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
83105193|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105194|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83105195|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
83105196|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83105197|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83105198|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105199|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105200|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105201|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105202|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
83105203|NCT05233358|Nivolumab|nivolumab|mesh-list
83105204|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83105205|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105206|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105207|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105208|NCT02387918|Dexamethasone|dexamethasone|mesh-list
83105209|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105210|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
83105211|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
83105212|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105213|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105214|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105215|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
83105216|NCT02387918|Hormones|hormones|mesh-ancestor
83105217|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105218|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83105219|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105220|NCT04312971|Norepinephrine|norepinephrine|mesh-list
83105221|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83105222|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83105223|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
83105224|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105225|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105226|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105227|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
83105228|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
83105229|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105230|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83105231|NCT05231330|Fluorides|fluorides|mesh-list
83105232|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
83105233|NCT05231330|Protective Agents|protective agents|mesh-ancestor
83467649|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105234|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105235|NCT03179475|Oxycodone|oxycodone|mesh-list
83105236|NCT03179475|Naloxone|naloxone|mesh-list
83105237|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83105238|NCT03179475|Narcotics|narcotics|mesh-ancestor
83105239|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83105240|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105242|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
83105243|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105244|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83105245|NCT03105986|Probenecid|probenecid|mesh-list
83105246|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
83105247|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
83105248|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105249|NCT03132129|Manganese|manganese|mesh-list
83105250|NCT03132129|Calcium|calcium|mesh-list
83105251|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83105252|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105253|NCT03132129|Trace Elements|trace elements|mesh-ancestor
83105254|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
83105255|NCT02391662|Paclitaxel|paclitaxel|mesh-list
83105256|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83105257|NCT02391662|Gemcitabine|gemcitabine|mesh-list
83105258|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83105259|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105260|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
83105261|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
83105262|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
83105263|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105264|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83105265|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
83105266|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
83105267|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83105268|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
83105269|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83105270|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83105271|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105272|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
83105273|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105274|NCT05173324|Vaccines|vaccines|mesh-list
83105275|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
83105276|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105277|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
83105278|NCT04029038|Fludarabine|fludarabine|mesh-list
83105279|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105280|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
83105281|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105282|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105283|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83105284|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
83105285|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105286|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105287|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83105288|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
83105289|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83105290|NCT04223518|Antibodies|antibodies|mesh-list
83105291|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
83105292|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105293|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
83105294|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
83105295|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83105296|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83105297|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105298|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105299|NCT02387450|Urological Agents|urological agents|mesh-ancestor
83105300|NCT02390882|Tamsulosin|tamsulosin|mesh-list
83105301|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83105302|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83105303|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83105304|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
83105305|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105306|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105307|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105308|NCT02390882|Urological Agents|urological agents|mesh-ancestor
83105309|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
83105310|NCT02387138|Irinotecan|irinotecan|mesh-list
83105311|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105312|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83105313|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83105314|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105315|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105316|NCT02387060|Fentanyl|fentanyl|mesh-list
83105317|NCT02387060|Bupivacaine|bupivacaine|mesh-list
83105318|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
83105319|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
83105320|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83105321|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105322|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
83105323|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105324|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83105325|NCT02387060|Narcotics|narcotics|mesh-ancestor
83105326|NCT02387060|Analgesics|analgesics|mesh-ancestor
83105327|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83105328|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83105329|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
83105330|NCT01365052|Naproxen|naproxen|mesh-list
83105331|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83105332|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105333|NCT01365052|Analgesics|analgesics|mesh-ancestor
83105334|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
83105335|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105336|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105337|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105338|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105339|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
83105340|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83105341|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105342|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105343|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
83105344|NCT05155215|Fludarabine|fludarabine|mesh-list
83105345|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105346|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
83105347|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105348|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105349|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83105350|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
83105351|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105352|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105353|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83105354|NCT03471585|Dronabinol|dronabinol|mesh-list
83105355|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
83105356|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105357|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83105358|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105359|NCT03471585|Analgesics|analgesics|mesh-ancestor
83105360|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
83105361|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105362|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83105363|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83105364|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105365|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105366|NCT03471585|Hormones|hormones|mesh-ancestor
83467674|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105367|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105368|NCT05072782|Infliximab|infliximab|mesh-list
83105369|NCT05072782|Methotrexate|methotrexate|mesh-list
83105370|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83105371|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
83105372|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83105373|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105374|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83105375|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
83105376|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105377|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105378|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105379|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105380|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83105381|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105382|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
83105383|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105384|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83105385|NCT05072782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83105386|NCT05072782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105387|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105388|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83105389|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
83105390|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
83105391|NCT03379389|Methenamine|methenamine|mesh-list
83105392|NCT03379389|Acriflavine|acriflavine|mesh-list
83105393|NCT03379389|Methylene Blue|methylene blue|mesh-list
83105394|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105395|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105396|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105397|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83105398|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83105400|NCT05170438|Lenvatinib|lenvatinib|mesh-list
83105401|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83105402|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105403|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
83105404|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
83105405|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
83105406|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105407|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83105408|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105409|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
83105410|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83105411|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105412|NCT03478605|Dexamethasone|dexamethasone|mesh-list
83105413|NCT03478605|Ondansetron|ondansetron|mesh-list
83105414|NCT03478605|Olanzapine|olanzapine|mesh-list
83105415|NCT03478605|Aprepitant|aprepitant|mesh-list
83105416|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105417|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
83105418|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
83105419|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105420|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105421|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105422|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
83105423|NCT03478605|Hormones|hormones|mesh-ancestor
83105424|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105425|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83105426|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105427|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
83105428|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105429|NCT03478605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83105430|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83105431|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
83105432|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105433|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105434|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83105435|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83105436|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83105437|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83105438|NCT03478605|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83105439|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83105440|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83105441|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83105442|NCT05109364|Terazosin|terazosin|mesh-list
83105443|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83105444|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83105445|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83105446|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
83105447|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105448|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105449|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105450|NCT05109364|Urological Agents|urological agents|mesh-ancestor
83105451|NCT05258799|Cytarabine|cytarabine|mesh-list
83105452|NCT05258799|Decitabine|decitabine|mesh-list
83105453|NCT05258799|Aclarubicin|aclarubicin|mesh-list
83105454|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83105455|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
83105456|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105457|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105458|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
83105459|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105460|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105461|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
83105462|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105463|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105464|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83105465|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83105466|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83105468|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83105469|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83105470|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105471|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83105472|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83105473|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83105474|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105475|NCT04233892|Estrogens|estrogens|mesh-list
83105476|NCT04233892|Hormones|hormones|mesh-ancestor
83105477|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105478|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105479|NCT02386358|Benzonidazole|benzonidazole|mesh-list
83105480|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105481|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
83105482|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105483|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83105484|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83105485|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83105486|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105487|NCT03283371|Natalizumab|natalizumab|mesh-list
83105488|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
83105489|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105490|NCT05069350|Bupivacaine|bupivacaine|mesh-list
83105491|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
83105492|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
83105493|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83105494|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105495|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
83105496|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105497|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
83105498|NCT03471351|Tenalisib|tenalisib|mesh-list
83105499|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105500|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105501|NCT03471351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83105502|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105503|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83105504|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105505|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
83105506|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83105507|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83105508|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105509|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
83105510|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105511|NCT02390258|S66913|s66913|mesh-list
83105512|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83105513|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83105514|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105515|NCT03891446|Bimatoprost|bimatoprost|mesh-list
83105516|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83105517|NCT03059511|Nalbuphine|nalbuphine|mesh-list
83105518|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83105519|NCT03059511|Narcotics|narcotics|mesh-ancestor
83105520|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83105521|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105522|NCT03059511|Analgesics|analgesics|mesh-ancestor
83105523|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
83105524|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105525|NCT04439786|Lidocaine|lidocaine|mesh-list
83105526|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
83105527|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
83105528|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83105529|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105530|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
83105531|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105532|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83105533|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83105534|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83105535|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83105536|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105537|NCT03821792|Prednisone|prednisone|mesh-list
83105538|NCT03821792|Cortisone|cortisone|mesh-list
83105539|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
83105540|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105541|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
83105542|NCT03821792|Hormones|hormones|mesh-ancestor
83105543|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105544|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105545|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83105546|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105547|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83105548|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105549|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105550|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
83105551|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83105552|NCT02665286|Naproxen|naproxen|mesh-list
83105553|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83105554|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83105555|NCT02665286|Orphenadrine|orphenadrine|mesh-list
83105556|NCT02665286|Methocarbamol|methocarbamol|mesh-list
83105557|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83105558|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105560|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
83105561|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105562|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105563|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105564|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
83105565|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83105566|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105567|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105568|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
83105569|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105570|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83105571|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83105572|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83105573|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83105574|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
83105575|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
83105576|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83105577|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83105578|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83105579|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
83105580|NCT02390102|Hematinics|hematinics|mesh-ancestor
83105581|NCT02134925|Poly ICLC|poly iclc|mesh-list
83105582|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
83105583|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
83105584|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105585|NCT03663673|Decanoic acid|decanoic acid|mesh-list
83105586|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
83105587|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105588|NCT04058743|Cobalt|cobalt|mesh-list
83105589|NCT04058743|Chromium|chromium|mesh-list
83105590|NCT04058743|Nickel|nickel|mesh-list
83105591|NCT04058743|Trace Elements|trace elements|mesh-ancestor
83105592|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
83105593|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105594|NCT03664063|Azithromycin|azithromycin|mesh-list
83105595|NCT03664063|Ivermectin|ivermectin|mesh-list
83105596|NCT03664063|Albendazole|albendazole|mesh-list
83105597|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
83105598|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83105599|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105600|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83105601|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
83105602|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
83105603|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83105604|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83105605|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
83105606|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
83105607|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
83105608|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105609|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105610|NCT03664063|Filaricides|filaricides|mesh-ancestor
83105611|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
83105612|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83105613|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105614|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
83105615|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83105616|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
83105617|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105618|NCT02911285|Expectorants|expectorants|mesh-ancestor
83105619|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
83105620|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83105621|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
83105622|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105623|NCT02911285|Protective Agents|protective agents|mesh-ancestor
83105624|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105625|NCT02911285|Antidotes|antidotes|mesh-ancestor
83105626|NCT04997902|Tipifarnib|tipifarnib|mesh-list
83105627|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105628|NCT01061515|Bevacizumab|bevacizumab|mesh-list
83105629|NCT01061515|Capecitabine|capecitabine|mesh-list
83105630|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
83105631|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105632|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105633|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83105634|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83105635|NCT01061515|Growth Substances|growth substances|mesh-ancestor
83105636|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105637|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
83105638|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83105639|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
83105640|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105641|NCT01069939|Esomeprazole|esomeprazole|mesh-list
83105642|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83105643|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105644|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83105645|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83467709|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83105646|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105647|NCT01069705|Tobramycin|tobramycin|mesh-list
83105648|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83105649|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105650|NCT01996865|Rituximab|rituximab|mesh-list
83105651|NCT01996865|Lenalidomide|lenalidomide|mesh-list
83105652|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105653|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105654|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
83105655|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105656|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105657|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83105658|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83105659|NCT01996865|Growth Substances|growth substances|mesh-ancestor
83105660|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
83105661|NCT01069627|Bevacizumab|bevacizumab|mesh-list
83105662|NCT01069627|Fotemustine|fotemustine|mesh-list
83105663|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105664|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105665|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83105666|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83105667|NCT01069627|Growth Substances|growth substances|mesh-ancestor
83105668|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105669|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
83105670|NCT04057261|Liraglutide|liraglutide|mesh-list
83105671|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83105672|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105673|NCT04057261|Incretins|incretins|mesh-ancestor
83105674|NCT04057261|Hormones|hormones|mesh-ancestor
83105675|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105676|NCT01947023|Lapatinib|lapatinib|mesh-list
83105677|NCT01947023|Dabrafenib|dabrafenib|mesh-list
83105678|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105679|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83105680|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105681|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105682|NCT01064245|Mannitol|mannitol|mesh-list
83105683|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
83105684|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83105685|NCT01064245|Diuretics|diuretics|mesh-ancestor
83105686|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
83105687|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105688|NCT01064245|Miotics|miotics|mesh-ancestor
83105689|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
83105690|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105691|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83105692|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83105693|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
83105694|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83105695|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83105696|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
83105697|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105698|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105699|NCT04056949|Paclitaxel|paclitaxel|mesh-list
83105700|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83105701|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83105702|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105703|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
83105704|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
83105705|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
83105706|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105707|NCT03662425|Oxytocin|oxytocin|mesh-list
83105708|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
83105709|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83105710|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105711|NCT03673163|Lidocaine|lidocaine|mesh-list
83105712|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
83105713|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
83105714|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83105715|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105716|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
83105717|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105718|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83105719|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83105720|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83105721|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83105722|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105723|NCT03662269|Indomethacin|indomethacin|mesh-list
83105724|NCT03662269|Omeprazole|omeprazole|mesh-list
83105725|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83105726|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105727|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83105728|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105729|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105730|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83105731|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105732|NCT03662269|Analgesics|analgesics|mesh-ancestor
83105733|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
83105734|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105735|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105736|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105737|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105738|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
83105739|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
83105740|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83105741|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83105742|NCT04056325|Ivermectin|ivermectin|mesh-list
83105743|NCT04056325|Moxidectin|moxidectin|mesh-list
83105744|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83105745|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105746|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
83105747|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
83105748|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83105749|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83105750|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83105751|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83105752|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
83105753|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105754|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105755|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105756|NCT01624805|Cyclosporine|cyclosporine|mesh-list
83105757|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
83105758|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83105759|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83105760|NCT01624805|Prednisolone|prednisolone|mesh-list
83105761|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
83105762|NCT01624805|Lenograstim|lenograstim|mesh-list
83105763|NCT01624805|Cyclosporins|cyclosporins|mesh-list
83105764|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
83105765|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83105766|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83105767|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
83105768|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83105769|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
83105770|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105771|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105772|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105773|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105774|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
83105775|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105776|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105777|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105778|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83105779|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105780|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
83105781|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
83105782|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105783|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105784|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
83105785|NCT01624805|Hormones|hormones|mesh-ancestor
83105786|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105787|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83105788|NCT01624805|Protective Agents|protective agents|mesh-ancestor
83105789|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83105790|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105791|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83105792|NCT01585025|Cathartics|cathartics|mesh-ancestor
83105793|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105794|NCT00328653|Cyclosporine|cyclosporine|mesh-list
83105795|NCT00328653|Cyclosporins|cyclosporins|mesh-list
83105796|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105797|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105798|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105799|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
83105800|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105801|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
83105802|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105803|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105804|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105805|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83105806|NCT03662113|Domperidone|domperidone|mesh-list
83105807|NCT03662113|Simethicone|simethicone|mesh-list
83105808|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
83105809|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
83105810|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105811|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105812|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105813|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83105814|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
83105815|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105816|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105817|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
83105818|NCT03662113|Emollients|emollients|mesh-ancestor
83105819|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105820|NCT03662035|Apatinib|apatinib|mesh-list
83105821|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105822|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83105823|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105824|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105825|NCT05798546|Cyclophosphamide|cyclophosphamide|mesh-list
83105826|NCT05798546|Fludarabine|fludarabine|mesh-list
83105827|NCT05798546|Interleukin-2|interleukin-2|mesh-list
83105828|NCT05798546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105829|NCT05798546|Immunologic Factors|immunologic factors|mesh-ancestor
83105830|NCT05798546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105831|NCT05798546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105832|NCT05798546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83105833|NCT05798546|Alkylating Agents|alkylating agents|mesh-ancestor
83105834|NCT05798546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105835|NCT05798546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105836|NCT05798546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83105837|NCT05798546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105838|NCT05798546|Analgesics|analgesics|mesh-ancestor
83105839|NCT05798546|Sensory System Agents|sensory system agents|mesh-ancestor
83105840|NCT05798546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105841|NCT05798533|Cyclophosphamide|cyclophosphamide|mesh-list
83105842|NCT05798533|Fludarabine|fludarabine|mesh-list
83105843|NCT05798533|Interleukin-2|interleukin-2|mesh-list
83105844|NCT05798533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105845|NCT05798533|Immunologic Factors|immunologic factors|mesh-ancestor
83528209|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
83105846|NCT05798533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105848|NCT05798533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83105849|NCT05798533|Alkylating Agents|alkylating agents|mesh-ancestor
83105850|NCT05798533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105851|NCT05798533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105852|NCT05798533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83105853|NCT05798533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83105854|NCT05798533|Analgesics|analgesics|mesh-ancestor
83105855|NCT05798533|Sensory System Agents|sensory system agents|mesh-ancestor
83105856|NCT05798533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105857|NCT05798403|Solifenacin Succinate|solifenacin succinate|mesh-list
83105858|NCT05798403|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83105859|NCT05798403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83105860|NCT05798403|Cholinergic Agents|cholinergic agents|mesh-ancestor
83105861|NCT05798403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105862|NCT05798403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105863|NCT05798403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105864|NCT05798403|Urological Agents|urological agents|mesh-ancestor
83105866|NCT05798195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83105867|NCT05798195|Antiemetics|antiemetics|mesh-ancestor
83105868|NCT05798195|Autonomic Agents|autonomic agents|mesh-ancestor
83105869|NCT05798195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105870|NCT05798195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105871|NCT05798195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105872|NCT05798195|Glucocorticoids|glucocorticoids|mesh-ancestor
83105873|NCT05798195|Hormones|hormones|mesh-ancestor
83105874|NCT05798195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105875|NCT05798195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83105876|NCT05798195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105877|NCT05797948|Cyclophosphamide|cyclophosphamide|mesh-list
83105878|NCT05797948|Fludarabine|fludarabine|mesh-list
83105879|NCT05797948|Lenalidomide|lenalidomide|mesh-list
83105880|NCT05797948|Azacitidine|azacitidine|mesh-list
83105881|NCT05797948|Obinutuzumab|obinutuzumab|mesh-list
83105882|NCT05797948|Zanubrutinib|zanubrutinib|mesh-list
83105883|NCT05797948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105884|NCT05797948|Immunologic Factors|immunologic factors|mesh-ancestor
83105885|NCT05797948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105886|NCT05797948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105887|NCT05797948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83105888|NCT05797948|Alkylating Agents|alkylating agents|mesh-ancestor
83105889|NCT05797948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105890|NCT05797948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105891|NCT05797948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83105892|NCT05797948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83105893|NCT05797948|Antimetabolites|antimetabolites|mesh-ancestor
83105894|NCT05797948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83105895|NCT05797948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83105896|NCT05797948|Growth Substances|growth substances|mesh-ancestor
83105897|NCT05797948|Growth Inhibitors|growth inhibitors|mesh-ancestor
83105898|NCT05797948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105899|NCT05797948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105900|NCT05797948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83105901|NCT05797870|Ethiodized Oil|ethiodized oil|mesh-list
83105902|NCT05797870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105903|NCT05797818|Chlorhexidine|chlorhexidine|mesh-list
83105904|NCT05797818|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83105905|NCT05797818|Methylene Blue|methylene blue|mesh-list
83105906|NCT05797818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83105907|NCT05797818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105908|NCT05797818|Disinfectants|disinfectants|mesh-ancestor
83105909|NCT05797818|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105910|NCT05797818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105911|NCT05797818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105912|NCT05797805|Pembrolizumab|pembrolizumab|mesh-list
83105913|NCT05797805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105914|NCT05797805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105915|NCT05797805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83105916|NCT05797805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105917|NCT05797792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83105918|NCT05797792|Plasminogen|plasminogen|mesh-list
83105919|NCT05797792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83105920|NCT05797792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83105921|NCT05797792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105922|NCT05797753|Itraconazole|itraconazole|mesh-list
83105923|NCT05797753|Erythromycin|erythromycin|mesh-list
83105924|NCT05797753|Erythromycin Estolate|erythromycin estolate|mesh-list
83105925|NCT05797753|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83105926|NCT05797753|Erythromycin stearate|erythromycin stearate|mesh-list
83105927|NCT05797753|Antifungal Agents|antifungal agents|mesh-ancestor
83105928|NCT05797753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105929|NCT05797753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83105930|NCT05797753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83105931|NCT05797753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105932|NCT05797753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105933|NCT05797753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83105934|NCT05797753|Hormone Antagonists|hormone antagonists|mesh-ancestor
83105935|NCT05797753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83105936|NCT05797753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105937|NCT05797753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83105938|NCT05797753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83105939|NCT05797753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83105940|NCT05797753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83105941|NCT05797740|Cladribine|cladribine|mesh-list
83105942|NCT05797740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105943|NCT05797740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105944|NCT05797740|Immunologic Factors|immunologic factors|mesh-ancestor
83105945|NCT05797740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105946|NCT05797714|Tenofovir|tenofovir|mesh-list
83105947|NCT05797714|Antiviral Agents|antiviral agents|mesh-ancestor
83105948|NCT05797714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105949|NCT05797714|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83105950|NCT05797714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83105951|NCT05797714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105952|NCT05797714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105953|NCT05797714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83105954|NCT05797714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83105955|NCT05797623|Cyclosporine|cyclosporine|mesh-list
83105956|NCT05797623|Cyclosporins|cyclosporins|mesh-list
83105957|NCT05797623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83105958|NCT05797623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105959|NCT05797623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83105960|NCT05797623|Immunologic Factors|immunologic factors|mesh-ancestor
83105961|NCT05797623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105962|NCT05797623|Antifungal Agents|antifungal agents|mesh-ancestor
83105963|NCT05797623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83105964|NCT05797623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83105965|NCT05797623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83105966|NCT05797623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83105967|NCT05797584|Dobutamine|dobutamine|mesh-list
83105968|NCT05797584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83105969|NCT05797584|Sympathomimetics|sympathomimetics|mesh-ancestor
83105970|NCT05797584|Autonomic Agents|autonomic agents|mesh-ancestor
83105971|NCT05797584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105972|NCT05797584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105973|NCT05797584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83105974|NCT05797584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83105975|NCT05797584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83105976|NCT05797584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83105977|NCT05797584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105978|NCT05797584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105979|NCT05797584|Protective Agents|protective agents|mesh-ancestor
83105980|NCT05797493|Atezolizumab|atezolizumab|mesh-list
83105981|NCT05797493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83105982|NCT05797493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105983|NCT05797493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83105984|NCT05797493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83105985|NCT05797220|Diltiazem|diltiazem|mesh-list
83105986|NCT05797220|Botulinum Toxins|botulinum toxins|mesh-list
83105987|NCT05797220|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83105988|NCT05797220|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83105989|NCT05797220|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83105990|NCT05797220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83105991|NCT05797220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83105992|NCT05797220|Cholinergic Agents|cholinergic agents|mesh-ancestor
83105993|NCT05797220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83105994|NCT05797220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83105995|NCT05797220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83105996|NCT05797220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83105997|NCT05797220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83105998|NCT05797220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83105999|NCT05797220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83106000|NCT05797220|Vasodilator Agents|vasodilator agents|mesh-ancestor
83106001|NCT05797077|Capecitabine|capecitabine|mesh-list
83106002|NCT05797077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106003|NCT05797077|Antimetabolites|antimetabolites|mesh-ancestor
83106004|NCT05797077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106005|NCT05797077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106006|NCT05797038|Tacrolimus|tacrolimus|mesh-list
83106007|NCT05797038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106008|NCT05797038|Immunologic Factors|immunologic factors|mesh-ancestor
83106009|NCT05797038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106010|NCT05797038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83106040|NCT05792774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106041|NCT05782127|Venetoclax|venetoclax|mesh-list
83106042|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106043|NCT05776927|Fluticasone|fluticasone|mesh-list
83106044|NCT05776927|Xhance|xhance|mesh-list
83106045|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83106046|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106047|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83106048|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
83106049|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106050|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106051|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83106052|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83106053|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
83106054|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83106055|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83106056|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83106057|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83106058|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
83106059|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106060|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106069|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
83106070|NCT05703854|Fludarabine|fludarabine|mesh-list
83106071|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
83106072|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106073|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
83106074|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106075|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106076|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83106077|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
83106078|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106079|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106080|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83467761|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83106081|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106082|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
83106083|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
83106084|NCT05692999|Pemetrexed|pemetrexed|mesh-list
83106085|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106086|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106087|NCT05692999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83106088|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106089|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106090|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83106091|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83106092|NCT05665140|Dexamethasone|dexamethasone|mesh-list
83106093|NCT05665140|Lenalidomide|lenalidomide|mesh-list
83106094|NCT05665140|Bortezomib|bortezomib|mesh-list
83106095|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106096|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
83106097|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
83106098|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106099|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106100|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83106101|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
83106102|NCT05665140|Hormones|hormones|mesh-ancestor
83106103|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106104|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83106105|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106106|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
83106107|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83106108|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83106109|NCT05665140|Growth Substances|growth substances|mesh-ancestor
83106110|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
83106111|NCT05661591|Fluconazole|fluconazole|mesh-list
83106112|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
83106113|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106114|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83106115|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83106116|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106117|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106118|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83106119|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
83106120|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106121|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106122|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83106123|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83106124|NCT05661201|Doxorubicin|doxorubicin|mesh-list
83106125|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83106126|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106127|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83106128|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83106129|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106130|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106131|NCT05653193|Interferons|interferons|mesh-list
83106132|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
83106133|NCT05653193|Clotrimazole|clotrimazole|mesh-list
83106135|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
83106136|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106137|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
83106138|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106139|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83106140|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83106141|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83106142|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106143|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106144|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83106145|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83106146|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106147|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83467766|NCT05750056|Analgesics|analgesics|mesh-ancestor
83106148|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83106149|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83106150|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
83106151|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83106152|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106153|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106154|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106155|NCT05634148|Analgesics|analgesics|mesh-ancestor
83106156|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
83106163|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106164|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
83106165|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83106166|NCT05631899|Paclitaxel|paclitaxel|mesh-list
83106167|NCT05631899|Antibodies|antibodies|mesh-list
83106168|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
83106169|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
83106170|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106171|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
83106172|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106173|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106174|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83106175|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
83106176|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106177|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106178|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83106179|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83106180|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
83106181|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
83106182|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
83106183|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83106184|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
83106185|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106186|NCT05622123|Exenatide|exenatide|mesh-list
83106187|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83106188|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106189|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83106190|NCT05622123|Incretins|incretins|mesh-ancestor
83106191|NCT05622123|Hormones|hormones|mesh-ancestor
83106192|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106193|NCT05601492|Thalidomide|thalidomide|mesh-list
83106194|NCT05601492|Apremilast|apremilast|mesh-list
83106195|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83106196|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106197|NCT05601492|Analgesics|analgesics|mesh-ancestor
83106198|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
83106199|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106200|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106201|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106202|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106203|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83106204|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83106205|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106206|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106207|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106208|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
83106209|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
83106210|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83106211|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106212|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83106213|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83106214|NCT05601492|Growth Substances|growth substances|mesh-ancestor
83106215|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
83106216|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106217|NCT05594082|Trastuzumab|trastuzumab|mesh-list
83106218|NCT05594082|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83106219|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106220|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467776|NCT05749900|Nivolumab|nivolumab|mesh-list
83106221|NCT05594082|Immunoconjugates|immunoconjugates|mesh-ancestor
83106222|NCT05594082|Immunologic Factors|immunologic factors|mesh-ancestor
83106223|NCT05594082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106230|NCT05582434|Clindamycin|clindamycin|mesh-list
83106231|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
83106232|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
83106233|NCT05582434|Adapalene|adapalene|mesh-list
83106234|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83106235|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83106236|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106237|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83106238|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106239|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106240|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
83106241|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83106242|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106243|NCT05582434|Analgesics|analgesics|mesh-ancestor
83106244|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
83106245|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106246|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106247|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106248|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106249|NCT05574374|Fexuprazan|fexuprazan|mesh-list
83106250|NCT05574374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83106251|NCT05566639|Vaccines|vaccines|mesh-list
83106252|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
83106253|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106254|NCT05542394|Curcumin|curcumin|mesh-list
83106255|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83106256|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106257|NCT05542394|Analgesics|analgesics|mesh-ancestor
83106258|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
83106259|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106260|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106261|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106262|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106263|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106264|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106265|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106266|NCT05525078|Nicotine|nicotine|mesh-list
83106267|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83106268|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
83106269|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106270|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106271|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83106272|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83106273|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
83106274|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106275|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106276|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83106277|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106278|NCT05522660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106279|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106280|NCT05506787|Esketamine|esketamine|mesh-list
83106281|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
83106282|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106283|NCT05503511|Bumetanide|bumetanide|mesh-list
83106284|NCT05503511|Diuretics|diuretics|mesh-ancestor
83106285|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
83106286|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106287|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83467780|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
83106288|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83106289|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106290|NCT05503355|Venetoclax|venetoclax|mesh-list
83106291|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106292|NCT05453851|Pancrelipase|pancrelipase|mesh-list
83106293|NCT05453851|Pancreatin|pancreatin|mesh-list
83106294|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83106295|NCT05453500|Prednisone|prednisone|mesh-list
83106296|NCT05453500|Cortisone|cortisone|mesh-list
83106297|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
83106298|NCT05453500|Rituximab|rituximab|mesh-list
83106299|NCT05453500|Doxorubicin|doxorubicin|mesh-list
83106300|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83106301|NCT05453500|Etoposide|etoposide|mesh-list
83106302|NCT05453500|Vincristine|vincristine|mesh-list
83106303|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
83106304|NCT05453500|Daunorubicin|daunorubicin|mesh-list
83106305|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
83106306|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83106307|NCT05453500|Antibodies|antibodies|mesh-list
83106308|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
83106309|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83106310|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106311|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
83106312|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106313|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106314|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83106315|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
83106316|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106317|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106318|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83106319|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83106320|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83106321|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83106322|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106323|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106324|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
83106325|NCT05453500|Hormones|hormones|mesh-ancestor
83106326|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106327|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83106328|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83106329|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
83106330|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
83106331|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
83106332|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
83106333|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
83106334|NCT05445024|Sufentanil|sufentanil|mesh-list
83106335|NCT05445024|Nalbuphine|nalbuphine|mesh-list
83106336|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83106337|NCT05445024|Narcotics|narcotics|mesh-ancestor
83106338|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106339|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106340|NCT05445024|Analgesics|analgesics|mesh-ancestor
83106341|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
83106342|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106343|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83106344|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83106345|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
83106346|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
83106347|NCT05429814|Menthol|menthol|mesh-list
83106348|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
83106349|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
83106350|NCT05420337|Morphine|morphine|mesh-list
83106351|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83106352|NCT05420337|Narcotics|narcotics|mesh-ancestor
83106353|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106354|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106355|NCT05420337|Analgesics|analgesics|mesh-ancestor
83106356|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
83106357|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106358|NCT05409872|Vitamin D|vitamin d|mesh-list
83106359|NCT05409872|Vitamins|vitamins|mesh-list
83106360|NCT05409872|Inositol|inositol|mesh-list
83106361|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
83106362|NCT05409872|Pyridoxal|pyridoxal|mesh-list
83106363|NCT05409872|Pyridoxine|pyridoxine|mesh-list
83106364|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83106365|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
83106366|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106367|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83106368|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
83106369|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
83106370|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106371|NCT05409872|Protective Agents|protective agents|mesh-ancestor
83106372|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83106373|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83106374|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106375|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83106376|NCT05390905|Tramadol|tramadol|mesh-list
83106377|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83106378|NCT05390905|Narcotics|narcotics|mesh-ancestor
83106379|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106380|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106381|NCT05390905|Analgesics|analgesics|mesh-ancestor
83106382|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
83106383|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106384|NCT05366621|Denosumab|denosumab|mesh-list
83106385|NCT05366621|Diphosphonates|diphosphonates|mesh-list
83106386|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106387|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83106388|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
83106389|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83106390|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106391|NCT05335252|Dronabinol|dronabinol|mesh-list
83106392|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
83106393|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106394|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106395|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106396|NCT05335252|Analgesics|analgesics|mesh-ancestor
83106397|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
83106398|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106399|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83106400|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83106401|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106402|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106403|NCT05335252|Hormones|hormones|mesh-ancestor
83106404|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106405|NCT05325775|SR 142801|sr 142801|mesh-list
83106406|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83106407|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83106408|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106409|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106410|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106411|NCT05289908|Folic Acid|folic acid|mesh-list
83106412|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
83106413|NCT05289908|Dexamethasone|dexamethasone|mesh-list
83106414|NCT05289908|Pemetrexed|pemetrexed|mesh-list
83106415|NCT05289908|Vitamins|vitamins|mesh-ancestor
83106416|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
83106417|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106418|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106419|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
83106420|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
83106421|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106422|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83106423|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
83106424|NCT05289908|Hormones|hormones|mesh-ancestor
83467808|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
83106425|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106426|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83106427|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106428|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106429|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106430|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83106431|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83106432|NCT05289908|Hematinics|hematinics|mesh-ancestor
83106433|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
83106434|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
83106435|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
83106436|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
83106437|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106438|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106439|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106440|NCT05254171|Paclitaxel|paclitaxel|mesh-list
83106441|NCT05254171|Gemcitabine|gemcitabine|mesh-list
83106442|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83106443|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106444|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
83106445|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
83106446|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
83106447|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106448|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106449|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
83106450|NCT05247905|Capecitabine|capecitabine|mesh-list
83106451|NCT05247905|Temozolomide|temozolomide|mesh-list
83106452|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83106453|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106454|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
83106455|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106456|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106457|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83106458|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
83106459|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83106460|NCT05226351|Dronabinol|dronabinol|mesh-list
83106461|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
83106462|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106463|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106464|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106465|NCT05226351|Analgesics|analgesics|mesh-ancestor
83106466|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
83106467|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106468|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83106469|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83106470|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106471|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106472|NCT05226351|Hormones|hormones|mesh-ancestor
83106473|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106474|NCT05215548|Afatinib|afatinib|mesh-list
83106475|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106476|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83106477|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106478|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106479|NCT05209555|Pilocarpine|pilocarpine|mesh-list
83106480|NCT05209555|Miotics|miotics|mesh-ancestor
83106481|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
83106482|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106483|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106484|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83106485|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83106486|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
83106487|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106488|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106489|NCT05202145|Cyclosporine|cyclosporine|mesh-list
83106490|NCT05202145|Tacrolimus|tacrolimus|mesh-list
83106491|NCT05202145|Cyclosporins|cyclosporins|mesh-list
83106492|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106493|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
83106494|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106495|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83106496|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106497|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106498|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
83106499|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106500|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83106501|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106502|NCT05150938|Vitamin K|vitamin k|mesh-list
83106503|NCT05150938|Heparin|heparin|mesh-list
83106504|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83106505|NCT05150938|Tinzaparin|tinzaparin|mesh-list
83106506|NCT05150938|Dalteparin|dalteparin|mesh-list
83106507|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
83106508|NCT05150938|Vitamins|vitamins|mesh-ancestor
83106509|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
83106510|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106511|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
83106512|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83106513|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83106514|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106515|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83106516|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
83106517|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83106518|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
83106519|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106520|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83106521|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
83106522|NCT05150938|Coagulants|coagulants|mesh-ancestor
83106523|NCT05142904|Iodine|iodine|mesh-list
83106524|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
83106525|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83106526|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106527|NCT05142904|Trace Elements|trace elements|mesh-ancestor
83106528|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
83106529|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106530|NCT05107856|Azacitidine|azacitidine|mesh-list
83106531|NCT05107856|Venetoclax|venetoclax|mesh-list
83106532|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106533|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
83106534|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106535|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106536|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106537|NCT05060549|Cariprazine|cariprazine|mesh-list
83106538|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83106539|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83106540|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106541|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106542|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106544|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83106545|NCT05042648|Narcotics|narcotics|mesh-ancestor
83106546|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106547|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106548|NCT05042648|Analgesics|analgesics|mesh-ancestor
83106549|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
83106550|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106551|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83106552|NCT05036317|Empagliflozin|empagliflozin|mesh-list
83106553|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83106554|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106555|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83106556|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106557|NCT04990388|Acetaminophen|acetaminophen|mesh-list
83106558|NCT04990388|Antipyretics|antipyretics|mesh-list
83106559|NCT04990388|Cetirizine|cetirizine|mesh-list
83106560|NCT04990388|Ibuprofen|ibuprofen|mesh-list
83106561|NCT04990388|Famotidine|famotidine|mesh-list
83106562|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106563|NCT04990388|Analgesics|analgesics|mesh-ancestor
83106564|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
83106565|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106566|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106567|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83106569|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106570|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83467818|NCT05449535|Omalizumab|omalizumab|mesh-list
83106571|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106572|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106573|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83106574|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83106575|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83106576|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
83106577|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
83106578|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106579|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83106580|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83106581|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83106582|NCT04916002|Cemiplimab|cemiplimab|mesh-list
83106583|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106584|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106585|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
83106586|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83106587|NCT04871269|Dronabinol|dronabinol|mesh-list
83106588|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
83106589|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106590|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106591|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106592|NCT04871269|Analgesics|analgesics|mesh-ancestor
83106593|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
83106594|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106595|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83106596|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83106597|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106598|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106599|NCT04871269|Hormones|hormones|mesh-ancestor
83106600|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106601|NCT04837131|Ixazomib|ixazomib|mesh-list
83106602|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106603|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
83106604|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106605|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106606|NCT05256745|Paclitaxel|paclitaxel|mesh-list
83106607|NCT05256745|Docetaxel|docetaxel|mesh-list
83106608|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
83106609|NCT05256745|Carboplatin|carboplatin|mesh-list
83106610|NCT05256745|Doxorubicin|doxorubicin|mesh-list
83106611|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83106612|NCT05256745|Trastuzumab|trastuzumab|mesh-list
83106613|NCT05256745|Pertuzumab|pertuzumab|mesh-list
83106614|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83106615|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106616|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
83106617|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
83106618|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
83106619|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106620|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106621|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
83106622|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106623|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106624|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83106625|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
83106626|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83106627|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83106628|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83106629|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83106630|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106631|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106632|NCT04768010|Misoprostol|misoprostol|mesh-list
83106633|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83106634|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
83106635|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83106636|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106637|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83106638|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83106639|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
83106640|NCT04764214|Osimertinib|osimertinib|mesh-list
83106641|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106642|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83106643|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106644|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106645|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83106646|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83106647|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106648|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106649|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
83106650|NCT04675710|Trametinib|trametinib|mesh-list
83106651|NCT04675710|Dabrafenib|dabrafenib|mesh-list
83106652|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106653|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106654|NCT04675710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83106655|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106656|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83106657|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106658|NCT04710030|Valacyclovir|valacyclovir|mesh-list
83106659|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
83106660|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106661|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
83106662|NCT04653818|Velpatasvir|velpatasvir|mesh-list
83106663|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83106664|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
83106665|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106666|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
83106667|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83106668|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106669|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106670|NCT04609566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83106671|NCT04609566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106672|NCT04609566|Immunotoxins|immunotoxins|mesh-ancestor
83106673|NCT04609566|Immunoconjugates|immunoconjugates|mesh-ancestor
83106674|NCT04609566|Immunologic Factors|immunologic factors|mesh-ancestor
83106675|NCT04609566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106676|NCT04608955|Bedaquiline|bedaquiline|mesh-list
83106677|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
83106678|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83106679|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106680|NCT04579848|Folic Acid|folic acid|mesh-list
83106681|NCT04579848|Methotrexate|methotrexate|mesh-list
83106682|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83106683|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
83106684|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83106685|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106686|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106687|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
83106688|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106689|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106696|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83106698|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
83106699|NCT04579848|Vitamins|vitamins|mesh-ancestor
83106700|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
83106701|NCT04578652|Metformin|metformin|mesh-list
83106702|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83106703|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106704|NCT04570631|Dexamethasone|dexamethasone|mesh-list
83106705|NCT04570631|Bortezomib|bortezomib|mesh-list
83106706|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106707|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
83106708|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
83106709|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106710|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106711|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83106712|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
83106713|NCT04570631|Hormones|hormones|mesh-ancestor
83106714|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106715|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83106716|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106717|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
83106718|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106719|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106720|NCT04555837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83106721|NCT04555837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106722|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
83106723|NCT04550832|Bedaquiline|bedaquiline|mesh-list
83106724|NCT04550832|Delpazolid|delpazolid|mesh-list
83106725|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83106726|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106727|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83106728|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83106729|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106730|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106731|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106732|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
83106733|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83106734|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
83106735|NCT04477629|Abatacept|abatacept|mesh-list
83106736|NCT04477629|Tacrolimus|tacrolimus|mesh-list
83106737|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106738|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
83106739|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106740|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83106741|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106742|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106743|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83106744|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106745|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83106746|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
83106747|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83106748|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106749|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83106750|NCT04477629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106751|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106752|NCT04476277|Biotin|biotin|mesh-list
83106753|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
83106754|NCT04476277|Vitamins|vitamins|mesh-ancestor
83106755|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
83106756|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106764|NCT04430517|Niacinamide|niacinamide|mesh-list
83106765|NCT04430517|Niacin|niacin|mesh-list
83106766|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
83106767|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
83106768|NCT04430517|Vitamins|vitamins|mesh-ancestor
83106769|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
83106770|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106771|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83106772|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
83106773|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106774|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83106775|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
83106776|NCT04414943|Ketamine|ketamine|mesh-list
83106777|NCT04414943|Esketamine|esketamine|mesh-list
83106778|NCT04414943|Analgesics|analgesics|mesh-ancestor
83106779|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
83106780|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106781|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106782|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83106783|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83106784|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
83106785|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
83106786|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106787|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83106788|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83106789|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106790|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106791|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
83106792|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106793|NCT04354025|Cytarabine|cytarabine|mesh-list
83106794|NCT04354025|Fludarabine|fludarabine|mesh-list
83106795|NCT04354025|Interleukin-2|interleukin-2|mesh-list
83106796|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106797|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106798|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
83106799|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106800|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106801|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
83106802|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106803|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
83106804|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106805|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106806|NCT04354025|Analgesics|analgesics|mesh-ancestor
83106807|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
83106808|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106810|NCT04347720|Ibuprofen|ibuprofen|mesh-list
83106811|NCT04347720|Indomethacin|indomethacin|mesh-list
83106812|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106813|NCT04347720|Analgesics|analgesics|mesh-ancestor
83106814|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
83106815|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106816|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106817|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
83106818|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83106819|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106820|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83106821|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83106822|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106823|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106824|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
83106825|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
83106826|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83106827|NCT04325802|Naltrexone|naltrexone|mesh-list
83106828|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83106829|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83106830|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106831|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
83106832|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106833|NCT04285346|Ganaxolone|ganaxolone|mesh-list
83106834|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
83106835|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106836|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106837|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106838|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
83106839|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
83106840|NCT04275999|Ivermectin|ivermectin|mesh-list
83106841|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83106842|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106843|NCT04241562|Mitogens|mitogens|mesh-list
83106844|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83106845|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106846|NCT04229004|Paclitaxel|paclitaxel|mesh-list
83106847|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83106848|NCT04229004|Gemcitabine|gemcitabine|mesh-list
83106849|NCT04229004|Spartalizumab|spartalizumab|mesh-list
83106850|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83106851|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106852|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83106853|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83106854|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83106855|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106856|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83106857|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
83106858|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83106859|NCT04229004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106860|NCT04209192|Amikacin|amikacin|mesh-list
83106861|NCT04209192|Fosfomycin|fosfomycin|mesh-list
83106862|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83106863|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106864|NCT04207931|Fluocinonide|fluocinonide|mesh-list
83106865|NCT04207931|Triamcinolone|triamcinolone|mesh-list
83106866|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83106867|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83106868|NCT04207931|Betamethasone|betamethasone|mesh-list
82735501|NCT00767286|Cobalt|cobalt|mesh-list
83106869|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
83106870|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83106871|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
83106872|NCT04207931|Clobetasol|clobetasol|mesh-list
83106873|NCT04207931|Minoxidil|minoxidil|mesh-list
83106874|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83106875|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83106876|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83106877|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
83106878|NCT04207931|Hormones|hormones|mesh-ancestor
83106879|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106880|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106881|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83106882|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
83106883|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106884|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106885|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83106886|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
83106887|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83106888|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83106889|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83106890|NCT04199468|Ketamine|ketamine|mesh-list
83106891|NCT04199468|Dronabinol|dronabinol|mesh-list
83106892|NCT04199468|Analgesics|analgesics|mesh-ancestor
83106893|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
83106894|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106895|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106896|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83106897|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83106898|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
83106899|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
83106900|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106901|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83106902|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83106903|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106904|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106905|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
83106906|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106907|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83106908|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83106909|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83106910|NCT04199468|Hormones|hormones|mesh-ancestor
83106911|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83106912|NCT04178148|Amikacin|amikacin|mesh-list
83106913|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83106914|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106915|NCT04126681|Interferons|interferons|mesh-list
83106916|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
83106917|NCT04126681|Dasatinib|dasatinib|mesh-list
83106918|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
83106919|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
83106920|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106921|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
83106922|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83106923|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83106924|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106925|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106926|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
83106927|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83106928|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83106929|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83106930|NCT04118855|Axitinib|axitinib|mesh-list
83106931|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106932|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83106933|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106934|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106935|NCT04084860|Ketamine|ketamine|mesh-list
83106936|NCT04084860|Analgesics|analgesics|mesh-ancestor
83106937|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
83106938|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106939|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106940|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83106941|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83106942|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
83106943|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
83106944|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106945|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83106946|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83106947|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106948|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106949|NCT04011150|Fentanyl|fentanyl|mesh-list
83106950|NCT04011150|Ropivacaine|ropivacaine|mesh-list
83106951|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
83106952|NCT04011150|Anesthetics|anesthetics|mesh-list
83106953|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106954|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106955|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
83106956|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106957|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83106958|NCT04011150|Narcotics|narcotics|mesh-ancestor
83106959|NCT04011150|Analgesics|analgesics|mesh-ancestor
83106960|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83106961|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83106962|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
83106963|NCT03994796|Entrectinib|entrectinib|mesh-list
83106964|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83106965|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83106966|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106967|NCT03927378|Ketamine|ketamine|mesh-list
83106968|NCT03927378|Esketamine|esketamine|mesh-list
83106969|NCT03927378|Analgesics|analgesics|mesh-ancestor
83106970|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
83106971|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83106972|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106973|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83106974|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83106975|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
83106976|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
83106977|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83106978|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83106979|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83106980|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83106981|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106982|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
83106983|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83106984|NCT03875391|Oxytocin|oxytocin|mesh-list
83106985|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
83106986|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83106987|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106988|NCT03836066|Bevacizumab|bevacizumab|mesh-list
83106989|NCT03836066|Atezolizumab|atezolizumab|mesh-list
83106990|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83106991|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83106992|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83106993|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83106994|NCT03836066|Growth Substances|growth substances|mesh-ancestor
83106995|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83106996|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
83106997|NCT03836066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83106998|NCT03836066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83106999|NCT03778242|Tranexamic Acid|tranexamic acid|mesh-list
83107000|NCT03778242|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83107001|NCT03778242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83107002|NCT03778242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107003|NCT03778242|Hemostatics|hemostatics|mesh-ancestor
83107004|NCT03778242|Coagulants|coagulants|mesh-ancestor
83107005|NCT03772613|Heparin|heparin|mesh-list
83107006|NCT03772613|Calcium heparin|calcium heparin|mesh-list
83107007|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
83107008|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83107009|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83107010|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107011|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107012|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83107013|NCT03739814|Blinatumomab|blinatumomab|mesh-list
83107014|NCT03739814|Antibodies|antibodies|mesh-list
83107015|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
83107016|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107017|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
83107018|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83107019|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
83107020|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107021|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107022|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107023|NCT03739814|Immunotoxins|immunotoxins|mesh-ancestor
83107024|NCT03739814|Immunoconjugates|immunoconjugates|mesh-ancestor
83107025|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107026|NCT03730194|Melatonin|melatonin|mesh-list
83107027|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
83107028|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107029|NCT03730194|Protective Agents|protective agents|mesh-ancestor
83107030|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107031|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83107032|NCT03698461|Leucovorin|leucovorin|mesh-list
83107033|NCT03698461|Bevacizumab|bevacizumab|mesh-list
83107034|NCT03698461|Atezolizumab|atezolizumab|mesh-list
83107035|NCT03698461|Fluorouracil|fluorouracil|mesh-list
83107036|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
83107037|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
83107038|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107039|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107040|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83107041|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83107042|NCT03698461|Growth Substances|growth substances|mesh-ancestor
83107043|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107044|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
83107045|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
83107046|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107047|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107048|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107049|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
83107050|NCT03698461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107051|NCT03698461|Antidotes|antidotes|mesh-ancestor
83107052|NCT03698461|Protective Agents|protective agents|mesh-ancestor
83107053|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
83107054|NCT03698461|Vitamins|vitamins|mesh-ancestor
83107055|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
83107056|NCT03612960|Nicotine|nicotine|mesh-list
83107057|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83107058|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
83107059|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107060|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107061|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83107062|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83107063|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
83107064|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83107065|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107066|NCT03601923|Niraparib|niraparib|mesh-list
83107067|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83107068|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107069|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107070|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107071|NCT03590652|Dexamethasone|dexamethasone|mesh-list
83107072|NCT03590652|Daratumumab|daratumumab|mesh-list
83107073|NCT03590652|Pomalidomide|pomalidomide|mesh-list
83107074|NCT03590652|Ixazomib|ixazomib|mesh-list
83107080|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83107081|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
83107082|NCT03590652|Hormones|hormones|mesh-ancestor
83107083|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107084|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83107085|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107086|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
83107087|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83107088|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83107089|NCT03590652|Growth Substances|growth substances|mesh-ancestor
83107090|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
83107091|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
83107092|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107093|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107094|NCT03535363|Osimertinib|osimertinib|mesh-list
83107095|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107096|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107097|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107098|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107099|NCT03483038|Irinotecan|irinotecan|mesh-list
83107100|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83107101|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107102|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107103|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107104|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107105|NCT03462459|Vancomycin|vancomycin|mesh-list
83107106|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83107107|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107108|NCT03417284|Melphalan|melphalan|mesh-list
83107109|NCT03417284|Lenograstim|lenograstim|mesh-list
83107110|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83107111|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
83107112|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107113|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107114|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
83107115|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107116|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107117|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107118|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107119|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
83107120|NCT03384836|Propranolol|propranolol|mesh-list
83107121|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107122|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107123|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107124|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107125|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83107126|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83107127|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
83107128|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83107129|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107130|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83107131|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83107132|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
83107133|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
83107134|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
83107135|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83107136|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83107137|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107138|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107139|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107140|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107146|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107147|NCT03290937|Cetuximab|cetuximab|mesh-list
83107148|NCT03290937|Irinotecan|irinotecan|mesh-list
83107149|NCT03290937|Camptothecin|camptothecin|mesh-list
83107150|NCT03290937|Antibodies|antibodies|mesh-list
83107151|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
83107152|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107153|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
83107154|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
83107155|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107156|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107157|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83107158|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107159|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107160|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107161|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107162|NCT03261102|Adalimumab|adalimumab|mesh-list
83107163|NCT03261102|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83107164|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107165|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107166|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
83107167|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83107168|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83107169|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
83107170|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107171|NCT03241732|Expectorants|expectorants|mesh-ancestor
83107172|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
83107173|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83107174|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
83107175|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107176|NCT03241732|Protective Agents|protective agents|mesh-ancestor
83107177|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107178|NCT03241732|Antidotes|antidotes|mesh-ancestor
83107179|NCT03224767|Vemurafenib|vemurafenib|mesh-list
83107180|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107181|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107182|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107183|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107184|NCT03206047|Poly I-C|poly i-c|mesh-list
83107185|NCT03206047|Atezolizumab|atezolizumab|mesh-list
83107186|NCT03206047|Guadecitabine|guadecitabine|mesh-list
83107187|NCT03206047|Azacitidine|azacitidine|mesh-list
83107188|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83107189|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107190|NCT03206047|Poly ICLC|poly iclc|mesh-list
83107191|NCT03206047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107192|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107193|NCT03206047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107194|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107195|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
83107196|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107197|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
83107198|NCT03206047|Laxatives|laxatives|mesh-ancestor
83107199|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83107200|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
83107201|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107202|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107203|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
83107204|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107205|NCT03150693|Cytarabine|cytarabine|mesh-list
83107206|NCT03150693|Dexamethasone|dexamethasone|mesh-list
83107207|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
83107208|NCT03150693|Rituximab|rituximab|mesh-list
83107209|NCT03150693|Doxorubicin|doxorubicin|mesh-list
83107210|NCT03150693|Methotrexate|methotrexate|mesh-list
83107211|NCT03150693|Vincristine|vincristine|mesh-list
83107212|NCT03150693|Daunorubicin|daunorubicin|mesh-list
83107213|NCT03150693|Asparaginase|asparaginase|mesh-list
83107214|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
83107215|NCT03150693|Thioguanine|thioguanine|mesh-list
83107216|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83107217|NCT03150693|Pegaspargase|pegaspargase|mesh-list
83107218|NCT03150693|Allopurinol|allopurinol|mesh-list
83107219|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107220|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
83107221|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107222|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107223|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107224|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
83107225|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107226|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107227|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107228|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107229|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107230|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
83107231|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
83107232|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107233|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83107234|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
83107235|NCT03150693|Hormones|hormones|mesh-ancestor
83107236|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107237|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83107238|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107239|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107240|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107241|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107242|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83107243|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
83107244|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83107245|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107246|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
83107247|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107248|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83107249|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83107250|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
83107251|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107252|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107253|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107254|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107255|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107256|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
83107257|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83107258|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
83107259|NCT03150693|Protective Agents|protective agents|mesh-ancestor
83107260|NCT03150693|Immunotoxins|immunotoxins|mesh-ancestor
83107261|NCT03150693|Immunoconjugates|immunoconjugates|mesh-ancestor
83107262|NCT02968212|Clofazimine|clofazimine|mesh-list
83107263|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107264|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
83107265|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83107266|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107267|NCT02967692|Trametinib|trametinib|mesh-list
83107268|NCT02967692|Dabrafenib|dabrafenib|mesh-list
83107269|NCT02967692|Spartalizumab|spartalizumab|mesh-list
83107270|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107271|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107272|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107273|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107274|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107275|NCT02967692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107276|NCT02931253|Metformin|metformin|mesh-list
83107277|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83107278|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107280|NCT02848131|Quercetin|quercetin|mesh-list
83107281|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107282|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107283|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107284|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107285|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
83107286|NCT02848131|Protective Agents|protective agents|mesh-ancestor
83107287|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107288|NCT02846376|Nivolumab|nivolumab|mesh-list
83107289|NCT02846376|Ipilimumab|ipilimumab|mesh-list
83107290|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107291|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83467878|NCT04094207|Protective Agents|protective agents|mesh-ancestor
83107292|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107293|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107294|NCT02598349|Capecitabine|capecitabine|mesh-list
83107295|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107296|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
83107297|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107298|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107299|NCT02590601|Bromocriptine|bromocriptine|mesh-list
83107300|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83107301|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83107302|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
83107303|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107304|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107305|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
83107307|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83107308|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107309|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
83107310|NCT02501096|Lenvatinib|lenvatinib|mesh-list
83107311|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107312|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107313|NCT02501096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107314|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107315|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107316|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107317|NCT02484443|Dinutuximab|dinutuximab|mesh-list
83107318|NCT02484443|Sargramostim|sargramostim|mesh-list
83107319|NCT02484443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107320|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
83107321|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107322|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107323|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
83107324|NCT02451982|Nivolumab|nivolumab|mesh-list
83107325|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
83107326|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107327|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107328|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107329|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107330|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
83107331|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107332|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107333|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107334|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107335|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107336|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
83107337|NCT02306161|Ifosfamide|ifosfamide|mesh-list
83107338|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
83107339|NCT02306161|Doxorubicin|doxorubicin|mesh-list
83107340|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83107341|NCT02306161|Etoposide|etoposide|mesh-list
83107342|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
83107343|NCT02306161|Vincristine|vincristine|mesh-list
83107344|NCT02306161|Daunorubicin|daunorubicin|mesh-list
83107345|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
83107346|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107347|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107348|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
83107349|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107350|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107351|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107352|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
83107353|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107354|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107355|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107356|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107357|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107358|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107359|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107360|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107361|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107362|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107363|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107364|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
83107365|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107366|NCT02254278|Cisplatin|cisplatin|mesh-list
83107367|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107368|NCT02253316|Dexamethasone|dexamethasone|mesh-list
83107369|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
83107370|NCT02253316|Lenalidomide|lenalidomide|mesh-list
83107371|NCT02253316|Ixazomib|ixazomib|mesh-list
83107372|NCT02253316|BB 1101|bb 1101|mesh-list
83107373|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107374|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
83107375|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
83107376|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107377|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107378|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83107379|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
83107380|NCT02253316|Hormones|hormones|mesh-ancestor
83107381|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107382|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83107383|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107384|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
83107385|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107386|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107387|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
83107388|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83107389|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83107390|NCT02253316|Growth Substances|growth substances|mesh-ancestor
83107391|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
83107392|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83107393|NCT02240498|Methylene Blue|methylene blue|mesh-list
83107394|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107395|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107396|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83107397|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83107398|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83107399|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83107400|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83107401|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
83107402|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107403|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83107404|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107405|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83107406|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107407|NCT02176148|Fluocinonide|fluocinonide|mesh-list
83107408|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107409|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
83107410|NCT02176148|Hormones|hormones|mesh-ancestor
83107411|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107412|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107413|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83107414|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
83107415|NCT02101853|Leucovorin|leucovorin|mesh-list
83107416|NCT02101853|Folic Acid|folic acid|mesh-list
83107417|NCT02101853|Cytarabine|cytarabine|mesh-list
83107418|NCT02101853|Dexamethasone|dexamethasone|mesh-list
83107419|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
83107420|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
83107421|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83107422|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83107423|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83107424|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
83107425|NCT02101853|Methotrexate|methotrexate|mesh-list
83107426|NCT02101853|Etoposide|etoposide|mesh-list
83107427|NCT02101853|Vincristine|vincristine|mesh-list
83107428|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
83107429|NCT02101853|Asparaginase|asparaginase|mesh-list
83107430|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
83107431|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
83107432|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
83107433|NCT02101853|Pegaspargase|pegaspargase|mesh-list
83107434|NCT02101853|Thioguanine|thioguanine|mesh-list
83107435|NCT02101853|Blinatumomab|blinatumomab|mesh-list
83107436|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107437|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
83107438|NCT02101853|Antibodies|antibodies|mesh-list
83107439|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
83107440|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107441|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83107442|NCT02101853|BB 1101|bb 1101|mesh-list
83107443|NCT02101853|Calcium|calcium|mesh-list
83107444|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
83107445|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
83107446|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107447|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
83107448|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107449|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107450|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107451|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
83107452|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107453|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107454|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107455|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107456|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
83107457|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
83107458|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107459|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83107460|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
83107462|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107463|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83107464|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
83107465|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107466|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83107467|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83107468|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83107469|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
83107470|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83107471|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107472|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
83107473|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107474|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83107475|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83107476|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107477|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107478|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107479|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
83107480|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107481|NCT02101853|Antidotes|antidotes|mesh-ancestor
83107482|NCT02101853|Protective Agents|protective agents|mesh-ancestor
83107483|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
83107484|NCT02101853|Vitamins|vitamins|mesh-ancestor
83107485|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
83107486|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107487|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107488|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107489|NCT02101853|Hematinics|hematinics|mesh-ancestor
83107490|NCT02101853|Analgesics|analgesics|mesh-ancestor
83107491|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
83107492|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
83107493|NCT01885689|Sirolimus|sirolimus|mesh-list
83107494|NCT01885689|Melphalan|melphalan|mesh-list
83107495|NCT01885689|Clofarabine|clofarabine|mesh-list
83107496|NCT01885689|Tacrolimus|tacrolimus|mesh-list
83107497|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107498|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
83107499|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107500|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83107501|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107502|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107503|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83107504|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107505|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107506|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107507|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
83107508|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107509|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
83107510|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107511|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107512|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
83107513|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
83107514|NCT01798004|Melphalan|melphalan|mesh-list
83107515|NCT01798004|Busulfan|busulfan|mesh-list
83107516|NCT01798004|Mechlorethamine|mechlorethamine|mesh-list
83107517|NCT01798004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83107518|NCT01798004|Cisplatin|cisplatin|mesh-list
83107519|NCT01798004|Doxorubicin|doxorubicin|mesh-list
83107520|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83107521|NCT01798004|Etoposide|etoposide|mesh-list
83107522|NCT01798004|Vincristine|vincristine|mesh-list
83107523|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
83107524|NCT01798004|Topotecan|topotecan|mesh-list
83107525|NCT01798004|Podophyllotoxin|podophyllotoxin|mesh-list
83107526|NCT01798004|Lenograstim|lenograstim|mesh-list
83107527|NCT01798004|Mesna|mesna|mesh-list
83107528|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107529|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
83107530|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107531|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107532|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107533|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
83107534|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107535|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107536|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107537|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107538|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107539|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107540|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107541|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107542|NCT01798004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83107543|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107544|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107545|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107546|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83107547|NCT01798004|Protective Agents|protective agents|mesh-ancestor
83107548|NCT01798004|Keratolytic Agents|keratolytic agents|mesh-ancestor
83107549|NCT01798004|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107550|NCT01693380|Vaccines|vaccines|mesh-list
83107551|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
83107552|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107553|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83107554|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83107555|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83107556|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107557|NCT01542879|Hematinics|hematinics|mesh-ancestor
83107558|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83107559|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83107560|NCT01492972|Leuprolide|leuprolide|mesh-list
83107561|NCT01492972|Goserelin|goserelin|mesh-list
83107562|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83107563|NCT01492972|Buserelin|buserelin|mesh-list
83107564|NCT01492972|Androgens|androgens|mesh-list
83107565|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83107566|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
83107567|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83107568|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107569|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83107570|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107571|NCT01492972|Hormones|hormones|mesh-ancestor
83107572|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107573|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
83107574|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83107575|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
83107576|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83107577|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
83107578|NCT01256398|Leucovorin|leucovorin|mesh-list
83107579|NCT01256398|Folic Acid|folic acid|mesh-list
83107580|NCT01256398|Cytarabine|cytarabine|mesh-list
83107581|NCT01256398|Dexamethasone|dexamethasone|mesh-list
83107582|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
83107583|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
83107584|NCT01256398|Melphalan|melphalan|mesh-list
83107585|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
83107586|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83107587|NCT01256398|Methotrexate|methotrexate|mesh-list
83107588|NCT01256398|Fludarabine|fludarabine|mesh-list
83107589|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
83107590|NCT01256398|Etoposide|etoposide|mesh-list
83107591|NCT01256398|Vincristine|vincristine|mesh-list
83107592|NCT01256398|Daunorubicin|daunorubicin|mesh-list
83107594|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
83107595|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
83107596|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
83107597|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107598|NCT01256398|Tacrolimus|tacrolimus|mesh-list
83107599|NCT01256398|Antibodies|antibodies|mesh-list
83107600|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
83107601|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107602|NCT01256398|Lenograstim|lenograstim|mesh-list
83107603|NCT01256398|BB 1101|bb 1101|mesh-list
83107604|NCT01256398|Calcium|calcium|mesh-list
83107605|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
83107606|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107607|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
83107608|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107609|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107610|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107611|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
83107612|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107613|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107614|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107615|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83107616|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
83107617|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
83107618|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107619|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83107620|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
83107621|NCT01256398|Hormones|hormones|mesh-ancestor
83107622|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107623|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83107624|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
83107625|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107626|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83107627|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83107628|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83107629|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
83107630|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83107631|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107632|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
83107633|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107634|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83107635|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83107636|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107637|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107638|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107639|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
83107640|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107641|NCT01256398|Antidotes|antidotes|mesh-ancestor
83107642|NCT01256398|Protective Agents|protective agents|mesh-ancestor
83107643|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
83107644|NCT01256398|Vitamins|vitamins|mesh-ancestor
83107645|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
83107646|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83107647|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83107648|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107649|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107650|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107651|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107652|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107653|NCT01256398|Hematinics|hematinics|mesh-ancestor
83107654|NCT01175356|Vitamin A|vitamin a|mesh-list
83107655|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
83107656|NCT01175356|Melphalan|melphalan|mesh-list
83107657|NCT01175356|Busulfan|busulfan|mesh-list
83107658|NCT01175356|Mechlorethamine|mechlorethamine|mesh-list
83107659|NCT01175356|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83107660|NCT01175356|Cisplatin|cisplatin|mesh-list
83107661|NCT01175356|Doxorubicin|doxorubicin|mesh-list
83107662|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83107663|NCT01175356|Etoposide|etoposide|mesh-list
83107664|NCT01175356|Vincristine|vincristine|mesh-list
83107665|NCT01175356|Topotecan|topotecan|mesh-list
83107666|NCT01175356|Tretinoin|tretinoin|mesh-list
83107667|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
83107668|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83107669|NCT01175356|Isotretinoin|isotretinoin|mesh-list
83107670|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107671|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
83107672|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107673|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107674|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107675|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
83107676|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107677|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107678|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107679|NCT01175356|Vitamins|vitamins|mesh-ancestor
83107680|NCT01175356|Micronutrients|micronutrients|mesh-ancestor
83107681|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107682|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107683|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107684|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107685|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107686|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107687|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107688|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107689|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83107690|NCT01175356|Keratolytic Agents|keratolytic agents|mesh-ancestor
83107691|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107692|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83107693|NCT01081262|Paclitaxel|paclitaxel|mesh-list
83107694|NCT01081262|Bevacizumab|bevacizumab|mesh-list
83107695|NCT01081262|Carboplatin|carboplatin|mesh-list
83107696|NCT01081262|Capecitabine|capecitabine|mesh-list
83107697|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
83107698|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83107699|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107700|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
83107702|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
83107703|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107704|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
83107705|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107706|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107707|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107708|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107709|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107710|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107711|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83107712|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83107713|NCT01081262|Growth Substances|growth substances|mesh-ancestor
83107714|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107715|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
83107716|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
83107717|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107718|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
83107719|NCT01020383|Abciximab|abciximab|mesh-list
83107720|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
83107721|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83107722|NCT00977574|Sirolimus|sirolimus|mesh-list
83107723|NCT00977574|Paclitaxel|paclitaxel|mesh-list
83107724|NCT00977574|Epothilones|epothilones|mesh-list
83107725|NCT00977574|Epothilone B|epothilone b|mesh-list
83107726|NCT00977574|Bevacizumab|bevacizumab|mesh-list
83107727|NCT00977574|Carboplatin|carboplatin|mesh-list
83107728|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83107729|NCT00977574|Temsirolimus|temsirolimus|mesh-list
83107730|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107731|NCT00977574|MTOR Inhibitors|mtor inhibitors|mesh-list
83107732|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
83107733|NCT00977574|Antibodies|antibodies|mesh-list
83107734|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
83107735|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107736|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
83107737|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107738|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107739|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107740|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107741|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107742|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107743|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83107744|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83107745|NCT00977574|Growth Substances|growth substances|mesh-ancestor
83107746|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107747|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
83107748|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
83107749|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83107750|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107751|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107752|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
83107753|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107754|NCT00977574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107755|NCT00977574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107757|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83107758|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107759|NCT00673010|Iodine|iodine|mesh-list
83107760|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83107761|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107762|NCT00673010|Trace Elements|trace elements|mesh-ancestor
83107763|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
83107764|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107765|NCT00587067|Floxuridine|floxuridine|mesh-list
83107766|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107767|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
83107768|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107769|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107770|NCT00577278|Sirolimus|sirolimus|mesh-list
83107771|NCT00577278|Rituximab|rituximab|mesh-list
83107772|NCT00577278|Fludarabine|fludarabine|mesh-list
83107773|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
83107774|NCT00577278|Melphalan|melphalan|mesh-list
83107775|NCT00577278|Tacrolimus|tacrolimus|mesh-list
83107776|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107777|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107778|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107779|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
83107780|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107781|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107782|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107783|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
83107784|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107785|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107786|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83107787|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107788|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83107789|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83107790|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107791|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
83107792|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107793|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
83107794|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107795|NCT00453154|Cisplatin|cisplatin|mesh-list
83107796|NCT00453154|Carboplatin|carboplatin|mesh-list
83107797|NCT00453154|Etoposide|etoposide|mesh-list
83107798|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
83107799|NCT00453154|Sunitinib|sunitinib|mesh-list
83107800|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
83107801|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107802|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107803|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107804|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107805|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107806|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107807|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83107808|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83107809|NCT00453154|Growth Substances|growth substances|mesh-ancestor
83107810|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107811|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
83107812|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83107813|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
83107814|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107815|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107816|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107817|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107818|NCT00334815|Bevacizumab|bevacizumab|mesh-list
83107819|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107820|NCT00334815|Cisplatin|cisplatin|mesh-list
83107821|NCT00334815|Docetaxel|docetaxel|mesh-list
83107822|NCT00334815|Etoposide|etoposide|mesh-list
83107823|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
83107824|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
83107825|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
83107826|NCT00334815|Antibodies|antibodies|mesh-list
83107827|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
83107828|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107829|NCT00334815|Lenograstim|lenograstim|mesh-list
83107830|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
83107831|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107832|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83107833|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83107834|NCT00334815|Growth Substances|growth substances|mesh-ancestor
83107835|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107836|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83107837|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
83107838|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107839|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107840|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107841|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107842|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107843|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107844|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107845|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107846|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83107847|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
83107848|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107849|NCT00309257|Valsartan|valsartan|mesh-list
83107850|NCT00309257|Benazepril|benazepril|mesh-list
83107851|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83107852|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83107853|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83107854|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107855|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83107856|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
83107857|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107859|NCT00258960|Doxorubicin|doxorubicin|mesh-list
83107860|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83107861|NCT00258960|Trastuzumab|trastuzumab|mesh-list
83107862|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107863|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
83107864|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107865|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107866|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107867|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
83107868|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107869|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107870|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107871|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107872|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107873|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107874|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107875|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107876|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
83107877|NCT00121992|Docetaxel|docetaxel|mesh-list
83107878|NCT00121992|Doxorubicin|doxorubicin|mesh-list
83107879|NCT00121992|Fluorouracil|fluorouracil|mesh-list
83107880|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107881|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
83107882|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107883|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107884|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107885|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
83107886|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107887|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107888|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107889|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107890|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107891|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107892|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107893|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107894|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107895|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107896|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
83107897|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107898|NCT00070564|Paclitaxel|paclitaxel|mesh-list
83107899|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
83107900|NCT00070564|Doxorubicin|doxorubicin|mesh-list
83107901|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83107902|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107903|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107904|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107905|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107906|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107907|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107908|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107909|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
83107910|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107911|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107912|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83107913|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
83107914|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83107915|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83107916|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83107917|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83107918|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83107919|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
83107920|NCT05158647|Analgesics|analgesics|mesh-ancestor
83107921|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
83107922|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107923|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107924|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
83107925|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83107926|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83107927|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
83107928|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83107929|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83107930|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107931|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83107932|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
83107933|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83107934|NCT02738151|Insulin|insulin|mesh-list
83107935|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83107936|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
83107937|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83107938|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107939|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
83107940|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
83107941|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83107942|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83107943|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107944|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83107945|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83107946|NCT03471039|Growth Substances|growth substances|mesh-ancestor
83107947|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107948|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
83107949|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83107950|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107951|NCT03472677|Capsaicin|capsaicin|mesh-list
83107952|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
83107953|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
83107954|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
83107955|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107956|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107957|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83107958|NCT02673567|Antibodies|antibodies|mesh-list
83107959|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
83107960|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83107961|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
83107962|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107963|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107964|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83107965|NCT00702195|Hormones|hormones|mesh-ancestor
83107966|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83107967|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107968|NCT02993731|Paclitaxel|paclitaxel|mesh-list
83107969|NCT02993731|Gemcitabine|gemcitabine|mesh-list
83107970|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83107971|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107972|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
83107973|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
83107974|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
83107975|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107976|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83107977|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
83107978|NCT02915159|Abatacept|abatacept|mesh-list
83528514|NCT00085735|Vincristine|vincristine|mesh-list
83107979|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83107980|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83107981|NCT02915159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83107982|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83107983|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83107984|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
83467966|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
83107985|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107986|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83107987|NCT03669263|Fentanyl|fentanyl|mesh-list
83107988|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83107989|NCT03669263|Narcotics|narcotics|mesh-ancestor
83107990|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83107991|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83107992|NCT03669263|Analgesics|analgesics|mesh-ancestor
83107993|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
83107994|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83107995|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83107996|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83107997|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
83107998|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
83107999|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83108000|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108001|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108002|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
83108003|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108004|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108005|NCT02521870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83108006|NCT02521870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108007|NCT02385656|Modafinil|modafinil|mesh-list
83108008|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83108009|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108010|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83108011|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83108012|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83108013|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108014|NCT02389868|Lovastatin|lovastatin|mesh-list
83108015|NCT02389868|L 647318|l 647318|mesh-list
83108016|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
83108017|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83108018|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83108019|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
83108020|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108021|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83108022|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83108023|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108024|NCT03623087|Dexamethasone|dexamethasone|mesh-list
83108025|NCT03623087|Gemcitabine|gemcitabine|mesh-list
83108026|NCT03623087|Etoposide|etoposide|mesh-list
83108027|NCT03623087|Asparaginase|asparaginase|mesh-list
83108028|NCT03623087|Ifosfamide|ifosfamide|mesh-list
83108029|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108030|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
83108031|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
83108032|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108033|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108034|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108035|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
83108036|NCT03623087|Hormones|hormones|mesh-ancestor
83108037|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83108038|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83108039|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108040|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83108041|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
83108042|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108043|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83108044|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83108045|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83108046|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108047|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83108048|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
83108049|NCT05420636|Paclitaxel|paclitaxel|mesh-list
83108050|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83108051|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108052|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
83108053|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
83108054|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
83108055|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108056|NCT05066308|Cannabidiol|cannabidiol|mesh-list
83108057|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
83108058|NCT03113396|Baclofen|baclofen|mesh-list
83108059|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83108060|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108061|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83108062|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108063|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83108064|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
83108065|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
83108066|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108067|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108068|NCT05065372|Metformin|metformin|mesh-list
83108069|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108070|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108071|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
83108072|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108073|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
83108074|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108075|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108076|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83108077|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
83108078|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83108079|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
83108080|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108081|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83108082|NCT03693170|Cetuximab|cetuximab|mesh-list
83108083|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108084|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108085|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
83108086|NCT05062954|Procyanidin|procyanidin|mesh-list
83108087|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
83108088|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108089|NCT05062954|Protective Agents|protective agents|mesh-ancestor
83108090|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108091|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83108092|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83108093|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108094|NCT05048524|Leucovorin|leucovorin|mesh-list
83108095|NCT05048524|Gemcitabine|gemcitabine|mesh-list
83108096|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
83108097|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83108098|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
83108099|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108100|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108101|NCT05048524|Antidotes|antidotes|mesh-ancestor
83108102|NCT05048524|Protective Agents|protective agents|mesh-ancestor
83108103|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108104|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
83108105|NCT05048524|Vitamins|vitamins|mesh-ancestor
83108106|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
83108107|NCT02389400|Methotrexate|methotrexate|mesh-list
83108108|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83108109|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
83108110|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83108111|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108112|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83108113|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
83108114|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108115|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108116|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
83108117|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108118|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83108119|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83108120|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
83108121|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108122|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83108123|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
83108124|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83108125|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
83108126|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108127|NCT05059600|Pregnanolone|pregnanolone|mesh-list
83108128|NCT05059600|Brexanolone|brexanolone|mesh-list
83108130|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108131|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108132|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
83108133|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108134|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108135|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
83108136|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
83108137|NCT03669029|Golimumab|golimumab|mesh-list
83108138|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83108139|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83108140|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108141|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83108142|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
83108143|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108144|NCT03668015|Sorbitol|sorbitol|mesh-list
83108145|NCT03668015|Cathartics|cathartics|mesh-ancestor
83108146|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108147|NCT02385734|Mitogens|mitogens|mesh-list
83108148|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83108149|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108150|NCT02385500|Fesoterodine|fesoterodine|mesh-list
83108151|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83108152|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83108153|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
83108154|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108155|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108156|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108157|NCT02385500|Urological Agents|urological agents|mesh-ancestor
83108158|NCT05058976|Vitamin D|vitamin d|mesh-list
83108159|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
83108160|NCT05058976|Calcium|calcium|mesh-list
83108161|NCT05058976|Vitamins|vitamins|mesh-ancestor
83108162|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
83108163|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108164|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83108165|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83108166|NCT02385422|Propranolol|propranolol|mesh-list
83108167|NCT02385422|Carvedilol|carvedilol|mesh-list
83108168|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83108169|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83108170|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
83108171|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108172|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108173|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108174|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83108175|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83108176|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
83108177|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
83108178|NCT02385422|Protective Agents|protective agents|mesh-ancestor
83108179|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83108180|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83108181|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83108182|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83108183|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83108184|NCT02520388|Methylphenidate|methylphenidate|mesh-list
83108185|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83108186|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108187|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83108188|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83108189|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83108190|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108191|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
83108192|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108193|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83108194|NCT03667937|Laxatives|laxatives|mesh-ancestor
83108195|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108196|NCT03667235|Glutaral|glutaral|mesh-list
83108197|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
83108198|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108199|NCT02668640|Adalimumab|adalimumab|mesh-list
83108200|NCT02668640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83108201|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108202|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108203|NCT05043766|Naltrexone|naltrexone|mesh-list
83108204|NCT05043766|Oxycodone|oxycodone|mesh-list
83108205|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83108206|NCT05043766|Narcotics|narcotics|mesh-ancestor
83108207|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108208|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108209|NCT05043766|Analgesics|analgesics|mesh-ancestor
83108210|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
83108211|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108212|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83108213|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83108214|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
83108215|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83108216|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
83108217|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83108218|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108219|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108220|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108221|NCT03011333|Epinephrine|epinephrine|mesh-list
83108222|NCT03011333|Bupivacaine|bupivacaine|mesh-list
83108223|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
83108224|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
83108225|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108226|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108227|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
83108228|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108229|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83108230|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83108231|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
83108232|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108233|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108234|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83108235|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83108236|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
83108237|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83108238|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
83108239|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
83108240|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
83108241|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83108242|NCT04570397|Ravulizumab|ravulizumab|mesh-list
83108243|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83108244|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83108245|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
83108246|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108247|NCT02385188|Acetaminophen|acetaminophen|mesh-list
83108248|NCT02385188|Imiquimod|imiquimod|mesh-list
83108249|NCT02385188|Lidocaine|lidocaine|mesh-list
83108250|NCT02385188|Petrolatum|petrolatum|mesh-list
83108251|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
83108252|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
83108253|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108254|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108255|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
83108256|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108257|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83108258|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83108259|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83108260|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83108261|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108262|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83108263|NCT02385188|Analgesics|analgesics|mesh-ancestor
83108264|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
83108265|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83108266|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
83108267|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108268|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
83108269|NCT02385188|Emollients|emollients|mesh-ancestor
83108270|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83108271|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83108272|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83108273|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108274|NCT02384954|Rituximab|rituximab|mesh-list
83108275|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108276|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108277|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
83108278|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108279|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108280|NCT02384876|Ephedrine|ephedrine|mesh-list
83108281|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
83108282|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83108283|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83108284|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108285|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
83108286|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
83108287|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108288|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83108289|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
83108290|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108291|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108292|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83108293|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83108294|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
83108295|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
83108296|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
83108297|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
83108298|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108299|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108300|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83108301|NCT02377388|Saxagliptin|saxagliptin|mesh-list
83108302|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108303|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108304|NCT02377388|Incretins|incretins|mesh-ancestor
83108306|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83108307|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83108308|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83108309|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108310|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108311|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83108312|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
83108313|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
83108314|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108315|NCT02382146|Dexamethasone|dexamethasone|mesh-list
83108316|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
83108317|NCT02382146|Ondansetron|ondansetron|mesh-list
83108318|NCT02382146|BB 1101|bb 1101|mesh-list
83108319|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108320|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
83108321|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
83108322|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108323|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108324|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108325|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
83108326|NCT02382146|Hormones|hormones|mesh-ancestor
83108327|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83108328|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83108329|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108330|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
83108331|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108332|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108333|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
83108334|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
83467993|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83108335|NCT02382146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83108336|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83108337|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
83108338|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108339|NCT02382068|Dexamethasone|dexamethasone|mesh-list
83108340|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108341|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
83108342|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
83108343|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108344|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108345|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108346|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
83108347|NCT02382068|Hormones|hormones|mesh-ancestor
83108348|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83108349|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83108350|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108351|NCT04731272|Dulaglutide|dulaglutide|mesh-list
83108352|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108353|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108354|NCT02381600|Vitamin D|vitamin d|mesh-list
83108355|NCT02381600|Vitamins|vitamins|mesh-ancestor
83108356|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
83108357|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108358|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83108359|NCT03113084|Heparin|heparin|mesh-list
83108360|NCT03113084|Calcium heparin|calcium heparin|mesh-list
83108361|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
83108362|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83108363|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83108364|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108365|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
83108366|NCT02377076|Calcium|calcium|mesh-list
83108367|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83108368|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108369|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83108370|NCT04439474|Vitamin D|vitamin d|mesh-list
83108371|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
83108372|NCT04439474|Vitamins|vitamins|mesh-ancestor
83108373|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
83108374|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108375|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83108376|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83108377|NCT02662556|Sufentanil|sufentanil|mesh-list
83108378|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83108379|NCT02662556|Narcotics|narcotics|mesh-ancestor
83108380|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108381|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108383|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
83108384|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108385|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83108386|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83108387|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
83108388|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
83108389|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
83108390|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
83108391|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83108392|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
83108393|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108394|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
83108395|NCT04262336|Protective Agents|protective agents|mesh-ancestor
83108396|NCT04262336|Antidotes|antidotes|mesh-ancestor
83108397|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
83108398|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108399|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
83108400|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83108401|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108402|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
83108403|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
83108404|NCT02376452|Leucovorin|leucovorin|mesh-list
83108405|NCT02376452|Fluorouracil|fluorouracil|mesh-list
83108406|NCT02376452|Raltitrexed|raltitrexed|mesh-list
83108407|NCT02376452|Irinotecan|irinotecan|mesh-list
83108408|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
83467995|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83108409|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108410|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83108411|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108412|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83108413|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
83108414|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108415|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83108416|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83108417|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108418|NCT02376452|Antidotes|antidotes|mesh-ancestor
83108419|NCT02376452|Protective Agents|protective agents|mesh-ancestor
83108420|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
83108421|NCT02376452|Vitamins|vitamins|mesh-ancestor
83108422|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
83108423|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83108424|NCT02516098|Scopolamine|scopolamine|mesh-list
83108425|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83108426|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83108427|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
83108428|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
83108429|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108430|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108431|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108432|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
83108433|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83108434|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
83108435|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108436|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108437|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83108438|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
83108439|NCT02372318|Nalmefene|nalmefene|mesh-list
83108440|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83108441|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108442|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
83108443|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108444|NCT03105674|Anesthetics|anesthetics|mesh-list
83108445|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
83108446|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108447|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108448|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
83108449|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108450|NCT02380898|Ketorolac|ketorolac|mesh-list
83108451|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83108452|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83108453|NCT02380898|Analgesics|analgesics|mesh-ancestor
83108454|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
83108455|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108456|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108457|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108458|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108459|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83108460|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108461|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108462|NCT02376296|Docetaxel|docetaxel|mesh-list
83108463|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108464|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
83108465|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
83108466|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
83108467|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108468|NCT01364428|Insulin|insulin|mesh-list
83108469|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83108470|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
83108471|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108472|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108473|NCT02380586|Anesthetics|anesthetics|mesh-list
83108474|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108475|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108476|NCT02375828|Glyburide|glyburide|mesh-list
83108477|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108478|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108479|NCT02371226|Insulin|insulin|mesh-list
83108480|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83108481|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108482|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108483|NCT02371304|Capecitabine|capecitabine|mesh-list
83108484|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83108485|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
83108486|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108487|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108488|NCT02380352|Amoxicillin|amoxicillin|mesh-list
83108489|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83108490|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108491|NCT02380118|Midazolam|midazolam|mesh-list
83108492|NCT02380118|Haloperidol|haloperidol|mesh-list
83108493|NCT02380118|Olanzapine|olanzapine|mesh-list
83108494|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
83108495|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83108496|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83108497|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108498|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108499|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83108500|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83108501|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83108502|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83108503|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
83108504|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
83108505|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
83108506|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
83108507|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83483505|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83108508|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108509|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
83108510|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
83108511|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108512|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108513|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83108514|NCT02380118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83108515|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83108516|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83108517|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
83108518|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83108519|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
83108520|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83108521|NCT03113708|Heparin|heparin|mesh-list
83108522|NCT03113708|Calcium heparin|calcium heparin|mesh-list
83108523|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
83108524|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83108525|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83108526|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108527|NCT02371148|Rituximab|rituximab|mesh-list
83108528|NCT02371148|Bortezomib|bortezomib|mesh-list
83108529|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83108530|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108531|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108532|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
83108533|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108534|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108535|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83108536|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
83108537|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108538|NCT02375360|Immunomodulating Agents|immunomodulating agents|mesh-list
83108539|NCT02375360|Immunologic Factors|immunologic factors|mesh-ancestor
83108540|NCT02375360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108541|NCT02370680|Aspirin|aspirin|mesh-list
83108542|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83108543|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83108544|NCT02370680|Analgesics|analgesics|mesh-ancestor
83108545|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
83108546|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108547|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108548|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108549|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108550|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83108551|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83108552|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108553|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83108554|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83108555|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108556|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
83108557|NCT02370758|Valganciclovir|valganciclovir|mesh-list
83108558|NCT02370758|Ganciclovir|ganciclovir|mesh-list
83108559|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83108560|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
83108561|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108562|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83108563|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108564|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108565|NCT04661150|Capecitabine|capecitabine|mesh-list
83108566|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
83108567|NCT04661150|Trastuzumab|trastuzumab|mesh-list
83108568|NCT04661150|Atezolizumab|atezolizumab|mesh-list
83108569|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83108570|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
83108571|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108572|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108573|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108574|NCT04661150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83108575|NCT02379026|Vitamin D|vitamin d|mesh-list
83108576|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
83108577|NCT02379026|Vitamins|vitamins|mesh-ancestor
83108578|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
83108579|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108580|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83108581|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83108582|NCT02991859|Fluticasone|fluticasone|mesh-list
83108585|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108586|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83108587|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
83108588|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108589|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108590|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83108591|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
83108592|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
83108593|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83108594|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
83108595|NCT02991859|Hormones|hormones|mesh-ancestor
83108596|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83108597|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
83108598|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83108599|NCT02374736|Antibodies|antibodies|mesh-list
83108600|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
83108601|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
83108602|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108603|NCT02369978|Benzonidazole|benzonidazole|mesh-list
83108604|NCT02369978|Nifurtimox|nifurtimox|mesh-list
83108605|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83108606|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
83108607|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108608|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83108609|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83108610|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83108611|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108612|NCT03661489|Propofol|propofol|mesh-list
83108613|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83108614|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108615|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108616|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83108617|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
83108618|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
83108619|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83108620|NCT04056169|Ezetimibe|ezetimibe|mesh-list
83108621|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83108622|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83108623|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
83108624|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108625|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83108626|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83108627|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108628|NCT05030194|Nicotine|nicotine|mesh-list
83108629|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83108630|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
83108631|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108632|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108633|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83108634|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83108635|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
83108636|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108637|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108638|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83108639|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83108640|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
83108641|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108642|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83108643|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108644|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83108645|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108646|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83108647|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83108648|NCT03008915|Aspirin|aspirin|mesh-list
83108649|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83108650|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
83108651|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83108652|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83108653|NCT03008915|Analgesics|analgesics|mesh-ancestor
83108654|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
83108655|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108656|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108657|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108658|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108659|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83108660|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83108661|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108662|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83108663|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83108664|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108665|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
83108666|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83108667|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83108668|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
83108669|NCT03622489|Acetaminophen|acetaminophen|mesh-list
83108670|NCT03622489|Dipyrone|dipyrone|mesh-list
83108671|NCT03622489|Ibuprofen|ibuprofen|mesh-list
83108672|NCT03622489|Morphine|morphine|mesh-list
83108673|NCT03622489|Tramadol|tramadol|mesh-list
83108674|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83108675|NCT03622489|Narcotics|narcotics|mesh-ancestor
83108676|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108677|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108678|NCT03622489|Analgesics|analgesics|mesh-ancestor
83108679|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
83108680|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108681|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83108682|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
83108683|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83108684|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108685|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108686|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83108687|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108688|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108689|NCT03667001|Lidocaine|lidocaine|mesh-list
83108690|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
83108691|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
83108692|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108693|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108694|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
83108695|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108696|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83108697|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83108698|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83108699|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83483506|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83108700|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108701|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
83108702|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
83108703|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83108704|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83108705|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108706|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108707|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108708|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108709|NCT03666299|Lidocaine|lidocaine|mesh-list
83108710|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
83108711|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
83108712|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108713|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108714|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
83108715|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108716|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83108717|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83108718|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83108719|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83108720|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108721|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
83108722|NCT03591380|Belimumab|belimumab|mesh-list
83108723|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83108724|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
83108725|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108726|NCT04057469|Tulobuterol|tulobuterol|mesh-list
83108727|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83108728|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83108729|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
83108730|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108731|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108732|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108733|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83108734|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
83108735|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108736|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83108737|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
83108738|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
83108739|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108740|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108741|NCT03658291|Levofloxacin|levofloxacin|mesh-list
83108742|NCT03658291|Ofloxacin|ofloxacin|mesh-list
83108743|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83108744|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108745|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83108746|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83108747|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83108748|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468028|NCT05481112|Buprenorphine|buprenorphine|mesh-list
83108749|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108750|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108751|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83108752|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83108753|NCT03658213|Goserelin|goserelin|mesh-list
83108754|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83108755|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108756|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
83108757|NCT03006887|Lenvatinib|lenvatinib|mesh-list
83108758|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108759|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108760|NCT03006887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83108761|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108762|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83108763|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108764|NCT02377856|Interferons|interferons|mesh-list
83108765|NCT02377856|Ribavirin|ribavirin|mesh-list
83108766|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
83108767|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
83108768|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83108769|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108770|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
83108771|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108772|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
83108773|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108774|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
83108775|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108776|NCT02377778|Thiopental|thiopental|mesh-list
83108777|NCT02377778|Propofol|propofol|mesh-list
83108778|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83108779|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108780|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108781|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83108782|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
83108783|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
83108784|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
83108785|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
83108786|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
83108787|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108788|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108789|NCT02514772|Rituximab|rituximab|mesh-list
83108790|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108791|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108792|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
83108793|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108794|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108795|NCT03658057|Rocuronium|rocuronium|mesh-list
83108796|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83108797|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83108798|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83108799|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108800|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108801|NCT03657979|Ropivacaine|ropivacaine|mesh-list
83108802|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
83108803|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
83108804|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108805|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108806|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
83108807|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108808|NCT03659851|Simendan|simendan|mesh-list
83108809|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83108810|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
83108811|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83468036|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83108812|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83108813|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108814|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108815|NCT03659851|Protective Agents|protective agents|mesh-ancestor
83108816|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108817|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83108818|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108819|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83108820|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
83108821|NCT02368730|Coagulants|coagulants|mesh-ancestor
83108822|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83108823|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
83108824|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108825|NCT03659305|Bevacizumab|bevacizumab|mesh-list
83108826|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108827|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108828|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83108829|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83108830|NCT03659305|Growth Substances|growth substances|mesh-ancestor
83108831|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108832|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
83108833|NCT02788981|Paclitaxel|paclitaxel|mesh-list
83108834|NCT02788981|Mifepristone|mifepristone|mesh-list
83483507|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
83108835|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83108836|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108837|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83108838|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83108839|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83108840|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108841|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83108842|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
83108843|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83108844|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108845|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83108846|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83108847|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83108848|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
83108849|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83108850|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83108851|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
83108852|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83108853|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
83108854|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83108855|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83108856|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83108857|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83108858|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
83108859|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83108860|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
83108861|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83108862|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108863|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83108864|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83108865|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108866|NCT02373722|Petrolatum|petrolatum|mesh-list
83108867|NCT02373722|Mineral Oil|mineral oil|mesh-list
83108868|NCT02373722|Emollients|emollients|mesh-ancestor
83108869|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
83108870|NCT03000179|Avelumab|avelumab|mesh-list
83108871|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83108872|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108873|NCT03658993|Rifaximin|rifaximin|mesh-list
83108874|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83108875|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83108876|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108877|NCT02373410|Bupivacaine|bupivacaine|mesh-list
83108878|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
83108879|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
83108880|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108881|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108882|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
83108883|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108884|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83108885|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108886|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
83108887|NCT02920177|Hormones|hormones|mesh-ancestor
83108888|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83108889|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108890|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83108891|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
83108892|NCT03006341|Telmisartan|telmisartan|mesh-list
83108893|NCT03006341|Warfarin|warfarin|mesh-list
83108894|NCT03006341|Dabigatran|dabigatran|mesh-list
83108895|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
83108896|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83108897|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83108898|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83108899|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108900|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
83108901|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83108902|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
83108903|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108904|NCT05022784|Nintedanib|nintedanib|mesh-list
83108905|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108906|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83108907|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108908|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108909|NCT04413799|Lidocaine|lidocaine|mesh-list
83108910|NCT04413799|Ketamine|ketamine|mesh-list
83108911|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
83108912|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
83108913|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108914|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108915|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
83108916|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108917|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83108918|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83108919|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83108920|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83108921|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108922|NCT04413799|Analgesics|analgesics|mesh-ancestor
83108923|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83108924|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83108925|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
83108926|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83108927|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83108928|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108929|NCT03665753|Ketorolac|ketorolac|mesh-list
83108930|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83108931|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83108932|NCT03665753|Analgesics|analgesics|mesh-ancestor
83108933|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
83108934|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108935|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108936|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108937|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108938|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83108939|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108940|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108941|NCT02512042|Brinzolamide|brinzolamide|mesh-list
83108942|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83108943|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108944|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108945|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83108946|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83108947|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83108948|NCT04386746|Gemcitabine|gemcitabine|mesh-list
83108949|NCT04386746|Docetaxel|docetaxel|mesh-list
83108950|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83108951|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
83108952|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108953|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83108954|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
83108955|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
83108956|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
83108957|NCT01066897|Pramipexole|pramipexole|mesh-list
83108958|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
83108959|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108960|NCT01066897|Protective Agents|protective agents|mesh-ancestor
83108961|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108962|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83108963|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83108964|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
83108965|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
83108966|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108967|NCT02373254|Acetaminophen|acetaminophen|mesh-list
83108968|NCT02373254|Ibuprofen|ibuprofen|mesh-list
83108969|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83108970|NCT02373254|Hydrocodone|hydrocodone|mesh-list
83108971|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83108972|NCT02373254|Analgesics|analgesics|mesh-ancestor
83108973|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
83528589|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
83108974|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83108975|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108976|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
83108977|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83108978|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83108979|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83108980|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83108981|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83108982|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108983|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83108984|NCT02373254|Narcotics|narcotics|mesh-ancestor
83108985|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108986|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
83108987|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
83108988|NCT03657355|Zolpidem|zolpidem|mesh-list
83108989|NCT03657355|Suvorexant|suvorexant|mesh-list
83108990|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83108991|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83108992|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83108993|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83108994|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83108995|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
83108996|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
83108997|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83108998|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83108999|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83109000|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
83109001|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83109002|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
83109003|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83109004|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109005|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83109006|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83109007|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83109008|NCT02365532|Dofetilide|dofetilide|mesh-list
83109009|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83109010|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83109011|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109012|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109013|NCT03113162|Cytarabine|cytarabine|mesh-list
83109014|NCT03113162|Etoposide|etoposide|mesh-list
83109015|NCT03113162|Melphalan|melphalan|mesh-list
83109016|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83109017|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109018|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83109019|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83109020|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109021|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109022|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83109023|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
83109024|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
83109025|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109026|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83109027|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
83109028|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109029|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83109030|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
83109031|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83109032|NCT02356705|Lidocaine|lidocaine|mesh-list
83109033|NCT02356705|Midazolam|midazolam|mesh-list
83109034|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83109035|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83109036|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109037|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109038|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83109039|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83109040|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83109041|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83109042|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
83109043|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
83109044|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
83109045|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
83109046|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109047|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109048|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
83109049|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
83109050|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83468104|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
83109051|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83109052|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83109053|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83109054|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109055|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
83109057|NCT03541850|Hormones|hormones|mesh-list
83109058|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83109059|NCT03541850|Androgens|androgens|mesh-list
83109060|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
83109061|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109062|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109063|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
83109064|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109065|NCT03541850|Protective Agents|protective agents|mesh-ancestor
83109066|NCT03541850|Vitamins|vitamins|mesh-ancestor
83109067|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
83109068|NCT03541850|Estrogens|estrogens|mesh-ancestor
83109069|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83109070|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109071|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
83109072|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
83109073|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
83109074|NCT02511184|Crizotinib|crizotinib|mesh-list
83109075|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83109076|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109077|NCT02511184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83109078|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109079|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83109080|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109081|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
83109082|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83109083|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83109084|NCT02367560|Prednisolone|prednisolone|mesh-list
83109085|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
83109086|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83109087|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
83109088|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109089|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
83109090|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
83109091|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109092|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109093|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109094|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
83109095|NCT02367560|Hormones|hormones|mesh-ancestor
83109096|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109097|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83109098|NCT02367560|Protective Agents|protective agents|mesh-ancestor
83109099|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83109100|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109101|NCT02372942|Progesterone|progesterone|mesh-list
83109102|NCT02372942|Progestins|progestins|mesh-ancestor
83109103|NCT02372942|Hormones|hormones|mesh-ancestor
83109104|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109105|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109106|NCT02364986|Interferons|interferons|mesh-list
83109107|NCT02364986|Interferon-beta|interferon-beta|mesh-list
83109108|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
83109109|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109110|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
83109111|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109112|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
83109113|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109114|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83109115|NCT02372786|Lidocaine|lidocaine|mesh-list
83109116|NCT02372786|Tetracaine|tetracaine|mesh-list
83109117|NCT02372786|Prilocaine|prilocaine|mesh-list
83109118|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
83109119|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
83109120|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109121|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109122|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
83109123|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109124|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83109125|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83109126|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83109127|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109128|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109129|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83109130|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83109131|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83109133|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109134|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109135|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109136|NCT02367404|Analgesics|analgesics|mesh-ancestor
83109137|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
83109138|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109139|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
83109140|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83109141|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
83109142|NCT03715946|Nivolumab|nivolumab|mesh-list
83109143|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83109144|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109145|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83109146|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109147|NCT02367248|Deferoxamine|deferoxamine|mesh-list
83109148|NCT02367248|Siderophores|siderophores|mesh-ancestor
83109149|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83109150|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
83109151|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
83109152|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109153|NCT03656965|Acyclovir|acyclovir|mesh-list
83109154|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
83109155|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109156|NCT02384239|Tamoxifen|tamoxifen|mesh-list
83109157|NCT02384239|Fulvestrant|fulvestrant|mesh-list
83109158|NCT02384239|Palbociclib|palbociclib|mesh-list
83109159|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83109160|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
83109161|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109162|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109163|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83109164|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109165|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83109166|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83109167|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83109168|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83109169|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83109170|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109171|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109172|NCT02364752|Diuretics|diuretics|mesh-list
83109173|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83109174|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
83109175|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109176|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109177|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109178|NCT02372240|Dexamethasone|dexamethasone|mesh-list
83109179|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109180|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
83109181|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
83109182|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109183|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109184|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109185|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
83109186|NCT02372240|Hormones|hormones|mesh-ancestor
83109187|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109188|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83109189|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109190|NCT02364206|Temozolomide|temozolomide|mesh-list
83109191|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83109192|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
83109193|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109194|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109195|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
83109196|NCT02366546|Fludarabine|fludarabine|mesh-list
83109197|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83109198|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
83109199|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109200|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109201|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83109202|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
83109203|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109204|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109205|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83109207|NCT03029702|Glyburide|glyburide|mesh-list
83109208|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83109209|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109210|NCT02364362|Docetaxel|docetaxel|mesh-list
83109211|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109212|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
83109213|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
83109214|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
83109215|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109216|NCT03004469|Finasteride|finasteride|mesh-list
83109217|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83109218|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83109219|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109220|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109221|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
83109222|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109223|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109224|NCT03004469|Urological Agents|urological agents|mesh-ancestor
83109225|NCT02358824|Amlodipine|amlodipine|mesh-list
83109226|NCT02358824|Telmisartan|telmisartan|mesh-list
83109227|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83109228|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83109229|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109230|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109231|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83109232|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109233|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
83109234|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83109235|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83109236|NCT02359136|Epinephrine|epinephrine|mesh-list
83109237|NCT02359136|Analgesics|analgesics|mesh-list
83109238|NCT02359136|Anesthetics|anesthetics|mesh-list
83109239|NCT02359136|Ropivacaine|ropivacaine|mesh-list
83109240|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109241|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109242|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
83109243|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
83109244|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109245|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83109246|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83109247|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109248|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109249|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109250|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83109251|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83109252|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
83109253|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83109254|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
83109255|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
83109256|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
83109257|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83109258|NCT02998151|Minocycline|minocycline|mesh-list
83109259|NCT02998151|Acamprosate|acamprosate|mesh-list
83109260|NCT02998151|Baclofen|baclofen|mesh-list
83109261|NCT02998151|Lovastatin|lovastatin|mesh-list
83109262|NCT02998151|L 647318|l 647318|mesh-list
83109263|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
83109264|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83109265|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109266|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83109267|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109268|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83109269|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109270|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83109271|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
83109272|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
83109273|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109274|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109275|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83109276|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83109277|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
83109279|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83109280|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109281|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83109282|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83109283|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83109284|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
83109285|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109286|NCT04057937|Apremilast|apremilast|mesh-list
83109287|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83109288|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83109289|NCT04057937|Analgesics|analgesics|mesh-ancestor
83109290|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
83109291|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109292|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109293|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109294|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109295|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83109296|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83109297|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109298|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109299|NCT01069523|Guanfacine|guanfacine|mesh-list
83109300|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83109301|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83109302|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83109303|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83109304|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109305|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109306|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109307|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109309|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
83109310|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83109311|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109312|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83109313|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
83468126|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109314|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109315|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109316|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83109317|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
83109318|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
83109319|NCT01069289|Hormones|hormones|mesh-ancestor
83109320|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109321|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83109322|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83109323|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83109324|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109325|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109326|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109327|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
83109328|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83109329|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109330|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83109331|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
83109332|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83109333|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109334|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109335|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109336|NCT02510794|Ranibizumab|ranibizumab|mesh-list
83109337|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83109338|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83109339|NCT02510794|Growth Substances|growth substances|mesh-ancestor
83109340|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109341|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
83109342|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109343|NCT04056923|Methylene Blue|methylene blue|mesh-list
83109344|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109345|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109346|NCT03664115|Itraconazole|itraconazole|mesh-list
83109347|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
83109348|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109349|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83109350|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83109351|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109352|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109353|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83109354|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
83109355|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109356|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109357|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83109358|NCT03664037|Dexamethasone|dexamethasone|mesh-list
83109359|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83109360|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109361|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
83109362|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
83109363|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109364|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109365|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109366|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
83109367|NCT03664037|Hormones|hormones|mesh-ancestor
83109368|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109369|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83109370|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109371|NCT04056845|Acetaminophen|acetaminophen|mesh-list
83109372|NCT04056845|Diclofenac|diclofenac|mesh-list
83109373|NCT04056845|Analgesics|analgesics|mesh-list
83109374|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83109375|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83109376|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
83109377|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109378|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109379|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109380|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109381|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83109382|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109383|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109385|NCT02510014|Buprenorphine|buprenorphine|mesh-list
83109386|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83109387|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83109388|NCT02510014|Narcotics|narcotics|mesh-ancestor
83109389|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109390|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109391|NCT02510014|Analgesics|analgesics|mesh-ancestor
83109392|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
83109393|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109394|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83109395|NCT02509312|Ketorolac|ketorolac|mesh-list
83109396|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83109397|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83109398|NCT02509312|Analgesics|analgesics|mesh-ancestor
83109399|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
83109400|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109401|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109402|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109403|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109404|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83109405|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109406|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109407|NCT02362958|Capecitabine|capecitabine|mesh-list
83109408|NCT02362958|Vinorelbine|vinorelbine|mesh-list
83109409|NCT02362958|Lapatinib|lapatinib|mesh-list
83109410|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83109411|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
83109412|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109413|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109414|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83109415|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
83109416|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
83109417|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
83109418|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83109419|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109420|NCT04973800|Simvastatin|simvastatin|mesh-list
83109421|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83109422|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83109423|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
83109424|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109425|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83109426|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83109427|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109428|NCT05020522|Phenobarbital|phenobarbital|mesh-list
83109429|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
83109430|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83109431|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109432|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109433|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83109434|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83109435|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109436|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109437|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
83109438|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
83109439|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83109440|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83109441|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83109442|NCT02519842|Dexamethasone|dexamethasone|mesh-list
83109443|NCT02519842|Ondansetron|ondansetron|mesh-list
83109444|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
83109445|NCT02519842|Aprepitant|aprepitant|mesh-list
83109446|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
83109447|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109448|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
83109449|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
83109450|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109451|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109452|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109453|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
83109454|NCT02519842|Hormones|hormones|mesh-ancestor
83109455|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109456|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83109457|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109458|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
83109459|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
83109460|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83109461|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
83109462|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109463|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109464|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83109465|NCT02509078|Cisatracurium|cisatracurium|mesh-list
83109466|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83109467|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83109468|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109469|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109470|NCT02993783|Vedolizumab|vedolizumab|mesh-list
83109471|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109472|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
83109473|NCT03661775|Analgesics|analgesics|mesh-ancestor
83109474|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
83109475|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109476|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109477|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
83109478|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109479|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83109480|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
83109481|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83109482|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109483|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109484|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83109485|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
83109486|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83109487|NCT03660761|Apatinib|apatinib|mesh-list
83109488|NCT03660761|Temozolomide|temozolomide|mesh-list
83109489|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109490|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83109491|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109492|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109493|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83109494|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
83109495|NCT02993471|Vitamin K|vitamin k|mesh-list
83109496|NCT02993471|Midazolam|midazolam|mesh-list
83109497|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
83109498|NCT02993471|Caffeine|caffeine|mesh-list
83109499|NCT02993471|Ixekizumab|ixekizumab|mesh-list
83109500|NCT02993471|Omeprazole|omeprazole|mesh-list
83109501|NCT02993471|Warfarin|warfarin|mesh-list
83109502|NCT02993471|Vitamins|vitamins|mesh-ancestor
83109503|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
83109504|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109505|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83109506|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83109507|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109508|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83109509|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83109510|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83109511|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83109512|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
83109513|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
83109514|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
83109515|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
83468163|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
83109516|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109517|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109518|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
83109519|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83109520|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83109521|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109522|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83109523|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83109524|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
83109525|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83109526|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109527|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83109528|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83109529|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83109530|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
83109531|NCT02993471|Coagulants|coagulants|mesh-ancestor
83109532|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
83109533|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
83109534|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83109535|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83109536|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
83109537|NCT01068743|Metformin|metformin|mesh-list
83109538|NCT01068743|Saxagliptin|saxagliptin|mesh-list
83109539|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83109540|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109541|NCT01068743|Incretins|incretins|mesh-ancestor
83109542|NCT01068743|Hormones|hormones|mesh-ancestor
83109543|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109544|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83109545|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
83109546|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109547|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109548|NCT03622541|Sorafenib|sorafenib|mesh-list
83109549|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109550|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83109551|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109552|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109553|NCT03658733|Amoxicillin|amoxicillin|mesh-list
83109554|NCT03658733|Tetracycline|tetracycline|mesh-list
83109555|NCT03658733|Furazolidone|furazolidone|mesh-list
83109556|NCT03658733|Esomeprazole|esomeprazole|mesh-list
83109557|NCT03658733|Rabeprazole|rabeprazole|mesh-list
83109558|NCT03658733|Bismuth|bismuth|mesh-list
83109559|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83109560|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109561|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83109562|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109563|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83109564|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109565|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109566|NCT03658733|Antacids|antacids|mesh-ancestor
83109567|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83109568|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83109569|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83109570|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83109571|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83109572|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83109573|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83109574|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
83109575|NCT04056143|Apixaban|apixaban|mesh-list
83109576|NCT04056143|Edoxaban|edoxaban|mesh-list
83109577|NCT04056143|Dabigatran|dabigatran|mesh-list
83109578|NCT04056143|Thromboplastin|thromboplastin|mesh-list
83109579|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83109580|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
83109581|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83109582|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
83109583|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109584|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109585|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
83109586|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
83109587|NCT04056143|Coagulants|coagulants|mesh-ancestor
83109588|NCT03661463|Aspirin|aspirin|mesh-list
83109589|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83109590|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83109591|NCT03661463|Analgesics|analgesics|mesh-ancestor
83109592|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
83109593|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109594|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109595|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109596|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109597|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83109598|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83109599|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109600|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83109601|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83109602|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109604|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
83109605|NCT03658421|Morphine|morphine|mesh-list
83109606|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83109607|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109608|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109609|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83109610|NCT03658421|Analgesics|analgesics|mesh-ancestor
83109611|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
83109612|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109613|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83109614|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83109615|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83109616|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109617|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109618|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109619|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83109620|NCT03658421|Narcotics|narcotics|mesh-ancestor
83109621|NCT03660293|Captopril|captopril|mesh-list
83109622|NCT03660293|Atorvastatin|atorvastatin|mesh-list
83109623|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83109624|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83109625|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
83109626|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109627|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83109628|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83109629|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109630|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83109631|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
83109632|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83109633|NCT02986139|Etanercept|etanercept|mesh-list
83109634|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83109635|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83109636|NCT02986139|Analgesics|analgesics|mesh-ancestor
83109637|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
83109638|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109639|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109640|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83109641|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109642|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109643|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83109644|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
83109645|NCT02906917|Insulin|insulin|mesh-list
83109646|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83109647|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
83109648|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
83109649|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
83109650|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83109651|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83109652|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109653|NCT01066585|Ivermectin|ivermectin|mesh-list
83109654|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83109655|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109656|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
83109657|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83109658|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
83109659|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109660|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109661|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83109662|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
83109663|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109665|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83109666|NCT02980783|Lidocaine|lidocaine|mesh-list
83109667|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
83109668|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
83109669|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109670|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109671|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
83109672|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109673|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83109674|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83109675|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83109676|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109677|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109678|NCT02989649|Metformin|metformin|mesh-list
83109679|NCT02989649|Pioglitazone|pioglitazone|mesh-list
83109680|NCT02989649|Alogliptin|alogliptin|mesh-list
83109681|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83109682|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109683|NCT02989649|Incretins|incretins|mesh-ancestor
83109684|NCT02989649|Hormones|hormones|mesh-ancestor
83109685|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109686|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83109687|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
83109688|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109689|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109690|NCT03659435|Rivastigmine|rivastigmine|mesh-list
83109691|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83109692|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109693|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109694|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
83109695|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109696|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109697|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83109698|NCT03659435|Protective Agents|protective agents|mesh-ancestor
83109699|NCT01067339|Darapladib|darapladib|mesh-list
83109700|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83109701|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109702|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109703|NCT04484675|Milrinone|milrinone|mesh-list
83109704|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83109705|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83109706|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
83109707|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83109708|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83109709|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109710|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109711|NCT04484675|Protective Agents|protective agents|mesh-ancestor
83109712|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109713|NCT03658109|Lidocaine|lidocaine|mesh-list
83109714|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
83109715|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
83109716|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83468194|NCT00002590|Etoposide|etoposide|mesh-list
83109717|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109718|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
83109719|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109720|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83109721|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83109722|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83109723|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109724|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109725|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
83109726|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83109727|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109728|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83109729|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109730|NCT03660917|Riluzole|riluzole|mesh-list
83109731|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
83109732|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83109733|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83109734|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83528738|NCT01889797|Rituximab|rituximab|mesh-list
83109735|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109736|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109737|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83109738|NCT03660917|Protective Agents|protective agents|mesh-ancestor
83109739|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
83109740|NCT02977507|Hydroquinone|hydroquinone|mesh-list
83109741|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83109742|NCT02977507|Protective Agents|protective agents|mesh-ancestor
83109743|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109744|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
83109745|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
83109746|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109747|NCT04471415|Atezolizumab|atezolizumab|mesh-list
83109748|NCT04471415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83109749|NCT04471415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109750|NCT04471415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83109751|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109752|NCT02976103|Analgesics|analgesics|mesh-list
83109753|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
83109754|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109755|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109756|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
83109757|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83109758|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109759|NCT03653845|Epinephrine|epinephrine|mesh-list
83109760|NCT03653845|Racepinephrine|racepinephrine|mesh-list
83109761|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
83109762|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83109763|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83109764|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109765|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109766|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109767|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109768|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83109769|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83109770|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
83109771|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109772|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83109773|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
83109774|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
83109775|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
83109776|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83109777|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83109778|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
83109779|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109780|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83109781|NCT01066039|Bisoprolol|bisoprolol|mesh-list
83109782|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83109783|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
83109784|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
83109785|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109786|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109787|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83109788|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83109789|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83109790|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109791|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109792|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109793|NCT04217967|Lenalidomide|lenalidomide|mesh-list
83109794|NCT04217967|Ixazomib|ixazomib|mesh-list
83109795|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
83109796|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109797|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83109798|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83109799|NCT04217967|Growth Substances|growth substances|mesh-ancestor
83109800|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
83109801|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109802|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
83109803|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109804|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109805|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83109806|NCT02919761|Hormones|hormones|mesh-ancestor
83109807|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109808|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109809|NCT02910167|Acetaminophen|acetaminophen|mesh-list
83109810|NCT02910167|Scopolamine|scopolamine|mesh-list
83109811|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83109812|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83109813|NCT02910167|Analgesics|analgesics|mesh-ancestor
83109814|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
83109815|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109816|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109817|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
83109818|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83109819|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
83109820|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
83109821|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83109822|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
83109823|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83109824|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83109825|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109826|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109827|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83109828|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
83109829|NCT04458285|Valsartan|valsartan|mesh-list
83109830|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83109831|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83109832|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83109833|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83468210|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83109834|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109835|NCT05156541|Interferons|interferons|mesh-list
83109836|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
83109837|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109838|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
83109839|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109840|NCT01067105|Ciclesonide|ciclesonide|mesh-list
83109841|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
83109842|NCT01067105|Hormones|hormones|mesh-ancestor
83109843|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83109844|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109845|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83109846|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
83109847|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83109848|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
83109849|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83109850|NCT03470649|Hematinics|hematinics|mesh-ancestor
83109851|NCT02910011|Doxycycline|doxycycline|mesh-list
83109852|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83109853|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109854|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
83109855|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83109856|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83109857|NCT04456803|Sevelamer|sevelamer|mesh-list
83109858|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
83109859|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
83109860|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109861|NCT02908529|Oxybutynin|oxybutynin|mesh-list
83109862|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83109863|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83109864|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83109865|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109866|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109867|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109868|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109869|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109870|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
83109871|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
83109872|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109873|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83109874|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83109875|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
83109876|NCT02908529|Urological Agents|urological agents|mesh-ancestor
83109877|NCT03469557|Capecitabine|capecitabine|mesh-list
83109878|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
83109879|NCT03469557|Tislelizumab|tislelizumab|mesh-list
83109880|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109881|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83109882|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
83109883|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109884|NCT03469557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83109885|NCT02643381|Ketamine|ketamine|mesh-list
83109886|NCT02643381|Etomidate|etomidate|mesh-list
83109887|NCT02643381|Analgesics|analgesics|mesh-ancestor
83109888|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
83109889|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109890|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109891|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83109892|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83109893|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
83109894|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
83109895|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109896|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83109897|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83109898|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109899|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109900|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83109901|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
83109902|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
83109903|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
83109904|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83109905|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83109906|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109907|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83109908|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109909|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109910|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
83109911|NCT04328961|Protective Agents|protective agents|mesh-ancestor
83109912|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109913|NCT04328961|Vitamins|vitamins|mesh-ancestor
83109914|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
83109915|NCT00455403|Chloroquine|chloroquine|mesh-list
83109916|NCT00455403|Amebicides|amebicides|mesh-ancestor
83109917|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83109918|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83109919|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109920|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
83109921|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83109922|NCT03470337|Wobenzym|wobenzym|mesh-list
83109923|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83109924|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
83109925|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109926|NCT03576261|Polygeline|polygeline|mesh-list
83109927|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
83109928|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
83109929|NCT03469323|Succinylcholine|succinylcholine|mesh-list
83109930|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83109931|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83109932|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83109933|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109934|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109935|NCT05160285|Nivolumab|nivolumab|mesh-list
83109936|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83109937|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109938|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83109939|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109940|NCT05160051|FAPI-46|fapi-46|mesh-list
83109941|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83109942|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109943|NCT03471819|Serotonin|serotonin|mesh-list
83109944|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83109945|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
83109946|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389740|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83109947|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109948|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109949|NCT03618693|Anesthetics|anesthetics|mesh-list
83109950|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83109951|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109952|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
83109953|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83528739|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
83109954|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83109955|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109956|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
83109957|NCT01064167|Coagulants|coagulants|mesh-ancestor
83109958|NCT04205305|Labetalol|labetalol|mesh-list
83109959|NCT04205305|Nicardipine|nicardipine|mesh-list
83109960|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83109961|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83109962|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
83109963|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83109964|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109965|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109966|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83109967|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
83109968|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
83109969|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83109970|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83109971|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83109972|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83109973|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83109974|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83109975|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
83109976|NCT03470103|Aflibercept|aflibercept|mesh-list
83109977|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83109978|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83109979|NCT03470103|Growth Substances|growth substances|mesh-ancestor
83109980|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83109981|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
83109982|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109983|NCT01064947|Retapamulin|retapamulin|mesh-list
83109984|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83109985|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83109986|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
83109987|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83109988|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83109989|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83109990|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
83109991|NCT03469947|Coagulants|coagulants|mesh-ancestor
83109992|NCT05157087|Omalizumab|omalizumab|mesh-list
83109993|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83109994|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83109995|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
83109996|NCT05163249|Osimertinib|osimertinib|mesh-list
83109997|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83109998|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83109999|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110000|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110001|NCT04054063|Etomidate|etomidate|mesh-list
83110002|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83110003|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110004|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110005|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83110006|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
83110007|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
83110008|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83110009|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110010|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110011|NCT03652441|Immunotoxins|immunotoxins|mesh-ancestor
83110012|NCT03652441|Immunoconjugates|immunoconjugates|mesh-ancestor
83110013|NCT03652441|Immunologic Factors|immunologic factors|mesh-ancestor
83110014|NCT03652441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110015|NCT05097651|Cannabidiol|cannabidiol|mesh-list
83110016|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
83110017|NCT02918071|Benralizumab|benralizumab|mesh-list
83110018|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83110019|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
83110020|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
83110021|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
83110022|NCT05162625|Cefazolin|cefazolin|mesh-list
83110023|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83110024|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83110025|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83110026|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110027|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83110028|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83110029|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83529265|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
83110030|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110031|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110032|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83110033|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83110034|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83110035|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
83110036|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110037|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83110038|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83110039|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
83110040|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110041|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110042|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83110043|NCT02506816|Olaparib|olaparib|mesh-list
83110044|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83110045|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110046|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110047|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110048|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
83110049|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
83110050|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110051|NCT05009901|Protective Agents|protective agents|mesh-ancestor
83110052|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110053|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
83110054|NCT05009901|Vitamins|vitamins|mesh-ancestor
83110055|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
83110056|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83110057|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83110058|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110059|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110060|NCT05162001|Disulfiram|disulfiram|mesh-list
83110061|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83110062|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83110063|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110064|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110065|NCT03469167|Epinephrine|epinephrine|mesh-list
83110066|NCT03469167|CEGP-003|cegp-003|mesh-list
83110067|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83110068|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83110069|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83110070|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110071|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110072|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110073|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83110074|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83110075|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
83110076|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110077|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83110078|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83110079|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
83110080|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
83110081|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83110082|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
83110083|NCT03469167|Coagulants|coagulants|mesh-ancestor
83110084|NCT01063153|Methylphenidate|methylphenidate|mesh-list
83110085|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83110086|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110087|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83110088|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83110089|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83110090|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110091|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
83110092|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110093|NCT05161221|Acetaminophen|acetaminophen|mesh-list
83110094|NCT05161221|Naproxen|naproxen|mesh-list
83110095|NCT05161221|Oxycodone|oxycodone|mesh-list
83110096|NCT05161221|Bupivacaine|bupivacaine|mesh-list
83468256|NCT00199082|Cytarabine|cytarabine|mesh-list
83110097|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
83110098|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
83110099|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110100|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110101|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
83110102|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110103|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83110104|NCT05161221|Narcotics|narcotics|mesh-ancestor
83110105|NCT05161221|Analgesics|analgesics|mesh-ancestor
83110106|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83110107|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83110108|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83110109|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110110|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
83110111|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83110112|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110113|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110114|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
83110115|NCT02505334|Liraglutide|liraglutide|mesh-list
83110116|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110117|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110118|NCT02505334|Incretins|incretins|mesh-ancestor
83110120|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110121|NCT03469089|Ketamine|ketamine|mesh-list
83110122|NCT03469089|Modafinil|modafinil|mesh-list
83110123|NCT03469089|Analgesics|analgesics|mesh-ancestor
83110124|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
83110125|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110126|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110127|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83110128|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83110129|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
83110130|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
83110131|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110132|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83110133|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83110134|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110135|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110136|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83110137|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83110138|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83110139|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83110140|NCT04969510|Pramoxine|pramoxine|mesh-list
83110141|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
83110142|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
83110143|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110144|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110145|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
83110146|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110147|NCT02504320|Febuxostat|febuxostat|mesh-list
83110148|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
83110149|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110150|NCT05014516|Xenon|xenon|mesh-list
83110151|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83110152|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
83110153|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
83110154|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110155|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110156|NCT01061671|Simvastatin|simvastatin|mesh-list
83110157|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83110158|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83110159|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
83110160|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110161|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83110162|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83110163|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110164|NCT04969120|Metoclopramide|metoclopramide|mesh-list
83110165|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
83110166|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
83110167|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110168|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110169|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83110170|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83110171|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83110172|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
83110173|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110174|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110175|NCT00709995|Sunitinib|sunitinib|mesh-list
83110176|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110177|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83110178|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83110179|NCT00709995|Growth Substances|growth substances|mesh-ancestor
83110180|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110181|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
83110182|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83110183|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110184|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110185|NCT02503540|Aflibercept|aflibercept|mesh-list
83110186|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83110187|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83110188|NCT02503540|Growth Substances|growth substances|mesh-ancestor
83110189|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110190|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
83110191|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110192|NCT04053985|Lenvatinib|lenvatinib|mesh-list
83110193|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110194|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83110195|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110196|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110197|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
83110198|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83110199|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
83110200|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110201|NCT04455243|Expectorants|expectorants|mesh-ancestor
83110202|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
83110203|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83110204|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
83110205|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110206|NCT04455243|Protective Agents|protective agents|mesh-ancestor
83110207|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110208|NCT04455243|Antidotes|antidotes|mesh-ancestor
83110209|NCT04454775|Protein C|protein c|mesh-list
83110210|NCT04454775|Antithrombins|antithrombins|mesh-list
83110211|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
83110212|NCT04454775|Protein S|protein s|mesh-list
83110213|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83110214|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
83110215|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110216|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110217|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
83110218|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83110219|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83110220|NCT03651661|Insulin|insulin|mesh-list
83110221|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83110222|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110223|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110224|NCT01060111|Topiramate|topiramate|mesh-list
83110225|NCT01060111|Propranolol|propranolol|mesh-list
83110226|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83110227|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83110228|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
83110229|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110230|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110231|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110232|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83110233|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83110234|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
83110235|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
83110236|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110237|NCT02969863|Pancrelipase|pancrelipase|mesh-list
83110238|NCT02969863|Pancreatin|pancreatin|mesh-list
83110239|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83110240|NCT03651427|Estradiol|estradiol|mesh-list
83110241|NCT03651427|Estrogens|estrogens|mesh-ancestor
83110242|NCT03651427|Hormones|hormones|mesh-ancestor
83110243|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110244|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110245|NCT05285293|Vitamin A|vitamin a|mesh-list
83110246|NCT05285293|Vitamins|vitamins|mesh-ancestor
83110247|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
83110248|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110249|NCT03650257|Temozolomide|temozolomide|mesh-list
83110250|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83110251|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
83110252|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110253|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110254|NCT03649243|Propolis|propolis|mesh-list
83529640|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110255|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110256|NCT03649165|Acetaminophen|acetaminophen|mesh-list
83110257|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83110258|NCT03649165|Analgesics|analgesics|mesh-ancestor
83110259|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
83110260|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110261|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110262|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
83110264|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
83110265|NCT03649009|Metoclopramide|metoclopramide|mesh-list
83110266|NCT03649009|Vitamins|vitamins|mesh-ancestor
83110267|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
83110268|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110269|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83110270|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
83110271|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
83110272|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
83110273|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110274|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83110275|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83110276|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83110277|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
83110278|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110279|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110280|NCT03650023|Chitosan|chitosan|mesh-list
83110281|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83110282|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83110283|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
83110284|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110285|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83110286|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
83110287|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
83110288|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
83110289|NCT03650023|Coagulants|coagulants|mesh-ancestor
83110290|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
83110291|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
83110292|NCT04054999|Methylene Blue|methylene blue|mesh-list
83110293|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110294|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110295|NCT04054999|Hematinics|hematinics|mesh-ancestor
83110296|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
83110297|NCT04054999|Vitamins|vitamins|mesh-ancestor
83110298|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
83110299|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110300|NCT03649945|Docetaxel|docetaxel|mesh-list
83110301|NCT03649945|Endostar protein|endostar protein|mesh-list
83110302|NCT03649945|Nedaplatin|nedaplatin|mesh-list
83110303|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110304|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
83110305|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
83110306|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
83468282|NCT00199082|Hormones|hormones|mesh-ancestor
83110307|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110308|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83110309|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83110310|NCT03649945|Growth Substances|growth substances|mesh-ancestor
83110311|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110312|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
83110313|NCT03650881|Adapalene|adapalene|mesh-list
83110314|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83110315|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
83110316|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83110317|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83110318|NCT03650881|Analgesics|analgesics|mesh-ancestor
83110319|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
83110320|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110321|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110322|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83110323|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110324|NCT02904265|Acetazolamide|acetazolamide|mesh-list
83110325|NCT02904265|Diazepam|diazepam|mesh-list
83110326|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
83110327|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83110328|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110329|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110330|NCT02904265|Diuretics|diuretics|mesh-ancestor
83110331|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
83110332|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110333|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83110334|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
83110335|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
83110336|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110337|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83110338|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83110339|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110340|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83110341|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83110342|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83110343|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83110344|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83110345|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83110346|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
83110347|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
83110348|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
83110349|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
83110350|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110351|NCT03648229|Timolol|timolol|mesh-list
83110352|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83110353|NCT03648229|Latanoprost|latanoprost|mesh-list
83110354|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83110355|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83110356|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83110357|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
83110358|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110359|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110360|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110361|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83110362|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83110363|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
83110364|NCT03648697|Fludarabine|fludarabine|mesh-list
83110365|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110366|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
83110367|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110368|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110369|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83110370|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
83110371|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110372|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110373|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83110374|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83110375|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
83110376|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110377|NCT02967679|Biotin|biotin|mesh-list
83110378|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
83110379|NCT02967679|Vitamins|vitamins|mesh-ancestor
83110380|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
83110381|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110382|NCT04447053|Belimumab|belimumab|mesh-list
83110383|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110384|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
83110385|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110386|NCT04361799|Insulin|insulin|mesh-list
83110387|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110388|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110389|NCT05390073|Hormones|hormones|mesh-list
83110390|NCT05390073|Mitogens|mitogens|mesh-list
83110391|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110392|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110393|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
83110394|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110395|NCT03647839|Nivolumab|nivolumab|mesh-list
83110396|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110397|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110398|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83110399|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110400|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83110401|NCT04454307|Tramadol|tramadol|mesh-list
83110402|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83110403|NCT04454307|Narcotics|narcotics|mesh-ancestor
83110404|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110405|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110406|NCT04454307|Analgesics|analgesics|mesh-ancestor
83110407|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
83110408|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110410|NCT05388123|Vemurafenib|vemurafenib|mesh-list
83110411|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110412|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110413|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
83110414|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110415|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110416|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83110417|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110418|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110419|NCT04455711|Lidocaine|lidocaine|mesh-list
83110420|NCT04455711|Remifentanil|remifentanil|mesh-list
83110421|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
83110422|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
83110423|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110424|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110425|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
83110426|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110427|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83110428|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83110429|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83110430|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83110431|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110432|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83110433|NCT04455711|Narcotics|narcotics|mesh-ancestor
83110434|NCT04455711|Analgesics|analgesics|mesh-ancestor
83110435|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
83110436|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83110437|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83110438|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83110439|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83110440|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110441|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
83110442|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110443|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110444|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83110445|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110446|NCT04062669|Vaccines|vaccines|mesh-list
83110447|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
83110448|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110449|NCT05387967|Valsartan|valsartan|mesh-list
83110450|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83110451|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83110452|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83110453|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83110454|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110455|NCT03856359|Rifaximin|rifaximin|mesh-list
83110456|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83110457|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110458|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83110459|NCT04052659|Azacitidine|azacitidine|mesh-list
83110460|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83110461|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
83110462|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110463|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110464|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110465|NCT02964247|Liraglutide|liraglutide|mesh-list
83110466|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110467|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110468|NCT02964247|Incretins|incretins|mesh-ancestor
83110469|NCT02964247|Hormones|hormones|mesh-ancestor
83110470|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110471|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83110472|NCT03654729|Edetic Acid|edetic acid|mesh-list
83110473|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
83110474|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83110475|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
83110476|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
83110477|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110478|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
83110480|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
83110481|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110482|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
83110483|NCT04052269|Tadalafil|tadalafil|mesh-list
83110484|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
83110485|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83110486|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83110487|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110488|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110489|NCT04052269|Urological Agents|urological agents|mesh-ancestor
83110490|NCT01377987|Acetazolamide|acetazolamide|mesh-list
83110491|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
83110492|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83110493|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110494|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110495|NCT01377987|Diuretics|diuretics|mesh-ancestor
83110496|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
83110497|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110498|NCT03645187|Celecoxib|celecoxib|mesh-list
83110499|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83110500|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83110501|NCT03645187|Analgesics|analgesics|mesh-ancestor
83110502|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
83110503|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110504|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110505|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83110506|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110507|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83110508|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83110509|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110510|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110511|NCT03645109|Vitamin D|vitamin d|mesh-list
83110512|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
83110513|NCT03645109|Vitamins|vitamins|mesh-ancestor
83110514|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
83110515|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110516|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83110517|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83110518|NCT04455555|Rotigotine|rotigotine|mesh-list
83110519|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
83110520|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
83110521|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110522|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110523|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110524|NCT02898259|Rituximab|rituximab|mesh-list
83110525|NCT02898259|Lenalidomide|lenalidomide|mesh-list
83110526|NCT02898259|Ixazomib|ixazomib|mesh-list
83110527|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110528|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110529|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
83110530|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110531|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110532|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83110533|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83110534|NCT02898259|Growth Substances|growth substances|mesh-ancestor
83110535|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
83110536|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
83110537|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110538|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110539|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83110540|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83110541|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83110542|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110543|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110544|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110546|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110547|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110548|NCT02963935|Incretins|incretins|mesh-ancestor
83110549|NCT02963935|Hormones|hormones|mesh-ancestor
83110550|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110552|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110553|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110554|NCT03644641|Propofol|propofol|mesh-list
83110555|NCT03644641|Desflurane|desflurane|mesh-list
83110556|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83110557|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110558|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110559|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83110560|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
83110561|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
83110562|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83110563|NCT05283421|Estrogens|estrogens|mesh-list
83110564|NCT05283421|Hormones|hormones|mesh-ancestor
83110565|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110566|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110567|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
83110568|NCT03630991|Edetic Acid|edetic acid|mesh-list
83110569|NCT03630991|Calcium|calcium|mesh-list
83110570|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
83110571|NCT03630991|Succimer|succimer|mesh-list
83110572|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110573|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83110574|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83110575|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
83110576|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83110577|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
83110578|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
83110579|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110580|NCT03630991|Antidotes|antidotes|mesh-ancestor
83110581|NCT03630991|Protective Agents|protective agents|mesh-ancestor
83110582|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83110583|NCT02963701|Ibuprofen|ibuprofen|mesh-list
83110584|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
83110585|NCT02963701|Ephedrine|ephedrine|mesh-list
83110586|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83110587|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83110588|NCT02963701|Analgesics|analgesics|mesh-ancestor
83110589|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
83110590|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110591|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110592|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83110593|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110594|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83110595|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110596|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110597|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83110598|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
83110599|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83110600|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83110601|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
83110602|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83110603|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83110604|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
83110605|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
83110606|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110607|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
83110608|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83110609|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110610|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83110611|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83110612|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110613|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110614|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110615|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83110616|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83110617|NCT03643549|Temozolomide|temozolomide|mesh-list
83110618|NCT03643549|Bortezomib|bortezomib|mesh-list
83110619|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83110620|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
83110621|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110622|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110623|NCT05262205|Anesthetics|anesthetics|mesh-list
83110624|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110625|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110626|NCT03641053|Iodine|iodine|mesh-list
83110627|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
83110628|NCT03641053|Povidone|povidone|mesh-list
83110629|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83110630|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110631|NCT03641053|Trace Elements|trace elements|mesh-ancestor
83110632|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
83110633|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110634|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
83110635|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
83110636|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83110637|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
83110638|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110639|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83110640|NCT03468777|Lansoprazole|lansoprazole|mesh-list
83110641|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
83110642|NCT03468777|Ranitidine|ranitidine|mesh-list
83110643|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83110644|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83110645|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83110646|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83110647|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110648|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110649|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83110650|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
83110651|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
83110652|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110653|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110654|NCT03640377|Praziquantel|praziquantel|mesh-list
83110655|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
83110656|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83110657|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110658|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
83110659|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83110660|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83110661|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110662|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
83110663|NCT05323149|Coagulants|coagulants|mesh-ancestor
83110664|NCT05303805|Sevoflurane|sevoflurane|mesh-list
83110665|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83110666|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83110667|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
83110668|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
83110669|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110670|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110671|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83110672|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
83110673|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110674|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
83110675|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
83110676|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83110677|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110678|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110679|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
83110680|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83110681|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110682|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110683|NCT03632187|Abatacept|abatacept|mesh-list
83110684|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83110685|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110686|NCT03632187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110687|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110688|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110689|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
83110690|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110691|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110692|NCT05110209|Bevacizumab|bevacizumab|mesh-list
83110693|NCT05110209|Ranibizumab|ranibizumab|mesh-list
83110694|NCT05110209|Aflibercept|aflibercept|mesh-list
83110695|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110696|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110697|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83110698|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83110699|NCT05110209|Growth Substances|growth substances|mesh-ancestor
83110700|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110701|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
83110703|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83110704|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110705|NCT05272683|Itraconazole|itraconazole|mesh-list
83110706|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
83110707|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110708|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83468333|NCT00002620|Cobalt|cobalt|mesh-list
83110709|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83110710|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110711|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110712|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83110713|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83110714|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110715|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110716|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83110717|NCT03934671|Antioxidants|antioxidants|mesh-list
83110718|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110719|NCT03934671|Protective Agents|protective agents|mesh-ancestor
83110720|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110721|NCT03130179|Nicotine|nicotine|mesh-list
83110722|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83110723|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
83110724|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110725|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110726|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83110727|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83110728|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
83110729|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110730|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110731|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83110732|NCT03466983|Hematinics|hematinics|mesh-ancestor
83110733|NCT05439213|Epinephrine|epinephrine|mesh-list
83110734|NCT05439213|Racepinephrine|racepinephrine|mesh-list
83110735|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83110736|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
83110737|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83110738|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83110739|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83110740|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110741|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110742|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110743|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83110744|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83110745|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
83110746|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110747|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83110748|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
83110750|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
83110751|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83110752|NCT05398653|Cyclosporine|cyclosporine|mesh-list
83110753|NCT05398653|Cyclosporins|cyclosporins|mesh-list
83110754|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110755|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110756|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110757|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
83110758|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110759|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
83110760|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110761|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
83110762|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110763|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83110764|NCT03466749|Paclitaxel|paclitaxel|mesh-list
83110765|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83110766|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110767|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83110768|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83110769|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83110770|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110771|NCT03466437|Methamphetamine|methamphetamine|mesh-list
83110772|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83110773|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110774|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
83110775|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
83110776|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110777|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
83110778|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110779|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110780|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83110781|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83110782|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83110783|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83110784|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83110785|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
83110786|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110787|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110788|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83110789|NCT01909245|Gastrins|gastrins|mesh-list
83110790|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
83110791|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110792|NCT01909245|Hormones|hormones|mesh-ancestor
83110793|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110794|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
83110795|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110796|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110797|NCT03465969|Tacrolimus|tacrolimus|mesh-list
83110798|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110799|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
83110800|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110801|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83110802|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110803|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110804|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83110805|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83110806|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
83110807|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83110808|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
83110809|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83529641|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
83110810|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110811|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83110812|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83110813|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110814|NCT03130101|Insulin|insulin|mesh-list
83110815|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110816|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110817|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
83110818|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
83110819|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83110820|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
83110821|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110822|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110823|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110824|NCT05397405|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83110825|NCT05397405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83110826|NCT05397405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83110827|NCT05397405|Antimetabolites|antimetabolites|mesh-ancestor
83110828|NCT05397405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110829|NCT05397405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83110830|NCT05397405|Protease Inhibitors|protease inhibitors|mesh-ancestor
83110831|NCT05397405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110832|NCT05397405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83110833|NCT02735577|Disulfiram|disulfiram|mesh-list
83110834|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83110835|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83110836|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110837|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110838|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83110839|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83110840|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
83110841|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83110842|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83110843|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110844|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
83110845|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
83110846|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83110847|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
83110848|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110849|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110850|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83110851|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
83110852|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
83110853|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83110854|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
83110855|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110856|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110857|NCT05396937|Bevacizumab|bevacizumab|mesh-list
83110858|NCT05396937|Atezolizumab|atezolizumab|mesh-list
83110859|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110860|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110861|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83110862|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83110863|NCT05396937|Growth Substances|growth substances|mesh-ancestor
83110864|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110865|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
83110866|NCT05396937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83110867|NCT05396937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110868|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
83110869|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83110870|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110871|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110872|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110873|NCT03642145|Deflazacort|deflazacort|mesh-list
83110874|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83110875|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110876|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
83110877|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110878|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
83110879|NCT01064791|Tacrolimus|tacrolimus|mesh-list
83110880|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110881|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
83110882|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110883|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83110884|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110885|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110886|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83110887|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110888|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83110889|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
83110890|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83110891|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110892|NCT03465423|Propofol|propofol|mesh-list
83110893|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
83110894|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110895|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110896|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83110897|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83110898|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
83110899|NCT05161351|Vitamin D|vitamin d|mesh-list
83110900|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
83110901|NCT05161351|Baclofen|baclofen|mesh-list
83110902|NCT05161351|Vitamins|vitamins|mesh-ancestor
83110903|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
83110904|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110905|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83110906|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83110907|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83110908|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83110909|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110910|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83110911|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
83110912|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
83110913|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83110914|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110915|NCT03465345|Metformin|metformin|mesh-list
83110916|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
83110917|NCT03465345|Procyanidin|procyanidin|mesh-list
83110918|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110919|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110920|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
83389741|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110921|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110922|NCT03465345|Protective Agents|protective agents|mesh-ancestor
83110923|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83110924|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83110925|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83110926|NCT04563507|Letrozole|letrozole|mesh-list
83110927|NCT04563507|Palbociclib|palbociclib|mesh-list
83110928|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110929|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83110930|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83110931|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110932|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110933|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83110934|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83110935|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83110936|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110937|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83110938|NCT02983799|Olaparib|olaparib|mesh-list
83110939|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83110940|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83110941|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110942|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110943|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
83110944|NCT05385705|Trastuzumab|trastuzumab|mesh-list
83110945|NCT05385705|Interleukin-2|interleukin-2|mesh-list
83110946|NCT05385705|Pertuzumab|pertuzumab|mesh-list
83110947|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110948|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
83110949|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110950|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110951|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83110952|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
83110953|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110954|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110955|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83110956|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110957|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83110958|NCT05385705|Analgesics|analgesics|mesh-ancestor
83110959|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
83110960|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110961|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
83110962|NCT03912831|Fludarabine|fludarabine|mesh-list
83110963|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83110964|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
83110965|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110966|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83110967|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83110968|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
83110969|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110970|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110971|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83110972|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
83110973|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83110974|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110975|NCT04373265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83110976|NCT04373265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110977|NCT02186847|Metformin|metformin|mesh-list
83110978|NCT02186847|Paclitaxel|paclitaxel|mesh-list
83110979|NCT02186847|Carboplatin|carboplatin|mesh-list
83110980|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83110981|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83110982|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
83110983|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
83110984|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
83110985|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83110986|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83110987|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110988|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
83110989|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83110990|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83110991|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83110992|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83110993|NCT05274789|Analgesics|analgesics|mesh-ancestor
83110994|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
83110995|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83110996|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83110997|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83110999|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111000|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111001|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111002|NCT02353247|Norethindrone|norethindrone|mesh-list
83111003|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
83111004|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83111005|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83111006|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83111007|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
83111008|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83111009|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111010|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83111011|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83111012|NCT04343651|Leronlimab|leronlimab|mesh-list
83111013|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83111014|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83111015|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111016|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83111017|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83111018|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
83111019|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111020|NCT03343431|Tenofovir|tenofovir|mesh-list
83111021|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
83111022|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111023|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83111024|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83111025|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111026|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111027|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83111028|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83111029|NCT05226897|Metformin|metformin|mesh-list
83111030|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
83111031|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111032|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111033|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83111034|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111035|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
83111036|NCT04453761|Vitamins|vitamins|mesh-ancestor
83111037|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
83111038|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111039|NCT03463317|Aspirin|aspirin|mesh-list
83111040|NCT03463317|Warfarin|warfarin|mesh-list
83111041|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
83111042|NCT03463317|Dabigatran|dabigatran|mesh-list
83111043|NCT03463317|Apixaban|apixaban|mesh-list
83111044|NCT03463317|Edoxaban|edoxaban|mesh-list
83111045|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
83111046|NCT03463317|Clopidogrel|clopidogrel|mesh-list
83111047|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83111048|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83111049|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83111050|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83468363|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
83111051|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
83111052|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111053|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111054|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111055|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
83111056|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83111057|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
83111058|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83111059|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
83111060|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111061|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83111062|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111063|NCT03463317|Analgesics|analgesics|mesh-ancestor
83111064|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
83111065|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111066|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83111067|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83111068|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83111069|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83111070|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83111071|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
83111072|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
83111074|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
83111075|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
83111076|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83111077|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111078|NCT02906579|Praliciguat|praliciguat|mesh-list
83111079|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83111080|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
83111081|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111082|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111083|NCT04975347|Naloxone|naloxone|mesh-list
83111084|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111085|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83111086|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
83111087|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111088|NCT03463083|Fentanyl|fentanyl|mesh-list
83111089|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
83111090|NCT03463083|Bupivacaine|bupivacaine|mesh-list
83111091|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
83111092|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
83111093|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111094|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111095|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
83111096|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111097|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83111098|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111099|NCT03463083|Analgesics|analgesics|mesh-ancestor
83111100|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83111101|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83111102|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83111103|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111104|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111105|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111106|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83111107|NCT03463083|Narcotics|narcotics|mesh-ancestor
83111108|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83111109|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83111110|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
83111111|NCT04971837|Cannabidiol|cannabidiol|mesh-list
83111112|NCT04971837|Sorbitol|sorbitol|mesh-list
83111113|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
83111114|NCT04971837|Cathartics|cathartics|mesh-ancestor
83111115|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111116|NCT01328535|Temozolomide|temozolomide|mesh-list
83111117|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83111118|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
83111119|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111120|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111121|NCT03463005|Propolis|propolis|mesh-list
83111122|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111123|NCT02522169|Infliximab|infliximab|mesh-list
83111124|NCT02522169|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83111125|NCT02522169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83111126|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111127|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111128|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83111129|NCT03656393|Carboplatin|carboplatin|mesh-list
83111130|NCT03656393|Vinorelbine|vinorelbine|mesh-list
83111131|NCT03656393|Gefitinib|gefitinib|mesh-list
83111132|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111133|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83111134|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
83111135|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
83111136|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
83111137|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111138|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111139|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111140|NCT02979197|Celecoxib|celecoxib|mesh-list
83111141|NCT02979197|Amlodipine|amlodipine|mesh-list
83111142|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83111143|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83111144|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111145|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111146|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83111147|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111148|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
83111149|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83111150|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111151|NCT02979197|Analgesics|analgesics|mesh-ancestor
83111152|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
83111153|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111154|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83111155|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83111156|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83111157|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83111158|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111159|NCT01837277|Efavirenz|efavirenz|mesh-list
83111160|NCT01837277|Dolutegravir|dolutegravir|mesh-list
83111161|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83111162|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83111163|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111164|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111165|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
83111166|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111167|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83111168|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83111169|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83111170|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83111171|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83111172|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83111173|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83111174|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83111175|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83111176|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83111177|NCT03655535|PAZ320|paz320|mesh-list
83111178|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111179|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111180|NCT03654365|Caffeine|caffeine|mesh-list
83111181|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83111182|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111183|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83111184|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111185|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111186|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83111187|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83111188|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
83111189|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111190|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
83111191|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83111192|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111193|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111194|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111195|NCT03655847|Analgesics|analgesics|mesh-ancestor
83111196|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
83111197|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111198|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83111199|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83111200|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83111201|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111202|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111203|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111204|NCT03655457|Poractant alfa|poractant alfa|mesh-list
83111205|NCT03655457|Beractant|beractant|mesh-list
83111206|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83111207|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
83111208|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83111209|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83111210|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
83111211|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111212|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83111213|NCT04453371|Plasminogen|plasminogen|mesh-list
83111214|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83111215|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83111216|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111217|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
83111218|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
83111219|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
83111220|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83111221|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
83111222|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83111223|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83111224|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111225|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83111226|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83111227|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111228|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111229|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111230|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111231|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83111232|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
83111233|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
83111234|NCT02980523|Protective Agents|protective agents|mesh-ancestor
83111235|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
83111236|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
83111237|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83111238|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83111239|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
83111240|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111241|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111242|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111243|NCT03468465|Urological Agents|urological agents|mesh-ancestor
83111244|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
83111246|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
83111247|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111248|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
83111249|NCT03460743|Coagulants|coagulants|mesh-ancestor
83111250|NCT02980133|Fluticasone|fluticasone|mesh-list
83111251|NCT02980133|Xhance|xhance|mesh-list
83111252|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83111253|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83111254|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83111255|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
83111256|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111257|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111258|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83111259|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
83111260|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111261|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83111262|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83111263|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83111264|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83111265|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111266|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111267|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111268|NCT03653663|Simvastatin|simvastatin|mesh-list
83111269|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83111270|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83111271|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
83111272|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111273|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83111274|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83111275|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111276|NCT02979431|Gontivimab|gontivimab|mesh-list
83111277|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
83111278|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111279|NCT03460275|Osimertinib|osimertinib|mesh-list
83111280|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111281|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111282|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111283|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111284|NCT03468231|Leucovorin|leucovorin|mesh-list
83111285|NCT03468231|Fluorouracil|fluorouracil|mesh-list
83111286|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
83111287|NCT03468231|Sorafenib|sorafenib|mesh-list
83111288|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
83111289|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111290|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83111291|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111292|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83111293|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
83111294|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111295|NCT03468231|Antidotes|antidotes|mesh-ancestor
83111296|NCT03468231|Protective Agents|protective agents|mesh-ancestor
83111297|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
83111299|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
83111300|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111301|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111302|NCT03468153|Immunomodulating Agents|immunomodulating agents|mesh-list
83111303|NCT03468153|Immunologic Factors|immunologic factors|mesh-ancestor
83111304|NCT03468153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111305|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
83111306|NCT03460041|Bupivacaine|bupivacaine|mesh-list
83111307|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
83111308|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
83111309|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111310|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111311|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
83111312|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111313|NCT03460041|Analgesics|analgesics|mesh-ancestor
83111314|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83111315|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
83111316|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83111317|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111318|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111319|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83111320|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
83111321|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83111322|NCT02522013|Aminophylline|aminophylline|mesh-list
83111323|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83111324|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
83111325|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111326|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111327|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83111328|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
83111329|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83111330|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83111331|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111332|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111333|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83111334|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83111335|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
83111336|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111337|NCT02522013|Protective Agents|protective agents|mesh-ancestor
83111338|NCT02978417|Naltrexone|naltrexone|mesh-list
83111339|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83111340|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83111341|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111342|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
83111343|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111344|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
83111345|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83111346|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111347|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83111348|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111349|NCT03457467|Apatinib|apatinib|mesh-list
83111350|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111351|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111352|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111353|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111354|NCT05191875|Doxycycline|doxycycline|mesh-list
83111355|NCT05191875|Furazolidone|furazolidone|mesh-list
83111356|NCT05191875|Bismuth|bismuth|mesh-list
83111357|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83111358|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111359|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
83111360|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83111361|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83111362|NCT05191875|Antacids|antacids|mesh-ancestor
83111363|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111364|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111365|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83111366|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83111367|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83111368|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83111369|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111370|NCT04370145|Meropenem|meropenem|mesh-list
83111371|NCT04370145|Tinidazole|tinidazole|mesh-list
83111372|NCT04370145|Teicoplanin|teicoplanin|mesh-list
83111374|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83111375|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111376|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
83111377|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111378|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83111379|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83111380|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83111381|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83111382|NCT03453723|Lidocaine|lidocaine|mesh-list
83111383|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
83111384|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
83111385|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111386|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111387|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
83111388|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111389|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83468398|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83111390|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83111391|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83111392|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111393|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111394|NCT04368429|Vaccines|vaccines|mesh-list
83111395|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
83111396|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111397|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
83111398|NCT04774965|Promethazine|promethazine|mesh-list
83111399|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83111400|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83111401|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111402|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111403|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
83111404|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
83111405|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
83111406|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111407|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
83111408|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
83111409|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111410|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83111411|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
83111412|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
83111413|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111414|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111415|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83111416|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
83111417|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111418|NCT03452553|Doxorubicin|doxorubicin|mesh-list
83111419|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83111420|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111421|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83111422|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83111423|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111424|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111425|NCT03452475|Lumefantrine|lumefantrine|mesh-list
83111426|NCT03452475|Artemether|artemether|mesh-list
83111427|NCT03452475|Piperaquine|piperaquine|mesh-list
83111428|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83111429|NCT03452475|Mefloquine|mefloquine|mesh-list
83111430|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
83111431|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83111432|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83111433|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111434|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
83111435|NCT03451227|Remifentanil|remifentanil|mesh-list
83111436|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83111437|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111438|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111439|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111440|NCT03451227|Analgesics|analgesics|mesh-ancestor
83111441|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
83111442|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111443|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83111444|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83111445|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83111446|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111447|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111448|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82740063|NCT04498923|Hormones|hormones|mesh-ancestor
83111449|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83111450|NCT03451227|Narcotics|narcotics|mesh-ancestor
83111451|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
83111452|NCT02529813|Fludarabine|fludarabine|mesh-list
83111453|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
83111454|NCT02529813|Tisagenlecleucel|tisagenlecleucel|mesh-list
83111455|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83111456|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
83111457|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111458|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83111459|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83111460|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
83111461|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111462|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111463|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83111464|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83111465|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
83111466|NCT02529813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83111467|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83111468|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83111469|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83111470|NCT05321511|Hormones|hormones|mesh-ancestor
83111471|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111472|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111473|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
83111474|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83111475|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
83111476|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83111477|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83111478|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83111479|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111480|NCT02417103|Liraglutide|liraglutide|mesh-list
83111481|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111482|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111483|NCT02417103|Incretins|incretins|mesh-ancestor
83111484|NCT02417103|Hormones|hormones|mesh-ancestor
83111485|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111486|NCT02097225|Trametinib|trametinib|mesh-list
83111487|NCT02097225|Dabrafenib|dabrafenib|mesh-list
83111488|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111489|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111490|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111491|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111492|NCT02958865|PF-06700841|pf-06700841|mesh-list
83111493|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111494|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111495|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111496|NCT02501902|Paclitaxel|paclitaxel|mesh-list
83111497|NCT02501902|Palbociclib|palbociclib|mesh-list
83111498|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83111499|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111500|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
83111501|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
83111502|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
83111503|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111504|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111505|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111506|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
83111507|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111508|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111509|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83468425|NCT01743872|Dextrans|dextrans|mesh-list
83111510|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111511|NCT03448731|Doxycycline|doxycycline|mesh-list
83111512|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83111513|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111514|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
83111515|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83111516|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83111517|NCT04452669|Epoprostenol|epoprostenol|mesh-list
83111518|NCT04452669|Tezosentan|tezosentan|mesh-list
83111519|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83111520|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83111521|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
83111522|NCT03719001|Clevidipine|clevidipine|mesh-list
83111524|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
83111525|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
83111526|NCT03719001|Calcium|calcium|mesh-list
83111527|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83111528|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111529|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83111530|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111531|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111532|NCT03719001|Analgesics|analgesics|mesh-ancestor
83111533|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
83111534|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111535|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83111536|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83111537|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83111538|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111539|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111540|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111541|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83111542|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
83111543|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
83111544|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
83111545|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83111546|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
83111547|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
83111548|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83111549|NCT03719001|Protective Agents|protective agents|mesh-ancestor
83111550|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83111551|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111552|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83111553|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83111554|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83111555|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111556|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111557|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111558|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111559|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111560|NCT04965064|Capecitabine|capecitabine|mesh-list
83111561|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83111562|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
83111563|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111564|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111565|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
83111566|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83111567|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111568|NCT02499952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83111569|NCT02499952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111571|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111572|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111573|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
83111574|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111575|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111576|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
83111577|NCT03205605|Oxybutynin|oxybutynin|mesh-list
83111578|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
83111579|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
83111580|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111581|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111582|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83111583|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83111584|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
83111585|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111586|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111587|NCT03205605|Urological Agents|urological agents|mesh-ancestor
83111588|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83111589|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111590|NCT05006638|Atropine|atropine|mesh-list
83111591|NCT05006638|Ondansetron|ondansetron|mesh-list
83111592|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83111593|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
83111594|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
83111595|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
83111596|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111598|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111599|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
83111600|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111601|NCT05006638|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83111602|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83111603|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
83111604|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111605|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111606|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83111607|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83111608|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83111609|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83111610|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
83111612|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
83111613|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83111614|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83111615|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
83111616|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83111617|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83111618|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
83111619|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
83111620|NCT02498236|Oxytocin|oxytocin|mesh-list
83111621|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
83111622|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83111623|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111624|NCT01283997|Minocycline|minocycline|mesh-list
83111625|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83111626|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111627|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
83111628|NCT02496676|Analgesics|analgesics|mesh-ancestor
83111629|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
83111630|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111631|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111632|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
83111633|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111634|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83111635|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
83111636|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83111637|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111638|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111639|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83111640|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
83111641|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83111642|NCT01160211|Trastuzumab|trastuzumab|mesh-list
83111643|NCT01160211|Lapatinib|lapatinib|mesh-list
83111644|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83111645|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83111646|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111647|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111648|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111649|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111650|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83111651|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83111652|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
83111653|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111654|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111655|NCT03443271|Bupivacaine|bupivacaine|mesh-list
83111656|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
83111657|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
83111658|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111659|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111660|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
83111661|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111662|NCT01064687|Metformin|metformin|mesh-list
83111663|NCT01064687|Pioglitazone|pioglitazone|mesh-list
83111664|NCT01064687|Exenatide|exenatide|mesh-list
83111665|NCT01064687|Dulaglutide|dulaglutide|mesh-list
83111666|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111667|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111668|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83111669|NCT01064687|Incretins|incretins|mesh-ancestor
83111670|NCT01064687|Hormones|hormones|mesh-ancestor
83111671|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111672|NCT03447873|Lamivudine|lamivudine|mesh-list
83111673|NCT03447873|Cobicistat|cobicistat|mesh-list
83111674|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83111675|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83111676|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83483508|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111677|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111678|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
83111679|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111680|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83111681|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83111682|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83111683|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83111684|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
83111685|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83111686|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83111687|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83111688|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111689|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111690|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
83111691|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111692|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111693|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83111694|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111695|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
83111696|NCT00740805|Doxorubicin|doxorubicin|mesh-list
83111697|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83111698|NCT00740805|Veliparib|veliparib|mesh-list
83111699|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83111700|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
83111701|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111702|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83111703|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83111704|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
83111705|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111706|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111707|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83111708|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83111709|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83111710|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83111711|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111712|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83111713|NCT03621995|Catalase|catalase|mesh-list
83111714|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
83111715|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111716|NCT03621995|Protective Agents|protective agents|mesh-ancestor
83111717|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111718|NCT03443037|Amantadine|amantadine|mesh-list
83111719|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83111720|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83111721|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
83111722|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111723|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
83111724|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111725|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111726|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111727|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111728|NCT03443037|Analgesics|analgesics|mesh-ancestor
83111729|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
83111730|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111731|NCT03442491|Hemostatics|hemostatics|mesh-list
83111732|NCT03442491|Coagulants|coagulants|mesh-ancestor
83111733|NCT02918279|Liraglutide|liraglutide|mesh-list
83111734|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111735|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111736|NCT02918279|Incretins|incretins|mesh-ancestor
83111737|NCT02918279|Hormones|hormones|mesh-ancestor
83111738|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111739|NCT02956837|Vaccines|vaccines|mesh-list
83111740|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
83111741|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111742|NCT03447093|Methimazole|methimazole|mesh-list
83111743|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
83111744|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
83111745|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83111746|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111747|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111748|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
83111749|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111750|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83111751|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83111752|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
83111753|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83111754|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
83111755|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111756|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
83111757|NCT03640351|Protective Agents|protective agents|mesh-ancestor
83111758|NCT03640273|Loratadine|loratadine|mesh-list
83111759|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
83111760|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111761|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83111762|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83111763|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83111764|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
83111765|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
83111766|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111767|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111768|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111769|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
83111770|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83111771|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83468472|NCT00002692|Antidotes|antidotes|mesh-ancestor
83111772|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111773|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
83111774|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111775|NCT01063283|Bevacizumab|bevacizumab|mesh-list
83111776|NCT01063283|Carboplatin|carboplatin|mesh-list
83111777|NCT01063283|Pemetrexed|pemetrexed|mesh-list
83111778|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83111779|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111780|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83111781|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83111782|NCT01063283|Growth Substances|growth substances|mesh-ancestor
83111783|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111784|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
83111785|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111786|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111787|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83111788|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83111789|NCT01062971|Timolol|timolol|mesh-list
83111790|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83111791|NCT01062971|Dorzolamide|dorzolamide|mesh-list
83111792|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83111793|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83111794|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
83111795|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111796|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111797|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111798|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83111799|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83111800|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83111801|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83111802|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83111803|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83111804|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111805|NCT03446937|Dexamethasone|dexamethasone|mesh-list
83111806|NCT03446937|Betamethasone|betamethasone|mesh-list
83111807|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
83111808|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83111809|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
83111810|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
83111811|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83111812|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83111813|NCT03446937|BB 1101|bb 1101|mesh-list
83111814|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83111815|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
83111816|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
83111817|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111818|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111819|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111820|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
83111822|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111823|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83111824|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111825|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83529717|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
83111826|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83111827|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
83111828|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111829|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111830|NCT03652493|Carboplatin|carboplatin|mesh-list
83111831|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111832|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
83111833|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83111834|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83111835|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83111836|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83111837|NCT02493868|Sertraline|sertraline|mesh-list
83111838|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
83111839|NCT02493868|Esketamine|esketamine|mesh-list
83111840|NCT02493868|Escitalopram|escitalopram|mesh-list
83111841|NCT02493868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83111842|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83111843|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111844|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111845|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111846|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
83111847|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111848|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111849|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83111850|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83111851|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83111852|NCT02493868|Analgesics|analgesics|mesh-ancestor
83111853|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
83111854|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
83111855|NCT03619057|Anesthetics|anesthetics|mesh-list
83111856|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111857|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111858|NCT04451655|Insulin|insulin|mesh-list
83111859|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111860|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111861|NCT03446625|Resveratrol|resveratrol|mesh-list
83111862|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
83111863|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111864|NCT03446625|Protective Agents|protective agents|mesh-ancestor
83111865|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111866|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111867|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83111868|NCT04594005|Paclitaxel|paclitaxel|mesh-list
83111869|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83111870|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111871|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83111872|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83111873|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83111874|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111875|NCT02516410|Ivacaftor|ivacaftor|mesh-list
83111876|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83111877|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111878|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111879|NCT02493712|Mesalamine|mesalamine|mesh-list
83111880|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83111881|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83111882|NCT02493712|Analgesics|analgesics|mesh-ancestor
83111883|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
83111884|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111885|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111886|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83111887|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83111888|NCT03446547|Durvalumab|durvalumab|mesh-list
83111889|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83111890|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111891|NCT02516332|Escitalopram|escitalopram|mesh-list
83111892|NCT02516332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83111893|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83111894|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111895|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111896|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83111897|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
83111898|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111899|NCT03437655|Eugenol|eugenol|mesh-list
83111900|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
83111901|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111902|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
83111903|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83111904|NCT03437655|Protective Agents|protective agents|mesh-ancestor
83111905|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111906|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111907|NCT01062425|Temozolomide|temozolomide|mesh-list
83111908|NCT01062425|Cediranib|cediranib|mesh-list
83111909|NCT01062425|Maleic acid|maleic acid|mesh-list
83111910|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83111911|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
83111912|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111913|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111914|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111915|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83111916|NCT03437187|Analgesics|analgesics|mesh-list
83111917|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111918|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
83111919|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111920|NCT02491684|Interferons|interferons|mesh-list
83111921|NCT02491684|Interferon-beta|interferon-beta|mesh-list
83111922|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
83111923|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83111924|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
83111925|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111926|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
83111927|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111928|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83111929|NCT03445611|Lidocaine|lidocaine|mesh-list
83111930|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83111931|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
83111932|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
83111933|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111934|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111935|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
83111936|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111937|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83111938|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83111939|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83111940|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83111941|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111942|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
83111943|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83111944|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83111945|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111946|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
83111947|NCT04360629|Coagulants|coagulants|mesh-ancestor
83111948|NCT04727229|Bupivacaine|bupivacaine|mesh-list
83111949|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
83111950|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
83111951|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83111952|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111953|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
83111954|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83111955|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83111956|NCT03436719|Metronidazole|metronidazole|mesh-list
83111957|NCT03436719|Erythromycin|erythromycin|mesh-list
83111958|NCT03436719|Cefoperazone|cefoperazone|mesh-list
83111959|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83111960|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83111961|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
83111962|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83111963|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83111964|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83111965|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83111966|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111967|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111968|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
83111969|NCT01061333|Nedocromil|nedocromil|mesh-list
83111971|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83111972|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
83111973|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83111974|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
83111975|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111976|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111977|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83111978|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83111979|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111980|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83111981|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
83111982|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83111983|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83111984|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
83111985|NCT02489968|Empagliflozin|empagliflozin|mesh-list
83111986|NCT02489968|Linagliptin|linagliptin|mesh-list
83111987|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83111988|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83111989|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83111990|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83111991|NCT02489968|Incretins|incretins|mesh-ancestor
83111992|NCT02489968|Hormones|hormones|mesh-ancestor
83111993|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83111994|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83111995|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
83111996|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83111997|NCT03436173|Fluoxetine|fluoxetine|mesh-list
83111998|NCT03436173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83111999|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83112000|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112001|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112002|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112003|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
83112004|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112005|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83112006|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
83112007|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112008|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83112009|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83112010|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112011|NCT03444831|Buspirone|buspirone|mesh-list
83112012|NCT03444831|Omeprazole|omeprazole|mesh-list
83112013|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83112014|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83112015|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83112016|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112017|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112018|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83112019|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83112020|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112021|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112022|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112023|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83112024|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
83112025|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112026|NCT02481934|Lenalidomide|lenalidomide|mesh-list
83112027|NCT02481934|Bortezomib|bortezomib|mesh-list
83112028|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
83112029|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112030|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83112031|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83112032|NCT02481934|Growth Substances|growth substances|mesh-ancestor
83112033|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
83112034|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112035|NCT03444519|Mannitol|mannitol|mesh-list
83112036|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83112037|NCT03444519|Diuretics|diuretics|mesh-ancestor
83112038|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
83112039|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112040|NCT03129009|Anesthetics|anesthetics|mesh-list
83112041|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112042|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112043|NCT02489500|Bortezomib|bortezomib|mesh-list
83112044|NCT02489500|Melphalan|melphalan|mesh-list
83112045|NCT02489500|Lenograstim|lenograstim|mesh-list
83112046|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112047|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83112048|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
83530022|NCT02295553|Analgesics|analgesics|mesh-ancestor
83112049|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112050|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83112051|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112052|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
83112053|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112054|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83112056|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83112057|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83112058|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112059|NCT03652571|Nortriptyline|nortriptyline|mesh-list
83112060|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83112061|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83112062|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112063|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83112064|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83112065|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112066|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112067|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
83112068|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112069|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112070|NCT03652103|Bupivacaine|bupivacaine|mesh-list
83112071|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
83112072|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
83112073|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112074|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112075|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
83112076|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112077|NCT03651947|Denosumab|denosumab|mesh-list
83112078|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83468520|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112079|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112080|NCT03651557|Salicylates|salicylates|mesh-list
83112081|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83112082|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83112083|NCT03651557|Analgesics|analgesics|mesh-ancestor
83112084|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
83112085|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112086|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112087|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83112088|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83112089|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83112090|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112091|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112092|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
83112093|NCT03432975|Povidone|povidone|mesh-list
83112094|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
83112095|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
83112096|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83112097|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112098|NCT04953130|Vaccines|vaccines|mesh-list
83112099|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
83112100|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112101|NCT02488330|Bevacizumab|bevacizumab|mesh-list
83112102|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83112103|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112104|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112105|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83112106|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83112107|NCT02488330|Growth Substances|growth substances|mesh-ancestor
83112108|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112109|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
83112110|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83112111|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112112|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112113|NCT03432663|Amiodarone|amiodarone|mesh-list
83112114|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83112115|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
83112116|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83112117|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112118|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112119|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83112120|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83112121|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83112122|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112123|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83112124|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83112125|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83112126|NCT03432273|Nicotine|nicotine|mesh-list
83112127|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83112128|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
83112129|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112130|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112131|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83112132|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83112133|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
83112134|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112135|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112136|NCT02481310|Cytarabine|cytarabine|mesh-list
83112137|NCT02481310|Prednisone|prednisone|mesh-list
83112138|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
83112139|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83112140|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83112141|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83112142|NCT02481310|Cortisone|cortisone|mesh-list
83112143|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
83112144|NCT02481310|Rituximab|rituximab|mesh-list
83112145|NCT02481310|Doxorubicin|doxorubicin|mesh-list
83112146|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83112147|NCT02481310|Methotrexate|methotrexate|mesh-list
83112148|NCT02481310|Etoposide|etoposide|mesh-list
83112149|NCT02481310|Vincristine|vincristine|mesh-list
83112150|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
83112151|NCT02481310|Ixazomib|ixazomib|mesh-list
83112152|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
83112153|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83112154|NCT02481310|Antibodies|antibodies|mesh-list
83112155|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
83112156|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83112157|NCT02481310|Glycine|glycine|mesh-list
83112158|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112159|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
83112160|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112161|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83112162|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83112163|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
83112164|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112165|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112166|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83112167|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83112168|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83112169|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83112170|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112171|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83112172|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
83112173|NCT02481310|Hormones|hormones|mesh-ancestor
83112174|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112175|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83112176|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83112177|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
83112178|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83112179|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83112180|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
83112181|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
83112182|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83112183|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83112184|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83112185|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
83112186|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112187|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
83112188|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
83112189|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
83112190|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
83112191|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
83112192|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
83112193|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112194|NCT03432195|Donepezil|donepezil|mesh-list
83112195|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83112196|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112197|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112198|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
83112199|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112200|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112201|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
83112202|NCT03431961|Triamcinolone|triamcinolone|mesh-list
83112203|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83112204|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83112205|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83112206|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83112207|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
83112208|NCT03431961|Hormones|hormones|mesh-ancestor
83112209|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112210|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112211|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112212|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
83112213|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112214|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112215|NCT02480764|Valsartan|valsartan|mesh-list
83112216|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83112217|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83112218|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83112219|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83112220|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112221|NCT03434691|Remifentanil|remifentanil|mesh-list
83112222|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83112223|NCT03434691|Narcotics|narcotics|mesh-ancestor
83112224|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112225|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112226|NCT03434691|Analgesics|analgesics|mesh-ancestor
83112227|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
83112228|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112229|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83112230|NCT03434613|Ezetimibe|ezetimibe|mesh-list
83112231|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83112232|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83112233|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
83112234|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112235|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83112236|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83112237|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112238|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
83112239|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112240|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83112241|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112242|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112243|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
83112244|NCT03428685|Progestins|progestins|mesh-ancestor
83112245|NCT03428685|Hormones|hormones|mesh-ancestor
83112246|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112247|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112248|NCT05665647|Ritonavir|ritonavir|mesh-list
83112249|NCT05665647|Itraconazole|itraconazole|mesh-list
83112250|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83112251|NCT05665647|Rifampin|rifampin|mesh-list
83112252|NCT05665647|Midazolam|midazolam|mesh-list
83112253|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83112254|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83112255|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112256|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112257|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83112258|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83112259|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112260|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83112261|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
83112262|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
83112263|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
83112264|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
83112265|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112266|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112267|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83112268|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83112269|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
83112270|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112271|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83112272|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83112273|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
83112274|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112275|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83112276|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83112277|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
83112278|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83112279|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83112280|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
83112281|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112282|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83112283|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
83112284|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83112285|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
83112286|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83112287|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83112288|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83112289|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83112290|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83112291|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83112292|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83112293|NCT03943173|Olaparib|olaparib|mesh-list
83112294|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83112295|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112296|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112297|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112298|NCT04941196|Ticagrelor|ticagrelor|mesh-list
83112299|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83112300|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83112301|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83112302|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83112303|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
83112304|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112305|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112306|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112307|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
83112308|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83112309|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83112310|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112311|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
83112312|NCT03431805|Coagulants|coagulants|mesh-ancestor
83112313|NCT03428607|Olaparib|olaparib|mesh-list
83112314|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83112315|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112316|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112317|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112318|NCT02521233|Losartan|losartan|mesh-list
83112319|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83112320|NCT02521233|Candesartan|candesartan|mesh-list
83112321|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
83112322|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
83112323|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83112324|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83112325|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83112326|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83112327|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112328|NCT02521233|Diuretics|diuretics|mesh-ancestor
83112329|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
83112330|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112331|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83112332|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112333|NCT03428529|Fluorouracil|fluorouracil|mesh-list
83112334|NCT03428529|Capecitabine|capecitabine|mesh-list
83112335|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
83112336|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112337|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83112338|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112339|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112340|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
83112341|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112342|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
83112343|NCT03431649|Beraprost|beraprost|mesh-list
83483583|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83112344|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112345|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
83112346|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83112347|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83112348|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112349|NCT03431649|Urological Agents|urological agents|mesh-ancestor
83112350|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83112351|NCT04450095|Ambrisentan|ambrisentan|mesh-list
83112352|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83112353|NCT03101475|Durvalumab|durvalumab|mesh-list
83112354|NCT03101475|Tremelimumab|tremelimumab|mesh-list
83112355|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112356|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112357|NCT01060007|Leucovorin|leucovorin|mesh-list
83112358|NCT01060007|Fluorouracil|fluorouracil|mesh-list
83112359|NCT01060007|Capecitabine|capecitabine|mesh-list
83112360|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
83112361|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
83112362|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112363|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83112364|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112365|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112366|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
83112367|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112368|NCT01060007|Antidotes|antidotes|mesh-ancestor
83112369|NCT01060007|Protective Agents|protective agents|mesh-ancestor
83112370|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
83112371|NCT01060007|Vitamins|vitamins|mesh-ancestor
83112372|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
83112373|NCT04175925|Famotidine|famotidine|mesh-list
83112374|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83112375|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83112376|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83112377|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
83112378|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
83112379|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112380|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112381|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112382|NCT02971007|Fluconazole|fluconazole|mesh-list
83112383|NCT02971007|Amphotericin B|amphotericin b|mesh-list
83112384|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83112385|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
83112386|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112387|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83112388|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83112389|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112390|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112391|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83112392|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
83112393|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112394|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112395|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83112396|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83112397|NCT02971007|Amebicides|amebicides|mesh-ancestor
83112398|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83112399|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83112400|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83112401|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
83112402|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
83112403|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112404|NCT03428139|Protective Agents|protective agents|mesh-ancestor
83112405|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112406|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
83112407|NCT03428139|Vitamins|vitamins|mesh-ancestor
83112408|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
83112409|NCT03650543|Amoxicillin|amoxicillin|mesh-list
83112410|NCT03650543|Clarithromycin|clarithromycin|mesh-list
83112411|NCT03650543|Omeprazole|omeprazole|mesh-list
83112412|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83112413|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112414|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83112415|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83112416|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83112417|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112418|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112419|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83112420|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83112421|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83112422|NCT03650777|Warfarin|warfarin|mesh-list
83112423|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
83112424|NCT02970305|Pimavanserin|pimavanserin|mesh-list
83112425|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83112426|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83112427|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83112428|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83112429|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112430|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112431|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112432|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83112433|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83112434|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
83112435|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112436|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112437|NCT03649763|Lidocaine|lidocaine|mesh-list
83112438|NCT03649763|Bupivacaine|bupivacaine|mesh-list
83112439|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
83112440|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
83112441|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112442|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112443|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
83112444|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112445|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83112446|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83112447|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83112448|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112449|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112450|NCT03427437|Epinephrine|epinephrine|mesh-list
83112451|NCT03427437|Racepinephrine|racepinephrine|mesh-list
83112452|NCT03427437|Bupivacaine|bupivacaine|mesh-list
83112453|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
83112454|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
83112455|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
83112456|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112457|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112458|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
83112459|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112460|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83112461|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83112462|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83112463|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112464|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112465|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83112466|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83112467|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
83112468|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83112469|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83112470|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
83112471|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
83112472|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83112473|NCT03427359|Capecitabine|capecitabine|mesh-list
83112474|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112475|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83112476|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
83112477|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112478|NCT05053659|Venetoclax|venetoclax|mesh-list
83112479|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83112481|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112482|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83112483|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83112484|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112485|NCT03649139|Immunomodulating Agents|immunomodulating agents|mesh-list
83112486|NCT03649139|Immunologic Factors|immunologic factors|mesh-ancestor
83112487|NCT03649139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112488|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
83112489|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112490|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
83112491|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
83112492|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
83112493|NCT03423225|Tacrolimus|tacrolimus|mesh-list
83112494|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112495|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
83112496|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112497|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83112498|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112499|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112500|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
83112501|NCT02521077|Vitamins|vitamins|mesh-ancestor
83112502|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
83112503|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112504|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
83112505|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112506|NCT02521077|Protective Agents|protective agents|mesh-ancestor
83112507|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
83112508|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83112509|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112510|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112511|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83112512|NCT03564093|Analgesics|analgesics|mesh-ancestor
83112513|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
83112514|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112515|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83112516|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83112517|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83112518|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83112519|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112520|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112521|NCT03429621|Simethicone|simethicone|mesh-list
83112522|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
83112523|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112524|NCT03429621|Emollients|emollients|mesh-ancestor
83112525|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83112526|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
83112527|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
83112528|NCT03426969|Melphalan|melphalan|mesh-list
83112529|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
83112530|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83112531|NCT03426969|Fludarabine|fludarabine|mesh-list
83112532|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
83112533|NCT03426969|Tacrolimus|tacrolimus|mesh-list
83112534|NCT03426969|Lenograstim|lenograstim|mesh-list
83112535|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112536|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
83112537|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112538|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83112539|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83112540|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
83112541|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112542|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112543|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83112544|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83112545|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
83112546|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83112547|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83112548|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112549|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83112550|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83112551|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
83112552|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83112553|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112554|NCT03422445|Temozolomide|temozolomide|mesh-list
83112555|NCT03422445|Apatinib|apatinib|mesh-list
83112556|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83112557|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
83112558|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112559|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112560|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83112561|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112562|NCT03429309|Propofol|propofol|mesh-list
83112563|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83112564|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112565|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112566|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83112567|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
83112568|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
83112569|NCT03429075|Psilocybin|psilocybin|mesh-list
83112570|NCT03429075|Escitalopram|escitalopram|mesh-list
83112571|NCT03429075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83112572|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83112573|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112574|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112575|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112576|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
83112577|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112578|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112579|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
83112580|NCT03422289|Folic Acid|folic acid|mesh-list
83112581|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
83112582|NCT03422289|Inositol|inositol|mesh-list
83112583|NCT03422289|Hematinics|hematinics|mesh-ancestor
83112584|NCT03422289|Vitamins|vitamins|mesh-ancestor
83112585|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
83112586|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112587|NCT03422055|Fucoidan|fucoidan|mesh-list
83112588|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83112589|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83112590|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
83112591|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112592|NCT04449471|Naproxen|naproxen|mesh-list
83112593|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83112594|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83112595|NCT04449471|Analgesics|analgesics|mesh-ancestor
83112596|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
83112597|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112598|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112599|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83112600|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83112601|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
83112602|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83112603|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112604|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112605|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
83112606|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83112607|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
83112608|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
83112609|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112610|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112611|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83112612|NCT03127371|Analgesics|analgesics|mesh-ancestor
83112613|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
83112614|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112615|NCT03421821|Ropivacaine|ropivacaine|mesh-list
83112616|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
83112617|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
83112618|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112619|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112620|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
83112621|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112622|NCT03421743|Molgramostim|molgramostim|mesh-list
83112623|NCT03421743|Sargramostim|sargramostim|mesh-list
83112624|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112625|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
83112626|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112627|NCT01103349|Montelukast|montelukast|mesh-list
83112628|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83112629|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
83112630|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83112631|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
83112632|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112633|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112634|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83112635|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83112636|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112638|NCT03421275|Esketamine|esketamine|mesh-list
83112639|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83112640|NCT03421275|Narcotics|narcotics|mesh-ancestor
83112641|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112642|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112643|NCT03421275|Analgesics|analgesics|mesh-ancestor
83112644|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
83112645|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112646|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83112647|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83112648|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
83112649|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
83112650|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
83112651|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112652|NCT03416517|Irinotecan|irinotecan|mesh-list
83112653|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83112654|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83112655|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112656|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112657|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112658|NCT03421119|Insulin|insulin|mesh-list
83112659|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83112660|NCT03421119|Metformin|metformin|mesh-list
83112661|NCT03421119|Liraglutide|liraglutide|mesh-list
83112662|NCT03421119|Secretagogues|secretagogues|mesh-list
83112663|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83112664|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112665|NCT03421119|Incretins|incretins|mesh-ancestor
83112666|NCT03421119|Hormones|hormones|mesh-ancestor
83112667|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112668|NCT03426033|Warfarin|warfarin|mesh-list
83112669|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
83112670|NCT02432547|Aflibercept|aflibercept|mesh-list
83112671|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83112672|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83112673|NCT02432547|Growth Substances|growth substances|mesh-ancestor
83112674|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112675|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
83112676|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112677|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83112678|NCT02345733|Amoxicillin|amoxicillin|mesh-list
83112679|NCT02345733|Metronidazole|metronidazole|mesh-list
83112680|NCT02345733|Doxycycline|doxycycline|mesh-list
83112681|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112682|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83112683|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83112684|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
83112685|NCT03415269|Ambroxol|ambroxol|mesh-list
83112686|NCT03415269|Expectorants|expectorants|mesh-ancestor
83112687|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
83112688|NCT03618589|Pregabalin|pregabalin|mesh-list
83112689|NCT03618589|Analgesics|analgesics|mesh-ancestor
83112690|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
83112691|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112692|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112693|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
83112694|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83112695|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112696|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112697|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83112698|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83112699|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83112700|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112701|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112702|NCT03127449|Aflutinib|aflutinib|mesh-list
83112703|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83112704|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112705|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112706|NCT02521155|Fenbendazole|fenbendazole|mesh-list
83112707|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
83112708|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
83112710|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112711|NCT03415191|Ketamine|ketamine|mesh-list
83112712|NCT03415191|Analgesics|analgesics|mesh-ancestor
83112713|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
83112714|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112715|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112716|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83112717|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83112718|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
83112719|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
83112720|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112721|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83112722|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83112723|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112724|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112726|NCT03419949|Lamotrigine|lamotrigine|mesh-list
83112727|NCT03419949|Analgesics|analgesics|mesh-ancestor
83112728|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
83112729|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112730|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112731|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
83112732|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83112733|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112734|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112735|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83112736|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83112737|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83112738|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112739|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112740|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83112741|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83112742|NCT03414879|Lidocaine|lidocaine|mesh-list
83112743|NCT03414879|Ketamine|ketamine|mesh-list
83112744|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
83112745|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
83112746|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112747|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112748|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
83112749|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112750|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83112751|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83112752|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83112753|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83112754|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112755|NCT03414879|Analgesics|analgesics|mesh-ancestor
83112756|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83112757|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83112758|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
83112759|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83112760|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83112761|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112762|NCT03419715|Bimatoprost|bimatoprost|mesh-list
83112763|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83112764|NCT03618355|Sirolimus|sirolimus|mesh-list
83112765|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83112766|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112767|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83112768|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112769|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
83112770|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112771|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
83112772|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112773|NCT04448457|Sufentanil|sufentanil|mesh-list
83112774|NCT04448457|Oxycodone|oxycodone|mesh-list
83112775|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83112776|NCT04448457|Narcotics|narcotics|mesh-ancestor
83112777|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112778|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112779|NCT04448457|Analgesics|analgesics|mesh-ancestor
83112780|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
83112781|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112782|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83112783|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83112784|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
83112785|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
83112787|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112788|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112789|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
83112790|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112791|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83112792|NCT03414333|Hormones|hormones|mesh-list
83112793|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112794|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112795|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
83112796|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112797|NCT03616639|Morphine|morphine|mesh-list
83112798|NCT03616639|Oxycodone|oxycodone|mesh-list
83112799|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83112800|NCT03616639|Narcotics|narcotics|mesh-ancestor
83112801|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112802|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112803|NCT03616639|Analgesics|analgesics|mesh-ancestor
83112804|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
83112805|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112806|NCT03616561|Apremilast|apremilast|mesh-list
83112807|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83112808|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83112809|NCT03616561|Analgesics|analgesics|mesh-ancestor
83112810|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
83112811|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112812|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112813|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83112814|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83112815|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83112816|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83112817|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112818|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112819|NCT03615313|Antibodies|antibodies|mesh-list
83112820|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
83112821|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112822|NCT03617575|Lactoferrin|lactoferrin|mesh-list
83112823|NCT03617575|Fesoterodine|fesoterodine|mesh-list
83112824|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112825|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83112826|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83112827|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
83112828|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112829|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112830|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112831|NCT03617575|Urological Agents|urological agents|mesh-ancestor
83112832|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
83112833|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112834|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112835|NCT03616405|Amoxicillin|amoxicillin|mesh-list
83112836|NCT03616405|Tetracycline|tetracycline|mesh-list
83112837|NCT03616405|Furazolidone|furazolidone|mesh-list
83112838|NCT03616405|Rabeprazole|rabeprazole|mesh-list
83112839|NCT03616405|Bismuth|bismuth|mesh-list
83112840|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83112841|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112842|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83112843|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83112844|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83112845|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112846|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112847|NCT03616405|Antacids|antacids|mesh-ancestor
83112848|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83112849|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83112850|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83112851|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83112852|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83112853|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83112854|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83112855|NCT03419559|Durvalumab|durvalumab|mesh-list
83112856|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112857|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112858|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
83112860|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83112861|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83112862|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83112863|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112864|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112865|NCT02873377|Nicotine|nicotine|mesh-list
83112866|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83112867|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
83112868|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112869|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112870|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83112871|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83112872|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
83112873|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112874|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112876|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
83112877|NCT03647579|Ketamine|ketamine|mesh-list
83112878|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83112879|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112880|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112881|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83112882|NCT03647579|Analgesics|analgesics|mesh-ancestor
83112883|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
83112884|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112885|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83112886|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83112887|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83112888|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
83112889|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112890|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112891|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83112892|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83112893|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
83112894|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
83112895|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83112896|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83112897|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83112898|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83112899|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83112900|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83112901|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
83112902|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
83112903|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
83112904|NCT04046861|Vitamins|vitamins|mesh-ancestor
83112905|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
83112906|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112907|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
83112908|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112909|NCT04046861|Protective Agents|protective agents|mesh-ancestor
83112910|NCT02236741|Pramipexole|pramipexole|mesh-list
83112911|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
83112912|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112913|NCT02236741|Protective Agents|protective agents|mesh-ancestor
83112914|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112915|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83112916|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83112917|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
83112918|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
83112919|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83112920|NCT03648671|Rasagiline|rasagiline|mesh-list
83112921|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83112923|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112924|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83112925|NCT03648671|Protective Agents|protective agents|mesh-ancestor
83112926|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112927|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
83112928|NCT03647423|Cetuximab|cetuximab|mesh-list
83112929|NCT03647423|Avelumab|avelumab|mesh-list
83112930|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83112931|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
83112932|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112933|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83112934|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83112935|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
83112936|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112937|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112938|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83112939|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112940|NCT04052711|Minocycline|minocycline|mesh-list
83112941|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83112942|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83112943|NCT03291847|Buprenorphine|buprenorphine|mesh-list
83112944|NCT03291847|Methadone|methadone|mesh-list
83112945|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83112946|NCT03291847|Naloxone|naloxone|mesh-list
83112947|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83112948|NCT03291847|Narcotics|narcotics|mesh-ancestor
83112949|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112950|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112951|NCT03291847|Analgesics|analgesics|mesh-ancestor
83112952|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
83112953|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112954|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83112955|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
83112956|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
83112957|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
83112958|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83112959|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112960|NCT03621683|Antioxidants|antioxidants|mesh-list
83112961|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112962|NCT03621683|Protective Agents|protective agents|mesh-ancestor
83112963|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112964|NCT03614065|Endostar protein|endostar protein|mesh-list
83112965|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83112966|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83112967|NCT03614065|Growth Substances|growth substances|mesh-ancestor
83112968|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112969|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
83112970|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112971|NCT03621527|Remifentanil|remifentanil|mesh-list
83112972|NCT03621527|Anesthetics|anesthetics|mesh-list
83112973|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83112974|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112975|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83112976|NCT03621527|Narcotics|narcotics|mesh-ancestor
83112977|NCT03621527|Analgesics|analgesics|mesh-ancestor
83112978|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
83112979|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83112980|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83112981|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83112982|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83112983|NCT03646721|Incretins|incretins|mesh-ancestor
83112984|NCT03646721|Hormones|hormones|mesh-ancestor
83112985|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83112986|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83112987|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
83112988|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112989|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112990|NCT03613753|Irinotecan|irinotecan|mesh-list
83112991|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83112992|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83112993|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83112994|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83112995|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83112996|NCT04051853|Sorafenib|sorafenib|mesh-list
83112997|NCT04051853|Midazolam|midazolam|mesh-list
83112998|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83112999|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83113000|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113001|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113002|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83113003|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83113004|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83113005|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83113006|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
83113007|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
83113008|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
83113009|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
83113010|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113011|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113012|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113013|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83113014|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113015|NCT03605927|Sirolimus|sirolimus|mesh-list
83113016|NCT03605927|Tacrolimus|tacrolimus|mesh-list
83113017|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83113018|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
83113019|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113020|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83113021|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113022|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113023|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83113024|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113025|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83113026|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113027|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
83113029|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
83113030|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
83113031|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113032|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113033|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
83113034|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113035|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
83113036|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83113037|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
83113038|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113039|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113040|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83113041|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
83113042|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83113043|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
83113044|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113045|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113046|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83113047|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
83113048|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
83113049|NCT03718793|Protective Agents|protective agents|mesh-ancestor
83113050|NCT02962739|Tenofovir|tenofovir|mesh-list
83113051|NCT02962739|Emtricitabine|emtricitabine|mesh-list
83113052|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
83113053|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113054|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83113055|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83113056|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113057|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113058|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83113059|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83113060|NCT01344629|Telmisartan|telmisartan|mesh-list
83113061|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83113062|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83113063|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83113064|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113065|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83113066|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83113067|NCT03642665|Estradiol|estradiol|mesh-list
83113068|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83113069|NCT03642665|Progesterone|progesterone|mesh-list
83113070|NCT03642665|Estrogens|estrogens|mesh-ancestor
83113071|NCT03642665|Hormones|hormones|mesh-ancestor
83483584|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83113072|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113073|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113074|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83113075|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
83113076|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83113077|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83113078|NCT03642665|Progestins|progestins|mesh-ancestor
83113079|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
83113080|NCT03642509|Apixaban|apixaban|mesh-list
83113081|NCT03642509|Edoxaban|edoxaban|mesh-list
83113082|NCT03642509|Dabigatran|dabigatran|mesh-list
83113083|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83113084|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
83113085|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83113086|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
83113087|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113088|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113089|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
83113090|NCT03642353|Listerine|listerine|mesh-list
83113091|NCT03642353|Triclosan|triclosan|mesh-list
83113092|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
83113093|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
83113094|NCT03642353|Protective Agents|protective agents|mesh-ancestor
83113095|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113096|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83113097|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113098|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83113099|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83113100|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
83113101|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113102|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83113103|NCT03424707|Eperisone|eperisone|mesh-list
83113104|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
83113105|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83113106|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83468624|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83113107|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113108|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83113109|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113110|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83113111|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83113112|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113113|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
83113114|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
83113115|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
83113116|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83113117|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83113118|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83113119|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113120|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113121|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113122|NCT03418935|Niacinamide|niacinamide|mesh-list
83113123|NCT03418935|Niacin|niacin|mesh-list
83113124|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
83113125|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
83113126|NCT03418935|Vitamins|vitamins|mesh-ancestor
83113127|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
83113128|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113129|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83113130|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
83113131|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113132|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83113133|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
83113134|NCT03413319|Tilavonemab|tilavonemab|mesh-list
83113135|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
83113136|NCT03424629|Methotrexate|methotrexate|mesh-list
83113137|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83113138|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
83113139|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83113140|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113141|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83113142|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
83113143|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113144|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113145|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83113146|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113147|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83113148|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83113149|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
83113150|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83113151|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83113153|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113154|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83113155|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113156|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113157|NCT04448379|Osimertinib|osimertinib|mesh-list
83113158|NCT04448379|Afatinib|afatinib|mesh-list
83113159|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113160|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83113161|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113162|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113163|NCT04448223|Latanoprost|latanoprost|mesh-list
83113164|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83113165|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83113166|NCT03644147|Acetaminophen|acetaminophen|mesh-list
83113167|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83113168|NCT03644147|Analgesics|analgesics|mesh-ancestor
83113169|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
83113170|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113171|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113172|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
83113173|NCT02743923|Paclitaxel|paclitaxel|mesh-list
83113174|NCT02743923|Bevacizumab|bevacizumab|mesh-list
83113175|NCT02743923|Carboplatin|carboplatin|mesh-list
83113176|NCT02743923|Pemetrexed|pemetrexed|mesh-list
83113177|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83113178|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113179|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
83113180|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
83113181|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
83113182|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113183|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113184|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83113185|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83113186|NCT02743923|Growth Substances|growth substances|mesh-ancestor
83113187|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113188|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
83113189|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113190|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83113191|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83113192|NCT01065779|Alendronate|alendronate|mesh-list
83113193|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83113194|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113195|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83113196|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113197|NCT03570359|Interferons|interferons|mesh-list
83113198|NCT03570359|Interferon-beta|interferon-beta|mesh-list
83113199|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
83113200|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113201|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
83113202|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113203|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
83113204|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113205|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83113206|NCT02358200|Paclitaxel|paclitaxel|mesh-list
83113207|NCT02358200|Carboplatin|carboplatin|mesh-list
83113208|NCT02358200|Talazoparib|talazoparib|mesh-list
83113209|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83113210|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113211|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83113212|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83113213|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83113214|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113215|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83113216|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113217|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
83113218|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
83113219|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113220|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83113221|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113222|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492541|NCT01561703|Clindamycin|clindamycin|mesh-list
83113223|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83113224|NCT03127605|Immunotoxins|immunotoxins|mesh-ancestor
83113225|NCT03127605|Immunoconjugates|immunoconjugates|mesh-ancestor
83113226|NCT03127605|Immunologic Factors|immunologic factors|mesh-ancestor
83113227|NCT03127605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113228|NCT03112538|Insulin|insulin|mesh-list
83113229|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83113230|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83113231|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113232|NCT05283551|Famciclovir|famciclovir|mesh-list
83113233|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
83113234|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113235|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83113236|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113237|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113238|NCT02357732|Nivolumab|nivolumab|mesh-list
83113239|NCT02357732|Trametinib|trametinib|mesh-list
83113240|NCT02357732|Dabrafenib|dabrafenib|mesh-list
83113241|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113242|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113243|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83113244|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113245|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83113246|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113247|NCT03160040|Minocycline|minocycline|mesh-list
83113248|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83113249|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113250|NCT03112148|Tofacitinib|tofacitinib|mesh-list
83113251|NCT03112148|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83113252|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83113253|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113254|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113255|NCT03423849|Gemcitabine|gemcitabine|mesh-list
83113256|NCT03423849|Capecitabine|capecitabine|mesh-list
83113257|NCT03423849|Vinorelbine|vinorelbine|mesh-list
83113258|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113259|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83113260|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
83113261|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113262|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83113263|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
83113264|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
83113265|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
83113266|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83113267|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
83113268|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113269|NCT02362256|Clonidine|clonidine|mesh-list
83113270|NCT02362256|Naltrexone|naltrexone|mesh-list
83113271|NCT02362256|Lorazepam|lorazepam|mesh-list
83113272|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83113273|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83113274|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113275|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
83113276|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113277|NCT02362256|Analgesics|analgesics|mesh-ancestor
83113278|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83113279|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
83113280|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
83113281|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83113282|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83113283|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83113284|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83113285|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113286|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113287|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
83113288|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
83113289|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113290|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83113291|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113292|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83113293|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83113294|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83113295|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
83113296|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
83113297|NCT03412305|Amoxicillin|amoxicillin|mesh-list
83113298|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83113299|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113300|NCT02109081|Dexamethasone|dexamethasone|mesh-list
83113301|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83113302|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
83113303|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
83113304|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113305|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113306|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113307|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
83113308|NCT02109081|Hormones|hormones|mesh-ancestor
83113309|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113310|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83113311|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113312|NCT04259996|Estradiol|estradiol|mesh-list
83113313|NCT04259996|Progesterone|progesterone|mesh-list
83113314|NCT04259996|Estrogens|estrogens|mesh-ancestor
83113315|NCT04259996|Hormones|hormones|mesh-ancestor
83113316|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113317|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113318|NCT04259996|Progestins|progestins|mesh-ancestor
83113319|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83113320|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83113321|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83113322|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
83113323|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83113324|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
83113325|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83113326|NCT03397875|Protective Agents|protective agents|mesh-ancestor
83113327|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113328|NCT02362022|Morphine|morphine|mesh-list
83113329|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83113330|NCT02362022|Narcotics|narcotics|mesh-ancestor
83113331|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113332|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113333|NCT02362022|Analgesics|analgesics|mesh-ancestor
83113334|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
83113335|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113336|NCT03412071|Metronidazole|metronidazole|mesh-list
83113337|NCT03412071|Clindamycin|clindamycin|mesh-list
83113338|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
83113339|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
83113340|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83113341|NCT03412071|Tinidazole|tinidazole|mesh-list
83113342|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113343|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83113344|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83113345|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83113346|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83113347|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113348|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113349|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83113350|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
83113351|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83113352|NCT03397797|Rocuronium|rocuronium|mesh-list
83113353|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83113354|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83113355|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83113356|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113357|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113358|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83113359|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113360|NCT05170581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113361|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113362|NCT02351882|Nabilone|nabilone|mesh-list
83113363|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
83113364|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
83113365|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113366|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113367|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113368|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83113369|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83113370|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113371|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83113372|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
83113373|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
83113374|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
83113375|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113376|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113377|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
83113378|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113380|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83113381|NCT05169801|Carboplatin|carboplatin|mesh-list
83113382|NCT05169801|Bevacizumab|bevacizumab|mesh-list
83113383|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83113384|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113385|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
83113386|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
83113387|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
83113388|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113389|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113390|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83113391|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83113392|NCT05169801|Growth Substances|growth substances|mesh-ancestor
83113393|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113394|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
83113395|NCT04447443|Loperamide|loperamide|mesh-list
83113396|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
83113397|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113398|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83113399|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83113400|NCT01345253|Belimumab|belimumab|mesh-list
83113401|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83113402|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
83113403|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113404|NCT03397329|Mitapivat|mitapivat|mesh-list
83113405|NCT03397329|Enzyme Activators|enzyme activators|mesh-ancestor
83113406|NCT03397329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113407|NCT03150134|Cyclosporine|cyclosporine|mesh-list
83113408|NCT03150134|Cyclosporins|cyclosporins|mesh-list
83113409|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83113410|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113411|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113412|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
83113413|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113414|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
83113415|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113416|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
83113417|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83113418|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83113420|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
83113421|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113422|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83113423|NCT02351804|Dexamethasone|dexamethasone|mesh-list
83113424|NCT02351804|Ropivacaine|ropivacaine|mesh-list
83113425|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83113426|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
83113427|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
83113428|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113429|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113430|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113431|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
83113432|NCT02351804|Hormones|hormones|mesh-ancestor
83113433|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113434|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83113435|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113436|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
83113437|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
83113438|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113439|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
83113440|NCT03640403|Artesunate|artesunate|mesh-list
83113441|NCT03640403|Piperaquine|piperaquine|mesh-list
83113442|NCT03640403|Amodiaquine|amodiaquine|mesh-list
83113443|NCT03640403|Artenimol|artenimol|mesh-list
83113444|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
83113445|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83113446|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83113447|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113448|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113449|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
83113450|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
83113451|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83113452|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
83113454|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
83113455|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83113456|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113457|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
83113458|NCT03397173|Azacitidine|azacitidine|mesh-list
83113459|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83113460|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
83113461|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113462|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113463|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113464|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
83113465|NCT03397173|Protective Agents|protective agents|mesh-ancestor
83113466|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113467|NCT03397173|Vitamins|vitamins|mesh-ancestor
83113468|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
83113469|NCT03640247|Acetaminophen|acetaminophen|mesh-list
83113470|NCT03640247|Ibuprofen|ibuprofen|mesh-list
83113471|NCT03640247|Oxycodone|oxycodone|mesh-list
83113472|NCT03640247|Tramadol|tramadol|mesh-list
83113473|NCT03640247|Hydrocodone|hydrocodone|mesh-list
83113474|NCT03640247|Narcotics|narcotics|mesh-list
83113475|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83113476|NCT03640247|Analgesics|analgesics|mesh-ancestor
83113477|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
83113478|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113479|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113480|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
83113481|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83113482|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83113483|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83113484|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83113485|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113486|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113487|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83113488|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113489|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
83113490|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
83113491|NCT03394131|Insulin|insulin|mesh-list
83113492|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83113493|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83113494|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113495|NCT02360618|Metformin|metformin|mesh-list
83113496|NCT02360618|Simvastatin|simvastatin|mesh-list
83113497|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83113498|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113499|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83113500|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83113501|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
83113502|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113503|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83113504|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83113505|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113506|NCT05214183|Rituximab|rituximab|mesh-list
83113507|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
83113508|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113509|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113510|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
83113511|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113512|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83113513|NCT01344161|Vitamin D|vitamin d|mesh-list
83113514|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
83113515|NCT01344161|Vitamins|vitamins|mesh-ancestor
83113516|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
83113517|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113518|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83113519|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83113520|NCT02451358|Vaccines|vaccines|mesh-list
83113521|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
83113522|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113523|NCT02360384|Linaclotide|linaclotide|mesh-list
83113524|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83113525|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
83113526|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113527|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113528|NCT03396861|Aflibercept|aflibercept|mesh-list
83113529|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83492542|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
83113530|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83113531|NCT03396861|Growth Substances|growth substances|mesh-ancestor
83113532|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113533|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83113534|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113535|NCT02749721|Vortioxetine|vortioxetine|mesh-list
83113536|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
83113537|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83113538|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83113539|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83113540|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113541|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113542|NCT02749721|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83113543|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83113544|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83113545|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113546|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113547|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
83113548|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83113549|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83113550|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83113551|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83113552|NCT02351102|Valacyclovir|valacyclovir|mesh-list
83113553|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
83113554|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113556|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83113557|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83113558|NCT02351024|Analgesics|analgesics|mesh-ancestor
83113560|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113561|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113562|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83113563|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83113564|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
83113565|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83113566|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113567|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113568|NCT02355704|Atorvastatin|atorvastatin|mesh-list
83113569|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83113570|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83113571|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
83113572|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113573|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83113574|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83113575|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113576|NCT03396393|Artenimol|artenimol|mesh-list
83113577|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
83113578|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83113579|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83113580|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113581|NCT03393819|Ethanol|ethanol|mesh-list
83113582|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
83113583|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83113584|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113585|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83468688|NCT00002716|Vitamins|vitamins|mesh-ancestor
83113586|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113587|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
83113588|NCT03393507|Apatinib|apatinib|mesh-list
83113589|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113590|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83113591|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113592|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113593|NCT01348139|AZD-3199|azd-3199|mesh-list
83113594|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83113595|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83113596|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83113597|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
83113598|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113599|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113600|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113601|NCT02355236|Celecoxib|celecoxib|mesh-list
83113602|NCT02355236|Naproxen|naproxen|mesh-list
83113603|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83113604|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83113605|NCT02355236|Analgesics|analgesics|mesh-ancestor
83113606|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
83113607|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113608|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113609|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83113610|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83113611|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83113612|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83113613|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113614|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113615|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
83113616|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83113617|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113618|NCT02359604|Esomeprazole|esomeprazole|mesh-list
83113619|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83113620|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113621|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83113622|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113623|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113624|NCT03410511|Nicotine|nicotine|mesh-list
83113625|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83113626|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
83113627|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113628|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113629|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83113630|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83113631|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
83113632|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113633|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113634|NCT05169021|Folic Acid|folic acid|mesh-list
83113635|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
83113636|NCT05169021|Amlodipine|amlodipine|mesh-list
83113637|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
83113638|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83113639|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83113640|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113641|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83113642|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113643|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
83113644|NCT05169021|Hematinics|hematinics|mesh-ancestor
83113645|NCT05169021|Vitamins|vitamins|mesh-ancestor
83113646|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
83113647|NCT02359292|Charcoal|charcoal|mesh-list
83113648|NCT02359292|Antidotes|antidotes|mesh-ancestor
83113649|NCT02359292|Protective Agents|protective agents|mesh-ancestor
83113650|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113651|NCT05168787|Valsartan|valsartan|mesh-list
83113652|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83113653|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83113654|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83113655|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83113656|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113657|NCT02359214|Vitamin D|vitamin d|mesh-list
83113658|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
83113659|NCT02359214|Vitamins|vitamins|mesh-ancestor
83113660|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
83113661|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113662|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83113663|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83113664|NCT02359370|Lidocaine|lidocaine|mesh-list
83113665|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
83113666|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
83113667|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
83113668|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113669|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113670|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
83113671|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113672|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83113673|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83113674|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83113675|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83113676|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113677|NCT02359370|Analgesics|analgesics|mesh-ancestor
83113678|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
83113679|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83113680|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83113681|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
83113682|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83113684|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
83113685|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113686|NCT02359448|Protective Agents|protective agents|mesh-ancestor
83113687|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113688|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113689|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83113690|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83113691|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
83113692|NCT02359526|Hormones|hormones|mesh-ancestor
83113693|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113694|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113695|NCT03618953|Atezolizumab|atezolizumab|mesh-list
83113696|NCT03618953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83113697|NCT03618953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113698|NCT03618953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113699|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113700|NCT02354768|Lanreotide|lanreotide|mesh-list
83113701|NCT02354768|Loperamide|loperamide|mesh-list
83113702|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
83113703|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113704|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113705|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
83113706|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83113707|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83113708|NCT02354612|Bevacizumab|bevacizumab|mesh-list
83113709|NCT02354612|Capecitabine|capecitabine|mesh-list
83113710|NCT02354612|Axitinib|axitinib|mesh-list
83113711|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113712|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113713|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83113714|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83113715|NCT02354612|Growth Substances|growth substances|mesh-ancestor
83113716|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113717|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
83113718|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83113719|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
83113720|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113721|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83113722|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113723|NCT02348450|Irinotecan|irinotecan|mesh-list
83113724|NCT02348450|Etoposide|etoposide|mesh-list
83113725|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113726|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83113727|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83113728|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113729|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113730|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83113731|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83113732|NCT03393273|Elotuzumab|elotuzumab|mesh-list
83113733|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113734|NCT03613597|Etoposide|etoposide|mesh-list
83113735|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
83113736|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113737|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83113738|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83113739|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83113740|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113741|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113742|NCT02348372|Glycine|glycine|mesh-list
83113743|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
83113744|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113745|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113746|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113747|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83113748|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
83113749|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113750|NCT03614533|Vaccines|vaccines|mesh-list
83113751|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
83113752|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113753|NCT03147404|Avelumab|avelumab|mesh-list
83113754|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113755|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113756|NCT03614455|Itraconazole|itraconazole|mesh-list
83113757|NCT03614455|Posaconazole|posaconazole|mesh-list
83113758|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
83113759|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
83113760|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113761|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83113762|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83113763|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113764|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113765|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83113766|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
83113767|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113768|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113769|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83113770|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83113771|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83113772|NCT03393117|Narcotics|narcotics|mesh-list
83113773|NCT03393117|Bupivacaine|bupivacaine|mesh-list
83113774|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
83113775|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
83113776|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113777|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113778|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
83113779|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113780|NCT03393117|Analgesics|analgesics|mesh-ancestor
83113781|NCT02032303|Ticagrelor|ticagrelor|mesh-list
83113782|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83113783|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83113784|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83113785|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83113786|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83113787|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
83113788|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113789|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113790|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113791|NCT04297293|Ramosetron|ramosetron|mesh-list
83113792|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
83113793|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
83113794|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113795|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113796|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113797|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83113798|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
83113799|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113800|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113801|NCT03392961|Insulin|insulin|mesh-list
83113802|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83113803|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113804|NCT02350946|Oxytocin|oxytocin|mesh-list
83113805|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
83113806|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83113807|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113808|NCT00000371|Cycloserine|cycloserine|mesh-list
83113809|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83113810|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113811|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83113812|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
83113813|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83113814|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
83113815|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113816|NCT02350712|Carboplatin|carboplatin|mesh-list
83113817|NCT02350712|Cetuximab|cetuximab|mesh-list
83113818|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113819|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83113820|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83113821|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83113822|NCT03618797|Fenofibrate|fenofibrate|mesh-list
83113823|NCT03618797|Pitavastatin|pitavastatin|mesh-list
83113824|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83113825|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
83113826|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113827|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83113828|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83113829|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83113830|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113831|NCT03149432|Gabapentin|gabapentin|mesh-list
83113832|NCT03149432|Analgesics|analgesics|mesh-ancestor
83113833|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
83113834|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113835|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113836|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
83113837|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83113838|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83113839|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113840|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83113841|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83113842|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83113843|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113844|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113845|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
83113846|NCT05384483|Cariprazine|cariprazine|mesh-list
83113847|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83113848|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83113849|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113850|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113851|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83113852|NCT05061563|Esomeprazole|esomeprazole|mesh-list
83113853|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83113854|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83113855|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83113856|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113857|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113858|NCT03147092|Losartan|losartan|mesh-list
83113859|NCT03147092|Atenolol|atenolol|mesh-list
83113860|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83113861|NCT03147092|Clonidine|clonidine|mesh-list
83113862|NCT03147092|Captopril|captopril|mesh-list
83113863|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83113864|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83113865|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83113866|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83113867|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113868|NCT03147092|Diuretics|diuretics|mesh-ancestor
83113869|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
83113870|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113871|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83113872|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83113873|NCT03147092|Analgesics|analgesics|mesh-ancestor
83113874|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
83113875|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113876|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
83113877|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
83113878|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83113879|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83113880|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83113881|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
83113882|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113883|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83113884|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83113885|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83113886|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83113887|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
83113888|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113889|NCT03149588|Propofol|propofol|mesh-list
83113890|NCT03149588|Sevoflurane|sevoflurane|mesh-list
83113891|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83113892|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113893|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113894|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83113895|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
83113896|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
83113897|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83113898|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83113899|NCT03613207|Lidocaine|lidocaine|mesh-list
83113900|NCT03613207|Prilocaine|prilocaine|mesh-list
83113901|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
83113902|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
83113903|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113904|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113905|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
83113906|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83113907|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83113908|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83113909|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83113910|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83113911|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113912|NCT03612739|Azacitidine|azacitidine|mesh-list
83113913|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83113914|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
83113915|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113916|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113917|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113918|NCT02350400|Irinotecan|irinotecan|mesh-list
83113919|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83113920|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83113921|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83113922|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113923|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113924|NCT03612817|Timolol|timolol|mesh-list
83113925|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83113926|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83113927|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
83113928|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113929|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113930|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113931|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83113932|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83113933|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
83113934|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113935|NCT03612349|Menthol|menthol|mesh-list
83113936|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
83113937|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
83113938|NCT03146858|Enoxaparin|enoxaparin|mesh-list
83113939|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
83113940|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83113941|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83113942|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113943|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83113944|NCT03408405|Hormones|hormones|mesh-ancestor
83113945|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113946|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113947|NCT03408093|Interferons|interferons|mesh-list
83113948|NCT03408093|Interferon-beta|interferon-beta|mesh-list
83113949|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
83113950|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113951|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
83113952|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83113953|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
83113954|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113955|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83113956|NCT04679623|Midazolam|midazolam|mesh-list
83113957|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83113958|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83113959|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83113960|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113961|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83113962|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83113963|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83113964|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83113965|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
83113967|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
83113968|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
83113969|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83113970|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113971|NCT02353988|Bicalutamide|bicalutamide|mesh-list
83113972|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
83113973|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
83113974|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83113975|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113976|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113977|NCT03392571|Paclitaxel|paclitaxel|mesh-list
83113978|NCT03392571|Cisplatin|cisplatin|mesh-list
83113979|NCT03392571|Gemcitabine|gemcitabine|mesh-list
83113980|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83113981|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83113982|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83113983|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83113984|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83113985|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113986|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83113987|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
83113988|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
83113989|NCT04656067|Ethamsylate|ethamsylate|mesh-list
83113990|NCT04656067|Oxytocin|oxytocin|mesh-list
83113991|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
83113992|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83113993|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83113994|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83113995|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83113996|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83113997|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
83113998|NCT04656067|Coagulants|coagulants|mesh-ancestor
83113999|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
83114000|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
83114001|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114002|NCT03612037|Protective Agents|protective agents|mesh-ancestor
83114003|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114004|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
83114005|NCT03612037|Vitamins|vitamins|mesh-ancestor
83114006|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
83114007|NCT04447209|Chrysarobin|chrysarobin|mesh-list
83114008|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83114009|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114010|NCT04447209|Analgesics|analgesics|mesh-ancestor
83468717|NCT00002734|Antibodies|antibodies|mesh-list
83114011|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
83114012|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114013|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114014|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114015|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114016|NCT04199624|Omeprazole|omeprazole|mesh-list
83114017|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114018|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83114019|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114020|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83114021|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114022|NCT03611491|Lidocaine|lidocaine|mesh-list
83114023|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
83114024|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
83114025|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114026|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114027|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
83114028|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114029|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83114030|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83114031|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83114032|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83114033|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114034|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83114035|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
83114036|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114037|NCT03611179|Bevacizumab|bevacizumab|mesh-list
83114038|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114039|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114040|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83114041|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83114042|NCT03611179|Growth Substances|growth substances|mesh-ancestor
83114043|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114044|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
83114045|NCT03126123|Acetic Acid|acetic acid|mesh-list
83114046|NCT03126123|Retinol acetate|retinol acetate|mesh-list
83114047|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83114048|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114049|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83114050|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
83114051|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114052|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83114053|NCT03126123|Protective Agents|protective agents|mesh-ancestor
83114054|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114055|NCT02353676|Bupivacaine|bupivacaine|mesh-list
83114056|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
83114057|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
83114058|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114059|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114060|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
83114061|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114062|NCT03617471|Acetaminophen|acetaminophen|mesh-list
83114063|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114064|NCT03617471|Analgesics|analgesics|mesh-ancestor
83114065|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
83114066|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114067|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114068|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
83114069|NCT05168007|Cariprazine|cariprazine|mesh-list
83114070|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83114071|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83114072|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114073|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114074|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83114075|NCT02032927|Acetaminophen|acetaminophen|mesh-list
83114077|NCT02032927|Codeine|codeine|mesh-list
83114078|NCT02032927|Naloxone|naloxone|mesh-list
83114079|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114080|NCT02032927|Analgesics|analgesics|mesh-ancestor
83114081|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
83114082|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114083|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114084|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
83114085|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83114086|NCT02032927|Narcotics|narcotics|mesh-ancestor
83114087|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114088|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83114089|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
83114090|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114091|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83114092|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
83114093|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114094|NCT03392103|Raltitrexed|raltitrexed|mesh-list
83114095|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83114096|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
83114097|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114098|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114099|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83114100|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114101|NCT03610945|Fluconazole|fluconazole|mesh-list
83114102|NCT03610945|Quinidine|quinidine|mesh-list
83114103|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
83114104|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114105|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83114106|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83114107|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114108|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114109|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83114110|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
83492619|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
83114111|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114112|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114113|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83114114|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83114115|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83114116|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83114117|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
83114118|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114119|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83114120|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
83114121|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83114122|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83114123|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83114124|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83114125|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
83114126|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83114127|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83114128|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83114129|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83114130|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
83114131|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83114133|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83114134|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114135|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114136|NCT02236715|Ipratropium|ipratropium|mesh-list
83114137|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83114138|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
83468735|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114139|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114140|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114141|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83114142|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114143|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83114144|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
83114145|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114146|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114147|NCT03823365|Blinatumomab|blinatumomab|mesh-list
83114148|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114149|NCT03616691|Bevacizumab|bevacizumab|mesh-list
83114150|NCT03616691|Atezolizumab|atezolizumab|mesh-list
83114151|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83114152|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114153|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114154|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83114155|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83114156|NCT03616691|Growth Substances|growth substances|mesh-ancestor
83114157|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114158|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
83114159|NCT03616691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83114160|NCT03616691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114161|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
83114162|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
83114163|NCT03158168|Astringents|astringents|mesh-ancestor
83114164|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114165|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
83114166|NCT02865499|Acarbose|acarbose|mesh-list
83114167|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83114168|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114169|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114170|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83114171|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114172|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
83114173|NCT03156062|Salicylates|salicylates|mesh-list
83114174|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114175|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
83114176|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
83114177|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83114178|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83114179|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114180|NCT03156062|Analgesics|analgesics|mesh-ancestor
83114181|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
83114182|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114183|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114184|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114185|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114186|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83114187|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114188|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114189|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83114190|NCT02568553|Lenalidomide|lenalidomide|mesh-list
83114191|NCT02568553|Blinatumomab|blinatumomab|mesh-list
83114192|NCT02568553|Antibodies|antibodies|mesh-list
83114193|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
83114194|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83114195|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
83114196|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83114197|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
83114198|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114199|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114200|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83114201|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83114202|NCT02568553|Growth Substances|growth substances|mesh-ancestor
83114203|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
83114204|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114205|NCT03404739|Ceftazidime|ceftazidime|mesh-list
83114206|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83114207|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114208|NCT02031965|Dexamethasone|dexamethasone|mesh-list
83114209|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114210|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
83114211|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
83114212|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114213|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114214|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114215|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
83114216|NCT02031965|Hormones|hormones|mesh-ancestor
83114217|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114218|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114219|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114220|NCT03149120|Nivolumab|nivolumab|mesh-list
83114221|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114222|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114223|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83114224|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114225|NCT04849325|Sirolimus|sirolimus|mesh-list
83114226|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83114227|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114228|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83114229|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114230|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
83114231|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114232|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
83114233|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114234|NCT03403023|Cyclosporine|cyclosporine|mesh-list
83114235|NCT03403023|Cyclosporins|cyclosporins|mesh-list
83114236|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114237|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114238|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114239|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
83114240|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114241|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
83114242|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114243|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
83114244|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114245|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83114246|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
83114247|NCT02864407|Olodaterol|olodaterol|mesh-list
83114248|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83114249|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
83114250|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114251|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114252|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83114253|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114254|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
83114255|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83114256|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
83114257|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114258|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114259|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83114260|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83114261|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114262|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83114263|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114264|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114265|NCT03394989|Fluticasone|fluticasone|mesh-list
83114266|NCT03394989|Xhance|xhance|mesh-list
83114267|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83468752|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
83114268|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83114269|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114270|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83114271|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
83114272|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114273|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114274|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83114275|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114276|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83114277|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83114278|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83114279|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83114280|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83114281|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
83114282|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114283|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114284|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
83114285|NCT03394989|Hormones|hormones|mesh-ancestor
83114286|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114287|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
83114288|NCT02033239|Insulin|insulin|mesh-list
83114289|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83114290|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
83114291|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
83114292|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83114293|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83114294|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114295|NCT02486302|Etanercept|etanercept|mesh-list
83114296|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83114297|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114298|NCT02486302|Analgesics|analgesics|mesh-ancestor
83114299|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
83114300|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114301|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114302|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114303|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114304|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114305|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114306|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
83114307|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83114308|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114309|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83114310|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114311|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114312|NCT03615833|Vitamin D|vitamin d|mesh-list
83114313|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
83114314|NCT03615833|Vitamins|vitamins|mesh-ancestor
83114315|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
83114316|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114317|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83114318|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83114319|NCT02747875|Fentanyl|fentanyl|mesh-list
83114320|NCT02747875|Methadone|methadone|mesh-list
83114321|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83114322|NCT02747875|Narcotics|narcotics|mesh-ancestor
83114323|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114324|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114325|NCT02747875|Analgesics|analgesics|mesh-ancestor
83114326|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
83114327|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114328|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83114329|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83114330|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
83114331|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
83114332|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
83114333|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114334|NCT03394833|Polygeline|polygeline|mesh-list
83114335|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
83114336|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
83114337|NCT02347358|Plasminogen|plasminogen|mesh-list
83114338|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83114339|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83114340|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83114341|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114342|NCT03610321|Gefarnate|gefarnate|mesh-list
83114343|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83114344|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114345|NCT02236793|Becaplermin|becaplermin|mesh-list
83114346|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
83114347|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83114348|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83114349|NCT02236793|Growth Substances|growth substances|mesh-ancestor
83114350|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114351|NCT02347046|Dotinurad|dotinurad|mesh-list
83114352|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
83114353|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
83114354|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114355|NCT03391245|Vitamin D|vitamin d|mesh-list
83114356|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83114357|NCT03391245|Calcifediol|calcifediol|mesh-list
83114358|NCT03391245|Vitamins|vitamins|mesh-ancestor
83114359|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
83114360|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114361|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83114362|NCT03401619|Vitamin D|vitamin d|mesh-list
83114363|NCT03401619|Calcitonin|calcitonin|mesh-list
83114364|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
83114365|NCT03401619|Diphosphonates|diphosphonates|mesh-list
83114366|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83114367|NCT03401619|Katacalcin|katacalcin|mesh-list
83114368|NCT03401619|Vitamins|vitamins|mesh-ancestor
83114369|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
83114370|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114371|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83114372|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83114373|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
83114374|NCT03399903|Mesalamine|mesalamine|mesh-list
83114375|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83114376|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114377|NCT03399903|Analgesics|analgesics|mesh-ancestor
83114378|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
83114379|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114380|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114381|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114382|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114383|NCT03146468|Nivolumab|nivolumab|mesh-list
83114384|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114385|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114386|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83114387|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114388|NCT02353130|Memantine|memantine|mesh-list
83114389|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83114390|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83114391|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
83114392|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114393|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114394|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114395|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83114396|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83114397|NCT02033551|Paclitaxel|paclitaxel|mesh-list
83114398|NCT02033551|Carboplatin|carboplatin|mesh-list
83114399|NCT02033551|Veliparib|veliparib|mesh-list
83114400|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83114401|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114402|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
83114403|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
83114404|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
83114405|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114406|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83114407|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114408|NCT02450578|Atovaquone|atovaquone|mesh-list
83114409|NCT02450578|Proguanil|proguanil|mesh-list
83114410|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83114411|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114412|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
83114413|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83114414|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83114415|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114416|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114417|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
83114418|NCT02346890|Sevelamer|sevelamer|mesh-list
83114419|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
83114420|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
83114421|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114422|NCT03146390|Listerine|listerine|mesh-list
83114423|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
83114424|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83114425|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114426|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
83114427|NCT03146390|Protective Agents|protective agents|mesh-ancestor
83114428|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114429|NCT02859415|Plicamycin|plicamycin|mesh-list
83114430|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83114431|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114432|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83114433|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114434|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83114435|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114436|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114437|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83114438|NCT02871791|Everolimus|everolimus|mesh-list
83114439|NCT02871791|Palbociclib|palbociclib|mesh-list
83114440|NCT02871791|Exemestane|exemestane|mesh-list
83114441|NCT02871791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83114442|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83114443|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114444|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114445|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114446|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
83114447|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114448|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114449|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83114450|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83114451|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83114452|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
83114453|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114454|NCT02346578|Flutamide|flutamide|mesh-list
83114455|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
83114456|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
83114457|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114458|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114459|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114460|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114461|NCT03112382|Vitamins|vitamins|mesh-list
83114462|NCT03112382|Vitamin A|vitamin a|mesh-list
83114463|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
83114464|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
83114465|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114466|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
83114467|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114468|NCT03112382|Protective Agents|protective agents|mesh-ancestor
83114469|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83114470|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114471|NCT03399669|Gefitinib|gefitinib|mesh-list
83114472|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114473|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83114474|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114475|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114476|NCT03148574|Misoprostol|misoprostol|mesh-list
83114477|NCT03148574|Oxytocin|oxytocin|mesh-list
83114478|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
83114479|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83114480|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114481|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83114482|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
83114483|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83114484|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114485|NCT02343536|Prednisone|prednisone|mesh-list
83114486|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
83114487|NCT02343536|Rituximab|rituximab|mesh-list
83114488|NCT02343536|Vincristine|vincristine|mesh-list
83114489|NCT02343536|Azacitidine|azacitidine|mesh-list
83114490|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114491|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
83114492|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114493|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114494|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83114495|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
83114496|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114497|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114498|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83114499|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114500|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114501|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
83114502|NCT02343536|Hormones|hormones|mesh-ancestor
83114503|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114504|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114505|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83114506|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
83114507|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
83114508|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
83114509|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83114510|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
83114511|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114512|NCT02343614|Celecoxib|celecoxib|mesh-list
83114513|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83114515|NCT02343614|Analgesics|analgesics|mesh-ancestor
83114516|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
83114517|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114518|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114519|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114520|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114521|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83114522|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83114523|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114524|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114525|NCT02871635|Adalimumab|adalimumab|mesh-list
83114526|NCT02871635|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83114527|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114528|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114529|NCT03390465|Amlodipine|amlodipine|mesh-list
83114530|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83114531|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83114532|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83114533|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83114534|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114535|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83114536|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114537|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
83114538|NCT03390465|Diuretics|diuretics|mesh-ancestor
83114539|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
83114540|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83114541|NCT03390387|Dexamethasone|dexamethasone|mesh-list
83114542|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
83114543|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
83114544|NCT03390387|Bortezomib|bortezomib|mesh-list
83114545|NCT03390387|Daunorubicin|daunorubicin|mesh-list
83114546|NCT03390387|Idarubicin|idarubicin|mesh-list
83114547|NCT03390387|BB 1101|bb 1101|mesh-list
83114548|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114549|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
83114550|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
83114551|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114552|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114553|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114554|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
83114555|NCT03390387|Hormones|hormones|mesh-ancestor
83133563|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114556|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114557|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114558|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114559|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
83114560|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114561|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114562|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83114563|NCT03390387|Protective Agents|protective agents|mesh-ancestor
83114564|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83114565|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83114566|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83114567|NCT03146000|Meloxicam|meloxicam|mesh-list
83114568|NCT03146000|Lidocaine|lidocaine|mesh-list
83114569|NCT03146000|Prilocaine|prilocaine|mesh-list
83114570|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83114571|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
83114572|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
83114573|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114574|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114575|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
83114576|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114577|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83114578|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83114579|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83114580|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83114581|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114582|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83114583|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114584|NCT03146000|Analgesics|analgesics|mesh-ancestor
83114585|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114586|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114587|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83114588|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83114589|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114590|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83114591|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
83114592|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
83114593|NCT02346188|Trace Elements|trace elements|mesh-ancestor
83114594|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
83114595|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114596|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83114597|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
83114598|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83114599|NCT02346188|Protective Agents|protective agents|mesh-ancestor
83114600|NCT02477332|Omalizumab|omalizumab|mesh-list
83114601|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83114602|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83114603|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114604|NCT02346110|Dexamethasone|dexamethasone|mesh-list
83114605|NCT02346110|Epinephrine|epinephrine|mesh-list
83114606|NCT02346110|Racepinephrine|racepinephrine|mesh-list
83114607|NCT02346110|Bupivacaine|bupivacaine|mesh-list
83114608|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
83114609|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114610|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
83114611|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
83114612|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114613|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114614|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114615|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
83114616|NCT02346110|Hormones|hormones|mesh-ancestor
83114617|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114618|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114619|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114620|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
83114621|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
83114622|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114623|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
83114624|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83114625|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83114626|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83114627|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114628|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114629|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83114630|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83114631|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83114632|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114633|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
83114634|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
83114635|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83114636|NCT02348528|Dexamethasone|dexamethasone|mesh-list
83114637|NCT02348528|Lenalidomide|lenalidomide|mesh-list
83114638|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114639|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
83114640|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
83114641|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114642|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114643|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114644|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
83114645|NCT02348528|Hormones|hormones|mesh-ancestor
83114646|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114647|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114648|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114649|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
83114650|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83114651|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83114652|NCT02348528|Growth Substances|growth substances|mesh-ancestor
83114653|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
83114654|NCT02342600|Trametinib|trametinib|mesh-list
83114655|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114656|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83114657|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114658|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114659|NCT03147638|Warfarin|warfarin|mesh-list
83468784|NCT01049945|Hormones|hormones|mesh-ancestor
83114660|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
83114661|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
83114662|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83114663|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83114664|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
83114665|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
83114666|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114667|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114668|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
83114669|NCT02862535|Nivolumab|nivolumab|mesh-list
83114670|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114671|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114672|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83114673|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114674|NCT02033707|Scopolamine|scopolamine|mesh-list
83114675|NCT02033707|Hallucinogens|hallucinogens|mesh-list
83114676|NCT02033707|Nicotine|nicotine|mesh-list
83114677|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
83114678|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83114679|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
83114680|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114681|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114682|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83114683|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83114684|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
83114685|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114686|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114687|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83114688|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
83114689|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114690|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
83114691|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83114692|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83114693|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
83114694|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83114695|NCT02039336|Docetaxel|docetaxel|mesh-list
83114696|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114697|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83114698|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
83114699|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83114700|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114701|NCT04935476|Dapsone|dapsone|mesh-list
83114702|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114703|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
83114704|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83114705|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83114706|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83114707|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133564|NCT03282513|Ivosidenib|ivosidenib|mesh-list
83114708|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114709|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
83114710|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83114712|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83114713|NCT02476006|Simvastatin|simvastatin|mesh-list
83114714|NCT02476006|Ezetimibe|ezetimibe|mesh-list
83114715|NCT02476006|Alirocumab|alirocumab|mesh-list
83114716|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83114717|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83114718|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
83114719|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114720|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83114721|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83114722|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114723|NCT02476006|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83114724|NCT02476006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83114725|NCT02476006|Protease Inhibitors|protease inhibitors|mesh-ancestor
83114726|NCT02344940|Tamoxifen|tamoxifen|mesh-list
83114727|NCT02344940|Toremifene|toremifene|mesh-list
83114728|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83114729|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
83114730|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114731|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114732|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114733|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114734|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83114735|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83114736|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83114737|NCT03615677|Esomeprazole|esomeprazole|mesh-list
83114738|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83114739|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114740|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83114741|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114742|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114743|NCT02344862|Dotinurad|dotinurad|mesh-list
83114744|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
83114745|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
83114746|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114747|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
83114748|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83114749|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114750|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
83114751|NCT03614273|Epinephrine|epinephrine|mesh-list
83114752|NCT03614273|Racepinephrine|racepinephrine|mesh-list
83114753|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
83114754|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83114755|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83114756|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
83468851|NCT00002788|Dexamethasone|dexamethasone|mesh-list
83114757|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114758|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114759|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114760|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83114761|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83114762|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
83114763|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114764|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83114765|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83114766|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
83114767|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
83114768|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83114769|NCT02336984|Trastuzumab|trastuzumab|mesh-list
83114770|NCT02336984|Pertuzumab|pertuzumab|mesh-list
83114771|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114772|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114773|NCT03145610|Triclosan|triclosan|mesh-list
83114774|NCT03145610|Fluorides|fluorides|mesh-list
83114775|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
83114776|NCT03145610|Protective Agents|protective agents|mesh-ancestor
83114777|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114778|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83114779|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114780|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83114781|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83114782|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
83114783|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114784|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83114785|NCT02341586|Iron|iron|mesh-list
83114786|NCT02341586|Trace Elements|trace elements|mesh-ancestor
83114787|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
83114788|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114789|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83114790|NCT02336906|Laxatives|laxatives|mesh-ancestor
83114791|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114792|NCT03613961|Anesthetics|anesthetics|mesh-list
83114793|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114794|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114795|NCT02341352|Fluorides|fluorides|mesh-list
83114796|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
83114797|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
83114798|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83114799|NCT02341352|Antibodies|antibodies|mesh-list
83114800|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
83114801|NCT02341352|Protective Agents|protective agents|mesh-ancestor
83114802|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114803|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
83114804|NCT02344550|Everolimus|everolimus|mesh-list
83114805|NCT02344550|Letrozole|letrozole|mesh-list
83114806|NCT02344550|Leuprolide|leuprolide|mesh-list
83114807|NCT02344550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83114808|NCT02344550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83114809|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114810|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114811|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114812|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
83468878|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83114813|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114814|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114815|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83114816|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83114817|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83114818|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
83114819|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114820|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83114821|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
83114822|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83114823|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114824|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
83114825|NCT02419612|Glimepiride|glimepiride|mesh-list
83114826|NCT02419612|Saxagliptin|saxagliptin|mesh-list
83114827|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83114828|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114829|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83114830|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114831|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83114832|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83114833|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
83114834|NCT02419612|Incretins|incretins|mesh-ancestor
83114835|NCT02419612|Hormones|hormones|mesh-ancestor
83114836|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114837|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83114838|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
83114839|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114840|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
83114841|NCT03612947|Bupivacaine|bupivacaine|mesh-list
83114842|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
83114843|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
83114844|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114845|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114846|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
83114847|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114848|NCT03612947|Analgesics|analgesics|mesh-ancestor
83114849|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83114850|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
83114851|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83114852|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83114853|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114854|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83114855|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
83114856|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83114857|NCT02344784|Methylphenidate|methylphenidate|mesh-list
83114858|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83114859|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114860|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83114861|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83114862|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83114863|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114864|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
83114865|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114866|NCT02447848|Sufentanil|sufentanil|mesh-list
83114867|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83114868|NCT02447848|Narcotics|narcotics|mesh-ancestor
83114869|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114870|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114871|NCT02447848|Analgesics|analgesics|mesh-ancestor
83114872|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
83114873|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114874|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83114875|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83114876|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
83114877|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
83114878|NCT02336516|Azithromycin|azithromycin|mesh-list
83114879|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83114880|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83114881|NCT05254652|Pregabalin|pregabalin|mesh-list
83114882|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83114883|NCT05254652|Analgesics|analgesics|mesh-ancestor
83114884|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
83114885|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114886|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114887|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
83114888|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83114889|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83114890|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114891|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83114892|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83114893|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83114894|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114895|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83114896|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83114897|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83114898|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114899|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
83114900|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
83114901|NCT02343926|Metformin|metformin|mesh-list
83114902|NCT02343926|Vildagliptin|vildagliptin|mesh-list
83114903|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83114904|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114905|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83114906|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
83114907|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114908|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114909|NCT03112226|Estradiol|estradiol|mesh-list
83114910|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
83114911|NCT03112226|Estrogens|estrogens|mesh-ancestor
83114912|NCT03112226|Hormones|hormones|mesh-ancestor
83114913|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114914|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114915|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
83114916|NCT02343692|Pancrelipase|pancrelipase|mesh-list
83114917|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114918|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
83114919|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83114920|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83114921|NCT02332616|Prednisolone|prednisolone|mesh-list
83114922|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
83114923|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83114924|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
83114925|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114926|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
83114927|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
83114928|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114929|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114930|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114931|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
83114932|NCT02332616|Hormones|hormones|mesh-ancestor
83133565|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114933|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114934|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83114935|NCT02332616|Protective Agents|protective agents|mesh-ancestor
83114936|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114937|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114938|NCT03345173|Ketamine|ketamine|mesh-list
83114939|NCT03345173|Analgesics|analgesics|mesh-ancestor
83114940|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
83114941|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114942|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114943|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83114944|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83114945|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
83114946|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
83114947|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114948|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83114949|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83114950|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114951|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114952|NCT03618173|Dexamethasone|dexamethasone|mesh-list
83114953|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
83114954|NCT03618173|BB 1101|bb 1101|mesh-list
83469091|NCT01055171|Propranolol|propranolol|mesh-list
83114955|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114956|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
83114957|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
83114958|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114959|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114960|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83114961|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
83114962|NCT03618173|Hormones|hormones|mesh-ancestor
83114963|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83114964|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83114965|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114966|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
83114967|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83114968|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114970|NCT02336048|Chlorambucil|chlorambucil|mesh-list
83114971|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83114972|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83114973|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83114974|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
83114975|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114976|NCT03612401|Mirabegron|mirabegron|mesh-list
83114977|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83114978|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83114979|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83114980|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
83114981|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83114982|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83114983|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114984|NCT03612401|Urological Agents|urological agents|mesh-ancestor
83114985|NCT03612323|Piroxicam|piroxicam|mesh-list
83114986|NCT03612323|Carticaine|carticaine|mesh-list
83114987|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
83114988|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
83114989|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83114990|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83114991|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
83114992|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83114993|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83114994|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83114995|NCT03612323|Analgesics|analgesics|mesh-ancestor
83114996|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83114997|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83114998|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83114999|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115000|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115001|NCT02994719|Amantadine|amantadine|mesh-list
83115002|NCT02994719|Levodopa|levodopa|mesh-list
83115003|NCT02994719|Carbidopa|carbidopa|mesh-list
83115004|NCT02994719|Pramipexole|pramipexole|mesh-list
83115005|NCT02994719|Ropinirole|ropinirole|mesh-list
83115006|NCT02994719|Entacapone|entacapone|mesh-list
83115007|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83115008|NCT02994719|Tolcapone|tolcapone|mesh-list
83115009|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83115010|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83115011|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
83115012|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115013|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115014|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115015|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83115016|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115018|NCT02994719|Protective Agents|protective agents|mesh-ancestor
83115019|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
83115020|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
83115021|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115022|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115023|NCT02994719|Analgesics|analgesics|mesh-ancestor
83115024|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
83115025|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115026|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83115027|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83115028|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
83115029|NCT04356638|Midazolam|midazolam|mesh-list
83115030|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
83115031|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83115032|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115033|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115034|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115035|NCT04356638|Analgesics|analgesics|mesh-ancestor
83115036|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
83115037|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115038|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83115039|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83115040|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83115041|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115042|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115043|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115044|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83115045|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83115046|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83115047|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83115048|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83115049|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
83115050|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
83115051|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
83115052|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
83115053|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
83115054|NCT04346108|Antibodies|antibodies|mesh-list
83115055|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
83115056|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83115057|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83115058|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
83115059|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
83115060|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115061|NCT02335736|Cetrorelix|cetrorelix|mesh-list
83115062|NCT02335736|Hormones|hormones|mesh-list
83115063|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
83115064|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115065|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115066|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83115067|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
83115068|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83115069|NCT03613259|Alovudine|alovudine|mesh-list
83115070|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
83115071|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115072|NCT02032355|Anesthetics|anesthetics|mesh-list
83115073|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115074|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115075|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
83115076|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83115077|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
83115078|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115079|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115080|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83115081|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
83115082|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
83115083|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83115084|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
83115085|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115086|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115087|NCT03612557|Penicillins|penicillins|mesh-list
83115088|NCT03612557|Penicillin G|penicillin g|mesh-list
83115089|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83115090|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
83115091|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83115092|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115093|NCT03067844|Alirocumab|alirocumab|mesh-list
83115094|NCT03067844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83115095|NCT03067844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83115096|NCT03067844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83115097|NCT03067844|Antimetabolites|antimetabolites|mesh-ancestor
83115098|NCT03067844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115099|NCT03067844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83115100|NCT03067844|Protease Inhibitors|protease inhibitors|mesh-ancestor
83115101|NCT03067844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115102|NCT03067844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83115103|NCT02340182|Metronidazole|metronidazole|mesh-list
83115104|NCT02340182|Vancomycin|vancomycin|mesh-list
83115105|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
83115106|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115107|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83115108|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83115109|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83115110|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83115111|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83115112|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115113|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115114|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115115|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83115116|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83115117|NCT02339714|Loratadine|loratadine|mesh-list
83115118|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
83115119|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
83115120|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83115121|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83115122|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83115123|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
83115124|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
83115125|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115126|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115127|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115129|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
83115130|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
83115131|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115132|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115133|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
83115134|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115135|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83115136|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83115137|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83115138|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83115139|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115140|NCT02339324|Interferons|interferons|mesh-list
83115141|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
83115142|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
83115143|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
83115144|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83115145|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115146|NCT02339324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83115147|NCT02339324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115148|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
83115149|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115150|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
83115151|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115152|NCT02418754|Aflibercept|aflibercept|mesh-list
83115153|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83115154|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83115155|NCT02418754|Growth Substances|growth substances|mesh-ancestor
83115156|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115157|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
83115158|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115159|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
83115161|NCT02334488|Tacrolimus|tacrolimus|mesh-list
83115162|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83115163|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
83115164|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115165|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83115166|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115167|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115168|NCT02334488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83115169|NCT02334488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83115170|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115171|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83115172|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83115173|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
83115174|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83115175|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115176|NCT02862457|Paclitaxel|paclitaxel|mesh-list
83115177|NCT02862457|Cisplatin|cisplatin|mesh-list
83115178|NCT02862457|Carboplatin|carboplatin|mesh-list
83115179|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
83115180|NCT02862457|Pemetrexed|pemetrexed|mesh-list
83115181|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83115182|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115183|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83115184|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83115185|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83115186|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115187|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83115188|NCT02862457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83115189|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115190|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83115191|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83115192|NCT02334254|Warfarin|warfarin|mesh-list
83115193|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
83115195|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83115196|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83115197|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83115198|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83115199|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
83115200|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115201|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115202|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115203|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
83115204|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83115205|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
83115206|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83115207|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
83115208|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115209|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
83115210|NCT02331602|Dabigatran|dabigatran|mesh-list
83115211|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83115212|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
83115213|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83115214|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
83115215|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115216|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115217|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
83115218|NCT02338934|Vitamin D|vitamin d|mesh-list
83115219|NCT02338934|Cinacalcet|cinacalcet|mesh-list
83115220|NCT02338934|Vitamins|vitamins|mesh-ancestor
83115221|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
83115222|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115223|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83115224|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83115225|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83115226|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
83115227|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115228|NCT03861039|Tirzepatide|tirzepatide|mesh-list
83115229|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83115230|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115231|NCT03861039|Incretins|incretins|mesh-ancestor
83115232|NCT03861039|Hormones|hormones|mesh-ancestor
83115233|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115234|NCT02334176|Lidocaine|lidocaine|mesh-list
83115235|NCT02334176|Epinephrine|epinephrine|mesh-list
83115236|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
83115238|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115239|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115240|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
83115241|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115242|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83115243|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83115244|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83115245|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83115246|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115247|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83115248|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83115249|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115250|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115251|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83115252|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83115253|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
83115254|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83115255|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83115256|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
83115257|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
83115258|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83115259|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
83115260|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115261|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83115262|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83115263|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115264|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115265|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
83115266|NCT03609307|Bevacizumab|bevacizumab|mesh-list
83115267|NCT03609307|Propranolol|propranolol|mesh-list
83115268|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83115269|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115270|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83115271|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83115272|NCT03609307|Growth Substances|growth substances|mesh-ancestor
83115273|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115274|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83115275|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83115276|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83115277|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115278|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115279|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115280|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83115281|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83115282|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
83115283|NCT03399435|Epinephrine|epinephrine|mesh-list
83115284|NCT03399435|Racepinephrine|racepinephrine|mesh-list
83115285|NCT03399435|Bupivacaine|bupivacaine|mesh-list
83115286|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
83115287|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
83115288|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
83115289|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
83115290|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115291|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115292|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
83115293|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115294|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83115295|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83115296|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115297|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115298|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115299|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83115300|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83115301|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
83115302|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83115303|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83115304|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
83115305|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
83115306|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83115307|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83115308|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83115309|NCT01936688|Etanercept|etanercept|mesh-list
83115310|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83115311|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115312|NCT01936688|Analgesics|analgesics|mesh-ancestor
83115313|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
83115314|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115315|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115316|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115317|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83115318|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83115319|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83115320|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
83115321|NCT02338544|Adapalene|adapalene|mesh-list
83115322|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83115323|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
83115324|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83115325|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115326|NCT02338544|Analgesics|analgesics|mesh-ancestor
83115327|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
83115328|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115329|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115330|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115331|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83115332|NCT04446663|Paclitaxel|paclitaxel|mesh-list
83115333|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83115334|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83115335|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115336|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
83115337|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
83115338|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
83115339|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115340|NCT01861496|Cisplatin|cisplatin|mesh-list
83115341|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115342|NCT02520219|Endostar protein|endostar protein|mesh-list
83115343|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83115344|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83115345|NCT02520219|Growth Substances|growth substances|mesh-ancestor
83115346|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115347|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
83115348|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115350|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115351|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83115352|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115353|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115354|NCT02338622|Olaparib|olaparib|mesh-list
83115355|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83115356|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115357|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115358|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115359|NCT02338466|Tenecteplase|tenecteplase|mesh-list
83115360|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83115361|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83115362|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115363|NCT03394209|Oseltamivir|oseltamivir|mesh-list
83115364|NCT03394209|Favipiravir|favipiravir|mesh-list
83115365|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
83115366|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115367|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469243|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
83115368|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115369|NCT03399201|Anesthetics|anesthetics|mesh-list
83115370|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115371|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115372|NCT02520453|Durvalumab|durvalumab|mesh-list
83115373|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83115374|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115375|NCT03389763|Remifentanil|remifentanil|mesh-list
83115376|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83115377|NCT03389763|Narcotics|narcotics|mesh-ancestor
83115378|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115379|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115380|NCT03389763|Analgesics|analgesics|mesh-ancestor
83115381|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
83115382|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115383|NCT02866175|Vitamin K|vitamin k|mesh-list
83115384|NCT02866175|Edoxaban|edoxaban|mesh-list
83115385|NCT02866175|Clopidogrel|clopidogrel|mesh-list
83115386|NCT02866175|Ticagrelor|ticagrelor|mesh-list
83115387|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83115388|NCT02866175|Vitamins|vitamins|mesh-ancestor
83115389|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
83115390|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115391|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83115392|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83115393|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83115394|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83115395|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
83115396|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115397|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115398|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83115399|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83115400|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
83115401|NCT02866175|Coagulants|coagulants|mesh-ancestor
83115402|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83115403|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
83115404|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83115405|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
83115406|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115407|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
83115408|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
83115409|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83115410|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
83115411|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115412|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
83115413|NCT02330822|Protective Agents|protective agents|mesh-ancestor
83115414|NCT02338310|Letrozole|letrozole|mesh-list
83115415|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83115416|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115417|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83115418|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115419|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115420|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83115421|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
83115422|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115423|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115424|NCT03389607|Anesthetics|anesthetics|mesh-list
83115425|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115426|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115427|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
83115428|NCT02817789|Clopidogrel|clopidogrel|mesh-list
83115429|NCT02817789|Ticagrelor|ticagrelor|mesh-list
83115430|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83115431|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83115432|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83469252|NCT01059929|Midazolam|midazolam|mesh-list
83115433|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83115434|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
83115435|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115436|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115437|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115438|NCT02817789|Analgesics|analgesics|mesh-ancestor
83115439|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
83115440|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115441|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83115442|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115443|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115444|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83115445|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83115446|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115447|NCT05383625|Vaccines|vaccines|mesh-list
83115448|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
83115449|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115450|NCT02926859|Cannabidiol|cannabidiol|mesh-list
83115451|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
83115452|NCT03389451|Edetic Acid|edetic acid|mesh-list
83115453|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83115454|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
83115455|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
83115456|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115457|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
83115458|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83115459|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83115460|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83115461|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83115462|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83115463|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83115464|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115465|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115466|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
83115467|NCT02330120|Propofol|propofol|mesh-list
83115468|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83115469|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115470|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115471|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115472|NCT02330120|Analgesics|analgesics|mesh-ancestor
83115473|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
83115474|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115475|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83115476|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83115477|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83115478|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115479|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115480|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115481|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83115482|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
83115483|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
83115484|NCT03389295|Cisplatin|cisplatin|mesh-list
83115485|NCT03389295|Docetaxel|docetaxel|mesh-list
83115486|NCT03389295|Fluorouracil|fluorouracil|mesh-list
83115487|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115488|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
83115489|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
83115490|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
83115491|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115492|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
83115493|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83115494|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83115495|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
83115496|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115497|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
83115498|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83115499|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115500|NCT03727880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83115501|NCT03727880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115502|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83115503|NCT03398811|Etonogestrel|etonogestrel|mesh-list
83115504|NCT03398811|Desogestrel|desogestrel|mesh-list
83115505|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
83115506|NCT03398811|Progesterone|progesterone|mesh-list
83115507|NCT03398811|Progestins|progestins|mesh-ancestor
83115508|NCT03398811|Hormones|hormones|mesh-ancestor
83115509|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115510|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115511|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83115512|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
83115513|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83115514|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83115515|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83115516|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83115517|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83115518|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83115519|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83115520|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115521|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
83115522|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83115523|NCT01300143|Estrogens|estrogens|mesh-ancestor
83115524|NCT01300143|Hormones|hormones|mesh-ancestor
83115525|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115526|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115527|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83115528|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115529|NCT01336205|Naloxegol|naloxegol|mesh-list
83115530|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83115531|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115532|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
83115533|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115534|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
83115535|NCT03610685|Prednisolone|prednisolone|mesh-list
83115536|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115537|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
83115538|NCT03610685|Hormones|hormones|mesh-ancestor
83115539|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115540|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115541|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83115542|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115543|NCT02327234|Ibuprofen|ibuprofen|mesh-list
83115544|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83115545|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115546|NCT02327234|Analgesics|analgesics|mesh-ancestor
83115547|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
83115548|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115549|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115550|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115551|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83115552|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83115553|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115554|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115555|NCT01123707|Aripiprazole|aripiprazole|mesh-list
83115556|NCT01123707|Escitalopram|escitalopram|mesh-list
83115557|NCT01123707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83115558|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83115559|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83115560|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115561|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115562|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
83115563|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115564|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
83115565|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83115566|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83115567|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83115568|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115569|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
83115570|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
83115571|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83115572|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83115573|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83115574|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83115575|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83115576|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83115577|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
83115578|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
83115579|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83115580|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
83115581|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115582|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115583|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83115584|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
83115585|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83115586|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83115587|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83115588|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115589|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115590|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115591|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115592|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
83115593|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83115594|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
83115595|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83115596|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115597|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115598|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115599|NCT02327156|Analgesics|analgesics|mesh-ancestor
83115600|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
83115601|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115602|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83115603|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83115604|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83115605|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115606|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115607|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115608|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83115609|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
83115610|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83115611|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
83115612|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115613|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
83115614|NCT02039804|Protective Agents|protective agents|mesh-ancestor
83115615|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115616|NCT03385161|Ethanol|ethanol|mesh-list
83115617|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
83115618|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83115619|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83115620|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83115621|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83115622|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115623|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83115624|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115625|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115626|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83115627|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115628|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115629|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83115630|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115631|NCT02327000|Pregabalin|pregabalin|mesh-list
83115632|NCT02327000|Analgesics|analgesics|mesh-ancestor
83115633|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
83115634|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115635|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115636|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
83115637|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83115638|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83115639|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115640|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83115641|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83115642|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83115643|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115644|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83115646|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
83115647|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
83115648|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115649|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115650|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
83115651|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115652|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
83115653|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83115654|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
83115655|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83115656|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115657|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83115658|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83115659|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83115660|NCT00862251|Atorvastatin|atorvastatin|mesh-list
83115661|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83115662|NCT00862251|Simvastatin|simvastatin|mesh-list
83115663|NCT00862251|Ezetimibe|ezetimibe|mesh-list
83115664|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83115665|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83115666|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
83115667|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115668|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83115669|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83115670|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115671|NCT03389139|Anesthetics|anesthetics|mesh-list
83115672|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115673|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115674|NCT00885963|Sapacitabine|sapacitabine|mesh-list
83115675|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115676|NCT00725127|Aspirin|aspirin|mesh-list
83115677|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83115678|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83115679|NCT00725127|Analgesics|analgesics|mesh-ancestor
83115680|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
83115681|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115682|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115683|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83115684|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83115685|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83115686|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83115687|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115688|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83115689|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83115690|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115691|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
83115692|NCT02328950|Cytarabine|cytarabine|mesh-list
83115693|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
83115694|NCT02328950|Busulfan|busulfan|mesh-list
83115695|NCT02328950|Fludarabine|fludarabine|mesh-list
83115696|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83115697|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
83115698|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115699|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83115700|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83115701|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
83115702|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115703|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115704|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83115705|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83115706|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
83115707|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
83115708|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115709|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
83115710|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83115711|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115712|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83115713|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115714|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
83115715|NCT03389061|Velpatasvir|velpatasvir|mesh-list
83115716|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83115717|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
83115718|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115719|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
83115720|NCT05078138|Hematinics|hematinics|mesh-ancestor
83115721|NCT02038868|Tamsulosin|tamsulosin|mesh-list
83115722|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83115723|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83115724|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83115725|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115726|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115727|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115728|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115729|NCT02038868|Urological Agents|urological agents|mesh-ancestor
83115730|NCT02328794|Varenicline|varenicline|mesh-list
83115731|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83115732|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83115733|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
83115734|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115735|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115736|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115737|NCT03388827|Misoprostol|misoprostol|mesh-list
83115738|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83115739|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
83115740|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83115741|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115742|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83115743|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83115744|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
83115745|NCT02328716|Cisplatin|cisplatin|mesh-list
83115746|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115747|NCT00445107|Montelukast|montelukast|mesh-list
83115748|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83115749|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
83115750|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83115751|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
83115752|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115753|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115754|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83115755|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83115756|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115757|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
83115758|NCT05077592|Povidone|povidone|mesh-list
83115759|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
83115760|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
83115761|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83115762|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115763|NCT00038727|Metformin|metformin|mesh-list
83115764|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83115765|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115766|NCT02864381|Nivolumab|nivolumab|mesh-list
83115767|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83115768|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115769|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83115770|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115771|NCT05230472|Simvastatin|simvastatin|mesh-list
83115772|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83115773|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83115774|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
83115775|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115776|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83115777|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83115778|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115779|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
83115780|NCT03398031|Antacids|antacids|mesh-ancestor
83115781|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115782|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83115783|NCT02039960|Bupropion|bupropion|mesh-list
83115784|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83115785|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
83115786|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83115787|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83115788|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83115789|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83115790|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115791|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
83115792|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115793|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115794|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83115795|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83115796|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115797|NCT05383313|Midazolam|midazolam|mesh-list
83115798|NCT05383313|Ketamine|ketamine|mesh-list
83115799|NCT05383313|Psilocybin|psilocybin|mesh-list
83115800|NCT05383313|Analgesics|analgesics|mesh-ancestor
83115801|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
83115802|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115803|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115804|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83115805|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83115806|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
83115807|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
83115808|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115809|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83115810|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83115811|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115812|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115813|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83115814|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83115815|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83115816|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83115817|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83115818|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
83115819|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
83115820|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
83115821|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83115822|NCT03144128|Vitamin D|vitamin d|mesh-list
83115823|NCT03144128|Vitamins|vitamins|mesh-ancestor
83115824|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
83115825|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115826|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83115827|NCT02326610|Hormones|hormones|mesh-list
83115828|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115829|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115830|NCT00409773|Atorvastatin|atorvastatin|mesh-list
83115831|NCT00409773|Simvastatin|simvastatin|mesh-list
83115832|NCT00409773|Ezetimibe|ezetimibe|mesh-list
83115833|NCT00409773|Calcium|calcium|mesh-list
83115834|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83115835|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115837|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83115838|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
83115839|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115840|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83115841|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83115842|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115843|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83115844|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83115845|NCT02034422|Antioxidants|antioxidants|mesh-list
83115846|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115847|NCT02034422|Protective Agents|protective agents|mesh-ancestor
83115848|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115849|NCT02325986|Fluorouracil|fluorouracil|mesh-list
83115850|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115851|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
83115852|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115853|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83115854|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83115855|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
83115856|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115857|NCT00398151|Montelukast|montelukast|mesh-list
83115858|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83115859|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
83115860|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83115861|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
83115862|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115863|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115864|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83115865|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83115866|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115868|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
83115869|NCT03610139|Vitamins|vitamins|mesh-ancestor
83115870|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
83115871|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115872|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83115873|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83115874|NCT02327624|Clopidogrel|clopidogrel|mesh-list
83115875|NCT02327624|Ticagrelor|ticagrelor|mesh-list
83115876|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83115877|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83115878|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83115879|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83115880|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
83115881|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115882|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115883|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115884|NCT03388671|Bupivacaine|bupivacaine|mesh-list
83115885|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
83115886|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
83115887|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115888|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115889|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
83115890|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115891|NCT02327936|Fesoterodine|fesoterodine|mesh-list
83115892|NCT02327936|Oxybutynin|oxybutynin|mesh-list
83469315|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
83115893|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83115894|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83115895|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
83115896|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115897|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115898|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115899|NCT02327936|Urological Agents|urological agents|mesh-ancestor
83115900|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
83115901|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
83115902|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115903|NCT03609827|Melphalan|melphalan|mesh-list
83115904|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83115905|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
83115906|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115907|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115908|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83115909|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83115910|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
83115911|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115912|NCT02858401|Vesatolimod|vesatolimod|mesh-list
83115913|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
83115914|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115915|NCT03144596|Tamsulosin|tamsulosin|mesh-list
83115916|NCT03144596|Alfuzosin|alfuzosin|mesh-list
83115917|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83115918|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83115919|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83115920|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83115921|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83115922|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115923|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115924|NCT03144596|Urological Agents|urological agents|mesh-ancestor
83115925|NCT00127647|Montelukast|montelukast|mesh-list
83115926|NCT00127647|Pranlukast|pranlukast|mesh-list
83115927|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83115928|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
83115929|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83115930|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
83115931|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83115932|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115933|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83115934|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83115935|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115936|NCT03111446|Anesthetics|anesthetics|mesh-list
83115937|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83115938|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115940|NCT02034071|Choline|choline|mesh-list
83115941|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
83115942|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83115943|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
83115944|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115945|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83115946|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83115947|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
83115948|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83115949|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
83115950|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
83115951|NCT03609359|Lenvatinib|lenvatinib|mesh-list
83115952|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83115953|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115954|NCT03609359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83115955|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115956|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83115957|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115958|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83115959|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83115960|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83115961|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
83115962|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115963|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83115964|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83115965|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115966|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
83115967|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83115968|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83115969|NCT04822376|Ansuvimab|ansuvimab|mesh-list
83115970|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
83115971|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115972|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
83115973|NCT05173545|Analgesics|analgesics|mesh-ancestor
83115974|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
83115975|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83115976|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83115977|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83115978|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83115979|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83115980|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115981|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115982|NCT05383183|Choline|choline|mesh-list
83115983|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
83115984|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83115985|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
83115986|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115987|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83115988|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83115989|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
83115990|NCT02327702|Emtricitabine|emtricitabine|mesh-list
83115991|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
83115992|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83115993|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83115994|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83115995|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83115996|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83115997|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83115998|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83115999|NCT03609775|Ethanol|ethanol|mesh-list
83116000|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83116001|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116002|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116003|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116004|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
83116005|NCT03690765|Progestins|progestins|mesh-ancestor
83116006|NCT03690765|Hormones|hormones|mesh-ancestor
83116007|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116008|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116009|NCT02033941|Phenol|phenol|mesh-list
83116010|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83116011|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116013|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83116014|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83116015|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
83116016|NCT03143972|Remifentanil|remifentanil|mesh-list
83116017|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83116018|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116019|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116020|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116021|NCT03143972|Analgesics|analgesics|mesh-ancestor
83116022|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
83116023|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116024|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83116025|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83116026|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83116027|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
83116028|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116029|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116030|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83116031|NCT03143972|Narcotics|narcotics|mesh-ancestor
83116032|NCT02237027|Tenofovir|tenofovir|mesh-list
83116033|NCT02237027|Emtricitabine|emtricitabine|mesh-list
83116034|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83116035|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
83116036|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116037|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83116038|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83116039|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116040|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116041|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83116042|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83116043|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83116044|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83116045|NCT03143738|Anesthetics|anesthetics|mesh-list
83116046|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116047|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116048|NCT04393753|Avelumab|avelumab|mesh-list
83116049|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116050|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116051|NCT04647903|Amphetamine|amphetamine|mesh-list
83116052|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
83116053|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83116054|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116055|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
83116056|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
83116057|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116058|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
83116059|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116060|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116061|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
83116062|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83116063|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83116064|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116065|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83116066|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83116067|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83116068|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83116069|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116070|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116071|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
83116072|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116073|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83116074|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83116075|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
83116076|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83116077|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116078|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83116079|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83116080|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116081|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116082|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116083|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83116084|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83116086|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83116087|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
83116088|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83116089|NCT02237053|Octreotide|octreotide|mesh-list
83116090|NCT02237053|Glucagon|glucagon|mesh-list
83116091|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116092|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116093|NCT02237053|Hormones|hormones|mesh-ancestor
83116094|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116095|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116096|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116097|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
83116098|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
83116099|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83116100|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83116101|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116102|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83116103|NCT04997174|Celecoxib|celecoxib|mesh-list
83116104|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83116105|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116106|NCT04997174|Analgesics|analgesics|mesh-ancestor
83116107|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
83116108|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116109|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116110|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116111|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116112|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83116113|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83116114|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116115|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116116|NCT02237209|Vaccines|vaccines|mesh-list
83116117|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
83116118|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116119|NCT03387111|Leucovorin|leucovorin|mesh-list
83116120|NCT03387111|Paclitaxel|paclitaxel|mesh-list
83116121|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
83116122|NCT03387111|Bevacizumab|bevacizumab|mesh-list
83116123|NCT03387111|Fluorouracil|fluorouracil|mesh-list
83116124|NCT03387111|Capecitabine|capecitabine|mesh-list
83116125|NCT03387111|Cetuximab|cetuximab|mesh-list
83116126|NCT03387111|Avelumab|avelumab|mesh-list
83116127|NCT03387111|Necitumumab|necitumumab|mesh-list
83116128|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83116129|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116130|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
83116131|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
83116132|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
83116133|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116134|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116135|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
83116136|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116137|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116138|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83116139|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
83116140|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83116141|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116142|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83116143|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83116144|NCT03387111|Growth Substances|growth substances|mesh-ancestor
83116145|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
83116146|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
83116147|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83116148|NCT03387111|Antidotes|antidotes|mesh-ancestor
83116149|NCT03387111|Protective Agents|protective agents|mesh-ancestor
83116150|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
83116151|NCT03387111|Vitamins|vitamins|mesh-ancestor
83116152|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
83116153|NCT03608293|Dimercaprol|dimercaprol|mesh-list
83116154|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
83116155|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
83116156|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116157|NCT03608501|Thalidomide|thalidomide|mesh-list
83116158|NCT03608501|Dexamethasone|dexamethasone|mesh-list
83116159|NCT03608501|Ixazomib|ixazomib|mesh-list
83116160|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116162|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
83116163|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116164|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116165|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116166|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
83116167|NCT03608501|Hormones|hormones|mesh-ancestor
83116168|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116169|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116170|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116171|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116172|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116173|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
83116174|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
83116175|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83116176|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116177|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83116178|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83116179|NCT03608501|Growth Substances|growth substances|mesh-ancestor
83116180|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
83116181|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
83116182|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116183|NCT03608761|Rebamipide|rebamipide|mesh-list
83116184|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83116185|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116186|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
83116187|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116188|NCT03608761|Protective Agents|protective agents|mesh-ancestor
83116189|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116190|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116191|NCT04554836|Cetuximab|cetuximab|mesh-list
83116192|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116193|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116194|NCT04536272|Heparin|heparin|mesh-list
83116195|NCT04536272|Calcium heparin|calcium heparin|mesh-list
83116196|NCT04536272|Enoxaparin|enoxaparin|mesh-list
83116197|NCT04536272|Nadroparin|nadroparin|mesh-list
83116198|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
83116199|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83116200|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83116201|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116202|NCT02731131|Ribavirin|ribavirin|mesh-list
83116203|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83116204|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
83116205|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116206|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
83116207|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116208|NCT04585724|Palbociclib|palbociclib|mesh-list
83116209|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116210|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83116211|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116212|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116213|NCT02237261|Prednisone|prednisone|mesh-list
83116214|NCT02237261|Bortezomib|bortezomib|mesh-list
83116215|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83116216|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116217|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
83116218|NCT02237261|Hormones|hormones|mesh-ancestor
83116219|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116220|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116221|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116222|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116223|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83116224|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
83116225|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116226|NCT03386643|Clobetasol|clobetasol|mesh-list
83116227|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116228|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
83116229|NCT03386643|Hormones|hormones|mesh-ancestor
83116230|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116231|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116232|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
83116233|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83116234|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116235|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116236|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116237|NCT05171985|Analgesics|analgesics|mesh-ancestor
83116238|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
83469350|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116239|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116240|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83116241|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83116242|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83116243|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
83116244|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116245|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116246|NCT02237365|Aspirin|aspirin|mesh-list
83116247|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83116248|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116249|NCT02237365|Analgesics|analgesics|mesh-ancestor
83116250|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
83116251|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116252|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116253|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116254|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116255|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83116256|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83116257|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116258|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83116259|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83116260|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116261|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
83116263|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
83116264|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116265|NCT03383367|Protective Agents|protective agents|mesh-ancestor
83116266|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116267|NCT02856113|Alogliptin|alogliptin|mesh-list
83116268|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83116269|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116270|NCT02856113|Incretins|incretins|mesh-ancestor
83116271|NCT02856113|Hormones|hormones|mesh-ancestor
83116272|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116273|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83116274|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
83116275|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116276|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116277|NCT03386565|Lidocaine|lidocaine|mesh-list
83116278|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83116279|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116280|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
83116281|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116282|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116283|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
83116284|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116285|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83116286|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83116287|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83116288|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116289|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116290|NCT02237339|Allopurinol|allopurinol|mesh-list
83116291|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
83116292|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116293|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116294|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
83116295|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116296|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83116297|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
83116298|NCT02237339|Protective Agents|protective agents|mesh-ancestor
83116299|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116300|NCT05171751|Octreotide|octreotide|mesh-list
83116301|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116302|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116303|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469353|NCT01063049|Cathartics|cathartics|mesh-ancestor
83116304|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
83116305|NCT03971084|Caseins|caseins|mesh-list
83116306|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83116307|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
83116308|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116309|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116310|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116311|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
83116312|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
83116313|NCT03379779|Dimercaprol|dimercaprol|mesh-list
83116314|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
83116315|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
83116316|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116317|NCT04083014|Bortezomib|bortezomib|mesh-list
83116318|NCT04083014|Antibodies|antibodies|mesh-list
83116319|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
83116320|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116321|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116322|NCT03563066|Benralizumab|benralizumab|mesh-list
83116323|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83116324|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
83116325|NCT03140384|Misoprostol|misoprostol|mesh-list
83116326|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83116327|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
83116328|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83116329|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116330|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83116331|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116332|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
83116333|NCT05117307|Bupivacaine|bupivacaine|mesh-list
83116334|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116335|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
83116336|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116337|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116338|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
83116339|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116340|NCT03739268|Sevelamer|sevelamer|mesh-list
83116341|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
83116342|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
83116343|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116344|NCT02787590|Simvastatin|simvastatin|mesh-list
83116345|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83116346|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83116347|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
83116348|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116349|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83116350|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83116351|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116352|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83116353|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
83116354|NCT03382743|Lidocaine|lidocaine|mesh-list
83116355|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116356|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
83116357|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116358|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116359|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
83116360|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469363|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
83116361|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83116362|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83116363|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83116364|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116365|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116366|NCT02854631|Prednisolone|prednisolone|mesh-list
83116367|NCT02854631|Selonsertib|selonsertib|mesh-list
83116368|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116369|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
83116370|NCT02854631|Hormones|hormones|mesh-ancestor
83116371|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116372|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116373|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116374|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116375|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83116376|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116377|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116378|NCT03607643|Leucovorin|leucovorin|mesh-list
83116379|NCT03607643|Bevacizumab|bevacizumab|mesh-list
83116380|NCT03607643|Gemcitabine|gemcitabine|mesh-list
83116381|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
83116382|NCT03607643|Irinotecan|irinotecan|mesh-list
83116383|NCT03607643|Temozolomide|temozolomide|mesh-list
83116384|NCT03607643|Bortezomib|bortezomib|mesh-list
83116385|NCT03607643|Cannabidiol|cannabidiol|mesh-list
83116386|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116387|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116388|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83116389|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83116390|NCT03607643|Growth Substances|growth substances|mesh-ancestor
83116391|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116392|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83116393|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83116394|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
83116395|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116396|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83116397|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83116398|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116399|NCT03607643|Antidotes|antidotes|mesh-ancestor
83116400|NCT03607643|Protective Agents|protective agents|mesh-ancestor
83116401|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
83116402|NCT03607643|Vitamins|vitamins|mesh-ancestor
83116403|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
83116404|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83116405|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
83116406|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
83116407|NCT02855359|Prednisone|prednisone|mesh-list
83116408|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
83116409|NCT02855359|Rituximab|rituximab|mesh-list
83116410|NCT02855359|Doxorubicin|doxorubicin|mesh-list
83116411|NCT02855359|Vincristine|vincristine|mesh-list
83116412|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116413|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
83116414|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116415|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116416|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83116417|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
83116418|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116419|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116420|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83116421|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116422|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83116423|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83116424|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83116425|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116426|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116427|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
83116428|NCT02855359|Hormones|hormones|mesh-ancestor
83133566|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116429|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116430|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116431|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83116432|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
83116433|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
83116434|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
83116435|NCT05084456|Docetaxel|docetaxel|mesh-list
83116436|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116437|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
83116438|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
83116439|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83116440|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116441|NCT03607903|Adalimumab|adalimumab|mesh-list
83116442|NCT03607903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83116443|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116444|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116445|NCT04438850|Ivermectin|ivermectin|mesh-list
83116446|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83116447|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116448|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83116449|NCT03385863|Poractant alfa|poractant alfa|mesh-list
83116450|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
83116451|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
83116452|NCT03939026|Fludarabine|fludarabine|mesh-list
83116453|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116454|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
83116455|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116456|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116457|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83116458|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
83116459|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116460|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116461|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83116462|NCT03382431|PC-786|pc-786|mesh-list
83116463|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
83116464|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116465|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116466|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116467|NCT03141632|Dulaglutide|dulaglutide|mesh-list
83116468|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83116469|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116470|NCT04282239|Lidocaine|lidocaine|mesh-list
83116471|NCT04282239|Epinephrine|epinephrine|mesh-list
83116472|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
83116473|NCT04282239|Ropivacaine|ropivacaine|mesh-list
83116474|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116475|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
83116476|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116477|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116478|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
83116479|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116480|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83116481|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83116482|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83116483|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116484|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116485|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83116486|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116487|NCT04282239|Analgesics|analgesics|mesh-ancestor
83469396|NCT04588792|Furosemide|furosemide|mesh-list
83116488|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83116489|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83116490|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83116491|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
83116492|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116493|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83116494|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83116495|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
83116496|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83116497|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
83116498|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
83116499|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
83116500|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83116501|NCT03605173|Vitamin D|vitamin d|mesh-list
83116502|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
83116503|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
83116504|NCT03605173|Vitamins|vitamins|mesh-list
83116505|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
83116506|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116507|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83116508|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83116509|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
83116510|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
83116511|NCT03382275|Iron|iron|mesh-list
83116512|NCT03382275|Ferric maltol|ferric maltol|mesh-list
83116513|NCT03382275|Trace Elements|trace elements|mesh-ancestor
83116514|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
83116515|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116516|NCT03382275|Hematinics|hematinics|mesh-ancestor
83116517|NCT05080478|Clopidogrel|clopidogrel|mesh-list
83116518|NCT05080478|Ticagrelor|ticagrelor|mesh-list
83116519|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83116520|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83116521|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83116522|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83116523|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
83116524|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116525|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116526|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116527|NCT05082974|Varenicline|varenicline|mesh-list
83116528|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83116529|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83116530|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
83116531|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116532|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116533|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116534|NCT03604471|Atorvastatin|atorvastatin|mesh-list
83116535|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83116536|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83116538|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116539|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83116540|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83116541|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116542|NCT03757130|Liraglutide|liraglutide|mesh-list
83116543|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83116544|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116545|NCT03757130|Incretins|incretins|mesh-ancestor
83116546|NCT03757130|Hormones|hormones|mesh-ancestor
83116547|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116548|NCT02237443|Bromides|bromides|mesh-list
83116549|NCT02237443|Rocuronium|rocuronium|mesh-list
83116550|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
83116551|NCT02237443|Succinylcholine|succinylcholine|mesh-list
83116552|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
83116553|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83116554|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83116555|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83116556|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116557|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116558|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83116559|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83116560|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83116561|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
83116562|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116563|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116564|NCT03141398|Pancrelipase|pancrelipase|mesh-list
83116565|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116566|NCT03733418|Vitamin D|vitamin d|mesh-list
83116567|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
83116568|NCT03733418|Vitamins|vitamins|mesh-ancestor
83116569|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
83116570|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116571|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83116572|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83116573|NCT03607331|Citalopram|citalopram|mesh-list
83116574|NCT03607331|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83116575|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83116576|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116577|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116578|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116579|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
83492849|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
83116580|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116581|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83116582|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
83116583|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83116584|NCT05082896|Anesthetics|anesthetics|mesh-list
83116585|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116586|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116587|NCT03607955|Paclitaxel|paclitaxel|mesh-list
83116588|NCT03607955|Carboplatin|carboplatin|mesh-list
83116589|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83116590|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116591|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83116592|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83116593|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83116594|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116595|NCT02067975|Tryptophan|tryptophan|mesh-list
83116596|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83116597|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
83116598|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83116599|NCT03143036|Thalidomide|thalidomide|mesh-list
83116600|NCT03143036|Dexamethasone|dexamethasone|mesh-list
83116601|NCT03143036|Daratumumab|daratumumab|mesh-list
83116602|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116603|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
83116604|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
83116605|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116606|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116607|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116608|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
83116609|NCT03143036|Hormones|hormones|mesh-ancestor
83116610|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116611|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116612|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116613|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116614|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
83116615|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
83116616|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83116617|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116618|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83116619|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83116620|NCT03143036|Growth Substances|growth substances|mesh-ancestor
83116621|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
83116622|NCT03607175|Triamcinolone|triamcinolone|mesh-list
83116623|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83116624|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116625|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
83116626|NCT03607175|Hormones|hormones|mesh-ancestor
83116627|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116628|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116629|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116630|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
83116631|NCT05082662|Diclofenac|diclofenac|mesh-list
83116632|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83116633|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116634|NCT05082662|Analgesics|analgesics|mesh-ancestor
83116635|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
83116636|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116637|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116638|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116639|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116640|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83116641|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116642|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116643|NCT05080010|Carboplatin|carboplatin|mesh-list
83116644|NCT05080010|Etoposide|etoposide|mesh-list
83116645|NCT05080010|Vincristine|vincristine|mesh-list
83116646|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116647|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83116648|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83116649|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83116650|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116651|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116652|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83116653|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83116654|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83116655|NCT03385551|Estradiol|estradiol|mesh-list
83116657|NCT03385551|Hormones|hormones|mesh-ancestor
83116658|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116659|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116660|NCT03606473|Amphetamine|amphetamine|mesh-list
83116661|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
83116662|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83116663|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116664|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
83116665|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
83116666|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116667|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
83116668|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116669|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116670|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
83116671|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83116672|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83116673|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116674|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83116675|NCT03316274|Nivolumab|nivolumab|mesh-list
83116676|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116677|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116678|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83116679|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116680|NCT03252626|Alprostadil|alprostadil|mesh-list
83116681|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83116682|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
83116683|NCT03252626|Urological Agents|urological agents|mesh-ancestor
83116684|NCT05072054|Atorvastatin|atorvastatin|mesh-list
83116685|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83116686|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83116687|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83116688|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
83116689|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116690|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83116691|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83116692|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116693|NCT03142880|Ropivacaine|ropivacaine|mesh-list
83116694|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116695|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
83116696|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116697|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116698|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
83116699|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116700|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
83116701|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116702|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
83116703|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83116704|NCT05049902|Amoxicillin|amoxicillin|mesh-list
83116705|NCT05049902|Metronidazole|metronidazole|mesh-list
83116706|NCT05049902|Clarithromycin|clarithromycin|mesh-list
83116707|NCT05049902|Tetracycline|tetracycline|mesh-list
83116708|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
83116710|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116711|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83116712|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116713|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83116714|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83116715|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83116716|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116717|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83116718|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83116719|NCT05049902|Antacids|antacids|mesh-ancestor
83116720|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116721|NCT05049902|Diuretics|diuretics|mesh-ancestor
83116722|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
83116723|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116724|NCT05049902|Expectorants|expectorants|mesh-ancestor
83116725|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
83116726|NCT05379803|Aflutinib|aflutinib|mesh-list
83116727|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83116728|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116729|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116730|NCT03381495|Sufentanil|sufentanil|mesh-list
83116731|NCT03381495|Ropivacaine|ropivacaine|mesh-list
83116732|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116733|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
83116734|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116735|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116736|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
83116737|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116738|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83116739|NCT03381495|Narcotics|narcotics|mesh-ancestor
83116740|NCT03381495|Analgesics|analgesics|mesh-ancestor
83116741|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83116742|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83116743|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
83116744|NCT03059498|Bupivacaine|bupivacaine|mesh-list
83116745|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116746|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
83116747|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116748|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116749|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
83116750|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116751|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83116752|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116753|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116754|NCT03264131|Immunotoxins|immunotoxins|mesh-ancestor
83116755|NCT03264131|Immunoconjugates|immunoconjugates|mesh-ancestor
83116756|NCT03264131|Immunologic Factors|immunologic factors|mesh-ancestor
83116757|NCT03264131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116758|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
83116759|NCT03142646|Fludarabine|fludarabine|mesh-list
83116760|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116761|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
83116762|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116763|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116764|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83116765|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
83116766|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116767|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116768|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83116769|NCT03541083|Blinatumomab|blinatumomab|mesh-list
83116770|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116771|NCT04962230|Ritonavir|ritonavir|mesh-list
83116772|NCT04962230|Nirmatrelvir|nirmatrelvir|mesh-list
83116773|NCT04962230|Carbamazepine|carbamazepine|mesh-list
83116774|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83116775|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83116776|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
83116777|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116778|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116779|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83116780|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83116781|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
83116782|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116783|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83116784|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83116785|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
83116786|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
83116787|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83116788|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116789|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116790|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83116791|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116792|NCT04962230|Analgesics|analgesics|mesh-ancestor
83116793|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
83116794|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116795|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83116796|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116797|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83116798|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83116799|NCT03602027|Gefitinib|gefitinib|mesh-list
83116800|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116801|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83116802|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116803|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116804|NCT03141476|Cefuroxime|cefuroxime|mesh-list
83116805|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
83116806|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83116807|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116808|NCT03601871|Thalidomide|thalidomide|mesh-list
83116809|NCT03601871|Dexamethasone|dexamethasone|mesh-list
83116810|NCT03601871|Palonosetron|palonosetron|mesh-list
83116811|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
83116812|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116813|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
83116814|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
83116815|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116816|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116817|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83116818|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
83116819|NCT03601871|Hormones|hormones|mesh-ancestor
83116820|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83116821|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83116822|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116823|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116824|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
83116825|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
83116826|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83116827|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116828|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83116829|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83116830|NCT03601871|Growth Substances|growth substances|mesh-ancestor
83116831|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
83116832|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83116833|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
83116834|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116835|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116836|NCT03380949|Remifentanil|remifentanil|mesh-list
83116837|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
83116838|NCT03380949|Narcotics|narcotics|mesh-ancestor
83116839|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116840|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116841|NCT03380949|Analgesics|analgesics|mesh-ancestor
83116842|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
83116843|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116844|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83116845|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83116846|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116847|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83116848|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83116849|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
83116850|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116851|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116852|NCT05078372|Midazolam|midazolam|mesh-list
83116853|NCT05078372|Ropivacaine|ropivacaine|mesh-list
83116854|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116855|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
83116856|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116857|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116858|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
83116859|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116860|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83116861|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83116862|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83116863|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83116864|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83116865|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83116866|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
83116867|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
83116868|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
83116869|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116870|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116871|NCT03380871|Carboplatin|carboplatin|mesh-list
83116872|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
83116873|NCT03380871|Pemetrexed|pemetrexed|mesh-list
83116874|NCT03380871|Poly ICLC|poly iclc|mesh-list
83116875|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116876|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116877|NCT03380871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83116878|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116879|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116880|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83492850|NCT04967664|Capsaicin|capsaicin|mesh-list
83116881|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83116882|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
83116883|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
83116884|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116885|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
83116886|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83116887|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116888|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116889|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116890|NCT02237495|Analgesics|analgesics|mesh-ancestor
83116891|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
83116892|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116893|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83116894|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83116895|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83116896|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
83116897|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116898|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116899|NCT02486666|Enoxaparin|enoxaparin|mesh-list
83116900|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
83116901|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
83116902|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83116903|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83469432|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83116904|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116905|NCT02237807|Dirithromycin|dirithromycin|mesh-list
83116906|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83116907|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116908|NCT03125187|Heparin|heparin|mesh-list
83116909|NCT03125187|Calcium heparin|calcium heparin|mesh-list
83116910|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
83116911|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83116912|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83116913|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116914|NCT02038946|Nivolumab|nivolumab|mesh-list
83116915|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83116916|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116917|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83116918|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116919|NCT03377907|Lidocaine|lidocaine|mesh-list
83116920|NCT03377907|Ketamine|ketamine|mesh-list
83116921|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
83116922|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
83116923|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116924|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116925|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
83116926|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116927|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83116928|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83116929|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83116930|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116931|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116932|NCT03377907|Analgesics|analgesics|mesh-ancestor
83116933|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83116934|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83116935|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
83116936|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83116937|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83116938|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83116939|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
83116940|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
83116941|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83116942|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116943|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
83116944|NCT03369795|Methotrexate|methotrexate|mesh-list
83116945|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83116946|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
83116947|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83116948|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116949|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83116950|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
83116951|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116952|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83116953|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
83116954|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116955|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83116956|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116957|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
83116958|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116959|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83116960|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
83116961|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
83116962|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83116963|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83116964|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83116965|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116966|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83116967|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83116968|NCT05393414|Acetaminophen|acetaminophen|mesh-list
83116969|NCT05393414|Ketorolac|ketorolac|mesh-list
83116970|NCT05393414|Morphine|morphine|mesh-list
83116971|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
83116972|NCT05393414|Narcotics|narcotics|mesh-ancestor
83116973|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83116974|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116975|NCT05393414|Analgesics|analgesics|mesh-ancestor
83116976|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
83116977|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83116978|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83116979|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
83116980|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83116981|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83116982|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83116983|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83116984|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83116985|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83116986|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
83116987|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
83116988|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83116989|NCT02034500|Vaccines|vaccines|mesh-list
83116990|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
83116991|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116992|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83116993|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
83116994|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
83116995|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83116996|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83116997|NCT03955640|Olaparib|olaparib|mesh-list
83116998|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83116999|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117000|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117001|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117002|NCT03369093|Amoxicillin|amoxicillin|mesh-list
83117003|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83117004|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117005|NCT03369015|Amphetamine|amphetamine|mesh-list
83117006|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
83117007|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83117008|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117009|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
83117010|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
83117011|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117012|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
83117013|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117014|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117015|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117016|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83117017|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83117018|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117019|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83117020|NCT03890744|Docetaxel|docetaxel|mesh-list
83117021|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117022|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
83117023|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
83117024|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83117025|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117026|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83117027|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83117028|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83117029|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83117030|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83117032|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
83117033|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83117034|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
83117035|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117036|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117037|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
83117038|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83117039|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117040|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
83117041|NCT05392166|Calcium|calcium|mesh-list
83117042|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83117043|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117044|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
83117045|NCT02853331|Sunitinib|sunitinib|mesh-list
83117046|NCT02853331|Axitinib|axitinib|mesh-list
83117047|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117048|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117049|NCT02853331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83117050|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117051|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83117052|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83117053|NCT02853331|Growth Substances|growth substances|mesh-ancestor
83117054|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117055|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
83117056|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117057|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117058|NCT03136640|Docetaxel|docetaxel|mesh-list
83117059|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117060|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
83117061|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
83117062|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
83117063|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117065|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117066|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117067|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83117068|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117069|NCT03604003|Losartan|losartan|mesh-list
83117070|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117071|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83117072|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83117073|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83117074|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117075|NCT03368391|Lidocaine|lidocaine|mesh-list
83117076|NCT03368391|Phenylephrine|phenylephrine|mesh-list
83117077|NCT03368391|Epinephrine|epinephrine|mesh-list
83117078|NCT03368391|Racepinephrine|racepinephrine|mesh-list
83117079|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
83117080|NCT03368391|Tetracaine|tetracaine|mesh-list
83117081|NCT03368391|Mepivacaine|mepivacaine|mesh-list
83117082|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
83117083|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117084|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
83117085|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117086|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117087|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
83117088|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117089|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117090|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83117091|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83117092|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117093|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117094|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83117095|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83117096|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117097|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117098|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83117099|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83117100|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
83117101|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83117102|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
83117103|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
83117104|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
83117105|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83117106|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
83117107|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83117108|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83117109|NCT03368391|Protective Agents|protective agents|mesh-ancestor
83117110|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83117111|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83117112|NCT03373305|Lenalidomide|lenalidomide|mesh-list
83117113|NCT03373305|Piperidine|piperidine|mesh-list
83117114|NCT03373305|Antibodies|antibodies|mesh-list
83117115|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
83117116|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83117117|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
83117118|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
83117119|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117120|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117121|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83117122|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83117123|NCT03373305|Growth Substances|growth substances|mesh-ancestor
83117124|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
83117125|NCT03373305|Immunotoxins|immunotoxins|mesh-ancestor
83117126|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83117127|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117128|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117129|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83117130|NCT03376737|Pemetrexed|pemetrexed|mesh-list
83117131|NCT03376737|Apatinib|apatinib|mesh-list
83117132|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117133|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117134|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117135|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83117136|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83117137|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117138|NCT03373227|Tacrolimus|tacrolimus|mesh-list
83117139|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83117140|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
83117141|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117142|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83117143|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117144|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117145|NCT02484716|Timolol|timolol|mesh-list
83117146|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83117147|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83117148|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117149|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117150|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117151|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117152|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117153|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83117154|NCT03373149|Hormones|hormones|mesh-list
83117155|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83117156|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117157|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117158|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
83117159|NCT05386784|Vitamin D|vitamin d|mesh-list
83117160|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83117161|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83117162|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117163|NCT05386784|Vitamins|vitamins|mesh-ancestor
83117164|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
83117165|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83117166|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83117167|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
83117168|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117169|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83117170|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83117171|NCT03602287|Lidocaine|lidocaine|mesh-list
83117172|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117173|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
83117174|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117175|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117176|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
83117177|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117178|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83469455|NCT00382954|Bortezomib|bortezomib|mesh-list
83117179|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83117180|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83117181|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117182|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117184|NCT03137498|Lidocaine|lidocaine|mesh-list
83117185|NCT03137498|Prilocaine|prilocaine|mesh-list
83117186|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117187|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
83117188|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117189|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117190|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
83117191|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117192|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117193|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83117194|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83117195|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117196|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117197|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83117198|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83117199|NCT03137498|Analgesics|analgesics|mesh-ancestor
83117200|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117201|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117202|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83117203|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117204|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83117205|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117206|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
83117207|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83117208|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117210|NCT03602131|Busulfan|busulfan|mesh-list
83117211|NCT03602131|Cladribine|cladribine|mesh-list
83117212|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83117213|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
83117214|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117215|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117216|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
83117217|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83117218|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
83117219|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117220|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83117221|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83117222|NCT05851560|Hyaluronic Acid|hyaluronic acid|mesh-list
83117223|NCT05851560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83117224|NCT05851560|Immunologic Factors|immunologic factors|mesh-ancestor
83117225|NCT05851560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117226|NCT05851560|Viscosupplements|viscosupplements|mesh-ancestor
83117227|NCT05851560|Protective Agents|protective agents|mesh-ancestor
83117228|NCT05851547|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83117229|NCT05851547|Androgens|androgens|mesh-list
83117230|NCT05851547|Hormones|hormones|mesh-ancestor
83117231|NCT05851547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117232|NCT05851547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117233|NCT05851547|Luteolytic Agents|luteolytic agents|mesh-ancestor
83117234|NCT05851547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83117235|NCT05851547|Contraceptive Agents|contraceptive agents|mesh-ancestor
83117236|NCT05851547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83117237|NCT05851547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83117238|NCT05851547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117239|NCT05851547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117240|NCT05851508|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83117241|NCT05851508|Methylprednisolone|methylprednisolone|mesh-list
83117242|NCT05851508|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83117243|NCT05851508|Prednisolone|prednisolone|mesh-list
83117244|NCT05851508|Prednisolone acetate|prednisolone acetate|mesh-list
83117245|NCT05851508|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83117246|NCT05851508|Prednisolone phosphate|prednisolone phosphate|mesh-list
83117247|NCT05851508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117248|NCT05851508|Antiemetics|antiemetics|mesh-ancestor
83117249|NCT05851508|Autonomic Agents|autonomic agents|mesh-ancestor
83117250|NCT05851508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117251|NCT05851508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117252|NCT05851508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117254|NCT05851508|Hormones|hormones|mesh-ancestor
83117255|NCT05851508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117256|NCT05851508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83117257|NCT05851508|Protective Agents|protective agents|mesh-ancestor
83117258|NCT05851508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117259|NCT05851508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117260|NCT05851391|Anesthetics|anesthetics|mesh-list
83117261|NCT05851391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117262|NCT05851391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117263|NCT05851352|Antibodies|antibodies|mesh-list
83117264|NCT05851352|Immunologic Factors|immunologic factors|mesh-ancestor
83117265|NCT05851352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117266|NCT05851014|Letrozole|letrozole|mesh-list
83117267|NCT05851014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117268|NCT05851014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83117269|NCT05851014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83117270|NCT05851014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117271|NCT05851014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117272|NCT05851014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83117273|NCT05851014|Hormone Antagonists|hormone antagonists|mesh-ancestor
83117274|NCT05851014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117275|NCT05851014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117276|NCT05850936|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83117277|NCT05850936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83117278|NCT05850871|Aztreonam|aztreonam|mesh-list
83117279|NCT05850871|Avibactam|avibactam|mesh-list
83117280|NCT05850871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83117281|NCT05850871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117282|NCT05850871|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83117283|NCT05850871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117284|NCT05850871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117285|NCT05850832|Magnesium Sulfate|magnesium sulfate|mesh-list
83117287|NCT05850832|Analgesics|analgesics|mesh-ancestor
83117288|NCT05850832|Sensory System Agents|sensory system agents|mesh-ancestor
83117289|NCT05850832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117290|NCT05850832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117291|NCT05850832|Anesthetics|anesthetics|mesh-ancestor
83117292|NCT05850832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117293|NCT05850832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117294|NCT05850832|Anticonvulsants|anticonvulsants|mesh-ancestor
83117295|NCT05850832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83117296|NCT05850832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117297|NCT05850832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117298|NCT05850832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83117299|NCT05850832|Tocolytic Agents|tocolytic agents|mesh-ancestor
83117300|NCT05850832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83117301|NCT05850832|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83117302|NCT05850832|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83117303|NCT05850832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83117304|NCT05850832|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117305|NCT05850832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117306|NCT05850702|Lidocaine|lidocaine|mesh-list
83117307|NCT05850702|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117308|NCT05850702|Anesthetics|anesthetics|mesh-ancestor
83117309|NCT05850702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117310|NCT05850702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117311|NCT05850702|Sensory System Agents|sensory system agents|mesh-ancestor
83117312|NCT05850702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117313|NCT05850702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117314|NCT05850702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83117315|NCT05850702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83117316|NCT05850702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117317|NCT05850702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117318|NCT05850559|Mitogens|mitogens|mesh-list
83117319|NCT05850559|Mitosis Modulators|mitosis modulators|mesh-ancestor
83117320|NCT05850559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117321|NCT05850546|Prednisone|prednisone|mesh-list
83117322|NCT05850546|Prednisolone|prednisolone|mesh-list
83117323|NCT05850546|Rituximab|rituximab|mesh-list
83117324|NCT05850546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117325|NCT05850546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117327|NCT05850546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117328|NCT05850546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117329|NCT05850546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117330|NCT05850546|Glucocorticoids|glucocorticoids|mesh-ancestor
83117331|NCT05850546|Hormones|hormones|mesh-ancestor
83117332|NCT05850546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117333|NCT05850546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117334|NCT05850507|Vaccines|vaccines|mesh-list
83117335|NCT05850507|Immunologic Factors|immunologic factors|mesh-ancestor
83117336|NCT05850507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117337|NCT05850468|Lidocaine|lidocaine|mesh-list
83117338|NCT05850468|Fentanyl|fentanyl|mesh-list
83117339|NCT05850468|Anesthetics|anesthetics|mesh-list
83117340|NCT05850468|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117341|NCT05850468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117342|NCT05850468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117343|NCT05850468|Sensory System Agents|sensory system agents|mesh-ancestor
83117344|NCT05850468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117345|NCT05850468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117346|NCT05850468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83117347|NCT05850468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83117348|NCT05850468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117349|NCT05850468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117350|NCT05850468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83117351|NCT05850468|Narcotics|narcotics|mesh-ancestor
83117352|NCT05850468|Analgesics|analgesics|mesh-ancestor
83117353|NCT05850468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83117354|NCT05850468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83117355|NCT05850468|Anesthetics, General|anesthetics, general|mesh-ancestor
83117356|NCT05850455|Lidocaine|lidocaine|mesh-list
83117357|NCT05850455|Dexmedetomidine|dexmedetomidine|mesh-list
83117358|NCT05850455|Bupivacaine|bupivacaine|mesh-list
83117359|NCT05850455|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117360|NCT05850455|Anesthetics|anesthetics|mesh-ancestor
83117361|NCT05850455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117362|NCT05850455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117363|NCT05850455|Sensory System Agents|sensory system agents|mesh-ancestor
83117364|NCT05850455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117365|NCT05850455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83117366|NCT05850455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83117367|NCT05850455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83117368|NCT05850455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117369|NCT05850455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117370|NCT05850455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83117371|NCT05850455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83117372|NCT05850455|Analgesics|analgesics|mesh-ancestor
83117373|NCT05850455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83117374|NCT05850455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83117375|NCT05850455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83117376|NCT05850455|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117377|NCT05850455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117378|NCT05850377|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83117379|NCT05850377|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83117380|NCT05850377|Dermatologic Agents|dermatologic agents|mesh-ancestor
83117381|NCT05850143|Dexamethasone|dexamethasone|mesh-list
83117382|NCT05850143|Prednisolone|prednisolone|mesh-list
83117383|NCT05850143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117384|NCT05850143|Antiemetics|antiemetics|mesh-ancestor
83117385|NCT05850143|Autonomic Agents|autonomic agents|mesh-ancestor
83117386|NCT05850143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117387|NCT05850143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117388|NCT05850143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117389|NCT05850143|Glucocorticoids|glucocorticoids|mesh-ancestor
83117390|NCT05850143|Hormones|hormones|mesh-ancestor
83117391|NCT05850143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117392|NCT05850143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117393|NCT05850143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117394|NCT05850117|Amoxicillin|amoxicillin|mesh-list
83117395|NCT05850117|Metronidazole|metronidazole|mesh-list
83117396|NCT05850117|Levofloxacin|levofloxacin|mesh-list
83117397|NCT05850117|Ofloxacin|ofloxacin|mesh-list
83117398|NCT05850117|Tetracycline|tetracycline|mesh-list
83117399|NCT05850117|Esomeprazole|esomeprazole|mesh-list
83117400|NCT05850117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83117401|NCT05850117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117402|NCT05850117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83117403|NCT05850117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83117404|NCT05850117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83117405|NCT05850117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117406|NCT05850117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83117407|NCT05850117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117408|NCT05850117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117409|NCT05850117|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83117410|NCT05850117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83117411|NCT05850117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83117412|NCT05850117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117413|NCT05850117|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83117414|NCT05850117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83117415|NCT05850117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83117416|NCT05850091|Colchicine|colchicine|mesh-list
83117417|NCT05850091|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83117418|NCT05850091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83117419|NCT05850091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83117420|NCT05850091|Antimetabolites|antimetabolites|mesh-ancestor
83117421|NCT05850091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117422|NCT05850091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83117423|NCT05850091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83117424|NCT05850091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117425|NCT05850091|Gout Suppressants|gout suppressants|mesh-ancestor
83117426|NCT05850091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117427|NCT05850091|Tubulin Modulators|tubulin modulators|mesh-ancestor
83117428|NCT05850091|Antimitotic Agents|antimitotic agents|mesh-ancestor
83117429|NCT05850091|Mitosis Modulators|mitosis modulators|mesh-ancestor
83117430|NCT05850091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117431|NCT05849883|Omeprazole|omeprazole|mesh-list
83117432|NCT05849883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83117433|NCT05849883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117434|NCT05849883|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83117436|NCT05849883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117437|NCT05849857|Dexamethasone|dexamethasone|mesh-list
83117438|NCT05849857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117439|NCT05849857|Antiemetics|antiemetics|mesh-ancestor
83117440|NCT05849857|Autonomic Agents|autonomic agents|mesh-ancestor
83117441|NCT05849857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117442|NCT05849857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117443|NCT05849857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117444|NCT05849857|Glucocorticoids|glucocorticoids|mesh-ancestor
83117445|NCT05849857|Hormones|hormones|mesh-ancestor
83117446|NCT05849857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117447|NCT05849857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117448|NCT05849857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117449|NCT05849766|Dapagliflozin|dapagliflozin|mesh-list
83117450|NCT05849766|Carvedilol|carvedilol|mesh-list
83117451|NCT05849766|Ramipril|ramipril|mesh-list
83117452|NCT05849766|Spironolactone|spironolactone|mesh-list
83117453|NCT05849766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83117454|NCT05849766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117455|NCT05849766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83117456|NCT05849766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117457|NCT05849766|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83117458|NCT05849766|Hormone Antagonists|hormone antagonists|mesh-ancestor
83117459|NCT05849766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117460|NCT05849766|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83117461|NCT05849766|Diuretics|diuretics|mesh-ancestor
83117462|NCT05849766|Natriuretic Agents|natriuretic agents|mesh-ancestor
83117463|NCT05849766|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83117464|NCT05849766|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83117465|NCT05849766|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117466|NCT05849766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117467|NCT05849766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83117468|NCT05849766|Antioxidants|antioxidants|mesh-ancestor
83117469|NCT05849766|Protective Agents|protective agents|mesh-ancestor
83117470|NCT05849766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83117471|NCT05849766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83117472|NCT05849766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83117473|NCT05849766|Vasodilator Agents|vasodilator agents|mesh-ancestor
83117474|NCT05849766|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83117475|NCT05849766|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83117476|NCT05849766|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83117477|NCT05849766|Protease Inhibitors|protease inhibitors|mesh-ancestor
83117478|NCT05849766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117480|NCT05849662|Fludarabine|fludarabine|mesh-list
83117481|NCT05849662|Azacitidine|azacitidine|mesh-list
83117482|NCT05849662|Trametinib|trametinib|mesh-list
83117483|NCT05849662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117484|NCT05849662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83117485|NCT05849662|Antimetabolites|antimetabolites|mesh-ancestor
83117486|NCT05849662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117487|NCT05849662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83117488|NCT05849662|Immunologic Factors|immunologic factors|mesh-ancestor
83117489|NCT05849662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117490|NCT05849662|Antiviral Agents|antiviral agents|mesh-ancestor
83117491|NCT05849662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117492|NCT05849662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117493|NCT05849662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117494|NCT05849597|Dexmedetomidine|dexmedetomidine|mesh-list
83117495|NCT05849597|Propofol|propofol|mesh-list
83117496|NCT05849597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83117497|NCT05849597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117498|NCT05849597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117499|NCT05849597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83117500|NCT05849597|Analgesics|analgesics|mesh-ancestor
83117501|NCT05849597|Sensory System Agents|sensory system agents|mesh-ancestor
83117502|NCT05849597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117503|NCT05849597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83117504|NCT05849597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83117505|NCT05849597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83117506|NCT05849597|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117507|NCT05849597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117508|NCT05849597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117509|NCT05849597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83117510|NCT05849597|Anesthetics, General|anesthetics, general|mesh-ancestor
83117511|NCT05849597|Anesthetics|anesthetics|mesh-ancestor
83117512|NCT05847283|Dydrogesterone|dydrogesterone|mesh-list
83117513|NCT05847283|Progestins|progestins|mesh-ancestor
83117514|NCT05847283|Hormones|hormones|mesh-ancestor
83117515|NCT05847283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117516|NCT05847283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117517|NCT05846724|Pembrolizumab|pembrolizumab|mesh-list
83117518|NCT05846724|Lenvatinib|lenvatinib|mesh-list
83117519|NCT05846724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117520|NCT05846724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117521|NCT05846724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83117522|NCT05846724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117523|NCT05846724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117524|NCT05846724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117525|NCT05846659|Pembrolizumab|pembrolizumab|mesh-list
83117526|NCT05846659|Nivolumab|nivolumab|mesh-list
83117527|NCT05846659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83117528|NCT05846659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117529|NCT05846659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117530|NCT05846659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117531|NCT05846620|Dimercaprol|dimercaprol|mesh-list
83117532|NCT05846620|Chelating Agents|chelating agents|mesh-ancestor
83117533|NCT05846620|Sequestering Agents|sequestering agents|mesh-ancestor
83117534|NCT05846620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117535|NCT05845580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83117536|NCT05845580|Red yeast rice|red yeast rice|mesh-list
83117537|NCT05845580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83117538|NCT05845580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83117539|NCT05845580|Antimetabolites|antimetabolites|mesh-ancestor
83117540|NCT05845580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117541|NCT05845580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117542|NCT05845580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83117543|NCT05845099|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83117544|NCT05845099|Vasodilator Agents|vasodilator agents|mesh-ancestor
83117545|NCT05845099|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83117546|NCT05845099|Protective Agents|protective agents|mesh-ancestor
83117547|NCT05845099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117548|NCT05843968|Mycophenolic Acid|mycophenolic acid|mesh-list
83117549|NCT05843968|Rituximab|rituximab|mesh-list
83117550|NCT05843968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117551|NCT05843968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117552|NCT05843968|Immunologic Factors|immunologic factors|mesh-ancestor
83117553|NCT05843968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117554|NCT05843968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117555|NCT05843968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83117556|NCT05843968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83117557|NCT05843968|Antitubercular Agents|antitubercular agents|mesh-ancestor
83117558|NCT05843968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83117559|NCT05843968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117560|NCT05843968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117561|NCT05843968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117563|NCT05841134|Oxaliplatin|oxaliplatin|mesh-list
83117564|NCT05841134|Tislelizumab|tislelizumab|mesh-list
83117565|NCT05841134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83117566|NCT05841134|Antimetabolites|antimetabolites|mesh-ancestor
83117567|NCT05841134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117568|NCT05841134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117569|NCT05841134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117570|NCT05837013|Anesthetics|anesthetics|mesh-list
83117571|NCT05837013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117572|NCT05837013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117573|NCT05831878|Disitamab vedotin|disitamab vedotin|mesh-list
83117574|NCT05831878|Immunoconjugates|immunoconjugates|mesh-ancestor
83117575|NCT05831878|Immunologic Factors|immunologic factors|mesh-ancestor
83117576|NCT05831878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117577|NCT05827705|Ephedrine|ephedrine|mesh-list
83117578|NCT05827705|Pseudoephedrine|pseudoephedrine|mesh-list
83117579|NCT05827705|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83117580|NCT05827705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117582|NCT05827705|Autonomic Agents|autonomic agents|mesh-ancestor
83117583|NCT05827705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117584|NCT05827705|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83117585|NCT05827705|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117586|NCT05827705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117587|NCT05827705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117588|NCT05827705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83117589|NCT05827705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83117590|NCT05827705|Respiratory System Agents|respiratory system agents|mesh-ancestor
83117591|NCT05827705|Nasal Decongestants|nasal decongestants|mesh-ancestor
83117592|NCT05822583|Abatacept|abatacept|mesh-list
83117593|NCT05822583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83117594|NCT05822583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117595|NCT05822583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117596|NCT05822583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117597|NCT05822583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83117598|NCT05822583|Immunologic Factors|immunologic factors|mesh-ancestor
83117599|NCT05822583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117600|NCT05822583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117601|NCT05816746|Decitabine|decitabine|mesh-list
83117602|NCT05816746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83117603|NCT05816746|Antimetabolites|antimetabolites|mesh-ancestor
83117604|NCT05816746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117605|NCT05816746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117606|NCT05816746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117607|NCT05813860|Infliximab|infliximab|mesh-list
83117608|NCT05813860|Azathioprine|azathioprine|mesh-list
83117609|NCT05813860|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83117610|NCT05813860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117611|NCT05813860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83117612|NCT05813860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117613|NCT05813860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117614|NCT05813860|Antimetabolites|antimetabolites|mesh-ancestor
83117615|NCT05813860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117616|NCT05813860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83117617|NCT05813860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117618|NCT05813860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83117619|NCT05813860|Immunologic Factors|immunologic factors|mesh-ancestor
83117620|NCT05813860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117621|NCT05798793|Cisplatin|cisplatin|mesh-list
83117622|NCT05798793|Docetaxel|docetaxel|mesh-list
83117623|NCT05798793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117624|NCT05798793|Tubulin Modulators|tubulin modulators|mesh-ancestor
83117625|NCT05798793|Antimitotic Agents|antimitotic agents|mesh-ancestor
83117626|NCT05798793|Mitosis Modulators|mitosis modulators|mesh-ancestor
83117627|NCT05798793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117628|NCT05795517|Ezetimibe|ezetimibe|mesh-list
83117629|NCT05795517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83117630|NCT05795517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83117631|NCT05795517|Antimetabolites|antimetabolites|mesh-ancestor
83117632|NCT05795517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117633|NCT05795517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83117634|NCT05789173|Efavirenz|efavirenz|mesh-list
83117635|NCT05789173|Clonidine|clonidine|mesh-list
83117636|NCT05789173|Methadone|methadone|mesh-list
83117637|NCT05789173|Tizanidine|tizanidine|mesh-list
83117638|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83117639|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83117640|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117641|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117642|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
83117643|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117644|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83117645|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83117646|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83117647|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83117648|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83117649|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83117650|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83117651|NCT05789173|Narcotics|narcotics|mesh-ancestor
83117652|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117653|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117654|NCT05789173|Analgesics|analgesics|mesh-ancestor
83117655|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
83117656|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117657|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
83117658|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
83117659|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
83117660|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83117661|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83117662|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
83117663|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
83117664|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83117665|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83117666|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83117667|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83117668|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117669|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83117670|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
83117671|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
83117672|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83117673|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117674|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83117675|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117676|NCT05782270|Warfarin|warfarin|mesh-list
83117677|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
83117678|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83117679|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
83117680|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117681|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117682|NCT05759572|Apatinib|apatinib|mesh-list
83117683|NCT05759572|Fulvestrant|fulvestrant|mesh-list
83117684|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117685|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117686|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117687|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117688|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117689|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83117690|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83117691|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
83117692|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117693|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117694|NCT05738694|Axitinib|axitinib|mesh-list
83117695|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117696|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117697|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117698|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117699|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
83117700|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117701|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117702|NCT05737199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83117703|NCT05737199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117704|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
83117705|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83117706|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
83117707|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117708|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
83117709|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83117710|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
83117711|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117712|NCT05708521|Hydromorphone|hydromorphone|mesh-list
83117713|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83117714|NCT05708521|Narcotics|narcotics|mesh-ancestor
83117715|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117716|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117717|NCT05708521|Analgesics|analgesics|mesh-ancestor
83117718|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
83117719|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117720|NCT05707234|Midazolam|midazolam|mesh-list
83117721|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83117722|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83117723|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117724|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117725|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83117726|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83117727|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83117728|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83117729|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
83117730|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
83117731|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
83117732|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
83117733|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117734|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117735|NCT05703672|Varenicline|varenicline|mesh-list
83117736|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83117737|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83117738|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
83117739|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117740|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117741|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117743|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
83117744|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
83117745|NCT05702359|Vitamins|vitamins|mesh-list
83117746|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
83117747|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117748|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83117749|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83117750|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
83117751|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83117752|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117753|NCT05690282|Acetaminophen|acetaminophen|mesh-list
83117754|NCT05690282|Ibuprofen|ibuprofen|mesh-list
83117755|NCT05690282|Gabapentin|gabapentin|mesh-list
83117756|NCT05690282|Bupivacaine|bupivacaine|mesh-list
83117757|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117758|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
83117759|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117760|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117761|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
83117762|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117763|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83117764|NCT05690282|Analgesics|analgesics|mesh-ancestor
83117765|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
83117766|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83117767|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117768|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117769|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83117770|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117771|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117772|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
83117773|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83117775|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83117776|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83117777|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83117778|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83117779|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
83117780|NCT05677334|Insulin|insulin|mesh-list
83117781|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83117782|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83117783|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117784|NCT05676645|Lumefantrine|lumefantrine|mesh-list
83117785|NCT05676645|Artemether|artemether|mesh-list
83117786|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83117787|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
83117788|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83117789|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83117790|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117791|NCT05661578|Atezolizumab|atezolizumab|mesh-list
83117792|NCT05661578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83117793|NCT05661578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117794|NCT05661578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117795|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117796|NCT05655949|Cisplatin|cisplatin|mesh-list
83117797|NCT05655949|Gemcitabine|gemcitabine|mesh-list
83117798|NCT05655949|Durvalumab|durvalumab|mesh-list
83117799|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117800|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83117801|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
83117802|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117803|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117804|NCT05652205|Linaclotide|linaclotide|mesh-list
83117805|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83117806|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
83117807|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117808|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117809|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83117811|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117812|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
83117813|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83117814|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
83117815|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117816|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
83117817|NCT05591651|Protective Agents|protective agents|mesh-ancestor
83117818|NCT05574504|Avelumab|avelumab|mesh-list
83117819|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83117820|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117821|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117822|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117823|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
83117824|NCT05570409|Prednisolone|prednisolone|mesh-list
83117825|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83117826|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
83117827|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83117828|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
83117829|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83117830|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
83117831|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83117832|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117833|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83117834|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
83117835|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83117836|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117837|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117838|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117839|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117840|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
83117841|NCT05570409|Hormones|hormones|mesh-ancestor
83117842|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117843|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117844|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117845|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
83117846|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
83117847|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117848|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117849|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83117850|NCT05570409|Protective Agents|protective agents|mesh-ancestor
83117852|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
83117853|NCT05555732|Pemetrexed|pemetrexed|mesh-list
83117854|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117855|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117856|NCT05555732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83117857|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117858|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117859|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83117860|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83117861|NCT05545670|Allopurinol|allopurinol|mesh-list
83117862|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
83117863|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117864|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117865|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
83469522|NCT03187834|Amoxicillin|amoxicillin|mesh-list
83117866|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117867|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83117868|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
83117869|NCT05545670|Protective Agents|protective agents|mesh-ancestor
83117870|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117871|NCT05544929|Tislelizumab|tislelizumab|mesh-list
83117872|NCT05544929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117873|NCT05544929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117874|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
83117875|NCT05537766|Fludarabine|fludarabine|mesh-list
83117876|NCT05537766|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
83117877|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83117878|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
83117879|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117880|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117881|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83117882|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
83117883|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117884|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117885|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83117886|NCT05537766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117887|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83117888|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117889|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117890|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117891|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83117892|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
83117893|NCT05487794|Testosterone|testosterone|mesh-list
83117894|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
83117895|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
83117896|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83117897|NCT05487794|Androgens|androgens|mesh-ancestor
83117898|NCT05487794|Hormones|hormones|mesh-ancestor
83117899|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117900|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117901|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117902|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117903|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
83117904|NCT05481684|Progesterone|progesterone|mesh-list
83117905|NCT05481684|Progestins|progestins|mesh-ancestor
83117906|NCT05481684|Hormones|hormones|mesh-ancestor
83117907|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117908|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117909|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
83117910|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83117911|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117912|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83117913|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83117914|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117915|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117916|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117917|NCT05461131|Azithromycin|azithromycin|mesh-list
83117918|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83117919|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83117920|NCT05459571|Dexamethasone|dexamethasone|mesh-list
83117921|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
83117922|NCT05459571|Fludarabine|fludarabine|mesh-list
83117923|NCT05459571|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83117924|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83117925|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
83117926|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117927|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83117928|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83117929|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
83117930|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117931|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83469531|NCT01206595|Bupivacaine|bupivacaine|mesh-list
83117932|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83117933|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83117934|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
83117935|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
83117936|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117937|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83117938|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
83117939|NCT05459571|Hormones|hormones|mesh-ancestor
83117940|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83117941|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83117942|NCT05459571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117943|NCT05458674|Trastuzumab|trastuzumab|mesh-list
83117944|NCT05458674|Tucatinib|tucatinib|mesh-list
83117945|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117946|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117947|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83117948|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83117949|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117950|NCT05458453|Esketamine|esketamine|mesh-list
83117951|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
83117952|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83117953|NCT05445778|Bevacizumab|bevacizumab|mesh-list
83117954|NCT05445778|Maytansine|maytansine|mesh-list
83117955|NCT05445778|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83117956|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83117957|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83117958|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83117959|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83117960|NCT05445778|Growth Substances|growth substances|mesh-ancestor
83117961|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117962|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
83117963|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83117964|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
83117965|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83117966|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83117967|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83117968|NCT05445778|Immunoconjugates|immunoconjugates|mesh-ancestor
83117969|NCT05445778|Immunologic Factors|immunologic factors|mesh-ancestor
83117970|NCT05429489|Morphine|morphine|mesh-list
83117971|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83117972|NCT05429489|Narcotics|narcotics|mesh-ancestor
83117973|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117974|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117975|NCT05429489|Analgesics|analgesics|mesh-ancestor
83117976|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
83117977|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117978|NCT05413863|Insulin|insulin|mesh-list
83117979|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83117980|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83117981|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117982|NCT05412914|Propofol|propofol|mesh-list
83117983|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83117984|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117985|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117986|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83117987|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
83117988|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
83117989|NCT05374499|Epinephrine|epinephrine|mesh-list
83117990|NCT05374499|Bupivacaine|bupivacaine|mesh-list
83117991|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
83117992|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
83117993|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83117994|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83117995|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
83117996|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83117997|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83117998|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83117999|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
83118000|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118001|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118002|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83118003|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83118004|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
83118005|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83118006|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83118007|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
83118008|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
83118009|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83118010|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83118011|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83118012|NCT05373264|Diuretics|diuretics|mesh-ancestor
83118013|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
83118014|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118015|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83118016|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83118017|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118018|NCT05367492|Varenicline|varenicline|mesh-list
83118019|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83118020|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83118021|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
83118022|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118023|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118024|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118025|NCT05358704|Leucovorin|leucovorin|mesh-list
83118026|NCT05358704|Fluorouracil|fluorouracil|mesh-list
83118027|NCT05358704|Capecitabine|capecitabine|mesh-list
83118028|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
83118029|NCT05358704|Irinotecan|irinotecan|mesh-list
83118031|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118032|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118033|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118034|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118035|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
83118036|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118037|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83118038|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83118039|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118040|NCT05358704|Antidotes|antidotes|mesh-ancestor
83118041|NCT05358704|Protective Agents|protective agents|mesh-ancestor
83118042|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
83118043|NCT05358704|Vitamins|vitamins|mesh-ancestor
83118044|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
83118045|NCT05358691|Durvalumab|durvalumab|mesh-list
83118046|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118047|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118048|NCT05357690|Bupivacaine|bupivacaine|mesh-list
83118049|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
83118050|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
83118051|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118052|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118053|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
83118054|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118055|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
83118056|NCT05341154|Ketamine|ketamine|mesh-list
83118057|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83118058|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118059|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118060|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83118061|NCT05341154|Analgesics|analgesics|mesh-ancestor
83118062|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
83118063|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118064|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83118065|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83118066|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83118067|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
83118068|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118069|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118070|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83118071|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83118072|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
83118073|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
83118074|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83118075|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83118076|NCT05330858|Rabeprazole|rabeprazole|mesh-list
83118077|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83118078|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118079|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83118080|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118081|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118082|NCT05328102|Lenalidomide|lenalidomide|mesh-list
83118083|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
83118084|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118085|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83118086|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83118087|NCT05328102|Growth Substances|growth substances|mesh-ancestor
83118088|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83118089|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118090|NCT05317676|Palmidrol|palmidrol|mesh-list
83118091|NCT05317676|Analgesics|analgesics|mesh-ancestor
83118092|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
83118093|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118094|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118095|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83118096|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83118097|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118098|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118099|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
83118100|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118101|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83118102|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83118103|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118104|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118105|NCT05317676|Hormones|hormones|mesh-ancestor
83118106|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118107|NCT05312268|Rasburicase|rasburicase|mesh-list
83118108|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
83118109|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118110|NCT05301361|Methylphenidate|methylphenidate|mesh-list
83118111|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83118112|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118113|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83118114|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83118115|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83118116|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118117|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
83118118|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118119|NCT05295927|Prednisone|prednisone|mesh-list
83118120|NCT05295927|Prednisolone|prednisolone|mesh-list
83118121|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
83118122|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118123|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
83118124|NCT05295927|Hormones|hormones|mesh-ancestor
83118125|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118126|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118127|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83118128|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118129|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83118130|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118131|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118132|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
83118133|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83118134|NCT05288673|Ravulizumab|ravulizumab|mesh-list
83118135|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83118136|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118137|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
83118138|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118139|NCT05288660|Ravulizumab|ravulizumab|mesh-list
83118140|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83118141|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118142|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
83118143|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118144|NCT05284812|Vaccines|vaccines|mesh-list
83118145|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
83118146|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118147|NCT05283226|Paclitaxel|paclitaxel|mesh-list
83118148|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83118149|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118150|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
83118151|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
83118152|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
83118153|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118154|NCT05257460|Insulin|insulin|mesh-list
83118155|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83118156|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
83118157|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83118158|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118159|NCT05254626|Pioglitazone|pioglitazone|mesh-list
83118160|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
83118161|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83118162|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118163|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83118164|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118165|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
83118166|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83118167|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83118168|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
83118169|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118170|NCT05243550|Mitomycins|mitomycins|mesh-list
83118171|NCT05243550|Mitomycin|mitomycin|mesh-list
83118172|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83118173|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118174|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
83118175|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118176|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83118177|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118178|NCT05223335|Clopidogrel|clopidogrel|mesh-list
83118179|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83118180|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83118181|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83118182|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83118183|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83118184|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
83118185|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118186|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118187|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118188|NCT05216653|Capecitabine|capecitabine|mesh-list
83118189|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
83118190|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118191|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
83118192|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118193|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118194|NCT05211791|Anesthetics|anesthetics|mesh-list
83118195|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118196|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118197|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
83118198|NCT05166811|Analgesics|analgesics|mesh-ancestor
83118199|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
83118200|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118201|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118202|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
83118203|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118204|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83118205|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
83118206|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83118207|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83118208|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118209|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83118210|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
83118211|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83118212|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
83118214|NCT05165225|Epirubicin|epirubicin|mesh-list
83118215|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118216|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
83118217|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118218|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118219|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83118220|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
83118221|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118222|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118223|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83118224|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83118225|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83118226|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83118227|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83118228|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83118229|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83118230|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118231|NCT05150587|Rifaximin|rifaximin|mesh-list
83118232|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83118233|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118234|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118235|NCT05143229|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83118236|NCT05143229|Immunoconjugates|immunoconjugates|mesh-ancestor
83118237|NCT05143229|Immunologic Factors|immunologic factors|mesh-ancestor
83118238|NCT05143229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118239|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
83118240|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118241|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118242|NCT05120596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83118243|NCT05120596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118244|NCT05116293|Acetaminophen|acetaminophen|mesh-list
83118245|NCT05116293|Digoxin|digoxin|mesh-list
83118246|NCT05116293|Midazolam|midazolam|mesh-list
83118247|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83118248|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83118249|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118250|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118251|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83118252|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83118253|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83118254|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83118255|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
83118256|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
83118257|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
83118258|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
83118259|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118260|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118261|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83118262|NCT05116293|Analgesics|analgesics|mesh-ancestor
83118263|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
83118264|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118265|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
83118266|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83118267|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83118268|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118269|NCT05116293|Protective Agents|protective agents|mesh-ancestor
83118270|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
83118271|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83118272|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118273|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118274|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83118275|NCT05099055|Analgesics|analgesics|mesh-ancestor
83118276|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
83118277|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118278|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83118279|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83118280|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83118281|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
83118282|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118283|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118284|NCT05024344|Dexamethasone|dexamethasone|mesh-list
83118285|NCT05024344|Ropivacaine|ropivacaine|mesh-list
83118286|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118287|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
83118288|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
83118289|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118290|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118291|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118292|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
83118294|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118295|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83118296|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118297|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
83118298|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
83118299|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118300|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
83118302|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83118303|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
83118304|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118305|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118306|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83118307|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83118308|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83118309|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83118310|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83118311|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
83118312|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118313|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118314|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
83118315|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83118316|NCT04993027|Vancomycin|vancomycin|mesh-list
83118317|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83118318|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118319|NCT04991324|Vitamin D|vitamin d|mesh-list
83118320|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
83118321|NCT04991324|Vitamins|vitamins|mesh-ancestor
83118322|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
83118323|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118324|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83118325|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83118326|NCT04984616|Atorvastatin|atorvastatin|mesh-list
83118327|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83118328|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83118329|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
83118330|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118331|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83118332|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83118333|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118334|NCT04983030|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83118335|NCT04983030|Antiviral Agents|antiviral agents|mesh-ancestor
83118336|NCT04983030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118337|NCT04966481|Cetuximab|cetuximab|mesh-list
83118338|NCT04966481|Palbociclib|palbociclib|mesh-list
83118339|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118340|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118341|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83118342|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118343|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118344|NCT04957329|Latanoprost|latanoprost|mesh-list
83118345|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83118346|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83118347|NCT04937881|Tenofovir|tenofovir|mesh-list
83118348|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
83118349|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118350|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83118351|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83118352|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118353|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118354|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83118355|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83118356|NCT04910568|Dexamethasone|dexamethasone|mesh-list
83118357|NCT04910568|Daratumumab|daratumumab|mesh-list
83118358|NCT04910568|Pomalidomide|pomalidomide|mesh-list
83118359|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118360|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
83118361|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
83118362|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118363|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118364|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118365|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
83118366|NCT04910568|Hormones|hormones|mesh-ancestor
83118367|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118368|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83118369|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118370|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
83118371|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83118372|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83118373|NCT04910568|Growth Substances|growth substances|mesh-ancestor
83118374|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
83118375|NCT04907721|Glucagon|glucagon|mesh-list
83118376|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83118377|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118378|NCT04907721|Hormones|hormones|mesh-ancestor
83118379|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118380|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118381|NCT04907721|Incretins|incretins|mesh-ancestor
83118382|NCT04905810|Azacitidine|azacitidine|mesh-list
83118383|NCT04905810|Decitabine|decitabine|mesh-list
83118384|NCT04905810|Venetoclax|venetoclax|mesh-list
83118385|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118386|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
83118387|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118388|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118389|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118390|NCT04871412|Vitamin D|vitamin d|mesh-list
83118391|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
83118392|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
83118393|NCT04871412|Vitamins|vitamins|mesh-list
83118394|NCT04871412|Curcumin|curcumin|mesh-list
83118395|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
83118396|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118397|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83118398|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83118399|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83118400|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83118401|NCT04871412|Analgesics|analgesics|mesh-ancestor
83118403|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118404|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118405|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118406|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118407|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118408|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118409|NCT04868877|Osimertinib|osimertinib|mesh-list
83118410|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118411|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83118412|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118413|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118414|NCT04818086|Buprenorphine|buprenorphine|mesh-list
83118415|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83118416|NCT04818086|Lemborexant|lemborexant|mesh-list
83118417|NCT04818086|Naloxone|naloxone|mesh-list
83118418|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83118419|NCT04818086|Narcotics|narcotics|mesh-ancestor
83118420|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118421|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118422|NCT04818086|Analgesics|analgesics|mesh-ancestor
83118423|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
83118424|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118425|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83118426|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83118427|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118428|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118429|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83118430|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83118431|NCT04799431|Poly I-C|poly i-c|mesh-list
83118432|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83118433|NCT04799431|Poly ICLC|poly iclc|mesh-list
83118434|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
83118435|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
83118436|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118437|NCT04799431|Laxatives|laxatives|mesh-ancestor
83118438|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118439|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
83118440|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118441|NCT04778397|Cytarabine|cytarabine|mesh-list
83118442|NCT04778397|Azacitidine|azacitidine|mesh-list
83118443|NCT04778397|Daunorubicin|daunorubicin|mesh-list
83118444|NCT04778397|Venetoclax|venetoclax|mesh-list
83118445|NCT04778397|Idarubicin|idarubicin|mesh-list
83118446|NCT04778397|Magrolimab|magrolimab|mesh-list
83118447|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83118448|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118449|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
83118450|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118451|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118452|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
83118453|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118454|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118455|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
83118456|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118457|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118458|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83118459|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83118460|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83118461|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83118462|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118463|NCT04745832|Prednisone|prednisone|mesh-list
83118464|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
83118465|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83118466|NCT04745832|Rituximab|rituximab|mesh-list
83118467|NCT04745832|Vincristine|vincristine|mesh-list
83118468|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118469|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
83118470|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118471|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118505|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
83118506|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118507|NCT04724668|Protective Agents|protective agents|mesh-ancestor
83118508|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118509|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118510|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
83118511|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83118512|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83118513|NCT04685772|Prednisolone|prednisolone|mesh-list
83118514|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
83118515|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83118516|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
83118517|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118518|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
83118519|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
83118520|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118521|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118522|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118523|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
83118524|NCT04685772|Hormones|hormones|mesh-ancestor
83118525|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118526|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83118527|NCT04685772|Protective Agents|protective agents|mesh-ancestor
83118528|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83118529|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118530|NCT04629209|TIC10 compound|tic10 compound|mesh-list
83118531|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118532|NCT04609189|Vitamin D|vitamin d|mesh-list
83118533|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
83118534|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
83118535|NCT04609189|Calcium|calcium|mesh-list
83118536|NCT04609189|Vitamins|vitamins|mesh-ancestor
83118537|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
83118538|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118539|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83118540|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83118541|NCT04609189|Antacids|antacids|mesh-ancestor
83118542|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118543|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118544|NCT04604795|Itraconazole|itraconazole|mesh-list
83118545|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
83118546|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118547|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83118548|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83118549|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118550|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118551|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83118552|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
83492851|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
83118553|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118554|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118555|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83118557|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
83118558|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118559|NCT04588233|Protective Agents|protective agents|mesh-ancestor
83118560|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118561|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118562|NCT04587128|Irinotecan|irinotecan|mesh-list
83118563|NCT04587128|Cetuximab|cetuximab|mesh-list
83118564|NCT04587128|Panitumumab|panitumumab|mesh-list
83118565|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83118566|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83118567|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118568|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118569|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118570|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118571|NCT04570150|Neostigmine|neostigmine|mesh-list
83118572|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83118573|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118574|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118575|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
83118576|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118577|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118578|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83118579|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
83118580|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118581|NCT04563273|Vaccines|vaccines|mesh-list
83118582|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
83118583|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
83118584|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118585|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83118586|NCT04552782|Ethanol|ethanol|mesh-list
83118587|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83118588|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118589|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118590|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118591|NCT04545866|Budesonide|budesonide|mesh-list
83118592|NCT04545866|Poractant alfa|poractant alfa|mesh-list
83118593|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83118594|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118595|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83118596|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
83118597|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118598|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118599|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83118600|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
83118601|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
83118602|NCT04545866|Hormones|hormones|mesh-ancestor
83118603|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118604|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
83118605|NCT04545762|Fludarabine|fludarabine|mesh-list
83118606|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
83118607|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118608|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
83118609|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118610|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118611|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83118612|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
83118613|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118614|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118615|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83118616|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118617|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
83118618|NCT04539977|Carboplatin|carboplatin|mesh-list
83118619|NCT04539977|Etoposide|etoposide|mesh-list
83118620|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
83118621|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118622|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83118623|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83118624|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83118625|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118626|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118627|NCT04535141|Olanzapine|olanzapine|mesh-list
83118628|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
83118629|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
83118630|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118631|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118632|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118633|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83118634|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83118635|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118636|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83118637|NCT04535141|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83118638|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83118639|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83118640|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118641|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118642|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
83118643|NCT04534023|Idebenone|idebenone|mesh-list
83118644|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
83118645|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118646|NCT04534023|Protective Agents|protective agents|mesh-ancestor
83118647|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118648|NCT04527393|Morphine|morphine|mesh-list
83118649|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83118650|NCT04527393|Narcotics|narcotics|mesh-ancestor
83118651|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118652|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118653|NCT04527393|Analgesics|analgesics|mesh-ancestor
83118654|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
83118655|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118656|NCT04510506|Pancrelipase|pancrelipase|mesh-list
83118657|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83118658|NCT04480918|Ketamine|ketamine|mesh-list
83118659|NCT04480918|Esketamine|esketamine|mesh-list
83118660|NCT04480918|Analgesics|analgesics|mesh-ancestor
83118661|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
83118662|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118663|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118664|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83118665|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83118666|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
83118667|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
83118668|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118669|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83118670|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83118671|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118672|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118673|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
83118674|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83118675|NCT04465487|Cemiplimab|cemiplimab|mesh-list
83118676|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118677|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118678|NCT04419909|Tisagenlecleucel|tisagenlecleucel|mesh-list
83118679|NCT04419909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118680|NCT04419909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118681|NCT04410796|Carboplatin|carboplatin|mesh-list
83118682|NCT04410796|Pemetrexed|pemetrexed|mesh-list
83118683|NCT04410796|Osimertinib|osimertinib|mesh-list
83118684|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118685|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118686|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118687|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83118688|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83118689|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83118690|NCT04374500|Verapamil|verapamil|mesh-list
83118691|NCT04374500|Nitroprusside|nitroprusside|mesh-list
83118692|NCT04374500|Acetylcholine|acetylcholine|mesh-list
83118693|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
83118694|NCT04374500|Bradykinin|bradykinin|mesh-list
83118695|NCT04374500|Substance P|substance p|mesh-list
83118696|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83118697|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83118698|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83118699|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83492852|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
83118700|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83118701|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118702|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83118703|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83118704|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83118705|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
83118706|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118708|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83118709|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
83118710|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118711|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118712|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83118713|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83118714|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
83118715|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118716|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118717|NCT04326283|Trametinib|trametinib|mesh-list
83118718|NCT04326283|Riluzole|riluzole|mesh-list
83118719|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118720|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83118721|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118722|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118723|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
83118724|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83118725|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83118726|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118727|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118728|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83118729|NCT04326283|Protective Agents|protective agents|mesh-ancestor
83118730|NCT04287062|Suvorexant|suvorexant|mesh-list
83118731|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83118732|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83118733|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118734|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118735|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83118736|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118737|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118738|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83118739|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
83118740|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83118741|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83118742|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83118743|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83118744|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118745|NCT04266353|Resveratrol|resveratrol|mesh-list
83118746|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
83118747|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118748|NCT04266353|Protective Agents|protective agents|mesh-ancestor
83118749|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118750|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118751|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83118752|NCT04249427|Erenumab|erenumab|mesh-list
83118753|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83118754|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118755|NCT04249427|Analgesics|analgesics|mesh-ancestor
83118756|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
83118757|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83469633|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
83118758|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118759|NCT04231643|Dronabinol|dronabinol|mesh-list
83118760|NCT04231643|Cannabidiol|cannabidiol|mesh-list
83118761|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
83118762|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118763|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83118764|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83118765|NCT04231643|Analgesics|analgesics|mesh-ancestor
83118766|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
83118767|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118768|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83118769|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83118770|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118771|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118772|NCT04231643|Hormones|hormones|mesh-ancestor
83118773|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118775|NCT04207190|Talazoparib|talazoparib|mesh-list
83118776|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
83118777|NCT04207190|Calicheamicins|calicheamicins|mesh-list
83118778|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83118779|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118780|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118781|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118782|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118783|NCT04207190|Immunotoxins|immunotoxins|mesh-ancestor
83118784|NCT04207190|Immunoconjugates|immunoconjugates|mesh-ancestor
83118785|NCT04207190|Immunologic Factors|immunologic factors|mesh-ancestor
83118786|NCT04207190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118787|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83118788|NCT04174196|Lenalidomide|lenalidomide|mesh-list
83118789|NCT04174196|Cc-486|cc-486|mesh-list
83118790|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
83118791|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118792|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83118793|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83118794|NCT04174196|Growth Substances|growth substances|mesh-ancestor
83118795|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
83118796|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118797|NCT04171167|Fluticasone|fluticasone|mesh-list
83118798|NCT04171167|Xhance|xhance|mesh-list
83118799|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118800|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83118801|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
83118802|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83118803|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118804|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83118805|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83118806|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
83118807|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83118808|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
83118809|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83118810|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118811|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118812|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118813|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
83118814|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83118815|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
83118816|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118817|NCT04119284|Protective Agents|protective agents|mesh-ancestor
83118818|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118819|NCT04117763|Empagliflozin|empagliflozin|mesh-list
83118820|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83118821|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118822|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83118823|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118824|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
83118825|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
83118826|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118827|NCT04078880|Protective Agents|protective agents|mesh-ancestor
83118828|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118829|NCT04078880|Vitamins|vitamins|mesh-ancestor
83118830|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
83118831|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83118832|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
83118833|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118834|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83118835|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
83118836|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118837|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118838|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83118839|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83118840|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83118841|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83118842|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83118843|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83118844|NCT04071574|Cetrorelix|cetrorelix|mesh-list
83118845|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83118846|NCT04071574|Hormones|hormones|mesh-ancestor
83118847|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118848|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118849|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
83118850|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83118851|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
83118852|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83118853|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83118854|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83118855|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118856|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83118857|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
83118858|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
83118859|NCT04046107|Cemiplimab|cemiplimab|mesh-list
83118860|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118861|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118862|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
83118863|NCT04023669|Gemcitabine|gemcitabine|mesh-list
83118864|NCT04023669|Lenograstim|lenograstim|mesh-list
83118865|NCT04023669|Prexasertib|prexasertib|mesh-list
83118866|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118867|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
83118868|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118869|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118870|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83118871|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
83118872|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118873|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118874|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83118875|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118876|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
83118877|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83118878|NCT04023669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83118879|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118880|NCT04002362|Triamcinolone|triamcinolone|mesh-list
83118881|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83118882|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83118883|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83118884|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83118885|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
83118886|NCT04002362|Hormones|hormones|mesh-ancestor
83118887|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83118888|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118889|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118890|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
83118891|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118892|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118893|NCT03992196|Rotigotine|rotigotine|mesh-list
83118894|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
83118895|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
83118896|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83118897|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118898|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118899|NCT03982381|Metformin|metformin|mesh-list
83118900|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
83118901|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83118902|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118903|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83118904|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118905|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
83118906|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
83118907|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83118908|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
83118909|NCT03970252|Leucovorin|leucovorin|mesh-list
83118910|NCT03970252|Folic Acid|folic acid|mesh-list
83118911|NCT03970252|Fluorouracil|fluorouracil|mesh-list
83118912|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
83118913|NCT03970252|Nivolumab|nivolumab|mesh-list
83118914|NCT03970252|Irinotecan|irinotecan|mesh-list
83118915|NCT03970252|Camptothecin|camptothecin|mesh-list
83118916|NCT03970252|Calcium|calcium|mesh-list
83118917|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
83118918|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83118919|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118920|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83118921|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
83118922|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118923|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118924|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118925|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118926|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
83118927|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118928|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83118929|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83118930|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83118931|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83118933|NCT03970252|Protective Agents|protective agents|mesh-ancestor
83118934|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
83118935|NCT03970252|Vitamins|vitamins|mesh-ancestor
83118936|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
83118937|NCT03970252|Hematinics|hematinics|mesh-ancestor
83118938|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83118939|NCT03969004|Cemiplimab|cemiplimab|mesh-list
83118940|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118941|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118942|NCT03942328|Bevacizumab|bevacizumab|mesh-list
83118943|NCT03942328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83118944|NCT03942328|Atezolizumab|atezolizumab|mesh-list
83118945|NCT03942328|Vaccines|vaccines|mesh-list
83118946|NCT03942328|Antibodies|antibodies|mesh-list
83118947|NCT03942328|Immunoglobulins|immunoglobulins|mesh-list
83118948|NCT03942328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83118949|NCT03942328|Immunoglobulin G|immunoglobulin g|mesh-list
83118950|NCT03942328|Endothelial Growth Factors|endothelial growth factors|mesh-list
83118951|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
83118952|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118953|NCT03942328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118954|NCT03942328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83118955|NCT03942328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83118956|NCT03942328|Growth Substances|growth substances|mesh-ancestor
83118957|NCT03942328|Growth Inhibitors|growth inhibitors|mesh-ancestor
83118958|NCT03942328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83118959|NCT03942328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118960|NCT03932409|Paclitaxel|paclitaxel|mesh-list
83118961|NCT03932409|Carboplatin|carboplatin|mesh-list
83118962|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
83118963|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83118964|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118965|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
83118966|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
83118967|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
83118968|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118969|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118970|NCT03932409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83118971|NCT03915613|Insulin|insulin|mesh-list
83118972|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83118973|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83118974|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118975|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
83118976|NCT03907852|Nivolumab|nivolumab|mesh-list
83118977|NCT03907852|Fludarabine|fludarabine|mesh-list
83118978|NCT03907852|Ipilimumab|ipilimumab|mesh-list
83118979|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83118980|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
83118981|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83118982|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83118983|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83118984|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
83118985|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118986|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118987|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83118988|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83118989|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83118990|NCT03904251|Cytarabine|cytarabine|mesh-list
83118991|NCT03904251|Daunorubicin|daunorubicin|mesh-list
83118992|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
83118993|NCT03904251|Calicheamicins|calicheamicins|mesh-list
83118994|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83118995|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
83118996|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83118997|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83118998|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
83118999|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119000|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119001|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
83119002|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119003|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83119004|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83119005|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83119006|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119007|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119009|NCT03904251|Immunoconjugates|immunoconjugates|mesh-ancestor
83119010|NCT03896633|Brinzolamide|brinzolamide|mesh-list
83119011|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83119012|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119013|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119014|NCT03890731|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83119015|NCT03890731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83119016|NCT03890731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119017|NCT03890731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119018|NCT03872180|Venetoclax|venetoclax|mesh-list
83119019|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83119020|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
83119021|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119022|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83119023|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
83119024|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119025|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119026|NCT03847649|Prednisone|prednisone|mesh-list
83119027|NCT03847649|Durvalumab|durvalumab|mesh-list
83119028|NCT03847649|Tremelimumab|tremelimumab|mesh-list
83469742|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
83119029|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119030|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
83119031|NCT03847649|Hormones|hormones|mesh-ancestor
83119032|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119033|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119034|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83119035|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119036|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119037|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
83119038|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119039|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83119040|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83119041|NCT03847311|Analgesics|analgesics|mesh-ancestor
83119042|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
83119043|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119044|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119045|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119046|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83119047|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119048|NCT03845543|Paclitaxel|paclitaxel|mesh-list
83119049|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119050|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119051|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119052|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119053|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119054|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119055|NCT03827889|Fluorides|fluorides|mesh-list
83119056|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
83119057|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
83119058|NCT03827889|Protective Agents|protective agents|mesh-ancestor
83119059|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119060|NCT03826563|Melatonin|melatonin|mesh-list
83119061|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
83119062|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119063|NCT03826563|Protective Agents|protective agents|mesh-ancestor
83119064|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119065|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119066|NCT03825796|Cytarabine|cytarabine|mesh-list
83119067|NCT03825796|Daunorubicin|daunorubicin|mesh-list
83119068|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119070|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119071|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119072|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
83493301|NCT03405584|Diuretics|diuretics|mesh-ancestor
83119074|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119075|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
83119076|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119077|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83119078|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83119079|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83119080|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119081|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
83119082|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119083|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119084|NCT03823131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119085|NCT03823131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119086|NCT03822091|Terlipressin|terlipressin|mesh-list
83119087|NCT03822091|Norepinephrine|norepinephrine|mesh-list
83119088|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83119089|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83119090|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83119091|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83119092|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119093|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119094|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119095|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119096|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
83119097|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
83119098|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119099|NCT03767348|Nivolumab|nivolumab|mesh-list
83119100|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119101|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119102|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119103|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119104|NCT03739619|Gemcitabine|gemcitabine|mesh-list
83119105|NCT03739619|Nivolumab|nivolumab|mesh-list
83119106|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83119107|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119108|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
83119109|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119110|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119111|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119112|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119113|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83119114|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
83119115|NCT03728933|Rotigotine|rotigotine|mesh-list
83119116|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
83119117|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
83119118|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119119|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119120|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119121|NCT03664544|Edaravone|edaravone|mesh-list
83119122|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83119123|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
83119124|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119125|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83119126|NCT03664544|Protective Agents|protective agents|mesh-ancestor
83119127|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119128|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
83119129|NCT03645928|Nivolumab|nivolumab|mesh-list
83119130|NCT03645928|Ipilimumab|ipilimumab|mesh-list
83119131|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119132|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119133|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119134|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119135|NCT03554083|Atezolizumab|atezolizumab|mesh-list
83119136|NCT03554083|Vemurafenib|vemurafenib|mesh-list
83119137|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83119138|NCT03554083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119139|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119140|NCT03554083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119141|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119143|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119144|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83119145|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119146|NCT03537495|Linezolid|linezolid|mesh-list
83119147|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83119148|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119149|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83119150|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119151|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119152|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119153|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
83119154|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119155|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119156|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
83119157|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119158|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119159|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119160|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119161|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119162|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119163|NCT03535259|Sorafenib|sorafenib|mesh-list
83119164|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119165|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83119166|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119167|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119168|NCT03521570|Nivolumab|nivolumab|mesh-list
83119169|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119170|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119171|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119172|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119173|NCT03484299|Gemcitabine|gemcitabine|mesh-list
83119174|NCT03484299|Folfirinox|folfirinox|mesh-list
83119175|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119176|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
83119177|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119178|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119179|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
83119180|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119181|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119182|NCT03468218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119183|NCT03468218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119184|NCT03408574|Mecamylamine|mecamylamine|mesh-list
83119185|NCT03408574|Nicotine|nicotine|mesh-list
83119186|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83119187|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
83119188|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119189|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119190|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83119191|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83119192|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
83119193|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119194|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119195|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83119196|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83119197|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83119198|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83119199|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
83119200|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119201|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119202|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83119203|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
83119204|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83119205|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
83119206|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119207|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119208|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119209|NCT03222570|Serotonin|serotonin|mesh-list
83469779|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119210|NCT03222570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83119211|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83119212|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
83119213|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119214|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119215|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119216|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119217|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119219|NCT03193853|Serabelisib|serabelisib|mesh-list
83119220|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119221|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119222|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119223|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119224|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119225|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119226|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119228|NCT03179904|Trastuzumab|trastuzumab|mesh-list
83119229|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83119230|NCT03179904|Letrozole|letrozole|mesh-list
83119231|NCT03179904|Fulvestrant|fulvestrant|mesh-list
83119232|NCT03179904|Anastrozole|anastrozole|mesh-list
83119233|NCT03179904|Exemestane|exemestane|mesh-list
83119234|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83119235|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83119236|NCT03179904|Antibodies|antibodies|mesh-list
83119237|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
83119238|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83119239|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119240|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119241|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119242|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119243|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119244|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119245|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
83119246|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119247|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83119248|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83119249|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119250|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83119251|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
83119252|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119253|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83119254|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83119255|NCT03143153|Fluorouracil|fluorouracil|mesh-list
83119256|NCT03143153|Nivolumab|nivolumab|mesh-list
83119257|NCT03143153|Ipilimumab|ipilimumab|mesh-list
83119258|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119259|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
83119260|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119261|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119262|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119263|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
83119264|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119265|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119266|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119267|NCT03136328|Edotreotide|edotreotide|mesh-list
83119268|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83119269|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119270|NCT03072771|Cytarabine|cytarabine|mesh-list
83119271|NCT03072771|Etoposide|etoposide|mesh-list
83119272|NCT03072771|Melphalan|melphalan|mesh-list
83119273|NCT03072771|Carmustine|carmustine|mesh-list
83119274|NCT03072771|Blinatumomab|blinatumomab|mesh-list
83119275|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119276|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119277|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83119278|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83119279|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119280|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119281|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119282|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
83119283|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
83119284|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119285|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119286|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
83119287|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119288|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83119289|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
83119290|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83119291|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
83119292|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83119293|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119294|NCT02966782|Azacitidine|azacitidine|mesh-list
83119295|NCT02966782|Venetoclax|venetoclax|mesh-list
83119296|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119297|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
83119298|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119299|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119300|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119302|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83119303|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119304|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119305|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
83119306|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119307|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119308|NCT02914938|Rituximab|rituximab|mesh-list
83119309|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
83119310|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119311|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119312|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
83119313|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119314|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83119315|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83119316|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119317|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119318|NCT02849457|Vigabatrin|vigabatrin|mesh-list
83119319|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
83119320|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119321|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119322|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
83119323|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119324|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119325|NCT02802631|Minocycline|minocycline|mesh-list
83119326|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83119327|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119328|NCT02759185|Dronabinol|dronabinol|mesh-list
83119329|NCT02759185|Cannabidiol|cannabidiol|mesh-list
83119330|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
83119331|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
83119332|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119333|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119334|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83119335|NCT02759185|Analgesics|analgesics|mesh-ancestor
83119336|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
83119337|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119338|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83119339|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83119340|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119341|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119342|NCT02759185|Hormones|hormones|mesh-ancestor
83119343|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119344|NCT02757898|Biotin|biotin|mesh-list
83119345|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
83119346|NCT02757898|Vitamins|vitamins|mesh-ancestor
83119347|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
83119348|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119349|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
83119350|NCT02730546|Leucovorin|leucovorin|mesh-list
83119351|NCT02730546|Folic Acid|folic acid|mesh-list
83119352|NCT02730546|Paclitaxel|paclitaxel|mesh-list
83119353|NCT02730546|Carboplatin|carboplatin|mesh-list
83119354|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
83119355|NCT02730546|Fluorouracil|fluorouracil|mesh-list
83119356|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
83119357|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83119358|NCT02730546|Calcium|calcium|mesh-list
83119359|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
83119360|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119361|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119362|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119363|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119364|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119365|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119366|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119367|NCT02730546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119368|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83119369|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119370|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83119372|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119373|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119375|NCT02730546|Antidotes|antidotes|mesh-ancestor
83119376|NCT02730546|Protective Agents|protective agents|mesh-ancestor
83119377|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
83119378|NCT02730546|Vitamins|vitamins|mesh-ancestor
83119379|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
83119380|NCT02730546|Hematinics|hematinics|mesh-ancestor
83119381|NCT02672098|Carboplatin|carboplatin|mesh-list
83119382|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119383|NCT02649335|Propranolol|propranolol|mesh-list
83119384|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83119385|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83119386|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119387|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119388|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119389|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119390|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83119391|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83119392|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
83119393|NCT02609386|Zinc|zinc|mesh-list
83119394|NCT02609386|Indomethacin|indomethacin|mesh-list
83119395|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
83119396|NCT02609386|Omeprazole|omeprazole|mesh-list
83119397|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83119398|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119399|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
83119400|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119401|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83119402|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83119403|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
83119404|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119405|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119406|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83119407|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
83119408|NCT02609386|Trace Elements|trace elements|mesh-ancestor
83119409|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83119410|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119411|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119412|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83119413|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83119414|NCT02609386|Analgesics|analgesics|mesh-ancestor
83119415|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
83119416|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119417|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119418|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
83119419|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
83119420|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83469803|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
83119421|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83119422|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
83119423|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119424|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119425|NCT02589496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83119426|NCT02589496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119427|NCT02543983|Ketamine|ketamine|mesh-list
83119428|NCT02543983|Analgesics|analgesics|mesh-ancestor
83119429|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
83119430|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119431|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119432|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83119433|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83119434|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
83119435|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
83119436|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119437|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83119438|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83119439|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119440|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119441|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119442|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
83119443|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119444|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119445|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
83119446|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119447|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119448|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119449|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119450|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119451|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119452|NCT02213575|Minocycline|minocycline|mesh-list
83119453|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83119454|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119455|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
83119456|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83119457|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
83119458|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119459|NCT02133872|Minocycline|minocycline|mesh-list
83119460|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83119461|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119462|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119463|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
83119464|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119465|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119466|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
83119467|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119468|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119469|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119470|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119471|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119472|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119473|NCT01820858|Paclitaxel|paclitaxel|mesh-list
83119474|NCT01820858|Carboplatin|carboplatin|mesh-list
83119475|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119476|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119477|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119478|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119479|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119480|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119481|NCT01802632|Osimertinib|osimertinib|mesh-list
83119482|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119483|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83119484|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119485|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119486|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119487|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
83119488|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119489|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119490|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
83119491|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119492|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119493|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119494|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119495|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119496|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119497|NCT01755897|Paclitaxel|paclitaxel|mesh-list
83119498|NCT01755897|Cisplatin|cisplatin|mesh-list
83119499|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119500|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119501|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119502|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119503|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119504|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119505|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83119506|NCT01738607|Psyllium|psyllium|mesh-list
83119507|NCT01738607|Laxatives|laxatives|mesh-ancestor
83119508|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119509|NCT01738607|Cathartics|cathartics|mesh-ancestor
83119510|NCT01728259|Dexamethasone|dexamethasone|mesh-list
83119511|NCT01728259|Bortezomib|bortezomib|mesh-list
83119512|NCT01728259|Pomalidomide|pomalidomide|mesh-list
83119513|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119514|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
83119515|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
83119516|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119517|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119518|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119519|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
83119520|NCT01728259|Hormones|hormones|mesh-ancestor
83119521|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119522|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83119523|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119524|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
83119525|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83119526|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83119527|NCT01728259|Growth Substances|growth substances|mesh-ancestor
83119528|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
83119529|NCT01722604|Brinzolamide|brinzolamide|mesh-list
83119530|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83119531|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119532|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119533|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119534|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
83119535|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119536|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119537|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
83119538|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119539|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119540|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119541|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119542|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119543|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119544|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83119545|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83119546|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119547|NCT01305499|Azacitidine|azacitidine|mesh-list
83119548|NCT01305499|Entinostat|entinostat|mesh-list
83119549|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119550|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
83119551|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119552|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119553|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119554|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83119555|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119556|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
83119557|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119558|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119559|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
83119560|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119561|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119562|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119563|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119564|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119565|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119566|NCT01202994|Flutemetamol|flutemetamol|mesh-list
83119567|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83119568|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119569|NCT00930943|Oxymorphone|oxymorphone|mesh-list
83119570|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83119571|NCT00930943|Narcotics|narcotics|mesh-ancestor
83119572|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119573|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119574|NCT00930943|Analgesics|analgesics|mesh-ancestor
83119575|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
83119576|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119577|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83119578|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
83119579|NCT00670670|Caseins|caseins|mesh-list
83119580|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83119581|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
83119582|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119583|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119584|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119585|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
83119586|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
83119587|NCT00670618|Fluorides|fluorides|mesh-list
83119588|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
83119589|NCT00670618|Protective Agents|protective agents|mesh-ancestor
83119590|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119591|NCT00620425|Sumatriptan|sumatriptan|mesh-list
83119592|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83119593|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83119594|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83119596|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119597|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119598|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119599|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
83119600|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83119601|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
83119602|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119603|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119604|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83119605|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
83119606|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83119607|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
83119608|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119609|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119610|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83119611|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
82748208|NCT00199069|Doxorubicin|doxorubicin|mesh-list
83119612|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
83119613|NCT00515281|Protective Agents|protective agents|mesh-ancestor
83119614|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83119615|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
83119616|NCT00504582|Coagulants|coagulants|mesh-ancestor
83119617|NCT00436254|Molgramostim|molgramostim|mesh-list
83119618|NCT00436254|Sargramostim|sargramostim|mesh-list
83119619|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
83119620|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119621|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119622|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119623|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
83119624|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119625|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119626|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
83119627|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119628|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119629|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119630|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119631|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119632|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119633|NCT00335114|Cyclosporine|cyclosporine|mesh-list
83119634|NCT00335114|Cyclosporins|cyclosporins|mesh-list
83119635|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119636|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119637|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119638|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
83119639|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119640|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
83119641|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119642|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
83119643|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83119644|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83119645|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83119646|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
83119647|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119648|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119649|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
83119650|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119651|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119652|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119653|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119654|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119655|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119656|NCT03606577|Dexamethasone|dexamethasone|mesh-list
83119657|NCT03606577|Lenalidomide|lenalidomide|mesh-list
83119658|NCT03606577|Daratumumab|daratumumab|mesh-list
83119659|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119660|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
83119661|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
83119662|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119663|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119664|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119665|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
83119666|NCT03606577|Hormones|hormones|mesh-ancestor
83119667|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119668|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83119669|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119670|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
83119671|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83119672|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83119673|NCT03606577|Growth Substances|growth substances|mesh-ancestor
83119674|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
83119675|NCT03601975|Gemcitabine|gemcitabine|mesh-list
83119676|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119677|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119678|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
83469836|NCT00383812|Bevacizumab|bevacizumab|mesh-list
83119679|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119680|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83119681|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83119682|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119683|NCT03137186|Metformin|metformin|mesh-list
83119684|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83119685|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119686|NCT03601897|Paclitaxel|paclitaxel|mesh-list
83119687|NCT03601897|Rebastinib|rebastinib|mesh-list
83119688|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119689|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119690|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119691|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119692|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119693|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119694|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83119695|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119696|NCT03137030|Acetaminophen|acetaminophen|mesh-list
83119697|NCT03137030|Hydrocodone|hydrocodone|mesh-list
83119698|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83119699|NCT03137030|Analgesics|analgesics|mesh-ancestor
83119700|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
83119701|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119702|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119703|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
83119704|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83119705|NCT03137030|Narcotics|narcotics|mesh-ancestor
83119706|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119707|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
83119708|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
83119709|NCT03596749|Sevelamer|sevelamer|mesh-list
83119710|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
83119711|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
83119712|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119713|NCT01595061|Cisplatin|cisplatin|mesh-list
83119714|NCT01595061|Gemcitabine|gemcitabine|mesh-list
83119715|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119716|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119717|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
83119718|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119719|NCT03367143|Carboplatin|carboplatin|mesh-list
83119720|NCT03367143|Etoposide|etoposide|mesh-list
83119721|NCT03367143|Lenalidomide|lenalidomide|mesh-list
83119722|NCT03367143|Ifosfamide|ifosfamide|mesh-list
83119723|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119724|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119725|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83119726|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83119727|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119728|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119729|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
83119730|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119731|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83119732|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83119733|NCT03367143|Growth Substances|growth substances|mesh-ancestor
83119734|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
83119735|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83119736|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
83119737|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
83119738|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119739|NCT04762316|Pyridoxal|pyridoxal|mesh-list
83119740|NCT04762316|Pyridoxine|pyridoxine|mesh-list
83119741|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
83119742|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83119743|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
83119744|NCT04762316|Vitamins|vitamins|mesh-ancestor
83119745|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
83119746|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119748|NCT03372447|Pyridoxine|pyridoxine|mesh-list
83119749|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
83119750|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
83119751|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
83119752|NCT03372447|Vitamins|vitamins|mesh-ancestor
83119753|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
83119754|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119755|NCT03372447|Hematinics|hematinics|mesh-ancestor
83119756|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
83119757|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83119758|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83119759|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119760|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
83119761|NCT04651166|Coagulants|coagulants|mesh-ancestor
83119762|NCT03376191|Apatinib|apatinib|mesh-list
83119763|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119764|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83119765|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119766|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119767|NCT03366597|Sevoflurane|sevoflurane|mesh-list
83119768|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83119769|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83119770|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
83119771|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
83119772|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119773|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119774|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
83119775|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83119776|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
83119777|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
83119778|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119779|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119780|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
83119781|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119782|NCT03109886|Maleic acid|maleic acid|mesh-list
83119783|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119784|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119785|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
83119786|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83119787|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83119788|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83119789|NCT03110198|Mesalamine|mesalamine|mesh-list
83119790|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119791|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83119792|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83119793|NCT03110198|Analgesics|analgesics|mesh-ancestor
83119794|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
83119795|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119796|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119797|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83119798|NCT04460781|Vaccines|vaccines|mesh-list
83119799|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
83119800|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119801|NCT03371589|Dexamethasone|dexamethasone|mesh-list
83119802|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119803|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
83119804|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
83119805|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119806|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83469863|NCT01281007|Acyclovir|acyclovir|mesh-list
83119807|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119808|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
83119809|NCT03371589|Hormones|hormones|mesh-ancestor
83119810|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119811|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83119812|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119813|NCT03365817|Fentanyl|fentanyl|mesh-list
83119814|NCT03365817|Morphine|morphine|mesh-list
83119815|NCT03365817|Oxycodone|oxycodone|mesh-list
83119816|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
83119817|NCT03365817|Tramadol|tramadol|mesh-list
83119818|NCT03365817|Methadone|methadone|mesh-list
83119819|NCT03365817|Narcotics|narcotics|mesh-ancestor
83119820|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119822|NCT03365817|Analgesics|analgesics|mesh-ancestor
83119823|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
83119824|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119825|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83119826|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83119827|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
83119828|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
83119829|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
83119830|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
83119831|NCT02852005|Vaccines|vaccines|mesh-list
83119832|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
83119833|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119834|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
83119835|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83119836|NCT03365115|Fentanyl|fentanyl|mesh-list
83119837|NCT03365115|Morphine|morphine|mesh-list
83119838|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83119839|NCT03365115|Narcotics|narcotics|mesh-ancestor
83119840|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119841|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119842|NCT03365115|Analgesics|analgesics|mesh-ancestor
83119843|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
83119844|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119845|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83119846|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83119847|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
83119848|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
83119849|NCT02237755|Citric Acid|citric acid|mesh-list
83119850|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
83119851|NCT02237755|Clomiphene|clomiphene|mesh-list
83119852|NCT02237755|Enclomiphene|enclomiphene|mesh-list
83119853|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
83119854|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
83119855|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83119856|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
83119857|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
83119858|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119859|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83119860|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83119861|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119862|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119863|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83119864|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
83119865|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83119866|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83119867|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83119868|NCT04524897|Triamcinolone|triamcinolone|mesh-list
83119869|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83119870|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83119871|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83119872|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83119873|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
83119874|NCT04524897|Hormones|hormones|mesh-ancestor
83119875|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83119876|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119877|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83119878|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
83119879|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119880|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119881|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
83119882|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83119883|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83119884|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119885|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
83119886|NCT03364569|Coagulants|coagulants|mesh-ancestor
83119887|NCT03363477|Enoxaparin|enoxaparin|mesh-list
83119888|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
83119889|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
83119890|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83119891|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83119892|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119893|NCT02879318|Paclitaxel|paclitaxel|mesh-list
83119894|NCT02879318|Gemcitabine|gemcitabine|mesh-list
83119895|NCT02879318|Durvalumab|durvalumab|mesh-list
83119896|NCT02879318|Tremelimumab|tremelimumab|mesh-list
83119897|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83119898|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119899|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83119900|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83119901|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83119902|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83493302|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
83119903|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83119905|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83119907|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83119908|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119909|NCT03592537|Fentanyl|fentanyl|mesh-list
83119910|NCT03592537|Midazolam|midazolam|mesh-list
83119911|NCT03592537|Bupivacaine|bupivacaine|mesh-list
83119912|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
83119913|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
83119914|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119915|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119916|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
83119917|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119918|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83119919|NCT03592537|Narcotics|narcotics|mesh-ancestor
83119920|NCT03592537|Analgesics|analgesics|mesh-ancestor
83119921|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83119922|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83119923|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
83119924|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83119925|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83119926|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83119927|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83119928|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
83119929|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
83119930|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119931|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119932|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
83119933|NCT03362853|Nemonoxacin|nemonoxacin|mesh-list
83119934|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83119935|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119936|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83119937|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83119938|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83119939|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119940|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83119941|NCT02849743|Oxytocin|oxytocin|mesh-list
83119942|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
83119943|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83119944|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119945|NCT05063006|Methamphetamine|methamphetamine|mesh-list
83119946|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83119947|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119948|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
83119949|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
83119950|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119951|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
83119952|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83119953|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119954|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
83119955|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83119956|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83119957|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83119958|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83119959|NCT03587077|Isosorbide|isosorbide|mesh-list
83119960|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83119961|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83119962|NCT03587077|Misoprostol|misoprostol|mesh-list
83119963|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83119964|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
83119965|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83119966|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119967|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83119968|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83119969|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
83119970|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83119971|NCT03587077|Diuretics|diuretics|mesh-ancestor
83119972|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
83119973|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
83119974|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83119975|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119976|NCT02238457|Losartan|losartan|mesh-list
83119977|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83119978|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83119979|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83119980|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83119981|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83119982|NCT02238535|Iloprost|iloprost|mesh-list
83119983|NCT02238535|Warfarin|warfarin|mesh-list
83119984|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
83119985|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83119986|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
83119987|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83119988|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83119989|NCT03909074|Vaccines|vaccines|mesh-list
83119990|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
83119991|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119992|NCT03138668|Ropivacaine|ropivacaine|mesh-list
83119993|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
83119994|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
83119995|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83119996|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83119997|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
83119998|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83119999|NCT03371043|Analgesics|analgesics|mesh-list
83120000|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
83120001|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120002|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120003|NCT03600961|Sirolimus|sirolimus|mesh-list
83120004|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83120005|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120006|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83120007|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120008|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
83120009|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83120010|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
83120011|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120012|NCT05013242|Goserelin|goserelin|mesh-list
83120013|NCT05013242|Dienogest|dienogest|mesh-list
83120014|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83120015|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120016|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83120017|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
83120018|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83120019|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120020|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83120021|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83120022|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83120023|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83120024|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
83120025|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120026|NCT05089604|Tacrolimus|tacrolimus|mesh-list
83120027|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83120028|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
83120029|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120030|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83120031|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120032|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120033|NCT03590275|Folfirinox|folfirinox|mesh-list
83120034|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120035|NCT05089448|Amlodipine|amlodipine|mesh-list
83120036|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83120037|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83120038|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83120039|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120040|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83120041|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120042|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
83120043|NCT00601003|Nifurtimox|nifurtimox|mesh-list
83120044|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
83120045|NCT00601003|Topotecan|topotecan|mesh-list
83120046|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83120047|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
83120048|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120049|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120050|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83120051|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
83120052|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120053|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120054|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83120055|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83120056|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83120057|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120058|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83120059|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83120060|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83120061|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120063|NCT02849509|Dabigatran|dabigatran|mesh-list
83120064|NCT02849509|Vitamins|vitamins|mesh-ancestor
83120065|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
83120066|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120067|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
83120068|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83120069|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
83120070|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120071|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120072|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
83120073|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83120074|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83120075|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
83120076|NCT02849509|Coagulants|coagulants|mesh-ancestor
83120077|NCT00151424|Olanzapine|olanzapine|mesh-list
83120078|NCT00151424|Asenapine|asenapine|mesh-list
83120079|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
83120080|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
83120081|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120082|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120083|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120084|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83120085|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83120086|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120087|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83120088|NCT00151424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83120089|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83120090|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83120091|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120092|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120093|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
83120094|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
83120095|NCT03600727|Propofol|propofol|mesh-list
83120096|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83120097|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120098|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120099|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120100|NCT03600727|Analgesics|analgesics|mesh-ancestor
83120101|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
83120102|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120103|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83120104|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83120105|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83120106|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83120107|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120108|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120109|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83120110|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
83120111|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
83120112|NCT02733133|Testosterone|testosterone|mesh-list
83120113|NCT02733133|Androgens|androgens|mesh-ancestor
83120114|NCT02733133|Hormones|hormones|mesh-ancestor
83120115|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120116|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120117|NCT03464942|Atezolizumab|atezolizumab|mesh-list
83120118|NCT03464942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83120119|NCT03464942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120120|NCT03464942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83120121|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120122|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
83120124|NCT03584893|Vitamins|vitamins|mesh-ancestor
83120125|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
83120126|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120127|NCT03362073|Ketamine|ketamine|mesh-list
83120128|NCT03362073|Analgesics|analgesics|mesh-ancestor
83120129|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
83120130|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120131|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120132|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83120133|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83120134|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
83120135|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
83120136|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120137|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83120138|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83120139|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120140|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120141|NCT03582865|Tamoxifen|tamoxifen|mesh-list
83120142|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83120143|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
83120144|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120145|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120146|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83120147|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120148|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83120149|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83120150|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83120151|NCT03136406|Leucovorin|leucovorin|mesh-list
83120152|NCT03136406|Paclitaxel|paclitaxel|mesh-list
83120153|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
83120154|NCT03136406|Bevacizumab|bevacizumab|mesh-list
83120155|NCT03136406|Fluorouracil|fluorouracil|mesh-list
83120156|NCT03136406|Capecitabine|capecitabine|mesh-list
83120157|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
83120158|NCT03136406|Avelumab|avelumab|mesh-list
83120159|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83120160|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120161|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83120162|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83120163|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83120164|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120165|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83120166|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
83120167|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120168|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120169|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83120170|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
83120171|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83120172|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83120173|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83120174|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83120175|NCT03136406|Growth Substances|growth substances|mesh-ancestor
83120176|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
83120177|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
83120178|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83120179|NCT03136406|Antidotes|antidotes|mesh-ancestor
83120180|NCT03136406|Protective Agents|protective agents|mesh-ancestor
83120181|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
83120182|NCT03136406|Vitamins|vitamins|mesh-ancestor
83120183|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
83120184|NCT03590197|Melatonin|melatonin|mesh-list
83120185|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
83120186|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120187|NCT03590197|Protective Agents|protective agents|mesh-ancestor
83120188|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120189|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120190|NCT03357315|Immunomodulating Agents|immunomodulating agents|mesh-list
83120191|NCT03357315|Immunologic Factors|immunologic factors|mesh-ancestor
83120192|NCT03357315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120193|NCT05057468|Cyclosporine|cyclosporine|mesh-list
83120194|NCT05057468|Rituximab|rituximab|mesh-list
83120195|NCT05057468|Cyclosporins|cyclosporins|mesh-list
83120196|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83120197|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120198|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
83120199|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120200|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120201|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120202|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120203|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83120204|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
83120205|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120206|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
83120207|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83120209|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83120210|NCT02518503|Simvastatin|simvastatin|mesh-list
83120211|NCT02518503|Pravastatin|pravastatin|mesh-list
83120212|NCT02518503|Lovastatin|lovastatin|mesh-list
83120213|NCT02518503|L 647318|l 647318|mesh-list
83120214|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
83120215|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83120216|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83120217|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
83120218|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120219|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83120220|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83120221|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120222|NCT03600493|Lidocaine|lidocaine|mesh-list
83120223|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
83120224|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
83120225|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
83120226|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120227|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120228|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
83120229|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120230|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83120231|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83120232|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83120233|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83120234|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120235|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83120236|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120237|NCT03600493|Analgesics|analgesics|mesh-ancestor
83120238|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83120239|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83120240|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83120241|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
83120242|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120243|NCT03138356|Metformin|metformin|mesh-list
83120244|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
83120245|NCT03138356|Saxagliptin|saxagliptin|mesh-list
83120246|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83120247|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120248|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83120249|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120250|NCT03138356|Incretins|incretins|mesh-ancestor
83120251|NCT03138356|Hormones|hormones|mesh-ancestor
83120252|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120253|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83120254|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
83120255|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120256|NCT03137966|Deferoxamine|deferoxamine|mesh-list
83120257|NCT03137966|Siderophores|siderophores|mesh-ancestor
83120258|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83120259|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
83120260|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
83120261|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120262|NCT02853305|Carboplatin|carboplatin|mesh-list
83120263|NCT02853305|Gemcitabine|gemcitabine|mesh-list
83120264|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
83120265|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120266|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83120267|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
83120268|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120269|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83120270|NCT02853305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83120271|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
83120272|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83120273|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
83120274|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120275|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
83120276|NCT04521387|Protective Agents|protective agents|mesh-ancestor
83120277|NCT03579979|Methylene Blue|methylene blue|mesh-list
83120278|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83469927|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83120279|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120280|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
83120281|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83493378|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
83120282|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83120283|NCT04509219|Prednisolone|prednisolone|mesh-list
83120284|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
83120285|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83120286|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
83120287|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120288|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
83120289|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
83120290|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120291|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120292|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120293|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
83120294|NCT04509219|Hormones|hormones|mesh-ancestor
83120295|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120296|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83120297|NCT04509219|Protective Agents|protective agents|mesh-ancestor
83120298|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83120299|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120300|NCT04444635|Fentanyl|fentanyl|mesh-list
83120301|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83120302|NCT04444635|Narcotics|narcotics|mesh-ancestor
83120303|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120304|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120305|NCT04444635|Analgesics|analgesics|mesh-ancestor
83120306|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
83120307|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120308|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83120309|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83120310|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
83120311|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
83120312|NCT03033446|Nivolumab|nivolumab|mesh-list
83120313|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83120314|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120315|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83120316|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120317|NCT03579823|Adalimumab|adalimumab|mesh-list
83120318|NCT03579823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83120319|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120320|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120321|NCT04444011|Amoxicillin|amoxicillin|mesh-list
83120322|NCT04444011|Clarithromycin|clarithromycin|mesh-list
83120323|NCT04444011|Bismuth|bismuth|mesh-list
83120324|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83120325|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120326|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83120327|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120328|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120329|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83120330|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83120331|NCT04444011|Antacids|antacids|mesh-ancestor
83120332|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120333|NCT04443387|Vitamin D|vitamin d|mesh-list
83120334|NCT04443387|Vitamins|vitamins|mesh-ancestor
83120335|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
83120336|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120337|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83120338|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
83120339|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83120340|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120341|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120342|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120343|NCT02316236|Analgesics|analgesics|mesh-ancestor
83120344|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
83120345|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120346|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83120347|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83120348|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83120349|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
83120350|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120351|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120352|NCT04521075|Nivolumab|nivolumab|mesh-list
83120353|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83120354|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120355|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83120356|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120357|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
83120358|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83120360|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
83120361|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83120362|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120363|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120364|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120365|NCT03601091|Analgesics|analgesics|mesh-ancestor
83120366|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
83120367|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120368|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83120369|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83120370|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83120371|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83120372|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120373|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120374|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83120375|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83120376|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83120377|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83120378|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83120379|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
83120380|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
83120381|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
83120382|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
83120383|NCT04508829|Antibodies|antibodies|mesh-list
83120384|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83120385|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
83120386|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120387|NCT04521309|Antibodies|antibodies|mesh-list
83120388|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
83120389|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120390|NCT02267252|Antibodies|antibodies|mesh-list
83120391|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
83120392|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120393|NCT04521153|Apatinib|apatinib|mesh-list
83120394|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120395|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83120396|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120397|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120398|NCT04362566|Bupivacaine|bupivacaine|mesh-list
83120399|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
83120400|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
83120401|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120402|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120403|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
83120404|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120405|NCT03579589|Neostigmine|neostigmine|mesh-list
83120406|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83120407|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120408|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120409|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
83120410|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120411|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120412|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83120413|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
83120414|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120415|NCT03600857|Misoprostol|misoprostol|mesh-list
83120416|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83120417|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
83120418|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83120419|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120420|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83120421|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120422|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
83120423|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
83120424|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83120425|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83120426|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120427|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
83120428|NCT02229968|Coagulants|coagulants|mesh-ancestor
83120429|NCT03600623|Paclitaxel|paclitaxel|mesh-list
83120430|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83120431|NCT03600623|Gemcitabine|gemcitabine|mesh-list
83120432|NCT03600623|Fluorouracil|fluorouracil|mesh-list
83120433|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
83120435|NCT03600623|Folfirinox|folfirinox|mesh-list
83120436|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83120437|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120438|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
83120439|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
83120440|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
83120441|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120442|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83120443|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
83120444|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83120445|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
83120446|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120447|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83120448|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83120449|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120450|NCT02848729|Acetaminophen|acetaminophen|mesh-list
83120451|NCT02848729|Morphine|morphine|mesh-list
83120452|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83120453|NCT02848729|Narcotics|narcotics|mesh-ancestor
83120454|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120455|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120456|NCT02848729|Analgesics|analgesics|mesh-ancestor
83120457|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
83120458|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120459|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120460|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
83120461|NCT03600467|Seviteronel|seviteronel|mesh-list
83120462|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120463|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83120464|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120465|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120466|NCT05737784|Pramoxine|pramoxine|mesh-list
83120467|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
83120468|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
83120469|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120470|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120471|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
83120472|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120473|NCT04520919|Anesthetics|anesthetics|mesh-list
83120474|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120475|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120476|NCT03600311|Vitamin D|vitamin d|mesh-list
83120477|NCT03600311|Calcium|calcium|mesh-list
83120478|NCT03600311|Vitamins|vitamins|mesh-ancestor
83120479|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
83120480|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120481|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83120482|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83120483|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
83120484|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83120485|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
83120486|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83120487|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
83120488|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
83120489|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83120490|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83120491|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120492|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120493|NCT03603119|Dexamethasone|dexamethasone|mesh-list
83120494|NCT03603119|Midazolam|midazolam|mesh-list
83120495|NCT03603119|Ondansetron|ondansetron|mesh-list
83120496|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120497|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
83120498|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
83120499|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120500|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120501|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120502|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
83120503|NCT03603119|Hormones|hormones|mesh-ancestor
83120504|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120505|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83120506|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120507|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83120508|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83120509|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120510|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83120511|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83120512|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83120513|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83120514|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
83120515|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
83120516|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
83120517|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
83120518|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120519|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120520|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
83120521|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
83120522|NCT03603119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83120523|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83120524|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
83120525|NCT03356769|Aspirin|aspirin|mesh-list
83120526|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
83120527|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83120528|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120529|NCT03356769|Analgesics|analgesics|mesh-ancestor
83120530|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
83120531|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120532|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120533|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120534|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120535|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83120536|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83120537|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120538|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83120539|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83120540|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120541|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
83120542|NCT04508439|Heparin|heparin|mesh-list
83120543|NCT04508439|Enoxaparin|enoxaparin|mesh-list
83120544|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83120545|NCT04508439|Tinzaparin|tinzaparin|mesh-list
83120546|NCT04508439|Dalteparin|dalteparin|mesh-list
83120547|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
83120548|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83120549|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83120550|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120551|NCT02237651|Anesthetics|anesthetics|mesh-list
83120552|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120553|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120554|NCT02237729|Adalimumab|adalimumab|mesh-list
83120555|NCT02237729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83120556|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120557|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120558|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
83120559|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
83120560|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83120561|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
83120562|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120563|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120564|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83120565|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
83120566|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83120567|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83120568|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83120569|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
83120570|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120571|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120572|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
83120573|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83120574|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
83120575|NCT03354117|Meloxicam|meloxicam|mesh-list
83120576|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
83120577|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83120578|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120579|NCT03354117|Analgesics|analgesics|mesh-ancestor
83120580|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
83120581|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120582|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120583|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120584|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120585|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83120586|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83120587|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120588|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120589|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83120590|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
83120591|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83120592|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83120593|NCT03360981|Incretins|incretins|mesh-list
83120594|NCT03360981|Hormones|hormones|mesh-ancestor
83120595|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120596|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120597|NCT03597815|Aflibercept|aflibercept|mesh-list
83120598|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83120599|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83120600|NCT03597815|Growth Substances|growth substances|mesh-ancestor
83120601|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120602|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83120603|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120604|NCT03595085|Streptokinase|streptokinase|mesh-list
83120605|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83120606|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83120607|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120608|NCT00158756|Vaccines|vaccines|mesh-list
83120609|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
83120610|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120611|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83120612|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
83120613|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83120614|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
83120615|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83120616|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120617|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83120618|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83120619|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120620|NCT03885713|Adalimumab|adalimumab|mesh-list
83120621|NCT03885713|Infliximab|infliximab|mesh-list
83120622|NCT03885713|Golimumab|golimumab|mesh-list
83120623|NCT03885713|Ustekinumab|ustekinumab|mesh-list
83120624|NCT03885713|Vedolizumab|vedolizumab|mesh-list
83120625|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83120626|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120627|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120628|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
83120629|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120630|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83120631|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
83120632|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120633|NCT04519125|Tenofovir|tenofovir|mesh-list
83120634|NCT04519125|Emtricitabine|emtricitabine|mesh-list
83120635|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
83120636|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120637|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83120638|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83120639|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120640|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120641|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83120642|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83120643|NCT02730195|Pioglitazone|pioglitazone|mesh-list
83120644|NCT02730195|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83120645|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83120646|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120647|NCT02730195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83120648|NCT02730195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120649|NCT02730195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120650|NCT03360279|Paclitaxel|paclitaxel|mesh-list
83120651|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83120652|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120653|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
83120654|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
83120655|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
83120656|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120657|NCT03353103|Listerine|listerine|mesh-list
83120658|NCT03353103|Fluorides|fluorides|mesh-list
83120659|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
83120660|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
83120661|NCT03353103|Protective Agents|protective agents|mesh-ancestor
83120662|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120663|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83120664|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120665|NCT03360123|Midazolam|midazolam|mesh-list
83120666|NCT03360123|Triazolam|triazolam|mesh-list
83120667|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83120668|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83120669|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120670|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120671|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83120672|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83120673|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83120674|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83120675|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
83120676|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
83120677|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
83120678|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
83120679|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120680|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120681|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
83120682|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
83120683|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83120684|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83120685|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120686|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
83120687|NCT03360045|Coagulants|coagulants|mesh-ancestor
83120688|NCT03353025|Dopamine|dopamine|mesh-list
83120689|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
83120690|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83120691|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
83120692|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
83120693|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120694|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120695|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
83120696|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120697|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120698|NCT03353025|Protective Agents|protective agents|mesh-ancestor
83120699|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83120700|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83120701|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120702|NCT04506957|Chrysarobin|chrysarobin|mesh-list
83120703|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83120704|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120705|NCT04506957|Analgesics|analgesics|mesh-ancestor
83120706|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
83120707|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120708|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120709|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120710|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120711|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83120712|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83120713|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120714|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
83120715|NCT03352947|Trametinib|trametinib|mesh-list
83120716|NCT03352947|Dabrafenib|dabrafenib|mesh-list
83120717|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120718|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83120719|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120720|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120721|NCT02730351|Fluticasone|fluticasone|mesh-list
83120722|NCT02730351|Xhance|xhance|mesh-list
83120723|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120724|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83120725|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
83120726|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120727|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120728|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83120729|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
83120730|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
83120731|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83120732|NCT03359655|Scopolamine|scopolamine|mesh-list
83120733|NCT03359655|Bromides|bromides|mesh-list
83120734|NCT03359655|Misoprostol|misoprostol|mesh-list
83120735|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83120736|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83120737|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
83120738|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83120739|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120740|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83120741|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120742|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
83120743|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
83120744|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83120745|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
83120746|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
83120747|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120748|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
83120749|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83120750|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
83120751|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120752|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120753|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83120754|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
83120755|NCT03352869|Metformin|metformin|mesh-list
83120756|NCT03352869|Exenatide|exenatide|mesh-list
83120757|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83120758|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120759|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83120760|NCT03352869|Incretins|incretins|mesh-ancestor
83120761|NCT03352869|Hormones|hormones|mesh-ancestor
83120762|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120763|NCT03359499|Trimebutine|trimebutine|mesh-list
83120764|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120765|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
83120766|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
83120767|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120768|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120769|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
83120770|NCT03352479|Narcotics|narcotics|mesh-ancestor
83120771|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120772|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120773|NCT03352479|Analgesics|analgesics|mesh-ancestor
83120774|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
83120775|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120776|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
83120777|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83120778|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120779|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120780|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83120781|NCT03355053|Analgesics|analgesics|mesh-ancestor
83120782|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
83120783|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120784|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83120785|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83120786|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83120787|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
83120788|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83120789|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120790|NCT03354897|Torsemide|torsemide|mesh-list
83120791|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83120792|NCT03354897|Diuretics|diuretics|mesh-ancestor
83120793|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
83120794|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120795|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83120796|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83120797|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120798|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83120799|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83120800|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120801|NCT03358953|Nicotine|nicotine|mesh-list
83120802|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83120803|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
83120804|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120805|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120806|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83120807|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83120808|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83120809|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482695|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120810|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120811|NCT04509999|Bicalutamide|bicalutamide|mesh-list
83120812|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
83120813|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
83120814|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120815|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120816|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120817|NCT04505943|Isoniazid|isoniazid|mesh-list
83120818|NCT04505943|Misoprostol|misoprostol|mesh-list
83120819|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83120820|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
83120821|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83120822|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120823|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83120824|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120825|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
83120826|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
83120827|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83120828|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120829|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83120830|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83120831|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
83120832|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120833|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83120834|NCT03358719|Poly I-C|poly i-c|mesh-list
83120835|NCT03358719|Nivolumab|nivolumab|mesh-list
83120836|NCT03358719|Decitabine|decitabine|mesh-list
83120837|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83120838|NCT03358719|Poly ICLC|poly iclc|mesh-list
83120839|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83120840|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120841|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83120842|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120843|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83120844|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
83120845|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120846|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
83120847|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
83120848|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120849|NCT03358719|Laxatives|laxatives|mesh-ancestor
83120850|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120851|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
83120852|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120853|NCT04505475|Hemostatics|hemostatics|mesh-list
83120854|NCT04505475|Coagulants|coagulants|mesh-ancestor
83120855|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83120856|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83120857|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
83120858|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120859|NCT03350373|Dotinurad|dotinurad|mesh-list
83120860|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
83120861|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
83120862|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83120863|NCT03350295|Nifurtimox|nifurtimox|mesh-list
83120864|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83120865|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83120866|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83120867|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120868|NCT03349983|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83120869|NCT03349983|Antiviral Agents|antiviral agents|mesh-ancestor
83120870|NCT03349983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120871|NCT03349827|Apatinib|apatinib|mesh-list
83120872|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120873|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83120874|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120875|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120876|NCT04503915|Estrogens|estrogens|mesh-list
83120877|NCT04503915|Hormones|hormones|mesh-ancestor
83120878|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120879|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120880|NCT04504851|Rifampin|rifampin|mesh-list
83120882|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
83120883|NCT04504851|Ethambutol|ethambutol|mesh-list
83120884|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83120885|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83120886|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83120887|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
83120888|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120889|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83120890|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83120891|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120892|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83120893|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
83120894|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83120895|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120896|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
83120897|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83120898|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83120899|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83120900|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83120901|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83120902|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83120903|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83120904|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83120905|NCT05509257|Naltrexone|naltrexone|mesh-list
83120906|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83120907|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83120908|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120909|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
83120910|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120911|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83120912|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
83120913|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83120914|NCT03030261|Dexamethasone|dexamethasone|mesh-list
83120915|NCT03030261|Pomalidomide|pomalidomide|mesh-list
83120916|NCT03030261|Elotuzumab|elotuzumab|mesh-list
83120917|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120918|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
83120919|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
83120920|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120921|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120922|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120923|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
83120924|NCT03030261|Hormones|hormones|mesh-ancestor
83120925|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120926|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83120927|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120928|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
83120929|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83120930|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83120931|NCT03030261|Growth Substances|growth substances|mesh-ancestor
83120932|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
83120933|NCT02176161|Metformin|metformin|mesh-list
83120934|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83120935|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120936|NCT03348735|Lidocaine|lidocaine|mesh-list
83120937|NCT03348735|Pregabalin|pregabalin|mesh-list
83120938|NCT03348735|Capsaicin|capsaicin|mesh-list
83120939|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
83120940|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
83120941|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83120942|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120943|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
83120944|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120945|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83120946|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83120947|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83120948|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83120949|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120950|NCT03348735|Analgesics|analgesics|mesh-ancestor
83120951|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
83120952|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83120953|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83120954|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83120955|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83120956|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83120957|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
83120958|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
83120959|NCT01700673|Azacitidine|azacitidine|mesh-list
83120960|NCT01700673|Sargramostim|sargramostim|mesh-list
83470003|NCT04348370|Vaccines|vaccines|mesh-list
83120961|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83120962|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
83120963|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120964|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120965|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83120966|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
83120967|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120968|NCT03898154|Dexamethasone|dexamethasone|mesh-list
83120969|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
83120970|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83120971|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83120972|NCT03898154|Prednisolone|prednisolone|mesh-list
83120973|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
83120974|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83120975|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
83120976|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83120977|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
83120978|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
83120979|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83120980|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83120981|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120982|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
83120983|NCT03898154|Hormones|hormones|mesh-ancestor
83120984|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83120985|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83120986|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83120987|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83120988|NCT03898154|Protective Agents|protective agents|mesh-ancestor
83120989|NCT02517957|Loperamide|loperamide|mesh-list
83120990|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
83120991|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83120992|NCT03348267|Caseins|caseins|mesh-list
83120993|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
83120994|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
83120995|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83120996|NCT03136796|Meropenem|meropenem|mesh-list
83120997|NCT03136796|Piperacillin|piperacillin|mesh-list
83120998|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83120999|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121000|NCT05243745|Fluorides|fluorides|mesh-list
83121001|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
83121002|NCT05243745|Protective Agents|protective agents|mesh-ancestor
83121003|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121004|NCT04500717|Carboplatin|carboplatin|mesh-list
83121005|NCT04500717|Pemetrexed|pemetrexed|mesh-list
83121006|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121007|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121008|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121009|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83121010|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83121011|NCT01680458|Fluconazole|fluconazole|mesh-list
83121012|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
83121013|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121014|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83121015|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83121016|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121017|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121018|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83121019|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
83121020|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121021|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121022|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83121023|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83121024|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83121025|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83121026|NCT03346317|Estradiol|estradiol|mesh-list
83121027|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83121028|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
83470011|NCT00002944|Lomustine|lomustine|mesh-list
83121029|NCT03346317|Estrogens|estrogens|mesh-ancestor
83121030|NCT03346317|Hormones|hormones|mesh-ancestor
83121031|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121032|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121033|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83121034|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
83121035|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83121036|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83121037|NCT03346317|Progestins|progestins|mesh-ancestor
83121038|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
83121039|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83121040|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
83121041|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121042|NCT01550432|Expectorants|expectorants|mesh-ancestor
83121043|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
83121044|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83121045|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
83121046|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121047|NCT01550432|Protective Agents|protective agents|mesh-ancestor
83121048|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121049|NCT01550432|Antidotes|antidotes|mesh-ancestor
83121050|NCT04502277|Fluconazole|fluconazole|mesh-list
83121051|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
83121052|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121053|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83121054|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83121055|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121056|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121057|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83121058|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
83121059|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121060|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121061|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83121062|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83121063|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83121064|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83121065|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121066|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
83121067|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121068|NCT04850144|Bromides|bromides|mesh-list
83121069|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
83121070|NCT04850144|Charcoal|charcoal|mesh-list
83121071|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83121072|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
83121073|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121074|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121075|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83121076|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83121077|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
83121078|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83121079|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
83121080|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121081|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121082|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
83121083|NCT04850144|Antidotes|antidotes|mesh-ancestor
83121084|NCT04850144|Protective Agents|protective agents|mesh-ancestor
83121085|NCT04590794|Plasminogen|plasminogen|mesh-list
83121086|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83121087|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83121088|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121089|NCT00709761|Paclitaxel|paclitaxel|mesh-list
83121090|NCT00709761|Lapatinib|lapatinib|mesh-list
83121091|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83121092|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121093|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
83121094|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
83121095|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
83121096|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121097|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83121098|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121099|NCT03346083|Betrixaban|betrixaban|mesh-list
83121100|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83121101|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
83121102|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83121103|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
83121104|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121105|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121106|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
83121107|NCT05584683|Amoxicillin|amoxicillin|mesh-list
83121108|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
83121109|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
83121110|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83121111|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83121112|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121113|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83121114|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121115|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121116|NCT02358031|Carboplatin|carboplatin|mesh-list
83121117|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
83121118|NCT02358031|Cetuximab|cetuximab|mesh-list
83121119|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121120|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121121|NCT02358031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83121122|NCT02358031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121123|NCT02516631|Misoprostol|misoprostol|mesh-list
83121124|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83121125|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
83121126|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83121127|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121128|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83121129|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121130|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
83121131|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
83121132|NCT02516475|Astringents|astringents|mesh-ancestor
83121133|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121134|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83121135|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83121136|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83121137|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83121138|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121139|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121140|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83121141|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121142|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121143|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
83121144|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121145|NCT03423680|Aripiprazole|aripiprazole|mesh-list
83121146|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
83121147|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83121148|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83121149|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83121150|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121151|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121152|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
83121153|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
83121154|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121155|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121156|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83121157|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83121158|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
83121159|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83121160|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83121161|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83121162|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83121163|NCT04975100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83121164|NCT04975100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83121165|NCT04975100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121166|NCT04975100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121167|NCT04975100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121168|NCT04975100|Serotonin Agents|serotonin agents|mesh-ancestor
83121169|NCT04975100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121170|NCT04443543|Fluorouracil|fluorouracil|mesh-list
83121171|NCT04443543|Capecitabine|capecitabine|mesh-list
83121172|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
83121173|NCT04443543|Irinotecan|irinotecan|mesh-list
83121174|NCT04443543|Tislelizumab|tislelizumab|mesh-list
83121175|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
83121176|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121177|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121178|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121179|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121180|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
83121181|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121182|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83121183|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83121184|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121185|NCT04443543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121186|NCT02516085|Metformin|metformin|mesh-list
83121187|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83121188|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121189|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
83121190|NCT02515929|Procyanidin|procyanidin|mesh-list
83121191|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
83121192|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121193|NCT02515929|Protective Agents|protective agents|mesh-ancestor
83121194|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121195|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83121196|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83121197|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121198|NCT03347721|Lidocaine|lidocaine|mesh-list
83121199|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
83121200|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
83121201|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121202|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121203|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
83121204|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121205|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83121206|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83121207|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83121208|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121209|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121210|NCT02848651|Atezolizumab|atezolizumab|mesh-list
83121211|NCT02848651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83121212|NCT02848651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121213|NCT02848651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121214|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121215|NCT00709059|Ribavirin|ribavirin|mesh-list
83121216|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83121217|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
83121218|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
83121219|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121220|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
83121221|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121222|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
83121223|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121224|NCT04500561|Gemcitabine|gemcitabine|mesh-list
83121225|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
83121226|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121227|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
83121228|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121229|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121230|NCT04507256|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83121231|NCT04507256|Antiviral Agents|antiviral agents|mesh-ancestor
83121232|NCT04507256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121233|NCT04968015|Cytarabine|cytarabine|mesh-list
83121234|NCT04968015|Venetoclax|venetoclax|mesh-list
83121235|NCT04968015|Idarubicin|idarubicin|mesh-list
83121236|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121237|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
83121238|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121239|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121240|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
83121241|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121242|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121243|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
83121244|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121245|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83121246|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83121247|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83121248|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121249|NCT05094596|Montelukast|montelukast|mesh-list
83121250|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83121251|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
83121252|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83121253|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
83121254|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121255|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121256|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83121257|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83121258|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121259|NCT01678820|Metformin|metformin|mesh-list
83121260|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83121261|NCT01678820|Glimepiride|glimepiride|mesh-list
83121262|NCT01678820|Simvastatin|simvastatin|mesh-list
83121263|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83121264|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121265|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83121266|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83121267|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
83121268|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121269|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83121270|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83121271|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121272|NCT01678820|Incretins|incretins|mesh-ancestor
83121273|NCT01678820|Hormones|hormones|mesh-ancestor
83121274|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121275|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83121276|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
83121277|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83121278|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121279|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
83121280|NCT02515695|Interferons|interferons|mesh-list
83121281|NCT02515695|Interferon-beta|interferon-beta|mesh-list
83121282|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
83121283|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121284|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
83121285|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121286|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
83121287|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121288|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83121289|NCT04788615|Interferons|interferons|mesh-list
83121290|NCT04788615|Interferon-beta|interferon-beta|mesh-list
83121291|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
83121292|NCT04788615|Teriflunomide|teriflunomide|mesh-list
83121293|NCT04788615|Ofatumumab|ofatumumab|mesh-list
83121294|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
83121295|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83121296|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
83121297|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121298|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
83121299|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470039|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
83121300|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
83121301|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121302|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83121303|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
83121304|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121305|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121306|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83121307|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83121308|NCT04788615|Analgesics|analgesics|mesh-ancestor
83121309|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
83121310|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121311|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121312|NCT03346629|Misoprostol|misoprostol|mesh-list
83121313|NCT03346629|Mifepristone|mifepristone|mesh-list
83121314|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83121315|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
83121316|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83121317|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121318|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83121319|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121320|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
83121321|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83121322|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83121323|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83121324|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83121325|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
83121326|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83121327|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83121328|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
83121329|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121330|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
83121331|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83121332|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83121333|NCT04501965|Azithromycin|azithromycin|mesh-list
83121334|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
83121335|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83121336|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121337|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
83121338|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83121339|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83121340|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121341|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121342|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121343|NCT04437836|Rifampin|rifampin|mesh-list
83121344|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83121345|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
83121346|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83121347|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121348|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
83121349|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83121350|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121351|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121352|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83121353|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83121354|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83121355|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83121356|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83121357|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83121358|NCT03122067|Oxytocin|oxytocin|mesh-list
83121359|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
83121360|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83121361|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121362|NCT04536194|Dopamine|dopamine|mesh-list
83121363|NCT04536194|Norepinephrine|norepinephrine|mesh-list
83121364|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83121365|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83121366|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
83121367|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121368|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121369|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121370|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
83121371|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
83121372|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121373|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83121374|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83121375|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
83121376|NCT04536194|Protective Agents|protective agents|mesh-ancestor
83121377|NCT03122769|Metformin|metformin|mesh-list
83121378|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83121379|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121380|NCT03121833|Endostar protein|endostar protein|mesh-list
83121381|NCT03121833|Endostatins|endostatins|mesh-list
83121382|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83121383|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83121384|NCT03121833|Growth Substances|growth substances|mesh-ancestor
83121385|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121386|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
83121387|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121388|NCT03121521|Melatonin|melatonin|mesh-list
83121389|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
83121390|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121391|NCT03121521|Protective Agents|protective agents|mesh-ancestor
83121392|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121393|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121394|NCT03046862|Gemcitabine|gemcitabine|mesh-list
83121395|NCT03046862|Durvalumab|durvalumab|mesh-list
83121396|NCT03046862|Tremelimumab|tremelimumab|mesh-list
83121397|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121398|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121400|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121401|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121402|NCT05590923|Dexamethasone|dexamethasone|mesh-list
83121403|NCT05590923|Olanzapine|olanzapine|mesh-list
83121404|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121405|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
83121406|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
83121407|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121408|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121409|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121410|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
83121411|NCT05590923|Hormones|hormones|mesh-ancestor
83121412|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121413|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83121414|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121415|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83121416|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83121417|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121418|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83121419|NCT05590923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83121420|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83121421|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121422|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121423|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121424|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
83121425|NCT00770809|Paclitaxel|paclitaxel|mesh-list
83121426|NCT00770809|Trastuzumab|trastuzumab|mesh-list
83121427|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83121428|NCT00770809|Lapatinib|lapatinib|mesh-list
83121429|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83121430|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83121431|NCT00770809|Antibodies|antibodies|mesh-list
83121432|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
83121433|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83121434|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83121435|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121436|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
83121437|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
83121438|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
83121439|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121440|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
83121441|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121442|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83121443|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121444|NCT02643056|Panitumumab|panitumumab|mesh-list
83121445|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121446|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121447|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83121448|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83121449|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121450|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83121451|NCT04263896|Laxatives|laxatives|mesh-ancestor
83121452|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121453|NCT04578639|Rituximab|rituximab|mesh-list
83121454|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
83121455|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121456|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121457|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
83121458|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121459|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121460|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83121461|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121462|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121463|NCT02238145|Ipratropium|ipratropium|mesh-list
83121464|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83121465|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
83121466|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121467|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121468|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83121469|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
83121470|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83121471|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83121472|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121473|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121474|NCT04550637|Apixaban|apixaban|mesh-list
83121475|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83121476|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
83121477|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83121478|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
83121479|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482696|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83121480|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121481|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
83121482|NCT03345303|Bortezomib|bortezomib|mesh-list
83121483|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121484|NCT03574909|Aspirin|aspirin|mesh-list
83121485|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83121486|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83121487|NCT03574909|Analgesics|analgesics|mesh-ancestor
83121488|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
83121489|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121490|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121491|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121492|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121493|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83121494|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83121495|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121496|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83121497|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83121498|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121499|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
83121500|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
83121501|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121502|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121503|NCT02515227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83121504|NCT02515227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121505|NCT03579043|Cocaine|cocaine|mesh-list
83121506|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
83121507|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
83121508|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121509|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121510|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
83121511|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121512|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83121513|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83121514|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83121515|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121516|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121517|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
83121518|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121519|NCT02187991|Paclitaxel|paclitaxel|mesh-list
83121520|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83121521|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121522|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83121523|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83121524|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83121525|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121526|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
83121527|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
83121528|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83121529|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83121530|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83121531|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121532|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121533|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
83121534|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121535|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121536|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83121537|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121538|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
83121539|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
83121540|NCT02660138|Coagulants|coagulants|mesh-ancestor
83121541|NCT03576469|Complement C1s|complement c1s|mesh-list
83121542|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83121543|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83121544|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
83121545|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121546|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83121547|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121548|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
83121549|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83121550|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121551|NCT05097950|Acetaminophen|acetaminophen|mesh-list
83121552|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83121553|NCT05097950|Analgesics|analgesics|mesh-ancestor
83121554|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
83121555|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121556|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121557|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
83121558|NCT05097248|Doxorubicin|doxorubicin|mesh-list
83121559|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83121560|NCT05097248|Losartan|losartan|mesh-list
83121561|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83121562|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121563|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83121564|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83121565|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121566|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121567|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83121568|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83121569|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83121570|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83121571|NCT01603394|Pregabalin|pregabalin|mesh-list
83121572|NCT01603394|Analgesics|analgesics|mesh-ancestor
83121573|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
83121574|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121575|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121576|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
83121577|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83121578|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121579|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470059|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
83121580|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83121581|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83121582|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83121583|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121584|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83121585|NCT04682522|Metronidazole|metronidazole|mesh-list
83121586|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121587|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83121588|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83121589|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83121590|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
83121591|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83121592|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83121593|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83121594|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121595|NCT02729025|Evolocumab|evolocumab|mesh-list
83121596|NCT02729025|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83121597|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83121598|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83121599|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
83121600|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121601|NCT02729025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83121602|NCT02729025|Protease Inhibitors|protease inhibitors|mesh-ancestor
83121603|NCT02729025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121604|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83121605|NCT05599971|Fluorouracil|fluorouracil|mesh-list
83121606|NCT05599971|Digoxin|digoxin|mesh-list
83121607|NCT05599971|Furosemide|furosemide|mesh-list
83121608|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
83121609|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121610|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121611|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121612|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121613|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
83121614|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121615|NCT05599971|Diuretics|diuretics|mesh-ancestor
83121616|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
83121617|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83121618|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83121619|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83121621|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121622|NCT05599971|Protective Agents|protective agents|mesh-ancestor
83121623|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
83121624|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83121625|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121626|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121627|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121628|NCT02511795|Olaparib|olaparib|mesh-list
83121629|NCT02511795|Adavosertib|adavosertib|mesh-list
83121630|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83121631|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121632|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121633|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121634|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
83121635|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
83121636|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121637|NCT04796636|Protective Agents|protective agents|mesh-ancestor
83121638|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121639|NCT04796636|Vitamins|vitamins|mesh-ancestor
83121640|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
83121641|NCT04501809|Misoprostol|misoprostol|mesh-list
83121642|NCT04501809|Oxytocin|oxytocin|mesh-list
83121643|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
83121644|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83121645|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121646|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83121647|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
83121648|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83121649|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121650|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
83121651|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
83121652|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83121653|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
83121654|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83121655|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121656|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83121657|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83121658|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83121659|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83121660|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121661|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83121662|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83121663|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121664|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121665|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121666|NCT02514681|Paclitaxel|paclitaxel|mesh-list
83121667|NCT02514681|Vinorelbine|vinorelbine|mesh-list
83121668|NCT02514681|Docetaxel|docetaxel|mesh-list
83121669|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83121670|NCT02514681|Gemcitabine|gemcitabine|mesh-list
83121671|NCT02514681|Capecitabine|capecitabine|mesh-list
83121672|NCT02514681|Trastuzumab|trastuzumab|mesh-list
83121673|NCT02514681|Pertuzumab|pertuzumab|mesh-list
83121674|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83121675|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121676|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
83121677|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
83121678|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
83121679|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121680|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121681|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
83121682|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121683|NCT02511639|Everolimus|everolimus|mesh-list
83121684|NCT02511639|Letrozole|letrozole|mesh-list
83121686|NCT02511639|Exemestane|exemestane|mesh-list
83121687|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83121688|NCT02511639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83121689|NCT02511639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83121690|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121691|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121692|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121693|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
83121694|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121695|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121696|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83121697|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83121698|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
83121699|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121700|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83121701|NCT02514603|Prexasertib|prexasertib|mesh-list
83121702|NCT02514603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83121703|NCT02514603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121704|NCT02514603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121705|NCT02511483|Propranolol|propranolol|mesh-list
83121706|NCT02511483|Morphine|morphine|mesh-list
83121707|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83121708|NCT02511483|Narcotics|narcotics|mesh-ancestor
83121709|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121710|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121711|NCT02511483|Analgesics|analgesics|mesh-ancestor
83121712|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
83121713|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121714|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83121715|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83121716|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
83121717|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121718|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121719|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83121720|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83121721|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
83121722|NCT04429802|Prucalopride|prucalopride|mesh-list
83121723|NCT04429802|Laxatives|laxatives|mesh-ancestor
83121724|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121725|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83121726|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83121727|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
83121728|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121729|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121730|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121731|NCT02511405|Bevacizumab|bevacizumab|mesh-list
83121732|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121733|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121734|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83121735|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83121736|NCT02511405|Growth Substances|growth substances|mesh-ancestor
83121737|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121738|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83121739|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
83121740|NCT04387760|Favipiravir|favipiravir|mesh-list
83121741|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
83121742|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83121743|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83121744|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121745|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121746|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121747|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121748|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
83121749|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
83121750|NCT05091086|Denosumab|denosumab|mesh-list
83121751|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83121752|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121753|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
83121754|NCT05091008|Ledipasvir|ledipasvir|mesh-list
83121755|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83121756|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
83121757|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121759|NCT02918084|Anastrozole|anastrozole|mesh-list
83121760|NCT02918084|Exemestane|exemestane|mesh-list
83121761|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121762|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83121763|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83121764|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121765|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121766|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83121767|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
83121768|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121769|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121770|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83121771|NCT01603082|Clopidogrel|clopidogrel|mesh-list
83121772|NCT01603082|Ticagrelor|ticagrelor|mesh-list
83121773|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83121774|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83121775|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83121776|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83121777|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
83121778|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121779|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121780|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121781|NCT04499313|Dexamethasone|dexamethasone|mesh-list
83121782|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
83121783|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83121784|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83121785|NCT04499313|Prednisolone|prednisolone|mesh-list
83121786|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
83121787|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83121788|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
83121789|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121790|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
83121791|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
83121792|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121793|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121794|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121795|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
83121796|NCT04499313|Hormones|hormones|mesh-ancestor
83121797|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83121798|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83121799|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121800|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83121801|NCT04499313|Protective Agents|protective agents|mesh-ancestor
83121802|NCT04331756|Anesthetics|anesthetics|mesh-list
83121803|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121804|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121805|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
83121806|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
83121807|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
83121808|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121809|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121810|NCT02499835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83121811|NCT02499835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121812|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
83121813|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121815|NCT02510781|Docetaxel|docetaxel|mesh-list
83121816|NCT02510781|Trastuzumab|trastuzumab|mesh-list
83121817|NCT02510781|Epirubicin|epirubicin|mesh-list
83121818|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121819|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
83121820|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
83121821|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
83121822|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470121|NCT00003418|Tamoxifen|tamoxifen|mesh-list
83121823|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83121824|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83121825|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83121826|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83121827|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121828|NCT03121599|Alovudine|alovudine|mesh-list
83121829|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
83121830|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121831|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
83121832|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121833|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
83121834|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
83121835|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
83121836|NCT04181606|Esmolol|esmolol|mesh-list
83121837|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83121838|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83121839|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83121840|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
83121841|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121842|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121843|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121844|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
83121845|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121846|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83121847|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83121848|NCT02510469|Apatinib|apatinib|mesh-list
83121849|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121850|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83121851|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121852|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121853|NCT05375630|Vitamin K|vitamin k|mesh-list
83121854|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
83121855|NCT05375630|Vitamins|vitamins|mesh-ancestor
83121856|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
83121857|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121858|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83121859|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83121860|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121861|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
83121862|NCT05375630|Coagulants|coagulants|mesh-ancestor
83121863|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
83121864|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83121865|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
83121866|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121867|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
83121868|NCT02510235|Protective Agents|protective agents|mesh-ancestor
83121869|NCT05081336|Alirocumab|alirocumab|mesh-list
83121870|NCT05081336|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83121871|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83121872|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83121873|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
83121874|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121875|NCT05081336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83121876|NCT05081336|Protease Inhibitors|protease inhibitors|mesh-ancestor
83121877|NCT05081336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121878|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83121879|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83121880|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121881|NCT03710876|Celecoxib|celecoxib|mesh-list
83121882|NCT03710876|Gemcitabine|gemcitabine|mesh-list
83121883|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121884|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
83121885|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121886|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121887|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83121888|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83121889|NCT03710876|Analgesics|analgesics|mesh-ancestor
83121890|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
83121891|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121892|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121893|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121894|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121895|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83121896|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83121897|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121898|NCT02513433|Bupivacaine|bupivacaine|mesh-list
83121899|NCT02513433|Ropivacaine|ropivacaine|mesh-list
83121900|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
83121901|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
83121902|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
83121903|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83121904|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121905|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
83121906|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121907|NCT02510157|Dexamethasone|dexamethasone|mesh-list
83121908|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121909|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
83121910|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
83121911|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83121912|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121913|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121914|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
83121915|NCT02510157|Hormones|hormones|mesh-ancestor
83121916|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83470165|NCT00002998|Gemcitabine|gemcitabine|mesh-list
83121917|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83121918|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121919|NCT03345147|Vitamins|vitamins|mesh-list
83121920|NCT03345147|Vitamin A|vitamin a|mesh-list
83121921|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
83121922|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
83121923|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121924|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
83121925|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121926|NCT03345147|Protective Agents|protective agents|mesh-ancestor
83121927|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83121928|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121929|NCT03662919|Adalimumab|adalimumab|mesh-list
83121930|NCT03662919|Infliximab|infliximab|mesh-list
83121931|NCT03662919|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83121932|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83121933|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121934|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
83121935|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83121936|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
83121937|NCT05375240|Propranolol|propranolol|mesh-list
83121938|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83121939|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83121940|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83121941|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83121942|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121943|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121944|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83121945|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83121946|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
83121947|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83121948|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121949|NCT00406393|Sirolimus|sirolimus|mesh-list
83121950|NCT00406393|Methotrexate|methotrexate|mesh-list
83121951|NCT00406393|Tacrolimus|tacrolimus|mesh-list
83121952|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83121953|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
83121954|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83121955|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121956|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83121957|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
83121958|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121959|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121960|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83121961|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83121962|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83121963|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121964|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
83121965|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121966|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83121967|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83121968|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83121969|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83121970|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83121971|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
83121973|NCT02513355|Endostar protein|endostar protein|mesh-list
83121974|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121975|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83121976|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83121977|NCT02513355|Growth Substances|growth substances|mesh-ancestor
83121978|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121979|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
83121980|NCT03329378|Paclitaxel|paclitaxel|mesh-list
83121981|NCT03329378|Docetaxel|docetaxel|mesh-list
83121982|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83121983|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
83121984|NCT03329378|Carboplatin|carboplatin|mesh-list
83121985|NCT03329378|Doxorubicin|doxorubicin|mesh-list
83121986|NCT03329378|Trastuzumab|trastuzumab|mesh-list
83121987|NCT03329378|Pertuzumab|pertuzumab|mesh-list
83121988|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83121989|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83121990|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
83121991|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
83121992|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
83121993|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83121994|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83121995|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
83121996|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83121997|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83121998|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83121999|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
83122000|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83122001|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83122002|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83122003|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83122004|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122005|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122006|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
83122007|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83122008|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83122009|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122010|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83122011|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83122012|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
83122013|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122014|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122015|NCT02509923|Rabeprazole|rabeprazole|mesh-list
83122016|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83122017|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122018|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83122019|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122020|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122021|NCT03578263|Oxytocin|oxytocin|mesh-list
83122022|NCT03578263|Carbetocin|carbetocin|mesh-list
83122023|NCT03578263|Ergonovine|ergonovine|mesh-list
83122024|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
83122025|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122026|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122027|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83122028|NCT05099198|Glimepiride|glimepiride|mesh-list
83122029|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83122030|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122031|NCT05099198|Incretins|incretins|mesh-ancestor
83122032|NCT05099198|Hormones|hormones|mesh-ancestor
83122033|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83122034|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83122035|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
83122036|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122037|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122038|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122039|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83122040|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
83122041|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83122042|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
83122043|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83122044|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83122045|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83122046|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122047|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122048|NCT02845375|Neostigmine|neostigmine|mesh-list
83122049|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83122050|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122051|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122052|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
83122053|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122054|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122055|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83122056|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
83122057|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122058|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
83122059|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83122060|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83122061|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
83122062|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122063|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122064|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122065|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
83122066|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
83122067|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122068|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
83122069|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83122070|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
83122071|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
83122072|NCT03344679|Adenosine|adenosine|mesh-list
83122073|NCT03344679|Bupivacaine|bupivacaine|mesh-list
83122074|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
83122075|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
83122076|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122077|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122078|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
83122079|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122080|NCT03344679|Analgesics|analgesics|mesh-ancestor
83122081|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122082|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
83122083|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83122084|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83470216|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
83122085|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122086|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83122087|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
83122088|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122089|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
83122090|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83122091|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
83122092|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
83122093|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122094|NCT02259829|Amlodipine|amlodipine|mesh-list
83122095|NCT02259829|Telmisartan|telmisartan|mesh-list
83122096|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83122097|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83122098|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83122099|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83122100|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122101|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83122102|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122103|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
83122104|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83122105|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83122106|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
83122107|NCT03344523|Hematinics|hematinics|mesh-ancestor
83122108|NCT02658734|Trastuzumab|trastuzumab|mesh-list
83122109|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83122110|NCT02658734|Maytansine|maytansine|mesh-list
83122111|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122112|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122113|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83122114|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83122115|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83122116|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83122117|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122118|NCT02658734|Immunotoxins|immunotoxins|mesh-ancestor
83122119|NCT02658734|Immunoconjugates|immunoconjugates|mesh-ancestor
83122120|NCT02658734|Immunologic Factors|immunologic factors|mesh-ancestor
83122121|NCT02658734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122122|NCT03344445|Anesthetics|anesthetics|mesh-list
83122123|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122124|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122126|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83122127|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
83122128|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83122129|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122130|NCT03143985|Pomalidomide|pomalidomide|mesh-list
83122131|NCT03143985|Vactosertib|vactosertib|mesh-list
83122132|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
83122133|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122134|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83122135|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83122136|NCT03143985|Growth Substances|growth substances|mesh-ancestor
83122137|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
83122138|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122139|NCT03143985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83122140|NCT03143985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122141|NCT03143985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122142|NCT02605148|Vitamin D|vitamin d|mesh-list
83122143|NCT02605148|Vitamins|vitamins|mesh-ancestor
83122144|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
83122145|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122146|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83122147|NCT02395640|Capecitabine|capecitabine|mesh-list
83122148|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
83122149|NCT02395640|Epirubicin|epirubicin|mesh-list
83122150|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83122151|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
83122152|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122153|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122154|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83122155|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83122156|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83122157|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122158|NCT02509143|Ramosetron|ramosetron|mesh-list
83122159|NCT02509143|Antiemetics|antiemetics|mesh-list
83122160|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
83122161|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122162|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122163|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122164|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83122165|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
83122166|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122167|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122168|NCT05100446|Amoxicillin|amoxicillin|mesh-list
83122169|NCT05100446|Esomeprazole|esomeprazole|mesh-list
83122170|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83122171|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122172|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83122173|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122174|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83122175|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122176|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122177|NCT02506803|Paclitaxel|paclitaxel|mesh-list
83122178|NCT02506803|Gemcitabine|gemcitabine|mesh-list
83122179|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83122180|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122181|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
83122182|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
83122183|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
83122184|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122185|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83122186|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
83122188|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122189|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83122190|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122191|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122193|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
83122194|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122195|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122196|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
83122197|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122198|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122199|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
83122200|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83122201|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122202|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83122203|NCT03571711|Meropenem|meropenem|mesh-list
83122204|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83122205|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122206|NCT03570541|Acetaminophen|acetaminophen|mesh-list
83122207|NCT03570541|Morphine|morphine|mesh-list
83122208|NCT03570541|Ropivacaine|ropivacaine|mesh-list
83122209|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83122210|NCT03570541|Narcotics|narcotics|mesh-ancestor
83122211|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122212|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122213|NCT03570541|Analgesics|analgesics|mesh-ancestor
83122214|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
83122215|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122216|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
83122217|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
83122218|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83122219|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
83122220|NCT00708435|Protein C|protein c|mesh-list
83122221|NCT00708435|Protein S|protein s|mesh-list
83122222|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
83122223|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83122224|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83122225|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122226|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
83122227|NCT02508753|Tazobactam|tazobactam|mesh-list
83122228|NCT02508753|Ceftolozane|ceftolozane|mesh-list
83122229|NCT02508753|Cephalosporins|cephalosporins|mesh-list
83122230|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83122231|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122232|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83122233|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83122234|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122235|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122236|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122237|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83122238|NCT02506647|Insulin|insulin|mesh-list
83122239|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83122240|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
83122241|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83122242|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122243|NCT02571530|Trastuzumab|trastuzumab|mesh-list
83122244|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122245|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122246|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
83122247|NCT04379024|Estrogens|estrogens|mesh-list
83122248|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83122249|NCT04379024|Hormones|hormones|mesh-ancestor
83122250|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83122251|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122252|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83122253|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83122254|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
83122255|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83122256|NCT04497831|Morphine|morphine|mesh-list
83122257|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83122258|NCT04497831|Narcotics|narcotics|mesh-ancestor
83122259|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122260|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122261|NCT04497831|Analgesics|analgesics|mesh-ancestor
83122262|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
83122263|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122264|NCT04498689|Paclitaxel|paclitaxel|mesh-list
83122265|NCT04498689|Gemcitabine|gemcitabine|mesh-list
83122266|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83122267|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122268|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83122269|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83122270|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83122271|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122272|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83122273|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
83122274|NCT05103098|Misoprostol|misoprostol|mesh-list
83122275|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83122276|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
83122277|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122278|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122279|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83122280|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122281|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
83122282|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83122283|NCT04272008|Estradiol|estradiol|mesh-list
83122284|NCT04272008|Estrogens|estrogens|mesh-ancestor
83122285|NCT04272008|Hormones|hormones|mesh-ancestor
83122286|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83122287|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122288|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83122289|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
83122290|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122291|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83122292|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83122293|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83122294|NCT05103020|Bevacizumab|bevacizumab|mesh-list
83122295|NCT05103020|Cetuximab|cetuximab|mesh-list
83122296|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
83122297|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122298|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122299|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83122300|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83122301|NCT05103020|Growth Substances|growth substances|mesh-ancestor
83122302|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122303|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
83122304|NCT02501109|Aripiprazole|aripiprazole|mesh-list
83122305|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
83122306|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83122307|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83122308|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83122309|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122310|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122311|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
83122312|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
83122313|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122314|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122315|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83122316|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83122317|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
83122318|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83122319|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83122320|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83122321|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83122322|NCT05060666|Ivermectin|ivermectin|mesh-list
83122323|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83122324|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122325|NCT02506335|Cholic Acids|cholic acids|mesh-list
83122326|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122327|NCT04725032|Propofol|propofol|mesh-list
83122328|NCT04725032|Sevoflurane|sevoflurane|mesh-list
83122329|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83122330|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122331|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122332|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83122333|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
83122334|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
83122335|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83122336|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83122337|NCT01353859|Methotrexate|methotrexate|mesh-list
83122338|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83122339|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
83122340|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122341|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122342|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83122343|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
83122344|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122345|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122346|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
83122347|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122348|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83122349|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83122350|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
83122351|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122352|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83122353|NCT02238197|Ipratropium|ipratropium|mesh-list
83122354|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83122355|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
83122356|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122357|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122358|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83122359|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
83122360|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83122361|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
83122362|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122363|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122364|NCT03592199|Sunitinib|sunitinib|mesh-list
83122365|NCT03592199|Axitinib|axitinib|mesh-list
83122366|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122367|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83122368|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83122369|NCT03592199|Growth Substances|growth substances|mesh-ancestor
83122370|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122371|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
83122372|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83122373|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122374|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122375|NCT02245867|Antibodies|antibodies|mesh-list
83122376|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83122377|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
83122378|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122379|NCT03139916|Temozolomide|temozolomide|mesh-list
83122380|NCT03139916|Bavituximab|bavituximab|mesh-list
83122381|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83122382|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
83122383|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122384|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122385|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122387|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83122388|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122389|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83122390|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
83122391|NCT02506023|Coagulants|coagulants|mesh-ancestor
83122392|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83122393|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
83122394|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122395|NCT02246179|Lidocaine|lidocaine|mesh-list
83122396|NCT02246179|Epinephrine|epinephrine|mesh-list
83122397|NCT02246179|Prilocaine|prilocaine|mesh-list
83122398|NCT02246179|Carticaine|carticaine|mesh-list
83122399|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83122400|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
83122401|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
83122402|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122403|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122404|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
83122405|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83470292|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122406|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122407|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83122408|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83122409|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83122410|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122411|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83122412|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83122413|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
83122414|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122415|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83122416|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83122417|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
83122418|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83122419|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
83122420|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
83122421|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
83122422|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83122423|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83122424|NCT02238275|Telmisartan|telmisartan|mesh-list
83122425|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83122426|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83122427|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83122428|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122429|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
83122430|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83122431|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122432|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122433|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83122434|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83122435|NCT04394117|Losartan|losartan|mesh-list
83122436|NCT04394117|Valsartan|valsartan|mesh-list
83122437|NCT04394117|Telmisartan|telmisartan|mesh-list
83122438|NCT04394117|Candesartan|candesartan|mesh-list
83122439|NCT04394117|Olmesartan|olmesartan|mesh-list
83122440|NCT04394117|Irbesartan|irbesartan|mesh-list
83122441|NCT04394117|Eprosartan|eprosartan|mesh-list
83122442|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83122443|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83122444|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83122445|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122446|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122447|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83122448|NCT02500563|Caseins|caseins|mesh-list
83122449|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
83122450|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
83122451|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122452|NCT02500329|Acarbose|acarbose|mesh-list
83122453|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83122454|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122455|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122456|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83122457|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122458|NCT02243137|Aspirin|aspirin|mesh-list
83122459|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
83122460|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83122461|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83122462|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83122463|NCT02243137|Analgesics|analgesics|mesh-ancestor
83122464|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
83122465|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122466|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122467|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83122468|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122469|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83122470|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83122471|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122472|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83122473|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83122474|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122475|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
83122476|NCT03343977|Docetaxel|docetaxel|mesh-list
83122477|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122478|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
83122479|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
83122480|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
83122481|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122482|NCT02850965|Adalimumab|adalimumab|mesh-list
83122483|NCT02850965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83122484|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83122485|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122486|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83122487|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83122488|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83122489|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
83122490|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122491|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83122492|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83122493|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122494|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
83122495|NCT01375959|Resveratrol|resveratrol|mesh-list
83122496|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
83122497|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122498|NCT01375959|Protective Agents|protective agents|mesh-ancestor
83122499|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122500|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122501|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83122502|NCT02238353|Fluticasone|fluticasone|mesh-list
83122503|NCT02238353|Azelastine|azelastine|mesh-list
83122504|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83122505|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83122506|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
83122507|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122508|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122509|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83122510|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
83122511|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
83122512|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83122513|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83122514|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122515|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122516|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83122517|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83122518|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
83122519|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
83122520|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122521|NCT04482686|Vitamin D|vitamin d|mesh-list
83122522|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
83122523|NCT04482686|Vitamins|vitamins|mesh-list
83122524|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
83122525|NCT04482686|Zinc|zinc|mesh-list
83122526|NCT04482686|Doxycycline|doxycycline|mesh-list
83122527|NCT04482686|Ivermectin|ivermectin|mesh-list
83122528|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
83122529|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
83122530|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122531|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83122532|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83122533|NCT04482686|Trace Elements|trace elements|mesh-ancestor
83122534|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
83122535|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122536|NCT04482686|Protective Agents|protective agents|mesh-ancestor
83122537|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83122538|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122539|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
83122540|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83122541|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83122543|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
83122544|NCT03580889|Atropine|atropine|mesh-list
83122545|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
83122546|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83122547|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122548|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83122549|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
83122550|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122551|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122552|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83122553|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
83122554|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
83122555|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
83122556|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83122557|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83122558|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
83122559|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122560|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122561|NCT02500017|Melatonin|melatonin|mesh-list
83122562|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
83122563|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122564|NCT02500017|Protective Agents|protective agents|mesh-ancestor
83122565|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122566|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122567|NCT02505633|Lidocaine|lidocaine|mesh-list
83122568|NCT02505633|Epinephrine|epinephrine|mesh-list
83122569|NCT02505633|Racepinephrine|racepinephrine|mesh-list
83122570|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
83122571|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83122572|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
83122573|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122574|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122575|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
83122576|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122577|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122578|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83122579|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83122580|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83122581|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122582|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83122583|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83122584|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
83122585|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122586|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83122587|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83122588|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
83122589|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83122590|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
83122591|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
83122592|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
83122593|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83122594|NCT03587441|Neostigmine|neostigmine|mesh-list
83122595|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83122596|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122597|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122598|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
83122599|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122600|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122601|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83122602|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
83122603|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122604|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
83122605|NCT05102396|Oxybutynin|oxybutynin|mesh-list
83122606|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
83122607|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
83122608|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122609|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122610|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83122611|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83122612|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
83122613|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122614|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122615|NCT05102396|Urological Agents|urological agents|mesh-ancestor
83122616|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83122617|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122618|NCT01165645|Ritonavir|ritonavir|mesh-list
83122619|NCT01165645|Lopinavir|lopinavir|mesh-list
83122620|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83122621|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83122622|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
83122623|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122624|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122625|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83122626|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83122627|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
83122628|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122629|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83122630|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83122631|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
83122632|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
83122633|NCT03579875|Busulfan|busulfan|mesh-list
83122634|NCT03579875|Rituximab|rituximab|mesh-list
83122635|NCT03579875|Fludarabine|fludarabine|mesh-list
83122636|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83122637|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
83122638|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122639|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122640|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83122641|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
83122642|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122643|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122644|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83122645|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122646|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83122647|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
83122648|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
83122649|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122650|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122651|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
83122652|NCT03579875|Hormones|hormones|mesh-ancestor
83122653|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83122654|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83122655|NCT03579875|Protective Agents|protective agents|mesh-ancestor
83122656|NCT03569995|Cytarabine|cytarabine|mesh-list
83122657|NCT03569995|Rituximab|rituximab|mesh-list
83122658|NCT03569995|Methotrexate|methotrexate|mesh-list
83122659|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122660|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122661|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
83122662|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122663|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122664|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83122665|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
83122666|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122667|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83122668|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
83122669|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122670|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
83122671|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122672|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83122673|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83122674|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83122675|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
83122676|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122677|NCT02238431|Leuprolide|leuprolide|mesh-list
83122678|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83122679|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
83122680|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122681|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122682|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83122683|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122684|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83122685|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122686|NCT02238509|Trastuzumab|trastuzumab|mesh-list
83122687|NCT02238509|Lapatinib|lapatinib|mesh-list
83122688|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122689|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122690|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83122691|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122692|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122693|NCT03579914|Metoprolol|metoprolol|mesh-list
83122694|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122695|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83122696|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
83122697|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
83122698|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122699|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122700|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83122701|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83122702|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83122703|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
83122704|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122705|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122706|NCT03573037|Anticoagulants|anticoagulants|mesh-list
83122707|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83122708|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122709|NCT03585413|Micronutrients|micronutrients|mesh-list
83122710|NCT03585413|Trace Elements|trace elements|mesh-list
83122711|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122712|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
83122713|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83122714|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
83122715|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122716|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
83122717|NCT03569683|Protective Agents|protective agents|mesh-ancestor
83122718|NCT00708201|Alvimopan|alvimopan|mesh-list
83122719|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122720|NCT03572959|Triamcinolone|triamcinolone|mesh-list
83122721|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83122722|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83122723|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83122724|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83122725|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
83122726|NCT03572959|Hormones|hormones|mesh-ancestor
83122727|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83122728|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122729|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83122730|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
83122731|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122732|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122733|NCT02500251|Rituximab|rituximab|mesh-list
83122734|NCT02500251|Bortezomib|bortezomib|mesh-list
83122735|NCT02500251|Belimumab|belimumab|mesh-list
83122736|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122737|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122738|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
83122739|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122740|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122741|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83122742|NCT03568513|Curcumin|curcumin|mesh-list
83122743|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83122744|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83122745|NCT03568513|Analgesics|analgesics|mesh-ancestor
83122746|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
83122747|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122748|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122749|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83122750|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83122751|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122752|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122753|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122754|NCT02982668|Metoclopramide|metoclopramide|mesh-list
83122755|NCT02982668|Mosapride|mosapride|mesh-list
83122756|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
83122757|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
83122758|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122759|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122760|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83122761|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83122762|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83122763|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
83122764|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122765|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122766|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83122767|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
83122768|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83122769|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122770|NCT05354479|Acetaminophen|acetaminophen|mesh-list
83122771|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83122772|NCT05354479|Analgesics|analgesics|mesh-ancestor
83122773|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
83122774|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122775|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122776|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
83122777|NCT02505399|Clopidogrel|clopidogrel|mesh-list
83122778|NCT02505399|Ticagrelor|ticagrelor|mesh-list
83122779|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83122780|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83122781|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83122782|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83122783|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
83122784|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83122785|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122786|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122787|NCT02728089|Tazobactam|tazobactam|mesh-list
83122788|NCT02728089|Ceftolozane|ceftolozane|mesh-list
83122789|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83122790|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122791|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83122792|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122793|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122794|NCT05110118|Bevacizumab|bevacizumab|mesh-list
83122795|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
83122796|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122797|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122798|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83122799|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83122800|NCT05110118|Growth Substances|growth substances|mesh-ancestor
83122801|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122802|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
83122803|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
83122804|NCT03572647|Hematinics|hematinics|mesh-ancestor
83122805|NCT02495181|Aflibercept|aflibercept|mesh-list
83122806|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83122807|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83122808|NCT02495181|Growth Substances|growth substances|mesh-ancestor
83122809|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122810|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
83122811|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122812|NCT02499861|Decitabine|decitabine|mesh-list
83122813|NCT02499861|Genistein|genistein|mesh-list
83122814|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83122815|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
83122816|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122817|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122818|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122819|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83122820|NCT02499861|Protective Agents|protective agents|mesh-ancestor
83122821|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122822|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83122823|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
83122824|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83122825|NCT02499861|Estrogens|estrogens|mesh-ancestor
83122826|NCT02499861|Hormones|hormones|mesh-ancestor
83122827|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83122828|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83122829|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
83122830|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83122831|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83122832|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83122833|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
83122834|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122835|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122836|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83122837|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83122838|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83122839|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83122840|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122841|NCT02840461|Ivermectin|ivermectin|mesh-list
83122842|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83122843|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122844|NCT05108714|Lidocaine|lidocaine|mesh-list
83122845|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
83122846|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
83122847|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122848|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122849|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
83122850|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122851|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122852|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83122853|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83122854|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83122855|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122856|NCT02495415|Fenretinide|fenretinide|mesh-list
83122857|NCT02495415|Retinamide|retinamide|mesh-list
83122858|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122859|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83122860|NCT02495415|Protective Agents|protective agents|mesh-ancestor
83122861|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122862|NCT02505009|Tenofovir|tenofovir|mesh-list
83122863|NCT02505009|Entecavir|entecavir|mesh-list
83122864|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
83122865|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122866|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83122867|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83122868|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83122869|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122870|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83122871|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83122872|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
83122873|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83122874|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83122875|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83122876|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83122877|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
83122878|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122879|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122880|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122881|NCT02499627|Immunotoxins|immunotoxins|mesh-ancestor
83122882|NCT02499627|Immunoconjugates|immunoconjugates|mesh-ancestor
83122883|NCT02499627|Immunologic Factors|immunologic factors|mesh-ancestor
83122884|NCT02499627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122885|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83122886|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83122887|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
83122888|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122889|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122890|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83122891|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83122892|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83122893|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122894|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
83122895|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83122896|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
83122897|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122898|NCT02505087|Expectorants|expectorants|mesh-ancestor
83122899|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
83122900|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83122901|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
83122902|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122903|NCT02505087|Protective Agents|protective agents|mesh-ancestor
83122904|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122905|NCT02505087|Antidotes|antidotes|mesh-ancestor
83122906|NCT02839681|Maytansine|maytansine|mesh-list
83122907|NCT02839681|Anetumab ravtansine|anetumab ravtansine|mesh-list
83122908|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83122909|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122910|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
83122911|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
83122912|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
83122913|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122914|NCT02839681|Immunoconjugates|immunoconjugates|mesh-ancestor
83122915|NCT02839681|Immunologic Factors|immunologic factors|mesh-ancestor
83122916|NCT02839681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122917|NCT02504463|Naltrexone|naltrexone|mesh-list
83122918|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83122919|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83122920|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122921|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
83122922|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122923|NCT03566329|Lidocaine|lidocaine|mesh-list
83122924|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
83122925|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83122926|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
83122927|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83470376|NCT00003064|Paclitaxel|paclitaxel|mesh-list
83122928|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122929|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
83122930|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122931|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122932|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83122933|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83122934|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83122935|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122936|NCT03566329|Analgesics|analgesics|mesh-ancestor
83122937|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
83122938|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83122939|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83122940|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
83122941|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122942|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
83122943|NCT02499237|Denosumab|denosumab|mesh-list
83122944|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83122945|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122946|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
83122947|NCT02499393|Analgesics|analgesics|mesh-ancestor
83122948|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
83122949|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83122950|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122951|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
83122952|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122953|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83122954|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
83122955|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83122956|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83122957|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122958|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83122959|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
83122960|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83122961|NCT02504307|Sirolimus|sirolimus|mesh-list
83122962|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83122963|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83122964|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83122965|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122966|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
83122967|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83122968|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
83122969|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122970|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
83122971|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122972|NCT03567343|Melatonin|melatonin|mesh-list
83122973|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
83122974|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83122975|NCT03567343|Protective Agents|protective agents|mesh-ancestor
83122976|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122977|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83122978|NCT04595864|Leucovorin|leucovorin|mesh-list
83122979|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
83122980|NCT04595864|Calcium|calcium|mesh-list
83122981|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
83122982|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83122983|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122985|NCT04595864|Antidotes|antidotes|mesh-ancestor
83122986|NCT04595864|Protective Agents|protective agents|mesh-ancestor
83122987|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
83122988|NCT04595864|Vitamins|vitamins|mesh-ancestor
83122989|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
83122990|NCT04583462|Metformin|metformin|mesh-list
83122991|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83122992|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83122993|NCT04456322|Cisplatin|cisplatin|mesh-list
83122994|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
83122995|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83122996|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83122997|NCT02503761|Meropenem|meropenem|mesh-list
83122998|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83122999|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123000|NCT04305548|Trabectedin|trabectedin|mesh-list
83123001|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83123002|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
83123003|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123004|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123005|NCT04097912|Aspirin|aspirin|mesh-list
83123006|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83123007|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123008|NCT04097912|Analgesics|analgesics|mesh-ancestor
83123009|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
83123010|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123011|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123012|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123013|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123014|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83123015|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83123016|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123017|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83123018|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83123019|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123020|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
83123021|NCT04966676|Nivolumab|nivolumab|mesh-list
83123022|NCT04966676|Ipilimumab|ipilimumab|mesh-list
83123023|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83123024|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123025|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83123026|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123027|NCT03340779|Dobutamine|dobutamine|mesh-list
83123028|NCT03340779|Norepinephrine|norepinephrine|mesh-list
83123029|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83123030|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123031|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123032|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123033|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123034|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123035|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
83123036|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
83123037|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123038|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83123039|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83123040|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83123041|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83123042|NCT03340779|Protective Agents|protective agents|mesh-ancestor
83123043|NCT04040738|Anesthetics|anesthetics|mesh-list
83123044|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123045|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123046|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
83123047|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83123048|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123049|NCT05087732|Lidocaine|lidocaine|mesh-list
83123050|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
83123051|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
83123052|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123053|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123054|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
83123055|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123056|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83123057|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83123059|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83123060|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123061|NCT03340701|Progesterone|progesterone|mesh-list
83123062|NCT03340701|Progestins|progestins|mesh-ancestor
83123063|NCT03340701|Hormones|hormones|mesh-ancestor
83123064|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123065|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123066|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
83123067|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83123068|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
83123069|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123070|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123071|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83123072|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
83123073|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83123074|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
83123075|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123076|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123077|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83123078|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
83123079|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
83123080|NCT02498535|Protective Agents|protective agents|mesh-ancestor
83123081|NCT04727138|Midazolam|midazolam|mesh-list
83123082|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83123083|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123084|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123085|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123086|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83123087|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83123088|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83123089|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123090|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
83123091|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
83123092|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
83123093|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
83123094|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123095|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123096|NCT02498457|Calcium|calcium|mesh-list
83123097|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83123098|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123099|NCT02498301|Rifaximin|rifaximin|mesh-list
83123100|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123101|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123102|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83123103|NCT03343665|Nivolumab|nivolumab|mesh-list
83123104|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83123105|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123106|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83123107|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123108|NCT02733614|SRX246|srx246|mesh-list
83123109|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83123110|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123111|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
83123112|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123113|NCT04674254|Bevacizumab|bevacizumab|mesh-list
83123114|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83123115|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123116|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83123117|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83123118|NCT04674254|Growth Substances|growth substances|mesh-ancestor
83123119|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123120|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
83123121|NCT03342807|Insulin|insulin|mesh-list
83123122|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83123123|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123124|NCT02570672|Metformin|metformin|mesh-list
83123125|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83123126|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123127|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
83123128|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83123129|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83123130|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123131|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
83123132|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123133|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123134|NCT04593914|Protective Agents|protective agents|mesh-list
83123135|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123136|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
83123137|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123138|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123139|NCT03342651|Vitamin D|vitamin d|mesh-list
83123140|NCT03342651|Vitamins|vitamins|mesh-ancestor
83123141|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
83123142|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123143|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83123144|NCT04819568|Terlipressin|terlipressin|mesh-list
83123145|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83123146|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83123147|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
83123148|NCT02502981|Spironolactone|spironolactone|mesh-list
83123149|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83123150|NCT02502981|Diuretics|diuretics|mesh-list
83123151|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83123152|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
83123153|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
83123154|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123155|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123156|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83123157|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
83123158|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83123159|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83123160|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123161|NCT02502981|Hormones|hormones|mesh-ancestor
83123162|NCT04230746|Trimethoprim|trimethoprim|mesh-list
83123163|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83123164|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
83123165|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83123166|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123167|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
83123168|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83123169|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123170|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83123171|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123172|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123173|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83123174|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83123175|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83123176|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123177|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83123178|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83123179|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
83123180|NCT05111444|Paclitaxel|paclitaxel|mesh-list
83123181|NCT05111444|Capecitabine|capecitabine|mesh-list
83123182|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
83123183|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83123184|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123185|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
83123186|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
83123187|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
82751774|NCT00856362|Moxidectin|moxidectin|mesh-list
83123188|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123189|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83123190|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
83123191|NCT03769688|Metronidazole|metronidazole|mesh-list
83123192|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123193|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123194|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83123195|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123196|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
83123197|NCT02502825|Miotics|miotics|mesh-ancestor
83123198|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
83123199|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123200|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123201|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83123202|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83123203|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
83123204|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83123205|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83123206|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
83123207|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123208|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123210|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83123211|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
83123212|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123213|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123214|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83123215|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83123216|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83123217|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123218|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123219|NCT02497911|Bupivacaine|bupivacaine|mesh-list
83123220|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
83123221|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
83123222|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123223|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123224|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
83123225|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123226|NCT02497833|Tretinoin|tretinoin|mesh-list
83123227|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123228|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
83123229|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
83123230|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
83123231|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83123232|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
83123233|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
83123234|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123235|NCT02493933|Expectorants|expectorants|mesh-ancestor
83123236|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
83123237|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83123238|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
83123239|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123240|NCT02493933|Protective Agents|protective agents|mesh-ancestor
83123241|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123242|NCT02493933|Antidotes|antidotes|mesh-ancestor
83123243|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83123244|NCT02493933|Estrogens|estrogens|mesh-ancestor
83123245|NCT02493933|Hormones|hormones|mesh-ancestor
83470426|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123246|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123247|NCT04153604|Doxycycline|doxycycline|mesh-list
83123248|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123249|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123250|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
83123251|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83123252|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123253|NCT03338205|Ketamine|ketamine|mesh-list
83123254|NCT03338205|Analgesics|analgesics|mesh-ancestor
83123255|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
83123256|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123257|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123258|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83123259|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123260|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
83123261|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
83123262|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123263|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83123264|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83123265|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123266|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123267|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
83123268|NCT04314050|Tramadol|tramadol|mesh-list
83123269|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123270|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123271|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123272|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123273|NCT04314050|Analgesics|analgesics|mesh-ancestor
83123274|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
83123275|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123276|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83123277|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83123278|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123279|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123280|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482697|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83123281|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123282|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83123283|NCT04314050|Narcotics|narcotics|mesh-ancestor
83123284|NCT03343509|Metronidazole|metronidazole|mesh-list
83123285|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123286|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123287|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83123288|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123289|NCT04516148|Clindamycin|clindamycin|mesh-list
83123290|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
83123291|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
83123292|NCT04516148|Cefazolin|cefazolin|mesh-list
83123293|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123294|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123295|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83123296|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123297|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123298|NCT02497365|Cefazolin|cefazolin|mesh-list
83123299|NCT02497365|Tobramycin|tobramycin|mesh-list
83123300|NCT02497365|Besifloxacin|besifloxacin|mesh-list
83123301|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123302|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123303|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83123304|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83123305|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123306|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123307|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123308|NCT02497053|Pemetrexed|pemetrexed|mesh-list
83123309|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123310|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123311|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123312|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83123313|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83123314|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83123315|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123316|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
83123317|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123318|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123319|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123320|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123321|NCT03337581|Analgesics|analgesics|mesh-ancestor
83123322|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
83123323|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123324|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83123325|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83123326|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123327|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123328|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123329|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123330|NCT02496975|Cyclosporine|cyclosporine|mesh-list
83123331|NCT02496975|Cyclosporins|cyclosporins|mesh-list
83123332|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123333|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123334|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83123335|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
83123336|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123337|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
83123338|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123339|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
83123340|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123341|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83123342|NCT03337503|Dronabinol|dronabinol|mesh-list
83123343|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
83123344|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123345|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83123346|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123347|NCT03337503|Analgesics|analgesics|mesh-ancestor
83123348|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
83123349|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123350|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83123351|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83123352|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123353|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123354|NCT03337503|Hormones|hormones|mesh-ancestor
83123355|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123356|NCT01675622|Morphine|morphine|mesh-list
83123357|NCT01675622|Oxycodone|oxycodone|mesh-list
83123358|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83123359|NCT01675622|Narcotics|narcotics|mesh-ancestor
83123360|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123361|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123362|NCT01675622|Analgesics|analgesics|mesh-ancestor
83123363|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
83123364|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123365|NCT02496741|Metformin|metformin|mesh-list
83123366|NCT02496741|Chloroquine|chloroquine|mesh-list
83123367|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83123368|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123369|NCT02496741|Amebicides|amebicides|mesh-ancestor
83123370|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83123371|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123372|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123373|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
83123374|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123375|NCT04496037|Rituximab|rituximab|mesh-list
83123376|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83123377|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123378|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
83123379|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123380|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123381|NCT04169828|Leucovorin|leucovorin|mesh-list
83123382|NCT04169828|Folic Acid|folic acid|mesh-list
83123383|NCT04169828|Methotrexate|methotrexate|mesh-list
83123384|NCT04169828|Ondansetron|ondansetron|mesh-list
83123385|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
83123386|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83123387|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
83123388|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83123389|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123390|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83123391|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
83123392|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123393|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123394|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83123395|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123396|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83123397|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83123398|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
83123399|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123400|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83123401|NCT04169828|Antidotes|antidotes|mesh-ancestor
83123402|NCT04169828|Protective Agents|protective agents|mesh-ancestor
83123403|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
83123404|NCT04169828|Vitamins|vitamins|mesh-ancestor
83123405|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
83123406|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
83123407|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
83123408|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123409|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83123410|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
83123411|NCT04169828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83123412|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83123413|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
83123414|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123415|NCT04169828|Hematinics|hematinics|mesh-ancestor
83123416|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83123417|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83123418|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123419|NCT04495881|Incretins|incretins|mesh-ancestor
83123420|NCT04495881|Hormones|hormones|mesh-ancestor
83123421|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123422|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83123423|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
83123424|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123425|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123426|NCT02493465|Everolimus|everolimus|mesh-list
83123427|NCT02493465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83123428|NCT02493465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83123429|NCT02493465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123430|NCT02493465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123431|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83123432|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
83123433|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123435|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
83123436|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123437|NCT04495569|Antibodies|antibodies|mesh-list
83123438|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83123439|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
83123440|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123441|NCT03337191|Morphine|morphine|mesh-list
83123442|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
83123443|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83123444|NCT03337191|Narcotics|narcotics|mesh-ancestor
83123445|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123446|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123448|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
83123449|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123450|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
83123451|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
83123452|NCT04494243|Rabeprazole|rabeprazole|mesh-list
83123453|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83123454|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83123455|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83123456|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123457|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123458|NCT03337035|Oxytocin|oxytocin|mesh-list
83123459|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
83123460|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83123461|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123462|NCT03330717|Anesthetics|anesthetics|mesh-list
83123463|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123464|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123465|NCT02655224|Relugolix|relugolix|mesh-list
83123466|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
83123467|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
83123468|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123469|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123470|NCT04494321|Budesonide|budesonide|mesh-list
83123471|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
83123472|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123473|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83123474|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
83123475|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123476|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123477|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83470487|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123478|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
83123479|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
83123480|NCT04494321|Hormones|hormones|mesh-ancestor
83123481|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123482|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83123483|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83123484|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123485|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123486|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123487|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123488|NCT03330171|Vaccines|vaccines|mesh-list
83123489|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
83123490|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123491|NCT05118542|Methimazole|methimazole|mesh-list
83123492|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
83123493|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
83123494|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
83123495|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123496|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123497|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
83123498|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123499|NCT03336801|Propofol|propofol|mesh-list
83123500|NCT03336801|Sevoflurane|sevoflurane|mesh-list
83123501|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123502|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123503|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123504|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123505|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
83123506|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
83123507|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83123508|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83123509|NCT05115578|Midazolam|midazolam|mesh-list
83123511|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83123512|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123513|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123514|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123515|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83123516|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83123517|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83123518|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123519|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
83123520|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
83123521|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
83123522|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
83123523|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123524|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123525|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83123526|NCT05115578|Narcotics|narcotics|mesh-ancestor
83123527|NCT05115578|Analgesics|analgesics|mesh-ancestor
83123528|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
83123529|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123530|NCT02636036|Nivolumab|nivolumab|mesh-list
83123531|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83123532|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123533|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83123534|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123535|NCT03329781|Curcumin|curcumin|mesh-list
83123536|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83123537|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123538|NCT03329781|Analgesics|analgesics|mesh-ancestor
83123539|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
83123540|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123541|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123542|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123543|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123544|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123545|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123546|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123547|NCT02437604|Fluticasone|fluticasone|mesh-list
83123548|NCT02437604|Xhance|xhance|mesh-list
83123549|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83123550|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83123551|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123552|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83123553|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
83123554|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123555|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123556|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83123557|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
83123558|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83123559|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83123560|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83123561|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83123562|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123563|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123564|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123565|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123566|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
83123567|NCT02437604|Hormones|hormones|mesh-ancestor
83123568|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123569|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
83123570|NCT03329547|Cefixime|cefixime|mesh-list
83123571|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123572|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123573|NCT05463627|Metformin|metformin|mesh-list
83123574|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83123575|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123576|NCT01975298|Interferons|interferons|mesh-list
83123577|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
83123578|NCT01975298|Interferon-beta|interferon-beta|mesh-list
83123579|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123580|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
83123581|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123582|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83123583|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
83493379|NCT03001349|Octreotide|octreotide|mesh-list
83123584|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123586|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83123587|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83123588|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123589|NCT05084534|Midodrine|midodrine|mesh-list
83123590|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
83123591|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
83123592|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123593|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123594|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83123595|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83123596|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83123597|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123598|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123599|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123600|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123601|NCT04645316|Propofol|propofol|mesh-list
83123602|NCT04645316|Sevoflurane|sevoflurane|mesh-list
83123603|NCT04645316|Desflurane|desflurane|mesh-list
83123604|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123605|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123606|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123607|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123608|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
83123609|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
83123610|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83123611|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83123612|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83123613|NCT00659126|Hematinics|hematinics|mesh-ancestor
83123614|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83123615|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83123616|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
83123617|NCT04594382|Narcotics|narcotics|mesh-ancestor
83123618|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123619|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123620|NCT04594382|Analgesics|analgesics|mesh-ancestor
83123621|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
83123622|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123623|NCT02491515|Denosumab|denosumab|mesh-list
83123624|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83123625|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123626|NCT05113628|Methylene Blue|methylene blue|mesh-list
83123627|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123628|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123629|NCT04247750|Sirolimus|sirolimus|mesh-list
83123630|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123631|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123632|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83123633|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123634|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
83123635|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83123636|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
83123637|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123638|NCT04513808|Anesthetics|anesthetics|mesh-list
83123639|NCT04513808|Propofol|propofol|mesh-list
83123640|NCT04513808|Sevoflurane|sevoflurane|mesh-list
83123641|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123642|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123643|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123644|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123645|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
83123646|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83123647|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83123648|NCT02493231|Ketamine|ketamine|mesh-list
83123649|NCT02493231|Nefopam|nefopam|mesh-list
83123650|NCT02493231|Analgesics|analgesics|mesh-ancestor
83123651|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
83123652|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123653|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123654|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83123655|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123656|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
83123657|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
83123658|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123659|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83123660|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83123661|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123662|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123663|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123664|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83123665|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83123666|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83123667|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83123668|NCT05112692|Cetrorelix|cetrorelix|mesh-list
83123669|NCT05112692|Menotropins|menotropins|mesh-list
83123670|NCT05112692|Estradiol|estradiol|mesh-list
83123671|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83123672|NCT05112692|Progesterone|progesterone|mesh-list
83123673|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
83123674|NCT05112692|Estrogens|estrogens|mesh-ancestor
83123675|NCT05112692|Hormones|hormones|mesh-ancestor
83123676|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123677|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123678|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83123679|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
83123680|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83123681|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83123682|NCT05112692|Progestins|progestins|mesh-ancestor
83123683|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
83123684|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83123685|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123686|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83123687|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
83123688|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
83123689|NCT03328533|Phenylephrine|phenylephrine|mesh-list
83123690|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
83123691|NCT03328533|Norepinephrine|norepinephrine|mesh-list
83123692|NCT03328533|Bupivacaine|bupivacaine|mesh-list
83123693|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
83123694|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
83123695|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123696|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123697|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
83123698|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123699|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83123700|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
83123701|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
83123702|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
83123703|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83123704|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
83123705|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
83123706|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83123707|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83123708|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123709|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123710|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123711|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123712|NCT03328533|Protective Agents|protective agents|mesh-ancestor
83123713|NCT05117372|Immunomodulating Agents|immunomodulating agents|mesh-list
83123714|NCT05117372|Immunologic Factors|immunologic factors|mesh-ancestor
83123715|NCT05117372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123716|NCT03324243|Cytarabine|cytarabine|mesh-list
83123717|NCT03324243|Fludarabine|fludarabine|mesh-list
83123718|NCT03324243|Crenolanib|crenolanib|mesh-list
83123719|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123720|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83123721|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
83123722|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123723|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83123724|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
83123725|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123726|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
83123727|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123728|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
83123729|NCT03328299|Bupivacaine|bupivacaine|mesh-list
83123730|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
83123731|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
83123732|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123733|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123734|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
83123735|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123736|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123737|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123738|NCT03328299|Analgesics|analgesics|mesh-ancestor
83123739|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83123740|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83123741|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83123742|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83123743|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123744|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123745|NCT03564301|Metronidazole|metronidazole|mesh-list
83123746|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123747|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123748|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83123749|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123750|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
83123751|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123752|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123753|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83123754|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83123755|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123756|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123757|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123759|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
83123760|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123761|NCT03335241|Doxorubicin|doxorubicin|mesh-list
83123762|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83123763|NCT03335241|Fludarabine|fludarabine|mesh-list
83123764|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83123765|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123766|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83123767|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83123768|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123769|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123770|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83123771|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83123772|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83123773|NCT03120663|Amoxicillin|amoxicillin|mesh-list
83123774|NCT03120663|Clindamycin|clindamycin|mesh-list
83123775|NCT03120663|Meropenem|meropenem|mesh-list
83123776|NCT03120663|Tazobactam|tazobactam|mesh-list
83123777|NCT03120663|Piperacillin|piperacillin|mesh-list
83123778|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
83123779|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
83123780|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83123781|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83123782|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123783|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123784|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83123785|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123786|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123787|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83123788|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
83123789|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83123790|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83123791|NCT02578394|Prednisolone|prednisolone|mesh-list
83123792|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
83123793|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83123794|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83123795|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
83123796|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123797|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
83123798|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
83123799|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123800|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123801|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83123802|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
83123803|NCT02578394|Hormones|hormones|mesh-ancestor
83123804|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83123805|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83123806|NCT02578394|Protective Agents|protective agents|mesh-ancestor
83123807|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83123808|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123809|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123810|NCT04493229|Oxytocin|oxytocin|mesh-list
83123811|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
83123812|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83123813|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123815|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
83123816|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83123817|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83123818|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83123819|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123820|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123821|NCT02122718|Allopurinol|allopurinol|mesh-list
83123822|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
83123823|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123824|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123825|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
83123826|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123827|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83123828|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
83123829|NCT02122718|Protective Agents|protective agents|mesh-ancestor
83123830|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123831|NCT04513652|Carticaine|carticaine|mesh-list
83123832|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
83123833|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
83123834|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123835|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123836|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
83123837|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123838|NCT00706797|Etanercept|etanercept|mesh-list
83123839|NCT00706797|Methotrexate|methotrexate|mesh-list
83123840|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83123841|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
83123842|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83123843|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123844|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83123845|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
83123846|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123847|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123848|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
83123849|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123850|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83123851|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83123852|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
83123853|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123854|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83123855|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83123856|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123857|NCT00706797|Analgesics|analgesics|mesh-ancestor
83123858|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
83123859|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123860|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123861|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83123862|NCT03323697|Escitalopram|escitalopram|mesh-list
83123863|NCT03323697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83123864|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83123865|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83123866|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123867|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123868|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
83123869|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123870|NCT00706641|Dasatinib|dasatinib|mesh-list
83123871|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123872|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83123873|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123874|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123875|NCT03335085|Oxytocin|oxytocin|mesh-list
83470571|NCT00003130|Paclitaxel|paclitaxel|mesh-list
83123876|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
83123877|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83123878|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123879|NCT03323619|Anesthetics|anesthetics|mesh-list
83123880|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123881|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123882|NCT03323541|Lenograstim|lenograstim|mesh-list
83123883|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83123884|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
83123885|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123886|NCT03335007|Aceclofenac|aceclofenac|mesh-list
83123887|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83123888|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123889|NCT03335007|Analgesics|analgesics|mesh-ancestor
83123890|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
83123891|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123892|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123893|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123894|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123895|NCT01362530|Ondansetron|ondansetron|mesh-list
83123896|NCT01362530|Aprepitant|aprepitant|mesh-list
83123897|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
83123898|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
83123899|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
83123900|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123901|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123902|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83123903|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
83123904|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
83123905|NCT01362530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83123906|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83123907|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
83123908|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123909|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123910|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83123911|NCT04494399|Interferons|interferons|mesh-list
83123912|NCT04494399|Ribavirin|ribavirin|mesh-list
83123913|NCT04494399|Interferon-beta|interferon-beta|mesh-list
83123914|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
83123915|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123916|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
83123917|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123918|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
83123919|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123920|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
83123921|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123922|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83123923|NCT01758614|Aspirin|aspirin|mesh-list
83123924|NCT01758614|Clopidogrel|clopidogrel|mesh-list
83123925|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83123926|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83123927|NCT01758614|Analgesics|analgesics|mesh-ancestor
83123928|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
83123929|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83123930|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123931|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83123932|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123933|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83123934|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83123935|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123936|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83123937|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83123938|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123939|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
83123940|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83123941|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83123942|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83123943|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
83123944|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83123945|NCT02490657|Iloprost|iloprost|mesh-list
83123946|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83123947|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83123948|NCT04323566|Rituximab|rituximab|mesh-list
83123949|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83123950|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123951|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
83123952|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123953|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83123954|NCT03109119|Propofol|propofol|mesh-list
83123955|NCT03109119|Sevoflurane|sevoflurane|mesh-list
83123956|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83123957|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83123958|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123959|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83123960|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
83123961|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
83123962|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83123963|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83123964|NCT05070104|Bevacizumab|bevacizumab|mesh-list
83123965|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83123966|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123967|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83123968|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83123969|NCT05070104|Growth Substances|growth substances|mesh-ancestor
83123970|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83123971|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
83123972|NCT03326661|Clindamycin|clindamycin|mesh-list
83123973|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
83123974|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
83123975|NCT03326661|Penicillins|penicillins|mesh-list
83123976|NCT03326661|Metronidazole|metronidazole|mesh-list
83123977|NCT03326661|Penicillin V|penicillin v|mesh-list
83123978|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83123979|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123980|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83123981|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123982|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123983|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83123984|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83123985|NCT05119712|Terbinafine|terbinafine|mesh-list
83123986|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
83123987|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83123988|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123989|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123990|NCT03333915|Pamiparib|pamiparib|mesh-list
83123991|NCT03333915|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83123992|NCT03333915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83123993|NCT03333915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83123994|NCT03333915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83123995|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83123996|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83123997|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83123998|NCT02654054|Norethindrone|norethindrone|mesh-list
83123999|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
83124000|NCT02654054|Estradiol|estradiol|mesh-list
83124001|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83124002|NCT02654054|Estrogens|estrogens|mesh-ancestor
83124003|NCT02654054|Hormones|hormones|mesh-ancestor
83124004|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124005|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124006|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83124007|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
83124008|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83124009|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83124010|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83124011|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83124012|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83124013|NCT03186404|Atorvastatin|atorvastatin|mesh-list
83124014|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83124015|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83124016|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
83124017|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124018|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83124019|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83124020|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124021|NCT02492373|Clobetasol|clobetasol|mesh-list
83124022|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83124023|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
83124024|NCT02492373|Hormones|hormones|mesh-ancestor
83124025|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124026|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124027|NCT03073070|Biotin|biotin|mesh-list
83124028|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
83124029|NCT03073070|Vitamins|vitamins|mesh-ancestor
83124030|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
83124031|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124032|NCT02905214|Sirolimus|sirolimus|mesh-list
83124033|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124034|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124035|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83124036|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124037|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
83124038|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83124039|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
83124040|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124041|NCT03333603|Esomeprazole|esomeprazole|mesh-list
83124042|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83124043|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83124044|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83124045|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124046|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124047|NCT03333525|Insulin|insulin|mesh-list
83124048|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83124049|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124050|NCT03333369|Levodopa|levodopa|mesh-list
83124051|NCT03333369|Benserazide|benserazide|mesh-list
83124052|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83124053|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83124054|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
83124055|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124056|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124057|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124058|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124059|NCT03325803|Lidocaine|lidocaine|mesh-list
83124060|NCT03325803|Prilocaine|prilocaine|mesh-list
83124061|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83124062|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
83124063|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
83124064|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124065|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124066|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
83124067|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124068|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83124069|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83124070|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83124071|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124072|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124073|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83124074|NCT05465343|Aflutinib|aflutinib|mesh-list
83124075|NCT05465343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83124076|NCT05465343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124077|NCT05465343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124078|NCT03325491|Acipimox|acipimox|mesh-list
83124079|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83124080|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
83124081|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124082|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83124083|NCT04150562|Avelumab|avelumab|mesh-list
83124084|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83124085|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124086|NCT03325413|Anesthetics|anesthetics|mesh-list
83124087|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124088|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124089|NCT03325335|Midazolam|midazolam|mesh-list
83124090|NCT03325335|Remifentanil|remifentanil|mesh-list
83124091|NCT03325335|Propofol|propofol|mesh-list
83124092|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83124093|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124094|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124095|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83124096|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
83124097|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
83124098|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83124099|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83124100|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83124101|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83124102|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
83124103|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
83124104|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124105|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124106|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83124107|NCT03325335|Narcotics|narcotics|mesh-ancestor
83124108|NCT03325335|Analgesics|analgesics|mesh-ancestor
83124109|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
83124110|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124111|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83124112|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
83124113|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
83124114|NCT05114720|Docetaxel|docetaxel|mesh-list
83124115|NCT05114720|Doxorubicin|doxorubicin|mesh-list
83124116|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83124117|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83124118|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83124119|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
83124120|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124121|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124122|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83124123|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
83124124|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124125|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124126|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83124127|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
83124128|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
83124129|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
83124130|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83124131|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83124132|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83124133|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124134|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124135|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83124136|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
83124137|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83124138|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83124139|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83124140|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83124141|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
83124142|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83124143|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83124144|NCT04493463|Prednisolone|prednisolone|mesh-list
83124145|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
83124146|NCT04493463|Ropivacaine|ropivacaine|mesh-list
83124147|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83124148|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
83124149|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
83124150|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
83124151|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124152|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124153|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
83124154|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124155|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83124156|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
83124157|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
83124158|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83124159|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
83124160|NCT04493463|Hormones|hormones|mesh-ancestor
83124161|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124162|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83124163|NCT04493463|Protective Agents|protective agents|mesh-ancestor
83124164|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83124165|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124166|NCT04493073|Mitomycins|mitomycins|mesh-list
83124167|NCT04493073|Mitomycin|mitomycin|mesh-list
83124168|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83124169|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124170|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
83124171|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124172|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83124173|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124174|NCT00748904|Rifaximin|rifaximin|mesh-list
83124175|NCT00748904|Lactulose|lactulose|mesh-list
83124176|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124177|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124178|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83124179|NCT03321903|Charcoal|charcoal|mesh-list
83124180|NCT03321903|Antidotes|antidotes|mesh-ancestor
83124181|NCT03321903|Protective Agents|protective agents|mesh-ancestor
83124182|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124183|NCT04411550|Pertuzumab|pertuzumab|mesh-list
83124184|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83124185|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124186|NCT03321825|Lidocaine|lidocaine|mesh-list
83124187|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
83124188|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
83124189|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
83124190|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124191|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124192|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
83124193|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124194|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83124195|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83124196|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83124197|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124198|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124199|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83124200|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
83124201|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
83124202|NCT03321825|Protective Agents|protective agents|mesh-ancestor
83124203|NCT02492217|Adalimumab|adalimumab|mesh-list
83124204|NCT02492217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83124205|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83124206|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124207|NCT05229536|Vaccines|vaccines|mesh-list
83124208|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
83124209|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124210|NCT04810910|Molgramostim|molgramostim|mesh-list
83124211|NCT04810910|Sargramostim|sargramostim|mesh-list
83124212|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
83124213|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124214|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124215|NCT04562558|Leucovorin|leucovorin|mesh-list
83124216|NCT04562558|Dactinomycin|dactinomycin|mesh-list
83124217|NCT04562558|Methotrexate|methotrexate|mesh-list
83124218|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124219|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83124220|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
83124221|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83124222|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83124223|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
83124224|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124225|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124226|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
83124227|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124228|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83124229|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83124230|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
83124231|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124232|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83124233|NCT04562558|Antidotes|antidotes|mesh-ancestor
83124234|NCT04562558|Protective Agents|protective agents|mesh-ancestor
83124235|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
83124236|NCT04562558|Vitamins|vitamins|mesh-ancestor
83124237|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
83124238|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124239|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124240|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83124241|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83124242|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
83124243|NCT03320187|Dinoprostone|dinoprostone|mesh-list
83124244|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
83124245|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
83124246|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83124247|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124248|NCT03320109|Vitamin D|vitamin d|mesh-list
83124249|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
83124250|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
83124251|NCT03320109|Vitamins|vitamins|mesh-list
83124252|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
83124253|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124254|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83124255|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83124256|NCT04529876|Abatacept|abatacept|mesh-list
83124257|NCT04529876|Tofacitinib|tofacitinib|mesh-list
83124258|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83124259|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124260|NCT04529876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83124261|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124262|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83124263|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
83124264|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124265|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124266|NCT04529876|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83124267|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83124268|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124269|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
83124270|NCT03320031|Linagliptin|linagliptin|mesh-list
83124271|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83124272|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124273|NCT03320031|Incretins|incretins|mesh-ancestor
83124274|NCT03320031|Hormones|hormones|mesh-ancestor
83124275|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124276|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83124278|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124279|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124280|NCT04510922|Droxidopa|droxidopa|mesh-list
83124281|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83124282|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83124283|NCT05465031|Valsartan|valsartan|mesh-list
83124284|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83124285|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83124286|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83124287|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83124288|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124289|NCT04510844|Evolocumab|evolocumab|mesh-list
83124290|NCT04510844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83124291|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83124292|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83124293|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
83124294|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124295|NCT04510844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83124296|NCT04510844|Protease Inhibitors|protease inhibitors|mesh-ancestor
83124297|NCT04510844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124298|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83124299|NCT05464953|Triamcinolone|triamcinolone|mesh-list
83124300|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83124301|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83124302|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83124303|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83124304|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
83124305|NCT05464953|Hormones|hormones|mesh-ancestor
83124306|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124307|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124308|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83124309|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
83124310|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124311|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124312|NCT02491749|Anesthetics|anesthetics|mesh-list
83124313|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124314|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124315|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
83124316|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83124317|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124318|NCT04408898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83124319|NCT04408898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124320|NCT02490345|Gabapentin|gabapentin|mesh-list
83124321|NCT02490345|Analgesics|analgesics|mesh-ancestor
83124322|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
83124323|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124324|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124325|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
83124326|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83124327|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83124328|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124329|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83124330|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83124331|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83124332|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124333|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124334|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
83124335|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
83124336|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83124337|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83124338|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124339|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
83124340|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
83124341|NCT03319563|Epinephrine|epinephrine|mesh-list
83124342|NCT03319563|Anesthetics|anesthetics|mesh-list
83124343|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
83124344|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124345|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124346|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83124347|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83124348|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
83124349|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124350|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124351|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83124352|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83124353|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
83124354|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124355|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83124356|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
83124357|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
83124358|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
83124359|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83124360|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
83124361|NCT02485119|Anetumab ravtansine|anetumab ravtansine|mesh-list
83124362|NCT02485119|Immunoconjugates|immunoconjugates|mesh-ancestor
83124363|NCT02485119|Immunologic Factors|immunologic factors|mesh-ancestor
83124364|NCT02485119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124365|NCT02484573|Propranolol|propranolol|mesh-list
83124366|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83124367|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83124368|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
83124369|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124370|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124371|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124372|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83124373|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83124374|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
83124375|NCT02489955|Tobramycin|tobramycin|mesh-list
83124376|NCT02489955|Amikacin|amikacin|mesh-list
83124377|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124378|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124379|NCT03734744|Vitamin D|vitamin d|mesh-list
83124380|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
83124381|NCT03734744|Vitamins|vitamins|mesh-ancestor
83124382|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
83124383|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124384|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83124385|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83124386|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83124387|NCT03576716|Calcifediol|calcifediol|mesh-list
83124388|NCT03576716|Vitamins|vitamins|mesh-ancestor
83124389|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
83124390|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124391|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83124392|NCT02487381|Dronabinol|dronabinol|mesh-list
83124393|NCT02487381|Cannabidiol|cannabidiol|mesh-list
83124394|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
83124395|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
83124396|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124397|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83124398|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83124399|NCT02487381|Analgesics|analgesics|mesh-ancestor
83124400|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
83124401|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124402|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83124403|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83124404|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124405|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124406|NCT02487381|Hormones|hormones|mesh-ancestor
83124407|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124408|NCT02487849|Carboplatin|carboplatin|mesh-list
83124409|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124410|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83124411|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124412|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
83124413|NCT04021550|Telmisartan|telmisartan|mesh-list
83124414|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83124415|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83124416|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83124417|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124418|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
83124419|NCT04021550|Protective Agents|protective agents|mesh-ancestor
83124420|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124421|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
83124422|NCT04021550|Vitamins|vitamins|mesh-ancestor
83124423|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
83124424|NCT02489487|Ritonavir|ritonavir|mesh-list
83124425|NCT02489487|Darunavir|darunavir|mesh-list
83124426|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
83124427|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83124428|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83124429|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
83124430|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124431|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124432|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83124433|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83124434|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
83124435|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124436|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83124437|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83124438|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83124439|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83124440|NCT02096354|Irinotecan|irinotecan|mesh-list
83124441|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124442|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83124443|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83124444|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477175|NCT04042142|Hormones|hormones|mesh-ancestor
83124445|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124446|NCT03177746|Tadalafil|tadalafil|mesh-list
83124447|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
83124448|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83124449|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83124450|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124451|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124452|NCT03177746|Urological Agents|urological agents|mesh-ancestor
83124453|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83124454|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83124455|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83124456|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
83124457|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124458|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83124459|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83124460|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124461|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83124462|NCT02483715|Amoxicillin|amoxicillin|mesh-list
83124463|NCT02483715|Metronidazole|metronidazole|mesh-list
83124464|NCT02483715|Tetracycline|tetracycline|mesh-list
83124465|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83124466|NCT02483715|Rabeprazole|rabeprazole|mesh-list
83124467|NCT02483715|Bismuth|bismuth|mesh-list
83124468|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83124469|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124470|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
83124471|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83124472|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83124473|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83124474|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83124475|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124476|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124477|NCT02483715|Antacids|antacids|mesh-ancestor
83124478|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83124479|NCT02483793|Tamsulosin|tamsulosin|mesh-list
83124480|NCT02483793|Oxybutynin|oxybutynin|mesh-list
83124481|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83124482|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83124483|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83124484|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
83124485|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124486|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124487|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124488|NCT02483793|Urological Agents|urological agents|mesh-ancestor
83124489|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
83124490|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
83124491|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124492|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83124493|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83124494|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
83124495|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
83124496|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83124497|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
83124498|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124499|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
83124500|NCT03200288|Protective Agents|protective agents|mesh-ancestor
83124501|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
83124502|NCT03318471|Analgesics|analgesics|mesh-ancestor
83124503|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
83124504|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124505|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124506|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
83124507|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124508|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83124509|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
83124510|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83124511|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124512|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124513|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83124514|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
83124515|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83124516|NCT04234022|Pomalidomide|pomalidomide|mesh-list
83124517|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
83124518|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124519|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83124520|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83124521|NCT04234022|Growth Substances|growth substances|mesh-ancestor
83124522|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
83124523|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124524|NCT02489409|Gemcitabine|gemcitabine|mesh-list
83124525|NCT02489409|Vinorelbine|vinorelbine|mesh-list
83124526|NCT02489409|Endostatins|endostatins|mesh-list
83124527|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83124528|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
83124529|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124530|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124531|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83124532|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
83124533|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
83124534|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
83124535|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83124536|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83124537|NCT02489409|Growth Substances|growth substances|mesh-ancestor
83124538|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124539|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
83124540|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
83124541|NCT03930602|Deucravacitinib|deucravacitinib|mesh-list
83124542|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83124543|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83124544|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124545|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124546|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83124547|NCT03930602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83124548|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83124549|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124550|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124551|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124552|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
83124553|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83124554|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
83124555|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83124556|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83124557|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124558|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83124559|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
83124560|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83124561|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83124562|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83124563|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83124564|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
83124565|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124566|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83124567|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83124568|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124570|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83124571|NCT02489019|Narcotics|narcotics|mesh-ancestor
83124572|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124573|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124574|NCT02489019|Analgesics|analgesics|mesh-ancestor
83124575|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
83124576|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124577|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83124578|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83124579|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
83124580|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
83124581|NCT02604446|Oxycodone|oxycodone|mesh-list
83124582|NCT02604446|Tapentadol|tapentadol|mesh-list
83124583|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83124584|NCT02604446|Narcotics|narcotics|mesh-ancestor
83124585|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124586|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124587|NCT02604446|Analgesics|analgesics|mesh-ancestor
83124588|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
83124589|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124590|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83124591|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83124592|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124593|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124594|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
83124595|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124596|NCT02847637|Factor VIII|factor viii|mesh-list
83124597|NCT02847637|Coagulants|coagulants|mesh-ancestor
83124598|NCT02652260|Tenofovir|tenofovir|mesh-list
83124599|NCT02652260|Lamivudine|lamivudine|mesh-list
83124600|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83124601|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
83124602|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124603|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83124604|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83124605|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124606|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124607|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83124608|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83124609|NCT01710176|Gemcitabine|gemcitabine|mesh-list
83124610|NCT01710176|Docetaxel|docetaxel|mesh-list
83124611|NCT01710176|Etoposide|etoposide|mesh-list
83124612|NCT01710176|Epirubicin|epirubicin|mesh-list
83124613|NCT01710176|Ifosfamide|ifosfamide|mesh-list
83124614|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
83124615|NCT01710176|Dacarbazine|dacarbazine|mesh-list
83124616|NCT01710176|Trabectedin|trabectedin|mesh-list
83124617|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83124618|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
83124619|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124620|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124621|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
83124622|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
83124623|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
83124624|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83124625|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83124626|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83124627|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124628|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83124629|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83124630|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
83124631|NCT00584246|Pregabalin|pregabalin|mesh-list
83124632|NCT00584246|Analgesics|analgesics|mesh-ancestor
83124633|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
83124634|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124635|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124636|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
83124637|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83124638|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124639|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124640|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83124641|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83124642|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83124643|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124644|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83124645|NCT05124314|Misoprostol|misoprostol|mesh-list
83124646|NCT05124314|Mifepristone|mifepristone|mesh-list
83124647|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83124648|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
83124649|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83124650|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124651|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83124652|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83124653|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
83124654|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83124655|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83124656|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83124657|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83124658|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
83124659|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83124660|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83124661|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
83124662|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124663|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
83124664|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83124665|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83124666|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
83124667|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
83124668|NCT03320967|Coagulants|coagulants|mesh-ancestor
83124669|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83124670|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83124671|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
83124672|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124673|NCT02483325|Fludarabine|fludarabine|mesh-list
83124674|NCT02483325|Busulfan|busulfan|mesh-list
83124675|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
83124676|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124677|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124678|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83124679|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
83124680|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124681|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
83124682|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83124683|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83124684|NCT04212026|Nivolumab|nivolumab|mesh-list
83124685|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83124686|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124687|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83124688|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124689|NCT04211090|Carboplatin|carboplatin|mesh-list
83124690|NCT04211090|Pemetrexed|pemetrexed|mesh-list
83124691|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124692|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124693|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124694|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83124695|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83124696|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
83124697|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83124698|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
83124699|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83124700|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
83124701|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124702|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124703|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
83124705|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83124706|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124707|NCT04538534|Nicardipine|nicardipine|mesh-list
83124708|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83124709|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83124710|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124711|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124712|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83124713|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124714|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
83124715|NCT03318159|Posaconazole|posaconazole|mesh-list
83124716|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
83124717|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124718|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83124719|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83124720|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83124721|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83124722|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83124723|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124724|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124725|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83124726|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
83124727|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124728|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124729|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
83124730|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
83124731|NCT02724410|Amoxicillin|amoxicillin|mesh-list
83124732|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
83124733|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
83124734|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83124735|NCT02724410|Ertapenem|ertapenem|mesh-list
83124736|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124737|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124738|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83124739|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124740|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124741|NCT02486601|Paclitaxel|paclitaxel|mesh-list
83124742|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83124743|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124744|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
83124745|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
83124746|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
83124747|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124748|NCT02487069|Cyclosporine|cyclosporine|mesh-list
83124749|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
83124750|NCT02487069|Methotrexate|methotrexate|mesh-list
83124751|NCT02487069|Cyclosporins|cyclosporins|mesh-list
83124752|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83124753|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83124754|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
83124755|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83124756|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124757|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83124758|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
83124759|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124760|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124761|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83124762|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124763|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83124764|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83124765|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
83124766|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124767|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83124768|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
83124769|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124770|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83124771|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83124772|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83124773|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
83124775|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
83124776|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124777|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124778|NCT03317847|Dexamethasone|dexamethasone|mesh-list
83124779|NCT03317847|Bromfenac|bromfenac|mesh-list
83124780|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83124781|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83124782|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
83124783|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
83124784|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124785|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124786|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83124787|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
83124788|NCT03317847|Hormones|hormones|mesh-ancestor
83124789|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124790|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83124791|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124792|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83124793|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83124794|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83124795|NCT03317847|Analgesics|analgesics|mesh-ancestor
83124796|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
83124797|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124798|NCT01342081|Timolol|timolol|mesh-list
83124799|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83124800|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83124801|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83124802|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83124803|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83124804|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124805|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124806|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124807|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83124808|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83124809|NCT03563833|Anesthetics|anesthetics|mesh-list
83124810|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124811|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124813|NCT02483169|Cilostazol|cilostazol|mesh-list
83124814|NCT02483169|Probucol|probucol|mesh-list
83124815|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83124816|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83124817|NCT02483169|Analgesics|analgesics|mesh-ancestor
83124818|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
83124819|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124820|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124821|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83124822|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124823|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83124824|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83124825|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124826|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83124827|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83124828|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124829|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
83124830|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83124831|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
83124832|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83124833|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
83124834|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
83124835|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83124836|NCT02483169|Protective Agents|protective agents|mesh-ancestor
83124837|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83124838|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83124839|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83124840|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83124841|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
83124842|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83124843|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
83124844|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
83124845|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83124846|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
83124847|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
83124848|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124849|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124851|NCT02489097|Analgesics|analgesics|mesh-ancestor
83124852|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
83124853|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124854|NCT02203682|Doxycycline|doxycycline|mesh-list
83124855|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124856|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124857|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
83124858|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83124859|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83124860|NCT02256800|Leucovorin|leucovorin|mesh-list
83124861|NCT02256800|Bevacizumab|bevacizumab|mesh-list
83124862|NCT02256800|Irinotecan|irinotecan|mesh-list
83124863|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83124864|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124865|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83124866|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83124867|NCT02256800|Growth Substances|growth substances|mesh-ancestor
83124868|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124869|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83124870|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83124871|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83124872|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124873|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124874|NCT02256800|Antidotes|antidotes|mesh-ancestor
83124875|NCT02256800|Protective Agents|protective agents|mesh-ancestor
83124876|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
83124877|NCT02256800|Vitamins|vitamins|mesh-ancestor
83124878|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
83124879|NCT01341457|Gemcitabine|gemcitabine|mesh-list
83124880|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83124881|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
83124882|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124883|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83124884|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
83124885|NCT02488473|Ropivacaine|ropivacaine|mesh-list
83124886|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83124887|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124888|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124889|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83124890|NCT02488473|Analgesics|analgesics|mesh-ancestor
83124891|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
83124892|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124893|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83124894|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83124895|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83124896|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
83124897|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83124898|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124899|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
83124900|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
83124901|NCT05128292|Selenium|selenium|mesh-list
83124902|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
83124903|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124904|NCT05128292|Protective Agents|protective agents|mesh-ancestor
83124905|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124906|NCT05128292|Trace Elements|trace elements|mesh-ancestor
83124907|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
83124908|NCT05127980|Antibodies|antibodies|mesh-list
83124909|NCT05127980|Autoantibodies|autoantibodies|mesh-list
83124910|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
83124911|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124912|NCT03971708|Lidocaine|lidocaine|mesh-list
83124913|NCT03971708|Ropivacaine|ropivacaine|mesh-list
83124914|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
83124915|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
83124916|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83124917|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124918|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
83124919|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124920|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83124921|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83124922|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83124923|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83124924|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124925|NCT02832037|BI 425809|bi 425809|mesh-list
83124926|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
83124927|NCT03966014|Amoxicillin|amoxicillin|mesh-list
83124928|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124929|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470649|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83124931|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83124932|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83124933|NCT02482857|Analgesics|analgesics|mesh-ancestor
83124934|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
83124935|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83124936|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124937|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83124938|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83124939|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83124940|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83124941|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124942|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83124943|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83124944|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124945|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
83124946|NCT02480049|Montelukast|montelukast|mesh-list
83124947|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83124948|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
83124949|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83124950|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
83124951|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83124952|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124953|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83124954|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83124955|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124956|NCT02479971|Clindamycin|clindamycin|mesh-list
83124957|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
83124958|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
83124959|NCT02479971|Gentamicins|gentamicins|mesh-list
83124960|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83124961|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124962|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83124963|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124964|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124965|NCT02486133|Ritonavir|ritonavir|mesh-list
83124966|NCT02486133|Darunavir|darunavir|mesh-list
83124967|NCT02486133|Tenofovir|tenofovir|mesh-list
83124968|NCT02486133|Lamivudine|lamivudine|mesh-list
83124969|NCT02486133|Emtricitabine|emtricitabine|mesh-list
83124970|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83124971|NCT02486133|Dolutegravir|dolutegravir|mesh-list
83124972|NCT02486133|Abacavir|abacavir|mesh-list
83124973|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83124974|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83124975|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83124976|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83124977|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83124978|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83124979|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83124980|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
83124981|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83124982|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83124983|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83124984|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83124985|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83124986|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83124987|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83124988|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
83124989|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
83124990|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83124991|NCT02486055|Vitamins|vitamins|mesh-ancestor
83124992|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
83124993|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
83124994|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
83124995|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83470654|NCT02668562|Ticagrelor|ticagrelor|mesh-list
83124996|NCT02485821|Misoprostol|misoprostol|mesh-list
83124997|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83124998|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83124999|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83125000|NCT02485821|Estradiol|estradiol|mesh-list
83125001|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83125002|NCT02485821|Estrogens|estrogens|mesh-ancestor
83125003|NCT02485821|Hormones|hormones|mesh-ancestor
83125004|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125005|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125006|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83125007|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
83125008|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83125009|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83125010|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83125011|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
83125012|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83125013|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125014|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
83125015|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83125016|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83125017|NCT02479815|Micronutrients|micronutrients|mesh-list
83125018|NCT02479815|Trace Elements|trace elements|mesh-list
83125019|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125020|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83125021|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
83125022|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83125023|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125024|NCT04119830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83125025|NCT04119830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125027|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125028|NCT04049786|Metoprolol|metoprolol|mesh-list
83125029|NCT04049786|Carvedilol|carvedilol|mesh-list
83125030|NCT04049786|Midazolam|midazolam|mesh-list
83125031|NCT04049786|Simvastatin|simvastatin|mesh-list
83125032|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83125033|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83125034|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125035|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125036|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83125037|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83125038|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83125039|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83125040|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
83125041|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
83125042|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
83125043|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
83125044|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125045|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125046|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83125047|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83125048|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
83125049|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83125050|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83125051|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125052|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83125053|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83125054|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
83125055|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
83125056|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125057|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83125058|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83125059|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83125060|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
83125061|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
83125062|NCT04049786|Protective Agents|protective agents|mesh-ancestor
83125063|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83125064|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83125065|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83125066|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
83125067|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83125068|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83125069|NCT02482311|Adavosertib|adavosertib|mesh-list
83125070|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125071|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125072|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
83125073|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
83125074|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125075|NCT03316599|Paclitaxel|paclitaxel|mesh-list
83125076|NCT03316599|Gemcitabine|gemcitabine|mesh-list
83125078|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125079|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83125080|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83125081|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83125082|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125083|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83125084|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
83125085|NCT02482155|Ibuprofen|ibuprofen|mesh-list
83125086|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83125087|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83125088|NCT02482155|Analgesics|analgesics|mesh-ancestor
83125089|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
83125090|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125091|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125092|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125093|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125094|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83125095|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125096|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125097|NCT01675154|Orlistat|orlistat|mesh-list
83125098|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125099|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125100|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83125101|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83125102|NCT02485431|Deflazacort|deflazacort|mesh-list
83125103|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125104|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83125105|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
83125106|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125107|NCT02744755|Adalimumab|adalimumab|mesh-list
83125108|NCT02744755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83125109|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125110|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125111|NCT03314493|Spironolactone|spironolactone|mesh-list
83125112|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83125113|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
83125114|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125115|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125116|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83125117|NCT03314493|Diuretics|diuretics|mesh-ancestor
83125118|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
83125119|NCT03912350|Balovaptan|balovaptan|mesh-list
83125120|NCT03912350|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83125121|NCT03912350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125122|NCT03912350|Natriuretic Agents|natriuretic agents|mesh-ancestor
83125123|NCT03912350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125124|NCT03829514|Fenofibrate|fenofibrate|mesh-list
83125125|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83125126|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
83125127|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125128|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83125129|NCT03801200|Apatinib|apatinib|mesh-list
83125130|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125131|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83125132|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125133|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125134|NCT02485041|Mirodenafil|mirodenafil|mesh-list
83125135|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83125136|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83125137|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125138|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125139|NCT02484963|Zolpidem|zolpidem|mesh-list
83125140|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83125141|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83125142|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125143|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125144|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83125145|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
83125146|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
83125147|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125148|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125150|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83125151|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125152|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83125153|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125154|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125155|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83125156|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83125157|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
83125158|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125159|NCT05708053|Metformin|metformin|mesh-list
83125160|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83125161|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125162|NCT02829775|Interferons|interferons|mesh-list
83125163|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
83125164|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
83125165|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83125166|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125167|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
83125168|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125169|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
83125170|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125171|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83125172|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83125173|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
83125174|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125175|NCT02476773|Antacids|antacids|mesh-ancestor
83125176|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125177|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125178|NCT04500860|Tadalafil|tadalafil|mesh-list
83125179|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83125180|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
83125181|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83125182|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83125183|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125184|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125185|NCT04500860|Urological Agents|urological agents|mesh-ancestor
83125186|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83125187|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83125188|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
83125189|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125190|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125191|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83125192|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125193|NCT02479581|Floxacillin|floxacillin|mesh-list
83125194|NCT02479581|Dexamethasone|dexamethasone|mesh-list
83125195|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
83125196|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83125197|NCT02479581|Scopolamine|scopolamine|mesh-list
83125198|NCT02479581|Morphine|morphine|mesh-list
83125199|NCT02479581|Anesthetics|anesthetics|mesh-list
83125200|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125201|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
83125202|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
83125203|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125204|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125205|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125206|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
83125207|NCT02479581|Hormones|hormones|mesh-ancestor
83125208|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125209|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83125210|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125211|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125212|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125213|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83125214|NCT02479581|Narcotics|narcotics|mesh-ancestor
83125215|NCT02479581|Analgesics|analgesics|mesh-ancestor
83125216|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
83125217|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83125218|NCT02479581|Protective Agents|protective agents|mesh-ancestor
83125219|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83125220|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
83125221|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83125222|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
83125223|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125224|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83125226|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125227|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
83125228|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
83125229|NCT02479347|Povidone|povidone|mesh-list
83125230|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83125231|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125232|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
83125233|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
83125234|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
83125235|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
83125236|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83125237|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
83125238|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83125239|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
83125240|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125241|NCT02481609|Expectorants|expectorants|mesh-ancestor
83125242|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
83125243|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83125244|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
83125245|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125246|NCT02481609|Protective Agents|protective agents|mesh-ancestor
83125247|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125248|NCT02481609|Antidotes|antidotes|mesh-ancestor
83125249|NCT05373225|Acetic Acid|acetic acid|mesh-list
83125250|NCT05373225|Retinol acetate|retinol acetate|mesh-list
83125251|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125252|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125253|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83125254|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
83125255|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125256|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83125257|NCT05373225|Protective Agents|protective agents|mesh-ancestor
83125258|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125259|NCT01355575|Rifaximin|rifaximin|mesh-list
83125260|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125261|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125262|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125263|NCT05125640|Progesterone|progesterone|mesh-list
83125264|NCT05125640|Progestins|progestins|mesh-ancestor
83125265|NCT05125640|Hormones|hormones|mesh-ancestor
83125266|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125267|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125268|NCT03314259|Tamsulosin|tamsulosin|mesh-list
83125269|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83125270|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83125271|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83125272|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
83125273|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125274|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125275|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125276|NCT03314259|Urological Agents|urological agents|mesh-ancestor
83125277|NCT05125328|Remifentanil|remifentanil|mesh-list
83125278|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83125279|NCT05125328|Narcotics|narcotics|mesh-ancestor
83125280|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125281|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125282|NCT05125328|Analgesics|analgesics|mesh-ancestor
83125283|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
83125284|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125285|NCT02481453|Sirolimus|sirolimus|mesh-list
83125286|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125287|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125288|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83125289|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125290|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
83125291|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83125292|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
83125293|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125294|NCT02825251|Insulin|insulin|mesh-list
83125295|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83125296|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
83125297|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
83125298|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83125299|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83125300|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125301|NCT03563365|Adapalene|adapalene|mesh-list
83125303|NCT03563365|Resveratrol|resveratrol|mesh-list
83125304|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
83125305|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125306|NCT03563365|Protective Agents|protective agents|mesh-ancestor
83125307|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125308|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125309|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83125310|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
83125311|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83125312|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83125313|NCT03563365|Analgesics|analgesics|mesh-ancestor
83125314|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
83125315|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125316|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125317|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125318|NCT02475915|Tenofovir|tenofovir|mesh-list
83125319|NCT02475915|Emtricitabine|emtricitabine|mesh-list
83125320|NCT02475915|Efavirenz|efavirenz|mesh-list
83125321|NCT02475915|Maraviroc|maraviroc|mesh-list
83125322|NCT02475915|Darunavir|darunavir|mesh-list
83125323|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
83125324|NCT02475915|Vorinostat|vorinostat|mesh-list
83125325|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
83125326|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125327|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83125328|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83125329|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125330|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125331|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83125332|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83125333|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
83125334|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83125335|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83125336|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125337|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83125338|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83125339|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83125340|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83125341|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83125342|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83125343|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125344|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83125345|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83125346|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83125347|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83125348|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83125349|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83125350|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
83125351|NCT05124457|Insulin|insulin|mesh-list
83125352|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83125353|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
83125354|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
83125355|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
83125356|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
83125357|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83125358|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125359|NCT03833323|Treprostinil|treprostinil|mesh-list
83125360|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83125361|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
83125362|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83125363|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
83125364|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83125365|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83125366|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125367|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83125368|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125369|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83125370|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125371|NCT02824627|Oxytocin|oxytocin|mesh-list
83125372|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
83125373|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83125374|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125375|NCT05384847|Hormones|hormones|mesh-list
83125376|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125377|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125378|NCT05020327|Amoxicillin|amoxicillin|mesh-list
83125379|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125380|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125381|NCT02478879|Teriparatide|teriparatide|mesh-list
83125382|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
83125383|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125384|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83125385|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83125386|NCT02478645|Ramosetron|ramosetron|mesh-list
83125387|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
83125388|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
83125389|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125390|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125391|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125392|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83125393|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
83125394|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125395|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125396|NCT05871957|Vitamin D|vitamin d|mesh-list
83125397|NCT05871957|Ergocalciferols|ergocalciferols|mesh-list
83125398|NCT05871957|Cholecalciferol|cholecalciferol|mesh-list
83125399|NCT05871957|Vitamins|vitamins|mesh-list
83125400|NCT05871957|Micronutrients|micronutrients|mesh-ancestor
83125401|NCT05871957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125421|NCT05871424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125422|NCT05871424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125423|NCT05871424|Analgesics|analgesics|mesh-ancestor
83125424|NCT05871424|Sensory System Agents|sensory system agents|mesh-ancestor
83125425|NCT05871424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125426|NCT05871424|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83125427|NCT05871333|Losartan|losartan|mesh-list
83125428|NCT05871333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83125429|NCT05871333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83125430|NCT05871333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83470696|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
83125431|NCT05871333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83125432|NCT05871333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125433|NCT05871073|Dexamethasone|dexamethasone|mesh-list
83125434|NCT05871073|Ropivacaine|ropivacaine|mesh-list
83125435|NCT05871073|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83125436|NCT05871073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125437|NCT05871073|Antiemetics|antiemetics|mesh-ancestor
83125438|NCT05871073|Autonomic Agents|autonomic agents|mesh-ancestor
83125439|NCT05871073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125440|NCT05871073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125441|NCT05871073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125442|NCT05871073|Glucocorticoids|glucocorticoids|mesh-ancestor
83125443|NCT05871073|Hormones|hormones|mesh-ancestor
83125444|NCT05871073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125445|NCT05871073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83125446|NCT05871073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125447|NCT05871073|Anesthetics, Local|anesthetics, local|mesh-ancestor
83125448|NCT05871073|Anesthetics|anesthetics|mesh-ancestor
83125449|NCT05871073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125450|NCT05871073|Sensory System Agents|sensory system agents|mesh-ancestor
83125451|NCT05871021|Bevacizumab|bevacizumab|mesh-list
83125452|NCT05871021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83125453|NCT05871021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125454|NCT05871021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83125455|NCT05871021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83125456|NCT05871021|Growth Substances|growth substances|mesh-ancestor
83125457|NCT05871021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125458|NCT05871021|Growth Inhibitors|growth inhibitors|mesh-ancestor
83125459|NCT05870969|Liver Extracts|liver extracts|mesh-list
83125460|NCT05870969|Hematinics|hematinics|mesh-ancestor
83125461|NCT05870917|Dexamethasone|dexamethasone|mesh-list
83125462|NCT05870917|Lenalidomide|lenalidomide|mesh-list
83125463|NCT05870917|Bortezomib|bortezomib|mesh-list
83125464|NCT05870917|Venetoclax|venetoclax|mesh-list
83125465|NCT05870917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125466|NCT05870917|Antiemetics|antiemetics|mesh-ancestor
83125467|NCT05870917|Autonomic Agents|autonomic agents|mesh-ancestor
83125468|NCT05870917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125469|NCT05870917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125470|NCT05870917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125471|NCT05870917|Glucocorticoids|glucocorticoids|mesh-ancestor
83125472|NCT05870917|Hormones|hormones|mesh-ancestor
83125473|NCT05870917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125474|NCT05870917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83125475|NCT05870917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125476|NCT05870917|Immunologic Factors|immunologic factors|mesh-ancestor
83125477|NCT05870917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83125478|NCT05870917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83125479|NCT05870917|Growth Substances|growth substances|mesh-ancestor
83125480|NCT05870917|Growth Inhibitors|growth inhibitors|mesh-ancestor
83125481|NCT05870761|Niraparib|niraparib|mesh-list
83125482|NCT05870761|Dostarlimab|dostarlimab|mesh-list
83125483|NCT05870761|Immunoglobulins|immunoglobulins|mesh-list
83125484|NCT05870761|Immunoglobulin G|immunoglobulin g|mesh-list
83125485|NCT05870761|Immunologic Factors|immunologic factors|mesh-ancestor
83125486|NCT05870761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125487|NCT05870761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83125488|NCT05870761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125489|NCT05870761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125490|NCT05870761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125491|NCT05870709|Valsartan|valsartan|mesh-list
83125492|NCT05870709|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83125493|NCT05870709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83125494|NCT05870709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83125495|NCT05870709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83125496|NCT05870709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125497|NCT05870683|Amoxicillin|amoxicillin|mesh-list
83125498|NCT05870683|Esomeprazole|esomeprazole|mesh-list
83125499|NCT05870683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125500|NCT05870683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125501|NCT05870683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83125502|NCT05870683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125503|NCT05870683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83125504|NCT05870683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125505|NCT05870683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125506|NCT05870553|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83125507|NCT05870553|Laxatives|laxatives|mesh-ancestor
83125508|NCT05870553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125509|NCT05870514|Propofol|propofol|mesh-list
83125510|NCT05870514|Fospropofol|fospropofol|mesh-list
83125511|NCT05870514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83125512|NCT05870514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125513|NCT05870514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125514|NCT05870514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83125515|NCT05870514|Anesthetics, General|anesthetics, general|mesh-ancestor
83125516|NCT05870514|Anesthetics|anesthetics|mesh-ancestor
83125517|NCT05870501|Midazolam|midazolam|mesh-list
83125518|NCT05870501|Ketamine|ketamine|mesh-list
83125519|NCT05870501|Analgesics|analgesics|mesh-ancestor
83125520|NCT05870501|Sensory System Agents|sensory system agents|mesh-ancestor
83125521|NCT05870501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125522|NCT05870501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125523|NCT05870501|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83125524|NCT05870501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83125525|NCT05870501|Anesthetics, General|anesthetics, general|mesh-ancestor
83125526|NCT05870501|Anesthetics|anesthetics|mesh-ancestor
83125527|NCT05870501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125528|NCT05870501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83125529|NCT05870501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83125530|NCT05870501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125531|NCT05870501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125532|NCT05870501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83125533|NCT05870501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83125534|NCT05870501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83125535|NCT05870501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83125536|NCT05870501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83125537|NCT05870501|GABA Modulators|gaba modulators|mesh-ancestor
83125538|NCT05870501|GABA Agents|gaba agents|mesh-ancestor
83125539|NCT05870475|Interferons|interferons|mesh-list
83125540|NCT05870475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125541|NCT05870475|Antiviral Agents|antiviral agents|mesh-ancestor
83125542|NCT05870475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125543|NCT05870436|Choline|choline|mesh-list
83125544|NCT05870436|Methacholine Chloride|methacholine chloride|mesh-list
83125545|NCT05870436|Lipotropic Agents|lipotropic agents|mesh-ancestor
83125547|NCT05870436|Antimetabolites|antimetabolites|mesh-ancestor
83125548|NCT05870436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125549|NCT05870436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125550|NCT05870436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83125551|NCT05870436|Nootropic Agents|nootropic agents|mesh-ancestor
83125552|NCT05870436|Miotics|miotics|mesh-ancestor
83125553|NCT05870436|Autonomic Agents|autonomic agents|mesh-ancestor
83125554|NCT05870436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125555|NCT05870436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125556|NCT05870436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83125557|NCT05870436|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83125558|NCT05870436|Respiratory System Agents|respiratory system agents|mesh-ancestor
83125559|NCT05870436|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83125560|NCT05870436|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83125561|NCT05870436|Cholinergic Agents|cholinergic agents|mesh-ancestor
83125562|NCT05870436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125563|NCT05870423|Olaparib|olaparib|mesh-list
83125564|NCT05870423|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83125565|NCT05870423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125566|NCT05870423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125567|NCT05870423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125568|NCT05870358|Melatonin|melatonin|mesh-list
83125569|NCT05870358|Antioxidants|antioxidants|mesh-ancestor
83125570|NCT05870358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125571|NCT05870358|Protective Agents|protective agents|mesh-ancestor
83125572|NCT05870358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125573|NCT05870358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125574|NCT05870111|Choline|choline|mesh-list
83125575|NCT05870111|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83125576|NCT05870111|Lipotropic Agents|lipotropic agents|mesh-ancestor
83125577|NCT05870111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83125578|NCT05870111|Antimetabolites|antimetabolites|mesh-ancestor
83125579|NCT05870111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125580|NCT05870111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125581|NCT05870111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83125582|NCT05870111|Nootropic Agents|nootropic agents|mesh-ancestor
83125583|NCT05870059|Chlorhexidine|chlorhexidine|mesh-list
83125584|NCT05870059|Propolis|propolis|mesh-list
83125585|NCT05870059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83125586|NCT05870059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125587|NCT05870059|Disinfectants|disinfectants|mesh-ancestor
83125588|NCT05870007|Atorvastatin|atorvastatin|mesh-list
83125589|NCT05870007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83125590|NCT05870007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83125591|NCT05870007|Antimetabolites|antimetabolites|mesh-ancestor
83125592|NCT05870007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125593|NCT05870007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83125594|NCT05870007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83125595|NCT05870007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125596|NCT05869955|Cyclophosphamide|cyclophosphamide|mesh-list
83125597|NCT05869955|Fludarabine|fludarabine|mesh-list
83125598|NCT05869955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83125599|NCT05869955|Immunologic Factors|immunologic factors|mesh-ancestor
83125600|NCT05869955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125601|NCT05869955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125602|NCT05869955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83125603|NCT05869955|Alkylating Agents|alkylating agents|mesh-ancestor
83125604|NCT05869955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125605|NCT05869955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125606|NCT05869955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83125607|NCT05868226|Trastuzumab|trastuzumab|mesh-list
83125608|NCT05868226|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83125609|NCT05868226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83125610|NCT05868226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125611|NCT05868226|Immunoconjugates|immunoconjugates|mesh-ancestor
83125612|NCT05868226|Immunologic Factors|immunologic factors|mesh-ancestor
83125613|NCT05868226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125614|NCT05866653|Lidocaine|lidocaine|mesh-list
83125615|NCT05866653|Anesthetics, Local|anesthetics, local|mesh-ancestor
83125616|NCT05866653|Anesthetics|anesthetics|mesh-ancestor
83125617|NCT05866653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125618|NCT05866653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125619|NCT05866653|Sensory System Agents|sensory system agents|mesh-ancestor
83125620|NCT05866653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125621|NCT05866653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83125622|NCT05866653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83125623|NCT05866653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83125624|NCT05866653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83125625|NCT05866653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125628|NCT05855395|Methylprednisolone|methylprednisolone|mesh-list
83125629|NCT05855395|Glucocorticoids|glucocorticoids|mesh-list
83125630|NCT05855395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125631|NCT05855395|Antiemetics|antiemetics|mesh-ancestor
83125632|NCT05855395|Autonomic Agents|autonomic agents|mesh-ancestor
83125633|NCT05855395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125634|NCT05855395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125635|NCT05855395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125636|NCT05855395|Hormones|hormones|mesh-ancestor
83125637|NCT05855395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125638|NCT05855395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83125639|NCT05855395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125640|NCT05855395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83125641|NCT05855395|Protective Agents|protective agents|mesh-ancestor
83125642|NCT05852262|Cephalexin|cephalexin|mesh-list
83125643|NCT05852262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125644|NCT05852262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125645|NCT05790577|Niacinamide|niacinamide|mesh-list
83125646|NCT05790577|Niacin|niacin|mesh-list
83125647|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
83125648|NCT05790577|Metformin|metformin|mesh-list
83125649|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83125650|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125651|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
83125652|NCT05790577|Vitamins|vitamins|mesh-ancestor
83125653|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
83125654|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83125655|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
83125656|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125657|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83125658|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
83125659|NCT05789589|Dexamethasone|dexamethasone|mesh-list
83125660|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
83125661|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125662|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
83125663|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
83125664|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125665|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125666|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125667|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
83125668|NCT05789589|Hormones|hormones|mesh-ancestor
83125669|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125670|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83125671|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125672|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83125673|NCT05789589|Protective Agents|protective agents|mesh-ancestor
83125674|NCT05778838|Midodrine|midodrine|mesh-list
83125675|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
83125676|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
83125677|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125678|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125679|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83125680|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83125681|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83125682|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83125683|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
83125684|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125685|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125686|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83125687|NCT05757544|Ganaxolone|ganaxolone|mesh-list
83125688|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
83125689|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83125690|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125691|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125692|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
83125693|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
83125694|NCT05746559|Ravulizumab|ravulizumab|mesh-list
83125695|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83125696|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83125697|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
83125698|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125699|NCT05730751|Anesthetics|anesthetics|mesh-list
83125700|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125701|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125702|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83125708|NCT05691712|Incretins|incretins|mesh-ancestor
83125709|NCT05691712|Hormones|hormones|mesh-ancestor
83125710|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125711|NCT05688943|Anesthetics|anesthetics|mesh-list
83125712|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125713|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125714|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
83125715|NCT05666310|Denosumab|denosumab|mesh-list
83125716|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83125717|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125718|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
83125719|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125720|NCT05635708|Paclitaxel|paclitaxel|mesh-list
83125721|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83125722|NCT05635708|Carboplatin|carboplatin|mesh-list
83125723|NCT05635708|Pemetrexed|pemetrexed|mesh-list
83125724|NCT05635708|Tislelizumab|tislelizumab|mesh-list
83125725|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83125726|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125727|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
83125728|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
83125729|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
83125730|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125731|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125732|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83125733|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83125734|NCT05635708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83125735|NCT05631405|Dexamethasone|dexamethasone|mesh-list
83125736|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125737|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
83125738|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
83125739|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125740|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125741|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83125742|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
83125743|NCT05631405|Hormones|hormones|mesh-ancestor
83125744|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125745|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83125746|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125747|NCT05621655|Vaccines|vaccines|mesh-list
83125748|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
83125749|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125750|NCT05620407|Deucravacitinib|deucravacitinib|mesh-list
83125751|NCT05620407|Dermatologic Agents|dermatologic agents|mesh-ancestor
83125752|NCT05620407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83125753|NCT05620407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125754|NCT05620407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125755|NCT05619653|Prednisolone|prednisolone|mesh-list
83125756|NCT05619653|Losartan|losartan|mesh-list
83125757|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83125758|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
83125759|NCT05619653|Hormones|hormones|mesh-ancestor
83125760|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125761|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125762|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83125763|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125764|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83125765|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83125766|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83125767|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83125768|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125774|NCT05617625|Fludarabine|fludarabine|mesh-list
83125775|NCT05617625|Melphalan|melphalan|mesh-list
83125776|NCT05617625|Busulfan|busulfan|mesh-list
83125777|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125778|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125779|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83125780|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
83125781|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125782|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83125783|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
83125784|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83125785|NCT05602519|Fentanyl|fentanyl|mesh-list
83125786|NCT05602519|Propofol|propofol|mesh-list
83125787|NCT05602519|Rocuronium|rocuronium|mesh-list
83125788|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83125789|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125790|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125791|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83125792|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
83125793|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
83125794|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83125795|NCT05602519|Narcotics|narcotics|mesh-ancestor
83125796|NCT05602519|Analgesics|analgesics|mesh-ancestor
83125797|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
83125798|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125799|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83125800|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83125801|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83125802|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83125803|NCT05586971|Allopurinol|allopurinol|mesh-list
83125804|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
83125805|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125806|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125807|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
83125808|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125809|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83125810|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
83125811|NCT05586971|Protective Agents|protective agents|mesh-ancestor
83125812|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125813|NCT05582096|Tirzepatide|tirzepatide|mesh-list
83125814|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83125815|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125816|NCT05582096|Incretins|incretins|mesh-ancestor
83125817|NCT05582096|Hormones|hormones|mesh-ancestor
83125818|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125819|NCT05576662|Ritonavir|ritonavir|mesh-list
83125820|NCT05576662|Nirmatrelvir|nirmatrelvir|mesh-list
83125821|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83125822|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83125823|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
83125824|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125825|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125826|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83125827|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83125828|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
83125829|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125830|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83470771|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
83125831|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83125832|NCT05576207|Micronutrients|micronutrients|mesh-list
83125833|NCT05576207|Trace Elements|trace elements|mesh-list
83125834|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125835|NCT05553522|Capecitabine|capecitabine|mesh-list
83125836|NCT05553522|Trastuzumab|trastuzumab|mesh-list
83125837|NCT05553522|Tucatinib|tucatinib|mesh-list
83125838|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83125839|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
83125840|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125841|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125842|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83125843|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83125844|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125845|NCT05586724|Norethindrone|norethindrone|mesh-list
83125846|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
83125847|NCT05586724|Progesterone|progesterone|mesh-list
83125848|NCT05586724|Estrogens|estrogens|mesh-list
83125849|NCT05586724|Progestins|progestins|mesh-ancestor
83125850|NCT05586724|Hormones|hormones|mesh-ancestor
83125851|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83125852|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125853|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83125854|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83125855|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83125857|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83125858|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83125859|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83125861|NCT05508152|Amoxicillin|amoxicillin|mesh-list
83125862|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
83125863|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
83125864|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83125865|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83125866|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125867|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83125868|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125869|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125870|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
83125871|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83125872|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
83125873|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125874|NCT05485558|Expectorants|expectorants|mesh-ancestor
83125875|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
83125876|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83125877|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
83125878|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125879|NCT05485558|Protective Agents|protective agents|mesh-ancestor
83125880|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125881|NCT05485558|Antidotes|antidotes|mesh-ancestor
83125882|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
83125883|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125884|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125885|NCT05478174|Propofol|propofol|mesh-list
83125886|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83125887|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125888|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125889|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83125890|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
83125891|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
83125892|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
83125893|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
83125894|NCT05457556|Melphalan|melphalan|mesh-list
83125895|NCT05457556|Busulfan|busulfan|mesh-list
83125896|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
83125897|NCT05457556|Thiotepa|thiotepa|mesh-list
83125898|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83125899|NCT05457556|Rituximab|rituximab|mesh-list
83125900|NCT05457556|Methotrexate|methotrexate|mesh-list
83125901|NCT05457556|Fludarabine|fludarabine|mesh-list
83125902|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83125903|NCT05457556|Tacrolimus|tacrolimus|mesh-list
83125904|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
83125905|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83125906|NCT05457556|Antibodies|antibodies|mesh-list
83125907|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
83125908|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83125909|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
83125910|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83125911|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83125912|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83125913|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
83125914|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125915|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125916|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83125917|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
83125918|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125919|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125920|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83125921|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83125922|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
83125923|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83125924|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83125925|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
83125926|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
83125927|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125928|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83125929|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83125930|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83125931|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83125932|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83125933|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
83125934|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83125935|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125936|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
83125937|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83125938|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83125939|NCT05447286|Oxycodone|oxycodone|mesh-list
83125940|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83125941|NCT05447286|Narcotics|narcotics|mesh-ancestor
83125942|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83125943|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125944|NCT05447286|Analgesics|analgesics|mesh-ancestor
83125945|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
83125946|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83125947|NCT05411237|Paclitaxel|paclitaxel|mesh-list
83125948|NCT05411237|Doxorubicin|doxorubicin|mesh-list
83125949|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83125950|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83125951|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125952|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83125953|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83125954|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83125955|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125956|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83125957|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83125958|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83125959|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125960|NCT05389462|Gemcitabine|gemcitabine|mesh-list
83125961|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83125962|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
83125963|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125964|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125965|NCT05383196|Paclitaxel|paclitaxel|mesh-list
83125966|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83125967|NCT05383196|Onvansertib|onvansertib|mesh-list
83125968|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83125969|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125970|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
83125971|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
83125972|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
83125973|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125974|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83125975|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83125976|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
83125977|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
83125978|NCT05382338|Lomustine|lomustine|mesh-list
83125979|NCT05382338|Cisplatin|cisplatin|mesh-list
83125980|NCT05382338|Vincristine|vincristine|mesh-list
83125982|NCT05382338|Antidotes|antidotes|mesh-list
83125983|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83125984|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
83125985|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83125986|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83125987|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83125988|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
83125989|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83125990|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83125991|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83125992|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83125993|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
83125994|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
83125995|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
83125996|NCT05382338|Protective Agents|protective agents|mesh-ancestor
83125997|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
83125998|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
83125999|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83126000|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126001|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
83126002|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
83126003|NCT05347238|Dopamine|dopamine|mesh-list
83126004|NCT05347238|Norepinephrine|norepinephrine|mesh-list
83126005|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83126006|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83126007|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
83126008|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126009|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126010|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126011|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
83126012|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
83126013|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126015|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83126016|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
83126017|NCT05347238|Protective Agents|protective agents|mesh-ancestor
83126018|NCT05340582|Acetaminophen|acetaminophen|mesh-list
83126019|NCT05340582|Ibuprofen|ibuprofen|mesh-list
83126020|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83126021|NCT05340582|Analgesics|analgesics|mesh-ancestor
83126022|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
83126023|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126024|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126025|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
83126026|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83126027|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126028|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126029|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83126030|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126031|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126032|NCT05324501|Lomustine|lomustine|mesh-list
83126033|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126034|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
83126035|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126036|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126037|NCT05304585|Dactinomycin|dactinomycin|mesh-list
83126038|NCT05304585|Cactinomycin|cactinomycin|mesh-list
83126039|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
83126040|NCT05304585|Vincristine|vincristine|mesh-list
83126041|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126042|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
83126043|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126044|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126045|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126046|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
83126047|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126048|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126049|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126050|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126051|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126052|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126053|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126054|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83126055|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126056|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83126057|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83126058|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126059|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83126060|NCT05298592|Paclitaxel|paclitaxel|mesh-list
83126061|NCT05298592|Carboplatin|carboplatin|mesh-list
83126062|NCT05298592|Nivolumab|nivolumab|mesh-list
83126063|NCT05298592|Pemetrexed|pemetrexed|mesh-list
83126064|NCT05298592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126065|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126066|NCT05298592|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126067|NCT05298592|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126068|NCT05298592|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126069|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126070|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126071|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83126072|NCT05298592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126073|NCT05298592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83126074|NCT05298592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83126075|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
83126076|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83126077|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
83126078|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83126079|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126080|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83126081|NCT05245474|Tislelizumab|tislelizumab|mesh-list
83126082|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83126083|NCT05245474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126084|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126085|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126086|NCT05222906|Venglustat|venglustat|mesh-list
83126087|NCT05222906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126088|NCT05222906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126090|NCT05206773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126091|NCT05206773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126092|NCT05179733|Rituximab|rituximab|mesh-list
83126093|NCT05179733|Lenalidomide|lenalidomide|mesh-list
83126094|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
83126095|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126096|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126097|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
83126098|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126099|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126100|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83126101|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83126102|NCT05179733|Growth Substances|growth substances|mesh-ancestor
83126103|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
83126104|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126105|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126106|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126107|NCT05174650|Atezolizumab|atezolizumab|mesh-list
83126108|NCT05174650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83126109|NCT05174650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126110|NCT05174650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126111|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126112|NCT05171647|Rituximab|rituximab|mesh-list
83126113|NCT05171647|Gemcitabine|gemcitabine|mesh-list
83126114|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
83126115|NCT05171647|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83126116|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126117|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126118|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
83126119|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126120|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126121|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83126122|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
83126123|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126124|NCT05171647|Immunoconjugates|immunoconjugates|mesh-ancestor
83126125|NCT05170334|Belinostat|belinostat|mesh-list
83126126|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126127|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83126128|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126129|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126130|NCT05166421|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83126131|NCT05166421|Antiviral Agents|antiviral agents|mesh-ancestor
83126132|NCT05166421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126133|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83126134|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
83126135|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126136|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83126137|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
83126138|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126139|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126140|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83126141|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83126142|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83126143|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
83126144|NCT05083247|Paclitaxel|paclitaxel|mesh-list
83126145|NCT05083247|Gemcitabine|gemcitabine|mesh-list
83126146|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126147|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126148|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126149|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126150|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126151|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126152|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83126153|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
83126154|NCT05076110|Acetaminophen|acetaminophen|mesh-list
83126156|NCT05076110|Oxycodone|oxycodone|mesh-list
83126157|NCT05076110|Gabapentin|gabapentin|mesh-list
83126158|NCT05076110|Methocarbamol|methocarbamol|mesh-list
83126159|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83126160|NCT05076110|Analgesics|analgesics|mesh-ancestor
83126161|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
83126162|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126163|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126165|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83126166|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126167|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126168|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83126169|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126170|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126171|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83126172|NCT05076110|Narcotics|narcotics|mesh-ancestor
83126173|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83126174|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
83126175|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83126176|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83126177|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83126178|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83126179|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83126180|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126181|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
83126182|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83126183|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83126184|NCT05063838|Anesthetics|anesthetics|mesh-list
83126185|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83126186|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126187|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83126188|NCT05014828|Lenvatinib|lenvatinib|mesh-list
83126189|NCT05014828|Tislelizumab|tislelizumab|mesh-list
83126190|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126191|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126192|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126193|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126194|NCT05014828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126195|NCT05014282|Nicotine|nicotine|mesh-list
83126196|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83126197|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
83126198|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126199|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126200|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83126201|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83126202|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
83126203|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126204|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126205|NCT05007821|Linezolid|linezolid|mesh-list
83126206|NCT05007821|Bedaquiline|bedaquiline|mesh-list
83126207|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
83126208|NCT05007821|Clofazimine|clofazimine|mesh-list
83126209|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83126210|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126211|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83126212|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126213|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126214|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
83126215|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126216|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
83126217|NCT04994132|Dactinomycin|dactinomycin|mesh-list
83126218|NCT04994132|Cactinomycin|cactinomycin|mesh-list
83126219|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
83126220|NCT04994132|Vincristine|vincristine|mesh-list
83126221|NCT04994132|Vinorelbine|vinorelbine|mesh-list
83126222|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126223|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
83126224|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126225|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126226|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126227|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
83126228|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126229|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126230|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126231|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126232|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126233|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126234|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126235|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83126236|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126237|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83126238|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83126240|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83126241|NCT04986579|Trastuzumab|trastuzumab|mesh-list
83126242|NCT04986579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83126243|NCT04986579|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83126244|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126245|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126246|NCT04986579|Immunoconjugates|immunoconjugates|mesh-ancestor
83126247|NCT04986579|Immunologic Factors|immunologic factors|mesh-ancestor
83126248|NCT04986579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126249|NCT04980222|Prednisone|prednisone|mesh-list
83126250|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
83126251|NCT04980222|Rituximab|rituximab|mesh-list
83126252|NCT04980222|Doxorubicin|doxorubicin|mesh-list
83126253|NCT04980222|Vincristine|vincristine|mesh-list
83126254|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126255|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
83126256|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126257|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126258|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126259|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
83126260|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126261|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126262|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126263|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126264|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83126265|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83126266|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126267|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126268|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126269|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
83126270|NCT04980222|Hormones|hormones|mesh-ancestor
83126271|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126272|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126273|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126274|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126275|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126276|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126277|NCT04940065|Ofatumumab|ofatumumab|mesh-list
83126278|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126279|NCT04939441|Tenofovir|tenofovir|mesh-list
83126280|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
83126281|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126282|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83126283|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83126284|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126285|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126286|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83126287|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83126288|NCT04937738|Leucovorin|leucovorin|mesh-list
83126289|NCT04937738|Docetaxel|docetaxel|mesh-list
83126290|NCT04937738|Fluorouracil|fluorouracil|mesh-list
83126291|NCT04937738|Capecitabine|capecitabine|mesh-list
83126292|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
83126293|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126294|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126295|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126296|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126297|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126298|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
83126299|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83126300|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126301|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
83126302|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126303|NCT04937738|Antidotes|antidotes|mesh-ancestor
83126304|NCT04937738|Protective Agents|protective agents|mesh-ancestor
83126305|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
83126306|NCT04937738|Vitamins|vitamins|mesh-ancestor
83126307|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
83126308|NCT04933617|Prednisone|prednisone|mesh-list
83126309|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
83126310|NCT04933617|Rituximab|rituximab|mesh-list
83126311|NCT04933617|Doxorubicin|doxorubicin|mesh-list
83126312|NCT04933617|Etoposide|etoposide|mesh-list
83126313|NCT04933617|Vincristine|vincristine|mesh-list
83126314|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126315|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
83126316|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126317|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126318|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126319|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
83126320|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126321|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126322|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126323|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126324|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83126325|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83126326|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126327|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126328|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126329|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
83126331|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126332|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126333|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126334|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126335|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126336|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126337|NCT04908189|Apremilast|apremilast|mesh-list
83126338|NCT04908189|Deucravacitinib|deucravacitinib|mesh-list
83126339|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83126340|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83126341|NCT04908189|Analgesics|analgesics|mesh-ancestor
83126342|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
83126343|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126344|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126345|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126346|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126347|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83126348|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83126349|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126350|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126351|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126352|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126353|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
83126354|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126355|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
83126356|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126357|NCT04860505|Doxycycline|doxycycline|mesh-list
83126358|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83126359|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126360|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
83126361|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83126362|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83126363|NCT04857034|Deucravacitinib|deucravacitinib|mesh-list
83126364|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126365|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126366|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126367|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126368|NCT04816643|Vaccines|vaccines|mesh-list
83126369|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
83126370|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126371|NCT04810559|Antibodies|antibodies|mesh-list
83126372|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
83126373|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126374|NCT04799288|Teriflunomide|teriflunomide|mesh-list
83126375|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83126376|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83126377|NCT04799288|Analgesics|analgesics|mesh-ancestor
83126378|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
83126379|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126380|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126381|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126382|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126383|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126384|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
83126385|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
83126386|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126387|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126388|NCT04799054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83126389|NCT04799054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126390|NCT04777357|Cariprazine|cariprazine|mesh-list
83126391|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83126392|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83126393|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83126394|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126395|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83126396|NCT04724018|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83126397|NCT04724018|Immunoconjugates|immunoconjugates|mesh-ancestor
83126398|NCT04724018|Immunologic Factors|immunologic factors|mesh-ancestor
83126399|NCT04724018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126400|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83126401|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
83126402|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126403|NCT04700527|Butyric Acid|butyric acid|mesh-list
83126404|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
83126405|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
83126406|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126407|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126408|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126409|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
83126410|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126411|NCT04684368|Carboplatin|carboplatin|mesh-list
83126412|NCT04684368|Etoposide|etoposide|mesh-list
83126413|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
83126414|NCT04684368|Ifosfamide|ifosfamide|mesh-list
83126415|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
83126416|NCT04684368|Thiotepa|thiotepa|mesh-list
83126417|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
83126418|NCT04684368|Lenograstim|lenograstim|mesh-list
83126419|NCT04684368|Mesna|mesna|mesh-list
83126420|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126421|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126422|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83126423|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126424|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126425|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126426|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83126427|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
83126428|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126429|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126430|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
83126431|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126432|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126433|NCT04684368|Protective Agents|protective agents|mesh-ancestor
83126434|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
83126435|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126436|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126437|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126438|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126439|NCT04653831|Pirfenidone|pirfenidone|mesh-list
83126440|NCT04653831|Analgesics|analgesics|mesh-ancestor
83126441|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
83126442|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126443|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126444|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83126445|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83126446|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126447|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126448|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126449|NCT04570956|Tamoxifen|tamoxifen|mesh-list
83126450|NCT04570956|Afimoxifene|afimoxifene|mesh-list
83126451|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83126452|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
83126453|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126454|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126455|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126456|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126457|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83126458|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83126459|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83126460|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83126461|NCT04512638|Amoxicillin|amoxicillin|mesh-list
83126462|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
83126463|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83126464|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126465|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83126467|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126468|NCT04512235|Dexamethasone|dexamethasone|mesh-list
83126469|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
83126470|NCT04512235|Bortezomib|bortezomib|mesh-list
83126471|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126472|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
83126473|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126474|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126475|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126476|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
83126477|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126478|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126479|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126480|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126481|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
83126482|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
83126483|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126484|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126485|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
83126486|NCT04512235|Hormones|hormones|mesh-ancestor
83126487|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126488|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126489|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
83126490|NCT04510428|Antibodies|antibodies|mesh-list
83126491|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
83126492|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83126493|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83126494|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
83126495|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126496|NCT04504825|Dexamethasone|dexamethasone|mesh-list
83126497|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
83126498|NCT04504825|Bortezomib|bortezomib|mesh-list
83126499|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126500|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
83126501|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126502|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126503|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126504|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
83126505|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126506|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126507|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126508|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126509|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
83126510|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
83126511|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126512|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126513|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
83126514|NCT04504825|Hormones|hormones|mesh-ancestor
83126515|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126516|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126517|NCT04437303|Anticoagulants|anticoagulants|mesh-list
83126518|NCT04436107|Lenalidomide|lenalidomide|mesh-list
83126519|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
83126520|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
83126521|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126522|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83126523|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83126524|NCT04436107|Growth Substances|growth substances|mesh-ancestor
83126525|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
83126526|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126527|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126528|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126529|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126530|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
83126531|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126532|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126533|NCT04429542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83126534|NCT04429542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126535|NCT04411693|Dexamethasone|dexamethasone|mesh-list
83126536|NCT04411693|Aflibercept|aflibercept|mesh-list
83126537|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126538|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
83126539|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
83493380|NCT03001349|Edotreotide|edotreotide|mesh-list
83126540|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126541|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126542|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126543|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
83126545|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126546|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126547|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126548|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83126549|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83126550|NCT04411693|Growth Substances|growth substances|mesh-ancestor
83126551|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
83126552|NCT04385277|Vitamin A|vitamin a|mesh-list
83126553|NCT04385277|Irinotecan|irinotecan|mesh-list
83126554|NCT04385277|Temozolomide|temozolomide|mesh-list
83126555|NCT04385277|Tretinoin|tretinoin|mesh-list
83126556|NCT04385277|Dinutuximab|dinutuximab|mesh-list
83126557|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83126558|NCT04385277|Isotretinoin|isotretinoin|mesh-list
83126559|NCT04385277|Sargramostim|sargramostim|mesh-list
83126560|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83126561|NCT04385277|Vitamins|vitamins|mesh-ancestor
83126562|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
83126563|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126564|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83126565|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126566|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126567|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126568|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126569|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126570|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
83126571|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
83126572|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
83126573|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126574|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83126575|NCT04380740|Abatacept|abatacept|mesh-list
83126576|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83126577|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126578|NCT04380740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126579|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126580|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126581|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
83126582|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126583|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126584|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
83126585|NCT04322318|Ifosfamide|ifosfamide|mesh-list
83126586|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
83126587|NCT04322318|Carboplatin|carboplatin|mesh-list
83126588|NCT04322318|Doxorubicin|doxorubicin|mesh-list
83126589|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83126590|NCT04322318|Irinotecan|irinotecan|mesh-list
83126591|NCT04322318|Etoposide|etoposide|mesh-list
83126592|NCT04322318|Vincristine|vincristine|mesh-list
83126593|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
83126594|NCT04322318|Daunorubicin|daunorubicin|mesh-list
83126595|NCT04322318|Topotecan|topotecan|mesh-list
83126596|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
83126597|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126598|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
83126599|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126600|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126601|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126602|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
83126603|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126604|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126605|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126606|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83126607|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83126608|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126609|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126610|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83126611|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126612|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126613|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126614|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126615|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
83126616|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126617|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
83126618|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
83126619|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126620|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126621|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126622|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126623|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126624|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
83126625|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83126626|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83126627|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126628|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
83126629|NCT04274335|Coagulants|coagulants|mesh-ancestor
83126630|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
83126631|NCT04267887|Prednisone|prednisone|mesh-list
83126632|NCT04267887|Cortisone|cortisone|mesh-list
83126633|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
83126634|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
83126635|NCT04267887|Hormones|hormones|mesh-list
83126636|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83126637|NCT04267887|Androgens|androgens|mesh-list
83126638|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
83126639|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126640|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
83126641|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126642|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126643|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126644|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126645|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83126646|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126647|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126648|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
83126649|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83126650|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
83126651|NCT04267887|Protective Agents|protective agents|mesh-ancestor
83126652|NCT04267887|Vitamins|vitamins|mesh-ancestor
83126653|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
83126654|NCT04267887|Estrogens|estrogens|mesh-ancestor
83126655|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
83126656|NCT04238819|Irinotecan|irinotecan|mesh-list
83126657|NCT04238819|Temozolomide|temozolomide|mesh-list
83126658|NCT04238819|Dinutuximab|dinutuximab|mesh-list
83126659|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83126660|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126661|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126662|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126663|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126664|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126665|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
83126666|NCT04238767|Dolutegravir|dolutegravir|mesh-list
83126667|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83126668|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83126669|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126670|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126671|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83126672|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83126673|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
83126674|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126675|NCT04232553|Mirikizumab|mirikizumab|mesh-list
83126676|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83126677|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83126678|NCT04232553|Analgesics|analgesics|mesh-ancestor
83126679|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
83126680|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126681|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126682|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126683|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126684|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83126685|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126686|NCT04195399|Imidazole|imidazole|mesh-list
83126687|NCT04195399|Nirogacestat|nirogacestat|mesh-list
83126688|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126689|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126690|NCT04195399|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83126691|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83126692|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83126693|NCT04177355|MEDI9197|medi9197|mesh-list
83126694|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83126695|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
83126696|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126697|NCT04177355|Antacids|antacids|mesh-ancestor
83126698|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126699|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126700|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
83126701|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83126702|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83126703|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
83126704|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126705|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126706|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126707|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
83126708|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
83126709|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126710|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
83126711|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83126712|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83126713|NCT04126200|Dexamethasone|dexamethasone|mesh-list
83126714|NCT04126200|Lenalidomide|lenalidomide|mesh-list
83126715|NCT04126200|Pomalidomide|pomalidomide|mesh-list
83126716|NCT04126200|Dostarlimab|dostarlimab|mesh-list
83126717|NCT04126200|Nirogacestat|nirogacestat|mesh-list
83126718|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126719|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
83126720|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
83126721|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126722|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126723|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126724|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
83126725|NCT04126200|Hormones|hormones|mesh-ancestor
83126726|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126727|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126728|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126729|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
83126730|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83126731|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83126732|NCT04126200|Growth Substances|growth substances|mesh-ancestor
83126733|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
83126734|NCT04126200|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83126735|NCT04126200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126736|NCT04126200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126737|NCT04063865|Everolimus|everolimus|mesh-list
83126738|NCT04063865|Tacrolimus|tacrolimus|mesh-list
83126739|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126740|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
83126741|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126742|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83126743|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126744|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126745|NCT04063865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83126746|NCT04063865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126747|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126748|NCT04045665|Anticoagulants|anticoagulants|mesh-list
83126749|NCT04015700|Coal Tar|coal tar|mesh-list
83126750|NCT04015700|Vaccines|vaccines|mesh-list
83126751|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
83126752|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126753|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
83126754|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126755|NCT04004416|Lorazepam|lorazepam|mesh-list
83126756|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
83126757|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
83126758|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
83126759|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126760|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126761|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126762|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83126763|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83126764|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83126765|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83126766|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83126767|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
83126768|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
83126769|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126770|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126771|NCT03996265|Bupropion|bupropion|mesh-list
83126772|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83126773|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
83126774|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83126775|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83126776|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83126777|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83126778|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126779|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
83126780|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126781|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126782|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83126783|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83126784|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126785|NCT03994211|Itraconazole|itraconazole|mesh-list
83126786|NCT03994211|Rifampin|rifampin|mesh-list
83126787|NCT03994211|Pamiparib|pamiparib|mesh-list
83126788|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
83126789|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126790|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83126791|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83126792|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126793|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126794|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83126795|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
83126796|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126797|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126798|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83126799|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83126800|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
83126801|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83126802|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
83126803|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83126804|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83126805|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83126806|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83126807|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83126808|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83126809|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83126810|NCT03994211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83126811|NCT03994211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126812|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
83126813|NCT03959085|Leucovorin|leucovorin|mesh-list
83126814|NCT03959085|Folic Acid|folic acid|mesh-list
83126815|NCT03959085|Cytarabine|cytarabine|mesh-list
83126816|NCT03959085|Dexamethasone|dexamethasone|mesh-list
83126817|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
83126818|NCT03959085|Prednisolone|prednisolone|mesh-list
83126819|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83126820|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
83126821|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83126822|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
83126823|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
83126824|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83126825|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83126826|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83126827|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
83126828|NCT03959085|Doxorubicin|doxorubicin|mesh-list
83126829|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83126830|NCT03959085|Methotrexate|methotrexate|mesh-list
83126831|NCT03959085|Vincristine|vincristine|mesh-list
83126832|NCT03959085|Daunorubicin|daunorubicin|mesh-list
83126833|NCT03959085|Asparaginase|asparaginase|mesh-list
83126834|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
83126835|NCT03959085|Pegaspargase|pegaspargase|mesh-list
83126836|NCT03959085|Thioguanine|thioguanine|mesh-list
83126837|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83126838|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83126839|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
83126840|NCT03959085|BB 1101|bb 1101|mesh-list
83126841|NCT03959085|Calcium|calcium|mesh-list
83126842|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
83126843|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
83126844|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126845|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
83126846|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126847|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126848|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126849|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
83126850|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126851|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126852|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83126853|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126855|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
83126856|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126857|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126858|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
83126859|NCT03959085|Hormones|hormones|mesh-ancestor
83126860|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126861|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126862|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
83126863|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126864|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83126865|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83126866|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126867|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83126868|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83126869|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83126870|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
83126871|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83126872|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83126873|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
83126874|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
83126875|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83126876|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83126877|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
83126878|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126879|NCT03959085|Antidotes|antidotes|mesh-ancestor
83126880|NCT03959085|Protective Agents|protective agents|mesh-ancestor
83126881|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
83126882|NCT03959085|Vitamins|vitamins|mesh-ancestor
83126883|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
83126884|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126885|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
83126886|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
83126887|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
83126888|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83126889|NCT03959085|Hematinics|hematinics|mesh-ancestor
83126890|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126891|NCT03959085|Immunotoxins|immunotoxins|mesh-ancestor
83126892|NCT03959085|Immunoconjugates|immunoconjugates|mesh-ancestor
83126893|NCT03952637|Sirolimus|sirolimus|mesh-list
83126894|NCT03952637|Prednisone|prednisone|mesh-list
83126895|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
83126896|NCT03952637|Rituximab|rituximab|mesh-list
83126897|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126898|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126899|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
83126900|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126901|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126902|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126903|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
83126904|NCT03952637|Hormones|hormones|mesh-ancestor
83126905|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126906|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83126907|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83126908|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126909|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83126910|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
83126911|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126912|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
83126913|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
83126914|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126915|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83126916|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83126917|NCT03952637|Protective Agents|protective agents|mesh-ancestor
83126918|NCT03950609|Everolimus|everolimus|mesh-list
83126919|NCT03950609|Lenvatinib|lenvatinib|mesh-list
83126920|NCT03950609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83126921|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126922|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126923|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126924|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126925|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
83126926|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126927|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126929|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83126930|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83126931|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126932|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126933|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83126935|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83126936|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126937|NCT03910660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83126938|NCT03910660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126939|NCT03875378|Estrogens|estrogens|mesh-list
83126940|NCT03875378|Hormones|hormones|mesh-ancestor
83126941|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83126942|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126943|NCT03823768|Tacrolimus|tacrolimus|mesh-list
83126944|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126945|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
83126946|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126947|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83126948|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126949|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126950|NCT03818607|Eculizumab|eculizumab|mesh-list
83126951|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83126952|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83126953|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
83126954|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126955|NCT03817398|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83126956|NCT03817398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83126957|NCT03817398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126958|NCT03817398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126959|NCT03796156|Aspirin|aspirin|mesh-list
83126960|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83126961|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83126962|NCT03796156|Analgesics|analgesics|mesh-ancestor
83126963|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
83126964|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83126965|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126966|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83126967|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83126968|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83126969|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83126970|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126971|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83126972|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83126973|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126974|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
83126975|NCT03794349|Eflornithine|eflornithine|mesh-list
83126976|NCT03794349|Irinotecan|irinotecan|mesh-list
83126977|NCT03794349|Camptothecin|camptothecin|mesh-list
83126978|NCT03794349|Temozolomide|temozolomide|mesh-list
83126979|NCT03794349|Dinutuximab|dinutuximab|mesh-list
83126980|NCT03794349|Sargramostim|sargramostim|mesh-list
83126981|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83126982|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83126983|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83126984|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83126985|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83126986|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83126987|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83126988|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
83126989|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
83126990|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83126991|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83126992|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83126993|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83126994|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83126995|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83126996|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83126997|NCT03737292|Bupivacaine|bupivacaine|mesh-list
83126998|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
83126999|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
83127000|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83127001|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127002|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
83127003|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127004|NCT03724747|BAY 2315497|bay 2315497|mesh-list
83127005|NCT03724747|Immunoconjugates|immunoconjugates|mesh-ancestor
83127006|NCT03724747|Immunologic Factors|immunologic factors|mesh-ancestor
83127007|NCT03724747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127008|NCT03710460|Metformin|metformin|mesh-list
83127009|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
83127010|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83127011|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127012|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83127013|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127014|NCT03650894|Nivolumab|nivolumab|mesh-list
83127015|NCT03650894|Ipilimumab|ipilimumab|mesh-list
83127016|NCT03650894|Bicalutamide|bicalutamide|mesh-list
83127017|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127018|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127019|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83127020|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127021|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
83127022|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
83127023|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127024|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127025|NCT03606694|Metformin|metformin|mesh-list
83127026|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83127027|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127028|NCT03599622|Deucravacitinib|deucravacitinib|mesh-list
83127029|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127030|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127031|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127032|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127033|NCT03544281|Dexamethasone|dexamethasone|mesh-list
83127034|NCT03544281|Lenalidomide|lenalidomide|mesh-list
83127035|NCT03544281|Bortezomib|bortezomib|mesh-list
83127036|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83127037|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
83127038|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
83127039|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127040|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127041|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83127042|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
83127043|NCT03544281|Hormones|hormones|mesh-ancestor
83127044|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127045|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127046|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127047|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
83127048|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83127049|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83127050|NCT03544281|Growth Substances|growth substances|mesh-ancestor
83127051|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83127052|NCT03533582|Cisplatin|cisplatin|mesh-list
83127053|NCT03533582|Carboplatin|carboplatin|mesh-list
83127054|NCT03533582|Gemcitabine|gemcitabine|mesh-list
83127055|NCT03533582|Doxorubicin|doxorubicin|mesh-list
83127056|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83127057|NCT03533582|Fluorouracil|fluorouracil|mesh-list
83127058|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
83127059|NCT03533582|Irinotecan|irinotecan|mesh-list
83127060|NCT03533582|Etoposide|etoposide|mesh-list
83127061|NCT03533582|Vincristine|vincristine|mesh-list
83127062|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
83127063|NCT03533582|Sorafenib|sorafenib|mesh-list
83127064|NCT03533582|Daunorubicin|daunorubicin|mesh-list
83127065|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
83127066|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127067|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127068|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
83127069|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127070|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127071|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83493453|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
83127072|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83127073|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127074|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127075|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
83127076|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127077|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83127078|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127079|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127080|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127081|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127082|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127083|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
83127084|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127086|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83127087|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83127088|NCT03519945|Analgesics|analgesics|mesh-ancestor
83127089|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
83127090|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127091|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127092|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83127093|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127094|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83127095|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83127096|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
83127097|NCT03432741|Rituximab|rituximab|mesh-list
83127098|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83127099|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
83127100|NCT03432741|Nivolumab|nivolumab|mesh-list
83127101|NCT03432741|Trastuzumab|trastuzumab|mesh-list
83127102|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
83127103|NCT03432741|Gemcitabine|gemcitabine|mesh-list
83127104|NCT03432741|Daratumumab|daratumumab|mesh-list
83127105|NCT03432741|Romidepsin|romidepsin|mesh-list
83127106|NCT03432741|Belinostat|belinostat|mesh-list
83127107|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83127108|NCT03432741|Antibodies|antibodies|mesh-list
83127109|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
83127110|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83127111|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83127112|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
83127113|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127114|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127115|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127116|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127117|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
83127118|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127119|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83127120|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127121|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83127122|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127123|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83127124|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127125|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
83127126|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83127127|NCT03387579|SMOFlipid|smoflipid|mesh-list
83127128|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83127129|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83127130|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83127131|NCT03366272|Rituximab|rituximab|mesh-list
83127132|NCT03366272|Nivolumab|nivolumab|mesh-list
83127133|NCT03366272|Gemcitabine|gemcitabine|mesh-list
83127134|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
83127135|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127136|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127137|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
83127138|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127139|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127140|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127141|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
83127142|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127143|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83127144|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
83127145|NCT03339635|Testosterone|testosterone|mesh-list
83127146|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
83127147|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
83127148|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83127150|NCT03339635|Hormones|hormones|mesh-ancestor
83127151|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127152|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127153|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127154|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127156|NCT03322215|Capecitabine|capecitabine|mesh-list
83127157|NCT03322215|Fulvestrant|fulvestrant|mesh-list
83127158|NCT03322215|Palbociclib|palbociclib|mesh-list
83127159|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127160|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
83127161|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127162|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127163|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127164|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83127165|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83127166|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
83127167|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127168|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127169|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127170|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127171|NCT03300817|Poly ICLC|poly iclc|mesh-list
83127172|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
83127173|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
83127174|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127175|NCT03282916|Valacyclovir|valacyclovir|mesh-list
83127176|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
83127177|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127178|NCT03271372|Avelumab|avelumab|mesh-list
83127179|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83127180|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127181|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127182|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
83127183|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127184|NCT03269994|Tazobactam|tazobactam|mesh-list
83127185|NCT03269994|Piperacillin|piperacillin|mesh-list
83127186|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83127187|NCT03269994|Cefoxitin|cefoxitin|mesh-list
83127188|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83127189|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83470867|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
83127190|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83127191|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127192|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127193|NCT03246750|Cisplatin|cisplatin|mesh-list
83127194|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127195|NCT03173950|Nivolumab|nivolumab|mesh-list
83127196|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127197|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127198|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83127199|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127200|NCT03126916|Vitamin A|vitamin a|mesh-list
83127201|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
83127202|NCT03126916|Melphalan|melphalan|mesh-list
83127203|NCT03126916|Busulfan|busulfan|mesh-list
83127204|NCT03126916|Thiotepa|thiotepa|mesh-list
83127205|NCT03126916|Cisplatin|cisplatin|mesh-list
83127206|NCT03126916|Carboplatin|carboplatin|mesh-list
83127207|NCT03126916|Doxorubicin|doxorubicin|mesh-list
83127208|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83127209|NCT03126916|Etoposide|etoposide|mesh-list
83127210|NCT03126916|Vincristine|vincristine|mesh-list
83127211|NCT03126916|Topotecan|topotecan|mesh-list
83127212|NCT03126916|Tretinoin|tretinoin|mesh-list
83127213|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
83127214|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83127215|NCT03126916|Dinutuximab|dinutuximab|mesh-list
83127216|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
83127217|NCT03126916|Razoxane|razoxane|mesh-list
83127218|NCT03126916|Isotretinoin|isotretinoin|mesh-list
83127219|NCT03126916|Sargramostim|sargramostim|mesh-list
83127220|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83127221|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127222|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
83127223|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127224|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127225|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83127226|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
83127227|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127228|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127229|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83127231|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
83127232|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127233|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83127234|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83127235|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127236|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127237|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127238|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127239|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127240|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83127241|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
83127242|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127243|NCT03126916|Protective Agents|protective agents|mesh-ancestor
83127244|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83127245|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83127246|NCT03094884|Paclitaxel|paclitaxel|mesh-list
83127247|NCT03094884|Carboplatin|carboplatin|mesh-list
83127248|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127249|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127250|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127251|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127252|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127253|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127254|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
83127255|NCT03092518|Mitomycins|mitomycins|mesh-list
83127256|NCT03092518|Mitomycin|mitomycin|mesh-list
83127257|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127258|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127259|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
83127260|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127261|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83127262|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127263|NCT03092518|Antidotes|antidotes|mesh-ancestor
83127264|NCT03092518|Protective Agents|protective agents|mesh-ancestor
83127265|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127266|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
83127267|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
83127268|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83127269|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127270|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
83127271|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
83127272|NCT03074513|Bevacizumab|bevacizumab|mesh-list
83127273|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83127274|NCT03074513|Atezolizumab|atezolizumab|mesh-list
83127275|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
83127276|NCT03074513|Antibodies|antibodies|mesh-list
83127277|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
83127278|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83127279|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
83127280|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127281|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83127282|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83127283|NCT03074513|Growth Substances|growth substances|mesh-ancestor
83127284|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127285|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
83127286|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
83127287|NCT03074513|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83127288|NCT03074513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127289|NCT03067181|Cisplatin|cisplatin|mesh-list
83127290|NCT03067181|Carboplatin|carboplatin|mesh-list
83127291|NCT03067181|Etoposide|etoposide|mesh-list
83127292|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
83127293|NCT03067181|Bleomycin|bleomycin|mesh-list
83127294|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
83127295|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127296|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127297|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83127298|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83127299|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127300|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127301|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127302|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
83127303|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127304|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127305|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127306|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127307|NCT03029390|Metformin|metformin|mesh-list
83127308|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83127309|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127311|NCT03007147|Leucovorin|leucovorin|mesh-list
83127312|NCT03007147|Folic Acid|folic acid|mesh-list
83127313|NCT03007147|Cytarabine|cytarabine|mesh-list
83127314|NCT03007147|Dexamethasone|dexamethasone|mesh-list
83127315|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
83127316|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
83127317|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83127318|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83127319|NCT03007147|Prednisolone|prednisolone|mesh-list
83127320|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
83127321|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
83127322|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83127323|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83127324|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83127325|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
83127326|NCT03007147|Ifosfamide|ifosfamide|mesh-list
83127327|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
83127328|NCT03007147|Doxorubicin|doxorubicin|mesh-list
83127329|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83127330|NCT03007147|Methotrexate|methotrexate|mesh-list
83127331|NCT03007147|Etoposide|etoposide|mesh-list
83127332|NCT03007147|Vincristine|vincristine|mesh-list
83127333|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
83127334|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
83127335|NCT03007147|Daunorubicin|daunorubicin|mesh-list
83127336|NCT03007147|Asparaginase|asparaginase|mesh-list
83127337|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
83127338|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
83127339|NCT03007147|Pegaspargase|pegaspargase|mesh-list
83127340|NCT03007147|Thioguanine|thioguanine|mesh-list
83127341|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
83127342|NCT03007147|Razoxane|razoxane|mesh-list
83127343|NCT03007147|Azathioprine|azathioprine|mesh-list
83127344|NCT03007147|Lenograstim|lenograstim|mesh-list
83127345|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83127346|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
83127347|NCT03007147|BB 1101|bb 1101|mesh-list
83127348|NCT03007147|Calcium|calcium|mesh-list
83127349|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
83127350|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
83127351|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127352|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
83127353|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127354|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127355|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83127356|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
83127357|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127358|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127359|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83127360|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83127361|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
83127362|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
83127363|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127364|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83127365|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
83127366|NCT03007147|Hormones|hormones|mesh-ancestor
83127367|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127368|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127369|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83127370|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127371|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127372|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83127373|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83127374|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83127375|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83127376|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83127377|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
83127378|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83127379|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127380|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
83127381|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127382|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83127383|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83127384|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127385|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
83127386|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127387|NCT03007147|Antidotes|antidotes|mesh-ancestor
83127388|NCT03007147|Protective Agents|protective agents|mesh-ancestor
83127389|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
83127391|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
83127392|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83127393|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127394|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127395|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127396|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83127397|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127398|NCT03007147|Hematinics|hematinics|mesh-ancestor
83127399|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
83127400|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83127401|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
83127402|NCT02981628|Leucovorin|leucovorin|mesh-list
83127403|NCT02981628|Folic Acid|folic acid|mesh-list
83127404|NCT02981628|Cytarabine|cytarabine|mesh-list
83127405|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
83127406|NCT02981628|Methotrexate|methotrexate|mesh-list
83127407|NCT02981628|Vincristine|vincristine|mesh-list
83127408|NCT02981628|Asparaginase|asparaginase|mesh-list
83127409|NCT02981628|Pegaspargase|pegaspargase|mesh-list
83127410|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83127411|NCT02981628|Calcium|calcium|mesh-list
83127412|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
83127413|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127414|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
83127415|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127416|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127417|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83127418|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
83127419|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127420|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127421|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83127422|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83127423|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83127424|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83127425|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
83127426|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83127427|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127428|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
83127429|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127430|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127431|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83127432|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83127433|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
83127434|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127435|NCT02981628|Antidotes|antidotes|mesh-ancestor
83127436|NCT02981628|Protective Agents|protective agents|mesh-ancestor
83127437|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
83127438|NCT02981628|Vitamins|vitamins|mesh-ancestor
83127439|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
83127440|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127441|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127442|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127443|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127444|NCT02981628|Hematinics|hematinics|mesh-ancestor
83127445|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127446|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127447|NCT02981628|Immunotoxins|immunotoxins|mesh-ancestor
83127448|NCT02981628|Immunoconjugates|immunoconjugates|mesh-ancestor
83127449|NCT02873962|Bevacizumab|bevacizumab|mesh-list
83127450|NCT02873962|Nivolumab|nivolumab|mesh-list
83127451|NCT02873962|Rucaparib|rucaparib|mesh-list
83127452|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127453|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127454|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83127455|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83127456|NCT02873962|Growth Substances|growth substances|mesh-ancestor
83127457|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127458|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83127459|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83127460|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127461|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83127462|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127463|NCT02822144|Lidocaine|lidocaine|mesh-list
83127464|NCT02822144|Remifentanil|remifentanil|mesh-list
83127465|NCT02822144|Propofol|propofol|mesh-list
83127466|NCT02822144|Etomidate|etomidate|mesh-list
83127467|NCT02822144|Succinylcholine|succinylcholine|mesh-list
83127468|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
83127469|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
83127470|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83127471|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127472|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
83127473|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127474|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83127475|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83127476|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83127477|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83127478|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127479|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83127480|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83127481|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
83127482|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83127483|NCT02822144|Narcotics|narcotics|mesh-ancestor
83127484|NCT02822144|Analgesics|analgesics|mesh-ancestor
83127485|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83127486|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83127487|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83127488|NCT02725060|Phenylephrine|phenylephrine|mesh-list
83127489|NCT02725060|Isoproterenol|isoproterenol|mesh-list
83127490|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
83127491|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83127492|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
83127493|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
83127494|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127495|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127496|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
83127497|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83127498|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
83127499|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
83127500|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83127501|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83127502|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83127503|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
83127504|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83127505|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127506|NCT02725060|Protective Agents|protective agents|mesh-ancestor
83127507|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83127508|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83127509|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83127510|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
83127511|NCT02724579|Lomustine|lomustine|mesh-list
83127512|NCT02724579|Cisplatin|cisplatin|mesh-list
83127513|NCT02724579|Vincristine|vincristine|mesh-list
83127514|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127515|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
83127516|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127517|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127518|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83127519|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
83127520|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127521|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127522|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83127523|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127524|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127525|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
83470904|NCT01258855|Analgesics|analgesics|mesh-ancestor
83127526|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127527|NCT02689427|Paclitaxel|paclitaxel|mesh-list
83127528|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83127529|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127530|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127531|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127532|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127533|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127534|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127535|NCT02565680|Prednisone|prednisone|mesh-list
83127536|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83127537|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
83127538|NCT02565680|Hormones|hormones|mesh-ancestor
83127539|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127540|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127541|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127542|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127543|NCT02531126|Ozanimod|ozanimod|mesh-list
83127544|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83127545|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127546|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127547|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
83127548|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127549|NCT02521285|Aspirin|aspirin|mesh-list
83127550|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83127551|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83127552|NCT02521285|Analgesics|analgesics|mesh-ancestor
83127553|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
83127554|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127555|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127556|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83127557|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127558|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83127559|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83127560|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127561|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83127562|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83127563|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127564|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
83470947|NCT00003634|Oregovomab|oregovomab|mesh-list
83127565|NCT02422615|Fulvestrant|fulvestrant|mesh-list
83127566|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127567|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127568|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83127569|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83127570|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
83127571|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127572|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127573|NCT02382406|Paclitaxel|paclitaxel|mesh-list
83127574|NCT02382406|Carboplatin|carboplatin|mesh-list
83127575|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
83127576|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127577|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127578|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127579|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127580|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127581|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127582|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127583|NCT02382406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83127584|NCT02203526|Cytarabine|cytarabine|mesh-list
83127585|NCT02203526|Isavuconazole|isavuconazole|mesh-list
83127586|NCT02203526|Rituximab|rituximab|mesh-list
83127587|NCT02203526|Methotrexate|methotrexate|mesh-list
83127588|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127589|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127590|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
83127591|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127592|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127593|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83127594|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
83127595|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83127596|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127597|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
83127598|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127599|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127600|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127601|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83127602|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127603|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83127604|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
83127605|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127606|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
83127607|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
83127608|NCT02176967|Carboplatin|carboplatin|mesh-list
83127609|NCT02176967|Doxorubicin|doxorubicin|mesh-list
83127610|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83127611|NCT02176967|Etoposide|etoposide|mesh-list
83127612|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
83127613|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
83127614|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127615|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
83127616|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127617|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127618|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83127619|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
83127620|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127621|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127622|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83127623|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127624|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83127625|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83127626|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127627|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127628|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
83127629|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127630|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127631|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127632|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127633|NCT02134327|Midazolam|midazolam|mesh-list
83127634|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
83127635|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83127636|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83127637|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127638|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83127639|NCT02134327|Analgesics|analgesics|mesh-ancestor
83127640|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
83127641|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127642|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83127643|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83127644|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83127645|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
83127646|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83127647|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127648|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83127649|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83127650|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83127651|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83127652|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83127653|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
83127654|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
83127655|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
83127656|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
83127657|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
83127658|NCT02112916|Leucovorin|leucovorin|mesh-list
83127659|NCT02112916|Folic Acid|folic acid|mesh-list
83127660|NCT02112916|Cytarabine|cytarabine|mesh-list
83127661|NCT02112916|Dexamethasone|dexamethasone|mesh-list
83127662|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
83127663|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
83127664|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83127665|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83127666|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83127667|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
83127668|NCT02112916|Ifosfamide|ifosfamide|mesh-list
83127669|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
83127670|NCT02112916|Doxorubicin|doxorubicin|mesh-list
83127671|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83127672|NCT02112916|Methotrexate|methotrexate|mesh-list
83127673|NCT02112916|Etoposide|etoposide|mesh-list
83127674|NCT02112916|Vincristine|vincristine|mesh-list
83127675|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
83127676|NCT02112916|Bortezomib|bortezomib|mesh-list
83127677|NCT02112916|Daunorubicin|daunorubicin|mesh-list
83127678|NCT02112916|Asparaginase|asparaginase|mesh-list
83127679|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
83127680|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
83127681|NCT02112916|Pegaspargase|pegaspargase|mesh-list
83127682|NCT02112916|Thioguanine|thioguanine|mesh-list
83127683|NCT02112916|BB 1101|bb 1101|mesh-list
83127684|NCT02112916|Calcium|calcium|mesh-list
83127685|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
83127686|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
83127687|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127688|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
83127689|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127690|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127691|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83127692|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
83127693|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127694|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127695|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83127696|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83127697|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
83127698|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
83493454|NCT03006419|Basiliximab|basiliximab|mesh-list
83127699|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127700|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83127701|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
83127702|NCT02112916|Hormones|hormones|mesh-ancestor
83127703|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127704|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127705|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
83127706|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127707|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127708|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83127709|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83127710|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83127711|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83127712|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83127713|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
83127714|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83127715|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127716|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
83127717|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127718|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83470999|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127719|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83127720|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127721|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
83127722|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127723|NCT02112916|Antidotes|antidotes|mesh-ancestor
83127724|NCT02112916|Protective Agents|protective agents|mesh-ancestor
83127725|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
83127726|NCT02112916|Vitamins|vitamins|mesh-ancestor
83127727|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
83127728|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127729|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127730|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127731|NCT02112916|Hematinics|hematinics|mesh-ancestor
83127732|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
83127733|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83127734|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127735|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127736|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127737|NCT01880515|Tetracycline|tetracycline|mesh-list
83127738|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83127739|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127740|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83127741|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127742|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127743|NCT01780883|Melatonin|melatonin|mesh-list
83127744|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
83127745|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127746|NCT01780883|Protective Agents|protective agents|mesh-ancestor
83127747|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127748|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83127749|NCT01668719|Dexamethasone|dexamethasone|mesh-list
83127750|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
83127751|NCT01668719|Lenalidomide|lenalidomide|mesh-list
83127752|NCT01668719|Bortezomib|bortezomib|mesh-list
83127753|NCT01668719|Elotuzumab|elotuzumab|mesh-list
83127754|NCT01668719|Ichthammol|ichthammol|mesh-list
83127755|NCT01668719|BB 1101|bb 1101|mesh-list
83127756|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83127757|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
83127758|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
83127759|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127760|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127761|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83127762|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
83127763|NCT01668719|Hormones|hormones|mesh-ancestor
83127764|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127765|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83127766|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127767|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
83127768|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83127769|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83127770|NCT01668719|Growth Substances|growth substances|mesh-ancestor
83127771|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
83127772|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
83127773|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127774|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127775|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
83127776|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
83127777|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83127778|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127779|NCT01631617|Doxycycline|doxycycline|mesh-list
83127780|NCT01631617|Cephalexin|cephalexin|mesh-list
83127781|NCT01631617|Trimethoprim|trimethoprim|mesh-list
83127782|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
83127783|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83127784|NCT01631617|Eusol|eusol|mesh-list
83127785|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83127786|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127787|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
83127788|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83127789|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83127790|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83127791|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83127792|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127793|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127794|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83127795|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83127796|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83127797|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
83127798|NCT01517100|Dronabinol|dronabinol|mesh-list
83127799|NCT01517100|Nabilone|nabilone|mesh-list
83127800|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
83127801|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
83127802|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127803|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127804|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83127805|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83127806|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83127807|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83127808|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83127809|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
83127810|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83127811|NCT01517100|Analgesics|analgesics|mesh-ancestor
83127812|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
83127813|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83127814|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83127815|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83471077|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
83127816|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127817|NCT01517100|Hormones|hormones|mesh-ancestor
83127818|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127819|NCT01488045|Fentanyl|fentanyl|mesh-list
83127820|NCT01488045|Midazolam|midazolam|mesh-list
83127821|NCT01488045|Propofol|propofol|mesh-list
83127822|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83127823|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83127824|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127825|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83127826|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
83127827|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
83127828|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83127829|NCT01488045|Narcotics|narcotics|mesh-ancestor
83127830|NCT01488045|Analgesics|analgesics|mesh-ancestor
83127831|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
83127832|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127833|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83127834|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83127835|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83127836|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83127837|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
83127838|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
83127839|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83127840|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127841|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83127842|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
83127843|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127844|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83127845|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
83127846|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83127847|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127848|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83127849|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83127850|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83127851|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
83127852|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
83127853|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83127854|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127855|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
83127856|NCT00946712|Paclitaxel|paclitaxel|mesh-list
83127857|NCT00946712|Bevacizumab|bevacizumab|mesh-list
83127858|NCT00946712|Carboplatin|carboplatin|mesh-list
83127859|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83127860|NCT00946712|Cetuximab|cetuximab|mesh-list
83127861|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83127862|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
83127863|NCT00946712|Antibodies|antibodies|mesh-list
83127864|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
83127865|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83127866|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
83127867|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127868|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127869|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127870|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127871|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127872|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127873|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83127874|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83127875|NCT00946712|Growth Substances|growth substances|mesh-ancestor
83127876|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127877|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
83127878|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
83127879|NCT00694850|Riociguat|riociguat|mesh-list
83127880|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
83127881|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127882|NCT00656669|Paclitaxel|paclitaxel|mesh-list
83127883|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
83127884|NCT00656669|Doxorubicin|doxorubicin|mesh-list
83127885|NCT00656669|Sunitinib|sunitinib|mesh-list
83127886|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83127887|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127888|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127889|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127890|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127891|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127892|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127893|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
83127894|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127895|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127896|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83127897|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
83127898|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83127899|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83127900|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83127901|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83127902|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127903|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83127904|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83127905|NCT00656669|Growth Substances|growth substances|mesh-ancestor
83127906|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83127907|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127908|NCT00494728|Nicotine|nicotine|mesh-list
83127909|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83127910|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
83127911|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127912|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127913|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83127914|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83127915|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
83127916|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83127917|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127918|NCT00470704|Trastuzumab|trastuzumab|mesh-list
83127919|NCT00470704|Lapatinib|lapatinib|mesh-list
83127920|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83127921|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127922|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127923|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127924|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127925|NCT00412594|Rituximab|rituximab|mesh-list
83493455|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
83127926|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83127927|NCT00412594|Cladribine|cladribine|mesh-list
83127928|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
83127929|NCT00412594|Antibodies|antibodies|mesh-list
83127930|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
83127931|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83127932|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
83127933|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127934|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127935|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83127936|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83127937|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83127938|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
83127939|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127940|NCT03829579|Esketamine|esketamine|mesh-list
83127941|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
83471107|NCT00002836|Thiotepa|thiotepa|mesh-list
83127942|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83127943|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83127944|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83127945|NCT01362296|Docetaxel|docetaxel|mesh-list
83127946|NCT01362296|Trametinib|trametinib|mesh-list
83127947|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83127948|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
83127949|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
83127950|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
83127951|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127952|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83127953|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127954|NCT01338415|Bosentan|bosentan|mesh-list
83127955|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83127956|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83127957|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127958|NCT04353128|Melatonin|melatonin|mesh-list
83127959|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
83127960|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127961|NCT04353128|Protective Agents|protective agents|mesh-ancestor
83127962|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127963|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83127964|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83127965|NCT04263350|Cobicistat|cobicistat|mesh-list
83127966|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83127967|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83127968|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
83127969|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83127970|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127971|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83127972|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83127973|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
83127974|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83127975|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83127976|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83127977|NCT03562585|Antibodies|antibodies|mesh-list
83127978|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83127979|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
83127980|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127981|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
83127982|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
83127983|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127984|NCT05124938|Hormones|hormones|mesh-list
83127985|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83127986|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127987|NCT02259985|Itasetron|itasetron|mesh-list
83127988|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
83127989|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
83127990|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83127991|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83127992|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83127993|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83127994|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83127995|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
83127996|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83127997|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83127998|NCT01371643|Octreotide|octreotide|mesh-list
83127999|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128000|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83493606|NCT03005639|Vemurafenib|vemurafenib|mesh-list
83128001|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128002|NCT03023462|Droperidol|droperidol|mesh-list
83128003|NCT03023462|Oxycodone|oxycodone|mesh-list
83128004|NCT03023462|Ondansetron|ondansetron|mesh-list
83128005|NCT03023462|Ropivacaine|ropivacaine|mesh-list
83128006|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
83128007|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
83128008|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128009|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128010|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
83128011|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128012|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83128013|NCT03023462|Narcotics|narcotics|mesh-ancestor
83128014|NCT03023462|Analgesics|analgesics|mesh-ancestor
83128015|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
83128016|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
83128017|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128018|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
83128019|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
83128020|NCT03023462|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83128021|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83128022|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
83128023|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128024|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128025|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83128026|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83128027|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83128028|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83128029|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83128030|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83128031|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
83128032|NCT02824952|Osimertinib|osimertinib|mesh-list
83128033|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128034|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83128035|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128036|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128037|NCT01371565|Mifepristone|mifepristone|mesh-list
83128038|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83128039|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
83128040|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83128041|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128042|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83128043|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83128044|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83128045|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
83128046|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83128047|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83128048|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
83128049|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128050|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
83128051|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83128052|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83128053|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83128054|NCT02821819|Hormones|hormones|mesh-ancestor
83128055|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128056|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128057|NCT04500548|Nivolumab|nivolumab|mesh-list
83128058|NCT04500548|Ipilimumab|ipilimumab|mesh-list
83128059|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128060|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128061|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128062|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128063|NCT05707819|Antibodies|antibodies|mesh-list
83128064|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
83471130|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
83128065|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128066|NCT03034538|Zonisamide|zonisamide|mesh-list
83128067|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
83128068|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83128069|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83128070|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128071|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83128072|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128073|NCT02468180|Polidocanol|polidocanol|mesh-list
83128074|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83128075|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83128077|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83128078|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83128079|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128080|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83128081|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83128082|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
83128083|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128084|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
83128085|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128086|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128087|NCT05053880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128088|NCT05053880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128089|NCT00094016|Beclomethasone|beclomethasone|mesh-list
83128090|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128091|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
83128092|NCT00094016|Hormones|hormones|mesh-ancestor
83128093|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128094|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128095|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83128096|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
83128097|NCT05134298|Meropenem|meropenem|mesh-list
83128098|NCT05134298|Tazobactam|tazobactam|mesh-list
83128099|NCT05134298|Piperacillin|piperacillin|mesh-list
83128100|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83128101|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83128102|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128103|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83128104|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128105|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128106|NCT05134220|Calcium|calcium|mesh-list
83128107|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83128108|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128109|NCT03562507|Nivolumab|nivolumab|mesh-list
83128110|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128111|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128112|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128113|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128114|NCT03954379|Dexamethasone|dexamethasone|mesh-list
83128115|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
83128116|NCT03954379|Analgesics|analgesics|mesh-list
83128117|NCT03954379|Anesthetics|anesthetics|mesh-list
83128118|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
83128119|NCT03954379|BB 1101|bb 1101|mesh-list
83128120|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128121|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
83128122|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
83128123|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128124|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128125|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128126|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
83128127|NCT03954379|Hormones|hormones|mesh-ancestor
83128128|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128129|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83128130|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128131|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
83128132|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128133|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128134|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128135|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
83128136|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
83128137|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83128138|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83128139|NCT02036125|Prednisolone|prednisolone|mesh-list
83128140|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
83128141|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83128142|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
83128143|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128144|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
83128145|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
83128146|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128147|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128148|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128149|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
83128150|NCT02036125|Hormones|hormones|mesh-ancestor
83128151|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128152|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83128153|NCT02036125|Protective Agents|protective agents|mesh-ancestor
83128154|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83128155|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128156|NCT05133752|Nemonoxacin|nemonoxacin|mesh-list
83128157|NCT05133752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83128158|NCT05133752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128159|NCT02818777|Cannabidiol|cannabidiol|mesh-list
83128160|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
83128161|NCT05128916|Terbinafine|terbinafine|mesh-list
83128162|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
83128163|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128164|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128165|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128166|NCT05133050|Ramipril|ramipril|mesh-list
83128167|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83128168|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
83128169|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128170|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128171|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83128172|NCT02817841|Drospirenone|drospirenone|mesh-list
83128173|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83128174|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
83128175|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128176|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128177|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83128178|NCT02817841|Diuretics|diuretics|mesh-ancestor
83128179|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
83128180|NCT05704933|Nivolumab|nivolumab|mesh-list
83128181|NCT05704933|Ipilimumab|ipilimumab|mesh-list
83128182|NCT05704933|Relatlimab|relatlimab|mesh-list
83128183|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128184|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128185|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128186|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128187|NCT05132270|Thalidomide|thalidomide|mesh-list
83128188|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
83128189|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83128190|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
83128191|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128192|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
83128193|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83128194|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128195|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83128196|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83128197|NCT05132270|Growth Substances|growth substances|mesh-ancestor
83128198|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
83128199|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128200|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
83128201|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128202|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128203|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83128204|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
83128205|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83128206|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
83128207|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83128208|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83128209|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128210|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83128211|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128212|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83128213|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128214|NCT05121038|Leucovorin|leucovorin|mesh-list
83128215|NCT05121038|Fluorouracil|fluorouracil|mesh-list
83128216|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
83128217|NCT05121038|Irinotecan|irinotecan|mesh-list
83128218|NCT05121038|Panitumumab|panitumumab|mesh-list
83128219|NCT05121038|Folfirinox|folfirinox|mesh-list
83128220|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
83128221|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128222|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83128223|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128224|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83128225|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
83128226|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128227|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83128228|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83128229|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128230|NCT05121038|Antidotes|antidotes|mesh-ancestor
83128231|NCT05121038|Protective Agents|protective agents|mesh-ancestor
83128232|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
83128233|NCT05121038|Vitamins|vitamins|mesh-ancestor
83128234|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
83128235|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128236|NCT05097794|Indapamide|indapamide|mesh-list
83128237|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83128238|NCT05097794|Diuretics|diuretics|mesh-ancestor
83128239|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
83128240|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128241|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83128242|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83128243|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128244|NCT02036281|Substance P|substance p|mesh-list
83128245|NCT02036281|Neurokinin A|neurokinin a|mesh-list
83128246|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128247|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128248|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128249|NCT02036359|Docetaxel|docetaxel|mesh-list
83128250|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83128251|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128252|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
83128253|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
83128254|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
83128255|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128256|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83128257|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128258|NCT02036437|Misoprostol|misoprostol|mesh-list
83128259|NCT02036437|Dinoprostone|dinoprostone|mesh-list
83128260|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83128261|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
83128262|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83128263|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128264|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83128265|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128266|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
83128267|NCT05027360|Nitroprusside|nitroprusside|mesh-list
83128268|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83128269|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
83128270|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83128271|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128272|NCT02036983|Anesthetics|anesthetics|mesh-list
83128273|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
83128274|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128275|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128276|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
83128277|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128278|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
83128279|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128280|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
83128281|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128282|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128283|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83128284|NCT05689177|Vaccines|vaccines|mesh-list
83128285|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
83128286|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128287|NCT04818320|Favipiravir|favipiravir|mesh-list
83128288|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
83128289|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128290|NCT02475135|Tenofovir|tenofovir|mesh-list
83128291|NCT02475135|Emtricitabine|emtricitabine|mesh-list
83128292|NCT02475135|Darunavir|darunavir|mesh-list
83128293|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83128294|NCT02475135|Cobicistat|cobicistat|mesh-list
83128295|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83128296|NCT02475135|Elvitegravir|elvitegravir|mesh-list
83128297|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83128298|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
83128299|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128300|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83128302|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128303|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128304|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83128305|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83128306|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83128307|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83128308|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
83128309|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83128310|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83128311|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83128312|NCT05161754|Hemostatics|hemostatics|mesh-list
83128313|NCT05161754|Coagulants|coagulants|mesh-ancestor
83128314|NCT05118620|Bupivacaine|bupivacaine|mesh-list
83128315|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
83128316|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
83128317|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128318|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128319|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
83128320|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128321|NCT02814643|Benralizumab|benralizumab|mesh-list
83128322|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83128323|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
83128324|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
83128325|NCT05080790|Interleukin-2|interleukin-2|mesh-list
83128326|NCT05080790|Dinutuximab|dinutuximab|mesh-list
83128327|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128328|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83128329|NCT05080790|Analgesics|analgesics|mesh-ancestor
83128330|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
83128331|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128332|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128333|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83128334|NCT02036827|Bromides|bromides|mesh-list
83128335|NCT02036827|Rocuronium|rocuronium|mesh-list
83128336|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
83128337|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83128338|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83128339|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83128340|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128341|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128342|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
83128343|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128344|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128345|NCT02475213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128346|NCT02475213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128347|NCT05328440|Fulvestrant|fulvestrant|mesh-list
83128348|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83128349|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128350|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83128351|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83128352|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
83128353|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128354|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128355|NCT05256056|Bupivacaine|bupivacaine|mesh-list
83128356|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
83128357|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
83128358|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128359|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128360|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
83128361|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128362|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
83128363|NCT05360511|Hematinics|hematinics|mesh-ancestor
83128364|NCT02724111|Rocuronium|rocuronium|mesh-list
83128365|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83128366|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83128367|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83128368|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128369|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128370|NCT02480751|Beraprost|beraprost|mesh-list
83128371|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83128372|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
83128373|NCT04227314|Apremilast|apremilast|mesh-list
83493682|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83128374|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83128375|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83128376|NCT04227314|Analgesics|analgesics|mesh-ancestor
83128377|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
83128378|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128379|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128380|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128381|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83128382|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83128383|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83128384|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128385|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128386|NCT04223648|Nivolumab|nivolumab|mesh-list
83128387|NCT04223648|Ipilimumab|ipilimumab|mesh-list
83128388|NCT04223648|Durvalumab|durvalumab|mesh-list
83128389|NCT04223648|Tremelimumab|tremelimumab|mesh-list
83128390|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128391|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128392|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128393|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128394|NCT02814175|Adalimumab|adalimumab|mesh-list
83128395|NCT02814175|Methotrexate|methotrexate|mesh-list
83128396|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83471184|NCT02308202|Perindopril|perindopril|mesh-list
83128397|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
83128398|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83128399|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128400|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83128401|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
83128402|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128403|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128404|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
83128405|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128406|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83128407|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83128408|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
83128409|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83128410|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83128411|NCT02814175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83128412|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128413|NCT02475057|Hormones|hormones|mesh-list
83128414|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83128415|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128416|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128417|NCT02474667|Mitogens|mitogens|mesh-list
83128418|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83128419|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128420|NCT03096080|XL647|xl647|mesh-list
83128421|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128422|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83128423|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128424|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128425|NCT01335997|Niacin|niacin|mesh-list
83128426|NCT01335997|Niacinamide|niacinamide|mesh-list
83128427|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
83128428|NCT01335997|Simvastatin|simvastatin|mesh-list
83128429|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83128430|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83128431|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
83128432|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128433|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83128434|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83128435|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128436|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
83128437|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
83128438|NCT01335997|Vitamins|vitamins|mesh-ancestor
83128439|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
83128440|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128441|NCT02048215|Ephedrine|ephedrine|mesh-list
83128442|NCT02048215|Caffeine|caffeine|mesh-list
83128443|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83128444|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128445|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83128446|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128447|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128448|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83128450|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
83128451|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128452|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
83128453|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
83128454|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128455|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83128456|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
83128457|NCT04849832|Fesoterodine|fesoterodine|mesh-list
83128458|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83128459|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83128460|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
83128461|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128462|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128463|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128464|NCT04849832|Urological Agents|urological agents|mesh-ancestor
83128465|NCT02048293|Remifentanil|remifentanil|mesh-list
83128466|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83128467|NCT02048293|Narcotics|narcotics|mesh-ancestor
83128468|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128469|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128470|NCT02048293|Analgesics|analgesics|mesh-ancestor
83128471|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
83128472|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128473|NCT02050009|Metformin|metformin|mesh-list
83128474|NCT02050009|Paclitaxel|paclitaxel|mesh-list
83128475|NCT02050009|Carboplatin|carboplatin|mesh-list
83128476|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83128477|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128478|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83128479|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83128480|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83128481|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128482|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83128483|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128484|NCT04495088|Leucovorin|leucovorin|mesh-list
83128485|NCT04495088|Folic Acid|folic acid|mesh-list
83128486|NCT04495088|Capecitabine|capecitabine|mesh-list
83128487|NCT04495088|Fluorouracil|fluorouracil|mesh-list
83128488|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
83128489|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
83128490|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83128491|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
83128492|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128493|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128494|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83128495|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
83128496|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128497|NCT04495088|Antidotes|antidotes|mesh-ancestor
83128498|NCT04495088|Protective Agents|protective agents|mesh-ancestor
83128499|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
83128500|NCT04495088|Vitamins|vitamins|mesh-ancestor
83128501|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
83128502|NCT04495088|Hematinics|hematinics|mesh-ancestor
83128503|NCT04717154|Nivolumab|nivolumab|mesh-list
83128504|NCT04717154|Ipilimumab|ipilimumab|mesh-list
83128505|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128506|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128507|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128508|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128509|NCT02474511|Anesthetics|anesthetics|mesh-list
83128510|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128511|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128512|NCT03108963|Metformin|metformin|mesh-list
83128513|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83128514|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128515|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
83128516|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
83128517|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83128518|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83128519|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128520|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128521|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128522|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83128523|NCT02474433|Misoprostol|misoprostol|mesh-list
83128524|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83128525|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
83128526|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83128527|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128528|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83128529|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128530|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
83128531|NCT04812002|Bevacizumab|bevacizumab|mesh-list
83128532|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83128533|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128534|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128535|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83128536|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83128537|NCT04812002|Growth Substances|growth substances|mesh-ancestor
83128538|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128539|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
83128540|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128541|NCT03424460|Hemostatics|hemostatics|mesh-list
83128542|NCT03424460|Coagulants|coagulants|mesh-ancestor
83128543|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
83128544|NCT05712837|Salicylates|salicylates|mesh-list
83128545|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128546|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
83128547|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
83128548|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
83128549|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83128550|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83128551|NCT05712837|Analgesics|analgesics|mesh-ancestor
83128552|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
83128553|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128554|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128555|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128556|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83128557|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83128558|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128559|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128560|NCT02472249|Norepinephrine|norepinephrine|mesh-list
83128561|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83128562|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83128563|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83128564|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128565|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128566|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128567|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
83128568|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
83128569|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128570|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83128572|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83128573|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83128574|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128575|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128576|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83128577|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83128578|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
83128579|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128580|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128581|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
83128582|NCT04821141|Estrogens|estrogens|mesh-list
83128583|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83128584|NCT04821141|Hormones|hormones|mesh-ancestor
83128585|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128586|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128587|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83128588|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83128589|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
83128590|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83128591|NCT04435652|Paclitaxel|paclitaxel|mesh-list
83128592|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83128593|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83128594|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128595|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
83128596|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
83128597|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
83128598|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128599|NCT02473887|Ondansetron|ondansetron|mesh-list
83128600|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
83128601|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
83128602|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128603|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128604|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128605|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
83128606|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
83128607|NCT02473887|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83128608|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83128609|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
83128610|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128611|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128612|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
83128613|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128614|NCT00071552|Fluticasone|fluticasone|mesh-list
83128616|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128617|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83128618|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
83128619|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128620|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128621|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83128622|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
83128623|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
83128624|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83128625|NCT05164263|Empagliflozin|empagliflozin|mesh-list
83128626|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83128627|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128628|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83128629|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128630|NCT04767711|Prednisolone|prednisolone|mesh-list
83128631|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128632|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
83128633|NCT04767711|Hormones|hormones|mesh-ancestor
83128634|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128635|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128636|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83128637|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128638|NCT02473809|Liraglutide|liraglutide|mesh-list
83128639|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83128640|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128641|NCT02473809|Incretins|incretins|mesh-ancestor
83128642|NCT02473809|Hormones|hormones|mesh-ancestor
83128643|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128644|NCT03976934|Tamsulosin|tamsulosin|mesh-list
83128645|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83128646|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83128647|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83128648|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
83128649|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128650|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128651|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128652|NCT03976934|Urological Agents|urological agents|mesh-ancestor
83128653|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83128654|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83128655|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
83128656|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128657|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128658|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83128659|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
83128660|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
83128661|NCT02416180|Hormones|hormones|mesh-ancestor
83128662|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128663|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
83128664|NCT02473575|Caffeine|caffeine|mesh-list
83128665|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83128666|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128667|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83128668|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128669|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128670|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83128671|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83128672|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
83128673|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128674|NCT03770546|Betamethasone|betamethasone|mesh-list
83128675|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128676|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
83128677|NCT03770546|Hormones|hormones|mesh-ancestor
83128678|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128679|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128680|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83128681|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
83128682|NCT04646967|Acetaminophen|acetaminophen|mesh-list
83128683|NCT04646967|Ibuprofen|ibuprofen|mesh-list
83128684|NCT04646967|Ketorolac|ketorolac|mesh-list
83128685|NCT04646967|Bupivacaine|bupivacaine|mesh-list
83128686|NCT04646967|Sevoflurane|sevoflurane|mesh-list
83128687|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83128688|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
83128689|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128690|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128691|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
83128692|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128693|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83128694|NCT04646967|Analgesics|analgesics|mesh-ancestor
83128695|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
83128696|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83128697|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128698|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83128699|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83128700|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128701|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128702|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83128703|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83128704|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
83128705|NCT05341323|Ketamine|ketamine|mesh-list
83128706|NCT05341323|Bupivacaine|bupivacaine|mesh-list
83128707|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
83128708|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
83128709|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128710|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128711|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
83128712|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128713|NCT05341323|Analgesics|analgesics|mesh-ancestor
83128714|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83128715|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83128716|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
83128717|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83128718|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83128719|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128720|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128721|NCT04622865|Quercetin|quercetin|mesh-list
83128722|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
83128723|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128724|NCT04622865|Protective Agents|protective agents|mesh-ancestor
83128725|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128726|NCT02473185|Methylphenidate|methylphenidate|mesh-list
83128727|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83128728|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128729|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83128730|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83128731|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83128732|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128733|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
83128734|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128735|NCT02445586|Docetaxel|docetaxel|mesh-list
83128736|NCT02445586|Trastuzumab|trastuzumab|mesh-list
83128737|NCT02445586|Pertuzumab|pertuzumab|mesh-list
83128738|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128739|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
83128740|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
83128741|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
83128742|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128743|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128744|NCT02471547|Mitomycins|mitomycins|mesh-list
83128745|NCT02471547|Mitomycin|mitomycin|mesh-list
83128746|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83128747|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128748|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
83128749|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128750|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83128751|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128752|NCT02477631|Deferiprone|deferiprone|mesh-list
83128753|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83128754|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
83128755|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
83128756|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128757|NCT01674062|Trastuzumab|trastuzumab|mesh-list
83128759|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128760|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128761|NCT02472873|Ethanol|ethanol|mesh-list
83128762|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83128763|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128764|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128765|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128766|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
83128767|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83128768|NCT02472886|Ledipasvir|ledipasvir|mesh-list
83128769|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
83128770|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128771|NCT04570839|Nivolumab|nivolumab|mesh-list
83128772|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128773|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128774|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83128775|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128776|NCT05283356|Ticagrelor|ticagrelor|mesh-list
83128777|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83128778|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83128779|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83128780|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83128781|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
83128782|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128783|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128784|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128785|NCT02472652|Aripiprazole|aripiprazole|mesh-list
83128786|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
83128787|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83128788|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83128789|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83128790|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83128791|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128792|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
83128793|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
83128794|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128795|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128796|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83128797|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83128798|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
83128799|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83128800|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83128801|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83128802|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83128803|NCT05243186|Methylphenidate|methylphenidate|mesh-list
83128804|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83128805|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128806|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83128807|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83128808|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83128809|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128810|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
83128811|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128812|NCT02808182|Niacin|niacin|mesh-list
83128813|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
83128814|NCT02808182|Niacinamide|niacinamide|mesh-list
83128815|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83128816|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
83128817|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128818|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83128819|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
83128820|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
83128821|NCT02808182|Vitamins|vitamins|mesh-ancestor
83128822|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
83128823|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128824|NCT04695704|Montelukast|montelukast|mesh-list
83128825|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83128826|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83128827|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
83128828|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
83128829|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128830|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128831|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83128832|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83128833|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128834|NCT02051569|Tryptophan|tryptophan|mesh-list
83128835|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83128836|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
83128837|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83128838|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83128839|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
83128840|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83128841|NCT05217758|Mifepristone|mifepristone|mesh-list
83128842|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83128843|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
83128844|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83128845|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128846|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83128847|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83128848|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83128849|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
83128850|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83128851|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83128852|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
83128853|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128854|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
83128855|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83128856|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83128857|NCT02051023|Fluorometholone|fluorometholone|mesh-list
83128858|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
83128859|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83128860|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83128861|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128862|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
83128863|NCT02051023|Hormones|hormones|mesh-ancestor
83128864|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128865|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128866|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83128867|NCT02415556|Insulin|insulin|mesh-list
83128868|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83128869|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83128870|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128871|NCT05192798|Paclitaxel|paclitaxel|mesh-list
83128872|NCT05192798|Bevacizumab|bevacizumab|mesh-list
83128873|NCT05192798|Apatinib|apatinib|mesh-list
83128874|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83128875|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83128876|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128877|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
83128878|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83128879|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
83128880|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128881|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128882|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83128883|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83128884|NCT05192798|Growth Substances|growth substances|mesh-ancestor
83128885|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128886|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
83128887|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83128888|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128889|NCT02048683|Sevoflurane|sevoflurane|mesh-list
83128890|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83128891|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83128892|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
83128893|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
83128894|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83493683|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83128895|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128896|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
83128897|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83128898|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83128899|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128900|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
83128901|NCT03108807|Coagulants|coagulants|mesh-ancestor
83128902|NCT02048761|Metformin|metformin|mesh-list
83128903|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83128904|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128905|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83128906|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
83128907|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83128908|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83128909|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83128910|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128911|NCT02048917|Bupropion|bupropion|mesh-list
83128912|NCT02048917|Varenicline|varenicline|mesh-list
83128913|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83128914|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
83128915|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83128916|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83128917|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83128918|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83128919|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128920|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
83128921|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128922|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128923|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83128924|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83128925|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128926|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83128927|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83128928|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
83128929|NCT02472717|Liraglutide|liraglutide|mesh-list
83128930|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83128931|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128932|NCT02472717|Incretins|incretins|mesh-ancestor
83128933|NCT02472717|Hormones|hormones|mesh-ancestor
83128934|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128935|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
83128936|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83128937|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83128938|NCT02049073|Prednisolone|prednisolone|mesh-list
83128939|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
83128940|NCT02049073|Zonisamide|zonisamide|mesh-list
83128941|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83128942|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
83128943|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128944|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
83128945|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
83128946|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128947|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128948|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83128949|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
83128950|NCT02049073|Hormones|hormones|mesh-ancestor
83128951|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83128952|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83128953|NCT02049073|Protective Agents|protective agents|mesh-ancestor
83128954|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83128955|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128956|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
83128957|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83128958|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83128959|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128960|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83128961|NCT04518345|Azacitidine|azacitidine|mesh-list
83128962|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83128963|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
83128964|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128965|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128966|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128967|NCT02260063|Epinastine|epinastine|mesh-list
83128968|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83128969|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
83128970|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
83128971|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83128972|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128973|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128975|NCT04398914|Trastuzumab|trastuzumab|mesh-list
83128976|NCT04398914|Pertuzumab|pertuzumab|mesh-list
83128977|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83128978|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83128979|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
83128980|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
83128981|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
83128982|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83128983|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83128984|NCT03561649|Adalimumab|adalimumab|mesh-list
83128985|NCT03561649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83128986|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128987|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83128988|NCT02807623|Ibuprofen|ibuprofen|mesh-list
83128989|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83128990|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83128991|NCT02807623|Analgesics|analgesics|mesh-ancestor
83128992|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
83128993|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83128994|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83128995|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83128996|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83128997|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83128998|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83128999|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129000|NCT05137964|Vitamin D|vitamin d|mesh-list
83129001|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83129002|NCT05137964|Vitamins|vitamins|mesh-ancestor
83129003|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
83129004|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129005|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83129006|NCT04374578|Dulaglutide|dulaglutide|mesh-list
83129007|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83129008|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129009|NCT02470923|Nicotine|nicotine|mesh-list
83129010|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83129011|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
83129012|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129013|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129014|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83129015|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83129016|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
83129017|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129018|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129019|NCT02049229|Everolimus|everolimus|mesh-list
83129020|NCT02049229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83129021|NCT02049229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129022|NCT02049229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129023|NCT02049229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129024|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83129025|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
83129026|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129027|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129028|NCT02805907|Calcifediol|calcifediol|mesh-list
83129029|NCT02805907|Vitamins|vitamins|mesh-ancestor
83129030|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
83129031|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129032|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83129033|NCT02477397|Fluticasone|fluticasone|mesh-list
83129035|NCT02477397|Budesonide|budesonide|mesh-list
83129036|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
83129037|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83129038|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83129039|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83129040|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83129041|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83129042|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
83129043|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129044|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129046|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
83129047|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
83129048|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83129050|NCT02477397|Hormones|hormones|mesh-ancestor
83129051|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129052|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83129053|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83129054|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83129055|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
83129056|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129057|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129058|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
83129059|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83129060|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83129061|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83129062|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129063|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129064|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129065|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129066|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83129067|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
83129068|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83129069|NCT02470767|Anticoagulants|anticoagulants|mesh-list
83129070|NCT02049541|Rituximab|rituximab|mesh-list
83129071|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83129072|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129073|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
83129074|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129075|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129076|NCT02470611|Alendronate|alendronate|mesh-list
83129077|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83129078|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129079|NCT05305898|Metformin|metformin|mesh-list
83129080|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83129081|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129082|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
83129083|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129084|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83129085|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83129086|NCT05580861|Analgesics|analgesics|mesh-ancestor
83129087|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
83129088|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129089|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129090|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83129091|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129092|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83129093|NCT02469831|Rocuronium|rocuronium|mesh-list
83129094|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83129095|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83129096|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83129097|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129098|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129099|NCT02995005|Tenofovir|tenofovir|mesh-list
83129100|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
83129101|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129102|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83129103|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83129104|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129105|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129106|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83129107|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83129108|NCT03561415|Posaconazole|posaconazole|mesh-list
83129109|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
83129110|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129111|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83129112|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83129113|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83129114|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83129115|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83129116|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129117|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129118|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83129119|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
83129120|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129121|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129123|NCT02477007|Ibuprofen|ibuprofen|mesh-list
83129124|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83129125|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83129126|NCT02477007|Analgesics|analgesics|mesh-ancestor
83129127|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
83129128|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129129|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129130|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83129131|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129132|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83129133|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129134|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129135|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
83129136|NCT02052973|Propolis|propolis|mesh-list
83129137|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129138|NCT04347434|Atorvastatin|atorvastatin|mesh-list
83129139|NCT04347434|Ezetimibe|ezetimibe|mesh-list
83129140|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83129141|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83129142|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
83129143|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129144|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83129145|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83129146|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129147|NCT02053519|Vitamin D|vitamin d|mesh-list
83129148|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
83129149|NCT02053519|Vitamins|vitamins|mesh-ancestor
83129150|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
83129151|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129152|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83129153|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83129154|NCT02053597|Paclitaxel|paclitaxel|mesh-list
83129155|NCT02053597|Doxorubicin|doxorubicin|mesh-list
83129156|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83129157|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129158|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
83129159|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
83129160|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
83129161|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129162|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83129163|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83129164|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83129165|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129166|NCT02801617|Latanoprost|latanoprost|mesh-list
83129167|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83129168|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83129169|NCT02056249|Norepinephrine|norepinephrine|mesh-list
83129170|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83129171|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83129172|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83129173|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129174|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129175|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129176|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
83129177|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
83129178|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129179|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83129180|NCT04140968|Progesterone|progesterone|mesh-list
83129181|NCT04140968|Progestins|progestins|mesh-ancestor
83129182|NCT04140968|Hormones|hormones|mesh-ancestor
83129183|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129184|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129185|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
83129186|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83129187|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129188|NCT04383938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83129189|NCT04383938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129190|NCT01334515|Isotretinoin|isotretinoin|mesh-list
83129191|NCT01334515|Sargramostim|sargramostim|mesh-list
83129192|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129193|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
83129194|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
83129196|NCT02415400|Vitamin K|vitamin k|mesh-list
83129197|NCT02415400|Apixaban|apixaban|mesh-list
83129198|NCT02415400|Vitamins|vitamins|mesh-ancestor
83129199|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
83129200|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129201|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83129202|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83129203|NCT02415400|Analgesics|analgesics|mesh-ancestor
83129204|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
83129205|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129206|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83129207|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129208|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83129209|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83129210|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129211|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83129212|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83129213|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129214|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
83129215|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83129216|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
83129217|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83129218|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
83129219|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
83129220|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83129221|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
83129222|NCT02415400|Coagulants|coagulants|mesh-ancestor
83129223|NCT02053675|Vasopressins|vasopressins|mesh-list
83129224|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
83129225|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
83129226|NCT02053675|Coagulants|coagulants|mesh-ancestor
83129227|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83129228|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83129229|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
83129230|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129231|NCT02037997|Docetaxel|docetaxel|mesh-list
83129232|NCT02037997|Pemetrexed|pemetrexed|mesh-list
83129233|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83129234|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129235|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
83129236|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
83129237|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
83129238|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129239|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129240|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83129241|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83129242|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129243|NCT02056405|Mosapride|mosapride|mesh-list
83129244|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83129245|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83129246|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
83129247|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129248|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129249|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129250|NCT02056717|Dexamethasone|dexamethasone|mesh-list
83129251|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83129252|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
83129253|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
83129254|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129255|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129256|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83129257|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
83129258|NCT02056717|Hormones|hormones|mesh-ancestor
83129259|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129260|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83129261|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129262|NCT04194801|Fisogatinib|fisogatinib|mesh-list
83129263|NCT04194801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129264|NCT02802865|Letrozole|letrozole|mesh-list
83129265|NCT02802865|Clomiphene|clomiphene|mesh-list
83129266|NCT02802865|Enclomiphene|enclomiphene|mesh-list
83129267|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
83129268|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129269|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129270|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83129271|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83129272|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129273|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83129274|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
83129275|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129276|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129277|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83129279|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83129280|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83129281|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83129283|NCT02414932|Ketamine|ketamine|mesh-list
83129284|NCT02414932|Analgesics|analgesics|mesh-ancestor
83129285|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
83129286|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129287|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129288|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83129289|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83129290|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
83129291|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
83129292|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129293|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83129294|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83129295|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129296|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129297|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83129298|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83129299|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83129300|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83129301|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83129302|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
83129303|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
83129304|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
83129305|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83129306|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
83129307|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
83129308|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129309|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129310|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83129311|NCT02476929|Analgesics|analgesics|mesh-ancestor
83129312|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
83129313|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129314|NCT02726997|Paclitaxel|paclitaxel|mesh-list
83129315|NCT02726997|Carboplatin|carboplatin|mesh-list
83129316|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83129317|NCT02726997|Durvalumab|durvalumab|mesh-list
83129318|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
83129319|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83129320|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
83129321|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83129322|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129323|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
83129324|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
83129325|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
83129326|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129327|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83129328|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
83129329|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129330|NCT02054143|Sevoflurane|sevoflurane|mesh-list
83129331|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83129332|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83129333|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
83129334|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
83129335|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129336|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129337|NCT02058667|Paclitaxel|paclitaxel|mesh-list
83129338|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83129339|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129340|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
83129341|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
83129342|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83129343|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129344|NCT02470455|Atorvastatin|atorvastatin|mesh-list
83129345|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83129346|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83129347|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
83129348|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129349|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83129350|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83129351|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129352|NCT02057263|Alendronate|alendronate|mesh-list
83129353|NCT02057263|Diphosphonates|diphosphonates|mesh-list
83129354|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83129355|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129357|NCT05550909|Lumefantrine|lumefantrine|mesh-list
83129358|NCT05550909|Artemether|artemether|mesh-list
83129359|NCT05550909|Primaquine|primaquine|mesh-list
83129360|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83129361|NCT05550909|Amodiaquine|amodiaquine|mesh-list
83129362|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
83129363|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
83129364|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83129365|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83129366|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129367|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129368|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
83129369|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
83129370|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83129371|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
83129372|NCT02054299|Thiamine|thiamine|mesh-list
83129373|NCT02054299|Proguanil|proguanil|mesh-list
83129374|NCT02054299|Sumatriptan|sumatriptan|mesh-list
83129375|NCT02054299|Amitriptyline|amitriptyline|mesh-list
83129376|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83129377|NCT02054299|Fenoterol|fenoterol|mesh-list
83129378|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83129379|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83129380|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83129381|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
83129382|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129383|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129384|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129385|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83129386|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
83129387|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83129388|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83129389|NCT02054299|Analgesics|analgesics|mesh-ancestor
83129390|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
83129391|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129392|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83129393|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83129394|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129395|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83129396|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
83129397|NCT02054299|Vitamins|vitamins|mesh-ancestor
83129398|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
83129399|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83129400|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
83129401|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83129402|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83129403|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129404|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
83129405|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83129406|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
83129407|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83129408|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
83129409|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
83129410|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
83129411|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83129412|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83129413|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83129414|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83129415|NCT02058823|Amlodipine|amlodipine|mesh-list
83129416|NCT02058823|Valsartan|valsartan|mesh-list
83129417|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83129418|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83129419|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129420|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129421|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83129422|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129423|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
83129424|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83129425|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83129426|NCT00704535|Ezetimibe|ezetimibe|mesh-list
83129427|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83129428|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83129429|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
83129430|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129431|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83129432|NCT02058901|Sunitinib|sunitinib|mesh-list
83129433|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129434|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83129435|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83129436|NCT02058901|Growth Substances|growth substances|mesh-ancestor
83129437|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129438|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
83129439|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129440|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129441|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129442|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
83129443|NCT03945591|Bortezomib|bortezomib|mesh-list
83129444|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83129445|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
83129446|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129447|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129448|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83129449|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
83129450|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129451|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129452|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83129453|NCT01955499|Lenalidomide|lenalidomide|mesh-list
83129454|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
83129455|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129456|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83129457|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83129458|NCT01955499|Growth Substances|growth substances|mesh-ancestor
83129459|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
83129460|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129461|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83129462|NCT02058979|Cefazolin|cefazolin|mesh-list
83129463|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129464|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83129465|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
83129466|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129467|NCT03893955|Paclitaxel|paclitaxel|mesh-list
83129468|NCT03893955|Carboplatin|carboplatin|mesh-list
83129469|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83129470|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129471|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83129472|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83129473|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83129474|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129475|NCT02648204|Dulaglutide|dulaglutide|mesh-list
83129476|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83471368|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129477|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129478|NCT03310749|Metformin|metformin|mesh-list
83129479|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83129480|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129481|NCT01217931|Bevacizumab|bevacizumab|mesh-list
83129482|NCT01217931|Everolimus|everolimus|mesh-list
83129483|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83129484|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129485|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83129486|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83129487|NCT01217931|Growth Substances|growth substances|mesh-ancestor
83129488|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129489|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
83129490|NCT01217931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83129491|NCT01217931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129492|NCT01217931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129493|NCT01217931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129494|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83129495|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
83129496|NCT05291325|Linaclotide|linaclotide|mesh-list
83129497|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83129498|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
83129499|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129500|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83129502|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
83129503|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
83129504|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83129505|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129506|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
83129507|NCT03810807|Osimertinib|osimertinib|mesh-list
83129508|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129509|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129510|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129511|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129512|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
83129513|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83129514|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
83129515|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83129516|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
83129517|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129518|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129519|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
83129520|NCT02058277|Aprepitant|aprepitant|mesh-list
83129521|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
83129522|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
83129523|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129524|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129525|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83129526|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83129527|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129528|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129529|NCT04813562|Vaccines|vaccines|mesh-list
83129530|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
83129531|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129532|NCT03314025|Tamsulosin|tamsulosin|mesh-list
83129533|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83129534|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83129535|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83129536|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
83129537|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129538|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129539|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129540|NCT03314025|Urological Agents|urological agents|mesh-ancestor
83129541|NCT02055079|Sirolimus|sirolimus|mesh-list
83129542|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83129543|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129544|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83129545|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83471382|NCT00003262|Epirubicin|epirubicin|mesh-list
83129546|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
83129547|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83129548|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
83129549|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129550|NCT02470065|Afatinib|afatinib|mesh-list
83129551|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129552|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129553|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129554|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129555|NCT03313869|Vitamin E|vitamin e|mesh-list
83129556|NCT03313869|Selenium|selenium|mesh-list
83129557|NCT03313869|Vitamins|vitamins|mesh-ancestor
83129558|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
83129559|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129560|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
83129561|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129562|NCT03313869|Protective Agents|protective agents|mesh-ancestor
83129563|NCT03313869|Trace Elements|trace elements|mesh-ancestor
83129564|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83129565|NCT00705159|Tobramycin|tobramycin|mesh-list
83129566|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83129567|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129568|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83129569|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83129570|NCT01673984|Goserelin|goserelin|mesh-list
83129571|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
83129572|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83129573|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
83129574|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83129575|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129576|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83129577|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83129578|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129579|NCT03313791|Caseins|caseins|mesh-list
83129580|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
83129581|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
83129582|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129583|NCT03310047|Lidocaine|lidocaine|mesh-list
83129584|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
83129585|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
83129586|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129587|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129588|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
83129589|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129590|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83129591|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83129592|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83129593|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129594|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129595|NCT03313557|Adavosertib|adavosertib|mesh-list
83129596|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129597|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129598|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
83129599|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83129600|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129601|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
83129602|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83129603|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129604|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129605|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83129606|NCT03313479|Analgesics|analgesics|mesh-ancestor
83129607|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
83129608|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129609|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83129610|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83129611|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83129612|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83129613|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129614|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129615|NCT04079738|Ixazomib|ixazomib|mesh-list
83129616|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129617|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
83129618|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129619|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129620|NCT03313401|Aflibercept|aflibercept|mesh-list
83129621|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83129622|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83129623|NCT03313401|Growth Substances|growth substances|mesh-ancestor
83129624|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129625|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
83129626|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129627|NCT05278065|Nicotine|nicotine|mesh-list
83129628|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83129629|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
83129630|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129631|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129632|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83129633|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83129634|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
83129635|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129636|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129637|NCT03313323|Ipilimumab|ipilimumab|mesh-list
83129638|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83129639|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129640|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83129641|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129642|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83129643|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
83129644|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83129645|NCT05302232|Prednisolone|prednisolone|mesh-list
83129646|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
83129647|NCT05302232|Lidocaine|lidocaine|mesh-list
83129648|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83129649|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
83129650|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
83129651|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
83129652|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129653|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129654|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
83129655|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129656|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83129657|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83129658|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83129659|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129660|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129661|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83129662|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
83129663|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
83129664|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83129665|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
83129666|NCT05302232|Hormones|hormones|mesh-ancestor
83129667|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129668|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83129669|NCT05302232|Protective Agents|protective agents|mesh-ancestor
83129670|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83129671|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129672|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83129673|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129674|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83129675|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129676|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129677|NCT03304431|Lidocaine|lidocaine|mesh-list
83129678|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
83129679|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
83129680|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129681|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129682|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
83129683|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129684|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83129685|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83129686|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83129687|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129688|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129689|NCT04741334|Anticoagulants|anticoagulants|mesh-list
83129690|NCT04741334|Dicumarol|dicumarol|mesh-list
83129691|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83129692|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129693|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129694|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
83129695|NCT03309735|Progesterone|progesterone|mesh-list
83129696|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
83129697|NCT03309735|Progestins|progestins|mesh-ancestor
83129698|NCT03309735|Hormones|hormones|mesh-ancestor
83129699|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129700|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129701|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83129702|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
83129703|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129704|NCT02926586|Cytarabine|cytarabine|mesh-list
83129705|NCT02926586|Fludarabine|fludarabine|mesh-list
83129706|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129707|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83129708|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
83129709|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129710|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83129711|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
83129712|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129713|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
83129714|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129715|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
83129716|NCT04490967|Salicylates|salicylates|mesh-list
83129717|NCT04490967|Silybin|silybin|mesh-list
83129718|NCT04490967|Silymarin|silymarin|mesh-list
83129719|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
83129720|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129721|NCT04490967|Protective Agents|protective agents|mesh-ancestor
83129722|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129723|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129724|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
83129725|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
83129726|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
83129727|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83129728|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83129729|NCT04490967|Analgesics|analgesics|mesh-ancestor
83129730|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
83129731|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129732|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83129733|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129734|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83129735|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129736|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83129737|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129738|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83129739|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
83129740|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129741|NCT03312777|Tramadol|tramadol|mesh-list
83129742|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83129743|NCT03312777|Narcotics|narcotics|mesh-ancestor
83129744|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129745|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129746|NCT03312777|Analgesics|analgesics|mesh-ancestor
83129747|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
83129748|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129749|NCT02332928|Melatonin|melatonin|mesh-list
83129750|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
83129751|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129752|NCT02332928|Protective Agents|protective agents|mesh-ancestor
83129753|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129754|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129755|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83129756|NCT03738878|Valsartan|valsartan|mesh-list
83129757|NCT03738878|Bradykinin|bradykinin|mesh-list
83129758|NCT03738878|Kininogens|kininogens|mesh-list
83129759|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83129760|NCT03738878|Substance P|substance p|mesh-list
83129761|NCT03738878|Neurokinin A|neurokinin a|mesh-list
83129762|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83129763|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129764|NCT03738878|Incretins|incretins|mesh-ancestor
83129765|NCT03738878|Hormones|hormones|mesh-ancestor
83129766|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129767|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83129768|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
83129769|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129770|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129771|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83129772|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83129773|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83129774|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
83129775|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83129776|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129777|NCT04682834|Probenecid|probenecid|mesh-list
83129778|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
83129779|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
83129780|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129781|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
83129782|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
83129783|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83129784|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129785|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129786|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
83129787|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83129788|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129789|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129790|NCT05426252|Sirolimus|sirolimus|mesh-list
83129791|NCT05426252|Abatacept|abatacept|mesh-list
83129792|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83129793|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129794|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83129795|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129796|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
83129797|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83129798|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
83129799|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129800|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129801|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83129802|NCT05426252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83129803|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83129804|NCT01506986|Metronidazole|metronidazole|mesh-list
83129805|NCT01506986|Clarithromycin|clarithromycin|mesh-list
83129806|NCT01506986|Lansoprazole|lansoprazole|mesh-list
83129807|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
83129808|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129809|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83129810|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83129811|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83129812|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83129813|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129814|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129815|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83129816|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83129817|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83129818|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83129819|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83129820|NCT05422664|Lacosamide|lacosamide|mesh-list
83129821|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
83129822|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83129823|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83129824|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129825|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129826|NCT02714894|Clozapine|clozapine|mesh-list
83129827|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83129828|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
83129829|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129830|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129831|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129832|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83129833|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83129834|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129835|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83129836|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
83129837|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
83129838|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
83129839|NCT03303651|Narcotics|narcotics|mesh-ancestor
83129840|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129841|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129842|NCT03303651|Analgesics|analgesics|mesh-ancestor
83129843|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
83129844|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129845|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83129846|NCT03312153|Eusol|eusol|mesh-list
83129847|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
83129848|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129849|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
83129850|NCT03303573|Hematinics|hematinics|mesh-ancestor
83129851|NCT03303495|Leucovorin|leucovorin|mesh-list
83129852|NCT03303495|Bevacizumab|bevacizumab|mesh-list
83129853|NCT03303495|Fluorouracil|fluorouracil|mesh-list
83129854|NCT03303495|Irinotecan|irinotecan|mesh-list
83129855|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83129856|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83129857|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83129858|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83129859|NCT03303495|Growth Substances|growth substances|mesh-ancestor
83129860|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129861|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
83129862|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
83129863|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129864|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83129865|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83129866|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
83129867|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83129868|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83129869|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129870|NCT03303495|Antidotes|antidotes|mesh-ancestor
83129871|NCT03303495|Protective Agents|protective agents|mesh-ancestor
83129872|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
83129873|NCT03303495|Vitamins|vitamins|mesh-ancestor
83129874|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
83129875|NCT03308955|Tramadol|tramadol|mesh-list
83129876|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83129877|NCT03308955|Narcotics|narcotics|mesh-ancestor
83129878|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129879|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129880|NCT03308955|Analgesics|analgesics|mesh-ancestor
83129881|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
83129882|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129883|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83129884|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
83129885|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129886|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83129887|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83129888|NCT03308643|Oxytocin|oxytocin|mesh-list
83129889|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
83129890|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83129891|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129892|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
83129893|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83129894|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83129895|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83129896|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129897|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129898|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
83129899|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129900|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129901|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83129902|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129903|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83129904|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83129905|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129906|NCT03308487|Vitamin D|vitamin d|mesh-list
83129907|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
83129908|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
83129909|NCT03308487|Vitamins|vitamins|mesh-list
83129910|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
83129911|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129912|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83129913|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83129914|NCT03308331|Nicotine|nicotine|mesh-list
83129915|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83129916|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
83129917|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129918|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129919|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83129920|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83129921|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
83129922|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129923|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129924|NCT02414854|Albuterol|albuterol|mesh-list
83129925|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83129926|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
83129927|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129928|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129929|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83129930|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
83129931|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
83129932|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83129933|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83129934|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83129935|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83129936|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
83129937|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129938|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129939|NCT03308253|Vancomycin|vancomycin|mesh-list
83129940|NCT03308253|Tobramycin|tobramycin|mesh-list
83129941|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83129942|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129943|NCT02467023|Lidocaine|lidocaine|mesh-list
83129945|NCT02467023|Midazolam|midazolam|mesh-list
83129946|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
83129947|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
83129948|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83129949|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129950|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
83129951|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83129952|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83129953|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83129954|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83129955|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83129956|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129957|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83129958|NCT02467023|Narcotics|narcotics|mesh-ancestor
83129959|NCT02467023|Analgesics|analgesics|mesh-ancestor
83129960|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83129961|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83129962|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
83129963|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83129964|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83129965|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83129966|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83129967|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
83129968|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
83129969|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129970|NCT02055703|Itraconazole|itraconazole|mesh-list
83129971|NCT02055703|Rifampin|rifampin|mesh-list
83129972|NCT02055703|Digoxin|digoxin|mesh-list
83129973|NCT02055703|Donepezil|donepezil|mesh-list
83129974|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
83129975|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83129976|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83129977|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83129978|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83129979|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83129980|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83129981|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
83129982|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83129983|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83129984|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83129985|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83129986|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
83129987|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83129988|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
83129989|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83129990|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
83129991|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83129992|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
83129993|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83129994|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83129995|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83129996|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83129997|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83129998|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83129999|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83130000|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83130001|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83130002|NCT02055703|Protective Agents|protective agents|mesh-ancestor
83130003|NCT02058433|Paclitaxel|paclitaxel|mesh-list
83130004|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83130005|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83130006|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130007|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
83130008|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
83130009|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
83130010|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130011|NCT03561181|Vaccines|vaccines|mesh-list
83130012|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
83130013|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130014|NCT02060149|Minocycline|minocycline|mesh-list
83130015|NCT02060149|Sulbactam|sulbactam|mesh-list
83130016|NCT02060149|Cefoperazone|cefoperazone|mesh-list
83130017|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83130018|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83130019|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130020|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83130021|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83482698|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83130022|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130023|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
83130024|NCT03302403|Fludarabine|fludarabine|mesh-list
83130025|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130026|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
83130027|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130028|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130029|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83130030|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
83130031|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130032|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130033|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83130035|NCT02038621|Capecitabine|capecitabine|mesh-list
83130036|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
83130037|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83130038|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130039|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
83130040|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
83130041|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
83130042|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130043|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130044|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
83130045|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
83130046|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130047|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130048|NCT03332498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83130049|NCT03332498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130050|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
83130051|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83130052|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130053|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130054|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130055|NCT05727969|Analgesics|analgesics|mesh-ancestor
83130056|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
83130057|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130058|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83130059|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83130060|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83130061|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
83130062|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130063|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130064|NCT01334125|Metformin|metformin|mesh-list
83130065|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130066|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130067|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83130068|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130069|NCT01333501|Interferons|interferons|mesh-list
83130070|NCT01333501|Interferon-beta|interferon-beta|mesh-list
83130071|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83130072|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
83130073|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130074|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
83130075|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130076|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
83130077|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130078|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83130079|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130080|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130081|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83130082|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
83130083|NCT01362140|Hematinics|hematinics|mesh-ancestor
83130084|NCT03307941|Fluorouracil|fluorouracil|mesh-list
83130085|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
83130086|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
83130087|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130088|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130089|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130090|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130091|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
83130092|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130093|NCT03307863|Topiramate|topiramate|mesh-list
83130094|NCT03307863|Carbamazepine|carbamazepine|mesh-list
83130095|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
83130096|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130097|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130098|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
83130099|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83130100|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130101|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83130102|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130103|NCT03307863|Analgesics|analgesics|mesh-ancestor
83130104|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
83130105|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130106|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83130107|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83130108|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130109|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83130110|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83130111|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
83130112|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83130113|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130114|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130115|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130116|NCT04656470|Analgesics|analgesics|mesh-ancestor
83130117|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
83130118|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130119|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83130120|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83130121|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83130122|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
83130123|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130124|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130125|NCT05391074|Vitamins|vitamins|mesh-list
83130126|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
83130127|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130128|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
83130129|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130130|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130131|NCT02467647|Thalidomide|thalidomide|mesh-list
83130132|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130133|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
83130134|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130135|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
83130136|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83130137|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130138|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83130139|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83130140|NCT02467647|Growth Substances|growth substances|mesh-ancestor
83130141|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
83130142|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130143|NCT03263936|Cytarabine|cytarabine|mesh-list
83130144|NCT03263936|Fludarabine|fludarabine|mesh-list
83130145|NCT03263936|Decitabine|decitabine|mesh-list
83130146|NCT03263936|Vorinostat|vorinostat|mesh-list
83130147|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130148|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130149|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
83130150|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130151|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130152|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
83130153|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130154|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
83130155|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130156|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130157|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83130158|NCT03307551|Propofol|propofol|mesh-list
83130159|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83130160|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130161|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130162|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83130163|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
83130164|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
83130165|NCT02060305|Bevacizumab|bevacizumab|mesh-list
83130166|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130168|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83130169|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83130170|NCT02060305|Growth Substances|growth substances|mesh-ancestor
83130171|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130172|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
83130173|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83130174|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83130175|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130176|NCT02059759|Aldesleukin|aldesleukin|mesh-list
83130177|NCT02059759|Interleukin-2|interleukin-2|mesh-list
83130178|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130179|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130180|NCT02059759|Analgesics|analgesics|mesh-ancestor
83130181|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
83130182|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130183|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130184|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83130185|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83130186|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
83130187|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130188|NCT03103022|Acetaminophen|acetaminophen|mesh-list
83130189|NCT03103022|Ibuprofen|ibuprofen|mesh-list
83130190|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130191|NCT03103022|Analgesics|analgesics|mesh-ancestor
83130192|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
83130193|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130194|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130195|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
83130196|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83130197|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130198|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130199|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83130200|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130201|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130202|NCT00702507|Miconazole|miconazole|mesh-list
83130203|NCT00702507|Clotrimazole|clotrimazole|mesh-list
83130204|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
83130205|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130206|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83130207|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83130208|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130209|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130210|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83130211|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83130212|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130213|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130214|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83130215|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83130216|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83130217|NCT03324932|Denosumab|denosumab|mesh-list
83130218|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83130219|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130220|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
83130221|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130222|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130223|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
83130224|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83130225|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83130226|NCT03301233|Estradiol|estradiol|mesh-list
83130227|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83130228|NCT03301233|Estrogens|estrogens|mesh-ancestor
83130229|NCT03301233|Hormones|hormones|mesh-ancestor
83130230|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130231|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130232|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83130233|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
83130234|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83130235|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83130236|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
83130237|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83471518|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83130238|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83130239|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130240|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130241|NCT03301233|Urological Agents|urological agents|mesh-ancestor
83130242|NCT02581748|Trastuzumab|trastuzumab|mesh-list
83130243|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130244|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130245|NCT01003028|Remifentanil|remifentanil|mesh-list
83130246|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83130247|NCT01003028|Narcotics|narcotics|mesh-ancestor
83130248|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130249|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130250|NCT01003028|Analgesics|analgesics|mesh-ancestor
83130251|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
83130252|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130253|NCT03113942|Thalidomide|thalidomide|mesh-list
83130254|NCT03113942|Pomalidomide|pomalidomide|mesh-list
83130255|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
83130256|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130257|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83130258|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83130259|NCT03113942|Growth Substances|growth substances|mesh-ancestor
83130260|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
83130261|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130262|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130263|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
83130264|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83130265|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130266|NCT04786340|Pirenzepine|pirenzepine|mesh-list
83130267|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83130268|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83130269|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83130270|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83130271|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83130272|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130273|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130274|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130275|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130276|NCT03104270|Dexamethasone|dexamethasone|mesh-list
83130277|NCT03104270|Pomalidomide|pomalidomide|mesh-list
83130278|NCT03104270|Elotuzumab|elotuzumab|mesh-list
83130279|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130280|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
83130281|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
83130282|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130283|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130284|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83130285|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
83130286|NCT03104270|Hormones|hormones|mesh-ancestor
83130287|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130288|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83130289|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130290|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
83130291|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83130292|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83130293|NCT03104270|Growth Substances|growth substances|mesh-ancestor
83130294|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
83130295|NCT03300765|Apatinib|apatinib|mesh-list
83130296|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130297|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83130298|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471525|NCT00003274|Sargramostim|sargramostim|mesh-list
83130299|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130300|NCT04064918|Timolol|timolol|mesh-list
83130301|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130302|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83130303|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83130304|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83130305|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130306|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130307|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83130308|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83130309|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83130310|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83130311|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83130312|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
83130313|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130314|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130315|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130316|NCT02467946|Immunotoxins|immunotoxins|mesh-ancestor
83130317|NCT02467946|Immunoconjugates|immunoconjugates|mesh-ancestor
83130318|NCT02467946|Immunologic Factors|immunologic factors|mesh-ancestor
83130319|NCT02467946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130320|NCT04688294|Valsartan|valsartan|mesh-list
83130321|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83130322|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83130323|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83130324|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83130325|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130326|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
83130327|NCT03300609|Leucovorin|leucovorin|mesh-list
83130328|NCT03300609|Folic Acid|folic acid|mesh-list
83130329|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
83130330|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83130331|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83130332|NCT03300609|Panitumumab|panitumumab|mesh-list
83130333|NCT03300609|Fluorouracil|fluorouracil|mesh-list
83130334|NCT03300609|Capecitabine|capecitabine|mesh-list
83130335|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
83130336|NCT03300609|Antibodies|antibodies|mesh-list
83130337|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
83130338|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83130339|NCT03300609|Calcium|calcium|mesh-list
83130340|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
83130341|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
83130342|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130343|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130344|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83130345|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83130346|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
83130347|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130348|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130349|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130350|NCT03300609|Antidotes|antidotes|mesh-ancestor
83130351|NCT03300609|Protective Agents|protective agents|mesh-ancestor
83130352|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
83130353|NCT03300609|Vitamins|vitamins|mesh-ancestor
83130354|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
83130355|NCT03300609|Hematinics|hematinics|mesh-ancestor
83130356|NCT00583778|Ipratropium|ipratropium|mesh-list
83130357|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83130358|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
83130359|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130360|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130361|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83471542|NCT00003718|Temozolomide|temozolomide|mesh-list
83130362|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
83130363|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83130364|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130365|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130366|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130367|NCT03300531|Betamethasone|betamethasone|mesh-list
83130368|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130369|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
83130370|NCT03300531|Hormones|hormones|mesh-ancestor
83130371|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130372|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130373|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83130374|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
83130375|NCT02467335|Fostemsavir|fostemsavir|mesh-list
83130376|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83130377|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83130378|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
83130379|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130380|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83130381|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83130382|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130383|NCT02809820|Metoprolol|metoprolol|mesh-list
83130384|NCT02809820|Carvedilol|carvedilol|mesh-list
83130385|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83130386|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83130387|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83130388|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
83130389|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
83130390|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130391|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130392|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83130394|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
83130395|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130396|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130397|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
83130398|NCT02809820|Protective Agents|protective agents|mesh-ancestor
83130399|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83130400|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83130401|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83130402|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
83130403|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83130404|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83130405|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
83130406|NCT04491357|Calcium|calcium|mesh-list
83130407|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83130408|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130409|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83130410|NCT01673594|Naltrexone|naltrexone|mesh-list
83130411|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83130412|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83130413|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130414|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
83130415|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130416|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83130417|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130418|NCT02786498|Vitamin D|vitamin d|mesh-list
83130419|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
83130420|NCT02786498|Vitamins|vitamins|mesh-ancestor
83130421|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
83130422|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130423|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83130424|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83130425|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83130426|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83130427|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130428|NCT02597660|Hormones|hormones|mesh-list
83130429|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130430|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130431|NCT02419664|Edotreotide|edotreotide|mesh-list
83130432|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83130433|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130434|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
83130435|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130436|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130437|NCT04435574|Lactoferrin|lactoferrin|mesh-list
83130438|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130439|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
83130440|NCT03104426|Hematinics|hematinics|mesh-ancestor
83130441|NCT02163356|Ketoconazole|ketoconazole|mesh-list
83130442|NCT02163356|Vincristine|vincristine|mesh-list
83130443|NCT02163356|Fenretinide|fenretinide|mesh-list
83130444|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83130445|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130446|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83130447|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83130448|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83130449|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130450|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
83130451|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130452|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83130453|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83130454|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130455|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83130456|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
83130457|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130458|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130459|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83130460|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83130461|NCT02163356|Protective Agents|protective agents|mesh-ancestor
83130462|NCT02021006|Amoxicillin|amoxicillin|mesh-list
83130463|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
83130464|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
83130465|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83130467|NCT02021006|Cefixime|cefixime|mesh-list
83130468|NCT02021006|Trimethoprim|trimethoprim|mesh-list
83130469|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
83130470|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83130471|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130472|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83130473|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
83130474|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83130475|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83130476|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83130477|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130478|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130479|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83130480|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83130481|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83130482|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83130483|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
83130484|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83130485|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
83130486|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
83130487|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130488|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130489|NCT03867110|Atorvastatin|atorvastatin|mesh-list
83130491|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83130492|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83130493|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
83471565|NCT00384202|Tacrolimus|tacrolimus|mesh-list
83130494|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130495|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83130496|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83130497|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130498|NCT03865082|Nivolumab|nivolumab|mesh-list
83130499|NCT03865082|Ipilimumab|ipilimumab|mesh-list
83130500|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130501|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130502|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83130503|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130504|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83130505|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
83130506|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83130507|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83130508|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130509|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130510|NCT03102398|Urological Agents|urological agents|mesh-ancestor
83130511|NCT01187810|Cytarabine|cytarabine|mesh-list
83130512|NCT01187810|Methotrexate|methotrexate|mesh-list
83130513|NCT01187810|Fenretinide|fenretinide|mesh-list
83130514|NCT01187810|Retinamide|retinamide|mesh-list
83130515|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83130516|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
83130517|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83130518|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130519|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130520|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
83130521|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130522|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130523|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83130524|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130525|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83130526|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130527|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
83130528|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130529|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83130530|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
83130531|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130532|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83130533|NCT01187810|Protective Agents|protective agents|mesh-ancestor
83130534|NCT03104036|Mesalamine|mesalamine|mesh-list
83130535|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83130536|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130537|NCT03104036|Analgesics|analgesics|mesh-ancestor
83130538|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
83130539|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130540|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130541|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130542|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130543|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
83130544|NCT03449888|Calcium|calcium|mesh-list
83130545|NCT03449888|Regadenoson|regadenoson|mesh-list
83130546|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83130547|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130548|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83130549|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83130550|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83130551|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
83130552|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
83130553|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130554|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130555|NCT03308396|Durvalumab|durvalumab|mesh-list
83130556|NCT03308396|Guadecitabine|guadecitabine|mesh-list
83130557|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130558|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130559|NCT02720523|Upadacitinib|upadacitinib|mesh-list
83130560|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83130561|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83130562|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130563|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130564|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130565|NCT02646332|Amoxicillin|amoxicillin|mesh-list
83130566|NCT02646332|Metronidazole|metronidazole|mesh-list
83130567|NCT02646332|Clarithromycin|clarithromycin|mesh-list
83130568|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
83130569|NCT02646332|Lansoprazole|lansoprazole|mesh-list
83130570|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83130571|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130572|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83130573|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83130574|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83130575|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130576|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130577|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83130578|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83130579|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83130580|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83130581|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83130582|NCT00015002|Betamethasone|betamethasone|mesh-list
83130583|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130584|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
83130585|NCT00015002|Hormones|hormones|mesh-ancestor
83130586|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130587|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130588|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83130589|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
83130590|NCT03103412|Tofacitinib|tofacitinib|mesh-list
83130591|NCT03103412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83130592|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83130593|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130594|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130595|NCT02061007|Misonidazole|misonidazole|mesh-list
83130596|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130597|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83130598|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83130599|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130600|NCT02086604|Lenalidomide|lenalidomide|mesh-list
83130601|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83130602|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
83130603|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130604|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83130605|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83130606|NCT02086604|Growth Substances|growth substances|mesh-ancestor
83130607|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
83130608|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130609|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130610|NCT02086604|Immunotoxins|immunotoxins|mesh-ancestor
83130611|NCT02086604|Immunoconjugates|immunoconjugates|mesh-ancestor
83130612|NCT03103568|Tolbutamide|tolbutamide|mesh-list
83130613|NCT03103568|Metoprolol|metoprolol|mesh-list
83130614|NCT03103568|Furosemide|furosemide|mesh-list
83130615|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
83130616|NCT03103568|Nitisinone|nitisinone|mesh-list
83130617|NCT03103568|Diuretics|diuretics|mesh-ancestor
83130618|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
83130619|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130620|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83130621|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83130622|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130623|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83130624|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83130625|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
83130626|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
83130627|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130628|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83130629|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83130630|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83130631|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
83130632|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130633|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130634|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130635|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83130636|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83130637|NCT05654467|Vaccines|vaccines|mesh-list
83130638|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
83130639|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130640|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83130641|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83130642|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130643|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
83130644|NCT02925195|Vitamin D|vitamin d|mesh-list
83130645|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
83130646|NCT02925195|Vitamins|vitamins|mesh-ancestor
83130647|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
83130648|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130649|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83130650|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83130651|NCT03103646|Itraconazole|itraconazole|mesh-list
83130652|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83130653|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
83130654|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130655|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83130656|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83130657|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130658|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130659|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83130660|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
83130661|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130662|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130663|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83130664|NCT01554410|Gemcitabine|gemcitabine|mesh-list
83130665|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130666|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130667|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
83130668|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130669|NCT01499888|Sirolimus|sirolimus|mesh-list
83130670|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
83130671|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83130672|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83130673|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83130674|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130675|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
83130676|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130677|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
83130678|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130679|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130680|NCT03299829|Trientine|trientine|mesh-list
83130681|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
83130682|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
83130683|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130684|NCT04968158|Acetaminophen|acetaminophen|mesh-list
83130685|NCT04968158|Etoricoxib|etoricoxib|mesh-list
83130686|NCT04968158|Tramadol|tramadol|mesh-list
83130687|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130688|NCT04968158|Analgesics|analgesics|mesh-ancestor
83130689|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
83130690|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130691|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130692|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
83130693|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83130694|NCT04968158|Narcotics|narcotics|mesh-ancestor
83130695|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130696|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83471587|NCT04329130|Growth Substances|growth substances|mesh-ancestor
83130697|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130698|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130699|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83130700|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83130701|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130702|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130703|NCT02059915|Oxycodone|oxycodone|mesh-list
83130704|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83130705|NCT02059915|Narcotics|narcotics|mesh-ancestor
83130706|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130707|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130708|NCT02059915|Analgesics|analgesics|mesh-ancestor
83130709|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
83130710|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130711|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
83130712|NCT02471404|Glimepiride|glimepiride|mesh-list
83130713|NCT02471404|Saxagliptin|saxagliptin|mesh-list
83130714|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83130715|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130716|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130717|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130718|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83130719|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130720|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
83130721|NCT02471404|Incretins|incretins|mesh-ancestor
83130722|NCT02471404|Hormones|hormones|mesh-ancestor
83130723|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83130724|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83130725|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
83130726|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130727|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
83130728|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130729|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
83130730|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83130731|NCT02061475|Lidocaine|lidocaine|mesh-list
83130732|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
83130733|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
83130734|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130735|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130736|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
83130737|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130738|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83130739|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83130740|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83130741|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83130742|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130743|NCT03100994|Bupivacaine|bupivacaine|mesh-list
83130744|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
83130745|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
83130746|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130747|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130748|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
83130749|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130750|NCT04160936|Bupivacaine|bupivacaine|mesh-list
83130751|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
83130752|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
83130753|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130754|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130755|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
83130756|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130757|NCT03103334|Methotrexate|methotrexate|mesh-list
83130758|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83130759|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
83130760|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83130761|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130762|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130763|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
83130764|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130765|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130766|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
83130767|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130768|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83130769|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130770|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
83130771|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130772|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83130773|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83130774|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
83130775|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130776|NCT00795158|Desloratadine|desloratadine|mesh-list
83130777|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83130778|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130779|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130780|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130781|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130782|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83130783|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83130784|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
83130785|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
83130786|NCT02063269|Rivastigmine|rivastigmine|mesh-list
83130787|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83130788|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130789|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130790|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130791|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130792|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130793|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83130794|NCT02063269|Protective Agents|protective agents|mesh-ancestor
83130795|NCT00794846|Cetirizine|cetirizine|mesh-list
83130796|NCT00794846|Desloratadine|desloratadine|mesh-list
83130797|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83130798|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83130799|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83130800|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
83130801|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
83130802|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130803|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130804|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130805|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83130806|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130807|NCT00794768|Fexofenadine|fexofenadine|mesh-list
83130808|NCT00794768|Desloratadine|desloratadine|mesh-list
83130809|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83130810|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130811|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130812|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130813|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130814|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83130815|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83130816|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
83130817|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
83130818|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83130820|NCT02060851|Trace Elements|trace elements|mesh-ancestor
83130821|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
83130822|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130823|NCT00779636|Desloratadine|desloratadine|mesh-list
83130824|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83130825|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130826|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130827|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130828|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130829|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83130830|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83130831|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
83130832|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
83130833|NCT02060929|Esketamine|esketamine|mesh-list
83130834|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
83130835|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83130836|NCT00757562|Desloratadine|desloratadine|mesh-list
83130837|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83130838|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
83130839|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83130840|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130841|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130842|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83130843|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83130844|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
83130845|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
83130847|NCT03299517|Amiodarone|amiodarone|mesh-list
83130848|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83130849|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
83130851|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130852|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130853|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
83130854|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130855|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83130856|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83130857|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83130858|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130859|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
83130860|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83130861|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83130862|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83130863|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130864|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83130865|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83130866|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83130867|NCT00651404|Ezetimibe|ezetimibe|mesh-list
83130868|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83130869|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83130870|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
83130871|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130872|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83130873|NCT00651014|Ezetimibe|ezetimibe|mesh-list
83130874|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83130875|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83130876|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
83130877|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130878|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83130879|NCT04435418|Apixaban|apixaban|mesh-list
83130880|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83130881|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
83130882|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83130883|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
83130884|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130885|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130886|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
83130887|NCT02062255|Aspirin|aspirin|mesh-list
83130888|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83130889|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83130890|NCT02062255|Analgesics|analgesics|mesh-ancestor
83130891|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
83130892|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83130893|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130894|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83130895|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83130896|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83130897|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83130898|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130899|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83130900|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83130901|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130902|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
83130903|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83130904|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
83130905|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83130906|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
83130907|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130908|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
83130909|NCT05547243|Vaccines|vaccines|mesh-list
83130910|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
83130911|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130912|NCT03100604|Sevoflurane|sevoflurane|mesh-list
83130913|NCT03100604|Desflurane|desflurane|mesh-list
83130914|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83130915|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83130916|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
83130917|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
83130918|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83130919|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130920|NCT00398294|Simvastatin|simvastatin|mesh-list
83130921|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83130922|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83130923|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
83130924|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130925|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83130926|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83130927|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130928|NCT04823403|Nivolumab|nivolumab|mesh-list
83130929|NCT04823403|Ipilimumab|ipilimumab|mesh-list
83130930|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130931|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130932|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83130933|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130934|NCT03493646|Azacitidine|azacitidine|mesh-list
83130935|NCT03493646|Cc-486|cc-486|mesh-list
83130936|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130937|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
83130938|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130939|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130940|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130941|NCT05519865|Tislelizumab|tislelizumab|mesh-list
83130942|NCT05519865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130943|NCT05519865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130944|NCT05500443|Vitamin K|vitamin k|mesh-list
83130945|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
83130946|NCT05500443|Menaquinone 7|menaquinone 7|mesh-list
83130947|NCT05500443|Vitamins|vitamins|mesh-ancestor
83130948|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
83130949|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130950|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83130951|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83130952|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130953|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
83130954|NCT05500443|Coagulants|coagulants|mesh-ancestor
83130955|NCT05244200|Insulin|insulin|mesh-list
83130956|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130957|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130958|NCT03451370|Bevacizumab|bevacizumab|mesh-list
83130959|NCT03451370|Capecitabine|capecitabine|mesh-list
83130960|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
83130961|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130962|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130963|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83130964|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83130965|NCT03451370|Growth Substances|growth substances|mesh-ancestor
83130966|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130967|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
83130968|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83130969|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
83130970|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130971|NCT03991832|Durvalumab|durvalumab|mesh-list
83130972|NCT03991832|Olaparib|olaparib|mesh-list
83130973|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83130974|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83130975|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83130976|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83130977|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130978|NCT01361594|Insulin|insulin|mesh-list
83130979|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83130980|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83130981|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130982|NCT04435028|Ketotifen|ketotifen|mesh-list
83130983|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
83130984|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83130985|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83130986|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
83130989|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83130990|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130991|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83130992|NCT03945812|Lenograstim|lenograstim|mesh-list
83130993|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83130994|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
83130995|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83130996|NCT05060198|Lumefantrine|lumefantrine|mesh-list
83130997|NCT05060198|Artemether|artemether|mesh-list
83130998|NCT05060198|Piperaquine|piperaquine|mesh-list
83493760|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
83130999|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83131000|NCT05060198|Artenimol|artenimol|mesh-list
83131001|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
83131002|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83131003|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83131004|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131005|NCT04478084|Vaccines|vaccines|mesh-list
83131006|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
83131007|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83131008|NCT04478084|Antibodies|antibodies|mesh-list
83131009|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
83131010|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131011|NCT03098888|Dimercaprol|dimercaprol|mesh-list
83131012|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
83131013|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
83131014|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131015|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
83131016|NCT03098810|Astringents|astringents|mesh-ancestor
83131017|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131018|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83131019|NCT02464761|Verteporfin|verteporfin|mesh-list
83131020|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83131021|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83131022|NCT02462889|Aflibercept|aflibercept|mesh-list
83131023|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83131024|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83131025|NCT02462889|Growth Substances|growth substances|mesh-ancestor
83131026|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131027|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
83131028|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131029|NCT02462577|Morphine|morphine|mesh-list
83131030|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83131031|NCT02462577|Narcotics|narcotics|mesh-ancestor
83131032|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83471625|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131033|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131034|NCT02462577|Analgesics|analgesics|mesh-ancestor
83131035|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
83131036|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131037|NCT02462499|Eplerenone|eplerenone|mesh-list
83131038|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83131039|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83131040|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131041|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131042|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83131043|NCT02462499|Diuretics|diuretics|mesh-ancestor
83131044|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
83131045|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83131046|NCT02464683|Vitamin D|vitamin d|mesh-list
83131047|NCT02464683|Vitamins|vitamins|mesh-ancestor
83131048|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
83131049|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131050|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83131051|NCT02061631|Dexamethasone|dexamethasone|mesh-list
83131052|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
83131053|NCT02061631|Docetaxel|docetaxel|mesh-list
83131054|NCT02061631|BB 1101|bb 1101|mesh-list
83131055|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131056|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
83131057|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
83131058|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131059|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131060|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83131061|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
83131062|NCT02061631|Hormones|hormones|mesh-ancestor
83131063|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131064|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83131065|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131066|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
83131067|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131068|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131069|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
83131070|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
83131071|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
83131072|NCT03098342|Amorolfine|amorolfine|mesh-list
83131073|NCT03098342|Methylene Blue|methylene blue|mesh-list
83131074|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131075|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131076|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
83131077|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131078|NCT05059418|Clonazepam|clonazepam|mesh-list
83131079|NCT05059418|Capsaicin|capsaicin|mesh-list
83131080|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
83131081|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
83131082|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
83131083|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131084|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131085|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
83131086|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
83131087|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
83131088|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131089|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131090|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
83131091|NCT02062333|Esmolol|esmolol|mesh-list
83131092|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83131093|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131094|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131095|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83131096|NCT02062333|Analgesics|analgesics|mesh-ancestor
83131097|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
83131098|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131099|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83131100|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83131101|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83131102|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
83131103|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131104|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131105|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83131106|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83131107|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83131108|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
83131109|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83131110|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
83131111|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131112|NCT05010668|Lenvatinib|lenvatinib|mesh-list
83131113|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131114|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83131115|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131116|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131117|NCT02063425|Fluoxetine|fluoxetine|mesh-list
83131118|NCT02063425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83131119|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83131120|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83131121|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131122|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131123|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
83131124|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131125|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83131126|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
83131127|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131128|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83131129|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83131130|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131131|NCT05071118|Pregabalin|pregabalin|mesh-list
83131132|NCT05071118|Analgesics|analgesics|mesh-ancestor
83131133|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
83131134|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131135|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131136|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
83131137|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83131139|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131140|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83131141|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83131142|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131143|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131144|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131145|NCT03559400|Gentamicins|gentamicins|mesh-list
83131146|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83131147|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131148|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83131149|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131150|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131152|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83131153|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83131154|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131155|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83131156|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131157|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
83131158|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
83131159|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131160|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131161|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131162|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
83131163|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131164|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131165|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131166|NCT05069870|Itraconazole|itraconazole|mesh-list
83131167|NCT05069870|Rifampin|rifampin|mesh-list
83131168|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
83131169|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
83131170|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131171|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83131172|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83131173|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131174|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131175|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83131176|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
83131177|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131178|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131179|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83131180|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83131181|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
83131182|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83131183|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
83131184|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83131185|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83131186|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83131187|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83131188|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83131189|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83131190|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83131191|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83131192|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
83131193|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83131194|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83131195|NCT05275491|Calcium|calcium|mesh-list
83131196|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
83131197|NCT05275491|Hormones|hormones|mesh-list
83131198|NCT05275491|Mitogens|mitogens|mesh-list
83131199|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83131200|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131201|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131202|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83131203|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131204|NCT04584255|Niraparib|niraparib|mesh-list
83131205|NCT04584255|Dostarlimab|dostarlimab|mesh-list
83131206|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83131207|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131208|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131209|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131210|NCT02976753|Factor VIII|factor viii|mesh-list
83131211|NCT02976753|Coagulants|coagulants|mesh-ancestor
83131212|NCT04559529|Levetiracetam|levetiracetam|mesh-list
83131213|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
83131214|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
83131215|NCT04490421|Etoposide|etoposide|mesh-list
83131216|NCT04490421|Apatinib|apatinib|mesh-list
83131217|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131218|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83131219|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83131220|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83131221|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131222|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131223|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83131224|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
83131225|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83131226|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131227|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83131228|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131229|NCT02462109|Lorazepam|lorazepam|mesh-list
83131230|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
83131231|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
83131232|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
83131233|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131234|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131235|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83131236|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83131237|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131238|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83131239|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131240|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131241|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
83131242|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
83131243|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131244|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131245|NCT02063581|Ipatasertib|ipatasertib|mesh-list
83131246|NCT02063581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131247|NCT02063581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83131248|NCT02063581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131249|NCT02063581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131250|NCT02056899|Gabapentin|gabapentin|mesh-list
83131251|NCT02056899|Analgesics|analgesics|mesh-ancestor
83131252|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
83131253|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131254|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131255|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
83131256|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83131257|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131258|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131259|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131260|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83131261|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83131262|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131263|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131264|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
83131265|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
83131266|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
83131267|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131268|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131269|NCT02462265|Analgesics|analgesics|mesh-ancestor
83131270|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
83131271|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131272|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83131273|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83131274|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131275|NCT02461875|Cabergoline|cabergoline|mesh-list
83131276|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83131277|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83131278|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
83131279|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
83131280|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131281|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131282|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131283|NCT02461719|Cyclosporine|cyclosporine|mesh-list
83131284|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83131285|NCT02461719|Cyclosporins|cyclosporins|mesh-list
83131286|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131287|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131288|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83131289|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
83131290|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83471658|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
83131291|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
83131292|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131293|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
83131294|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83131295|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83131296|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83131297|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
83131298|NCT04322643|Nivolumab|nivolumab|mesh-list
83131299|NCT04322643|Atezolizumab|atezolizumab|mesh-list
83131300|NCT04322643|Durvalumab|durvalumab|mesh-list
83131301|NCT04322643|Avelumab|avelumab|mesh-list
83131302|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83131303|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131304|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83131305|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131306|NCT02796391|Nicotine|nicotine|mesh-list
83131307|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83131308|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
83131309|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131310|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131311|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83131312|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83131313|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
83131314|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131315|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131316|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
83131317|NCT02064049|Velpatasvir|velpatasvir|mesh-list
83131318|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83131319|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
83131320|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131321|NCT02064829|Paclitaxel|paclitaxel|mesh-list
83131322|NCT02064829|genexol-PM|genexol-pm|mesh-list
83131323|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83131324|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83131325|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131326|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83131327|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83131328|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83131329|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131330|NCT02064517|Calcium|calcium|mesh-list
83131331|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83131332|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131333|NCT02067949|Simvastatin|simvastatin|mesh-list
83131334|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83131335|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83131336|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
83131337|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131338|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83131339|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83131340|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131341|NCT02068339|Oltipraz|oltipraz|mesh-list
83131342|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
83131343|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131344|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
83131345|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83131346|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
83131347|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83131348|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83131349|NCT02068339|Protective Agents|protective agents|mesh-ancestor
83131350|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131351|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131352|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83131353|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83131354|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131355|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131356|NCT02065843|Midazolam|midazolam|mesh-list
83131357|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83131358|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83471670|NCT00003742|Paclitaxel|paclitaxel|mesh-list
83131359|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131360|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131361|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83131362|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131363|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131364|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83131365|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
83131366|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
83131367|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
83131368|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
83131369|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131370|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131371|NCT02066077|Propofol|propofol|mesh-list
83131372|NCT02066077|Etomidate|etomidate|mesh-list
83131373|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83131374|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131375|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131376|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83131377|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
83131378|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
83131379|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83131380|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
83131381|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131382|NCT02065063|Palbociclib|palbociclib|mesh-list
83131383|NCT02065063|Trametinib|trametinib|mesh-list
83131384|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131385|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83131386|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131387|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131388|NCT02069197|Orlistat|orlistat|mesh-list
83131389|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131390|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131391|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83131392|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83131393|NCT02069431|Oxytocin|oxytocin|mesh-list
83131394|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
83131395|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83131396|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131397|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
83131398|NCT01652872|Hematinics|hematinics|mesh-ancestor
83131399|NCT02065219|Bupivacaine|bupivacaine|mesh-list
83131400|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
83131401|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
83131402|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131403|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131404|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
83131405|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131406|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
83131407|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83131408|NCT03560011|Antibodies|antibodies|mesh-list
83131409|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
83131410|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131411|NCT02069665|Ribavirin|ribavirin|mesh-list
83131412|NCT02069665|Ibuprofen|ibuprofen|mesh-list
83131413|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
83131414|NCT02069665|Albuterol|albuterol|mesh-list
83131415|NCT02069665|Guaifenesin|guaifenesin|mesh-list
83131416|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83131417|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
83131418|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131419|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
83131420|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131421|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83131422|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83131423|NCT02069665|Analgesics|analgesics|mesh-ancestor
83131424|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
83131425|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131426|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131427|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131428|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83131429|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83131430|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131431|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83131432|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
83131433|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83131434|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
83131435|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
83131436|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83131437|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83131438|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83131439|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83131440|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
83131441|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131442|NCT02069665|Expectorants|expectorants|mesh-ancestor
83131443|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83131444|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
83131445|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83131446|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
83131447|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
83131448|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83131449|NCT04938856|Lamotrigine|lamotrigine|mesh-list
83131450|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
83131451|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83131452|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83131453|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131454|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83131455|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131456|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83131457|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131458|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131459|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131460|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83131462|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
83131463|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
83131464|NCT02463825|Pimozide|pimozide|mesh-list
83131465|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83131466|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131467|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131468|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131469|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131470|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83131471|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
83131472|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131473|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131474|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83131475|NCT02069977|Aripiprazole|aripiprazole|mesh-list
83131476|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
83131477|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131478|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83131479|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131480|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131481|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131482|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
83131483|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
83131484|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131485|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131486|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83131487|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83131488|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
83131489|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83131490|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83131491|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83131492|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83131493|NCT04490031|Ketamine|ketamine|mesh-list
83131494|NCT04490031|Analgesics|analgesics|mesh-ancestor
83471690|NCT00004006|Etoposide|etoposide|mesh-list
83131495|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
83131496|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131497|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131498|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83131499|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83131500|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
83131501|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
83131502|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131503|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83131504|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83131505|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131506|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131507|NCT02443402|Insulin|insulin|mesh-list
83131508|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83131509|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
83131510|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83131511|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
83131512|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
83131513|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83131514|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131515|NCT02443402|Incretins|incretins|mesh-ancestor
83131516|NCT02443402|Hormones|hormones|mesh-ancestor
83131517|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131518|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83131519|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
83131520|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131521|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131522|NCT02067013|Ranibizumab|ranibizumab|mesh-list
83131523|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83131524|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83131525|NCT02067013|Growth Substances|growth substances|mesh-ancestor
83131526|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131527|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
83131528|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131529|NCT03298581|Clobetasol|clobetasol|mesh-list
83131530|NCT03298581|Halobetasol|halobetasol|mesh-list
83131531|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83131532|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131533|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
83131534|NCT03298581|Hormones|hormones|mesh-ancestor
83131535|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131536|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131537|NCT02412670|Cisplatin|cisplatin|mesh-list
83131538|NCT02412670|Carboplatin|carboplatin|mesh-list
83131539|NCT02412670|Gemcitabine|gemcitabine|mesh-list
83131540|NCT02412670|Doxorubicin|doxorubicin|mesh-list
83131541|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83131542|NCT02412670|Methotrexate|methotrexate|mesh-list
83131543|NCT02412670|Vinblastine|vinblastine|mesh-list
83131544|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131545|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83131546|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
83131547|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131548|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83131549|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83131550|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83131551|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131552|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83131553|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
83131554|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83131555|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131556|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
83131557|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83131558|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83131559|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
83131560|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83131561|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83131562|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83131563|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
83131564|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
83131565|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
83131566|NCT01370005|Empagliflozin|empagliflozin|mesh-list
83131567|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83131568|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131569|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83131570|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131571|NCT02070133|Simvastatin|simvastatin|mesh-list
83131572|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83131573|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83131574|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
83131575|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131576|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83131577|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83131578|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131579|NCT02070289|PF-06372865|pf-06372865|mesh-list
83131580|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
83131581|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
83131582|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131583|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131584|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131586|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83131587|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
83131588|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131589|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131590|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131591|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
83131592|NCT02072083|Ketamine|ketamine|mesh-list
83131593|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83131594|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131595|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131596|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83131597|NCT02072083|Analgesics|analgesics|mesh-ancestor
83131598|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
83131599|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131600|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83131601|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83131602|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83131603|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83131604|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131605|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131606|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83131607|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83131608|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
83131609|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
83131610|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83131611|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83131612|NCT02070679|Vitamin E|vitamin e|mesh-list
83131613|NCT02070679|Tocopherols|tocopherols|mesh-list
83131614|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
83131615|NCT02070679|Vitamins|vitamins|mesh-ancestor
83131616|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
83131617|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131618|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
83131619|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131620|NCT02070679|Protective Agents|protective agents|mesh-ancestor
83131621|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83131622|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
83131623|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83131624|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83471707|NCT00003316|Gemcitabine|gemcitabine|mesh-list
83131625|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83131626|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
83131627|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83131628|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131629|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83131630|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83131631|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83131632|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83131633|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131634|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83131635|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83131636|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131637|NCT02072317|Raltitrexed|raltitrexed|mesh-list
83131638|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83131639|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
83131640|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131641|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131642|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83131643|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131644|NCT01651000|Calcifediol|calcifediol|mesh-list
83131645|NCT01651000|Vitamins|vitamins|mesh-ancestor
83131646|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
83131647|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131648|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83131649|NCT02469610|Bupivacaine|bupivacaine|mesh-list
83131650|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
83131651|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
83131652|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131653|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131654|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
83131655|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131656|NCT02071069|Fluorouracil|fluorouracil|mesh-list
83131657|NCT02071069|Irinotecan|irinotecan|mesh-list
83131658|NCT02071069|Cetuximab|cetuximab|mesh-list
83131659|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
83131660|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131661|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83131662|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131663|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83131664|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
83131665|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131666|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83131667|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83131668|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131669|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83131670|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
83131671|NCT02076373|Hematinics|hematinics|mesh-ancestor
83131672|NCT02072785|Vincristine|vincristine|mesh-list
83131673|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83471712|NCT00089024|Leucovorin|leucovorin|mesh-list
83131674|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131675|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
83131676|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
83131677|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
83131678|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131679|NCT02469298|Oseltamivir|oseltamivir|mesh-list
83131680|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
83131681|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131682|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131683|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131684|NCT02076451|DS-8273a|ds-8273a|mesh-list
83131685|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83131686|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131687|NCT02071303|Celecoxib|celecoxib|mesh-list
83131688|NCT02071303|Tramadol|tramadol|mesh-list
83131689|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83131690|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83131691|NCT02071303|Analgesics|analgesics|mesh-ancestor
83131692|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
83131693|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131694|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131695|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131696|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83131697|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83131698|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83131699|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131700|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131701|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83131702|NCT02071303|Narcotics|narcotics|mesh-ancestor
83131703|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131704|NCT02076529|Ramosetron|ramosetron|mesh-list
83131705|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
83131706|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
83131707|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131708|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131709|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83131710|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83131711|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
83131712|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131713|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131714|NCT02411578|Glucagon|glucagon|mesh-list
83131715|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83131716|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83131717|NCT02411578|Hormones|hormones|mesh-ancestor
83131718|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131719|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131720|NCT02411578|Incretins|incretins|mesh-ancestor
83131721|NCT02076685|Isoniazid|isoniazid|mesh-list
83131722|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
83131723|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83131724|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131725|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83131726|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83131727|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
83131728|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131729|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83131730|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
83471739|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
83131731|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83131732|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
83131733|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131734|NCT05077917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83131735|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131736|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83131737|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
83131739|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83131740|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83131741|NCT02463747|Vancomycin|vancomycin|mesh-list
83131742|NCT02463747|Meropenem|meropenem|mesh-list
83131743|NCT02463747|Tazobactam|tazobactam|mesh-list
83131744|NCT02463747|Piperacillin|piperacillin|mesh-list
83131745|NCT02463747|Ceftazidime|ceftazidime|mesh-list
83131746|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83131747|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83131748|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131749|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83131750|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131751|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131752|NCT02071537|Chloroquine|chloroquine|mesh-list
83131753|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83131754|NCT02071537|Carboplatin|carboplatin|mesh-list
83131755|NCT02071537|Gemcitabine|gemcitabine|mesh-list
83131756|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131757|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83131758|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
83131759|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131760|NCT02071537|Amebicides|amebicides|mesh-ancestor
83131761|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83131762|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83131763|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131764|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
83131765|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83131766|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83131767|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83131768|NCT02071537|Analgesics|analgesics|mesh-ancestor
83131769|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
83131770|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131771|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131772|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131773|NCT02071537|Filaricides|filaricides|mesh-ancestor
83131774|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
83131775|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
83131776|NCT02076841|Interferons|interferons|mesh-list
83131777|NCT02076841|Interferon-beta|interferon-beta|mesh-list
83131778|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
83131779|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131780|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
83131781|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131782|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
83131783|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131784|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83131785|NCT02442310|Deferiprone|deferiprone|mesh-list
83131786|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83131787|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
83131788|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
83131789|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131791|NCT02071615|Methylphenidate|methylphenidate|mesh-list
83131792|NCT02071615|Modafinil|modafinil|mesh-list
83471755|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131793|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83131794|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131795|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83131796|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131797|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131798|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83131799|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83131800|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
83131801|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131802|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83131803|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83131804|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83131805|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
83131806|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83131807|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83131808|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83131809|NCT02077231|Vitamins|vitamins|mesh-list
83131810|NCT02077231|Vitamin A|vitamin a|mesh-list
83131811|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
83131812|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
83131813|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131814|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
83131815|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131816|NCT02077231|Protective Agents|protective agents|mesh-ancestor
83131817|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83131818|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131819|NCT02077309|Linagliptin|linagliptin|mesh-list
83131820|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83131821|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131822|NCT02077309|Incretins|incretins|mesh-ancestor
83131823|NCT02077309|Hormones|hormones|mesh-ancestor
83131824|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131825|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83131826|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
83131827|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131828|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131829|NCT01369849|Rituximab|rituximab|mesh-list
83131830|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83131831|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83131832|NCT01369849|Antibodies|antibodies|mesh-list
83131833|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
83131834|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83131835|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
83131836|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131837|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131838|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83131839|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83131840|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
83131841|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131842|NCT02716779|Interferons|interferons|mesh-list
83131843|NCT02716779|Ribavirin|ribavirin|mesh-list
83131844|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131845|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
83131846|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131847|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
83131848|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131849|NCT02074189|Gemcitabine|gemcitabine|mesh-list
83131850|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131851|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83131852|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
83131853|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131854|NCT02463591|Thrombin|thrombin|mesh-list
83131855|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
83131856|NCT02463591|Coagulants|coagulants|mesh-ancestor
83131857|NCT02079961|Micronutrients|micronutrients|mesh-list
83131858|NCT02079961|Trace Elements|trace elements|mesh-list
83131859|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131860|NCT03298347|Caffeine|caffeine|mesh-list
83131861|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83131862|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131863|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83131864|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131865|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131866|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83131867|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83131868|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
83131869|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131870|NCT02074267|Gabapentin|gabapentin|mesh-list
83131871|NCT02074267|Analgesics|analgesics|mesh-ancestor
83131872|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
83131873|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131874|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131875|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
83131876|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83131877|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83131878|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131879|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83131880|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83131881|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83131882|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131883|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131884|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
83131885|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83131886|NCT02077777|Mesalamine|mesalamine|mesh-list
83131887|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83131888|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83131889|NCT02077777|Analgesics|analgesics|mesh-ancestor
83131890|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
83131891|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131892|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131893|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131894|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83131895|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
83131896|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83131897|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131898|NCT05036421|Empagliflozin|empagliflozin|mesh-list
83471796|NCT00003334|Paclitaxel|paclitaxel|mesh-list
83131899|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83131900|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131901|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83131902|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131903|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
83131904|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
83131905|NCT03298191|Ritodrine|ritodrine|mesh-list
83131906|NCT03298191|Calcium|calcium|mesh-list
83131907|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83131908|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131909|NCT03298191|Analgesics|analgesics|mesh-ancestor
83131910|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
83131911|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131912|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
83131913|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131914|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83131915|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
83131916|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83131917|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131918|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
83131919|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83131920|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
83131921|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
83131922|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83131923|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83131924|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83131925|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83131926|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83131927|NCT01369615|Oxycodone|oxycodone|mesh-list
83131928|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83131929|NCT01369615|Narcotics|narcotics|mesh-ancestor
83131930|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131931|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131932|NCT01369615|Analgesics|analgesics|mesh-ancestor
83131933|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
83131934|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131935|NCT02077933|Everolimus|everolimus|mesh-list
83131936|NCT02077933|Exemestane|exemestane|mesh-list
83131937|NCT02077933|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83131938|NCT02077933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83131939|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131940|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131941|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83131942|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
83131943|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131944|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83131945|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83131946|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83131947|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83131948|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
83131949|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131950|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
83131951|NCT02078089|Morphine|morphine|mesh-list
83131952|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83131953|NCT02078089|Narcotics|narcotics|mesh-ancestor
83131954|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83131955|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131956|NCT02078089|Analgesics|analgesics|mesh-ancestor
83471823|NCT00003760|Irofulven|irofulven|mesh-list
83131957|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
83131958|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83131959|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
83131960|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83131961|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83131962|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83131963|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131964|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83131965|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83131966|NCT02074891|Tenofovir|tenofovir|mesh-list
83131967|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
83131968|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83131969|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83131970|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83131971|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131972|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131973|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83131974|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83131975|NCT02078167|Policosanol|policosanol|mesh-list
83131976|NCT02078167|Red yeast rice|red yeast rice|mesh-list
83131977|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83131978|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83131979|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83131980|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
83131981|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131982|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83131983|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83131984|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83131985|NCT02078323|Linaclotide|linaclotide|mesh-list
83131986|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83131987|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
83131988|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83131989|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83131990|NCT02075749|Triamcinolone|triamcinolone|mesh-list
83131991|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83131992|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83131993|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83131994|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83131995|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
83131996|NCT02075749|Hormones|hormones|mesh-ancestor
83131997|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83131998|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83131999|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132000|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
83132001|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132002|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132003|NCT02081287|Inositol|inositol|mesh-list
83132004|NCT02081287|Lamotrigine|lamotrigine|mesh-list
83132005|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
83132006|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83132007|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83132008|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132009|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83132010|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82760529|NCT00841880|Felodipine|felodipine|mesh-list
83132012|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83132013|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132014|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83132015|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83132016|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
83132017|NCT02081287|Vitamins|vitamins|mesh-ancestor
83132018|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
83132019|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83132020|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83132021|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83132022|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132023|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132024|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83132025|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83132026|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132027|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
83132028|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132030|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
83132031|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132032|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
83132033|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132034|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132035|NCT02083315|Morphine|morphine|mesh-list
83132036|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83132037|NCT02083315|Narcotics|narcotics|mesh-ancestor
83132038|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132039|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132040|NCT02083315|Analgesics|analgesics|mesh-ancestor
83132041|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
83132042|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132043|NCT03559387|Lenograstim|lenograstim|mesh-list
83132044|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83132045|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
83132046|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132047|NCT05519059|Paclitaxel|paclitaxel|mesh-list
83132048|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83132049|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132050|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83132051|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83132052|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83132053|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132054|NCT02079337|Rocuronium|rocuronium|mesh-list
83132055|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83132056|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83132057|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83132058|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132059|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132060|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
83132061|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83132062|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83132063|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132064|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
83132065|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132066|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83132067|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83132068|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83471849|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
83132069|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132070|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132071|NCT02079727|Celecoxib|celecoxib|mesh-list
83132072|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83132073|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83132074|NCT02079727|Analgesics|analgesics|mesh-ancestor
83132075|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
83132076|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132077|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132078|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83132079|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132080|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83132081|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83132082|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132083|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132085|NCT02082067|Morphine|morphine|mesh-list
83132086|NCT02082067|Anesthetics|anesthetics|mesh-list
83132087|NCT02082067|Ropivacaine|ropivacaine|mesh-list
83132088|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
83132089|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
83132090|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132091|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132092|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83132093|NCT02082067|Narcotics|narcotics|mesh-ancestor
83132094|NCT02082067|Analgesics|analgesics|mesh-ancestor
83132095|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
83132096|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132097|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83132098|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83132099|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83132100|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132101|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83132102|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132103|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132104|NCT02084563|Cytarabine|cytarabine|mesh-list
83132105|NCT02084563|Decitabine|decitabine|mesh-list
83132106|NCT02084563|Daunorubicin|daunorubicin|mesh-list
83132107|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83132108|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
83132109|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132110|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132111|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
83132112|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132113|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132114|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
83132115|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132116|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83132117|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83132118|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83132119|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132120|NCT02084719|Antibodies|antibodies|mesh-list
83132121|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
83132122|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132123|NCT02084875|Tofacitinib|tofacitinib|mesh-list
83132124|NCT02084875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83132125|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83132126|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132127|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132128|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
83132129|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83132130|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132131|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
83132132|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132133|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132134|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83132135|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83132136|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132137|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132138|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132139|NCT02082613|Polidocanol|polidocanol|mesh-list
83132140|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83132141|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83132142|NCT02085109|Theobromine|theobromine|mesh-list
83132143|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83132144|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
83132145|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132146|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132147|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83132148|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
83132149|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
83132150|NCT03557983|Fenofibrate|fenofibrate|mesh-list
83132151|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132152|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
83132153|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132154|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83132155|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
83132156|NCT03558919|Mirabegron|mirabegron|mesh-list
83132157|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83132158|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83132159|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83132160|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132161|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132162|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132163|NCT03558919|Urological Agents|urological agents|mesh-ancestor
83132164|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83132165|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83132166|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83132167|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83132168|NCT02085577|Acetaminophen|acetaminophen|mesh-list
83132169|NCT02085577|Sufentanil|sufentanil|mesh-list
83132170|NCT02085577|Ketamine|ketamine|mesh-list
83132171|NCT02085577|Morphine|morphine|mesh-list
83132172|NCT02085577|Dsuvia|dsuvia|mesh-list
83132173|NCT02085577|Ondansetron|ondansetron|mesh-list
83132174|NCT02085577|Analgesics|analgesics|mesh-ancestor
83132175|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
83132176|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132177|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132178|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83132179|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83132180|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
83132181|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
83132182|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132183|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83132184|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83132185|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132186|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132187|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83132188|NCT02085577|Narcotics|narcotics|mesh-ancestor
83132189|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83132190|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
83132191|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
83132192|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
83132193|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132194|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
83132195|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132196|NCT02085577|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83132197|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83132198|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
83132199|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83132200|NCT02085655|Thalidomide|thalidomide|mesh-list
83132201|NCT02085655|Dexamethasone|dexamethasone|mesh-list
83132202|NCT02085655|Gemcitabine|gemcitabine|mesh-list
83132203|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
83132204|NCT02085655|Methotrexate|methotrexate|mesh-list
83132205|NCT02085655|Pegaspargase|pegaspargase|mesh-list
83132206|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83132207|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
83132208|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
83132209|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132210|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132211|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132212|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
83132214|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132215|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83471927|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83132216|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132217|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83132218|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
83132219|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132220|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83132221|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
83132222|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83132223|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132224|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132225|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83132226|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132227|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
83132228|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132229|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83132230|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
83132231|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132232|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132233|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83132234|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83132235|NCT02085655|Growth Substances|growth substances|mesh-ancestor
83132236|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
83132237|NCT02085967|Itraconazole|itraconazole|mesh-list
83132238|NCT02085967|Rifampin|rifampin|mesh-list
83132239|NCT02085967|Midazolam|midazolam|mesh-list
83132240|NCT02085967|Bupropion|bupropion|mesh-list
83132241|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83132242|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83132243|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132244|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132245|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83132246|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83132247|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83132248|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83132249|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
83132250|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
83132251|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
83132252|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
83132253|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132254|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132255|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83132256|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
83132257|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83132258|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83132259|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83132260|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
83132261|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83132262|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83132263|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132264|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
83132265|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132266|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83132267|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83132268|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
83132269|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132270|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83132271|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83132272|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
83132273|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132274|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
83132275|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83132276|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83132277|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83132278|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83132279|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83132280|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83132281|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83132282|NCT02091505|Ranibizumab|ranibizumab|mesh-list
83132283|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83132284|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83132285|NCT02091505|Growth Substances|growth substances|mesh-ancestor
83132286|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132287|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
83132288|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132289|NCT02091817|Oxytocin|oxytocin|mesh-list
83132290|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
83132291|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83132292|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132293|NCT02086279|Hormones|hormones|mesh-list
83132294|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132295|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132296|NCT02091973|Everolimus|everolimus|mesh-list
83132297|NCT02091973|Tacrolimus|tacrolimus|mesh-list
83132298|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132299|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
83132300|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132301|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83132302|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132303|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132304|NCT02091973|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83132305|NCT02091973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83132306|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132307|NCT03558295|Anticoagulants|anticoagulants|mesh-list
83132308|NCT02089399|Olmesartan|olmesartan|mesh-list
83132309|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83132310|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83132311|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132312|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
83132313|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132314|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83132315|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83132316|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132317|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83132318|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83132319|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83132320|NCT03557437|Amoxicillin|amoxicillin|mesh-list
83132321|NCT03557437|Metronidazole|metronidazole|mesh-list
83132322|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
83132323|NCT03557437|Esomeprazole|esomeprazole|mesh-list
83132324|NCT03557437|Bismuth|bismuth|mesh-list
83132325|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132326|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83494131|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83132327|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132328|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83132329|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83132330|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83132331|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132332|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83132333|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132334|NCT03557437|Antacids|antacids|mesh-ancestor
83132335|NCT03557437|Diuretics|diuretics|mesh-ancestor
83132336|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
83132337|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132338|NCT03557437|Expectorants|expectorants|mesh-ancestor
83132339|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83132340|NCT02089633|BCT-100|bct-100|mesh-list
83132341|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132342|NCT02086747|Acetaminophen|acetaminophen|mesh-list
83132343|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83132344|NCT02086747|Analgesics|analgesics|mesh-ancestor
83132345|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
83132346|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132347|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132348|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
83132349|NCT02086825|Rifaximin|rifaximin|mesh-list
83132350|NCT02086825|Lactulose|lactulose|mesh-list
83132351|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132352|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132353|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132354|NCT02086903|Clopidogrel|clopidogrel|mesh-list
83132355|NCT02086903|Ticagrelor|ticagrelor|mesh-list
83132356|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83132357|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83132358|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83132359|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83132360|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
83132361|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132362|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132363|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132364|NCT02087215|Boron|boron|mesh-list
83132365|NCT02087215|Trace Elements|trace elements|mesh-ancestor
83132366|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
83132367|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132368|NCT02087527|Dexamethasone|dexamethasone|mesh-list
83132369|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83132370|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
83132371|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
83132372|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132373|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132374|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132375|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
83132376|NCT02087527|Hormones|hormones|mesh-ancestor
83132377|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132378|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83132379|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132380|NCT02087683|Vitamin D|vitamin d|mesh-list
83132381|NCT02087683|Vitamins|vitamins|mesh-ancestor
83132382|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
83132383|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132384|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83132385|NCT02092363|Paclitaxel|paclitaxel|mesh-list
83132386|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83132387|NCT02092363|Carboplatin|carboplatin|mesh-list
83132388|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83132389|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83132390|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132391|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
83132392|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
83132393|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
83132394|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132395|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
83132396|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132397|NCT03558139|Avelumab|avelumab|mesh-list
83132398|NCT03558139|Magrolimab|magrolimab|mesh-list
83132399|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83132400|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132401|NCT02089867|Ezetimibe|ezetimibe|mesh-list
83132402|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83132403|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132404|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
83494132|NCT04934904|Ropivacaine|ropivacaine|mesh-list
83132405|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132406|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83132407|NCT02092597|Exenatide|exenatide|mesh-list
83132408|NCT02092597|Linagliptin|linagliptin|mesh-list
83132409|NCT02092597|Gliclazide|gliclazide|mesh-list
83132410|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83132411|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132412|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83132413|NCT02092597|Incretins|incretins|mesh-ancestor
83132414|NCT02092597|Hormones|hormones|mesh-ancestor
83132415|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132416|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83132417|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
83132418|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132419|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132420|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83132421|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132422|NCT02093143|Remifentanil|remifentanil|mesh-list
83132423|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83132424|NCT02093143|Narcotics|narcotics|mesh-ancestor
83132425|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132426|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132427|NCT02093143|Analgesics|analgesics|mesh-ancestor
83132428|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
83132429|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132430|NCT02093299|Clopidogrel|clopidogrel|mesh-list
83132431|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83132432|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83132433|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83132434|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83132435|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
83132436|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132437|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132438|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132439|NCT00454753|Dasatinib|dasatinib|mesh-list
83132440|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132441|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83132442|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132443|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132444|NCT02093533|Eculizumab|eculizumab|mesh-list
83132445|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83472004|NCT00004060|Exatecan|exatecan|mesh-list
83132446|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132447|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
83132448|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132449|NCT03297879|Metformin|metformin|mesh-list
83132450|NCT03297879|Exenatide|exenatide|mesh-list
83132451|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83132452|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132453|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83132454|NCT03297879|Incretins|incretins|mesh-ancestor
83132455|NCT03297879|Hormones|hormones|mesh-ancestor
83132456|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132457|NCT02093845|Everolimus|everolimus|mesh-list
83132458|NCT02093845|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83132459|NCT02093845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83132460|NCT02093845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132461|NCT02093845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132462|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132464|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132465|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132466|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
83132467|NCT04489797|Rabeprazole|rabeprazole|mesh-list
83132468|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83132469|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132470|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83132471|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132472|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132473|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132474|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83132475|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83132476|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132477|NCT02096419|Clopidogrel|clopidogrel|mesh-list
83132478|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83132479|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83132480|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83132481|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83132482|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
83132483|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132484|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132485|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132486|NCT02094157|Heparin|heparin|mesh-list
83132487|NCT02094157|Calcium heparin|calcium heparin|mesh-list
83132488|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83132489|NCT02094157|Tinzaparin|tinzaparin|mesh-list
83132490|NCT02094157|Dalteparin|dalteparin|mesh-list
83132491|NCT02094157|Warfarin|warfarin|mesh-list
83132492|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
83132493|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83132494|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83132495|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132496|NCT02094313|Atorvastatin|atorvastatin|mesh-list
83132497|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
83132498|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132499|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
83132500|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132501|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83472021|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
83132502|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83132503|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132504|NCT02094391|Ipilimumab|ipilimumab|mesh-list
83132505|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83132506|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132507|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83132508|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132509|NCT02094469|Cilostazol|cilostazol|mesh-list
83132510|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83132511|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
83132512|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132513|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132514|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83132515|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
83132516|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83132517|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83132518|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132519|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83132520|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
83132521|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83132522|NCT02094469|Protective Agents|protective agents|mesh-ancestor
83132523|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83132524|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83132525|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132526|NCT02094703|Levofloxacin|levofloxacin|mesh-list
83132527|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
83132528|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83132529|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132530|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132531|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83132532|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83132533|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132534|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132535|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132536|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83132537|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83132538|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83132539|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83132540|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
83132541|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132542|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132543|NCT02094703|Urological Agents|urological agents|mesh-ancestor
83132544|NCT02098837|Dolutegravir|dolutegravir|mesh-list
83132545|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83132546|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83132547|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132548|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132549|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83132550|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83132551|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
83132552|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132553|NCT02098915|Metoclopramide|metoclopramide|mesh-list
83132554|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
83132555|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
83132556|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132557|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132558|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132559|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83132560|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83132561|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
83132562|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132563|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132564|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
83132565|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83132566|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132567|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83132568|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132569|NCT05046860|Dalbavancin|dalbavancin|mesh-list
83132570|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132571|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132572|NCT02095405|Caffeine|caffeine|mesh-list
83132573|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83132574|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132575|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83132576|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132577|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132578|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83132579|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83132580|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
83132581|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132582|NCT04434482|Temozolomide|temozolomide|mesh-list
83132583|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83132584|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
83132585|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132586|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132587|NCT02096965|Tolvaptan|tolvaptan|mesh-list
83132588|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83132589|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132590|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
83132591|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132592|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
83132593|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83132594|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132595|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
83132596|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83132597|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132598|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
83132599|NCT02095717|Curcumin|curcumin|mesh-list
83132600|NCT02095717|Docetaxel|docetaxel|mesh-list
83132601|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132602|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83132603|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83132604|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83132605|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132606|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83132607|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83132608|NCT02095717|Analgesics|analgesics|mesh-ancestor
83132609|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
83132610|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132611|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132612|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83132613|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132614|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132615|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
83132616|NCT03099824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83132618|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132619|NCT03099824|Protective Agents|protective agents|mesh-ancestor
83132620|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132621|NCT02718417|Paclitaxel|paclitaxel|mesh-list
83132622|NCT02718417|Carboplatin|carboplatin|mesh-list
83132623|NCT02718417|Avelumab|avelumab|mesh-list
83132624|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83132625|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83132626|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132627|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83132628|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83132629|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83132630|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132631|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83132632|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
83132633|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132635|NCT05067530|Carboplatin|carboplatin|mesh-list
83132636|NCT05067530|Palbociclib|palbociclib|mesh-list
83132637|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83132638|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132639|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
83132640|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
83132641|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
83132642|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132643|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83132644|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132645|NCT02640404|Vaccines|vaccines|mesh-list
83132646|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
83132647|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132648|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
83132649|NCT05003895|Fludarabine|fludarabine|mesh-list
83132650|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132651|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
83132652|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132653|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132654|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83132655|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
83132656|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132657|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132658|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83132659|NCT03097406|Imidacloprid|imidacloprid|mesh-list
83132660|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
83132661|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132662|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132663|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132664|NCT03099590|Puerarin|puerarin|mesh-list
83132665|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
83132666|NCT04999761|Futibatinib|futibatinib|mesh-list
83132667|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132668|NCT05054426|Methotrexate|methotrexate|mesh-list
83132669|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83132670|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
83132671|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83132672|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132673|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83132674|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
83132675|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132676|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132677|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132678|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132679|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83132680|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132681|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
83132682|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132683|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83132684|NCT00701727|Ezetimibe|ezetimibe|mesh-list
83132685|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83132686|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132687|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
83132688|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132689|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83132690|NCT02463513|Vitamins|vitamins|mesh-list
83132691|NCT02463513|Riboflavin|riboflavin|mesh-list
83132692|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
83132693|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
83132694|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132695|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83132696|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132697|NCT04990323|Vidarabine|vidarabine|mesh-list
83132698|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
83132699|NCT04990323|Busulfan|busulfan|mesh-list
83132700|NCT04990323|Thiotepa|thiotepa|mesh-list
83132701|NCT04990323|Fludarabine|fludarabine|mesh-list
83132702|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
83132703|NCT04990323|Clofarabine|clofarabine|mesh-list
83132704|NCT04990323|Tacrolimus|tacrolimus|mesh-list
83132705|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132706|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
83132707|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132708|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83132709|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83132710|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
83132711|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132712|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132713|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83132714|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83132715|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
83132716|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
83132717|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132718|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83132719|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132720|NCT04155008|Dexamethasone|dexamethasone|mesh-list
83132721|NCT04155008|Dronabinol|dronabinol|mesh-list
83132722|NCT04155008|Mirtazapine|mirtazapine|mesh-list
83132723|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83132724|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
83132725|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
83132726|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132727|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132728|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132729|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
83132730|NCT04155008|Hormones|hormones|mesh-ancestor
83132731|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132732|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83494133|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
83494134|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
83494135|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494136|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494137|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
83494138|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494139|NCT02219321|Lidocaine|lidocaine|mesh-list
83494140|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
83494141|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
83132733|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132734|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
83132735|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83132736|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83132737|NCT04155008|Analgesics|analgesics|mesh-ancestor
83132738|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
83132739|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83132740|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83132741|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132742|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132743|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
83132744|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83132745|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
83132746|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
83132747|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83132748|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83132749|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132750|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83472081|NCT00004852|Lamivudine|lamivudine|mesh-list
83132751|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83132752|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83132753|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
83132754|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83132755|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83132756|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
83132757|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83132758|NCT05044364|Clevidipine|clevidipine|mesh-list
83132759|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83132760|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83132761|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132762|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83132763|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132765|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
83132766|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132767|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
83132768|NCT04150640|Nivolumab|nivolumab|mesh-list
83132769|NCT04150640|Trastuzumab|trastuzumab|mesh-list
83132770|NCT04150640|Fluorouracil|fluorouracil|mesh-list
83132771|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
83132772|NCT04150640|Irinotecan|irinotecan|mesh-list
83132773|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83132774|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132775|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83132776|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132777|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
83132778|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83132779|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83132780|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
83132781|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132782|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83132783|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83132784|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132785|NCT04959981|Osimertinib|osimertinib|mesh-list
83132786|NCT04959981|Sotorasib|sotorasib|mesh-list
83132787|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132788|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83132789|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132790|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494519|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494520|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494521|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494522|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
83494523|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83494524|NCT04370288|Methylene Blue|methylene blue|mesh-list
83494525|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494526|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
83494527|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494528|NCT04370288|Protective Agents|protective agents|mesh-ancestor
83494529|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
83494530|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494531|NCT04370288|Expectorants|expectorants|mesh-ancestor
83494532|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83494533|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83494534|NCT04370288|Antidotes|antidotes|mesh-ancestor
83494535|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494536|NCT02993705|Trabectedin|trabectedin|mesh-list
83494537|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83494538|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
83494539|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494540|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494542|NCT02243618|Polaprezinc|polaprezinc|mesh-list
83494543|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83494544|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83494545|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
83494546|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494547|NCT02243618|Protective Agents|protective agents|mesh-ancestor
83494548|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494549|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83494550|NCT02243852|Hormones|hormones|mesh-list
83221022|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494551|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83494552|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494553|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
83494554|NCT03150329|Vorinostat|vorinostat|mesh-list
83494555|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494556|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494557|NCT03150329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83530323|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83132791|NCT04959981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83132792|NCT04959981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83132793|NCT05054114|Interferons|interferons|mesh-list
83132794|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
83132795|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132796|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
83132797|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132798|NCT04665531|Ropivacaine|ropivacaine|mesh-list
83132799|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
83132800|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
83132801|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132802|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132803|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
83132804|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132806|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83132807|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83132808|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132809|NCT02097511|Metoprolol|metoprolol|mesh-list
83132810|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
83132811|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83132812|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83132813|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
83132814|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
83132815|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132816|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132817|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83132818|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83132819|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83132820|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83494705|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83494706|NCT04362332|Amebicides|amebicides|mesh-ancestor
83494707|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83494708|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83494709|NCT04362332|Analgesics|analgesics|mesh-ancestor
83494710|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
83494711|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494712|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494713|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83494714|NCT04362332|Filaricides|filaricides|mesh-ancestor
83494715|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
83494716|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
83494717|NCT02308241|Ribavirin|ribavirin|mesh-list
83494718|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
83494719|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494720|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
83494721|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83494722|NCT00932282|Omalizumab|omalizumab|mesh-list
83494723|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83494724|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83494725|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
83494726|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
83494727|NCT02159495|Fludarabine|fludarabine|mesh-list
83494728|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
83494729|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83494730|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
83494806|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83494807|NCT02452320|Analgesics|analgesics|mesh-ancestor
83494808|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
83494809|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494810|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494811|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
83494812|NCT02459964|Fentanyl|fentanyl|mesh-list
83494813|NCT02459964|Hydromorphone|hydromorphone|mesh-list
83494814|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83494815|NCT02459964|Narcotics|narcotics|mesh-ancestor
83494816|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494817|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494819|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
83494820|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83494821|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83494822|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83494823|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
83494824|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
83494825|NCT01635101|Acetaminophen|acetaminophen|mesh-list
83494902|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
83494903|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83494904|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494905|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
83494906|NCT02451930|Necitumumab|necitumumab|mesh-list
83494907|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83494908|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83494909|NCT02451930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83494910|NCT02451930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494911|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
83494912|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83494913|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
83494914|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494915|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
83494916|NCT04358120|Protective Agents|protective agents|mesh-ancestor
83494917|NCT00932828|Immunomodulating Agents|immunomodulating agents|mesh-list
83494918|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
83494919|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494920|NCT00928694|Fenofibrate|fenofibrate|mesh-list
83494921|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83494922|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
83494923|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83494924|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83494925|NCT01639157|Buspirone|buspirone|mesh-list
83494926|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83494927|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83494928|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83494929|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83494930|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83132821|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132822|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132823|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83132824|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83132825|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83132826|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83132827|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
83132828|NCT03957681|Brodalumab|brodalumab|mesh-list
83132829|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132830|NCT05043740|Evolocumab|evolocumab|mesh-list
83132831|NCT05043740|Alirocumab|alirocumab|mesh-list
83132832|NCT05043740|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83132833|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83132834|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132835|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
83495232|NCT01649609|Antimetabolites|antimetabolites|mesh-list
83495530|NCT01703507|Ipilimumab|ipilimumab|mesh-list
83495531|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83495532|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495533|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83495534|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495535|NCT02158520|Paclitaxel|paclitaxel|mesh-list
83495536|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83495537|NCT02158520|Bevacizumab|bevacizumab|mesh-list
83495538|NCT02158520|Ipilimumab|ipilimumab|mesh-list
83495539|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83495540|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
83495541|NCT02158520|Antibodies|antibodies|mesh-list
83495542|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
83495543|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83495544|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
83495545|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83495546|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83495547|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
83495548|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
83495549|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
83495550|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83495551|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83495552|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83495553|NCT02158520|Growth Substances|growth substances|mesh-ancestor
83495554|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83495555|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
82761505|NCT02544932|Warfarin|warfarin|mesh-list
83495556|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
83495557|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83495559|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
83496235|NCT01016834|Sumatriptan|sumatriptan|mesh-list
83496236|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83496237|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83496238|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83496239|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
83496240|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83496241|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83496242|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496243|NCT04923594|Mazindol|mazindol|mesh-list
83496244|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83496245|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83496246|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83496247|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83496248|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83497228|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83497229|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83497230|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497231|NCT03520790|Paclitaxel|paclitaxel|mesh-list
83497232|NCT03520790|Gemcitabine|gemcitabine|mesh-list
83497233|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83497234|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497235|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
83497236|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
83497237|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
83530324|NCT04265053|Estradiol|estradiol|mesh-list
83132836|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132837|NCT05043740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83132838|NCT05043740|Protease Inhibitors|protease inhibitors|mesh-ancestor
83132840|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83132841|NCT03928275|Aldesleukin|aldesleukin|mesh-list
83132842|NCT03928275|Interleukin-2|interleukin-2|mesh-list
83132843|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
83132844|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132845|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83132846|NCT03928275|Analgesics|analgesics|mesh-ancestor
83132847|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
83132848|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132849|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132850|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83132851|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83132852|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
83132853|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132854|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83132855|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
83132856|NCT05043896|Tadalafil|tadalafil|mesh-list
83132857|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
83132858|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83132859|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83132860|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132861|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132862|NCT05043896|Urological Agents|urological agents|mesh-ancestor
83132864|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83132865|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83132866|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
83132867|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132868|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132869|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132870|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
83132871|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
83132872|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132873|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
83497392|NCT01077596|Serotonin|serotonin|mesh-list
83497393|NCT01077596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83497394|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83497395|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83497396|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83497397|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83497398|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83497561|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83497548|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83497549|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497550|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83497551|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83497552|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497553|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83497554|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83497555|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83497556|NCT02170220|Vortioxetine|vortioxetine|mesh-list
83497557|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
83497558|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83497559|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83497560|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83132874|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83132875|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
83132876|NCT03096704|Vitamin D|vitamin d|mesh-list
83132877|NCT03096704|Vitamins|vitamins|mesh-ancestor
83132878|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
83132879|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132880|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83132881|NCT02099695|Oxybutynin|oxybutynin|mesh-list
83132882|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
83132883|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
83132884|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132885|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132886|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83132887|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83132888|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
83132889|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83497637|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497638|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497639|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497640|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
83497641|NCT02179892|Hormones|hormones|mesh-ancestor
83497642|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83497643|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83497644|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497645|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
83497646|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
83530325|NCT04265053|Testosterone|testosterone|mesh-list
83497724|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83497725|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83497726|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
83497727|NCT00585195|Itraconazole|itraconazole|mesh-list
83497728|NCT00585195|Rifampin|rifampin|mesh-list
83497729|NCT00585195|Crizotinib|crizotinib|mesh-list
83497730|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
83497731|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497732|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83530326|NCT04265053|Ganirelix|ganirelix|mesh-list
83497882|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
83497883|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
83497884|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83497885|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497886|NCT02425449|Succinylcholine|succinylcholine|mesh-list
83497887|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83497888|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83497889|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83497890|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83497891|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497892|NCT02455167|Ribavirin|ribavirin|mesh-list
83497893|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
83497894|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
83497895|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497896|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
83497897|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83497898|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83497899|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83497900|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83497901|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
83497902|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497903|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83497981|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83497982|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83497983|NCT01100606|Pancrelipase|pancrelipase|mesh-list
83497984|NCT01100606|Pancreatin|pancreatin|mesh-list
83497985|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83497986|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
83497987|NCT03013010|Tegafur|tegafur|mesh-list
83497988|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83497989|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83497990|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
83497991|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83497992|NCT02518191|Goserelin|goserelin|mesh-list
83498066|NCT02980094|Vitamin E|vitamin e|mesh-list
83498067|NCT02980094|Tocopherols|tocopherols|mesh-list
83498068|NCT02980094|Tocotrienols|tocotrienols|mesh-list
83498069|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
83498070|NCT02980094|Selenium|selenium|mesh-list
83498071|NCT02980094|Antioxidants|antioxidants|mesh-list
83498072|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
83498073|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498074|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498075|NCT02980094|Protective Agents|protective agents|mesh-ancestor
83498076|NCT02980094|Trace Elements|trace elements|mesh-ancestor
83498077|NCT03013322|Physostigmine|physostigmine|mesh-list
83498300|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83498301|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83498302|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498303|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498304|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83498305|NCT02411292|Enoxaparin|enoxaparin|mesh-list
83498306|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
83498307|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83132890|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132891|NCT02099695|Urological Agents|urological agents|mesh-ancestor
83132892|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
83132893|NCT05066516|Linagliptin|linagliptin|mesh-list
83132894|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83132895|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132896|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83132897|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132898|NCT05066516|Incretins|incretins|mesh-ancestor
83132900|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132901|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83132902|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
83132903|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132904|NCT02097589|Atorvastatin|atorvastatin|mesh-list
83132905|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83132906|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
83132907|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132908|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83132909|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83132910|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
83132911|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132912|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83498385|NCT05305508|Calcium|calcium|mesh-list
83498386|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83498387|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498388|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83498389|NCT05305508|Diuretics|diuretics|mesh-ancestor
83498390|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
83498391|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
83498392|NCT05305508|Coagulants|coagulants|mesh-ancestor
83498393|NCT01170884|Timolol|timolol|mesh-list
83498394|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83498395|NCT01170884|Bimatoprost|bimatoprost|mesh-list
83498396|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83498397|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83498398|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498399|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83498400|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83498401|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
83498402|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498403|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498404|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83498405|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83498406|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83498407|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83498408|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83498410|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83498411|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498412|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498413|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
83498414|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498415|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498416|NCT01171118|Miotics|miotics|mesh-ancestor
83498417|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
83498418|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498419|NCT03011918|Vitamin D|vitamin d|mesh-list
83498420|NCT03011918|Vitamins|vitamins|mesh-ancestor
83498421|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
83498422|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498423|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83498424|NCT05296460|Dapsone|dapsone|mesh-list
83498425|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498426|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
83498427|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83498428|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83498429|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83498430|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498431|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498432|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
83498433|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498434|NCT01136798|Exenatide|exenatide|mesh-list
83498435|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83498436|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498437|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83498438|NCT01136798|Incretins|incretins|mesh-ancestor
83498439|NCT01136798|Hormones|hormones|mesh-ancestor
83498440|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498441|NCT01172522|Fexofenadine|fexofenadine|mesh-list
83498442|NCT01172522|Terfenadine|terfenadine|mesh-list
83498443|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83498444|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83498445|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83498446|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
83498447|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
83498448|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83498449|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498450|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498451|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
83498452|NCT01172600|Entonox|entonox|mesh-list
83498453|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83498454|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
83498455|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
83498456|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498457|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498458|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83498459|NCT01172600|Analgesics|analgesics|mesh-ancestor
83498460|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
83498461|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498462|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83498463|NCT02246816|Opium|opium|mesh-list
83498464|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83498465|NCT02246816|Narcotics|narcotics|mesh-ancestor
83498466|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498467|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498468|NCT02246816|Analgesics|analgesics|mesh-ancestor
83498469|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
83498470|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498471|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
83498472|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498473|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
83498474|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
83498475|NCT01137890|Zonisamide|zonisamide|mesh-list
83498476|NCT01137890|Cocaine|cocaine|mesh-list
83498477|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
83498478|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83498479|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83498480|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498481|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83472088|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
83498482|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498483|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
83498484|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
83498485|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498486|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
83498487|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498488|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83498489|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83498490|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83498491|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
83482699|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482700|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482701|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
83482702|NCT00420992|Naltrexone|naltrexone|mesh-list
83482703|NCT00420992|Morphine|morphine|mesh-list
83482704|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83482705|NCT00420992|Narcotics|narcotics|mesh-ancestor
83482706|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482707|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482708|NCT00420992|Analgesics|analgesics|mesh-ancestor
83482709|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
83498567|NCT03011996|Pantoprazole|pantoprazole|mesh-list
83498568|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83498569|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83498570|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83498571|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498572|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498573|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83498574|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83498575|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83498576|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498577|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83498578|NCT01178216|Rituximab|rituximab|mesh-list
83498579|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83498878|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
83498879|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498880|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498881|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83498882|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83498883|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83498884|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83498885|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
83498886|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
83498887|NCT02581839|Dexamethasone|dexamethasone|mesh-list
83498888|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
83498889|NCT02581839|Ondansetron|ondansetron|mesh-list
83498890|NCT02581839|BB 1101|bb 1101|mesh-list
83498891|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83498892|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
83498893|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
83498894|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83498895|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83498896|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83498897|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
83498898|NCT02581839|Hormones|hormones|mesh-ancestor
83498899|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83498900|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83498901|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83498902|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
83498903|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83498904|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83498905|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
83498906|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132913|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83132914|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132915|NCT03836001|Serlopitant|serlopitant|mesh-list
83132916|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83132917|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132918|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132919|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132920|NCT02465866|Promethazine|promethazine|mesh-list
83132921|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
83132922|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
83132923|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83499056|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
83499057|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499058|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83499059|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83499060|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
83499061|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
83499062|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
83499063|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83499064|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83499065|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
83499741|NCT05543629|Carboplatin|carboplatin|mesh-list
83499742|NCT05543629|Nivolumab|nivolumab|mesh-list
83499744|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83499745|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83499746|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
83499747|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
83499748|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
83499749|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83499977|NCT04847453|Ixazomib|ixazomib|mesh-list
83499978|NCT04847453|Ichthammol|ichthammol|mesh-list
83499979|NCT04847453|BB 1101|bb 1101|mesh-list
83499980|NCT04847453|Glycine|glycine|mesh-list
83499981|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83499982|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
83499983|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
83499984|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83499985|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132924|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
83132925|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
83132926|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83132927|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132928|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132929|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83132931|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83132932|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132933|NCT05052008|Analgesics|analgesics|mesh-ancestor
83132934|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
83132935|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132936|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132937|NCT04727307|Bevacizumab|bevacizumab|mesh-list
83132938|NCT04727307|Atezolizumab|atezolizumab|mesh-list
83132939|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83132940|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83132941|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132942|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83132943|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83132944|NCT04727307|Growth Substances|growth substances|mesh-ancestor
83132945|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132946|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83132947|NCT04727307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83132948|NCT04727307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132949|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
83132950|NCT05066360|Hormones|hormones|mesh-list
83132951|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132952|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132953|NCT02439970|Valganciclovir|valganciclovir|mesh-list
83132954|NCT02439970|Brincidofovir|brincidofovir|mesh-list
83132955|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
83132956|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132957|NCT03290859|Propofol|propofol|mesh-list
83132958|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83132959|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83132960|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132961|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83132962|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
83132963|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
83132964|NCT05065658|Posaconazole|posaconazole|mesh-list
83132965|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
83132966|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83132967|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83132968|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83132969|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83132970|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83132971|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83132972|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132973|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500062|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
83500063|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500064|NCT04658849|Pioglitazone|pioglitazone|mesh-list
83500065|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83500066|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500067|NCT04616313|Xenon|xenon|mesh-list
83500068|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83500069|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
83500070|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
83500071|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500072|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500073|NCT04577404|Edaravone|edaravone|mesh-list
83500074|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83500075|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
83500076|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500077|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83500078|NCT04577404|Protective Agents|protective agents|mesh-ancestor
83500079|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500081|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83500082|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
83500083|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500084|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83500085|NCT04569084|Protective Agents|protective agents|mesh-ancestor
83500086|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500087|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
83500088|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500090|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83500091|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500092|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83500093|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500094|NCT04452747|Dinoprostone|dinoprostone|mesh-list
83500095|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
83500096|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83500097|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500099|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
83500100|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500101|NCT04421339|Protective Agents|protective agents|mesh-ancestor
83500102|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500103|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500104|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
83500105|NCT04418661|Adagrasib|adagrasib|mesh-list
83500106|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500107|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500108|NCT04418661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500109|NCT04418661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500110|NCT04391049|Paclitaxel|paclitaxel|mesh-list
83500112|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83500113|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83500114|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500115|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500116|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500117|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500118|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500119|NCT04342572|Melphalan|melphalan|mesh-list
83500120|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83500121|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
83500356|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83132974|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83132975|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
83132976|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132977|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83132978|NCT02102815|Dexamethasone|dexamethasone|mesh-list
83132979|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83132980|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
83132981|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
83132982|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83132983|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500349|NCT03505710|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83500350|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500351|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500352|NCT03505710|Immunoconjugates|immunoconjugates|mesh-ancestor
83500353|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
83500354|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500355|NCT03435458|Misoprostol|misoprostol|mesh-list
83500357|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
83500358|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83500359|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500360|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83500361|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83500362|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
83500363|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
83500364|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500365|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500366|NCT03338959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83500367|NCT03338959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500368|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
83500369|NCT03323476|Prednisone|prednisone|mesh-list
83500370|NCT03323476|Rituximab|rituximab|mesh-list
83500520|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
83500521|NCT02760329|Protective Agents|protective agents|mesh-ancestor
83500522|NCT02723500|Xenon|xenon|mesh-list
83500523|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83500524|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
83500525|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
83500526|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500527|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500528|NCT02678182|Capecitabine|capecitabine|mesh-list
83500530|NCT02678182|Durvalumab|durvalumab|mesh-list
83500531|NCT02678182|Ramucirumab|ramucirumab|mesh-list
83500532|NCT02678182|Rucaparib|rucaparib|mesh-list
83500533|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500534|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
83500535|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500536|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500537|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500538|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83500539|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500540|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
83500541|NCT02620865|Leucovorin|leucovorin|mesh-list
83500543|NCT02620865|Aldesleukin|aldesleukin|mesh-list
83500544|NCT02620865|Paclitaxel|paclitaxel|mesh-list
83500545|NCT02620865|Camptothecin|camptothecin|mesh-list
83500546|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83500547|NCT02620865|Gemcitabine|gemcitabine|mesh-list
83500548|NCT02620865|Fluorouracil|fluorouracil|mesh-list
83500549|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
83500550|NCT02620865|Irinotecan|irinotecan|mesh-list
83500551|NCT02620865|Interleukin-2|interleukin-2|mesh-list
83500552|NCT02620865|Antibodies|antibodies|mesh-list
83500553|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
83500554|NCT02620865|Sargramostim|sargramostim|mesh-list
83500556|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
83500557|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83500558|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83500559|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500560|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500561|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500562|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500563|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
83500564|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500565|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83500566|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
83500645|NCT02505477|Expectorants|expectorants|mesh-ancestor
83500646|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
83500647|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83500648|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
83500649|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83500650|NCT02505477|Protective Agents|protective agents|mesh-ancestor
83500651|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500652|NCT02505477|Antidotes|antidotes|mesh-ancestor
83500653|NCT02484885|Xenon|xenon|mesh-list
83500654|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83500655|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
83500656|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
83500657|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500658|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500659|NCT02418572|Testosterone|testosterone|mesh-list
83500660|NCT02418572|Androgens|androgens|mesh-ancestor
83500661|NCT02418572|Hormones|hormones|mesh-ancestor
83500662|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83500663|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500664|NCT02345330|Interleukin-12|interleukin-12|mesh-list
83132984|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132985|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
83132986|NCT02102815|Hormones|hormones|mesh-ancestor
83132987|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83132988|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83132989|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83132990|NCT04935112|Pantoprazole|pantoprazole|mesh-list
83132991|NCT04935112|Famotidine|famotidine|mesh-list
83132992|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83132993|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83132994|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83132995|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83132996|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83132997|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83500816|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
83500817|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
83500818|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83500819|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83500820|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83500821|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83500822|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83500823|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83500825|NCT05220813|Bupivacaine|bupivacaine|mesh-list
83500826|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
83500827|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
83500828|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83500829|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83500830|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
83500831|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83500832|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83500833|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83501055|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501056|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501057|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83501058|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
83501059|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83501060|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501061|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83501062|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
83501063|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83501064|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83501065|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83501066|NCT01291784|Antibodies|antibodies|mesh-list
83501067|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83501068|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
83530327|NCT04265053|Estrogens|estrogens|mesh-ancestor
83501145|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
83501146|NCT00003407|Amifostine|amifostine|mesh-list
83501147|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83501148|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
83501149|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501150|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501151|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
83501152|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501153|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83501154|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
83501155|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501156|NCT00003407|Analgesics|analgesics|mesh-ancestor
83501157|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
83501158|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501159|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83501160|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83501161|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501162|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83501163|NCT00003407|Protective Agents|protective agents|mesh-ancestor
83501165|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83501166|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83501167|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
83501168|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83501169|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83501170|NCT01710137|Varenicline|varenicline|mesh-list
83501171|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83501172|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83501173|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
83501174|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501175|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501176|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501177|NCT01710839|Ranibizumab|ranibizumab|mesh-list
83501178|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83132999|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
83133000|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133001|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133002|NCT02102971|Liver Extracts|liver extracts|mesh-list
83133003|NCT02102971|Hematinics|hematinics|mesh-ancestor
83133004|NCT05043350|Loratadine|loratadine|mesh-list
83133005|NCT05043350|Famotidine|famotidine|mesh-list
83133006|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83133007|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133008|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83133009|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
83133010|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
83133011|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133012|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133013|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133014|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
83133015|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
83133016|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83133017|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83133018|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83133019|NCT03555487|Choline|choline|mesh-list
83133020|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
83133021|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83133022|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
83133023|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133024|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133025|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133026|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
83133027|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83133028|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83133029|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133030|NCT02103049|Ezetimibe|ezetimibe|mesh-list
83133031|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83133032|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83133033|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
83501255|NCT01292798|Growth Substances|growth substances|mesh-ancestor
83501256|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501257|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
83501258|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501259|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
83501260|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83501261|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83501262|NCT03009500|Prednisolone|prednisolone|mesh-list
83501263|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
83501265|NCT03009500|Bupivacaine|bupivacaine|mesh-list
83501266|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83501267|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
83501268|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83501269|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
83501270|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501271|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501272|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
83501273|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501274|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501275|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83501276|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83501277|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83501278|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501279|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501280|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
83501281|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
83501282|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83501283|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
83501284|NCT03009500|Hormones|hormones|mesh-ancestor
83501285|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83501286|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83501287|NCT03009500|Protective Agents|protective agents|mesh-ancestor
83501288|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83501289|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83501290|NCT01715207|Atenolol|atenolol|mesh-list
83501291|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501292|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83501293|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
83501294|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
83501295|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501296|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501297|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83501298|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83501299|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83501300|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
83501301|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501302|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501303|NCT01716221|Dexetimide|dexetimide|mesh-list
83501304|NCT01716221|Bupropion|bupropion|mesh-list
83501305|NCT01716221|Citalopram|citalopram|mesh-list
83501306|NCT01716221|Escitalopram|escitalopram|mesh-list
83501307|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83501308|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
83501309|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83501310|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83501311|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83501312|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83501313|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501314|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
83501315|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501316|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501317|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83501318|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83501319|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83501472|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83501473|NCT01234922|Protective Agents|protective agents|mesh-ancestor
83501474|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501475|NCT01337336|Fluticasone|fluticasone|mesh-list
83501477|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
83501478|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83501479|NCT01337336|Ipratropium|ipratropium|mesh-list
83501480|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83501481|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83501482|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83501483|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
83501484|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501485|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501486|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83501487|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
83501488|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
83501489|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83501490|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
83501491|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
83501492|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83501493|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501494|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83501495|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83501496|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83501497|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482710|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482711|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83482712|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83482713|NCT00423878|Olanzapine|olanzapine|mesh-list
83482714|NCT00423878|Risperidone|risperidone|mesh-list
83482715|NCT00423878|Aripiprazole|aripiprazole|mesh-list
83482716|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83482717|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83482718|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
83482719|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482720|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482721|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482722|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83482723|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83482724|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83482725|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83482726|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83482727|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
83482728|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
83482729|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
83482730|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482731|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83482732|NCT00423878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83482733|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83482734|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83482735|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
83482736|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
83482737|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83482738|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83482739|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83482740|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83482741|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
83482742|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83482743|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501498|NCT01239212|Levetiracetam|levetiracetam|mesh-list
83501499|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
83501500|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
83501501|NCT01242644|Ketorolac|ketorolac|mesh-list
83501502|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83501503|NCT01242644|Morphine|morphine|mesh-list
83501504|NCT01242644|Ropivacaine|ropivacaine|mesh-list
83501505|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83501506|NCT01242644|Narcotics|narcotics|mesh-ancestor
83501507|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501508|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501509|NCT01242644|Analgesics|analgesics|mesh-ancestor
83501510|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
83482744|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482745|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83482746|NCT00480740|Analgesics|analgesics|mesh-ancestor
83482747|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
83482748|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83482749|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83482750|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83482751|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83482752|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482753|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83482754|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83482755|NCT00424502|Rituximab|rituximab|mesh-list
83482756|NCT00424502|Methotrexate|methotrexate|mesh-list
83482757|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83482758|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83482759|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
83482760|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482761|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83482762|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83482763|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
83482764|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83501735|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
83501736|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
83501737|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83501738|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83501739|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
83501740|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83501741|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83501742|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83501743|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83501744|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83501745|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502049|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
83502050|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502051|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502052|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
83502053|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502054|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83502055|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
83502056|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502057|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83502058|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83502059|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83502060|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502061|NCT01349972|Analgesics|analgesics|mesh-ancestor
83502062|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
83502063|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502064|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
83502065|NCT01349972|Growth Substances|growth substances|mesh-ancestor
83133034|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133035|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133037|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83133038|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83133039|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
83133040|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133041|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133042|NCT02103205|Iron|iron|mesh-list
83133043|NCT02103205|Lactoferrin|lactoferrin|mesh-list
83133044|NCT02103205|Trace Elements|trace elements|mesh-ancestor
83133046|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133047|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133048|NCT03290703|Rabeprazole|rabeprazole|mesh-list
83133049|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83133050|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133051|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83133052|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133053|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133054|NCT02408068|Dexamethasone|dexamethasone|mesh-list
83133055|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
83133056|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83133057|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83133058|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83502289|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83502290|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83502291|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83502292|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
83502293|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
83502294|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83502295|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502296|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502298|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83502299|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502300|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502301|NCT01316042|Metformin|metformin|mesh-list
83502302|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83502303|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502304|NCT01754909|Enalapril|enalapril|mesh-list
83502305|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83502306|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
83502307|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502308|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502457|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
83502458|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502459|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502460|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
83502461|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502462|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83502463|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83502464|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83502465|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502466|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502468|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83502469|NCT01355588|Lidocaine|lidocaine|mesh-list
83502470|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
83502471|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
83502472|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83502473|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502474|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
83502475|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502476|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83502477|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83502478|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83502479|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83502480|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502557|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83502558|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
83502559|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502560|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83502561|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83502562|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83502563|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
83502564|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83502565|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83502566|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83502567|NCT05315999|Palonosetron|palonosetron|mesh-list
83502568|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
83502569|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
83502570|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502571|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502572|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83502573|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83502574|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83502575|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
83502576|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502577|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502578|NCT01763645|Paclitaxel|paclitaxel|mesh-list
83502579|NCT01763645|Bevacizumab|bevacizumab|mesh-list
83502580|NCT01763645|Carboplatin|carboplatin|mesh-list
83502581|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83502582|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502583|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
83502584|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
83502585|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
83502586|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502587|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83502588|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83502745|NCT01364090|Interferons|interferons|mesh-list
83502746|NCT01364090|Ribavirin|ribavirin|mesh-list
83502747|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
83502748|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
83502749|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83502750|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83502751|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
83502752|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83502753|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
83502754|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83502755|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
83502756|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83502757|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
83502758|NCT03684785|Cemiplimab|cemiplimab|mesh-list
83503213|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83503214|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83503215|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
83503216|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503217|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83503218|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83503219|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503220|NCT02327741|Clopidogrel|clopidogrel|mesh-list
83503221|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83503222|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83503223|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83503374|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83503375|NCT05049525|Terbinafine|terbinafine|mesh-list
83503376|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
83503377|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83503378|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83472111|NCT00004858|Hormones|hormones|mesh-ancestor
83503379|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83503380|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83503381|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83503382|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83503384|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83503385|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503386|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83503387|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
83503388|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
83503389|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83503390|NCT02639637|Valsartan|valsartan|mesh-list
83503391|NCT02639637|Enalaprilat|enalaprilat|mesh-list
83503392|NCT02639637|Enalapril|enalapril|mesh-list
83503393|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83503394|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503395|NCT02639637|Incretins|incretins|mesh-ancestor
83503396|NCT02639637|Hormones|hormones|mesh-ancestor
83503469|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83503471|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
83503472|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
83503473|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83503474|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
83503475|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
83503476|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83503477|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83503478|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83503479|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
83503480|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83503481|NCT01333592|Mitiglinide|mitiglinide|mesh-list
83503482|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83503483|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503484|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
83503485|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83503486|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83503487|NCT01267292|Buspirone|buspirone|mesh-list
83503488|NCT01267292|Methylphenidate|methylphenidate|mesh-list
83504085|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
83504086|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83504087|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
83504088|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83504089|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
83504090|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504091|NCT01394510|Expectorants|expectorants|mesh-ancestor
83504092|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504093|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83504094|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
83504095|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504096|NCT01394510|Protective Agents|protective agents|mesh-ancestor
83504097|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504098|NCT01394510|Antidotes|antidotes|mesh-ancestor
83504099|NCT05580549|Ethanol|ethanol|mesh-list
83504100|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83504101|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504102|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504103|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504104|NCT05327621|Pamiparib|pamiparib|mesh-list
83504105|NCT05327621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83504106|NCT05327621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504107|NCT05327621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133059|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83133060|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
83133061|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
83133062|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133063|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133065|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
83133066|NCT02408068|Hormones|hormones|mesh-ancestor
83133067|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133068|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83133069|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133070|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
83133071|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83133072|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
83133073|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133074|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
83133075|NCT02465853|Protective Agents|protective agents|mesh-ancestor
83133076|NCT02465385|Linaclotide|linaclotide|mesh-list
83133077|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83133078|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
83133079|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133080|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133081|NCT05050604|Choline|choline|mesh-list
83133082|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
83133083|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83133084|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
83133085|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133086|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133087|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133088|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
83133089|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
83133090|NCT03290625|Ketamine|ketamine|mesh-list
83133091|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83133092|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133093|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133094|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83133095|NCT03290625|Analgesics|analgesics|mesh-ancestor
83133096|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
83133097|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133098|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83504185|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83504186|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504187|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
83504188|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504189|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83504190|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83504191|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
83504192|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83504193|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504194|NCT04172961|Cyclosporine|cyclosporine|mesh-list
83504195|NCT04172961|Lifitegrast|lifitegrast|mesh-list
83504196|NCT04172961|Cyclosporins|cyclosporins|mesh-list
83504197|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83504198|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504656|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
83504657|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504658|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504660|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83504661|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
83504662|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83504663|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504664|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83504665|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
83504666|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83504667|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
83504897|NCT02651259|Isoniazid|isoniazid|mesh-list
83504898|NCT02651259|Rifapentine|rifapentine|mesh-list
83504899|NCT02651259|Rifamycins|rifamycins|mesh-list
83504900|NCT02651259|Hydrazine|hydrazine|mesh-list
83504901|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
83504902|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504903|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
83504904|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83504905|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83504906|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83504908|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
83504909|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83504910|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83504911|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83504912|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
83504913|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83504914|NCT02271425|Evacetrapib|evacetrapib|mesh-list
83504915|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83504916|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83504917|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
83504992|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
83504993|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
83504994|NCT03021083|Fentanyl|fentanyl|mesh-list
83504995|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83504996|NCT03021083|Narcotics|narcotics|mesh-ancestor
83504997|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83504998|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83504999|NCT03021083|Analgesics|analgesics|mesh-ancestor
83505000|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
83505077|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
83505078|NCT02664909|Coagulants|coagulants|mesh-ancestor
83505079|NCT00368589|Atorvastatin|atorvastatin|mesh-list
83505080|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83505081|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83505082|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
83505083|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505084|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133099|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83133100|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83133101|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
83133102|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133103|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133104|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83133105|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83133107|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
83133108|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83133109|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83133110|NCT02250781|TIC10 compound|tic10 compound|mesh-list
83133111|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133112|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
83133113|NCT03099122|Prednisone|prednisone|mesh-list
83133114|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
83133115|NCT03099122|Tacrolimus|tacrolimus|mesh-list
83133116|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
83133117|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83133118|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
83133119|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83133120|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
83133122|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133123|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133124|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83133125|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133126|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133127|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
83133128|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83133129|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133130|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133131|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83133132|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83133133|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
83133134|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83133135|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133137|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
83133138|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133139|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133140|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83133141|NCT03099122|Protective Agents|protective agents|mesh-ancestor
83133142|NCT04335201|Defibrotide|defibrotide|mesh-list
83133143|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83133144|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83133145|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133146|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83133147|NCT03295851|Iron|iron|mesh-list
83133148|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
83133149|NCT03295851|Trace Elements|trace elements|mesh-ancestor
83133150|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
83133151|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133152|NCT03096470|Anesthetics|anesthetics|mesh-list
83133153|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133154|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133155|NCT02100553|Itraconazole|itraconazole|mesh-list
83133156|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83133157|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
83133158|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133159|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83133160|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83133161|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133162|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133163|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83133164|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
83133165|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133166|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133167|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83133168|NCT05389813|Pregabalin|pregabalin|mesh-list
83133169|NCT05389813|Oxycodone|oxycodone|mesh-list
83133170|NCT05389813|Analgesics|analgesics|mesh-ancestor
83133171|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
83133172|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133173|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133174|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
83133175|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83133176|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133177|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133178|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83133180|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83133181|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133182|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83133183|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83133184|NCT05389813|Narcotics|narcotics|mesh-ancestor
83133185|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83133186|NCT02100787|Laxatives|laxatives|mesh-ancestor
83133187|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133188|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83133189|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83133190|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133191|NCT04718805|Darunavir|darunavir|mesh-list
83133192|NCT04718805|Cobicistat|cobicistat|mesh-list
83133193|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83133194|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83133195|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83133196|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
83133197|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133198|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133199|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83133200|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83133201|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
83133202|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133203|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83133204|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83133205|NCT05042336|Lenvatinib|lenvatinib|mesh-list
83133206|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133207|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83133208|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505157|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
83505158|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505159|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505160|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83505161|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83505162|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505163|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83505317|NCT00367965|Zopiclone|zopiclone|mesh-list
83505318|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83505319|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505320|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505321|NCT02904291|Amlodipine|amlodipine|mesh-list
83505322|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83505323|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83505324|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505325|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505326|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83505327|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505328|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
83505329|NCT02683161|Varenicline|varenicline|mesh-list
83505330|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83505331|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83505332|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
83505333|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505334|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505335|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505336|NCT02683707|Lidocaine|lidocaine|mesh-list
83505337|NCT02683707|Fentanyl|fentanyl|mesh-list
83505339|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
83505340|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
83505341|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505342|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505343|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
83505344|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505345|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83221023|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83505346|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83505347|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83505348|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133209|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133210|NCT03096392|Insulin|insulin|mesh-list
83133211|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83133212|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
83133213|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83133214|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133215|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
83133216|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83133217|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83133218|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505653|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
83505654|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83505655|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505656|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
83505657|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83505658|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83505659|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83505660|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83505661|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83505662|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505663|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83505664|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83505665|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83505666|NCT04732455|Analgesics|analgesics|mesh-ancestor
83505667|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
83505668|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83505669|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
83133219|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133220|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133221|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83133222|NCT02460393|Antibodies|antibodies|mesh-list
83133223|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
83133224|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83133225|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
83133226|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133227|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133228|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83133230|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133231|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
83133232|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83133233|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133234|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
83133235|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
83133236|NCT03295383|Rituximab|rituximab|mesh-list
83133237|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133238|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
83133239|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133240|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83505670|NCT04306965|Apremilast|apremilast|mesh-list
83505967|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505968|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505969|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
83505970|NCT04135989|Everolimus|everolimus|mesh-list
83505971|NCT04135989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83505972|NCT04135989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83505973|NCT04135989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83472114|NCT00004864|Docetaxel|docetaxel|mesh-list
83505974|NCT04135989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505975|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83505976|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
83505977|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505978|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505979|NCT02011971|Vinpocetine|vinpocetine|mesh-list
83505980|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83505982|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505983|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
83505984|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83505985|NCT02011971|Protective Agents|protective agents|mesh-ancestor
83505986|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83505987|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
83505988|NCT01854255|Cisplatin|cisplatin|mesh-list
83505989|NCT01854255|Doxorubicin|doxorubicin|mesh-list
83505990|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83505991|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83505992|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83505993|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83505994|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83505995|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83505996|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83505997|NCT01555281|Nelfinavir|nelfinavir|mesh-list
83505998|NCT01555281|Dexamethasone|dexamethasone|mesh-list
83505999|NCT01555281|Lenalidomide|lenalidomide|mesh-list
83506000|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506001|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
83506002|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
83506003|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506004|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506005|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506006|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
83506007|NCT01555281|Hormones|hormones|mesh-ancestor
83506008|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506009|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83506010|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506011|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
83506012|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83506013|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83506014|NCT01555281|Growth Substances|growth substances|mesh-ancestor
83506015|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83506016|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83506017|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83506018|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83506019|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506020|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506021|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83506022|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83506023|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
83506024|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506025|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
83506026|NCT04938765|Analgesics|analgesics|mesh-ancestor
83506027|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
83506028|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506029|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506030|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
83506031|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506032|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83506033|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
83506034|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83506035|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83506036|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506037|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83506038|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
83506039|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83506040|NCT00370539|Triamcinolone|triamcinolone|mesh-list
83506041|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83506042|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83506043|NCT00370539|Bevacizumab|bevacizumab|mesh-list
83506044|NCT00370539|Verteporfin|verteporfin|mesh-list
83530328|NCT04265053|Hormones|hormones|mesh-ancestor
83133241|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83133242|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
83221024|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133243|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133244|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133245|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83133246|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83133248|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
83133249|NCT02101255|Protective Agents|protective agents|mesh-ancestor
83133250|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133252|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
83133253|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133254|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83133255|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83133256|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133257|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133258|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83133259|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
83133260|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133261|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133262|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83133263|NCT02104297|Remifentanil|remifentanil|mesh-list
83133264|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83133265|NCT02104297|Narcotics|narcotics|mesh-ancestor
83506344|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83506345|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83506346|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83506347|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83506348|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506349|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
83506350|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83133266|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133267|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133268|NCT02104297|Analgesics|analgesics|mesh-ancestor
83133269|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
83133270|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133271|NCT02106481|Ropivacaine|ropivacaine|mesh-list
83133272|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
83133273|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
83133274|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133275|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133276|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
83133277|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133278|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83133280|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133281|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
83506426|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
83506427|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83506428|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506429|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83506430|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
83506431|NCT03289299|Hormones|hormones|mesh-ancestor
83506432|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83506433|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83506434|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83506435|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
83506436|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83506437|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83506438|NCT03289299|Growth Substances|growth substances|mesh-ancestor
83506439|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
83506440|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83506441|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83506442|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83133282|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83133283|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
83133284|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83133285|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83133286|NCT05047874|Prednisolone|prednisolone|mesh-list
83133287|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
83133288|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83133289|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
83133290|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83133291|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
83133292|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
83133293|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133294|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133295|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133296|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
83133297|NCT05047874|Hormones|hormones|mesh-ancestor
83133298|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133299|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83133300|NCT05047874|Protective Agents|protective agents|mesh-ancestor
83133301|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83133302|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133303|NCT04488705|Albuterol|albuterol|mesh-list
83133304|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83133305|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
83133306|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133307|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133308|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83133309|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
83133310|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
83133311|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83133312|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83133313|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83133314|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83133315|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
83133316|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133317|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133318|NCT02106637|Varenicline|varenicline|mesh-list
83133319|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83133320|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83133321|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
83133322|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133323|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133324|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133325|NCT05062304|Fluticasone|fluticasone|mesh-list
83133326|NCT05062304|Xhance|xhance|mesh-list
83133327|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83506516|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
83506517|NCT02762331|Vitamins|vitamins|mesh-ancestor
83506518|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
83506519|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506520|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
83506521|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506522|NCT02762331|Protective Agents|protective agents|mesh-ancestor
83506523|NCT02762799|Lenograstim|lenograstim|mesh-list
83506524|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83506525|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
83506526|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506527|NCT01447706|Paclitaxel|paclitaxel|mesh-list
83530403|NCT01992523|Ticagrelor|ticagrelor|mesh-list
83133328|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83133329|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
83133330|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133331|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133332|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83133333|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83133334|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
83133335|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83133337|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133338|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
83506751|NCT01454414|Permethrin|permethrin|mesh-list
83506752|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506753|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83506754|NCT04335513|Insulin|insulin|mesh-list
83506755|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83506756|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506757|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83506758|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83506759|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
83506760|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83506761|NCT01568528|Oxytocin|oxytocin|mesh-list
83506762|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
83506763|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83133339|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133340|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
83133341|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83133342|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
83133343|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83133344|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133345|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83133346|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83133347|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83133348|NCT02106793|Mitomycins|mitomycins|mesh-list
83133349|NCT02106793|Mitomycin|mitomycin|mesh-list
83133350|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83133351|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133352|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
83133353|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133354|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83133355|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133356|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83133357|NCT02104843|Asunaprevir|asunaprevir|mesh-list
83133358|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83133359|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83133360|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
83133361|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133362|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133363|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83133364|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133365|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
83133366|NCT05041790|Choline|choline|mesh-list
83133367|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
83133368|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83133370|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133371|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133372|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133373|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
83133374|NCT02105077|Anesthetics|anesthetics|mesh-list
83133375|NCT02105077|Xenon|xenon|mesh-list
83133376|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133377|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133378|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83133379|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
83133380|NCT02101567|Oxytocin|oxytocin|mesh-list
83133382|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
83133383|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83133384|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133385|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
83133386|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83133387|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83133388|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83133389|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133390|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133391|NCT02106871|Urological Agents|urological agents|mesh-ancestor
83133392|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
83133393|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133394|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
83133395|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
83133396|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
83133397|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83133398|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83133399|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133401|NCT02407990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83133402|NCT02407990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133403|NCT02105155|Tacrolimus|tacrolimus|mesh-list
83133404|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133405|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
83133406|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133407|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83133408|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133409|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133410|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83133411|NCT03294525|Mirtazapine|mirtazapine|mesh-list
83133412|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
83133413|NCT03294525|Escitalopram|escitalopram|mesh-list
83133414|NCT03294525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83506991|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
83506992|NCT02787057|Vancomycin|vancomycin|mesh-list
83506993|NCT02787057|Ceftazidime|ceftazidime|mesh-list
83506994|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83506995|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83506996|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83506997|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83506998|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83506999|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507000|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507001|NCT01972347|Trametinib|trametinib|mesh-list
83507002|NCT01972347|Dabrafenib|dabrafenib|mesh-list
83507003|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507004|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83507005|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507006|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507007|NCT01468532|Prednisone|prednisone|mesh-list
83507008|NCT01468532|Docetaxel|docetaxel|mesh-list
83507009|NCT01468532|Pasireotide|pasireotide|mesh-list
83507010|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83507011|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
83507012|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
83507013|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
83507014|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507015|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83507016|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
83507017|NCT01468532|Hormones|hormones|mesh-ancestor
83507018|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83507399|NCT02889393|Protective Agents|protective agents|mesh-ancestor
83507400|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507401|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
83507402|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83507403|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83507404|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83507405|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83507406|NCT02818569|Analgesics|analgesics|mesh-ancestor
83507407|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
83507408|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83507409|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83507410|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83507411|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83507412|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
83507413|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83507414|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507415|NCT03581409|Aspirin|aspirin|mesh-list
83507416|NCT03581409|Cilostazol|cilostazol|mesh-list
83507417|NCT03581409|Clopidogrel|clopidogrel|mesh-list
83507418|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83507419|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83507716|NCT02988089|Metronidazole|metronidazole|mesh-list
83507717|NCT02988089|Clarithromycin|clarithromycin|mesh-list
83507718|NCT02988089|Levofloxacin|levofloxacin|mesh-list
83507719|NCT02988089|Ofloxacin|ofloxacin|mesh-list
83507720|NCT02988089|Tetracycline|tetracycline|mesh-list
83507721|NCT02988089|Tinidazole|tinidazole|mesh-list
83507722|NCT02988089|Furazolidone|furazolidone|mesh-list
83507723|NCT02988089|Bismuth|bismuth|mesh-list
83507724|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83507725|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83507726|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83507727|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83507728|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83507729|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83507730|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83507731|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83133415|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83133417|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133418|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133419|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
83133420|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133421|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133422|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83133423|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83133424|NCT03294525|Analgesics|analgesics|mesh-ancestor
83133425|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
83133426|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
83133427|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83133428|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
83133429|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
83133430|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83133431|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83133432|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133433|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83133434|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83133435|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83133436|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
83133437|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83133438|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83133439|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83133440|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
83133441|NCT05036174|Promethazine|promethazine|mesh-list
83133442|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83133443|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83133444|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133445|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133446|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
83133447|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
83133448|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
83133449|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133450|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
83133451|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
83133452|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133453|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83508037|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83508038|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508039|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83508040|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83508041|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
83508042|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
83508043|NCT02918097|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83508121|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
83508122|NCT02998970|Empagliflozin|empagliflozin|mesh-list
83508123|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83508124|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508125|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83508126|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508127|NCT05406752|Acetaminophen|acetaminophen|mesh-list
83508128|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83508129|NCT05406752|Analgesics|analgesics|mesh-ancestor
83508130|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
83508738|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
83508739|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508740|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83508741|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83508742|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83508743|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
83508744|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83508745|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
83530558|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83508900|NCT04976777|Dexamethasone|dexamethasone|mesh-list
83508901|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508902|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
83508903|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
83508904|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508905|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508906|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508907|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
83508908|NCT04976777|Hormones|hormones|mesh-ancestor
83508909|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83508910|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83508911|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83508912|NCT02247596|Resveratrol|resveratrol|mesh-list
83508913|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
83508914|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508915|NCT02247596|Protective Agents|protective agents|mesh-ancestor
83508916|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508917|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508918|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83508919|NCT03686657|Metformin|metformin|mesh-list
83508920|NCT03686657|Celecoxib|celecoxib|mesh-list
83508921|NCT03686657|Valsartan|valsartan|mesh-list
83508922|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83221026|NCT03175705|Tegafur|tegafur|mesh-list
83508923|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508924|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83508925|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83508926|NCT03686657|Analgesics|analgesics|mesh-ancestor
83508927|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
83508928|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508929|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83508930|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83508931|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83508932|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83508933|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83508934|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83508935|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83508936|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83508937|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83508938|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
83508939|NCT02476058|Promethazine|promethazine|mesh-list
83508940|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83508941|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83508942|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83508943|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83508944|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
83508945|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
83508946|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
83508947|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83508948|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
83508949|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
83508950|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83508951|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83508952|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
83508953|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
83508954|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133454|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
83133455|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
83133456|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133457|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133458|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83133459|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
83133460|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
83133461|NCT03283059|Donepezil|donepezil|mesh-list
83133462|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83133463|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133464|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133465|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
83133466|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133467|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133468|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
83133469|NCT05060588|Valsartan|valsartan|mesh-list
83133470|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83133471|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83133472|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83133473|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83133474|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133475|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83133476|NCT02105311|Travoprost|travoprost|mesh-list
83133477|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83133478|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83133479|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133480|NCT03554395|Antibodies|antibodies|mesh-list
83133481|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83133482|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
83133483|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133484|NCT03282825|Paclitaxel|paclitaxel|mesh-list
83133485|NCT03282825|Decitabine|decitabine|mesh-list
83133486|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83133487|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133488|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83133489|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83133490|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83133491|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133492|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83133493|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
83133494|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82763399|NCT05332587|Rituximab|rituximab|mesh-list
83133495|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83133496|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83133497|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83133498|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
83133499|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133500|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83133501|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83133502|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133503|NCT05039606|Nedaplatin|nedaplatin|mesh-list
83133504|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133505|NCT03288051|Dobutamine|dobutamine|mesh-list
83133506|NCT03288051|Norepinephrine|norepinephrine|mesh-list
83509335|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
83509336|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83509337|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
83509338|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
83509339|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
83509340|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83509341|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
83509342|NCT01691534|Clofazimine|clofazimine|mesh-list
83509343|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
83509344|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509345|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509346|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509347|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
83509348|NCT01691690|Acetaminophen|acetaminophen|mesh-list
83509349|NCT01691690|Dexamethasone|dexamethasone|mesh-list
83509350|NCT01691690|Midazolam|midazolam|mesh-list
83509351|NCT01691690|Morphine|morphine|mesh-list
83509352|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
83509353|NCT01691690|Ondansetron|ondansetron|mesh-list
83509354|NCT01691690|Propofol|propofol|mesh-list
83509355|NCT01691690|Sevoflurane|sevoflurane|mesh-list
83509356|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509357|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
83509358|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
83509359|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509360|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509361|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83509362|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
83509363|NCT01691690|Hormones|hormones|mesh-ancestor
83509364|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509365|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83509366|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509367|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83509368|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83509369|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83509370|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
83509371|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
83509372|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83509373|NCT01691690|Narcotics|narcotics|mesh-ancestor
83509374|NCT01691690|Analgesics|analgesics|mesh-ancestor
83509375|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
83509376|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83509377|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83509378|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83509379|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509380|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
83509382|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509383|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509384|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83509385|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
83472138|NCT00003814|Eflornithine|eflornithine|mesh-list
83509386|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83509387|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83509388|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
83509389|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
83509390|NCT01691690|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83509391|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83509392|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
83509393|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
83509394|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83509395|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
83509396|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509397|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83509398|NCT02283827|Phenytoin|phenytoin|mesh-list
83509399|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
83509400|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83509401|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83530942|NCT01960075|Levetiracetam|levetiracetam|mesh-list
83509557|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
83509558|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
83509559|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509560|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
83509561|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509562|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509563|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
83509564|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83509565|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83509566|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509567|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83509568|NCT01938989|Hormones|hormones|mesh-ancestor
83509569|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83509570|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
83509571|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83509572|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
83509573|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509574|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509575|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83509576|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
83509577|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83509578|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
83509579|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509580|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509581|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83509582|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
83509583|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
83509584|NCT01939301|Protective Agents|protective agents|mesh-ancestor
83509586|NCT03078075|Bupropion|bupropion|mesh-list
83509587|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83509588|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83509589|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509590|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
83509591|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509592|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83509593|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
83509594|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509595|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83509596|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83509597|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83509598|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509599|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
83509600|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509601|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83509602|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83509603|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83509604|NCT01926977|Ranibizumab|ranibizumab|mesh-list
83509605|NCT01926977|Aflibercept|aflibercept|mesh-list
83509606|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83509607|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83509608|NCT01926977|Growth Substances|growth substances|mesh-ancestor
83509609|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509610|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
83509611|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509613|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
83509614|NCT01928693|Besifloxacin|besifloxacin|mesh-list
83509615|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83509616|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83509617|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83509618|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509619|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509620|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83509696|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
83509697|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509698|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509699|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83509700|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83509701|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83509702|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83509703|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
83509704|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
83509705|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83509706|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83509707|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
83509708|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83509709|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509710|NCT03076112|Incretins|incretins|mesh-ancestor
83509711|NCT03076112|Hormones|hormones|mesh-ancestor
83509785|NCT03134703|Analgesics|analgesics|mesh-ancestor
83509786|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
83509787|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83509788|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
83509789|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
83509790|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83509791|NCT01951391|Triclocarban|triclocarban|mesh-list
83509792|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83509793|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509794|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
83509795|NCT02342886|Rifampin|rifampin|mesh-list
83509796|NCT02342886|Isoniazid|isoniazid|mesh-list
83509797|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
83509798|NCT02342886|Ethambutol|ethambutol|mesh-list
83509799|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83509800|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83509801|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83133507|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83133508|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83133509|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83133510|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133511|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133512|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133514|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
83133515|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133516|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83133517|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83133518|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83133519|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83133520|NCT03288051|Protective Agents|protective agents|mesh-ancestor
83133522|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
83133523|NCT05035472|Norepinephrine|norepinephrine|mesh-list
83133524|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83133525|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83133526|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
83133527|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
83133528|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133529|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133530|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
83133531|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
83133532|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
83133533|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83133534|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83133535|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83133536|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
83133537|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133538|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133539|NCT05035472|Protective Agents|protective agents|mesh-ancestor
83133540|NCT02460627|Lidocaine|lidocaine|mesh-list
83133541|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
83133542|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
83509951|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83509952|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
83509953|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83509954|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83509955|NCT04707027|Aflibercept|aflibercept|mesh-list
83509956|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83509957|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83509958|NCT04707027|Growth Substances|growth substances|mesh-ancestor
83509959|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83509960|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
83509961|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83509962|NCT01602068|Dexamethasone|dexamethasone|mesh-list
83509963|NCT01602068|Citric Acid|citric acid|mesh-list
83509964|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
83510344|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
83510345|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83510346|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83510347|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510348|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
83510349|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
83510350|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510351|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
83510352|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83510353|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
83510354|NCT03028883|Buprenorphine|buprenorphine|mesh-list
83510355|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83510356|NCT03028883|Narcotics|narcotics|mesh-ancestor
83510357|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83510358|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510359|NCT03028883|Analgesics|analgesics|mesh-ancestor
83510360|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
83510361|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83510362|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83510363|NCT05238467|Antibodies|antibodies|mesh-list
83510364|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
83510365|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83510366|NCT02290613|Ambrisentan|ambrisentan|mesh-list
83510367|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83510368|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
83510369|NCT05736419|Dexamethasone|dexamethasone|mesh-list
83510370|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
83173243|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173244|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173245|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
83173246|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173247|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173248|NCT00660881|Epratuzumab|epratuzumab|mesh-list
83173249|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173250|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173251|NCT02359552|Rasagiline|rasagiline|mesh-list
83173252|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83173253|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173254|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478128|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
83478129|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
83478130|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478131|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478132|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478133|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
83478134|NCT02106494|Hormones|hormones|mesh-ancestor
83478135|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83478136|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83478137|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478138|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
83478139|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
83478140|NCT02106494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83478141|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83478142|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
83173255|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83173257|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173258|NCT02279537|Aflibercept|aflibercept|mesh-list
83173259|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83173260|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83173261|NCT02279537|Growth Substances|growth substances|mesh-ancestor
83173262|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173263|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
83173264|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173265|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
83173266|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83173267|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83173268|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83173269|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173270|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173271|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
83173272|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173273|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173274|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83173275|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173276|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
83173277|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83173278|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83173279|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83173280|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173281|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173282|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
83173283|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173284|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173285|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83173286|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173287|NCT00656357|Cocaine|cocaine|mesh-list
83173288|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
83173289|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
83173290|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173291|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173292|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
83173293|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83541494|NCT02626455|Vincristine|vincristine|mesh-list
83173294|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83173295|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83173296|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83173297|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173298|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173299|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
83173300|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173301|NCT02280629|Mesalamine|mesalamine|mesh-list
83173302|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83173303|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83173304|NCT02280629|Analgesics|analgesics|mesh-ancestor
83542096|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
83542097|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542098|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542099|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542100|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
83542101|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542102|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542179|NCT00104884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542180|NCT00096174|Cisplatin|cisplatin|mesh-list
83542181|NCT00096174|Cetuximab|cetuximab|mesh-list
83542182|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542183|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542184|NCT00080938|Temozolomide|temozolomide|mesh-list
83542185|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83542187|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83542188|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542189|NCT00078949|Cytarabine|cytarabine|mesh-list
83542190|NCT00078949|Dexamethasone|dexamethasone|mesh-list
83542191|NCT00078949|Rituximab|rituximab|mesh-list
83542192|NCT00078949|Gemcitabine|gemcitabine|mesh-list
83542193|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83542194|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83542195|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
83542196|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83542197|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83542198|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83542199|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
83542200|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
83542201|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173305|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
83173306|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173307|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173308|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173309|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173311|NCT03134573|Interferon-beta|interferon-beta|mesh-list
83173312|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
83173313|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173314|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
83173315|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173316|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
83173317|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173318|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83173319|NCT00743795|Ribavirin|ribavirin|mesh-list
83173320|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83173321|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
83173322|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173323|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
83173324|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173326|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83173327|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173328|NCT03134417|Vitamin D|vitamin d|mesh-list
83173329|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
83173330|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
83173331|NCT03134417|Vitamins|vitamins|mesh-list
83173332|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
83173333|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173334|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83173335|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83173336|NCT00649025|Fluticasone|fluticasone|mesh-list
83173337|NCT00649025|Xhance|xhance|mesh-list
83173338|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173339|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83173340|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
83173341|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173342|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173343|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83173344|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173345|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
83173346|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83133567|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133569|NCT02107807|Vaccines|vaccines|mesh-list
83133570|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
83133571|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133572|NCT02107807|Cathartics|cathartics|mesh-ancestor
83133573|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133574|NCT01673282|Lacosamide|lacosamide|mesh-list
83133575|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
83133576|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83133577|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83173347|NCT00647231|Ketoprofen|ketoprofen|mesh-list
83133578|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133579|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133580|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83133581|NCT02113735|Hormones|hormones|mesh-ancestor
83133582|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133583|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133585|NCT02113813|Midazolam|midazolam|mesh-list
83133586|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83133587|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83133588|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133589|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133591|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83133592|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83133593|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83133594|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
83133595|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
83133596|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
83133597|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
83133598|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133599|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133600|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133601|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83133602|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133603|NCT03095144|Anesthetics|anesthetics|mesh-list
83133604|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133605|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133607|NCT03095222|Analgesics|analgesics|mesh-ancestor
83133608|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
83133609|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133610|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133611|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83133612|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83133613|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
83133614|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
83133615|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133616|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83133617|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83133618|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133619|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133620|NCT02113891|Eculizumab|eculizumab|mesh-list
83133621|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83133622|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133623|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
83133624|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133625|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
83133626|NCT03095378|Tetracycline|tetracycline|mesh-list
83133627|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83133628|NCT03095378|Citric Acid|citric acid|mesh-list
83133629|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
83133630|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83133631|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133632|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133633|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
83133634|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83133635|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
83133636|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
83133638|NCT05025098|Venetoclax|venetoclax|mesh-list
83133639|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83133640|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
83133641|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133642|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133643|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133644|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
83133645|NCT05038202|Bromides|bromides|mesh-list
83133647|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83133648|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83133649|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83133650|NCT02114359|Cisplatin|cisplatin|mesh-list
83133651|NCT02114359|Fluorouracil|fluorouracil|mesh-list
83133652|NCT02114359|Capecitabine|capecitabine|mesh-list
83133653|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
83133654|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133655|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
83133656|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133657|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83133658|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133659|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
83133660|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133661|NCT02110303|Ticagrelor|ticagrelor|mesh-list
83133662|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83133663|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83133664|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83133665|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83133666|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
83133667|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133668|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133669|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133670|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
83133671|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83133672|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
83133673|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133674|NCT02108353|Melatonin|melatonin|mesh-list
83133675|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
83133676|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133677|NCT02108353|Protective Agents|protective agents|mesh-ancestor
83133678|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133679|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133680|NCT04157751|Empagliflozin|empagliflozin|mesh-list
83133681|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83133682|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133683|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83133684|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133685|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
83133687|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133688|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83133689|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83133690|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133691|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133692|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133693|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83133694|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83133695|NCT02110459|Murepavadin|murepavadin|mesh-list
83133696|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83133697|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133698|NCT03287505|Aripiprazole|aripiprazole|mesh-list
83133699|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
83133700|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83133701|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83133702|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83133703|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133704|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133705|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
83133706|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
83133707|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133708|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133709|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83133710|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83133711|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
83133712|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83133713|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83133714|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83133715|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83133716|NCT03090698|Triamcinolone|triamcinolone|mesh-list
83133718|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83133719|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
83133720|NCT03090698|Hormones|hormones|mesh-ancestor
83133721|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133722|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133723|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
83133724|NCT03090698|Protective Agents|protective agents|mesh-ancestor
83133725|NCT03293511|Oxytocin|oxytocin|mesh-list
83133726|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
83133727|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83133728|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133729|NCT02251171|Ritonavir|ritonavir|mesh-list
83133730|NCT02251171|Tipranavir|tipranavir|mesh-list
83133731|NCT02251171|Rifabutin|rifabutin|mesh-list
83133732|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83133733|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83133734|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
83133735|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133736|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133737|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83133738|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83133739|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
83133740|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133741|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83133742|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83133743|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83133744|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83133745|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
83133746|NCT02110537|Flecainide|flecainide|mesh-list
83133747|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83133748|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83133749|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83133750|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133751|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133752|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
83133753|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83133754|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133755|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133756|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83133757|NCT03293277|Analgesics|analgesics|mesh-ancestor
83133758|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
83133759|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133760|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83133761|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83133762|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83133763|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
83133764|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133765|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133766|NCT02108743|Albuterol|albuterol|mesh-list
83133767|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83133768|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
83133769|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133770|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133771|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83133772|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
83133773|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
83133774|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83133775|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83133776|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83133777|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83133778|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
83133779|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133780|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133781|NCT03292965|Neostigmine|neostigmine|mesh-list
83133782|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83133783|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133784|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133785|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
83133786|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133787|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133788|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83133789|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
83133790|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133791|NCT05024084|Anesthetics|anesthetics|mesh-list
83133792|NCT05024084|Sevoflurane|sevoflurane|mesh-list
83133793|NCT05024084|Desflurane|desflurane|mesh-list
83133794|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133795|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133796|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83133797|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83133798|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
83133799|NCT02109289|Etanercept|etanercept|mesh-list
83133800|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83133801|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83133802|NCT02109289|Analgesics|analgesics|mesh-ancestor
83133803|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
83133804|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133805|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133806|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83133807|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83133808|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133809|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133810|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
83133811|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83133812|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83133813|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83133814|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
83133815|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133816|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133817|NCT03292731|Progestins|progestins|mesh-ancestor
83133818|NCT03292731|Hormones|hormones|mesh-ancestor
83133819|NCT03553303|Valsartan|valsartan|mesh-list
83133820|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83133821|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83133822|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83133823|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83133824|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133826|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83133827|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133828|NCT03292575|Anticoagulants|anticoagulants|mesh-list
83133829|NCT02115529|Nabilone|nabilone|mesh-list
83133830|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
83133831|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
83133832|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133833|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133834|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83133835|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83133836|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83133837|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133838|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83133839|NCT01652716|Exenatide|exenatide|mesh-list
83133840|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83133841|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133842|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83133843|NCT01652716|Incretins|incretins|mesh-ancestor
83133844|NCT01652716|Hormones|hormones|mesh-ancestor
83133845|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133846|NCT02459613|Annexin A5|annexin a5|mesh-list
83133847|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133848|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133849|NCT02251249|Acetaminophen|acetaminophen|mesh-list
83133850|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83133852|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
83133853|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133854|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133855|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
83133856|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
83133857|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83133858|NCT03292263|Nivolumab|nivolumab|mesh-list
83133859|NCT03292263|Melphalan|melphalan|mesh-list
83133860|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83133861|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133862|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83478143|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133863|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133864|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83133865|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
83133866|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83133867|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133868|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
83133869|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133870|NCT02115763|Caffeine|caffeine|mesh-list
83133871|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83133872|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133873|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83133874|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133875|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133876|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83133877|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83133878|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
83133879|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133882|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133883|NCT03292185|Insulin|insulin|mesh-list
83133884|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83133885|NCT03292185|Liraglutide|liraglutide|mesh-list
83133886|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
83133887|NCT03292185|Xultophy|xultophy|mesh-list
83133888|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83133889|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133890|NCT03292185|Incretins|incretins|mesh-ancestor
83133891|NCT03292185|Hormones|hormones|mesh-ancestor
83478293|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83478294|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
83478295|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83478296|NCT01189409|Sennosides|sennosides|mesh-list
83478297|NCT01189409|Laxatives|laxatives|mesh-ancestor
83478298|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478299|NCT03010475|Furosemide|furosemide|mesh-list
83478300|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83478301|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83478302|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83478303|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
83478304|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478305|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83221027|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133892|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133894|NCT04239339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83133895|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83133896|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133897|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133898|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133899|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
83133900|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133901|NCT02109679|Metformin|metformin|mesh-list
83133902|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83133903|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133905|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83133906|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
83133907|NCT05023304|Hormones|hormones|mesh-ancestor
83133908|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133909|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133910|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83133911|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133912|NCT02109913|Everolimus|everolimus|mesh-list
83133913|NCT02109913|Exemestane|exemestane|mesh-list
83133914|NCT02109913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83133915|NCT02109913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83133916|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133917|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133918|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133919|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
83133920|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133921|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133922|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83133923|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83133924|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83133925|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
83133926|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83133928|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133929|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
83133930|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83133931|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
83133932|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
83133933|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83133934|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
83133935|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133936|NCT02116465|Levodopa|levodopa|mesh-list
83133937|NCT02116465|Carbidopa|carbidopa|mesh-list
83133938|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83133940|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83133941|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
83133942|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133943|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133944|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133945|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83133946|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133947|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83133948|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
83133949|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
83133950|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83133951|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83133952|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
83133953|NCT02119117|Vitamins|vitamins|mesh-ancestor
83133954|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
83133955|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133956|NCT05016128|Ketamine|ketamine|mesh-list
83133957|NCT05016128|Esketamine|esketamine|mesh-list
83133958|NCT05016128|Analgesics|analgesics|mesh-ancestor
83133959|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
83133960|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83133961|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133962|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83133963|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83133964|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
83133965|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
83133966|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83133967|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83133968|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83133969|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83133970|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133971|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
83133972|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83133973|NCT02111317|Verapamil|verapamil|mesh-list
83133974|NCT02111317|Peficitinib|peficitinib|mesh-list
83133975|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83133976|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83133977|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83133978|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133979|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83133980|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83133981|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
83133982|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133983|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83133984|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
83133985|NCT03553615|Ivermectin|ivermectin|mesh-list
83133986|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83133987|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133988|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
83133989|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83133990|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83133991|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83133992|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83133993|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83133994|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83133995|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83133996|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83133997|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83133998|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
83133999|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83134000|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134001|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83134002|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83134003|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83134004|NCT02111473|Testosterone|testosterone|mesh-list
83134005|NCT02111473|Androgens|androgens|mesh-ancestor
83134006|NCT02111473|Hormones|hormones|mesh-ancestor
83134007|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134008|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134009|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
83134010|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83134011|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83134012|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
83134013|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134014|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134015|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134016|NCT02119273|Prednisone|prednisone|mesh-list
83134017|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134018|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
83134019|NCT02119273|Hormones|hormones|mesh-ancestor
83134020|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134021|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134022|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134023|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134024|NCT05029076|Liraglutide|liraglutide|mesh-list
83134025|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83134027|NCT05029076|Incretins|incretins|mesh-ancestor
83134028|NCT05029076|Hormones|hormones|mesh-ancestor
83134029|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134030|NCT05016440|Lisinopril|lisinopril|mesh-list
83134031|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83134032|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
83134033|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134034|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134035|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83134036|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83134037|NCT05016440|Protective Agents|protective agents|mesh-ancestor
83134038|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134039|NCT02111629|Fluconazole|fluconazole|mesh-list
83134040|NCT02111629|Secnidazole|secnidazole|mesh-list
83134041|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
83134042|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134043|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83134044|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83134045|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134046|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134047|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83134048|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
83134049|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134050|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389813|NCT04434144|Azithromycin|azithromycin|mesh-list
83389814|NCT04434144|Doxycycline|doxycycline|mesh-list
83389815|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
83389816|NCT04434144|Ivermectin|ivermectin|mesh-list
83389817|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83389818|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389819|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
83389820|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83389821|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83389822|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389823|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389824|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389825|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
83134051|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83134052|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83134053|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83134054|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83134055|NCT02111707|Indomethacin|indomethacin|mesh-list
83134056|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134057|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134058|NCT02111707|Analgesics|analgesics|mesh-ancestor
83472265|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
83134059|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
83134060|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134061|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134062|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134063|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134064|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
83134065|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
83134066|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83134067|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83134068|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134069|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134070|NCT03552601|Methamphetamine|methamphetamine|mesh-list
83134071|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83134072|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134073|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
83134074|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
83389826|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83389974|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389975|NCT03079830|Pirinitramide|pirinitramide|mesh-list
83389976|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83389977|NCT03079830|Narcotics|narcotics|mesh-ancestor
83389978|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389979|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389980|NCT03079830|Analgesics|analgesics|mesh-ancestor
83389981|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
83389982|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389983|NCT02242695|Clotrimazole|clotrimazole|mesh-list
83389984|NCT02242695|Dequalinium|dequalinium|mesh-list
83389985|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83389986|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389987|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
83389988|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83389989|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83389990|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389991|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389992|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83389993|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
83389994|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83389995|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389996|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
83389997|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83389998|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389999|NCT04999800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83390000|NCT04999800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390001|NCT02242851|Telmisartan|telmisartan|mesh-list
83134075|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134076|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
83134077|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134078|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134079|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134080|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83134081|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83134082|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83134083|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83134084|NCT05021588|Anticoagulants|anticoagulants|mesh-list
83134085|NCT03087890|Trimethoprim|trimethoprim|mesh-list
83134086|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83134087|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
83134088|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83134089|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134090|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
83134091|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83134092|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83134093|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83134094|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390077|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83390078|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
83390079|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83390080|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83390081|NCT03076320|Analgesics|analgesics|mesh-ancestor
83390082|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
83390083|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390084|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390085|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83390086|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390087|NCT04365309|Aspirin|aspirin|mesh-list
83390088|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83390089|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83390090|NCT04365309|Analgesics|analgesics|mesh-ancestor
83478385|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478386|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83478387|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83478388|NCT01283555|Tenofovir|tenofovir|mesh-list
83478389|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
83478390|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478391|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83478392|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83478393|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478394|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478395|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83478396|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83478397|NCT01194089|Nicotine|nicotine|mesh-list
83478398|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83478399|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
83478400|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134095|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134096|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83134097|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83134098|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83134099|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83134101|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134102|NCT02117401|Midazolam|midazolam|mesh-list
83134103|NCT02117401|Ketamine|ketamine|mesh-list
83134104|NCT02117401|Remifentanil|remifentanil|mesh-list
83134105|NCT02117401|Propofol|propofol|mesh-list
83134106|NCT02117401|Mivacurium|mivacurium|mesh-list
83134107|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83134108|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134109|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134110|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83134111|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
83134112|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
83134113|NCT02117401|Analgesics|analgesics|mesh-ancestor
83134114|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
83134115|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134116|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83134117|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83134118|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83134119|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390169|NCT05006664|Doxorubicin|doxorubicin|mesh-list
83390170|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83390171|NCT05006664|Etoposide|etoposide|mesh-list
83390172|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
83390173|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83390174|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83390175|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
83390176|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478401|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478402|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83478403|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83478404|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
83478405|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478406|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478407|NCT01650350|Naltrexone|naltrexone|mesh-list
83478409|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83478410|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478411|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
83478412|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478413|NCT00349388|Mesalamine|mesalamine|mesh-list
83478414|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83478415|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83478416|NCT00349388|Analgesics|analgesics|mesh-ancestor
83478417|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
83478418|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478419|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478420|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478421|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478422|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
83478424|NCT00349778|Carmustine|carmustine|mesh-list
83478425|NCT00349778|Etoposide|etoposide|mesh-list
83478426|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
83478427|NCT00349778|Lenograstim|lenograstim|mesh-list
83478428|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478429|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
83478430|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478431|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478432|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83478433|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
83478434|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478435|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478436|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83134120|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134121|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83134122|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83134123|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83134124|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83134125|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
83134126|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
83134127|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83134128|NCT02117401|Narcotics|narcotics|mesh-ancestor
83134129|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83134130|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83134131|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83134132|NCT04434404|Silymarin|silymarin|mesh-list
83134133|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
83134134|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134135|NCT04434404|Protective Agents|protective agents|mesh-ancestor
83134136|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134137|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
83390178|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83390179|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
83390180|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390181|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390182|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83390183|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83390184|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83134138|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83134140|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
83134141|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134142|NCT02117869|Furocoumarins|furocoumarins|mesh-list
83134143|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
83134144|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83134145|NCT02120599|Folic Acid|folic acid|mesh-list
83134146|NCT02120599|Hematinics|hematinics|mesh-ancestor
83134147|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
83134148|NCT02120599|Vitamins|vitamins|mesh-ancestor
83134149|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
83134150|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134151|NCT02112097|Etanercept|etanercept|mesh-list
83134152|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134153|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134154|NCT02112097|Analgesics|analgesics|mesh-ancestor
83134155|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
83134156|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134157|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134158|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134159|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134160|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83134161|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83134163|NCT02112175|Lenalidomide|lenalidomide|mesh-list
83134164|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
83134165|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134166|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83134167|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83134168|NCT02112175|Growth Substances|growth substances|mesh-ancestor
83134169|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
83134170|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134171|NCT03553537|Prednisone|prednisone|mesh-list
83134172|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
83134173|NCT03553537|Doxorubicin|doxorubicin|mesh-list
83134174|NCT03553537|Vincristine|vincristine|mesh-list
83134175|NCT03553537|Decitabine|decitabine|mesh-list
83134176|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83134177|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
83134178|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134179|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134180|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83134181|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
83134182|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134183|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134184|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83134185|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83134186|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83134187|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83134188|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134189|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134190|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
83134192|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134193|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134194|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83134195|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
83134196|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
83134197|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
83134198|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83134199|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
83134200|NCT04434170|Valsartan|valsartan|mesh-list
83134201|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83134202|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83478437|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83478438|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83478439|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83478440|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478441|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83478442|NCT00305084|Doxorubicin|doxorubicin|mesh-list
83478443|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83478444|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478445|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83478446|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83478447|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134203|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83134204|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83134205|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134207|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83134208|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
83134209|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134210|NCT03085784|Aflibercept|aflibercept|mesh-list
83134211|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83134212|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83134213|NCT03085784|Growth Substances|growth substances|mesh-ancestor
83134214|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134215|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
83134216|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134217|NCT05021276|Basiliximab|basiliximab|mesh-list
83134218|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83134219|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
83134220|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134221|NCT05014490|Etoricoxib|etoricoxib|mesh-list
83134222|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134223|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134224|NCT05014490|Analgesics|analgesics|mesh-ancestor
83134225|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
83134226|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134227|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134228|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134229|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134230|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83134231|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83134232|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134233|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134234|NCT05020964|Trastuzumab|trastuzumab|mesh-list
83390259|NCT02244255|Urological Agents|urological agents|mesh-ancestor
83390260|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
83390261|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
83390262|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390263|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390264|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390265|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390442|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83390418|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390419|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
83390420|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
83390421|NCT00927849|Glycerol|glycerol|mesh-list
83390422|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83390423|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83390424|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390425|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
83390426|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390427|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390428|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83390429|NCT00927849|Protective Agents|protective agents|mesh-ancestor
83390430|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
83390431|NCT04149587|Brodalumab|brodalumab|mesh-list
83134235|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83134237|NCT05014100|Lenalidomide|lenalidomide|mesh-list
83134238|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
83134239|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134240|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83134241|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83134242|NCT05014100|Growth Substances|growth substances|mesh-ancestor
83134243|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
83134244|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134245|NCT05027126|Folic Acid|folic acid|mesh-list
83134246|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
83134247|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83134248|NCT05027126|Vitamins|vitamins|mesh-ancestor
83134249|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
83134250|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134251|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134252|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134253|NCT05027126|Analgesics|analgesics|mesh-ancestor
83134254|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
83134255|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390432|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
83390433|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83472308|NCT00003880|Paclitaxel|paclitaxel|mesh-list
83390435|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390436|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390437|NCT02985125|Everolimus|everolimus|mesh-list
83390438|NCT02985125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83390439|NCT02985125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83390440|NCT02985125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390441|NCT02985125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390444|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390445|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83390446|NCT04912596|Albuterol|albuterol|mesh-list
83390447|NCT04912596|Procaterol|procaterol|mesh-list
83390448|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
83390449|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83390450|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
83390451|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83390452|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390453|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83390454|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
83390455|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
83390456|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83390457|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83390458|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83390459|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83390460|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
83390613|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
83390614|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
83390615|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83390616|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83390617|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83390618|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83390619|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390620|NCT04147481|Anesthetics|anesthetics|mesh-list
83390621|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
83415814|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83134256|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134257|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134258|NCT05027126|Hematinics|hematinics|mesh-ancestor
83134259|NCT02120677|Itraconazole|itraconazole|mesh-list
83134260|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
83134261|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134262|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83134263|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83134264|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134265|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134266|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83134267|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
83134268|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134269|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134270|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83134271|NCT02120911|Trastuzumab|trastuzumab|mesh-list
83134273|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83134274|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134275|NCT02112487|Macitentan|macitentan|mesh-list
83134276|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83134277|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83134278|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134279|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83134280|NCT03094442|Dexamethasone|dexamethasone|mesh-list
83134281|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134282|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
83134283|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
83134284|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134285|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134286|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83134287|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
83134288|NCT03094442|Hormones|hormones|mesh-ancestor
83134289|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134290|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134291|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134292|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
83134293|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83134294|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134295|NCT02112643|Selenium|selenium|mesh-list
83134296|NCT02112643|Selenic Acid|selenic acid|mesh-list
83134297|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
83134298|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134299|NCT02112643|Protective Agents|protective agents|mesh-ancestor
83134300|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134301|NCT02112643|Trace Elements|trace elements|mesh-ancestor
83134302|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
83134303|NCT02112721|Vitamin D|vitamin d|mesh-list
83134304|NCT02112721|Vitamins|vitamins|mesh-ancestor
83134305|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
83134306|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134307|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83134308|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83134309|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
83134310|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134311|NCT02122939|Escitalopram|escitalopram|mesh-list
83134312|NCT02122939|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83134313|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83134314|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83134315|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134316|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134317|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
83134318|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134319|NCT04434248|Ritonavir|ritonavir|mesh-list
83134320|NCT04434248|Lopinavir|lopinavir|mesh-list
83134321|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
83134322|NCT04434248|Chloroquine|chloroquine|mesh-list
83134323|NCT04434248|Favipiravir|favipiravir|mesh-list
83134324|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83134325|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83134326|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
83134327|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134328|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134330|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83134331|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
83134332|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134333|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83134334|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83134335|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
83134337|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83134338|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134339|NCT04434248|Amebicides|amebicides|mesh-ancestor
83134340|NCT02121457|Selenium|selenium|mesh-list
83134341|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
83134342|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134343|NCT02121457|Protective Agents|protective agents|mesh-ancestor
83134344|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134345|NCT02121457|Trace Elements|trace elements|mesh-ancestor
83134346|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
83134347|NCT02251795|Aspirin|aspirin|mesh-list
83134348|NCT02251795|Ritonavir|ritonavir|mesh-list
83134349|NCT02251795|Darunavir|darunavir|mesh-list
83134350|NCT02251795|Tipranavir|tipranavir|mesh-list
83390847|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
83390848|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
83390849|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
83390850|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390851|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83390853|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
83390854|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390855|NCT04146155|Liraglutide|liraglutide|mesh-list
83390856|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83390857|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83390858|NCT04146155|Incretins|incretins|mesh-ancestor
83390859|NCT04146155|Hormones|hormones|mesh-ancestor
83390860|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83390861|NCT04990752|Urinastatin|urinastatin|mesh-list
83390862|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83390863|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83390864|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
83390865|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83390866|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390867|NCT02245191|Phenylephrine|phenylephrine|mesh-list
83390868|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
83390869|NCT02245191|Ephedrine|ephedrine|mesh-list
83390870|NCT02245191|Metaraminol|metaraminol|mesh-list
83390871|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83390872|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
83390873|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
83134351|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134352|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134353|NCT02251795|Analgesics|analgesics|mesh-ancestor
83134354|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
83134355|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134356|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134357|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134358|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134359|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83134360|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83134361|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134362|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83134363|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83134364|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134365|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
83134366|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83134367|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83134368|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
83134369|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83134370|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83134371|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
83134372|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134373|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83134374|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83134375|NCT05013164|Leucovorin|leucovorin|mesh-list
83134376|NCT05013164|Folic Acid|folic acid|mesh-list
83134377|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
83134378|NCT05013164|Antidotes|antidotes|mesh-ancestor
83134379|NCT05013164|Protective Agents|protective agents|mesh-ancestor
83134380|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134381|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
83134382|NCT05013164|Vitamins|vitamins|mesh-ancestor
83134383|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
83134384|NCT05013164|Hematinics|hematinics|mesh-ancestor
83134385|NCT02251951|Paclitaxel|paclitaxel|mesh-list
83134386|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83134387|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134388|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
83134389|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
83134390|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
83134391|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134392|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83134393|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83134394|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
83134395|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134396|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83134397|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83134398|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
83134399|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
83134400|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134401|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134402|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
83134403|NCT02121613|Tamsulosin|tamsulosin|mesh-list
83134404|NCT02121613|Urological Agents|urological agents|mesh-ancestor
83134405|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83134406|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83134407|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83134408|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134409|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134410|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134411|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134412|NCT03091712|Insulin|insulin|mesh-list
83134413|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83134414|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134415|NCT03552211|Biotin|biotin|mesh-list
83134417|NCT03552211|Vitamins|vitamins|mesh-ancestor
83134418|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
83134419|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134420|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
83134421|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134422|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83134423|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83134424|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
83134425|NCT03281187|Testosterone|testosterone|mesh-list
83134426|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
83134427|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
83134428|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83134429|NCT03281187|Androgens|androgens|mesh-ancestor
83134430|NCT03281187|Hormones|hormones|mesh-ancestor
83134431|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134432|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134433|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134434|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134435|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
83134436|NCT05009342|Calpastatin|calpastatin|mesh-list
83134437|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83134438|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
83134439|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134440|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134442|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83134443|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83134444|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83134445|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134446|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134447|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
83134448|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
83134449|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83134450|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134451|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134452|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134453|NCT05013320|Analgesics|analgesics|mesh-ancestor
83134454|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
83134455|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134456|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83134457|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83134458|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83134459|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134460|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134461|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134462|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83134463|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83134464|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83134465|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
83134466|NCT02437162|Golimumab|golimumab|mesh-list
83134467|NCT02437162|Ustekinumab|ustekinumab|mesh-list
83134468|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
83134469|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83134470|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134471|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83134472|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
83134473|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134475|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83134476|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134477|NCT02123563|Listerine|listerine|mesh-list
83134478|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83134479|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134480|NCT02122003|Sorafenib|sorafenib|mesh-list
83134481|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134482|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83134483|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134484|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134485|NCT03079388|Azithromycin|azithromycin|mesh-list
83134486|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
83134487|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
83134488|NCT03079388|Albendazole|albendazole|mesh-list
83134489|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83134490|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83134491|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134492|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
83134493|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83134494|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83134495|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83134496|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134497|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134498|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83134499|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
83134500|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
83134501|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83134502|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
83134503|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
83134504|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
83134505|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134506|NCT03079544|Asparaginase|asparaginase|mesh-list
83134507|NCT03079544|Pegaspargase|pegaspargase|mesh-list
83134508|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134510|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83134511|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134512|NCT02437084|Atorvastatin|atorvastatin|mesh-list
83134513|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83134514|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83134515|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
83134516|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134517|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83134518|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83134519|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134520|NCT05009498|Vitamin D|vitamin d|mesh-list
83134521|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
83134522|NCT05009498|Vitamins|vitamins|mesh-ancestor
83134523|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
83134524|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134525|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83134526|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83134527|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83134528|NCT02406586|Carvedilol|carvedilol|mesh-list
83134529|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83134530|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83134531|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83134532|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134533|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134534|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134535|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134536|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83134537|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
83134538|NCT02406586|Protective Agents|protective agents|mesh-ancestor
83134539|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83134540|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83134541|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83134542|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
83134543|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83134544|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83134545|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83134546|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83134547|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83134548|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134549|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134550|NCT02406586|Analgesics|analgesics|mesh-ancestor
83134551|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
83134552|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134553|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134554|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134555|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
83134556|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83134557|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134558|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134559|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134561|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
83134562|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134563|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83134564|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83134565|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83134566|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134567|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134568|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134569|NCT02122393|Sertraline|sertraline|mesh-list
83134570|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
83134571|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83134572|NCT02122393|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83134573|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83134574|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83134575|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134576|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134577|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
83134578|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134579|NCT03821883|Aspirin|aspirin|mesh-list
83134580|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134581|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134582|NCT03821883|Analgesics|analgesics|mesh-ancestor
83134583|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
83134584|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134585|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134586|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134587|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134588|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83134589|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83134590|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134591|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83134592|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83134593|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134594|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
83134595|NCT03080480|Pioglitazone|pioglitazone|mesh-list
83134596|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83134597|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134598|NCT02126761|Vaccines|vaccines|mesh-list
83134599|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
83134600|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134601|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83390950|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83390951|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
83390952|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83390953|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83390954|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
83390955|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
83390956|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83390957|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83390958|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83390959|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134602|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83134603|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83134604|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83134605|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134606|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134607|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134608|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134609|NCT03280641|Warfarin|warfarin|mesh-list
83134610|NCT03280641|Dabigatran|dabigatran|mesh-list
83134611|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
83134612|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
83134613|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83134614|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
83134615|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134616|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134617|NCT03285165|Propofol|propofol|mesh-list
83134618|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83134619|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134620|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134621|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83134622|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
83134623|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
83134624|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
83134625|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83134626|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134627|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134628|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134629|NCT03285087|Analgesics|analgesics|mesh-ancestor
83134630|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
83134631|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134632|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83134633|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83134634|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83134635|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134636|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134637|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134638|NCT02122627|Vitamin D|vitamin d|mesh-list
83134639|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
83134640|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
83134641|NCT02122627|Vitamins|vitamins|mesh-list
83134642|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
83134643|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134644|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83134645|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83134646|NCT02122705|Remifentanil|remifentanil|mesh-list
83134647|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83134648|NCT02122705|Narcotics|narcotics|mesh-ancestor
83134649|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134650|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134651|NCT02122705|Analgesics|analgesics|mesh-ancestor
83134652|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
83134653|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134654|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83134655|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83134656|NCT03384225|Cytarabine|cytarabine|mesh-list
83134657|NCT03384225|Fludarabine|fludarabine|mesh-list
83134658|NCT03384225|Busulfan|busulfan|mesh-list
83134660|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134661|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83134662|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
83134663|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134664|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83134665|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
83134666|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134667|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
83134668|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134669|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
83134670|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83134671|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83134672|NCT05019326|Andrographolide|andrographolide|mesh-list
83134673|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134674|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134675|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134676|NCT05019326|Analgesics|analgesics|mesh-ancestor
83134677|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
83134678|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134679|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134680|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134681|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83134682|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83134683|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134684|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
83134685|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83134687|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83134688|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83134689|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
83134690|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
83134691|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134692|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134693|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83134694|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83134695|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83134696|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134697|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134698|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134699|NCT03079076|Bupivacaine|bupivacaine|mesh-list
83134700|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
83134701|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
83134702|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134703|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134705|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134707|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134708|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134709|NCT03280407|Leucovorin|leucovorin|mesh-list
83134710|NCT03280407|Capecitabine|capecitabine|mesh-list
83134711|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
83134712|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
83134713|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83134714|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
83134715|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134716|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134717|NCT03280407|Antidotes|antidotes|mesh-ancestor
83134718|NCT03280407|Protective Agents|protective agents|mesh-ancestor
83134719|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134720|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
83134721|NCT03280407|Vitamins|vitamins|mesh-ancestor
83134722|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
83134723|NCT03078842|Zinc|zinc|mesh-list
83134724|NCT03078842|Trace Elements|trace elements|mesh-ancestor
83134725|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
83134726|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134727|NCT05007860|Vaccines|vaccines|mesh-list
83134728|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
83134729|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134730|NCT03270033|Dexamethasone|dexamethasone|mesh-list
83134731|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
83134732|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
83134733|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83134734|NCT03270033|BB 1101|bb 1101|mesh-list
83134735|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134736|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
83134737|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
83134738|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134739|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134740|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83134741|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
83134742|NCT03270033|Hormones|hormones|mesh-ancestor
83134743|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134744|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134745|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134746|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
83134747|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478675|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478676|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83478677|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83478678|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478679|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478680|NCT00317720|Trastuzumab|trastuzumab|mesh-list
83478681|NCT00317720|Everolimus|everolimus|mesh-list
83478682|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83391187|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83391188|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391189|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83391190|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
83391191|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83391192|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83391193|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83391194|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83391195|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391196|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
83391197|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83391199|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
83391200|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83391201|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
83391202|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391203|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391204|NCT05003700|Lenvatinib|lenvatinib|mesh-list
83391205|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391206|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83391207|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391208|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391209|NCT04143191|Sorafenib|sorafenib|mesh-list
83391210|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391211|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83391212|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391213|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391214|NCT04661007|Lenalidomide|lenalidomide|mesh-list
83472396|NCT00004918|Sargramostim|sargramostim|mesh-list
83391215|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
83391216|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391292|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
83391293|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
83391294|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391295|NCT03021629|Vitamin D|vitamin d|mesh-list
83391296|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83391297|NCT03021629|Vitamins|vitamins|mesh-ancestor
83391298|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
83391299|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391300|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83391301|NCT03021395|Decitabine|decitabine|mesh-list
83391302|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83134748|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134749|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83134750|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134751|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134752|NCT03270033|Analgesics|analgesics|mesh-ancestor
83134753|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
83134754|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83134755|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83134756|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83134757|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83391304|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391305|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391306|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391307|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83391308|NCT03021317|Hormones|hormones|mesh-ancestor
83391309|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391310|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391311|NCT04987632|Letrozole|letrozole|mesh-list
83391312|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391313|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83391314|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83391315|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391316|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391317|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83391318|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
83391319|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391320|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391321|NCT03032367|Bedaquiline|bedaquiline|mesh-list
83391322|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
83391323|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83391324|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391325|NCT02634606|Tocotrienols|tocotrienols|mesh-list
83391327|NCT02634606|Tocopherols|tocopherols|mesh-list
83391328|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
83391329|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391330|NCT02634606|Protective Agents|protective agents|mesh-ancestor
83391331|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391332|NCT02634606|Vitamins|vitamins|mesh-ancestor
83391333|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
83391334|NCT05002686|Paclitaxel|paclitaxel|mesh-list
83391335|NCT05002686|Capecitabine|capecitabine|mesh-list
83391336|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
83391337|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83391338|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391339|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
83134758|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134759|NCT04959812|Sufentanil|sufentanil|mesh-list
83134760|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83134761|NCT04959812|Narcotics|narcotics|mesh-ancestor
83134762|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134763|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134764|NCT04959812|Analgesics|analgesics|mesh-ancestor
83134765|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
83134766|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134767|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83134768|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83134769|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
83134770|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
83134771|NCT03280095|Acetaminophen|acetaminophen|mesh-list
83134772|NCT03280095|Codeine|codeine|mesh-list
83134773|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134774|NCT03280095|Analgesics|analgesics|mesh-ancestor
83134775|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
83134776|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134777|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134778|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
83134779|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83134780|NCT03280095|Narcotics|narcotics|mesh-ancestor
83134781|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134782|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
83134783|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
83134784|NCT04463030|Vitamins|vitamins|mesh-list
83134785|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
83134786|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
83134787|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134789|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134790|NCT04463030|Protective Agents|protective agents|mesh-ancestor
83134791|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
83134792|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
83134793|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134794|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
83134795|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134796|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134797|NCT05010434|Bevacizumab|bevacizumab|mesh-list
83134798|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83134799|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134800|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83134801|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83134802|NCT05010434|Growth Substances|growth substances|mesh-ancestor
83134803|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134804|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
83134806|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83134807|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134808|NCT03269955|Thrombin|thrombin|mesh-list
83134809|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
83134810|NCT03269955|Coagulants|coagulants|mesh-ancestor
83134811|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
83134812|NCT05006846|Narcotics|narcotics|mesh-ancestor
83134813|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134814|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134815|NCT05006846|Analgesics|analgesics|mesh-ancestor
83134816|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
83134817|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134818|NCT02457520|Isotretinoin|isotretinoin|mesh-list
83134819|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
83134820|NCT02457585|Infliximab|infliximab|mesh-list
83134821|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83134822|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134823|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83134824|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83134825|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83134827|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
83134828|NCT02457507|Vitamins|vitamins|mesh-ancestor
83134829|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
83134830|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134831|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
83134832|NCT02457507|Hematinics|hematinics|mesh-ancestor
83134833|NCT03265197|Lidocaine|lidocaine|mesh-list
83134834|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
83134835|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
83134836|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134837|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134838|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
83134839|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134840|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83134841|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83134842|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83134843|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83478683|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478684|NCT00317720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83478685|NCT00317720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83478686|NCT00317720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478687|NCT00317720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478688|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83478689|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
83478690|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478691|NCT00357032|Belinostat|belinostat|mesh-list
83478692|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478693|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83478694|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478695|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478696|NCT00357734|Gefitinib|gefitinib|mesh-list
83478697|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134844|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134846|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
83134847|NCT04944836|Clomiphene|clomiphene|mesh-list
83134848|NCT04944836|Enclomiphene|enclomiphene|mesh-list
83134849|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
83134850|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83134851|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
83134852|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134853|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134854|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83134855|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
83134856|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83134857|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83134858|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83134860|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83134861|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
83134862|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
83134863|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134864|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134865|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134866|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134867|NCT04940390|Analgesics|analgesics|mesh-ancestor
83134868|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
83134869|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134870|NCT02788279|Atezolizumab|atezolizumab|mesh-list
83134871|NCT02788279|Antibodies|antibodies|mesh-list
83134872|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
83134873|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134874|NCT02788279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83134875|NCT02788279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134876|NCT02788279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83134877|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134878|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83134879|NCT03264651|Anastrozole|anastrozole|mesh-list
83391340|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
83391341|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
83391342|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391343|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83391344|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
83391345|NCT03588689|Ropivacaine|ropivacaine|mesh-list
83391346|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
83391347|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
83391348|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83391349|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391350|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
83391351|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83391352|NCT04985526|Octenidine|octenidine|mesh-list
83391353|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391354|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83391355|NCT03588611|Hirudins|hirudins|mesh-list
83134880|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134881|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134882|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83134883|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83134884|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134885|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134886|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83134887|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
83134888|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134889|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134891|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134892|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
83134893|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
83134894|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134895|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134896|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83134897|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
83134898|NCT03078062|Hormones|hormones|mesh-ancestor
83134899|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134900|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83134901|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134902|NCT02435992|Ozanimod|ozanimod|mesh-list
83134903|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83134904|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134905|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83134906|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
83134907|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134908|NCT02457351|Itraconazole|itraconazole|mesh-list
83134909|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
83134910|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134911|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83134912|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83134913|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134914|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134915|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83134916|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
83134917|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83134918|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134919|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83134920|NCT02788513|BI 425809|bi 425809|mesh-list
83134921|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
83134922|NCT03077828|Carboplatin|carboplatin|mesh-list
83134923|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
83134924|NCT03077828|Etoposide|etoposide|mesh-list
83134925|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
83134926|NCT03077828|Ifosfamide|ifosfamide|mesh-list
83134927|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
83134929|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134930|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83134931|NCT03077828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83472445|NCT05776888|Ofatumumab|ofatumumab|mesh-list
83134932|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134933|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83134934|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83134935|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83134936|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391356|NCT03588611|Bivalirudin|bivalirudin|mesh-list
83391357|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
83391358|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83391359|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
83391360|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391361|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391362|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
83391363|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83391364|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83391365|NCT03588533|Capecitabine|capecitabine|mesh-list
83391366|NCT03588533|Trastuzumab|trastuzumab|mesh-list
83391367|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391368|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83391369|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
83391370|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83415966|NCT02140151|Ranibizumab|ranibizumab|mesh-list
83134937|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83134938|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
83134939|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
83134940|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83134941|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
83134942|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
83134943|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
83134945|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83134947|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83134948|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
83134949|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83134950|NCT04459052|Expectorants|expectorants|mesh-ancestor
83134951|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
83134952|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83134953|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
83134954|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134955|NCT04459052|Protective Agents|protective agents|mesh-ancestor
83134956|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134957|NCT04459052|Antidotes|antidotes|mesh-ancestor
83134958|NCT05257291|Melatonin|melatonin|mesh-list
83134959|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
83134960|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134961|NCT05257291|Protective Agents|protective agents|mesh-ancestor
83134962|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134963|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83134964|NCT04930900|Epinephrine|epinephrine|mesh-list
83134965|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83134966|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83134967|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
83134968|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83134969|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134970|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134971|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83134972|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83134973|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
83134974|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134975|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83134976|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
83134977|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
83134978|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
83134979|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83134980|NCT02458209|Bococizumab|bococizumab|mesh-list
83134981|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83134982|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83134983|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
83134984|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134985|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83134986|NCT02127151|Talazoparib|talazoparib|mesh-list
83134987|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83134988|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83134989|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83134990|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83134992|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83134993|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83134994|NCT03077516|Analgesics|analgesics|mesh-ancestor
83134995|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
83134996|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83134997|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83134998|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83134999|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83135000|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83135001|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83135002|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135003|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135004|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83135005|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83135007|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83135008|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135009|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135010|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135011|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135012|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135013|NCT05300035|Antibodies|antibodies|mesh-list
83135014|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83135015|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
83135016|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135017|NCT03072992|Curcumin|curcumin|mesh-list
83135018|NCT03072992|Paclitaxel|paclitaxel|mesh-list
83135019|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83135021|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135022|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135023|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135024|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135025|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83135026|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83135027|NCT03072992|Analgesics|analgesics|mesh-ancestor
83135028|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
83135029|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135030|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135031|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135032|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83135033|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135034|NCT03267771|Progesterone|progesterone|mesh-list
83135035|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
83135036|NCT03267771|Progestins|progestins|mesh-ancestor
83135037|NCT03267771|Hormones|hormones|mesh-ancestor
83135038|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135039|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135040|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83135041|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
83135042|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83135043|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83135044|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135045|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
83135046|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
83135047|NCT02456961|Riboflavin|riboflavin|mesh-list
83135048|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
83135049|NCT02456961|Vitamins|vitamins|mesh-ancestor
83135050|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
83135051|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135052|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83135053|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
83135054|NCT03551197|Budesonide|budesonide|mesh-list
83135055|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
83135056|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135057|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83135058|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
83135059|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135060|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135061|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83135062|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
83135063|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
83135064|NCT03551197|Hormones|hormones|mesh-ancestor
83135065|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135066|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83391823|NCT04801797|Venetoclax|venetoclax|mesh-list
83391824|NCT04801797|Idarubicin|idarubicin|mesh-list
83391825|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83391826|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
83391827|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391828|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83391829|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
83391830|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83391831|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83391832|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
83391833|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391834|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391835|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83391836|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83391837|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83391838|NCT03033537|Verapamil|verapamil|mesh-list
83391839|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
83391840|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83391841|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391842|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83391843|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83135067|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83135068|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83135069|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
83135070|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135071|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135072|NCT02435836|Aripiprazole|aripiprazole|mesh-list
83135073|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
83135074|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83135075|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83135076|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83135077|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135078|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135079|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
83135080|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
83135081|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135082|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135083|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83135084|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83135085|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
83135086|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83135087|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83135088|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83135089|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83135090|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83135091|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83135092|NCT05075265|Methadone|methadone|mesh-list
83135093|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135094|NCT05075265|Narcotics|narcotics|mesh-ancestor
83135095|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135096|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135097|NCT05075265|Analgesics|analgesics|mesh-ancestor
83135098|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
83135099|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135100|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
83135101|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
83135102|NCT02127541|Exenatide|exenatide|mesh-list
83135103|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83135104|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135105|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83135106|NCT02127541|Incretins|incretins|mesh-ancestor
83135107|NCT02127541|Hormones|hormones|mesh-ancestor
83135108|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135110|NCT03263871|Trace Elements|trace elements|mesh-list
83135111|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135112|NCT04992182|Vaccines|vaccines|mesh-list
83135113|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
83135114|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135115|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
83135116|NCT02124655|Listerine|listerine|mesh-list
83135117|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83135118|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135119|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
83135120|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
83135122|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135123|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135124|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
83135125|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83135126|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
83135127|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135128|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83391993|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83391994|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83391995|NCT01673399|Atosiban|atosiban|mesh-list
83391996|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
83391997|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83391998|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83391999|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
83392000|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83392001|NCT02235701|Ifosfamide|ifosfamide|mesh-list
83392002|NCT02235701|Doxorubicin|doxorubicin|mesh-list
83392003|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83392004|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
83392005|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83392006|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392007|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83392008|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83135129|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83135130|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
83135131|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135132|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135133|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83135134|NCT03266991|Isoniazid|isoniazid|mesh-list
83135135|NCT03266991|Rifapentine|rifapentine|mesh-list
83135136|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
83135137|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83135138|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135139|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83135140|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83135141|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
83135142|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135143|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83135144|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83135145|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
83135146|NCT02456740|Erenumab|erenumab|mesh-list
83135147|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83135148|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135149|NCT02456740|Analgesics|analgesics|mesh-ancestor
83135150|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
83135151|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135152|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135153|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83135154|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83135155|NCT03266601|Interferons|interferons|mesh-list
83135156|NCT03266601|Ribavirin|ribavirin|mesh-list
83135157|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135158|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
83135159|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135160|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
83135161|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135162|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83135163|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83135164|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
83135165|NCT02458755|Atorvastatin|atorvastatin|mesh-list
83135166|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83135167|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83135168|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83135169|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
83135170|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135171|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83135172|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83135173|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135174|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
83135175|NCT04462406|Nivolumab|nivolumab|mesh-list
83135176|NCT04462406|Ipilimumab|ipilimumab|mesh-list
83135177|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83135178|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135179|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83135180|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135181|NCT02400580|Acetaminophen|acetaminophen|mesh-list
83135182|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83135183|NCT02400580|Analgesics|analgesics|mesh-ancestor
83135184|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
83135185|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135186|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135187|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
83135188|NCT03262857|Lidocaine|lidocaine|mesh-list
83135189|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
83135190|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
83135191|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
83135192|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135193|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135194|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
83135195|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135196|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83135197|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83135198|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83135199|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83135200|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135201|NCT03262857|Analgesics|analgesics|mesh-ancestor
83135202|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
83135203|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83135204|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83135205|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
83135206|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83135207|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
83135208|NCT02127697|Albuterol|albuterol|mesh-list
83135209|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83135210|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
83135211|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135212|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135213|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83135214|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
83135215|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
83135216|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83135217|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83135218|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83135219|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83135220|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
83135221|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135222|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135223|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83135224|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83135225|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83135226|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
83135228|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
83135229|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83135230|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
83135231|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
83135232|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83135233|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
83135234|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135235|NCT02252341|Expectorants|expectorants|mesh-ancestor
83135236|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
83135237|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83135238|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
83135239|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135240|NCT02252341|Protective Agents|protective agents|mesh-ancestor
83135241|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135242|NCT02252341|Antidotes|antidotes|mesh-ancestor
83135243|NCT02127853|Gabapentin|gabapentin|mesh-list
83135244|NCT02127853|Analgesics|analgesics|mesh-ancestor
83135245|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
83135246|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135247|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135248|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
83135249|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83135250|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83135251|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135252|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83135253|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83135254|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83135255|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135256|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135257|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
83135258|NCT03266445|Buprenorphine|buprenorphine|mesh-list
83135259|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83135260|NCT03266445|Naloxone|naloxone|mesh-list
83135261|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135262|NCT03266445|Narcotics|narcotics|mesh-ancestor
83135263|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135264|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135265|NCT03266445|Analgesics|analgesics|mesh-ancestor
83135266|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
83135267|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135268|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83135269|NCT01367119|Ketamine|ketamine|mesh-list
83135270|NCT01367119|Methohexital|methohexital|mesh-list
83135271|NCT01367119|Analgesics|analgesics|mesh-ancestor
83135272|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
83135273|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135274|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135275|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83135276|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83135277|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
83135279|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135280|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83135281|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83135282|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135283|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135284|NCT02252107|Decitabine|decitabine|mesh-list
83135285|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83135286|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
83135287|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135288|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135289|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135290|NCT03262545|Apatinib|apatinib|mesh-list
83135291|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135292|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83135293|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135294|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135295|NCT03262077|Methylene Blue|methylene blue|mesh-list
83135296|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135297|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135298|NCT03265899|Lactitol|lactitol|mesh-list
83135299|NCT03265899|Oxytocin|oxytocin|mesh-list
83135300|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
83135301|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83135302|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135303|NCT03265899|Cathartics|cathartics|mesh-ancestor
83135304|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83135305|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
83135306|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
83135307|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135308|NCT03934905|Sulforaphane|sulforaphane|mesh-list
83135309|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83135310|NCT03934905|Protective Agents|protective agents|mesh-ancestor
83135311|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135312|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135314|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135315|NCT02125201|Narcotics|narcotics|mesh-ancestor
83135316|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135317|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135318|NCT02125201|Analgesics|analgesics|mesh-ancestor
83135319|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
83135320|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135321|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83135322|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83135323|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
83135324|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
83135325|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
83135326|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135327|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83135328|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135329|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135330|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
83135331|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135332|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135333|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83135334|NCT03074942|Reslizumab|reslizumab|mesh-list
83135335|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83135336|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
83135337|NCT02125435|ASP2408|asp2408|mesh-list
83135338|NCT02125435|Immunoconjugates|immunoconjugates|mesh-ancestor
83135339|NCT02125435|Immunologic Factors|immunologic factors|mesh-ancestor
83135340|NCT02125435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135341|NCT02458911|Paclitaxel|paclitaxel|mesh-list
83135342|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83135343|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135344|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135345|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
83472578|NCT05775770|Insulin|insulin|mesh-list
83135346|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135347|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135348|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
83135349|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
83135350|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135351|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
83135352|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135353|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135354|NCT04998344|Vaccines|vaccines|mesh-list
83135355|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
83135356|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135358|NCT02128243|Cisplatin|cisplatin|mesh-list
83135359|NCT02128243|Docetaxel|docetaxel|mesh-list
83135360|NCT02128243|Fluorouracil|fluorouracil|mesh-list
83135361|NCT02128243|Capecitabine|capecitabine|mesh-list
83135362|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
83135363|NCT02128243|Epirubicin|epirubicin|mesh-list
83135364|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
83135365|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135366|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135367|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135368|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135369|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135370|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
83135371|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83135372|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83135373|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
83135374|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135375|NCT02128243|Antidotes|antidotes|mesh-ancestor
83135376|NCT02128243|Protective Agents|protective agents|mesh-ancestor
83135377|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
83135378|NCT02128243|Vitamins|vitamins|mesh-ancestor
83135379|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
83135380|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83135381|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83135382|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83135383|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135384|NCT03072290|Triamcinolone|triamcinolone|mesh-list
83135385|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83135386|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83135387|NCT03072290|Lidocaine|lidocaine|mesh-list
83135388|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83135389|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83135390|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
83135391|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135392|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135393|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
83135394|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135395|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83135396|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83135397|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83135398|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83135399|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135400|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135401|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
83135402|NCT03072290|Hormones|hormones|mesh-ancestor
83135403|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135404|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83135405|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
83135406|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135407|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83135408|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83135409|NCT02132689|Heparin|heparin|mesh-list
83135410|NCT02132689|Calcium heparin|calcium heparin|mesh-list
83135411|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83478698|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83478699|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478700|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478701|NCT00318812|Iron|iron|mesh-list
83478702|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83478703|NCT00318812|Trace Elements|trace elements|mesh-ancestor
83478704|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
83478705|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478706|NCT00318812|Hematinics|hematinics|mesh-ancestor
83478707|NCT00362882|Docetaxel|docetaxel|mesh-list
83478708|NCT00362882|Bortezomib|bortezomib|mesh-list
83478709|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478710|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
83478711|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
83478712|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
83478713|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478714|NCT00365144|Bevacizumab|bevacizumab|mesh-list
83478715|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83478716|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83478717|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478718|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83478719|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83478720|NCT00365144|Growth Substances|growth substances|mesh-ancestor
83478721|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478722|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83135412|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135413|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
83135414|NCT02128321|Repaglinide|repaglinide|mesh-list
83135415|NCT02128321|Isavuconazole|isavuconazole|mesh-list
83135416|NCT02128321|Caffeine|caffeine|mesh-list
83135417|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83135418|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135419|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83135420|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135421|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135422|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83135423|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83135425|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135426|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83135427|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
83135428|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135429|NCT02457975|Ranibizumab|ranibizumab|mesh-list
83135430|NCT02457975|Aflibercept|aflibercept|mesh-list
83135431|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135432|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83135433|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83135434|NCT02457975|Growth Substances|growth substances|mesh-ancestor
83135435|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135436|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
83135437|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83135438|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135439|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83135440|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135441|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135442|NCT02125903|Ropivacaine|ropivacaine|mesh-list
83135443|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
83135444|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
83135445|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135446|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135447|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
83135448|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135449|NCT04997564|Tenofovir|tenofovir|mesh-list
83135450|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
83135451|NCT04997564|Velpatasvir|velpatasvir|mesh-list
83135452|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83135453|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
83135454|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135455|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83135456|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83135457|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135458|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135459|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83135460|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83135461|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
83135462|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83135463|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83135464|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135465|NCT03842943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83478723|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83135466|NCT03842943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135468|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83135469|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83135470|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
83221028|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83135471|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135472|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83135473|NCT02126293|Zinc|zinc|mesh-list
83135474|NCT02126293|Trace Elements|trace elements|mesh-ancestor
83135475|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
83135476|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135477|NCT03261921|Dexamethasone|dexamethasone|mesh-list
83135478|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
83135479|NCT03261921|Bupivacaine|bupivacaine|mesh-list
83135480|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135481|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
83135482|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
83135483|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135484|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135485|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83135486|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
83135487|NCT03261921|Hormones|hormones|mesh-ancestor
83135488|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135489|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83135490|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135491|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
83135492|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
83135493|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135494|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
83135495|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83135496|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83135497|NCT03261921|Analgesics|analgesics|mesh-ancestor
83135498|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83135499|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83135500|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83135501|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
83135502|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135503|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135504|NCT02635724|Peramivir|peramivir|mesh-list
83135505|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
83135506|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135507|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478724|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478725|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478726|NCT05339022|Coal Tar|coal tar|mesh-list
83478727|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
83478728|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
83478729|NCT00366626|Naltrexone|naltrexone|mesh-list
83478730|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83478731|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83478732|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478733|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
83478734|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478735|NCT00367016|Omalizumab|omalizumab|mesh-list
83135508|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135509|NCT02133469|Vaccines|vaccines|mesh-list
83135510|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83135511|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
83135512|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135513|NCT03905265|Moxidectin|moxidectin|mesh-list
83135514|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
83135515|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83135516|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135517|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
83135518|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
83135519|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135520|NCT02126527|Sirolimus|sirolimus|mesh-list
83135521|NCT02126527|Auranofin|auranofin|mesh-list
83135522|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83135523|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135524|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83135525|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135527|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83135528|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
83135529|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135530|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83135531|NCT02133625|Pioglitazone|pioglitazone|mesh-list
83135532|NCT02133625|Carboplatin|carboplatin|mesh-list
83135533|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135534|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83135535|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135536|NCT02260687|Aflibercept|aflibercept|mesh-list
83135537|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83135538|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83135539|NCT02260687|Growth Substances|growth substances|mesh-ancestor
83135540|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135541|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
83135542|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135543|NCT03071822|Dexamethasone|dexamethasone|mesh-list
83135544|NCT03071822|Gemcitabine|gemcitabine|mesh-list
83135545|NCT03071822|Etoposide|etoposide|mesh-list
83135546|NCT03071822|Asparaginase|asparaginase|mesh-list
83135547|NCT03071822|Ifosfamide|ifosfamide|mesh-list
83135548|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135549|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
83135550|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
83135551|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135552|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135553|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83135554|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
83135555|NCT03071822|Hormones|hormones|mesh-ancestor
83478736|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83135556|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135558|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135559|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83135560|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
83135561|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135562|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83135563|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83135564|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83135565|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135566|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83135568|NCT04991012|Triamcinolone|triamcinolone|mesh-list
83135569|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83135570|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83135571|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83135572|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135573|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
83135574|NCT04991012|Hormones|hormones|mesh-ancestor
83392158|NCT00957333|Analgesics|analgesics|mesh-ancestor
83135575|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135576|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135577|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83135578|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
83135579|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135580|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135581|NCT02252731|Warfarin|warfarin|mesh-list
83135582|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
83135583|NCT02128633|Listerine|listerine|mesh-list
83135584|NCT02128633|Fluorides|fluorides|mesh-list
83135585|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
83135586|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
83135587|NCT02128633|Protective Agents|protective agents|mesh-ancestor
83135588|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135589|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83135590|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135591|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
83135592|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
83135593|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83135594|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83135595|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135596|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135597|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135598|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83135599|NCT03252561|Anesthetics|anesthetics|mesh-list
83135600|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
83135601|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135602|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135603|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
83135604|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135605|NCT02252263|Elotuzumab|elotuzumab|mesh-list
83135606|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135607|NCT04996550|Metoprolol|metoprolol|mesh-list
83135608|NCT04996550|Carvedilol|carvedilol|mesh-list
83135609|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83135610|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83135611|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
83135612|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
83135613|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135614|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135615|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83135616|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83135617|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83135618|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
83135619|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135620|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135622|NCT04996550|Protective Agents|protective agents|mesh-ancestor
83135623|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83135624|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83135625|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83135626|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
83135627|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83135628|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83135629|NCT03252171|Immunomodulating Agents|immunomodulating agents|mesh-list
83135630|NCT03252171|Immunologic Factors|immunologic factors|mesh-ancestor
83135631|NCT03252171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135632|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83135633|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
83135634|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135635|NCT02135965|Caffeine|caffeine|mesh-list
83135636|NCT02135965|Albuterol|albuterol|mesh-list
83135637|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83135638|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135639|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83135640|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135641|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135642|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83135643|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83135644|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
83135645|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135646|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83135647|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
83135648|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135649|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83135650|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
83135651|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
83135652|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83135653|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83135654|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83135655|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83135656|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
83135657|NCT02455401|Remifentanil|remifentanil|mesh-list
83135658|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135659|NCT02455401|Narcotics|narcotics|mesh-ancestor
83135660|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135661|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135662|NCT02455401|Analgesics|analgesics|mesh-ancestor
83135663|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
83135664|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135665|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
83135666|NCT03260829|Vitamins|vitamins|mesh-ancestor
83135667|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
83135668|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135669|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
83135670|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135671|NCT03260829|Protective Agents|protective agents|mesh-ancestor
83135672|NCT02134093|Midazolam|midazolam|mesh-list
83135673|NCT02134093|Sufentanil|sufentanil|mesh-list
83135674|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
83135675|NCT02134093|Remifentanil|remifentanil|mesh-list
83135676|NCT02134093|Anesthetics|anesthetics|mesh-list
83135677|NCT02134093|Propofol|propofol|mesh-list
83135678|NCT02134093|Etomidate|etomidate|mesh-list
83135679|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
83135680|NCT02134093|Rocuronium|rocuronium|mesh-list
83392310|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
83135681|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135682|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135683|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83135684|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83135685|NCT02134093|Analgesics|analgesics|mesh-ancestor
83135686|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
83135687|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135688|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83135689|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83135690|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83135691|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83135692|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135693|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135694|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83135695|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
83135696|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83135697|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83135698|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83135699|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83135700|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
83135701|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
83135702|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135703|NCT02134093|Narcotics|narcotics|mesh-ancestor
83135704|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83135705|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83135706|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83135707|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83392466|NCT01016691|Bimatoprost|bimatoprost|mesh-list
83135708|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83135709|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
83135710|NCT03074786|Tenofovir|tenofovir|mesh-list
83135711|NCT03074786|Emtricitabine|emtricitabine|mesh-list
83135712|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83135713|NCT03074786|Dapivirine|dapivirine|mesh-list
83135714|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
83135715|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135716|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83135717|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83135718|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135719|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135720|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83135721|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83135722|NCT03377049|Acetazolamide|acetazolamide|mesh-list
83135723|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
83135724|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83135725|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135726|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135727|NCT03377049|Diuretics|diuretics|mesh-ancestor
83135728|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
83135729|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135730|NCT03070028|Phenol|phenol|mesh-list
83135731|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83135732|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135733|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
83135734|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83135735|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83135736|NCT03260439|Tramadol|tramadol|mesh-list
83135737|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135738|NCT03260439|Narcotics|narcotics|mesh-ancestor
83392771|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135739|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135740|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135742|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
83135743|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135744|NCT02634788|Buprenorphine|buprenorphine|mesh-list
83135745|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135746|NCT02634788|Narcotics|narcotics|mesh-ancestor
83135747|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135748|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135749|NCT02634788|Analgesics|analgesics|mesh-ancestor
83472753|NCT05463341|Analgesics|analgesics|mesh-ancestor
83135750|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
83135751|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135752|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83135753|NCT03260283|Fentanyl|fentanyl|mesh-list
83135754|NCT03260283|Meperidine|meperidine|mesh-list
83135755|NCT03260283|Ropivacaine|ropivacaine|mesh-list
83135756|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
83135757|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
83135758|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135759|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135760|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
83135761|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135762|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83135763|NCT03260283|Narcotics|narcotics|mesh-ancestor
83135764|NCT03260283|Analgesics|analgesics|mesh-ancestor
83135765|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83135766|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83135768|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
83135769|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83135770|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83135771|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135772|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
83135773|NCT03251469|Coagulants|coagulants|mesh-ancestor
83135774|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
83135775|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83135776|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
83135777|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135778|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
83135779|NCT04986644|Protective Agents|protective agents|mesh-ancestor
83135780|NCT02785939|Docetaxel|docetaxel|mesh-list
83135781|NCT02785939|Palbociclib|palbociclib|mesh-list
83135782|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135783|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135784|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135785|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135786|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135787|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83135788|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135789|NCT03583229|Aspirin|aspirin|mesh-list
83135790|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83135791|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83135792|NCT03583229|Analgesics|analgesics|mesh-ancestor
83135793|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
83135794|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135795|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135796|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135797|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83135798|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83135799|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83135800|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135801|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83135802|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83135803|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135804|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
83135806|NCT02259803|Telmisartan|telmisartan|mesh-list
83135807|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83135808|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83135809|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83135810|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83135811|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135812|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83135813|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135814|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
83135815|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83135816|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83135818|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135819|NCT03069950|Leucovorin|leucovorin|mesh-list
83135820|NCT03069950|Dexamethasone|dexamethasone|mesh-list
83135821|NCT03069950|Fluorouracil|fluorouracil|mesh-list
83135822|NCT03069950|Irinotecan|irinotecan|mesh-list
83135823|NCT03069950|Panitumumab|panitumumab|mesh-list
83135824|NCT03069950|Floxuridine|floxuridine|mesh-list
83135825|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135826|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
83135827|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
83135828|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135829|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135830|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83135831|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
83135832|NCT03069950|Hormones|hormones|mesh-ancestor
83135833|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135834|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83135835|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135836|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
83135837|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135838|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83135839|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83135840|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
83135841|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83135842|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83135843|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135845|NCT03069950|Protective Agents|protective agents|mesh-ancestor
83135846|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
83135847|NCT03069950|Vitamins|vitamins|mesh-ancestor
83135848|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
83135849|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83135850|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83135851|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135852|NCT03577457|Oxytocin|oxytocin|mesh-list
83135854|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83135855|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135856|NCT02455245|Carboplatin|carboplatin|mesh-list
83135857|NCT02455245|Vincristine|vincristine|mesh-list
83135858|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135859|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83135860|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135861|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135862|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135863|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135864|NCT03537599|Daratumumab|daratumumab|mesh-list
83135865|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135866|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83135867|NCT04986254|Meropenem|meropenem|mesh-list
83135868|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
83135869|NCT04986254|Tazobactam|tazobactam|mesh-list
83135871|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83135872|NCT04986254|Penicillin G|penicillin g|mesh-list
83135873|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83135874|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
83135875|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135876|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83135877|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135878|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135879|NCT03257943|Ivermectin|ivermectin|mesh-list
83135880|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83135881|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135882|NCT04996160|Dexamethasone|dexamethasone|mesh-list
83135883|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
83135884|NCT04996160|Doxorubicin|doxorubicin|mesh-list
83135885|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83135887|NCT04996160|Palbociclib|palbociclib|mesh-list
83135888|NCT04996160|BB 1101|bb 1101|mesh-list
83135889|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135890|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
83135891|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
83135892|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135893|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135894|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83135895|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
83135896|NCT04996160|Hormones|hormones|mesh-ancestor
83392772|NCT02246049|Antidotes|antidotes|mesh-ancestor
83135897|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135898|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83135899|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135900|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
83135901|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135902|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135903|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83135904|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83135905|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83135906|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83135907|NCT04986098|Paclitaxel|paclitaxel|mesh-list
83135908|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83135909|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135910|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135911|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135912|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135913|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135914|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
83135915|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
83135916|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83135917|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83135918|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135919|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83135920|NCT02239445|Analgesics|analgesics|mesh-ancestor
83135921|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
83135922|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135923|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83135924|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83135925|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83135926|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
83135927|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83135928|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135929|NCT03071042|Docetaxel|docetaxel|mesh-list
83135930|NCT03071042|Apatinib|apatinib|mesh-list
83135931|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135932|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135933|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135934|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135935|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135936|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83135937|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135938|NCT03582605|Amoxicillin|amoxicillin|mesh-list
83135939|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83135940|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83135941|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
83135943|NCT04989140|Dexamethasone|dexamethasone|mesh-list
83135944|NCT04989140|Pomalidomide|pomalidomide|mesh-list
83135945|NCT04989140|Ixazomib|ixazomib|mesh-list
83135946|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135947|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
83135948|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
83135949|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83135950|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135951|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83135952|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
83135953|NCT04989140|Hormones|hormones|mesh-ancestor
83135954|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83135955|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83135956|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135957|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
83135958|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83135959|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83135960|NCT04989140|Growth Substances|growth substances|mesh-ancestor
83135961|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
83135962|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
83135963|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83135964|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135965|NCT03246009|Lenograstim|lenograstim|mesh-list
83135966|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83135967|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
83135968|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135969|NCT03246399|Lorecivivint|lorecivivint|mesh-list
83135970|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83135971|NCT02134249|Cabergoline|cabergoline|mesh-list
83135972|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83135973|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83135974|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
83135975|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
83135976|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221029|NCT03175705|Analgesics|analgesics|mesh-ancestor
83135977|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83135978|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135979|NCT03245853|Riboflavin|riboflavin|mesh-list
83135980|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
83135981|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
83135982|NCT03245853|Vitamins|vitamins|mesh-ancestor
83135983|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
83135984|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83135985|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83135986|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
83135987|NCT03574649|Paclitaxel|paclitaxel|mesh-list
83135988|NCT03574649|Docetaxel|docetaxel|mesh-list
83135989|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
83135990|NCT03574649|Carboplatin|carboplatin|mesh-list
83135991|NCT03574649|Fluorouracil|fluorouracil|mesh-list
83135992|NCT03574649|Avelumab|avelumab|mesh-list
83135993|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83135994|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83135995|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
83135996|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
83135997|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
83135998|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136000|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
83136001|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136002|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136003|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83136004|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
83136005|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83136006|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
83136007|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136008|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83136009|NCT02128945|Fludarabine|fludarabine|mesh-list
83136010|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136011|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83136012|NCT03073928|Ropivacaine|ropivacaine|mesh-list
83136014|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
83136015|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136016|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136017|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
83136018|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136019|NCT02134405|Esomeprazole|esomeprazole|mesh-list
83136020|NCT02134405|Rebamipide|rebamipide|mesh-list
83136021|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83392773|NCT02246049|Protective Agents|protective agents|mesh-ancestor
83136022|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136023|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83136024|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136025|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136026|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
83136027|NCT02134405|Protective Agents|protective agents|mesh-ancestor
83136028|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136029|NCT03574415|Fexuprazan|fexuprazan|mesh-list
83136030|NCT03574415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136031|NCT02456025|Tacrolimus|tacrolimus|mesh-list
83136032|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83136033|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
83136034|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136035|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83136036|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136037|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136038|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
83136039|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83136040|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136041|NCT02136511|Rituximab|rituximab|mesh-list
83136042|NCT02136511|Idelalisib|idelalisib|mesh-list
83136043|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83136044|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136045|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
83136046|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136047|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136048|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136049|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136050|NCT02136589|Diclofenac|diclofenac|mesh-list
83136051|NCT02136589|Travoprost|travoprost|mesh-list
83136052|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83136053|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83136054|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83136055|NCT02136589|Analgesics|analgesics|mesh-ancestor
83136056|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
83136057|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83392774|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
83136058|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136059|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83136060|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136061|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83136062|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136063|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136064|NCT02134639|Edotreotide|edotreotide|mesh-list
83136065|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83392775|NCT02246049|Vitamins|vitamins|mesh-ancestor
83136066|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136067|NCT02129101|Azacitidine|azacitidine|mesh-list
83136069|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136070|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
83136071|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136072|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136073|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136074|NCT02134717|Maraviroc|maraviroc|mesh-list
83136075|NCT02134717|Dimercaprol|dimercaprol|mesh-list
83136076|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83136077|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83136078|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136079|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83136080|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83136081|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
83136082|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136083|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83136084|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
83136085|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
83136086|NCT03245385|Halobetasol|halobetasol|mesh-list
83136087|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83136088|NCT02136823|Isradipine|isradipine|mesh-list
83136089|NCT02136823|Riluzole|riluzole|mesh-list
83136090|NCT02136823|Memantine|memantine|mesh-list
83136091|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83136092|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83136093|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
83136094|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136095|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83472949|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83136097|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83136098|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83136099|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
83136100|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83136101|NCT02136823|Protective Agents|protective agents|mesh-ancestor
83136102|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83136103|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83136104|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136105|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83136106|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
83136107|NCT03250143|Cyclosporine|cyclosporine|mesh-list
83136108|NCT03250143|Azathioprine|azathioprine|mesh-list
83136109|NCT03250143|Cyclosporins|cyclosporins|mesh-list
83136110|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136111|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136112|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83136113|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
83136114|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136115|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
83136116|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136117|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83136119|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83136120|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
83136121|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136122|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136123|NCT03073850|Anticoagulants|anticoagulants|mesh-list
83136124|NCT03073850|Edoxaban|edoxaban|mesh-list
83136125|NCT03073850|Clopidogrel|clopidogrel|mesh-list
83136126|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136127|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136128|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83136129|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136130|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83136131|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83136132|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83136133|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
83136134|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136135|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83136137|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83136138|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136139|NCT03257319|Morphine|morphine|mesh-list
83136140|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83136141|NCT03257319|Narcotics|narcotics|mesh-ancestor
83136142|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136143|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136145|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
83136146|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136147|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83136148|NCT03070574|Mesalamine|mesalamine|mesh-list
83472955|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
83136149|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83136150|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83136151|NCT03070574|Analgesics|analgesics|mesh-ancestor
83136152|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
83136153|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136154|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136155|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83136156|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136157|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
83136158|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83136159|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136160|NCT03257241|Cytarabine|cytarabine|mesh-list
83136161|NCT03257241|Fludarabine|fludarabine|mesh-list
83136162|NCT03257241|Daunorubicin|daunorubicin|mesh-list
83136163|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
83136164|NCT03257241|Idarubicin|idarubicin|mesh-list
83136165|NCT03257241|Cladribine|cladribine|mesh-list
83136166|NCT03257241|Lenograstim|lenograstim|mesh-list
83136167|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136168|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136169|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
83136170|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136171|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83136172|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
83136173|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136174|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
83136175|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136176|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83136177|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83136178|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83136179|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83136180|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136181|NCT03257241|Analgesics|analgesics|mesh-ancestor
83136182|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
83136183|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136184|NCT02129179|Glucagon|glucagon|mesh-list
83136185|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83136186|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136187|NCT02129179|Hormones|hormones|mesh-ancestor
83136188|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136189|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136190|NCT02129179|Incretins|incretins|mesh-ancestor
83136191|NCT02129257|Leucovorin|leucovorin|mesh-list
83136192|NCT02129257|Folic Acid|folic acid|mesh-list
83136193|NCT02129257|Fluorouracil|fluorouracil|mesh-list
83136194|NCT02129257|Irinotecan|irinotecan|mesh-list
83136195|NCT02129257|Aflibercept|aflibercept|mesh-list
83136196|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
83136197|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
83136198|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136199|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136200|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136201|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83136202|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
83136203|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136204|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83136205|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83136206|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136207|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83136208|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83136209|NCT02129257|Growth Substances|growth substances|mesh-ancestor
83136210|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
83136211|NCT02129257|Antidotes|antidotes|mesh-ancestor
83136212|NCT02129257|Protective Agents|protective agents|mesh-ancestor
83136213|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
83136214|NCT02129257|Vitamins|vitamins|mesh-ancestor
83136215|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
83136216|NCT02129257|Hematinics|hematinics|mesh-ancestor
83136217|NCT03245307|Apatinib|apatinib|mesh-list
83136218|NCT03245307|Nifedipine|nifedipine|mesh-list
83136219|NCT03245307|Warfarin|warfarin|mesh-list
83136220|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
83136221|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136222|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83136223|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136224|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136225|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83136226|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136227|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83136228|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136229|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
83136230|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
83136231|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83136232|NCT02136979|Propofol|propofol|mesh-list
83136233|NCT02136979|Sevoflurane|sevoflurane|mesh-list
83392776|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
83136234|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83136235|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136236|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136237|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83136238|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
83136239|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
83136240|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83136241|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83136242|NCT02455011|Volagidemab|volagidemab|mesh-list
83136243|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83136244|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136245|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83136246|NCT03249285|Perindopril|perindopril|mesh-list
83136247|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83136248|NCT03249285|Diuretics|diuretics|mesh-ancestor
83136249|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
83136250|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136251|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83136252|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83478737|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83136253|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136254|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83136255|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136256|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136257|NCT03249519|Cisplatin|cisplatin|mesh-list
83136258|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136259|NCT04983524|Propolis|propolis|mesh-list
83136260|NCT04983524|Calcium|calcium|mesh-list
83136261|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83136262|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136263|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136264|NCT03576911|Ubiquinone|ubiquinone|mesh-list
83136265|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
83136266|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
83136267|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136268|NCT03576911|Vitamins|vitamins|mesh-ancestor
83136269|NCT02634320|Aripiprazole|aripiprazole|mesh-list
83136270|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
83136271|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
83136272|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83136273|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83136274|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83136275|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136276|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136277|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
83136278|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
83136279|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136280|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136281|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83136282|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83136283|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
83136284|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83136285|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83136286|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83136287|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83136288|NCT02435680|Carboplatin|carboplatin|mesh-list
83136289|NCT02435680|Gemcitabine|gemcitabine|mesh-list
83136290|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136291|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136292|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
83136293|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136294|NCT04988048|Vaccines|vaccines|mesh-list
83136295|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
83136296|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136297|NCT04982900|Aflutinib|aflutinib|mesh-list
83136298|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83136299|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136300|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136302|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136303|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
83136304|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136305|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136306|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136307|NCT04912856|Ezogabine|ezogabine|mesh-list
83136308|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
83136309|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136310|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136311|NCT03248817|Phenylephrine|phenylephrine|mesh-list
83136312|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
83136313|NCT03248817|Bupivacaine|bupivacaine|mesh-list
83136314|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
83136315|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
83136316|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136317|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136318|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
83136319|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136320|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83136321|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
83136322|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
83136323|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
83136324|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83136325|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
83136326|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
83136327|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83136328|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83136329|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83136330|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
83473018|NCT04662710|Leucovorin|leucovorin|mesh-list
83136331|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136332|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136333|NCT03248817|Protective Agents|protective agents|mesh-ancestor
83136334|NCT03647774|Naltrexone|naltrexone|mesh-list
83136335|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83136336|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83136337|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136338|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
83136339|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136340|NCT03248973|Ampicillin|ampicillin|mesh-list
83136341|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83136342|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136343|NCT02832531|Aspirin|aspirin|mesh-list
83136344|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
83136345|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83136346|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83136347|NCT02832531|Analgesics|analgesics|mesh-ancestor
83136348|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
83136349|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136350|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136351|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83136352|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136353|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83136354|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83136355|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136356|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83136357|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83136358|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136359|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
83136360|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83136361|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
83136362|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83136363|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136364|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
83136365|NCT03248427|Paclitaxel|paclitaxel|mesh-list
83136366|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
83136367|NCT03248427|Doxorubicin|doxorubicin|mesh-list
83136368|NCT03248427|Letrozole|letrozole|mesh-list
83136369|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83136370|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136371|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
83136372|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
83136373|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
83136374|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136375|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83136376|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
83136377|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136378|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136379|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83136380|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
83136381|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83136382|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83136383|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83136384|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83136385|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136386|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83136387|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83136388|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83136389|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
83136390|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136391|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83136392|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136393|NCT05635370|Cilostazol|cilostazol|mesh-list
83136394|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
83136395|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83136396|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136397|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136398|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83136399|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83136400|NCT05635370|Protective Agents|protective agents|mesh-ancestor
83136401|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136402|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
83136403|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83136404|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
83136405|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83136406|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
83136407|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136408|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83136409|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
83136410|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83136411|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83136412|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83136413|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83136414|NCT03243903|Insulin|insulin|mesh-list
83136415|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83136416|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83136417|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136418|NCT03576677|Simendan|simendan|mesh-list
83136419|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83136420|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
83136421|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83392777|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
83136422|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83136423|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136424|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136425|NCT03576677|Protective Agents|protective agents|mesh-ancestor
83136426|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136427|NCT03247257|Lidocaine|lidocaine|mesh-list
83136428|NCT03247257|Anesthetics|anesthetics|mesh-list
83136429|NCT03247257|Propofol|propofol|mesh-list
83136430|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
83136431|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136432|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136433|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
83136434|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136435|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83136436|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83136437|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83136438|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136439|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136440|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83136441|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83136442|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
83136443|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
83136444|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83136445|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136446|NCT02239835|Ritonavir|ritonavir|mesh-list
83136447|NCT02239835|Saquinavir|saquinavir|mesh-list
83136448|NCT02239835|Tipranavir|tipranavir|mesh-list
83136449|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83136450|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83136451|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136452|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136453|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136454|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83136455|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83136456|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
83136457|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83392778|NCT05395143|Astringents|astringents|mesh-ancestor
83136458|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83136459|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83136460|NCT02239913|Topiramate|topiramate|mesh-list
83136461|NCT02239913|Phentermine|phentermine|mesh-list
83136462|NCT02239913|Cocaine|cocaine|mesh-list
83136463|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
83136464|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83136465|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136466|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
83136467|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
83136468|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136469|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
83136470|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136471|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83136472|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83136473|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83136474|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136475|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136476|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
83136477|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136478|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83136479|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
83136480|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83136481|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
83136482|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
83136483|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
83136484|NCT03576287|Apremilast|apremilast|mesh-list
83136485|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83136486|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83136487|NCT03576287|Analgesics|analgesics|mesh-ancestor
83136488|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
83136489|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136490|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136491|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83136492|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83392856|NCT04790448|Vemurafenib|vemurafenib|mesh-list
83136493|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83136494|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83136495|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136496|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136497|NCT02455869|Alendronate|alendronate|mesh-list
83136498|NCT02455869|Atorvastatin|atorvastatin|mesh-list
83136499|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83136500|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83136501|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
83136502|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136503|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83136504|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83136505|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136506|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83136507|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136508|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83136509|NCT03246555|Perindopril|perindopril|mesh-list
83136510|NCT03246555|Indapamide|indapamide|mesh-list
83136511|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83136512|NCT03246555|Diuretics|diuretics|mesh-ancestor
83136513|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
83393010|NCT00979017|Bevacizumab|bevacizumab|mesh-list
83136514|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136515|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83473050|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83136516|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136517|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136518|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83136519|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136520|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136522|NCT03576053|Serotonin|serotonin|mesh-list
83136523|NCT03576053|Histamine|histamine|mesh-list
83136524|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
83136525|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
83136526|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136527|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136528|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
83136529|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136530|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83136531|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83136532|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83136533|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136534|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136535|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83136536|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
83136537|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136538|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
83136539|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
83136540|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
83136541|NCT03242967|Hematinics|hematinics|mesh-ancestor
83136542|NCT03239457|Mitogens|mitogens|mesh-list
83136543|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83136544|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136545|NCT00075803|Fluconazole|fluconazole|mesh-list
83136546|NCT00075803|Voriconazole|voriconazole|mesh-list
83136547|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
83136548|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136549|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83136550|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83136551|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136552|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136553|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83136554|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
83136555|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136556|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136557|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83136558|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83136559|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83136560|NCT03242499|Lovastatin|lovastatin|mesh-list
83136561|NCT03242499|L 647318|l 647318|mesh-list
83136562|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
83136563|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83136564|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83136565|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
83136566|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136567|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83136568|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83136569|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136570|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
83136571|NCT02523911|Simethicone|simethicone|mesh-list
83136572|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
83136573|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83136574|NCT02523911|Analgesics|analgesics|mesh-ancestor
83136575|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
83136576|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136577|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136578|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
83136579|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136580|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83136581|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
83136582|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83136583|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136584|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136585|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83136586|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
83136587|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83136588|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
83136589|NCT02523911|Emollients|emollients|mesh-ancestor
83136590|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
83136591|NCT02523911|Cathartics|cathartics|mesh-ancestor
83136592|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136593|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
83136594|NCT03572231|Mirabegron|mirabegron|mesh-list
83136595|NCT03572231|Fesoterodine|fesoterodine|mesh-list
83136596|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83136597|NCT03572231|Oxybutynin|oxybutynin|mesh-list
83136598|NCT03572231|Darifenacin|darifenacin|mesh-list
83136599|NCT03572231|Propiverine|propiverine|mesh-list
83136600|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83136601|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83136602|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
83136603|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136604|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136605|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136607|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83136608|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83136609|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83136610|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
83136611|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
83136612|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
83136613|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136614|NCT02135029|Atorvastatin|atorvastatin|mesh-list
83136615|NCT02135029|Bococizumab|bococizumab|mesh-list
83136616|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83136617|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83136618|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
83136619|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136620|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83393011|NCT00979017|Irinotecan|irinotecan|mesh-list
83136621|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83136622|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136623|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
83136624|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83136625|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83136626|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136627|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
83136628|NCT03573245|Coagulants|coagulants|mesh-ancestor
83136629|NCT02241161|Bacteriocins|bacteriocins|mesh-list
83136630|NCT02241161|Antioxidants|antioxidants|mesh-list
83136631|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136632|NCT02241161|Protective Agents|protective agents|mesh-ancestor
83136633|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136634|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83136635|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136636|NCT02135263|Enalapril|enalapril|mesh-list
83136637|NCT02135263|Methylphenidate|methylphenidate|mesh-list
83136638|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83136639|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136640|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83136641|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83136642|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136643|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136644|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
83136645|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136646|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83136647|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136648|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136649|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83136650|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
83136651|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83136652|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83136653|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83136654|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83136655|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136656|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136657|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
83136658|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136659|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136660|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83136661|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136662|NCT02239523|Denosumab|denosumab|mesh-list
83136663|NCT02239523|Teriparatide|teriparatide|mesh-list
83136664|NCT02239523|Diphosphonates|diphosphonates|mesh-list
83136665|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83136666|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136667|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83136668|NCT02137213|Naloxone|naloxone|mesh-list
83136670|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136671|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
83136672|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136673|NCT03571919|Lidocaine|lidocaine|mesh-list
83136674|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
83136675|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
83136676|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136677|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136678|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
83136679|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136680|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83136681|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83136682|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83136683|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136684|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136685|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
83136686|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83136688|NCT02252809|Prednisolone|prednisolone|mesh-list
83136689|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
83136690|NCT02252809|Adalimumab|adalimumab|mesh-list
83136691|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83136692|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
83136693|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83136694|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
83136695|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
83136696|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136697|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136698|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136699|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
83136700|NCT02252809|Hormones|hormones|mesh-ancestor
83136701|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136702|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83136703|NCT02252809|Protective Agents|protective agents|mesh-ancestor
83136704|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83136705|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136706|NCT02252809|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83136707|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136708|NCT02137525|Fentanyl|fentanyl|mesh-list
83136709|NCT02137525|Morphine|morphine|mesh-list
83136710|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83136711|NCT02137525|Narcotics|narcotics|mesh-ancestor
83136712|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136713|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136714|NCT02137525|Analgesics|analgesics|mesh-ancestor
83136715|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
83136716|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136717|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83136718|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83136719|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
83136720|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
83136721|NCT02137681|Rituximab|rituximab|mesh-list
83136722|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83136723|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136724|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
83136725|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136726|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136727|NCT02842073|Naltrexone|naltrexone|mesh-list
83136729|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83136730|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83136731|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136732|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
83136733|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136734|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83136735|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
83136736|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83136737|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83136738|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83136739|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136740|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473130|NCT04439279|Protective Agents|protective agents|mesh-ancestor
83136742|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136743|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83136744|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83136745|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136746|NCT02135887|Leucovorin|leucovorin|mesh-list
83136747|NCT02135887|Folic Acid|folic acid|mesh-list
83136748|NCT02135887|Fluorouracil|fluorouracil|mesh-list
83136749|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
83136750|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
83136751|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
83393012|NCT00979017|Temozolomide|temozolomide|mesh-list
83136752|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136753|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136754|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136755|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83136756|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
83136757|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136759|NCT02135887|Protective Agents|protective agents|mesh-ancestor
83136760|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
83136761|NCT02135887|Vitamins|vitamins|mesh-ancestor
83136762|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
83136763|NCT02135887|Hematinics|hematinics|mesh-ancestor
83136764|NCT02137993|Olanzapine|olanzapine|mesh-list
83136766|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
83136767|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136768|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136769|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136770|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83136771|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83136772|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136773|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83136774|NCT02137993|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83136775|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83136776|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136777|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136778|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136779|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
83136780|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83136781|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83136782|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136783|NCT05579119|Incretins|incretins|mesh-ancestor
83136784|NCT05579119|Hormones|hormones|mesh-ancestor
83136785|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136786|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83136787|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136788|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136789|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136790|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83136791|NCT02245841|Hormones|hormones|mesh-ancestor
83136792|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136793|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136794|NCT05709041|Anesthetics|anesthetics|mesh-list
83136795|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136796|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136797|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83136798|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83136799|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83136800|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83136801|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136802|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
83136803|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136804|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136805|NCT03570281|Enoxaparin|enoxaparin|mesh-list
83136806|NCT03570281|Edoxaban|edoxaban|mesh-list
83136807|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
83136808|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83136809|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83136810|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136811|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83136812|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
83136813|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83136814|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83136815|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136817|NCT02242799|Lumefantrine|lumefantrine|mesh-list
83136818|NCT02242799|Artemether|artemether|mesh-list
83136819|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83136820|NCT02242799|Amodiaquine|amodiaquine|mesh-list
83136821|NCT02242799|Dolutegravir|dolutegravir|mesh-list
83136822|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
83136823|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83136824|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83136825|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136826|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136827|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
83136828|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
83136829|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83136830|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
83136831|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83136832|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83136833|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136834|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136835|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83136836|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83136837|NCT02138383|Paclitaxel|paclitaxel|mesh-list
83136838|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83136839|NCT02138383|Gemcitabine|gemcitabine|mesh-list
83136840|NCT02138383|Androgens|androgens|mesh-list
83136841|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83136842|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136843|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
83136844|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
83136845|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
83136846|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136847|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83136848|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
83136849|NCT02138383|Hormones|hormones|mesh-ancestor
83136850|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136851|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136852|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
83136853|NCT02243735|Trace Elements|trace elements|mesh-ancestor
83136855|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136856|NCT02138539|Hydroquinone|hydroquinone|mesh-list
83136857|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
83136858|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136859|NCT02138539|Protective Agents|protective agents|mesh-ancestor
83136860|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136861|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83136862|NCT02252419|Acetaminophen|acetaminophen|mesh-list
83136863|NCT02252419|Dexamethasone|dexamethasone|mesh-list
83136864|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83136865|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
83136866|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
83136867|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136868|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136869|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136870|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
83136871|NCT02252419|Hormones|hormones|mesh-ancestor
83393088|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136872|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136873|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83136874|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136875|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83136876|NCT02252419|Analgesics|analgesics|mesh-ancestor
83136877|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
83136878|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
83136879|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
83136881|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83136882|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136883|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
83136884|NCT02252497|Coagulants|coagulants|mesh-ancestor
83136885|NCT02138773|Tamsulosin|tamsulosin|mesh-list
83136886|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83136887|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83136888|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83136889|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
83136890|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136891|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83473199|NCT03630705|Vaccines|vaccines|mesh-list
83136892|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136893|NCT02138773|Urological Agents|urological agents|mesh-ancestor
83136894|NCT01367275|Irinotecan|irinotecan|mesh-list
83136895|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83136896|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83136897|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136898|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136899|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136900|NCT02138929|Everolimus|everolimus|mesh-list
83136901|NCT02138929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83136902|NCT02138929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83136903|NCT02138929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136904|NCT02138929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136905|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83136906|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
83136907|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136908|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83136910|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83136911|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136912|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136913|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83136914|NCT02253199|Analgesics|analgesics|mesh-ancestor
83136915|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
83136916|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136917|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83136918|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83136919|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83136920|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
83136921|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136922|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136924|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
83136925|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136926|NCT02139241|Ramosetron|ramosetron|mesh-list
83136927|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
83136928|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
83136929|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136930|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136931|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83136932|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83136933|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
83136934|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136935|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136936|NCT03569579|Memantine|memantine|mesh-list
83136937|NCT03569579|Donepezil|donepezil|mesh-list
83136938|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83136939|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136940|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136941|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
83136942|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83136943|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136944|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
83136945|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83136946|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83136947|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
83136948|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83136949|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83136950|NCT02130661|Itraconazole|itraconazole|mesh-list
83136951|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
83136952|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83136953|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83136954|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83136955|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478738|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
83478739|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
83478740|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478741|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83478742|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478743|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478744|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83136956|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136957|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83136958|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
83136959|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83136960|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136961|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83136962|NCT02130739|Fentanyl|fentanyl|mesh-list
83136963|NCT02130739|Propofol|propofol|mesh-list
83136964|NCT02130739|Ropivacaine|ropivacaine|mesh-list
83136965|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
83136966|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136967|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136968|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83136969|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83136970|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
83136971|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
83136972|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
83136973|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136974|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83136975|NCT02130739|Narcotics|narcotics|mesh-ancestor
83136976|NCT02130739|Analgesics|analgesics|mesh-ancestor
83136977|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83136978|NCT02248493|Acetaminophen|acetaminophen|mesh-list
83136979|NCT02248493|Ketoprofen|ketoprofen|mesh-list
83136980|NCT02248493|Morphine|morphine|mesh-list
83136981|NCT02248493|Tramadol|tramadol|mesh-list
83136982|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83136983|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83136984|NCT02248493|Narcotics|narcotics|mesh-ancestor
83136985|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83136986|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83136987|NCT02248493|Analgesics|analgesics|mesh-ancestor
83136988|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
83136989|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83136990|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83136991|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
83478745|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
83393316|NCT05074056|Analgesics|analgesics|mesh-ancestor
83393317|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
83393318|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393319|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393320|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83393321|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393322|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83393323|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393324|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393325|NCT03656549|Pemetrexed|pemetrexed|mesh-list
83393326|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83393327|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393708|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478746|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478748|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
83478749|NCT05334654|Bivalirudin|bivalirudin|mesh-list
83478750|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
83478751|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83473233|NCT03414658|Trastuzumab|trastuzumab|mesh-list
83478752|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83478753|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478754|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
83478755|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83478756|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
83478757|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478758|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
83478759|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478760|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83478761|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83478762|NCT03561584|Analgesics|analgesics|mesh-ancestor
83478763|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
83393479|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
83136992|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83136993|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83136994|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83136995|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83136996|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83136997|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83136998|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
83136999|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83137000|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137001|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137002|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83137003|NCT05577871|Analgesics|analgesics|mesh-ancestor
83137004|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
83137005|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137006|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83137007|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83137008|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83137009|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
83137010|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137011|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137012|NCT03140423|Mupirocin|mupirocin|mesh-list
83137013|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83137014|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137015|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83137016|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137017|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137018|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
83137019|NCT02130817|Dexamethasone|dexamethasone|mesh-list
83137020|NCT02130817|Prednisone|prednisone|mesh-list
83137021|NCT02130817|Abatacept|abatacept|mesh-list
83137022|NCT02130817|Tacrolimus|tacrolimus|mesh-list
83137023|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
83137024|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83137025|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
83137026|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83137027|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
83137028|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
83137029|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83137030|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83137031|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
83137032|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
83137033|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137034|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137035|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83137036|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
83137037|NCT02130817|Hormones|hormones|mesh-ancestor
83221030|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
83137038|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137039|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83137040|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137041|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137042|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137043|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137044|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
83137045|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83137046|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83137047|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83137048|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
83137049|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83137050|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137051|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83137052|NCT02130817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137053|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83137054|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
83137055|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
83137056|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137057|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137058|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137059|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
83137060|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
83137061|NCT02130973|Denosumab|denosumab|mesh-list
83137062|NCT02130973|Teriparatide|teriparatide|mesh-list
83137063|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83137064|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137065|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83137066|NCT02456662|Ondansetron|ondansetron|mesh-list
83137067|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
83137068|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
83137069|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137070|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137071|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83137072|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
83137073|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83137074|NCT02456662|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83137075|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83137076|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
83137077|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137078|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137079|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
83137080|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
83137081|NCT03548311|Vitamins|vitamins|mesh-ancestor
83137082|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
83137083|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137084|NCT01653262|Brivaracetam|brivaracetam|mesh-list
83137085|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
83137086|NCT02455336|Fenofibrate|fenofibrate|mesh-list
83137087|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83137088|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
83137089|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137090|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83137091|NCT02253121|Insulin|insulin|mesh-list
83473260|NCT03297359|Dalteparin|dalteparin|mesh-list
83137092|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83137093|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
83137094|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83137095|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393706|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83137096|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83137097|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137098|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
83137099|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83137100|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
83137101|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137102|NCT03568721|Acetaminophen|acetaminophen|mesh-list
83137103|NCT03568721|Ibuprofen|ibuprofen|mesh-list
83137104|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83137105|NCT03568721|Analgesics|analgesics|mesh-ancestor
83137106|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
83137107|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137108|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137109|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
83137110|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83137111|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83137112|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83137113|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83137114|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137115|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137116|NCT05354375|Immunomodulating Agents|immunomodulating agents|mesh-list
83137117|NCT05354375|Immunologic Factors|immunologic factors|mesh-ancestor
83137118|NCT05354375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137119|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
83137120|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83137121|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137122|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137123|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83137124|NCT03566303|Vitamin K|vitamin k|mesh-list
83137125|NCT03566303|Warfarin|warfarin|mesh-list
83137126|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
83137127|NCT03566303|Vitamins|vitamins|mesh-ancestor
83137128|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
83393707|NCT04974060|Narcotics|narcotics|mesh-ancestor
83393785|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83393786|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83393787|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393788|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
83393789|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83393790|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393791|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393792|NCT01023477|Analgesics|analgesics|mesh-ancestor
83393793|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
83393794|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393795|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137129|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137130|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
83137131|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83137132|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
83137133|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83137134|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
83137135|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137136|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137137|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83137138|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83137140|NCT03566303|Coagulants|coagulants|mesh-ancestor
83137141|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83137142|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137143|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83137144|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137145|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137146|NCT03567941|Acetaminophen|acetaminophen|mesh-list
83137147|NCT03567941|Hydrocodone|hydrocodone|mesh-list
83137148|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83137149|NCT03567941|Analgesics|analgesics|mesh-ancestor
83137150|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
83137151|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137152|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137153|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
83137154|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83137155|NCT03567941|Narcotics|narcotics|mesh-ancestor
83137156|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137157|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
83137158|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
83137159|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83137160|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83137161|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83137163|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137164|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83137165|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83137166|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137167|NCT03566225|Metformin|metformin|mesh-list
83137168|NCT03566225|Pioglitazone|pioglitazone|mesh-list
83137169|NCT03566225|Clomiphene|clomiphene|mesh-list
83137170|NCT03566225|Enclomiphene|enclomiphene|mesh-list
83137171|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
83137173|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137174|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83137175|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
83137176|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137177|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83137178|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
83137179|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137180|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83137181|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83137182|NCT02397694|Dolutegravir|dolutegravir|mesh-list
83137183|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83137184|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83137185|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137186|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137187|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83137188|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83137189|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
83137190|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137191|NCT03566069|Oxytocin|oxytocin|mesh-list
83137192|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
83137193|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137194|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137195|NCT04916548|Ketamine|ketamine|mesh-list
83137196|NCT04916548|Analgesics|analgesics|mesh-ancestor
83137197|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
83137198|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137199|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137200|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83137201|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83137202|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
83137203|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
83137204|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137205|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83137206|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83137207|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137208|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137209|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
83137210|NCT03567629|Leucovorin|leucovorin|mesh-list
83137211|NCT03567629|Bevacizumab|bevacizumab|mesh-list
83137212|NCT03567629|Cetuximab|cetuximab|mesh-list
83137213|NCT03567629|Fluorouracil|fluorouracil|mesh-list
83137214|NCT03567629|Capecitabine|capecitabine|mesh-list
83137215|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
83137216|NCT03567629|Irinotecan|irinotecan|mesh-list
83137217|NCT03567629|Calcium|calcium|mesh-list
83137219|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137220|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137221|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83137222|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83137223|NCT03567629|Growth Substances|growth substances|mesh-ancestor
83137224|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137225|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
83137226|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83137227|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83137228|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
83137229|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137230|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83137231|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137232|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
83137233|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83137234|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83137235|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137236|NCT03567629|Antidotes|antidotes|mesh-ancestor
83137237|NCT03567629|Protective Agents|protective agents|mesh-ancestor
83137238|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
83137239|NCT03567629|Vitamins|vitamins|mesh-ancestor
83137240|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
83137241|NCT02783599|Doxorubicin|doxorubicin|mesh-list
83137242|NCT02783599|Olaratumab|olaratumab|mesh-list
83137243|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83137244|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137245|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83137246|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83137247|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137248|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137249|NCT03567395|Melatonin|melatonin|mesh-list
83137251|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137252|NCT03567395|Protective Agents|protective agents|mesh-ancestor
83137253|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137254|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137255|NCT03565133|Quinine|quinine|mesh-list
83137256|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
83137257|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83137258|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83137259|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137260|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83137261|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137262|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83137263|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137264|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83137265|NCT03565133|Analgesics|analgesics|mesh-ancestor
83137266|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
83137267|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83137268|NCT05353673|Danazol|danazol|mesh-list
83137269|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83137270|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137271|NCT05353673|Incretins|incretins|mesh-ancestor
83137272|NCT05353673|Hormones|hormones|mesh-ancestor
83137273|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137274|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83137275|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
83137276|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137277|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137278|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83137279|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
83137280|NCT05353205|Flumatinib|flumatinib|mesh-list
83137281|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83137282|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137283|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137284|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83137285|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83137286|NCT03564509|Hormones|hormones|mesh-ancestor
83137287|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137288|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137289|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137290|NCT03068234|Pirfenidone|pirfenidone|mesh-list
83137291|NCT03068234|Analgesics|analgesics|mesh-ancestor
83137292|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
83137293|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137294|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137295|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83137296|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83137297|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83137298|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83137299|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137300|NCT05339399|Oxytocin|oxytocin|mesh-list
83137301|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
83137302|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137303|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137304|NCT04092179|Venetoclax|venetoclax|mesh-list
83137305|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137306|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
83137307|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83137308|NCT05634824|Antibodies|antibodies|mesh-list
83137309|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
83137310|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83137311|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
83137312|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137314|NCT02454478|Lenvatinib|lenvatinib|mesh-list
83137315|NCT02454478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83137316|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83137317|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137318|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137319|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137320|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
83137321|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137322|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137323|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83137325|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83137326|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83137327|NCT05284214|Ipilimumab|ipilimumab|mesh-list
83137329|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137330|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137331|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83137332|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137333|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
83137334|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137335|NCT03563963|Lidocaine|lidocaine|mesh-list
83137336|NCT03563963|Ropivacaine|ropivacaine|mesh-list
83137337|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83137338|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
83137339|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
83137340|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137341|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137342|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
83137343|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137344|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83137345|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83137346|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83473373|NCT02106988|Etoposide|etoposide|mesh-list
83137347|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83137348|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137349|NCT03066518|Melatonin|melatonin|mesh-list
83137350|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
83137351|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137352|NCT03066518|Protective Agents|protective agents|mesh-ancestor
83137353|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137354|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137355|NCT03069248|Interferons|interferons|mesh-list
83137356|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
83137357|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83137358|NCT03069248|Rituximab|rituximab|mesh-list
83137359|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137360|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137361|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
83137362|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137363|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83137364|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
83137365|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137366|NCT05730062|Oxycodone|oxycodone|mesh-list
83137367|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83137368|NCT05730062|Narcotics|narcotics|mesh-ancestor
83137369|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137370|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137371|NCT05730062|Analgesics|analgesics|mesh-ancestor
83137372|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
83137373|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137374|NCT03068936|Cisplatin|cisplatin|mesh-list
83137375|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137376|NCT05017610|Lomustine|lomustine|mesh-list
83137377|NCT05017610|Methimazole|methimazole|mesh-list
83137378|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83137379|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
83478764|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83478765|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478766|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83478767|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83478768|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478769|NCT00389610|Pancrelipase|pancrelipase|mesh-list
83478770|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83478771|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83478772|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83473408|NCT00684073|Naloxone|naloxone|mesh-list
83478773|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83478774|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478775|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478776|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83478777|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
83478778|NCT00324272|Coagulants|coagulants|mesh-ancestor
83478779|NCT00369590|Aflibercept|aflibercept|mesh-list
83478780|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
83478781|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83478782|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83478783|NCT00369590|Growth Substances|growth substances|mesh-ancestor
83478784|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478785|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
83478786|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478787|NCT03932136|Sulforaphane|sulforaphane|mesh-list
83478788|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83478789|NCT03932136|Protective Agents|protective agents|mesh-ancestor
83478790|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478791|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478792|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83478793|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83478794|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478795|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83478796|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83478797|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
83478798|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478799|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478800|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83478801|NCT00390182|Gemcitabine|gemcitabine|mesh-list
83478802|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83478803|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
83478804|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478805|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478806|NCT05366868|Metformin|metformin|mesh-list
83478807|NCT05366868|Vildagliptin|vildagliptin|mesh-list
83478808|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83478809|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478810|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83478811|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
83478812|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478813|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478814|NCT00369746|Citalopram|citalopram|mesh-list
83478815|NCT00369746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83478816|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83478817|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83478818|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478819|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478820|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
83478821|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478970|NCT05902078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83478971|NCT05901935|Capecitabine|capecitabine|mesh-list
83478972|NCT05901935|Trastuzumab|trastuzumab|mesh-list
83478973|NCT05901935|Vinorelbine|vinorelbine|mesh-list
83478974|NCT05901935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83478975|NCT05901935|Antimetabolites|antimetabolites|mesh-ancestor
83478976|NCT05901935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478977|NCT05901935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478978|NCT05901935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83478979|NCT05901935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83478980|NCT05901935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83478981|NCT05901935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83478982|NCT05901935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83478983|NCT05901766|Micronutrients|micronutrients|mesh-list
83478984|NCT05901766|Trace Elements|trace elements|mesh-list
83478985|NCT05901766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478986|NCT05901714|Phenytoin|phenytoin|mesh-list
83478987|NCT05901714|Midazolam|midazolam|mesh-list
83478988|NCT05901714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83478989|NCT05901714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83478990|NCT05901714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83478991|NCT05901714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478992|NCT05901714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83478993|NCT05901714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83478994|NCT05901714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83478995|NCT05901714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83478996|NCT05901714|Anesthetics, General|anesthetics, general|mesh-ancestor
83478997|NCT05901714|Anesthetics|anesthetics|mesh-ancestor
83478998|NCT05901714|GABA Modulators|gaba modulators|mesh-ancestor
83478999|NCT05901714|GABA Agents|gaba agents|mesh-ancestor
83393947|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
83393948|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83393949|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83393950|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83393951|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83393952|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393953|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83393954|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
83393955|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83393956|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393957|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83393958|NCT01031043|Bethanechol|bethanechol|mesh-list
83393959|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83393960|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
83393961|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83393962|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393963|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83393964|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83393965|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
83393966|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83393967|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83393968|NCT01050153|Aspirin|aspirin|mesh-list
83393969|NCT01050153|Dalteparin|dalteparin|mesh-list
83393970|NCT01050153|Tinzaparin|tinzaparin|mesh-list
83393971|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83393972|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83393973|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83393974|NCT01050153|Analgesics|analgesics|mesh-ancestor
83393975|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
83393976|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83394052|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83394053|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83394054|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83394055|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
83394056|NCT01054911|Sunitinib|sunitinib|mesh-list
83394057|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83394058|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83394059|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83394060|NCT01054911|Growth Substances|growth substances|mesh-ancestor
83394061|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394062|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
83394063|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83394064|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394065|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83394066|NCT01055223|Troglitazone|troglitazone|mesh-list
83394067|NCT01055223|Amiloride|amiloride|mesh-list
83394068|NCT01055223|Spironolactone|spironolactone|mesh-list
83137380|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137381|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137382|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
83137383|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
83137384|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137385|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137386|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
83137387|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83137388|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
83137389|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137390|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137391|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
83137392|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137393|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137394|NCT04454528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83137395|NCT04454528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137396|NCT05004116|Irinotecan|irinotecan|mesh-list
83137397|NCT05004116|Temozolomide|temozolomide|mesh-list
83137398|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83137399|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83137400|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83394219|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
83479000|NCT05901714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479001|NCT05901714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479002|NCT05901714|Anticonvulsants|anticonvulsants|mesh-ancestor
83479003|NCT05901714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83479004|NCT05901714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83479005|NCT05901714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479006|NCT05901714|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83479007|NCT05901714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83479008|NCT05901701|Salicylic Acid|salicylic acid|mesh-list
83479009|NCT05901701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137401|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137402|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137403|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83137404|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
83137406|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
83137407|NCT02452762|Vitamins|vitamins|mesh-ancestor
83137408|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
83137409|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137410|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83137411|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83137412|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
83137413|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83137414|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137415|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
83137416|NCT05633420|Artesunate|artesunate|mesh-list
83137417|NCT05633420|Pyronaridine|pyronaridine|mesh-list
83137418|NCT05633420|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83137419|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
83137420|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83137421|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83137422|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137423|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137424|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
83137425|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
83137426|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83137427|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
83137428|NCT05729594|Bimatoprost|bimatoprost|mesh-list
83137429|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83137430|NCT02631746|Nivolumab|nivolumab|mesh-list
83137431|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137432|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137433|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479010|NCT05901701|Antifungal Agents|antifungal agents|mesh-ancestor
83479011|NCT05901701|Keratolytic Agents|keratolytic agents|mesh-ancestor
83479012|NCT05901701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83479013|NCT05901571|Dexetimide|dexetimide|mesh-list
83479014|NCT05901571|Citalopram|citalopram|mesh-list
83479015|NCT05901571|Escitalopram|escitalopram|mesh-list
83479016|NCT05901571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83479017|NCT05901571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83394442|NCT04730531|Bupivacaine|bupivacaine|mesh-list
83394443|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
83394444|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
83394445|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83394446|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394447|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
83394448|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137434|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137435|NCT04699058|Antibodies|antibodies|mesh-list
83137436|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
83137437|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137438|NCT04626128|Aflibercept|aflibercept|mesh-list
83137439|NCT04626128|Axitinib|axitinib|mesh-list
83137440|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83137441|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83137442|NCT04626128|Growth Substances|growth substances|mesh-ancestor
83395426|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83137443|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137445|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137446|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83137447|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137448|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137449|NCT05487092|Letrozole|letrozole|mesh-list
83137450|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137451|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83137452|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83137453|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137454|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137455|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83137456|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
83137457|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137458|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137459|NCT05728892|Melatonin|melatonin|mesh-list
83137460|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
83137461|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137462|NCT05728892|Protective Agents|protective agents|mesh-ancestor
83137463|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137464|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137465|NCT03067688|Amlodipine|amlodipine|mesh-list
83137466|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83137467|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83137468|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83137469|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83137470|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83137471|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137472|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83137473|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137474|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
83137475|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83137476|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83137477|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
83395503|NCT04704063|Protective Agents|protective agents|mesh-ancestor
83395504|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
83395505|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83395506|NCT04703036|Glycine|glycine|mesh-list
83395507|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
83395508|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83395509|NCT04703036|Expectorants|expectorants|mesh-ancestor
83395510|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
83395511|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83395512|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
83395513|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83395514|NCT04703036|Protective Agents|protective agents|mesh-ancestor
83396046|NCT03236324|Bupivacaine|bupivacaine|mesh-list
83396047|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
83396048|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
83396049|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83396050|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396051|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
83396052|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396204|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
83396206|NCT02829957|Apixaban|apixaban|mesh-list
83396207|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83396208|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
83396209|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83396210|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
83396211|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396212|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396213|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
83396214|NCT02823028|Nicotine|nicotine|mesh-list
83396215|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83396216|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
83396217|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396218|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396219|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83396220|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83396221|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
83396222|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396223|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396224|NCT02785224|Vasopressins|vasopressins|mesh-list
83396225|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
83396226|NCT02785224|Epinephrine|epinephrine|mesh-list
83396227|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83396228|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83396229|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
83137478|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83137479|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83137480|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137481|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83137482|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83137483|NCT02396758|Plasminogen|plasminogen|mesh-list
83137484|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83137485|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83137486|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83137487|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137488|NCT05728424|Amoxicillin|amoxicillin|mesh-list
83137489|NCT05728424|Levofloxacin|levofloxacin|mesh-list
83137490|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83137491|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137492|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83137493|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83137494|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83137495|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137496|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137497|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137498|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83137499|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83137500|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
83137501|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83137502|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
83137503|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137504|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
83137505|NCT05728346|Protective Agents|protective agents|mesh-ancestor
83137506|NCT05515796|Trastuzumab|trastuzumab|mesh-list
83137507|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137508|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137510|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83137511|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137512|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
83137513|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
83137514|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
83137515|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137516|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
83137517|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83137518|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137519|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83137520|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137521|NCT04926844|Midazolam|midazolam|mesh-list
83137522|NCT04926844|Levetiracetam|levetiracetam|mesh-list
83137523|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83137524|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83137525|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137526|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137527|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83137528|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83137529|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83137530|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83137531|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
83137532|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
83137533|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
83137534|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
83137535|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137536|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137537|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
83137538|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
83137539|NCT05482256|Listerine|listerine|mesh-list
83137540|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
83137541|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
83137542|NCT05482256|Protective Agents|protective agents|mesh-ancestor
83137543|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137544|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83137545|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137546|NCT01651936|Methotrexate|methotrexate|mesh-list
83137547|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83137548|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
83137549|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137550|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137551|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83137552|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
83137553|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137554|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137555|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
83137556|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137557|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83137558|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137559|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
83137560|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83137561|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83137562|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83137563|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
83137564|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137565|NCT03065504|Turmeric extract|turmeric extract|mesh-list
83137566|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
83137567|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137568|NCT03065504|Protective Agents|protective agents|mesh-ancestor
83137569|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137570|NCT02630966|Vedolizumab|vedolizumab|mesh-list
83137571|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83137572|NCT05724212|Interferons|interferons|mesh-list
83137573|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
83137574|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137575|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
83137576|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137577|NCT05723588|Nicotine|nicotine|mesh-list
83137578|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83137579|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
83137580|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137581|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137582|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83137583|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83137584|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
83137585|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479018|NCT05901571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479019|NCT05901571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479020|NCT05901571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479021|NCT05901571|Serotonin Agents|serotonin agents|mesh-ancestor
83479022|NCT05901571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479023|NCT05901571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83479024|NCT05901571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83137586|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137588|NCT01651780|Calcium heparin|calcium heparin|mesh-list
83137589|NCT01651780|Bivalirudin|bivalirudin|mesh-list
83137590|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
83137591|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83137592|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83137593|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137594|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
83137595|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83137596|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
83137597|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137598|NCT02394730|Vorapaxar|vorapaxar|mesh-list
83137599|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83137600|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83137601|NCT05376878|Trastuzumab|trastuzumab|mesh-list
83137602|NCT05376878|Camptothecin|camptothecin|mesh-list
83137603|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83137604|NCT05376878|Antibodies|antibodies|mesh-list
83137605|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
83137606|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83137607|NCT05376878|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83137608|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
83137609|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
83137610|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137611|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137612|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137613|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83137614|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83137615|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83137616|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137618|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
83137619|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137620|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
83137621|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137623|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83137624|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83137625|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83137626|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83479025|NCT05901571|Parasympatholytics|parasympatholytics|mesh-ancestor
83479026|NCT05901571|Autonomic Agents|autonomic agents|mesh-ancestor
83479027|NCT05901571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479028|NCT05901571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83479029|NCT05901571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83479030|NCT05901571|Cholinergic Agents|cholinergic agents|mesh-ancestor
83479031|NCT05901571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83479032|NCT05901571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83479033|NCT05901571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83479034|NCT05901545|Panitumumab|panitumumab|mesh-list
83479035|NCT05901545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479036|NCT05901545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479037|NCT05901519|Prednisone|prednisone|mesh-list
83479038|NCT05901519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479039|NCT05901519|Glucocorticoids|glucocorticoids|mesh-ancestor
83479040|NCT05901519|Hormones|hormones|mesh-ancestor
83137627|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137628|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137629|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83137630|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83137631|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83137632|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
83137633|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137634|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137635|NCT02394340|Luliconazole|luliconazole|mesh-list
83137636|NCT02394340|Omeprazole|omeprazole|mesh-list
83137637|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83137638|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83396305|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83396306|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
83396307|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83396308|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396309|NCT02494258|Azacitidine|azacitidine|mesh-list
83396310|NCT02494258|Cc-486|cc-486|mesh-list
83396311|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83396312|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
83396313|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396314|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396315|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396316|NCT02437045|Meropenem|meropenem|mesh-list
83137639|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83137640|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137641|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137642|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
83137643|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137644|NCT01672736|Dexamethasone|dexamethasone|mesh-list
83137645|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
83137646|NCT01672736|Bortezomib|bortezomib|mesh-list
83137647|NCT01672736|BB 1101|bb 1101|mesh-list
83137648|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83137649|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
83137650|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
83137651|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137652|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137653|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83137654|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
83137655|NCT01672736|Hormones|hormones|mesh-ancestor
83137656|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137657|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83137658|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137659|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
83137660|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137661|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137662|NCT03065660|Mifepristone|mifepristone|mesh-list
83137663|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83137664|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
83137665|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137666|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137667|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83137668|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83137669|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83137670|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
83137671|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83137672|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83137673|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
83137674|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137675|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
83137676|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83137677|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83137678|NCT03893630|Aspirin|aspirin|mesh-list
83137679|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83137680|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83137681|NCT03893630|Analgesics|analgesics|mesh-ancestor
83137682|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
83137683|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137684|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137685|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83137687|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83137688|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83137689|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137690|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83137691|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83473716|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
83137692|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137693|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
83137694|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
83137695|NCT03065816|Antacids|antacids|mesh-ancestor
83137696|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137697|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83137698|NCT05619848|Midazolam|midazolam|mesh-list
83137699|NCT05619848|Remifentanil|remifentanil|mesh-list
83137700|NCT05619848|Bromides|bromides|mesh-list
83137701|NCT05619848|Propofol|propofol|mesh-list
83137703|NCT05619848|Rocuronium|rocuronium|mesh-list
83137704|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83137705|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137706|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137707|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83137708|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
83137709|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
83137710|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83137711|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83137712|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83137713|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83137714|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
83137715|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
83137716|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137717|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137718|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83137719|NCT05619848|Narcotics|narcotics|mesh-ancestor
83137720|NCT05619848|Analgesics|analgesics|mesh-ancestor
83137721|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
83137722|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137723|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
83137724|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83137725|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83137726|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83137727|NCT01560637|Treprostinil|treprostinil|mesh-list
83137728|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83137730|NCT04447352|Docetaxel|docetaxel|mesh-list
83137731|NCT04447352|Fluorouracil|fluorouracil|mesh-list
83137733|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137734|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83137735|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83137736|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83137737|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137738|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
83137739|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83137740|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137741|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
83137742|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137743|NCT04447352|Antidotes|antidotes|mesh-ancestor
83137744|NCT04447352|Protective Agents|protective agents|mesh-ancestor
83137745|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
83137746|NCT04447352|Vitamins|vitamins|mesh-ancestor
83137747|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
83137748|NCT04157036|Ibuprofen|ibuprofen|mesh-list
83137749|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
83137750|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83137751|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83137752|NCT04157036|Prednisolone|prednisolone|mesh-list
83137753|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
83137754|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83137755|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
83137756|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83137757|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83137758|NCT04157036|Analgesics|analgesics|mesh-ancestor
83396317|NCT02437045|Tazobactam|tazobactam|mesh-list
83396318|NCT02437045|Piperacillin|piperacillin|mesh-list
83396319|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83396320|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83396321|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83396322|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83396323|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83396324|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396325|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
83396326|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
83396327|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396328|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396329|NCT02362035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83396330|NCT02362035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396331|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
83396332|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396333|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
83396334|NCT02308527|Temozolomide|temozolomide|mesh-list
83396335|NCT02308527|Bevacizumab|bevacizumab|mesh-list
83396336|NCT02308527|Irinotecan|irinotecan|mesh-list
83396337|NCT02308527|Topotecan|topotecan|mesh-list
83396338|NCT02308527|Dinutuximab|dinutuximab|mesh-list
83396339|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137759|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
83137760|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137761|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137762|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83137763|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83137764|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83137765|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137766|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137767|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
83137768|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
83137769|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83137770|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
83137771|NCT04157036|Hormones|hormones|mesh-ancestor
83396340|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
83396341|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396342|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83396343|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83396344|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
83396345|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396346|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83396347|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83396348|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83396349|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83396350|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83396351|NCT02308527|Growth Substances|growth substances|mesh-ancestor
83396352|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
83396353|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83479262|NCT05837000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83479263|NCT05837000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83479264|NCT05837000|Adrenergic Agents|adrenergic agents|mesh-ancestor
83479265|NCT05837000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479266|NCT05837000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479267|NCT05837000|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83479268|NCT05837000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83479269|NCT05837000|Anesthetics, General|anesthetics, general|mesh-ancestor
83479270|NCT05837000|Anesthetics|anesthetics|mesh-ancestor
83479271|NCT05837000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83479272|NCT05837000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83479273|NCT05837000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83479274|NCT05837000|Anticonvulsants|anticonvulsants|mesh-ancestor
83479275|NCT05837000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83479276|NCT05837000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479277|NCT05837000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83479278|NCT05837000|Tocolytic Agents|tocolytic agents|mesh-ancestor
83479279|NCT05837000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83479280|NCT05834036|Amoxicillin|amoxicillin|mesh-list
83479281|NCT05834036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83479282|NCT05834036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479283|NCT05833139|Itraconazole|itraconazole|mesh-list
83479284|NCT05833139|Antifungal Agents|antifungal agents|mesh-ancestor
83479285|NCT05833139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479286|NCT05833139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83479287|NCT05833139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83479288|NCT05833139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479289|NCT05833139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83396664|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83396665|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
83396666|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
83396667|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83396668|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396669|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83396670|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
83396671|NCT00492999|Hormones|hormones|mesh-ancestor
83397877|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83397878|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83397879|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397880|NCT00088595|Pasireotide|pasireotide|mesh-list
83397881|NCT00088595|Hormones|hormones|mesh-ancestor
83397882|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83397883|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397884|NCT03450707|Thiamine|thiamine|mesh-list
83397885|NCT03450707|Vitamins|vitamins|mesh-ancestor
83397886|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
83397887|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397888|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
83397889|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
83397890|NCT01678079|Calcium|calcium|mesh-list
83397891|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83397892|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397893|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83397894|NCT01678235|Insulin|insulin|mesh-list
83397895|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83397896|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
83397897|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
83397898|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83397899|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397900|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
83397901|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83397902|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
83397903|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83397904|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
83397905|NCT01197495|Protective Agents|protective agents|mesh-ancestor
83397906|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83397907|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83397908|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83397909|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397910|NCT03011931|Simvastatin|simvastatin|mesh-list
83397911|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83397912|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83397913|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
83397914|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397915|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83397916|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83397917|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397918|NCT02185131|Mirtazapine|mirtazapine|mesh-list
83397992|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83397993|NCT01202721|Atenolol|atenolol|mesh-list
83397994|NCT01202721|Telmisartan|telmisartan|mesh-list
83397995|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83397996|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83397997|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83397998|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83397999|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83479290|NCT05833139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83479291|NCT05833139|Hormone Antagonists|hormone antagonists|mesh-ancestor
83479292|NCT05833139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479293|NCT05833139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479294|NCT05833139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83479295|NCT05821296|Methamphetamine|methamphetamine|mesh-list
83479296|NCT05821296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83479297|NCT05821296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479298|NCT05821296|Sympathomimetics|sympathomimetics|mesh-ancestor
83479299|NCT05821296|Autonomic Agents|autonomic agents|mesh-ancestor
83479300|NCT05821296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479301|NCT05821296|Dopamine Agents|dopamine agents|mesh-ancestor
83479302|NCT05821296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479303|NCT05821296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479304|NCT05821296|Adrenergic Agents|adrenergic agents|mesh-ancestor
83479305|NCT05821296|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83479306|NCT05821296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83479307|NCT05821296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83479308|NCT05821296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83479309|NCT05810597|Tirzepatide|tirzepatide|mesh-list
83479310|NCT05810597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83479311|NCT05810597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479312|NCT05810597|Incretins|incretins|mesh-ancestor
83479313|NCT05810597|Hormones|hormones|mesh-ancestor
83398000|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
83398001|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
83398002|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398003|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398004|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83398005|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83398006|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83398007|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
83398008|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83398009|NCT00084617|Capecitabine|capecitabine|mesh-list
83398010|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
83398011|NCT00084617|Irinotecan|irinotecan|mesh-list
83398012|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83398013|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
83398014|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398015|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398016|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83398017|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83398018|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398019|NCT04270175|Dexamethasone|dexamethasone|mesh-list
83398020|NCT04270175|Daratumumab|daratumumab|mesh-list
83398021|NCT04270175|Pomalidomide|pomalidomide|mesh-list
83398022|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398023|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
83398024|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
83398025|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398026|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479389|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479390|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83479391|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479392|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479393|NCT05661643|Temozolomide|temozolomide|mesh-list
83479394|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83479395|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
83479396|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479397|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479398|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
83479399|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83479400|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479402|NCT05659056|Trastuzumab|trastuzumab|mesh-list
83479403|NCT05659056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83479404|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479405|NCT05659056|Tubulin Modulators|tubulin modulators|mesh-ancestor
83479406|NCT05659056|Antimitotic Agents|antimitotic agents|mesh-ancestor
83479407|NCT05659056|Mitosis Modulators|mitosis modulators|mesh-ancestor
83479408|NCT05659056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398252|NCT03084029|Oxytocin|oxytocin|mesh-list
83398254|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83398255|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398256|NCT04278053|Inositol|inositol|mesh-list
83398257|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
83398258|NCT04278053|Vitamins|vitamins|mesh-ancestor
83398259|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
83398260|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398261|NCT05346107|Paclitaxel|paclitaxel|mesh-list
83398262|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
83479409|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83479410|NCT05654649|Dexamethasone|dexamethasone|mesh-list
83479411|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479412|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
83479413|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
83479414|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83479415|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479416|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83173348|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83173349|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83173351|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
83173352|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173353|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173354|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173355|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173356|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83173357|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173358|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173359|NCT00739349|Cyclosporine|cyclosporine|mesh-list
83173360|NCT00739349|Cyclosporins|cyclosporins|mesh-list
83173361|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173362|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173363|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173364|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
83173365|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173367|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173368|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
83173369|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173370|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83173371|NCT00152009|Guanfacine|guanfacine|mesh-list
83173372|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83173373|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83173374|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83173375|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83173376|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
83173377|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173378|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173379|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173380|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83173381|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173382|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173383|NCT02280785|Immunotoxins|immunotoxins|mesh-ancestor
83173384|NCT02280785|Immunoconjugates|immunoconjugates|mesh-ancestor
83173385|NCT02280785|Immunologic Factors|immunologic factors|mesh-ancestor
83173386|NCT02280785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173387|NCT04158635|Paclitaxel|paclitaxel|mesh-list
83173388|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83173389|NCT04158635|Gemcitabine|gemcitabine|mesh-list
83173390|NCT04158635|Bosentan|bosentan|mesh-list
83173391|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83173392|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173393|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83173394|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83173395|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83173396|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173397|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83173398|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
83137772|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83137773|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83137774|NCT04157036|Protective Agents|protective agents|mesh-ancestor
83137775|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83137776|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137778|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137779|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83137780|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137781|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137782|NCT01353911|Interferons|interferons|mesh-list
83137783|NCT01353911|Ribavirin|ribavirin|mesh-list
83137784|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
83137785|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
83137786|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83137787|NCT01353911|Grazoprevir|grazoprevir|mesh-list
83137788|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137789|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
83137790|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137791|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
83137792|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137793|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
83137794|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137795|NCT05575297|Rifampin|rifampin|mesh-list
83137796|NCT05575297|Methotrexate|methotrexate|mesh-list
83137798|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83137799|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
83137800|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137801|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137802|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83137803|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
83137804|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137805|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137807|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137808|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83137809|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83137810|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
83137811|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83137812|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83137813|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83137814|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
83137815|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83137816|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137817|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
83137818|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83137819|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83137820|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83137821|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83137822|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83137823|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83137824|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
83137825|NCT01671488|Mitomycins|mitomycins|mesh-list
83137826|NCT01671488|Mitomycin|mitomycin|mesh-list
83137827|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83137828|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137829|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
83137830|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137831|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83137832|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137833|NCT05400889|Tofacitinib|tofacitinib|mesh-list
83137834|NCT05400889|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83137835|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83137836|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137837|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137839|NCT05395117|Midazolam|midazolam|mesh-list
83137840|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83137841|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83479417|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
83479418|NCT05654649|Hormones|hormones|mesh-ancestor
83479419|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83479420|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83479421|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479422|NCT05649748|Treprostinil|treprostinil|mesh-list
83479423|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83479424|NCT05629234|Osimertinib|osimertinib|mesh-list
83479425|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479426|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83479427|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137842|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83137843|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137844|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137845|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83137846|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83137847|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83137848|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83137849|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
83137850|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
83137851|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
83137852|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
83137853|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137854|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137855|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83137856|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83137857|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
83137858|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83137859|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83137860|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137861|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83137862|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83137863|NCT05395117|Protective Agents|protective agents|mesh-ancestor
83137864|NCT05325229|Bevacizumab|bevacizumab|mesh-list
83137866|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137867|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137868|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83137869|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83137870|NCT05325229|Growth Substances|growth substances|mesh-ancestor
83137871|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137872|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
83137873|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
83137874|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
83137875|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
83137876|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137877|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
83137878|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83137879|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83137880|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83137881|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83137882|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137883|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
83137884|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137885|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137886|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83137887|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137888|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83137889|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83137890|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83137891|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83137892|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137893|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83137894|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83137895|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83137896|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83137897|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83137898|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137899|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137900|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83137901|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83137902|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
83137903|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83137904|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83137905|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
83137906|NCT05573425|Tazarotene|tazarotene|mesh-list
83137907|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
83137908|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
83137909|NCT02253901|Ritonavir|ritonavir|mesh-list
83137910|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83137911|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83137912|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83137913|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
83137914|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137915|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137916|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83137917|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83137918|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
83137919|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83137920|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83137921|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83137922|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83137923|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83137924|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
83137925|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83137926|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83137927|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173399|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83173400|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83173401|NCT00734435|Zonisamide|zonisamide|mesh-list
83173402|NCT00734435|Olanzapine|olanzapine|mesh-list
83173403|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
83173404|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
83173405|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173406|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173407|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83173408|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83173409|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83173410|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173411|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83173412|NCT00734435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83173413|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83173414|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173415|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173416|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173417|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
83173418|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
83173419|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83479581|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83479582|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83479583|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83479584|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83479585|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83479586|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479587|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
83479588|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83479589|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83479590|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
83398263|NCT05346107|Doxorubicin|doxorubicin|mesh-list
83398264|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83398265|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83398266|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398267|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
83398268|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
83398269|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
83398270|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398271|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83398272|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
83398273|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398274|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83398275|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83398276|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
83398277|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83137928|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137929|NCT03546283|Protective Agents|protective agents|mesh-ancestor
83137930|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137931|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83137932|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83137934|NCT04940546|Capecitabine|capecitabine|mesh-list
83137935|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
83137936|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83137937|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137938|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83137939|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83137940|NCT04940546|Growth Substances|growth substances|mesh-ancestor
83137941|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137942|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
83137943|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83137944|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
83137945|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137946|NCT03547219|Escitalopram|escitalopram|mesh-list
83137947|NCT03547219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83137948|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83137949|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83137950|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137951|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137952|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
83137953|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137955|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83137956|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
83137957|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137958|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
83137959|NCT05188898|Protective Agents|protective agents|mesh-ancestor
83137960|NCT04116320|Poly ICLC|poly iclc|mesh-list
83137961|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
83137962|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
83137963|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137964|NCT04069819|Cilostazol|cilostazol|mesh-list
83137965|NCT04069819|Escitalopram|escitalopram|mesh-list
83137966|NCT04069819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83137967|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83137968|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83137969|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137970|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83137971|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
83137972|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137973|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
83137974|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137975|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83137976|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83137977|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
83137978|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83137979|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83398430|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83398431|NCT02189889|Hematinics|hematinics|mesh-ancestor
83398432|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83398433|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83398434|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83398435|NCT01148745|Hematinics|hematinics|mesh-ancestor
83398436|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83398437|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83398438|NCT04761029|Tramadol|tramadol|mesh-list
83398439|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83398440|NCT04761029|Narcotics|narcotics|mesh-ancestor
83398441|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398442|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398443|NCT04761029|Analgesics|analgesics|mesh-ancestor
83398444|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
83398445|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83137980|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83137981|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
83137982|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83137983|NCT04069819|Protective Agents|protective agents|mesh-ancestor
83137984|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83137985|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83137986|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83137987|NCT04084496|Folfirinox|folfirinox|mesh-list
83137988|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137989|NCT02831855|Methotrexate|methotrexate|mesh-list
83137990|NCT02831855|Tofacitinib|tofacitinib|mesh-list
83137991|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83137992|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
83137993|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83137994|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83137995|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83137996|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
83137997|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83137998|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83137999|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
83138000|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138002|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138003|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
83138004|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138005|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83138006|NCT02831855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83138007|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83138008|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
83398446|NCT05687981|Dexamethasone|dexamethasone|mesh-list
83398447|NCT05687981|Bupivacaine|bupivacaine|mesh-list
83398448|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83398449|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
83398450|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
83398451|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398452|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398453|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83398454|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
83398455|NCT05687981|Hormones|hormones|mesh-ancestor
83398456|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138009|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83138010|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138011|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83138012|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138013|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
83138014|NCT01356407|Cathartics|cathartics|mesh-ancestor
83138015|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138016|NCT05289323|Neostigmine|neostigmine|mesh-list
83138017|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83138018|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138019|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138021|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138022|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138023|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83138024|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
83138025|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138026|NCT00109837|Leucovorin|leucovorin|mesh-list
83138027|NCT00109837|Cytarabine|cytarabine|mesh-list
83138028|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83138029|NCT00109837|Dexamethasone|dexamethasone|mesh-list
83138031|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
83138032|NCT00109837|Doxorubicin|doxorubicin|mesh-list
83138033|NCT00109837|Methotrexate|methotrexate|mesh-list
83138034|NCT00109837|Vincristine|vincristine|mesh-list
83138035|NCT00109837|Daunorubicin|daunorubicin|mesh-list
83138036|NCT00109837|Asparaginase|asparaginase|mesh-list
83138037|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
83138038|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
83138039|NCT00109837|Thioguanine|thioguanine|mesh-list
83138040|NCT00109837|Allopurinol|allopurinol|mesh-list
83138041|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138042|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
83138043|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138044|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138045|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83138046|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
83138047|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138048|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138049|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83138050|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83138051|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
83138052|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
83138053|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138054|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138055|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
83138056|NCT00109837|Hormones|hormones|mesh-ancestor
83138057|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138058|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138059|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83138060|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83138061|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138062|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138063|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83138064|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
83138065|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83138066|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138067|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
83138068|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
83138069|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83138070|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83138071|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
83138072|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138073|NCT00109837|Antidotes|antidotes|mesh-ancestor
83138074|NCT00109837|Protective Agents|protective agents|mesh-ancestor
83138075|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
83138076|NCT00109837|Vitamins|vitamins|mesh-ancestor
83138077|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
83138078|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83138079|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138080|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138081|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138082|NCT00109837|Analgesics|analgesics|mesh-ancestor
83138083|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
83138084|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
83138085|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83138086|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
83138087|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83138088|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83138089|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
83138090|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83138091|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83138092|NCT05229445|Insulin|insulin|mesh-list
83138093|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83138094|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138095|NCT01671332|Suramin|suramin|mesh-list
83138096|NCT01671332|Docetaxel|docetaxel|mesh-list
83138097|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138098|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138099|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138100|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138101|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138102|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
83138103|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
83138104|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83138105|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138106|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83138107|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83138108|NCT03063242|Sargramostim|sargramostim|mesh-list
83138109|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
83138110|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138111|NCT03897062|Suvorexant|suvorexant|mesh-list
83474009|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
83138112|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83138113|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83138114|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138115|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138116|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83138117|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138118|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138119|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
83138120|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138121|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138122|NCT04795661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83138123|NCT04795661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138124|NCT00100802|Temozolomide|temozolomide|mesh-list
83138125|NCT00100802|Lomustine|lomustine|mesh-list
83138126|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83138127|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
83138128|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138129|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138130|NCT01355159|Folic Acid|folic acid|mesh-list
83138131|NCT01355159|Hematinics|hematinics|mesh-ancestor
83138132|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
83138133|NCT01355159|Vitamins|vitamins|mesh-ancestor
83138134|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
83138135|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138136|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
83138137|NCT04661852|Topotecan|topotecan|mesh-list
83138138|NCT04661852|Mitogens|mitogens|mesh-list
83138139|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138140|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
83138141|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138142|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138143|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83138144|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
83138145|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138146|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138147|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83138148|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83138149|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138150|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138151|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138152|NCT02630186|Atezolizumab|atezolizumab|mesh-list
83138153|NCT02630186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83138154|NCT02630186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138155|NCT02630186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83398608|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83398609|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398611|NCT03296813|Furosemide|furosemide|mesh-list
83398612|NCT03296813|Diuretics|diuretics|mesh-ancestor
83398613|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
83398839|NCT03262103|Laxatives|laxatives|mesh-ancestor
83398840|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83474030|NCT00028262|Cysteamine|cysteamine|mesh-list
83398841|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
83398842|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83398843|NCT04777643|Cannabidiol|cannabidiol|mesh-list
83398844|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
83398845|NCT04775225|Lidocaine|lidocaine|mesh-list
83398846|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
83398847|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
83398848|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83398849|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398850|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
83398851|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83398852|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83398853|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83398854|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83398855|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83398856|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83398857|NCT04731467|Paclitaxel|paclitaxel|mesh-list
83398858|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83398859|NCT04731467|Gemcitabine|gemcitabine|mesh-list
83398860|NCT04731467|Nivolumab|nivolumab|mesh-list
83398861|NCT04731467|Fluorouracil|fluorouracil|mesh-list
83398862|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83398863|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83398864|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
83398865|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
83398866|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138156|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138157|NCT00002462|Cobalt|cobalt|mesh-list
83138158|NCT00002462|Prednisone|prednisone|mesh-list
83138159|NCT00002462|Doxorubicin|doxorubicin|mesh-list
83138160|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83138161|NCT00002462|Bleomycin|bleomycin|mesh-list
83138162|NCT00002462|Vincristine|vincristine|mesh-list
83138163|NCT00002462|Vinblastine|vinblastine|mesh-list
83138164|NCT00002462|Procarbazine|procarbazine|mesh-list
83138165|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
83138166|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83138167|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138168|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83138169|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138170|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83400072|NCT04394533|Prilocaine|prilocaine|mesh-list
83400073|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
83400074|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
83400075|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83400076|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400077|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
83400078|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83400079|NCT05602129|Heparin|heparin|mesh-list
83400080|NCT05602129|Calcium heparin|calcium heparin|mesh-list
83138171|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138172|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83138174|NCT00002462|Hormones|hormones|mesh-ancestor
83138175|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138176|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138177|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138178|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83138179|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138180|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138181|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138182|NCT00002462|Trace Elements|trace elements|mesh-ancestor
83138183|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
83138184|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
83138185|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83138186|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
83138187|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
83138188|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
83138189|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83138190|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83138191|NCT01669928|Renin Inhibitors|renin inhibitors|mesh-list
83138192|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83138193|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138194|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138195|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
83138196|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138197|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83138198|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138199|NCT01995578|Azacitidine|azacitidine|mesh-list
83400081|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
83138200|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138201|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
83138202|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138203|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138204|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138206|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
83138207|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138208|NCT03595592|Paclitaxel|paclitaxel|mesh-list
83138209|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83138210|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
83138211|NCT03595592|Carboplatin|carboplatin|mesh-list
83138212|NCT03595592|Doxorubicin|doxorubicin|mesh-list
83138213|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83138214|NCT03595592|Trastuzumab|trastuzumab|mesh-list
83138215|NCT03595592|Atezolizumab|atezolizumab|mesh-list
83138217|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83138219|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138220|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138221|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138222|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138223|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138224|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
83138225|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138226|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138227|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83138228|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
83138229|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83138230|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83400082|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83138231|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83138232|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138233|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138234|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138235|NCT03595592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83138236|NCT01355081|Vortioxetine|vortioxetine|mesh-list
83138237|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
83138238|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83138239|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83138240|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83138241|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138242|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138243|NCT01355081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83400160|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
83138244|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83400914|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
83138245|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138246|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138247|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138248|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
83401068|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
83401069|NCT01926197|Vitamins|vitamins|mesh-ancestor
83401070|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
83138249|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83138250|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83401225|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
83138251|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83138252|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83138253|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83138255|NCT02259959|Olodaterol|olodaterol|mesh-list
83138256|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83138258|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138259|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138260|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83138261|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
83138262|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
83138263|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83138264|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
83138265|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138266|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138267|NCT03062462|Clopidogrel|clopidogrel|mesh-list
83138268|NCT03062462|Ticagrelor|ticagrelor|mesh-list
83138269|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83138270|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83138271|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83138272|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83138273|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
83138274|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138275|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138276|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138277|NCT04433078|Doxycycline|doxycycline|mesh-list
83138278|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83138279|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138280|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
83138281|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83138282|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83138283|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
83138284|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138285|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83138286|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138287|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138288|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
83138289|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138290|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138291|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83138292|NCT05212571|Ketamine|ketamine|mesh-list
83138293|NCT05212571|Esketamine|esketamine|mesh-list
83138294|NCT05212571|Analgesics|analgesics|mesh-ancestor
83138295|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
83138296|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138297|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138298|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83138299|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83138300|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
83138301|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
83138302|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138303|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83138304|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83138305|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138306|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138307|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83138308|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83138309|NCT04368533|Fluorides|fluorides|mesh-list
83138310|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
83138311|NCT04368533|Protective Agents|protective agents|mesh-ancestor
83138312|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138313|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83138314|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83138315|NCT02627144|Interferons|interferons|mesh-list
83138316|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
83138317|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
83138318|NCT02627144|Bevacizumab|bevacizumab|mesh-list
83138319|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138320|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138321|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83138322|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83138323|NCT02627144|Growth Substances|growth substances|mesh-ancestor
83138324|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138325|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83138326|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
83138327|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138328|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
83138329|NCT04586335|Olaparib|olaparib|mesh-list
83138330|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83138331|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138332|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138333|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138334|NCT04981886|Bimatoprost|bimatoprost|mesh-list
83138335|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83138336|NCT03900637|Letrozole|letrozole|mesh-list
83138337|NCT03900637|Leuprolide|leuprolide|mesh-list
83138338|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138339|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83138340|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83138341|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138342|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138343|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83138344|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
83138345|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138346|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138347|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83138348|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
83138349|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83138350|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138351|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83138352|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
83138353|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138354|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
83474099|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
83138355|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
83138356|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
83138357|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138358|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138359|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
83138360|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138361|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
83138362|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83138363|NCT03493178|Glycine|glycine|mesh-list
83138364|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
83138365|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138366|NCT03493178|Expectorants|expectorants|mesh-ancestor
83138367|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
83138368|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83138369|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
83138370|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138371|NCT03493178|Protective Agents|protective agents|mesh-ancestor
83138372|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138373|NCT03493178|Antidotes|antidotes|mesh-ancestor
83138374|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
83138375|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138376|NCT04548440|Paclitaxel|paclitaxel|mesh-list
83138377|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83138378|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83138379|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138380|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138381|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138382|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138383|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138384|NCT03742921|Romidepsin|romidepsin|mesh-list
83138385|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83138386|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138387|NCT03742921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83138388|NCT03742921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138389|NCT03742921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138390|NCT02626520|Paclitaxel|paclitaxel|mesh-list
83138391|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83138392|NCT02626520|Gemcitabine|gemcitabine|mesh-list
83138393|NCT02626520|Fluorouracil|fluorouracil|mesh-list
83138394|NCT02626520|Irinotecan|irinotecan|mesh-list
83138395|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83138396|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138397|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138398|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138399|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138400|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138401|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138402|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
83138403|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138404|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
83138405|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138406|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83138407|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138408|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138409|NCT03063710|Olaparib|olaparib|mesh-list
83138410|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83138411|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138412|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138413|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138414|NCT05084521|Famotidine|famotidine|mesh-list
83138415|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83138416|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138417|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83138418|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
83138419|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
83138420|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138421|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138422|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138423|NCT05069857|Apatinib|apatinib|mesh-list
83138424|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83138425|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138426|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83138427|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138428|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138429|NCT05069857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138430|NCT02971891|Furosemide|furosemide|mesh-list
83138431|NCT02971891|Diuretics|diuretics|mesh-ancestor
83138432|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
83138433|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138434|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83138435|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138436|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138437|NCT05063851|Memantine|memantine|mesh-list
83138438|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83138439|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83138440|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
83138441|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138442|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138443|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138444|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83138445|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83138446|NCT04392037|Dexamethasone|dexamethasone|mesh-list
83138447|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
83138448|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138449|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
83138450|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138451|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138452|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83138453|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
83138454|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138455|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138456|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83138457|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83138458|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
83138459|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
83138460|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138461|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138462|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
83138463|NCT04392037|Hormones|hormones|mesh-ancestor
83138464|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138465|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138466|NCT03359161|Furosemide|furosemide|mesh-list
83138467|NCT03359161|Diuretics|diuretics|mesh-ancestor
83138468|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
83138469|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138470|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83138471|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138472|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138473|NCT05030623|Tadalafil|tadalafil|mesh-list
83138474|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
83138475|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83138476|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83138477|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138478|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138479|NCT05030623|Urological Agents|urological agents|mesh-ancestor
83138480|NCT04986631|Topiramate|topiramate|mesh-list
83138481|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
83138482|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83138483|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138484|NCT03277339|Paroxetine|paroxetine|mesh-list
83138485|NCT03277339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83138486|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83138487|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138488|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138489|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138490|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
83138491|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138492|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83138493|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83138494|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83138495|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83138496|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83138497|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138498|NCT03145675|Enoxaparin|enoxaparin|mesh-list
83138499|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
83138500|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
83138501|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83138502|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83138503|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138505|NCT04251715|Dexamethasone|dexamethasone|mesh-list
83138506|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
83138507|NCT04251715|Fluorouracil|fluorouracil|mesh-list
83138508|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
83138509|NCT04251715|Irinotecan|irinotecan|mesh-list
83138510|NCT04251715|Floxuridine|floxuridine|mesh-list
83138511|NCT04251715|BB 1101|bb 1101|mesh-list
83138512|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
83138513|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83138514|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
83138515|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
83138516|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138517|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138518|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138519|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
83138520|NCT04251715|Hormones|hormones|mesh-ancestor
83138521|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138522|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138523|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138524|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
83138525|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138526|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138527|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
83138528|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138529|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138530|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
83138531|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83138532|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138533|NCT04251715|Antidotes|antidotes|mesh-ancestor
83138534|NCT04251715|Protective Agents|protective agents|mesh-ancestor
83138535|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
83138536|NCT04251715|Vitamins|vitamins|mesh-ancestor
83138537|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
83138538|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
83138539|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83138540|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138541|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138542|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83138543|NCT04042727|Analgesics|analgesics|mesh-ancestor
83138544|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
83138545|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138546|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83138547|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83138548|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83138549|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83138550|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138551|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138552|NCT02035943|Insulin|insulin|mesh-list
83138553|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83138554|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83138555|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138556|NCT03819413|Antibodies|antibodies|mesh-list
83138557|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
83138558|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
83138559|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138560|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83138561|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138562|NCT02394028|Etrolizumab|etrolizumab|mesh-list
83138563|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138564|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
83138565|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138566|NCT04079621|Primaquine|primaquine|mesh-list
83138567|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
83138568|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83138569|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83138570|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138571|NCT02819297|Laxatives|laxatives|mesh-list
83138572|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138573|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
83138574|NCT05134441|Calcium|calcium|mesh-list
83138575|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83138576|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138577|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83138578|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
83138579|NCT04925557|Siponimod|siponimod|mesh-list
83138580|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
83138581|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138582|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83138583|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138584|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138586|NCT03063788|Trace Elements|trace elements|mesh-ancestor
83138587|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
83474169|NCT00004276|Growth Substances|growth substances|mesh-ancestor
83138588|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138589|NCT02821715|Flecainide|flecainide|mesh-list
83138590|NCT02821715|Modafinil|modafinil|mesh-list
83138591|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83138592|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138593|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83138594|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83138595|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83138596|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138597|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83138598|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83138599|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83138600|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138601|NCT04377932|Cyclophosphamide|cyclophosphamide|mesh-list
83138602|NCT04377932|Fludarabine|fludarabine|mesh-list
83138603|NCT04377932|Fludarabine phosphate|fludarabine phosphate|mesh-list
83138604|NCT04377932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138605|NCT04377932|Immunologic Factors|immunologic factors|mesh-ancestor
83138606|NCT04377932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138607|NCT04377932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138608|NCT04377932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83138609|NCT04377932|Alkylating Agents|alkylating agents|mesh-ancestor
83138610|NCT04377932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138611|NCT04377932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138612|NCT04377932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83138613|NCT04377932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138614|NCT04377932|Antimetabolites|antimetabolites|mesh-ancestor
83138615|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83138616|NCT03545347|Nandrolone|nandrolone|mesh-list
83138617|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83138618|NCT03545347|Androgens|androgens|mesh-ancestor
83138619|NCT03545347|Hormones|hormones|mesh-ancestor
83138620|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138621|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138622|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
83138623|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83138624|NCT02815397|Metformin|metformin|mesh-list
83138625|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83138626|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138627|NCT04980404|Decitabine|decitabine|mesh-list
83138628|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138629|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
83138630|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138631|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138632|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138633|NCT02427958|Leuprolide|leuprolide|mesh-list
83138634|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83138635|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
83138636|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83138637|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138638|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138639|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138640|NCT03715127|Psilocybin|psilocybin|mesh-list
83138641|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
83138642|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138643|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83138644|NCT02260037|Epinastine|epinastine|mesh-list
83138645|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83138646|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
83138647|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
83138648|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138649|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138650|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138651|NCT02036489|Prednisone|prednisone|mesh-list
83138652|NCT02036489|Vincristine|vincristine|mesh-list
83138653|NCT02036489|Daunorubicin|daunorubicin|mesh-list
83138654|NCT02036489|Asparaginase|asparaginase|mesh-list
83138655|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
83138656|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83138657|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
83138658|NCT02036489|Hormones|hormones|mesh-ancestor
83138659|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138660|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138661|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138662|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138663|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83138664|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138665|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138666|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138667|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138668|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83138669|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83138670|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138671|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138672|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
83138673|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138674|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138675|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
83138676|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83138677|NCT02392624|Omalizumab|omalizumab|mesh-list
83138678|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83138679|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83138680|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
83138681|NCT02047565|Edoxaban|edoxaban|mesh-list
83138682|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83138683|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
83138684|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83138685|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
83138686|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138687|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138688|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
83138689|NCT05701241|Octreotide|octreotide|mesh-list
83138690|NCT05701241|Lanreotide|lanreotide|mesh-list
83138691|NCT05701241|Somatostatin|somatostatin|mesh-list
83138692|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138693|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138694|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138695|NCT05701241|Hormones|hormones|mesh-ancestor
83138696|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138697|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138698|NCT03063866|Fentanyl|fentanyl|mesh-list
83138699|NCT03063866|Midazolam|midazolam|mesh-list
83138700|NCT03063866|Propofol|propofol|mesh-list
83138701|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83138702|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138703|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138704|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83138705|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
83138707|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83138708|NCT03063866|Narcotics|narcotics|mesh-ancestor
83138709|NCT03063866|Analgesics|analgesics|mesh-ancestor
83138710|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
83138711|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138712|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83138713|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83138714|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83138715|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83138716|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
83138717|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
83138718|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138719|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138720|NCT02037191|Methotrexate|methotrexate|mesh-list
83138721|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83138722|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
83138723|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83138724|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138725|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83138726|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
83138727|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138728|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138729|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83138730|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138731|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83138732|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138733|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
83138734|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138735|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83138736|NCT04980170|Amoxicillin|amoxicillin|mesh-list
83138737|NCT04980170|Clindamycin|clindamycin|mesh-list
83138738|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
83138739|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
83138740|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83138741|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
83138742|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
83138743|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83138744|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138745|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83138746|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138747|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138748|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83138749|NCT02387164|Vitamin D|vitamin d|mesh-list
83138750|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
83138751|NCT02387164|Vitamins|vitamins|mesh-ancestor
83138752|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
83138753|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138754|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83138755|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83138756|NCT02047799|Calcitriol|calcitriol|mesh-list
83138757|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83138758|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138759|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83138760|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138761|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138762|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83138763|NCT02047799|Vitamins|vitamins|mesh-ancestor
83138764|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
83138765|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83138766|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
83138767|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83138768|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138769|NCT02392234|Ivacaftor|ivacaftor|mesh-list
83138770|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83138771|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138772|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138773|NCT02036723|Bevacizumab|bevacizumab|mesh-list
83138774|NCT02036723|Ranibizumab|ranibizumab|mesh-list
83138775|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138776|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138777|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83138778|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83138779|NCT02036723|Growth Substances|growth substances|mesh-ancestor
83138780|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138781|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
83138782|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83138783|NCT02036879|Norethindrone|norethindrone|mesh-list
83138784|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
83138785|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83138786|NCT02036879|Estradiol|estradiol|mesh-list
83138787|NCT02036879|Estrogens|estrogens|mesh-ancestor
83138788|NCT02036879|Hormones|hormones|mesh-ancestor
83138789|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138790|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138791|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83138792|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
83138793|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83138794|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83138795|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83138796|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83138797|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83138798|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83138799|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83138800|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83138801|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
83138802|NCT02963090|Topotecan|topotecan|mesh-list
83138803|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138804|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138805|NCT02963090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83138806|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138807|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83138808|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83138809|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138810|NCT02048423|Ketamine|ketamine|mesh-list
83138811|NCT02048423|Analgesics|analgesics|mesh-ancestor
83138812|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
83138813|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138814|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138815|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83138816|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83138817|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
83138818|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
83138819|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138820|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83138821|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83138822|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138823|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138824|NCT02037035|Ketamine|ketamine|mesh-list
83138825|NCT02037035|Analgesics|analgesics|mesh-ancestor
83138826|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
83138827|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138828|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138829|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83138830|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83138831|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
83138832|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
83138833|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138834|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83138835|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83138836|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138837|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138838|NCT04979468|Lamivudine|lamivudine|mesh-list
83138839|NCT04979468|Dolutegravir|dolutegravir|mesh-list
83138840|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83138841|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83138842|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138843|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138844|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
83138845|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138846|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83138847|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83138848|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83138849|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83138850|NCT03562169|Thalidomide|thalidomide|mesh-list
83138852|NCT03562169|Ixazomib|ixazomib|mesh-list
83138853|NCT03562169|Glycine|glycine|mesh-list
83138854|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83138855|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
83138856|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
83138857|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138858|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138859|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138860|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
83138861|NCT03562169|Hormones|hormones|mesh-ancestor
83138862|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138863|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83138864|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138865|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138866|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
83138867|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
83138868|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83138869|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138870|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83138871|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83138872|NCT03562169|Growth Substances|growth substances|mesh-ancestor
83138873|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
83138874|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
83138875|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138876|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138877|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
83138878|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138879|NCT02427802|Gentamicins|gentamicins|mesh-list
83138880|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83138881|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138882|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83138883|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83138884|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138885|NCT02050529|Labetalol|labetalol|mesh-list
83138886|NCT02050529|Hydralazine|hydralazine|mesh-list
83138887|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83138888|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83138889|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
83138890|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138891|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138892|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138893|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83138894|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
83138895|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
83138896|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138897|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83138898|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83138899|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
83138900|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83138901|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83138902|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
83138903|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83138904|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83138905|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138906|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138907|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83138908|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138909|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138910|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
83138911|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138912|NCT02048969|Flumazenil|flumazenil|mesh-list
83138913|NCT02048969|Antidotes|antidotes|mesh-ancestor
83138914|NCT02048969|Protective Agents|protective agents|mesh-ancestor
83138915|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138916|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
83138917|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
83138918|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138919|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138920|NCT03561935|Propafenone|propafenone|mesh-list
83138921|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83138922|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83138923|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83138924|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83138925|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138926|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
83138927|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83138928|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
83138929|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138930|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138931|NCT02808143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83138932|NCT02808143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138933|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83474327|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
83138934|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
83138935|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138936|NCT02620280|Paclitaxel|paclitaxel|mesh-list
83138937|NCT02620280|Carboplatin|carboplatin|mesh-list
83138938|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83138939|NCT02620280|Atezolizumab|atezolizumab|mesh-list
83138940|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83138941|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138942|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
83138943|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
83138944|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
83138945|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138946|NCT02620280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83138947|NCT02620280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138948|NCT02806973|Glucagon|glucagon|mesh-list
83138949|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83138950|NCT02806973|Hormones|hormones|mesh-ancestor
83138951|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138952|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138953|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
83138954|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
83138955|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138956|NCT02037737|Abatacept|abatacept|mesh-list
83138957|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83474365|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
83138958|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138959|NCT02037737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138960|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138961|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138962|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
83138963|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138964|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83138965|NCT02037503|Ketamine|ketamine|mesh-list
83138966|NCT02037503|Analgesics|analgesics|mesh-ancestor
83138967|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
83138968|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83138969|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138970|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83138971|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83138972|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
83138973|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
83138974|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83138975|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83138976|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83138977|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83138978|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138979|NCT02049671|Hormones|hormones|mesh-list
83138980|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83138981|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138982|NCT02037815|Mannitol|mannitol|mesh-list
83138983|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83138984|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83138985|NCT02037815|Diuretics|diuretics|mesh-ancestor
83138986|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
83138987|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83138988|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83138989|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83138990|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
83138991|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83138992|NCT02053727|Abatacept|abatacept|mesh-list
83138993|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83138994|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83138995|NCT02053727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83138996|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83138997|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83138998|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
83138999|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139000|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139001|NCT02051153|Modafinil|modafinil|mesh-list
83139002|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83139003|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139004|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83139005|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83139006|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83139007|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139008|NCT02807363|Leuprolide|leuprolide|mesh-list
83139009|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83139010|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
83139011|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83139012|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139013|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83139014|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139015|NCT02051231|Oxytocin|oxytocin|mesh-list
83139016|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
83139017|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83139018|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139019|NCT02051387|Cannabidiol|cannabidiol|mesh-list
83139020|NCT02051387|Olanzapine|olanzapine|mesh-list
83139021|NCT02051387|Risperidone|risperidone|mesh-list
83139022|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83139023|NCT02051387|Amisulpride|amisulpride|mesh-list
83139024|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83139025|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
83139026|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139027|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139028|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139029|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83139030|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83139031|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139032|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83139033|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83139034|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
83139035|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
83139036|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
83139037|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139038|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83139039|NCT02051387|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83139040|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83139041|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139042|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
83139043|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
83139044|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83139045|NCT02052167|Methotrexate|methotrexate|mesh-list
83139046|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83139047|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
83139048|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83139049|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139050|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83139051|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
83139052|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139053|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139054|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
83139055|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139056|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83139057|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139058|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
83139059|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139060|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83139061|NCT03573947|Paclitaxel|paclitaxel|mesh-list
83139062|NCT03573947|Nivolumab|nivolumab|mesh-list
83139063|NCT03573947|Ipilimumab|ipilimumab|mesh-list
83139064|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83139065|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139066|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
83139067|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
83139068|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
83139069|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139070|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83139071|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83139072|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
83139073|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83139074|NCT03524417|Antibodies|antibodies|mesh-list
83139075|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
83139076|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139077|NCT02054429|Insulin|insulin|mesh-list
83139078|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83139079|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83139080|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139081|NCT03806543|Vancomycin|vancomycin|mesh-list
83139082|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83139083|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139084|NCT02052323|Artesunate|artesunate|mesh-list
83139085|NCT02052323|Mefloquine|mefloquine|mesh-list
83139086|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
83139087|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83139088|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83139089|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139090|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139091|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
83139092|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
83139093|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83139094|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
83139095|NCT02056223|Acetaminophen|acetaminophen|mesh-list
83139096|NCT02056223|Ibuprofen|ibuprofen|mesh-list
83139097|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83139098|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139099|NCT02056223|Analgesics|analgesics|mesh-ancestor
83139100|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
83401226|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
83139101|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139102|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139103|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139104|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139105|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83139106|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139107|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139108|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
83139109|NCT02056379|Dexamethasone|dexamethasone|mesh-list
83139111|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139112|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
83139113|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
83139114|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139115|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83474467|NCT00004450|Interferon-beta|interferon-beta|mesh-list
83139116|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83139117|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
83139118|NCT02056379|Hormones|hormones|mesh-ancestor
83139119|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139120|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83139121|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139122|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83139123|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83139124|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
83139125|NCT02383966|Carboplatin|carboplatin|mesh-list
83139126|NCT02383966|Fluorouracil|fluorouracil|mesh-list
83139127|NCT02383966|Cetuximab|cetuximab|mesh-list
83139128|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139129|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
83139130|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139131|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83139132|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139133|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
83139134|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139135|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83139136|NCT02054663|Clopidogrel|clopidogrel|mesh-list
83139137|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83139138|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83139139|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83139140|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83139141|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
83139142|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139143|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139144|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139145|NCT02054975|Vitamin D|vitamin d|mesh-list
83139146|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
83139147|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
83139148|NCT02054975|Vitamins|vitamins|mesh-list
83139149|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
83139150|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139151|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83139152|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83139153|NCT02055131|Aspirin|aspirin|mesh-list
83139154|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83139155|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139156|NCT02055131|Analgesics|analgesics|mesh-ancestor
83139157|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
83139158|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139159|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139160|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139161|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139162|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83139163|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83139164|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139165|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83139166|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83139167|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139168|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
83139169|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
83139170|NCT02056847|Pitavastatin|pitavastatin|mesh-list
83139171|NCT02056847|Calcium|calcium|mesh-list
83139172|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83139173|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139174|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83139175|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83139176|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83139177|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83139178|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
83139179|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139180|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139181|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83139182|NCT02052713|Tamsulosin|tamsulosin|mesh-list
83139183|NCT02052713|Dutasteride|dutasteride|mesh-list
83139184|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83139185|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83139186|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83139187|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83139188|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139189|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139190|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139191|NCT02052713|Urological Agents|urological agents|mesh-ancestor
83139192|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83139193|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83139194|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139195|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
83139196|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139197|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
83139198|NCT02057003|Grazoprevir|grazoprevir|mesh-list
83139199|NCT02057003|Ledipasvir|ledipasvir|mesh-list
83139200|NCT02057003|Velpatasvir|velpatasvir|mesh-list
83139201|NCT02057003|Simeprevir|simeprevir|mesh-list
83139202|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
83139203|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139204|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
83139205|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139206|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139207|NCT02426086|Niacinamide|niacinamide|mesh-list
83139208|NCT02426086|Imetelstat|imetelstat|mesh-list
83139209|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
83139210|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139211|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139212|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83139213|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
83139214|NCT02426086|Vitamins|vitamins|mesh-ancestor
83139215|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
83139216|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139217|NCT02055911|Ranibizumab|ranibizumab|mesh-list
83139218|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83139219|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83139220|NCT02055911|Growth Substances|growth substances|mesh-ancestor
83139221|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139222|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
83139223|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139224|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83139225|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
83139226|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139227|NCT02390362|Rituximab|rituximab|mesh-list
83474500|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
83139228|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83139229|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139230|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
83139231|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139232|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139233|NCT02389816|Vortioxetine|vortioxetine|mesh-list
83139234|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
83139235|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83139236|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83139237|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83139238|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139239|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139240|NCT02389816|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83139241|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83139242|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139243|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139244|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139245|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
83139246|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83139247|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83139248|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83139249|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83139251|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
83139252|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83139253|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83139254|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83139255|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139256|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139257|NCT02382640|Febuxostat|febuxostat|mesh-list
83139258|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
83139259|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139260|NCT02801669|Edoxaban|edoxaban|mesh-list
83139261|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83139262|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
83139263|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83139264|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
83139265|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139266|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139267|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
83139268|NCT02804399|Rifampin|rifampin|mesh-list
83139269|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83139270|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
83139271|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83139272|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139273|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
83139274|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83139275|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139276|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139277|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83139278|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83139279|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83139280|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83139281|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83139282|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83139283|NCT05614037|Felodipine|felodipine|mesh-list
83139284|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83139285|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83139286|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83139287|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139288|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139289|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83139290|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139291|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
83139292|NCT02058875|Cyclosporine|cyclosporine|mesh-list
83139293|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
83139294|NCT02058875|Prednisone|prednisone|mesh-list
83139295|NCT02058875|Cyclosporins|cyclosporins|mesh-list
83139296|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139297|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
83139298|NCT02058875|Hormones|hormones|mesh-ancestor
83139299|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139300|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139301|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83139302|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139303|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139304|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139305|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139306|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
83139307|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
83139308|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139309|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83139310|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139311|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83139312|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83139313|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83139314|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
83139315|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83139316|NCT02059031|Cabotegravir|cabotegravir|mesh-list
83139317|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83139318|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83139319|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139320|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139321|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83139322|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83139323|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
83139324|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139325|NCT01333865|Memantine|memantine|mesh-list
83139326|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83139327|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83139328|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
83139329|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139330|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139331|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139332|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83139333|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83139334|NCT04978688|Relugolix|relugolix|mesh-list
83139335|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
83139336|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
83139337|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139338|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139339|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
83139340|NCT04434326|Vorolanib|vorolanib|mesh-list
83139341|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83139342|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139343|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139344|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
83139345|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83139346|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83139347|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83139348|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139349|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139350|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
83139351|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139352|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139353|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83139354|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139355|NCT02172872|Decitabine|decitabine|mesh-list
83139356|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83139357|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
83139358|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139359|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139360|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139361|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83139362|NCT02059655|Bimatoprost|bimatoprost|mesh-list
83139363|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83139364|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83139365|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83139366|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83139367|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139368|NCT05636501|Prednisolone|prednisolone|mesh-list
83139369|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139370|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
83139371|NCT05636501|Hormones|hormones|mesh-ancestor
83139372|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139373|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139374|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83139375|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139376|NCT02058173|Chloroquine|chloroquine|mesh-list
83139377|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83139378|NCT02058173|Amebicides|amebicides|mesh-ancestor
83139379|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83139380|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83139381|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139382|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
83139383|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139384|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83139385|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139386|NCT02058173|Analgesics|analgesics|mesh-ancestor
83139387|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
83139388|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83474556|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
83139389|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139390|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139391|NCT02058173|Filaricides|filaricides|mesh-ancestor
83139392|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
83139393|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
83139394|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
83139395|NCT02060201|Saxagliptin|saxagliptin|mesh-list
83139396|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83139397|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139398|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83139399|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139400|NCT02060201|Incretins|incretins|mesh-ancestor
83139401|NCT02060201|Hormones|hormones|mesh-ancestor
83139402|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139403|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83139404|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
83139405|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139406|NCT03561233|Omeprazole|omeprazole|mesh-list
83139407|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83139408|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83139409|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83139410|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139411|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139412|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83139413|NCT02058485|Midazolam|midazolam|mesh-list
83139414|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
83139415|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83139416|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139417|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139418|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139419|NCT02058485|Analgesics|analgesics|mesh-ancestor
83139420|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
83139421|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139422|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83139423|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83139424|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83139425|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83139426|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139427|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139428|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83139429|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83139430|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83139431|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83139432|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83139433|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
83139434|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
83139435|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
83139436|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
83139437|NCT02060279|Carotenoids|carotenoids|mesh-list
83139438|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
83139439|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139440|NCT02060279|Protective Agents|protective agents|mesh-ancestor
83139441|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139442|NCT02058641|Darapladib|darapladib|mesh-list
83139443|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83139444|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139445|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139447|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83139448|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83139449|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139450|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
83139451|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
83139452|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139453|NCT02059967|Paclitaxel|paclitaxel|mesh-list
83139454|NCT02059967|Carboplatin|carboplatin|mesh-list
83139455|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83139456|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139457|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
83139458|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
83139459|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
83139460|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139461|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83139462|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83139463|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139464|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139465|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
83139466|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139467|NCT02061449|Romidepsin|romidepsin|mesh-list
83139468|NCT02061449|Poly ICLC|poly iclc|mesh-list
83139469|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
83139470|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
83139471|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83401227|NCT01925729|Ephedrine|ephedrine|mesh-list
83139472|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83139473|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139474|NCT02061449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83139475|NCT02061449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139476|NCT02061449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139477|NCT02060591|Bupivacaine|bupivacaine|mesh-list
83139478|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83139479|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
83139480|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139481|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139482|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
83139483|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139484|NCT02060669|Capecitabine|capecitabine|mesh-list
83139485|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83139486|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
83139487|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139488|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139489|NCT04428008|Thymalfasin|thymalfasin|mesh-list
83139490|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83139491|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
83139492|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139493|NCT02046590|Propofol|propofol|mesh-list
83139494|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
83139495|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139496|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139497|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83139498|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83139499|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
83139500|NCT02796755|Riluzole|riluzole|mesh-list
83139501|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
83139502|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83139503|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83139504|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83474590|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139505|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139506|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139507|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83139508|NCT02796755|Protective Agents|protective agents|mesh-ancestor
83139509|NCT02061917|Lobeline|lobeline|mesh-list
83139510|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83139511|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
83139512|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139513|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139514|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83139515|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83139516|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
83139517|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139518|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139519|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
83139520|NCT03560375|Empagliflozin|empagliflozin|mesh-list
83139521|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83139522|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139523|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83139524|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139525|NCT02382016|Macitentan|macitentan|mesh-list
83139526|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83139527|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83139528|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139529|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83139530|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83139531|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83139532|NCT02422186|Sertraline|sertraline|mesh-list
83139533|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
83139534|NCT02422186|Esketamine|esketamine|mesh-list
83139535|NCT02422186|Escitalopram|escitalopram|mesh-list
83139536|NCT02422186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83139537|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83139538|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139539|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139540|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139541|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
83139542|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139543|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401228|NCT01925729|Histamine|histamine|mesh-list
83139544|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83139545|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83139546|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83139547|NCT02422186|Analgesics|analgesics|mesh-ancestor
83139548|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
83139549|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
83139551|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
83139552|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
83139553|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83139554|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
83139555|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139556|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139557|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83139558|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
83139559|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83139560|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83139561|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83139562|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
83139563|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139564|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139565|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
83139566|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83139567|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
83139568|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
83139569|NCT04973462|Oseltamivir|oseltamivir|mesh-list
83139570|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
83139571|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139572|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139573|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139574|NCT02378506|Etanercept|etanercept|mesh-list
83139575|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83139576|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139577|NCT02378506|Analgesics|analgesics|mesh-ancestor
83139578|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
83139579|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139580|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139581|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139582|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139583|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83139584|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139585|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
83139586|NCT02794883|Durvalumab|durvalumab|mesh-list
83139587|NCT02794883|Ipilimumab|ipilimumab|mesh-list
83139588|NCT02794883|Tremelimumab|tremelimumab|mesh-list
83139589|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
83139590|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83139591|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
83139592|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83139593|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139594|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
83139595|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139596|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83139597|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139598|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
83139599|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83139600|NCT02063789|Antibodies|antibodies|mesh-list
83139601|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
83474650|NCT00005806|Paclitaxel|paclitaxel|mesh-list
83139602|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139603|NCT02063945|Risperidone|risperidone|mesh-list
83139604|NCT02063945|Methylphenidate|methylphenidate|mesh-list
83139605|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83139606|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
83139607|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139608|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139609|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139610|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83139611|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83139612|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139613|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83139614|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83139615|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
83139616|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83139617|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83139618|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83139620|NCT02064023|Insulin|insulin|mesh-list
83139621|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83139622|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83139623|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139624|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
83139625|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
83139626|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
83139627|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139628|NCT01370603|Atorvastatin|atorvastatin|mesh-list
83139629|NCT01370603|Ezetimibe|ezetimibe|mesh-list
83139630|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83139631|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83139632|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
83139633|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139634|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83139635|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83139636|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139637|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83139638|NCT02659397|Atorvastatin|atorvastatin|mesh-list
83139639|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83139640|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83139641|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
83139642|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139643|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83139644|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83139645|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139646|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83139647|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139648|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
83139649|NCT02347072|Bromides|bromides|mesh-list
83139650|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
83139651|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
83139652|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83139653|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
83139654|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139655|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139656|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83139657|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
83139658|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83139659|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83139660|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83139661|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83139662|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139663|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139664|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
83139665|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83139666|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
83139667|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
83139668|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83139669|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83139670|NCT02064491|Paclitaxel|paclitaxel|mesh-list
83139671|NCT02064491|Docetaxel|docetaxel|mesh-list
83139672|NCT02064491|Cisplatin|cisplatin|mesh-list
83139673|NCT02064491|Carboplatin|carboplatin|mesh-list
83139674|NCT02064491|Pemetrexed|pemetrexed|mesh-list
83139675|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83139676|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83139677|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139678|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
83139679|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
83139680|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83139681|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139682|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139683|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83139684|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83139685|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83139686|NCT02064881|Metformin|metformin|mesh-list
83139687|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83139688|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139689|NCT02346370|Docetaxel|docetaxel|mesh-list
83139690|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139691|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
83139692|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
83139693|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
83139694|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139695|NCT02065739|Itraconazole|itraconazole|mesh-list
83139696|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
83139697|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
83139698|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139699|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83139700|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83139701|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139702|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139703|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83139704|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
83139705|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139706|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139707|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83139708|NCT02068079|Vemurafenib|vemurafenib|mesh-list
83139709|NCT02068079|Trientine|trientine|mesh-list
83139710|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139711|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83139712|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139713|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139714|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
83139715|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
83139716|NCT02793947|Epinephrine|epinephrine|mesh-list
83139717|NCT02793947|Morphine|morphine|mesh-list
83139718|NCT02793947|Ropivacaine|ropivacaine|mesh-list
83139719|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83139720|NCT02793947|Narcotics|narcotics|mesh-ancestor
83139721|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139722|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139723|NCT02793947|Analgesics|analgesics|mesh-ancestor
83139724|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
83139725|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139726|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
83139727|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
83139728|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83139729|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83139730|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
83139731|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139732|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139733|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83139734|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83139735|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
83139736|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83139737|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
83139738|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
83139739|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
83139740|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83139741|NCT02068235|Ponesimod|ponesimod|mesh-list
83139742|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83139743|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139744|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139745|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
83139746|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139747|NCT01370213|Interleukin-2|interleukin-2|mesh-list
83139748|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83139749|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139750|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139751|NCT01370213|Analgesics|analgesics|mesh-ancestor
83139752|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
83139753|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139754|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139755|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
83139756|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139757|NCT02066207|Atorvastatin|atorvastatin|mesh-list
83139758|NCT02066207|Fenofibrate|fenofibrate|mesh-list
83139759|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83139760|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83139761|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
83139762|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139763|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83139764|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83139765|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139766|NCT01370525|Esomeprazole|esomeprazole|mesh-list
83139767|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83139768|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83139769|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83139770|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139771|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139772|NCT02065349|ASP8477|asp8477|mesh-list
83139773|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474698|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83139774|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139775|NCT02068625|Rasagiline|rasagiline|mesh-list
83139776|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83139777|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139778|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139779|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83139780|NCT02068625|Protective Agents|protective agents|mesh-ancestor
83139781|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139782|NCT02068859|Diclofenac|diclofenac|mesh-list
83139783|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83139784|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139785|NCT02068859|Analgesics|analgesics|mesh-ancestor
83139786|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
83139787|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139788|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139789|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139790|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139791|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83139792|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139793|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139794|NCT02068937|Furosemide|furosemide|mesh-list
83139795|NCT02068937|Diuretics|diuretics|mesh-ancestor
83139796|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
83139797|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139798|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83139799|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139800|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139801|NCT02066675|Trabectedin|trabectedin|mesh-list
83139802|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83139803|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
83139804|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139805|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139806|NCT02072135|Bupivacaine|bupivacaine|mesh-list
83139807|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
83139808|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
83139809|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139810|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139811|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
83139812|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139813|NCT02067065|Propofol|propofol|mesh-list
83139814|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83139815|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139816|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139817|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83139818|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
83139819|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
83139820|NCT02067143|Cytarabine|cytarabine|mesh-list
83139821|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83139822|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
83139823|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139824|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139825|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
83139826|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139827|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139828|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
83139829|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139830|NCT02072213|Tamsulosin|tamsulosin|mesh-list
83139831|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83139832|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83139833|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83139834|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83139835|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139836|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139837|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139838|NCT02072213|Urological Agents|urological agents|mesh-ancestor
83139839|NCT02072291|Nifedipine|nifedipine|mesh-list
83139840|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83139841|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139842|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139843|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83139844|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139845|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
83139846|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
83139847|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83139848|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83139849|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
83139850|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139851|NCT03059888|Abatacept|abatacept|mesh-list
83139852|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83139853|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139854|NCT03059888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83139855|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139856|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139857|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
83139858|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139859|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139860|NCT04976816|Triamcinolone|triamcinolone|mesh-list
83139861|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83139862|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83139863|NCT04976816|Betamethasone|betamethasone|mesh-list
83139864|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
83139865|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83139866|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
83139867|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83139868|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83139869|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139870|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
83139871|NCT04976816|Hormones|hormones|mesh-ancestor
83139872|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139873|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139874|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83139875|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
83139876|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139877|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139878|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83139879|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
83139880|NCT03061838|Rituximab|rituximab|mesh-list
83139881|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83139882|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83139883|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
83139884|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139885|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139886|NCT04964180|Indomethacin|indomethacin|mesh-list
83139887|NCT04964180|Lidocaine|lidocaine|mesh-list
83139888|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
83139889|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
83474730|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
83139890|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83139891|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139892|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
83139893|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139894|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83139895|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83139896|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83139897|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83139898|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139899|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83139900|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83139901|NCT04964180|Analgesics|analgesics|mesh-ancestor
83139902|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139903|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83139904|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
83139905|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
83139906|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83139907|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83139908|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139909|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
83139910|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83139911|NCT02067377|Antibodies|antibodies|mesh-list
83139912|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
83139913|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139914|NCT02073149|Iron|iron|mesh-list
83139915|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
83139916|NCT02073149|Trace Elements|trace elements|mesh-ancestor
83139917|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
83139918|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139919|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83139920|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
83139921|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
83139922|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139923|NCT02625974|Nifurtimox|nifurtimox|mesh-list
83139924|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83139925|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83139926|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83139927|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139928|NCT02067767|Lamivudine|lamivudine|mesh-list
83139929|NCT02067767|Abacavir|abacavir|mesh-list
83139930|NCT02067767|Dolutegravir|dolutegravir|mesh-list
83139931|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83139932|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83139933|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83139934|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139935|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
83139936|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83139937|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83139938|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83139939|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83139940|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83139941|NCT02073227|Metformin|metformin|mesh-list
83139942|NCT02073227|Canagliflozin|canagliflozin|mesh-list
83139943|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83139944|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139945|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83139946|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139947|NCT03060044|Fluticasone|fluticasone|mesh-list
83139948|NCT03060044|Xhance|xhance|mesh-list
83139949|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83139950|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83139951|NCT03060044|Charcoal|charcoal|mesh-list
83139952|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83139953|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83139954|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
83139955|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83139956|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139957|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83139958|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
83139959|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
83139960|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83139961|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83139962|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83139963|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83139964|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
83139965|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139966|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139967|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
83139968|NCT03060044|Hormones|hormones|mesh-ancestor
83139969|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83139970|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
83139971|NCT03060044|Antidotes|antidotes|mesh-ancestor
83139972|NCT03060044|Protective Agents|protective agents|mesh-ancestor
83139973|NCT02070653|Ticagrelor|ticagrelor|mesh-list
83139974|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83139975|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83139976|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83139977|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83139978|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
83139979|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139980|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139981|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139982|NCT04831892|Isosorbide|isosorbide|mesh-list
83139983|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83139984|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83139985|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83139986|NCT04831892|Diuretics|diuretics|mesh-ancestor
83139987|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
83139988|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139989|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
83139990|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83139991|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139993|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83139994|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83139995|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
83139996|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83139997|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83139998|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83139999|NCT03062150|Cycloserine|cycloserine|mesh-list
83140000|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
83140001|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83140002|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140003|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83140004|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
83140005|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83140006|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
83140007|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140008|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140009|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
83140010|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83140011|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83140012|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140013|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
83140014|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
83140015|NCT02076659|Methotrexate|methotrexate|mesh-list
83140016|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83140017|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
83140018|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83140019|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140020|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140021|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
83140022|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140023|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140024|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
83140025|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140026|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83140027|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140028|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
83140029|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140030|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83140031|NCT04975724|Citalopram|citalopram|mesh-list
83140032|NCT04975724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83140033|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83140034|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140035|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140036|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140037|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
83140038|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140039|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83140040|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
83140041|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83140042|NCT02076815|Anagrelide|anagrelide|mesh-list
83140043|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83140044|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83140045|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140046|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83140047|NCT02071043|Capecitabine|capecitabine|mesh-list
83140048|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
83140049|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140050|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
83140051|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140052|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140053|NCT02076893|Ibuprofen|ibuprofen|mesh-list
83140054|NCT02076893|Gabapentin|gabapentin|mesh-list
83140055|NCT02076893|Tramadol|tramadol|mesh-list
83140056|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83140057|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140058|NCT02076893|Analgesics|analgesics|mesh-ancestor
83140059|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
83140060|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140061|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140062|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140063|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140064|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83140065|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140066|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140067|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
83140068|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83140069|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83474788|NCT01273207|Cyclosporine|cyclosporine|mesh-list
83140070|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140071|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83140072|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83140073|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83140074|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140075|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
83140076|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83140077|NCT02076893|Narcotics|narcotics|mesh-ancestor
83140078|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83140079|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83140080|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83140081|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140082|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140083|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83140084|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140085|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140086|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
83140087|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140088|NCT04963088|Capecitabine|capecitabine|mesh-list
83140089|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
83140090|NCT04963088|Tislelizumab|tislelizumab|mesh-list
83140091|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140092|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
83140093|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140094|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140095|NCT04963088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140096|NCT02074319|Methotrexate|methotrexate|mesh-list
83140097|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83140098|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
83140099|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83140100|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140101|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140102|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
83474800|NCT01342549|Naltrexone|naltrexone|mesh-list
83140103|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140104|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140105|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
83140106|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140107|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83140108|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140109|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
83140110|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140111|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83140112|NCT04975022|Insulin|insulin|mesh-list
83140113|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83140114|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140115|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83140116|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
83140117|NCT03061604|Octreotide|octreotide|mesh-list
83140118|NCT03061604|Hemostatics|hemostatics|mesh-list
83140119|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140120|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83140121|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83140122|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140123|NCT03061604|Coagulants|coagulants|mesh-ancestor
83140124|NCT04974944|Paclitaxel|paclitaxel|mesh-list
83140125|NCT04974944|Bevacizumab|bevacizumab|mesh-list
83140126|NCT04974944|Carboplatin|carboplatin|mesh-list
83140127|NCT04974944|Apatinib|apatinib|mesh-list
83140128|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83140129|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140130|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
83140131|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
83140132|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
83140133|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140134|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140135|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83140136|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83140137|NCT04974944|Growth Substances|growth substances|mesh-ancestor
83140138|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140139|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
83140140|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140141|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140142|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83140143|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83140144|NCT04962386|Hormones|hormones|mesh-list
83140145|NCT04962386|Estradiol|estradiol|mesh-list
83140146|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83140147|NCT04962386|Progesterone|progesterone|mesh-list
83140148|NCT04962386|Estrogens|estrogens|mesh-list
83140149|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140150|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140151|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83140152|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
83140153|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83140154|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83140155|NCT04962386|Progestins|progestins|mesh-ancestor
83140156|NCT02071355|Simeprevir|simeprevir|mesh-list
83140157|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
83140158|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140159|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
83140160|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140161|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140162|NCT02071433|Iodine|iodine|mesh-list
83140163|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83140164|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140165|NCT02071433|Trace Elements|trace elements|mesh-ancestor
83140166|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
83140167|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140168|NCT04962308|Vaccines|vaccines|mesh-list
83140169|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
83140170|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140171|NCT02071589|Nifedipine|nifedipine|mesh-list
83140172|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83140173|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140174|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140175|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83140176|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140177|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
83140178|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
83140179|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83140180|NCT04970342|Alprazolam|alprazolam|mesh-list
83140181|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140182|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83140183|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140184|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140185|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83140186|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140188|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83140189|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
83140190|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
83140191|NCT02077751|Biotin|biotin|mesh-list
83140192|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
83140193|NCT02077751|Vitamins|vitamins|mesh-ancestor
83140194|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
83140195|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140196|NCT04961684|Amorolfine|amorolfine|mesh-list
83140197|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
83140198|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140199|NCT03061058|Docetaxel|docetaxel|mesh-list
83140200|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
83140201|NCT03061058|Irinotecan|irinotecan|mesh-list
83140202|NCT03061058|Pemetrexed|pemetrexed|mesh-list
83140203|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140204|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
83140205|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
83140206|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
83140207|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140208|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83140209|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83140210|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140211|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83140212|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83140213|NCT04961918|Durvalumab|durvalumab|mesh-list
83140214|NCT04961918|Lenvatinib|lenvatinib|mesh-list
83140215|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140216|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140217|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140218|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140219|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140220|NCT04954040|Azithromycin|azithromycin|mesh-list
83140221|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
83140222|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83140223|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140224|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
83140225|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83140226|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83140227|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140228|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140229|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140230|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
83140231|NCT04424654|Testosterone|testosterone|mesh-list
83140232|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
83140233|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
83140234|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83140235|NCT04424654|Androgens|androgens|mesh-ancestor
83140236|NCT04424654|Hormones|hormones|mesh-ancestor
83140237|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140238|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140239|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83140240|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140241|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
83140242|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
83140243|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
83140244|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83140245|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140246|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140247|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140248|NCT04968392|Analgesics|analgesics|mesh-ancestor
83140249|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
83140250|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140251|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83140252|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83140253|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83140254|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
83140255|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140256|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140257|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83140258|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
83140259|NCT02792699|Rituximab|rituximab|mesh-list
83140260|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140261|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140262|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
83140263|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140264|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140265|NCT04968002|Apatinib|apatinib|mesh-list
83140266|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140267|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140268|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140269|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140270|NCT04961138|Lenvatinib|lenvatinib|mesh-list
83140271|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140272|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140273|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83474864|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140274|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140275|NCT03061136|Clonazepam|clonazepam|mesh-list
83140276|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
83140277|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
83140278|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
83140279|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140280|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140281|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140282|NCT04952792|Apixaban|apixaban|mesh-list
83140283|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83140284|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
83140285|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83140286|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
83140287|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140288|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140289|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
83140290|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83140291|NCT02080169|Fentanyl|fentanyl|mesh-list
83140292|NCT02080169|Midazolam|midazolam|mesh-list
83140293|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
83140294|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83140295|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140296|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140297|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140298|NCT02080169|Analgesics|analgesics|mesh-ancestor
83140299|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
83140300|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140301|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83140302|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83140303|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83140304|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
83140305|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140306|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140307|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83140308|NCT02080169|Narcotics|narcotics|mesh-ancestor
83140309|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83140310|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83140311|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
83140312|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
83140313|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83140314|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83140315|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83140316|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
83140317|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
83140318|NCT02078063|Mepivacaine|mepivacaine|mesh-list
83140319|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
83140320|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
83140321|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140322|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140323|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
83140324|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140325|NCT04951856|Evolocumab|evolocumab|mesh-list
83140326|NCT04951856|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83140327|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83140328|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83140329|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
83140330|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140331|NCT04951856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83140332|NCT04951856|Protease Inhibitors|protease inhibitors|mesh-ancestor
83140333|NCT04951856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140334|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83140335|NCT04951232|Cinepazide|cinepazide|mesh-list
83140336|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
83140337|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
83140338|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
83140339|NCT04959578|Hematinics|hematinics|mesh-ancestor
83140340|NCT04959500|Temozolomide|temozolomide|mesh-list
83140341|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83140342|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
83140343|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140344|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140346|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140347|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
83140348|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140349|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140350|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140351|NCT02080715|Tolcapone|tolcapone|mesh-list
83140352|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83140353|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83140354|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83140355|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140356|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140357|NCT04965662|Tenofovir|tenofovir|mesh-list
83140358|NCT04965662|Emtricitabine|emtricitabine|mesh-list
83140359|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83140360|NCT04965662|Maraviroc|maraviroc|mesh-list
83140361|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
83140362|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140363|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83140364|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83140365|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140366|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140367|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83140368|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83140369|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83140370|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83140371|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83140373|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140374|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140375|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140376|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140377|NCT04957940|SMOFlipid|smoflipid|mesh-list
83140378|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83140379|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83140380|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83140381|NCT03060278|Nicotine|nicotine|mesh-list
83140382|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83140383|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
83140384|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140385|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140386|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83140387|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83140388|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
83140389|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140390|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140391|NCT02083991|Prednisolone|prednisolone|mesh-list
83140392|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
83140393|NCT02083991|Basiliximab|basiliximab|mesh-list
83140394|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140395|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
83140396|NCT02083991|Hormones|hormones|mesh-ancestor
83140397|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140398|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140399|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83140400|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140401|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
83140402|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140403|NCT02081027|Riluzole|riluzole|mesh-list
83140404|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
83140405|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83140406|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83140407|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140408|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140409|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140410|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83140411|NCT02081027|Protective Agents|protective agents|mesh-ancestor
83140412|NCT04948034|Tislelizumab|tislelizumab|mesh-list
83140413|NCT04948034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140414|NCT04948034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140415|NCT04947956|Apatinib|apatinib|mesh-list
83140416|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140417|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140418|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140419|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140420|NCT03254511|Enoxaparin|enoxaparin|mesh-list
83140421|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
83140422|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
83140423|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83140424|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83140425|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140426|NCT04947566|Ibuprofen|ibuprofen|mesh-list
83140427|NCT04947566|Naproxen|naproxen|mesh-list
83140428|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83140429|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140430|NCT04947566|Analgesics|analgesics|mesh-ancestor
83140431|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
83140432|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140433|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140434|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140435|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140436|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83140437|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140438|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140439|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
83140440|NCT03241875|Pregabalin|pregabalin|mesh-list
83140441|NCT03241875|Gabapentin|gabapentin|mesh-list
83140442|NCT03241875|Analgesics|analgesics|mesh-ancestor
83140443|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
83140444|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140445|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140446|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
83140447|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83140448|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140449|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140450|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83140451|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83140452|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83140453|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140454|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83474923|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83140455|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83140456|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83140457|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140458|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
83140459|NCT03058094|Pemetrexed|pemetrexed|mesh-list
83140460|NCT03058094|Abivertinib|abivertinib|mesh-list
83140461|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140462|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140463|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140464|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83140465|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83140466|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140467|NCT04413266|Curcumin|curcumin|mesh-list
83140468|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83140469|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140470|NCT04413266|Analgesics|analgesics|mesh-ancestor
83140471|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
83140472|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140473|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140474|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140475|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140476|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140477|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140478|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140479|NCT04944524|Methotrexate|methotrexate|mesh-list
83140480|NCT04944524|Tofacitinib|tofacitinib|mesh-list
83140481|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83140482|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
83140483|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83140484|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140485|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140486|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
83140487|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140488|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140490|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140491|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83140492|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140493|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
83140494|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140495|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83140496|NCT04944524|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83140497|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140498|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83140499|NCT04412876|Imipramine|imipramine|mesh-list
83140500|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83140501|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83140502|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140503|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140504|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140505|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140506|NCT04412876|Analgesics|analgesics|mesh-ancestor
83140507|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
83140508|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140509|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
83140510|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83140511|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
83140512|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83140513|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83140514|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
83140515|NCT03241563|Triamcinolone|triamcinolone|mesh-list
83140516|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
83140517|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140518|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
83140519|NCT03241563|Hormones|hormones|mesh-ancestor
83140520|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140521|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140522|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83140523|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83140524|NCT03241641|Tenofovir|tenofovir|mesh-list
83140525|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
83140526|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140527|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83140528|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83140529|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140530|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140531|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83140532|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83140533|NCT04486521|Siltuximab|siltuximab|mesh-list
83140534|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140535|NCT04955834|Insulin|insulin|mesh-list
83140536|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83140537|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140538|NCT03241407|Triclosan|triclosan|mesh-list
83140539|NCT03241407|Fluorides|fluorides|mesh-list
83140540|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
83140541|NCT03241407|Protective Agents|protective agents|mesh-ancestor
83140542|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140543|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83140544|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140545|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83140546|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83140547|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
83140548|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140549|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83140550|NCT03238131|Ivermectin|ivermectin|mesh-list
83140551|NCT03238131|Albendazole|albendazole|mesh-list
83140552|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83140553|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140554|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
83140555|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
83140556|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83140557|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83140558|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
83140559|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
83140560|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
83140561|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140562|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140564|NCT01369433|Paclitaxel|paclitaxel|mesh-list
83140565|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83140566|NCT01369433|Capecitabine|capecitabine|mesh-list
83140567|NCT01369433|Temsirolimus|temsirolimus|mesh-list
83140568|NCT01369433|MTOR Inhibitors|mtor inhibitors|mesh-list
83140569|NCT01369433|Tivozanib|tivozanib|mesh-list
83140570|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83140571|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140572|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
83140573|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
83140574|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
83140575|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140576|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140577|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
83140578|NCT01369433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140579|NCT01369433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140580|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140581|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
83140582|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140583|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83140584|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140585|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83140586|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
83140587|NCT04946162|Tadalafil|tadalafil|mesh-list
83140588|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
83140589|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83140590|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83140591|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140592|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140593|NCT04946162|Urological Agents|urological agents|mesh-ancestor
83140594|NCT02084225|Lidocaine|lidocaine|mesh-list
83140595|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
83140596|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
83140597|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140598|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140599|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
83140600|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140601|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83140602|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83140603|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83140604|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140605|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140606|NCT04945694|Fentanyl|fentanyl|mesh-list
83140607|NCT04945694|Propofol|propofol|mesh-list
83140608|NCT04945694|Sevoflurane|sevoflurane|mesh-list
83140609|NCT04945694|Atracurium|atracurium|mesh-list
83140610|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83140611|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83474991|NCT01409239|Insulin|insulin|mesh-list
83140612|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140613|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83140614|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
83140615|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
83140616|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83140617|NCT04945694|Narcotics|narcotics|mesh-ancestor
83140618|NCT04945694|Analgesics|analgesics|mesh-ancestor
83140619|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
83140620|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140621|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83140622|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83140623|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83140624|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83140625|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83140626|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83140627|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83140628|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83140629|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83140630|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140631|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140632|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83140633|NCT02084303|Hematinics|hematinics|mesh-ancestor
83140634|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83140635|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83140636|NCT02420847|Gemcitabine|gemcitabine|mesh-list
83140637|NCT02420847|Doxorubicin|doxorubicin|mesh-list
83140638|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83140639|NCT02420847|Ixazomib|ixazomib|mesh-list
83140640|NCT02420847|Glycine|glycine|mesh-list
83140641|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140642|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
83140643|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140644|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140645|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83140646|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83140647|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83140648|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140649|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
83140650|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
83140651|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140652|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140653|NCT03253887|Ethanol|ethanol|mesh-list
83140654|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83140655|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140656|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140657|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140658|NCT02453607|Infliximab|infliximab|mesh-list
83140659|NCT02453607|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83140660|NCT02453607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140661|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
83140662|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83140663|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140664|NCT02453529|Nafithromycin|nafithromycin|mesh-list
83140665|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83140666|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140667|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83140668|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140669|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140670|NCT03241017|Durvalumab|durvalumab|mesh-list
83401378|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83140671|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140672|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140673|NCT03237741|Rabeprazole|rabeprazole|mesh-list
83140674|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83140675|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83140676|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83140677|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140678|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140680|NCT03240939|Dutasteride|dutasteride|mesh-list
83140681|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
83140682|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83140683|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83140684|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140685|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140686|NCT03240939|Urological Agents|urological agents|mesh-ancestor
83140687|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83140688|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83140689|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
83140690|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140691|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140692|NCT02624492|Rituximab|rituximab|mesh-list
83140693|NCT02624492|BI 836826|bi 836826|mesh-list
83140694|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140695|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140696|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
83140697|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140698|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140699|NCT03240783|Dexamethasone|dexamethasone|mesh-list
83140700|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
83140701|NCT03240783|Betamethasone|betamethasone|mesh-list
83140702|NCT03240783|BB 1101|bb 1101|mesh-list
83140703|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140704|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
83140705|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
83140706|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140707|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140708|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83140709|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
83140710|NCT03240783|Hormones|hormones|mesh-ancestor
83140711|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140712|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83140713|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140714|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
83140715|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140716|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140717|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83140718|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
83140720|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
83140721|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83140722|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140723|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
83140724|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
83140725|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
83140726|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140727|NCT04945226|Finasteride|finasteride|mesh-list
83140728|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83140729|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83140730|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140731|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140732|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
83140733|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140734|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140735|NCT04945226|Urological Agents|urological agents|mesh-ancestor
83140736|NCT01975831|Durvalumab|durvalumab|mesh-list
83140737|NCT01975831|Tremelimumab|tremelimumab|mesh-list
83140738|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140739|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140740|NCT04945070|Insulin|insulin|mesh-list
83140741|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83140742|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140743|NCT03240471|Calpastatin|calpastatin|mesh-list
83140744|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83140745|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
83140746|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140747|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140748|NCT04942652|Itraconazole|itraconazole|mesh-list
83140749|NCT04942652|Esomeprazole|esomeprazole|mesh-list
83140750|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83140751|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83140752|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83140753|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140754|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140755|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
83140756|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140757|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83140758|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83140759|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83140760|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
83140761|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140762|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140763|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83140764|NCT03240549|Bevacizumab|bevacizumab|mesh-list
83140765|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140766|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140767|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83140768|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83140769|NCT03240549|Growth Substances|growth substances|mesh-ancestor
83140770|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140771|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
83140772|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
83140773|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
83140774|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83140775|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83140776|NCT04933292|Prednisolone|prednisolone|mesh-list
83140777|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
83140778|NCT04933292|Azathioprine|azathioprine|mesh-list
83140779|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83140780|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
83140781|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83140782|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140783|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83140784|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
83140785|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83140786|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140787|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140788|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140789|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140790|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
83140791|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
83140792|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140793|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140794|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83140795|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
83140796|NCT04933292|Hormones|hormones|mesh-ancestor
83140797|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140798|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83140799|NCT04933292|Protective Agents|protective agents|mesh-ancestor
83140800|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83140801|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
83140802|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140803|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140804|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
83140805|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140806|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
83140807|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83140808|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83140809|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140810|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
83140811|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
83140812|NCT04941872|FAPI-46|fapi-46|mesh-list
83140813|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83140814|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140815|NCT03237117|Hormones|hormones|mesh-list
83140816|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83140817|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140818|NCT03239691|ACT-709478|act-709478|mesh-list
83140820|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140821|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140822|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83140823|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140824|NCT04944602|Omalizumab|omalizumab|mesh-list
83140825|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83475070|NCT01359007|Vitamins|vitamins|mesh-ancestor
83140826|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83140827|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
83140828|NCT03253107|Trastuzumab|trastuzumab|mesh-list
83140829|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140830|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140831|NCT03236883|Gemcitabine|gemcitabine|mesh-list
83140832|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140833|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
83140834|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140835|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140836|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
83140837|NCT03236961|Metronidazole|metronidazole|mesh-list
83140838|NCT03236961|Levofloxacin|levofloxacin|mesh-list
83140839|NCT03236961|Ertapenem|ertapenem|mesh-list
83140840|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83140841|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140842|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83140843|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83140844|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140845|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140846|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140847|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83140848|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83140849|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83140850|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83140851|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83140852|NCT05234619|Ketorolac|ketorolac|mesh-list
83140853|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83140854|NCT05234619|Lidocaine|lidocaine|mesh-list
83140855|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
83140856|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
83140857|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140858|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140859|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
83140860|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140861|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83140862|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83140863|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83140864|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140865|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140866|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83140867|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140868|NCT05234619|Analgesics|analgesics|mesh-ancestor
83140869|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140870|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140871|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83140872|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140873|NCT04921904|Ramucirumab|ramucirumab|mesh-list
83140874|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140875|NCT02622386|Riboflavin|riboflavin|mesh-list
83140876|NCT02622386|Vitamins|vitamins|mesh-ancestor
83140877|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
83140878|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140879|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
83140880|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83140881|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
83140882|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
83140883|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83140884|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83140885|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140886|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
83140887|NCT04427618|Coagulants|coagulants|mesh-ancestor
83140888|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
83140889|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83140890|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140891|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140892|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140893|NCT03236727|Analgesics|analgesics|mesh-ancestor
83140894|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
83140895|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140896|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83140897|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83140898|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83140899|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83140900|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140901|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140902|NCT03236493|PF-06700841|pf-06700841|mesh-list
83140903|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83140904|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140905|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140906|NCT04921124|Teriparatide|teriparatide|mesh-list
83140907|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83140908|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140909|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83140910|NCT04921046|Lidocaine|lidocaine|mesh-list
83140911|NCT04921046|Midazolam|midazolam|mesh-list
83140912|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83140913|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83140914|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140915|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140916|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83140917|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83140918|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83140919|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83140920|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
83140921|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
83140922|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
83140923|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
83140924|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140925|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140926|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
83140927|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
83140928|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140929|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83140930|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83140931|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83140932|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140933|NCT02792231|Teriflunomide|teriflunomide|mesh-list
83140934|NCT02792231|Ofatumumab|ofatumumab|mesh-list
83140935|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83140936|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140937|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
83140938|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140939|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83140940|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83140941|NCT02792231|Analgesics|analgesics|mesh-ancestor
83140942|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
83140943|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140944|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83140945|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140946|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140947|NCT04930952|Ethanol|ethanol|mesh-list
83140948|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83140949|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140950|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83140951|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140952|NCT04920968|Rituximab|rituximab|mesh-list
83140953|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
83140954|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83140955|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140956|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
83140957|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140958|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83140959|NCT00700401|Ribavirin|ribavirin|mesh-list
83140960|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83140961|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
83140962|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140963|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
83140964|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140965|NCT04931108|Atenolol|atenolol|mesh-list
83140966|NCT04931108|Nitrendipine|nitrendipine|mesh-list
83140967|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83140968|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83140969|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
83140970|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
83140971|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83140972|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140973|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83140974|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83140975|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83140976|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
83140977|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83140978|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140979|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83140980|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83140981|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83140982|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
83140983|NCT04920500|Cytarabine|cytarabine|mesh-list
83140984|NCT04920500|Daunorubicin|daunorubicin|mesh-list
83140985|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83140986|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
83140987|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83140988|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83140989|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
83140990|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83140991|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83140992|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
83140993|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83140994|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83140995|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83140996|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83140997|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83140998|NCT02084615|Aspirin|aspirin|mesh-list
83140999|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83141000|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83141001|NCT02084615|Analgesics|analgesics|mesh-ancestor
83141002|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
83141003|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141004|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141005|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141006|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83141007|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83141008|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83141009|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141010|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83141011|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83141012|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141013|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
83141015|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83141016|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
83141017|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141018|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141019|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83141020|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83141021|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
83141022|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141023|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141024|NCT03234699|Midazolam|midazolam|mesh-list
83141025|NCT03234699|Cenobamate|cenobamate|mesh-list
83141026|NCT03234699|Bupropion|bupropion|mesh-list
83141027|NCT03234699|Omeprazole|omeprazole|mesh-list
83141028|NCT03234699|Warfarin|warfarin|mesh-list
83141029|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83141030|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83141031|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141032|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141033|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83141034|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83141035|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141036|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83141037|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
83141038|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
83141039|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
83141040|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
83141041|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141042|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141043|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
83141044|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83141045|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141046|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83141047|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141048|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83141049|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
83141050|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83141051|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83141052|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141053|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
83141054|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83141055|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83141056|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
83141057|NCT03228771|Atorvastatin|atorvastatin|mesh-list
83141058|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83141059|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83141060|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
83141061|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141062|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83141063|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83141064|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141065|NCT02081339|Ranibizumab|ranibizumab|mesh-list
83141066|NCT02081339|Aflibercept|aflibercept|mesh-list
83141067|NCT02081339|Verteporfin|verteporfin|mesh-list
83141068|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83141069|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83141070|NCT02081339|Growth Substances|growth substances|mesh-ancestor
83141071|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141072|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83141073|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141074|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83141075|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
83141076|NCT04939766|Insulin|insulin|mesh-list
83141077|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141078|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141079|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83141080|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
83141081|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141082|NCT03559673|Lacosamide|lacosamide|mesh-list
83141083|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
83141084|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83141085|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83141086|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141087|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141088|NCT03234387|Acetylcholine|acetylcholine|mesh-list
83141089|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83475191|NCT00257894|Baclofen|baclofen|mesh-list
83141090|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
83141091|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83141092|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
83141093|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141094|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141095|NCT03235947|Trimethoprim|trimethoprim|mesh-list
83141096|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
83141097|NCT03235947|Fosfomycin|fosfomycin|mesh-list
83141098|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83141099|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141100|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
83141101|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83141102|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83141103|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83141104|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141105|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141106|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83141107|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83141108|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83141109|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83141110|NCT03057470|Insulin|insulin|mesh-list
83141111|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83141112|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141113|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141115|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
83141116|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141117|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
83141118|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141119|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83141120|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141121|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141122|NCT02085005|Capecitabine|capecitabine|mesh-list
83141123|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
83141124|NCT02085005|Aflibercept|aflibercept|mesh-list
83141125|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83141126|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
83141127|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141128|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141129|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83141130|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83141131|NCT02085005|Growth Substances|growth substances|mesh-ancestor
83141132|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141133|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
83141134|NCT03235869|Durvalumab|durvalumab|mesh-list
83141135|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83141136|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83475209|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83141137|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83141138|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
83141139|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141140|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
83141141|NCT03057314|Calcium|calcium|mesh-list
83141142|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83141143|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141144|NCT03057314|Antacids|antacids|mesh-ancestor
83141145|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141146|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141147|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83141148|NCT02081495|Doxorubicin|doxorubicin|mesh-list
83141149|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83141150|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141151|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83141152|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83141153|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141154|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141156|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141157|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83141158|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
83141159|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83141160|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83141161|NCT03227679|Bupropion|bupropion|mesh-list
83141162|NCT03227679|Nicotine|nicotine|mesh-list
83141163|NCT03227679|Varenicline|varenicline|mesh-list
83141164|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83141165|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
83141166|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141167|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141168|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83141169|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83141170|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
83141171|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141172|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141173|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83141174|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
83141175|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141176|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83141177|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83141178|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141179|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
83141180|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83141181|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83141182|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141183|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83141184|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83141185|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83141186|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141187|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141189|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141190|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141191|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83141192|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141193|NCT04937894|Tigecycline|tigecycline|mesh-list
83141194|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83141195|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141196|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83141197|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141198|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141199|NCT04919252|Vedolizumab|vedolizumab|mesh-list
83141200|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141201|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
83141202|NCT04919174|Remifentanil|remifentanil|mesh-list
83141203|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83141204|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141205|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141206|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83141207|NCT04919174|Analgesics|analgesics|mesh-ancestor
83141208|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
83141209|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141210|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83141211|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83141212|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83141213|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141214|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141215|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141216|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83141217|NCT04919174|Narcotics|narcotics|mesh-ancestor
83141218|NCT02085239|Lidocaine|lidocaine|mesh-list
83141219|NCT02085239|Ropivacaine|ropivacaine|mesh-list
83141220|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
83141221|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
83141222|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141223|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141224|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
83141225|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141226|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83141227|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83141228|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83141229|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141230|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141231|NCT05143489|Lidocaine|lidocaine|mesh-list
83141232|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
83141233|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
83141234|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141235|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141236|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
83141237|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141238|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83141239|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83141240|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83141241|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141242|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141243|NCT02085317|Nitroprusside|nitroprusside|mesh-list
83141244|NCT02085317|Acetylcholine|acetylcholine|mesh-list
83141245|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83141246|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
83141247|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83141248|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141249|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83141250|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
83141251|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141252|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141253|NCT03234153|Durvalumab|durvalumab|mesh-list
83141254|NCT03234153|Tremelimumab|tremelimumab|mesh-list
83141255|NCT03234153|Immunomodulating Agents|immunomodulating agents|mesh-list
83141256|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
83141257|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83401379|NCT04394897|Narcotics|narcotics|mesh-ancestor
83141258|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141259|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141261|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
83141262|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141263|NCT05523401|Psilocybin|psilocybin|mesh-list
83141264|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83141265|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
83141266|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
83141267|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141268|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141269|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
83141270|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141271|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141272|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83141273|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83141274|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141275|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141276|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83141277|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83141278|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83141279|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
83141280|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83141281|NCT04918862|Granisetron|granisetron|mesh-list
83141282|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
83141283|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
83141284|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141285|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141286|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141287|NCT04918862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83141288|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83141289|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
83141290|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141291|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141292|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
83141293|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83141294|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141295|NCT02081885|Chitosan|chitosan|mesh-list
83141296|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83141297|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83141298|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
83141299|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141300|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83141301|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
83141302|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
83141303|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
83141304|NCT02081885|Coagulants|coagulants|mesh-ancestor
83141305|NCT03235245|Nivolumab|nivolumab|mesh-list
83141306|NCT03235245|Ipilimumab|ipilimumab|mesh-list
83141307|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83141308|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141309|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83141310|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141311|NCT02452281|Ipilimumab|ipilimumab|mesh-list
83141312|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83141313|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141314|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83141315|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141316|NCT02452125|Nicotine|nicotine|mesh-list
83141317|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83141318|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
83141319|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141320|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141321|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83141322|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83141323|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
83141324|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141325|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141326|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83141327|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
83141328|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83141329|NCT02619812|Antibodies|antibodies|mesh-list
83141330|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
83141331|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141332|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83141333|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83141334|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
83141335|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141336|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83141338|NCT04928066|Tofacitinib|tofacitinib|mesh-list
83141339|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141340|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
83141341|NCT04928066|Hormones|hormones|mesh-ancestor
83141342|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83141343|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141344|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83141345|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141346|NCT04928066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83141347|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83141348|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141349|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141350|NCT03222765|Metformin|metformin|mesh-list
83141351|NCT03222765|Linagliptin|linagliptin|mesh-list
83141352|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141353|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141354|NCT03222765|Incretins|incretins|mesh-ancestor
83141355|NCT03222765|Hormones|hormones|mesh-ancestor
83141356|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83141357|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83141358|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
83141359|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141360|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141361|NCT04485585|Tamsulosin|tamsulosin|mesh-list
83141362|NCT04485585|Mirabegron|mirabegron|mesh-list
83141363|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83141364|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83141365|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83141366|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141367|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141368|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141369|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141370|NCT04485585|Urological Agents|urological agents|mesh-ancestor
83141371|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83141372|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83141373|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83141374|NCT03222687|Prednisone|prednisone|mesh-list
83141375|NCT03222687|Tacrolimus|tacrolimus|mesh-list
83141376|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141377|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
83141378|NCT03222687|Hormones|hormones|mesh-ancestor
83141379|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83141380|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141381|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83141382|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141383|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83141384|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
83475278|NCT03015701|Mifepristone|mifepristone|mesh-list
83141385|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83141386|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141387|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141388|NCT03055442|Inositol|inositol|mesh-list
83141389|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
83141390|NCT03055442|Vitamins|vitamins|mesh-ancestor
83141391|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
83141392|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141393|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
83141394|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
83141395|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141396|NCT03226431|Protective Agents|protective agents|mesh-ancestor
83141397|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141398|NCT03226431|Vitamins|vitamins|mesh-ancestor
83141399|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
83141400|NCT02451579|Cetirizine|cetirizine|mesh-list
83141401|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
83141402|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83141403|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83141404|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83141405|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
83141406|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141407|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141408|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141409|NCT04935788|Caseins|caseins|mesh-list
83141410|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
83141411|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
83141412|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141413|NCT03233295|Vitamin D|vitamin d|mesh-list
83141414|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
83141415|NCT03233295|Vitamins|vitamins|mesh-ancestor
83141416|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
83141417|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141418|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83141419|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83141420|NCT04917458|Vitamin D|vitamin d|mesh-list
83141421|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
83141422|NCT04917458|Vitamins|vitamins|mesh-ancestor
83141423|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
83141424|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141425|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83141426|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83141427|NCT03225963|Temozolomide|temozolomide|mesh-list
83141428|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83141429|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
83141430|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141431|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141432|NCT03221907|Pregabalin|pregabalin|mesh-list
83141433|NCT03221907|Analgesics|analgesics|mesh-ancestor
83141434|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
83141435|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141436|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141437|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
83141438|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83141439|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141440|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141441|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83141442|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83141443|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83141444|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141445|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141446|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83141447|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
83141448|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83141449|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
83141450|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141451|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141452|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83141453|NCT03107481|Acetaminophen|acetaminophen|mesh-list
83141454|NCT03107481|Hydromorphone|hydromorphone|mesh-list
83141455|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83141456|NCT03107481|Analgesics|analgesics|mesh-ancestor
83141457|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
83141458|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141459|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141460|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
83141461|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83141462|NCT03107481|Narcotics|narcotics|mesh-ancestor
83141463|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141464|NCT04934852|Ephedrine|ephedrine|mesh-list
83141465|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
83141466|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83141467|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141468|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
83141469|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
83141470|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141471|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83141472|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141473|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141474|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141475|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83141476|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83141477|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
83141478|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
83141479|NCT04934618|Irinotecan|irinotecan|mesh-list
83141480|NCT04934618|Apatinib|apatinib|mesh-list
83141481|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83141483|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141484|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141485|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141486|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83141487|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83141488|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83141489|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141490|NCT04916522|Colchicine|colchicine|mesh-list
83141491|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
83141492|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83141493|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
83141494|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
83141495|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
83141496|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141497|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141498|NCT04407650|Metformin|metformin|mesh-list
83141499|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83141500|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83475311|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
83141501|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141502|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83141503|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141504|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
83141505|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83141506|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83141507|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
83141508|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141509|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83141510|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83141511|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141512|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141513|NCT03220815|Methamphetamine|methamphetamine|mesh-list
83141514|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83141515|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141516|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
83141517|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
83141518|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141519|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
83141520|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141521|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141522|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141523|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83141524|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83141525|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141526|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83141527|NCT04913402|Sufentanil|sufentanil|mesh-list
83141528|NCT04913402|Dsuvia|dsuvia|mesh-list
83141529|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83141530|NCT04913402|Narcotics|narcotics|mesh-ancestor
83141531|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141532|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141533|NCT04913402|Analgesics|analgesics|mesh-ancestor
83141534|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
83141535|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141536|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83141537|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83141538|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
83141539|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
83141540|NCT04912934|Insulin|insulin|mesh-list
83141541|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141542|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141543|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83141544|NCT04915586|Plasminogen|plasminogen|mesh-list
83141545|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83141546|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83141547|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141548|NCT03232125|Ramosetron|ramosetron|mesh-list
83141549|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
83141550|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
83141551|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141552|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141553|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141554|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83141555|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
83141556|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475324|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
83141557|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141558|NCT03224637|Acetaminophen|acetaminophen|mesh-list
83141559|NCT03224637|Ketorolac|ketorolac|mesh-list
83141560|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83141561|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83141562|NCT03224637|Analgesics|analgesics|mesh-ancestor
83141563|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
83141564|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141565|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141566|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
83141567|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83141568|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141569|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83141570|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83141571|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141572|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141573|NCT04912700|Vaccines|vaccines|mesh-list
83141574|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
83141575|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141576|NCT03224871|Aldesleukin|aldesleukin|mesh-list
83141577|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
83141578|NCT03224871|Nivolumab|nivolumab|mesh-list
83141579|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83141580|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141581|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83141582|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141583|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83141584|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83141585|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
83141586|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141587|NCT03220425|Insulin|insulin|mesh-list
83141588|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83141589|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
83141590|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
83141591|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
83141592|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
83141593|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141594|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141595|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83141596|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83141597|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141598|NCT04402346|Pancrelipase|pancrelipase|mesh-list
83141599|NCT04402346|Pancreatin|pancreatin|mesh-list
83141600|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141601|NCT03220191|Palbociclib|palbociclib|mesh-list
83141602|NCT03220191|Rabeprazole|rabeprazole|mesh-list
83141603|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141604|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83141605|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141606|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141607|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83141608|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141609|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83141610|NCT03220113|Thiamine|thiamine|mesh-list
83141611|NCT03220113|Dexamethasone|dexamethasone|mesh-list
83141612|NCT03220113|Lidocaine|lidocaine|mesh-list
83141613|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141614|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
83141615|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
83141616|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141617|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141618|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141619|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
83141620|NCT03220113|Hormones|hormones|mesh-ancestor
83141621|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83141622|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83141623|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141624|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
83141626|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141627|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
83141628|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83141629|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83141630|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83141631|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141632|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141633|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
83141634|NCT03220113|Vitamins|vitamins|mesh-ancestor
83141635|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
83141636|NCT02254525|Ibuprofen|ibuprofen|mesh-list
83141637|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83141638|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83141639|NCT02254525|Analgesics|analgesics|mesh-ancestor
83141640|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
83141641|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141642|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141643|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141644|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83141645|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83141646|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141647|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141648|NCT03231813|Emollients|emollients|mesh-list
83141649|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83141650|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
83141651|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
83141652|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141653|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141654|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141655|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
83141656|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83141657|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141658|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141659|NCT02143531|Haloperidol|haloperidol|mesh-list
83141660|NCT02143531|Ondansetron|ondansetron|mesh-list
83141661|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
83141662|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
83141663|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
83141664|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141665|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141666|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141667|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
83141668|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
83141669|NCT02143531|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83141670|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83141671|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
83141672|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141673|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141674|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83141675|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83141676|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141677|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141678|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83141679|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
83141680|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83141681|NCT04485117|Anesthetics|anesthetics|mesh-list
83141682|NCT04485117|Propofol|propofol|mesh-list
83141683|NCT04485117|Sevoflurane|sevoflurane|mesh-list
83141684|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141685|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141686|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83141687|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83141688|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
83141689|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83141690|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83141691|NCT00803569|Sargramostim|sargramostim|mesh-list
83141692|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
83141693|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141694|NCT02143687|Sevoflurane|sevoflurane|mesh-list
83141695|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83141696|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83141697|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
83141698|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
83141699|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141700|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141701|NCT02143765|Acarbose|acarbose|mesh-list
83141702|NCT02143765|Mitiglinide|mitiglinide|mesh-list
83141703|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83141704|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141705|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141706|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141707|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141708|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
83141709|NCT02148367|Hematinics|hematinics|mesh-ancestor
83141710|NCT00482833|Methotrexate|methotrexate|mesh-list
83141711|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
83141712|NCT00482833|Idarubicin|idarubicin|mesh-list
83141713|NCT00482833|Tretinoin|tretinoin|mesh-list
83141714|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
83141715|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83141716|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
83141717|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83141718|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141719|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83141720|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
83141721|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141722|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141723|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
83141724|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141725|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83141726|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83141727|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
83141728|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83141729|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83141730|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83141731|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83141732|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83141733|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
83141734|NCT02451033|Hormones|hormones|mesh-list
83141735|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83141736|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141737|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
83141738|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83141739|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83141740|NCT04485429|Prednisolone|prednisolone|mesh-list
83141741|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
83141742|NCT04485429|Heparin|heparin|mesh-list
83141743|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83141744|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
83141745|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141746|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
83141747|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
83141748|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141749|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141750|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141751|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
83141752|NCT04485429|Hormones|hormones|mesh-ancestor
83141753|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83141754|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83141755|NCT04485429|Protective Agents|protective agents|mesh-ancestor
83141756|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83141757|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141758|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
83141759|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83141760|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83141761|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141762|NCT00112957|Vaccines|vaccines|mesh-list
83141763|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
83141764|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141765|NCT02140801|Clopidogrel|clopidogrel|mesh-list
83141766|NCT02140801|Ticagrelor|ticagrelor|mesh-list
83141767|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83141768|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83141769|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83141770|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83141771|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
83141772|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141773|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141774|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141775|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83141776|NCT02148601|Vancomycin|vancomycin|mesh-list
83141777|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141778|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
83141779|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
83141780|NCT02141035|Vitamins|vitamins|mesh-ancestor
83141781|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
83141782|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141783|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
83141784|NCT03214653|Propofol|propofol|mesh-list
83141785|NCT03214653|Sevoflurane|sevoflurane|mesh-list
83141786|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83141787|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141788|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141789|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83141790|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
83141791|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
83141792|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83141793|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83141794|NCT02450877|Azacitidine|azacitidine|mesh-list
83141795|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83141796|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
83141797|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141798|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141799|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141800|NCT02141113|Guanfacine|guanfacine|mesh-list
83141801|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83141802|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83141803|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83141804|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83141805|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141806|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141807|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141808|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141809|NCT03213639|Esomeprazole|esomeprazole|mesh-list
83141810|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83141811|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141812|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83141813|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141814|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141815|NCT03231033|Pioglitazone|pioglitazone|mesh-list
83141816|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141817|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141818|NCT02141347|Durvalumab|durvalumab|mesh-list
83141819|NCT02141347|Tremelimumab|tremelimumab|mesh-list
83141820|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83141821|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141822|NCT02254759|Midazolam|midazolam|mesh-list
83141823|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83141824|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83141825|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141826|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141827|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83141828|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83141829|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141830|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83141831|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
83141832|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
83141833|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
83141834|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
83141835|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141836|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141837|NCT03208257|Esmolol|esmolol|mesh-list
83141838|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83141839|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83141840|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83141841|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141842|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141843|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141844|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141845|NCT02141425|Peficitinib|peficitinib|mesh-list
83141846|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479591|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83141847|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141848|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83141849|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
83141850|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141852|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83141853|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83141854|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
83141855|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141856|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141857|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83141858|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83141859|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
83141860|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141861|NCT03208101|Vaccines|vaccines|mesh-list
83141862|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
83141863|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141864|NCT02149225|Poly I-C|poly i-c|mesh-list
83141865|NCT02149225|Molgramostim|molgramostim|mesh-list
83141866|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83141867|NCT02149225|Vaccines|vaccines|mesh-list
83141868|NCT02149225|Sargramostim|sargramostim|mesh-list
83141869|NCT02149225|Poly ICLC|poly iclc|mesh-list
83141870|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
83141871|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141872|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141873|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
83141874|NCT02149225|Laxatives|laxatives|mesh-ancestor
83141875|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141876|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
83141877|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83141878|NCT03208335|Endostatins|endostatins|mesh-list
83141879|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141880|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83141881|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83141882|NCT03208335|Growth Substances|growth substances|mesh-ancestor
83141883|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141884|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83141885|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
83141886|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83141887|NCT03211065|Antibodies|antibodies|mesh-list
83141888|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
83141889|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141890|NCT02149459|Metformin|metformin|mesh-list
83141891|NCT02149459|Biguanides|biguanides|mesh-list
83141892|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83141893|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141894|NCT02376790|Etanercept|etanercept|mesh-list
83141895|NCT02376790|Methotrexate|methotrexate|mesh-list
83141896|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83141897|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
83141898|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83141899|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141900|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83475444|NCT01111331|Warfarin|warfarin|mesh-list
83141901|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
83141902|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141903|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141904|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
83141905|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141906|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83141907|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83141908|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
83141909|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83141910|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83141911|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83141912|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83141913|NCT02376790|Analgesics|analgesics|mesh-ancestor
83141914|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
83141915|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141916|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83141917|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83141918|NCT02141737|Lidocaine|lidocaine|mesh-list
83141919|NCT02141737|Fentanyl|fentanyl|mesh-list
83141920|NCT02141737|Midazolam|midazolam|mesh-list
83141921|NCT02141737|Etomidate|etomidate|mesh-list
83141922|NCT02141737|Rocuronium|rocuronium|mesh-list
83141923|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
83141924|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
83141925|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141926|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141927|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
83141928|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141929|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83141930|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83141931|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83141932|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83141933|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141934|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83141935|NCT02141737|Narcotics|narcotics|mesh-ancestor
83141936|NCT02141737|Analgesics|analgesics|mesh-ancestor
83141937|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83141938|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83141939|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
83141940|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83141941|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83141942|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83141943|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83141944|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
83141945|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
83141946|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141947|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83141948|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83141949|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83141950|NCT02254447|Candesartan|candesartan|mesh-list
83141951|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
83141952|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83141953|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83141954|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83141955|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141956|NCT02376166|Metformin|metformin|mesh-list
83141957|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83141958|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141959|NCT03207165|Dobutamine|dobutamine|mesh-list
83141960|NCT03207165|Milrinone|milrinone|mesh-list
83141961|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
83141962|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83475455|NCT01859819|Rituximab|rituximab|mesh-list
83141963|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
83141964|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
83141965|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141966|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141967|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83141968|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83141969|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83141970|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
83141971|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83141972|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141973|NCT03207165|Protective Agents|protective agents|mesh-ancestor
83141974|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83141975|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
83141976|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83141977|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83141978|NCT02142205|Natalizumab|natalizumab|mesh-list
83141979|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
83141980|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141982|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83141983|NCT03209427|Narcotics|narcotics|mesh-ancestor
83141984|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83141985|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83141986|NCT03209427|Analgesics|analgesics|mesh-ancestor
83141987|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
83141988|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83141989|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
83141990|NCT03544723|Nivolumab|nivolumab|mesh-list
83141991|NCT03544723|Atezolizumab|atezolizumab|mesh-list
83141992|NCT03544723|Durvalumab|durvalumab|mesh-list
83141993|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83141994|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83141995|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83141996|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83141997|NCT03209661|Menthol|menthol|mesh-list
83141998|NCT03209661|Nicotine|nicotine|mesh-list
83141999|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83142000|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
83142001|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142002|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142003|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83142004|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83142005|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
83142006|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142007|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142008|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
83142009|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
83142010|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83142011|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
83142012|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142013|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
83142014|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
83142015|NCT03209115|Calcium|calcium|mesh-list
83142016|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83142017|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142018|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83142019|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83142020|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142021|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
83142022|NCT03209193|Sevoflurane|sevoflurane|mesh-list
83142023|NCT03209193|Desflurane|desflurane|mesh-list
83142024|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83142025|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83142026|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
83142027|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
83142028|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142029|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142030|NCT02142595|Midazolam|midazolam|mesh-list
83142031|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
83142032|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83142033|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142034|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142035|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83142036|NCT02142595|Analgesics|analgesics|mesh-ancestor
83142037|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
83142038|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142039|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83142040|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83142041|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83142042|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
83142043|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142044|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142045|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83142046|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83142047|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83142048|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83142049|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83142050|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
83142051|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
83142052|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
83142053|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
83142054|NCT04898374|Cisplatin|cisplatin|mesh-list
83142055|NCT04898374|Gemcitabine|gemcitabine|mesh-list
83142056|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142057|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83142058|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
83142059|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142060|NCT03207477|Mydriatics|mydriatics|mesh-list
83142061|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
83142062|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142063|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142064|NCT02452515|Fulacimstat|fulacimstat|mesh-list
83142065|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142066|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142067|NCT03206931|Selitrectinib|selitrectinib|mesh-list
83142068|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142069|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142070|NCT02344342|Diuretics|diuretics|mesh-list
83142071|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
83142072|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142073|NCT02452437|Oxycodone|oxycodone|mesh-list
83142074|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83142075|NCT02452437|Narcotics|narcotics|mesh-ancestor
83142076|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83401380|NCT04394897|Analgesics|analgesics|mesh-ancestor
83142077|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142078|NCT02452437|Analgesics|analgesics|mesh-ancestor
83142079|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
83142080|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142081|NCT03208413|Thalidomide|thalidomide|mesh-list
83142082|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142083|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
83142084|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142085|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
83142086|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83142087|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142088|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83142089|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83142090|NCT03208413|Growth Substances|growth substances|mesh-ancestor
83475488|NCT02176031|Hormones|hormones|mesh-ancestor
83142091|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
83142092|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142093|NCT03201159|Pentamidine|pentamidine|mesh-list
83142094|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
83142095|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142096|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83142097|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83142098|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83142099|NCT02149927|Sevoflurane|sevoflurane|mesh-list
83142100|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83142101|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83142102|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
83142103|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
83142104|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142105|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142106|NCT02142751|Meropenem|meropenem|mesh-list
83142107|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
83142108|NCT02142751|Fosfomycin|fosfomycin|mesh-list
83142109|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83142110|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83142111|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142112|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
83142113|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83142114|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142115|NCT02343952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83142116|NCT02343952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142117|NCT02142829|Bupivacaine|bupivacaine|mesh-list
83142118|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
83142119|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
83142120|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142121|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142122|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
83142123|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142124|NCT03200691|Antibodies|antibodies|mesh-list
83142125|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
83142126|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142127|NCT02150161|Lidocaine|lidocaine|mesh-list
83142128|NCT02150161|Fentanyl|fentanyl|mesh-list
83142129|NCT02150161|Ketamine|ketamine|mesh-list
83142130|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
83142131|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
83142132|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142133|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142134|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
83142135|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142136|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83142137|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83142138|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83142139|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83142140|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142141|NCT02150161|Analgesics|analgesics|mesh-ancestor
83142142|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83142143|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83142144|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
83142145|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83142146|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83142147|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142148|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83142149|NCT02150161|Narcotics|narcotics|mesh-ancestor
83142150|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83142151|NCT03200613|Heparin|heparin|mesh-list
83142152|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83142153|NCT03200613|Tinzaparin|tinzaparin|mesh-list
83142154|NCT03200613|Dalteparin|dalteparin|mesh-list
83142155|NCT03200613|Apixaban|apixaban|mesh-list
83142156|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
83142157|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83142158|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83142159|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142160|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83142161|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
83142162|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83142163|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
83142164|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142165|NCT02150317|Sorafenib|sorafenib|mesh-list
83142166|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
83142167|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142168|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142169|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142170|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142171|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83142172|NCT02150317|Estrogens|estrogens|mesh-ancestor
83142173|NCT02150317|Hormones|hormones|mesh-ancestor
83142174|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83142175|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142176|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83142177|NCT02310568|PF-06372865|pf-06372865|mesh-list
83142178|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
83142179|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
83142180|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142181|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142182|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142183|NCT02448069|Argatroban|argatroban|mesh-list
83142184|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
83142185|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83142186|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
83142187|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142188|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142189|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
83142190|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83142191|NCT02449941|Rabeprazole|rabeprazole|mesh-list
83142192|NCT02449941|Pantoprazole|pantoprazole|mesh-list
83142193|NCT02449941|Lansoprazole|lansoprazole|mesh-list
83142194|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
83142195|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83142196|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83142197|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83142198|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142199|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142200|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
83142201|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83142202|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
83142203|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83142204|NCT03199989|Capecitabine|capecitabine|mesh-list
83142205|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
83142206|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83142207|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
83142208|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142209|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142210|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
83142211|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83142212|NCT03195543|Thrombin|thrombin|mesh-list
83142213|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
83142214|NCT03195543|Coagulants|coagulants|mesh-ancestor
83142215|NCT03204669|Trace Elements|trace elements|mesh-list
83142216|NCT03204669|Micronutrients|micronutrients|mesh-list
83142217|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142218|NCT03199677|Apatinib|apatinib|mesh-list
83142219|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142220|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142221|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142222|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142223|NCT02780167|Abrocitinib|abrocitinib|mesh-list
83142224|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142225|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142226|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142227|NCT02447757|Remifentanil|remifentanil|mesh-list
83142228|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83142229|NCT02447757|Narcotics|narcotics|mesh-ancestor
83142230|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142231|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142232|NCT02447757|Analgesics|analgesics|mesh-ancestor
83142233|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
83142234|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142235|NCT02447835|Olanzapine|olanzapine|mesh-list
83142236|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
83142237|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
83142238|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142239|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142240|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83142241|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83142242|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83142243|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142244|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83142245|NCT02447835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83142246|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83142247|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83142248|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142249|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142250|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
83142251|NCT02447679|Tegafur|tegafur|mesh-list
83142252|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83142253|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
83142254|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142255|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142256|NCT03203967|Morphine|morphine|mesh-list
83142257|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83142258|NCT03203967|Narcotics|narcotics|mesh-ancestor
83142259|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142260|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142261|NCT03203967|Analgesics|analgesics|mesh-ancestor
83142262|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
83142263|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142264|NCT03204045|Fentanyl|fentanyl|mesh-list
83142265|NCT03204045|Oxycodone|oxycodone|mesh-list
83142266|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83142267|NCT03204045|Narcotics|narcotics|mesh-ancestor
83142268|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142269|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142270|NCT03204045|Analgesics|analgesics|mesh-ancestor
83142271|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
83142272|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142273|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83142274|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83142275|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
83142276|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
83142277|NCT03199521|Thrombin|thrombin|mesh-list
83142278|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
83142279|NCT03199521|Coagulants|coagulants|mesh-ancestor
83142280|NCT03195153|Allopurinol|allopurinol|mesh-list
83142281|NCT03195153|Atorvastatin|atorvastatin|mesh-list
83142282|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83142283|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83142284|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
83142285|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142286|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83142287|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83475510|NCT01316341|Empagliflozin|empagliflozin|mesh-list
83142288|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142289|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
83142290|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142291|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83142292|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
83142293|NCT03195153|Protective Agents|protective agents|mesh-ancestor
83142294|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142295|NCT03195309|Fentanyl|fentanyl|mesh-list
83142296|NCT03195309|Ropivacaine|ropivacaine|mesh-list
83142297|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
83142298|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
83142299|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142300|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142301|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
83142302|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142303|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83142304|NCT03195309|Narcotics|narcotics|mesh-ancestor
83142305|NCT03195309|Analgesics|analgesics|mesh-ancestor
83142306|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83142307|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83142308|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
83142310|NCT03198819|Cefoxitin|cefoxitin|mesh-list
83142311|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83142312|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142313|NCT02447601|Simvastatin|simvastatin|mesh-list
83142314|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83142315|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83142316|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
83142317|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142318|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83142319|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83142320|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142321|NCT03118713|Metformin|metformin|mesh-list
83142322|NCT03118713|Glimepiride|glimepiride|mesh-list
83142323|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
83142324|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83142325|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142326|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83142327|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142328|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
83142329|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83142330|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142331|NCT03198585|Empagliflozin|empagliflozin|mesh-list
83142332|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83142333|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142334|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83142335|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142336|NCT02447289|Midazolam|midazolam|mesh-list
83142337|NCT02447289|Ketamine|ketamine|mesh-list
83142338|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83142339|NCT02447289|Analgesics|analgesics|mesh-ancestor
83142340|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
83142341|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142342|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142343|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83142344|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83142345|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
83142346|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
83142347|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142348|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83142349|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83142350|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142351|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142352|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83142353|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83142354|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83142355|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83142356|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83142357|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
83142358|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
83142359|NCT02447211|Doxepin|doxepin|mesh-list
83142360|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83142361|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83142362|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142363|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142364|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83142365|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
83142366|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83142367|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
83142368|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
83142369|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142370|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142371|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
83142372|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142373|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
83142374|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142375|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142376|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83142377|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
83142378|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142379|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142380|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83142381|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
83142382|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
83142383|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83142384|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
83142385|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142386|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142387|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
83142388|NCT03203031|Anesthetics|anesthetics|mesh-list
83142389|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142390|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142391|NCT03118479|Anastrozole|anastrozole|mesh-list
83142392|NCT03118479|Testosterone|testosterone|mesh-list
83142393|NCT03118479|Androgens|androgens|mesh-ancestor
83142394|NCT03118479|Hormones|hormones|mesh-ancestor
83142395|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83142396|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142397|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83142398|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142399|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83142400|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83142401|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142402|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142403|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83142404|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
83142405|NCT03197961|Tenofovir|tenofovir|mesh-list
83142406|NCT03197961|Emtricitabine|emtricitabine|mesh-list
83142407|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83142408|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
83142409|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
83142410|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142411|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83142412|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83142413|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142414|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142415|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83142416|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83142417|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83142418|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83142419|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83142420|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
83142421|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83142422|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142423|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83142424|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83142425|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83142426|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83142427|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142428|NCT03202875|Insulin|insulin|mesh-list
83142429|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83142430|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
83142431|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
83142432|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83142433|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83142434|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142435|NCT03197571|Leucovorin|leucovorin|mesh-list
83142436|NCT03197571|Paclitaxel|paclitaxel|mesh-list
83142437|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
83142438|NCT03197571|Bevacizumab|bevacizumab|mesh-list
83142439|NCT03197571|Fluorouracil|fluorouracil|mesh-list
83142440|NCT03197571|Capecitabine|capecitabine|mesh-list
83142441|NCT03197571|Fulvestrant|fulvestrant|mesh-list
83142442|NCT03197571|Avelumab|avelumab|mesh-list
83142443|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83142444|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142445|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83142446|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83142447|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83142448|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142449|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142450|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
83142451|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142452|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142453|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83142454|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
83142455|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83401688|NCT05792111|Anesthetics|anesthetics|mesh-ancestor
83142456|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83142457|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83142458|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83142459|NCT03197571|Growth Substances|growth substances|mesh-ancestor
83142460|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
83142461|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
83142462|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83142464|NCT03197571|Protective Agents|protective agents|mesh-ancestor
83142465|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
83142466|NCT03197571|Vitamins|vitamins|mesh-ancestor
83142467|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
83142468|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83142469|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83142470|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83142471|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
83142472|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83142473|NCT02446977|Riboflavin|riboflavin|mesh-list
83142474|NCT02446977|Vitamins|vitamins|mesh-ancestor
83142475|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
83142476|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142477|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
83142478|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83142479|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
83142480|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
83142481|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
83142482|NCT02447055|Melphalan|melphalan|mesh-list
83142483|NCT02447055|Fludarabine|fludarabine|mesh-list
83142484|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
83142485|NCT02447055|Tacrolimus|tacrolimus|mesh-list
83142486|NCT02447055|Lenograstim|lenograstim|mesh-list
83142487|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142488|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
83142489|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142490|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142491|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83142492|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
83142493|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142494|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142495|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83142496|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83142497|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
83142498|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83142499|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83142500|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142501|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83142502|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83142503|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
83142504|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83142505|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142506|NCT03202563|Metformin|metformin|mesh-list
83142507|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
83142508|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83142509|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142510|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83142511|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142512|NCT03197493|Levodopa|levodopa|mesh-list
83142513|NCT03197493|Carbidopa|carbidopa|mesh-list
83142514|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83142515|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83142516|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83142517|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
83142518|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475591|NCT01317901|Rituximab|rituximab|mesh-list
83142519|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142520|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142521|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83142522|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142523|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83142524|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
83142525|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
83142526|NCT02450175|Everolimus|everolimus|mesh-list
83142527|NCT02450175|Letrozole|letrozole|mesh-list
83142528|NCT02450175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83142529|NCT02450175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142530|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142531|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142533|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
83142534|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142535|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142536|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83142537|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83142538|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83142539|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
83142540|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83142541|NCT03202719|Vaccines|vaccines|mesh-list
83142542|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
83142543|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142544|NCT03202407|Calcium|calcium|mesh-list
83142545|NCT03202407|Sevelamer|sevelamer|mesh-list
83142546|NCT03202407|Calcium acetate|calcium acetate|mesh-list
83142547|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83142548|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142549|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
83142550|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
83142551|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142552|NCT02261077|Scopolamine|scopolamine|mesh-list
83142553|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83142554|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83142555|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
83142556|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
83142557|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142558|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142559|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83142560|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
83142561|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83142562|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
83142563|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142564|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142565|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83142566|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
83142567|NCT03196869|Cisplatin|cisplatin|mesh-list
83142568|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142569|NCT02150473|Adalimumab|adalimumab|mesh-list
83142570|NCT02150473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83142571|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83142572|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142573|NCT02446431|Sirolimus|sirolimus|mesh-list
83142574|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
83142575|NCT02446431|Bevacizumab|bevacizumab|mesh-list
83142576|NCT02446431|Temsirolimus|temsirolimus|mesh-list
83142577|NCT02446431|MTOR Inhibitors|mtor inhibitors|mesh-list
83142578|NCT02446431|Valproic Acid|valproic acid|mesh-list
83142579|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142580|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
83142581|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142582|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142583|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83142584|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
83142585|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142586|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142587|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83142588|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83142589|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83142590|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83142591|NCT02446431|Growth Substances|growth substances|mesh-ancestor
83142592|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
83142593|NCT02446431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142594|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142595|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83142596|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142597|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83142598|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
83142599|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
83142600|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
83142601|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142602|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
83142603|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83142604|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142605|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83142606|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
83142607|NCT02446353|Megestrol|megestrol|mesh-list
83142608|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83142609|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142610|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
83142611|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83142612|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142613|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83142614|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83142615|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83142616|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
83142617|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83142618|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83142619|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83142620|NCT02144389|Praziquantel|praziquantel|mesh-list
83142621|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
83142622|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83142623|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142624|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
83142625|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83142626|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
83142627|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142628|NCT03197103|Expectorants|expectorants|mesh-ancestor
83142629|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
83142630|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83142631|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
83142632|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142633|NCT03197103|Protective Agents|protective agents|mesh-ancestor
83142634|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142635|NCT03197103|Antidotes|antidotes|mesh-ancestor
83142636|NCT02144623|Valproic Acid|valproic acid|mesh-list
83142637|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
83142638|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142639|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142640|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
83142641|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142642|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142643|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
83142644|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83142645|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142646|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83142647|NCT03201861|Paclitaxel|paclitaxel|mesh-list
83142648|NCT03201861|Docetaxel|docetaxel|mesh-list
83142649|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83142650|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83142651|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142652|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
83142653|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
83142654|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
83142655|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142656|NCT03194685|FF-10101|ff-10101|mesh-list
83142657|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142658|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142659|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142660|NCT00105079|Ritonavir|ritonavir|mesh-list
83142661|NCT00105079|Lopinavir|lopinavir|mesh-list
83142662|NCT00105079|Saquinavir|saquinavir|mesh-list
83142663|NCT00105079|Tenofovir|tenofovir|mesh-list
83142664|NCT00105079|Emtricitabine|emtricitabine|mesh-list
83142665|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83142666|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83142667|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83142668|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
83142669|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142670|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142671|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83142672|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83142673|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
83142674|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142675|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83142676|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83142677|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83142678|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83142679|NCT03196401|Durvalumab|durvalumab|mesh-list
83142680|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83142681|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142682|NCT02150707|Liraglutide|liraglutide|mesh-list
83142683|NCT02150707|Exenatide|exenatide|mesh-list
83142684|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83142685|NCT02150707|Glucagon|glucagon|mesh-list
83142686|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83142687|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83142688|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142689|NCT02150707|Incretins|incretins|mesh-ancestor
83142690|NCT02150707|Hormones|hormones|mesh-ancestor
83142691|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83142692|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83142693|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83142694|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
83475633|NCT00258830|Vaccines|vaccines|mesh-list
83142695|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142696|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142697|NCT03196479|Ketamine|ketamine|mesh-list
83142698|NCT03196479|Propofol|propofol|mesh-list
83142699|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83142700|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142701|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142702|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83142703|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
83142704|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
83142705|NCT03196479|Analgesics|analgesics|mesh-ancestor
83142706|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
83142707|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142708|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83142709|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83142710|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83142711|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142712|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142713|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
83142714|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
83142715|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83142716|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142717|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142718|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
83142719|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83142720|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142721|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142722|NCT02151721|Gefitinib|gefitinib|mesh-list
83142723|NCT02151721|Vorinostat|vorinostat|mesh-list
83142724|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142725|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142726|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142727|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142728|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83142729|NCT03201393|Acetaminophen|acetaminophen|mesh-list
83142730|NCT03201393|Naltrexone|naltrexone|mesh-list
83142731|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83142732|NCT03201393|Analgesics|analgesics|mesh-ancestor
83142733|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
83142734|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142735|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142736|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
83142737|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83142738|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83142739|NCT03192969|Abatacept|abatacept|mesh-list
83142740|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
83142741|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83142742|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142743|NCT03192969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83142744|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142745|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142746|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
83142747|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142748|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142749|NCT03192969|Hormones|hormones|mesh-ancestor
83142750|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83142751|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
83142752|NCT03194139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83142753|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
83142754|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142755|NCT03194139|Protective Agents|protective agents|mesh-ancestor
83142756|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142757|NCT03118167|Antioxidants|antioxidants|mesh-list
83142758|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142759|NCT03118167|Protective Agents|protective agents|mesh-ancestor
83142760|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142762|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83142763|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
83142764|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142765|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142766|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
83142767|NCT02444949|Cisplatin|cisplatin|mesh-list
83142768|NCT02444949|Endostar protein|endostar protein|mesh-list
83142769|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142770|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83142771|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83142772|NCT02444949|Growth Substances|growth substances|mesh-ancestor
83142773|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142774|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
83142775|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83142776|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83142777|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83142778|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
83142779|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142780|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83142781|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83142782|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142783|NCT03192657|Basiliximab|basiliximab|mesh-list
83142784|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83142785|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142786|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
83142787|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142788|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142789|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142790|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
83142791|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83142792|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
83142793|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142794|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
83142795|NCT02444169|Protective Agents|protective agents|mesh-ancestor
83142796|NCT03194061|Cisplatin|cisplatin|mesh-list
83142797|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142798|NCT02343406|Temozolomide|temozolomide|mesh-list
83142799|NCT02343406|Lomustine|lomustine|mesh-list
83142800|NCT02343406|ABT-414|abt-414|mesh-list
83142801|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83142802|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
83142803|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142804|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142805|NCT02343406|Immunoconjugates|immunoconjugates|mesh-ancestor
83142806|NCT02343406|Immunologic Factors|immunologic factors|mesh-ancestor
83142807|NCT02343406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142808|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
83142809|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142810|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
83142811|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142812|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142813|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83142814|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
83142815|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142816|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142817|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83142818|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
83142819|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83142820|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
83142821|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142822|NCT03193749|Amiodarone|amiodarone|mesh-list
83142823|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83142824|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
83142825|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83142826|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83142827|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142828|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83142829|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83142830|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83142831|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142832|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83142833|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83142834|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83142835|NCT02444013|Folic Acid|folic acid|mesh-list
83142836|NCT02444013|Uric Acid|uric acid|mesh-list
83142837|NCT02444013|Hematinics|hematinics|mesh-ancestor
83142838|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
83142839|NCT02444013|Vitamins|vitamins|mesh-ancestor
83142840|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
83142841|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142842|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
83142843|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142844|NCT02444013|Protective Agents|protective agents|mesh-ancestor
83142845|NCT02444637|Rivastigmine|rivastigmine|mesh-list
83142846|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83142847|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142848|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142849|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
83142850|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142851|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142852|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83142853|NCT02444637|Protective Agents|protective agents|mesh-ancestor
83142854|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
83142855|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83142856|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
83142857|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83142858|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142859|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83142860|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83142861|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83142862|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83142863|NCT02710071|Nebivolol|nebivolol|mesh-list
83142864|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83142865|NCT02710071|Diuretics|diuretics|mesh-ancestor
83142866|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
83142867|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142868|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83142869|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83142870|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142871|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
83142872|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83142873|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83142874|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83142875|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
83142876|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142878|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83142879|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
83142880|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
83142881|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142882|NCT02439489|Carboplatin|carboplatin|mesh-list
83142883|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142884|NCT02444481|Polymyxins|polymyxins|mesh-list
83142885|NCT02444481|Neomycin|neomycin|mesh-list
83142886|NCT02444481|Nystatin|nystatin|mesh-list
83142887|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83142888|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142889|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83142890|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142891|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142892|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
83142893|NCT02444481|Ionophores|ionophores|mesh-ancestor
83142894|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83142895|NCT02444559|Clonidine|clonidine|mesh-list
83142896|NCT02444559|Ropivacaine|ropivacaine|mesh-list
83142897|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
83142898|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
83142899|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83142900|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142901|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
83142902|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142903|NCT02444559|Analgesics|analgesics|mesh-ancestor
83142904|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83142905|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
83142906|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
83142907|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83142908|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83142909|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83142910|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
83142911|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83142912|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142913|NCT03190239|Pemetrexed|pemetrexed|mesh-list
83142914|NCT03190239|Apatinib|apatinib|mesh-list
83142915|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142916|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142917|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142918|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83142919|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83142920|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142921|NCT02439411|Trametinib|trametinib|mesh-list
83142922|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142923|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83142924|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142925|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142926|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
83142927|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142928|NCT02443311|Betamethasone|betamethasone|mesh-list
83142929|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
83142930|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83142931|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
83142932|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
83142933|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83142934|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83142935|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
83142936|NCT02443311|Hormones|hormones|mesh-ancestor
83142937|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83142938|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142939|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83142940|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
83142941|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83142942|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83142943|NCT02443311|Analgesics|analgesics|mesh-ancestor
83142944|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
83142945|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142946|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142947|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83142948|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142949|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
83142950|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83142951|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142952|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142953|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
83142954|NCT02373202|Mizoribine|mizoribine|mesh-list
83142955|NCT02373202|Bucillamine|bucillamine|mesh-list
83142956|NCT02373202|Tacrolimus|tacrolimus|mesh-list
83142957|NCT02373202|Leflunomide|leflunomide|mesh-list
83142958|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142959|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
83142960|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83142961|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83142962|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83142963|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142964|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83142965|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83142966|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83142967|NCT02373202|Analgesics|analgesics|mesh-ancestor
83142968|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
83142969|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83142970|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83142971|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83142972|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83142973|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
83142974|NCT02373202|Protective Agents|protective agents|mesh-ancestor
83142975|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83142976|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83142977|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142978|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
83142979|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83142980|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83142981|NCT03192111|Entinostat|entinostat|mesh-list
83142982|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142983|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83142984|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475713|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83142985|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142986|NCT02622074|Paclitaxel|paclitaxel|mesh-list
83142987|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83142988|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
83142989|NCT02622074|Carboplatin|carboplatin|mesh-list
83142990|NCT02622074|Doxorubicin|doxorubicin|mesh-list
83142991|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
83142992|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83142993|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83142994|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
83142995|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
83142996|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
83142997|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83142998|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83142999|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
83143000|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143001|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143002|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83143003|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
83143004|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83143005|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83143006|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83143007|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83143008|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143009|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143010|NCT02622074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83143011|NCT02438709|Etoricoxib|etoricoxib|mesh-list
83143012|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83143013|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83143014|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143015|NCT02438709|Analgesics|analgesics|mesh-ancestor
83143016|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
83143017|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143018|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143019|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143020|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143021|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83143022|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143023|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143024|NCT05438758|Ketamine|ketamine|mesh-list
83143026|NCT05438758|Analgesics|analgesics|mesh-ancestor
83143027|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
83143028|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143029|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143030|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83143031|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83143032|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
83143033|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
83143034|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143035|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83143036|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83143037|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143038|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143039|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
83143040|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143041|NCT02442921|Colchicine|colchicine|mesh-list
83143042|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
83143043|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143044|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83143045|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83143046|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83143047|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143048|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143049|NCT02438865|Epirubicin|epirubicin|mesh-list
83143050|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83143051|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143052|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83143053|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83143054|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143055|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143056|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
83143057|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
83143058|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143059|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
83143060|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
83143061|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
83143062|NCT02342704|Natalizumab|natalizumab|mesh-list
83143063|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83143064|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
83143065|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143066|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83143067|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143068|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143069|NCT02442453|Turmeric extract|turmeric extract|mesh-list
83143070|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
83143071|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143072|NCT02442453|Protective Agents|protective agents|mesh-ancestor
83143073|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143074|NCT02438397|Insulin|insulin|mesh-list
83143075|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83143076|NCT02438397|Metformin|metformin|mesh-list
83143077|NCT02438397|Acarbose|acarbose|mesh-list
83143078|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143079|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143080|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83143081|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143082|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143083|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
83143084|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83143085|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83143086|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83143087|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83143088|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143089|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
83143090|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143091|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143092|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83143093|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143094|NCT02442531|Docetaxel|docetaxel|mesh-list
83143095|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143096|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
83143097|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
83143098|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83143099|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143100|NCT03193203|Etanercept|etanercept|mesh-list
83143101|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83143102|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143103|NCT03193203|Analgesics|analgesics|mesh-ancestor
83143104|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
83143105|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143106|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143107|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143108|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143109|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83143110|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143111|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
83143112|NCT02442063|Paclitaxel|paclitaxel|mesh-list
83475754|NCT00262730|Temozolomide|temozolomide|mesh-list
83143113|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83143114|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83143115|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143116|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
83143117|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
83143118|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
83143119|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143120|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83143121|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83143122|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83143123|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
83143124|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143125|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143126|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83143127|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
83143128|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83143129|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
83143130|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83143131|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479592|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83143132|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143133|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83143134|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143136|NCT03054662|Coagulants|coagulants|mesh-ancestor
83143137|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
83143138|NCT04922996|Calcium|calcium|mesh-list
83143139|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83143140|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143141|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
83143142|NCT04922996|Coagulants|coagulants|mesh-ancestor
83143143|NCT04913480|Durvalumab|durvalumab|mesh-list
83143144|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143145|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143146|NCT02441907|Aflibercept|aflibercept|mesh-list
83143147|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83143148|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83143149|NCT02441907|Growth Substances|growth substances|mesh-ancestor
83143150|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143151|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
83143152|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143153|NCT02437461|Triamcinolone|triamcinolone|mesh-list
83143154|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83143155|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83143156|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83143157|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143158|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
83143159|NCT02437461|Hormones|hormones|mesh-ancestor
83143160|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143161|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143162|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143163|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
83143164|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143165|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143166|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
83143167|NCT04910594|Hematinics|hematinics|mesh-ancestor
83143168|NCT02441673|Ephedrine|ephedrine|mesh-list
83143169|NCT02441673|Meperidine|meperidine|mesh-list
83143170|NCT02441673|Tramadol|tramadol|mesh-list
83143171|NCT02441673|Nefopam|nefopam|mesh-list
83143172|NCT02441673|Metoclopramide|metoclopramide|mesh-list
83143173|NCT02441673|Ranitidine|ranitidine|mesh-list
83143174|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83143175|NCT02441673|Oxytocin|oxytocin|mesh-list
83143176|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
83143177|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83143178|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143179|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83143180|NCT02441673|Narcotics|narcotics|mesh-ancestor
83143181|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143182|NCT02441673|Analgesics|analgesics|mesh-ancestor
83143183|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
83143184|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143185|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
83143186|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
83143187|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83143188|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83143189|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83143190|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
83143191|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143192|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143193|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83143194|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
83143195|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83143196|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
83143197|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83143198|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83143199|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
83143200|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
83143201|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83143202|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143203|NCT04910126|Doxorubicin|doxorubicin|mesh-list
83143204|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83143205|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83143206|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143207|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83143208|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83143209|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143210|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143212|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83143213|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83143214|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143215|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
83143216|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
83143217|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
83143218|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143219|NCT04922450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143220|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
83143221|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
83143222|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143223|NCT04903808|Protective Agents|protective agents|mesh-ancestor
83143224|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143225|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83143226|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143227|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83143228|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143229|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
83143230|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
83143231|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143232|NCT02436993|Paclitaxel|paclitaxel|mesh-list
83143233|NCT02436993|Bevacizumab|bevacizumab|mesh-list
83143234|NCT02436993|Carboplatin|carboplatin|mesh-list
83143235|NCT02436993|Trastuzumab|trastuzumab|mesh-list
83143236|NCT02436993|Pertuzumab|pertuzumab|mesh-list
83143237|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83143238|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143239|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83143240|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83143241|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83143242|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143243|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143244|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83143245|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83143246|NCT02436993|Growth Substances|growth substances|mesh-ancestor
83143247|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143248|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
83143249|NCT04893980|Aldesleukin|aldesleukin|mesh-list
83143250|NCT04893980|Interleukin-2|interleukin-2|mesh-list
83143251|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143252|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143253|NCT04893980|Analgesics|analgesics|mesh-ancestor
83143254|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
83143255|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143256|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143257|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83143258|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83143259|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
83143260|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143261|NCT04149470|Omeprazole|omeprazole|mesh-list
83143262|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83143263|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83143264|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83143265|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143266|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143267|NCT04902638|Dexamethasone|dexamethasone|mesh-list
83143268|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143269|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
83143270|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
83143271|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143272|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143273|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83143274|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
83143275|NCT04902638|Hormones|hormones|mesh-ancestor
83143276|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143277|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83143278|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143279|NCT02617628|Naltrexone|naltrexone|mesh-list
83143280|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83143281|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83143282|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143283|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
83479593|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
83143284|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143286|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
83143287|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
83143288|NCT03053414|Vitamins|vitamins|mesh-ancestor
83143289|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
83143290|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143291|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83143292|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83143293|NCT04892732|Budesonide|budesonide|mesh-list
83143294|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
83143295|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143296|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83143297|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
83143298|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143299|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143300|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83143301|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
83143302|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
83143303|NCT04892732|Hormones|hormones|mesh-ancestor
83143304|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143305|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83143306|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83143307|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83143308|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
83143309|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143310|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143311|NCT02308540|Vaccines|vaccines|mesh-list
83143312|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83143313|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
83143314|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143315|NCT02308228|Metformin|metformin|mesh-list
83143316|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143317|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143318|NCT03051932|Acetaminophen|acetaminophen|mesh-list
83143319|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143320|NCT03051932|Analgesics|analgesics|mesh-ancestor
83143321|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
83143322|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143323|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143324|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
83143325|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
83143327|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
83143328|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143329|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143330|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143331|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83143332|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83143333|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143334|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143335|NCT04908566|Folfirinox|folfirinox|mesh-list
83143336|NCT04908566|Antibodies|antibodies|mesh-list
83143337|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
83143338|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
83143339|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143340|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143341|NCT04892654|Dolutegravir|dolutegravir|mesh-list
83143342|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83143343|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83143344|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143345|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143346|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83143347|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83143348|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
83143349|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143350|NCT04899674|Bupropion|bupropion|mesh-list
83143351|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83143352|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
83143353|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143354|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83143355|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83143356|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83143357|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143358|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
83143359|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143360|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143361|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83143362|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83143363|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143364|NCT04907708|Metformin|metformin|mesh-list
83143365|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143366|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143367|NCT04890626|Tenofovir|tenofovir|mesh-list
83143368|NCT04890626|Emtricitabine|emtricitabine|mesh-list
83143369|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83143370|NCT04890626|Dexamethasone|dexamethasone|mesh-list
83143371|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
83143372|NCT04890626|BB 1101|bb 1101|mesh-list
83143373|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143374|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
83143375|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
83143376|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143377|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143378|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83143379|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
83143380|NCT04890626|Hormones|hormones|mesh-ancestor
83143381|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143382|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83143383|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143384|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
83143385|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475784|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
83143386|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143387|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
83143388|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143389|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83143390|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83143391|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83143392|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83143393|NCT04907864|Ibuprofen|ibuprofen|mesh-list
83143394|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83143395|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143396|NCT04907864|Analgesics|analgesics|mesh-ancestor
83143397|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
83143398|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143399|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143400|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143401|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143402|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83143403|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143404|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143405|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83143406|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83143407|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143408|NCT04907474|Phenylephrine|phenylephrine|mesh-list
83143409|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
83143410|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83143411|NCT04907474|Tropicamide|tropicamide|mesh-list
83143412|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83143413|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83143414|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
83143415|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
83143416|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143417|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143418|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
83143419|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83143420|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
83143421|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
83143422|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83143423|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83143424|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83143425|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
83143426|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143427|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143428|NCT04907474|Protective Agents|protective agents|mesh-ancestor
83143429|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83143430|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83143431|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
83143432|NCT04899050|Cannabidiol|cannabidiol|mesh-list
83143433|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
83143434|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
83143435|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83143436|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143437|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
83143438|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
83143439|NCT04890392|Tislelizumab|tislelizumab|mesh-list
83143440|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83143441|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143442|NCT04890392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143443|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143444|NCT04900532|Tocotrienols|tocotrienols|mesh-list
83143445|NCT04900532|Vitamin E|vitamin e|mesh-list
83143446|NCT04900532|Tocopherols|tocopherols|mesh-list
83143447|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
83143448|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143449|NCT04900532|Protective Agents|protective agents|mesh-ancestor
83143450|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143451|NCT04900532|Vitamins|vitamins|mesh-ancestor
83143452|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
83143453|NCT02616614|Clindamycin|clindamycin|mesh-list
83143454|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
83143455|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
83143456|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83143457|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83143458|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143459|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83143460|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143461|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143462|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
83143463|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
83143464|NCT04906772|Ketamine|ketamine|mesh-list
83143465|NCT04906772|Propofol|propofol|mesh-list
83143466|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83143467|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143468|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143469|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143470|NCT04906772|Analgesics|analgesics|mesh-ancestor
83143471|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
83143472|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143473|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83143474|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83143475|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83143476|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
83143477|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143478|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143479|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83143480|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
83143482|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83143483|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83143484|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83143485|NCT04404140|Docetaxel|docetaxel|mesh-list
83143486|NCT04404140|Atezolizumab|atezolizumab|mesh-list
83143487|NCT04404140|Ipatasertib|ipatasertib|mesh-list
83143488|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143489|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83143490|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83143491|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83143492|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143493|NCT04404140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83143494|NCT04404140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143495|NCT04404140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83143496|NCT04404140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143497|NCT04898504|Floxuridine|floxuridine|mesh-list
83143498|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83143499|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
83143500|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143501|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143502|NCT04890470|Vasopressins|vasopressins|mesh-list
83143503|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
83143504|NCT04890470|Oxytocin|oxytocin|mesh-list
83143505|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
83143506|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83143507|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143508|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
83143509|NCT04890470|Coagulants|coagulants|mesh-ancestor
83143510|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83143511|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83143512|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
83143513|NCT04889768|Antibodies|antibodies|mesh-list
83143514|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
83143515|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143516|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
83143517|NCT04898270|Flupenthixol|flupenthixol|mesh-list
83143518|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83143519|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83143520|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143521|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143522|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143523|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83143524|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
83143525|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83475795|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
83143526|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143527|NCT04897958|Leuprolide|leuprolide|mesh-list
83143528|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83143529|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
83143530|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83143531|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143532|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83143533|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143534|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
83143535|NCT04906304|Cyclosporine|cyclosporine|mesh-list
83143536|NCT04906304|Everolimus|everolimus|mesh-list
83143537|NCT04906304|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83143538|NCT04906304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83143539|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143540|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143541|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143542|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
83143543|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143544|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143545|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83143546|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83143547|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
83143548|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83143549|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143550|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
83143551|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
83143552|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143553|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83143554|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83143555|NCT03051698|Metronidazole|metronidazole|mesh-list
83143556|NCT03051698|Vancomycin|vancomycin|mesh-list
83143557|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
83143558|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83143559|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143560|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83143561|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83143562|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83143563|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83143564|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143565|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143566|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143567|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83143568|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83143569|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83143570|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143571|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
83143572|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143573|NCT04896164|Curcumin|curcumin|mesh-list
83143574|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83143575|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143576|NCT04896164|Analgesics|analgesics|mesh-ancestor
83143577|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
83143578|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143579|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143580|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143581|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143582|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143583|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143584|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143585|NCT04887818|Lidocaine|lidocaine|mesh-list
83143586|NCT04887818|Diltiazem|diltiazem|mesh-list
83143587|NCT04887818|Nifedipine|nifedipine|mesh-list
83143588|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
83143589|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
83143590|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143591|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143592|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
83143593|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143594|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83143595|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83143596|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83143597|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83143598|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143599|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83143600|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83143601|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
83143602|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
83143603|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83143604|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83143605|NCT04883996|Pilocarpine|pilocarpine|mesh-list
83143607|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
83143608|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143609|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143610|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83143611|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83143612|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
83143613|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143614|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143615|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
83143616|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83143617|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
83143618|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83143619|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143620|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
83143621|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
83143622|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83143623|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
83143624|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143625|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
83143626|NCT04884464|Protective Agents|protective agents|mesh-ancestor
83143627|NCT05028608|Carbamazepine|carbamazepine|mesh-list
83143628|NCT05028608|Midazolam|midazolam|mesh-list
83143629|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83143630|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83143631|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143632|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143633|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83143634|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83143635|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143636|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83143637|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
83143638|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
83143639|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
83143640|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
83143641|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143642|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143643|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
83143644|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
83143645|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143646|NCT05028608|Analgesics|analgesics|mesh-ancestor
83143647|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
83143648|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143649|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83143650|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83143651|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83143652|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83143653|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
83143654|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
83143655|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83143656|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83143657|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143658|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143659|NCT04882826|Urological Agents|urological agents|mesh-ancestor
83143660|NCT04309916|Esomeprazole|esomeprazole|mesh-list
83143661|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83143662|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83143663|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83143664|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143665|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143666|NCT01596062|Cyclosporine|cyclosporine|mesh-list
83143667|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
83143668|NCT01596062|Everolimus|everolimus|mesh-list
83143669|NCT01596062|Cyclosporins|cyclosporins|mesh-list
83143670|NCT01596062|Basiliximab|basiliximab|mesh-list
83143671|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143672|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143673|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143674|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
83143675|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143676|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
83143677|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143678|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
83143679|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143680|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83143681|NCT01596062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83143682|NCT01596062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83143683|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143684|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83143685|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83143686|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
83143687|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83143688|NCT02614898|Eculizumab|eculizumab|mesh-list
83143689|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83143690|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143691|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
83143692|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143693|NCT02145091|Psilocybin|psilocybin|mesh-list
83143694|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83143695|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
83143696|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143697|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143698|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83143699|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
83143700|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143701|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143702|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83143703|NCT03352934|Avelumab|avelumab|mesh-list
83143704|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143705|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143706|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
83143707|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
83143708|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143709|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143710|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83143711|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
83143712|NCT04881110|Liraglutide|liraglutide|mesh-list
83143713|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143714|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143715|NCT04881110|Incretins|incretins|mesh-ancestor
83143716|NCT04881110|Hormones|hormones|mesh-ancestor
83143717|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143718|NCT02152423|Enoxaparin|enoxaparin|mesh-list
83143719|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
83143720|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83143721|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83143722|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143723|NCT02145559|Metformin|metformin|mesh-list
83143724|NCT02145559|Sirolimus|sirolimus|mesh-list
83143725|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143726|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143727|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83143728|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143729|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83143730|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143731|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
83143732|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143733|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
83143734|NCT02145637|Afatinib|afatinib|mesh-list
83143735|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143736|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83143737|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143738|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143740|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83143741|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
83143742|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143743|NCT03154580|Expectorants|expectorants|mesh-ancestor
83143744|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
83143745|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83143746|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
83143747|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143748|NCT03154580|Protective Agents|protective agents|mesh-ancestor
83143749|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143750|NCT03154580|Antidotes|antidotes|mesh-ancestor
83143751|NCT02145715|Thalidomide|thalidomide|mesh-list
83143752|NCT02145715|Dexamethasone|dexamethasone|mesh-list
83143753|NCT02145715|Bortezomib|bortezomib|mesh-list
83143754|NCT02145715|Panobinostat|panobinostat|mesh-list
83143755|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143756|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
83143757|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
83143758|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143759|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143760|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83143761|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
83143762|NCT02145715|Hormones|hormones|mesh-ancestor
83143763|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143764|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83143765|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143766|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143767|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
83143768|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
83143769|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83143770|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143771|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83143772|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83143773|NCT02145715|Growth Substances|growth substances|mesh-ancestor
83143774|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
83143775|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83143776|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143777|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143778|NCT04871750|Caseins|caseins|mesh-list
83143779|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
83143780|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
83143781|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143782|NCT02152579|Isosorbide|isosorbide|mesh-list
83143783|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83143784|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83143785|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83143786|NCT02152579|Diuretics|diuretics|mesh-ancestor
83143787|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
83143788|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143789|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
83143790|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83143791|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143792|NCT02155777|Norinyl|norinyl|mesh-list
83143793|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83143794|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83143795|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83143796|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
83143797|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83143798|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143799|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83143800|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83143801|NCT02145949|Tryptophan|tryptophan|mesh-list
83143802|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83143803|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
83143804|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143805|NCT00806390|Metoprolol|metoprolol|mesh-list
83143806|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83143807|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83143808|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
83143809|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
83143810|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143811|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143812|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83143813|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83143814|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83143815|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
83143816|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143817|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143818|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
83143819|NCT00566618|Dasatinib|dasatinib|mesh-list
83143820|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143821|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83143822|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143823|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143824|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83143825|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143826|NCT02769481|Glimepiride|glimepiride|mesh-list
83143827|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
83143828|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83143829|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143830|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143831|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83143832|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
83143833|NCT04877210|Insulin|insulin|mesh-list
83143834|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83143835|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143836|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143837|NCT02152969|Amlodipine|amlodipine|mesh-list
83143838|NCT02152969|Telmisartan|telmisartan|mesh-list
83143839|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
83143840|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83143841|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83143842|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83143843|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143844|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83143845|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143846|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
83143847|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83143848|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83143849|NCT02152969|Diuretics|diuretics|mesh-ancestor
83143850|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
83143851|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83143852|NCT04879004|Ropivacaine|ropivacaine|mesh-list
83143853|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
83143855|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143856|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143857|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
83143858|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143859|NCT02153125|Eplerenone|eplerenone|mesh-list
83143860|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83143861|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
83475844|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143862|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83143863|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143864|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83143865|NCT02153125|Diuretics|diuretics|mesh-ancestor
83143866|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
83143867|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83143868|NCT04878926|Midazolam|midazolam|mesh-list
83143869|NCT04878926|Propofol|propofol|mesh-list
83143870|NCT04878926|Anesthetics|anesthetics|mesh-list
83143871|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
83143872|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83143873|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143874|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143875|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83143876|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
83143877|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83143878|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83143879|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83143880|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143881|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
83143882|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
83143883|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143884|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143885|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
83143886|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143887|NCT04862767|Aldesleukin|aldesleukin|mesh-list
83143888|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143889|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83143890|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83143891|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
83143892|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143893|NCT02146261|Quetmolimab|quetmolimab|mesh-list
83143894|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143895|NCT02153281|Phenelzine|phenelzine|mesh-list
83143896|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
83143897|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83143898|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83143899|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143900|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143901|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
83143902|NCT03542851|Convulsants|convulsants|mesh-ancestor
83143903|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83143904|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143905|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
83143906|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
83143907|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143908|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143909|NCT02769247|Naproxen|naproxen|mesh-list
83143910|NCT02769247|Lidocaine|lidocaine|mesh-list
83143911|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
83143912|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
83143913|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83143914|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143915|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
83143916|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143917|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83143918|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83143919|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83143920|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83143921|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143922|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83143923|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83143924|NCT02769247|Analgesics|analgesics|mesh-ancestor
83143925|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83143926|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83143927|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
83143928|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83143929|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83143931|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83143932|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83143933|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
83143934|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143935|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143936|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143937|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83143938|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
83143939|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
83143940|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83143941|NCT02146651|Insulin|insulin|mesh-list
83143942|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83143943|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
83143944|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83143945|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143946|NCT03542149|Tocopherols|tocopherols|mesh-list
83143947|NCT03542149|Vitamin E|vitamin e|mesh-list
83143948|NCT03542149|Tocotrienols|tocotrienols|mesh-list
83143949|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
83143950|NCT03542149|Piperaquine|piperaquine|mesh-list
83143951|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
83143952|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83143953|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83143954|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83143955|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
83143956|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143957|NCT03542149|Protective Agents|protective agents|mesh-ancestor
83143958|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143959|NCT03542149|Vitamins|vitamins|mesh-ancestor
83143960|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
83143961|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
83143962|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83143963|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83143964|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83143965|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143966|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
83143967|NCT02153593|Coagulants|coagulants|mesh-ancestor
83143968|NCT02154217|Timolol|timolol|mesh-list
83143969|NCT02154217|Bimatoprost|bimatoprost|mesh-list
83143970|NCT02154217|Latanoprost|latanoprost|mesh-list
83143971|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83143972|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83143973|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
83143974|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83143975|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143976|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143977|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83143978|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83143979|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83143980|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83143981|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83143982|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
83143983|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83143984|NCT02147041|Protective Agents|protective agents|mesh-ancestor
83143985|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143986|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83143987|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83143988|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143989|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83143990|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
83143991|NCT02767765|Hematinics|hematinics|mesh-ancestor
83143992|NCT00103207|Cetuximab|cetuximab|mesh-list
83143993|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83143994|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83143995|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
83143996|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83143997|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
83143998|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83143999|NCT02157181|Rituximab|rituximab|mesh-list
83144000|NCT02157181|Cladribine|cladribine|mesh-list
83144001|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83144002|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144003|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
83144004|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144005|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83144006|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83144008|NCT02159287|Calcium heparin|calcium heparin|mesh-list
83144009|NCT02159287|Enoxaparin|enoxaparin|mesh-list
83144010|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
83144011|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
83144012|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83144013|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83144014|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144015|NCT05005273|Nivolumab|nivolumab|mesh-list
83144016|NCT05005273|Ipilimumab|ipilimumab|mesh-list
83144017|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83144018|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144019|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83144020|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144021|NCT02157337|Atorvastatin|atorvastatin|mesh-list
83144022|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83144023|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83144024|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
83144025|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144026|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83144027|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83144028|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144029|NCT02159599|Ritonavir|ritonavir|mesh-list
83144030|NCT02159599|Darunavir|darunavir|mesh-list
83144031|NCT02159599|Tenofovir|tenofovir|mesh-list
83144032|NCT02159599|Lamivudine|lamivudine|mesh-list
83144033|NCT02159599|Emtricitabine|emtricitabine|mesh-list
83144034|NCT02159599|Abacavir|abacavir|mesh-list
83144035|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83144036|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83144037|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
83144038|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144039|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144040|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83144041|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83144042|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
83144043|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144044|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83144045|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83144046|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83144047|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83144048|NCT03541681|Anesthetics|anesthetics|mesh-list
83144049|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
83144050|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144051|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144053|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144054|NCT02157415|Polihexanide|polihexanide|mesh-list
83144055|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
83144056|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144057|NCT02157571|Levofloxacin|levofloxacin|mesh-list
83144058|NCT02157571|Ofloxacin|ofloxacin|mesh-list
83144059|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
83144060|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
83144061|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83144062|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144063|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83144064|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83144065|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83144066|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144067|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144068|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144069|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83144070|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83144071|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83144072|NCT01369355|Ustekinumab|ustekinumab|mesh-list
83144073|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83144074|NCT03541993|Resveratrol|resveratrol|mesh-list
83144075|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
83144076|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144077|NCT03541993|Protective Agents|protective agents|mesh-ancestor
83144078|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144079|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144080|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83144081|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
83144082|NCT02157649|Codeine|codeine|mesh-list
83144083|NCT02157649|Guaifenesin|guaifenesin|mesh-list
83144084|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83144085|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83144086|NCT02157649|Narcotics|narcotics|mesh-ancestor
83144087|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144088|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144089|NCT02157649|Analgesics|analgesics|mesh-ancestor
83144090|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
83144091|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144092|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
83144093|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
83144094|NCT02157649|Expectorants|expectorants|mesh-ancestor
83144095|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83144096|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83144097|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144098|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144099|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144100|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
83144101|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83144102|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
83144103|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
83144104|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
83144105|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83144106|NCT02159911|Misoprostol|misoprostol|mesh-list
83144107|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83144108|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
83144109|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83144110|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144111|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83144112|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144113|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
83144114|NCT03542617|Dexamethasone|dexamethasone|mesh-list
83144115|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144116|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
83144117|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
83144118|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144119|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144120|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144121|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
83144122|NCT03542617|Hormones|hormones|mesh-ancestor
83144123|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144124|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83144125|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144126|NCT04878770|Cyclosporine|cyclosporine|mesh-list
83144127|NCT04878770|Cyclosporins|cyclosporins|mesh-list
83144128|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144129|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144130|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83144131|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
83144132|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144133|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
83144134|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144135|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
83144136|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83144137|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83144138|NCT02086019|Ramipril|ramipril|mesh-list
83144139|NCT02086019|Bisoprolol|bisoprolol|mesh-list
83144140|NCT02086019|Heparin|heparin|mesh-list
83144141|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83144142|NCT02086019|Tinzaparin|tinzaparin|mesh-list
83144143|NCT02086019|Dalteparin|dalteparin|mesh-list
83144144|NCT02086019|Clopidogrel|clopidogrel|mesh-list
83144145|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83144146|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144147|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144148|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83144149|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83144150|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144151|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83144152|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83475863|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
83144153|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83144154|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83144155|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83144156|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
83144157|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144158|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
83144159|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
83144160|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83144161|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83144162|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83144163|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144164|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
83144165|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
83144166|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83144167|NCT02086097|Ibuprofen|ibuprofen|mesh-list
83144168|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83144169|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83144170|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83144171|NCT02086097|Analgesics|analgesics|mesh-ancestor
83144172|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
83144173|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144174|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144175|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144176|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83144177|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83144178|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144179|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144180|NCT02307682|Aflibercept|aflibercept|mesh-list
83144181|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83144182|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83144183|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83144184|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83144185|NCT02307682|Growth Substances|growth substances|mesh-ancestor
83144186|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144187|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
83144188|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144189|NCT02088515|Docetaxel|docetaxel|mesh-list
83144190|NCT02088515|Nedaplatin|nedaplatin|mesh-list
83144191|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144192|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
83144193|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
83144194|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
83144195|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144196|NCT02086253|BQ 788|bq 788|mesh-list
83144197|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83144198|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83144199|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144200|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83144201|NCT04870502|Clomiphene|clomiphene|mesh-list
83144202|NCT04870502|Enclomiphene|enclomiphene|mesh-list
83144203|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
83144204|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83144205|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
83144206|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144207|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144208|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83144209|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
83144210|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83144211|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83144212|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83144213|NCT02088671|Propofol|propofol|mesh-list
83144214|NCT02088671|Desflurane|desflurane|mesh-list
83144215|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83144216|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144217|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144218|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83144219|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
83144220|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
83144221|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83144222|NCT04870190|Osimertinib|osimertinib|mesh-list
83144223|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144224|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83144225|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144226|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144227|NCT03049046|Caffeic acid|caffeic acid|mesh-list
83144228|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
83144229|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144230|NCT03049046|Protective Agents|protective agents|mesh-ancestor
83144231|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144233|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
83144234|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
83144235|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144236|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144237|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
83144238|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144239|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83144240|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144241|NCT03048110|Itraconazole|itraconazole|mesh-list
83144242|NCT03048110|Rifampin|rifampin|mesh-list
83144243|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
83144244|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144245|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83144246|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83144247|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144248|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144249|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83144250|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
83144251|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144252|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144253|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83144254|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83144255|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
83144256|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83144257|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
83144258|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83144259|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83144260|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83144261|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83144262|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83144263|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83144264|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83144265|NCT05256758|Fenofibrate|fenofibrate|mesh-list
83144266|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83144267|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
83479594|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
83144268|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144269|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83144270|NCT02791763|Glycine|glycine|mesh-list
83144271|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
83144272|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144273|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144274|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144275|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
83144276|NCT02086409|Vitamin D|vitamin d|mesh-list
83144277|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
83144278|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
83144279|NCT02086409|Vitamins|vitamins|mesh-list
83144280|NCT02086409|Calcium|calcium|mesh-list
83144281|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
83144282|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144283|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83144284|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83144285|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
83144286|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
83144287|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144288|NCT02613572|Protective Agents|protective agents|mesh-ancestor
83144289|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144290|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
83144291|NCT02613572|Vitamins|vitamins|mesh-ancestor
83144292|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
83144293|NCT02088983|Choline|choline|mesh-list
83144294|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83144295|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
83144296|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83144297|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
83144298|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144299|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144300|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83144301|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
83144302|NCT02089061|Atorvastatin|atorvastatin|mesh-list
83144303|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83144304|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83144305|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83144306|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
83144307|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144308|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83144309|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83144310|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144311|NCT02082665|Dabrafenib|dabrafenib|mesh-list
83144312|NCT02082665|Midazolam|midazolam|mesh-list
83144313|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83144314|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83144315|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83144316|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144317|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144318|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83144319|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83144320|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83144321|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83144322|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
83144323|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
83144324|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
83144325|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
83144326|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144327|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144328|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83144329|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83144330|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
83144331|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83144332|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83144333|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144334|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144335|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83144336|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
83144337|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83144338|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
83144339|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144340|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
83144341|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144342|NCT02341456|Paclitaxel|paclitaxel|mesh-list
83144343|NCT02341456|Carboplatin|carboplatin|mesh-list
83144344|NCT02341456|Adavosertib|adavosertib|mesh-list
83401760|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83144345|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83144346|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144347|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
83144348|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
83144349|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83144350|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144351|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144352|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
83144353|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
83144354|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83144355|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144356|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144357|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83144358|NCT02083055|Analgesics|analgesics|mesh-ancestor
83144359|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
83144360|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144361|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83144362|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83144363|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83144364|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144365|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144366|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144367|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
83144368|NCT02089295|Oxycodone|oxycodone|mesh-list
83144369|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83144370|NCT02089295|Narcotics|narcotics|mesh-ancestor
83144371|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144372|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144373|NCT02089295|Analgesics|analgesics|mesh-ancestor
83144374|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
83144375|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144376|NCT02370784|Atorvastatin|atorvastatin|mesh-list
83144377|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83144378|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83144379|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
83144380|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144381|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83144382|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83144383|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144385|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83144386|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144387|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
83144388|NCT01595438|Ceftazidime|ceftazidime|mesh-list
83144389|NCT01595438|Avibactam|avibactam|mesh-list
83144390|NCT01595438|Doripenem|doripenem|mesh-list
83144391|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83144392|NCT01595438|Trimethoprim|trimethoprim|mesh-list
83144393|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
83144394|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83144395|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144396|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83144397|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83144398|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144399|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144400|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144401|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83144402|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83144403|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83144404|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
83144405|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83144406|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83144407|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83144408|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83144409|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83144410|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83144411|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
83144412|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83144413|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144414|NCT02340520|Theophylline|theophylline|mesh-list
83144415|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83144416|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
83144417|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144418|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144419|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83144420|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
83144421|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83144422|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144423|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144424|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
83144425|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83144426|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83144427|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
83144428|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144429|NCT02087579|Olanzapine|olanzapine|mesh-list
83144430|NCT02087579|Risperidone|risperidone|mesh-list
83144431|NCT02087579|Aripiprazole|aripiprazole|mesh-list
83144432|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83144433|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83144434|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83144435|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
83144436|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144437|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144438|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144439|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83144440|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83144441|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144442|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83144443|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83144444|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
83144445|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
83144446|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
83144447|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144448|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144449|NCT02087579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83144450|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83144451|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83144452|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
83144453|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
83144454|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83144455|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83144456|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83144457|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83144458|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83144459|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83144460|NCT02339584|Brinzolamide|brinzolamide|mesh-list
83144461|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83144462|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83144463|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83144464|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83144465|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83144466|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144467|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144468|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144469|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144470|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83144471|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144472|NCT02339506|Cosyntropin|cosyntropin|mesh-list
83144473|NCT02339506|Hormones|hormones|mesh-ancestor
83144474|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144475|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144476|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
83144477|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83144478|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
83144479|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83144480|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
83144481|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144482|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
83144483|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
83144484|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144485|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144486|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144487|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
83144488|NCT02087813|Hormones|hormones|mesh-ancestor
83144489|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144490|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83144491|NCT02087813|Protective Agents|protective agents|mesh-ancestor
83144492|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83144493|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144494|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144495|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144496|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83144497|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83144498|NCT02089529|Ibuprofen|ibuprofen|mesh-list
83144499|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83144500|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83144501|NCT02089529|Analgesics|analgesics|mesh-ancestor
83144502|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
83144503|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144504|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144505|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144506|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83144507|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83144508|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144509|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144510|NCT02090933|Celecoxib|celecoxib|mesh-list
83144511|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83144512|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83144513|NCT02090933|Analgesics|analgesics|mesh-ancestor
83144514|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
83144515|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144516|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144517|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144518|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83144519|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83144520|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83144521|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144522|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144523|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
83144524|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83144525|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144526|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144527|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83144528|NCT03046238|Analgesics|analgesics|mesh-ancestor
83144529|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
83144530|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144531|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83144532|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83144533|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83144534|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144535|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144536|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144537|NCT02089763|BCT-100|bct-100|mesh-list
83144538|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144539|NCT04884802|Phenylephrine|phenylephrine|mesh-list
83144540|NCT04884802|Norepinephrine|norepinephrine|mesh-list
83144541|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83144542|NCT04884802|Propofol|propofol|mesh-list
83144543|NCT04884802|Etomidate|etomidate|mesh-list
83144544|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83144545|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144546|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144547|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83144548|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
83144549|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
83144550|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83144551|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
83144552|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
83144553|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144554|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
83144555|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
83144556|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
83144557|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83144558|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83144559|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83144560|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144561|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144562|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144563|NCT04884802|Protective Agents|protective agents|mesh-ancestor
83144564|NCT02089841|Lumefantrine|lumefantrine|mesh-list
83144565|NCT02089841|Artemether|artemether|mesh-list
83144566|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83144567|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
83144568|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83144569|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83144570|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144572|NCT03045770|Paclitaxel|paclitaxel|mesh-list
83144573|NCT03045770|Fluorouracil|fluorouracil|mesh-list
83144574|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
83144575|NCT03045770|Irinotecan|irinotecan|mesh-list
83144576|NCT03045770|Calcium|calcium|mesh-list
83144577|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
83144578|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83144579|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144580|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
83144581|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
83144582|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
83144583|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144584|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83144585|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144586|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
83144587|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83144588|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83144589|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
83144590|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83144591|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83144592|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144593|NCT03045770|Antidotes|antidotes|mesh-ancestor
83144594|NCT03045770|Protective Agents|protective agents|mesh-ancestor
83144595|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
83144596|NCT03045770|Vitamins|vitamins|mesh-ancestor
83144597|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
83144598|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
83144599|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144600|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83144601|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144602|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144603|NCT02095847|Proflavine|proflavine|mesh-list
83144604|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83144605|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144606|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
83144607|NCT02091401|Analgesics|analgesics|mesh-ancestor
83144608|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
83144609|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144610|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144611|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
83144612|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144613|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83144614|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
83144615|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83144616|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83144617|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144618|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83144619|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
83144620|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83144621|NCT01594970|Bimatoprost|bimatoprost|mesh-list
83144622|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83144623|NCT04869176|Caffeine|caffeine|mesh-list
83144624|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
83144625|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144626|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83144627|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144628|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83144629|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144630|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83144631|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83144632|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
83144633|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144634|NCT03557255|Simendan|simendan|mesh-list
83144635|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83144636|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
83144637|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83144638|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83144639|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144640|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144641|NCT03557255|Protective Agents|protective agents|mesh-ancestor
83144642|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144643|NCT04868552|Naloxone|naloxone|mesh-list
83144644|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83144645|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144646|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
83144647|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144648|NCT02090153|Leucovorin|leucovorin|mesh-list
83144649|NCT02090153|Tegafur|tegafur|mesh-list
83144650|NCT02090153|Antidotes|antidotes|mesh-ancestor
83144651|NCT02090153|Protective Agents|protective agents|mesh-ancestor
83144652|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144653|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
83144654|NCT02090153|Vitamins|vitamins|mesh-ancestor
83144655|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
83144656|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83144657|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
83144658|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144659|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144660|NCT00358163|Paclitaxel|paclitaxel|mesh-list
83144661|NCT00358163|Vatalanib|vatalanib|mesh-list
83144662|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83144663|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144664|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83144665|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83144666|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83144667|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144668|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83144669|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144670|NCT02096315|Murepavadin|murepavadin|mesh-list
83144671|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83144672|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144673|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
83144674|NCT02337946|Leucovorin|leucovorin|mesh-list
83144675|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
83144676|NCT02337946|Fluorouracil|fluorouracil|mesh-list
83144677|NCT02337946|Panitumumab|panitumumab|mesh-list
83144678|NCT02337946|Calcium|calcium|mesh-list
83144679|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
83144680|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83144681|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144682|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83144683|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144684|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
83144685|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144686|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83144687|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83144688|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
83144689|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83144690|NCT02337946|Antidotes|antidotes|mesh-ancestor
83144691|NCT02337946|Protective Agents|protective agents|mesh-ancestor
83144692|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
83144693|NCT02337946|Vitamins|vitamins|mesh-ancestor
83144694|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
83144695|NCT04865510|Heparin|heparin|mesh-list
83144696|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
83144697|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144698|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83144699|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83144700|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
83144701|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144702|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
83144703|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83144704|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
83144705|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144706|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
83144707|NCT03047096|Protective Agents|protective agents|mesh-ancestor
83144708|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
83144709|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
83144710|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83144711|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
83144712|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83144713|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
83144714|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144715|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144716|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
83144717|NCT02093195|Bosentan|bosentan|mesh-list
83144718|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83144719|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83144720|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
83144721|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83144722|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83144723|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144724|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
83144725|NCT03555617|Itraconazole|itraconazole|mesh-list
83144726|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
83144727|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144728|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83144729|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83144730|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144731|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144732|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83144733|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
83144734|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144735|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144736|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83144737|NCT02098889|Scopolamine|scopolamine|mesh-list
83144738|NCT02098889|Bromides|bromides|mesh-list
83144739|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83144740|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
83144741|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83144742|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
83144743|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
83144744|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144745|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144746|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144747|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
83144748|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83144749|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
83144750|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144751|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144752|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83144753|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
83144754|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83144755|NCT01369199|Entecavir|entecavir|mesh-list
83144756|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
83144757|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144758|NCT02097173|Methotrexate|methotrexate|mesh-list
83144759|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83144760|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
83144761|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83144762|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144763|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83144764|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
83144765|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144766|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144767|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
83144768|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144769|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83144770|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83144771|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
83144772|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83144773|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83144774|NCT02097329|Palbociclib|palbociclib|mesh-list
83144775|NCT02097329|Rabeprazole|rabeprazole|mesh-list
83144776|NCT02097329|Famotidine|famotidine|mesh-list
83144777|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
83144778|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
83144779|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83144780|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83144781|NCT02097329|Antacids|antacids|mesh-list
83144782|NCT02097329|TEMPO|tempo|mesh-list
83144783|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144784|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83144785|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144786|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144787|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144788|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83144789|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83144790|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
83144791|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
83144792|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144793|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144794|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
83144795|NCT02097329|Protective Agents|protective agents|mesh-ancestor
83144796|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83144797|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
83144798|NCT02093585|Tenofovir|tenofovir|mesh-list
83144799|NCT02093585|Abacavir|abacavir|mesh-list
83144800|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
83144801|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144802|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83144803|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83144804|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144805|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144806|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83144807|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83144808|NCT02099357|Vitamin D|vitamin d|mesh-list
83144809|NCT02099357|Vitamins|vitamins|mesh-ancestor
83144810|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
83144811|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144812|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83144813|NCT02093741|Factor VIII|factor viii|mesh-list
83144814|NCT02093741|Coagulants|coagulants|mesh-ancestor
83144815|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
83144816|NCT02097407|Propofol|propofol|mesh-list
83144817|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83144818|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144819|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144820|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83144821|NCT02097407|Analgesics|analgesics|mesh-ancestor
83144822|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
83144823|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144824|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83144825|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83144826|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83144827|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144828|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144829|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144830|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83144831|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
83144832|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
83144833|NCT02250599|Paclitaxel|paclitaxel|mesh-list
83144834|NCT02250599|Bevacizumab|bevacizumab|mesh-list
83144835|NCT02250599|Carboplatin|carboplatin|mesh-list
83144836|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83144837|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144838|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83144839|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83144840|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83144841|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144842|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83144843|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83144844|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83144845|NCT02250599|Growth Substances|growth substances|mesh-ancestor
83144846|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144847|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
83144848|NCT02094053|Donepezil|donepezil|mesh-list
83144849|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83144850|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144851|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144852|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
83144853|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144854|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144855|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
83144856|NCT03555929|Dexamethasone|dexamethasone|mesh-list
83144857|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83144858|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
83144859|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
83144860|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144861|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144862|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144863|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
83144864|NCT03555929|Hormones|hormones|mesh-ancestor
83144865|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144866|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83144867|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144868|NCT02099981|Pimagedine|pimagedine|mesh-list
83144869|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144870|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144871|NCT02250209|Capecitabine|capecitabine|mesh-list
83144872|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
83144873|NCT02250209|Trastuzumab|trastuzumab|mesh-list
83144874|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83144875|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
83144876|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144877|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144878|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83144879|NCT02097953|Rifampin|rifampin|mesh-list
83144880|NCT02097953|Daptomycin|daptomycin|mesh-list
83144881|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83144882|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
83144883|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83144884|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144885|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
83144886|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83144887|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144888|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144889|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83144890|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83144891|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83144892|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83144893|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83144894|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83144895|NCT02094287|Dimethindene|dimethindene|mesh-list
83144896|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
83144897|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
83144898|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83144899|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
83144900|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
83144901|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144902|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144903|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144904|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83144905|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
83144906|NCT02100293|Analgesics|analgesics|mesh-ancestor
83144907|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
83144908|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144909|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144910|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
83144911|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144912|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83144913|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
83144914|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83144915|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83144916|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144917|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83144918|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
83144919|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83144920|NCT02094599|Dronabinol|dronabinol|mesh-list
83144921|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
83144922|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144923|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83144924|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83144925|NCT02094599|Analgesics|analgesics|mesh-ancestor
83144926|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
83144927|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144928|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83144929|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83144930|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144931|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144932|NCT02094599|Hormones|hormones|mesh-ancestor
83144933|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144934|NCT02094833|Vaccines|vaccines|mesh-list
83144935|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
83144936|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144937|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
83144938|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
83144939|NCT02100605|Ephedrine|ephedrine|mesh-list
83144940|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83144941|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
83144942|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83144943|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144944|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
83144945|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
83144946|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144947|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
83144948|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144949|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144950|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83144951|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83144952|NCT02100761|Voriconazole|voriconazole|mesh-list
83144953|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
83144954|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83144955|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83144956|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83144957|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83144958|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144959|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83144960|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
83144961|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83144962|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144963|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83144964|NCT02100917|Trastuzumab|trastuzumab|mesh-list
83144965|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83144966|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83144967|NCT02098421|Oxytocin|oxytocin|mesh-list
83144968|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
83144969|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83144970|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144971|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
83144972|NCT02098499|Promethazine|promethazine|mesh-list
83144973|NCT02098499|Haloperidol|haloperidol|mesh-list
83144974|NCT02098499|Metoclopramide|metoclopramide|mesh-list
83144975|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
83144976|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83144977|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83144978|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83144979|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83144980|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
83144981|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
83144982|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
83144983|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83144984|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
83144985|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
83144986|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83144987|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83144988|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
83144989|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
83144990|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83144991|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83144992|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83144993|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
83144994|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
83144995|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83144996|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83144997|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83144998|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83144999|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
83145000|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83145001|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83145002|NCT02097017|Lidocaine|lidocaine|mesh-list
83145003|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
83145004|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
83145005|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145006|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145007|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
83145008|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145009|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83145010|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83145011|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83145012|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83145013|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145014|NCT03555383|Hemostatics|hemostatics|mesh-list
83145015|NCT03555383|Coagulants|coagulants|mesh-ancestor
83145016|NCT02101151|Vitamin D|vitamin d|mesh-list
83145017|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
83145018|NCT02101151|Vitamins|vitamins|mesh-ancestor
83145019|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
83145020|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145021|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83145022|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83145023|NCT02101229|Insulin|insulin|mesh-list
83145024|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83145025|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83145026|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145027|NCT02102555|Acetaminophen|acetaminophen|mesh-list
83145028|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145029|NCT02102555|Analgesics|analgesics|mesh-ancestor
83145030|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
83145031|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145032|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145033|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
83145034|NCT02102633|Dabigatran|dabigatran|mesh-list
83145035|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
83145036|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83145037|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
83145038|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145039|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145040|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
83145041|NCT02102711|Vitamin A|vitamin a|mesh-list
83145042|NCT02102711|Vitamins|vitamins|mesh-ancestor
83145043|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
83145044|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145045|NCT02106767|Rifampin|rifampin|mesh-list
83145046|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83145047|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83145048|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145049|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
83145050|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145051|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145052|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83145053|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145054|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83145055|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
83145056|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83145057|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145058|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
83145059|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83145060|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83145061|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83145062|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83145063|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83145064|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83145065|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83145066|NCT02103023|Imiquimod|imiquimod|mesh-list
83145067|NCT02103023|Vaccines|vaccines|mesh-list
83145068|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
83145069|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145070|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83145071|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145072|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
83145073|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83145074|NCT02101931|Levulinic acid|levulinic acid|mesh-list
83145075|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83145076|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
83145077|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145078|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145079|NCT02106845|Digoxin|digoxin|mesh-list
83145080|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83145081|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83145082|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145083|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
83145084|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145085|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145086|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83145087|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145088|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83145089|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83145090|NCT02106845|Protective Agents|protective agents|mesh-ancestor
83145091|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145092|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
83145093|NCT03554447|Dexetimide|dexetimide|mesh-list
83145094|NCT03554447|Citalopram|citalopram|mesh-list
83145095|NCT03554447|Escitalopram|escitalopram|mesh-list
83145096|NCT03554447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83145097|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83145098|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83145099|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145100|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145101|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
83145102|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145103|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83145104|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83145105|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
83145106|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
83145107|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145108|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83145109|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83145110|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
83145111|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83145112|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
83145113|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83145114|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83145115|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145116|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83145117|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83145118|NCT03554447|Protective Agents|protective agents|mesh-ancestor
83145119|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
83145120|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83145121|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
83145122|NCT02103335|Dexamethasone|dexamethasone|mesh-list
83145123|NCT02103335|Pomalidomide|pomalidomide|mesh-list
83145124|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145125|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
83145126|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
83145127|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145128|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145129|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83145130|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
83145131|NCT02103335|Hormones|hormones|mesh-ancestor
83145132|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145133|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83145134|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145135|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
83145136|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83145137|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83145138|NCT02103335|Growth Substances|growth substances|mesh-ancestor
83145139|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83145141|NCT02610140|Maytansine|maytansine|mesh-list
83145142|NCT02610140|Anetumab ravtansine|anetumab ravtansine|mesh-list
83145143|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83145144|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145145|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83145146|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83145147|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83145148|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145149|NCT02610140|Immunoconjugates|immunoconjugates|mesh-ancestor
83145150|NCT02610140|Immunologic Factors|immunologic factors|mesh-ancestor
83145151|NCT02610140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145152|NCT02102321|Albendazole|albendazole|mesh-list
83145153|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
83145154|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83145155|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145156|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
83145157|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83145158|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83145159|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
83145160|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
83145161|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
83145162|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145163|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145164|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83145165|NCT02103569|Norethindrone|norethindrone|mesh-list
83145166|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
83145167|NCT02103569|Estradiol|estradiol|mesh-list
83145168|NCT02103569|Asunaprevir|asunaprevir|mesh-list
83145169|NCT02103569|Estrogens|estrogens|mesh-ancestor
83145170|NCT02103569|Hormones|hormones|mesh-ancestor
83145171|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145172|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145173|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83145174|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
83145175|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83145176|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83145177|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83145178|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83145179|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83145180|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
83145181|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145182|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145183|NCT02103647|Pregabalin|pregabalin|mesh-list
83145184|NCT02103647|Analgesics|analgesics|mesh-ancestor
83145185|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
83145186|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145187|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145188|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
83145189|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83145190|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83145191|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145192|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83145193|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83145194|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83145195|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145196|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83145197|NCT02109965|Midazolam|midazolam|mesh-list
83145198|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
83145199|NCT02109965|Propofol|propofol|mesh-list
83145200|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83145201|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145202|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145203|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145204|NCT02109965|Analgesics|analgesics|mesh-ancestor
83145205|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
83145206|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145207|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83145208|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83145209|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83145210|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
83145211|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145212|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145213|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83145214|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
83145215|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
83145216|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83145217|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83145218|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83145219|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83145220|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
83145221|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
83145222|NCT02789657|Paclitaxel|paclitaxel|mesh-list
83145223|NCT02789657|Carboplatin|carboplatin|mesh-list
83145224|NCT02789657|Trastuzumab|trastuzumab|mesh-list
83145225|NCT02789657|Pertuzumab|pertuzumab|mesh-list
83145226|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83145227|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145228|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
83145229|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
83145230|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83145231|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145232|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83145233|NCT03555071|Vaccines|vaccines|mesh-list
83145234|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
83145235|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145236|NCT02609984|Atezolizumab|atezolizumab|mesh-list
83145237|NCT02609984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83145238|NCT02609984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145239|NCT02609984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83145240|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145241|NCT02107079|Melatonin|melatonin|mesh-list
83145242|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
83145243|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145244|NCT02107079|Protective Agents|protective agents|mesh-ancestor
83145245|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145246|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145247|NCT02107235|ON 01910|on 01910|mesh-list
83145248|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145249|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83145250|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145251|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145252|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
83145253|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83145254|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145255|NCT02103725|Analgesics|analgesics|mesh-ancestor
83145256|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
83145257|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145258|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145259|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145260|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145261|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
83145262|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83145263|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
83145264|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83145265|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145266|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145267|NCT03042260|Trimethoprim|trimethoprim|mesh-list
83145268|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83145269|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
83145270|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83145271|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145272|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
83145273|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83145274|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83145275|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83145276|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145277|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145278|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83145279|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83145280|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83145281|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83145284|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145285|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83145286|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145287|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145288|NCT02107391|Leuprolide|leuprolide|mesh-list
83145289|NCT02107391|Goserelin|goserelin|mesh-list
83145290|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83145291|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
83145292|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83145293|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145294|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83145295|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145296|NCT02103881|Ketamine|ketamine|mesh-list
83145297|NCT02103881|Haloperidol|haloperidol|mesh-list
83145298|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
83145299|NCT02103881|Analgesics|analgesics|mesh-ancestor
83145300|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
83145301|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145302|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145303|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83145304|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83145305|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
83145306|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
83145307|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145308|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83145309|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83145310|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145311|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145312|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
83145313|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
83145314|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83145315|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83145316|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83145317|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83145318|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83145319|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
83145320|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83145321|NCT03554915|Midazolam|midazolam|mesh-list
83145322|NCT03554915|Ketamine|ketamine|mesh-list
83145323|NCT03554915|Analgesics|analgesics|mesh-ancestor
83145324|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
83145325|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145326|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145327|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83145328|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83145329|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
83145330|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
83145331|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145332|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83145333|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83145334|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145335|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145336|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83145337|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83145338|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83145339|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83145340|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83145341|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
83145342|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
83145343|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
83145344|NCT03044522|Narcotics|narcotics|mesh-ancestor
83145345|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145346|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145347|NCT03044522|Analgesics|analgesics|mesh-ancestor
83145348|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
83145349|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145350|NCT03044366|Anesthetics|anesthetics|mesh-list
83145351|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145352|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145353|NCT02250833|Amlodipine|amlodipine|mesh-list
83145354|NCT02250833|Telmisartan|telmisartan|mesh-list
83145355|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83145356|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83145357|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83145358|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145359|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83145360|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145361|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
83145362|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83145363|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83145364|NCT02110745|Propofol|propofol|mesh-list
83145365|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83145366|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145367|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145368|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83145369|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
83145370|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
83145371|NCT04857320|Insulin|insulin|mesh-list
83145372|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83145373|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83145374|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145375|NCT03041948|Acetaminophen|acetaminophen|mesh-list
83145376|NCT03041948|Dexamethasone|dexamethasone|mesh-list
83145377|NCT03041948|Ketorolac|ketorolac|mesh-list
83145378|NCT03041948|Morphine|morphine|mesh-list
83145379|NCT03041948|Remifentanil|remifentanil|mesh-list
83145380|NCT03041948|Ondansetron|ondansetron|mesh-list
83145381|NCT03041948|Propofol|propofol|mesh-list
83145382|NCT03041948|Sevoflurane|sevoflurane|mesh-list
83145383|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145384|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
83145385|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
83145386|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145387|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145388|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83145389|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
83145390|NCT03041948|Hormones|hormones|mesh-ancestor
83145391|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145392|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83145393|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145394|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83145395|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145396|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83145397|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
83145398|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
83145399|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83145400|NCT03041948|Narcotics|narcotics|mesh-ancestor
83145401|NCT03041948|Analgesics|analgesics|mesh-ancestor
83145402|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
83145403|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145404|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
83145405|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83145406|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83145407|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
83145408|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
83145409|NCT03041948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83145410|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83145411|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
83145412|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145413|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145414|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83145415|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145416|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83145417|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145418|NCT02104193|Simvastatin|simvastatin|mesh-list
83145419|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83145420|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145421|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
83145422|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145423|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145424|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83145425|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145426|NCT03042182|Vaccines|vaccines|mesh-list
83145427|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
83145428|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145429|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
83145430|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
83145431|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83145432|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83145433|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83145434|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145435|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83145436|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83145437|NCT02611778|Ranibizumab|ranibizumab|mesh-list
83145438|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83145439|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83145440|NCT02611778|Growth Substances|growth substances|mesh-ancestor
83145441|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145442|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
83145443|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145444|NCT04867226|Colchicine|colchicine|mesh-list
83145445|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
83145446|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145447|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
83145448|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
83145449|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
83145450|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145451|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145452|NCT04856852|Iodine|iodine|mesh-list
83145453|NCT04856852|Temozolomide|temozolomide|mesh-list
83145454|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83145455|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
83145456|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145457|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145458|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83145459|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145460|NCT04856852|Trace Elements|trace elements|mesh-ancestor
83145461|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
83145462|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145463|NCT02711553|Gemcitabine|gemcitabine|mesh-list
83145464|NCT02711553|Ramucirumab|ramucirumab|mesh-list
83145465|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145466|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83145467|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
83145468|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145469|NCT01453179|Diclofenac|diclofenac|mesh-list
83145470|NCT01453179|Imiquimod|imiquimod|mesh-list
83145471|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83145472|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145473|NCT01453179|Analgesics|analgesics|mesh-ancestor
83145474|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
83145475|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83401915|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
83145476|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145477|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145478|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145479|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83145480|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145481|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145482|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83145483|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
83145484|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145485|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
83145486|NCT03192033|Hemostatics|hemostatics|mesh-list
83145487|NCT03192033|Coagulants|coagulants|mesh-ancestor
83145488|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
83145489|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
83145490|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83145491|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
83145492|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145493|NCT03188445|Protective Agents|protective agents|mesh-ancestor
83145494|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145495|NCT03188445|Vitamins|vitamins|mesh-ancestor
83145496|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
83145497|NCT03188445|Trace Elements|trace elements|mesh-ancestor
83145498|NCT03188445|Hematinics|hematinics|mesh-ancestor
83145499|NCT04483635|Vitamin D|vitamin d|mesh-list
83145500|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
83145501|NCT04483635|Vitamins|vitamins|mesh-ancestor
83145502|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
83145503|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145504|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83145505|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83145506|NCT04865900|Antibodies|antibodies|mesh-list
83145507|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
83145508|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145509|NCT03191721|Triclosan|triclosan|mesh-list
83145510|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
83145511|NCT03191721|Fluorides|fluorides|mesh-list
83145512|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
83145513|NCT03191721|Protective Agents|protective agents|mesh-ancestor
83145514|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145515|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83145516|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83145517|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145518|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
83477860|NCT01454791|Diclofenac|diclofenac|mesh-list
83145519|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145520|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145521|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
83145522|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83145523|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
83145524|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145525|NCT04864496|Expectorants|expectorants|mesh-ancestor
83145526|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
83145527|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83145528|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
83145529|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145530|NCT04864496|Protective Agents|protective agents|mesh-ancestor
83145531|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145532|NCT04864496|Antidotes|antidotes|mesh-ancestor
83145533|NCT03188289|Chitosan|chitosan|mesh-list
83145534|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
83145535|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83145536|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
83145537|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145538|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
83145539|NCT03188289|Protective Agents|protective agents|mesh-ancestor
83145540|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83145541|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145542|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
83145543|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145544|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145545|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
83145546|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
83145547|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
83145548|NCT03188289|Coagulants|coagulants|mesh-ancestor
83145549|NCT03044912|Mirabegron|mirabegron|mesh-list
83145550|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83145551|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83145552|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83145553|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
83145554|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145555|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145556|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145557|NCT03044912|Urological Agents|urological agents|mesh-ancestor
83145558|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83145559|NCT03041012|Romidepsin|romidepsin|mesh-list
83145560|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
83145561|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
83145562|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145563|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83145564|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145565|NCT03041012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83145566|NCT03041012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145567|NCT03041012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145568|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
83145569|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145570|NCT03187899|Ropivacaine|ropivacaine|mesh-list
83145571|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
83145572|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
83145573|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145574|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145575|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
83145576|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145577|NCT01648582|Metformin|metformin|mesh-list
83145578|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
83145579|NCT01648582|Dulaglutide|dulaglutide|mesh-list
83145580|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83145581|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145582|NCT02440347|Anesthetics|anesthetics|mesh-list
83145583|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145584|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145585|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83145586|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83145587|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
83145588|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145589|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145590|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83145591|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83145592|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83145593|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
83145594|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
83145595|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145596|NCT04854668|Bevacizumab|bevacizumab|mesh-list
83145597|NCT04854668|Capecitabine|capecitabine|mesh-list
83145598|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
83145599|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83145600|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145601|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83145602|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83145603|NCT04854668|Growth Substances|growth substances|mesh-ancestor
83145604|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145605|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
83145606|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83145607|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
83145608|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145609|NCT03189069|Warfarin|warfarin|mesh-list
83145610|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
83145611|NCT03189069|Dabigatran|dabigatran|mesh-list
83145612|NCT03189069|Apixaban|apixaban|mesh-list
83145613|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
83145614|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83145615|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
83145616|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83145617|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
83145618|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145619|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145620|NCT03040934|Sirolimus|sirolimus|mesh-list
83145621|NCT03040934|Everolimus|everolimus|mesh-list
83145622|NCT03040934|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83145623|NCT03040934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83145624|NCT03040934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145625|NCT03040934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145626|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83145627|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
83145628|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145629|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145630|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83145631|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145632|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83145633|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
83145634|NCT04861142|Denosumab|denosumab|mesh-list
83145635|NCT04861142|Alendronate|alendronate|mesh-list
83145636|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83145637|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145638|NCT03117855|Capecitabine|capecitabine|mesh-list
83145639|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83145640|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
83145641|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145642|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145643|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
83145644|NCT02607800|Velpatasvir|velpatasvir|mesh-list
83145645|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
83145646|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145647|NCT02304484|Evolocumab|evolocumab|mesh-list
83145648|NCT02304484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83145649|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83145650|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145651|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
83145652|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145653|NCT02304484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83145654|NCT02304484|Protease Inhibitors|protease inhibitors|mesh-ancestor
83145655|NCT02304484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145656|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145657|NCT02434029|Budesonide|budesonide|mesh-list
83145658|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145659|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83145660|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
83145661|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145662|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145663|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83145664|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
83145665|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
83145666|NCT02434029|Hormones|hormones|mesh-ancestor
83145667|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145668|NCT02708355|Esomeprazole|esomeprazole|mesh-list
83145669|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83145670|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83145671|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83145672|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145673|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145674|NCT04854044|TIC10 compound|tic10 compound|mesh-list
83145675|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145676|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
83145677|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83145678|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145679|NCT02337478|Vincristine|vincristine|mesh-list
83145680|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83145681|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145682|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
83145683|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
83145684|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
83145685|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145686|NCT02434653|Chrysarobin|chrysarobin|mesh-list
83145687|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83145688|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145689|NCT02434653|Analgesics|analgesics|mesh-ancestor
83145690|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
83145691|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145692|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145693|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145694|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145695|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83145696|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83145697|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145698|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
83145699|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145700|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145701|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83145702|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145703|NCT03188835|Glycerol|glycerol|mesh-list
83145704|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83145705|NCT03188835|Protective Agents|protective agents|mesh-ancestor
83145706|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145707|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83145709|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83145710|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145711|NCT04847024|Analgesics|analgesics|mesh-ancestor
83145712|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
83145713|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145714|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145715|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145716|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145717|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83145718|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83145719|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145720|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145721|NCT04860674|Carboplatin|carboplatin|mesh-list
83145722|NCT04860674|Etoposide|etoposide|mesh-list
83145723|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83145724|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145725|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83145726|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83145727|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83145728|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145729|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145730|NCT04860674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83145731|NCT04853342|Aflutinib|aflutinib|mesh-list
83145732|NCT04853342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83145733|NCT04853342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145734|NCT04853342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145735|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
83145736|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83145737|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145739|NCT02430363|Ipatasertib|ipatasertib|mesh-list
83145740|NCT02430363|Dactolisib|dactolisib|mesh-list
83145741|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83145742|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145743|NCT02430363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83145744|NCT02430363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145745|NCT02430363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83145746|NCT02430363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145747|NCT02429973|Sirolimus|sirolimus|mesh-list
83145748|NCT02429973|Gemcitabine|gemcitabine|mesh-list
83145749|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83145750|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
83145751|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145752|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145753|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83145754|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145755|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83145756|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
83145757|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83145758|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
83145759|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145760|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
83145761|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
83145762|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83145763|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83145764|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145765|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145766|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145767|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145768|NCT04846634|Paclitaxel|paclitaxel|mesh-list
83145769|NCT04846634|Docetaxel|docetaxel|mesh-list
83145770|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83145771|NCT04846634|Cisplatin|cisplatin|mesh-list
83145772|NCT04846634|Carboplatin|carboplatin|mesh-list
83145773|NCT04846634|Gemcitabine|gemcitabine|mesh-list
83145774|NCT04846634|Pemetrexed|pemetrexed|mesh-list
83145775|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83145776|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145777|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83145778|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83145779|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83145780|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145781|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83145782|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
83145783|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145784|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83145785|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83145786|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83145787|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83145788|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83145789|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145790|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145791|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83145792|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83145793|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83145794|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
83145795|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145796|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145797|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83145798|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83145799|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
83145800|NCT02429817|Edetic Acid|edetic acid|mesh-list
83145801|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
83145802|NCT02429817|Antidotes|antidotes|mesh-ancestor
83145803|NCT02429817|Protective Agents|protective agents|mesh-ancestor
83145804|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145805|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
83145806|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
83145807|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145808|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83145809|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
83145810|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83145811|NCT04851860|Immunomodulating Agents|immunomodulating agents|mesh-list
83145812|NCT04851860|Immunologic Factors|immunologic factors|mesh-ancestor
83145813|NCT04851860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145814|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
83145815|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83145816|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
83145817|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145818|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
83145819|NCT04851548|Protective Agents|protective agents|mesh-ancestor
83145820|NCT02706951|Methotrexate|methotrexate|mesh-list
83145821|NCT02706951|Upadacitinib|upadacitinib|mesh-list
83145822|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83145823|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
83145824|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83145825|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145826|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83145827|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
83145828|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145829|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145830|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
83145831|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145832|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83145833|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83145834|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
83145835|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83145836|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83145837|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83145838|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83145839|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83145840|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145841|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145842|NCT04851392|Dronabinol|dronabinol|mesh-list
83145843|NCT04851392|Cannabidiol|cannabidiol|mesh-list
83145844|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
83145845|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
83145846|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145847|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83145848|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145849|NCT04851392|Analgesics|analgesics|mesh-ancestor
83145850|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
83145851|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145852|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83145853|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83145854|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145855|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145856|NCT04851392|Hormones|hormones|mesh-ancestor
83145857|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145858|NCT02429193|Prednisone|prednisone|mesh-list
83145859|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
83145860|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145861|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
83145862|NCT02429193|Hormones|hormones|mesh-ancestor
83145863|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145864|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145865|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83145866|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145867|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83145868|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145869|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145870|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83145871|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83145872|NCT04859738|Lidocaine|lidocaine|mesh-list
83145873|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
83145874|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
83145875|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83145876|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145877|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
83145878|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145879|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83145880|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83145881|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83145882|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83145883|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145884|NCT02429271|Clopidogrel|clopidogrel|mesh-list
83145886|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83145887|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83145888|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83145889|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83145890|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
83145891|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145892|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145893|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145894|NCT02429505|Miltefosine|miltefosine|mesh-list
83145895|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
83145896|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145897|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145898|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83145899|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83145900|NCT04851002|Mitogens|mitogens|mesh-list
83145901|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
83221031|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145902|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145903|NCT04844996|Ezetimibe|ezetimibe|mesh-list
83145904|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83145905|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83145906|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
83145907|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145908|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83145909|NCT02425137|Gemcitabine|gemcitabine|mesh-list
83145910|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83145911|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
83145912|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145913|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145914|NCT04841018|Dexamethasone|dexamethasone|mesh-list
83145915|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
83145916|NCT04841018|BB 1101|bb 1101|mesh-list
83145917|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145918|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
83145919|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
83145920|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145921|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145922|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83145923|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
83145924|NCT04841018|Hormones|hormones|mesh-ancestor
83145925|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145926|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83145927|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145928|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
83145930|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145931|NCT04840550|Lansoprazole|lansoprazole|mesh-list
83145932|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
83145933|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83145934|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83145935|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83145936|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83145937|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145938|NCT03182595|Acetaminophen|acetaminophen|mesh-list
83145939|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83145940|NCT03182595|Analgesics|analgesics|mesh-ancestor
83145941|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
83145942|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145943|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145944|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
83145945|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
83145946|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
83145947|NCT02429037|Cisplatin|cisplatin|mesh-list
83145948|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145949|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
83145950|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83145951|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83145952|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83145953|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83145954|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83145955|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145956|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145957|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83145958|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83145959|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145960|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
83145961|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145962|NCT04833218|Propranolol|propranolol|mesh-list
83145963|NCT04833218|Clonidine|clonidine|mesh-list
83145964|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83145965|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83145966|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
83145967|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83145968|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83145969|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145970|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83145971|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83145972|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83145973|NCT04833218|Analgesics|analgesics|mesh-ancestor
83145974|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
83145975|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145976|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
83145977|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
83145978|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83145979|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83145980|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83145981|NCT04833374|Prednisone|prednisone|mesh-list
83145982|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
83145983|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83145984|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83145985|NCT04833374|Prednisolone|prednisolone|mesh-list
83145986|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
83145987|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83145988|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
83145989|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83145990|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
83145991|NCT04833374|Hormones|hormones|mesh-ancestor
83145992|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83145993|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83145994|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83145995|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83145996|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
83145997|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
83145998|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83145999|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146000|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83146001|NCT04833374|Protective Agents|protective agents|mesh-ancestor
83146002|NCT02707965|Topiramate|topiramate|mesh-list
83146003|NCT02707965|Lamotrigine|lamotrigine|mesh-list
83146004|NCT02707965|Zonisamide|zonisamide|mesh-list
83146005|NCT02707965|Carbamazepine|carbamazepine|mesh-list
83146006|NCT02707965|Phenytoin|phenytoin|mesh-list
83146007|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
83146008|NCT02707965|Levetiracetam|levetiracetam|mesh-list
83146009|NCT02707965|Valproic Acid|valproic acid|mesh-list
83146010|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
83146011|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83146012|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146013|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
83146014|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83146015|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146016|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146017|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83146018|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83146019|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83146020|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146021|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83475984|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
83146022|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83146023|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
83146024|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146025|NCT02707965|Analgesics|analgesics|mesh-ancestor
83146026|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
83146027|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146028|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83146029|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83146030|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146031|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
83146032|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146033|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83146034|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83146035|NCT04839536|Sevoflurane|sevoflurane|mesh-list
83146036|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83146037|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83146038|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
83146039|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
83146040|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146041|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146042|NCT02428257|Ephedrine|ephedrine|mesh-list
83146043|NCT02428257|Bupivacaine|bupivacaine|mesh-list
83146044|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
83146045|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
83146046|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146047|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146048|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
83146049|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146050|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83146051|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
83146052|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
83146053|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83146054|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
83146055|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146056|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146057|NCT04839224|Phenylephrine|phenylephrine|mesh-list
83146058|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
83146059|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83146060|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
83146061|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
83146062|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146063|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146064|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
83146065|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83146066|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
83146067|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
83146068|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83146069|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83146070|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83146071|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
83146072|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146073|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146074|NCT04839224|Protective Agents|protective agents|mesh-ancestor
83146075|NCT03036644|Nicotine|nicotine|mesh-list
83146076|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83146077|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
83146078|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146079|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146080|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83146081|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83146082|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
83146083|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146084|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146086|NCT02424201|Misoprostol|misoprostol|mesh-list
83146087|NCT02424201|Vitamins|vitamins|mesh-ancestor
83146088|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
83146089|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
82777452|NCT05917691|Anesthetics|anesthetics|mesh-list
83146090|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83146091|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
83146092|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83146093|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83146094|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146095|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
83146096|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
83146097|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146098|NCT02424201|Protective Agents|protective agents|mesh-ancestor
83146099|NCT02432781|Insulin|insulin|mesh-list
83146100|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83146101|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146102|NCT01667900|Dulaglutide|dulaglutide|mesh-list
83146103|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83146104|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146105|NCT04843280|Coal Tar|coal tar|mesh-list
83146106|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
83146107|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
83146108|NCT04833296|Ropivacaine|ropivacaine|mesh-list
83146109|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83146110|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
83146111|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146112|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146113|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
83146114|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146115|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
83146116|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83146117|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
83146118|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83146119|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146120|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83146122|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83146123|NCT00702273|Ganirelix|ganirelix|mesh-list
83146124|NCT00702273|Progestins|progestins|mesh-ancestor
83146125|NCT00702273|Hormones|hormones|mesh-ancestor
83146126|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146127|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146128|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
83146129|NCT02433795|Rituximab|rituximab|mesh-list
83146130|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83146131|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83146132|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146133|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
83146134|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146135|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146136|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83146137|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
83146138|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146139|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
83146140|NCT03038516|Vitamin D|vitamin d|mesh-list
83146141|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83146142|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146143|NCT03038516|Vitamins|vitamins|mesh-ancestor
83146144|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
83146145|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83146146|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
83146147|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83146148|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83146149|NCT02424435|Prednisolone|prednisolone|mesh-list
83146150|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
83146151|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83146152|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
83146153|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146154|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
83146155|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
83146156|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146157|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146158|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146159|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
83146161|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146162|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83146163|NCT02424435|Protective Agents|protective agents|mesh-ancestor
83146164|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83146165|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146166|NCT04842968|Methylene Blue|methylene blue|mesh-list
83146167|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146168|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146169|NCT04832204|Apatinib|apatinib|mesh-list
83146170|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146171|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83146172|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146173|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146174|NCT03038282|Chromium|chromium|mesh-list
83146175|NCT03038282|Chromous chloride|chromous chloride|mesh-list
83146176|NCT03038282|Trace Elements|trace elements|mesh-ancestor
83146177|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
83146178|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146179|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
83146180|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146181|NCT03038282|Protective Agents|protective agents|mesh-ancestor
83146182|NCT02424045|Dexamethasone|dexamethasone|mesh-list
83146183|NCT02424045|Carboplatin|carboplatin|mesh-list
83146184|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83146185|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146186|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
83146187|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
83146188|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146189|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146190|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146191|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
83146192|NCT02424045|Hormones|hormones|mesh-ancestor
83146193|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146194|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83146195|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146196|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83146197|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
83146198|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146199|NCT03037970|Becaplermin|becaplermin|mesh-list
83146200|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
83146201|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83146202|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83146203|NCT03037970|Growth Substances|growth substances|mesh-ancestor
83146204|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146205|NCT04841720|Metformin|metformin|mesh-list
83146206|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83146207|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146208|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83146209|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83146210|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146211|NCT03039842|Valproic Acid|valproic acid|mesh-list
83146212|NCT03039842|Memantine|memantine|mesh-list
83146213|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
83146214|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83146215|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83146216|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
83146217|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146218|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146219|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146220|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83146221|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83146222|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
83146223|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
83146224|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
83146225|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146226|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
83146227|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
83146228|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83146229|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146230|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83146231|NCT03181815|Cytarabine|cytarabine|mesh-list
83146232|NCT03181815|Cladribine|cladribine|mesh-list
83146233|NCT03181815|Aclarubicin|aclarubicin|mesh-list
83146234|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
83146235|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83146236|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
83146237|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146238|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146239|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
83146240|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146241|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146242|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
83146243|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146244|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83146245|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83146246|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83146247|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146248|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83146249|NCT03038048|Ranibizumab|ranibizumab|mesh-list
83146250|NCT03038048|Aflibercept|aflibercept|mesh-list
83146251|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83146252|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83146253|NCT03038048|Growth Substances|growth substances|mesh-ancestor
83146254|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146255|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
83146256|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146257|NCT03185871|Celecoxib|celecoxib|mesh-list
83146258|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83146259|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146260|NCT03185871|Analgesics|analgesics|mesh-ancestor
83146261|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
83146262|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146263|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146264|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146265|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146266|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83146267|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83146268|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146269|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146270|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83146271|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83146272|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
83146273|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146274|NCT03180957|Adalimumab|adalimumab|mesh-list
83146275|NCT03180957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83146276|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146277|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146278|NCT02427165|Albuterol|albuterol|mesh-list
83146279|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83146280|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
83146281|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146282|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146283|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83146284|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
83146285|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
83146286|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83146287|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83146288|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83146289|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83146290|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
83146291|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146292|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146293|NCT03037736|Bevacizumab|bevacizumab|mesh-list
83146294|NCT03037736|Fluorouracil|fluorouracil|mesh-list
83146295|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83146296|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146297|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83146298|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83146299|NCT03037736|Growth Substances|growth substances|mesh-ancestor
83146300|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146301|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
83146302|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
83146303|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146304|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83146305|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146306|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
83146307|NCT04838132|Ropivacaine|ropivacaine|mesh-list
83146308|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
83146309|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
83146310|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146311|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146312|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
83146313|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146314|NCT03037892|Fentanyl|fentanyl|mesh-list
83146315|NCT03037892|Midazolam|midazolam|mesh-list
83146316|NCT03037892|Remifentanil|remifentanil|mesh-list
83146317|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83146318|NCT03037892|Narcotics|narcotics|mesh-ancestor
83146319|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146320|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146321|NCT03037892|Analgesics|analgesics|mesh-ancestor
83146322|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
83146323|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146324|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83146325|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83146326|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
83146327|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
83146328|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83146329|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83146330|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83146331|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83146332|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
83146333|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
83146334|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146335|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146336|NCT03183843|Warfarin|warfarin|mesh-list
83146337|NCT03183843|Dabigatran|dabigatran|mesh-list
83146338|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
83146339|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
83146340|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83146341|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
83146342|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82777807|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146343|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146344|NCT03180879|Ibuprofen|ibuprofen|mesh-list
83146345|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83146346|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146347|NCT03180879|Analgesics|analgesics|mesh-ancestor
83146348|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
83146349|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146350|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146351|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146352|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146353|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83146354|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146355|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146356|NCT03180723|Cyclosporine|cyclosporine|mesh-list
83146357|NCT03180723|Rituximab|rituximab|mesh-list
83146358|NCT03180723|Cyclosporins|cyclosporins|mesh-list
83146359|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83146360|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146361|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
83146362|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146363|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146364|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146365|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146366|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146367|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
83146368|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146369|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
83146370|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83146371|NCT04841096|Metformin|metformin|mesh-list
83146372|NCT04841096|Glimepiride|glimepiride|mesh-list
83146373|NCT04841096|Vildagliptin|vildagliptin|mesh-list
83146374|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83146375|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146376|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83146377|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146378|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
83146379|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83146380|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
83146381|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146382|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146383|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83146384|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
83146385|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146386|NCT02426697|Fentanyl|fentanyl|mesh-list
83146387|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83146388|NCT02426697|Narcotics|narcotics|mesh-ancestor
83146389|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146390|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146391|NCT02426697|Analgesics|analgesics|mesh-ancestor
83146392|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
83146393|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146394|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83146395|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83146396|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
83146397|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
83146398|NCT03039608|Prednisone|prednisone|mesh-list
83146399|NCT03039608|Triamcinolone|triamcinolone|mesh-list
83146400|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146401|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
83146402|NCT03039608|Hormones|hormones|mesh-ancestor
83146403|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146404|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83476017|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
83146405|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83146406|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146407|NCT02423811|Fursultiamin|fursultiamin|mesh-list
83146408|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
83146409|NCT02423811|Vitamins|vitamins|mesh-ancestor
83146410|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
83146411|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146412|NCT04837664|Nystatin|nystatin|mesh-list
83146413|NCT04837664|Curcumin|curcumin|mesh-list
83146414|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83146415|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146416|NCT04837664|Analgesics|analgesics|mesh-ancestor
83146417|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
83146418|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146419|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146420|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146421|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146422|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146423|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146424|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146425|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83146426|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146427|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
83146428|NCT04837664|Ionophores|ionophores|mesh-ancestor
83146429|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146430|NCT01331837|Etanercept|etanercept|mesh-list
83146431|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83146432|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146433|NCT01331837|Analgesics|analgesics|mesh-ancestor
83146434|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
83146435|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146436|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146437|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146438|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146439|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146440|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146441|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
83146442|NCT02706483|Plecanatide|plecanatide|mesh-list
83146443|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83146444|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
83146445|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146446|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146447|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
83146448|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146449|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
83146450|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146451|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146452|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83146453|NCT03183297|Fexofenadine|fexofenadine|mesh-list
83146454|NCT03183297|Naproxen|naproxen|mesh-list
83146455|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83146456|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146457|NCT03183297|Analgesics|analgesics|mesh-ancestor
83146458|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
83146459|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146460|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146461|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146462|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146463|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
83146464|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83146465|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146466|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146467|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83146468|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83146469|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83146470|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
83146471|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
83146472|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146473|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83146474|NCT02426619|Fluorides|fluorides|mesh-list
83146475|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
83146476|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
83146477|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
83146478|NCT02426619|Protective Agents|protective agents|mesh-ancestor
83146479|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146480|NCT02108483|Dapsone|dapsone|mesh-list
83146481|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146482|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
83146483|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83146484|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83146485|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83146486|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146487|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146488|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
83146489|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83146490|NCT01648348|Bevacizumab|bevacizumab|mesh-list
83146491|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83146492|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
83146493|NCT01648348|Antibodies|antibodies|mesh-list
83146494|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
83146495|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83146496|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
83146497|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146498|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83146499|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83146500|NCT01648348|Growth Substances|growth substances|mesh-ancestor
83146501|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146502|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
83146503|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
83146504|NCT03180255|Dexamethasone|dexamethasone|mesh-list
83146505|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
83146506|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83146507|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146508|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
83146509|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
83146510|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146511|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146512|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146513|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
83146514|NCT03180255|Hormones|hormones|mesh-ancestor
83146515|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476033|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
83146516|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83146517|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146518|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
83146519|NCT02431221|Perhexiline|perhexiline|mesh-list
83146520|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83146521|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146522|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146523|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83146524|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146525|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
83146526|NCT02108639|Asunaprevir|asunaprevir|mesh-list
83146527|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83146528|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146529|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146530|NCT03180099|Bupivacaine|bupivacaine|mesh-list
83146531|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
83146532|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
83146533|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146534|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146535|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
83146536|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146537|NCT04770272|Paclitaxel|paclitaxel|mesh-list
83146538|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
83146539|NCT04770272|Carboplatin|carboplatin|mesh-list
83146540|NCT04770272|Atezolizumab|atezolizumab|mesh-list
83146541|NCT04770272|Epirubicin|epirubicin|mesh-list
83146542|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83146543|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83146544|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146545|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
83146546|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
83146547|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
83146548|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146549|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146550|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
83146551|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146552|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146553|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83146554|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
83146555|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83146556|NCT04770272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83146557|NCT04770272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83146558|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83146559|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83146560|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83146561|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146562|NCT02251145|Ritonavir|ritonavir|mesh-list
83146563|NCT02251145|Tenofovir|tenofovir|mesh-list
83146564|NCT02251145|Tipranavir|tipranavir|mesh-list
83146565|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83146566|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83146567|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
83146568|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146569|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146570|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83146571|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83146572|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
83146573|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146574|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83146575|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83146576|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83146577|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83146578|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83146579|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83146580|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146581|NCT00709371|Zonisamide|zonisamide|mesh-list
83146582|NCT00709371|Bupropion|bupropion|mesh-list
83146583|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83146584|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
83146585|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83146586|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83146587|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83146588|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146589|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146590|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
83146591|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146592|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146593|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83146594|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83146595|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146596|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
83146597|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83146598|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83146599|NCT02426463|Oxycodone|oxycodone|mesh-list
83146600|NCT02426463|Propofol|propofol|mesh-list
83146601|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83146602|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146603|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146604|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83146605|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
83146606|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
83146607|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83146608|NCT02426463|Narcotics|narcotics|mesh-ancestor
83146609|NCT02426463|Analgesics|analgesics|mesh-ancestor
83146610|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
83146611|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146612|NCT02426229|Dabigatran|dabigatran|mesh-list
83146613|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
83146614|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83146615|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
83146616|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146617|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146618|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
83146619|NCT01648270|Buprenorphine|buprenorphine|mesh-list
83146620|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83146621|NCT01648270|Narcotics|narcotics|mesh-ancestor
83146622|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146623|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146624|NCT01648270|Analgesics|analgesics|mesh-ancestor
83146625|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
83146626|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146627|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83146628|NCT02108795|Remifentanil|remifentanil|mesh-list
83146629|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83146630|NCT02108795|Narcotics|narcotics|mesh-ancestor
83146631|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146632|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146633|NCT02108795|Analgesics|analgesics|mesh-ancestor
83146634|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
83146635|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146636|NCT02431143|Miltefosine|miltefosine|mesh-list
83146637|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
83146638|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146639|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146640|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83146641|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83476077|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
83146643|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146644|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
83146645|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146646|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146647|NCT02431065|Ropivacaine|ropivacaine|mesh-list
83146648|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
83146649|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
83146650|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146651|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146652|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
83146653|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146654|NCT04836806|Cetirizine|cetirizine|mesh-list
83146655|NCT04836806|Famotidine|famotidine|mesh-list
83146656|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83146657|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146658|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83146659|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
83146660|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
83146661|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146662|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146663|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146664|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83146665|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83146666|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83146667|NCT04836728|Paclitaxel|paclitaxel|mesh-list
83146668|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83146669|NCT04836728|Carboplatin|carboplatin|mesh-list
83146670|NCT04836728|Pemetrexed|pemetrexed|mesh-list
83146671|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83146672|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83146673|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146674|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
83146675|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
83146676|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
83146677|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146678|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146679|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83146680|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83146681|NCT04836728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83146682|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
83146683|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146684|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
83146685|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83146686|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
83146687|NCT02430909|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83146688|NCT02430909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146689|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146690|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
83146691|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146692|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146693|NCT02105675|Docetaxel|docetaxel|mesh-list
83146694|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146695|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
83146696|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
83146697|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
83146698|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146699|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
83146700|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146701|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
83146702|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146703|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83146704|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
83146705|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146706|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83146707|NCT04824404|Buprenorphine|buprenorphine|mesh-list
83146708|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83146709|NCT04824404|Narcotics|narcotics|mesh-ancestor
83476083|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146710|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146711|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146712|NCT04824404|Analgesics|analgesics|mesh-ancestor
83146713|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
83146714|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146715|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83146716|NCT02109341|Paclitaxel|paclitaxel|mesh-list
83146717|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83146718|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83146719|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146720|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
83146721|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
83146722|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
83146723|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146724|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
83146725|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83146726|NCT02336074|Vorinostat|vorinostat|mesh-list
83146727|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146728|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83146729|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146730|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146731|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83146732|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
83146733|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146734|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83146735|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83146736|NCT04367168|Colchicine|colchicine|mesh-list
83146737|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
83146738|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146739|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
83146740|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
83146741|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
83146742|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146743|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146744|NCT02113943|Citalopram|citalopram|mesh-list
83146745|NCT02113943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83146746|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83146747|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146748|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146749|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146750|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
83146751|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146752|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83146753|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
83146754|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83146755|NCT02114021|Betamethasone|betamethasone|mesh-list
83146756|NCT02114021|Lidocaine|lidocaine|mesh-list
83146757|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
83146758|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
83146759|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146760|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146761|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
83146762|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146763|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83401916|NCT05292664|Hormones|hormones|mesh-ancestor
83146764|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83146765|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83146766|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146767|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146768|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146769|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
83146770|NCT02114021|Hormones|hormones|mesh-ancestor
83146771|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146772|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83146773|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
83146774|NCT04826822|Dexamethasone|dexamethasone|mesh-list
83146775|NCT04826822|Spironolactone|spironolactone|mesh-list
83146776|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146777|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
83146778|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
83146779|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146780|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146781|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83146782|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
83146783|NCT04826822|Hormones|hormones|mesh-ancestor
83146784|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146785|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83146786|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146787|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83146788|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
83146789|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83146790|NCT04826822|Diuretics|diuretics|mesh-ancestor
83146791|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
83146792|NCT02251457|Ranolazine|ranolazine|mesh-list
83146793|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83146794|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146795|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146796|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
83146797|NCT02112305|Analgesics|analgesics|mesh-ancestor
83146798|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
83146799|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146800|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146801|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
83146802|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146803|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83146804|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
83146805|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83146806|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83146807|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146808|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83146809|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
83146810|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83146811|NCT02114099|Atorvastatin|atorvastatin|mesh-list
83146812|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83146813|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83146814|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
83146815|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146816|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83146817|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83146818|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146820|NCT02251223|Tipranavir|tipranavir|mesh-list
83146821|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83146822|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83146823|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
83146824|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146825|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146826|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83146827|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83146828|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
83146829|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146830|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83146831|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83146832|NCT02114333|Vaccines|vaccines|mesh-list
83146833|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
83146834|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146835|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
83146836|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83146837|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146838|NCT02114645|Leuprolide|leuprolide|mesh-list
83146839|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83146840|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83146841|NCT02114645|Estradiol|estradiol|mesh-list
83146842|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83146843|NCT02114645|Progesterone|progesterone|mesh-list
83146844|NCT02114645|Estrogens|estrogens|mesh-ancestor
83146845|NCT02114645|Hormones|hormones|mesh-ancestor
83146846|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146847|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146848|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83146849|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
83146850|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83146851|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83146852|NCT02114645|Progestins|progestins|mesh-ancestor
83146853|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83146854|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
83146855|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83146856|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146857|NCT02112695|Diprenorphine|diprenorphine|mesh-list
83146858|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83146859|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146860|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
83146861|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146862|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83146863|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83146864|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146865|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146866|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83146867|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82778462|NCT04880785|Lamivudine|lamivudine|mesh-list
83146868|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146869|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
83146870|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146871|NCT04361162|Nivolumab|nivolumab|mesh-list
83146872|NCT04361162|Ipilimumab|ipilimumab|mesh-list
83146873|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83146874|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146875|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83146876|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146877|NCT04823390|Fentanyl|fentanyl|mesh-list
83146878|NCT04823390|Midazolam|midazolam|mesh-list
83146879|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83146880|NCT04823390|Narcotics|narcotics|mesh-ancestor
83146881|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146882|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146883|NCT04823390|Analgesics|analgesics|mesh-ancestor
83146884|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
83146885|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146886|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83146887|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83146888|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
83146889|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
83146890|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83146891|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83146892|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83146893|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83146894|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
83146895|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
83146896|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146897|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146898|NCT05618912|Petrolatum|petrolatum|mesh-list
83146899|NCT05618912|Emollients|emollients|mesh-ancestor
83146900|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
83146901|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
83146902|NCT04826510|Perospirone|perospirone|mesh-list
83146903|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
83146904|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83146905|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146906|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146907|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
83146908|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83146909|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146910|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146911|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83146912|NCT03036800|Liraglutide|liraglutide|mesh-list
83146913|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83146914|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146916|NCT03036800|Hormones|hormones|mesh-ancestor
83146917|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83146918|NCT02301988|Paclitaxel|paclitaxel|mesh-list
83146919|NCT02301988|Ipatasertib|ipatasertib|mesh-list
83146920|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83146921|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146922|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
83146923|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
83146924|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
83146925|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146926|NCT02301988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83146927|NCT02301988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146928|NCT04326920|Sargramostim|sargramostim|mesh-list
83146929|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
83146930|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146931|NCT02112929|Xenon|xenon|mesh-list
83146932|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83146933|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
83146934|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
83146935|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146936|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146937|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
83146938|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83146939|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146940|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83146941|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83146942|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476119|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
83146943|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146944|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146946|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146947|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83146948|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146949|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146950|NCT02113319|Dasatinib|dasatinib|mesh-list
83146951|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83146952|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83146953|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146954|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146955|NCT02113397|Tobramycin|tobramycin|mesh-list
83146956|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83146957|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146958|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
83146959|NCT04822064|Ketamine|ketamine|mesh-list
83146960|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
83146961|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83146962|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83146963|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146964|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146965|NCT04822064|Analgesics|analgesics|mesh-ancestor
83146966|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
83146967|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146968|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83146969|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83146970|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83146971|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
83146972|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83146973|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146974|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83146975|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83146976|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
83146977|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
83146978|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83146979|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83146980|NCT03553433|Apremilast|apremilast|mesh-list
83146981|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83146982|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83146983|NCT03553433|Analgesics|analgesics|mesh-ancestor
83146984|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
83146985|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83146986|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83146987|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83146988|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83146989|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83146990|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83146991|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83146992|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83146993|NCT02604212|Tenofovir|tenofovir|mesh-list
83146994|NCT02604212|Entecavir|entecavir|mesh-list
83146995|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
83146996|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83146997|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
83146998|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83146999|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83147000|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83147001|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147002|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147003|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83147004|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83147005|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
83147006|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147007|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147008|NCT02115659|Triptolide|triptolide|mesh-list
83147009|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83147010|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147011|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83147012|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
83147013|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83147014|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83147015|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
83147016|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83147017|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
83147018|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147019|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147020|NCT02113631|Interferons|interferons|mesh-list
83147021|NCT02113631|Ribavirin|ribavirin|mesh-list
83147022|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
83147023|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
83147024|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83147025|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147026|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
83147027|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147028|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
83147029|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147030|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
83147031|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147032|NCT02123069|Nitroprusside|nitroprusside|mesh-list
83147033|NCT02123069|Phenylephrine|phenylephrine|mesh-list
83147034|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
83147035|NCT02123069|Norepinephrine|norepinephrine|mesh-list
83147036|NCT02123069|Acetylcholine|acetylcholine|mesh-list
83147037|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83147038|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
83147039|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
83147040|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147041|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147042|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
83147043|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83147044|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
83147045|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
83147046|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83147047|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83147048|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83147049|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147050|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147051|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147052|NCT02123069|Protective Agents|protective agents|mesh-ancestor
83147053|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83147054|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
83147055|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83147056|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83147057|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
83147058|NCT04428632|Berotralstat|berotralstat|mesh-list
83147059|NCT04428632|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83147060|NCT04428632|Protease Inhibitors|protease inhibitors|mesh-ancestor
83147061|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147062|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147063|NCT05618210|Anesthetics|anesthetics|mesh-list
83147064|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147065|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147066|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83147067|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83147068|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83147069|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83147070|NCT02789111|Alvimopan|alvimopan|mesh-list
83147071|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83147072|NCT04807166|Paclitaxel|paclitaxel|mesh-list
83147073|NCT04807166|Carboplatin|carboplatin|mesh-list
83147074|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83147075|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147076|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
83147077|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
83147078|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
83147079|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147080|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83147081|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83147082|NCT02251925|Estradiol|estradiol|mesh-list
83147083|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83147084|NCT02251925|Estrogens|estrogens|mesh-ancestor
83147085|NCT02251925|Hormones|hormones|mesh-ancestor
83147086|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147087|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147088|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83147089|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
83147090|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83147091|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83147092|NCT03552653|Vitamin D|vitamin d|mesh-list
83147093|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
83147094|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
83147096|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
83147097|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147098|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83147099|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83147100|NCT01359644|Ribavirin|ribavirin|mesh-list
83147101|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
83147102|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
83147103|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147104|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
83147105|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147106|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
83147107|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83147108|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83147109|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147110|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147111|NCT04806230|Mirtazapine|mirtazapine|mesh-list
83147112|NCT04806230|Citalopram|citalopram|mesh-list
83147113|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83147114|NCT04806230|Sertraline|sertraline|mesh-list
83147115|NCT04806230|Escitalopram|escitalopram|mesh-list
83147116|NCT04806230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83147117|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83147118|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83147119|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147120|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147121|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
83147122|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147123|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83147124|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
83147125|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83147126|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83147127|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83147128|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
83147129|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
83147130|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83147131|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83147132|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147133|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83147134|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83147135|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83147136|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147137|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83147138|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83147139|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83147140|NCT02603120|Tenofovir|tenofovir|mesh-list
83147141|NCT02603120|Emtricitabine|emtricitabine|mesh-list
83147142|NCT02603120|Lamivudine|lamivudine|mesh-list
83147143|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83147144|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
83147145|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147146|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83147147|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83147148|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147149|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147150|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83147151|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83147153|NCT04815200|Nickel|nickel|mesh-list
83147154|NCT04815200|Trace Elements|trace elements|mesh-ancestor
83147155|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
83147156|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147157|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83147158|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147159|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147160|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83147161|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147162|NCT04814030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83147163|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147164|NCT04412252|Tofacitinib|tofacitinib|mesh-list
83147165|NCT04412252|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83147166|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83147167|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147168|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147169|NCT04813952|Sevoflurane|sevoflurane|mesh-list
83147170|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83147171|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83147172|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
83147173|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
83147174|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147175|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147176|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
83147177|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83147178|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
83147179|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
83147180|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147181|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147182|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83147183|NCT04813874|Analgesics|analgesics|mesh-ancestor
83147184|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
83147185|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147186|NCT04803500|Simvastatin|simvastatin|mesh-list
83147187|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83147188|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83147189|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
83147190|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147191|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83221032|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147192|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83147193|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147194|NCT01331681|Aflibercept|aflibercept|mesh-list
83147195|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83147196|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83147197|NCT01331681|Growth Substances|growth substances|mesh-ancestor
83147198|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147199|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83147200|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147201|NCT02120339|Carvedilol|carvedilol|mesh-list
83147202|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83147203|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83147204|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147205|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147206|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147207|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147208|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83147209|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
83147210|NCT02120339|Protective Agents|protective agents|mesh-ancestor
83147211|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83147212|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83147213|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83147214|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
83147215|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83147216|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83147217|NCT02123381|Cetuximab|cetuximab|mesh-list
83147218|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83147219|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147220|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
83147221|NCT02123615|Antibodies|antibodies|mesh-list
83147222|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
83147223|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83147224|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83147225|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
83147226|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
83147227|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147228|NCT02120651|Hemostatics|hemostatics|mesh-list
83147229|NCT02120651|Coagulants|coagulants|mesh-ancestor
83147230|NCT02117219|Azacitidine|azacitidine|mesh-list
83147231|NCT02117219|Durvalumab|durvalumab|mesh-list
83147232|NCT02117219|Tremelimumab|tremelimumab|mesh-list
83147233|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83147234|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
83147235|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147236|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147237|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147238|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83147239|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83147240|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83147241|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83147242|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
83147243|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147244|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83147245|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83147246|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147247|NCT02124005|Bupivacaine|bupivacaine|mesh-list
83476145|NCT01439815|Xhance|xhance|mesh-list
83147248|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
83147249|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
83147250|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147251|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147252|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
83147253|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147254|NCT03551873|Plecanatide|plecanatide|mesh-list
83147255|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83147256|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
83147257|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147258|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83147259|NCT02117765|Ustekinumab|ustekinumab|mesh-list
83147260|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
83147262|NCT02121119|Bupivacaine|bupivacaine|mesh-list
83147263|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
83147264|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
83147265|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147266|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147267|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
83147268|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147269|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83147270|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83147271|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83147272|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83147273|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147274|NCT02121197|Dexamethasone|dexamethasone|mesh-list
83147275|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147276|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
83147277|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
83147278|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147279|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147280|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83147281|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
83147282|NCT02121197|Hormones|hormones|mesh-ancestor
83147283|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147284|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83147285|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147286|NCT02124317|Paclitaxel|paclitaxel|mesh-list
83147287|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83147288|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83147289|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147290|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
83147291|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
83147292|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
83147293|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147294|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
83147295|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147296|NCT02121353|Ranibizumab|ranibizumab|mesh-list
83147297|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83147298|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83147299|NCT02121353|Growth Substances|growth substances|mesh-ancestor
83147300|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147301|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
83147302|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147303|NCT05617430|Leucovorin|leucovorin|mesh-list
83147304|NCT05617430|Bevacizumab|bevacizumab|mesh-list
83147305|NCT05617430|Fluorouracil|fluorouracil|mesh-list
83147306|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
83147307|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83147308|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147309|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83147310|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83147311|NCT05617430|Growth Substances|growth substances|mesh-ancestor
83147312|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147313|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
83147314|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
83147315|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147316|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83147317|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83147318|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
83147319|NCT05617430|Antidotes|antidotes|mesh-ancestor
83147320|NCT05617430|Protective Agents|protective agents|mesh-ancestor
83147321|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
83147322|NCT05617430|Vitamins|vitamins|mesh-ancestor
83147323|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
83147324|NCT02251691|Tacrolimus|tacrolimus|mesh-list
83147325|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83147326|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
83147327|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147328|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83147329|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147330|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147331|NCT02595398|Triamcinolone|triamcinolone|mesh-list
83147332|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83147333|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83147334|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83147335|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147336|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
83147337|NCT02595398|Hormones|hormones|mesh-ancestor
83147338|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147339|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147340|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83147341|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
83147342|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147343|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147344|NCT02251769|Ritonavir|ritonavir|mesh-list
83147345|NCT02251769|Tipranavir|tipranavir|mesh-list
83147346|NCT02251769|Clarithromycin|clarithromycin|mesh-list
83147347|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83147348|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83147349|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
83147350|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147351|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147352|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83147353|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83147354|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
83147355|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147356|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83147357|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83147358|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83147359|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83147360|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
83147361|NCT02118311|Fludarabine|fludarabine|mesh-list
83147362|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83147363|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
83147364|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147365|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83147366|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83147367|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
83147368|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147369|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147370|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83147371|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83147372|NCT01368497|Entecavir|entecavir|mesh-list
83147373|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
83147374|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147375|NCT04812860|Tramadol|tramadol|mesh-list
83147376|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83147377|NCT04812860|Narcotics|narcotics|mesh-ancestor
83147378|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147379|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147380|NCT04812860|Analgesics|analgesics|mesh-ancestor
83147381|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
83147382|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147383|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
83147384|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83147385|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83147386|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147387|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
83147388|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
83147389|NCT04427540|Oxytocin|oxytocin|mesh-list
83147390|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
83147391|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83147392|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147393|NCT04801940|Apixaban|apixaban|mesh-list
83147394|NCT04801940|Atorvastatin|atorvastatin|mesh-list
83147395|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83147396|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83147397|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
83147398|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147399|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83147400|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83147401|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147402|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83147403|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
83147404|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83147405|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
83147406|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
83147407|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83147408|NCT02251847|Ezetimibe|ezetimibe|mesh-list
83147409|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83147410|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83147411|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
83147412|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147413|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83147414|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83147415|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147416|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83147417|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83147418|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147419|NCT02127047|Incretins|incretins|mesh-ancestor
83147420|NCT02127047|Hormones|hormones|mesh-ancestor
83147421|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147422|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83147423|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83147424|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147425|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147426|NCT02122055|Fentanyl|fentanyl|mesh-list
83147427|NCT02122055|Midazolam|midazolam|mesh-list
83147428|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
83147429|NCT02122055|Propofol|propofol|mesh-list
83147430|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83147431|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147432|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147433|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83147434|NCT02122055|Analgesics|analgesics|mesh-ancestor
83147435|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
83147436|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147437|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83147438|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83147439|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83147440|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147441|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147442|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147443|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83147444|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
83147445|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
83147446|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83147447|NCT02122055|Narcotics|narcotics|mesh-ancestor
83147448|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83147449|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83147450|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83147451|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83147452|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
83147453|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
83147454|NCT02125409|Aspirin|aspirin|mesh-list
83147455|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83147456|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83147457|NCT02125409|Analgesics|analgesics|mesh-ancestor
83147458|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
83147459|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147460|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147461|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147462|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83147463|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83147464|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83476197|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147465|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147466|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83147467|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83147468|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147470|NCT04816838|Osimertinib|osimertinib|mesh-list
83147471|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147472|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83147473|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147474|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147475|NCT02788175|Vedolizumab|vedolizumab|mesh-list
83147476|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83147477|NCT03551171|Niraparib|niraparib|mesh-list
83147478|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83147479|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147480|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147481|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147482|NCT02787083|Mirabegron|mirabegron|mesh-list
83147483|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83147484|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83147485|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83147486|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147487|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147488|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147489|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147490|NCT02787083|Urological Agents|urological agents|mesh-ancestor
83147491|NCT02122211|Betaine|betaine|mesh-list
83147492|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83147493|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
83147494|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83147495|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
83147496|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147497|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83147498|NCT02125565|Lidocaine|lidocaine|mesh-list
83147499|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
83147500|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
83147501|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147502|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147503|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
83147504|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147505|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83147506|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83147507|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83147508|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83147509|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147510|NCT02125643|Caffeine|caffeine|mesh-list
83147511|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83147512|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147513|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83147514|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147515|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147516|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83147517|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83147518|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
83147519|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147520|NCT02127437|Lanreotide|lanreotide|mesh-list
83147521|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147522|NCT05319587|Cytarabine|cytarabine|mesh-list
83147523|NCT05319587|Annamycin|annamycin|mesh-list
83147524|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83147525|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
83147526|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147527|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147528|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
83147529|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147530|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83147531|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
83147532|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147533|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83147534|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
83147535|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83147536|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
83147537|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147538|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
83147539|NCT02122601|Protective Agents|protective agents|mesh-ancestor
83147540|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
83147541|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83147542|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83147543|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83147544|NCT02127593|Norgestimate|norgestimate|mesh-list
83147545|NCT02127593|Norgestrel|norgestrel|mesh-list
83147546|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83147547|NCT02127593|Estradiol|estradiol|mesh-list
83147548|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83147549|NCT02127593|Estrogens|estrogens|mesh-ancestor
83147550|NCT02127593|Hormones|hormones|mesh-ancestor
83147551|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147552|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147553|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83147554|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
83147555|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83147556|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83147557|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83147558|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83147559|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83147560|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83147561|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147562|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83147563|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83147564|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147565|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147566|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147567|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83147568|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
83147569|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83147570|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83147571|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147572|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
83147573|NCT02122679|Coagulants|coagulants|mesh-ancestor
83147574|NCT04810754|Daratumumab|daratumumab|mesh-list
83147575|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147576|NCT02127749|Metronidazole|metronidazole|mesh-list
83147577|NCT02127749|Vancomycin|vancomycin|mesh-list
83147578|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
83147579|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147580|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83147581|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83147582|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83147583|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83147584|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83147585|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147586|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147587|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147588|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83147589|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83147590|NCT04797338|Nafarelin|nafarelin|mesh-list
83147591|NCT04797338|Progesterone|progesterone|mesh-list
83147592|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83147593|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83147594|NCT04797338|Estradiol|estradiol|mesh-list
83147595|NCT04797338|Progestins|progestins|mesh-ancestor
83147596|NCT04797338|Hormones|hormones|mesh-ancestor
83147597|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147598|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147599|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83147600|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
83147601|NCT04797338|Estrogens|estrogens|mesh-ancestor
83147602|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83147603|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83147604|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
83147605|NCT05272865|Dronabinol|dronabinol|mesh-list
83147606|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
83147607|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147608|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83147609|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83147610|NCT05272865|Analgesics|analgesics|mesh-ancestor
83147611|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
83147612|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147613|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83147614|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83147615|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147616|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147617|NCT05272865|Hormones|hormones|mesh-ancestor
83147618|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147619|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83147620|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
83147621|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147622|NCT04809818|Aspirin|aspirin|mesh-list
83147623|NCT04809818|Dabigatran|dabigatran|mesh-list
83147624|NCT04809818|Apixaban|apixaban|mesh-list
83147625|NCT04809818|Clopidogrel|clopidogrel|mesh-list
83147626|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83147627|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83147628|NCT04809818|Analgesics|analgesics|mesh-ancestor
83147629|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
83147630|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147631|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147632|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147633|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83147634|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83147635|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83147636|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147637|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83147638|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83147639|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147640|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
83147641|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83147642|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83147643|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83147644|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
83147645|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147646|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
83147647|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83147648|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
83147649|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
83147650|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83147651|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
83147652|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
83147653|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147654|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
83147655|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147656|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83147657|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
83147658|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
83147659|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83147660|NCT02126267|Azithromycin|azithromycin|mesh-list
83147661|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83147662|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147663|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
83147664|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83402069|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83147665|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83147666|NCT02128061|Rituximab|rituximab|mesh-list
83147667|NCT02128061|Lenalidomide|lenalidomide|mesh-list
83147668|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83147669|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147670|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
83147671|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147672|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83147673|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83147674|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83147675|NCT02128061|Growth Substances|growth substances|mesh-ancestor
83147676|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
83147677|NCT02596958|Bevacizumab|bevacizumab|mesh-list
83147678|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83147679|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147680|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83147681|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83147682|NCT02596958|Growth Substances|growth substances|mesh-ancestor
83147683|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147684|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
83147685|NCT02126579|Poly ICLC|poly iclc|mesh-list
83147686|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
83147687|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
83147688|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147689|NCT04808648|Itraconazole|itraconazole|mesh-list
83147690|NCT04808648|Rifampin|rifampin|mesh-list
83147691|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
83147692|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147693|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83147694|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83147695|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147696|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147697|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83147698|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
83147699|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147700|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147701|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83147702|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83147703|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
83147704|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83147705|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
83147706|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83147707|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83147708|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83147709|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83147710|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83147711|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83147712|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83147713|NCT02126657|Glycolic acid|glycolic acid|mesh-list
83147714|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
83147715|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
83147716|NCT02128451|Fentanyl|fentanyl|mesh-list
83147717|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83147718|NCT02128451|Narcotics|narcotics|mesh-ancestor
83147719|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147720|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147721|NCT02128451|Analgesics|analgesics|mesh-ancestor
83147722|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
83147723|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147724|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83147725|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83147726|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
83147727|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
83147728|NCT04785716|Niraparib|niraparib|mesh-list
83147729|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83147730|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147731|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83476226|NCT00265850|Hematinics|hematinics|mesh-ancestor
83147732|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147733|NCT01367249|Bromfenac|bromfenac|mesh-list
83147734|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83147735|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83147736|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83147737|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83147738|NCT01367249|Analgesics|analgesics|mesh-ancestor
83147739|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
83147740|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147741|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147742|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147743|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83147744|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
83147745|NCT02128685|Progestins|progestins|mesh-ancestor
83147746|NCT02128685|Hormones|hormones|mesh-ancestor
83147747|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147748|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147749|NCT02252627|Phenylephrine|phenylephrine|mesh-list
83147750|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
83147751|NCT02252627|Ephedrine|ephedrine|mesh-list
83147752|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83147753|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
83147754|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
83147755|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147756|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147757|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
83147758|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83147759|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
83147760|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
83147761|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83147762|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83147763|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83147764|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147765|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147766|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147767|NCT02252627|Protective Agents|protective agents|mesh-ancestor
83147768|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83147769|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
83147770|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83147771|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
83147772|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83147773|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
83147774|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147775|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147776|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
83147777|NCT03550859|Telmisartan|telmisartan|mesh-list
83147778|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83147779|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83147780|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83147781|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
83147782|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147783|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83147784|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83147785|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147786|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83147787|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83147788|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83147789|NCT03550781|Prednisone|prednisone|mesh-list
83147790|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
83147791|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83147792|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
83147793|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147794|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83147795|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83147796|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
83147797|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147798|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147799|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83147800|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147801|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
83147802|NCT03550781|Hormones|hormones|mesh-ancestor
83147803|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147804|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83147805|NCT02260661|Fulvestrant|fulvestrant|mesh-list
83147806|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83147807|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147808|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83147809|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83147810|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
83402146|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147811|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147812|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147813|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
83147814|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
83147815|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83147816|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83147817|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147818|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147819|NCT02136329|Urological Agents|urological agents|mesh-ancestor
83147820|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
83147821|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83147822|NCT02129231|Simvastatin|simvastatin|mesh-list
83147823|NCT02129231|Ezetimibe|ezetimibe|mesh-list
83147824|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83147825|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83147826|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83147827|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
83147828|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147829|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83147830|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83147831|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147832|NCT02129231|Antacids|antacids|mesh-ancestor
83147833|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83147834|NCT02136641|Fentanyl|fentanyl|mesh-list
83147835|NCT02136641|Midazolam|midazolam|mesh-list
83147836|NCT02136641|Ketamine|ketamine|mesh-list
83147837|NCT02136641|Analgesics|analgesics|mesh-ancestor
83147838|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
83147839|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147840|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147841|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83147842|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83147843|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
83147844|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
83147845|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147846|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83147847|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83147848|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147849|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147850|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83147851|NCT02136641|Narcotics|narcotics|mesh-ancestor
83147852|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83147853|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83147854|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83147855|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83147856|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83147857|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
83147858|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
83147859|NCT03549689|Tenofovir|tenofovir|mesh-list
83147860|NCT03549689|Lamivudine|lamivudine|mesh-list
83147861|NCT03549689|Dolutegravir|dolutegravir|mesh-list
83147862|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
83147863|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147864|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83147865|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83147866|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147867|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147868|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83147869|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83147870|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83147871|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83147872|NCT02129621|Spironolactone|spironolactone|mesh-list
83147873|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83147874|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
83147875|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147876|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147877|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83147878|NCT02129621|Diuretics|diuretics|mesh-ancestor
83147879|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
83147880|NCT02129699|Denosumab|denosumab|mesh-list
83147881|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83147882|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147883|NCT03549923|Esmolol|esmolol|mesh-list
83147884|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83147885|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83147886|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83147887|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147888|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147889|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147890|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147891|NCT02136875|Fluticasone|fluticasone|mesh-list
83147892|NCT02136875|Xhance|xhance|mesh-list
83147893|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83147894|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147895|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83147896|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
83147897|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147898|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147899|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83147900|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
83147901|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83147902|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83147903|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83147904|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83147905|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83147906|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
83147907|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147908|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147910|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83147911|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147912|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83147913|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83147914|NCT02129933|Growth Substances|growth substances|mesh-ancestor
83147915|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147916|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
83147917|NCT02132897|Carbamazepine|carbamazepine|mesh-list
83147918|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
83147919|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
83147920|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83147921|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83147922|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147923|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83147925|NCT02132897|Analgesics|analgesics|mesh-ancestor
83147926|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
83147927|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147928|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83147929|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83147930|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147931|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83147932|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83147933|NCT02133053|Beclomethasone|beclomethasone|mesh-list
83147934|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147935|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
83147936|NCT02133053|Hormones|hormones|mesh-ancestor
83147937|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83147938|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147939|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83147940|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83147941|NCT02137109|Natalizumab|natalizumab|mesh-list
83147942|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
83147943|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147944|NCT02130167|Atropine|atropine|mesh-list
83147945|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83147946|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83147947|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83147948|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
83147949|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147950|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147951|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83147952|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83147953|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
83147954|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
83147955|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83147956|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83147957|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83147958|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147959|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147961|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83147962|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
83147963|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147964|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83147965|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
83147966|NCT03549611|Acetaminophen|acetaminophen|mesh-list
83147967|NCT03549611|Celecoxib|celecoxib|mesh-list
83147968|NCT03549611|Oxycodone|oxycodone|mesh-list
83147970|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83147971|NCT03549611|Analgesics|analgesics|mesh-ancestor
83402223|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
83147972|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
83402224|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
83147973|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83147974|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83147976|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83147977|NCT03549611|Narcotics|narcotics|mesh-ancestor
83147978|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83402380|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
83147979|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83147980|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83147982|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83147983|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83147984|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83147985|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83147986|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
83147987|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83147988|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83147989|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83147990|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83147991|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83147992|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83147993|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
83147994|NCT02133287|Sirolimus|sirolimus|mesh-list
83147995|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
83147996|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83147997|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83147998|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83147999|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148001|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83148002|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
83148003|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148005|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83148006|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
83148007|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83402837|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
83148008|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148009|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83148010|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
83148011|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83148012|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83148013|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83148015|NCT02592434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83402987|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
83403066|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
83148016|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83148017|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148018|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148019|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
83148020|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83403067|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83403068|NCT01347255|Betamethasone|betamethasone|mesh-list
83148021|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83403069|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
83403372|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
83403522|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83148022|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83148023|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479595|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83148024|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148025|NCT02137421|Resveratrol|resveratrol|mesh-list
83148026|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
83148027|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148028|NCT02137421|Protective Agents|protective agents|mesh-ancestor
83148029|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148030|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148031|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83148032|NCT02133677|Temozolomide|temozolomide|mesh-list
83148033|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83148034|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
83148035|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148036|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148037|NCT02137733|Carvedilol|carvedilol|mesh-list
83148038|NCT02137733|Bisoprolol|bisoprolol|mesh-list
83479596|NCT05415215|Trastuzumab|trastuzumab|mesh-list
83403523|NCT04937946|Narcotics|narcotics|mesh-ancestor
83148039|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83148040|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83148041|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148042|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148043|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83403601|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83148044|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403677|NCT04844905|Artenimol|artenimol|mesh-list
83476252|NCT01042145|Dexamethasone|dexamethasone|mesh-list
83403678|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83148045|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83148046|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
83148047|NCT02137733|Protective Agents|protective agents|mesh-ancestor
83403828|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148048|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83148049|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148050|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83148051|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
83148052|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83404512|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
83404513|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83148053|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83148054|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
83148055|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
83404664|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148056|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83404740|NCT05873738|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83479598|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83148057|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83148058|NCT02133755|Bromocriptine|bromocriptine|mesh-list
83148059|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83148060|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83148061|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83479599|NCT05415215|Maytansine|maytansine|mesh-list
83404741|NCT05873738|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83404742|NCT05873738|Cholinergic Agents|cholinergic agents|mesh-ancestor
83404894|NCT05872256|Dermatologic Agents|dermatologic agents|mesh-ancestor
83173420|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83173422|NCT04040231|Sargramostim|sargramostim|mesh-list
83148062|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148063|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148064|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
83148065|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
83148067|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148068|NCT02130869|Cytarabine|cytarabine|mesh-list
83148069|NCT02130869|Aldesleukin|aldesleukin|mesh-list
83148070|NCT02130869|Carboplatin|carboplatin|mesh-list
83148071|NCT02130869|Etoposide|etoposide|mesh-list
83148072|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
83148073|NCT02130869|Melphalan|melphalan|mesh-list
83148074|NCT02130869|Busulfan|busulfan|mesh-list
83148075|NCT02130869|Interleukin-2|interleukin-2|mesh-list
83148076|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83148077|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
83148079|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148080|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83148081|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83148082|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83404895|NCT05872256|Keratolytic Agents|keratolytic agents|mesh-ancestor
83404973|NCT05868174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148084|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148085|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83148086|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
83148087|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
83148088|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83405427|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
83405428|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
83148089|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83148090|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
83148091|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148092|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83148093|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
83148094|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83148095|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83148096|NCT02130869|Analgesics|analgesics|mesh-ancestor
83148097|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
83148098|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148099|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83148100|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83148101|NCT02133911|Ranolazine|ranolazine|mesh-list
83148102|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83148103|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148104|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148105|NCT02133989|Ticlopidine|ticlopidine|mesh-list
83148106|NCT02133989|Clopidogrel|clopidogrel|mesh-list
83148107|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83148108|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83148109|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83148110|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83148111|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
83148112|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148113|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148114|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148115|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83148116|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83148117|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83148118|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83148119|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148120|NCT02138045|Liraglutide|liraglutide|mesh-list
83148121|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83148122|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148124|NCT02138045|Hormones|hormones|mesh-ancestor
83148125|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148126|NCT02134067|Paclitaxel|paclitaxel|mesh-list
83148127|NCT02134067|TAS-119|tas-119|mesh-list
83148128|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83148129|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148130|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
83148131|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
83148132|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
83148133|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148134|NCT02134067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83148135|NCT02134067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148136|NCT04091126|Dexamethasone|dexamethasone|mesh-list
83148137|NCT04091126|Lenalidomide|lenalidomide|mesh-list
83148138|NCT04091126|Bortezomib|bortezomib|mesh-list
83148139|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148140|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
83148141|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
83406034|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83148143|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148144|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148146|NCT04091126|Hormones|hormones|mesh-ancestor
83148147|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148148|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83148149|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148150|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
83148151|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83148152|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83148153|NCT04091126|Growth Substances|growth substances|mesh-ancestor
83148154|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
83148155|NCT03962114|Niacinamide|niacinamide|mesh-list
83148156|NCT03962114|Niacin|niacin|mesh-list
83148157|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
83148158|NCT03962114|Vitamins|vitamins|mesh-ancestor
83148159|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
83148160|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148161|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
83148162|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83148163|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
83148164|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148165|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83148166|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
83148167|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
83148168|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
83148169|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
83148170|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148171|NCT05472896|Epirubicin|epirubicin|mesh-list
83148172|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83148173|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83406035|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83148174|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83148175|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83148176|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148177|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148178|NCT02138357|Buprenorphine|buprenorphine|mesh-list
83148179|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83148180|NCT02138357|Narcotics|narcotics|mesh-ancestor
83148181|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148182|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148183|NCT02138357|Analgesics|analgesics|mesh-ancestor
83148184|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
83148185|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148187|NCT03596918|Vincristine|vincristine|mesh-list
83148188|NCT03596918|Bleomycin|bleomycin|mesh-list
83148189|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83148190|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148191|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
83148192|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
83148193|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
83148194|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148195|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83148196|NCT03535298|Interferons|interferons|mesh-list
83148197|NCT03535298|Interferon-beta|interferon-beta|mesh-list
83148198|NCT03535298|Teriflunomide|teriflunomide|mesh-list
83148199|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
83148200|NCT03535298|Ofatumumab|ofatumumab|mesh-list
83148201|NCT03535298|Cladribine|cladribine|mesh-list
83148202|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
83148203|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83148204|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
83148205|NCT03535298|Natalizumab|natalizumab|mesh-list
83148206|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83148207|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
83148208|NCT03535298|Ozanimod|ozanimod|mesh-list
83148209|NCT03535298|Ponesimod|ponesimod|mesh-list
83148210|NCT03535298|Siponimod|siponimod|mesh-list
83148211|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83148212|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148213|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
83148214|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148215|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148216|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
83148217|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148218|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173423|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83148219|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83148220|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148221|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
83148222|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83221033|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83148223|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83148224|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83148225|NCT03535298|Analgesics|analgesics|mesh-ancestor
83148226|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
83148227|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83406258|NCT05909072|Protective Agents|protective agents|mesh-ancestor
83148228|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148229|NCT02134379|Clotrimazole|clotrimazole|mesh-list
83148231|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83476487|NCT00183092|Quinacrine|quinacrine|mesh-list
83476861|NCT01474213|Narcotics|narcotics|mesh-ancestor
83476985|NCT00210470|Zinc|zinc|mesh-list
83477035|NCT04352153|Febuxostat|febuxostat|mesh-list
83221034|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
83477414|NCT01149785|Ketoconazole|ketoconazole|mesh-list
83477482|NCT01177709|Metformin|metformin|mesh-list
83477944|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478049|NCT01481545|Antidotes|antidotes|mesh-ancestor
83148232|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83478308|NCT03010475|Diuretics|diuretics|mesh-ancestor
83148233|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
83148234|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83148235|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83148236|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479045|NCT05901467|Hormones|hormones|mesh-list
83479117|NCT05900895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479434|NCT05610319|Faricimab|faricimab|mesh-list
83479519|NCT05463133|Sirolimus|sirolimus|mesh-list
83479607|NCT05415215|Immunotoxins|immunotoxins|mesh-ancestor
83148237|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148238|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83480179|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
83148239|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
83480372|NCT04191499|Fulvestrant|fulvestrant|mesh-list
83480444|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
83480523|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83480603|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83480811|NCT02972840|Rituximab|rituximab|mesh-list
83480971|NCT01856478|Methotrexate|methotrexate|mesh-list
83481050|NCT00777036|Dasatinib|dasatinib|mesh-list
83481135|NCT00393380|Teriparatide|teriparatide|mesh-list
83481296|NCT00401414|Warfarin|warfarin|mesh-list
83481625|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221035|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221036|NCT00301457|Anastrozole|anastrozole|mesh-list
83221037|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83482121|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83482202|NCT05480046|Risperidone|risperidone|mesh-list
83482486|NCT03463460|Sunitinib|sunitinib|mesh-list
83482619|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
83482856|NCT00546104|Dasatinib|dasatinib|mesh-list
83482940|NCT00493064|Vitamins|vitamins|mesh-ancestor
83221038|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83483586|NCT05070156|Vaccines|vaccines|mesh-list
83221039|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83221040|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83221041|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83484420|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484496|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83484576|NCT02129426|Analgesics|analgesics|mesh-ancestor
83484736|NCT01571557|Dexamethasone|dexamethasone|mesh-list
83485026|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
83485174|NCT00585182|Enoxaparin|enoxaparin|mesh-list
83485399|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83485475|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83485622|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148240|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83486072|NCT00251576|Tinzaparin|tinzaparin|mesh-list
83486373|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83486447|NCT00595556|Zonisamide|zonisamide|mesh-list
83148241|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83486840|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
83148242|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83487136|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
83487523|NCT01270490|Interferons|interferons|mesh-list
83487671|NCT00731588|Biotin|biotin|mesh-list
83487745|NCT01275170|Imipenem|imipenem|mesh-list
83488283|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
83488510|NCT00780494|Bevacizumab|bevacizumab|mesh-list
83488658|NCT01250717|Dexamethasone|dexamethasone|mesh-list
83488888|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
83489035|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
83148243|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83148244|NCT03511118|Metformin|metformin|mesh-list
83489726|NCT03839888|Atropine|atropine|mesh-list
83148245|NCT03511118|Topiramate|topiramate|mesh-list
83490566|NCT01419275|Xenon|xenon|mesh-list
83148246|NCT03511118|Azithromycin|azithromycin|mesh-list
83148247|NCT03511118|Doxycycline|doxycycline|mesh-list
83148249|NCT03511118|Levofloxacin|levofloxacin|mesh-list
83148250|NCT03511118|Clindamycin|clindamycin|mesh-list
83148251|NCT03511118|Valganciclovir|valganciclovir|mesh-list
83148252|NCT03511118|Remdesivir|remdesivir|mesh-list
83148253|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
83492008|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83492312|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492620|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83492694|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83492929|NCT03409874|Analgesics|analgesics|mesh-ancestor
83493232|NCT01723748|Hormones|hormones|mesh-list
83148254|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83493386|NCT03001193|Oxytocin|oxytocin|mesh-list
83493690|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
83148255|NCT03511118|Verapamil|verapamil|mesh-list
83148256|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83148257|NCT03511118|Labetalol|labetalol|mesh-list
83493910|NCT03401294|Antidotes|antidotes|mesh-ancestor
83148258|NCT03511118|Nifedipine|nifedipine|mesh-list
83148259|NCT03511118|Furosemide|furosemide|mesh-list
83494293|NCT02221739|Ipilimumab|ipilimumab|mesh-list
83494457|NCT03399539|Venetoclax|venetoclax|mesh-list
83148260|NCT03511118|Sumatriptan|sumatriptan|mesh-list
83148261|NCT03511118|Oxycodone|oxycodone|mesh-list
83148262|NCT03511118|Gabapentin|gabapentin|mesh-list
83495248|NCT02449902|Estradiol|estradiol|mesh-list
83148263|NCT03511118|Ondansetron|ondansetron|mesh-list
83148264|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
83148265|NCT03511118|Trazodone|trazodone|mesh-list
83495383|NCT04355936|Telmisartan|telmisartan|mesh-list
83148266|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
83495642|NCT03875144|Doxorubicin|doxorubicin|mesh-list
83148267|NCT03511118|Methylphenidate|methylphenidate|mesh-list
83148268|NCT03511118|Citalopram|citalopram|mesh-list
83148269|NCT03511118|Sertraline|sertraline|mesh-list
83496329|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
83496559|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
83496631|NCT01788020|Dexamethasone|dexamethasone|mesh-list
83148270|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83148271|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
83148272|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83497411|NCT02740868|Xenon|xenon|mesh-list
83497474|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
83148273|NCT03511118|Escitalopram|escitalopram|mesh-list
83497906|NCT02435901|Cyclosporine|cyclosporine|mesh-list
83148274|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83406259|NCT05909059|Cyclophosphamide|cyclophosphamide|mesh-list
83498659|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
83498741|NCT01143818|Hormones|hormones|mesh-ancestor
83498807|NCT02501265|Nicotine|nicotine|mesh-list
83499364|NCT02432040|Atorvastatin|atorvastatin|mesh-list
83148275|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148276|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83500576|NCT02620865|Vitamins|vitamins|mesh-ancestor
83500755|NCT01333046|Azacitidine|azacitidine|mesh-list
83148277|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83500908|NCT01286402|Bupropion|bupropion|mesh-list
83148278|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
83501321|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
83501414|NCT01232504|Molgramostim|molgramostim|mesh-list
83501513|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
83148279|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83501661|NCT01739699|Acetaminophen|acetaminophen|mesh-list
83148280|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83501822|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83502067|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
83502141|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83502309|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83502593|NCT02253173|Estradiol|estradiol|mesh-list
83502834|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83502913|NCT02631057|Warfarin|warfarin|mesh-list
83503062|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83503304|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
83148281|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83503503|NCT01734161|Dexamethasone|dexamethasone|mesh-list
83148282|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148283|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83504108|NCT05327621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148284|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83148285|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
83504683|NCT02735187|Vitamin D|vitamin d|mesh-list
83148286|NCT03511118|Coagulants|coagulants|mesh-ancestor
83504920|NCT05442411|Parecoxib|parecoxib|mesh-list
83148287|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83148288|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83505756|NCT00369603|Donepezil|donepezil|mesh-list
83148289|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83148290|NCT03511118|Narcotics|narcotics|mesh-ancestor
83505899|NCT03022877|Simendan|simendan|mesh-list
83506122|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
83148291|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83506273|NCT05451381|Analgesics|analgesics|mesh-ancestor
83506353|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
83148292|NCT03511118|Analgesics|analgesics|mesh-ancestor
83506680|NCT01512446|Alendronate|alendronate|mesh-list
83507021|NCT05062317|Leucovorin|leucovorin|mesh-list
83507099|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83507248|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83507421|NCT03581409|Analgesics|analgesics|mesh-ancestor
83148293|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
83507738|NCT02988089|Antacids|antacids|mesh-ancestor
83507965|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
83508051|NCT05408585|Anesthetics|anesthetics|mesh-list
83508217|NCT04523480|Hormones|hormones|mesh-ancestor
83508295|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
83508747|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83508830|NCT03045861|Cobicistat|cobicistat|mesh-list
83509111|NCT02944461|Dapsone|dapsone|mesh-list
83509183|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
83509621|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83509818|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
83148294|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148295|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
83148296|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83148297|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83148298|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83148299|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83510900|NCT03744663|Analgesics|analgesics|mesh-ancestor
83510981|NCT05293509|Hormones|hormones|mesh-ancestor
83511126|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83511279|NCT02196155|Cortisone|cortisone|mesh-list
83148300|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83148301|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148302|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
83148303|NCT03511118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83148304|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83406560|NCT05903703|Canagliflozin|canagliflozin|mesh-list
83148305|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148306|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
83148307|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
83148308|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83148309|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
83148310|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
83148311|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83512100|NCT02018627|Glucagon|glucagon|mesh-list
83512250|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
83148312|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
83148313|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83512628|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83148314|NCT03511118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83148315|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83148316|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83148317|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83148318|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
83513773|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83148319|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83513926|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83148320|NCT03511118|Diuretics|diuretics|mesh-ancestor
83514079|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
83148321|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
83514234|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
83514307|NCT00376701|Bevacizumab|bevacizumab|mesh-list
83514459|NCT01863134|Eptifibatide|eptifibatide|mesh-list
83514756|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148322|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83148323|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
83515224|NCT00550550|Analgesics|analgesics|mesh-ancestor
83515371|NCT01880840|Azelastine|azelastine|mesh-list
83515677|NCT01189071|Darifenacin|darifenacin|mesh-list
83148324|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83148326|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83515948|NCT01904864|Iron|iron|mesh-list
83515977|NCT00965055|Atorvastatin|atorvastatin|mesh-list
83148327|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83148328|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148329|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83148330|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83148331|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83517103|NCT00000225|Analgesics|analgesics|mesh-ancestor
83406561|NCT05903703|Gemcitabine|gemcitabine|mesh-list
83517791|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83148332|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83148333|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83518109|NCT05270057|Prednisone|prednisone|mesh-list
83148334|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83518325|NCT00002097|Nystatin|nystatin|mesh-list
83148335|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
83518554|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
83518786|NCT00002187|Fomivirsen|fomivirsen|mesh-list
83518861|NCT00002397|Lamivudine|lamivudine|mesh-list
83518937|NCT00002415|Tenofovir|tenofovir|mesh-list
83519012|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83519169|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
83148336|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83519867|NCT05806723|Atorvastatin|atorvastatin|mesh-list
83148337|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83520251|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
83148338|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83148339|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
83148340|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
83520860|NCT01370811|Mandelic Acids|mandelic acids|mesh-list
83521092|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83521170|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83521555|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83521934|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
83148341|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83522084|NCT01655563|Tacrolimus|tacrolimus|mesh-list
83148342|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83522607|NCT02287376|Analgesics|analgesics|mesh-ancestor
83522681|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
83522981|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
83148343|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83523364|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83523443|NCT01707043|Hormones|hormones|mesh-ancestor
83148344|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83523822|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
83148345|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83148346|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83524205|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
83148348|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83148349|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83148350|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83148351|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83524958|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148352|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83148353|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83148354|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148355|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
83148356|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83148357|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83148358|NCT02134457|Ranibizumab|ranibizumab|mesh-list
83148359|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83525034|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148360|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83525720|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
83148361|NCT02134457|Growth Substances|growth substances|mesh-ancestor
83526701|NCT02268955|Ibuprofen|ibuprofen|mesh-list
83148362|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148363|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
83148364|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148365|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
83527078|NCT02647099|Aspirin|aspirin|mesh-list
83527160|NCT02989129|Quercetin|quercetin|mesh-list
83148366|NCT04090190|Fesoterodine|fesoterodine|mesh-list
83527462|NCT05688215|Vitamins|vitamins|mesh-ancestor
83148367|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83527611|NCT02823145|Fenfluramine|fenfluramine|mesh-list
83148369|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83148370|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83148371|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
83527917|NCT00367211|Naproxen|naproxen|mesh-list
83528057|NCT05044871|Bevacizumab|bevacizumab|mesh-list
83528303|NCT02268864|Simeprevir|simeprevir|mesh-list
83528440|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
83528530|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
83528665|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83528745|NCT00369551|Paclitaxel|paclitaxel|mesh-list
83528818|NCT03137771|Gemcitabine|gemcitabine|mesh-list
83148372|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83529139|NCT05364515|Clobetasol|clobetasol|mesh-list
83529193|NCT00371111|Hormones|hormones|mesh-ancestor
83529273|NCT01898689|Ropivacaine|ropivacaine|mesh-list
83529417|NCT04921007|Bupivacaine|bupivacaine|mesh-list
83529492|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83529642|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83529720|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83530030|NCT02296099|Bupivacaine|bupivacaine|mesh-list
83148373|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148374|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148375|NCT04090190|Urological Agents|urological agents|mesh-ancestor
83530806|NCT02810873|Copper|copper|mesh-list
83530868|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
83148376|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
83148377|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
83148378|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531101|NCT01999400|Mesalamine|mesalamine|mesh-list
83148380|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
83531251|NCT02829983|Clarithromycin|clarithromycin|mesh-list
83531321|NCT01973036|Oxytocin|oxytocin|mesh-list
83148381|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
83148382|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148383|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148384|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
83531771|NCT01985425|Colchicine|colchicine|mesh-list
83148385|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83531930|NCT02354378|Analgesics|analgesics|mesh-ancestor
83148386|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83532230|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83532304|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83148387|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83532529|NCT02996591|Hormones|hormones|mesh-ancestor
83148388|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83148389|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148390|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148391|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
83148392|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148393|NCT02253095|Micronutrients|micronutrients|mesh-list
83148394|NCT02253095|Trace Elements|trace elements|mesh-list
83148395|NCT02253095|Albendazole|albendazole|mesh-list
83148396|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
83148397|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83148398|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148399|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
83148400|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83148401|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83148402|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83148404|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83533207|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83533359|NCT00376181|Pioglitazone|pioglitazone|mesh-list
83533667|NCT03994874|Furosemide|furosemide|mesh-list
83533749|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83533903|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83533977|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83534202|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
83534438|NCT02977832|Alfuzosin|alfuzosin|mesh-list
83534658|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83534733|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83534809|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
83535130|NCT05647512|Hormones|hormones|mesh-ancestor
83535263|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148405|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148406|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148407|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148408|NCT03358706|Vitamin K|vitamin k|mesh-list
83148409|NCT03358706|Midazolam|midazolam|mesh-list
83148410|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
83537252|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
83148411|NCT03358706|Caffeine|caffeine|mesh-list
83148412|NCT03358706|Ustekinumab|ustekinumab|mesh-list
83148413|NCT03358706|Omeprazole|omeprazole|mesh-list
83148414|NCT03358706|Warfarin|warfarin|mesh-list
83538300|NCT05167825|Macitentan|macitentan|mesh-list
83148415|NCT03358706|Vitamins|vitamins|mesh-ancestor
83148416|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
83538761|NCT04940039|Risperidone|risperidone|mesh-list
83538833|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
83538915|NCT04847063|Mitomycins|mitomycins|mesh-list
83148417|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83539068|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
83539156|NCT04704154|Nivolumab|nivolumab|mesh-list
83539288|NCT04630028|Ustekinumab|ustekinumab|mesh-list
83539365|NCT04578756|Cariprazine|cariprazine|mesh-list
83539537|NCT04523207|Relugolix|relugolix|mesh-list
83148418|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83540126|NCT04175600|Selexipag|selexipag|mesh-list
83148419|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83540443|NCT04008030|Antidotes|antidotes|mesh-ancestor
83148420|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83540745|NCT03816332|Prednisone|prednisone|mesh-list
83148421|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83540915|NCT03635489|Paclitaxel|paclitaxel|mesh-list
83540978|NCT03576612|Valacyclovir|valacyclovir|mesh-list
83148422|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83148423|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83148424|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83148425|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
83148426|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
83148427|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
83148428|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
83148429|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148430|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148431|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
83541271|NCT03096782|Melphalan|melphalan|mesh-list
83541340|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148432|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83542029|NCT00665600|Albuterol|albuterol|mesh-list
83542202|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148433|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83148434|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148435|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83148436|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83148437|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
83148438|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83148439|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148440|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83148441|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83148442|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83148443|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83148444|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
83148445|NCT03358706|Coagulants|coagulants|mesh-ancestor
83148446|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
83148447|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
83148448|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83148449|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83148450|NCT04791332|Aticaprant|aticaprant|mesh-list
83148451|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83148452|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148453|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
83406711|NCT05899140|Clindamycin|clindamycin|mesh-list
83406712|NCT05899140|Clindamycin palmitate|clindamycin palmitate|mesh-list
83148454|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148455|NCT05461820|Methimazole|methimazole|mesh-list
83148456|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
83148457|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
83148458|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148459|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148460|NCT04791020|Lidocaine|lidocaine|mesh-list
83148461|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
83148462|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
83148463|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83406788|NCT05878093|Budesonide|budesonide|mesh-list
83148464|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148465|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
83148466|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148467|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83148468|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83148469|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83148470|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148471|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148472|NCT02531906|Oxycodone|oxycodone|mesh-list
83148473|NCT02531906|Methadone|methadone|mesh-list
83148474|NCT02531906|Gabapentin|gabapentin|mesh-list
83148475|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83148476|NCT02531906|Narcotics|narcotics|mesh-ancestor
83148477|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148478|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148479|NCT02531906|Analgesics|analgesics|mesh-ancestor
83148480|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
83148481|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148482|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
83148483|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83148484|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83148485|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83148486|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83148487|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83148488|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148489|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148491|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
83148492|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
83148493|NCT02783729|Zolpidem|zolpidem|mesh-list
83148494|NCT02783729|Lemborexant|lemborexant|mesh-list
83148495|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83406867|NCT05857163|Natriuretic Agents|natriuretic agents|mesh-ancestor
83407619|NCT05324059|Narcotics|narcotics|mesh-ancestor
83407620|NCT05319730|Paclitaxel|paclitaxel|mesh-list
83407621|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
83407622|NCT05319730|Irinotecan|irinotecan|mesh-list
83407623|NCT05319730|Lenvatinib|lenvatinib|mesh-list
83407624|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
83407625|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83407626|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407627|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
83407628|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
83407629|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
83407630|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148496|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83148497|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148498|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148499|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83148500|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
83148501|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
83148502|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148503|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148504|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83148505|NCT02227940|Paclitaxel|paclitaxel|mesh-list
83148506|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83148507|NCT02227940|Cisplatin|cisplatin|mesh-list
83148508|NCT02227940|Gemcitabine|gemcitabine|mesh-list
83148509|NCT02227940|Ceritinib|ceritinib|mesh-list
83148510|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83148511|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148512|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
83148513|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
83148514|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
83173424|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148515|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83407707|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
83148516|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83148517|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
83148518|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83148519|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148520|NCT02072486|Sorafenib|sorafenib|mesh-list
83148521|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148522|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83148523|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148524|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148526|NCT00988364|Ezetimibe|ezetimibe|mesh-list
83148527|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83148528|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83148529|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83148530|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
83148531|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148532|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83407708|NCT05253651|Vitamins|vitamins|mesh-ancestor
83148533|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83148534|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148535|NCT05578001|Pilocarpine|pilocarpine|mesh-list
83148536|NCT05578001|Miotics|miotics|mesh-ancestor
83148537|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
83148538|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83407709|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
83148539|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148540|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83148541|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83148542|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83148543|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173425|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83408157|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83408158|NCT04790786|Sotrovimab|sotrovimab|mesh-list
83148544|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148545|NCT05577923|Trastuzumab|trastuzumab|mesh-list
83148546|NCT05577923|Fulvestrant|fulvestrant|mesh-list
83408160|NCT04790786|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83408161|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
83408162|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83408163|NCT04786210|Triamcinolone|triamcinolone|mesh-list
83408164|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83408165|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83408166|NCT04786210|Fluorouracil|fluorouracil|mesh-list
83408167|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83408168|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
83408169|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83408474|NCT04494425|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83408773|NCT04117074|Bupivacaine|bupivacaine|mesh-list
83408774|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
83408775|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
83148547|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83148548|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148549|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83148550|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83148551|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83148552|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
83148553|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148554|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148555|NCT04790708|Octreotide|octreotide|mesh-list
83148556|NCT04790708|Edotreotide|edotreotide|mesh-list
83148557|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
83148558|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83148559|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148560|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148561|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83148562|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148563|NCT05615012|Metformin|metformin|mesh-list
83148564|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83148565|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83148566|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148567|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83148568|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83148569|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
83148570|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148571|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83148572|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83148573|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148574|NCT05614934|Clarithromycin|clarithromycin|mesh-list
83148575|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83148576|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148577|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83148578|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148579|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148580|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83148581|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83148582|NCT02135393|Folic Acid|folic acid|mesh-list
83148583|NCT02135393|Hematinics|hematinics|mesh-ancestor
83148584|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
83148585|NCT02135393|Vitamins|vitamins|mesh-ancestor
83148586|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
83148587|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148588|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
83148589|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83148590|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83148591|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83148592|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148593|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148594|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83148595|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148596|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83148597|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83148598|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148599|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83148600|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83148601|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
83148602|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148603|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148604|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83148605|NCT02139761|Analgesics|analgesics|mesh-ancestor
83148606|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
83148607|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148608|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
83148609|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83148610|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148611|NCT05474924|Prednisolone|prednisolone|mesh-list
83148612|NCT05474924|Budesonide|budesonide|mesh-list
83148613|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148614|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
83148615|NCT05474924|Hormones|hormones|mesh-ancestor
83148616|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148617|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148618|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83148619|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148620|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
83148621|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148622|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83148623|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83148624|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
83148625|NCT02135627|Epinephrine|epinephrine|mesh-list
83148626|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83148627|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83148628|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148629|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148630|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148631|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148632|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83148633|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83148634|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
83148635|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148636|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83148637|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
83148638|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
83148639|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
83148640|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83148641|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
83148642|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83148643|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83148644|NCT05613062|Analgesics|analgesics|mesh-ancestor
83148645|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
83148646|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148647|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148648|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148649|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148650|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83148651|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
83148652|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83148653|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
83148654|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
83148655|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148656|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148657|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
83148658|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83148659|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83148660|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
83148661|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148662|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148663|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83148664|NCT03548129|Fosfomycin|fosfomycin|mesh-list
83148665|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
83148666|NCT02140073|Domperidone|domperidone|mesh-list
83148667|NCT02140073|Omeprazole|omeprazole|mesh-list
83148668|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83148669|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148670|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83148671|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148672|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148673|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
83148674|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
83148675|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148676|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148677|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83148678|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
83148679|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148680|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
83148681|NCT05474690|Carboplatin|carboplatin|mesh-list
83148683|NCT05474690|Trastuzumab|trastuzumab|mesh-list
83148684|NCT05474690|Epirubicin|epirubicin|mesh-list
83148685|NCT05474690|Pertuzumab|pertuzumab|mesh-list
83148686|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83148687|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
83148688|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148689|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148690|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83148691|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
83148692|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148693|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148694|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83148695|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83148696|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83148697|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83148698|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83148699|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83148700|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83148701|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83148702|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148703|NCT05575973|Rituximab|rituximab|mesh-list
83148704|NCT05575973|Lenalidomide|lenalidomide|mesh-list
83148705|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
83148706|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83408852|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148707|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148708|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
83148709|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148710|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148711|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83148712|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83148713|NCT05575973|Growth Substances|growth substances|mesh-ancestor
83148714|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
83148715|NCT05575973|Analgesics|analgesics|mesh-ancestor
83148716|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
83148717|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148718|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83148719|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83148720|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148721|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148722|NCT03547895|Vitamin K|vitamin k|mesh-list
83148723|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
83148724|NCT03547895|Ribavirin|ribavirin|mesh-list
83148725|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
83148726|NCT03547895|Furosemide|furosemide|mesh-list
83148727|NCT03547895|Spironolactone|spironolactone|mesh-list
83148728|NCT03547895|Silymarin|silymarin|mesh-list
83148729|NCT03547895|Vitamins|vitamins|mesh-ancestor
83148730|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
83148731|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148732|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
83148733|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148734|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
83148735|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148736|NCT03547895|Diuretics|diuretics|mesh-ancestor
83148737|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
83148738|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83148739|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148740|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83148741|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
83148742|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148743|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83148744|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83148745|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83148746|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
83148747|NCT03547895|Coagulants|coagulants|mesh-ancestor
83148748|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
83148749|NCT03547895|Protective Agents|protective agents|mesh-ancestor
83148750|NCT01359254|Fludarabine|fludarabine|mesh-list
83148751|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
83148752|NCT01359254|Melphalan|melphalan|mesh-list
83148753|NCT01359254|Busulfan|busulfan|mesh-list
83148754|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83148755|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148756|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83148757|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
83148758|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148759|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83148760|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
83148761|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148762|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83148763|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
83148764|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83148765|NCT05575739|Antioxidants|antioxidants|mesh-list
83148766|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
83148767|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148768|NCT05575739|Protective Agents|protective agents|mesh-ancestor
83148769|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148770|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83148771|NCT05035862|Interferons|interferons|mesh-list
83148772|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
83148773|NCT05035862|Prednisone|prednisone|mesh-list
83148774|NCT05035862|Albuterol|albuterol|mesh-list
83148775|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148776|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
83148777|NCT05035862|Hormones|hormones|mesh-ancestor
83148778|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148779|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148780|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83148781|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148782|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
83148783|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148784|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83148785|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
83148786|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148787|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83148788|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
83148789|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
83148790|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83148791|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83148792|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83148793|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83148794|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148795|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148796|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148797|NCT03549221|Ketorolac|ketorolac|mesh-list
83148798|NCT03549221|Epinephrine|epinephrine|mesh-list
83148799|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
83148800|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83148801|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83148802|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148803|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148804|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148805|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148806|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83148807|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83148808|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
83148809|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148810|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83148811|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
83148812|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
83148813|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
83148814|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83148815|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83148816|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83148817|NCT03549221|Analgesics|analgesics|mesh-ancestor
83148818|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
83148819|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148820|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148821|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83148822|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148823|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
83148825|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148826|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
83148827|NCT05013632|Remdesivir|remdesivir|mesh-list
83148828|NCT05013632|Sotrovimab|sotrovimab|mesh-list
83148829|NCT05013632|Molnupiravir|molnupiravir|mesh-list
83148830|NCT05013632|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83148831|NCT05013632|Antibodies|antibodies|mesh-list
83148832|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83148833|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
83148834|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148835|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148836|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
83148837|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148838|NCT05614544|Propofol|propofol|mesh-list
83148839|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83148840|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148841|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148842|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83148843|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
83148844|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
83148845|NCT05185505|Bevacizumab|bevacizumab|mesh-list
83148846|NCT05185505|Atezolizumab|atezolizumab|mesh-list
83148847|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83148848|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148849|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83148850|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83148851|NCT05185505|Growth Substances|growth substances|mesh-ancestor
83389742|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389743|NCT04020263|Protective Agents|protective agents|mesh-ancestor
83390002|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83390267|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83390696|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83390772|NCT04990830|Tinzaparin|tinzaparin|mesh-list
83390876|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
83391118|NCT04358367|Analgesics|analgesics|mesh-ancestor
83391454|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
83391534|NCT03461445|Tacrolimus|tacrolimus|mesh-list
83391603|NCT03076203|Niraparib|niraparib|mesh-list
83391918|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83392416|NCT04364802|Iodine|iodine|mesh-list
83392699|NCT03788759|Vitamins|vitamins|mesh-ancestor
83392779|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83393242|NCT00981669|Vaccines|vaccines|mesh-list
83393333|NCT03062904|Miotics|miotics|mesh-ancestor
83393710|NCT04974060|Analgesics|analgesics|mesh-ancestor
83393977|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83394369|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
83394525|NCT05853263|Analgesics|analgesics|mesh-ancestor
83394686|NCT05851898|Analgesics|analgesics|mesh-ancestor
83394974|NCT05477108|Antidotes|antidotes|mesh-ancestor
83395427|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83395593|NCT04569877|Molgramostim|molgramostim|mesh-list
83395671|NCT04310059|Folic Acid|folic acid|mesh-list
83395747|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
83396230|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83396506|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83396758|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
83396822|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83396975|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83397277|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
83397592|NCT03536039|Hormones|hormones|mesh-ancestor
83398028|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
83398108|NCT01679795|Hormones|hormones|mesh-ancestor
83398536|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83398991|NCT01237041|Niacin|niacin|mesh-list
83399022|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83399094|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83399321|NCT03934307|Irbesartan|irbesartan|mesh-list
83399469|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
83399542|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83399997|NCT00638027|Memantine|memantine|mesh-list
83400161|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83400235|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83400392|NCT03098485|Azithromycin|azithromycin|mesh-list
83400692|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83400778|NCT03111485|Levodopa|levodopa|mesh-list
83400995|NCT01922843|Vitamins|vitamins|mesh-ancestor
83401072|NCT01923545|Lenograstim|lenograstim|mesh-list
83401229|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83401305|NCT01927835|Vaccines|vaccines|mesh-list
83402074|NCT04713969|Pantoprazole|pantoprazole|mesh-list
83402226|NCT04265105|Fluticasone|fluticasone|mesh-list
83402534|NCT02660905|Tenofovir|tenofovir|mesh-list
83402609|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
83402684|NCT03060018|Oxitropium|oxitropium|mesh-list
83402913|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83403146|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83403449|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
83403680|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
83403753|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83403830|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83403903|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
83403978|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83404131|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83404514|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83404592|NCT03012321|Hormones|hormones|mesh-ancestor
83404665|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83404897|NCT05872204|Letrozole|letrozole|mesh-list
83404975|NCT05865457|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83405049|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83405123|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83405200|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
83405280|NCT05288166|Prednisone|prednisone|mesh-list
83405513|NCT04885712|Metformin|metformin|mesh-list
83405579|NCT04675827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83405713|NCT04293393|Taxane|taxane|mesh-list
83405737|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
83405815|NCT04177810|Plerixafor|plerixafor|mesh-list
83405960|NCT03942419|Atropine|atropine|mesh-list
83406037|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83406186|NCT05909462|Glucocorticoids|glucocorticoids|mesh-ancestor
83406337|NCT05908747|Paclitaxel|paclitaxel|mesh-list
83406714|NCT05899140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83406945|NCT05815173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83407020|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83407182|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
83407245|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83407322|NCT05478291|Vitamin D|vitamin d|mesh-list
83407479|NCT05382871|Vaccines|vaccines|mesh-list
83407549|NCT05350371|Pirfenidone|pirfenidone|mesh-list
83407639|NCT05319353|Maribavir|maribavir|mesh-list
83407710|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83407807|NCT05153408|Pemetrexed|pemetrexed|mesh-list
83407866|NCT05113251|Immunoconjugates|immunoconjugates|mesh-ancestor
83408170|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83408418|NCT04538378|Durvalumab|durvalumab|mesh-list
83408551|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
83408931|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409084|NCT03834493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83409543|NCT03367871|Growth Substances|growth substances|mesh-ancestor
83409696|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83409770|NCT03131908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83410084|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83410251|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
83410312|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
83410387|NCT02196181|Trametinib|trametinib|mesh-list
83410551|NCT01927744|Docetaxel|docetaxel|mesh-list
83410637|NCT01618136|Paclitaxel|paclitaxel|mesh-list
83410698|NCT01328171|Hematinics|hematinics|mesh-ancestor
83411023|NCT00217737|Leucovorin|leucovorin|mesh-list
83411170|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
83411318|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83411466|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83411547|NCT01383759|Dexamethasone|dexamethasone|mesh-list
83411619|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83411695|NCT01596504|Metformin|metformin|mesh-list
83411844|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83411933|NCT04891458|Propofol|propofol|mesh-list
83412075|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83412224|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83412299|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83412536|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83412619|NCT04122599|Melatonin|melatonin|mesh-list
83412915|NCT03046758|Metronidazole|metronidazole|mesh-list
83412998|NCT04392557|Metformin|metformin|mesh-list
83413071|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83413144|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413309|NCT04874844|Antibodies|antibodies|mesh-list
83413797|NCT01452737|Bisacodyl|bisacodyl|mesh-list
83414060|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
83414068|NCT02508311|Albuterol|albuterol|mesh-list
83414147|NCT00198991|Hormones|hormones|mesh-ancestor
83414223|NCT01456481|Midodrine|midodrine|mesh-list
83414291|NCT01459679|Riboflavin|riboflavin|mesh-list
83414365|NCT01419639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83414522|NCT03042936|Insulin|insulin|mesh-list
83414671|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
83414743|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
83414822|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83414898|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
83415053|NCT01427595|Metformin|metformin|mesh-list
83415658|NCT02379377|Fluorides|fluorides|mesh-list
83415820|NCT01495923|Gabapentin|gabapentin|mesh-list
83415967|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83416277|NCT04835922|Anesthetics|anesthetics|mesh-list
83416347|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83416428|NCT01319981|Rituximab|rituximab|mesh-list
83416503|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83416895|NCT01579305|Lidocaine|lidocaine|mesh-list
83416969|NCT04826016|Paclitaxel|paclitaxel|mesh-list
83417044|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417155|NCT01471340|Prednisone|prednisone|mesh-list
83417280|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83417351|NCT01515657|Aspirin|aspirin|mesh-list
83417431|NCT04775303|Cyclosporine|cyclosporine|mesh-list
83417818|NCT01894451|Bevacizumab|bevacizumab|mesh-list
83418042|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83418198|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83418274|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83418500|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418577|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83418728|NCT02219997|Hormones|hormones|mesh-ancestor
83418863|NCT01625013|Hylan|hylan|mesh-list
83418960|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83419034|NCT05466318|Cytarabine|cytarabine|mesh-list
83419488|NCT00189475|Montelukast|montelukast|mesh-list
83419565|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
83419644|NCT04338984|Narcotics|narcotics|mesh-ancestor
83419873|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83419948|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83420026|NCT03085680|Analgesics|analgesics|mesh-ancestor
83420250|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83420398|NCT00048893|Metronidazole|metronidazole|mesh-list
83420473|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83420563|NCT02642640|Melatonin|melatonin|mesh-list
83420701|NCT05549778|Polaprezinc|polaprezinc|mesh-list
83420856|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
83420928|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83420929|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83420930|NCT00061373|Analgesics|analgesics|mesh-ancestor
83420931|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
83420932|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83420933|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420934|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83420942|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
82710944|NCT00741351|Narcotics|narcotics|mesh-ancestor
82711021|NCT00738530|Interferons|interferons|mesh-list
82711168|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82711238|NCT04137354|Trace Elements|trace elements|mesh-ancestor
82711308|NCT00737048|Acetaminophen|acetaminophen|mesh-list
82711456|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
82712404|NCT00716456|Cetuximab|cetuximab|mesh-list
82712601|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83148852|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148853|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
83148854|NCT05185505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83148855|NCT05185505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148856|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83148857|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
83148858|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148859|NCT05575271|Norepinephrine|norepinephrine|mesh-list
83148860|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83148861|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83148862|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148863|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148864|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148865|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148866|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
83148867|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
83148868|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148869|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83148870|NCT04750460|Teriparatide|teriparatide|mesh-list
83148871|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83148872|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148873|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83148874|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83148875|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
83148876|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148877|NCT05574881|Trastuzumab|trastuzumab|mesh-list
83148878|NCT05574881|Pertuzumab|pertuzumab|mesh-list
83148879|NCT05574881|Fulvestrant|fulvestrant|mesh-list
83148880|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83148881|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83148882|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83148883|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83148884|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83148885|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
83148886|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83148887|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148888|NCT05612984|Aspirin|aspirin|mesh-list
83148889|NCT05612984|Folic Acid|folic acid|mesh-list
83148890|NCT05612984|Micronutrients|micronutrients|mesh-list
83148891|NCT05612984|Trace Elements|trace elements|mesh-list
83148892|NCT05612984|Calcium|calcium|mesh-list
83148893|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83148894|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148895|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83148896|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83148897|NCT05612984|Analgesics|analgesics|mesh-ancestor
83148898|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
83148899|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148900|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83148901|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83148902|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83148903|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83148904|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148905|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83148906|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83148908|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
83148909|NCT05612984|Hematinics|hematinics|mesh-ancestor
83148910|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
83148911|NCT05612984|Vitamins|vitamins|mesh-ancestor
83148912|NCT04787510|Heparin|heparin|mesh-list
83148913|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83148914|NCT04787510|Tinzaparin|tinzaparin|mesh-list
83148915|NCT04787510|Dalteparin|dalteparin|mesh-list
83148916|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
83148917|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83148918|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83148919|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148920|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
83148921|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
83148922|NCT05424263|Calcium|calcium|mesh-list
83148923|NCT05424263|Calcium acetate|calcium acetate|mesh-list
83148924|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83148925|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148926|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83148927|NCT05424263|Antacids|antacids|mesh-ancestor
83148928|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148929|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148930|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
83148931|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
83148932|NCT05398757|Midazolam|midazolam|mesh-list
83148933|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
83148934|NCT05398757|Propofol|propofol|mesh-list
83148935|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83148936|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148937|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148938|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83148939|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
83148940|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
83148941|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83148942|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83148943|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83148944|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83148945|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
83148946|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
83148947|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148948|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148949|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83148950|NCT05398757|Analgesics|analgesics|mesh-ancestor
83148951|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
83148952|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148953|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83148954|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83148955|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83148956|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
83148957|NCT04787276|Rifaximin|rifaximin|mesh-list
83148958|NCT04787276|Lactulose|lactulose|mesh-list
83148959|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83148960|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83148961|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83148962|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
83148963|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83148964|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83148965|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83148966|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83148967|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148968|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
83148969|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83148970|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148971|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83148972|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83148973|NCT05613140|Valsartan|valsartan|mesh-list
83148974|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83148975|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83148976|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83148977|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83148978|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148979|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83148980|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
83148981|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83148982|NCT03547505|Protective Agents|protective agents|mesh-ancestor
83148983|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83148985|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
83148986|NCT04462952|Adavosertib|adavosertib|mesh-list
83148987|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83148988|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83148989|NCT04429022|Acetaminophen|acetaminophen|mesh-list
83148990|NCT04429022|Celecoxib|celecoxib|mesh-list
83148991|NCT04429022|Ketorolac|ketorolac|mesh-list
83148992|NCT04429022|Oxycodone|oxycodone|mesh-list
83148993|NCT04429022|Gabapentin|gabapentin|mesh-list
83148994|NCT04429022|Hydromorphone|hydromorphone|mesh-list
83148995|NCT04429022|Ropivacaine|ropivacaine|mesh-list
83148996|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
83148997|NCT04429022|Anesthetics|anesthetics|mesh-list
83148998|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83148999|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149000|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
83149001|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149002|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83149003|NCT04429022|Analgesics|analgesics|mesh-ancestor
83149004|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
83149005|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83149006|NCT04429022|Narcotics|narcotics|mesh-ancestor
83149007|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83149008|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149009|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149010|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83149011|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83149012|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149013|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149014|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
83149015|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83149016|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83149017|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83149018|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83149019|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83149020|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149021|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
83149022|NCT02253485|Telbivudine|telbivudine|mesh-list
83149023|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
83149024|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149025|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83149026|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149027|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149028|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83149029|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83149030|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149031|NCT02589626|Empagliflozin|empagliflozin|mesh-list
83149032|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83149033|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149034|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83149035|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149036|NCT04976036|Nintedanib|nintedanib|mesh-list
83149037|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149038|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83149039|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149040|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149041|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83149042|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
83149043|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83149044|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
83149045|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83149046|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149047|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83149048|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83149049|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149050|NCT05557136|Ether|ether|mesh-list
83149051|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83149052|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
83149053|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
83149054|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149055|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149056|NCT05556122|Betamethasone|betamethasone|mesh-list
83149057|NCT05556122|Ropivacaine|ropivacaine|mesh-list
83149058|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
83149059|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
83149060|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149061|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149062|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
83149063|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149064|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149065|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
83149066|NCT05556122|Hormones|hormones|mesh-ancestor
83149067|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149068|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83149069|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
83149070|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
83149071|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83149072|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149073|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149074|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83149075|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83149076|NCT05611268|Protective Agents|protective agents|mesh-ancestor
83149077|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149078|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
83149079|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83149080|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
83149081|NCT05549570|Metformin|metformin|mesh-list
83149082|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83149083|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83149084|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149085|NCT05549570|Incretins|incretins|mesh-ancestor
83149086|NCT05549570|Hormones|hormones|mesh-ancestor
83149087|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149088|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83149089|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
83149090|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149091|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149092|NCT05549492|Buprenorphine|buprenorphine|mesh-list
83149093|NCT05549492|Ropivacaine|ropivacaine|mesh-list
83149094|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
83149095|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
83149096|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149097|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149098|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
83149099|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149100|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83149101|NCT05549492|Narcotics|narcotics|mesh-ancestor
83149102|NCT05549492|Analgesics|analgesics|mesh-ancestor
83149103|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83149104|NCT04331132|Tolvaptan|tolvaptan|mesh-list
83149105|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83149106|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149107|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
83149108|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149109|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83149110|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149111|NCT05549336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149112|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149113|NCT04759274|Diuretics|diuretics|mesh-list
83149114|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
83149115|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149116|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83149117|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83149118|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149119|NCT01666730|Leucovorin|leucovorin|mesh-list
83149120|NCT01666730|Metformin|metformin|mesh-list
83149121|NCT01666730|Fluorouracil|fluorouracil|mesh-list
83149122|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
83149123|NCT01666730|Calcium|calcium|mesh-list
83149124|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
83149125|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83149126|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149127|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83149128|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
83149129|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149130|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83149131|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149132|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149133|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
83149134|NCT01666730|Antidotes|antidotes|mesh-ancestor
83149135|NCT01666730|Protective Agents|protective agents|mesh-ancestor
83149136|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
83149138|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
83149139|NCT05554094|Psilocybin|psilocybin|mesh-list
83149140|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
83149141|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149142|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83149143|NCT04434560|Nivolumab|nivolumab|mesh-list
83149144|NCT04434560|Ipilimumab|ipilimumab|mesh-list
83149145|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149146|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149147|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83149148|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149149|NCT05700656|Capecitabine|capecitabine|mesh-list
83149150|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83149151|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
83149152|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149153|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149154|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
83149155|NCT00103285|Leucovorin|leucovorin|mesh-list
83149156|NCT00103285|Folic Acid|folic acid|mesh-list
83149157|NCT00103285|Cytarabine|cytarabine|mesh-list
83149158|NCT00103285|Dexamethasone|dexamethasone|mesh-list
83149159|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
83149160|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
83149161|NCT00103285|Doxorubicin|doxorubicin|mesh-list
83149162|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83149163|NCT00103285|Methotrexate|methotrexate|mesh-list
83149165|NCT00103285|Asparaginase|asparaginase|mesh-list
83149166|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
83149167|NCT00103285|Pegaspargase|pegaspargase|mesh-list
83149168|NCT00103285|Thioguanine|thioguanine|mesh-list
83149169|NCT00103285|BB 1101|bb 1101|mesh-list
83149170|NCT00103285|Calcium|calcium|mesh-list
83149171|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
83149172|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
83149173|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149174|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
83149175|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149176|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149177|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83149178|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
83149179|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149180|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149181|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83149182|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149183|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
83149184|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
83149185|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149186|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83149187|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
83149188|NCT00103285|Hormones|hormones|mesh-ancestor
83149189|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149190|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83149191|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
83149192|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149193|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83149194|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83149195|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83149196|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83149197|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83149198|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83149199|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
83149200|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83149201|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83149202|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
83149203|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
83149204|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83149205|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83149206|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
83149207|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149208|NCT00103285|Antidotes|antidotes|mesh-ancestor
83149209|NCT00103285|Protective Agents|protective agents|mesh-ancestor
83149210|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
83149211|NCT00103285|Vitamins|vitamins|mesh-ancestor
83149212|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
83149213|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83149214|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
83149215|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
83149216|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
83149217|NCT00103285|Hematinics|hematinics|mesh-ancestor
83149218|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
83149219|NCT03541915|Analgesics|analgesics|mesh-ancestor
83149220|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
83149221|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149222|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149223|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
83149224|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149225|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83149226|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
83149227|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83149228|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149229|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149230|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83149231|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
83149232|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83149233|NCT03541837|Ropivacaine|ropivacaine|mesh-list
83149234|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
83149235|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
83149236|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149237|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149238|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
83149239|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149240|NCT02158117|Naloxone|naloxone|mesh-list
83149241|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83149242|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149243|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
83149244|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149245|NCT03541603|Simendan|simendan|mesh-list
83149246|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83149247|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
83149248|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83149249|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83149250|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149251|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149252|NCT03541603|Protective Agents|protective agents|mesh-ancestor
83149253|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149254|NCT02160223|Neostigmine|neostigmine|mesh-list
83149255|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83149256|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149257|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149258|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
83149259|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149260|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149261|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83149262|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
83149263|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149264|NCT04802837|Vancomycin|vancomycin|mesh-list
83149265|NCT04802837|Ridinilazole|ridinilazole|mesh-list
83149266|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83149267|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149268|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
83149269|NCT05256797|Apixaban|apixaban|mesh-list
83149270|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83149271|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
83149272|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83149273|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
83149274|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149275|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149276|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
83149277|NCT02160301|Acetaminophen|acetaminophen|mesh-list
83149278|NCT02160301|Dexamethasone|dexamethasone|mesh-list
83149279|NCT02160301|Celecoxib|celecoxib|mesh-list
83149280|NCT02160301|Oxycodone|oxycodone|mesh-list
83149281|NCT02160301|Gabapentin|gabapentin|mesh-list
83149282|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149284|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
83149285|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149286|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149287|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83149288|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
83149289|NCT02160301|Hormones|hormones|mesh-ancestor
83149290|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149291|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83149292|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149293|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83149294|NCT02160301|Analgesics|analgesics|mesh-ancestor
83149295|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
83149296|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
83149297|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83149298|NCT02160301|Narcotics|narcotics|mesh-ancestor
83149299|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149300|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83149301|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149302|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83149303|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83149304|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149305|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149306|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
83149307|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83149308|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83149309|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83408853|NCT04046614|Nivolumab|nivolumab|mesh-list
83149310|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83149311|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83149312|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149314|NCT03541759|Hydromorphone|hydromorphone|mesh-list
83149315|NCT03541759|Pirinitramide|pirinitramide|mesh-list
83149316|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83149317|NCT03541759|Narcotics|narcotics|mesh-ancestor
83149318|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149319|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149320|NCT03541759|Analgesics|analgesics|mesh-ancestor
83149321|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
83149322|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149323|NCT05206955|Tadalafil|tadalafil|mesh-list
83149324|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
83149325|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83149326|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83149327|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149328|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149329|NCT05206955|Urological Agents|urological agents|mesh-ancestor
83149330|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83149331|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
83149332|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83149333|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
83149334|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149335|NCT01666652|Antacids|antacids|mesh-ancestor
83149336|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149337|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83149338|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83149339|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
83149340|NCT05174585|Antibodies|antibodies|mesh-list
83149341|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
83149342|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83149343|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
83149344|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149345|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149346|NCT05174585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83149347|NCT05174585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149348|NCT04428086|Metformin|metformin|mesh-list
83149349|NCT04428086|Apatinib|apatinib|mesh-list
83149350|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83149351|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83149352|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149353|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83149354|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83149355|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
83149356|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149357|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83149358|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83149360|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149361|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83149362|NCT05125055|Paclitaxel|paclitaxel|mesh-list
83149363|NCT05125055|Docetaxel|docetaxel|mesh-list
83149364|NCT05125055|Fluorouracil|fluorouracil|mesh-list
83149365|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83149366|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149367|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
83149368|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
83149369|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83149370|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149372|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83149373|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149374|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
83149375|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149376|NCT04355858|Paclitaxel|paclitaxel|mesh-list
83149377|NCT04355858|Capecitabine|capecitabine|mesh-list
83149378|NCT04355858|Everolimus|everolimus|mesh-list
83149379|NCT04355858|Fluzoparib|fluzoparib|mesh-list
83149380|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83149381|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149382|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
83149383|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
83149384|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
83149385|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149386|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83149387|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
83149388|NCT04355858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83149389|NCT04355858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83149390|NCT04355858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149391|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149392|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
83149393|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149394|NCT04355858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83149395|NCT05610956|Empagliflozin|empagliflozin|mesh-list
83149396|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83149397|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149398|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83149399|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149400|NCT00109733|Hormones|hormones|mesh-list
83149401|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149402|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149403|NCT05699876|Gabapentin|gabapentin|mesh-list
83149404|NCT05699876|Melatonin|melatonin|mesh-list
83149405|NCT05699876|Analgesics|analgesics|mesh-ancestor
83149406|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
83149407|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149408|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149409|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
83149410|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83149411|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83149412|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149413|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83149414|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83149415|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83149416|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149417|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149418|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
83149419|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
83149420|NCT05699876|Protective Agents|protective agents|mesh-ancestor
83149421|NCT05610878|Curcumin|curcumin|mesh-list
83149422|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83149423|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83149424|NCT05610878|Analgesics|analgesics|mesh-ancestor
83149425|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
83149426|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149427|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149428|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149429|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149430|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149431|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149432|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149434|NCT02706405|Fludarabine|fludarabine|mesh-list
83149435|NCT02706405|Durvalumab|durvalumab|mesh-list
83149436|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
83149437|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83149438|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
83149439|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149440|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
83149441|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149442|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149443|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83149444|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
83149445|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149446|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149447|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83149448|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149449|NCT02254031|Maytansine|maytansine|mesh-list
83149450|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
83149451|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83149452|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149453|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
83149454|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
83149455|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
83149456|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149457|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149458|NCT02254031|Immunotoxins|immunotoxins|mesh-ancestor
83149459|NCT02254031|Immunoconjugates|immunoconjugates|mesh-ancestor
83149460|NCT02254031|Immunologic Factors|immunologic factors|mesh-ancestor
83149461|NCT02254031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149462|NCT03545711|Irinotecan|irinotecan|mesh-list
83149463|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83149464|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83149465|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149466|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149467|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149468|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
83149469|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83149470|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149471|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149472|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
83149473|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149474|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149475|NCT03998813|Ropivacaine|ropivacaine|mesh-list
83149476|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
83149477|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
83149478|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149479|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149480|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
83149481|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149482|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83149483|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83149484|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83149485|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149486|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149487|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83149488|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83149489|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83149490|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83149491|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
83149492|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149493|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149494|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83149495|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83149496|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
83149497|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83149498|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83149499|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
83149500|NCT02253953|Ritonavir|ritonavir|mesh-list
83149501|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83149502|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83149503|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
83149504|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149505|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149506|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83149507|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83149508|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
83149509|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149510|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83149511|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83149512|NCT03546803|Protective Agents|protective agents|mesh-list
83149513|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149515|NCT02422953|Trace Elements|trace elements|mesh-list
83149516|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149517|NCT04053140|Penicillins|penicillins|mesh-list
83149518|NCT04053140|Penicillin G|penicillin g|mesh-list
83149519|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83149520|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
83149521|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83149522|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149523|NCT03713879|Indomethacin|indomethacin|mesh-list
83149524|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83149525|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83149526|NCT03713879|Analgesics|analgesics|mesh-ancestor
83149527|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
83149528|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149529|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149530|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149531|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149532|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
83149533|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
83149534|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83149535|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83149536|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149537|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149538|NCT03107169|Vancomycin|vancomycin|mesh-list
83149539|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83149540|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149541|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
83149542|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
83149543|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149544|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149545|NCT05064059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83149546|NCT05064059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149547|NCT02425605|Sorafenib|sorafenib|mesh-list
83149548|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149549|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83149550|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149551|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149552|NCT02422563|Paclitaxel|paclitaxel|mesh-list
83149553|NCT02422563|Carboplatin|carboplatin|mesh-list
83149554|NCT02422563|Ifosfamide|ifosfamide|mesh-list
83149555|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83149556|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149557|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
83149558|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
83149559|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
83149560|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149561|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83149562|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
83149563|NCT03185403|Sufentanil|sufentanil|mesh-list
83149564|NCT03185403|Ropivacaine|ropivacaine|mesh-list
83149565|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
83149566|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
83149567|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149568|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149569|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
83149570|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149571|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83149572|NCT03185403|Narcotics|narcotics|mesh-ancestor
83149573|NCT03185403|Analgesics|analgesics|mesh-ancestor
83149574|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83149575|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83149576|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
83149577|NCT04329806|Amlodipine|amlodipine|mesh-list
83149578|NCT04329806|Moxonidine|moxonidine|mesh-list
83149579|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83149580|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83149581|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149582|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149583|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83149584|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149585|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
83149587|NCT03635021|Panitumumab|panitumumab|mesh-list
83149588|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149589|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149590|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83149591|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83149592|NCT03635021|Growth Substances|growth substances|mesh-ancestor
83149593|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149594|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
83149595|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83149596|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83149597|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83149598|NCT02422485|Analgesics|analgesics|mesh-ancestor
83149599|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
83149600|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149601|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149602|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149603|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149604|NCT05551910|Remifentanil|remifentanil|mesh-list
83149605|NCT05551910|Propofol|propofol|mesh-list
83149606|NCT05551910|Esketamine|esketamine|mesh-list
83149607|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83149608|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149609|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149610|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83149611|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
83149612|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
83149613|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83149614|NCT05551910|Narcotics|narcotics|mesh-ancestor
83149615|NCT05551910|Analgesics|analgesics|mesh-ancestor
83149616|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
83149617|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149618|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
83149619|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83149620|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
83149621|NCT05699720|Analgesics|analgesics|mesh-ancestor
83149622|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
83149623|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149624|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149625|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
83149626|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149627|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83149628|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
83149629|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83149630|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149631|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149632|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83149633|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
83149634|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83149635|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
83149636|NCT05546762|Povidone|povidone|mesh-list
83149637|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
83149638|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
83149639|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83149640|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149641|NCT03863288|Oxytocin|oxytocin|mesh-list
83149642|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
83149643|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83149644|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149645|NCT03535883|Anticoagulants|anticoagulants|mesh-list
83149646|NCT03535883|Coagulants|coagulants|mesh-list
83149647|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
83149648|NCT05551598|Analgesics|analgesics|mesh-ancestor
83149649|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
83149650|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149651|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149652|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149653|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83149654|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83149655|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149656|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149658|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83149659|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149660|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149661|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
83149662|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149663|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149664|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
83149665|NCT03185793|Benzbromarone|benzbromarone|mesh-list
83149666|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
83149667|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
83149668|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149669|NCT03660488|Penicillins|penicillins|mesh-list
83149670|NCT03660488|Cefixime|cefixime|mesh-list
83149671|NCT03660488|Penicillin G|penicillin g|mesh-list
83149672|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83149673|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
83149674|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83149675|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149676|NCT02422017|Timolol|timolol|mesh-list
83149677|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83149678|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83149679|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
83149680|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149681|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149682|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149683|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83149684|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83149685|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
83149686|NCT02761915|Fludarabine|fludarabine|mesh-list
83149687|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149688|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
83149689|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149690|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149691|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83149692|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
83479600|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149693|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149695|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83149696|NCT03464084|Melatonin|melatonin|mesh-list
83149697|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
83149698|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149699|NCT03464084|Protective Agents|protective agents|mesh-ancestor
83149700|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149701|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149702|NCT05551208|Bevacizumab|bevacizumab|mesh-list
83149703|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149704|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149705|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83149706|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83149707|NCT05551208|Growth Substances|growth substances|mesh-ancestor
83149708|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149709|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
83149710|NCT03334682|Doxycycline|doxycycline|mesh-list
83149711|NCT03334682|Spironolactone|spironolactone|mesh-list
83149712|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83149713|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149714|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
83149715|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83149716|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83149717|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83149718|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
83149719|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149720|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149721|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83149722|NCT03334682|Diuretics|diuretics|mesh-ancestor
83149723|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
83149724|NCT02764333|Durvalumab|durvalumab|mesh-list
83149725|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149726|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149727|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
83149728|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83149729|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83149730|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83149731|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149732|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149733|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
83149734|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149735|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149736|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83149737|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149738|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83149739|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83149740|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149742|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149743|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
83149744|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149745|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83149746|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149747|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149748|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83149749|NCT03173066|Hematinics|hematinics|mesh-ancestor
83149750|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83149751|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83149752|NCT05546060|Dexamethasone|dexamethasone|mesh-list
83149753|NCT05546060|Etoposide|etoposide|mesh-list
83149754|NCT05546060|Venetoclax|venetoclax|mesh-list
83149755|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149756|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
83149757|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
83149758|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149759|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149760|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83149761|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
83149762|NCT05546060|Hormones|hormones|mesh-ancestor
83149763|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149764|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83149765|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149766|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83149767|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83149768|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83149769|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149770|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149771|NCT02416869|Dexamethasone|dexamethasone|mesh-list
83149772|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
83149773|NCT02416869|BB 1101|bb 1101|mesh-list
83149774|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149775|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
83149776|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
83149777|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149778|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149779|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83149780|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
83149781|NCT02416869|Hormones|hormones|mesh-ancestor
83149782|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149783|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83149784|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149785|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
83149786|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149787|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149788|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
83149789|NCT02588612|Fludarabine|fludarabine|mesh-list
83149790|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83149791|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
83149792|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149793|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149794|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83149795|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
83149796|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149797|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149798|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83149799|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
83149800|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
83149801|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149802|NCT03540979|Letrozole|letrozole|mesh-list
83149803|NCT03540979|Progesterone|progesterone|mesh-list
83149804|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149805|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83149806|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83149807|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149808|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149809|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83149810|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
83149811|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149812|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149813|NCT03540979|Progestins|progestins|mesh-ancestor
83149814|NCT03540979|Hormones|hormones|mesh-ancestor
83149815|NCT02946788|Minocycline|minocycline|mesh-list
83149816|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83149817|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149818|NCT02159131|Cabotegravir|cabotegravir|mesh-list
83149819|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
83149820|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83149821|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
83149822|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83149823|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149824|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83149825|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83149827|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83149828|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83149829|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149830|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149831|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83149832|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83149833|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
83149834|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149835|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83149836|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83149837|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83149838|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149839|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149840|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149841|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149842|NCT05550506|Analgesics|analgesics|mesh-ancestor
83149843|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
83149844|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149845|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
83149846|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83149847|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
83149848|NCT03174795|Meropenem|meropenem|mesh-list
83149849|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83149850|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149851|NCT02163655|Furosemide|furosemide|mesh-list
83149852|NCT02163655|Diuretics|diuretics|mesh-ancestor
83149853|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
83149854|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149855|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83149856|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149857|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149858|NCT02410083|Aspirin|aspirin|mesh-list
83149859|NCT02410083|Clopidogrel|clopidogrel|mesh-list
83149860|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83149861|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83149862|NCT02410083|Analgesics|analgesics|mesh-ancestor
83149863|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
83149864|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149865|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149866|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149867|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149868|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83149869|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83149870|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149871|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83149872|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83149873|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149874|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
83149875|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83149876|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83149877|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83149878|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
83149879|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149881|NCT02416245|Trace Elements|trace elements|mesh-list
83149882|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149884|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
83149885|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
83149886|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149887|NCT01463072|Paclitaxel|paclitaxel|mesh-list
83149888|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83149889|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83149890|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149891|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
83149892|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
83149893|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
83149894|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149895|NCT02166853|Midazolam|midazolam|mesh-list
83149896|NCT02166853|Sevoflurane|sevoflurane|mesh-list
83149897|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83149898|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83149899|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83149900|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149901|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83149902|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83149903|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83149904|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83149905|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
83149906|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
83149907|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
83149908|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
83149909|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149910|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149911|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83149912|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83149913|NCT02162251|Donepezil|donepezil|mesh-list
83149914|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83149915|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149916|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149917|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
83149918|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83149919|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149920|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
83149921|NCT02164045|Fostemsavir|fostemsavir|mesh-list
83149922|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83149923|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83149924|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
83149925|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83149926|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83149927|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83149928|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149929|NCT02410005|Calcitriol|calcitriol|mesh-list
83149930|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83149931|NCT02410005|Losartan|losartan|mesh-list
83149932|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83149933|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83149934|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83149935|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83149936|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149937|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83149938|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149939|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83149940|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83149941|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83149942|NCT02410005|Vitamins|vitamins|mesh-ancestor
83149943|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
83149944|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83149945|NCT05543330|Cisplatin|cisplatin|mesh-list
83149946|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149947|NCT03174561|Choline|choline|mesh-list
83149948|NCT03174561|Silymarin|silymarin|mesh-list
83149949|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
83149950|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83149951|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
83149952|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149953|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83149954|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83149955|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
83149956|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
83149957|NCT03174561|Protective Agents|protective agents|mesh-ancestor
83149958|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149959|NCT05545592|Estrogens|estrogens|mesh-list
83149960|NCT05545592|Hormones|hormones|mesh-ancestor
83149961|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83149962|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149963|NCT05545436|Capecitabine|capecitabine|mesh-list
83149964|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
83149965|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83149966|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
83149967|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149968|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149969|NCT02167165|Digoxin|digoxin|mesh-list
83149970|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83149971|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83149972|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149973|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149974|NCT02167165|Protective Agents|protective agents|mesh-ancestor
83149975|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149976|NCT05545124|Tislelizumab|tislelizumab|mesh-list
83149977|NCT05545124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83149978|NCT05545124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149979|NCT02409849|Octreotide|octreotide|mesh-list
83149980|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83149981|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83149982|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83149983|NCT00664040|Aspirin|aspirin|mesh-list
83149984|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83149985|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83149986|NCT00664040|Analgesics|analgesics|mesh-ancestor
83149987|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
83149988|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83149989|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83149990|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83149991|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83149992|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83149993|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83149994|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83149995|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83149996|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83149997|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83149998|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
83149999|NCT02162407|Insulin|insulin|mesh-list
83150000|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83150001|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
83150002|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83150003|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150004|NCT02162485|Fluticasone|fluticasone|mesh-list
83150005|NCT02162485|Xhance|xhance|mesh-list
83150006|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83150007|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83150008|NCT02162485|Charcoal|charcoal|mesh-list
83150009|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150010|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83150011|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
83150012|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150013|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150014|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83150015|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
83150016|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
83150017|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83150018|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83150019|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83150020|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83150021|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83150022|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150023|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150024|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
83150025|NCT02162485|Hormones|hormones|mesh-ancestor
83150026|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83150027|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
83150028|NCT02162485|Antidotes|antidotes|mesh-ancestor
83150029|NCT02162485|Protective Agents|protective agents|mesh-ancestor
83150030|NCT02415777|Riboflavin|riboflavin|mesh-list
83150031|NCT02415777|Thiamine|thiamine|mesh-list
83150032|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83150033|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
83150034|NCT02415777|Vitamins|vitamins|mesh-ancestor
83150035|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
83150036|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150037|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83150038|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
83150039|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83150040|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83150041|NCT05544968|Antibodies|antibodies|mesh-list
83150042|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83150043|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
83150044|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150045|NCT03178539|Diclofenac|diclofenac|mesh-list
83150046|NCT03178539|Ketorolac|ketorolac|mesh-list
83150047|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150048|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150049|NCT03178539|Analgesics|analgesics|mesh-ancestor
83150050|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
83150051|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150052|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150053|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150054|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150055|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83150056|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150057|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150058|NCT03174483|Fluticasone|fluticasone|mesh-list
83150059|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150060|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83150061|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
83150062|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150063|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150064|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83150065|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
83150066|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
83150067|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83150068|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83150069|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83150070|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150071|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
83150072|NCT04320914|Ibuprofen|ibuprofen|mesh-list
83150073|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150074|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150075|NCT04320914|Analgesics|analgesics|mesh-ancestor
83150076|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
83150077|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150078|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150079|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150080|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150081|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83150082|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150083|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150084|NCT05544812|Cetuximab|cetuximab|mesh-list
83150085|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83150086|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150087|NCT02415699|Leucovorin|leucovorin|mesh-list
83150088|NCT02415699|Fluorouracil|fluorouracil|mesh-list
83150089|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
83150090|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
83150091|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150092|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83150093|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150094|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150095|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
83150096|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150097|NCT02415699|Antidotes|antidotes|mesh-ancestor
83150098|NCT02415699|Protective Agents|protective agents|mesh-ancestor
83150099|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
83150100|NCT02415699|Vitamins|vitamins|mesh-ancestor
83150101|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
83150102|NCT05544656|Tolperisone|tolperisone|mesh-list
83150103|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83150104|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150105|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83150106|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150107|NCT02409537|Resveratrol|resveratrol|mesh-list
83150108|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
83150109|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150110|NCT02409537|Protective Agents|protective agents|mesh-ancestor
83150111|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150112|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150113|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83150114|NCT03177993|Ivermectin|ivermectin|mesh-list
83150115|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83150116|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150117|NCT04425590|Aspirin|aspirin|mesh-list
83150118|NCT04425590|Atorvastatin|atorvastatin|mesh-list
83150119|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150120|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150121|NCT04425590|Analgesics|analgesics|mesh-ancestor
83150122|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
83150123|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150124|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150125|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150126|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150127|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83150128|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83150129|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150130|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83150131|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83150132|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150133|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
83150134|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83150135|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83150136|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
83150137|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83150138|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83150139|NCT00707889|Leucovorin|leucovorin|mesh-list
83150140|NCT00707889|Folic Acid|folic acid|mesh-list
83150141|NCT00707889|Bevacizumab|bevacizumab|mesh-list
83150142|NCT00707889|Fluorouracil|fluorouracil|mesh-list
83150143|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
83150144|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
83150145|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83150146|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150147|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83150148|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83150149|NCT00707889|Growth Substances|growth substances|mesh-ancestor
83150150|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150151|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
83150152|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
83150153|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150154|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83150155|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150156|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
83150157|NCT00707889|Antidotes|antidotes|mesh-ancestor
83150158|NCT00707889|Protective Agents|protective agents|mesh-ancestor
83150159|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
83150160|NCT00707889|Vitamins|vitamins|mesh-ancestor
83150161|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
83150162|NCT00707889|Hematinics|hematinics|mesh-ancestor
83150163|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
83150164|NCT00109031|Etoposide|etoposide|mesh-list
83150165|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150166|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
83150167|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150168|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150169|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83150170|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
83150171|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150172|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150173|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83150174|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83150175|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83150176|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83150177|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150178|NCT02419443|Gabapentin|gabapentin|mesh-list
83150179|NCT02419443|Analgesics|analgesics|mesh-ancestor
83150180|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
83150181|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150182|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150183|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
83150184|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83150185|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83150186|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150187|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83150188|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83150189|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83150190|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150191|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150192|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
83150193|NCT02409147|Nystatin|nystatin|mesh-list
83150194|NCT02409147|Prednisone|prednisone|mesh-list
83150195|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
83150196|NCT02409147|Basiliximab|basiliximab|mesh-list
83150197|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150198|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
83150199|NCT02409147|Hormones|hormones|mesh-ancestor
83150200|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83150201|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150202|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83150203|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150204|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150205|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150206|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
83150207|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83150208|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150209|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
83150210|NCT02409147|Ionophores|ionophores|mesh-ancestor
83150211|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83150212|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83150213|NCT05017103|Antibodies|antibodies|mesh-list
83150214|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
83150215|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83150216|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
83150217|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150218|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150219|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
83150220|NCT02414919|Etonogestrel|etonogestrel|mesh-list
83150221|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83150222|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
83150223|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150224|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150225|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83150226|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83150227|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83150228|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
83150229|NCT05005559|Paraproteins|paraproteins|mesh-list
83150230|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
83150231|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150233|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83150234|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150235|NCT02408679|Vitamin D|vitamin d|mesh-list
83150236|NCT02408679|Vitamins|vitamins|mesh-ancestor
83150237|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
83150238|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150239|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83150240|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
83150241|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83150242|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150243|NCT04486781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83150244|NCT04486781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150245|NCT05089565|Interferons|interferons|mesh-list
83150246|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
83150247|NCT05089565|Antibodies|antibodies|mesh-list
83150248|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
83150249|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
83150250|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150251|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150252|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
83150253|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150254|NCT03174171|Everolimus|everolimus|mesh-list
83150255|NCT03174171|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83150256|NCT03174171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83150257|NCT03174171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150258|NCT03174171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150259|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150260|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
83150261|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150262|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150263|NCT02414529|Vitamin D|vitamin d|mesh-list
83150264|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
83150265|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
83150266|NCT02414529|Vitamins|vitamins|mesh-list
83150267|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
83150268|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150269|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83150270|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83150271|NCT02418273|Denosumab|denosumab|mesh-list
83150272|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83150273|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150274|NCT02414685|Paclitaxel|paclitaxel|mesh-list
83150275|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83150276|NCT02414685|Cisplatin|cisplatin|mesh-list
83150277|NCT02414685|Ifosfamide|ifosfamide|mesh-list
83150278|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
83150279|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83150280|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150281|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
83150282|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
83150283|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
83150284|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150285|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83150286|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
83150287|NCT04425824|Rituximab|rituximab|mesh-list
83150288|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83150289|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150290|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
83408854|NCT04046614|Nintedanib|nintedanib|mesh-list
83150291|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150292|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150293|NCT02414451|Propranolol|propranolol|mesh-list
83150294|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83150295|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83150296|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
83150297|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150298|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150299|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150300|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83150301|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83150302|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
83150303|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
83150304|NCT02408289|Procyanidin|procyanidin|mesh-list
83150305|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
83150306|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150307|NCT02408289|Protective Agents|protective agents|mesh-ancestor
83150308|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150309|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83150310|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83150311|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150312|NCT02417883|Furosemide|furosemide|mesh-list
83150313|NCT02417883|Diuretics|diuretics|mesh-ancestor
83150314|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
83150315|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150316|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83150317|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83150318|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150319|NCT01664624|Exenatide|exenatide|mesh-list
83150320|NCT01664624|Alogliptin|alogliptin|mesh-list
83150321|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83150322|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150323|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83150324|NCT01664624|Incretins|incretins|mesh-ancestor
83150325|NCT01664624|Hormones|hormones|mesh-ancestor
83150326|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83150327|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83150328|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150329|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150330|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150331|NCT03173781|Droxidopa|droxidopa|mesh-list
83150332|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83150333|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83150334|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83150335|NCT05540834|Plasminogen|plasminogen|mesh-list
83150336|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83150337|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83150338|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150339|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
83150340|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83150341|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150342|NCT02407899|Vitamin D|vitamin d|mesh-list
83150343|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
83150344|NCT02407899|Insulin|insulin|mesh-list
83150345|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83150346|NCT02407899|Metformin|metformin|mesh-list
83150347|NCT02407899|Saxagliptin|saxagliptin|mesh-list
83150348|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83150349|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83150350|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150351|NCT02407899|Vitamins|vitamins|mesh-ancestor
83150352|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
83150353|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83150354|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83150355|NCT02407899|Incretins|incretins|mesh-ancestor
83150356|NCT02407899|Hormones|hormones|mesh-ancestor
83150357|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83150358|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150359|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150360|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150361|NCT02417493|Epinephrine|epinephrine|mesh-list
83150362|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83150363|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83150364|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
83150365|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150366|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150367|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150368|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83150369|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83150370|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
83150371|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150372|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83150373|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
83150374|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
83150375|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
83150376|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83150377|NCT05540600|Digoxin|digoxin|mesh-list
83150378|NCT05540600|Bisoprolol|bisoprolol|mesh-list
83150379|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83150380|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83150381|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150382|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150383|NCT05540600|Protective Agents|protective agents|mesh-ancestor
83150384|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150385|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83150386|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
83150387|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
83150388|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150389|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83150390|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83150391|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83150392|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
83150393|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150394|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
83150395|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83150396|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
83150397|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150398|NCT03265574|Enalapril|enalapril|mesh-list
83150399|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83150400|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150401|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150402|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150403|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83150404|NCT03177837|Acetazolamide|acetazolamide|mesh-list
83150405|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
83150406|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83150407|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150408|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150409|NCT03177837|Diuretics|diuretics|mesh-ancestor
83150410|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
83150411|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150412|NCT02414373|Bupivacaine|bupivacaine|mesh-list
83150413|NCT02414373|Ropivacaine|ropivacaine|mesh-list
83150414|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
83150415|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
83150416|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150417|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150418|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
83150419|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150420|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
83150421|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150422|NCT03173235|Vitamin D|vitamin d|mesh-list
83150423|NCT03173235|Vitamins|vitamins|mesh-ancestor
83150424|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
83150425|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150426|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83150427|NCT05697692|Heparin|heparin|mesh-list
83150428|NCT05697692|Calcium heparin|calcium heparin|mesh-list
83150429|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
83150430|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83409005|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
83150431|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83150432|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150434|NCT02761057|Crizotinib|crizotinib|mesh-list
83150435|NCT02761057|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83150436|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150437|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83150438|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83150439|NCT02761057|Growth Substances|growth substances|mesh-ancestor
83150440|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150441|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
83150442|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83150443|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150444|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150445|NCT02407821|Escitalopram|escitalopram|mesh-list
83150446|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83150447|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83150448|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83150449|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150450|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150451|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
83150452|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150453|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83150454|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83150455|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150456|NCT02417337|Acetaminophen|acetaminophen|mesh-list
83150457|NCT02417337|Ibuprofen|ibuprofen|mesh-list
83150458|NCT02417337|Diclofenac|diclofenac|mesh-list
83150459|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
83150460|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150461|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150462|NCT02417337|Analgesics|analgesics|mesh-ancestor
83150463|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
83150464|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150465|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150466|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150467|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150468|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83150469|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150470|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150471|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
83150472|NCT02167321|Leucovorin|leucovorin|mesh-list
83150473|NCT02167321|Fluorouracil|fluorouracil|mesh-list
83150474|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
83150475|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
83150476|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150477|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83150478|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150479|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150480|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
83150481|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150483|NCT02167321|Protective Agents|protective agents|mesh-ancestor
83150484|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
83150485|NCT02167321|Vitamins|vitamins|mesh-ancestor
83150486|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
83150487|NCT02162797|Zinc|zinc|mesh-list
83150488|NCT02162797|Trace Elements|trace elements|mesh-ancestor
83150489|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
83150490|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150491|NCT02162875|Praziquantel|praziquantel|mesh-list
83150492|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
83150493|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83150494|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150495|NCT02167633|Pantoprazole|pantoprazole|mesh-list
83150496|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83150497|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
83150498|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83150499|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83150500|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150501|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150502|NCT02167633|Hormones|hormones|mesh-ancestor
83150503|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83150504|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150505|NCT02413281|Buprenorphine|buprenorphine|mesh-list
83150506|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83150507|NCT02413281|Narcotics|narcotics|mesh-ancestor
83150508|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150509|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150510|NCT02413281|Analgesics|analgesics|mesh-ancestor
83150511|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
83150512|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150513|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83150514|NCT02170909|Dabigatran|dabigatran|mesh-list
83150515|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
83150516|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83150517|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150518|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150519|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150520|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
83150521|NCT02164825|Morphine|morphine|mesh-list
83150522|NCT02164825|Ropivacaine|ropivacaine|mesh-list
83150523|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83150524|NCT02164825|Narcotics|narcotics|mesh-ancestor
83150525|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150526|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150527|NCT02164825|Analgesics|analgesics|mesh-ancestor
83150528|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
83150529|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150530|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
83150531|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
83150532|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
83150533|NCT02170987|Dabigatran|dabigatran|mesh-list
83150534|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83150535|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150536|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83150537|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83150538|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479601|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150539|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150540|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150541|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
83150542|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83150543|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150544|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
83150545|NCT03176121|Oxycodone|oxycodone|mesh-list
83150546|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83150547|NCT03176121|Narcotics|narcotics|mesh-ancestor
83150548|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150549|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150550|NCT03176121|Analgesics|analgesics|mesh-ancestor
83150551|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
83150552|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150553|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83150554|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150555|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150556|NCT02171143|ASP2409|asp2409|mesh-list
83150557|NCT02171143|Immunoconjugates|immunoconjugates|mesh-ancestor
83150558|NCT02171143|Immunologic Factors|immunologic factors|mesh-ancestor
83150559|NCT02171143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150560|NCT03176199|Oxycodone|oxycodone|mesh-list
83150561|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83150562|NCT03176199|Narcotics|narcotics|mesh-ancestor
83150563|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150564|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150566|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
83150567|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150568|NCT05697614|Lamotrigine|lamotrigine|mesh-list
83150569|NCT05697614|Carbamazepine|carbamazepine|mesh-list
83150570|NCT05697614|Phenytoin|phenytoin|mesh-list
83150571|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
83150572|NCT05697614|Valproic Acid|valproic acid|mesh-list
83150573|NCT05697614|Clobazam|clobazam|mesh-list
83150574|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
83150575|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83150576|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83150577|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150578|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83150579|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150580|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83150581|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83150582|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150583|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83150584|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83150585|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150586|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
83150587|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150588|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
83150589|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150590|NCT05697614|Analgesics|analgesics|mesh-ancestor
83150591|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
83150592|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150593|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83150594|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83150595|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83150596|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83150597|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83150598|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83150599|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
83150600|NCT02171221|DFP-11207|dfp-11207|mesh-list
83150601|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83150602|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
83150603|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150604|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150605|NCT02413515|Nifedipine|nifedipine|mesh-list
83150606|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83150607|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83150608|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150609|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83150610|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150611|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
83150612|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
83150613|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150614|NCT03194906|Memantine|memantine|mesh-list
83150615|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83150616|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83150617|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
83150618|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150619|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150620|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150621|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83150622|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83150623|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
83150624|NCT03171987|Lidocaine|lidocaine|mesh-list
83150625|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
83150626|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
83150627|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150628|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150629|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
83150630|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150631|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83150632|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83150633|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83150634|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83150635|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150636|NCT03171987|Analgesics|analgesics|mesh-ancestor
83150637|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150638|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150639|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150640|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150641|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83150642|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150643|NCT05540288|Nalmefene|nalmefene|mesh-list
83150644|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83150645|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150646|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
83150647|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150648|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
83150649|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83150650|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150651|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150652|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150653|NCT03172065|Analgesics|analgesics|mesh-ancestor
83150654|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
83150655|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150656|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83150657|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83150658|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83150659|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
83150660|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150661|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150662|NCT02171299|Ropivacaine|ropivacaine|mesh-list
83150663|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
83150664|NCT02171299|Anesthetics|anesthetics|mesh-list
83150665|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150666|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150667|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
83150668|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150669|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
83150670|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
83150671|NCT03171831|Busulfan|busulfan|mesh-list
83150672|NCT03171831|Methotrexate|methotrexate|mesh-list
83150673|NCT03171831|Fludarabine|fludarabine|mesh-list
83150674|NCT03171831|Tacrolimus|tacrolimus|mesh-list
83150675|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
83150676|NCT03171831|Basiliximab|basiliximab|mesh-list
83150677|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150678|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
83150679|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150680|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150681|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83150682|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
83150683|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150684|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150685|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83150686|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83150687|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
83150688|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150689|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83150690|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
83150691|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83150692|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150693|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83150694|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83150695|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83150696|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83150697|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83150698|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
83150699|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83150700|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150701|NCT02171455|Dabigatran|dabigatran|mesh-list
83150702|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
83150703|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83150704|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150705|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150706|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150707|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
83150708|NCT02171533|Verapamil|verapamil|mesh-list
83150709|NCT02171533|Dabigatran|dabigatran|mesh-list
83150710|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
83150711|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83150712|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150714|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150715|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
83150716|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83150717|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83150718|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83150719|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83150720|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150721|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
83150722|NCT04482543|Methotrexate|methotrexate|mesh-list
83150723|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83150724|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
83150725|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150726|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150727|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83150728|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
83150729|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150730|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150731|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
83150732|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150733|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83150734|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150735|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
83150736|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150737|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83150738|NCT04728230|Carboplatin|carboplatin|mesh-list
83150739|NCT04728230|Etoposide|etoposide|mesh-list
83150740|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
83150741|NCT04728230|Durvalumab|durvalumab|mesh-list
83150742|NCT04728230|Olaparib|olaparib|mesh-list
83150743|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
83150744|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
83150745|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83150746|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
83150747|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150748|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83150749|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83150750|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83150751|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150752|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150753|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83150754|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
83150755|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150756|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83150757|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
83150758|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
83150759|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83150760|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83150761|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83150762|NCT02406183|Ipilimumab|ipilimumab|mesh-list
83150763|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83150764|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150765|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83150766|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150767|NCT04723472|Cefuroxime|cefuroxime|mesh-list
83150768|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
83150769|NCT04723472|Bismuth|bismuth|mesh-list
83150770|NCT04723472|Antacids|antacids|mesh-ancestor
83150771|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150772|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83150773|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83150774|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150775|NCT02412813|Cobalt|cobalt|mesh-list
83150776|NCT02412813|Trace Elements|trace elements|mesh-ancestor
83150777|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
83150778|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150779|NCT03116295|Opicapone|opicapone|mesh-list
83150780|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83150781|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150782|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150783|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83150784|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83150785|NCT02405715|Oxytocin|oxytocin|mesh-list
83150786|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
83150787|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150788|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150789|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
83150790|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150791|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
83150792|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150793|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150794|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83150795|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
83150796|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150797|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150798|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83150799|NCT02412345|Alprostadil|alprostadil|mesh-list
83150800|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83150801|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
83150802|NCT02412345|Urological Agents|urological agents|mesh-ancestor
83150803|NCT05679050|Folfirinox|folfirinox|mesh-list
83150804|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150805|NCT02412267|Carboplatin|carboplatin|mesh-list
83150806|NCT02412267|Etoposide|etoposide|mesh-list
83150807|NCT02412267|Ifosfamide|ifosfamide|mesh-list
83150808|NCT02412267|Ofatumumab|ofatumumab|mesh-list
83150809|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150810|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83150811|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83150812|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83150813|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150814|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150815|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83150816|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
83150817|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83150818|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83150819|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83150820|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150821|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150822|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150823|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
83150824|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83150825|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
83150826|NCT05698394|Esketamine|esketamine|mesh-list
83150827|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
83150828|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83150829|NCT05539118|Interferons|interferons|mesh-list
83150830|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150831|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
83150832|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150833|NCT02405793|Meloxicam|meloxicam|mesh-list
83150834|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150835|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150836|NCT02405793|Analgesics|analgesics|mesh-ancestor
83150837|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
83150838|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150839|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150840|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150841|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150842|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83150843|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83150844|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150845|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150846|NCT05695664|Ibuprofen|ibuprofen|mesh-list
83150847|NCT05695664|Ketorolac|ketorolac|mesh-list
83150848|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150849|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150850|NCT05695664|Analgesics|analgesics|mesh-ancestor
83150851|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
83150852|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150853|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150854|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150855|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150856|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83150857|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150858|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150859|NCT02412189|Norepinephrine|norepinephrine|mesh-list
83150860|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83150861|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83150862|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
83150863|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83150864|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150865|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150866|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
83150867|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
83150868|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150869|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83150870|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
83150871|NCT02411955|Tazarotene|tazarotene|mesh-list
83150872|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
83150873|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
83150874|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
83150875|NCT02411955|Vitamins|vitamins|mesh-ancestor
83150876|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
83150877|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150878|NCT03172533|Dienogest|dienogest|mesh-list
83150879|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83150880|NCT03172533|Estradiol|estradiol|mesh-list
83150881|NCT03172533|Estrogens|estrogens|mesh-ancestor
83150882|NCT03172533|Hormones|hormones|mesh-ancestor
83150883|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83150884|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150885|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83150886|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
83150887|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150888|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83150889|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83150890|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83150891|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83150892|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
83150893|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83150894|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150895|NCT02412033|Misoprostol|misoprostol|mesh-list
83150896|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83150897|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
83150898|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150899|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150900|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83150901|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83150902|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
83150903|NCT02401971|Thalidomide|thalidomide|mesh-list
83150904|NCT02401971|Irinotecan|irinotecan|mesh-list
83150905|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83150906|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83150907|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150908|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150909|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150910|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83150911|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
83150912|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150913|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
83150914|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83150915|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150916|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83150917|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83150918|NCT02401971|Growth Substances|growth substances|mesh-ancestor
83150919|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
83150921|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83150922|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83150923|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
83150924|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150925|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83150926|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83150927|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150928|NCT05678738|Antioxidants|antioxidants|mesh-list
83150929|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150930|NCT05678738|Protective Agents|protective agents|mesh-ancestor
83150931|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150932|NCT03175653|Oxycodone|oxycodone|mesh-list
83150933|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83150934|NCT03175653|Narcotics|narcotics|mesh-ancestor
83150935|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83150936|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150937|NCT03175653|Analgesics|analgesics|mesh-ancestor
83150938|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
83150939|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150940|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83150941|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
83150942|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83150943|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
83150944|NCT03175341|Vitamins|vitamins|mesh-ancestor
83150945|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
83150946|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150947|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
83150948|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150949|NCT03175341|Protective Agents|protective agents|mesh-ancestor
83150950|NCT05538026|Mesalamine|mesalamine|mesh-list
83150951|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150952|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150953|NCT05538026|Analgesics|analgesics|mesh-ancestor
83150954|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
83150955|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150956|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150957|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150958|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150959|NCT02401425|Letrozole|letrozole|mesh-list
83150960|NCT02401425|Misoprostol|misoprostol|mesh-list
83150961|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83150962|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83150963|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83150964|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150965|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150966|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83150967|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
83150968|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83150969|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150970|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83150971|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
83150972|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83150973|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83150974|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83150976|NCT05537948|Pitavastatin|pitavastatin|mesh-list
83150977|NCT05537948|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83150978|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83150979|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83150980|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83150981|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
83150982|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150983|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83150984|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83150985|NCT05537948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83150986|NCT05537948|Protease Inhibitors|protease inhibitors|mesh-ancestor
83150987|NCT02401269|Aspirin|aspirin|mesh-list
83150988|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83150989|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83150990|NCT02401269|Analgesics|analgesics|mesh-ancestor
83150991|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
83150992|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83150993|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83150994|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83150995|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83150996|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83150997|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83150998|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83150999|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83151000|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83151001|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151002|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
83151003|NCT04480827|Cholic Acids|cholic acids|mesh-list
83151004|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151005|NCT02582684|Lamivudine|lamivudine|mesh-list
83151006|NCT02582684|Dolutegravir|dolutegravir|mesh-list
83151007|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83151008|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83151009|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151010|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151011|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
83151012|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151013|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83151014|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83151016|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83151017|NCT02411877|Clotrimazole|clotrimazole|mesh-list
83151018|NCT02411877|Miconazole|miconazole|mesh-list
83151019|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83151020|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151021|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
83151022|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83151023|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151024|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151025|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151026|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83151027|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
83151028|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151029|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151030|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83151031|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83151032|NCT03169569|Hemostatics|hemostatics|mesh-list
83151033|NCT03169569|Coagulants|coagulants|mesh-ancestor
83151034|NCT02585960|Factor VIII|factor viii|mesh-list
83151035|NCT02585960|BAX 855|bax 855|mesh-list
83151036|NCT02585960|Coagulants|coagulants|mesh-ancestor
83151037|NCT03169413|Adenosine|adenosine|mesh-list
83151038|NCT03169413|Analgesics|analgesics|mesh-ancestor
83151039|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
83151040|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151041|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151042|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83151043|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
83151044|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83151045|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
83151046|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
83151047|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151048|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151049|NCT03169335|Paclitaxel|paclitaxel|mesh-list
83151050|NCT03169335|Bevacizumab|bevacizumab|mesh-list
83151051|NCT03169335|Carboplatin|carboplatin|mesh-list
83151052|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83151053|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151054|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
83151055|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83151056|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83151057|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151058|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83151059|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83151060|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83151061|NCT03169335|Growth Substances|growth substances|mesh-ancestor
83151062|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151063|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83151064|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
83151065|NCT03106623|Mirabegron|mirabegron|mesh-list
83151066|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83151067|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83151068|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
83151069|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151070|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151071|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151072|NCT03106623|Urological Agents|urological agents|mesh-ancestor
83151073|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83151074|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83151075|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83151076|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
83151077|NCT02411175|Ethanol|ethanol|mesh-list
83151078|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83151079|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151080|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151081|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151082|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
83151083|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83151084|NCT02411331|Ethanol|ethanol|mesh-list
83151085|NCT02411331|Enoxaparin|enoxaparin|mesh-list
83151086|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
83151087|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83151088|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83151089|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151090|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83151091|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151092|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151093|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151094|NCT00100789|Paclitaxel|paclitaxel|mesh-list
83151095|NCT00100789|Gemcitabine|gemcitabine|mesh-list
83151096|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83151097|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151098|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
83151099|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
83151100|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
83151101|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151102|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83151103|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
83151104|NCT02410863|Trametinib|trametinib|mesh-list
83151105|NCT02410863|Dabrafenib|dabrafenib|mesh-list
83151106|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151107|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83151108|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151109|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151110|NCT05678192|Hormones|hormones|mesh-list
83151111|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151112|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151113|NCT00708123|Listerine|listerine|mesh-list
83151114|NCT00708123|Fluorides|fluorides|mesh-list
83151115|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
83151116|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
83151117|NCT00708123|Protective Agents|protective agents|mesh-ancestor
83151118|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151119|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83151120|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151121|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
83151122|NCT05678036|Narcotics|narcotics|mesh-ancestor
83151123|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151124|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151125|NCT05678036|Analgesics|analgesics|mesh-ancestor
83151126|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
83151127|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151128|NCT05537090|Midazolam|midazolam|mesh-list
83151129|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83151130|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83151131|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151132|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151133|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83151134|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83151135|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83151136|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83151137|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
83151138|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
83151139|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
83151140|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
83151141|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151142|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151143|NCT02400879|Sufentanil|sufentanil|mesh-list
83151144|NCT02400879|Remifentanil|remifentanil|mesh-list
83151145|NCT02400879|Sevoflurane|sevoflurane|mesh-list
83151146|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83151147|NCT02400879|Narcotics|narcotics|mesh-ancestor
83151148|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151149|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151150|NCT02400879|Analgesics|analgesics|mesh-ancestor
83151151|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
83151152|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151153|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83151154|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83151155|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
83151156|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
83151157|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83151158|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83151159|NCT04133480|Cannabidiol|cannabidiol|mesh-list
83151160|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
83151161|NCT02400645|Ketorolac|ketorolac|mesh-list
83151162|NCT02400645|Bupivacaine|bupivacaine|mesh-list
83151163|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
83151164|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
83151165|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151166|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151167|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
83151168|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151169|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83151170|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83151171|NCT02400645|Analgesics|analgesics|mesh-ancestor
83151172|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83151173|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83151174|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83151175|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151176|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151177|NCT02165215|Etrolizumab|etrolizumab|mesh-list
83151178|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151179|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
83151180|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151181|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83151182|NCT02400801|Dienogest|dienogest|mesh-list
83151183|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83151184|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
83151185|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83151186|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
83151187|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83151188|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151189|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83151190|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83151191|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151192|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83151193|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83151194|NCT02400801|Estrogens|estrogens|mesh-ancestor
83151195|NCT02400801|Hormones|hormones|mesh-ancestor
83151196|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151197|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83151198|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
83151199|NCT02168569|Artesunate|artesunate|mesh-list
83151200|NCT02168569|Lumefantrine|lumefantrine|mesh-list
83151201|NCT02168569|Artemether|artemether|mesh-list
83151202|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83151203|NCT02168569|Amodiaquine|amodiaquine|mesh-list
83151204|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
83151205|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83151206|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83151207|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151208|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151209|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
83151210|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
83151211|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83151212|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
83151213|NCT02400255|Crenolanib|crenolanib|mesh-list
83151214|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151215|NCT02171689|Afatinib|afatinib|mesh-list
83151216|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151217|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83151218|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151219|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151220|NCT02171767|Afatinib|afatinib|mesh-list
83151221|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151222|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83151223|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151224|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151225|NCT02400021|Progesterone|progesterone|mesh-list
83151226|NCT02400021|Progestins|progestins|mesh-ancestor
83151227|NCT02400021|Hormones|hormones|mesh-ancestor
83151228|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151229|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151230|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
83151231|NCT05677490|Leucovorin|leucovorin|mesh-list
83151232|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
83151233|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83151234|NCT05677490|Fluorouracil|fluorouracil|mesh-list
83151235|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
83151236|NCT05677490|Nivolumab|nivolumab|mesh-list
83151237|NCT05677490|Irinotecan|irinotecan|mesh-list
83151238|NCT05677490|Calcium|calcium|mesh-list
83151239|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
83151240|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83151241|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151242|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83151243|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
83151244|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151245|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83151246|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151247|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83151248|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
83151249|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83151250|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83151251|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83151252|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83151253|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151254|NCT05677490|Antidotes|antidotes|mesh-ancestor
83151255|NCT05677490|Protective Agents|protective agents|mesh-ancestor
83151256|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
83151257|NCT05677490|Vitamins|vitamins|mesh-ancestor
83151258|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
83151259|NCT02165449|Ketamine|ketamine|mesh-list
83151260|NCT02165449|Analgesics|analgesics|mesh-ancestor
83151261|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
83151262|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151263|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151264|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83151265|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83151266|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
83151267|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
83151268|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151269|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83151270|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83151271|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151272|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151273|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83151274|NCT02172001|Hematinics|hematinics|mesh-ancestor
83151275|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
83151276|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83151277|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83151278|NCT05535998|Estrogens|estrogens|mesh-ancestor
83151279|NCT05535998|Hormones|hormones|mesh-ancestor
83151280|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151281|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151282|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83151283|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151284|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151285|NCT05535998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83151286|NCT05531942|Aspirin|aspirin|mesh-list
83151287|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83151288|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83151289|NCT05531942|Analgesics|analgesics|mesh-ancestor
83151290|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
83151291|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151292|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151293|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83151294|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83151295|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83151296|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83151297|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151298|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83151299|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83151300|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151301|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
83151302|NCT03540199|Antibodies|antibodies|mesh-list
83151303|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83151304|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
83151305|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151306|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
83151307|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83151308|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
83151309|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151310|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
83151311|NCT02165917|Protective Agents|protective agents|mesh-ancestor
83151312|NCT02168881|Misoprostol|misoprostol|mesh-list
83151313|NCT02168881|Dinoprostone|dinoprostone|mesh-list
83151314|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83151315|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
83151316|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83151317|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151318|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83151319|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151321|NCT02168959|Bupivacaine|bupivacaine|mesh-list
83151322|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
83151323|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
83151324|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151325|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151326|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
83151327|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151329|NCT05696678|Ropivacaine|ropivacaine|mesh-list
83151330|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83151331|NCT05696678|Narcotics|narcotics|mesh-ancestor
83151332|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151333|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151334|NCT05696678|Analgesics|analgesics|mesh-ancestor
83151335|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
83151336|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151337|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
83151338|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
83151339|NCT05450822|Lamotrigine|lamotrigine|mesh-list
83151340|NCT05450822|Levetiracetam|levetiracetam|mesh-list
83151341|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
83151342|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
83151343|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83151344|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83151345|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151346|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83151347|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151348|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83151349|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83151350|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151351|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83151352|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83151353|NCT02172157|Olodaterol|olodaterol|mesh-list
83151354|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83151355|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
83151356|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151357|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151358|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83151359|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
83151360|NCT02172235|Pioglitazone|pioglitazone|mesh-list
83151361|NCT02172235|Empagliflozin|empagliflozin|mesh-list
83151362|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83151363|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151364|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83151365|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151366|NCT02166229|Valproic Acid|valproic acid|mesh-list
83151367|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
83151368|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151369|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151370|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
83151371|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151372|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151373|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
83151374|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83151375|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151376|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83151377|NCT05297864|Niraparib|niraparib|mesh-list
83151378|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83151379|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151380|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151381|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151382|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
83151383|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83151384|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151385|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151386|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83151387|NCT02757625|Analgesics|analgesics|mesh-ancestor
83151388|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
83151389|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151390|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83151391|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83151392|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83151393|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
83151394|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151395|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151396|NCT05691920|Fentanyl|fentanyl|mesh-list
83151397|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83151398|NCT05691920|Narcotics|narcotics|mesh-ancestor
83151399|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151400|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151401|NCT05691920|Analgesics|analgesics|mesh-ancestor
83151402|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
83151403|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151404|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83151405|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83151406|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
83151407|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
83151408|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83151410|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83151411|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151412|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83151413|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151414|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83151415|NCT05613842|Copper|copper|mesh-list
83151416|NCT05613842|Bombesin|bombesin|mesh-list
83151417|NCT05613842|Trace Elements|trace elements|mesh-ancestor
83151418|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
83151419|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151420|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151421|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151422|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
83151423|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83151424|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
83151425|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151426|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151427|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83151428|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
83151429|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
83151430|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83151431|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
83151432|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151433|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151434|NCT00109681|Iloprost|iloprost|mesh-list
83151435|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83151436|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
83151437|NCT02172469|Bromides|bromides|mesh-list
83151438|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
83151439|NCT02172469|Ipratropium|ipratropium|mesh-list
83151440|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83151441|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
83151442|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151443|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151444|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83151445|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
83151446|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
83151447|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83151448|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
83151449|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151450|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151451|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
83151452|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
83151453|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83151454|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
83151455|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151456|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151457|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83151458|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
83151459|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
83151460|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83151461|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
83151462|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151463|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151465|NCT02174887|Gemcitabine|gemcitabine|mesh-list
83151466|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83151467|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151468|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
83151469|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
83151470|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
83151471|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151472|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83151473|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
83151474|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83151475|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
83151476|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
83151477|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151479|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
83151480|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151481|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
83151482|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151483|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151484|NCT04298528|Dronabinol|dronabinol|mesh-list
83151485|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
83151486|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151487|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83151488|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83151489|NCT04298528|Analgesics|analgesics|mesh-ancestor
83151490|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
83151491|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151492|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83151493|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83151494|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151495|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151496|NCT04298528|Hormones|hormones|mesh-ancestor
83151497|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151498|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
83151499|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151500|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83151501|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
83151502|NCT02581202|Ritonavir|ritonavir|mesh-list
83151503|NCT02581202|Lopinavir|lopinavir|mesh-list
83151504|NCT02581202|Lamivudine|lamivudine|mesh-list
83151505|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83151506|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83151507|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151508|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151509|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151510|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83151511|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83151512|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
83151513|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151514|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83151515|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151516|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83151517|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83151518|NCT02758171|Empagliflozin|empagliflozin|mesh-list
83151519|NCT02758171|Linagliptin|linagliptin|mesh-list
83151520|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83151521|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151522|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83151523|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151524|NCT02758171|Incretins|incretins|mesh-ancestor
83151525|NCT02758171|Hormones|hormones|mesh-ancestor
83151526|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151527|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83151528|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151529|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151530|NCT00101101|Aldesleukin|aldesleukin|mesh-list
83151531|NCT00101101|Dexamethasone|dexamethasone|mesh-list
83151532|NCT00101101|Prednisone|prednisone|mesh-list
83151533|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
83151534|NCT00101101|Doxorubicin|doxorubicin|mesh-list
83151535|NCT00101101|Vincristine|vincristine|mesh-list
83151536|NCT00101101|Interleukin-2|interleukin-2|mesh-list
83151537|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83151538|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
83151539|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151540|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83151541|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83151542|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
83151543|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151544|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151545|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83151546|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83151547|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
83151548|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
83151549|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151550|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151551|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
83151552|NCT00101101|Hormones|hormones|mesh-ancestor
83151553|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151554|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83151555|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83151556|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83151557|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83151558|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151559|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83151560|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
83151561|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
83151562|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
83151563|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83151564|NCT00101101|Analgesics|analgesics|mesh-ancestor
83151565|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
83151566|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83151567|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83151568|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
83151569|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151570|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
83151571|NCT02172781|Ipratropium|ipratropium|mesh-list
83151572|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83151573|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
83151574|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151575|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151576|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83151577|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
83151578|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
83151579|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83151580|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
83151581|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151582|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151583|NCT02173093|Aldesleukin|aldesleukin|mesh-list
83151584|NCT02173093|Interleukin-2|interleukin-2|mesh-list
83151585|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151586|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83151587|NCT02173093|Analgesics|analgesics|mesh-ancestor
83151588|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
83151589|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151590|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151591|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83151592|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83151593|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
83151594|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151595|NCT01465100|Liver Extracts|liver extracts|mesh-list
83151596|NCT01465100|Hematinics|hematinics|mesh-ancestor
83151597|NCT05142085|Mineral Oil|mineral oil|mesh-list
83151598|NCT05142085|Emollients|emollients|mesh-ancestor
83151599|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
83151600|NCT00103831|Taxane|taxane|mesh-list
83151601|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151602|NCT03538483|Bupivacaine|bupivacaine|mesh-list
83151603|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
83151604|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
83151605|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151606|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151607|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
83151608|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151609|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
83151610|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83151611|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151612|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83151613|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151614|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83151615|NCT02175355|Telmisartan|telmisartan|mesh-list
83151616|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83151618|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
83151619|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151620|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83151621|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83151622|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151623|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83151624|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83151625|NCT03538327|Silybin|silybin|mesh-list
83151626|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83151627|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151628|NCT03538327|Protective Agents|protective agents|mesh-ancestor
83151629|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151630|NCT02170597|Dabigatran|dabigatran|mesh-list
83151631|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
83151632|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83151633|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151634|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151635|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151636|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
83151637|NCT02170675|Ketoconazole|ketoconazole|mesh-list
83151638|NCT02170675|Dabigatran|dabigatran|mesh-list
83151639|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
83151640|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83151641|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151642|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151643|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151644|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
83151645|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
83151646|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151647|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83151648|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151649|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83151650|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
83151651|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151652|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151653|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83151654|NCT02175433|AGS67E|ags67e|mesh-list
83151655|NCT02175433|Immunoconjugates|immunoconjugates|mesh-ancestor
83151656|NCT02175433|Immunologic Factors|immunologic factors|mesh-ancestor
83151657|NCT02175433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151658|NCT04154150|Ketamine|ketamine|mesh-list
83151659|NCT04154150|Analgesics|analgesics|mesh-ancestor
83151660|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
83151661|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151662|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151663|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83151664|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83151665|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
83151666|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
83151667|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151668|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83151669|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83151670|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151671|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151672|NCT00521846|Cimetidine|cimetidine|mesh-list
83151673|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83151674|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151675|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83151676|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
83151677|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
83151678|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151679|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151680|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151681|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83151682|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151683|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151684|NCT02170831|Dabigatran|dabigatran|mesh-list
83151685|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
83151686|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83151687|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151688|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151689|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151690|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
83151691|NCT02175589|Colchicine|colchicine|mesh-list
83151692|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
83151693|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83151694|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
83151695|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
83151696|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83151697|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151698|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151699|NCT05438186|Liraglutide|liraglutide|mesh-list
83151700|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83151701|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151702|NCT05438186|Incretins|incretins|mesh-ancestor
83151704|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151705|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83151706|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151707|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83151708|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151709|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151710|NCT02173639|Metformin|metformin|mesh-list
83151711|NCT02173639|Linagliptin|linagliptin|mesh-list
83151712|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83151713|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151714|NCT02173639|Incretins|incretins|mesh-ancestor
83151715|NCT02173639|Hormones|hormones|mesh-ancestor
83151716|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151717|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83151718|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151719|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151720|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151721|NCT02173717|Rifampin|rifampin|mesh-list
83151722|NCT02173717|Dabigatran|dabigatran|mesh-list
83151723|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
83151724|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83151725|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151726|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151727|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151728|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
83151729|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83151730|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
83151731|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83151732|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151733|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
83151734|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83151735|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83151736|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83151737|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83151738|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83151739|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83151740|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83151741|NCT04067648|Sufentanil|sufentanil|mesh-list
83151742|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83151743|NCT04067648|Narcotics|narcotics|mesh-ancestor
83151744|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151745|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151746|NCT04067648|Analgesics|analgesics|mesh-ancestor
83151747|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
83151748|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151749|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83151750|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83151751|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
83151752|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
83151753|NCT02173795|Fenoterol|fenoterol|mesh-list
83151754|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83151755|NCT02173795|Ipratropium|ipratropium|mesh-list
83151756|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83151757|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
83151758|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151759|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151760|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83151761|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
83151762|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
83151763|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
83151764|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83151765|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83151766|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83151767|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83151768|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83151769|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151770|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151771|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83151772|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
83151773|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83151774|NCT02175901|Amoxicillin|amoxicillin|mesh-list
83151775|NCT02175901|Metronidazole|metronidazole|mesh-list
83151776|NCT02175901|Clarithromycin|clarithromycin|mesh-list
83151777|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83151778|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
83151779|NCT02175901|Lansoprazole|lansoprazole|mesh-list
83151780|NCT02175901|Bismuth|bismuth|mesh-list
83151781|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83151782|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151783|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151784|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
83151785|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83151786|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83151787|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83151788|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151789|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83151790|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151791|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83151792|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151793|NCT02175901|Antacids|antacids|mesh-ancestor
83151794|NCT02175901|Diuretics|diuretics|mesh-ancestor
83151795|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
83151796|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151797|NCT02175901|Expectorants|expectorants|mesh-ancestor
83151798|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
83151799|NCT05534750|Linezolid|linezolid|mesh-list
83151800|NCT05534750|Tedizolid|tedizolid|mesh-list
83151801|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
83151802|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83151803|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151804|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83151805|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151806|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151807|NCT02173873|Aflibercept|aflibercept|mesh-list
83151808|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83151809|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83151810|NCT02173873|Growth Substances|growth substances|mesh-ancestor
83151811|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151812|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
83151813|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151814|NCT02176057|Azithromycin|azithromycin|mesh-list
83151815|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83151816|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151817|NCT02173951|Deferiprone|deferiprone|mesh-list
83151818|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83151819|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
83151820|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
83151821|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151823|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83151824|NCT02176213|Dexamethasone|dexamethasone|mesh-list
83151825|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
83151826|NCT02176213|Pomalidomide|pomalidomide|mesh-list
83151827|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83151828|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
83151829|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151830|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83151831|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83151832|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
83151833|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151834|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151835|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83151836|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83151837|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
83151838|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
83151839|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151840|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151841|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
83151842|NCT02176213|Hormones|hormones|mesh-ancestor
83151843|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151844|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83151845|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83151846|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83151847|NCT02176213|Growth Substances|growth substances|mesh-ancestor
83151848|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
83151849|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
83151850|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
83151851|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
83151852|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83151853|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151854|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151855|NCT04305002|Exenatide|exenatide|mesh-list
83151856|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83151857|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151858|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83151859|NCT04305002|Incretins|incretins|mesh-ancestor
83151860|NCT04305002|Hormones|hormones|mesh-ancestor
83151861|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83151862|NCT02253797|Ritonavir|ritonavir|mesh-list
83151863|NCT02253797|Tipranavir|tipranavir|mesh-list
83151864|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83151865|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83151866|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151867|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151868|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151869|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83151870|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83151871|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
83151872|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151873|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83151874|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151875|NCT04620746|Penicillins|penicillins|mesh-list
83151876|NCT04620746|Penicillin G|penicillin g|mesh-list
83151877|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83151878|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151879|NCT02253875|Ritonavir|ritonavir|mesh-list
83151880|NCT02253875|Tipranavir|tipranavir|mesh-list
83151881|NCT02253875|Omeprazole|omeprazole|mesh-list
83151882|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83151883|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83151884|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
83151885|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151886|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151887|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83151888|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83151889|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
83151890|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151891|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83151892|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151893|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83151894|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83151895|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83151896|NCT05534672|Sirolimus|sirolimus|mesh-list
83151897|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83151898|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151899|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83151900|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151901|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
83151902|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83151903|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
83151904|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151905|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83151906|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83151907|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151909|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
83151910|NCT04597268|Ketamine|ketamine|mesh-list
83151911|NCT04597268|Propofol|propofol|mesh-list
83151912|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83151913|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151914|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151915|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83151916|NCT04597268|Analgesics|analgesics|mesh-ancestor
83151917|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
83151918|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151919|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83151920|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83151921|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83151922|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
83151923|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83151924|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151925|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83151926|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
83151928|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83151929|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83151930|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83151931|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83151932|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83151933|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83151934|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83151935|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
83151936|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
83151937|NCT04976543|Nadroparin|nadroparin|mesh-list
83151938|NCT04976543|Warfarin|warfarin|mesh-list
83151939|NCT04976543|Calcium|calcium|mesh-list
83151940|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83151941|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151942|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
83151943|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83151944|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83151945|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151946|NCT04310930|Azithromycin|azithromycin|mesh-list
83151947|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
83151948|NCT04310930|Clarithromycin|clarithromycin|mesh-list
83151949|NCT04310930|Doxycycline|doxycycline|mesh-list
83151950|NCT04310930|Linezolid|linezolid|mesh-list
83151951|NCT04310930|Imipenem|imipenem|mesh-list
83151952|NCT04310930|Amikacin|amikacin|mesh-list
83151953|NCT04310930|Ethambutol|ethambutol|mesh-list
83151954|NCT04310930|Rifabutin|rifabutin|mesh-list
83151955|NCT04310930|Tigecycline|tigecycline|mesh-list
83151956|NCT04310930|Bedaquiline|bedaquiline|mesh-list
83151957|NCT04310930|Clofazimine|clofazimine|mesh-list
83151958|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83151959|NCT04310930|Cefoxitin|cefoxitin|mesh-list
83151960|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83151961|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83151962|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83151963|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83151964|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151965|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151966|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151967|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83151968|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83151969|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83151970|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
83151971|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83151972|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83151973|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
83151974|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83151975|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83151976|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
83151977|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83151978|NCT05533892|Lenvatinib|lenvatinib|mesh-list
83151979|NCT05533892|Tislelizumab|tislelizumab|mesh-list
83151980|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
83151981|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83151982|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83151983|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83151984|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83151985|NCT05533892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83151986|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83151987|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
83151988|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151989|NCT02924441|Lidocaine|lidocaine|mesh-list
83151990|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
83151991|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
83151992|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83151993|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83151994|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
83151995|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83151997|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83151998|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83151999|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83152000|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152001|NCT04526288|Cytarabine|cytarabine|mesh-list
83152002|NCT04526288|Daunorubicin|daunorubicin|mesh-list
83409006|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
83152003|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83152004|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
83152005|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152006|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152007|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
83152008|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152009|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83152010|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
83152011|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152012|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83152013|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83152014|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83152015|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152016|NCT00109967|Sirolimus|sirolimus|mesh-list
83152017|NCT00109967|Rituximab|rituximab|mesh-list
83152018|NCT00109967|Temsirolimus|temsirolimus|mesh-list
83152019|NCT00109967|MTOR Inhibitors|mtor inhibitors|mesh-list
83152020|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83152021|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152022|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
83152023|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152024|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152025|NCT00109967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152026|NCT00109967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152027|NCT00109967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152028|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83152029|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83152030|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152031|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83152032|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
83152033|NCT02579096|Allopurinol|allopurinol|mesh-list
83152034|NCT02579096|Febuxostat|febuxostat|mesh-list
83152035|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
83152036|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152037|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152038|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
83152039|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152040|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83152041|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
83152042|NCT02579096|Protective Agents|protective agents|mesh-ancestor
83152043|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152044|NCT02578862|Propofol|propofol|mesh-list
83152045|NCT02578862|Sevoflurane|sevoflurane|mesh-list
83152046|NCT02578862|Isoflurane|isoflurane|mesh-list
83152047|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83152048|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83152049|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152050|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83152051|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
83152052|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
83409693|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
83152053|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83152054|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83152055|NCT02578706|Aspirin|aspirin|mesh-list
83152056|NCT02578706|Clopidogrel|clopidogrel|mesh-list
83152057|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83152058|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152059|NCT02578706|Analgesics|analgesics|mesh-ancestor
83152060|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
83152061|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152062|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152063|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152064|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152065|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83152066|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83152067|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152068|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83152069|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83152071|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
83152072|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83152073|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83409694|NCT03202628|Hormones|hormones|mesh-ancestor
83152074|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83152075|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
83152076|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152077|NCT03455504|Venetoclax|venetoclax|mesh-list
83409844|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
83409845|NCT03044587|Vitamins|vitamins|mesh-ancestor
83409846|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
83152078|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152079|NCT00108953|Doxorubicin|doxorubicin|mesh-list
83152080|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83152081|NCT00108953|Sorafenib|sorafenib|mesh-list
83152082|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83152083|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83409847|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
83152084|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83409848|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
83152085|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83152087|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152088|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152089|NCT04464980|Naltrexone|naltrexone|mesh-list
83152090|NCT04464980|Buprenorphine|buprenorphine|mesh-list
83152091|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83152092|NCT04464980|Narcotics|narcotics|mesh-ancestor
83152093|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83152094|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152095|NCT04464980|Analgesics|analgesics|mesh-ancestor
83152096|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
83152097|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152098|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83152099|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83410008|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152100|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83152101|NCT03054896|Venetoclax|venetoclax|mesh-list
83152102|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152104|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152105|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152106|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152107|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152108|NCT05532878|Apixaban|apixaban|mesh-list
83152109|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83152110|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
83152111|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83152112|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152113|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83410540|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83479602|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83479603|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
83479604|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
83152114|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152116|NCT02576678|Apremilast|apremilast|mesh-list
83152117|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83152118|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152119|NCT02576678|Analgesics|analgesics|mesh-ancestor
83152120|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
83152121|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152122|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152123|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152124|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152125|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83479605|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
83152126|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83152127|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152128|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83479758|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83173426|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173427|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
83173428|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173429|NCT00728351|Metformin|metformin|mesh-list
83173430|NCT00728351|Vildagliptin|vildagliptin|mesh-list
83362162|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362163|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83362164|NCT05339542|Protective Agents|protective agents|mesh-ancestor
83362165|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362166|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362167|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
83362168|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83362169|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362170|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83362172|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173431|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362173|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362174|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362175|NCT05257018|Doxorubicin|doxorubicin|mesh-list
83362176|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83152133|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152136|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173432|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152137|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83152138|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
83152139|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83152140|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83152141|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83152142|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152143|NCT05532254|Aripiprazole|aripiprazole|mesh-list
83152144|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
83152145|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83152146|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83152147|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83410541|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
83410928|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
83152148|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83152149|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152150|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
83152151|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
83152152|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152153|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152154|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83152155|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83152156|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
83410929|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
83152157|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83152158|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83410930|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
83152159|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83152160|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83152161|NCT05471648|Pertuzumab|pertuzumab|mesh-list
83152162|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83152163|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152169|NCT00108745|Paclitaxel|paclitaxel|mesh-list
83152170|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83152171|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83152172|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83152173|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152174|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
83152175|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
83152176|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
83152177|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152179|NCT05532020|Choline|choline|mesh-list
83152180|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
83152181|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83152182|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
83411086|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
83411087|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
83411163|NCT03449108|Aldesleukin|aldesleukin|mesh-list
83173433|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83152183|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173434|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152184|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83152185|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83152186|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
83152187|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83152188|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
83152189|NCT02098343|Carboplatin|carboplatin|mesh-list
83152190|NCT02098343|Doxorubicin|doxorubicin|mesh-list
83152191|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83152192|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173435|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152193|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83411164|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
83411165|NCT03449108|Nivolumab|nivolumab|mesh-list
83411166|NCT03449108|Fludarabine|fludarabine|mesh-list
83411167|NCT03449108|Ipilimumab|ipilimumab|mesh-list
83152194|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83152195|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83152196|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152197|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152198|NCT02176369|Vinorelbine|vinorelbine|mesh-list
83152199|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83152200|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152201|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
83152203|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
83479759|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83479760|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
83479761|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
83152204|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152205|NCT02716805|Melphalan|melphalan|mesh-list
83152207|NCT02716805|Tremelimumab|tremelimumab|mesh-list
83411244|NCT03113617|Bombesin|bombesin|mesh-list
83152208|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83152209|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
83152210|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152211|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152212|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83411920|NCT01976065|Minocycline|minocycline|mesh-list
83411996|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83152213|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83152215|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152216|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83152217|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
83152218|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
83152219|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
83152220|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152221|NCT04152473|Proglumide|proglumide|mesh-list
83152222|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83152223|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83152224|NCT04099355|Dronabinol|dronabinol|mesh-list
83152225|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
83152226|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152227|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83152228|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152229|NCT04099355|Analgesics|analgesics|mesh-ancestor
83152230|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
83152231|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152232|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83152233|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83152234|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152235|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152236|NCT04099355|Hormones|hormones|mesh-ancestor
83152237|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152239|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
83411997|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
83152240|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83152241|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83412149|NCT01406223|Nicotine|nicotine|mesh-list
83152242|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152243|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
83152244|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
83152245|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
83479762|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83412150|NCT01406223|Varenicline|varenicline|mesh-list
83412372|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
83152246|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152247|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83152248|NCT02581982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83152249|NCT03751397|Cystatins|cystatins|mesh-list
83412373|NCT02177071|Azathioprine|azathioprine|mesh-list
83412374|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83412375|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
83412376|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83412377|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412378|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83412379|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
83412380|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83412381|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83412382|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
83412383|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412384|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83152250|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83152251|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152252|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152253|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152254|NCT02176681|Vildagliptin|vildagliptin|mesh-list
83152255|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152256|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83412610|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
83152257|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83152258|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152259|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83412612|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
83412613|NCT02143219|Hematinics|hematinics|mesh-ancestor
83412614|NCT04122911|Temozolomide|temozolomide|mesh-list
83479763|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83152260|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152261|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
83412690|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152262|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83412993|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
83152263|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83413443|NCT03820193|Celecoxib|celecoxib|mesh-list
83152264|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413444|NCT03820193|Ketorolac|ketorolac|mesh-list
83479764|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83479765|NCT05123040|Protective Agents|protective agents|mesh-ancestor
83152265|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152266|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
83152267|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152268|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83479766|NCT05096702|Primaquine|primaquine|mesh-list
83152270|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152272|NCT02254577|Progestins|progestins|mesh-ancestor
83152273|NCT02254577|Hormones|hormones|mesh-ancestor
83479767|NCT05096702|Tafenoquine|tafenoquine|mesh-list
83479768|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
83152274|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152275|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152277|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
83152278|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
83152279|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83152280|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
83152281|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
83479769|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83152282|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152283|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
83479770|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83152284|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83413748|NCT01896349|Bupropion|bupropion|mesh-list
83152285|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152286|NCT02576990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83152287|NCT02576990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152288|NCT03538171|Exemestane|exemestane|mesh-list
83152289|NCT03538171|Entinostat|entinostat|mesh-list
83413750|NCT01896349|Fluoxetine|fluoxetine|mesh-list
83413751|NCT01896349|Paroxetine|paroxetine|mesh-list
83413752|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83413753|NCT01896349|Nortriptyline|nortriptyline|mesh-list
83413754|NCT01896349|Imipramine|imipramine|mesh-list
83413755|NCT01896349|Clomipramine|clomipramine|mesh-list
83413756|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
83413757|NCT01896349|Escitalopram|escitalopram|mesh-list
83152290|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152291|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83413832|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
83414211|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
83414364|NCT01419639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83152292|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83152293|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83414820|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
83414821|NCT01485393|Zolpidem|zolpidem|mesh-list
83414897|NCT04854252|Analgesics|analgesics|mesh-ancestor
83415733|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
83415734|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83152294|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152295|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83152296|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
83415735|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
83415736|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
83415813|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83479771|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83479772|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
83479774|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83479775|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
83479776|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83479777|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
83479778|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83530943|NCT01960075|Valproic Acid|valproic acid|mesh-list
83173436|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173437|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83173438|NCT00616811|Vildagliptin|vildagliptin|mesh-list
83173439|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83173440|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173441|NCT00616811|Incretins|incretins|mesh-ancestor
83173442|NCT00616811|Hormones|hormones|mesh-ancestor
83530944|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
83530945|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
83152297|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83530946|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83531021|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83531022|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
83152298|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152299|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83152301|NCT05312216|Lenvatinib|lenvatinib|mesh-list
83152302|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83152303|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152304|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152305|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152306|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152307|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
83152308|NCT02256319|Propofol|propofol|mesh-list
83152309|NCT02256319|Imidazole|imidazole|mesh-list
83152310|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83152311|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531246|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
83152312|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152313|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152314|NCT02256319|Analgesics|analgesics|mesh-ancestor
83152315|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
83152316|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152317|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83152318|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83152319|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83531543|NCT02070692|Tamoxifen|tamoxifen|mesh-list
83152321|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83531544|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83531545|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
83152322|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152323|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83152324|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
83152326|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152328|NCT04510285|Trastuzumab|trastuzumab|mesh-list
83531693|NCT01981759|Cycloserine|cycloserine|mesh-list
83531844|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
83531845|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
83531846|NCT02035345|Carboplatin|carboplatin|mesh-list
83531922|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83152329|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83152330|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152331|NCT04510285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83152332|NCT04510285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152333|NCT05450432|Ketamine|ketamine|mesh-list
83152334|NCT05450432|Esketamine|esketamine|mesh-list
83152335|NCT05450432|Analgesics|analgesics|mesh-ancestor
83152336|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
83152337|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152338|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152339|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83152340|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83152341|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
83152342|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
83152343|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83531923|NCT02353754|Narcotics|narcotics|mesh-ancestor
83152344|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83152345|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83152346|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152347|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152348|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
83152349|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83152350|NCT02179255|Hormones|hormones|mesh-list
83531924|NCT02353754|Analgesics|analgesics|mesh-ancestor
83152351|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83476468|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83476469|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
83152352|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83476470|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83152353|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152354|NCT02182063|Nintedanib|nintedanib|mesh-list
83476471|NCT01093469|Decanoic acid|decanoic acid|mesh-list
83152355|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152356|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152357|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83476472|NCT01093469|Petrolatum|petrolatum|mesh-list
83476473|NCT01093469|Emollients|emollients|mesh-ancestor
83476474|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
83476475|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
83152358|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152359|NCT02182141|Nintedanib|nintedanib|mesh-list
83152360|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83531925|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
83152361|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152362|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152363|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152364|NCT02182219|Nintedanib|nintedanib|mesh-list
83152365|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152366|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152367|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152368|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152369|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
83152370|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
83152371|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152372|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83152373|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152374|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
83152375|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83152376|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83152377|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
83152378|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152379|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83152380|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83152381|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152382|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152383|NCT02179567|Bevacizumab|bevacizumab|mesh-list
83532076|NCT02877485|Triamcinolone|triamcinolone|mesh-list
83532151|NCT00374465|Verapamil|verapamil|mesh-list
83532152|NCT00374465|Carvedilol|carvedilol|mesh-list
83152385|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83532903|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
83532904|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83532905|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83532906|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83532907|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83532908|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
83532909|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83532910|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
83532911|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83532912|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83532913|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83532914|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
83532974|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
83152386|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152387|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83533052|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152388|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83152389|NCT02179567|Growth Substances|growth substances|mesh-ancestor
83152390|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152391|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
83152392|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83152393|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83152394|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83476478|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83152395|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152397|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83476479|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83477940|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83477941|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
83152398|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152399|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152400|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152401|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
83152403|NCT02182531|Epinastine|epinastine|mesh-list
83152404|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83152405|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
83533585|NCT03323801|Isotretinoin|isotretinoin|mesh-list
83152406|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152407|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533665|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
83152408|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83152409|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
83152410|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
83152411|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83152412|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83152413|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
83152414|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
83152415|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152416|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152417|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83152418|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
83152419|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
83152420|NCT01990352|Doxorubicin|doxorubicin|mesh-list
83152421|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83152422|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83152423|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83533741|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
83152424|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83152425|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83152426|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152427|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152428|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83152430|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83152431|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
83152432|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152433|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152434|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83152435|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
83152436|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
83152437|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83152438|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
83152439|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152440|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152441|NCT02182765|Nevirapine|nevirapine|mesh-list
83152442|NCT02182765|Abacavir|abacavir|mesh-list
83152443|NCT02182765|Amprenavir|amprenavir|mesh-list
83152444|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83152445|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83152446|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152447|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152448|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
83152449|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152450|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83152451|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83152452|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83152453|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83152454|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83152455|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
83533743|NCT03220022|Doxorubicin|doxorubicin|mesh-list
83152456|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83533744|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83533745|NCT03220022|Etoposide|etoposide|mesh-list
83152457|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83533746|NCT03220022|Vincristine|vincristine|mesh-list
83152458|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83152459|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152460|NCT02179645|Celecoxib|celecoxib|mesh-list
83533747|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
83533748|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
83533899|NCT01349192|Rifampin|rifampin|mesh-list
83478017|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533900|NCT01349192|Trimethoprim|trimethoprim|mesh-list
83152461|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83152462|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152463|NCT02179645|Analgesics|analgesics|mesh-ancestor
83533901|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
83152464|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
83152465|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152466|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83533902|NCT01349192|Mupirocin|mupirocin|mesh-list
83533976|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
83534049|NCT02376283|Ticagrelor|ticagrelor|mesh-list
83534883|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
83534960|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
83534962|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83535791|NCT05922306|Interferon alpha-2|interferon alpha-2|mesh-list
83536020|NCT05920213|Lactulose|lactulose|mesh-list
83536021|NCT05920213|N-Methylaspartate|n-methylaspartate|mesh-list
83152467|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152468|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152469|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83152470|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83152471|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152472|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152473|NCT03537157|Rifaximin|rifaximin|mesh-list
83152474|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83152475|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152476|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83152477|NCT01606202|Nabiximols|nabiximols|mesh-list
83152478|NCT01606202|Analgesics|analgesics|mesh-ancestor
83152479|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
83152480|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152481|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152482|NCT05529290|Acetaminophen|acetaminophen|mesh-list
83152483|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83152484|NCT05529290|Ketoprofen|ketoprofen|mesh-list
83152485|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152486|NCT05529290|Analgesics|analgesics|mesh-ancestor
83152487|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
83152488|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152489|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152490|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
83152491|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83152492|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152493|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152494|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83152495|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478018|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83536100|NCT05919173|Anesthetics, Local|anesthetics, local|mesh-ancestor
83536175|NCT05898828|Immunologic Factors|immunologic factors|mesh-ancestor
83536701|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
83478019|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152496|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152499|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
83152500|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
83152501|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83152502|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152503|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478023|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
83152504|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152506|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83152507|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83478024|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478026|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152508|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83478027|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
83152510|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
83152511|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83536851|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83536926|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
83152512|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152513|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
83152514|NCT02183077|Meloxicam|meloxicam|mesh-list
83152515|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83152516|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152517|NCT02183077|Analgesics|analgesics|mesh-ancestor
83152518|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
83152519|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152520|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83536927|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83537007|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
83152521|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152522|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152523|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83537008|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
83152524|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83152525|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152526|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152527|NCT02183155|Indomethacin|indomethacin|mesh-list
83478028|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152529|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83478030|NCT01481545|Bevacizumab|bevacizumab|mesh-list
83152530|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152531|NCT02183155|Analgesics|analgesics|mesh-ancestor
83152532|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
83152533|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152534|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83478031|NCT01481545|Fluorouracil|fluorouracil|mesh-list
83478032|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
83152535|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152536|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152537|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
83152539|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83478033|NCT01481545|Raltitrexed|raltitrexed|mesh-list
83152540|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83152541|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478034|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
83537158|NCT05633654|Immunologic Factors|immunologic factors|mesh-ancestor
83478035|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83478036|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83478037|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83152542|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83537386|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
83152543|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83152544|NCT02177461|Telmisartan|telmisartan|mesh-list
83152545|NCT02177461|Clonidine|clonidine|mesh-list
83152546|NCT02177461|Enalapril|enalapril|mesh-list
83152547|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83152548|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83152549|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83152550|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152551|NCT02177461|Analgesics|analgesics|mesh-ancestor
83152552|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
83538146|NCT05222555|Lenalidomide|lenalidomide|mesh-list
83152553|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152554|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152555|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
83152556|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
83152557|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83152558|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83152559|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83152560|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
83152561|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152562|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83152563|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152564|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152565|NCT03545243|Pantoprazole|pantoprazole|mesh-list
83152566|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83152567|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83152568|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83152569|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152570|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152571|NCT02183311|Linagliptin|linagliptin|mesh-list
83152572|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152573|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152574|NCT02183311|Incretins|incretins|mesh-ancestor
83152575|NCT02183311|Hormones|hormones|mesh-ancestor
83152576|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152577|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83152578|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152579|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152580|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152581|NCT05518526|Annamycin|annamycin|mesh-list
83152582|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83152583|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152584|NCT01464593|Doxorubicin|doxorubicin|mesh-list
83152585|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83152586|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83152587|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152588|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83152589|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83152590|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152591|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152592|NCT02183389|Linagliptin|linagliptin|mesh-list
83152593|NCT02183389|Warfarin|warfarin|mesh-list
83152594|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
83152595|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152596|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152597|NCT02183389|Incretins|incretins|mesh-ancestor
83152598|NCT02183389|Hormones|hormones|mesh-ancestor
83478038|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83152599|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152600|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83152601|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152602|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152603|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152604|NCT02177539|Phenylephrine|phenylephrine|mesh-list
83152605|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
83152606|NCT02177539|Tropicamide|tropicamide|mesh-list
83152607|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
83152608|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83152609|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
83152610|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
83152611|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152612|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152613|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
83152614|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83152615|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
83152616|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
83152617|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83152618|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83152619|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83152620|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
83152621|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152622|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152623|NCT02177539|Protective Agents|protective agents|mesh-ancestor
83152624|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83152625|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83152626|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
83152627|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
83152628|NCT04141904|Tofacitinib|tofacitinib|mesh-list
83152629|NCT04141904|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83152630|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152631|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152632|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152633|NCT05523986|Vitamin D|vitamin d|mesh-list
83152634|NCT05523986|Vitamins|vitamins|mesh-ancestor
83152635|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
83152636|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152637|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83152638|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83152639|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
83152640|NCT01361711|Ofatumumab|ofatumumab|mesh-list
83152641|NCT01361711|Antibodies|antibodies|mesh-list
83152642|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
83152643|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83152644|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
83152645|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152646|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152647|NCT05527418|Dasatinib|dasatinib|mesh-list
83152648|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152649|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83152650|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152651|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152652|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83152653|NCT05527340|Dexamethasone|dexamethasone|mesh-list
83152654|NCT05527340|Daratumumab|daratumumab|mesh-list
83152655|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152656|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
83152657|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
83152658|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152659|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152660|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83152661|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
83152662|NCT05527340|Hormones|hormones|mesh-ancestor
83152663|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152664|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83152665|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152666|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
83152667|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83152668|NCT05527106|Vitamins|vitamins|mesh-ancestor
83152669|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
83152670|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152671|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
83152672|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152673|NCT05527106|Protective Agents|protective agents|mesh-ancestor
83152674|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
83152675|NCT05526794|Analgesics|analgesics|mesh-list
83152676|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
83152677|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152678|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152679|NCT05522894|Paclitaxel|paclitaxel|mesh-list
83152680|NCT05522894|Cisplatin|cisplatin|mesh-list
83152681|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83152682|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152683|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
83152684|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
83152685|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
83152686|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152687|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
83152688|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152689|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152690|NCT02573870|Fluticasone|fluticasone|mesh-list
83152691|NCT02573870|Xhance|xhance|mesh-list
83152692|NCT02573870|Albuterol|albuterol|mesh-list
83152693|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152694|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83152695|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
83152696|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152697|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152698|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83152699|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
83152700|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
83152701|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83152702|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
83152703|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83152704|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83152705|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83152706|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83152707|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83152708|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152709|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152710|NCT05149898|Cannabidiol|cannabidiol|mesh-list
83152711|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
83152712|NCT05148026|Heparin|heparin|mesh-list
83152713|NCT05148026|Calcium heparin|calcium heparin|mesh-list
83152714|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
83152715|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
83152716|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83152717|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83152718|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152719|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83152720|NCT05522270|Mitogens|mitogens|mesh-list
83152721|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
83152722|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152723|NCT05522192|Venetoclax|venetoclax|mesh-list
83152724|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
83152725|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152726|NCT05522192|Analgesics|analgesics|mesh-ancestor
83152727|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
83152728|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152729|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152730|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83152731|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83152732|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152733|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152734|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83152735|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83152736|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
83152737|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83152738|NCT05515874|Hematinics|hematinics|mesh-ancestor
83152739|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83152740|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83152741|NCT05525234|Thalidomide|thalidomide|mesh-list
83152742|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83152743|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
83152744|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152745|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
83152746|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83152747|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152748|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83152749|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83152750|NCT05525234|Growth Substances|growth substances|mesh-ancestor
83152751|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
83152752|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152753|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83152754|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83152755|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152756|NCT04300790|Metformin|metformin|mesh-list
83152757|NCT04300790|Letrozole|letrozole|mesh-list
83152759|NCT04300790|Exemestane|exemestane|mesh-list
83152760|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152761|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152762|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152763|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83152764|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83152765|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152766|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152767|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83152768|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
83152769|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152770|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83152771|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83152772|NCT04295330|Lidocaine|lidocaine|mesh-list
83152773|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
83152774|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
83152775|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83152776|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152777|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
83152778|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152779|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83152780|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83152781|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83152782|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83152783|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152784|NCT05525156|Aspirin|aspirin|mesh-list
83152785|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83152786|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152787|NCT05525156|Analgesics|analgesics|mesh-ancestor
83152788|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
83152789|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152790|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152791|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152792|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152793|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83152794|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83152795|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152796|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83152797|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83152799|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
83152800|NCT05512364|Tamoxifen|tamoxifen|mesh-list
83152801|NCT05512364|Letrozole|letrozole|mesh-list
83152802|NCT05512364|Anastrozole|anastrozole|mesh-list
83152803|NCT05512364|Exemestane|exemestane|mesh-list
83152804|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152805|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83152806|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83152807|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152808|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152809|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83152810|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
83152811|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152812|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152813|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83152814|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83152815|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83152816|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83152817|NCT04424641|Antibodies|antibodies|mesh-list
83152818|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
83152819|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83152820|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
83152821|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83152822|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
83152823|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152824|NCT05512130|Empagliflozin|empagliflozin|mesh-list
83152825|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83152826|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152827|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152828|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152829|NCT02180425|Adapalene|adapalene|mesh-list
83152830|NCT02180425|Tretinoin|tretinoin|mesh-list
83152831|NCT02180425|Isotretinoin|isotretinoin|mesh-list
83152832|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
83152833|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83152834|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152835|NCT02180425|Analgesics|analgesics|mesh-ancestor
83152836|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
83152837|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152838|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152839|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152840|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83152841|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152842|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
83152843|NCT02183467|Linagliptin|linagliptin|mesh-list
83152844|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
83152845|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83152846|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152847|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83152848|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83152849|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152850|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152851|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83152852|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152853|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152854|NCT02183467|Incretins|incretins|mesh-ancestor
83152855|NCT02183467|Hormones|hormones|mesh-ancestor
83152856|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152857|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83152858|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152859|NCT02180503|Linagliptin|linagliptin|mesh-list
83152860|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152861|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152862|NCT02180503|Incretins|incretins|mesh-ancestor
83152863|NCT02180503|Hormones|hormones|mesh-ancestor
83152864|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152865|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83152866|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152867|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152868|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152870|NCT02177851|Trace Elements|trace elements|mesh-ancestor
83152871|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
83152872|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152873|NCT05075876|Granisetron|granisetron|mesh-list
83152874|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
83152875|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
83152876|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152877|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152878|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83152879|NCT05075876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83152880|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83152881|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
83152882|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152883|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152884|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
83152885|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83152886|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83152887|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152888|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83152889|NCT02180737|Analgesics|analgesics|mesh-ancestor
83152890|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
83152891|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152892|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83152893|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83152894|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83152895|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
83152896|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152897|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152898|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
83152899|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
83152900|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
83152901|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83152902|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
83152903|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
83152904|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152905|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152906|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152907|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83152908|NCT02183623|Linagliptin|linagliptin|mesh-list
83152909|NCT02183623|Simvastatin|simvastatin|mesh-list
83152910|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83152911|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83152912|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
83152913|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152914|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83152915|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83152916|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152917|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83152918|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152919|NCT02183623|Incretins|incretins|mesh-ancestor
83152920|NCT02183623|Hormones|hormones|mesh-ancestor
83152921|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152922|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83152923|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
83152924|NCT02183701|Losartan|losartan|mesh-list
83152925|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83152926|NCT02183701|Telmisartan|telmisartan|mesh-list
83152927|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83152928|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83152929|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83152930|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83152931|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152932|NCT02183701|Diuretics|diuretics|mesh-ancestor
83152933|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
83152934|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152935|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83152936|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83152937|NCT02183779|Fluconazole|fluconazole|mesh-list
83152938|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
83152939|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152940|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83152941|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83152942|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152943|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152944|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83152945|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
83152946|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152947|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152948|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83152949|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83152950|NCT02184091|Nevirapine|nevirapine|mesh-list
83152951|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83152952|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83152953|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152954|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152955|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
83152956|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83152957|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83152958|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83152959|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83152960|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83152962|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83152963|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
83152964|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83152965|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152966|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83152967|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
83152968|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83152969|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152970|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152971|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
83152972|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83152973|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83152974|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
83152975|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83152976|NCT04292756|Triamcinolone|triamcinolone|mesh-list
83152977|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83152978|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83152979|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83152980|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83152981|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
83152982|NCT04292756|Hormones|hormones|mesh-ancestor
83152983|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83152984|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152985|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83152986|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
83152987|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83152988|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83152989|NCT05074706|Antibodies|antibodies|mesh-list
83152990|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
83152991|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
83152992|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152993|NCT02181205|Bupivacaine|bupivacaine|mesh-list
83152994|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
83152995|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
83152996|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83152997|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83152998|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
83152999|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153000|NCT02184559|Ropivacaine|ropivacaine|mesh-list
83153001|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
83153002|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
83153003|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153004|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153005|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
83153006|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153007|NCT02185651|Miglustat|miglustat|mesh-list
83153008|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153009|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153010|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83153011|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83153012|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
83153013|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153014|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83153015|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83153016|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153018|NCT02181361|Hirudins|hirudins|mesh-list
83153019|NCT02181361|Warfarin|warfarin|mesh-list
83153020|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153021|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153022|NCT02181361|Analgesics|analgesics|mesh-ancestor
83153023|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
83153024|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153025|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153026|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153027|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153028|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83153029|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83153030|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153031|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83153032|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153033|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153034|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
83153035|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
83153036|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
83153037|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83153038|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
83153039|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
83153040|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
83153041|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153042|NCT02184637|Lumefantrine|lumefantrine|mesh-list
83153043|NCT02184637|Artemether|artemether|mesh-list
83153044|NCT02184637|Piperaquine|piperaquine|mesh-list
83153045|NCT02184637|Artenimol|artenimol|mesh-list
83153046|NCT02184637|Tafenoquine|tafenoquine|mesh-list
83153047|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83153048|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
83153049|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83153050|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83153051|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153052|NCT05048342|Remibrutinib|remibrutinib|mesh-list
83153053|NCT05048342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83153054|NCT05048342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153055|NCT05048342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153056|NCT04870424|Colchicine|colchicine|mesh-list
83153057|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
83153058|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153059|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
83153060|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
83153061|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
83153062|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153063|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153064|NCT03536845|Vitamin D|vitamin d|mesh-list
83153065|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
83153066|NCT03536845|Vitamins|vitamins|mesh-ancestor
83153067|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
83153068|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153069|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83153070|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83153071|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83153072|NCT02181985|Heparin|heparin|mesh-list
83153073|NCT02181985|Enoxaparin|enoxaparin|mesh-list
83153074|NCT02181985|Tenecteplase|tenecteplase|mesh-list
83153075|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83153076|NCT02181985|Abciximab|abciximab|mesh-list
83153077|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
83153078|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83153079|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83153080|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153081|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83153082|NCT05514080|Insulin|insulin|mesh-list
83153083|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83153084|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153085|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83153086|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83153087|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83153088|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
83153089|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153090|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83153091|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83153092|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153093|NCT05513924|Fluorouracil|fluorouracil|mesh-list
83153094|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83153095|NCT05513924|Latanoprost|latanoprost|mesh-list
83153096|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
83153097|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153098|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153099|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153100|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153101|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
83153102|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153103|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83153104|NCT02186119|Ranibizumab|ranibizumab|mesh-list
83153105|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83153106|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83153107|NCT02186119|Growth Substances|growth substances|mesh-ancestor
83153108|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153109|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
83153110|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153111|NCT02185261|Interferons|interferons|mesh-list
83153112|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
83153113|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
83153114|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153115|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
83153116|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153117|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
83153118|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153119|NCT02573012|Prednisone|prednisone|mesh-list
83153120|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153121|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
83153122|NCT02573012|Hormones|hormones|mesh-ancestor
83153123|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83153124|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153125|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83153126|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153127|NCT04128176|Omalizumab|omalizumab|mesh-list
83153128|NCT04128176|Rituximab|rituximab|mesh-list
83153129|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83153130|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153131|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
83153132|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153133|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153134|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83153135|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83153136|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83153137|NCT02186275|Vitamin D|vitamin d|mesh-list
83153138|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
83153139|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
83153140|NCT02186275|Vitamins|vitamins|mesh-list
83153141|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
83153142|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153143|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83153144|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83153145|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
83153146|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
83153147|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
83153148|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153149|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153150|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
83153151|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153152|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
83153153|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83153154|NCT05519072|Cephalexin|cephalexin|mesh-list
83153155|NCT05519072|Fosfomycin|fosfomycin|mesh-list
83153156|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
83153157|NCT05519072|Trimethoprim|trimethoprim|mesh-list
83153158|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
83153159|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83153160|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153161|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83153162|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83153163|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153164|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153165|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153166|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83153167|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83153168|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83153169|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
83153170|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83153171|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83153172|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83153173|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83153174|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83153175|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83153176|NCT04411706|Capecitabine|capecitabine|mesh-list
83153177|NCT04411706|Apatinib|apatinib|mesh-list
83153178|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153179|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
83153180|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153181|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153182|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83153183|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153184|NCT05518994|Bevacizumab|bevacizumab|mesh-list
83153185|NCT05518994|Tislelizumab|tislelizumab|mesh-list
83153186|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83153187|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153188|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83153189|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83153190|NCT05518994|Growth Substances|growth substances|mesh-ancestor
83153191|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153192|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
83153193|NCT02256943|Amitriptyline|amitriptyline|mesh-list
83153194|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83153195|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83153196|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
83153197|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83153198|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153199|NCT02256943|Analgesics|analgesics|mesh-ancestor
83153200|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
83153201|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153202|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153203|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83153204|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83153205|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153206|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153207|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
83153208|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153209|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83153210|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83153211|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
83153212|NCT02256943|Urological Agents|urological agents|mesh-ancestor
83153213|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83153214|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153215|NCT05059951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83153216|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153218|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153219|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153220|NCT05510024|Immunomodulating Agents|immunomodulating agents|mesh-list
83153221|NCT05510024|Immunologic Factors|immunologic factors|mesh-ancestor
83153222|NCT05510024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153223|NCT02752633|Allopurinol|allopurinol|mesh-list
83153224|NCT02752633|Febuxostat|febuxostat|mesh-list
83153225|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
83153226|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153227|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153228|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
83153229|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153230|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83153231|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
83153232|NCT02752633|Protective Agents|protective agents|mesh-ancestor
83153233|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153234|NCT02191189|Nevirapine|nevirapine|mesh-list
83153235|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83153236|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83153237|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153238|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153239|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
83153240|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153241|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83153242|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83153243|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83153244|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83153245|NCT05512520|Capecitabine|capecitabine|mesh-list
83153246|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153247|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
83153248|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153249|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153250|NCT02187133|Rituximab|rituximab|mesh-list
83153251|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83153252|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83153253|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153254|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
83153255|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153256|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153257|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83153258|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
83153259|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153260|NCT04411862|Choline|choline|mesh-list
83153261|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
83153262|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83153263|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
83153264|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153265|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153266|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83153267|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
83153268|NCT02187211|Minocycline|minocycline|mesh-list
83153269|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83153270|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153271|NCT04766996|Aspirin|aspirin|mesh-list
83153272|NCT04766996|Acetaminophen|acetaminophen|mesh-list
83153273|NCT04766996|Prednisone|prednisone|mesh-list
83153274|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83153275|NCT04766996|Meloxicam|meloxicam|mesh-list
83153276|NCT04766996|Diclofenac|diclofenac|mesh-list
83153277|NCT04766996|Lidocaine|lidocaine|mesh-list
83153278|NCT04766996|Pregabalin|pregabalin|mesh-list
83153279|NCT04766996|Tramadol|tramadol|mesh-list
83153280|NCT04766996|Bupivacaine|bupivacaine|mesh-list
83153281|NCT04766996|Propofol|propofol|mesh-list
83153282|NCT04766996|Omeprazole|omeprazole|mesh-list
83153283|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
83153284|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
83153285|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
83153286|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153287|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153288|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
83153289|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153290|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83153291|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83153292|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83153293|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153294|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153295|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153296|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
83153297|NCT04766996|Hormones|hormones|mesh-ancestor
83153298|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83153299|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83153300|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153301|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83153302|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83153303|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
83153304|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153305|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153306|NCT04766996|Analgesics|analgesics|mesh-ancestor
83153307|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153308|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83153309|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83153310|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83153311|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153312|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153313|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
83153314|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153315|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
83153316|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83153317|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83153318|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83153319|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83153320|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83153321|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83153322|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
83153323|NCT04766996|Coagulants|coagulants|mesh-ancestor
83153324|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83153325|NCT04766996|Narcotics|narcotics|mesh-ancestor
83153326|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83153327|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83153328|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83153330|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
83153331|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83153332|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153333|NCT05509946|Celecoxib|celecoxib|mesh-list
83153334|NCT05509946|Pregabalin|pregabalin|mesh-list
83153335|NCT05509946|Analgesics|analgesics|mesh-ancestor
83153336|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
83153337|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153338|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153339|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
83153340|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83153341|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153342|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153343|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83153344|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83153345|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83153346|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153347|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83153348|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153349|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153350|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153351|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153352|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83153353|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153354|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153355|NCT04304209|Capecitabine|capecitabine|mesh-list
83153356|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
83153357|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153358|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
83153359|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153360|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153361|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
83153362|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153363|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
83153364|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153365|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153366|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83153367|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
83153368|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153369|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153370|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83153371|NCT02187445|Budesonide|budesonide|mesh-list
83153372|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153373|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83153374|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
83153375|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153376|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153377|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83153379|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
83153380|NCT02187445|Hormones|hormones|mesh-ancestor
83153381|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83153382|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83153383|NCT02187523|Telmisartan|telmisartan|mesh-list
83153384|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83153385|NCT02187523|Diuretics|diuretics|mesh-ancestor
83153386|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
83153387|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153388|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83153389|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153390|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153391|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83153392|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83153393|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83153394|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83153395|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83153396|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153397|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153398|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
83153399|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153400|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153401|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83153402|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153403|NCT05507606|Bevacizumab|bevacizumab|mesh-list
83153404|NCT05507606|Carboplatin|carboplatin|mesh-list
83153405|NCT05507606|Pemetrexed|pemetrexed|mesh-list
83153406|NCT05507606|Osimertinib|osimertinib|mesh-list
83153407|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83153408|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153409|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83153410|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83153411|NCT05507606|Growth Substances|growth substances|mesh-ancestor
83153412|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153413|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
83153414|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153415|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153416|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83153417|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83153418|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83153419|NCT02191657|Deferiprone|deferiprone|mesh-list
83153420|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83153421|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
83153422|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
83153423|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153424|NCT02191891|Afatinib|afatinib|mesh-list
83153425|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153426|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83153427|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153428|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153429|NCT05507372|Pimozide|pimozide|mesh-list
83153430|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83153431|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83153432|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153433|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153434|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83153435|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83153436|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
83153437|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153438|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153439|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83153440|NCT02192203|Diclofenac|diclofenac|mesh-list
83153441|NCT02192203|Menthol|menthol|mesh-list
83153442|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153443|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153444|NCT02192203|Analgesics|analgesics|mesh-ancestor
83153445|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
83153446|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153447|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153448|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153449|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153450|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153451|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153452|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153453|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
83153454|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
83153455|NCT02257021|Ritonavir|ritonavir|mesh-list
83153456|NCT02257021|Tipranavir|tipranavir|mesh-list
83153457|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83153458|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83153459|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
83153460|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153461|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153462|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83153463|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83153464|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
83153465|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153466|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83153467|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83153468|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
83153469|NCT03536065|Narcotics|narcotics|mesh-ancestor
83153470|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153471|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153472|NCT03536065|Analgesics|analgesics|mesh-ancestor
83153473|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
83153474|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153475|NCT02192827|Dexamethasone|dexamethasone|mesh-list
83153476|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
83153477|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83153478|NCT02192827|BB 1101|bb 1101|mesh-list
83153479|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153480|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
83153481|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
83153482|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153483|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153484|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153485|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
83153486|NCT02192827|Hormones|hormones|mesh-ancestor
83153487|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83153488|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83153489|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153490|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
83153491|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153492|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153493|NCT02188225|Fluoxetine|fluoxetine|mesh-list
83153494|NCT02188225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83153495|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83153496|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153497|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153498|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153499|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
83153500|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153501|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83153502|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
83153503|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83153504|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83153505|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83153506|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153507|NCT04535089|Lidocaine|lidocaine|mesh-list
83153508|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
83153509|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
83153510|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
83153511|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153512|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153513|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
83153514|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153515|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83153516|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83153517|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83153518|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153519|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153520|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83153521|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153522|NCT04535089|Analgesics|analgesics|mesh-ancestor
83153523|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83153524|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83153525|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83153526|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
83153527|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153528|NCT02188537|Nelfinavir|nelfinavir|mesh-list
83153529|NCT02188537|Dexamethasone|dexamethasone|mesh-list
83153530|NCT02188537|Bortezomib|bortezomib|mesh-list
83153531|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153532|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
83153533|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
83153534|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153535|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153536|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153537|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
83153538|NCT02188537|Hormones|hormones|mesh-ancestor
83153539|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83153540|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83153541|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153542|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83153543|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83153544|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
83153545|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153546|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153547|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83153548|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83153549|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
83153550|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153551|NCT03535051|Tacrolimus|tacrolimus|mesh-list
83153552|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153553|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
83153554|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153555|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83153556|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153557|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153558|NCT02188615|Vinorelbine|vinorelbine|mesh-list
83153559|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153560|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83153561|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83153562|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83153563|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83153564|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153565|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
83153566|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83153567|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
83153568|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153569|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
83153570|NCT02188771|Protective Agents|protective agents|mesh-ancestor
83153571|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
83153572|NCT02194075|Methylphenidate|methylphenidate|mesh-list
83153573|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83153574|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153575|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83153576|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83153577|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153578|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153579|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
83153580|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153581|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83153582|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83153583|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153584|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83153585|NCT02194075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83153586|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
83153587|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83153588|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
83153589|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83153590|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83153591|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153592|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83153593|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83153594|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83153595|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153596|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153597|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
83153598|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153599|NCT03534973|Caffeine|caffeine|mesh-list
83153600|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83153601|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153602|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83153603|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153604|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153605|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83153606|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83153607|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
83153608|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153609|NCT03534895|Midazolam|midazolam|mesh-list
83153610|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
83153611|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153612|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153613|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83153614|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83153615|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83153616|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83153617|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83153618|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83153619|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
83153620|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
83153621|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
83153622|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153623|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153624|NCT03535753|Decitabine|decitabine|mesh-list
83153625|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153626|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
83153627|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153628|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153630|NCT02189395|Insulin|insulin|mesh-list
83153631|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
83153632|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83153633|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83153634|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153635|NCT03535519|Methotrexate|methotrexate|mesh-list
83153636|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83153637|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
83153638|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83153639|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153640|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153641|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
83153642|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153643|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153644|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83153645|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153646|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83153647|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153648|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
83153649|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153650|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83153651|NCT02194153|Tenecteplase|tenecteplase|mesh-list
83153652|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83153653|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83153654|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153655|NCT02194231|Trabectedin|trabectedin|mesh-list
83153656|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83153657|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
83153658|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153659|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153660|NCT04292054|Cefazolin|cefazolin|mesh-list
83153661|NCT04292054|Tazobactam|tazobactam|mesh-list
83153662|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83153663|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153664|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83153665|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153666|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153667|NCT04291508|Acetaminophen|acetaminophen|mesh-list
83153668|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153669|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153670|NCT04291508|Analgesics|analgesics|mesh-ancestor
83153671|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
83153672|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153673|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
83153674|NCT02933671|Ropivacaine|ropivacaine|mesh-list
83153675|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
83153676|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
83153677|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153678|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153679|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
83153680|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153682|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83153683|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153684|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83153685|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153686|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153687|NCT05509478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83153688|NCT02194309|Amlodipine|amlodipine|mesh-list
83153689|NCT02194309|Telmisartan|telmisartan|mesh-list
83153690|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83153691|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83153692|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83153693|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153694|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83153695|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153696|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
83153697|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83153698|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83153700|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83153701|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153702|NCT05502458|Propofol|propofol|mesh-list
83153703|NCT05502458|Desflurane|desflurane|mesh-list
83153704|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83153705|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153706|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153707|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83153708|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
83153709|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
83153710|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83153711|NCT03534037|Febuxostat|febuxostat|mesh-list
83153712|NCT03534037|Benzbromarone|benzbromarone|mesh-list
83153713|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
83153714|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153715|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
83153716|NCT03533959|Alirocumab|alirocumab|mesh-list
83153717|NCT03533959|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83153718|NCT03533959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83153719|NCT03533959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83153720|NCT03533959|Antimetabolites|antimetabolites|mesh-ancestor
83153721|NCT03533959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153722|NCT03533959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83153723|NCT03533959|Protease Inhibitors|protease inhibitors|mesh-ancestor
83153724|NCT03533959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153725|NCT03533959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83153726|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83153727|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153728|NCT02567708|Nemiralisib|nemiralisib|mesh-list
83153729|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83153730|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153731|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153732|NCT05509244|Acetaminophen|acetaminophen|mesh-list
83153733|NCT05509244|Ibuprofen|ibuprofen|mesh-list
83153734|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153735|NCT05509244|Analgesics|analgesics|mesh-ancestor
83153736|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
83153737|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153738|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153739|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
83153740|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153741|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153742|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153743|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153744|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153745|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153746|NCT05502068|Vitamin D|vitamin d|mesh-list
83153747|NCT05502068|Vitamins|vitamins|mesh-ancestor
83153748|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
83153749|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153750|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83153751|NCT02194777|Olcegepant|olcegepant|mesh-list
83153752|NCT02194777|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83153753|NCT02194777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153754|NCT02194777|Analgesics|analgesics|mesh-ancestor
83153755|NCT02194777|Sensory System Agents|sensory system agents|mesh-ancestor
83153756|NCT02194777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153757|NCT02194777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153758|NCT02030977|Resveratrol|resveratrol|mesh-list
83153759|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
83153760|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153761|NCT02030977|Protective Agents|protective agents|mesh-ancestor
83153762|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153763|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153764|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83153765|NCT02194855|Rocuronium|rocuronium|mesh-list
83153766|NCT02194855|Cisatracurium|cisatracurium|mesh-list
83153767|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83153768|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83153770|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153771|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153772|NCT03534661|Teduglutide|teduglutide|mesh-list
83153773|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83153774|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153775|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153776|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153777|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83153778|NCT03534661|Protective Agents|protective agents|mesh-ancestor
83153779|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153780|NCT02562716|Paclitaxel|paclitaxel|mesh-list
83153781|NCT02562716|Camptothecin|camptothecin|mesh-list
83153782|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83153783|NCT02562716|Gemcitabine|gemcitabine|mesh-list
83153784|NCT02562716|Fluorouracil|fluorouracil|mesh-list
83153785|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
83153786|NCT02562716|Irinotecan|irinotecan|mesh-list
83153787|NCT02562716|Pancrelipase|pancrelipase|mesh-list
83153788|NCT02562716|Pancreatin|pancreatin|mesh-list
83153789|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83153790|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153791|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
83153792|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
83153793|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
83153794|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153795|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83153796|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
83153797|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153798|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
83153799|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153800|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83153801|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83153802|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153803|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153804|NCT02031211|Etanercept|etanercept|mesh-list
83153805|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153806|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153807|NCT02031211|Analgesics|analgesics|mesh-ancestor
83153808|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
83153809|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153810|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153811|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153812|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153813|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153814|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153815|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
83153816|NCT02195089|Vaccines|vaccines|mesh-list
83153817|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
83153818|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153819|NCT02031289|Folic Acid|folic acid|mesh-list
83153820|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
83153821|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
83153822|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
83153823|NCT02031289|Vitamins|vitamins|mesh-ancestor
83153824|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
83153825|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153826|NCT02031289|Hematinics|hematinics|mesh-ancestor
83153827|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
83153828|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
83153829|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83153830|NCT02197741|Narcotics|narcotics|mesh-ancestor
83153831|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153832|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153833|NCT02197741|Analgesics|analgesics|mesh-ancestor
83153834|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
83153835|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153836|NCT02196493|Azithromycin|azithromycin|mesh-list
83153837|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83153838|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153839|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
83153840|NCT03533803|Indomethacin|indomethacin|mesh-list
83153841|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153842|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153843|NCT03533803|Analgesics|analgesics|mesh-ancestor
83153844|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
83153845|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153846|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153847|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153848|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153849|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
83153850|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
83153851|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83153852|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153853|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153854|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153855|NCT02198209|Liraglutide|liraglutide|mesh-list
83153856|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83153857|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153858|NCT02198209|Incretins|incretins|mesh-ancestor
83153859|NCT02198209|Hormones|hormones|mesh-ancestor
83153860|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83153861|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83153863|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
83153864|NCT02195557|Protective Agents|protective agents|mesh-ancestor
83153865|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153866|NCT02195635|Octreotide|octreotide|mesh-list
83153867|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153868|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83153869|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153870|NCT03534505|Ketorolac|ketorolac|mesh-list
83153871|NCT03534505|Bupivacaine|bupivacaine|mesh-list
83153872|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
83153873|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
83153874|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83153875|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153876|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
83153877|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153878|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153879|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153880|NCT03534505|Analgesics|analgesics|mesh-ancestor
83153881|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153882|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153883|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153884|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153885|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153886|NCT02195791|Pioglitazone|pioglitazone|mesh-list
83153887|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83153888|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153889|NCT02196805|Probucol|probucol|mesh-list
83153890|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83153891|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83153892|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
83153893|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153894|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83153895|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
83153896|NCT02196805|Protective Agents|protective agents|mesh-ancestor
83153897|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153898|NCT02198443|Ritonavir|ritonavir|mesh-list
83153899|NCT02198443|Lopinavir|lopinavir|mesh-list
83153900|NCT02198443|Tenofovir|tenofovir|mesh-list
83153901|NCT02198443|Emtricitabine|emtricitabine|mesh-list
83153902|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83153903|NCT02198443|Cobicistat|cobicistat|mesh-list
83153904|NCT02198443|Elvitegravir|elvitegravir|mesh-list
83478039|NCT01481545|Growth Substances|growth substances|mesh-ancestor
83153905|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83153906|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83153907|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83153908|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153909|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153910|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83153911|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83153912|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
83153913|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153914|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83153915|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83153916|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83153917|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83153918|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83153920|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83153921|NCT03533179|Esmolol|esmolol|mesh-list
83153922|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83153923|NCT03533179|Hormones|hormones|mesh-ancestor
83153924|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83153925|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153926|NCT03533179|Incretins|incretins|mesh-ancestor
83153927|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83153928|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83153929|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83153930|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
83153931|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83153932|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153933|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83153935|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153936|NCT05261971|Etodolac|etodolac|mesh-list
83153937|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83153938|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83153939|NCT05261971|Analgesics|analgesics|mesh-ancestor
83153940|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
83153941|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83153942|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153943|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83153944|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83153945|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83153946|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83153947|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153948|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153949|NCT02201563|Minocycline|minocycline|mesh-list
83153950|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83153951|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153952|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83153953|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83153954|NCT02206477|Protective Agents|protective agents|mesh-ancestor
83153955|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153956|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83153957|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
83153958|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153959|NCT02201641|Calcium|calcium|mesh-list
83153960|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83153961|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153962|NCT02206555|Tenofovir|tenofovir|mesh-list
83153963|NCT02206555|Emtricitabine|emtricitabine|mesh-list
83153964|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83153965|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
83153966|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153967|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83153968|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83153969|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153970|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153971|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83153972|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83153973|NCT02206711|BMS-955176|bms-955176|mesh-list
83153974|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83153975|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83153976|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
83153977|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153978|NCT02202187|Gepotidacin|gepotidacin|mesh-list
83153979|NCT02202187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83153980|NCT02202187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153981|NCT02202187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153982|NCT02202187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83153983|NCT02206789|Cyclosporine|cyclosporine|mesh-list
83153984|NCT02206789|Prednisolone|prednisolone|mesh-list
83153985|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83153986|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
83153987|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83153988|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
83153990|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83153991|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
83153992|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83153993|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83153994|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83153995|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
83153996|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83153997|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
83153998|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83153999|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
83154000|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83154001|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83154002|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154003|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
83154004|NCT02206789|Hormones|hormones|mesh-ancestor
83154005|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154006|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83154007|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154008|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
83154009|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
83154010|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154011|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154012|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83154013|NCT02206789|Protective Agents|protective agents|mesh-ancestor
83154014|NCT03892369|Ethanol|ethanol|mesh-list
83154015|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83154016|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154017|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154018|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154020|NCT02206867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83154021|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154022|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83154023|NCT02751931|Mirabegron|mirabegron|mesh-list
83154024|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83154025|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83154026|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83154027|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154028|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154029|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154030|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154031|NCT02751931|Urological Agents|urological agents|mesh-ancestor
83154032|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83154033|NCT05261581|Analgesics|analgesics|mesh-list
83154034|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
83154035|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154036|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154037|NCT02199223|Panitumumab|panitumumab|mesh-list
83154038|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83154039|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154040|NCT02207335|Carboplatin|carboplatin|mesh-list
83154041|NCT02207335|Gemcitabine|gemcitabine|mesh-list
83154042|NCT02207335|Capecitabine|capecitabine|mesh-list
83154043|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154044|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83154045|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
83154046|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154047|NCT02561078|Insulin|insulin|mesh-list
83154048|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83154049|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83154050|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154051|NCT02202889|Calcium|calcium|mesh-list
83154052|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154053|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154054|NCT04058197|Deferoxamine|deferoxamine|mesh-list
83154055|NCT04058197|Siderophores|siderophores|mesh-ancestor
83154056|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83154057|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
83154058|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
83154059|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154060|NCT02202967|Misoprostol|misoprostol|mesh-list
83154061|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83154062|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
83154063|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83154064|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154065|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83154066|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154067|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
83154068|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
83154069|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
83154070|NCT03532867|Protective Agents|protective agents|mesh-ancestor
83154071|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154073|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83154074|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154075|NCT02567552|Progesterone|progesterone|mesh-list
83154076|NCT02567552|Progestins|progestins|mesh-ancestor
83154077|NCT02567552|Hormones|hormones|mesh-ancestor
83154078|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83538147|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
83154079|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154080|NCT02208427|Isoniazid|isoniazid|mesh-list
83154081|NCT02208427|Rifapentine|rifapentine|mesh-list
83154082|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
83154083|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83154084|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154085|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83154086|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83154087|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
83154088|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154089|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83154090|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83154091|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
83154092|NCT05508620|Sirolimus|sirolimus|mesh-list
83154093|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83154094|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154095|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83154096|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154097|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
83154098|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83154099|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
83154100|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154101|NCT03803605|Vorinostat|vorinostat|mesh-list
83154102|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154103|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83154104|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154105|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154106|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
83154107|NCT02208505|Remifentanil|remifentanil|mesh-list
83154108|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154109|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154110|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154111|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154112|NCT02208505|Analgesics|analgesics|mesh-ancestor
83154113|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
83154114|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154115|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83154116|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83154117|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83154118|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154119|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154120|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154121|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83154122|NCT02208505|Narcotics|narcotics|mesh-ancestor
83154123|NCT02208583|Prednisone|prednisone|mesh-list
83154124|NCT02208583|Cisplatin|cisplatin|mesh-list
83154125|NCT02208583|Docetaxel|docetaxel|mesh-list
83154126|NCT02208583|Etoposide|etoposide|mesh-list
83154127|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
83154128|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154129|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83154130|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83154131|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83154132|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154133|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154134|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
83154135|NCT02208583|Hormones|hormones|mesh-ancestor
83154136|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154137|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154138|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83154139|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83154140|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83154141|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83154142|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154143|NCT05501288|Pholcodine|pholcodine|mesh-list
83154144|NCT05501288|Analgesics|analgesics|mesh-ancestor
83154145|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
83154146|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154147|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154148|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
83154149|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83154150|NCT04738292|Fulvestrant|fulvestrant|mesh-list
83154151|NCT04738292|Onapristone|onapristone|mesh-list
83154152|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83154153|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154154|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83154155|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83154156|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
83154157|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154158|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154159|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83154160|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
83154161|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83154162|NCT02199379|Lenvatinib|lenvatinib|mesh-list
83154163|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154164|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83154165|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154166|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154167|NCT03532711|Leucovorin|leucovorin|mesh-list
83154168|NCT03532711|Fluorouracil|fluorouracil|mesh-list
83154169|NCT03532711|Capecitabine|capecitabine|mesh-list
83154170|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
83154171|NCT03532711|Irinotecan|irinotecan|mesh-list
83154172|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
83154173|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154174|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
83154175|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154176|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83154177|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154178|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83154179|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
83154180|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83154181|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83154182|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154183|NCT03532711|Antidotes|antidotes|mesh-ancestor
83154184|NCT03532711|Protective Agents|protective agents|mesh-ancestor
83154185|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
83154186|NCT03532711|Vitamins|vitamins|mesh-ancestor
83154187|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
83154188|NCT04714112|Dexamethasone|dexamethasone|mesh-list
83154189|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
83154190|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83154191|NCT04714112|BB 1101|bb 1101|mesh-list
83154192|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154193|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
83154194|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
83154195|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154196|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154197|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154198|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
83154199|NCT04714112|Hormones|hormones|mesh-ancestor
83154200|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154201|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83154202|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154203|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
83154204|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154205|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154206|NCT02199613|Darunavir|darunavir|mesh-list
83154207|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83154208|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83154209|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
83154210|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154211|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154212|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83154213|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83154214|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
83154215|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154216|NCT02209441|Sorafenib|sorafenib|mesh-list
83154217|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154218|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83154219|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154220|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154221|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
83154222|NCT04772222|Morphine|morphine|mesh-list
83154223|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154224|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154225|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154226|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154227|NCT04772222|Analgesics|analgesics|mesh-ancestor
83154228|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
83154229|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154230|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83154231|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83154232|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83154233|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154234|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154235|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154236|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83154237|NCT04772222|Narcotics|narcotics|mesh-ancestor
83154238|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
83154239|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83154240|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83154241|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
83154242|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154243|NCT03338647|Doxorubicin|doxorubicin|mesh-list
83154244|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83154245|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154246|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83154247|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83154248|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154249|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154250|NCT05500742|Selenium|selenium|mesh-list
83154251|NCT05500742|Ubiquinone|ubiquinone|mesh-list
83154252|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
83154253|NCT05500742|Resveratrol|resveratrol|mesh-list
83154254|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
83154255|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154256|NCT05500742|Protective Agents|protective agents|mesh-ancestor
83154257|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154258|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154259|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83154260|NCT05500742|Trace Elements|trace elements|mesh-ancestor
83154261|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
83154262|NCT05500742|Vitamins|vitamins|mesh-ancestor
83154263|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
83154264|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
83154265|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83154266|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154267|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
83154268|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
83154269|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
83154270|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154271|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154272|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154273|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154274|NCT02200159|Analgesics|analgesics|mesh-ancestor
83154275|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
83154276|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154277|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83154278|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83154279|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83154280|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154281|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154282|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154283|NCT02204527|Vitamin D|vitamin d|mesh-list
83154284|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
83154285|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
83154286|NCT02204527|Vitamins|vitamins|mesh-list
83154287|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
83154288|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154289|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83154290|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154291|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
83154292|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83154293|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
83154294|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154295|NCT02200237|Antacids|antacids|mesh-ancestor
83154296|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154297|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154299|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83154300|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154301|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83154302|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154303|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154304|NCT01663532|Aripiprazole|aripiprazole|mesh-list
83154305|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
83154306|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83154307|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83154308|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83154309|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154310|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154311|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
83154312|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
83154313|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154314|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154315|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83154316|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83154317|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
83154318|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83154319|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83154320|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83154321|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83154322|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
83154323|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83154324|NCT02204683|Aflibercept|aflibercept|mesh-list
83154325|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83154326|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83154327|NCT02204683|Growth Substances|growth substances|mesh-ancestor
83154328|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154329|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
83154330|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154331|NCT02204839|Insulin|insulin|mesh-list
83154332|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
83154333|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
83154334|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83154335|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154336|NCT02209909|Aspirin|aspirin|mesh-list
83154337|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83154338|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154339|NCT02209909|Analgesics|analgesics|mesh-ancestor
83154340|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
83154341|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154342|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154343|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154344|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83154345|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83154346|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83154347|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154348|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83154349|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83154350|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154351|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
83154352|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83154353|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
83154354|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154355|NCT02205151|Amlodipine|amlodipine|mesh-list
83154356|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83154357|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83154358|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83154359|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154360|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154361|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154362|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
83154364|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83154365|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154366|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
83154367|NCT05504720|Trastuzumab|trastuzumab|mesh-list
83154368|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83154369|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154370|NCT05504720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83154371|NCT05504720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154372|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
83154373|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83154374|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
83154375|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154376|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154377|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83154378|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
83154379|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83154380|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
83154381|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154382|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154383|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83154384|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
83154385|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
83154386|NCT04476992|Protective Agents|protective agents|mesh-ancestor
83154387|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
83154388|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
83154389|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154390|NCT02220673|Protective Agents|protective agents|mesh-ancestor
83154391|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154392|NCT05499572|Minocycline|minocycline|mesh-list
83154393|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83154394|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154395|NCT02220751|Doxycycline|doxycycline|mesh-list
83154396|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83154397|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154398|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
83154399|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83154400|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83154402|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83154403|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83154404|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
83154405|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154406|NCT02205619|Glycine|glycine|mesh-list
83154407|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
83154408|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154409|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154410|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154411|NCT05504330|Aspirin|aspirin|mesh-list
83154412|NCT05504330|Clopidogrel|clopidogrel|mesh-list
83154413|NCT05504330|Atorvastatin|atorvastatin|mesh-list
83154414|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83154415|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154416|NCT05504330|Analgesics|analgesics|mesh-ancestor
83154417|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
83154418|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154419|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154420|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154421|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83154422|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83154423|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83154424|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154425|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83154426|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83154427|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154428|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
83154429|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83154430|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83154431|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
83154432|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83154433|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83538447|NCT05090384|Prednisone|prednisone|mesh-list
83154434|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83154435|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83154436|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83154437|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
83154438|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154439|NCT02220829|Silodosin|silodosin|mesh-list
83154440|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83154441|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83154442|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83154443|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154444|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154445|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154446|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154447|NCT02220829|Urological Agents|urological agents|mesh-ancestor
83154448|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
83154449|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83154450|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83154451|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
83154452|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154453|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83154454|NCT02215213|Vitamin D|vitamin d|mesh-list
83154455|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
83154456|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
83154457|NCT02215213|Vitamins|vitamins|mesh-list
83154458|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
83154459|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154460|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83154461|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154462|NCT04419272|Methylphenidate|methylphenidate|mesh-list
83154463|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83538679|NCT05005728|Olaparib|olaparib|mesh-list
83154464|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154465|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83154466|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83154467|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83154468|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154469|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
83154470|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154471|NCT02205775|Atorvastatin|atorvastatin|mesh-list
83154472|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83154473|NCT02205775|Ezetimibe|ezetimibe|mesh-list
83154474|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83154475|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83154476|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
83154477|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154478|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83154479|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83154480|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154481|NCT02217787|PF-06372865|pf-06372865|mesh-list
83154482|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
83154483|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
83154484|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154485|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154486|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154487|NCT02205931|Topiramate|topiramate|mesh-list
83154488|NCT02205931|Lamotrigine|lamotrigine|mesh-list
83154489|NCT02205931|Zonisamide|zonisamide|mesh-list
83154490|NCT02205931|Carbamazepine|carbamazepine|mesh-list
83154491|NCT02205931|Phenytoin|phenytoin|mesh-list
83154492|NCT02205931|Rufinamide|rufinamide|mesh-list
83154493|NCT02205931|Levetiracetam|levetiracetam|mesh-list
83154494|NCT02205931|Valproic Acid|valproic acid|mesh-list
83154495|NCT02205931|Clonazepam|clonazepam|mesh-list
83154496|NCT02205931|Vigabatrin|vigabatrin|mesh-list
83154497|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
83154498|NCT02205931|Clobazam|clobazam|mesh-list
83154499|NCT02205931|Ethosuximide|ethosuximide|mesh-list
83154500|NCT02205931|Stiripentol|stiripentol|mesh-list
83154501|NCT02205931|Nitrazepam|nitrazepam|mesh-list
83154502|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83154503|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154504|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
83154505|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83154506|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83154507|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154508|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154509|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83154510|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83154511|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154512|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83154513|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83154514|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154515|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
83154516|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154517|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
83154518|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154519|NCT02205931|Analgesics|analgesics|mesh-ancestor
83154520|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
83154521|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154522|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83154523|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83154524|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83154525|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83154526|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
83154527|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83154528|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83154529|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
83154530|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154531|NCT04528004|Niacinamide|niacinamide|mesh-list
83154533|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
83154534|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
83154535|NCT04528004|Vitamins|vitamins|mesh-ancestor
83154536|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
83154537|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154538|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83154539|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
83154540|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154541|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83154542|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
83154543|NCT02221063|Thiamine|thiamine|mesh-list
83154544|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
83154545|NCT02221063|Vitamins|vitamins|mesh-ancestor
83154546|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
83154547|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154548|NCT02220049|Bortezomib|bortezomib|mesh-list
83154549|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154550|NCT01351805|Vitamin D|vitamin d|mesh-list
83154551|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
83154552|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
83154553|NCT01351805|Vitamins|vitamins|mesh-list
83154554|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
83154555|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154556|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83154557|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154558|NCT02206165|Amlodipine|amlodipine|mesh-list
83154559|NCT02206165|Candesartan|candesartan|mesh-list
83154560|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
83154561|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83154562|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83154563|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83154564|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154565|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154566|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154567|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
83154568|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83154569|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83154570|NCT04356950|Thrombin|thrombin|mesh-list
83154571|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
83154572|NCT04356950|Coagulants|coagulants|mesh-ancestor
83154573|NCT02425943|Mannitol|mannitol|mesh-list
83154574|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83154575|NCT02425943|Diuretics|diuretics|mesh-ancestor
83154576|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
83154577|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154578|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83154579|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83154580|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
83154581|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154582|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154583|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83154584|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
83154585|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83154586|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83154587|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83154588|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154589|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154590|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154591|NCT05563610|Amoxicillin|amoxicillin|mesh-list
83154592|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83154593|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154594|NCT05503706|Selenium|selenium|mesh-list
83154595|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
83154596|NCT05503706|Salicylates|salicylates|mesh-list
83154597|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
83154598|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
83154599|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154600|NCT05503706|Protective Agents|protective agents|mesh-ancestor
83154601|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154602|NCT05503706|Trace Elements|trace elements|mesh-ancestor
83154603|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
83154604|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154605|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
83154606|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
83154607|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83154608|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83154609|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154610|NCT05503706|Analgesics|analgesics|mesh-ancestor
83154611|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
83154612|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154613|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154614|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83154615|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83154616|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154617|NCT02174861|Erenumab|erenumab|mesh-list
83154618|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83154619|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154620|NCT02174861|Analgesics|analgesics|mesh-ancestor
83154621|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
83154622|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154623|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154624|NCT02221375|Ciclesonide|ciclesonide|mesh-list
83154625|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
83154626|NCT02221375|Hormones|hormones|mesh-ancestor
83154627|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154628|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154629|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83154630|NCT02399709|Simvastatin|simvastatin|mesh-list
83154631|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83154632|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83154633|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
83154634|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154635|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83154636|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83154637|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154638|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
83154639|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154640|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154641|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154642|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154643|NCT02220361|Analgesics|analgesics|mesh-ancestor
83154644|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
83154645|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154646|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83154647|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83154648|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83154649|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154650|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154651|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154652|NCT05175001|Betamethasone|betamethasone|mesh-list
83154653|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
83154654|NCT05175001|Ropivacaine|ropivacaine|mesh-list
83154655|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
83154656|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
83154657|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154658|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154659|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
83154660|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154661|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154662|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
83154663|NCT05175001|Hormones|hormones|mesh-ancestor
83154664|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154665|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83154666|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
83154667|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83154668|NCT00140855|Ipilimumab|ipilimumab|mesh-list
83154669|NCT00140855|Antibodies|antibodies|mesh-list
83154670|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
83154671|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83154672|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
83154673|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154674|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154675|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83154676|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154677|NCT02399397|Fentanyl|fentanyl|mesh-list
83154678|NCT02399397|Midazolam|midazolam|mesh-list
83154679|NCT02399397|Anesthetics|anesthetics|mesh-list
83154680|NCT02399397|Propofol|propofol|mesh-list
83154681|NCT02399397|Rocuronium|rocuronium|mesh-list
83154682|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154683|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154684|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154685|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83154686|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
83154687|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83154688|NCT02399397|Narcotics|narcotics|mesh-ancestor
83154689|NCT02399397|Analgesics|analgesics|mesh-ancestor
83154690|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
83154691|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154692|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83154693|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83154694|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83154695|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83154696|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
83154697|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
83154698|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154699|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154700|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83154701|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83154702|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83154703|NCT02221453|Triamcinolone|triamcinolone|mesh-list
83154704|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83154705|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83154706|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83154707|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154708|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
83154709|NCT02221453|Hormones|hormones|mesh-ancestor
83154710|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154711|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154712|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83154713|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
83154714|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154715|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154716|NCT03106545|Bupivacaine|bupivacaine|mesh-list
83154717|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
83154718|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
83154719|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154720|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154721|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
83154722|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154723|NCT02221531|Carbetocin|carbetocin|mesh-list
83154724|NCT02221531|Oxytocin|oxytocin|mesh-list
83154725|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
83154726|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83154727|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154728|NCT02231125|Losartan|losartan|mesh-list
83154729|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83154730|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83154731|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83154732|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83154733|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154734|NCT02396433|Carboplatin|carboplatin|mesh-list
83154735|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83154736|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154737|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154738|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154739|NCT02231203|Tocopherols|tocopherols|mesh-list
83154740|NCT02231203|Antioxidants|antioxidants|mesh-list
83154741|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154742|NCT02231203|Protective Agents|protective agents|mesh-ancestor
83154743|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154744|NCT02231203|Vitamins|vitamins|mesh-ancestor
83154745|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
83154746|NCT02231281|Ritonavir|ritonavir|mesh-list
83154747|NCT02231281|Lopinavir|lopinavir|mesh-list
83154748|NCT02231281|Tenofovir|tenofovir|mesh-list
83154749|NCT02231281|Lamivudine|lamivudine|mesh-list
83154750|NCT02231281|Zidovudine|zidovudine|mesh-list
83154751|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83154752|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83154753|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83154754|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154755|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154757|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83154758|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
83154759|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154760|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83154761|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83154762|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83154763|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83154764|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
83154765|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83154766|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83154767|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
83154768|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154769|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154770|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83154771|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
83154772|NCT02780687|Afatinib|afatinib|mesh-list
83154773|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154774|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83154775|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154776|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154777|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83154778|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83154779|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
83154780|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154781|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154782|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83154783|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83154784|NCT02147873|Azacitidine|azacitidine|mesh-list
83154785|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83154786|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
83154787|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154788|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154789|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154790|NCT02398929|Bisoprolol|bisoprolol|mesh-list
83154791|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83154792|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
83154793|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
83154794|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154795|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154796|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83154797|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83154798|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83154799|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154800|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154801|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154802|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
83154803|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154804|NCT02221765|Hormones|hormones|mesh-ancestor
83154805|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154806|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154807|NCT05069129|Vaccines|vaccines|mesh-list
83154808|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
83154809|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154810|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83154811|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83154812|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154813|NCT03544073|Leuprolide|leuprolide|mesh-list
83154814|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83154815|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
83154816|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83154817|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154818|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83154819|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154820|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83154821|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154822|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
83154823|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83154824|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83154825|NCT02781311|Finasteride|finasteride|mesh-list
83154826|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83154827|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83154828|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154829|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154830|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
83154831|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154832|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154833|NCT02781311|Urological Agents|urological agents|mesh-ancestor
83154834|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
83154835|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83154836|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154837|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83154838|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83154839|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154840|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83154841|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
83154842|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154843|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83154844|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
83154845|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154847|NCT02221999|Letrozole|letrozole|mesh-list
83154848|NCT02221999|Hormones|hormones|mesh-list
83154849|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83154850|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154851|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
83154852|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
83154853|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
83154854|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154855|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154856|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154857|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83154858|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83154859|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154860|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83154861|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
83154862|NCT02564198|Ramucirumab|ramucirumab|mesh-list
83154863|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154864|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
83154865|NCT02398539|Triamcinolone|triamcinolone|mesh-list
83154866|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154867|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
83154868|NCT02398539|Hormones|hormones|mesh-ancestor
83154869|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83154870|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154871|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83154872|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154873|NCT02144753|Psyllium|psyllium|mesh-list
83154874|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
83154875|NCT02144753|Cathartics|cathartics|mesh-ancestor
83154876|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154877|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
83154878|NCT02231905|Pramipexole|pramipexole|mesh-list
83154879|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
83154880|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154881|NCT02231905|Protective Agents|protective agents|mesh-ancestor
83154882|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154883|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83154884|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83154886|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
83154887|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154888|NCT02141087|Pirfenidone|pirfenidone|mesh-list
83154889|NCT02141087|Analgesics|analgesics|mesh-ancestor
83154890|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
83154891|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154892|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154893|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83154894|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154895|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83154896|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83154897|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154898|NCT02698293|Vitamin D|vitamin d|mesh-list
83154899|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
83154900|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
83154901|NCT02698293|Vitamins|vitamins|mesh-list
83154902|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
83154903|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154904|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83154905|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83154906|NCT02226289|Bevacizumab|bevacizumab|mesh-list
83154907|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83154908|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154909|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83154910|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83154911|NCT02226289|Growth Substances|growth substances|mesh-ancestor
83154912|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154913|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
83154914|NCT04480593|Propolis|propolis|mesh-list
83154915|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83154916|NCT05079217|Vaccines|vaccines|mesh-list
83154917|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
83154918|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154919|NCT02141321|Alprostadil|alprostadil|mesh-list
83154920|NCT02141321|Misoprostol|misoprostol|mesh-list
83154921|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83154922|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
83154923|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83154924|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154925|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83154926|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154927|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
83154928|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83154929|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
83154930|NCT02141321|Urological Agents|urological agents|mesh-ancestor
83154931|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83154932|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83154933|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83154935|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
83154936|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83154937|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
83154938|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154939|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154940|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83154941|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83154942|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83154943|NCT02232139|Midazolam|midazolam|mesh-list
83154944|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83154945|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154946|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154947|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154948|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83154949|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83154950|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83154951|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83154952|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
83154953|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
83154954|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
83154955|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
83154956|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154957|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154958|NCT04288778|Metformin|metformin|mesh-list
83154959|NCT04288778|Canagliflozin|canagliflozin|mesh-list
83154960|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83154961|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154962|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83154963|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154964|NCT02226601|Aprepitant|aprepitant|mesh-list
83154965|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
83154966|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
83154967|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154968|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154969|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83154970|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83154971|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154972|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154973|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
83154974|NCT02397603|Bupivacaine|bupivacaine|mesh-list
83154975|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
83154976|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
83154977|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83154978|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83154979|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
83154980|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83154981|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83154982|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83154983|NCT02397603|Analgesics|analgesics|mesh-ancestor
83154984|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83154985|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83154986|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83154987|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
83154988|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83154989|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154990|NCT02145065|Paclitaxel|paclitaxel|mesh-list
83154991|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83154992|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83154993|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
83154994|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
83154995|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
83154996|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83154997|NCT02226757|Paclitaxel|paclitaxel|mesh-list
83154998|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83154999|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155000|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
83155001|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
83155002|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
83155003|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155004|NCT04616924|Clarithromycin|clarithromycin|mesh-list
83155005|NCT04616924|Rifabutin|rifabutin|mesh-list
83155006|NCT04616924|Clofazimine|clofazimine|mesh-list
83155007|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83155008|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155009|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83155010|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155011|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155012|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83155013|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83155014|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83155015|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
83155016|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155017|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
83155018|NCT02226913|Lidocaine|lidocaine|mesh-list
83155019|NCT02226913|Epinephrine|epinephrine|mesh-list
83155020|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
83155021|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
83155022|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155023|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155024|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
83155025|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155026|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83155027|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83155028|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83155029|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155030|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155031|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83155032|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83155033|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
83155034|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155035|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83155036|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83155037|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
83155038|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83155039|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
83155040|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
83155041|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
83155042|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83155043|NCT05491616|Nivolumab|nivolumab|mesh-list
83155044|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83155045|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155046|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83155047|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155049|NCT02254655|Puerarin|puerarin|mesh-list
83155050|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
83155051|NCT02226991|Ritonavir|ritonavir|mesh-list
83155052|NCT02226991|Tipranavir|tipranavir|mesh-list
83155053|NCT02226991|Efavirenz|efavirenz|mesh-list
83155054|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83155055|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83155056|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
83155057|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155058|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155059|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83155060|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83155061|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
83155062|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155063|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83155064|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83155065|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83155066|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83155067|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83155068|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83155069|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83155070|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83155071|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83155072|NCT04616534|Gemcitabine|gemcitabine|mesh-list
83155073|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83155074|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
83155075|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155076|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155077|NCT05042791|Capecitabine|capecitabine|mesh-list
83155078|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83155079|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
83155080|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155081|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155082|NCT00705783|Aripiprazole|aripiprazole|mesh-list
83155083|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
83155084|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83155085|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83155086|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83155087|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155088|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155089|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
83155090|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
83155091|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155092|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155093|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83155094|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83155096|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83155097|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83155098|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83155099|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83155100|NCT03719768|Avelumab|avelumab|mesh-list
83155101|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83155102|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155103|NCT02145611|Vildagliptin|vildagliptin|mesh-list
83155104|NCT02145611|Glyburide|glyburide|mesh-list
83155105|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83155106|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155107|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83155108|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
83155109|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155110|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155111|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
83155112|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83155113|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155114|NCT03543683|Aspirin|aspirin|mesh-list
83155115|NCT03543683|Osimertinib|osimertinib|mesh-list
83155116|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83155117|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83155118|NCT03543683|Analgesics|analgesics|mesh-ancestor
83155119|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
83155120|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155121|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155122|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155123|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155124|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83155125|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83155126|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155127|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83155128|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83155129|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155130|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
83155131|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155132|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83155134|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83155135|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83155136|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83155137|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155138|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155139|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
83155140|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155141|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155142|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83155143|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155145|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83155146|NCT02396979|Narcotics|narcotics|mesh-ancestor
83155147|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155148|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155149|NCT02396979|Analgesics|analgesics|mesh-ancestor
83155150|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
83155151|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155152|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
83155153|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
83155154|NCT02145767|Progesterone|progesterone|mesh-list
83155155|NCT02145767|Progestins|progestins|mesh-ancestor
83155156|NCT02145767|Hormones|hormones|mesh-ancestor
83155157|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155158|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155159|NCT02031523|Analgesics|analgesics|mesh-list
83155160|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
83155161|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155162|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155163|NCT02397213|Cyclosporine|cyclosporine|mesh-list
83155164|NCT02397213|Cyclosporins|cyclosporins|mesh-list
83155165|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155166|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155167|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83155168|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
83155169|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155170|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
83155171|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155172|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
83155173|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155174|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83155175|NCT04480281|Lidocaine|lidocaine|mesh-list
83155176|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
83155177|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
83155178|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155179|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155180|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
83155181|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155182|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83155183|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83155184|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83155185|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155186|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155187|NCT03544775|Anesthetics|anesthetics|mesh-list
83155188|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155189|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155190|NCT02258815|Dinutuximab|dinutuximab|mesh-list
83155191|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155192|NCT02149433|Prednisone|prednisone|mesh-list
83155193|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155194|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
83155196|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155197|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155198|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83155199|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155200|NCT02228005|Sertraline|sertraline|mesh-list
83155201|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
83155202|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83155203|NCT02228005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83155204|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83155205|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155206|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155207|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155208|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
83155209|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155211|NCT02228083|Epinephrine|epinephrine|mesh-list
83155212|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
83155213|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
83155214|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155215|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155216|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
83155217|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155218|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83155219|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83155220|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83155221|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155222|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155223|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83155224|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83155225|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83155226|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155227|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83155228|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83155229|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
83155230|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83155231|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
83155232|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
83155233|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
83155234|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83155235|NCT02394483|Olorofim|olorofim|mesh-list
83155236|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
83155237|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155238|NCT02142335|Rituximab|rituximab|mesh-list
83155239|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83155240|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155241|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
83155242|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155243|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155245|NCT02228239|Esketamine|esketamine|mesh-list
83155246|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
83155247|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83155248|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83155249|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
83155250|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
83155251|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155252|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155253|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155254|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83155255|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83155256|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155257|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83155258|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83155259|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83155260|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
83155261|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83155262|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83155263|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
83155264|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83155265|NCT03167385|Apatinib|apatinib|mesh-list
83155267|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83155268|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155269|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155270|NCT02142569|Tocotrienols|tocotrienols|mesh-list
83155271|NCT02142569|Vitamin E|vitamin e|mesh-list
83155272|NCT02142569|Tocopherols|tocopherols|mesh-list
83155273|NCT02142569|Red yeast rice|red yeast rice|mesh-list
83155274|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
83155275|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155276|NCT02142569|Protective Agents|protective agents|mesh-ancestor
83155277|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155278|NCT02142569|Vitamins|vitamins|mesh-ancestor
83155279|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
83155280|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83155281|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83155282|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83155283|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
83155284|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155285|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83155286|NCT02228473|Atropine|atropine|mesh-list
83155287|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
83155288|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83155289|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83155290|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83155291|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
83155292|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155293|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155294|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83155295|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
83155296|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
83155297|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
83155298|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83155299|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83155300|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
83155301|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155302|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155303|NCT02394093|Aspirin|aspirin|mesh-list
83155304|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83155305|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83155306|NCT02394093|Analgesics|analgesics|mesh-ancestor
83155307|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
83155308|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155309|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155310|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155311|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155312|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83155313|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83155314|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155315|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83155316|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83155317|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155318|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
83155319|NCT02146391|Enclomiphene|enclomiphene|mesh-list
83155320|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83155321|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
83155322|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155323|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155324|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83155325|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
83155326|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83155327|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83155328|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83155329|NCT04225273|Lidocaine|lidocaine|mesh-list
83155330|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
83155331|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
83155332|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155333|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155334|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
83538756|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
83155335|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155336|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83155337|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83155338|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83155339|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155340|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155341|NCT02146547|Aripiprazole|aripiprazole|mesh-list
83155342|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83155343|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
83155344|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83155345|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83155346|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83155347|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155348|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155349|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
83155350|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
83155351|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155352|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155353|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83155354|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83155355|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
83155356|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83155357|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83155358|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83155359|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83155360|NCT02394015|Doxorubicin|doxorubicin|mesh-list
83155361|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83155362|NCT02394015|Trabectedin|trabectedin|mesh-list
83155363|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83155364|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155365|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83155366|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83155367|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155368|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155369|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83155370|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
83155371|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
83155372|NCT02146703|Gemcitabine|gemcitabine|mesh-list
83155373|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83155374|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
83155375|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155376|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155377|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83155378|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83155379|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83155380|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155381|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155382|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83155383|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155384|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155385|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
83155386|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155388|NCT02782169|Analgesics|analgesics|mesh-ancestor
83155389|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
83155390|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155391|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155392|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
83155393|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83155394|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155395|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155396|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83155397|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83155398|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83155399|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155400|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83155401|NCT04163185|Meloxicam|meloxicam|mesh-list
83155402|NCT04163185|Rizatriptan|rizatriptan|mesh-list
83155403|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83155404|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83155405|NCT04163185|Analgesics|analgesics|mesh-ancestor
83155406|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
83155407|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155408|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155409|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155410|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155411|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83155412|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83155413|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155414|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155415|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83155416|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
83155417|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155418|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
83155420|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83155421|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
83155422|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155423|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155424|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83155425|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
83155426|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
83155427|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83155428|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83155429|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
83155430|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
83155431|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155432|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155433|NCT04440267|Dexamethasone|dexamethasone|mesh-list
83155434|NCT04440267|Prednisone|prednisone|mesh-list
83155435|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
83155436|NCT04440267|Methotrexate|methotrexate|mesh-list
83155437|NCT04440267|Vincristine|vincristine|mesh-list
83155438|NCT04440267|Daunorubicin|daunorubicin|mesh-list
83155439|NCT04440267|Asparaginase|asparaginase|mesh-list
83155440|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
83155441|NCT04440267|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83155442|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83155443|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
83155444|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155445|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155446|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83155447|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
83155448|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155449|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155450|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83155451|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155452|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
83155453|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
83155454|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155455|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155456|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
83155457|NCT04440267|Hormones|hormones|mesh-ancestor
83155458|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155459|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83155460|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83155461|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
83155462|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83155463|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83155464|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
83155465|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83155466|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155467|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83155468|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83539665|NCT04476446|Esketamine|esketamine|mesh-list
83155469|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83155470|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
83155471|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
83155472|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
83155473|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83155474|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83155475|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83155476|NCT04440267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83155478|NCT02043847|Lenograstim|lenograstim|mesh-list
83155479|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83155480|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
83155481|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155482|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83155483|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
83155484|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155485|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155486|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83155487|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83155488|NCT02146937|Bicalutamide|bicalutamide|mesh-list
83155489|NCT02146937|Finasteride|finasteride|mesh-list
83155490|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
83155491|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
83155492|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155493|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155494|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155495|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83155496|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83155497|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155498|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155499|NCT02146937|Urological Agents|urological agents|mesh-ancestor
83155500|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83155501|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
83155502|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
83155503|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
83155504|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
83155505|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155506|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155507|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
83155508|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
83155509|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155510|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155511|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155512|NCT02147015|Hormones|hormones|mesh-ancestor
83155513|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155514|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83155515|NCT02147015|Protective Agents|protective agents|mesh-ancestor
83155516|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155517|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155518|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83155519|NCT02229175|Bevacizumab|bevacizumab|mesh-list
83155520|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83155521|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155522|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83155523|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83155524|NCT02229175|Growth Substances|growth substances|mesh-ancestor
83155525|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155526|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
83155527|NCT05744739|Azacitidine|azacitidine|mesh-list
83155528|NCT05744739|Venetoclax|venetoclax|mesh-list
83155529|NCT05744739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83155530|NCT05744739|Antimetabolites|antimetabolites|mesh-ancestor
83155531|NCT05744739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155532|NCT05744739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155533|NCT05744739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155534|NCT04947007|Bupivacaine|bupivacaine|mesh-list
83155535|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83155536|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
83155537|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155538|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155539|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
83155540|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155541|NCT04104685|Minocycline|minocycline|mesh-list
83155542|NCT04104685|Adapalene|adapalene|mesh-list
83155543|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83155544|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155545|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83155546|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83155547|NCT04104685|Analgesics|analgesics|mesh-ancestor
83155548|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
83155549|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155550|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155551|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155552|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155553|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
83155554|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83155555|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155556|NCT02392845|Docetaxel|docetaxel|mesh-list
83155557|NCT02392845|Epirubicin|epirubicin|mesh-list
83155558|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155559|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83155560|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83155561|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83155562|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155563|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83155564|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83155565|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83155566|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155568|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83155569|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83155570|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155571|NCT03166605|Simethicone|simethicone|mesh-list
83155572|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
83155573|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155574|NCT03166605|Emollients|emollients|mesh-ancestor
83155575|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83155576|NCT03699956|Carboplatin|carboplatin|mesh-list
83155577|NCT03699956|Etoposide|etoposide|mesh-list
83155578|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155579|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83155580|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83155581|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83155582|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155583|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155584|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
83155585|NCT03166527|Antibodies|antibodies|mesh-list
83155586|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
83155587|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83155588|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83155589|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
83155590|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155591|NCT02695719|Lubiprostone|lubiprostone|mesh-list
83155592|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83155593|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155594|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155595|NCT05498012|Cannabidiol|cannabidiol|mesh-list
83155596|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
83155597|NCT02150291|Folic Acid|folic acid|mesh-list
83155598|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
83155599|NCT02150291|Hematinics|hematinics|mesh-ancestor
83155600|NCT02150291|Vitamins|vitamins|mesh-ancestor
83155601|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
83155602|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155603|NCT04907071|Coal Tar|coal tar|mesh-list
83155604|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
83155605|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
83155606|NCT02155517|Propofol|propofol|mesh-list
83155607|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83155608|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155609|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155610|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83155611|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
83155612|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
83155613|NCT05497934|Glycerol|glycerol|mesh-list
83155614|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83155615|NCT05497934|Protective Agents|protective agents|mesh-ancestor
83155616|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155617|NCT02229721|Oxytocin|oxytocin|mesh-list
83155618|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
83155619|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83155620|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155621|NCT05497700|Norepinephrine|norepinephrine|mesh-list
83155622|NCT05497700|Ephedrine|ephedrine|mesh-list
83155623|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83155624|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83155625|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
83155626|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155627|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155628|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155629|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
83155630|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
83155631|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155632|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83155633|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83155634|NCT03106389|Misoprostol|misoprostol|mesh-list
83155635|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83155636|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
83155637|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83155638|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155639|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83155640|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155641|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
83155642|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83155643|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83155644|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155645|NCT02255045|Diclofenac|diclofenac|mesh-list
83155646|NCT02255045|Meloxicam|meloxicam|mesh-list
83155647|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83155648|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83155649|NCT02255045|Analgesics|analgesics|mesh-ancestor
83155650|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
83155651|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155652|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155653|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155654|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155655|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83155656|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155657|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155658|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83155659|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83155660|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83155661|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83155662|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155663|NCT02150447|Lansoprazole|lansoprazole|mesh-list
83155664|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83155665|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83155666|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155667|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155668|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155669|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83155670|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155671|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155672|NCT02229955|Cyclosporine|cyclosporine|mesh-list
83155673|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83155674|NCT02229955|Cyclosporins|cyclosporins|mesh-list
83155675|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155676|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155677|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83155678|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
83155679|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155680|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
83155681|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155682|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
83155683|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155684|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83155685|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83155686|NCT02230033|Itraconazole|itraconazole|mesh-list
83155687|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
83155688|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
83155689|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155690|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83155691|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83155692|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155693|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155694|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83155695|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
83155696|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155697|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155698|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83155699|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83155700|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
83155701|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83155702|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83155703|NCT05740371|Argatroban|argatroban|mesh-list
83155704|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
83155705|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83155706|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
83155707|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155708|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155709|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
83155710|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83155711|NCT02223949|Alprostadil|alprostadil|mesh-list
83155712|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83155713|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
83155714|NCT02223949|Urological Agents|urological agents|mesh-ancestor
83155716|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
83155717|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155718|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
83155719|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83155720|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155721|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155722|NCT02151695|Aflibercept|aflibercept|mesh-list
83155723|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83155724|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83155725|NCT02151695|Growth Substances|growth substances|mesh-ancestor
83155726|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155727|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
83155728|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155729|NCT02151929|Everolimus|everolimus|mesh-list
83155730|NCT02151929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83155731|NCT02151929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83155732|NCT02151929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155733|NCT02151929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155734|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83155735|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
83155736|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155737|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155738|NCT03542357|Calcitonin|calcitonin|mesh-list
83155739|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
83155740|NCT03542357|Sumatriptan|sumatriptan|mesh-list
83155741|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83155742|NCT03542357|Katacalcin|katacalcin|mesh-list
83155743|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83155744|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83155745|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83155746|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
83155747|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155748|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155749|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155750|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83155751|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83155752|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
83155753|NCT04811001|Osimertinib|osimertinib|mesh-list
83155754|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155755|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83155756|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155757|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155758|NCT02150993|Ritonavir|ritonavir|mesh-list
83155759|NCT02150993|Lopinavir|lopinavir|mesh-list
83155760|NCT02150993|Tenofovir|tenofovir|mesh-list
83155761|NCT02150993|Lamivudine|lamivudine|mesh-list
83155762|NCT02150993|Emtricitabine|emtricitabine|mesh-list
83155763|NCT02150993|Zidovudine|zidovudine|mesh-list
83155764|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
83155765|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83155766|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83155767|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83155768|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
83155769|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155770|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155771|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83155772|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83155773|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
83155774|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155775|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83155776|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83155777|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83155778|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83155779|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
83155780|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83155781|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83155782|NCT02690727|Tenalisib|tenalisib|mesh-list
83155783|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83155784|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155785|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155786|NCT02224105|Prednisolone|prednisolone|mesh-list
83155787|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83155788|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
83155789|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83155790|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
83155791|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83155792|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
83155793|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155794|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
83155795|NCT02224105|Hormones|hormones|mesh-ancestor
83155796|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155797|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155798|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83155799|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155800|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
83155801|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
83155802|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155803|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155804|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83155805|NCT02224105|Protective Agents|protective agents|mesh-ancestor
83155806|NCT02156375|Ustekinumab|ustekinumab|mesh-list
83155807|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
83155808|NCT04057131|Icatibant|icatibant|mesh-list
83155809|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83155810|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83155811|NCT04057131|Analgesics|analgesics|mesh-ancestor
83155812|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
83155813|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155814|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155815|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155816|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83155817|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83155818|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83155819|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155820|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83155821|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83155822|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
83155823|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
83155824|NCT03542279|Hormones|hormones|mesh-ancestor
83155825|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155826|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155827|NCT02230735|Epinephrine|epinephrine|mesh-list
83155828|NCT02230735|Racepinephrine|racepinephrine|mesh-list
83155829|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
83155830|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83155831|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83155832|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
83155833|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155834|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155835|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155836|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83155837|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83155838|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
83155839|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155840|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83155841|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83155842|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
83155843|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
83155844|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83155845|NCT02258581|Tenofovir|tenofovir|mesh-list
83155846|NCT02258581|Vesatolimod|vesatolimod|mesh-list
83155847|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
83155848|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155849|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83155850|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83155851|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155852|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155853|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83155854|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83155855|NCT05746377|Metoclopramide|metoclopramide|mesh-list
83155856|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
83155857|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
83155858|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155859|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155860|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155861|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83155862|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83155863|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
83155864|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155865|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155866|NCT03165825|Dexamethasone|dexamethasone|mesh-list
83155867|NCT03165825|Betamethasone|betamethasone|mesh-list
83155868|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155869|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
83155870|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
83155871|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155872|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155873|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155874|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
83155875|NCT03165825|Hormones|hormones|mesh-ancestor
83155876|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155877|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83155878|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155879|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83155880|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
83155881|NCT03167853|Antibodies|antibodies|mesh-list
83155882|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83155883|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
83155884|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155885|NCT05746143|Zolpidem|zolpidem|mesh-list
83155886|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83155887|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83155888|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83155889|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155890|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83155891|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
83155892|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
83155893|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155894|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155895|NCT03165591|Vaccines|vaccines|mesh-list
83155896|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
83155897|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155898|NCT03114813|Carvedilol|carvedilol|mesh-list
83155899|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83155900|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83155901|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
83155902|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83155903|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155904|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155905|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83155906|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
83155907|NCT03114813|Protective Agents|protective agents|mesh-ancestor
83155908|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83155909|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83155910|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83155911|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
83155912|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83155913|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83155914|NCT01358864|Interferons|interferons|mesh-list
83155915|NCT01358864|Ribavirin|ribavirin|mesh-list
83155916|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
83155917|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155918|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
83155919|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155920|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
83155921|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155922|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
83155923|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155924|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
83155925|NCT02750761|Tedizolid|tedizolid|mesh-list
83155926|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
83155927|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83155928|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155929|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83155930|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155931|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155932|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83155933|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83155934|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83155935|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155936|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155938|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155939|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83155940|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83155941|NCT02814019|Idebenone|idebenone|mesh-list
83155942|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
83155943|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155944|NCT02814019|Protective Agents|protective agents|mesh-ancestor
83155945|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155946|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
83155947|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
83155948|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83155949|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83155950|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155951|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155952|NCT03364244|Urological Agents|urological agents|mesh-ancestor
83155953|NCT03165123|Azithromycin|azithromycin|mesh-list
83155954|NCT03165123|Dexamethasone|dexamethasone|mesh-list
83155955|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83155956|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
83155957|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
83155958|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83155959|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155960|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83155961|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
83155962|NCT03165123|Hormones|hormones|mesh-ancestor
83155963|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83155964|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83155965|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155966|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83155967|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155968|NCT01131169|Vidarabine|vidarabine|mesh-list
83155969|NCT01131169|Fludarabine|fludarabine|mesh-list
83155970|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
83155971|NCT01131169|Melphalan|melphalan|mesh-list
83155972|NCT01131169|Busulfan|busulfan|mesh-list
83155973|NCT01131169|Lenograstim|lenograstim|mesh-list
83155974|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83155975|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83155976|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
83155977|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155978|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83155979|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
83155980|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155981|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
83155982|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83155983|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83155984|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
83155985|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83155986|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83155987|NCT02688933|Insulin|insulin|mesh-list
83155988|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83155989|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
83155990|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83155991|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83155992|NCT04372628|Ritonavir|ritonavir|mesh-list
83155993|NCT04372628|Lopinavir|lopinavir|mesh-list
83155994|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83155995|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83155996|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
83155997|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83155998|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83155999|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83156000|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83156001|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
83156002|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156003|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83156004|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83156005|NCT03626545|Docetaxel|docetaxel|mesh-list
83156006|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156007|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
83156008|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156009|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156010|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156011|NCT04230980|Gabapentin|gabapentin|mesh-list
83156012|NCT04230980|Analgesics|analgesics|mesh-ancestor
83156013|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
83156014|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156015|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156016|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
83156017|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83156018|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83156019|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156020|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83156021|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83156022|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83156023|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156024|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156025|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
83156026|NCT00882505|Vitamin D|vitamin d|mesh-list
83156027|NCT00882505|Vitamins|vitamins|mesh-ancestor
83156028|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
83156029|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156030|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83156031|NCT04480359|Meloxicam|meloxicam|mesh-list
83156032|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83156033|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83156034|NCT04480359|Analgesics|analgesics|mesh-ancestor
83156035|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
83156036|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156037|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156038|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156039|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156040|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83156041|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83156042|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156043|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156044|NCT03724825|Testosterone|testosterone|mesh-list
83156045|NCT03724825|Androgens|androgens|mesh-ancestor
83156046|NCT03724825|Hormones|hormones|mesh-ancestor
83156047|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156048|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156049|NCT04227704|Ketamine|ketamine|mesh-list
83156050|NCT04227704|Analgesics|analgesics|mesh-ancestor
83156051|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
83156052|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156053|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156054|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83156055|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83156056|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
83156057|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
83156058|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156059|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83156060|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83156061|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156062|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156063|NCT03720613|Naloxegol|naloxegol|mesh-list
83156064|NCT03720613|Lubiprostone|lubiprostone|mesh-list
83156065|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83156066|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156067|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156068|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83156069|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156070|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
83156071|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156072|NCT02709512|Cisplatin|cisplatin|mesh-list
83156073|NCT02709512|Pemetrexed|pemetrexed|mesh-list
83156074|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156075|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156076|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156077|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83156078|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83156079|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
83156080|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156081|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
83156082|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156083|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156084|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83156085|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
83156086|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156087|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156088|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83156089|NCT03659929|Amphetamine|amphetamine|mesh-list
83156090|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83156091|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156092|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
83156093|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
83156094|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156095|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
83156096|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156097|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156098|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83156099|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83156100|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83156101|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156102|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83156103|NCT02811679|Blinatumomab|blinatumomab|mesh-list
83156104|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156105|NCT03448081|Calcipotriene|calcipotriene|mesh-list
83156106|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
83156107|NCT04721977|Capecitabine|capecitabine|mesh-list
83156108|NCT04721977|Trastuzumab|trastuzumab|mesh-list
83156109|NCT04721977|Tucatinib|tucatinib|mesh-list
83156110|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156111|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
83156112|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156113|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156114|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156115|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83156116|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156117|NCT02232607|Lacidipine|lacidipine|mesh-list
83156118|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83156119|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83156120|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156121|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156122|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83156123|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156124|NCT02232685|Choline|choline|mesh-list
83156125|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
83156126|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83156127|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
83156128|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156129|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156130|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83156131|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
83156132|NCT02232763|Losartan|losartan|mesh-list
83156133|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83156134|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83156135|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83156136|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83156137|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156138|NCT04294784|Paclitaxel|paclitaxel|mesh-list
83156139|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83156140|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83156141|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156142|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156143|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
83156144|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156145|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156146|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156147|NCT04294784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156148|NCT02262559|Telmisartan|telmisartan|mesh-list
83156149|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83156150|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83156151|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83156152|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156153|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
83156154|NCT05491460|Apixaban|apixaban|mesh-list
83156155|NCT05491460|Edoxaban|edoxaban|mesh-list
83156156|NCT05491460|Dabigatran|dabigatran|mesh-list
83156157|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83156158|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
83156159|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83156160|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
83156161|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156162|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156163|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
83156164|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
83156165|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83156166|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83156167|NCT02762929|Bupivacaine|bupivacaine|mesh-list
83156168|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
83156169|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
83156170|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156171|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156172|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
83156173|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156174|NCT02262637|Telmisartan|telmisartan|mesh-list
83156175|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83156176|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83156177|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83156178|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83156179|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156180|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83156181|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156182|NCT02262637|Diuretics|diuretics|mesh-ancestor
83156183|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
83156184|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156185|NCT03301051|Vaccines|vaccines|mesh-list
83156186|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
83156187|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156188|NCT02606305|Bevacizumab|bevacizumab|mesh-list
83156189|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
83156190|NCT02606305|Carboplatin|carboplatin|mesh-list
83156191|NCT02606305|Doxorubicin|doxorubicin|mesh-list
83156192|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83156193|NCT02606305|Maytansine|maytansine|mesh-list
83156194|NCT02606305|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83156195|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156196|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156197|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83156198|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83156199|NCT02606305|Growth Substances|growth substances|mesh-ancestor
83156200|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156201|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
83156202|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83156203|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83156204|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83156205|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83539969|NCT04267848|Gemcitabine|gemcitabine|mesh-list
83156206|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156207|NCT02606305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83156208|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156209|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
83156210|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156211|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156212|NCT02606305|Immunoconjugates|immunoconjugates|mesh-ancestor
83156213|NCT02606305|Immunologic Factors|immunologic factors|mesh-ancestor
83156214|NCT01662986|Bromides|bromides|mesh-list
83156215|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
83156216|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83156217|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
83156218|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156219|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156220|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83156221|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
83156222|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
83156223|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83156224|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
83156225|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156226|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156227|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
83156228|NCT05497232|Pancrelipase|pancrelipase|mesh-list
83156229|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156230|NCT00054158|Thalidomide|thalidomide|mesh-list
83156231|NCT00054158|Dexamethasone|dexamethasone|mesh-list
83156232|NCT00054158|Doxorubicin|doxorubicin|mesh-list
83156233|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83156234|NCT00054158|Vincristine|vincristine|mesh-list
83156235|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156236|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
83156237|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
83156238|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156239|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156240|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156241|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
83156242|NCT00054158|Hormones|hormones|mesh-ancestor
83156243|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156244|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83156245|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156246|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83156247|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83156248|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83156249|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156250|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156251|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156252|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
83156253|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156254|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156255|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156256|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
83156257|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
83156258|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156259|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156260|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83156261|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83156262|NCT00054158|Growth Substances|growth substances|mesh-ancestor
83156263|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
83156264|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83156265|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
83156266|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156267|NCT05496764|Dexamethasone|dexamethasone|mesh-list
83156268|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156269|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
83156270|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
83156271|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156272|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156273|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156274|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
83156275|NCT05496764|Hormones|hormones|mesh-ancestor
83156276|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156277|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83156278|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156279|NCT05496530|Triamcinolone|triamcinolone|mesh-list
83156280|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83156281|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83156282|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83156283|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156284|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
83156285|NCT05496530|Hormones|hormones|mesh-ancestor
83156286|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156287|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156288|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156289|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
83156290|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156291|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156292|NCT02744833|Enoxaparin|enoxaparin|mesh-list
83156293|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
83156294|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
83156295|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83156296|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83156297|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156298|NCT02234869|Interferons|interferons|mesh-list
83156299|NCT02234869|Interferon-beta|interferon-beta|mesh-list
83156300|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
83156301|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
83156302|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156303|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
83156304|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156305|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
83156306|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156307|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83156308|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83156309|NCT05499026|Cathartics|cathartics|mesh-ancestor
83156310|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156311|NCT05498714|Lactulose|lactulose|mesh-list
83156312|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156313|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
83156314|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
83156315|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83156316|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
83156317|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156318|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
83156319|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156320|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156321|NCT01338025|Lamivudine|lamivudine|mesh-list
83156322|NCT01338025|Emtricitabine|emtricitabine|mesh-list
83156323|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83156324|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83156325|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156326|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156327|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
83156328|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156329|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83539970|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
83156330|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83156331|NCT05498636|Prednisone|prednisone|mesh-list
83156332|NCT05498636|Etoposide|etoposide|mesh-list
83156333|NCT05498636|Lenalidomide|lenalidomide|mesh-list
83156334|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156335|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
83156336|NCT05498636|Hormones|hormones|mesh-ancestor
83156337|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156338|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156339|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83156340|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156341|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156342|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83156343|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83156344|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156345|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156346|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
83156347|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83156348|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83156349|NCT05498636|Growth Substances|growth substances|mesh-ancestor
83156350|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
83156351|NCT02262715|Oseltamivir|oseltamivir|mesh-list
83156352|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
83156353|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156354|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156355|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156356|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
83156357|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83156358|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83156359|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83156360|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156361|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156362|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
83156363|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156364|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156365|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83156366|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156367|NCT02588677|Riluzole|riluzole|mesh-list
83156368|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
83156369|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83156370|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83156371|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156372|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156373|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156374|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83156375|NCT02588677|Protective Agents|protective agents|mesh-ancestor
83156376|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
83156377|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
83156378|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83156379|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83156380|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156381|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156382|NCT05490680|Urological Agents|urological agents|mesh-ancestor
83156383|NCT04424420|Acetaminophen|acetaminophen|mesh-list
83156384|NCT04424420|Ibuprofen|ibuprofen|mesh-list
83156385|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83156386|NCT04424420|Analgesics|analgesics|mesh-ancestor
83156387|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
83156388|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156389|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156390|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
83156391|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83156392|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156393|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156394|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83156395|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156396|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156397|NCT05495750|Bupivacaine|bupivacaine|mesh-list
83156398|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
83156399|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
83156400|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156401|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156402|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
83156403|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156404|NCT02233075|Interferons|interferons|mesh-list
83156405|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
83156406|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
83156407|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83156409|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156410|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
83156411|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156412|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
83156413|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156414|NCT04300244|Nivolumab|nivolumab|mesh-list
83156415|NCT04300244|Ipilimumab|ipilimumab|mesh-list
83156416|NCT04300244|Sargramostim|sargramostim|mesh-list
83156417|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156418|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156419|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83156420|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156421|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
83156422|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156423|NCT02578771|Methylene Blue|methylene blue|mesh-list
83156424|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156425|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156426|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
83156427|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83156428|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
83156429|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
83156430|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156431|NCT02259595|Expectorants|expectorants|mesh-ancestor
83156432|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
83156433|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83156434|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
83156435|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156436|NCT02259595|Protective Agents|protective agents|mesh-ancestor
83156437|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156438|NCT02259595|Antidotes|antidotes|mesh-ancestor
83156439|NCT02804035|Furosemide|furosemide|mesh-list
83156440|NCT02804035|Diuretics|diuretics|mesh-ancestor
83156441|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
83156442|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156443|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83156444|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156445|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156446|NCT02262793|Telmisartan|telmisartan|mesh-list
83156447|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83156448|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83156449|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83156450|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156451|NCT02559206|Linaclotide|linaclotide|mesh-list
83156452|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83156453|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
83156454|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156455|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156456|NCT05485766|Paclitaxel|paclitaxel|mesh-list
83156457|NCT05485766|Carboplatin|carboplatin|mesh-list
83156458|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
83156459|NCT05485766|Olaparib|olaparib|mesh-list
83156460|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156461|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156463|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156464|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156465|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156466|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156467|NCT05485766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83156468|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83156469|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156470|NCT04402723|Cytarabine|cytarabine|mesh-list
83156471|NCT04402723|Daunorubicin|daunorubicin|mesh-list
83156472|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156473|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
83156474|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156475|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156476|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
83156477|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156478|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156479|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
83156480|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156481|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83156482|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83156483|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83156484|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156485|NCT02235337|Riboflavin|riboflavin|mesh-list
83156486|NCT02235337|Vitamins|vitamins|mesh-ancestor
83156487|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
83156488|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156489|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
83156490|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83156491|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
83156492|NCT02233231|Varenicline|varenicline|mesh-list
83156493|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83156494|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83156495|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
83156496|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156497|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156498|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156499|NCT02263027|Vaccines|vaccines|mesh-list
83156500|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
83156501|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156502|NCT02263105|Temozolomide|temozolomide|mesh-list
83156503|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83156504|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
83156505|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156506|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156507|NCT05485064|Fentanyl|fentanyl|mesh-list
83156508|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83156509|NCT05485064|Narcotics|narcotics|mesh-ancestor
83156510|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156511|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156512|NCT05485064|Analgesics|analgesics|mesh-ancestor
83156513|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
83156514|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156515|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83156516|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83156517|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
83156518|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
83156519|NCT05626153|Anesthetics|anesthetics|mesh-list
83156520|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156521|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156522|NCT02553343|Vaccines|vaccines|mesh-list
83156523|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
83156524|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156525|NCT02235415|Lacidipine|lacidipine|mesh-list
83156526|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83156527|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83156528|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156529|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156530|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83156531|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156532|NCT03995017|Nivolumab|nivolumab|mesh-list
83156533|NCT03995017|Ramucirumab|ramucirumab|mesh-list
83156534|NCT03995017|Rucaparib|rucaparib|mesh-list
83156535|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156536|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156537|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83156538|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156539|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83156540|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156542|NCT02558894|Tremelimumab|tremelimumab|mesh-list
83156543|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83156544|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156545|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156546|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
83156547|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156549|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156550|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156551|NCT02510599|Solithromycin|solithromycin|mesh-list
83156552|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156553|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156554|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
83156555|NCT02235805|Cathartics|cathartics|mesh-ancestor
83156556|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156557|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83156558|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156559|NCT02688387|Ambrisentan|ambrisentan|mesh-list
83156560|NCT02688387|Tadalafil|tadalafil|mesh-list
83156561|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
83156562|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83156563|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83156564|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156565|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156566|NCT02688387|Urological Agents|urological agents|mesh-ancestor
83156567|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83156568|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
83156569|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83156570|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156571|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156572|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83156573|NCT05489900|Analgesics|analgesics|mesh-ancestor
83156574|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
83156575|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156576|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83156577|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83156578|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83156579|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
83156580|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156581|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156582|NCT05542849|Acarbose|acarbose|mesh-list
83156583|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83156584|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156585|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156586|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83156587|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156588|NCT05489666|Vitamin D|vitamin d|mesh-list
83156589|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
83156590|NCT05489666|Vitamins|vitamins|mesh-ancestor
83156591|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
83539971|NCT04267848|Pemetrexed|pemetrexed|mesh-list
83156592|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156593|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83156594|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83156595|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83156596|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156598|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83156599|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83156600|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
83156601|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156602|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83156603|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83156604|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156605|NCT01621243|Paclitaxel|paclitaxel|mesh-list
83156606|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83156607|NCT01621243|Gemcitabine|gemcitabine|mesh-list
83156608|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156609|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156610|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83156611|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156612|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156613|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156614|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156615|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
83156616|NCT04076761|Trifluridine|trifluridine|mesh-list
83156617|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
83156618|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156619|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
83156620|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156621|NCT04046887|Paclitaxel|paclitaxel|mesh-list
83156622|NCT04046887|Gemcitabine|gemcitabine|mesh-list
83156623|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156624|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156625|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
83156626|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156627|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156628|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156629|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156631|NCT02235961|Liraglutide|liraglutide|mesh-list
83156632|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83156633|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156634|NCT02235961|Incretins|incretins|mesh-ancestor
83156635|NCT02235961|Hormones|hormones|mesh-ancestor
83156636|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156637|NCT01610245|Oseltamivir|oseltamivir|mesh-list
83156638|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
83156639|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
83156640|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156641|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156642|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156643|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83156644|NCT04138628|Atezolizumab|atezolizumab|mesh-list
83156645|NCT04138628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83156646|NCT04138628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156647|NCT04138628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156648|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156649|NCT02741791|Bupropion|bupropion|mesh-list
83156650|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83156651|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
83156652|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83156653|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83156654|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83156655|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156656|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156657|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
83156658|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156659|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156660|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83156661|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83156662|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156663|NCT04275518|Cytarabine|cytarabine|mesh-list
83156664|NCT04275518|Azacitidine|azacitidine|mesh-list
83156665|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156666|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
83156667|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156668|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156669|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
83156670|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156671|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156672|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
83156673|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156674|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156675|NCT02263495|Paclitaxel|paclitaxel|mesh-list
83156676|NCT02263495|Gemcitabine|gemcitabine|mesh-list
83156677|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83156678|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156679|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
83156680|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
83156681|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
83156682|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156683|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156685|NCT02687451|Oxymorphone|oxymorphone|mesh-list
83156686|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83156687|NCT02687451|Narcotics|narcotics|mesh-ancestor
83156688|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156689|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156690|NCT02687451|Analgesics|analgesics|mesh-ancestor
83156691|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
83156692|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156693|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83156694|NCT02557646|Ribavirin|ribavirin|mesh-list
83156695|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83156696|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
83156697|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156698|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
83156699|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156700|NCT03859687|Vitamins|vitamins|mesh-list
83156701|NCT03859687|Vitamin A|vitamin a|mesh-list
83156702|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
83156703|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
83156704|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156705|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
83156706|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156707|NCT03859687|Protective Agents|protective agents|mesh-ancestor
83156708|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83156709|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156710|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
83156711|NCT02679573|Linezolid|linezolid|mesh-list
83156712|NCT02679573|Delafloxacin|delafloxacin|mesh-list
83156713|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156714|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156715|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83156716|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83156717|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156718|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156719|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156720|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83156721|NCT05493332|Leucovorin|leucovorin|mesh-list
83156722|NCT05493332|Fluorouracil|fluorouracil|mesh-list
83156723|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
83156724|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
83156725|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156726|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156727|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156728|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156729|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
83156730|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156731|NCT05493332|Antidotes|antidotes|mesh-ancestor
83156732|NCT05493332|Protective Agents|protective agents|mesh-ancestor
83156733|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
83156734|NCT05493332|Vitamins|vitamins|mesh-ancestor
83156735|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
83156736|NCT01591447|Solithromycin|solithromycin|mesh-list
83156737|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156738|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156739|NCT01578655|Prednisone|prednisone|mesh-list
83156740|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156741|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
83156742|NCT01578655|Hormones|hormones|mesh-ancestor
83156743|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156744|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156745|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83156746|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156747|NCT05361447|Diazepam|diazepam|mesh-list
83156748|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83156749|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
83156750|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
83156751|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
83156752|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156753|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156754|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156755|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83156756|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156757|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83156758|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83156759|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83156760|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83156761|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83156762|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83156763|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
83156764|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
83156765|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
83156766|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
83156767|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156768|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156769|NCT01577173|Cetuximab|cetuximab|mesh-list
83156770|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156771|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156772|NCT01573351|Interferons|interferons|mesh-list
83156773|NCT01573351|Ribavirin|ribavirin|mesh-list
83156774|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
83156775|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
83156776|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83156777|NCT01573351|Asunaprevir|asunaprevir|mesh-list
83156778|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156779|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
83156780|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156781|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
83156782|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156783|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
83156784|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156785|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
83156786|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156787|NCT02685033|Dalbavancin|dalbavancin|mesh-list
83156788|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156789|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156790|NCT05579223|Hydromorphone|hydromorphone|mesh-list
83156791|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83156792|NCT05579223|Narcotics|narcotics|mesh-ancestor
83156793|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156794|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156795|NCT05579223|Analgesics|analgesics|mesh-ancestor
83156796|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
83156797|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156798|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
83156799|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
83156800|NCT00258427|Busulfan|busulfan|mesh-list
83156801|NCT00258427|Fludarabine|fludarabine|mesh-list
83156802|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
83156803|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83156804|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156805|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
83156806|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156807|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156808|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83156809|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
83156810|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156811|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156812|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83156813|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156814|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
83156815|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156816|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
83156817|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
83156818|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156819|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156820|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
83156821|NCT00258427|Hormones|hormones|mesh-ancestor
83156822|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156823|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83156824|NCT00258427|Protective Agents|protective agents|mesh-ancestor
83156825|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
83156826|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83156827|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83156828|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156829|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83156830|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83156831|NCT02233621|Estradiol|estradiol|mesh-list
83156832|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83156833|NCT02233621|Estrogens|estrogens|mesh-ancestor
83156834|NCT02233621|Hormones|hormones|mesh-ancestor
83156835|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156836|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156837|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83156838|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
83156839|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83156840|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83156841|NCT02557100|Adalimumab|adalimumab|mesh-list
83156842|NCT02557100|Methotrexate|methotrexate|mesh-list
83156843|NCT02557100|Abatacept|abatacept|mesh-list
83156844|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83156845|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
83156846|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83156847|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156848|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83156849|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
83156850|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156851|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156852|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
83156853|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156854|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83156855|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83156856|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
83156857|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156858|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83156859|NCT02557100|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83156860|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156861|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83156862|NCT02557100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83156863|NCT02233777|Pregabalin|pregabalin|mesh-list
83156864|NCT02233777|Analgesics|analgesics|mesh-ancestor
83156865|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
83156866|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156867|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156868|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
83156869|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83156870|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83156871|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156872|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83156873|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83156874|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83540123|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156875|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156876|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83156877|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83156878|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83156879|NCT01520545|Baclofen|baclofen|mesh-list
83156880|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83156881|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156882|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83156883|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156884|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83156885|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
83156886|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
83156887|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156888|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156889|NCT05488106|Riboflavin|riboflavin|mesh-list
83156890|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
83156891|NCT05488106|Vitamins|vitamins|mesh-ancestor
83156892|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
83156893|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156894|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83156895|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
83156896|NCT05492318|Clarithromycin|clarithromycin|mesh-list
83156897|NCT05492318|Midazolam|midazolam|mesh-list
83156898|NCT05492318|Dabigatran|dabigatran|mesh-list
83156899|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83156900|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83156901|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83156902|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156903|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156904|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83156905|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83156906|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83156907|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83156908|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
83156909|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
83156910|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
83156911|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
83156912|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83156913|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156914|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156915|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156916|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83156918|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83156919|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83156920|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
83156921|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83156922|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
83156923|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
83156924|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83156925|NCT01337635|Vitamin D|vitamin d|mesh-list
83156926|NCT01337635|Vitamins|vitamins|mesh-ancestor
83156927|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
83156928|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156929|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83156930|NCT02264041|Itraconazole|itraconazole|mesh-list
83156931|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
83156932|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156933|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83156934|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83156935|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156936|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156937|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83156938|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
83156939|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83156940|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156941|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83156942|NCT02261779|Tretinoin|tretinoin|mesh-list
83156943|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
83156944|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156945|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
83156946|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
83156947|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
83156948|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83156949|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83156950|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156951|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156952|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83156953|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83156954|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83156955|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156956|NCT05157685|Azithromycin|azithromycin|mesh-list
83156957|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156958|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156959|NCT02556632|Curcumin|curcumin|mesh-list
83156960|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83156961|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83156962|NCT02556632|Analgesics|analgesics|mesh-ancestor
83156963|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
83156964|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83156965|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156966|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83156967|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83156968|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156969|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156970|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156971|NCT05491928|Tempol|tempol|mesh-list
83156972|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
83156973|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156974|NCT05491928|Protective Agents|protective agents|mesh-ancestor
83156975|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83156976|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83156977|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156978|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83156979|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83156980|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
83156981|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83156982|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83156983|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83156984|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83156985|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156986|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156987|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83156988|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83156989|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83156990|NCT02262169|Omeprazole|omeprazole|mesh-list
83156991|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83156992|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83156993|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83156994|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83156995|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83156996|NCT05491694|Paclitaxel|paclitaxel|mesh-list
83156997|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
83156998|NCT05491694|Carboplatin|carboplatin|mesh-list
83156999|NCT05491694|Epirubicin|epirubicin|mesh-list
83157000|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83157001|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157002|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83157003|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
83157004|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83157005|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157006|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157007|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
83157008|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157009|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157010|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83157011|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
83157012|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83157013|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83157014|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83157015|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83157016|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157017|NCT05105035|Meropenem|meropenem|mesh-list
83157018|NCT05105035|Ceftazidime|ceftazidime|mesh-list
83157019|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157020|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157021|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83157022|NCT01501513|Laxatives|laxatives|mesh-ancestor
83157023|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83157024|NCT05480072|Palmidrol|palmidrol|mesh-list
83157025|NCT05480072|Analgesics|analgesics|mesh-ancestor
83157026|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
83157027|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157028|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157029|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83157030|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157031|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157032|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157033|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
83157034|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157035|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83157036|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83157037|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157038|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157039|NCT05480072|Hormones|hormones|mesh-ancestor
83157040|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157041|NCT01499563|Risperidone|risperidone|mesh-list
83157042|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83157043|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
83157044|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157045|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157047|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83157048|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83157049|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83157050|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83157051|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83157052|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
83157053|NCT03922880|Nivolumab|nivolumab|mesh-list
83157054|NCT03922880|Ipilimumab|ipilimumab|mesh-list
83157055|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157056|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157057|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83157058|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157059|NCT02264119|Pantoprazole|pantoprazole|mesh-list
83157060|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83157061|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83157062|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83157063|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157064|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157065|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
83157066|NCT02262481|Progestins|progestins|mesh-ancestor
83157068|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157069|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157070|NCT01435369|Pidilizumab|pidilizumab|mesh-list
83157071|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157072|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157073|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83157074|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83157075|NCT01252693|Goserelin|goserelin|mesh-list
83157076|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157077|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157078|NCT03980509|Curcumin|curcumin|mesh-list
83157079|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83157080|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157081|NCT03980509|Analgesics|analgesics|mesh-ancestor
83157082|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
83157083|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157084|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157085|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157086|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157087|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157088|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157089|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157090|NCT01486849|Riluzole|riluzole|mesh-list
83157091|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
83157092|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83157093|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83157094|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157095|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157096|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157097|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83157098|NCT01486849|Protective Agents|protective agents|mesh-ancestor
83157099|NCT01484119|Cetirizine|cetirizine|mesh-list
83157100|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83157101|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83157102|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83157103|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
83157104|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
83157105|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157106|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157107|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157108|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83157109|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
83157110|NCT01482403|Ribavirin|ribavirin|mesh-list
83157111|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
83157112|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157113|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
83157114|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157115|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
83157116|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157117|NCT01481077|Latanoprost|latanoprost|mesh-list
83157118|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83157119|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83157120|NCT02268409|Luspatercept|luspatercept|mesh-list
83157121|NCT02268409|Hematinics|hematinics|mesh-ancestor
83157122|NCT02268487|Sertraline|sertraline|mesh-list
83157123|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
83157124|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83157125|NCT02268487|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83157126|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83157127|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83157128|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157129|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157130|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
83157131|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157132|NCT02265289|Clopidogrel|clopidogrel|mesh-list
83157133|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83157134|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83157135|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83157136|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83157137|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
83157138|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157139|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157140|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157141|NCT02265445|beta-Lactams|beta-lactams|mesh-list
83157142|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157143|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157144|NCT04476121|Aspirin|aspirin|mesh-list
83157145|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83157146|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157147|NCT04476121|Analgesics|analgesics|mesh-ancestor
83157148|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
83157149|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157150|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157151|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157152|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157153|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83157154|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83157155|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157156|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83157157|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83157158|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157159|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
83157160|NCT01234519|Doxorubicin|doxorubicin|mesh-list
83157161|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83157162|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157163|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83157164|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83157165|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157166|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157167|NCT01474135|Travoprost|travoprost|mesh-list
83157168|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83157169|NCT02268565|Aspirin|aspirin|mesh-list
83157170|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83157171|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83157172|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157173|NCT02268565|Analgesics|analgesics|mesh-ancestor
83157174|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
83157175|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157176|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157177|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157178|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83157179|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83157180|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157181|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83157182|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83157183|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157184|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
83157185|NCT05479448|Prednisone|prednisone|mesh-list
83157186|NCT05479448|Hormones|hormones|mesh-list
83157187|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157188|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
83157189|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157190|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157191|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157192|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157193|NCT02264587|Domperidone|domperidone|mesh-list
83157194|NCT02264587|Mosapride|mosapride|mesh-list
83157195|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
83157196|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
83157197|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157198|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157199|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83157200|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83157201|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
83157202|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157203|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157204|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83157205|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
83157206|NCT05475080|Anticoagulants|anticoagulants|mesh-list
83157207|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83157208|NCT02264665|Everolimus|everolimus|mesh-list
83157210|NCT02264665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83157211|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157212|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157213|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157214|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157215|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
83157216|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157217|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157218|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83157219|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83157220|NCT02264665|Growth Substances|growth substances|mesh-ancestor
83157221|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
83157222|NCT02683941|Lanreotide|lanreotide|mesh-list
83157223|NCT02683941|Somatostatin|somatostatin|mesh-list
83157224|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157225|NCT02683941|Hormones|hormones|mesh-ancestor
83157226|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157227|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157228|NCT01225393|Adalimumab|adalimumab|mesh-list
83157229|NCT01225393|Methotrexate|methotrexate|mesh-list
83157230|NCT01225393|Leflunomide|leflunomide|mesh-list
83157231|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83157232|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
83157233|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83157234|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157235|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83157236|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
83157237|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157238|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157239|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83157240|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157241|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83157242|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157243|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
83157244|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157245|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83157246|NCT01225393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83157247|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157248|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83157249|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83157251|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83157252|NCT02264743|Estrogens|estrogens|mesh-ancestor
83157253|NCT02264743|Hormones|hormones|mesh-ancestor
83157254|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157255|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157256|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83157257|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
83157258|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83157259|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83157260|NCT01220947|Ritonavir|ritonavir|mesh-list
83157261|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83157262|NCT01220947|Lactams|lactams|mesh-list
83157263|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83157264|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83157265|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
83157266|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157267|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157268|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83157269|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83157270|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
83157271|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157272|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83157273|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83157274|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157275|NCT03953833|Antibodies|antibodies|mesh-list
83157276|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83157277|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
83157278|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157279|NCT01393639|Prednisone|prednisone|mesh-list
83157280|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157281|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
83157282|NCT01393639|Hormones|hormones|mesh-ancestor
83157283|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157284|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157285|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157286|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157287|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
83157288|NCT01379209|Sirolimus|sirolimus|mesh-list
83157289|NCT01379209|Methotrexate|methotrexate|mesh-list
83157290|NCT01379209|KRN 7000|krn 7000|mesh-list
83157291|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83540275|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
83157292|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83157293|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
83157294|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83157295|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157296|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83157297|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
83157298|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157299|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157300|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
83157301|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157302|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83157303|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157304|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
83157305|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157306|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83157307|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83157308|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83157309|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
83157310|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157311|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157312|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
83157313|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83157314|NCT01204099|Docetaxel|docetaxel|mesh-list
83157315|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157316|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
83157317|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
83157318|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
83157319|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157320|NCT02853500|Doxorubicin|doxorubicin|mesh-list
83157321|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83157322|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157323|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83157324|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83157325|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157326|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157327|NCT01188187|Dexamethasone|dexamethasone|mesh-list
83157328|NCT01188187|Prednisone|prednisone|mesh-list
83157329|NCT01188187|Docetaxel|docetaxel|mesh-list
83157330|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157331|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
83157332|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
83157333|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157334|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83540276|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83157335|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83157337|NCT01188187|Hormones|hormones|mesh-ancestor
83157338|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157339|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157340|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157341|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
83157342|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
83157343|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
83157344|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157345|NCT05478356|Atropine|atropine|mesh-list
83157346|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83157347|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83157348|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83157349|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83157350|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83157351|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
83157352|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157353|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157354|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83157355|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
83157356|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
83157357|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
83157358|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83157359|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83157360|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
83157361|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157362|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157363|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83157364|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157365|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157366|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157367|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157368|NCT01175785|Cyclosporine|cyclosporine|mesh-list
83157369|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
83157370|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
83157371|NCT01175785|Fludarabine|fludarabine|mesh-list
83157372|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
83157373|NCT01175785|Cyclosporins|cyclosporins|mesh-list
83157374|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157375|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
83157376|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157377|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157378|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83157379|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
83157380|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157381|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157382|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83157383|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83157384|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
83157385|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157386|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
83157387|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157388|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83157389|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83157390|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83157391|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83157392|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
83540355|NCT04077463|Lazertinib|lazertinib|mesh-list
83157393|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157394|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
83157395|NCT05478044|Vitamins|vitamins|mesh-ancestor
83157396|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
83157397|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157398|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
83157399|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157400|NCT05478044|Protective Agents|protective agents|mesh-ancestor
83157401|NCT05472506|Nivolumab|nivolumab|mesh-list
83157402|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157403|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157404|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83157405|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157406|NCT01445899|Ranibizumab|ranibizumab|mesh-list
83157407|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83157408|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83157409|NCT01445899|Growth Substances|growth substances|mesh-ancestor
83157410|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157411|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
83157412|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157413|NCT03649724|Leuprolide|leuprolide|mesh-list
83157414|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83157415|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
83157416|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83157417|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157418|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157419|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157420|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
83157421|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83157422|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83157423|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83157424|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83157425|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157426|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
83157427|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157428|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157429|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83157430|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157431|NCT02266303|Insulin|insulin|mesh-list
83157432|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83157433|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157434|NCT02551874|Metformin|metformin|mesh-list
83157435|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
83157436|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
83157437|NCT02551874|Saxagliptin|saxagliptin|mesh-list
83157438|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83157439|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157440|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83157441|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157442|NCT02551874|Incretins|incretins|mesh-ancestor
83157443|NCT02551874|Hormones|hormones|mesh-ancestor
83157444|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157445|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83157446|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
83157447|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157448|NCT03646604|Upadacitinib|upadacitinib|mesh-list
83157449|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83157450|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157451|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157452|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157453|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157454|NCT01354717|Fluorouracil|fluorouracil|mesh-list
83157455|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
83157456|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157457|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83157458|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157459|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157460|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
83157461|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157462|NCT01072981|Gemcitabine|gemcitabine|mesh-list
83157463|NCT01072981|Fluorouracil|fluorouracil|mesh-list
83157464|NCT01072981|Pancrelipase|pancrelipase|mesh-list
83157465|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
83157466|NCT01072981|Immunomodulating Agents|immunomodulating agents|mesh-list
83157467|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83157468|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
83157469|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157470|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157471|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157472|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157473|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83157474|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83157475|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
83157476|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83157477|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
83157478|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157479|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
83157480|NCT03347708|Protective Agents|protective agents|mesh-ancestor
83157481|NCT01159249|Vildagliptin|vildagliptin|mesh-list
83157482|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83157483|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157484|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83157485|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
83157486|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157487|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157488|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
83157489|NCT01156753|Immunoconjugates|immunoconjugates|mesh-ancestor
83157490|NCT01156753|Immunologic Factors|immunologic factors|mesh-ancestor
83157491|NCT01156753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157492|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157493|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157494|NCT01345045|Pregabalin|pregabalin|mesh-list
83157495|NCT01345045|Analgesics|analgesics|mesh-ancestor
83157496|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
83157497|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157498|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157499|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
83157500|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83157501|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83157502|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157503|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83157504|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83157505|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83157506|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83157507|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83157508|NCT01344187|Riboflavin|riboflavin|mesh-list
83157509|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83157510|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
83157511|NCT01344187|Vitamins|vitamins|mesh-ancestor
83157512|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
83157513|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157514|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83157515|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
83157516|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83157517|NCT01338883|Efavirenz|efavirenz|mesh-list
83157518|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
83157519|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83157520|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83157521|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157522|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157523|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
83157524|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157525|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83157526|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83157527|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83157528|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83157529|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83157530|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83157531|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83157532|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83157533|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83157534|NCT05625919|Sirolimus|sirolimus|mesh-list
83157535|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157536|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157537|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83157538|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157539|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
83157540|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157541|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
83157542|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157543|NCT02682927|Fenfluramine|fenfluramine|mesh-list
83157544|NCT02682927|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83157545|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83157546|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83157547|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157548|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157549|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
83157550|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157551|NCT02266537|Doxazosin|doxazosin|mesh-list
83157552|NCT02266537|Tamsulosin|tamsulosin|mesh-list
83157553|NCT02266537|Alfuzosin|alfuzosin|mesh-list
83157554|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83157555|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83157556|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83157557|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
83157558|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157559|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157560|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157561|NCT02266537|Urological Agents|urological agents|mesh-ancestor
83157562|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83157563|NCT02269735|Insulin|insulin|mesh-list
83157564|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83157565|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
83157566|NCT02269735|MK-2640|mk-2640|mesh-list
83157567|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83157568|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157569|NCT05625373|Vancomycin|vancomycin|mesh-list
83157570|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157571|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157572|NCT01038739|Mesalamine|mesalamine|mesh-list
83157573|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83157574|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157575|NCT01038739|Analgesics|analgesics|mesh-ancestor
83157576|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
83157577|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157578|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157579|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157580|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157581|NCT01336465|Etrolizumab|etrolizumab|mesh-list
83157582|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83157583|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
83157584|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157585|NCT03315026|Siltuximab|siltuximab|mesh-list
83157586|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157587|NCT02769065|Donepezil|donepezil|mesh-list
83157588|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83157589|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157590|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157591|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
83157592|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157593|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157594|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
83157595|NCT02540954|Aflibercept|aflibercept|mesh-list
83157596|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83157597|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83157598|NCT02540954|Growth Substances|growth substances|mesh-ancestor
83157599|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157600|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
83157601|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157602|NCT05265975|Rituximab|rituximab|mesh-list
83157603|NCT05265975|Lenalidomide|lenalidomide|mesh-list
83157604|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157605|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157606|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
83157607|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157608|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157609|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83157610|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83157611|NCT05265975|Growth Substances|growth substances|mesh-ancestor
83157612|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
83157613|NCT02151305|Remifentanil|remifentanil|mesh-list
83157614|NCT02151305|Propofol|propofol|mesh-list
83157615|NCT02151305|Sevoflurane|sevoflurane|mesh-list
83157616|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83157617|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83157618|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157619|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83157620|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
83157621|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
83157622|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83157623|NCT02151305|Narcotics|narcotics|mesh-ancestor
83157624|NCT02151305|Analgesics|analgesics|mesh-ancestor
83157625|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
83157626|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157627|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83157628|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83157629|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
83157630|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83157631|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
83157632|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157633|NCT03164421|Expectorants|expectorants|mesh-ancestor
83157634|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
83157635|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83157636|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
83157637|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157638|NCT03164421|Protective Agents|protective agents|mesh-ancestor
83157639|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157640|NCT03164421|Antidotes|antidotes|mesh-ancestor
83157641|NCT05476952|Rocuronium|rocuronium|mesh-list
83157642|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83157643|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83157644|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83157645|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157646|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157647|NCT05228613|Vaccines|vaccines|mesh-list
83157648|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
83157649|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157650|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83157651|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157652|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157653|NCT02628704|Dexamethasone|dexamethasone|mesh-list
83157654|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157655|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
83157656|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
83157657|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157658|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157659|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83157660|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
83157662|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157663|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157664|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157665|NCT02152475|Curcumin|curcumin|mesh-list
83157666|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83157667|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157668|NCT02152475|Analgesics|analgesics|mesh-ancestor
83157669|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
83157670|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157671|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157672|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157673|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157674|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157675|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83478040|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157676|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157677|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
83157678|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83157679|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157680|NCT03161457|Rituximab|rituximab|mesh-list
83157681|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157682|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157683|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
83157684|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157685|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157686|NCT02576912|Dronabinol|dronabinol|mesh-list
83157687|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
83157688|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157689|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83157690|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157691|NCT02576912|Analgesics|analgesics|mesh-ancestor
83157692|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
83157693|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157694|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83157695|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83157696|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157697|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157698|NCT02576912|Hormones|hormones|mesh-ancestor
83157699|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157700|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83157701|NCT02159573|Natalizumab|natalizumab|mesh-list
83157702|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
83157703|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157704|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
83157705|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157706|NCT02152709|Vaccines|vaccines|mesh-list
83157707|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
83157708|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157709|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
83157710|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
83157711|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157712|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157713|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83157714|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83157715|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157716|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157717|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157718|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157719|NCT03164109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83157720|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
83157721|NCT03164109|Protective Agents|protective agents|mesh-ancestor
83157722|NCT02152787|Propofol|propofol|mesh-list
83157723|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83157724|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83157725|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157726|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83157727|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
83157728|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
83157729|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
83157730|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
83157731|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157732|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157733|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157734|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157735|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
83157736|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83157737|NCT02765399|Liraglutide|liraglutide|mesh-list
83157738|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83157739|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157740|NCT02765399|Incretins|incretins|mesh-ancestor
83157741|NCT02765399|Hormones|hormones|mesh-ancestor
83157742|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157743|NCT03970304|Vaccines|vaccines|mesh-list
83157744|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
83157745|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157746|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83157747|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83157748|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83157749|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83157750|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157751|NCT01037179|Analgesics|analgesics|mesh-ancestor
83157752|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
83157753|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157754|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157755|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157756|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157757|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83157758|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83157759|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83157760|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
83157761|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
83157762|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157763|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157764|NCT02269969|Tobramycin|tobramycin|mesh-list
83157765|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157766|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157767|NCT03555578|Leuprolide|leuprolide|mesh-list
83157768|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83157769|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
83157770|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83157771|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157772|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157773|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157774|NCT03232424|Temozolomide|temozolomide|mesh-list
83157775|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83157776|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
83157777|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157778|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157779|NCT02484404|Durvalumab|durvalumab|mesh-list
83157780|NCT02484404|Olaparib|olaparib|mesh-list
83157781|NCT02484404|Cediranib|cediranib|mesh-list
83157782|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157783|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157784|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83157785|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157786|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157787|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157788|NCT03163407|Norepinephrine|norepinephrine|mesh-list
83157789|NCT03163407|Ephedrine|ephedrine|mesh-list
83157790|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83157791|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83157792|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83157793|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157794|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157795|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157796|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
83157797|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
83157798|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157799|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83157800|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83157801|NCT02547974|Vaccines|vaccines|mesh-list
83157802|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
83157803|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157804|NCT00154297|Everolimus|everolimus|mesh-list
83157805|NCT00154297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83157806|NCT00154297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157807|NCT00154297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157808|NCT00154297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157809|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157810|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
83157811|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157812|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157813|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
83157814|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83157815|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83157816|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157817|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157818|NCT02270281|Analgesics|analgesics|mesh-ancestor
83157819|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
83157820|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157821|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83157822|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83157823|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83157824|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
83157825|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157826|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157827|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83157828|NCT01033123|Iniparib|iniparib|mesh-list
83157829|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157830|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157831|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157832|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
83157833|NCT03163173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83157834|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
83157835|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157836|NCT03163173|Protective Agents|protective agents|mesh-ancestor
83157837|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157838|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
83157839|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83157840|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83157841|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157842|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83157843|NCT03162861|Anesthetics|anesthetics|mesh-list
83157844|NCT03162861|Propofol|propofol|mesh-list
83157845|NCT03162861|Sevoflurane|sevoflurane|mesh-list
83157846|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83157847|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157848|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83157849|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83157850|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
83157851|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83157852|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83157853|NCT04506554|Nivolumab|nivolumab|mesh-list
83157854|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83157855|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157856|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83157857|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157858|NCT05476172|Dienogest|dienogest|mesh-list
83157859|NCT05476172|Norethindrone|norethindrone|mesh-list
83157860|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
83157861|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83157862|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83157863|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83157864|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
83157865|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83157866|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157867|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83157868|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83157869|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83157870|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
83157871|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157872|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83157873|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157874|NCT02765165|Lomustine|lomustine|mesh-list
83157875|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83157876|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
83157877|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157878|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157879|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
83157880|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
83157881|NCT02156843|Vitamins|vitamins|mesh-ancestor
83157882|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
83157883|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157884|NCT02675907|Meloxicam|meloxicam|mesh-list
83157885|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83157886|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83157887|NCT02675907|Analgesics|analgesics|mesh-ancestor
83157888|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
83157889|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157890|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157891|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157892|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83157893|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83157894|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83157895|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157896|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157897|NCT02152865|Lupeol|lupeol|mesh-list
83157898|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83157899|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83157900|NCT02152943|Trastuzumab|trastuzumab|mesh-list
83157901|NCT02152943|Everolimus|everolimus|mesh-list
83157902|NCT02152943|Letrozole|letrozole|mesh-list
83157903|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83157904|NCT02152943|Antibodies|antibodies|mesh-list
83157905|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
83157906|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83157907|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
83157908|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157909|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157910|NCT02152943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83157911|NCT02152943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157912|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157913|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157914|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157915|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83157916|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83157917|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83157918|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
83157919|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83157920|NCT02156999|Vitamin D|vitamin d|mesh-list
83157921|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
83157922|NCT02156999|Vitamins|vitamins|mesh-ancestor
83157923|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
83157924|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157925|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83157926|NCT05014581|Norepinephrine|norepinephrine|mesh-list
83157927|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83157928|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83157929|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83157930|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83157931|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157932|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157933|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
83157934|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
83157935|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83157936|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83157937|NCT02159651|Tacrolimus|tacrolimus|mesh-list
83157938|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83157939|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
83157940|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157941|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83157942|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157943|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157944|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83157945|NCT02774681|Trastuzumab|trastuzumab|mesh-list
83157946|NCT02774681|Palbociclib|palbociclib|mesh-list
83157947|NCT02774681|Antibodies|antibodies|mesh-list
83157948|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
83157949|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83157950|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
83157951|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83157952|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83157953|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83157954|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157955|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157956|NCT02157311|Tenofovir|tenofovir|mesh-list
83157957|NCT02157311|Lamivudine|lamivudine|mesh-list
83157958|NCT02157311|Emtricitabine|emtricitabine|mesh-list
83157959|NCT02157311|Efavirenz|efavirenz|mesh-list
83157960|NCT02157311|Lopinavir|lopinavir|mesh-list
83157961|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83157962|NCT02157311|Darunavir|darunavir|mesh-list
83157963|NCT02157311|Abacavir|abacavir|mesh-list
83157964|NCT02157311|Rilpivirine|rilpivirine|mesh-list
83157965|NCT02157311|Etravirine|etravirine|mesh-list
83157966|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
83157967|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157968|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83157969|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83157970|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157971|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157972|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83157973|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83157974|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83157975|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83157976|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83157977|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83157978|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83157979|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83157980|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83157981|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83157982|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
83157983|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83157984|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
83157985|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83157986|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83157987|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157988|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
83157989|NCT04784039|Coagulants|coagulants|mesh-ancestor
83157990|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
83157991|NCT02157467|BMS-955176|bms-955176|mesh-list
83157992|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83157993|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83157994|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83157995|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83157996|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83157997|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83157998|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83157999|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158000|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83158001|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
83158002|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158003|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158004|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83158005|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83158006|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83158007|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83158008|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83158009|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
83158010|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83158011|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
83158012|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83158013|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
83158014|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158015|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158016|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83158017|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158018|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158019|NCT00152971|Enoxaparin|enoxaparin|mesh-list
83158020|NCT00152971|Dabigatran|dabigatran|mesh-list
83158021|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
83158022|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83158023|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83158024|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158025|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
83158026|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83158027|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
83158028|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158029|NCT02538614|Idelalisib|idelalisib|mesh-list
83158031|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158032|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158033|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158034|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158035|NCT03504644|Vincristine|vincristine|mesh-list
83158036|NCT03504644|Venetoclax|venetoclax|mesh-list
83158037|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83158038|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158039|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
83158040|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
83158041|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158042|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158043|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83158044|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83158045|NCT02160275|Insulin|insulin|mesh-list
83158046|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83158047|NCT02160275|Pancrelipase|pancrelipase|mesh-list
83158048|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83158049|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158050|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158051|NCT03126968|Epinephrine|epinephrine|mesh-list
83158052|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83158053|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83158054|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
83158055|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158056|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158057|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158058|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83158059|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83158060|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
83158061|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158062|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83158063|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
83158064|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
83158065|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
83158066|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83158067|NCT02266849|Loperamide|loperamide|mesh-list
83158068|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
83158069|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158070|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83158071|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83158072|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83158073|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158074|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158075|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158076|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158077|NCT01309945|Analgesics|analgesics|mesh-ancestor
83158078|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
83158079|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158080|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
83158081|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83158082|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
83158083|NCT02153567|Escitalopram|escitalopram|mesh-list
83158084|NCT02153567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83158085|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83158086|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158087|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158088|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158089|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
83158090|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158091|NCT02441660|Capsaicin|capsaicin|mesh-list
83158092|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
83158093|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158094|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
83158095|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158096|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158097|NCT01303783|Candesartan|candesartan|mesh-list
83158098|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
83158099|NCT01303783|Nifedipine|nifedipine|mesh-list
83158100|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83158101|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83158102|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83158103|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158104|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83158105|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158106|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83158107|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158108|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
83158109|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
83158110|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158111|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
83158112|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83158113|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83158114|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158115|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
83158116|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158117|NCT02153879|Niacin|niacin|mesh-list
83158118|NCT02153879|Fenofibrate|fenofibrate|mesh-list
83158119|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83158120|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
83158121|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158122|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83158123|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
83158124|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
83158125|NCT02153879|Vitamins|vitamins|mesh-ancestor
83158126|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
83158127|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158128|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
83158129|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83158130|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83158131|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158132|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83158133|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83158134|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158135|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158136|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158137|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83158138|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
83158139|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158140|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158141|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83158142|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83158143|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83158144|NCT02160743|Metformin|metformin|mesh-list
83158145|NCT02160743|Atorvastatin|atorvastatin|mesh-list
83158146|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83158147|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158148|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83158149|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83158150|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
83158151|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158152|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83158153|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83158154|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158155|NCT02158013|Diltiazem|diltiazem|mesh-list
83158156|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83158157|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83158158|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158159|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158160|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83158161|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158162|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
83158163|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
83158164|NCT01023295|Combretastatin|combretastatin|mesh-list
83158165|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83158166|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158167|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
83158168|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
83158169|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158170|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158171|NCT05468138|Antibodies|antibodies|mesh-list
83158172|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
83158173|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158174|NCT01140217|Norethindrone|norethindrone|mesh-list
83158175|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
83158176|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83158177|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83158178|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83158179|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
83158180|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158181|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158182|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83158183|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83158184|NCT01297543|Lenograstim|lenograstim|mesh-list
83158185|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83158186|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
83158187|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158188|NCT03541265|Bupivacaine|bupivacaine|mesh-list
83158189|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
83158190|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
83158191|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83158192|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158193|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
83158194|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158195|NCT02547038|Amoxicillin|amoxicillin|mesh-list
83158196|NCT02547038|Metronidazole|metronidazole|mesh-list
83158197|NCT02547038|Clarithromycin|clarithromycin|mesh-list
83158198|NCT02547038|Tetracycline|tetracycline|mesh-list
83158199|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83158200|NCT02547038|Pantoprazole|pantoprazole|mesh-list
83158202|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83158203|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158204|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83158205|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83158206|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83158207|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158208|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158209|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83158210|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83158211|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83158212|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158213|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83158214|NCT02547038|Antacids|antacids|mesh-ancestor
83158215|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83158216|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83158217|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83158218|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158219|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158220|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83158221|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158222|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158223|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
83158224|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158225|NCT02161055|Insulin|insulin|mesh-list
83158226|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83158227|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83158228|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158229|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83158230|NCT02764697|Hormones|hormones|mesh-ancestor
83158231|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158232|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158233|NCT04822337|Dexamethasone|dexamethasone|mesh-list
83158234|NCT04822337|Lenalidomide|lenalidomide|mesh-list
83158235|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158237|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
83158238|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158239|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158240|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158241|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
83158242|NCT04822337|Hormones|hormones|mesh-ancestor
83158243|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158244|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158245|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158246|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
83158247|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83158248|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83158249|NCT04822337|Growth Substances|growth substances|mesh-ancestor
83158250|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
83158251|NCT02266927|Fluticasone|fluticasone|mesh-list
83158252|NCT02266927|Xhance|xhance|mesh-list
83158253|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158254|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83158255|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
83158256|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158257|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158258|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83158259|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83158260|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158261|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83158262|NCT02158481|Carotenoids|carotenoids|mesh-list
83158263|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
83158264|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158265|NCT02158481|Protective Agents|protective agents|mesh-ancestor
83158266|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158267|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83158268|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158269|NCT01020565|Entecavir|entecavir|mesh-list
83158270|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
83158271|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158272|NCT04965597|Methotrexate|methotrexate|mesh-list
83158273|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
83158274|NCT04965597|Fludarabine|fludarabine|mesh-list
83158275|NCT04965597|Treosulfan|treosulfan|mesh-list
83158276|NCT04965597|Busulfan|busulfan|mesh-list
83158277|NCT04965597|Tacrolimus|tacrolimus|mesh-list
83158278|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
83158279|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83158280|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
83158281|NCT04965597|Antibodies|antibodies|mesh-list
83158282|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
83158283|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83158284|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83158285|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83158286|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
83158287|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158288|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158289|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83158290|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
83158291|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158292|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158293|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158294|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158295|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83158296|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83158297|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
83158298|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158299|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83158300|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83158301|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83158302|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
83158303|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83158304|NCT01020097|Fluorides|fluorides|mesh-list
83158305|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
83158306|NCT01020097|Protective Agents|protective agents|mesh-ancestor
83158307|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158308|NCT02154269|Lenograstim|lenograstim|mesh-list
83158309|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83158310|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
83158311|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158312|NCT04914741|Prednisolone|prednisolone|mesh-list
83158313|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
83158314|NCT04914741|Rituximab|rituximab|mesh-list
83158315|NCT04914741|Doxorubicin|doxorubicin|mesh-list
83158316|NCT04914741|Vincristine|vincristine|mesh-list
83158317|NCT04914741|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83158318|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83158319|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
83158320|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158321|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158322|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83158323|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
83158324|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158325|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158326|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83158327|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158328|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83158329|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83158330|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83158331|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158332|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83158333|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
83158334|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
83158335|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158336|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158337|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
83158338|NCT04914741|Hormones|hormones|mesh-ancestor
83158339|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158340|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158341|NCT04914741|Immunoconjugates|immunoconjugates|mesh-ancestor
83158342|NCT03738683|Tazobactam|tazobactam|mesh-list
83158343|NCT03738683|Piperacillin|piperacillin|mesh-list
83158344|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83158345|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83158346|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158347|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83158348|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158349|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158350|NCT04475887|Iron|iron|mesh-list
83158351|NCT04475887|Trace Elements|trace elements|mesh-ancestor
83158352|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
83158353|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158354|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
83158355|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83158356|NCT02267239|Listerine|listerine|mesh-list
83158357|NCT02267239|Hexetidine|hexetidine|mesh-list
83158358|NCT02267239|Menthol|menthol|mesh-list
83158359|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
83158360|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83158361|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158362|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
83158363|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158364|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
83158365|NCT02267239|Protective Agents|protective agents|mesh-ancestor
83158366|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158367|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
83158368|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
83158369|NCT02766023|Metronidazole|metronidazole|mesh-list
83158370|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158371|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83158372|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83158373|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83158374|NCT05466500|Dexamethasone|dexamethasone|mesh-list
83158375|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
83158376|NCT05466500|Bupivacaine|bupivacaine|mesh-list
83158377|NCT05466500|BB 1101|bb 1101|mesh-list
83158378|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158379|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
83158380|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
83158381|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158382|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158383|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158384|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
83158385|NCT05466500|Hormones|hormones|mesh-ancestor
83158386|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158387|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158388|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158389|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
83158390|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158391|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158392|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83158393|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
83158394|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83158395|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
83158396|NCT04475107|Artesunate|artesunate|mesh-list
83158397|NCT04475107|Pyronaridine|pyronaridine|mesh-list
83158398|NCT04475107|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83158399|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
83158400|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83158401|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83158402|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158403|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158404|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
83158405|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
83158406|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83158407|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
83158408|NCT02254967|Vancomycin|vancomycin|mesh-list
83158409|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
83158410|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83158411|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158412|NCT05444036|Ketamine|ketamine|mesh-list
83158413|NCT05444036|Analgesics|analgesics|mesh-ancestor
83158414|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
83158415|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158416|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158417|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83158418|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83158419|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
83158420|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
83158421|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83158422|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83158423|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83158424|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158425|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158426|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
83158427|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83158428|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83158429|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158430|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
83158431|NCT03923959|Coagulants|coagulants|mesh-ancestor
83158432|NCT02161367|Simethicone|simethicone|mesh-list
83158433|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
83158434|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158435|NCT02161367|Emollients|emollients|mesh-ancestor
83158436|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158438|NCT03542825|Lactoferrin|lactoferrin|mesh-list
83158439|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
83158440|NCT03542825|Trace Elements|trace elements|mesh-ancestor
83158441|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
83158442|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158443|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158444|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
83158445|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
83158446|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158447|NCT01001923|Fasinumab|fasinumab|mesh-list
83158448|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83158449|NCT01001923|Analgesics|analgesics|mesh-ancestor
83158450|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
83158451|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158452|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158453|NCT02154503|Minoxidil|minoxidil|mesh-list
83158454|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83158455|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
83158456|NCT02536976|Mirabegron|mirabegron|mesh-list
83158457|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83158458|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83158459|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83158460|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
83158461|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158462|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158463|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158464|NCT02536976|Urological Agents|urological agents|mesh-ancestor
83158465|NCT04310397|Trametinib|trametinib|mesh-list
83158466|NCT04310397|Dabrafenib|dabrafenib|mesh-list
83158467|NCT04310397|Spartalizumab|spartalizumab|mesh-list
83158468|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158469|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83158470|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158471|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158472|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83158473|NCT04310397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158474|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
83158475|NCT00992563|Ranibizumab|ranibizumab|mesh-list
83158476|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83158477|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83158478|NCT00992563|Growth Substances|growth substances|mesh-ancestor
83158479|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158480|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
83158481|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158482|NCT02267707|Paclitaxel|paclitaxel|mesh-list
83158483|NCT02267707|Gemcitabine|gemcitabine|mesh-list
83158484|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83158485|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158486|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83158487|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83158488|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158489|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158490|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83158491|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
83158492|NCT01373229|Plerixafor|plerixafor|mesh-list
83158493|NCT01373229|Rituximab|rituximab|mesh-list
83158494|NCT01373229|Lenalidomide|lenalidomide|mesh-list
83158495|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158496|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158497|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
83158498|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158499|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158500|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83158501|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83158502|NCT01373229|Growth Substances|growth substances|mesh-ancestor
83158503|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
83158504|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83158505|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83158506|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
83158507|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158508|NCT02671461|Aspirin|aspirin|mesh-list
83158509|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83158510|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83158511|NCT02671461|Analgesics|analgesics|mesh-ancestor
83158512|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
83158513|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158514|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158515|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158517|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83158518|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83158519|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158520|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83158521|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83158522|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158523|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
83158524|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83158525|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
83158526|NCT05467033|Coagulants|coagulants|mesh-ancestor
83158527|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83158528|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
83158529|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158530|NCT04196283|Paclitaxel|paclitaxel|mesh-list
83158531|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83158532|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158533|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
83158534|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
83158535|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158536|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158537|NCT02268019|Epinephrine|epinephrine|mesh-list
83158538|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83158539|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83158540|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83158541|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158542|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158543|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158544|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83158545|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83158546|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
83158547|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158548|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83158549|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
83158550|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
83158551|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
83158552|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83158553|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83158554|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83158555|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158556|NCT01110889|Agomelatine|agomelatine|mesh-list
83158557|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83158558|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83158559|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158560|NCT01106989|Lidocaine|lidocaine|mesh-list
83158561|NCT01106989|Tetracaine|tetracaine|mesh-list
83158562|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
83158563|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
83158564|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83158565|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158566|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
83158567|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158568|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83158569|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83158570|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83158571|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158572|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158573|NCT00975091|Entecavir|entecavir|mesh-list
83158574|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
83158575|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158576|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
83158577|NCT02535416|Promethazine|promethazine|mesh-list
83158578|NCT02535416|Cetirizine|cetirizine|mesh-list
83158579|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83158580|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83158581|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83158582|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158583|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
83158584|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
83158585|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
83158586|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158587|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
83158588|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
83158589|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158590|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83158591|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
83158592|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
83158593|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158594|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158595|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83158596|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
83158597|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
83158598|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83158599|NCT00911443|Interferons|interferons|mesh-list
83158600|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
83158601|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
83158602|NCT00911443|Dacarbazine|dacarbazine|mesh-list
83158603|NCT00911443|Thymalfasin|thymalfasin|mesh-list
83158604|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158605|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
83158606|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158607|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
83158608|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158609|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83158610|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
83158611|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158612|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83158613|NCT03949478|Ibuprofen|ibuprofen|mesh-list
83158614|NCT03949478|Nifedipine|nifedipine|mesh-list
83158615|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83158616|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83158617|NCT03949478|Analgesics|analgesics|mesh-ancestor
83158618|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
83158619|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158620|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158621|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158622|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158623|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83158624|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158625|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158626|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83158627|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83158628|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83158629|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
83158630|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
83158631|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158632|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83158633|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
83158634|NCT00909649|Coagulants|coagulants|mesh-ancestor
83158635|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83158636|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
83158637|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158639|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83158640|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158641|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158642|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83158643|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83158644|NCT02670915|Insulin|insulin|mesh-list
83158645|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83158646|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
83158647|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
83158648|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83158649|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83158650|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158651|NCT02545868|Vaccines|vaccines|mesh-list
83158652|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
83158653|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158654|NCT00821977|Vildagliptin|vildagliptin|mesh-list
83158655|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83158656|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158657|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83158658|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
83158659|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158660|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158661|NCT04474327|Montelukast|montelukast|mesh-list
83158662|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83158663|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
83158664|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83158665|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
83158666|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158667|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158668|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83158669|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83158670|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158671|NCT04745949|Prednisone|prednisone|mesh-list
83158672|NCT04745949|Cortisone|cortisone|mesh-list
83158673|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
83158674|NCT04745949|Rituximab|rituximab|mesh-list
83158675|NCT04745949|Doxorubicin|doxorubicin|mesh-list
83158676|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83158677|NCT04745949|Nivolumab|nivolumab|mesh-list
83158678|NCT04745949|Daunorubicin|daunorubicin|mesh-list
83158679|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83158680|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83158681|NCT04745949|Antibodies|antibodies|mesh-list
83158682|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
83158683|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83158684|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
83158685|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83158686|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
83158687|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158688|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158689|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83158690|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
83158691|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158692|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158693|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83158694|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83158695|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83158696|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83158697|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158698|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158699|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
83158700|NCT04745949|Hormones|hormones|mesh-ancestor
83158701|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158702|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158703|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83158704|NCT04745949|Immunotoxins|immunotoxins|mesh-ancestor
83158705|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
83158706|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
83158707|NCT00961675|Dexamethasone|dexamethasone|mesh-list
83158708|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
83158709|NCT00961675|Povidone|povidone|mesh-list
83158710|NCT00961675|BB 1101|bb 1101|mesh-list
83158711|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158712|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
83158713|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
83158714|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158715|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158716|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158717|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
83158718|NCT00961675|Hormones|hormones|mesh-ancestor
83158719|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158720|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158721|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158722|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
83158723|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158724|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158725|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83158726|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158727|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83158728|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83158729|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83158730|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83158731|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
83158732|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
83158733|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83158734|NCT00819169|Conatumumab|conatumumab|mesh-list
83158735|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158736|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158737|NCT02161679|Carboplatin|carboplatin|mesh-list
83158738|NCT02161679|Camptothecin|camptothecin|mesh-list
83158739|NCT02161679|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83158740|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
83158741|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158742|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
83158743|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158744|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83158745|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83158746|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83158747|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158748|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158749|NCT04729725|Cemiplimab|cemiplimab|mesh-list
83158750|NCT04729725|Antibodies|antibodies|mesh-list
83158751|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83158752|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
83158753|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158754|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158755|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158756|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
83158757|NCT04262492|Apixaban|apixaban|mesh-list
83158758|NCT04262492|Edoxaban|edoxaban|mesh-list
83158759|NCT04262492|Dabigatran|dabigatran|mesh-list
83158760|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83158761|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
83158762|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83158763|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
83158764|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158765|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158766|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
83158767|NCT00955981|Lesinurad|lesinurad|mesh-list
83158768|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
83158769|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158770|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
83158771|NCT03541031|Micronutrients|micronutrients|mesh-list
83158772|NCT03541031|Trace Elements|trace elements|mesh-list
83158773|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158774|NCT05454709|Glucagon|glucagon|mesh-list
83158775|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158776|NCT05454709|Hormones|hormones|mesh-ancestor
83158777|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158778|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158779|NCT02154737|Gemcitabine|gemcitabine|mesh-list
83158780|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83158781|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83158782|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
83158783|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158784|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158785|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83158786|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158788|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83158789|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83158790|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158791|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158792|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158793|NCT04030455|Cisplatin|cisplatin|mesh-list
83158794|NCT04030455|Carboplatin|carboplatin|mesh-list
83158795|NCT04030455|Docetaxel|docetaxel|mesh-list
83158796|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
83158797|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158798|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
83158799|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
83158800|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158801|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158802|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158803|NCT04030455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83158804|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83158805|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158806|NCT05440916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158807|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158808|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83158809|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83158810|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
83158811|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
83158812|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83158813|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158814|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158815|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
83158816|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83158817|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83158818|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158819|NCT02159027|Maraviroc|maraviroc|mesh-list
83158820|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83158821|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83158822|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158823|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83158824|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83158825|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
83158826|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158827|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83158828|NCT02161991|Aprepitant|aprepitant|mesh-list
83158829|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
83158830|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
83158831|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158832|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158833|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158834|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83158835|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83158836|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158837|NCT00948961|Poly I-C|poly i-c|mesh-list
83158838|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83158839|NCT00948961|Poly ICLC|poly iclc|mesh-list
83158840|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
83158841|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
83158842|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158843|NCT00948961|Laxatives|laxatives|mesh-ancestor
83158844|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158845|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
83158846|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158847|NCT02159105|Chrysarobin|chrysarobin|mesh-list
83158848|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83158849|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83158850|NCT02159105|Analgesics|analgesics|mesh-ancestor
83158851|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
83158852|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158853|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158854|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158855|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158856|NCT00890305|Pidilizumab|pidilizumab|mesh-list
83158857|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83158858|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158859|NCT01661972|Capecitabine|capecitabine|mesh-list
83158860|NCT01661972|Aflibercept|aflibercept|mesh-list
83158861|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83158862|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
83158863|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158864|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158865|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83158866|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83158867|NCT01661972|Growth Substances|growth substances|mesh-ancestor
83158868|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158869|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
83158870|NCT02155049|Bimatoprost|bimatoprost|mesh-list
83158871|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83158872|NCT03540953|Mitomycins|mitomycins|mesh-list
83158873|NCT03540953|Mitomycin|mitomycin|mesh-list
83158874|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83158876|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
83158877|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158878|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83158879|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158880|NCT00888355|Losartan|losartan|mesh-list
83158881|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83158882|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83158883|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83158884|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83158885|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158886|NCT00794677|Ezetimibe|ezetimibe|mesh-list
83158887|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83158888|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83158889|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
83158890|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158891|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83158892|NCT00792727|Ketoprofen|ketoprofen|mesh-list
83158893|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83158894|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83158895|NCT00792727|Analgesics|analgesics|mesh-ancestor
83158896|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
83158897|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158898|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158899|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158900|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158901|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83158902|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158903|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158904|NCT00945763|Ibuprofen|ibuprofen|mesh-list
83158905|NCT00945763|Meloxicam|meloxicam|mesh-list
83158906|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83158907|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83158908|NCT00945763|Analgesics|analgesics|mesh-ancestor
83158909|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
83158910|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158911|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158912|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158913|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158914|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83158915|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158916|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158917|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83158918|NCT02770391|Leuprolide|leuprolide|mesh-list
83158919|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83158920|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
83158921|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83158922|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158923|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158924|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158925|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
83158926|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83158927|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158928|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83158929|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83158930|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158931|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158932|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158933|NCT00938587|Prednisone|prednisone|mesh-list
83158934|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158935|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
83158936|NCT00938587|Hormones|hormones|mesh-ancestor
83158937|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158938|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158939|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158940|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158942|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
83158943|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158944|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
83158945|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
83158946|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
83158947|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158948|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158949|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
83158950|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
83158951|NCT05430308|Povidone|povidone|mesh-list
83158952|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83158953|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158954|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
83158955|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
83158956|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
83158957|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
83158958|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158959|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
83158960|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158961|NCT04707703|Isavuconazole|isavuconazole|mesh-list
83158962|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
83158963|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83158964|NCT04681105|Acetaminophen|acetaminophen|mesh-list
83158965|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
83158966|NCT04681105|Promethazine|promethazine|mesh-list
83158967|NCT04681105|Dexamethasone|dexamethasone|mesh-list
83158968|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
83158969|NCT04681105|Ibuprofen|ibuprofen|mesh-list
83158970|NCT04681105|Ranitidine|ranitidine|mesh-list
83158971|NCT04681105|Antibodies|antibodies|mesh-list
83158972|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
83158973|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83158974|NCT04681105|BB 1101|bb 1101|mesh-list
83158975|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
83158976|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83158977|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83158978|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
83158979|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
83158980|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83158981|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83158982|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
83158983|NCT04681105|Hormones|hormones|mesh-ancestor
83158984|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83158985|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83158986|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83158987|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
83158988|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83158989|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83158990|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83158991|NCT04681105|Analgesics|analgesics|mesh-ancestor
83158992|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
83158993|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
83158994|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83158995|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83158996|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83158997|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83158998|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83158999|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159000|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
83159001|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
83159002|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83159003|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
83159004|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
83159005|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159006|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83159007|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
83159008|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
83159009|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83159010|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83159011|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
83159012|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159013|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159014|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83159015|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83159016|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159017|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159018|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159019|NCT00934921|Ondansetron|ondansetron|mesh-list
83159020|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
83159021|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
83159022|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159023|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159024|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83159025|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
83159026|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
83159027|NCT00934921|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83159028|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83159029|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
83159030|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159031|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159032|NCT05429450|Triamcinolone|triamcinolone|mesh-list
83159033|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83159034|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83159035|NCT05429450|Methotrexate|methotrexate|mesh-list
83159036|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83159037|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83159038|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
83159039|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83159040|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159041|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83159042|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
83159043|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159044|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159045|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
83159046|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159047|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83159048|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83159049|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
83159050|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83159051|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83159052|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159053|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
83159054|NCT05429450|Hormones|hormones|mesh-ancestor
83159055|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159056|NCT00103259|Irinotecan|irinotecan|mesh-list
83159057|NCT00103259|Bortezomib|bortezomib|mesh-list
83159058|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83159059|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83159060|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159061|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159062|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159063|NCT02162381|Methylphenidate|methylphenidate|mesh-list
83159064|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83159065|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159066|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83159067|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83159068|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83159069|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159070|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
83159071|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159072|NCT00782431|Vaccines|vaccines|mesh-list
83159073|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
83159074|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159075|NCT02155439|Triamcinolone|triamcinolone|mesh-list
83159076|NCT02155439|Fluorouracil|fluorouracil|mesh-list
83159077|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
83159078|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159079|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83159080|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159081|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83159082|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
83159083|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159084|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159085|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
83159086|NCT02155439|Hormones|hormones|mesh-ancestor
83159087|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159088|NCT04627285|Lacosamide|lacosamide|mesh-list
83159089|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
83159090|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83159091|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83159092|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83159093|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159094|NCT02544152|Lubiprostone|lubiprostone|mesh-list
83159095|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83159096|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83159097|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159098|NCT02162537|Bevacizumab|bevacizumab|mesh-list
83159099|NCT02162537|Pemetrexed|pemetrexed|mesh-list
83159100|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83478041|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
83159101|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159102|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83159103|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83159104|NCT02162537|Growth Substances|growth substances|mesh-ancestor
83159105|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159106|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
83159107|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159108|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159109|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83159110|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83159111|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83159112|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83159113|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159114|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
83159115|NCT00864175|Docetaxel|docetaxel|mesh-list
83159116|NCT00864175|Trastuzumab|trastuzumab|mesh-list
83159117|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159118|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83159119|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83159120|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83159121|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159122|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83159123|NCT02166593|Atorvastatin|atorvastatin|mesh-list
83159124|NCT02166593|Pravastatin|pravastatin|mesh-list
83159125|NCT02166593|Fenofibrate|fenofibrate|mesh-list
83159126|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83159127|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83159128|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
83159129|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159130|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83159131|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83159132|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159133|NCT00858871|Sorafenib|sorafenib|mesh-list
83159134|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159135|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83159136|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159137|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159138|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
83159139|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83159140|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
83159141|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159142|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
83159143|NCT02162693|Protective Agents|protective agents|mesh-ancestor
83159144|NCT02163161|Abrocitinib|abrocitinib|mesh-list
83159145|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83159146|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159147|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159148|NCT00917293|Pyridoxal|pyridoxal|mesh-list
83159149|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83159150|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
83159151|NCT00917293|Vitamins|vitamins|mesh-ancestor
83159152|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
83159153|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159154|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83159155|NCT00845299|Latanoprost|latanoprost|mesh-list
83159156|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
83159157|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83159158|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83159159|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83159160|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159161|NCT02255591|Lidocaine|lidocaine|mesh-list
83159162|NCT02255591|Epinephrine|epinephrine|mesh-list
83159163|NCT02255591|Racepinephrine|racepinephrine|mesh-list
83159164|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
83159165|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83159166|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
83159167|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159168|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159169|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
83159170|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159171|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83159172|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83159173|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83159174|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83159175|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159176|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83159177|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83159178|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
83159179|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159180|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83159181|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83159182|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
83159183|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83159184|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
83159185|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
83159186|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
83159187|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83159188|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83159189|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
83159190|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159191|NCT02167061|Metformin|metformin|mesh-list
83159192|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83159193|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159194|NCT03715465|Melatonin|melatonin|mesh-list
83159195|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
83159196|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159197|NCT03715465|Protective Agents|protective agents|mesh-ancestor
83159198|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159199|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159200|NCT04706741|Prednisone|prednisone|mesh-list
83159201|NCT04706741|Prednisolone|prednisolone|mesh-list
83159202|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159203|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
83159204|NCT04706741|Hormones|hormones|mesh-ancestor
83159205|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159206|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159207|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83159208|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159209|NCT02171039|Dabigatran|dabigatran|mesh-list
83159210|NCT02171039|Atorvastatin|atorvastatin|mesh-list
83159211|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83159212|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83159213|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
83159214|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159215|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83159216|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83159217|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159218|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
83159219|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83159220|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159221|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
83159222|NCT00840073|Trandolapril|trandolapril|mesh-list
83159223|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83159224|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159225|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159226|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159227|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83159228|NCT02261207|Axitinib|axitinib|mesh-list
83159229|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159230|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83159231|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159232|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159233|NCT00838279|Lamotrigine|lamotrigine|mesh-list
83159234|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
83159235|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83159236|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362177|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159237|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159238|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83159239|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159240|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83159241|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83159242|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159243|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83159244|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83159245|NCT02163707|Psilocybin|psilocybin|mesh-list
83159246|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
83159247|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159248|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83159249|NCT00769795|Goserelin|goserelin|mesh-list
83159250|NCT00769795|Bicalutamide|bicalutamide|mesh-list
83159251|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83159252|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159253|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
83159254|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
83159255|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159256|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159257|NCT03134677|Bupivacaine|bupivacaine|mesh-list
83159258|NCT03134677|Sevoflurane|sevoflurane|mesh-list
83159259|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
83159260|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
83159261|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159262|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159263|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
83159264|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159265|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83159266|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83159267|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
83159268|NCT00722917|Pioglitazone|pioglitazone|mesh-list
83159269|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83159270|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159271|NCT02164097|Heparin|heparin|mesh-list
83159272|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
83159273|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83159274|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83159275|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159276|NCT00717457|Exenatide|exenatide|mesh-list
83159277|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83159278|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83159279|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159280|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83159281|NCT00717457|Incretins|incretins|mesh-ancestor
83159282|NCT00717457|Hormones|hormones|mesh-ancestor
83478042|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
83159283|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159284|NCT02171507|Diclofenac|diclofenac|mesh-list
83159285|NCT02171507|Dabigatran|dabigatran|mesh-list
83159286|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83159287|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83159288|NCT02171507|Analgesics|analgesics|mesh-ancestor
83159289|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
83159290|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159291|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159292|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159293|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83159294|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83159295|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159296|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159297|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
83159298|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83159299|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159300|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
83159301|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83159302|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83159303|NCT00758953|Danazol|danazol|mesh-list
83159304|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83159305|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
83159306|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159307|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159308|NCT02167685|Brincidofovir|brincidofovir|mesh-list
83159309|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
83159310|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159311|NCT00758563|Triclosan|triclosan|mesh-list
83159312|NCT00758563|Fluorides|fluorides|mesh-list
83159313|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
83159314|NCT00758563|Protective Agents|protective agents|mesh-ancestor
83159315|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159316|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83159317|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159318|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83159319|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83159320|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
83159321|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159322|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83159323|NCT02171585|Clarithromycin|clarithromycin|mesh-list
83159324|NCT02171585|Dabigatran|dabigatran|mesh-list
83159325|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159326|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159327|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83159328|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159329|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159330|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83159331|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83159332|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
83159333|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83159334|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159335|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
83159336|NCT03134443|Andrographolide|andrographolide|mesh-list
83159337|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159338|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83159339|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83159341|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
83159342|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159343|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159344|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83159345|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83159346|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83159347|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159348|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
83159349|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83159350|NCT02171663|Afatinib|afatinib|mesh-list
83159351|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159352|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83159353|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159354|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159355|NCT02171741|Docetaxel|docetaxel|mesh-list
83159356|NCT02171741|Afatinib|afatinib|mesh-list
83159357|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159358|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
83159359|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
83159360|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
83159361|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159362|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83159363|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159364|NCT00835705|Amoxicillin|amoxicillin|mesh-list
83159365|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83159366|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
83159367|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
83159368|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159369|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159370|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83159371|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159372|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159373|NCT02938520|Rilpivirine|rilpivirine|mesh-list
83159374|NCT02938520|Cabotegravir|cabotegravir|mesh-list
83159375|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83159376|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83159377|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159378|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159379|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
83159380|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159381|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83159382|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83159383|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83159384|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83159385|NCT00713401|Esmolol|esmolol|mesh-list
83159386|NCT00713401|Tecadenoson|tecadenoson|mesh-list
83159387|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83159388|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83159389|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83159390|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
83159391|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159392|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159393|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159394|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83159395|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
83159396|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
83159397|NCT02171975|Anesthetics|anesthetics|mesh-list
83159398|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159399|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159401|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159402|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159403|NCT02164253|Deferiprone|deferiprone|mesh-list
83159404|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83159405|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
83159406|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
83159407|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159408|NCT00755287|Metformin|metformin|mesh-list
83159409|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
83159410|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83159411|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83159412|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159413|NCT00755287|Incretins|incretins|mesh-ancestor
83159414|NCT00755287|Hormones|hormones|mesh-ancestor
83159415|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159416|NCT02168075|Mannitol|mannitol|mesh-list
83159417|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83159418|NCT02168075|Diuretics|diuretics|mesh-ancestor
83159419|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
83159420|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159421|NCT00712699|Adderall|adderall|mesh-list
83159422|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83159423|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159424|NCT03945825|Vaccines|vaccines|mesh-list
83159425|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
83159426|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159427|NCT03819517|Resveratrol|resveratrol|mesh-list
83159428|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
83159429|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159430|NCT03819517|Protective Agents|protective agents|mesh-ancestor
83159431|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159432|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159433|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83159434|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
83159435|NCT02759315|Ruzasvir|ruzasvir|mesh-list
83159436|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
83159437|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159438|NCT00697099|Enoxaparin|enoxaparin|mesh-list
83159439|NCT00697099|Semuloparin|semuloparin|mesh-list
83159440|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
83159441|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
83159442|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83159443|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83159444|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159445|NCT02172131|Olodaterol|olodaterol|mesh-list
83159446|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83159447|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
83159448|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159449|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159450|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83159451|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
83159452|NCT05435768|Denosumab|denosumab|mesh-list
83159453|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83159454|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159455|NCT00835081|Cefadroxil|cefadroxil|mesh-list
83159456|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159457|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159458|NCT02543918|Ixekizumab|ixekizumab|mesh-list
83159459|NCT02543918|Vaccines|vaccines|mesh-list
83159460|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83159461|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
83159462|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159463|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
83159464|NCT03539003|Remifentanil|remifentanil|mesh-list
83159465|NCT03539003|Propofol|propofol|mesh-list
83159466|NCT03539003|Sevoflurane|sevoflurane|mesh-list
83159467|NCT03539003|Desflurane|desflurane|mesh-list
83159468|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83159469|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159470|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159471|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83159472|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
83159473|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
83159474|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83159475|NCT03539003|Narcotics|narcotics|mesh-ancestor
83159476|NCT03539003|Analgesics|analgesics|mesh-ancestor
83159477|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
83159478|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159479|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83159480|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83159481|NCT00751231|Clopidogrel|clopidogrel|mesh-list
83159482|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83159483|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83159484|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83159485|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83159486|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
83159487|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159488|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159489|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159490|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
83159491|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83159492|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83159493|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159494|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
83159495|NCT02164565|Coagulants|coagulants|mesh-ancestor
83159496|NCT04265534|Folic Acid|folic acid|mesh-list
83159497|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
83159498|NCT04265534|Dexamethasone|dexamethasone|mesh-list
83159499|NCT04265534|Carboplatin|carboplatin|mesh-list
83159500|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
83159501|NCT04265534|Pemetrexed|pemetrexed|mesh-list
83159502|NCT04265534|Vitamins|vitamins|mesh-ancestor
83159503|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
83159504|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159505|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159506|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
83159507|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
83159508|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159509|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83159510|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
83159511|NCT04265534|Hormones|hormones|mesh-ancestor
83159512|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159513|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83159514|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159515|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83159516|NCT04265534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83159517|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159518|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159519|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83159520|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83159521|NCT04265534|Hematinics|hematinics|mesh-ancestor
83159522|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
83159523|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
83159524|NCT00750295|Hematinics|hematinics|mesh-ancestor
83159525|NCT02172209|Empagliflozin|empagliflozin|mesh-list
83159526|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83159527|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159528|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83159529|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159530|NCT02168543|Alendronate|alendronate|mesh-list
83159531|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83159532|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159533|NCT01372995|Vitamin D|vitamin d|mesh-list
83159534|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
83159535|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
83159536|NCT01372995|Vitamins|vitamins|mesh-list
83159537|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
83159538|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159539|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83159540|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83159541|NCT04239859|Cyclosporine|cyclosporine|mesh-list
83159542|NCT04239859|Methotrexate|methotrexate|mesh-list
83159543|NCT04239859|Acitretin|acitretin|mesh-list
83159544|NCT04239859|Cyclosporins|cyclosporins|mesh-list
83159545|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83159546|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
83159547|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83159548|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159549|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83159550|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
83159551|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159552|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159553|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
83159554|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159555|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83159556|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83159557|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
83159558|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83159559|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83159560|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
83159561|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159562|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83159563|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
83159564|NCT02938923|Testosterone|testosterone|mesh-list
83159565|NCT02938923|Androgens|androgens|mesh-ancestor
83159566|NCT02938923|Hormones|hormones|mesh-ancestor
83159567|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159568|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159569|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
83159570|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83159571|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
83159572|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
83159573|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159574|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159575|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83159576|NCT02757521|Analgesics|analgesics|mesh-ancestor
83159577|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
83159578|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159579|NCT00744367|Metformin|metformin|mesh-list
83159580|NCT00744367|Pioglitazone|pioglitazone|mesh-list
83159581|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83159582|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83159583|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159584|NCT00744367|Incretins|incretins|mesh-ancestor
83159585|NCT00744367|Hormones|hormones|mesh-ancestor
83159586|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159587|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
83159588|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83159589|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83159590|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
83159591|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159592|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159593|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83159594|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
83159595|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
83159596|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83159597|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
83159598|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159599|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159600|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83159601|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83159602|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83159603|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
83159604|NCT02261129|Telmisartan|telmisartan|mesh-list
83159605|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83159606|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83159607|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83159608|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159609|NCT00694135|Dexamethasone|dexamethasone|mesh-list
83159610|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
83159611|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83159612|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83159613|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83159614|NCT00694135|BB 1101|bb 1101|mesh-list
83159615|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159616|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
83159617|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
83159618|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159619|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159620|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83159621|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
83159622|NCT00694135|Hormones|hormones|mesh-ancestor
83159623|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159624|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83159625|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159626|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159627|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159628|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159629|NCT03540095|Bupivacaine|bupivacaine|mesh-list
83159630|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
83159631|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
83159632|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159633|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159634|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
83159635|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159636|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
83159637|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83159638|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159639|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159640|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83159641|NCT03071185|Analgesics|analgesics|mesh-ancestor
83159642|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
83159643|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159644|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83159645|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83159646|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83159647|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
83159648|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159649|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159650|NCT00741715|Atorvastatin|atorvastatin|mesh-list
83159651|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83159652|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83159653|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
83159654|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159655|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83159656|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83159657|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159659|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159660|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83159661|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
83159662|NCT02172443|Ipratropium|ipratropium|mesh-list
83159663|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83159664|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
83159665|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159666|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159667|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83159668|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
83159669|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
83159670|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83159671|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
83159672|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159673|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159674|NCT00834613|Metformin|metformin|mesh-list
83159675|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83159676|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159677|NCT02172521|Bromides|bromides|mesh-list
83159678|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
83159679|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83159680|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
83159681|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159682|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159683|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83159684|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
83159685|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
83159686|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83159687|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
83159688|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159689|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159690|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
83159691|NCT00834535|Cefdinir|cefdinir|mesh-list
83159692|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159693|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159695|NCT00691717|Anecortave|anecortave|mesh-list
83159696|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83159697|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83159698|NCT00691717|Growth Substances|growth substances|mesh-ancestor
83159699|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159700|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
83159701|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159702|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159703|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83159704|NCT00834067|Moexipril|moexipril|mesh-list
83159705|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83159706|NCT00834067|Diuretics|diuretics|mesh-ancestor
83159707|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
83159708|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159709|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83159710|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83159711|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159712|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83159713|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159714|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159715|NCT00682981|Carboplatin|carboplatin|mesh-list
83159716|NCT00682981|Etoposide|etoposide|mesh-list
83159717|NCT00682981|Obatoclax|obatoclax|mesh-list
83159718|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159719|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83159720|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83159721|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83159722|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159723|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159724|NCT00833521|Zolpidem|zolpidem|mesh-list
83159725|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83159726|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83159727|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159728|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159729|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83159730|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
83159731|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
83159732|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159733|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159734|NCT00832507|Cicletanine|cicletanine|mesh-list
83159735|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83159736|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83159737|NCT00832507|Diuretics|diuretics|mesh-ancestor
83159738|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
83159739|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159740|NCT04862143|Fulvestrant|fulvestrant|mesh-list
83159741|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83159742|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159743|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83159744|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83159745|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
83159746|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159747|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159748|NCT02721459|Vemurafenib|vemurafenib|mesh-list
83159749|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159750|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83159751|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159752|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159753|NCT02802943|Imiquimod|imiquimod|mesh-list
83159754|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83159755|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
83159756|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159757|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159758|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
83159760|NCT02165033|Procaterol|procaterol|mesh-list
83159761|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159762|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83159763|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
83159764|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159765|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159766|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83159767|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
83159768|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
83159769|NCT02165033|Hormones|hormones|mesh-ancestor
83159770|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159771|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
83159772|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83159773|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83159774|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83159775|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83159776|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159777|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159778|NCT00734461|Naltrexone|naltrexone|mesh-list
83159779|NCT00734461|Oxycodone|oxycodone|mesh-list
83159780|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83159781|NCT00734461|Narcotics|narcotics|mesh-ancestor
83159782|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159783|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159784|NCT00734461|Analgesics|analgesics|mesh-ancestor
83159785|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
83159786|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159787|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83159788|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83159789|NCT02169713|Tamsulosin|tamsulosin|mesh-list
83159790|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
83159791|NCT02169713|Mirabegron|mirabegron|mesh-list
83159792|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83159793|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83159794|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83159795|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83159796|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159797|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159798|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159799|NCT02169713|Urological Agents|urological agents|mesh-ancestor
83159800|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83159801|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83159802|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
83159803|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83159804|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83159805|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83159806|NCT03980041|Nivolumab|nivolumab|mesh-list
83159807|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83159808|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159809|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83159810|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159811|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83159812|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83159813|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83159814|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159815|NCT00829309|Pravastatin|pravastatin|mesh-list
83159816|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83159817|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83159818|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
83159819|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159820|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83159821|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83159822|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159823|NCT02165189|Ribavirin|ribavirin|mesh-list
83159824|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
83159825|NCT02165189|Simeprevir|simeprevir|mesh-list
83159826|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
83159827|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159828|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
83159829|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159830|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159831|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159832|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83159833|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
83159834|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159835|NCT00725881|Protective Agents|protective agents|mesh-ancestor
83159836|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159837|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83159838|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159839|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
83159840|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83159841|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159842|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
83159843|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83159844|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
83159845|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83159846|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
83159847|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159848|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159849|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
83159850|NCT01950403|Linaclotide|linaclotide|mesh-list
83159851|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83159852|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
83159853|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159854|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83159855|NCT03607539|Pemetrexed|pemetrexed|mesh-list
83159856|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159857|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83159858|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159859|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83159860|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83159861|NCT00629941|Azithromycin|azithromycin|mesh-list
83159862|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159863|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159864|NCT02404779|Cisatracurium|cisatracurium|mesh-list
83159865|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83159866|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83159867|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159868|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159869|NCT00629551|Paroxetine|paroxetine|mesh-list
83159870|NCT00629551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83159871|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83159872|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83159873|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159874|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159875|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
83159876|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159877|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83159878|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
83159879|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83540433|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
83159880|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83159881|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83159883|NCT00625651|Bevacizumab|bevacizumab|mesh-list
83159884|NCT00625651|Conatumumab|conatumumab|mesh-list
83159885|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83159886|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159887|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83159888|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83159889|NCT00625651|Growth Substances|growth substances|mesh-ancestor
83159890|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159891|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
83159892|NCT00672997|Timolol|timolol|mesh-list
83159893|NCT00672997|Travoprost|travoprost|mesh-list
83159894|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83159895|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83159896|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83159897|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83159898|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83159899|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159900|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159901|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159902|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83159903|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83159904|NCT02130453|Regadenoson|regadenoson|mesh-list
83159905|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83159906|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83159907|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
83159908|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
83159909|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159910|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159911|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159912|NCT02669043|Ketamine|ketamine|mesh-list
83159914|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
83159915|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159916|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159917|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83159918|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83159919|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
83159920|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
83159921|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159922|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83159923|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83159924|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83159925|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159926|NCT02760407|Adalimumab|adalimumab|mesh-list
83159927|NCT02760407|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83159928|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159929|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83159930|NCT02281045|Citric Acid|citric acid|mesh-list
83159931|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
83159932|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
83159933|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83159934|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
83159935|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
83159936|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159937|NCT04472689|Lidocaine|lidocaine|mesh-list
83159938|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
83159939|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
83159940|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83159941|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159942|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
83159943|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159944|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83159945|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83159946|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83159947|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83159948|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159949|NCT02405013|Ribavirin|ribavirin|mesh-list
83159950|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
83159951|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83159952|NCT02405013|Ledipasvir|ledipasvir|mesh-list
83159953|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
83159954|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159955|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
83159956|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159957|NCT02173145|Azithromycin|azithromycin|mesh-list
83159958|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83159959|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159960|NCT00670033|Travoprost|travoprost|mesh-list
83159961|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83159962|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83159963|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83159964|NCT02283775|Dexamethasone|dexamethasone|mesh-list
83159965|NCT02283775|Pomalidomide|pomalidomide|mesh-list
83159966|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83159967|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
83159968|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
83159969|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83159970|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159971|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83159972|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
83159973|NCT02283775|Hormones|hormones|mesh-ancestor
83159974|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159975|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83159976|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83159977|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
83159978|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83159979|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83159980|NCT02283775|Growth Substances|growth substances|mesh-ancestor
83159981|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
83159982|NCT04479891|Itraconazole|itraconazole|mesh-list
83159983|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
83159984|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83159985|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83159986|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83159988|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83159989|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83159990|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
83159991|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83159992|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83159993|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83159994|NCT02281201|Thrombin|thrombin|mesh-list
83159995|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
83159996|NCT02281201|Coagulants|coagulants|mesh-ancestor
83159997|NCT02281279|Rituximab|rituximab|mesh-list
83159998|NCT02281279|Lenalidomide|lenalidomide|mesh-list
83159999|NCT02281279|Romidepsin|romidepsin|mesh-list
83160000|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83160001|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160002|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
83160003|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160004|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160005|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83160006|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83160007|NCT02281279|Growth Substances|growth substances|mesh-ancestor
83160008|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
83160009|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83160010|NCT02281279|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83160011|NCT02281279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160012|NCT02281279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160013|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83160014|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83160015|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160016|NCT02173457|Incretins|incretins|mesh-ancestor
83160017|NCT02173457|Hormones|hormones|mesh-ancestor
83160018|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160019|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83160020|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160021|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160022|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160023|NCT00805129|Everolimus|everolimus|mesh-list
83160024|NCT00805129|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83160025|NCT00805129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83160026|NCT00805129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160027|NCT00805129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160028|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160029|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
83160030|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160031|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160032|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
83160033|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83160034|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160035|NCT00501709|Abatacept|abatacept|mesh-list
83160036|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83160037|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83160038|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160039|NCT00501709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83160040|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160041|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
83160042|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160043|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160044|NCT02273635|Andrographolide|andrographolide|mesh-list
83160045|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160046|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160047|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160048|NCT02273635|Analgesics|analgesics|mesh-ancestor
83160049|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
83160050|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160051|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160052|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160053|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83160054|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83160055|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160056|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
83160057|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83160058|NCT02170415|Pregabalin|pregabalin|mesh-list
83160059|NCT02170415|Anesthetics|anesthetics|mesh-list
83160060|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
83160061|NCT02170415|Analgesics|analgesics|mesh-ancestor
83160062|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
83160063|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160064|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160065|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
83160066|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83160067|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83160068|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160069|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83160070|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83160071|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83160072|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160073|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83160074|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
83160075|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160076|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83160077|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83160078|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160079|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160080|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
83160081|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
83160082|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83160083|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83160084|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
83160085|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160086|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160087|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83160088|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
83160089|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
83160090|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83160091|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
83160092|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160093|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160094|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83160095|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83160096|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83160097|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160098|NCT02274259|Ranibizumab|ranibizumab|mesh-list
83160099|NCT02274259|Aflibercept|aflibercept|mesh-list
83160100|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83540434|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
83160101|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83160102|NCT02274259|Growth Substances|growth substances|mesh-ancestor
83160103|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160104|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
83160105|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160106|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83160107|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83160108|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160109|NCT02404623|Vitamin D|vitamin d|mesh-list
83160110|NCT02404623|Vitamins|vitamins|mesh-ancestor
83160111|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
83160112|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160113|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83160114|NCT02170571|Dabigatran|dabigatran|mesh-list
83160115|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
83160116|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83160117|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160118|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160119|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160120|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
83160121|NCT04481841|Vitamins|vitamins|mesh-list
83160122|NCT04481841|Vitamin E|vitamin e|mesh-list
83160123|NCT04481841|Riboflavin|riboflavin|mesh-list
83160124|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
83160125|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160126|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
83160127|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
83160128|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160129|NCT04481841|Protective Agents|protective agents|mesh-ancestor
83160130|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83160131|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
83160132|NCT02388477|Doxycycline|doxycycline|mesh-list
83160133|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83160134|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160135|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
83160136|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83160137|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83160138|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83160139|NCT02166359|Icodextrin|icodextrin|mesh-list
83160140|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
83160141|NCT00488839|Baclofen|baclofen|mesh-list
83160142|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83160143|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160144|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83160145|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160146|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83160147|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
83160148|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
83160149|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160150|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160151|NCT02255747|Lactulose|lactulose|mesh-list
83160152|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83160153|NCT01654731|Bezafibrate|bezafibrate|mesh-list
83160154|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83160155|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
83160156|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160157|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83160158|NCT00485563|Folic Acid|folic acid|mesh-list
83160159|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
83160160|NCT00485563|Interferons|interferons|mesh-list
83160161|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
83160162|NCT00485563|Interleukin-2|interleukin-2|mesh-list
83160163|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
83160164|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160165|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
83160166|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160167|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
83160168|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160169|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160170|NCT00485563|Analgesics|analgesics|mesh-ancestor
83160171|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
83160172|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160173|NCT00485563|Hematinics|hematinics|mesh-ancestor
83160174|NCT00485563|Vitamins|vitamins|mesh-ancestor
83160175|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
83160176|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83160177|NCT02170805|Pantoprazole|pantoprazole|mesh-list
83160178|NCT02170805|Dabigatran|dabigatran|mesh-list
83160179|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83160180|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83160181|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83160182|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160183|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160184|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
83160185|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83160186|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160187|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
83160188|NCT00606697|Vofopitant|vofopitant|mesh-list
83160189|NCT00606697|Vestipitant|vestipitant|mesh-list
83160190|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83160191|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160192|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160193|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160194|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
83160195|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
83160196|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160197|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83160198|NCT02404077|Clonidine|clonidine|mesh-list
83160199|NCT02404077|Analgesics|analgesics|mesh-ancestor
83160200|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
83160201|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160202|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160203|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83160204|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
83160205|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
83160206|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83160207|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83160208|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83160209|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160210|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160211|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160212|NCT02174939|Cilostazol|cilostazol|mesh-list
83160213|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83160214|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
83160215|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160216|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160217|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83160218|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
83160219|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83160220|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83160221|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160222|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83160223|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
83160224|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83160225|NCT02174939|Protective Agents|protective agents|mesh-ancestor
83160226|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83160227|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83160228|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160229|NCT02404233|Darunavir|darunavir|mesh-list
83160230|NCT02404233|Cobicistat|cobicistat|mesh-list
83160231|NCT02404233|Rilpivirine|rilpivirine|mesh-list
83160232|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83160233|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83160234|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83160235|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160236|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160237|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160238|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83160239|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83160240|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
83160241|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160242|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83160243|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83160244|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83160245|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83160246|NCT00603577|Xaliproden|xaliproden|mesh-list
83160247|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83160248|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83160249|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
83160250|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160251|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160252|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160253|NCT02178293|Ketoprofen|ketoprofen|mesh-list
83160254|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
83160255|NCT02178293|Benzydamine|benzydamine|mesh-list
83160256|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160257|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160258|NCT02178293|Analgesics|analgesics|mesh-ancestor
83160259|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
83160260|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160261|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160262|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160263|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160264|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83160265|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160266|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160267|NCT03170895|Sorafenib|sorafenib|mesh-list
83160268|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
83160269|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160270|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83160271|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160272|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160273|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83160274|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83160275|NCT02277847|Cytarabine|cytarabine|mesh-list
83160276|NCT02277847|Idarubicin|idarubicin|mesh-list
83160277|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83160278|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
83160279|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160280|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160281|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
83160282|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160283|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160284|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
83160285|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160286|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83160287|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83160288|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83160289|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160290|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
83160291|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83160292|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
83160293|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160294|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160295|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83160296|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
83160297|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83160298|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
83160299|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160300|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160301|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83160302|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
83160303|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
83160304|NCT01457781|Protective Agents|protective agents|mesh-ancestor
83160305|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
83160306|NCT00468403|Abatacept|abatacept|mesh-list
83160307|NCT00468403|Tacrolimus|tacrolimus|mesh-list
83160308|NCT00468403|Basiliximab|basiliximab|mesh-list
83160309|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160310|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
83160311|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160312|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83160313|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160314|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160315|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83160316|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160317|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83160318|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
83160319|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83160320|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160321|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83160322|NCT00468403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83160323|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160324|NCT02175017|Nivolumab|nivolumab|mesh-list
83160325|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83160326|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160327|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83160328|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160329|NCT02178449|Dexamethasone|dexamethasone|mesh-list
83160330|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
83160331|NCT02178449|Ropivacaine|ropivacaine|mesh-list
83160332|NCT02178449|BB 1101|bb 1101|mesh-list
83160333|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160334|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
83160335|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
83160336|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160337|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160338|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83160339|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
83160340|NCT02178449|Hormones|hormones|mesh-ancestor
83160341|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160342|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83160343|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160344|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
83160345|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
83160346|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160347|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
83160348|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160349|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160350|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160351|NCT02387931|Vitamin D|vitamin d|mesh-list
83160352|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
83160353|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
83160354|NCT02387931|Vitamins|vitamins|mesh-list
83160355|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
83160356|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160357|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83160358|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83160359|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83160360|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83160361|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83160362|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160363|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
83160364|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83160365|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
83160366|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
83160367|NCT02178683|Tacrolimus|tacrolimus|mesh-list
83160368|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160369|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
83160370|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160371|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83160372|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160373|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160374|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83160375|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160376|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83160377|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
83160378|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83160379|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160380|NCT03170739|Dopamine|dopamine|mesh-list
83160381|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
83160382|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83160383|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160384|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160385|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160386|NCT03170739|Analgesics|analgesics|mesh-ancestor
83160387|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
83160388|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160389|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83160390|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83160391|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83160392|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160393|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160394|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160395|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83160396|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
83160397|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
83160398|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
83160399|NCT03170739|Protective Agents|protective agents|mesh-ancestor
83160400|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
83160401|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83160402|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160403|NCT05309421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83160404|NCT05309421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160405|NCT00459745|Fenofibrate|fenofibrate|mesh-list
83160406|NCT00459745|Pravastatin|pravastatin|mesh-list
83160407|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83160408|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
83160409|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160411|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83160412|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83160413|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160414|NCT02178761|Chromium|chromium|mesh-list
83160415|NCT02178761|Everolimus|everolimus|mesh-list
83160416|NCT02178761|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83160417|NCT02178761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83160418|NCT02178761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160419|NCT02178761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160420|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160421|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
83160422|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160423|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160424|NCT02178761|Trace Elements|trace elements|mesh-ancestor
83160425|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
83160426|NCT02742181|Alvimopan|alvimopan|mesh-list
83160427|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83160428|NCT02175407|Itraconazole|itraconazole|mesh-list
83160429|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
83160430|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160431|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83160432|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83160433|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160434|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160435|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83160436|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
83160437|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160438|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160439|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83160440|NCT02182193|Nintedanib|nintedanib|mesh-list
83160442|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83160443|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160444|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160445|NCT02175485|Fexofenadine|fexofenadine|mesh-list
83160446|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83160447|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83160448|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83160449|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
83160450|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
83160451|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160452|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160453|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160454|NCT04575779|Cyclosporine|cyclosporine|mesh-list
83160455|NCT04575779|Cyclosporins|cyclosporins|mesh-list
83160456|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160457|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160458|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160459|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
83160460|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160461|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
83160462|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160463|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
83160464|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160465|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83160467|NCT02741713|Clonidine|clonidine|mesh-list
83160468|NCT02741713|Epinephrine|epinephrine|mesh-list
83160469|NCT02741713|Racepinephrine|racepinephrine|mesh-list
83160470|NCT02741713|Bupivacaine|bupivacaine|mesh-list
83160471|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83160472|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
83160473|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
83160474|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
83160475|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160476|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160477|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
83160478|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160479|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83160480|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83160481|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83160482|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83160483|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160484|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83160485|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83160486|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160487|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160488|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83160489|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83160490|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
83160491|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83160492|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
83160493|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
83160494|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
83160495|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83160496|NCT02741713|Analgesics|analgesics|mesh-ancestor
83160497|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83160498|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
83160499|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83160500|NCT00459277|Fentanyl|fentanyl|mesh-list
83160501|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83160502|NCT00459277|Narcotics|narcotics|mesh-ancestor
83160503|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160504|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160505|NCT00459277|Analgesics|analgesics|mesh-ancestor
83160506|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
83160507|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160508|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83160509|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83160510|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
83160511|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
83160512|NCT00602329|Leucovorin|leucovorin|mesh-list
83160513|NCT00602329|Bevacizumab|bevacizumab|mesh-list
83160514|NCT00602329|Fluorouracil|fluorouracil|mesh-list
83160515|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
83160516|NCT00602329|Calcium|calcium|mesh-list
83160517|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
83160518|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83160519|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160520|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83160521|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83160522|NCT00602329|Growth Substances|growth substances|mesh-ancestor
83160523|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160524|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
83160525|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83160526|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
83160527|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160528|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83160529|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160530|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
83160531|NCT00602329|Antidotes|antidotes|mesh-ancestor
83160532|NCT00602329|Protective Agents|protective agents|mesh-ancestor
83160533|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
83160534|NCT00602329|Vitamins|vitamins|mesh-ancestor
83160535|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
83160536|NCT02182505|Fenoterol|fenoterol|mesh-list
83160537|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83160538|NCT02182505|Ipratropium|ipratropium|mesh-list
83160539|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83160540|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
83160541|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160542|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160543|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83160544|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
83160545|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
83160546|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
83160547|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83160548|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83160549|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83160550|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83160551|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160552|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160553|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160554|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83160555|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
83160556|NCT02387619|Amlodipine|amlodipine|mesh-list
83160557|NCT02387619|Telmisartan|telmisartan|mesh-list
83160558|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83160559|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83160560|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83160561|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83160562|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83160563|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160564|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83160565|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160566|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
83160567|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83160568|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83160569|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
83160570|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83160571|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83160572|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160573|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83160574|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83160575|NCT03537443|Vitamin D|vitamin d|mesh-list
83160576|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
83160577|NCT03537443|Vitamins|vitamins|mesh-ancestor
83160578|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
83160579|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160580|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83160581|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83160582|NCT00595699|Escitalopram|escitalopram|mesh-list
83160583|NCT00595699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83160584|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83160585|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83160586|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160587|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160588|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
83160589|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160590|NCT02256215|Vitamin D|vitamin d|mesh-list
83160591|NCT02256215|Vitamins|vitamins|mesh-ancestor
83160592|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
83160593|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160594|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83160595|NCT02182583|Oxitropium|oxitropium|mesh-list
83160596|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
83160597|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
83160598|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160599|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160600|NCT03133975|Vitamin D|vitamin d|mesh-list
83160601|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
83160602|NCT03133975|Vitamins|vitamins|mesh-ancestor
83160603|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
83160604|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160605|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83160606|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83160607|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83160608|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83160609|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160610|NCT02182661|Oxitropium|oxitropium|mesh-list
83160611|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
83160612|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
83160613|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160614|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160615|NCT02663271|Bevacizumab|bevacizumab|mesh-list
83160616|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83160617|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160618|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83160619|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83160620|NCT02663271|Growth Substances|growth substances|mesh-ancestor
83160621|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160622|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
83160623|NCT00659191|Cabotegravir|cabotegravir|mesh-list
83160624|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83160625|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83160626|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160627|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160628|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83160629|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83160631|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160632|NCT02182739|Meloxicam|meloxicam|mesh-list
83160633|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160634|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160635|NCT02182739|Analgesics|analgesics|mesh-ancestor
83160636|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
83160637|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160638|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160639|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160640|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160641|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83160642|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83160643|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160644|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160645|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83160646|NCT00583609|Laxatives|laxatives|mesh-ancestor
83160647|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83160648|NCT03170115|Aspirin|aspirin|mesh-list
83160649|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160650|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160651|NCT03170115|Analgesics|analgesics|mesh-ancestor
83160652|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
83160653|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160654|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160655|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160656|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160657|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83160658|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83160659|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160660|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83160661|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83160662|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160663|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
83160664|NCT03169959|Metformin|metformin|mesh-list
83160665|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
83160666|NCT03169959|Saxagliptin|saxagliptin|mesh-list
83160667|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83160668|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160669|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83160670|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160671|NCT03169959|Incretins|incretins|mesh-ancestor
83160672|NCT03169959|Hormones|hormones|mesh-ancestor
83160673|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160674|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83160675|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160676|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160677|NCT02176187|Fenoterol|fenoterol|mesh-list
83160678|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
83160679|NCT02176187|Ipratropium|ipratropium|mesh-list
83160680|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83160681|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
83160682|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160683|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160684|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83160685|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
83160686|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
83160687|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
83160688|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83160689|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83160690|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83160691|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83160692|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160693|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160694|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160695|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83160696|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
83160697|NCT02176499|Telmisartan|telmisartan|mesh-list
83160698|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83160699|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83160700|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83160701|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160702|NCT02176733|Cyclosporine|cyclosporine|mesh-list
83160703|NCT02176733|Cyclosporins|cyclosporins|mesh-list
83160704|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160705|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160706|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160707|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
83160708|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160709|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
83160710|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160711|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
83160712|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160713|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83160714|NCT03536741|Anesthetics|anesthetics|mesh-list
83160715|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83160716|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160717|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160718|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
83160719|NCT02403687|Topiramate|topiramate|mesh-list
83160720|NCT02403687|Diclofenac|diclofenac|mesh-list
83160721|NCT02403687|Meloxicam|meloxicam|mesh-list
83160722|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
83160723|NCT02403687|Lidocaine|lidocaine|mesh-list
83160724|NCT02403687|Clonidine|clonidine|mesh-list
83160725|NCT02403687|Sumatriptan|sumatriptan|mesh-list
83160726|NCT02403687|Ketamine|ketamine|mesh-list
83160727|NCT02403687|Gabapentin|gabapentin|mesh-list
83160728|NCT02403687|Amitriptyline|amitriptyline|mesh-list
83160729|NCT02403687|Tizanidine|tizanidine|mesh-list
83160730|NCT02403687|Bupivacaine|bupivacaine|mesh-list
83160731|NCT02403687|Prilocaine|prilocaine|mesh-list
83160732|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
83160733|NCT02403687|Baclofen|baclofen|mesh-list
83160734|NCT02403687|Capsaicin|capsaicin|mesh-list
83160735|NCT02403687|Menthol|menthol|mesh-list
83160736|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
83160737|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
83160738|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160739|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160740|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
83160741|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160742|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83160743|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83160744|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83160745|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83160746|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160747|NCT02403687|Analgesics|analgesics|mesh-ancestor
83160748|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83160749|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83160750|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
83160751|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83160752|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83160753|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160754|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
83160755|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83160756|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83160757|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83160758|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
83160759|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160760|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160761|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160762|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160763|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83160764|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160765|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83160766|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
83160767|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
83160768|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83160769|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83160770|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83160771|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
83160772|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
83160773|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83160774|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83160775|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83160776|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
83160777|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83160778|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83160779|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
83160780|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83160781|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83160782|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160783|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
83160784|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
83160785|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83160786|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83160787|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83160788|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83160789|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
83160791|NCT02742649|Bimatoprost|bimatoprost|mesh-list
83160792|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83160793|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83160794|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83160795|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160796|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160797|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160798|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83160799|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83160800|NCT02183051|Ibuprofen|ibuprofen|mesh-list
83160801|NCT02183051|Meloxicam|meloxicam|mesh-list
83160802|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160803|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160804|NCT02183051|Analgesics|analgesics|mesh-ancestor
83160805|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
83160806|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160807|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160808|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160809|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160810|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83160811|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160812|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160813|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83160814|NCT03169725|Vaccines|vaccines|mesh-list
83160815|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
83160816|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160817|NCT02403531|Docetaxel|docetaxel|mesh-list
83160818|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160819|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
83160820|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
83160821|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83160822|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160823|NCT02183129|Diclofenac|diclofenac|mesh-list
83160824|NCT02183129|Meloxicam|meloxicam|mesh-list
83160825|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160826|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160827|NCT02183129|Analgesics|analgesics|mesh-ancestor
83160828|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
83160829|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160830|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160831|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160832|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160833|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83160834|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160835|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160836|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83160837|NCT02279953|Vortioxetine|vortioxetine|mesh-list
83160838|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
83160839|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83160840|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83160841|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83160842|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83160843|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160844|NCT02279953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83160845|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83160846|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83160847|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160848|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160849|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
83160850|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83160851|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83160852|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83160853|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83160854|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
83160855|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83160856|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83160857|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160858|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83160859|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83160860|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160861|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160862|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160863|NCT02387307|Interferons|interferons|mesh-list
83160864|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83160865|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
83160866|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160867|NCT02183363|Linagliptin|linagliptin|mesh-list
83160868|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83160869|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160870|NCT02183363|Incretins|incretins|mesh-ancestor
83160871|NCT02183363|Hormones|hormones|mesh-ancestor
83160872|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160873|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83160874|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160875|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160876|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160877|NCT02183441|Linagliptin|linagliptin|mesh-list
83160878|NCT02183441|Ritonavir|ritonavir|mesh-list
83160879|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83160880|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83160881|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
83160882|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160883|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160884|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83160885|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83160886|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
83160887|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160888|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83160889|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83160890|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83160891|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160892|NCT02183441|Incretins|incretins|mesh-ancestor
83160893|NCT02183441|Hormones|hormones|mesh-ancestor
83160894|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160895|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83160896|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83160897|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
83160898|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83160899|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83160900|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83160901|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83160902|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160904|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160905|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160906|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83160907|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160908|NCT03537287|Progesterone|progesterone|mesh-list
83160909|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
83160910|NCT03537287|Progestins|progestins|mesh-ancestor
83160911|NCT03537287|Hormones|hormones|mesh-ancestor
83160912|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160913|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160914|NCT02280031|Aspirin|aspirin|mesh-list
83160915|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83160916|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83160917|NCT02280031|Analgesics|analgesics|mesh-ancestor
83160918|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
83160919|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160920|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160921|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83160922|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83160923|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83160924|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83160925|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160926|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83160927|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83160928|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160929|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
83160930|NCT00449605|Metformin|metformin|mesh-list
83160931|NCT00449605|Glimepiride|glimepiride|mesh-list
83160932|NCT00449605|Rimonabant|rimonabant|mesh-list
83160933|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83160934|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160935|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83160936|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83160937|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
83160938|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83160939|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83160940|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83160941|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160942|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160943|NCT00449605|Hormones|hormones|mesh-ancestor
83160944|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160945|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
83160946|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83160947|NCT02774239|Antibodies|antibodies|mesh-list
83160948|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
83160949|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
83160950|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160951|NCT02280109|Tenofovir|tenofovir|mesh-list
83160953|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83160954|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83160955|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83160956|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160957|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160958|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83160959|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83160960|NCT00576667|Rimonabant|rimonabant|mesh-list
83160961|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83160962|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83160963|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83160964|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160965|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160966|NCT00576667|Hormones|hormones|mesh-ancestor
83160967|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83160968|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160969|NCT02403063|Neostigmine|neostigmine|mesh-list
83160970|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83160971|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83160972|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160973|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
83160974|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160975|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160976|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83160977|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
83160978|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83160979|NCT02177357|Pramipexole|pramipexole|mesh-list
83160980|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
83160981|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83160982|NCT02177357|Protective Agents|protective agents|mesh-ancestor
83160983|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160984|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83160985|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83160986|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
83160987|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
83160988|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83160989|NCT02386449|Mannitol|mannitol|mesh-list
83160990|NCT02386449|Bisacodyl|bisacodyl|mesh-list
83160991|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
83160992|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
83160993|NCT02386449|Citric Acid|citric acid|mesh-list
83160994|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
83160995|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83160996|NCT02386449|Diuretics|diuretics|mesh-ancestor
83160997|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
83160998|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83160999|NCT02386449|Cathartics|cathartics|mesh-ancestor
83161000|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83161001|NCT02386449|Laxatives|laxatives|mesh-ancestor
83161002|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
83161003|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83161004|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
83161005|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
83161006|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161007|NCT02386449|Antacids|antacids|mesh-ancestor
83161008|NCT00656539|Azithromycin|azithromycin|mesh-list
83161009|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83161010|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161011|NCT02179775|Propranolol|propranolol|mesh-list
83161012|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83161013|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83161014|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83161015|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161016|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161017|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161018|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83161019|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83161020|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
83161021|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83161022|NCT02177435|Telmisartan|telmisartan|mesh-list
83161023|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83161024|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83161025|NCT02177435|Diuretics|diuretics|mesh-ancestor
83161026|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
83161027|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161028|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83161029|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83161030|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161031|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83161032|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83161033|NCT02280265|Factor VIII|factor viii|mesh-list
83161034|NCT02280265|Coagulants|coagulants|mesh-ancestor
83161035|NCT02179931|Flupenthixol|flupenthixol|mesh-list
83161036|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83161037|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83161038|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83161039|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161040|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161041|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83161042|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83161043|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
83161044|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161045|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161046|NCT02184065|Meloxicam|meloxicam|mesh-list
83161047|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83161048|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83161049|NCT02184065|Analgesics|analgesics|mesh-ancestor
83161050|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
83161051|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161052|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161053|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161054|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161055|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83161056|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83161057|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161058|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161059|NCT00564421|Epinastine|epinastine|mesh-list
83161060|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83161061|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
83161062|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
83161063|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161064|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161065|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161066|NCT02665689|Ranibizumab|ranibizumab|mesh-list
83161067|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83161068|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83161069|NCT02665689|Growth Substances|growth substances|mesh-ancestor
83161070|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161071|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
83161072|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161073|NCT02386293|Irbesartan|irbesartan|mesh-list
83161074|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83161075|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83161076|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83161077|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161078|NCT00563563|Naltrexone|naltrexone|mesh-list
83161079|NCT00563563|Bupropion|bupropion|mesh-list
83161080|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83161081|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83161082|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161083|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
83161084|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161085|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83161086|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
83161087|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83161088|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83161089|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83161090|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83161091|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161092|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
83161093|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161094|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83161095|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83161096|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161097|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83161098|NCT05149365|Cyclosporine|cyclosporine|mesh-list
83161099|NCT05149365|Methotrexate|methotrexate|mesh-list
83161100|NCT05149365|Cyclosporins|cyclosporins|mesh-list
83161101|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83161102|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
83161103|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83161104|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161105|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83161106|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
83161107|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161108|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161109|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
83161110|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161111|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83161112|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83161113|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
83161114|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161115|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83161116|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
83161117|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161118|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83161119|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161120|NCT05149365|Incretins|incretins|mesh-ancestor
83161122|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161123|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83161124|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161125|NCT02180087|Ketoprofen|ketoprofen|mesh-list
83161126|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83161127|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83161128|NCT02180087|Analgesics|analgesics|mesh-ancestor
83161129|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
83161130|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161131|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161132|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161133|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161134|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83161135|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161136|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161137|NCT02184299|Nevirapine|nevirapine|mesh-list
83161138|NCT02184299|Prednisone|prednisone|mesh-list
83161139|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161140|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
83161141|NCT02184299|Hormones|hormones|mesh-ancestor
83161142|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161143|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161144|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161145|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161146|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83161147|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83161148|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161149|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161150|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
83161151|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161152|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83161153|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83161154|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83161155|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83161156|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
83161157|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83161158|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83161159|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161160|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161161|NCT02282371|Cetuximab|cetuximab|mesh-list
83161162|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83161163|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161164|NCT02402595|Itraconazole|itraconazole|mesh-list
83161165|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
83161166|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161167|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83161168|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83161169|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161170|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161171|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83161172|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
83161173|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161174|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161175|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83161176|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
83161177|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83161178|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83161179|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161180|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
83161181|NCT02180321|Coagulants|coagulants|mesh-ancestor
83161182|NCT00547651|Topotecan|topotecan|mesh-list
83161183|NCT00547651|Amrubicin|amrubicin|mesh-list
83161184|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83161185|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83161186|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161187|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161188|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161189|NCT00546793|Veltuzumab|veltuzumab|mesh-list
83161190|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161191|NCT02402283|Metronidazole|metronidazole|mesh-list
83161192|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161193|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83161194|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83161195|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83161196|NCT02184533|Selenious Acid|selenious acid|mesh-list
83161197|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
83161198|NCT02184533|Trace Elements|trace elements|mesh-ancestor
83161199|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
83161200|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161201|NCT02386059|Dexamethasone|dexamethasone|mesh-list
83161202|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
83161203|NCT02386059|Ondansetron|ondansetron|mesh-list
83161204|NCT02386059|BB 1101|bb 1101|mesh-list
83161205|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161206|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
83161207|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
83161208|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161209|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161210|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83161211|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
83161212|NCT02386059|Hormones|hormones|mesh-ancestor
83161213|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161214|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161215|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161216|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161217|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161218|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161219|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
83161220|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
83161221|NCT02386059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83161222|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83161223|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
83161224|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161225|NCT00443287|Cilostazol|cilostazol|mesh-list
83161226|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
83161227|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83161228|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
83161229|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161230|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161231|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83161232|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
83161233|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83161234|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83161235|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161236|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83161237|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
83161238|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83161239|NCT00443287|Protective Agents|protective agents|mesh-ancestor
83161240|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83161241|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83161242|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161243|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
83161244|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
83161245|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
83161246|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83161247|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161248|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161249|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
83161250|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83161251|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161252|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161253|NCT02390739|Aldesleukin|aldesleukin|mesh-list
83161254|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
83161255|NCT02390739|Fludarabine|fludarabine|mesh-list
83161256|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83161257|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
83161258|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161259|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161260|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83161261|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
83161262|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161263|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161264|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83161265|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83161266|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83161267|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
83161268|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161269|NCT02385825|Vaccines|vaccines|mesh-list
83161270|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
83161271|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161272|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
83161273|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161274|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83161275|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161276|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161277|NCT02390817|Neostigmine|neostigmine|mesh-list
83161278|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83161279|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161280|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161281|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
83161282|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161283|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161284|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83161285|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
83161286|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161287|NCT00537043|Carvedilol|carvedilol|mesh-list
83161288|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83161289|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83161290|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83161291|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161292|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161293|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161294|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83161295|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
83161296|NCT00537043|Protective Agents|protective agents|mesh-ancestor
83161297|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83161298|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83161299|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83161300|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
83161301|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83161302|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83161303|NCT00387907|Trastuzumab|trastuzumab|mesh-list
83161304|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83161305|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161306|NCT02180789|Tamsulosin|tamsulosin|mesh-list
83161307|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83161308|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83161309|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83161310|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
83161311|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161312|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161313|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161314|NCT02180789|Urological Agents|urological agents|mesh-ancestor
83161315|NCT02282683|Prednisone|prednisone|mesh-list
83161316|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161317|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
83161318|NCT02282683|Hormones|hormones|mesh-ancestor
83161319|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161320|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161321|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161322|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83540664|NCT03845010|Flecainide|flecainide|mesh-list
83161323|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83161324|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83161325|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83161326|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
83161327|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161328|NCT00375193|Amrubicin|amrubicin|mesh-list
83161329|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161330|NCT00151411|Metformin|metformin|mesh-list
83161331|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161332|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161333|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
83161334|NCT04471441|Everolimus|everolimus|mesh-list
83161335|NCT04471441|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83161336|NCT04471441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83161337|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161338|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161339|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83161340|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
83161341|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161342|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161343|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83161344|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83161345|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
83161346|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83161347|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161348|NCT02662569|Atorvastatin|atorvastatin|mesh-list
83161349|NCT02662569|Evolocumab|evolocumab|mesh-list
83161350|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83161351|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83161352|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
83161353|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161354|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83161355|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83161356|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161357|NCT02662569|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83161358|NCT02662569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83161359|NCT02662569|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161360|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
83161361|NCT02178137|Astringents|astringents|mesh-ancestor
83161362|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161363|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
83161364|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
83161365|NCT02181023|Bromides|bromides|mesh-list
83161366|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
83161367|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83161368|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83161369|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83161370|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
83161371|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161372|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161373|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161374|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
83161375|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83161376|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83161377|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161378|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
83161379|NCT02286973|Coagulants|coagulants|mesh-ancestor
83161380|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
83161381|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83161382|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161383|NCT02287129|Paclitaxel|paclitaxel|mesh-list
83161384|NCT02287129|Carboplatin|carboplatin|mesh-list
83161385|NCT02287129|Capecitabine|capecitabine|mesh-list
83161386|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
83161387|NCT02287129|Epirubicin|epirubicin|mesh-list
83161388|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83161389|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161390|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
83161391|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
83161392|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
83161393|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161394|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83161395|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
83161396|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83161397|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83161398|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83161399|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161400|NCT02256683|Dabigatran|dabigatran|mesh-list
83161401|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
83161402|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
83161403|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83161404|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161405|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161406|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161407|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
83161408|NCT00411385|Interferons|interferons|mesh-list
83161409|NCT00411385|Ribavirin|ribavirin|mesh-list
83161410|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
83161411|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
83161412|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83161413|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161414|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
83161415|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161416|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
83161417|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161418|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
83161419|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161420|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83161421|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
83161422|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161423|NCT02185547|Sertraline|sertraline|mesh-list
83161424|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
83161425|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83161426|NCT02185547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83161427|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83161428|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83161429|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161430|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161431|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
83161432|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161433|NCT02030483|Dexamethasone|dexamethasone|mesh-list
83161434|NCT02030483|Lenalidomide|lenalidomide|mesh-list
83161435|NCT02030483|Palbociclib|palbociclib|mesh-list
83161436|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161437|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
83161438|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
83161439|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161440|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161441|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83161442|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
83161443|NCT02030483|Hormones|hormones|mesh-ancestor
83161444|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161445|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161446|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161447|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
83161448|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83161449|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83161450|NCT02030483|Growth Substances|growth substances|mesh-ancestor
83161451|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
83161452|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83161453|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161454|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161455|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83161456|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83161457|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83161458|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83161459|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161460|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
83161461|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161462|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161463|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
83161464|NCT02385435|Bupivacaine|bupivacaine|mesh-list
83161465|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
83161466|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
83161467|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161468|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161469|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
83161470|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161471|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83161472|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83161473|NCT02385435|Analgesics|analgesics|mesh-ancestor
83161474|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83161475|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83161476|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83161477|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
83161478|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161479|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161480|NCT02753075|Fluorides|fluorides|mesh-list
83161481|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
83161482|NCT02753075|Protective Agents|protective agents|mesh-ancestor
83161483|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161484|NCT03133897|Dexamethasone|dexamethasone|mesh-list
83161485|NCT03133897|Prednisone|prednisone|mesh-list
83161486|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161487|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
83161488|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
83161489|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161490|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161491|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83161492|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
83161493|NCT03133897|Hormones|hormones|mesh-ancestor
83161494|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161495|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161496|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161497|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
83161498|NCT05443425|Leflunomide|leflunomide|mesh-list
83161499|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161500|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161501|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83161502|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
83161503|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161504|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83161505|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83161506|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
83161507|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83161508|NCT02190149|Factor VIII|factor viii|mesh-list
83161509|NCT02190149|Coagulants|coagulants|mesh-ancestor
83161510|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
83161511|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161512|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
83161513|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161514|NCT02185859|Lidocaine|lidocaine|mesh-list
83161515|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
83161516|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
83161517|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
83161518|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161519|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161520|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
83161521|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161522|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83161523|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83161524|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83161525|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83161526|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161527|NCT02185859|Analgesics|analgesics|mesh-ancestor
83161528|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
83161529|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83161530|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83161531|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
83161532|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83161533|NCT02332720|Ribavirin|ribavirin|mesh-list
83161534|NCT02332720|Grazoprevir|grazoprevir|mesh-list
83161535|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
83161536|NCT02332720|Ruzasvir|ruzasvir|mesh-list
83161537|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
83161538|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161539|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
83161540|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161541|NCT05089175|Aspirin|aspirin|mesh-list
83161542|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83161543|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83161544|NCT05089175|Analgesics|analgesics|mesh-ancestor
83161545|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
83161546|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161547|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161548|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161549|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161550|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83161551|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83161552|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161553|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83161554|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83161555|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161556|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
83161557|NCT02181335|Budesonide|budesonide|mesh-list
83161558|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161559|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83161560|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
83161561|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161562|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161563|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83161564|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
83161565|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
83161566|NCT02181335|Hormones|hormones|mesh-ancestor
83161567|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161568|NCT00517153|Miglustat|miglustat|mesh-list
83161569|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161570|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161571|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83161572|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83161573|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
83161574|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161575|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83161576|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161577|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161578|NCT02285101|BCT-100|bct-100|mesh-list
83161579|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161580|NCT00359437|Satavaptan|satavaptan|mesh-list
83161581|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83161582|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161583|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
83161584|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161585|NCT05064449|Itraconazole|itraconazole|mesh-list
83161586|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
83161587|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
83161588|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161589|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83161590|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83161591|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161592|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161593|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83161594|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83161595|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161596|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161597|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83161598|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83161599|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83161601|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
83161602|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161603|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161604|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161605|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83161606|NCT00401011|Dexamethasone|dexamethasone|mesh-list
83161607|NCT00401011|Bortezomib|bortezomib|mesh-list
83161608|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161609|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
83161610|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
83161611|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161612|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161613|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83161614|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
83161615|NCT00401011|Hormones|hormones|mesh-ancestor
83161616|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161617|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161618|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161619|NCT01645930|Dexamethasone|dexamethasone|mesh-list
83161620|NCT01645930|Lenalidomide|lenalidomide|mesh-list
83161621|NCT01645930|Ixazomib|ixazomib|mesh-list
83161622|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161623|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
83161624|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
83161625|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161626|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161627|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83161628|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
83161629|NCT01645930|Hormones|hormones|mesh-ancestor
83161630|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161631|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161632|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161634|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83161635|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83161636|NCT01645930|Growth Substances|growth substances|mesh-ancestor
83161637|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
83161638|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161639|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161640|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161641|NCT02190695|Carboplatin|carboplatin|mesh-list
83161642|NCT02190695|Decitabine|decitabine|mesh-list
83161643|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
83161644|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161645|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83161646|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
83161647|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161648|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161649|NCT00514267|Prednisone|prednisone|mesh-list
83161650|NCT00514267|Docetaxel|docetaxel|mesh-list
83161651|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161652|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
83161653|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
83161654|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
83161655|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161656|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161657|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
83161658|NCT00514267|Hormones|hormones|mesh-ancestor
83161659|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161660|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161661|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83161662|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
83161663|NCT04199104|Lenvatinib|lenvatinib|mesh-list
83161664|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83161665|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161666|NCT04199104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83161667|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161668|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83161669|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161670|NCT02384967|Darunavir|darunavir|mesh-list
83161671|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83161672|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83161673|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161674|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161675|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161676|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83161677|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83161678|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
83161679|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161680|NCT02186249|Nivolumab|nivolumab|mesh-list
83161681|NCT02186249|Ipilimumab|ipilimumab|mesh-list
83161682|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83161683|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161684|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83161685|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161686|NCT00511459|Paclitaxel|paclitaxel|mesh-list
83161687|NCT00511459|Bevacizumab|bevacizumab|mesh-list
83161688|NCT00511459|Trebananib|trebananib|mesh-list
83161689|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83161690|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161691|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
83161692|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
83161693|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
83161694|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161695|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83161696|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83161697|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83161698|NCT00511459|Growth Substances|growth substances|mesh-ancestor
83161699|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161700|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
83161701|NCT02384889|Eflornithine|eflornithine|mesh-list
83161702|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161703|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83161704|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83161705|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83161706|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161707|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83161708|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161709|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161710|NCT02299336|Aflibercept|aflibercept|mesh-list
83161711|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83161712|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83161713|NCT02299336|Growth Substances|growth substances|mesh-ancestor
83161714|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161715|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
83161716|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161717|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
83161718|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161719|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161720|NCT02186483|Metformin|metformin|mesh-list
83161721|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83161722|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161723|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161724|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83161725|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83161726|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
83161727|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161728|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83161729|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83161730|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161731|NCT02256605|Vitamin D|vitamin d|mesh-list
83161732|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
83161733|NCT02256605|Vitamins|vitamins|mesh-ancestor
83161734|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
83161735|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161736|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83161737|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83161738|NCT00393991|Fluticasone|fluticasone|mesh-list
83161740|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
83161741|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161742|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83161743|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
83161744|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161745|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161746|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83161747|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
83161748|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
83161749|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83161750|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83161751|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83161752|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83161753|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
83161754|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161755|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161756|NCT02664441|Exenatide|exenatide|mesh-list
83161757|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161758|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161759|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83161760|NCT02664441|Incretins|incretins|mesh-ancestor
83161761|NCT02664441|Hormones|hormones|mesh-ancestor
83161762|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161763|NCT02191007|Calcitriol|calcitriol|mesh-list
83161764|NCT02191007|Betamethasone|betamethasone|mesh-list
83161765|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
83161766|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83161767|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
83161768|NCT02191007|Calcipotriene|calcipotriene|mesh-list
83161769|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83161770|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161771|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
83161772|NCT02191007|Hormones|hormones|mesh-ancestor
83161773|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161774|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161775|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83161776|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
83161777|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83161778|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83161779|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83161780|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83161781|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161782|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83161784|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
83161785|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83161786|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
83161787|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83161788|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
83161789|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161790|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161791|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83161792|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
83161793|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161794|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161795|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83161796|NCT04470115|Anesthetics|anesthetics|mesh-list
83161797|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161798|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161799|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
83161800|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83161801|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161802|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161803|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83161804|NCT02384343|Analgesics|analgesics|mesh-ancestor
83161805|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
83161806|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161807|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83161808|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83161809|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83161810|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
83161811|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161812|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161813|NCT05033639|Melatonin|melatonin|mesh-list
83161814|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
83161815|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161816|NCT05033639|Protective Agents|protective agents|mesh-ancestor
83161817|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161818|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161819|NCT02328040|Insulin|insulin|mesh-list
83161820|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83161821|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83161822|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
83161823|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161824|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161825|NCT02328040|Incretins|incretins|mesh-ancestor
83161826|NCT02328040|Hormones|hormones|mesh-ancestor
83161827|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83161828|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83161829|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161830|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161831|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161833|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83161834|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
83161835|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161836|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161837|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83161838|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
83161839|NCT02384499|Coagulants|coagulants|mesh-ancestor
83161840|NCT02186951|Amoxicillin|amoxicillin|mesh-list
83161841|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
83161842|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
83161843|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83161844|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161845|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161846|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161847|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83161848|NCT02285413|Cisplatin|cisplatin|mesh-list
83161849|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161850|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83161851|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
83161852|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161853|NCT02187107|Darunavir|darunavir|mesh-list
83161854|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83161855|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83161856|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161857|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161858|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161859|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83161860|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83161861|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
83161862|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161863|NCT02285491|Bupivacaine|bupivacaine|mesh-list
83161864|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
83161865|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
83161866|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161867|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161868|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
83161869|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161870|NCT02298868|Baclofen|baclofen|mesh-list
83161871|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83161872|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161874|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161875|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83161876|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
83161877|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
83161878|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161879|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161880|NCT02389179|Vitamin D|vitamin d|mesh-list
83161881|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
83161882|NCT02389179|Vitamins|vitamins|mesh-ancestor
83161883|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
83161884|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161885|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83161886|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83161887|NCT02285647|Rolapitant|rolapitant|mesh-list
83161888|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83161889|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161890|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161891|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161892|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83161893|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161894|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161895|NCT02187497|Telmisartan|telmisartan|mesh-list
83161896|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83161897|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83161898|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83161899|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161900|NCT04195750|Everolimus|everolimus|mesh-list
83161901|NCT04195750|Belzutifan|belzutifan|mesh-list
83161902|NCT04195750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83161903|NCT04195750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83161904|NCT04195750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161905|NCT04195750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161906|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83161907|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
83161908|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161909|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83161910|NCT00099853|Pioglitazone|pioglitazone|mesh-list
83161911|NCT00099853|Vildagliptin|vildagliptin|mesh-list
83161912|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83161913|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161914|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83161915|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161916|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161917|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161918|NCT02381145|Resveratrol|resveratrol|mesh-list
83161919|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
83161920|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161921|NCT02381145|Protective Agents|protective agents|mesh-ancestor
83540740|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83161922|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161923|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161924|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83161926|NCT00097357|Warfarin|warfarin|mesh-list
83161927|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
83161928|NCT00097357|Apixaban|apixaban|mesh-list
83161929|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
83161930|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83161931|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83161932|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161933|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83161935|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83161936|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
83161937|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161938|NCT02296840|Acetaminophen|acetaminophen|mesh-list
83161939|NCT02296840|Ibuprofen|ibuprofen|mesh-list
83161940|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83161941|NCT02296840|Hydrocodone|hydrocodone|mesh-list
83161942|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83161943|NCT02296840|Analgesics|analgesics|mesh-ancestor
83161944|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
83161945|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83161946|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161947|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
83161948|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83161949|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83161950|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83161951|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83161952|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161953|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161954|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83161955|NCT02296840|Narcotics|narcotics|mesh-ancestor
83161956|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83161957|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
83161958|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
83161959|NCT02191319|Nevirapine|nevirapine|mesh-list
83161960|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83161961|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83161962|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161963|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161964|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
83161965|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161966|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83161967|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83161968|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83161969|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83161970|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83161971|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83161972|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161973|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83161974|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161975|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161976|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
83161977|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
83161978|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
83161979|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83161980|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83161981|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83161982|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161983|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161984|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
83161985|NCT00326287|Linezolid|linezolid|mesh-list
83161986|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
83161987|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83161988|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83161989|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83161990|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83161991|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83161992|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83161993|NCT02191943|Fluorides|fluorides|mesh-list
83161994|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
83161995|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
83161996|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
83161997|NCT02191943|Protective Agents|protective agents|mesh-ancestor
83161998|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83161999|NCT02663895|Treprostinil|treprostinil|mesh-list
83162000|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162001|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
83162002|NCT00320203|Anecortave|anecortave|mesh-list
83162003|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83162004|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83162005|NCT00320203|Growth Substances|growth substances|mesh-ancestor
83162006|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162007|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
83162008|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162009|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162010|NCT00071461|Bosentan|bosentan|mesh-list
83162011|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162012|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83162013|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162014|NCT00069745|Prednisone|prednisone|mesh-list
83162015|NCT00069745|Satraplatin|satraplatin|mesh-list
83162016|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162017|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
83162018|NCT00069745|Hormones|hormones|mesh-ancestor
83162019|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162020|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162021|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83162022|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162023|NCT02192411|Lidocaine|lidocaine|mesh-list
83162024|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
83162025|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
83162026|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162027|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162028|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
83162029|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162030|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83162031|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83162032|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83162033|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83162034|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162035|NCT02193893|Coal Tar|coal tar|mesh-list
83162036|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
83162037|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
83162038|NCT02384187|Gabapentin|gabapentin|mesh-list
83162039|NCT02384187|Analgesics|analgesics|mesh-ancestor
83162040|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
83162041|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162042|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162043|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
83162044|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83162045|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83162046|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162047|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83162048|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83162049|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83162050|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162051|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162052|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
83162053|NCT02192723|Olanzapine|olanzapine|mesh-list
83162054|NCT02192723|Risperidone|risperidone|mesh-list
83162055|NCT02192723|Aripiprazole|aripiprazole|mesh-list
83162056|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83162057|NCT02192723|Ziprasidone|ziprasidone|mesh-list
83162058|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
83162059|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83162060|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
83162061|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162062|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162063|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162064|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83162065|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162066|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83162067|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83162068|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
83162069|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
83162070|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
83162071|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162072|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83162073|NCT02192723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83162074|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83162075|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83162076|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
83162077|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
83162078|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83162079|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83162080|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83162081|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83162082|NCT00319969|Topotecan|topotecan|mesh-list
83162083|NCT00319969|Amrubicin|amrubicin|mesh-list
83162084|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83162085|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83162086|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162087|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162088|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162089|NCT00317395|Heparin|heparin|mesh-list
83162090|NCT00317395|Calcium heparin|calcium heparin|mesh-list
83162091|NCT00317395|Otamixaban|otamixaban|mesh-list
83162092|NCT00317395|Eptifibatide|eptifibatide|mesh-list
83162093|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
83162094|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83162095|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83162096|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162097|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83162098|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83162099|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
83162100|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83162101|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83162102|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162103|NCT02383563|Metformin|metformin|mesh-list
83162104|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83162105|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162106|NCT03535961|Etoposide|etoposide|mesh-list
83162107|NCT03535961|Apatinib|apatinib|mesh-list
83162108|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83162109|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162110|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83162111|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83162112|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162113|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162114|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83162115|NCT02380755|Clomiphene|clomiphene|mesh-list
83162116|NCT02380755|Enclomiphene|enclomiphene|mesh-list
83162117|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
83162118|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83162119|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83162120|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162121|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162122|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83162123|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
83162124|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83162125|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83162126|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83162127|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
83162128|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83162129|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83162130|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83162131|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83162132|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83162133|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162134|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
83162135|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162136|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162137|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83162138|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162139|NCT02380521|Exenatide|exenatide|mesh-list
83162140|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83162141|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162142|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83162143|NCT02380521|Incretins|incretins|mesh-ancestor
83162144|NCT02380521|Hormones|hormones|mesh-ancestor
83162145|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162147|NCT00315757|Mapatumumab|mapatumumab|mesh-list
83162148|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83162149|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162150|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
83162151|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162152|NCT02377401|Zanamivir|zanamivir|mesh-list
83162153|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
83162154|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162155|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162156|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162157|NCT00312091|Lamivudine|lamivudine|mesh-list
83162158|NCT00312091|Nevirapine|nevirapine|mesh-list
83162159|NCT00312091|Stavudine|stavudine|mesh-list
83162160|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83162161|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83162162|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162163|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162164|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
83162165|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162166|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83162167|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83162168|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83162169|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83162170|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
83162171|NCT00389779|Guanfacine|guanfacine|mesh-list
83162172|NCT00389779|Darusentan|darusentan|mesh-list
83162173|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162174|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83162175|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83162176|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83162177|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
83162178|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162179|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162180|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162181|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83162182|NCT00389155|Gemcitabine|gemcitabine|mesh-list
83162183|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83162184|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
83162185|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162186|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162187|NCT02188511|Nicotine|nicotine|mesh-list
83162188|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83162189|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
83162190|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162191|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162192|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83162193|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83162194|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
83162195|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162196|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162197|NCT02380131|Capecitabine|capecitabine|mesh-list
83162198|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
83162199|NCT02380131|Trastuzumab|trastuzumab|mesh-list
83162200|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83162201|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
83540741|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83162202|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162203|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162204|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83162205|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83162206|NCT03535103|Hormones|hormones|mesh-ancestor
83162207|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162208|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162209|NCT04360941|Palbociclib|palbociclib|mesh-list
83162210|NCT04360941|Avelumab|avelumab|mesh-list
83162211|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162212|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83162213|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162214|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162215|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83162216|NCT04551365|Chitosan|chitosan|mesh-list
83162217|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83162218|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83162219|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
83162220|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162221|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83162222|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
83162223|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
83162224|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
83162225|NCT04551365|Coagulants|coagulants|mesh-ancestor
83162226|NCT00028639|Bortezomib|bortezomib|mesh-list
83162227|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162228|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
83162229|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83162230|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
83162231|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162232|NCT02371941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83162233|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162234|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83162235|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
83162236|NCT00298987|Dasatinib|dasatinib|mesh-list
83162237|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162238|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83162239|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162240|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162241|NCT02380053|Celiprolol|celiprolol|mesh-list
83162242|NCT02380053|Bisoprolol|bisoprolol|mesh-list
83162243|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162244|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
83162245|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
83162246|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162247|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162248|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83162249|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83162250|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83162251|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
83162252|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162253|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162254|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83162255|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
83162256|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
83162257|NCT03725761|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83162258|NCT03725761|Immunoconjugates|immunoconjugates|mesh-ancestor
83162259|NCT03725761|Immunologic Factors|immunologic factors|mesh-ancestor
83162260|NCT03725761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162261|NCT02371707|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83162262|NCT02371707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83162263|NCT02371707|Serotonin Agents|serotonin agents|mesh-ancestor
83162264|NCT02371707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162265|NCT02371707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162266|NCT02371707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162267|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83162268|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83162269|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83162270|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83162271|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
83162272|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162273|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162274|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83162275|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83162276|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83162277|NCT03535415|Hormones|hormones|mesh-list
83162278|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162279|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162280|NCT02030717|Clonidine|clonidine|mesh-list
83162281|NCT02030717|Anesthetics|anesthetics|mesh-list
83162282|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162283|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162284|NCT02030717|Analgesics|analgesics|mesh-ancestor
83162285|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
83162286|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162287|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162289|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
83162290|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83162291|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83162292|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83162293|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
83162294|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162295|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162296|NCT02371473|Acetazolamide|acetazolamide|mesh-list
83162297|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
83162298|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83162299|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162300|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162301|NCT02371473|Diuretics|diuretics|mesh-ancestor
83162302|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
83162303|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162304|NCT04301661|Tenofovir|tenofovir|mesh-list
83162305|NCT04301661|Lamivudine|lamivudine|mesh-list
83162306|NCT04301661|Emtricitabine|emtricitabine|mesh-list
83162307|NCT04301661|Abacavir|abacavir|mesh-list
83162308|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
83162309|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162310|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83162311|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83162312|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162313|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162314|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83162315|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83162316|NCT02194049|Etoposide|etoposide|mesh-list
83162317|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
83162318|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162319|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83162320|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83162321|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83162322|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162323|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162324|NCT02379663|Enoxaparin|enoxaparin|mesh-list
83162325|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
83162326|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83162327|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
83162328|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83162329|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83162330|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162331|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162332|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
83162333|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83162334|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83162335|NCT02030639|ON 01910|on 01910|mesh-list
83162336|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162337|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83162338|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162339|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162340|NCT00004897|Leucovorin|leucovorin|mesh-list
83162341|NCT00004897|Interferons|interferons|mesh-list
83162342|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
83162343|NCT00004897|Fluorouracil|fluorouracil|mesh-list
83162344|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
83162345|NCT00004897|Calcium|calcium|mesh-list
83162346|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
83162347|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162348|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83162349|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162350|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
83162351|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162352|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83162353|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83162354|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
83162355|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
83162356|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162357|NCT00004897|Antidotes|antidotes|mesh-ancestor
83162358|NCT00004897|Protective Agents|protective agents|mesh-ancestor
83162359|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
83162360|NCT00004897|Vitamins|vitamins|mesh-ancestor
83162361|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
83162362|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
83162363|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162364|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83162365|NCT00004231|Leucovorin|leucovorin|mesh-list
83162366|NCT00004231|Interferons|interferons|mesh-list
83162367|NCT00004231|Cytarabine|cytarabine|mesh-list
83162368|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
83162369|NCT00004231|Aldesleukin|aldesleukin|mesh-list
83162370|NCT00004231|Prednisone|prednisone|mesh-list
83162371|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
83162372|NCT00004231|Busulfan|busulfan|mesh-list
83162373|NCT00004231|Doxorubicin|doxorubicin|mesh-list
83162374|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83162375|NCT00004231|Methotrexate|methotrexate|mesh-list
83162376|NCT00004231|Vincristine|vincristine|mesh-list
83162377|NCT00004231|Teniposide|teniposide|mesh-list
83162378|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
83162379|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83162380|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
83162381|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162382|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83162383|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83162384|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
83162385|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162386|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162387|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83162388|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83162389|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83162390|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83162391|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162392|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162393|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
83162394|NCT00004231|Hormones|hormones|mesh-ancestor
83162395|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162396|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83162397|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83162398|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
83162399|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83162400|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83162401|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
83162402|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
83162403|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83162404|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83162405|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
83162406|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162407|NCT00004231|Antidotes|antidotes|mesh-ancestor
83162408|NCT00004231|Protective Agents|protective agents|mesh-ancestor
83162409|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
83162410|NCT00004231|Vitamins|vitamins|mesh-ancestor
83162411|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
83162412|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83162413|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
83162414|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
83162415|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
83162416|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83162417|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83162418|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83162419|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162420|NCT04681131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83162421|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162422|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
83162423|NCT00004171|Busulfan|busulfan|mesh-list
83162424|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83162425|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
83162426|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162427|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83162428|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83162429|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
83162430|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162431|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162432|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83162433|NCT00004165|Melphalan|melphalan|mesh-list
83162434|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
83162435|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162436|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83162437|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
83162438|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162439|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162440|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83162441|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83162442|NCT00004093|Paclitaxel|paclitaxel|mesh-list
83162443|NCT00004093|Vinorelbine|vinorelbine|mesh-list
83162444|NCT00004093|Carboplatin|carboplatin|mesh-list
83162445|NCT00004093|Gemcitabine|gemcitabine|mesh-list
83162446|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83162447|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162448|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
83162449|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
83162450|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
83162451|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162452|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83162453|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
83162454|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83162455|NCT02193269|Minocycline|minocycline|mesh-list
83162456|NCT02193269|Tetracycline|tetracycline|mesh-list
83162457|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162458|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83162459|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162460|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162461|NCT00002479|Tretinoin|tretinoin|mesh-list
83162462|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162463|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
83162464|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
83162465|NCT00002371|Lamivudine|lamivudine|mesh-list
83162466|NCT00002371|Zidovudine|zidovudine|mesh-list
83162467|NCT00002371|Stavudine|stavudine|mesh-list
83162468|NCT00002371|Indinavir|indinavir|mesh-list
83162469|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83162470|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83162471|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162472|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162473|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
83162474|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162475|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83162476|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83162477|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
83162478|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83162479|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83162480|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
83162481|NCT02189681|Anesthetics|anesthetics|mesh-list
83162482|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162483|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162484|NCT05715385|Bromfenac|bromfenac|mesh-list
83162485|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83162486|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83162487|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83162488|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83162489|NCT05715385|Analgesics|analgesics|mesh-ancestor
83162490|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
83162491|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162492|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162493|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162494|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83162495|NCT04182633|Vancomycin|vancomycin|mesh-list
83162496|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83162497|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83162498|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162499|NCT04182633|Laxatives|laxatives|mesh-ancestor
83162500|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83162501|NCT02194283|Ambroxol|ambroxol|mesh-list
83162502|NCT02194283|Expectorants|expectorants|mesh-ancestor
83162503|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
83162504|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
83162505|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83162506|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83162507|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162508|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83162509|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83162510|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83162511|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83162512|NCT00263341|Estrogens|estrogens|mesh-ancestor
83162513|NCT00263341|Hormones|hormones|mesh-ancestor
83162514|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162515|NCT03534869|Analgesics|analgesics|mesh-list
83162516|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
83162517|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162518|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162519|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
83162520|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162521|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83162522|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
83162523|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
83162524|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83162525|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83162526|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162527|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162528|NCT02378649|Urological Agents|urological agents|mesh-ancestor
83162529|NCT02197169|Interferons|interferons|mesh-list
83162530|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
83162531|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162532|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
83162533|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162535|NCT02376309|Androgens|androgens|mesh-ancestor
83162536|NCT02376309|Hormones|hormones|mesh-ancestor
83162537|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162538|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162539|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
83162540|NCT00232141|Pregabalin|pregabalin|mesh-list
83162542|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
83162543|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162544|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162545|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
83162546|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83162547|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83162548|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162549|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83162550|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83162551|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83162552|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162553|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83162554|NCT02378415|Ketamine|ketamine|mesh-list
83162555|NCT02378415|Analgesics|analgesics|mesh-ancestor
83162556|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
83162557|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162558|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162559|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83162560|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83162561|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
83162562|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
83162563|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162564|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83162565|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83162566|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162567|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162568|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
83162569|NCT02197403|Propofol|propofol|mesh-list
83162570|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83162571|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162572|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162573|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83162574|NCT02197403|Analgesics|analgesics|mesh-ancestor
83162575|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
83162576|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162577|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83162578|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83162579|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83162580|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
83162581|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162582|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162583|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83162584|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
83162585|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
83162586|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83162587|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
83162588|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162589|NCT03534713|Paclitaxel|paclitaxel|mesh-list
83162590|NCT03534713|Carboplatin|carboplatin|mesh-list
83162591|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83162592|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162593|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
83162594|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
83162595|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
83162596|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162597|NCT02376075|Linagliptin|linagliptin|mesh-list
83162598|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83162599|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162600|NCT02376075|Incretins|incretins|mesh-ancestor
83162601|NCT02376075|Hormones|hormones|mesh-ancestor
83162602|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162603|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83162604|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
83162605|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162606|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162607|NCT02197637|Vinorelbine|vinorelbine|mesh-list
83162608|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83162609|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162610|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
83162611|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
83162612|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
83162613|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162614|NCT04469413|Acetaminophen|acetaminophen|mesh-list
83162615|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83162616|NCT04469413|Analgesics|analgesics|mesh-ancestor
83162617|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
83162618|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162619|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162620|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
83162621|NCT03532087|Denosumab|denosumab|mesh-list
83162622|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83162623|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162624|NCT02369523|Bupivacaine|bupivacaine|mesh-list
83162625|NCT02369523|Ropivacaine|ropivacaine|mesh-list
83162626|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
83162627|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
83162628|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162629|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162630|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
83162631|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162632|NCT02288923|Acetaminophen|acetaminophen|mesh-list
83162633|NCT02288923|Ibuprofen|ibuprofen|mesh-list
83162634|NCT02288923|Morphine|morphine|mesh-list
83162635|NCT02288923|Antiemetics|antiemetics|mesh-list
83162636|NCT02288923|Anesthetics|anesthetics|mesh-list
83162637|NCT02288923|Emetics|emetics|mesh-list
83162638|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162639|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162640|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83162641|NCT02288923|Narcotics|narcotics|mesh-ancestor
83162642|NCT02288923|Analgesics|analgesics|mesh-ancestor
83162643|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
83162644|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162645|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83162646|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83162647|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162648|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83162649|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83162650|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162651|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162652|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
83162653|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
83162654|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83162655|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83162656|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83162657|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
83162658|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162659|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162660|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83162661|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
83162662|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
83162663|NCT02195375|Hormones|hormones|mesh-ancestor
83162664|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162665|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
83162666|NCT03531931|Apatinib|apatinib|mesh-list
83162667|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162668|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83162669|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162670|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162671|NCT03601455|Durvalumab|durvalumab|mesh-list
83162672|NCT03601455|Ipilimumab|ipilimumab|mesh-list
83162673|NCT03601455|Tremelimumab|tremelimumab|mesh-list
83162674|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
83162675|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83162676|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
83162677|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83162678|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162679|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
83162680|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162681|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83162682|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162683|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83162684|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83162685|NCT02369133|Acetaminophen|acetaminophen|mesh-list
83162686|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83162687|NCT02369133|Analgesics|analgesics|mesh-ancestor
83162688|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
83162689|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162690|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162691|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
83162692|NCT02377635|Selenious Acid|selenious acid|mesh-list
83162693|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
83162694|NCT02377635|Trace Elements|trace elements|mesh-ancestor
83162695|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
83162696|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162697|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
83162698|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
83162699|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162700|NCT02198027|Bupivacaine|bupivacaine|mesh-list
83162701|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
83162702|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
83162703|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162704|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162705|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
83162706|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162707|NCT02257463|Theophylline|theophylline|mesh-list
83162708|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
83162709|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
83162710|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162711|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162712|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83162713|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
83162714|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162715|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162716|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83162717|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162718|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
83162719|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83162720|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83162721|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
83162723|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162724|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
83162725|NCT03533699|Propranolol|propranolol|mesh-list
83162726|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83162727|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83162728|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
83162729|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162730|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162731|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162732|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83162733|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162734|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
83162735|NCT00135421|Escitalopram|escitalopram|mesh-list
83162736|NCT00135421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83162737|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83162738|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83162739|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162740|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162741|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
83162742|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162743|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
83162744|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83162745|NCT02200991|Lixisenatide|lixisenatide|mesh-list
83162746|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83162747|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162748|NCT02200991|Incretins|incretins|mesh-ancestor
83162749|NCT02200991|Hormones|hormones|mesh-ancestor
83162750|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162751|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83162752|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
83162753|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162754|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162755|NCT01979367|Analgesics|analgesics|mesh-list
83162756|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
83162757|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162758|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162759|NCT02368743|Mesalamine|mesalamine|mesh-list
83162760|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83162761|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83162762|NCT02368743|Analgesics|analgesics|mesh-ancestor
83162763|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
83162764|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162765|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162766|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162767|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83162768|NCT00135343|Ritonavir|ritonavir|mesh-list
83162769|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83162770|NCT00135343|Efavirenz|efavirenz|mesh-list
83162771|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83162772|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83162773|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
83162774|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162775|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162776|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83162778|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
83162779|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162780|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83162781|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83162782|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83162783|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83162784|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83162785|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83162786|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83162787|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83162788|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83162789|NCT02201225|Micronutrients|micronutrients|mesh-list
83162790|NCT02201225|Trace Elements|trace elements|mesh-list
83162791|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162792|NCT02365155|Vitamin D|vitamin d|mesh-list
83162793|NCT02365155|Vitamins|vitamins|mesh-ancestor
83162794|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
83162795|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162796|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83162797|NCT05724745|Albuterol|albuterol|mesh-list
83162798|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83162799|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
83162800|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162801|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162802|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83162803|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
83162804|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
83162805|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83162806|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83162807|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83162808|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83162809|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
83162810|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162811|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162812|NCT02198339|Olcegepant|olcegepant|mesh-list
83162813|NCT02198339|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83162814|NCT02198339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162816|NCT02198339|Sensory System Agents|sensory system agents|mesh-ancestor
83162817|NCT02198339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162818|NCT02198339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162819|NCT02198807|Piperaquine|piperaquine|mesh-list
83162820|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
83162821|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
83162822|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83162823|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83162824|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162825|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83162826|NCT02198417|Metformin|metformin|mesh-list
83162827|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83162828|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162829|NCT02201459|Interferons|interferons|mesh-list
83162830|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
83162831|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
83162832|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83162833|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162834|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
83162835|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162836|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
83162837|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162838|NCT05724589|Mitogens|mitogens|mesh-list
83162839|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83162840|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162841|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83162842|NCT02198495|Hematinics|hematinics|mesh-ancestor
83162843|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83162844|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83162845|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83162846|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
83162847|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162848|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
83162849|NCT02375217|Neostigmine|neostigmine|mesh-list
83162850|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83162851|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162852|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162853|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
83162854|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162855|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162856|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83162857|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
83162858|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162859|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83162860|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83162861|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83162862|NCT02206295|Selexipag|selexipag|mesh-list
83162863|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83162864|NCT02375139|Metformin|metformin|mesh-list
83162865|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83162866|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162867|NCT02202005|Nevirapine|nevirapine|mesh-list
83162868|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83162869|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83162870|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162871|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162872|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
83162873|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162874|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83162875|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83162876|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83162877|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83162878|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83162879|NCT02741245|Ezetimibe|ezetimibe|mesh-list
83162880|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83162881|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83162882|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
83162883|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162884|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83162885|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83162886|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162887|NCT02202239|Fentanyl|fentanyl|mesh-list
83162888|NCT02202239|Midazolam|midazolam|mesh-list
83162889|NCT02202239|Remifentanil|remifentanil|mesh-list
83162890|NCT02202239|Propofol|propofol|mesh-list
83162891|NCT02202239|Etomidate|etomidate|mesh-list
83162892|NCT02202239|Sevoflurane|sevoflurane|mesh-list
83162893|NCT02202239|Cisatracurium|cisatracurium|mesh-list
83162894|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83162895|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162896|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162897|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83162898|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
83162899|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
83162900|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83162901|NCT02202239|Narcotics|narcotics|mesh-ancestor
83162902|NCT02202239|Analgesics|analgesics|mesh-ancestor
83162903|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
83162904|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162905|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83162906|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83162907|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83162908|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83162909|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
83162910|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
83162911|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83162912|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162913|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83162914|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83162915|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83162916|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83162917|NCT02368197|Paclitaxel|paclitaxel|mesh-list
83162918|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83162919|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162920|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83162921|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83162922|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83162923|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162924|NCT02364765|Remifentanil|remifentanil|mesh-list
83162925|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83162926|NCT02364765|Narcotics|narcotics|mesh-ancestor
83162927|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162928|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162929|NCT02364765|Analgesics|analgesics|mesh-ancestor
83162930|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
83162931|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162932|NCT03529201|Fentanyl|fentanyl|mesh-list
83162933|NCT03529201|Oxycodone|oxycodone|mesh-list
83162934|NCT03529201|Sevoflurane|sevoflurane|mesh-list
83162935|NCT03529201|Rocuronium|rocuronium|mesh-list
83162936|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83162937|NCT03529201|Narcotics|narcotics|mesh-ancestor
83162938|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83162939|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162940|NCT03529201|Analgesics|analgesics|mesh-ancestor
83162941|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
83162942|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162943|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83162944|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83162945|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
83162946|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
83162947|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83162948|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83162949|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83162950|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83162951|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83162952|NCT04547049|Cytarabine|cytarabine|mesh-list
83162953|NCT04547049|Cyclosporine|cyclosporine|mesh-list
83162954|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
83162955|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
83162956|NCT04547049|Busulfan|busulfan|mesh-list
83162957|NCT04547049|Cyclosporins|cyclosporins|mesh-list
83162958|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83162959|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
83162960|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83162961|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
83162962|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162963|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83162964|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83162965|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
83162966|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83162967|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83162968|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83162969|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83162970|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
83162971|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
83162972|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83162973|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83162974|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
83162975|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
83162976|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83162977|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83162978|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83162979|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
83162980|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83162981|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
83162982|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83162983|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
83162984|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
83162985|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162986|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162987|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83162988|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
83162989|NCT05647291|Hormones|hormones|mesh-ancestor
83162990|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83162991|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83162992|NCT05647291|Protective Agents|protective agents|mesh-ancestor
83162993|NCT03105765|Ketamine|ketamine|mesh-list
83162994|NCT03105765|Analgesics|analgesics|mesh-ancestor
83162995|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
83162996|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83162997|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83162998|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83162999|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83163000|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
83163001|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
83163002|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163003|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83163004|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83163005|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163006|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163007|NCT02202473|Lamivudine|lamivudine|mesh-list
83163008|NCT02202473|Oxymatrine|oxymatrine|mesh-list
83163009|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83163010|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83163011|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163012|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163013|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
83163014|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163015|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83163016|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83163017|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83163018|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
83163019|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163020|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83163021|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163022|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163023|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
83163024|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163025|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163026|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83163027|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83163028|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83163029|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163030|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163031|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163032|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163033|NCT02202707|Gabapentin|gabapentin|mesh-list
83163034|NCT02202707|Analgesics|analgesics|mesh-ancestor
83163035|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
83163036|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163037|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163038|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
83163039|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83163040|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83163041|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163042|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83163043|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83163044|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83163046|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163047|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
83163048|NCT02367807|Tenofovir|tenofovir|mesh-list
83163049|NCT02367807|Emtricitabine|emtricitabine|mesh-list
83163050|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
83163051|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163052|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83163053|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83163054|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163055|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163056|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83163057|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83163058|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
83163059|NCT02364609|Afatinib|afatinib|mesh-list
83163060|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163061|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163062|NCT02364609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163063|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163064|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163065|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163066|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83163067|NCT02364453|Growth Substances|growth substances|mesh-ancestor
83163068|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163069|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
83163070|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163071|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163072|NCT02258009|Ranibizumab|ranibizumab|mesh-list
83163073|NCT02258009|Aflibercept|aflibercept|mesh-list
83163074|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83163075|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83163076|NCT02258009|Growth Substances|growth substances|mesh-ancestor
83163077|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163078|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
83163079|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163080|NCT02203097|Propofol|propofol|mesh-list
83163081|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83163082|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163083|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163084|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83163085|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
83163086|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
83163087|NCT04439487|Anesthetics|anesthetics|mesh-list
83163088|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163089|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163090|NCT03528967|Aspirin|aspirin|mesh-list
83163091|NCT03528967|Enoxaparin|enoxaparin|mesh-list
83163092|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83163093|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83163094|NCT03528967|Analgesics|analgesics|mesh-ancestor
83163095|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
83163096|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163097|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163098|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163099|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163100|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83163101|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83163102|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163103|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83163104|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83163105|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163106|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
83163107|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
83163108|NCT02363985|Vitamin A|vitamin a|mesh-list
83163109|NCT02363985|Vitamins|vitamins|mesh-ancestor
83163110|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
83540742|NCT03816358|Immunoconjugates|immunoconjugates|mesh-ancestor
83163111|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163113|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83163114|NCT02363829|Nelfinavir|nelfinavir|mesh-list
83163115|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83163116|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83163117|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
83163118|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163119|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163120|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83163121|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83163122|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
83163123|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163124|NCT03113019|Immunomodulating Agents|immunomodulating agents|mesh-list
83163125|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
83163126|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163127|NCT02363751|Bevacizumab|bevacizumab|mesh-list
83163128|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163129|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163130|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83163131|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83163132|NCT02363751|Growth Substances|growth substances|mesh-ancestor
83163133|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163134|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
83163135|NCT03240861|Aldesleukin|aldesleukin|mesh-list
83163136|NCT03240861|Plerixafor|plerixafor|mesh-list
83163137|NCT03240861|Fludarabine|fludarabine|mesh-list
83163138|NCT03240861|Busulfan|busulfan|mesh-list
83163139|NCT03240861|Interleukin-2|interleukin-2|mesh-list
83163140|NCT03240861|Lenograstim|lenograstim|mesh-list
83163141|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163142|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163143|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163144|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
83163145|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163146|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83163147|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
83163148|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83163149|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83163150|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83163151|NCT03240861|Analgesics|analgesics|mesh-ancestor
83163152|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
83163153|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163154|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83163155|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83163156|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
83163157|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163158|NCT03527251|Ipilimumab|ipilimumab|mesh-list
83163159|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163160|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163161|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163162|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163163|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
83163164|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
83163165|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163166|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
83163167|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
83163168|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
83163169|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163170|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163171|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
83163172|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163173|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
83163174|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163175|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163176|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163177|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163178|NCT04594915|Edoxaban|edoxaban|mesh-list
83163179|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83163180|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
83163181|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83163182|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
83163183|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163184|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163185|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
83163186|NCT04546633|Lumefantrine|lumefantrine|mesh-list
83163187|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
83163188|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83163189|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83163190|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163191|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
83163192|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83163193|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
83163194|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83163195|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
83163196|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163197|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163198|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
83163199|NCT04462471|Vemurafenib|vemurafenib|mesh-list
83163200|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163201|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163202|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163203|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163204|NCT02366949|Paclitaxel|paclitaxel|mesh-list
83163205|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83163206|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163207|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
83163208|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
83163209|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
83163210|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163211|NCT03532919|Cystatins|cystatins|mesh-list
83163212|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83163213|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
83163214|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163215|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163216|NCT05503225|Colchicine|colchicine|mesh-list
83163217|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
83163218|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163219|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83163220|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83163221|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83163222|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163223|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163224|NCT02203175|Fentanyl|fentanyl|mesh-list
83163225|NCT02203175|Propofol|propofol|mesh-list
83163226|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83163227|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163228|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163229|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83163230|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
83163231|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
83163232|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83163233|NCT02203175|Narcotics|narcotics|mesh-ancestor
83163234|NCT02203175|Analgesics|analgesics|mesh-ancestor
83163235|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
83163236|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163237|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83163238|NCT05791799|Etonogestrel|etonogestrel|mesh-list
83163239|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83163240|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
83163241|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83163242|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163243|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83163244|NCT05791721|Dexamethasone|dexamethasone|mesh-list
83163245|NCT05791721|Etoricoxib|etoricoxib|mesh-list
83163246|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163247|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
83163248|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
83163249|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163250|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163251|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83163252|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
83163253|NCT05791721|Hormones|hormones|mesh-ancestor
83163254|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163255|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163256|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163257|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83163258|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83163259|NCT05791721|Analgesics|analgesics|mesh-ancestor
83163260|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
83163261|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163262|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83163263|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83163264|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163265|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163266|NCT05791669|Listerine|listerine|mesh-list
83163267|NCT05791669|Fluorides|fluorides|mesh-list
83163268|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
83163269|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
83163270|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
83163271|NCT05791669|Protective Agents|protective agents|mesh-ancestor
83163272|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163273|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83163274|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163275|NCT05791487|Budesonide|budesonide|mesh-list
83163276|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163277|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83163278|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
83163279|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163280|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163281|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83163282|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
83163283|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
83163284|NCT05791487|Hormones|hormones|mesh-ancestor
83163285|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163286|NCT05791409|Venetoclax|venetoclax|mesh-list
83163287|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163288|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83163289|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
83163290|NCT05791136|Immunomodulating Agents|immunomodulating agents|mesh-list
83163291|NCT05791136|Immunologic Factors|immunologic factors|mesh-ancestor
83163292|NCT05791136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163293|NCT05791097|Paclitaxel|paclitaxel|mesh-list
83163294|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83163295|NCT05791097|Carboplatin|carboplatin|mesh-list
83163296|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
83163297|NCT05791097|Pemetrexed|pemetrexed|mesh-list
83163298|NCT05791097|Tislelizumab|tislelizumab|mesh-list
83163299|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83163300|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163301|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
83163302|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
83163303|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
83163304|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163305|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163306|NCT05791097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163307|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163308|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83163309|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83163310|NCT05791058|Anesthetics|anesthetics|mesh-list
83163311|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163312|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163313|NCT05790941|Minoxidil|minoxidil|mesh-list
83163314|NCT05790941|Latanoprost|latanoprost|mesh-list
83163315|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83163316|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83163317|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83163318|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
83163319|NCT05790902|Tamsulosin|tamsulosin|mesh-list
83163320|NCT05790902|Silodosin|silodosin|mesh-list
83163321|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83163322|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83163323|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83163324|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83163325|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163326|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163327|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163328|NCT05790902|Urological Agents|urological agents|mesh-ancestor
83163329|NCT05790720|Propofol|propofol|mesh-list
83163330|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83163331|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163332|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163333|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83163334|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
83163335|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
83163336|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
83163337|NCT05790629|Calcium|calcium|mesh-list
83163338|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83163339|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163340|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83163341|NCT05790603|Hemostatics|hemostatics|mesh-list
83163342|NCT05790603|Coagulants|coagulants|mesh-ancestor
83163343|NCT05790525|Bismuth|bismuth|mesh-list
83163344|NCT05790525|Antacids|antacids|mesh-ancestor
83163345|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163346|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83163348|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83163349|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83163350|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
83163351|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163352|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83163353|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83163354|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163355|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83163356|NCT05790447|Thymalfasin|thymalfasin|mesh-list
83163357|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83163358|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
83163359|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163360|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163361|NCT05790447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163362|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163363|NCT05790330|Methotrexate|methotrexate|mesh-list
83163364|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83163365|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
83163366|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83163367|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163368|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83163369|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
83163370|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163371|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163372|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
83163373|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163374|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83163375|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163376|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
83163377|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163378|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83163379|NCT05790239|Amphetamine|amphetamine|mesh-list
83163380|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
83163381|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83163382|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83163383|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163384|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
83163385|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
83163386|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163387|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
83163388|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163389|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163390|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
83163391|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83163392|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83163393|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83163394|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83163395|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
83163396|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83163397|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
83163398|NCT05786716|Trastuzumab|trastuzumab|mesh-list
83163399|NCT05786716|Pertuzumab|pertuzumab|mesh-list
83163400|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163401|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163402|NCT05786599|Methadone|methadone|mesh-list
83163403|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83163404|NCT05786599|Narcotics|narcotics|mesh-ancestor
83163405|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163406|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163407|NCT05786599|Analgesics|analgesics|mesh-ancestor
83163408|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
83163409|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163410|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
83163411|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
83163412|NCT05768178|Vemurafenib|vemurafenib|mesh-list
83163413|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163414|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163415|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163416|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163417|NCT05746481|Carboplatin|carboplatin|mesh-list
83163418|NCT05746481|Pemetrexed|pemetrexed|mesh-list
83163419|NCT05746481|Atezolizumab|atezolizumab|mesh-list
83163420|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163421|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163422|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163423|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83163424|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83163425|NCT05746481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163426|NCT05746481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163427|NCT05704725|Aflibercept|aflibercept|mesh-list
83163428|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83163429|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83163430|NCT05704725|Growth Substances|growth substances|mesh-ancestor
83163431|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163432|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
83163433|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163434|NCT05683444|Octreotide|octreotide|mesh-list
83163435|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83163436|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163437|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163438|NCT05681195|Pemetrexed|pemetrexed|mesh-list
83163439|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
83163440|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163441|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163442|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163443|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83163444|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83163445|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163446|NCT05669274|Caseins|caseins|mesh-list
83163447|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
83163448|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
83163449|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163450|NCT05667090|Vitamin D|vitamin d|mesh-list
83163451|NCT05667090|Vitamins|vitamins|mesh-ancestor
83163452|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
83163453|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163454|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83163455|NCT05647343|Ciclopirox|ciclopirox|mesh-list
83163456|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
83163457|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163458|NCT05644561|Ravulizumab|ravulizumab|mesh-list
83163459|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83163460|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163461|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
83163462|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163463|NCT05643170|Xanomeline|xanomeline|mesh-list
83163464|NCT05643170|Trospium chloride|trospium chloride|mesh-list
83163465|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
83163466|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
83163467|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163468|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163469|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83163470|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83163471|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
83163472|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163473|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163474|NCT05643170|Urological Agents|urological agents|mesh-ancestor
83163475|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83163476|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83163477|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83163478|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83163479|NCT05559879|Dostarlimab|dostarlimab|mesh-list
83163480|NCT05559879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163481|NCT05553392|Petrolatum|petrolatum|mesh-list
83163482|NCT05553392|Emollients|emollients|mesh-ancestor
83163483|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
83163484|NCT05530421|Dexamethasone|dexamethasone|mesh-list
83163485|NCT05530421|Venetoclax|venetoclax|mesh-list
83163486|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163487|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
83163488|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
83163489|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163490|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163491|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83163492|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
83163493|NCT05530421|Hormones|hormones|mesh-ancestor
83163494|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163495|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163496|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163497|NCT05523596|Benzonidazole|benzonidazole|mesh-list
83163498|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163499|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
83163500|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163501|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83163502|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83163503|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83163504|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163505|NCT05518734|Itraconazole|itraconazole|mesh-list
83163507|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83163508|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83163509|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163510|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163511|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83163512|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83163513|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83163514|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83163515|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
83163516|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
83163517|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
83163518|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
83163519|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163520|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163521|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
83163522|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163523|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83163524|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83163525|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163526|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83163527|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
83163528|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163529|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83163530|NCT05513365|Goserelin|goserelin|mesh-list
83163531|NCT05513365|Bicalutamide|bicalutamide|mesh-list
83163532|NCT05513365|Dutasteride|dutasteride|mesh-list
83163533|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163534|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163535|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
83163536|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
83163537|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163538|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163539|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83163540|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83163541|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163542|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163543|NCT05442749|Niraparib|niraparib|mesh-list
83163544|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83163545|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163546|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163547|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163548|NCT05370911|Psilocybin|psilocybin|mesh-list
83163549|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
83163550|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163551|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83163552|NCT05361655|Palbociclib|palbociclib|mesh-list
83163553|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83163554|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163555|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163556|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163557|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163558|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83163559|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83163560|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
83163561|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163562|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163563|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
83163564|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83163565|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163566|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
83163567|NCT05320887|Nicotine|nicotine|mesh-list
83163568|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83163569|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
83163570|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163571|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163572|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83163573|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83163574|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
83163575|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83540743|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
83163576|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163577|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83163578|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
83163579|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163580|NCT05308056|Anesthetics|anesthetics|mesh-list
83163581|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163582|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163583|NCT05276284|Atezolizumab|atezolizumab|mesh-list
83163584|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
83163585|NCT05276284|Thioguanine|thioguanine|mesh-list
83163586|NCT05276284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163587|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163588|NCT05276284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163589|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163590|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
83163591|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83163592|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163593|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
83163594|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163595|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83163596|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163597|NCT05244226|Fentanyl|fentanyl|mesh-list
83163598|NCT05244226|Methadone|methadone|mesh-list
83163599|NCT05244226|Hydromorphone|hydromorphone|mesh-list
83163600|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83163601|NCT05244226|Narcotics|narcotics|mesh-ancestor
83163602|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163603|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163604|NCT05244226|Analgesics|analgesics|mesh-ancestor
83163605|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
83163606|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163607|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83163608|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83163609|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
83163610|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
83163611|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
83163612|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
83163613|NCT05237960|Metformin|metformin|mesh-list
83163614|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83163615|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163616|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
83163617|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83163618|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163619|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83163620|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163621|NCT05144698|Sirolimus|sirolimus|mesh-list
83163622|NCT05144698|Temsirolimus|temsirolimus|mesh-list
83163623|NCT05144698|MTOR Inhibitors|mtor inhibitors|mesh-list
83163624|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83163625|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163626|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83163627|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163628|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
83163629|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163630|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
83163631|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163632|NCT05144698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83163633|NCT05144698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163634|NCT05144698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163635|NCT05122182|Propagermanium|propagermanium|mesh-list
83163636|NCT05122182|Candesartan|candesartan|mesh-list
83163637|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
83163638|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83163639|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83163640|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83163641|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163642|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163643|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
83163644|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
83163645|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163646|NCT05065801|Folfirinox|folfirinox|mesh-list
83163647|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163648|NCT05045066|Vitamin D|vitamin d|mesh-list
83163649|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
83163650|NCT05045066|Vitamins|vitamins|mesh-ancestor
83163651|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
83163652|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163653|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83163654|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83163655|NCT04995484|Belzutifan|belzutifan|mesh-list
83163656|NCT04995484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163657|NCT04994522|Belzutifan|belzutifan|mesh-list
83163658|NCT04994522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163659|NCT04979442|Trabectedin|trabectedin|mesh-list
83163660|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83163661|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
83163662|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163663|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163664|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
83163665|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
83163666|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
83163667|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163668|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163669|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
83163670|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163671|NCT04910061|Niacinamide|niacinamide|mesh-list
83163672|NCT04910061|Niacin|niacin|mesh-list
83163673|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
83163674|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
83163675|NCT04910061|Vitamins|vitamins|mesh-ancestor
83163677|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163678|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83163679|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
83163680|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163681|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83163682|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
83163683|NCT04892264|Dexamethasone|dexamethasone|mesh-list
83163684|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
83163685|NCT04892264|Lenalidomide|lenalidomide|mesh-list
83163686|NCT04892264|Daratumumab|daratumumab|mesh-list
83163687|NCT04892264|Ichthammol|ichthammol|mesh-list
83163688|NCT04892264|BB 1101|bb 1101|mesh-list
83163689|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163690|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
83163691|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
83163692|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163693|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163694|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83163695|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
83163696|NCT04892264|Hormones|hormones|mesh-ancestor
83163697|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163698|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163699|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163700|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
83163701|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163702|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163703|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
83163704|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83163705|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83163706|NCT04892264|Growth Substances|growth substances|mesh-ancestor
83163707|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
83163708|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
83163709|NCT04887467|Apomorphine|apomorphine|mesh-list
83163710|NCT04887467|Emetics|emetics|mesh-ancestor
83163711|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163712|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
83163713|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163714|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83163715|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
83163716|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
83163717|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163718|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163719|NCT04868409|Rocuronium|rocuronium|mesh-list
83163720|NCT04868409|Succinylcholine|succinylcholine|mesh-list
83163721|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83163722|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83163723|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83163724|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163725|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163726|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83163728|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83163729|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163730|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83163731|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163732|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
83163733|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163734|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
83163735|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163736|NCT04846335|Doxycycline|doxycycline|mesh-list
83163737|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83163738|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163739|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
83163740|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83163741|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83163742|NCT04817241|Cytarabine|cytarabine|mesh-list
83163743|NCT04817241|Decitabine|decitabine|mesh-list
83163744|NCT04817241|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83163745|NCT04817241|Daunorubicin|daunorubicin|mesh-list
83163746|NCT04817241|Venetoclax|venetoclax|mesh-list
83163747|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83163748|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
83163749|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163750|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163751|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
83163752|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163753|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163754|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
83163755|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163756|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83163757|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83163758|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83163759|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163760|NCT04796220|Gemcitabine|gemcitabine|mesh-list
83163761|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83163762|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
83163763|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163764|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163765|NCT04777045|Diltiazem|diltiazem|mesh-list
83163766|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83163767|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83163768|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83163769|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163770|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83163771|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163772|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
83163773|NCT04632238|Metronidazole|metronidazole|mesh-list
83163774|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163775|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83163776|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83163777|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83163778|NCT04597190|Norepinephrine|norepinephrine|mesh-list
83163780|NCT04597190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83163781|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83163782|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83163783|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
83163784|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163785|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163786|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163787|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
83163788|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
83163789|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163790|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83163791|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83163792|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
83163793|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83163794|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83163795|NCT04577638|Nivolumab|nivolumab|mesh-list
83163796|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163797|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163798|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83362178|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83163799|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163800|NCT04529772|Prednisone|prednisone|mesh-list
83163801|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
83163802|NCT04529772|Rituximab|rituximab|mesh-list
83163803|NCT04529772|Doxorubicin|doxorubicin|mesh-list
83163804|NCT04529772|Vincristine|vincristine|mesh-list
83163805|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
83163806|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83163807|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
83163808|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163809|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163810|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83163811|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
83163812|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163813|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163814|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83163815|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163816|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83163817|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83163818|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83163819|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163820|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163821|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
83163822|NCT04529772|Hormones|hormones|mesh-ancestor
83163823|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163824|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163825|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83163826|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83163827|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83163828|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83163829|NCT04517799|Cannabidiol|cannabidiol|mesh-list
83163830|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
83163831|NCT04495296|Paclitaxel|paclitaxel|mesh-list
83163832|NCT04495296|Gemcitabine|gemcitabine|mesh-list
83163833|NCT04495296|Capecitabine|capecitabine|mesh-list
83163834|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
83163835|NCT04495296|Nivolumab|nivolumab|mesh-list
83163836|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83163837|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163838|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
83163839|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
83163840|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
83163841|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163842|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83163843|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
83163844|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163845|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163846|NCT04404062|Antibodies|antibodies|mesh-list
83163847|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
83163848|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
83163849|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163850|NCT04352777|Fulvestrant|fulvestrant|mesh-list
83163851|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83163852|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163853|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163854|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83163855|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83163856|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
83163857|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163858|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163859|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83163860|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163861|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163862|NCT04276363|Nicotine|nicotine|mesh-list
83163863|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83163864|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
83163865|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163866|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163867|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83163868|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83163869|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
83163870|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163871|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163872|NCT04260854|Bupivacaine|bupivacaine|mesh-list
83163873|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
83163874|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
83163875|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83163876|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163877|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
83163878|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163879|NCT04147546|Artenimol|artenimol|mesh-list
83163880|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
83163881|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83163882|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83163883|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163884|NCT04141579|Evolocumab|evolocumab|mesh-list
83163885|NCT04141579|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83163886|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83163887|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83163888|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
83163889|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163890|NCT04141579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83163891|NCT04141579|Protease Inhibitors|protease inhibitors|mesh-ancestor
83163892|NCT04141579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163893|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83163894|NCT04095689|Docetaxel|docetaxel|mesh-list
83163895|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
83163896|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163897|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83163898|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83163899|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83163900|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163901|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163902|NCT04095689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163903|NCT04059484|Tamoxifen|tamoxifen|mesh-list
83163904|NCT04059484|Letrozole|letrozole|mesh-list
83163905|NCT04059484|Fulvestrant|fulvestrant|mesh-list
83163906|NCT04059484|Anastrozole|anastrozole|mesh-list
83163907|NCT04059484|Exemestane|exemestane|mesh-list
83163908|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163909|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83163910|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83163911|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163912|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163913|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83163915|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83163916|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163917|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83163918|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83163919|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83163920|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83163921|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83163922|NCT04038502|Carboplatin|carboplatin|mesh-list
83163923|NCT04038502|Olaparib|olaparib|mesh-list
83163924|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163925|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83163926|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163927|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163928|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83163929|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83163930|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163931|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163932|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83163933|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83163934|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163935|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
83163936|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83163937|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
83163938|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163939|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163940|NCT03867175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163941|NCT03867175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163942|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83163943|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
83163944|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83163945|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
83163946|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163947|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163948|NCT03849469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163949|NCT03849469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163950|NCT03816397|Adalimumab|adalimumab|mesh-list
83163951|NCT03816397|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83163952|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163953|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163954|NCT03805607|Ketorolac|ketorolac|mesh-list
83163955|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83163956|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83163957|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83163958|NCT03805607|Analgesics|analgesics|mesh-ancestor
83163959|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
83163960|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83163961|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163962|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83163963|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163964|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83163965|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83163966|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163967|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83163968|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
83163969|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163970|NCT03671018|Rituximab|rituximab|mesh-list
83163971|NCT03671018|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83163972|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163973|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163974|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
83163975|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163976|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83163977|NCT03671018|Immunoconjugates|immunoconjugates|mesh-ancestor
83163978|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83163979|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163980|NCT03514368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163981|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163982|NCT03496766|Tipifarnib|tipifarnib|mesh-list
83163983|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163984|NCT03484819|Nivolumab|nivolumab|mesh-list
83163985|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83163986|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83163987|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83163988|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83163989|NCT03467789|Vitamin D|vitamin d|mesh-list
83163990|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
83163991|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
83163992|NCT03467789|Vitamins|vitamins|mesh-list
83163993|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
83163994|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83163995|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83163996|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83163997|NCT03406715|Nivolumab|nivolumab|mesh-list
83163998|NCT03406715|Ipilimumab|ipilimumab|mesh-list
83163999|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164000|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164001|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83164002|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164003|NCT03363763|Sirolimus|sirolimus|mesh-list
83164004|NCT03363763|Temsirolimus|temsirolimus|mesh-list
83164005|NCT03363763|MTOR Inhibitors|mtor inhibitors|mesh-list
83164006|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164007|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164008|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164009|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164010|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
83164011|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164012|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
83164013|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164014|NCT03363763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83164015|NCT03363763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164016|NCT03363763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164017|NCT03224507|Dexamethasone|dexamethasone|mesh-list
83164018|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
83164019|NCT03224507|Lenalidomide|lenalidomide|mesh-list
83164020|NCT03224507|Daratumumab|daratumumab|mesh-list
83164021|NCT03224507|BB 1101|bb 1101|mesh-list
83164022|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83164023|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164024|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
83164026|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164027|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164028|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83164029|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
83164030|NCT03224507|Hormones|hormones|mesh-ancestor
83164031|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164032|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83164033|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164034|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
83164035|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164036|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164037|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
83164038|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83164039|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83164040|NCT03224507|Growth Substances|growth substances|mesh-ancestor
83164041|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
83164042|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
83164043|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83164044|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83164045|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164046|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
83164047|NCT03182751|Coagulants|coagulants|mesh-ancestor
83164048|NCT03105245|Thiopental|thiopental|mesh-list
83164049|NCT03105245|Anesthetics|anesthetics|mesh-list
83164050|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164051|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164052|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
83164053|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83164054|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83164055|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
83164056|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
83164057|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
83164058|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164059|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164060|NCT03057106|Durvalumab|durvalumab|mesh-list
83164061|NCT03057106|Tremelimumab|tremelimumab|mesh-list
83164062|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164063|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164064|NCT03020199|Betamethasone|betamethasone|mesh-list
83164065|NCT03020199|Calcipotriene|calcipotriene|mesh-list
83164066|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83164067|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164068|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
83164069|NCT03020199|Hormones|hormones|mesh-ancestor
83164070|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164071|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164072|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83164073|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
83164074|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
83164075|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
83164076|NCT03019588|Paclitaxel|paclitaxel|mesh-list
83164077|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
83164078|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164079|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164080|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164081|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164082|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164083|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164084|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164085|NCT03019588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83164086|NCT02959944|Prednisone|prednisone|mesh-list
83164087|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164088|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
83164089|NCT02959944|Hormones|hormones|mesh-ancestor
83164090|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164091|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164092|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83164093|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164094|NCT02823002|Lidocaine|lidocaine|mesh-list
83164095|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
83164096|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
83164097|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164098|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164099|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
83164100|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164101|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83164102|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83164103|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83164104|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83164105|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164106|NCT02806687|Gemcitabine|gemcitabine|mesh-list
83164107|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83164108|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
83164109|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164110|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164111|NCT02581137|Metformin|metformin|mesh-list
83164112|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83164113|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164114|NCT02559180|Aflibercept|aflibercept|mesh-list
83164115|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83164116|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83164117|NCT02559180|Growth Substances|growth substances|mesh-ancestor
83164118|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164119|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
83164120|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164121|NCT02539966|Sirolimus|sirolimus|mesh-list
83164122|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164123|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164124|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164125|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164126|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
83164127|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164128|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
83164129|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164130|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83164131|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83164132|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164133|NCT02455557|Temozolomide|temozolomide|mesh-list
83164134|NCT02455557|Sargramostim|sargramostim|mesh-list
83164135|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83164136|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83164137|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
83164138|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164139|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164140|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
83164141|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164142|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83164143|NCT02401139|Ketamine|ketamine|mesh-list
83164144|NCT02401139|Analgesics|analgesics|mesh-ancestor
83164145|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
83164146|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164147|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164148|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83164149|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83164150|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
83164151|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
83164152|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164153|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83164154|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83164155|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164156|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164157|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
83164158|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83164159|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83164160|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164161|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
83164162|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
83164163|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164164|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
83164166|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
83164167|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83164168|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83164169|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164170|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83164171|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83164172|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
83164173|NCT02195895|Vitamin D|vitamin d|mesh-list
83164174|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
83164175|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
83164176|NCT02195895|Alendronate|alendronate|mesh-list
83164177|NCT02195895|Vitamins|vitamins|mesh-list
83164178|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
83164179|NCT02195895|Antacids|antacids|mesh-list
83164180|NCT02195895|Calcium|calcium|mesh-list
83164181|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
83164182|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164183|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83164184|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83164185|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164186|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83164187|NCT01970722|Paclitaxel|paclitaxel|mesh-list
83164188|NCT01970722|Cisplatin|cisplatin|mesh-list
83164189|NCT01970722|Carboplatin|carboplatin|mesh-list
83164190|NCT01970722|Gemcitabine|gemcitabine|mesh-list
83164191|NCT01970722|Doxorubicin|doxorubicin|mesh-list
83164192|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83164193|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83164194|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164195|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164196|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164197|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164198|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164199|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164200|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83164201|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
83164202|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164203|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83164204|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83164205|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164206|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
83164207|NCT01953900|Fludarabine|fludarabine|mesh-list
83164208|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164209|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
83164210|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164211|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164212|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83164213|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
83164214|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164215|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164216|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83164217|NCT01913951|Azacitidine|azacitidine|mesh-list
83164218|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83164219|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
83164220|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164221|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164222|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164223|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
83164224|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83164225|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83164226|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
83164227|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164228|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83164229|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83164230|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164231|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164232|NCT01709136|Sirolimus|sirolimus|mesh-list
83164233|NCT01709136|Temsirolimus|temsirolimus|mesh-list
83164234|NCT01709136|MTOR Inhibitors|mtor inhibitors|mesh-list
83164235|NCT01709136|Tacrolimus|tacrolimus|mesh-list
83164236|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164237|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
83164238|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164239|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83164240|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164241|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164242|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164243|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164244|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164245|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164246|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
83164247|NCT01709136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83164248|NCT01570868|Ponatinib|ponatinib|mesh-list
83164249|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164250|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83164251|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164252|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164254|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164255|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164256|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164257|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164258|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164259|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164260|NCT01371630|Cytarabine|cytarabine|mesh-list
83164261|NCT01371630|Dexamethasone|dexamethasone|mesh-list
83164262|NCT01371630|Prednisone|prednisone|mesh-list
83164263|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
83164264|NCT01371630|Rituximab|rituximab|mesh-list
83164266|NCT01371630|Vincristine|vincristine|mesh-list
83164267|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
83164268|NCT01371630|Blinatumomab|blinatumomab|mesh-list
83164269|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83164270|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164271|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
83164272|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164273|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164274|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83164275|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
83164276|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164277|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164278|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83164279|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164280|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164281|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
83164282|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
83164283|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164284|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83164285|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
83164286|NCT01371630|Hormones|hormones|mesh-ancestor
83164287|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164288|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83164289|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83164290|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
83164291|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83164292|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83164293|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
83164294|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
83164295|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164296|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83164297|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83164298|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
83164299|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164300|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164301|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164302|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164303|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164304|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164305|NCT01371630|Immunotoxins|immunotoxins|mesh-ancestor
83164306|NCT01371630|Immunoconjugates|immunoconjugates|mesh-ancestor
83164307|NCT01036087|Paclitaxel|paclitaxel|mesh-list
83164309|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
83164310|NCT01036087|Carboplatin|carboplatin|mesh-list
83164311|NCT01036087|Fluorouracil|fluorouracil|mesh-list
83164312|NCT01036087|Epirubicin|epirubicin|mesh-list
83164313|NCT01036087|Panitumumab|panitumumab|mesh-list
83164314|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164315|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164316|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164317|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164318|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164319|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164320|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164321|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
83164322|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164323|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164324|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83164325|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
83164326|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83164327|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
83164328|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83164329|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164330|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83164331|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83164332|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164333|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164334|NCT00783367|Dexamethasone|dexamethasone|mesh-list
83164335|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
83164336|NCT00783367|Rituximab|rituximab|mesh-list
83164337|NCT00783367|Lenalidomide|lenalidomide|mesh-list
83164338|NCT00783367|BB 1101|bb 1101|mesh-list
83164339|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164340|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164341|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
83164342|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164343|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164344|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164345|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
83164346|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
83164347|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164348|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83164349|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
83164350|NCT00783367|Hormones|hormones|mesh-ancestor
83164351|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164352|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83164353|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
83164354|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164355|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164356|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83164357|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83164358|NCT00783367|Growth Substances|growth substances|mesh-ancestor
83164359|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
83164360|NCT00572156|Mecasermin|mecasermin|mesh-list
83164361|NCT00572156|Growth Substances|growth substances|mesh-ancestor
83164362|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164363|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
83164364|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83164365|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83164366|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83164367|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83164368|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164369|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
83164370|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164371|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164372|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83164373|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164374|NCT00255216|Policosanol|policosanol|mesh-list
83164375|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83164376|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83164377|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
83164378|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164379|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83164380|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83164381|NCT00079066|Cetuximab|cetuximab|mesh-list
83164382|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164383|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164384|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
83164385|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83164386|NCT02257697|Mizoribine|mizoribine|mesh-list
83164387|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
83164388|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164389|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
83164390|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164391|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164392|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83164393|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
83164394|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164395|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164396|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83164397|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83164398|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83164399|NCT02257697|Analgesics|analgesics|mesh-ancestor
83164400|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
83164401|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164402|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164403|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164404|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164405|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164406|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
83164407|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83164408|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83164409|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164410|NCT04468711|Vitamin D|vitamin d|mesh-list
83164411|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
83164412|NCT04468711|Vitamins|vitamins|mesh-ancestor
83164413|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
83164414|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164415|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83164416|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164417|NCT02207387|Rasagiline|rasagiline|mesh-list
83164418|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83164419|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164420|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164421|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83164422|NCT02207387|Protective Agents|protective agents|mesh-ancestor
83164423|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164424|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
83164425|NCT03528421|Fludarabine|fludarabine|mesh-list
83164426|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164427|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
83164428|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164429|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164430|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83164431|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
83164432|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164433|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164434|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83164435|NCT02374047|Atorvastatin|atorvastatin|mesh-list
83164436|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83164437|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83164438|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
83164439|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164440|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83164441|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83164442|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164443|NCT02203253|Thalidomide|thalidomide|mesh-list
83164444|NCT02203253|Dexamethasone|dexamethasone|mesh-list
83164445|NCT02203253|Palonosetron|palonosetron|mesh-list
83164446|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164447|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
83164448|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
83164449|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164450|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164451|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83164452|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
83164453|NCT02203253|Hormones|hormones|mesh-ancestor
83164454|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164455|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83164456|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164457|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164458|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
83164459|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
83164460|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164461|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164462|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83164463|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83164464|NCT02203253|Growth Substances|growth substances|mesh-ancestor
83164465|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
83164466|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83164467|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83164468|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
83164469|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164470|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164471|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
83164472|NCT02207699|Benzonatate|benzonatate|mesh-list
83164473|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164474|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164475|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83164476|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83164477|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164478|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164479|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164480|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
83164481|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
83164482|NCT01838187|Vorinostat|vorinostat|mesh-list
83164483|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83164484|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164485|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83164486|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164487|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164488|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83164489|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
83164490|NCT02296138|Olodaterol|olodaterol|mesh-list
83164491|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83164492|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
83164493|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164494|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164495|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83164496|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
83164497|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
83164498|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83164499|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
83164500|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164501|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164502|NCT01306942|Paclitaxel|paclitaxel|mesh-list
83164503|NCT01306942|Trastuzumab|trastuzumab|mesh-list
83164504|NCT01306942|Dasatinib|dasatinib|mesh-list
83164505|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164506|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164507|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164508|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164509|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164510|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164511|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164512|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83164513|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164514|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
83164515|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
83164516|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
83164517|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164518|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164519|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
83164520|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164521|NCT01345851|Paclitaxel|paclitaxel|mesh-list
83164522|NCT01345851|Carboplatin|carboplatin|mesh-list
83164523|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164524|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164525|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164526|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164527|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164528|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164529|NCT03532841|Tramadol|tramadol|mesh-list
83164530|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83164531|NCT03532841|Narcotics|narcotics|mesh-ancestor
83164532|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164533|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164534|NCT03532841|Analgesics|analgesics|mesh-ancestor
83164535|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
83164536|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164537|NCT02199431|Itraconazole|itraconazole|mesh-list
83164538|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
83164539|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164540|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83164541|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83164542|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164543|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164544|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83164545|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
83164546|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164547|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164548|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83164549|NCT02203799|Immunomodulating Agents|immunomodulating agents|mesh-list
83164550|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
83164551|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164552|NCT03532763|Tocotrienols|tocotrienols|mesh-list
83164553|NCT03532763|Vitamin E|vitamin e|mesh-list
83164554|NCT03532763|Tocopherols|tocopherols|mesh-list
83164555|NCT03532763|Tocovid|tocovid|mesh-list
83164556|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
83164557|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164558|NCT03532763|Protective Agents|protective agents|mesh-ancestor
83164559|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164560|NCT03532763|Vitamins|vitamins|mesh-ancestor
83164561|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
83164562|NCT02208245|Ropivacaine|ropivacaine|mesh-list
83164563|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
83164564|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
83164565|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164566|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164567|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
83164568|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164569|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
83164570|NCT03514901|Nivolumab|nivolumab|mesh-list
83164571|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164572|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164573|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83164574|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164576|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164577|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164578|NCT03533387|Ibudilast|ibudilast|mesh-list
83164579|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83164580|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
83164581|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164582|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164583|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83164584|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83164585|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83164586|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164587|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164588|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83164589|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
83164590|NCT02324842|Liraglutide|liraglutide|mesh-list
83164591|NCT02324842|Canagliflozin|canagliflozin|mesh-list
83164592|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83164593|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164594|NCT02324842|Incretins|incretins|mesh-ancestor
83164595|NCT02324842|Hormones|hormones|mesh-ancestor
83164596|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164597|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83164598|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164599|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
83164600|NCT02295280|Promethazine|promethazine|mesh-list
83164601|NCT02295280|Codeine|codeine|mesh-list
83164602|NCT02295280|Metoclopramide|metoclopramide|mesh-list
83164603|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83164604|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83164605|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164606|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164607|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
83164608|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
83164609|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
83164610|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164611|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
83164612|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
83164613|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83164614|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83164615|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
83164616|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
83164617|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164618|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164619|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83164620|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
83164621|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
83164622|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83164623|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83164624|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
83164625|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83164626|NCT02295280|Narcotics|narcotics|mesh-ancestor
83164627|NCT02295280|Analgesics|analgesics|mesh-ancestor
83164628|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
83164629|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
83164630|NCT05263505|Methotrexate|methotrexate|mesh-list
83164631|NCT05263505|Azathioprine|azathioprine|mesh-list
83164632|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83164633|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
83164634|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83164635|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164636|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83164637|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
83164638|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164639|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164640|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
83164641|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164642|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83164643|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164644|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
83164645|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164646|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83164647|NCT05488405|Mesalamine|mesalamine|mesh-list
83164648|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83164649|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83164650|NCT05488405|Analgesics|analgesics|mesh-ancestor
83164651|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
83164652|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164653|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164654|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164655|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164656|NCT02204501|Midazolam|midazolam|mesh-list
83164657|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83164658|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83164659|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164660|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164661|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83164662|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83164663|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83164664|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83164665|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
83164666|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
83164667|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
83164668|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
83164669|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164670|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164671|NCT02294734|Nemiralisib|nemiralisib|mesh-list
83164672|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83164673|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164674|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164675|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83164676|NCT03533231|Metronidazole|metronidazole|mesh-list
83164677|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
83164678|NCT03533231|Propolis|propolis|mesh-list
83164679|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164680|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83164681|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83164682|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83164683|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83164684|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164685|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164686|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164687|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83164688|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83164689|NCT02200757|Topotecan|topotecan|mesh-list
83164690|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83164691|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83164692|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164693|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164694|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164695|NCT05374057|Ibuprofen|ibuprofen|mesh-list
83164696|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83164697|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83164698|NCT05374057|Analgesics|analgesics|mesh-ancestor
83164699|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
83164700|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164701|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164702|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83164703|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164704|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83164706|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164708|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164709|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164710|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83164711|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164712|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
83164713|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164714|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
83164715|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164716|NCT05223101|Telmisartan|telmisartan|mesh-list
83164717|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83164718|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83164719|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83164720|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164721|NCT05438953|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83164722|NCT05438953|Antiviral Agents|antiviral agents|mesh-ancestor
83164723|NCT05438953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164724|NCT02852057|Timolol|timolol|mesh-list
83164725|NCT02852057|Dorzolamide|dorzolamide|mesh-list
83164726|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164727|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164728|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83164729|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83164730|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83164731|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164732|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164733|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83164734|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83164735|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83164736|NCT04020445|Insulin|insulin|mesh-list
83164737|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83164738|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164739|NCT03524833|Amoxicillin|amoxicillin|mesh-list
83164740|NCT03524833|Metronidazole|metronidazole|mesh-list
83164741|NCT03524833|Lansoprazole|lansoprazole|mesh-list
83164742|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
83164743|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164744|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164745|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83164746|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83164747|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83164748|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83164749|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83164750|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164751|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164752|NCT02220647|Metformin|metformin|mesh-list
83164753|NCT02220647|Linagliptin|linagliptin|mesh-list
83164754|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83164755|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164756|NCT02220647|Incretins|incretins|mesh-ancestor
83164757|NCT02220647|Hormones|hormones|mesh-ancestor
83164758|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164759|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83164760|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
83164761|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164762|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164763|NCT05426395|Vitamins|vitamins|mesh-list
83164764|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
83164765|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
83164766|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
83164767|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
83164768|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164769|NCT05426395|Hematinics|hematinics|mesh-ancestor
83164770|NCT03544567|Paclitaxel|paclitaxel|mesh-list
83164771|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83164772|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164773|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
83164774|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
83164775|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
83164776|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164777|NCT02209025|Theobromine|theobromine|mesh-list
83164778|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83164779|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
83164780|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164781|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164782|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83164783|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83164784|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
83164785|NCT02220803|Acetazolamide|acetazolamide|mesh-list
83164786|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
83164787|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83164788|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164789|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164790|NCT02220803|Diuretics|diuretics|mesh-ancestor
83164791|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
83164792|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164793|NCT04972123|Phenylephrine|phenylephrine|mesh-list
83164794|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
83164795|NCT04972123|Caffeine|caffeine|mesh-list
83164796|NCT04972123|Capsaicin|capsaicin|mesh-list
83164797|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83164798|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164799|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83164800|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164801|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164802|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83164803|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83164804|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
83164805|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164806|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83164807|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
83164808|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
83164809|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164810|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
83164811|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83164812|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
83164813|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
83164814|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83164815|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83164816|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83164817|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
83164818|NCT04972123|Protective Agents|protective agents|mesh-ancestor
83164819|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
83164820|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
83164821|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
83164822|NCT02322892|Thiamine|thiamine|mesh-list
83164823|NCT02322892|Vitamins|vitamins|mesh-ancestor
83164824|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
83164825|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164826|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
83164827|NCT03274375|Rituximab|rituximab|mesh-list
83164828|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83164829|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164830|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
83164831|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164832|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83164833|NCT03088813|Irinotecan|irinotecan|mesh-list
83164834|NCT03088813|Topotecan|topotecan|mesh-list
83164835|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83164836|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83164837|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164838|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164839|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164840|NCT02739997|Metronidazole|metronidazole|mesh-list
83164841|NCT02739997|Tazobactam|tazobactam|mesh-list
83164842|NCT02739997|Ceftolozane|ceftolozane|mesh-list
83164843|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83164844|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83164845|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83164846|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83164847|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83164848|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164849|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164850|NCT04467931|Losartan|losartan|mesh-list
83164851|NCT04467931|Timolol|timolol|mesh-list
83164852|NCT04467931|Propranolol|propranolol|mesh-list
83164853|NCT04467931|Metoprolol|metoprolol|mesh-list
83164854|NCT04467931|Atenolol|atenolol|mesh-list
83164855|NCT04467931|Verapamil|verapamil|mesh-list
83164856|NCT04467931|Felodipine|felodipine|mesh-list
83164857|NCT04467931|Nadolol|nadolol|mesh-list
83164858|NCT04467931|Acebutolol|acebutolol|mesh-list
83164859|NCT04467931|Amlodipine|amlodipine|mesh-list
83164860|NCT04467931|Valsartan|valsartan|mesh-list
83164861|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83164862|NCT04467931|Telmisartan|telmisartan|mesh-list
83164863|NCT04467931|Clonidine|clonidine|mesh-list
83164864|NCT04467931|Carvedilol|carvedilol|mesh-list
83164865|NCT04467931|Candesartan|candesartan|mesh-list
83164866|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
83164867|NCT04467931|Ramipril|ramipril|mesh-list
83164868|NCT04467931|Olmesartan|olmesartan|mesh-list
83164869|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83164870|NCT04467931|Enalapril|enalapril|mesh-list
83164871|NCT04467931|Enalaprilat|enalaprilat|mesh-list
83164872|NCT04467931|Lisinopril|lisinopril|mesh-list
83164873|NCT04467931|Irbesartan|irbesartan|mesh-list
83164874|NCT04467931|Eplerenone|eplerenone|mesh-list
83164875|NCT04467931|Nebivolol|nebivolol|mesh-list
83164876|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
83164877|NCT04467931|Bisoprolol|bisoprolol|mesh-list
83164878|NCT04467931|Perindopril|perindopril|mesh-list
83164879|NCT04467931|Diltiazem|diltiazem|mesh-list
83164880|NCT04467931|Minoxidil|minoxidil|mesh-list
83164881|NCT04467931|Guanfacine|guanfacine|mesh-list
83164882|NCT04467931|Prazosin|prazosin|mesh-list
83164883|NCT04467931|Doxazosin|doxazosin|mesh-list
83164884|NCT04467931|Benazepril|benazepril|mesh-list
83164885|NCT04467931|Labetalol|labetalol|mesh-list
83164886|NCT04467931|Hydralazine|hydralazine|mesh-list
83164887|NCT04467931|Captopril|captopril|mesh-list
83164888|NCT04467931|Indapamide|indapamide|mesh-list
83164889|NCT04467931|Nicardipine|nicardipine|mesh-list
83164890|NCT04467931|Quinapril|quinapril|mesh-list
83164891|NCT04467931|Metolazone|metolazone|mesh-list
83164892|NCT04467931|Trandolapril|trandolapril|mesh-list
83164893|NCT04467931|Torsemide|torsemide|mesh-list
83164894|NCT04467931|Methyldopa|methyldopa|mesh-list
83164895|NCT04467931|Fosinopril|fosinopril|mesh-list
83164896|NCT04467931|Isradipine|isradipine|mesh-list
83164897|NCT04467931|Eprosartan|eprosartan|mesh-list
83164898|NCT04467931|Pindolol|pindolol|mesh-list
83164899|NCT04467931|Betaxolol|betaxolol|mesh-list
83164900|NCT04467931|Moexipril|moexipril|mesh-list
83164901|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
83164902|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
83164903|NCT04467931|Reserpine|reserpine|mesh-list
83164904|NCT04467931|Guanabenz|guanabenz|mesh-list
83164905|NCT04467931|Nisoldipine|nisoldipine|mesh-list
83164906|NCT04467931|Penbutolol|penbutolol|mesh-list
83164907|NCT04467931|Nifedipine|nifedipine|mesh-list
83164908|NCT04467931|Amiloride|amiloride|mesh-list
83164909|NCT04467931|Triamterene|triamterene|mesh-list
83164910|NCT04467931|Furosemide|furosemide|mesh-list
83164911|NCT04467931|Spironolactone|spironolactone|mesh-list
83164912|NCT04467931|Bumetanide|bumetanide|mesh-list
83164913|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
83164914|NCT04467931|Terazosin|terazosin|mesh-list
83164915|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83164916|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83164917|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83164918|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83164919|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83164920|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164921|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83164922|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164923|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83164924|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83164925|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83164926|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83164927|NCT04467931|Diuretics|diuretics|mesh-ancestor
83164928|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
83164929|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83164930|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83164931|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83164932|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
83164933|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83164934|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83164935|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
83164936|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
83164937|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164938|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83164939|NCT04467931|Analgesics|analgesics|mesh-ancestor
83164940|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
83164941|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83164942|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83164943|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83164944|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83164945|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
83164946|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83164947|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83164948|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
83164949|NCT04467931|Protective Agents|protective agents|mesh-ancestor
83164950|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83164951|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83164952|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
83164953|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164954|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
83164955|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83164956|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83164957|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83164958|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83164959|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83164960|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83164961|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83164962|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
83164963|NCT04467931|Urological Agents|urological agents|mesh-ancestor
83164964|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83164965|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83164966|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
83164967|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83164968|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83164969|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164970|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83164971|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83164972|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83164973|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
83164974|NCT03705559|Narcotics|narcotics|mesh-ancestor
83164975|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83164976|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164977|NCT03705559|Analgesics|analgesics|mesh-ancestor
83164978|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
83164979|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83164981|NCT03522649|Fluorouracil|fluorouracil|mesh-list
83164982|NCT03522649|Irinotecan|irinotecan|mesh-list
83164983|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
83164984|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83164985|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83164986|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83164987|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83164988|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
83164989|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83164990|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83164991|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83164992|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83164993|NCT03522649|Antidotes|antidotes|mesh-ancestor
83164994|NCT03522649|Protective Agents|protective agents|mesh-ancestor
83164995|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
83164996|NCT03522649|Vitamins|vitamins|mesh-ancestor
83164997|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
83164998|NCT02366481|Vitamins|vitamins|mesh-list
83164999|NCT02366481|Vitamin K|vitamin k|mesh-list
83165000|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
83165001|NCT02366481|Menaquinone 7|menaquinone 7|mesh-list
83165002|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
83165003|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165004|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83165005|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83165006|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165007|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
83165008|NCT02366481|Coagulants|coagulants|mesh-ancestor
83165009|NCT02366247|Adefovir|adefovir|mesh-list
83165010|NCT02366247|Thymalfasin|thymalfasin|mesh-list
83165011|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
83165012|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165013|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83165014|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83165015|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165016|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165017|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83165018|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
83165019|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165020|NCT02373735|Mannitol|mannitol|mesh-list
83165021|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83165022|NCT02373735|Diuretics|diuretics|mesh-ancestor
83165023|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
83165024|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165025|NCT03526315|Fluorides|fluorides|mesh-list
83165026|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
83165027|NCT03526315|Protective Agents|protective agents|mesh-ancestor
83165028|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165029|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
83165030|NCT03112551|Analgesics|analgesics|mesh-ancestor
83165031|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
83165032|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165033|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165034|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
83165035|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165036|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83165037|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
83165038|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83165039|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165040|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165041|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83165042|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
83165043|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83165044|NCT04466917|Paclitaxel|paclitaxel|mesh-list
83165045|NCT04466917|Bevacizumab|bevacizumab|mesh-list
83165046|NCT04466917|Carboplatin|carboplatin|mesh-list
83165047|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83165048|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165049|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
83165050|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
83165051|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
83165052|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165053|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165054|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83165055|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83165056|NCT04466917|Growth Substances|growth substances|mesh-ancestor
83165057|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165058|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
83165059|NCT05373433|Ritonavir|ritonavir|mesh-list
83165060|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83165061|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83165062|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
83165063|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165064|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165065|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83165066|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83165067|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
83165068|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165069|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83165070|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83165071|NCT02363127|Progesterone|progesterone|mesh-list
83165072|NCT02363127|Progestins|progestins|mesh-ancestor
83165073|NCT02363127|Hormones|hormones|mesh-ancestor
83165074|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165075|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165076|NCT03526159|Gentamicins|gentamicins|mesh-list
83165077|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83165078|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165079|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83165080|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165081|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165082|NCT03523741|Clozapine|clozapine|mesh-list
83165083|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83165084|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
83165085|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165086|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165087|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165088|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83165089|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83165090|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165091|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83165092|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
83165093|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
83165094|NCT02362581|Factor VIII|factor viii|mesh-list
83165095|NCT02362581|Coagulants|coagulants|mesh-ancestor
83165096|NCT03525925|Nivolumab|nivolumab|mesh-list
83165097|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165098|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165099|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83165100|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165101|NCT02373579|Methotrexate|methotrexate|mesh-list
83165102|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83165103|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
83165104|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83165105|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165106|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83165107|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
83165108|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165109|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165110|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
83165111|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165112|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83165113|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83165114|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
83165115|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83165116|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83165117|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
83165118|NCT02365857|Bupivacaine|bupivacaine|mesh-list
83165119|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
83165120|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
83165121|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165122|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165123|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
83165124|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165125|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83165126|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165127|NCT02365857|Analgesics|analgesics|mesh-ancestor
83165128|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83165129|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83165130|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83165131|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
83165132|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165133|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165135|NCT02365935|Cisplatin|cisplatin|mesh-list
83165136|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83165137|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165138|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83165139|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83165140|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83165141|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165142|NCT02365623|Bedaquiline|bedaquiline|mesh-list
83165143|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
83165144|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
83165145|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83165146|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165147|NCT03112707|Aspirin|aspirin|mesh-list
83165148|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83165149|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165150|NCT03112707|Analgesics|analgesics|mesh-ancestor
83165151|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
83165152|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165153|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165154|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83165155|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83165156|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83165157|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83165158|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165159|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83165160|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83165161|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165162|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
83165163|NCT05262413|Lenvatinib|lenvatinib|mesh-list
83165164|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165165|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83165166|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165167|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165168|NCT02209649|Telmisartan|telmisartan|mesh-list
83165169|NCT02209649|Lacidipine|lacidipine|mesh-list
83165170|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83165171|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83165172|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83165173|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165174|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83165175|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165176|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83165177|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165178|NCT02361567|Acetaminophen|acetaminophen|mesh-list
83165179|NCT02361567|Oxycodone|oxycodone|mesh-list
83165180|NCT02361567|Tramadol|tramadol|mesh-list
83165181|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83165182|NCT02361567|Narcotics|narcotics|mesh-ancestor
83165183|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165184|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165185|NCT02361567|Analgesics|analgesics|mesh-ancestor
83165186|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
83165187|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165188|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165189|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
83165190|NCT03112785|Cimetidine|cimetidine|mesh-list
83165191|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83165192|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83165193|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83165194|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
83165195|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
83165196|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165197|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165198|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165199|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83165200|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83165201|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165202|NCT02361879|Leuprolide|leuprolide|mesh-list
83165203|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
83165204|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83165205|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
83165206|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83165207|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165208|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83165209|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165210|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83165211|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
83165212|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83165213|NCT05262335|Paclitaxel|paclitaxel|mesh-list
83165214|NCT05262335|Docetaxel|docetaxel|mesh-list
83165215|NCT05262335|Capecitabine|capecitabine|mesh-list
83165216|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
83165217|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83165218|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165219|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
83165220|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83165221|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83165222|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165223|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83165224|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
83165225|NCT02361645|Ketorolac|ketorolac|mesh-list
83165226|NCT02361645|Indomethacin|indomethacin|mesh-list
83165227|NCT02361645|Nepafenac|nepafenac|mesh-list
83165228|NCT02361645|Bromfenac|bromfenac|mesh-list
83165229|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83165230|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83165231|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165232|NCT02361645|Analgesics|analgesics|mesh-ancestor
83165233|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
83165234|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165235|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165236|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83165237|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83165238|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83165239|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165240|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165241|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
83165242|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
83165243|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83165244|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83165245|NCT03522181|Insulin|insulin|mesh-list
83165246|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83165247|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83165248|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165249|NCT02373033|Folic Acid|folic acid|mesh-list
83165250|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
83165251|NCT02373033|Hematinics|hematinics|mesh-ancestor
83165252|NCT02373033|Vitamins|vitamins|mesh-ancestor
83165253|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
83165254|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165255|NCT05186129|Clopidogrel|clopidogrel|mesh-list
83165256|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83165257|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83165258|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83165259|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83165260|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
83165261|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165262|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165263|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165265|NCT02361723|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83165266|NCT02361723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165267|NCT02361723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165268|NCT02361723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165269|NCT03596281|Bevacizumab|bevacizumab|mesh-list
83165270|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
83165271|NCT03596281|Doxorubicin|doxorubicin|mesh-list
83165272|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83165273|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165274|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165275|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83165276|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83165277|NCT03596281|Growth Substances|growth substances|mesh-ancestor
83165278|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165279|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83165280|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83165281|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83165282|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83165283|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165284|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165285|NCT03596281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83165286|NCT05172167|Antibodies|antibodies|mesh-list
83165287|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
83165288|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165289|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
83165290|NCT02359149|Growth Substances|growth substances|mesh-ancestor
83165291|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165292|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
83165293|NCT02221583|Tacrolimus|tacrolimus|mesh-list
83165294|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83165295|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
83165296|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165297|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83165298|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165299|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165300|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83165301|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165302|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83165303|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
83165304|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83165305|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165306|NCT03514069|Temozolomide|temozolomide|mesh-list
83165307|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83165308|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
83165309|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165310|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165311|NCT03500731|Rituximab|rituximab|mesh-list
83165312|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
83165313|NCT03500731|Fludarabine|fludarabine|mesh-list
83165314|NCT03500731|Thiotepa|thiotepa|mesh-list
83165315|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
83165316|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165317|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165318|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
83165319|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165320|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83165321|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165322|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83165323|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83165324|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
83165325|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83165326|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
83165327|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165328|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83165329|NCT02751359|Cannabidiol|cannabidiol|mesh-list
83165330|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
83165331|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
83165332|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
83165333|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
83165334|NCT02358993|Methenamine|methenamine|mesh-list
83165335|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83165336|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165337|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83165338|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83165339|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165340|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165341|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165342|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83165343|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83165344|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83165345|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
83165346|NCT04059445|Calcium|calcium|mesh-list
83165347|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83165348|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165349|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83165350|NCT03395197|Talazoparib|talazoparib|mesh-list
83165351|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83165352|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165353|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165354|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165355|NCT05092841|Naltrexone|naltrexone|mesh-list
83165356|NCT05092841|Baclofen|baclofen|mesh-list
83165357|NCT05092841|Sorbitol|sorbitol|mesh-list
83165358|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83165359|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83165360|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165361|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
83165362|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165363|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83165364|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83165365|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83165366|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
83165367|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
83165368|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165369|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165370|NCT05092841|Cathartics|cathartics|mesh-ancestor
83165371|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83165372|NCT02224937|Melatonin|melatonin|mesh-list
83165373|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
83165374|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165375|NCT02224937|Protective Agents|protective agents|mesh-ancestor
83165376|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165377|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165378|NCT02290327|Pantoprazole|pantoprazole|mesh-list
83165379|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83165380|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83165381|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83165382|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165383|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165384|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
83165385|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83165386|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165387|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83165388|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165389|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
83165390|NCT02358057|Alfentanil|alfentanil|mesh-list
83165391|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83165392|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165393|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165394|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165395|NCT02358057|Analgesics|analgesics|mesh-ancestor
83165396|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
83165397|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165398|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83165399|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83165400|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83165401|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83165402|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165403|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165404|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83165405|NCT02358057|Narcotics|narcotics|mesh-ancestor
83165406|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83165407|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
83165408|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
83165409|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
83165410|NCT02225093|Caffeine|caffeine|mesh-list
83165411|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83165412|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165413|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83165414|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165415|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165416|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83165417|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83165418|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
83165419|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165420|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
83165421|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
83165422|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83165423|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83165424|NCT02212535|Plerixafor|plerixafor|mesh-list
83165425|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83165426|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83165427|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
83165428|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165429|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
83165430|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165431|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83165432|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83165433|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83165434|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165435|NCT02372487|Urological Agents|urological agents|mesh-ancestor
83165436|NCT02361177|Oxytocin|oxytocin|mesh-list
83165437|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
83165438|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83165439|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165440|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83165441|NCT05055713|Somatostatin|somatostatin|mesh-list
83165442|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83165443|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83165444|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165445|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165446|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165447|NCT05055713|Hormones|hormones|mesh-ancestor
83165448|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165449|NCT02360709|Sirolimus|sirolimus|mesh-list
83165450|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83165451|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165452|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83165453|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165454|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
83165455|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83165456|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
83165457|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165458|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
83165459|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165460|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165461|NCT04624113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83165462|NCT04624113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165463|NCT05030519|Trastuzumab|trastuzumab|mesh-list
83165464|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165465|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165466|NCT02357277|Budesonide|budesonide|mesh-list
83165467|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83165468|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83165469|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
83165470|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165471|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165472|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83165473|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
83165475|NCT02357277|Hormones|hormones|mesh-ancestor
83165476|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165477|NCT02222441|Pioglitazone|pioglitazone|mesh-list
83165478|NCT02222441|Palbociclib|palbociclib|mesh-list
83165479|NCT02222441|Modafinil|modafinil|mesh-list
83165480|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83165481|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165482|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165483|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83165484|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165485|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165486|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83165487|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83165488|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83165489|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83165490|NCT02290717|Fluticasone|fluticasone|mesh-list
83165491|NCT02290717|Xhance|xhance|mesh-list
83165492|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83165493|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83165494|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
83165495|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165496|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165497|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83165498|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
83165499|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83165500|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83165501|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
83165502|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83165503|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
83165504|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83165505|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
83165506|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165507|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83165508|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83165509|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
83165510|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165511|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165512|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83165513|NCT02360007|Buprenorphine|buprenorphine|mesh-list
83165514|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83165515|NCT02360007|Narcotics|narcotics|mesh-ancestor
83165516|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165517|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165519|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
83165520|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165521|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83165522|NCT02294305|Vortioxetine|vortioxetine|mesh-list
83165523|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
83165524|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83165525|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83165526|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83165527|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165528|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165529|NCT02294305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83165530|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83165531|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165532|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165533|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165534|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
83165535|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83165536|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83165537|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83165538|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83165539|NCT01672255|Fluoxetine|fluoxetine|mesh-list
83165540|NCT01672255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83165541|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83165542|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165543|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165544|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165545|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
83165546|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165547|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83165548|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
83165549|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83165550|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83165551|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83165552|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165553|NCT02222519|Bromides|bromides|mesh-list
83165554|NCT02222519|Rocuronium|rocuronium|mesh-list
83165555|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
83165556|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83165557|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83165558|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83165559|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165560|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165561|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
83540894|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83165562|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83165563|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
83165564|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165565|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165566|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83165567|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
83165568|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83165569|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
83165570|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165571|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165572|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83165573|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
83165574|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
83165575|NCT02220023|Protective Agents|protective agents|mesh-ancestor
83165576|NCT02356965|Ketamine|ketamine|mesh-list
83165577|NCT02356965|Analgesics|analgesics|mesh-ancestor
83165578|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
83165579|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165580|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165581|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83165582|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83165583|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
83165584|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
83165585|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165586|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83165587|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83165588|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165589|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165590|NCT02359695|Hormones|hormones|mesh-list
83165591|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165592|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165593|NCT02294539|Losartan|losartan|mesh-list
83165594|NCT02294539|Amlodipine|amlodipine|mesh-list
83165595|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83165596|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83165597|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83165598|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165599|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165600|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83165601|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165602|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
83165603|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83165604|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83165605|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83165606|NCT02294539|Diuretics|diuretics|mesh-ancestor
83165607|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
83165608|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83165609|NCT02359617|Insulin|insulin|mesh-list
83165610|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83165611|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165612|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83165613|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
83165614|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83165616|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83165617|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
83165618|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83165619|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165620|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83165621|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83165622|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83165623|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83165624|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165625|NCT02294617|Nicotine|nicotine|mesh-list
83165626|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83165627|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
83165628|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165629|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165630|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83165631|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83165632|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
83165633|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165634|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165635|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83165636|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83165637|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83165638|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165639|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165640|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165641|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165642|NCT02291341|Analgesics|analgesics|mesh-ancestor
83165643|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
83165644|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165645|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
83165646|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83165647|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
83165648|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
83165649|NCT02352987|Salicylates|salicylates|mesh-list
83165650|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165651|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
83165652|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
83165653|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83165654|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83165655|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165656|NCT02352987|Analgesics|analgesics|mesh-ancestor
83165657|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
83165658|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165659|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165660|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83165661|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83165662|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83165663|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165664|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165665|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
83165666|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83165667|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83165668|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165669|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83165670|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
83165671|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83165672|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165673|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165674|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165675|NCT02226341|Hormones|hormones|mesh-ancestor
83165676|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165677|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165678|NCT02222987|Clopidogrel|clopidogrel|mesh-list
83165679|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83165680|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83165681|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83165682|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83165683|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
83165684|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165685|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165686|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165688|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165689|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165690|NCT02481245|Bezafibrate|bezafibrate|mesh-list
83165691|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83165692|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
83165693|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165694|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83165695|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83165696|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83165697|NCT02352597|Clomiphene|clomiphene|mesh-list
83165698|NCT02352597|Enclomiphene|enclomiphene|mesh-list
83165699|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
83165700|NCT02352597|Estradiol|estradiol|mesh-list
83165701|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83165702|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
83165703|NCT02352597|Estrogens|estrogens|mesh-ancestor
83165704|NCT02352597|Hormones|hormones|mesh-ancestor
83165705|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165706|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165707|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83165708|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
83165709|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83165710|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83165711|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83165712|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
83165713|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83165714|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
83165715|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83165716|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83165717|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83165718|NCT03521167|Acetaminophen|acetaminophen|mesh-list
83165719|NCT03521167|Lidocaine|lidocaine|mesh-list
83165720|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
83165721|NCT03521167|Ketamine|ketamine|mesh-list
83165722|NCT03521167|Gabapentin|gabapentin|mesh-list
83165723|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
83165724|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
83165725|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165726|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165727|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
83165728|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165729|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83165730|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83165731|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83165732|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165733|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165734|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83165735|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165736|NCT03521167|Analgesics|analgesics|mesh-ancestor
83165737|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83165738|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83165739|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83165740|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83165741|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165742|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83165743|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83165744|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
83165745|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83165746|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83165747|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
83165748|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83165749|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83165750|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83165751|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
83165753|NCT02352519|Anesthetics|anesthetics|mesh-list
83165754|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
83165755|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165756|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165757|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
83165758|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165759|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
83165760|NCT02356419|Hematinics|hematinics|mesh-ancestor
83165761|NCT02220335|Digoxin|digoxin|mesh-list
83165762|NCT02220335|Diuretics|diuretics|mesh-list
83165763|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83165764|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83165765|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83165766|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83165767|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165768|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165769|NCT02220335|Protective Agents|protective agents|mesh-ancestor
83165770|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165771|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
83165772|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
83165773|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
83165774|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165775|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83165776|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83165777|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83165778|NCT02223299|Tryptophan|tryptophan|mesh-list
83165779|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83165780|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
83165781|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83165782|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83165783|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83165784|NCT02223377|Morphine|morphine|mesh-list
83165785|NCT02223377|Hydromorphone|hydromorphone|mesh-list
83165786|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83165787|NCT02223377|Narcotics|narcotics|mesh-ancestor
83165788|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165789|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165790|NCT02223377|Analgesics|analgesics|mesh-ancestor
83165791|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
83165792|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165793|NCT02291887|Ranibizumab|ranibizumab|mesh-list
83165794|NCT02291887|Aflibercept|aflibercept|mesh-list
83165795|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83165796|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83165797|NCT02291887|Growth Substances|growth substances|mesh-ancestor
83165798|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165799|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
83165800|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165801|NCT02352285|Tolvaptan|tolvaptan|mesh-list
83165802|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83165803|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165804|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
83165805|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165806|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
83165807|NCT03521713|Hematinics|hematinics|mesh-ancestor
83165808|NCT02223533|Morphine|morphine|mesh-list
83165809|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83165810|NCT02223533|Narcotics|narcotics|mesh-ancestor
83165811|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83165812|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165813|NCT02223533|Analgesics|analgesics|mesh-ancestor
83165814|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
83165815|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165816|NCT02231021|Pioglitazone|pioglitazone|mesh-list
83165817|NCT02231021|Alogliptin|alogliptin|mesh-list
83165818|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83165819|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165820|NCT02231021|Incretins|incretins|mesh-ancestor
83165821|NCT02231021|Hormones|hormones|mesh-ancestor
83165822|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165823|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83165824|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
83165825|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165826|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165827|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83165828|NCT04465123|Spironolactone|spironolactone|mesh-list
83165829|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83165830|NCT04465123|Diuretics|diuretics|mesh-ancestor
83165831|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
83165832|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165833|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83165834|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165835|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165836|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83165837|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
83165838|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165839|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83165840|NCT02401347|Talazoparib|talazoparib|mesh-list
83165841|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83165842|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165843|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165844|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165845|NCT02231255|Pramipexole|pramipexole|mesh-list
83165846|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
83165847|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165848|NCT02231255|Protective Agents|protective agents|mesh-ancestor
83165849|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165850|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83165851|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83165852|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
83165853|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
83165854|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165855|NCT02352051|Methylphenidate|methylphenidate|mesh-list
83165856|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83165857|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83165858|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165859|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83165860|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83165861|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165862|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165863|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
83165864|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165865|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83165866|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83165867|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83165868|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
83165869|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
83165870|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165871|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165872|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
83165873|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
83165874|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165875|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83165876|NCT02292121|Mannitol|mannitol|mesh-list
83165877|NCT02292121|Lactitol|lactitol|mesh-list
83165878|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83165879|NCT02292121|Diuretics|diuretics|mesh-ancestor
83165880|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
83165881|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165882|NCT02292121|Cathartics|cathartics|mesh-ancestor
83165883|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83165884|NCT02223611|Cisplatin|cisplatin|mesh-list
83165885|NCT02223611|Vinorelbine|vinorelbine|mesh-list
83165886|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165887|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83165888|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
83165889|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
83165890|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
83165891|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165892|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
83165893|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83165894|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165895|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165896|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83165897|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83165898|NCT02231333|Protective Agents|protective agents|mesh-ancestor
83165899|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165900|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
83165901|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83165902|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
83165903|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83165904|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83165905|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83165906|NCT02227433|Immunotoxins|immunotoxins|mesh-ancestor
83165907|NCT02227433|Immunoconjugates|immunoconjugates|mesh-ancestor
83165908|NCT02227433|Immunologic Factors|immunologic factors|mesh-ancestor
83165909|NCT02227433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165910|NCT02351973|Amiloride|amiloride|mesh-list
83165911|NCT02351973|Diuretics|diuretics|mesh-ancestor
83165912|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
83165913|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165914|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83165915|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83165916|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83165917|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165918|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83165919|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83165921|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83165922|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83165923|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165924|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
83165925|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
83165926|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83165927|NCT03520543|Clonidine|clonidine|mesh-list
83165928|NCT03520543|Yohimbine|yohimbine|mesh-list
83165929|NCT03520543|Analgesics|analgesics|mesh-ancestor
83165930|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
83165931|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165932|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165933|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83165934|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
83165935|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
83165936|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83165937|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83165938|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83165939|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
83165940|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165941|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165942|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
83165943|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83165944|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83165945|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83165946|NCT03520543|Urological Agents|urological agents|mesh-ancestor
83165947|NCT02355639|Betamethasone|betamethasone|mesh-list
83165948|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
83165949|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83165950|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
83165952|NCT02355639|Petrolatum|petrolatum|mesh-list
83165953|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83165954|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83165955|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
83165956|NCT02355639|Hormones|hormones|mesh-ancestor
83165957|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83165958|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165959|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83165960|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
83165961|NCT02355639|Emollients|emollients|mesh-ancestor
83165962|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
83165963|NCT02351895|Copper|copper|mesh-list
83165964|NCT02351895|Trace Elements|trace elements|mesh-ancestor
83165965|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
83165966|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165967|NCT00503035|Celecoxib|celecoxib|mesh-list
83165968|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83165969|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83165970|NCT00503035|Analgesics|analgesics|mesh-ancestor
83165971|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
83165972|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83165973|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165974|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83165975|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83165976|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83165977|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83165978|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165979|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165980|NCT02227745|Dorzolamide|dorzolamide|mesh-list
83165981|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
83165982|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83165983|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
83165984|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83165985|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
83165986|NCT02227745|Protective Agents|protective agents|mesh-ancestor
83165987|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83165988|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83165989|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83165990|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83165991|NCT03517033|Nebivolol|nebivolol|mesh-list
83165992|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83165993|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
83165994|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83165995|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83165996|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83165997|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
83165998|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83165999|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166000|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166001|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83166002|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83166003|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83166004|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
83166005|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166006|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83166007|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83166008|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166009|NCT02259179|Naltrexone|naltrexone|mesh-list
83166010|NCT02259179|Bupropion|bupropion|mesh-list
83166011|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83166012|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83166013|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166014|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
83166015|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166016|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83166017|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
83166018|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83166019|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83166020|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83166021|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83166022|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166023|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
83166024|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166025|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83166026|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83166027|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166028|NCT02355093|Ropivacaine|ropivacaine|mesh-list
83166029|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
83166030|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
83166031|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166032|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166033|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
83166034|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166035|NCT02227823|Bromides|bromides|mesh-list
83166036|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83166037|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
83166038|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83166039|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166040|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166041|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
83166042|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166043|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166044|NCT02295475|Warfarin|warfarin|mesh-list
83166045|NCT02295475|Apixaban|apixaban|mesh-list
83166046|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
83166047|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83166048|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
83166049|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83166050|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
83166051|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166052|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166053|NCT02227901|Temozolomide|temozolomide|mesh-list
83166054|NCT02227901|Tipifarnib|tipifarnib|mesh-list
83166055|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166056|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
83166057|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166058|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166059|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
83166060|NCT03146793|Antidotes|antidotes|mesh-ancestor
83166061|NCT03146793|Protective Agents|protective agents|mesh-ancestor
83166062|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166063|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
83166064|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166065|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
83166066|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83166067|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166068|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
83166069|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
83166070|NCT03133195|Vitamin D|vitamin d|mesh-list
83166071|NCT03133195|Teriparatide|teriparatide|mesh-list
83166072|NCT03133195|Calcium|calcium|mesh-list
83166073|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
83166074|NCT03133195|Vitamins|vitamins|mesh-ancestor
83166075|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
83166076|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166077|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83166078|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83166079|NCT03159741|Glucagon|glucagon|mesh-list
83166080|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83166081|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166082|NCT03159741|Hormones|hormones|mesh-ancestor
83166083|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166084|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166085|NCT03159741|Incretins|incretins|mesh-ancestor
83166086|NCT02292277|Ticagrelor|ticagrelor|mesh-list
83166087|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83166088|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83166089|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83166090|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83166091|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
83166092|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166093|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166094|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166095|NCT02228135|Dexamethasone|dexamethasone|mesh-list
83166096|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166097|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
83166098|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
83166099|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166100|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166101|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166102|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
83166103|NCT02228135|Hormones|hormones|mesh-ancestor
83166104|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166105|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83166106|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166107|NCT03152877|Bupivacaine|bupivacaine|mesh-list
83166108|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
83166109|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
83166110|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166111|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166112|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
83166113|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166114|NCT02295709|Dexamethasone|dexamethasone|mesh-list
83166115|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
83166116|NCT02295709|BB 1101|bb 1101|mesh-list
83166117|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166118|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
83166119|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
83166120|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166121|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166122|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166123|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
83166124|NCT02295709|Hormones|hormones|mesh-ancestor
83166125|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166126|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83166127|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166128|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
83166129|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166130|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166131|NCT02354937|Cabotegravir|cabotegravir|mesh-list
83166132|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83166133|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83166134|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166135|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166136|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83166137|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83166138|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
83166139|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166140|NCT02295787|Ketamine|ketamine|mesh-list
83166141|NCT02295787|Analgesics|analgesics|mesh-ancestor
83166142|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
83166143|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166144|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166145|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83166146|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83166147|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
83166148|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
83166149|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166150|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83166151|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83166152|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166153|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166154|NCT04464967|Trastuzumab|trastuzumab|mesh-list
83166155|NCT04464967|Cetuximab|cetuximab|mesh-list
83166156|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83166157|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166158|NCT02228369|Osimertinib|osimertinib|mesh-list
83166159|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166160|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83166161|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166162|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166163|NCT03146871|Azacitidine|azacitidine|mesh-list
83166164|NCT03146871|Decitabine|decitabine|mesh-list
83166165|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83166166|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
83166167|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166168|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166169|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166170|NCT02231957|Vaccines|vaccines|mesh-list
83166171|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
83166172|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166173|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
83166174|NCT02354547|Topotecan|topotecan|mesh-list
83166175|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166176|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
83166177|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166178|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166179|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166180|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
83166181|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166182|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166183|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83166184|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83166185|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83166186|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166187|NCT02232035|Diazepam|diazepam|mesh-list
83166188|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83166189|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
83166190|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
83166191|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
83166192|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166193|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166194|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166195|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83166196|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166197|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83166198|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83166199|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83166200|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83166201|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83166202|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83166203|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
83166204|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
83166205|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
83166206|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
83166207|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166208|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166209|NCT02296021|Amoxicillin|amoxicillin|mesh-list
83166210|NCT02296021|Clarithromycin|clarithromycin|mesh-list
83166211|NCT02296021|Esomeprazole|esomeprazole|mesh-list
83166213|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83166214|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166215|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83166216|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166217|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83166218|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166219|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166220|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83166221|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83166222|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83166223|NCT02296021|Antacids|antacids|mesh-ancestor
83166224|NCT02289391|Anesthetics|anesthetics|mesh-list
83166225|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166226|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166227|NCT02354313|Lenalidomide|lenalidomide|mesh-list
83166228|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
83166229|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166230|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83166231|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83166232|NCT02354313|Growth Substances|growth substances|mesh-ancestor
83166233|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
83166234|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166235|NCT02292667|Acetaminophen|acetaminophen|mesh-list
83166236|NCT02292667|Morphine|morphine|mesh-list
83166237|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83166238|NCT02292667|Narcotics|narcotics|mesh-ancestor
83166239|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166240|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166241|NCT02292667|Analgesics|analgesics|mesh-ancestor
83166242|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
83166243|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166244|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166245|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
83166246|NCT02232269|Felodipine|felodipine|mesh-list
83166247|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83166248|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83166249|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83166250|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83166251|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166252|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83166253|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166254|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
83166255|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
83166256|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83166257|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166258|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83166259|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83166260|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
83166261|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166262|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166263|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83166264|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83166265|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83166266|NCT02347839|Gefitinib|gefitinib|mesh-list
83166267|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166268|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83166269|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166270|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166271|NCT02289547|Capecitabine|capecitabine|mesh-list
83166272|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83166273|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
83166274|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166275|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166276|NCT02351427|Bortezomib|bortezomib|mesh-list
83166277|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166278|NCT02232971|Glucagon|glucagon|mesh-list
83166279|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166280|NCT02232971|Hormones|hormones|mesh-ancestor
83166281|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166282|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166283|NCT02296333|Ondansetron|ondansetron|mesh-list
83166284|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
83166285|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
83166286|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166287|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166288|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166289|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
83166290|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
83166291|NCT02296333|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83166292|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83166293|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
83166294|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166295|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166296|NCT03149913|Paclitaxel|paclitaxel|mesh-list
83166297|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83166298|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166299|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
83166300|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
83166301|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
83166302|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166303|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
83166304|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83166305|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
83166306|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83166307|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
83166308|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166309|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166310|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
83166312|NCT02232347|Ketamine|ketamine|mesh-list
83166313|NCT02232347|Analgesics|analgesics|mesh-ancestor
83166314|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
83166315|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166316|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166317|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83166318|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83166319|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
83166320|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
83166321|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166322|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83166323|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83166324|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166325|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166326|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83166327|NCT02232347|Narcotics|narcotics|mesh-ancestor
83166328|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83166329|NCT03542669|Doxorubicin|doxorubicin|mesh-list
83166330|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83166331|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166332|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83166333|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83166334|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166335|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166336|NCT03146481|Aceclofenac|aceclofenac|mesh-list
83166337|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83166338|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166339|NCT03146481|Analgesics|analgesics|mesh-ancestor
83166340|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
83166341|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166342|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166343|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166344|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166345|NCT03541655|Celecoxib|celecoxib|mesh-list
83166346|NCT03541655|Bupivacaine|bupivacaine|mesh-list
83166347|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
83166348|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
83166349|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166350|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166351|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
83166352|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166353|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83166354|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166355|NCT03541655|Analgesics|analgesics|mesh-ancestor
83166356|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166357|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166358|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83166359|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83166360|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166361|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166362|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
83166363|NCT02296411|Bromides|bromides|mesh-list
83166364|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
83166365|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83166366|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83166367|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83166368|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
83166369|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166370|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166371|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166372|NCT04581473|Paclitaxel|paclitaxel|mesh-list
83166373|NCT04581473|Irinotecan|irinotecan|mesh-list
83166374|NCT04581473|Apatinib|apatinib|mesh-list
83166375|NCT04581473|Antibodies|antibodies|mesh-list
83166376|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83166377|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166378|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
83166379|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
83166380|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
83166381|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166382|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
83166383|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166384|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83166385|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83166386|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166387|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83166388|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
83166389|NCT02229617|Testosterone|testosterone|mesh-list
83166390|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
83166391|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
83166392|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83166393|NCT02229617|Androgens|androgens|mesh-ancestor
83166394|NCT02229617|Hormones|hormones|mesh-ancestor
83166395|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166396|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166397|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83166398|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166399|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
83166400|NCT02347059|Dopamine|dopamine|mesh-list
83166401|NCT02347059|Levodopa|levodopa|mesh-list
83166402|NCT02347059|Pramipexole|pramipexole|mesh-list
83166403|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
83166404|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83166405|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83166406|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
83166407|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166408|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166409|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166410|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
83166411|NCT02347059|Protective Agents|protective agents|mesh-ancestor
83166412|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83166413|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
83166414|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
83166415|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166416|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83166417|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83166418|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166419|NCT02296567|Bevacizumab|bevacizumab|mesh-list
83166420|NCT02296567|Ranibizumab|ranibizumab|mesh-list
83166421|NCT02296567|Aflibercept|aflibercept|mesh-list
83166422|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83166423|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166424|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83166425|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83166426|NCT02296567|Growth Substances|growth substances|mesh-ancestor
83166427|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166428|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
83166429|NCT02296723|Valganciclovir|valganciclovir|mesh-list
83166430|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
83166431|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166432|NCT02289937|Ropivacaine|ropivacaine|mesh-list
83166433|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
83166434|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
83166435|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166436|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166437|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
83166438|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166439|NCT03446807|Droxidopa|droxidopa|mesh-list
83166440|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83166441|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83166442|NCT03519061|Budesonide|budesonide|mesh-list
83166443|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166444|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83166445|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
83166446|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166447|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166448|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83166449|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
83166450|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
83166451|NCT03519061|Hormones|hormones|mesh-ancestor
83166452|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166453|NCT02229773|Pravastatin|pravastatin|mesh-list
83166454|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83166455|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83166456|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
83166457|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166458|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83166459|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83166460|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166461|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
83166462|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
83166463|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83166464|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166465|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166466|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
83166467|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83166468|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166469|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166470|NCT03515707|Etoposide|etoposide|mesh-list
83166471|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
83166472|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
83166473|NCT03515707|Busulfan|busulfan|mesh-list
83166474|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83166475|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166476|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83166477|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83166478|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166479|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166480|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
83166481|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166482|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
83166483|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166484|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166485|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83166486|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
83166487|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83166488|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83166489|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83166490|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83166491|NCT02298205|Beclomethasone|beclomethasone|mesh-list
83166492|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166493|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
83166494|NCT02298205|Hormones|hormones|mesh-ancestor
83166495|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166496|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166497|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83166498|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
83166499|NCT03514771|Valacyclovir|valacyclovir|mesh-list
83166500|NCT03514771|Isotretinoin|isotretinoin|mesh-list
83166501|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
83166502|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166503|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
83166504|NCT02298283|Prednisone|prednisone|mesh-list
83166505|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
83166506|NCT02298283|Doxorubicin|doxorubicin|mesh-list
83166507|NCT02298283|Etoposide|etoposide|mesh-list
83166508|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83166509|NCT02298283|Vincristine|vincristine|mesh-list
83166510|NCT02298283|Bleomycin|bleomycin|mesh-list
83166511|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83166512|NCT02298283|Procarbazine|procarbazine|mesh-list
83166513|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166514|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
83166515|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166516|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166517|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166518|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
83166519|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166520|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166521|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83166522|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83166523|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83166524|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83166525|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166526|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166527|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
83166528|NCT02298283|Hormones|hormones|mesh-ancestor
83166529|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166530|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83166531|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83166532|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
83166533|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
83166534|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
83166535|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83166536|NCT02298283|Immunotoxins|immunotoxins|mesh-ancestor
83166537|NCT02298283|Immunoconjugates|immunoconjugates|mesh-ancestor
83166538|NCT02346357|Ropivacaine|ropivacaine|mesh-list
83166539|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
83166540|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
83166541|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166542|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166543|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
83166544|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166545|NCT03146247|Apremilast|apremilast|mesh-list
83166546|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83166547|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166548|NCT03146247|Analgesics|analgesics|mesh-ancestor
83166549|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
83166550|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166551|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166552|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166553|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166554|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83166555|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83166556|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166557|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166558|NCT03263273|Minocycline|minocycline|mesh-list
83166559|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83166560|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166561|NCT03146325|Metronidazole|metronidazole|mesh-list
83166562|NCT03146325|Tetracycline|tetracycline|mesh-list
83166563|NCT03146325|Omeprazole|omeprazole|mesh-list
83166564|NCT03146325|Bismuth|bismuth|mesh-list
83166565|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166566|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83166567|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83166568|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83166569|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83166570|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166571|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83166572|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166573|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166574|NCT03146325|Antacids|antacids|mesh-ancestor
83166575|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83166576|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83166577|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83166578|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166579|NCT02233049|Everolimus|everolimus|mesh-list
83166580|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83166581|NCT02233049|Dasatinib|dasatinib|mesh-list
83166582|NCT02233049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83166583|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83166584|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166585|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166586|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166587|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
83166588|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166589|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166590|NCT02350725|Furosemide|furosemide|mesh-list
83166591|NCT02350725|Diuretics|diuretics|mesh-ancestor
83166592|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
83166593|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166594|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83166595|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83166596|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166597|NCT02350959|Atorvastatin|atorvastatin|mesh-list
83166598|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83166599|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83166600|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
83166601|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166602|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83166603|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83166604|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166605|NCT02350335|Nicotine|nicotine|mesh-list
83166606|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83166607|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
83166608|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166609|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166610|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83166611|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83166612|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
83166613|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166614|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166615|NCT02293447|Lidocaine|lidocaine|mesh-list
83166616|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
83166617|NCT02293447|Anesthetics|anesthetics|mesh-list
83166618|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166619|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166620|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
83166621|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166622|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83166623|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83166624|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83166625|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83166626|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166627|NCT04464811|Furosemide|furosemide|mesh-list
83166628|NCT04464811|Diuretics|diuretics|mesh-ancestor
83166629|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
83166630|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166631|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83166632|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83166633|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166634|NCT02293525|Morphine|morphine|mesh-list
83166635|NCT02293525|Oxycodone|oxycodone|mesh-list
83166636|NCT02293525|Ropivacaine|ropivacaine|mesh-list
83166637|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83166638|NCT02293525|Narcotics|narcotics|mesh-ancestor
83166639|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166640|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166641|NCT02293525|Analgesics|analgesics|mesh-ancestor
83166642|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
83166643|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166644|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
83166645|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
83166646|NCT02298595|Cetuximab|cetuximab|mesh-list
83166647|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166648|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83166649|NCT02345343|Apixaban|apixaban|mesh-list
83166650|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83166651|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
83166652|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83166653|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
83166654|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166655|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166656|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
83166657|NCT03949673|Celecoxib|celecoxib|mesh-list
83166658|NCT03949673|Diclofenac|diclofenac|mesh-list
83166659|NCT03949673|Naproxen|naproxen|mesh-list
83166660|NCT03949673|Fasinumab|fasinumab|mesh-list
83166661|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83166662|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166663|NCT03949673|Analgesics|analgesics|mesh-ancestor
83166664|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
83166665|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166666|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166667|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166668|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166669|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83166670|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83166671|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166672|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166673|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
83166675|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83166676|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83166677|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166678|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
83166679|NCT02350179|Coagulants|coagulants|mesh-ancestor
83166680|NCT02233205|Gemcitabine|gemcitabine|mesh-list
83166681|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83166682|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
83166683|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166684|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166685|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83166686|NCT02293681|Infliximab|infliximab|mesh-list
83166687|NCT02293681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83166688|NCT02293681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166689|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
83166690|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83166691|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166692|NCT02259491|Calcium|calcium|mesh-list
83166693|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83166694|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166695|NCT05255523|Capecitabine|capecitabine|mesh-list
83166696|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83166697|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
83166698|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166699|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166700|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
83166701|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166702|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
83166703|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166704|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166705|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166706|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
83166707|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166708|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166709|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83166710|NCT02298985|Curcumin|curcumin|mesh-list
83166711|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
83166712|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83166713|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166714|NCT02298985|Analgesics|analgesics|mesh-ancestor
83166715|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
83166716|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166717|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166718|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166719|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166720|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166721|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166722|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166723|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83166724|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166725|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83166726|NCT03149445|Metoprolol|metoprolol|mesh-list
83166727|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83166728|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83166729|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
83166730|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
83166731|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166732|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166733|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83166734|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83166735|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83166736|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
83166737|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166738|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166739|NCT02345187|Micronutrients|micronutrients|mesh-list
83166740|NCT02345187|Trace Elements|trace elements|mesh-list
83166741|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166742|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
83166743|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83166744|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166745|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166746|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166747|NCT02299063|Analgesics|analgesics|mesh-ancestor
83166748|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
83166749|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166750|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83166751|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83166752|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83166753|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
83166754|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166755|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166756|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
83166757|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166758|NCT05624801|Vitamin D|vitamin d|mesh-list
83166759|NCT05624801|Vitamins|vitamins|mesh-ancestor
83166760|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
83166761|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166762|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83166763|NCT05255211|Propofol|propofol|mesh-list
83166764|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83166765|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83166766|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166767|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83166768|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
83166769|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
83166770|NCT03514381|Doxorubicin|doxorubicin|mesh-list
83166771|NCT03514381|Ifosfamide|ifosfamide|mesh-list
83166772|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83166773|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166774|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83166775|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83166776|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166777|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166778|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166779|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
83166780|NCT02343393|Hydralazine|hydralazine|mesh-list
83166781|NCT02343393|Isosorbide|isosorbide|mesh-list
83166782|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83166783|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83166784|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83166785|NCT02343393|Diuretics|diuretics|mesh-ancestor
83166786|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
83166787|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166788|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
83166789|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83166790|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166791|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83166792|NCT03896009|Meloxicam|meloxicam|mesh-list
83166793|NCT03896009|Rizatriptan|rizatriptan|mesh-list
83166794|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83166795|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166796|NCT03896009|Analgesics|analgesics|mesh-ancestor
83166797|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
83166798|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166799|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166800|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166801|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166802|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83166803|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83166804|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166805|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166806|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83166807|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
83166808|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166809|NCT02344875|Dotinurad|dotinurad|mesh-list
83166810|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
83166811|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
83166812|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166813|NCT03145623|Grazoprevir|grazoprevir|mesh-list
83166814|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83166815|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
83166816|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166817|NCT02294071|Acetaminophen|acetaminophen|mesh-list
83166818|NCT02294071|Ibuprofen|ibuprofen|mesh-list
83166819|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83166820|NCT02294071|Analgesics|analgesics|mesh-ancestor
83166821|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
83166822|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83166823|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166824|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
83166825|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83166826|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166827|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166828|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83166829|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166830|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166831|NCT02233439|Galactogogues|galactogogues|mesh-list
83166832|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166833|NCT02350023|Betamethasone|betamethasone|mesh-list
83166834|NCT02350023|Latanoprost|latanoprost|mesh-list
83166835|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83166836|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83166837|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166838|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
83166839|NCT02350023|Hormones|hormones|mesh-ancestor
83166840|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166841|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166842|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83166843|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
83166844|NCT02342925|Metformin|metformin|mesh-list
83166845|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83166846|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166847|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83166848|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83166849|NCT02344641|Exenatide|exenatide|mesh-list
83166850|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83166851|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166852|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83166853|NCT02344641|Incretins|incretins|mesh-ancestor
83166854|NCT02344641|Hormones|hormones|mesh-ancestor
83166855|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166856|NCT03798743|Docetaxel|docetaxel|mesh-list
83166857|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166858|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
83166859|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
83166860|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
83166861|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166862|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
83166863|NCT04083183|Sirolimus|sirolimus|mesh-list
83166864|NCT04083183|Vidarabine|vidarabine|mesh-list
83166865|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
83166866|NCT04083183|Fludarabine|fludarabine|mesh-list
83166867|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
83166868|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83166869|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
83166870|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83166871|NCT04083183|Antibodies|antibodies|mesh-list
83166872|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
83166873|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83166874|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
83166875|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83166876|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83166877|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166878|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
83166879|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166880|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166881|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166882|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
83166883|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166884|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166885|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83166886|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83166887|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
83166888|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83166889|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83166890|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
83166891|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83166892|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166893|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166894|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
83166895|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
83166896|NCT02342769|Dolutegravir|dolutegravir|mesh-list
83166897|NCT02342769|Abacavir|abacavir|mesh-list
83166898|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83166899|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83166900|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166901|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166902|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83166903|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83166904|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
83166905|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166906|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83166907|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83166908|NCT03766295|Gemcitabine|gemcitabine|mesh-list
83166909|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83166910|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
83166911|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166912|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166913|NCT03761225|Prednisone|prednisone|mesh-list
83166914|NCT03761225|Docetaxel|docetaxel|mesh-list
83166915|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166916|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
83166917|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
83166918|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83166919|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166920|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166921|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
83166922|NCT03761225|Hormones|hormones|mesh-ancestor
83166923|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166924|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166925|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83166926|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83166927|NCT02349945|Hormones|hormones|mesh-ancestor
83166928|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166929|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166930|NCT02302495|Prednisone|prednisone|mesh-list
83166931|NCT02302495|Melphalan|melphalan|mesh-list
83166932|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83166933|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
83166934|NCT02302495|Hormones|hormones|mesh-ancestor
83166935|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166936|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166937|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83166938|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166939|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83166940|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
83166941|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166942|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83166943|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166944|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
83166945|NCT02813447|Sertraline|sertraline|mesh-list
83166946|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
83166947|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83166948|NCT02813447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83166949|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83166950|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83166951|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166952|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83166953|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
83166954|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166955|NCT02342145|Cyclosporine|cyclosporine|mesh-list
83166956|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
83166957|NCT02342145|Methotrexate|methotrexate|mesh-list
83166958|NCT02342145|Cyclosporins|cyclosporins|mesh-list
83166959|NCT02342145|Basiliximab|basiliximab|mesh-list
83166960|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83166961|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
83166962|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83166963|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166964|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83166965|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
83166966|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83166967|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166968|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83166969|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83166970|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83166971|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83166972|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
83166973|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83166974|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83166975|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
83166976|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83166977|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83166978|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83166979|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83166980|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
83166981|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83166982|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
83166983|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83166984|NCT02349399|Cyproterone|cyproterone|mesh-list
83166985|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83166986|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83166987|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83166988|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83166989|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
83166990|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83166991|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83166992|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83166993|NCT02349399|Estrogens|estrogens|mesh-ancestor
83166994|NCT02349399|Hormones|hormones|mesh-ancestor
83166995|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83166996|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
83166997|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
83166998|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83166999|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83167000|NCT02306473|Mannitol|mannitol|mesh-list
83167001|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83167002|NCT02306473|Diuretics|diuretics|mesh-ancestor
83167003|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
83167004|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167005|NCT03737123|Carboplatin|carboplatin|mesh-list
83167006|NCT03737123|Gemcitabine|gemcitabine|mesh-list
83167007|NCT03737123|Docetaxel|docetaxel|mesh-list
83167008|NCT03737123|Atezolizumab|atezolizumab|mesh-list
83167009|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167010|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83167011|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
83540895|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
83167012|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167013|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167014|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167015|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167016|NCT03737123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83167017|NCT03737123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167018|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83167019|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83167020|NCT02344095|Paclitaxel|paclitaxel|mesh-list
83167021|NCT02344095|Cisplatin|cisplatin|mesh-list
83167022|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83167023|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167024|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167025|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167026|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167027|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167028|NCT00157339|Insulin|insulin|mesh-list
83167029|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83167030|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83167031|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167032|NCT02342067|Pioglitazone|pioglitazone|mesh-list
83167033|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
83167034|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83167035|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167036|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83167037|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167038|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83167039|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83167040|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
83167041|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167042|NCT02344017|Prednisone|prednisone|mesh-list
83167043|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167044|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
83167045|NCT02344017|Hormones|hormones|mesh-ancestor
83167046|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83167047|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167048|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83167049|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167050|NCT02343861|Emollients|emollients|mesh-list
83167051|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
83167052|NCT03676751|Azithromycin|azithromycin|mesh-list
83167053|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167054|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167055|NCT02302729|Micronutrients|micronutrients|mesh-list
83167056|NCT02302729|Trace Elements|trace elements|mesh-list
83167057|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167058|NCT03513601|Rituximab|rituximab|mesh-list
83167059|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167060|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167061|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
83167062|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167063|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167064|NCT03647111|Crizotinib|crizotinib|mesh-list
83167065|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167066|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167067|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167068|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167069|NCT03507829|Insulin|insulin|mesh-list
83167070|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83167071|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
83167072|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
83167073|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
83167074|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
83167075|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83167076|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167077|NCT02232581|Alovudine|alovudine|mesh-list
83167078|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
83167079|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
83167080|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167081|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
83167082|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167083|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83167084|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83167085|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167086|NCT02341833|Sevoflurane|sevoflurane|mesh-list
83167087|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83167088|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83167089|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
83167090|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
83167091|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167092|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167093|NCT02337231|Borage oil|borage oil|mesh-list
83167094|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167095|NCT03507751|Meropenem|meropenem|mesh-list
83167096|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167097|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167098|NCT02306629|Epratuzumab|epratuzumab|mesh-list
83167099|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167100|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167101|NCT03510793|Anesthetics|anesthetics|mesh-list
83167102|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167103|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167104|NCT05230797|Zinc|zinc|mesh-list
83167105|NCT05230797|Propolis|propolis|mesh-list
83167106|NCT05230797|Eugenol|eugenol|mesh-list
83167107|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
83167108|NCT05230797|Trace Elements|trace elements|mesh-ancestor
83167109|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
83167110|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167111|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167112|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
83167113|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
83167114|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83167115|NCT05230797|Protective Agents|protective agents|mesh-ancestor
83167116|NCT02341365|Vitamin D|vitamin d|mesh-list
83167117|NCT02341365|Vitamins|vitamins|mesh-ancestor
83167118|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
83167119|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167120|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83167121|NCT02299687|Omeprazole|omeprazole|mesh-list
83167122|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83167123|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167124|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83167125|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167126|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167127|NCT02349243|Entacapone|entacapone|mesh-list
83167128|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83167129|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83167130|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83167131|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167132|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167133|NCT02341209|Doxycycline|doxycycline|mesh-list
83167134|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167135|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167136|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
83167137|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83167138|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83167139|NCT02349165|Riboflavin|riboflavin|mesh-list
83167140|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
83167141|NCT02349165|Vitamins|vitamins|mesh-ancestor
83167143|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167144|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83167145|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
83167146|NCT03112005|Mydriatics|mydriatics|mesh-list
83167147|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
83167148|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167149|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167150|NCT02306785|Mesalamine|mesalamine|mesh-list
83167151|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83167152|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83167153|NCT02306785|Analgesics|analgesics|mesh-ancestor
83167154|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
83167155|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167156|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167157|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167158|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167159|NCT02299765|Carboplatin|carboplatin|mesh-list
83167160|NCT02299765|Gemcitabine|gemcitabine|mesh-list
83167161|NCT02299765|Gefitinib|gefitinib|mesh-list
83167162|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167163|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83167164|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
83167165|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167166|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167167|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167168|NCT04771923|Epinephrine|epinephrine|mesh-list
83167169|NCT04771923|Racepinephrine|racepinephrine|mesh-list
83167170|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
83167171|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
83167172|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83167173|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83167174|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167175|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
83167176|NCT04771923|Coagulants|coagulants|mesh-ancestor
83167177|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83167178|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83167179|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
83167180|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167181|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167182|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83167183|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83167184|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
83167185|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167186|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83167187|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
83167188|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
83167189|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
83167190|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83167191|NCT04718415|Paclitaxel|paclitaxel|mesh-list
83167192|NCT04718415|Carboplatin|carboplatin|mesh-list
83167193|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83167194|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167195|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167196|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167197|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167198|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167199|NCT04598321|Talazoparib|talazoparib|mesh-list
83167200|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83167201|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167202|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167203|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167204|NCT05254899|Gemcitabine|gemcitabine|mesh-list
83167205|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
83167206|NCT05254899|Tislelizumab|tislelizumab|mesh-list
83167207|NCT05254899|Pegaspargase|pegaspargase|mesh-list
83167208|NCT05254899|Antibodies|antibodies|mesh-list
83167209|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83167210|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
83167211|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167212|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83167213|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
83167214|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167215|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167216|NCT05254899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167217|NCT03148509|Risperidone|risperidone|mesh-list
83167218|NCT03148509|Aripiprazole|aripiprazole|mesh-list
83167219|NCT03148509|Bupropion|bupropion|mesh-list
83167220|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83167221|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
83167222|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167223|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167224|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167225|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83167226|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83167227|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167228|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83167229|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83167230|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
83167231|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83167232|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
83167233|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83167234|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83167235|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83167236|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83167237|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83167238|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167239|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
83167240|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83167241|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83167242|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83167243|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83167244|NCT05254665|Docetaxel|docetaxel|mesh-list
83167245|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167246|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167247|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167248|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167249|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167250|NCT03513055|Insulin|insulin|mesh-list
83167251|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83167252|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167253|NCT03510325|Olanzapine|olanzapine|mesh-list
83167254|NCT03510325|Risperidone|risperidone|mesh-list
83167255|NCT03510325|Aripiprazole|aripiprazole|mesh-list
83167256|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83167257|NCT03510325|Amisulpride|amisulpride|mesh-list
83167258|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83167259|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
83167260|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167261|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167262|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167263|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83167264|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83167265|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167266|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83167267|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83167268|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
83167269|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
83167270|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
83167271|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167272|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167273|NCT03510325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83167274|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83167275|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83167276|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
83167277|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
83167278|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83167279|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83167280|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83167281|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83167282|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83167283|NCT03507127|Varenicline|varenicline|mesh-list
83167284|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83167285|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83167286|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
83167287|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167288|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167289|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167290|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83167291|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83167292|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167293|NCT02336529|Bupivacaine|bupivacaine|mesh-list
83167294|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
83167295|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
83167296|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167297|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167298|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
83167299|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167300|NCT02307487|Mitomycins|mitomycins|mesh-list
83167301|NCT02307487|Mitomycin|mitomycin|mesh-list
83167302|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83167303|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167304|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
83167305|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167306|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83167307|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167308|NCT02307565|Midodrine|midodrine|mesh-list
83167309|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
83167310|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
83167311|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167312|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167313|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83167314|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83167315|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83167316|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83167317|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
83167318|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167319|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167320|NCT03510013|Anesthetics|anesthetics|mesh-list
83167321|NCT03510013|Sevoflurane|sevoflurane|mesh-list
83167322|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
83167323|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167324|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167325|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83167326|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
83167327|NCT02307721|Remifentanil|remifentanil|mesh-list
83167328|NCT02307721|Naloxone|naloxone|mesh-list
83167329|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83167330|NCT02307721|Narcotics|narcotics|mesh-ancestor
83167331|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167332|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167333|NCT02307721|Analgesics|analgesics|mesh-ancestor
83167334|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
83167335|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167336|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83167337|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
83167338|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83167339|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
83167340|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83167341|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
83167342|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167343|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167344|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
83167345|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83167346|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167347|NCT02348463|Clindamycin|clindamycin|mesh-list
83167348|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
83167349|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
83167350|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167351|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167352|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83167353|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167354|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167355|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
83167356|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83167357|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83167358|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
83167359|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167360|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167361|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167362|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
83167363|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
83167364|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167365|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
83167366|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83167367|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83167368|NCT02300623|Lamivudine|lamivudine|mesh-list
83167369|NCT02300623|Stavudine|stavudine|mesh-list
83167370|NCT02300623|Indinavir|indinavir|mesh-list
83167371|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83167372|NCT02300623|Interleukin-2|interleukin-2|mesh-list
83167373|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83167374|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83167375|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167376|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167377|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
83167378|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167379|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83167380|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167381|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83167382|NCT02300623|Analgesics|analgesics|mesh-ancestor
83167383|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
83167384|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167385|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167386|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
83167387|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83167388|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83167389|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
83167390|NCT04463953|Dexamethasone|dexamethasone|mesh-list
83167391|NCT04463953|Ixazomib|ixazomib|mesh-list
83167392|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
83167393|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167394|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
83167395|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
83167396|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167397|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167398|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167399|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
83167400|NCT04463953|Hormones|hormones|mesh-ancestor
83167401|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83167402|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83167403|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167404|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
83167405|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167406|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167407|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167408|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
83167409|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
83167410|NCT02307955|Protective Agents|protective agents|mesh-ancestor
83167411|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167412|NCT03147963|Docetaxel|docetaxel|mesh-list
83167413|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167414|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167415|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167416|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167417|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167418|NCT02348307|Dotinurad|dotinurad|mesh-list
83167419|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
83167420|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
83167421|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167422|NCT02340117|Paclitaxel|paclitaxel|mesh-list
83167423|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83167425|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83167426|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167427|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167428|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167429|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167430|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167431|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83167432|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
83167433|NCT02300701|Omalizumab|omalizumab|mesh-list
83167434|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83167435|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83167436|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83167437|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
83167438|NCT02336139|Velpatasvir|velpatasvir|mesh-list
83167439|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
83167440|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167441|NCT02340195|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83167442|NCT02340195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83167443|NCT02340195|Serotonin Agents|serotonin agents|mesh-ancestor
83167444|NCT02340195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167445|NCT02340195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167446|NCT02340195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167447|NCT02300935|Paclitaxel|paclitaxel|mesh-list
83167448|NCT02300935|Trametinib|trametinib|mesh-list
83167449|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83167450|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167451|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167452|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167453|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167454|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167455|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167456|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167457|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83167458|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83167459|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167460|NCT02301091|Mitomycins|mitomycins|mesh-list
83167461|NCT02301091|Mitomycin|mitomycin|mesh-list
83167463|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83167464|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167465|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
83167466|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167467|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83167468|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167469|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
83167470|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
83167471|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83167472|NCT02335593|Hematinics|hematinics|mesh-ancestor
83167473|NCT02335593|Astringents|astringents|mesh-ancestor
83167474|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167475|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83167476|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83167477|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83167478|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
83167479|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167480|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83167481|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83167482|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
83167483|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167484|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167485|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83167486|NCT02309281|Aflibercept|aflibercept|mesh-list
83167487|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83167488|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83167489|NCT02309281|Growth Substances|growth substances|mesh-ancestor
83167490|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167491|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83167492|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167493|NCT02335281|Mesalamine|mesalamine|mesh-list
83167494|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83167495|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83167496|NCT02335281|Analgesics|analgesics|mesh-ancestor
83167497|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
83167498|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167499|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167500|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167501|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167502|NCT02309437|Oxycodone|oxycodone|mesh-list
83167503|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83167504|NCT02309437|Narcotics|narcotics|mesh-ancestor
83167505|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167506|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167507|NCT02309437|Analgesics|analgesics|mesh-ancestor
83167508|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
83167509|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167510|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
83167511|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83167512|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83167513|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167514|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
83167515|NCT02335359|Coagulants|coagulants|mesh-ancestor
83167516|NCT03511261|Curcumin|curcumin|mesh-list
83167517|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83167518|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83167519|NCT03511261|Analgesics|analgesics|mesh-ancestor
83167520|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
83167521|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167522|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167523|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167524|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167525|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167526|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167527|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167528|NCT03509701|Antibodies|antibodies|mesh-list
83167529|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
83167530|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167531|NCT03511183|Bevacizumab|bevacizumab|mesh-list
83167532|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167533|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167534|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83167535|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83167536|NCT03511183|Growth Substances|growth substances|mesh-ancestor
83167537|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167538|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
83167539|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
83167540|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83167541|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83167542|NCT02303587|Prednisolone|prednisolone|mesh-list
83167543|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
83167544|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83167545|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
83167546|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167547|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
83167548|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
83167549|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167550|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167551|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167552|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
83167553|NCT02303587|Hormones|hormones|mesh-ancestor
83167554|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83167555|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83167556|NCT02303587|Protective Agents|protective agents|mesh-ancestor
83167557|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83167558|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167559|NCT03916419|Paclitaxel|paclitaxel|mesh-list
83167560|NCT03916419|Carboplatin|carboplatin|mesh-list
83167561|NCT03916419|Durvalumab|durvalumab|mesh-list
83167562|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83167563|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167564|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
83167565|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
83167566|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
83167567|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167568|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167569|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
83167570|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167571|NCT03107871|Valganciclovir|valganciclovir|mesh-list
83167572|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
83167573|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167574|NCT03064113|Ipratropium|ipratropium|mesh-list
83167575|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83167576|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
83167577|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167578|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167579|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83167580|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
83167581|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83167582|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
83167583|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167584|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167585|NCT02301715|Oxytocin|oxytocin|mesh-list
83167586|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
83167587|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167588|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167589|NCT03509545|Torsemide|torsemide|mesh-list
83167590|NCT03509545|Furosemide|furosemide|mesh-list
83167591|NCT03509545|Diuretics|diuretics|mesh-ancestor
83167592|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
83167593|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167594|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83167595|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83167596|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167597|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83167598|NCT02301949|Thalidomide|thalidomide|mesh-list
83167599|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83167600|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
83167601|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167602|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
83167603|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167604|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167605|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83167606|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83167607|NCT02301949|Growth Substances|growth substances|mesh-ancestor
83167608|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
83167609|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167610|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83167611|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
83167612|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83167613|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83167614|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83167615|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
83167616|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167617|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167618|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83167619|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83167620|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83167621|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83167622|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167623|NCT02303899|Gemcitabine|gemcitabine|mesh-list
83167624|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
83167625|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83167626|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
83167627|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167628|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167629|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167630|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167631|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83167632|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83167633|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167634|NCT03510871|Nivolumab|nivolumab|mesh-list
83167635|NCT03510871|Ipilimumab|ipilimumab|mesh-list
83167636|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167637|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167638|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83167639|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167640|NCT02331771|Donepezil|donepezil|mesh-list
83167641|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83167642|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167643|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167644|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
83167645|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167646|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167647|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
83167648|NCT02334501|Lansoprazole|lansoprazole|mesh-list
83167649|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
83167650|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83167651|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167652|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83167653|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167654|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167655|NCT02331927|Aflibercept|aflibercept|mesh-list
83167656|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83167657|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83167658|NCT02331927|Growth Substances|growth substances|mesh-ancestor
83167659|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167660|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
83167661|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167662|NCT02322190|Methoxsalen|methoxsalen|mesh-list
83167663|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83167664|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
83167665|NCT02304055|Oxytocin|oxytocin|mesh-list
83167666|NCT02304055|Carbetocin|carbetocin|mesh-list
83167667|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
83167668|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167669|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167670|NCT05012865|Avelumab|avelumab|mesh-list
83167671|NCT05012865|Axitinib|axitinib|mesh-list
83167672|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167673|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167674|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167675|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167676|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167677|NCT03505489|Mannitol|mannitol|mesh-list
83167678|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
83167679|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83167680|NCT03505489|Diuretics|diuretics|mesh-ancestor
83167681|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
83167682|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167683|NCT03505489|Miotics|miotics|mesh-ancestor
83167684|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
83167685|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167686|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83167687|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83167688|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
83167689|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83167690|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83167691|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
83167692|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167693|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167694|NCT02310373|Nicotine|nicotine|mesh-list
83167695|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83167696|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
83167697|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167698|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167699|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83167700|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83167701|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
83167702|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167703|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167704|NCT02338323|Febuxostat|febuxostat|mesh-list
83167705|NCT02338323|Benzbromarone|benzbromarone|mesh-list
83167706|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
83167707|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167708|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
83167709|NCT02321800|Imipenem|imipenem|mesh-list
83167710|NCT02321800|Cilastatin|cilastatin|mesh-list
83167711|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167712|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167713|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
83167714|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167715|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167716|NCT02310295|Triamcinolone|triamcinolone|mesh-list
83167717|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83167718|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83167719|NCT02310295|Bevacizumab|bevacizumab|mesh-list
83167720|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83167721|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167722|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167723|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83167724|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83167725|NCT02310295|Growth Substances|growth substances|mesh-ancestor
83167726|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167727|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
83167728|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167729|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
83167730|NCT02310295|Hormones|hormones|mesh-ancestor
83167731|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83167732|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83167733|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
83167734|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167735|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167736|NCT02338089|Oxytocin|oxytocin|mesh-list
83167737|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
83167738|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167739|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167740|NCT02338245|Capecitabine|capecitabine|mesh-list
83167741|NCT02338245|Lapatinib|lapatinib|mesh-list
83167742|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83167743|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
83167744|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167745|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167746|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167747|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167748|NCT02332005|Choline|choline|mesh-list
83167749|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
83167750|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83167751|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
83167752|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167753|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167754|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83167755|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
83167756|NCT02304211|Insulin|insulin|mesh-list
83167757|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83167758|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167759|NCT02311777|Pregabalin|pregabalin|mesh-list
83167760|NCT02311777|Ketamine|ketamine|mesh-list
83167761|NCT02311777|Analgesics|analgesics|mesh-ancestor
83167762|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
83167763|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167764|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167765|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83167766|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83167767|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
83167768|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
83167769|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167770|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83167771|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83167772|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167773|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167774|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
83167775|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83167776|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83167777|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83167778|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83167779|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83167780|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83167781|NCT03504865|Bupivacaine|bupivacaine|mesh-list
83167782|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
83167783|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
83167784|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167785|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167786|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
83167787|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167788|NCT02304289|Artesunate|artesunate|mesh-list
83167789|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
83167790|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83167791|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83167792|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167793|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167794|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
83167795|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
83167796|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83167797|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
83167798|NCT02292784|Atosiban|atosiban|mesh-list
83167799|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
83167800|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83167801|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167803|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167804|NCT02338011|Gefitinib|gefitinib|mesh-list
83167805|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167806|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83167807|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167808|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167809|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83167810|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83167811|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
83167812|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167814|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167815|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167816|NCT02320396|Desloratadine|desloratadine|mesh-list
83167817|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83167818|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
83167819|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167820|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167821|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167822|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83167823|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83167824|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
83167825|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
83167826|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83167827|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
83167828|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83167829|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
83167830|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167831|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167832|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83167833|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83167834|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167835|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
83167836|NCT02310997|Melphalan|melphalan|mesh-list
83167837|NCT02310997|Busulfan|busulfan|mesh-list
83167838|NCT02310997|Fludarabine|fludarabine|mesh-list
83167839|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83167840|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
83167841|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167842|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167843|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83167844|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
83167845|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167846|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167847|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83167848|NCT03505411|Melatonin|melatonin|mesh-list
83167849|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
83167850|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167851|NCT03505411|Protective Agents|protective agents|mesh-ancestor
83167852|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167853|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167854|NCT02292238|Benphothiamine|benphothiamine|mesh-list
83167855|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83167856|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
83167857|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167858|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
83167859|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
83167860|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167861|NCT02631447|Nivolumab|nivolumab|mesh-list
83167862|NCT02631447|Ipilimumab|ipilimumab|mesh-list
83167863|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83167864|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167865|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83167866|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167867|NCT03867123|Temozolomide|temozolomide|mesh-list
83167868|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83167869|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
83167870|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167871|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167872|NCT03504475|Paroxetine|paroxetine|mesh-list
83167873|NCT03504475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83167874|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83167875|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83167876|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167877|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167878|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
83167879|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167880|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83167881|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
83167882|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83167883|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83167884|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83167885|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167886|NCT02327247|Felodipine|felodipine|mesh-list
83167887|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83167888|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83167889|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83167890|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83167891|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167892|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83167893|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167894|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
83167895|NCT03505255|Neostigmine|neostigmine|mesh-list
83167896|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83167897|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167898|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167899|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
83167900|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83167901|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167902|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83167903|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
83167904|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167905|NCT02333799|Linezolid|linezolid|mesh-list
83167906|NCT02333799|Bedaquiline|bedaquiline|mesh-list
83167907|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167908|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167909|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83167910|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167911|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167912|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
83167913|NCT02311231|Heparin|heparin|mesh-list
83167914|NCT02311231|Calcium heparin|calcium heparin|mesh-list
83167915|NCT02311231|Bivalirudin|bivalirudin|mesh-list
83167916|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
83167917|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83167918|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83167919|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167920|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
83167921|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83167922|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
83167923|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167924|NCT03508999|Metronidazole|metronidazole|mesh-list
83167925|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83167926|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83167927|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83167928|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83167929|NCT03105375|Omeprazole|omeprazole|mesh-list
83167930|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83167931|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167932|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83167933|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167934|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167935|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
83167936|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83167937|NCT02304445|Estrogens|estrogens|mesh-ancestor
83167938|NCT02304445|Hormones|hormones|mesh-ancestor
83167939|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83167940|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167941|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83167942|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167943|NCT02316301|Misoprostol|misoprostol|mesh-list
83167944|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83167945|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
83167946|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167947|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167948|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83167949|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83167951|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
83167952|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83167953|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83167954|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167955|NCT02327091|Vitamins|vitamins|mesh-ancestor
83167956|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
83167957|NCT02316535|Capecitabine|capecitabine|mesh-list
83167958|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83167959|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
83167960|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167961|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167962|NCT02333253|Cetrorelix|cetrorelix|mesh-list
83167963|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83167964|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
83167965|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83167966|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167967|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
83167968|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83167969|NCT02039661|Lidocaine|lidocaine|mesh-list
83167970|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
83167971|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
83167972|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83167973|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167974|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
83167975|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167976|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83167977|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83167978|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83167979|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83167980|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167981|NCT02326779|Aspirin|aspirin|mesh-list
83167982|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83167983|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83167984|NCT02326779|Analgesics|analgesics|mesh-ancestor
83167985|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
83167986|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83167987|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83167988|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83167989|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83167990|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83167991|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83167992|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83167993|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83167994|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83167995|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83167996|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
83167997|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83167998|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83167999|NCT02312635|Cycloserine|cycloserine|mesh-list
83540896|NCT03660826|Maleic acid|maleic acid|mesh-list
83168000|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83168001|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168002|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83168003|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
83168004|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83168006|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168007|NCT03144453|Atropine|atropine|mesh-list
83168008|NCT03144453|Neostigmine|neostigmine|mesh-list
83168009|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83168010|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83168011|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83168012|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
83168013|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168014|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168015|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83168016|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
83168017|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
83168018|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
83168019|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83168020|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83168021|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
83168022|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168023|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168024|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83168025|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168026|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83168027|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
83168028|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168029|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168030|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168031|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168032|NCT02332941|Rituximab|rituximab|mesh-list
83168033|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83168034|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168035|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
83168036|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168037|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168038|NCT03503227|Aspirin|aspirin|mesh-list
83168039|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
83168040|NCT03503227|Prednisolone|prednisolone|mesh-list
83168041|NCT03503227|Salicylates|salicylates|mesh-list
83168042|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168043|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
83168044|NCT03503227|Hormones|hormones|mesh-ancestor
83168045|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168046|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168047|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83168048|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168049|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168050|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168051|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
83168052|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
83168053|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
83168054|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83168055|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168056|NCT03503227|Analgesics|analgesics|mesh-ancestor
83168057|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
83168058|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168059|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83168060|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168061|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168062|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83168063|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83168064|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83168065|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
83168066|NCT02305069|Pioglitazone|pioglitazone|mesh-list
83168067|NCT02305069|Octreotide|octreotide|mesh-list
83168068|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83168069|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168070|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168071|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83168072|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168073|NCT02317237|Anesthetics|anesthetics|mesh-list
83168074|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168075|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168076|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83168077|NCT02332473|Molgramostim|molgramostim|mesh-list
83168078|NCT02332473|Sargramostim|sargramostim|mesh-list
83168079|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
83168080|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168081|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
83168082|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168083|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168084|NCT03501433|Niacinamide|niacinamide|mesh-list
83168085|NCT03501433|Niacin|niacin|mesh-list
83168086|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
83168087|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
83168088|NCT03501433|Vitamins|vitamins|mesh-ancestor
83168089|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
83168090|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168091|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83168092|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
83168093|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168094|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83168095|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
83168096|NCT02383251|Paclitaxel|paclitaxel|mesh-list
83168097|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83168098|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168100|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83168101|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83168102|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168103|NCT02313103|Lofexidine|lofexidine|mesh-list
83168104|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83168105|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83168106|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168107|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
83168108|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168109|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83168110|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168111|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168112|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168113|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168114|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168115|NCT01959633|Interferons|interferons|mesh-list
83168116|NCT01959633|Vemurafenib|vemurafenib|mesh-list
83168117|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168118|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
83168119|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168120|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168121|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168122|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168123|NCT02326623|Anesthetics|anesthetics|mesh-list
83168124|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
83168125|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168126|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168127|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
83168128|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168130|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168131|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
83168132|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83168133|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83168134|NCT02332629|Prednisolone|prednisolone|mesh-list
83168135|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
83168136|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83168137|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
83168138|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168139|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
83168140|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
83168141|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168142|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168143|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168144|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
83168145|NCT02332629|Hormones|hormones|mesh-ancestor
83168146|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168147|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83168148|NCT02332629|Protective Agents|protective agents|mesh-ancestor
83168149|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83168150|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168151|NCT02313337|Fentanyl|fentanyl|mesh-list
83168152|NCT02313337|Midazolam|midazolam|mesh-list
83168153|NCT02313337|Anesthetics|anesthetics|mesh-list
83168154|NCT02313337|Propofol|propofol|mesh-list
83168155|NCT02313337|Atracurium|atracurium|mesh-list
83168156|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168157|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168158|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83168159|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83168160|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
83168161|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83168162|NCT02313337|Narcotics|narcotics|mesh-ancestor
83168163|NCT02313337|Analgesics|analgesics|mesh-ancestor
83168164|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
83168165|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168166|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83168167|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83168168|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83168169|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83168170|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
83168171|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
83168172|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168173|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168174|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83168175|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83168176|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83168177|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83168178|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83168179|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
83168180|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83168181|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83168182|NCT02330757|Clomiphene|clomiphene|mesh-list
83168183|NCT02330757|Enclomiphene|enclomiphene|mesh-list
83168184|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
83168185|NCT02330757|Estradiol|estradiol|mesh-list
83168186|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83168187|NCT02330757|Estrogens|estrogens|mesh-ancestor
83168188|NCT02330757|Hormones|hormones|mesh-ancestor
83168189|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168190|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168191|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83168192|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
83168193|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83168194|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83168195|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83168196|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
83168197|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83168198|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
83168199|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83168200|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83168201|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83168202|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168203|NCT02305615|Bevacizumab|bevacizumab|mesh-list
83168204|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83168205|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168206|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83168207|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83168208|NCT02305615|Growth Substances|growth substances|mesh-ancestor
83168209|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168210|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
83168211|NCT02305693|Letrozole|letrozole|mesh-list
83168212|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168213|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83168214|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83168215|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168216|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168217|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83168218|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
83168219|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168220|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168221|NCT02317861|Febuxostat|febuxostat|mesh-list
83168222|NCT02317861|Verinurad|verinurad|mesh-list
83168223|NCT02317861|Benzbromarone|benzbromarone|mesh-list
83168224|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
83168225|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168226|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
83168227|NCT02318017|Methylphenidate|methylphenidate|mesh-list
83168228|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83168229|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168230|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83168231|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83168232|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83168233|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168234|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
83168235|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168236|NCT02313727|Pamidronate|pamidronate|mesh-list
83168237|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83168238|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168239|NCT02313805|Insulin|insulin|mesh-list
83168240|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83168241|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168242|NCT03132493|Nivolumab|nivolumab|mesh-list
83168243|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83168244|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168245|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83168246|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168247|NCT02313883|Taurolidine|taurolidine|mesh-list
83168248|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168249|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83168250|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168251|NCT03500653|Curcumin|curcumin|mesh-list
83168252|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83168253|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168254|NCT03500653|Analgesics|analgesics|mesh-ancestor
83168255|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
83168256|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168257|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168258|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168259|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168260|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168261|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168262|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168263|NCT02305927|Vitamin D|vitamin d|mesh-list
83168264|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
83168265|NCT02305927|Vitamins|vitamins|mesh-ancestor
83168266|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
83168267|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168268|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83168269|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83168270|NCT02440009|Itraconazole|itraconazole|mesh-list
83168271|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
83168272|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
83168273|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168274|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83168275|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83168276|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168277|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168278|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83168279|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
83168280|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168281|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168282|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83168283|NCT02440009|Hormones|hormones|mesh-ancestor
83168284|NCT02318563|Cannabidiol|cannabidiol|mesh-list
83168285|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83168286|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
83168287|NCT02314195|Serotonin|serotonin|mesh-list
83168288|NCT02314195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83168289|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83168290|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
83168291|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168292|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168293|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168294|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83168295|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83168296|NCT02314273|Oprelvekin|oprelvekin|mesh-list
83168297|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168298|NCT02314351|Fentanyl|fentanyl|mesh-list
83168299|NCT02314351|Metoclopramide|metoclopramide|mesh-list
83168300|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83168301|NCT02314351|Narcotics|narcotics|mesh-ancestor
83168302|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168303|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168304|NCT02314351|Analgesics|analgesics|mesh-ancestor
83168305|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
83168306|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168307|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83168308|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83168309|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
83168310|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
83168311|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
83168312|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
83168313|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168314|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83168315|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83168316|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
83168317|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83541187|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
83168318|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168320|NCT04463875|Riboflavin|riboflavin|mesh-list
83168321|NCT04463875|Ubiquinone|ubiquinone|mesh-list
83168322|NCT04463875|Andrographolide|andrographolide|mesh-list
83168323|NCT04463875|Vitamins|vitamins|mesh-ancestor
83168324|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
83168325|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168326|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
83168327|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83168328|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83168329|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168330|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83168331|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168332|NCT04463875|Analgesics|analgesics|mesh-ancestor
83168333|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
83168334|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168335|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168336|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83168337|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83168338|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168339|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
83168340|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83168341|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
83168342|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83168343|NCT02330991|Temozolomide|temozolomide|mesh-list
83168344|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83168345|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
83168346|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168347|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168348|NCT04462939|Micronutrients|micronutrients|mesh-list
83168349|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168350|NCT02306239|Terlipressin|terlipressin|mesh-list
83168351|NCT02306239|Norepinephrine|norepinephrine|mesh-list
83168352|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168353|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168354|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168355|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168356|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168357|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168358|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
83168359|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
83168360|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168361|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83168362|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83168363|NCT02319187|Irinotecan|irinotecan|mesh-list
83168364|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83168365|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83168366|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168367|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168368|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168369|NCT02319265|Melatonin|melatonin|mesh-list
83168370|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
83168371|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168372|NCT02319265|Protective Agents|protective agents|mesh-ancestor
83168373|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168374|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168375|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
83168376|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83168377|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83168378|NCT02319343|Prednisolone|prednisolone|mesh-list
83168379|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
83168380|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83168381|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
83168382|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168383|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
83168384|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
83168385|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168386|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168387|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168388|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
83168389|NCT02319343|Hormones|hormones|mesh-ancestor
83168390|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168391|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83168392|NCT02319343|Protective Agents|protective agents|mesh-ancestor
83168393|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83168394|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168395|NCT02319499|Vitamin A|vitamin a|mesh-list
83168396|NCT02319499|Iron|iron|mesh-list
83168397|NCT02319499|Zinc|zinc|mesh-list
83168398|NCT02319499|Vitamins|vitamins|mesh-ancestor
83168399|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
83168400|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168401|NCT02319499|Trace Elements|trace elements|mesh-ancestor
83168402|NCT03499639|Ritonavir|ritonavir|mesh-list
83168403|NCT03499639|Ribavirin|ribavirin|mesh-list
83168404|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83168405|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83168406|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83168407|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168408|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168409|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83168410|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83168411|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
83168412|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168413|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83168414|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83168415|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
83168416|NCT03502135|Phenylephrine|phenylephrine|mesh-list
83168417|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
83168418|NCT03502135|Tetracaine|tetracaine|mesh-list
83168419|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
83168420|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
83168421|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168422|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168423|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
83168424|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168425|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168426|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168427|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168428|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168429|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168430|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
83168431|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
83168432|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
83168433|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83168434|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
83168435|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83168436|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
83168437|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83168438|NCT03502135|Protective Agents|protective agents|mesh-ancestor
83168439|NCT02315287|Pioglitazone|pioglitazone|mesh-list
83168440|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83168441|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168442|NCT02319577|Vinorelbine|vinorelbine|mesh-list
83168443|NCT02319577|Gefitinib|gefitinib|mesh-list
83168444|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83168445|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168446|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83168447|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83168448|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83168449|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168450|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168451|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168452|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83168453|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168454|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
83168455|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83168456|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168457|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168458|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168460|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
83168461|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168462|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83168463|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168464|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168465|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168466|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168467|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168468|NCT03499171|Citalopram|citalopram|mesh-list
83168469|NCT03499171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83168470|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83168471|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83168472|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168473|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168474|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
83168475|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168476|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83168477|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
83168478|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83168479|NCT02447419|Gefitinib|gefitinib|mesh-list
83168480|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168481|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168482|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168483|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168484|NCT02319889|Paclitaxel|paclitaxel|mesh-list
83168485|NCT02319889|Carboplatin|carboplatin|mesh-list
83168486|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83168487|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83168488|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168489|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
83168490|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
83168491|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
83168492|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168493|NCT02324413|Clonidine|clonidine|mesh-list
83168494|NCT02324413|Analgesics|analgesics|mesh-ancestor
83168495|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
83168496|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168497|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168498|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83168499|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
83168500|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
83168501|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83168502|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168503|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168504|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168505|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168506|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168507|NCT03498703|Azathioprine|azathioprine|mesh-list
83168508|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
83168509|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168510|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83168511|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168512|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83168513|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
83168514|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168515|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168517|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83168518|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83168519|NCT02324491|Growth Substances|growth substances|mesh-ancestor
83168520|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168521|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
83168522|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168523|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83168524|NCT03494257|Brinzolamide|brinzolamide|mesh-list
83168525|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83168526|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83168527|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168528|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168529|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168530|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168531|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168532|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168533|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83168534|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168535|NCT03132181|Empagliflozin|empagliflozin|mesh-list
83168536|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83168537|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168538|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83168539|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168540|NCT02320045|Exenatide|exenatide|mesh-list
83168541|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83168542|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168543|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83168544|NCT02320045|Incretins|incretins|mesh-ancestor
83168545|NCT02320045|Hormones|hormones|mesh-ancestor
83168546|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168547|NCT02320357|Clopidogrel|clopidogrel|mesh-list
83168548|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83168549|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83168550|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83168551|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83168552|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
83168553|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168554|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168555|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168556|NCT03498235|Propofol|propofol|mesh-list
83168557|NCT03498235|Sevoflurane|sevoflurane|mesh-list
83168558|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83168559|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168560|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168561|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83168562|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
83168563|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
83168564|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83168565|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83168566|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
83168567|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83168568|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
83168569|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168570|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
83168571|NCT03491761|Protective Agents|protective agents|mesh-ancestor
83168572|NCT03132103|Vitamin D|vitamin d|mesh-list
83168573|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
83168574|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
83168575|NCT03132103|Vitamins|vitamins|mesh-list
83168576|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
83168577|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168578|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83168579|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83168580|NCT04635943|Ivermectin|ivermectin|mesh-list
83168581|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83168582|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168583|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83168584|NCT04461925|Azithromycin|azithromycin|mesh-list
83168585|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
83168586|NCT04461925|Dexamethasone|dexamethasone|mesh-list
83168587|NCT04461925|Enoxaparin|enoxaparin|mesh-list
83168588|NCT04461925|Anticoagulants|anticoagulants|mesh-list
83168589|NCT04461925|Hormones|hormones|mesh-list
83168590|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168591|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
83168592|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
83168593|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168594|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168595|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168596|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
83168597|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168598|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83168599|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168600|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168601|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168602|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83168603|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83168604|NCT02325583|Midazolam|midazolam|mesh-list
83168605|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83168606|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83168607|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168608|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168609|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83168610|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83168611|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83168612|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83168613|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
83168614|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
83168615|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
83168616|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
83168617|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168618|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168619|NCT02321293|Curcumin|curcumin|mesh-list
83168620|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83168621|NCT02321293|Gefitinib|gefitinib|mesh-list
83168622|NCT02321293|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83168623|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168624|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168625|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168626|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168627|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83168628|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168629|NCT02321293|Analgesics|analgesics|mesh-ancestor
83168630|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
83168631|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168632|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168633|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168634|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168635|NCT02321371|Rifaximin|rifaximin|mesh-list
83168636|NCT02321371|Lactulose|lactulose|mesh-list
83168637|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83168638|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168639|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168640|NCT04002037|Dexamethasone|dexamethasone|mesh-list
83168641|NCT04002037|Triamcinolone|triamcinolone|mesh-list
83168642|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83168643|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83168644|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83168645|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168646|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
83168647|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
83168648|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168649|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168650|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168651|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
83168652|NCT04002037|Hormones|hormones|mesh-ancestor
83168653|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168654|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83168655|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168656|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83168657|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
83168658|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168659|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168660|NCT03491371|Apatinib|apatinib|mesh-list
83168661|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168662|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168663|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168664|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168665|NCT03546829|Vancomycin|vancomycin|mesh-list
83168666|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83168667|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168668|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
83168669|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83168670|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83168671|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83168672|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83168673|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168674|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
83168675|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168676|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168677|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83168678|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168679|NCT03493087|Vitamin K|vitamin k|mesh-list
83168680|NCT03493087|Vitamins|vitamins|mesh-ancestor
83168681|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
83168682|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168683|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83168684|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83168685|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168686|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
83168687|NCT03493087|Coagulants|coagulants|mesh-ancestor
83168689|NCT03136627|Tivozanib|tivozanib|mesh-list
83168690|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83168691|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168692|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83168693|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168694|NCT03136627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168695|NCT03136627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168696|NCT02922985|Acetaminophen|acetaminophen|mesh-list
83168697|NCT02922985|Ketorolac|ketorolac|mesh-list
83168698|NCT02922985|Bupivacaine|bupivacaine|mesh-list
83168699|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
83168700|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
83168701|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168702|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168703|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
83168704|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168705|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83168706|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168707|NCT02922985|Analgesics|analgesics|mesh-ancestor
83168708|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168709|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168710|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83168711|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168712|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168713|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
83168715|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83168716|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83168717|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168718|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168719|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83168720|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83168721|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
83168722|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168723|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168724|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
83168725|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83168726|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
83168727|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83168728|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
83168729|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168730|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168731|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
83168732|NCT03492931|Ticagrelor|ticagrelor|mesh-list
83168733|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83168734|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83168735|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83168736|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83168737|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
83168738|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168739|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168740|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168741|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
83168742|NCT04715191|Fludarabine|fludarabine|mesh-list
83168743|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
83168744|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83168745|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
83168746|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168747|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168748|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83168749|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
83168750|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168751|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168752|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83168753|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83168754|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
83168755|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
83168756|NCT02234921|Imiquimod|imiquimod|mesh-list
83168757|NCT02234921|Vaccines|vaccines|mesh-list
83168758|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
83168759|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168760|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83168761|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168762|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83168763|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
83168764|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168765|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168766|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83168767|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83168768|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
83168769|NCT02321761|Amantadine|amantadine|mesh-list
83168770|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83168771|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83168772|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
83168773|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168774|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
83168775|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168776|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168777|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168778|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168779|NCT02321761|Analgesics|analgesics|mesh-ancestor
83168780|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
83168781|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168782|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
83168783|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83168784|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168785|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168786|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168787|NCT04674241|Analgesics|analgesics|mesh-ancestor
83168788|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
83168789|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168790|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83168791|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168792|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168793|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168794|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168795|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168796|NCT02259647|Sorafenib|sorafenib|mesh-list
83168797|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168798|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83168799|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168800|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168801|NCT02321839|Ranibizumab|ranibizumab|mesh-list
83168802|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83168803|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83168804|NCT02321839|Growth Substances|growth substances|mesh-ancestor
83168805|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168806|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
83168807|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168808|NCT03490279|Lactoferrin|lactoferrin|mesh-list
83168809|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168810|NCT02750345|Nitisinone|nitisinone|mesh-list
83168811|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168812|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168813|NCT01329263|Menthol|menthol|mesh-list
83168814|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
83168815|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
83168816|NCT03490123|Azithromycin|azithromycin|mesh-list
83168817|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83168818|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168819|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
83168820|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83168821|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168822|NCT02182687|Doxorubicin|doxorubicin|mesh-list
83168823|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83168824|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83168825|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168826|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83168827|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83168828|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168829|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168830|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83168831|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83168832|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83168833|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168834|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83168835|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83168836|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83168837|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83168838|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83168839|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83168840|NCT01388491|Desogestrel|desogestrel|mesh-list
83168841|NCT01388491|Estradiol|estradiol|mesh-list
83168842|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83168843|NCT01388491|Estrogens|estrogens|mesh-ancestor
83168844|NCT01388491|Hormones|hormones|mesh-ancestor
83168845|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168846|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168847|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83168848|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
83168849|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83168850|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83168851|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83168852|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83168853|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83168854|NCT01388491|Progestins|progestins|mesh-ancestor
83168855|NCT02236169|Bromides|bromides|mesh-list
83168856|NCT02236169|Norflurane|norflurane|mesh-list
83168857|NCT02236169|Ipratropium|ipratropium|mesh-list
83168858|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
83168859|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83168860|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
83168861|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168862|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168863|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83168864|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
83168865|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83168866|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
83168867|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168868|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168869|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
83541416|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
83168870|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168871|NCT02749799|Betamethasone|betamethasone|mesh-list
83168872|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
83168873|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83168874|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
83168875|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83168876|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83168877|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
83168879|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168880|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168881|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83168882|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83168883|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83168884|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83168885|NCT03492385|Ticagrelor|ticagrelor|mesh-list
83168886|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83168887|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83168888|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83168889|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83168890|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
83168891|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168892|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168893|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168894|NCT03736265|Carvedilol|carvedilol|mesh-list
83168895|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83168896|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83168897|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168898|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168899|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168900|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168901|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83168902|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
83168903|NCT03736265|Protective Agents|protective agents|mesh-ancestor
83168904|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83168905|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83168906|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83168907|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
83168908|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83168909|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83168910|NCT04939363|Venetoclax|venetoclax|mesh-list
83168911|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
83168912|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168913|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83168914|NCT02236403|Metronidazole|metronidazole|mesh-list
83168915|NCT02236403|Ivermectin|ivermectin|mesh-list
83168916|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168917|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83168918|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83168919|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83168920|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83168921|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83168922|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
83168923|NCT03491527|Pemetrexed|pemetrexed|mesh-list
83168924|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168925|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168926|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168927|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83168928|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83168929|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83168930|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
83168931|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
83168932|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
83168933|NCT02934529|Leucovorin|leucovorin|mesh-list
83168934|NCT02934529|Folic Acid|folic acid|mesh-list
83168935|NCT02934529|Bevacizumab|bevacizumab|mesh-list
83168936|NCT02934529|Cetuximab|cetuximab|mesh-list
83168937|NCT02934529|Fluorouracil|fluorouracil|mesh-list
83168938|NCT02934529|Capecitabine|capecitabine|mesh-list
83168939|NCT02934529|Irinotecan|irinotecan|mesh-list
83168940|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
83168941|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83168942|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83168943|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83168944|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83168945|NCT02934529|Growth Substances|growth substances|mesh-ancestor
83168946|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168947|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
83168948|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
83168949|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168950|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83168951|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83168952|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
83168953|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83168954|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83168955|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168956|NCT02934529|Antidotes|antidotes|mesh-ancestor
83168957|NCT02934529|Protective Agents|protective agents|mesh-ancestor
83168958|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
83168959|NCT02934529|Vitamins|vitamins|mesh-ancestor
83168960|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
83168961|NCT02934529|Hematinics|hematinics|mesh-ancestor
83168962|NCT02638805|Metformin|metformin|mesh-list
83168963|NCT02638805|Liraglutide|liraglutide|mesh-list
83168964|NCT02638805|Exenatide|exenatide|mesh-list
83168965|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83168966|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168967|NCT02638805|Incretins|incretins|mesh-ancestor
83168968|NCT02638805|Hormones|hormones|mesh-ancestor
83168969|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83168970|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83168971|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
83168972|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83168973|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83168974|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168975|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83168976|NCT02261675|Analgesics|analgesics|mesh-ancestor
83168977|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
83168978|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83168979|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83168980|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83168981|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83168982|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
83168983|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83168984|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168985|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83168986|NCT02262143|Fenofibrate|fenofibrate|mesh-list
83168987|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83168988|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83168989|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
83168990|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83168991|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83168992|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83168993|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83168994|NCT02620553|Insulin|insulin|mesh-list
83168995|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83168996|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83168997|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83168998|NCT04588727|Aspirin|aspirin|mesh-list
83168999|NCT04588727|Ticagrelor|ticagrelor|mesh-list
83169000|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169001|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169002|NCT04588727|Analgesics|analgesics|mesh-ancestor
83169003|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
83541492|NCT02626455|Rituximab|rituximab|mesh-list
83169004|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169005|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169006|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169007|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169008|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83169009|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83169010|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169011|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83169012|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83169013|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169014|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
83169015|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83169016|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83169017|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83169018|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
83169019|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169020|NCT02262299|Pirfenidone|pirfenidone|mesh-list
83169021|NCT02262299|Analgesics|analgesics|mesh-ancestor
83169022|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
83169023|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169024|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169025|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169026|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169027|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169028|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169029|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169030|NCT02608697|Atorvastatin|atorvastatin|mesh-list
83169031|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83169032|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83169033|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
83169034|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169035|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83169036|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83169037|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169038|NCT02262455|Doxorubicin|doxorubicin|mesh-list
83169039|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83169040|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83169041|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169042|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83169043|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83169044|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169045|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169047|NCT02262533|Apixaban|apixaban|mesh-list
83169048|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83169049|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
83169050|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83169051|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
83169052|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169053|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169054|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
83169055|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83169056|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83169057|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
83169058|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
83169059|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169060|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169061|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83169062|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83169063|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83169064|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83169065|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169066|NCT02262611|Telmisartan|telmisartan|mesh-list
83169067|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83169068|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83169069|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83169070|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83169071|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169072|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83169073|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83169074|NCT02262611|Diuretics|diuretics|mesh-ancestor
83169075|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
83169076|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169077|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
83169078|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
83169079|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
83169080|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169081|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169082|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83169083|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
83169084|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83169085|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
83169086|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83169087|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83169088|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169089|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83169090|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169091|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83169092|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169093|NCT02543567|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83169094|NCT02543567|Antiviral Agents|antiviral agents|mesh-ancestor
83169095|NCT02543567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169096|NCT02515175|Vaccines|vaccines|mesh-list
83169097|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
83169098|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169099|NCT02513303|Sirolimus|sirolimus|mesh-list
83169100|NCT02513303|Temsirolimus|temsirolimus|mesh-list
83169101|NCT02513303|MTOR Inhibitors|mtor inhibitors|mesh-list
83169102|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83169103|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169104|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83169105|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169106|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
83169107|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83169108|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
83169109|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169110|NCT02513303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83169111|NCT02513303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169112|NCT02513303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169113|NCT01616303|Paclitaxel|paclitaxel|mesh-list
83169114|NCT01616303|Carboplatin|carboplatin|mesh-list
83169115|NCT01616303|Oregovomab|oregovomab|mesh-list
83169116|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83169117|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169118|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169119|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169120|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169121|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169122|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169123|NCT01590719|Leucovorin|leucovorin|mesh-list
83169124|NCT01590719|Folic Acid|folic acid|mesh-list
83169125|NCT01590719|Fluorouracil|fluorouracil|mesh-list
83169126|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
83169127|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
83169128|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
83169129|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169130|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83169131|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169132|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83169133|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
83169134|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169135|NCT01590719|Antidotes|antidotes|mesh-ancestor
83169136|NCT01590719|Protective Agents|protective agents|mesh-ancestor
83169137|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
83169138|NCT01590719|Vitamins|vitamins|mesh-ancestor
83169139|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
83169140|NCT01590719|Hematinics|hematinics|mesh-ancestor
83169141|NCT01536041|Montelukast|montelukast|mesh-list
83169142|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83169143|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
83169144|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83169145|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
83169146|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169147|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169148|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83169149|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83169150|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169151|NCT01534403|Epratuzumab|epratuzumab|mesh-list
83169152|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169153|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169154|NCT01522469|Crenolanib|crenolanib|mesh-list
83169155|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169156|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
83169157|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83169158|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169159|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83169160|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83169161|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169162|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169163|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169164|NCT02264093|Propranolol|propranolol|mesh-list
83169165|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83169166|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83169167|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
83169168|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169169|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169170|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169171|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83169172|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83169173|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
83169174|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
83169175|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83169176|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83169177|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
83169178|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169179|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83169180|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
83169181|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83169182|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
83169183|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169184|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169185|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83169186|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
83169187|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169188|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169189|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83169190|NCT01516073|Fluticasone|fluticasone|mesh-list
83169191|NCT01516073|Xhance|xhance|mesh-list
83169192|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169193|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83169194|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
83169195|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169196|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169197|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83169198|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
83169199|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
83169200|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83169201|NCT01495247|Paclitaxel|paclitaxel|mesh-list
83169202|NCT01495247|Dactolisib|dactolisib|mesh-list
83169203|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83169204|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169205|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169206|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169207|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169208|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169209|NCT01495013|Glimepiride|glimepiride|mesh-list
83169210|NCT01495013|Atorvastatin|atorvastatin|mesh-list
83169211|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83169212|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83169213|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
83169214|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169215|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83169216|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83169217|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169218|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83169219|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83169220|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169221|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83169222|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
83169223|NCT02264171|Ketoconazole|ketoconazole|mesh-list
83169225|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83169226|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83169227|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83169228|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83169229|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169230|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169231|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169232|NCT02264171|Urological Agents|urological agents|mesh-ancestor
83169233|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
83169234|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169235|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83169236|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83169237|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169238|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83169239|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
83169240|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169241|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83169242|NCT01481051|Latanoprost|latanoprost|mesh-list
83169243|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83169244|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83169245|NCT01480583|Alovudine|alovudine|mesh-list
83169246|NCT01480583|Trastuzumab|trastuzumab|mesh-list
83169247|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169248|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169249|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
83169250|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169251|NCT01470131|Dexamethasone|dexamethasone|mesh-list
83169252|NCT01470131|Bortezomib|bortezomib|mesh-list
83169253|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169254|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
83169255|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
83169256|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169257|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169258|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83169259|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
83169260|NCT01470131|Hormones|hormones|mesh-ancestor
83169261|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169262|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83169263|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169264|NCT02264561|Caffeine|caffeine|mesh-list
83169265|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83169266|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169267|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83169268|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169269|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169270|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83169271|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83169272|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
83169273|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169274|NCT01464437|Metformin|metformin|mesh-list
83169275|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83169276|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169277|NCT01461317|Etrolizumab|etrolizumab|mesh-list
83169278|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83169279|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
83169280|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169281|NCT01449071|Epratuzumab|epratuzumab|mesh-list
83169282|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169283|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169284|NCT01445795|Ribavirin|ribavirin|mesh-list
83169285|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
83169286|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169287|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
83169288|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169289|NCT02264795|Lidocaine|lidocaine|mesh-list
83169290|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
83169291|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
83169292|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169293|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169294|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
83169295|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169296|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83169297|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83169298|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83169299|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83169300|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169301|NCT02264873|Decitabine|decitabine|mesh-list
83169302|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83169303|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
83169304|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169305|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169306|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169307|NCT00156533|Zolpidem|zolpidem|mesh-list
83169308|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83169309|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83169310|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169311|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169312|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83169313|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
83169314|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
83169315|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169316|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169317|NCT01410695|Methotrexate|methotrexate|mesh-list
83169318|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83169319|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
83169320|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83169321|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169322|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83169323|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
83169324|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169325|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169326|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
83169327|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169328|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83169329|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83169330|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
83169331|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169332|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83169333|NCT01660022|Piperaquine|piperaquine|mesh-list
83169334|NCT01660022|Artefenomel|artefenomel|mesh-list
83169335|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
83169336|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83169337|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83169338|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169339|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
83169340|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83169341|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
83169342|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169343|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
83169344|NCT02265575|Protective Agents|protective agents|mesh-ancestor
83169345|NCT02265731|Rituximab|rituximab|mesh-list
83169346|NCT02265731|Venetoclax|venetoclax|mesh-list
83169347|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169348|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169349|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
83169350|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169351|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169352|NCT02265809|Aldesleukin|aldesleukin|mesh-list
83169353|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169354|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83169355|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83169356|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
83169357|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169358|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
83169359|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83169360|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
83169361|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169362|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
83169363|NCT01372475|Protective Agents|protective agents|mesh-ancestor
83169364|NCT00156065|Haloperidol|haloperidol|mesh-list
83169365|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
83169366|NCT00156065|Asenapine|asenapine|mesh-list
83169367|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
83169368|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
83169369|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169370|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169371|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83169372|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83169373|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83169374|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169375|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83169376|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83169377|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
83169378|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169379|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169380|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83169381|NCT04476173|Morphine|morphine|mesh-list
83169382|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
83169383|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83169384|NCT04476173|Narcotics|narcotics|mesh-ancestor
83169385|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169386|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169387|NCT04476173|Analgesics|analgesics|mesh-ancestor
83169388|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
83169389|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169390|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83169391|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
83169392|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
83169393|NCT01554956|Plasminogen|plasminogen|mesh-list
83169394|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83169395|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83169396|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169397|NCT01360853|Gemcitabine|gemcitabine|mesh-list
83169398|NCT01360853|ON 01910|on 01910|mesh-list
83169399|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83169400|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
83169401|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169402|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169403|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83169404|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169405|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83169406|NCT01355393|Sargramostim|sargramostim|mesh-list
83169407|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
83169408|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169409|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
83169410|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169411|NCT02266355|Omalizumab|omalizumab|mesh-list
83169412|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83169413|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83169414|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
83169415|NCT02266511|Tamsulosin|tamsulosin|mesh-list
83169416|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83169417|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83169418|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83169419|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83169420|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169421|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169422|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169423|NCT02266511|Urological Agents|urological agents|mesh-ancestor
83169424|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
83169425|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169426|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83169427|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83169428|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83169429|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169430|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169431|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169432|NCT01298687|Travoprost|travoprost|mesh-list
83169433|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83169434|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83169435|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83169436|NCT02267057|Acetaminophen|acetaminophen|mesh-list
83169437|NCT02267057|Buprenorphine|buprenorphine|mesh-list
83169438|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169439|NCT02267057|Analgesics|analgesics|mesh-ancestor
83169440|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
83169441|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169442|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169443|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
83169444|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83169445|NCT02267057|Narcotics|narcotics|mesh-ancestor
83169446|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169447|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83169448|NCT05260541|Pramoxine|pramoxine|mesh-list
83169449|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
83169450|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
83169451|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169452|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169453|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
83169454|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169455|NCT01262261|Buprenorphine|buprenorphine|mesh-list
83169456|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83169457|NCT01262261|Narcotics|narcotics|mesh-ancestor
83169458|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169459|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169460|NCT01262261|Analgesics|analgesics|mesh-ancestor
83169461|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
83169462|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169463|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83169464|NCT02267681|Fentanyl|fentanyl|mesh-list
83169465|NCT02267681|Alfentanil|alfentanil|mesh-list
83169466|NCT02267681|Propofol|propofol|mesh-list
83169467|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83169468|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169469|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169470|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83169471|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
83169472|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
83169473|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83169474|NCT02267681|Narcotics|narcotics|mesh-ancestor
83169475|NCT02267681|Analgesics|analgesics|mesh-ancestor
83169476|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
83169477|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169478|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83169479|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
83169480|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83169481|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83169482|NCT05177939|Prednisolone|prednisolone|mesh-list
83169483|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
83169484|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83169485|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
83169486|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
83169487|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83169488|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
83169489|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83169490|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169491|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
83169492|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
83169493|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169494|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169495|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83169496|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
83169497|NCT05177939|Hormones|hormones|mesh-ancestor
83169498|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169499|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83169500|NCT05177939|Protective Agents|protective agents|mesh-ancestor
83169501|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83169502|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169503|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
83169504|NCT05174507|Empagliflozin|empagliflozin|mesh-list
83541493|NCT02626455|Doxorubicin|doxorubicin|mesh-list
83169505|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83169506|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83169507|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169508|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83169509|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169510|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169512|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
83169513|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83169514|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83169515|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169516|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169517|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169518|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169520|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169521|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169522|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
83169523|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169524|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169525|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
83169526|NCT02268149|Prednisone|prednisone|mesh-list
83169527|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169528|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
83169529|NCT02268149|Hormones|hormones|mesh-ancestor
83169530|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169531|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169532|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83169533|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169534|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83169535|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
83169536|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169537|NCT01255709|Epinephrine|epinephrine|mesh-list
83169538|NCT01255709|Racepinephrine|racepinephrine|mesh-list
83169539|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
83169540|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83169541|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83169542|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
83169543|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169544|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169545|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169546|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83169547|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83169548|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
83169549|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169550|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83169551|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
83169552|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
83169553|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
83169554|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83169555|NCT02233907|Oxitropium|oxitropium|mesh-list
83169556|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
83169557|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
83169558|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169559|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169560|NCT01253603|Fluticasone|fluticasone|mesh-list
83169561|NCT01253603|Xhance|xhance|mesh-list
83169562|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
83169563|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169564|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83169565|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
83169566|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169567|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169568|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83169569|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
83169570|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83169571|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83169572|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83169573|NCT01253603|Growth Substances|growth substances|mesh-ancestor
83169574|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
83169575|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169576|NCT02268383|Luspatercept|luspatercept|mesh-list
83169577|NCT02268383|Hematinics|hematinics|mesh-ancestor
83169578|NCT01329419|Adefovir|adefovir|mesh-list
83169579|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83169580|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
83169581|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169582|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83169583|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83169584|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169585|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169586|NCT01235039|Insulin|insulin|mesh-list
83169587|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
83169588|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83169589|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83169590|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169591|NCT01234025|Prednisone|prednisone|mesh-list
83169592|NCT01234025|Docetaxel|docetaxel|mesh-list
83169593|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169594|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169595|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169596|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169597|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169598|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169599|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
83169601|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169602|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169603|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83169604|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83169605|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169606|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83169607|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169608|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169609|NCT01207115|Naproxen|naproxen|mesh-list
83169610|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169611|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169612|NCT01207115|Analgesics|analgesics|mesh-ancestor
83169613|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
83169614|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169615|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169616|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169617|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169618|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
83169619|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83169620|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169621|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169622|NCT01186991|Paclitaxel|paclitaxel|mesh-list
83169623|NCT01186991|Bevacizumab|bevacizumab|mesh-list
83169624|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83169625|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83169626|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169627|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169628|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169629|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169630|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169631|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169632|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83169633|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83169634|NCT01186991|Growth Substances|growth substances|mesh-ancestor
83169635|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169636|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
83169637|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
83169638|NCT02268773|Aspirin|aspirin|mesh-list
83169639|NCT02268773|Dipyridamole|dipyridamole|mesh-list
83169640|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
83169641|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169642|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169643|NCT02268773|Analgesics|analgesics|mesh-ancestor
83169644|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
83169645|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169646|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169647|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169648|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169649|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83169650|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83169651|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169652|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83169653|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83169654|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169655|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
83169656|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83169657|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
83169658|NCT01183949|Bortezomib|bortezomib|mesh-list
83169659|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169660|NCT01092065|Levodopa|levodopa|mesh-list
83169661|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83169662|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83169663|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
83169664|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83478121|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169665|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169666|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169667|NCT05626829|Tranilast|tranilast|mesh-list
83169668|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169669|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169670|NCT05626829|Analgesics|analgesics|mesh-ancestor
83169671|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
83169672|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169673|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169674|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169675|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169676|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83169677|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83169678|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169679|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83169680|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83169681|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
83169682|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
83169683|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169684|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83169685|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83169687|NCT01173497|Iniparib|iniparib|mesh-list
83169688|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83169689|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83169690|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169691|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169692|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169693|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83169694|NCT01171313|Carbidopa|carbidopa|mesh-list
83169695|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83169696|NCT01171313|Levodopa|levodopa|mesh-list
83169697|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83169698|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83169699|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
83169700|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169701|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169702|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169703|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83169704|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169705|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83169706|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
83169707|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
83169708|NCT02269319|Linezolid|linezolid|mesh-list
83169709|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83169710|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169711|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83169712|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169713|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169714|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
83169715|NCT01071239|Busulfan|busulfan|mesh-list
83169716|NCT01071239|Fludarabine|fludarabine|mesh-list
83169717|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83169718|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
83169719|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169720|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169721|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83169722|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
83169723|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169724|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169725|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83169726|NCT01156415|Agomelatine|agomelatine|mesh-list
83169727|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83169728|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169729|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169730|NCT01057667|Ribavirin|ribavirin|mesh-list
83169731|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83169732|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
83169733|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169734|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
83169735|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169736|NCT01027013|Rebamipide|rebamipide|mesh-list
83169737|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83169738|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83169739|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83169740|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83169741|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
83169742|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169743|NCT01027013|Protective Agents|protective agents|mesh-ancestor
83169744|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169745|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169746|NCT04197076|Immunomodulating Agents|immunomodulating agents|mesh-list
83169747|NCT04197076|Immunologic Factors|immunologic factors|mesh-ancestor
83169748|NCT04197076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169749|NCT01138163|Docetaxel|docetaxel|mesh-list
83169750|NCT01138163|Bavituximab|bavituximab|mesh-list
83169751|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169752|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169753|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169754|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169755|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169756|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83169757|NCT01022801|Entecavir|entecavir|mesh-list
83169758|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
83169759|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169760|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
83169761|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83169762|NCT05628389|Nicotine|nicotine|mesh-list
83169763|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83169764|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
83169765|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169766|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169767|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83169768|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83169769|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
83169770|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169771|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169772|NCT01128335|Tacrolimus|tacrolimus|mesh-list
83169773|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83169774|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
83169775|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169776|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83169777|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169778|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169779|NCT01012895|Interferons|interferons|mesh-list
83169780|NCT01012895|Ribavirin|ribavirin|mesh-list
83169781|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
83169782|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
83169783|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83169784|NCT01012895|Asunaprevir|asunaprevir|mesh-list
83169785|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169786|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
83169787|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169788|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
83169789|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169790|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
83169791|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169792|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
83169793|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169794|NCT01009775|Docetaxel|docetaxel|mesh-list
83169795|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169796|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169797|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169798|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169799|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169800|NCT02319148|Itraconazole|itraconazole|mesh-list
83169801|NCT02319148|Verapamil|verapamil|mesh-list
83169802|NCT02319148|Diltiazem|diltiazem|mesh-list
83169803|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
83169804|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169805|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83169806|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83169807|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169808|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169809|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83169810|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
83169811|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169812|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169813|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83169814|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83169815|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83169816|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83169817|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83169818|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
83169819|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83169820|NCT02526212|Buprenorphine|buprenorphine|mesh-list
83169821|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83169822|NCT02526212|Narcotics|narcotics|mesh-ancestor
83169823|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169824|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169825|NCT02526212|Analgesics|analgesics|mesh-ancestor
83169826|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
83169827|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169828|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83169829|NCT05627843|Curcumin|curcumin|mesh-list
83169830|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169831|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169832|NCT05627843|Analgesics|analgesics|mesh-ancestor
83169833|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
83169834|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169835|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169836|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169837|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169838|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169839|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169840|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169841|NCT01004081|Exemestane|exemestane|mesh-list
83169842|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169843|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83169844|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83169845|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169846|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169847|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83169848|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
83169849|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169850|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169851|NCT05401916|Acetaminophen|acetaminophen|mesh-list
83169852|NCT05401916|Ibuprofen|ibuprofen|mesh-list
83169853|NCT05401916|Tramadol|tramadol|mesh-list
83169854|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169855|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169856|NCT05401916|Analgesics|analgesics|mesh-ancestor
83169857|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
83169858|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169859|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169860|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169861|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169862|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83169863|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169864|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169865|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
83169866|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83169867|NCT05401916|Narcotics|narcotics|mesh-ancestor
83169868|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169869|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
83169870|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83169871|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
83169872|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169873|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169874|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83169875|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
83169876|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83169877|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83169878|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83169879|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
83169880|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169881|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169882|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83169883|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
83169884|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169885|NCT05401214|Prednisone|prednisone|mesh-list
83169886|NCT05401214|Prednisolone|prednisolone|mesh-list
83169887|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
83169888|NCT05401214|Niraparib|niraparib|mesh-list
83169889|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169890|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
83169891|NCT05401214|Hormones|hormones|mesh-ancestor
83169892|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169893|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169894|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83169895|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169896|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83169897|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169898|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169899|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
83169900|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83169901|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83169902|NCT02532374|Nicotine|nicotine|mesh-list
83169903|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83169904|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
83169905|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169906|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169907|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83169908|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83169909|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
83169910|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83169911|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169912|NCT01745588|Clarithromycin|clarithromycin|mesh-list
83169913|NCT01745588|Dexamethasone|dexamethasone|mesh-list
83169914|NCT01745588|Pomalidomide|pomalidomide|mesh-list
83169915|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169916|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
83169917|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
83169918|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169919|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169920|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83169921|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
83169922|NCT01745588|Hormones|hormones|mesh-ancestor
83478123|NCT02106494|Ondansetron|ondansetron|mesh-list
83169923|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83169924|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83169925|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169926|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83169927|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83169928|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83169929|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169930|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169931|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83169932|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83169933|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
83169934|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83169935|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83169936|NCT01745588|Growth Substances|growth substances|mesh-ancestor
83169937|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
83169939|NCT05398874|Diclofenac|diclofenac|mesh-list
83169940|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169941|NCT05398874|Analgesics|analgesics|mesh-ancestor
83169942|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
83169943|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169944|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169945|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
83169946|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169947|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169948|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169949|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83169950|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169951|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169952|NCT01281176|Paclitaxel|paclitaxel|mesh-list
83169953|NCT01281176|Carboplatin|carboplatin|mesh-list
83169954|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83169955|NCT01281176|Vorinostat|vorinostat|mesh-list
83169956|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83169957|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169958|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169959|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169960|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169961|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169962|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83169963|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83169964|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
83169965|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83169966|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169967|NCT05360732|Folfirinox|folfirinox|mesh-list
83169968|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169969|NCT00152477|Paclitaxel|paclitaxel|mesh-list
83169970|NCT00152477|Carboplatin|carboplatin|mesh-list
83169971|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83169972|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83169973|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83169974|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83169975|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83169976|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83169977|NCT01111955|Metformin|metformin|mesh-list
83169978|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83169979|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169980|NCT01106807|Adapalene|adapalene|mesh-list
83169981|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83169982|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83169983|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
83169984|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83169985|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83169986|NCT01106807|Analgesics|analgesics|mesh-ancestor
83169987|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
83169988|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83169989|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169990|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83169991|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83169993|NCT05533229|Morphine|morphine|mesh-list
83169994|NCT05533229|Bupivacaine|bupivacaine|mesh-list
83169995|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
83169996|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
83169997|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83169998|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83169999|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
83170000|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170001|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83170002|NCT05533229|Narcotics|narcotics|mesh-ancestor
83170003|NCT05533229|Analgesics|analgesics|mesh-ancestor
83170004|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83170005|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83170006|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
83170007|NCT00153179|Acipimox|acipimox|mesh-list
83170008|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83170009|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
83170010|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170011|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83170012|NCT02743949|Esomeprazole|esomeprazole|mesh-list
83170013|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83170014|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170015|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83170016|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170017|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170018|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
83170019|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170020|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170021|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170022|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170023|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170024|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170025|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170026|NCT02289898|Gemcitabine|gemcitabine|mesh-list
83170027|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83170028|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83170029|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
83170030|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170031|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170032|NCT01659554|Cisplatin|cisplatin|mesh-list
83170033|NCT01659554|Doxorubicin|doxorubicin|mesh-list
83170034|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83170035|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170036|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170037|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170038|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170039|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170040|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170041|NCT05355350|Meropenem|meropenem|mesh-list
83170042|NCT05355350|Tazobactam|tazobactam|mesh-list
83170043|NCT05355350|Piperacillin|piperacillin|mesh-list
83170044|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83170045|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170046|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170047|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83170048|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170049|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170050|NCT01054196|Lenalidomide|lenalidomide|mesh-list
83170051|NCT01054196|Melphalan|melphalan|mesh-list
83170052|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
83170053|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170054|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83170055|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83170056|NCT01054196|Growth Substances|growth substances|mesh-ancestor
83170057|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
83170058|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170059|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83170060|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
83170061|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170062|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83170063|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170064|NCT01659320|Minocycline|minocycline|mesh-list
83170065|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170066|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170067|NCT05414084|Phenol|phenol|mesh-list
83170068|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83170069|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170070|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
83170071|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83170072|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83170073|NCT01660334|Voriconazole|voriconazole|mesh-list
83170074|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
83170075|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170076|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83170077|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83170078|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170079|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170080|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83170081|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
83170082|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170083|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170084|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83170085|NCT01660256|Rebamipide|rebamipide|mesh-list
83170086|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83170087|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170088|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
83170089|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170090|NCT01660256|Protective Agents|protective agents|mesh-ancestor
83170091|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170092|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170093|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83170094|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
83170095|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170096|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83170097|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
83170098|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170099|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170100|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83170101|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83170102|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83170103|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
83170104|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83170105|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170106|NCT02330367|Abivertinib|abivertinib|mesh-list
83170107|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170108|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170109|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170110|NCT02318602|Cannabidiol|cannabidiol|mesh-list
83170111|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
83170112|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
83170113|NCT05077215|Lenvatinib|lenvatinib|mesh-list
83170114|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83170115|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170116|NCT05077215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83170117|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170118|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170119|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170120|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83170121|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83170122|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83170123|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83170124|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170125|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170126|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170127|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
83170128|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83170129|NCT05559008|Azacitidine|azacitidine|mesh-list
83170130|NCT05559008|Apatinib|apatinib|mesh-list
83170131|NCT05559008|Dasatinib|dasatinib|mesh-list
83170132|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83170133|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
83170134|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170135|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170136|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170137|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170138|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83170139|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170140|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170141|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170142|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170143|NCT05053425|Cytarabine|cytarabine|mesh-list
83170144|NCT05053425|Azacitidine|azacitidine|mesh-list
83170145|NCT05053425|Venetoclax|venetoclax|mesh-list
83170146|NCT05053425|Idarubicin|idarubicin|mesh-list
83170147|NCT05053425|Cladribine|cladribine|mesh-list
83170148|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83170149|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
83170150|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170151|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170152|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
83170153|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170154|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170155|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
83170156|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170157|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170158|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170159|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170160|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170161|NCT02317510|Anesthetics|anesthetics|mesh-list
83170162|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170163|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170164|NCT05350124|Vitamins|vitamins|mesh-list
83170165|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
83170166|NCT05350124|Vitamin E|vitamin e|mesh-list
83170167|NCT05350124|Tocopherols|tocopherols|mesh-list
83170168|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
83170169|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170170|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
83170171|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170172|NCT05350124|Protective Agents|protective agents|mesh-ancestor
83170173|NCT04925427|Naloxone|naloxone|mesh-list
83170174|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83170175|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170176|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
83170177|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170178|NCT00494234|Olaparib|olaparib|mesh-list
83170179|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83170180|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170181|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170182|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170183|NCT05556746|Rifampin|rifampin|mesh-list
83170184|NCT05556746|Clofazimine|clofazimine|mesh-list
83170185|NCT05556746|Isoniazid|isoniazid|mesh-list
83170186|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
83170187|NCT05556746|Ethambutol|ethambutol|mesh-list
83170188|NCT05556746|Bedaquiline|bedaquiline|mesh-list
83170189|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83170190|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
83170191|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170192|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170193|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
83170194|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83170195|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170196|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170197|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83170198|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83170199|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83170200|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83170201|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83170202|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83170203|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83170204|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83170206|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83170207|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170208|NCT05554406|Cytarabine|cytarabine|mesh-list
83170209|NCT05554406|Azacitidine|azacitidine|mesh-list
83170210|NCT05554406|Daunorubicin|daunorubicin|mesh-list
83170211|NCT05554406|Venetoclax|venetoclax|mesh-list
83170212|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83170213|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
83170214|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170215|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170216|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
83170217|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170218|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170219|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
83170220|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170221|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170222|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170223|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170224|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170225|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
83170226|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83170227|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83170228|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170229|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
83170230|NCT04803591|Coagulants|coagulants|mesh-ancestor
83170231|NCT05536856|Fluorouracil|fluorouracil|mesh-list
83170232|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
83170233|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170234|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83170235|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170236|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170237|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
83170238|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170239|NCT04735263|Atorvastatin|atorvastatin|mesh-list
83170240|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83170241|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83170242|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
83170243|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170244|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83170245|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83170246|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170247|NCT00493298|Natalizumab|natalizumab|mesh-list
83170248|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
83170249|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170250|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83170251|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83170252|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170253|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
83170254|NCT04662723|Empagliflozin|empagliflozin|mesh-list
83170255|NCT04662723|Canagliflozin|canagliflozin|mesh-list
83170256|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83170257|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
83170258|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83170259|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83170260|NCT04662723|Prednisolone|prednisolone|mesh-list
83170261|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
83170262|NCT04662723|Losartan|losartan|mesh-list
83170263|NCT04662723|Ramipril|ramipril|mesh-list
83170264|NCT04662723|Lisinopril|lisinopril|mesh-list
83170265|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83170266|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
83170267|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170269|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
83170270|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170271|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170272|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170273|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
83170274|NCT04662723|Hormones|hormones|mesh-ancestor
83170275|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170276|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83170277|NCT04662723|Protective Agents|protective agents|mesh-ancestor
83170278|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83170279|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170280|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170281|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83170282|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83170283|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83170284|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83170285|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83170286|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83170287|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
83170288|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170289|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83170290|NCT05307926|Lenvatinib|lenvatinib|mesh-list
83170291|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83170292|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170293|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170294|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170295|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170296|NCT05307926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83170297|NCT04026945|Lidocaine|lidocaine|mesh-list
83170298|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
83170299|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
83170300|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170301|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170302|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
83170303|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170304|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83170305|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83170306|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83170307|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83170308|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170309|NCT02328729|Epinephrine|epinephrine|mesh-list
83170310|NCT02328729|Racepinephrine|racepinephrine|mesh-list
83170311|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
83170312|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83170313|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83170314|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
83170315|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170316|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170317|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170318|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83170319|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83170320|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
83170321|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170322|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83170323|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
83170324|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
83170325|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
83170326|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83170327|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
83170328|NCT02328963|Everolimus|everolimus|mesh-list
83170329|NCT02328963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83170330|NCT02328963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170331|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170332|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170333|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170334|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
83170335|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170336|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170337|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170339|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
83170340|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170341|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170342|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
83170343|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170344|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
83170345|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170346|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170347|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83170348|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
83478124|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
83170349|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170350|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170351|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83170352|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
83170353|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83170354|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83170355|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170356|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
83170357|NCT03353259|Coagulants|coagulants|mesh-ancestor
83170359|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
83170360|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170361|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
83170362|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170363|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83170364|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83170365|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83170366|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83170367|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83170368|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
83170369|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170370|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170371|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170372|NCT05337566|Azithromycin|azithromycin|mesh-list
83170373|NCT05337566|Cefuroxime|cefuroxime|mesh-list
83170374|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
83170375|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170376|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170377|NCT02328495|Misoprostol|misoprostol|mesh-list
83170378|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83170379|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
83170380|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83170381|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170382|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83170383|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170384|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
83170385|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83170386|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83170387|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170388|NCT02287402|Voglibose|voglibose|mesh-list
83170389|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83170390|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170391|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83170392|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170393|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170394|NCT02913495|Progesterone|progesterone|mesh-list
83170395|NCT02913495|Progestins|progestins|mesh-ancestor
83170396|NCT02913495|Hormones|hormones|mesh-ancestor
83170397|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170398|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170399|NCT03111069|Doxorubicin|doxorubicin|mesh-list
83170400|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83170401|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170402|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170403|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170404|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170405|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170406|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170407|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83170408|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83170409|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
83170410|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170411|NCT03110757|Antacids|antacids|mesh-ancestor
83170412|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170413|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170415|NCT05303792|Dexamethasone|dexamethasone|mesh-list
83170416|NCT05303792|Prednisone|prednisone|mesh-list
83170417|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
83170418|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
83170419|NCT05303792|Rituximab|rituximab|mesh-list
83170420|NCT05303792|Doxorubicin|doxorubicin|mesh-list
83170421|NCT05303792|Methotrexate|methotrexate|mesh-list
83170422|NCT05303792|Vincristine|vincristine|mesh-list
83170423|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
83170424|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83170425|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170426|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
83170427|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170428|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170429|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83170430|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
83170431|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170432|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170433|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83170434|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83170435|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170436|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
83170437|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
83170438|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170439|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170440|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
83170441|NCT05303792|Hormones|hormones|mesh-ancestor
83170442|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170443|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83170444|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170445|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170446|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170447|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170448|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83170449|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
83170450|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83170451|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83170452|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
83170453|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83170454|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83170455|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83170456|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
83170457|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170458|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83170459|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
83170460|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
83170461|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
83170462|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83170463|NCT05303792|Protective Agents|protective agents|mesh-ancestor
83170464|NCT05303792|Immunotoxins|immunotoxins|mesh-ancestor
83170465|NCT05303792|Immunoconjugates|immunoconjugates|mesh-ancestor
83170466|NCT05080569|Progesterone|progesterone|mesh-list
83170467|NCT05080569|Progestins|progestins|mesh-ancestor
83170468|NCT05080569|Hormones|hormones|mesh-ancestor
83170469|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170470|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170471|NCT03145467|Acetaminophen|acetaminophen|mesh-list
83170472|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
83170473|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83170474|NCT03145467|Analgesics|analgesics|mesh-ancestor
83170475|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
83170476|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170477|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170478|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
83170479|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83170480|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83170481|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
83170482|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170483|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170484|NCT05302856|Antibodies|antibodies|mesh-list
83170485|NCT05302856|Testosterone|testosterone|mesh-list
83170486|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
83170487|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170489|NCT05302856|Hormones|hormones|mesh-ancestor
83170490|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170491|NCT02328183|Polymyxins|polymyxins|mesh-list
83170492|NCT02328183|Polymyxin B|polymyxin b|mesh-list
83170493|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170494|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170495|NCT05610488|Faricimab|faricimab|mesh-list
83170496|NCT05610488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83170497|NCT05610488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83170498|NCT05610488|Growth Substances|growth substances|mesh-ancestor
83170499|NCT05610488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170500|NCT05610488|Growth Inhibitors|growth inhibitors|mesh-ancestor
83170501|NCT05610488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170502|NCT01646398|Vaccines|vaccines|mesh-list
83170503|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83170504|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
83170505|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170506|NCT05382104|Maribavir|maribavir|mesh-list
83170507|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
83170508|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170509|NCT01646320|Metformin|metformin|mesh-list
83170510|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
83170511|NCT01646320|Saxagliptin|saxagliptin|mesh-list
83170512|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83170513|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170514|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83170515|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170516|NCT01646320|Incretins|incretins|mesh-ancestor
83170517|NCT01646320|Hormones|hormones|mesh-ancestor
83170518|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170519|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83170520|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
83170521|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170522|NCT03141645|Ondansetron|ondansetron|mesh-list
83170523|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
83170524|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
83170525|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170526|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170527|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170528|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
83170529|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
83170530|NCT03141645|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83170531|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83170532|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
83170533|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170534|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170535|NCT05327426|Vaccines|vaccines|mesh-list
83170536|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
83170537|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170538|NCT05327270|Nivolumab|nivolumab|mesh-list
83170539|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83170540|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170541|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83170542|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170543|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
83170544|NCT05297396|Narcotics|narcotics|mesh-ancestor
83170545|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170546|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170547|NCT05297396|Analgesics|analgesics|mesh-ancestor
83170548|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
83170549|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170550|NCT01658150|Isradipine|isradipine|mesh-list
83170551|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83170552|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83170553|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83170554|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170555|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83170556|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170557|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
83170558|NCT02285998|Vaccines|vaccines|mesh-list
83170559|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
83170560|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170561|NCT02285920|Spironolactone|spironolactone|mesh-list
83170562|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83170563|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
83170564|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170565|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170566|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83170567|NCT02285920|Diuretics|diuretics|mesh-ancestor
83170568|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
83170569|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83170570|NCT05292872|Cathartics|cathartics|mesh-ancestor
83170571|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170572|NCT02035137|Irinotecan|irinotecan|mesh-list
83170573|NCT02035137|Vincristine|vincristine|mesh-list
83170574|NCT02035137|Vorinostat|vorinostat|mesh-list
83170575|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83170576|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83170577|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170578|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170579|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170580|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170581|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83170582|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83170583|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83170584|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83170585|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83170586|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83170587|NCT05321810|Warfarin|warfarin|mesh-list
83170588|NCT05321810|Apixaban|apixaban|mesh-list
83170589|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
83170590|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83170591|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
83170592|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83170593|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
83170594|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170595|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170596|NCT05264870|Norepinephrine|norepinephrine|mesh-list
83170597|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83170598|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83170599|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83170600|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170601|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170602|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170603|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
83170604|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
83170605|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170606|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83170607|NCT04249232|Abaloparatide|abaloparatide|mesh-list
83170608|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83170609|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170610|NCT05079087|Midazolam|midazolam|mesh-list
83170611|NCT05079087|Ketamine|ketamine|mesh-list
83170612|NCT05079087|Analgesics|analgesics|mesh-ancestor
83170613|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
83170614|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170615|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170616|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83170617|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83170618|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
83170619|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
83170620|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170621|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83170622|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83170623|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170624|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170625|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83170626|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83170627|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83170628|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83170629|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83170630|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
83170631|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
83170632|NCT02522780|Mesalamine|mesalamine|mesh-list
83170633|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83170634|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83170635|NCT02522780|Analgesics|analgesics|mesh-ancestor
83170636|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
83170637|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170638|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170639|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170640|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170641|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83170642|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83170643|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83170644|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83170645|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170646|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170647|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170648|NCT03618225|Analgesics|analgesics|mesh-ancestor
83170649|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
83170650|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170651|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
83170652|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83170653|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
83170654|NCT03566199|Panobinostat|panobinostat|mesh-list
83170655|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170656|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83170657|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170658|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170659|NCT03561831|Propofol|propofol|mesh-list
83170660|NCT03561831|Sevoflurane|sevoflurane|mesh-list
83170661|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83170662|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170663|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170664|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83170665|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
83170666|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
83170667|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83170668|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83170669|NCT05289830|Escitalopram|escitalopram|mesh-list
83170670|NCT05289830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83170671|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83170672|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83170673|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170674|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170675|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
83170676|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170677|NCT03144843|Apatinib|apatinib|mesh-list
83170678|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170679|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170680|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170681|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170682|NCT05288348|Sufentanil|sufentanil|mesh-list
83170683|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83170684|NCT05288348|Narcotics|narcotics|mesh-ancestor
83170685|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170686|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170687|NCT05288348|Analgesics|analgesics|mesh-ancestor
83170688|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
83170689|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170690|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83170691|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83170692|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
83170693|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
83170694|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83170695|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83170696|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170697|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170698|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83170699|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
83170700|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170701|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170702|NCT05259800|Peppermint oil|peppermint oil|mesh-list
83170703|NCT05259800|Mineral Oil|mineral oil|mesh-list
83170704|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
83170705|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
83170706|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170707|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170708|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170709|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
83170711|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
83170712|NCT03199755|Lumefantrine|lumefantrine|mesh-list
83170713|NCT03199755|Artemether|artemether|mesh-list
83170714|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83170715|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
83170716|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83170717|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83170718|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170719|NCT05318066|Norepinephrine|norepinephrine|mesh-list
83170720|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83170721|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83170722|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
83170723|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170724|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170725|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170726|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
83170727|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
83170728|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170729|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83170730|NCT02327793|Labetalol|labetalol|mesh-list
83170731|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
83170732|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
83170733|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83170734|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83170735|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
83170736|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170737|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170738|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170739|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83170740|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
83170741|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
83170742|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170743|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83170744|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83170745|NCT02327715|Emtricitabine|emtricitabine|mesh-list
83170746|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
83170747|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170748|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83170749|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83170750|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170751|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170752|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83170753|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83170754|NCT02951013|Chrysarobin|chrysarobin|mesh-list
83170755|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83170756|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83170757|NCT02951013|Analgesics|analgesics|mesh-ancestor
83170758|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
83170759|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170760|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170761|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170762|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170763|NCT05080803|Bevacizumab|bevacizumab|mesh-list
83170764|NCT05080803|Ranibizumab|ranibizumab|mesh-list
83170765|NCT05080803|Aflibercept|aflibercept|mesh-list
83170766|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83170767|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170768|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83170769|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83170770|NCT05080803|Growth Substances|growth substances|mesh-ancestor
83170771|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170772|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
83170773|NCT02285062|Prednisone|prednisone|mesh-list
83170774|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
83170775|NCT02285062|Rituximab|rituximab|mesh-list
83170776|NCT02285062|Doxorubicin|doxorubicin|mesh-list
83170777|NCT02285062|Vincristine|vincristine|mesh-list
83170778|NCT02285062|Lenalidomide|lenalidomide|mesh-list
83170779|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170780|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
83170781|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170782|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170783|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83170784|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
83170785|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170786|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170787|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83170788|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83170789|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170790|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170791|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170792|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170793|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170794|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
83170795|NCT02285062|Hormones|hormones|mesh-ancestor
83170796|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170797|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83170798|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83170799|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83170800|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83170801|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83170802|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83170803|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83170804|NCT02285062|Growth Substances|growth substances|mesh-ancestor
83170805|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
83170806|NCT02431767|Interleukin-12|interleukin-12|mesh-list
83170807|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83170808|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
83170809|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170810|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83170811|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83170812|NCT02431767|Growth Substances|growth substances|mesh-ancestor
83170813|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
83170814|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170815|NCT05313620|Adalimumab|adalimumab|mesh-list
83170816|NCT05313620|Infliximab|infliximab|mesh-list
83170817|NCT05313620|Golimumab|golimumab|mesh-list
83170818|NCT05313620|Tofacitinib|tofacitinib|mesh-list
83170819|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83170820|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170821|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170822|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
83170823|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170824|NCT05313620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83170825|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83170826|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170827|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170828|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170829|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
83170830|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170831|NCT04571697|Methotrexate|methotrexate|mesh-list
83170832|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83170833|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
83170834|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83170835|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170836|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83170837|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
83170838|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170839|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170840|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
83170841|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170842|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83170843|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170844|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
83170845|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170846|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83170847|NCT05482334|Molgramostim|molgramostim|mesh-list
83170848|NCT05482334|Sargramostim|sargramostim|mesh-list
83170849|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
83170850|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170851|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170852|NCT05253794|Colchicine|colchicine|mesh-list
83170853|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
83170854|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170855|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83170856|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83170857|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83170858|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170859|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170860|NCT03140943|Thalidomide|thalidomide|mesh-list
83170861|NCT03140943|Dexamethasone|dexamethasone|mesh-list
83170862|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83170863|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
83170864|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
83170865|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170866|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170867|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83170868|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
83170869|NCT03140943|Hormones|hormones|mesh-ancestor
83170870|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170871|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83170872|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170873|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170874|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
83170875|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
83170876|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170877|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170878|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83170879|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83170880|NCT03140943|Growth Substances|growth substances|mesh-ancestor
83170881|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
83170882|NCT02038257|Petrolatum|petrolatum|mesh-list
83170883|NCT02038257|Emollients|emollients|mesh-ancestor
83170884|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
83170885|NCT05311436|Iron|iron|mesh-list
83170886|NCT05311436|Folic Acid|folic acid|mesh-list
83170887|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170888|NCT05311436|Trace Elements|trace elements|mesh-ancestor
83170889|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
83170890|NCT05311436|Hematinics|hematinics|mesh-ancestor
83170891|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
83170892|NCT05311436|Vitamins|vitamins|mesh-ancestor
83170893|NCT05199753|Antibodies|antibodies|mesh-list
83170894|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
83170895|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170896|NCT01352741|Pregabalin|pregabalin|mesh-list
83170897|NCT01352741|Tapentadol|tapentadol|mesh-list
83170898|NCT01352741|Analgesics|analgesics|mesh-ancestor
83170899|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
83170900|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170901|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170902|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
83170903|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83170904|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83170905|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170906|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83170907|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83170908|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83170909|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170910|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83170911|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83170912|NCT01352741|Narcotics|narcotics|mesh-ancestor
83170913|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83170914|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83170915|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
83170916|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83170917|NCT04422392|Paclitaxel|paclitaxel|mesh-list
83170918|NCT04422392|Carboplatin|carboplatin|mesh-list
83170919|NCT04422392|Pemetrexed|pemetrexed|mesh-list
83170920|NCT04422392|Antibodies|antibodies|mesh-list
83170921|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83170922|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170923|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
83170924|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
83170925|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
83170926|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170927|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
83170928|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170929|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170930|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83170931|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83170932|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
83170933|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83170934|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170935|NCT00911963|Ribavirin|ribavirin|mesh-list
83170936|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83170937|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
83170938|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170939|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
83170940|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170941|NCT01657292|Octenidine|octenidine|mesh-list
83170942|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170943|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83170944|NCT04167033|Hormones|hormones|mesh-list
83170945|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83170946|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170947|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
83170948|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170949|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170950|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83170951|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
83170952|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83170953|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83170954|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83170955|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170956|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
83170957|NCT03140553|Carboplatin|carboplatin|mesh-list
83170958|NCT03140553|Docetaxel|docetaxel|mesh-list
83170959|NCT03140553|Trastuzumab|trastuzumab|mesh-list
83170960|NCT03140553|Epirubicin|epirubicin|mesh-list
83170961|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83170962|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
83170963|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170964|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83170965|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83170966|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
83170967|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83170968|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83170969|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83170970|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
83170971|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
83170972|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
83170973|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83170974|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83170975|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83170976|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83170978|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
83170979|NCT05279456|Paraproteins|paraproteins|mesh-list
83170980|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
83170981|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170982|NCT00905567|Topiramate|topiramate|mesh-list
83170983|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
83170984|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83170985|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170986|NCT05277896|Ketamine|ketamine|mesh-list
83170987|NCT05277896|Etomidate|etomidate|mesh-list
83170988|NCT05277896|Analgesics|analgesics|mesh-ancestor
83170989|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
83170990|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83170991|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83170992|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83170993|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83170994|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
83170995|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
83170996|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83170997|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83170998|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83170999|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171000|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171001|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83171002|NCT02282020|Olaparib|olaparib|mesh-list
83171003|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83171004|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171005|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171006|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171007|NCT05249972|Calcitriol|calcitriol|mesh-list
83171008|NCT05249972|Betamethasone|betamethasone|mesh-list
83171009|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
83171010|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83171011|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
83171012|NCT05249972|Calcipotriene|calcipotriene|mesh-list
83171013|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83171014|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83171015|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
83171016|NCT05249972|Hormones|hormones|mesh-ancestor
83171017|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171018|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171019|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83171020|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
83171021|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
83171022|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171023|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83171024|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171025|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171026|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83171027|NCT05249972|Vitamins|vitamins|mesh-ancestor
83171028|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
83171029|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83171030|NCT00904943|Topiramate|topiramate|mesh-list
83171031|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
83171032|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171033|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171034|NCT00902291|Gemcitabine|gemcitabine|mesh-list
83171035|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83171036|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
83171037|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171038|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171039|NCT05217680|Bevacizumab|bevacizumab|mesh-list
83171040|NCT05217680|Ranibizumab|ranibizumab|mesh-list
83171041|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171042|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171043|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83171044|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83171045|NCT05217680|Growth Substances|growth substances|mesh-ancestor
83171046|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171047|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
83171048|NCT02281552|Tofacitinib|tofacitinib|mesh-list
83171049|NCT02281552|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83171050|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83171051|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171052|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171053|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
83171054|NCT03832647|Salicylates|salicylates|mesh-list
83171055|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171056|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
83171057|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
83171058|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
83171059|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83171060|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83171061|NCT03832647|Analgesics|analgesics|mesh-ancestor
83171062|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
83171063|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171064|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171065|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83171066|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171067|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83171068|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171069|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171070|NCT00901979|Metformin|metformin|mesh-list
83171071|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83171072|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171073|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171074|NCT00901979|Incretins|incretins|mesh-ancestor
83171075|NCT00901979|Hormones|hormones|mesh-ancestor
83171076|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171077|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83171078|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
83171079|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171080|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171081|NCT03778671|Fentanyl|fentanyl|mesh-list
83171082|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
83171083|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
83171084|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83171085|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171086|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171087|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83171088|NCT03778671|Analgesics|analgesics|mesh-ancestor
83171089|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
83171090|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171091|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83171092|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83171093|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83171094|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171095|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171096|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171098|NCT03778671|Narcotics|narcotics|mesh-ancestor
83171099|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83171100|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83171101|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
83171102|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
83171103|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
83171104|NCT00978497|Ribavirin|ribavirin|mesh-list
83171105|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
83171106|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171107|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
83171108|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171109|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
83171110|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83171111|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171112|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83171113|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83171114|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171115|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171116|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171117|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83171118|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83171119|NCT03558789|Lactoferrin|lactoferrin|mesh-list
83171120|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171121|NCT00890591|Amlodipine|amlodipine|mesh-list
83171122|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83171123|NCT00890591|Olmesartan|olmesartan|mesh-list
83171124|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83171125|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171126|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83171127|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171128|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171129|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171130|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171131|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
83171132|NCT00890591|Diuretics|diuretics|mesh-ancestor
83171133|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
83171134|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83171135|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83171136|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83171137|NCT05248334|Ranibizumab|ranibizumab|mesh-list
83171138|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83171139|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83171140|NCT05248334|Growth Substances|growth substances|mesh-ancestor
83171141|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171142|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
83171143|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171144|NCT03140787|Lidocaine|lidocaine|mesh-list
83171145|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
83171146|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
83171147|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171148|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171149|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
83171150|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171151|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83171152|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83171153|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83171154|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171155|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171156|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
83171157|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83171158|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171159|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83171160|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83171161|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171162|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171164|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83171165|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83171166|NCT03317223|Amoxicillin|amoxicillin|mesh-list
83171167|NCT03317223|Clarithromycin|clarithromycin|mesh-list
83171168|NCT03317223|Lansoprazole|lansoprazole|mesh-list
83171169|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83171170|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171171|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83171172|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171173|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171174|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83171175|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83171176|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83171177|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83171178|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83171179|NCT02284906|Pioglitazone|pioglitazone|mesh-list
83171180|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171181|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171182|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
83171183|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83171184|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171185|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171186|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83171187|NCT02566863|Analgesics|analgesics|mesh-ancestor
83171188|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
83171189|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171190|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83171191|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83171192|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83171193|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171194|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171195|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171196|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
83171197|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171198|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
83171199|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83171200|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83171201|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83171202|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171203|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171204|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
83171205|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171206|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171207|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83171208|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171209|NCT04474457|Favipiravir|favipiravir|mesh-list
83171210|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
83171211|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171212|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83171213|NCT00880217|Methylphenidate|methylphenidate|mesh-list
83171214|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83171215|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83171216|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171217|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83171218|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83171219|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171220|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171221|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
83171222|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171223|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83171224|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171225|NCT01657760|Citalopram|citalopram|mesh-list
83171226|NCT01657760|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83171227|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83171228|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171229|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171230|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171231|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
83171232|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171233|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83171234|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
83171235|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83171236|NCT00966953|Honokiol|honokiol|mesh-list
83171237|NCT00966953|Triclosan|triclosan|mesh-list
83171238|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83171239|NCT00966953|Fluorides|fluorides|mesh-list
83171240|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
83171241|NCT00966953|Protective Agents|protective agents|mesh-ancestor
83171242|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171243|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83171244|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171245|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83171246|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83171247|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
83171248|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171249|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83171250|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83171251|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83171252|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171253|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171254|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171255|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83171256|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83171257|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83171258|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83171259|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83171261|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83171262|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83171263|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171264|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171265|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171266|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171267|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83171268|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
83171269|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
83171270|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171271|NCT05084079|Insulin|insulin|mesh-list
83171272|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83171273|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171274|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171275|NCT05084001|Listerine|listerine|mesh-list
83171276|NCT05084001|Fluorides|fluorides|mesh-list
83171277|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
83171278|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
83171279|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
83171280|NCT05084001|Protective Agents|protective agents|mesh-ancestor
83171281|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171282|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83171283|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171284|NCT05245916|Rituximab|rituximab|mesh-list
83171285|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171286|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171287|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
83171288|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171289|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171290|NCT00875459|Insulin|insulin|mesh-list
83171291|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83171292|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171293|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171294|NCT03837353|Docetaxel|docetaxel|mesh-list
83171295|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171296|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
83171297|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
83171298|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
83171299|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171300|NCT03140709|Oxytocin|oxytocin|mesh-list
83171301|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
83171302|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83171303|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171305|NCT02283658|Letrozole|letrozole|mesh-list
83171306|NCT02283658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83171307|NCT02283658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83171308|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171309|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171310|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83171311|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
83171312|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171313|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171314|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83171315|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83171316|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83171317|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
83171318|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171319|NCT00872885|Morphine|morphine|mesh-list
83171320|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83171321|NCT00872885|Narcotics|narcotics|mesh-ancestor
83171322|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171323|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171324|NCT00872885|Analgesics|analgesics|mesh-ancestor
83171325|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
83171326|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171327|NCT00871481|Aldesleukin|aldesleukin|mesh-list
83171328|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
83171329|NCT00871481|Ipilimumab|ipilimumab|mesh-list
83171330|NCT00871481|Interleukin-2|interleukin-2|mesh-list
83171331|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83171332|NCT00871481|Antibodies|antibodies|mesh-list
83171333|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
83171334|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83171335|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83171336|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
83171337|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171338|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171339|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83171340|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
83171341|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171342|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171343|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83171344|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83171345|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83171346|NCT00871481|Analgesics|analgesics|mesh-ancestor
83171347|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
83171348|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171349|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83171350|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83171351|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
83171352|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171353|NCT05456165|Ipilimumab|ipilimumab|mesh-list
83171354|NCT05456165|Atezolizumab|atezolizumab|mesh-list
83171355|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171356|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171357|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83171358|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171359|NCT05083689|Bevacizumab|bevacizumab|mesh-list
83171360|NCT05083689|Timolol|timolol|mesh-list
83171361|NCT05083689|Dorzolamide|dorzolamide|mesh-list
83171362|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
83171363|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171364|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171365|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83171366|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83171367|NCT05083689|Growth Substances|growth substances|mesh-ancestor
83171368|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171369|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
83171370|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83171371|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83171372|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171373|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171374|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171375|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83171376|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171377|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83171378|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83171379|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83171380|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171381|NCT05165966|Vaccines|vaccines|mesh-list
83171382|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
83171383|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171384|NCT05165732|Vaccines|vaccines|mesh-list
83171385|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
83171386|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171387|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
83171388|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
83171389|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83171390|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83171391|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171392|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171393|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171394|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171395|NCT03138759|Probenecid|probenecid|mesh-list
83171396|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
83171397|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
83171398|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171399|NCT03079921|Propranolol|propranolol|mesh-list
83171400|NCT03079921|Phentolamine|phentolamine|mesh-list
83171401|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83171402|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83171403|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171404|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171405|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171406|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171407|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83171408|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171409|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
83171410|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83171411|NCT04473989|Teriparatide|teriparatide|mesh-list
83171412|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171413|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171414|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83171415|NCT05209490|Iodine|iodine|mesh-list
83171416|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83171417|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171418|NCT05209490|Trace Elements|trace elements|mesh-ancestor
83171419|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
83171420|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171421|NCT05083455|Enoxaparin|enoxaparin|mesh-list
83171422|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
83171423|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83171424|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
83171425|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83171426|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
83171427|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171428|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171429|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
83171430|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83171431|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83171432|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
83171433|NCT04473911|Sirolimus|sirolimus|mesh-list
83171434|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
83171435|NCT04473911|Melphalan|melphalan|mesh-list
83171436|NCT04473911|Fludarabine|fludarabine|mesh-list
83171437|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83171438|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
83171439|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171440|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171441|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83171442|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
83171443|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171444|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171445|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83171446|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83171447|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83171448|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
83171449|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83171450|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171451|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171452|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
83171453|NCT05162222|Itraconazole|itraconazole|mesh-list
83171454|NCT05162222|Diltiazem|diltiazem|mesh-list
83171455|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
83171456|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171457|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83171458|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83171459|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171460|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171461|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83171462|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
83171463|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171464|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171465|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83171466|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171467|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83171468|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171469|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171470|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
83171471|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
83171472|NCT05088057|Docetaxel|docetaxel|mesh-list
83171473|NCT05088057|Doxorubicin|doxorubicin|mesh-list
83171474|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83171475|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
83171476|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171477|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171478|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83171479|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
83171480|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171481|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171482|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83171483|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
83171484|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
83171485|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
83171486|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83171487|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83171488|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83171489|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171490|NCT03132025|Capecitabine|capecitabine|mesh-list
83171491|NCT03132025|Apatinib|apatinib|mesh-list
83171492|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83171493|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
83171494|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171495|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171496|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83171497|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171498|NCT00857285|Losartan|losartan|mesh-list
83171499|NCT00857285|Olmesartan|olmesartan|mesh-list
83171500|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83171501|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83171502|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171503|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83171504|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83171505|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171506|NCT04461379|Vaccines|vaccines|mesh-list
83171507|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
83171508|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
83171509|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171510|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83171511|NCT00854945|ON 01910|on 01910|mesh-list
83171512|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171513|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83171514|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171515|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171516|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
83171517|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83171518|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83171519|NCT04876534|Prednisolone|prednisolone|mesh-list
83171520|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
83171521|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83171522|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83171523|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
83171524|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83171525|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
83171526|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
83171527|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171528|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171529|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83171530|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
83171531|NCT04876534|Hormones|hormones|mesh-ancestor
83171532|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171533|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83171534|NCT04876534|Protective Agents|protective agents|mesh-ancestor
83171535|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83171536|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171537|NCT05082753|Ivermectin|ivermectin|mesh-list
83171539|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171540|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
83171541|NCT02443831|Fludarabine|fludarabine|mesh-list
83171542|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83171543|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
83171544|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171545|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171546|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83171547|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
83171548|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171549|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171550|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83171551|NCT00851045|Leucovorin|leucovorin|mesh-list
83171552|NCT00851045|Bevacizumab|bevacizumab|mesh-list
83171553|NCT00851045|Fluorouracil|fluorouracil|mesh-list
83171554|NCT00851045|Irinotecan|irinotecan|mesh-list
83171555|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83171556|NCT00851045|Calcium|calcium|mesh-list
83171557|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
83171558|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171559|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171560|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83171561|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83171562|NCT00851045|Growth Substances|growth substances|mesh-ancestor
83171563|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171564|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
83171565|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171566|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
83171567|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171568|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83171569|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83171570|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
83171571|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83171572|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83171573|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171574|NCT00851045|Antidotes|antidotes|mesh-ancestor
83171575|NCT00851045|Protective Agents|protective agents|mesh-ancestor
83171576|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
83171577|NCT00851045|Vitamins|vitamins|mesh-ancestor
83171578|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
83171579|NCT00850577|Paclitaxel|paclitaxel|mesh-list
83171580|NCT00850577|Bevacizumab|bevacizumab|mesh-list
83171581|NCT00850577|Carboplatin|carboplatin|mesh-list
83171582|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83171583|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83171584|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171585|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83171586|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83171587|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83171588|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171589|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171590|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83171591|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83171592|NCT00850577|Growth Substances|growth substances|mesh-ancestor
83171593|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171594|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
83171595|NCT00838981|Methadone|methadone|mesh-list
83171596|NCT00838981|Modafinil|modafinil|mesh-list
83171597|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83171598|NCT00838981|Narcotics|narcotics|mesh-ancestor
83171599|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171600|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171601|NCT00838981|Analgesics|analgesics|mesh-ancestor
83171602|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
83171603|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171604|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
83171605|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
83171606|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83171607|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83171608|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83171609|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83171610|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171611|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
83171612|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
83171613|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83171614|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83171615|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171616|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171617|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83171618|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83171620|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
83171621|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
83171622|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171623|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171624|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
83171625|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171626|NCT00950885|Melatonin|melatonin|mesh-list
83171627|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
83171628|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171629|NCT00950885|Protective Agents|protective agents|mesh-ancestor
83171630|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171631|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171632|NCT00849485|Levetiracetam|levetiracetam|mesh-list
83171633|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
83171634|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
83171635|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
83171636|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
83171637|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83171638|NCT03140397|Estrogens|estrogens|mesh-ancestor
83171639|NCT03140397|Hormones|hormones|mesh-ancestor
83171640|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171641|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171642|NCT05047445|Vaccines|vaccines|mesh-list
83171643|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
83171644|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171645|NCT05235542|Paclitaxel|paclitaxel|mesh-list
83171646|NCT05235542|Docetaxel|docetaxel|mesh-list
83171647|NCT05235542|Capecitabine|capecitabine|mesh-list
83171648|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
83171649|NCT05235542|Irinotecan|irinotecan|mesh-list
83171650|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83171651|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171652|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
83171653|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
83171654|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
83171655|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171656|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83171657|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
83171658|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83171659|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83171660|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171661|NCT00840281|Cefprozil|cefprozil|mesh-list
83171662|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83171663|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171664|NCT00840203|Mesalamine|mesalamine|mesh-list
83171665|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83171666|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83171667|NCT00840203|Analgesics|analgesics|mesh-ancestor
83171668|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
83171669|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171670|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171671|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83171672|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171673|NCT00838799|Pregabalin|pregabalin|mesh-list
83171674|NCT00838799|Analgesics|analgesics|mesh-ancestor
83171675|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
83171676|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171677|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171678|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
83171679|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83171680|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171681|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171682|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171683|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83171684|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83171685|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171686|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83171687|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
83171688|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83171689|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171690|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171691|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171693|NCT00836069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83171694|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83171695|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171696|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171697|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171698|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
83171699|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171700|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83171701|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
83171702|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83171703|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83171704|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83171705|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171706|NCT03134729|Ropivacaine|ropivacaine|mesh-list
83171707|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
83171708|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
83171709|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171710|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171711|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
83171712|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171713|NCT03134651|Propofol|propofol|mesh-list
83171714|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83171715|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171716|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171717|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83171718|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
83171719|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
83171720|NCT05202860|Vaccines|vaccines|mesh-list
83171721|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
83171722|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171723|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
83171724|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171725|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83171726|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171727|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171728|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
83171729|NCT05202080|Narcotics|narcotics|mesh-ancestor
83171730|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171731|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171732|NCT05202080|Analgesics|analgesics|mesh-ancestor
83171733|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
83171734|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171735|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83171736|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83171737|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171738|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171739|NCT05155124|Cetuximab|cetuximab|mesh-list
83171740|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171741|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171742|NCT00927641|Ketoprofen|ketoprofen|mesh-list
83171743|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83171744|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83171745|NCT00927641|Analgesics|analgesics|mesh-ancestor
83171746|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
83171747|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171748|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171749|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83171751|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83171752|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171753|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171754|NCT05200364|Bevacizumab|bevacizumab|mesh-list
83171755|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171756|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171757|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83171758|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83171759|NCT05200364|Growth Substances|growth substances|mesh-ancestor
83171760|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171761|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
83171762|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83171763|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
83171764|NCT00835991|Metformin|metformin|mesh-list
83171765|NCT00835991|Glyburide|glyburide|mesh-list
83171766|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171767|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171768|NCT05200052|Colchicine|colchicine|mesh-list
83171769|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
83171770|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83171771|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
83171772|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
83171773|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
83171774|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171775|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171776|NCT00925535|Rifabutin|rifabutin|mesh-list
83171777|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83171778|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171779|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83171780|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
83171781|NCT02276872|Treprostinil|treprostinil|mesh-list
83171782|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171783|NCT00835367|Amlodipine|amlodipine|mesh-list
83171784|NCT00835367|Benazepril|benazepril|mesh-list
83171785|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171786|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83171787|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171788|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171789|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171790|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171791|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
83171792|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83171793|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
83171794|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171795|NCT02276560|Paclitaxel|paclitaxel|mesh-list
83171796|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83171797|NCT02276560|Cisplatin|cisplatin|mesh-list
83171798|NCT02276560|Gemcitabine|gemcitabine|mesh-list
83171799|NCT02276560|Pemetrexed|pemetrexed|mesh-list
83171800|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83171801|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171802|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
83171803|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
83171804|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
83171805|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171806|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83171807|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
83171808|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171809|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83171810|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83171811|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83171812|NCT02276482|Metronidazole|metronidazole|mesh-list
83171813|NCT02276482|Vancomycin|vancomycin|mesh-list
83171814|NCT02276482|Clindamycin|clindamycin|mesh-list
83171815|NCT02276482|Cefazolin|cefazolin|mesh-list
83171816|NCT02276482|Linezolid|linezolid|mesh-list
83171817|NCT02276482|Cephalexin|cephalexin|mesh-list
83171818|NCT02276482|Aztreonam|aztreonam|mesh-list
83171819|NCT02276482|Tedizolid|tedizolid|mesh-list
83171820|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171821|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83171822|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83171823|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83171824|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171825|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171826|NCT00924833|Carvedilol|carvedilol|mesh-list
83171827|NCT00924833|Nebivolol|nebivolol|mesh-list
83171828|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83171829|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83171830|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171831|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171832|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171833|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171834|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171835|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
83171836|NCT00924833|Protective Agents|protective agents|mesh-ancestor
83171837|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83171838|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171839|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171840|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
83171841|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83171842|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83171843|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83171844|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83171845|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83171846|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
83171847|NCT05142254|Tadalafil|tadalafil|mesh-list
83171848|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
83171849|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83171850|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83171851|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171852|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171853|NCT05142254|Urological Agents|urological agents|mesh-ancestor
83171854|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171855|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
83171856|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83171857|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83171858|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
83171859|NCT00835211|Coagulants|coagulants|mesh-ancestor
83171860|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83171861|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
83171862|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171863|NCT00834977|Amlodipine|amlodipine|mesh-list
83171864|NCT00834977|Benazepril|benazepril|mesh-list
83171865|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83171866|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83171867|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171868|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171869|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83171870|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171871|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
83171872|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83171873|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
83171874|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171875|NCT05227664|Paclitaxel|paclitaxel|mesh-list
83171876|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83171877|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83171878|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171879|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
83171880|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
83171881|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
83171882|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171883|NCT00834743|Metformin|metformin|mesh-list
83171884|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171885|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171886|NCT00834587|Metformin|metformin|mesh-list
83171887|NCT00834587|Glipizide|glipizide|mesh-list
83171888|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83171889|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171890|NCT00834431|Famciclovir|famciclovir|mesh-list
83171891|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
83171892|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171893|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83171894|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171895|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171896|NCT04875767|Coal Tar|coal tar|mesh-list
83171897|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
83171898|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
83171899|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83171900|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83171901|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171902|NCT00834275|Cefadroxil|cefadroxil|mesh-list
83171903|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83171904|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171905|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
83171906|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171907|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171908|NCT05191472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83171909|NCT05191472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171910|NCT00834197|Mirtazapine|mirtazapine|mesh-list
83171911|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
83171912|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83171913|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83171914|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
83171915|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
83171916|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171917|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171918|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171919|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83171920|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83171921|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83171922|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83171923|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83171924|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83171925|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
83171926|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83171927|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83171928|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
83171929|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83171930|NCT00833495|Prednisolone|prednisolone|mesh-list
83171931|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83171932|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
83171933|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83171934|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
83171935|NCT00833495|Prednisone|prednisone|mesh-list
83171936|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83171937|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
83171938|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83171939|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
83171940|NCT00833495|Hormones|hormones|mesh-ancestor
83171941|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171942|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171943|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83171944|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171945|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
83171946|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
83171947|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171948|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83171949|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83171950|NCT00833495|Protective Agents|protective agents|mesh-ancestor
83171951|NCT00830219|Ropinirole|ropinirole|mesh-list
83171952|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83171953|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83171954|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
83171955|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
83171956|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171957|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171958|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171959|NCT05191004|Fulvestrant|fulvestrant|mesh-list
83171960|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83171961|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171962|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83171963|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83171964|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
83171965|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83171966|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171967|NCT02274766|Amantadine|amantadine|mesh-list
83171968|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83171969|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83171970|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
83171971|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83171972|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
83171973|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171974|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171975|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171976|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83171977|NCT02274766|Analgesics|analgesics|mesh-ancestor
83171978|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
83171979|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83171980|NCT05134922|Gedatolisib|gedatolisib|mesh-list
83171981|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83171982|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83171983|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171984|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
83171985|NCT04757363|Nivolumab|nivolumab|mesh-list
83171986|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83171987|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83171988|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83171989|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171990|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83171991|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83171992|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83171993|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83171994|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83171995|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83171996|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83171997|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
83171998|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83171999|NCT05221658|Cisplatin|cisplatin|mesh-list
83172000|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172001|NCT05132114|Lugol's solution|lugol's solution|mesh-list
83172002|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
83172003|NCT05132114|Coagulants|coagulants|mesh-ancestor
83172005|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83172006|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172007|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
83172008|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
83172009|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
83172010|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172011|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
83172012|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83172013|NCT05109104|Protective Agents|protective agents|mesh-ancestor
83172014|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172015|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
83172016|NCT05108870|Paclitaxel|paclitaxel|mesh-list
83172017|NCT05108870|Carboplatin|carboplatin|mesh-list
83172018|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83172019|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172020|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
83172021|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
83172022|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
83172023|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172024|NCT05126342|Niraparib|niraparib|mesh-list
83172025|NCT05126342|Dostarlimab|dostarlimab|mesh-list
83172026|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83172027|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172028|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172029|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172030|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
83172031|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83172032|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172033|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83172034|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
83172035|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172036|NCT05473910|Protective Agents|protective agents|mesh-ancestor
83172037|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172038|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83172039|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172040|NCT05180708|Sirolimus|sirolimus|mesh-list
83172041|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83172042|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172043|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83172044|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172045|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
83172046|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172047|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
83172048|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172049|NCT02273752|Everolimus|everolimus|mesh-list
83172050|NCT02273752|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83172051|NCT02273752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83172052|NCT02273752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172053|NCT02273752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172054|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172055|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
83172056|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172057|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172058|NCT05102552|Huperzine A|huperzine a|mesh-list
83172059|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83172060|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172061|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172062|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
83172063|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172064|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172065|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83172066|NCT05102552|Protective Agents|protective agents|mesh-ancestor
83172067|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
83172069|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172070|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172071|NCT05096390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172072|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172073|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83172074|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172075|NCT02273050|Metformin|metformin|mesh-list
83172076|NCT02273050|Saxagliptin|saxagliptin|mesh-list
83172077|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172078|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172079|NCT02273050|Incretins|incretins|mesh-ancestor
83172080|NCT02273050|Hormones|hormones|mesh-ancestor
83172081|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172082|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83172083|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
83172084|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172085|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172086|NCT02272816|Carboplatin|carboplatin|mesh-list
83172087|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172088|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83172089|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
83172090|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172091|NCT05170256|Trastuzumab|trastuzumab|mesh-list
83172092|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172093|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172094|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
83172095|NCT05386979|Anesthetics|anesthetics|mesh-list
83172096|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83172097|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172098|NCT05386979|Narcotics|narcotics|mesh-ancestor
83172099|NCT05386979|Analgesics|analgesics|mesh-ancestor
83172100|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
83172101|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172102|NCT02367352|Paclitaxel|paclitaxel|mesh-list
83172103|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83172104|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172105|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
83172106|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
83172107|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83478125|NCT02106494|Aprepitant|aprepitant|mesh-list
83172108|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172109|NCT02270944|Vaccines|vaccines|mesh-list
83172110|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
83172111|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172112|NCT05648734|Pirfenidone|pirfenidone|mesh-list
83172113|NCT05648734|Colchicine|colchicine|mesh-list
83172114|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
83172115|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83172116|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
83172117|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
83172118|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
83172119|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172120|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172121|NCT05648734|Analgesics|analgesics|mesh-ancestor
83172122|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
83172123|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172124|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172125|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83172126|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83172127|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172128|NCT02365558|Omeprazole|omeprazole|mesh-list
83172129|NCT02365558|Evacetrapib|evacetrapib|mesh-list
83172130|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83172131|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172132|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83172133|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172134|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172135|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83172136|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83172137|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
83172138|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83172139|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
83172140|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172141|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172142|NCT02270242|Aspirin|aspirin|mesh-list
83172143|NCT02270242|Ticagrelor|ticagrelor|mesh-list
83172144|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83172145|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83172146|NCT02270242|Analgesics|analgesics|mesh-ancestor
83172147|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
83172148|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172149|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172150|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172151|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83172152|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83172153|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83172154|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172155|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83172156|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83172157|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172158|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
83172159|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83172160|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83172161|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83172162|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
83172163|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172164|NCT04875364|Eszopiclone|eszopiclone|mesh-list
83172165|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83172166|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83172167|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172168|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
83172169|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83172170|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172171|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172172|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172173|NCT05648266|Analgesics|analgesics|mesh-list
83172174|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
83172175|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172176|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172177|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
83172178|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172179|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172180|NCT05047094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172181|NCT05047094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172182|NCT04993352|Antibodies|antibodies|mesh-list
83172183|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83172184|NCT04993352|Mitogens|mitogens|mesh-list
83172185|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
83172186|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
83172187|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172188|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
83172189|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172190|NCT04993352|Growth Substances|growth substances|mesh-ancestor
83172191|NCT04992026|Prednisone|prednisone|mesh-list
83172192|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
83172193|NCT04992026|Hormones|hormones|mesh-list
83172194|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83172195|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172196|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
83172197|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172198|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172199|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83172200|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172201|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83172202|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172203|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172204|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
83172205|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83172206|NCT04991402|Dolutegravir|dolutegravir|mesh-list
83172207|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83172208|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83172209|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83172210|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172211|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172212|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83172213|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
83172214|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172215|NCT05042102|Donepezil|donepezil|mesh-list
83172216|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83172217|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172218|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172219|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
83172220|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172221|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172222|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
83172223|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83172224|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172225|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172226|NCT05038982|Abrocitinib|abrocitinib|mesh-list
83172227|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83172228|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172229|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172230|NCT05036798|Lenvatinib|lenvatinib|mesh-list
83172231|NCT05036798|Tislelizumab|tislelizumab|mesh-list
83172232|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172233|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83172234|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172235|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172236|NCT05036798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172237|NCT04209218|Dexamethasone|dexamethasone|mesh-list
83172238|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
83172239|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172240|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
83172241|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
83172242|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172243|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172244|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172246|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172247|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83172248|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172249|NCT04218968|Carvedilol|carvedilol|mesh-list
83172250|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83172251|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83172252|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
83172253|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172254|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172255|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172256|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83172257|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
83172258|NCT04218968|Protective Agents|protective agents|mesh-ancestor
83172259|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83172260|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83172261|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83172262|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
83172263|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83172264|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83172265|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
83172266|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83172267|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172268|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172269|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172270|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83172271|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
83172272|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83172273|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83172274|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
83172275|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172276|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
83172277|NCT04421300|Protective Agents|protective agents|mesh-ancestor
83172278|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83172279|NCT05026736|Antibodies|antibodies|mesh-list
83172280|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
83172281|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83172282|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
83172283|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172284|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172285|NCT02268058|Acetaminophen|acetaminophen|mesh-list
83172286|NCT02268058|Ibuprofen|ibuprofen|mesh-list
83172287|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83172288|NCT02268058|Analgesics|analgesics|mesh-ancestor
83172289|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
83172290|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172291|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172292|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
83172293|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83172294|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172295|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83172296|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83172297|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172298|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172299|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
83172300|NCT02267746|Tazarotene|tazarotene|mesh-list
83172301|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
83172302|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
83172303|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
83172304|NCT02267746|Vitamins|vitamins|mesh-ancestor
83172305|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
83478126|NCT02106494|Granisetron|granisetron|mesh-list
83172306|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172307|NCT04970108|Empagliflozin|empagliflozin|mesh-list
83172308|NCT04970108|Telmisartan|telmisartan|mesh-list
83172309|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83172310|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172311|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172312|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172313|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83172314|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83172315|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83172316|NCT04421534|Lactoferrin|lactoferrin|mesh-list
83172317|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172318|NCT05059028|Oxytocin|oxytocin|mesh-list
83172319|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
83172320|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83172321|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172322|NCT04205552|Nivolumab|nivolumab|mesh-list
83172323|NCT04205552|Relatlimab|relatlimab|mesh-list
83172324|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83172325|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172326|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172327|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172328|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172329|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83172330|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83172331|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83172332|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172333|NCT04215848|Budesonide|budesonide|mesh-list
83172334|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
83172335|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172336|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83172337|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
83172338|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172339|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172340|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83172341|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
83172342|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
83172343|NCT04215848|Hormones|hormones|mesh-ancestor
83172344|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172345|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83172346|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83172347|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83172348|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
83172349|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172350|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172351|NCT04215146|Paclitaxel|paclitaxel|mesh-list
83172352|NCT04215146|Avelumab|avelumab|mesh-list
83172353|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83172354|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172355|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83172356|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83172357|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83172358|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172359|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172360|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83172361|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83172362|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
83172363|NCT04214678|Hormones|hormones|mesh-ancestor
83172364|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172365|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172366|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172367|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172368|NCT05010200|Poly ICLC|poly iclc|mesh-list
83172369|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
83172370|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
83172371|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172372|NCT04959266|Itraconazole|itraconazole|mesh-list
83172373|NCT04959266|Rifampin|rifampin|mesh-list
83172374|NCT04959266|Omeprazole|omeprazole|mesh-list
83172375|NCT04959266|Adavosertib|adavosertib|mesh-list
83172376|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83172377|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172378|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83172379|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172380|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172381|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
83172382|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172383|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83172384|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83172385|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83172386|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
83172387|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172388|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172389|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83172390|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83172391|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
83172392|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83172393|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
83172394|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83172395|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83172396|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83172397|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83172398|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83172399|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83172400|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83172401|NCT05008484|Vitamin D|vitamin d|mesh-list
83172402|NCT05008484|Vitamins|vitamins|mesh-ancestor
83172403|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
83172404|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172405|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83172406|NCT04212416|Leflunomide|leflunomide|mesh-list
83172407|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172408|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172409|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172410|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
83172411|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172412|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
83172413|NCT04947254|Prednisone|prednisone|mesh-list
83172414|NCT04947254|Cortisone|cortisone|mesh-list
83172415|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
83172416|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
83172417|NCT04947254|Niraparib|niraparib|mesh-list
83172418|NCT04947254|Hormones|hormones|mesh-list
83172419|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83172420|NCT04947254|Androgens|androgens|mesh-list
83172421|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
83172422|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172423|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
83172424|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172425|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172426|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83172427|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172428|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83172429|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172430|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172431|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
83172432|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83172433|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83172434|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
83172435|NCT04947254|Protective Agents|protective agents|mesh-ancestor
83172436|NCT04947254|Vitamins|vitamins|mesh-ancestor
83172437|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
83172438|NCT04947254|Estrogens|estrogens|mesh-ancestor
83172439|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
83172440|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
83172441|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
83172442|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
83172443|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172444|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172445|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172446|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83172447|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
83172448|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
83172449|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172450|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172451|NCT04946864|Palbociclib|palbociclib|mesh-list
83172452|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172453|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83172454|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172455|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172456|NCT04945148|Metformin|metformin|mesh-list
83172457|NCT04945148|Temozolomide|temozolomide|mesh-list
83172458|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172459|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172460|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83172461|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
83172462|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172463|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172464|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83172465|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83172466|NCT05003570|Fentanyl|fentanyl|mesh-list
83172467|NCT05003570|Remifentanil|remifentanil|mesh-list
83172468|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83172469|NCT05003570|Narcotics|narcotics|mesh-ancestor
83172470|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83172471|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172472|NCT05003570|Analgesics|analgesics|mesh-ancestor
83172473|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
83172474|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172475|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83172476|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83172477|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
83172478|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
83172479|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83172480|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172481|NCT02483078|Leronlimab|leronlimab|mesh-list
83172482|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83172483|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83172484|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172485|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83172486|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83172487|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
83172488|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172490|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83172491|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
83172492|NCT02514122|Ketamine|ketamine|mesh-list
83172493|NCT02514122|Analgesics|analgesics|mesh-ancestor
83172494|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
83172495|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172496|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172497|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83172498|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83172499|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
83172500|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
83172501|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83172502|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83172503|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83172504|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172505|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172507|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172508|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172509|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172510|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172511|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
83172512|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83172513|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
83172514|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172515|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172516|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83172517|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
83172518|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
83172519|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83172520|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
83172521|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172522|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172523|NCT04462003|Enoxaparin|enoxaparin|mesh-list
83172524|NCT04462003|Apixaban|apixaban|mesh-list
83172525|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
83172526|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83172527|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83172528|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172529|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83172530|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
83172531|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83172532|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
83172533|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172534|NCT03489265|Eluxadoline|eluxadoline|mesh-list
83172535|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172536|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
83172537|NCT03344341|Acarbose|acarbose|mesh-list
83172538|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83172539|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172540|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172541|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172542|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83172543|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172544|NCT03260881|Liraglutide|liraglutide|mesh-list
83172545|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172546|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172547|NCT03260881|Incretins|incretins|mesh-ancestor
83172548|NCT03260881|Hormones|hormones|mesh-ancestor
83172549|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172550|NCT03238495|Metformin|metformin|mesh-list
83172551|NCT03238495|Carboplatin|carboplatin|mesh-list
83172552|NCT03238495|Docetaxel|docetaxel|mesh-list
83172553|NCT03238495|Trastuzumab|trastuzumab|mesh-list
83172554|NCT03238495|Pertuzumab|pertuzumab|mesh-list
83172555|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172556|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172557|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172558|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
83172559|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
83172560|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
83172561|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172562|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172563|NCT02536339|Trastuzumab|trastuzumab|mesh-list
83172564|NCT02536339|Pertuzumab|pertuzumab|mesh-list
83172565|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172566|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172567|NCT01869361|Indomethacin|indomethacin|mesh-list
83172568|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83172569|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83172570|NCT01869361|Analgesics|analgesics|mesh-ancestor
83172571|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
83172572|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172573|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172574|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172575|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83172576|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
83172577|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
83172578|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83172579|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83172580|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172581|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172582|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
83172583|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83172584|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172585|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83172586|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83172587|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172588|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172589|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172590|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83172591|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172592|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172593|NCT01578967|Immunotoxins|immunotoxins|mesh-ancestor
83172594|NCT01578967|Immunoconjugates|immunoconjugates|mesh-ancestor
83172595|NCT01578967|Immunologic Factors|immunologic factors|mesh-ancestor
83172596|NCT01578967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172597|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
83172598|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172599|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172600|NCT02322853|Tamoxifen|tamoxifen|mesh-list
83172601|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83172602|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
83172603|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172604|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172605|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83172606|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172607|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83172608|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83172609|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83172610|NCT03488719|Metoprolol|metoprolol|mesh-list
83172611|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83172612|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83172613|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
83172614|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
83172615|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172616|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172617|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83172618|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83172619|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83172620|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
83172621|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172622|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172623|NCT03496831|Adalimumab|adalimumab|mesh-list
83172624|NCT03496831|Infliximab|infliximab|mesh-list
83172625|NCT03496831|Golimumab|golimumab|mesh-list
83172626|NCT03496831|Etanercept|etanercept|mesh-list
83172627|NCT03496831|Abatacept|abatacept|mesh-list
83172628|NCT03496831|Ustekinumab|ustekinumab|mesh-list
83172629|NCT03496831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172630|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172631|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
83172632|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172633|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83172634|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83172635|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172636|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83172637|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172638|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83172639|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83172640|NCT03496831|Analgesics|analgesics|mesh-ancestor
83172641|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
83172642|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172643|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172644|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172645|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172646|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
83172647|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
83172648|NCT03488485|Ledipasvir|ledipasvir|mesh-list
83172649|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172650|NCT00821249|Dexamethasone|dexamethasone|mesh-list
83172651|NCT00821249|Filanesib|filanesib|mesh-list
83172652|NCT00821249|Lenograstim|lenograstim|mesh-list
83172653|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172654|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
83172655|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
83172656|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172657|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172658|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172659|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
83172660|NCT00821249|Hormones|hormones|mesh-ancestor
83172661|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172662|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83172663|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172664|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83172665|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
83172666|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
83172667|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
83172668|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172669|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
83172670|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
83172671|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172672|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
83172673|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172674|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83172675|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83172676|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
83172677|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172678|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172679|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83172680|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172681|NCT03752723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172682|NCT04472585|Ivermectin|ivermectin|mesh-list
83172683|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83172684|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172685|NCT03496519|Durvalumab|durvalumab|mesh-list
83172686|NCT03496519|Trabectedin|trabectedin|mesh-list
83172687|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83172688|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172689|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172690|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
83172691|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172692|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83172693|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
83172694|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172695|NCT00813605|Conatumumab|conatumumab|mesh-list
83172696|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172697|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172698|NCT00724841|Temozolomide|temozolomide|mesh-list
83172699|NCT00724841|Obatoclax|obatoclax|mesh-list
83172700|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83172701|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
83172702|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172703|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172704|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172705|NCT03675815|Ritonavir|ritonavir|mesh-list
83172706|NCT03675815|Darunavir|darunavir|mesh-list
83172707|NCT03675815|Tenofovir|tenofovir|mesh-list
83172708|NCT03675815|Lamivudine|lamivudine|mesh-list
83172709|NCT03675815|Emtricitabine|emtricitabine|mesh-list
83172710|NCT03675815|Dolutegravir|dolutegravir|mesh-list
83172711|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83172712|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83172713|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83172714|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
83172715|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172716|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172717|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83172718|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83172719|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
83172720|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172721|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83172722|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83172723|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83172724|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83172725|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83172726|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
83172727|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83172728|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83172729|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83172730|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83172731|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172732|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
83172733|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172734|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172735|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83172736|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172737|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83172738|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
83172739|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
83172740|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172741|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172742|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83172743|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83172744|NCT00805805|Growth Substances|growth substances|mesh-ancestor
83172745|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172746|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
83172747|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172748|NCT03488173|Lansoprazole|lansoprazole|mesh-list
83172749|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
83172750|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83172751|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172752|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83172753|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172754|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172755|NCT03420521|Nivolumab|nivolumab|mesh-list
83172756|NCT03420521|Ipilimumab|ipilimumab|mesh-list
83172757|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172758|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172759|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172760|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172761|NCT04750759|Niclosamide|niclosamide|mesh-list
83172762|NCT04750759|Camostat|camostat|mesh-list
83172763|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
83172764|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172765|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172766|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83172767|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83172768|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
83172769|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83172770|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
83172771|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83172772|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172773|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
83172774|NCT03382925|Triamcinolone|triamcinolone|mesh-list
83172775|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83172776|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83172777|NCT03382925|Lidocaine|lidocaine|mesh-list
83172778|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83172779|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
83172780|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
83172781|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83172782|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172783|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
83172784|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172785|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83172786|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83172787|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83172788|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83172789|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172790|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172791|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
83172792|NCT03382925|Hormones|hormones|mesh-ancestor
83172793|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172794|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172795|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
83172796|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172797|NCT03487939|Fluorouracil|fluorouracil|mesh-list
83172798|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
83172799|NCT03487939|Irinotecan|irinotecan|mesh-list
83172800|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
83172801|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172802|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83172803|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172804|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172805|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
83172806|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172807|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83172808|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83172809|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172810|NCT00796289|Citric Acid|citric acid|mesh-list
83172811|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
83172812|NCT00796289|Clomiphene|clomiphene|mesh-list
83172813|NCT00796289|Enclomiphene|enclomiphene|mesh-list
83172814|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
83172815|NCT00796289|Hormones|hormones|mesh-list
83172816|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83172817|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
83172818|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83172819|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
83172820|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
83172821|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172822|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172823|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172824|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83172825|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
83172826|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83172827|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
83172828|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83172829|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83172830|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83172831|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
83172832|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
83172833|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172834|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
83172835|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83172836|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
83172837|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172838|NCT04460521|Expectorants|expectorants|mesh-ancestor
83172839|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
83172840|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83172841|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
83172842|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172843|NCT04460521|Protective Agents|protective agents|mesh-ancestor
83172844|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172845|NCT04460521|Antidotes|antidotes|mesh-ancestor
83172846|NCT00698789|Metformin|metformin|mesh-list
83172847|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172848|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172849|NCT03487783|Aripiprazole|aripiprazole|mesh-list
83172850|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83172851|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
83172852|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83172853|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83172854|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83172855|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83172856|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172857|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
83172858|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
83172859|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83172860|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172861|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83172862|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83172863|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
83172864|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83172865|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83172866|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83172867|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83172868|NCT03495739|Dabigatran|dabigatran|mesh-list
83172869|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
83172870|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83172871|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
83172872|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172873|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172874|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
83172875|NCT03298061|Prednisolone|prednisolone|mesh-list
83172876|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172877|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
83172878|NCT03298061|Hormones|hormones|mesh-ancestor
83172879|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172880|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172881|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83172882|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172883|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83172884|NCT04071613|Plasminogen|plasminogen|mesh-list
83172885|NCT04071613|Tenecteplase|tenecteplase|mesh-list
83172886|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83172887|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83172888|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172889|NCT00678119|Sunitinib|sunitinib|mesh-list
83172890|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172891|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83172892|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83172893|NCT00678119|Growth Substances|growth substances|mesh-ancestor
83172894|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172895|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
83172896|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83172897|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172898|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172899|NCT02812667|Nivolumab|nivolumab|mesh-list
83172900|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172901|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172902|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172903|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172904|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
83172905|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172906|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172907|NCT02799095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172908|NCT02799095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172909|NCT02011321|Clevidipine|clevidipine|mesh-list
83172910|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83172911|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83172912|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172913|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83172914|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172915|NCT01352585|Anagrelide|anagrelide|mesh-list
83172916|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83172917|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83172918|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172919|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83172920|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
83172921|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
83172922|NCT03484507|Prednisolone|prednisolone|mesh-list
83172923|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83172924|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
83172925|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83172926|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
83172927|NCT03484507|Povidone|povidone|mesh-list
83172928|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83172929|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
83172930|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83172931|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
83172932|NCT03484507|Hormones|hormones|mesh-ancestor
83172933|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172934|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172935|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83172936|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172937|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
83172938|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
83172939|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172940|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83172941|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83172942|NCT03484507|Protective Agents|protective agents|mesh-ancestor
83172943|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83172944|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172945|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
83172946|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
83172947|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
83172948|NCT02773355|Liraglutide|liraglutide|mesh-list
83172949|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83172950|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172951|NCT02773355|Incretins|incretins|mesh-ancestor
83172952|NCT02773355|Hormones|hormones|mesh-ancestor
83172953|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83172954|NCT02744183|Benzocaine|benzocaine|mesh-list
83172955|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
83172956|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
83172957|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83172958|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172959|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
83172960|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172961|NCT03484195|Fluorouracil|fluorouracil|mesh-list
83172962|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
83172963|NCT03484195|Irinotecan|irinotecan|mesh-list
83172964|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
83172965|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172966|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83172967|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172968|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83172969|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
83172970|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172971|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83172972|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83172973|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83172974|NCT02713607|Doxycycline|doxycycline|mesh-list
83172975|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83172976|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172977|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
83172978|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83172979|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83172980|NCT04526821|Lactoferrin|lactoferrin|mesh-list
83172981|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83172982|NCT02681549|Bevacizumab|bevacizumab|mesh-list
83172983|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
83172984|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83172985|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83172986|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83172987|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83172988|NCT02681549|Growth Substances|growth substances|mesh-ancestor
83172989|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83172990|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
83172991|NCT02681549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83172992|NCT02681549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83172993|NCT02323399|Phenylephrine|phenylephrine|mesh-list
83172994|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
83172995|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83172996|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
83172997|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
83172998|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83172999|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173000|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
83173001|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83173002|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
83173003|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173004|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83173005|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83173006|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83173007|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
83173008|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173009|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173010|NCT02323399|Protective Agents|protective agents|mesh-ancestor
83173011|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
83173012|NCT01352507|Tadalafil|tadalafil|mesh-list
83173013|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
83173014|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83173015|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83173016|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173017|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173018|NCT01352507|Urological Agents|urological agents|mesh-ancestor
83173019|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
83173020|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83173021|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83173022|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
83173023|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173024|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173025|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83173026|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173027|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83173028|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
83173029|NCT04460963|Protective Agents|protective agents|mesh-ancestor
83173030|NCT00873275|Leucovorin|leucovorin|mesh-list
83173031|NCT00873275|Bevacizumab|bevacizumab|mesh-list
83173032|NCT00873275|Fluorouracil|fluorouracil|mesh-list
83173033|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
83173034|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83173035|NCT00873275|Calcium|calcium|mesh-list
83173036|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
83173037|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173038|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173039|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83173040|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83173041|NCT00873275|Growth Substances|growth substances|mesh-ancestor
83173042|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173043|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
83173044|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83173045|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
83173046|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173047|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83173048|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173049|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
83173050|NCT00873275|Antidotes|antidotes|mesh-ancestor
83173051|NCT00873275|Protective Agents|protective agents|mesh-ancestor
83173052|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
83173053|NCT00873275|Vitamins|vitamins|mesh-ancestor
83173054|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
83173055|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83173056|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83173057|NCT04403243|Colchicine|colchicine|mesh-list
83173058|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
83173059|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173060|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83173061|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83173062|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83478127|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173063|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173064|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173065|NCT05648032|Triamcinolone|triamcinolone|mesh-list
83173066|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83173067|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83173068|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83173069|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173070|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
83173071|NCT05648032|Hormones|hormones|mesh-ancestor
83173072|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173073|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173074|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173075|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
83173076|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173077|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173078|NCT00774761|Fluticasone|fluticasone|mesh-list
83173079|NCT00774761|Xhance|xhance|mesh-list
83173080|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
83173081|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173082|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83173083|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
83173084|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173085|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173086|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83173087|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173088|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83173089|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83173090|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83173091|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83173092|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83173093|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
83173094|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173095|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173097|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
83173098|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173100|NCT05647954|Temozolomide|temozolomide|mesh-list
83173101|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
83173102|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173103|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173104|NCT05647954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83173105|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173106|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83173107|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
83173108|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83173109|NCT05647954|Estrogens|estrogens|mesh-ancestor
83173111|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173112|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173113|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83173114|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83173115|NCT00770081|Vildagliptin|vildagliptin|mesh-list
83173116|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83173117|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173118|NCT00770081|Incretins|incretins|mesh-ancestor
83173119|NCT00770081|Hormones|hormones|mesh-ancestor
83173120|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173121|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83173122|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
83173123|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173124|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173125|NCT02360098|Anesthetics|anesthetics|mesh-list
83173126|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173127|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173128|NCT02273609|Vitamin K|vitamin k|mesh-list
83173129|NCT02273609|Warfarin|warfarin|mesh-list
83173130|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
83173131|NCT02273609|Vitamins|vitamins|mesh-ancestor
83173132|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
83173133|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173134|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
83173135|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83173136|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83173137|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173138|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
83173139|NCT02273609|Coagulants|coagulants|mesh-ancestor
83173140|NCT02273843|Vitamin D|vitamin d|mesh-list
83173141|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
83173142|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
83173143|NCT02273843|Vitamins|vitamins|mesh-list
83173144|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
83173145|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173146|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83173147|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83173148|NCT00666497|Azacitidine|azacitidine|mesh-list
83173149|NCT00666497|Mocetinostat|mocetinostat|mesh-list
83173150|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83173151|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
83173152|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173153|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173154|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173155|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83173156|NCT02274077|Bupivacaine|bupivacaine|mesh-list
83173157|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
83173158|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
83173159|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173160|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173161|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
83173162|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173163|NCT00765323|Octreotide|octreotide|mesh-list
83173164|NCT00765323|Somatostatin|somatostatin|mesh-list
83173165|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83173166|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83173167|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173168|NCT00765323|Hormones|hormones|mesh-ancestor
83173169|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173170|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173171|NCT02276495|Ketorolac|ketorolac|mesh-list
83173172|NCT02276495|Clonidine|clonidine|mesh-list
83173173|NCT02276495|Epinephrine|epinephrine|mesh-list
83173174|NCT02276495|Ropivacaine|ropivacaine|mesh-list
83173176|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
83173177|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173178|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173179|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
83173180|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173181|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83173182|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83173183|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
83173184|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173185|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173186|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83173187|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83173188|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
83173189|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83173190|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173191|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
83173192|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
83173193|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83173194|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83173195|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83173196|NCT02276495|Analgesics|analgesics|mesh-ancestor
83173197|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173198|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173199|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83173200|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173201|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83173202|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
83173203|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83173204|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
83173205|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83173206|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83173207|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83173208|NCT02277587|Cortisone|cortisone|mesh-list
83173209|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
83173211|NCT02277587|Hormones|hormones|mesh-ancestor
83173212|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173213|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173214|NCT00663767|Celecoxib|celecoxib|mesh-list
83173215|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83173216|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83173217|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83173218|NCT00663767|Analgesics|analgesics|mesh-ancestor
83173219|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
83173220|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173221|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173222|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173223|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173224|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83173225|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173226|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173227|NCT00662597|Paclitaxel|paclitaxel|mesh-list
83173228|NCT00662597|Carboplatin|carboplatin|mesh-list
83173229|NCT00662597|Vadimezan|vadimezan|mesh-list
83173230|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83173231|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173232|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
83173233|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
83173234|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
83173235|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173236|NCT02266888|Rituximab|rituximab|mesh-list
83173237|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173238|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173239|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
83173240|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173241|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173242|NCT01641952|Rituximab|rituximab|mesh-list
83173443|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173444|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83173445|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
83173446|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173447|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173448|NCT00615251|Progesterone|progesterone|mesh-list
83173449|NCT00615251|Progestins|progestins|mesh-ancestor
83173450|NCT00615251|Hormones|hormones|mesh-ancestor
83173451|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173452|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173453|NCT02265796|Ranolazine|ranolazine|mesh-list
83173454|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83173455|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173456|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173457|NCT05647642|Midazolam|midazolam|mesh-list
83173458|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
83173459|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83173460|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173461|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173462|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83173463|NCT05647642|Analgesics|analgesics|mesh-ancestor
83173464|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
83173465|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173466|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83173467|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83173468|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83173469|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
83173470|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173471|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173472|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83173473|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83173474|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83173475|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83173476|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83173478|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
83173479|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
83173480|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
83173481|NCT02357368|Copper|copper|mesh-list
83173482|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83173483|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
83173484|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
83173485|NCT02357368|Etonogestrel|etonogestrel|mesh-list
83173486|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
83173487|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83173488|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83173489|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173490|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83173491|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83173492|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83173493|NCT02357368|Trace Elements|trace elements|mesh-ancestor
83173494|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
83173495|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83173496|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83173497|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83173498|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173499|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
83173500|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83173501|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173502|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83173503|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83173504|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83416195|NCT01517243|MTOR Inhibitors|mtor inhibitors|mesh-list
83173505|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173506|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173508|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173509|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
83173510|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
83173511|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173512|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173513|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83173514|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
83173515|NCT05647408|Hormones|hormones|mesh-ancestor
83173516|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173517|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83173518|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173519|NCT03483415|Morphine|morphine|mesh-list
83173520|NCT03483415|Bupivacaine|bupivacaine|mesh-list
83173521|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
83173522|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
83173523|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173524|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173525|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
83173526|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173527|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83173528|NCT03483415|Narcotics|narcotics|mesh-ancestor
83173529|NCT03483415|Analgesics|analgesics|mesh-ancestor
83173530|NCT03487003|Bromides|bromides|mesh-list
83173531|NCT03487003|Rocuronium|rocuronium|mesh-list
83173532|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
83173533|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83173534|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83173535|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83173536|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173537|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173538|NCT03486925|Oxytocin|oxytocin|mesh-list
83173539|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
83173540|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83173541|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173542|NCT02262754|Naproxen|naproxen|mesh-list
83173543|NCT02262754|PF-06372865|pf-06372865|mesh-list
83173544|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83173545|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83173546|NCT02262754|Analgesics|analgesics|mesh-ancestor
83173547|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
83173548|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173549|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173550|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173551|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173552|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
83173553|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83173554|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173555|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173556|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
83173557|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
83173558|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173559|NCT03483181|Enoxaparin|enoxaparin|mesh-list
83173560|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
83173561|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83173562|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
83173563|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83173564|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
83173565|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173566|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173567|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
83173568|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83173569|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83173571|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173572|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83173573|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83173574|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83173575|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173576|NCT00309985|Docetaxel|docetaxel|mesh-list
83173577|NCT00309985|Androgens|androgens|mesh-list
83173578|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173579|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83173580|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83173581|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83173582|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173583|NCT00309985|Hormones|hormones|mesh-ancestor
83173584|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173585|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173586|NCT02356588|Sufentanil|sufentanil|mesh-list
83173587|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83173588|NCT02356588|Narcotics|narcotics|mesh-ancestor
83173589|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173590|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173591|NCT02356588|Analgesics|analgesics|mesh-ancestor
83173592|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
83173593|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173594|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83173595|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83173596|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
83173597|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
83173598|NCT04445389|Vaccines|vaccines|mesh-list
83173599|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
83173600|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173601|NCT02355028|Ranibizumab|ranibizumab|mesh-list
83173602|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83173603|NCT02355028|Acrizanib|acrizanib|mesh-list
83173604|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83173605|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83173606|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83173607|NCT02355028|Growth Substances|growth substances|mesh-ancestor
83173608|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173609|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
83173610|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173611|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83173612|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173613|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173614|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
83173615|NCT05647330|Chloroquine|chloroquine|mesh-list
83173616|NCT05647330|Gemcitabine|gemcitabine|mesh-list
83173617|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83173618|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
83173619|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173620|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173621|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
83173622|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83173623|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83173624|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173625|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173626|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173627|NCT05647330|Amebicides|amebicides|mesh-ancestor
83173628|NCT01643668|Busulfan|busulfan|mesh-list
83173629|NCT01643668|Clofarabine|clofarabine|mesh-list
83173630|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
83173631|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173632|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173633|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
83173634|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173635|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83173636|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173637|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83173638|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83173640|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83173641|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
83173642|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173643|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
83173644|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
83173645|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173646|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173647|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83173648|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173649|NCT02260804|Rituximab|rituximab|mesh-list
83173650|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173651|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173652|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
83173653|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173654|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173655|NCT03486457|Tofacitinib|tofacitinib|mesh-list
83173656|NCT03486457|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83173657|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83173658|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173659|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173660|NCT02260648|Atorvastatin|atorvastatin|mesh-list
83173661|NCT02260648|Ezetimibe|ezetimibe|mesh-list
83173662|NCT02260648|Evacetrapib|evacetrapib|mesh-list
83173663|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83173664|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83173665|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
83173666|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173667|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83173668|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83173669|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173670|NCT04179019|Amlodipine|amlodipine|mesh-list
83173671|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83173672|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83173673|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173674|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173675|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83173676|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173677|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
83173678|NCT02260492|Fluticasone|fluticasone|mesh-list
83173679|NCT02260492|Xhance|xhance|mesh-list
83173680|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83173681|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83173682|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173683|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83173684|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
83173685|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173686|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173687|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83173688|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173689|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
83173690|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83173691|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83173692|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83173693|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83173694|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
83173695|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173696|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173697|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
83173698|NCT02260492|Hormones|hormones|mesh-ancestor
83173699|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173700|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
83173701|NCT03966625|Autoantibodies|autoantibodies|mesh-list
83173702|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
83173703|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173705|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83173706|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83173707|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83173708|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173709|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173710|NCT05151679|Iron|iron|mesh-list
83173711|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83173712|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
83173713|NCT05151679|Trace Elements|trace elements|mesh-ancestor
83173714|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
83173715|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173716|NCT05151679|Hematinics|hematinics|mesh-ancestor
83173717|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
83173718|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
83173719|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173720|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
83173721|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83173722|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173723|NCT02353468|Dexamethasone|dexamethasone|mesh-list
83173724|NCT02353468|Lenalidomide|lenalidomide|mesh-list
83173725|NCT02353468|Bortezomib|bortezomib|mesh-list
83173726|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173727|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
83173728|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
83173729|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173730|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173731|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83173732|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
83173733|NCT02353468|Hormones|hormones|mesh-ancestor
83173734|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173735|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83173736|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173737|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
83173738|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83173739|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83173740|NCT02353468|Growth Substances|growth substances|mesh-ancestor
83173741|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
83173742|NCT02523859|Propofol|propofol|mesh-list
83173743|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83173744|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173745|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173746|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83173747|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
83173748|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
83173749|NCT04459663|Axitinib|axitinib|mesh-list
83173750|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173751|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83173752|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173753|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173754|NCT05150899|Fexofenadine|fexofenadine|mesh-list
83173755|NCT05150899|Tamsulosin|tamsulosin|mesh-list
83173756|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83173757|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83173758|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83173759|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
83173760|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173761|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173762|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173763|NCT05150899|Urological Agents|urological agents|mesh-ancestor
83173764|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83173765|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83173766|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83173767|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
83173768|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
83173770|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173771|NCT00593905|Bosentan|bosentan|mesh-list
83173772|NCT00593905|Ambrisentan|ambrisentan|mesh-list
83173773|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
83173774|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83173775|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83173776|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173777|NCT02259088|Ranibizumab|ranibizumab|mesh-list
83173778|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83173779|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83173780|NCT02259088|Growth Substances|growth substances|mesh-ancestor
83173781|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173782|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
83173783|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173784|NCT02830477|Factor VIII|factor viii|mesh-list
83173785|NCT02830477|Coagulants|coagulants|mesh-ancestor
83173786|NCT02259010|Itraconazole|itraconazole|mesh-list
83173787|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
83173788|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173789|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83173790|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83173791|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173792|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173793|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83173794|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
83173795|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173796|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173797|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83173798|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83173799|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
83173800|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173801|NCT05153785|Lidocaine|lidocaine|mesh-list
83173802|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
83173803|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
83173804|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173805|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173806|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
83173807|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173808|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83173809|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83173810|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83173811|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173812|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173813|NCT00151775|Olmesartan|olmesartan|mesh-list
83173814|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83173815|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83173816|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83173817|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83173818|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173819|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83173820|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173821|NCT03476941|Clindamycin|clindamycin|mesh-list
83173822|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
83173823|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
83173824|NCT03476941|Gentamicins|gentamicins|mesh-list
83173825|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83173826|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173827|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83173828|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173829|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173830|NCT00609323|Lidocaine|lidocaine|mesh-list
83173831|NCT00609323|Tetracaine|tetracaine|mesh-list
83173832|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
83173833|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
83173834|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173835|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173836|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
83173837|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173838|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83173839|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83173840|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83173841|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83173842|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173843|NCT02682901|Bromocriptine|bromocriptine|mesh-list
83173844|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83173845|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83173846|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
83173847|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173848|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173849|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
83173850|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
83173851|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173852|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173853|NCT02258074|Niacinamide|niacinamide|mesh-list
83173855|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
83173856|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
83173857|NCT02258074|Vitamins|vitamins|mesh-ancestor
83173858|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
83173859|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173860|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83173861|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
83173862|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173863|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83173864|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
83173865|NCT04473053|Nafamostat|nafamostat|mesh-list
83173866|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83173867|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83173868|NCT04473053|Analgesics|analgesics|mesh-ancestor
83173869|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
83173870|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173871|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173872|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83173873|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173874|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
83173875|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
83173876|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173877|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173878|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83173879|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83173880|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83173881|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173882|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
83173883|NCT02281643|Doxycycline|doxycycline|mesh-list
83173884|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83173885|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173886|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
83173887|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83173888|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83173889|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
83173890|NCT02281721|Antacids|antacids|mesh-ancestor
83173891|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173892|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83173893|NCT01642732|Everolimus|everolimus|mesh-list
83173894|NCT01642732|Leuprolide|leuprolide|mesh-list
83173895|NCT01642732|Bicalutamide|bicalutamide|mesh-list
83173896|NCT01642732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83173897|NCT01642732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83173898|NCT01642732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173899|NCT01642732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173900|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173901|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
83173902|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173903|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173904|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83173905|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
83173906|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83173907|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83173908|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
83173909|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
83173910|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173911|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
83173912|NCT02281799|Azathioprine|azathioprine|mesh-list
83173913|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
83173914|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173915|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83173916|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173917|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83173918|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
83173919|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173920|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83173921|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173922|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83173923|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83173924|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83173925|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83173926|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
83173927|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173928|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83173929|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83173930|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173931|NCT00589823|Fentanyl|fentanyl|mesh-list
83173932|NCT00589823|Morphine|morphine|mesh-list
83173933|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83173934|NCT00589823|Narcotics|narcotics|mesh-ancestor
83173935|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83173936|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173937|NCT00589823|Analgesics|analgesics|mesh-ancestor
83173938|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
83173939|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173940|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83173941|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83173942|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
83173943|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
83173944|NCT02190721|Lenograstim|lenograstim|mesh-list
83173945|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83173946|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
83173947|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173948|NCT00581477|Droxidopa|droxidopa|mesh-list
83173949|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83173950|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83173951|NCT03134339|Nicotine|nicotine|mesh-list
83173952|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83173953|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
83173954|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173955|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173956|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83173957|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83173958|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
83173959|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83173960|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173961|NCT02282267|Gefitinib|gefitinib|mesh-list
83173962|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83173963|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83173964|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173965|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173966|NCT02283905|Voriconazole|voriconazole|mesh-list
83173967|NCT02283905|Amphotericin B|amphotericin b|mesh-list
83173968|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83173969|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
83173970|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83173971|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83173972|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83173973|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83173974|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83173975|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83173976|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
83173977|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83173978|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173979|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83173980|NCT02283905|Amebicides|amebicides|mesh-ancestor
83173981|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83173982|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83173983|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83173984|NCT03480997|Bromides|bromides|mesh-list
83173985|NCT03480997|Albuterol|albuterol|mesh-list
83173986|NCT03480997|Ipratropium|ipratropium|mesh-list
83173987|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
83173988|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83173989|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
83173990|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83173991|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83173992|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83173993|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
83173994|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
83173995|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83173996|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83173997|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83173998|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83173999|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174000|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174001|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174002|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83174003|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
83174004|NCT04660747|Anticoagulants|anticoagulants|mesh-list
83174005|NCT02348008|Bevacizumab|bevacizumab|mesh-list
83174006|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
83174007|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174008|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174009|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83174010|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83174011|NCT02348008|Growth Substances|growth substances|mesh-ancestor
83174012|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174013|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
83174014|NCT02348008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83174015|NCT02348008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174017|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
83174018|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174019|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83174020|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83174021|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83174022|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
83174023|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174024|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174025|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83174026|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83174027|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
83174028|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174029|NCT00495131|Interferons|interferons|mesh-list
83174030|NCT00495131|Ribavirin|ribavirin|mesh-list
83174031|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
83174032|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
83174033|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83174034|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174035|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
83174036|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174037|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
83174038|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174039|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
83174040|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174041|NCT02257372|Albuterol|albuterol|mesh-list
83174042|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83174043|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
83174044|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174045|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174046|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83174047|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
83174048|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
83174049|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83174050|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83174051|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83174052|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83174053|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174054|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174055|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174056|NCT02256982|Cisplatin|cisplatin|mesh-list
83174057|NCT02256982|Gemcitabine|gemcitabine|mesh-list
83174058|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174059|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174060|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
83174061|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174062|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
83174063|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83174064|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
83174065|NCT03480607|Dexamethasone|dexamethasone|mesh-list
83174066|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
83174067|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174068|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
83174069|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
83174070|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174071|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174072|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83174073|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
83174074|NCT03480607|Hormones|hormones|mesh-ancestor
83174075|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83174076|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83174077|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174078|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83174079|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174080|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83174081|NCT03480607|Analgesics|analgesics|mesh-ancestor
83174082|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
83174083|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83174084|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83174085|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83174086|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174087|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174088|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174090|NCT00489203|Methotrexate|methotrexate|mesh-list
83174091|NCT00489203|Tacrolimus|tacrolimus|mesh-list
83174092|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83174093|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
83174094|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83174095|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174096|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174097|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
83174098|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174099|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174100|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
83174101|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174102|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83174103|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83174104|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
83174105|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83174106|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83174107|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83174108|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174109|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
83174110|NCT00489203|Hormones|hormones|mesh-ancestor
83174111|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83174112|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83174113|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
83174114|NCT05646394|Aspirin|aspirin|mesh-list
83174115|NCT05646394|Vitamins|vitamins|mesh-list
83174116|NCT05646394|Vitamin K|vitamin k|mesh-list
83174117|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83174118|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
83174119|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174120|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83174121|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83174122|NCT05646394|Analgesics|analgesics|mesh-ancestor
83174123|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
83174124|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174125|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174126|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83174127|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83174128|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83174129|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174130|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83174131|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174132|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
83174133|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83174134|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
83174135|NCT05646394|Coagulants|coagulants|mesh-ancestor
83174136|NCT00563459|Topiramate|topiramate|mesh-list
83174137|NCT00563459|Levetiracetam|levetiracetam|mesh-list
83174138|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
83174139|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83174140|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174141|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
83174142|NCT04947631|Tadalafil|tadalafil|mesh-list
83174143|NCT04947631|Dutasteride|dutasteride|mesh-list
83174144|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
83174145|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83174146|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83174147|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174148|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174149|NCT04947631|Urological Agents|urological agents|mesh-ancestor
83174150|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83174151|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83174152|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
83174153|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83174154|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174155|NCT00561743|Dexamethasone|dexamethasone|mesh-list
83174156|NCT00561743|Doxorubicin|doxorubicin|mesh-list
83174157|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83174158|NCT00561743|Bortezomib|bortezomib|mesh-list
83174159|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174160|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
83174161|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
83174162|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174163|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174164|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83174165|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
83174166|NCT00561743|Hormones|hormones|mesh-ancestor
83174167|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83174168|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83174169|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174170|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83174171|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83174172|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83174173|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174174|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174175|NCT00488267|Ketoprofen|ketoprofen|mesh-list
83174176|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83174177|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83174178|NCT00488267|Analgesics|analgesics|mesh-ancestor
83174179|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
83174180|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174181|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174182|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174183|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83174184|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83174185|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174186|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174187|NCT00560183|Morphine|morphine|mesh-list
83174188|NCT00560183|Oxycodone|oxycodone|mesh-list
83174189|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83174190|NCT00560183|Narcotics|narcotics|mesh-ancestor
83174191|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174192|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174193|NCT00560183|Analgesics|analgesics|mesh-ancestor
83174194|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
83174195|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174196|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83174197|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
83174198|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174199|NCT00542633|Insulin|insulin|mesh-list
83174200|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83174201|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83174202|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174203|NCT02523547|Entecavir|entecavir|mesh-list
83174204|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
83174205|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174206|NCT00483977|Oxycodone|oxycodone|mesh-list
83174207|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83174208|NCT00483977|Narcotics|narcotics|mesh-ancestor
83174209|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174210|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174211|NCT00483977|Analgesics|analgesics|mesh-ancestor
83174212|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
83174213|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174214|NCT00481325|Escitalopram|escitalopram|mesh-list
83174215|NCT00481325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83174216|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83174217|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83174218|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174219|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174220|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
83174221|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174222|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
83174223|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83174224|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83174225|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174226|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174227|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174228|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
83174229|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83174230|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
83174231|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174232|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
83174233|NCT03480295|Protective Agents|protective agents|mesh-ancestor
83174234|NCT03472963|Darunavir|darunavir|mesh-list
83174235|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83174236|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83174237|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83174238|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
83174239|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174240|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174241|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83174242|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83174243|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
83174244|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174245|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83174246|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83174247|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174248|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174249|NCT00465959|Trospium chloride|trospium chloride|mesh-list
83174250|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
83174251|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
83174252|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174253|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174254|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83174255|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83174256|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
83174257|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174258|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174259|NCT00465959|Urological Agents|urological agents|mesh-ancestor
83174260|NCT00465803|Timolol|timolol|mesh-list
83174261|NCT00465803|Travoprost|travoprost|mesh-list
83174262|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83174263|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83174264|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174265|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83174266|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83174267|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174268|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174269|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174270|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83174271|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83174272|NCT02282891|Ketamine|ketamine|mesh-list
83174273|NCT02282891|Propofol|propofol|mesh-list
83174274|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83174275|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174276|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174277|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83174278|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
83174279|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
83174280|NCT02282891|Analgesics|analgesics|mesh-ancestor
83174281|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
83174282|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174283|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83174284|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83174285|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83174286|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174287|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174288|NCT00464633|Alvocidib|alvocidib|mesh-list
83174289|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174290|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
83174291|NCT00464633|Growth Substances|growth substances|mesh-ancestor
83174292|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174293|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83174294|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174295|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174296|NCT00464555|Sirolimus|sirolimus|mesh-list
83174297|NCT00464555|Lisofylline|lisofylline|mesh-list
83174298|NCT00464555|Tacrolimus|tacrolimus|mesh-list
83174299|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83174300|NCT00464555|Basiliximab|basiliximab|mesh-list
83174301|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83174302|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
83174303|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174304|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83174305|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174306|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174307|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83174308|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174309|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83174310|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174311|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
83174312|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83174313|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83174314|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83174315|NCT00464555|Analgesics|analgesics|mesh-ancestor
83174316|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
83174317|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174318|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174319|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83174320|NCT00464243|Volinanserin|volinanserin|mesh-list
83174321|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83174322|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
83174323|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174324|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174325|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174326|NCT03336541|Ketamine|ketamine|mesh-list
83174327|NCT03336541|Analgesics|analgesics|mesh-ancestor
83174328|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
83174329|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174330|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174331|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83174332|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83174333|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
83174334|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
83416271|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83174335|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174336|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83174337|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83174338|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174339|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174340|NCT00525941|Indiplon|indiplon|mesh-list
83174341|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83174342|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174343|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174344|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
83174345|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
83174346|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174347|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174348|NCT03476083|Tenofovir|tenofovir|mesh-list
83174349|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
83174350|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174351|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83174352|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83174353|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174354|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174355|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83174356|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83174357|NCT02738203|Lidocaine|lidocaine|mesh-list
83174358|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
83174359|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
83174360|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174361|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174362|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
83174363|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174364|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83174365|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83174366|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83174367|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83174368|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174369|NCT00457457|Tamsulosin|tamsulosin|mesh-list
83174370|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83174371|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83174372|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83174373|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174374|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174375|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174376|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174377|NCT00457457|Urological Agents|urological agents|mesh-ancestor
83174378|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83174379|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
83174380|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
83174381|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174382|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
83174383|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174384|NCT03472651|Flupenthixol|flupenthixol|mesh-list
83174385|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83174386|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83174387|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83174388|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174389|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174390|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83174391|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83174392|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
83174393|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174394|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174395|NCT00517049|Rituximab|rituximab|mesh-list
83174396|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174397|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174398|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
83174399|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174400|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83174401|NCT02283203|Acetaminophen|acetaminophen|mesh-list
83174402|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83174403|NCT02283203|Analgesics|analgesics|mesh-ancestor
83174404|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
83174405|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174406|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174407|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
83174408|NCT02536183|Doxorubicin|doxorubicin|mesh-list
83174409|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83174410|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83174411|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174412|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83174413|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83174414|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174415|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174416|NCT02523313|Nivolumab|nivolumab|mesh-list
83174417|NCT02523313|Ipilimumab|ipilimumab|mesh-list
83174418|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174419|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174420|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83174421|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174422|NCT02452034|Posaconazole|posaconazole|mesh-list
83174423|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
83174424|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174425|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83174426|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83174427|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83174428|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83174429|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83174430|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174431|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174432|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83174433|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
83174434|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83174435|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174436|NCT02283359|Irinotecan|irinotecan|mesh-list
83174437|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83174438|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83174439|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174440|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174441|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174442|NCT00511043|Vatalanib|vatalanib|mesh-list
83174443|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83174444|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174445|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174446|NCT00508625|Paclitaxel|paclitaxel|mesh-list
83174447|NCT00508625|Bevacizumab|bevacizumab|mesh-list
83174448|NCT00508625|Carboplatin|carboplatin|mesh-list
83174449|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83174450|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174451|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
83174452|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
83174453|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
83174454|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174455|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174456|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83174457|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83174458|NCT00508625|Growth Substances|growth substances|mesh-ancestor
83174459|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174460|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
83174461|NCT02284529|Leucovorin|leucovorin|mesh-list
83174462|NCT02284529|Fluorouracil|fluorouracil|mesh-list
83174463|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
83174464|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174465|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174466|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174467|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83174468|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
83174469|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174470|NCT02284529|Antidotes|antidotes|mesh-ancestor
83174471|NCT02284529|Protective Agents|protective agents|mesh-ancestor
83174472|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
83174473|NCT02284529|Vitamins|vitamins|mesh-ancestor
83174474|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
83174475|NCT02482298|Ticagrelor|ticagrelor|mesh-list
83174476|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83174477|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83174478|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83174479|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83174480|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
83174481|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174482|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174483|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174484|NCT04470479|Pilocarpine|pilocarpine|mesh-list
83174485|NCT04470479|Miotics|miotics|mesh-ancestor
83174486|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
83174487|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174488|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174489|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83174490|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83174491|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
83174492|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174493|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174494|NCT00383513|Epratuzumab|epratuzumab|mesh-list
83174495|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174496|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174497|NCT00382811|Carboplatin|carboplatin|mesh-list
83174498|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174499|NCT02286635|Clarithromycin|clarithromycin|mesh-list
83174500|NCT02286635|Rifampin|rifampin|mesh-list
83174501|NCT02286635|Deflazacort|deflazacort|mesh-list
83174502|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83174503|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174504|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83174505|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174506|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174507|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83174508|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83174509|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83174510|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
83174511|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
83174512|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83174513|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83174514|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83174515|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83174516|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83174517|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83174518|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83174519|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174520|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83174521|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
83174522|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174523|NCT00440531|Vaccines|vaccines|mesh-list
83174524|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
83174525|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174526|NCT00380159|Lamivudine|lamivudine|mesh-list
83174527|NCT00380159|Emtricitabine|emtricitabine|mesh-list
83174528|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
83174529|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83174530|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83174531|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174532|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174533|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
83174534|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174535|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83174536|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83174537|NCT00437021|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83174538|NCT00437021|Antiviral Agents|antiviral agents|mesh-ancestor
83174539|NCT00437021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174540|NCT00375791|Dexamethasone|dexamethasone|mesh-list
83174541|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174542|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
83174543|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
83174544|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174545|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174546|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83174547|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
83174548|NCT00375791|Hormones|hormones|mesh-ancestor
83174549|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83174550|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83174551|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174552|NCT00431873|Mocetinostat|mocetinostat|mesh-list
83174553|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83174554|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174555|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174556|NCT02287181|Remifentanil|remifentanil|mesh-list
83174557|NCT02287181|Propofol|propofol|mesh-list
83174558|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83174559|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174560|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174561|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83174562|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
83174563|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
83174564|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83174565|NCT02287181|Narcotics|narcotics|mesh-ancestor
83174566|NCT02287181|Analgesics|analgesics|mesh-ancestor
83174567|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
83174568|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174569|NCT02287259|Olanzapine|olanzapine|mesh-list
83174570|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
83174571|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
83174572|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174573|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174574|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83174575|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83174576|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83174577|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174578|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83174579|NCT02287259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83174580|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83174581|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83174582|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174583|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174584|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
83174585|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
83174586|NCT00429923|Difluprednate|difluprednate|mesh-list
83174587|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
83174588|NCT00429923|Hormones|hormones|mesh-ancestor
83174589|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83174590|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174591|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174592|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
83174593|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83174594|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83362179|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83174595|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174596|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
83174597|NCT04470557|Coagulants|coagulants|mesh-ancestor
83174598|NCT00372437|Gemcitabine|gemcitabine|mesh-list
83174599|NCT00372437|Mocetinostat|mocetinostat|mesh-list
83174600|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174601|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
83174602|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174603|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174604|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83174605|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174606|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83174607|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
83174608|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174609|NCT04470791|Antivenins|antivenins|mesh-list
83174610|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
83174611|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174612|NCT00364247|Tapentadol|tapentadol|mesh-list
83174613|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83174614|NCT00364247|Narcotics|narcotics|mesh-ancestor
83174615|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174616|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174617|NCT00364247|Analgesics|analgesics|mesh-ancestor
83174618|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
83174619|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174620|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83174621|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83174622|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83174623|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174624|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
83416500|NCT01189643|Bevacizumab|bevacizumab|mesh-list
83174625|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174626|NCT00424697|Lorazepam|lorazepam|mesh-list
83174627|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
83174628|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
83174629|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
83174630|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174631|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174632|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83174633|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83174634|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174635|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83174636|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83174637|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83174638|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
83174639|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
83174640|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174641|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174642|NCT00360035|Obatoclax|obatoclax|mesh-list
83174643|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174644|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174645|NCT00356681|Niacinamide|niacinamide|mesh-list
83174646|NCT00356681|Paclitaxel|paclitaxel|mesh-list
83174647|NCT00356681|Bevacizumab|bevacizumab|mesh-list
83174648|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
83174649|NCT00356681|Imetelstat|imetelstat|mesh-list
83174650|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83174651|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174652|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
83174653|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
83174654|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
83174655|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174656|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174657|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83174658|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83174659|NCT00356681|Growth Substances|growth substances|mesh-ancestor
83174660|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174661|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83174662|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83174663|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174664|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
83174665|NCT00356681|Vitamins|vitamins|mesh-ancestor
83174666|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
83174667|NCT00417209|Fluorouracil|fluorouracil|mesh-list
83174668|NCT00417209|Capecitabine|capecitabine|mesh-list
83174669|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
83174670|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174671|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174672|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174673|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83174674|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
83174675|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174676|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83174677|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83174678|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83174679|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83174680|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174681|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
83174682|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174683|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174684|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83174685|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174686|NCT00355355|Talaporfin|talaporfin|mesh-list
83174687|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174688|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83174689|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
83174690|NCT00407303|Bortezomib|bortezomib|mesh-list
83174691|NCT00407303|Obatoclax|obatoclax|mesh-list
83174692|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174693|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174694|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174695|NCT00344045|Acetaminophen|acetaminophen|mesh-list
83174696|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83174697|NCT00344045|Analgesics|analgesics|mesh-ancestor
83174698|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
83174699|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174700|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174701|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
83174702|NCT02256436|Paclitaxel|paclitaxel|mesh-list
83174703|NCT02256436|Docetaxel|docetaxel|mesh-list
83174704|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
83174705|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83174706|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174707|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
83174708|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
83174709|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
83174710|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174711|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174712|NCT02256436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83174713|NCT00343109|Sargramostim|sargramostim|mesh-list
83174714|NCT00343109|Vaccines|vaccines|mesh-list
83174715|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
83174716|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174717|NCT02481830|Nivolumab|nivolumab|mesh-list
83174718|NCT02481830|Topotecan|topotecan|mesh-list
83174719|NCT02481830|Amrubicin|amrubicin|mesh-list
83174720|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174721|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174722|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83174723|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174724|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83174725|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83174726|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174727|NCT00405743|Cytarabine|cytarabine|mesh-list
83174728|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174729|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
83174730|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174731|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174732|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
83174733|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174734|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83174735|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
83174736|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174737|NCT00403169|Lenalidomide|lenalidomide|mesh-list
83174738|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
83174739|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174740|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83174741|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83174742|NCT00403169|Growth Substances|growth substances|mesh-ancestor
83174743|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
83174744|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174745|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
83174746|NCT00332657|Anecortave|anecortave|mesh-list
83174747|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83174748|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83174749|NCT00332657|Growth Substances|growth substances|mesh-ancestor
83174750|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174751|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
83174752|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174753|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174755|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83174756|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83174757|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174758|NCT00327743|Capecitabine|capecitabine|mesh-list
83174759|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174760|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
83174761|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174762|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174764|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83174765|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174766|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83174767|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174768|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83174769|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174770|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174771|NCT00398879|Capecitabine|capecitabine|mesh-list
83174772|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83174773|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
83174774|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174775|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174776|NCT00309179|Cetuximab|cetuximab|mesh-list
83174777|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83174778|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174779|NCT00394199|Fluticasone|fluticasone|mesh-list
83174780|NCT00394199|Xhance|xhance|mesh-list
83174781|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
83174782|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174783|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83174784|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
83174785|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174786|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174787|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83174788|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
83174789|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
83174790|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83174791|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83174792|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83174793|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83174794|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174795|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174796|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174797|NCT00394121|Fluticasone|fluticasone|mesh-list
83174798|NCT00394121|Xhance|xhance|mesh-list
83174799|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
83174800|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174801|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83174802|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
83174803|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174804|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174805|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83174806|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83174807|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
83174808|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83174809|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83174810|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83174811|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83174812|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174813|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174814|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174815|NCT02480114|Acetaminophen|acetaminophen|mesh-list
83174816|NCT02480114|Ibuprofen|ibuprofen|mesh-list
83174817|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83174818|NCT02480114|Fentanyl|fentanyl|mesh-list
83174819|NCT02480114|Oxycodone|oxycodone|mesh-list
83174820|NCT02480114|Hydrocodone|hydrocodone|mesh-list
83174821|NCT02480114|Gabapentin|gabapentin|mesh-list
83174822|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83174823|NCT02480114|Narcotics|narcotics|mesh-ancestor
83174824|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174825|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174826|NCT02480114|Analgesics|analgesics|mesh-ancestor
83174827|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
83174828|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174829|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83174830|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83174831|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
83174832|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
83174833|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83174834|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
83174835|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83174836|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174837|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83174838|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83174839|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174840|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174841|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
83174842|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83174843|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83174844|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83174845|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83174846|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83174847|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174848|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
83174849|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
83174850|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
83174851|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
83174852|NCT00299507|Anecortave|anecortave|mesh-list
83174853|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83174854|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83174855|NCT00299507|Growth Substances|growth substances|mesh-ancestor
83174856|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174857|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
83174858|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174859|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83174860|NCT02285309|Enoximone|enoximone|mesh-list
83174861|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83174862|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
83174863|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83174864|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83174865|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174866|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174867|NCT02285309|Protective Agents|protective agents|mesh-ancestor
83174868|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174869|NCT02479880|Tenofovir|tenofovir|mesh-list
83174870|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
83174871|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174872|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83174873|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83174874|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174875|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174876|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83174877|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83174878|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
83174879|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174880|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174881|NCT00297089|Pemetrexed|pemetrexed|mesh-list
83174882|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174883|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174884|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174885|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83174886|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83174887|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
83174888|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83174889|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174890|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83174891|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
83174892|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83174893|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174894|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83174895|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83362180|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174896|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83174897|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
83174898|NCT02285699|Citalopram|citalopram|mesh-list
83174899|NCT02285699|Fluoxetine|fluoxetine|mesh-list
83174900|NCT02285699|Paroxetine|paroxetine|mesh-list
83174901|NCT02285699|Sertraline|sertraline|mesh-list
83174902|NCT02285699|Escitalopram|escitalopram|mesh-list
83174903|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83174904|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83174905|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83174906|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174907|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174908|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
83174909|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174910|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83174911|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
83174912|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83174913|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83174914|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83174915|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174916|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83174917|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83174918|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83174919|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83174920|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83174921|NCT02288429|Colistin|colistin|mesh-list
83174922|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83174923|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174924|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
83174925|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83174926|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174927|NCT00265655|Satraplatin|satraplatin|mesh-list
83174928|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174929|NCT00254891|Paclitaxel|paclitaxel|mesh-list
83174930|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83174931|NCT00254891|Carboplatin|carboplatin|mesh-list
83174932|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83174933|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174934|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
83174935|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
83174936|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
83174937|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174938|NCT02479412|Albuterol|albuterol|mesh-list
83174939|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83174940|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
83174941|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174942|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174943|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83174944|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
83174945|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
83174946|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83174947|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83174948|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83174949|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83174950|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174951|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174952|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174954|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174955|NCT00252005|Apixaban|apixaban|mesh-list
83174956|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83174957|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
83174958|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83174959|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
83174960|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174961|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174962|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
83174963|NCT02288507|Sorafenib|sorafenib|mesh-list
83174964|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174965|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83174966|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174967|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174968|NCT00231257|Sirolimus|sirolimus|mesh-list
83174969|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83174970|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83174971|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83174972|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83174973|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
83174974|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83174975|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
83174976|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174977|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
83174978|NCT00224003|Hematinics|hematinics|mesh-ancestor
83174979|NCT00216593|Galantamine|galantamine|mesh-list
83174980|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83174981|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83174982|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174983|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
83174984|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174985|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83174986|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83174987|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
83174988|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83174989|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
83174990|NCT00389675|Guanfacine|guanfacine|mesh-list
83174991|NCT00389675|Darusentan|darusentan|mesh-list
83174992|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83174993|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83174994|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83174995|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83174996|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
83174997|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83174998|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83174999|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175000|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83175001|NCT02288741|Dexamethasone|dexamethasone|mesh-list
83175002|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
83175003|NCT02288741|Melphalan|melphalan|mesh-list
83175004|NCT02288741|BB 1101|bb 1101|mesh-list
83175005|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175006|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
83175007|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
83175008|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175009|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175010|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83175011|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
83175012|NCT02288741|Hormones|hormones|mesh-ancestor
83175013|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83416501|NCT01189643|Irinotecan|irinotecan|mesh-list
83175014|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83175015|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175016|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175017|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175018|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175019|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83175020|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
83175021|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83175022|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175023|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
83175024|NCT02450552|Ezogabine|ezogabine|mesh-list
83175025|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
83175026|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175027|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175028|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
83175029|NCT02508428|Diuretics|diuretics|mesh-ancestor
83175030|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
83175031|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175032|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83175033|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175034|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175035|NCT02448446|Ranibizumab|ranibizumab|mesh-list
83175036|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83175037|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83175038|NCT02448446|Growth Substances|growth substances|mesh-ancestor
83175039|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175040|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
83175041|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175042|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
83175043|NCT02478398|Loratadine|loratadine|mesh-list
83175044|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83175045|NCT02478398|Epinephrine|epinephrine|mesh-list
83175046|NCT02478398|Albuterol|albuterol|mesh-list
83175047|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83175048|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83175049|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
83175050|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175051|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175052|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175053|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83175054|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83175055|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
83175056|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175057|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83175058|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
83175059|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
83175060|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
83175061|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83175062|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
83175063|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83175064|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83175065|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175066|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175067|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83175068|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
83175069|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83175070|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83175071|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
83175072|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
83175073|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83175074|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175075|NCT02478398|Analgesics|analgesics|mesh-ancestor
83175076|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
83175077|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175078|NCT02478164|Ponatinib|ponatinib|mesh-list
83175079|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175080|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83175081|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175082|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175083|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83175084|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83175085|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83175086|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83175087|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
83175088|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83175089|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175090|NCT05259319|Atezolizumab|atezolizumab|mesh-list
83175091|NCT05259319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83175092|NCT05259319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175093|NCT05259319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83175094|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175095|NCT05259007|Amoxicillin|amoxicillin|mesh-list
83175096|NCT05259007|Clarithromycin|clarithromycin|mesh-list
83175097|NCT05259007|Propolis|propolis|mesh-list
83175098|NCT05259007|Lansoprazole|lansoprazole|mesh-list
83175099|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
83175100|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83175101|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175102|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83175103|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175104|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175105|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83175106|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83175107|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83175108|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83175109|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83175110|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
83175111|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83175112|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175113|NCT00380653|Sapacitabine|sapacitabine|mesh-list
83175114|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175115|NCT03472339|Diclofenac|diclofenac|mesh-list
83175116|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83175117|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175118|NCT03472339|Analgesics|analgesics|mesh-ancestor
83175119|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
83175120|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175121|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175122|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175123|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175124|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83175125|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175126|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175127|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
83175128|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83175129|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83175130|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83175131|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175132|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175133|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
83175134|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175135|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175136|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83175137|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175138|NCT03951025|Melatonin|melatonin|mesh-list
83175139|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
83175140|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175141|NCT03951025|Protective Agents|protective agents|mesh-ancestor
83175142|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175143|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175144|NCT02255500|Bupivacaine|bupivacaine|mesh-list
83175145|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83175146|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
83175147|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175148|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175149|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
83175150|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175151|NCT03475693|Acetaminophen|acetaminophen|mesh-list
83175152|NCT03475693|Ondansetron|ondansetron|mesh-list
83175153|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
83175154|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175155|NCT03475693|Analgesics|analgesics|mesh-ancestor
83175156|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
83175157|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175158|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175159|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
83175160|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
83175161|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
83175162|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83175163|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
83175164|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175165|NCT03475693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83175166|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83175167|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
83175168|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175169|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175170|NCT03475693|Antacids|antacids|mesh-ancestor
83175171|NCT05156749|Calpastatin|calpastatin|mesh-list
83175172|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83175173|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175174|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175175|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175176|NCT03475615|Paclitaxel|paclitaxel|mesh-list
83175177|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
83175178|NCT03475615|Tegafur|tegafur|mesh-list
83175179|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83175180|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175181|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
83175182|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
83175183|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
83175184|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175185|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83175186|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
83175187|NCT03478423|Oxycodone|oxycodone|mesh-list
83175188|NCT03478423|Hydromorphone|hydromorphone|mesh-list
83175189|NCT03478423|Codeine|codeine|mesh-list
83175190|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83175191|NCT03478423|Narcotics|narcotics|mesh-ancestor
83175192|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175193|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175194|NCT03478423|Analgesics|analgesics|mesh-ancestor
83175195|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
83175196|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175198|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
83175199|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
83175200|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175201|NCT03130933|Amoxicillin|amoxicillin|mesh-list
83175202|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83175203|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175204|NCT05155969|Ketamine|ketamine|mesh-list
83175205|NCT05155969|Esketamine|esketamine|mesh-list
83175206|NCT05155969|Analgesics|analgesics|mesh-ancestor
83175207|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
83175208|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175209|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175210|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83175211|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83175212|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
83175213|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
83175214|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175215|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83175216|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83175217|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175218|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175219|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
83175220|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83175221|NCT05112913|Vaccines|vaccines|mesh-list
83175222|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
83175223|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175224|NCT03475459|Melatonin|melatonin|mesh-list
83175225|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
83175226|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175227|NCT03475459|Protective Agents|protective agents|mesh-ancestor
83175228|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175229|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175230|NCT03478111|Infliximab|infliximab|mesh-list
83175231|NCT03478111|Methotrexate|methotrexate|mesh-list
83175232|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83175233|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
83175234|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83175235|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175236|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83175237|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
83175238|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175239|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175240|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175241|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175242|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83175243|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175244|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
83175245|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175246|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83175247|NCT03478111|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83175248|NCT03478111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175249|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83175250|NCT03478033|Rifampin|rifampin|mesh-list
83175251|NCT03478033|Rifabutin|rifabutin|mesh-list
83175252|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83175253|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
83175254|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83175255|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175257|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83175258|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175259|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175260|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83175261|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83175262|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83175263|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83175264|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83175265|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83175266|NCT03477955|Silicon|silicon|mesh-list
83175267|NCT03477955|Trace Elements|trace elements|mesh-ancestor
83175268|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
83175269|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175270|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
83175271|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175272|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83175273|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175274|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175275|NCT05084599|Metaraminol|metaraminol|mesh-list
83175276|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
83175277|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
83175278|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175279|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175280|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83175281|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83175282|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83175283|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83175284|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
83175285|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175286|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175287|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
83175288|NCT02505542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83175289|NCT02505542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175290|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175291|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
83175292|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175293|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175294|NCT00701623|Heparin|heparin|mesh-list
83175295|NCT00701623|Calcium heparin|calcium heparin|mesh-list
83175296|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
83175297|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83175298|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83175299|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175300|NCT04456153|Atovaquone|atovaquone|mesh-list
83175301|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175302|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
83175303|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83175304|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83175305|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175306|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175307|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
83175308|NCT04403971|Listerine|listerine|mesh-list
83175309|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83175310|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175311|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
83175312|NCT02447432|Vaccines|vaccines|mesh-list
83175313|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83175314|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
83175315|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175316|NCT02446886|Hormones|hormones|mesh-list
83175317|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83175318|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83175319|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
83175320|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83175321|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175322|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175323|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175324|NCT04351243|Gimsilumab|gimsilumab|mesh-list
83175325|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175326|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
83175327|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175328|NCT05008003|Vitamin D|vitamin d|mesh-list
83175329|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
83175330|NCT05008003|Vitamins|vitamins|mesh-ancestor
83175331|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
83175332|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175333|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83175334|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83175335|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
83175336|NCT03475225|Vitamin D|vitamin d|mesh-list
83175337|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83175338|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175339|NCT03475225|Vitamins|vitamins|mesh-ancestor
83175340|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
83175341|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83175342|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83175343|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175344|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
83175345|NCT02504294|Hematinics|hematinics|mesh-ancestor
83175346|NCT02446418|Fluticasone|fluticasone|mesh-list
83175347|NCT02446418|Xhance|xhance|mesh-list
83175348|NCT02446418|Budesonide|budesonide|mesh-list
83175349|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
83175350|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83175351|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175352|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83175353|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
83175354|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175355|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175356|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83175357|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
83175358|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175359|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83175360|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
83175361|NCT02446418|Hormones|hormones|mesh-ancestor
83175362|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83175363|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83175364|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83175365|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83175366|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
83175367|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175368|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175369|NCT04859062|Lidocaine|lidocaine|mesh-list
83175370|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
83175371|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
83175372|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175373|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175374|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
83175375|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175376|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83175377|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83175378|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83175379|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175380|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175381|NCT04864210|Bupivacaine|bupivacaine|mesh-list
83175382|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
83175383|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
83175384|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175385|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175386|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
83175387|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175388|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
83175389|NCT01641640|Ribavirin|ribavirin|mesh-list
83175390|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
83175391|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175392|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
83175393|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175394|NCT05650216|Paclitaxel|paclitaxel|mesh-list
83175395|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83175396|NCT05650216|Carboplatin|carboplatin|mesh-list
83175397|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83175398|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175399|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
83175400|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
83175401|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
83175402|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175403|NCT04848688|Ivermectin|ivermectin|mesh-list
83175404|NCT04848688|Moxidectin|moxidectin|mesh-list
83175405|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83175406|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175407|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
83175408|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
83175409|NCT05369650|Lidocaine|lidocaine|mesh-list
83175410|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
83175411|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
83175412|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175413|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175414|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
83175415|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175416|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83175417|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83175418|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83175419|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175420|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175421|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83175422|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83175423|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83175424|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175425|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175426|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
83175427|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175428|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175429|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83175430|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83175431|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175433|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
83175434|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175435|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175436|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175437|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175438|NCT01601626|Pyridoxine|pyridoxine|mesh-list
83175439|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
83175440|NCT01601626|Ritonavir|ritonavir|mesh-list
83175441|NCT01601626|Lopinavir|lopinavir|mesh-list
83175442|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
83175443|NCT01601626|Rifampin|rifampin|mesh-list
83175444|NCT01601626|Isoniazid|isoniazid|mesh-list
83175445|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
83175446|NCT01601626|Ethambutol|ethambutol|mesh-list
83175447|NCT01601626|Rifabutin|rifabutin|mesh-list
83175448|NCT01601626|Vitamins|vitamins|mesh-ancestor
83175449|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
83175450|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175451|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83175452|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83175453|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175454|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175455|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175456|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175457|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175458|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
83175459|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175460|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83175461|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83175462|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
83175463|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83175464|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83175465|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83175466|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
83175467|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83175468|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
83175469|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83175470|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83175471|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83175472|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83175473|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83175474|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83175475|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83175476|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83175477|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83175478|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
83175479|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83175480|NCT05428150|Pirfenidone|pirfenidone|mesh-list
83175481|NCT05428150|Analgesics|analgesics|mesh-ancestor
83175482|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
83175483|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175484|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175485|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83175486|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175487|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175488|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175489|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175490|NCT02737501|Crizotinib|crizotinib|mesh-list
83175491|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175492|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83175493|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175494|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175496|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83175497|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83175498|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
83175499|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175500|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175501|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175503|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
83175504|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
83175505|NCT05642182|Vitamins|vitamins|mesh-list
83175506|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
83175507|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175508|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83175509|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83175510|NCT03471559|Cannabidiol|cannabidiol|mesh-list
83175511|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
83175512|NCT05641480|Donepezil|donepezil|mesh-list
83175513|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83175514|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175515|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175516|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
83175517|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175518|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175519|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
83175520|NCT05640934|Melatonin|melatonin|mesh-list
83175521|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
83175522|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175523|NCT05640934|Protective Agents|protective agents|mesh-ancestor
83175524|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175525|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175526|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83175527|NCT03377803|Cantharidin|cantharidin|mesh-list
83175528|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175529|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175530|NCT03471325|Methamphetamine|methamphetamine|mesh-list
83175531|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83175532|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175533|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
83175534|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
83175535|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175536|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
83175537|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175538|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175539|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
83175540|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83175541|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83175542|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175543|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83175544|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
83175545|NCT04844164|Vitamin D|vitamin d|mesh-list
83175546|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83175547|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175548|NCT04844164|Vitamins|vitamins|mesh-ancestor
83175549|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
83175550|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83175551|NCT05392972|Anesthetics|anesthetics|mesh-list
83175552|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175553|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175554|NCT03474601|Hormones|hormones|mesh-list
83175555|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83175556|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175557|NCT04988308|Adalimumab|adalimumab|mesh-list
83175558|NCT04988308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83175559|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175560|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175561|NCT04984798|Vitamin E|vitamin e|mesh-list
83175562|NCT04984798|Tocopherols|tocopherols|mesh-list
83175563|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
83175564|NCT04984798|Vitamins|vitamins|mesh-ancestor
83175565|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
83175566|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175567|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
83175568|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175569|NCT04984798|Protective Agents|protective agents|mesh-ancestor
83175570|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
83175571|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83175573|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
83175574|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175576|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83175577|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175578|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
83175579|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
83175580|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
83175581|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175582|NCT00135395|Ritonavir|ritonavir|mesh-list
83175583|NCT00135395|Lopinavir|lopinavir|mesh-list
83175584|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83175585|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83175586|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83175587|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175588|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175589|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175590|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175591|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175592|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
83175593|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175594|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83175595|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83175596|NCT02230553|Lapatinib|lapatinib|mesh-list
83175597|NCT02230553|Trametinib|trametinib|mesh-list
83175598|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175599|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83175600|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175601|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175602|NCT04261049|Triamcinolone|triamcinolone|mesh-list
83175603|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83175604|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83175605|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83175606|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175607|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
83175608|NCT04261049|Hormones|hormones|mesh-ancestor
83175609|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83175610|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175611|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175612|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
83175613|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175614|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175615|NCT00057473|Carboplatin|carboplatin|mesh-list
83175616|NCT00057473|Irinotecan|irinotecan|mesh-list
83175617|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175618|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83175619|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83175620|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175621|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175622|NCT00035789|Entecavir|entecavir|mesh-list
83175623|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
83175624|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175625|NCT00035633|Entecavir|entecavir|mesh-list
83175627|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175628|NCT00028301|Ritonavir|ritonavir|mesh-list
83175629|NCT00028301|Lopinavir|lopinavir|mesh-list
83175630|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83175631|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83175632|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83175633|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175634|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175635|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175636|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175637|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175638|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
83175639|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175640|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83175641|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83175642|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83175643|NCT00028067|Nelfinavir|nelfinavir|mesh-list
83175644|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83175645|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83175646|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175647|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175648|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175649|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175650|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175651|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
83175652|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175653|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
83175654|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175655|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
83175657|NCT00004907|Etoposide|etoposide|mesh-list
83175658|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175659|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
83175660|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175661|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175662|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83175663|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
83175664|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175665|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175666|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83175667|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83175668|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83175669|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83175670|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175671|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
83175672|NCT04469777|Hematinics|hematinics|mesh-ancestor
83175673|NCT00004895|Octreotide|octreotide|mesh-list
83175674|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83175675|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83175676|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175677|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
83175678|NCT00004181|Busulfan|busulfan|mesh-list
83175679|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175680|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
83175681|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175682|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175683|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83175684|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
83175685|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175686|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175687|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83175688|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
83175689|NCT00004175|Docetaxel|docetaxel|mesh-list
83175690|NCT00004175|Doxorubicin|doxorubicin|mesh-list
83175691|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83175692|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175693|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
83175694|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175695|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175696|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83175697|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
83175698|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175699|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175700|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83175701|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83175702|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83175703|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83175704|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83175705|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83175706|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83175707|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175708|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83175709|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83175710|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83175711|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
83175712|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175713|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83175714|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83175715|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175716|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
83175717|NCT00004169|Carboplatin|carboplatin|mesh-list
83175718|NCT00004169|Etoposide|etoposide|mesh-list
83175719|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175720|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
83175721|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175722|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175723|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83175724|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
83175725|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175726|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175727|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83175728|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83175729|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83175730|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83175731|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175732|NCT00002429|Lamivudine|lamivudine|mesh-list
83175733|NCT00002429|Zidovudine|zidovudine|mesh-list
83175734|NCT00002429|Stavudine|stavudine|mesh-list
83175735|NCT00002429|Didanosine|didanosine|mesh-list
83175736|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83175737|NCT00002429|Nelfinavir|nelfinavir|mesh-list
83175738|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83175739|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83175740|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175741|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175742|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
83175743|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175744|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175745|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175746|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
83175747|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83175748|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83175749|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175751|NCT00002411|Zidovudine|zidovudine|mesh-list
83175752|NCT00002411|Stavudine|stavudine|mesh-list
83175753|NCT00002411|Didanosine|didanosine|mesh-list
83175754|NCT00002411|Nelfinavir|nelfinavir|mesh-list
83175755|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83175756|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83175757|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175758|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175759|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
83175760|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175761|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175762|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175763|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
83175764|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83175765|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83175766|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175767|NCT03530033|Lidocaine|lidocaine|mesh-list
83175768|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
83175769|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
83175770|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175771|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175772|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
83175773|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175774|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83175775|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83175776|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83175777|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83175778|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175779|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
83175780|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83175781|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175782|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175783|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175784|NCT03529643|Analgesics|analgesics|mesh-ancestor
83175785|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
83175786|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175787|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83175788|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83175789|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83175790|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
83175791|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175792|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175793|NCT03529331|Acetaminophen|acetaminophen|mesh-list
83175794|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83175795|NCT03529331|Morphine|morphine|mesh-list
83175796|NCT03529331|Oxycodone|oxycodone|mesh-list
83175797|NCT03529331|Hydrocodone|hydrocodone|mesh-list
83175798|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83175800|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175801|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175802|NCT03529331|Analgesics|analgesics|mesh-ancestor
83175803|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
83175804|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175805|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175806|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
83175807|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
83175808|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
83175809|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83175810|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175811|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175812|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83175813|NCT03529253|Alirocumab|alirocumab|mesh-list
83175814|NCT03529253|Calcium|calcium|mesh-list
83175815|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83175816|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175817|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83175818|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83175819|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
83175820|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175821|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83175822|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83175823|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175824|NCT03529253|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83175825|NCT03529253|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83175826|NCT03529253|Protease Inhibitors|protease inhibitors|mesh-ancestor
83175828|NCT03529175|Gemcitabine|gemcitabine|mesh-list
83175829|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83175830|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83175831|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175832|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83175833|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83175834|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83175835|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175836|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83175837|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
83175838|NCT00002207|Stavudine|stavudine|mesh-list
83175839|NCT00002207|Didanosine|didanosine|mesh-list
83175840|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
83175841|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175842|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83175843|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83175844|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175845|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
83175846|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175847|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175848|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175849|NCT03529097|Dipyrone|dipyrone|mesh-list
83175850|NCT03529097|Diclofenac|diclofenac|mesh-list
83175851|NCT03529097|Morphine|morphine|mesh-list
83175852|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83175853|NCT03529097|Narcotics|narcotics|mesh-ancestor
83175854|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175855|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175856|NCT03529097|Analgesics|analgesics|mesh-ancestor
83175857|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
83175858|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175859|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83175860|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83175861|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83175862|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175863|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83175864|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175865|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175866|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
83175867|NCT05614349|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83175868|NCT05614349|Antiviral Agents|antiviral agents|mesh-ancestor
83175869|NCT05614349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175870|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
83175871|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
83175872|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175873|NCT03531749|Protective Agents|protective agents|mesh-ancestor
83175874|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175875|NCT03531749|Vitamins|vitamins|mesh-ancestor
83175876|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
83175877|NCT03528785|Leucovorin|leucovorin|mesh-list
83175878|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
83175879|NCT03528785|Irinotecan|irinotecan|mesh-list
83175880|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
83175881|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175882|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83175883|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83175884|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175885|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175886|NCT03528785|Antidotes|antidotes|mesh-ancestor
83175887|NCT03528785|Protective Agents|protective agents|mesh-ancestor
83175888|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175889|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
83175890|NCT03528785|Vitamins|vitamins|mesh-ancestor
83175891|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
83175892|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83175893|NCT03531437|Gestodene|gestodene|mesh-list
83175894|NCT03531437|Estradiol|estradiol|mesh-list
83175895|NCT03531437|Estrogens|estrogens|mesh-ancestor
83175896|NCT03531437|Hormones|hormones|mesh-ancestor
83175897|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83175898|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175899|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83175900|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
83175901|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83175902|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83175903|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83175904|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83175905|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83175906|NCT03531437|Progestins|progestins|mesh-ancestor
83175907|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
83175908|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83175909|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
83175910|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175911|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175912|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83175913|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
83175914|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83175915|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
83175916|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175917|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175918|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83175919|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
83175920|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
83175921|NCT03527381|Protective Agents|protective agents|mesh-ancestor
83175922|NCT04441385|Maraviroc|maraviroc|mesh-list
83175923|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83175924|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83175925|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175926|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83175927|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83175928|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
83175929|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175930|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83175931|NCT03531359|Midazolam|midazolam|mesh-list
83175932|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83175933|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83175934|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83175935|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175936|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83175937|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83175938|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83175939|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83175940|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
83175941|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
83175942|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
83175943|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
83175944|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175945|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175946|NCT03531281|Sirolimus|sirolimus|mesh-list
83175947|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
83175948|NCT03531281|Etoposide|etoposide|mesh-list
83175949|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
83175950|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
83175951|NCT03531281|Tacrolimus|tacrolimus|mesh-list
83175952|NCT03531281|Mitogens|mitogens|mesh-list
83175953|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83175954|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
83175955|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175956|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83175957|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83175958|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
83175959|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175960|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175961|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83175962|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83175963|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83175964|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83175965|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83175966|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83175967|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83175968|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83175969|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83175970|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
83175971|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83175972|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
83175973|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175974|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83175975|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83175976|NCT04468685|Ondansetron|ondansetron|mesh-list
83175977|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
83175978|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
83175979|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83175980|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175981|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83175982|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
83175983|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175984|NCT04468685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83175985|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83175986|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
83175987|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83175988|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83175989|NCT03531047|Riboflavin|riboflavin|mesh-list
83175990|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
83175991|NCT03531047|Vitamins|vitamins|mesh-ancestor
83175992|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
83175993|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83175994|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83175995|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
83175997|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83175998|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83175999|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83176000|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176001|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176002|NCT04440917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176003|NCT04192019|Glucagon|glucagon|mesh-list
83176004|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83176005|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176006|NCT04192019|Hormones|hormones|mesh-ancestor
83176007|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176008|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176009|NCT04192019|Incretins|incretins|mesh-ancestor
83176010|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
83176011|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176012|NCT05062031|Atropine|atropine|mesh-list
83176013|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83176014|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83176015|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83176016|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83176017|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
83176018|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176019|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176020|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83176021|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
83176022|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
83176023|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
83176024|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83176025|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83176026|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
83176027|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176028|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176029|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83176030|NCT05446571|Valacyclovir|valacyclovir|mesh-list
83176031|NCT05446571|Letermovir|letermovir|mesh-list
83176032|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
83176033|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176034|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83176035|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176036|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176037|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176038|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
83176039|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83176040|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176041|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176042|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83176043|NCT05439005|Analgesics|analgesics|mesh-ancestor
83176044|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
83176045|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176046|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83176047|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83176048|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83176049|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176050|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176051|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176052|NCT05258747|Olaparib|olaparib|mesh-list
83176053|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83176054|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176055|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176056|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176057|NCT04468139|Quercetin|quercetin|mesh-list
83176058|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176059|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
83176060|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176061|NCT04468139|Protective Agents|protective agents|mesh-ancestor
83176062|NCT03526445|Glucagon|glucagon|mesh-list
83176063|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176064|NCT03526445|Hormones|hormones|mesh-ancestor
83176065|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176066|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176067|NCT04939649|Midazolam|midazolam|mesh-list
83176068|NCT04939649|Ketamine|ketamine|mesh-list
83176069|NCT04939649|Analgesics|analgesics|mesh-ancestor
83176070|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
83176071|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176072|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176073|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83176074|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83176075|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
83176076|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
83176077|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176078|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83176079|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83176080|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176081|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176082|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83176083|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83176084|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83176085|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83176086|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83176087|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
83176088|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
83176089|NCT04927949|Cangrelor|cangrelor|mesh-list
83176090|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83176091|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83176092|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83176093|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83176094|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
83176095|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430103|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176096|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176097|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176098|NCT04589819|Teriparatide|teriparatide|mesh-list
83176099|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83176100|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176101|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83176102|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83176103|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83176104|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83176105|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
83176106|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176107|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83176108|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83176109|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176110|NCT04467983|Denosumab|denosumab|mesh-list
83176111|NCT04467983|Abaloparatide|abaloparatide|mesh-list
83176112|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83176113|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176114|NCT04839731|Fluorouracil|fluorouracil|mesh-list
83176115|NCT04839731|Calcipotriene|calcipotriene|mesh-list
83176116|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
83176117|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176118|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83176119|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176120|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176121|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
83176122|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176123|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176124|NCT03525509|Morphine|morphine|mesh-list
83176125|NCT03525509|Methadone|methadone|mesh-list
83176126|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83176127|NCT03525509|Narcotics|narcotics|mesh-ancestor
83176128|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176129|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176130|NCT03525509|Analgesics|analgesics|mesh-ancestor
83176131|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
83176132|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176133|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
83176134|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
83176135|NCT04699721|Paclitaxel|paclitaxel|mesh-list
83176136|NCT04699721|Carboplatin|carboplatin|mesh-list
83176137|NCT04699721|Nivolumab|nivolumab|mesh-list
83176138|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83176139|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176140|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
83176141|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
83176142|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
83176143|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176144|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176145|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83176146|NCT05179499|Norepinephrine|norepinephrine|mesh-list
83176147|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83176148|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83176149|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176150|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176151|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176152|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176153|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
83176154|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
83176155|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176156|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83176157|NCT03525821|Ketamine|ketamine|mesh-list
83176158|NCT03525821|Analgesics|analgesics|mesh-ancestor
83176159|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
83176160|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176161|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176162|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83176163|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83176164|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
83176165|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
83176166|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176167|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83176168|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83176169|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176170|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176171|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83176172|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
83176173|NCT04221035|Temozolomide|temozolomide|mesh-list
83176174|NCT04221035|Melphalan|melphalan|mesh-list
83176175|NCT04221035|Busulfan|busulfan|mesh-list
83176177|NCT04221035|Thiotepa|thiotepa|mesh-list
83176178|NCT04221035|Dacarbazine|dacarbazine|mesh-list
83176179|NCT04221035|Carboplatin|carboplatin|mesh-list
83176180|NCT04221035|Doxorubicin|doxorubicin|mesh-list
83176181|NCT04221035|Irinotecan|irinotecan|mesh-list
83176182|NCT04221035|Etoposide|etoposide|mesh-list
83176183|NCT04221035|Vincristine|vincristine|mesh-list
83176184|NCT04221035|Vindesine|vindesine|mesh-list
83176185|NCT04221035|Dinutuximab|dinutuximab|mesh-list
83176186|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176187|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
83176188|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176189|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176190|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83176191|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
83176192|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176193|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176194|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83176195|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83176196|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83176197|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83176198|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176199|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83176200|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83176201|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83176202|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83176203|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83176204|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
83176205|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83176206|NCT04842682|Diazepam|diazepam|mesh-list
83176207|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83176208|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
83176209|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
83176210|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
83176211|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176212|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176213|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176214|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83430104|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
83176215|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176216|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83176217|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83176218|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83176219|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83176220|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83176221|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83176222|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
83176223|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
83176224|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
83176225|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
83176226|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176227|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176228|NCT04969276|Vaccines|vaccines|mesh-list
83176229|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
83176230|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176231|NCT04969198|Nicotine|nicotine|mesh-list
83176232|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83176233|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
83176234|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176235|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176236|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83176237|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83176238|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
83176239|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176240|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176241|NCT04666636|Mirabegron|mirabegron|mesh-list
83176242|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83176243|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83176244|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83176245|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176246|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176247|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176248|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176249|NCT04666636|Urological Agents|urological agents|mesh-ancestor
83176250|NCT04890106|Bimatoprost|bimatoprost|mesh-list
83176251|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83176252|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83176253|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83176254|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83176255|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83176256|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83176257|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176259|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176260|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176261|NCT05206084|Sirolimus|sirolimus|mesh-list
83176262|NCT05206084|Everolimus|everolimus|mesh-list
83176263|NCT05206084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83176264|NCT05206084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83176265|NCT05206084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176266|NCT05206084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176267|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176268|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
83176269|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176270|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176271|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176272|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176273|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83176274|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
83176275|NCT05198362|Metoprolol|metoprolol|mesh-list
83176276|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83176277|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83176278|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
83176279|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
83176280|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176281|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176282|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83176283|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83176284|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83176285|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176286|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176287|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176288|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83176289|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
83176290|NCT04810156|Prednisone|prednisone|mesh-list
83176291|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
83176292|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83176293|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83176294|NCT04810156|Prednisolone|prednisolone|mesh-list
83176295|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
83176296|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83176297|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83176298|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
83176299|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176300|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
83176301|NCT04810156|Hormones|hormones|mesh-ancestor
83176302|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176303|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176304|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83176305|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176306|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83176307|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83176308|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
83176309|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176310|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176311|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176312|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176313|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
83176314|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
83176315|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176316|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176317|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83176318|NCT04810156|Protective Agents|protective agents|mesh-ancestor
83176319|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83176320|NCT04837924|Acetaminophen|acetaminophen|mesh-list
83176321|NCT04837924|Tramadol|tramadol|mesh-list
83176322|NCT04837924|Analgesics|analgesics|mesh-list
83176323|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
83176324|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83176325|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
83176326|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176327|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176328|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
83176329|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83176330|NCT04837924|Narcotics|narcotics|mesh-ancestor
83176331|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176332|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
83176333|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
83176334|NCT05406466|Lenvatinib|lenvatinib|mesh-list
83176335|NCT05406466|Tislelizumab|tislelizumab|mesh-list
83176336|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176337|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83176338|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176339|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176340|NCT05406466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176341|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
83176342|NCT05152420|Apixaban|apixaban|mesh-list
83176343|NCT05152420|Edoxaban|edoxaban|mesh-list
83176344|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83176345|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
83176346|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83176347|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
83176348|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176349|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176350|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
83176351|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
83176352|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83176353|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
83176354|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83176355|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83176356|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176357|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176358|NCT01601470|Urological Agents|urological agents|mesh-ancestor
83176359|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83176360|NCT04418908|Cetrorelix|cetrorelix|mesh-list
83176361|NCT04418908|Estradiol|estradiol|mesh-list
83176362|NCT04418908|Estrogens|estrogens|mesh-ancestor
83176363|NCT04418908|Hormones|hormones|mesh-ancestor
83176364|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176365|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176366|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83176367|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83176368|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
83176369|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
83176370|NCT04546126|Dexamethasone|dexamethasone|mesh-list
83176371|NCT04546126|Cosyntropin|cosyntropin|mesh-list
83176372|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176373|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
83176374|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
83176375|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176376|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176377|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176378|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
83176379|NCT04546126|Hormones|hormones|mesh-ancestor
83176380|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176381|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83176382|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176383|NCT04762498|Methotrexate|methotrexate|mesh-list
83176384|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83176385|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
83176386|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83176387|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176388|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83176389|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
83176390|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176391|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176392|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176393|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176394|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83176395|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176396|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
83176397|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176398|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83176399|NCT04831450|Cemiplimab|cemiplimab|mesh-list
83176400|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176401|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176402|NCT04830982|Diazoxide|diazoxide|mesh-list
83176403|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83176404|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
83176406|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176407|NCT05302804|Menthol|menthol|mesh-list
83176408|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
83176409|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176410|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
83176411|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176412|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176413|NCT04508140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83176414|NCT04508140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176415|NCT04820452|Aflibercept|aflibercept|mesh-list
83176416|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83176417|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83176418|NCT04820452|Growth Substances|growth substances|mesh-ancestor
83176419|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176420|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
83176421|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176422|NCT05298202|Capsaicin|capsaicin|mesh-list
83176423|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
83176424|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176425|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
83176426|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176427|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176428|NCT01637272|Pasireotide|pasireotide|mesh-list
83176429|NCT01637272|Hormones|hormones|mesh-ancestor
83176430|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176431|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176432|NCT04458922|Atezolizumab|atezolizumab|mesh-list
83176433|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83176434|NCT04458922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83176435|NCT04458922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176436|NCT04458922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176437|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176438|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
83176439|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176440|NCT03178864|Heparin|heparin|mesh-list
83176441|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
83176442|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
83176443|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83176444|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83176445|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176446|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83176447|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
83176448|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83176449|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
83176450|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176451|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83176452|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
83176453|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176454|NCT05323552|Curare|curare|mesh-list
83176455|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83176456|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83176457|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83176458|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176459|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176460|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83176461|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83176462|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
83176463|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176464|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176465|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
83176466|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176467|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
83176468|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176469|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176470|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83176471|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83176472|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176473|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176474|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176475|NCT02987686|Infliximab|infliximab|mesh-list
83176476|NCT02987686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83176477|NCT02987686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176478|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176479|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176480|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176481|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
83176482|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83176483|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
83176484|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83176485|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
83176486|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176487|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176488|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
83176489|NCT05277922|Nitroprusside|nitroprusside|mesh-list
83176490|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83176491|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
83176492|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83176493|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176494|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
83176495|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
83176496|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83176497|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83176498|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176499|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176500|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176501|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176502|NCT02917096|Vidarabine|vidarabine|mesh-list
83176503|NCT02917096|Sirolimus|sirolimus|mesh-list
83176504|NCT02917096|Fludarabine|fludarabine|mesh-list
83176505|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
83176506|NCT02917096|Melphalan|melphalan|mesh-list
83176507|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
83176508|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83176509|NCT02917096|Tacrolimus|tacrolimus|mesh-list
83176510|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176511|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83176512|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
83176513|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176514|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176515|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
83176516|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176517|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
83176518|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176519|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83176520|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176521|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176522|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83176523|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
83176524|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83176525|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
83176526|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83176527|NCT04194424|Metformin|metformin|mesh-list
83176528|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83176529|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176530|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
83176531|NCT02473640|Esomeprazole|esomeprazole|mesh-list
83176532|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83176533|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176534|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83176535|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176536|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176537|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176538|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176539|NCT01637584|Prazosin|prazosin|mesh-list
83176540|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83176541|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83176542|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83176543|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83176544|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176545|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176546|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176547|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176548|NCT03875092|Paclitaxel|paclitaxel|mesh-list
83176549|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83176550|NCT03875092|Carboplatin|carboplatin|mesh-list
83176551|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
83176552|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83176553|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176554|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
83176555|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
83176556|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
83176557|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176558|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176559|NCT03875092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83176560|NCT02728102|Lenalidomide|lenalidomide|mesh-list
83176561|NCT02728102|Melphalan|melphalan|mesh-list
83176562|NCT02728102|Molgramostim|molgramostim|mesh-list
83176563|NCT02728102|Vaccines|vaccines|mesh-list
83176564|NCT02728102|Sargramostim|sargramostim|mesh-list
83176565|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
83176566|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176567|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83176568|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83176569|NCT02728102|Growth Substances|growth substances|mesh-ancestor
83176570|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83176571|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176572|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83176573|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
83176574|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176575|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83176576|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176577|NCT02502734|Fluticasone|fluticasone|mesh-list
83176578|NCT02502734|Xhance|xhance|mesh-list
83176579|NCT02502734|Albuterol|albuterol|mesh-list
83176580|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176581|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83176582|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
83176583|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176584|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176585|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83176586|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83176587|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176588|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83176589|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
83176590|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83176591|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83176592|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83176593|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83176594|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176595|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176596|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176597|NCT04193878|Budesonide|budesonide|mesh-list
83176598|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
83176599|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176600|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83176601|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
83176602|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176603|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176604|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83176605|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
83176606|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
83176607|NCT04193878|Hormones|hormones|mesh-ancestor
83176608|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176609|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83176610|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83176611|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83176612|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176613|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176614|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176615|NCT02473250|Fluoxetine|fluoxetine|mesh-list
83176616|NCT02473250|Citalopram|citalopram|mesh-list
83176617|NCT02473250|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83176618|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83176619|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83176620|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176621|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176622|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
83176623|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176624|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83176625|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
83176626|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83176627|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83176628|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83176629|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176630|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83176631|NCT04253626|Hematinics|hematinics|mesh-ancestor
83176632|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83176633|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83176635|NCT03840148|Cefepime|cefepime|mesh-list
83176636|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176637|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176638|NCT04821778|Paclitaxel|paclitaxel|mesh-list
83176639|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
83176640|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83176641|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176642|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
83176643|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83176644|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83176645|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176646|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176647|NCT02611024|Irinotecan|irinotecan|mesh-list
83176648|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83176649|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83176650|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176651|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176652|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176653|NCT04222504|Tenofovir|tenofovir|mesh-list
83176654|NCT04222504|Emtricitabine|emtricitabine|mesh-list
83176655|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
83176656|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176657|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83176658|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83176659|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176660|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176661|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83176662|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83176663|NCT02500706|Insulin|insulin|mesh-list
83176664|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83176665|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
83176666|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
83176667|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83176668|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83176669|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176670|NCT04201496|Empagliflozin|empagliflozin|mesh-list
83176671|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83176672|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176673|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83176674|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176675|NCT02456974|Amoxicillin|amoxicillin|mesh-list
83176676|NCT02456974|Vancomycin|vancomycin|mesh-list
83176677|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
83176678|NCT02456974|Meropenem|meropenem|mesh-list
83176679|NCT02456974|Tazobactam|tazobactam|mesh-list
83176680|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
83176681|NCT02456974|Amikacin|amikacin|mesh-list
83176682|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83176683|NCT02456974|Teicoplanin|teicoplanin|mesh-list
83176684|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176685|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176686|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83176687|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83176688|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176689|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176690|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176691|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83176692|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83176693|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83176694|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
83176695|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
83176696|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83176697|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83176698|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176699|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176700|NCT04797286|Urological Agents|urological agents|mesh-ancestor
83176701|NCT03682276|Nivolumab|nivolumab|mesh-list
83176702|NCT03682276|Ipilimumab|ipilimumab|mesh-list
83176703|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176704|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176705|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83176706|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176707|NCT05653024|Albuterol|albuterol|mesh-list
83176708|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83176709|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
83176710|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176711|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176712|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83176713|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
83176714|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
83176715|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83176716|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83176717|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83176718|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83176719|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176720|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176721|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176722|NCT02499770|Carboplatin|carboplatin|mesh-list
83176723|NCT02499770|Etoposide|etoposide|mesh-list
83176724|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176725|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83176726|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83176727|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83176728|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176729|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176730|NCT04418674|Fentanyl|fentanyl|mesh-list
83176731|NCT04418674|Ketamine|ketamine|mesh-list
83176732|NCT04418674|Analgesics|analgesics|mesh-ancestor
83176733|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
83176734|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176735|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176736|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83176737|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83176738|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
83176739|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
83176740|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176741|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83176742|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83176743|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176744|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176745|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83176746|NCT04418674|Narcotics|narcotics|mesh-ancestor
83176747|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83176748|NCT02442284|Ritonavir|ritonavir|mesh-list
83176749|NCT02442284|Ribavirin|ribavirin|mesh-list
83176750|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83176751|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83176752|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
83176753|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176754|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176755|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83176756|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83176757|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
83176758|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176759|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83176760|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83176761|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
83176762|NCT03781960|Nivolumab|nivolumab|mesh-list
83176763|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176764|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176765|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83176766|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176767|NCT02499146|Letrozole|letrozole|mesh-list
83176768|NCT02499146|Palbociclib|palbociclib|mesh-list
83176769|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176770|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83176771|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83176772|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176773|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176774|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83176775|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
83176776|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176777|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176778|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83176779|NCT01634854|Misoprostol|misoprostol|mesh-list
83176780|NCT01634854|Oxytocin|oxytocin|mesh-list
83176781|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
83176782|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83176783|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176784|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83176785|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
83176786|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83176787|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176788|NCT05651464|Vancomycin|vancomycin|mesh-list
83176789|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176790|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176791|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83176792|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176793|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83176794|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176795|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176796|NCT02441114|Fluticasone|fluticasone|mesh-list
83176797|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
83176798|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83176799|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83176800|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176801|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83176802|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
83176803|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176804|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176805|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83176806|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
83176807|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
83176808|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83176809|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
83176810|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83176811|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
83176812|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176813|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176814|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83176815|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83176816|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83176817|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
83176818|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
83176819|NCT02441114|Hormones|hormones|mesh-ancestor
83176820|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176821|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
83176822|NCT02498444|Treprostinil|treprostinil|mesh-list
83176823|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83176824|NCT05235256|Dexamethasone|dexamethasone|mesh-list
83176825|NCT05235256|Lidocaine|lidocaine|mesh-list
83176826|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176827|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
83176828|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
83176829|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176830|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176831|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176832|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
83176833|NCT05235256|Hormones|hormones|mesh-ancestor
83176834|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176835|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83176836|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176837|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
83176838|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
83176839|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176840|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
83176841|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83176842|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83176843|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83176844|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83176845|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176846|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
83176847|NCT02497976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83176848|NCT02497976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83176849|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176850|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
83176851|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176852|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176853|NCT04791514|Treprostinil|treprostinil|mesh-list
83176854|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83176855|NCT04810546|Lactoferrin|lactoferrin|mesh-list
83176856|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176857|NCT04596826|Dronabinol|dronabinol|mesh-list
83176858|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
83176859|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176860|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83176861|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83176862|NCT04596826|Analgesics|analgesics|mesh-ancestor
83176863|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
83176864|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176865|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83176866|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83176867|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176868|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176869|NCT04596826|Hormones|hormones|mesh-ancestor
83176870|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176871|NCT02440568|Cytarabine|cytarabine|mesh-list
83176872|NCT02440568|Idarubicin|idarubicin|mesh-list
83176873|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
83176874|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83176875|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
83176876|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176877|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176878|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
83176879|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176880|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176881|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
83176882|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176883|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83176884|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83176885|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83176886|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176887|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83176888|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83176889|NCT00679120|Cimetidine|cimetidine|mesh-list
83176890|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83176891|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83176892|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83176893|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
83176894|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
83176895|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176896|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176897|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176898|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83176899|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83176900|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176901|NCT04420624|Colchicine|colchicine|mesh-list
83176902|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
83176903|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176904|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
83176905|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
83176906|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
83176907|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176908|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176909|NCT04782778|Bupivacaine|bupivacaine|mesh-list
83176910|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
83176911|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
83176912|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176913|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176914|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
83176915|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176916|NCT00434434|Omalizumab|omalizumab|mesh-list
83176917|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83176918|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83176919|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83176920|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83176921|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
83176922|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176923|NCT04047797|Rituximab|rituximab|mesh-list
83176924|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83176925|NCT04047797|Ixazomib|ixazomib|mesh-list
83176926|NCT04047797|Antibodies|antibodies|mesh-list
83176927|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
83176928|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83176929|NCT04047797|Glycine|glycine|mesh-list
83176930|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
83176931|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176932|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176933|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176934|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176935|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
83176936|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83176937|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
83176938|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176939|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
83176940|NCT04002401|Rituximab|rituximab|mesh-list
83176941|NCT04002401|Fludarabine|fludarabine|mesh-list
83176942|NCT04002401|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83176943|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83176944|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
83176945|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176946|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83176947|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83176948|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
83176949|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176950|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176951|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83176952|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83176953|NCT03046511|Cefazolin|cefazolin|mesh-list
83176954|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83176955|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176956|NCT02439320|Lasmiditan|lasmiditan|mesh-list
83176957|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83176958|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
83176959|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176960|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176961|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176962|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
83176963|NCT02468648|Velpatasvir|velpatasvir|mesh-list
83176964|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
83176965|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83176966|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83176967|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83176968|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176969|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83176970|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83176971|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83176972|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176973|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
83176974|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83176975|NCT01633060|Fulvestrant|fulvestrant|mesh-list
83176976|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83176977|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176978|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83176979|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83176980|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
83176981|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83176982|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176983|NCT03906695|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83176984|NCT03906695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83176985|NCT03906695|Antimetabolites|antimetabolites|mesh-ancestor
83176986|NCT03906695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83176987|NCT03906695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83176988|NCT03878459|Pioglitazone|pioglitazone|mesh-list
83176989|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83176990|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176991|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
83176992|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83176993|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83176994|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83176995|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83176996|NCT02819141|Analgesics|analgesics|mesh-ancestor
83176997|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
83176998|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83176999|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83177000|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83177001|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83177002|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
83177003|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177004|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177005|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
83177006|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177007|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
83177008|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177009|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177010|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83177011|NCT04240756|Amphetamine|amphetamine|mesh-list
83177012|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83177013|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177014|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
83177015|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
83177016|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177017|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
83177018|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177019|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177020|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
83177021|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83177022|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83177023|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83177024|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83177025|NCT04467125|Lidocaine|lidocaine|mesh-list
83177026|NCT04467125|Prilocaine|prilocaine|mesh-list
83177027|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83177028|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
83177029|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
83177030|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177031|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177032|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
83177033|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177034|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83177035|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83177036|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83177037|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83177038|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177039|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83177040|NCT02692313|Epinephrine|epinephrine|mesh-list
83177041|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83177042|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83177043|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
83177044|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177045|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177046|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177047|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83177048|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83177049|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
83177050|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177051|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83177052|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
83177053|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
83177054|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
83177055|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83177056|NCT02465528|Ceritinib|ceritinib|mesh-list
83177057|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177058|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177059|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177060|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177061|NCT02532257|Rituximab|rituximab|mesh-list
83177062|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83177063|NCT02532257|Lenalidomide|lenalidomide|mesh-list
83177064|NCT02532257|Antibodies|antibodies|mesh-list
83177065|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
83177066|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83177067|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
83177068|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177069|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177070|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177071|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83177072|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83177073|NCT02532257|Growth Substances|growth substances|mesh-ancestor
83177074|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
83177075|NCT03524261|Antibodies|antibodies|mesh-list
83177076|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83177077|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
83177078|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177079|NCT03386721|Gemcitabine|gemcitabine|mesh-list
83177080|NCT03386721|Atezolizumab|atezolizumab|mesh-list
83177081|NCT03386721|Vinorelbine|vinorelbine|mesh-list
83177082|NCT03386721|Antibodies|antibodies|mesh-list
83177083|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
83177084|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177085|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83177086|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
83177087|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177088|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177089|NCT03386721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83177090|NCT03386721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177091|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83177092|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
83177093|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
83177094|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
83177095|NCT02462720|Polidocanol|polidocanol|mesh-list
83177096|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83177097|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83177098|NCT02246218|Glycerol|glycerol|mesh-list
83177099|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83177100|NCT02246218|Protective Agents|protective agents|mesh-ancestor
83177101|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177102|NCT05073939|Oxytocin|oxytocin|mesh-list
83177103|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
83177104|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83177105|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177106|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
83177107|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83177108|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
83177109|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177110|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
83177111|NCT04192630|Protective Agents|protective agents|mesh-ancestor
83177113|NCT00159783|Asenapine|asenapine|mesh-list
83177114|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
83177115|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
83177116|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177117|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177118|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83177119|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83177120|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83177121|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177122|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83177123|NCT00159783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83177124|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83177125|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83177126|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177127|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177128|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
83177129|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
83177130|NCT01023737|Vorinostat|vorinostat|mesh-list
83177131|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
83177132|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83177133|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83177134|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177135|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177136|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177137|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177138|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177139|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83177140|NCT00646204|Memantine|memantine|mesh-list
83177141|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83177142|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83177143|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
83177144|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177145|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177146|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177147|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83177148|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83177149|NCT04105270|Carboplatin|carboplatin|mesh-list
83177150|NCT04105270|Pemetrexed|pemetrexed|mesh-list
83177151|NCT04105270|Durvalumab|durvalumab|mesh-list
83177152|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177153|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177154|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177155|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83177156|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83177157|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177158|NCT02243176|Saxagliptin|saxagliptin|mesh-list
83177159|NCT02243176|Acarbose|acarbose|mesh-list
83177160|NCT02243176|Incretins|incretins|mesh-ancestor
83177161|NCT02243176|Hormones|hormones|mesh-ancestor
83177162|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177163|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177164|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83177165|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
83177166|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177167|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177168|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83177169|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83177170|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
83177171|NCT00692939|Melphalan|melphalan|mesh-list
83177172|NCT00692939|Thiotepa|thiotepa|mesh-list
83177173|NCT00692939|Rituximab|rituximab|mesh-list
83177174|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
83177175|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
83177176|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83177177|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83177178|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
83177179|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177180|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177181|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83177182|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
83177183|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177184|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177185|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83177186|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177187|NCT04551261|Ritonavir|ritonavir|mesh-list
83177188|NCT04551261|Tenofovir|tenofovir|mesh-list
83177189|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83177190|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83177191|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
83177192|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177193|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177194|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83177195|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83177196|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
83177197|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177198|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83177199|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83177200|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83177201|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83177202|NCT04534257|Sirolimus|sirolimus|mesh-list
83177203|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83177204|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177205|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83177206|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177207|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
83177208|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83177209|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
83177210|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177212|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83177213|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177214|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177215|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
83177216|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83177217|NCT03138681|Protective Agents|protective agents|mesh-ancestor
83177218|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177219|NCT05392257|Rituximab|rituximab|mesh-list
83177220|NCT05392257|Lenalidomide|lenalidomide|mesh-list
83177221|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
83177222|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177223|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177224|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
83177225|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177226|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177227|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83177228|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83177229|NCT05392257|Growth Substances|growth substances|mesh-ancestor
83177230|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
83177231|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177232|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177233|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177234|NCT02240680|Linagliptin|linagliptin|mesh-list
83177235|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83177236|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177237|NCT02240680|Incretins|incretins|mesh-ancestor
83177239|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177240|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83177241|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
83177242|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177243|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177244|NCT05391867|Sorafenib|sorafenib|mesh-list
83177245|NCT05391867|Lenvatinib|lenvatinib|mesh-list
83177246|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177247|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177248|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177249|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177250|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
83177251|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83177252|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
83177253|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177254|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
83177255|NCT03110679|Protective Agents|protective agents|mesh-ancestor
83177256|NCT05391789|Urinastatin|urinastatin|mesh-list
83177257|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83177258|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83177259|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
83177260|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177261|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177262|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
83177263|NCT04699071|Lenvatinib|lenvatinib|mesh-list
83177264|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177265|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177266|NCT04699071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83177267|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177268|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177269|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177270|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
83177271|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
83177272|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83177273|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
83177274|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177275|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177276|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83177277|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
83177278|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177279|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177280|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83177281|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177282|NCT03139851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83177283|NCT03967288|Bupivacaine|bupivacaine|mesh-list
83177284|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
83177285|NCT03967288|Procaine|procaine|mesh-list
83177286|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
83177287|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
83177288|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177289|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177290|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
83177291|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177292|NCT04167111|Vitamin D|vitamin d|mesh-list
83177293|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
83177294|NCT04167111|Vitamins|vitamins|mesh-ancestor
83177295|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
83177296|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177297|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83177298|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83177299|NCT03962062|Moxidectin|moxidectin|mesh-list
83177300|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
83177301|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83177302|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177303|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
83177304|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83177305|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177306|NCT02239510|Linaclotide|linaclotide|mesh-list
83177307|NCT02239510|Sennosides|sennosides|mesh-list
83177308|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83177309|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
83177310|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177311|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83177312|NCT02239510|Laxatives|laxatives|mesh-ancestor
83177313|NCT04507581|Anesthetics|anesthetics|mesh-list
83177314|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177315|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177317|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83177318|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177319|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
83177320|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177321|NCT03899961|Oxytocin|oxytocin|mesh-list
83177322|NCT03899961|Carbetocin|carbetocin|mesh-list
83177323|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
83177324|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83177325|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177326|NCT02462486|Ranibizumab|ranibizumab|mesh-list
83177327|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83177328|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83177329|NCT02462486|Growth Substances|growth substances|mesh-ancestor
83177330|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177331|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
83177332|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177333|NCT03521219|Apatinib|apatinib|mesh-list
83177334|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177335|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177336|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177337|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177338|NCT05318157|Emedastine|emedastine|mesh-list
83177339|NCT05318157|Budesonide|budesonide|mesh-list
83177340|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83177341|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83177342|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177343|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83177344|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
83177345|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177346|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177347|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83177348|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
83177349|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
83177350|NCT05318157|Hormones|hormones|mesh-ancestor
83177351|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177352|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83177353|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
83177354|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
83177355|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177356|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177357|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83177358|NCT02294279|Beclomethasone|beclomethasone|mesh-list
83177359|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177360|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
83177361|NCT02294279|Hormones|hormones|mesh-ancestor
83177362|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177363|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177364|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83177365|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
83177366|NCT02294357|Dexamethasone|dexamethasone|mesh-list
83177367|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
83177368|NCT02294357|Prednisone|prednisone|mesh-list
83177369|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
83177370|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83177371|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83177372|NCT02294357|Prednisolone|prednisolone|mesh-list
83177373|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
83177374|NCT02294357|Lenalidomide|lenalidomide|mesh-list
83177375|NCT02294357|Pomalidomide|pomalidomide|mesh-list
83177376|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83177377|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
83177378|NCT02294357|BB 1101|bb 1101|mesh-list
83177379|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177381|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
83177382|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177383|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177384|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83177385|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
83177386|NCT02294357|Hormones|hormones|mesh-ancestor
83177387|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177388|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83177389|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177390|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
83177391|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177392|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177393|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
83177394|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83177395|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83177396|NCT02294357|Growth Substances|growth substances|mesh-ancestor
83177397|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
83177398|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83177399|NCT02294357|Protective Agents|protective agents|mesh-ancestor
83177400|NCT03880539|Vancomycin|vancomycin|mesh-list
83177401|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83177402|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177403|NCT03518021|Naloxone|naloxone|mesh-list
83177404|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83177405|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177406|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
83177407|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177408|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83177409|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83177410|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83177411|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177412|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
83177413|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83177414|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
83177415|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177416|NCT02294591|Expectorants|expectorants|mesh-ancestor
83177417|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
83177418|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83177419|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
83177420|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177421|NCT02294591|Protective Agents|protective agents|mesh-ancestor
83177422|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177423|NCT02294591|Antidotes|antidotes|mesh-ancestor
83177424|NCT03521063|Budesonide|budesonide|mesh-list
83177425|NCT03521063|Poractant alfa|poractant alfa|mesh-list
83177426|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177427|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83177428|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
83177429|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177430|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177431|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83177432|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
83177433|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
83177434|NCT03521063|Hormones|hormones|mesh-ancestor
83177435|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177436|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83177437|NCT03520985|Dexamethasone|dexamethasone|mesh-list
83177438|NCT03520985|Pomalidomide|pomalidomide|mesh-list
83177439|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177440|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
83177441|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
83177442|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177443|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177444|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83177445|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
83177446|NCT03520985|Hormones|hormones|mesh-ancestor
83177447|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177448|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83177449|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177450|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
83177451|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83177452|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83177453|NCT03520985|Growth Substances|growth substances|mesh-ancestor
83177454|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
83177456|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
83177457|NCT03517943|Ephedrine|ephedrine|mesh-list
83177458|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
83177459|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
83177460|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83177461|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83177462|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83177463|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
83177464|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
83177465|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177466|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177467|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177468|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83177469|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
83177470|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177471|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83177472|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
83177473|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
83177474|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83177475|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83177476|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
83177477|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
83177478|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
83177479|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83177480|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83177481|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83177482|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83177483|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83177484|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177485|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
83177486|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177487|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177488|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83177489|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177490|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
83177491|NCT04465175|Analgesics|analgesics|mesh-ancestor
83177492|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
83177493|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177494|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177495|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
83177496|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177497|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83177498|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
83177499|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83177500|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83177501|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177502|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83177503|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
83177504|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83177505|NCT03158883|Avelumab|avelumab|mesh-list
83177506|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177507|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177508|NCT03138447|Insulin|insulin|mesh-list
83177509|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83177510|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177511|NCT03109977|Pertuzumab|pertuzumab|mesh-list
83177512|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177513|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177514|NCT03520595|Diclofenac|diclofenac|mesh-list
83177515|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83177516|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83177517|NCT03520595|Analgesics|analgesics|mesh-ancestor
83177518|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
83177519|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177520|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177521|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177522|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177523|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83177524|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177525|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177526|NCT03520439|Mifepristone|mifepristone|mesh-list
83177527|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83177528|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
83177529|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83177530|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177531|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83177532|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83177533|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83177534|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
83177535|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83177536|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83177537|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
83177538|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177539|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
83177540|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83177541|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83177542|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
83177543|NCT04543227|Narcotics|narcotics|mesh-ancestor
83177544|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177545|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177546|NCT04543227|Analgesics|analgesics|mesh-ancestor
83177547|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
83177548|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177550|NCT04542993|Resveratrol|resveratrol|mesh-list
83177551|NCT04542993|Picolinic acid|picolinic acid|mesh-list
83177552|NCT04542993|Trace Elements|trace elements|mesh-ancestor
83177553|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
83177554|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177555|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
83177556|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177557|NCT04542993|Protective Agents|protective agents|mesh-ancestor
83177558|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177559|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83177560|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83177561|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
83177562|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
83177563|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83177564|NCT02292173|Sorafenib|sorafenib|mesh-list
83177565|NCT02292173|Trametinib|trametinib|mesh-list
83177566|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177567|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177568|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177569|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177570|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
83177571|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83177572|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83177573|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83177574|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83177575|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177576|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
83177577|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177578|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177579|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83177580|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177581|NCT03520049|Oseltamivir|oseltamivir|mesh-list
83177582|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
83177583|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177584|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177585|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177586|NCT03517631|Busulfan|busulfan|mesh-list
83177587|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
83177588|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177589|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83177590|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
83177591|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177592|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83177593|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177594|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83177595|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
83177596|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83177597|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177599|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83177600|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83177601|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177602|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177603|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83177604|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83177605|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83177606|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83177607|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
83177608|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
83177609|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
83177610|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
83177611|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177612|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177613|NCT02296073|Fentanyl|fentanyl|mesh-list
83177614|NCT02296073|Midazolam|midazolam|mesh-list
83177615|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
83177616|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83177617|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177618|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177619|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83177620|NCT02296073|Analgesics|analgesics|mesh-ancestor
83177621|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
83177622|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177623|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83177624|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83177625|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83177626|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
83177627|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177628|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177629|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83177630|NCT02296073|Narcotics|narcotics|mesh-ancestor
83177631|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83177632|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83177633|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
83177634|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
83177635|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83177636|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83177637|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83177638|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
83177639|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
83177640|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83177641|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83177642|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83177643|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83177644|NCT02293187|Vitamin D|vitamin d|mesh-list
83177645|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
83177646|NCT02293187|Vitamins|vitamins|mesh-ancestor
83177647|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
83177648|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177649|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83177650|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83177651|NCT02296463|Vaccines|vaccines|mesh-list
83177652|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
83177653|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177654|NCT02495168|Budesonide|budesonide|mesh-list
83177655|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
83177656|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83177657|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177658|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83177659|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
83177660|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177661|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177662|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83177663|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
83177664|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
83177665|NCT02495168|Hormones|hormones|mesh-ancestor
83177666|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177667|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83177668|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83177669|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83177670|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
83177671|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177672|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177673|NCT04934072|Denosumab|denosumab|mesh-list
83177674|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83177675|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177676|NCT03518489|Lappaconitine|lappaconitine|mesh-list
83177677|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83177678|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83177679|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83177680|NCT03518489|Analgesics|analgesics|mesh-ancestor
83177681|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
83177682|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177683|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177684|NCT04933526|Dasatinib|dasatinib|mesh-list
83177685|NCT04933526|Flumatinib|flumatinib|mesh-list
83177686|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177687|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177688|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177689|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177690|NCT02293889|Vitamin D|vitamin d|mesh-list
83177691|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
83177692|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
83177693|NCT02293889|Vitamins|vitamins|mesh-list
83177694|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
83177695|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177696|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83177697|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83177698|NCT02298335|Prednisone|prednisone|mesh-list
83177699|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177700|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
83177701|NCT02298335|Hormones|hormones|mesh-ancestor
83177702|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177703|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177704|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83177705|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177706|NCT03514667|Curcumin|curcumin|mesh-list
83177707|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83177708|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83177709|NCT03514667|Analgesics|analgesics|mesh-ancestor
83177710|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
83177711|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177712|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177713|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177714|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177715|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177716|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177717|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177718|NCT04465097|Exemestane|exemestane|mesh-list
83177719|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177720|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83177721|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83177722|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177723|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177724|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83177725|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
83177726|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177727|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177729|NCT02493764|Tazobactam|tazobactam|mesh-list
83177730|NCT02493764|Piperacillin|piperacillin|mesh-list
83177731|NCT02493764|Imipenem|imipenem|mesh-list
83177732|NCT02493764|Relebactam|relebactam|mesh-list
83177733|NCT02493764|Cilastatin|cilastatin|mesh-list
83177734|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83177735|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177736|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83177737|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177738|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177739|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83177740|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
83177741|NCT02297477|Artesunate|artesunate|mesh-list
83177742|NCT02297477|Atovaquone|atovaquone|mesh-list
83177743|NCT02297477|Proguanil|proguanil|mesh-list
83177744|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83177745|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
83177746|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83177747|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83177748|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177749|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177750|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
83177751|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
83177752|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83177753|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
83177754|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177755|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177756|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
83177757|NCT02460380|Vitamin D|vitamin d|mesh-list
83177758|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
83177759|NCT02460380|Vitamins|vitamins|mesh-ancestor
83177760|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
83177761|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177762|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83177763|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83177764|NCT02299115|Prednisolone|prednisolone|mesh-list
83177765|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83177766|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
83177767|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83177768|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
83177769|NCT02299115|Vigabatrin|vigabatrin|mesh-list
83177770|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83177771|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
83177772|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177773|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
83177774|NCT02299115|Hormones|hormones|mesh-ancestor
83177775|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177776|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177777|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83177778|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177779|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
83177780|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
83177781|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177782|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83177784|NCT02299115|Protective Agents|protective agents|mesh-ancestor
83177785|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
83177786|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177787|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177788|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
83177789|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177790|NCT03515213|Fenofibrate|fenofibrate|mesh-list
83177791|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83177792|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
83177793|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177794|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83177795|NCT02297945|Metyrapone|metyrapone|mesh-list
83177796|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
83177797|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177798|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177799|NCT02492984|Factor VIII|factor viii|mesh-list
83177800|NCT02492984|Coagulants|coagulants|mesh-ancestor
83177801|NCT03132623|Andrographolide|andrographolide|mesh-list
83177802|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177803|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83177804|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83177805|NCT03132623|Analgesics|analgesics|mesh-ancestor
83177806|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
83177807|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177808|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177809|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177810|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83177811|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83177812|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177813|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
83177814|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83177815|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83177816|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
83177817|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177818|NCT02298101|Edetic Acid|edetic acid|mesh-list
83177819|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
83177820|NCT02298101|Antidotes|antidotes|mesh-ancestor
83177821|NCT02298101|Protective Agents|protective agents|mesh-ancestor
83177822|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177823|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
83177824|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
83177825|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177826|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83177827|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
83177828|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83177829|NCT02491892|Pertuzumab|pertuzumab|mesh-list
83177830|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83177831|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177832|NCT03476811|Analgesics|analgesics|mesh-list
83177833|NCT03476811|Bupivacaine|bupivacaine|mesh-list
83177834|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
83177835|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
83177836|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177837|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177838|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
83177839|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177840|NCT02834403|Aspirin|aspirin|mesh-list
83177841|NCT02834403|Docetaxel|docetaxel|mesh-list
83177842|NCT02834403|Amlodipine|amlodipine|mesh-list
83177843|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83177844|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177845|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
83177846|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
83177847|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83177848|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177849|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83177850|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83177851|NCT02834403|Analgesics|analgesics|mesh-ancestor
83177852|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
83177853|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177854|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177855|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177856|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177857|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83177858|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83177859|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83177860|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83177861|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177862|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
83177863|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83177864|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83177865|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83177866|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83177867|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
83177868|NCT02299271|Ropivacaine|ropivacaine|mesh-list
83177869|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
83177870|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
83177871|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177872|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177873|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
83177874|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177875|NCT02302469|Lenalidomide|lenalidomide|mesh-list
83177876|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
83177877|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177878|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83177879|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83177880|NCT02302469|Growth Substances|growth substances|mesh-ancestor
83177881|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
83177882|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177883|NCT02302547|Ritonavir|ritonavir|mesh-list
83177884|NCT02302547|Lopinavir|lopinavir|mesh-list
83177885|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83177886|NCT02302547|Darunavir|darunavir|mesh-list
83177887|NCT02302547|Indinavir|indinavir|mesh-list
83177888|NCT02302547|Saquinavir|saquinavir|mesh-list
83177889|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
83177890|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83177891|NCT02302547|Tenofovir|tenofovir|mesh-list
83177892|NCT02302547|Emtricitabine|emtricitabine|mesh-list
83177893|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
83177894|NCT02302547|Nevirapine|nevirapine|mesh-list
83177895|NCT02302547|Dolutegravir|dolutegravir|mesh-list
83177896|NCT02302547|Maraviroc|maraviroc|mesh-list
83177897|NCT02302547|Cobicistat|cobicistat|mesh-list
83177898|NCT02302547|Rilpivirine|rilpivirine|mesh-list
83177899|NCT02302547|Tipranavir|tipranavir|mesh-list
83177900|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
83177901|NCT02302547|Elvitegravir|elvitegravir|mesh-list
83177902|NCT02302547|Efavirenz|efavirenz|mesh-list
83177903|NCT02302547|Etravirine|etravirine|mesh-list
83177904|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83177905|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
83177906|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
83177907|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83177908|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177909|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177910|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83177911|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83177912|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
83177913|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177914|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83177915|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83177916|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83177917|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83177918|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83177919|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83177920|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83177921|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83177922|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83177923|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83177924|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83177925|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83177927|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
83177928|NCT01190787|Melphalan|melphalan|mesh-list
83177929|NCT01190787|Bortezomib|bortezomib|mesh-list
83177930|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83177931|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
83177932|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177933|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83177934|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83177935|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
83177936|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177937|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177938|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83177939|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83177940|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
83177941|NCT01190787|Hormones|hormones|mesh-ancestor
83177942|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177943|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83177944|NCT03515369|Liver Extracts|liver extracts|mesh-list
83177945|NCT03515369|Hematinics|hematinics|mesh-ancestor
83177946|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83177947|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83177948|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177949|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
83177950|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
83177951|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83177952|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177953|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
83177954|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83177955|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177956|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83177957|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83177958|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
83177959|NCT03510611|Ensartinib|ensartinib|mesh-list
83177960|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177961|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177962|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177963|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177964|NCT02299817|Denosumab|denosumab|mesh-list
83177965|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83177966|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177968|NCT01679613|Nintedanib|nintedanib|mesh-list
83177969|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
83177970|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83177971|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83177972|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83177973|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83177974|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177975|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83177976|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
83177977|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83177978|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177979|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83177980|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83177981|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83177982|NCT02489630|Ketamine|ketamine|mesh-list
83177983|NCT02489630|Analgesics|analgesics|mesh-list
83177984|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
83177985|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83177986|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83177987|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83177988|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83177989|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
83177990|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
83177991|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83177992|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83177993|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83177994|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83177995|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83177997|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83177998|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83177999|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83178000|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83178001|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178002|NCT05089383|Progesterone|progesterone|mesh-list
83178003|NCT05089383|Progestins|progestins|mesh-ancestor
83178004|NCT05089383|Hormones|hormones|mesh-ancestor
83178005|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178006|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178007|NCT03510533|Autoantibodies|autoantibodies|mesh-list
83178008|NCT03510533|alpha-MSH|alpha-msh|mesh-list
83178009|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
83178010|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178011|NCT03510533|Hormones|hormones|mesh-ancestor
83178012|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178013|NCT03512873|Tranilast|tranilast|mesh-list
83178014|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83178015|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83178016|NCT03512873|Analgesics|analgesics|mesh-ancestor
83178017|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
83178018|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178019|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178020|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178021|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178022|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83178023|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178024|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178025|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83178026|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83178028|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
83178029|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178030|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83178031|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83178032|NCT01678911|Gabapentin|gabapentin|mesh-list
83178033|NCT01678911|Analgesics|analgesics|mesh-ancestor
83178034|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
83178035|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178036|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178037|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
83178038|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83178039|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83178040|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178041|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178042|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83178043|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83178044|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178045|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178046|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
83178047|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
83178048|NCT03132701|Analgesics|analgesics|mesh-ancestor
83178049|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
83178050|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178051|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178052|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
83178053|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178054|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83178055|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
83178056|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83178057|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178058|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178059|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83178060|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
83178061|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83178062|NCT02322099|Alendronate|alendronate|mesh-list
83178063|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
83178064|NCT02322099|Vitamin D|vitamin d|mesh-list
83178065|NCT02322099|Tenofovir|tenofovir|mesh-list
83178066|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
83178067|NCT02322099|Calcium|calcium|mesh-list
83178068|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83178069|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178070|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
83178071|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178072|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83178073|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83178074|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178075|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178076|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83178077|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83178078|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83178079|NCT02322099|Antacids|antacids|mesh-ancestor
83178080|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178081|NCT02322099|Vitamins|vitamins|mesh-ancestor
83178082|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
83178083|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
83178084|NCT02487446|Bromides|bromides|mesh-list
83178085|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
83178086|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178087|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83178088|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83178089|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83178090|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
83178091|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178092|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178093|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
83178094|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178095|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
83178096|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178097|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178098|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83178099|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
83178100|NCT04464005|Analgesics|analgesics|mesh-ancestor
83178101|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
83178102|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178103|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178104|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
83178105|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178106|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83178107|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
83178108|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83178109|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178110|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178111|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83178112|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
83178113|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83178114|NCT02303327|Androgens|androgens|mesh-list
83178115|NCT02303327|Hormones|hormones|mesh-ancestor
83178116|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178117|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178118|NCT03510221|Antioxidants|antioxidants|mesh-list
83178119|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178120|NCT03510221|Protective Agents|protective agents|mesh-ancestor
83178121|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178122|NCT03509831|Irsogladine|irsogladine|mesh-list
83178123|NCT03509831|Nizatidine|nizatidine|mesh-list
83178124|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178125|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83178126|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178127|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83178128|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
83178129|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
83178130|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178131|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178132|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178133|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83178134|NCT03509831|Protective Agents|protective agents|mesh-ancestor
83178135|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83178136|NCT02303483|Niacinamide|niacinamide|mesh-list
83178137|NCT02303483|Niacin|niacin|mesh-list
83178138|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
83178139|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
83178140|NCT02303483|Vitamins|vitamins|mesh-ancestor
83178141|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
83178142|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178143|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83178144|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
83178145|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178146|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83178147|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
83178148|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83178149|NCT05378061|Growth Substances|growth substances|mesh-ancestor
83178150|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178151|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
83178152|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430105|NCT00504751|Hormones|hormones|mesh-ancestor
83178153|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178154|NCT02303639|Amiodarone|amiodarone|mesh-list
83178155|NCT02303639|Sotalol|sotalol|mesh-list
83178156|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83178157|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
83178158|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83178159|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178160|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178161|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83178162|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83178163|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83178164|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178165|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83178166|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83178167|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83178168|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83178169|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83178170|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
83178171|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178172|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178173|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
83178174|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
83178175|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178176|NCT02303873|Alendronate|alendronate|mesh-list
83178177|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83178178|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178179|NCT04757493|Prucalopride|prucalopride|mesh-list
83178180|NCT04757493|Laxatives|laxatives|mesh-ancestor
83178181|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178182|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83178183|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83178184|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
83178185|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178186|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178187|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178188|NCT02303951|Atezolizumab|atezolizumab|mesh-list
83178189|NCT02303951|Vemurafenib|vemurafenib|mesh-list
83178190|NCT02303951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83178191|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178192|NCT02303951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83178193|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178194|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83178195|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178196|NCT04406415|Nafamostat|nafamostat|mesh-list
83178197|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83178198|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83178199|NCT04406415|Analgesics|analgesics|mesh-ancestor
83178200|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
83178201|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178202|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178203|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178204|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178205|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
83178206|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
83178208|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178209|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83178210|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83178211|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83178212|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83178213|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
83178214|NCT02304107|Letrozole|letrozole|mesh-list
83178215|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178216|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83178217|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83178218|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178219|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178220|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83178221|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
83178222|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178223|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178224|NCT03509285|Cenobamate|cenobamate|mesh-list
83178225|NCT03509285|Alprazolam|alprazolam|mesh-list
83178226|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83178227|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178228|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178229|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83178230|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83178231|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178232|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
83178233|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
83178234|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178235|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178236|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
83178237|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83178238|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83178239|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83178240|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83178241|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
83178242|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178243|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83178244|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83178245|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178246|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83178247|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83178248|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178249|NCT03135795|Parecoxib|parecoxib|mesh-list
83178250|NCT03135795|Sufentanil|sufentanil|mesh-list
83178251|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
83178252|NCT03135795|Remifentanil|remifentanil|mesh-list
83178254|NCT03135795|Bromides|bromides|mesh-list
83178255|NCT03135795|Propofol|propofol|mesh-list
83178256|NCT03135795|Sevoflurane|sevoflurane|mesh-list
83178257|NCT03135795|Citric Acid|citric acid|mesh-list
83178258|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
83178259|NCT03135795|Rocuronium|rocuronium|mesh-list
83178260|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83178261|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178262|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178263|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83178264|NCT03135795|Analgesics|analgesics|mesh-ancestor
83178265|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
83178266|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178267|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83178268|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83178269|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83178270|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83178271|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178272|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178273|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83178274|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
83178275|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
83178276|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
83178277|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83178278|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
83178279|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
83178280|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83178281|NCT03135795|Narcotics|narcotics|mesh-ancestor
83178282|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83178283|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83178284|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
83178285|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83178286|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83178287|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83178288|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83178289|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83178290|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83178291|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178292|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83178293|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178294|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178295|NCT04958967|Aflutinib|aflutinib|mesh-list
83178296|NCT04958967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83178297|NCT04958967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178298|NCT04958967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178299|NCT03469531|Cisplatin|cisplatin|mesh-list
83178300|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
83178301|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178302|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83178303|NCT03309007|Metformin|metformin|mesh-list
83178304|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
83178305|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83178306|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178307|NCT03309007|Antacids|antacids|mesh-ancestor
83178308|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178309|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178310|NCT03508817|Atropine|atropine|mesh-list
83178311|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83178312|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83178313|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83178314|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83178315|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83178316|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
83178317|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178318|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178319|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83178320|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
83178321|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
83178322|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
83178323|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83178324|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83178325|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
83178326|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178327|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178328|NCT05158777|Vaccines|vaccines|mesh-list
83178329|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
83178330|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178331|NCT01678209|Methylphenidate|methylphenidate|mesh-list
83178332|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83178333|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83178334|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178335|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83178336|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83178337|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178338|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178339|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
83178340|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178341|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83178342|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
83178343|NCT02239120|Dabigatran|dabigatran|mesh-list
83178344|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
83178345|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83178346|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83178347|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178348|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178349|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
83178350|NCT04464863|Metronidazole|metronidazole|mesh-list
83178351|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178352|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83178353|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83178354|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83178355|NCT05158699|Dexamethasone|dexamethasone|mesh-list
83178356|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
83178357|NCT05158699|Triamcinolone|triamcinolone|mesh-list
83178358|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83178359|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83178360|NCT05158699|Ketorolac|ketorolac|mesh-list
83178361|NCT05158699|Bromfenac|bromfenac|mesh-list
83178362|NCT05158699|Phenylephrine|phenylephrine|mesh-list
83178363|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83178364|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83178365|NCT05158699|BB 1101|bb 1101|mesh-list
83178366|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83178367|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178368|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
83178369|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
83178370|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178371|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178372|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178373|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
83178374|NCT05158699|Hormones|hormones|mesh-ancestor
83178375|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178376|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83178377|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178378|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
83178379|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178380|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178381|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83178382|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
83178383|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83178384|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83178386|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
83178387|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178388|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83178389|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83178390|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
83178391|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
83178392|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83178393|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
83178394|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
83178395|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83178396|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83178397|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83178398|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
83178399|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178400|NCT05158699|Protective Agents|protective agents|mesh-ancestor
83178401|NCT04464629|Prednisolone|prednisolone|mesh-list
83178402|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83178403|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
83178404|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83178405|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
83178406|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83178407|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
83178408|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178409|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
83178410|NCT04464629|Hormones|hormones|mesh-ancestor
83178411|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178412|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178413|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83178414|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178415|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
83178416|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
83178417|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178418|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178419|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83178420|NCT04464629|Protective Agents|protective agents|mesh-ancestor
83178421|NCT02304887|Denosumab|denosumab|mesh-list
83178422|NCT02304887|Teriparatide|teriparatide|mesh-list
83178423|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83178424|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178425|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83178426|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83178427|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83178428|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178429|NCT03474133|Immunotoxins|immunotoxins|mesh-ancestor
83178430|NCT03474133|Immunoconjugates|immunoconjugates|mesh-ancestor
83178431|NCT03474133|Immunologic Factors|immunologic factors|mesh-ancestor
83178432|NCT03474133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178433|NCT03512171|Amphetamine|amphetamine|mesh-list
83178434|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
83178435|NCT03512171|Fallypride|fallypride|mesh-list
83178436|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83178437|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178438|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
83178439|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
83416502|NCT01189643|Temozolomide|temozolomide|mesh-list
83178440|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178441|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
83178442|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178443|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178444|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83178445|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83178446|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83178447|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178448|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83178449|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83178450|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83178451|NCT03739099|Pancrelipase|pancrelipase|mesh-list
83178452|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178453|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83178454|NCT03469375|Folfirinox|folfirinox|mesh-list
83178455|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178456|NCT01603407|Prednisone|prednisone|mesh-list
83178457|NCT01603407|Deflazacort|deflazacort|mesh-list
83178458|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178459|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
83178460|NCT01603407|Hormones|hormones|mesh-ancestor
83178461|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178462|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178463|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83178464|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178465|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83178466|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
83178467|NCT02305355|Atorvastatin|atorvastatin|mesh-list
83178468|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83178469|NCT02305355|Simvastatin|simvastatin|mesh-list
83178470|NCT02305355|Pravastatin|pravastatin|mesh-list
83178471|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83178472|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83178473|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
83178474|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178475|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83178476|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83178477|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178478|NCT03511703|Apatinib|apatinib|mesh-list
83178479|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178480|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83178481|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178482|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178483|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83178484|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83178485|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83178486|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178487|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178488|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83178489|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178490|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178491|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
83178492|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178493|NCT02301221|Vancomycin|vancomycin|mesh-list
83178494|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83178495|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178496|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
83178497|NCT03122431|Thalidomide|thalidomide|mesh-list
83178498|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
83178499|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83178500|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83178501|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178502|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178503|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178504|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178505|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83178506|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
83178507|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178508|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
83178509|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83178510|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83178511|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83178512|NCT03122431|Growth Substances|growth substances|mesh-ancestor
83178513|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
83178514|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178515|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83178516|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83178517|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178518|NCT02305823|Aripiprazole|aripiprazole|mesh-list
83178519|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83178520|NCT02305823|Ziprasidone|ziprasidone|mesh-list
83178521|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
83178522|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178523|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83178524|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83178525|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178526|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178527|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
83178528|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
83178529|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178530|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178531|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83178532|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83178533|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
83178534|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83178535|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83178536|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83178537|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83178538|NCT05376189|Vitamin D|vitamin d|mesh-list
83178539|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
83178540|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
83178541|NCT05376189|Vitamins|vitamins|mesh-list
83178542|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
83178543|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178544|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83178545|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83178546|NCT02235298|Metformin|metformin|mesh-list
83178547|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
83178548|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83178549|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178550|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83178551|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178552|NCT02305901|Repaglinide|repaglinide|mesh-list
83178553|NCT02305901|Bupropion|bupropion|mesh-list
83178554|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83178555|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
83178556|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178557|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83178558|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83178559|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178560|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178561|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
83178562|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178563|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178564|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83178565|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83178566|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178567|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83178568|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
83178569|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83178570|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83178571|NCT03942887|Prednisolone|prednisolone|mesh-list
83178572|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
83178573|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
83178574|NCT03942887|Rituximab|rituximab|mesh-list
83178575|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83178576|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
83178577|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83178578|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
83178579|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178581|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83178582|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
83178583|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178584|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178585|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83178586|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83178587|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178588|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
83178589|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
83178590|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178591|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178592|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
83178593|NCT03942887|Hormones|hormones|mesh-ancestor
83178594|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178595|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83178596|NCT03942887|Protective Agents|protective agents|mesh-ancestor
83178597|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83178598|NCT02234596|Nintedanib|nintedanib|mesh-list
83178599|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178600|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83178601|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178602|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178603|NCT02305979|Loratadine|loratadine|mesh-list
83178604|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
83178605|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
83178606|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83178607|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83178608|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83178609|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
83178610|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
83178611|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178612|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178613|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178614|NCT04539951|Memantine|memantine|mesh-list
83178615|NCT04539951|Aripiprazole|aripiprazole|mesh-list
83178617|NCT04539951|Sertraline|sertraline|mesh-list
83178618|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83178619|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
83178620|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178621|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83178622|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83178623|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178624|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178625|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
83178626|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
83178627|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178628|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178629|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83178630|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83178631|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
83178632|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83178633|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83178634|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83178635|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83178636|NCT04539951|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83178637|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83178638|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178639|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83178640|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83178641|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83178642|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83178643|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83178644|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83178645|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83178646|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83178647|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83178648|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178649|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83178650|NCT04539327|Rucaparib|rucaparib|mesh-list
83178651|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83178652|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178653|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178654|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178656|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
83178657|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178658|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83178659|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83178660|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178661|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178662|NCT02234362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83178663|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83178664|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178665|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178666|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178667|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
83178668|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83178669|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83178670|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83178671|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83178672|NCT05091177|Acetylcholine|acetylcholine|mesh-list
83178673|NCT05091177|Antibodies|antibodies|mesh-list
83178674|NCT05091177|Neostigmine|neostigmine|mesh-list
83178675|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
83178676|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178677|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83178678|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178679|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178680|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
83178681|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178682|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83178683|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
83178684|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178685|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
83178686|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83178687|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
83178688|NCT05091099|Alendronate|alendronate|mesh-list
83178689|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83178690|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178691|NCT05197426|Azacitidine|azacitidine|mesh-list
83178692|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83178693|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
83178694|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178695|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178696|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178697|NCT03505151|BI 409306|bi 409306|mesh-list
83178698|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83178699|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178700|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178701|NCT02232880|Abatacept|abatacept|mesh-list
83178702|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83178703|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178704|NCT02232880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83178705|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178706|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83178707|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
83178708|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178709|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178710|NCT02896855|Docetaxel|docetaxel|mesh-list
83178711|NCT02896855|Trastuzumab|trastuzumab|mesh-list
83178712|NCT02896855|Pertuzumab|pertuzumab|mesh-list
83178713|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178714|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
83178715|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
83178716|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
83178717|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178718|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83178719|NCT02311439|Folfirinox|folfirinox|mesh-list
83178720|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178721|NCT02311517|Ropivacaine|ropivacaine|mesh-list
83178722|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
83178723|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
83178724|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178725|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178726|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
83178727|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178728|NCT02232802|Enoxaparin|enoxaparin|mesh-list
83178729|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
83178730|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
83178731|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83178732|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83178733|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178734|NCT04463459|Vitamins|vitamins|mesh-list
83178735|NCT04463459|Vitamin E|vitamin e|mesh-list
83178736|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
83178737|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178738|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
83178739|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178741|NCT02434328|Aflibercept|aflibercept|mesh-list
83178742|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83178743|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83178744|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83178745|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83178746|NCT02434328|Growth Substances|growth substances|mesh-ancestor
83178747|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178748|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
83178749|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178750|NCT04785274|Chrysarobin|chrysarobin|mesh-list
83178751|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83178752|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83178753|NCT04785274|Analgesics|analgesics|mesh-ancestor
83178754|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
83178755|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178756|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178757|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178758|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178759|NCT04778176|Levodopa|levodopa|mesh-list
83178760|NCT04778176|Carbidopa|carbidopa|mesh-list
83178761|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83178762|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83178763|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
83178764|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178765|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178766|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178767|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83178768|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178769|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
83178770|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83178771|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83178772|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178773|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
83178774|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
83178775|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178776|NCT05076253|Ivermectin|ivermectin|mesh-list
83178777|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83178778|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178779|NCT05077839|Trifluridine|trifluridine|mesh-list
83178780|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
83178781|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178782|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
83178783|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178784|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
83178785|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83178786|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
83178787|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83178788|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
83178789|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178790|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178791|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
83178792|NCT03132233|Calcium|calcium|mesh-list
83178793|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83178794|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178795|NCT02307227|Paclitaxel|paclitaxel|mesh-list
83178796|NCT02307227|Docetaxel|docetaxel|mesh-list
83178797|NCT02307227|Trastuzumab|trastuzumab|mesh-list
83178798|NCT02307227|Epirubicin|epirubicin|mesh-list
83178799|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83178800|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178802|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83178803|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83178804|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178805|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83178806|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83178807|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83178808|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83178809|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178810|NCT02307305|Acetaminophen|acetaminophen|mesh-list
83178811|NCT02307305|Celecoxib|celecoxib|mesh-list
83178812|NCT02307305|Naproxen|naproxen|mesh-list
83178813|NCT02307305|Oxycodone|oxycodone|mesh-list
83178814|NCT02307305|Tramadol|tramadol|mesh-list
83178815|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83178816|NCT02307305|Naloxone|naloxone|mesh-list
83178817|NCT02307305|Esomeprazole|esomeprazole|mesh-list
83178818|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83178819|NCT02307305|Analgesics|analgesics|mesh-ancestor
83178820|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
83178821|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178822|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178823|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
83178824|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83178825|NCT02307305|Narcotics|narcotics|mesh-ancestor
83178826|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178827|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83178828|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178829|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83178830|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83178831|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83178832|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178833|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178834|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83178835|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178836|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83178837|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83178838|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83178839|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178840|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178841|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
83178842|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178843|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
83178844|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
83178845|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83178846|NCT02660229|Morphine|morphine|mesh-list
83178847|NCT02660229|Oxycodone|oxycodone|mesh-list
83178848|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83178849|NCT02660229|Narcotics|narcotics|mesh-ancestor
83178850|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178851|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178852|NCT02660229|Analgesics|analgesics|mesh-ancestor
83178853|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
83178854|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178855|NCT02307383|Lactitol|lactitol|mesh-list
83178856|NCT02307383|Cathartics|cathartics|mesh-ancestor
83178857|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178858|NCT02232178|Bupivacaine|bupivacaine|mesh-list
83178859|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
83178860|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
83178861|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178862|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178863|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
83178864|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178865|NCT04457323|Metoprolol|metoprolol|mesh-list
83178866|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83178867|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83178868|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
83178869|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
83178870|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178871|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178872|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83178873|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83178874|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83178875|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
83178876|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178877|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178878|NCT04448431|Vortioxetine|vortioxetine|mesh-list
83178879|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83178880|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
83178881|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83178882|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83178883|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83178884|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83178885|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178886|NCT04448431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83178887|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83178888|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83178889|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178890|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178891|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
83178892|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83178893|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83178894|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83178895|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83178896|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83178897|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83178898|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178899|NCT02307695|Saxagliptin|saxagliptin|mesh-list
83178900|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83178901|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83178902|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178903|NCT02307695|Incretins|incretins|mesh-ancestor
83178904|NCT02307695|Hormones|hormones|mesh-ancestor
83178905|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178906|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
83178907|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178908|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178909|NCT05161975|Vitamin K|vitamin k|mesh-list
83178910|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
83178911|NCT05161975|Vitamins|vitamins|mesh-ancestor
83178912|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
83178913|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178914|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83178915|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83178916|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178917|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
83178918|NCT05161975|Coagulants|coagulants|mesh-ancestor
83178919|NCT03504527|Budesonide|budesonide|mesh-list
83178920|NCT03504527|Bromides|bromides|mesh-list
83178921|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
83178922|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178923|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83178924|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
83416654|NCT01896323|Ketoconazole|ketoconazole|mesh-list
83178925|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178926|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178927|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83178928|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
83178929|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
83178930|NCT03504527|Hormones|hormones|mesh-ancestor
83178931|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178932|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
83178933|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83178934|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
83178935|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83178936|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178937|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
83178938|NCT01678131|Ribavirin|ribavirin|mesh-list
83178939|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83178940|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
83178941|NCT01678131|Liver Extracts|liver extracts|mesh-list
83178942|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
83178943|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178944|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
83178945|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178946|NCT01678131|Hematinics|hematinics|mesh-ancestor
83178947|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178948|NCT04579783|Triamcinolone|triamcinolone|mesh-list
83178949|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83178950|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83178951|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83178952|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178953|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
83178954|NCT04579783|Hormones|hormones|mesh-ancestor
83178955|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178956|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178957|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83178958|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
83178959|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178960|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178961|NCT02231164|Docetaxel|docetaxel|mesh-list
83178962|NCT02231164|Nintedanib|nintedanib|mesh-list
83178963|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178964|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
83178965|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
83178966|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
83178967|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178968|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83178969|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83178970|NCT03506789|Dexamethasone|dexamethasone|mesh-list
83178971|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83178972|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
83178973|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
83178974|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178975|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178976|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178977|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
83178978|NCT03506789|Hormones|hormones|mesh-ancestor
83178979|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83178980|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83178981|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83178982|NCT02312297|Minocycline|minocycline|mesh-list
83178983|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83178984|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83178985|NCT05108974|Choline|choline|mesh-list
83178986|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
83178987|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83178989|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83178990|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83178991|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83178992|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
83178993|NCT03473431|Ketamine|ketamine|mesh-list
83178994|NCT03473431|Analgesics|analgesics|mesh-ancestor
83178995|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
83178996|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83178997|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83178998|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83178999|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83179000|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
83179001|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
83179002|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179003|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83179004|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83179005|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179006|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179007|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83179008|NCT02378805|Ramipril|ramipril|mesh-list
83179009|NCT02378805|Spironolactone|spironolactone|mesh-list
83179010|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83179011|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83179012|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
83179013|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179014|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179015|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83179016|NCT02378805|Diuretics|diuretics|mesh-ancestor
83179017|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
83179018|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
83179019|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179020|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179021|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83179022|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179023|NCT05094375|Misoprostol|misoprostol|mesh-list
83179024|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83179025|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
83179026|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83179027|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179028|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83179029|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179031|NCT04345861|Azithromycin|azithromycin|mesh-list
83179032|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
83179033|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179034|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179035|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
83179036|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83179037|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83179038|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179039|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179040|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83179042|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179043|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
83179044|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
83179045|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
83179046|NCT02230306|Vemurafenib|vemurafenib|mesh-list
83179047|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179048|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83179049|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179050|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179051|NCT04266379|Insulin|insulin|mesh-list
83179052|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83179053|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179054|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179055|NCT02308319|Tenofovir|tenofovir|mesh-list
83179056|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
83179057|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179058|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83179059|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83179060|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179061|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179062|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83179063|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83179064|NCT02312375|Amlodipine|amlodipine|mesh-list
83179065|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83179066|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83179067|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179068|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179069|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83179070|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179071|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
83179072|NCT05062174|Mifepristone|mifepristone|mesh-list
83179073|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83179074|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
83179075|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83179076|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179077|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83179078|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83179079|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83179080|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
83179081|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83179082|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83179083|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
83179084|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179085|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
83179086|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83179087|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83179088|NCT05095467|Paclitaxel|paclitaxel|mesh-list
83179089|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83179090|NCT05095467|Tegafur|tegafur|mesh-list
83179091|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83179092|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179093|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
83179094|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
83179095|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
83179096|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179097|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83179098|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
83179099|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
83179100|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83179101|NCT02312531|Antibodies|antibodies|mesh-list
83179102|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
83179103|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179104|NCT04234477|Metoprolol|metoprolol|mesh-list
83179105|NCT04234477|Verapamil|verapamil|mesh-list
83179106|NCT04234477|Diltiazem|diltiazem|mesh-list
83179107|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
83179108|NCT04234477|Calcium|calcium|mesh-list
83179109|NCT04234477|Esmolol|esmolol|mesh-list
83179110|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83179111|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83179112|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179113|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83179114|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83179115|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
83179116|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
83179117|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179118|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83179119|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83179120|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
83179121|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179122|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179123|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179124|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
83179125|NCT02449031|Tobramycin|tobramycin|mesh-list
83179126|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179127|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179128|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
83179129|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
83179130|NCT01680861|Everolimus|everolimus|mesh-list
83179131|NCT01680861|Tacrolimus|tacrolimus|mesh-list
83179132|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83179133|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
83179134|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179135|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83179136|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179137|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179138|NCT01680861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83179139|NCT01680861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83179140|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179141|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83179142|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83179143|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
83179144|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179145|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179146|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83179147|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
83179148|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
83179149|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179150|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179151|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
83179152|NCT01680861|Hormones|hormones|mesh-ancestor
83179153|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179154|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83179155|NCT01680861|Protective Agents|protective agents|mesh-ancestor
83179156|NCT02229214|Topiramate|topiramate|mesh-list
83179157|NCT02229214|Phentermine|phentermine|mesh-list
83179158|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
83179159|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179160|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179161|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83179162|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
83179163|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83179164|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
83179165|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
83179166|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179167|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
83179168|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179169|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179170|NCT02308553|Paclitaxel|paclitaxel|mesh-list
83179171|NCT02308553|Nintedanib|nintedanib|mesh-list
83179172|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83179173|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179174|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
83179175|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
83179176|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
83179177|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179178|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83179179|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179180|NCT05093907|Capecitabine|capecitabine|mesh-list
83179181|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83179182|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
83179183|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179184|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179185|NCT02228980|Vaccines|vaccines|mesh-list
83179186|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
83179187|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179188|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
83179189|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
83179190|NCT03783091|Hematinics|hematinics|mesh-ancestor
83179191|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
83179192|NCT03783091|Vitamins|vitamins|mesh-ancestor
83179193|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
83179194|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179195|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
83179196|NCT05057481|Rituximab|rituximab|mesh-list
83179197|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179198|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179199|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
83179200|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179201|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83179202|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83179203|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83179204|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
83179205|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179206|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179207|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179208|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179209|NCT02312609|Minocycline|minocycline|mesh-list
83179210|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179211|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179212|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
83179213|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83179214|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
83179215|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
83179216|NCT03506399|Estradiol|estradiol|mesh-list
83179217|NCT03506399|Estrogens|estrogens|mesh-ancestor
83179218|NCT03506399|Hormones|hormones|mesh-ancestor
83179219|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179220|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179221|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83179222|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83179223|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83179224|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83179225|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83179226|NCT02228590|Apomorphine|apomorphine|mesh-list
83179227|NCT02228590|Emetics|emetics|mesh-ancestor
83179228|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179229|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
83179230|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179231|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179232|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
83179233|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
83179234|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179235|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179236|NCT03503201|Chromium|chromium|mesh-list
83179237|NCT03503201|Trace Elements|trace elements|mesh-ancestor
83179238|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
83179239|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179240|NCT05095077|Tadalafil|tadalafil|mesh-list
83179241|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
83179242|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83179243|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83179244|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179245|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179246|NCT05095077|Urological Agents|urological agents|mesh-ancestor
83179247|NCT02309177|Paclitaxel|paclitaxel|mesh-list
83179248|NCT02309177|Carboplatin|carboplatin|mesh-list
83179249|NCT02309177|Gemcitabine|gemcitabine|mesh-list
83179250|NCT02309177|Nivolumab|nivolumab|mesh-list
83179251|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83179252|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179253|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83179254|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83179255|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83179256|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179257|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83179258|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
83179259|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179260|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83179261|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
83179262|NCT02227108|Immunotoxins|immunotoxins|mesh-ancestor
83179263|NCT02227108|Immunoconjugates|immunoconjugates|mesh-ancestor
83179264|NCT02227108|Immunologic Factors|immunologic factors|mesh-ancestor
83179265|NCT02227108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179266|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179267|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83179268|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83179269|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
83179270|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83179271|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83179272|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
83179273|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83179274|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83179275|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
83179276|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83430153|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179277|NCT02313077|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83179278|NCT02313077|Antiviral Agents|antiviral agents|mesh-ancestor
83179279|NCT02313077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179280|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
83179281|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83179282|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83179283|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179284|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179285|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179286|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83179287|NCT03423355|Diuretics|diuretics|mesh-ancestor
83179288|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
83179289|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83179290|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179291|NCT02226562|Listerine|listerine|mesh-list
83179292|NCT02226562|Fluorides|fluorides|mesh-list
83179293|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
83179294|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
83179295|NCT02226562|Protective Agents|protective agents|mesh-ancestor
83179296|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179297|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83179298|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179299|NCT04430985|Leucovorin|leucovorin|mesh-list
83179300|NCT04430985|Fluorouracil|fluorouracil|mesh-list
83179301|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
83179302|NCT04430985|Nivolumab|nivolumab|mesh-list
83179303|NCT04430985|Ipilimumab|ipilimumab|mesh-list
83179304|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
83179305|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179306|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83179307|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179308|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83179309|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
83179310|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179311|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179312|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83179313|NCT04430985|Antidotes|antidotes|mesh-ancestor
83179314|NCT04430985|Protective Agents|protective agents|mesh-ancestor
83179315|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
83179316|NCT04430985|Vitamins|vitamins|mesh-ancestor
83179317|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
83179318|NCT03365635|Ribavirin|ribavirin|mesh-list
83179319|NCT03365635|Grazoprevir|grazoprevir|mesh-list
83179320|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83179321|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
83179322|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179323|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
83179324|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179325|NCT04658277|Clarithromycin|clarithromycin|mesh-list
83179326|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179327|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179328|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83179329|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179330|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179331|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83179332|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83179334|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
83179335|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83179336|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83179337|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83179338|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179339|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179340|NCT04456777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83179341|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83179342|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179343|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179344|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179345|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
83179346|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83179347|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83179348|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83179349|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83179350|NCT02874430|Metformin|metformin|mesh-list
83179351|NCT02874430|Doxycycline|doxycycline|mesh-list
83179352|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179353|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179354|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179355|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179356|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
83179357|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83179358|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83179359|NCT05160727|Irinotecan|irinotecan|mesh-list
83179360|NCT05160727|Tislelizumab|tislelizumab|mesh-list
83179361|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83179362|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83179363|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179364|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179365|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179366|NCT05160727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179367|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83179368|NCT03506009|Argatroban|argatroban|mesh-list
83179369|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83179370|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83179371|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179372|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
83179373|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83179374|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
83179375|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179376|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
83179377|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83179378|NCT03130855|Carticaine|carticaine|mesh-list
83179379|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
83179380|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
83179381|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179382|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179383|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
83179384|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179385|NCT02309801|Daidzin|daidzin|mesh-list
83179386|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83179387|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179388|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179389|NCT04456387|Factor VIII|factor viii|mesh-list
83179390|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83179391|NCT04456387|Coagulants|coagulants|mesh-ancestor
83179392|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
83179393|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179394|NCT02309879|Lidocaine|lidocaine|mesh-list
83179395|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
83179396|NCT02309879|Remifentanil|remifentanil|mesh-list
83179397|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
83179398|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
83179399|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179400|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179401|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
83179402|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179403|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83179404|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83179405|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83179406|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179407|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179408|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83179409|NCT02309879|Narcotics|narcotics|mesh-ancestor
83179410|NCT02309879|Analgesics|analgesics|mesh-ancestor
83179411|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
83179412|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83179413|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83179414|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
83179415|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83179416|NCT02476786|Tamoxifen|tamoxifen|mesh-list
83179417|NCT02476786|Fulvestrant|fulvestrant|mesh-list
83179418|NCT02476786|Anastrozole|anastrozole|mesh-list
83179419|NCT02476786|Goserelin|goserelin|mesh-list
83179420|NCT02476786|Exemestane|exemestane|mesh-list
83179421|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83179422|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
83179423|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179424|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179425|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83179426|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179427|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83179428|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83179429|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83179430|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83179431|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83179432|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83179433|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179434|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179435|NCT02820961|Exemestane|exemestane|mesh-list
83179436|NCT02820961|Entinostat|entinostat|mesh-list
83179437|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179438|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83179439|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83179440|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179441|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179442|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83179443|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
83179444|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179445|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179446|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83179447|NCT04658173|Alfentanil|alfentanil|mesh-list
83179448|NCT04658173|Propofol|propofol|mesh-list
83179449|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83179450|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179451|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179452|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83179453|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
83179454|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
83179455|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83179456|NCT04658173|Narcotics|narcotics|mesh-ancestor
83179457|NCT04658173|Analgesics|analgesics|mesh-ancestor
83179458|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
83179459|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179460|NCT02399410|Bevacizumab|bevacizumab|mesh-list
83179461|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
83179462|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179463|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179464|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83179465|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83179466|NCT02399410|Growth Substances|growth substances|mesh-ancestor
83179467|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179468|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
83179469|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
83179470|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83179471|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83179472|NCT03636165|Prednisolone|prednisolone|mesh-list
83179473|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
83179474|NCT03636165|Ropivacaine|ropivacaine|mesh-list
83179475|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83179476|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
83179477|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
83179478|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
83179479|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179480|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179481|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
83179482|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179483|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83179484|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
83179485|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
83179486|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179487|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
83179488|NCT03636165|Hormones|hormones|mesh-ancestor
83179489|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179490|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83179491|NCT03636165|Protective Agents|protective agents|mesh-ancestor
83179492|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83179493|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179494|NCT02310347|Dronabinol|dronabinol|mesh-list
83179495|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
83179496|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179497|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83179498|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83179499|NCT02310347|Analgesics|analgesics|mesh-ancestor
83179500|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
83179501|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179502|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83179503|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83179504|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179505|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179506|NCT02310347|Hormones|hormones|mesh-ancestor
83416655|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
83179507|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179508|NCT04429425|Anesthetics|anesthetics|mesh-list
83179509|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179510|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179511|NCT03502889|Ropivacaine|ropivacaine|mesh-list
83179512|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
83179513|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
83179514|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179515|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179516|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
83179517|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179518|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83179519|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
83179520|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83179521|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83179522|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83179523|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179524|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179525|NCT05098119|Paclitaxel|paclitaxel|mesh-list
83179526|NCT05098119|Carboplatin|carboplatin|mesh-list
83179527|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83179528|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179529|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
83179530|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
83179531|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
83179532|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179533|NCT02738879|Metformin|metformin|mesh-list
83179534|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
83179535|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83179536|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179537|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179538|NCT02738879|Incretins|incretins|mesh-ancestor
83179539|NCT02738879|Hormones|hormones|mesh-ancestor
83179540|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179541|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83179542|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
83179543|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179544|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179545|NCT03253913|Sirolimus|sirolimus|mesh-list
83179546|NCT03253913|Resveratrol|resveratrol|mesh-list
83179547|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179548|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179549|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83179550|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179551|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
83179552|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83179553|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
83179554|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179555|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179556|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179557|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
83179558|NCT03253913|Protective Agents|protective agents|mesh-ancestor
83179559|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83179560|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
83179561|NCT03237819|Analgesics|analgesics|mesh-ancestor
83179562|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
83179563|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179564|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179565|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
83179566|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179567|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83179568|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
83179569|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83179570|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179571|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179572|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83179573|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
83179574|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83179575|NCT03468907|Tenofovir|tenofovir|mesh-list
83179576|NCT03468907|Telbivudine|telbivudine|mesh-list
83179577|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
83179578|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179579|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83179580|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83179581|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179582|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179583|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83179584|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83179585|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
83179586|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
83179587|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83179588|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83179589|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83179590|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179591|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179592|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
83179593|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179594|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179595|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83179596|NCT05089851|Protective Agents|protective agents|mesh-ancestor
83179597|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83179598|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83179599|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179600|NCT04657809|Insulin|insulin|mesh-list
83179601|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179602|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179603|NCT05350917|Tislelizumab|tislelizumab|mesh-list
83179604|NCT05350917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179605|NCT05350917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179606|NCT02311205|Sorafenib|sorafenib|mesh-list
83179607|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179608|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83179609|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179610|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179611|NCT05390749|Rituximab|rituximab|mesh-list
83179612|NCT05390749|Methotrexate|methotrexate|mesh-list
83179613|NCT05390749|Pomalidomide|pomalidomide|mesh-list
83179614|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179615|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179616|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
83179617|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179618|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83179619|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83179620|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
83179621|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83179622|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83179623|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
83179624|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179625|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83179626|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179627|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83179628|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83179629|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83179630|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83179631|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83179632|NCT05390749|Growth Substances|growth substances|mesh-ancestor
83179633|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
83179636|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179637|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179638|NCT03468829|Gontivimab|gontivimab|mesh-list
83179639|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
83179640|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179641|NCT04912791|Anesthetics|anesthetics|mesh-list
83179642|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179643|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179644|NCT02316197|Peposertib|peposertib|mesh-list
83179645|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83179646|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179647|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179648|NCT02314013|Metronidazole|metronidazole|mesh-list
83179649|NCT02314013|Cephalosporins|cephalosporins|mesh-list
83179650|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179651|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179652|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83179653|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83179654|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
83179655|NCT01677195|Antacids|antacids|mesh-ancestor
83179656|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179657|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179658|NCT05331807|Vitamin D|vitamin d|mesh-list
83179659|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
83179660|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
83179661|NCT05331807|Vitamins|vitamins|mesh-list
83179662|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
83179663|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179664|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83179665|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83179666|NCT02314325|Factor VIII|factor viii|mesh-list
83179667|NCT02314325|Coagulants|coagulants|mesh-ancestor
83179668|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
83179669|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83179670|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179671|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179672|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179673|NCT02314481|Trastuzumab|trastuzumab|mesh-list
83179674|NCT02314481|Atezolizumab|atezolizumab|mesh-list
83179675|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83179676|NCT02314481|Vemurafenib|vemurafenib|mesh-list
83179677|NCT02314481|Maytansine|maytansine|mesh-list
83179678|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179679|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179680|NCT02314481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83179681|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179682|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83179683|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179684|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83179685|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
83179686|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
83179687|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
83179688|NCT02314481|Immunotoxins|immunotoxins|mesh-ancestor
83179689|NCT02314481|Immunoconjugates|immunoconjugates|mesh-ancestor
83179690|NCT02314481|Immunologic Factors|immunologic factors|mesh-ancestor
83179691|NCT02314481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179692|NCT03502421|Ketamine|ketamine|mesh-list
83179693|NCT03502421|Analgesics|analgesics|mesh-ancestor
83416731|NCT02096107|Everolimus|everolimus|mesh-list
83179694|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
83179695|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179696|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179697|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83179698|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83179699|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
83179700|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
83179701|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179702|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83179703|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83179704|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179705|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179706|NCT03502343|Paclitaxel|paclitaxel|mesh-list
83179707|NCT03502343|Gemcitabine|gemcitabine|mesh-list
83179708|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83179709|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179710|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
83179711|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
83179712|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
83179713|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179714|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83179715|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
83179716|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83179717|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
83179718|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179719|NCT04345887|Spironolactone|spironolactone|mesh-list
83179720|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83179721|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
83179722|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179723|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179724|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83179725|NCT04345887|Diuretics|diuretics|mesh-ancestor
83179726|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
83179727|NCT02316899|Linaclotide|linaclotide|mesh-list
83179728|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83179729|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
83179730|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179731|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179732|NCT02314871|Morphine|morphine|mesh-list
83179733|NCT02314871|Pirinitramide|pirinitramide|mesh-list
83179734|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83179735|NCT02314871|Narcotics|narcotics|mesh-ancestor
83179736|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179737|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179738|NCT02314871|Analgesics|analgesics|mesh-ancestor
83179739|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
83179740|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179741|NCT02224846|Tadalafil|tadalafil|mesh-list
83179742|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
83179743|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83179744|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83179745|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179746|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179747|NCT02224846|Urological Agents|urological agents|mesh-ancestor
83179748|NCT03470077|Nalbuphine|nalbuphine|mesh-list
83179749|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179750|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179751|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83179752|NCT03470077|Narcotics|narcotics|mesh-ancestor
83179753|NCT03470077|Analgesics|analgesics|mesh-ancestor
83179754|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
83179755|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179756|NCT03519295|Atezolizumab|atezolizumab|mesh-list
83179757|NCT03519295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83179758|NCT03519295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179759|NCT03519295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179760|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179761|NCT02224690|Cannabidiol|cannabidiol|mesh-list
83179762|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
83179763|NCT05150431|Parecoxib|parecoxib|mesh-list
83179764|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83179765|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83179766|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179767|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179768|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83179769|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83179770|NCT05150431|Analgesics|analgesics|mesh-ancestor
83179771|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
83179772|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179773|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179774|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83179775|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83179776|NCT03501251|Albendazole|albendazole|mesh-list
83179777|NCT03501251|Moxidectin|moxidectin|mesh-list
83179778|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
83179779|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83179780|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179781|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
83179782|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83179783|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83179784|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83179785|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83179786|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83179787|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179788|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179789|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
83179790|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83179791|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
83179792|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179793|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83179794|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83179795|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
83179796|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179797|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179798|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83179799|NCT05390203|Testosterone|testosterone|mesh-list
83179800|NCT05390203|Androgens|androgens|mesh-ancestor
83179801|NCT05390203|Hormones|hormones|mesh-ancestor
83179802|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179803|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179804|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
83179805|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83179806|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
83179807|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179808|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179809|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83179810|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
83179811|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
83179812|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83179813|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
83179814|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179815|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179816|NCT02315495|Saxagliptin|saxagliptin|mesh-list
83179818|NCT02315495|Incretins|incretins|mesh-ancestor
83179819|NCT02315495|Hormones|hormones|mesh-ancestor
83179820|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179821|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179822|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83179823|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
83179824|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179825|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179826|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83179827|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83179828|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
83179829|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83179830|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83179831|NCT02317601|Prednisolone|prednisolone|mesh-list
83179832|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
83179833|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83179834|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
83179835|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83179836|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
83179837|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
83179838|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179839|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179840|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179841|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
83179842|NCT02317601|Hormones|hormones|mesh-ancestor
83179843|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179844|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83179845|NCT02317601|Protective Agents|protective agents|mesh-ancestor
83179846|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83179847|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179848|NCT05101785|Lidocaine|lidocaine|mesh-list
83179849|NCT05101785|Epinephrine|epinephrine|mesh-list
83179850|NCT05101785|Racepinephrine|racepinephrine|mesh-list
83179851|NCT05101785|Carticaine|carticaine|mesh-list
83179852|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
83179854|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
83179855|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179856|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179857|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
83179858|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179859|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83179860|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83179861|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83179862|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179863|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179864|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83179865|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83179866|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83179867|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179868|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83179869|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83179870|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
83179871|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83179872|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
83179874|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
83179875|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83179876|NCT02315573|Lidocaine|lidocaine|mesh-list
83179877|NCT02315573|Epinephrine|epinephrine|mesh-list
83179878|NCT02315573|Racepinephrine|racepinephrine|mesh-list
83179879|NCT02315573|Bupivacaine|bupivacaine|mesh-list
83179880|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
83179881|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
83179882|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
83179883|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179884|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179885|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
83179886|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179887|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83179888|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83179889|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83179890|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179891|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179892|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83179893|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83179894|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
83179895|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179896|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83179897|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83179898|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
83179899|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83179900|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
83179901|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
83179902|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
83179903|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83179904|NCT02724241|Nicotine|nicotine|mesh-list
83179905|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83179906|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
83179907|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179908|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179909|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83179910|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83179911|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
83179912|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179913|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179914|NCT02315651|Ubiquinone|ubiquinone|mesh-list
83179915|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
83179916|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
83179917|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179918|NCT02315651|Vitamins|vitamins|mesh-ancestor
83179919|NCT05366725|Avelumab|avelumab|mesh-list
83179920|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83179921|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83179922|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
83179923|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
83179924|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83179925|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83179926|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179927|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179928|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179930|NCT02317679|Bosentan|bosentan|mesh-list
83179931|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83179932|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83179933|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179934|NCT03475381|Ivacaftor|ivacaftor|mesh-list
83179935|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83179936|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83179937|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179938|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83179939|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83179940|NCT04535505|Erythromycin|erythromycin|mesh-list
83179941|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
83179942|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83179943|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
83179944|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179945|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179946|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179947|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83179948|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83179949|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179950|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
83179951|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83179952|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
83179953|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179954|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179955|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83179956|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
83179957|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83179958|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
83179959|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83179960|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83179961|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83179962|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
83179963|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
83179964|NCT03500783|Protective Agents|protective agents|mesh-ancestor
83179965|NCT03353233|Ropivacaine|ropivacaine|mesh-list
83179966|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
83179967|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
83179968|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179969|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179970|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
83179971|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179972|NCT02320877|Methaqualone|methaqualone|mesh-list
83179973|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83179974|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83179975|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179976|NCT01322971|Metronidazole|metronidazole|mesh-list
83179977|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83179978|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83179979|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83179980|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83179981|NCT04454281|Naloxone|naloxone|mesh-list
83179982|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83179983|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179984|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
83179985|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83179986|NCT02318225|Misoprostol|misoprostol|mesh-list
83179987|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83179988|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
83179989|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83179990|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179991|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83179992|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83179993|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
83179994|NCT01378429|Ciclesonide|ciclesonide|mesh-list
83179995|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
83179996|NCT01378429|Hormones|hormones|mesh-ancestor
83179997|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83179998|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83179999|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83180000|NCT01599754|Axitinib|axitinib|mesh-list
83180001|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83416732|NCT02096107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83180002|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83180003|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180004|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180005|NCT02321267|Ranibizumab|ranibizumab|mesh-list
83180006|NCT02321267|Aflibercept|aflibercept|mesh-list
83180007|NCT02321267|Verteporfin|verteporfin|mesh-list
83180008|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83180009|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83180010|NCT02321267|Growth Substances|growth substances|mesh-ancestor
83180011|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180012|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
83180013|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180014|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83180015|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180016|NCT02318537|Cannabidiol|cannabidiol|mesh-list
83180017|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83180018|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
83180019|NCT04642261|Empagliflozin|empagliflozin|mesh-list
83180020|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83180021|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180022|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180023|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180024|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
83180025|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180026|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180027|NCT02318771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83180028|NCT02318771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180030|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180031|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180032|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83180033|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180034|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
83180035|NCT02319161|Calcium|calcium|mesh-list
83180036|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83180037|NCT02319161|Esmolol|esmolol|mesh-list
83180038|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180039|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180040|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83180041|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83180042|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180043|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180044|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180045|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83180046|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
83180047|NCT02321579|Pyridoxal|pyridoxal|mesh-list
83180048|NCT02321579|Pyridoxine|pyridoxine|mesh-list
83180049|NCT02321579|Vitamins|vitamins|mesh-ancestor
83180050|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
83180051|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180052|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
83180053|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
83180054|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83180055|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83180056|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
83180057|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
83180058|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180059|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180060|NCT03109691|Dexamethasone|dexamethasone|mesh-list
83180061|NCT03109691|Bupivacaine|bupivacaine|mesh-list
83180062|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180063|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
83180064|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
83180065|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180066|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180067|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83180068|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
83180070|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180071|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83180072|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180073|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
83180074|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
83180075|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180076|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
83180077|NCT03497351|Nicardipine|nicardipine|mesh-list
83180078|NCT03497351|Urapidil|urapidil|mesh-list
83180079|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83180080|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83180081|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180082|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180083|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180084|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180085|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
83180086|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83180087|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
83180088|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180089|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83180090|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83180091|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83180092|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83180093|NCT02223364|Bupivacaine|bupivacaine|mesh-list
83180094|NCT02223364|Ropivacaine|ropivacaine|mesh-list
83180095|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
83180096|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
83180097|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180098|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180099|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
83180100|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180101|NCT01378975|Vemurafenib|vemurafenib|mesh-list
83180102|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180103|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83180104|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180105|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180106|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
83180107|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83180108|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83180109|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180110|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
83180111|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180112|NCT03499457|Amoxicillin|amoxicillin|mesh-list
83180113|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83180114|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180115|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
83180116|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83180117|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
83180118|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83180119|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180120|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83180121|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83180122|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83180123|NCT02322203|Niacin|niacin|mesh-list
83180124|NCT02322203|Niacinamide|niacinamide|mesh-list
83180125|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
83180126|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83180127|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
83180128|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180129|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83180130|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
83180131|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
83180132|NCT02322203|Vitamins|vitamins|mesh-ancestor
83180133|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
83180134|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180135|NCT04638751|Immunomodulating Agents|immunomodulating agents|mesh-list
83180136|NCT04638751|Immunologic Factors|immunologic factors|mesh-ancestor
83180137|NCT04638751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180138|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83180139|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83180140|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83180141|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
83180142|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83180143|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83180144|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180145|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
83180146|NCT04691362|Coagulants|coagulants|mesh-ancestor
83180147|NCT03499223|Ranibizumab|ranibizumab|mesh-list
83180148|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83180149|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83180150|NCT03499223|Growth Substances|growth substances|mesh-ancestor
83180151|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180152|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
83180153|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180154|NCT02319707|Oxytocin|oxytocin|mesh-list
83180155|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
83180156|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83180157|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180158|NCT05398861|Bevacizumab|bevacizumab|mesh-list
83180159|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180160|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180161|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83180162|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83180163|NCT05398861|Growth Substances|growth substances|mesh-ancestor
83180164|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180165|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83180166|NCT02448329|Paclitaxel|paclitaxel|mesh-list
83180167|NCT02448329|Adavosertib|adavosertib|mesh-list
83180168|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83180169|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180170|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
83180171|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
83180172|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
83180173|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180174|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180175|NCT05398393|Tenofovir|tenofovir|mesh-list
83180176|NCT05398393|Amlodipine|amlodipine|mesh-list
83180177|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83180178|NCT05398393|Atorvastatin|atorvastatin|mesh-list
83180179|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
83180180|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83180181|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
83180182|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180183|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83180184|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83180185|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180186|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
83180187|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180188|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83180189|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83180190|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83180191|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83180192|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83180193|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83180194|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180195|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180196|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180197|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
83180198|NCT01356628|Palbociclib|palbociclib|mesh-list
83180199|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180200|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83180201|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180202|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180203|NCT02319941|Clopidogrel|clopidogrel|mesh-list
83180204|NCT02319941|Ticagrelor|ticagrelor|mesh-list
83180205|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83180206|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83180207|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83180208|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83180209|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
83180210|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180211|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180212|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180213|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
83180214|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
83180215|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83180216|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180217|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180218|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83180219|NCT05164627|Analgesics|analgesics|mesh-ancestor
83180220|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
83180221|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180222|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83180223|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83180224|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83180225|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83180226|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180227|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180228|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
83180229|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83180230|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
83180231|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83180232|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180233|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180234|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
83180235|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83180236|NCT02322671|Montelukast|montelukast|mesh-list
83180237|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83180238|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
83180239|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83180240|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
83180241|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180242|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180243|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83180244|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83180245|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180246|NCT05096143|Valsartan|valsartan|mesh-list
83180247|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83180248|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83180249|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83180250|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83180251|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180252|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
83180253|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
83180254|NCT03494387|Antioxidants|antioxidants|mesh-list
83180255|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
83180256|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180257|NCT03494387|Expectorants|expectorants|mesh-ancestor
83180258|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83180259|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83180260|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180261|NCT03494387|Protective Agents|protective agents|mesh-ancestor
83180262|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180263|NCT03494387|Vitamins|vitamins|mesh-ancestor
83180264|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
83180265|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83180266|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83180267|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180268|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180269|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
83180270|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180271|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180272|NCT02324621|TIC10 compound|tic10 compound|mesh-list
83180273|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180274|NCT03821545|Lidocaine|lidocaine|mesh-list
83180275|NCT03821545|Ketamine|ketamine|mesh-list
83180276|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
83180277|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
83180278|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180279|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180280|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
83180281|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180282|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83180283|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83180284|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83180285|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180286|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180287|NCT03821545|Analgesics|analgesics|mesh-ancestor
83180288|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83180289|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83180290|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
83180291|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83180292|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83180293|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180294|NCT02324933|Fentanyl|fentanyl|mesh-list
83180295|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83180296|NCT02324933|Narcotics|narcotics|mesh-ancestor
83180297|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180298|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180299|NCT02324933|Analgesics|analgesics|mesh-ancestor
83180300|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
83180301|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180302|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83180303|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83180304|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
83180305|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
83180306|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
83180307|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83180308|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
83180309|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180310|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180311|NCT01378117|Incretins|incretins|mesh-ancestor
83180312|NCT01378117|Hormones|hormones|mesh-ancestor
83180313|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180314|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83180315|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
83180316|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180317|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180318|NCT02323139|Azacitidine|azacitidine|mesh-list
83180319|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83180320|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
83180321|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180322|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180323|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180324|NCT02325245|Metformin|metformin|mesh-list
83180325|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180326|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180327|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
83180328|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83180329|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83180330|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180331|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
83180332|NCT02323373|Coagulants|coagulants|mesh-ancestor
83180333|NCT02325479|Enoxaparin|enoxaparin|mesh-list
83180334|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
83180335|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83180336|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83180337|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180338|NCT05236231|Tadalafil|tadalafil|mesh-list
83180339|NCT05236231|Macitentan|macitentan|mesh-list
83180340|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
83180341|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83180342|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83180343|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180344|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180345|NCT05236231|Urological Agents|urological agents|mesh-ancestor
83180346|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83180347|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83180348|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83180349|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
83180350|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180351|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180352|NCT02325557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83180353|NCT02325557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180354|NCT03495323|Prexasertib|prexasertib|mesh-list
83180355|NCT03495323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83180356|NCT03495323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180357|NCT03495323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180358|NCT02323451|Chitosan|chitosan|mesh-list
83180359|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
83180360|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83180361|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
83180362|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180363|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
83180364|NCT02323451|Protective Agents|protective agents|mesh-ancestor
83180365|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83180366|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83180367|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
83180368|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180369|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83180370|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
83180371|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
83180373|NCT02323451|Coagulants|coagulants|mesh-ancestor
83180374|NCT02323529|Nitisinone|nitisinone|mesh-list
83180375|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180376|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180377|NCT02323607|Cytarabine|cytarabine|mesh-list
83180378|NCT02323607|Decitabine|decitabine|mesh-list
83180379|NCT02323607|Daunorubicin|daunorubicin|mesh-list
83180380|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83180381|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
83180382|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180383|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180384|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
83180385|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180386|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83180387|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
83180388|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180389|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83180390|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83180391|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83180392|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180393|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
83180394|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
83180395|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180396|NCT03493841|Protective Agents|protective agents|mesh-ancestor
83180397|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180398|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
83180399|NCT03493841|Vitamins|vitamins|mesh-ancestor
83180400|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
83180401|NCT05118737|Colchicine|colchicine|mesh-list
83180402|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
83180403|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83180404|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
83180405|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
83180406|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
83180407|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180408|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180409|NCT04987931|Talazoparib|talazoparib|mesh-list
83180410|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83180411|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180412|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180413|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180414|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
83180415|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83180416|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83180417|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180418|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
83180419|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180420|NCT03491579|Cytarabine|cytarabine|mesh-list
83180421|NCT03491579|Cladribine|cladribine|mesh-list
83180422|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83180423|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
83180424|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180425|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180426|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
83180427|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180428|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83180429|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
83180430|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180431|NCT04600895|Favipiravir|favipiravir|mesh-list
83180432|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
83180433|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180434|NCT03492593|Beta Carotene|beta carotene|mesh-list
83180435|NCT03492593|Lycopene|lycopene|mesh-list
83180436|NCT03492593|Carotenoids|carotenoids|mesh-list
83180437|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180438|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
83180439|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180440|NCT03492593|Protective Agents|protective agents|mesh-ancestor
83180441|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180442|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83180443|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83180444|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180445|NCT03492593|Provitamins|provitamins|mesh-ancestor
83180446|NCT03492593|Vitamins|vitamins|mesh-ancestor
83180447|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
83180448|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
83180449|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
83180450|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83180451|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83180452|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180453|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180454|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180455|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83180456|NCT04034459|Leucovorin|leucovorin|mesh-list
83180457|NCT04034459|Folic Acid|folic acid|mesh-list
83180458|NCT04034459|Bevacizumab|bevacizumab|mesh-list
83180459|NCT04034459|Cetuximab|cetuximab|mesh-list
83180460|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
83180461|NCT04034459|Irinotecan|irinotecan|mesh-list
83180462|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
83180463|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180464|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180465|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83180466|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83180467|NCT04034459|Growth Substances|growth substances|mesh-ancestor
83180468|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180469|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
83180470|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83180471|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83180472|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180473|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180474|NCT04034459|Antidotes|antidotes|mesh-ancestor
83180475|NCT04034459|Protective Agents|protective agents|mesh-ancestor
83180476|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
83180477|NCT04034459|Vitamins|vitamins|mesh-ancestor
83180478|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
83180479|NCT04034459|Hematinics|hematinics|mesh-ancestor
83180480|NCT03914885|Fludarabine|fludarabine|mesh-list
83180481|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83180482|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180483|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180484|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83180485|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
83180486|NCT03779243|Melatonin|melatonin|mesh-list
83180487|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
83180488|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180489|NCT03779243|Protective Agents|protective agents|mesh-ancestor
83180490|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180491|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180492|NCT03757013|Apremilast|apremilast|mesh-list
83180493|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83180494|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83180495|NCT03757013|Analgesics|analgesics|mesh-ancestor
83180496|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
83180497|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180498|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180499|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180500|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83180501|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83180502|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83180503|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180504|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180505|NCT02736409|Budesonide|budesonide|mesh-list
83180506|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180507|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83180508|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
83180509|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180510|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180511|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83180512|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
83180513|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
83180514|NCT02736409|Hormones|hormones|mesh-ancestor
83430154|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83180515|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180516|NCT05396677|Acetaminophen|acetaminophen|mesh-list
83180517|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83180518|NCT05396677|Analgesics|analgesics|mesh-ancestor
83180519|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
83180520|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180521|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180522|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
83180523|NCT05131867|Nimodipine|nimodipine|mesh-list
83180524|NCT05131867|Milrinone|milrinone|mesh-list
83180525|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83180526|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83180527|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
83180528|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83180529|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83180530|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180531|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180532|NCT05131867|Protective Agents|protective agents|mesh-ancestor
83180533|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180534|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83180535|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83180536|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180537|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180538|NCT02837783|Linaclotide|linaclotide|mesh-list
83180539|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83180540|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
83180541|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180542|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83180543|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83180544|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83180545|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83180546|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180547|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180548|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
83180549|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180550|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180551|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83180552|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180553|NCT05007145|Paclitaxel|paclitaxel|mesh-list
83180554|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83180555|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83180556|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83180557|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180558|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
83180559|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
83180560|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
83180561|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180562|NCT05007145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180563|NCT04952857|Vitamin D|vitamin d|mesh-list
83180564|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
83180565|NCT04952857|Vitamins|vitamins|mesh-ancestor
83180566|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
83180567|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180568|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83180569|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180570|NCT02220712|Aripiprazole|aripiprazole|mesh-list
83180571|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
83180572|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83180573|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83180574|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83180575|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180576|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180577|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
83180578|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
83180579|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180580|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180581|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83180582|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83180583|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
83180584|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83180585|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83180586|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83180587|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83180588|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
83180589|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83180590|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180591|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180592|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180593|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
83180594|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
83180595|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
83180596|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180597|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180598|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83180599|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83180600|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
83180601|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
83180602|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180603|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180604|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
83180605|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83180606|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180607|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180609|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
83180610|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
83180611|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83180612|NCT00846430|Celecoxib|celecoxib|mesh-list
83180613|NCT00846430|Vincristine|vincristine|mesh-list
83180614|NCT00846430|Temozolomide|temozolomide|mesh-list
83180615|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180616|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
83180617|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180618|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83180619|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
83180620|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
83180621|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
83180622|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180623|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83180624|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
83180625|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
83180626|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180627|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83180628|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83180629|NCT00846430|Analgesics|analgesics|mesh-ancestor
83180630|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
83180631|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180632|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180633|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83180634|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83180635|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83180636|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180637|NCT05439577|Heparinoids|heparinoids|mesh-list
83180638|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
83180639|NCT05439577|Hormones|hormones|mesh-ancestor
83180640|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180641|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180642|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180643|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
83180644|NCT05385523|Dexamethasone|dexamethasone|mesh-list
83180645|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180646|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
83180647|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
83180648|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180649|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180650|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83180651|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
83180652|NCT05385523|Hormones|hormones|mesh-ancestor
83180653|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180654|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83180655|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180656|NCT03910621|Miglustat|miglustat|mesh-list
83180657|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180658|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180659|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83180660|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83180661|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
83180662|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180663|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83180664|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180665|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180666|NCT02218372|Vancomycin|vancomycin|mesh-list
83180667|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
83180668|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83180669|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180670|NCT02217982|Simethicone|simethicone|mesh-list
83180671|NCT02217982|Loperamide|loperamide|mesh-list
83180672|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
83180673|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83180674|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
83180675|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180676|NCT02217982|Emollients|emollients|mesh-ancestor
83180677|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180678|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
83180679|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83180680|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
83180681|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180682|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
83180683|NCT02207608|Protective Agents|protective agents|mesh-ancestor
83180684|NCT03530995|Itraconazole|itraconazole|mesh-list
83180685|NCT03530995|Rifampin|rifampin|mesh-list
83180686|NCT03530995|Omeprazole|omeprazole|mesh-list
83180687|NCT03530995|Rabeprazole|rabeprazole|mesh-list
83180688|NCT03530995|Belumosudil|belumosudil|mesh-list
83180689|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83180690|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83180691|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83180692|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180693|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180694|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
83180695|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180696|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83180697|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83180698|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83180699|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
83180700|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180701|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180702|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83180703|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83180704|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
83180705|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83180706|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
83180707|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83180708|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83180709|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83180710|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83180711|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83180712|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83180713|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83180714|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83180715|NCT05438875|Tretinoin|tretinoin|mesh-list
83180716|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180717|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
83180718|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180719|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
83180720|NCT04740307|Lenvatinib|lenvatinib|mesh-list
83180721|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180722|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180723|NCT04740307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83180724|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180725|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83180726|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180727|NCT02207530|Durvalumab|durvalumab|mesh-list
83180728|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180729|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180731|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
83180732|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180733|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
83180734|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180735|NCT02616055|XL647|xl647|mesh-list
83180736|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180737|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83180738|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180739|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180740|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83180741|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
83180742|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180743|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180744|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180745|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180746|NCT02786537|Ritonavir|ritonavir|mesh-list
83180747|NCT02786537|Ribavirin|ribavirin|mesh-list
83180748|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
83180749|NCT02786537|Grazoprevir|grazoprevir|mesh-list
83180750|NCT02786537|Ledipasvir|ledipasvir|mesh-list
83180751|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83180752|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83180753|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83180754|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
83180755|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180756|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180757|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83180758|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83180759|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
83180760|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180761|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83180762|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83180763|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
83180764|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
83180765|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83180766|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180767|NCT03307759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83180768|NCT03307759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180769|NCT03466645|Vancomycin|vancomycin|mesh-list
83180770|NCT03466645|Cefazolin|cefazolin|mesh-list
83180771|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83180772|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180773|NCT04461665|Vitamin D|vitamin d|mesh-list
83180774|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
83180775|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
83180776|NCT04461665|Vitamins|vitamins|mesh-list
83180777|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
83180778|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180779|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83180780|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180781|NCT02252536|Gabapentin|gabapentin|mesh-list
83180782|NCT02252536|Analgesics|analgesics|mesh-ancestor
83180783|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
83180784|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180785|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180786|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
83180787|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83180788|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83180789|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180790|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83180791|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83180792|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83180793|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180794|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180795|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
83180796|NCT03490487|Prednisolone|prednisolone|mesh-list
83180797|NCT03490487|Carbamazepine|carbamazepine|mesh-list
83180798|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
83180799|NCT03490487|Levetiracetam|levetiracetam|mesh-list
83180800|NCT03490487|Valproic Acid|valproic acid|mesh-list
83180801|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
83180802|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180803|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
83180804|NCT03490487|Hormones|hormones|mesh-ancestor
83180805|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180806|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180807|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83180808|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180809|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180810|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
83180811|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180812|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180813|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
83180814|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83180815|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
83180816|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83180817|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180818|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83180819|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83180820|NCT03490487|Analgesics|analgesics|mesh-ancestor
83180821|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
83180822|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83180823|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180824|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83180825|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83180826|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83180827|NCT05271331|Anesthetics|anesthetics|mesh-list
83180828|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
83180829|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180830|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180831|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
83180832|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180833|NCT03466567|Cyclosporine|cyclosporine|mesh-list
83180834|NCT03466567|Probenecid|probenecid|mesh-list
83180835|NCT03466567|Cyclosporins|cyclosporins|mesh-list
83180836|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180837|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180838|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83180839|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
83180840|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180841|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
83180842|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180843|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180844|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83180845|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83180846|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
83180847|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
83180849|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
83180850|NCT03130153|Salicylates|salicylates|mesh-list
83180851|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83180852|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83180853|NCT03130153|Analgesics|analgesics|mesh-ancestor
83180854|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
83180855|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180856|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180857|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83180858|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83180859|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83180860|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83180861|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180862|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83180863|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83180864|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180865|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
83180866|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180867|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
83180868|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
83180869|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180870|NCT03466333|Enalapril|enalapril|mesh-list
83180871|NCT03466333|Enalaprilat|enalaprilat|mesh-list
83180872|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180873|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180874|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83180875|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
83180876|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83180877|NCT05382715|Ozanimod|ozanimod|mesh-list
83180878|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83180879|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180880|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83180881|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
83180882|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180883|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
83180884|NCT03492047|Paclitaxel|paclitaxel|mesh-list
83180885|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83180886|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83180887|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180888|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
83180889|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
83180890|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
83180891|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180892|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
83180893|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180894|NCT03492047|Expectorants|expectorants|mesh-ancestor
83180895|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83180896|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83180897|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
83180898|NCT03492047|Protective Agents|protective agents|mesh-ancestor
83180899|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180900|NCT03492047|Antidotes|antidotes|mesh-ancestor
83180901|NCT02251990|Grazoprevir|grazoprevir|mesh-list
83180902|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83180903|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
83180904|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180905|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
83180906|NCT03490097|Simvastatin|simvastatin|mesh-list
83180907|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83180908|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83180909|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
83180910|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180911|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83180912|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83180913|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180914|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
83180915|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180916|NCT04453735|Atorvastatin|atorvastatin|mesh-list
83180917|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83180918|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83180919|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
83180920|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180921|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83180922|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83180923|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180924|NCT03490019|Metformin|metformin|mesh-list
83180925|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180926|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180927|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
83180928|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
83180929|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180930|NCT03491969|Protective Agents|protective agents|mesh-ancestor
83180931|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180932|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
83180933|NCT03491969|Vitamins|vitamins|mesh-ancestor
83180934|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
83180935|NCT05349409|Fluzoparib|fluzoparib|mesh-list
83180936|NCT05349409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83180937|NCT05349409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180938|NCT05349409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180939|NCT05349409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180940|NCT02251912|Oxytocin|oxytocin|mesh-list
83180941|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
83180942|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83180943|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180944|NCT01976273|Glycolic acid|glycolic acid|mesh-list
83180945|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
83180946|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180947|NCT02206048|Proflavine|proflavine|mesh-list
83180948|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83180949|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180950|NCT03466021|Liraglutide|liraglutide|mesh-list
83180951|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83180952|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180953|NCT03466021|Incretins|incretins|mesh-ancestor
83180954|NCT03466021|Hormones|hormones|mesh-ancestor
83430155|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
83180955|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83180956|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83180957|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
83180958|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
83180959|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83180960|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83180961|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180962|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83180963|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83180964|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
83180965|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180966|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83180967|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
83180968|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180969|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83180970|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83180971|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180972|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
83180973|NCT03489005|Zamicastat|zamicastat|mesh-list
83180974|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83180975|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180976|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83180977|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83180978|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83180979|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180980|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83180981|NCT02215252|Pregabalin|pregabalin|mesh-list
83180982|NCT02215252|Analgesics|analgesics|mesh-ancestor
83180983|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
83180984|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83180985|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83180986|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
83180987|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83180988|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83180989|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83180990|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83180991|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83180992|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83180993|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83180994|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83180995|NCT04894721|Ivermectin|ivermectin|mesh-list
83180996|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83180997|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83180998|NCT02204410|Methylphenidate|methylphenidate|mesh-list
83180999|NCT02204410|Amphetamine|amphetamine|mesh-list
83181000|NCT02204410|Adderall|adderall|mesh-list
83181001|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
83181002|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83181003|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181004|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83181005|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83181006|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181007|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181008|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
83181009|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181010|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
83181011|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
83181012|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181013|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
83181014|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83181015|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
83181016|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
83181017|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181018|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83181019|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
83181020|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181021|NCT03461575|Cyclosporine|cyclosporine|mesh-list
83181022|NCT03461575|Cyclosporins|cyclosporins|mesh-list
83181023|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181024|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181025|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83181026|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
83181027|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181028|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
83181029|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181030|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
83181031|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83181032|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83181033|NCT03131843|Ethanol|ethanol|mesh-list
83181034|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83181035|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181036|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181037|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181038|NCT02213380|Anesthetics|anesthetics|mesh-list
83181039|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181040|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181041|NCT03488147|Esomeprazole|esomeprazole|mesh-list
83181042|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83181043|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181044|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83181045|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181046|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181047|NCT03797261|Venetoclax|venetoclax|mesh-list
83181048|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181049|NCT02202850|Etanercept|etanercept|mesh-list
83181050|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83181051|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83181052|NCT02202850|Analgesics|analgesics|mesh-ancestor
83181053|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
83181054|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181055|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181056|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181057|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83181058|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181059|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83181060|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
83181061|NCT03489395|Edoxaban|edoxaban|mesh-list
83181062|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83181063|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
83416809|NCT04834752|Famotidine|famotidine|mesh-list
83181064|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83181065|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83181066|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181067|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181068|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
83181069|NCT03489317|Metformin|metformin|mesh-list
83181070|NCT03489317|Amlodipine|amlodipine|mesh-list
83181071|NCT03489317|Simvastatin|simvastatin|mesh-list
83181072|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83181073|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181074|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83181075|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83181076|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181077|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181078|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83181079|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
83181080|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83181081|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83181082|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
83181083|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83181084|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83181085|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181086|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
83181087|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83181088|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
83181089|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181090|NCT02212678|Expectorants|expectorants|mesh-ancestor
83181091|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
83181092|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83181093|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
83181094|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181095|NCT02212678|Protective Agents|protective agents|mesh-ancestor
83181096|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181097|NCT02212678|Antidotes|antidotes|mesh-ancestor
83181098|NCT03489239|Tenofovir|tenofovir|mesh-list
83181099|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
83181100|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181101|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83181102|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83181103|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181104|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181105|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83181106|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83181107|NCT03489161|Buprenorphine|buprenorphine|mesh-list
83181108|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83181109|NCT03489161|Narcotics|narcotics|mesh-ancestor
83181110|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181111|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181112|NCT03489161|Analgesics|analgesics|mesh-ancestor
83181113|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
83181114|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181115|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83181116|NCT04804709|Panobinostat|panobinostat|mesh-list
83181117|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181118|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83181119|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181120|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181121|NCT04690673|Acetaminophen|acetaminophen|mesh-list
83181122|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83181123|NCT04690673|Analgesics|analgesics|mesh-ancestor
83181124|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
83181125|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181126|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181127|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
83181128|NCT03104075|Vaccines|vaccines|mesh-list
83181129|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83181130|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
83181131|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181132|NCT02907983|Bupivacaine|bupivacaine|mesh-list
83181133|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
83181134|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
83181135|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181136|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181137|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
83181138|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181139|NCT02841215|Ivermectin|ivermectin|mesh-list
83181140|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83181141|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181142|NCT02799641|Lidocaine|lidocaine|mesh-list
83181143|NCT02799641|Diazepam|diazepam|mesh-list
83181144|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
83181145|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
83181146|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181147|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181148|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
83181149|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181150|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83181151|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83181152|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83181153|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181154|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181155|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83181156|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
83181157|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
83181158|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
83181159|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181160|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83181161|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83181162|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83181163|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83181164|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83181165|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83181166|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83181167|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
83181168|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
83181169|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
83181170|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181171|NCT04388501|Atorvastatin|atorvastatin|mesh-list
83181172|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83181173|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83181174|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
83181175|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181176|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83181177|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83181178|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181180|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
83181181|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83181182|NCT02249182|Ledipasvir|ledipasvir|mesh-list
83181183|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
83181184|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181185|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
83181186|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181187|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
83181188|NCT04006769|Entacapone|entacapone|mesh-list
83181189|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181190|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181191|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181192|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181193|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83181194|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83181195|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83181196|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83181197|NCT03487211|Escitalopram|escitalopram|mesh-list
83181198|NCT03487211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83181199|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83181200|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181201|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181202|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181203|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
83181204|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181205|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181206|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
83181207|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83181208|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83181209|NCT03487211|Analgesics|analgesics|mesh-ancestor
83181210|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
83181211|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
83181212|NCT03487133|Dexamethasone|dexamethasone|mesh-list
83181213|NCT03487133|Bortezomib|bortezomib|mesh-list
83181214|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181215|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
83181216|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
83181217|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181218|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181219|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181220|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
83181221|NCT03487133|Hormones|hormones|mesh-ancestor
83181222|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181223|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83181224|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181225|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83181226|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83181227|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83181228|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181229|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181230|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181231|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181232|NCT02248480|Analgesics|analgesics|mesh-ancestor
83181233|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
83181234|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181235|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
83181236|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83181237|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
83181238|NCT01653158|Docetaxel|docetaxel|mesh-list
83181239|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181240|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
83181241|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
83181242|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
83181243|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181245|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83181246|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
83181247|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181248|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181249|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83181250|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83181251|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
83181252|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181253|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181254|NCT02247466|Rocuronium|rocuronium|mesh-list
83181255|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83181256|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83181257|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83181258|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181259|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181260|NCT03417479|Gabapentin|gabapentin|mesh-list
83181261|NCT03417479|Analgesics|analgesics|mesh-ancestor
83181262|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
83181263|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181264|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181265|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
83181266|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83181267|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83181268|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181269|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83181270|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83181271|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83181272|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181273|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181274|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
83181275|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
83181276|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
83181277|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83181278|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83181279|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181280|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
83181281|NCT03317795|Coagulants|coagulants|mesh-ancestor
83181282|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83181283|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
83181284|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83181285|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181286|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83181287|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83181288|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83181289|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
83181290|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181291|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83181292|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83181293|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83181294|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
83181295|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181296|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181297|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83181298|NCT03876119|Plasminogen|plasminogen|mesh-list
83181299|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83181300|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83181301|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181302|NCT02455076|Exenatide|exenatide|mesh-list
83181303|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
83181304|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83181305|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181306|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83181307|NCT02455076|Incretins|incretins|mesh-ancestor
83181308|NCT02455076|Hormones|hormones|mesh-ancestor
83181309|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181310|NCT02432846|Sunitinib|sunitinib|mesh-list
83181311|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181312|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83181313|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83181314|NCT02432846|Growth Substances|growth substances|mesh-ancestor
83181315|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181316|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
83181317|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181318|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181319|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181320|NCT03486509|Afatinib|afatinib|mesh-list
83181321|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181322|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181323|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181324|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181325|NCT04460807|Exemestane|exemestane|mesh-list
83181326|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181327|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83181328|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83181329|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181330|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181331|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83181332|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
83181333|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181334|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181335|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83181336|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
83181337|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181338|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83181339|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83181340|NCT04928222|Doxorubicin|doxorubicin|mesh-list
83181341|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83181342|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181343|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83181344|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83181345|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181346|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181347|NCT00805961|Bevacizumab|bevacizumab|mesh-list
83181348|NCT00805961|Everolimus|everolimus|mesh-list
83181349|NCT00805961|Temozolomide|temozolomide|mesh-list
83181350|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83181351|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181352|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83181353|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83181354|NCT00805961|Growth Substances|growth substances|mesh-ancestor
83181355|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181356|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
83181357|NCT00805961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83181358|NCT00805961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181359|NCT00805961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181360|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181361|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83181362|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
83181363|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83181364|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
83181365|NCT02454608|Verapamil|verapamil|mesh-list
83181366|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83181367|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83181368|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181369|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181370|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83181371|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181372|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
83181373|NCT05152355|Budesonide|budesonide|mesh-list
83181374|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181375|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83181376|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
83181377|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181378|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181379|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83181380|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
83181381|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
83181382|NCT05152355|Hormones|hormones|mesh-ancestor
83181383|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181384|NCT02246764|Timolol|timolol|mesh-list
83181385|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83181386|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83181387|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181388|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83181389|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83181390|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
83181391|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181392|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181393|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83181394|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83181396|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
83181397|NCT03484091|Protective Agents|protective agents|mesh-ancestor
83181398|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181399|NCT03486353|Azacitidine|azacitidine|mesh-list
83181400|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83181401|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
83181402|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181403|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181404|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181405|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83181406|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83181407|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83181408|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83181409|NCT02431676|Metformin|metformin|mesh-list
83181410|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83181411|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181412|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83181413|NCT03483545|Hormones|hormones|mesh-ancestor
83181414|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181415|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181417|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83181418|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181419|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181420|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181421|NCT03486119|Nivolumab|nivolumab|mesh-list
83181422|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83181423|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181424|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83181425|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181426|NCT02523833|Albuterol|albuterol|mesh-list
83181427|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83181428|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
83181429|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181430|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181431|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83181432|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
83181433|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
83181434|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83181435|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83181436|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83181437|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83181438|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
83181439|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181440|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181441|NCT04349579|Rifamycins|rifamycins|mesh-list
83181442|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
83181443|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83181444|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181445|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83181446|NCT04234529|Caffeine|caffeine|mesh-list
83181447|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83181448|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181449|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83181450|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181451|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181452|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83181453|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83181454|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
83181455|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181456|NCT01652690|Denosumab|denosumab|mesh-list
83181457|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83181458|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181459|NCT03481517|Bupivacaine|bupivacaine|mesh-list
83181460|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
83181461|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
83181462|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181463|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181464|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
83181465|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181466|NCT02429258|Metformin|metformin|mesh-list
83181467|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
83181468|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83181469|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181470|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83181471|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181472|NCT02201524|Abrocitinib|abrocitinib|mesh-list
83181473|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181474|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181475|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181476|NCT05153603|Olaparib|olaparib|mesh-list
83181477|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83181478|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181479|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181480|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181481|NCT05152901|Epinephrine|epinephrine|mesh-list
83181482|NCT05152901|Racepinephrine|racepinephrine|mesh-list
83181483|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
83181484|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83181485|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83181486|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
83181487|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181488|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181489|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181490|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83181491|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83181492|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
83181493|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181494|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83181495|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
83181496|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
83181497|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
83181498|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83181500|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83181501|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83181502|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181503|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
83181504|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181505|NCT05152667|Dienogest|dienogest|mesh-list
83181506|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
83181507|NCT05152667|Progestins|progestins|mesh-list
83181508|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83181509|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
83181510|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83181511|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181512|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83181513|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83181514|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83181515|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83181516|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83181517|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
83181518|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181519|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83181520|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181521|NCT05152667|Hormones|hormones|mesh-ancestor
83181522|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
83181523|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83181524|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181525|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181526|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83181527|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83181528|NCT05152511|Protective Agents|protective agents|mesh-ancestor
83181529|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181530|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
83181531|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83181532|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
83181533|NCT02568449|Nintedanib|nintedanib|mesh-list
83181534|NCT02568449|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83181535|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181536|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181537|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181538|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181539|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
83181540|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
83181541|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181542|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
83181543|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83181544|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
83181545|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
83181546|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181547|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181548|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83181549|NCT04884893|Analgesics|analgesics|mesh-ancestor
83181550|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
83181551|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181552|NCT03479879|Misoprostol|misoprostol|mesh-list
83181553|NCT03479879|Estradiol|estradiol|mesh-list
83181554|NCT03479879|Estrogens|estrogens|mesh-ancestor
83181555|NCT03479879|Hormones|hormones|mesh-ancestor
83181556|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181557|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181558|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83181559|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83181560|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
83181561|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83181562|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181563|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
83181564|NCT03479411|Itraconazole|itraconazole|mesh-list
83181565|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83181566|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
83181567|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181568|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83181569|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83181570|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181571|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181572|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83181573|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
83181574|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181575|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181576|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83181577|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
83181578|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83181579|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181580|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181581|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83181582|NCT03131375|Analgesics|analgesics|mesh-ancestor
83181583|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
83181584|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181585|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83181586|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83181587|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83181588|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83181589|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181590|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181591|NCT03475589|Apatinib|apatinib|mesh-list
83181592|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181593|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181594|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181595|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181596|NCT03478709|Norepinephrine|norepinephrine|mesh-list
83181597|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83181598|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83181599|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
83181600|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181601|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181602|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181603|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
83181604|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
83181605|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181606|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83181607|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
83181608|NCT03478475|Vitamin D|vitamin d|mesh-list
83181609|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83181610|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181611|NCT03478475|Vitamins|vitamins|mesh-ancestor
83181612|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
83181613|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83181614|NCT03475121|Topotecan|topotecan|mesh-list
83181615|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83181616|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83181617|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181618|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181619|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181620|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83181621|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181622|NCT02523755|Ropivacaine|ropivacaine|mesh-list
83181623|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
83181624|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
83181625|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181626|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181627|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
83181628|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181629|NCT02168842|Isradipine|isradipine|mesh-list
83181630|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83181631|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83181632|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181633|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181634|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83181635|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181636|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
83181637|NCT03347123|Nivolumab|nivolumab|mesh-list
83181638|NCT03347123|Ipilimumab|ipilimumab|mesh-list
83181639|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83181640|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181641|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83181642|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181643|NCT03131141|Lefamulin|lefamulin|mesh-list
83181644|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83181645|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181646|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83181647|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83181648|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181649|NCT03477929|Cetrorelix|cetrorelix|mesh-list
83181650|NCT03477929|Ganirelix|ganirelix|mesh-list
83181651|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
83181652|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181653|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181654|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83181655|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
83181656|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83181657|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83181658|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83181659|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181660|NCT03474263|Antibodies|antibodies|mesh-list
83181661|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83181662|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
83181663|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181664|NCT03477461|Terlipressin|terlipressin|mesh-list
83181665|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83181666|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83181667|NCT02553161|Escitalopram|escitalopram|mesh-list
83181668|NCT02553161|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83181669|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83181670|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181671|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181672|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181673|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
83181674|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181675|NCT03473093|Pregabalin|pregabalin|mesh-list
83181676|NCT03473093|Morphine|morphine|mesh-list
83181677|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83181678|NCT03473093|Narcotics|narcotics|mesh-ancestor
83181679|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181680|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181681|NCT03473093|Analgesics|analgesics|mesh-ancestor
83181682|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
83181683|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181684|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
83181685|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83181686|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181687|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181688|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83181689|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83181690|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83181691|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83181692|NCT02523131|Insulin|insulin|mesh-list
83181693|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83181694|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181695|NCT04339049|Lidocaine|lidocaine|mesh-list
83181696|NCT04339049|Misoprostol|misoprostol|mesh-list
83181697|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
83181698|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
83181699|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181700|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181701|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
83181702|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181703|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83181704|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83181705|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83181706|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181707|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181708|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83181709|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
83181710|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83181712|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181713|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
83181714|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
83181715|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
83181716|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181717|NCT02133664|Protective Agents|protective agents|mesh-ancestor
83181718|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181719|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
83181720|NCT02133664|Vitamins|vitamins|mesh-ancestor
83181721|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
83181722|NCT02133352|Ranolazine|ranolazine|mesh-list
83181723|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83181724|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181725|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181726|NCT04418128|Nafamostat|nafamostat|mesh-list
83181727|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83181728|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83181729|NCT04418128|Analgesics|analgesics|mesh-ancestor
83181730|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
83181731|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181732|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181733|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181734|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83181735|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
83181736|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
83181737|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181738|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181739|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83181740|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83181741|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83181742|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83181743|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
83181744|NCT02555657|Gemcitabine|gemcitabine|mesh-list
83181745|NCT02555657|Capecitabine|capecitabine|mesh-list
83181746|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
83181747|NCT02555657|Vinorelbine|vinorelbine|mesh-list
83181748|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83181749|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
83181750|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181751|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181752|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83181753|NCT02555657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83181754|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83181755|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
83181756|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
83181757|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83181758|NCT02195518|Tenofovir|tenofovir|mesh-list
83181759|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
83181760|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181761|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83181762|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83181763|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181764|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181765|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83181766|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83181767|NCT03990077|Docetaxel|docetaxel|mesh-list
83181768|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181769|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
83181770|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
83181771|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
83181772|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181773|NCT05134415|Menthol|menthol|mesh-list
83181774|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
83181775|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
83181776|NCT03380507|Thiamine|thiamine|mesh-list
83181777|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
83181778|NCT03380507|Vitamins|vitamins|mesh-ancestor
83181779|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
83181780|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181781|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181782|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
83181783|NCT03471455|Itraconazole|itraconazole|mesh-list
83181784|NCT03471455|Terbinafine|terbinafine|mesh-list
83181785|NCT03471455|Isotretinoin|isotretinoin|mesh-list
83181786|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
83181787|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181788|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83181789|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83181790|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181791|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181792|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83181793|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
83181794|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181795|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181796|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83181797|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
83181798|NCT02824679|Scopolamine|scopolamine|mesh-list
83181799|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83181800|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83181801|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
83181802|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
83181803|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181804|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181805|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181806|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
83181807|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83181808|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
83181809|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181810|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181811|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83181812|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
83181813|NCT03202667|Empagliflozin|empagliflozin|mesh-list
83181814|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83181815|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181816|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83181817|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181818|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
83181819|NCT02133742|Axitinib|axitinib|mesh-list
83181820|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83181821|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181822|NCT02133742|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83181823|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181824|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83181825|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181826|NCT05157893|Analgesics|analgesics|mesh-list
83181827|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
83181828|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181829|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181830|NCT02523053|Fluorouracil|fluorouracil|mesh-list
83181831|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
83181832|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181833|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83181834|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181835|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83181836|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
83181837|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181838|NCT04457609|Azithromycin|azithromycin|mesh-list
83181839|NCT04457609|Oseltamivir|oseltamivir|mesh-list
83181840|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83181841|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181842|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
83181843|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181844|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181845|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
83181846|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83181847|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181848|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
83181849|NCT04457765|Povidone|povidone|mesh-list
83181850|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
83181851|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
83181852|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83181853|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181854|NCT03795233|Vancomycin|vancomycin|mesh-list
83181855|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83181856|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181857|NCT03645863|Iron|iron|mesh-list
83181858|NCT03645863|Trace Elements|trace elements|mesh-ancestor
83181859|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
83181860|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181861|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83181862|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
83181863|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83181865|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181866|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181867|NCT03470597|Iodine|iodine|mesh-list
83181868|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83181869|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181870|NCT03470597|Trace Elements|trace elements|mesh-ancestor
83181871|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
83181872|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181873|NCT02522897|Ranibizumab|ranibizumab|mesh-list
83181874|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83181875|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83181876|NCT02522897|Growth Substances|growth substances|mesh-ancestor
83181877|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181878|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
83181879|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181880|NCT04351061|Acetazolamide|acetazolamide|mesh-list
83181881|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
83181882|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83181883|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181884|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181885|NCT04351061|Diuretics|diuretics|mesh-ancestor
83181886|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
83181887|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181888|NCT03130829|Fucoidan|fucoidan|mesh-list
83181889|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83181890|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181891|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
83181892|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181893|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83181894|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
83181895|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
83181896|NCT04206761|Bromides|bromides|mesh-list
83181897|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
83181898|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181899|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
83181900|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83181901|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83181902|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83181903|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83181904|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
83181905|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83181906|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181907|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181908|NCT03181529|Psilocybin|psilocybin|mesh-list
83181909|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
83181910|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181911|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83181912|NCT03668639|Dexamethasone|dexamethasone|mesh-list
83181913|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83181914|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
83181915|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
83181916|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181917|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181918|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83181919|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
83181920|NCT03668639|Hormones|hormones|mesh-ancestor
83181921|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181922|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83181923|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181924|NCT03470363|Sufentanil|sufentanil|mesh-list
83181925|NCT03470363|Bupivacaine|bupivacaine|mesh-list
83181926|NCT03470363|Sevoflurane|sevoflurane|mesh-list
83181927|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
83181928|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
83181929|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83181930|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181931|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
83181932|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83181933|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83181934|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83181935|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
83181936|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83181937|NCT03470363|Narcotics|narcotics|mesh-ancestor
83181938|NCT03470363|Analgesics|analgesics|mesh-ancestor
83181939|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83181940|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83181942|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181943|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83181944|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181945|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
83181946|NCT05160623|Povidone|povidone|mesh-list
83181947|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
83181948|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
83181949|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83181950|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181951|NCT04713137|Erythritol|erythritol|mesh-list
83181952|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
83181953|NCT04456985|Folic Acid|folic acid|mesh-list
83181954|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
83181955|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
83181956|NCT04456985|Vitamins|vitamins|mesh-ancestor
83181957|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
83181958|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181959|NCT04456985|Hematinics|hematinics|mesh-ancestor
83181960|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
83181961|NCT03469583|Entecavir|entecavir|mesh-list
83181962|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
83181963|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83181964|NCT05096039|Valsartan|valsartan|mesh-list
83181965|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83181966|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83181967|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83181968|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83181969|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181970|NCT05604131|Deferiprone|deferiprone|mesh-list
83181971|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83181972|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
83181973|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
83181974|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181975|NCT03469271|Calcitriol|calcitriol|mesh-list
83181976|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83181977|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83181978|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181979|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83181980|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83181981|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181982|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83181983|NCT03469271|Vitamins|vitamins|mesh-ancestor
83181984|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
83181985|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83181986|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
83181987|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83181988|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83181989|NCT03361865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83181990|NCT03361865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83181991|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83181992|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83181993|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
83181994|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83181995|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83181996|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83181997|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83181998|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83181999|NCT02421341|Fentanyl|fentanyl|mesh-list
83182000|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
83182001|NCT02421341|Analgesics|analgesics|mesh-list
83182002|NCT02421341|Narcotics|narcotics|mesh-ancestor
83182003|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182004|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182005|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
83182006|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182007|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83182008|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83182009|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
83182010|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
83182011|NCT02149121|Rituximab|rituximab|mesh-list
83182012|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182013|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182014|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
83182015|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182016|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182017|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
83182018|NCT05162417|Methylene Blue|methylene blue|mesh-list
83182019|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182020|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182021|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
83182022|NCT05162417|Coagulants|coagulants|mesh-ancestor
83182023|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
83182024|NCT05162183|Liraglutide|liraglutide|mesh-list
83182025|NCT05162183|Glimepiride|glimepiride|mesh-list
83182026|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83182027|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182028|NCT05162183|Incretins|incretins|mesh-ancestor
83182029|NCT05162183|Hormones|hormones|mesh-ancestor
83182030|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182031|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83182032|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83182033|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
83182034|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
83182035|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83182036|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
83182037|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182038|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
83182039|NCT05161403|Protective Agents|protective agents|mesh-ancestor
83182040|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
83182041|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83182042|NCT03166085|Paclitaxel|paclitaxel|mesh-list
83430106|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182043|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
83182044|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83182045|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182046|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
83182047|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
83182048|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
83182049|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182050|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
83182052|NCT05390255|Hormones|hormones|mesh-list
83182053|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182054|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182055|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182056|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
83182057|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83182058|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83182059|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
83182060|NCT04456829|Resveratrol|resveratrol|mesh-list
83182061|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
83182062|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182063|NCT04456829|Protective Agents|protective agents|mesh-ancestor
83182064|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182065|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182066|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83182067|NCT02492867|Paclitaxel|paclitaxel|mesh-list
83182068|NCT02492867|Carboplatin|carboplatin|mesh-list
83182069|NCT02492867|Durvalumab|durvalumab|mesh-list
83182070|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83182071|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182072|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
83182073|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
83182074|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
83182075|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182076|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182077|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
83182078|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83182079|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83182080|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
83182081|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182082|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182083|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182084|NCT02522221|Warfarin|warfarin|mesh-list
83182085|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
83182086|NCT05389943|Vitamin D|vitamin d|mesh-list
83182087|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
83182088|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
83182089|NCT05389943|Vitamins|vitamins|mesh-list
83182090|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
83182091|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182092|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83182093|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83182094|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
83182095|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182096|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182097|NCT04575961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83182098|NCT04575961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182099|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
83182100|NCT02522975|Hematinics|hematinics|mesh-ancestor
83182101|NCT04508803|Trastuzumab|trastuzumab|mesh-list
83182102|NCT04508803|Niraparib|niraparib|mesh-list
83182103|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182104|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182105|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83182106|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182107|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182108|NCT04492033|Paclitaxel|paclitaxel|mesh-list
83182109|NCT04492033|Irinotecan|irinotecan|mesh-list
83182110|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83182111|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182112|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83182113|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83182114|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83182115|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182116|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83182117|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83182118|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182119|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83182120|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83182121|NCT03461185|Growth Substances|growth substances|mesh-ancestor
83182122|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182123|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
83182124|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182125|NCT04453423|Carboplatin|carboplatin|mesh-list
83182126|NCT04453423|Pemetrexed|pemetrexed|mesh-list
83182127|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182128|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182129|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182130|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83182131|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83182132|NCT04453189|Lansoprazole|lansoprazole|mesh-list
83182133|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
83182134|NCT04453189|Famotidine|famotidine|mesh-list
83182135|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83182136|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83182137|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83182138|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182139|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182140|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83182141|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
83182142|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
83182143|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182144|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182145|NCT03465085|Heparin|heparin|mesh-list
83182146|NCT03465085|Calcium heparin|calcium heparin|mesh-list
83182147|NCT03465085|Streptokinase|streptokinase|mesh-list
83182148|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
83182149|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83182150|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83182151|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182152|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
83182153|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182154|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
83182155|NCT05030155|Azathioprine|azathioprine|mesh-list
83182156|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83182157|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
83182158|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182159|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182160|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83182161|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
83182162|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182163|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182164|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83182165|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
83182166|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83182168|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83182169|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
83182170|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182171|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
83182172|NCT04453111|Protective Agents|protective agents|mesh-ancestor
83182174|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83182175|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182176|NCT04453345|Thalidomide|thalidomide|mesh-list
83182177|NCT04453345|Prednisone|prednisone|mesh-list
83182178|NCT04453345|Methotrexate|methotrexate|mesh-list
83182179|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182180|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
83182181|NCT04453345|Hormones|hormones|mesh-ancestor
83182182|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182183|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182184|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83182185|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182186|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83182187|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
83182188|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83182189|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83182190|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
83182191|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182192|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
83182193|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182194|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83182195|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83182196|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
83182197|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182198|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83182199|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
83182200|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83182201|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182202|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83182203|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83182204|NCT04453345|Growth Substances|growth substances|mesh-ancestor
83182205|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
83182206|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
83182207|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182208|NCT03464539|Chitosan|chitosan|mesh-list
83182209|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83182210|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83182211|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
83182212|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182213|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83182214|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
83182215|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
83182216|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
83182217|NCT03464539|Coagulants|coagulants|mesh-ancestor
83182218|NCT01633541|Carboplatin|carboplatin|mesh-list
83182219|NCT01633541|Docetaxel|docetaxel|mesh-list
83182220|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182221|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
83182222|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
83182223|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
83182224|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182225|NCT03460405|Vaccines|vaccines|mesh-list
83182226|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
83182227|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182228|NCT05166005|Vitamin D|vitamin d|mesh-list
83182229|NCT05166005|Vitamins|vitamins|mesh-ancestor
83182230|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
83182231|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182232|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83182233|NCT03464305|Aspirin|aspirin|mesh-list
83182234|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83182235|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83182236|NCT03464305|Analgesics|analgesics|mesh-ancestor
83182237|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
83182238|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182239|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182240|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182241|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182242|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83182243|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83182244|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182245|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83182246|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83182247|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182248|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
83182250|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83182251|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182252|NCT03468439|Phenol|phenol|mesh-list
83182253|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83182254|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182255|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
83182256|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83182257|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83182258|NCT05165303|Lidocaine|lidocaine|mesh-list
83182259|NCT05165303|Propofol|propofol|mesh-list
83182260|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
83182261|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
83182262|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182263|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182264|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
83182265|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182266|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83182267|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83182268|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83182269|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83182270|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182271|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83182272|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83182273|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
83182274|NCT03376763|Aripiprazole|aripiprazole|mesh-list
83182275|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
83182276|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83182277|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83182278|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83182279|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182280|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182281|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
83182282|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
83182283|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182284|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182285|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83182286|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83182287|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
83182288|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83182289|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83182290|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83182291|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83182292|NCT05153135|Palbociclib|palbociclib|mesh-list
83182293|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182294|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182295|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182296|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182297|NCT02616185|Tremelimumab|tremelimumab|mesh-list
83182298|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182299|NCT04857307|Alprazolam|alprazolam|mesh-list
83182300|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83182301|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182302|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182303|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83182304|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83182305|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83182306|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
83182307|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
83182308|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182309|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182310|NCT03467893|Antacids|antacids|mesh-list
83182311|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182312|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83182313|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
83182314|NCT05170711|Anesthetics|anesthetics|mesh-list
83182315|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182316|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182317|NCT03454945|Doxycycline|doxycycline|mesh-list
83182318|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83182319|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182320|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
83182321|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83182322|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83182323|NCT01857115|Dexamethasone|dexamethasone|mesh-list
83182324|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
83182325|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83182326|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
83182327|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182328|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182329|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83182330|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
83182331|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182332|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182333|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83182334|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182335|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
83182336|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
83182337|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182338|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83182339|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
83182341|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182342|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83182343|NCT03453541|Ketorolac|ketorolac|mesh-list
83182344|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83182345|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83182346|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83182347|NCT03453541|Analgesics|analgesics|mesh-ancestor
83182348|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
83182349|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182350|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182351|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182352|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182353|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83182354|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182355|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182356|NCT00893789|Modafinil|modafinil|mesh-list
83182357|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83182358|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182359|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83182360|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83182361|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83182362|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182363|NCT03449251|Verapamil|verapamil|mesh-list
83182364|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83182365|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83182366|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83182367|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83182368|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182369|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83182370|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182371|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
83182372|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182374|NCT05322499|Docetaxel|docetaxel|mesh-list
83182375|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83182376|NCT05322499|Irinotecan|irinotecan|mesh-list
83182377|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83182378|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182379|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83182380|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83182381|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83182382|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182383|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83182384|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83182385|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182386|NCT03449173|Sunitinib|sunitinib|mesh-list
83182387|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182388|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83182389|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83182390|NCT03449173|Growth Substances|growth substances|mesh-ancestor
83182391|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182393|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182394|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182395|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182396|NCT04760041|Midazolam|midazolam|mesh-list
83182397|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83182398|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83182399|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182400|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182401|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83182402|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83182403|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83182404|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83182405|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
83182406|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
83182407|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
83182408|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
83182409|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182410|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182411|NCT04754035|Venetoclax|venetoclax|mesh-list
83182412|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182413|NCT05322265|Epinephrine|epinephrine|mesh-list
83182414|NCT05322265|Racepinephrine|racepinephrine|mesh-list
83182415|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
83182416|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83182417|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83182418|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
83182419|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182420|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182421|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182422|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83182423|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83182424|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
83182425|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182426|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83182427|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
83182429|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
83182430|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83182431|NCT02164864|Aspirin|aspirin|mesh-list
83182432|NCT02164864|Warfarin|warfarin|mesh-list
83182433|NCT02164864|Dabigatran|dabigatran|mesh-list
83182434|NCT02164864|Clopidogrel|clopidogrel|mesh-list
83182435|NCT02164864|Ticagrelor|ticagrelor|mesh-list
83182436|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83182437|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83182438|NCT02164864|Analgesics|analgesics|mesh-ancestor
83182439|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
83182440|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182441|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182442|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182443|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182444|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83182445|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83182446|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182447|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83182448|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83182449|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182450|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
83182451|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83182452|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83182453|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83182454|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
83182455|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182456|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
83182457|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
83182458|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83182459|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
83182460|NCT05579249|Liraglutide|liraglutide|mesh-list
83182461|NCT05579249|Topiramate|topiramate|mesh-list
83182462|NCT05579249|Orlistat|orlistat|mesh-list
83182463|NCT05579249|Phentermine|phentermine|mesh-list
83182464|NCT05579249|Naltrexone|naltrexone|mesh-list
83182465|NCT05579249|Bupropion|bupropion|mesh-list
83182466|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83182467|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83182468|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182469|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
83182470|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182471|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83182472|NCT05579249|Incretins|incretins|mesh-ancestor
83182473|NCT05579249|Hormones|hormones|mesh-ancestor
83182474|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182475|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83182476|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
83182477|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83182478|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83182479|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83182480|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83182481|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182482|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
83182483|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182484|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83182485|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83182486|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182487|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
83182488|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83182489|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83182490|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83182491|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
83182492|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
83182493|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
83182494|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83182495|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83182496|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83182497|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83182498|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182499|NCT05386589|Molnupiravir|molnupiravir|mesh-list
83182500|NCT05386589|Antiviral Agents|antiviral agents|mesh-ancestor
83182501|NCT05386589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182502|NCT01998529|Cisplatin|cisplatin|mesh-list
83182503|NCT01998529|Amifostine|amifostine|mesh-list
83182504|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182505|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83182506|NCT01998529|Protective Agents|protective agents|mesh-ancestor
83182507|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182508|NCT03448705|Vaccines|vaccines|mesh-list
83182509|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
83182510|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182511|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
83182512|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83182513|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
83182514|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182515|NCT03448549|Capecitabine|capecitabine|mesh-list
83182516|NCT03448549|Tegafur|tegafur|mesh-list
83182517|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
83182518|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83182519|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
83182520|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182521|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182522|NCT03679091|Clopidogrel|clopidogrel|mesh-list
83182523|NCT03679091|Ticagrelor|ticagrelor|mesh-list
83182524|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83182525|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83182526|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83182527|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83182528|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
83182529|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182530|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182531|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182532|NCT01628926|Ropinirole|ropinirole|mesh-list
83182533|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83182534|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83182535|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
83182536|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
83182537|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182538|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182539|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182540|NCT05313659|Ketamine|ketamine|mesh-list
83182541|NCT05313659|Analgesics|analgesics|mesh-ancestor
83182542|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
83182543|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182544|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182545|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83182546|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83182547|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
83182548|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
83182549|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182550|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83182551|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83182552|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182553|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182554|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
83182555|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83182556|NCT05322187|Lenvatinib|lenvatinib|mesh-list
83182557|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182558|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182559|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182560|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182561|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182562|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
83182563|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
83182564|NCT03436199|Amantadine|amantadine|mesh-list
83182565|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83182566|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83182567|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
83182568|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182569|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
83182570|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182571|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182572|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182573|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83182574|NCT03436199|Analgesics|analgesics|mesh-ancestor
83182575|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
83182576|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182577|NCT02131324|Clobetasol|clobetasol|mesh-list
83182578|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182579|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
83182580|NCT02131324|Hormones|hormones|mesh-ancestor
83182581|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182582|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182583|NCT04749394|Apatinib|apatinib|mesh-list
83182584|NCT04749394|Antibodies|antibodies|mesh-list
83182585|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
83182586|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83182587|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
83182588|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182589|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182590|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182591|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182592|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182593|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
83182594|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83182595|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
83182596|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182597|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182598|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83182599|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
83182600|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182601|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182602|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83182603|NCT05159219|Colchicine|colchicine|mesh-list
83182604|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
83182605|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182606|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
83182607|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
83182608|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
83182609|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182610|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182611|NCT05321329|Capecitabine|capecitabine|mesh-list
83182612|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83182613|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
83182614|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182615|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182616|NCT02521831|Bupivacaine|bupivacaine|mesh-list
83182617|NCT02521831|Anesthetics|anesthetics|mesh-list
83182618|NCT02521831|Isoflurane|isoflurane|mesh-list
83182619|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
83182620|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182621|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182622|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
83182623|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182624|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83182625|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
83182626|NCT01425541|Progesterone|progesterone|mesh-list
83182627|NCT01425541|Estradiol|estradiol|mesh-list
83182628|NCT01425541|Estrogens|estrogens|mesh-list
83182629|NCT01425541|Progestins|progestins|mesh-ancestor
83182630|NCT01425541|Hormones|hormones|mesh-ancestor
83182631|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182632|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182633|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
83182634|NCT03447925|Salicylates|salicylates|mesh-list
83182635|NCT03447925|Petrolatum|petrolatum|mesh-list
83182636|NCT03447925|Emollients|emollients|mesh-ancestor
83182637|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
83182638|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83182639|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83182640|NCT03447925|Analgesics|analgesics|mesh-ancestor
83182641|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
83182642|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182643|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182644|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182645|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83182646|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83182647|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182648|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182649|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182650|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
83182651|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
83182652|NCT04928183|Nitroprusside|nitroprusside|mesh-list
83182653|NCT04928183|Phenylephrine|phenylephrine|mesh-list
83182654|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
83182655|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
83182656|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83182657|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
83182658|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
83182659|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182660|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182661|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
83182662|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83182663|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
83182664|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
83182665|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83182666|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83182667|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83182668|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
83182669|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182670|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182671|NCT04928183|Protective Agents|protective agents|mesh-ancestor
83182672|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
83182673|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
83182674|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83182675|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
83182676|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83182677|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
83182678|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83182679|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83182680|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182681|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
83182682|NCT04311073|Coagulants|coagulants|mesh-ancestor
83182683|NCT03447691|Remifentanil|remifentanil|mesh-list
83182684|NCT03447691|Anesthetics|anesthetics|mesh-list
83182685|NCT03447691|Propofol|propofol|mesh-list
83182686|NCT03447691|Desflurane|desflurane|mesh-list
83182687|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182688|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182689|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83182690|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83182691|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
83182692|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83182693|NCT03447691|Narcotics|narcotics|mesh-ancestor
83182694|NCT03447691|Analgesics|analgesics|mesh-ancestor
83182695|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
83182696|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182697|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83182698|NCT04923659|Nimodipine|nimodipine|mesh-list
83182699|NCT04923659|Carbamazepine|carbamazepine|mesh-list
83182700|NCT04923659|Lorazepam|lorazepam|mesh-list
83182701|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
83182702|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
83182703|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
83182704|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83182705|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83182706|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182707|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83416810|NCT04834752|Ranitidine|ranitidine|mesh-list
83182708|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182710|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
83182711|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
83182712|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182713|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83182714|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83182715|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182716|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83182717|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83182718|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83182719|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
83182720|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
83182721|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
83182722|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83182723|NCT04923659|Analgesics|analgesics|mesh-ancestor
83182724|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
83182725|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83182726|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83182727|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83182728|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83182729|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83182730|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83182731|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83182732|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
83182733|NCT05398679|Amoxicillin|amoxicillin|mesh-list
83182734|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
83182735|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
83182736|NCT05398679|Levofloxacin|levofloxacin|mesh-list
83182737|NCT05398679|Ofloxacin|ofloxacin|mesh-list
83182738|NCT05398679|Clindamycin|clindamycin|mesh-list
83182739|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
83182740|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
83182741|NCT05398679|Rifampin|rifampin|mesh-list
83182742|NCT05398679|Linezolid|linezolid|mesh-list
83182743|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83182744|NCT05398679|Tedizolid|tedizolid|mesh-list
83182745|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
83182746|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
83182747|NCT05398679|Cefaclor|cefaclor|mesh-list
83182748|NCT05398679|Trimethoprim|trimethoprim|mesh-list
83182749|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
83182750|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
83182751|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83182752|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83182753|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182754|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83182755|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83182756|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182757|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182758|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182759|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83182760|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
83182761|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83182762|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182763|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83182764|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83182765|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83182766|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83182767|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83182768|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83182769|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83182770|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83182771|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
83182772|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
83182773|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83182774|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83182775|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83182776|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83182777|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83182778|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83182779|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83182780|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
83182781|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83182782|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83182783|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83182784|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83182785|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83182786|NCT04817501|Edetic Acid|edetic acid|mesh-list
83182787|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
83182788|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83182789|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
83182790|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
83182791|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182792|NCT05398055|Azithromycin|azithromycin|mesh-list
83182793|NCT05398055|Doxycycline|doxycycline|mesh-list
83182794|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83182795|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182796|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
83182797|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83182798|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83182799|NCT01378325|Phenylephrine|phenylephrine|mesh-list
83182800|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
83182801|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83182802|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
83182803|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
83182804|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182805|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182806|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
83182807|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83182808|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
83182809|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
83182810|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83182811|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83182812|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83182813|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
83182814|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83182815|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182816|NCT01378325|Protective Agents|protective agents|mesh-ancestor
83182817|NCT03854903|Fulvestrant|fulvestrant|mesh-list
83182818|NCT03854903|Palbociclib|palbociclib|mesh-list
83182819|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83182820|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182821|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83182822|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83182823|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
83182824|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182825|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182826|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182827|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182828|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182829|NCT01093573|Azacitidine|azacitidine|mesh-list
83182830|NCT01093573|Midostaurin|midostaurin|mesh-list
83182831|NCT01093573|Staurosporine|staurosporine|mesh-list
83182832|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83182833|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
83182834|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182835|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182836|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182837|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182839|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182840|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182841|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83182842|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182843|NCT03402503|Montelukast|montelukast|mesh-list
83182844|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83182845|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83182846|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83182847|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
83182848|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182849|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182850|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83182851|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83182852|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182853|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
83182854|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
83182855|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182856|NCT05174845|Protective Agents|protective agents|mesh-ancestor
83182857|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182858|NCT05174845|Vitamins|vitamins|mesh-ancestor
83182859|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
83182860|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
83182861|NCT04155203|Mupirocin|mupirocin|mesh-list
83182862|NCT04155203|Calcium|calcium|mesh-list
83182863|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83182864|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182865|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83182866|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83182867|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182868|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83182869|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182870|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182871|NCT04238143|Complement Factor H|complement factor h|mesh-list
83182872|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83182873|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83182874|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
83182875|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182876|NCT04073615|Trifluridine|trifluridine|mesh-list
83182877|NCT04073615|Apatinib|apatinib|mesh-list
83182878|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182879|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182880|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182881|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182882|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
83182883|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
83182884|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182885|NCT05303311|Dexamethasone|dexamethasone|mesh-list
83182886|NCT05303311|Meperidine|meperidine|mesh-list
83182887|NCT05303311|Bupivacaine|bupivacaine|mesh-list
83182888|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182889|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
83182890|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
83182891|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182892|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182893|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83182894|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
83182895|NCT05303311|Hormones|hormones|mesh-ancestor
83182896|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83182897|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83182898|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182899|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
83182900|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
83182901|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83182902|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
83182903|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83182904|NCT05303311|Narcotics|narcotics|mesh-ancestor
83182905|NCT05303311|Analgesics|analgesics|mesh-ancestor
83182906|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83182907|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
83182908|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182909|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182910|NCT03057613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83182911|NCT03057613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182912|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
83182913|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182914|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182915|NCT03446911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83182916|NCT03446911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182917|NCT02974621|Bevacizumab|bevacizumab|mesh-list
83182918|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83182919|NCT02974621|Olaparib|olaparib|mesh-list
83182920|NCT02974621|Cediranib|cediranib|mesh-list
83182921|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
83182922|NCT02974621|Antibodies|antibodies|mesh-list
83182923|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
83182924|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83182925|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
83182926|NCT02974621|Maleic acid|maleic acid|mesh-list
83182927|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182928|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83182929|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83182930|NCT02974621|Growth Substances|growth substances|mesh-ancestor
83182931|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182932|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
83182933|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
83182934|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182935|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83182936|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182937|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83182938|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
83182939|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
83182940|NCT03446599|Methylene Blue|methylene blue|mesh-list
83182941|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182942|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182943|NCT03446599|Hematinics|hematinics|mesh-ancestor
83182944|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
83182945|NCT03446599|Vitamins|vitamins|mesh-ancestor
83182946|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
83182947|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182948|NCT02856451|Nivolumab|nivolumab|mesh-list
83182949|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83182950|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182951|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83182952|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182953|NCT03446443|Metronidazole|metronidazole|mesh-list
83182954|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182955|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83182956|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83182957|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83182958|NCT05102071|Metformin|metformin|mesh-list
83182959|NCT05102071|Empagliflozin|empagliflozin|mesh-list
83182960|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83182961|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182962|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83182963|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182964|NCT03443869|Valganciclovir|valganciclovir|mesh-list
83182965|NCT03443869|Acyclovir|acyclovir|mesh-list
83182966|NCT03443869|Letermovir|letermovir|mesh-list
83182967|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
83182968|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182969|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83182970|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83182971|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83182972|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182973|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
83182974|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83182975|NCT03130517|Antibodies|antibodies|mesh-list
83182976|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
83182977|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83182978|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
83182979|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182980|NCT03445897|Miltefosine|miltefosine|mesh-list
83182981|NCT03445897|Pentamidine|pentamidine|mesh-list
83182982|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
83182983|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83182984|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83182985|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83182986|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83182987|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83182988|NCT03237611|Dexamethasone|dexamethasone|mesh-list
83182989|NCT03237611|Ondansetron|ondansetron|mesh-list
83182990|NCT03237611|Aprepitant|aprepitant|mesh-list
83182991|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
83182992|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83182993|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
83182994|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
83182995|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83182996|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83182997|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83182998|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
83183000|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183001|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83183002|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183003|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
83183004|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83183005|NCT03237611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83183006|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83183007|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
83183008|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183009|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183010|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83183011|NCT03234491|Insulin|insulin|mesh-list
83183012|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83183013|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83183014|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183015|NCT01961063|Busulfan|busulfan|mesh-list
83183016|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
83183017|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183018|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183019|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
83183020|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183021|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83183022|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183023|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83183024|NCT02951377|Dexamethasone|dexamethasone|mesh-list
83183025|NCT02951377|Lidocaine|lidocaine|mesh-list
83183026|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183027|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
83183028|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
83183029|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183030|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183031|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83183032|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
83183033|NCT02951377|Hormones|hormones|mesh-ancestor
83183034|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183035|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83183036|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183037|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
83183038|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
83183039|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183040|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
83183041|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83183042|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83183043|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83183044|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83183045|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183046|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
83183047|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183048|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183049|NCT05082259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183050|NCT05082259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183051|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
83183052|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183053|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183054|NCT03442621|Cortisone|cortisone|mesh-list
83183055|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183056|NCT03444649|Cytarabine|cytarabine|mesh-list
83183057|NCT03444649|Daunorubicin|daunorubicin|mesh-list
83183058|NCT03444649|Idarubicin|idarubicin|mesh-list
83183059|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83183060|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
83416811|NCT04834752|Cimetidine|cimetidine|mesh-list
83183061|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183062|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183063|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
83183064|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183065|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183066|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
83183067|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183068|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83183069|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83183070|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83183071|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183072|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83183073|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83183074|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183075|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83183076|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183077|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83183078|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183079|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183081|NCT03466775|Giapreza|giapreza|mesh-list
83183082|NCT03466775|Antibodies|antibodies|mesh-list
83183083|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
83183084|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
83183085|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183086|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83183087|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83183088|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
83183089|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183090|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183091|NCT02611817|Vedolizumab|vedolizumab|mesh-list
83183092|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83183093|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
83183094|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83183095|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83183096|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83183097|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83183098|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183099|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
83183100|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183101|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183102|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83183103|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183104|NCT02557139|Belumosudil|belumosudil|mesh-list
83183105|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83183106|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183107|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183108|NCT01677741|Dabrafenib|dabrafenib|mesh-list
83183109|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183110|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83183111|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183112|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183113|NCT02457221|Prednisone|prednisone|mesh-list
83183114|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
83183115|NCT02457221|Tacrolimus|tacrolimus|mesh-list
83183116|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183117|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
83183118|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183119|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83183120|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83183121|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
83183122|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183123|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183124|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83183125|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183126|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
83183127|NCT02457221|Hormones|hormones|mesh-ancestor
83183128|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183129|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83183130|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83183131|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183132|NCT05263895|Ritonavir|ritonavir|mesh-list
83183133|NCT05263895|Nirmatrelvir|nirmatrelvir|mesh-list
83183134|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83183135|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83183136|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
83183137|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183138|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183139|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83183140|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83183141|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
83183142|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183143|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83183144|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83183145|NCT01709981|Colchicine|colchicine|mesh-list
83183146|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
83183147|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83183148|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83183149|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83183150|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83183151|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183152|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183153|NCT03268083|Vaccines|vaccines|mesh-list
83183154|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
83183155|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183156|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
83183157|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183158|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83183159|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183160|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183161|NCT03170817|Regadenoson|regadenoson|mesh-list
83183162|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83183163|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83183164|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
83183165|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
83183166|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183167|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183168|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183169|NCT05101005|Sirolimus|sirolimus|mesh-list
83183170|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83183171|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183172|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83183173|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183174|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
83183175|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183176|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
83183177|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183178|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83183179|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83183180|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183181|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
83183182|NCT05015387|Procyanidin|procyanidin|mesh-list
83183183|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
83183184|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183185|NCT05015387|Protective Agents|protective agents|mesh-ancestor
83416812|NCT04834752|Nizatidine|nizatidine|mesh-list
83183186|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183187|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83183188|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83183189|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183190|NCT00003857|Tamoxifen|tamoxifen|mesh-list
83183191|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83183192|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
83183193|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183194|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183195|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83183196|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183197|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83183198|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83183199|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83183200|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83183201|NCT03464435|Tobramycin|tobramycin|mesh-list
83183202|NCT03464435|Tacrolimus|tacrolimus|mesh-list
83183203|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183204|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
83183205|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183206|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83183207|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183208|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183209|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83183210|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183211|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83183212|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83183213|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183214|NCT03463967|Lycopene|lycopene|mesh-list
83183215|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183216|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
83183217|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183218|NCT03463967|Protective Agents|protective agents|mesh-ancestor
83183219|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183220|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83183221|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83183222|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183223|NCT03463733|Temozolomide|temozolomide|mesh-list
83183224|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
83183225|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83183226|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
83183227|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183228|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183229|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
83183230|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183231|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83183232|NCT04222595|Vaccines|vaccines|mesh-list
83183233|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
83183234|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183235|NCT03468023|Calpastatin|calpastatin|mesh-list
83183236|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83183237|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
83183238|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183239|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183240|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
83183241|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
83183242|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183243|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183244|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183245|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
83183246|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
83183247|NCT05100303|Cytarabine|cytarabine|mesh-list
83183248|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
83183249|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83183250|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
83183251|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183252|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183253|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
83183254|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183255|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183256|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
83183257|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183258|NCT05100303|Analgesics|analgesics|mesh-ancestor
83183259|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
83183260|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183261|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83183262|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83183263|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183264|NCT03462173|Yimitasvir|yimitasvir|mesh-list
83183265|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
83183266|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183267|NCT05096715|Bevacizumab|bevacizumab|mesh-list
83183268|NCT05096715|Atezolizumab|atezolizumab|mesh-list
83183269|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183270|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183271|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83183272|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83183273|NCT05096715|Growth Substances|growth substances|mesh-ancestor
83183274|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183275|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
83183276|NCT05096715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183277|NCT05096715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183278|NCT04984889|Protein C|protein c|mesh-list
83183279|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
83183280|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83183281|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83183282|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183283|NCT05099601|Silymarin|silymarin|mesh-list
83183284|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
83183285|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183286|NCT05099601|Protective Agents|protective agents|mesh-ancestor
83183287|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183288|NCT03736629|Azithromycin|azithromycin|mesh-list
83183289|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83183290|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183291|NCT03461783|Charcoal|charcoal|mesh-list
83183292|NCT03461783|Antidotes|antidotes|mesh-ancestor
83183293|NCT03461783|Protective Agents|protective agents|mesh-ancestor
83183294|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183295|NCT01677507|Timolol|timolol|mesh-list
83183297|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83183298|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83183299|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183301|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183302|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183303|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83183304|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83183305|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83183306|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83183307|NCT04796363|Anesthetics|anesthetics|mesh-list
83183308|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183309|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183310|NCT03593109|Immunomodulating Agents|immunomodulating agents|mesh-list
83183311|NCT03593109|Immunologic Factors|immunologic factors|mesh-ancestor
83183312|NCT03593109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183313|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83183314|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83183315|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
83183317|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183318|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183319|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183320|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183321|NCT05103813|Beraprost|beraprost|mesh-list
83183322|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83183323|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
83183324|NCT03461627|Fluticasone|fluticasone|mesh-list
83183325|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83183326|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83183327|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183328|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83183329|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
83183330|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183331|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183332|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83183333|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
83183334|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
83183335|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83183336|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83183337|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83183338|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83183339|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183340|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183341|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183342|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
83183343|NCT03461627|Hormones|hormones|mesh-ancestor
83183344|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183345|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
83183346|NCT04452929|Calcitonin|calcitonin|mesh-list
83183347|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
83183348|NCT04452929|Cilostazol|cilostazol|mesh-list
83183349|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83183350|NCT04452929|Erenumab|erenumab|mesh-list
83183351|NCT04452929|Katacalcin|katacalcin|mesh-list
83183352|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83183353|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
83183354|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183355|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183356|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83183357|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
83183358|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83183359|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83183360|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183361|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83183362|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
83183363|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83183364|NCT04452929|Protective Agents|protective agents|mesh-ancestor
83183365|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83183366|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83183367|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183368|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83183370|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
83183371|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83183372|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83183373|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
83183374|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83183375|NCT05103501|Fluorouracil|fluorouracil|mesh-list
83183376|NCT05103501|Cisplatin|cisplatin|mesh-list
83183377|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183378|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183379|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183380|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
83183381|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83183382|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183383|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
83183384|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183385|NCT02522117|Atorvastatin|atorvastatin|mesh-list
83183386|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83183387|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83183388|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
83183389|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183390|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83183391|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83183392|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183393|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
83183394|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83183395|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83183396|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183397|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
83183398|NCT05087199|Coagulants|coagulants|mesh-ancestor
83183399|NCT04628429|Erenumab|erenumab|mesh-list
83183400|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83183401|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183402|NCT04628429|Analgesics|analgesics|mesh-ancestor
83183403|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
83183404|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183405|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183406|NCT03461081|Amlodipine|amlodipine|mesh-list
83183407|NCT03461081|Telmisartan|telmisartan|mesh-list
83183408|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83183409|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83183410|NCT03461081|Atorvastatin|atorvastatin|mesh-list
83183411|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83183412|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83183413|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
83183414|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183415|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83183416|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83183417|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183418|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83183419|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83183420|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83183421|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83183422|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183423|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
83183424|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83183425|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83183426|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
83183427|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83183428|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
83183429|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183430|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
83183431|NCT04557527|Protective Agents|protective agents|mesh-ancestor
83183432|NCT02522039|Timolol|timolol|mesh-list
83183433|NCT02522039|Dorzolamide|dorzolamide|mesh-list
83183434|NCT02522039|Latanoprost|latanoprost|mesh-list
83183435|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83183436|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83183437|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183438|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183439|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183440|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183441|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83183442|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83183443|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83183444|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83183445|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83183446|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183447|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83183448|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83183450|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
83183451|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183452|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183453|NCT04430699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183454|NCT04430699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183455|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83183456|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
83183457|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183458|NCT04358003|Coal Tar|coal tar|mesh-list
83183459|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
83183460|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
83183461|NCT04519905|Paclitaxel|paclitaxel|mesh-list
83183462|NCT04519905|Carboplatin|carboplatin|mesh-list
83183463|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83183464|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183465|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
83183466|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
83183467|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
83183468|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183469|NCT04423341|Cannabidiol|cannabidiol|mesh-list
83183470|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
83183471|NCT03378479|Posaconazole|posaconazole|mesh-list
83183472|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
83183473|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183474|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83183475|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83183476|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83183477|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83183478|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83183479|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183480|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183481|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83183482|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
83183483|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183484|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183485|NCT03460145|Propofol|propofol|mesh-list
83183486|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83183487|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183488|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183489|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83183490|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
83183491|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
83183492|NCT04125771|Diclofenac|diclofenac|mesh-list
83183493|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83183494|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83183495|NCT04125771|Analgesics|analgesics|mesh-ancestor
83183496|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
83183497|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183498|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183499|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183500|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83183501|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83183502|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183503|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183504|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83183505|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83183506|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83183507|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83183508|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183509|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183510|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183511|NCT05115123|Analgesics|analgesics|mesh-ancestor
83183512|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
83183513|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183519|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83183520|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83183521|NCT04636671|Prednisolone|prednisolone|mesh-list
83183522|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
83183523|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83183524|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
83183525|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183526|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
83183527|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
83183528|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183529|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183530|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83183531|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
83183532|NCT04636671|Hormones|hormones|mesh-ancestor
83183533|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183534|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83183535|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183536|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83183537|NCT04636671|Protective Agents|protective agents|mesh-ancestor
83183538|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83183539|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83183540|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183541|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83183542|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183543|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183549|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
83183550|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83183551|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183552|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183553|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83183554|NCT03645603|Analgesics|analgesics|mesh-ancestor
83183555|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
83183556|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183557|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83183558|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83183559|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83183560|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183561|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183562|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183563|NCT04019873|Lamivudine|lamivudine|mesh-list
83183564|NCT04019873|Rilpivirine|rilpivirine|mesh-list
83183565|NCT04019873|Dolutegravir|dolutegravir|mesh-list
83183566|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83183567|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83183568|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183569|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183570|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
83183571|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183572|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83183573|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83183574|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83183575|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83183576|NCT04771689|Buprenorphine|buprenorphine|mesh-list
83183577|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83183578|NCT04771689|Naloxone|naloxone|mesh-list
83183579|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83183580|NCT04771689|Narcotics|narcotics|mesh-ancestor
83183581|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183582|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183583|NCT04771689|Analgesics|analgesics|mesh-ancestor
83183584|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
83183585|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183586|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83183587|NCT04674345|Sorafenib|sorafenib|mesh-list
83183588|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183589|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83183590|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183591|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183592|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
83183593|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
83183594|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183595|NCT04165239|Protective Agents|protective agents|mesh-ancestor
83183596|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183597|NCT03756311|Paclitaxel|paclitaxel|mesh-list
83183598|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83183599|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83183600|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183601|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
83183602|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83183603|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
83183604|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183605|NCT04576767|Anesthetics|anesthetics|mesh-list
83183606|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183607|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183608|NCT03248531|Adalimumab|adalimumab|mesh-list
83183609|NCT03248531|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83183610|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183611|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83183612|NCT03866525|Irinotecan|irinotecan|mesh-list
83183613|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83183614|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83183615|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183616|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183617|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183618|NCT03129347|Nalmefene|nalmefene|mesh-list
83183619|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83183620|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183621|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
83183622|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183623|NCT02262923|Metoclopramide|metoclopramide|mesh-list
83183624|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
83183625|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
83183626|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183627|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183628|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83183629|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83183630|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83183631|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
83183632|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183633|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183634|NCT02194595|Insulin|insulin|mesh-list
83183635|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83183636|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
83183637|NCT02194595|Exenatide|exenatide|mesh-list
83183638|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
83183639|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83183640|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183641|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83183642|NCT02194595|Incretins|incretins|mesh-ancestor
83183643|NCT02194595|Hormones|hormones|mesh-ancestor
83183644|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183645|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83183646|NCT02656329|Lugol's solution|lugol's solution|mesh-list
83183647|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183648|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183649|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183650|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83183651|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
83183652|NCT02656329|Coagulants|coagulants|mesh-ancestor
83183653|NCT02712905|Nivolumab|nivolumab|mesh-list
83183654|NCT02712905|Azacitidine|azacitidine|mesh-list
83183655|NCT02712905|Tretinoin|tretinoin|mesh-list
83183656|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183657|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183658|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183659|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183660|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83183661|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
83183662|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183663|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
83183664|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
83183665|NCT01166633|Atorvastatin|atorvastatin|mesh-list
83183666|NCT01166633|Pitavastatin|pitavastatin|mesh-list
83183667|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83183668|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83183669|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
83183670|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183671|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83183672|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83183673|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183674|NCT04315311|Pancrelipase|pancrelipase|mesh-list
83183675|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83183676|NCT03596073|Calcipotriene|calcipotriene|mesh-list
83183677|NCT03596073|Petrolatum|petrolatum|mesh-list
83183678|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
83183679|NCT03596073|Emollients|emollients|mesh-ancestor
83183680|NCT05320757|Olaparib|olaparib|mesh-list
83183681|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83183682|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183683|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183684|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183685|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
83183686|NCT03449693|Antacids|antacids|mesh-ancestor
83183687|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183688|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83183689|NCT03449537|Caseins|caseins|mesh-list
83183690|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
83183691|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
83183692|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183693|NCT02237183|Iloprost|iloprost|mesh-list
83183694|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83183695|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
83183696|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
83183697|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183698|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183699|NCT03371979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183700|NCT03371979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183701|NCT05104437|Vaccines|vaccines|mesh-list
83183702|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
83183703|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183704|NCT03179943|Atezolizumab|atezolizumab|mesh-list
83183705|NCT03179943|Guadecitabine|guadecitabine|mesh-list
83183706|NCT03179943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183707|NCT03179943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183708|NCT03179943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183709|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183710|NCT04528173|Ketorolac|ketorolac|mesh-list
83183711|NCT04528173|Fentanyl|fentanyl|mesh-list
83183712|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
83183713|NCT04528173|Morphine|morphine|mesh-list
83183714|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83183715|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183716|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183717|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83183718|NCT04528173|Analgesics|analgesics|mesh-ancestor
83183719|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
83183720|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183721|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83183722|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83183723|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83183724|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183725|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83416813|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83183726|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183727|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83183728|NCT04528173|Narcotics|narcotics|mesh-ancestor
83183729|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83183730|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83183731|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
83183732|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
83183733|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83183734|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183735|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83183736|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83183737|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183738|NCT05114499|Donepezil|donepezil|mesh-list
83183739|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83183740|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183741|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183742|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83183743|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183744|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183745|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
83183746|NCT04520997|Hyaluronic Acid|hyaluronic acid|mesh-list
83183747|NCT04520997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83183748|NCT04520997|Immunologic Factors|immunologic factors|mesh-ancestor
83183749|NCT04520997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183750|NCT04520997|Viscosupplements|viscosupplements|mesh-ancestor
83183751|NCT04520997|Protective Agents|protective agents|mesh-ancestor
83183752|NCT04649385|Tislelizumab|tislelizumab|mesh-list
83183753|NCT04649385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183754|NCT04649385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183755|NCT05109585|Antibodies|antibodies|mesh-list
83183756|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
83183757|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
83183758|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
83183759|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183760|NCT02142803|Bevacizumab|bevacizumab|mesh-list
83183761|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83183762|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
83183763|NCT02142803|Antibodies|antibodies|mesh-list
83183764|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
83183765|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83183766|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
83183767|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183768|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83183769|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83183770|NCT02142803|Growth Substances|growth substances|mesh-ancestor
83183771|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183772|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
83183773|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
83183774|NCT05283161|Dronabinol|dronabinol|mesh-list
83183775|NCT05283161|Cannabidiol|cannabidiol|mesh-list
83183776|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
83183777|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
83183778|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183779|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83183780|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83183781|NCT05283161|Analgesics|analgesics|mesh-ancestor
83183782|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
83183783|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183784|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83183785|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83183786|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183787|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183788|NCT05283161|Hormones|hormones|mesh-ancestor
83183789|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183790|NCT03691311|Denosumab|denosumab|mesh-list
83183791|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83183792|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183793|NCT03448835|Docetaxel|docetaxel|mesh-list
83183794|NCT03448835|Capecitabine|capecitabine|mesh-list
83183795|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
83183797|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183798|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83183799|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83183800|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83183801|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183802|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83183803|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
83183804|NCT03448835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183805|NCT03448835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183806|NCT03690453|Ivermectin|ivermectin|mesh-list
83183807|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83183808|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183809|NCT05211635|Vitamin D|vitamin d|mesh-list
83183810|NCT05211635|Vitamins|vitamins|mesh-ancestor
83183811|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
83183812|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183813|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83183814|NCT05184335|RP5063|rp5063|mesh-list
83183815|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83183816|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83183817|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183818|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183819|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83183820|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
83183821|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183822|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183823|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83183824|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83183825|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183826|NCT01709123|Chromium|chromium|mesh-list
83183827|NCT01709123|Trace Elements|trace elements|mesh-ancestor
83183828|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
83183829|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183830|NCT01301807|Panobinostat|panobinostat|mesh-list
83183831|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183832|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83183833|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183834|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183835|NCT04962893|Vaccines|vaccines|mesh-list
83183836|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
83183837|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183838|NCT03443141|Vitamin E|vitamin e|mesh-list
83183839|NCT03443141|Vitamins|vitamins|mesh-ancestor
83183840|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
83183841|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183842|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
83183843|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183844|NCT03443141|Protective Agents|protective agents|mesh-ancestor
83183845|NCT04937543|Beclomethasone|beclomethasone|mesh-list
83183846|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
83183847|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
83183848|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83183849|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
83183850|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183851|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183852|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83183853|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
83183854|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83183855|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83183856|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83183857|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183858|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183859|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183860|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83183861|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
83183862|NCT04937543|Hormones|hormones|mesh-ancestor
83183863|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83183864|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83183865|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83183866|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83183867|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
83183868|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83183869|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
83183870|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83183871|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183872|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183873|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83183874|NCT04923737|Analgesics|analgesics|mesh-ancestor
83183875|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
83183876|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183877|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83183878|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83183879|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83183880|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183881|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183882|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183883|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
83183884|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183885|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183886|NCT02452424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183887|NCT02452424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183888|NCT04921943|Azithromycin|azithromycin|mesh-list
83183889|NCT04921943|Rifampin|rifampin|mesh-list
83183890|NCT04921943|Ethambutol|ethambutol|mesh-list
83183891|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83183892|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183893|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83183894|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
83183895|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
83183896|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83183897|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183898|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183899|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83183900|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83183901|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83183902|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83183903|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83183904|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83183905|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83183906|NCT02419508|Bimatoprost|bimatoprost|mesh-list
83183907|NCT02419508|Travoprost|travoprost|mesh-list
83183908|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83183909|NCT02419508|Latanoprost|latanoprost|mesh-list
83183910|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83183911|NCT02419508|Brinzolamide|brinzolamide|mesh-list
83183912|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83183913|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83183914|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83183915|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83183916|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
83183917|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183918|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183919|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183920|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83183921|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183922|NCT03442283|Vitamins|vitamins|mesh-list
83183923|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
83183924|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183925|NCT03441815|Histamine|histamine|mesh-list
83183926|NCT03441815|Glutarimide|glutarimide|mesh-list
83183927|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
83183928|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
83183929|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83183930|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183931|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183932|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83183933|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183934|NCT02426918|Vancomycin|vancomycin|mesh-list
83183935|NCT02426918|Linezolid|linezolid|mesh-list
83183936|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83183937|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183938|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83183939|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183940|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183941|NCT02387762|Methotrexate|methotrexate|mesh-list
83183942|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
83183943|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83183944|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
83183945|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83183946|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183947|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83183948|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
83183949|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183950|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183951|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
83183952|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183953|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83183954|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83183955|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
83183956|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83183957|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83183958|NCT02418182|Acetaminophen|acetaminophen|mesh-list
83183959|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83183960|NCT02418182|Analgesics|analgesics|mesh-ancestor
83183961|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
83183962|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83183963|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183964|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
83183965|NCT02387372|Tazobactam|tazobactam|mesh-list
83183966|NCT02387372|Ceftolozane|ceftolozane|mesh-list
83183967|NCT02387372|Cephalosporins|cephalosporins|mesh-list
83183968|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83183969|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
83183970|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83183971|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83183972|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83183973|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83183974|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183975|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83183976|NCT03446495|Trabectedin|trabectedin|mesh-list
83183977|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83183978|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
83183979|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183980|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183981|NCT03441035|Anesthetics|anesthetics|mesh-list
83183982|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83183983|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83183984|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83183985|NCT05105633|Tenecteplase|tenecteplase|mesh-list
83183986|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83183987|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83183988|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183989|NCT04807673|Paclitaxel|paclitaxel|mesh-list
83183990|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
83183991|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83183992|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83183993|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83183994|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83183995|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83183996|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83183997|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83183998|NCT04807673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83183999|NCT02656173|Tamsulosin|tamsulosin|mesh-list
83184000|NCT02656173|Mirabegron|mirabegron|mesh-list
83184001|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83184002|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83184003|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83184004|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184005|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184006|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184007|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184008|NCT02656173|Urological Agents|urological agents|mesh-ancestor
83184009|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83184010|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83184011|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83184012|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83184013|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184014|NCT04418895|Leucovorin|leucovorin|mesh-list
83184015|NCT04418895|Fluorouracil|fluorouracil|mesh-list
83184016|NCT04418895|Capecitabine|capecitabine|mesh-list
83184017|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
83184018|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
83184019|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184020|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
83184021|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184022|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83184023|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184024|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83184025|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
83184026|NCT04418895|Antidotes|antidotes|mesh-ancestor
83184027|NCT04418895|Protective Agents|protective agents|mesh-ancestor
83184028|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
83184029|NCT04418895|Vitamins|vitamins|mesh-ancestor
83184030|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
83184031|NCT04715633|Apatinib|apatinib|mesh-list
83184032|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83184033|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184034|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83184035|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184036|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184037|NCT04715633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83184038|NCT03439943|Lixisenatide|lixisenatide|mesh-list
83184039|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83184040|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184041|NCT03439787|Epinephrine|epinephrine|mesh-list
83184042|NCT03439787|Bupivacaine|bupivacaine|mesh-list
83184043|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184044|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
83416966|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
83184045|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184046|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184047|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
83184048|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184049|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83184050|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83184051|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184052|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184053|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184054|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83184055|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83184056|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
83184057|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83184058|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184059|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
83184060|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
83184061|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83184062|NCT05082155|Bupivacaine|bupivacaine|mesh-list
83184063|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184064|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
83184065|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184066|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184067|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
83184068|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184069|NCT02656017|Metformin|metformin|mesh-list
83184070|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83184071|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184072|NCT03439709|Lanreotide|lanreotide|mesh-list
83184073|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184074|NCT04451447|SMOFlipid|smoflipid|mesh-list
83184075|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83184076|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83184077|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83184078|NCT04516941|Colchicine|colchicine|mesh-list
83184079|NCT04516941|Edoxaban|edoxaban|mesh-list
83184080|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
83184081|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184082|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
83184083|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
83184084|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
83184085|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184086|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184087|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83184088|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
83184089|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83184090|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
83184091|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184092|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
83184093|NCT03444467|Glucagon|glucagon|mesh-list
83184094|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83184095|NCT03444467|Hormones|hormones|mesh-ancestor
83184096|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184097|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184098|NCT02657343|Trastuzumab|trastuzumab|mesh-list
83184099|NCT02657343|Fulvestrant|fulvestrant|mesh-list
83184100|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83184101|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184102|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184103|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83184104|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83184105|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
83184106|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184107|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184108|NCT03445169|Belzutifan|belzutifan|mesh-list
83184109|NCT03445169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184110|NCT04542837|Lenvatinib|lenvatinib|mesh-list
83184111|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184112|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83184113|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184114|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184115|NCT02655237|Leuprolide|leuprolide|mesh-list
83184116|NCT02655237|Relugolix|relugolix|mesh-list
83184117|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83184118|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
83184119|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83184120|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184121|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184122|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184123|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
83184124|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
83184125|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184126|NCT03443999|Sirolimus|sirolimus|mesh-list
83184127|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184128|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184129|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83184130|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184131|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
83184132|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83184133|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
83184134|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184135|NCT03890133|Pregabalin|pregabalin|mesh-list
83184136|NCT03890133|Analgesics|analgesics|mesh-ancestor
83184137|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
83184138|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184139|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184140|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
83184141|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83184142|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184143|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184144|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83184145|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83184146|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83184147|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184148|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83184149|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83184150|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83184151|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184152|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184153|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184154|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184155|NCT03443921|Paclitaxel|paclitaxel|mesh-list
83184156|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83184157|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184158|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83184159|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83184160|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83184161|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184162|NCT03443843|Fluticasone|fluticasone|mesh-list
83184163|NCT03443843|Xhance|xhance|mesh-list
83184164|NCT03443843|Loratadine|loratadine|mesh-list
83184165|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
83184166|NCT03443843|Ephedrine|ephedrine|mesh-list
83184167|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83416967|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
83184168|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83184170|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184171|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184172|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83184173|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184174|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
83184175|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83184176|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
83184177|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83184178|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83184179|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
83184180|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
83184181|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184182|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184183|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
83184184|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83184185|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83184186|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
83184187|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184188|NCT03438227|Dextrans|dextrans|mesh-list
83184189|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
83184190|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
83184191|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
83184192|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
83184193|NCT03438227|Hematinics|hematinics|mesh-ancestor
83184194|NCT03433235|Edoxaban|edoxaban|mesh-list
83184195|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83184196|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
83184197|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83184198|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
83184199|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184200|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184201|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
83184202|NCT03783351|Clopidogrel|clopidogrel|mesh-list
83184203|NCT03783351|Ticagrelor|ticagrelor|mesh-list
83184204|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83184205|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83184206|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83184207|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83184208|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
83184209|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184210|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184211|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184212|NCT03342417|Nivolumab|nivolumab|mesh-list
83184213|NCT03342417|Ipilimumab|ipilimumab|mesh-list
83184214|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83184215|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184216|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83184217|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184218|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83184219|NCT03234309|Hematinics|hematinics|mesh-ancestor
83184220|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83184221|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83184222|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
83184223|NCT02657031|Promethazine|promethazine|mesh-list
83184224|NCT02657031|Ketamine|ketamine|mesh-list
83184225|NCT02657031|Ondansetron|ondansetron|mesh-list
83184226|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
83184227|NCT02657031|Analgesics|analgesics|mesh-ancestor
83184228|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
83184229|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184230|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184231|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83184232|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83184233|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
83184234|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
83184235|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184236|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83184237|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83184238|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184239|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184240|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
83184241|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
83184242|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83184243|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
83184244|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
83184245|NCT02657031|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83184246|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83184247|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
83184248|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83184249|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83184250|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184251|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83184252|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
83184253|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
83184254|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83184255|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83184256|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83184257|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83184258|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83184259|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
83184260|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
83184261|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83184262|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83184263|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83184264|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184265|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184266|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83184267|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184268|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184269|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83184270|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184271|NCT03433001|Dexamethasone|dexamethasone|mesh-list
83184272|NCT03433001|Lenalidomide|lenalidomide|mesh-list
83184273|NCT03433001|Ixazomib|ixazomib|mesh-list
83184274|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184275|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
83184276|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
83184277|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184278|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184279|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83184280|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
83184281|NCT03433001|Hormones|hormones|mesh-ancestor
83184282|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184283|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184284|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184285|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
83184286|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83184287|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83184288|NCT03433001|Growth Substances|growth substances|mesh-ancestor
83184289|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83184290|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
83184291|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184292|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184293|NCT03797469|Niacinamide|niacinamide|mesh-list
83184294|NCT03797469|Niacin|niacin|mesh-list
83184295|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
83184296|NCT03797469|Vitamins|vitamins|mesh-ancestor
83184297|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
83184298|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184299|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
83184300|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83184301|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
83184302|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184303|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83184304|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
83184305|NCT03432923|Benzocaine|benzocaine|mesh-list
83184306|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184307|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
83184308|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184309|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184310|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
83184311|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184312|NCT02384577|Budesonide|budesonide|mesh-list
83184313|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
83184314|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184315|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83184316|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
83184317|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184318|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184319|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83184320|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184321|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
83184322|NCT02384577|Hormones|hormones|mesh-ancestor
83184323|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184324|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83184325|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83184326|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83184327|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184328|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184329|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184330|NCT03437213|Anesthetics|anesthetics|mesh-list
83184331|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184332|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184333|NCT02030457|Beclomethasone|beclomethasone|mesh-list
83184334|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184335|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
83184336|NCT02030457|Hormones|hormones|mesh-ancestor
83184337|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184338|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184339|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83184340|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184341|NCT03432767|Chrysarobin|chrysarobin|mesh-list
83184342|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83184343|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184344|NCT03432767|Analgesics|analgesics|mesh-ancestor
83184345|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
83184346|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184347|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184348|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184349|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184350|NCT03437057|Aspirin|aspirin|mesh-list
83184351|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83184352|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184353|NCT03437057|Analgesics|analgesics|mesh-ancestor
83184354|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
83184355|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184356|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184357|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184358|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184359|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83184360|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83184361|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184362|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83184363|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83184364|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184365|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
83184366|NCT03579693|Niacinamide|niacinamide|mesh-list
83184368|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
83184369|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
83184370|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
83184371|NCT03579693|Vitamins|vitamins|mesh-ancestor
83184372|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
83184373|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184374|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83184375|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
83184376|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184377|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83184378|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
83184379|NCT03432689|Cycloserine|cycloserine|mesh-list
83184380|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83184381|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184382|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83184383|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
83184384|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184385|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
83184386|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184387|NCT02991807|Everolimus|everolimus|mesh-list
83184388|NCT02991807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83184389|NCT02991807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83184390|NCT02991807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184391|NCT02991807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184392|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83184393|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
83184394|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184395|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184396|NCT04380311|Tacrolimus|tacrolimus|mesh-list
83184397|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83184398|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
83184399|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184400|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83184401|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184402|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184403|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83184404|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83184405|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83184406|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184407|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184408|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184409|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184410|NCT05018013|Analgesics|analgesics|mesh-ancestor
83184411|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
83184412|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184413|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
83184414|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83184416|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83184417|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83184418|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83184419|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184420|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184421|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184422|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184423|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
83184424|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83184426|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
83184427|NCT04360421|Bupivacaine|bupivacaine|mesh-list
83184428|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184429|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
83184430|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184431|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184432|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
83184433|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184434|NCT02387216|Docetaxel|docetaxel|mesh-list
83184435|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184436|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
83184437|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
83184438|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
83184439|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184440|NCT03431909|Aspirin|aspirin|mesh-list
83184441|NCT03431909|Kallikreins|kallikreins|mesh-list
83184442|NCT03431909|Clopidogrel|clopidogrel|mesh-list
83184443|NCT03431909|Atorvastatin|atorvastatin|mesh-list
83184444|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83184445|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184446|NCT03431909|Analgesics|analgesics|mesh-ancestor
83184447|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
83184448|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184449|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184450|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184451|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184452|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83184453|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83184454|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184455|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83184456|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83184457|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184458|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
83184459|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83184460|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83184461|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
83184462|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83184463|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83184464|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83184465|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83184466|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83184467|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
83184468|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184469|NCT03431909|Coagulants|coagulants|mesh-ancestor
83184470|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
83184471|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
83184472|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83184473|NCT03436121|Midazolam|midazolam|mesh-list
83184474|NCT03436121|Ketamine|ketamine|mesh-list
83184475|NCT03436121|Analgesics|analgesics|mesh-ancestor
83184476|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
83184477|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184478|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184479|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83184480|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83184481|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
83184482|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
83184483|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184484|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83184485|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83184486|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184487|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184489|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83184490|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83184491|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83184492|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83184493|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
83184494|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
83184495|NCT02417246|Metoprolol|metoprolol|mesh-list
83184496|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83184497|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83184498|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
83184499|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
83184500|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184501|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184502|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83184503|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83184504|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83184505|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184506|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184507|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184508|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
83184509|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184510|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184511|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83184512|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83184513|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184514|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184515|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184516|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83184517|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83184518|NCT02424734|Ampicillin|ampicillin|mesh-list
83184519|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83184520|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184521|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184522|NCT03431597|Micronutrients|micronutrients|mesh-list
83184523|NCT03431597|Trace Elements|trace elements|mesh-list
83184524|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184525|NCT02424578|Diclofenac|diclofenac|mesh-list
83184526|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83184527|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184528|NCT02424578|Analgesics|analgesics|mesh-ancestor
83184529|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
83184530|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184531|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184532|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184533|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184534|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83184535|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184536|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184537|NCT03431285|Ketamine|ketamine|mesh-list
83184538|NCT03431285|Morphine|morphine|mesh-list
83184539|NCT03431285|Analgesics|analgesics|mesh-ancestor
83184540|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
83184541|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184542|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184543|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83184544|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83184545|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
83184546|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
83184547|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184548|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83184549|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83184550|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184551|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184552|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83184553|NCT03431285|Narcotics|narcotics|mesh-ancestor
83184554|NCT02416934|Dexamethasone|dexamethasone|mesh-list
83184555|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184556|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
83184557|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
83184558|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184559|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184560|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83184561|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
83184563|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184564|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184565|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184566|NCT02819635|Upadacitinib|upadacitinib|mesh-list
83184567|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83184568|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83184569|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184570|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184571|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184572|NCT03874325|Durvalumab|durvalumab|mesh-list
83184573|NCT03874325|Letrozole|letrozole|mesh-list
83184574|NCT03874325|Anastrozole|anastrozole|mesh-list
83184575|NCT03874325|Exemestane|exemestane|mesh-list
83184576|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83184577|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184578|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83184579|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83184580|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184581|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184582|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83184583|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
83184584|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184585|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184586|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184587|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
83184588|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83184589|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
83184590|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184591|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184592|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83184593|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184594|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83184595|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83184596|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83184597|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184598|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184599|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184600|NCT03861611|Ibuprofen|ibuprofen|mesh-list
83184601|NCT03861611|Diclofenac|diclofenac|mesh-list
83184602|NCT03861611|Ketorolac|ketorolac|mesh-list
83184603|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83184604|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184605|NCT03861611|Analgesics|analgesics|mesh-ancestor
83184606|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
83184607|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184608|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184609|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184610|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184611|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83184612|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184613|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184614|NCT03430817|Amantadine|amantadine|mesh-list
83184615|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83184616|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83184617|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83184618|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
83184619|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184620|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
83184621|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184622|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184623|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184624|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184625|NCT03430817|Analgesics|analgesics|mesh-ancestor
83184626|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
83184627|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184628|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
83184629|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83184630|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83184631|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184632|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83184633|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184634|NCT03799835|Atezolizumab|atezolizumab|mesh-list
83184635|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
83184636|NCT03799835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83184637|NCT03799835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184638|NCT03799835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83184639|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184640|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83184641|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
83184642|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184643|NCT03430505|Albuterol|albuterol|mesh-list
83184644|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83184645|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
83184646|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184647|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184648|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83184649|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184650|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
83184651|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83184652|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83184653|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83184654|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83184655|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184656|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184657|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184658|NCT03434951|Morphine|morphine|mesh-list
83184659|NCT03434951|Bupivacaine|bupivacaine|mesh-list
83184660|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184661|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
83184662|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184663|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184664|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
83184665|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184666|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83184667|NCT03434951|Narcotics|narcotics|mesh-ancestor
83184668|NCT03434951|Analgesics|analgesics|mesh-ancestor
83184669|NCT02234323|Factor VIII|factor viii|mesh-list
83184670|NCT02234323|Coagulants|coagulants|mesh-ancestor
83184671|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
83184672|NCT02413346|Sarecycline|sarecycline|mesh-list
83184673|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184674|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184675|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
83184676|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83184677|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83184678|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83184679|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184680|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184681|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83184682|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184683|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184684|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
83184685|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184686|NCT03429179|Butorphanol|butorphanol|mesh-list
83184687|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83184688|NCT03429179|Narcotics|narcotics|mesh-ancestor
83184689|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184690|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184691|NCT03429179|Analgesics|analgesics|mesh-ancestor
83184692|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
83184693|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184694|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
83184695|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184696|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83184697|NCT03429101|Trastuzumab|trastuzumab|mesh-list
83184698|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83184699|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83184700|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184701|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
83184702|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
83184703|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
83184704|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184705|NCT03429101|Immunotoxins|immunotoxins|mesh-ancestor
83184706|NCT03429101|Immunoconjugates|immunoconjugates|mesh-ancestor
83184707|NCT03429101|Immunologic Factors|immunologic factors|mesh-ancestor
83184708|NCT03429101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184709|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83184710|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
83184711|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184712|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83184713|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83184714|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83184715|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83184716|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
83184717|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83184718|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184719|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83184720|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83184721|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83184722|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83184723|NCT02732639|Interferons|interferons|mesh-list
83184724|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184725|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
83184726|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184728|NCT03428633|Ropivacaine|ropivacaine|mesh-list
83184729|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83184730|NCT03428633|Narcotics|narcotics|mesh-ancestor
83184731|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184732|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184733|NCT03428633|Analgesics|analgesics|mesh-ancestor
83184734|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
83184735|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184736|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184737|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
83184738|NCT02412878|Dexamethasone|dexamethasone|mesh-list
83184739|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184740|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
83184741|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
83184742|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184743|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184744|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83184745|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
83184746|NCT02412878|Hormones|hormones|mesh-ancestor
83184747|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184748|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184749|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184750|NCT03423329|Ibuprofen|ibuprofen|mesh-list
83184751|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83184752|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184753|NCT03423329|Analgesics|analgesics|mesh-ancestor
83184754|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
83184755|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184756|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184757|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184758|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83184759|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83184760|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184761|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184762|NCT02380742|Lidocaine|lidocaine|mesh-list
83184763|NCT02380742|Prilocaine|prilocaine|mesh-list
83184764|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83184765|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184766|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
83184767|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184768|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184769|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
83184770|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184771|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83184772|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83184773|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83184774|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184775|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184776|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83184777|NCT02944019|Edoxaban|edoxaban|mesh-list
83184778|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83184779|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
83184780|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83184781|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
83184782|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184783|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184785|NCT02022059|Lidocaine|lidocaine|mesh-list
83184786|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184787|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
83184788|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184789|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184790|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
83184791|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184792|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83184793|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83184794|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83184795|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184796|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184797|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83184798|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83184799|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
83184800|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83184801|NCT03422315|Propofol|propofol|mesh-list
83184802|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83184803|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184804|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184805|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83184806|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
83184807|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
83184808|NCT03427385|Ropivacaine|ropivacaine|mesh-list
83184809|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184810|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
83184811|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184812|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184813|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
83417193|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83184814|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184816|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184817|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184818|NCT04449185|Amoxicillin|amoxicillin|mesh-list
83184819|NCT04449185|Clarithromycin|clarithromycin|mesh-list
83184820|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184821|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184822|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83184823|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184824|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184825|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83184826|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83184827|NCT03426761|Vancomycin|vancomycin|mesh-list
83184828|NCT03426761|Cefazolin|cefazolin|mesh-list
83184829|NCT03426761|Daptomycin|daptomycin|mesh-list
83184830|NCT03426761|Dalbavancin|dalbavancin|mesh-list
83184831|NCT03426761|Nafcillin|nafcillin|mesh-list
83184832|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184833|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184834|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
83184835|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
83184836|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
83184837|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184838|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184839|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83184840|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184841|NCT03426527|Analgesics|analgesics|mesh-ancestor
83184842|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
83184843|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184844|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83184845|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83184846|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83184847|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
83184848|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184849|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184850|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184851|NCT02805257|Mitomycins|mitomycins|mesh-list
83184852|NCT02805257|Mitomycin|mitomycin|mesh-list
83184853|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83184854|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184855|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
83184856|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184857|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83184859|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83184860|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
83184861|NCT02636387|Coagulants|coagulants|mesh-ancestor
83184862|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83184863|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
83184864|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184865|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
83184866|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
83184867|NCT03425747|Calcium|calcium|mesh-list
83184868|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83184869|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184870|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83184871|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184872|NCT03425747|Antacids|antacids|mesh-ancestor
83184873|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83184874|NCT03425669|Methylphenidate|methylphenidate|mesh-list
83184875|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83184876|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184877|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83184878|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83184879|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83417271|NCT04779047|Lopinavir|lopinavir|mesh-list
83184880|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184881|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
83184882|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184883|NCT03424889|Xylometazoline|xylometazoline|mesh-list
83184884|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
83184885|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83184886|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
83184887|NCT03424733|Acetaminophen|acetaminophen|mesh-list
83184888|NCT03424733|Interferons|interferons|mesh-list
83184889|NCT03424733|Interferon-beta|interferon-beta|mesh-list
83184890|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
83184891|NCT03424733|Prednisone|prednisone|mesh-list
83184892|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184893|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
83184894|NCT03424733|Hormones|hormones|mesh-ancestor
83184895|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184896|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184897|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184898|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184899|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
83184900|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184901|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83184902|NCT03424733|Analgesics|analgesics|mesh-ancestor
83184903|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
83184904|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184905|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
83184906|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
83184907|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83184908|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83184909|NCT03441841|Lidocaine|lidocaine|mesh-list
83184910|NCT03441841|Prilocaine|prilocaine|mesh-list
83184911|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83184912|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
83184913|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
83184914|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184915|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184916|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
83184917|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184918|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83184919|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83184920|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83184921|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83184922|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184923|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83184924|NCT02692339|Dexamethasone|dexamethasone|mesh-list
83184925|NCT02692339|Lenalidomide|lenalidomide|mesh-list
83184926|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184927|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
83184928|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
83184929|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83184930|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184932|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
83184933|NCT02692339|Hormones|hormones|mesh-ancestor
83184934|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184935|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184936|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184937|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
83184938|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83184939|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83184940|NCT02692339|Growth Substances|growth substances|mesh-ancestor
83184941|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83184942|NCT03444025|Goserelin|goserelin|mesh-list
83184943|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83184944|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184945|NCT03438253|Anesthetics|anesthetics|mesh-list
83184946|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184947|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184949|NCT02535325|Pemetrexed|pemetrexed|mesh-list
83184950|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184951|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184952|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184953|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83184954|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83184955|NCT03441529|Tazobactam|tazobactam|mesh-list
83184956|NCT03441529|Piperacillin|piperacillin|mesh-list
83184957|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83184958|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83184959|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184960|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83184961|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184962|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184963|NCT03441373|Histamine|histamine|mesh-list
83184964|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
83184965|NCT03441373|Glutarimide|glutarimide|mesh-list
83184966|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
83184967|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
83184968|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83184969|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184970|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184971|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83184972|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184973|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
83184974|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83184975|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83184976|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83184977|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83184978|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
83184979|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83184980|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83184981|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184982|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184983|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
83184984|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83184985|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184986|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83184987|NCT03437785|Ethanol|ethanol|mesh-list
83184988|NCT03437785|Rebamipide|rebamipide|mesh-list
83184989|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83184990|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83184991|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83184992|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83184993|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83184994|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83184995|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
83184996|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83184997|NCT03437785|Protective Agents|protective agents|mesh-ancestor
83184998|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83184999|NCT03437707|Acetaminophen|acetaminophen|mesh-list
83185000|NCT03437707|Ibuprofen|ibuprofen|mesh-list
83185001|NCT03437707|Morphine|morphine|mesh-list
83185002|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83185003|NCT03437707|Narcotics|narcotics|mesh-ancestor
83185004|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185005|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185007|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
83185008|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185009|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185010|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185011|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185012|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185013|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83185014|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185015|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185016|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
83185018|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83185019|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185020|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83185021|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
83185022|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185023|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185024|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185025|NCT03441217|Scopolamine|scopolamine|mesh-list
83185026|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83185027|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83185028|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
83185029|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
83185030|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185031|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185032|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83185033|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
83185034|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83185035|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
83185036|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185037|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185038|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83185039|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
83185040|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
83185041|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185042|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
83185043|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185044|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185045|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83185046|NCT02521441|Lenograstim|lenograstim|mesh-list
83185047|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83185048|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
83185049|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185050|NCT03432871|Niacinamide|niacinamide|mesh-list
83185051|NCT03432871|Niacin|niacin|mesh-list
83185052|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
83185053|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
83185054|NCT03432871|Vitamins|vitamins|mesh-ancestor
83185055|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
83185056|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185057|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83185058|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
83185059|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185060|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83185061|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83185062|NCT04451239|Cyclosporine|cyclosporine|mesh-list
83185063|NCT04451239|Cyclosporins|cyclosporins|mesh-list
83185064|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185065|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185066|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83185067|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
83185068|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185069|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
83185070|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185071|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
83185072|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185073|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83185074|NCT03440515|Prednisone|prednisone|mesh-list
83185076|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
83185077|NCT03440515|Hormones|hormones|mesh-ancestor
83185078|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185079|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185080|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83185081|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185082|NCT03432793|Itraconazole|itraconazole|mesh-list
83185083|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
83185084|NCT03432793|Caffeine|caffeine|mesh-list
83185085|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83185086|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185087|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83185088|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185089|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185090|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83185091|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83185092|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
83185093|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185094|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
83185095|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185096|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83185097|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83185098|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83185099|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
83185100|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185101|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83185102|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83185103|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83185104|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185105|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83185106|NCT03432793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83185107|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83185108|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83185109|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
83185110|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83185111|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
83185112|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83185113|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83185114|NCT03436693|Canagliflozin|canagliflozin|mesh-list
83185115|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83185116|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185117|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83185118|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185119|NCT03432637|Anesthetics|anesthetics|mesh-list
83185120|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185121|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185122|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
83185123|NCT03436303|Progestins|progestins|mesh-ancestor
83185124|NCT03436303|Hormones|hormones|mesh-ancestor
83185125|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185126|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185127|NCT03436225|Dexamethasone|dexamethasone|mesh-list
83185128|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
83185129|NCT03436225|Budesonide|budesonide|mesh-list
83185130|NCT03436225|Albuterol|albuterol|mesh-list
83185131|NCT03436225|BB 1101|bb 1101|mesh-list
83185132|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185133|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
83185134|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
83185135|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185136|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185137|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83185138|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
83185139|NCT03436225|Hormones|hormones|mesh-ancestor
83185140|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185141|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83185142|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185143|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
83185144|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185145|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185146|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83185147|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83185148|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
83185149|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
83185150|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83185151|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83185152|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83185153|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83185154|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
83185155|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185156|NCT03440359|Letrozole|letrozole|mesh-list
83185157|NCT03440359|Progesterone|progesterone|mesh-list
83185158|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185159|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83185160|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83185161|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185162|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185163|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83185164|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
83185165|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185166|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185167|NCT03440359|Progestins|progestins|mesh-ancestor
83185168|NCT03440359|Hormones|hormones|mesh-ancestor
83185169|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83185170|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
83185171|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185172|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83185173|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
83185174|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
83185175|NCT03431623|Hematinics|hematinics|mesh-ancestor
83185176|NCT04451395|Micronutrients|micronutrients|mesh-list
83185177|NCT04451395|Trace Elements|trace elements|mesh-list
83185178|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185179|NCT04451083|Camostat|camostat|mesh-list
83185180|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
83185181|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185182|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185183|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83185184|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83185185|NCT03435289|Paclitaxel|paclitaxel|mesh-list
83185186|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83185187|NCT03435289|Gemcitabine|gemcitabine|mesh-list
83185188|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83185189|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185190|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
83185191|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
83185192|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
83185193|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185194|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83185195|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
83185196|NCT03435133|Ticagrelor|ticagrelor|mesh-list
83185197|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83185198|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83185199|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83185200|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83185201|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83185202|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
83185203|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185204|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185205|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185206|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
83185207|NCT03431077|Giapreza|giapreza|mesh-list
83185208|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
83185209|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83185210|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83185211|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
83185212|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185213|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185214|NCT03439501|Avelumab|avelumab|mesh-list
83185215|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83185216|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185217|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83185218|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83185219|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185220|NCT04255381|Pancrelipase|pancrelipase|mesh-list
83185221|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83185222|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
83185223|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83185224|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185225|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185226|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185227|NCT03757897|Analgesics|analgesics|mesh-ancestor
83185228|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
83185229|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185230|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83185231|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83185232|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83185233|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
83185234|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185235|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185236|NCT03434197|Diclofenac|diclofenac|mesh-list
83185237|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185238|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185239|NCT03434197|Analgesics|analgesics|mesh-ancestor
83185240|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
83185241|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185242|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185243|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185244|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185245|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83185246|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185247|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185248|NCT03430609|Hormones|hormones|mesh-list
83185249|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185250|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185251|NCT03438955|Telmisartan|telmisartan|mesh-list
83185252|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83185253|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83185254|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83185255|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185256|NCT03430297|Dacarbazine|dacarbazine|mesh-list
83185257|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83185258|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
83185259|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185260|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185261|NCT04219735|Minocycline|minocycline|mesh-list
83185262|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83185263|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185264|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83185265|NCT03621553|Vitamin D|vitamin d|mesh-list
83185266|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
83185267|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
83185268|NCT03621553|Vitamins|vitamins|mesh-list
83185269|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
83185270|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185271|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83185272|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83185273|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
83185274|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83185275|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
83185276|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185277|NCT03423667|Expectorants|expectorants|mesh-ancestor
83185278|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
83185279|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83185280|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
83185281|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185282|NCT03423667|Protective Agents|protective agents|mesh-ancestor
83185283|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185284|NCT03423667|Antidotes|antidotes|mesh-ancestor
83185285|NCT01559363|XL647|xl647|mesh-list
83185286|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185287|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83185288|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185289|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185290|NCT03569839|Propofol|propofol|mesh-list
83185291|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83185292|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185293|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185294|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83185295|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
83185296|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
83185297|NCT01504919|Nicotine|nicotine|mesh-list
83185298|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83185299|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
83185300|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185301|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185302|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83185303|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83185304|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
83185305|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185306|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185307|NCT02732327|Vancomycin|vancomycin|mesh-list
83185308|NCT02732327|Meropenem|meropenem|mesh-list
83185309|NCT02732327|Linezolid|linezolid|mesh-list
83185310|NCT02732327|Tazobactam|tazobactam|mesh-list
83185311|NCT02732327|Piperacillin|piperacillin|mesh-list
83185312|NCT02732327|Cefepime|cefepime|mesh-list
83185313|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83185314|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83185315|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185316|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83185317|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185318|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185319|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83185320|NCT03428503|Acetaminophen|acetaminophen|mesh-list
83185321|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83185322|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185323|NCT03428503|Analgesics|analgesics|mesh-ancestor
83185324|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
83185325|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185326|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185327|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
83185328|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185329|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185330|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185331|NCT03428425|Paclitaxel|paclitaxel|mesh-list
83185332|NCT03428425|Apatinib|apatinib|mesh-list
83185333|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83185334|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185335|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
83185336|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
83185337|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
83185338|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185339|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83185340|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185341|NCT03416777|Tocopherols|tocopherols|mesh-list
83185342|NCT03416777|Vitamin E|vitamin e|mesh-list
83185343|NCT03416777|Tocotrienols|tocotrienols|mesh-list
83185344|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
83185345|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
83185346|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185347|NCT03416777|Protective Agents|protective agents|mesh-ancestor
83185348|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185349|NCT03416777|Vitamins|vitamins|mesh-ancestor
83185350|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
83185351|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
83185352|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185353|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
83185354|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83185355|NCT03422887|Nalbuphine|nalbuphine|mesh-list
83185356|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83185357|NCT03422887|Narcotics|narcotics|mesh-ancestor
83185358|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185359|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185360|NCT03422887|Analgesics|analgesics|mesh-ancestor
83185361|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
83185362|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185363|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185364|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185365|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185366|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185367|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83185368|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185369|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185370|NCT02521207|Ibuprofen|ibuprofen|mesh-list
83185371|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185372|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185373|NCT02521207|Analgesics|analgesics|mesh-ancestor
83185374|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
83185375|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185376|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185377|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185378|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185379|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83185380|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185381|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185382|NCT03179605|Clobetasol|clobetasol|mesh-list
83185383|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185384|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
83185386|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185387|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185388|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
83185389|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
83185390|NCT03173053|Clarithromycin|clarithromycin|mesh-list
83185391|NCT03173053|Doxycycline|doxycycline|mesh-list
83185392|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
83185393|NCT03173053|Rifampin|rifampin|mesh-list
83185394|NCT03173053|Clindamycin|clindamycin|mesh-list
83185395|NCT03173053|Trimethoprim|trimethoprim|mesh-list
83185396|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
83185397|NCT03173053|Mupirocin|mupirocin|mesh-list
83185398|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
83185399|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83185400|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83185401|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185402|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
83185403|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83185404|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83185405|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185406|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185407|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83185408|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83185409|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
83185410|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83185411|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83185412|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83185413|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83185414|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185415|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83185416|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83185417|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
83185418|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
83185419|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83185420|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83185421|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83185422|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83185423|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83185424|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83185425|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83185426|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83185427|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83185428|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83185429|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83185430|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83185431|NCT03109795|Clonidine|clonidine|mesh-list
83185432|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83185433|NCT03109795|Diuretics|diuretics|mesh-ancestor
83185434|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
83185435|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185436|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83185437|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83185438|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185439|NCT03109795|Analgesics|analgesics|mesh-ancestor
83185440|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
83185441|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185442|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
83185443|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
83185444|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83185445|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83185446|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83185447|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83185448|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185449|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
83185450|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83185451|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83185453|NCT03428191|Remifentanil|remifentanil|mesh-list
83185454|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83185455|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185456|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185457|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185458|NCT03428191|Analgesics|analgesics|mesh-ancestor
83185459|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
83185460|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185461|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83185462|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83185463|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83185464|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83185465|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185466|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185467|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83185468|NCT03428191|Narcotics|narcotics|mesh-ancestor
83185469|NCT03422575|Etoricoxib|etoricoxib|mesh-list
83185470|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185471|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185472|NCT03422575|Analgesics|analgesics|mesh-ancestor
83185473|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
83185474|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185475|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185476|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185477|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185478|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83185479|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83185480|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185481|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185482|NCT02412722|Paclitaxel|paclitaxel|mesh-list
83185483|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83185484|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185485|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
83185486|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
83185487|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
83185488|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185489|NCT03422419|Heparin|heparin|mesh-list
83185490|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
83185491|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83185492|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83185493|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185494|NCT04449289|Lidocaine|lidocaine|mesh-list
83185495|NCT04449289|Ropivacaine|ropivacaine|mesh-list
83185496|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
83185497|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
83185498|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185499|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185500|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
83185501|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185502|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83185503|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83185504|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83185505|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83185506|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185507|NCT03128203|Oxytocin|oxytocin|mesh-list
83185508|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
83185509|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83185510|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185511|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
83185512|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83185513|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83185514|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83185515|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83185516|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185517|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
83185518|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185519|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185520|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83185521|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185522|NCT02935309|Capecitabine|capecitabine|mesh-list
83185523|NCT02935309|Lenvatinib|lenvatinib|mesh-list
83185524|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83185525|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
83185526|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185527|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185528|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83185529|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185530|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
83185532|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
83185533|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83185534|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185535|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83185536|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83185537|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185538|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
83185539|NCT03463993|Coagulants|coagulants|mesh-ancestor
83185540|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83185541|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83185542|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185543|NCT03417037|Nivolumab|nivolumab|mesh-list
83185544|NCT03417037|Linrodostat|linrodostat|mesh-list
83185545|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83185546|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185547|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83185548|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185549|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185550|NCT02378480|Linezolid|linezolid|mesh-list
83185551|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83185552|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185553|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83185554|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185555|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185556|NCT03421717|Chitosan|chitosan|mesh-list
83185557|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83185558|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83185559|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
83185560|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185561|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83185562|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
83185563|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
83185564|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
83185565|NCT03421717|Coagulants|coagulants|mesh-ancestor
83185566|NCT03427801|Hematinics|hematinics|mesh-list
83185567|NCT03416569|Prazosin|prazosin|mesh-list
83185568|NCT03416569|Nicotine|nicotine|mesh-list
83185569|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83185570|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
83185571|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185572|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185573|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83185574|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83185575|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
83185576|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185577|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185578|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83185579|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83185580|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83185581|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83185582|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
83185583|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83185584|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83185585|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83185586|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
83185587|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185588|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185589|NCT01004029|Progestins|progestins|mesh-ancestor
83185590|NCT01004029|Hormones|hormones|mesh-ancestor
83185591|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
83185592|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
83185593|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185594|NCT03420937|Atropine|atropine|mesh-list
83185595|NCT03420937|Neostigmine|neostigmine|mesh-list
83185596|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83185597|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83185598|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83185599|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
83185600|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185601|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185602|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83185603|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83185605|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
83185606|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83185607|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83185608|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
83185609|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185610|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185611|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83185612|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185613|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83185614|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
83185615|NCT02900443|Azathioprine|azathioprine|mesh-list
83185616|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83185617|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185618|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83185619|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
83185620|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83185621|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185622|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185623|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185624|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
83185625|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83185626|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83185627|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
83185628|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185629|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185630|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
83185631|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83185632|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83185633|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83185634|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83185635|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83185636|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185637|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
83185638|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185639|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185640|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83185641|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185642|NCT03420703|Morphine|morphine|mesh-list
83185643|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83185644|NCT03420703|Narcotics|narcotics|mesh-ancestor
83185645|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185646|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185647|NCT03420703|Analgesics|analgesics|mesh-ancestor
83185648|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
83185649|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185650|NCT03420469|Bupropion|bupropion|mesh-list
83185651|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83185652|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
83185653|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83185654|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83185655|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83185656|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83185657|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185658|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
83185659|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185660|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185661|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83185662|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83185663|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185664|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
83185665|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185666|NCT03415711|Mesalamine|mesalamine|mesh-list
83185667|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185668|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185669|NCT03415711|Analgesics|analgesics|mesh-ancestor
83185670|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
83185671|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185672|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185674|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185675|NCT03420313|Buprenorphine|buprenorphine|mesh-list
83185676|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83185677|NCT03420313|Naloxone|naloxone|mesh-list
83185678|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83185679|NCT03420313|Narcotics|narcotics|mesh-ancestor
83185680|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185681|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185682|NCT03420313|Analgesics|analgesics|mesh-ancestor
83185683|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
83185684|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185685|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83185686|NCT03415555|Acetaminophen|acetaminophen|mesh-list
83185687|NCT03415555|Oxycodone|oxycodone|mesh-list
83185688|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185689|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185690|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185691|NCT03415555|Analgesics|analgesics|mesh-ancestor
83185692|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
83185693|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185694|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
83185695|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83185696|NCT03415555|Narcotics|narcotics|mesh-ancestor
83185697|NCT03415477|Denosumab|denosumab|mesh-list
83185698|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83185699|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185700|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
83185701|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
83185702|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185703|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83185704|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83185705|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185706|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185707|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83185708|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83185709|NCT03419923|Citric Acid|citric acid|mesh-list
83185710|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
83185711|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
83185712|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83185713|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
83185714|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
83185715|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185716|NCT03426553|Riboflavin|riboflavin|mesh-list
83185717|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
83185718|NCT03426553|Vitamins|vitamins|mesh-ancestor
83185719|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
83185720|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185721|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83185722|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
83185723|NCT03415087|Fentanyl|fentanyl|mesh-list
83185724|NCT03415087|Bupivacaine|bupivacaine|mesh-list
83185725|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
83185726|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
83185727|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185728|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185729|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
83185730|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185731|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83185732|NCT03415087|Narcotics|narcotics|mesh-ancestor
83185733|NCT03415087|Analgesics|analgesics|mesh-ancestor
83185734|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83185735|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83185736|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
83185737|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
83185738|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185739|NCT03419767|Melatonin|melatonin|mesh-list
83185740|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
83185741|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185742|NCT03419767|Protective Agents|protective agents|mesh-ancestor
83185743|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185744|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185745|NCT03414931|Sertraline|sertraline|mesh-list
83185746|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
83185747|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83185748|NCT03414931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83185749|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83185750|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83185751|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185752|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185753|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
83185754|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185755|NCT04699591|Domperidone|domperidone|mesh-list
83185756|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
83185757|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
83185758|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185759|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185760|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83185761|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83185762|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
83185763|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185764|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185765|NCT04448821|Metformin|metformin|mesh-list
83185766|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83185767|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185768|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83185769|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
83185770|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
83185771|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185772|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83185773|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83185774|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
83185775|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185776|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185777|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83185778|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83185779|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83185780|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83185781|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83185782|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185783|NCT04448587|Incretins|incretins|mesh-ancestor
83185784|NCT04448587|Hormones|hormones|mesh-ancestor
83185785|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185786|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83185787|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
83185788|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185789|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185790|NCT03426085|Liraglutide|liraglutide|mesh-list
83185791|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83185792|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185793|NCT03426085|Incretins|incretins|mesh-ancestor
83185794|NCT03426085|Hormones|hormones|mesh-ancestor
83185795|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185796|NCT03418597|Anesthetics|anesthetics|mesh-list
83185797|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185798|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185799|NCT03425929|Oxytocin|oxytocin|mesh-list
83185800|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
83185801|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83185802|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185803|NCT03127189|Rilpivirine|rilpivirine|mesh-list
83185804|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83185805|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83185806|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185807|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185808|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
83185809|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185810|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83185811|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83185812|NCT02521051|Bevacizumab|bevacizumab|mesh-list
83185813|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83185814|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185815|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83185816|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83185817|NCT02521051|Growth Substances|growth substances|mesh-ancestor
83185818|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185819|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
83185820|NCT01239797|Dexamethasone|dexamethasone|mesh-list
83185821|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
83185822|NCT01239797|Lenalidomide|lenalidomide|mesh-list
83185823|NCT01239797|Elotuzumab|elotuzumab|mesh-list
83185824|NCT01239797|BB 1101|bb 1101|mesh-list
83185825|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185826|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
83185827|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
83185828|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185829|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185830|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83185832|NCT01239797|Hormones|hormones|mesh-ancestor
83185833|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185834|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83185835|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185836|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
83185837|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185838|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185839|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
83185840|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83185841|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83185842|NCT01239797|Growth Substances|growth substances|mesh-ancestor
83185843|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
83185844|NCT02639065|Durvalumab|durvalumab|mesh-list
83185845|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83185846|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185847|NCT01236521|Analgesics|analgesics|mesh-list
83185848|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
83185849|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185850|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185851|NCT01092143|Fluticasone|fluticasone|mesh-list
83185852|NCT01092143|Xhance|xhance|mesh-list
83185853|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185854|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83185855|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
83185856|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185857|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185858|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83185859|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
83185860|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83185861|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83185862|NCT00950989|Folic Acid|folic acid|mesh-list
83185863|NCT00950989|Methotrexate|methotrexate|mesh-list
83185864|NCT00950989|Brodalumab|brodalumab|mesh-list
83185865|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83185866|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
83185867|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83185868|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185869|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83185870|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
83185871|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185872|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185873|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83185874|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185875|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83185876|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83185877|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
83185878|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185879|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83185880|NCT00950989|Hematinics|hematinics|mesh-ancestor
83185881|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
83185882|NCT00950989|Vitamins|vitamins|mesh-ancestor
83185883|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
83185884|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83185885|NCT03420911|Midazolam|midazolam|mesh-list
83185886|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83185887|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83185888|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83185889|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185890|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83185891|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83185892|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83185893|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83185894|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
83185895|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
83185896|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
83185897|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
83185898|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83185899|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185900|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83185901|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83185902|NCT03420911|Analgesics|analgesics|mesh-ancestor
83185903|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
83185904|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185905|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185906|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185907|NCT03416231|Docetaxel|docetaxel|mesh-list
83185908|NCT03416231|Apatinib|apatinib|mesh-list
83185909|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185910|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
83185911|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
83185912|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
83185913|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185914|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83185915|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185916|NCT03415763|Leucovorin|leucovorin|mesh-list
83185917|NCT03415763|Capecitabine|capecitabine|mesh-list
83185918|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
83185919|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83185920|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
83185921|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185922|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185923|NCT03415763|Antidotes|antidotes|mesh-ancestor
83185924|NCT03415763|Protective Agents|protective agents|mesh-ancestor
83185925|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185926|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
83185927|NCT03415763|Vitamins|vitamins|mesh-ancestor
83185928|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
83185929|NCT00593567|Levofloxacin|levofloxacin|mesh-list
83185930|NCT00593567|Gentamicins|gentamicins|mesh-list
83185931|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83185932|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185933|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83185934|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83185935|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83185936|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185937|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185938|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185939|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83185940|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83185941|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83185942|NCT03419975|Latanoprost|latanoprost|mesh-list
83185943|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83185944|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83185945|NCT00006455|Leucovorin|leucovorin|mesh-list
83185946|NCT00006455|Cytarabine|cytarabine|mesh-list
83185947|NCT00006455|Dexamethasone|dexamethasone|mesh-list
83185948|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
83185949|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83185950|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83185951|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83185952|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
83185953|NCT00006455|Ifosfamide|ifosfamide|mesh-list
83185954|NCT00006455|Doxorubicin|doxorubicin|mesh-list
83185955|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83185956|NCT00006455|Methotrexate|methotrexate|mesh-list
83185957|NCT00006455|Etoposide|etoposide|mesh-list
83185958|NCT00006455|Vinblastine|vinblastine|mesh-list
83185959|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
83185960|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83185961|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
83185962|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83185963|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83185964|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83185965|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
83185966|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83185967|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83185968|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83185969|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83185970|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
83185971|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
83185972|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83185973|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83185974|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
83185975|NCT00006455|Hormones|hormones|mesh-ancestor
83185976|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83185977|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83185978|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83185979|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83185980|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83185981|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83185982|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83185983|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
83185984|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83185985|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83185986|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
83185987|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
83185988|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83185989|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83185990|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83185991|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
83185992|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83185993|NCT00006455|Antidotes|antidotes|mesh-ancestor
83185994|NCT00006455|Protective Agents|protective agents|mesh-ancestor
83185995|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
83185996|NCT00006455|Vitamins|vitamins|mesh-ancestor
83185997|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
83185998|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
83185999|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186000|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186001|NCT01602315|Cetuximab|cetuximab|mesh-list
83186002|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83186003|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186004|NCT02537197|Naltrexone|naltrexone|mesh-list
83186005|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83186006|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83186007|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186008|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
83186009|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186010|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83186011|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83186012|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83186013|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83186014|NCT03413371|Acetaminophen|acetaminophen|mesh-list
83186015|NCT03413371|Lidocaine|lidocaine|mesh-list
83186016|NCT03413371|Bupivacaine|bupivacaine|mesh-list
83186017|NCT03413371|Ropivacaine|ropivacaine|mesh-list
83186018|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
83186019|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
83186020|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186021|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186022|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
83186023|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186024|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83186025|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83186026|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83186027|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83186028|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186029|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83186030|NCT03413371|Analgesics|analgesics|mesh-ancestor
83186031|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
83186032|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
83186033|NCT05116995|Ticagrelor|ticagrelor|mesh-list
83186034|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83186035|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83186036|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83186037|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83186038|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
83186039|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186040|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186041|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186042|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83186043|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
83186044|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83186045|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
83186046|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186047|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
83186048|NCT02344004|Amikacin|amikacin|mesh-list
83186049|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83186050|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186051|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
83186052|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83186053|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186054|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186055|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83186056|NCT03677115|Analgesics|analgesics|mesh-ancestor
83186057|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
83186058|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186059|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83186060|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83186061|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83186062|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186063|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186064|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186065|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
83186066|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83186067|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
83186068|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
83186069|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83186070|NCT05116371|Estradiol|estradiol|mesh-list
83186071|NCT05116371|Estrogens|estrogens|mesh-ancestor
83186072|NCT05116371|Hormones|hormones|mesh-ancestor
83186073|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83186074|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186075|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83186076|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83186077|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83186078|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83186079|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83186081|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
83186082|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83186083|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83186084|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83186085|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186086|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186087|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
83186088|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
83186089|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186090|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186091|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83186092|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83186093|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
83186094|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83186095|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83186096|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83186097|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83186098|NCT03417427|Cytarabine|cytarabine|mesh-list
83186099|NCT03417427|Decitabine|decitabine|mesh-list
83186100|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83186101|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
83186102|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186103|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186104|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
83186105|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186106|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83186107|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
83186108|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186109|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186110|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
83186111|NCT03425617|Olodaterol|olodaterol|mesh-list
83186112|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83186113|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
83186114|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186115|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186116|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83186117|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
83186118|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
83186119|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83186120|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
83186121|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186122|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186123|NCT03419429|Simvastatin|simvastatin|mesh-list
83186124|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83186125|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83186126|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
83186127|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186128|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83186129|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83186130|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186131|NCT02654145|Omalizumab|omalizumab|mesh-list
83186132|NCT02654145|Albuterol|albuterol|mesh-list
83186133|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83186134|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
83186135|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186136|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186137|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83186138|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
83186139|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
83186140|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83186141|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83186142|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83186143|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83186144|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186145|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186146|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186147|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83186148|NCT05122455|Edoxaban|edoxaban|mesh-list
83186149|NCT05122455|Clopidogrel|clopidogrel|mesh-list
83186150|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83186151|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83186152|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83186153|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83186154|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
83186155|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186156|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186157|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186158|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83186159|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
83186160|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83186161|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
83186162|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186163|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
83186164|NCT03413059|Triamcinolone|triamcinolone|mesh-list
83186165|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83186166|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83186167|NCT03413059|Morphine|morphine|mesh-list
83186168|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83186169|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83186170|NCT03413059|Narcotics|narcotics|mesh-ancestor
83186171|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186172|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186173|NCT03413059|Analgesics|analgesics|mesh-ancestor
83186174|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
83186175|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186176|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186177|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
83186178|NCT03413059|Hormones|hormones|mesh-ancestor
83186179|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83186180|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83186181|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
83186182|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186183|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186184|NCT05122377|Goserelin|goserelin|mesh-list
83186185|NCT05122377|Leuprolide|leuprolide|mesh-list
83186186|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83186187|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186188|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83186189|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
83186190|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83186191|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186192|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83186193|NCT03425461|Nivolumab|nivolumab|mesh-list
83186194|NCT03425461|Ipilimumab|ipilimumab|mesh-list
83186195|NCT03425461|Antibodies|antibodies|mesh-list
83186196|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
83186197|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83186198|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
83186199|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186200|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186201|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83186202|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186203|NCT04753437|Amoxicillin|amoxicillin|mesh-list
83186204|NCT04753437|Clarithromycin|clarithromycin|mesh-list
83186205|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
83186206|NCT04753437|Esomeprazole|esomeprazole|mesh-list
83186207|NCT04753437|Bismuth|bismuth|mesh-list
83186208|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186209|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83186210|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186211|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83186212|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186213|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83186214|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186215|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83186216|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83186217|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83186218|NCT04753437|Antacids|antacids|mesh-ancestor
83186219|NCT04753437|Diuretics|diuretics|mesh-ancestor
83186220|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
83186221|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186222|NCT04753437|Expectorants|expectorants|mesh-ancestor
83186223|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83186224|NCT03411109|Hydromorphone|hydromorphone|mesh-list
83186225|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83186226|NCT03411109|Narcotics|narcotics|mesh-ancestor
83186227|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186228|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186229|NCT03411109|Analgesics|analgesics|mesh-ancestor
83186230|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
83186231|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186232|NCT01111565|Aripiprazole|aripiprazole|mesh-list
83186233|NCT01111565|Escitalopram|escitalopram|mesh-list
83186234|NCT01111565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83186235|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83186236|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83186237|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186238|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186239|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
83186240|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186241|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
83186242|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83186243|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83186244|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83186245|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186246|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
83186247|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
83186248|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83186249|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83186250|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83186251|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83417272|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
83186252|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83186253|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83186254|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83186255|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83186256|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186257|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186258|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186259|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186261|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83186262|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83186263|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83186264|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186265|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186266|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186267|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186268|NCT03412513|Urological Agents|urological agents|mesh-ancestor
83186269|NCT04370379|Aflibercept|aflibercept|mesh-list
83186270|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83186271|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83186272|NCT04370379|Growth Substances|growth substances|mesh-ancestor
83186273|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186274|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
83186275|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186277|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83186278|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83186279|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186280|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
83186281|NCT03413891|Coagulants|coagulants|mesh-ancestor
83186282|NCT03317613|Capsaicin|capsaicin|mesh-list
83186283|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
83186284|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
83186285|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
83186286|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186287|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186288|NCT03126877|Mitomycins|mitomycins|mesh-list
83186289|NCT03126877|Mitomycin|mitomycin|mesh-list
83186290|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83186291|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186292|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
83186293|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186294|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83186295|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186296|NCT04260477|Rifampin|rifampin|mesh-list
83186297|NCT04260477|Isoniazid|isoniazid|mesh-list
83186298|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
83186299|NCT04260477|Ethambutol|ethambutol|mesh-list
83186300|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83186301|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
83186302|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83186303|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186304|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
83186305|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83186306|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186307|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186308|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83186309|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83186310|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83186311|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83186312|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83186313|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83186314|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83186315|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83186316|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
83186317|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83186318|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
83186319|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
83186320|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83186321|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
83186322|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186323|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186324|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83186325|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
83186326|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83186327|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83186328|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83186329|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186330|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186331|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186332|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83186333|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83186334|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83186335|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
83186336|NCT03424759|Osimertinib|osimertinib|mesh-list
83186337|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186338|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186339|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186340|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186341|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
83186342|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83186343|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186344|NCT04814745|Morphine|morphine|mesh-list
83186345|NCT04814745|Tramadol|tramadol|mesh-list
83186346|NCT04814745|Ropivacaine|ropivacaine|mesh-list
83186347|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83186348|NCT04814745|Narcotics|narcotics|mesh-ancestor
83186349|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186350|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186351|NCT04814745|Analgesics|analgesics|mesh-ancestor
83186352|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
83186353|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186354|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
83186355|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
83186356|NCT04640571|Metformin|metformin|mesh-list
83186357|NCT04640571|Valacyclovir|valacyclovir|mesh-list
83186358|NCT04640571|Enalaprilat|enalaprilat|mesh-list
83186359|NCT04640571|Enalapril|enalapril|mesh-list
83186360|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83186361|NCT04640571|Pravastatin|pravastatin|mesh-list
83186362|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83186363|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186364|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83186365|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83186366|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
83186367|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186368|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83186369|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83186370|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186372|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186373|NCT04640571|Cathartics|cathartics|mesh-ancestor
83186374|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186375|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83186376|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
83186377|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83186378|NCT04431141|Empagliflozin|empagliflozin|mesh-list
83186379|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83186380|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186381|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83186382|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186383|NCT05229627|Methylphenidate|methylphenidate|mesh-list
83186384|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83186385|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83186386|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186387|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83186388|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83186389|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83186390|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186391|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
83186392|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186393|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83186394|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186395|NCT01976169|Palbociclib|palbociclib|mesh-list
83186396|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83186397|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186398|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186399|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186400|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186401|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83186402|NCT01976169|Immunotoxins|immunotoxins|mesh-ancestor
83186403|NCT01976169|Immunoconjugates|immunoconjugates|mesh-ancestor
83186404|NCT01976169|Immunologic Factors|immunologic factors|mesh-ancestor
83186405|NCT01976169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186406|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
83186407|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186408|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186409|NCT00148629|Mebendazole|mebendazole|mesh-list
83186410|NCT00148629|Piperazine|piperazine|mesh-list
83186411|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
83186412|NCT00148629|DMP 777|dmp 777|mesh-list
83186413|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
83186414|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
83186416|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186417|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
83186418|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186419|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186420|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186421|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186422|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186423|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
83186425|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186426|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186427|NCT04448015|Analgesics|analgesics|mesh-ancestor
83186428|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
83186429|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186430|NCT01328041|Dolutegravir|dolutegravir|mesh-list
83186431|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83186432|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83186433|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186434|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186435|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83186436|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83186437|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
83186438|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186439|NCT03412721|Analgesics|analgesics|mesh-list
83186440|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
83186441|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186442|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186443|NCT03418337|Lansoprazole|lansoprazole|mesh-list
83186444|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
83186445|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83186446|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186447|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83186448|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186449|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186450|NCT03411967|Docetaxel|docetaxel|mesh-list
83186451|NCT03411967|Apatinib|apatinib|mesh-list
83186452|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186453|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
83186454|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186455|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186456|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186457|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186458|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186459|NCT05228925|Vitamin D|vitamin d|mesh-list
83186460|NCT05228925|Vitamins|vitamins|mesh-ancestor
83186461|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
83186462|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186463|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83186464|NCT03412409|Cytarabine|cytarabine|mesh-list
83186465|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
83186466|NCT03412409|Busulfan|busulfan|mesh-list
83186467|NCT03412409|Semustine|semustine|mesh-list
83186468|NCT03412409|Fludarabine|fludarabine|mesh-list
83186469|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83186470|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83186471|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
83186472|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186473|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83186474|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83186475|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
83186476|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186477|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186478|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83186479|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83186480|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
83186481|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
83186482|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186483|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
83186484|NCT02410772|Rifapentine|rifapentine|mesh-list
83186485|NCT02410772|Rifampin|rifampin|mesh-list
83186486|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83186487|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186488|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83186489|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83186490|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186491|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186492|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186493|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83186494|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
83186495|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
83186496|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83186497|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83186498|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83186500|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83186501|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83186502|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83186503|NCT03814317|Treprostinil|treprostinil|mesh-list
83186504|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83186505|NCT03127319|Docetaxel|docetaxel|mesh-list
83186506|NCT03127319|Apatinib|apatinib|mesh-list
83186507|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186508|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
83186509|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186510|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186511|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186512|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186513|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186514|NCT03417947|Vitamin D|vitamin d|mesh-list
83186515|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
83186516|NCT03417947|Vitamins|vitamins|mesh-ancestor
83186517|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
83186518|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186519|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83186520|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83186521|NCT03905811|Terazosin|terazosin|mesh-list
83186522|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83186523|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83186524|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83186525|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186526|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186527|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186528|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186529|NCT03905811|Urological Agents|urological agents|mesh-ancestor
83186530|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83186531|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83186532|NCT05171309|Apatinib|apatinib|mesh-list
83186533|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186534|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186535|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186536|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186537|NCT03409237|Mannitol|mannitol|mesh-list
83186538|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83186539|NCT03409237|Diuretics|diuretics|mesh-ancestor
83186540|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
83186541|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186542|NCT03408847|Beclomethasone|beclomethasone|mesh-list
83186543|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186544|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
83186545|NCT03408847|Hormones|hormones|mesh-ancestor
83186546|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83186547|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186548|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83186549|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
83186550|NCT03424291|Apatinib|apatinib|mesh-list
83186551|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186552|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186553|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186554|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186555|NCT04412889|Immunomodulating Agents|immunomodulating agents|mesh-list
83186556|NCT04412889|Immunologic Factors|immunologic factors|mesh-ancestor
83186557|NCT04412889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186558|NCT03407521|Isosorbide|isosorbide|mesh-list
83186559|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83186560|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83186561|NCT03407521|Misoprostol|misoprostol|mesh-list
83186562|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83186563|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
83186564|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83186565|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186566|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83186567|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186568|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
83186569|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83186570|NCT03407521|Diuretics|diuretics|mesh-ancestor
83186571|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
83186572|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
83186573|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83186574|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186576|NCT03424135|Promethazine|promethazine|mesh-list
83186577|NCT03424135|Naproxen|naproxen|mesh-list
83186578|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83186579|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83186580|NCT03424135|Analgesics|analgesics|mesh-ancestor
83186581|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
83186582|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186583|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186584|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186585|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83186586|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
83186587|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83186588|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186589|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186590|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83186591|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83186592|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186593|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
83186594|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
83186595|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
83186596|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
83186597|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186598|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83186599|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
83186600|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
83186601|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186602|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83186603|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
83186604|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
83186605|NCT03411941|Aflibercept|aflibercept|mesh-list
83186606|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83186607|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83186608|NCT03411941|Growth Substances|growth substances|mesh-ancestor
83186609|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186610|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
83186611|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186612|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83186613|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
83186614|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83186615|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186616|NCT03406819|Nitroprusside|nitroprusside|mesh-list
83186617|NCT03406819|Tirofiban|tirofiban|mesh-list
83186618|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83186619|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
83186620|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83186621|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186622|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83186623|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83186624|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83186625|NCT05170217|Cannabidiol|cannabidiol|mesh-list
83186626|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
83186627|NCT03411551|Anesthetics|anesthetics|mesh-list
83186628|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186629|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186630|NCT05170061|Valsartan|valsartan|mesh-list
83186631|NCT05170061|Nebivolol|nebivolol|mesh-list
83186632|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83186633|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83186634|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83186635|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186636|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
83186637|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83186638|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83186639|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83186640|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186641|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186642|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186643|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
83186644|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83186645|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83186646|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
83186647|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186648|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83186649|NCT02520635|Temozolomide|temozolomide|mesh-list
83186650|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83186651|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
83186652|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186653|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186654|NCT03404947|Ethanol|ethanol|mesh-list
83186655|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83186656|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186657|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186658|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186659|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
83186660|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83186661|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186662|NCT03411473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83186663|NCT03411473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186664|NCT03423823|Ranibizumab|ranibizumab|mesh-list
83186665|NCT03423823|Aflibercept|aflibercept|mesh-list
83186666|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186667|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83186668|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83186669|NCT03423823|Growth Substances|growth substances|mesh-ancestor
83186670|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186671|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
83186672|NCT03411161|Paclitaxel|paclitaxel|mesh-list
83186673|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83186674|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83186675|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186676|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
83186677|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186678|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186679|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186680|NCT04737603|Buprenorphine|buprenorphine|mesh-list
83186681|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83186682|NCT04737603|Naloxone|naloxone|mesh-list
83186683|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83186684|NCT04737603|Narcotics|narcotics|mesh-ancestor
83186685|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186686|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186687|NCT04737603|Analgesics|analgesics|mesh-ancestor
83186688|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
83186689|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186690|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83186691|NCT05168137|Colchicine|colchicine|mesh-list
83186692|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
83186693|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83186694|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83186695|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186696|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186697|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186698|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186699|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83186700|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186701|NCT05168059|Clevidipine|clevidipine|mesh-list
83186702|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83186703|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83186704|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186705|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83186706|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186707|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
83186708|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83186709|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
83186710|NCT02375295|Trimethoprim|trimethoprim|mesh-list
83186711|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83186712|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186713|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83186714|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83186715|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186716|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186717|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186718|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83186719|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83186720|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83186721|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
83186722|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83186723|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83186724|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83186725|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83186726|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83186727|NCT03394105|Docetaxel|docetaxel|mesh-list
83186728|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186729|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
83186730|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
83186731|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
83186732|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186733|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
83186734|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83186735|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83186736|NCT03393949|Prednisolone|prednisolone|mesh-list
83186737|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
83186738|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83186739|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
83186740|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186741|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
83186742|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
83186743|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186744|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186745|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186746|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
83186747|NCT03393949|Hormones|hormones|mesh-ancestor
83186748|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83186749|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83186750|NCT03393949|Protective Agents|protective agents|mesh-ancestor
83186751|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83186752|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186753|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
83186754|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83186755|NCT03818061|Bevacizumab|bevacizumab|mesh-list
83186756|NCT03818061|Atezolizumab|atezolizumab|mesh-list
83186757|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83186758|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186759|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83186760|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83186761|NCT03818061|Growth Substances|growth substances|mesh-ancestor
83186762|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186763|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
83186764|NCT03818061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83186765|NCT03818061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186766|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
83186767|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83186768|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186769|NCT04435743|Lenalidomide|lenalidomide|mesh-list
83186770|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
83186771|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186772|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83186773|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83186774|NCT04435743|Growth Substances|growth substances|mesh-ancestor
83186775|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
83186776|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186777|NCT03393715|Perindopril|perindopril|mesh-list
83186778|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83186779|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
83186780|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186781|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186782|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83186783|NCT03397537|Letrozole|letrozole|mesh-list
83186784|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186785|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83186786|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83186787|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186788|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186789|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83186790|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
83186791|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83186792|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186793|NCT03612921|Amantadine|amantadine|mesh-list
83186794|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83186795|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83186796|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
83186797|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186798|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
83186799|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186800|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186801|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186802|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83186803|NCT03612921|Analgesics|analgesics|mesh-ancestor
83186804|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
83186805|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186806|NCT03393481|Enoxaparin|enoxaparin|mesh-list
83186807|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
83186808|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83186809|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83186810|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186811|NCT01936857|Buprenorphine|buprenorphine|mesh-list
83186812|NCT01936857|Methadone|methadone|mesh-list
83186813|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83186814|NCT01936857|Naloxone|naloxone|mesh-list
83186815|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83186816|NCT01936857|Narcotics|narcotics|mesh-ancestor
83186817|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186818|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186819|NCT01936857|Analgesics|analgesics|mesh-ancestor
83186820|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
83186821|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186822|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83186823|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
83186824|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
83186825|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
83186826|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83186827|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186828|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186829|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83186830|NCT03393403|Analgesics|analgesics|mesh-ancestor
83186831|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
83186832|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186833|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83186834|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83186835|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83186836|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186837|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186838|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186839|NCT03399955|Amphotericin B|amphotericin b|mesh-list
83186840|NCT03399955|Paromomycin|paromomycin|mesh-list
83186841|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83186842|NCT03399955|Miltefosine|miltefosine|mesh-list
83186843|NCT03399955|Amebicides|amebicides|mesh-ancestor
83186844|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83186845|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83186846|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83186847|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83186848|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
83186849|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186850|NCT03397199|Apatinib|apatinib|mesh-list
83186851|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186852|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186853|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186854|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186855|NCT05188053|Ketorolac|ketorolac|mesh-list
83186856|NCT05188053|Epinephrine|epinephrine|mesh-list
83186857|NCT05188053|Ropivacaine|ropivacaine|mesh-list
83186858|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
83186859|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
83186860|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186861|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186862|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
83186863|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186864|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83186865|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83186866|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
83186867|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186868|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186869|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83186870|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83186871|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
83186872|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83186873|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
83186874|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
83186875|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
83186876|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83186877|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83186878|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83186879|NCT05188053|Analgesics|analgesics|mesh-ancestor
83186880|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186881|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83186882|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83186883|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186884|NCT03393325|Tadalafil|tadalafil|mesh-list
83186885|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
83186886|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83186887|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83186888|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186889|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186890|NCT03393325|Urological Agents|urological agents|mesh-ancestor
83186891|NCT03399643|Atezolizumab|atezolizumab|mesh-list
83186892|NCT03399643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83186893|NCT03399643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186894|NCT03399643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83186895|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186896|NCT03393247|Infliximab|infliximab|mesh-list
83186897|NCT03393247|Azathioprine|azathioprine|mesh-list
83186898|NCT03393247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83186899|NCT03393247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186900|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
83186901|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186902|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83186903|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
83186904|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186905|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83186906|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186907|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83186908|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
83186909|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186910|NCT03407027|Triamcinolone|triamcinolone|mesh-list
83186911|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83186912|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83186913|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83186914|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186915|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
83186916|NCT03407027|Hormones|hormones|mesh-ancestor
83186917|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83186918|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186919|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83186920|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
83186921|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186922|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186923|NCT03343197|Ivosidenib|ivosidenib|mesh-list
83186924|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186925|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186926|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186927|NCT01602224|Dexamethasone|dexamethasone|mesh-list
83186928|NCT01602224|Bortezomib|bortezomib|mesh-list
83186929|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83186930|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
83186931|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
83186932|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186933|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186934|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186935|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
83186936|NCT01602224|Hormones|hormones|mesh-ancestor
83186937|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83186938|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83186939|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186940|NCT03399487|Ceritinib|ceritinib|mesh-list
83186941|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186942|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83186943|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83186944|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186945|NCT05161429|Insulin|insulin|mesh-list
83186946|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83186947|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186948|NCT03984045|Lidocaine|lidocaine|mesh-list
83186949|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
83186950|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
83186951|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
83186952|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186953|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186954|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
83186955|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83186956|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83186957|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83186958|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83186959|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83186960|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186961|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
83186962|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
83186963|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83186964|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83186965|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83186966|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83186967|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83186968|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
83186969|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186970|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83186971|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83186972|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83186973|NCT05060991|Antimetabolites|antimetabolites|mesh-list
83186974|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186975|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83186976|NCT03397069|Midazolam|midazolam|mesh-list
83186977|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83186978|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83186979|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83186980|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83186981|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83186982|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83186983|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83186984|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83186985|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
83186986|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
83186987|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
83186988|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
83186989|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83186990|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186991|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
83186992|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83186993|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83186994|NCT03396497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83186995|NCT03396497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83186996|NCT03399019|Midazolam|midazolam|mesh-list
83186997|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
83186998|NCT03399019|Propofol|propofol|mesh-list
83186999|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187000|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187001|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187002|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187003|NCT03399019|Analgesics|analgesics|mesh-ancestor
83187004|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
83187005|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187006|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83187007|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83187008|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83187009|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187010|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187011|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187012|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187013|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
83187014|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
83187015|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83187016|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83187017|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83187018|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187019|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
83187020|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
83187022|NCT04452383|Propofol|propofol|mesh-list
83187023|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187024|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187025|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187026|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187027|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
83187028|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
83187029|NCT04452383|Analgesics|analgesics|mesh-ancestor
83187030|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
83187031|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187032|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83187033|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83187034|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83187035|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187036|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187037|NCT02520479|Pegaspargase|pegaspargase|mesh-list
83187038|NCT02520479|Asparaginase|asparaginase|mesh-list
83187040|NCT02520947|Desflurane|desflurane|mesh-list
83187041|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83187042|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
83187043|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
83187044|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187045|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187046|NCT03398941|Octreotide|octreotide|mesh-list
83187047|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83187048|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83187049|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187050|NCT03396601|Ketamine|ketamine|mesh-list
83187051|NCT03396601|Analgesics|analgesics|mesh-ancestor
83187052|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
83187053|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187054|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187055|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83187056|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187057|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
83187058|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
83187059|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187060|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83187061|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83187062|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187063|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187064|NCT03392623|Niacinamide|niacinamide|mesh-list
83187065|NCT03392623|Niacin|niacin|mesh-list
83187066|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
83187067|NCT03392623|Tretinoin|tretinoin|mesh-list
83187068|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
83187069|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187070|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
83187071|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83187072|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83187073|NCT03392623|Protective Agents|protective agents|mesh-ancestor
83187074|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187075|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
83187076|NCT03392623|Vitamins|vitamins|mesh-ancestor
83187077|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
83187078|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83187079|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
83187080|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187081|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83187082|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
83187083|NCT03396107|Dexamethasone|dexamethasone|mesh-list
83187084|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83187085|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
83187086|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
83187087|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187088|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187089|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83187090|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
83187091|NCT03396107|Hormones|hormones|mesh-ancestor
83187092|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187093|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83187094|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187095|NCT03398785|Epinephrine|epinephrine|mesh-list
83187096|NCT03398785|Racepinephrine|racepinephrine|mesh-list
83187097|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
83187098|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83187099|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83187100|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187101|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187102|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187103|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187104|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83187105|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83187106|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
83187107|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187108|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83187109|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187110|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
83187111|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
83187112|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83187113|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
83187114|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
83187115|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187116|NCT03126695|Ticagrelor|ticagrelor|mesh-list
83187117|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83187118|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83187119|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83187120|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83187121|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
83187122|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187123|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187124|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187125|NCT04300595|Anesthetics|anesthetics|mesh-list
83187126|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187127|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187128|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83187129|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187130|NCT04647643|Paclitaxel|paclitaxel|mesh-list
83187131|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83187132|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187133|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83187134|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83187135|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83187136|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187137|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
83187138|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83187139|NCT04167761|Glipizide|glipizide|mesh-list
83187140|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187141|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83187142|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187143|NCT03401177|Naproxen|naproxen|mesh-list
83187144|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83187145|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187146|NCT03401177|Analgesics|analgesics|mesh-ancestor
83187147|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
83417273|NCT04779047|Ivermectin|ivermectin|mesh-list
83187148|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187149|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187150|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83187151|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83187152|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
83187153|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83187154|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187155|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187156|NCT04446715|Sufentanil|sufentanil|mesh-list
83187157|NCT04446715|Meperidine|meperidine|mesh-list
83187158|NCT04446715|Bupivacaine|bupivacaine|mesh-list
83187159|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
83187160|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
83187161|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187162|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187163|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
83187164|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187165|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83187166|NCT04446715|Narcotics|narcotics|mesh-ancestor
83187167|NCT04446715|Analgesics|analgesics|mesh-ancestor
83187168|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83187169|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187170|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
83187171|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
83187172|NCT03398473|Hematinics|hematinics|mesh-ancestor
83187173|NCT03395951|Diuretics|diuretics|mesh-list
83187174|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
83187175|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187176|NCT04535791|Vitamin D|vitamin d|mesh-list
83187177|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
83187178|NCT04535791|Vitamins|vitamins|mesh-ancestor
83187179|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
83187180|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187181|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83187182|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83187183|NCT03395873|Decitabine|decitabine|mesh-list
83187184|NCT03395873|Avelumab|avelumab|mesh-list
83187185|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83187186|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
83187187|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187188|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187189|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187190|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187191|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83187192|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83187193|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187194|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
83187195|NCT03396523|Losartan|losartan|mesh-list
83187196|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83187197|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83187198|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83187199|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83187200|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187201|NCT03126097|Drospirenone|drospirenone|mesh-list
83187202|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83187203|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83187204|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83187205|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83187206|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83187207|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
83187208|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83187209|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187210|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83187211|NCT03126097|Estrogens|estrogens|mesh-ancestor
83187212|NCT03126097|Hormones|hormones|mesh-ancestor
83187213|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187214|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83187215|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
83187216|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83187217|NCT03126097|Diuretics|diuretics|mesh-ancestor
83187218|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
83187219|NCT03398083|Alprazolam|alprazolam|mesh-list
83187220|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187221|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187222|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187223|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83187224|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83187225|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187226|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
83187227|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
83187228|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187229|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187230|NCT03392311|Calcipotriene|calcipotriene|mesh-list
83187231|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83187232|NCT03126721|Midazolam|midazolam|mesh-list
83187233|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83187234|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187235|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187236|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187237|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83187238|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83187239|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187240|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187241|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
83187242|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
83187243|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
83187244|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
83187245|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187246|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187247|NCT04928521|Bupivacaine|bupivacaine|mesh-list
83187248|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
83187250|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187251|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187252|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
83187253|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187254|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
83187255|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
83187256|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187257|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
83187258|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187259|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187260|NCT03391843|Cetuximab|cetuximab|mesh-list
83187261|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
83187262|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187263|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187264|NCT03389659|Vitamin D|vitamin d|mesh-list
83187265|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
83187266|NCT03389659|Vitamins|vitamins|mesh-ancestor
83187267|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
83187268|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187269|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83187270|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83187271|NCT04446637|Albuterol|albuterol|mesh-list
83187272|NCT04446637|Ipratropium|ipratropium|mesh-list
83187273|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83187274|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
83187275|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187276|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187277|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83187278|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187279|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
83187280|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83187281|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83187282|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83187283|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83187284|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187285|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187286|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187287|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83187288|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
83187290|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
83187291|NCT03395171|Vitamins|vitamins|mesh-ancestor
83187292|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
83187293|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187294|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83187295|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83187296|NCT03395977|Febuxostat|febuxostat|mesh-list
83187297|NCT03395977|Rasburicase|rasburicase|mesh-list
83187298|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
83187299|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83187300|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
83187301|NCT02678143|Sirolimus|sirolimus|mesh-list
83187302|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
83187303|NCT02678143|Fludarabine|fludarabine|mesh-list
83187304|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
83187305|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83187306|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
83187307|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187308|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83187309|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83187310|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
83187311|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187312|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187313|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83187314|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83187315|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83187316|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
83187317|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83187318|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187319|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187320|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
83187321|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187322|NCT03395093|Fentanyl|fentanyl|mesh-list
83187323|NCT03395093|Midazolam|midazolam|mesh-list
83187324|NCT03395093|Propofol|propofol|mesh-list
83187325|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187327|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187328|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187329|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
83187330|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
83187331|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83187332|NCT03395093|Narcotics|narcotics|mesh-ancestor
83187333|NCT03395093|Analgesics|analgesics|mesh-ancestor
83417274|NCT04779047|Remdesivir|remdesivir|mesh-list
83187334|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
83187335|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187336|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83187337|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83187338|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83187339|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187340|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
83187341|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
83187342|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187343|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187344|NCT03389191|Acyclovir|acyclovir|mesh-list
83187345|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
83187346|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187347|NCT04330183|Ketamine|ketamine|mesh-list
83187348|NCT04330183|Analgesics|analgesics|mesh-ancestor
83187349|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
83187350|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187351|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187352|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83187353|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187354|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
83187355|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
83187356|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187357|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83187358|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83187359|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187360|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187361|NCT03398993|Clomiphene|clomiphene|mesh-list
83187362|NCT03398993|Enclomiphene|enclomiphene|mesh-list
83187363|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
83187364|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83187365|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83187366|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
83187367|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187368|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187369|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83187370|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
83187371|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83187372|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83187373|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83187374|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
83187375|NCT04249297|Progestins|progestins|mesh-ancestor
83187376|NCT04249297|Hormones|hormones|mesh-ancestor
83187377|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187378|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187379|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
83187380|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187381|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187382|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187383|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187384|NCT03391609|Analgesics|analgesics|mesh-ancestor
83187385|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
83187386|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187387|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83187388|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83187389|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83187390|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187391|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417426|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
83187392|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187394|NCT03398837|Lenabasum|lenabasum|mesh-list
83187395|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83187396|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83187397|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187398|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187399|NCT03398837|Hormones|hormones|mesh-ancestor
83187400|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187401|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187402|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
83187403|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187404|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187406|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
83187407|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187408|NCT03398759|Butorphanol|butorphanol|mesh-list
83187409|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83187410|NCT03398759|Narcotics|narcotics|mesh-ancestor
83187411|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187412|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187413|NCT03398759|Analgesics|analgesics|mesh-ancestor
83187414|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
83187415|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187416|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
83187417|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187418|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83187419|NCT03391219|Bevacizumab|bevacizumab|mesh-list
83187420|NCT03391219|Fasudil|fasudil|mesh-list
83187421|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187422|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187423|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83187424|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83187425|NCT03391219|Growth Substances|growth substances|mesh-ancestor
83187426|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187427|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
83187428|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83187429|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83187430|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187431|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83187432|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
83187433|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83187434|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187435|NCT04446923|Propranolol|propranolol|mesh-list
83187436|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83187437|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83187438|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187439|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187440|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187441|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187442|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83187443|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83187444|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
83187445|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
83187446|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83187447|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187448|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187449|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
83187450|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83187451|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83187452|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187453|NCT04447105|Anesthetics|anesthetics|mesh-list
83187454|NCT04447105|Propofol|propofol|mesh-list
83187455|NCT04447105|Desflurane|desflurane|mesh-list
83187456|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187457|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187458|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187459|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187460|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
83187461|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83187462|NCT03126461|Nivolumab|nivolumab|mesh-list
83187463|NCT03126461|Ipilimumab|ipilimumab|mesh-list
83187464|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187465|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187466|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83187467|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187468|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83187469|NCT03394001|Ketorolac|ketorolac|mesh-list
83187470|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83187471|NCT03394001|Lidocaine|lidocaine|mesh-list
83187472|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
83187473|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
83187474|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187475|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187476|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
83187477|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187478|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83187479|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83187480|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83187481|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83187482|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187483|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83187484|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187486|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83187487|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83187488|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83187489|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187490|NCT03393767|Ranibizumab|ranibizumab|mesh-list
83187491|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83187492|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83187493|NCT03393767|Growth Substances|growth substances|mesh-ancestor
83187494|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187495|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
83187496|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187497|NCT03389321|Macitentan|macitentan|mesh-list
83187498|NCT03389321|Riociguat|riociguat|mesh-list
83187499|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83187500|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83187501|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187502|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83187503|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
83187504|NCT03393377|Valsartan|valsartan|mesh-list
83187505|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83187506|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83187507|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83187508|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187509|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
83187510|NCT05181527|Serotonin|serotonin|mesh-list
83187511|NCT05181527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83187512|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
83187513|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187514|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83187515|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83187516|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187517|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187518|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187519|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83187520|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
83187521|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83187522|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83187523|NCT02421263|Psilocybin|psilocybin|mesh-list
83187524|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
83187525|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187526|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187527|NCT01889303|Docetaxel|docetaxel|mesh-list
83187528|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187529|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
83187530|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
83187531|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
83187532|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187533|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83187534|NCT00783263|Ezetimibe|ezetimibe|mesh-list
83187535|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83187536|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83187537|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
83187538|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187539|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83187540|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83187541|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187542|NCT00664937|Montelukast|montelukast|mesh-list
83187543|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83187544|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187545|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83187546|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
83187547|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187548|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187549|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83187550|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83187551|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187553|NCT00540839|Xhance|xhance|mesh-list
83187554|NCT00540839|Montelukast|montelukast|mesh-list
83187555|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83187556|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83187557|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
83187558|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187559|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187560|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83187561|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187562|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
83187563|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83187564|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83187565|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
83187566|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187567|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83187568|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83187569|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187570|NCT03389087|Etoposide|etoposide|mesh-list
83187571|NCT03389087|Apatinib|apatinib|mesh-list
83187572|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83187573|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187574|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83187575|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83187576|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187577|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187578|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83187579|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
83187580|NCT03388853|Doxofylline|doxofylline|mesh-list
83187581|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83187582|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
83187583|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187584|NCT03388853|Expectorants|expectorants|mesh-ancestor
83187585|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187586|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83187587|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
83187588|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187589|NCT03388853|Protective Agents|protective agents|mesh-ancestor
83187590|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187591|NCT03388853|Antidotes|antidotes|mesh-ancestor
83187592|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
83187593|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83187594|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
83187595|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187596|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83187597|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83187598|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187599|NCT00380705|Montelukast|montelukast|mesh-list
83187600|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83187601|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187602|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83187603|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
83187604|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187605|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187606|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83187607|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83187608|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187609|NCT03388697|Insulin|insulin|mesh-list
83187610|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83187611|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187612|NCT03987919|Tirzepatide|tirzepatide|mesh-list
83187613|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83187614|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187615|NCT03987919|Incretins|incretins|mesh-ancestor
83187616|NCT03987919|Hormones|hormones|mesh-ancestor
83187617|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187618|NCT03388957|Propranolol|propranolol|mesh-list
83187619|NCT03388957|Midazolam|midazolam|mesh-list
83187621|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187622|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187623|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187624|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83187625|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83187626|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187627|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187628|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
83187629|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
83187630|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
83187631|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
83187632|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187633|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187634|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83187635|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83187636|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187637|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83187638|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83187639|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
83187641|NCT03395665|Progesterone|progesterone|mesh-list
83187642|NCT03395665|Estrogens|estrogens|mesh-ancestor
83187643|NCT03395665|Hormones|hormones|mesh-ancestor
83187644|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187645|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187646|NCT03395665|Progestins|progestins|mesh-ancestor
83187647|NCT00535405|Atorvastatin|atorvastatin|mesh-list
83187648|NCT00535405|Simvastatin|simvastatin|mesh-list
83187649|NCT00535405|Ezetimibe|ezetimibe|mesh-list
83187650|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83187651|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83187652|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
83187653|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187654|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83187655|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83187656|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187657|NCT03390595|Carboplatin|carboplatin|mesh-list
83187658|NCT03390595|Gemcitabine|gemcitabine|mesh-list
83187659|NCT03390595|Avelumab|avelumab|mesh-list
83187660|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187661|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83187662|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
83187663|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187664|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187665|NCT00271817|Niacin|niacin|mesh-list
83187666|NCT00271817|Niacinamide|niacinamide|mesh-list
83187667|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
83187668|NCT00271817|Simvastatin|simvastatin|mesh-list
83187669|NCT00271817|Ezetimibe|ezetimibe|mesh-list
83187670|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83187671|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83187672|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83187673|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
83187674|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187675|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83187676|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83187677|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187678|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
83187679|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
83187680|NCT00271817|Vitamins|vitamins|mesh-ancestor
83187681|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
83187682|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187683|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
83187684|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187685|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187686|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187687|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187688|NCT03388541|Analgesics|analgesics|mesh-ancestor
83187689|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
83187690|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187691|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83187692|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83187693|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83187694|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187695|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187696|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187697|NCT00092989|Montelukast|montelukast|mesh-list
83187698|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83187699|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
83187700|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83187701|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
83187702|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187703|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187704|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83187705|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83187706|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187707|NCT03388463|Omeprazole|omeprazole|mesh-list
83187708|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83187709|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83187710|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83187711|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187712|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187713|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
83187714|NCT03858049|Progestins|progestins|mesh-ancestor
83187715|NCT03858049|Hormones|hormones|mesh-ancestor
83187716|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187717|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187718|NCT03388151|Midazolam|midazolam|mesh-list
83187719|NCT03388151|Propofol|propofol|mesh-list
83187720|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187721|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187722|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187723|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187724|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
83187725|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
83187726|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83187727|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83187728|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83187729|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83187730|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
83187731|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
83187732|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187733|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187734|NCT03392909|Gentamicins|gentamicins|mesh-list
83187735|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83187736|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187737|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83187738|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187739|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187740|NCT04501211|Granisetron|granisetron|mesh-list
83187741|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
83187742|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
83187743|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187744|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187745|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83187746|NCT04501211|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83187747|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83187748|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
83187749|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187750|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187751|NCT03126071|Bevacizumab|bevacizumab|mesh-list
83187752|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
83187753|NCT03126071|Irinotecan|irinotecan|mesh-list
83187754|NCT03126071|Raltitrexed|raltitrexed|mesh-list
83187755|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187756|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187757|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83187758|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83187759|NCT03126071|Growth Substances|growth substances|mesh-ancestor
83187760|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187761|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
83187762|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83187763|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83187764|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187765|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187766|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83187767|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
83187768|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83187770|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83187771|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83187772|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83187773|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83187774|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
83187775|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187776|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187777|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187778|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
83187779|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83187780|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83187781|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
83187782|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83187783|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187784|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
83187785|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
83187786|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83187787|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
83187788|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187789|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
83187790|NCT04446533|Protective Agents|protective agents|mesh-ancestor
83187791|NCT03386591|Naloxone|naloxone|mesh-list
83187792|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83187793|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187794|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
83187795|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187796|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
83187797|NCT03386279|Abrocitinib|abrocitinib|mesh-list
83187798|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83187799|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187800|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83187801|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83187802|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187803|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187804|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187805|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83187806|NCT03386201|Methylene Blue|methylene blue|mesh-list
83187807|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187808|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187809|NCT03391427|Lidocaine|lidocaine|mesh-list
83187810|NCT03391427|Ketamine|ketamine|mesh-list
83187811|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
83187812|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
83187813|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187814|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187815|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
83187816|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187817|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83187818|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83187819|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83187820|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83187821|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187822|NCT03391427|Analgesics|analgesics|mesh-ancestor
83187823|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83187824|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83187825|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
83187826|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83187827|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83187828|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187829|NCT03268811|Teduglutide|teduglutide|mesh-list
83187830|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83187831|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83187832|NCT03268811|Protective Agents|protective agents|mesh-ancestor
83187833|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187834|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
83187835|NCT03385967|Ropivacaine|ropivacaine|mesh-list
83187836|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83187837|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187838|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187839|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83187840|NCT03385967|Analgesics|analgesics|mesh-ancestor
83187841|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
83187842|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187843|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83187844|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83187845|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83187846|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
83187847|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187848|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187849|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83187850|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
83187851|NCT02732015|Dexamethasone|dexamethasone|mesh-list
83187852|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
83187853|NCT02732015|Doxorubicin|doxorubicin|mesh-list
83187854|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83187855|NCT02732015|Vincristine|vincristine|mesh-list
83187856|NCT02732015|Daunorubicin|daunorubicin|mesh-list
83187857|NCT02732015|Ifosfamide|ifosfamide|mesh-list
83187858|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
83187859|NCT02732015|Ondansetron|ondansetron|mesh-list
83187860|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
83187861|NCT02732015|Aprepitant|aprepitant|mesh-list
83187862|NCT02732015|BB 1101|bb 1101|mesh-list
83187863|NCT02732015|Rolapitant|rolapitant|mesh-list
83187864|NCT02732015|Mesna|mesna|mesh-list
83187865|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83187866|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
83187867|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
83187868|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187869|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187870|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83187871|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
83187872|NCT02732015|Hormones|hormones|mesh-ancestor
83187873|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187874|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83187875|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187876|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
83187877|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187878|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187879|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83187880|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83187881|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83187882|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83187883|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83187884|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83187885|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83187886|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
83187887|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
83187888|NCT02732015|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83187889|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83187890|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
83187891|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187892|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83187893|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
83187894|NCT02732015|Protective Agents|protective agents|mesh-ancestor
83187895|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83187896|NCT02520245|Cemiplimab|cemiplimab|mesh-list
83187897|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187898|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187899|NCT03537833|Pemetrexed|pemetrexed|mesh-list
83187900|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187901|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187902|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187903|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83187904|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83187905|NCT03439085|Durvalumab|durvalumab|mesh-list
83187906|NCT03439085|Interleukin-12|interleukin-12|mesh-list
83187907|NCT03439085|Vaccines|vaccines|mesh-list
83187908|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
83187909|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83187910|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
83187911|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
83187912|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187913|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83187914|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187915|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83187916|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83187917|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83187918|NCT03439085|Growth Substances|growth substances|mesh-ancestor
83187919|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
83187920|NCT01964807|Nicotine|nicotine|mesh-list
83187921|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83187922|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
83187923|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187924|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187925|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83187926|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83187927|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
83187928|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83187929|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187931|NCT01164995|Adavosertib|adavosertib|mesh-list
83187932|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187933|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187934|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187935|NCT00999401|Roscovitine|roscovitine|mesh-list
83187936|NCT00999401|Sapacitabine|sapacitabine|mesh-list
83187937|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187938|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
83187939|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83187940|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83187941|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187942|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187943|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83187944|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
83187945|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187946|NCT04446065|Protective Agents|protective agents|mesh-ancestor
83187947|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187948|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83187949|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83187950|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187951|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83187952|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
83187953|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83187954|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
83187955|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187956|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
83187957|NCT00225095|Protective Agents|protective agents|mesh-ancestor
83187958|NCT02732119|Everolimus|everolimus|mesh-list
83187959|NCT02732119|Exemestane|exemestane|mesh-list
83187960|NCT02732119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83187961|NCT02732119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83187962|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83187963|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83187964|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83187965|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
83187966|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187967|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83187968|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83187969|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83187970|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83187971|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
83187972|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187974|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
83187975|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187976|NCT05174195|Desogestrel|desogestrel|mesh-list
83187977|NCT05174195|Etonogestrel|etonogestrel|mesh-list
83187978|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83187979|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83187980|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83187981|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
83187982|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83187983|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187984|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83187985|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83187986|NCT05174195|Progestins|progestins|mesh-ancestor
83187987|NCT05174195|Hormones|hormones|mesh-ancestor
83187988|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83187989|NCT05238727|Mepivacaine|mepivacaine|mesh-list
83187990|NCT05238727|Carticaine|carticaine|mesh-list
83187991|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
83187992|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
83187993|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83187994|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83187995|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
83187996|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83187997|NCT03754153|Atropine|atropine|mesh-list
83187998|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83187999|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83188000|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83188001|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
83188002|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188003|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188004|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83188005|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188006|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
83188007|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
83188008|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83188009|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83188010|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
83188011|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188012|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188013|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
83188014|NCT03380039|Fludarabine|fludarabine|mesh-list
83188015|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83188016|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
83188017|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188018|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83188019|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83188020|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
83188021|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188022|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188023|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83188024|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83188025|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
83188026|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188027|NCT02520817|Vitamins|vitamins|mesh-list
83188028|NCT02520817|Vitamin E|vitamin e|mesh-list
83188030|NCT02520817|Lactulose|lactulose|mesh-list
83188031|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
83188032|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188033|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
83188034|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188035|NCT02520817|Protective Agents|protective agents|mesh-ancestor
83188036|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83188037|NCT03387943|Cisplatin|cisplatin|mesh-list
83188038|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188039|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
83188040|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83188041|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
83188042|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188043|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
83188044|NCT03384095|Protective Agents|protective agents|mesh-ancestor
83188045|NCT03379181|Propranolol|propranolol|mesh-list
83188046|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83188047|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83188048|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
83188049|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188050|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188051|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188052|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83188053|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83188054|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
83188055|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83188056|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83188057|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83188058|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
83188059|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188060|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188061|NCT03379103|Propofol|propofol|mesh-list
83188062|NCT03379103|Sevoflurane|sevoflurane|mesh-list
83188063|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83188064|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188065|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188066|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83188067|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
83188068|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
83188069|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83188070|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83188071|NCT03387631|Lumefantrine|lumefantrine|mesh-list
83188072|NCT03387631|Artemether|artemether|mesh-list
83188073|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83188074|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
83188075|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83188076|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83188077|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188078|NCT03383393|Adenosine|adenosine|mesh-list
83188079|NCT03383393|Eptifibatide|eptifibatide|mesh-list
83188080|NCT03383393|Analgesics|analgesics|mesh-ancestor
83188081|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
83188082|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188083|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188084|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83188085|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
83188086|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83188087|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
83188088|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
83188089|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188090|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188091|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83188092|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
83188093|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
83188094|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
83188095|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188096|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188097|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
83188098|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188100|NCT03383315|Metoclopramide|metoclopramide|mesh-list
83188101|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83188102|NCT03383315|Narcotics|narcotics|mesh-ancestor
83188103|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188104|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188105|NCT03383315|Analgesics|analgesics|mesh-ancestor
83188106|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
83188107|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188108|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
83188109|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
83188110|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83188111|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83188112|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83188113|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
83188114|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188115|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188116|NCT03394729|Propolis|propolis|mesh-list
83188117|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188118|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
83188119|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83188120|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
83188121|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188122|NCT03252925|Expectorants|expectorants|mesh-ancestor
83188123|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188124|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83188125|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
83188126|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188127|NCT03252925|Protective Agents|protective agents|mesh-ancestor
83188128|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188129|NCT03252925|Antidotes|antidotes|mesh-ancestor
83188130|NCT03383237|Apatinib|apatinib|mesh-list
83188131|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188132|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188133|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188134|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188135|NCT03387241|Fluticasone|fluticasone|mesh-list
83188136|NCT03387241|Xhance|xhance|mesh-list
83188137|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
83188138|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83188139|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83188140|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83188141|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83188142|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
83188143|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188144|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188145|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83188146|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188147|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
83188148|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83188149|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83188150|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83188151|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83188152|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83188153|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83417427|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83188154|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188155|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
83188157|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188158|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
83188159|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
83188160|NCT03378791|Trace Elements|trace elements|mesh-ancestor
83188161|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
83188162|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188163|NCT03383003|Amoxicillin|amoxicillin|mesh-list
83188164|NCT03383003|Metronidazole|metronidazole|mesh-list
83188165|NCT03383003|Clarithromycin|clarithromycin|mesh-list
83188166|NCT03383003|Esomeprazole|esomeprazole|mesh-list
83188167|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188168|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188169|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83188170|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83188171|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83188172|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83188173|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83188174|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188175|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188176|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83188177|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83188178|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83188179|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
83188180|NCT03378713|Testosterone|testosterone|mesh-list
83188181|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
83188182|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
83188183|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83188184|NCT03378713|Androgens|androgens|mesh-ancestor
83188185|NCT03378713|Hormones|hormones|mesh-ancestor
83188186|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188187|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188188|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83188189|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188190|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
83188191|NCT03378401|Octenidine|octenidine|mesh-list
83188192|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188193|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83188194|NCT03378323|Anesthetics|anesthetics|mesh-list
83188195|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
83188196|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188197|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188198|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
83188199|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188200|NCT01327885|Dacarbazine|dacarbazine|mesh-list
83188201|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83188202|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
83417428|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
83188203|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188204|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188205|NCT03381833|Hepcidins|hepcidins|mesh-list
83188206|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188207|NCT02976337|Naloxone|naloxone|mesh-list
83188208|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83188209|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188210|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
83188211|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188212|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83188213|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
83188214|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
83188215|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188216|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188217|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188218|NCT03381755|Ticagrelor|ticagrelor|mesh-list
83188219|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83188220|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83188221|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83188222|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83188223|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
83188224|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188225|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188226|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188227|NCT03387163|Valsartan|valsartan|mesh-list
83188228|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83188229|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83188230|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83188231|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83188232|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188233|NCT04446403|Anesthetics|anesthetics|mesh-list
83188234|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188235|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188236|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
83188237|NCT05237791|Analgesics|analgesics|mesh-ancestor
83188238|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
83188239|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188240|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188241|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
83188242|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188243|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83188244|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
83188245|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83188246|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83188247|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188248|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83188249|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
83188250|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83188251|NCT03381599|Lenograstim|lenograstim|mesh-list
83188252|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83188253|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
83188254|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188255|NCT03394573|Aflibercept|aflibercept|mesh-list
83188256|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83188257|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83188258|NCT03394573|Growth Substances|growth substances|mesh-ancestor
83188259|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188260|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
83188261|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188263|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188264|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188265|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188266|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188267|NCT03380975|Montelukast|montelukast|mesh-list
83188268|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83188269|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188270|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83188271|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
83188272|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188273|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188274|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83188275|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83188276|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188277|NCT03460015|Propofol|propofol|mesh-list
83188278|NCT03460015|Sevoflurane|sevoflurane|mesh-list
83188279|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83188280|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188281|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188282|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83188283|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
83188284|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
83188285|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83188286|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83188287|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
83188288|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83188289|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188290|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83188291|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83188292|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
83188293|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188295|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83188296|NCT03375515|Narcotics|narcotics|mesh-ancestor
83188297|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188298|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188299|NCT03375515|Analgesics|analgesics|mesh-ancestor
83188300|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
83188301|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188302|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
83188303|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83188304|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188305|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188306|NCT03374501|PAZ320|paz320|mesh-list
83188307|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83188308|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188309|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
83188310|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188311|NCT03374345|Mitogens|mitogens|mesh-ancestor
83188312|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
83188313|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188314|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
83188315|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83188316|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188317|NCT03373955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83188318|NCT03373955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188319|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
83188320|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
83188321|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188322|NCT02814695|Protective Agents|protective agents|mesh-ancestor
83188323|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188324|NCT02814695|Vitamins|vitamins|mesh-ancestor
83188325|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
83188326|NCT03386305|Tacrolimus|tacrolimus|mesh-list
83188327|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83188328|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
83188329|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188330|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83188331|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188332|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188333|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83188334|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188335|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
83188336|NCT05237323|Azathioprine|azathioprine|mesh-list
83188337|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83188338|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188339|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83188340|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
83188341|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188342|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188343|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188344|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188345|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
83188346|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83188347|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83188348|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
83188349|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188350|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83188351|NCT02520505|Citric Acid|citric acid|mesh-list
83188352|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
83188353|NCT02520505|Clomiphene|clomiphene|mesh-list
83188354|NCT02520505|Enclomiphene|enclomiphene|mesh-list
83188355|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
83188356|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
83188357|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83188358|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
83188359|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
83188360|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188361|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83188362|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
83188363|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188364|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188365|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83188366|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
83188367|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83188368|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83188370|NCT03380689|Bevacizumab|bevacizumab|mesh-list
83188371|NCT03380689|Irinotecan|irinotecan|mesh-list
83188372|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83188373|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188374|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83188375|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83188376|NCT03380689|Growth Substances|growth substances|mesh-ancestor
83188377|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188378|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
83188379|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83188380|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83188381|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188382|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188383|NCT03380533|Buprenorphine|buprenorphine|mesh-list
83188384|NCT03380533|Tramadol|tramadol|mesh-list
83188385|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83188386|NCT03380533|Narcotics|narcotics|mesh-ancestor
83188387|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188388|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188389|NCT03380533|Analgesics|analgesics|mesh-ancestor
83188390|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
83188391|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188392|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83188393|NCT03386149|Loxoprofen|loxoprofen|mesh-list
83188394|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83188395|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83188396|NCT03386149|Analgesics|analgesics|mesh-ancestor
83188397|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
83188398|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188399|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188400|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83188401|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83188402|NCT03386071|Trametinib|trametinib|mesh-list
83188403|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188404|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188405|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188406|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188407|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
83188408|NCT03231085|Trace Elements|trace elements|mesh-ancestor
83188409|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
83188410|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188411|NCT03385135|Allopurinol|allopurinol|mesh-list
83188412|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
83188413|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188414|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188415|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
83188416|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83188417|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83188418|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
83188419|NCT03385135|Protective Agents|protective agents|mesh-ancestor
83188420|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188421|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
83188422|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83188423|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188424|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83188425|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188426|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188427|NCT04436965|Cisplatin|cisplatin|mesh-list
83188428|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188429|NCT04420741|Iloprost|iloprost|mesh-list
83188430|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83188431|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
83188432|NCT04409041|Naltrexone|naltrexone|mesh-list
83188433|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83188434|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83188435|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188436|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
83188437|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188438|NCT03090997|Vitamins|vitamins|mesh-list
83188439|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
83188440|NCT03090997|Resveratrol|resveratrol|mesh-list
83188441|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
83188442|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188443|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
83188444|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188446|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188447|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83188448|NCT04446091|Irinotecan|irinotecan|mesh-list
83188449|NCT04446091|Apatinib|apatinib|mesh-list
83188450|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83188451|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83188452|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83188453|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188454|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188455|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188456|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188457|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83188458|NCT04446091|Growth Substances|growth substances|mesh-ancestor
83188459|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188460|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
83188461|NCT04445935|Bivalirudin|bivalirudin|mesh-list
83188462|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
83188463|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83188464|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83188465|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188466|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188467|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
83188468|NCT03385057|Acetaminophen|acetaminophen|mesh-list
83188469|NCT03385057|Ibuprofen|ibuprofen|mesh-list
83188470|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83188471|NCT03385057|Analgesics|analgesics|mesh-ancestor
83188472|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
83188473|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188474|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188475|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
83188476|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83188477|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83188478|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83188479|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83188480|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188481|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188482|NCT02051309|Guanfacine|guanfacine|mesh-list
83188483|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83188484|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83188485|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83188486|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83188487|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
83188488|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188489|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188490|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188491|NCT00372073|Roscovitine|roscovitine|mesh-list
83188492|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188493|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
83188494|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188495|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188496|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188497|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188498|NCT03373409|Albuterol|albuterol|mesh-list
83188499|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83188500|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
83188501|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188502|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188503|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83188504|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188505|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
83188506|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83188507|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83188508|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83188509|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83188510|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
83188511|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188512|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188513|NCT03379987|Morphine|morphine|mesh-list
83188514|NCT03379987|Bupivacaine|bupivacaine|mesh-list
83188515|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
83188516|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
83188517|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188518|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188520|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188521|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83188522|NCT03379987|Narcotics|narcotics|mesh-ancestor
83188523|NCT03379987|Analgesics|analgesics|mesh-ancestor
83188524|NCT02730793|Aztreonam|aztreonam|mesh-list
83188525|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188526|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188527|NCT03379909|Metformin|metformin|mesh-list
83188528|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83188529|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188530|NCT02678533|Plerixafor|plerixafor|mesh-list
83188531|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83188532|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83188533|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
83188534|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188535|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
83188536|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83188537|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188538|NCT03379441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83188539|NCT03379441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188540|NCT03384511|Apatinib|apatinib|mesh-list
83188541|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188542|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188543|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188544|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188545|NCT03385525|Valproic Acid|valproic acid|mesh-list
83188546|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
83188547|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188548|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188549|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
83188550|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188551|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188552|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
83188553|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83188554|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188555|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83188556|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
83188557|NCT05172739|Anesthetics|anesthetics|mesh-list
83188558|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188559|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188560|NCT05172739|Narcotics|narcotics|mesh-ancestor
83188561|NCT05172739|Analgesics|analgesics|mesh-ancestor
83188562|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
83188563|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188564|NCT03375463|Tirzepatide|tirzepatide|mesh-list
83188565|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83188566|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188567|NCT03375463|Incretins|incretins|mesh-ancestor
83188568|NCT03375463|Hormones|hormones|mesh-ancestor
83188569|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188570|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83188571|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83188572|NCT04445311|Ivermectin|ivermectin|mesh-list
83188573|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83188574|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188575|NCT03384121|Rifampin|rifampin|mesh-list
83188576|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83188577|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
83188578|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188579|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188580|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
83188581|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83188582|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188583|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188584|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83188585|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83188586|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83188587|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83188588|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83188589|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83188590|NCT03378661|Benzonidazole|benzonidazole|mesh-list
83188591|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83188592|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
83188593|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188594|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83188595|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83188596|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83188597|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188598|NCT03378427|Doxycycline|doxycycline|mesh-list
83188599|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
83188600|NCT03378427|Levofloxacin|levofloxacin|mesh-list
83188601|NCT03378427|Ofloxacin|ofloxacin|mesh-list
83188602|NCT03378427|Minocycline|minocycline|mesh-list
83188603|NCT03378427|Rifampin|rifampin|mesh-list
83188604|NCT03378427|Clindamycin|clindamycin|mesh-list
83188605|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83188606|NCT03378427|Tedizolid|tedizolid|mesh-list
83188607|NCT03378427|Teicoplanin|teicoplanin|mesh-list
83188608|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
83188609|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
83188610|NCT03378427|Trimethoprim|trimethoprim|mesh-list
83188611|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
83188612|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188613|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188614|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
83188615|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83188616|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83188617|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83188618|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83188619|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188620|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188621|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188622|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83188623|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83188624|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83188625|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83188626|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
83188627|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
83188628|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83188629|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83188630|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83188631|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83188632|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83188633|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83188634|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83188635|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83188636|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83188637|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83188638|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83188639|NCT05172115|Heparin|heparin|mesh-list
83188640|NCT05172115|Enoxaparin|enoxaparin|mesh-list
83188641|NCT05172115|Plasminogen|plasminogen|mesh-list
83188642|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83188643|NCT05172115|Tinzaparin|tinzaparin|mesh-list
83188644|NCT05172115|Dalteparin|dalteparin|mesh-list
83188645|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83188646|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
83188647|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83188648|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83188649|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188650|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83188651|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
83188652|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
83188653|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
83188654|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83188655|NCT03383185|Progestins|progestins|mesh-list
83188656|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83188657|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188658|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83188659|NCT03383185|Hormones|hormones|mesh-ancestor
83188660|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188661|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83188662|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83188663|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83188664|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83188665|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83188666|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188667|NCT03377725|Decitabine|decitabine|mesh-list
83188668|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
83188669|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83188670|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
83188671|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188672|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188673|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188674|NCT03374293|Antibodies|antibodies|mesh-list
83188675|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
83188676|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188677|NCT02730871|Timolol|timolol|mesh-list
83188678|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83188679|NCT02730871|Travoprost|travoprost|mesh-list
83188680|NCT02730871|Brinzolamide|brinzolamide|mesh-list
83188681|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83188682|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83188683|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
83188684|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188685|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188686|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188687|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83188688|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83188689|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83188690|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83188691|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83188692|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83188693|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188694|NCT03377335|Metformin|metformin|mesh-list
83188695|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
83188696|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83188697|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188698|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83188699|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188700|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
83188701|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
83188702|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83188703|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83188704|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
83188705|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188706|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188707|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188708|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188709|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83188710|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188712|NCT03373903|Dactolisib|dactolisib|mesh-list
83188713|NCT03373903|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83188714|NCT03373903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188715|NCT03373903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188716|NCT03373903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188717|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83188718|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
83188719|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188720|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188721|NCT04445857|Calcitonin|calcitonin|mesh-list
83188722|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
83188723|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83188724|NCT04445857|Katacalcin|katacalcin|mesh-list
83188725|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83188726|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188727|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83188728|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
83188729|NCT03373825|Fentanyl|fentanyl|mesh-list
83188730|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83188731|NCT03373825|Narcotics|narcotics|mesh-ancestor
83188732|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188733|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188734|NCT03373825|Analgesics|analgesics|mesh-ancestor
83188735|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
83188736|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188737|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83188738|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83188739|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
83188740|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
83188741|NCT04445779|Ubiquinone|ubiquinone|mesh-list
83188742|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
83188743|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
83188744|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188745|NCT04445779|Vitamins|vitamins|mesh-ancestor
83188746|NCT03377101|Fulvestrant|fulvestrant|mesh-list
83188747|NCT03377101|Palbociclib|palbociclib|mesh-list
83188748|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83188749|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188750|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83188751|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83188752|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
83188753|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188754|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188755|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83188756|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188757|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188758|NCT04445467|Favipiravir|favipiravir|mesh-list
83188759|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
83188760|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188762|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
83188763|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188764|NCT03382717|Amorolfine|amorolfine|mesh-list
83188765|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
83188766|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188767|NCT03125473|Vaccines|vaccines|mesh-list
83188768|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
83188769|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188770|NCT03376789|MYL-1501D|myl-1501d|mesh-list
83188771|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83188772|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188773|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
83188774|NCT03376555|Acetylcholine|acetylcholine|mesh-list
83188775|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
83188776|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83188777|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
83188778|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188779|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188780|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188781|NCT03376243|Emollients|emollients|mesh-list
83188782|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
83188783|NCT03700411|Morphine|morphine|mesh-list
83188784|NCT03700411|Pirinitramide|pirinitramide|mesh-list
83188785|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83188786|NCT03700411|Narcotics|narcotics|mesh-ancestor
83188787|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188788|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188789|NCT03700411|Analgesics|analgesics|mesh-ancestor
83188790|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
83188791|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188792|NCT03691051|Capecitabine|capecitabine|mesh-list
83188793|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83188794|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
83188795|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188796|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188797|NCT03381859|Grazoprevir|grazoprevir|mesh-list
83188798|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83188799|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
83188800|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188801|NCT03381781|Cytarabine|cytarabine|mesh-list
83188802|NCT03381781|Decitabine|decitabine|mesh-list
83188803|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
83188804|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83188805|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
83188806|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188807|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188808|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
83188809|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188810|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83188811|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
83188812|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188813|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188814|NCT03381703|YH12852|yh12852|mesh-list
83188815|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83188816|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83188817|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
83188818|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188819|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188820|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188821|NCT03372265|Ropivacaine|ropivacaine|mesh-list
83188822|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
83188823|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
83188824|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188825|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188826|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
83188828|NCT03372109|Calcium|calcium|mesh-list
83188829|NCT03372109|Turmeric extract|turmeric extract|mesh-list
83188830|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83188831|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188832|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
83188833|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188834|NCT03372109|Protective Agents|protective agents|mesh-ancestor
83188835|NCT03371953|Atracurium|atracurium|mesh-list
83188836|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
83188837|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83188838|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83188839|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83188840|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188841|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188842|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83188843|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83188844|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83188845|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188846|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188847|NCT03371797|Amlodipine|amlodipine|mesh-list
83188848|NCT03371797|Valsartan|valsartan|mesh-list
83188849|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83188850|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83188851|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83188852|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188853|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83188854|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188855|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
83188856|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83188857|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83188858|NCT02520115|Dexamethasone|dexamethasone|mesh-list
83188859|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
83188860|NCT02520115|Valproic Acid|valproic acid|mesh-list
83188861|NCT02520115|Ichthammol|ichthammol|mesh-list
83188862|NCT02520115|BB 1101|bb 1101|mesh-list
83188863|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83188864|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
83188865|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
83188866|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188867|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188868|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83188869|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
83188870|NCT02520115|Hormones|hormones|mesh-ancestor
83188871|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188872|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83188873|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188874|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
83188875|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188876|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188877|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
83188878|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
83188879|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188880|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
83188881|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83188882|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188883|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83188884|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
83188885|NCT03375775|Immunomodulating Agents|immunomodulating agents|mesh-list
83188886|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
83188887|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188888|NCT04527133|Aprotinin|aprotinin|mesh-list
83188889|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
83188890|NCT04527133|Coagulants|coagulants|mesh-ancestor
83188891|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83188892|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83188893|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83188894|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188895|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188896|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83188897|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188898|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83188899|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
83188900|NCT03369847|Budesonide|budesonide|mesh-list
83188901|NCT03369847|Beclomethasone|beclomethasone|mesh-list
83188902|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83188903|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83188904|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
83188905|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188906|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188907|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83188908|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
83188909|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
83188910|NCT03369847|Hormones|hormones|mesh-ancestor
83188911|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83188912|NCT04526353|Oxybutynin|oxybutynin|mesh-list
83188913|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
83188914|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
83188915|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188916|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188917|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83188918|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83188919|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
83188920|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83188921|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188922|NCT04526353|Urological Agents|urological agents|mesh-ancestor
83188923|NCT03371173|Ferric maltol|ferric maltol|mesh-list
83188924|NCT03371173|Hematinics|hematinics|mesh-ancestor
83188925|NCT03371095|Infliximab|infliximab|mesh-list
83188926|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
83188927|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83188928|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
83188929|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188930|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83188931|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83188932|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
83188933|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188934|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188935|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83188936|NCT03371095|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83188937|NCT03371095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83188938|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
83188939|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83188940|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83188941|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188942|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
83188943|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83188944|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83188945|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83188946|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83188947|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188948|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188949|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83188950|NCT03370861|Immunomodulating Agents|immunomodulating agents|mesh-list
83188951|NCT03370861|Immunologic Factors|immunologic factors|mesh-ancestor
83188952|NCT03370861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83417657|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
83188953|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83188954|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
83188955|NCT03370705|Captopril|captopril|mesh-list
83188956|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83188957|NCT03370705|Atorvastatin|atorvastatin|mesh-list
83188958|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83188959|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83188960|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83188961|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
83188962|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188963|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83188964|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83188965|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83188966|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
83188967|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83188968|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
83188969|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83188970|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83188971|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83188972|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188973|NCT03370705|Analgesics|analgesics|mesh-ancestor
83188974|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
83188975|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188976|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83188977|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83188978|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83188979|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83188980|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83188981|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
83188982|NCT03369379|Vitamins|vitamins|mesh-ancestor
83188983|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
83188984|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188985|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83188986|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83188987|NCT03362905|Lidocaine|lidocaine|mesh-list
83188988|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
83188989|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
83188990|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83188991|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83188992|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
83188993|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83188994|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83188995|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83188996|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83188997|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83188998|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83188999|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
83189000|NCT03370159|Docetaxel|docetaxel|mesh-list
83189001|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189002|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83189003|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83189004|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83189005|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189006|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
83189007|NCT03370159|Protective Agents|protective agents|mesh-ancestor
83189008|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189009|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
83189010|NCT03370159|Vitamins|vitamins|mesh-ancestor
83189011|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
83189012|NCT04522297|Octreotide|octreotide|mesh-list
83189013|NCT04522297|Epinephrine|epinephrine|mesh-list
83189014|NCT04522297|Midodrine|midodrine|mesh-list
83189015|NCT04522297|Norepinephrine|norepinephrine|mesh-list
83189016|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83189017|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83189018|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
83189019|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189020|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189021|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189022|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83189023|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83189024|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
83189025|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189026|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83189027|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
83189028|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
83189029|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
83189030|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83189031|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189032|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83189033|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189034|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83189035|NCT03369067|Insulin|insulin|mesh-list
83189036|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83189037|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189038|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189039|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83189040|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189041|NCT04525729|Rituximab|rituximab|mesh-list
83189042|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83189043|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189044|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
83189045|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189046|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189047|NCT04525495|Dopamine|dopamine|mesh-list
83189048|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83189049|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
83189050|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
83189051|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189052|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189053|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
83189054|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189055|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189056|NCT04525495|Protective Agents|protective agents|mesh-ancestor
83189057|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83189058|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189059|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83189060|NCT03362281|Amoxicillin|amoxicillin|mesh-list
83189061|NCT03362281|Clarithromycin|clarithromycin|mesh-list
83189062|NCT03362281|Omeprazole|omeprazole|mesh-list
83189063|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83189064|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189065|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83189066|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189067|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83189068|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189069|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189070|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83189071|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83189072|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83189073|NCT02518789|Fentanyl|fentanyl|mesh-list
83189074|NCT02518789|Midazolam|midazolam|mesh-list
83189075|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
83189076|NCT02518789|Remifentanil|remifentanil|mesh-list
83189077|NCT02518789|Propofol|propofol|mesh-list
83189078|NCT02518789|Etomidate|etomidate|mesh-list
83189079|NCT02518789|Atracurium|atracurium|mesh-list
83189080|NCT02518789|Rocuronium|rocuronium|mesh-list
83189081|NCT02518789|Cisatracurium|cisatracurium|mesh-list
83189082|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83189083|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189084|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189085|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83189086|NCT02518789|Analgesics|analgesics|mesh-ancestor
83189087|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
83189088|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189089|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83189090|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83189091|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83189092|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
83189093|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189094|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189095|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189096|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
83189097|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
83189098|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83189099|NCT02518789|Narcotics|narcotics|mesh-ancestor
83189100|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83189101|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83189102|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83189103|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83189104|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
83189105|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
83189106|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83189107|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83189108|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83189109|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83189110|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83189111|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
83189112|NCT03357757|Avelumab|avelumab|mesh-list
83189113|NCT03357757|Valproic Acid|valproic acid|mesh-list
83189114|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83189115|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189116|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
83189117|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189118|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189119|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
83189120|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189121|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189122|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
83189123|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83189124|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189126|NCT02929485|Bromocriptine|bromocriptine|mesh-list
83189127|NCT02929485|Tolcapone|tolcapone|mesh-list
83189128|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83189129|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83189130|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
83189131|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189132|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189133|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
83189134|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
83189135|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189136|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189137|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83189138|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189139|NCT04523623|Ibuprofen|ibuprofen|mesh-list
83189140|NCT04523623|Oxycodone|oxycodone|mesh-list
83189141|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83189142|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83189143|NCT04523623|Analgesics|analgesics|mesh-ancestor
83189144|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
83189145|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189146|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189147|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83189148|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189149|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83189150|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189151|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189152|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83189153|NCT04523623|Narcotics|narcotics|mesh-ancestor
83189154|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189155|NCT03357289|Immunomodulating Agents|immunomodulating agents|mesh-list
83189156|NCT03357289|Immunologic Factors|immunologic factors|mesh-ancestor
83189157|NCT03357289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189158|NCT03368131|Capecitabine|capecitabine|mesh-list
83189159|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
83189160|NCT03368131|Trastuzumab|trastuzumab|mesh-list
83189161|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83189162|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
83189163|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189164|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189165|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83189166|NCT04521751|Acarbose|acarbose|mesh-list
83189167|NCT04521751|Orlistat|orlistat|mesh-list
83189168|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83189169|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189170|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189171|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189172|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189173|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83189174|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83189175|NCT04521517|Imidacloprid|imidacloprid|mesh-list
83189176|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
83189177|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189178|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189179|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189180|NCT01675167|Buprenorphine|buprenorphine|mesh-list
83189181|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83189182|NCT01675167|Narcotics|narcotics|mesh-ancestor
83189183|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189184|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189185|NCT01675167|Analgesics|analgesics|mesh-ancestor
83189186|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
83189187|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189188|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83189189|NCT03370627|Antibodies|antibodies|mesh-list
83189190|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
83189191|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189192|NCT03367663|Prednisone|prednisone|mesh-list
83189193|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83189194|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
83189195|NCT03367663|Hormones|hormones|mesh-ancestor
83189196|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189197|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189198|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83189199|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189200|NCT03123289|Gallium citrate|gallium citrate|mesh-list
83189201|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189202|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83189204|NCT04521049|Incretins|incretins|mesh-ancestor
83189205|NCT04521049|Hormones|hormones|mesh-ancestor
83189206|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189207|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189208|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83189209|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83189210|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189211|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189212|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189213|NCT02267343|Nivolumab|nivolumab|mesh-list
83189214|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83189215|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189216|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83189217|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189218|NCT03123445|Gemcitabine|gemcitabine|mesh-list
83189219|NCT03123445|Endostar protein|endostar protein|mesh-list
83189220|NCT03123445|Endostatins|endostatins|mesh-list
83189221|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189222|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83189223|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
83189224|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189225|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83189226|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83189227|NCT03123445|Growth Substances|growth substances|mesh-ancestor
83189228|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189229|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
83189230|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83189231|NCT03357133|Tirofiban|tirofiban|mesh-list
83189232|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83189233|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83189234|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189235|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83189236|NCT03357055|Ketamine|ketamine|mesh-list
83189237|NCT03357055|Analgesics|analgesics|mesh-ancestor
83189238|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
83189239|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189240|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189241|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83189242|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189243|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
83189244|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
83189245|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189246|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83189247|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83189248|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189249|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189250|NCT03367585|Vitamin D|vitamin d|mesh-list
83189251|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
83189252|NCT03367585|Vitamins|vitamins|mesh-ancestor
83189253|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
83189254|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189255|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83189256|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83189257|NCT03360955|Anesthetics|anesthetics|mesh-list
83189258|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189259|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189260|NCT00584025|Levetiracetam|levetiracetam|mesh-list
83189261|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
83189262|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
83189263|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
83189264|NCT01735461|Calcium|calcium|mesh-list
83417736|NCT01596699|Busulfan|busulfan|mesh-list
83189265|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83189266|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189267|NCT01735461|Antacids|antacids|mesh-ancestor
83189268|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189269|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189270|NCT01595841|Sirolimus|sirolimus|mesh-list
83189271|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83189273|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83189274|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189275|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
83189276|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83189277|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
83189278|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189279|NCT05405049|Lidocaine|lidocaine|mesh-list
83189280|NCT05405049|Fentanyl|fentanyl|mesh-list
83189281|NCT05405049|Morphine|morphine|mesh-list
83189282|NCT05405049|Bupivacaine|bupivacaine|mesh-list
83189283|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
83189284|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
83189285|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189286|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189287|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
83189288|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189289|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83189290|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83189291|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83189292|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83189293|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189294|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83189295|NCT05405049|Narcotics|narcotics|mesh-ancestor
83189296|NCT05405049|Analgesics|analgesics|mesh-ancestor
83189297|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83189298|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189299|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
83189300|NCT04520503|Propofol|propofol|mesh-list
83189301|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83189302|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189303|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189304|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189305|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
83189306|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
83189307|NCT02871843|Temozolomide|temozolomide|mesh-list
83189308|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83189309|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
83189310|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189311|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189312|NCT03356899|Bupivacaine|bupivacaine|mesh-list
83189313|NCT03356899|Anesthetics|anesthetics|mesh-list
83189314|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
83189315|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189316|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189317|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
83189318|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189319|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
83189320|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
83189321|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83189322|NCT04523467|Growth Substances|growth substances|mesh-ancestor
83189323|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189324|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
83189325|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189326|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83189327|NCT02801097|Irinotecan|irinotecan|mesh-list
83189328|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83189329|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83189330|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189331|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189332|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189333|NCT03367195|Omeprazole|omeprazole|mesh-list
83189334|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83189335|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189336|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83189337|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189338|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189340|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189341|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189342|NCT04523233|Vitamins|vitamins|mesh-list
83189343|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
83189344|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189345|NCT05127369|Fluoxetine|fluoxetine|mesh-list
83189346|NCT05127369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83189347|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83189348|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83189349|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189350|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189351|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
83189352|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189353|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83189354|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
83189355|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83189356|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83189357|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83189358|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189359|NCT05126901|Ferric maltol|ferric maltol|mesh-list
83189360|NCT05126901|Hematinics|hematinics|mesh-ancestor
83189361|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
83189362|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189363|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
83189364|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83189365|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83189366|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189367|NCT03356353|Urological Agents|urological agents|mesh-ancestor
83189368|NCT04520035|Paclitaxel|paclitaxel|mesh-list
83189369|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83189370|NCT04520035|Cisplatin|cisplatin|mesh-list
83189371|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83189372|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189373|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83189374|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83189375|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83189376|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189377|NCT04208997|Amiodarone|amiodarone|mesh-list
83189378|NCT04208997|Sotalol|sotalol|mesh-list
83189379|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83189380|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
83189381|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83189382|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83189383|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189384|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83189385|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83189386|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83189387|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189388|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83189389|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83189390|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83189391|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83189392|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83189393|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83189394|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189395|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189397|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
83189398|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189399|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
83189400|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83189401|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83189402|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83189403|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83189404|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189405|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
83189406|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189407|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189408|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83189409|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189410|NCT04518475|Rituximab|rituximab|mesh-list
83189411|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83189412|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189413|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
83189414|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189415|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189416|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83189417|NCT04278651|Hematinics|hematinics|mesh-ancestor
83189418|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83189420|NCT05125575|Metformin|metformin|mesh-list
83189421|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189422|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189423|NCT03366883|Paclitaxel|paclitaxel|mesh-list
83189424|NCT03366883|Cisplatin|cisplatin|mesh-list
83189425|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83189426|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189427|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83189428|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83189429|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83189430|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189431|NCT03366571|Entecavir|entecavir|mesh-list
83189432|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
83189433|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189434|NCT05124951|Carboplatin|carboplatin|mesh-list
83189435|NCT05124951|Etoposide|etoposide|mesh-list
83189436|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
83189437|NCT05124951|Ifosfamide|ifosfamide|mesh-list
83189438|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189439|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83189440|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83189441|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83189442|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189443|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189444|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83189445|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
83189446|NCT04523077|Antibodies|antibodies|mesh-list
83189447|NCT04523077|Hormones|hormones|mesh-list
83189448|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
83189449|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189450|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189451|NCT05124717|Metformin|metformin|mesh-list
83189452|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189453|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189454|NCT04139655|Colchicine|colchicine|mesh-list
83189455|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
83189456|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189457|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83189458|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83189459|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83189460|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189461|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189462|NCT03366259|Misoprostol|misoprostol|mesh-list
83189463|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83189464|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
83189465|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83189466|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189467|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83189468|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189469|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
83189470|NCT03366025|Progesterone|progesterone|mesh-list
83189471|NCT03366025|Progestins|progestins|mesh-ancestor
83189472|NCT03366025|Hormones|hormones|mesh-ancestor
83189473|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189474|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189475|NCT05115591|Anesthetics|anesthetics|mesh-list
83189476|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189477|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189478|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
83189479|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83189480|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
83189481|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189482|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
83189483|NCT05403099|Protective Agents|protective agents|mesh-ancestor
83189484|NCT03365869|Sirolimus|sirolimus|mesh-list
83189485|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83189486|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189487|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83189488|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189489|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
83189490|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83189491|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
83189492|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189493|NCT04932213|Tropicamide|tropicamide|mesh-list
83189494|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
83189495|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
83189496|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189497|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189498|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83189499|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83189500|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
83189501|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189502|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189504|NCT03684213|Norepinephrine|norepinephrine|mesh-list
83189505|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
83189506|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
83189507|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189508|NCT03684213|Protective Agents|protective agents|mesh-ancestor
83189509|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189510|NCT03684213|Vitamins|vitamins|mesh-ancestor
83189511|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
83189512|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83189513|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83189514|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
83189515|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189516|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
83189517|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
83189518|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189519|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83189520|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189521|NCT03365479|Iloprost|iloprost|mesh-list
83189522|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83189523|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
83189524|NCT03355027|Atorvastatin|atorvastatin|mesh-list
83189525|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83189526|NCT03355027|Simvastatin|simvastatin|mesh-list
83189527|NCT03355027|Ezetimibe|ezetimibe|mesh-list
83189528|NCT03355027|Alirocumab|alirocumab|mesh-list
83189529|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83189530|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83189531|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
83189532|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189533|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83189534|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83189535|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189536|NCT03355027|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83189537|NCT03355027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83189538|NCT03355027|Protease Inhibitors|protease inhibitors|mesh-ancestor
83189539|NCT03828045|Apremilast|apremilast|mesh-list
83189540|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83189541|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83189542|NCT03828045|Analgesics|analgesics|mesh-ancestor
83189543|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
83189544|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189545|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189546|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83189547|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189548|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83189549|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83189550|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189551|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189552|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
83189553|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83189554|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189555|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83189556|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
83189557|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83189558|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
83189559|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189560|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
83189561|NCT02519335|Razoxane|razoxane|mesh-list
83189562|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189563|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83189564|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83189565|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83189566|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189567|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189568|NCT02519335|Protective Agents|protective agents|mesh-ancestor
83189569|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189570|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
83189571|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
83189572|NCT04509583|Vitamin E|vitamin e|mesh-list
83189573|NCT04509583|Vitamins|vitamins|mesh-ancestor
83189574|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
83189575|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189576|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
83189577|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189578|NCT04509583|Protective Agents|protective agents|mesh-ancestor
83189579|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
83189580|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
83189581|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189582|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189583|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83189584|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
83189585|NCT03350737|Heparin|heparin|mesh-list
83189586|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
83189587|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83189588|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83189589|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189590|NCT03350659|Midodrine|midodrine|mesh-list
83189591|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83189592|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83189593|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83189594|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83189595|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189596|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
83189597|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189598|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189599|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
83189600|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
83189601|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189602|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83189603|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83189604|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83189605|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83189606|NCT04443517|Propofol|propofol|mesh-list
83189607|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
83189608|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189609|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189610|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83189611|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189612|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
83189613|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
83189614|NCT03350347|Hematinics|hematinics|mesh-ancestor
83189615|NCT03350191|Exenatide|exenatide|mesh-list
83189616|NCT03350191|Glucagon|glucagon|mesh-list
83189617|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189618|NCT03350191|Hormones|hormones|mesh-ancestor
83189619|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189620|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189621|NCT03350191|Incretins|incretins|mesh-ancestor
83189622|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189623|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83189624|NCT02649231|Ketamine|ketamine|mesh-list
83189625|NCT02649231|Analgesics|analgesics|mesh-ancestor
83189626|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
83189627|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189628|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189629|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83189630|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189631|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
83189632|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
83189633|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189634|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83189635|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83189636|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189637|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189638|NCT03364075|Propranolol|propranolol|mesh-list
83189639|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83189640|NCT03364075|Serotonin|serotonin|mesh-list
83189641|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83189642|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83189643|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83189644|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189645|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189648|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
83189649|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189650|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
83189651|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83189652|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
83189653|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83189654|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83189655|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
83189656|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83189657|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83189658|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
83189659|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83189660|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
83189661|NCT03349957|Idarubicin|idarubicin|mesh-list
83189662|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83189663|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189664|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83189665|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83189666|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189667|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189668|NCT04524169|Thymalfasin|thymalfasin|mesh-list
83189669|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83189670|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
83189671|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189672|NCT03568929|Idelalisib|idelalisib|mesh-list
83189673|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189674|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189675|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189676|NCT04503967|Nivolumab|nivolumab|mesh-list
83189677|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83189678|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189679|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83189680|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189681|NCT04841499|Niacinamide|niacinamide|mesh-list
83189682|NCT04841499|Niacin|niacin|mesh-list
83189683|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
83189684|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
83189685|NCT04841499|Vitamins|vitamins|mesh-ancestor
83189686|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
83189687|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189688|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83189689|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
83189690|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189691|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83189692|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
83189693|NCT04773405|Lidocaine|lidocaine|mesh-list
83189694|NCT04773405|Epinephrine|epinephrine|mesh-list
83189695|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
83189696|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
83189697|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
83189698|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189699|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189700|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
83189701|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189702|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83189703|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83189704|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83189705|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83189706|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189707|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83189708|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83189709|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83189710|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189711|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83189712|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83189713|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
83189714|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83189715|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
83189716|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
83189717|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
83189718|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83189719|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
83189720|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83189721|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189722|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189723|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189724|NCT01376245|Fluticasone|fluticasone|mesh-list
83189725|NCT01376245|Xhance|xhance|mesh-list
83189726|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83189727|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83189728|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
83189729|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189730|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189731|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83189732|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
83189733|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
83189734|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83189735|NCT04754061|Psilocybin|psilocybin|mesh-list
83189736|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
83189737|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189738|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83189739|NCT03349489|Insulin|insulin|mesh-list
83189740|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83189741|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189742|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189743|NCT04584567|Doxycycline|doxycycline|mesh-list
83189744|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83189745|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189746|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
83189747|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83189748|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83189749|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
83189750|NCT03349177|Docetaxel|docetaxel|mesh-list
83189751|NCT03349177|Fluorouracil|fluorouracil|mesh-list
83189752|NCT03349177|Epirubicin|epirubicin|mesh-list
83189753|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83189754|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
83189755|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189756|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189757|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83189758|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
83189759|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189760|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189761|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83189762|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83189763|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83189764|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83189765|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
83189766|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83189767|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83189768|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83189769|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83189770|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189771|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
83189772|NCT04691505|Methotrexate|methotrexate|mesh-list
83189773|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83189774|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
83189775|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83189776|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189777|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83189778|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
83189779|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189780|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189781|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
83189782|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189783|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83189784|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83189785|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
83189786|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189787|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83189788|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
83189789|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83189790|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83189791|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189792|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83189793|NCT05400265|Antibodies|antibodies|mesh-list
83189794|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
83189795|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83189796|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
83189797|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189798|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189799|NCT05364619|Bismuth|bismuth|mesh-list
83189800|NCT05364619|Antacids|antacids|mesh-ancestor
83189801|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189802|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189803|NCT03353857|Rifampin|rifampin|mesh-list
83189804|NCT03353857|Dienogest|dienogest|mesh-list
83189805|NCT03353857|Drospirenone|drospirenone|mesh-list
83189806|NCT03353857|Midazolam|midazolam|mesh-list
83189807|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
83189808|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83189809|NCT03353857|Norethindrone|norethindrone|mesh-list
83189810|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
83189811|NCT03353857|Desogestrel|desogestrel|mesh-list
83189812|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83189813|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83189814|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189815|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189816|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83189817|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83189818|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83189819|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189820|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
83189821|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
83189822|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
83189823|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
83189824|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189825|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189826|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83189827|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
83189828|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83189829|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83189830|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83189831|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83189832|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83189833|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
83189834|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83189835|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189836|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
83189837|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83189838|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189839|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83189840|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83189841|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83189842|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83189843|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83189844|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83189845|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83189846|NCT03353857|Estrogens|estrogens|mesh-ancestor
83189847|NCT03353857|Hormones|hormones|mesh-ancestor
83189848|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189849|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83189850|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
83189851|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83189852|NCT03353857|Diuretics|diuretics|mesh-ancestor
83189853|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
83189854|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83189855|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83189856|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189857|NCT03353857|Progestins|progestins|mesh-ancestor
83189858|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83189859|NCT04499859|Ezetimibe|ezetimibe|mesh-list
83189860|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83189861|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83189862|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
83189863|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189864|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83189865|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83189866|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189867|NCT05306899|Ketamine|ketamine|mesh-list
83189868|NCT05306899|Analgesics|analgesics|mesh-ancestor
83189869|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
83189870|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189871|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189872|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83189873|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83189874|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
83189875|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
83189876|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83189877|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83189878|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83189879|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189880|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189881|NCT00807651|Insulin|insulin|mesh-list
83189882|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83189883|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83189884|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189885|NCT00700791|Vitamins|vitamins|mesh-list
83189886|NCT00700791|Vitamin E|vitamin e|mesh-list
83189887|NCT00700791|Tocopherols|tocopherols|mesh-list
83189888|NCT00700791|Tocotrienols|tocotrienols|mesh-list
83189889|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
83189890|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
83189891|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189892|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
83189893|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189894|NCT00700791|Protective Agents|protective agents|mesh-ancestor
83189895|NCT05344365|Iloperidone|iloperidone|mesh-list
83189896|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83189897|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83189899|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189900|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83189901|NCT04373733|Favipiravir|favipiravir|mesh-list
83189902|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
83189903|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189904|NCT05403489|Dimercaprol|dimercaprol|mesh-list
83189905|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
83189906|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
83189907|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189908|NCT04969731|Gemcitabine|gemcitabine|mesh-list
83189909|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83189910|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
83189911|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189912|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189913|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
83189914|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
83189915|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
83189916|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189917|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189918|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189919|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83189920|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
83189921|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
83189922|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83189923|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189924|NCT01674621|Abaloparatide|abaloparatide|mesh-list
83189925|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
83189926|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83189927|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189928|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83189929|NCT04644705|Niclosamide|niclosamide|mesh-list
83189930|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
83189931|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83189932|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
83189933|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83189934|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83189935|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
83189936|NCT04038489|Aspirin|aspirin|mesh-list
83189937|NCT04038489|Tamoxifen|tamoxifen|mesh-list
83189938|NCT04038489|Paclitaxel|paclitaxel|mesh-list
83189939|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
83189940|NCT04038489|Doxorubicin|doxorubicin|mesh-list
83189941|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83189942|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189943|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
83189944|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
83189945|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
83189946|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189947|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83189948|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
83189949|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189950|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83189951|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83189952|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
83189953|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83189954|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83189955|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83189956|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83189957|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189958|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83189959|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83189960|NCT04038489|Analgesics|analgesics|mesh-ancestor
83189961|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
83189962|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189963|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83189964|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83189965|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83189966|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83189967|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83189968|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
83189969|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83189970|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
83189971|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189972|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83189973|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83189974|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83189975|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83189976|NCT04468425|Tofacitinib|tofacitinib|mesh-list
83189977|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83189978|NCT04468425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83189979|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83189980|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83189981|NCT04287855|Dexamethasone|dexamethasone|mesh-list
83189982|NCT04287855|Pomalidomide|pomalidomide|mesh-list
83189983|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83189984|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
83189985|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
83189986|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83189987|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83189988|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83189989|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
83189990|NCT04287855|Hormones|hormones|mesh-ancestor
83189991|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83189992|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83189993|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83189994|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
83189995|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83189996|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83189997|NCT04287855|Growth Substances|growth substances|mesh-ancestor
83189998|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
83189999|NCT04435587|Ritonavir|ritonavir|mesh-list
83190000|NCT04435587|Darunavir|darunavir|mesh-list
83190001|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
83190002|NCT04435587|Ivermectin|ivermectin|mesh-list
83190003|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83190004|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83190005|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
83190006|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190007|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190008|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83190009|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83190010|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
83190011|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190012|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83190013|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83190014|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
83190015|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83190016|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83190017|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190018|NCT05131893|Tamoxifen|tamoxifen|mesh-list
83190019|NCT05131893|Docetaxel|docetaxel|mesh-list
83190020|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
83190021|NCT05131893|Capecitabine|capecitabine|mesh-list
83190022|NCT05131893|Trastuzumab|trastuzumab|mesh-list
83190023|NCT05131893|Letrozole|letrozole|mesh-list
83190024|NCT05131893|Epirubicin|epirubicin|mesh-list
83190025|NCT05131893|Pertuzumab|pertuzumab|mesh-list
83190027|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190028|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
83190029|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
83190030|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
83190031|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190032|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83190033|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
83190034|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190035|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190036|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83190037|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
83190038|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83190039|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190040|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
83190041|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190042|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83190043|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83190044|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190045|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83190046|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
83190047|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190048|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83190049|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83190050|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83190051|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83190052|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83190053|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83190054|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83190055|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
83190056|NCT02889237|Vitamin D|vitamin d|mesh-list
83190057|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
83190058|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
83190059|NCT02889237|Vitamins|vitamins|mesh-list
83190060|NCT02889237|Calcium|calcium|mesh-list
83190061|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
83190062|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190063|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83190064|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83190065|NCT02689167|Sunitinib|sunitinib|mesh-list
83190066|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190067|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83190068|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83190069|NCT02689167|Growth Substances|growth substances|mesh-ancestor
83190070|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190071|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83190072|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83190073|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190074|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190075|NCT02582697|Cisplatin|cisplatin|mesh-list
83190076|NCT02582697|Etoposide|etoposide|mesh-list
83190077|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
83190078|NCT02582697|Bleomycin|bleomycin|mesh-list
83190079|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190080|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83190081|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83190082|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83190083|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190084|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190085|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83190086|NCT01503489|Norepinephrine|norepinephrine|mesh-list
83190087|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
83190088|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
83190089|NCT01503489|Serotonin|serotonin|mesh-list
83190090|NCT01503489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83190091|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83190092|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83190093|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
83190094|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190095|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190096|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190097|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
83190098|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
83190099|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190100|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83190101|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83190102|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83190103|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
83190104|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83190105|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83190106|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83190107|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83190108|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190109|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190110|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83190111|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83190112|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190113|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
83190114|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190115|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
83190116|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83190117|NCT05135715|Trastuzumab|trastuzumab|mesh-list
83190118|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190119|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190120|NCT05185167|Propofol|propofol|mesh-list
83190121|NCT05185167|Anesthetics|anesthetics|mesh-list
83190122|NCT05185167|Desflurane|desflurane|mesh-list
83190123|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
83190124|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83190125|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190126|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190127|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83190128|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83190129|NCT05133453|Pirfenidone|pirfenidone|mesh-list
83190130|NCT05133453|Analgesics|analgesics|mesh-ancestor
83190131|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
83190132|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190133|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190134|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83190135|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83190136|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190137|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190138|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190139|NCT05125185|Insulin|insulin|mesh-list
83190140|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83190141|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190142|NCT04244877|Rifaximin|rifaximin|mesh-list
83190143|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190144|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190145|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83190146|NCT04495179|Durvalumab|durvalumab|mesh-list
83190147|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190148|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190149|NCT05118945|Insulin|insulin|mesh-list
83190150|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83190151|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83190152|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190153|NCT05305131|Bevacizumab|bevacizumab|mesh-list
83190154|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
83190155|NCT05305131|Cisplatin|cisplatin|mesh-list
83190156|NCT05305131|Gemcitabine|gemcitabine|mesh-list
83190157|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190158|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190159|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83190160|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83190161|NCT05305131|Growth Substances|growth substances|mesh-ancestor
83190162|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190163|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
83190164|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190165|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
83190166|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190167|NCT05305131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83190168|NCT03122665|Nefopam|nefopam|mesh-list
83190169|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83190170|NCT03122665|Analgesics|analgesics|mesh-ancestor
83190171|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
83190172|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190173|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190174|NCT05099913|Flupenthixol|flupenthixol|mesh-list
83190175|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83190176|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83190177|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190178|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190179|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83190180|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83190181|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
83190182|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190183|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190184|NCT03346993|Bupivacaine|bupivacaine|mesh-list
83190185|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
83190186|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
83190187|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190188|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190189|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
83190190|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190191|NCT03346837|Itraconazole|itraconazole|mesh-list
83190192|NCT03346837|Rifampin|rifampin|mesh-list
83190193|NCT03346837|Linrodostat|linrodostat|mesh-list
83190194|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
83190195|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190196|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83190197|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83190198|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190199|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190200|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83190201|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
83190202|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190203|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190204|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83190205|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83190206|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
83190207|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190208|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
83190209|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83190210|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83190211|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83190212|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83190213|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83190214|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83190215|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83190216|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
83190217|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
83190218|NCT05303961|Rebamipide|rebamipide|mesh-list
83190219|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83190220|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83190221|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
83190222|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190223|NCT05303961|Protective Agents|protective agents|mesh-ancestor
83190224|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190225|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190226|NCT03122353|Calcitriol|calcitriol|mesh-list
83190227|NCT03122353|Betamethasone|betamethasone|mesh-list
83190228|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
83190229|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83190230|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
83190231|NCT03122353|Calcipotriene|calcipotriene|mesh-list
83190232|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83190233|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190234|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
83190235|NCT03122353|Hormones|hormones|mesh-ancestor
83190236|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190237|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190238|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83190239|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
83190240|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
83190241|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83190242|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83190243|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83190244|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190245|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83190246|NCT03122353|Vitamins|vitamins|mesh-ancestor
83190247|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
83190248|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83190249|NCT05303259|Bevacizumab|bevacizumab|mesh-list
83190250|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190251|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190252|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83190253|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83190254|NCT05303259|Growth Substances|growth substances|mesh-ancestor
83190255|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190256|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
83190257|NCT03121963|Acetaminophen|acetaminophen|mesh-list
83190258|NCT03121963|Celecoxib|celecoxib|mesh-list
83190259|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83190260|NCT03121963|Oxycodone|oxycodone|mesh-list
83190261|NCT03121963|Gabapentin|gabapentin|mesh-list
83190262|NCT03121963|Hydrocodone|hydrocodone|mesh-list
83190263|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83190264|NCT03121963|Analgesics|analgesics|mesh-ancestor
83190265|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
83190266|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190267|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190268|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
83190269|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83190270|NCT03121963|Narcotics|narcotics|mesh-ancestor
83190271|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190272|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83190273|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190274|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190275|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83190276|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83190277|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190278|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190279|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
83190280|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83190281|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83190282|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83190283|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83190284|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83190285|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190286|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
83190287|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
83190288|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
83190289|NCT04502251|Naltrexone|naltrexone|mesh-list
83190290|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83190291|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83190292|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190293|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
83190294|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190295|NCT02648217|Insulin|insulin|mesh-list
83190296|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83190297|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
83190298|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
83190299|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83190300|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
83190301|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83190302|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190303|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83190304|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83190305|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190306|NCT03122041|Incretins|incretins|mesh-ancestor
83190307|NCT03122041|Hormones|hormones|mesh-ancestor
83190308|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190309|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83190310|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
83190311|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190312|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190313|NCT04943679|Interferons|interferons|mesh-list
83190314|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
83190315|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190316|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
83190317|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190318|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
83190319|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190320|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
83190321|NCT04507165|Anesthetics|anesthetics|mesh-list
83190322|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190323|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190324|NCT04507165|Narcotics|narcotics|mesh-ancestor
83190325|NCT04507165|Analgesics|analgesics|mesh-ancestor
83190326|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
83190327|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190328|NCT04475991|Maraviroc|maraviroc|mesh-list
83190329|NCT04475991|Favipiravir|favipiravir|mesh-list
83190330|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83190331|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83190332|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190333|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83190334|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83190335|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
83190336|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190337|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83190338|NCT03387475|Deferasirox|deferasirox|mesh-list
83190339|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83190340|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
83190341|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
83190342|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190343|NCT04502017|Clopidogrel|clopidogrel|mesh-list
83190344|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83190345|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83190346|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83190347|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83190348|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
83190349|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190350|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190351|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190352|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
83190353|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
83190354|NCT05302713|Calcium|calcium|mesh-list
83190355|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83190356|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190357|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83190358|NCT05302713|Antacids|antacids|mesh-ancestor
83190359|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190360|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83190361|NCT04921033|Prednisolone|prednisolone|mesh-list
83190362|NCT04921033|Budesonide|budesonide|mesh-list
83190363|NCT04921033|Azathioprine|azathioprine|mesh-list
83190364|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190365|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
83190366|NCT04921033|Hormones|hormones|mesh-ancestor
83190367|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190368|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190369|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83190370|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190371|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
83190372|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190373|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83190374|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83190375|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
83190376|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
83190377|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190378|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190379|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83190380|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
83190381|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190382|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
83190383|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83190384|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
83190385|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190386|NCT03346681|Expectorants|expectorants|mesh-ancestor
83190387|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
83190388|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83190389|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
83190390|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190391|NCT03346681|Protective Agents|protective agents|mesh-ancestor
83190392|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190393|NCT03346681|Antidotes|antidotes|mesh-ancestor
83190394|NCT04488315|Dexamethasone|dexamethasone|mesh-list
83190395|NCT04488315|Ropivacaine|ropivacaine|mesh-list
83190396|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190397|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
83190398|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
83190399|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190400|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190401|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83190402|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
83190403|NCT04488315|Hormones|hormones|mesh-ancestor
83190404|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190405|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83190406|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190407|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
83190408|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
83190409|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190410|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
83190411|NCT00709735|Propranolol|propranolol|mesh-list
83190412|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83190413|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83190414|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
83190415|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190416|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190417|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190418|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83190419|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83190420|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
83190421|NCT04505995|Azacitidine|azacitidine|mesh-list
83190422|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
83190423|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190424|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
83190425|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190426|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190427|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190428|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83190429|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83190430|NCT04486911|Letrozole|letrozole|mesh-list
83190431|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190432|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83190433|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83190434|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190435|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190436|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83190438|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190439|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190440|NCT05135013|Drospirenone|drospirenone|mesh-list
83190441|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83190442|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83190443|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83190444|NCT05135013|Norethindrone|norethindrone|mesh-list
83190445|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
83190446|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83190447|NCT05135013|Estradiol|estradiol|mesh-list
83190448|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83190449|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
83190450|NCT05135013|Estrogens|estrogens|mesh-ancestor
83190451|NCT05135013|Hormones|hormones|mesh-ancestor
83190452|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190453|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190454|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83190455|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
83190456|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83190457|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83190458|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83190459|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83190460|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83190461|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
83190462|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83190463|NCT05135013|Diuretics|diuretics|mesh-ancestor
83190464|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
83190465|NCT05135013|Progestins|progestins|mesh-ancestor
83190466|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83190467|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83190468|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190469|NCT04505917|Misoprostol|misoprostol|mesh-list
83190470|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83190471|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
83190472|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83190473|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190474|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83190475|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83190476|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
83190477|NCT04505683|Ertapenem|ertapenem|mesh-list
83190478|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190479|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190480|NCT05576155|Compound 21|compound 21|mesh-list
83190481|NCT05576155|Losartan|losartan|mesh-list
83190482|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83190483|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83190484|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83190485|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83190486|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190487|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190488|NCT04501783|Favipiravir|favipiravir|mesh-list
83190489|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
83190490|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190491|NCT03351751|PF-06372865|pf-06372865|mesh-list
83190492|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
83190493|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
83190494|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190495|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190496|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190497|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
83190498|NCT03347461|Dexamethasone|dexamethasone|mesh-list
83190499|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190500|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
83190501|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
83190502|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190503|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190504|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83190506|NCT03347461|Hormones|hormones|mesh-ancestor
83190507|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190508|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83190509|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190510|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190511|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190512|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190513|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190514|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83190515|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83190516|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83190517|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83190518|NCT03351517|Tapentadol|tapentadol|mesh-list
83190519|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83190520|NCT03351517|Narcotics|narcotics|mesh-ancestor
83190521|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190522|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190523|NCT03351517|Analgesics|analgesics|mesh-ancestor
83190524|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
83190525|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190526|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83190527|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83190528|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83190529|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190530|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
83190531|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190532|NCT03346525|Penicillins|penicillins|mesh-list
83190533|NCT03346525|Penicillin G|penicillin g|mesh-list
83190534|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83190535|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
83190536|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190537|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190538|NCT05060523|Tolvaptan|tolvaptan|mesh-list
83190539|NCT05060523|Midodrine|midodrine|mesh-list
83190540|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83190541|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190542|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
83190543|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190544|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
83190545|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
83190546|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190547|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83190548|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83190549|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83190550|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83190551|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83190552|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190553|NCT04502641|Docetaxel|docetaxel|mesh-list
83190554|NCT04502641|Fluorouracil|fluorouracil|mesh-list
83190555|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190556|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
83190557|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
83190558|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
83190559|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190560|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
83190561|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190562|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83190563|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
83190564|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190566|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
83190567|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83190568|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
83190569|NCT05555797|Tazarotene|tazarotene|mesh-list
83190570|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83190571|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190572|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
83190573|NCT05555797|Hormones|hormones|mesh-ancestor
83190574|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190575|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190576|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83190577|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
83190578|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
83190579|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
83190580|NCT03955575|Liraglutide|liraglutide|mesh-list
83190581|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83190582|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83190583|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190584|NCT03955575|Incretins|incretins|mesh-ancestor
83190585|NCT03955575|Hormones|hormones|mesh-ancestor
83190586|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190587|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83190588|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83190589|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
83190590|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190591|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83190592|NCT04163419|Tanezumab|tanezumab|mesh-list
83190593|NCT04163419|Analgesics|analgesics|mesh-ancestor
83190594|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
83190595|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190596|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190597|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83190598|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83190599|NCT03351205|Estradiol|estradiol|mesh-list
83190600|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83190601|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
83190602|NCT03351205|Estrogens|estrogens|mesh-ancestor
83190603|NCT03351205|Hormones|hormones|mesh-ancestor
83190604|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190605|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190606|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83190607|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
83190608|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83190609|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83190610|NCT03351205|Progestins|progestins|mesh-ancestor
83190611|NCT04698057|Amoxicillin|amoxicillin|mesh-list
83190612|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
83190613|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
83190614|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
83190615|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83190616|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190617|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190618|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83190619|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83190620|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190621|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190622|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190623|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83190624|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83190625|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83190626|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83190627|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
83190628|NCT02449005|Coagulants|coagulants|mesh-ancestor
83190629|NCT04132791|Aspirin|aspirin|mesh-list
83190630|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83190631|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83190632|NCT04132791|Analgesics|analgesics|mesh-ancestor
83190633|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
83190634|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190635|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190636|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190637|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190638|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83190639|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83190640|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190641|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83190642|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83190643|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190644|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
83190645|NCT04065009|Ropivacaine|ropivacaine|mesh-list
83190646|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
83190647|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
83190648|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190649|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190650|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
83190651|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190652|NCT04250493|Insulin|insulin|mesh-list
83190653|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83190654|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190655|NCT01868451|Doxorubicin|doxorubicin|mesh-list
83190656|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83190657|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83190658|NCT01868451|Dacarbazine|dacarbazine|mesh-list
83190659|NCT01868451|Vinblastine|vinblastine|mesh-list
83190660|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83190661|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190662|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83190663|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83190664|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190665|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190666|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190667|NCT01868451|Immunotoxins|immunotoxins|mesh-ancestor
83190668|NCT01868451|Immunoconjugates|immunoconjugates|mesh-ancestor
83190669|NCT01868451|Immunologic Factors|immunologic factors|mesh-ancestor
83190670|NCT01868451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190671|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83190672|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
83190673|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83190674|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
83190675|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
83190676|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
83190677|NCT03833479|Dostarlimab|dostarlimab|mesh-list
83190678|NCT03833479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190679|NCT04147221|Imipenem|imipenem|mesh-list
83190680|NCT04147221|Relebactam|relebactam|mesh-list
83190681|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190682|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190683|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83190684|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190685|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190686|NCT02517619|Dexamethasone|dexamethasone|mesh-list
83190687|NCT02517619|Prednisolone|prednisolone|mesh-list
83190688|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83190689|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
83190690|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83190691|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
83190692|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83190693|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83190694|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
83190695|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83190696|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190697|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
83190698|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
83190699|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190700|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190701|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83190702|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
83190703|NCT02517619|Hormones|hormones|mesh-ancestor
83190704|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190705|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83190706|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190707|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83190708|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83190709|NCT02517619|Protective Agents|protective agents|mesh-ancestor
83190710|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83190711|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190712|NCT03892395|Vitamin D|vitamin d|mesh-list
83190713|NCT03892395|Vitamins|vitamins|mesh-list
83190714|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
83190715|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
83190716|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190717|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83190718|NCT04481451|Ropivacaine|ropivacaine|mesh-list
83190719|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
83190720|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
83190721|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190722|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190723|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
83190724|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190725|NCT03376659|Bevacizumab|bevacizumab|mesh-list
83190726|NCT03376659|Durvalumab|durvalumab|mesh-list
83190727|NCT03376659|Capecitabine|capecitabine|mesh-list
83190728|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190729|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190730|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83190731|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83190732|NCT03376659|Growth Substances|growth substances|mesh-ancestor
83190733|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190734|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
83190735|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190736|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
83190737|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190738|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
83190739|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83190740|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83190741|NCT04086147|Tenecteplase|tenecteplase|mesh-list
83190742|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83190743|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83190744|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190745|NCT03161223|Azacitidine|azacitidine|mesh-list
83190746|NCT03161223|Durvalumab|durvalumab|mesh-list
83190747|NCT03161223|Romidepsin|romidepsin|mesh-list
83190748|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190749|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
83190750|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190751|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190752|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190753|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190754|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83190755|NCT03161223|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83190756|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83190757|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
83190758|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83190759|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
83190760|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83190761|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190762|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83190763|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83190764|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190765|NCT01285557|Cisplatin|cisplatin|mesh-list
83190766|NCT01285557|Fluorouracil|fluorouracil|mesh-list
83190767|NCT01285557|Tegafur|tegafur|mesh-list
83190768|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190769|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
83190770|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190771|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190772|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83190773|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
83190774|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190775|NCT03083067|Budesonide|budesonide|mesh-list
83190776|NCT03083067|Bromides|bromides|mesh-list
83190777|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
83190778|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
83190779|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190780|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83190781|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
83190782|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190783|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190784|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83190785|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
83190786|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
83190787|NCT03083067|Hormones|hormones|mesh-ancestor
83190788|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190789|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83190790|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83190791|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83190792|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
83190793|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190794|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190795|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
83190796|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83190797|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
83190798|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
83190799|NCT03218137|Adenosine|adenosine|mesh-list
83190800|NCT03218137|Verapamil|verapamil|mesh-list
83190801|NCT03218137|Analgesics|analgesics|mesh-ancestor
83190802|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
83190803|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190804|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190805|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83190806|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
83190807|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83190808|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
83190809|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
83190810|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190811|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190812|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83190813|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83190814|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83190815|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
83190816|NCT05638399|Denosumab|denosumab|mesh-list
83190817|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83190818|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190819|NCT02512471|Ropivacaine|ropivacaine|mesh-list
83190820|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
83190821|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
83190822|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190823|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190824|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
83190825|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190827|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83190828|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
83190829|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190830|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190831|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83190832|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83190833|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
83190834|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190835|NCT02512315|Cisplatin|cisplatin|mesh-list
83190836|NCT02512315|Docetaxel|docetaxel|mesh-list
83190837|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190838|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
83190839|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83190840|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83190841|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190842|NCT02507323|Ticagrelor|ticagrelor|mesh-list
83190843|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83190844|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83190845|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83190846|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83190847|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83190848|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
83190849|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190850|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190851|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190852|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
83190853|NCT05431413|Fluoxetine|fluoxetine|mesh-list
83190854|NCT05431413|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83190855|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83190856|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83190857|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190858|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83190859|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
83190860|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190861|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83190862|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
83190863|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83190864|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83190865|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83190866|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190867|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83190868|NCT05431413|Protective Agents|protective agents|mesh-ancestor
83190869|NCT02507245|Hormones|hormones|mesh-list
83190870|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
83190871|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83190872|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190873|NCT02517307|Heparin|heparin|mesh-list
83190874|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83190875|NCT02517307|Glycerol|glycerol|mesh-list
83190876|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
83190877|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83190878|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83190879|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190880|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83417737|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
83190881|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83190882|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83190883|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83190884|NCT02517307|Protective Agents|protective agents|mesh-ancestor
83190885|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190886|NCT05431257|Venetoclax|venetoclax|mesh-list
83190887|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190888|NCT05431023|Lactoferrin|lactoferrin|mesh-list
83190889|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190890|NCT02507167|Rifampin|rifampin|mesh-list
83190891|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83190892|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
83190893|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190894|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190895|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
83190896|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83190897|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190898|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190899|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83190900|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83190901|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83190902|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83190903|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83190904|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83190905|NCT01376167|Chloroquine|chloroquine|mesh-list
83190906|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83190907|NCT01376167|Primaquine|primaquine|mesh-list
83190908|NCT01376167|Tafenoquine|tafenoquine|mesh-list
83190909|NCT01376167|Amebicides|amebicides|mesh-ancestor
83190910|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83190911|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83190912|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190913|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
83190914|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190915|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83190916|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83190917|NCT01376167|Analgesics|analgesics|mesh-ancestor
83190918|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
83190919|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190920|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190921|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83190922|NCT01376167|Filaricides|filaricides|mesh-ancestor
83190923|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
83190924|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
83190925|NCT02511613|Squalamine|squalamine|mesh-list
83190926|NCT02511613|Ranibizumab|ranibizumab|mesh-list
83190927|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83190928|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83190929|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83190930|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83190931|NCT02511613|Growth Substances|growth substances|mesh-ancestor
83190932|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190933|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
83190934|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190935|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83190936|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83190937|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83190938|NCT02511613|Protective Agents|protective agents|mesh-ancestor
83190939|NCT02506699|Analgesics|analgesics|mesh-list
83190940|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
83190941|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190942|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190943|NCT02506777|Metformin|metformin|mesh-list
83190944|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
83190945|NCT02506777|Doxorubicin|doxorubicin|mesh-list
83190946|NCT02506777|Fluorouracil|fluorouracil|mesh-list
83190947|NCT02506777|Melatonin|melatonin|mesh-list
83190948|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83190949|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
83190950|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190951|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83190952|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83190953|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
83190954|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190955|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190956|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83190957|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83190958|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83190959|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83190960|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83190961|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190962|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
83190963|NCT02506777|Protective Agents|protective agents|mesh-ancestor
83190964|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190965|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
83190966|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83190967|NCT02516527|Ipilimumab|ipilimumab|mesh-list
83190968|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83190969|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190970|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83190971|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190972|NCT02511847|Afatinib|afatinib|mesh-list
83190973|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190974|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83190975|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190976|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190977|NCT02506855|Ropivacaine|ropivacaine|mesh-list
83190978|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
83190979|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
83190980|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190981|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190982|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
83190983|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190984|NCT02511223|Olaparib|olaparib|mesh-list
83190985|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83190986|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83190987|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83190988|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83190989|NCT02516059|Oxycodone|oxycodone|mesh-list
83190990|NCT02516059|Naloxone|naloxone|mesh-list
83190991|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83190992|NCT02516059|Narcotics|narcotics|mesh-ancestor
83190993|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83190994|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83190995|NCT02516059|Analgesics|analgesics|mesh-ancestor
83190996|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
83190997|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83190998|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83190999|NCT02506231|Leucovorin|leucovorin|mesh-list
83191000|NCT02506231|Folic Acid|folic acid|mesh-list
83191001|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
83191002|NCT02506231|Antidotes|antidotes|mesh-ancestor
83191003|NCT02506231|Protective Agents|protective agents|mesh-ancestor
83191004|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191005|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
83191006|NCT02506231|Vitamins|vitamins|mesh-ancestor
83191007|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
83191008|NCT02506231|Hematinics|hematinics|mesh-ancestor
83191009|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83191010|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83191011|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83191012|NCT02505997|Delafloxacin|delafloxacin|mesh-list
83191013|NCT02505997|Midazolam|midazolam|mesh-list
83191014|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83191015|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191016|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191017|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191018|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83191019|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83191020|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83191021|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191022|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
83191024|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
83191025|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
83191026|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191027|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191028|NCT02505997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191029|NCT02511067|Ranibizumab|ranibizumab|mesh-list
83191030|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83191031|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83191032|NCT02511067|Growth Substances|growth substances|mesh-ancestor
83191033|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191034|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
83191035|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191036|NCT02505841|Ropivacaine|ropivacaine|mesh-list
83191037|NCT02505841|Succinylcholine|succinylcholine|mesh-list
83191038|NCT02505841|Curare|curare|mesh-list
83191039|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
83191040|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
83191041|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191042|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191043|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
83191044|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191045|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83191046|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83191047|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83191048|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83191049|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83191050|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83191051|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
83191052|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191053|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191054|NCT03345667|Ranibizumab|ranibizumab|mesh-list
83191055|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83191056|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83191057|NCT03345667|Growth Substances|growth substances|mesh-ancestor
83191058|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191059|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
83191060|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191061|NCT04499989|Isoniazid|isoniazid|mesh-list
83191062|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
83191063|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83191064|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191065|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83191066|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83191067|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
83191068|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191069|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83191070|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
83191071|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
83191072|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191073|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
83191074|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
83191075|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191076|NCT02505451|Dobutamine|dobutamine|mesh-list
83191077|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83191078|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
83191079|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
83191080|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191081|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191082|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83191083|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83191084|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191085|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191086|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191087|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191088|NCT02505451|Protective Agents|protective agents|mesh-ancestor
83191090|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
83191091|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191092|NCT02505295|Protective Agents|protective agents|mesh-ancestor
83191093|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191094|NCT02505295|Trace Elements|trace elements|mesh-ancestor
83191095|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
83191096|NCT02510911|Caffeine|caffeine|mesh-list
83191097|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83191098|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191099|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83191100|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191101|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191102|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83191103|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83191104|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
83191105|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191106|NCT03121807|Leucovorin|leucovorin|mesh-list
83191107|NCT03121807|Fluorouracil|fluorouracil|mesh-list
83191108|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
83191109|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
83191110|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191111|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83191112|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191113|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83191114|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
83191115|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191116|NCT03121807|Antidotes|antidotes|mesh-ancestor
83191117|NCT03121807|Protective Agents|protective agents|mesh-ancestor
83191118|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
83191119|NCT03121807|Vitamins|vitamins|mesh-ancestor
83191120|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
83191121|NCT03343873|Midazolam|midazolam|mesh-list
83191122|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
83191123|NCT03343873|Propofol|propofol|mesh-list
83191124|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191125|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191126|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191127|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191128|NCT03343873|Analgesics|analgesics|mesh-ancestor
83191129|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
83191130|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191131|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83191132|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83191133|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191134|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191135|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191136|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191137|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191138|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
83191140|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83191141|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83191142|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83191143|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83191144|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
83191145|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
83191146|NCT03343795|Progesterone|progesterone|mesh-list
83191147|NCT03343795|Progestins|progestins|mesh-ancestor
83191148|NCT03343795|Hormones|hormones|mesh-ancestor
83191149|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83191150|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191151|NCT02510287|Lidocaine|lidocaine|mesh-list
83191152|NCT02510287|Fentanyl|fentanyl|mesh-list
83191153|NCT02510287|Bupivacaine|bupivacaine|mesh-list
83191154|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
83191155|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
83191156|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191157|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191158|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
83191159|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191160|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83191161|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83191162|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83191163|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83191164|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191165|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83191166|NCT02510287|Narcotics|narcotics|mesh-ancestor
83191167|NCT02510287|Analgesics|analgesics|mesh-ancestor
83191168|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83191169|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191170|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
83191171|NCT02515435|Apatinib|apatinib|mesh-list
83191172|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191173|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83191174|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191175|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191176|NCT02515201|Taurolidine|taurolidine|mesh-list
83191177|NCT02515201|Heparin|heparin|mesh-list
83191178|NCT02515201|Calcium heparin|calcium heparin|mesh-list
83191179|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
83191180|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83191181|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83191182|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191183|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191184|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83191185|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191186|NCT02504983|Sorafenib|sorafenib|mesh-list
83191187|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191188|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83191189|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191190|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191191|NCT02510053|Caspofungin|caspofungin|mesh-list
83191192|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
83191193|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191194|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191195|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191196|NCT02504359|Cytarabine|cytarabine|mesh-list
83191197|NCT02504359|Methotrexate|methotrexate|mesh-list
83191198|NCT02504359|Etoposide|etoposide|mesh-list
83191199|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
83191200|NCT02504359|Melphalan|melphalan|mesh-list
83191201|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
83191202|NCT02504359|Carmustine|carmustine|mesh-list
83191203|NCT02504359|Ixazomib|ixazomib|mesh-list
83191204|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
83191205|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83191207|NCT02504359|Glycine|glycine|mesh-list
83191208|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83191209|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
83191210|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191211|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191212|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83191213|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
83191214|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191215|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191216|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83191217|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191218|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83191219|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83191220|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
83191221|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83191222|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83191223|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83191224|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83191225|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83191226|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
83191227|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191228|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83191229|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83191230|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
83191231|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83191232|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
83191233|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
83191234|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
83191235|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
83191236|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
83191237|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
83191238|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191239|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
83191240|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83191241|NCT02729545|Cyproterone|cyproterone|mesh-list
83191242|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83191243|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83191244|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83191245|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
83191246|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191247|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191248|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83191249|NCT02729545|Estrogens|estrogens|mesh-ancestor
83191250|NCT02729545|Hormones|hormones|mesh-ancestor
83191251|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83191252|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
83191253|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83191254|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191255|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83191256|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
83191257|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83191258|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83191259|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191260|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
83191261|NCT02504125|Coagulants|coagulants|mesh-ancestor
83191262|NCT02509429|Insulin|insulin|mesh-list
83191263|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83191264|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
83191265|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
83191266|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83191267|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
83191268|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83191269|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191270|NCT02509273|Clonidine|clonidine|mesh-list
83191271|NCT02509273|Midazolam|midazolam|mesh-list
83191272|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83191273|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191274|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191275|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191276|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83191277|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83191278|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83191279|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191280|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
83191281|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
83191282|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
83191283|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
83191284|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191285|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191286|NCT02509273|Analgesics|analgesics|mesh-ancestor
83191287|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
83191288|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191289|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83191290|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
83191291|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
83191292|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83191293|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83191294|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191295|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191296|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
83191297|NCT02514343|Bupivacaine|bupivacaine|mesh-list
83191298|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
83191299|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
83191300|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191301|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191302|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
83191303|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191304|NCT02514343|Analgesics|analgesics|mesh-ancestor
83191305|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83191306|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
83191307|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83191308|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83191309|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191310|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83191311|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
83191312|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191313|NCT02514421|Paclitaxel|paclitaxel|mesh-list
83191314|NCT02514421|Gemcitabine|gemcitabine|mesh-list
83191315|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83191316|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191317|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
83191319|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
83191320|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191321|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83191322|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
83191323|NCT04499209|Naproxen|naproxen|mesh-list
83191324|NCT04499209|Pregabalin|pregabalin|mesh-list
83191325|NCT04499209|Analgesics|analgesics|mesh-ancestor
83191326|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
83191327|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191328|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191329|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
83191330|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83191331|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83191332|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191333|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83191334|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83191335|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83191336|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191337|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83191338|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83191339|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191340|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191341|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83191342|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
83191343|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83191344|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191345|NCT02509351|Misoprostol|misoprostol|mesh-list
83191346|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83191347|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
83191348|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191349|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191350|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83191351|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83191352|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
83191353|NCT02509195|Lamivudine|lamivudine|mesh-list
83191354|NCT02509195|Abacavir|abacavir|mesh-list
83191355|NCT02509195|Dolutegravir|dolutegravir|mesh-list
83191356|NCT02509195|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
83191357|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83191358|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83191359|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191360|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191361|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
83191362|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191363|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83191364|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83191365|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83191366|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83191367|NCT02508805|Diclofenac|diclofenac|mesh-list
83191368|NCT02508805|Tizanidine|tizanidine|mesh-list
83191369|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83191370|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191371|NCT02508805|Analgesics|analgesics|mesh-ancestor
83191372|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
83191373|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191374|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191375|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191376|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83191377|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83191378|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191379|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191380|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
83191381|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83191382|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83191383|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
83191384|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
83191385|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83191386|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83191387|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191388|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191389|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191390|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83191391|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83191392|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83191393|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83191394|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191395|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191396|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191397|NCT03121573|Analgesics|analgesics|mesh-ancestor
83191398|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
83191399|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191400|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
83191401|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83191402|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
83191403|NCT03121417|Nivolumab|nivolumab|mesh-list
83191404|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83191405|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191406|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83191407|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191408|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83191409|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83191410|NCT02502643|Picibanil|picibanil|mesh-list
83191411|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191412|NCT02502565|Uric Acid|uric acid|mesh-list
83191413|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
83191414|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191415|NCT02502565|Protective Agents|protective agents|mesh-ancestor
83191416|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191417|NCT04498897|Acamprosate|acamprosate|mesh-list
83191418|NCT04498897|Vortioxetine|vortioxetine|mesh-list
83191419|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
83191420|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83191421|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83191422|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83191423|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191424|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191425|NCT04498897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83191426|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83191427|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83191428|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191429|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191430|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
83191431|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83191432|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83191433|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83191434|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83191435|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83191436|NCT02502877|Midazolam|midazolam|mesh-list
83191437|NCT02502877|Propofol|propofol|mesh-list
83191438|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191439|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191440|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191441|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191442|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
83191443|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
83191444|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83191445|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83191446|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83191447|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83191448|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
83191449|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
83191450|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191451|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191452|NCT03121339|Vaccines|vaccines|mesh-list
83191453|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
83191454|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191455|NCT03343327|Hydrocortisone|hydrocortisone|mesh-list
83191456|NCT03343327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191457|NCT02502175|Methadone|methadone|mesh-list
83191458|NCT02502175|Opium|opium|mesh-list
83191459|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83191460|NCT02502175|Narcotics|narcotics|mesh-ancestor
83191461|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191462|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191463|NCT02502175|Analgesics|analgesics|mesh-ancestor
83191464|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
83191465|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191466|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
83191467|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
83191468|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
83191469|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83191470|NCT02501941|Ketamine|ketamine|mesh-list
83191471|NCT02501941|Analgesics|analgesics|mesh-ancestor
83191472|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
83191473|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191474|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191475|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83191476|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191477|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
83191478|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
83191479|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191480|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83191481|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83191482|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191483|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191484|NCT02500927|Naquotinib|naquotinib|mesh-list
83191485|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191486|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83191487|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191488|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191489|NCT02501863|Fentanyl|fentanyl|mesh-list
83191490|NCT02501863|Ropivacaine|ropivacaine|mesh-list
83191491|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
83191492|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
83191493|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191494|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191495|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
83191496|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191497|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83191498|NCT02501863|Narcotics|narcotics|mesh-ancestor
83191499|NCT02501863|Analgesics|analgesics|mesh-ancestor
83191500|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83191501|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191502|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
83191503|NCT02500459|Topotecan|topotecan|mesh-list
83191504|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83191505|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83191506|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191507|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191508|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191509|NCT02500225|Sevoflurane|sevoflurane|mesh-list
83191510|NCT02500225|Etomidate|etomidate|mesh-list
83191511|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83191512|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83191513|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
83191514|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
83191515|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191516|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191517|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191518|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191519|NCT02507635|Levocetirizine|levocetirizine|mesh-list
83191520|NCT02507635|Desloratadine|desloratadine|mesh-list
83191521|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83191522|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83191523|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
83191524|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
83191525|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191526|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191527|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191528|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83191529|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
83191530|NCT04495933|Vaccines|vaccines|mesh-list
83191531|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83191532|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
83191533|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191534|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83191536|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
83191537|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
83191538|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191539|NCT03344029|Vaccines|vaccines|mesh-list
83191540|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
83191541|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191542|NCT03120637|Methylene Blue|methylene blue|mesh-list
83191543|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191544|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191545|NCT02499757|Nicotine|nicotine|mesh-list
83191546|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83191547|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
83191548|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191549|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191550|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83191551|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83191552|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
83191553|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191554|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191555|NCT00706849|Mipomersen|mipomersen|mesh-list
83191556|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83191557|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83191558|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
83191559|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191560|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83191561|NCT02499445|Sufentanil|sufentanil|mesh-list
83191562|NCT02499445|Remifentanil|remifentanil|mesh-list
83191563|NCT02499445|Propofol|propofol|mesh-list
83191564|NCT02499445|Sevoflurane|sevoflurane|mesh-list
83191565|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191566|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191567|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191568|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83191569|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
83191570|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
83191571|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83191572|NCT02499445|Narcotics|narcotics|mesh-ancestor
83191573|NCT02499445|Analgesics|analgesics|mesh-ancestor
83191574|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
83191575|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191576|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83191577|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83191578|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83191579|NCT04443049|Mebendazole|mebendazole|mesh-list
83191580|NCT04443049|Piperazine|piperazine|mesh-list
83191581|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
83191582|NCT04443049|Lenvatinib|lenvatinib|mesh-list
83191583|NCT04443049|DMP 777|dmp 777|mesh-list
83191584|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191585|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83191586|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191587|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191588|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
83191589|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
83191590|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83191591|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191592|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83191593|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83191594|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83191595|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83191596|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
83191597|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191598|NCT03341845|Avelumab|avelumab|mesh-list
83191599|NCT03341845|Axitinib|axitinib|mesh-list
83191600|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83191601|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191602|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83191603|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191604|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191605|NCT02498977|Cyclosporine|cyclosporine|mesh-list
83191606|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
83191607|NCT02498977|Azathioprine|azathioprine|mesh-list
83191608|NCT02498977|Tacrolimus|tacrolimus|mesh-list
83191609|NCT02498977|Cyclosporins|cyclosporins|mesh-list
83191610|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83191611|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
83191612|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191613|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83191614|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191615|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191616|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
83191617|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191618|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
83191619|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83191620|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83191621|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191622|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83191623|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
83191624|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83191625|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
83191626|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83191627|NCT02494687|Domperidone|domperidone|mesh-list
83191628|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
83191629|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
83191630|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191631|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191632|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83191633|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83191634|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
83191635|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191636|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191637|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83191638|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
83191639|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
83191640|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191641|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191642|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83191643|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83191644|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191645|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83191646|NCT03341767|Clofazimine|clofazimine|mesh-list
83191647|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191648|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
83191649|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83191650|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191651|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
83191652|NCT02498509|Levocabastine|levocabastine|mesh-list
83191653|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191654|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
83191655|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83191656|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83191657|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83191658|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
83191659|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
83191660|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191661|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191662|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191663|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
83191664|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83191665|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
83191666|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191667|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191668|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83191669|NCT02493283|Dapsone|dapsone|mesh-list
83191670|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191671|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
83191672|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83191673|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83191674|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83191675|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191676|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191677|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
83191678|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83191679|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
83191680|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191681|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191682|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191683|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191685|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
83191686|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191687|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83191688|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83191689|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191690|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191691|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191692|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191693|NCT02493049|Domperidone|domperidone|mesh-list
83191694|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191695|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
83191696|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
83191697|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191698|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191699|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83191700|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83191701|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
83191702|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191703|NCT03120715|Heparin|heparin|mesh-list
83191704|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83191705|NCT03120715|Tinzaparin|tinzaparin|mesh-list
83191706|NCT03120715|Dalteparin|dalteparin|mesh-list
83191707|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83191708|NCT03120715|Progesterone|progesterone|mesh-list
83191709|NCT03120715|Estrogens|estrogens|mesh-list
83191710|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
83191711|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83191712|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83191713|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191714|NCT03120715|Progestins|progestins|mesh-ancestor
83191715|NCT03120715|Hormones|hormones|mesh-ancestor
83191716|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83191717|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191718|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191719|NCT03120403|Morphine|morphine|mesh-list
83191720|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83191721|NCT03120403|Narcotics|narcotics|mesh-ancestor
83191722|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191723|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191724|NCT03120403|Analgesics|analgesics|mesh-ancestor
83191725|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
83191726|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191727|NCT03335293|Epinephrine|epinephrine|mesh-list
83191728|NCT03335293|Racepinephrine|racepinephrine|mesh-list
83191729|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
83191730|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83191731|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191732|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191733|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191734|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191735|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191736|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83191737|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83191738|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
83191739|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191740|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83191741|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
83191742|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
83191743|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
83191744|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83191745|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
83191746|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83191747|NCT03340753|Hormones|hormones|mesh-ancestor
83191748|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83191749|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191750|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
83191751|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83191752|NCT03340753|Diuretics|diuretics|mesh-ancestor
83191753|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
83191754|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83191755|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83191756|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191757|NCT03340597|Olorofim|olorofim|mesh-list
83191758|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
83191759|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191760|NCT00707161|Cisplatin|cisplatin|mesh-list
83191761|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191762|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
83191763|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83191764|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191765|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191766|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191767|NCT03120247|Analgesics|analgesics|mesh-ancestor
83191768|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
83191769|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191770|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83191771|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83191772|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191773|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191774|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191775|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191776|NCT03335059|Mitomycins|mitomycins|mesh-list
83191777|NCT03335059|Mitomycin|mitomycin|mesh-list
83191778|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83191779|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191780|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
83191781|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191782|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83191783|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191784|NCT03334981|Buprenorphine|buprenorphine|mesh-list
83191785|NCT03334981|Methadone|methadone|mesh-list
83191786|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83191787|NCT03334981|Narcotics|narcotics|mesh-ancestor
83191788|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191789|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191790|NCT03334981|Analgesics|analgesics|mesh-ancestor
83191791|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
83191792|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191793|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83191794|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
83191795|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
83191796|NCT02492503|Paclitaxel|paclitaxel|mesh-list
83191797|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83191798|NCT02492503|Carboplatin|carboplatin|mesh-list
83191799|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83191800|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191801|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
83191802|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
83191803|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
83191804|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191805|NCT03334591|Apatinib|apatinib|mesh-list
83191806|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191807|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83191808|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191809|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191810|NCT03334513|Bevacizumab|bevacizumab|mesh-list
83191811|NCT03334513|Ranibizumab|ranibizumab|mesh-list
83191812|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83191813|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191814|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83191815|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83191816|NCT03334513|Growth Substances|growth substances|mesh-ancestor
83191817|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191818|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
83191819|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
83191820|NCT02130466|Trametinib|trametinib|mesh-list
83191821|NCT02130466|Dabrafenib|dabrafenib|mesh-list
83191822|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83191823|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191824|NCT02130466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83191825|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191826|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83191827|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191828|NCT03339427|Vitamin D|vitamin d|mesh-list
83191829|NCT03339427|Vitamins|vitamins|mesh-ancestor
83191830|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
83191831|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191832|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83191833|NCT03339349|Enoxaparin|enoxaparin|mesh-list
83191835|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83191836|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83191837|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191838|NCT02496715|Fluticasone|fluticasone|mesh-list
83191839|NCT02496715|Xhance|xhance|mesh-list
83191840|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83191841|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191842|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83191843|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
83191844|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191845|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191846|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83191847|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83191848|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
83191849|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83191850|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83191851|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83191852|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83191853|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191854|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191855|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191856|NCT02492581|Nalmefene|nalmefene|mesh-list
83191857|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83191858|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191859|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
83191860|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191861|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
83191862|NCT03342079|Anesthetics|anesthetics|mesh-list
83191863|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
83191864|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191865|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191866|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
83191867|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191868|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83191869|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
83191870|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191871|NCT03342079|Analgesics|analgesics|mesh-ancestor
83191872|NCT04494763|Propranolol|propranolol|mesh-list
83191873|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83191874|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83191875|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
83191876|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191877|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191878|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191879|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83191880|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83191881|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
83191882|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
83191883|NCT02162758|Lansoprazole|lansoprazole|mesh-list
83191884|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83191885|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83191886|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83191887|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191888|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191889|NCT03333499|Trimetazidine|trimetazidine|mesh-list
83191890|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
83191891|NCT04494529|Betamethasone|betamethasone|mesh-list
83191892|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
83191893|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83191894|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
83191895|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83191896|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191897|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
83191898|NCT04494529|Hormones|hormones|mesh-ancestor
83191899|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83191900|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191901|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83191902|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
83191903|NCT02491879|Ketoprofen|ketoprofen|mesh-list
83191904|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83191905|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191906|NCT02491879|Analgesics|analgesics|mesh-ancestor
83191907|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
83191908|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191909|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191910|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191912|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83191913|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191914|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191915|NCT03332953|Nicotine|nicotine|mesh-list
83191916|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83191917|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
83191918|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191919|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191920|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83191921|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83191922|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83191923|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191924|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191925|NCT02491723|Azithromycin|azithromycin|mesh-list
83191926|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83191927|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191928|NCT03332719|Etanercept|etanercept|mesh-list
83191929|NCT03332719|Methotrexate|methotrexate|mesh-list
83191930|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83191931|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
83191932|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83191933|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191934|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83191935|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
83191936|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191937|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191938|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
83191939|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83191940|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83191941|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83191942|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
83191943|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83191944|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83191945|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83191946|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83191947|NCT03332719|Analgesics|analgesics|mesh-ancestor
83191948|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
83191949|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191950|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191951|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83191952|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
83191953|NCT03330613|Anesthetics|anesthetics|mesh-list
83191954|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83191955|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191956|NCT03332329|Entecavir|entecavir|mesh-list
83191957|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83191958|NCT03332329|Molgramostim|molgramostim|mesh-list
83191959|NCT03332329|Vaccines|vaccines|mesh-list
83191960|NCT03332329|Sargramostim|sargramostim|mesh-list
83191961|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
83191962|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191963|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
83191964|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83191965|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191966|NCT03330223|Clopidogrel|clopidogrel|mesh-list
83191967|NCT03330223|Ticagrelor|ticagrelor|mesh-list
83191968|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83191969|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83191970|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83191971|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83191972|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
83191973|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83191974|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83191975|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191976|NCT03331861|Metformin|metformin|mesh-list
83191977|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83191978|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191979|NCT03329443|Spironolactone|spironolactone|mesh-list
83191980|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83191981|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
83191982|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83191988|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83191990|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
83191991|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83191992|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83191993|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83191994|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
83191995|NCT03328975|Hormones|hormones|mesh-ancestor
83191996|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83191997|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83191998|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83191999|NCT05430711|Dinoprostone|dinoprostone|mesh-list
83192000|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
83192001|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192002|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192003|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
83192004|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83192005|NCT03324685|Estradiol|estradiol|mesh-list
83192006|NCT03324685|Estrogens|estrogens|mesh-ancestor
83192007|NCT03324685|Hormones|hormones|mesh-ancestor
83417738|NCT01596699|Clofarabine|clofarabine|mesh-list
83192008|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192009|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192010|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83192011|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
83192012|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192013|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83192014|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83192015|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83192016|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83192017|NCT03324139|Heparin|heparin|mesh-list
83192018|NCT03324139|Calcium heparin|calcium heparin|mesh-list
83192019|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83192020|NCT03324139|Tinzaparin|tinzaparin|mesh-list
83192021|NCT03324139|Dalteparin|dalteparin|mesh-list
83192022|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
83192023|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83192024|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83192025|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192026|NCT03324061|Fulvestrant|fulvestrant|mesh-list
83192027|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192028|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192029|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83192030|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83192031|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
83192032|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192033|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192034|NCT02488603|Tamoxifen|tamoxifen|mesh-list
83192035|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83192036|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
83192037|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192038|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192039|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192040|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192041|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83192042|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83192043|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83192049|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
83192050|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192051|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83192052|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192053|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192054|NCT05430087|Vitamin D|vitamin d|mesh-list
83192055|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
83192056|NCT05430087|Curcumin|curcumin|mesh-list
83192058|NCT05430087|Vitamins|vitamins|mesh-ancestor
83192059|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
83192060|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192061|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83192062|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83192063|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83192064|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192065|NCT05430087|Analgesics|analgesics|mesh-ancestor
83192066|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
83192067|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192068|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192069|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83192070|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192071|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192072|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192073|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83192074|NCT03327727|Voriconazole|voriconazole|mesh-list
83192075|NCT03327727|Amphotericin B|amphotericin b|mesh-list
83192076|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83192077|NCT03327727|Isavuconazole|isavuconazole|mesh-list
83192078|NCT03327727|VL-2397|vl-2397|mesh-list
83192079|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
83192080|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192081|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83192082|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83192083|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192084|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192085|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83192086|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
83192087|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192088|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192089|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83192090|NCT03327727|Amebicides|amebicides|mesh-ancestor
83192091|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83192092|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83192093|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83192094|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
83192095|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83192096|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192097|NCT03323671|Analgesics|analgesics|mesh-ancestor
83192098|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
83192099|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192100|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192101|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192102|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83192103|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83192104|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192105|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192106|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
83192107|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83192108|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192109|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192110|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192111|NCT03323593|Analgesics|analgesics|mesh-ancestor
83192112|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
83192113|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192114|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83192115|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83192116|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83192117|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
83192118|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192119|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192120|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
83192121|NCT02499003|Pixantrone|pixantrone|mesh-list
83192122|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83192123|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192124|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83192125|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83192126|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192127|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192128|NCT04492813|Remifentanil|remifentanil|mesh-list
83192129|NCT04492813|Propofol|propofol|mesh-list
83192130|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83192131|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192132|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192133|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83192134|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
83192135|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
83192136|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83192137|NCT04492813|Narcotics|narcotics|mesh-ancestor
83192138|NCT04492813|Analgesics|analgesics|mesh-ancestor
83192139|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
83192140|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192142|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83192143|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83192144|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192145|NCT02488057|Liraglutide|liraglutide|mesh-list
83192146|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83192147|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192148|NCT02488057|Incretins|incretins|mesh-ancestor
83192149|NCT02488057|Hormones|hormones|mesh-ancestor
83192150|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192151|NCT04039347|Cyclosporine|cyclosporine|mesh-list
83192152|NCT04039347|Cyclosporins|cyclosporins|mesh-list
83192153|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192154|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192155|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192156|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
83192157|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192158|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
83192159|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192160|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
83192161|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83192162|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83192163|NCT05253573|Nicotine|nicotine|mesh-list
83192164|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83192165|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
83192166|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192167|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192168|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83192169|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83192170|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
83192171|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192172|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192173|NCT02488291|Sufentanil|sufentanil|mesh-list
83192174|NCT02488291|Dsuvia|dsuvia|mesh-list
83192175|NCT02488291|Ropivacaine|ropivacaine|mesh-list
83192176|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
83192177|NCT02488291|Anesthetics|anesthetics|mesh-list
83192178|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192179|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192180|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
83192181|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192182|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83192183|NCT02488291|Narcotics|narcotics|mesh-ancestor
83192184|NCT02488291|Analgesics|analgesics|mesh-ancestor
83192185|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83192186|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83192187|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
83192188|NCT03323047|Acetaminophen|acetaminophen|mesh-list
83192189|NCT03323047|Dexamethasone|dexamethasone|mesh-list
83192190|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
83192191|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83192192|NCT03323047|BB 1101|bb 1101|mesh-list
83192193|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192194|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
83192195|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
83192196|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192197|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192198|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192199|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
83192200|NCT03323047|Hormones|hormones|mesh-ancestor
83192201|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192202|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192203|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192204|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83192205|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192206|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192207|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192208|NCT03323047|Analgesics|analgesics|mesh-ancestor
83192209|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
83192210|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
83192211|NCT03322969|Paclitaxel|paclitaxel|mesh-list
83192212|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83192213|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192214|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
83192215|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
83192216|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
83192217|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192218|NCT05464303|Antibodies|antibodies|mesh-list
83192219|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83192220|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
83192221|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83192222|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
83192223|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192224|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
83192225|NCT03322735|Fludarabine|fludarabine|mesh-list
83192226|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192227|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
83192228|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192229|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83192230|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83192231|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
83192232|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192233|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192234|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83192235|NCT02487823|Bicalutamide|bicalutamide|mesh-list
83192236|NCT02487823|Buserelin|buserelin|mesh-list
83192237|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
83192238|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
83192239|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192240|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192241|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192242|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83192243|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
83192244|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192245|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83192246|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83192247|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192248|NCT02487433|Tofacitinib|tofacitinib|mesh-list
83192249|NCT02487433|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83192250|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83192251|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192252|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192253|NCT04493125|Mosapride|mosapride|mesh-list
83192254|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192255|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192256|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83192257|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
83192258|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192259|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192260|NCT03318835|Thalidomide|thalidomide|mesh-list
83192261|NCT03318835|Prednisone|prednisone|mesh-list
83192262|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
83192263|NCT03318835|Vincristine|vincristine|mesh-list
83192264|NCT03318835|Rituximab|rituximab|mesh-list
83192265|NCT03318835|Doxorubicin|doxorubicin|mesh-list
83192266|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192267|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
83192268|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192269|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
83192270|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83192271|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192272|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83192273|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83192274|NCT03318835|Growth Substances|growth substances|mesh-ancestor
83192275|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
83192276|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192277|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83192278|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83192279|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
83192280|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192281|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83192282|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192283|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
83192285|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192286|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192287|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83192288|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
83192289|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
83192290|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
83192291|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83192292|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83192293|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83192294|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83192295|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192296|NCT03318757|Bupivacaine|bupivacaine|mesh-list
83192297|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
83192298|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
83192299|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192300|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192301|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
83192302|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192303|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
83192304|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
83192305|NCT02487355|Bupivacaine|bupivacaine|mesh-list
83192306|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
83192307|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
83192308|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192309|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192310|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
83192311|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192312|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83192313|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192314|NCT02487355|Analgesics|analgesics|mesh-ancestor
83192315|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83192316|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83192317|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83192318|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83192319|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192320|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192321|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83192322|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
83192323|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83192324|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83192325|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83192326|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
83192327|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192328|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
83192329|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83192330|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192331|NCT03325465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83192332|NCT03325465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192333|NCT01876953|Cytarabine|cytarabine|mesh-list
83192334|NCT01876953|Dasatinib|dasatinib|mesh-list
83192335|NCT01876953|Idarubicin|idarubicin|mesh-list
83192336|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83192337|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
83192338|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192339|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192340|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
83192341|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192342|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192343|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
83192344|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192345|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83192346|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192347|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83192348|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83192349|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83192350|NCT03321955|Ziconotide|ziconotide|mesh-list
83192351|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83192352|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83192353|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192354|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83192355|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192356|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83192357|NCT03321955|Protective Agents|protective agents|mesh-ancestor
83192358|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192360|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
83192361|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192362|NCT04493281|Edaravone|edaravone|mesh-list
83192363|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83192364|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
83192365|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192366|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83192367|NCT04493281|Protective Agents|protective agents|mesh-ancestor
83192368|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192369|NCT01764711|Cosyntropin|cosyntropin|mesh-list
83192370|NCT01764711|Hormones|hormones|mesh-ancestor
83192371|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192372|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192373|NCT04493515|Oxytocin|oxytocin|mesh-list
83192374|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
83192375|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192376|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192377|NCT03318445|Irinotecan|irinotecan|mesh-list
83192378|NCT03318445|Rucaparib|rucaparib|mesh-list
83192379|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83192380|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83192381|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192382|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192383|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192384|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83192386|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192387|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83192388|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192389|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192390|NCT04941573|Xenon|xenon|mesh-list
83192391|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83192392|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
83192393|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
83192394|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192395|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192396|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
83192397|NCT03316339|Remifentanil|remifentanil|mesh-list
83192398|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83192399|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192400|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192401|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192402|NCT03316339|Analgesics|analgesics|mesh-ancestor
83192403|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
83192404|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192405|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83192406|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83192407|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83192408|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
83192409|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192410|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192411|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83192412|NCT03316339|Narcotics|narcotics|mesh-ancestor
83192413|NCT02490865|RNS60|rns60|mesh-list
83192414|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83192415|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192416|NCT02490865|Analgesics|analgesics|mesh-ancestor
83192417|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
83192418|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192419|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192420|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192421|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83192422|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83192423|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
83192424|NCT03318211|Analgesics|analgesics|mesh-ancestor
83192425|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
83192426|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192427|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192428|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
83192429|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192430|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83192431|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
83192432|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83192433|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83192434|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192435|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83192436|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
83192437|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192438|NCT02483767|Goserelin|goserelin|mesh-list
83192439|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192440|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192441|NCT02483845|Natalizumab|natalizumab|mesh-list
83192442|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
83192443|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192445|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83192446|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192447|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83192448|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
83192449|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83192450|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83192451|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83192452|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192453|NCT02483923|Ropivacaine|ropivacaine|mesh-list
83192454|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
83192455|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
83192456|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192457|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192458|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
83192459|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192460|NCT02483689|Bupivacaine|bupivacaine|mesh-list
83192461|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
83192462|NCT02483689|Anesthetics|anesthetics|mesh-list
83192463|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192464|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192465|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
83192466|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192467|NCT02490085|Insulin|insulin|mesh-list
83192468|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83192469|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83192470|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192471|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
83192472|NCT03102021|Hematinics|hematinics|mesh-ancestor
83192473|NCT04916691|Ropivacaine|ropivacaine|mesh-list
83192474|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
83192475|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
83192476|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192477|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192478|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
83192479|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192480|NCT05105139|Triclosan|triclosan|mesh-list
83192481|NCT05105139|Coal Tar|coal tar|mesh-list
83192482|NCT05105139|Allantoin|allantoin|mesh-list
83192483|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83192484|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192485|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83192486|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83192487|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
83192488|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192489|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83192490|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
83192491|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
83192492|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
83192493|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83192494|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192495|NCT03317275|Fluorides|fluorides|mesh-list
83192496|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
83192497|NCT03317275|Protective Agents|protective agents|mesh-ancestor
83192498|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192499|NCT03317197|Vasopressins|vasopressins|mesh-list
83192500|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
83192501|NCT03317197|Epinephrine|epinephrine|mesh-list
83192502|NCT03317197|Racepinephrine|racepinephrine|mesh-list
83192503|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
83192504|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83192505|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83192506|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
83192507|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192508|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192509|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192510|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83192511|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83192512|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
83192513|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192514|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83192515|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
83192516|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
83192517|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
83192518|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83192519|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
83192520|NCT03317197|Coagulants|coagulants|mesh-ancestor
83192521|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83192522|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
83192523|NCT02483299|Metformin|metformin|mesh-list
83192524|NCT02483299|Liraglutide|liraglutide|mesh-list
83192525|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83192526|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192527|NCT02483299|Incretins|incretins|mesh-ancestor
83192528|NCT02483299|Hormones|hormones|mesh-ancestor
83192529|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192530|NCT01597479|Anesthetics|anesthetics|mesh-list
83192531|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
83192532|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
83192533|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192534|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192535|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
83192536|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192537|NCT03316963|Neostigmine|neostigmine|mesh-list
83192538|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83192539|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192540|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192541|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
83192542|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192543|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192544|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83192545|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
83192546|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192547|NCT02489929|Azacitidine|azacitidine|mesh-list
83192548|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83192549|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
83192550|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192551|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192552|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192553|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83192554|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
83192555|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
83192556|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
83192557|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192558|NCT02483143|Expectorants|expectorants|mesh-ancestor
83192559|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
83192560|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83192561|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
83192562|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192563|NCT02483143|Protective Agents|protective agents|mesh-ancestor
83192564|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192565|NCT02483221|Morphine|morphine|mesh-list
83192566|NCT02483221|Hydromorphone|hydromorphone|mesh-list
83192567|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83192568|NCT02483221|Narcotics|narcotics|mesh-ancestor
83192569|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192570|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192571|NCT02483221|Analgesics|analgesics|mesh-ancestor
83192572|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
83192573|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192574|NCT02489461|Efavirenz|efavirenz|mesh-list
83192575|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
83192576|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83192577|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83192578|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83192579|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192580|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192581|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
83192582|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192583|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83192584|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83192585|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83192586|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83192587|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83192588|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83192589|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83192591|NCT05129475|Nirmatrelvir|nirmatrelvir|mesh-list
83192592|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83192593|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83192594|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
83192595|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192596|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192597|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83192598|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83192599|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
83192600|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192601|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83192602|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83192603|NCT02485873|Vitamin K|vitamin k|mesh-list
83192604|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
83192605|NCT02485873|Vitamins|vitamins|mesh-ancestor
83192606|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
83192607|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192608|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83192609|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
83192610|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83192611|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
83192612|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192613|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192614|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
83192615|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83192616|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83192617|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
83192618|NCT02485873|Coagulants|coagulants|mesh-ancestor
83192619|NCT04412421|Vitamins|vitamins|mesh-list
83192620|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
83192621|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192622|NCT03315091|Adavosertib|adavosertib|mesh-list
83192623|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192624|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192625|NCT02488993|Rifaximin|rifaximin|mesh-list
83192626|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83192627|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192628|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192629|NCT02485327|Insulin|insulin|mesh-list
83192630|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83192631|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83192632|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192633|NCT02485249|Dexamethasone|dexamethasone|mesh-list
83192634|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
83192635|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83192636|NCT02485249|BB 1101|bb 1101|mesh-list
83192637|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192638|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
83192639|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
83192640|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192641|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192642|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192643|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
83192644|NCT02485249|Hormones|hormones|mesh-ancestor
83430107|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192645|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192646|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192647|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192648|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
83192649|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192650|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192652|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192653|NCT03320629|Apatinib|apatinib|mesh-list
83192654|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192655|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83192656|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192657|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192658|NCT03316417|Immunomodulating Agents|immunomodulating agents|mesh-list
83192659|NCT03316417|Immunologic Factors|immunologic factors|mesh-ancestor
83192660|NCT03316417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192661|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83192662|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83192663|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83192665|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192666|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83192667|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83192668|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192669|NCT02476981|Ephedrine|ephedrine|mesh-list
83192670|NCT02476981|Midazolam|midazolam|mesh-list
83192671|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
83192672|NCT02476981|Remifentanil|remifentanil|mesh-list
83192673|NCT02476981|Propofol|propofol|mesh-list
83192674|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83192675|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192676|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192677|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83192678|NCT02476981|Analgesics|analgesics|mesh-ancestor
83192679|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
83192680|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192681|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83192682|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83192683|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83192684|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
83192685|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192686|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192687|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83192688|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
83192689|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
83192690|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83192691|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83192692|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83192693|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83192694|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
83192695|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
83192696|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83192697|NCT02476981|Narcotics|narcotics|mesh-ancestor
83192698|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83192699|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
83192700|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
83192701|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83192702|NCT04248465|Ravulizumab|ravulizumab|mesh-list
83192703|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83192704|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192705|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
83192706|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192707|NCT02480335|Bosentan|bosentan|mesh-list
83192708|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83192709|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83192710|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192711|NCT05456269|Cytarabine|cytarabine|mesh-list
83192712|NCT05456269|Decitabine|decitabine|mesh-list
83192713|NCT05456269|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83192714|NCT05456269|Bisantrene|bisantrene|mesh-list
83192715|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83192716|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
83192717|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192718|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192719|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
83192720|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192721|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192722|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
83192723|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192724|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192725|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83192726|NCT02476825|Fluticasone|fluticasone|mesh-list
83192727|NCT02476825|Xhance|xhance|mesh-list
83192728|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192729|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83192730|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
83192731|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192732|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192733|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83192734|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
83192735|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
83192736|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83192737|NCT05245227|Misoprostol|misoprostol|mesh-list
83192738|NCT05245227|Oxytocin|oxytocin|mesh-list
83192739|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
83192740|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192741|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192742|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83192743|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
83192744|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83192745|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192746|NCT02479867|Cefadroxil|cefadroxil|mesh-list
83192747|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83192748|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192749|NCT05244837|Paclitaxel|paclitaxel|mesh-list
83192750|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83192751|NCT05244837|Carboplatin|carboplatin|mesh-list
83192752|NCT05244837|Pemetrexed|pemetrexed|mesh-list
83192753|NCT05244837|Tislelizumab|tislelizumab|mesh-list
83192754|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83192755|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192756|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
83192757|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
83192758|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
83192759|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192760|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192761|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83192762|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83192763|NCT05244837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83192764|NCT03103893|Sirolimus|sirolimus|mesh-list
83192765|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83192766|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192767|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83192768|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192769|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
83192770|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192771|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
83192772|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192773|NCT02479789|Lidocaine|lidocaine|mesh-list
83192774|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
83192775|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
83192776|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192777|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192778|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
83192779|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192780|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83192781|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83192782|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83192783|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83192784|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192785|NCT02726113|Vitamin D|vitamin d|mesh-list
83192786|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
83192787|NCT02726113|Vitamins|vitamins|mesh-ancestor
83192788|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
83192789|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192790|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83192791|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83192792|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83192793|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83192794|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192795|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
83192796|NCT05243355|Endostatins|endostatins|mesh-list
83192797|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192798|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83192799|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83192800|NCT05243355|Growth Substances|growth substances|mesh-ancestor
83192801|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192802|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
83192803|NCT02479711|Methamphetamine|methamphetamine|mesh-list
83192804|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83192805|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192806|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
83192807|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
83192808|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192809|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
83192810|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83192811|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192812|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
83192813|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83192814|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83192815|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83192816|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83192817|NCT05196945|Amoxicillin|amoxicillin|mesh-list
83192818|NCT05196945|Clarithromycin|clarithromycin|mesh-list
83192819|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
83192820|NCT05196945|Esomeprazole|esomeprazole|mesh-list
83192821|NCT05196945|Bismuth|bismuth|mesh-list
83192822|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192823|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83192824|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192825|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83192826|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192827|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83192828|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192829|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83192830|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83192831|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83192832|NCT05196945|Antacids|antacids|mesh-ancestor
83192833|NCT05196945|Diuretics|diuretics|mesh-ancestor
83192834|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
83192835|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192836|NCT05196945|Expectorants|expectorants|mesh-ancestor
83192837|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
83192838|NCT03800979|Tofacitinib|tofacitinib|mesh-list
83192839|NCT03800979|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83192840|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83192841|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192842|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192843|NCT02476123|Nivolumab|nivolumab|mesh-list
83192844|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
83192845|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83192846|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192847|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83192848|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192849|NCT02481193|Cisatracurium|cisatracurium|mesh-list
83192850|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83192851|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83192852|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192853|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192854|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
83192855|NCT03101709|Fludarabine|fludarabine|mesh-list
83192856|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192857|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
83192858|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192859|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83192860|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83192861|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
83192862|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192863|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192864|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83192865|NCT03101319|Vitamin D|vitamin d|mesh-list
83192866|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
83192867|NCT03101319|Vitamins|vitamins|mesh-ancestor
83192868|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
83192869|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192870|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83192871|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83192872|NCT02479555|Dexamethasone|dexamethasone|mesh-list
83192873|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
83192874|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83192875|NCT02479555|BB 1101|bb 1101|mesh-list
83192876|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192877|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
83192878|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
83192879|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192880|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192881|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192882|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
83192883|NCT02479555|Hormones|hormones|mesh-ancestor
83192884|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192885|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192886|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192887|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
83192888|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192889|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192890|NCT02476045|Leucovorin|leucovorin|mesh-list
83192891|NCT02476045|Fluorouracil|fluorouracil|mesh-list
83192892|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
83192893|NCT02476045|Panitumumab|panitumumab|mesh-list
83192894|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
83192895|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
83192896|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192897|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83192898|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83418040|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83192899|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83192900|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
83192901|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192902|NCT02476045|Antidotes|antidotes|mesh-ancestor
83192903|NCT02476045|Protective Agents|protective agents|mesh-ancestor
83192904|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
83192905|NCT02476045|Vitamins|vitamins|mesh-ancestor
83192906|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
83192907|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83192908|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
83192909|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83192910|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192911|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83192912|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192913|NCT03885921|Atorvastatin|atorvastatin|mesh-list
83192914|NCT03885921|Simvastatin|simvastatin|mesh-list
83192915|NCT03885921|Ezetimibe|ezetimibe|mesh-list
83192916|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83192917|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83192918|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
83192919|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192920|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83192921|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83192922|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192923|NCT02480881|Fostemsavir|fostemsavir|mesh-list
83192924|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
83192925|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83192926|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
83192927|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192928|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192929|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83192930|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83192931|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83192932|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83192933|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83192934|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83192935|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83192936|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83192937|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
83192938|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83192939|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83192940|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83192941|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192942|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
83192943|NCT02480647|Etonogestrel|etonogestrel|mesh-list
83192944|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83192945|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
83192946|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83192947|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192948|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83192949|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83192950|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83192951|NCT03100071|Apixaban|apixaban|mesh-list
83192952|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83192953|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
83192954|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83192955|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
83192956|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83192957|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192958|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
83192959|NCT02479165|Oxycodone|oxycodone|mesh-list
83192960|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83192961|NCT02479165|Narcotics|narcotics|mesh-ancestor
83192962|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83192963|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192965|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
83192966|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192967|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
83192968|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83192969|NCT05072691|Antibodies|antibodies|mesh-list
83192970|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
83192971|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192972|NCT05714839|Dexamethasone|dexamethasone|mesh-list
83192973|NCT05714839|Lenalidomide|lenalidomide|mesh-list
83192974|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83192975|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
83192976|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
83192977|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83192978|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192979|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83192980|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
83192981|NCT05714839|Hormones|hormones|mesh-ancestor
83192982|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83192983|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83192984|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192985|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
83192986|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83192987|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83192988|NCT05714839|Growth Substances|growth substances|mesh-ancestor
83192989|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
83192990|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
83192991|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83192992|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83192993|NCT05378425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83192994|NCT05378425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83192995|NCT05377255|Naloxone|naloxone|mesh-list
83192996|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83192997|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83192998|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
83192999|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193000|NCT02475499|Metformin|metformin|mesh-list
83193001|NCT02475499|Pioglitazone|pioglitazone|mesh-list
83193002|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83193003|NCT02475499|Liraglutide|liraglutide|mesh-list
83193004|NCT02475499|Exenatide|exenatide|mesh-list
83193005|NCT02475499|Glimepiride|glimepiride|mesh-list
83193006|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
83193007|NCT02475499|Vildagliptin|vildagliptin|mesh-list
83193008|NCT02475499|Saxagliptin|saxagliptin|mesh-list
83193009|NCT02475499|Acarbose|acarbose|mesh-list
83193010|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83193011|NCT02475499|Repaglinide|repaglinide|mesh-list
83193012|NCT02475499|Gliclazide|gliclazide|mesh-list
83193013|NCT02475499|Glipizide|glipizide|mesh-list
83193014|NCT02475499|Biguanides|biguanides|mesh-list
83193015|NCT02475499|Tolbutamide|tolbutamide|mesh-list
83193016|NCT02475499|Voglibose|voglibose|mesh-list
83193017|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83193018|NCT02475499|Nateglinide|nateglinide|mesh-list
83193019|NCT02475499|Miglitol|miglitol|mesh-list
83193020|NCT02475499|Troglitazone|troglitazone|mesh-list
83193021|NCT02475499|Meglitinide|meglitinide|mesh-list
83193022|NCT02475499|Acetohexamide|acetohexamide|mesh-list
83193023|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
83193024|NCT02475499|Phenformin|phenformin|mesh-list
83193025|NCT02475499|Buformin|buformin|mesh-list
83193026|NCT02475499|Gliquidone|gliquidone|mesh-list
83193027|NCT02475499|Carbutamide|carbutamide|mesh-list
83193028|NCT02475499|Tolazamide|tolazamide|mesh-list
83193029|NCT02475499|Glibornuride|glibornuride|mesh-list
83418041|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
83193030|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83193031|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83193033|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193034|NCT02475499|Hormones|hormones|mesh-ancestor
83193035|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193036|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
83193037|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193038|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193039|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83193040|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83193041|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193042|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
83193043|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
83193044|NCT03375645|Narcotics|narcotics|mesh-ancestor
83193045|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193046|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193047|NCT03375645|Analgesics|analgesics|mesh-ancestor
83193048|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
83193049|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193050|NCT03136809|Copper|copper|mesh-list
83193051|NCT03136809|Trace Elements|trace elements|mesh-ancestor
83193052|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
83193053|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193054|NCT02475421|Glucagon|glucagon|mesh-list
83193055|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193056|NCT02475421|Hormones|hormones|mesh-ancestor
83193057|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193058|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193059|NCT03646617|Nivolumab|nivolumab|mesh-list
83193060|NCT03646617|Ipilimumab|ipilimumab|mesh-list
83193061|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193062|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193063|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83193064|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193065|NCT02475343|Riboflavin|riboflavin|mesh-list
83193066|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
83193067|NCT02475343|Vitamins|vitamins|mesh-ancestor
83193068|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
83193069|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193070|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83193071|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
83193072|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83193073|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83193074|NCT04492501|Remdesivir|remdesivir|mesh-list
83193075|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
83193076|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193077|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
83193078|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193079|NCT03101085|Equol|equol|mesh-list
83193080|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
83193081|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83193082|NCT03101085|Estrogens|estrogens|mesh-ancestor
83193083|NCT03101085|Hormones|hormones|mesh-ancestor
83193084|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193085|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193086|NCT05070195|Midazolam|midazolam|mesh-list
83193087|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83193088|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83193089|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193090|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193091|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83193092|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193093|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193094|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83193095|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
83193096|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
83193097|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
83193098|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
83193099|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193100|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193101|NCT02474953|Curcumin|curcumin|mesh-list
83193102|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83193103|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83193104|NCT02474953|Analgesics|analgesics|mesh-ancestor
83193105|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
83193106|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193107|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193108|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193109|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193110|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193111|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193112|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193113|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
83193114|NCT05714371|Nivolumab|nivolumab|mesh-list
83193115|NCT05714371|Ipilimumab|ipilimumab|mesh-list
83193116|NCT05714371|Trametinib|trametinib|mesh-list
83193117|NCT05714371|Dabrafenib|dabrafenib|mesh-list
83193118|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193119|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193120|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83193121|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193122|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83193123|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193124|NCT02472613|Fluoxetine|fluoxetine|mesh-list
83193125|NCT02472613|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83193126|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83193127|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193128|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193129|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193130|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
83193131|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193132|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83193133|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
83193134|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193135|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83193136|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83193137|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193138|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
83193139|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193140|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
83193141|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83193142|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
83193143|NCT02478229|Ledipasvir|ledipasvir|mesh-list
83193144|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
83193145|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193146|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83193147|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83193148|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83193149|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193150|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
83193151|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83193152|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83193153|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193154|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
83193155|NCT05713045|Coagulants|coagulants|mesh-ancestor
83193156|NCT05713045|Vitamins|vitamins|mesh-ancestor
83193157|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
83193158|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193159|NCT00653835|Simvastatin|simvastatin|mesh-list
83193160|NCT00653835|Ezetimibe|ezetimibe|mesh-list
83193161|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83193162|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83193163|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
83193164|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193165|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83193166|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83193167|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193168|NCT03099759|Vitamin D|vitamin d|mesh-list
83193169|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
83193170|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
83193171|NCT03099759|Vitamins|vitamins|mesh-ancestor
83193172|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
83193173|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193174|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83193175|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83193176|NCT05244577|Olanzapine|olanzapine|mesh-list
83193177|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
83193178|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
83193179|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193180|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193181|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193182|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83193183|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193184|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193185|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193186|NCT05244577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83193187|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83193188|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193189|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193190|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193191|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
83193192|NCT05710237|Risperidone|risperidone|mesh-list
83193193|NCT05710237|Psilocybin|psilocybin|mesh-list
83193194|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83193195|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
83193196|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193197|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193198|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193199|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83193200|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193201|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193202|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193203|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83193204|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
83193205|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
83193206|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83193207|NCT05067699|Calcifediol|calcifediol|mesh-list
83193208|NCT05067699|Vitamins|vitamins|mesh-ancestor
83193209|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
83193210|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193211|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83193212|NCT05067153|Heparin|heparin|mesh-list
83193213|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83193214|NCT05067153|Tinzaparin|tinzaparin|mesh-list
83193215|NCT05067153|Dalteparin|dalteparin|mesh-list
83193216|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
83193217|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83193218|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83193219|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193220|NCT05067309|Letrozole|letrozole|mesh-list
83193221|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193222|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83193223|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83193224|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193225|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193226|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83193227|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
83193228|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193229|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193231|NCT02474563|Bortezomib|bortezomib|mesh-list
83193232|NCT02474563|Melphalan|melphalan|mesh-list
83193233|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193234|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
83193235|NCT02474563|Hormones|hormones|mesh-ancestor
83193236|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193237|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193238|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83193239|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193240|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83193241|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
83193242|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193243|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83193244|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193245|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
83193246|NCT02477995|Vaccines|vaccines|mesh-list
83193247|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
83193248|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193249|NCT03098823|Prednisone|prednisone|mesh-list
83193250|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193251|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
83193252|NCT03098823|Hormones|hormones|mesh-ancestor
83193253|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193254|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193255|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83193256|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193257|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
83193258|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83193259|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193260|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193261|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83193262|NCT03108937|Analgesics|analgesics|mesh-ancestor
83193263|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
83193264|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193265|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83193266|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83193267|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83193268|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
83193269|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193270|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193271|NCT03913845|Lidocaine|lidocaine|mesh-list
83193272|NCT03913845|Epinephrine|epinephrine|mesh-list
83193273|NCT03913845|Racepinephrine|racepinephrine|mesh-list
83193274|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
83193275|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
83193276|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
83193277|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193278|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193279|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
83193280|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193281|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83193282|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83193283|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83193284|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193285|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193286|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83193287|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83193288|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
83193289|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193290|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83193291|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83193292|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
83193293|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83193294|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
83193295|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
83193296|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
83193297|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83193298|NCT00705523|Varenicline|varenicline|mesh-list
83193299|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83193300|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83193301|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
83193302|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193303|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193304|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193305|NCT03903939|Iloprost|iloprost|mesh-list
83193306|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83193307|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
83193308|NCT05065905|Interferons|interferons|mesh-list
83193309|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
83193310|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193311|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
83193312|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193313|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83193314|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83193315|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
83193316|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193317|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193318|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193319|NCT05010681|Lenvatinib|lenvatinib|mesh-list
83193320|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193321|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83193322|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193323|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193324|NCT02725411|Celecoxib|celecoxib|mesh-list
83193325|NCT02725411|Tanezumab|tanezumab|mesh-list
83193326|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83193327|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83193328|NCT02725411|Analgesics|analgesics|mesh-ancestor
83193329|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
83193330|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193331|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193332|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193333|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193334|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83193335|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83193336|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193337|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193338|NCT05058105|Meropenem|meropenem|mesh-list
83193339|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83193340|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193341|NCT05649943|Androgens|androgens|mesh-list
83193342|NCT05649943|Hormones|hormones|mesh-ancestor
83193343|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193344|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193345|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
83193346|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83193347|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193348|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
83193349|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83193350|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193351|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193352|NCT04474353|Temozolomide|temozolomide|mesh-list
83193353|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83193354|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
83193355|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193356|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193358|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83193359|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
83193360|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193361|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193362|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83193363|NCT05061147|Azacitidine|azacitidine|mesh-list
83193364|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83193365|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
83193366|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193367|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193368|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193369|NCT02127970|Dalbavancin|dalbavancin|mesh-list
83193370|NCT02127970|Teicoplanin|teicoplanin|mesh-list
83193371|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83193372|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193373|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
83193374|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193375|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83193376|NCT02471677|Hormones|hormones|mesh-ancestor
83193377|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193378|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193379|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
83193380|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83193381|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
83193382|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193383|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
83193384|NCT04755634|Protective Agents|protective agents|mesh-ancestor
83193385|NCT05395507|Interferons|interferons|mesh-list
83193386|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
83193387|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
83193388|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83193389|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193390|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
83193391|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193392|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
83193393|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193394|NCT04470843|Acetazolamide|acetazolamide|mesh-list
83193395|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
83193396|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83193397|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193398|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193399|NCT04470843|Diuretics|diuretics|mesh-ancestor
83193400|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
83193401|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193402|NCT05161741|Insulin|insulin|mesh-list
83193403|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83193404|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193405|NCT02473627|Pioglitazone|pioglitazone|mesh-list
83193406|NCT02473627|Tolbutamide|tolbutamide|mesh-list
83193407|NCT02473627|DS-1971a|ds-1971a|mesh-list
83193408|NCT02473627|Midazolam|midazolam|mesh-list
83193409|NCT02473627|Omeprazole|omeprazole|mesh-list
83193410|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83193411|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83193412|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193413|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193414|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83193415|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193416|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193417|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83193418|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
83193419|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
83193420|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
83193421|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
83193422|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193423|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193424|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83193425|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83193426|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193427|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83193428|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193429|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83193430|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83193431|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193432|NCT03095703|Sirolimus|sirolimus|mesh-list
83193433|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83193434|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193435|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83193436|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193437|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
83193438|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193439|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
83193440|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193441|NCT05035953|Edaravone|edaravone|mesh-list
83193442|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83193443|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
83193444|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193445|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83193446|NCT05035953|Protective Agents|protective agents|mesh-ancestor
83193447|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193448|NCT02471209|Sevoflurane|sevoflurane|mesh-list
83193449|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83193450|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83193451|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
83193452|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
83193453|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193454|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193455|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
83193456|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83193457|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
83193458|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193459|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
83193460|NCT02476903|Protective Agents|protective agents|mesh-ancestor
83193461|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
83193462|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83193463|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
83193464|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193465|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193466|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83193467|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
83193468|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
83193469|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83193470|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
83193471|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193472|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193473|NCT03403621|Pentamidine|pentamidine|mesh-list
83193474|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
83193475|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193476|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83193477|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83193478|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83193479|NCT04220125|Midazolam|midazolam|mesh-list
83193480|NCT04220125|Ketamine|ketamine|mesh-list
83193481|NCT04220125|Analgesics|analgesics|mesh-ancestor
83193482|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
83193483|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193484|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193485|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83193486|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83193487|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
83193488|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
83193489|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193490|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83193491|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83193492|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193493|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193494|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83193495|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83193497|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193498|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193499|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
83193500|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
83193501|NCT02472691|Lenalidomide|lenalidomide|mesh-list
83193502|NCT02472691|Azacitidine|azacitidine|mesh-list
83193503|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
83193504|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193505|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83193506|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83193507|NCT02472691|Growth Substances|growth substances|mesh-ancestor
83193508|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
83193509|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193510|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83193511|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
83193512|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193513|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193514|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
83193515|NCT02470663|Calcium|calcium|mesh-list
83193516|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83193517|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193518|NCT02470663|Antacids|antacids|mesh-ancestor
83193519|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193520|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193521|NCT00705367|Abatacept|abatacept|mesh-list
83193522|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83193523|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193524|NCT00705367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193525|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193526|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193527|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
83193528|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193529|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193530|NCT03043729|Leucovorin|leucovorin|mesh-list
83193531|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
83193532|NCT03043729|Aflibercept|aflibercept|mesh-list
83193533|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193534|NCT03043729|Antidotes|antidotes|mesh-ancestor
83193535|NCT03043729|Protective Agents|protective agents|mesh-ancestor
83193536|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193537|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
83193538|NCT03043729|Vitamins|vitamins|mesh-ancestor
83193539|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
83193540|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83193541|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83193542|NCT03043729|Growth Substances|growth substances|mesh-ancestor
83193543|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
83193544|NCT05306431|Biguanides|biguanides|mesh-list
83193545|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83193546|NCT05306431|Polihexanide|polihexanide|mesh-list
83193547|NCT05306431|Eusol|eusol|mesh-list
83193548|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
83193549|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193550|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83193551|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193552|NCT03108313|Fluorides|fluorides|mesh-list
83193553|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
83193554|NCT03108313|Protective Agents|protective agents|mesh-ancestor
83193555|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193556|NCT03108625|Vortioxetine|vortioxetine|mesh-list
83193557|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
83193558|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193559|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83193560|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193561|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193562|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193563|NCT03108625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83193564|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83193565|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193566|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193567|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193568|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
83193569|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83193570|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83193571|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83193572|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83193573|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
83193574|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193575|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193576|NCT03310567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83193577|NCT03310567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193578|NCT03900949|Cytarabine|cytarabine|mesh-list
83193579|NCT03900949|Daunorubicin|daunorubicin|mesh-list
83193580|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
83193581|NCT03900949|Midostaurin|midostaurin|mesh-list
83193582|NCT03900949|Calicheamicins|calicheamicins|mesh-list
83193583|NCT03900949|Staurosporine|staurosporine|mesh-list
83193584|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83193585|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
83193586|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193587|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193588|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
83193589|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193590|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193591|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
83193592|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193593|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83193594|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83193595|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83193596|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193597|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193598|NCT03900949|Immunotoxins|immunotoxins|mesh-ancestor
83193599|NCT03900949|Immunoconjugates|immunoconjugates|mesh-ancestor
83193600|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83193601|NCT02864251|Carboplatin|carboplatin|mesh-list
83193602|NCT02864251|Nivolumab|nivolumab|mesh-list
83193603|NCT02864251|Pemetrexed|pemetrexed|mesh-list
83193604|NCT02864251|Ipilimumab|ipilimumab|mesh-list
83193605|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193606|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193607|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83193608|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193609|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193610|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83193611|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83193612|NCT02757859|Pancrelipase|pancrelipase|mesh-list
83193613|NCT02757859|Pancreatin|pancreatin|mesh-list
83193614|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193615|NCT02468791|Rituximab|rituximab|mesh-list
83193616|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193617|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193618|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
83193619|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193620|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193621|NCT02693821|Gabapentin|gabapentin|mesh-list
83193622|NCT02693821|Analgesics|analgesics|mesh-ancestor
83193623|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
83193624|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193625|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193626|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
83193627|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83193628|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193629|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193630|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193631|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83193632|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83193633|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193634|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193635|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
83193636|NCT02470117|Antacids|antacids|mesh-list
83193637|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193638|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193639|NCT03310333|Dinoprostone|dinoprostone|mesh-list
83193640|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
83193641|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83193642|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193643|NCT02299999|Vincristine|vincristine|mesh-list
83193644|NCT02299999|Vinorelbine|vinorelbine|mesh-list
83193645|NCT02299999|Vinblastine|vinblastine|mesh-list
83193646|NCT02299999|Docetaxel|docetaxel|mesh-list
83193647|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
83193648|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
83193651|NCT02299999|Carboplatin|carboplatin|mesh-list
83193652|NCT02299999|Gemcitabine|gemcitabine|mesh-list
83193653|NCT02299999|Doxorubicin|doxorubicin|mesh-list
83193654|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83193655|NCT02299999|Capecitabine|capecitabine|mesh-list
83193656|NCT02299999|Methotrexate|methotrexate|mesh-list
83193657|NCT02299999|Durvalumab|durvalumab|mesh-list
83193658|NCT02299999|Epirubicin|epirubicin|mesh-list
83193659|NCT02299999|Olaparib|olaparib|mesh-list
83193660|NCT02299999|Mitomycins|mitomycins|mesh-list
83193661|NCT02299999|Mitomycin|mitomycin|mesh-list
83193662|NCT02299999|Bicalutamide|bicalutamide|mesh-list
83193663|NCT02299999|Taxane|taxane|mesh-list
83193664|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83193665|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193666|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
83193667|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
83193668|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
83193669|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193670|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193671|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
83193672|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193673|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193674|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83193675|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
83193676|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83193677|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193678|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83193679|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83193680|NCT02299999|Growth Substances|growth substances|mesh-ancestor
83193681|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
83193682|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83193683|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
83193684|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83193685|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83193686|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83193687|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193688|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83193689|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
83193690|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83193691|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
83193692|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83193693|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83193694|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83193695|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
83193696|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
83193697|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193698|NCT00705289|Infliximab|infliximab|mesh-list
83193699|NCT00705289|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83193700|NCT00705289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193701|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
83193702|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193703|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193704|NCT02263729|Losartan|losartan|mesh-list
83193705|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83193706|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83193707|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83193708|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83193709|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193710|NCT03309865|Vedolizumab|vedolizumab|mesh-list
83193711|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193712|NCT02111941|Vaccines|vaccines|mesh-list
83193713|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
83193714|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193715|NCT02038777|Cytarabine|cytarabine|mesh-list
83193716|NCT02038777|Azacitidine|azacitidine|mesh-list
83193717|NCT02038777|Daunorubicin|daunorubicin|mesh-list
83193718|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83193719|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
83193720|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193721|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193722|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
83193723|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193724|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193725|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
83193726|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193727|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193728|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83193729|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83193730|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83193732|NCT03744793|Avelumab|avelumab|mesh-list
83193733|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83193734|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193735|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193736|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193737|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83193738|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83193739|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193740|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
83193741|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193742|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
83193743|NCT03713593|Lenvatinib|lenvatinib|mesh-list
83193744|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193745|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193746|NCT03713593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83193747|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193748|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83193749|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193750|NCT03309709|Progesterone|progesterone|mesh-list
83193751|NCT03309709|Progestins|progestins|mesh-ancestor
83193752|NCT03309709|Hormones|hormones|mesh-ancestor
83193753|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193754|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193755|NCT01720147|Quercetin|quercetin|mesh-list
83193756|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
83193757|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193758|NCT01720147|Protective Agents|protective agents|mesh-ancestor
83193759|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193760|NCT01141309|Everolimus|everolimus|mesh-list
83193761|NCT01141309|Sorafenib|sorafenib|mesh-list
83193762|NCT01141309|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83193763|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83193764|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193765|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193766|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193767|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
83193768|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193769|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193770|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
83193771|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83193772|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193773|NCT03309163|Tramadol|tramadol|mesh-list
83193774|NCT03309163|Hydromorphone|hydromorphone|mesh-list
83193775|NCT03309163|Ropivacaine|ropivacaine|mesh-list
83193776|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
83193777|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
83193778|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193779|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193780|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
83193781|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193782|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83193783|NCT03309163|Narcotics|narcotics|mesh-ancestor
83193784|NCT03309163|Analgesics|analgesics|mesh-ancestor
83193785|NCT03174847|Eplerenone|eplerenone|mesh-list
83193786|NCT03174847|Amiloride|amiloride|mesh-list
83193787|NCT03174847|Spironolactone|spironolactone|mesh-list
83193788|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83193789|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
83193790|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
83193791|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193792|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193793|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83193794|NCT03174847|Diuretics|diuretics|mesh-ancestor
83193795|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
83193796|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83193797|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83193798|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83193799|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193800|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193801|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83193802|NCT03174847|Hormones|hormones|mesh-ancestor
83193803|NCT03313531|Thrombin|thrombin|mesh-list
83193804|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
83193805|NCT03313531|Coagulants|coagulants|mesh-ancestor
83193806|NCT02468167|Polidocanol|polidocanol|mesh-list
83193807|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83193808|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83193809|NCT03308149|Triamcinolone|triamcinolone|mesh-list
83193810|NCT03308149|Bupivacaine|bupivacaine|mesh-list
83193811|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
83193812|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
83193813|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193814|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193815|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
83193816|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193817|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193818|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
83193819|NCT03308149|Hormones|hormones|mesh-ancestor
83193820|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193821|NCT03303235|Methylergonovine|methylergonovine|mesh-list
83193822|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
83193823|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83193824|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193825|NCT03307993|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83193826|NCT03307993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83193827|NCT03307993|Serotonin Agents|serotonin agents|mesh-ancestor
83193828|NCT03307993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193829|NCT03307993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193830|NCT03307993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193831|NCT03302845|Omeprazole|omeprazole|mesh-list
83193832|NCT03302845|Famotidine|famotidine|mesh-list
83193833|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83193834|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193835|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83193836|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193837|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193838|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83193839|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
83193840|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
83193841|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193842|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193843|NCT03302689|Ropivacaine|ropivacaine|mesh-list
83193844|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
83193845|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83193846|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
83193847|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
83193848|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193849|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193850|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
83193851|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193852|NCT03307603|Nivolumab|nivolumab|mesh-list
83193853|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83193854|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193855|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83193856|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193857|NCT02468323|Ondansetron|ondansetron|mesh-list
83193858|NCT02468323|Palonosetron|palonosetron|mesh-list
83193859|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
83193860|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
83193861|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193862|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193863|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83193864|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
83193865|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
83193866|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83193867|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83193868|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
83193869|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193870|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193871|NCT02469259|Oxytocin|oxytocin|mesh-list
83193872|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
83193873|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83193874|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193875|NCT03307213|Sirolimus|sirolimus|mesh-list
83193876|NCT03307213|Umirolimus|umirolimus|mesh-list
83193877|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83193878|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83193879|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
83193880|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193881|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83193882|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193883|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83193884|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193885|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
83193887|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
83193888|NCT03302299|Isoniazid|isoniazid|mesh-list
83193889|NCT03302299|Vitamins|vitamins|mesh-ancestor
83193890|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
83193891|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193892|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
83193893|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
83193894|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83193895|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193896|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83193897|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83193898|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
83193899|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193900|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83193901|NCT03302221|Ropivacaine|ropivacaine|mesh-list
83193902|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
83193903|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193904|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193905|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
83193906|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
83193907|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193908|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
83193909|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83193910|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
83193911|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193912|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193913|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83193914|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
83193915|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
83193916|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83193917|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
83193918|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193919|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193920|NCT03306745|Folic Acid|folic acid|mesh-list
83193921|NCT03306745|Hematinics|hematinics|mesh-ancestor
83193922|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
83193923|NCT03306745|Vitamins|vitamins|mesh-ancestor
83193924|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
83193925|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193926|NCT03306667|Dotinurad|dotinurad|mesh-list
83193927|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
83193928|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
83193929|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83193930|NCT03312283|Ranibizumab|ranibizumab|mesh-list
83193931|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83418118|NCT01535001|Pantoprazole|pantoprazole|mesh-list
83193932|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83193933|NCT03312283|Growth Substances|growth substances|mesh-ancestor
83193934|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193935|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
83193936|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83193938|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83193939|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193940|NCT03301207|Midazolam|midazolam|mesh-list
83193941|NCT03301207|Bupropion|bupropion|mesh-list
83193942|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
83193943|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83193944|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83193945|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83193946|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83193947|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193948|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193949|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83193950|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83193951|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83193952|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83193953|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
83193954|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
83193955|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
83193956|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
83193957|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193958|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193959|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83193960|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
83193961|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83193962|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83193963|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193964|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
83193965|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83193966|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83193967|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83193968|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83193969|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
83193970|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83193971|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83193972|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83193973|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83193974|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83193975|NCT03301207|Estrogens|estrogens|mesh-ancestor
83193976|NCT03301207|Hormones|hormones|mesh-ancestor
83193977|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83193978|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83193979|NCT03311971|Methamphetamine|methamphetamine|mesh-list
83193980|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83193981|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193982|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
83193983|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
83193984|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83193985|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
83193986|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83193987|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83193988|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
83193989|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83193990|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83193991|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83193992|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83193993|NCT03311737|Anesthetics|anesthetics|mesh-list
83193994|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83193995|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83193996|NCT02467543|Ethanol|ethanol|mesh-list
83193997|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83193998|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83193999|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194000|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194001|NCT03311581|Propofol|propofol|mesh-list
83194002|NCT03311581|Sevoflurane|sevoflurane|mesh-list
83194003|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83194004|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194005|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194006|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83194007|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
83194008|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
83194009|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83194010|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83194011|NCT03311425|Dexamethasone|dexamethasone|mesh-list
83194012|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
83194013|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83194014|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83194015|NCT03311425|Prednisolone|prednisolone|mesh-list
83194016|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
83194017|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83194018|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
83194019|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194020|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
83194021|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
83194022|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194023|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194024|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194025|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
83194026|NCT03311425|Hormones|hormones|mesh-ancestor
83194027|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194028|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83194030|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83194031|NCT03311425|Protective Agents|protective agents|mesh-ancestor
83194032|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
83194033|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
83194034|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83194035|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83194036|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194037|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194038|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194039|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194040|NCT03300115|Abivertinib|abivertinib|mesh-list
83194041|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83194042|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194043|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194044|NCT02916979|Methotrexate|methotrexate|mesh-list
83194045|NCT02916979|Fludarabine|fludarabine|mesh-list
83194046|NCT02916979|Busulfan|busulfan|mesh-list
83194047|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
83418194|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
83194048|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83194049|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
83194050|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83194051|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194052|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83194053|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
83194054|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194055|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194056|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
83194057|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194058|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83194059|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194060|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
83194061|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194062|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83194063|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
83194064|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83194065|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83194066|NCT00702949|Pregabalin|pregabalin|mesh-list
83194067|NCT00702949|Analgesics|analgesics|mesh-ancestor
83194068|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
83194069|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194070|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194071|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
83194072|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83194073|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194074|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194075|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83194076|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83194077|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83194078|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194079|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83194080|NCT04791475|Dexamethasone|dexamethasone|mesh-list
83194081|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
83194082|NCT04791475|Bupivacaine|bupivacaine|mesh-list
83194083|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194084|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
83194085|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
83194086|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194087|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194088|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194089|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
83194090|NCT04791475|Hormones|hormones|mesh-ancestor
83194091|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194092|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83194093|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194094|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
83194095|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
83194096|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194097|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
83194098|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83194099|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83194100|NCT04791475|Analgesics|analgesics|mesh-ancestor
83194101|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83194102|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83194103|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83194104|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194105|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194106|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194107|NCT03299725|Bismuth|bismuth|mesh-list
83194108|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194109|NCT03299725|Antacids|antacids|mesh-ancestor
83194110|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194111|NCT02466997|Tacrolimus|tacrolimus|mesh-list
83194112|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194113|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
83194114|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194115|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83194116|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194117|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194118|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
83194119|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83194120|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83194121|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83194122|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194123|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194124|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
83194125|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194126|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194127|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83194128|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194130|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83194131|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194132|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194133|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
83194134|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194135|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194136|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
83194137|NCT02466373|Clonidine|clonidine|mesh-list
83194138|NCT02466373|Analgesics|analgesics|mesh-ancestor
83194139|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
83194140|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194141|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194142|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83194143|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
83194144|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
83194145|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83194146|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83194147|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83194148|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194149|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194150|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194151|NCT05727397|Aflibercept|aflibercept|mesh-list
83194152|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83194153|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83194154|NCT05727397|Growth Substances|growth substances|mesh-ancestor
83194155|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194156|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
83194157|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194158|NCT05378269|Tamoxifen|tamoxifen|mesh-list
83194159|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83194160|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
83194161|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194162|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194163|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83194164|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194165|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83194166|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83194167|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83194168|NCT02466919|Amoxicillin|amoxicillin|mesh-list
83194169|NCT02466919|Metronidazole|metronidazole|mesh-list
83194170|NCT02466919|Clarithromycin|clarithromycin|mesh-list
83194171|NCT02466919|Levofloxacin|levofloxacin|mesh-list
83194172|NCT02466919|Pantoprazole|pantoprazole|mesh-list
83194173|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83194174|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194175|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83194176|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83194177|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83194178|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194179|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194180|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83194181|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83194182|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83194183|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83194184|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83194185|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194186|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83194187|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83194188|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194189|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83194191|NCT05727163|Dexamethasone|dexamethasone|mesh-list
83194192|NCT05727163|Anisodamine|anisodamine|mesh-list
83194193|NCT05727163|Bevacizumab|bevacizumab|mesh-list
83194194|NCT05727163|Fluorouracil|fluorouracil|mesh-list
83194195|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
83194196|NCT05727163|Irinotecan|irinotecan|mesh-list
83194197|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
83194198|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194199|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194200|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83194201|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83194202|NCT05727163|Growth Substances|growth substances|mesh-ancestor
83194203|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194204|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
83194205|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194206|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
83194207|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
83194208|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194209|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194210|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
83194211|NCT05727163|Hormones|hormones|mesh-ancestor
83194212|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194213|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83194214|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
83194215|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194216|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83194217|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194218|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
83194219|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83194220|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83194221|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194222|NCT05727163|Antidotes|antidotes|mesh-ancestor
83194223|NCT05727163|Protective Agents|protective agents|mesh-ancestor
83194224|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
83194225|NCT05727163|Vitamins|vitamins|mesh-ancestor
83194226|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
83194227|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83194228|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83194229|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194230|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194231|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83194232|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83194233|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83194234|NCT05727163|Analgesics|analgesics|mesh-ancestor
83194235|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
83194236|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194237|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83194238|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
83194239|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
83194240|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83194241|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
83194242|NCT05259709|Cemiplimab|cemiplimab|mesh-list
83194243|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194244|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194245|NCT05302531|Amoxicillin|amoxicillin|mesh-list
83194246|NCT05302531|Levofloxacin|levofloxacin|mesh-list
83194247|NCT05302531|Ofloxacin|ofloxacin|mesh-list
83194248|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83194249|NCT05302531|Trimethoprim|trimethoprim|mesh-list
83194250|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
83194251|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83194252|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194253|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83194254|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83194255|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83194256|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194257|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194258|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194259|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83194260|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83194261|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
83194262|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83194263|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83194264|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83194265|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83194266|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83194267|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
83194268|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194269|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83194270|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194271|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194273|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
83194274|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83194275|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194276|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83194277|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
83194278|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194279|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194280|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83194281|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
83194282|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
83194283|NCT00702325|Hormones|hormones|mesh-ancestor
83194284|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194285|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83194286|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83194287|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83194288|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194289|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194290|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194291|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83194292|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
83194293|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194294|NCT02464813|Pregabalin|pregabalin|mesh-list
83194295|NCT02464813|Oxycodone|oxycodone|mesh-list
83194296|NCT02464813|Analgesics|analgesics|mesh-ancestor
83194297|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
83194298|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194299|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194300|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
83194301|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83194302|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194303|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194304|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83194305|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83194306|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83194307|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194308|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83194309|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83194310|NCT02464813|Narcotics|narcotics|mesh-ancestor
83194311|NCT05726929|Capsaicin|capsaicin|mesh-list
83194312|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
83194313|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
83194314|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
83194315|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194316|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194317|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83194318|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
83194319|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83194320|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
83194321|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83194322|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194323|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83194324|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83194325|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83194326|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194327|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83194329|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83194330|NCT05122351|Acetaminophen|acetaminophen|mesh-list
83194331|NCT05122351|Bupivacaine|bupivacaine|mesh-list
83194332|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
83194333|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
83194334|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194335|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194336|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
83194337|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194338|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83194339|NCT05122351|Analgesics|analgesics|mesh-ancestor
83194340|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
83194341|NCT02464501|Paclitaxel|paclitaxel|mesh-list
83194342|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83194343|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194344|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
83194345|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
83194346|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
83194347|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194348|NCT02465827|Ropivacaine|ropivacaine|mesh-list
83194349|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
83194350|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
83194351|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194352|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194353|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
83194354|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194355|NCT04368403|Brodalumab|brodalumab|mesh-list
83194356|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83194357|NCT04298203|Topiramate|topiramate|mesh-list
83194358|NCT04298203|Phentermine|phentermine|mesh-list
83194359|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
83194360|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83194361|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194362|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83194363|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
83194364|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83194365|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
83194366|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
83194367|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194368|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194369|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194370|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194371|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
83194372|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83194373|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194374|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
83194375|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
83194376|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194377|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
83194378|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194379|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194380|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83194381|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
83194382|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194383|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194384|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83194385|NCT02465749|Vitamins|vitamins|mesh-list
83194386|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
83194387|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194388|NCT00701779|Tamsulosin|tamsulosin|mesh-list
83194389|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83194390|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83194391|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83194392|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194393|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194394|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194395|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194396|NCT00701779|Urological Agents|urological agents|mesh-ancestor
83194397|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
83194398|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
83194399|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83194400|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194401|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194402|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
83194403|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83194404|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194405|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194406|NCT02463643|Rabeprazole|rabeprazole|mesh-list
83194407|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83194408|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194409|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83194410|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194411|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194412|NCT04927975|Upadacitinib|upadacitinib|mesh-list
83194413|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83194414|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83194415|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194416|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194417|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194418|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83194419|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83194421|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194422|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194423|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
83194424|NCT02465359|Antibodies|antibodies|mesh-list
83194425|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
83194426|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83194427|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83194428|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
83194429|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194430|NCT02463019|Tenofovir|tenofovir|mesh-list
83194431|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
83194432|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194433|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83194434|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83194435|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194436|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194437|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83194438|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83194439|NCT02462941|Adenosine|adenosine|mesh-list
83194440|NCT02462941|Analgesics|analgesics|mesh-ancestor
83418195|NCT04813848|Fluorides|fluorides|mesh-list
83194441|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
83194442|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194443|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194444|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83194446|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83194447|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
83194448|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
83194449|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194450|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194451|NCT02462707|Nirogacestat|nirogacestat|mesh-list
83194452|NCT02462707|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83194453|NCT02462707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194454|NCT02462707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194455|NCT04042831|Olaparib|olaparib|mesh-list
83194456|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83194457|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194458|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194459|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194460|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
83194461|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83194462|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83194463|NCT04824391|Vaccines|vaccines|mesh-list
83194464|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
83194465|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194466|NCT03297073|Acetaminophen|acetaminophen|mesh-list
83194467|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83194468|NCT03297073|Analgesics|analgesics|mesh-ancestor
83194469|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
83194470|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194471|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194472|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
83194473|NCT02462317|Baclofen|baclofen|mesh-list
83194474|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83194475|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83194476|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83194477|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194478|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83194479|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194480|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83194481|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
83194482|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
83194483|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194484|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194485|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83194486|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194487|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
83194488|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83194489|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83194490|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194491|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
83194492|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194493|NCT03332095|Tenofovir|tenofovir|mesh-list
83194494|NCT03332095|Lamivudine|lamivudine|mesh-list
83194495|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83194496|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
83194497|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194498|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83194499|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83194500|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194501|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194502|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83194503|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
83194504|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83194505|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194506|NCT04489849|Apixaban|apixaban|mesh-list
83194507|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83194508|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
83194509|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83194510|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
83194511|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194512|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194513|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
83194514|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
83194515|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83194516|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83194517|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194518|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
83194519|NCT04488367|Coagulants|coagulants|mesh-ancestor
83194520|NCT03734653|Testosterone|testosterone|mesh-list
83194521|NCT03734653|Androgens|androgens|mesh-ancestor
83194522|NCT03734653|Hormones|hormones|mesh-ancestor
83194523|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194524|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194525|NCT04489459|Meropenem|meropenem|mesh-list
83194526|NCT04489459|Colistin|colistin|mesh-list
83194527|NCT04489459|Tigecycline|tigecycline|mesh-list
83194528|NCT04489459|Polymyxins|polymyxins|mesh-list
83194529|NCT04489459|Polymyxin B|polymyxin b|mesh-list
83194530|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83194531|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194532|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83194533|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194534|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194535|NCT03296137|Aldesleukin|aldesleukin|mesh-list
83194536|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
83194537|NCT03296137|Nivolumab|nivolumab|mesh-list
83194538|NCT03296137|Ipilimumab|ipilimumab|mesh-list
83194539|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
83194540|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194541|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
83194542|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194543|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194544|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83194545|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
83194546|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194547|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194548|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83194549|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194550|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83194551|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83194552|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
83194553|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83194554|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83194555|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
83194556|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194557|NCT03295903|Cannabidiol|cannabidiol|mesh-list
83194558|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
83194559|NCT02460913|Morphine|morphine|mesh-list
83194560|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83194561|NCT02460913|Narcotics|narcotics|mesh-ancestor
83194562|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194563|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194564|NCT02460913|Analgesics|analgesics|mesh-ancestor
83194565|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
83194566|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194567|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
83194568|NCT02973997|Lenvatinib|lenvatinib|mesh-list
83194569|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194570|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194571|NCT02973997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83194572|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194573|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83194574|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194575|NCT03295825|Heparin|heparin|mesh-list
83194576|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
83194577|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83194578|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83194579|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194580|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
83194581|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83194582|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
83194583|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194584|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
83194585|NCT03290365|Protective Agents|protective agents|mesh-ancestor
83194586|NCT02764489|Thrombin|thrombin|mesh-list
83194587|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
83194588|NCT02764489|Coagulants|coagulants|mesh-list
83194589|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
83194590|NCT02462161|Insulin|insulin|mesh-list
83194591|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83194592|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
83194593|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
83194594|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83194595|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83194596|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194597|NCT03289819|Paclitaxel|paclitaxel|mesh-list
83194598|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83194599|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
83194600|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
83194601|NCT03289819|Epirubicin|epirubicin|mesh-list
83194602|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83194603|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194604|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
83194605|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
83194606|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
83194607|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194608|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194609|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
83194610|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194611|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194612|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83194613|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
83194614|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83194615|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194616|NCT03289819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83194617|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83194618|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83194619|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83194620|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194621|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
83194622|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194623|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194624|NCT02713867|Nivolumab|nivolumab|mesh-list
83194625|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194626|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194627|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83194628|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194629|NCT03372785|Aspirin|aspirin|mesh-list
83194630|NCT03372785|Metoprolol|metoprolol|mesh-list
83194631|NCT03372785|Clopidogrel|clopidogrel|mesh-list
83194632|NCT03372785|Ticagrelor|ticagrelor|mesh-list
83194633|NCT03372785|Atorvastatin|atorvastatin|mesh-list
83194634|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83194635|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83194636|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83194637|NCT03372785|Analgesics|analgesics|mesh-ancestor
83194638|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
83194639|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194640|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194641|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194642|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194643|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83194644|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83194645|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83418196|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
83194646|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83194647|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83194648|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194649|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
83194650|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83194651|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83194652|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
83194653|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83194654|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83194655|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83194656|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83194657|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83194658|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
83194659|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194660|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83194661|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83194662|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
83194663|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
83194664|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83194665|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83194666|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83194667|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194668|NCT03372473|Loratadine|loratadine|mesh-list
83194669|NCT03372473|Montelukast|montelukast|mesh-list
83194670|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83194671|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
83194672|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83194673|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
83194674|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194675|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194676|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83194677|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83194678|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194679|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
83194680|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
83194681|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83194682|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83194683|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83194684|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
83194685|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
83194686|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194687|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
83194688|NCT03289429|Atorvastatin|atorvastatin|mesh-list
83194689|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83194690|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83194691|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
83194692|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194693|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83194694|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83194695|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194696|NCT03289429|Analgesics|analgesics|mesh-ancestor
83194697|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
83194698|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194699|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194701|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194702|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83194703|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
83194704|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83194705|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194706|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83194707|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
83194708|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83194709|NCT03372239|Tryptophan|tryptophan|mesh-list
83194710|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83194711|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
83194712|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83194713|NCT03294967|Vitamin E|vitamin e|mesh-list
83194714|NCT03294967|Caffeine|caffeine|mesh-list
83194715|NCT03294967|Vitamins|vitamins|mesh-ancestor
83194716|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
83194717|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194718|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83194719|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83194721|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194722|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83194723|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83194724|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
83194725|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194726|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
83194727|NCT03294967|Protective Agents|protective agents|mesh-ancestor
83194728|NCT03371849|Montelukast|montelukast|mesh-list
83194729|NCT03371849|Levocetirizine|levocetirizine|mesh-list
83194730|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83194731|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
83194732|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83194733|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
83194734|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194735|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194736|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83194737|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83194738|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194739|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83194740|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83194741|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
83194742|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
83194743|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194744|NCT04307329|Trastuzumab|trastuzumab|mesh-list
83194745|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83194746|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194747|NCT03371069|Methylphenidate|methylphenidate|mesh-list
83194748|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83194749|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194750|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83194751|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83194752|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194753|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194754|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
83194755|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194756|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
83194757|NCT03294577|Docetaxel|docetaxel|mesh-list
83194758|NCT03294577|Doxorubicin|doxorubicin|mesh-list
83194759|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194760|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
83194761|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194762|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194763|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83194764|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
83194765|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194766|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194767|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83194768|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83194769|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83194770|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83194771|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83194772|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83194773|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83194774|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194775|NCT03370835|Metoprolol|metoprolol|mesh-list
83194776|NCT03370835|Carvedilol|carvedilol|mesh-list
83194777|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83194778|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83194779|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
83194780|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
83194781|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194782|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194783|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83194784|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83194785|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83194786|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194787|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194788|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194790|NCT03370835|Protective Agents|protective agents|mesh-ancestor
83194791|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83194792|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194793|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83194794|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
83194795|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83194796|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83194797|NCT02460367|Docetaxel|docetaxel|mesh-list
83194798|NCT02460367|Tryptophan|tryptophan|mesh-list
83194799|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194800|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
83194801|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
83194802|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
83194803|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194804|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83194805|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
83194806|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83194807|NCT03370601|Infliximab|infliximab|mesh-list
83194808|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
83194809|NCT03370601|Azathioprine|azathioprine|mesh-list
83194810|NCT03370601|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83194811|NCT03370601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194812|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
83194813|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194814|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194815|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
83194816|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194817|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83194818|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194819|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83194820|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
83194821|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194822|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83194823|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194824|NCT03376529|Tazobactam|tazobactam|mesh-list
83194825|NCT03376529|Piperacillin|piperacillin|mesh-list
83194826|NCT03376529|Ceftazidime|ceftazidime|mesh-list
83194827|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83194828|NCT03376529|Aztreonam|aztreonam|mesh-list
83194829|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83194830|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194831|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83194832|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194833|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194834|NCT04132661|Bisacodyl|bisacodyl|mesh-list
83194835|NCT04132661|Cathartics|cathartics|mesh-ancestor
83194836|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194837|NCT04132661|Laxatives|laxatives|mesh-ancestor
83194838|NCT03700541|Morphine|morphine|mesh-list
83194839|NCT03700541|Pirinitramide|pirinitramide|mesh-list
83194840|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83194841|NCT03700541|Narcotics|narcotics|mesh-ancestor
83194842|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194843|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194844|NCT03700541|Analgesics|analgesics|mesh-ancestor
83194845|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
83194846|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362181|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194847|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83194848|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83194849|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83194850|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
83194851|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194852|NCT02460211|Vitamin D|vitamin d|mesh-list
83194853|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
83194854|NCT02460211|Vitamins|vitamins|mesh-ancestor
83194855|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
83194856|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194857|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83194858|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83194859|NCT03288259|Anesthetics|anesthetics|mesh-list
83194860|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
83194861|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194862|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194863|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
83194864|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194865|NCT01653925|Dutasteride|dutasteride|mesh-list
83194866|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83194867|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83194868|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194869|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194870|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
83194871|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194872|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194873|NCT02730455|Natalizumab|natalizumab|mesh-list
83194874|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
83194875|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194876|NCT03376139|Zonisamide|zonisamide|mesh-list
83194877|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
83194878|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83194879|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83194880|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194881|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83194882|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194883|NCT03369119|Montelukast|montelukast|mesh-list
83194884|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83194885|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
83194886|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83194887|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
83194888|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83194889|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194890|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83194891|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83194892|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194893|NCT03287011|Listerine|listerine|mesh-list
83194894|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
83194895|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
83194896|NCT03287011|Protective Agents|protective agents|mesh-ancestor
83194897|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194898|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83194899|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194900|NCT03293641|Folic Acid|folic acid|mesh-list
83194901|NCT03293641|Penicillins|penicillins|mesh-list
83194902|NCT03293641|Penicillin V|penicillin v|mesh-list
83194903|NCT03293641|Proguanil|proguanil|mesh-list
83194904|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
83194905|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
83194906|NCT03293641|Hematinics|hematinics|mesh-ancestor
83194907|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
83194908|NCT03293641|Vitamins|vitamins|mesh-ancestor
83194909|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
83194910|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194911|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83194912|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
83194913|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194914|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194915|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83194916|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83194917|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83194918|NCT03293641|Astringents|astringents|mesh-ancestor
83194919|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
83194920|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
83194921|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83194922|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83194923|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
83194924|NCT02519543|Metformin|metformin|mesh-list
83194925|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83194926|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194927|NCT03293407|Iloprost|iloprost|mesh-list
83194928|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83194929|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
83194930|NCT02519699|Norepinephrine|norepinephrine|mesh-list
83194931|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83194932|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83194933|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
83194934|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194935|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194936|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194937|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
83194938|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
83194939|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194940|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83194941|NCT00701311|Apremilast|apremilast|mesh-list
83194942|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83194943|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83194944|NCT00701311|Analgesics|analgesics|mesh-ancestor
83194945|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
83194946|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194947|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194948|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194949|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194950|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83194951|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83194952|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83194953|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194954|NCT03375671|Midazolam|midazolam|mesh-list
83194955|NCT03375671|Ketamine|ketamine|mesh-list
83194956|NCT03375671|Haloperidol|haloperidol|mesh-list
83194957|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
83194958|NCT03375671|Analgesics|analgesics|mesh-ancestor
83194959|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
83194960|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194961|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194962|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83194963|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83194964|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
83194965|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
83194966|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83194967|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83194968|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83194969|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83194970|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83194971|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83194972|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83194973|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83194974|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83194975|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83194976|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
83194977|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
83194978|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
83194979|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
83194980|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83194981|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83194982|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83194983|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
83194984|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83194985|NCT03375593|Acetaminophen|acetaminophen|mesh-list
83194986|NCT03375593|Ibuprofen|ibuprofen|mesh-list
83194987|NCT03375593|Oxycodone|oxycodone|mesh-list
83194988|NCT03375593|Hydrocodone|hydrocodone|mesh-list
83194989|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83194990|NCT03375593|Analgesics|analgesics|mesh-ancestor
83194991|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
83194992|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83194993|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83194994|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
83194995|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83418273|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83194996|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83194997|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83194998|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83194999|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195000|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195001|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83195003|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195004|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
83195005|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
83195006|NCT04525235|Tolbutamide|tolbutamide|mesh-list
83195007|NCT04525235|Rifampin|rifampin|mesh-list
83195008|NCT04525235|Digoxin|digoxin|mesh-list
83195009|NCT04525235|Midazolam|midazolam|mesh-list
83195010|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
83195011|NCT04525235|Caffeine|caffeine|mesh-list
83195012|NCT04525235|Omeprazole|omeprazole|mesh-list
83195013|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83195014|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83195015|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195016|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195017|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83195018|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83195019|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83195020|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83195021|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
83195022|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
83195023|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
83195024|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
83195025|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195026|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195027|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83195028|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83195029|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195030|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83195031|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83195032|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
83195033|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83195034|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195035|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83195036|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83195037|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
83195038|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83195039|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195040|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
83195041|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83195042|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83195043|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83195044|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83195045|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83195046|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83195047|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83195048|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83195049|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83195050|NCT04525235|Protective Agents|protective agents|mesh-ancestor
83195051|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
83195052|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
83195053|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83195054|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83195055|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195056|NCT03363815|Vitamin K|vitamin k|mesh-list
83195057|NCT03363815|Metformin|metformin|mesh-list
83195058|NCT03363815|Nintedanib|nintedanib|mesh-list
83195059|NCT03363815|Digoxin|digoxin|mesh-list
83195060|NCT03363815|Midazolam|midazolam|mesh-list
83195061|NCT03363815|Omeprazole|omeprazole|mesh-list
83195062|NCT03363815|Warfarin|warfarin|mesh-list
83195063|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83195064|NCT03363815|Vitamins|vitamins|mesh-ancestor
83195065|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
83195066|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195067|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195068|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83195069|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83195070|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195071|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83195072|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83195073|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83195074|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83195075|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
83195076|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
83195077|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
83195078|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
83195079|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195080|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195081|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83195082|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83195083|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
83195084|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83195085|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83195086|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195087|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
83195088|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83195089|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195090|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83195091|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83195092|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83195093|NCT03363815|Protective Agents|protective agents|mesh-ancestor
83195094|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83195095|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83195096|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
83195097|NCT03363815|Coagulants|coagulants|mesh-ancestor
83195098|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195099|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83195100|NCT03363659|Copper|copper|mesh-list
83195101|NCT03363659|Temozolomide|temozolomide|mesh-list
83195102|NCT03363659|Disulfiram|disulfiram|mesh-list
83195103|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83195104|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
83195105|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195106|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195107|NCT03363659|Trace Elements|trace elements|mesh-ancestor
83195108|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
83195109|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195110|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83195111|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83195112|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195113|NCT03363425|Lidocaine|lidocaine|mesh-list
83195114|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
83195115|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
83195116|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
83195117|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195118|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195119|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
83195120|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195121|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83195122|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83195123|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83195124|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83195125|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195127|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195128|NCT03363425|Analgesics|analgesics|mesh-ancestor
83195129|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83195130|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83195131|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83195132|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
83195133|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195134|NCT02459977|Basiliximab|basiliximab|mesh-list
83195135|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195136|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
83195137|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195138|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
83195139|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
83195140|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83195141|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83195142|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195143|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195144|NCT02519153|Urological Agents|urological agents|mesh-ancestor
83195145|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
83195146|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83195147|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195148|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83195149|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83195150|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195151|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195152|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195153|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83195154|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83195155|NCT03363191|Fluticasone|fluticasone|mesh-list
83195157|NCT03363191|Albuterol|albuterol|mesh-list
83195158|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195159|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83195160|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
83195161|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195162|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195163|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83195164|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
83195165|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83195166|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83195167|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
83195168|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195169|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83195170|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83195171|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83195172|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83195173|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195174|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195175|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
83195176|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83195177|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83195178|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195179|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
83195180|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195181|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195182|NCT03285607|Paclitaxel|paclitaxel|mesh-list
83195183|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
83195184|NCT03285607|Doxorubicin|doxorubicin|mesh-list
83195185|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83195187|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
83195188|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
83195189|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
83195190|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195191|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195192|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
83195193|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195194|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83195195|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83195196|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
83195197|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83195198|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83195199|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83195200|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83195201|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195202|NCT03298321|Azacitidine|azacitidine|mesh-list
83195203|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83195204|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
83195205|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195206|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195207|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195208|NCT04527055|Metronidazole|metronidazole|mesh-list
83195209|NCT04527055|Tetracycline|tetracycline|mesh-list
83195210|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83195211|NCT04527055|Esomeprazole|esomeprazole|mesh-list
83195212|NCT04527055|Bismuth|bismuth|mesh-list
83195213|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195214|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83195215|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83195216|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83195217|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83195218|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195219|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83195220|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195221|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195222|NCT04527055|Antacids|antacids|mesh-ancestor
83195223|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83195224|NCT02518763|Vitamin D|vitamin d|mesh-list
83195225|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
83195226|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
83195227|NCT02518763|Vitamins|vitamins|mesh-list
83195228|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
83195229|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195230|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83195231|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83195232|NCT04019093|Ethanol|ethanol|mesh-list
83195233|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83195234|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195235|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195236|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195237|NCT03362411|Linrodostat|linrodostat|mesh-list
83195238|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195239|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195240|NCT02460289|Minoxidil|minoxidil|mesh-list
83195241|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83195242|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
83195243|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
83195244|NCT03291457|Hormones|hormones|mesh-ancestor
83195245|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195246|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195247|NCT03361709|Dexamethasone|dexamethasone|mesh-list
83195248|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195249|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
83195251|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195252|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195253|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195254|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
83195255|NCT03361709|Hormones|hormones|mesh-ancestor
83195256|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195257|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83195258|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195259|NCT03284749|Copper|copper|mesh-list
83195260|NCT03284749|Trace Elements|trace elements|mesh-ancestor
83195261|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
83195262|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195263|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
83195264|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83195265|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
83195266|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195267|NCT04523675|Expectorants|expectorants|mesh-ancestor
83195268|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
83195269|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83195270|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
83195271|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195272|NCT04523675|Protective Agents|protective agents|mesh-ancestor
83195273|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195274|NCT04523675|Antidotes|antidotes|mesh-ancestor
83195275|NCT03298009|Canagliflozin|canagliflozin|mesh-list
83195276|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83195277|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195278|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195279|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195280|NCT03291145|Spironolactone|spironolactone|mesh-list
83195281|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83195282|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83195283|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
83195284|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195285|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195286|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83195287|NCT03291145|Diuretics|diuretics|mesh-ancestor
83195288|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
83195289|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83195290|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83195291|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195292|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195293|NCT03297931|Iproplatin|iproplatin|mesh-list
83195294|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195295|NCT03284593|Azacitidine|azacitidine|mesh-list
83195296|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83195297|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
83195298|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195299|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195300|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195301|NCT03361397|Lidocaine|lidocaine|mesh-list
83195302|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
83195303|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
83195304|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195305|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195306|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
83195307|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195308|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83195309|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83195310|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83195311|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83195312|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195313|NCT03109379|Trospium chloride|trospium chloride|mesh-list
83195314|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
83195315|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
83418576|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
83195316|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195317|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195318|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83195319|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83195320|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
83195321|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195322|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195323|NCT03109379|Urological Agents|urological agents|mesh-ancestor
83195324|NCT03361319|Paclitaxel|paclitaxel|mesh-list
83195325|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83195326|NCT03361319|Nintedanib|nintedanib|mesh-list
83195327|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83195328|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195329|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
83195330|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
83195331|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
83195332|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195333|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83195334|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195335|NCT04489147|Metformin|metformin|mesh-list
83195336|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195337|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195338|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
83195339|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
83195340|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83195341|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83195342|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195343|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
83195344|NCT03365999|Coagulants|coagulants|mesh-ancestor
83195345|NCT02460055|Dexamethasone|dexamethasone|mesh-list
83195346|NCT02460055|Fentanyl|fentanyl|mesh-list
83195347|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
83195348|NCT02460055|Ondansetron|ondansetron|mesh-list
83195349|NCT02460055|Propofol|propofol|mesh-list
83195350|NCT02460055|Sevoflurane|sevoflurane|mesh-list
83195351|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195352|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
83195353|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
83195354|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195355|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195356|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195357|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
83195358|NCT02460055|Hormones|hormones|mesh-ancestor
83195359|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195360|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83195361|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195362|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83195363|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195364|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83195365|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
83195366|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
83195367|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83195368|NCT02460055|Narcotics|narcotics|mesh-ancestor
83195369|NCT02460055|Analgesics|analgesics|mesh-ancestor
83195370|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
83195371|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83195372|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83195373|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83195374|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
83195375|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
83195376|NCT02460055|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83362182|NCT00368602|Timolol|timolol|mesh-list
83195377|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83195378|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
83195379|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195380|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195381|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195382|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
83195383|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83195384|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83195385|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
83195386|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195387|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195388|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195389|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83195390|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83195391|NCT03365765|Fluorouracil|fluorouracil|mesh-list
83195392|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
83195394|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
83195395|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195396|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83195397|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195398|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195399|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
83195400|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195401|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83195402|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195403|NCT03297463|Ipilimumab|ipilimumab|mesh-list
83195404|NCT03297463|Interleukin-2|interleukin-2|mesh-list
83195405|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83195406|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195407|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83195408|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195409|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195410|NCT03297463|Analgesics|analgesics|mesh-ancestor
83195411|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
83195412|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195413|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195414|NCT03282643|Heparin|heparin|mesh-list
83195415|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83195416|NCT03282643|Tinzaparin|tinzaparin|mesh-list
83195417|NCT03282643|Dalteparin|dalteparin|mesh-list
83195418|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
83195419|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
83195420|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83195421|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83195422|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195423|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83195424|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
83195425|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83195426|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
83195427|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195428|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
83195429|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195430|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
83195431|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
83195432|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
83195433|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83195434|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83195435|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195436|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
83195437|NCT02458729|Coagulants|coagulants|mesh-ancestor
83195438|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83195439|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
83195440|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83195441|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
83195442|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195443|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
83195444|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
83195445|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83195446|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83195447|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83195448|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83195449|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195450|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195451|NCT03920527|Itraconazole|itraconazole|mesh-list
83195476|NCT03536455|Acetazolamide|acetazolamide|mesh-list
83195477|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
83195478|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83195479|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195480|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195481|NCT03536455|Diuretics|diuretics|mesh-ancestor
83195482|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
83195483|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195484|NCT03529825|Rifaximin|rifaximin|mesh-list
83195485|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83195486|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195487|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195488|NCT03281941|Capsaicin|capsaicin|mesh-list
83195489|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
83195490|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
83195491|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
83195492|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195493|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195494|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
83195495|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83195496|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195497|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195498|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195499|NCT02459509|Analgesics|analgesics|mesh-ancestor
83195500|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
83195501|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195502|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83195503|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83195504|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83195505|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
83195506|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195507|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195508|NCT03264781|CycloProvera|cycloprovera|mesh-list
83195509|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83195510|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83195511|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83195512|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
83195513|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195514|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195515|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83195516|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83195517|NCT03281863|Antibodies|antibodies|mesh-list
83195518|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
83195519|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
83195520|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195521|NCT03264625|Vitamin D|vitamin d|mesh-list
83195522|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
83195523|NCT03264625|Vitamins|vitamins|mesh-ancestor
83195524|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
83195525|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195526|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83195527|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83195528|NCT03269929|Midazolam|midazolam|mesh-list
83195529|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83195530|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83195531|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195532|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195533|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83195534|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83195535|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83195536|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83195537|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
83195538|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
83195539|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
83195540|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
83195541|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195542|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195543|NCT02730377|Liraglutide|liraglutide|mesh-list
83195544|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83195545|NCT02730377|Meglitinide|meglitinide|mesh-list
83195546|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83195547|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83195548|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83195549|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195550|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195551|NCT02730377|Incretins|incretins|mesh-ancestor
83195552|NCT02730377|Hormones|hormones|mesh-ancestor
83195553|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195554|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195555|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
83195556|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195557|NCT03264547|Paclitaxel|paclitaxel|mesh-list
83195558|NCT03264547|Docetaxel|docetaxel|mesh-list
83195559|NCT03264547|Trastuzumab|trastuzumab|mesh-list
83195560|NCT03264547|Pertuzumab|pertuzumab|mesh-list
83195561|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83195562|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195563|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
83195564|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
83195565|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
83195566|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195567|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83195568|NCT03365141|Triamcinolone|triamcinolone|mesh-list
83195569|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83195570|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83195571|NCT03365141|Tacrolimus|tacrolimus|mesh-list
83195572|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83195573|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195574|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
83195575|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195576|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83195577|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195578|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195579|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195580|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
83195581|NCT03365141|Hormones|hormones|mesh-ancestor
83195582|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195583|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
83195584|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83195585|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195586|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195587|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195588|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
83195589|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83195590|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83195591|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83195592|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83195593|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195594|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195595|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195596|NCT03359837|Insulin|insulin|mesh-list
83195597|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83195598|NCT03359837|Metformin|metformin|mesh-list
83195599|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
83195600|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
83195601|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
83195602|NCT03359837|Acarbose|acarbose|mesh-list
83195603|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83195604|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
83195605|NCT03359837|Repaglinide|repaglinide|mesh-list
83195606|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195607|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195608|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83195609|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195610|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195611|NCT03359681|Metformin|metformin|mesh-list
83195612|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195613|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195614|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
83195615|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83195616|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83195617|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195618|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
83195619|NCT03359525|Coagulants|coagulants|mesh-ancestor
83195620|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
83195621|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83195622|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83195623|NCT03359291|Macitentan|macitentan|mesh-list
83195624|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83195625|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83195626|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
83195627|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195628|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83195629|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83195630|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195631|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83195632|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83195633|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83195634|NCT03358277|Methylphenidate|methylphenidate|mesh-list
83195635|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195636|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
83195637|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195638|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195639|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83195640|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83195641|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83195642|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83195644|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
83195645|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
83195646|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83195647|NCT03359057|Estradiol|estradiol|mesh-list
83195648|NCT03359057|Estrogens|estrogens|mesh-ancestor
83195649|NCT03359057|Hormones|hormones|mesh-ancestor
83195650|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195651|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195652|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83195653|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
83195654|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195655|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83195656|NCT03359057|Hematinics|hematinics|mesh-ancestor
83195657|NCT03359057|Vitamins|vitamins|mesh-ancestor
83195658|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
83195659|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83195660|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83195661|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83195662|NCT02714569|Atorvastatin|atorvastatin|mesh-list
83195663|NCT02714569|Simvastatin|simvastatin|mesh-list
83195664|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83195665|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83195666|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
83195667|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195668|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83195669|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83195670|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195671|NCT04522037|Morphine|morphine|mesh-list
83195672|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83195673|NCT04522037|Narcotics|narcotics|mesh-ancestor
83195674|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195675|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195676|NCT04522037|Analgesics|analgesics|mesh-ancestor
83195677|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
83195678|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195679|NCT03357653|Losartan|losartan|mesh-list
83195680|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83195681|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83195682|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83195683|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83195684|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195685|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83195686|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195687|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
83195688|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83195689|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
83195690|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195692|NCT03357575|Protective Agents|protective agents|mesh-ancestor
83195693|NCT03280927|Efinaconazole|efinaconazole|mesh-list
83195694|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
83195695|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195696|NCT03269383|Bupivacaine|bupivacaine|mesh-list
83195697|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
83195698|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
83195699|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195700|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195701|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
83195702|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195703|NCT03280849|Chitosan|chitosan|mesh-list
83195704|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83195705|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83195706|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
83195707|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195708|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83195709|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
83195710|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
83195711|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
83195712|NCT03280849|Coagulants|coagulants|mesh-ancestor
83195713|NCT04521491|Leucovorin|leucovorin|mesh-list
83195714|NCT04521491|Fluorouracil|fluorouracil|mesh-list
83195715|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
83195716|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
83195717|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195718|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83195719|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195720|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195721|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
83195722|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195723|NCT04521491|Antidotes|antidotes|mesh-ancestor
83195724|NCT04521491|Protective Agents|protective agents|mesh-ancestor
83195725|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
83195726|NCT04521491|Vitamins|vitamins|mesh-ancestor
83195727|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
83195728|NCT04509635|Cetuximab|cetuximab|mesh-list
83195729|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83195730|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195731|NCT04444817|Tacrolimus|tacrolimus|mesh-list
83195732|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195733|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
83195734|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195735|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83195736|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195737|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195738|NCT03264079|Itraconazole|itraconazole|mesh-list
83195739|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
83195740|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195741|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83195742|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83195743|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195744|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195745|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83195746|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
83195747|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195748|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195749|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83195750|NCT04509323|Huperzine A|huperzine a|mesh-list
83195751|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83195752|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195753|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195754|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
83195755|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195756|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195757|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83195758|NCT04509323|Protective Agents|protective agents|mesh-ancestor
83195759|NCT04443647|Oxytocin|oxytocin|mesh-list
83195760|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
83195761|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195762|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195763|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83195764|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83195766|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83195767|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
83195768|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195769|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195770|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83195771|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
83195772|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195773|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195774|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
83195775|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195776|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83195777|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195778|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
83195779|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83195780|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83195781|NCT03268525|Bupivacaine|bupivacaine|mesh-list
83195782|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
83195783|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
83195784|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195785|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195786|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
83195787|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195788|NCT02456935|Esomeprazole|esomeprazole|mesh-list
83195789|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83195790|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195791|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83195792|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195793|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195794|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83195795|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83195796|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195797|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
83195798|NCT03263689|Morphine|morphine|mesh-list
83195799|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83195800|NCT03263689|Narcotics|narcotics|mesh-ancestor
83195801|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195802|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195803|NCT03263689|Analgesics|analgesics|mesh-ancestor
83195804|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
83195805|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195806|NCT03279679|Ropivacaine|ropivacaine|mesh-list
83195807|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
83195808|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
83195809|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195810|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195811|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
83195812|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195813|NCT02518451|Valsartan|valsartan|mesh-list
83195814|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83195815|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83195816|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83195817|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195818|NCT03263299|Aspirin|aspirin|mesh-list
83195819|NCT03263299|Cabergoline|cabergoline|mesh-list
83195820|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83195821|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195822|NCT03263299|Analgesics|analgesics|mesh-ancestor
83195823|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
83195824|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195825|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195826|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195827|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83195828|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83195829|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83195830|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195831|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83195832|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83195833|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195834|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
83195835|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83195836|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83195837|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
83195838|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
83195839|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195840|NCT04444349|Ubiquinone|ubiquinone|mesh-list
83195841|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
83195842|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
83195843|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195844|NCT04444349|Vitamins|vitamins|mesh-ancestor
83195845|NCT03263533|Vorinostat|vorinostat|mesh-list
83195846|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195847|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83195848|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195849|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195850|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
83195851|NCT03123107|Vitamins|vitamins|mesh-ancestor
83195852|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
83195853|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195854|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
83195855|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195856|NCT03123107|Protective Agents|protective agents|mesh-ancestor
83195857|NCT04516655|Rituximab|rituximab|mesh-list
83195858|NCT04516655|Methotrexate|methotrexate|mesh-list
83195859|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83195860|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195861|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
83195862|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195863|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83195864|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83195865|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
83195866|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195867|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83195868|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
83195869|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195870|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
83195871|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195872|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83195873|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83195874|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83195875|NCT02458183|Vaccines|vaccines|mesh-list
83195876|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
83195877|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195878|NCT04444193|Durvalumab|durvalumab|mesh-list
83195879|NCT04444193|Lenvatinib|lenvatinib|mesh-list
83195880|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83195881|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83195882|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195883|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
83195884|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195885|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83195886|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195887|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195888|NCT03984955|Mannitol|mannitol|mesh-list
83195889|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
83195890|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83195891|NCT03984955|Diuretics|diuretics|mesh-ancestor
83195892|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
83195893|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195894|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83195895|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
83195896|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
83195897|NCT03984955|Protective Agents|protective agents|mesh-ancestor
83195898|NCT03946969|Paclitaxel|paclitaxel|mesh-list
83195899|NCT03946969|Cisplatin|cisplatin|mesh-list
83195900|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83195901|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83195902|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
83195903|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
83195904|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
83195905|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195906|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83195907|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83195908|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195909|NCT03277573|Analgesics|analgesics|mesh-ancestor
83195910|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
83195911|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195912|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195913|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195914|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83195915|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
83195916|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83195917|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
83195918|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195919|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
83195920|NCT03353909|Protective Agents|protective agents|mesh-ancestor
83195921|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
83195922|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83195923|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195924|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83195925|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195926|NCT04508231|Hormones|hormones|mesh-list
83195927|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83195928|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195929|NCT03263065|Psyllium|psyllium|mesh-list
83195930|NCT03263065|Cathartics|cathartics|mesh-ancestor
83195931|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195932|NCT02518373|Omeprazole|omeprazole|mesh-list
83195933|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83195934|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83195935|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83195936|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195937|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195938|NCT03266965|Carbidopa|carbidopa|mesh-list
83195939|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83195940|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83195941|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
83195942|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195943|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195944|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195945|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83195946|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195947|NCT03266731|Aspirin|aspirin|mesh-list
83195948|NCT03266731|Clopidogrel|clopidogrel|mesh-list
83195949|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83195950|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195951|NCT03266731|Analgesics|analgesics|mesh-ancestor
83195952|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
83195953|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195954|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195955|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83195956|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83195957|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83195958|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83195959|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195960|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83195961|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83195962|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83195963|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
83195964|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83195965|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83195966|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83195967|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
83195968|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195969|NCT02458963|Menotropins|menotropins|mesh-list
83195970|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83195971|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
83195972|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83195973|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195974|NCT04507607|Tenofovir|tenofovir|mesh-list
83195975|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
83195976|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83195977|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83195978|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83195980|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195981|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83195982|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83195983|NCT03353441|Glycine|glycine|mesh-list
83195984|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
83195985|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83195986|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83195987|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195988|NCT03353363|Bupivacaine|bupivacaine|mesh-list
83195989|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
83195990|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
83195991|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83195992|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83195993|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
83195994|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83195995|NCT04511195|Diclofenac|diclofenac|mesh-list
83195996|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83195997|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83195998|NCT04511195|Analgesics|analgesics|mesh-ancestor
83195999|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
83196000|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196001|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196002|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196003|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196004|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83196005|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196006|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196007|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
83196008|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
83196009|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
83196010|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83196011|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83196012|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196013|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196014|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196015|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196016|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
83196017|NCT03262363|Curcumin|curcumin|mesh-list
83196018|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83196019|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83196020|NCT03262363|Analgesics|analgesics|mesh-ancestor
83196021|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
83196022|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196023|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196024|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196025|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196026|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196027|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196028|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196029|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
83196030|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83196031|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
83196032|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196033|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
83196034|NCT04506827|Protective Agents|protective agents|mesh-ancestor
83196035|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
83196036|NCT03352895|Resveratrol|resveratrol|mesh-list
83196037|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
83196038|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196039|NCT03352895|Protective Agents|protective agents|mesh-ancestor
83196040|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196041|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196042|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83196043|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83196044|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196045|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83196046|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196047|NCT03350633|Azathioprine|azathioprine|mesh-list
83196048|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
83196049|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196050|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83196051|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196052|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83196053|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
83196054|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196055|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196056|NCT03265795|Ether|ether|mesh-list
83196057|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83196058|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
83196059|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
83196060|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196061|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196062|NCT03350399|Mitogens|mitogens|mesh-list
83196063|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83196064|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196065|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
83196066|NCT03350321|Hematinics|hematinics|mesh-ancestor
83196067|NCT03352349|Terlipressin|terlipressin|mesh-list
83196068|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83196069|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83196070|NCT03265171|Plasminogen|plasminogen|mesh-list
83196071|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83196072|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83196073|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196074|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
83196075|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196076|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196077|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196078|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196079|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83196080|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83196081|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83196082|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
83196083|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196084|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83196085|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83196086|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196087|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83196088|NCT04669561|Lifitegrast|lifitegrast|mesh-list
83196089|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83196090|NCT02729909|Lubiprostone|lubiprostone|mesh-list
83196091|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83196092|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196093|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196094|NCT03352115|Prednisolone|prednisolone|mesh-list
83196095|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196096|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
83196097|NCT03352115|Hormones|hormones|mesh-ancestor
83196098|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196099|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196100|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83196101|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196102|NCT03252457|Dexamethasone|dexamethasone|mesh-list
83196103|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
83196104|NCT03252457|Decitabine|decitabine|mesh-list
83196105|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196106|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
83196107|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
83196108|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196109|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196110|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196111|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
83196112|NCT03252457|Hormones|hormones|mesh-ancestor
83196113|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196114|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83196115|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196116|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83196117|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
83196118|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196119|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196120|NCT03258931|Cytarabine|cytarabine|mesh-list
83196121|NCT03258931|Midostaurin|midostaurin|mesh-list
83196123|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83196124|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
83196125|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196126|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196127|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
83196128|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196129|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83196130|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
83196131|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196132|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196133|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196134|NCT04506125|Chrysarobin|chrysarobin|mesh-list
83196135|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83196136|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83196137|NCT04506125|Analgesics|analgesics|mesh-ancestor
83196138|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
83196139|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196140|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196141|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196142|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196143|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
83196144|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83196145|NCT03261349|Ledipasvir|ledipasvir|mesh-list
83196146|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
83196147|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196148|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
83196149|NCT02455609|Ketamine|ketamine|mesh-list
83196150|NCT02455609|Bupivacaine|bupivacaine|mesh-list
83196151|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196152|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
83196153|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196154|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196155|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
83196156|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196157|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83196158|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83196159|NCT02455609|Analgesics|analgesics|mesh-ancestor
83196160|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83196161|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83196162|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83196163|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83196164|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196165|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196166|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83196167|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83196168|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
83196169|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83196170|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83196171|NCT05723627|Propofol|propofol|mesh-list
83196172|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83196173|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196174|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196176|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
83196177|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
83196178|NCT03349619|Resveratrol|resveratrol|mesh-list
83196179|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
83196180|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196181|NCT03349619|Protective Agents|protective agents|mesh-ancestor
83196182|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196183|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196184|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83196185|NCT04505657|Celecoxib|celecoxib|mesh-list
83196186|NCT04505657|Lidocaine|lidocaine|mesh-list
83196187|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196188|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
83196189|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196190|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196191|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
83196192|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196193|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83196194|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83196195|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83196196|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196197|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196198|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83196199|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83196201|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196202|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196203|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83196204|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83196205|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196206|NCT03259243|Bupivacaine|bupivacaine|mesh-list
83196207|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196208|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
83196209|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196210|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196211|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
83196212|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196213|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
83196214|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196215|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
83196216|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196217|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196218|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
83196219|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196220|NCT02456701|Vemurafenib|vemurafenib|mesh-list
83196221|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196222|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196223|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196224|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196225|NCT03252067|Azithromycin|azithromycin|mesh-list
83196226|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83196227|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83196228|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196229|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83196230|NCT03252223|Hormones|hormones|mesh-list
83196231|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83196232|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196233|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196234|NCT05513807|Niacinamide|niacinamide|mesh-list
83196235|NCT05513807|Niacin|niacin|mesh-list
83196236|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
83196237|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
83196238|NCT05513807|Vitamins|vitamins|mesh-ancestor
83196239|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
83418801|NCT04785222|Bupivacaine|bupivacaine|mesh-list
83196240|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196241|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83196242|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
83196243|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196244|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83196245|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
83196246|NCT04504877|Cannabidiol|cannabidiol|mesh-list
83196247|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
83196249|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196250|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83196251|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
83196252|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83196253|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83196254|NCT03257683|Ranolazine|ranolazine|mesh-list
83196255|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83196256|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196257|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196258|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
83196259|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83196260|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196261|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196262|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
83196263|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196264|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196265|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
83196266|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83196267|NCT03351569|Antibodies|antibodies|mesh-list
83196268|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
83196269|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83196270|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
83196271|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196273|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
83196274|NCT03348917|Povidone|povidone|mesh-list
83196275|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83196276|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196277|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
83196278|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
83196279|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
83196280|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
83196281|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
83196282|NCT03251365|Gemcitabine|gemcitabine|mesh-list
83196283|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83196284|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
83196285|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196286|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196287|NCT03251443|Apatinib|apatinib|mesh-list
83196288|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196289|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196290|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196291|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196292|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83196293|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83196294|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196295|NCT05350943|Gemcitabine|gemcitabine|mesh-list
83196296|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
83196297|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83196298|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
83196299|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196300|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196301|NCT03261427|Pregabalin|pregabalin|mesh-list
83196302|NCT03261427|Analgesics|analgesics|mesh-ancestor
83196303|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
83196304|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196305|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196306|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
83196307|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83196308|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196309|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196310|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83196311|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83196312|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83196313|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196314|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83196315|NCT03261115|Anesthetics|anesthetics|mesh-list
83196316|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196317|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196318|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
83196319|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
83196320|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
83196321|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196322|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196323|NCT05320133|Bismuth|bismuth|mesh-list
83196324|NCT05320133|Antacids|antacids|mesh-ancestor
83196325|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196326|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196327|NCT03122561|Acetaminophen|acetaminophen|mesh-list
83196328|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83196329|NCT03122561|Analgesics|analgesics|mesh-ancestor
83196330|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
83196331|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196332|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196333|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
83196334|NCT04503629|Rabeprazole|rabeprazole|mesh-list
83196335|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83196336|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196337|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83196338|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196339|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196340|NCT03256981|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83196341|NCT03256981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196342|NCT03256981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196343|NCT03256981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196344|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
83196345|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83196346|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
83196347|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
83196348|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196349|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196350|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
83196351|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83196352|NCT03348371|Ethanol|ethanol|mesh-list
83196353|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83196354|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196355|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196356|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196357|NCT05231603|Ivermectin|ivermectin|mesh-list
83196358|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83196359|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196360|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83196361|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83196362|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196363|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83196365|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
83196366|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83196367|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83196368|NCT03434041|Sertraline|sertraline|mesh-list
83196369|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
83196370|NCT03434041|Esketamine|esketamine|mesh-list
83196371|NCT03434041|Escitalopram|escitalopram|mesh-list
83196372|NCT03434041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83196373|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83196374|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196375|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196376|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196377|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
83196378|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196379|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196380|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83196381|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83196382|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83196383|NCT03434041|Analgesics|analgesics|mesh-ancestor
83196384|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
83196385|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
83196386|NCT03250741|Rotigotine|rotigotine|mesh-list
83196387|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
83196388|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
83196389|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196390|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196391|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196392|NCT03255811|Apatinib|apatinib|mesh-list
83196393|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196394|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196395|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196396|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196397|NCT01842035|Regadenoson|regadenoson|mesh-list
83196398|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83196399|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83196400|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
83196401|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
83196402|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196403|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196404|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196405|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
83196406|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196407|NCT05585177|Hormones|hormones|mesh-list
83196408|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196409|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196410|NCT03250039|Abrocitinib|abrocitinib|mesh-list
83196411|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196412|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196413|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196414|NCT02517827|Paclitaxel|paclitaxel|mesh-list
83196415|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83196416|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196417|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83196418|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83196419|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83196420|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196421|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83196422|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83196423|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196424|NCT03246451|Metformin|metformin|mesh-list
83196425|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83196426|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196427|NCT05013437|Acetaminophen|acetaminophen|mesh-list
83196428|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
83196429|NCT05013437|Promethazine|promethazine|mesh-list
83196430|NCT05013437|Melphalan|melphalan|mesh-list
83196431|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
83196432|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83196433|NCT05013437|Analgesics|analgesics|mesh-ancestor
83196434|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
83196435|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196436|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196437|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
83196438|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83196439|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
83196440|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196441|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196442|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83196443|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83196444|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
83196445|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83196446|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83196447|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196448|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196449|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
83196450|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
83196451|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
83196452|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196453|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83196454|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
83196455|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
83196456|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196457|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83196458|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
83196459|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83196460|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83196461|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83196462|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83196463|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83196464|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
83196465|NCT03246295|Insulin|insulin|mesh-list
83196466|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83196467|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196468|NCT03346733|Psyllium|psyllium|mesh-list
83196469|NCT03346733|Cathartics|cathartics|mesh-ancestor
83196470|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196471|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83196472|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83196473|NCT03346187|Atorvastatin|atorvastatin|mesh-list
83196474|NCT03346187|Fenofibrate|fenofibrate|mesh-list
83196475|NCT03346187|Calcium|calcium|mesh-list
83196476|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83196477|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196478|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83196479|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83196480|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
83196481|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196483|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83196484|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196485|NCT04487743|Liraglutide|liraglutide|mesh-list
83196486|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83196487|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196488|NCT04487743|Incretins|incretins|mesh-ancestor
83196489|NCT04487743|Hormones|hormones|mesh-ancestor
83196490|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196491|NCT05010629|Carboplatin|carboplatin|mesh-list
83196492|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196493|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
83196494|NCT05584631|Antibodies|antibodies|mesh-list
83196495|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
83196496|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83196497|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83196498|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
83196499|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
83196500|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196502|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
83196503|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83196504|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
83196505|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196506|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196507|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83196508|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
83196509|NCT04487587|Olaparib|olaparib|mesh-list
83196510|NCT04487587|Cediranib|cediranib|mesh-list
83196511|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83196512|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196513|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196514|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196515|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196516|NCT04833413|Insulin|insulin|mesh-list
83196517|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83196518|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83196519|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196520|NCT02454751|Fentanyl|fentanyl|mesh-list
83196521|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83196522|NCT02454751|Narcotics|narcotics|mesh-ancestor
83196523|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196524|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196525|NCT02454751|Analgesics|analgesics|mesh-ancestor
83196526|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
83196527|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196528|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83196529|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83196530|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
83196531|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
83196532|NCT02455921|Atropine|atropine|mesh-list
83196533|NCT02455921|Neostigmine|neostigmine|mesh-list
83196534|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83196535|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83196536|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83196537|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
83196538|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196539|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196540|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83196541|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
83196542|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
83196543|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
83196544|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83196545|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83196546|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
83196547|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196548|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196549|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83196550|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196551|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83196552|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
83196553|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83196554|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
83196555|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196556|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
83196557|NCT04786613|Protective Agents|protective agents|mesh-ancestor
83196558|NCT04767191|Lumefantrine|lumefantrine|mesh-list
83196559|NCT04767191|Artemether|artemether|mesh-list
83196560|NCT04767191|Piperaquine|piperaquine|mesh-list
83196561|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83196562|NCT04767191|Artenimol|artenimol|mesh-list
83196563|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
83196564|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83196565|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83196566|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196567|NCT00700999|Paroxetine|paroxetine|mesh-list
83196568|NCT00700999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83196569|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83196570|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196571|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196572|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196573|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
83196574|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196575|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83196576|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
83196577|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83196578|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83196579|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83196580|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196581|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
83196583|NCT04502771|Miconazole|miconazole|mesh-list
83196584|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196585|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83196586|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83196587|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83196588|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196589|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196590|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83196591|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
83196592|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196593|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196594|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83196595|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83196596|NCT04502849|Vitamin E|vitamin e|mesh-list
83196597|NCT04502849|Tocopherols|tocopherols|mesh-list
83196598|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
83196599|NCT04502849|Vitamins|vitamins|mesh-ancestor
83196600|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
83196601|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196602|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
83196603|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196604|NCT04502849|Protective Agents|protective agents|mesh-ancestor
83196605|NCT04761887|Ropivacaine|ropivacaine|mesh-list
83196606|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196607|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
83196608|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196609|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196610|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
83196611|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196613|NCT03249025|Ketamine|ketamine|mesh-list
83196614|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196615|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
83196616|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196617|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196618|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
83196619|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196620|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83196621|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83196622|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83196623|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196624|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196625|NCT03249025|Analgesics|analgesics|mesh-ancestor
83196626|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83196627|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83196628|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
83196629|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83196630|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83196631|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196632|NCT03248713|Mifepristone|mifepristone|mesh-list
83196633|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83196634|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
83196635|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83196636|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196637|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83196638|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83196639|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83196640|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
83196641|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83196642|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83196643|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
83196644|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196645|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
83196646|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83196647|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83196648|NCT03245671|Dexamethasone|dexamethasone|mesh-list
83196649|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
83196650|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83196651|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83196652|NCT03245671|BB 1101|bb 1101|mesh-list
83196653|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196654|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
83196655|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
83196656|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196657|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196658|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196659|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
83196660|NCT03245671|Hormones|hormones|mesh-ancestor
83196661|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196662|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83196663|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196664|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
83196665|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196666|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196667|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83196668|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
83196669|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83196670|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83196671|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196673|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83196674|NCT03245515|Branebrutinib|branebrutinib|mesh-list
83196675|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83196676|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196677|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196678|NCT03363503|Fluticasone|fluticasone|mesh-list
83196679|NCT03363503|Xhance|xhance|mesh-list
83196680|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83196681|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196682|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83196683|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
83196684|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196685|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196686|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83196687|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83196688|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
83196689|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83196690|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83196691|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83196692|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83196693|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83196694|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196695|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196696|NCT03248791|Phenylephrine|phenylephrine|mesh-list
83196697|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
83196698|NCT03248791|Norepinephrine|norepinephrine|mesh-list
83196699|NCT03248791|Bupivacaine|bupivacaine|mesh-list
83196700|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196701|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
83196702|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196703|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196704|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
83196705|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196706|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83196707|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
83196708|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
83196709|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
83196710|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83196711|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
83196712|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
83196713|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83196714|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83196715|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83196716|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
83196717|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196718|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196719|NCT03248791|Protective Agents|protective agents|mesh-ancestor
83196720|NCT03254173|Mirtazapine|mirtazapine|mesh-list
83196721|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
83196722|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83196723|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83196724|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
83196725|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
83196726|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196727|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196728|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196729|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83196730|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83196731|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196732|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83196733|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83196734|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83196735|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83196736|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83196737|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83196738|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
83196739|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83196740|NCT03248401|Aspirin|aspirin|mesh-list
83196741|NCT03248401|Cilostazol|cilostazol|mesh-list
83196742|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83196743|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83196744|NCT03248401|Analgesics|analgesics|mesh-ancestor
83196745|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
83196746|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196747|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196748|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196749|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196750|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83196751|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83196752|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196753|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83196754|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83196755|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196756|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
83196757|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83196758|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
83196759|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83196760|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
83196761|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
83196762|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83196763|NCT03248401|Protective Agents|protective agents|mesh-ancestor
83196764|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83196765|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83196766|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
83196767|NCT02516423|Dexamethasone|dexamethasone|mesh-list
83196768|NCT02516423|Lenalidomide|lenalidomide|mesh-list
83196769|NCT02516423|Ixazomib|ixazomib|mesh-list
83196770|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196771|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
83196772|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
83196773|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196774|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196775|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196776|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
83196777|NCT02516423|Hormones|hormones|mesh-ancestor
83196778|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196779|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83196780|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196781|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
83196782|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83196783|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83196784|NCT02516423|Growth Substances|growth substances|mesh-ancestor
83196785|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
83196786|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83196787|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
83196788|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196789|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196790|NCT03245281|Diuretics|diuretics|mesh-list
83196791|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
83196792|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196793|NCT02515955|Minocycline|minocycline|mesh-list
83196794|NCT02515955|Amphetamine|amphetamine|mesh-list
83196795|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
83196796|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83196797|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196798|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83196799|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196800|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
83196801|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
83418802|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
83196802|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196803|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
83196804|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196805|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196806|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
83196807|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83196808|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83196809|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83196810|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83196811|NCT03345797|Testosterone|testosterone|mesh-list
83196812|NCT03345797|Androgens|androgens|mesh-ancestor
83196814|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196815|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196816|NCT04500743|Leuprolide|leuprolide|mesh-list
83196817|NCT04500743|Dienogest|dienogest|mesh-list
83196818|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83196819|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
83196820|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83196821|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196822|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83196823|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196824|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83196825|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
83196826|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83196827|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83196828|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83196829|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83196830|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
83196831|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196832|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83196833|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196834|NCT03239353|Entecavir|entecavir|mesh-list
83196835|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
83196836|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196837|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
83196838|NCT03347591|Hemostatics|hemostatics|mesh-list
83196839|NCT03347591|Coagulants|coagulants|mesh-ancestor
83196840|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83196841|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
83196842|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196843|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83196844|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196845|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
83196846|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196847|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
83196848|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83196849|NCT03347591|Protective Agents|protective agents|mesh-ancestor
83196850|NCT04486651|Irinotecan|irinotecan|mesh-list
83196851|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83196852|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83196853|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196854|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196855|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196856|NCT03347513|Glycine|glycine|mesh-list
83196857|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
83196858|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196859|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196860|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196861|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
83196862|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
83196863|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196864|NCT04088591|Protective Agents|protective agents|mesh-ancestor
83196865|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196866|NCT04088591|Vitamins|vitamins|mesh-ancestor
83196867|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
83196868|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
83196869|NCT04501289|Analgesics|analgesics|mesh-ancestor
83196870|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
83196886|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196888|NCT03244423|Coagulants|coagulants|mesh-ancestor
83196907|NCT03347357|Tacrolimus|tacrolimus|mesh-list
83196908|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83196909|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
83196910|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196911|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83196912|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196913|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196914|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83196915|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196916|NCT02515877|Carboplatin|carboplatin|mesh-list
83196917|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196918|NCT03952091|Dexamethasone|dexamethasone|mesh-list
83196919|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
83196920|NCT03952091|Lenalidomide|lenalidomide|mesh-list
83196921|NCT03952091|BB 1101|bb 1101|mesh-list
83196922|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196923|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
83196924|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
83196925|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196926|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196927|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83196928|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
83196929|NCT03952091|Hormones|hormones|mesh-ancestor
83196930|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83196931|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83196932|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196933|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
83196934|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196935|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196936|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
83196937|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83196938|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83196939|NCT03952091|Growth Substances|growth substances|mesh-ancestor
83196940|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
83196941|NCT03246919|Oxytocin|oxytocin|mesh-list
83196942|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
83196943|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83196944|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196945|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
83196946|NCT04502537|Hematinics|hematinics|mesh-ancestor
83196947|NCT02453659|Nicotine|nicotine|mesh-list
83196948|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83196949|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
83196950|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83196951|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196952|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83196953|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83196954|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
83196955|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196956|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196957|NCT02513147|Lopinavir|lopinavir|mesh-list
83196958|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83196959|NCT02513147|Darunavir|darunavir|mesh-list
83196960|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
83196961|NCT02513147|Dolutegravir|dolutegravir|mesh-list
83196962|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83196963|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83196964|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83196965|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83196966|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196967|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83196968|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83196969|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
83196970|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83196971|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83196972|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83196973|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83196974|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83196975|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
83196976|NCT02714881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83196977|NCT02714881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83196978|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83196979|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
83418803|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
83196980|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196981|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83196982|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
83196983|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83196984|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83196985|NCT03246685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83196986|NCT03246685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196987|NCT02453893|Risperidone|risperidone|mesh-list
83196988|NCT02453893|Iloperidone|iloperidone|mesh-list
83196989|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83196990|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
83196991|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83196992|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83196993|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83196994|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83196995|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83196996|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83196997|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83196998|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83196999|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
83197000|NCT03664895|Goserelin|goserelin|mesh-list
83197001|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83197002|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197003|NCT02513069|Nicotine|nicotine|mesh-list
83197004|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
83197005|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83197006|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
83197007|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197008|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197009|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83197010|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83197011|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
83197012|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197013|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197014|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
83197015|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
83197016|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
83197017|NCT02454205|Levofloxacin|levofloxacin|mesh-list
83197018|NCT02454205|Isoniazid|isoniazid|mesh-list
83197019|NCT02454205|Linezolid|linezolid|mesh-list
83197020|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
83197021|NCT02454205|Bedaquiline|bedaquiline|mesh-list
83197022|NCT02454205|Ethionamide|ethionamide|mesh-list
83197023|NCT02454205|Kanamycin|kanamycin|mesh-list
83197024|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197025|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197026|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83197027|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83197028|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197029|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197030|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197031|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83197032|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83197033|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83197034|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
83197035|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83197036|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83197037|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
83197038|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83197039|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83197041|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83197042|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197043|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197044|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83197045|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83197046|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
83197047|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197048|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83197049|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83197050|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83197051|NCT03234673|Calcipotriene|calcipotriene|mesh-list
83197052|NCT03234673|Tacrolimus|tacrolimus|mesh-list
83197053|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83197054|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
83197055|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197056|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83197057|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197058|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197059|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
83197060|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
83197061|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
83197062|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197063|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
83197064|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197065|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197066|NCT03243643|Apatinib|apatinib|mesh-list
83197067|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197068|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83197069|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197070|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197071|NCT03234517|Clindamycin|clindamycin|mesh-list
83197072|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
83197073|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
83197074|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197075|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197076|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83197077|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197078|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197079|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
83197080|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83197081|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
83197082|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197083|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
83197084|NCT03238183|Protective Agents|protective agents|mesh-ancestor
83197085|NCT02729051|Albuterol|albuterol|mesh-list
83197086|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83197087|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
83197088|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197089|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197090|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83197091|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
83197092|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
83197093|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83197094|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83197095|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83197096|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83197097|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197098|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197099|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197101|NCT03237637|Atenolol|atenolol|mesh-list
83197102|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83197103|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83197104|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197105|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197106|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197107|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197108|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83197109|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83197110|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
83197111|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
83197112|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
83197113|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197114|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83197115|NCT03243331|Gedatolisib|gedatolisib|mesh-list
83197116|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83197117|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197118|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197119|NCT03237715|Bilirubin|bilirubin|mesh-list
83197120|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
83418957|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83197121|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197123|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197124|NCT02515565|Erythromycin|erythromycin|mesh-list
83197125|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
83197126|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83197127|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
83197128|NCT02515565|Cephalosporins|cephalosporins|mesh-list
83197129|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197130|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197131|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83197132|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83197133|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197134|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197135|NCT05600075|Insulin|insulin|mesh-list
83197136|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83197137|NCT05600075|Glycolic acid|glycolic acid|mesh-list
83197138|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197139|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197140|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
83197141|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
83197142|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83197143|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
83197144|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83197145|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
83197146|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197147|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83197148|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83197149|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83197150|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197151|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197152|NCT03233815|Propofol|propofol|mesh-list
83197153|NCT03233815|Sevoflurane|sevoflurane|mesh-list
83197154|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83197155|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197156|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197157|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83197158|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
83197159|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
83197160|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83197161|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83197162|NCT02507609|Rocuronium|rocuronium|mesh-list
83197163|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197164|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83197165|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83197166|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83197167|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197168|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83197169|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197170|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197171|NCT02512523|Incretins|incretins|mesh-ancestor
83197172|NCT02512523|Hormones|hormones|mesh-ancestor
83197173|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83197174|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83197175|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
83197176|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197177|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197178|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
83197179|NCT03233893|Calcium|calcium|mesh-list
83197180|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197181|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197182|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83197183|NCT05597813|Timolol|timolol|mesh-list
83197184|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83197185|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83197186|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197187|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197188|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197189|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197190|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83197191|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83197192|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
83197193|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83197194|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
83197195|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197196|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
83197197|NCT03242707|Protective Agents|protective agents|mesh-ancestor
83197198|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
83197199|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83197200|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197201|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197202|NCT02512055|Atropine|atropine|mesh-list
83197203|NCT02512055|Ketamine|ketamine|mesh-list
83197204|NCT02512055|Analgesics|analgesics|mesh-ancestor
83197205|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
83197206|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197207|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197208|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83197209|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83197210|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
83197211|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
83197212|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197213|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83197214|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83197215|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197216|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197217|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83197218|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83197219|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83197220|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
83197221|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83197222|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
83197223|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
83197224|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
83197225|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83197226|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83197227|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
83197228|NCT02514941|Acetaminophen|acetaminophen|mesh-list
83197229|NCT02514941|Amoxicillin|amoxicillin|mesh-list
83197230|NCT02514941|Talinolol|talinolol|mesh-list
83197231|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197232|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197233|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197234|NCT02514941|Analgesics|analgesics|mesh-ancestor
83197235|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
83197236|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197237|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197238|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
83197239|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83197240|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83197241|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197242|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197243|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197244|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83197245|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83197246|NCT02511665|Metformin|metformin|mesh-list
83197247|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197248|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197249|NCT02514629|Metformin|metformin|mesh-list
83197250|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
83197251|NCT02514629|Testosterone|testosterone|mesh-list
83197252|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
83197253|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
83197254|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83197255|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197256|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197257|NCT02514629|Androgens|androgens|mesh-ancestor
83197258|NCT02514629|Hormones|hormones|mesh-ancestor
83197259|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83197260|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83197261|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197262|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
83197263|NCT02511353|Ivermectin|ivermectin|mesh-list
83197264|NCT02511353|Piperaquine|piperaquine|mesh-list
83197265|NCT02511353|Artenimol|artenimol|mesh-list
83197266|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83197267|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197268|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
83197269|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83197270|NCT03242317|Mitomycins|mitomycins|mesh-list
83197271|NCT03242317|Mitomycin|mitomycin|mesh-list
83197272|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83197273|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197274|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
83197275|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197276|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83197277|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197278|NCT02453503|Triamcinolone|triamcinolone|mesh-list
83197279|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83197280|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83197281|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83197282|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83197283|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
83197284|NCT02453503|Hormones|hormones|mesh-ancestor
83197285|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83197286|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197287|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83197288|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
83197289|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197290|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197291|NCT04499885|Mineral Oil|mineral oil|mesh-list
83197292|NCT04499885|Emollients|emollients|mesh-ancestor
83197293|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83197294|NCT02453425|Norepinephrine|norepinephrine|mesh-list
83197295|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83197296|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83197297|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197298|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197299|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197300|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197301|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
83197302|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
83197303|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197304|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83197305|NCT03233035|Ketamine|ketamine|mesh-list
83197306|NCT03233035|Analgesics|analgesics|mesh-ancestor
83197307|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
83197308|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197309|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197310|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83197311|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83197312|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
83197313|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
83197314|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197315|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83197316|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83197317|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197318|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197319|NCT03242239|Trastuzumab|trastuzumab|mesh-list
83197320|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83197321|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197322|NCT03232957|Morphine|morphine|mesh-list
83197323|NCT03232957|Bupivacaine|bupivacaine|mesh-list
83197324|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
83197325|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
83197326|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197327|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197328|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
83197329|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197330|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83197331|NCT03232957|Narcotics|narcotics|mesh-ancestor
83197332|NCT03232957|Analgesics|analgesics|mesh-ancestor
83197333|NCT02513849|Tamoxifen|tamoxifen|mesh-list
83197334|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83197335|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
83197336|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83197337|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197338|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83197339|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197340|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83197341|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83197342|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83197343|NCT02513927|Metoprolol|metoprolol|mesh-list
83197344|NCT02513927|Nifedipine|nifedipine|mesh-list
83197345|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83197346|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83197347|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
83197348|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
83197349|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197350|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197351|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83197352|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83197353|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83197354|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197355|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197356|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197357|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83197358|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83197359|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197360|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
83197361|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
83197362|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83197363|NCT03236623|Menthol|menthol|mesh-list
83197364|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
83197365|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
83197366|NCT03121313|Tegafur|tegafur|mesh-list
83197367|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83197368|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
83197369|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197370|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197372|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
83197373|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197374|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197375|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197376|NCT02513693|Rocuronium|rocuronium|mesh-list
83197377|NCT02513693|Neostigmine|neostigmine|mesh-list
83197378|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83197379|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83197380|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83197381|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197382|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197383|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83197384|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197385|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197386|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
83197387|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197388|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83197389|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
83197390|NCT03121547|Tramadol|tramadol|mesh-list
83197391|NCT03121547|Tapentadol|tapentadol|mesh-list
83197392|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197393|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83197394|NCT03121547|Narcotics|narcotics|mesh-ancestor
83197395|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197396|NCT03121547|Analgesics|analgesics|mesh-ancestor
83197397|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
83197398|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197399|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83197400|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83197401|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83197402|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197403|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197404|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197405|NCT03241381|Vitamin D|vitamin d|mesh-list
83197406|NCT03241381|Vitamins|vitamins|mesh-ancestor
83197407|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
83197408|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197409|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83197410|NCT03241303|Acarbose|acarbose|mesh-list
83197411|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83197412|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197413|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197414|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197415|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197416|NCT02510963|Tenofovir|tenofovir|mesh-list
83197417|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
83197418|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197419|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83197420|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83197421|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197422|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197423|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83197424|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83197425|NCT02513381|Vitamin D|vitamin d|mesh-list
83197426|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
83197427|NCT02513381|Vitamins|vitamins|mesh-ancestor
83197428|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
83197429|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197430|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83197431|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197432|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
83197433|NCT03236155|Narcotics|narcotics|mesh-ancestor
83197434|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197435|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197436|NCT03236155|Analgesics|analgesics|mesh-ancestor
83197437|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
83197438|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197439|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
83197440|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
83197441|NCT03232021|Pregabalin|pregabalin|mesh-list
83197442|NCT03232021|Analgesics|analgesics|mesh-ancestor
83197443|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
83197444|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197445|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197446|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
83197447|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83197448|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83197449|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197450|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197451|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83197452|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83197453|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197454|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83197455|NCT03235609|Fentanyl|fentanyl|mesh-list
83197456|NCT03235609|Ketamine|ketamine|mesh-list
83197457|NCT03235609|Analgesics|analgesics|mesh-ancestor
83197458|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
83197459|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197460|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197461|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83197462|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83197463|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
83197464|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
83197465|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197466|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83197467|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83197468|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197469|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197470|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83197471|NCT03235609|Narcotics|narcotics|mesh-ancestor
83197472|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83197473|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
83197474|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83197475|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197476|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197477|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197478|NCT02509949|Analgesics|analgesics|mesh-ancestor
83197479|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
83197480|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197481|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83197482|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83197483|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83197484|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197485|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197486|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197487|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
83197488|NCT03344705|Fludarabine|fludarabine|mesh-list
83197489|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83197490|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
83197491|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197492|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197493|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83197494|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
83197495|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197496|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197497|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83197498|NCT02501603|Paclitaxel|paclitaxel|mesh-list
83197499|NCT02501603|Afatinib|afatinib|mesh-list
83197500|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83197501|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197502|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
83197503|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
83197504|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
83197505|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197506|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83197507|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197508|NCT03344627|Meropenem|meropenem|mesh-list
83197509|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197510|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197511|NCT02501213|Furosemide|furosemide|mesh-list
83197512|NCT02501213|Spironolactone|spironolactone|mesh-list
83197513|NCT02501213|Diuretics|diuretics|mesh-ancestor
83197514|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
83197515|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197516|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83197517|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83197518|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197519|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83197520|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
83197521|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83197522|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83197523|NCT02501291|Thalidomide|thalidomide|mesh-list
83197524|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83197525|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
83197526|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197527|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
83197528|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197529|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197530|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83197531|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83197532|NCT02501291|Growth Substances|growth substances|mesh-ancestor
83197533|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
83197534|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197535|NCT02509559|Propranolol|propranolol|mesh-list
83197536|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83197537|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83197538|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197539|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197540|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197541|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197542|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83197543|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83197544|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
83197545|NCT00707993|Alogliptin|alogliptin|mesh-list
83197546|NCT00707993|Glipizide|glipizide|mesh-list
83197547|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197548|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197549|NCT00707993|Incretins|incretins|mesh-ancestor
83197550|NCT00707993|Hormones|hormones|mesh-ancestor
83197551|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83197552|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83197553|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
83197554|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197555|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197556|NCT02509091|Amikacin|amikacin|mesh-list
83197557|NCT02509091|Dimercaprol|dimercaprol|mesh-list
83197558|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197559|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197560|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
83197561|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
83197562|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197563|NCT02508857|Ketorolac|ketorolac|mesh-list
83197564|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
83197565|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83197566|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197567|NCT02508857|Analgesics|analgesics|mesh-ancestor
83197568|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
83197569|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197570|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197571|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83197572|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197573|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83197574|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197575|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197576|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
83197577|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197578|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83197579|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
83197580|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83197581|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83197582|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197583|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
83197584|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83197585|NCT02508623|Rifaximin|rifaximin|mesh-list
83197586|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197587|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197588|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83197589|NCT02500667|Rifampin|rifampin|mesh-list
83197590|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83197591|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
83197592|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197593|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197594|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
83197595|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83197596|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197597|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197598|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83197599|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83197600|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83197601|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83197602|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83197603|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83197604|NCT02500511|Vaccines|vaccines|mesh-list
83197605|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
83197606|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197607|NCT03344393|Ketamine|ketamine|mesh-list
83197608|NCT03344393|Analgesics|analgesics|mesh-ancestor
83197609|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
83197610|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197611|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197612|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83197613|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83197614|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
83197615|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
83197616|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197617|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83197618|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83197619|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197620|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197621|NCT04498793|Paclitaxel|paclitaxel|mesh-list
83197622|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
83197623|NCT04498793|Doxorubicin|doxorubicin|mesh-list
83197624|NCT04498793|Epirubicin|epirubicin|mesh-list
83197625|NCT04498793|Tislelizumab|tislelizumab|mesh-list
83197626|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83197627|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197628|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
83197629|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
83197630|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
83197631|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197632|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83197633|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
83197634|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197635|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197636|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83197637|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
83197638|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83197639|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83197640|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83197641|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83197642|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197643|NCT04498793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83197644|NCT04498325|Antibodies|antibodies|mesh-list
83197645|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
83197646|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197647|NCT02507843|Vitamin D|vitamin d|mesh-list
83197648|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
83197649|NCT02507843|Vitamins|vitamins|mesh-ancestor
83197650|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
83197651|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197652|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83197653|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197654|NCT02425891|Paclitaxel|paclitaxel|mesh-list
83197655|NCT02425891|Atezolizumab|atezolizumab|mesh-list
83197656|NCT02425891|Antibodies|antibodies|mesh-list
83197657|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83197658|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83197659|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197660|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
83197661|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
83197662|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
83197663|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197664|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
83197665|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197666|NCT02425891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83197667|NCT02425891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83197668|NCT02499965|Anesthetics|anesthetics|mesh-list
83197669|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
83197670|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197671|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197672|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
83197673|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
83197674|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197675|NCT05504057|Amantadine|amantadine|mesh-list
83197676|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
83197677|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83197678|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83197679|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83197680|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
83197681|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197682|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
83197683|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197684|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197685|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197686|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197687|NCT05504057|Analgesics|analgesics|mesh-ancestor
83197688|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
83197689|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197690|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
83197691|NCT03344003|Factor VIII|factor viii|mesh-list
83197692|NCT03344003|Coagulants|coagulants|mesh-ancestor
83197693|NCT03235531|Valproic Acid|valproic acid|mesh-list
83197694|NCT03235531|Lorazepam|lorazepam|mesh-list
83197695|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
83197696|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197697|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197698|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
83197699|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197700|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197701|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
83197702|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83197703|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197704|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83197705|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
83197706|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
83197707|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197708|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83197709|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83197710|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83197712|NCT02506829|Nicotine|nicotine|mesh-list
83197713|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83197714|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
83197715|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197716|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197717|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83197718|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83197719|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83197720|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197721|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197722|NCT02506439|Vitamin D|vitamin d|mesh-list
83197723|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
83197724|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
83197725|NCT02506439|Vitamins|vitamins|mesh-list
83197726|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
83197727|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197728|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83197729|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197730|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
83197731|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197732|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83197733|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197734|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197735|NCT02499341|Ketamine|ketamine|mesh-list
83197736|NCT02499341|Tramadol|tramadol|mesh-list
83197737|NCT02499341|Analgesics|analgesics|mesh-ancestor
83197738|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
83197739|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197740|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197741|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83197742|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83197743|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
83197744|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
83197745|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197746|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83197747|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83197748|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197749|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197750|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83197751|NCT02499341|Narcotics|narcotics|mesh-ancestor
83197752|NCT02495285|Polygeline|polygeline|mesh-list
83197753|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
83197754|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
83197755|NCT02495363|Bupivacaine|bupivacaine|mesh-list
83197756|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
83197757|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
83197758|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197759|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197760|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
83197761|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197762|NCT03121079|Interferons|interferons|mesh-list
83197763|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
83197764|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197765|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
83197766|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197767|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
83197768|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197769|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
83197770|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197771|NCT02494895|Aspirin|aspirin|mesh-list
83197772|NCT02494895|Ticagrelor|ticagrelor|mesh-list
83197773|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83197774|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197775|NCT02494895|Analgesics|analgesics|mesh-ancestor
83197776|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
83197777|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197778|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197779|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83197780|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197781|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83197782|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83197783|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197784|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83197785|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83197786|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197787|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
83197788|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83197789|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83197790|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83197791|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
83197792|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197793|NCT03341741|Tobramycin|tobramycin|mesh-list
83197794|NCT03341741|Colistin|colistin|mesh-list
83197795|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197796|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197797|NCT01597245|Etanercept|etanercept|mesh-list
83197798|NCT01597245|Ixekizumab|ixekizumab|mesh-list
83197799|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83197800|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197801|NCT01597245|Analgesics|analgesics|mesh-ancestor
83197802|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
83197803|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197804|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197805|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83197806|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197807|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83197808|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83197809|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
83197810|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
83197811|NCT03341429|Liraglutide|liraglutide|mesh-list
83197812|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197813|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197814|NCT03341429|Incretins|incretins|mesh-ancestor
83197815|NCT03341429|Hormones|hormones|mesh-ancestor
83197816|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83197817|NCT04494659|Rifampin|rifampin|mesh-list
83197818|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83197819|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
83197820|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197821|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197822|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
83197823|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83197824|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197825|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197826|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83197827|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83197828|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83197829|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83197830|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83197831|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83197832|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
83197833|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
83197834|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197835|NCT03342599|Protective Agents|protective agents|mesh-ancestor
83197836|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197837|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
83197838|NCT03342599|Vitamins|vitamins|mesh-ancestor
83197839|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
83197840|NCT03341117|Aspirin|aspirin|mesh-list
83197841|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
83197842|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83197843|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197844|NCT03341117|Analgesics|analgesics|mesh-ancestor
83197845|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
83197846|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197847|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197848|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83197849|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197850|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83197851|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83197852|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197853|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83197854|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83197855|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197856|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
83197857|NCT03341117|Antacids|antacids|mesh-ancestor
83197858|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83197859|NCT02498171|Fentanyl|fentanyl|mesh-list
83197860|NCT02498171|Morphine|morphine|mesh-list
83197861|NCT02498171|Bupivacaine|bupivacaine|mesh-list
83197862|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
83197863|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
83197864|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197865|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197866|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
83197867|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197868|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83197869|NCT02498171|Narcotics|narcotics|mesh-ancestor
83197870|NCT02498171|Analgesics|analgesics|mesh-ancestor
83197871|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83197872|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83197873|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
83197874|NCT03120533|Treprostinil|treprostinil|mesh-list
83197875|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83197876|NCT03342443|Memantine|memantine|mesh-list
83197877|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83197878|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83197879|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
83197880|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197881|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197882|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197883|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83197884|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83197885|NCT05035485|Phenylephrine|phenylephrine|mesh-list
83197886|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
83197887|NCT05035485|Norepinephrine|norepinephrine|mesh-list
83197888|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83197889|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83197890|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
83197891|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
83197892|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197893|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197894|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
83197895|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
83197896|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
83197897|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83197898|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83197899|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83197900|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197901|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197902|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197903|NCT05035485|Protective Agents|protective agents|mesh-ancestor
83197904|NCT02498015|Ribavirin|ribavirin|mesh-list
83197905|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
83197906|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197907|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
83197908|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197909|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
83197910|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83197911|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197912|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83197913|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
83197914|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83197915|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83197916|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197917|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197918|NCT03340493|Tenecteplase|tenecteplase|mesh-list
83197919|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83197920|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83197921|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197922|NCT03098199|Menotropins|menotropins|mesh-list
83197923|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197924|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83197925|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
83197926|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83197928|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83197929|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197930|NCT00707057|Analgesics|analgesics|mesh-ancestor
83197931|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
83197932|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197933|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197934|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83197935|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83197936|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83197937|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83197938|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197939|NCT02494349|Tamsulosin|tamsulosin|mesh-list
83197940|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
83197941|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83197942|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83197943|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83197944|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197945|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197946|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197947|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197948|NCT02494349|Urological Agents|urological agents|mesh-ancestor
83197949|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83197950|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83197951|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
83197952|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
83197953|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83197954|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83197955|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197956|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83197957|NCT03095469|Analgesics|analgesics|mesh-ancestor
83197958|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
83197959|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83197960|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83197961|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83197962|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83197963|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
83197964|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83197965|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197966|NCT02497547|Oxytocin|oxytocin|mesh-list
83197967|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
83197968|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83197969|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197970|NCT05043129|Vaccines|vaccines|mesh-list
83197971|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
83197972|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197973|NCT02497313|Metformin|metformin|mesh-list
83197974|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
83197975|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83197976|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197977|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83197978|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83197979|NCT02497157|Leucovorin|leucovorin|mesh-list
83197980|NCT02497157|Bevacizumab|bevacizumab|mesh-list
83197981|NCT02497157|Fluorouracil|fluorouracil|mesh-list
83197982|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
83197983|NCT02497157|Irinotecan|irinotecan|mesh-list
83197984|NCT02497157|Calcium|calcium|mesh-list
83197985|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
83197986|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83197987|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83197988|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83197989|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83197990|NCT02497157|Growth Substances|growth substances|mesh-ancestor
83197991|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83197992|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
83197993|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83197994|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
83197995|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83197996|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83197997|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83197998|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
83197999|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83198000|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83198001|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198002|NCT02497157|Antidotes|antidotes|mesh-ancestor
83198003|NCT02497157|Protective Agents|protective agents|mesh-ancestor
83198004|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
83198005|NCT02497157|Vitamins|vitamins|mesh-ancestor
83198006|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
83198007|NCT03095235|Riboflavin|riboflavin|mesh-list
83198008|NCT03095235|Vitamins|vitamins|mesh-ancestor
83198009|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
83198010|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198011|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
83198012|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83198013|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83198014|NCT03095079|Endostatins|endostatins|mesh-list
83198015|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83198016|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83198017|NCT03095079|Growth Substances|growth substances|mesh-ancestor
83198018|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198019|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
83198020|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198021|NCT03120923|Triamcinolone|triamcinolone|mesh-list
83198022|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83198023|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83198024|NCT03120923|Lidocaine|lidocaine|mesh-list
83198025|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83198026|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198027|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
83198028|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198029|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198030|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
83198031|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198032|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83198033|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83198034|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83198035|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83198036|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198037|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198038|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
83198039|NCT03120923|Hormones|hormones|mesh-ancestor
83198040|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198041|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83198042|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
83198043|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198044|NCT02497079|Formaldehyde|formaldehyde|mesh-list
83198045|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
83198046|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198047|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
83198048|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83198049|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
83198050|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83198051|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
83198052|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198053|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198054|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
83198055|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
83198056|NCT02639247|Velpatasvir|velpatasvir|mesh-list
83198057|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
83198058|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198059|NCT05033535|Olmesartan|olmesartan|mesh-list
83198060|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83198061|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83198062|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83198063|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83198064|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198065|NCT05053893|Valsartan|valsartan|mesh-list
83198066|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83198067|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83198068|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83198069|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83198070|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198071|NCT03096327|Montelukast|montelukast|mesh-list
83198072|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83198073|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198074|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83198075|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
83198076|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198077|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198078|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83198079|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83198080|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198081|NCT03098121|Grazoprevir|grazoprevir|mesh-list
83198082|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
83198083|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198084|NCT03095001|Paclitaxel|paclitaxel|mesh-list
83198085|NCT03095001|Bevacizumab|bevacizumab|mesh-list
83198086|NCT03095001|Carboplatin|carboplatin|mesh-list
83198087|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83198088|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198089|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
83198090|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
83198091|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
83198092|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198093|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83198094|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83198095|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83198096|NCT03095001|Growth Substances|growth substances|mesh-ancestor
83198097|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198098|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
83198099|NCT05042271|Meropenem|meropenem|mesh-list
83198100|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83198101|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198102|NCT02138955|Curcumin|curcumin|mesh-list
83198103|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83198104|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83198105|NCT02138955|Analgesics|analgesics|mesh-ancestor
83198106|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
83198107|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198108|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198109|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198110|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198111|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198112|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198113|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198114|NCT03096405|Methicillin|methicillin|mesh-list
83198115|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83198116|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198117|NCT05032287|Tamsulosin|tamsulosin|mesh-list
83198118|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83198119|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83198120|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83198121|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
83198122|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198123|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198124|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198125|NCT05032287|Urological Agents|urological agents|mesh-ancestor
83198126|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83198127|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83198128|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198129|NCT02493959|Incretins|incretins|mesh-ancestor
83198130|NCT02493959|Hormones|hormones|mesh-ancestor
83198131|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198132|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83198133|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
83198134|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198135|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198136|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
83198137|NCT02496377|Glycine|glycine|mesh-list
83198138|NCT02496377|Hematinics|hematinics|mesh-ancestor
83198139|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
83198140|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198141|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198142|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198143|NCT02496455|Tramadol|tramadol|mesh-list
83198144|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198145|NCT02496455|Narcotics|narcotics|mesh-ancestor
83198146|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198147|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198148|NCT02496455|Analgesics|analgesics|mesh-ancestor
83198149|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
83198150|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198151|NCT02496299|Dexamethasone|dexamethasone|mesh-list
83198152|NCT02496299|Bupivacaine|bupivacaine|mesh-list
83198153|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198154|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
83198155|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
83198156|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198157|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198158|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83198159|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
83198160|NCT02496299|Hormones|hormones|mesh-ancestor
83198161|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198162|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83198163|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198164|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198165|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
83418958|NCT01490918|Acarbose|acarbose|mesh-list
83198166|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198167|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
83198169|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83198170|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83198171|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
83198172|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198173|NCT04467957|Xenon|xenon|mesh-list
83198174|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83198175|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
83198176|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
83198177|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198178|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198179|NCT02121405|Capecitabine|capecitabine|mesh-list
83198180|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
83198181|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83198182|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
83198183|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198184|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198185|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
83198186|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83198187|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198188|NCT03337841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83198189|NCT03337841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198190|NCT02493335|Budesonide|budesonide|mesh-list
83198191|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198192|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83198193|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
83198194|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198195|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198196|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83198197|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198198|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
83198199|NCT02493335|Hormones|hormones|mesh-ancestor
83198200|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198201|NCT03336593|Vaccines|vaccines|mesh-list
83198202|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
83198203|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198204|NCT03337607|Celecoxib|celecoxib|mesh-list
83198205|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83198206|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83198207|NCT03337607|Eperisone|eperisone|mesh-list
83198208|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
83198209|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83198210|NCT03337607|Analgesics|analgesics|mesh-ancestor
83198211|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
83198212|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198213|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198214|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198215|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83198216|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83198217|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198218|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198219|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
83198220|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83198221|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83198222|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83198223|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83198224|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83198225|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
83198226|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
83198227|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
83198228|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83198229|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83198231|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
83198232|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198233|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198234|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198235|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198236|NCT03336437|Estradiol|estradiol|mesh-list
83198237|NCT03336437|Estrogens|estrogens|mesh-ancestor
83198238|NCT03336437|Hormones|hormones|mesh-ancestor
83198239|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198240|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198241|NCT03337373|Cisatracurium|cisatracurium|mesh-list
83198242|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83198243|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83198244|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198245|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198246|NCT03336281|Ustekinumab|ustekinumab|mesh-list
83198247|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
83198248|NCT03336125|Vitamin D|vitamin d|mesh-list
83198249|NCT03336125|Vitamins|vitamins|mesh-ancestor
83198250|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
83198251|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198252|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83198253|NCT05051163|Gentamicins|gentamicins|mesh-list
83198254|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
83198255|NCT05051163|Ampicillin|ampicillin|mesh-list
83198256|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83198257|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198258|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83198259|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198260|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198261|NCT03331211|Dasatinib|dasatinib|mesh-list
83198262|NCT03331211|Ponatinib|ponatinib|mesh-list
83198263|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198264|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83198265|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198266|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198267|NCT01929915|Fentanyl|fentanyl|mesh-list
83198268|NCT01929915|Morphine|morphine|mesh-list
83198269|NCT01929915|Bupivacaine|bupivacaine|mesh-list
83198270|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198271|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
83198272|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198273|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198274|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
83198275|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198276|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198277|NCT01929915|Narcotics|narcotics|mesh-ancestor
83198278|NCT01929915|Analgesics|analgesics|mesh-ancestor
83198279|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83198280|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83198281|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
83198282|NCT05464745|Perindopril|perindopril|mesh-list
83198283|NCT05464745|Indapamide|indapamide|mesh-list
83198284|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83198285|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
83198286|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198287|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198288|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83198289|NCT05464745|Diuretics|diuretics|mesh-ancestor
83198290|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
83198291|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198292|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83198293|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83198294|NCT03094533|Propofol|propofol|mesh-list
83198295|NCT03094533|Sevoflurane|sevoflurane|mesh-list
83198296|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83198297|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198298|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198299|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83198300|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
83198301|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
83198302|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83198303|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83198304|NCT05028231|Immunomodulating Agents|immunomodulating agents|mesh-list
83198305|NCT05028231|Immunologic Factors|immunologic factors|mesh-ancestor
83198306|NCT05028231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198307|NCT03335579|Sufentanil|sufentanil|mesh-list
83198308|NCT03335579|Remifentanil|remifentanil|mesh-list
83198309|NCT03335579|Propofol|propofol|mesh-list
83198310|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
83198311|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198312|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198313|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83198314|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83198315|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
83198316|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198317|NCT03335579|Narcotics|narcotics|mesh-ancestor
83198318|NCT03335579|Analgesics|analgesics|mesh-ancestor
83198319|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
83198320|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198321|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83198322|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
83198323|NCT05050071|Calcium|calcium|mesh-list
83198324|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83198325|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198326|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83198327|NCT03335501|Pancrelipase|pancrelipase|mesh-list
83198328|NCT03335501|Hormones|hormones|mesh-list
83198329|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198330|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198331|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83198332|NCT02492945|Lidocaine|lidocaine|mesh-list
83198333|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83198334|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198335|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
83198336|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198337|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198338|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
83198339|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198340|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83198341|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83198342|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83198343|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83198344|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198345|NCT03335423|Metformin|metformin|mesh-list
83198346|NCT03335423|Codeine|codeine|mesh-list
83198347|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83198348|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198349|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198350|NCT03335423|Narcotics|narcotics|mesh-ancestor
83198351|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198352|NCT03335423|Analgesics|analgesics|mesh-ancestor
83198353|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
83198354|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198355|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
83198356|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198357|NCT05038605|Metronidazole|metronidazole|mesh-list
83198358|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198359|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83198360|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83198361|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83198362|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83198363|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83198364|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83198365|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
83198366|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198367|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83198368|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83198369|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198370|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83198372|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83198373|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198374|NCT03095547|Cyclosporine|cyclosporine|mesh-list
83198375|NCT03095547|Posaconazole|posaconazole|mesh-list
83198376|NCT03095547|Olorofim|olorofim|mesh-list
83198377|NCT03095547|Pantoprazole|pantoprazole|mesh-list
83198378|NCT03095547|Tacrolimus|tacrolimus|mesh-list
83198379|NCT03095547|Cyclosporins|cyclosporins|mesh-list
83198380|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83198381|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
83198382|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198383|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83198384|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198385|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198386|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
83198387|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198388|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
83198389|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198390|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83198391|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83198392|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83198393|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83198394|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83198395|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83198396|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83198397|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83198398|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83198399|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
83198400|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198401|NCT03329651|Metformin|metformin|mesh-list
83198402|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83198403|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198404|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83198405|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83198406|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198407|NCT04968951|Metronidazole|metronidazole|mesh-list
83198408|NCT04968951|Vancomycin|vancomycin|mesh-list
83198409|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198410|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83198411|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83198412|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83198413|NCT05049681|Apatinib|apatinib|mesh-list
83198414|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198415|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83198416|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198417|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198418|NCT03334487|Dexamethasone|dexamethasone|mesh-list
83198419|NCT03334487|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83198420|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198421|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
83198422|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
83198423|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198424|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198425|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83198426|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
83198427|NCT03334487|Hormones|hormones|mesh-ancestor
83198428|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198429|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83198430|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198431|NCT03334487|Immunoconjugates|immunoconjugates|mesh-ancestor
83198432|NCT03334487|Immunologic Factors|immunologic factors|mesh-ancestor
83198433|NCT05038449|Colchicine|colchicine|mesh-list
83198434|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
83198435|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198436|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83198437|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83198438|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83198439|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198440|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198441|NCT05038059|Acetic Acid|acetic acid|mesh-list
83198442|NCT05038059|Retinol acetate|retinol acetate|mesh-list
83198443|NCT05038059|Ethylene|ethylene|mesh-list
83198444|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83198445|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198446|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83198447|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
83198448|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198449|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83198450|NCT05038059|Protective Agents|protective agents|mesh-ancestor
83198451|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198452|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83198453|NCT05038059|Growth Substances|growth substances|mesh-ancestor
83198454|NCT01236547|Paclitaxel|paclitaxel|mesh-list
83198455|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83198456|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83198457|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198458|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
83198459|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
83198460|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
83198461|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198462|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
83198463|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
83198464|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198465|NCT03329339|Protective Agents|protective agents|mesh-ancestor
83198466|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198467|NCT03329339|Vitamins|vitamins|mesh-ancestor
83198468|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
83198469|NCT03329261|Clopidogrel|clopidogrel|mesh-list
83198470|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83198471|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83198472|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83198473|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83198474|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
83198475|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198476|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198477|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198478|NCT03329183|Irinotecan|irinotecan|mesh-list
83198479|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83198480|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83198481|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198482|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198483|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198484|NCT05048511|Vitamin D|vitamin d|mesh-list
83198485|NCT05048511|Vitamins|vitamins|mesh-ancestor
83198486|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
83198487|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198488|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83198489|NCT02167945|Ritonavir|ritonavir|mesh-list
83198490|NCT02167945|Ribavirin|ribavirin|mesh-list
83198491|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83198492|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83198493|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
83198494|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198495|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198496|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83198497|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83198498|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
83198499|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198500|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83198501|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83198502|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
83198503|NCT03328481|Anesthetics|anesthetics|mesh-list
83198504|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198505|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198506|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
83198507|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83198508|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83198509|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
83198510|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198511|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198512|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198513|NCT02452879|Urological Agents|urological agents|mesh-ancestor
83198514|NCT01191697|Bevacizumab|bevacizumab|mesh-list
83198515|NCT01191697|Trastuzumab|trastuzumab|mesh-list
83198516|NCT01191697|Capecitabine|capecitabine|mesh-list
83198517|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
83198518|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83198519|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198520|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83198521|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83198522|NCT01191697|Growth Substances|growth substances|mesh-ancestor
83198523|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198524|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
83198525|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83198526|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
83198527|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198528|NCT05024799|Fentanyl|fentanyl|mesh-list
83198529|NCT05024799|Butorphanol|butorphanol|mesh-list
83198530|NCT05024799|Propofol|propofol|mesh-list
83198531|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83198532|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198533|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198534|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83198535|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
83198536|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
83198537|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198538|NCT05024799|Narcotics|narcotics|mesh-ancestor
83198539|NCT05024799|Analgesics|analgesics|mesh-ancestor
83198540|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
83198541|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198542|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83198543|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
83198544|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198545|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83198546|NCT05018637|Teriparatide|teriparatide|mesh-list
83198547|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83198548|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198549|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83198550|NCT03333395|Heparin|heparin|mesh-list
83198551|NCT03333395|Albuterol|albuterol|mesh-list
83198552|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
83198553|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83198554|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83198555|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198556|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83198557|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
83198558|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198559|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198560|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83198561|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198562|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
83198563|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83198564|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83198565|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83198566|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83198567|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
83198568|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198569|NCT03327701|Benralizumab|benralizumab|mesh-list
83198570|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83198571|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198572|NCT01991977|Temozolomide|temozolomide|mesh-list
83198573|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83198574|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
83198575|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198576|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198577|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
83198578|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83198579|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198580|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198581|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83198582|NCT03327389|Analgesics|analgesics|mesh-ancestor
83198583|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
83198584|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198585|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83198586|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83198587|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83198588|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
83198589|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198590|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198591|NCT03333083|Lamivudine|lamivudine|mesh-list
83198592|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
83198593|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83198594|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83198595|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198596|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198597|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
83198598|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198599|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83198600|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83198601|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83198602|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83198603|NCT03093597|Petrolatum|petrolatum|mesh-list
83198605|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
83198606|NCT03327155|Tenofovir|tenofovir|mesh-list
83198607|NCT03327155|Emtricitabine|emtricitabine|mesh-list
83198608|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
83198609|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198610|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83198611|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83198612|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198613|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198614|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83198615|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83198616|NCT05024877|Stanozolol|stanozolol|mesh-list
83198617|NCT05024877|Androgens|androgens|mesh-ancestor
83198618|NCT05024877|Hormones|hormones|mesh-ancestor
83198619|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198620|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198621|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
83198622|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
83198623|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83198624|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83198625|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83198626|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83418959|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83198627|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198628|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
83198629|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198630|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198631|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83198632|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198633|NCT03230851|Aspirin|aspirin|mesh-list
83198634|NCT03230851|Indobufen|indobufen|mesh-list
83198635|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83198636|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83198637|NCT03230851|Analgesics|analgesics|mesh-ancestor
83198638|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
83198639|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198640|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198641|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198642|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198643|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83198644|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83198645|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198646|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83198647|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83198648|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198649|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
83198650|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
83198651|NCT05464433|Tislelizumab|tislelizumab|mesh-list
83198652|NCT05464433|Analgesics|analgesics|mesh-ancestor
83198653|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
83198654|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198655|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198656|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198657|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83198658|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83198659|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198660|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198661|NCT05464433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83198662|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83198663|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198664|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83198665|NCT05024565|Lactams|lactams|mesh-list
83198666|NCT05024565|beta-Lactams|beta-lactams|mesh-list
83198667|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198668|NCT03228901|Oxytocin|oxytocin|mesh-list
83198669|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
83198670|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83198671|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198672|NCT03228823|Amiodarone|amiodarone|mesh-list
83198673|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83198674|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
83198675|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83198676|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83198677|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198678|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83198679|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83198680|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83198681|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198682|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83198683|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83198684|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83198685|NCT03332225|Interferons|interferons|mesh-list
83198686|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
83198687|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83198688|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198689|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
83198690|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198691|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198692|NCT05023941|Acetazolamide|acetazolamide|mesh-list
83198694|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83198695|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198696|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198697|NCT05023941|Diuretics|diuretics|mesh-ancestor
83198698|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
83198699|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198700|NCT03332069|Cisplatin|cisplatin|mesh-list
83198701|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198702|NCT03090087|Regadenoson|regadenoson|mesh-list
83198703|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83198704|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83198705|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
83198706|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
83198707|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198708|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198709|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198710|NCT03326609|Ropivacaine|ropivacaine|mesh-list
83198711|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198712|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
83198713|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198714|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198715|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
83198716|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198717|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
83198718|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83198719|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83198720|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83198721|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83198722|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198723|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
83198724|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198725|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198726|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83198727|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198728|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
83198729|NCT03090009|Analgesics|analgesics|mesh-ancestor
83198730|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
83198731|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198732|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198733|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83198734|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83198735|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198736|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198737|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83198738|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198739|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198740|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
83198741|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83198742|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83198743|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198744|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
83198745|NCT02492087|Coagulants|coagulants|mesh-ancestor
83198746|NCT03093129|Artesunate|artesunate|mesh-list
83198747|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
83198748|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83198749|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83198750|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83198751|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198752|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
83198753|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
83198754|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83198755|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
83198756|NCT02491697|Capecitabine|capecitabine|mesh-list
83198757|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83198758|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
83198759|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198760|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198761|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
83198762|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83198763|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198764|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
83198765|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83198766|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83198767|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198768|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
83198769|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198770|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198771|NCT03331523|Betamethasone|betamethasone|mesh-list
83198772|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
83198773|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83198774|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
83198775|NCT03331523|Calcipotriene|calcipotriene|mesh-list
83198776|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83198777|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198778|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
83198779|NCT03331523|Hormones|hormones|mesh-ancestor
83198780|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83198781|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198782|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83198783|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198784|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
83198785|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
83198786|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
83198787|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198788|NCT05023863|Protective Agents|protective agents|mesh-ancestor
83198789|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198790|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
83198791|NCT05023863|Vitamins|vitamins|mesh-ancestor
83198792|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
83198793|NCT05463809|Oxycodone|oxycodone|mesh-list
83198794|NCT05463809|Analgesics|analgesics|mesh-list
83198795|NCT05463809|Ropivacaine|ropivacaine|mesh-list
83198796|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198797|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
83198798|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198799|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198800|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
83198801|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198802|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198803|NCT05463809|Narcotics|narcotics|mesh-ancestor
83198804|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
83198805|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83198806|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
83198807|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198808|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198809|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83198810|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198811|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83198812|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
83198813|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198814|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198815|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83198816|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
83198817|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
83198818|NCT03331445|Protective Agents|protective agents|mesh-ancestor
83198819|NCT05008029|Anesthetics|anesthetics|mesh-list
83198820|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198821|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198822|NCT05008263|Liver Extracts|liver extracts|mesh-list
83198823|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
83198824|NCT05008263|Hematinics|hematinics|mesh-ancestor
83198825|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83198826|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198827|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83198828|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198830|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
83198831|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83198832|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198833|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83198834|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
83198835|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198836|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198837|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83198838|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
83198839|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83198840|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
83198841|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83198842|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
83198843|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198844|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198845|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83198846|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198847|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83198848|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
83198849|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198850|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198851|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83198852|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
83198853|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
83198854|NCT03078933|Protective Agents|protective agents|mesh-ancestor
83198855|NCT03092193|Naproxen|naproxen|mesh-list
83198856|NCT03092193|Esomeprazole|esomeprazole|mesh-list
83198857|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83198858|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83198859|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83198860|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198861|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198862|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83198863|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83198864|NCT03092193|Analgesics|analgesics|mesh-ancestor
83198865|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
83198866|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198867|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198868|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198869|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83198870|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
83198871|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83198872|NCT05015907|Ropivacaine|ropivacaine|mesh-list
83198873|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198874|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
83198875|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198876|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198877|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
83198878|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198879|NCT05015595|Memantine|memantine|mesh-list
83198880|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83198881|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83198882|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
83198883|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198884|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198885|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198886|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83198887|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83198888|NCT05015829|Dobutamine|dobutamine|mesh-list
83198889|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83198890|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
83198891|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
83198892|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198893|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198894|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83198895|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83198896|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83198897|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
83198898|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198899|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198900|NCT05015829|Protective Agents|protective agents|mesh-ancestor
83198901|NCT05015361|Propofol|propofol|mesh-list
83198902|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83198903|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198904|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198905|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83198906|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
83198907|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
83198908|NCT01375075|Atorvastatin|atorvastatin|mesh-list
83198909|NCT01375075|Evacetrapib|evacetrapib|mesh-list
83198910|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83198911|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83198912|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
83198913|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198914|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83198915|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83198916|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83198917|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83198918|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83198919|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
83198920|NCT03240055|Etomidate|etomidate|mesh-list
83198921|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
83198922|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198923|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198924|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83198925|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83198926|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
83198927|NCT03087201|Nabiximols|nabiximols|mesh-list
83198928|NCT03087201|Analgesics|analgesics|mesh-ancestor
83198929|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
83198930|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198931|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198932|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
83198933|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83198934|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
83198935|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83198936|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198937|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83198938|NCT03239743|Midazolam|midazolam|mesh-list
83198939|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83198940|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83198941|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198942|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198943|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83198944|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83198945|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83198946|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83198947|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
83198948|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
83198949|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
83198950|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
83198951|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198952|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198953|NCT03239821|Codeine|codeine|mesh-list
83198954|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198955|NCT03239821|Narcotics|narcotics|mesh-ancestor
83198956|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198957|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198958|NCT03239821|Analgesics|analgesics|mesh-ancestor
83198959|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
83198960|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198961|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
83198962|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198963|NCT03230227|Bupivacaine|bupivacaine|mesh-list
83198964|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
83198965|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
83198966|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198967|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198968|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
83198969|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198970|NCT03078465|Clopidogrel|clopidogrel|mesh-list
83198971|NCT03078465|Ticagrelor|ticagrelor|mesh-list
83198972|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83198973|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83198974|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83198975|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83198976|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
83198977|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83198978|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83198979|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198980|NCT03324815|Morphine|morphine|mesh-list
83198981|NCT03324815|Methadone|methadone|mesh-list
83198982|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83198983|NCT03324815|Narcotics|narcotics|mesh-ancestor
83198984|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83198985|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83198986|NCT03324815|Analgesics|analgesics|mesh-ancestor
83198987|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
83198988|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198989|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
83198990|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
83198991|NCT05006469|Dexamethasone|dexamethasone|mesh-list
83198992|NCT05006469|Doxorubicin|doxorubicin|mesh-list
83198993|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83198994|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83198995|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83198996|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
83198997|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
83198998|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83198999|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199000|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199001|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
83199002|NCT05006469|Hormones|hormones|mesh-ancestor
83199003|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199004|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83199005|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199006|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199007|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199008|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83199009|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83199010|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83199011|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83199012|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
83199013|NCT03084783|Dexamethasone|dexamethasone|mesh-list
83199014|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199015|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
83199016|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
83199017|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199018|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199019|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199020|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
83199021|NCT03084783|Hormones|hormones|mesh-ancestor
83199022|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199023|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83199024|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199025|NCT03228355|Cromakalim|cromakalim|mesh-list
83199026|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83199027|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83199028|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
83199029|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199030|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199031|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83199032|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
83199033|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
83199034|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
83199035|NCT03324503|Prednisone|prednisone|mesh-list
83199036|NCT03324503|Prednisolone|prednisolone|mesh-list
83199037|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83199038|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
83199039|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83199040|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
83199041|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83199042|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
83199043|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
83199044|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199045|NCT03324503|Hormones|hormones|mesh-ancestor
83199046|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199047|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199048|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83199049|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199050|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
83199051|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
83199052|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199053|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199054|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83199055|NCT03324503|Protective Agents|protective agents|mesh-ancestor
83199056|NCT05006001|Colchicine|colchicine|mesh-list
83199057|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
83199058|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199060|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
83199061|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
83199062|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199063|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199064|NCT04493489|Propranolol|propranolol|mesh-list
83199065|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83199066|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83199067|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199068|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199069|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199070|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199071|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83199072|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83199073|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
83199074|NCT03228043|Apatinib|apatinib|mesh-list
83199075|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199076|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83199077|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199078|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199079|NCT03119857|Docetaxel|docetaxel|mesh-list
83199080|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
83199081|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199082|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
83199083|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
83199084|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
83199085|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199086|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
83199087|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199088|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199089|NCT03320603|Thrombin|thrombin|mesh-list
83199090|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
83199091|NCT03320603|Coagulants|coagulants|mesh-ancestor
83199092|NCT03227653|Ritonavir|ritonavir|mesh-list
83199093|NCT03227653|Lopinavir|lopinavir|mesh-list
83199094|NCT03227653|Nevirapine|nevirapine|mesh-list
83199095|NCT03227653|Efavirenz|efavirenz|mesh-list
83199096|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83199097|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83199098|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
83199099|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199100|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199101|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83199102|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83199103|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
83199104|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199105|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83199106|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83199107|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83199108|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83199109|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83199110|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83199111|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83199112|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83199113|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83199114|NCT03320447|Lidocaine|lidocaine|mesh-list
83199115|NCT03320447|Prilocaine|prilocaine|mesh-list
83199116|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83199117|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83199118|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83199119|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
83199120|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
83199121|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199122|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199123|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
83199124|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199125|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83199126|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83199127|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83199128|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83199129|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199130|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83199131|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
83199132|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83199133|NCT04434105|Triamcinolone|triamcinolone|mesh-list
83199134|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83199135|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83199136|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83199137|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199138|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
83199139|NCT04434105|Hormones|hormones|mesh-ancestor
83199140|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199141|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199142|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83199143|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
83199144|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199145|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199146|NCT03078777|Fexofenadine|fexofenadine|mesh-list
83199147|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83199148|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83199149|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83199150|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
83199151|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
83199152|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199153|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199154|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199155|NCT03078309|Cannabidiol|cannabidiol|mesh-list
83199156|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
83199157|NCT03227419|Abatacept|abatacept|mesh-list
83199158|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83199159|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199160|NCT03227419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83199161|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199162|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83199163|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
83199164|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199165|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199166|NCT03208309|Diacerein|diacerein|mesh-list
83199167|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199168|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83199169|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
83199170|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
83199171|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199172|NCT03323567|Lidocaine|lidocaine|mesh-list
83199173|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83199174|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
83199175|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
83199176|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199177|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199178|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
83199179|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199180|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83199181|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83199182|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83199183|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83199184|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199185|NCT04492709|Midazolam|midazolam|mesh-list
83199186|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83199187|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83199188|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199189|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199190|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83199191|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83199192|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83199193|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83199194|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
83199195|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
83199196|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
83199197|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
83199198|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199199|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199200|NCT05006235|Epinephrine|epinephrine|mesh-list
83199201|NCT05006235|Albuterol|albuterol|mesh-list
83199202|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83199203|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83199204|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199205|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199206|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199207|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199208|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83199209|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83199210|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
83199211|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199212|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83199213|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
83199214|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
83199215|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
83199216|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83199217|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
83199218|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83199219|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83199220|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83199221|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83199222|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199223|NCT03319823|Diuretics|diuretics|mesh-ancestor
83199224|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
83199225|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199226|NCT02487953|Nicotine|nicotine|mesh-list
83199227|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83199228|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
83199229|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199230|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199231|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83199232|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83199233|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83199234|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199235|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199236|NCT03091569|Vitamin K|vitamin k|mesh-list
83199237|NCT03091569|Vitamins|vitamins|mesh-ancestor
83199238|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
83199239|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199240|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83199241|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83199242|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199243|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
83199244|NCT03091569|Coagulants|coagulants|mesh-ancestor
83199245|NCT04948749|Sirolimus|sirolimus|mesh-list
83199246|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83199247|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199248|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83199249|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199250|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
83199251|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83199252|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
83199253|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199254|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
83199255|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199256|NCT02487719|Teferrol|teferrol|mesh-list
83199257|NCT02487719|Hematinics|hematinics|mesh-ancestor
83199258|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83199259|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
83199260|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199261|NCT04940871|Favipiravir|favipiravir|mesh-list
83199262|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
83199263|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199264|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83199265|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83199266|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199268|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
83199269|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199270|NCT03221881|Docetaxel|docetaxel|mesh-list
83199271|NCT03221881|Doxorubicin|doxorubicin|mesh-list
83199272|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83199273|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199274|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83199275|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83199276|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83199277|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199278|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83199279|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83199280|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83199281|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199283|NCT03091257|Dabrafenib|dabrafenib|mesh-list
83199284|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199285|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83199286|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199287|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199288|NCT03206671|Cytarabine|cytarabine|mesh-list
83199289|NCT03206671|Dexamethasone|dexamethasone|mesh-list
83199290|NCT03206671|Prednisolone|prednisolone|mesh-list
83199291|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
83199292|NCT03206671|Ifosfamide|ifosfamide|mesh-list
83199293|NCT03206671|Rituximab|rituximab|mesh-list
83199294|NCT03206671|Doxorubicin|doxorubicin|mesh-list
83199295|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83199296|NCT03206671|Methotrexate|methotrexate|mesh-list
83199297|NCT03206671|Etoposide|etoposide|mesh-list
83199298|NCT03206671|Vincristine|vincristine|mesh-list
83199299|NCT03206671|Vindesine|vindesine|mesh-list
83199300|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83199301|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
83199302|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199303|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199304|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83199305|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
83199306|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199307|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199308|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83199309|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83199310|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199311|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
83199312|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
83199313|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199314|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199315|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
83199316|NCT03206671|Hormones|hormones|mesh-ancestor
83199317|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199318|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83199319|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83199320|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83199321|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83199322|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199323|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83199324|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
83199325|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83199326|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83199327|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
83199328|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83199329|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83199330|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83199331|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83199332|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
83199333|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199334|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83199335|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83199336|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83199337|NCT03078231|Mydriatics|mydriatics|mesh-list
83199338|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
83199339|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199340|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199341|NCT03319121|Theophylline|theophylline|mesh-list
83199342|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
83199343|NCT03319121|Lansoprazole|lansoprazole|mesh-list
83199344|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83199345|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
83199346|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199347|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199348|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83199349|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83199350|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83199351|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199352|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199353|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
83199354|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83199355|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83199356|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
83199357|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199358|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83199359|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199360|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83199362|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83199363|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
83199364|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83199365|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83199366|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199367|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199368|NCT02487407|Protective Agents|protective agents|mesh-ancestor
83199369|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199370|NCT03221569|Ketorolac|ketorolac|mesh-list
83199371|NCT03221569|Ketamine|ketamine|mesh-list
83199372|NCT03221569|Analgesics|analgesics|mesh-ancestor
83199373|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
83199374|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199375|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199376|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83199377|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83199378|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
83199379|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
83199380|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199381|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83199382|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83199383|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199384|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199385|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83199386|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83199387|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199388|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199389|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83199390|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199391|NCT03319043|Budesonide|budesonide|mesh-list
83199392|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
83199393|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199394|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83199395|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
83199396|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199397|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199398|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83199399|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
83199400|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
83199401|NCT03319043|Hormones|hormones|mesh-ancestor
83199402|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199403|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83199404|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83199405|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83199406|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199407|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199408|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199409|NCT02451475|Amitriptyline|amitriptyline|mesh-list
83199410|NCT02451475|Paroxetine|paroxetine|mesh-list
83199411|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83199412|NCT02451475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83199413|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83199414|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83199415|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199416|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199417|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
83199418|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199419|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83199420|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
83199421|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83199422|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83199423|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83199424|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199425|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83199426|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83199427|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83199428|NCT02451475|Analgesics|analgesics|mesh-ancestor
83199429|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
83199430|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199431|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83199432|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199433|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83199434|NCT05019417|Glycerol|glycerol|mesh-list
83199435|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83199436|NCT05019417|Protective Agents|protective agents|mesh-ancestor
83199437|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199438|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199439|NCT03225937|Trastuzumab|trastuzumab|mesh-list
83199440|NCT03225937|Pertuzumab|pertuzumab|mesh-list
83199441|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83199442|NCT03225937|Lapatinib|lapatinib|mesh-list
83199443|NCT03225937|Maytansine|maytansine|mesh-list
83199444|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83199445|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199446|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83199447|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199448|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199449|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83199450|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
83199451|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
83199452|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
83199453|NCT03225937|Immunotoxins|immunotoxins|mesh-ancestor
83199454|NCT03225937|Immunoconjugates|immunoconjugates|mesh-ancestor
83199455|NCT03225937|Immunologic Factors|immunologic factors|mesh-ancestor
83199456|NCT03225937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199457|NCT03318887|Ribavirin|ribavirin|mesh-list
83199458|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
83199459|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
83199460|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199461|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
83199462|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199463|NCT03119077|Itraconazole|itraconazole|mesh-list
83199464|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
83199465|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199466|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83199467|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83199468|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199469|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199470|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83199471|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
83199472|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199473|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199474|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83199475|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
83199476|NCT02487329|Calcium|calcium|mesh-list
83199477|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83199478|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199479|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83199480|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
83199481|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83199482|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199483|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83199484|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199485|NCT04493099|Decitabine|decitabine|mesh-list
83199486|NCT04493099|Venetoclax|venetoclax|mesh-list
83199487|NCT04493099|Alvocidib|alvocidib|mesh-list
83199488|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83199489|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
83199490|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199491|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199492|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199493|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
83199494|NCT04493099|Growth Substances|growth substances|mesh-ancestor
83199495|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199496|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83199497|NCT05004909|Tretinoin|tretinoin|mesh-list
83199498|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199499|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
83199500|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
83199501|NCT03119623|Valsartan|valsartan|mesh-list
83199502|NCT03119623|Enalapril|enalapril|mesh-list
83199503|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83199504|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83199505|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83199506|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83199507|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199508|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83199509|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
83199510|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199511|NCT03318419|Cytarabine|cytarabine|mesh-list
83199512|NCT03318419|Pegaspargase|pegaspargase|mesh-list
83199513|NCT03318419|Asparaginase|asparaginase|mesh-list
83199514|NCT03318419|Cladribine|cladribine|mesh-list
83199515|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83199516|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
83199517|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199518|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199519|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
83199520|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199521|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83199522|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
83199523|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199524|NCT03321773|Amoxicillin|amoxicillin|mesh-list
83199525|NCT03321773|Metronidazole|metronidazole|mesh-list
83199526|NCT03321773|Clarithromycin|clarithromycin|mesh-list
83199527|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83199528|NCT03321773|Pantoprazole|pantoprazole|mesh-list
83199529|NCT03321773|Bismuth|bismuth|mesh-list
83199530|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83199531|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199532|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83199533|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83199534|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83199535|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199536|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199537|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83199538|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83199539|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83199540|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199541|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83199542|NCT03321773|Antacids|antacids|mesh-ancestor
83199543|NCT03077217|Rifaximin|rifaximin|mesh-list
83199544|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83199545|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199546|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199547|NCT05001243|Bromfenac|bromfenac|mesh-list
83199548|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83199549|NCT05001243|Phenylephrine|phenylephrine|mesh-list
83199550|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
83199551|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
83199552|NCT05001243|Pilocarpine|pilocarpine|mesh-list
83199553|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83199554|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
83199555|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199556|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
83199557|NCT05001243|Protective Agents|protective agents|mesh-ancestor
83199558|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83199559|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83199560|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83199561|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83199562|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199563|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199564|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199565|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
83199566|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
83199567|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199568|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
83199569|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83199570|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
83199571|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83199572|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
83199573|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83199574|NCT05001243|Miotics|miotics|mesh-ancestor
83199575|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83199576|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83199577|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
83199578|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83199579|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83199580|NCT05001243|Analgesics|analgesics|mesh-ancestor
83199581|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
83199582|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199583|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199584|NCT03225781|Bleomycin|bleomycin|mesh-list
83199585|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83199586|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199587|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83199588|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83199589|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199590|NCT03205891|Immunotoxins|immunotoxins|mesh-ancestor
83199591|NCT03205891|Immunoconjugates|immunoconjugates|mesh-ancestor
83199592|NCT03205891|Immunologic Factors|immunologic factors|mesh-ancestor
83199593|NCT03205891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199594|NCT03221023|Vancomycin|vancomycin|mesh-list
83199595|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83199596|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199597|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83199598|NCT02490839|Amoxicillin|amoxicillin|mesh-list
83199599|NCT02490839|Metronidazole|metronidazole|mesh-list
83199600|NCT02490839|Tetracycline|tetracycline|mesh-list
83199601|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83199602|NCT02490839|Rabeprazole|rabeprazole|mesh-list
83199603|NCT02490839|Bismuth|bismuth|mesh-list
83199604|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83199605|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199606|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
83199607|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83199608|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83199609|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83199610|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199611|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199612|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199613|NCT02490839|Antacids|antacids|mesh-ancestor
83199614|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83199615|NCT02490527|Simvastatin|simvastatin|mesh-list
83199616|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83199617|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83199618|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
83199619|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199620|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83199621|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83199622|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199623|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
83199624|NCT02490449|Lansoprazole|lansoprazole|mesh-list
83199625|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83199626|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199627|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83199628|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199629|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199630|NCT02452177|Vitamin D|vitamin d|mesh-list
83199631|NCT02452177|Vitamins|vitamins|mesh-ancestor
83199632|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
83199633|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199634|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83199635|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
83199636|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199637|NCT03224923|Aspirin|aspirin|mesh-list
83199638|NCT03224923|Clopidogrel|clopidogrel|mesh-list
83199639|NCT03224923|Ticagrelor|ticagrelor|mesh-list
83199640|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83199641|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83199642|NCT03224923|Analgesics|analgesics|mesh-ancestor
83199643|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
83199644|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199645|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199646|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199647|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199648|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83199649|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83199650|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199651|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83199652|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83199653|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199655|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83199656|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83199657|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83199658|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
83199659|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199660|NCT05004753|Artemisinins|artemisinins|mesh-list
83199661|NCT05004753|Artemisinin|artemisinin|mesh-list
83199662|NCT05004753|Dexamethasone|dexamethasone|mesh-list
83199663|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199664|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
83199665|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
83199666|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199667|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199668|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199669|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
83199670|NCT05004753|Hormones|hormones|mesh-ancestor
83199671|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199672|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83199673|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199674|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
83199675|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83199676|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83199677|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199678|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
83199679|NCT05004519|Remifentanil|remifentanil|mesh-list
83199680|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83199681|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199682|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199683|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83199684|NCT05004519|Analgesics|analgesics|mesh-ancestor
83199685|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
83199686|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199687|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83199688|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83199689|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83199690|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199691|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199692|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199693|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83199694|NCT05004519|Narcotics|narcotics|mesh-ancestor
83199695|NCT02486549|Bupivacaine|bupivacaine|mesh-list
83199696|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
83199697|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
83199698|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199699|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199700|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
83199701|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199702|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
83199703|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199704|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
83199705|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
83199706|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83199707|NCT03073317|Mitogens|mitogens|mesh-list
83199708|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
83199709|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199710|NCT04485403|Ibuprofen|ibuprofen|mesh-list
83199711|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83199712|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83199713|NCT04485403|Analgesics|analgesics|mesh-ancestor
83199714|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
83199715|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199716|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199717|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199718|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199719|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83199720|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199721|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199722|NCT03220867|Risperidone|risperidone|mesh-list
83199723|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83199724|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
83199725|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199726|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199727|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199728|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83199729|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83199730|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199731|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83199732|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83199733|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
83199734|NCT03318029|Vitamin D|vitamin d|mesh-list
83199735|NCT03318029|Vitamins|vitamins|mesh-ancestor
83199736|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
83199737|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199738|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83199739|NCT03076281|Metformin|metformin|mesh-list
83199740|NCT03076281|Doxycycline|doxycycline|mesh-list
83199741|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83199742|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199743|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83199744|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199745|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
83199746|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83199747|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83199748|NCT02452255|Propranolol|propranolol|mesh-list
83199749|NCT02452255|Metoprolol|metoprolol|mesh-list
83199750|NCT02452255|Fenofibrate|fenofibrate|mesh-list
83199751|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83199752|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83199753|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199754|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199755|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199756|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199757|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83199758|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83199759|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
83199760|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
83199761|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
83199762|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199763|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83199764|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83199765|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
83199766|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83199767|NCT03205033|Melatonin|melatonin|mesh-list
83199768|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
83199769|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199770|NCT03205033|Protective Agents|protective agents|mesh-ancestor
83199771|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199772|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199773|NCT03076905|Olorofim|olorofim|mesh-list
83199774|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
83199775|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199776|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83199777|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83199778|NCT02452099|Protective Agents|protective agents|mesh-ancestor
83199779|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199780|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83199781|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
83199782|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199783|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83199784|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83199785|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199786|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199787|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83199788|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83199789|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199791|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199792|NCT03220789|Methamphetamine|methamphetamine|mesh-list
83199793|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83199794|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199795|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
83199796|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
83199797|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199798|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
83199799|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199800|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199801|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
83199802|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83199803|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83199804|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83199805|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83199806|NCT03220555|Lidocaine|lidocaine|mesh-list
83199807|NCT03220555|Prilocaine|prilocaine|mesh-list
83199808|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
83199809|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
83199810|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199811|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199812|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
83199813|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199814|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83199815|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83199816|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83199817|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83199818|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199820|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
83199821|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199822|NCT03204877|Protective Agents|protective agents|mesh-ancestor
83199823|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199824|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199825|NCT03204799|Metformin|metformin|mesh-list
83199826|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83199827|NCT03204799|Ezetimibe|ezetimibe|mesh-list
83199828|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83199829|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199830|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83199831|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83199832|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
83199833|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199834|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83199835|NCT03317327|Nivolumab|nivolumab|mesh-list
83199836|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83199837|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199838|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83199839|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199840|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83199841|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83199842|NCT03204331|Norethindrone|norethindrone|mesh-list
83199843|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
83199844|NCT03204331|Estradiol|estradiol|mesh-list
83199845|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83199846|NCT03204331|Relugolix|relugolix|mesh-list
83199847|NCT03204331|Estrogens|estrogens|mesh-ancestor
83199848|NCT03204331|Hormones|hormones|mesh-ancestor
83199849|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199850|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199851|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83199852|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
83199853|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83199854|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83199855|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83199856|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83199857|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83199858|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
83199859|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
83199860|NCT03072849|Fluticasone|fluticasone|mesh-list
83199861|NCT03072849|Azithromycin|azithromycin|mesh-list
83199862|NCT03072849|Montelukast|montelukast|mesh-list
83199863|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199864|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83199865|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
83199866|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199867|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199868|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83199869|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
83199870|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83199871|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83199872|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83199873|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199874|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83199875|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
83199876|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199877|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83199878|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83199879|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199880|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
83199881|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
83199882|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83199883|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199884|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199885|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
83199886|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83199887|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199888|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199889|NCT03075657|Haloperidol|haloperidol|mesh-list
83199890|NCT03075657|Risperidone|risperidone|mesh-list
83199891|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
83199892|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83199893|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
83199894|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199895|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199896|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199897|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83199898|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83199899|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199900|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83199901|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83199902|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
83199903|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
83199904|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
83199905|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199906|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199907|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83199908|NCT02451865|Docetaxel|docetaxel|mesh-list
83199909|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199910|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
83199911|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
83199912|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
83199913|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199914|NCT05004207|Lactulose|lactulose|mesh-list
83199915|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83199916|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
83199917|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83199918|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83199919|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199920|NCT02489513|Ivosidenib|ivosidenib|mesh-list
83199921|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199922|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199923|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199924|NCT03317015|Fluticasone|fluticasone|mesh-list
83199925|NCT03317015|Triamcinolone|triamcinolone|mesh-list
83199926|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199927|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83199928|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
83199929|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199930|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199931|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83199932|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
83199933|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
83199934|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83199935|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
83199936|NCT03317015|Hormones|hormones|mesh-ancestor
83199937|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83199938|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
83199939|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83199940|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
83199941|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199942|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
83199943|NCT03204565|Protective Agents|protective agents|mesh-ancestor
83199944|NCT03224377|Antibodies|antibodies|mesh-list
83199945|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
83199946|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
83199947|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199948|NCT02451787|Vitamin D|vitamin d|mesh-list
83199949|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
83199950|NCT02451787|Vitamins|vitamins|mesh-ancestor
83199951|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
83199952|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199953|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83199954|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83199955|NCT03224221|Fluorouracil|fluorouracil|mesh-list
83199956|NCT03224221|Apatinib|apatinib|mesh-list
83199957|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
83199958|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199959|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83199960|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83199961|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83199962|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
83199963|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199964|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83199965|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199966|NCT03204097|Alendronate|alendronate|mesh-list
83199967|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83199968|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199969|NCT03223519|Ibuprofen|ibuprofen|mesh-list
83199970|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199971|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83199972|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83199973|NCT03223519|Analgesics|analgesics|mesh-ancestor
83199974|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
83199975|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83199976|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83199977|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83199978|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83199979|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83199980|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199981|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
83199982|NCT03320915|Vitamin D|vitamin d|mesh-list
83199983|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83199984|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199985|NCT03320915|Vitamins|vitamins|mesh-ancestor
83199986|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
83199987|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83199988|NCT02488889|Ethanol|ethanol|mesh-list
83199989|NCT02488889|Varenicline|varenicline|mesh-list
83199990|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83199991|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83199992|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83199993|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83199994|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83199995|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83199996|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
83199997|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83199998|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83199999|NCT03220009|Nivolumab|nivolumab|mesh-list
83200000|NCT03220009|Ipilimumab|ipilimumab|mesh-list
83200001|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200002|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200003|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83200004|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200005|NCT02485613|Dexamethasone|dexamethasone|mesh-list
83200006|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200007|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
83200008|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
83200009|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200010|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200011|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83200012|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
83200013|NCT02485613|Hormones|hormones|mesh-ancestor
83200014|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200015|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83200016|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200017|NCT02484833|Cetuximab|cetuximab|mesh-list
83200018|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200019|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200020|NCT03204019|Thalidomide|thalidomide|mesh-list
83200021|NCT03204019|Temozolomide|temozolomide|mesh-list
83200022|NCT03204019|Tegafur|tegafur|mesh-list
83200023|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83200024|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
83200025|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200026|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200027|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83200028|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
83200029|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200030|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
83200031|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83200032|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200033|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83200034|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83200036|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
83200037|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83200038|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
83200039|NCT02485145|Diclofenac|diclofenac|mesh-list
83200040|NCT02485145|Orphenadrine|orphenadrine|mesh-list
83200041|NCT02485145|Bupivacaine|bupivacaine|mesh-list
83200042|NCT02485145|Baclofen|baclofen|mesh-list
83200043|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200044|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
83200045|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200046|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200047|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
83200048|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200049|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83200050|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83200051|NCT02485145|Analgesics|analgesics|mesh-ancestor
83200052|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200053|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200054|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83200055|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200056|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200057|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83200058|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83200059|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83200060|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
83200061|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
83200062|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200063|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83200064|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83200065|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
83200066|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
83200067|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83200068|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83200069|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83200070|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83200071|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83200072|NCT02484755|Gefitinib|gefitinib|mesh-list
83200073|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200074|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83200075|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200076|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200077|NCT03316469|Clomiphene|clomiphene|mesh-list
83200078|NCT03316469|Enclomiphene|enclomiphene|mesh-list
83200079|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
83200080|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83200081|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
83200082|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200083|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200084|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83200085|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
83200086|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83200087|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83200088|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83200089|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83200090|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83200091|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83200092|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
83200093|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200094|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200095|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200096|NCT02485067|Urological Agents|urological agents|mesh-ancestor
83200097|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83200098|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83200099|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83200100|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83200101|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200102|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
83200103|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200104|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200105|NCT03203317|Insulin|insulin|mesh-list
83200106|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200107|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200108|NCT03316313|Antibodies|antibodies|mesh-list
83200109|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
83200110|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
83200111|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200112|NCT03201601|Inositol|inositol|mesh-list
83200113|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
83200114|NCT03201601|Vitamins|vitamins|mesh-ancestor
83200115|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
83200116|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200117|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
83200118|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83200119|NCT02480387|Ledipasvir|ledipasvir|mesh-list
83200120|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
83200121|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200122|NCT04999293|Clopidogrel|clopidogrel|mesh-list
83200123|NCT04999293|Ticagrelor|ticagrelor|mesh-list
83200124|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83200125|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83200126|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83200127|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83200128|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
83200129|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200130|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200131|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200132|NCT03315923|Rituximab|rituximab|mesh-list
83200133|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
83200134|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
83200135|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200136|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200137|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
83200138|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200139|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200140|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83200141|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83200142|NCT03315845|Anesthetics|anesthetics|mesh-list
83200143|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200144|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200145|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
83200146|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83200147|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
83200148|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83200149|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
83200150|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200151|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200152|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
83200153|NCT04998903|Dimercaprol|dimercaprol|mesh-list
83200154|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
83200155|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
83200156|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200157|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83200158|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200159|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
83200160|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
83200161|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83200162|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
83200163|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200164|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200165|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83200166|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
83200167|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200168|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200169|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83200171|NCT02484209|Glimepiride|glimepiride|mesh-list
83200172|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200173|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200174|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83200175|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83200176|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
83200177|NCT04999137|Vitamins|vitamins|mesh-list
83200178|NCT04999137|Thiamine|thiamine|mesh-list
83200179|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
83200180|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200181|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
83200182|NCT02484053|Rituximab|rituximab|mesh-list
83200183|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200184|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200185|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
83200186|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200187|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200188|NCT03200821|Gemcitabine|gemcitabine|mesh-list
83200189|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83200190|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
83200191|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200192|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200193|NCT05353361|Paclitaxel|paclitaxel|mesh-list
83200194|NCT05353361|Pertuzumab|pertuzumab|mesh-list
83200195|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83200196|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200197|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
83200198|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
83200199|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
83200200|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200201|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200202|NCT02483897|Tetracaine|tetracaine|mesh-list
83200203|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83200204|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200205|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
83200206|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200207|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200208|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
83200209|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200210|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83200211|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83200212|NCT01374919|Hematinics|hematinics|mesh-ancestor
83200213|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83200214|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83200215|NCT03202615|Lactoferrin|lactoferrin|mesh-list
83200216|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200217|NCT03202459|Pregabalin|pregabalin|mesh-list
83200218|NCT03202459|Gabapentin|gabapentin|mesh-list
83200219|NCT03202459|Analgesics|analgesics|mesh-ancestor
83200220|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
83200221|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200222|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200223|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
83200224|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83200225|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83200226|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200227|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83200228|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83200229|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83200230|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200231|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83200232|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83200233|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83200235|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
83200236|NCT04991181|Zamicastat|zamicastat|mesh-list
83200237|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200238|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200239|NCT04492319|Neostigmine|neostigmine|mesh-list
83200240|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83200241|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200242|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200243|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
83200244|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200245|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200246|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83200247|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
83200248|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200249|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83200250|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200251|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200252|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83200253|NCT04456959|Immunotoxins|immunotoxins|mesh-ancestor
83200254|NCT04456959|Immunoconjugates|immunoconjugates|mesh-ancestor
83200255|NCT04456959|Immunologic Factors|immunologic factors|mesh-ancestor
83200256|NCT04456959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200257|NCT05713721|Dopamine|dopamine|mesh-list
83200258|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
83200259|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83200260|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
83200261|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
83200262|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200263|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200264|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
83200265|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200266|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200267|NCT05713721|Protective Agents|protective agents|mesh-ancestor
83200268|NCT05002725|Lidocaine|lidocaine|mesh-list
83200269|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200270|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
83200271|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200272|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200273|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
83200274|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200275|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83200276|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83200277|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83200278|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83200279|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200280|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83200281|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83200282|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83200283|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83419485|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
83200284|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200285|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200286|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200287|NCT03315533|Analgesics|analgesics|mesh-ancestor
83200288|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
83200289|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200290|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
83200291|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83200292|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
83200293|NCT05437835|Ropivacaine|ropivacaine|mesh-list
83200294|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200295|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
83200296|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200297|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200298|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
83200299|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200300|NCT03200197|Menthol|menthol|mesh-list
83200301|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
83200302|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
83200303|NCT04997967|Ketamine|ketamine|mesh-list
83200304|NCT04997967|Propofol|propofol|mesh-list
83200305|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83200306|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200307|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200308|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83200309|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
83200310|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
83200311|NCT04997967|Analgesics|analgesics|mesh-ancestor
83200312|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
83200313|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200314|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83200315|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83200316|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83200317|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200318|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200319|NCT02483195|Minoxidil|minoxidil|mesh-list
83200320|NCT02483195|Spironolactone|spironolactone|mesh-list
83200321|NCT02483195|Finasteride|finasteride|mesh-list
83200322|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83200323|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
83200324|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200325|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200326|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83200327|NCT02483195|Diuretics|diuretics|mesh-ancestor
83200328|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
83200329|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83200330|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
83200331|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83200332|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83200333|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200334|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200335|NCT02483195|Urological Agents|urological agents|mesh-ancestor
83200337|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200338|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83200339|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200340|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200341|NCT02479217|Docetaxel|docetaxel|mesh-list
83200342|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200343|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
83200344|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
83200345|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
83200346|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200347|NCT02479529|Norepinephrine|norepinephrine|mesh-list
83200348|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83200349|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83200350|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
83200351|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200352|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200353|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200354|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
83200355|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
83200356|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200357|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83200358|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
83200359|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83200360|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
83200361|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200362|NCT03202147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83200363|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200364|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83200365|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
83200366|NCT03213769|Ubiquinone|ubiquinone|mesh-list
83200367|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
83200368|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
83200369|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200370|NCT03213769|Vitamins|vitamins|mesh-ancestor
83200371|NCT05002101|Zinc|zinc|mesh-list
83200372|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
83200373|NCT05002101|Trace Elements|trace elements|mesh-ancestor
83200374|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
83200375|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200376|NCT05002101|Astringents|astringents|mesh-ancestor
83200377|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83200378|NCT03201913|Estrogens|estrogens|mesh-list
83200379|NCT03201913|Hormones|hormones|mesh-ancestor
83200380|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200381|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200382|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83200383|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
83200384|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83200385|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
83200386|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83200387|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200388|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83200389|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83200390|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200391|NCT03212677|Iron|iron|mesh-list
83200392|NCT03212677|Trace Elements|trace elements|mesh-ancestor
83200393|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
83200394|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200395|NCT03199339|Midazolam|midazolam|mesh-list
83200396|NCT03199339|Bupropion|bupropion|mesh-list
83200397|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83200398|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83200399|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200400|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200401|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83200402|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83200403|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83200404|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83200405|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
83200406|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
83200407|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
83200408|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
83200409|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200410|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200411|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83200412|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83200413|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83200414|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83200415|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83200416|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
83200417|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83200418|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83200419|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200420|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
83200421|NCT03071679|Imiquimod|imiquimod|mesh-list
83200422|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83200423|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
83200424|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200425|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200426|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
83200427|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200428|NCT03199261|Exenatide|exenatide|mesh-list
83200429|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200430|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200431|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83200432|NCT03199261|Incretins|incretins|mesh-ancestor
83200433|NCT03199261|Hormones|hormones|mesh-ancestor
83200434|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200435|NCT02482961|Colistin|colistin|mesh-list
83200436|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83200437|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200438|NCT04990713|Ropivacaine|ropivacaine|mesh-list
83200439|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
83200440|NCT04990713|Anesthetics|anesthetics|mesh-list
83200441|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200442|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200443|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
83200444|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200445|NCT04990791|Aspirin|aspirin|mesh-list
83200446|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
83200447|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83200448|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83200449|NCT04990791|Analgesics|analgesics|mesh-ancestor
83200450|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
83200451|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200452|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200453|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200454|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200455|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83200456|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83200457|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200458|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83200459|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83200460|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200461|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
83200462|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83200463|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
83200464|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83200465|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
83200466|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
83200467|NCT03201835|Nabiximols|nabiximols|mesh-list
83200468|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200469|NCT03201835|Analgesics|analgesics|mesh-ancestor
83200470|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
83200471|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200472|NCT02478515|Ranibizumab|ranibizumab|mesh-list
83200473|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83200474|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83200475|NCT02478515|Growth Substances|growth substances|mesh-ancestor
83200476|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200477|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
83200478|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200480|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
83200481|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83200482|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83200484|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
83200485|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200486|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200487|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200488|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83200489|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83200490|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200491|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200492|NCT03071289|Cisplatin|cisplatin|mesh-list
83200493|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200494|NCT03199105|Tetracaine|tetracaine|mesh-list
83200495|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200496|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
83200497|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200498|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200499|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
83200500|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200501|NCT02482649|Methylphenidate|methylphenidate|mesh-list
83200502|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83200503|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83200504|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200505|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83200506|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83200507|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83200508|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200509|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
83200510|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200511|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83200512|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
83200513|NCT03198637|Cisatracurium|cisatracurium|mesh-list
83200514|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83200515|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83200516|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200517|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200518|NCT02478281|Methylene Blue|methylene blue|mesh-list
83200519|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200520|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200521|NCT02478125|Docetaxel|docetaxel|mesh-list
83200522|NCT02478125|Lenograstim|lenograstim|mesh-list
83200523|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200524|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
83200525|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
83200526|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
83200527|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200528|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83200529|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
83200530|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200531|NCT02478047|Dexamethasone|dexamethasone|mesh-list
83200532|NCT02478047|Ramosetron|ramosetron|mesh-list
83200533|NCT02478047|Antiemetics|antiemetics|mesh-list
83200534|NCT02478047|Tropisetron|tropisetron|mesh-list
83200535|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200536|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
83200537|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200538|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200539|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83200540|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
83200541|NCT02478047|Hormones|hormones|mesh-ancestor
83200542|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200543|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83200544|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200545|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83200546|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
83200547|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200548|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200549|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83200550|NCT04996485|Ustekinumab|ustekinumab|mesh-list
83200551|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
83200552|NCT02447965|Bupivacaine|bupivacaine|mesh-list
83200553|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200554|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
83200555|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200556|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200557|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
83200558|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200559|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83200560|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
83200561|NCT03070275|Coagulants|coagulants|mesh-ancestor
83200562|NCT05713019|Adenosine|adenosine|mesh-list
83200563|NCT05713019|Capsaicin|capsaicin|mesh-list
83200564|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83200565|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
83200566|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
83200567|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
83200568|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200569|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200570|NCT05713019|Analgesics|analgesics|mesh-ancestor
83200571|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83200572|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
83200573|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83200574|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
83200575|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
83200576|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200577|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200578|NCT03198403|Epinephrine|epinephrine|mesh-list
83200579|NCT03198403|Bupivacaine|bupivacaine|mesh-list
83200580|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200581|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
83200582|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200583|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200584|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
83200585|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200586|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83200587|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83200588|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
83200589|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200590|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200591|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83200592|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83200593|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
83200594|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83200595|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
83200596|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
83200597|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
83200598|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83200599|NCT03198949|Everolimus|everolimus|mesh-list
83200600|NCT03198949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83200601|NCT03198949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83200602|NCT03198949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83419486|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
83200603|NCT03198949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200604|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83200605|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
83200606|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200607|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200609|NCT02447809|Clopidogrel|clopidogrel|mesh-list
83200610|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83200611|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83200612|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83200613|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83200614|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
83200615|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200616|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200617|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200618|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83200619|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83200620|NCT02447809|Analgesics|analgesics|mesh-ancestor
83200621|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
83200622|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200623|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200624|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200625|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83200626|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83200627|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83200628|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200629|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
83200630|NCT04989855|Tislelizumab|tislelizumab|mesh-list
83200631|NCT04989855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200632|NCT04989855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200633|NCT04915287|Maleic acid|maleic acid|mesh-list
83200634|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200635|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200636|NCT05709353|Methamphetamine|methamphetamine|mesh-list
83200637|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83200638|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200639|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
83200640|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
83200641|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200642|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
83200643|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200644|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200645|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
83200646|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83200647|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83200648|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83200649|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83200650|NCT03195673|Terazosin|terazosin|mesh-list
83200651|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83200652|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83200653|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83200654|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
83200655|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200656|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200657|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200658|NCT03195673|Urological Agents|urological agents|mesh-ancestor
83200659|NCT02481791|Remifentanil|remifentanil|mesh-list
83200660|NCT02481791|Propofol|propofol|mesh-list
83200661|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83200662|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200663|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200664|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83200665|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
83200667|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83200668|NCT02481791|Narcotics|narcotics|mesh-ancestor
83200669|NCT02481791|Analgesics|analgesics|mesh-ancestor
83200670|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
83200671|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200672|NCT04484467|Menthol|menthol|mesh-list
83200673|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
83200674|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
83200675|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
83200676|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83200677|NCT02726399|Capecitabine|capecitabine|mesh-list
83200678|NCT02726399|Trastuzumab|trastuzumab|mesh-list
83200679|NCT02726399|Ramucirumab|ramucirumab|mesh-list
83200680|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200681|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83200682|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
83200683|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200684|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83200685|NCT02477969|Metformin|metformin|mesh-list
83200686|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200687|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200688|NCT03195205|Antibodies|antibodies|mesh-list
83200689|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
83200690|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200691|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83200692|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
83200693|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200694|NCT02481323|Cilostazol|cilostazol|mesh-list
83200695|NCT02481323|Isosorbide|isosorbide|mesh-list
83200696|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83200697|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83200698|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83200699|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
83200700|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200701|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200702|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83200703|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83200704|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83200705|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83200706|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200707|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83200708|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
83200709|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83200710|NCT02481323|Protective Agents|protective agents|mesh-ancestor
83200711|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83200712|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83200713|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200714|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83200715|NCT02481323|Diuretics|diuretics|mesh-ancestor
83200716|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
83200717|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83200718|NCT03197779|Aspirin|aspirin|mesh-list
83200719|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83200720|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83200721|NCT03197779|Analgesics|analgesics|mesh-ancestor
83200722|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
83200723|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200724|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200725|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200726|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200727|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83200728|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83200729|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200730|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83200731|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83200732|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200733|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
83200734|NCT03197623|Alendronate|alendronate|mesh-list
83200735|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83200736|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200737|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
83200738|NCT02449603|Exenatide|exenatide|mesh-list
83200739|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
83200740|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83200741|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200742|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200743|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83200744|NCT02449603|Incretins|incretins|mesh-ancestor
83200745|NCT02449603|Hormones|hormones|mesh-ancestor
83200746|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200747|NCT02481479|Saxagliptin|saxagliptin|mesh-list
83200748|NCT02481479|Incretins|incretins|mesh-ancestor
83200749|NCT02481479|Hormones|hormones|mesh-ancestor
83200750|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200751|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200752|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83200753|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
83200754|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200755|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200756|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200757|NCT03195049|Bilirubin|bilirubin|mesh-list
83200758|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
83200759|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200760|NCT03195049|Protective Agents|protective agents|mesh-ancestor
83200761|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200762|NCT03198013|Prednisolone|prednisolone|mesh-list
83200763|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200764|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
83200765|NCT03198013|Hormones|hormones|mesh-ancestor
83200766|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200767|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200768|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83200769|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200770|NCT05651399|Propofol|propofol|mesh-list
83200771|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83200772|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200773|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200774|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83200775|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
83200776|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
83200777|NCT02477891|Daratumumab|daratumumab|mesh-list
83200778|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200779|NCT02477813|Temozolomide|temozolomide|mesh-list
83200780|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83430108|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83200782|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200783|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200785|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83200786|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
83200787|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83200788|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200789|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83200790|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83200791|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
83200792|NCT03197233|Vitamin D|vitamin d|mesh-list
83200793|NCT03197233|Vitamins|vitamins|mesh-list
83200794|NCT03197233|Vitamin A|vitamin a|mesh-list
83200795|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
83200796|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
83200797|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200798|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
83200799|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200800|NCT03197233|Protective Agents|protective agents|mesh-ancestor
83200801|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83200802|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200803|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83200804|NCT02447185|Triamcinolone|triamcinolone|mesh-list
83200805|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83200806|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83200807|NCT02447185|Ranibizumab|ranibizumab|mesh-list
83200808|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83200809|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83200810|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83200811|NCT02447185|Growth Substances|growth substances|mesh-ancestor
83200812|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200813|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
83200814|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200815|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200816|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
83200817|NCT02447185|Hormones|hormones|mesh-ancestor
83200818|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200819|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83200820|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
83200821|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200822|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200823|NCT03196921|Amphotericin B|amphotericin b|mesh-list
83200824|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83200825|NCT03196921|Amebicides|amebicides|mesh-ancestor
83200826|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83200827|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83200828|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200829|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83200830|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
83200831|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83200832|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200833|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200834|NCT02480465|Incretins|incretins|mesh-ancestor
83200835|NCT02480465|Hormones|hormones|mesh-ancestor
83200836|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200837|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83200838|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
83200839|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200840|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200841|NCT05633771|Adalimumab|adalimumab|mesh-list
83200842|NCT05633771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83200843|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200844|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200845|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83200846|NCT03208465|Empagliflozin|empagliflozin|mesh-list
83200847|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200848|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200849|NCT03208465|Incretins|incretins|mesh-ancestor
83200851|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200852|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83200853|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
83200854|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200855|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200856|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83200857|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
83200858|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83200859|NCT04484779|Insulin|insulin|mesh-list
83200860|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
83200861|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
83200862|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83200863|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200864|NCT02477501|Norepinephrine|norepinephrine|mesh-list
83200865|NCT02477501|Ephedrine|ephedrine|mesh-list
83200866|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83200867|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83200868|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
83200869|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200870|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200871|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200872|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
83200873|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
83200874|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200875|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83200876|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83200877|NCT02446795|Sunitinib|sunitinib|mesh-list
83200878|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200879|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83200880|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83200881|NCT02446795|Growth Substances|growth substances|mesh-ancestor
83200882|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200883|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
83200884|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83200885|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200886|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200887|NCT02477267|Buprenorphine|buprenorphine|mesh-list
83200888|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83200889|NCT02477267|Naloxone|naloxone|mesh-list
83200890|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83200891|NCT02477267|Narcotics|narcotics|mesh-ancestor
83200892|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200893|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200894|NCT02477267|Analgesics|analgesics|mesh-ancestor
83200895|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
83200896|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200897|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83200898|NCT03196843|Raltitrexed|raltitrexed|mesh-list
83200899|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83200900|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
83200901|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200902|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200903|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83200904|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200905|NCT02476955|Paclitaxel|paclitaxel|mesh-list
83200906|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83200907|NCT02476955|Carboplatin|carboplatin|mesh-list
83200908|NCT02476955|Anastrozole|anastrozole|mesh-list
83200909|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83200910|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200911|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83200912|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83200913|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83200914|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200915|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83200916|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83200917|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83200918|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200919|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83200920|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
83200921|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83200922|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200923|NCT02634801|Methotrexate|methotrexate|mesh-list
83200924|NCT02634801|Ixekizumab|ixekizumab|mesh-list
83200925|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83200926|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
83200927|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83200928|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200929|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83200930|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
83200931|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200932|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83200933|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
83200934|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200935|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83200936|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83200937|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
83200938|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200939|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83200940|NCT03196531|Loratadine|loratadine|mesh-list
83200941|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
83200942|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
83200943|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83200944|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83200945|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83200946|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
83200947|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
83200948|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200949|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200950|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200951|NCT02476799|Ketorolac|ketorolac|mesh-list
83200952|NCT02476799|Fentanyl|fentanyl|mesh-list
83200953|NCT02476799|Ropivacaine|ropivacaine|mesh-list
83200954|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
83200955|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
83200956|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200957|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200958|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
83200959|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200960|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83200961|NCT02476799|Narcotics|narcotics|mesh-ancestor
83200962|NCT02476799|Analgesics|analgesics|mesh-ancestor
83200963|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83200964|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83200965|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
83200966|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83200967|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83200968|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83200969|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83200970|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83200971|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83200972|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200973|NCT02449369|Acetaminophen|acetaminophen|mesh-list
83200974|NCT02449369|Oxycodone|oxycodone|mesh-list
83200975|NCT02449369|Hydromorphone|hydromorphone|mesh-list
83200976|NCT02449369|Orphenadrine|orphenadrine|mesh-list
83200977|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83200978|NCT02449369|Analgesics|analgesics|mesh-ancestor
83200979|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
83200980|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83200981|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83200982|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
83200983|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83200984|NCT02449369|Narcotics|narcotics|mesh-ancestor
83200985|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83200986|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83200987|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83200988|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83200989|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83200990|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
83200991|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
83200992|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83200993|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83200994|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
83200995|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83200996|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83200997|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83200998|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83200999|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201000|NCT03192943|Nivolumab|nivolumab|mesh-list
83201001|NCT03192943|Linrodostat|linrodostat|mesh-list
83201002|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201003|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201004|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83201005|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201006|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201008|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83201009|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83201010|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201011|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
83201012|NCT04986813|Coagulants|coagulants|mesh-ancestor
83201013|NCT04986735|Empagliflozin|empagliflozin|mesh-list
83201014|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83201015|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201016|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201017|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201018|NCT02475863|Warfarin|warfarin|mesh-list
83201019|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
83201020|NCT03071055|Ranibizumab|ranibizumab|mesh-list
83201021|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83201022|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83201023|NCT03071055|Growth Substances|growth substances|mesh-ancestor
83201024|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201025|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
83201026|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201027|NCT04433559|Tadalafil|tadalafil|mesh-list
83201028|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
83201029|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83201030|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83201031|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201032|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201033|NCT04433559|Urological Agents|urological agents|mesh-ancestor
83201034|NCT04911959|Lenvatinib|lenvatinib|mesh-list
83201035|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201036|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83201037|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201038|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201039|NCT03070665|Norepinephrine|norepinephrine|mesh-list
83201040|NCT03070665|Ephedrine|ephedrine|mesh-list
83201041|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83201042|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201043|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201044|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201045|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201046|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201047|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
83201048|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
83201049|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201050|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83201051|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83201052|NCT04891809|Dexamethasone|dexamethasone|mesh-list
83201053|NCT04891809|Lenalidomide|lenalidomide|mesh-list
83201054|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201055|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
83201056|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
83201057|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201058|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201059|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83201060|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
83201061|NCT04891809|Hormones|hormones|mesh-ancestor
83201062|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201063|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83201064|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201065|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
83201066|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83201067|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83201068|NCT04891809|Growth Substances|growth substances|mesh-ancestor
83201069|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
83201070|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83201071|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83201072|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83201073|NCT02475161|Rabeprazole|rabeprazole|mesh-list
83201074|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83201075|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83201076|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83201077|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201078|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201079|NCT03074097|Bupivacaine|bupivacaine|mesh-list
83201080|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
83201081|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
83201082|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201083|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201084|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
83201085|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201087|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
83201088|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83201089|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
83201090|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201091|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201092|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
83201093|NCT04860635|Celecoxib|celecoxib|mesh-list
83201094|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83201095|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83201096|NCT04860635|Analgesics|analgesics|mesh-ancestor
83201097|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
83201098|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201099|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201100|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201101|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201102|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83201103|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83201104|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201105|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201106|NCT04988607|Bevacizumab|bevacizumab|mesh-list
83201107|NCT04988607|Osimertinib|osimertinib|mesh-list
83201108|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201109|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201110|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83201111|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83201112|NCT04988607|Growth Substances|growth substances|mesh-ancestor
83201113|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201114|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
83201115|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83201116|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201117|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201118|NCT02475317|Volixibat|volixibat|mesh-list
83201119|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83201120|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83201121|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83201122|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201123|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83201124|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83201125|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201126|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201127|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
83201128|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201129|NCT05322473|Adalimumab|adalimumab|mesh-list
83201130|NCT05322473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83201131|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201132|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201133|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
83201134|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
83201135|NCT02472275|Hormones|hormones|mesh-list
83201136|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83201137|NCT02472275|Androgens|androgens|mesh-list
83201138|NCT02472275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83201139|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
83201140|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201141|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201142|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
83201143|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201144|NCT02472275|Protective Agents|protective agents|mesh-ancestor
83201145|NCT02472275|Vitamins|vitamins|mesh-ancestor
83201146|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
83201147|NCT02472275|Estrogens|estrogens|mesh-ancestor
83201148|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83201149|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201150|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
83201151|NCT02472275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83201152|NCT02472275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201153|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
83201154|NCT04491773|Tadalafil|tadalafil|mesh-list
83201156|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83201157|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83201158|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201159|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201160|NCT04491773|Urological Agents|urological agents|mesh-ancestor
83201161|NCT03070353|Dextrans|dextrans|mesh-list
83201162|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
83201163|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
83201164|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
83201165|NCT03073863|Atorvastatin|atorvastatin|mesh-list
83201166|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83201167|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83201168|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
83201169|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201170|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83201171|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83201172|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201173|NCT02471963|Empagliflozin|empagliflozin|mesh-list
83201174|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83201175|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201176|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201177|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201178|NCT01375751|Evolocumab|evolocumab|mesh-list
83201179|NCT01375751|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83201180|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83201181|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83201182|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
83201183|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201184|NCT01375751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83201185|NCT01375751|Protease Inhibitors|protease inhibitors|mesh-ancestor
83201186|NCT01375751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201187|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83201188|NCT05249621|Mannitol|mannitol|mesh-list
83201189|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83201190|NCT05249621|Diuretics|diuretics|mesh-ancestor
83201191|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
83201192|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201193|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83201194|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83201195|NCT00705575|Diuretics|diuretics|mesh-ancestor
83201196|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
83201197|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201198|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83201199|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201200|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201201|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83201202|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83201203|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83201204|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201205|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201206|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201207|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201208|NCT03068247|Analgesics|analgesics|mesh-ancestor
83201209|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
83201210|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201211|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
83201212|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83201213|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
83201214|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83201215|NCT03108833|Saruplase|saruplase|mesh-list
83201216|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83201217|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83201218|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201219|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
83201220|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201221|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201222|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83201223|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83201224|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201225|NCT04450953|Eplerenone|eplerenone|mesh-list
83201226|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83201227|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
83201228|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201229|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201230|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83201231|NCT04450953|Diuretics|diuretics|mesh-ancestor
83201232|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
83201233|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83201234|NCT04983849|Metronidazole|metronidazole|mesh-list
83201235|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201236|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83201237|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83201238|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83201239|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83201240|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83201241|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83201242|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201243|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201244|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
83201245|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201246|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83201247|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83201248|NCT02474225|Bevacizumab|bevacizumab|mesh-list
83201249|NCT02474225|Ranibizumab|ranibizumab|mesh-list
83201250|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
83201251|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201252|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201253|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83201254|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83201255|NCT02474225|Growth Substances|growth substances|mesh-ancestor
83201256|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201258|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
83201259|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201260|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201261|NCT04521413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83201262|NCT04521413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201263|NCT04448873|Sirolimus|sirolimus|mesh-list
83201264|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83201265|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201266|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83201267|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201268|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
83201269|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83201270|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
83201271|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201272|NCT04430855|Upadacitinib|upadacitinib|mesh-list
83201273|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83201274|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83201275|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201276|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201277|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201278|NCT02471105|Bimatoprost|bimatoprost|mesh-list
83201279|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83201280|NCT03108989|Neostigmine|neostigmine|mesh-list
83201281|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83201282|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201283|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201284|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
83201285|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201286|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201287|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83201288|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
83201289|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201290|NCT02473601|Mivacurium|mivacurium|mesh-list
83201291|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83201292|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83201293|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83201294|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201295|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201296|NCT04359017|Lidocaine|lidocaine|mesh-list
83201297|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
83201298|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
83201299|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201300|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201301|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
83201302|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201303|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83201304|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83201305|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83201306|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201307|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201308|NCT02470559|Aldesleukin|aldesleukin|mesh-list
83201309|NCT02470559|Interleukin-2|interleukin-2|mesh-list
83201310|NCT02470559|Sargramostim|sargramostim|mesh-list
83201311|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83201312|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201313|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83201314|NCT02470559|Analgesics|analgesics|mesh-ancestor
83201315|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
83201316|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201317|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201318|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
83201319|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83201320|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83201321|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
83201322|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201323|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
83201324|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
83201325|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201326|NCT02470637|Insulin|insulin|mesh-list
83201327|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83201328|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
83201329|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201330|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201332|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83201333|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201334|NCT03652961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201335|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201336|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83201337|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
83201338|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201339|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201340|NCT03948347|Liraglutide|liraglutide|mesh-list
83201341|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201342|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201343|NCT03948347|Incretins|incretins|mesh-ancestor
83201344|NCT03948347|Hormones|hormones|mesh-ancestor
83201345|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201346|NCT02723591|Tacrolimus|tacrolimus|mesh-list
83201347|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83201348|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
83201349|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201350|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83201351|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201352|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201353|NCT00705341|Fluticasone|fluticasone|mesh-list
83201354|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201355|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83201356|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
83201357|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201358|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201359|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83201360|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
83201361|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
83201362|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83201363|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
83201364|NCT03193931|Methotrexate|methotrexate|mesh-list
83201365|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201366|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201367|NCT03193931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83201368|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201369|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83201370|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
83201371|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83201372|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201373|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83201374|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
83201375|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
83201376|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201377|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83201378|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83201379|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
83201380|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201381|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83201383|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83201384|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
83201385|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201386|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
83201387|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201388|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
83201389|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83201390|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83201391|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201392|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
83201393|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
83201394|NCT03310463|Durlobactam|durlobactam|mesh-list
83201395|NCT03310463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83201396|NCT03310463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201397|NCT03310463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201398|NCT03310463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83201399|NCT03310463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201400|NCT02215265|Cisplatin|cisplatin|mesh-list
83201401|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201402|NCT00704405|Interferons|interferons|mesh-list
83201403|NCT00704405|Ribavirin|ribavirin|mesh-list
83201404|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201405|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
83201406|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201407|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
83201408|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201409|NCT01470755|Albuterol|albuterol|mesh-list
83201410|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83201411|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
83201412|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201413|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201414|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83201415|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
83201416|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
83201417|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83201418|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83201419|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83201420|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201421|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201422|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201423|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201424|NCT03310073|Vaccines|vaccines|mesh-list
83201425|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
83201426|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201427|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
83201428|NCT03309527|Promethazine|promethazine|mesh-list
83201429|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83201430|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83201431|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201432|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201433|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
83201434|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
83201435|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
83201436|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201437|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
83201438|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
83201439|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83201440|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83201441|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
83201442|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
83201443|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201444|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201445|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83201446|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
83201447|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
83201448|NCT03313661|Gliclazide|gliclazide|mesh-list
83201449|NCT03313661|Cabergoline|cabergoline|mesh-list
83201450|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83201451|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83201452|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
83201453|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
83201454|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201455|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201456|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201457|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201458|NCT00703781|Bromfenac|bromfenac|mesh-list
83201459|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83201460|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83201461|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83201462|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83201463|NCT00703781|Analgesics|analgesics|mesh-ancestor
83201464|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
83201465|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201466|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201467|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201468|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201470|NCT03309215|Trace Elements|trace elements|mesh-ancestor
83201471|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
83201472|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201473|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
83201474|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
83201475|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
83201476|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83201477|NCT03309059|Protective Agents|protective agents|mesh-ancestor
83201478|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201479|NCT02469545|Sertraline|sertraline|mesh-list
83201480|NCT02469545|Escitalopram|escitalopram|mesh-list
83201481|NCT02469545|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83201482|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83201483|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201484|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201485|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201486|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
83201487|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201488|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
83201489|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83201490|NCT03308357|Infliximab|infliximab|mesh-list
83201491|NCT03308357|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83201492|NCT03308357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201493|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
83201494|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83201495|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201496|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
83201497|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83201498|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83201499|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201500|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
83201501|NCT03308201|Letrozole|letrozole|mesh-list
83201502|NCT03308201|Fulvestrant|fulvestrant|mesh-list
83201503|NCT03308201|Exemestane|exemestane|mesh-list
83201504|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201505|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83201506|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83201507|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201508|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201509|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83201510|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
83201511|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201512|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201513|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83201514|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83201515|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
83201516|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83201517|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201518|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201519|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83201520|NCT03312413|Analgesics|analgesics|mesh-ancestor
83201521|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
83201522|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201523|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83201524|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83201525|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201526|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201527|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201528|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201529|NCT02722967|Aripiprazole|aripiprazole|mesh-list
83201530|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
83201531|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83201532|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83201533|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83201534|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201535|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201536|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
83201537|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
83201538|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201539|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201540|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83201541|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83201542|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
83201543|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83201544|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83201545|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83201546|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83201548|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
83201549|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201550|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83201551|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83201552|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201553|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201554|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83201555|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
83201556|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201557|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201558|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83201559|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83201561|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201562|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83201563|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83201564|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
83201565|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201566|NCT03312179|Incretins|incretins|mesh-list
83201567|NCT03312179|Hormones|hormones|mesh-ancestor
83201568|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201569|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201570|NCT02468531|Xenon|xenon|mesh-list
83201571|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83201572|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
83201573|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
83201574|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201575|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201576|NCT03311945|Lamivudine|lamivudine|mesh-list
83201577|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
83201578|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83201579|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83201580|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201581|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201582|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
83201583|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201584|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83201585|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83201586|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83201587|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83201588|NCT03311789|Gemcitabine|gemcitabine|mesh-list
83201589|NCT03311789|Nivolumab|nivolumab|mesh-list
83201590|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83201591|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201592|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83201593|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
83201594|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201595|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201596|NCT02468999|Insulin|insulin|mesh-list
83201597|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83201598|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201599|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201601|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
83201602|NCT03311321|Menaquinone 7|menaquinone 7|mesh-list
83201603|NCT03311321|Vitamins|vitamins|mesh-ancestor
83201604|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
83201605|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201606|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83201607|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83201608|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201609|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
83201610|NCT03311321|Coagulants|coagulants|mesh-ancestor
83201611|NCT02468297|Ibuprofen|ibuprofen|mesh-list
83201612|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83201613|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83201614|NCT02468297|Analgesics|analgesics|mesh-ancestor
83201615|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
83201616|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201617|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201618|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201619|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201620|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83201621|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201622|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201623|NCT02468375|Mirabegron|mirabegron|mesh-list
83201624|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83201625|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83201626|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201627|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201628|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201629|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201630|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201631|NCT02468375|Urological Agents|urological agents|mesh-ancestor
83201632|NCT03304457|Olanzapine|olanzapine|mesh-list
83201633|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83201635|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
83201636|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201637|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201638|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83201639|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83201640|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83201641|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201642|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83201643|NCT03304457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83201644|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83201645|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201646|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201647|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201648|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
83201649|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83201650|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83201651|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83201652|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201653|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83201654|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83201655|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83201656|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83201657|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
83201658|NCT04490837|Antibodies|antibodies|mesh-list
83201659|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
83201660|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201661|NCT03305471|Sevelamer|sevelamer|mesh-list
83201662|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
83201663|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
83201664|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201665|NCT03303677|Vancomycin|vancomycin|mesh-list
83201666|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
83201667|NCT03303677|Gentamicins|gentamicins|mesh-list
83201668|NCT03303677|Mupirocin|mupirocin|mesh-list
83201669|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83201670|NCT03303677|Trimethoprim|trimethoprim|mesh-list
83201671|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
83201672|NCT03303677|Budesonide|budesonide|mesh-list
83201673|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201674|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83201675|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
83201676|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201677|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201678|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83201679|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
83201680|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
83201681|NCT03303677|Hormones|hormones|mesh-ancestor
83201682|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201683|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201684|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83201685|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83201686|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201687|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201688|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201689|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83419562|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83201690|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83201691|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83201692|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83201693|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
83201694|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83201695|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83201696|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83201697|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83201698|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83201699|NCT02468063|Terlipressin|terlipressin|mesh-list
83201700|NCT02468063|Norepinephrine|norepinephrine|mesh-list
83201701|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83201702|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83201703|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83201704|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201705|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201706|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201707|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201708|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201709|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
83201710|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
83201711|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201712|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
83201713|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83201714|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201715|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201716|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201717|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
83201718|NCT03303209|Narcotics|narcotics|mesh-ancestor
83201719|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201720|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201721|NCT03303209|Analgesics|analgesics|mesh-ancestor
83201722|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
83201723|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201724|NCT03303053|Prednisolone|prednisolone|mesh-list
83201725|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
83201726|NCT03303053|Carbimazole|carbimazole|mesh-list
83201727|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201728|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
83201729|NCT03303053|Hormones|hormones|mesh-ancestor
83201730|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201731|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201732|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83201733|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201734|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83201735|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83201736|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
83201737|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201738|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83201739|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
83201740|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83201741|NCT02467907|Paclitaxel|paclitaxel|mesh-list
83201742|NCT02467907|Bevacizumab|bevacizumab|mesh-list
83201743|NCT02467907|Carboplatin|carboplatin|mesh-list
83201744|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83201745|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201746|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
83201747|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
83201748|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83201749|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201750|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83201751|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83201752|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83201753|NCT02467907|Growth Substances|growth substances|mesh-ancestor
83201754|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201755|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
83201757|NCT02467127|Vitamins|vitamins|mesh-ancestor
83201758|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
83201759|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201760|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83201761|NCT03302585|Vitamin D|vitamin d|mesh-list
83201762|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
83201763|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
83201764|NCT03302585|Vitamins|vitamins|mesh-list
83201765|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
83201766|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201767|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83201768|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83201769|NCT05727761|Metformin|metformin|mesh-list
83201770|NCT05727761|Pioglitazone|pioglitazone|mesh-list
83201771|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83201772|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201773|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
83201774|NCT03302351|Ketamine|ketamine|mesh-list
83201775|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83201776|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201777|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201778|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83201779|NCT03302351|Analgesics|analgesics|mesh-ancestor
83201780|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
83201781|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201782|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83201783|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83201784|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201785|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201786|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201787|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201788|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83201789|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83201790|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
83201791|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
83201792|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83201793|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83201794|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
83201795|NCT05727683|Fludarabine|fludarabine|mesh-list
83201796|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83201797|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
83201798|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201799|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83201800|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83201801|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
83201802|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201803|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201804|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83201805|NCT03302039|Phenylephrine|phenylephrine|mesh-list
83201806|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
83201807|NCT03302039|Bupivacaine|bupivacaine|mesh-list
83201808|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
83201809|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
83201810|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201811|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201812|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
83201813|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201814|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83201815|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
83201816|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
83201817|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
83201818|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83201819|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
83201820|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83201821|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83201822|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83201823|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201824|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201825|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201826|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201827|NCT03302039|Protective Agents|protective agents|mesh-ancestor
83201829|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83201830|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
83201831|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201832|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201833|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201834|NCT02466503|Fluticasone|fluticasone|mesh-list
83201835|NCT02466503|Xhance|xhance|mesh-list
83201836|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83201837|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83201838|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83201839|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
83201840|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201841|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201842|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83201843|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83201844|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
83201845|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83201846|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83201847|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83201848|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83201849|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201850|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201851|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201852|NCT03301181|Itraconazole|itraconazole|mesh-list
83201853|NCT03301181|Rifampin|rifampin|mesh-list
83201854|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
83201855|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
83201856|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83201857|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83201858|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83201859|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83201860|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201861|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83201862|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
83201863|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201864|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201865|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83201866|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83201867|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
83201868|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83201869|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
83201870|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83201871|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83201872|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83201873|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83201874|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83201875|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83201876|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83201877|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201878|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83201879|NCT00702221|Vaccines|vaccines|mesh-list
83201880|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
83201881|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201882|NCT03301025|Pregabalin|pregabalin|mesh-list
83201883|NCT03301025|Analgesics|analgesics|mesh-ancestor
83201884|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
83201885|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201886|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201887|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
83201888|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83201889|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201890|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201891|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83201892|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83201893|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83201894|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201895|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83201896|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83201897|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
83201898|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83201899|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
83201900|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83201901|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201902|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83201903|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83201904|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83201905|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83201906|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83201907|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83201908|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83201909|NCT02467595|Fentanyl|fentanyl|mesh-list
83201910|NCT02467595|Bromides|bromides|mesh-list
83201911|NCT02467595|Propofol|propofol|mesh-list
83201912|NCT02467595|Sevoflurane|sevoflurane|mesh-list
83201913|NCT02467595|Rocuronium|rocuronium|mesh-list
83201914|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83201915|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201916|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201917|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83201918|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
83201919|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
83201920|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83201921|NCT02467595|Narcotics|narcotics|mesh-ancestor
83201922|NCT02467595|Analgesics|analgesics|mesh-ancestor
83201923|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
83201924|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201925|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83201926|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83201927|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83201928|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
83201929|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83201930|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83201931|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83201932|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
83201933|NCT02467517|Ketamine|ketamine|mesh-list
83201934|NCT02467517|Analgesics|analgesics|mesh-ancestor
83201935|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
83201936|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201937|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201938|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83201939|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83201940|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
83201941|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
83201942|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201943|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83201944|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83201945|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201946|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201947|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83201948|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
83201949|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83201950|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83201951|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83201952|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
83201953|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83201954|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83201955|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83201956|NCT02467673|Estradiol|estradiol|mesh-list
83201957|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83201958|NCT02467673|Progesterone|progesterone|mesh-list
83201959|NCT02467673|Estrogens|estrogens|mesh-ancestor
83201960|NCT02467673|Hormones|hormones|mesh-ancestor
83201961|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83201962|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201963|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83201964|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
83201965|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83201966|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83201967|NCT02467673|Progestins|progestins|mesh-ancestor
83201968|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83201969|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
83201970|NCT02953145|Coagulants|coagulants|mesh-ancestor
83201971|NCT03300089|Anesthetics|anesthetics|mesh-list
83201972|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201973|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201974|NCT05725031|Ephedrine|ephedrine|mesh-list
83201975|NCT05725031|Rocuronium|rocuronium|mesh-list
83201976|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83201977|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83201978|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83201979|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201980|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201981|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83201982|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
83201983|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
83201984|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83201985|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
83201986|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83201987|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83201988|NCT04983615|Fentanyl|fentanyl|mesh-list
83201989|NCT04983615|Midazolam|midazolam|mesh-list
83201990|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83201991|NCT04983615|Narcotics|narcotics|mesh-ancestor
83201992|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83201993|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83201994|NCT04983615|Analgesics|analgesics|mesh-ancestor
83201995|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
83201996|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83201997|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83201998|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83201999|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
83202000|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
83202001|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83202002|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83202003|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83202004|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83202005|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
83202006|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
83202007|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202008|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202009|NCT00702923|Tremelimumab|tremelimumab|mesh-list
83202010|NCT00702923|Bicalutamide|bicalutamide|mesh-list
83202011|NCT00702923|Ipilimumab|ipilimumab|mesh-list
83202012|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83202013|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202014|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
83202015|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202016|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
83202017|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
83202018|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202019|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202020|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83419563|NCT05614440|Narcotics|narcotics|mesh-ancestor
83202021|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202022|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
83202023|NCT05294055|Etoposide|etoposide|mesh-list
83202024|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83202025|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
83202026|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202027|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83202028|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83202029|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
83202030|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202031|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202032|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83202033|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83202034|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83202035|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83202036|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202037|NCT03299621|Rocuronium|rocuronium|mesh-list
83202038|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83202039|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83202040|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83202041|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202042|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202043|NCT05718167|Tislelizumab|tislelizumab|mesh-list
83202044|NCT05718167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202045|NCT05718167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202046|NCT03299387|Gentamicins|gentamicins|mesh-list
83202047|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
83202048|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83202049|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202050|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83202051|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202052|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202053|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83202054|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
83202055|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83202056|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202057|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
83202058|NCT02658981|Nivolumab|nivolumab|mesh-list
83202059|NCT02658981|Relatlimab|relatlimab|mesh-list
83202060|NCT02658981|Antibodies|antibodies|mesh-list
83202061|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83202062|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
83202063|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202064|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202065|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202066|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83202067|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202068|NCT04794699|Paclitaxel|paclitaxel|mesh-list
83202069|NCT04794699|Docetaxel|docetaxel|mesh-list
83202070|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83202071|NCT04794699|Gemcitabine|gemcitabine|mesh-list
83202072|NCT04794699|Pemetrexed|pemetrexed|mesh-list
83202073|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83202074|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202075|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
83202076|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
83202077|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
83202078|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202079|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83202080|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
83202081|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202082|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83202083|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83202084|NCT04782687|Dexamethasone|dexamethasone|mesh-list
83202085|NCT04782687|Lenalidomide|lenalidomide|mesh-list
83202086|NCT04782687|Daratumumab|daratumumab|mesh-list
83202087|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83202088|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
83202089|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
83202090|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202091|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202092|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83202093|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
83202094|NCT04782687|Hormones|hormones|mesh-ancestor
83202095|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202096|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83202097|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202098|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
83202099|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83202100|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83202101|NCT04782687|Growth Substances|growth substances|mesh-ancestor
83202102|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
83202103|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
83202104|NCT05655689|Vancomycin|vancomycin|mesh-list
83202105|NCT05655689|Gentamicins|gentamicins|mesh-list
83202106|NCT05655689|Ceftazidime|ceftazidime|mesh-list
83202107|NCT05655689|Natamycin|natamycin|mesh-list
83202108|NCT05655689|Voriconazole|voriconazole|mesh-list
83202109|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83202110|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83202111|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83202112|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202113|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83202114|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83202115|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202116|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202117|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202118|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202119|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83202120|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
83202121|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83202122|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83202123|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83202124|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
83202125|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202126|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83202127|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83202128|NCT02466347|Fluticasone|fluticasone|mesh-list
83202129|NCT02466347|Xhance|xhance|mesh-list
83202130|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83202131|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83202132|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83202133|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
83202134|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202135|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202136|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83202137|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
83202138|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
83202139|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83202140|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83202141|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83202142|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83202143|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
83202144|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202145|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202146|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
83202147|NCT03067935|Immunoconjugates|immunoconjugates|mesh-ancestor
83202148|NCT03067935|Immunologic Factors|immunologic factors|mesh-ancestor
83202149|NCT03067935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202150|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202151|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202152|NCT02466191|Gabapentin|gabapentin|mesh-list
83202153|NCT02466191|Memantine|memantine|mesh-list
83202154|NCT02466191|Analgesics|analgesics|mesh-ancestor
83202155|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
83202156|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202157|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202158|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
83202159|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83202160|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83202161|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202162|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83202163|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83202164|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83202165|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202166|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202167|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
83202168|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83202169|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83202170|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
83202171|NCT05555069|Menthol|menthol|mesh-list
83202172|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
83202173|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
83202174|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
83202175|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
83202176|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202177|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
83202178|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202179|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202180|NCT03069339|Carvedilol|carvedilol|mesh-list
83202181|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83202182|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83202183|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
83202184|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202185|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202186|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202187|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83202189|NCT03069339|Protective Agents|protective agents|mesh-ancestor
83202190|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83202191|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202192|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83202193|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
83202194|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83202195|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83202196|NCT05546411|Leucovorin|leucovorin|mesh-list
83202197|NCT05546411|Fluorouracil|fluorouracil|mesh-list
83202198|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
83202199|NCT05546411|Irinotecan|irinotecan|mesh-list
83202200|NCT05546411|Camptothecin|camptothecin|mesh-list
83202201|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
83202202|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202203|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
83202204|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202205|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83202206|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202207|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83202208|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
83202209|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83202210|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83202211|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202212|NCT05546411|Antidotes|antidotes|mesh-ancestor
83202213|NCT05546411|Protective Agents|protective agents|mesh-ancestor
83202214|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
83202215|NCT05546411|Vitamins|vitamins|mesh-ancestor
83202216|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
83202217|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83202218|NCT05542589|Phenytoin|phenytoin|mesh-list
83202219|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
83202220|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83202221|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83202222|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202223|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202224|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83202225|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83202226|NCT03069027|Lidocaine|lidocaine|mesh-list
83202227|NCT03069027|Epinephrine|epinephrine|mesh-list
83202228|NCT03069027|Racepinephrine|racepinephrine|mesh-list
83202229|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
83202230|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
83202231|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
83202232|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202233|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202234|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
83202235|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202236|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83202237|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83202238|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83202239|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202240|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202241|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83202242|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83202243|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
83202244|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202245|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83202246|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83202247|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
83202248|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83202249|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
83202250|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
83202251|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
83202252|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83202253|NCT05635071|Nintedanib|nintedanib|mesh-list
83202254|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202255|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83202256|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202257|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202258|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83202259|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202260|NCT02720081|Albuterol|albuterol|mesh-list
83202261|NCT02720081|Montelukast|montelukast|mesh-list
83202262|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83202263|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
83202264|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83202265|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
83202266|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202267|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202268|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83202269|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83202270|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202271|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83202273|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202274|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
83202275|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83202276|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83202277|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83202278|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83202279|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83202280|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202281|NCT04552197|Tofacitinib|tofacitinib|mesh-list
83202282|NCT04552197|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83202283|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83202284|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202285|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202286|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83202287|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202288|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202289|NCT05244473|Immunotoxins|immunotoxins|mesh-ancestor
83202290|NCT05244473|Immunoconjugates|immunoconjugates|mesh-ancestor
83202291|NCT05244473|Immunologic Factors|immunologic factors|mesh-ancestor
83202292|NCT05244473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202293|NCT05634759|Azithromycin|azithromycin|mesh-list
83202294|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83202295|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202296|NCT04809233|Tipifarnib|tipifarnib|mesh-list
83202297|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202298|NCT02310269|Pasireotide|pasireotide|mesh-list
83202299|NCT02310269|Hormones|hormones|mesh-ancestor
83202300|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202301|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202302|NCT03069183|Ropivacaine|ropivacaine|mesh-list
83202303|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
83202304|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
83202305|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202306|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202307|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
83202308|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202310|NCT04489745|Hormones|hormones|mesh-ancestor
83202311|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202312|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202313|NCT02464865|Thiamine|thiamine|mesh-list
83202314|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
83202315|NCT02464865|Vitamins|vitamins|mesh-ancestor
83202316|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
83202317|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202318|NCT02466035|Caseins|caseins|mesh-list
83202319|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
83202320|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
83202321|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202322|NCT05173337|Nefopam|nefopam|mesh-list
83202323|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83202324|NCT05173337|Analgesics|analgesics|mesh-ancestor
83202325|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
83202326|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202327|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202328|NCT02464631|Ribavirin|ribavirin|mesh-list
83202329|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
83202330|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
83202331|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202332|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
83202333|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202334|NCT04880577|Tenofovir|tenofovir|mesh-list
83202335|NCT04880577|Rituximab|rituximab|mesh-list
83202336|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
83202337|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202338|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202339|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
83202340|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202341|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83202342|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
83202343|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202344|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83202345|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83202346|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202347|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202348|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83202349|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83202350|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83202351|NCT04490213|Laxatives|laxatives|mesh-ancestor
83202352|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83202353|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
83202354|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83202355|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202356|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
83202357|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202358|NCT04562597|Expectorants|expectorants|mesh-ancestor
83202359|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83202360|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83202361|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
83202362|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202363|NCT04562597|Protective Agents|protective agents|mesh-ancestor
83202364|NCT04562597|Antidotes|antidotes|mesh-ancestor
83202365|NCT04562129|Aldesleukin|aldesleukin|mesh-list
83202366|NCT04562129|Nivolumab|nivolumab|mesh-list
83202367|NCT04562129|Ipilimumab|ipilimumab|mesh-list
83202368|NCT04562129|Interleukin-2|interleukin-2|mesh-list
83202369|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202370|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202371|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83202372|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202373|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83202374|NCT04562129|Analgesics|analgesics|mesh-ancestor
83202375|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
83202376|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202377|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202378|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83202379|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83202380|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
83202381|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202382|NCT04504175|Ketamine|ketamine|mesh-list
83202383|NCT04504175|Analgesics|analgesics|mesh-ancestor
83202384|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
83202385|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202386|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202387|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83202388|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83202389|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
83202390|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
83202391|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202392|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83202393|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83202394|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202395|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202396|NCT05723367|Anesthetics|anesthetics|mesh-list
83202397|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
83202398|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202399|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202400|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
83202401|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202402|NCT03853395|Antibodies|antibodies|mesh-list
83202403|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
83202404|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202405|NCT04433169|Tretinoin|tretinoin|mesh-list
83202406|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202407|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
83202408|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
83202409|NCT02717195|Olanzapine|olanzapine|mesh-list
83202410|NCT02717195|Risperidone|risperidone|mesh-list
83202411|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83202412|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
83202413|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202414|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202415|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202416|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83202417|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83202418|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202419|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83202420|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83202421|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
83202422|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
83202423|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
83202424|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202425|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83202426|NCT02717195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83202427|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83202428|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202429|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
83202430|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83202431|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202432|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202434|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
83202435|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202436|NCT05582031|Tislelizumab|tislelizumab|mesh-list
83202437|NCT05582031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202438|NCT05582031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202439|NCT04424225|Niacin|niacin|mesh-list
83202440|NCT04424225|Psilocybin|psilocybin|mesh-list
83202441|NCT04424225|Vitamins|vitamins|mesh-ancestor
83202442|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
83202443|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202444|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
83202445|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83202446|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
83202447|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202448|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83202449|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
83202450|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
83202451|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83202452|NCT05581719|Nivolumab|nivolumab|mesh-list
83202453|NCT05581719|Tislelizumab|tislelizumab|mesh-list
83202454|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202455|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202456|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83202457|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202458|NCT05626101|Gemcitabine|gemcitabine|mesh-list
83202459|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83202460|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
83202461|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202462|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202463|NCT05537883|Bupivacaine|bupivacaine|mesh-list
83202464|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
83202465|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
83202466|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202467|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202468|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
83202469|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202470|NCT02465801|Lenograstim|lenograstim|mesh-list
83202471|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83202472|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
83202473|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202474|NCT02465645|Carvedilol|carvedilol|mesh-list
83202475|NCT02465645|Simvastatin|simvastatin|mesh-list
83202476|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83202477|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83202478|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
83202479|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202480|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83202481|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83202482|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202483|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83202484|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83202485|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
83202486|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202487|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202488|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83202489|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
83202490|NCT02465645|Protective Agents|protective agents|mesh-ancestor
83202491|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83202492|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202493|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83202494|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
83202495|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83202496|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83202497|NCT05565495|Hydromorphone|hydromorphone|mesh-list
83202498|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83202499|NCT05565495|Narcotics|narcotics|mesh-ancestor
83202500|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202501|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202502|NCT05565495|Analgesics|analgesics|mesh-ancestor
83202503|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
83202504|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202505|NCT04872257|Vitamin D|vitamin d|mesh-list
83202507|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
83202508|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202509|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83202510|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83202511|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83202512|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83202513|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202514|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202515|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202516|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202517|NCT04970121|Analgesics|analgesics|mesh-ancestor
83202518|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
83202519|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202520|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
83202521|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83202522|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
83202523|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
83202524|NCT02463929|Promethazine|promethazine|mesh-list
83202525|NCT02463929|Ketamine|ketamine|mesh-list
83202526|NCT02463929|Bupivacaine|bupivacaine|mesh-list
83202527|NCT02463929|Sevoflurane|sevoflurane|mesh-list
83202528|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
83202529|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
83202530|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202531|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202532|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
83202533|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202534|NCT02463929|Analgesics|analgesics|mesh-ancestor
83202535|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83202536|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83202537|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
83202538|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83202539|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83202540|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202541|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202542|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83202543|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83202544|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83202545|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83202546|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
83202547|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
83202548|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83202549|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83202550|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
83202551|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
83202552|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83202553|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
83202554|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
83202555|NCT02465255|Acetaminophen|acetaminophen|mesh-list
83202556|NCT02465255|Ketorolac|ketorolac|mesh-list
83202557|NCT02465255|Tramadol|tramadol|mesh-list
83202558|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83202559|NCT02465255|Analgesics|analgesics|mesh-ancestor
83202560|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
83202561|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202562|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202563|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
83202564|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83202565|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83202566|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83202567|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83202568|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202569|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202570|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83202571|NCT02465255|Narcotics|narcotics|mesh-ancestor
83202572|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202573|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83202574|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83202575|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83202576|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
83202577|NCT02462915|Lidocaine|lidocaine|mesh-list
83202578|NCT02462915|Fentanyl|fentanyl|mesh-list
83202579|NCT02462915|Propofol|propofol|mesh-list
83202580|NCT02462915|Cisatracurium|cisatracurium|mesh-list
83202581|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
83202582|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
83202583|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202584|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202585|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
83202586|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202587|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83202588|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83202589|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83202590|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202591|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202592|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83202593|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83202594|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
83202595|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83202596|NCT02462915|Narcotics|narcotics|mesh-ancestor
83202597|NCT02462915|Analgesics|analgesics|mesh-ancestor
83202598|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83202599|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83202600|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83202601|NCT05505123|Propofol|propofol|mesh-list
83202602|NCT05505123|Sevoflurane|sevoflurane|mesh-list
83202603|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83202604|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202605|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202606|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83202607|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
83202608|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
83202609|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83202610|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83202611|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
83202612|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202613|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202614|NCT04914897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83202615|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202616|NCT02462525|Dexamethasone|dexamethasone|mesh-list
83202617|NCT02462525|Pomalidomide|pomalidomide|mesh-list
83202618|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83202619|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
83202620|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
83202621|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202622|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202623|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83202624|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
83202625|NCT02462525|Hormones|hormones|mesh-ancestor
83202626|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202627|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83202628|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202629|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
83202630|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83202631|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83202632|NCT02462525|Growth Substances|growth substances|mesh-ancestor
83202634|NCT04111419|Amlodipine|amlodipine|mesh-list
83202635|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83202636|NCT04111419|Atorvastatin|atorvastatin|mesh-list
83202637|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83202638|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83202639|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
83202640|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202641|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83202642|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83202643|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202644|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83202645|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83202646|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202647|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83202648|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202649|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
83202651|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
83202652|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83202653|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
83202654|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202655|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83202656|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83202657|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
83202658|NCT02462681|Ketamine|ketamine|mesh-list
83202659|NCT02462681|Analgesics|analgesics|mesh-ancestor
83202660|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
83202661|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202662|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202663|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83202664|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83202665|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
83202666|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
83202667|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202668|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83419564|NCT05614440|Analgesics|analgesics|mesh-ancestor
83202670|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202671|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202672|NCT04129151|Palbociclib|palbociclib|mesh-list
83202673|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202674|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83202675|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202676|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202677|NCT02462369|Glimepiride|glimepiride|mesh-list
83202678|NCT02462369|Saxagliptin|saxagliptin|mesh-list
83202679|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83202680|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83202681|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202682|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83202683|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
83202684|NCT02462369|Incretins|incretins|mesh-ancestor
83202685|NCT02462369|Hormones|hormones|mesh-ancestor
83202686|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202687|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83202688|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
83202689|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202690|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202691|NCT04072835|Etripamil|etripamil|mesh-list
83202692|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83202693|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202694|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202695|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83202696|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202697|NCT04083963|Paclitaxel|paclitaxel|mesh-list
83202698|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
83202699|NCT04083963|Carboplatin|carboplatin|mesh-list
83202700|NCT04083963|Doxorubicin|doxorubicin|mesh-list
83202701|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83202702|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202703|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83202704|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83202705|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83202706|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202707|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83202708|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
83202709|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202710|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83202711|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83202712|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
83202713|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83202714|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83202715|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83202716|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83202717|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202718|NCT02463383|Ibuprofen|ibuprofen|mesh-list
83202719|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83202720|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83202721|NCT02463383|Analgesics|analgesics|mesh-ancestor
83202722|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
83202723|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202724|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202725|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83202726|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83202727|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83202728|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202729|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202731|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202732|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83202733|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202734|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202735|NCT03108365|Hemostatics|hemostatics|mesh-list
83202736|NCT03108365|Chitosan|chitosan|mesh-list
83202737|NCT03108365|Coagulants|coagulants|mesh-ancestor
83202738|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83202739|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83202740|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
83202741|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202742|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83202743|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
83202744|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
83202745|NCT05345457|Amoxicillin|amoxicillin|mesh-list
83202746|NCT05345457|Azithromycin|azithromycin|mesh-list
83202747|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83202748|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202749|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83202750|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83202751|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83202752|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202753|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202754|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83202755|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202756|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202757|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
83202758|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202759|NCT04729179|Cannabidiol|cannabidiol|mesh-list
83202760|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
83202761|NCT04706715|Cemiplimab|cemiplimab|mesh-list
83202762|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202763|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202764|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
83202765|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
83202766|NCT03064191|Calcium|calcium|mesh-list
83202767|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83202768|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202769|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83202770|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83202771|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202772|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
83202773|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
83202774|NCT02629965|Olodaterol|olodaterol|mesh-list
83202775|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83202776|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
83202777|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202778|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202779|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83202780|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
83202781|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
83202782|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83202783|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
83202784|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83202785|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202786|NCT03062787|Triamcinolone|triamcinolone|mesh-list
83202787|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83202788|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83202789|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
83202790|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83202791|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83202792|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
83202793|NCT03062787|Hormones|hormones|mesh-ancestor
83202794|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202795|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202796|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83202797|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
83202798|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202799|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202800|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83202801|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
83202802|NCT03062787|Protective Agents|protective agents|mesh-ancestor
83202803|NCT04601883|Colchicine|colchicine|mesh-list
83202804|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
83202805|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83202806|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83202807|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83202808|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83202809|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202810|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202811|NCT05223075|Lidocaine|lidocaine|mesh-list
83202812|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83202813|NCT05223075|Carticaine|carticaine|mesh-list
83202814|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
83202815|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
83202816|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202817|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202818|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
83202819|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202820|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83202821|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83202822|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83202823|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202824|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202825|NCT03064035|Thrombin|thrombin|mesh-list
83202826|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
83202827|NCT03064035|Coagulants|coagulants|mesh-ancestor
83202828|NCT03719313|Interferons|interferons|mesh-list
83202829|NCT03719313|Ritonavir|ritonavir|mesh-list
83202830|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
83202831|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83202832|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
83202833|NCT03719313|Lonafarnib|lonafarnib|mesh-list
83202834|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202835|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
83202836|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202837|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83202838|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83202839|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
83202840|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202841|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202842|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83202843|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83202844|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83202845|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83202846|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
83202847|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202848|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
83202849|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
83202850|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202851|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
83202852|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83202853|NCT03063723|Ledipasvir|ledipasvir|mesh-list
83202854|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
83202855|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202856|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83202857|NCT04338321|Esketamine|esketamine|mesh-list
83202858|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
83202859|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83202860|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83202861|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83202862|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202863|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202864|NCT00379041|Prednisone|prednisone|mesh-list
83202865|NCT00379041|Doxorubicin|doxorubicin|mesh-list
83202866|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83202867|NCT00379041|Bleomycin|bleomycin|mesh-list
83202868|NCT00379041|Vincristine|vincristine|mesh-list
83202869|NCT00379041|Vinblastine|vinblastine|mesh-list
83202870|NCT00379041|Procarbazine|procarbazine|mesh-list
83202871|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
83202872|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83202873|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202874|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83202875|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83202876|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202877|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202878|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83202879|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
83202880|NCT00379041|Hormones|hormones|mesh-ancestor
83202881|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83202882|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202883|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83202884|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83202885|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83202886|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83202887|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83202888|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
83202889|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83202890|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83202891|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83202892|NCT03305445|Nivolumab|nivolumab|mesh-list
83202893|NCT03305445|Ipilimumab|ipilimumab|mesh-list
83202894|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202895|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202896|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83202897|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202898|NCT04436913|Fluorides|fluorides|mesh-list
83202899|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
83202900|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
83202901|NCT04436913|Protective Agents|protective agents|mesh-ancestor
83202902|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202903|NCT02487095|Topotecan|topotecan|mesh-list
83202904|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83202905|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83202906|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202907|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202908|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202909|NCT03837899|Durvalumab|durvalumab|mesh-list
83202910|NCT03837899|Tremelimumab|tremelimumab|mesh-list
83202911|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83202912|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83202913|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202914|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
83202915|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202916|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83202917|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83202918|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202919|NCT03742193|Apatinib|apatinib|mesh-list
83202920|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202921|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83202922|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202923|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202924|NCT03108287|Amoxicillin|amoxicillin|mesh-list
83202925|NCT03108287|Clarithromycin|clarithromycin|mesh-list
83202926|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
83202927|NCT03108287|Rabeprazole|rabeprazole|mesh-list
83202928|NCT03108287|Bismuth|bismuth|mesh-list
83202929|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83202930|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202931|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83202932|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202933|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202934|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83202935|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83202936|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83202937|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83202938|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83202939|NCT03108287|Antacids|antacids|mesh-ancestor
83202940|NCT02461121|Cyclosporine|cyclosporine|mesh-list
83202941|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
83202942|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
83202943|NCT02461121|Fludarabine|fludarabine|mesh-list
83202944|NCT02461121|Cyclosporins|cyclosporins|mesh-list
83202945|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83202946|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83202947|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
83202948|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202949|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83202950|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83202951|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
83202952|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202953|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202954|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83202955|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83202956|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
83202957|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83202958|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
83202959|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83202960|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83202961|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83202962|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
83202963|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83202965|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202966|NCT02461043|Paclitaxel|paclitaxel|mesh-list
83202967|NCT02461043|Cisplatin|cisplatin|mesh-list
83202968|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83202969|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83202970|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
83202971|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
83202972|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
83202973|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202974|NCT03296657|Fluorides|fluorides|mesh-list
83202975|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
83202976|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
83202977|NCT03296657|Protective Agents|protective agents|mesh-ancestor
83202978|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202979|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
83202980|NCT03296579|Aminophylline|aminophylline|mesh-list
83202981|NCT03296579|Albuterol|albuterol|mesh-list
83202982|NCT03296579|Ipratropium|ipratropium|mesh-list
83202983|NCT03296579|Analgesics|analgesics|mesh-ancestor
83202984|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
83202985|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83202986|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83202987|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
83202988|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83202989|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83202990|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
83202991|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83202992|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83202993|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83202994|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83202995|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
83202996|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83202997|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83202998|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
83202999|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83203000|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
83203001|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83203002|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83203003|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83203004|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
83203005|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203006|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83203007|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
83203008|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83203009|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83203010|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203011|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83203012|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83203013|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
83203014|NCT03296579|Protective Agents|protective agents|mesh-ancestor
83203015|NCT02461667|Alendronate|alendronate|mesh-list
83203016|NCT02461667|Metformin|metformin|mesh-list
83203017|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83203018|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203019|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83203020|NCT01670877|Trastuzumab|trastuzumab|mesh-list
83203021|NCT01670877|Fulvestrant|fulvestrant|mesh-list
83203022|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203023|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203024|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83203025|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83203026|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83203027|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
83203028|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203029|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203030|NCT00701129|Rituximab|rituximab|mesh-list
83203031|NCT00701129|Methotrexate|methotrexate|mesh-list
83203032|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203033|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203034|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
83203035|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203036|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83203037|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83203038|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
83203039|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83203040|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83203041|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
83203042|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203043|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
83203044|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203045|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83203046|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83203047|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83203048|NCT03296189|Dexamethasone|dexamethasone|mesh-list
83203049|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
83203050|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
83203051|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83203052|NCT03296189|BB 1101|bb 1101|mesh-list
83203053|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203054|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
83203055|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
83203056|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203057|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203058|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203059|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
83203060|NCT03296189|Hormones|hormones|mesh-ancestor
83203061|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203062|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83203063|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203064|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
83203065|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
83203066|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203067|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
83203068|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
83203069|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203070|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203071|NCT03295955|Amoxicillin|amoxicillin|mesh-list
83203072|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
83203073|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
83203074|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83203075|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83203076|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203077|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83203078|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203079|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203080|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83203081|NCT03298373|Nandrolone|nandrolone|mesh-list
83203082|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83203083|NCT03298373|Androgens|androgens|mesh-ancestor
83203084|NCT03298373|Hormones|hormones|mesh-ancestor
83203085|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203086|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203087|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
83203088|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83203089|NCT01670721|Leucovorin|leucovorin|mesh-list
83203090|NCT01670721|Fluorouracil|fluorouracil|mesh-list
83203091|NCT01670721|Irinotecan|irinotecan|mesh-list
83203092|NCT01670721|Aflibercept|aflibercept|mesh-list
83203093|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
83203094|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203095|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83203096|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203097|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83203098|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
83203099|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203100|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83203101|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83203102|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203103|NCT01670721|Antidotes|antidotes|mesh-ancestor
83203104|NCT01670721|Protective Agents|protective agents|mesh-ancestor
83203105|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
83203106|NCT01670721|Vitamins|vitamins|mesh-ancestor
83203107|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
83203108|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83203109|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83203110|NCT01670721|Growth Substances|growth substances|mesh-ancestor
83203111|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
83203112|NCT03287427|Tislelizumab|tislelizumab|mesh-list
83203113|NCT03287427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203114|NCT03287427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203115|NCT04491695|Tirofiban|tirofiban|mesh-list
83203116|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83203117|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83203118|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203119|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83203120|NCT04982055|Nadroparin|nadroparin|mesh-list
83203121|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
83203122|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83203123|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83203124|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203125|NCT04981743|Vitamin D|vitamin d|mesh-list
83203126|NCT04981743|Vitamins|vitamins|mesh-ancestor
83203127|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
83203128|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203129|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83203130|NCT04489121|Omalizumab|omalizumab|mesh-list
83203131|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83203132|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83203133|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83203134|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
83203135|NCT04982211|Propranolol|propranolol|mesh-list
83203136|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83203137|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83203138|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
83203139|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203140|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203141|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203142|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83203143|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83203144|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
83203145|NCT03290963|Ketamine|ketamine|mesh-list
83203146|NCT03290963|Analgesics|analgesics|mesh-ancestor
83203147|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
83203148|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203149|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203150|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83203151|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83203152|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
83203153|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
83203154|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203155|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83203156|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83203157|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203158|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203159|NCT03294707|Coal Tar|coal tar|mesh-list
83203160|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
83203161|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83203162|NCT03062319|Anticoagulants|anticoagulants|mesh-list
83203163|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83203164|NCT03290495|Ketamine|ketamine|mesh-list
83203165|NCT03290495|Analgesics|analgesics|mesh-ancestor
83203166|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
83203167|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203168|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203169|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83203170|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83203171|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
83203172|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
83203173|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203174|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83203175|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83203176|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203177|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203178|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
83203179|NCT04429893|Bupivacaine|bupivacaine|mesh-list
83203180|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
83203181|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
83203182|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203183|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203184|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
83203185|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203186|NCT04429893|Analgesics|analgesics|mesh-ancestor
83203187|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83203188|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
83203189|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83203190|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83203191|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203192|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83203193|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
83203194|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83203195|NCT03290417|Vitamin D|vitamin d|mesh-list
83203196|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
83203197|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
83203198|NCT03290417|Vitamins|vitamins|mesh-list
83203199|NCT03290417|Curcumin|curcumin|mesh-list
83203200|NCT03290417|Turmeric extract|turmeric extract|mesh-list
83203201|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
83203202|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203203|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83203204|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83203205|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83203206|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203207|NCT03290417|Analgesics|analgesics|mesh-ancestor
83203208|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
83203209|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203210|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203211|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83203212|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203213|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203214|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203216|NCT03290417|Protective Agents|protective agents|mesh-ancestor
83203217|NCT04429347|Gabapentin|gabapentin|mesh-list
83203218|NCT04429347|Tizanidine|tizanidine|mesh-list
83203219|NCT04429347|Analgesics|analgesics|mesh-ancestor
83203220|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
83203221|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203222|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203223|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
83203224|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83203225|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83203226|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203227|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203228|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83203229|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83203230|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203231|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203232|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
83203233|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83203234|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83203235|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
83203236|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
83203237|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83203238|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83203239|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83203240|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
83203241|NCT03294551|Vaccines|vaccines|mesh-list
83203242|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
83203243|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203244|NCT04156581|Dexamethasone|dexamethasone|mesh-list
83203245|NCT04156581|Bupivacaine|bupivacaine|mesh-list
83203246|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203247|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
83203248|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
83203249|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203250|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203251|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203252|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
83203253|NCT04156581|Hormones|hormones|mesh-ancestor
83203254|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203255|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83203256|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203257|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
83203258|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
83203259|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203260|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
83203261|NCT02983071|Fulvestrant|fulvestrant|mesh-list
83203262|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83203263|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203264|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83203265|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83203266|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
83203267|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203268|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203269|NCT03294395|Gentamicins|gentamicins|mesh-list
83203270|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
83203271|NCT03294395|Ertapenem|ertapenem|mesh-list
83203272|NCT03294395|Fosfomycin|fosfomycin|mesh-list
83203273|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83203274|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203275|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83203276|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203277|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203278|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
83203279|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83203280|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83203281|NCT04980105|Prednisolone|prednisolone|mesh-list
83203282|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
83203283|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83203284|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
83203285|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
83203286|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203287|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
83203288|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
83419871|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
83203289|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203290|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203291|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203292|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
83203293|NCT04980105|Hormones|hormones|mesh-ancestor
83203294|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203295|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83203296|NCT04980105|Protective Agents|protective agents|mesh-ancestor
83203297|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83203298|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203299|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83203300|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
83203301|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
83203302|NCT04973319|Trastuzumab|trastuzumab|mesh-list
83203303|NCT04973319|Pertuzumab|pertuzumab|mesh-list
83203304|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203305|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203306|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83203307|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83203308|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83203309|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203310|NCT03289871|Amorolfine|amorolfine|mesh-list
83203311|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
83203312|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203313|NCT03289637|Vitamin D|vitamin d|mesh-list
83203314|NCT03289637|Vitamins|vitamins|mesh-ancestor
83203315|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
83203316|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203317|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83203318|NCT04854837|Remdesivir|remdesivir|mesh-list
83203319|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
83203320|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203321|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
83203322|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203323|NCT02460497|Minoxidil|minoxidil|mesh-list
83203324|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83203325|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
83203326|NCT03289559|Testosterone|testosterone|mesh-list
83203327|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83203328|NCT03289559|Androgens|androgens|mesh-ancestor
83203329|NCT03289559|Hormones|hormones|mesh-ancestor
83203330|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203331|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203332|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83203333|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203334|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203335|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83203336|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
83203337|NCT03293927|Fentanyl|fentanyl|mesh-list
83203338|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
83203339|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83203340|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203341|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203342|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203343|NCT03293927|Analgesics|analgesics|mesh-ancestor
83203344|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
83203345|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203346|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83203347|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83203348|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83203349|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
83203350|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203351|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203352|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83203353|NCT03293927|Narcotics|narcotics|mesh-ancestor
83203354|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83203355|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83203356|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
83203357|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
83203358|NCT02730429|Letrozole|letrozole|mesh-list
83203359|NCT02730429|Palbociclib|palbociclib|mesh-list
83203360|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203361|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83203362|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83203363|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203364|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203365|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83203366|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
83203367|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203368|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203369|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83203370|NCT04971759|Fentanyl|fentanyl|mesh-list
83203371|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
83203372|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
83203373|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83203374|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203375|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203376|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203377|NCT04971759|Analgesics|analgesics|mesh-ancestor
83203378|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
83203379|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203380|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83203381|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83203382|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83203383|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
83203384|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203385|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203386|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83203387|NCT04971759|Narcotics|narcotics|mesh-ancestor
83203388|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83203389|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83203390|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
83203391|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
83203392|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
83203393|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83203394|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83203395|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203396|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203397|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83203398|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83203399|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203400|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
83203401|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203402|NCT04979091|Hormones|hormones|mesh-list
83203403|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203404|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203406|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83203407|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
83203408|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203409|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83203410|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83203411|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83203412|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203413|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
83203414|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203415|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203416|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83203417|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83203418|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203420|NCT03107507|Phenobarbital|phenobarbital|mesh-list
83203421|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
83203422|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
83203423|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83203424|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203425|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203426|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83203427|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83203428|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203429|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203430|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
83203431|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
83203432|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83203433|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83203434|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83203435|NCT02711137|Paclitaxel|paclitaxel|mesh-list
83203436|NCT02711137|Gemcitabine|gemcitabine|mesh-list
83203437|NCT02711137|Azacitidine|azacitidine|mesh-list
83203438|NCT02711137|Rucaparib|rucaparib|mesh-list
83203439|NCT02711137|INCB057643|incb057643|mesh-list
83203440|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83203441|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203442|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83203443|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83203444|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83203445|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203446|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83203447|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
83203448|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203449|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83203450|NCT04155411|Dasatinib|dasatinib|mesh-list
83203451|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203452|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83203453|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203454|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203455|NCT04970667|Flupenthixol|flupenthixol|mesh-list
83203456|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83203457|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83203458|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83203459|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203460|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203461|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203462|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83203463|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
83203464|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203465|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203466|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
83203467|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
83203468|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203469|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
83203470|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203471|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203472|NCT03288077|Tryptophan|tryptophan|mesh-list
83203473|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83203474|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
83203475|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203476|NCT00777127|Diclofenac|diclofenac|mesh-list
83203477|NCT00777127|Imiquimod|imiquimod|mesh-list
83203478|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83203479|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203480|NCT00777127|Analgesics|analgesics|mesh-ancestor
83203481|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
83203482|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203483|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203484|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203485|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83203486|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83203487|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203488|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203489|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83203490|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
83203491|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203492|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
83203493|NCT00761371|Imiquimod|imiquimod|mesh-list
83203494|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83203495|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
83203496|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203497|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203498|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
83203499|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
83203500|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
83203501|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203502|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203503|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83203504|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
83203505|NCT03287609|Evolocumab|evolocumab|mesh-list
83203506|NCT03287609|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83203507|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83203508|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83203509|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
83203510|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203511|NCT03287609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83203512|NCT03287609|Protease Inhibitors|protease inhibitors|mesh-ancestor
83203513|NCT03287609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203514|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83203515|NCT03291899|Folfirinox|folfirinox|mesh-list
83203516|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203517|NCT03194815|Rituximab|rituximab|mesh-list
83203518|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
83203519|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83203520|NCT03194815|Antibodies|antibodies|mesh-list
83203521|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
83203522|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83203523|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203524|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203525|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
83203526|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203527|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83203528|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83203529|NCT03291821|Cetrorelix|cetrorelix|mesh-list
83203530|NCT03291821|Menotropins|menotropins|mesh-list
83203531|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83203532|NCT03291821|Ganirelix|ganirelix|mesh-list
83203533|NCT03291821|Hormones|hormones|mesh-ancestor
83203534|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203535|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203536|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
83203537|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83203538|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
83203539|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83203540|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83203541|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83203542|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203543|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83203544|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
83203545|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
83203546|NCT02448901|Edoxaban|edoxaban|mesh-list
83203547|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83203548|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
83203549|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83203550|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
83203551|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203552|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203553|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
83203554|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
83203555|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203557|NCT03291353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83203558|NCT03291353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203559|NCT02460341|Ondansetron|ondansetron|mesh-list
83203560|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
83203561|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
83203562|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203563|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203564|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203565|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
83203566|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
83203567|NCT02460341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83203568|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83203569|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
83203570|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203571|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203572|NCT00189319|Flecainide|flecainide|mesh-list
83203573|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83203574|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83203575|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83203576|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83203577|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203578|NCT00189241|Imiquimod|imiquimod|mesh-list
83203579|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83203580|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
83203581|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203582|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203583|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
83203584|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
83203585|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83203586|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83203587|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83203588|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83203589|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203590|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
83203591|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203592|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203593|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83203594|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203595|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
83203596|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
83203597|NCT03286673|Calcium|calcium|mesh-list
83203598|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83203599|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203600|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83203601|NCT03286673|Antacids|antacids|mesh-ancestor
83419872|NCT01647945|Tacrolimus|tacrolimus|mesh-list
83203602|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203603|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203604|NCT02448589|TAS-119|tas-119|mesh-list
83203605|NCT02448589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203606|NCT02448589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83203607|NCT02448589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203608|NCT02448589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203609|NCT02445703|Vaccines|vaccines|mesh-list
83203610|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
83203611|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203612|NCT03194659|Choline|choline|mesh-list
83203613|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
83203614|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83203615|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
83203616|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203617|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203618|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83203619|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
83203620|NCT02445547|Hormones|hormones|mesh-list
83203621|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203622|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203623|NCT03190603|Celecoxib|celecoxib|mesh-list
83203624|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83203625|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203626|NCT03190603|Analgesics|analgesics|mesh-ancestor
83203627|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
83203628|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203629|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203630|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203631|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83203632|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83203633|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83203634|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203635|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203636|NCT05233579|Sulforaphane|sulforaphane|mesh-list
83203637|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83203638|NCT05233579|Protective Agents|protective agents|mesh-ancestor
83203639|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203640|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203641|NCT03285503|Aripiprazole|aripiprazole|mesh-list
83203642|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
83203643|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203644|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83203645|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83203646|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203647|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203648|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
83203649|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
83203650|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203651|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203652|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83203653|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83203654|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
83203655|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83203656|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83203657|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83203658|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83203659|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
83203660|NCT02439697|Hematinics|hematinics|mesh-ancestor
83203661|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
83203662|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203663|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203664|NCT05179603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83420173|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
83203665|NCT05179603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203666|NCT03284645|Tenofovir|tenofovir|mesh-list
83203667|NCT03284645|Lamivudine|lamivudine|mesh-list
83203668|NCT03284645|Zidovudine|zidovudine|mesh-list
83203669|NCT03284645|Efavirenz|efavirenz|mesh-list
83203670|NCT03284645|Abacavir|abacavir|mesh-list
83203671|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
83203672|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203673|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83203674|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83203675|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203676|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203677|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83203678|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83203679|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
83203680|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83203681|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83203682|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83203683|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83203684|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83203685|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83203686|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83203687|NCT03190447|Laxatives|laxatives|mesh-ancestor
83203688|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203689|NCT03284177|Calcium|calcium|mesh-list
83203690|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83203691|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203692|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
83203693|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
83203694|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83203695|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83203696|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203697|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203698|NCT03192709|Urological Agents|urological agents|mesh-ancestor
83203699|NCT03283943|Durvalumab|durvalumab|mesh-list
83203700|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83203701|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203703|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
83203704|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203705|NCT02444767|Bimatoprost|bimatoprost|mesh-list
83203706|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83203707|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
83203708|NCT02443285|Cefotaxime|cefotaxime|mesh-list
83203709|NCT02443285|Cefoxitin|cefoxitin|mesh-list
83203710|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83203711|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203712|NCT03193957|Etanercept|etanercept|mesh-list
83203713|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83203714|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203715|NCT03193957|Analgesics|analgesics|mesh-ancestor
83203716|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
83203717|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203718|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203719|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203720|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83203721|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203722|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83203723|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
83203724|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
83203725|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83203726|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
83203727|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203728|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203729|NCT02444611|Vaccines|vaccines|mesh-list
83203730|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
83203731|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
83203732|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203733|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83203734|NCT02438761|Gedatolisib|gedatolisib|mesh-list
83203735|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83203736|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203737|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203738|NCT03536429|Acetazolamide|acetazolamide|mesh-list
83203739|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
83203740|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83203741|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203742|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203743|NCT03536429|Diuretics|diuretics|mesh-ancestor
83203744|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
83203745|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203746|NCT02438683|BI 409306|bi 409306|mesh-list
83203747|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83203748|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203749|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203750|NCT03270839|Meclizine|meclizine|mesh-list
83203751|NCT03270839|Scopolamine|scopolamine|mesh-list
83203752|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83203753|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
83203754|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
83203755|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203756|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203757|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203758|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
83203759|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83203760|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
83203761|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203762|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203763|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83203764|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83203765|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
83203766|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
83203767|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83203768|NCT02458547|Bupivacaine|bupivacaine|mesh-list
83203769|NCT02458547|Propofol|propofol|mesh-list
83203770|NCT02458547|Desflurane|desflurane|mesh-list
83203771|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
83203772|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
83203773|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203774|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203775|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
83203776|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203777|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83203778|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83203779|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
83203780|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83203782|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83203783|NCT02458625|Trace Elements|trace elements|mesh-ancestor
83203784|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
83203785|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203786|NCT02458625|Hematinics|hematinics|mesh-ancestor
83203787|NCT04978155|Anesthetics|anesthetics|mesh-list
83203788|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203789|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203790|NCT04970043|Pemetrexed|pemetrexed|mesh-list
83203791|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203792|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203793|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203794|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83203795|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83203796|NCT04977843|Dimercaprol|dimercaprol|mesh-list
83203797|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
83203798|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
83203799|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203800|NCT04432233|Metronidazole|metronidazole|mesh-list
83203801|NCT04432233|Levofloxacin|levofloxacin|mesh-list
83203802|NCT04432233|Esomeprazole|esomeprazole|mesh-list
83203803|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203804|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83203805|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83203806|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83203807|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83203808|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203809|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83203810|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203811|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203812|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83203813|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83203814|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83203815|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203816|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83203817|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83203818|NCT03269747|Prednisone|prednisone|mesh-list
83203819|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203820|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
83203821|NCT03269747|Hormones|hormones|mesh-ancestor
83203822|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203823|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203824|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83203825|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203826|NCT04369469|Ravulizumab|ravulizumab|mesh-list
83203827|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83203828|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83203829|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
83203830|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203831|NCT03269591|Diclofenac|diclofenac|mesh-list
83203832|NCT03269591|Progesterone|progesterone|mesh-list
83203833|NCT03269591|Progestins|progestins|mesh-ancestor
83203834|NCT03269591|Hormones|hormones|mesh-ancestor
83203835|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203836|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203837|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83203838|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203839|NCT03269591|Analgesics|analgesics|mesh-ancestor
83203840|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
83203841|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203842|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83203843|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83203844|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83203845|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203846|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203847|NCT03989609|Midazolam|midazolam|mesh-list
83203848|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
83203849|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83203850|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203851|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203852|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83203853|NCT03989609|Analgesics|analgesics|mesh-ancestor
83203854|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
83203855|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203856|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83203857|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83203858|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83203859|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83203860|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203861|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203862|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83203863|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83203864|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83203865|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203866|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83203867|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
83203869|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
83203870|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
83203871|NCT03988205|Cytarabine|cytarabine|mesh-list
83203872|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83203873|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
83203874|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203875|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203876|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
83203877|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203878|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83203879|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
83203880|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203881|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83203882|NCT03280277|Hematinics|hematinics|mesh-ancestor
83203883|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83203884|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83203885|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
83203886|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83203887|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203888|NCT03269279|Misoprostol|misoprostol|mesh-list
83203889|NCT03269279|Mifepristone|mifepristone|mesh-list
83203890|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83203891|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
83203892|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83203893|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203894|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83203895|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203896|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
83203897|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83203898|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83203899|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83203900|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83203901|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
83203902|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83203903|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83203904|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
83203905|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83203906|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
83203907|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83203908|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83203909|NCT03278483|Rifampin|rifampin|mesh-list
83203910|NCT03278483|Isoniazid|isoniazid|mesh-list
83203911|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83203912|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
83203913|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83203914|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203915|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
83203916|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83203917|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203918|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203919|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83203920|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83203921|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83203922|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83203923|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83203924|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83203925|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83203926|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83203927|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
83203928|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83203929|NCT03268733|Folic Acid|folic acid|mesh-list
83203930|NCT03268733|Hematinics|hematinics|mesh-ancestor
83203931|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
83203932|NCT03268733|Vitamins|vitamins|mesh-ancestor
83203933|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
83203934|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203935|NCT03277391|Droperidol|droperidol|mesh-list
83203936|NCT03277391|Morphine|morphine|mesh-list
83203937|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83203938|NCT03277391|Narcotics|narcotics|mesh-ancestor
83203939|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203940|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203941|NCT03277391|Analgesics|analgesics|mesh-ancestor
83203942|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
83203943|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83203944|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83203945|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
83203946|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
83203947|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83203948|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83203949|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83203950|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203951|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83203952|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83203953|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
83203954|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203955|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203956|NCT03277001|Enoxaparin|enoxaparin|mesh-list
83203957|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
83203958|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83203959|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
83203960|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83203961|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
83203962|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203963|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203964|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
83203965|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83203966|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83203967|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83203968|NCT03272711|Vortioxetine|vortioxetine|mesh-list
83203969|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
83203970|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83203971|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83203972|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83203973|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83203974|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83203975|NCT03272711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83203976|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83203977|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83203978|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203979|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83203980|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
83203981|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83203982|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83203983|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83203984|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83203985|NCT03961919|Fludarabine|fludarabine|mesh-list
83203986|NCT03961919|Treosulfan|treosulfan|mesh-list
83203987|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83203988|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203989|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83203990|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
83203991|NCT03267407|Fluconazole|fluconazole|mesh-list
83203992|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
83203993|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83203994|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83203995|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83203996|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83203997|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83203998|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83203999|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
83204000|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204001|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204002|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83204003|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83204004|NCT03267329|Telmisartan|telmisartan|mesh-list
83204005|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83204006|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83204007|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83204008|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204009|NCT05074589|Leucovorin|leucovorin|mesh-list
83204010|NCT05074589|Fluorouracil|fluorouracil|mesh-list
83204011|NCT05074589|Irinotecan|irinotecan|mesh-list
83204012|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
83204013|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
83204014|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204015|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83204016|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204017|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83204018|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
83204019|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204020|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83204021|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83204022|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204023|NCT05074589|Antidotes|antidotes|mesh-ancestor
83204024|NCT05074589|Protective Agents|protective agents|mesh-ancestor
83204025|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
83204026|NCT05074589|Vitamins|vitamins|mesh-ancestor
83204027|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
83204028|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
83204029|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204030|NCT05073965|Vitamin D|vitamin d|mesh-list
83204031|NCT05073965|Vitamins|vitamins|mesh-ancestor
83204032|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
83204033|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204034|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83204035|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
83204036|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83204037|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204038|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204039|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
83204040|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204041|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204042|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
83204043|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204044|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204045|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204046|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83204047|NCT05065775|Analgesics|analgesics|mesh-ancestor
83204048|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
83204049|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204050|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83204051|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83204052|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83204053|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
83204054|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204055|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204056|NCT03266159|Trametinib|trametinib|mesh-list
83204057|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204058|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204059|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204060|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204061|NCT02458781|Metronidazole|metronidazole|mesh-list
83204062|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
83204063|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
83204064|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204065|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204066|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83204067|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83204068|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83204069|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83204070|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204071|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204072|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204073|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83204074|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83204075|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83204077|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83204078|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204079|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204080|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83204081|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204082|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204083|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204084|NCT02458157|Furosemide|furosemide|mesh-list
83204085|NCT02458157|Diuretics|diuretics|mesh-ancestor
83204086|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
83204087|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204088|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83204089|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204090|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204091|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
83204092|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83204093|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204094|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204095|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83204096|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83204097|NCT02458079|Protective Agents|protective agents|mesh-ancestor
83204098|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204099|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
83204100|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83204101|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
83204102|NCT03264911|Amoxicillin|amoxicillin|mesh-list
83204103|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83420174|NCT01661283|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83204104|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204106|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
83204107|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
83204108|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204109|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204110|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
83204111|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204112|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
83204113|NCT02456363|Adalimumab|adalimumab|mesh-list
83204114|NCT02456363|Golimumab|golimumab|mesh-list
83204115|NCT02456363|Etanercept|etanercept|mesh-list
83204116|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83204117|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204118|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204119|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83204120|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83204121|NCT02456363|Analgesics|analgesics|mesh-ancestor
83204122|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
83204123|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204124|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204125|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204126|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83204127|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
83204128|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204129|NCT03259607|Nicotine|nicotine|mesh-list
83204130|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83204131|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
83204132|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204133|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204134|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83204135|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83204136|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
83204137|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204138|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204139|NCT02456129|Itraconazole|itraconazole|mesh-list
83204140|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
83204141|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204142|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83204143|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83204144|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204145|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204146|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83204147|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
83204148|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204149|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204150|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83204151|NCT03263741|Paclitaxel|paclitaxel|mesh-list
83204152|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83204153|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
83204154|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83204155|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204156|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
83204157|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
83204158|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
83204159|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204160|NCT02456207|Rituximab|rituximab|mesh-list
83204161|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204163|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
83204164|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204165|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204166|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
83204167|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
83204168|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83204169|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
83204170|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204171|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204172|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83204173|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
83204174|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83204175|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83204176|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83204177|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
83204178|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204179|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204180|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
83204181|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83204182|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
83204183|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
83204184|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204185|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204186|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83204187|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83204188|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204189|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204190|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204191|NCT04976673|Triamcinolone|triamcinolone|mesh-list
83204192|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83204193|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83204194|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83204195|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204196|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
83204197|NCT04976673|Hormones|hormones|mesh-ancestor
83204198|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204199|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204200|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83204201|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
83204202|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204203|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204204|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
83204205|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83204206|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83204207|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
83204208|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204209|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204210|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204211|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83204212|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204213|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
83204214|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204215|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204216|NCT03263039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83204217|NCT03263039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204218|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
83204219|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204220|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
83204221|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83204222|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83204223|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204224|NCT03262961|Urological Agents|urological agents|mesh-ancestor
83204225|NCT01670097|Dexamethasone|dexamethasone|mesh-list
83204226|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204227|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
83204228|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
83204229|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204230|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204231|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204232|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
83204233|NCT01670097|Hormones|hormones|mesh-ancestor
83204234|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204235|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83204236|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204237|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
83204238|NCT03257423|Metronidazole|metronidazole|mesh-list
83204239|NCT03257423|Levofloxacin|levofloxacin|mesh-list
83204240|NCT03257423|Ertapenem|ertapenem|mesh-list
83204241|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204242|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204243|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83204244|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83204245|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204246|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204247|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204248|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83204249|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83204250|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83204251|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83204252|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83204253|NCT01670019|Asenapine|asenapine|mesh-list
83204254|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83204255|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83204256|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204257|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204258|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83204259|NCT03262727|Deucravacitinib|deucravacitinib|mesh-list
83204260|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83204261|NCT03262727|Norethindrone|norethindrone|mesh-list
83204262|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
83204263|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83204264|NCT03262727|Estradiol|estradiol|mesh-list
83204265|NCT03262727|Estrogens|estrogens|mesh-ancestor
83204266|NCT03262727|Hormones|hormones|mesh-ancestor
83204267|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204268|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204269|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83204270|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
83204271|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83204272|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83204273|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83204274|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83204275|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83204276|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
83204277|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204278|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204279|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204280|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83204281|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83204282|NCT04975971|Dexamethasone|dexamethasone|mesh-list
83204283|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204284|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
83204285|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
83204286|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204287|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204288|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204289|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
83204291|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204292|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83204293|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204294|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
83204295|NCT03062163|Resveratrol|resveratrol|mesh-list
83204296|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
83204297|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204298|NCT03062163|Protective Agents|protective agents|mesh-ancestor
83204299|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204300|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204301|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83204302|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
83204304|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
83204305|NCT02456597|Lidocaine|lidocaine|mesh-list
83204306|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
83204307|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
83204308|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204309|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204310|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
83204311|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204312|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83204313|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83204314|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83204315|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204316|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204317|NCT03261635|Indomethacin|indomethacin|mesh-list
83204318|NCT03261635|Ranibizumab|ranibizumab|mesh-list
83204319|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83204320|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83204321|NCT03261635|Growth Substances|growth substances|mesh-ancestor
83204322|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204323|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
83204324|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204325|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83204326|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83204327|NCT03261635|Analgesics|analgesics|mesh-ancestor
83204328|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
83204329|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204330|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204331|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204332|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
83204333|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
83204334|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83204335|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83204336|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204337|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204338|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
83204339|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83204340|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83204341|NCT03059979|Prednisolone|prednisolone|mesh-list
83204342|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
83204343|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83204344|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
83204345|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204346|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
83204347|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
83204348|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204349|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204350|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204351|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
83204352|NCT03059979|Hormones|hormones|mesh-ancestor
83204353|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204354|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83204355|NCT03059979|Protective Agents|protective agents|mesh-ancestor
83204356|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83204357|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204358|NCT03256721|Docetaxel|docetaxel|mesh-list
83204359|NCT03256721|Pemetrexed|pemetrexed|mesh-list
83204360|NCT03256721|Apatinib|apatinib|mesh-list
83204361|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204362|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
83204363|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
83204364|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
83204365|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204366|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204367|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83204368|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83204369|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204370|NCT04967859|Gentamicins|gentamicins|mesh-list
83204371|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204372|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204373|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83204374|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204375|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204377|NCT03256487|Buprenorphine|buprenorphine|mesh-list
83204378|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83204379|NCT03256487|Narcotics|narcotics|mesh-ancestor
83204380|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204381|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204382|NCT03256487|Analgesics|analgesics|mesh-ancestor
83204383|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
83204384|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204385|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83204386|NCT03061227|Glucagon|glucagon|mesh-list
83204387|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204388|NCT03061227|Hormones|hormones|mesh-ancestor
83204389|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204390|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204391|NCT03261791|Apatinib|apatinib|mesh-list
83204392|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204393|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204394|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204395|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204396|NCT03643367|Propofol|propofol|mesh-list
83204397|NCT03643367|Sevoflurane|sevoflurane|mesh-list
83204398|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204399|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204400|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204401|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83204402|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
83204403|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
83204404|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83204405|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83204406|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
83204407|NCT03060603|Hematinics|hematinics|mesh-ancestor
83204408|NCT04488107|Letrozole|letrozole|mesh-list
83204409|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204410|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83204411|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83204412|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204413|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204414|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83204415|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
83204416|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204417|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204418|NCT04974723|Teriparatide|teriparatide|mesh-list
83204419|NCT04974723|Abaloparatide|abaloparatide|mesh-list
83204420|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83204421|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204422|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83204423|NCT03060681|Bupivacaine|bupivacaine|mesh-list
83204424|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
83204425|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
83204426|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204427|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204428|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
83204429|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204430|NCT04967469|Calcitriol|calcitriol|mesh-list
83204431|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
83204432|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83204433|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83204434|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204435|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83204436|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204437|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204438|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83204439|NCT04967469|Vitamins|vitamins|mesh-ancestor
83204440|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
83204441|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83204442|NCT03254849|Empagliflozin|empagliflozin|mesh-list
83204443|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83204444|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83204445|NCT03254849|Diuretics|diuretics|mesh-ancestor
83204446|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
83204447|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204448|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83204449|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204450|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204451|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83204452|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83204453|NCT04963881|Antibodies|antibodies|mesh-list
83204454|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
83204455|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204457|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83204458|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
83204459|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
83204460|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204461|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204462|NCT04487951|Vitamin D|vitamin d|mesh-list
83204463|NCT04487951|Vitamins|vitamins|mesh-ancestor
83204464|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
83204465|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204466|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83204467|NCT04963257|Aripiprazole|aripiprazole|mesh-list
83204468|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
83204469|NCT04963257|Sertraline|sertraline|mesh-list
83204470|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
83204471|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83204472|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83204473|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83204474|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204475|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204476|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
83204477|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
83204478|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204479|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204480|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83204481|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83204482|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
83204483|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83204484|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83204485|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83204486|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83204487|NCT04963257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83204488|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83204489|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204490|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83204491|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83204492|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83204493|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83204494|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204495|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83204496|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
83204497|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
83204498|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204499|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
83204500|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204501|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204502|NCT04953741|Fluticasone|fluticasone|mesh-list
83204504|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204505|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83204506|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
83204507|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204508|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204509|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83204510|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
83204511|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
83204512|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83204513|NCT03259919|Metformin|metformin|mesh-list
83204514|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83204515|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204516|NCT04965831|Aflutinib|aflutinib|mesh-list
83204517|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204518|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204519|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204521|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83204522|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204523|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
83204524|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
83204525|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
83204526|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204527|NCT03259529|Rituximab|rituximab|mesh-list
83204528|NCT03259529|Nivolumab|nivolumab|mesh-list
83204529|NCT03259529|Gemcitabine|gemcitabine|mesh-list
83204530|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83204531|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204532|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204533|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
83204534|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204535|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204536|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83204537|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
83204538|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204539|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83204540|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83204541|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
83204542|NCT03252665|Nicorandil|nicorandil|mesh-list
83204543|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
83204544|NCT03252665|Alprostadil|alprostadil|mesh-list
83204545|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
83204546|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83204547|NCT03252665|Urological Agents|urological agents|mesh-ancestor
83204548|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83204549|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83204550|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
83204551|NCT03252665|Vitamins|vitamins|mesh-ancestor
83204552|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
83204553|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204554|NCT03059667|Carboplatin|carboplatin|mesh-list
83204555|NCT03059667|Etoposide|etoposide|mesh-list
83204556|NCT03059667|Atezolizumab|atezolizumab|mesh-list
83204557|NCT03059667|Topotecan|topotecan|mesh-list
83204558|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204559|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83204560|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83204561|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83204562|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204563|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204564|NCT03059667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83204565|NCT03059667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204566|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83204567|NCT03058419|Midazolam|midazolam|mesh-list
83204568|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
83204569|NCT03058419|Caffeine|caffeine|mesh-list
83204570|NCT03058419|Bupropion|bupropion|mesh-list
83204571|NCT03058419|Omeprazole|omeprazole|mesh-list
83204572|NCT03058419|Warfarin|warfarin|mesh-list
83204573|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83204574|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204575|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204576|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204577|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83204578|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83204579|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83204580|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83204581|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
83204583|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
83204584|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
83204585|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204586|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204587|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
83204588|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83204589|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83204590|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204591|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83204592|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83204593|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
83204594|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83204595|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204596|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83204597|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83204598|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
83204599|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83204600|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83204601|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204602|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
83204603|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83204604|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83204605|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
83204606|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
83204607|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83204608|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83204609|NCT04965051|Insulin|insulin|mesh-list
83204610|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83204611|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
83204612|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83204613|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204614|NCT04952571|Bevacizumab|bevacizumab|mesh-list
83204615|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204616|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204617|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83204618|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83204619|NCT04952571|Growth Substances|growth substances|mesh-ancestor
83204620|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204621|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
83204622|NCT02455271|Eszopiclone|eszopiclone|mesh-list
83204623|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204624|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204625|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204626|NCT04964583|Azithromycin|azithromycin|mesh-list
83204627|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
83204628|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204629|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204630|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
83204631|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83204632|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83204633|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204634|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204635|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204636|NCT03251417|Irinotecan|irinotecan|mesh-list
83204637|NCT03251417|Apatinib|apatinib|mesh-list
83204638|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83204639|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83204640|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83420775|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
83204641|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204642|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204643|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204645|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83204646|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204647|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83204648|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204649|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
83204650|NCT02454881|Oxycodone|oxycodone|mesh-list
83204651|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204652|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204653|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204654|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83204655|NCT02454881|Analgesics|analgesics|mesh-ancestor
83204656|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
83204657|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204658|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83204659|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83204660|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83204661|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
83204662|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204663|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204664|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83204665|NCT02454881|Narcotics|narcotics|mesh-ancestor
83204666|NCT03058341|Propofol|propofol|mesh-list
83204667|NCT03058341|Sevoflurane|sevoflurane|mesh-list
83204668|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204669|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204670|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204671|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83204672|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
83204674|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83204675|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83204676|NCT04951791|SMOFlipid|smoflipid|mesh-list
83204677|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83204678|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83204679|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83204680|NCT04951713|Clarithromycin|clarithromycin|mesh-list
83204681|NCT04951713|Rifampin|rifampin|mesh-list
83204682|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204683|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204684|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83204685|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204686|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204687|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83204688|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83204689|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83204690|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
83204691|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
83204692|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83204693|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83204694|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83204695|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83204696|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83204697|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83204698|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83204699|NCT04944069|Bevacizumab|bevacizumab|mesh-list
83204700|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204701|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204702|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83204703|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83204704|NCT04944069|Growth Substances|growth substances|mesh-ancestor
83204705|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204706|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
83204707|NCT04951167|Norepinephrine|norepinephrine|mesh-list
83204708|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83204709|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83204710|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83204711|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204712|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204713|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204714|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
83204715|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
83204716|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204717|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83204718|NCT04950933|Riluzole|riluzole|mesh-list
83204719|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
83204720|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83204721|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83204722|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204723|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204724|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204725|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83204726|NCT04950933|Protective Agents|protective agents|mesh-ancestor
83204727|NCT04961307|Trastuzumab|trastuzumab|mesh-list
83204728|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204729|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204730|NCT03058263|Neostigmine|neostigmine|mesh-list
83204731|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83204732|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204733|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204734|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
83204735|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204736|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204737|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83204738|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
83204739|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204740|NCT04415853|Irinotecan|irinotecan|mesh-list
83204741|NCT04415853|Tegafur|tegafur|mesh-list
83204742|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83204743|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83204744|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204745|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204746|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204747|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83204749|NCT04415151|Tofacitinib|tofacitinib|mesh-list
83204750|NCT04415151|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83204751|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204752|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204753|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204754|NCT03059277|Aflibercept|aflibercept|mesh-list
83204755|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83204756|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83204757|NCT03059277|Growth Substances|growth substances|mesh-ancestor
83204758|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204759|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
83204760|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204761|NCT00700817|Metformin|metformin|mesh-list
83204762|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83204763|NCT00700817|Liraglutide|liraglutide|mesh-list
83204764|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83204766|NCT00700817|Incretins|incretins|mesh-ancestor
83204767|NCT00700817|Hormones|hormones|mesh-ancestor
83204768|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204769|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83204770|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
83204771|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204772|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204773|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83204774|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
83204775|NCT04960293|Coagulants|coagulants|mesh-ancestor
83204776|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83204777|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204778|NCT04941417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204779|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204780|NCT04948125|Apatinib|apatinib|mesh-list
83204781|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204782|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204783|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204784|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204785|NCT02455115|Chromium|chromium|mesh-list
83204786|NCT02455115|Norepinephrine|norepinephrine|mesh-list
83204787|NCT02455115|Edetic Acid|edetic acid|mesh-list
83204788|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
83204789|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83204790|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83204791|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
83204792|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204793|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204794|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204795|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
83204796|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
83204797|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204798|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83204799|NCT02455115|Trace Elements|trace elements|mesh-ancestor
83204800|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
83204801|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
83204802|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83204803|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
83204804|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
83204805|NCT02455115|Antidotes|antidotes|mesh-ancestor
83204806|NCT02455115|Protective Agents|protective agents|mesh-ancestor
83204807|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83204808|NCT03094247|Amoxicillin|amoxicillin|mesh-list
83204809|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204810|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204811|NCT04947423|Scopolamine|scopolamine|mesh-list
83204812|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83204813|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
83204814|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
83204815|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204816|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204817|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204818|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
83204819|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83204820|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
83204821|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204822|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204823|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83204824|NCT03250481|Oxycodone|oxycodone|mesh-list
83204825|NCT03250481|Propofol|propofol|mesh-list
83204826|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204827|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204828|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204829|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83204830|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
83204831|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
83204832|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83204833|NCT03250481|Narcotics|narcotics|mesh-ancestor
83204834|NCT03250481|Analgesics|analgesics|mesh-ancestor
83204835|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
83204836|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204837|NCT04947267|Epinephrine|epinephrine|mesh-list
83204838|NCT04947267|Mepivacaine|mepivacaine|mesh-list
83204839|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83204840|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83204841|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
83204842|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204843|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204844|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204845|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83204846|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83204847|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
83204848|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204849|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83204850|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
83204851|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
83204852|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
83204853|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83204854|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
83204855|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
83204856|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204857|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
83204858|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
83204859|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83204860|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
83204861|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204862|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204863|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83204864|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
83204865|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204866|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204867|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83204868|NCT04423731|Leucovorin|leucovorin|mesh-list
83204869|NCT04423731|Paclitaxel|paclitaxel|mesh-list
83204870|NCT04423731|Gemcitabine|gemcitabine|mesh-list
83204871|NCT04423731|Fluorouracil|fluorouracil|mesh-list
83204872|NCT04423731|Folfirinox|folfirinox|mesh-list
83204873|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83204874|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204875|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
83204876|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
83204877|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
83204878|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204879|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83204880|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
83204881|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83204882|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
83204883|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204884|NCT04423731|Antidotes|antidotes|mesh-ancestor
83204885|NCT04423731|Protective Agents|protective agents|mesh-ancestor
83204886|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
83204887|NCT04423731|Vitamins|vitamins|mesh-ancestor
83204888|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
83204889|NCT04947111|Antibodies|antibodies|mesh-list
83204890|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
83204891|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
83204892|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
83204893|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204894|NCT04947345|Propofol|propofol|mesh-list
83204895|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83204896|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204897|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204898|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83204899|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
83204900|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
83204901|NCT04947189|Dexamethasone|dexamethasone|mesh-list
83204902|NCT04947189|Docetaxel|docetaxel|mesh-list
83204903|NCT04947189|Seviteronel|seviteronel|mesh-list
83204904|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83204905|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
83204906|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
83204907|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204908|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204909|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204910|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
83204911|NCT04947189|Hormones|hormones|mesh-ancestor
83204912|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83204913|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83204914|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204915|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
83204916|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
83204917|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
83204918|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204919|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83204920|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204921|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83204922|NCT03249311|Milnacipran|milnacipran|mesh-list
83204923|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
83204924|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83204925|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83204926|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204927|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204928|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83204929|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204930|NCT03249311|Analgesics|analgesics|mesh-ancestor
83204931|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
83204932|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204933|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
83204934|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83204935|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
83204936|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83204937|NCT04413123|Nivolumab|nivolumab|mesh-list
83204938|NCT04413123|Ipilimumab|ipilimumab|mesh-list
83204939|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204940|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204941|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83204942|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204943|NCT02454491|Verapamil|verapamil|mesh-list
83204944|NCT02454491|Heparin|heparin|mesh-list
83204945|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
83204946|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83204947|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83204948|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204949|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83204950|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83204951|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83204952|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83204953|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204954|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
83204955|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
83204956|NCT03248765|Narcotics|narcotics|mesh-ancestor
83204957|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83204958|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204959|NCT03248765|Analgesics|analgesics|mesh-ancestor
83204960|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
83204961|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83204963|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
83204964|NCT04939779|Delpazolid|delpazolid|mesh-list
83204965|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
83204966|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83204967|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83204968|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83204969|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204970|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204971|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
83204972|NCT03247595|Bisacodyl|bisacodyl|mesh-list
83204973|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83204974|NCT03247595|Cathartics|cathartics|mesh-ancestor
83204975|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83204976|NCT03247595|Laxatives|laxatives|mesh-ancestor
83204977|NCT04938453|Nintedanib|nintedanib|mesh-list
83204978|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204979|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204980|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204981|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204982|NCT03247283|Linrodostat|linrodostat|mesh-list
83204983|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204984|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83204985|NCT04938297|Rituximab|rituximab|mesh-list
83204986|NCT04938297|Lenalidomide|lenalidomide|mesh-list
83204987|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
83204988|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83204989|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83204990|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
83204991|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83204992|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83204993|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83204994|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83204995|NCT04938297|Growth Substances|growth substances|mesh-ancestor
83204996|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
83204997|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83204998|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83204999|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205000|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
83205001|NCT04937907|Benazepril|benazepril|mesh-list
83205002|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
83205003|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83205004|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83205005|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205006|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205007|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205008|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83205009|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83205010|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
83205011|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83205012|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
83205013|NCT02625909|Velpatasvir|velpatasvir|mesh-list
83205014|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
83205015|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205016|NCT03246659|Polygeline|polygeline|mesh-list
83205017|NCT03246659|Gastrins|gastrins|mesh-list
83205018|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
83205019|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
83205020|NCT03246659|Hormones|hormones|mesh-ancestor
83205021|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205022|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205023|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
83205024|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83205025|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
83205026|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205027|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205028|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83205029|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
83205030|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
83205031|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83205032|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
83205033|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205034|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205035|NCT03246113|Temozolomide|temozolomide|mesh-list
83205036|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83205037|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
83205038|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205039|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205040|NCT04937673|Paclitaxel|paclitaxel|mesh-list
83205041|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83205042|NCT04937673|Cisplatin|cisplatin|mesh-list
83205043|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83205044|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205045|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83205046|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83205047|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83205048|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205050|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
83205051|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205052|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
83205053|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205054|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205055|NCT03245177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83205056|NCT03245177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205057|NCT03245333|Hormones|hormones|mesh-list
83205058|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205059|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205060|NCT04958187|Mitogens|mitogens|mesh-list
83205061|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
83205062|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205063|NCT03244319|Warfarin|warfarin|mesh-list
83205064|NCT03244319|Edoxaban|edoxaban|mesh-list
83205065|NCT03244319|Anticoagulants|anticoagulants|mesh-list
83205066|NCT03244319|Coagulants|coagulants|mesh-list
83205067|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83205068|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
83205069|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83205070|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
83205071|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205072|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205073|NCT03244553|Prucalopride|prucalopride|mesh-list
83205074|NCT03244553|Laxatives|laxatives|mesh-ancestor
83205075|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205076|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83205077|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83205078|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
83205079|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205080|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205081|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205082|NCT03244241|Insulin|insulin|mesh-list
83205083|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83205084|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205085|NCT03243851|Metformin|metformin|mesh-list
83205086|NCT03243851|Temozolomide|temozolomide|mesh-list
83205087|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83205088|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205089|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83205090|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
83205091|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205092|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205093|NCT02623959|Doxycycline|doxycycline|mesh-list
83205094|NCT02623959|Fentanyl|fentanyl|mesh-list
83205095|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83205096|NCT02623959|Narcotics|narcotics|mesh-ancestor
83205097|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205098|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205099|NCT02623959|Analgesics|analgesics|mesh-ancestor
83205100|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
83205101|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205102|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83205103|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83205104|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
83205105|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
83205106|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205107|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205108|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
83205109|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83205110|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83205111|NCT03242993|Folic Acid|folic acid|mesh-list
83205112|NCT03242993|Hematinics|hematinics|mesh-ancestor
83205113|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
83205114|NCT03242993|Vitamins|vitamins|mesh-ancestor
83205115|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
83205116|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205117|NCT04487093|Vaccines|vaccines|mesh-list
83205118|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
83205119|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205120|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
83205121|NCT04936971|Everolimus|everolimus|mesh-list
83205122|NCT04936971|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83205123|NCT04936971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83205124|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205125|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205126|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205127|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
83205128|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205129|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205130|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83205131|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83205132|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
83205133|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205134|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205135|NCT04931433|Lidocaine|lidocaine|mesh-list
83205136|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
83205137|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
83205138|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205139|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205140|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
83205141|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205142|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83205143|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83205144|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83205145|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205146|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205147|NCT04931121|Viscosupplements|viscosupplements|mesh-list
83205148|NCT04931121|Protective Agents|protective agents|mesh-ancestor
83205149|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205150|NCT03241901|Lumefantrine|lumefantrine|mesh-list
83205151|NCT03241901|Artemether|artemether|mesh-list
83205152|NCT03241901|Primaquine|primaquine|mesh-list
83205153|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83205154|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
83205155|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83205156|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83205157|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205158|NCT03241745|Nivolumab|nivolumab|mesh-list
83205159|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205160|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205161|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83205162|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205163|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
83205164|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205165|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83205166|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205167|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205168|NCT03241043|Tacrolimus|tacrolimus|mesh-list
83205169|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205170|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
83205171|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205172|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83205173|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205174|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205175|NCT02453867|Tacrolimus|tacrolimus|mesh-list
83205176|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205177|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
83205178|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205179|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83205180|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205181|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205182|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83205183|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
83205184|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
83205185|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205186|NCT03239327|Alprostadil|alprostadil|mesh-list
83205187|NCT03239327|Misoprostol|misoprostol|mesh-list
83205188|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83205189|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
83205190|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83205191|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205192|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83205193|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205194|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
83205195|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83205196|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
83205197|NCT03239327|Urological Agents|urological agents|mesh-ancestor
83205198|NCT04930185|Vaccines|vaccines|mesh-list
83205199|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
83205200|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205201|NCT02314559|Propofol|propofol|mesh-list
83205202|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83205203|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205204|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205205|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83205206|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
83205207|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
83205208|NCT03238703|Tamoxifen|tamoxifen|mesh-list
83205209|NCT03238703|Toremifene|toremifene|mesh-list
83205210|NCT03238703|Letrozole|letrozole|mesh-list
83205211|NCT03238703|Anastrozole|anastrozole|mesh-list
83205212|NCT03238703|Exemestane|exemestane|mesh-list
83205213|NCT03238703|Citric Acid|citric acid|mesh-list
83205214|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
83205215|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
83205216|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83205217|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
83205218|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
83205219|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205220|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205221|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83205222|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83205223|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205224|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83205225|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
83205226|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205227|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205228|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83205229|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83205230|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83205231|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83205232|NCT03238625|Lidocaine|lidocaine|mesh-list
83205233|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
83205234|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
83205235|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205236|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205237|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
83205238|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205239|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83205240|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83205241|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83205242|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205243|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205244|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
83205245|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83205246|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
83205247|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205248|NCT05387681|Endostatins|endostatins|mesh-list
83205249|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205250|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83205251|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83205252|NCT05387681|Growth Substances|growth substances|mesh-ancestor
83205253|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205254|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83205255|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83205256|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205257|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
83205258|NCT03238157|Hormones|hormones|mesh-ancestor
83205259|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205260|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205261|NCT04485845|Metformin|metformin|mesh-list
83205262|NCT04485845|Vildagliptin|vildagliptin|mesh-list
83205263|NCT04485845|Captopril|captopril|mesh-list
83205264|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83205265|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205266|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83205267|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
83205268|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205269|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205270|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83205271|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83205272|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83205273|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83205274|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83205275|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205276|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205277|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
83205278|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205279|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205281|NCT03237533|Doxycycline|doxycycline|mesh-list
83205282|NCT03237533|Nystatin|nystatin|mesh-list
83205283|NCT03237533|Dexamethasone|dexamethasone|mesh-list
83205284|NCT03237533|Triamcinolone|triamcinolone|mesh-list
83205285|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205286|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
83205287|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
83205288|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205289|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205290|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205291|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
83205292|NCT03237533|Hormones|hormones|mesh-ancestor
83205293|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205294|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83205295|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83430109|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83205296|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205297|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205298|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205299|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
83205300|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83205301|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83205302|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
83205303|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
83205304|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83205305|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
83205306|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
83205307|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205308|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83205309|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
83205310|NCT03237533|Ionophores|ionophores|mesh-ancestor
83205311|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205312|NCT03235973|Fludarabine|fludarabine|mesh-list
83205313|NCT03235973|Busulfan|busulfan|mesh-list
83205314|NCT03235973|Cladribine|cladribine|mesh-list
83205315|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205316|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205317|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205318|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
83205319|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205320|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
83205321|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83205322|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83205323|NCT02453087|Rituximab|rituximab|mesh-list
83205324|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
83205325|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205326|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205327|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
83205328|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205329|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83205330|NCT02124772|Trametinib|trametinib|mesh-list
83205331|NCT02124772|Dabrafenib|dabrafenib|mesh-list
83205332|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205333|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83205334|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205335|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205336|NCT02159482|Interferons|interferons|mesh-list
83205337|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
83205338|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
83205339|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205340|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
83205341|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205342|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
83205343|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205344|NCT05269030|Ivermectin|ivermectin|mesh-list
83205345|NCT05269030|Budesonide|budesonide|mesh-list
83205346|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205347|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83205348|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
83205349|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205350|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205351|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83205352|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
83205353|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
83205355|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205356|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83205357|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205358|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
83205359|NCT02622321|Coagulants|coagulants|mesh-ancestor
83205360|NCT02187172|Ustekinumab|ustekinumab|mesh-list
83205361|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
83205362|NCT03057015|Dexamethasone|dexamethasone|mesh-list
83205363|NCT03057015|Clonidine|clonidine|mesh-list
83205364|NCT03057015|Epinephrine|epinephrine|mesh-list
83205365|NCT03057015|Ropivacaine|ropivacaine|mesh-list
83205366|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205367|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
83205368|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
83205369|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205370|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205371|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205372|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
83205373|NCT03057015|Hormones|hormones|mesh-ancestor
83205374|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205375|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83205376|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205377|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
83205378|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
83205379|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205380|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
83205381|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83205382|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83205383|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
83205384|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205385|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205386|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83205387|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83205388|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83205389|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
83205390|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
83205391|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
83205392|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83205393|NCT03057015|Analgesics|analgesics|mesh-ancestor
83205394|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83205395|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
83205396|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83205397|NCT04934475|Lenalidomide|lenalidomide|mesh-list
83205398|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
83205399|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205400|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83205401|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83205402|NCT04934475|Growth Substances|growth substances|mesh-ancestor
83205403|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
83205404|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205405|NCT03057483|Vaccines|vaccines|mesh-list
83205406|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
83205407|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205408|NCT04922151|Ranibizumab|ranibizumab|mesh-list
83205409|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83205410|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83205411|NCT04922151|Growth Substances|growth substances|mesh-ancestor
83205412|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205413|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
83205414|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205415|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
83205416|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
83205417|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83205418|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
83205419|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205420|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205421|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83205422|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
83205423|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83205425|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205426|NCT04927299|Losartan|losartan|mesh-list
83205427|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83205428|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
83205429|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83205430|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83205431|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83205432|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83205433|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205434|NCT04927299|Diuretics|diuretics|mesh-ancestor
83205435|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
83205436|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205437|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83205438|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205439|NCT03056625|Vitamin A|vitamin a|mesh-list
83205440|NCT03056625|Vitamins|vitamins|mesh-ancestor
83205441|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
83205442|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205443|NCT04913103|Rituximab|rituximab|mesh-list
83205444|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83205445|NCT04913103|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83205446|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205447|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205448|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
83205449|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205450|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83205451|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83205452|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
83205453|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205454|NCT04913103|Immunoconjugates|immunoconjugates|mesh-ancestor
83205455|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
83205456|NCT04920669|Bupivacaine|bupivacaine|mesh-list
83205457|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
83205458|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
83205459|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205460|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205461|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
83205462|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205463|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83205464|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83205465|NCT04920669|Analgesics|analgesics|mesh-ancestor
83205466|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83205467|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83205468|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83205469|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
83205470|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205471|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205472|NCT04926753|Fluorouracil|fluorouracil|mesh-list
83205473|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205474|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
83205475|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205476|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83205477|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205478|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
83205479|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205480|NCT02621931|Calcitonin|calcitonin|mesh-list
83205481|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83205482|NCT02621931|Katacalcin|katacalcin|mesh-list
83205483|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83205484|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205485|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83205486|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
83205487|NCT04925973|Tofacitinib|tofacitinib|mesh-list
83205488|NCT04925973|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83205489|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83205490|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205491|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205492|NCT04400175|Silicon|silicon|mesh-list
83205493|NCT04400175|Trace Elements|trace elements|mesh-ancestor
83205494|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
83205495|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205496|NCT04912167|Valsartan|valsartan|mesh-list
83205497|NCT04912167|Enalapril|enalapril|mesh-list
83205498|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83205499|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83205500|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83205501|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83205502|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205503|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83205504|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83205505|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205506|NCT03056703|Aspirin|aspirin|mesh-list
83205507|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83205508|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83205509|NCT03056703|Analgesics|analgesics|mesh-ancestor
83205510|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
83205511|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205512|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205513|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205514|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83205515|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83205516|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83205517|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205518|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83205519|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83205520|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205521|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
83205522|NCT02158936|Azacitidine|azacitidine|mesh-list
83205523|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83205524|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
83205525|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205526|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205527|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205528|NCT04924647|Dexamethasone|dexamethasone|mesh-list
83205529|NCT04924647|Lenalidomide|lenalidomide|mesh-list
83205530|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205531|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
83205532|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
83205533|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205535|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205536|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
83205537|NCT04924647|Hormones|hormones|mesh-ancestor
83205538|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205539|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83205540|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205541|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
83205542|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83205543|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83205544|NCT04924647|Growth Substances|growth substances|mesh-ancestor
83205545|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
83205546|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
83205547|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83205548|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
83205549|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205550|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205551|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83205552|NCT04912011|Diuretics|diuretics|mesh-ancestor
83205553|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
83205554|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
83205555|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83205556|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
83205557|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205558|NCT04918719|Expectorants|expectorants|mesh-ancestor
83205559|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
83205560|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83205561|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
83205562|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205563|NCT04918719|Protective Agents|protective agents|mesh-ancestor
83205564|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205565|NCT04918719|Antidotes|antidotes|mesh-ancestor
83205566|NCT03056391|Acetaminophen|acetaminophen|mesh-list
83205567|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83205568|NCT03056391|Analgesics|analgesics|mesh-ancestor
83205569|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
83205570|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205571|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205572|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
83205573|NCT04924413|Tislelizumab|tislelizumab|mesh-list
83205574|NCT04924413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205575|NCT04924413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205576|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
83205577|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205578|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205579|NCT04747054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83205580|NCT04747054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205581|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
83205582|NCT04918563|Acetylcholine|acetylcholine|mesh-list
83205583|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
83205584|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83205585|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
83205586|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205587|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205588|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205589|NCT02123446|Cephalexin|cephalexin|mesh-list
83205590|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205591|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205592|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
83205593|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83205594|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83205595|NCT04918953|Prednisolone|prednisolone|mesh-list
83205596|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
83205597|NCT04918953|Budesonide|budesonide|mesh-list
83205598|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83205599|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
83205600|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205601|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
83205602|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
83205603|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205604|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205605|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205606|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
83205607|NCT04918953|Hormones|hormones|mesh-ancestor
83205608|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205609|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83205610|NCT04918953|Protective Agents|protective agents|mesh-ancestor
83205611|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83205612|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205613|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83205614|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83205615|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
83205616|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
83205617|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83205618|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205619|NCT03054207|Clopidogrel|clopidogrel|mesh-list
83205620|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83205621|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83205622|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83205623|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83205624|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83205625|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
83205626|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205627|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205628|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205629|NCT02185534|Clopidogrel|clopidogrel|mesh-list
83205630|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83205631|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83205632|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83205633|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83205634|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
83205635|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205636|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205637|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205638|NCT03056079|Aflibercept|aflibercept|mesh-list
83205639|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83205640|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83205641|NCT03056079|Growth Substances|growth substances|mesh-ancestor
83205642|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205643|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
83205644|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205645|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83205646|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83205647|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83205648|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205649|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205650|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83205651|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205652|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205653|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
83205654|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205655|NCT02157376|Esomeprazole|esomeprazole|mesh-list
83205656|NCT02157376|Cimetidine|cimetidine|mesh-list
83205657|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83205658|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205659|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83205660|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205661|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205663|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
83205664|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
83205665|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205666|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205667|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83205668|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83205669|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83205670|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205671|NCT04922541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205672|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205673|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
83205674|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83205675|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205676|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83205677|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205678|NCT03054285|Levetiracetam|levetiracetam|mesh-list
83205679|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
83205680|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
83205681|NCT04917627|Vancomycin|vancomycin|mesh-list
83205682|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205683|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205684|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
83205685|NCT04903743|Bupivacaine|bupivacaine|mesh-list
83205686|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
83205687|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
83205688|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205689|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205690|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
83205691|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205692|NCT04903743|Analgesics|analgesics|mesh-ancestor
83205693|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83205694|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
83205695|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83205696|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205697|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205698|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83205699|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
83205700|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83205701|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
83205702|NCT04903275|Fluorides|fluorides|mesh-list
83205703|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
83205704|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
83205705|NCT04903275|Protective Agents|protective agents|mesh-ancestor
83205706|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205707|NCT02121262|Dexamethasone|dexamethasone|mesh-list
83205708|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205709|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
83205710|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
83205711|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205712|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205713|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83205714|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
83205715|NCT02121262|Hormones|hormones|mesh-ancestor
83205716|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205717|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83205718|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205719|NCT03053739|Bosentan|bosentan|mesh-list
83205720|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
83205721|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
83205722|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83205723|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83205724|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205725|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205726|NCT03053739|Urological Agents|urological agents|mesh-ancestor
83205727|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83205728|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83205729|NCT04916925|Vitamin D|vitamin d|mesh-list
83205730|NCT04916925|Vitamins|vitamins|mesh-ancestor
83205731|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
83205732|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205733|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83205734|NCT04902261|Paclitaxel|paclitaxel|mesh-list
83205735|NCT04902261|Gemcitabine|gemcitabine|mesh-list
83205736|NCT04902261|Tislelizumab|tislelizumab|mesh-list
83205737|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83205738|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205739|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
83205740|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
83205741|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
83205742|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205743|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83205744|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
83205745|NCT04902261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205746|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
83205747|NCT04902027|Analgesics|analgesics|mesh-ancestor
83205748|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
83205749|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205750|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205751|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205752|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83205753|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83205754|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205755|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205756|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
83205757|NCT04902105|Valproic Acid|valproic acid|mesh-list
83205758|NCT04902105|Ecopipam|ecopipam|mesh-list
83205759|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
83205760|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205761|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205762|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
83205763|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205764|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205765|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
83205766|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83205767|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205768|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83205769|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83205770|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83205771|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
83205772|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83205773|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83205774|NCT04902105|Analgesics|analgesics|mesh-ancestor
83205775|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
83205776|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205777|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83205778|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83205779|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83205780|NCT02120950|Aflibercept|aflibercept|mesh-list
83205781|NCT02120950|Verteporfin|verteporfin|mesh-list
83205782|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83205783|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83205784|NCT02120950|Growth Substances|growth substances|mesh-ancestor
83205785|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205786|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
83205787|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205789|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83205791|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83205792|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205793|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
83205794|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
83205795|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83205796|NCT04900311|Paclitaxel|paclitaxel|mesh-list
83205797|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83205798|NCT04900311|Trastuzumab|trastuzumab|mesh-list
83205799|NCT04900311|Pertuzumab|pertuzumab|mesh-list
83205800|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83205801|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205802|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
83205803|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83205804|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
83205805|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205806|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205807|NCT04900155|Atorvastatin|atorvastatin|mesh-list
83205808|NCT04900155|Ezetimibe|ezetimibe|mesh-list
83205809|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83205810|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83205811|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
83205812|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205813|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83205814|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83205815|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205816|NCT02155738|Acetaminophen|acetaminophen|mesh-list
83205817|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83205818|NCT02155738|Analgesics|analgesics|mesh-ancestor
83205819|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
83205820|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205821|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205822|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
83205823|NCT03053505|Vancomycin|vancomycin|mesh-list
83205824|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
83205825|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205826|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205827|NCT02181790|Acitretin|acitretin|mesh-list
83205828|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
83205829|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
83205830|NCT03051945|Ketamine|ketamine|mesh-list
83205831|NCT03051945|Analgesics|analgesics|mesh-ancestor
83205832|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
83205833|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205834|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205835|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83205836|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83205837|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
83205838|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
83205839|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205840|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83205841|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83205842|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83205843|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205844|NCT04899765|Vaccines|vaccines|mesh-list
83205845|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
83205846|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
83205847|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205848|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83205849|NCT04899453|Rituximab|rituximab|mesh-list
83205850|NCT04899453|Methotrexate|methotrexate|mesh-list
83205851|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
83205852|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205853|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205854|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
83205855|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205856|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83205857|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83205858|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
83205859|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83205860|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83205861|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
83205862|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205863|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
83205864|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205865|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83205866|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205867|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83205868|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83205869|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83205870|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83205871|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205872|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
83205873|NCT04898751|Nivolumab|nivolumab|mesh-list
83205874|NCT04898751|Ipilimumab|ipilimumab|mesh-list
83205875|NCT04898751|Atezolizumab|atezolizumab|mesh-list
83205876|NCT04898751|Durvalumab|durvalumab|mesh-list
83205877|NCT04898751|Avelumab|avelumab|mesh-list
83205878|NCT04898751|Cemiplimab|cemiplimab|mesh-list
83205879|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83205880|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205881|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205882|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205883|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
83205884|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83205885|NCT04898907|Mitogens|mitogens|mesh-list
83205886|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205887|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205888|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83205889|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83205890|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205891|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205892|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205893|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83205894|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
83205895|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83205896|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205897|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83205898|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83205899|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83205900|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
83205901|NCT04908813|Capecitabine|capecitabine|mesh-list
83205902|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
83205903|NCT04908813|Trastuzumab|trastuzumab|mesh-list
83205904|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83205905|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
83205906|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205907|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205908|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205909|NCT04913571|Tislelizumab|tislelizumab|mesh-list
83205910|NCT04913571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83205911|NCT04913571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205912|NCT03051711|Pyrazole|pyrazole|mesh-list
83205913|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205914|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205915|NCT04908345|Fentanyl|fentanyl|mesh-list
83205916|NCT04908345|Methadone|methadone|mesh-list
83205917|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83205918|NCT04908345|Narcotics|narcotics|mesh-ancestor
83205919|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205920|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205921|NCT04908345|Analgesics|analgesics|mesh-ancestor
83205922|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
83205923|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83205924|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83205925|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83205926|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
83205927|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
83205928|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
83205929|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
83205930|NCT04893993|Thiamine|thiamine|mesh-list
83205931|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
83205932|NCT04893993|Vitamins|vitamins|mesh-ancestor
83205933|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
83205934|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205935|NCT03051243|Insulin|insulin|mesh-list
83205936|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83205937|NCT03051243|Linagliptin|linagliptin|mesh-list
83205938|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83205939|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205940|NCT03051243|Incretins|incretins|mesh-ancestor
83205941|NCT03051243|Hormones|hormones|mesh-ancestor
83205942|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205943|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83205944|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
83205945|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205946|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205947|NCT04897737|Tenofovir|tenofovir|mesh-list
83205948|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
83205949|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205950|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83205951|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83205952|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205953|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205954|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83205955|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83205956|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
83205957|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83205958|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83205959|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205960|NCT04897269|Progesterone|progesterone|mesh-list
83205961|NCT04897269|Progestins|progestins|mesh-ancestor
83205962|NCT04897269|Hormones|hormones|mesh-ancestor
83205963|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83205964|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205965|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83205966|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
83205967|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205968|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
83205969|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205970|NCT04896177|Sirolimus|sirolimus|mesh-list
83205971|NCT04896177|Paclitaxel|paclitaxel|mesh-list
83205972|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83205973|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83205974|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83205975|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83205976|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83205977|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205978|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83205979|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83205980|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83205981|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
83205982|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83205983|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
83205984|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205985|NCT03052569|Agerafenib|agerafenib|mesh-list
83205986|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83205987|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83205988|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83205989|NCT04906317|Midazolam|midazolam|mesh-list
83205990|NCT04906317|Dezocine|dezocine|mesh-list
83205991|NCT04906317|Propofol|propofol|mesh-list
83205992|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83205993|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83205994|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83205995|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83205996|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
83205997|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
83205998|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83205999|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83206000|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83206001|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83206002|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
83206003|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
83206004|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206005|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206006|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83206007|NCT04906317|Narcotics|narcotics|mesh-ancestor
83206008|NCT04906317|Analgesics|analgesics|mesh-ancestor
83206009|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
83206010|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206011|NCT03051087|Ganirelix|ganirelix|mesh-list
83206012|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
83206013|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206014|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206015|NCT04430361|Dexamethasone|dexamethasone|mesh-list
83206017|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
83206018|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206019|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
83206020|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
83206021|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206022|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206023|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206024|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
83206025|NCT04430361|Hormones|hormones|mesh-ancestor
83206026|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206027|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206028|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206029|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83206030|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83206031|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83206032|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
83206033|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83206034|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83206035|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83206036|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
83206037|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83206038|NCT04906083|Mitogens|mitogens|mesh-list
83206039|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206040|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206041|NCT02616783|Lamivudine|lamivudine|mesh-list
83206042|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83206043|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83206044|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206045|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206046|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
83206047|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206048|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83206049|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83206050|NCT04895007|Vaccines|vaccines|mesh-list
83206051|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
83206052|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206053|NCT04890561|Lemborexant|lemborexant|mesh-list
83206054|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83206055|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206056|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206057|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83206058|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206059|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206060|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206061|NCT04894617|Amantadine|amantadine|mesh-list
83206062|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83206063|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83206064|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
83206065|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206066|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
83206067|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206068|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206069|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206070|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83206071|NCT04894617|Analgesics|analgesics|mesh-ancestor
83206072|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
83206073|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206074|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83206075|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83206076|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
83206077|NCT04398537|Hormones|hormones|mesh-ancestor
83206078|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206079|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206080|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206081|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206082|NCT04397991|Furosemide|furosemide|mesh-list
83206083|NCT04397991|Diuretics|diuretics|mesh-ancestor
83206084|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
83206085|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206086|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83206087|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83206088|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206089|NCT04906161|Vitamin D|vitamin d|mesh-list
83206090|NCT04906161|Calcium|calcium|mesh-list
83206091|NCT04906161|Vitamins|vitamins|mesh-ancestor
83206092|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
83206093|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206094|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83206095|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83206096|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83206097|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
83206098|NCT03051009|Coagulants|coagulants|mesh-ancestor
83206099|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83206100|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
83206101|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206102|NCT04889781|Dexamethasone|dexamethasone|mesh-list
83206103|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
83206104|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206105|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
83206106|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
83206107|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206108|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206109|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206110|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
83206111|NCT04889781|Hormones|hormones|mesh-ancestor
83206112|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206113|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206114|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206115|NCT02616393|XL647|xl647|mesh-list
83206116|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206117|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83206118|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206119|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206120|NCT04905147|Mosapride|mosapride|mesh-list
83206121|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206122|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83206123|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
83206124|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206125|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206126|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206127|NCT03050229|Empagliflozin|empagliflozin|mesh-list
83206128|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83206129|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206130|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83206131|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206132|NCT04882683|Prednisone|prednisone|mesh-list
83206133|NCT04882683|Adalimumab|adalimumab|mesh-list
83206134|NCT04882683|Azathioprine|azathioprine|mesh-list
83206135|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206136|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
83206137|NCT04882683|Hormones|hormones|mesh-ancestor
83206138|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206139|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206140|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206141|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206142|NCT04882683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83206143|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83206144|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
83206145|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206146|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83206147|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83206148|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
83206149|NCT02155660|Benralizumab|benralizumab|mesh-list
83206150|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83206151|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
83206152|NCT04753372|Aspirin|aspirin|mesh-list
83206153|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
83206154|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83206155|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
83206156|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83206157|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
83206158|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206159|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206160|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
83206161|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83206162|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83206163|NCT04753372|Analgesics|analgesics|mesh-ancestor
83206164|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
83206165|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206166|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206167|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206168|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83206169|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83206170|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83206171|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83206172|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83206173|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
83206174|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83206175|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83206176|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83206177|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
83206178|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206179|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83206180|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83206181|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206182|NCT04880811|Afatinib|afatinib|mesh-list
83206183|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206184|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83206185|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206186|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206187|NCT02181634|Paclitaxel|paclitaxel|mesh-list
83206188|NCT02181634|Gemcitabine|gemcitabine|mesh-list
83206189|NCT02181634|Antimetabolites|antimetabolites|mesh-list
83206190|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83206191|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206192|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
83206193|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
83206194|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206195|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206196|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83206197|NCT04569045|Lidocaine|lidocaine|mesh-list
83206198|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
83206199|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
83206200|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206201|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206202|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
83206203|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206204|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83206205|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83206206|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83206207|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83206208|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206209|NCT04425291|Vaccines|vaccines|mesh-list
83206210|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
83206211|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206212|NCT04879407|Warfarin|warfarin|mesh-list
83206213|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
83206214|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
83206215|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83206216|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
83206217|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83206218|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
83206219|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206220|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206221|NCT04886193|Leucovorin|leucovorin|mesh-list
83206222|NCT04886193|Docetaxel|docetaxel|mesh-list
83206223|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
83206224|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206225|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
83206226|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
83206227|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206228|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206229|NCT04886193|Antidotes|antidotes|mesh-ancestor
83206230|NCT04886193|Protective Agents|protective agents|mesh-ancestor
83206231|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206232|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
83206233|NCT04886193|Vitamins|vitamins|mesh-ancestor
83206234|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
83206235|NCT04337073|Propofol|propofol|mesh-list
83206236|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206237|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206238|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206239|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83206240|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
83206241|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
83206242|NCT04885803|Vitamin D|vitamin d|mesh-list
83206243|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
83206244|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
83206245|NCT04885803|Vitamins|vitamins|mesh-list
83206246|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
83206247|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206248|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83206249|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83206250|NCT03049059|Hydroquinone|hydroquinone|mesh-list
83206251|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
83206252|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206253|NCT03049059|Protective Agents|protective agents|mesh-ancestor
83206254|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206255|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83206256|NCT04885413|Niraparib|niraparib|mesh-list
83206257|NCT04885413|Antibodies|antibodies|mesh-list
83206258|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
83206259|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206260|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83206261|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206262|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206263|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206264|NCT03049293|Midazolam|midazolam|mesh-list
83206265|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83206266|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206267|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206268|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206269|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83206270|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83206271|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83206272|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83206273|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
83206274|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
83206275|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
83206276|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
83206277|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206278|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206279|NCT01595529|Trimethoprim|trimethoprim|mesh-list
83206280|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
83206281|NCT01595529|Cephalexin|cephalexin|mesh-list
83206282|NCT01595529|Cefixime|cefixime|mesh-list
83206283|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83206284|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206285|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
83206286|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83206287|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83206288|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83206289|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206290|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206291|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83206292|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83206293|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83206294|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83206295|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
83206296|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206297|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
83206298|NCT04147533|Dasatinib|dasatinib|mesh-list
83206299|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206300|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83206301|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206302|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206303|NCT05257395|Letrozole|letrozole|mesh-list
83206304|NCT05257395|Anastrozole|anastrozole|mesh-list
83206305|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206306|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83206307|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83206308|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206309|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206310|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83206311|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
83206312|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206313|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206314|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206315|NCT05256693|Vancomycin|vancomycin|mesh-list
83206316|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83206317|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206318|NCT03046953|Avelumab|avelumab|mesh-list
83206319|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83206320|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206321|NCT03047109|Phenylephrine|phenylephrine|mesh-list
83206322|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
83206323|NCT03047109|Ephedrine|ephedrine|mesh-list
83206324|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83206325|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
83206326|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
83206327|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206328|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206329|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
83206330|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83206331|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
83206332|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
83206333|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83206334|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83206335|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83206336|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
83206337|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206338|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206339|NCT03047109|Protective Agents|protective agents|mesh-ancestor
83206340|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83206341|NCT03047265|Paclitaxel|paclitaxel|mesh-list
83206342|NCT03047265|Cisplatin|cisplatin|mesh-list
83206343|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83206344|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206345|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
83206346|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
83206347|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206348|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206349|NCT05256147|Ibuprofen|ibuprofen|mesh-list
83206350|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83206351|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83206352|NCT05256147|Analgesics|analgesics|mesh-ancestor
83206353|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
83206354|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206355|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206356|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206357|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83206358|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83206359|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206360|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206361|NCT05255913|Fluorides|fluorides|mesh-list
83206362|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
83206363|NCT05255913|Protective Agents|protective agents|mesh-ancestor
83206364|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206365|NCT05214417|Ketamine|ketamine|mesh-list
83206366|NCT05214417|Analgesics|analgesics|mesh-ancestor
83206367|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
83206368|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206369|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206370|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83206371|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83206372|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
83206373|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
83206374|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206375|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83206376|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83206377|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206378|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206379|NCT04870671|Tenofovir|tenofovir|mesh-list
83206380|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
83206381|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206382|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83206383|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83206384|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206385|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206386|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83206387|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83206388|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
83206389|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83206390|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206391|NCT04387461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83206392|NCT04387461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206393|NCT03046719|Bupivacaine|bupivacaine|mesh-list
83206394|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
83206395|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
83206396|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206397|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206398|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
83206399|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206400|NCT04876755|TEMPO|tempo|mesh-list
83206401|NCT04876755|TEMPOL-H|tempol-h|mesh-list
83206402|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
83206403|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206404|NCT04876755|Protective Agents|protective agents|mesh-ancestor
83206405|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206406|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83206407|NCT04876521|Olanzapine|olanzapine|mesh-list
83206408|NCT04876521|Amisulpride|amisulpride|mesh-list
83206409|NCT04876521|Fluoxetine|fluoxetine|mesh-list
83206410|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
83206411|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
83206412|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206413|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206414|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206415|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83206416|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83206417|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206418|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83206419|NCT04876521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83206420|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83206421|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83206422|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206423|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206424|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
83206425|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83206426|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
83206427|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83206428|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83206429|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206430|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83206431|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
83206432|NCT02119156|Belimumab|belimumab|mesh-list
83206433|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83206434|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
83206435|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206436|NCT02181556|Aflibercept|aflibercept|mesh-list
83206437|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83206438|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83206439|NCT02181556|Growth Substances|growth substances|mesh-ancestor
83206440|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206441|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
83206442|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206443|NCT04865991|Propofol|propofol|mesh-list
83206444|NCT04865991|Sevoflurane|sevoflurane|mesh-list
83206445|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206446|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206447|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206448|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83206449|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
83206450|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
83206451|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83206452|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83206453|NCT04870203|Adalimumab|adalimumab|mesh-list
83206454|NCT04870203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83206455|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206456|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83206457|NCT04865211|Bupivacaine|bupivacaine|mesh-list
83206458|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
83206459|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
83206460|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206461|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206462|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
83206463|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206465|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83206466|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206467|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206468|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206469|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83206470|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83206471|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83206472|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83206473|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
83206474|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
83206475|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
83206476|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
83206477|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206478|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206479|NCT04875819|Vaccines|vaccines|mesh-list
83206480|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83206481|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
83206482|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206483|NCT04864977|Insulin|insulin|mesh-list
83206484|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83206485|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206486|NCT03046173|Mitogens|mitogens|mesh-list
83206487|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206488|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206489|NCT04869579|Selenium|selenium|mesh-list
83206490|NCT04869579|Selenious Acid|selenious acid|mesh-list
83206491|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
83206492|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206493|NCT04869579|Protective Agents|protective agents|mesh-ancestor
83206494|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206495|NCT04869579|Trace Elements|trace elements|mesh-ancestor
83206496|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
83206497|NCT03235037|Levodopa|levodopa|mesh-list
83206498|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83206499|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83206500|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
83206501|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206502|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206503|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206504|NCT00700271|Amlodipine|amlodipine|mesh-list
83206505|NCT00700271|Valsartan|valsartan|mesh-list
83206506|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83206507|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83206508|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83206509|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206510|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83206511|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206512|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
83206513|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83206514|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83206515|NCT02613507|Docetaxel|docetaxel|mesh-list
83206516|NCT02613507|Nivolumab|nivolumab|mesh-list
83206517|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206518|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
83206519|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
83206520|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206521|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206522|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83206523|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83206524|NCT03228797|Ropivacaine|ropivacaine|mesh-list
83206525|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
83206526|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
83206527|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206528|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206529|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
83206530|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206531|NCT03044379|Dapivirine|dapivirine|mesh-list
83206532|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83206533|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83206534|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
83206535|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206536|NCT04864509|Melatonin|melatonin|mesh-list
83206537|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
83206538|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206539|NCT04864509|Protective Agents|protective agents|mesh-ancestor
83206540|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206541|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206542|NCT04875039|Dexamethasone|dexamethasone|mesh-list
83206543|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
83206544|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
83206545|NCT04875039|BB 1101|bb 1101|mesh-list
83206546|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206547|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
83206548|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
83206549|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206550|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206551|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206553|NCT04875039|Hormones|hormones|mesh-ancestor
83206554|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206555|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206556|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206557|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
83206558|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206559|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206560|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206561|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206562|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83206563|NCT04875039|Analgesics|analgesics|mesh-ancestor
83206564|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
83206565|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83206566|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83206567|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83206568|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
83206569|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206570|NCT02452385|Vorolanib|vorolanib|mesh-list
83206571|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83206572|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206573|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206574|NCT03045783|Cefotiam|cefotiam|mesh-list
83206575|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83206576|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206577|NCT01375049|Aztreonam|aztreonam|mesh-list
83206578|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83206579|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206580|NCT04146207|Prednisone|prednisone|mesh-list
83206581|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206582|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
83206583|NCT04146207|Hormones|hormones|mesh-ancestor
83206584|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206585|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206586|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206587|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206588|NCT04863807|Anesthetics|anesthetics|mesh-list
83206589|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206590|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206591|NCT02452307|Imiquimod|imiquimod|mesh-list
83206592|NCT02452307|Molgramostim|molgramostim|mesh-list
83206593|NCT02452307|Protamines|protamines|mesh-list
83206595|NCT02452307|Sargramostim|sargramostim|mesh-list
83206596|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83206597|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
83206598|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206599|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206600|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
83206601|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
83206602|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206603|NCT02452307|Coagulants|coagulants|mesh-ancestor
83206604|NCT02452151|Infliximab|infliximab|mesh-list
83206605|NCT02452151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83206606|NCT02452151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206607|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
83206608|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206609|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83206610|NCT04485299|Listerine|listerine|mesh-list
83206611|NCT04485299|Fluorides|fluorides|mesh-list
83206612|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
83206613|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
83206614|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
83206615|NCT04485299|Protective Agents|protective agents|mesh-ancestor
83206616|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206617|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83206618|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206619|NCT01594749|Dexamethasone|dexamethasone|mesh-list
83206620|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
83206621|NCT01594749|Ondansetron|ondansetron|mesh-list
83206622|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
83206623|NCT01594749|Aprepitant|aprepitant|mesh-list
83206624|NCT01594749|BB 1101|bb 1101|mesh-list
83206625|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206626|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
83206627|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
83206628|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206629|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206630|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206631|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
83206632|NCT01594749|Hormones|hormones|mesh-ancestor
83206633|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206634|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206635|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206636|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
83206637|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206638|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206639|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
83206640|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
83206641|NCT01594749|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83206642|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83206643|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
83206644|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206645|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83206646|NCT03226145|Scopolamine|scopolamine|mesh-list
83206647|NCT03226145|Bisacodyl|bisacodyl|mesh-list
83206648|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83206649|NCT03226145|Cathartics|cathartics|mesh-ancestor
83206650|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206651|NCT03226145|Laxatives|laxatives|mesh-ancestor
83206652|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83206653|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
83206654|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
83206655|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206656|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206657|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
83206658|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83206659|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83206660|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206661|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206662|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83206663|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
83206664|NCT04863183|Triamcinolone|triamcinolone|mesh-list
83206665|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83206666|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83206667|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83206668|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206669|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
83206670|NCT04863183|Hormones|hormones|mesh-ancestor
83206671|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206672|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206673|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83206674|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
83206675|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206676|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206677|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
83206678|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83206679|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83206680|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83206681|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83206682|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206683|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
83206684|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206685|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206686|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83206687|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206688|NCT04380753|Sotorasib|sotorasib|mesh-list
83206689|NCT04380753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83206690|NCT04380753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206691|NCT04380753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83206692|NCT04380753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206694|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206695|NCT02453009|Prednisone|prednisone|mesh-list
83206696|NCT02453009|Docetaxel|docetaxel|mesh-list
83206697|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206698|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83206699|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83206700|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206701|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206702|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206703|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
83206704|NCT02453009|Hormones|hormones|mesh-ancestor
83420776|NCT00476190|Cytarabine|cytarabine|mesh-list
83206705|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206706|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206707|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206708|NCT04868175|Timolol|timolol|mesh-list
83206709|NCT04868175|Travoprost|travoprost|mesh-list
83206710|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83206711|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83206712|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
83206713|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206714|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206715|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206716|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83206717|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83206718|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83206719|NCT02452775|Poly ICLC|poly iclc|mesh-list
83206720|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83206721|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
83206722|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206723|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
83206724|NCT03045627|Cytarabine|cytarabine|mesh-list
83206725|NCT03045627|Aclarubicin|aclarubicin|mesh-list
83206726|NCT03045627|Lenograstim|lenograstim|mesh-list
83206727|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83206728|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
83206729|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206730|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206731|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
83206732|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206733|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83206734|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
83206735|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206736|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83206737|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83206738|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83206739|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83206740|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206741|NCT04868019|Fenofibrate|fenofibrate|mesh-list
83206742|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83206743|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
83206744|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206745|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83206746|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
83206747|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206748|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83206749|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206750|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206751|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
83206752|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206753|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206754|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83206755|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
83206756|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83206757|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206758|NCT02179918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83206759|NCT02179918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206760|NCT03233321|Heparin|heparin|mesh-list
83206761|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83206762|NCT03233321|Tinzaparin|tinzaparin|mesh-list
83206763|NCT03233321|Dalteparin|dalteparin|mesh-list
83206764|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
83206765|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83206766|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83206767|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206768|NCT04868253|Oxazepam|oxazepam|mesh-list
83206769|NCT04868253|Metyrapone|metyrapone|mesh-list
83206770|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
83206771|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206772|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206773|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206774|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206775|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206776|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83206777|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83206778|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83206779|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
83206780|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
83206781|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206782|NCT02153788|Temazepam|temazepam|mesh-list
83206783|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206784|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206785|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206786|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83206787|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83206788|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83206789|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
83206790|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
83206791|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206792|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206793|NCT03224039|Sufentanil|sufentanil|mesh-list
83206794|NCT03224039|Morphine|morphine|mesh-list
83206795|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83206796|NCT03224039|Narcotics|narcotics|mesh-ancestor
83206797|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206798|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206799|NCT03224039|Analgesics|analgesics|mesh-ancestor
83206800|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
83206801|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206802|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83206803|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83206804|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
83206805|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
83206806|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
83206807|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206808|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83206809|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206810|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206811|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
83206812|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206813|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206814|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83206815|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
83206816|NCT03223961|Hematinics|hematinics|mesh-ancestor
83206817|NCT03045471|Prednisolone|prednisolone|mesh-list
83206818|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83206819|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
83206820|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83206821|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
83206822|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
83206823|NCT03045471|Rituximab|rituximab|mesh-list
83206824|NCT03045471|Etoposide|etoposide|mesh-list
83206825|NCT03045471|Vincristine|vincristine|mesh-list
83206826|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83206827|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
83206828|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83206829|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
83206830|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206831|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83206832|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83206833|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
83206834|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206835|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206836|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83206837|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83206838|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83206839|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83206840|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83206841|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206842|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206844|NCT03045471|Hormones|hormones|mesh-ancestor
83206845|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206846|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83206847|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
83206848|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
83206849|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206850|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206851|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83206852|NCT03045471|Protective Agents|protective agents|mesh-ancestor
83206853|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
83206854|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
83206855|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206856|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
83206857|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83206858|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83206859|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83206860|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83206861|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206862|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83206863|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206864|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206865|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83206866|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206867|NCT03223025|Hormones|hormones|mesh-list
83206868|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83206869|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206870|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
83206871|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206872|NCT04873479|Ketamine|ketamine|mesh-list
83206873|NCT04873479|Esketamine|esketamine|mesh-list
83206874|NCT04873479|Analgesics|analgesics|mesh-ancestor
83206875|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
83206876|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206877|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206878|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83206879|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83206880|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
83206881|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
83206882|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206883|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83206884|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83206885|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206886|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206887|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
83206888|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83206889|NCT02451527|Digoxin|digoxin|mesh-list
83206890|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83206891|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83206892|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206893|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206894|NCT02451527|Protective Agents|protective agents|mesh-ancestor
83206895|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206896|NCT04873011|Quinine|quinine|mesh-list
83206897|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
83206898|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83206899|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83206900|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206901|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83206902|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206903|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83206904|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206905|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83206906|NCT04873011|Analgesics|analgesics|mesh-ancestor
83206907|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
83206908|NCT02451605|Analgesics|analgesics|mesh-list
83206909|NCT02451605|Ropivacaine|ropivacaine|mesh-list
83206910|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
83206911|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
83206912|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206913|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206914|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
83206915|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206916|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
83206917|NCT03222323|Ropivacaine|ropivacaine|mesh-list
83206918|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83206919|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83206920|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206921|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83206922|NCT03222323|Analgesics|analgesics|mesh-ancestor
83206923|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
83206924|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206925|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83206926|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83206927|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83206928|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
83206929|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206930|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206931|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
83206932|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
83206933|NCT03043677|Adalimumab|adalimumab|mesh-list
83206934|NCT03043677|Infliximab|infliximab|mesh-list
83206935|NCT03043677|Golimumab|golimumab|mesh-list
83206936|NCT03043677|Ustekinumab|ustekinumab|mesh-list
83206937|NCT03043677|Vedolizumab|vedolizumab|mesh-list
83206938|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83206939|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83206940|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83206941|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
83206942|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206943|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83206944|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
83206945|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206946|NCT03222089|Leucovorin|leucovorin|mesh-list
83206947|NCT03222089|Fluorouracil|fluorouracil|mesh-list
83206948|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
83206949|NCT03222089|Irinotecan|irinotecan|mesh-list
83206950|NCT03222089|Interleukin-2|interleukin-2|mesh-list
83206951|NCT03222089|Molgramostim|molgramostim|mesh-list
83206952|NCT03222089|Sargramostim|sargramostim|mesh-list
83206953|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
83206954|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
83206955|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206956|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83206957|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206958|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83206959|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
83206960|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206961|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83206962|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83206963|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206964|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83206965|NCT03222089|Analgesics|analgesics|mesh-ancestor
83206966|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
83206967|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206968|NCT03222089|Antidotes|antidotes|mesh-ancestor
83206969|NCT03222089|Protective Agents|protective agents|mesh-ancestor
83206970|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
83206971|NCT03222089|Vitamins|vitamins|mesh-ancestor
83206972|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
83206973|NCT03043989|Clarithromycin|clarithromycin|mesh-list
83206974|NCT03043989|Docetaxel|docetaxel|mesh-list
83206975|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83206976|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
83206977|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
83206978|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
83206979|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83206980|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83206981|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206982|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83206983|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83206984|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83206985|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83206986|NCT03222167|Grazoprevir|grazoprevir|mesh-list
83206987|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83206988|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
83206989|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83206990|NCT03221855|Domperidone|domperidone|mesh-list
83206991|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
83206992|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
83206993|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83206994|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83206995|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83206996|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83206997|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
83206998|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83206999|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207000|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
83207001|NCT03043521|Lansoprazole|lansoprazole|mesh-list
83207002|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83207003|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83207004|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83207005|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207006|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207007|NCT03047733|Tacrolimus|tacrolimus|mesh-list
83207008|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207009|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
83207010|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207011|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83207012|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207013|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207014|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
83207015|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83207016|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
83207017|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207018|NCT03221231|Expectorants|expectorants|mesh-ancestor
83207019|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
83207020|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83207021|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
83207022|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207023|NCT03221231|Protective Agents|protective agents|mesh-ancestor
83207024|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207025|NCT03221231|Antidotes|antidotes|mesh-ancestor
83207026|NCT03221621|Adalimumab|adalimumab|mesh-list
83207027|NCT03221621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83207028|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207029|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207030|NCT03220841|Adalimumab|adalimumab|mesh-list
83207031|NCT03220841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83207032|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207033|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207034|NCT03045393|Maytansine|maytansine|mesh-list
83207035|NCT03045393|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83207036|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83207037|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207038|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
83207039|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
83207040|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
83207041|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207042|NCT03045393|Immunoconjugates|immunoconjugates|mesh-ancestor
83207043|NCT03045393|Immunologic Factors|immunologic factors|mesh-ancestor
83207044|NCT03045393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207045|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
83207046|NCT01374971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83207047|NCT01374971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207048|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207049|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
83207050|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207051|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207052|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
83207053|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207054|NCT02505971|Propranolol|propranolol|mesh-list
83207055|NCT02505971|Nadolol|nadolol|mesh-list
83207056|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83207057|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83207058|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
83207059|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207060|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207061|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207062|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83207063|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83207064|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
83207065|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
83207066|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
83207067|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207068|NCT02505581|Metronidazole|metronidazole|mesh-list
83207069|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
83207070|NCT02505581|Cefuroxime|cefuroxime|mesh-list
83207071|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
83207072|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207073|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83207074|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83207075|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83207076|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83207077|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83207078|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207079|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207080|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207081|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83207082|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83207083|NCT02451293|Melatonin|melatonin|mesh-list
83207084|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
83207085|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207086|NCT02451293|Protective Agents|protective agents|mesh-ancestor
83207087|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207088|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207089|NCT02505113|Montelukast|montelukast|mesh-list
83207090|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83207091|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
83207092|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83207093|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
83207094|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207095|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207096|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83207097|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83207098|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207099|NCT02504801|Budesonide|budesonide|mesh-list
83207100|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207101|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83207102|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
83207103|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207104|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207105|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83207106|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
83207107|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
83207108|NCT02504801|Hormones|hormones|mesh-ancestor
83207109|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207110|NCT02504333|Paclitaxel|paclitaxel|mesh-list
83207111|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83207112|NCT02504333|Gemcitabine|gemcitabine|mesh-list
83207113|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83207114|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207115|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83207116|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83207117|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83420777|NCT00476190|Dexamethasone|dexamethasone|mesh-list
83207118|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207119|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83207120|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
83207121|NCT02504177|Anticoagulants|anticoagulants|mesh-list
83207122|NCT02450981|Bevacizumab|bevacizumab|mesh-list
83207123|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83207124|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207125|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83207126|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83207127|NCT02450981|Growth Substances|growth substances|mesh-ancestor
83207128|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207129|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
83207130|NCT02503943|Metformin|metformin|mesh-list
83207131|NCT02503943|Liraglutide|liraglutide|mesh-list
83207132|NCT02503943|Mitiglinide|mitiglinide|mesh-list
83207133|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83207134|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207135|NCT02503943|Incretins|incretins|mesh-ancestor
83207136|NCT02503943|Hormones|hormones|mesh-ancestor
83207137|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207138|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
83207139|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83207140|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207141|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207142|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207143|NCT03213743|Analgesics|analgesics|mesh-ancestor
83207144|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
83207145|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207146|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83207147|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83207148|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83207149|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
83207150|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207151|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207152|NCT03212495|Neostigmine|neostigmine|mesh-list
83207153|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207154|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207155|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207156|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207157|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83207158|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207159|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
83207160|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83207161|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
83207162|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
83207163|NCT02503319|Oxytocin|oxytocin|mesh-list
83207164|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
83207165|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83207166|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207167|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83207168|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83207169|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207170|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
83207171|NCT02503319|Coagulants|coagulants|mesh-ancestor
83207172|NCT02610777|Azacitidine|azacitidine|mesh-list
83207173|NCT02610777|Pevonedistat|pevonedistat|mesh-list
83207174|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83207175|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
83207176|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207177|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207178|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207179|NCT01628692|Ribavirin|ribavirin|mesh-list
83207180|NCT01628692|Simeprevir|simeprevir|mesh-list
83207181|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
83207182|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207183|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
83207184|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207185|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
83207186|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207187|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83207188|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83207189|NCT04496921|Vitamins|vitamins|mesh-list
83207190|NCT04496921|Vitamin K|vitamin k|mesh-list
83207191|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
83207192|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207193|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83207194|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83207195|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207196|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
83207197|NCT04496921|Coagulants|coagulants|mesh-ancestor
83207198|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
83207199|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83207200|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83207201|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83207202|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83207203|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207204|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
83207205|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207206|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207207|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83207208|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207209|NCT03043443|Melatonin|melatonin|mesh-list
83207210|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
83207211|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207212|NCT03043443|Protective Agents|protective agents|mesh-ancestor
83207213|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207214|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207215|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
83207216|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
83207217|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207218|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207220|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83207221|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83207222|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
83207223|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207224|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
83207225|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
83207226|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
83207227|NCT03209219|Interferons|interferons|mesh-list
83207228|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
83207229|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
83207230|NCT03209219|Cyclosporine|cyclosporine|mesh-list
83207231|NCT03209219|Cyclosporins|cyclosporins|mesh-list
83207232|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207233|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
83207234|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207235|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207236|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207237|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207238|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
83207239|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207240|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
83207241|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83207242|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207243|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83207244|NCT04872231|Voriconazole|voriconazole|mesh-list
83207245|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
83207246|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207247|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83207248|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83207249|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207250|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207251|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83207252|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
83207253|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207254|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207255|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83207256|NCT04860531|Betamethasone|betamethasone|mesh-list
83207258|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
83207259|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
83207260|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207261|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207262|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
83207263|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207264|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83207265|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83207266|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83207267|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83207268|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207269|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207270|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
83207271|NCT04860531|Hormones|hormones|mesh-ancestor
83207272|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207273|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83207274|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
83207275|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
83207276|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83207277|NCT01594827|Vancomycin|vancomycin|mesh-list
83207278|NCT01594827|Doxycycline|doxycycline|mesh-list
83207279|NCT01594827|Rifampin|rifampin|mesh-list
83207280|NCT01594827|Trimethoprim|trimethoprim|mesh-list
83207281|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
83207282|NCT01594827|Mupirocin|mupirocin|mesh-list
83207283|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83207284|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207285|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
83207286|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83207287|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83207288|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
83207289|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83207290|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83207291|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83207292|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
83207293|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
83207294|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83207295|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207296|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207297|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83207298|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83207299|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83207300|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83207301|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83207302|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83207303|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83207304|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83207305|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83207306|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83207307|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83207308|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83207309|NCT04849845|Insulin|insulin|mesh-list
83207310|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83207311|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83207312|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207313|NCT04429191|Antibodies|antibodies|mesh-list
83207314|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83207315|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
83207316|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207317|NCT02610231|Istradefylline|istradefylline|mesh-list
83207318|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83207319|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83207320|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83207321|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
83207322|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207323|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207324|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207325|NCT04850157|Tislelizumab|tislelizumab|mesh-list
83207326|NCT04850157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83207327|NCT04850157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207328|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
83207329|NCT04849533|Prednisone|prednisone|mesh-list
83207330|NCT04849533|Everolimus|everolimus|mesh-list
83207331|NCT04849533|Abatacept|abatacept|mesh-list
83207332|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
83207333|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83207334|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207335|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
83207336|NCT04849533|Hormones|hormones|mesh-ancestor
83207337|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207338|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207339|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83207340|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207341|NCT04849533|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83207342|NCT04849533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83207343|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207344|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207345|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207346|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
83207347|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83207348|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83207349|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
83207350|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83207351|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207352|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83207353|NCT04849533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83207354|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207355|NCT03040635|Risdiplam|risdiplam|mesh-list
83207356|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83207357|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207358|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207359|NCT02178358|Sorafenib|sorafenib|mesh-list
83207360|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207361|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83207362|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207363|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207364|NCT01598896|Clonidine|clonidine|mesh-list
83207365|NCT01598896|Dronabinol|dronabinol|mesh-list
83207366|NCT01598896|Analgesics|analgesics|mesh-ancestor
83207367|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
83207368|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207369|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207370|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83207371|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
83207372|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
83207373|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83207374|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83207375|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83207376|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
83207377|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207378|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207379|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
83207380|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83207381|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207382|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83207383|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83207384|NCT01598896|Hormones|hormones|mesh-ancestor
83207385|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207386|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
83207387|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83207388|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
83207389|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83207390|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207391|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83207392|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83207393|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83207394|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
83207395|NCT03042429|Ifosfamide|ifosfamide|mesh-list
83207396|NCT03042429|Cisplatin|cisplatin|mesh-list
83207397|NCT03042429|Doxorubicin|doxorubicin|mesh-list
83207398|NCT03042429|Etoposide|etoposide|mesh-list
83207399|NCT03042429|Topotecan|topotecan|mesh-list
83207400|NCT03042429|Vindesine|vindesine|mesh-list
83207401|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207402|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
83207403|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207404|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207405|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83207406|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
83207407|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207408|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207409|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83207410|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83207411|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83207412|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83207413|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207414|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83207415|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83207416|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83207417|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83207418|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83207419|NCT04849299|Cyclosporine|cyclosporine|mesh-list
83207420|NCT04849299|Cyclosporins|cyclosporins|mesh-list
83207421|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207422|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207423|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207424|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
83207425|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207426|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
83207427|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207428|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
83207429|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207430|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83207431|NCT02117050|Interferons|interferons|mesh-list
83207432|NCT02117050|Interferon-beta|interferon-beta|mesh-list
83207433|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
83207434|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207435|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
83207436|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207437|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
83207438|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207439|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83207441|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207442|NCT02728895|Vedolizumab|vedolizumab|mesh-list
83207443|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83207444|NCT04847895|Ranibizumab|ranibizumab|mesh-list
83207445|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83207446|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83207448|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207449|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
83207450|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207451|NCT02450513|Adalimumab|adalimumab|mesh-list
83207452|NCT02450513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83207453|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207454|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207455|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
83207456|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83207457|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207458|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207459|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207460|NCT04859283|Analgesics|analgesics|mesh-ancestor
83207461|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
83207462|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207463|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83207464|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83207465|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83207466|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
83207467|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207468|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207469|NCT04857801|Teduglutide|teduglutide|mesh-list
83207470|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83207471|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83207472|NCT04857801|Protective Agents|protective agents|mesh-ancestor
83207473|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207474|NCT03208361|Amoxicillin|amoxicillin|mesh-list
83207475|NCT03208361|Penicillins|penicillins|mesh-list
83207476|NCT03208361|Penicillin V|penicillin v|mesh-list
83207477|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83207478|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207479|NCT02501837|Oxytocin|oxytocin|mesh-list
83207480|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
83207481|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83207482|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207483|NCT04859361|Imiquimod|imiquimod|mesh-list
83207484|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83207485|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
83207486|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207487|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207488|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
83207489|NCT04496141|Antibodies|antibodies|mesh-list
83207490|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
83207491|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207492|NCT03039075|Metformin|metformin|mesh-list
83207493|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83207494|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207495|NCT04857177|Ranibizumab|ranibizumab|mesh-list
83207496|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83207497|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83207498|NCT04857177|Growth Substances|growth substances|mesh-ancestor
83207499|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207500|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
83207501|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207502|NCT02606877|Pirfenidone|pirfenidone|mesh-list
83207503|NCT02606877|Nintedanib|nintedanib|mesh-list
83207504|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207505|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83207506|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207507|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207509|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
83207510|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207511|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207512|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83207513|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207514|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207515|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207516|NCT03206957|Endostatins|endostatins|mesh-list
83207517|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
83207518|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207519|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83207520|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83207521|NCT03206957|Growth Substances|growth substances|mesh-ancestor
83207522|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207523|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
83207524|NCT03206723|Hydrocodone|hydrocodone|mesh-list
83207525|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83207526|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83207527|NCT03206723|Narcotics|narcotics|mesh-ancestor
83207528|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207529|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207530|NCT03206723|Analgesics|analgesics|mesh-ancestor
83207531|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
83207532|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207533|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
83207534|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
83207535|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83207536|NCT03201185|Ramipril|ramipril|mesh-list
83207537|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83207538|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
83207539|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207540|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207541|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83207542|NCT04856787|Fluorouracil|fluorouracil|mesh-list
83207543|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
83207544|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207545|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83207546|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207547|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207548|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
83207549|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207550|NCT03206177|Paclitaxel|paclitaxel|mesh-list
83207551|NCT03206177|Carboplatin|carboplatin|mesh-list
83207552|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83207553|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207554|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83207555|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83207556|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83207557|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207558|NCT04839627|Progesterone|progesterone|mesh-list
83207559|NCT04839627|Progestins|progestins|mesh-ancestor
83207560|NCT04839627|Hormones|hormones|mesh-ancestor
83207561|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207562|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207563|NCT04845399|Factor VIII|factor viii|mesh-list
83207564|NCT04845399|Coagulants|coagulants|mesh-ancestor
83207565|NCT04839471|Afatinib|afatinib|mesh-list
83207566|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207567|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83207568|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207569|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207570|NCT04839237|Metformin|metformin|mesh-list
83207571|NCT04839237|Liraglutide|liraglutide|mesh-list
83207572|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83207573|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207574|NCT04839237|Incretins|incretins|mesh-ancestor
83207575|NCT04839237|Hormones|hormones|mesh-ancestor
83207576|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207577|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
83207578|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83207579|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
83207580|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207581|NCT03038607|Aspirin|aspirin|mesh-list
83207582|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83207583|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207584|NCT03038607|Analgesics|analgesics|mesh-ancestor
83207585|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
83207586|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207587|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207588|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207589|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207590|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83207591|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83207592|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207593|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83207594|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83207595|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207596|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
83207597|NCT03038451|Amlodipine|amlodipine|mesh-list
83207598|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83207599|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83207600|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83207601|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207602|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83207603|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207604|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
83207605|NCT03040401|Aldesleukin|aldesleukin|mesh-list
83207606|NCT03040401|Interleukin-2|interleukin-2|mesh-list
83207607|NCT03040401|Histamine|histamine|mesh-list
83207608|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
83207609|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207610|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83207611|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83207612|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
83207613|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207614|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207615|NCT03040401|Analgesics|analgesics|mesh-ancestor
83207616|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
83207617|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207618|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207619|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
83207620|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
83207621|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207622|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207623|NCT03038295|Propranolol|propranolol|mesh-list
83207624|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83207625|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83207626|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
83207627|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207628|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207629|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207630|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83207631|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83207632|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
83207633|NCT03038217|Capecitabine|capecitabine|mesh-list
83207634|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
83207635|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83207636|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
83207637|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207638|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207639|NCT02609607|Bisacodyl|bisacodyl|mesh-list
83207640|NCT02609607|Cathartics|cathartics|mesh-ancestor
83207641|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83207642|NCT02609607|Laxatives|laxatives|mesh-ancestor
83207643|NCT03040167|Epinephrine|epinephrine|mesh-list
83207644|NCT03040167|Bupivacaine|bupivacaine|mesh-list
83207645|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
83207646|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
83207647|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207648|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207649|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
83207650|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207651|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83207652|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83207653|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83207654|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207655|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207656|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83207657|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83207658|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
83207659|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83207660|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
83207661|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
83207662|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
83207663|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83207664|NCT04843839|Nepafenac|nepafenac|mesh-list
83207665|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83207666|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83207667|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
83207668|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83207669|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83207670|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207671|NCT04843839|Analgesics|analgesics|mesh-ancestor
83207672|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
83207673|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207674|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207675|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207676|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207677|NCT04843839|Laxatives|laxatives|mesh-ancestor
83207678|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83207679|NCT04838145|Ribavirin|ribavirin|mesh-list
83207680|NCT04838145|Pleconaril|pleconaril|mesh-list
83207681|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
83207682|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207683|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
83207684|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207685|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83207686|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83207687|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207688|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
83207689|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207690|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
83207691|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207692|NCT03041259|Protective Agents|protective agents|mesh-ancestor
83207693|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207694|NCT04429035|Vitamin K|vitamin k|mesh-list
83207695|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
83207696|NCT04429035|Vitamins|vitamins|mesh-ancestor
83207697|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
83207698|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207699|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83207700|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83207701|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207702|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
83207703|NCT04429035|Coagulants|coagulants|mesh-ancestor
83207704|NCT04843449|Itraconazole|itraconazole|mesh-list
83207705|NCT04843449|Rifampin|rifampin|mesh-list
83207706|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
83207707|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207708|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83207709|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83207710|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207711|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207712|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83207713|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83207714|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207715|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207716|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83207717|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83207718|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
83207719|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83207720|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
83207721|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83207722|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83207723|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83207724|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83207725|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83207726|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83207727|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83207728|NCT03037593|Vitamin D|vitamin d|mesh-list
83207729|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
83207730|NCT03037593|Vitamins|vitamins|mesh-ancestor
83207731|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
83207732|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207733|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83207734|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83207736|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83207737|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83207738|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207739|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
83207740|NCT03037515|Coagulants|coagulants|mesh-ancestor
83207741|NCT04842825|Cetrorelix|cetrorelix|mesh-list
83207742|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83207743|NCT04842825|Hormones|hormones|mesh-ancestor
83207744|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207745|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207746|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83207747|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
83207748|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83207749|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
83207750|NCT02606253|Metolazone|metolazone|mesh-list
83207751|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
83207752|NCT02606253|Tolvaptan|tolvaptan|mesh-list
83207753|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83207754|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207755|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
83207756|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207757|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83207758|NCT02606253|Diuretics|diuretics|mesh-ancestor
83207759|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83207760|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83207761|NCT04779645|Volagidemab|volagidemab|mesh-list
83207762|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83207763|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207764|NCT04854759|Amantadine|amantadine|mesh-list
83207765|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83207766|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83207767|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
83207768|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207769|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
83207770|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207771|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207772|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207773|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207774|NCT04854759|Analgesics|analgesics|mesh-ancestor
83207775|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
83207776|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207777|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
83207778|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83207779|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
83207780|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207781|NCT04774419|Dostarlimab|dostarlimab|mesh-list
83207782|NCT04774419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207783|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
83207784|NCT02607735|Velpatasvir|velpatasvir|mesh-list
83207785|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
83207786|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207787|NCT04772313|Methotrexate|methotrexate|mesh-list
83207788|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83207789|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
83207790|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83207791|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207792|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83207793|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
83207794|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207795|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207796|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
83207797|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207798|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83207799|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207800|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
83207801|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207802|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83207803|NCT03040791|Nivolumab|nivolumab|mesh-list
83207804|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83207805|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207806|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83207807|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207808|NCT04428879|Topotecan|topotecan|mesh-list
83207810|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83207811|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207812|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207813|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207814|NCT04836819|Lidocaine|lidocaine|mesh-list
83207815|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
83207816|NCT04836819|Ketamine|ketamine|mesh-list
83207817|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
83207818|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
83207819|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207820|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207821|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
83207822|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207823|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83207824|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83207825|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83207826|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83207827|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207828|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83207829|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207830|NCT04836819|Analgesics|analgesics|mesh-ancestor
83207831|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83207832|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83207833|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83207834|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
83207835|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83207836|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83207837|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83207838|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
83207839|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83207840|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83207841|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
83207842|NCT04836507|Fludarabine|fludarabine|mesh-list
83207843|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83207844|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
83207845|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207846|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207847|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83207848|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
83207849|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207850|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207851|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83207852|NCT04835259|Selenium|selenium|mesh-list
83207853|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
83207854|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207855|NCT04835259|Protective Agents|protective agents|mesh-ancestor
83207856|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207857|NCT04835259|Trace Elements|trace elements|mesh-ancestor
83207858|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
83207859|NCT04853901|Remdesivir|remdesivir|mesh-list
83207860|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207861|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207862|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
83207863|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
83207864|NCT01668537|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83207865|NCT01668537|Antiviral Agents|antiviral agents|mesh-ancestor
83207866|NCT01668537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207867|NCT04834791|Letrozole|letrozole|mesh-list
83207868|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207869|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83207870|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83207871|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207872|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207873|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83207874|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
83207875|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207876|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207877|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83207878|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207879|NCT04835025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83207880|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207881|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
83207882|NCT03038919|Testosterone|testosterone|mesh-list
83207883|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
83207884|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
83207885|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83207886|NCT03038919|Androgens|androgens|mesh-ancestor
83207887|NCT03038919|Hormones|hormones|mesh-ancestor
83207888|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207889|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207890|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83207891|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207892|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
83207893|NCT03036891|Naloxegol|naloxegol|mesh-list
83207894|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83207895|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207896|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
83207897|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207898|NCT01668147|Ritonavir|ritonavir|mesh-list
83207899|NCT01668147|Efavirenz|efavirenz|mesh-list
83207900|NCT01668147|Loperamide|loperamide|mesh-list
83207901|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
83207902|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83207903|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83207904|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83207905|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207906|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207907|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83207908|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83207909|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
83207910|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207911|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83207912|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83207913|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83207914|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83207915|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83207916|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83207917|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83207918|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83207919|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83207920|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83207921|NCT04833777|Lidocaine|lidocaine|mesh-list
83207922|NCT04833777|Bupivacaine|bupivacaine|mesh-list
83207923|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
83207924|NCT04833777|Anesthetics|anesthetics|mesh-list
83207925|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83207926|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207927|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
83207928|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207929|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83207930|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83207931|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83207932|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83207933|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207934|NCT03036501|Risdiplam|risdiplam|mesh-list
83207935|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83207936|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83207937|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207938|NCT04851015|Trimethoprim|trimethoprim|mesh-list
83207939|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83207940|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
83207941|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83207942|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207943|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
83207944|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83207945|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83207946|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83207947|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207948|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207949|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83207950|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83207951|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83207952|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83207954|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
83207955|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
83207956|NCT04365933|Entecavir|entecavir|mesh-list
83207957|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83207958|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207959|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
83207960|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207961|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
83207962|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207963|NCT04824261|Clotrimazole|clotrimazole|mesh-list
83207964|NCT04824261|Miconazole|miconazole|mesh-list
83207965|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83207966|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83207967|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
83207968|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83207969|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83207970|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83207971|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207972|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83207973|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
83207974|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83207975|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207976|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83207977|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83207978|NCT04850235|Paclitaxel|paclitaxel|mesh-list
83207979|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83207980|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83207981|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
83207982|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
83207983|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
83207984|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207985|NCT04850001|Aspirin|aspirin|mesh-list
83207986|NCT04850001|Clopidogrel|clopidogrel|mesh-list
83207987|NCT04850001|Atorvastatin|atorvastatin|mesh-list
83207988|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83207989|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83207990|NCT04850001|Analgesics|analgesics|mesh-ancestor
83207991|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
83207993|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83207994|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83207995|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83207996|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83207997|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83207998|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83207999|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83208000|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83208001|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208002|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
83208003|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83208004|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83208005|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
83208006|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83208007|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83208008|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83208009|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83208010|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83208011|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
83208012|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208013|NCT03036111|Trimebutine|trimebutine|mesh-list
83208014|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208015|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
83208016|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
83208017|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208018|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208019|NCT04830579|Etoricoxib|etoricoxib|mesh-list
83208020|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83208021|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83208022|NCT04830579|Analgesics|analgesics|mesh-ancestor
83208023|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
83208024|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208025|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208026|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208027|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208028|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83208029|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83208030|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208031|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208032|NCT04816461|Piperaquine|piperaquine|mesh-list
83208033|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
83208034|NCT04816461|Amodiaquine|amodiaquine|mesh-list
83208035|NCT04816461|Artenimol|artenimol|mesh-list
83208036|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
83208037|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83208038|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83208039|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208040|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83208041|NCT04427865|Lactoferrin|lactoferrin|mesh-list
83208042|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208043|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
83208044|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83208045|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208046|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83208047|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83208048|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208049|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208050|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208051|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83208052|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83208053|NCT04427787|Lanreotide|lanreotide|mesh-list
83208054|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208055|NCT04821843|Paclitaxel|paclitaxel|mesh-list
83208056|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
83208057|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208058|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208059|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208060|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208061|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208062|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208063|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208064|NCT04829487|Vitamin D|vitamin d|mesh-list
83208065|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
83208066|NCT04829487|Vitamins|vitamins|mesh-ancestor
83208067|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
83208068|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208069|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83208070|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83208071|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
83208072|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83208073|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208074|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208075|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
83208076|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208077|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208078|NCT04821765|Paclitaxel|paclitaxel|mesh-list
83208079|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83208080|NCT04821765|Antibodies|antibodies|mesh-list
83208081|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208082|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208083|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208084|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208085|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208086|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208087|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
83208088|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208089|NCT04829097|Temozolomide|temozolomide|mesh-list
83208090|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83208091|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
83208092|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208093|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208094|NCT04829019|Osimertinib|osimertinib|mesh-list
83208095|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208096|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83208097|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208098|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208100|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83208101|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83208102|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83208103|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208104|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83208105|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83208106|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208107|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208108|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208109|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83208110|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
83208111|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83208112|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208113|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83208114|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83208115|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83208116|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83208117|NCT03976245|Etanercept|etanercept|mesh-list
83208118|NCT03976245|Tofacitinib|tofacitinib|mesh-list
83208119|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83208120|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83208121|NCT03976245|Analgesics|analgesics|mesh-ancestor
83208122|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
83208123|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208124|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208125|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208126|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208127|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208128|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83208129|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
83208130|NCT03976245|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83208131|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83208132|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208133|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208134|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
83208135|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
83208136|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
83208137|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208138|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83208139|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
83208140|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
83208141|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208142|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208143|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208144|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83208145|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
83208146|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83208147|NCT04828395|Paclitaxel|paclitaxel|mesh-list
83208148|NCT04828395|Etoposide|etoposide|mesh-list
83208149|NCT04828395|Cisplatin|cisplatin|mesh-list
83208150|NCT04828395|Carboplatin|carboplatin|mesh-list
83208151|NCT04828395|Pemetrexed|pemetrexed|mesh-list
83208152|NCT04828395|Fluzoparib|fluzoparib|mesh-list
83208153|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208154|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208155|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208156|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208157|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208158|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208159|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83208160|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83208161|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208162|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83208163|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83208164|NCT04828395|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83208165|NCT04820439|Pertuzumab|pertuzumab|mesh-list
83208166|NCT04820439|Antibodies|antibodies|mesh-list
83208167|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83208168|NCT04820439|Mitogens|mitogens|mesh-list
83208169|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
83208170|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208171|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208172|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208173|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208174|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208175|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
83208176|NCT05619315|Calcium|calcium|mesh-list
83208177|NCT05619315|Charcoal|charcoal|mesh-list
83208178|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83208179|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208180|NCT05619315|Antacids|antacids|mesh-ancestor
83208181|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208182|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208183|NCT05619315|Antidotes|antidotes|mesh-ancestor
83208184|NCT05619315|Protective Agents|protective agents|mesh-ancestor
83208185|NCT04814511|Permethrin|permethrin|mesh-list
83208186|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208187|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208188|NCT04814043|Lenvatinib|lenvatinib|mesh-list
83208189|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83208190|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208191|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83208192|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208193|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208194|NCT04814043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208195|NCT04814589|Ezetimibe|ezetimibe|mesh-list
83208196|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83208197|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83208198|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
83208199|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208200|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83208201|NCT04819503|Anesthetics|anesthetics|mesh-list
83208202|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208203|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208204|NCT04826679|Paclitaxel|paclitaxel|mesh-list
83208205|NCT04826679|Cisplatin|cisplatin|mesh-list
83208206|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208207|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208208|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208209|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208210|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208211|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208212|NCT02601573|Ribavirin|ribavirin|mesh-list
83208213|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
83208214|NCT02601573|Grazoprevir|grazoprevir|mesh-list
83208215|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
83208216|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208217|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
83208218|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208219|NCT04818723|Montelukast|montelukast|mesh-list
83208220|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83208221|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
83208222|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83208223|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
83208224|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208225|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208226|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83208227|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83208228|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208229|NCT02601027|Acetaminophen|acetaminophen|mesh-list
83208230|NCT02601027|Oxycodone|oxycodone|mesh-list
83208231|NCT02601027|Hydromorphone|hydromorphone|mesh-list
83208232|NCT02601027|Ondansetron|ondansetron|mesh-list
83208233|NCT02601027|Bupivacaine|bupivacaine|mesh-list
83208234|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
83208235|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
83208236|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208237|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208238|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
83208239|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208240|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83208241|NCT02601027|Narcotics|narcotics|mesh-ancestor
83208242|NCT02601027|Analgesics|analgesics|mesh-ancestor
83208243|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
83208244|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
83208245|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208246|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
83208247|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
83208248|NCT02601027|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83208249|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83208250|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
83208251|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208252|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208253|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83208254|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
83208255|NCT04411875|Amlodipine|amlodipine|mesh-list
83208256|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83208257|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83208258|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208259|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208260|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83208261|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208263|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
83208264|NCT02600871|Povidone|povidone|mesh-list
83208265|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
83208266|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
83208267|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83208268|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208269|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83208270|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208271|NCT04818099|Vortioxetine|vortioxetine|mesh-list
83208272|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
83208273|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83208274|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83208275|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83208276|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208277|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208278|NCT04818099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83208279|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83208280|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208281|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208282|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208283|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
83208284|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83208285|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83208286|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83208287|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83208288|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
83208289|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208290|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
83208291|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83208292|NCT04807569|Tamsulosin|tamsulosin|mesh-list
83208293|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83208294|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83208295|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83208296|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
83208297|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208298|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208299|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208300|NCT04807569|Urological Agents|urological agents|mesh-ancestor
83208301|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
83208302|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83208303|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
83208304|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208305|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208306|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83208307|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
83208308|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83208309|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
83208310|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208311|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208312|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83208313|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
83208314|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
83208315|NCT04807413|Protective Agents|protective agents|mesh-ancestor
83208316|NCT04356729|Bevacizumab|bevacizumab|mesh-list
83208317|NCT04356729|Atezolizumab|atezolizumab|mesh-list
83208318|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208319|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208320|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83208321|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83208322|NCT04356729|Growth Substances|growth substances|mesh-ancestor
83208323|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208324|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
83208325|NCT04356729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83208326|NCT04356729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208328|NCT04807335|Ketamine|ketamine|mesh-list
83208329|NCT04807335|Analgesics|analgesics|mesh-ancestor
83208330|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
83208331|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208332|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208333|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83208334|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83208335|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
83208336|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
83208337|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208338|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83208339|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83208340|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208341|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208342|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83208343|NCT04807335|Narcotics|narcotics|mesh-ancestor
83208344|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83208345|NCT05616507|Fucoidan|fucoidan|mesh-list
83208346|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83208347|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208348|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
83208349|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208350|NCT04806945|Paclitaxel|paclitaxel|mesh-list
83208351|NCT04806945|Carboplatin|carboplatin|mesh-list
83208352|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208353|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208354|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208355|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208356|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208357|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208358|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
83208359|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83208360|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208361|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83208362|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208363|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
83208364|NCT04805229|Narcotics|narcotics|mesh-ancestor
83208365|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208366|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208367|NCT04805229|Analgesics|analgesics|mesh-ancestor
83208368|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
83208369|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208370|NCT04811313|Bupivacaine|bupivacaine|mesh-list
83208371|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
83208372|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
83208373|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
83208374|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208375|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208376|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
83208377|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208378|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83208379|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83208380|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208381|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
83208382|NCT04811313|Coagulants|coagulants|mesh-ancestor
83208384|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83208385|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83208386|NCT04352439|Analgesics|analgesics|mesh-ancestor
83208387|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
83208388|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208389|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208390|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208391|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208392|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83208393|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83208394|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208395|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83208396|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83208397|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208399|NCT04796025|Bevacizumab|bevacizumab|mesh-list
83208400|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208401|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208402|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83208403|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83208404|NCT04796025|Growth Substances|growth substances|mesh-ancestor
83208405|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208406|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
83208407|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
83208408|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83208409|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208410|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83208411|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83208412|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208413|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208414|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208415|NCT02595723|Megestrol|megestrol|mesh-list
83208416|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
83208417|NCT02595723|Phenytoin|phenytoin|mesh-list
83208418|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83208419|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83208420|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83208421|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
83208422|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83208423|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208424|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83208425|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83208426|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83208427|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208428|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
83208429|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83208430|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
83208431|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83208432|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83208433|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208434|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208435|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83208436|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83208437|NCT01667679|Sumatriptan|sumatriptan|mesh-list
83208438|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83208439|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83208440|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83208441|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
83208442|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208443|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208444|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208445|NCT02597049|Metformin|metformin|mesh-list
83208446|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
83208447|NCT02597049|Empagliflozin|empagliflozin|mesh-list
83208448|NCT02597049|Canagliflozin|canagliflozin|mesh-list
83208450|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83208451|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83208452|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208453|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208454|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
83208455|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208456|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
83208457|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
83208458|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
83208459|NCT04802967|Ketoprofen|ketoprofen|mesh-list
83208460|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
83208461|NCT04802967|Gabapentin|gabapentin|mesh-list
83208462|NCT04802967|Analgesics|analgesics|mesh-ancestor
83208463|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
83208464|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208465|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208466|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
83208467|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83208468|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83208469|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208470|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83208471|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83208472|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83208473|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208474|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208475|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
83208476|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83208477|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83208478|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208479|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208480|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83208481|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208482|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83208483|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208484|NCT05616117|Vitamin D|vitamin d|mesh-list
83208485|NCT05616117|Vitamins|vitamins|mesh-list
83208486|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
83208487|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208488|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83208489|NCT02594163|Rituximab|rituximab|mesh-list
83208490|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83208491|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83208492|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208493|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208494|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
83208495|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208496|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208497|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83208498|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
83208499|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208500|NCT02594163|Immunotoxins|immunotoxins|mesh-ancestor
83208501|NCT02594163|Immunoconjugates|immunoconjugates|mesh-ancestor
83208502|NCT04801485|Inositol|inositol|mesh-list
83208503|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
83208504|NCT04801485|Vitamins|vitamins|mesh-ancestor
83208505|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
83208506|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208507|NCT03206255|Vaccines|vaccines|mesh-list
83208508|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
83208509|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208510|NCT03206411|Hormones|hormones|mesh-list
83208511|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208512|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208513|NCT03206021|Carboplatin|carboplatin|mesh-list
83208514|NCT03206021|Azacitidine|azacitidine|mesh-list
83208515|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208516|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83208517|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
83208518|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208519|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208520|NCT03200561|Prednisolone|prednisolone|mesh-list
83208521|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
83208522|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83208523|NCT03200561|Antibodies|antibodies|mesh-list
83208524|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208526|NCT03200561|Hormones|hormones|mesh-ancestor
83208527|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208528|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208529|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83208530|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208531|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
83208532|NCT02449811|Amlodipine|amlodipine|mesh-list
83208533|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83208534|NCT02449811|Olmesartan|olmesartan|mesh-list
83208535|NCT02449811|Perindopril|perindopril|mesh-list
83208536|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83208537|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83208538|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208539|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208540|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83208541|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208542|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
83208543|NCT02449811|Diuretics|diuretics|mesh-ancestor
83208544|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
83208545|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83208546|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83208547|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83208548|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83208549|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
83208550|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208551|NCT03200093|Vancomycin|vancomycin|mesh-list
83208552|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83208553|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208555|NCT03204929|Trace Elements|trace elements|mesh-ancestor
83208556|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
83208557|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208558|NCT02596971|Prednisone|prednisone|mesh-list
83208559|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
83208560|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83208561|NCT02596971|Rituximab|rituximab|mesh-list
83208562|NCT02596971|Doxorubicin|doxorubicin|mesh-list
83208563|NCT02596971|Vincristine|vincristine|mesh-list
83208564|NCT02596971|Atezolizumab|atezolizumab|mesh-list
83208565|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
83208566|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83208567|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
83208568|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208569|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208570|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83208571|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
83208572|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208573|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208574|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83208575|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208576|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83208577|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83208578|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83208579|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208580|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208581|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
83208582|NCT02596971|Hormones|hormones|mesh-ancestor
83208583|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208584|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83208585|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208586|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208587|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208588|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208589|NCT02596971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83208590|NCT04808739|Adalimumab|adalimumab|mesh-list
83208591|NCT04808739|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83208592|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208593|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208595|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83208596|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83208597|NCT04808895|Analgesics|analgesics|mesh-ancestor
83208598|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
83208599|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208600|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208601|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208602|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208603|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83208604|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83208605|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208606|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83208607|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83208608|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208609|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
83208610|NCT04485689|Capsaicin|capsaicin|mesh-list
83208611|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
83208612|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
83208613|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
83208614|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208615|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208616|NCT03204071|Metformin|metformin|mesh-list
83208617|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83208618|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208619|NCT04801017|Artemisinins|artemisinins|mesh-list
83208620|NCT04801017|Artemisinin|artemisinin|mesh-list
83208621|NCT04801017|Trabedersen|trabedersen|mesh-list
83208622|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
83208623|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83208624|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83208625|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208626|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208627|NCT03107429|Acetazolamide|acetazolamide|mesh-list
83208628|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
83208629|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83208630|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208631|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208632|NCT03107429|Diuretics|diuretics|mesh-ancestor
83208633|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
83208634|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208635|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
83208636|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83208637|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83208638|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208639|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
83208640|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
83208641|NCT04800081|Valsartan|valsartan|mesh-list
83208642|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83208643|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83208644|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83208645|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83208646|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208647|NCT03202979|Trazodone|trazodone|mesh-list
83208648|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83208649|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83208650|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208651|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208652|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83208653|NCT03202979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83208654|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83208655|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208656|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208657|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208658|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
83208659|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83208660|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
83208661|NCT04799925|Febuxostat|febuxostat|mesh-list
83208662|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
83208663|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208664|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
83208665|NCT04793529|Vitamin D|vitamin d|mesh-list
83208666|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83208667|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208668|NCT04793529|Vitamins|vitamins|mesh-ancestor
83208669|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
83208670|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83208671|NCT03232307|Dexamethasone|dexamethasone|mesh-list
83208672|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
83208673|NCT03232307|Rituximab|rituximab|mesh-list
83208674|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83208675|NCT03232307|Lenalidomide|lenalidomide|mesh-list
83208676|NCT03232307|Antibodies|antibodies|mesh-list
83208677|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
83208678|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83208679|NCT03232307|BB 1101|bb 1101|mesh-list
83208680|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
83208681|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208682|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208683|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83208684|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208685|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
83208686|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
83208687|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208688|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208689|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
83208690|NCT03232307|Hormones|hormones|mesh-ancestor
83208691|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208692|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83208693|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83208694|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83208695|NCT03232307|Growth Substances|growth substances|mesh-ancestor
83208696|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
83208697|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
83208698|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208699|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208700|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
83208702|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83208703|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208704|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208705|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83208706|NCT05615727|Analgesics|analgesics|mesh-ancestor
83208707|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
83208708|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208709|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83208710|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83208711|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83208712|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83208713|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208714|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208715|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83208716|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83208717|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
83208718|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
83208719|NCT02450279|Edetic Acid|edetic acid|mesh-list
83208720|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
83208721|NCT02450279|Antidotes|antidotes|mesh-ancestor
83208722|NCT02450279|Protective Agents|protective agents|mesh-ancestor
83208723|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208724|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
83208725|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
83208726|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208727|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83208728|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
83208729|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83208730|NCT03231683|Ketamine|ketamine|mesh-list
83208731|NCT03231683|Remifentanil|remifentanil|mesh-list
83208732|NCT03231683|Propofol|propofol|mesh-list
83208733|NCT03231683|Esketamine|esketamine|mesh-list
83208734|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83208735|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208736|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208737|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83208738|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
83208739|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
83208740|NCT03231683|Analgesics|analgesics|mesh-ancestor
83208741|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
83208742|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208743|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83208744|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83208745|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83208746|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208747|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208748|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83208749|NCT03231683|Narcotics|narcotics|mesh-ancestor
83208750|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
83208751|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83208752|NCT02593773|Interferons|interferons|mesh-list
83208753|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
83208754|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208755|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
83208756|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208757|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
83208758|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83208759|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
83208760|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208761|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
83208762|NCT04798443|Protective Agents|protective agents|mesh-ancestor
83208763|NCT02450045|Bupivacaine|bupivacaine|mesh-list
83208764|NCT02450045|Ropivacaine|ropivacaine|mesh-list
83208765|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
83208766|NCT02450045|Anesthetics|anesthetics|mesh-list
83208767|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208768|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208769|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
83208770|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208771|NCT02593539|Nemiralisib|nemiralisib|mesh-list
83208772|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83208773|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208774|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208775|NCT02593305|Methamphetamine|methamphetamine|mesh-list
83208776|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83208777|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208778|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
83208779|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
83208780|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208781|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
83208782|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208783|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208784|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
83208785|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83208786|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83208787|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208788|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83208789|NCT04389411|Montelukast|montelukast|mesh-list
83208790|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83208791|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
83208792|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83208793|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
83208794|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208795|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208796|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83208797|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83208798|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208799|NCT02448251|Abivertinib|abivertinib|mesh-list
83208800|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83208801|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208802|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208804|NCT03195569|Bevacizumab|bevacizumab|mesh-list
83208805|NCT03195569|Carboplatin|carboplatin|mesh-list
83208806|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208807|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208808|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208809|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208810|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208811|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208812|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208813|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83208814|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83208815|NCT03195569|Growth Substances|growth substances|mesh-ancestor
83208816|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208817|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
83208818|NCT02447939|Trametinib|trametinib|mesh-list
83208819|NCT02447939|Dabrafenib|dabrafenib|mesh-list
83208820|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208821|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83208822|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208823|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208824|NCT04785183|Melatonin|melatonin|mesh-list
83208825|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
83208826|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208827|NCT04785183|Protective Agents|protective agents|mesh-ancestor
83208828|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208829|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208830|NCT03195491|Nivolumab|nivolumab|mesh-list
83208831|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83208832|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208833|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83208834|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208835|NCT03195413|Lidocaine|lidocaine|mesh-list
83208836|NCT03195413|Epinephrine|epinephrine|mesh-list
83208837|NCT03195413|Racepinephrine|racepinephrine|mesh-list
83208838|NCT03195413|Bupivacaine|bupivacaine|mesh-list
83208839|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
83208840|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
83208841|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
83208842|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208843|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208844|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
83208845|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208846|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83208847|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83208848|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83208849|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208850|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208851|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83208852|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83208853|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
83208854|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208855|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83208856|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83208857|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
83208858|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83208859|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
83208861|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
83208862|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83208863|NCT04338399|Paclitaxel|paclitaxel|mesh-list
83208864|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83208865|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208866|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
83208867|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
83208868|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
83208869|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208870|NCT02447705|Telbivudine|telbivudine|mesh-list
83208871|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
83208872|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208873|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83208874|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208875|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208876|NCT03195257|Glucagon|glucagon|mesh-list
83208877|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
83208878|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83208879|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208880|NCT03195257|Hormones|hormones|mesh-ancestor
83208881|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208882|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208883|NCT03195257|Incretins|incretins|mesh-ancestor
83208884|NCT02447393|Cetirizine|cetirizine|mesh-list
83208885|NCT02447393|Levocetirizine|levocetirizine|mesh-list
83208886|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83208887|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83208888|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83208889|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
83208890|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
83208891|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208892|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208893|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208894|NCT02447315|Pilocarpine|pilocarpine|mesh-list
83208895|NCT02447315|Miotics|miotics|mesh-ancestor
83208896|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
83208897|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208898|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208899|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83208900|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83208901|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
83208902|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83208903|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208904|NCT04792515|Apatinib|apatinib|mesh-list
83208905|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208906|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83208907|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208908|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208910|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83208911|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208912|NCT03195023|Amlodipine|amlodipine|mesh-list
83208913|NCT03195023|Lisinopril|lisinopril|mesh-list
83208914|NCT03195023|Lercanidipine|lercanidipine|mesh-list
83208915|NCT03195023|Furosemide|furosemide|mesh-list
83208916|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83208917|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83208918|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83208919|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83208920|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83208921|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208922|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83208923|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208924|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
83208926|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
83208927|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83208928|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
83208929|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83208930|NCT03195023|Protective Agents|protective agents|mesh-ancestor
83208931|NCT02446301|Nalbuphine|nalbuphine|mesh-list
83208932|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83208933|NCT02446301|Narcotics|narcotics|mesh-ancestor
83208934|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83208935|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208936|NCT02446301|Analgesics|analgesics|mesh-ancestor
83208937|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
83208938|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208939|NCT04791345|Dexamethasone|dexamethasone|mesh-list
83208940|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
83208941|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
83208942|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83208943|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83208944|NCT04791345|Prednisolone|prednisolone|mesh-list
83208945|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
83208946|NCT04791345|Deflazacort|deflazacort|mesh-list
83208947|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83208948|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
83208949|NCT04791345|BB 1101|bb 1101|mesh-list
83208950|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208951|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
83208952|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
83208953|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208954|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208955|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208956|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
83208957|NCT04791345|Hormones|hormones|mesh-ancestor
83208958|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208959|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83208960|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208961|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
83208962|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83208963|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208964|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83208965|NCT04791345|Protective Agents|protective agents|mesh-ancestor
83208966|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83208967|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
83208968|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
83208969|NCT02445989|NuvaRing|nuvaring|mesh-list
83208970|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83208971|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208972|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83208973|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
83208974|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83208975|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208976|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83208977|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
83208978|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83208979|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83208980|NCT03231215|Dexamethasone|dexamethasone|mesh-list
83208981|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83208982|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
83208983|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
83208984|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83208985|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208986|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83208987|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
83208988|NCT03231215|Hormones|hormones|mesh-ancestor
83208989|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83208990|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83208991|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83208992|NCT04784481|Ivermectin|ivermectin|mesh-list
83208993|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83208994|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83208995|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
83208996|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
83208997|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83208998|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83208999|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83209000|NCT03526185|Nivolumab|nivolumab|mesh-list
83209001|NCT03526185|Ipilimumab|ipilimumab|mesh-list
83209002|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83209003|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209004|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83209005|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209006|NCT02445599|Dipyrone|dipyrone|mesh-list
83209007|NCT02445599|Diclofenac|diclofenac|mesh-list
83209008|NCT02445599|Atropine|atropine|mesh-list
83209009|NCT02445599|Fentanyl|fentanyl|mesh-list
83209010|NCT02445599|Midazolam|midazolam|mesh-list
83209011|NCT02445599|Tramadol|tramadol|mesh-list
83209012|NCT02445599|Nalbuphine|nalbuphine|mesh-list
83209013|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83209014|NCT02445599|Narcotics|narcotics|mesh-ancestor
83209015|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209016|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209017|NCT02445599|Analgesics|analgesics|mesh-ancestor
83209018|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
83209019|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209020|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83209021|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83209022|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
83209023|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
83209024|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83209025|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83209026|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83209027|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83209028|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
83209029|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
83209030|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209031|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209032|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83209033|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209034|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209035|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209036|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83209037|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209038|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83209039|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83209040|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
83209041|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83209042|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209043|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
83209044|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
83209045|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83209046|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83209047|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
83209048|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
83209049|NCT03194633|Nifedipine|nifedipine|mesh-list
83209050|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83209051|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209052|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209053|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83209054|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209055|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
83209056|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
83209057|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209058|NCT03194555|Acetaminophen|acetaminophen|mesh-list
83209059|NCT03194555|Naltrexone|naltrexone|mesh-list
83209060|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209061|NCT03194555|Analgesics|analgesics|mesh-ancestor
83209062|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
83209063|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209064|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209065|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
83209066|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83209067|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83209068|NCT04344717|Apixaban|apixaban|mesh-list
83209069|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83209070|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
83209071|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83209072|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
83209073|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209074|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209075|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
83209076|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
83209077|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
83209078|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209079|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83209080|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
83209081|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
83209082|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209083|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209084|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209085|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83209086|NCT04790331|Verapamil|verapamil|mesh-list
83209087|NCT04790331|Diltiazem|diltiazem|mesh-list
83209088|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83209089|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83209090|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209091|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209092|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83209093|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209094|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
83209095|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83209096|NCT04789941|Irinotecan|irinotecan|mesh-list
83209097|NCT04789941|Cisplatin|cisplatin|mesh-list
83209098|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83209099|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83209100|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209101|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209102|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209103|NCT02445053|Ivacaftor|ivacaftor|mesh-list
83209104|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83209105|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209106|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209107|NCT02444897|Fentanyl|fentanyl|mesh-list
83209108|NCT02444897|Nefopam|nefopam|mesh-list
83209109|NCT02444897|Ramosetron|ramosetron|mesh-list
83209110|NCT02444897|Ropivacaine|ropivacaine|mesh-list
83209111|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
83209112|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
83209113|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209114|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209115|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
83209116|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209117|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83209118|NCT02444897|Narcotics|narcotics|mesh-ancestor
83209119|NCT02444897|Analgesics|analgesics|mesh-ancestor
83209120|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83209121|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83209122|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
83209123|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
83209124|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
83209125|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209126|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83209127|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
83209128|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209129|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209130|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209131|NCT03016533|Lamivudine|lamivudine|mesh-list
83209132|NCT03016533|Dolutegravir|dolutegravir|mesh-list
83209133|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83209134|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83209135|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209136|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209137|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
83209138|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209139|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83209140|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83209141|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83209142|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83209143|NCT03229889|Tadalafil|tadalafil|mesh-list
83209144|NCT03229889|Tamsulosin|tamsulosin|mesh-list
83209145|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
83209146|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83209147|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83209148|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209149|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209150|NCT03229889|Urological Agents|urological agents|mesh-ancestor
83209151|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83209152|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83209153|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83209154|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209155|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209156|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209158|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83209159|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209160|NCT03120221|Iodine|iodine|mesh-list
83209161|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83209162|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209163|NCT03120221|Trace Elements|trace elements|mesh-ancestor
83209164|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
83209165|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209166|NCT03193073|Mitogens|mitogens|mesh-list
83209167|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
83209168|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209169|NCT02715609|Copper|copper|mesh-list
83209170|NCT02715609|Temozolomide|temozolomide|mesh-list
83209171|NCT02715609|Disulfiram|disulfiram|mesh-list
83209172|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83209173|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
83209174|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209175|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209176|NCT02715609|Trace Elements|trace elements|mesh-ancestor
83209177|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
83209178|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209179|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83209180|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83209181|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209182|NCT02444507|Esomeprazole|esomeprazole|mesh-list
83209183|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83209184|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209185|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83209186|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209187|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209188|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
83209189|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83209190|NCT02572791|Mupirocin|mupirocin|mesh-list
83209191|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83209192|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209193|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
83209194|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209195|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83209196|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83209197|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209198|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209199|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83209200|NCT01626352|Ofatumumab|ofatumumab|mesh-list
83209201|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83209202|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
83209203|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209204|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209205|NCT02080767|Tecovirimat|tecovirimat|mesh-list
83209206|NCT02080767|Antiviral Agents|antiviral agents|mesh-ancestor
83209207|NCT02080767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209208|NCT01626118|Indomethacin|indomethacin|mesh-list
83209209|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83209210|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209211|NCT01626118|Analgesics|analgesics|mesh-ancestor
83209212|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
83209213|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209214|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209215|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209216|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209217|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
83209218|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
83209219|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209220|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83209221|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209222|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209223|NCT04789005|Phenylephrine|phenylephrine|mesh-list
83209224|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
83209225|NCT04789005|Norepinephrine|norepinephrine|mesh-list
83209226|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83209227|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
83209228|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
83209229|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209230|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209231|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
83209232|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83209233|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
83209234|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209235|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83209236|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83209237|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83209238|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209239|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209240|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209241|NCT04789005|Protective Agents|protective agents|mesh-ancestor
83209243|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83209244|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
83209245|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
83209246|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83209247|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209248|NCT05469243|Hallucinogens|hallucinogens|mesh-list
83209249|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209250|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83209251|NCT02177266|Colchicine|colchicine|mesh-list
83209252|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
83209253|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209254|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
83209255|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
83209256|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
83209257|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209258|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209259|NCT04788381|Bevacizumab|bevacizumab|mesh-list
83209260|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83209261|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209262|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83209263|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83209264|NCT04788381|Growth Substances|growth substances|mesh-ancestor
83209265|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209266|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
83209267|NCT05474937|Midazolam|midazolam|mesh-list
83209268|NCT05474937|Ketamine|ketamine|mesh-list
83209269|NCT05474937|Propofol|propofol|mesh-list
83209270|NCT05474937|Sevoflurane|sevoflurane|mesh-list
83209271|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83209272|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209273|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209274|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83209275|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
83209276|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
83209277|NCT05474937|Analgesics|analgesics|mesh-ancestor
83209278|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
83209279|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209280|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83209281|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83209282|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83209283|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209284|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209285|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83209286|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83209287|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83209288|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83209289|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
83209290|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
83209291|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83209292|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83209294|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83209295|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209296|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83209297|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83209298|NCT04787289|Growth Substances|growth substances|mesh-ancestor
83209299|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209300|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
83209301|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83209302|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
83209303|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209304|NCT02177032|Vaccines|vaccines|mesh-list
83209305|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
83209306|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83209307|NCT02177032|Antibodies|antibodies|mesh-list
83209308|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
83209309|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209311|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209312|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
83209313|NCT02116972|Hormones|hormones|mesh-ancestor
83209314|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209315|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209316|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83209317|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
83209318|NCT02176642|Oxybutynin|oxybutynin|mesh-list
83209319|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
83209320|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
83209321|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209322|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209323|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83209324|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83209325|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
83209326|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209327|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209328|NCT02176642|Urological Agents|urological agents|mesh-ancestor
83209329|NCT02116660|Ritonavir|ritonavir|mesh-list
83209330|NCT02116660|Lopinavir|lopinavir|mesh-list
83209331|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83209332|NCT02116660|Darunavir|darunavir|mesh-list
83209333|NCT02116660|Tenofovir|tenofovir|mesh-list
83209334|NCT02116660|Lamivudine|lamivudine|mesh-list
83209335|NCT02116660|Emtricitabine|emtricitabine|mesh-list
83209336|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
83209337|NCT02116660|Nevirapine|nevirapine|mesh-list
83209338|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83209339|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83209340|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
83209341|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209342|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209343|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83209344|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83209345|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
83209346|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209347|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83209348|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83209349|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83209350|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83209351|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83209352|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83209353|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83209354|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83209355|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83209356|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209357|NCT02176018|Quinidine|quinidine|mesh-list
83209358|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
83209359|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
83209360|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209361|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83209362|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83209363|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209364|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209365|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209366|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83209367|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83209368|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209369|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83209370|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
83209371|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83209372|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83209373|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209374|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209375|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83209376|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83209377|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
83209378|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83209379|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83209380|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209381|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83209382|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83209383|NCT05611827|Quercetin|quercetin|mesh-list
83209384|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
83209385|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209386|NCT05611827|Protective Agents|protective agents|mesh-ancestor
83209387|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209388|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
83209389|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83209390|NCT05612607|Antibodies|antibodies|mesh-list
83209391|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
83209392|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209393|NCT02589639|Empagliflozin|empagliflozin|mesh-list
83209394|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83209395|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209396|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83209397|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209398|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83209399|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83209400|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83209401|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209402|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209403|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209404|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209405|NCT05611749|Analgesics|analgesics|mesh-ancestor
83209406|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
83209407|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209408|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
83209409|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83209410|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
83209411|NCT00555555|Factor VIII|factor viii|mesh-list
83209412|NCT00555555|Coagulants|coagulants|mesh-ancestor
83209413|NCT05611593|Finasteride|finasteride|mesh-list
83209414|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83209415|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83209416|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430110|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83209417|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209418|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
83209419|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209420|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209421|NCT05611593|Urological Agents|urological agents|mesh-ancestor
83209422|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83209423|NCT05612451|Calcium|calcium|mesh-list
83209424|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83209425|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209426|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209427|NCT02151682|Morphine|morphine|mesh-list
83209428|NCT02151682|Tapentadol|tapentadol|mesh-list
83209429|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83209430|NCT02151682|Narcotics|narcotics|mesh-ancestor
83209431|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209432|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209433|NCT02151682|Analgesics|analgesics|mesh-ancestor
83209434|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
83209435|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209436|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83209437|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83209438|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209439|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209440|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209441|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209442|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83209443|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83209444|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83209445|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209446|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209447|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209448|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209449|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209450|NCT04331691|Amiloride|amiloride|mesh-list
83209451|NCT04331691|Spironolactone|spironolactone|mesh-list
83209452|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83209453|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
83209454|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209455|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209456|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83209457|NCT04331691|Diuretics|diuretics|mesh-ancestor
83209458|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
83209459|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83209460|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83209461|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209462|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209463|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83209464|NCT05304273|Letrozole|letrozole|mesh-list
83209465|NCT05304273|Misoprostol|misoprostol|mesh-list
83209466|NCT05304273|Mifepristone|mifepristone|mesh-list
83209467|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209468|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83209469|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83209470|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209471|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209472|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83209473|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
83209474|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209475|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209476|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83209477|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
83209478|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209479|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83209480|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209481|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
83209482|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83209483|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83209484|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83209485|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83209486|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
83209487|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83209488|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83209489|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
83209490|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83209491|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83209492|NCT02174848|Deferiprone|deferiprone|mesh-list
83209493|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83209494|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
83209495|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
83209496|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209497|NCT02151058|Listerine|listerine|mesh-list
83209498|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
83209499|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
83209500|NCT02151058|Protective Agents|protective agents|mesh-ancestor
83209501|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209502|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83209503|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209504|NCT05205759|Sotrovimab|sotrovimab|mesh-list
83209505|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
83209506|NCT05205759|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83209507|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
83209508|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209509|NCT02149264|Testosterone|testosterone|mesh-list
83209510|NCT02149264|Androgens|androgens|mesh-ancestor
83209511|NCT02149264|Hormones|hormones|mesh-ancestor
83209512|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209513|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209514|NCT05610969|Midazolam|midazolam|mesh-list
83209515|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83209516|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83209517|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209518|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209519|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83209520|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83209521|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83209522|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83209523|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
83209524|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
83209525|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
83209526|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
83209527|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209528|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209529|NCT05557149|Cocaine|cocaine|mesh-list
83209530|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
83209531|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
83209532|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209533|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209534|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
83209535|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209536|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83209537|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83209538|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83209539|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209540|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209541|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
83209542|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209543|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
83209544|NCT02115256|Terbutaline|terbutaline|mesh-list
83209545|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
83209546|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83209547|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
83209548|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209549|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209550|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83209551|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209552|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
83209553|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
83209554|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209555|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83209556|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83209557|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83209558|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209559|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209560|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209561|NCT02173054|Adapalene|adapalene|mesh-list
83209562|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83209563|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209564|NCT02173054|Analgesics|analgesics|mesh-ancestor
83209565|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
83209566|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209567|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209568|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209569|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209570|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209571|NCT04225221|Leuprolide|leuprolide|mesh-list
83209572|NCT04225221|Estradiol|estradiol|mesh-list
83209573|NCT04225221|Progesterone|progesterone|mesh-list
83209574|NCT04225221|Estrogens|estrogens|mesh-ancestor
83209575|NCT04225221|Hormones|hormones|mesh-ancestor
83209576|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209577|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209578|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209579|NCT04225221|Progestins|progestins|mesh-ancestor
83209580|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83209581|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
83209582|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83209583|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209584|NCT04425993|Indomethacin|indomethacin|mesh-list
83209585|NCT04425993|Isosorbide|isosorbide|mesh-list
83209586|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83209587|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83209588|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83209589|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209590|NCT04425993|Analgesics|analgesics|mesh-ancestor
83209591|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
83209592|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209593|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209594|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209596|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
83209597|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
83209598|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209599|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83209600|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209601|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209602|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83209603|NCT04425993|Diuretics|diuretics|mesh-ancestor
83209604|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
83209605|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83209606|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83209607|NCT03971643|Vilobelimab|vilobelimab|mesh-list
83209608|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83209609|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83209610|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
83209611|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209612|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83209614|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209615|NCT02149108|Nintedanib|nintedanib|mesh-list
83209616|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209617|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83209618|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209619|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209620|NCT02148718|Adalimumab|adalimumab|mesh-list
83209621|NCT02148718|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83209622|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209623|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209624|NCT03397953|Vinorelbine|vinorelbine|mesh-list
83209625|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83209626|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209627|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83209628|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83209629|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83209630|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209631|NCT05549973|Dexamethasone|dexamethasone|mesh-list
83209632|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209633|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
83209634|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
83209635|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209636|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209637|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209638|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
83209639|NCT05549973|Hormones|hormones|mesh-ancestor
83209640|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209641|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83209642|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209643|NCT02148250|Insulin|insulin|mesh-list
83209644|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83209645|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83209646|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209647|NCT04870359|Prednisolone|prednisolone|mesh-list
83209648|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83209649|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209650|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
83209651|NCT04870359|Hormones|hormones|mesh-ancestor
83209652|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209653|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209654|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83209655|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209656|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
83209657|NCT02705859|Trastuzumab|trastuzumab|mesh-list
83209658|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83209659|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209660|NCT05549583|Metformin|metformin|mesh-list
83209661|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83209662|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83209663|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209664|NCT05549583|Incretins|incretins|mesh-ancestor
83209665|NCT05549583|Hormones|hormones|mesh-ancestor
83209666|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209667|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83209668|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83209669|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209670|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209671|NCT05554731|Hemostatics|hemostatics|mesh-list
83209672|NCT05554731|Coagulants|coagulants|mesh-ancestor
83209673|NCT02172040|Celecoxib|celecoxib|mesh-list
83209674|NCT02172040|Amlodipine|amlodipine|mesh-list
83209675|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83209676|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83209677|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430111|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209678|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209679|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83209680|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209681|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
83209682|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83209683|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209685|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
83209686|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209687|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209688|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209689|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83209690|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83209691|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209692|NCT02367105|Testosterone|testosterone|mesh-list
83209693|NCT02367105|Androgens|androgens|mesh-ancestor
83209694|NCT02367105|Hormones|hormones|mesh-ancestor
83209695|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209696|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209697|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83209698|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209699|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209700|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83209701|NCT01318317|Plerixafor|plerixafor|mesh-list
83209702|NCT01318317|Rituximab|rituximab|mesh-list
83209703|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83209704|NCT01318317|Antibodies|antibodies|mesh-list
83209705|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
83209706|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83209707|NCT01318317|Lenograstim|lenograstim|mesh-list
83209708|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
83209709|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209710|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209711|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209712|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83209713|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83209714|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83209715|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
83209716|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209717|NCT05554185|Aspirin|aspirin|mesh-list
83209718|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83209719|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209720|NCT05554185|Analgesics|analgesics|mesh-ancestor
83209721|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
83209722|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209723|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209724|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209725|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209726|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83209727|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83209728|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209729|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83209730|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83209731|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209732|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
83209733|NCT05558397|Morphine|morphine|mesh-list
83209734|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83209735|NCT05558397|Narcotics|narcotics|mesh-ancestor
83209736|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209737|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209738|NCT05558397|Analgesics|analgesics|mesh-ancestor
83209739|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
83209740|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209741|NCT05558319|Dexamethasone|dexamethasone|mesh-list
83209742|NCT05558319|Lenalidomide|lenalidomide|mesh-list
83209743|NCT05558319|Bortezomib|bortezomib|mesh-list
83209744|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209745|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
83209746|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
83209747|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209748|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209749|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209750|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
83209751|NCT05558319|Hormones|hormones|mesh-ancestor
83209752|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209753|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83209754|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209755|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
83209756|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83209757|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83209758|NCT05558319|Growth Substances|growth substances|mesh-ancestor
83209759|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
83209760|NCT05553717|Carvedilol|carvedilol|mesh-list
83209761|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83209762|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83209763|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209764|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209765|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209766|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209767|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83209768|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
83209769|NCT05553717|Protective Agents|protective agents|mesh-ancestor
83209770|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83209771|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209772|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83209773|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
83209774|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83209775|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83209776|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
83209777|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83209778|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
83209779|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209780|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209781|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83209782|NCT05553093|Insulin|insulin|mesh-list
83209783|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83209784|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
83209785|NCT05553093|Tirzepatide|tirzepatide|mesh-list
83209786|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83209787|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209788|NCT05553093|Incretins|incretins|mesh-ancestor
83209789|NCT05553093|Hormones|hormones|mesh-ancestor
83209790|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209791|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
83209792|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83209793|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83209794|NCT04757740|Prednisolone|prednisolone|mesh-list
83209795|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
83209796|NCT04757740|Lidocaine|lidocaine|mesh-list
83209797|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83209798|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
83209799|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
83209800|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
83209801|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209802|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209803|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
83209804|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209805|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83209806|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83209807|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83209808|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209809|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209810|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209811|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
83209812|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
83209813|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209814|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
83209815|NCT04757740|Hormones|hormones|mesh-ancestor
83209816|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209817|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83209819|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83209820|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209821|NCT05552937|Lenalidomide|lenalidomide|mesh-list
83209822|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
83209823|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209824|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83209825|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83209826|NCT05552937|Growth Substances|growth substances|mesh-ancestor
83209827|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
83209828|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209829|NCT02112448|Acetaminophen|acetaminophen|mesh-list
83209830|NCT02112448|Ketorolac|ketorolac|mesh-list
83209831|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83209832|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83209833|NCT02112448|Analgesics|analgesics|mesh-ancestor
83209834|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
83209835|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209836|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209837|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
83209838|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83209839|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209840|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83209841|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83209842|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209843|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209844|NCT02109562|Risperidone|risperidone|mesh-list
83209845|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83209846|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
83209847|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209848|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209849|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209850|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83209851|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83209852|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209853|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83209854|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83209855|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
83209856|NCT02109484|Vaccines|vaccines|mesh-list
83209857|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
83209858|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209859|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
83209860|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83209861|NCT05134792|Antibodies|antibodies|mesh-list
83209862|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
83209863|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83209864|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
83209865|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209866|NCT04738318|Dexamethasone|dexamethasone|mesh-list
83209867|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
83209868|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
83209869|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209870|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
83209871|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
83209872|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209873|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209874|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209875|NCT04738318|Hormones|hormones|mesh-ancestor
83209876|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83209877|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83209878|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83209879|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83209880|NCT04738318|Protective Agents|protective agents|mesh-ancestor
83209881|NCT02105974|Fluticasone|fluticasone|mesh-list
83209882|NCT02105974|Xhance|xhance|mesh-list
83209883|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209884|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83209885|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
83209886|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209887|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209888|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83209889|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209890|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209891|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83209892|NCT02105662|Grazoprevir|grazoprevir|mesh-list
83209893|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
83209894|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209895|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
83209896|NCT02142712|Promethazine|promethazine|mesh-list
83209897|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
83209898|NCT02142712|Pantoprazole|pantoprazole|mesh-list
83209899|NCT02142712|Famotidine|famotidine|mesh-list
83209900|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83209901|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209902|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83209903|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83209904|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209905|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83209906|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83209907|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209908|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209909|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
83209910|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
83209911|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
83209912|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209913|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
83209914|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
83209915|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83209916|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
83209917|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
83209918|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209919|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83209920|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
83209921|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209922|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
83209923|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209924|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83209925|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83209926|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83209927|NCT02105272|Carteolol|carteolol|mesh-list
83209928|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83209929|NCT02105272|Latanoprost|latanoprost|mesh-list
83209930|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83209931|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83209932|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83209933|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209934|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209935|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209936|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209937|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83209938|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83209939|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
83209940|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
83209941|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209942|NCT02141854|Fluticasone|fluticasone|mesh-list
83209943|NCT02141854|Xhance|xhance|mesh-list
83209944|NCT02141854|Albuterol|albuterol|mesh-list
83209945|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83209946|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
83209947|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83209948|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83209949|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
83209950|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209951|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209952|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83209953|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209954|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
83209955|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83209956|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83209957|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83209958|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
83209959|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209960|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209961|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
83209962|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83209963|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
83209965|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83209966|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
83209967|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83209968|NCT02141620|Expectorants|expectorants|mesh-ancestor
83209969|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
83209970|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83209971|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
83209972|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83209973|NCT02141620|Protective Agents|protective agents|mesh-ancestor
83209974|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209975|NCT02141620|Antidotes|antidotes|mesh-ancestor
83209976|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
83209977|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
83209978|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209979|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
83209980|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83209981|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83209982|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83209983|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83209984|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83209985|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
83209986|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83209987|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83209988|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83209989|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
83209990|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83209991|NCT01664949|Laxatives|laxatives|mesh-ancestor
83209992|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83209993|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
83209994|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
83209995|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
83209996|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83209997|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83209998|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
83209999|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210000|NCT02587065|Interferons|interferons|mesh-list
83210001|NCT02587065|Interferon-beta|interferon-beta|mesh-list
83210002|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
83210003|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210004|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
83210005|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210006|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
83210007|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210008|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83210009|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
83210010|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83210011|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210012|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83210013|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83210014|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210015|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210016|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210017|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83210018|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83210019|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
83210020|NCT05552391|Ketamine|ketamine|mesh-list
83210021|NCT05552391|Bupivacaine|bupivacaine|mesh-list
83210022|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
83210023|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
83210024|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210025|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210026|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
83210027|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210028|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83210029|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83210030|NCT05552391|Analgesics|analgesics|mesh-ancestor
83210031|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83210032|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83210033|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83210034|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210035|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210036|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210037|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83210038|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83210039|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
83210040|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83210041|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83210042|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
83210043|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83210044|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210045|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210046|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83210047|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210048|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83210049|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
83210050|NCT04740814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83210051|NCT04740814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210052|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83210053|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
83210054|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210055|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210057|NCT02105116|Fludarabine|fludarabine|mesh-list
83210058|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
83210059|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210060|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83210061|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
83210062|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210063|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83210064|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
83210065|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210066|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
83210067|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210068|NCT05551767|Cisplatin|cisplatin|mesh-list
83210069|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
83210070|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210071|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210072|NCT05551767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83210073|NCT05551767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210074|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83210075|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83210076|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210077|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83210078|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83210079|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210080|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210081|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
83210082|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210083|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83210084|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83210085|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83210086|NCT05547789|Analgesics|analgesics|mesh-ancestor
83210087|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
83210088|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210089|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210090|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210091|NCT05542095|Simvastatin|simvastatin|mesh-list
83210092|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83210093|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83210094|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
83210095|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210096|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83210097|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83210098|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210099|NCT05551221|Tamsulosin|tamsulosin|mesh-list
83210100|NCT05551221|Silodosin|silodosin|mesh-list
83210101|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83210102|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83210103|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83210104|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210105|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210106|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210107|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210108|NCT05551221|Urological Agents|urological agents|mesh-ancestor
83210109|NCT02104804|Insulin|insulin|mesh-list
83210110|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83210111|NCT02104804|Metformin|metformin|mesh-list
83210112|NCT02104804|Saxagliptin|saxagliptin|mesh-list
83210113|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
83210114|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210115|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210116|NCT02104804|Incretins|incretins|mesh-ancestor
83210117|NCT02104804|Hormones|hormones|mesh-ancestor
83210118|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210119|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83210120|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
83210121|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210122|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210123|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
83210124|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83210125|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210126|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210127|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210129|NCT05550207|Rizatriptan|rizatriptan|mesh-list
83210130|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83210131|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83210132|NCT05550207|Analgesics|analgesics|mesh-ancestor
83210133|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
83210134|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210135|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210136|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210137|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210138|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83210139|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83210140|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210141|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210142|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83210143|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
83210144|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210145|NCT05546853|Leucovorin|leucovorin|mesh-list
83210146|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
83210147|NCT05546853|Irinotecan|irinotecan|mesh-list
83210148|NCT05546853|Calcium|calcium|mesh-list
83210149|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
83210150|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83210151|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210152|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210153|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83210154|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83210155|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210156|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210157|NCT05546853|Antidotes|antidotes|mesh-ancestor
83210158|NCT05546853|Protective Agents|protective agents|mesh-ancestor
83210159|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
83210160|NCT05546853|Vitamins|vitamins|mesh-ancestor
83210161|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
83210162|NCT05546619|Tislelizumab|tislelizumab|mesh-list
83210163|NCT05546619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210164|NCT05546619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210165|NCT05540145|Paclitaxel|paclitaxel|mesh-list
83210166|NCT05540145|Antibodies|antibodies|mesh-list
83210167|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83210168|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210169|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
83210170|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
83210171|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
83210172|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210173|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
83210174|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210175|NCT05592327|Citric Acid|citric acid|mesh-list
83210176|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
83210177|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
83210178|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83210179|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
83210180|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
83210181|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210182|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
83210183|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83210184|NCT05592171|Estrogens|estrogens|mesh-ancestor
83210185|NCT05592171|Hormones|hormones|mesh-ancestor
83210186|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210187|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210188|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83210189|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210190|NCT05539521|Propofol|propofol|mesh-list
83210191|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83210192|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210193|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210194|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83210195|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
83210196|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
83210197|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83210198|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83210199|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210200|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210201|NCT05538507|Memantine|memantine|mesh-list
83210202|NCT05538507|Donepezil|donepezil|mesh-list
83210203|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83210204|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210205|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210206|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
83210207|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210208|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210209|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
83210210|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83210211|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83210212|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
83210213|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83210214|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83210215|NCT05591235|Metformin|metformin|mesh-list
83210216|NCT05591235|Pioglitazone|pioglitazone|mesh-list
83210217|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
83210218|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210219|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210220|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83210221|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210222|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83210224|NCT05545527|Hematinics|hematinics|mesh-ancestor
83210225|NCT01666119|Buprenorphine|buprenorphine|mesh-list
83210226|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83210227|NCT01666119|Narcotics|narcotics|mesh-ancestor
83210228|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210229|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210230|NCT01666119|Analgesics|analgesics|mesh-ancestor
83210231|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
83210232|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210233|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83210234|NCT05361993|Aripiprazole|aripiprazole|mesh-list
83210235|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
83210236|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83210237|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83210238|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83210239|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210240|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210241|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
83210242|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
83210243|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210244|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210245|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83210246|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83210247|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
83210248|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83210249|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83210250|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83210251|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83210252|NCT04425681|Bevacizumab|bevacizumab|mesh-list
83210253|NCT04425681|Osimertinib|osimertinib|mesh-list
83210254|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210255|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210256|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83210257|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83210258|NCT04425681|Growth Substances|growth substances|mesh-ancestor
83210259|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210260|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
83210261|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83210262|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210263|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210264|NCT05545059|Amlodipine|amlodipine|mesh-list
83210265|NCT05545059|Valsartan|valsartan|mesh-list
83210266|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83210267|NCT05545059|Spironolactone|spironolactone|mesh-list
83210268|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83210269|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83210270|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83210271|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210272|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210273|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83210274|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210275|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
83210276|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83210277|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83210278|NCT05545059|Diuretics|diuretics|mesh-ancestor
83210279|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
83210280|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83210281|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83210282|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
83210283|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210284|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83210286|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83210287|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
83210288|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210289|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210290|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83210291|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210292|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83210293|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83210294|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83210295|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
83210296|NCT05536011|Methylphenidate|methylphenidate|mesh-list
83210297|NCT05536011|Modafinil|modafinil|mesh-list
83210298|NCT05536011|Amphetamine|amphetamine|mesh-list
83210299|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83210300|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210301|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83210302|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83210303|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210304|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210305|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
83210306|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210307|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83210308|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83210309|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83210310|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
83210311|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
83210312|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210313|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210314|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83210315|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83210316|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83210317|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
83210318|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
83210319|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210320|NCT04809051|Metronidazole|metronidazole|mesh-list
83210321|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210322|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83210323|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83210324|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83210325|NCT04015869|Pregnanolone|pregnanolone|mesh-list
83210326|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
83210327|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210328|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210329|NCT04677855|Prednisone|prednisone|mesh-list
83210330|NCT04677855|Dutasteride|dutasteride|mesh-list
83210331|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210332|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
83210333|NCT04677855|Hormones|hormones|mesh-ancestor
83210334|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210335|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210336|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83210337|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210338|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83210339|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83210340|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210341|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210343|NCT02584959|Complement C1s|complement c1s|mesh-list
83210344|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83210345|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83210346|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
83210347|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210348|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83210349|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83210350|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
83210351|NCT05544045|Antacids|antacids|mesh-ancestor
83210352|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210353|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83210354|NCT02584257|Albuterol|albuterol|mesh-list
83210355|NCT02584257|Procaterol|procaterol|mesh-list
83210356|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
83210357|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83210358|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
83210359|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210360|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210361|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83210362|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
83210363|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
83210364|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83210365|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83210366|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83210367|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83210368|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210369|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210370|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210371|NCT02584257|Miotics|miotics|mesh-ancestor
83210372|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83210373|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83210374|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83210375|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83210376|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
83210377|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
83210378|NCT04090203|Immunomodulating Agents|immunomodulating agents|mesh-list
83210379|NCT04090203|Immunologic Factors|immunologic factors|mesh-ancestor
83210380|NCT04090203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210381|NCT04062201|Levofloxacin|levofloxacin|mesh-list
83210382|NCT04062201|Ofloxacin|ofloxacin|mesh-list
83210383|NCT04062201|Isoniazid|isoniazid|mesh-list
83210384|NCT04062201|Linezolid|linezolid|mesh-list
83210385|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
83210386|NCT04062201|Ethambutol|ethambutol|mesh-list
83210387|NCT04062201|Bedaquiline|bedaquiline|mesh-list
83210388|NCT04062201|Clofazimine|clofazimine|mesh-list
83210389|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83210390|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210391|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83210392|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83210393|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83210394|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210395|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210396|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210397|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83210398|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83210399|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
83210400|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83210401|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83210402|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
83210403|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83210404|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83210405|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210406|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
83210408|NCT02583477|Gemcitabine|gemcitabine|mesh-list
83210409|NCT02583477|Durvalumab|durvalumab|mesh-list
83210410|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83210411|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83210412|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210413|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83210414|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83210415|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83210416|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210417|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83210418|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
83210419|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210420|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
83210421|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210422|NCT02583399|Ibuprofen|ibuprofen|mesh-list
83210423|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83210424|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83210425|NCT02583399|Analgesics|analgesics|mesh-ancestor
83210426|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
83210427|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210428|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210429|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210430|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210431|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83210432|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210433|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210434|NCT02580591|Empagliflozin|empagliflozin|mesh-list
83210435|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83210436|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210437|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210438|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210439|NCT05552001|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83210440|NCT05552001|Immunoconjugates|immunoconjugates|mesh-ancestor
83210441|NCT05552001|Immunologic Factors|immunologic factors|mesh-ancestor
83210442|NCT05552001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210443|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
83210444|NCT05390307|Liraglutide|liraglutide|mesh-list
83210445|NCT05390307|Glucagon|glucagon|mesh-list
83210446|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83210447|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83210448|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210449|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210450|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210451|NCT05390307|Incretins|incretins|mesh-ancestor
83210452|NCT05390307|Hormones|hormones|mesh-ancestor
83210453|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210454|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83210455|NCT05319249|Talazoparib|talazoparib|mesh-list
83210456|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83210457|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210458|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210459|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210460|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83210461|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83210462|NCT02577315|Metformin|metformin|mesh-list
83210463|NCT02577315|Empagliflozin|empagliflozin|mesh-list
83210464|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210465|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210466|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83210467|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210468|NCT05529069|Venetoclax|venetoclax|mesh-list
83210469|NCT05529069|Pirtobrutinib|pirtobrutinib|mesh-list
83210470|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210471|NCT05529069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83210472|NCT05529069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210473|NCT05529069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210474|NCT01582269|Lomustine|lomustine|mesh-list
83210475|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83210476|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
83210477|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210478|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210479|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
83210480|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210481|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210482|NCT03526887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83210483|NCT03526887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210484|NCT03496779|Gemcitabine|gemcitabine|mesh-list
83210485|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83210486|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83210487|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83210488|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
83210489|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210490|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210491|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210492|NCT03496779|Immunotoxins|immunotoxins|mesh-ancestor
83210493|NCT03496779|Immunoconjugates|immunoconjugates|mesh-ancestor
83210494|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
83210495|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210496|NCT03398655|Paclitaxel|paclitaxel|mesh-list
83210497|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83210498|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83210499|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210500|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83210501|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83210502|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83210503|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210504|NCT05695287|Propofol|propofol|mesh-list
83210505|NCT05695287|Sevoflurane|sevoflurane|mesh-list
83210506|NCT05695287|Isoflurane|isoflurane|mesh-list
83210507|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83210508|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210509|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210510|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83210511|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
83210512|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
83210513|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83210514|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83210515|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
83210516|NCT03808025|Narcotics|narcotics|mesh-ancestor
83210517|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210518|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210519|NCT03808025|Analgesics|analgesics|mesh-ancestor
83210520|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
83210521|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210522|NCT03009201|Doxorubicin|doxorubicin|mesh-list
83210523|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83210524|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83210525|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210526|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83210527|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83210528|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210529|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210530|NCT00591227|Insulin|insulin|mesh-list
83210531|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83210532|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
83210533|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
83210534|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210535|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210536|NCT00408473|Flecainide|flecainide|mesh-list
83210537|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83210538|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83210539|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83210540|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210541|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210542|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
83210543|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
83210544|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210545|NCT00328601|Protective Agents|protective agents|mesh-ancestor
83210546|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210547|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
83210548|NCT00328601|Vitamins|vitamins|mesh-ancestor
83210549|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
83210550|NCT00189293|Imiquimod|imiquimod|mesh-list
83210551|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83210552|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
83210553|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210554|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210555|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
83210556|NCT03194009|Metformin|metformin|mesh-list
83210557|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210558|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210559|NCT02581995|Aflibercept|aflibercept|mesh-list
83210560|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83210561|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83210562|NCT02581995|Growth Substances|growth substances|mesh-ancestor
83210563|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210564|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
83210565|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210566|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83210567|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83210568|NCT03193307|BI 409306|bi 409306|mesh-list
83210569|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83210570|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210571|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210572|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83210573|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
83210574|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83210575|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210576|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83210577|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83210578|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83210579|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83210580|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83210581|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83210582|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83210583|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83210584|NCT02910843|Capecitabine|capecitabine|mesh-list
83210585|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83210586|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
83210587|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210588|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210589|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83210590|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
83210591|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83210592|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
83210593|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83210594|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83420778|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
83210595|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83210596|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83210597|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210599|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83210600|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83210601|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83210602|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210603|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210604|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
83210605|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210606|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210607|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83210608|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210609|NCT03193463|Topotecan|topotecan|mesh-list
83210610|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83210611|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83210612|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210613|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210614|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210615|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83210616|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
83210617|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210618|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210619|NCT02577003|Incretins|incretins|mesh-ancestor
83210620|NCT02577003|Hormones|hormones|mesh-ancestor
83210621|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210622|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83210623|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
83210624|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210625|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210626|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83210627|NCT05487417|Minocycline|minocycline|mesh-list
83210628|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83210629|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210630|NCT03471611|Lenograstim|lenograstim|mesh-list
83210631|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83210632|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
83210633|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210634|NCT05694819|Goserelin|goserelin|mesh-list
83210635|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83210636|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210638|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
83210639|NCT02600897|Lenalidomide|lenalidomide|mesh-list
83210640|NCT02600897|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83210641|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210642|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210643|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
83210644|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210645|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210646|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83210647|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83210648|NCT02600897|Growth Substances|growth substances|mesh-ancestor
83210649|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
83210650|NCT02600897|Immunoconjugates|immunoconjugates|mesh-ancestor
83210651|NCT05674305|Cisplatin|cisplatin|mesh-list
83210652|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210653|NCT03192449|Albendazole|albendazole|mesh-list
83210654|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
83210655|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83210656|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210657|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
83210658|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83210659|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83210660|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
83210661|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
83210662|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
83210663|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210664|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210665|NCT05691933|Morphine|morphine|mesh-list
83210666|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83210667|NCT05691933|Narcotics|narcotics|mesh-ancestor
83210668|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210669|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210670|NCT05691933|Analgesics|analgesics|mesh-ancestor
83210671|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
83210672|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210673|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
83210674|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
83210675|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210676|NCT00977483|Protective Agents|protective agents|mesh-ancestor
83210677|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210678|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
83210679|NCT00977483|Vitamins|vitamins|mesh-ancestor
83210680|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
83210681|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
83210682|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83210683|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210684|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210685|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83210686|NCT02439905|Analgesics|analgesics|mesh-ancestor
83210687|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
83210688|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210689|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83210690|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83210691|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83210692|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210693|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210694|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210695|NCT03192371|Vaccines|vaccines|mesh-list
83210696|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
83210697|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210698|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
83210699|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83210700|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210701|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
83210702|NCT05663073|Amlodipine|amlodipine|mesh-list
83210703|NCT05663073|Irbesartan|irbesartan|mesh-list
83210704|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83210705|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83210706|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210707|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210708|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83210709|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210710|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
83210711|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83210712|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83210713|NCT02442791|Exenatide|exenatide|mesh-list
83210714|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210715|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210716|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83210717|NCT02442791|Incretins|incretins|mesh-ancestor
83210718|NCT02442791|Hormones|hormones|mesh-ancestor
83210719|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210720|NCT04756557|Fluorides|fluorides|mesh-list
83210721|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
83210722|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
83210723|NCT04756557|Protective Agents|protective agents|mesh-ancestor
83210724|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210725|NCT04742673|Guanfacine|guanfacine|mesh-list
83210726|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83210727|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83210728|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83210729|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83210730|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210731|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210732|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210733|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210734|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
83210735|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83210736|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83210737|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210738|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210739|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83210740|NCT02442713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83210741|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83210742|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210743|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210744|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210745|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
83210746|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83210747|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
83210748|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83210749|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83210750|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210751|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83210752|NCT03189953|Exenatide|exenatide|mesh-list
83210753|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210754|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210755|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83210756|NCT03189953|Incretins|incretins|mesh-ancestor
83210757|NCT03189953|Hormones|hormones|mesh-ancestor
83210758|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210759|NCT02204085|Decitabine|decitabine|mesh-list
83210760|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83210761|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
83210762|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210763|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210764|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210765|NCT04314843|Lenzilumab|lenzilumab|mesh-list
83210766|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
83210767|NCT04314843|Fludarabine|fludarabine|mesh-list
83210768|NCT04314843|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83210769|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83210770|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
83210771|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210772|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210773|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83210774|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
83210775|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210776|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210777|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83210778|NCT04314843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210779|NCT04314843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210781|NCT03192293|Fulvestrant|fulvestrant|mesh-list
83210782|NCT03192293|Simvastatin|simvastatin|mesh-list
83210783|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210784|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210785|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83210786|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83210787|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
83210788|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210789|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83210790|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83210791|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210792|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83210793|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210794|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83210795|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83210796|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
83210797|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210798|NCT02439125|Eltoprazine|eltoprazine|mesh-list
83210799|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83210800|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
83210801|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210802|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210803|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210804|NCT02441933|Carboplatin|carboplatin|mesh-list
83210805|NCT02441933|Taxane|taxane|mesh-list
83210806|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210807|NCT01604265|Nabiximols|nabiximols|mesh-list
83210808|NCT01604265|Analgesics|analgesics|mesh-ancestor
83210809|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
83210810|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210811|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210812|NCT04483427|Ketorolac|ketorolac|mesh-list
83210813|NCT04483427|Nalbuphine|nalbuphine|mesh-list
83210814|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83210815|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83210816|NCT04483427|Analgesics|analgesics|mesh-ancestor
83210817|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
83210818|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210819|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210820|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210821|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210822|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83210823|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210824|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210825|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83210826|NCT04483427|Narcotics|narcotics|mesh-ancestor
83210827|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210828|NCT01664247|Liraglutide|liraglutide|mesh-list
83210829|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83210830|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210831|NCT01664247|Incretins|incretins|mesh-ancestor
83210832|NCT01664247|Hormones|hormones|mesh-ancestor
83210833|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210834|NCT02441465|Vemurafenib|vemurafenib|mesh-list
83210835|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210836|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83210837|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210838|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210839|NCT02438657|Lidocaine|lidocaine|mesh-list
83210840|NCT02438657|Epinephrine|epinephrine|mesh-list
83210841|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
83210842|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
83210843|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210844|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210845|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
83210846|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210847|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83210848|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83210849|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83210850|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210851|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210852|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83210853|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83210854|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210855|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210856|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83210857|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83210858|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
83210859|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83210861|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
83210862|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
83210863|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83210864|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
83210865|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83210866|NCT01441947|Fulvestrant|fulvestrant|mesh-list
83210867|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83210868|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210869|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83210870|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83210871|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
83210872|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210873|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210874|NCT03192059|Aspirin|aspirin|mesh-list
83210875|NCT03192059|Vitamin D|vitamin d|mesh-list
83210876|NCT03192059|Curcumin|curcumin|mesh-list
83210877|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
83210878|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
83210879|NCT03192059|Lansoprazole|lansoprazole|mesh-list
83210881|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83210882|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
83210883|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210884|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210885|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83210886|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
83210887|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210888|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210889|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83210890|NCT03192059|Vitamins|vitamins|mesh-ancestor
83210891|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
83210892|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210893|NCT03192059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83210894|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83210895|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83210896|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83210897|NCT03192059|Analgesics|analgesics|mesh-ancestor
83210898|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
83210899|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210900|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210901|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83210902|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83210903|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83210904|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83210905|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210906|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
83210907|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83210908|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83210909|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83210910|NCT02441075|Ethanol|ethanol|mesh-list
83210911|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83210912|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210913|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83210914|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210915|NCT05562999|Bromides|bromides|mesh-list
83210916|NCT05562999|Rocuronium|rocuronium|mesh-list
83210917|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
83210918|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83210919|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83210920|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83210921|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210922|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210923|NCT02438345|Leronlimab|leronlimab|mesh-list
83210924|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83210925|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83210926|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210927|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83210928|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83210929|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
83210930|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210931|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
83210932|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
83210933|NCT03191981|Lenalidomide|lenalidomide|mesh-list
83210934|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83210935|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
83210936|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210937|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83210938|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83210939|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
83210940|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210941|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210942|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83210943|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210944|NCT03191981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83210945|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83210946|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83210947|NCT03191981|Growth Substances|growth substances|mesh-ancestor
83210948|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
83210949|NCT05535075|Vancomycin|vancomycin|mesh-list
83210950|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83210951|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83210952|NCT05530785|Bevacizumab|bevacizumab|mesh-list
83210953|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83210954|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83210955|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83210956|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83210957|NCT05530785|Growth Substances|growth substances|mesh-ancestor
83210958|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210959|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
83210960|NCT05530395|Testosterone|testosterone|mesh-list
83210961|NCT05530395|Androgens|androgens|mesh-ancestor
83210962|NCT05530395|Hormones|hormones|mesh-ancestor
83210963|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83210964|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210965|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
83210966|NCT05389995|Methamphetamine|methamphetamine|mesh-list
83210967|NCT05389995|Citric Acid|citric acid|mesh-list
83210968|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
83210969|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
83210970|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83210971|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
83210972|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
83210973|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210974|NCT05389995|Diuretics|diuretics|mesh-ancestor
83210975|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
83210976|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83210977|NCT05389995|Expectorants|expectorants|mesh-ancestor
83210978|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
83210979|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83210980|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
83210981|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
83210982|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83210983|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
83210984|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83210985|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
83210986|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83210987|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83210988|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83210989|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83210990|NCT04529265|Methylene Blue|methylene blue|mesh-list
83210991|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83210992|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83210993|NCT03191903|Triamcinolone|triamcinolone|mesh-list
83210994|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83210995|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83210996|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83210997|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83210998|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
83210999|NCT03191903|Hormones|hormones|mesh-ancestor
83211000|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211001|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211002|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211003|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
83211004|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211005|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211006|NCT05534685|Budesonide|budesonide|mesh-list
83211007|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83211008|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211009|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83211010|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
83211011|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211012|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211013|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83211014|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
83211015|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
83211016|NCT05534685|Hormones|hormones|mesh-ancestor
83211017|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211018|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
83211019|NCT02437955|Trace Elements|trace elements|mesh-ancestor
83211020|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
83211021|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211022|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
83211023|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83211024|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211025|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83211026|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83211027|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83211028|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211029|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
83211030|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211031|NCT02437721|Folic Acid|folic acid|mesh-list
83211032|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
83211033|NCT02437721|Hematinics|hematinics|mesh-ancestor
83211034|NCT02437721|Vitamins|vitamins|mesh-ancestor
83211035|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
83211036|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211037|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
83211038|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211039|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
83211040|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
83211041|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83211042|NCT05533983|Nivolumab|nivolumab|mesh-list
83211043|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83211044|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211045|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83211046|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211047|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
83211048|NCT02436395|Povidone|povidone|mesh-list
83211049|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
83211050|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
83211051|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83211052|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211053|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83211054|NCT02436083|Cefuroxime|cefuroxime|mesh-list
83211055|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
83211056|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211057|NCT03117335|Endostatins|endostatins|mesh-list
83211058|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211059|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83211060|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83211061|NCT03117335|Growth Substances|growth substances|mesh-ancestor
83211062|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211063|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83211064|NCT02435927|Leucovorin|leucovorin|mesh-list
83211065|NCT02435927|Fluorouracil|fluorouracil|mesh-list
83211066|NCT02435927|Capecitabine|capecitabine|mesh-list
83211067|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
83211068|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
83211069|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211070|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83211071|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211072|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211073|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
83211074|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211075|NCT02435927|Antidotes|antidotes|mesh-ancestor
83211076|NCT02435927|Protective Agents|protective agents|mesh-ancestor
83211077|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
83211078|NCT02435927|Vitamins|vitamins|mesh-ancestor
83211079|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
83211080|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
83211081|NCT02435771|Vitamin D|vitamin d|mesh-list
83211082|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83211083|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211084|NCT02435771|Vitamins|vitamins|mesh-ancestor
83211085|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
83211086|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83211088|NCT02440841|Rifampin|rifampin|mesh-list
83211089|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
83211090|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211091|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83211092|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83211093|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211094|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211095|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83211096|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
83211097|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211098|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211099|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83211100|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83211101|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
83211102|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211103|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
83211104|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83211105|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83211106|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83211107|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83211108|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83211109|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83211110|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83211112|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211113|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
83211114|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211115|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
83211116|NCT02435537|Morphine|morphine|mesh-list
83211117|NCT02435537|Bupivacaine|bupivacaine|mesh-list
83211118|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
83211119|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
83211120|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211121|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211122|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
83211123|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211124|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83211125|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83211126|NCT02435537|Analgesics|analgesics|mesh-ancestor
83211127|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83211128|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83211129|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83211130|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
83211131|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211132|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211133|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83211134|NCT02435537|Narcotics|narcotics|mesh-ancestor
83211135|NCT02576067|Methotrexate|methotrexate|mesh-list
83211136|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83211137|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
83211138|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83211139|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211140|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83211141|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
83211142|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211143|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211144|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
83211145|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211146|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83211147|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211148|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
83211149|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211150|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83211151|NCT02435459|Calcium|calcium|mesh-list
83211152|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83211153|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211154|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
83211155|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211156|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83211157|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211158|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211159|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
83211160|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
83211161|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83211162|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83211163|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211164|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211165|NCT02435303|Urological Agents|urological agents|mesh-ancestor
83211166|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83211167|NCT02434757|Hormones|hormones|mesh-ancestor
83211168|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211169|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211170|NCT03189329|Lidocaine|lidocaine|mesh-list
83211171|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
83211172|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83211173|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
83211174|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211175|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211176|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
83211177|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211178|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83211179|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83211180|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83211181|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83211182|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211183|NCT02575833|Erenumab|erenumab|mesh-list
83211184|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83211185|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211186|NCT02575833|Analgesics|analgesics|mesh-ancestor
83211187|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
83211188|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211189|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211190|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
83211191|NCT02709083|Dasatinib|dasatinib|mesh-list
83211192|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211193|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83211194|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211195|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211196|NCT02709005|Monolaurin|monolaurin|mesh-list
83211197|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
83211198|NCT02709005|Protective Agents|protective agents|mesh-ancestor
83211199|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211200|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
83211201|NCT03188471|Aspirin|aspirin|mesh-list
83211202|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211203|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83211204|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83211205|NCT03188471|Analgesics|analgesics|mesh-ancestor
83211206|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
83211207|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211208|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211209|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211210|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83211211|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83211212|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211213|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83211214|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83211215|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211216|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
83211217|NCT04650087|Apixaban|apixaban|mesh-list
83211218|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83211219|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
83211220|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83211221|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
83211222|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211223|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211224|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
83211225|NCT03188159|Vinorelbine|vinorelbine|mesh-list
83211226|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83211227|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211228|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
83211229|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
83211230|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
83211231|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211232|NCT05532501|Oxytocin|oxytocin|mesh-list
83211234|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83211235|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211236|NCT05524857|Decitabine|decitabine|mesh-list
83211237|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83211238|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
83211239|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211240|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211241|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211242|NCT05192889|Leucovorin|leucovorin|mesh-list
83211243|NCT05192889|Cytarabine|cytarabine|mesh-list
83211244|NCT05192889|Dexamethasone|dexamethasone|mesh-list
83211245|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
83211246|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
83211247|NCT05192889|Methotrexate|methotrexate|mesh-list
83211248|NCT05192889|Etoposide|etoposide|mesh-list
83211249|NCT05192889|Vincristine|vincristine|mesh-list
83211250|NCT05192889|Venetoclax|venetoclax|mesh-list
83211251|NCT05192889|Asparaginase|asparaginase|mesh-list
83211252|NCT05192889|Dasatinib|dasatinib|mesh-list
83211253|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
83211254|NCT05192889|Pegaspargase|pegaspargase|mesh-list
83211255|NCT05192889|Blinatumomab|blinatumomab|mesh-list
83211256|NCT05192889|Navitoclax|navitoclax|mesh-list
83211257|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211258|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
83211259|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211260|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211261|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83211262|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
83211263|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211264|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211265|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83211266|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211267|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
83211268|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
83211269|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211270|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83211271|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
83211272|NCT05192889|Hormones|hormones|mesh-ancestor
83211273|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211274|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83211275|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83211276|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
83211277|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83211278|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83211279|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
83211280|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
83211281|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211282|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83211283|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83211284|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83211285|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83211286|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83211287|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
83211288|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211289|NCT05192889|Antidotes|antidotes|mesh-ancestor
83211290|NCT05192889|Protective Agents|protective agents|mesh-ancestor
83211291|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
83211292|NCT05192889|Vitamins|vitamins|mesh-ancestor
83211293|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
83211294|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
83211295|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
83211296|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
83211297|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83211298|NCT05327439|Nicotine|nicotine|mesh-list
83211299|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83211300|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
83211301|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211302|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211303|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83211304|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83211305|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83211306|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211307|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211308|NCT03187691|Amphotericin B|amphotericin b|mesh-list
83211309|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83211310|NCT03187691|Amebicides|amebicides|mesh-ancestor
83211311|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83211312|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83211313|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211314|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211315|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
83211317|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83211318|NCT02433899|Dexamethasone|dexamethasone|mesh-list
83211319|NCT02433899|Epinephrine|epinephrine|mesh-list
83211320|NCT02433899|Mepivacaine|mepivacaine|mesh-list
83211321|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211322|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
83211323|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
83211324|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211325|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211326|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83211327|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
83211328|NCT02433899|Hormones|hormones|mesh-ancestor
83211329|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211330|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83211331|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211332|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83211333|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211334|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
83211335|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
83211336|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83211337|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83211338|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
83211339|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211340|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211341|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83211342|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83211343|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83211344|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
83211345|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
83211346|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
83211347|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83211348|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
83211349|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
83211350|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211351|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
83211352|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
83211353|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211354|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211355|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83211356|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83211357|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211358|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211359|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211360|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83211361|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83211362|NCT03187457|Metronidazole|metronidazole|mesh-list
83211363|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211364|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211365|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83211366|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83211367|NCT03187223|Melphalan|melphalan|mesh-list
83211368|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83211369|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83211370|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
83211371|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211372|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211373|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83211374|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211375|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
83211376|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211377|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
83211378|NCT05532111|Rituximab|rituximab|mesh-list
83211379|NCT05532111|Tacrolimus|tacrolimus|mesh-list
83211380|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
83211381|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211382|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
83211383|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211384|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211385|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83211386|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
83211387|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211388|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211389|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83211390|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83211391|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83211392|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211393|NCT05532111|Hormones|hormones|mesh-ancestor
83211394|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211395|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83211396|NCT04299867|Metronidazole|metronidazole|mesh-list
83211397|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211398|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211399|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83211400|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83211401|NCT02433587|Aspirin|aspirin|mesh-list
83211402|NCT02433587|Clopidogrel|clopidogrel|mesh-list
83211403|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83211404|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83211406|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
83211407|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211408|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211409|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211410|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211411|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83211412|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83211413|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211414|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83211415|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83211416|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211417|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
83211418|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83211419|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83211420|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83211421|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
83211422|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211423|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83211424|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83211425|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83211426|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83211427|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211428|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211429|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211430|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83211431|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
83211432|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83211433|NCT05307627|Naltrexone|naltrexone|mesh-list
83211434|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83211435|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83211436|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211437|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
83211438|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211439|NCT03190733|Fludarabine|fludarabine|mesh-list
83211440|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211441|NCT04425135|Carboplatin|carboplatin|mesh-list
83211442|NCT04425135|Apatinib|apatinib|mesh-list
83211443|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211444|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83211445|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211446|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211447|NCT02573883|Clobetasol|clobetasol|mesh-list
83211448|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211449|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
83211450|NCT02573883|Hormones|hormones|mesh-ancestor
83211451|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211452|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211453|NCT02432885|Enalapril|enalapril|mesh-list
83211454|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83211455|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
83211456|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211457|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211458|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83211459|NCT02433041|Ketamine|ketamine|mesh-list
83211460|NCT02433041|Haloperidol|haloperidol|mesh-list
83211461|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
83211462|NCT02433041|Analgesics|analgesics|mesh-ancestor
83211463|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
83211464|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211465|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211466|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83211467|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83211468|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
83211469|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
83211470|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211471|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83211472|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83211473|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211474|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211475|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
83211476|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
82735837|NCT00890955|Amrubicin|amrubicin|mesh-list
83211477|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83211478|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83211479|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83211480|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83211481|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83211482|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
83211483|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83211485|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
83211486|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211487|NCT02429921|Protective Agents|protective agents|mesh-ancestor
83211488|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211489|NCT02429921|Trace Elements|trace elements|mesh-ancestor
83211490|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
83211491|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83211492|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83211493|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83211494|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211495|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211496|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
83211497|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211498|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83211499|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83211500|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83211501|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83211502|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211503|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211504|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
83211505|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211506|NCT02432807|Vancomycin|vancomycin|mesh-list
83211507|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211508|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211509|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
83211510|NCT05527275|Analgesics|analgesics|mesh-ancestor
83211511|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
83211512|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211513|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211514|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211515|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83211516|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83211517|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211518|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211519|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
83211520|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83211521|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
83211522|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211523|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211524|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83211525|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83211526|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83211527|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83211528|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83211529|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83211530|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362183|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83211531|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211532|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
83211533|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83211534|NCT03186053|Protective Agents|protective agents|mesh-ancestor
83211535|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211536|NCT02429219|Ethanol|ethanol|mesh-list
83211537|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83211538|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211539|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211540|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211541|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83211542|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
83211543|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211544|NCT02429453|Thrombin|thrombin|mesh-list
83211545|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
83211546|NCT02429453|Coagulants|coagulants|mesh-ancestor
83211547|NCT02428751|Prednisone|prednisone|mesh-list
83211548|NCT02428751|Rituximab|rituximab|mesh-list
83211549|NCT02428751|Doxorubicin|doxorubicin|mesh-list
83211550|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83211551|NCT02428751|Vincristine|vincristine|mesh-list
83211552|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83211553|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211554|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
83211555|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211556|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211557|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83211558|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83211559|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83211560|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211561|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211562|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211563|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
83211564|NCT02428751|Hormones|hormones|mesh-ancestor
83211565|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211566|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83211567|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83211568|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83211569|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83211570|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83211571|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83211572|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83211573|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83211574|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83211575|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83211576|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
83211577|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211578|NCT02432651|Xanthohumol|xanthohumol|mesh-list
83211579|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211580|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83211581|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83211582|NCT02432651|Growth Substances|growth substances|mesh-ancestor
83211583|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211584|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
83211585|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83211586|NCT02707757|Hematinics|hematinics|mesh-ancestor
83211587|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
83211588|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83211589|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211590|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83211591|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
83211592|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211593|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211594|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211595|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211596|NCT03184805|Aspirin|aspirin|mesh-list
83211597|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83211598|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83211599|NCT03184805|Analgesics|analgesics|mesh-ancestor
83211600|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
83211601|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211602|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211603|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211605|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83211606|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83211607|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211608|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83211609|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83211610|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211611|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
83211612|NCT05518383|Cytarabine|cytarabine|mesh-list
83211613|NCT05518383|Dexamethasone|dexamethasone|mesh-list
83211614|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
83211615|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
83211616|NCT05518383|Melphalan|melphalan|mesh-list
83211617|NCT05518383|Ifosfamide|ifosfamide|mesh-list
83211618|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
83211619|NCT05518383|Doxorubicin|doxorubicin|mesh-list
83211620|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83211621|NCT05518383|Methotrexate|methotrexate|mesh-list
83211622|NCT05518383|Etoposide|etoposide|mesh-list
83211623|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
83211624|NCT05518383|Vincristine|vincristine|mesh-list
83211625|NCT05518383|Idarubicin|idarubicin|mesh-list
83211626|NCT05518383|Carboplatin|carboplatin|mesh-list
83211627|NCT05518383|BB 1101|bb 1101|mesh-list
83211628|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211629|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
83211630|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211631|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211632|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83211633|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
83211634|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211635|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211636|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83211637|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211638|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
83211639|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
83211640|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211641|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83211642|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
83211643|NCT05518383|Hormones|hormones|mesh-ancestor
83211644|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211645|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83211646|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
83211647|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211648|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83211649|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83211650|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83211651|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83211652|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
83211653|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83211654|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83211655|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
83211656|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
83211657|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83211658|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83211659|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83211660|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
83211661|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211662|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
83211663|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
83211664|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
83211665|NCT02432027|Betamethasone|betamethasone|mesh-list
83211666|NCT02432027|Calcipotriene|calcipotriene|mesh-list
83211667|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211668|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
83211669|NCT02432027|Hormones|hormones|mesh-ancestor
83430156|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83211670|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211671|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211672|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83211673|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
83211674|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
83211675|NCT02428439|Lamotrigine|lamotrigine|mesh-list
83211676|NCT02428439|Bupropion|bupropion|mesh-list
83211677|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83211678|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
83211679|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83211680|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83211681|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83362184|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
83211682|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83211683|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211684|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
83211685|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211686|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211687|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83211688|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83211689|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211690|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
83211691|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83211692|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83211693|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83211694|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83211695|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211696|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83211697|NCT03186443|Pregabalin|pregabalin|mesh-list
83211698|NCT03186443|Gabapentin|gabapentin|mesh-list
83211699|NCT03186443|Analgesics|analgesics|mesh-ancestor
83211700|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
83211701|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211702|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211703|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
83211704|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83211705|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83211706|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211707|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83211708|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83211709|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83211710|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211711|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83211712|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83211713|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83211714|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211715|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
83211716|NCT03186131|Vitamin D|vitamin d|mesh-list
83211717|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
83211718|NCT03186131|Vitamins|vitamins|mesh-ancestor
83211719|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
83211720|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211721|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83211722|NCT03184649|Acetaminophen|acetaminophen|mesh-list
83211723|NCT03184649|Ibuprofen|ibuprofen|mesh-list
83211724|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83211725|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83211726|NCT03184649|Analgesics|analgesics|mesh-ancestor
83211727|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
83211728|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211729|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211730|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211731|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211732|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83211733|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211734|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211735|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
83211736|NCT05105841|Venetoclax|venetoclax|mesh-list
83211737|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
83211738|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211739|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83211740|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
83211741|NCT02432261|ST 1435|st 1435|mesh-list
83211742|NCT02432261|Testosterone|testosterone|mesh-list
83211743|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
83211744|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
83211745|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83211746|NCT02432261|Androgens|androgens|mesh-ancestor
83211747|NCT02432261|Hormones|hormones|mesh-ancestor
83211748|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211749|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211750|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83211751|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211752|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
83211753|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83211754|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
83211755|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83211756|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83211757|NCT02428283|Remifentanil|remifentanil|mesh-list
83211758|NCT02428283|Ropivacaine|ropivacaine|mesh-list
83211759|NCT02428283|Sevoflurane|sevoflurane|mesh-list
83211760|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
83211761|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
83211762|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211763|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211764|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
83211765|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211766|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83211767|NCT02428283|Narcotics|narcotics|mesh-ancestor
83211768|NCT02428283|Analgesics|analgesics|mesh-ancestor
83211769|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83211770|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83211771|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
83211772|NCT02427893|Vemurafenib|vemurafenib|mesh-list
83211773|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211774|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83211775|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211776|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211777|NCT03184493|Metformin|metformin|mesh-list
83211778|NCT03184493|Celecoxib|celecoxib|mesh-list
83211779|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83211780|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211781|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83211782|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83211783|NCT03184493|Analgesics|analgesics|mesh-ancestor
83211784|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
83211785|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211786|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211787|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211788|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83211789|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83211790|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211791|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211792|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
83211793|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211794|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83211795|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211796|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211797|NCT02431325|Teduglutide|teduglutide|mesh-list
83211798|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83211799|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83211800|NCT02431325|Protective Agents|protective agents|mesh-ancestor
83211801|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211802|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
83211803|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
83211804|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
83211805|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211806|NCT02103478|Decitabine|decitabine|mesh-list
83211807|NCT02103478|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83211808|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83211809|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
83211810|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211811|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211812|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211814|NCT02431013|Simvastatin|simvastatin|mesh-list
83211815|NCT02431013|Pravastatin|pravastatin|mesh-list
83211816|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83211817|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83211818|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
83211819|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211820|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83211821|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83211822|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211823|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83211824|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
83211825|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211826|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211827|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83211828|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
83211829|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83211830|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83211831|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83211832|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
83211833|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83211834|NCT02431013|Protective Agents|protective agents|mesh-ancestor
83211835|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83211836|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83211837|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
83211838|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
83211839|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211840|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83211841|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211842|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83211843|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
83211844|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211845|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211846|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83211847|NCT02430545|Rifampin|rifampin|mesh-list
83211848|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83211849|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
83211850|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83211851|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211852|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
83211853|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83211854|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211855|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211856|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83211857|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83211858|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83211859|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83211860|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83211861|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83211862|NCT03117725|Melatonin|melatonin|mesh-list
83211863|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
83211864|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211865|NCT03117725|Protective Agents|protective agents|mesh-ancestor
83211866|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211867|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211868|NCT03185351|Midazolam|midazolam|mesh-list
83211869|NCT03185351|Bupivacaine|bupivacaine|mesh-list
83211870|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
83211871|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
83211872|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211873|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211874|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
83211875|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211876|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83211877|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83211878|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83211879|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83211880|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83211881|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83211883|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
83211884|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
83211885|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211886|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211887|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
83211888|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83211889|NCT02707601|Ledipasvir|ledipasvir|mesh-list
83211890|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83211891|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
83211892|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83211893|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83211894|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83211895|NCT03183557|Vitamin D|vitamin d|mesh-list
83211896|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
83211897|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
83211898|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83211899|NCT03183557|Vitamins|vitamins|mesh-ancestor
83211900|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
83211901|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211902|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83211903|NCT02426723|Dexamethasone|dexamethasone|mesh-list
83211904|NCT02426723|Lenalidomide|lenalidomide|mesh-list
83211905|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211906|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
83211907|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
83211908|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211909|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211910|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83211911|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
83211912|NCT02426723|Hormones|hormones|mesh-ancestor
83211913|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211914|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83211915|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211916|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
83211917|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83211918|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83211919|NCT02426723|Growth Substances|growth substances|mesh-ancestor
83211920|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
83211921|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
83211922|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
83211923|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83211924|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83211925|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
83211926|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211927|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211928|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211929|NCT02425241|Vaccines|vaccines|mesh-list
83211930|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
83211931|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211932|NCT03182855|Ticagrelor|ticagrelor|mesh-list
83211933|NCT03182855|Cangrelor|cangrelor|mesh-list
83211934|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83211935|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83211936|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83211937|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83211938|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
83211939|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211940|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211941|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211942|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
83211943|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83211944|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83211945|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211946|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211947|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
83211948|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211949|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211950|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83211952|NCT02426177|Nifedipine|nifedipine|mesh-list
83211953|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83211954|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83211955|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211956|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83211957|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211958|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
83211959|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
83211960|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83211961|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83211962|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83211963|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
83211964|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83211965|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83211966|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
83211967|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
83211968|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211969|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83211970|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83211971|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
83211972|NCT02426099|Spironolactone|spironolactone|mesh-list
83211973|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83211974|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
83211975|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83211976|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211977|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83211978|NCT02426099|Diuretics|diuretics|mesh-ancestor
83211979|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
83211980|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83211981|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
83211982|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211983|NCT02425709|Diclofenac|diclofenac|mesh-list
83211984|NCT02425709|Tramadol|tramadol|mesh-list
83211985|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83211986|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83211987|NCT02425709|Analgesics|analgesics|mesh-ancestor
83211988|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
83211989|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83211990|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83211991|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83211992|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83211993|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83211994|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83211995|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83211996|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83211997|NCT02425709|Narcotics|narcotics|mesh-ancestor
83211998|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83211999|NCT02073682|Heparin|heparin|mesh-list
83212000|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83212002|NCT02073682|Dalteparin|dalteparin|mesh-list
83212003|NCT02073682|Edoxaban|edoxaban|mesh-list
83212004|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
83212005|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83212006|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83212007|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212008|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83212009|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
83212010|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83212011|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212012|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212013|NCT03181919|Letrozole|letrozole|mesh-list
83212014|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212015|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83212016|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83212017|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212018|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212019|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83212020|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
83212021|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212022|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212023|NCT02706899|Azacitidine|azacitidine|mesh-list
83212024|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212025|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
83212026|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212027|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212028|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212029|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
83212030|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
83212031|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83212032|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83212033|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212034|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212035|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212036|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212037|NCT02424695|Gabapentin|gabapentin|mesh-list
83212038|NCT02424695|Analgesics|analgesics|mesh-ancestor
83212039|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
83212040|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212041|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212042|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
83212043|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83212044|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83212045|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212046|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83212047|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83212048|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83212049|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212050|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212051|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
83212052|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
83212053|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83212054|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
83212055|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83212056|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212057|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212058|NCT02422277|Urological Agents|urological agents|mesh-ancestor
83212060|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83212061|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83212062|NCT02422121|Analgesics|analgesics|mesh-ancestor
83212063|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
83212064|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212065|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212066|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212067|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212068|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83212069|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
83212070|NCT02424461|Ofloxacin|ofloxacin|mesh-list
83212071|NCT02424461|Levofloxacin|levofloxacin|mesh-list
83212072|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83212073|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212074|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83212075|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83212076|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83212077|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212078|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212079|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212080|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83212081|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83212082|NCT02072824|Pregabalin|pregabalin|mesh-list
83212083|NCT02072824|Analgesics|analgesics|mesh-ancestor
83212084|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
83212085|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212086|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212087|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
83212088|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83212089|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83212090|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212091|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83212092|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83212093|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83212094|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212095|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83212096|NCT03117257|Cisplatin|cisplatin|mesh-list
83212097|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212098|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
83212099|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83212100|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
83212101|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83212102|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212103|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212104|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212105|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
83212106|NCT03181685|Cetrorelix|cetrorelix|mesh-list
83212107|NCT03181685|Progesterone|progesterone|mesh-list
83212108|NCT03181685|Progestins|progestins|mesh-ancestor
83212109|NCT03181685|Hormones|hormones|mesh-ancestor
83212110|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212111|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212112|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83212113|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
83212114|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83212115|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
83212116|NCT02424071|Melatonin|melatonin|mesh-list
83212117|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
83212118|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212119|NCT02424071|Protective Agents|protective agents|mesh-ancestor
83212120|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212121|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212122|NCT03178955|Etanercept|etanercept|mesh-list
83212123|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83212124|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83212125|NCT03178955|Analgesics|analgesics|mesh-ancestor
83212126|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
83212127|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212128|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212129|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212130|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212131|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83212132|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212133|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
83212134|NCT01598506|Hydromorphone|hydromorphone|mesh-list
83212135|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83212136|NCT01598506|Narcotics|narcotics|mesh-ancestor
83212137|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212138|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212140|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
83212141|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212142|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
83212143|NCT02423915|Sirolimus|sirolimus|mesh-list
83212144|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
83212145|NCT02423915|Rituximab|rituximab|mesh-list
83212146|NCT02423915|Fludarabine|fludarabine|mesh-list
83212147|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
83212148|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212149|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
83212150|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212151|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212152|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212153|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
83212154|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212155|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212156|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83212157|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212158|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212159|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
83212160|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212161|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83212162|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83212163|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
83212164|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83212165|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212166|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
83212167|NCT02423837|Rituximab|rituximab|mesh-list
83212168|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83212169|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212170|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212171|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
83212172|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212173|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212174|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212175|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
83212176|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212177|NCT02140060|Travoprost|travoprost|mesh-list
83212178|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83212179|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83212180|NCT02140060|Brinzolamide|brinzolamide|mesh-list
83212181|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83212182|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83212183|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212184|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212185|NCT03178721|Calcium|calcium|mesh-list
83212186|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83212187|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212188|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
83212189|NCT02421029|Edetic Acid|edetic acid|mesh-list
83212190|NCT02421029|Calcium|calcium|mesh-list
83212191|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
83212192|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83212193|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212194|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83212195|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
83212196|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83212197|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
83212198|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
83212199|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212200|NCT02421029|Antidotes|antidotes|mesh-ancestor
83212201|NCT02421029|Protective Agents|protective agents|mesh-ancestor
83212202|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83212203|NCT02139982|Ropivacaine|ropivacaine|mesh-list
83212204|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
83212205|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
83212206|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212207|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212208|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
83212209|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212210|NCT03178643|Piperaquine|piperaquine|mesh-list
83212211|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
83212212|NCT03178643|Amodiaquine|amodiaquine|mesh-list
83212213|NCT03178643|Artenimol|artenimol|mesh-list
83212214|NCT03178643|Proguanil|proguanil|mesh-list
83212215|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
83212216|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83212217|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83212218|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212219|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83212220|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
83212221|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212222|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83212223|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212224|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212225|NCT02139592|Immunotoxins|immunotoxins|mesh-ancestor
83212226|NCT02139592|Immunoconjugates|immunoconjugates|mesh-ancestor
83212227|NCT02139592|Immunologic Factors|immunologic factors|mesh-ancestor
83212228|NCT02139592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212229|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
83212230|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212231|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
83212232|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212233|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212234|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212235|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
83212236|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212237|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212238|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83212239|NCT02072434|Enoxaparin|enoxaparin|mesh-list
83212240|NCT02072434|Warfarin|warfarin|mesh-list
83212241|NCT02072434|Edoxaban|edoxaban|mesh-list
83212242|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
83212243|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83212244|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83212245|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212246|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83212247|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
83212248|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83212249|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212250|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212251|NCT04725994|Irinotecan|irinotecan|mesh-list
83212252|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83212253|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83212254|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212255|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212256|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212257|NCT02139046|Naproxen|naproxen|mesh-list
83212258|NCT02139046|Colchicine|colchicine|mesh-list
83212259|NCT02139046|Febuxostat|febuxostat|mesh-list
83212260|NCT02139046|Lansoprazole|lansoprazole|mesh-list
83212261|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
83212262|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83212263|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83212264|NCT02139046|Analgesics|analgesics|mesh-ancestor
83212265|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
83212266|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212267|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212268|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212269|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212270|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
83212271|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83212272|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212273|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212274|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
83212275|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
83212276|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
83212277|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212278|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83212279|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83212280|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83212281|NCT04734262|Paclitaxel|paclitaxel|mesh-list
83212282|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83212283|NCT04734262|Tislelizumab|tislelizumab|mesh-list
83212284|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83212285|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212286|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
83212287|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
83212288|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
83212289|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212290|NCT04734262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212291|NCT02100670|Diclofenac|diclofenac|mesh-list
83212292|NCT02100670|Menthol|menthol|mesh-list
83212293|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83212294|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83212295|NCT02100670|Analgesics|analgesics|mesh-ancestor
83212296|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
83212297|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212298|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212299|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212300|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212301|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83212302|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212303|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212304|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
83212305|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212306|NCT02100514|Bococizumab|bococizumab|mesh-list
83212307|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83212308|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83212309|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
83212310|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212311|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83212312|NCT02069392|Nicotine|nicotine|mesh-list
83212313|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83212314|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
83212315|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212316|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212317|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83212318|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83212319|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
83212320|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212321|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212322|NCT05522361|Risdiplam|risdiplam|mesh-list
83212323|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83212324|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212325|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212326|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
83212327|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83212328|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212329|NCT02046616|Methotrexate|methotrexate|mesh-list
83212330|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83212331|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
83212332|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83212333|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212334|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212335|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
83212336|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212337|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212338|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212339|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212340|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83212342|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
83212343|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212344|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83212346|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83212347|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
83212348|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212349|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212350|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83212351|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212352|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83212353|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83212354|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83212355|NCT04706026|Anesthetics|anesthetics|mesh-list
83212356|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212357|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212358|NCT02068222|Ritonavir|ritonavir|mesh-list
83212359|NCT02068222|Ribavirin|ribavirin|mesh-list
83212360|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83212361|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83212362|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212363|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212364|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212365|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83212366|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83212367|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
83212368|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212369|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83212370|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83212371|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
83212372|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
83212373|NCT05517213|Etoposide|etoposide|mesh-list
83212374|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212375|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
83212376|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212377|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212378|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212379|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
83212380|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212381|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212382|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83212383|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83212384|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83212385|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83212386|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212387|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
83212388|NCT05516589|Paclitaxel|paclitaxel|mesh-list
83212389|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83212390|NCT05516589|Tislelizumab|tislelizumab|mesh-list
83212391|NCT05516589|Afatinib|afatinib|mesh-list
83212392|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83212393|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212394|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
83212395|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
83212396|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
83212397|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212398|NCT05516589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212399|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83212400|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212401|NCT02099110|Metformin|metformin|mesh-list
83212402|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
83212403|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83212405|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
83212406|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83212407|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212408|NCT02099110|Incretins|incretins|mesh-ancestor
83212409|NCT02099110|Hormones|hormones|mesh-ancestor
83212410|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212411|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83212412|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212413|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212414|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212415|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83212416|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212417|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
83212418|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83212420|NCT02098876|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83212421|NCT02098876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83212422|NCT02098876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212423|NCT02098876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212424|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212425|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
83212426|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212427|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212428|NCT01624090|Plicamycin|plicamycin|mesh-list
83212429|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83212430|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212431|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83212432|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212433|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83212434|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212435|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212436|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83212437|NCT02571777|Fluticasone|fluticasone|mesh-list
83212438|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83212439|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212440|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83212441|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
83212442|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212443|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212444|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83212445|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
83212446|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212447|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83212448|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83212449|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83212450|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83212451|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
83212452|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212453|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212454|NCT05511831|Ketotifen|ketotifen|mesh-list
83212455|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
83212456|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212457|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83212458|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
83212459|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
83212460|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212461|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212462|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212463|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83212464|NCT02705105|Nivolumab|nivolumab|mesh-list
83212465|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
83212466|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212467|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212468|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83212469|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212470|NCT05521347|Caffeine|caffeine|mesh-list
83212471|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83212472|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212473|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83212474|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212475|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212476|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83212477|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83212478|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
83212479|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212480|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83212481|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
83212482|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212483|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
83212484|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212485|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
83212486|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
83212487|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212488|NCT05093517|Volagidemab|volagidemab|mesh-list
83212489|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83212490|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212491|NCT02420171|Insulin|insulin|mesh-list
83212492|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83212493|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212494|NCT03180593|Valsartan|valsartan|mesh-list
83212495|NCT03180593|Nebivolol|nebivolol|mesh-list
83212496|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83212497|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83212498|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83212499|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212500|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
83212501|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83212502|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83212503|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83212504|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
83212505|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212506|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212507|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
83212508|NCT02423759|Gentamicins|gentamicins|mesh-list
83212509|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83212510|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212511|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83212512|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83212513|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212514|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212515|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212516|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83212517|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83212518|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83212519|NCT01623310|Fluticasone|fluticasone|mesh-list
83212521|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212522|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83212523|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
83212524|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212525|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212526|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83212527|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
83212528|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212529|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83212530|NCT03180125|Lidocaine|lidocaine|mesh-list
83212531|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
83212532|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
83212533|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
83212534|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212535|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212536|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
83212537|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212538|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83212539|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83212540|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83212541|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83212542|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212543|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83212544|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
83212545|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
83212546|NCT03180125|Protective Agents|protective agents|mesh-ancestor
83212547|NCT02423603|Paclitaxel|paclitaxel|mesh-list
83212548|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83212549|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212550|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
83212551|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
83212552|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
83212553|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212554|NCT03178409|Liver Extracts|liver extracts|mesh-list
83212555|NCT03178409|Hematinics|hematinics|mesh-ancestor
83212556|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83212557|NCT03180281|Glimepiride|glimepiride|mesh-list
83212558|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83212559|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212560|NCT03180281|Incretins|incretins|mesh-ancestor
83212561|NCT03180281|Hormones|hormones|mesh-ancestor
83212562|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212563|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83212564|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212565|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212566|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212567|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83212568|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212569|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
83212570|NCT03116945|Gallium citrate|gallium citrate|mesh-list
83212571|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212572|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83212573|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
83212574|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83212575|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212576|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212577|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83212578|NCT03117023|Analgesics|analgesics|mesh-ancestor
83212579|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
83212580|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212581|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83212582|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83212583|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83212584|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
83212585|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212586|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212587|NCT02097238|Halichondrin B|halichondrin b|mesh-list
83212588|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
83212589|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
83212590|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
83212591|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212592|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212593|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
83212594|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212595|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
83212596|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83212597|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212599|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83212600|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83212601|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212602|NCT02419391|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83212603|NCT02419391|Antiviral Agents|antiviral agents|mesh-ancestor
83212604|NCT02419391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212605|NCT02419235|Ethanol|ethanol|mesh-list
83212606|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83212607|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212608|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212609|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212610|NCT02422823|Epinephrine|epinephrine|mesh-list
83212611|NCT02422823|Carticaine|carticaine|mesh-list
83212612|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83212613|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83212614|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
83212615|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212616|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212617|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212618|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83212619|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83212620|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
83212621|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212622|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83212623|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
83212624|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
83212625|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
83212626|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83212627|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
83212628|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
83212629|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212630|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
83212631|NCT02422589|Ceritinib|ceritinib|mesh-list
83212632|NCT02422589|Midazolam|midazolam|mesh-list
83212633|NCT02422589|Warfarin|warfarin|mesh-list
83212634|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83212635|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83212636|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212637|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212638|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83212639|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83212640|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83212641|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83212642|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
83212644|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
83212645|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
83212646|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212647|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212648|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
83212649|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212650|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83212651|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212653|NCT02422199|Lapatinib|lapatinib|mesh-list
83212654|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212655|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
83212656|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212657|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212658|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83212659|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212660|NCT02416739|Niacinamide|niacinamide|mesh-list
83212661|NCT02416739|Niacin|niacin|mesh-list
83212662|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
83212663|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
83212664|NCT02416739|Vitamins|vitamins|mesh-ancestor
83212665|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
83212666|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212667|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83212668|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
83212669|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212670|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83212671|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
83212672|NCT02416583|Oxytocin|oxytocin|mesh-list
83212673|NCT02416583|Dinoprostone|dinoprostone|mesh-list
83212674|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
83212675|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83212676|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212677|NCT02416427|Atorvastatin|atorvastatin|mesh-list
83212678|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83212679|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83212680|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
83212681|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212682|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83212683|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83212684|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212685|NCT02416271|Vitamin D|vitamin d|mesh-list
83212686|NCT02416271|Alendronate|alendronate|mesh-list
83212687|NCT02416271|Teriparatide|teriparatide|mesh-list
83212688|NCT02416271|Calcium|calcium|mesh-list
83212689|NCT02416271|Vitamins|vitamins|mesh-ancestor
83212690|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
83212691|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212692|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83212693|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83212694|NCT02416115|Morphine|morphine|mesh-list
83212695|NCT02416115|Ramosetron|ramosetron|mesh-list
83212696|NCT02416115|Naloxone|naloxone|mesh-list
83212697|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83212698|NCT02416115|Narcotics|narcotics|mesh-ancestor
83212699|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212700|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212701|NCT02416115|Analgesics|analgesics|mesh-ancestor
83212702|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
83212703|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212704|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83212705|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
83212706|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
83212707|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83212708|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83212709|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
83212710|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212711|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212712|NCT02415881|Panitumumab|panitumumab|mesh-list
83212713|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212714|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212716|NCT02415803|Ticagrelor|ticagrelor|mesh-list
83212717|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83212718|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83212719|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83212720|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83212721|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
83212722|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212723|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212724|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212725|NCT04482881|Isosorbide|isosorbide|mesh-list
83212726|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83212727|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83212728|NCT04482881|Misoprostol|misoprostol|mesh-list
83212729|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83212730|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
83212731|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83212732|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212733|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83212734|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83212735|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
83212736|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83212737|NCT04482881|Diuretics|diuretics|mesh-ancestor
83212738|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
83212739|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
83212740|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83212741|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212742|NCT03176693|Doxazosin|doxazosin|mesh-list
83212743|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
83212744|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83212745|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83212746|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83212747|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83212748|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83212749|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212750|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212751|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212752|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
83212753|NCT02415569|Bisacodyl|bisacodyl|mesh-list
83212754|NCT02415569|Cathartics|cathartics|mesh-ancestor
83212755|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83212756|NCT02415569|Laxatives|laxatives|mesh-ancestor
83212757|NCT02415335|Dexamethasone|dexamethasone|mesh-list
83212758|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
83212759|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83212760|NCT02415335|BB 1101|bb 1101|mesh-list
83212761|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212762|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
83212763|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
83212764|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212765|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212766|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83212767|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
83212768|NCT02415335|Hormones|hormones|mesh-ancestor
83212769|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212770|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83212771|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212772|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212773|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212774|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212775|NCT02415257|Gentamicins|gentamicins|mesh-list
83212776|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83212777|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212779|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212780|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212781|NCT02415179|Fluticasone|fluticasone|mesh-list
83212782|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
83212783|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
83212784|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83212785|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83212786|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212787|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83212788|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
83212789|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212790|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212791|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83212792|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
83212793|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212794|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83212795|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83212796|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83212797|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83212798|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
83212799|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212800|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212801|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
83212802|NCT02415179|Hormones|hormones|mesh-ancestor
83212803|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212804|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
83212805|NCT02415023|Paclitaxel|paclitaxel|mesh-list
83212806|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83212807|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83212808|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212809|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
83212810|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
83212811|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
83212812|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212813|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
83212814|NCT02414945|Fludarabine|fludarabine|mesh-list
83212815|NCT02414945|Interleukin-2|interleukin-2|mesh-list
83212816|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212817|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
83212818|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212819|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212820|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212821|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
83212822|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212823|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212824|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83212825|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83212826|NCT02414945|Analgesics|analgesics|mesh-ancestor
83212827|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
83212828|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212829|NCT02414555|Phenylephrine|phenylephrine|mesh-list
83212830|NCT02414555|Norepinephrine|norepinephrine|mesh-list
83212831|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83212832|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83212833|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
83212834|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
83212835|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212836|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212837|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
83212838|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
83212839|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
83212840|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83212841|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83212842|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83212843|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
83212844|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212845|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212846|NCT02414555|Protective Agents|protective agents|mesh-ancestor
83212848|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83212849|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212850|NCT02046070|Dexamethasone|dexamethasone|mesh-list
83212851|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
83212852|NCT02046070|Ixazomib|ixazomib|mesh-list
83212853|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212854|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
83212855|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212856|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212857|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212858|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
83212859|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212860|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212861|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83212862|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212863|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
83212864|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
83212865|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212866|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83212867|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
83212868|NCT02046070|Hormones|hormones|mesh-ancestor
83212869|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83212870|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83212871|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83212872|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212873|NCT01663857|Carboplatin|carboplatin|mesh-list
83212874|NCT01663857|Gemcitabine|gemcitabine|mesh-list
83212875|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212876|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212877|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
83212878|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212879|NCT02414165|Flucytosine|flucytosine|mesh-list
83212880|NCT02414165|Bevacizumab|bevacizumab|mesh-list
83212881|NCT02414165|Temozolomide|temozolomide|mesh-list
83212882|NCT02414165|Lomustine|lomustine|mesh-list
83212883|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212884|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212885|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83212886|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83212887|NCT02414165|Growth Substances|growth substances|mesh-ancestor
83212888|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212889|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
83212890|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212891|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
83212892|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212893|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
83212894|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83212895|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
83212896|NCT02094898|Ketamine|ketamine|mesh-list
83212897|NCT02094898|Analgesics|analgesics|mesh-ancestor
83212898|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
83212899|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212900|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212901|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83212902|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83212903|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
83212904|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
83212905|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83212906|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83212907|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83212908|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83212909|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212910|NCT04887831|Carboplatin|carboplatin|mesh-list
83212911|NCT04887831|Gemcitabine|gemcitabine|mesh-list
83212912|NCT04887831|Avelumab|avelumab|mesh-list
83212913|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212914|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212915|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
83212916|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212917|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212919|NCT02414009|Fluorouracil|fluorouracil|mesh-list
83212920|NCT02414009|Capecitabine|capecitabine|mesh-list
83212921|NCT02414009|Irinotecan|irinotecan|mesh-list
83212922|NCT02414009|Temozolomide|temozolomide|mesh-list
83212923|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
83212924|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212925|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212926|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212927|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212928|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
83212929|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212930|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83212931|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83212932|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212933|NCT02414009|Antidotes|antidotes|mesh-ancestor
83212934|NCT02414009|Protective Agents|protective agents|mesh-ancestor
83212935|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
83212936|NCT02414009|Vitamins|vitamins|mesh-ancestor
83212937|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
83212938|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83212939|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
83212940|NCT02413853|Leucovorin|leucovorin|mesh-list
83212941|NCT02413853|Bevacizumab|bevacizumab|mesh-list
83212942|NCT02413853|Fluorouracil|fluorouracil|mesh-list
83212943|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
83212944|NCT02413853|Calcium|calcium|mesh-list
83212945|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
83212946|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83212947|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83212948|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83212949|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83212950|NCT02413853|Growth Substances|growth substances|mesh-ancestor
83212951|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212952|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
83212953|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83212954|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
83212955|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212956|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83212957|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83212958|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
83212959|NCT02413853|Antidotes|antidotes|mesh-ancestor
83212960|NCT02413853|Protective Agents|protective agents|mesh-ancestor
83212961|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
83212962|NCT02413853|Vitamins|vitamins|mesh-ancestor
83212963|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
83212964|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
83212965|NCT00704483|Sevelamer|sevelamer|mesh-list
83212966|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
83212967|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
83212968|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212969|NCT00704483|Hematinics|hematinics|mesh-ancestor
83212970|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
83212971|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212972|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83212973|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83212974|NCT03176537|Testosterone|testosterone|mesh-list
83212975|NCT03176537|Androgens|androgens|mesh-ancestor
83212976|NCT03176537|Hormones|hormones|mesh-ancestor
83212977|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
82736727|NCT00901719|Nitroprusside|nitroprusside|mesh-list
83212978|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212979|NCT05511441|Aspirin|aspirin|mesh-list
83212980|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83212981|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83212982|NCT05511441|Analgesics|analgesics|mesh-ancestor
83212983|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
83212984|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83212985|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83212986|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83212987|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83212988|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83212989|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83212990|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83212991|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83212992|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83212993|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83212994|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
83212995|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83212996|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83212997|NCT02413541|Polymyxins|polymyxins|mesh-list
83212998|NCT02413541|Polymyxin B|polymyxin b|mesh-list
83212999|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83213000|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213001|NCT02045836|Vaccines|vaccines|mesh-list
83213002|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83213003|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
83213004|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213005|NCT02412917|Valacyclovir|valacyclovir|mesh-list
83213006|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
83213007|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213008|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
83213009|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213010|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
83213011|NCT04588311|Hematinics|hematinics|mesh-ancestor
83213012|NCT02569437|Fluticasone|fluticasone|mesh-list
83213013|NCT02569437|Doxycycline|doxycycline|mesh-list
83213014|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
83213015|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83213016|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83213017|NCT02569437|Prednisolone|prednisolone|mesh-list
83213018|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
83213019|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83213020|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
83213021|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213022|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
83213023|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
83213024|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213025|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213026|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83213027|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
83213028|NCT02569437|Hormones|hormones|mesh-ancestor
83213029|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213030|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83213031|NCT02569437|Protective Agents|protective agents|mesh-ancestor
83213032|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83213033|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213034|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83213035|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213036|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
83213037|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83213038|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83213039|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83213040|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83213041|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
83213042|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83213043|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83213045|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
83213046|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213047|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213048|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213049|NCT02412059|Prednisolone|prednisolone|mesh-list
83213050|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83213051|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
83213052|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83213053|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
83213054|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83213055|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
83213056|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213057|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
83213058|NCT02412059|Hormones|hormones|mesh-ancestor
83213059|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213060|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213061|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83213062|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213063|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
83213064|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
83213065|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213066|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83213067|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83213068|NCT02412059|Protective Agents|protective agents|mesh-ancestor
83213069|NCT05090085|Z 350|z 350|mesh-list
83213070|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83213071|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83213072|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213073|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213074|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
83213075|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213076|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213077|NCT03175679|Interleukin-2|interleukin-2|mesh-list
83213078|NCT03175679|Tegafur|tegafur|mesh-list
83213079|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213080|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83213081|NCT03175679|Analgesics|analgesics|mesh-ancestor
83213082|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
83213083|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213084|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213085|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83213086|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
83213087|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213088|NCT05520645|Propofol|propofol|mesh-list
83213089|NCT05520645|Etomidate|etomidate|mesh-list
83213090|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83213091|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213092|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213093|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83213094|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
83213095|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
83213096|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83213097|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83213098|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83213099|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
83213100|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213101|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83213102|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83213103|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213104|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
83213105|NCT05515185|Fludarabine|fludarabine|mesh-list
83213106|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213107|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
83213108|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213109|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213110|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83213111|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
83213112|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213113|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213114|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83213115|NCT02044822|Rituximab|rituximab|mesh-list
83213116|NCT02044822|Idelalisib|idelalisib|mesh-list
83213117|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83213118|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213119|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
83213120|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213121|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213122|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213123|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213124|NCT03116555|Irinotecan|irinotecan|mesh-list
83213125|NCT03116555|Apatinib|apatinib|mesh-list
83213126|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83213127|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83213128|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213129|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213130|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213131|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83213132|NCT02044510|Mirabegron|mirabegron|mesh-list
83213133|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83213134|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83213135|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83213136|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83213137|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213138|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213139|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213140|NCT02044510|Urological Agents|urological agents|mesh-ancestor
83213141|NCT02411903|Clopidogrel|clopidogrel|mesh-list
83213142|NCT02411903|Atorvastatin|atorvastatin|mesh-list
83213143|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83213144|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83213145|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83213146|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
83213147|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213148|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83213149|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83213150|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213151|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83213152|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83213153|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83213154|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83213155|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
83213156|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213157|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213158|NCT02411825|Metformin|metformin|mesh-list
83213159|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213160|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213161|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
83213162|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83213163|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83213164|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
83213165|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213166|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83213167|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83213168|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213169|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213170|NCT05514405|Propofol|propofol|mesh-list
83213171|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83213172|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213173|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213174|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83213175|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
83213178|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
83213179|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83213180|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213181|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83213182|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
83213183|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213184|NCT05510505|Antibodies|antibodies|mesh-list
83213185|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83213186|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
83213187|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213188|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
83213189|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83213190|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
83213191|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213192|NCT04987775|Expectorants|expectorants|mesh-ancestor
83213193|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
83213194|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83213195|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
83213196|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213197|NCT04987775|Protective Agents|protective agents|mesh-ancestor
83213198|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213199|NCT04987775|Antidotes|antidotes|mesh-ancestor
83213200|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
83213201|NCT05514015|Rituximab|rituximab|mesh-list
83213202|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213203|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
83213204|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213205|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213206|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83213207|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
83213208|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213209|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213210|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83213211|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83213212|NCT03174821|Insulin|insulin|mesh-list
83213213|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83213214|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213215|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213216|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
83213217|NCT05520021|Nifedipine|nifedipine|mesh-list
83213218|NCT05520021|Analgesics|analgesics|mesh-ancestor
83213219|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
83213220|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213221|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213222|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
83213223|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213224|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83213225|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
83213226|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83213227|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83213228|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213229|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83213230|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
83213231|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83213232|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
83213233|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
83213234|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83213235|NCT02410031|Cyproterone|cyproterone|mesh-list
83213236|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83213237|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83213238|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83213239|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83213240|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
83213241|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83213242|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213243|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83213244|NCT02410031|Estrogens|estrogens|mesh-ancestor
83213245|NCT02410031|Hormones|hormones|mesh-ancestor
83213246|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213247|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
83213248|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
83213249|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213250|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83213251|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
83213252|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83213253|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213254|NCT04939701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83213255|NCT04939701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213256|NCT05513625|Pritelivir|pritelivir|mesh-list
83213257|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
83213258|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213259|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213260|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213261|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83213262|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83213263|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83213264|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83213265|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
83213266|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213267|NCT02067676|Antacids|antacids|mesh-ancestor
83213268|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213269|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83213270|NCT02409407|Alprostadil|alprostadil|mesh-list
83213271|NCT02409407|Misoprostol|misoprostol|mesh-list
83213272|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83213273|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
83213274|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83213275|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213276|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83213277|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83213278|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
83213279|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83213280|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
83213281|NCT02409407|Urological Agents|urological agents|mesh-ancestor
83213282|NCT02409563|Budesonide|budesonide|mesh-list
83213283|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213284|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83213285|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
83213286|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213287|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213288|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83213289|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
83213290|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
83213291|NCT02409563|Hormones|hormones|mesh-ancestor
83213292|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213293|NCT05513313|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83213294|NCT05513313|Antiviral Agents|antiviral agents|mesh-ancestor
83213295|NCT05513313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213296|NCT02409017|Insulin|insulin|mesh-list
83213297|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213298|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213299|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
83213300|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213301|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83213302|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213303|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213304|NCT02065570|Adalimumab|adalimumab|mesh-list
83213305|NCT02065570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83213306|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213307|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213308|NCT02408705|Acetaminophen|acetaminophen|mesh-list
83213309|NCT02408705|Liraglutide|liraglutide|mesh-list
83213310|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83213311|NCT02408705|Analgesics|analgesics|mesh-ancestor
83213312|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
83213313|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213314|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213315|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
83213316|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213317|NCT02408705|Incretins|incretins|mesh-ancestor
83213318|NCT02408705|Hormones|hormones|mesh-ancestor
83213319|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213320|NCT05509569|Icatibant|icatibant|mesh-list
83213321|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83213322|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83213324|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
83213325|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213326|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213327|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213328|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213329|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83213330|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83213331|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213332|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83213333|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213334|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
83213335|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
83213336|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83213337|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213338|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
83213339|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
83213340|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213341|NCT05507697|Protective Agents|protective agents|mesh-ancestor
83213342|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213343|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
83213344|NCT05507697|Vitamins|vitamins|mesh-ancestor
83213345|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
83213346|NCT04292223|Pimavanserin|pimavanserin|mesh-list
83213347|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83213348|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83213349|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83213350|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83213351|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213352|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213353|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83213354|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83213355|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83213356|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
83213357|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213358|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213359|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83213360|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
83213361|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83213362|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83213363|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83213364|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213365|NCT03174041|Itraconazole|itraconazole|mesh-list
83213366|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83213367|NCT03174041|Midazolam|midazolam|mesh-list
83213368|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83213369|NCT03174041|Simvastatin|simvastatin|mesh-list
83213370|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83213371|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83213372|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213373|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213374|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83213375|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83213376|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83213377|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83213378|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
83213380|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
83213381|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
83213382|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213383|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213384|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83213385|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83213386|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
83213387|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83213388|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83213389|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213390|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
83213391|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213392|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83213393|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83213394|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83213395|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
83213396|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213397|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83213398|NCT02566005|Misoprostol|misoprostol|mesh-list
83213399|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83213400|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
83213401|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83213402|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213403|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83213404|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83213405|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
83213406|NCT02408393|Ropivacaine|ropivacaine|mesh-list
83213407|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
83213408|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
83213409|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213410|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213411|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
83213412|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213413|NCT05041335|Heparin|heparin|mesh-list
83213414|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
83213415|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83213416|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83213417|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213418|NCT03173963|Empagliflozin|empagliflozin|mesh-list
83213419|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83213420|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213421|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213422|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213423|NCT05507229|Vaccines|vaccines|mesh-list
83213424|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
83213425|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213426|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
83213427|NCT03173417|Fludarabine|fludarabine|mesh-list
83213428|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213429|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
83213430|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213431|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213432|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83213433|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
83213434|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213435|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213436|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83213437|NCT03173339|Remifentanil|remifentanil|mesh-list
83213438|NCT03173339|Sevoflurane|sevoflurane|mesh-list
83213439|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83213440|NCT03173339|Narcotics|narcotics|mesh-ancestor
83213441|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213442|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213443|NCT03173339|Analgesics|analgesics|mesh-ancestor
83213444|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
83213445|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213446|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83213447|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83213448|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
83213449|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
83213450|NCT03172871|Aripiprazole|aripiprazole|mesh-list
83213451|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
83213452|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83213453|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83213454|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83213455|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213456|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213457|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
83213458|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
83213459|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213460|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213461|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83213462|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83213463|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
83213464|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83213465|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83213466|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83213467|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83213468|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
83213469|NCT02065336|Entecavir|entecavir|mesh-list
83213470|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
83213471|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213472|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
83213473|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
83213474|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83213475|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
83213476|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
83213477|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213478|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213479|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213480|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83213481|NCT02408003|Simendan|simendan|mesh-list
83213482|NCT02408003|Milrinone|milrinone|mesh-list
83213483|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83213484|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
83213485|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83213486|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83213487|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213488|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213489|NCT02408003|Protective Agents|protective agents|mesh-ancestor
83213490|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213491|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83213492|NCT05518929|Propofol|propofol|mesh-list
83213493|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83213494|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213495|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213496|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83213497|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
83213498|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
83213499|NCT02406911|Ticagrelor|ticagrelor|mesh-list
83213500|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83213501|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83213502|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83213503|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83213504|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
83213505|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213506|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213507|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213508|NCT03172793|Telavancin|telavancin|mesh-list
83213509|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83213510|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213511|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
83213512|NCT03116087|Testosterone|testosterone|mesh-list
83213513|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
83213514|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
83213515|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83213516|NCT03116087|Androgens|androgens|mesh-ancestor
83213517|NCT03116087|Hormones|hormones|mesh-ancestor
83213518|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213519|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213520|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83213521|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213522|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
83213523|NCT02701985|Petesicatib|petesicatib|mesh-list
83213524|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213525|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213526|NCT02406521|Sorafenib|sorafenib|mesh-list
83213527|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83213528|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213529|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83213530|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213531|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213532|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83213533|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83213534|NCT02406053|Antioxidants|antioxidants|mesh-list
83213535|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213536|NCT02406053|Protective Agents|protective agents|mesh-ancestor
83213537|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213538|NCT02064166|Insulin|insulin|mesh-list
83213539|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213540|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213541|NCT03171623|Globalagliatin|globalagliatin|mesh-list
83213542|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
83213543|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213545|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213546|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83213547|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213548|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213549|NCT05508633|Mebeverine|mebeverine|mesh-list
83213550|NCT05508633|Alverine|alverine|mesh-list
83213551|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
83213552|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
83213553|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213554|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213555|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
83213556|NCT04482257|Irinotecan|irinotecan|mesh-list
83213557|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83213558|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83213559|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213560|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213561|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213562|NCT05502705|Lidocaine|lidocaine|mesh-list
83213563|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
83213564|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
83213565|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213566|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213567|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
83213568|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213569|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83213570|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83213571|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83213572|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83213573|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213574|NCT05506137|Pilocarpine|pilocarpine|mesh-list
83213575|NCT05506137|Miotics|miotics|mesh-ancestor
83213576|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
83213577|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213578|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213579|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83213580|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83213581|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
83213582|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213583|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213584|NCT04742283|Timolol|timolol|mesh-list
83213585|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83213586|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83213587|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213588|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83213589|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83213590|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
83213591|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213592|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213593|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83213594|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83213595|NCT04289805|Letrozole|letrozole|mesh-list
83213596|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213597|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83213598|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83213599|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213600|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213601|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83213602|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
83213603|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213604|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213605|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
83213606|NCT05508009|Melphalan|melphalan|mesh-list
83213607|NCT05508009|Rituximab|rituximab|mesh-list
83213608|NCT05508009|Fludarabine|fludarabine|mesh-list
83213609|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213610|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
83213611|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213612|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213613|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83213614|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
83213615|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213616|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213617|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83213618|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83213619|NCT05505591|Cangrelor|cangrelor|mesh-list
83213620|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83213621|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83213622|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83213623|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83213624|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
83213625|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213626|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213627|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213628|NCT05448807|Phentolamine|phentolamine|mesh-list
83213629|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83213630|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83213631|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
83213632|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213633|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213634|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213635|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83213636|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
83213637|NCT01662999|Saxagliptin|saxagliptin|mesh-list
83213638|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83213639|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213640|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213641|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213642|NCT01662999|Incretins|incretins|mesh-ancestor
83213643|NCT01662999|Hormones|hormones|mesh-ancestor
83213644|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213645|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83213646|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
83213647|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213649|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
83213650|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213651|NCT02565381|Nicotine|nicotine|mesh-list
83213652|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83213653|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
83213654|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213655|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213656|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83213657|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83213658|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
83213659|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213660|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213661|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
83213662|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
83213663|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83213664|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83213665|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213666|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83213667|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213668|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83213669|NCT02063698|Auranofin|auranofin|mesh-list
83213670|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213671|NCT04701333|Cabergoline|cabergoline|mesh-list
83213672|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83213673|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83213674|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
83213675|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
83213676|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213677|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213678|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213679|NCT04701034|Prednisolone|prednisolone|mesh-list
83213680|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
83213681|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83213682|NCT04701034|Antibodies|antibodies|mesh-list
83213683|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
83213684|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83213685|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213686|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
83213687|NCT04701034|Hormones|hormones|mesh-ancestor
83213688|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213689|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213690|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83213691|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213692|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
83213693|NCT01663623|Azathioprine|azathioprine|mesh-list
83213694|NCT01663623|Belimumab|belimumab|mesh-list
83213695|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
83213696|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213697|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83213698|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213699|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213700|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
83213701|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213702|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213703|NCT04582305|Bleomycin|bleomycin|mesh-list
83213704|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83213705|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213706|NCT05504967|Dexamethasone|dexamethasone|mesh-list
83213707|NCT05504967|Ropivacaine|ropivacaine|mesh-list
83213708|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213709|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
83213710|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
83213711|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213712|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213713|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83213714|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
83213715|NCT05504967|Hormones|hormones|mesh-ancestor
83213716|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213717|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83213718|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213719|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
83213720|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
83213721|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213722|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
83213723|NCT02565147|Heparin|heparin|mesh-list
83213724|NCT02565147|Bivalirudin|bivalirudin|mesh-list
83213725|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
83213726|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83213727|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83213728|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213729|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
83213730|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83213731|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83213732|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213733|NCT02061280|Fluticasone|fluticasone|mesh-list
83213735|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83213736|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83213737|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213738|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83213739|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
83213740|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213741|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213742|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83213743|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
83213744|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
83213745|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83213746|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83213747|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83213748|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83213749|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
83213750|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213751|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213752|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
83213753|NCT02061280|Hormones|hormones|mesh-ancestor
83213754|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213755|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
83213756|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
83213757|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213758|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83213759|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83213760|NCT04664361|Niacinamide|niacinamide|mesh-list
83213761|NCT04664361|Niacin|niacin|mesh-list
83213762|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
83213763|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
83213764|NCT04664361|Vitamins|vitamins|mesh-ancestor
83213765|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
83213766|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213767|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83213768|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
83213769|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213770|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83213771|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
83213773|NCT04698850|Aflibercept|aflibercept|mesh-list
83213774|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83213775|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83213776|NCT04698850|Growth Substances|growth substances|mesh-ancestor
83213777|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213778|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
83213779|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213780|NCT04698226|Temazepam|temazepam|mesh-list
83213781|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83213782|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213783|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213784|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83213785|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83213786|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83213787|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
83213788|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
83213789|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213790|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213791|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
83213792|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
83213793|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83213794|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83213795|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213796|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
83213797|NCT05504577|Coagulants|coagulants|mesh-ancestor
83213798|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
83213799|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83213800|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83213801|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213802|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83213803|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83213804|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213805|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213806|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
83213807|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
83213808|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83213809|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83213810|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213811|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213812|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213813|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213814|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
83213815|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83213816|NCT05504265|Analgesics|analgesics|mesh-ancestor
83213817|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
83213818|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213819|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213820|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83213821|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83213822|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213823|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213824|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83213825|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213826|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213827|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
83213828|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
83213829|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83213830|NCT04740099|Naloxone|naloxone|mesh-list
83213831|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83213832|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213833|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
83213834|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213835|NCT02560389|Levodopa|levodopa|mesh-list
83213836|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83213837|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83213838|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
83213839|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213840|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213841|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213842|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83213843|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
83213844|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
82736803|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
83213845|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213846|NCT02564211|Incretins|incretins|mesh-ancestor
83213847|NCT02564211|Hormones|hormones|mesh-ancestor
83213848|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213849|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83213850|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
83213851|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213852|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213853|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83213854|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
83213855|NCT04639245|Fludarabine|fludarabine|mesh-list
83213856|NCT04639245|Atezolizumab|atezolizumab|mesh-list
83213857|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83213858|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83213859|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213860|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
83213861|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213862|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213863|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83213864|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
83213865|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213866|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213867|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83213868|NCT04639245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83213869|NCT04596579|Antibodies|antibodies|mesh-list
83213870|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
83213871|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213872|NCT04465383|Propofol|propofol|mesh-list
83213873|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83213874|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213875|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213876|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83213877|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
83213878|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
83213879|NCT05500677|Lidocaine|lidocaine|mesh-list
83213880|NCT05500677|Fentanyl|fentanyl|mesh-list
83213881|NCT05500677|Tramadol|tramadol|mesh-list
83213882|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
83213883|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
83213884|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213885|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213886|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
83213887|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213888|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83213889|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83213890|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83213891|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83213892|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213893|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83213894|NCT05500677|Narcotics|narcotics|mesh-ancestor
83213895|NCT05500677|Analgesics|analgesics|mesh-ancestor
83213896|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83213897|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83213898|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
83213900|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
83213901|NCT02093026|Rituximab|rituximab|mesh-list
83213902|NCT02093026|Methotrexate|methotrexate|mesh-list
83213903|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83213904|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213905|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
83213906|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213907|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213908|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83213909|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
83213910|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83213911|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83213912|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
83213913|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213914|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
83213915|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213916|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83213917|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83213918|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83213919|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213920|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
83213921|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
83213922|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213923|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83213924|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
83213925|NCT02093026|Hormones|hormones|mesh-ancestor
83213926|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213927|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83213928|NCT02093026|Protective Agents|protective agents|mesh-ancestor
83213929|NCT02093026|Hematinics|hematinics|mesh-ancestor
83213930|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
83213931|NCT02093026|Vitamins|vitamins|mesh-ancestor
83213932|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
83213933|NCT04697602|Colchicine|colchicine|mesh-list
83213934|NCT04697602|Febuxostat|febuxostat|mesh-list
83213935|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
83213936|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83213937|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
83213938|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
83213939|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
83213940|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213941|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83213942|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
83213943|NCT02059174|MK-1293|mk-1293|mesh-list
83213944|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213945|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213946|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83213947|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
83213948|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213949|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83213950|NCT04417582|Liraglutide|liraglutide|mesh-list
83213951|NCT04417582|Orlistat|orlistat|mesh-list
83213952|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83213953|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213954|NCT04417582|Incretins|incretins|mesh-ancestor
83213955|NCT04417582|Hormones|hormones|mesh-ancestor
83213956|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213957|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83213958|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213959|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83213960|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83213961|NCT02040766|Beclomethasone|beclomethasone|mesh-list
83213962|NCT02040766|Albuterol|albuterol|mesh-list
83213963|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
83213964|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
83213965|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213966|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213967|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83213968|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
83213969|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
83213970|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83213971|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83213972|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83213973|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83213974|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
83213975|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83213976|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213977|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83213978|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
83213979|NCT02040766|Hormones|hormones|mesh-ancestor
83213980|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83213981|NCT02040532|Gabapentin|gabapentin|mesh-list
83213982|NCT02040532|Analgesics|analgesics|mesh-ancestor
83213983|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
83213984|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83213985|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213986|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
83213987|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83213988|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83213989|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83213990|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83213991|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83213992|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83213993|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362185|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
83213994|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83213995|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
83213996|NCT02039908|Methylphenidate|methylphenidate|mesh-list
83213997|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83213998|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83213999|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83214000|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83214001|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214002|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214003|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
83214004|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214005|NCT04417348|Tretinoin|tretinoin|mesh-list
83214006|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214007|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
83214008|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214009|NCT02058940|Exenatide|exenatide|mesh-list
83214010|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83214011|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214012|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83214013|NCT02058940|Incretins|incretins|mesh-ancestor
83214014|NCT02058940|Hormones|hormones|mesh-ancestor
83214015|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214017|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
83214018|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
83214019|NCT02058628|Azelaic acid|azelaic acid|mesh-list
83214020|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83214021|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214022|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83214023|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214024|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214025|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214026|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214027|NCT02058160|Insulin|insulin|mesh-list
83214028|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83214029|NCT02058160|Metformin|metformin|mesh-list
83214030|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
83214031|NCT02058160|Lixisenatide|lixisenatide|mesh-list
83214032|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83214033|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214034|NCT02090764|Ozenoxacin|ozenoxacin|mesh-list
83214035|NCT02090764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83214036|NCT02090764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214037|NCT02090764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83214038|NCT02090764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214039|NCT02090764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214040|NCT02090764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214041|NCT02088034|Metformin|metformin|mesh-list
83214042|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83214043|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214044|NCT02037256|Bortezomib|bortezomib|mesh-list
83214045|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214046|NCT02035696|Vaccines|vaccines|mesh-list
83214047|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
83214048|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214049|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
83214050|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
83214051|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83214052|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83214053|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214054|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214055|NCT02057458|Urological Agents|urological agents|mesh-ancestor
83214056|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
83214057|NCT02087176|Adavosertib|adavosertib|mesh-list
83214058|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214059|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214060|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
83214061|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214062|NCT02056288|Fentanyl|fentanyl|mesh-list
83214063|NCT02056288|Ropivacaine|ropivacaine|mesh-list
83214064|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
83214065|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
83214066|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214067|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214068|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
83214069|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214070|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83214071|NCT02056288|Narcotics|narcotics|mesh-ancestor
83214072|NCT02056288|Analgesics|analgesics|mesh-ancestor
83214073|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83214074|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83214075|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
83214076|NCT03115697|Rifaximin|rifaximin|mesh-list
83214077|NCT03115697|Lactulose|lactulose|mesh-list
83214078|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83214079|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214080|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83214081|NCT03115775|Vitamin D|vitamin d|mesh-list
83214082|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
83214083|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
83214084|NCT03115775|Vitamins|vitamins|mesh-list
83214085|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
83214086|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214087|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83214088|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83214089|NCT02404259|Ritonavir|ritonavir|mesh-list
83214090|NCT02404259|Lopinavir|lopinavir|mesh-list
83214091|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83214092|NCT02404259|Tenofovir|tenofovir|mesh-list
83214093|NCT02404259|Efavirenz|efavirenz|mesh-list
83214094|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83214095|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83214096|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
83214097|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214098|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214099|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83214100|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83214101|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
83214102|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214103|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83214104|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83214105|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83214106|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83214107|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83214108|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83214109|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83214110|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83214111|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83214112|NCT03170687|Calpastatin|calpastatin|mesh-list
83214113|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83214114|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
83214115|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214116|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214117|NCT03169751|Caffeine|caffeine|mesh-list
83214118|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83214119|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214120|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83214121|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214122|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214123|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83214124|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83214125|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
83214126|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214127|NCT02403713|Fluticasone|fluticasone|mesh-list
83214128|NCT02403713|Xhance|xhance|mesh-list
83214129|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
83214130|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214131|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83214132|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
83214133|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214134|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214135|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83214136|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
83214137|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214138|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83214139|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83214140|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83214141|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83214142|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83214143|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214144|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214145|NCT02700815|Diclofenac|diclofenac|mesh-list
83214147|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83214148|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83214149|NCT02700815|Analgesics|analgesics|mesh-ancestor
83214150|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
83214151|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214152|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214153|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214154|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214155|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83214156|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214157|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214158|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
83214159|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214160|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
83214161|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83214162|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
83214163|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83214164|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214165|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83214166|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83214167|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83214168|NCT02402621|Fentanyl|fentanyl|mesh-list
83214169|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83214170|NCT02402621|Narcotics|narcotics|mesh-ancestor
83214171|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214172|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214173|NCT02402621|Analgesics|analgesics|mesh-ancestor
83214174|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
83214175|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214176|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83214177|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83214178|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
83214179|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
83214180|NCT04481789|Furosemide|furosemide|mesh-list
83214181|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
83214182|NCT04481789|Edaravone|edaravone|mesh-list
83214183|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83214184|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83214185|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83214186|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
83214187|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214188|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83214189|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83214190|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214191|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
83214192|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83214193|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83214194|NCT04481789|Urological Agents|urological agents|mesh-ancestor
83214195|NCT04481789|Diuretics|diuretics|mesh-ancestor
83214196|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
83214197|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214198|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83214199|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214200|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83214201|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
83214202|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83214203|NCT04481789|Protective Agents|protective agents|mesh-ancestor
83214204|NCT02402465|Fluticasone|fluticasone|mesh-list
83214205|NCT02402465|Xhance|xhance|mesh-list
83214206|NCT02402465|Azelastine|azelastine|mesh-list
83214207|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214208|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83214209|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
83214210|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214211|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214212|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83214213|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
83214214|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214215|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83214216|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83214217|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214218|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214219|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83214220|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83214221|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
83214222|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
83214223|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214225|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83214226|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83214227|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
83214228|NCT02402543|Acetaminophen|acetaminophen|mesh-list
83214229|NCT02402543|Dexamethasone|dexamethasone|mesh-list
83214230|NCT02402543|Ketamine|ketamine|mesh-list
83214231|NCT02402543|Gabapentin|gabapentin|mesh-list
83214232|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214233|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
83214234|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
83214235|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214236|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214237|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83214238|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
83214239|NCT02402543|Hormones|hormones|mesh-ancestor
83214240|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214241|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214242|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214243|NCT02402543|Analgesics|analgesics|mesh-ancestor
83214244|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
83214245|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83214246|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83214247|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
83214248|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
83214249|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214250|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83214251|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83214252|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214253|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214254|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83214255|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
83214256|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
83214257|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83214258|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83214259|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83214260|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
83214261|NCT02401295|Itraconazole|itraconazole|mesh-list
83214262|NCT02401295|Celecoxib|celecoxib|mesh-list
83214263|NCT02401295|Tretinoin|tretinoin|mesh-list
83214264|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83214265|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83214266|NCT02401295|Analgesics|analgesics|mesh-ancestor
83214267|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
83214268|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214269|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214270|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214271|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214272|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83214273|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83214274|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214275|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214276|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
83214277|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214278|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83214279|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83214280|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83214282|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214283|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83214284|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214285|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
83214286|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214287|NCT00708305|Listerine|listerine|mesh-list
83214288|NCT00708305|Fluorides|fluorides|mesh-list
83214289|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
83214290|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
83214291|NCT00708305|Protective Agents|protective agents|mesh-ancestor
83214292|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214293|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83214294|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214295|NCT03169127|Ibuprofen|ibuprofen|mesh-list
83214296|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83214297|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83214298|NCT03169127|Analgesics|analgesics|mesh-ancestor
83214299|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
83214300|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214301|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214302|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214303|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214304|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83214305|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214306|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214307|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83214308|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
83214309|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83214310|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
83214311|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83214312|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214313|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83214314|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214315|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214316|NCT02418533|Menotropins|menotropins|mesh-list
83214318|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83214319|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214320|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214321|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83214322|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
83214323|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83214324|NCT02418065|Testosterone|testosterone|mesh-list
83214325|NCT02418065|Androgens|androgens|mesh-ancestor
83214326|NCT02418065|Hormones|hormones|mesh-ancestor
83214327|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214328|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214329|NCT05058443|Denosumab|denosumab|mesh-list
83214330|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83214331|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214332|NCT02400281|Cytarabine|cytarabine|mesh-list
83214333|NCT02400281|Fludarabine|fludarabine|mesh-list
83214334|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
83214335|NCT02400281|Etoposide|etoposide|mesh-list
83214336|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
83214337|NCT02400281|Azacitidine|azacitidine|mesh-list
83214338|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
83214339|NCT02400281|Idarubicin|idarubicin|mesh-list
83214340|NCT02400281|Crenolanib|crenolanib|mesh-list
83214341|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214342|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83214343|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
83214344|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214345|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83214346|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
83214347|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214348|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
83214349|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214350|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83214351|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83214352|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83214353|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214354|NCT02400281|Analgesics|analgesics|mesh-ancestor
83214355|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
83214356|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214357|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83214358|NCT02055976|Ezetimibe|ezetimibe|mesh-list
83214359|NCT02055976|Bococizumab|bococizumab|mesh-list
83214360|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83214361|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83214362|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
83214363|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214364|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83214365|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
83214366|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83214367|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83214368|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
83214369|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
83214370|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214371|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214372|NCT04406259|Verapamil|verapamil|mesh-list
83214373|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83214374|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83214375|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214376|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214377|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
82736960|NCT00982618|Narcotics|narcotics|mesh-ancestor
83214378|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214379|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
83214380|NCT04603911|Dexamethasone|dexamethasone|mesh-list
83214381|NCT04603911|Clonidine|clonidine|mesh-list
83214382|NCT04603911|Epinephrine|epinephrine|mesh-list
83214383|NCT04603911|Bupivacaine|bupivacaine|mesh-list
83214384|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214385|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
83214386|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
83214387|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214388|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214389|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83214390|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
83214391|NCT04603911|Hormones|hormones|mesh-ancestor
83214392|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214393|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214394|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214395|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
83214396|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
83214397|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214398|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
83214399|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83214400|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83214401|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
83214402|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214403|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214404|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83214405|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83214406|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83214407|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
83214408|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
83214409|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
83214410|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83214411|NCT04603911|Analgesics|analgesics|mesh-ancestor
83214412|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83214413|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
83214414|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83214415|NCT05498025|Charcoal|charcoal|mesh-list
83214416|NCT05498025|Antidotes|antidotes|mesh-ancestor
83214417|NCT05498025|Protective Agents|protective agents|mesh-ancestor
83214418|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214419|NCT03972111|Tecovirimat|tecovirimat|mesh-list
83214420|NCT03972111|Antiviral Agents|antiviral agents|mesh-ancestor
83214421|NCT03972111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214422|NCT02699099|Vitamin A|vitamin a|mesh-list
83214423|NCT02699099|Vaccines|vaccines|mesh-list
83214424|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
83214425|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214426|NCT02699099|Vitamins|vitamins|mesh-ancestor
83214427|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
83214428|NCT02400047|Dexamethasone|dexamethasone|mesh-list
83214429|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
83214430|NCT02400047|Ketoprofen|ketoprofen|mesh-list
83214431|NCT02400047|BB 1101|bb 1101|mesh-list
83214432|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214433|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
83214434|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
83214435|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214436|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214437|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83214438|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
83214439|NCT02400047|Hormones|hormones|mesh-ancestor
82737103|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
83214440|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214441|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214442|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214443|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83214444|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214445|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214446|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83214447|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83214448|NCT02400047|Analgesics|analgesics|mesh-ancestor
83214449|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
83214450|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214451|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83214452|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
83214453|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83214454|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
83214455|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214456|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
83214457|NCT02698865|Protective Agents|protective agents|mesh-ancestor
83214458|NCT05499897|Anesthetics|anesthetics|mesh-list
83214459|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214460|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214461|NCT02417207|Entecavir|entecavir|mesh-list
83214462|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
83214463|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214464|NCT02698475|Ustekinumab|ustekinumab|mesh-list
83214465|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214466|NCT02399657|Dexamethasone|dexamethasone|mesh-list
83214467|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214468|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
83214469|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
83214470|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214471|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214472|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83214473|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
83214474|NCT02399657|Hormones|hormones|mesh-ancestor
83214475|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214476|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214477|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214478|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
83214479|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83214480|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214481|NCT02559687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83214482|NCT02559687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214483|NCT04278729|Apixaban|apixaban|mesh-list
83214484|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83214485|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
83214486|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83214487|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
83214488|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214489|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214490|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
83214491|NCT03177317|Dexamethasone|dexamethasone|mesh-list
83214492|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214493|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
83214494|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
83214495|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214496|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214497|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83214498|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
83214499|NCT03177317|Hormones|hormones|mesh-ancestor
83214500|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214501|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214502|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214503|NCT03177239|Nivolumab|nivolumab|mesh-list
83214504|NCT03177239|Ipilimumab|ipilimumab|mesh-list
83214505|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83214506|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214507|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83214508|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214509|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
83214510|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83214511|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83214512|NCT04480775|Prednisolone|prednisolone|mesh-list
83214513|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
83214514|NCT04480775|Triamcinolone|triamcinolone|mesh-list
83214515|NCT04480775|Bupivacaine|bupivacaine|mesh-list
83214516|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83214517|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
83214518|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
83214519|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
83214520|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214521|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214522|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
83214523|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214524|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214525|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
83214526|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
83214527|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83214528|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
83214529|NCT04480775|Hormones|hormones|mesh-ancestor
83214530|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214531|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83214532|NCT04480775|Protective Agents|protective agents|mesh-ancestor
83214533|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214534|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214535|NCT02416817|Thrombin|thrombin|mesh-list
83214536|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
83214537|NCT02416817|Coagulants|coagulants|mesh-ancestor
83214538|NCT02399189|Methotrexate|methotrexate|mesh-list
83214539|NCT02399189|Temozolomide|temozolomide|mesh-list
83214540|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214541|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
83214542|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214543|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214544|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83214545|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
83214546|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83214547|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83214548|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
83214549|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214550|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214551|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214552|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83214553|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83214554|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83214555|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83214556|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
83214557|NCT03176849|Vitamin D|vitamin d|mesh-list
83214558|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
83214559|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
83214560|NCT03176849|Vitamins|vitamins|mesh-list
83214561|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
83214562|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214563|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83214564|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83214565|NCT03106571|Methamphetamine|methamphetamine|mesh-list
83214566|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83214567|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214568|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
83214569|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
83214570|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214571|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
83214572|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214573|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214574|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
83214575|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83214576|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83214577|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214578|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83214579|NCT03177083|Interferons|interferons|mesh-list
83214580|NCT03177083|Interferon-beta|interferon-beta|mesh-list
83214581|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
83214582|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
83214583|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214584|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
83214585|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214586|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
83214587|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214588|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83214590|NCT03629925|Gemcitabine|gemcitabine|mesh-list
83214591|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214592|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83214593|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
83214594|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214595|NCT02398487|Nicotine|nicotine|mesh-list
83214596|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83214597|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
83214598|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214599|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214600|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83214601|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83214602|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
83214603|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214604|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214606|NCT03250299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83214607|NCT03250299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214608|NCT03250299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83214609|NCT03250299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214610|NCT02697617|Pioglitazone|pioglitazone|mesh-list
83214611|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83214612|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214613|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
83214614|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83214615|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214616|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214617|NCT02396225|Voriconazole|voriconazole|mesh-list
83214618|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
83214619|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214620|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83214621|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83214622|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214623|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214624|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83214625|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
83214626|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214627|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214628|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83214629|NCT04272801|Tamoxifen|tamoxifen|mesh-list
83214630|NCT04272801|Letrozole|letrozole|mesh-list
83214631|NCT04272801|Anastrozole|anastrozole|mesh-list
83214632|NCT04272801|Exemestane|exemestane|mesh-list
83214633|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214634|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83214635|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83214636|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214637|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214638|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83214639|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
83214640|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214641|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214642|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214643|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83214644|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83214645|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83214646|NCT02396303|Carbetocin|carbetocin|mesh-list
83214647|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
83214648|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83214649|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214650|NCT01918527|Capecitabine|capecitabine|mesh-list
83214651|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
83214652|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83214653|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
83214654|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214655|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214656|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83214657|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214658|NCT02397863|Cannabidiol|cannabidiol|mesh-list
83214659|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
83214660|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
83214661|NCT04357587|Capecitabine|capecitabine|mesh-list
83214662|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83214663|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214664|NCT04357587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83214665|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214666|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83214667|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
83214668|NCT04058717|Nicotine|nicotine|mesh-list
83214669|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83214670|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
83214671|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214672|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214673|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83214674|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83214675|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
83214676|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214677|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214678|NCT03168035|NC-4016|nc-4016|mesh-list
83214679|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214680|NCT02397395|Simeprevir|simeprevir|mesh-list
83214681|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
83214682|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214683|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83214684|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214685|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214686|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83214687|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83214688|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214689|NCT03168191|Menthol|menthol|mesh-list
83214690|NCT03168191|Nicotine|nicotine|mesh-list
83214691|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83214692|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
83214693|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214694|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214695|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83214696|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83214697|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
83214698|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214699|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214700|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
83214701|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83214702|NCT05496075|Orlistat|orlistat|mesh-list
83214703|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214704|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214705|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83214706|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83214707|NCT04280055|Psilocybin|psilocybin|mesh-list
83214708|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
83214709|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214710|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83214711|NCT05499117|Fluoxetine|fluoxetine|mesh-list
83214712|NCT05499117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83214713|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83214714|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214715|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214716|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214717|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
83214718|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214719|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83214720|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
83214721|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83214722|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83214723|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83214724|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214725|NCT04311723|Anesthetics|anesthetics|mesh-list
83214726|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214727|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214728|NCT05498337|Calcium|calcium|mesh-list
83214729|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83214730|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214731|NCT01663233|Amlodipine|amlodipine|mesh-list
83214732|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83214733|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83214734|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83214735|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214736|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214737|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83214738|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214739|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
83214740|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83214741|NCT05494281|Anesthetics|anesthetics|mesh-list
83214742|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
83214743|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214744|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214745|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
83214746|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214747|NCT05494047|Vaccines|vaccines|mesh-list
83214748|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
83214749|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214750|NCT05493969|Lamivudine|lamivudine|mesh-list
83214751|NCT05493969|Dolutegravir|dolutegravir|mesh-list
83214752|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83214753|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83214754|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214755|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214756|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
83214757|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214758|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83214759|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83214760|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83214761|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83214762|NCT05493657|Aspirin|aspirin|mesh-list
83214763|NCT05493657|Clopidogrel|clopidogrel|mesh-list
83214764|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83214765|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83214766|NCT05493657|Analgesics|analgesics|mesh-ancestor
83214767|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
83214768|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214769|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214770|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83214771|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214772|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83214773|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83214774|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214775|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83214776|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83214777|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214778|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
83214779|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83214780|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83214781|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83214782|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
83214783|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214784|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
83214785|NCT05493267|Interleukin-2|interleukin-2|mesh-list
83214786|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214787|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214788|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83214789|NCT05493267|Analgesics|analgesics|mesh-ancestor
83214790|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
83214791|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214792|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83214793|NCT05492565|Tenofovir|tenofovir|mesh-list
83214794|NCT05492565|Emtricitabine|emtricitabine|mesh-list
83214795|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
83214796|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214797|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83214798|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83214799|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214800|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214801|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83214802|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83214803|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
83214804|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
83214805|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83214806|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
83214807|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83214808|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214809|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83214810|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83214811|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83214812|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83214813|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214814|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
83214815|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83214816|NCT05492019|Doxycycline|doxycycline|mesh-list
83214817|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83214818|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214819|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
83214820|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83214821|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83214822|NCT05491785|Oxycodone|oxycodone|mesh-list
83214823|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83214824|NCT05491785|Narcotics|narcotics|mesh-ancestor
83214825|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214826|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214827|NCT05491785|Analgesics|analgesics|mesh-ancestor
83214828|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
83214829|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214830|NCT05484687|Anesthetics|anesthetics|mesh-list
83214831|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214832|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214833|NCT05484375|Capecitabine|capecitabine|mesh-list
83214834|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83214835|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
83214836|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214837|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214838|NCT05480007|Metformin|metformin|mesh-list
83214839|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83214840|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83214841|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214842|NCT05480007|Incretins|incretins|mesh-ancestor
83214843|NCT05480007|Hormones|hormones|mesh-ancestor
83214844|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214845|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83214846|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83214847|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214848|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214849|NCT05489601|Oxycodone|oxycodone|mesh-list
83214850|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83214851|NCT05489601|Narcotics|narcotics|mesh-ancestor
83214852|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214853|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214854|NCT05489601|Analgesics|analgesics|mesh-ancestor
83214855|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
83214856|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214857|NCT04016805|Venetoclax|venetoclax|mesh-list
83214858|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
83214859|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214860|NCT04276155|Anticoagulants|anticoagulants|mesh-list
83214861|NCT05488899|Iodine|iodine|mesh-list
83214862|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
83214863|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83214864|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214865|NCT05488899|Trace Elements|trace elements|mesh-ancestor
83214866|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
83214867|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214868|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
83214869|NCT05483439|Carboplatin|carboplatin|mesh-list
83214870|NCT05483439|Docetaxel|docetaxel|mesh-list
83214871|NCT05483439|Trastuzumab|trastuzumab|mesh-list
83214872|NCT05483439|Epirubicin|epirubicin|mesh-list
83214873|NCT05483439|Pertuzumab|pertuzumab|mesh-list
83214874|NCT05483439|Antibodies|antibodies|mesh-list
83214875|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83214876|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83214877|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
83214878|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214879|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83214880|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83214881|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
83214882|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214883|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214884|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83214885|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
83214886|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
83214887|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
83214888|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83214889|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83214890|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83214891|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83214892|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214893|NCT03748095|Tazobactam|tazobactam|mesh-list
83214894|NCT03748095|Piperacillin|piperacillin|mesh-list
83214895|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83214896|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214897|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83214898|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214899|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214900|NCT04275375|Anesthetics|anesthetics|mesh-list
83214901|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214902|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214903|NCT05488353|Disitamab vedotin|disitamab vedotin|mesh-list
83214904|NCT05488353|Immunoconjugates|immunoconjugates|mesh-ancestor
83214905|NCT05488353|Immunologic Factors|immunologic factors|mesh-ancestor
83214906|NCT05488353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214907|NCT04543071|Paclitaxel|paclitaxel|mesh-list
83214908|NCT04543071|Gemcitabine|gemcitabine|mesh-list
83214909|NCT04543071|Cemiplimab|cemiplimab|mesh-list
83214910|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83214911|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214912|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
83214913|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
83214914|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
83214915|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214916|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83214917|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
83214918|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83214919|NCT05487963|Tofacitinib|tofacitinib|mesh-list
83214920|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214921|NCT05487963|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83214922|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83214923|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214924|NCT05487885|Ketamine|ketamine|mesh-list
83214925|NCT05487885|Analgesics|analgesics|mesh-ancestor
83214926|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
83214927|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214928|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214929|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83214930|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83214931|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
83214932|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
83214933|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214934|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83214935|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83214936|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214937|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214938|NCT05487807|Nicotine|nicotine|mesh-list
83214939|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83214940|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
83214941|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214942|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214943|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83214944|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83214945|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
83214946|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214947|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214948|NCT03602859|Niraparib|niraparib|mesh-list
83214949|NCT03602859|Dostarlimab|dostarlimab|mesh-list
83214950|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83214951|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214952|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214953|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83214954|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83214955|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
83214956|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214957|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
83214958|NCT05476731|Clotrimazole|clotrimazole|mesh-list
83214959|NCT05476731|Miconazole|miconazole|mesh-list
83214960|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83214961|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83214962|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83214963|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83214964|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83214965|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214966|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83214967|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
83214968|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83214969|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214970|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83214971|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83214972|NCT05482113|Bupivacaine|bupivacaine|mesh-list
83214973|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
83214974|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
83214975|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214976|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214977|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
83214978|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83214979|NCT05481957|Vortioxetine|vortioxetine|mesh-list
83214980|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
83214981|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83214982|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83214983|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83214984|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83214985|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83214986|NCT05481957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83214987|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83214988|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83214989|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83214990|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83214991|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
83214992|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83214993|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83214994|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83214995|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83214996|NCT05475561|Bupivacaine|bupivacaine|mesh-list
83214997|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
83214998|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
83214999|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215000|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215001|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
83215002|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215003|NCT05476341|Bevacizumab|bevacizumab|mesh-list
83215004|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215005|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215006|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83215007|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83215008|NCT05476341|Growth Substances|growth substances|mesh-ancestor
83215009|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215010|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
83215011|NCT05481723|Norepinephrine|norepinephrine|mesh-list
83215012|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83215013|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83215014|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
83215015|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215016|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215017|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215018|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
83215019|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
83215020|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215021|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83215023|NCT05481645|Carboplatin|carboplatin|mesh-list
83215024|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83215025|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215026|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
83215027|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
83215028|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
83215029|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215030|NCT04272021|Methylphenidate|methylphenidate|mesh-list
83215031|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83215032|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215033|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83215034|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83215035|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83215036|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215037|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
83215038|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215039|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
83215040|NCT03434769|Fludarabine|fludarabine|mesh-list
83215041|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215042|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
83215043|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215044|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215045|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215046|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
83215047|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215048|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215049|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83215050|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
83215051|NCT03426891|Temozolomide|temozolomide|mesh-list
83215053|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83215054|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215055|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215056|NCT03426891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215057|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215058|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215059|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
83215060|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215062|NCT02697773|Analgesics|analgesics|mesh-ancestor
83215063|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
83215064|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215065|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215066|NCT02394821|Metronidazole|metronidazole|mesh-list
83215067|NCT02394821|Polihexanide|polihexanide|mesh-list
83215068|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215069|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83215070|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83215071|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83215072|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
83215073|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83215074|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83215075|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215076|NCT05745857|Bevacizumab|bevacizumab|mesh-list
83215077|NCT05745857|Cetuximab|cetuximab|mesh-list
83215078|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215079|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215080|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83215081|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83215082|NCT05745857|Growth Substances|growth substances|mesh-ancestor
83215083|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215084|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
83215085|NCT05745779|Vitamin D|vitamin d|mesh-list
83215086|NCT05745779|Vitamins|vitamins|mesh-list
83215087|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
83215088|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
83215089|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
83215090|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215091|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83215092|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
83215093|NCT05745779|Hematinics|hematinics|mesh-ancestor
83215094|NCT02394197|Chloroquine|chloroquine|mesh-list
83215095|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83215096|NCT02394197|Primaquine|primaquine|mesh-list
83215097|NCT02394197|Amebicides|amebicides|mesh-ancestor
83215098|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83215099|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83215100|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215101|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
83215102|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215103|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83215104|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83215105|NCT02394197|Analgesics|analgesics|mesh-ancestor
83215106|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
83215107|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215108|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215109|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215110|NCT02394197|Filaricides|filaricides|mesh-ancestor
83215111|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
83215112|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
83215113|NCT02394119|Rituximab|rituximab|mesh-list
83215114|NCT02394119|Ofatumumab|ofatumumab|mesh-list
83215115|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215116|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215117|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
83215118|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215119|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215120|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
83215121|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83215122|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
83215123|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215124|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
83215125|NCT03167333|Protective Agents|protective agents|mesh-ancestor
83215126|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
83215127|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83215128|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83215129|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215130|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
83215131|NCT02393963|Coagulants|coagulants|mesh-ancestor
83215132|NCT03115619|Pirfenidone|pirfenidone|mesh-list
83215133|NCT03115619|Analgesics|analgesics|mesh-ancestor
83215134|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
83215135|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215136|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215137|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83215138|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83215139|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215140|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215141|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215142|NCT02393573|Metformin|metformin|mesh-list
83215143|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83215144|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215145|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
83215146|NCT05745467|Povidone|povidone|mesh-list
83215147|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
83215148|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
83215149|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83215150|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215151|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
83215152|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83215153|NCT02693171|Dinutuximab|dinutuximab|mesh-list
83215154|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215155|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
83215156|NCT05745233|Nivolumab|nivolumab|mesh-list
83215157|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215158|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215159|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215160|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215161|NCT02392793|Irinotecan|irinotecan|mesh-list
83215162|NCT02392793|Temozolomide|temozolomide|mesh-list
83215163|NCT02392793|Talazoparib|talazoparib|mesh-list
83215164|NCT02392793|Lenograstim|lenograstim|mesh-list
83215165|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83215166|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83215167|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215168|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215169|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215170|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83215171|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
83215172|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215173|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215174|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
83215175|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83215176|NCT03167177|Leucovorin|leucovorin|mesh-list
83215177|NCT03167177|Paclitaxel|paclitaxel|mesh-list
83215178|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
83215179|NCT03167177|Bevacizumab|bevacizumab|mesh-list
83215180|NCT03167177|Fluorouracil|fluorouracil|mesh-list
83215181|NCT03167177|Capecitabine|capecitabine|mesh-list
83215182|NCT03167177|Nivolumab|nivolumab|mesh-list
83215183|NCT03167177|Avelumab|avelumab|mesh-list
83215184|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83215185|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215186|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
83215187|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
83215188|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
83215189|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215190|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215191|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
83215192|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215194|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215195|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
83215196|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83215197|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215198|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83215199|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83215200|NCT03167177|Growth Substances|growth substances|mesh-ancestor
83215201|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
83215202|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
83215203|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83215204|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215205|NCT03167177|Antidotes|antidotes|mesh-ancestor
83215206|NCT03167177|Protective Agents|protective agents|mesh-ancestor
83215207|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
83215208|NCT03167177|Vitamins|vitamins|mesh-ancestor
83215209|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
83215210|NCT02392169|Methylphenidate|methylphenidate|mesh-list
83215211|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83215212|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215213|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83215214|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83215215|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83215216|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215217|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
83215218|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215219|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
83215220|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83215221|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
83215222|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215223|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
83215224|NCT03166865|Protective Agents|protective agents|mesh-ancestor
83215225|NCT03166787|Tadalafil|tadalafil|mesh-list
83215226|NCT03166787|Charcoal|charcoal|mesh-list
83215227|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
83215228|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215229|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215230|NCT03166787|Protective Agents|protective agents|mesh-ancestor
83215231|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
83215232|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83215233|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83215234|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215235|NCT03166787|Urological Agents|urological agents|mesh-ancestor
83215236|NCT03166787|Antidotes|antidotes|mesh-ancestor
83215237|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
83215238|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
83215239|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215240|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
83215241|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215242|NCT03167957|Amphotericin B|amphotericin b|mesh-list
83215243|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83215244|NCT03167957|Amebicides|amebicides|mesh-ancestor
83215245|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83215246|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83215247|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215248|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83215249|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
83215250|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
83215251|NCT03166397|Nivolumab|nivolumab|mesh-list
83215252|NCT03166397|Fludarabine|fludarabine|mesh-list
83215253|NCT03166397|Ipilimumab|ipilimumab|mesh-list
83215254|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215255|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
83215256|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215257|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215258|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215259|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
83215260|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215261|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
82737630|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83215263|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215264|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215265|NCT05745935|Oxytocin|oxytocin|mesh-list
83215266|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
83215267|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83215268|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215269|NCT05744375|Trastuzumab|trastuzumab|mesh-list
83215270|NCT05744375|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83215271|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215272|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215273|NCT05744375|Immunoconjugates|immunoconjugates|mesh-ancestor
83215274|NCT05744375|Immunologic Factors|immunologic factors|mesh-ancestor
83215275|NCT05744375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215276|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
83215277|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215278|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215279|NCT02552355|Metformin|metformin|mesh-list
83215280|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83215281|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215282|NCT02551731|Cannabidiol|cannabidiol|mesh-list
83215283|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
83215284|NCT04479657|Cefuroxime|cefuroxime|mesh-list
83215285|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
83215286|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83215287|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215288|NCT05475873|Ondansetron|ondansetron|mesh-list
83215289|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
83215290|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
83215291|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215292|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215293|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215294|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
83215295|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
83215296|NCT05475873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83215297|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83215298|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
83215299|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215300|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215301|NCT05471661|PENTA|penta|mesh-list
83215302|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
83215303|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83215304|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83215305|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215306|NCT05480631|Mitogens|mitogens|mesh-list
83215307|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
83215308|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215309|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83215310|NCT02542605|Erenumab|erenumab|mesh-list
83215311|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83215312|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215313|NCT02542605|Analgesics|analgesics|mesh-ancestor
83215314|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
83215315|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215316|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215317|NCT02542605|Growth Substances|growth substances|mesh-ancestor
83215318|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
83215319|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215320|NCT02723955|Paclitaxel|paclitaxel|mesh-list
83215321|NCT02723955|Docetaxel|docetaxel|mesh-list
83215322|NCT02723955|Carboplatin|carboplatin|mesh-list
83215323|NCT02723955|Gemcitabine|gemcitabine|mesh-list
83215324|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
83215325|NCT02723955|Fluorouracil|fluorouracil|mesh-list
83215326|NCT02723955|Pemetrexed|pemetrexed|mesh-list
83215327|NCT02723955|Dostarlimab|dostarlimab|mesh-list
83215328|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83215329|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215330|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83215331|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83215332|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83215333|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215334|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83215335|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
83215336|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215337|NCT02723955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215338|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215339|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
83215340|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215341|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215342|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83215343|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83215344|NCT03299049|Rilpivirine|rilpivirine|mesh-list
83215345|NCT03299049|Cabotegravir|cabotegravir|mesh-list
83215346|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83215347|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83215348|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215349|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215350|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
83215351|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215352|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83215353|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83215354|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83215355|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83215356|NCT02550795|Dexamethasone|dexamethasone|mesh-list
83215357|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
83215358|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215359|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
83215360|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
83215361|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215362|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215363|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215364|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
83215365|NCT02550795|Hormones|hormones|mesh-ancestor
83215366|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215367|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83215368|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215369|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83215370|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215371|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83215372|NCT02550795|Analgesics|analgesics|mesh-ancestor
83215373|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
83215374|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83215375|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83215376|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83215377|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83215378|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215379|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215380|NCT02541903|Afatinib|afatinib|mesh-list
83215381|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215382|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83215383|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215384|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215385|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83215386|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83215387|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83215388|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215389|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83215390|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83215391|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215392|NCT05454891|Insulin|insulin|mesh-list
83215393|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83215394|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83215395|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215396|NCT02688647|Belumosudil|belumosudil|mesh-list
83215397|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83215398|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215399|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215400|NCT05453799|Antibodies|antibodies|mesh-list
83215401|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
83215402|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83215403|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
83215404|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215405|NCT05453487|Vaccines|vaccines|mesh-list
83215406|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
83215407|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215408|NCT05431725|Vaccines|vaccines|mesh-list
83215409|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
83215410|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215411|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83215412|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83215413|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
83215414|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83215415|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215416|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83215417|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83215418|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83215419|NCT05451615|Abatacept|abatacept|mesh-list
83215420|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83215421|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215422|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215423|NCT05451615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215424|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215425|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215426|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
83215427|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215428|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215429|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83215430|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215432|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215433|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215434|NCT02534883|Misoprostol|misoprostol|mesh-list
83215435|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83215436|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
83215437|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83215438|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215439|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83215440|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215441|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
83215442|NCT05626439|Alprazolam|alprazolam|mesh-list
83215443|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83215444|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215445|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215446|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83215447|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83215448|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83215449|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
83215450|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
83215451|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215452|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215453|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
83215454|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215455|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215456|NCT05430009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215457|NCT05430009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215458|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
83215459|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215460|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215461|NCT05429697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215462|NCT05429697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215463|NCT02540265|Meloxicam|meloxicam|mesh-list
83215464|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83215465|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83215466|NCT02540265|Analgesics|analgesics|mesh-ancestor
83215467|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
83215468|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215469|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215470|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215471|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215472|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83215473|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83215474|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215475|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215476|NCT02684357|Ustekinumab|ustekinumab|mesh-list
83215477|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83215478|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
83215479|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
83215480|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215481|NCT03115073|Clotrimazole|clotrimazole|mesh-list
83215482|NCT03115073|Miconazole|miconazole|mesh-list
83215483|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83215484|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215485|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
83215486|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83215487|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83215488|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215489|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215490|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83215491|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
83215492|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215493|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215494|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83215495|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83215496|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
83215497|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83215498|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215499|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
83215500|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
83215501|NCT03165929|Analgesics|analgesics|mesh-ancestor
83215502|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
83215503|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215504|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215505|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83215506|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83215507|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215508|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215509|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83215510|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215511|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215512|NCT03206073|Durvalumab|durvalumab|mesh-list
83215513|NCT03206073|Tremelimumab|tremelimumab|mesh-list
83215514|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215515|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215516|NCT03190941|Aldesleukin|aldesleukin|mesh-list
83215517|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
83215518|NCT03190941|Fludarabine|fludarabine|mesh-list
83215519|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215520|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
83215521|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215522|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215523|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215524|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
83215525|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215526|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215527|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83215528|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83215529|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83215530|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
83215531|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215532|NCT03142893|Ketoconazole|ketoconazole|mesh-list
83215533|NCT03142893|Dexamethasone|dexamethasone|mesh-list
83215534|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
83215536|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83215537|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83215538|NCT03142893|Hormones|hormones|mesh-list
83215539|NCT03142893|Cosyntropin|cosyntropin|mesh-list
83215540|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83215541|NCT03142893|BB 1101|bb 1101|mesh-list
83215542|NCT03142893|Ganirelix|ganirelix|mesh-list
83215543|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215544|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
83215545|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
83215546|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215547|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215548|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215549|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
83215550|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215551|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83215552|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215553|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
83215554|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215555|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215556|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
83215557|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215558|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83215559|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83215560|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83215561|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
83215562|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83215563|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83215564|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83215565|NCT05428215|Estradiol|estradiol|mesh-list
83215566|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83215567|NCT05428215|Estrogens|estrogens|mesh-ancestor
83215568|NCT05428215|Hormones|hormones|mesh-ancestor
83215569|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215570|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215571|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83215572|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
83215573|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83215574|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83215575|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83215576|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83215577|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215578|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
83215579|NCT02420613|Sirolimus|sirolimus|mesh-list
83215580|NCT02420613|Temsirolimus|temsirolimus|mesh-list
83215581|NCT02420613|Vorinostat|vorinostat|mesh-list
83215582|NCT02420613|MTOR Inhibitors|mtor inhibitors|mesh-list
83215583|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83215584|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215585|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83215586|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215587|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
83215588|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215589|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
83215590|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215591|NCT02420613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83215592|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215593|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82737704|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83215594|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83215595|NCT02546193|Misoprostol|misoprostol|mesh-list
83215596|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83215597|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
83215598|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83215599|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215600|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83215601|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215602|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
83215603|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
83215604|NCT01661595|Tadalafil|tadalafil|mesh-list
83215605|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
83215606|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83215607|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83215608|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215609|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215610|NCT01661595|Urological Agents|urological agents|mesh-ancestor
83215611|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
83215612|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83215613|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215614|NCT02957097|Gabapentin|gabapentin|mesh-list
83215615|NCT02957097|Analgesics|analgesics|mesh-ancestor
83215616|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
83215617|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215618|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215619|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
83215620|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83215621|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83215622|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215623|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83215624|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83215625|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83215626|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215627|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215628|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
83215629|NCT03165383|Morphine|morphine|mesh-list
83215630|NCT03165383|Bupivacaine|bupivacaine|mesh-list
83215631|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
83215632|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
83215633|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215634|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215635|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
83215636|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215637|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83215638|NCT03165383|Narcotics|narcotics|mesh-ancestor
83215639|NCT03165383|Analgesics|analgesics|mesh-ancestor
83215640|NCT03162185|Escitalopram|escitalopram|mesh-list
83215641|NCT03162185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83215642|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83215643|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83215644|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215645|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215646|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
83215647|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215648|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83215649|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83215650|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215652|NCT05286437|Letrozole|letrozole|mesh-list
83215653|NCT05286437|Lenvatinib|lenvatinib|mesh-list
83215654|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215655|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215656|NCT05286437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215657|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215658|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83215659|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83215660|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215661|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83215662|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
83215663|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215664|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215665|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83215666|NCT05464173|Fulvestrant|fulvestrant|mesh-list
83215667|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83215668|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215669|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83215670|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83215671|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
83215672|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215673|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215674|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83215675|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83215676|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215677|NCT02683187|Incretins|incretins|mesh-ancestor
83215678|NCT02683187|Hormones|hormones|mesh-ancestor
83215679|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215680|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83215681|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
83215682|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215683|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215684|NCT05515601|Mirikizumab|mirikizumab|mesh-list
83215685|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83215686|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83215687|NCT05515601|Analgesics|analgesics|mesh-ancestor
83215688|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
83215689|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215690|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215691|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215692|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215693|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83215694|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215695|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
83215696|NCT02683109|Olodaterol|olodaterol|mesh-list
83215697|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83215698|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
83215699|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215700|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215701|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83215702|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
83215703|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
83215704|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83215705|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
83215706|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215707|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215708|NCT02544321|Bromocriptine|bromocriptine|mesh-list
83215709|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83215710|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83215711|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83215712|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215713|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215714|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
83215715|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
83215716|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215717|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215718|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
83215719|NCT02533401|Rituximab|rituximab|mesh-list
83215720|NCT02533401|Fludarabine|fludarabine|mesh-list
83215721|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215722|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
83215723|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215724|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215725|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215726|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
83215727|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215728|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215729|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83215730|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215731|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
83215732|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83215733|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215734|NCT05178173|Ethanol|ethanol|mesh-list
83215735|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
83215736|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83215737|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215738|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215739|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215740|NCT02536833|Lorecivivint|lorecivivint|mesh-list
83215741|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215742|NCT02680847|Naltrexone|naltrexone|mesh-list
83215743|NCT02680847|Oxycodone|oxycodone|mesh-list
83215744|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83215745|NCT02680847|Narcotics|narcotics|mesh-ancestor
83215746|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83215747|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215748|NCT02680847|Analgesics|analgesics|mesh-ancestor
83215749|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
83215750|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215751|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83215752|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83215753|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
83215754|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
83215755|NCT03959241|Methotrexate|methotrexate|mesh-list
83215756|NCT03959241|Tacrolimus|tacrolimus|mesh-list
83215757|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215758|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
83215759|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215760|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215761|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215762|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
83215763|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215764|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215765|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83215766|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83215767|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
83215768|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83215769|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83215770|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
83215771|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
83215772|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215773|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83215774|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83215775|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83215776|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83215777|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83215778|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
83215779|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83215780|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215782|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
83215783|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215784|NCT02532855|Metformin|metformin|mesh-list
83215785|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83215786|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
83215787|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83215788|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215789|NCT02532855|Incretins|incretins|mesh-ancestor
83215790|NCT02532855|Hormones|hormones|mesh-ancestor
83215791|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215792|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83215793|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83215794|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215795|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215796|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83215797|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
83215798|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
83215799|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215801|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215802|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215803|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215804|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
83215805|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215806|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215807|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83215808|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215809|NCT04262427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215810|NCT02530125|Pidilizumab|pidilizumab|mesh-list
83215811|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215812|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215813|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83215814|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83215815|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215816|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
83215817|NCT05421819|Vitamin D|vitamin d|mesh-list
83215818|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
83215819|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
83215820|NCT05421819|Vitamins|vitamins|mesh-list
83215821|NCT05421819|Calcium|calcium|mesh-list
83215822|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
83215823|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215824|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83215825|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83215826|NCT02055820|Prednisone|prednisone|mesh-list
83215827|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
83215828|NCT02055820|Rituximab|rituximab|mesh-list
83215829|NCT02055820|Doxorubicin|doxorubicin|mesh-list
83215830|NCT02055820|Vincristine|vincristine|mesh-list
83215831|NCT02055820|Venetoclax|venetoclax|mesh-list
83215832|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
83215833|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215834|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
83215835|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215836|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215837|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83215838|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
83215839|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215840|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215841|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83215842|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215843|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83215844|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83215845|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83215846|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215847|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215848|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
83215849|NCT02055820|Hormones|hormones|mesh-ancestor
83215850|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215851|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83215852|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83215853|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
83215854|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
83215855|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
83215856|NCT05408559|Sulforaphane|sulforaphane|mesh-list
83215857|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83215858|NCT05408559|Protective Agents|protective agents|mesh-ancestor
83215859|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215860|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215861|NCT02055352|Fluticasone|fluticasone|mesh-list
83215862|NCT02055352|Budesonide|budesonide|mesh-list
83215863|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83215864|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215865|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83215866|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
83215867|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215868|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215869|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83215870|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
83215871|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
83215872|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83215873|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
83215874|NCT02055352|Hormones|hormones|mesh-ancestor
83215875|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215876|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83215877|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83215878|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83215879|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
83215880|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83215881|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215882|NCT02034916|Talazoparib|talazoparib|mesh-list
83215883|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83215884|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215885|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215886|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215887|NCT01374425|Leucovorin|leucovorin|mesh-list
83215888|NCT01374425|Bevacizumab|bevacizumab|mesh-list
83215889|NCT01374425|Fluorouracil|fluorouracil|mesh-list
83215890|NCT01374425|Capecitabine|capecitabine|mesh-list
83215891|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
83215892|NCT01374425|Irinotecan|irinotecan|mesh-list
83215893|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215894|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215895|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83215896|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83215897|NCT01374425|Growth Substances|growth substances|mesh-ancestor
83215898|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215899|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
83215900|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
83215901|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215902|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83215903|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83215904|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
83215905|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83215906|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83215907|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215908|NCT01374425|Antidotes|antidotes|mesh-ancestor
83215909|NCT01374425|Protective Agents|protective agents|mesh-ancestor
83215910|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
83215911|NCT01374425|Vitamins|vitamins|mesh-ancestor
83215912|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
83215913|NCT02085460|Rebamipide|rebamipide|mesh-list
83215914|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83215915|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215916|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
83215917|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215918|NCT02085460|Protective Agents|protective agents|mesh-ancestor
83215919|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215920|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215921|NCT03164291|Rifabutin|rifabutin|mesh-list
83215922|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83215923|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215924|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83215925|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
83215926|NCT02084134|Dexamethasone|dexamethasone|mesh-list
83215927|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
83215928|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
83215929|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83215930|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83215931|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83215932|NCT02084134|BB 1101|bb 1101|mesh-list
83215933|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83215934|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
83215935|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
83215936|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215937|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215938|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83215939|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
83215940|NCT02084134|Hormones|hormones|mesh-ancestor
83215941|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83215942|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83215943|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215944|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
83215945|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215946|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215947|NCT01374269|Acetaminophen|acetaminophen|mesh-list
83215948|NCT01374269|Celecoxib|celecoxib|mesh-list
83215949|NCT01374269|Naproxen|naproxen|mesh-list
83215950|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83215952|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83215953|NCT01374269|Analgesics|analgesics|mesh-ancestor
83215954|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
83215955|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83215956|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83215957|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
83215958|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83215959|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83215960|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83215961|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215962|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215963|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
83215964|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
83215965|NCT05036681|Futibatinib|futibatinib|mesh-list
83215966|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215967|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215968|NCT05036681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83215969|NCT05036681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215970|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83215971|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83215972|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215973|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
83215974|NCT03163589|Hematinics|hematinics|mesh-ancestor
83215975|NCT03163277|Emtricitabine|emtricitabine|mesh-list
83215976|NCT03163277|Maraviroc|maraviroc|mesh-list
83215977|NCT03163277|Darunavir|darunavir|mesh-list
83215978|NCT03163277|Cobicistat|cobicistat|mesh-list
83215979|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83215980|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
83215981|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83215982|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83215983|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83215984|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83215985|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83215986|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83215987|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83215988|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83215989|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83215990|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83215991|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83215992|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83215993|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
83215994|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83215995|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83215996|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
83215997|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83215998|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83215999|NCT05419817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83216000|NCT05419817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216001|NCT05676749|Aldesleukin|aldesleukin|mesh-list
83216002|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
83216003|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216004|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216005|NCT05676749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83216006|NCT05676749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216007|NCT05676749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83216008|NCT05676749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83216009|NCT05676749|Antiviral Agents|antiviral agents|mesh-ancestor
83216010|NCT05676749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216011|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83216012|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83216013|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216014|NCT02679755|Letrozole|letrozole|mesh-list
83216015|NCT02679755|Palbociclib|palbociclib|mesh-list
83216016|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216017|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83216018|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83216019|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216020|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216021|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83216022|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83216023|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216024|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216025|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83216026|NCT02675231|Trastuzumab|trastuzumab|mesh-list
83216027|NCT02675231|Fulvestrant|fulvestrant|mesh-list
83216028|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216029|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216030|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83216031|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83216032|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83216033|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
83216034|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216035|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216036|NCT03163121|Vaccines|vaccines|mesh-list
83216037|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
83216038|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216039|NCT03114371|Oxytocin|oxytocin|mesh-list
83216040|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
83216041|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83216042|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216043|NCT04905407|Azacitidine|azacitidine|mesh-list
83216044|NCT04905407|Venetoclax|venetoclax|mesh-list
83216045|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216046|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
83216047|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216048|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216049|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216050|NCT03162653|Allopurinol|allopurinol|mesh-list
83216051|NCT03162653|Mannitol|mannitol|mesh-list
83216052|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
83216053|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216054|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216055|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
83216056|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216057|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83216058|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
83216059|NCT03162653|Protective Agents|protective agents|mesh-ancestor
83216060|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216061|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83216062|NCT03162653|Diuretics|diuretics|mesh-ancestor
83216063|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
83216064|NCT04708067|Atezolizumab|atezolizumab|mesh-list
83216065|NCT04708067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83216066|NCT04708067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216067|NCT04708067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216068|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216069|NCT03114215|Biotin|biotin|mesh-list
83216070|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
83216071|NCT03114215|Vitamins|vitamins|mesh-ancestor
83216072|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
83216073|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216074|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
83216075|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83216076|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216077|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216078|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83216079|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83216080|NCT05675813|Azacitidine|azacitidine|mesh-list
83216081|NCT05675813|Tislelizumab|tislelizumab|mesh-list
83216082|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216083|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
83216084|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216085|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216086|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216087|NCT05675813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216088|NCT02397083|Everolimus|everolimus|mesh-list
83216089|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
83216090|NCT02397083|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83216091|NCT02397083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83216092|NCT02397083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216093|NCT02397083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216094|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216095|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
83216096|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216097|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216098|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83216099|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
83216100|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83216101|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83216102|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83216103|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83216104|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83216105|NCT01738139|Ipilimumab|ipilimumab|mesh-list
83216106|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
83216107|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216108|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216109|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83216110|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216111|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83216112|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216113|NCT01729091|Lenalidomide|lenalidomide|mesh-list
83216114|NCT01729091|Melphalan|melphalan|mesh-list
83216115|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
83216116|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83216117|NCT01729091|Elotuzumab|elotuzumab|mesh-list
83216118|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
83216119|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216120|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83216121|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83216122|NCT01729091|Growth Substances|growth substances|mesh-ancestor
83216123|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
83216124|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216125|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83216126|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
83216127|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216128|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83216129|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216130|NCT04205903|Paclitaxel|paclitaxel|mesh-list
83216131|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83216132|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83216133|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216134|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
83216135|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
83216136|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
83216137|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216138|NCT01515527|Cytarabine|cytarabine|mesh-list
83216139|NCT01515527|Decitabine|decitabine|mesh-list
83216140|NCT01515527|Cladribine|cladribine|mesh-list
83216141|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216142|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
83216143|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216144|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216145|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
83216146|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216147|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216148|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
83216149|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216150|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216151|NCT02670551|Cariprazine|cariprazine|mesh-list
83216152|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83216153|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83216154|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216155|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216156|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83216157|NCT01430351|Metformin|metformin|mesh-list
83216158|NCT01430351|Mefloquine|mefloquine|mesh-list
83216159|NCT01430351|Temozolomide|temozolomide|mesh-list
83216160|NCT01430351|Memantine|memantine|mesh-list
83216161|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83216162|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216163|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83216164|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
83216165|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216166|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216167|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83216168|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83216169|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
83216170|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216171|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83216172|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83216173|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
83216174|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83216175|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83216176|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216177|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
83216178|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216179|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216180|NCT00893399|Immunotoxins|immunotoxins|mesh-ancestor
83216181|NCT00893399|Immunoconjugates|immunoconjugates|mesh-ancestor
83216182|NCT00893399|Immunologic Factors|immunologic factors|mesh-ancestor
83216183|NCT00893399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216184|NCT05675033|Bevacizumab|bevacizumab|mesh-list
83216185|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216186|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216187|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83216188|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83216189|NCT05675033|Growth Substances|growth substances|mesh-ancestor
83216190|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216191|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
83216192|NCT04103489|Eculizumab|eculizumab|mesh-list
83216193|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83216194|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216195|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
83216196|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216197|NCT04479527|Apatinib|apatinib|mesh-list
83216198|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216199|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83216200|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216201|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216202|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83216203|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
83216204|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
83216205|NCT02391077|Povidone|povidone|mesh-list
83216206|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216207|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83216208|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
83216209|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
83216210|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
83216211|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83216212|NCT02390921|Hematinics|hematinics|mesh-ancestor
83216213|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
83216214|NCT02390843|Topotecan|topotecan|mesh-list
83216215|NCT02390843|Simvastatin|simvastatin|mesh-list
83216216|NCT02390843|Lenograstim|lenograstim|mesh-list
83216217|NCT02390843|Mitogens|mitogens|mesh-list
83216218|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216219|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
83216220|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216221|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216222|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83216223|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
83216224|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216225|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216226|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83216227|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83216228|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83216229|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
83216230|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83216231|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83216232|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216233|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83216234|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83216235|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
83216236|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83216237|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83216238|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83216239|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83216240|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
83216241|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216242|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83216243|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83216244|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216245|NCT03806309|Leucovorin|leucovorin|mesh-list
83216246|NCT03806309|Fluorouracil|fluorouracil|mesh-list
83216247|NCT03806309|Irinotecan|irinotecan|mesh-list
83216248|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
83216249|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216250|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216251|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216252|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216253|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
83216254|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216255|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83216256|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83216257|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216259|NCT03806309|Protective Agents|protective agents|mesh-ancestor
83216260|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
83216261|NCT03806309|Vitamins|vitamins|mesh-ancestor
83216262|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
83216263|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
83216264|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83216265|NCT03489629|Minocycline|minocycline|mesh-list
83216266|NCT03489629|Trimethoprim|trimethoprim|mesh-list
83216267|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
83216268|NCT03489629|Mupirocin|mupirocin|mesh-list
83216269|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83216270|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83216271|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216272|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
83216273|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83216274|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216275|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83216276|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
83216277|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83216278|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83216279|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83216280|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216281|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216282|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83216283|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83216284|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83216285|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83216286|NCT02389751|Paclitaxel|paclitaxel|mesh-list
83216287|NCT02389751|Carboplatin|carboplatin|mesh-list
83216288|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83216289|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83216290|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216291|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
83216292|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
83216293|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83216294|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216295|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
83216296|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216297|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
83216298|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216299|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216300|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83216301|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
83216302|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216303|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216304|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83216305|NCT02388035|Cefotaxime|cefotaxime|mesh-list
83216306|NCT02388035|Cefoxitin|cefoxitin|mesh-list
83216307|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216308|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216309|NCT02389439|Artesunate|artesunate|mesh-list
83216310|NCT02389439|Pyronaridine|pyronaridine|mesh-list
83216311|NCT02389439|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83216312|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
83216313|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83216314|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83216315|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216316|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216317|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
83216318|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
83216319|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83216320|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
83216321|NCT02663687|Complement C1s|complement c1s|mesh-list
83216322|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83216323|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83216324|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
83216325|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216326|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83216327|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216328|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83216329|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83216330|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83216331|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83216332|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
83216333|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83216334|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83216335|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216336|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
83216337|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216338|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216339|NCT02388581|Amoxicillin|amoxicillin|mesh-list
83216340|NCT02388581|Metronidazole|metronidazole|mesh-list
83216341|NCT02388581|Clarithromycin|clarithromycin|mesh-list
83216342|NCT02388581|Lansoprazole|lansoprazole|mesh-list
83216343|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
83216344|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216345|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216346|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83216347|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83216348|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83216349|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216350|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216351|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83216352|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83216353|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83216354|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83216355|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83216356|NCT02387567|Lidocaine|lidocaine|mesh-list
83216357|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
83216358|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
83216359|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216360|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216361|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
83216362|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216363|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83216364|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83216365|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83216366|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83216367|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216368|NCT02383121|Midodrine|midodrine|mesh-list
83216369|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
83216370|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
83216371|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216372|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216373|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83216374|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83216375|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83216376|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83216377|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83216378|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216379|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216380|NCT02387021|Ropivacaine|ropivacaine|mesh-list
83216381|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
83216382|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
83216383|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216384|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216385|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
83216386|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216387|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83216388|NCT02386943|Saxagliptin|saxagliptin|mesh-list
83216389|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83216390|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216391|NCT02386943|Incretins|incretins|mesh-ancestor
83216392|NCT02386943|Hormones|hormones|mesh-ancestor
83216393|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216394|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83216395|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
83216396|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216397|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216398|NCT02084056|Metformin|metformin|mesh-list
83216399|NCT02084056|Linagliptin|linagliptin|mesh-list
83216400|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83216401|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216402|NCT02084056|Incretins|incretins|mesh-ancestor
83216403|NCT02084056|Hormones|hormones|mesh-ancestor
83216404|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216405|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83216406|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
83216407|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216408|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216409|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
83216410|NCT04714372|Fludarabine|fludarabine|mesh-list
83216411|NCT04714372|Daratumumab|daratumumab|mesh-list
83216412|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216413|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
83216414|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216415|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216416|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83216417|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
83216418|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216419|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216420|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83216421|NCT04787471|Riboflavin|riboflavin|mesh-list
83216422|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
83216423|NCT04787471|Vitamins|vitamins|mesh-ancestor
83216424|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
83216425|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216426|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83216427|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
83216428|NCT02386397|Gemcitabine|gemcitabine|mesh-list
83216429|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
83216430|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216431|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
83216432|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216433|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216434|NCT02386475|Dexetimide|dexetimide|mesh-list
83216435|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83216436|NCT02386475|Citalopram|citalopram|mesh-list
83216437|NCT02386475|Escitalopram|escitalopram|mesh-list
83216438|NCT02386475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83216439|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83216440|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83216441|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216442|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216443|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
83216444|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216445|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83216446|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
83216447|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83216448|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83216449|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83216450|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
83216451|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
83216452|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216453|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83216454|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83216455|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
83216456|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83216457|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
83216458|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
83216459|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
83216460|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83216461|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83216462|NCT02382653|Piroxicam|piroxicam|mesh-list
83216463|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83216464|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83216465|NCT02382653|Analgesics|analgesics|mesh-ancestor
83216466|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
83216467|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216468|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216469|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83216470|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216471|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83216472|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216473|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216474|NCT02382263|Paclitaxel|paclitaxel|mesh-list
83216475|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83216476|NCT02382263|Gemcitabine|gemcitabine|mesh-list
83216477|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83216478|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216479|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
83216480|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
83216481|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
83216482|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216483|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216484|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
83216485|NCT02382029|Clonazepam|clonazepam|mesh-list
83216486|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
83216487|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
83216488|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
83216489|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216490|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216491|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216492|NCT02385617|Octreotide|octreotide|mesh-list
83216493|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83216494|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83216495|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216496|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
83216497|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
83216498|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
83216499|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216500|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216501|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
83216502|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216503|NCT02385461|Heparin|heparin|mesh-list
83216504|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83216505|NCT02385461|Tinzaparin|tinzaparin|mesh-list
83216506|NCT02385461|Dalteparin|dalteparin|mesh-list
83216507|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
83216508|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83216509|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83216510|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216511|NCT02381717|Morphine|morphine|mesh-list
83216512|NCT02381717|Bupivacaine|bupivacaine|mesh-list
83216513|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
83216514|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
83216515|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216516|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216517|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
83216518|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216519|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83216520|NCT02381717|Narcotics|narcotics|mesh-ancestor
83216521|NCT02381717|Analgesics|analgesics|mesh-ancestor
83216522|NCT02385305|Anesthetics|anesthetics|mesh-list
83216523|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216524|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216525|NCT02385227|Nicotine|nicotine|mesh-list
83216526|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83216527|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
83216528|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216529|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216530|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83216531|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83216532|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
83216533|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216534|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216535|NCT02381249|Octreotide|octreotide|mesh-list
83216536|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83216537|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83216538|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216539|NCT02385071|Simeprevir|simeprevir|mesh-list
83216540|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
83216541|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216542|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
83216543|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216544|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216545|NCT02384915|Prilocaine|prilocaine|mesh-list
83216546|NCT02384915|Mepivacaine|mepivacaine|mesh-list
83216547|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
83216548|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216549|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216550|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
83216551|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
83216552|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216553|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
83216554|NCT04895735|Pemetrexed|pemetrexed|mesh-list
82738036|NCT00908817|Hormones|hormones|mesh-ancestor
83216555|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216556|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216557|NCT04895735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83216558|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216559|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216560|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83216561|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83216562|NCT02384837|Sirolimus|sirolimus|mesh-list
83216563|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216564|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216565|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83216566|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216567|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
83216568|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216569|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
83216570|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216571|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
83216572|NCT03105791|Narcotics|narcotics|mesh-ancestor
83216573|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216574|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216575|NCT03105791|Analgesics|analgesics|mesh-ancestor
83216576|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
83216577|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216578|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
83216579|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83216580|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83216581|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216582|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
83216583|NCT02384135|Coagulants|coagulants|mesh-ancestor
83216584|NCT02380625|Azithromycin|azithromycin|mesh-list
83216585|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83216586|NCT02380625|Sunitinib|sunitinib|mesh-list
83216587|NCT02380625|Irbesartan|irbesartan|mesh-list
83216588|NCT02380625|Atorvastatin|atorvastatin|mesh-list
83216589|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83216590|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83216591|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
83216592|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216593|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83216594|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83216595|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216596|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216597|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83216598|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216599|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216600|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83216601|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83216602|NCT02380625|Growth Substances|growth substances|mesh-ancestor
83216603|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216604|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
83216605|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83216606|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83216607|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83216608|NCT02380313|Prednisone|prednisone|mesh-list
83216609|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83216610|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
83216611|NCT02380313|Hormones|hormones|mesh-ancestor
83216612|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216613|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216614|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83216615|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216616|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83216617|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83216618|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216619|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216620|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
83216621|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216622|NCT02383901|Methotrexate|methotrexate|mesh-list
83216623|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83216624|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
83216625|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83216626|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216627|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216628|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
83216629|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216630|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216631|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
83216632|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216633|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83216634|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216635|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
83216636|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216637|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83216638|NCT02383823|Estradiol|estradiol|mesh-list
83216639|NCT02383823|Estrogens|estrogens|mesh-list
83216640|NCT02383823|Hormones|hormones|mesh-ancestor
83216641|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216642|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216643|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83216644|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83216645|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83216646|NCT02380001|Analgesics|analgesics|mesh-ancestor
83216647|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
83216648|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216649|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216650|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83216651|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216652|NCT02379767|Harmine|harmine|mesh-list
83216653|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
83216654|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216655|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83216656|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83216657|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216658|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216659|NCT02661815|Paclitaxel|paclitaxel|mesh-list
83216660|NCT02661815|Bevacizumab|bevacizumab|mesh-list
83216661|NCT02661815|Ricolinostat|ricolinostat|mesh-list
83216662|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83216663|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216664|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
83216665|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
83216666|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
83216667|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216668|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216669|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83216670|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83216671|NCT02661815|Growth Substances|growth substances|mesh-ancestor
83216672|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216673|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83216674|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83216675|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216676|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
83216677|NCT02377193|Tacrolimus|tacrolimus|mesh-list
83216678|NCT02377193|Basiliximab|basiliximab|mesh-list
83216679|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216680|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
83216681|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216682|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83216683|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216684|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216685|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83216686|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216687|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83216688|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
83216689|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216690|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216691|NCT04688021|Cytarabine|cytarabine|mesh-list
83216692|NCT04688021|Cyclosporine|cyclosporine|mesh-list
83216693|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
83216694|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
83216695|NCT04688021|Busulfan|busulfan|mesh-list
83216696|NCT04688021|Cyclosporins|cyclosporins|mesh-list
83216697|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83216698|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
83216699|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83216700|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
83216701|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216702|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216703|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83216704|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
83216705|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216706|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216707|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83216708|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83216709|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
83216710|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
83216711|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216712|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216713|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
83216714|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
83216715|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83216716|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83216717|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83216718|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
83216719|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216720|NCT02053246|Nebivolol|nebivolol|mesh-list
83216721|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83216722|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
83216723|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83216724|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83216725|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83216726|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
83216727|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216728|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216729|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216730|NCT04678661|Insulin|insulin|mesh-list
83216731|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83216732|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216733|NCT02379299|Hormones|hormones|mesh-list
83216734|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216735|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216736|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
83216737|NCT02376881|Hematinics|hematinics|mesh-ancestor
83216738|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
83216739|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
83216740|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216741|NCT02376803|Warfarin|warfarin|mesh-list
83216742|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
83216743|NCT04132427|Vancomycin|vancomycin|mesh-list
83216744|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
83216745|NCT04132427|Citric Acid|citric acid|mesh-list
83216746|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
83216747|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
83216748|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83216749|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
83216750|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
83216751|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216752|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83216753|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216754|NCT04132427|Cathartics|cathartics|mesh-ancestor
83216755|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83216756|NCT02031640|Beclomethasone|beclomethasone|mesh-list
83216757|NCT02031640|Albuterol|albuterol|mesh-list
83216758|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
83216759|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
83216760|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216761|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216762|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83216763|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
83216764|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
83216765|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83216766|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83216767|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83216768|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83216769|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
83216770|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216771|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216772|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83216773|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
83216774|NCT02031640|Hormones|hormones|mesh-ancestor
83216775|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216776|NCT02376413|Trastuzumab|trastuzumab|mesh-list
83216777|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216778|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216779|NCT02378441|Metformin|metformin|mesh-list
83216780|NCT02378441|Atorvastatin|atorvastatin|mesh-list
83216781|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83216782|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216783|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83216784|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83216785|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
83216786|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216787|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83216788|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83216789|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216790|NCT04072445|Trifluridine|trifluridine|mesh-list
83216791|NCT04072445|Irinotecan|irinotecan|mesh-list
83216792|NCT04072445|Camptothecin|camptothecin|mesh-list
83216793|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83216794|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83216795|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216796|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216797|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216798|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83216799|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
83216800|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
83216801|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216802|NCT04600427|Anesthetics|anesthetics|mesh-list
83216803|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216804|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216805|NCT04595981|Cisplatin|cisplatin|mesh-list
83216806|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216807|NCT02378129|Methamphetamine|methamphetamine|mesh-list
83216808|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83216809|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216810|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
83216811|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
83216812|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216813|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
83216814|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216815|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216816|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
83216817|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83216818|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83216819|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83216820|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83216821|NCT02376335|Rituximab|rituximab|mesh-list
83216822|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216823|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216824|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
83216825|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216826|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216827|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
83216828|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83216829|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83216830|NCT02375867|Prednisolone|prednisolone|mesh-list
83216831|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
83216832|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83216833|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
83216834|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83216835|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
83216836|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
83216837|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216838|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216839|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83216840|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
83216841|NCT02375867|Hormones|hormones|mesh-ancestor
83216842|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216843|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83216844|NCT02375867|Protective Agents|protective agents|mesh-ancestor
83216845|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83216846|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216847|NCT04540133|Dexamethasone|dexamethasone|mesh-list
83216848|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
83216849|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83216850|NCT04540133|BB 1101|bb 1101|mesh-list
83216851|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83216852|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
83216853|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
83216854|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216855|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216856|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83216857|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
83216858|NCT04540133|Hormones|hormones|mesh-ancestor
83216859|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216860|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83216861|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216862|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
83216863|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216864|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216865|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
83216866|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83216867|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216868|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216869|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83216870|NCT02375243|Analgesics|analgesics|mesh-ancestor
83216871|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
83216872|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216873|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83216874|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83216875|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83216876|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83216877|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216878|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216879|NCT02374931|Estradiol|estradiol|mesh-list
83216880|NCT02374931|Estrogens|estrogens|mesh-ancestor
83216881|NCT02374931|Hormones|hormones|mesh-ancestor
83216882|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216883|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216884|NCT02377661|Amlodipine|amlodipine|mesh-list
83216885|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83216886|NCT02377661|Olmesartan|olmesartan|mesh-list
83216887|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83216888|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83216889|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83216890|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83216891|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216892|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83216893|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216894|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
83216895|NCT02377661|Diuretics|diuretics|mesh-ancestor
83216896|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
83216897|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83216898|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83216899|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83216900|NCT02372357|Posaconazole|posaconazole|mesh-list
83216901|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
83216902|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83216903|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83216904|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83216905|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83216906|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83216907|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83216908|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216909|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216910|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83216911|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
83216912|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216913|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216914|NCT03672773|Temozolomide|temozolomide|mesh-list
83216915|NCT03672773|Talazoparib|talazoparib|mesh-list
83216916|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83216917|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
83216918|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216919|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216920|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83216921|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216922|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
83216923|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216924|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216925|NCT02371577|Lenalidomide|lenalidomide|mesh-list
83216926|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
83216927|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216928|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83216929|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83216930|NCT02371577|Growth Substances|growth substances|mesh-ancestor
83216931|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
83216932|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216934|NCT02373449|Analgesics|analgesics|mesh-ancestor
83216935|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
83216936|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216937|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216938|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83216939|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83216940|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
83216941|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
83216942|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216943|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83216944|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83216945|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216946|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216947|NCT02371421|Allopurinol|allopurinol|mesh-list
83216948|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
83216949|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216950|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216951|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
83216952|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83216953|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83216955|NCT02371421|Protective Agents|protective agents|mesh-ancestor
83216956|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216957|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83216958|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
83216959|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83216960|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216961|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216962|NCT03959891|Letrozole|letrozole|mesh-list
83216963|NCT03959891|Fulvestrant|fulvestrant|mesh-list
83216964|NCT03959891|Palbociclib|palbociclib|mesh-list
83216965|NCT03959891|Ipatasertib|ipatasertib|mesh-list
83216966|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83216967|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216968|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83216969|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216970|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216971|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83216972|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
83216973|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83216974|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216975|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83216976|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83216977|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83216978|NCT02373215|Nalbuphine|nalbuphine|mesh-list
83216979|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83216980|NCT02373215|Narcotics|narcotics|mesh-ancestor
83216981|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83216982|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83216983|NCT02373215|Analgesics|analgesics|mesh-ancestor
83216984|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
83216985|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83216986|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
83216987|NCT03785249|Cetuximab|cetuximab|mesh-list
83216988|NCT03785249|Afatinib|afatinib|mesh-list
83216989|NCT03785249|Adagrasib|adagrasib|mesh-list
83216990|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216991|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83216992|NCT03785249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83216993|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83216994|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83216995|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83216996|NCT03765983|Trastuzumab|trastuzumab|mesh-list
83216997|NCT03765983|GDC-0084|gdc-0084|mesh-list
83216998|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83216999|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217000|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217001|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217003|NCT02372903|Analgesics|analgesics|mesh-ancestor
83217004|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
83217005|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217006|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217007|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217008|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217009|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217010|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217011|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
83217012|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217013|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83217014|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83217015|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217016|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217018|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217019|NCT02372591|Buprenorphine|buprenorphine|mesh-list
83217020|NCT02372591|Hydromorphone|hydromorphone|mesh-list
83217021|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83217022|NCT02372591|Narcotics|narcotics|mesh-ancestor
83217023|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217024|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217025|NCT02372591|Analgesics|analgesics|mesh-ancestor
83217026|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
83217027|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217028|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83217029|NCT02372669|Chitosan|chitosan|mesh-list
83217030|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83217031|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83217032|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
83217033|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217034|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83217035|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
83217036|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
83217037|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
83217038|NCT02372669|Coagulants|coagulants|mesh-ancestor
83217039|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83217040|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
83217041|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83217042|NCT02369939|Fluorouracil|fluorouracil|mesh-list
83217043|NCT02369939|Mitomycins|mitomycins|mesh-list
83217044|NCT02369939|Mitomycin|mitomycin|mesh-list
83217045|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
83217046|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217047|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217048|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217049|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217050|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
83217051|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217052|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83217053|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
83217054|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83217055|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217056|NCT02369549|Curcumin|curcumin|mesh-list
83217057|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217058|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217059|NCT02369549|Analgesics|analgesics|mesh-ancestor
83217060|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
83217061|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217062|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217063|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217064|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217065|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217066|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217067|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217068|NCT02365415|Sirolimus|sirolimus|mesh-list
83217069|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217070|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217071|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83217072|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217073|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
83217074|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217075|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
83217076|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217077|NCT02369081|Bisoprolol|bisoprolol|mesh-list
83217078|NCT02369081|Doxazosin|doxazosin|mesh-list
83217079|NCT02369081|Spironolactone|spironolactone|mesh-list
83217080|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83217081|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217082|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217083|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217084|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83217085|NCT02369081|Diuretics|diuretics|mesh-ancestor
83217086|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
83217087|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83217088|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
83217089|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
83217090|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217091|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83217092|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83217093|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83217094|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83217095|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217096|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217097|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83217098|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83217099|NCT02365493|Cefazolin|cefazolin|mesh-list
83217100|NCT02365493|Lactams|lactams|mesh-list
83217101|NCT02365493|beta-Lactams|beta-lactams|mesh-list
83217102|NCT02365493|Floxacillin|floxacillin|mesh-list
83217103|NCT02365493|Cloxacillin|cloxacillin|mesh-list
83217104|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217105|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217106|NCT02365181|Ropivacaine|ropivacaine|mesh-list
83217107|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
83217108|NCT02365181|Anesthetics|anesthetics|mesh-list
83217109|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217110|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217111|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
83217112|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217113|NCT05653895|Metformin|metformin|mesh-list
83217114|NCT05653895|Resveratrol|resveratrol|mesh-list
83217115|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83217116|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217117|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
83217118|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217119|NCT05653895|Protective Agents|protective agents|mesh-ancestor
83217120|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217121|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83217122|NCT02364479|Etanercept|etanercept|mesh-list
83217123|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217124|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217125|NCT02364479|Analgesics|analgesics|mesh-ancestor
83217126|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
83217127|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217128|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217129|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217130|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217131|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217132|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217133|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
83217134|NCT05653817|Paclitaxel|paclitaxel|mesh-list
83217135|NCT05653817|Apatinib|apatinib|mesh-list
83217136|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83217137|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83217138|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217139|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
83217140|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
83217141|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
83217142|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217143|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83217144|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217145|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
83217146|NCT02052310|Hematinics|hematinics|mesh-ancestor
83217147|NCT02368379|Metyrapone|metyrapone|mesh-list
83217148|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
83217149|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217150|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217151|NCT02051296|Minocycline|minocycline|mesh-list
83217152|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217154|NCT02367755|Lorazepam|lorazepam|mesh-list
83217155|NCT02367755|Propofol|propofol|mesh-list
83217156|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83217157|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217158|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217159|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83217160|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
83217161|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
83217162|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
83217163|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
83217164|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
83217165|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217166|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217167|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83217168|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83217169|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83217170|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
83217171|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
83217172|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217173|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217174|NCT02364089|Epinephrine|epinephrine|mesh-list
83217175|NCT02364089|Racepinephrine|racepinephrine|mesh-list
83217176|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
83217177|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83217178|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83217179|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
83217180|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217181|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217182|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217183|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83217184|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83217185|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
83217186|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217187|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83217188|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217189|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
83217190|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
83217191|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83217192|NCT02363699|Lidocaine|lidocaine|mesh-list
83217193|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
83217194|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
83217195|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217196|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217197|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
83217198|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217199|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83217200|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83217201|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83217202|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83217203|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217204|NCT02049814|Metformin|metformin|mesh-list
83217205|NCT02049814|Acarbose|acarbose|mesh-list
83217206|NCT02049814|Voglibose|voglibose|mesh-list
83217207|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83217208|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217209|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83217210|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217211|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217212|NCT03344159|Spironolactone|spironolactone|mesh-list
83217213|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83217214|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217215|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217216|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217217|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83217218|NCT03344159|Diuretics|diuretics|mesh-ancestor
83217219|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
83217220|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
83217221|NCT03324113|Promethazine|promethazine|mesh-list
83217222|NCT03324113|Dexamethasone|dexamethasone|mesh-list
83217223|NCT03324113|Naphazoline|naphazoline|mesh-list
83217224|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83217225|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217226|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
83217227|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
83217228|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217229|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217230|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217231|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
83217233|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217234|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83217235|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217236|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83217237|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83217238|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83217239|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217240|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
83217241|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
83217242|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
83217243|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83217244|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
83217245|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
83217246|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217247|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217248|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83217249|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
83217250|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
83217251|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83217252|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83217253|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83217254|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
83217255|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83217256|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217257|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
83217258|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83217259|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217260|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217261|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83217262|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
83217263|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83217264|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217265|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83217266|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83217267|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83217268|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217269|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
83217270|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217271|NCT02367053|Glucagon|glucagon|mesh-list
83217272|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217273|NCT02367053|Hormones|hormones|mesh-ancestor
83217274|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217275|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217276|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83217277|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83217278|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83217279|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
83217280|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217281|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83217282|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83217283|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217284|NCT02366975|Testosterone|testosterone|mesh-list
83217285|NCT02366975|Androgens|androgens|mesh-ancestor
83217286|NCT02366975|Hormones|hormones|mesh-ancestor
83217287|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217288|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217289|NCT04479371|Bupivacaine|bupivacaine|mesh-list
83217290|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
83217291|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
83217292|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217293|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217294|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
83217295|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217296|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83217297|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83217298|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
83217299|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83217300|NCT02366585|Cyclosporine|cyclosporine|mesh-list
83217301|NCT02366585|Cyclosporins|cyclosporins|mesh-list
83217302|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217303|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217304|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217305|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
83217306|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217307|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
83217308|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217309|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
83217310|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217311|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83217312|NCT02079532|Rituximab|rituximab|mesh-list
83217313|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83217314|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217315|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
83217316|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217317|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217318|NCT02958917|Pirfenidone|pirfenidone|mesh-list
83217319|NCT02958917|Analgesics|analgesics|mesh-ancestor
83217320|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
83217321|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217322|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217323|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217324|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217325|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217326|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217327|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217328|NCT02362529|Minocycline|minocycline|mesh-list
83217329|NCT02362529|Celecoxib|celecoxib|mesh-list
83217330|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217331|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217332|NCT02362529|Analgesics|analgesics|mesh-ancestor
83217333|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
83217334|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217335|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217336|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217337|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217338|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83217339|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83217340|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217341|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217342|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217343|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217344|NCT02794571|Paclitaxel|paclitaxel|mesh-list
83217345|NCT02794571|Etoposide|etoposide|mesh-list
83217346|NCT02794571|Bevacizumab|bevacizumab|mesh-list
83217347|NCT02794571|Carboplatin|carboplatin|mesh-list
83217348|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
83217349|NCT02794571|Capecitabine|capecitabine|mesh-list
83217350|NCT02794571|Pemetrexed|pemetrexed|mesh-list
83217351|NCT02794571|Atezolizumab|atezolizumab|mesh-list
83217352|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83217353|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217354|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83217355|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83217356|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83217357|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217358|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83217359|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83217360|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83217361|NCT02794571|Growth Substances|growth substances|mesh-ancestor
83217362|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217363|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
83217364|NCT02794571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83217365|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217366|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
83217367|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83217368|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83217369|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217370|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83217371|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83217372|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
83217373|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83217374|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83217376|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
83217377|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83217378|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
83217379|NCT02769689|Natalizumab|natalizumab|mesh-list
83217380|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217381|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
83217382|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
83217383|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217384|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217385|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217386|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
83217387|NCT02769689|Hormones|hormones|mesh-ancestor
83217388|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217389|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83217390|NCT02769689|Protective Agents|protective agents|mesh-ancestor
83217391|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83217392|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217393|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
83217394|NCT02365571|Itraconazole|itraconazole|mesh-list
83217395|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
83217396|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217397|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83217398|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83217399|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217400|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217401|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83217402|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217403|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217404|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217405|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83217406|NCT02365727|Clonidine|clonidine|mesh-list
83217407|NCT02365727|Epinephrine|epinephrine|mesh-list
83217408|NCT02365727|Bupivacaine|bupivacaine|mesh-list
83217409|NCT02365727|Ropivacaine|ropivacaine|mesh-list
83217410|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
83217411|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
83217412|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217413|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217414|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
83217415|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217416|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83217417|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83217418|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83217419|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217420|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217421|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83217422|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83217423|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
83217424|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83217425|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217426|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
83217427|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
83217428|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83217429|NCT02365727|Analgesics|analgesics|mesh-ancestor
83217430|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83217431|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
83217432|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83217433|NCT02365805|Paclitaxel|paclitaxel|mesh-list
83217434|NCT02365805|Docetaxel|docetaxel|mesh-list
83217435|NCT02365805|Fluorouracil|fluorouracil|mesh-list
83217436|NCT02365805|Epirubicin|epirubicin|mesh-list
83217437|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
83217438|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83217439|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217440|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
83217441|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
83217442|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
83217443|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217444|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
83217445|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217446|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217447|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
83217448|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217449|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83217450|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83217451|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83217452|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217453|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217454|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83217455|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
83217456|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83217457|NCT03112889|Valproic Acid|valproic acid|mesh-list
83217458|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
83217459|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217460|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217461|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
83217462|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217463|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217464|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
83217465|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83217466|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217467|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83217468|NCT03112577|Fluticasone|fluticasone|mesh-list
83217469|NCT03112577|Xhance|xhance|mesh-list
83217470|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217471|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83217472|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
83217473|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217474|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217475|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83217476|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217477|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
83217478|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83217479|NCT02361905|Leuprolide|leuprolide|mesh-list
83217480|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
83217481|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83217482|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
83217483|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83217484|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217485|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83217486|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217487|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83217488|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
83217489|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83217490|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
83217491|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83217492|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83217493|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217494|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
83217495|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217496|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217497|NCT04372433|Azacitidine|azacitidine|mesh-list
83217498|NCT04372433|Venetoclax|venetoclax|mesh-list
83217499|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217500|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
83217501|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217502|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217503|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217504|NCT02358707|Ibuprofen|ibuprofen|mesh-list
83217505|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217506|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217507|NCT02358707|Analgesics|analgesics|mesh-ancestor
83217508|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
83217509|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217510|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217511|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217512|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217513|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83217514|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217515|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217516|NCT02360501|Docetaxel|docetaxel|mesh-list
83217517|NCT02360501|Capecitabine|capecitabine|mesh-list
83217518|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217519|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
83217520|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
83217521|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
83217522|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217523|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217524|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
83217525|NCT02360423|Sirolimus|sirolimus|mesh-list
83217526|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217527|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217528|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83217529|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217530|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
83217531|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217532|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
83217533|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217534|NCT02358161|Paclitaxel|paclitaxel|mesh-list
83217535|NCT02358161|Gemcitabine|gemcitabine|mesh-list
83217536|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83217537|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217538|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
83217539|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
83217540|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
83217541|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217542|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217543|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
83217544|NCT02357849|Aripiprazole|aripiprazole|mesh-list
83217545|NCT02357849|Fluoxetine|fluoxetine|mesh-list
83217546|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
83217547|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83217548|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83217549|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83217550|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217551|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217552|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
83217553|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
83217554|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217555|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217556|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83217557|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83217558|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
83217559|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83217560|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83217561|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83217562|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83217563|NCT02357849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83217564|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83217565|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83217566|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83217567|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83217568|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83217569|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217570|NCT02357693|Aprepitant|aprepitant|mesh-list
83217571|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
83217572|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
83217573|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217574|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217575|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217576|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83217577|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217578|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217579|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83217580|NCT02357615|Nifedipine|nifedipine|mesh-list
83217581|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83217582|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83217583|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217584|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83217585|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217586|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
83217587|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
83217588|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83217589|NCT03160001|Niclosamide|niclosamide|mesh-list
83217590|NCT03160001|Etanercept|etanercept|mesh-list
83217591|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217592|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217593|NCT03160001|Analgesics|analgesics|mesh-ancestor
83217594|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
83217595|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217596|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217597|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217598|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217599|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217600|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217601|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
83217602|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
83217603|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83217604|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
83217605|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83217606|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217607|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
83217609|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217610|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217611|NCT02359643|Analgesics|analgesics|mesh-ancestor
83217612|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
83217613|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217614|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217615|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217616|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217617|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83217618|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83217619|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217620|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83217621|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83217622|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217623|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
83217624|NCT02359721|Clarithromycin|clarithromycin|mesh-list
83217625|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217626|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217627|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83217628|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82773335|NCT00949026|Sirolimus|sirolimus|mesh-list
83217629|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217630|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83217631|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83217632|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
83217633|NCT02357303|Simethicone|simethicone|mesh-list
83217634|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83217635|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
83217636|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217637|NCT02357303|Expectorants|expectorants|mesh-ancestor
83217638|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217639|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83217640|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
83217641|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217642|NCT02357303|Protective Agents|protective agents|mesh-ancestor
83217643|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217644|NCT02357303|Antidotes|antidotes|mesh-ancestor
83217645|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
83217646|NCT02357303|Emollients|emollients|mesh-ancestor
83217647|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
83217648|NCT02357225|Bromides|bromides|mesh-list
83217649|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83217650|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
83217651|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83217652|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217653|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217654|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
83217655|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217656|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217657|NCT02357069|Etanercept|etanercept|mesh-list
83217658|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83217659|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83217660|NCT02357069|Analgesics|analgesics|mesh-ancestor
83217661|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
83217662|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217663|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217664|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217665|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217666|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217667|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217668|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
83217669|NCT02356913|Nicotine|nicotine|mesh-list
83217670|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83217671|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
83217672|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217673|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217674|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83217675|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83217676|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
83217677|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217678|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217679|NCT02352545|Montelukast|montelukast|mesh-list
83217680|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83217681|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217682|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83217683|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217684|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217685|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217686|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83217687|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83217688|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217689|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
83217690|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83217691|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
83217692|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217693|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217694|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83217695|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217696|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83217697|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
83217698|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217699|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217700|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83217701|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
83217702|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
83217703|NCT02356835|Protective Agents|protective agents|mesh-ancestor
83217704|NCT02352701|Amoxicillin|amoxicillin|mesh-list
83217705|NCT02352701|Levofloxacin|levofloxacin|mesh-list
83217706|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217707|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217708|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83217709|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83217710|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83217711|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217712|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217713|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217714|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83217715|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83217717|NCT02356445|Methotrexate|methotrexate|mesh-list
83217718|NCT02356445|Azathioprine|azathioprine|mesh-list
83217719|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83217720|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
83217721|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83217722|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217723|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217724|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
83217725|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217726|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217727|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
83217728|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217729|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83217730|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217731|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
83217732|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217733|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83217734|NCT02356445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83217735|NCT02356445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83217736|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217737|NCT02356679|Ethanol|ethanol|mesh-list
83217738|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83217739|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217740|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217741|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217742|NCT02352155|Epinephrine|epinephrine|mesh-list
83217743|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83217744|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83217745|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
83217746|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362186|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217747|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217748|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217749|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83217750|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83217751|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
83217752|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217753|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83217754|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
83217755|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
83217756|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
83217757|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83217758|NCT02352311|Tadalafil|tadalafil|mesh-list
83217759|NCT02352311|Dutasteride|dutasteride|mesh-list
83217760|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
83217761|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83217762|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83217763|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217764|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217765|NCT02352311|Urological Agents|urological agents|mesh-ancestor
83217766|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83217767|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83217768|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217769|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217770|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217771|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83217772|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217773|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83217774|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217775|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217776|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
83217777|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
83217778|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83217779|NCT02351687|Albendazole|albendazole|mesh-list
83217780|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
83217781|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83217782|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83217783|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217784|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83217785|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217786|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217787|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83217788|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
83217789|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
83217790|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83217791|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
83217792|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
83217793|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
83217794|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217795|NCT02355509|Acarbose|acarbose|mesh-list
83217796|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83217797|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217798|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217799|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83217800|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217801|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
83217802|NCT02355197|Vitamins|vitamins|mesh-ancestor
83217803|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
83217804|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217805|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
83217806|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217807|NCT02355197|Protective Agents|protective agents|mesh-ancestor
83217808|NCT02351297|Caseins|caseins|mesh-list
83217809|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
83217810|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
83217811|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217812|NCT02355119|Gemcitabine|gemcitabine|mesh-list
83217813|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83217814|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
83217815|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217816|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217817|NCT03149939|Febuxostat|febuxostat|mesh-list
83217818|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
83217819|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217820|NCT03149783|Ropivacaine|ropivacaine|mesh-list
83217821|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
83217822|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
83217823|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217824|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217825|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
83217826|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217827|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
83217828|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83217829|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83217830|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217831|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
83217832|NCT02354885|Coagulants|coagulants|mesh-ancestor
83217833|NCT02354807|Mirabegron|mirabegron|mesh-list
83217834|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83217835|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83217836|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83217837|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
83217838|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217839|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82774325|NCT00653159|Copper|copper|mesh-list
83217840|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217841|NCT02354807|Urological Agents|urological agents|mesh-ancestor
83217842|NCT03159845|Levofloxacin|levofloxacin|mesh-list
83217843|NCT03159845|Fluconazole|fluconazole|mesh-list
83217844|NCT03159845|Acyclovir|acyclovir|mesh-list
83217845|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
83217846|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83217847|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217848|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83217849|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83217850|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83217851|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217852|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217853|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217854|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83217855|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83217856|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
83217857|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83217858|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83217859|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217860|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217861|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217862|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83217863|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83217864|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
83217865|NCT03159845|Astringents|astringents|mesh-ancestor
83217866|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
83217867|NCT02350751|MEDI8852|medi8852|mesh-list
83217868|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
83217869|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217870|NCT02350985|Propranolol|propranolol|mesh-list
83217871|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83217872|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83217873|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83217874|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
83217875|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217876|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217877|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217878|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83217879|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83217880|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
83217881|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83217882|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83217883|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83217884|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83217885|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
83217886|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83217887|NCT02354261|Itraconazole|itraconazole|mesh-list
83217888|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
83217889|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83217890|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83217891|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83217892|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217893|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217894|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83217895|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217896|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217897|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217898|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83217899|NCT02350439|Adenosine|adenosine|mesh-list
83217900|NCT02350439|Analgesics|analgesics|mesh-ancestor
83217901|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
83217902|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217903|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217904|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83217905|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
83217906|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83217907|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
83217908|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
83217909|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217910|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217911|NCT02350673|Atezolizumab|atezolizumab|mesh-list
83217912|NCT02350673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83217913|NCT02350673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217914|NCT02350673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83217915|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217917|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83217918|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83217919|NCT02350361|Growth Substances|growth substances|mesh-ancestor
83217920|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217921|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
83217922|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217923|NCT02353949|Flutemetamol|flutemetamol|mesh-list
83217924|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83217925|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217926|NCT02354027|Metformin|metformin|mesh-list
83217927|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83217928|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217929|NCT03149393|Mosapride|mosapride|mesh-list
83217930|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217931|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83217932|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83217933|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
83217934|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217935|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217936|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
83217937|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217938|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83217939|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83217940|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217941|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
83217942|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83217943|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217944|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83217945|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
83217946|NCT02353325|Fesoterodine|fesoterodine|mesh-list
83217947|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
83217948|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217949|NCT02353325|Protective Agents|protective agents|mesh-ancestor
83217950|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217951|NCT02353325|Vitamins|vitamins|mesh-ancestor
83217952|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
83217953|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83217954|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83217955|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
83217956|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83217957|NCT02353325|Urological Agents|urological agents|mesh-ancestor
83217958|NCT03157505|Immunomodulating Agents|immunomodulating agents|mesh-list
83217959|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
83217960|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217961|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
83217962|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83217963|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
83217964|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217965|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
83217966|NCT03157193|Protective Agents|protective agents|mesh-ancestor
83217967|NCT03149159|Nivolumab|nivolumab|mesh-list
83217968|NCT03149159|Ipilimumab|ipilimumab|mesh-list
83217969|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83217970|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217971|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83217972|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83217974|NCT03155477|Vitamin D|vitamin d|mesh-list
83217975|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83217976|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217977|NCT03155477|Vitamins|vitamins|mesh-ancestor
83217978|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
83217979|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83217980|NCT02349581|Bupivacaine|bupivacaine|mesh-list
83217981|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
83217982|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
83217983|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83217984|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217985|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
83217986|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83217987|NCT03154385|Rituximab|rituximab|mesh-list
83217988|NCT03154385|Belimumab|belimumab|mesh-list
83217989|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83217990|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83217991|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
83217992|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217993|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83217994|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83217995|NCT03112187|Iron|iron|mesh-list
83217996|NCT03112187|Trace Elements|trace elements|mesh-ancestor
83217997|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
83217998|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83217999|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
83218000|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83218001|NCT03147677|Irbesartan|irbesartan|mesh-list
83218002|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83218003|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83218004|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83218005|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218006|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83218007|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218008|NCT03147677|Vitamins|vitamins|mesh-ancestor
83218009|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
83218010|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
83218011|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
83218012|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218013|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218014|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218015|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
83218016|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218017|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218018|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218019|NCT03147599|Mebeverine|mebeverine|mesh-list
83218020|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
83218021|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
83218022|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
83218023|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218024|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218025|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83218026|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83218027|NCT02349113|Estrogens|estrogens|mesh-list
83218028|NCT02349113|Estradiol|estradiol|mesh-list
83218029|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83218030|NCT02349113|Hormones|hormones|mesh-ancestor
83430112|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218031|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218032|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218033|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83218034|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
83218035|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83218036|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83218037|NCT04183205|Sertraline|sertraline|mesh-list
83218038|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
83218039|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218040|NCT04183205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83218041|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83218042|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218043|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218044|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218045|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
83218046|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218047|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83218048|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218049|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83218050|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218051|NCT02348177|Ritonavir|ritonavir|mesh-list
83218052|NCT02348177|Lopinavir|lopinavir|mesh-list
83218053|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83218054|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83218055|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
83218056|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218057|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218058|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83218059|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83218060|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
83218061|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218062|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83218063|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218064|NCT02348255|Bevacizumab|bevacizumab|mesh-list
83218065|NCT02348255|Carmustine|carmustine|mesh-list
83218066|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83218067|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218068|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83218069|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83218070|NCT02348255|Growth Substances|growth substances|mesh-ancestor
83218071|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218072|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
83218073|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83218074|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
83218075|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218076|NCT02348333|Dotinurad|dotinurad|mesh-list
83218077|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
83218078|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
83218079|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83218080|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
83218081|NCT02343419|Miotics|miotics|mesh-ancestor
83218082|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
83218083|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218084|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218085|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83218086|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83218087|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
83218088|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83218089|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83218090|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218091|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218092|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218093|NCT02342717|Itraconazole|itraconazole|mesh-list
83218094|NCT02342717|BI 425809|bi 425809|mesh-list
83218095|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
83218096|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218097|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83218098|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218099|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218100|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218101|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83218102|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
83218103|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218104|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218105|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83218106|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
83218107|NCT04478357|Fesoterodine|fesoterodine|mesh-list
83218108|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83218109|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83218110|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218111|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218112|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218113|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218114|NCT04478357|Urological Agents|urological agents|mesh-ancestor
83218115|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
83218116|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83218117|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218118|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218119|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218120|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218121|NCT04478513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83218122|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83218123|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218124|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218125|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218126|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
83218127|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83218128|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
83218129|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83218130|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218131|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218132|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83218133|NCT02342093|Drospirenone|drospirenone|mesh-list
83218134|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83218135|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83218136|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218137|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218138|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83218139|NCT02342093|Diuretics|diuretics|mesh-ancestor
83218140|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
83218141|NCT02347319|Silymarin|silymarin|mesh-list
83218142|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
83218143|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218144|NCT02347319|Protective Agents|protective agents|mesh-ancestor
83218145|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218146|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
83218147|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83218148|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218149|NCT02341703|Metformin|metformin|mesh-list
83218150|NCT02341703|Pioglitazone|pioglitazone|mesh-list
83218151|NCT02341703|Letrozole|letrozole|mesh-list
83218152|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83218153|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218154|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218155|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83218156|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83218157|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218158|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218159|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83218160|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
83218161|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218162|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
83218163|NCT02341547|Hematinics|hematinics|mesh-ancestor
83218164|NCT02341079|Bupivacaine|bupivacaine|mesh-list
83218165|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
83218166|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
83218167|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218168|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218169|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
83218170|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218171|NCT02346539|Nicotine|nicotine|mesh-list
83218172|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83218173|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
83218174|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218175|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218176|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83218177|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83218178|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218179|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218180|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218181|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83218182|NCT02340455|Pregabalin|pregabalin|mesh-list
83218183|NCT02340455|Analgesics|analgesics|mesh-ancestor
83218184|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
83218185|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218186|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218187|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
83218188|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83218189|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218190|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218191|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83218193|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218194|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218195|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218196|NCT02345837|Clomiphene|clomiphene|mesh-list
83218197|NCT02345837|Enclomiphene|enclomiphene|mesh-list
83218198|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
83218199|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83218200|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
83218201|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218202|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218203|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83218204|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
83218205|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83218206|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83218207|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83218208|NCT02345993|Beclomethasone|beclomethasone|mesh-list
83218209|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
83218210|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83218211|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
83218212|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218213|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218214|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83218215|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
83218216|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83218217|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83218218|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83218219|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
83218220|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218221|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218222|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83218223|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
83218224|NCT02345993|Hormones|hormones|mesh-ancestor
83218225|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218226|NCT02345681|Furosemide|furosemide|mesh-list
83218227|NCT02345681|Diuretics|diuretics|mesh-ancestor
83218228|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
83218229|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218230|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83218231|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218232|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218233|NCT02340611|Olaparib|olaparib|mesh-list
83218234|NCT02340611|Cediranib|cediranib|mesh-list
83218235|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83218236|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218237|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218238|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218239|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83218240|NCT03145649|Insulin|insulin|mesh-list
83218241|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83218242|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218243|NCT02345213|Donepezil|donepezil|mesh-list
83218244|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83218245|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218246|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218247|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218248|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218249|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218250|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
83218251|NCT02339753|Carboplatin|carboplatin|mesh-list
83218252|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218253|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
83218254|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
83218255|NCT02339441|Methotrexate|methotrexate|mesh-list
83218256|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83218257|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
83218258|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218259|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83218260|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83218261|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
83218262|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218263|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218264|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83218265|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83218266|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
83218267|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83218268|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83218269|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
83218270|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
83218271|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218272|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83218273|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83218274|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83218275|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83218276|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
83218277|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218278|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218279|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83218280|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
83218281|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83218282|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83218283|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218284|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218285|NCT02344823|Urological Agents|urological agents|mesh-ancestor
83218287|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83218288|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218289|NCT03145961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83218290|NCT03145961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218292|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
83218293|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218294|NCT02344511|Vancomycin|vancomycin|mesh-list
83218295|NCT02344511|Cefazolin|cefazolin|mesh-list
83218296|NCT02344511|Dalbavancin|dalbavancin|mesh-list
83218297|NCT02344511|Oxacillin|oxacillin|mesh-list
83218298|NCT02344511|Nafcillin|nafcillin|mesh-list
83218299|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218300|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218301|NCT02344589|Lidocaine|lidocaine|mesh-list
83218302|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
83218303|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
83218304|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218305|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218306|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
83218307|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218308|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83218309|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83218310|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83218311|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218312|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218313|NCT02338115|Paclitaxel|paclitaxel|mesh-list
83218314|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83218315|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218316|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
83218317|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
83218318|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
83218319|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218320|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
83218321|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
83218322|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83218323|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83218324|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218325|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218326|NCT02337881|Urological Agents|urological agents|mesh-ancestor
83218327|NCT02337257|Vitamin D|vitamin d|mesh-list
83218328|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
83218329|NCT02337257|Vitamins|vitamins|mesh-ancestor
83218330|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
83218331|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218332|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83218333|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83218334|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83218335|NCT02337413|Laxatives|laxatives|mesh-ancestor
83218336|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83218337|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
83218338|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83218339|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218340|NCT04477811|Vitamins|vitamins|mesh-list
83218341|NCT04477811|Vitamin K|vitamin k|mesh-list
83218342|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
83218343|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
83218344|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
83218345|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218346|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83218347|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83218348|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218349|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
83218350|NCT04477811|Coagulants|coagulants|mesh-ancestor
83218351|NCT02332031|Sorafenib|sorafenib|mesh-list
83218352|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218353|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83218354|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218355|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218356|NCT03112031|Tamoxifen|tamoxifen|mesh-list
83218357|NCT03112031|Fluconazole|fluconazole|mesh-list
83218358|NCT03112031|Amphotericin B|amphotericin b|mesh-list
83218359|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83218360|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83218361|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
83218362|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218363|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218364|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83218365|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218366|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83218367|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83218368|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83218369|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
83218370|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218371|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83218372|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218373|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218374|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218375|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83218376|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83218377|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83218378|NCT03112031|Amebicides|amebicides|mesh-ancestor
83218379|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83218380|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83218381|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218382|NCT03111797|Morphine|morphine|mesh-list
83218383|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83218384|NCT03111797|Narcotics|narcotics|mesh-ancestor
83218385|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218386|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218387|NCT03111797|Analgesics|analgesics|mesh-ancestor
83218388|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
83218389|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218390|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
83218391|NCT02938013|Velpatasvir|velpatasvir|mesh-list
83218392|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83218393|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
83218394|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218395|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
83218396|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218397|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218398|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83218399|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83218400|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218401|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218402|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218403|NCT02336633|Resveratrol|resveratrol|mesh-list
83218404|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
83218405|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218406|NCT02336633|Protective Agents|protective agents|mesh-ancestor
83218407|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218408|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218409|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83218411|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
82774584|NCT00963222|Vitamin A|vitamin a|mesh-list
83218412|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83218413|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83218414|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218415|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218416|NCT04624451|Dalbavancin|dalbavancin|mesh-list
83218417|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218418|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218420|NCT02642315|Analgesics|analgesics|mesh-ancestor
83218421|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
83218422|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218423|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218424|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
83218425|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83218426|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218427|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218428|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218429|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83218430|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83218431|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218432|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218433|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
83218434|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
83218435|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83218436|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
83218437|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218438|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218439|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83218440|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
83218441|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
83218442|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83218443|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218444|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218445|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218446|NCT02709889|Dexamethasone|dexamethasone|mesh-list
83218447|NCT02709889|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83218448|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83218449|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
83218450|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
83218451|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218452|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218453|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83218454|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
83218455|NCT02709889|Hormones|hormones|mesh-ancestor
83218456|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218457|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83218458|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218459|NCT02709889|Immunoconjugates|immunoconjugates|mesh-ancestor
83218460|NCT02709889|Immunologic Factors|immunologic factors|mesh-ancestor
83218461|NCT03189901|Simendan|simendan|mesh-list
83218462|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83218463|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
83218464|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83218465|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83218466|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218467|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218468|NCT03189901|Protective Agents|protective agents|mesh-ancestor
83218469|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218470|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83218471|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
83218472|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83218473|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
82775109|NCT00964704|Bevacizumab|bevacizumab|mesh-list
83218474|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218475|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218476|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218477|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218478|NCT02711995|Laxatives|laxatives|mesh-ancestor
83218479|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83218480|NCT03193723|Anesthetics|anesthetics|mesh-list
83218481|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218482|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218483|NCT02437825|Octreotide|octreotide|mesh-list
83218484|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83218485|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83218486|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218487|NCT02442817|Linagliptin|linagliptin|mesh-list
83218488|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83218489|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218490|NCT02442817|Incretins|incretins|mesh-ancestor
83218491|NCT02442817|Hormones|hormones|mesh-ancestor
83218492|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218493|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83218494|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
83218495|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218496|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218497|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
83218498|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218499|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218500|NCT02442739|Ketamine|ketamine|mesh-list
83218501|NCT02442739|Analgesics|analgesics|mesh-ancestor
83218502|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
83218503|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218504|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218505|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83218506|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83218507|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
83218508|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
83218509|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218510|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83218511|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83218512|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218513|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218514|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83218515|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83218516|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83218517|NCT02442427|Palivizumab|palivizumab|mesh-list
83218518|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
83218519|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218520|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
83218521|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83218522|NCT05233735|Betamethasone|betamethasone|mesh-list
83218523|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83218524|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
83218525|NCT05233735|Hormones|hormones|mesh-ancestor
83218526|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218527|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218528|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83218529|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83218530|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
83218531|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83218532|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83218533|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83218534|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218535|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218536|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218537|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218538|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218539|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83218540|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218541|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
83218542|NCT02331563|Bupivacaine|bupivacaine|mesh-list
83218543|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
83218544|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
83218545|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218546|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218547|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
83218548|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218549|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83218550|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83218551|NCT02331563|Analgesics|analgesics|mesh-ancestor
83218552|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83218553|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83218554|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83218555|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
83218556|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218557|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218558|NCT02331173|Dorzolamide|dorzolamide|mesh-list
83218559|NCT02331173|Brinzolamide|brinzolamide|mesh-list
83218560|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83218561|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83218562|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218563|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218564|NCT02709109|Ivacaftor|ivacaftor|mesh-list
83218565|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83218566|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218567|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218568|NCT03117595|Fentanyl|fentanyl|mesh-list
83218569|NCT03117595|Morphine|morphine|mesh-list
83218570|NCT03117595|Bupivacaine|bupivacaine|mesh-list
83218571|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
83218572|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
83218573|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218574|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218575|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
83218576|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218577|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83218578|NCT03117595|Narcotics|narcotics|mesh-ancestor
83218579|NCT03117595|Analgesics|analgesics|mesh-ancestor
83218580|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83218581|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83218582|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
83218583|NCT02039531|Mitogens|mitogens|mesh-list
83218584|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
83218585|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
83218586|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218587|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83218588|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
83218589|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218590|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
83218591|NCT02039531|Protective Agents|protective agents|mesh-ancestor
83218592|NCT02331251|Paclitaxel|paclitaxel|mesh-list
83218593|NCT02331251|Vinorelbine|vinorelbine|mesh-list
83218594|NCT02331251|Docetaxel|docetaxel|mesh-list
83218595|NCT02331251|Gemcitabine|gemcitabine|mesh-list
83218596|NCT02331251|Doxorubicin|doxorubicin|mesh-list
83218597|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83218598|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
83218599|NCT02331251|Irinotecan|irinotecan|mesh-list
83218600|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83218601|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218602|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83218603|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83218604|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83218605|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
82775466|NCT00546000|Xhance|xhance|mesh-list
83218606|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83218607|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
83218608|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83218609|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83218610|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83218611|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218612|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83218613|NCT02331251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83218614|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83218615|NCT02435797|Nicorandil|nicorandil|mesh-list
83218616|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83218617|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83218618|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
83218619|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
83218620|NCT02435797|Vitamins|vitamins|mesh-ancestor
83218621|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
83218622|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218623|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83218624|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83218625|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218626|NCT02330783|Bevacizumab|bevacizumab|mesh-list
83218627|NCT02330783|Sorafenib|sorafenib|mesh-list
83218628|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83218629|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218630|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83218631|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83218632|NCT02330783|Growth Substances|growth substances|mesh-ancestor
83218633|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218634|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
83218635|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83218636|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218637|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218639|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83218640|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
83218641|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
83218642|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218643|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218644|NCT02441803|Cytarabine|cytarabine|mesh-list
83218645|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
83218646|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
83218647|NCT02441803|Busulfan|busulfan|mesh-list
83218648|NCT02441803|Fludarabine|fludarabine|mesh-list
83218649|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
83218650|NCT02441803|Decitabine|decitabine|mesh-list
83218651|NCT02441803|Idarubicin|idarubicin|mesh-list
83218652|NCT02441803|Clofarabine|clofarabine|mesh-list
83218653|NCT02441803|Tacrolimus|tacrolimus|mesh-list
83218654|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
83218655|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83218656|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83218657|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
83218658|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218659|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83218660|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83218661|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
83218662|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218663|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218664|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83218665|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83218666|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
83218667|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
83218668|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218669|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83218670|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218671|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83218672|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83218673|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
83218674|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218675|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83218676|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83218677|NCT02709655|Vortioxetine|vortioxetine|mesh-list
83218678|NCT02709655|Fluoxetine|fluoxetine|mesh-list
83218679|NCT02709655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83218680|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83218681|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218682|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218683|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218684|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
83218685|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218686|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83218687|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
83218688|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218689|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83218690|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218691|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218692|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83218693|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218694|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218695|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83218696|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83218697|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83218698|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83218699|NCT02334605|Capsaicin|capsaicin|mesh-list
83218700|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
83218701|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83218702|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
83218703|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218704|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218705|NCT02329535|Progesterone|progesterone|mesh-list
83218706|NCT02329535|Progestins|progestins|mesh-ancestor
83218707|NCT02329535|Hormones|hormones|mesh-ancestor
83218708|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218709|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218710|NCT03187795|Mirabegron|mirabegron|mesh-list
83218711|NCT03187795|Oxybutynin|oxybutynin|mesh-list
83218712|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83218713|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83218714|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83218715|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83218716|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218717|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218718|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218719|NCT03187795|Urological Agents|urological agents|mesh-ancestor
83218720|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
83218721|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
83218722|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218723|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83218724|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83218725|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218726|NCT02435563|Ritonavir|ritonavir|mesh-list
83218727|NCT02435563|Ticagrelor|ticagrelor|mesh-list
83218728|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83218729|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83218730|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
83218731|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218732|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218733|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83218734|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83218735|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
83218736|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218737|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83218738|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218739|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83218740|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83218741|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83218742|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83218743|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
83218744|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218745|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218746|NCT04031729|Aspirin|aspirin|mesh-list
83218747|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83218748|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83218749|NCT04031729|Analgesics|analgesics|mesh-ancestor
83218750|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
83218751|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218752|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218753|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83218754|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83218755|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83218756|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83218757|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218758|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83218759|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83218760|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218761|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
83218762|NCT02433847|Mosapride|mosapride|mesh-list
83218763|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83218764|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83218765|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
83218766|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218767|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218768|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218769|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
83218770|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218771|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218772|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218773|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218774|NCT02328521|Nicorandil|nicorandil|mesh-list
83218775|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83218776|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83218777|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
83218778|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
83218779|NCT02328521|Vitamins|vitamins|mesh-ancestor
83218780|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
83218781|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218782|NCT03831503|Antibodies|antibodies|mesh-list
83218783|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
83218784|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218785|NCT03187093|Vortioxetine|vortioxetine|mesh-list
83218786|NCT03187093|Escitalopram|escitalopram|mesh-list
83218787|NCT03187093|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83218788|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83218789|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218790|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218791|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218792|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
83218793|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218794|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
83218795|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218796|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83218797|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218798|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218799|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83218800|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83218801|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83218802|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83218804|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
83218805|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83218806|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
83218807|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83218808|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
83218809|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
83218810|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218811|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
83218812|NCT02434861|Digoxin|digoxin|mesh-list
83218813|NCT02434861|Rolapitant|rolapitant|mesh-list
83218814|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83218815|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83218816|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218817|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218818|NCT02434861|Protective Agents|protective agents|mesh-ancestor
83218819|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218820|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218821|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83218822|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83218823|NCT02434861|Analgesics|analgesics|mesh-ancestor
83218824|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
83218825|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218826|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83218827|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83218828|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83218829|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83218830|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218831|NCT03187015|Entinostat|entinostat|mesh-list
83218832|NCT03187015|Midazolam|midazolam|mesh-list
83218833|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83218834|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83218835|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218836|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218837|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83218838|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218839|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218840|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83218841|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
83218842|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
83218843|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
83218844|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
83218845|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218846|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218847|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218848|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83218849|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218850|NCT02328053|Voriconazole|voriconazole|mesh-list
83218851|NCT02328053|Natamycin|natamycin|mesh-list
83218852|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
83218853|NCT02328053|Clotrimazole|clotrimazole|mesh-list
83218854|NCT02328053|Miconazole|miconazole|mesh-list
83218855|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218856|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83218857|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218858|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
82775479|NCT00968006|Incretins|incretins|mesh-ancestor
83218859|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218860|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83218861|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
83218862|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218863|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218864|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83218865|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83218866|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218867|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83218868|NCT02022748|Ticagrelor|ticagrelor|mesh-list
83218869|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83218870|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83218871|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83218872|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83218873|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
83218874|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218875|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218876|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218877|NCT02333513|Vincristine|vincristine|mesh-list
83218878|NCT02333513|Lomustine|lomustine|mesh-list
83218879|NCT02333513|Procarbazine|procarbazine|mesh-list
83218880|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83218881|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218882|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
83218883|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
83218884|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
83218885|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218886|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83218887|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
83218888|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83218889|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83218890|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83218891|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218892|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
83218893|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218894|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218895|NCT02328209|Ranibizumab|ranibizumab|mesh-list
83218896|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83218897|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83218898|NCT02328209|Growth Substances|growth substances|mesh-ancestor
83218899|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218900|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
83218901|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83218902|NCT02328443|Itraconazole|itraconazole|mesh-list
83218903|NCT02328443|Rifampin|rifampin|mesh-list
83218904|NCT02328443|Midazolam|midazolam|mesh-list
83218905|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83218906|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83218907|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83218908|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218909|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83218910|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83218911|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83218912|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83218913|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
83218914|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
83218915|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
83218916|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
83218917|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218918|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218919|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
83218920|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218921|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
82775855|NCT00972660|Prednisone|prednisone|mesh-list
83218922|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83218923|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218924|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83218925|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
83218926|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83218927|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83218928|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83218929|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
83218930|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83218931|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
83218932|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83218933|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83218934|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83218935|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83218936|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83218937|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83218938|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83218939|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83218940|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83218941|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83218942|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83218943|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83218944|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83218945|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83218946|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218947|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218948|NCT03191539|Apremilast|apremilast|mesh-list
83218949|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83218950|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83218951|NCT03191539|Analgesics|analgesics|mesh-ancestor
83218952|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
83218953|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218954|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218955|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83218956|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83218957|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83218958|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83218959|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218960|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218961|NCT02433925|Resveratrol|resveratrol|mesh-list
83218962|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
83218963|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218964|NCT02433925|Protective Agents|protective agents|mesh-ancestor
83218965|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218966|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218967|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83218968|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
83218969|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218970|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218971|NCT02327663|Emtricitabine|emtricitabine|mesh-list
83218972|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
83218973|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83218974|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83218975|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83218976|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218977|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218978|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83218979|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83218980|NCT02333123|Aspirin|aspirin|mesh-list
83218981|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83218982|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83218983|NCT02333123|Analgesics|analgesics|mesh-ancestor
83218984|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
83218985|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83218986|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83218987|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83218988|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83218989|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83218990|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83218991|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83218992|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83218993|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83218994|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83218995|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
83218996|NCT02332811|Sevelamer|sevelamer|mesh-list
83218997|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
83218998|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
83218999|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219000|NCT02433457|Omeprazole|omeprazole|mesh-list
83219001|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83219002|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219003|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83219004|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219005|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219006|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
83219007|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83219008|NCT02021656|Ledipasvir|ledipasvir|mesh-list
83219009|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
83219010|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219011|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83219012|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219013|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
83219014|NCT03145025|Hormones|hormones|mesh-ancestor
83219015|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219016|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219017|NCT03144947|Docetaxel|docetaxel|mesh-list
83219018|NCT03144947|Trastuzumab|trastuzumab|mesh-list
83219019|NCT03144947|Pertuzumab|pertuzumab|mesh-list
83219020|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219021|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
83219022|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
83219023|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
83219024|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219025|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83219026|NCT02433535|Simvastatin|simvastatin|mesh-list
83219027|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83219028|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83219029|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
83219030|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219031|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83219032|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83219033|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219034|NCT03144713|Terlipressin|terlipressin|mesh-list
83219035|NCT03144713|Midodrine|midodrine|mesh-list
83219036|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
83219037|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
83219038|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219039|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219040|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83219041|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83219042|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83219043|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83219044|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83219045|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219046|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219047|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83219048|NCT03191383|Vaccines|vaccines|mesh-list
83219049|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
83219050|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219051|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
83219052|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219053|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
83219054|NCT02075632|Hormones|hormones|mesh-ancestor
83219055|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219056|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219057|NCT02430259|Isoniazid|isoniazid|mesh-list
83219058|NCT02430259|Rifapentine|rifapentine|mesh-list
83219059|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
83219060|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83219061|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219062|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83219063|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83219064|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
83219065|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219066|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83219067|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83219068|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
83219069|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
83219070|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83219071|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219072|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83219073|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219074|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
83219075|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83219076|NCT03142607|Metronidazole|metronidazole|mesh-list
83219077|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83219078|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219079|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
83219080|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
83219081|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83219082|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83219083|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83219084|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
83219085|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83219086|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83219087|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83219088|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219089|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219090|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
83219091|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219092|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219093|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83219094|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219095|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
83219096|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
83219097|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
83219098|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219099|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219100|NCT02326727|Fentanyl|fentanyl|mesh-list
83219101|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
83219102|NCT02326727|Propofol|propofol|mesh-list
83219104|NCT02326727|Isoflurane|isoflurane|mesh-list
83219105|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83219106|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219107|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219108|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83219109|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
83219110|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
83219111|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
83219112|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
83219113|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219114|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83219115|NCT02326727|Narcotics|narcotics|mesh-ancestor
83219116|NCT02326727|Analgesics|analgesics|mesh-ancestor
83219117|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83219118|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83219119|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219120|NCT02432911|Cytarabine|cytarabine|mesh-list
83219121|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
83219122|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83219123|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
83219124|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219125|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219126|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
83219127|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219128|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83219129|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
83219130|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219131|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83219132|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83219133|NCT03588767|Vitamin D|vitamin d|mesh-list
83219134|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
83219135|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
83219136|NCT03588767|Vitamins|vitamins|mesh-list
83219137|NCT03588767|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
83219138|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
83219139|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
83219140|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219141|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83219142|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83219143|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
83219144|NCT03588767|Hormones|hormones|mesh-ancestor
83219145|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219146|NCT03588767|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
83219147|NCT02440399|Acetaminophen|acetaminophen|mesh-list
83219148|NCT02440399|Diclofenac|diclofenac|mesh-list
83219149|NCT02440399|Morphine|morphine|mesh-list
83219150|NCT02440399|Oxycodone|oxycodone|mesh-list
83219151|NCT02440399|Tramadol|tramadol|mesh-list
83219152|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83219153|NCT02440399|Narcotics|narcotics|mesh-ancestor
83219154|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219155|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219156|NCT02440399|Analgesics|analgesics|mesh-ancestor
83219157|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
83219158|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219159|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219160|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
83219161|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83219162|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219163|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219164|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83219165|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219166|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219167|NCT03574571|Docetaxel|docetaxel|mesh-list
83219168|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219169|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
83219170|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
83219171|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
83219172|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219173|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
83219174|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83219175|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83219176|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
83219177|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219178|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219179|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219180|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
83219181|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
83219182|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219183|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
83219184|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83219185|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
83219186|NCT03191305|Warfarin|warfarin|mesh-list
83219187|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
83219188|NCT03144401|Misoprostol|misoprostol|mesh-list
83219189|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83219190|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
83219191|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83219192|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219193|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83219194|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219195|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
83219196|NCT04483765|Anesthetics|anesthetics|mesh-list
83219197|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219198|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219199|NCT03186313|Ribavirin|ribavirin|mesh-list
83219200|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
83219201|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
83219202|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219203|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
83219204|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219205|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
83219206|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83219207|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219208|NCT03144245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83219209|NCT03144245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219210|NCT04996199|Zileuton|zileuton|mesh-list
83219211|NCT04996199|Carbamazepine|carbamazepine|mesh-list
83219212|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
83219213|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
83219214|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
83219215|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83219216|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219217|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219218|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83219219|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219220|NCT04996199|Analgesics|analgesics|mesh-ancestor
83219221|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
83219222|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219223|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83219224|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219225|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219226|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83219227|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83219228|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83219229|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83219230|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219231|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219232|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83219233|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219234|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83219235|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219236|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219237|NCT02432833|Tacrolimus|tacrolimus|mesh-list
83219238|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83219239|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
83219240|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219241|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83219242|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219243|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219244|NCT02429323|Sevoflurane|sevoflurane|mesh-list
83219245|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83219246|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83219247|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
83219248|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
83219249|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219250|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219251|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
83219252|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83219253|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219254|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83219255|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83219256|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219257|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219258|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219259|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83219260|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219262|NCT04984733|Temozolomide|temozolomide|mesh-list
83219263|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83219264|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219265|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83219266|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219267|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83219268|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
83219269|NCT02707861|Ibalizumab|ibalizumab|mesh-list
83219270|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83219271|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
83219272|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219273|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83219274|NCT02432599|Choline|choline|mesh-list
83219275|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
83219276|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83219277|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
83219278|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219279|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219280|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83219281|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
83219282|NCT03185143|Acetaminophen|acetaminophen|mesh-list
83219283|NCT03185143|Sumatriptan|sumatriptan|mesh-list
83219284|NCT03185143|Naltrexone|naltrexone|mesh-list
83219285|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219286|NCT03185143|Analgesics|analgesics|mesh-ancestor
83219287|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
83219288|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219289|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219290|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
83219291|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83219292|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83219293|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83219294|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83219295|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83219296|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
83219297|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219298|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219299|NCT05076773|Morphine|morphine|mesh-list
83219300|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83219301|NCT05076773|Narcotics|narcotics|mesh-ancestor
83219302|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219303|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219304|NCT05076773|Analgesics|analgesics|mesh-ancestor
83219305|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
83219306|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219307|NCT02432677|Remifentanil|remifentanil|mesh-list
83219308|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83219309|NCT02432677|Narcotics|narcotics|mesh-ancestor
83219310|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219311|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219312|NCT02432677|Analgesics|analgesics|mesh-ancestor
83219313|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
83219314|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219315|NCT03442673|Gemcitabine|gemcitabine|mesh-list
83219316|NCT03442673|Vinorelbine|vinorelbine|mesh-list
83219317|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83219318|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
83219319|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219320|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219321|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83219322|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83219323|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83219324|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83219325|NCT02432365|Paclitaxel|paclitaxel|mesh-list
83219326|NCT02432365|Cisplatin|cisplatin|mesh-list
83219327|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83219328|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219329|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
83219330|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
83219331|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
83219332|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219333|NCT05076695|Trastuzumab|trastuzumab|mesh-list
83219334|NCT05076695|Fulvestrant|fulvestrant|mesh-list
83219335|NCT05076695|Palbociclib|palbociclib|mesh-list
83219336|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83219337|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219338|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83219339|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83219340|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83219341|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219342|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219343|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219344|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83219345|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219346|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219347|NCT03143933|Fentanyl|fentanyl|mesh-list
83219348|NCT03143933|Propofol|propofol|mesh-list
83219349|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83219350|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219351|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219352|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83219353|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
83219354|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
83219355|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83219356|NCT03143933|Narcotics|narcotics|mesh-ancestor
83219357|NCT03143933|Analgesics|analgesics|mesh-ancestor
83219358|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
83219359|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219360|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83219361|NCT02440243|Vaccines|vaccines|mesh-list
83219362|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
83219363|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219364|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
83219365|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83219366|NCT05076461|Ondansetron|ondansetron|mesh-list
83219367|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
83219368|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
83219369|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219370|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219371|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219373|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
83219374|NCT05076461|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83219375|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83219376|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
83219377|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219378|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219379|NCT02428933|Bromocriptine|bromocriptine|mesh-list
83219380|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83219381|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83219382|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219383|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219384|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219385|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
83219386|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
83219387|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219388|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219389|NCT02428777|Diclofenac|diclofenac|mesh-list
83219390|NCT02428777|Tramadol|tramadol|mesh-list
83219391|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83219392|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219393|NCT02428777|Analgesics|analgesics|mesh-ancestor
83219394|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
83219395|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219396|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219397|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219398|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219399|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83219400|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219401|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219402|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83219403|NCT02428777|Narcotics|narcotics|mesh-ancestor
83219404|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219405|NCT02432053|Tacrolimus|tacrolimus|mesh-list
83219406|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83219407|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
83219408|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219409|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83219410|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219411|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219412|NCT03141827|Insulin|insulin|mesh-list
83219413|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83219414|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219415|NCT03190681|Methylphenidate|methylphenidate|mesh-list
83219416|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83219417|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219418|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83219419|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83219420|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219421|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219422|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
83219423|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219424|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83219425|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83219426|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83219427|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219428|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219429|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83219430|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219431|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219432|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83219433|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219434|NCT04593563|Psilocybin|psilocybin|mesh-list
83219435|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
83219436|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219437|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83219438|NCT04551911|Calcifediol|calcifediol|mesh-list
83219439|NCT04551911|Vitamins|vitamins|mesh-ancestor
83219440|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
83219441|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219442|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83219443|NCT02431975|Ritonavir|ritonavir|mesh-list
83219444|NCT02431975|Lopinavir|lopinavir|mesh-list
83219445|NCT02431975|Lamivudine|lamivudine|mesh-list
83219446|NCT02431975|Zidovudine|zidovudine|mesh-list
83219447|NCT02431975|Nevirapine|nevirapine|mesh-list
83219448|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83219449|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83219450|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
83219451|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219452|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219453|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83219455|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
83219456|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219457|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83219458|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219459|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83219460|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83219461|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
83219462|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83219463|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83219464|NCT03143465|Calcitonin|calcitonin|mesh-list
83219465|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
83219466|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
83219467|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83219468|NCT03143465|Katacalcin|katacalcin|mesh-list
83219469|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
83219470|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83219471|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83219472|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219473|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219474|NCT03143465|Urological Agents|urological agents|mesh-ancestor
83219475|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83219476|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219477|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83219478|NCT05034809|Melatonin|melatonin|mesh-list
83219479|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
83219480|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219481|NCT05034809|Protective Agents|protective agents|mesh-ancestor
83219482|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219483|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219484|NCT02428543|Cytarabine|cytarabine|mesh-list
83219485|NCT02428543|Ponatinib|ponatinib|mesh-list
83219486|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83219487|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
83219488|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219489|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219490|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
83219491|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219492|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83219493|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
83219494|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219495|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83219496|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219497|NCT04428203|Cannabidiol|cannabidiol|mesh-list
83219498|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
83219499|NCT02431663|Ketamine|ketamine|mesh-list
83219500|NCT02431663|Analgesics|analgesics|mesh-ancestor
83219501|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
83219502|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219503|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219504|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83219505|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83219506|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
83219507|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
83219508|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219509|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83219510|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83219511|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219512|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219513|NCT03185845|Warfarin|warfarin|mesh-list
83219514|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
83219515|NCT03182803|Antibodies|antibodies|mesh-list
83219516|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
83219517|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219518|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83219519|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219520|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219521|NCT03185611|Rifaximin|rifaximin|mesh-list
83219522|NCT03185611|Azathioprine|azathioprine|mesh-list
83219523|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83219524|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219525|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219526|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
83219527|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219528|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83219529|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219530|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83219531|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
83219532|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219533|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219534|NCT02431429|Miltefosine|miltefosine|mesh-list
83219535|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
83219536|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219537|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219538|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83219539|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83219540|NCT02027428|Paclitaxel|paclitaxel|mesh-list
83219541|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83219542|NCT02027428|Carboplatin|carboplatin|mesh-list
83219543|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83219544|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219545|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
83219546|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
83219547|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
83219548|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219549|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83219550|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83219551|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83219552|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219553|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219554|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83219555|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219556|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219558|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219559|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83219560|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219561|NCT01995136|Travoprost|travoprost|mesh-list
83219562|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83219563|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83219564|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83219565|NCT03141593|Vitamin D|vitamin d|mesh-list
83219566|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
83219567|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
83219568|NCT03141593|Vitamins|vitamins|mesh-list
83219569|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
83219570|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219571|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83219572|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83219573|NCT04102241|Hemay005|hemay005|mesh-list
83219574|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
83219575|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83219576|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83219577|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219578|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219579|NCT03576443|Idelalisib|idelalisib|mesh-list
83219580|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219581|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219582|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219583|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83219584|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83219585|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219586|NCT04667572|Riboflavin|riboflavin|mesh-list
83219587|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
83219588|NCT04667572|Vitamins|vitamins|mesh-ancestor
83219589|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
83219590|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219591|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83219592|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83219593|NCT04438733|Anastrozole|anastrozole|mesh-list
83219594|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83219595|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219596|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83219597|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83219598|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219599|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219600|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83219601|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219602|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219603|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219605|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219606|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219607|NCT02427295|Octreotide|octreotide|mesh-list
83219608|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219609|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83219610|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219611|NCT01994590|Prednisone|prednisone|mesh-list
83219612|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
83219613|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219614|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
83219615|NCT01994590|Hormones|hormones|mesh-ancestor
83219616|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219617|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219618|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83219619|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219620|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83219621|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219622|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219623|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219624|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219625|NCT05387603|Capecitabine|capecitabine|mesh-list
83219626|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
83219627|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83219628|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
83219629|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219630|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219631|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83219632|NCT03182413|Modafinil|modafinil|mesh-list
83219633|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83219634|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219635|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83219636|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83219637|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83219638|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219639|NCT03182257|ONO-7579|ono-7579|mesh-list
83219640|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83219641|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219642|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219643|NCT03183739|ASP8062|asp8062|mesh-list
83219644|NCT03183739|Analgesics|analgesics|mesh-ancestor
83219645|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
83219646|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219647|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219648|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
83219649|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
83219650|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219651|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219652|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
83219653|NCT03117439|Clotrimazole|clotrimazole|mesh-list
83219654|NCT03117439|Miconazole|miconazole|mesh-list
83219655|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219656|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83219657|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83219658|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219659|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219660|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219661|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83219662|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219663|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219664|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219665|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83219666|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83219667|NCT02426905|Trientine|trientine|mesh-list
83219668|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
83219669|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
83219670|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219672|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83219673|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83219674|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219675|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219676|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
83219677|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219678|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83219679|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219680|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83219681|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83219682|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83219683|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83219684|NCT03141125|Ethanol|ethanol|mesh-list
83219685|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83219686|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219687|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219688|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219689|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
83219690|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
83219691|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
83219692|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83219693|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83219694|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219695|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219696|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219697|NCT03142763|Choline|choline|mesh-list
83219698|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
83219699|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83219700|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
83219701|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219702|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219703|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83219704|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
83219705|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
83219706|NCT03511391|Nivolumab|nivolumab|mesh-list
83219707|NCT03511391|Atezolizumab|atezolizumab|mesh-list
83219708|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83219709|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83219710|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219711|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219712|NCT05081765|Olaparib|olaparib|mesh-list
83219713|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83219714|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219715|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219716|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219717|NCT05078177|Rituximab|rituximab|mesh-list
83219718|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83219719|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219720|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
83219721|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219722|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219723|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
83219724|NCT05081687|Irinotecan|irinotecan|mesh-list
83219725|NCT05081687|Folfirinox|folfirinox|mesh-list
83219726|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219727|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83219728|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83219729|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219730|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219731|NCT05387369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83219732|NCT05387369|Antiviral Agents|antiviral agents|mesh-ancestor
83219733|NCT05387369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219734|NCT05080985|Bupivacaine|bupivacaine|mesh-list
83219735|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
83219736|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
83219737|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219738|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219739|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
83219740|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219741|NCT03139487|Dalteparin|dalteparin|mesh-list
83219742|NCT03139487|Tinzaparin|tinzaparin|mesh-list
83219743|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83219744|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
83219745|NCT03139487|Apixaban|apixaban|mesh-list
83219746|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83219747|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
83219748|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83219749|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
83219750|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219751|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219752|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
83219753|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83219754|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83219755|NCT04976387|Acetaminophen|acetaminophen|mesh-list
83219756|NCT04976387|Ibuprofen|ibuprofen|mesh-list
83219757|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83219758|NCT04976387|Hydrocodone|hydrocodone|mesh-list
83219759|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219760|NCT04976387|Analgesics|analgesics|mesh-ancestor
83219761|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
83219762|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219763|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219764|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
83219765|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83219766|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219767|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219768|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83219769|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219770|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219771|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83219772|NCT04976387|Narcotics|narcotics|mesh-ancestor
83219773|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219774|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
83219775|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83219776|NCT03139253|Amoxicillin|amoxicillin|mesh-list
83219777|NCT03139253|Clarithromycin|clarithromycin|mesh-list
83219778|NCT03139253|Levofloxacin|levofloxacin|mesh-list
83219779|NCT03139253|Tetracycline|tetracycline|mesh-list
83219780|NCT03139253|Tinidazole|tinidazole|mesh-list
83219781|NCT03139253|Furazolidone|furazolidone|mesh-list
83219782|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83219783|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219784|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83219785|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219786|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219787|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83219788|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219789|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83219790|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83219791|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83219792|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219793|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83219794|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83219795|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83219796|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83219797|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83219798|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83219799|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
83219800|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
83219801|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83219802|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219803|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
83219804|NCT02019472|Adalimumab|adalimumab|mesh-list
83219805|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83219806|NCT02019472|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83219807|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219808|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219809|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
83219810|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219811|NCT00157937|Theophylline|theophylline|mesh-list
83219812|NCT00157937|Montelukast|montelukast|mesh-list
83219813|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219814|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219815|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219816|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
83219817|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219818|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83219819|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83219820|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83219821|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219822|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219823|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83219824|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83219825|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83219826|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83219827|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219828|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
83219829|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83219830|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83219831|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
83219832|NCT03139565|Vaccines|vaccines|mesh-list
83219833|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
83219834|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219835|NCT03139331|Irinotecan|irinotecan|mesh-list
83219836|NCT03139331|Temozolomide|temozolomide|mesh-list
83219837|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83219838|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83219839|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219840|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219841|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219842|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83219843|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
83219844|NCT04423601|Itraconazole|itraconazole|mesh-list
83219845|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
83219846|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219847|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83219848|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219849|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219850|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219851|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83219852|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
83219853|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219854|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219855|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83219856|NCT05022563|Warfarin|warfarin|mesh-list
83219857|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
83219858|NCT05022563|Dabigatran|dabigatran|mesh-list
83219859|NCT05022563|Apixaban|apixaban|mesh-list
83219860|NCT05022563|Anticoagulants|anticoagulants|mesh-list
83219861|NCT05022563|Edoxaban|edoxaban|mesh-list
83219862|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83219863|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
83219864|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83219865|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
83219866|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219867|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219868|NCT04983095|Hormones|hormones|mesh-list
83219869|NCT04983095|Androgens|androgens|mesh-list
83219870|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
83219871|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83219872|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219873|NCT02936687|Ambrisentan|ambrisentan|mesh-list
83219874|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83219875|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
83219876|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83219877|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219878|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219879|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
83219880|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83219881|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219882|NCT05083793|Pregabalin|pregabalin|mesh-list
83219883|NCT05083793|Analgesics|analgesics|mesh-ancestor
83219884|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
83219885|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219886|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219887|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
83219888|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83219889|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83219890|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219891|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83219892|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83219893|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83219894|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219895|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83219896|NCT05083013|Chrysarobin|chrysarobin|mesh-list
83219897|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83219898|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219899|NCT05083013|Analgesics|analgesics|mesh-ancestor
83219900|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
83219901|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219902|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219903|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219904|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219905|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83219906|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83219907|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219908|NCT03223883|Curcumin|curcumin|mesh-list
83219909|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83219910|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83219911|NCT03223883|Analgesics|analgesics|mesh-ancestor
83219912|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
83219913|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219914|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219915|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219916|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83219917|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219918|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219919|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219920|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83219921|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83219922|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83219923|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
83219924|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219925|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83219926|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83219927|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219928|NCT05048069|Rebamipide|rebamipide|mesh-list
83219929|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83219930|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83219931|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
83219932|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219933|NCT05048069|Protective Agents|protective agents|mesh-ancestor
83219934|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219935|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219936|NCT03194165|Ritonavir|ritonavir|mesh-list
83219937|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83219938|NCT03194165|Darunavir|darunavir|mesh-list
83219939|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
83219940|NCT03194165|Nevirapine|nevirapine|mesh-list
83219941|NCT03194165|Dolutegravir|dolutegravir|mesh-list
83219942|NCT03194165|Rilpivirine|rilpivirine|mesh-list
83219943|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83219944|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83219945|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
83219946|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83219947|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83219948|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83219949|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83219950|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
83219951|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219952|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83219953|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83219954|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83219955|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83219956|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83219957|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83219958|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83219959|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83219960|NCT04065113|Ethanol|ethanol|mesh-list
83219961|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83219962|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219963|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219964|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219965|NCT03116737|Benzocaine|benzocaine|mesh-list
83219966|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83219967|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
83219968|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
83219969|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83219970|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219971|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
83219972|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83219973|NCT03116659|Doxycycline|doxycycline|mesh-list
83219974|NCT03116659|Imiquimod|imiquimod|mesh-list
83219975|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83219976|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83219977|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
83219978|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83219979|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83219980|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83219981|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
83219982|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83219983|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83219984|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
83219985|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83219986|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
83219987|NCT01993888|Coagulants|coagulants|mesh-ancestor
83219988|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
83219989|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83219990|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83219991|NCT02425813|Prednisolone|prednisolone|mesh-list
83219992|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
83219993|NCT02425813|Budesonide|budesonide|mesh-list
83219994|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83219995|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
83219996|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83219997|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
83219998|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
83219999|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220000|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220001|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220002|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
83220003|NCT02425813|Hormones|hormones|mesh-ancestor
83220004|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220005|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83220006|NCT02425813|Protective Agents|protective agents|mesh-ancestor
83220007|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83220008|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220009|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83220010|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83220011|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
83220012|NCT03106831|Norepinephrine|norepinephrine|mesh-list
83220013|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83220014|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83220015|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
83220016|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220017|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220018|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220019|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
83220020|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
83220021|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220022|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83220023|NCT03138785|Itraconazole|itraconazole|mesh-list
83220024|NCT03138785|Voriconazole|voriconazole|mesh-list
83220025|NCT03138785|Levofloxacin|levofloxacin|mesh-list
83220026|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
83220027|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220028|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83220029|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220030|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220031|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220032|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83220033|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
83220034|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220035|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220036|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83220037|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83220039|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83220040|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83220041|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220042|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83220044|NCT03106597|Manidipine|manidipine|mesh-list
83220045|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83220046|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83220047|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220048|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220049|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83220050|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220051|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
83220052|NCT02018458|Paclitaxel|paclitaxel|mesh-list
83220053|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83220054|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
83220055|NCT02018458|Carboplatin|carboplatin|mesh-list
83220056|NCT02018458|Doxorubicin|doxorubicin|mesh-list
83220057|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83220058|NCT02018458|Vaccines|vaccines|mesh-list
83220059|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
83220060|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220061|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83220062|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220063|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
83220064|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
83220065|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
83220066|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220067|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83220068|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83220069|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83220070|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
83220071|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83220072|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83220073|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83220074|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83220075|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220076|NCT02423083|Guanabenz|guanabenz|mesh-list
83220077|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83220078|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83220079|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83220080|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83220081|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83220082|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220083|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220084|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220085|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
83220086|NCT02423863|Nivolumab|nivolumab|mesh-list
83220087|NCT02423863|Atezolizumab|atezolizumab|mesh-list
83220088|NCT02423863|Durvalumab|durvalumab|mesh-list
83220089|NCT02423863|Cemiplimab|cemiplimab|mesh-list
83220090|NCT02423863|Poly ICLC|poly iclc|mesh-list
83220091|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83220092|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220093|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83220094|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220095|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
83220096|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
83220097|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220098|NCT03178747|Methylene Blue|methylene blue|mesh-list
83220099|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220100|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220101|NCT05392673|Bilirubin|bilirubin|mesh-list
83220102|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
83220103|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220104|NCT05392673|Protective Agents|protective agents|mesh-ancestor
83220105|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220106|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
83220107|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
83220108|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220109|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
83220110|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220111|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220112|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
83220113|NCT03178591|Vildagliptin|vildagliptin|mesh-list
83220114|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83220115|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220116|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83220117|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220118|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83220119|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
83220120|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220121|NCT01993186|Glycerol|glycerol|mesh-list
83220122|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83220123|NCT01993186|Protective Agents|protective agents|mesh-ancestor
83220124|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220125|NCT03181243|Anesthetics|anesthetics|mesh-list
83220126|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220127|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220128|NCT02420665|Acetic Acid|acetic acid|mesh-list
83220129|NCT02420665|Proflavine|proflavine|mesh-list
83220130|NCT02420665|Retinol acetate|retinol acetate|mesh-list
83220131|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83220132|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220133|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83220134|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
83220135|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220136|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83220137|NCT02420665|Protective Agents|protective agents|mesh-ancestor
83220138|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220139|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83220140|NCT02016898|Mitomycins|mitomycins|mesh-list
83220141|NCT02016898|Mitomycin|mitomycin|mesh-list
83220142|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83220143|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220144|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
83220145|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220146|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83220147|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220148|NCT04482907|Hormones|hormones|mesh-list
83220149|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220150|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220151|NCT02420509|Leucovorin|leucovorin|mesh-list
83220152|NCT02420509|Capecitabine|capecitabine|mesh-list
83220153|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220154|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220155|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83220156|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
83220157|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220158|NCT02420509|Antidotes|antidotes|mesh-ancestor
83220159|NCT02420509|Protective Agents|protective agents|mesh-ancestor
83220160|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
83220161|NCT02420509|Vitamins|vitamins|mesh-ancestor
83220162|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
83220163|NCT02416531|Clobetasol|clobetasol|mesh-list
83220164|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83220165|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
83220166|NCT02416531|Hormones|hormones|mesh-ancestor
83220167|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220168|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220169|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
83220170|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83220171|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83220172|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220173|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
83220174|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220175|NCT02416141|Tramadol|tramadol|mesh-list
83220176|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83220177|NCT02416141|Narcotics|narcotics|mesh-ancestor
83220178|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220179|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220180|NCT02416141|Analgesics|analgesics|mesh-ancestor
83220181|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
83220182|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220183|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83220184|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83220185|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220186|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
83220187|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83220188|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220189|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220190|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83220191|NCT02416063|Analgesics|analgesics|mesh-ancestor
83220192|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
83220193|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220194|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83220195|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83220196|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83220197|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
83220198|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220199|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220200|NCT01828697|Enoxaparin|enoxaparin|mesh-list
83220201|NCT01828697|Dalteparin|dalteparin|mesh-list
83220202|NCT01828697|Tinzaparin|tinzaparin|mesh-list
83220203|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83220204|NCT01828697|Nadroparin|nadroparin|mesh-list
83220205|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
83220206|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
83220207|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83220208|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83220209|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220211|NCT02415985|Rifabutin|rifabutin|mesh-list
83220212|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83220213|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83220214|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
83220215|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220216|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220217|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83220218|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83220219|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
83220220|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220221|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83220222|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220223|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83220224|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83220225|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
83220226|NCT02415907|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83220227|NCT02415907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83220228|NCT02415907|Serotonin Agents|serotonin agents|mesh-ancestor
83220229|NCT02415907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220230|NCT02415907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220231|NCT02415907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220232|NCT02415829|Capecitabine|capecitabine|mesh-list
83220233|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
83220234|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83220235|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
83220236|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220237|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220238|NCT04631393|Alfentanil|alfentanil|mesh-list
83220239|NCT04631393|Propofol|propofol|mesh-list
83220240|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83220241|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220242|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220243|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83220244|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
83220245|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
83220246|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83220247|NCT04631393|Narcotics|narcotics|mesh-ancestor
83220248|NCT04631393|Analgesics|analgesics|mesh-ancestor
83220249|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
83220250|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220251|NCT03180775|Glycine|glycine|mesh-list
83220252|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
83220253|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220254|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220255|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220256|NCT03137927|Vaccines|vaccines|mesh-list
83220257|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
83220258|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220259|NCT04482985|Meclizine|meclizine|mesh-list
83220260|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
83220261|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
83220262|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220263|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220264|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220265|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83220266|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
83220267|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
83220268|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220269|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220270|NCT04482985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83220271|NCT04482985|Cholinergic Agents|cholinergic agents|mesh-ancestor
83220272|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83220273|NCT05385263|Nivolumab|nivolumab|mesh-list
83220274|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83220275|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220276|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83220277|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220278|NCT03180229|Granisetron|granisetron|mesh-list
83220279|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
83220280|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
83220281|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220282|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220283|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220284|NCT03180229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83220285|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83220286|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
83220287|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220288|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220290|NCT03178123|Antibodies|antibodies|mesh-list
83220291|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83220292|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
83220293|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220294|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220295|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
83220296|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220297|NCT03820817|Rifaximin|rifaximin|mesh-list
83220298|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83220299|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220300|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220301|NCT05111197|Immunomodulating Agents|immunomodulating agents|mesh-list
83220302|NCT05111197|Immunologic Factors|immunologic factors|mesh-ancestor
83220303|NCT05111197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220304|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
83220305|NCT05106517|Denosumab|denosumab|mesh-list
83220306|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83220307|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220308|NCT03140033|Misoprostol|misoprostol|mesh-list
83220309|NCT03140033|Ranitidine|ranitidine|mesh-list
83220310|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83220311|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83220312|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
83220313|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83220314|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220315|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83220316|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220317|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
83220318|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83220319|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
83220320|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
83220321|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220322|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220323|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
83220324|NCT05338931|Gossypol|gossypol|mesh-list
83220325|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83220326|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220327|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83220328|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
83220329|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83220330|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220331|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
83220332|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
83220333|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83220334|NCT02706691|Infigratinib|infigratinib|mesh-list
83220335|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220336|NCT02419729|Estrogens|estrogens|mesh-list
83220337|NCT02419729|Hormones|hormones|mesh-ancestor
83220338|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220339|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220340|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83220341|NCT03697031|Hormones|hormones|mesh-ancestor
83220342|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220343|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220344|NCT02419651|Diclofenac|diclofenac|mesh-list
83220345|NCT02419651|Tramadol|tramadol|mesh-list
83220346|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83220347|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83220348|NCT02419651|Analgesics|analgesics|mesh-ancestor
83220349|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
83220350|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220351|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220352|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83220353|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83220354|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83220355|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220356|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220357|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83220358|NCT02419651|Narcotics|narcotics|mesh-ancestor
83220359|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220360|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83220361|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220362|NCT02419261|Analgesics|analgesics|mesh-list
83220363|NCT02419261|Ropivacaine|ropivacaine|mesh-list
83220364|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
83220365|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
83220366|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220367|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220368|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
83220369|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220370|NCT02414503|Oxytocin|oxytocin|mesh-list
83220371|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
83220372|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83220373|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220374|NCT03137615|Anesthetics|anesthetics|mesh-list
83220375|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
83220376|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220377|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220378|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
83220379|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220380|NCT03415061|Insulin|insulin|mesh-list
83220381|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83220382|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83220383|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220384|NCT05088083|Paclitaxel|paclitaxel|mesh-list
83220385|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83220386|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220387|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83220388|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83220389|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83220390|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220391|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83220392|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83220393|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220394|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
83220395|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83220396|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83220397|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220398|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
83220399|NCT01990768|Coagulants|coagulants|mesh-ancestor
83220400|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
83220401|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220402|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
83220403|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
83220404|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220405|NCT02624765|Digoxin|digoxin|mesh-list
83220406|NCT02624765|Sotalol|sotalol|mesh-list
83220407|NCT02624765|Flecainide|flecainide|mesh-list
83220408|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83220409|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83220410|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220411|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220412|NCT02624765|Protective Agents|protective agents|mesh-ancestor
83220413|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220414|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83220415|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83220416|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83220417|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220418|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
83220419|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
83220420|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220421|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83220422|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83220423|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220424|NCT05085587|Fluticasone|fluticasone|mesh-list
83220425|NCT05085587|Xhance|xhance|mesh-list
83220426|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83220427|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83220428|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83220429|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83220430|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
83220431|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220432|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220433|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83220434|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
83220435|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220436|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83220437|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83220438|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83220439|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83220440|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
83220441|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220442|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220443|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
83220444|NCT05085587|Hormones|hormones|mesh-ancestor
83220445|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220446|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
83220447|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83220448|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83220449|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220450|NCT01990534|Immunotoxins|immunotoxins|mesh-ancestor
83220451|NCT01990534|Immunoconjugates|immunoconjugates|mesh-ancestor
83220452|NCT01990534|Immunologic Factors|immunologic factors|mesh-ancestor
83220453|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220454|NCT05084573|Bupivacaine|bupivacaine|mesh-list
83220455|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
83220456|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
83220457|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220458|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220459|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
83220460|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220461|NCT05088707|Misoprostol|misoprostol|mesh-list
83220462|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83220463|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
83220464|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83220465|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220466|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83220467|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220468|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
83220469|NCT05028257|Vaccines|vaccines|mesh-list
83220470|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
83220471|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220472|NCT01990300|Pioglitazone|pioglitazone|mesh-list
83220473|NCT01990300|Alogliptin|alogliptin|mesh-list
83220474|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83220475|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220476|NCT01990300|Incretins|incretins|mesh-ancestor
83220477|NCT01990300|Hormones|hormones|mesh-ancestor
83220478|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220479|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83220480|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
83220481|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220482|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220483|NCT03135977|Etoposide|etoposide|mesh-list
83220484|NCT03135977|Apatinib|apatinib|mesh-list
83220485|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83220486|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220487|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83220488|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83220489|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220490|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220491|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83220492|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83220493|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83220494|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220495|NCT04850651|Fluconazole|fluconazole|mesh-list
83220496|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
83220497|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220498|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83220499|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220500|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220501|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220502|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83220503|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
83220504|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220505|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220506|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83220507|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83220508|NCT04837235|Hemay005|hemay005|mesh-list
83220509|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220510|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83220511|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83220512|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220513|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220514|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
83220515|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83220516|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220517|NCT02702401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83220518|NCT02702401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220519|NCT03116971|Etoposide|etoposide|mesh-list
83220520|NCT03116971|Peposertib|peposertib|mesh-list
83220521|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220522|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83220523|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83220524|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83220525|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220526|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220527|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83220528|NCT02414581|Ethanol|ethanol|mesh-list
83220529|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
83220530|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83220531|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83220532|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220533|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220534|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220535|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
83220536|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220538|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
83220539|NCT02419105|Testosterone|testosterone|mesh-list
83220540|NCT02419105|Vitamins|vitamins|mesh-ancestor
83220541|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
83220542|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220543|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83220544|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83220545|NCT02419105|Androgens|androgens|mesh-ancestor
83220546|NCT02419105|Hormones|hormones|mesh-ancestor
83220547|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220548|NCT04643249|Repaglinide|repaglinide|mesh-list
83220549|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
83220550|NCT04643249|Midazolam|midazolam|mesh-list
83220551|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
83220552|NCT04643249|Caffeine|caffeine|mesh-list
83220553|NCT04643249|Bupropion|bupropion|mesh-list
83220554|NCT04643249|Omeprazole|omeprazole|mesh-list
83220555|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83220556|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83220557|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220558|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220559|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83220560|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83220561|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83220562|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83220563|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
83220564|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
83220565|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
83220566|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
83220567|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220568|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220569|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83220570|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83220571|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220572|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83220573|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83220574|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
83220575|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83220576|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220577|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83220578|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83220579|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
83220580|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83220581|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83220582|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220583|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
83220584|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83220585|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220586|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
83220587|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
83220588|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83220589|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83220590|NCT04643249|Analgesics|analgesics|mesh-ancestor
83220591|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
83220592|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220593|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83220594|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83220595|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83220596|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83220597|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83220598|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83220599|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
83220600|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83220601|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83220602|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83220603|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220604|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220605|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
83220606|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220607|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220608|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83220609|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220610|NCT03116893|Itraconazole|itraconazole|mesh-list
83220611|NCT03116893|Rifampin|rifampin|mesh-list
83220612|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
83220613|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220614|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83220615|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220616|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220617|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220618|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83220619|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
83220620|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220621|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220622|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83220623|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83220624|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
83220625|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83220626|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
83220627|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83220628|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83220629|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83220630|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83220631|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83220632|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83220633|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83220634|NCT05737511|Diazepam|diazepam|mesh-list
83220635|NCT05737511|Gabapentin|gabapentin|mesh-list
83220636|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83220637|NCT05737511|Milnacipran|milnacipran|mesh-list
83220638|NCT05737511|Levetiracetam|levetiracetam|mesh-list
83220639|NCT05737511|Lorazepam|lorazepam|mesh-list
83220640|NCT05737511|Clonazepam|clonazepam|mesh-list
83220641|NCT05737511|Dexetimide|dexetimide|mesh-list
83220642|NCT05737511|Olanzapine|olanzapine|mesh-list
83220643|NCT05737511|Alprazolam|alprazolam|mesh-list
83220644|NCT05737511|Mirtazapine|mirtazapine|mesh-list
83220646|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
83220647|NCT05737511|Risperidone|risperidone|mesh-list
83220648|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83220649|NCT05737511|Citalopram|citalopram|mesh-list
83220650|NCT05737511|Bupropion|bupropion|mesh-list
83220651|NCT05737511|Sertraline|sertraline|mesh-list
83220652|NCT05737511|Fluoxetine|fluoxetine|mesh-list
83220653|NCT05737511|Paroxetine|paroxetine|mesh-list
83220654|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83220655|NCT05737511|Reboxetine|reboxetine|mesh-list
83220656|NCT05737511|Imipramine|imipramine|mesh-list
83220657|NCT05737511|Clomipramine|clomipramine|mesh-list
83220658|NCT05737511|Phenelzine|phenelzine|mesh-list
83220659|NCT05737511|Moclobemide|moclobemide|mesh-list
83220660|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
83220661|NCT05737511|Escitalopram|escitalopram|mesh-list
83220662|NCT05737511|Analgesics|analgesics|mesh-ancestor
83220663|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
83220664|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220665|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220666|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
83220667|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83220668|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83220669|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220670|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83220671|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83220672|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83220673|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220674|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220675|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
83220676|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83220677|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
83220678|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83220679|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83220680|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
83220681|NCT05737511|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83220682|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83220683|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220684|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83220685|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83220686|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
83220687|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
83220688|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83220689|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83220690|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
83220691|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83220692|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
83220693|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
83220694|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220695|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83220696|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83220697|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220698|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220699|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83220700|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
83220701|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83220702|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
83220703|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
83220704|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83220705|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
83220706|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
83220707|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83220708|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83220709|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83220710|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
83220711|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83220712|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83220713|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83220714|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83220715|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83220716|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83220717|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
83220718|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
83220719|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83220720|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83220721|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83220722|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83220723|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83220725|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
83220726|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83220727|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
83220728|NCT03179839|Sertraline|sertraline|mesh-list
83220729|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
83220730|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83220731|NCT03179839|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83220732|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83220733|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220734|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220735|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220736|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
83220737|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220738|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83220739|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83220740|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220741|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83220742|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83220743|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220744|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220745|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83220746|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
83220747|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83220748|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
83220749|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220750|NCT05736887|Expectorants|expectorants|mesh-ancestor
83220751|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
83220752|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83220753|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
83220754|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220755|NCT05736887|Protective Agents|protective agents|mesh-ancestor
83220756|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220757|NCT05736887|Antidotes|antidotes|mesh-ancestor
83220758|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
83220759|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83220760|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220761|NCT05735639|Enoxaparin|enoxaparin|mesh-list
83220762|NCT05735639|Dalteparin|dalteparin|mesh-list
83220763|NCT05735639|Tinzaparin|tinzaparin|mesh-list
83220764|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83220765|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
83220766|NCT05735639|Apixaban|apixaban|mesh-list
83220767|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
83220768|NCT05735639|Dabigatran|dabigatran|mesh-list
83220769|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83220770|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
83220771|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83220772|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83220773|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220774|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220775|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
83220776|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83220777|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83220778|NCT04483219|Antibodies|antibodies|mesh-list
83220779|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
83220780|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220781|NCT03176563|Fosfomycin|fosfomycin|mesh-list
83220782|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83220783|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220784|NCT03827447|Vancomycin|vancomycin|mesh-list
83220785|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83220786|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220787|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
83220788|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83220789|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
83220790|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220791|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
83220792|NCT01680497|Protective Agents|protective agents|mesh-ancestor
83220793|NCT02423395|Orphenadrine|orphenadrine|mesh-list
83220794|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220795|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83220796|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83220797|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83220798|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83220799|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220800|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
83220801|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
83220802|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83220803|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83220804|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
83220805|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220806|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220807|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83220808|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83220809|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220810|NCT05694689|Vitamin D|vitamin d|mesh-list
83220811|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
83220812|NCT05694689|Vitamins|vitamins|mesh-ancestor
83220813|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
83220814|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220815|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83220816|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83220817|NCT02423239|Paclitaxel|paclitaxel|mesh-list
83220818|NCT02423239|Gemcitabine|gemcitabine|mesh-list
83220819|NCT02423239|Sorafenib|sorafenib|mesh-list
83220820|NCT02423239|HU 211|hu 211|mesh-list
83220821|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83220822|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220823|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
83220824|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
83220825|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
83220826|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220827|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83220828|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
83220829|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83220830|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220831|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83220832|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
83220833|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
83220834|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220835|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220836|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220837|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83220838|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83220839|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220840|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83220841|NCT02423239|Protective Agents|protective agents|mesh-ancestor
83220842|NCT02449733|Tenofovir|tenofovir|mesh-list
83220843|NCT02449733|Emtricitabine|emtricitabine|mesh-list
83220844|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83220845|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
83220846|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220847|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83220848|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83220849|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220850|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220851|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83220852|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83220853|NCT02417467|Nicotine|nicotine|mesh-list
83220854|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83220855|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
83220856|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220857|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220858|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83220859|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83220860|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
83220861|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220862|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220863|NCT02417389|Alendronate|alendronate|mesh-list
83220864|NCT02417389|Cinacalcet|cinacalcet|mesh-list
83220865|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83220866|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220867|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83220868|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83220869|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
83220870|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83220871|NCT02413021|Cytarabine|cytarabine|mesh-list
83220872|NCT02413021|Deferasirox|deferasirox|mesh-list
83220873|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83220874|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
83220875|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220876|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220877|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
83220878|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220879|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83220880|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
83220881|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220882|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83220883|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
83220884|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
83220886|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83220887|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
83220888|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
83220889|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83220890|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83220891|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220892|NCT03177811|Acetazolamide|acetazolamide|mesh-list
83220893|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
83220894|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83220895|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220896|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220897|NCT03177811|Diuretics|diuretics|mesh-ancestor
83220898|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
83220899|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220900|NCT03175939|Fluorouracil|fluorouracil|mesh-list
83220901|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220902|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
83220903|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220904|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83220905|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83220906|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
83220907|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220908|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
83220909|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83220910|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83220911|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83220912|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83220913|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220914|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220915|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83220916|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220917|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220918|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
83220919|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220920|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
83220921|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83220922|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
83220923|NCT02412475|Cytarabine|cytarabine|mesh-list
83220924|NCT02412475|Fludarabine|fludarabine|mesh-list
83220925|NCT02412475|Sorafenib|sorafenib|mesh-list
83220926|NCT02412475|Decitabine|decitabine|mesh-list
83220927|NCT02412475|Vorinostat|vorinostat|mesh-list
83220928|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220929|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83220930|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
83220931|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220932|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83220933|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
83220934|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220935|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
83220936|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83220937|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83220938|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83220939|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83220940|NCT04543643|Carvedilol|carvedilol|mesh-list
83220941|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83220942|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83220943|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
83220944|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220945|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220946|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220947|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83220948|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
83220949|NCT04543643|Protective Agents|protective agents|mesh-ancestor
83220950|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83220951|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83220952|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83220953|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
83220954|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83220955|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83220956|NCT05377619|Buspirone|buspirone|mesh-list
83220957|NCT05377619|Prucalopride|prucalopride|mesh-list
83220958|NCT05377619|Laxatives|laxatives|mesh-ancestor
83220959|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83220960|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83220961|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83220962|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
83220963|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83220964|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220965|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220966|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83220967|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83220968|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220969|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83220970|NCT03199157|Fentanyl|fentanyl|mesh-list
83220971|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83220972|NCT03199157|Narcotics|narcotics|mesh-ancestor
83220973|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83220974|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220975|NCT03199157|Analgesics|analgesics|mesh-ancestor
83220976|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
83220977|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83220978|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83220979|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83220980|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
83220981|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
83220982|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
83220983|NCT00641381|Carmustine|carmustine|mesh-list
83220984|NCT00641381|Etoposide|etoposide|mesh-list
83220985|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83220986|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
83220987|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83220988|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83220989|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83220990|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
83220991|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83220992|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83220993|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83220994|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83221042|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221043|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83221044|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
83221045|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221046|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221047|NCT03177109|Fluorides|fluorides|mesh-list
83221048|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
83221049|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
83221050|NCT03177109|Protective Agents|protective agents|mesh-ancestor
83221051|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221052|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
83221053|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83221054|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
83221055|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221056|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221057|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221058|NCT02421913|Ketamine|ketamine|mesh-list
83221059|NCT02421913|Analgesics|analgesics|mesh-ancestor
83221060|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
83221061|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221062|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221063|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83221064|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83221065|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
83221066|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
83221067|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221068|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83221069|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83221070|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221071|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221072|NCT03179293|Propofol|propofol|mesh-list
83221073|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83221074|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221075|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221076|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83221077|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
83221078|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
83221079|NCT02416765|Glucagon|glucagon|mesh-list
83221080|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221081|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83221082|NCT02416765|Hormones|hormones|mesh-ancestor
83221083|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221084|NCT02703259|Acetaminophen|acetaminophen|mesh-list
83221085|NCT02703259|Celecoxib|celecoxib|mesh-list
83221086|NCT02703259|Gabapentin|gabapentin|mesh-list
83221087|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83221088|NCT02703259|Analgesics|analgesics|mesh-ancestor
83221089|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
83221090|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221091|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221092|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
83221093|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83221094|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221095|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221096|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83221097|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83221098|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221099|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221100|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
83221101|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83221102|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83221103|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221104|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83221105|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83221106|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83221107|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221108|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
83221109|NCT02416687|Etonogestrel|etonogestrel|mesh-list
83221110|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83221111|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
83221112|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83221113|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221114|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83221115|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
83221116|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
83221117|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221118|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221119|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221120|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
83221121|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
83221122|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
83221123|NCT05093231|Olaparib|olaparib|mesh-list
83221124|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83221125|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221126|NCT05093231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83221127|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221128|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83221129|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221130|NCT02411149|Epinephrine|epinephrine|mesh-list
83221131|NCT02411149|Racepinephrine|racepinephrine|mesh-list
83221132|NCT02411149|Morphine|morphine|mesh-list
83221133|NCT02411149|Ropivacaine|ropivacaine|mesh-list
83221134|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
83221135|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83221136|NCT02411149|Narcotics|narcotics|mesh-ancestor
83221137|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221138|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221139|NCT02411149|Analgesics|analgesics|mesh-ancestor
83221140|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
83221141|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221142|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221143|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
83221144|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83221145|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83221146|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83221147|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221148|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221149|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83221150|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83221151|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
83221152|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83221153|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83221154|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
83221155|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
83221156|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83221157|NCT04413227|Docetaxel|docetaxel|mesh-list
83221158|NCT04413227|Endostatins|endostatins|mesh-list
83221159|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221160|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83221161|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83221162|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83221163|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221164|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83221165|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83221166|NCT04413227|Growth Substances|growth substances|mesh-ancestor
83221167|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221168|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
83221169|NCT02410135|Mirabegron|mirabegron|mesh-list
83221170|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83221171|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83221172|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83221173|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
83221174|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221175|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221176|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221177|NCT02410135|Urological Agents|urological agents|mesh-ancestor
83221178|NCT02410759|Carbetocin|carbetocin|mesh-list
83221179|NCT02410759|Ergonovine|ergonovine|mesh-list
83221180|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
83221181|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83221182|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221183|NCT03175081|Ropivacaine|ropivacaine|mesh-list
83221184|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221185|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
83221186|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221187|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221188|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
83221189|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221190|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
83221191|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83221192|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221193|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221194|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83221195|NCT02401477|Amoxicillin|amoxicillin|mesh-list
83221196|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83221197|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221198|NCT03174457|Micafungin|micafungin|mesh-list
83221199|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
83221200|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221201|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
83221202|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83221203|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221204|NCT02409433|Lacosamide|lacosamide|mesh-list
83221205|NCT02409433|Phenytoin|phenytoin|mesh-list
83221206|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
83221207|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83221208|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83221209|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83221210|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221211|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83221212|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83221213|NCT01989754|Canagliflozin|canagliflozin|mesh-list
83221214|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83221215|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221216|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83221217|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221218|NCT01619878|Lumefantrine|lumefantrine|mesh-list
83221219|NCT01619878|Artemether|artemether|mesh-list
83221220|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83221221|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
83221222|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83221223|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83221224|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221225|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
83221226|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83221227|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
83221228|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221229|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
83221231|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83221232|NCT01619410|Clindamycin|clindamycin|mesh-list
83221233|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
83221234|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
83221235|NCT01619410|Linezolid|linezolid|mesh-list
83221236|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83221237|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221238|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83221239|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221240|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221241|NCT04666714|Pregabalin|pregabalin|mesh-list
83221242|NCT04666714|Analgesics|analgesics|mesh-ancestor
83221243|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
83221244|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221245|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221246|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
83221247|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83221248|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83221249|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221250|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83221251|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83221252|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83221253|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221254|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83221255|NCT01261247|Panobinostat|panobinostat|mesh-list
83221256|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83221257|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221258|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221259|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221260|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83221261|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83221262|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83221263|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
83221264|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221265|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83221266|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83221267|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221268|NCT02449655|Paclitaxel|paclitaxel|mesh-list
83221269|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83221270|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83221271|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221272|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
83221273|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
83221274|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
83221275|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221276|NCT04254731|Methadone|methadone|mesh-list
83221277|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83221278|NCT04254731|Narcotics|narcotics|mesh-ancestor
83221279|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221280|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221281|NCT04254731|Analgesics|analgesics|mesh-ancestor
83221282|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
83221283|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221284|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
83221285|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
83221286|NCT01603277|Antibodies|antibodies|mesh-list
83221287|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83221288|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
83221289|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221290|NCT01678313|Celecoxib|celecoxib|mesh-list
83221291|NCT01678313|Doxazosin|doxazosin|mesh-list
83221292|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83221293|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83221294|NCT01678313|Analgesics|analgesics|mesh-ancestor
83221295|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
83221296|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221297|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221298|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221299|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221300|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83221301|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83221302|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221303|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221304|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83221305|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83221306|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83221307|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83221308|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
83221309|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221310|NCT03197207|Camphor|camphor|mesh-list
83221311|NCT03197207|Salicylates|salicylates|mesh-list
83221312|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
83221313|NCT03197207|Menthol|menthol|mesh-list
83221314|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83221315|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221316|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
83221317|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
83221318|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83221319|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83221320|NCT03197207|Analgesics|analgesics|mesh-ancestor
83221321|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
83221322|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221323|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221324|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221325|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221326|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83221327|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221328|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221329|NCT01603121|Lisofylline|lisofylline|mesh-list
83221330|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83221331|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
83221332|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221333|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83221334|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83221335|NCT01603121|Analgesics|analgesics|mesh-ancestor
83221336|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
83221337|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221338|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221339|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221340|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221342|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
83221343|NCT02449265|Doxorubicin|doxorubicin|mesh-list
83221344|NCT02449265|Vincristine|vincristine|mesh-list
83221345|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221346|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
83221347|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221348|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221349|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83221350|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
83221351|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221352|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221353|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83221354|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83221355|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83221356|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83221357|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221358|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221359|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
83221360|NCT02449265|Hormones|hormones|mesh-ancestor
83221361|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221362|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83221363|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83221364|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
83221365|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
83221366|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
83221367|NCT03196817|Betamethasone|betamethasone|mesh-list
83221368|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
83221369|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83221370|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
83221371|NCT03196817|Lidocaine|lidocaine|mesh-list
83221372|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83221373|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221374|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
83221375|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221376|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221377|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
83221378|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221379|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83221380|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83221381|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83221382|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83221383|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221384|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221385|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
83221386|NCT03196817|Hormones|hormones|mesh-ancestor
83221387|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221388|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83221389|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
83221390|NCT05091359|Calcium|calcium|mesh-list
83221391|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83221392|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221393|NCT03593759|Prednisone|prednisone|mesh-list
83221394|NCT03593759|Prednisolone|prednisolone|mesh-list
83221395|NCT03593759|Methotrexate|methotrexate|mesh-list
83221396|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221397|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
83221399|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221400|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221401|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83221402|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221403|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83221404|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
83221405|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83221406|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83221407|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
83221408|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221409|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
83221410|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221411|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83221412|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221413|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
83221414|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221415|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83221416|NCT03564821|Ivosidenib|ivosidenib|mesh-list
83221417|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221418|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221419|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221420|NCT02014402|Thrombin|thrombin|mesh-list
83221421|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
83221422|NCT02014402|Coagulants|coagulants|mesh-ancestor
83221423|NCT01988662|Ranibizumab|ranibizumab|mesh-list
83221424|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83221425|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83221426|NCT01988662|Growth Substances|growth substances|mesh-ancestor
83221427|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221428|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
83221429|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221430|NCT00127673|Sertraline|sertraline|mesh-list
83221431|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
83221432|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83221433|NCT00127673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83221434|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83221435|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83221436|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221437|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221438|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
83221439|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221440|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
83221441|NCT02449187|Metformin|metformin|mesh-list
83221442|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83221443|NCT02449187|Calcium|calcium|mesh-list
83221444|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83221445|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221446|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83221447|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83221448|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83221449|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83221450|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
83221451|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221452|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83221453|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83221454|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221455|NCT05095571|Niacinamide|niacinamide|mesh-list
83221456|NCT05095571|Niacin|niacin|mesh-list
83221457|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
83221458|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
83221459|NCT05095571|Vitamins|vitamins|mesh-ancestor
83221460|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
83221461|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221462|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83221463|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
83221464|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221465|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83221466|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
83221467|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
83221468|NCT02677181|Methotrexate|methotrexate|mesh-list
83221469|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
83221470|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83221471|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
83221472|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83221473|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221474|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83221475|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
83221476|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221477|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221478|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
83221479|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221480|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83221481|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221482|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
83221483|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221484|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83221485|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83221486|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83221487|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
83221488|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83221489|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221490|NCT05095025|Bupivacaine|bupivacaine|mesh-list
83221491|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221492|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
83221493|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221494|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221495|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
83221496|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221497|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83221498|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83221499|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221500|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
83221501|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
83221502|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221503|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221504|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221505|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
83221506|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
83221507|NCT05084027|Fludarabine|fludarabine|mesh-list
83221508|NCT05084027|Melphalan|melphalan|mesh-list
83221509|NCT05084027|Venetoclax|venetoclax|mesh-list
83221510|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221511|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221512|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221513|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
83221514|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221515|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83221516|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
83221517|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83221518|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
83221519|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
83221520|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221521|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221522|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221523|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
83221524|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
83221525|NCT02448797|Vinorelbine|vinorelbine|mesh-list
83221526|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83221527|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221528|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
83221529|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
83221530|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
83221531|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221532|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
83221533|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83221534|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83221535|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
83221536|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83221537|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221538|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
83221539|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
83221540|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83221541|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
83221542|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221543|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
83221544|NCT04438421|Protective Agents|protective agents|mesh-ancestor
83221545|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
83221546|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83221547|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83221548|NCT04438577|Lidocaine|lidocaine|mesh-list
83221549|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221550|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
83221551|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221552|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221553|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
83221554|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221555|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83221556|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83221557|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83221558|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83221559|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221560|NCT05087615|Ondansetron|ondansetron|mesh-list
83221561|NCT05087615|Metoclopramide|metoclopramide|mesh-list
83221562|NCT05087615|Granisetron|granisetron|mesh-list
83221563|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
83221564|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
83221565|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221566|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221567|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83221568|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
83221569|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
83221570|NCT05087615|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83221571|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83221572|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
83221573|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221574|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221575|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83221576|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83221577|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
83221578|NCT01987102|Leucovorin|leucovorin|mesh-list
83221579|NCT01987102|Calcium|calcium|mesh-list
83221580|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
83221581|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83221582|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221583|NCT01987102|Antidotes|antidotes|mesh-ancestor
83221584|NCT01987102|Protective Agents|protective agents|mesh-ancestor
83221585|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
83221586|NCT01987102|Vitamins|vitamins|mesh-ancestor
83221587|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
83221588|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83221589|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83221590|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
83221591|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221592|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
83221593|NCT03968939|Promethazine|promethazine|mesh-list
83221594|NCT03968939|Melatonin|melatonin|mesh-list
83221595|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
83221596|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221597|NCT03968939|Protective Agents|protective agents|mesh-ancestor
83221598|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221599|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221600|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83221601|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83221602|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221603|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
83221604|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
83221605|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221606|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
83221607|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
83221608|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83221609|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83221610|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
83221611|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
83221612|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221613|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83221614|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
83221615|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
83221616|NCT03856619|Teriflunomide|teriflunomide|mesh-list
83221617|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83221618|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83221619|NCT03856619|Analgesics|analgesics|mesh-ancestor
83221620|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
83221621|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221622|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221623|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221624|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221625|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221626|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
83221627|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
83221628|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83221629|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
83221630|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221631|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
83221632|NCT02448407|Protective Agents|protective agents|mesh-ancestor
83221633|NCT05098847|Lenvatinib|lenvatinib|mesh-list
83221634|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221635|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83221636|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221637|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221638|NCT04517357|Apatinib|apatinib|mesh-list
83221639|NCT04517357|Fluzoparib|fluzoparib|mesh-list
83221640|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221641|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83221642|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221643|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221644|NCT04517357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83221645|NCT02012296|Mifepristone|mifepristone|mesh-list
83221646|NCT02012296|Androgens|androgens|mesh-list
83221647|NCT02012296|Hormones|hormones|mesh-ancestor
83221648|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221649|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221650|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83221651|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
83221652|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83221653|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83221654|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83221655|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83221656|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
83221657|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83221658|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83221659|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
83221660|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
83221661|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83221662|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83221663|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
83221664|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
83221665|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221666|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221667|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221668|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
83221669|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
83221670|NCT04177498|ON 01910|on 01910|mesh-list
83221671|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221672|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83221673|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221674|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221675|NCT04658836|Triamcinolone|triamcinolone|mesh-list
83221676|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83221677|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83221678|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83221679|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221680|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
83221681|NCT04658836|Hormones|hormones|mesh-ancestor
83221682|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221683|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221684|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221685|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
83221686|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221687|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221688|NCT01677377|Risperidone|risperidone|mesh-list
83221689|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83221690|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
83221691|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221692|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221693|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221694|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83221695|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83221696|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221698|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83221699|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
83221700|NCT05097911|Bevacizumab|bevacizumab|mesh-list
83221701|NCT05097911|Atezolizumab|atezolizumab|mesh-list
83221702|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83221703|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221704|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83221705|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83221706|NCT05097911|Growth Substances|growth substances|mesh-ancestor
83221707|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221708|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
83221709|NCT05097911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83221710|NCT05097911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221711|NCT05097365|Folic Acid|folic acid|mesh-list
83221712|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
83221713|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
83221714|NCT05097365|Vitamins|vitamins|mesh-ancestor
83221715|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
83221716|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221718|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
83221719|NCT01964716|Vaccines|vaccines|mesh-list
83221720|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83221721|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
83221722|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221723|NCT01964560|Lacosamide|lacosamide|mesh-list
83221724|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
83221725|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83221726|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83221727|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83221728|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221729|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
83221730|NCT02659943|Fludarabine|fludarabine|mesh-list
83221731|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83221732|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
83221733|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221734|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221735|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83221736|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
83221737|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221738|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221739|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83221740|NCT05083325|Oseltamivir|oseltamivir|mesh-list
83221741|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
83221742|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221743|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221744|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221745|NCT01677299|Metformin|metformin|mesh-list
83221746|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83221747|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221748|NCT04999631|Ethanol|ethanol|mesh-list
83221749|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
83221750|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83221751|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221752|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221753|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221754|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83221755|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
83221756|NCT02718833|Dexamethasone|dexamethasone|mesh-list
83221757|NCT02718833|Bortezomib|bortezomib|mesh-list
83221758|NCT02718833|Pomalidomide|pomalidomide|mesh-list
83221759|NCT02718833|Elotuzumab|elotuzumab|mesh-list
83221760|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221761|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
83221762|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
83221763|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221764|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221765|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83221766|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
83221767|NCT02718833|Hormones|hormones|mesh-ancestor
83221768|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83221769|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83221770|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221771|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
83221772|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83221773|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83221774|NCT02718833|Growth Substances|growth substances|mesh-ancestor
83221775|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
83221776|NCT04908293|Listerine|listerine|mesh-list
83221777|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
83221778|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
83221779|NCT04908293|Protective Agents|protective agents|mesh-ancestor
83221780|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221781|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83221782|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221783|NCT01964326|Atorvastatin|atorvastatin|mesh-list
83221784|NCT01964326|Calcium|calcium|mesh-list
83221785|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83221786|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221787|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83221788|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83221789|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
83221790|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221791|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83221792|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83221793|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221795|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83221796|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83221797|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83221798|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
83221799|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221800|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221801|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221802|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83221803|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83221804|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221805|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
83221806|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
83221807|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
83221808|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83221809|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83221810|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221811|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221812|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221813|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221814|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
83221815|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221816|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
83221817|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221818|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221819|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
83221820|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221821|NCT05101811|Vitamin D|vitamin d|mesh-list
83221822|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
83221823|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
83221824|NCT05101811|Vitamins|vitamins|mesh-list
83221825|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
83221826|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221827|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83221828|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83221829|NCT04088123|Ticagrelor|ticagrelor|mesh-list
83221830|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83221831|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83221832|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83221833|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83221834|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
83221835|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221836|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221837|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221838|NCT05164367|Atropine|atropine|mesh-list
83221839|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83221840|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83221841|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83221842|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
83221843|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221844|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221845|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83221846|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
83221847|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
83221848|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
83221849|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83221850|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83221851|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
83221852|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221853|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221855|NCT03847181|Warfarin|warfarin|mesh-list
83221856|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
83221857|NCT03847181|Apixaban|apixaban|mesh-list
83221858|NCT03847181|Anticoagulants|anticoagulants|mesh-list
83221859|NCT03847181|Vitamins|vitamins|mesh-ancestor
83221860|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
83221861|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221862|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83221863|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
83221864|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83221865|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
83221866|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221867|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221868|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83221869|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83221870|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
83221871|NCT03847181|Coagulants|coagulants|mesh-ancestor
83221872|NCT03477851|Tramadol|tramadol|mesh-list
83221873|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83221874|NCT03477851|Narcotics|narcotics|mesh-ancestor
83221875|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221876|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221877|NCT03477851|Analgesics|analgesics|mesh-ancestor
83221878|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
83221879|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221880|NCT02409199|Docetaxel|docetaxel|mesh-list
83221881|NCT02409199|Apatinib|apatinib|mesh-list
83221882|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83221883|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
83221884|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
83221885|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
83221886|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221887|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83221888|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221889|NCT03115489|Ketamine|ketamine|mesh-list
83221890|NCT03115489|Propofol|propofol|mesh-list
83221891|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83221892|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221893|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221894|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83221895|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
83221896|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
83221897|NCT03115489|Analgesics|analgesics|mesh-ancestor
83221898|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
83221899|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221900|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83221901|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83221902|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83221903|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221904|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221905|NCT03168997|Memantine|memantine|mesh-list
83221906|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83221907|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83221908|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
83221909|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221910|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221911|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221912|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83221913|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83221914|NCT03171727|Heparin|heparin|mesh-list
83221915|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83221916|NCT03171727|Tinzaparin|tinzaparin|mesh-list
83221917|NCT03171727|Dalteparin|dalteparin|mesh-list
83221918|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
83221919|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83221920|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83221921|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221922|NCT02400931|Rocuronium|rocuronium|mesh-list
83221923|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83221924|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83221926|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221927|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221928|NCT03116269|Aspirin|aspirin|mesh-list
83221929|NCT03116269|Cilostazol|cilostazol|mesh-list
83221930|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83221931|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83221932|NCT03116269|Analgesics|analgesics|mesh-ancestor
83221933|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
83221934|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221935|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221936|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83221937|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83221938|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83221939|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83221940|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221941|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83221942|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83221943|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83221944|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
83221945|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83221946|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
83221947|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83221948|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
83221949|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
83221950|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83221951|NCT03116269|Protective Agents|protective agents|mesh-ancestor
83221952|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83221953|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83221954|NCT03174067|Clonidine|clonidine|mesh-list
83221955|NCT03174067|Buprenorphine|buprenorphine|mesh-list
83221956|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83221957|NCT03174067|Narcotics|narcotics|mesh-ancestor
83221958|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221959|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221960|NCT03174067|Analgesics|analgesics|mesh-ancestor
83221961|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
83221962|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221963|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83221964|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83221965|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
83221966|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
83221967|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83221968|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83221969|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83221970|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
83221971|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83221972|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221973|NCT02408185|Colistin|colistin|mesh-list
83221974|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83221975|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83221976|NCT02408419|Bupivacaine|bupivacaine|mesh-list
83221977|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
83221978|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
83221979|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221980|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221981|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
83221982|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83221983|NCT00708097|Fluorides|fluorides|mesh-list
83221984|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
83221985|NCT00708097|Protective Agents|protective agents|mesh-ancestor
83221986|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221987|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83221988|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83221989|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83221990|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83221991|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
83221992|NCT02405689|Remifentanil|remifentanil|mesh-list
83221993|NCT02405689|Sevoflurane|sevoflurane|mesh-list
83221994|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83221995|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83221996|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83221997|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83221998|NCT02405689|Analgesics|analgesics|mesh-ancestor
83221999|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
83222000|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222001|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83222002|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83222003|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83222004|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83222005|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222006|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222007|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83222008|NCT02405689|Narcotics|narcotics|mesh-ancestor
83222009|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83222010|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83222011|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
83222012|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
83222013|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
83222014|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83222015|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83222016|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83222017|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83222018|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222019|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
83222020|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222021|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222022|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83222023|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222024|NCT05083949|Metformin|metformin|mesh-list
83222025|NCT05083949|Empagliflozin|empagliflozin|mesh-list
83222026|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83222027|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222028|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83222029|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222030|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83222031|NCT02699125|Guanfacine|guanfacine|mesh-list
83222032|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83222033|NCT02699125|Diuretics|diuretics|mesh-ancestor
83222034|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
83222035|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222036|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83222037|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83222038|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222039|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83222040|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83222041|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83222042|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83222043|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222044|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
83222045|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
83222046|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222047|NCT04279535|Protective Agents|protective agents|mesh-ancestor
83222048|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222049|NCT04279535|Vitamins|vitamins|mesh-ancestor
83222050|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
83222051|NCT02400151|Vitamin D|vitamin d|mesh-list
83222052|NCT02400151|Vitamins|vitamins|mesh-ancestor
83222053|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
83222054|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222055|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83222056|NCT02400385|Nivolumab|nivolumab|mesh-list
83222057|NCT02400385|Sunitinib|sunitinib|mesh-list
83222058|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222059|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222060|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83222061|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222062|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83222063|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83222065|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222066|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
83222067|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83222068|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222069|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83222070|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83222071|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83222072|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83222073|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83222074|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
83222075|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222076|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222077|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222078|NCT05100719|Mebeverine|mebeverine|mesh-list
83222079|NCT05100719|Simethicone|simethicone|mesh-list
83222080|NCT05100719|Citric Acid|citric acid|mesh-list
83222081|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
83222082|NCT05100719|Alverine|alverine|mesh-list
83222083|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
83222084|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83222085|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
83222086|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
83222087|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222088|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
83222089|NCT05100719|Emollients|emollients|mesh-ancestor
83222090|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
83222091|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
83222092|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
83222093|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222094|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222095|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
83222096|NCT05100563|Naltrexone|naltrexone|mesh-list
83222097|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83222098|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83222099|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222100|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
83222101|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222102|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
83222103|NCT05100329|Analgesics|analgesics|mesh-ancestor
83222104|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
83222105|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222106|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222107|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222108|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83222109|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83222110|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222111|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222112|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
83222113|NCT04530539|Melatonin|melatonin|mesh-list
83222114|NCT04530539|Vitamins|vitamins|mesh-ancestor
83222115|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
83222116|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222117|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
83222118|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222119|NCT04530539|Protective Agents|protective agents|mesh-ancestor
83222120|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222121|NCT02698891|Paclitaxel|paclitaxel|mesh-list
83222122|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83222123|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222124|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
83222125|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
83222126|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
83222127|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222128|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
83222129|NCT04719065|Analgesics|analgesics|mesh-ancestor
83222131|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222132|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222133|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222134|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83222135|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83222136|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222137|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222138|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83222139|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222140|NCT05108051|Oseltamivir|oseltamivir|mesh-list
83222141|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
83222142|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222143|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222144|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222145|NCT03765359|Metformin|metformin|mesh-list
83222146|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83222147|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222148|NCT04351295|Chloroquine|chloroquine|mesh-list
83222149|NCT04351295|Favipiravir|favipiravir|mesh-list
83222150|NCT04351295|Amebicides|amebicides|mesh-ancestor
83222151|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83222152|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83222153|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222154|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
83222155|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222156|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
83222158|NCT02399137|Gemcitabine|gemcitabine|mesh-list
83222159|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83222160|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222161|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83222162|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83222163|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83222164|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222165|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83222166|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
83222167|NCT05093387|Carboplatin|carboplatin|mesh-list
83222168|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
83222169|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222170|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222171|NCT05093387|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83222172|NCT05093387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222173|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
83222174|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222175|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222176|NCT02407171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83222177|NCT02407171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222178|NCT02850263|Aflibercept|aflibercept|mesh-list
83222179|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83222180|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83222181|NCT02850263|Growth Substances|growth substances|mesh-ancestor
83222182|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222183|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
83222184|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222185|NCT04481815|Rituximab|rituximab|mesh-list
83222186|NCT04481815|Methotrexate|methotrexate|mesh-list
83222187|NCT04481815|Lenalidomide|lenalidomide|mesh-list
83222188|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222189|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222190|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
83222191|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222192|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222193|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83222194|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
83222195|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83222196|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83222197|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
83222198|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222199|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
83222200|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222201|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83222202|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83222203|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83222204|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83222205|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83222206|NCT04481815|Growth Substances|growth substances|mesh-ancestor
83222207|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83222208|NCT05106803|Amoxicillin|amoxicillin|mesh-list
83222209|NCT05106803|Vancomycin|vancomycin|mesh-list
83222210|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
83222211|NCT05106803|Clindamycin|clindamycin|mesh-list
83222212|NCT05106803|Gentamicins|gentamicins|mesh-list
83222213|NCT05106803|Tetracycline|tetracycline|mesh-list
83222214|NCT05106803|Penicillins|penicillins|mesh-list
83222215|NCT05106803|Erythromycin|erythromycin|mesh-list
83222216|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
83222217|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
83222218|NCT05106803|Ampicillin|ampicillin|mesh-list
83222219|NCT05106803|Cefepime|cefepime|mesh-list
83222220|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83222221|NCT05106803|Norfloxacin|norfloxacin|mesh-list
83222222|NCT05106803|Oxacillin|oxacillin|mesh-list
83222223|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
83222224|NCT05106803|Trimethoprim|trimethoprim|mesh-list
83222225|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
83222226|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83222227|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222228|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83222229|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83222230|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222231|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222232|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222233|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83222234|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83222235|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83222236|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83222237|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
83222238|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83222239|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83222240|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83222241|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83222242|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83222243|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83222244|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83222245|NCT02398357|Nadroparin|nadroparin|mesh-list
83222246|NCT02398357|Warfarin|warfarin|mesh-list
83222247|NCT02398357|Calcium|calcium|mesh-list
83222248|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83222249|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222250|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
83222251|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83222252|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83222253|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222254|NCT02398201|Bezafibrate|bezafibrate|mesh-list
83222255|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83222256|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
83222257|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222258|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83222259|NCT05106179|Propranolol|propranolol|mesh-list
83222260|NCT05106179|Atenolol|atenolol|mesh-list
83222261|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83222263|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
83222264|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222265|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222266|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222267|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83222268|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83222269|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
83222270|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
83222271|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
83222272|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222273|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83222274|NCT04670471|Remifentanil|remifentanil|mesh-list
83222275|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83222276|NCT04670471|Narcotics|narcotics|mesh-ancestor
83222277|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222278|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222279|NCT04670471|Analgesics|analgesics|mesh-ancestor
83222280|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
83222281|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222282|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
83222283|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
83222284|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222285|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222286|NCT02406781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83222287|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222288|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83222289|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
83222290|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222291|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222292|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83222293|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
83222294|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83222295|NCT05106023|Temozolomide|temozolomide|mesh-list
83222296|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83222297|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
83222298|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222299|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222300|NCT02398123|Bupivacaine|bupivacaine|mesh-list
83222301|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
83222302|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
83222303|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222304|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222305|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
83222306|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222307|NCT04486625|Aztreonam|aztreonam|mesh-list
83222308|NCT04486625|Avibactam|avibactam|mesh-list
83222309|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83222310|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222311|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83222312|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222313|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222314|NCT02404363|Clopidogrel|clopidogrel|mesh-list
83222315|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83222316|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83222317|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83222318|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83222319|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
83222320|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222321|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222322|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222323|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
83222324|NCT02404519|Vitamin K|vitamin k|mesh-list
83222325|NCT02404519|Menaquinone 7|menaquinone 7|mesh-list
83222326|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83222327|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83222328|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222329|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
83222330|NCT02404519|Coagulants|coagulants|mesh-ancestor
83222331|NCT02404519|Vitamins|vitamins|mesh-ancestor
83222332|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
83222333|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222334|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
83222335|NCT03173131|Narcotics|narcotics|mesh-ancestor
83222336|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222337|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222338|NCT03173131|Analgesics|analgesics|mesh-ancestor
83222339|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
83222340|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222341|NCT04524611|Ustekinumab|ustekinumab|mesh-list
83222342|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83222343|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83222344|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
83222345|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222346|NCT02658149|Ketorolac|ketorolac|mesh-list
83222347|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83222348|NCT02658149|Epinephrine|epinephrine|mesh-list
83222349|NCT02658149|Morphine|morphine|mesh-list
83222350|NCT02658149|Ropivacaine|ropivacaine|mesh-list
83222351|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83222352|NCT02658149|Narcotics|narcotics|mesh-ancestor
83222353|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222354|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222355|NCT02658149|Analgesics|analgesics|mesh-ancestor
83222356|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
83222357|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222358|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
83222359|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
83222360|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83222361|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83222362|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83222363|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222364|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222365|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83222366|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83222367|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
83222368|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83222369|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83222370|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
83222371|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
83222372|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83222373|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83222374|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83222375|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222376|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222377|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83222378|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222379|NCT03701711|Lenalidomide|lenalidomide|mesh-list
83222380|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
83222381|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222382|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83222383|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83222384|NCT03701711|Growth Substances|growth substances|mesh-ancestor
83222385|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
83222386|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222387|NCT04481971|Prednisolone|prednisolone|mesh-list
83222388|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222389|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
83222390|NCT04481971|Hormones|hormones|mesh-ancestor
83222391|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83222392|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222393|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83222394|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222395|NCT03172741|Dronabinol|dronabinol|mesh-list
83222396|NCT03172741|Cannabidiol|cannabidiol|mesh-list
83222397|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
83222398|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
83222400|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83222401|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83222402|NCT03172741|Analgesics|analgesics|mesh-ancestor
83222403|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
83222404|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222405|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83222406|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83222407|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222408|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222409|NCT03172741|Hormones|hormones|mesh-ancestor
83222410|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83222411|NCT02702011|Empagliflozin|empagliflozin|mesh-list
83222412|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83222413|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222414|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83222415|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222416|NCT03170713|Ibuprofen|ibuprofen|mesh-list
83222417|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83222418|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83222419|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83222420|NCT03170713|Analgesics|analgesics|mesh-ancestor
83222421|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
83222422|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222423|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222424|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222425|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222426|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83222427|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222428|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222429|NCT02657369|Lenvatinib|lenvatinib|mesh-list
83222430|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222431|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83222432|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222433|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222434|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
83222435|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83222436|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222437|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83222438|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222439|NCT04952779|Insulin|insulin|mesh-list
83222440|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83222441|NCT04952779|Liraglutide|liraglutide|mesh-list
83222442|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
83222443|NCT04952779|Xultophy|xultophy|mesh-list
83222444|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83222445|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222446|NCT04952779|Incretins|incretins|mesh-ancestor
83222447|NCT04952779|Hormones|hormones|mesh-ancestor
83222448|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83222449|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
83222450|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83222452|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222453|NCT04832009|Protective Agents|protective agents|mesh-ancestor
83222454|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222455|NCT04832009|Vitamins|vitamins|mesh-ancestor
83222456|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
83222457|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83222458|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83222459|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83222460|NCT03129113|Metformin|metformin|mesh-list
83222461|NCT03129113|Maraviroc|maraviroc|mesh-list
83222462|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83222463|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222464|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83222465|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83222466|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222467|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83222468|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83222469|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
83222470|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222471|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83222472|NCT05105009|Furosemide|furosemide|mesh-list
83222473|NCT05105009|Diuretics|diuretics|mesh-ancestor
83222474|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
83222475|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222476|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83222477|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83222478|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222479|NCT05104931|Piroxicam|piroxicam|mesh-list
83222480|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83222481|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83222482|NCT05104931|Analgesics|analgesics|mesh-ancestor
83222483|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
83222484|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222485|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222486|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222487|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222488|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83222489|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222490|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222491|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83222492|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83222493|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
83222494|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222495|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222496|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83222497|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83222498|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83222499|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83222500|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83222501|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
83222502|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222503|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222504|NCT02406703|Mepivacaine|mepivacaine|mesh-list
83222505|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
83222506|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
83222507|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
83222508|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222509|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222510|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
83222511|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222512|NCT02682641|Rituximab|rituximab|mesh-list
83222513|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222514|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222515|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
83222516|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222517|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222518|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
83222519|NCT05110469|Meperidine|meperidine|mesh-list
83222520|NCT05110469|Analgesics|analgesics|mesh-ancestor
83222521|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
83222522|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222523|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222524|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
83222525|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222526|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83222527|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
83222528|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83222529|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83222530|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222531|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83222532|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
83222533|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83222534|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83222535|NCT05110469|Narcotics|narcotics|mesh-ancestor
83222536|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83222537|NCT02404051|Everolimus|everolimus|mesh-list
83222538|NCT02404051|Fulvestrant|fulvestrant|mesh-list
83222539|NCT02404051|Exemestane|exemestane|mesh-list
83222540|NCT02404051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83222541|NCT02404051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83222542|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222543|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222544|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83222545|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
83222546|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222547|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222548|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83222549|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83222550|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83222551|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
83222552|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83222553|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83222554|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83222555|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83222556|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
83222557|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222558|NCT05094323|Bupivacaine|bupivacaine|mesh-list
83222559|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
83222560|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
83222561|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222562|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222563|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
83222564|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222565|NCT03170323|Cyclosporine|cyclosporine|mesh-list
83222566|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
83222567|NCT03170323|Cyclosporins|cyclosporins|mesh-list
83222568|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222569|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222570|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83222571|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
83222572|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222573|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
83222574|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222575|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
83222576|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222577|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83222578|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83222579|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222580|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83222581|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
83222582|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83222583|NCT02396563|Ropivacaine|ropivacaine|mesh-list
83222584|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
83222585|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
83222586|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222587|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222588|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
83222589|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222590|NCT05109377|Tadalafil|tadalafil|mesh-list
83222591|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
83222592|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83222593|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83222594|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222595|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222596|NCT05109377|Urological Agents|urological agents|mesh-ancestor
83222597|NCT05109299|Fluorides|fluorides|mesh-list
83222598|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
83222599|NCT05109299|Protective Agents|protective agents|mesh-ancestor
83222600|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222601|NCT05108597|Misoprostol|misoprostol|mesh-list
83222602|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83222603|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
83222604|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83222605|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222606|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83222607|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83222608|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
83222609|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
83222610|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
83222611|NCT02396329|Povidone|povidone|mesh-list
83222612|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83222613|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222614|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
83222615|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
83222616|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
83222617|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
83222618|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222619|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222620|NCT03168139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83222621|NCT03168139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222622|NCT02395783|Melatonin|melatonin|mesh-list
83222623|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
83222624|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222625|NCT02395783|Protective Agents|protective agents|mesh-ancestor
83222626|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222627|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222628|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
83222629|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83222630|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83222631|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222632|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
83222633|NCT04555343|Coagulants|coagulants|mesh-ancestor
83222634|NCT04528667|Abivertinib|abivertinib|mesh-list
83222635|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222636|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222637|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83222638|NCT04383119|Gemcitabine|gemcitabine|mesh-list
83222639|NCT04383119|Trabectedin|trabectedin|mesh-list
83222640|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83222641|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
83222642|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222643|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222644|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83222645|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
83222646|NCT04522739|Spironolactone|spironolactone|mesh-list
83222647|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83222648|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
83222649|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83222650|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222651|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83222652|NCT04522739|Diuretics|diuretics|mesh-ancestor
83222653|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
83222654|NCT04309877|Theophylline|theophylline|mesh-list
83222655|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83222656|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
83222657|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222658|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222659|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83222660|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
83222661|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83222662|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222663|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222664|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
83222665|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83222666|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83222667|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
83222668|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222669|NCT04367909|Carboplatin|carboplatin|mesh-list
83222670|NCT04367909|Docetaxel|docetaxel|mesh-list
83222671|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
83222672|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222673|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
83222674|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
83222675|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
83222676|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222677|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222679|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83222680|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
83222681|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83222682|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222683|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83222684|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83222685|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83222686|NCT04196075|Andrographolide|andrographolide|mesh-list
83222687|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222688|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83222690|NCT04196075|Analgesics|analgesics|mesh-ancestor
83222691|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
83222692|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222693|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222694|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222695|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83222696|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83222697|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222698|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
83222699|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83222700|NCT03863483|Docetaxel|docetaxel|mesh-list
83222701|NCT03863483|Pemetrexed|pemetrexed|mesh-list
83222702|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222703|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
83222704|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
83222705|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
83222706|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222707|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222708|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83222709|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83222710|NCT03830411|Docetaxel|docetaxel|mesh-list
83222711|NCT03830411|Pemetrexed|pemetrexed|mesh-list
83222712|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222713|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
83222714|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
83222715|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
83222716|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222717|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222718|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83222719|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83222720|NCT03300479|Urapidil|urapidil|mesh-list
83222721|NCT03300479|Clevidipine|clevidipine|mesh-list
83222722|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83222723|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83222724|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222725|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83222726|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222727|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83222728|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
83222729|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83222730|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
83222731|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222732|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83222733|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83222734|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83222735|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83222736|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
83222737|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222738|NCT03540875|Remifentanil|remifentanil|mesh-list
83222739|NCT03540875|Propofol|propofol|mesh-list
83222740|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
83222741|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222742|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222743|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83222744|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83222745|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
83222746|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83222747|NCT03540875|Narcotics|narcotics|mesh-ancestor
83222748|NCT03540875|Analgesics|analgesics|mesh-ancestor
83222749|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
83222750|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222751|NCT03536507|Acetazolamide|acetazolamide|mesh-list
83222752|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
83222753|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83222754|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222755|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222756|NCT03536507|Diuretics|diuretics|mesh-ancestor
83222757|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
83222758|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222759|NCT04765787|Acetaminophen|acetaminophen|mesh-list
83222760|NCT04765787|Orphenadrine|orphenadrine|mesh-list
83222761|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83222762|NCT04765787|Analgesics|analgesics|mesh-ancestor
83222763|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
83222764|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222765|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222767|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83222768|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83222769|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83222770|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83222771|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
83222772|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
83222773|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83222774|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83222775|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
83222776|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222777|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222778|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83222779|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83222780|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222781|NCT02944799|Vitamin D|vitamin d|mesh-list
83222782|NCT02944799|Alendronate|alendronate|mesh-list
83222783|NCT02944799|Calcium|calcium|mesh-list
83222784|NCT02944799|Vitamins|vitamins|mesh-ancestor
83222785|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
83222786|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222787|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83222788|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83222789|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83222790|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
83222791|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222792|NCT05115149|Protective Agents|protective agents|mesh-ancestor
83222793|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222794|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83222795|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222796|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83222797|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222798|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
83222799|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
83222800|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83222801|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83222802|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222803|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
83222804|NCT04521881|Coagulants|coagulants|mesh-ancestor
83222805|NCT04305899|Deucravacitinib|deucravacitinib|mesh-list
83222806|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
83222807|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83222808|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222809|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222810|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
83222811|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83222812|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
83222813|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222814|NCT01675661|Expectorants|expectorants|mesh-ancestor
83222815|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
83222816|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83222817|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
83222818|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222819|NCT01675661|Protective Agents|protective agents|mesh-ancestor
83222820|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222821|NCT01675661|Antidotes|antidotes|mesh-ancestor
83222822|NCT05113511|Bevacizumab|bevacizumab|mesh-list
83222823|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83222824|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222825|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83222826|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83222827|NCT05113511|Growth Substances|growth substances|mesh-ancestor
83222828|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222829|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
83222830|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83222832|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83222833|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83222834|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
83222835|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222836|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83222837|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83222838|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222839|NCT04161989|Progesterone|progesterone|mesh-list
83222840|NCT04161989|Progestins|progestins|mesh-ancestor
83222841|NCT04161989|Hormones|hormones|mesh-ancestor
83222842|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83222843|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222844|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
83222845|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83222846|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
83222847|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222848|NCT01986010|Antacids|antacids|mesh-ancestor
83222849|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222850|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83222851|NCT04160117|Colchicine|colchicine|mesh-list
83222852|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
83222853|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222854|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
83222855|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
83222856|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
83222857|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222858|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222859|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83222860|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83222861|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83222862|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
83222863|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222864|NCT03115255|Ranibizumab|ranibizumab|mesh-list
83222865|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83222866|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83222867|NCT03115255|Growth Substances|growth substances|mesh-ancestor
83222868|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222869|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
83222870|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222871|NCT02009878|Tolvaptan|tolvaptan|mesh-list
83222872|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83222873|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222874|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
83222875|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222876|NCT02009722|Morphine|morphine|mesh-list
83222877|NCT02009722|Hydromorphone|hydromorphone|mesh-list
83222878|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83222879|NCT02009722|Narcotics|narcotics|mesh-ancestor
83222880|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222881|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222882|NCT02009722|Analgesics|analgesics|mesh-ancestor
83222883|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
83222884|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222885|NCT02655419|Metronidazole|metronidazole|mesh-list
83222886|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222887|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83222888|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83222889|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83222890|NCT01962922|Tacrolimus|tacrolimus|mesh-list
83222891|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83222892|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
83222893|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222894|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83222895|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222896|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222897|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
83222898|NCT04198961|Narcotics|narcotics|mesh-ancestor
83222899|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83222900|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222902|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
83222903|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222904|NCT01984684|Vancomycin|vancomycin|mesh-list
83222905|NCT01984684|Aztreonam|aztreonam|mesh-list
83222906|NCT01984684|Delafloxacin|delafloxacin|mesh-list
83222907|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83222908|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222909|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
83222910|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222911|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
83222912|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83222913|NCT04585841|Cannabidiol|cannabidiol|mesh-list
83222914|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
83222915|NCT02694523|Adalimumab|adalimumab|mesh-list
83222916|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83222917|NCT02694523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83222918|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83222919|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222920|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
83222921|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222922|NCT05038475|Antibodies|antibodies|mesh-list
83222923|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
83222924|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222925|NCT02009332|Sirolimus|sirolimus|mesh-list
83222926|NCT02009332|Gemcitabine|gemcitabine|mesh-list
83222927|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83222928|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
83222929|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222930|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222931|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83222932|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222933|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83222934|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
83222935|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83222936|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
83222937|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222938|NCT04518293|Amlodipine|amlodipine|mesh-list
83222939|NCT04518293|Telmisartan|telmisartan|mesh-list
83222940|NCT04518293|Indapamide|indapamide|mesh-list
83222941|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83222942|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83222943|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83222944|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222945|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83222946|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222947|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
83222948|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83222949|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83222950|NCT04518293|Diuretics|diuretics|mesh-ancestor
83222951|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
83222952|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83222953|NCT01984294|Ribavirin|ribavirin|mesh-list
83222954|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
83222955|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83222956|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
83222957|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222958|NCT03170479|Vitamin D|vitamin d|mesh-list
83222959|NCT03170479|Vitamins|vitamins|mesh-ancestor
83222960|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
83222961|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222962|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83222963|NCT01962298|Rocuronium|rocuronium|mesh-list
83222964|NCT01962298|Neostigmine|neostigmine|mesh-list
83222965|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83222966|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83222967|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83222968|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222969|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222970|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83222971|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83222972|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222973|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
83222974|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83222975|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83222976|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
83222977|NCT03169933|Androgens|androgens|mesh-list
83222978|NCT03169933|Hormones|hormones|mesh-ancestor
83222979|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83222980|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222981|NCT04416334|Acetaminophen|acetaminophen|mesh-list
83222982|NCT04416334|Colchicine|colchicine|mesh-list
83222983|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83222984|NCT04416334|Analgesics|analgesics|mesh-ancestor
83222985|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
83222986|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83222987|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83222988|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
83222989|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
83222990|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83222991|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
83222992|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
83222993|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
83222994|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83222995|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83222996|NCT02403349|Atenolol|atenolol|mesh-list
83222997|NCT02403349|Valsartan|valsartan|mesh-list
83222998|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83222999|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83223000|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83223001|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223002|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83223003|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
83223004|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
83223005|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223006|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223007|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83223008|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83223009|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83223010|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
83223011|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223012|NCT04735822|Belumosudil|belumosudil|mesh-list
83223013|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83223014|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223015|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223016|NCT01984138|Estradiol|estradiol|mesh-list
83223017|NCT01984138|Estrogens|estrogens|mesh-ancestor
83223018|NCT01984138|Hormones|hormones|mesh-ancestor
83223019|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223020|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223021|NCT01982812|Levetiracetam|levetiracetam|mesh-list
83223022|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
83223023|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
83223024|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
83223025|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83223026|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223027|NCT02007070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83223028|NCT02007070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223029|NCT03906617|Dexamethasone|dexamethasone|mesh-list
83223030|NCT03906617|Epinephrine|epinephrine|mesh-list
83223031|NCT03906617|Bupivacaine|bupivacaine|mesh-list
83223032|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223033|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
83223034|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
83223035|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223036|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223037|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83223038|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
83223039|NCT03906617|Hormones|hormones|mesh-ancestor
83223040|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223041|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83223042|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223043|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223044|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
83223045|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223046|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
83223047|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83223048|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83223049|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
83223050|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223051|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223052|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83223053|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83223054|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83223055|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
83223056|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
83223057|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
83223058|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83223059|NCT04655482|Aflibercept|aflibercept|mesh-list
83223060|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83223061|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83223062|NCT04655482|Growth Substances|growth substances|mesh-ancestor
83223063|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223064|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
83223065|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223066|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
83223067|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223068|NCT02184767|Loxapine|loxapine|mesh-list
83223069|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83223070|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83223071|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223072|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223073|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83223074|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83223075|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
83223076|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223077|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223078|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
83223079|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83223080|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83223081|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
83223082|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223083|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223084|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223085|NCT01981954|Urological Agents|urological agents|mesh-ancestor
83223086|NCT03727139|Rasagiline|rasagiline|mesh-list
83223087|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83223088|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223089|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223090|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83223091|NCT03727139|Protective Agents|protective agents|mesh-ancestor
83223092|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223093|NCT05120687|Cyclosporine|cyclosporine|mesh-list
83223094|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
83223095|NCT05120687|Adalimumab|adalimumab|mesh-list
83223096|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
83223097|NCT05120687|Methotrexate|methotrexate|mesh-list
83223098|NCT05120687|Cyclosporins|cyclosporins|mesh-list
83223099|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83223100|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
83223101|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223102|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223103|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83223104|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
83223105|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223106|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223107|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83223108|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83223109|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
83223110|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83223111|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83223112|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
83223113|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
83223114|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223115|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83223116|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83223117|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
83223118|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223119|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83223120|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83223121|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83223122|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
83223123|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83223124|NCT05120687|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83223125|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223128|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223129|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223130|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83223131|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83223132|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223133|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83223134|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83223135|NCT04224545|Colchicine|colchicine|mesh-list
83223136|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
83223137|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223138|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
83223139|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
83223140|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
83223141|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223142|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223143|NCT05121233|Diclofenac|diclofenac|mesh-list
83223144|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83223145|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223146|NCT05121233|Analgesics|analgesics|mesh-ancestor
83223147|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
83223148|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223149|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223150|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223151|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223152|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83223153|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223154|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223155|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83223156|NCT05745259|Tenecteplase|tenecteplase|mesh-list
83223157|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83223158|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83223159|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223160|NCT02893241|Theodrenaline|theodrenaline|mesh-list
83223161|NCT02893241|Cafedrine|cafedrine|mesh-list
83223162|NCT02893241|Ephedrine|ephedrine|mesh-list
83223163|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83223164|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223165|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
83223166|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
83223167|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223168|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83223169|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83223170|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223171|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223172|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83223173|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
83223174|NCT02395237|Glimepiride|glimepiride|mesh-list
83223175|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83223176|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223177|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223178|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83223179|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
83223180|NCT02394847|Propofol|propofol|mesh-list
83223181|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83223182|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223183|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223184|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83223185|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
83223186|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
83223187|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
83223188|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83223189|NCT05021861|Estradiol|estradiol|mesh-list
83223190|NCT05021861|Cyproterone|cyproterone|mesh-list
83223191|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
83223192|NCT05021861|Estrogens|estrogens|mesh-ancestor
83223193|NCT05021861|Hormones|hormones|mesh-ancestor
83223194|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223195|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223196|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83223197|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
83223198|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83223199|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83223200|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83223201|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83223202|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
83223203|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
83223204|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223205|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83223206|NCT02403037|Dexamethasone|dexamethasone|mesh-list
83223207|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
83223208|NCT02403037|Antiemetics|antiemetics|mesh-list
83223209|NCT02403037|Emetics|emetics|mesh-list
83223210|NCT02403037|BB 1101|bb 1101|mesh-list
83223211|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223212|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
83223213|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223214|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223215|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83223216|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
83223217|NCT02403037|Hormones|hormones|mesh-ancestor
83223218|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223219|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83223220|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223221|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
83223222|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223223|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223224|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
83223225|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83223226|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223227|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83223228|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83223229|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
83223230|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223231|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
83223232|NCT04480333|Remdesivir|remdesivir|mesh-list
83223233|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
83223234|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223235|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
83223236|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223237|NCT04480333|Protective Agents|protective agents|mesh-ancestor
83223238|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223239|NCT03166891|Chiauranib|chiauranib|mesh-list
83223240|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223241|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83223242|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223243|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223244|NCT01980940|Etoricoxib|etoricoxib|mesh-list
83223245|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83413585|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223246|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83223247|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223248|NCT01980940|Analgesics|analgesics|mesh-ancestor
83223249|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
83223250|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223251|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223252|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223253|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223254|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83223255|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83223256|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223257|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223258|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83223259|NCT01980940|Protective Agents|protective agents|mesh-ancestor
83223260|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83223261|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
83223262|NCT01960114|Acetaminophen|acetaminophen|mesh-list
83223263|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223264|NCT01960114|Analgesics|analgesics|mesh-ancestor
83223265|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
83223266|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223267|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223268|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
83223269|NCT04752527|Sorafenib|sorafenib|mesh-list
83223270|NCT04752527|Decitabine|decitabine|mesh-list
83223271|NCT04752527|Venetoclax|venetoclax|mesh-list
83223272|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223273|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83223274|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223275|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223276|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83223277|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
83223278|NCT05229497|Carboplatin|carboplatin|mesh-list
83223279|NCT05229497|Fluorouracil|fluorouracil|mesh-list
83223280|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223281|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
83223282|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223283|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83223284|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83223285|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
83223286|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223287|NCT03169777|Leucovorin|leucovorin|mesh-list
83223288|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
83223289|NCT03169777|Bevacizumab|bevacizumab|mesh-list
83223290|NCT03169777|Fluorouracil|fluorouracil|mesh-list
83223291|NCT03169777|Capecitabine|capecitabine|mesh-list
83223292|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
83223293|NCT03169777|Nivolumab|nivolumab|mesh-list
83223294|NCT03169777|Cetuximab|cetuximab|mesh-list
83223295|NCT03169777|Fulvestrant|fulvestrant|mesh-list
83223296|NCT03169777|Avelumab|avelumab|mesh-list
83223297|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223298|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223299|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83223300|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
83223301|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223302|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223303|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83223304|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
83223305|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83223306|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83223307|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83223308|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83223309|NCT03169777|Growth Substances|growth substances|mesh-ancestor
83223310|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
83223311|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
83223312|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83223313|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83223314|NCT03169777|Antidotes|antidotes|mesh-ancestor
83223315|NCT03169777|Protective Agents|protective agents|mesh-ancestor
83223316|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
83223317|NCT03169777|Vitamins|vitamins|mesh-ancestor
83223318|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
83223319|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83223320|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83223321|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83223322|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
83223323|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223324|NCT01980706|Baclofen|baclofen|mesh-list
83223325|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83223326|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223327|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83223328|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223329|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83223330|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
83223331|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
83223332|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223333|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223334|NCT02092571|Progesterone|progesterone|mesh-list
83223335|NCT02092571|Progestins|progestins|mesh-ancestor
83223336|NCT02092571|Hormones|hormones|mesh-ancestor
83223337|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223338|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223339|NCT02402725|Dexamethasone|dexamethasone|mesh-list
83223340|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
83223341|NCT02402725|BB 1101|bb 1101|mesh-list
83223342|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223343|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
83223344|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
83223345|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223346|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223347|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83223348|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
83223349|NCT02402725|Hormones|hormones|mesh-ancestor
83223350|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223351|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83223352|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223354|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223355|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223356|NCT02394145|Clopidogrel|clopidogrel|mesh-list
83223357|NCT02394145|Ticagrelor|ticagrelor|mesh-list
83223358|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83223359|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83223360|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83223361|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83223362|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
83223363|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223364|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223365|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223366|NCT02004886|Metformin|metformin|mesh-list
83223367|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223368|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223369|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
83223370|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83223371|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223372|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
83223373|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83223374|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83223375|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
83223376|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
83223377|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83223378|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83223379|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
83223380|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
83223381|NCT04255277|Charcoal|charcoal|mesh-list
83223382|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83223383|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223384|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83223385|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83223386|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223387|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223388|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223389|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83223390|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83223391|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223392|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83223393|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83223394|NCT04255277|Antidotes|antidotes|mesh-ancestor
83223395|NCT04255277|Protective Agents|protective agents|mesh-ancestor
83223396|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83223397|NCT04255277|Estrogens|estrogens|mesh-ancestor
83223398|NCT04255277|Hormones|hormones|mesh-ancestor
83223399|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223400|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83223401|NCT04435925|Fentanyl|fentanyl|mesh-list
83223402|NCT04435925|Remifentanil|remifentanil|mesh-list
83223403|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83223404|NCT04435925|Narcotics|narcotics|mesh-ancestor
83223405|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223406|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223407|NCT04435925|Analgesics|analgesics|mesh-ancestor
83223408|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
83223409|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223410|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83223411|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83223412|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
83223413|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
83223414|NCT04649476|Cisplatin|cisplatin|mesh-list
83223415|NCT04649476|Docetaxel|docetaxel|mesh-list
83223416|NCT04649476|Fluorouracil|fluorouracil|mesh-list
83223417|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223418|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
83223419|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
83223420|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
83223421|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223422|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
83223423|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83223424|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83223425|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
83223426|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223427|NCT05117957|Sorafenib|sorafenib|mesh-list
83223428|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223429|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83223430|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223431|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223433|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83223434|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223435|NCT04507919|Dabrafenib|dabrafenib|mesh-list
83223436|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223437|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83223438|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223439|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223440|NCT03251729|Progesterone|progesterone|mesh-list
83223441|NCT03251729|Progestins|progestins|mesh-ancestor
83223442|NCT03251729|Hormones|hormones|mesh-ancestor
83223443|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223444|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223445|NCT02696785|Adalimumab|adalimumab|mesh-list
83223446|NCT02696785|Ixekizumab|ixekizumab|mesh-list
83223447|NCT02696785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83223448|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223449|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223450|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83223452|NCT02004262|Pancrelipase|pancrelipase|mesh-list
83223453|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83223454|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
83223455|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223456|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223457|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83223458|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
83223459|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223460|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223461|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83223462|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83223463|NCT02393599|Cocaine|cocaine|mesh-list
83223464|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223465|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
83223466|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223467|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223468|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
83223469|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223470|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83223471|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83223472|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83223473|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83223474|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223475|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
83223476|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223477|NCT02402491|Aspirin|aspirin|mesh-list
83223478|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
83223479|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83223480|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223481|NCT02402491|Analgesics|analgesics|mesh-ancestor
83223482|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
83223483|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223484|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223485|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223486|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223487|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83223488|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83223489|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223490|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83223491|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83223492|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223493|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
83223494|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83223495|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83223496|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
83223497|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223498|NCT02402413|Androgens|androgens|mesh-list
83223499|NCT02402413|Hormones|hormones|mesh-ancestor
83223500|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223501|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223502|NCT02393443|Oxytocin|oxytocin|mesh-list
83223503|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
83223504|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83223505|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223506|NCT01977898|Morphine|morphine|mesh-list
83223507|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83223508|NCT01977898|Narcotics|narcotics|mesh-ancestor
83223509|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223510|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223511|NCT01977898|Analgesics|analgesics|mesh-ancestor
83223512|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
83223513|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223514|NCT05744479|Metformin|metformin|mesh-list
83223515|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223516|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223518|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83223519|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
83223520|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223521|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83223522|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
83223523|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
83223524|NCT02003638|Vitamins|vitamins|mesh-ancestor
83223525|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
83223526|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223527|NCT04649398|Nimodipine|nimodipine|mesh-list
83223528|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83223529|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83223530|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83223531|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223532|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83223533|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223534|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
83223535|NCT02402179|Tryptophan|tryptophan|mesh-list
83223536|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83223537|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
83223538|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83223539|NCT02401945|Aflibercept|aflibercept|mesh-list
83223540|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83223541|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83223542|NCT02401945|Growth Substances|growth substances|mesh-ancestor
83223543|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223544|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
83223545|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223546|NCT02003014|Pioglitazone|pioglitazone|mesh-list
83223547|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223548|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223549|NCT01977352|Bupivacaine|bupivacaine|mesh-list
83223550|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223551|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
83223552|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223553|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223554|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
83223555|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223556|NCT03166111|Lidocaine|lidocaine|mesh-list
83223557|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223558|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
83223559|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223560|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223561|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
83223562|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223563|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83223564|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83223565|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83223566|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83223567|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223568|NCT05117021|Bupivacaine|bupivacaine|mesh-list
83223569|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223570|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
83223571|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223572|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223573|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
83223574|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223575|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83223576|NCT02392117|Insulin|insulin|mesh-list
83223577|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223578|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223579|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
83223580|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
83223581|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83223582|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83223583|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223584|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223585|NCT02812433|Urological Agents|urological agents|mesh-ancestor
83223586|NCT02392039|Loratadine|loratadine|mesh-list
83223587|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
83223588|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
83223589|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83223590|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83223591|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83223592|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
83223593|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
83223594|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223595|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223596|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223597|NCT03106363|Ethanol|ethanol|mesh-list
83223598|NCT03106363|Dronabinol|dronabinol|mesh-list
83223599|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83223600|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223601|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223602|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223603|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
83223604|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83223605|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223606|NCT03106363|Analgesics|analgesics|mesh-ancestor
83223607|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
83223608|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223609|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83223610|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83223611|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223612|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223613|NCT03106363|Hormones|hormones|mesh-ancestor
83223614|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223615|NCT03106519|Bupivacaine|bupivacaine|mesh-list
83223616|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223617|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
83223618|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223619|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223620|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
83223621|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223622|NCT02687815|Vitamin D|vitamin d|mesh-list
83223623|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
83223624|NCT02687815|Vitamins|vitamins|mesh-ancestor
83223625|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
83223626|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223627|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83223628|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83223629|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
83223630|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83223631|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223632|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
83223633|NCT01959334|Glucagon|glucagon|mesh-list
83223634|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83223635|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83223636|NCT01959334|Hormones|hormones|mesh-ancestor
83223637|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223638|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223639|NCT01959334|Incretins|incretins|mesh-ancestor
83223640|NCT01958476|Morphine|morphine|mesh-list
83223641|NCT01958476|Methadone|methadone|mesh-list
83223642|NCT01958476|Phenobarbital|phenobarbital|mesh-list
83223643|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83223644|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83223645|NCT01958476|Narcotics|narcotics|mesh-ancestor
83223646|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223647|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223648|NCT01958476|Analgesics|analgesics|mesh-ancestor
83223649|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
83223650|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223651|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
83223652|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
83223653|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
83223655|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83223656|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83223657|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223658|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223659|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
83223660|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
83223661|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83223662|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83223663|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83223664|NCT04809181|Azacitidine|azacitidine|mesh-list
83223665|NCT04809181|Venetoclax|venetoclax|mesh-list
83223666|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83223667|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
83223668|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223669|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223670|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223671|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83223672|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83223673|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223674|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223675|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
83223676|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223677|NCT01057121|Lenalidomide|lenalidomide|mesh-list
83223678|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
83223679|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223680|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83223681|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83223682|NCT01057121|Growth Substances|growth substances|mesh-ancestor
83223683|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
83223684|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223685|NCT02695537|Cannabidiol|cannabidiol|mesh-list
83223686|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
83223687|NCT04620941|Chrysarobin|chrysarobin|mesh-list
83223688|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83223689|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223690|NCT04620941|Analgesics|analgesics|mesh-ancestor
83223691|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
83223692|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223693|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223694|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223695|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223696|NCT04210349|Vaccines|vaccines|mesh-list
83223697|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
83223698|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223699|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
83223700|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223701|NCT04746989|Allopurinol|allopurinol|mesh-list
83223702|NCT04746989|Probenecid|probenecid|mesh-list
83223703|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
83223704|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223705|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223706|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
83223707|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223708|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83223709|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
83223710|NCT04746989|Protective Agents|protective agents|mesh-ancestor
83223711|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223712|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
83223713|NCT04393103|Atropine|atropine|mesh-list
83223714|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83223715|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83223716|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83223717|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83223718|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
83223719|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223720|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223721|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83223722|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
83223723|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
83223724|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
83223725|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83223726|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83223727|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
83223728|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223729|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223730|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83223731|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83223732|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83223733|NCT04671953|Metformin|metformin|mesh-list
83223734|NCT04671953|Deucravacitinib|deucravacitinib|mesh-list
83223735|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223736|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223737|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
83223738|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83223739|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223740|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223741|NCT04585061|Lidocaine|lidocaine|mesh-list
83223742|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223743|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
83223744|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223745|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223746|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
83223747|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223748|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83223749|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83223750|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83223751|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83223752|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223753|NCT03874091|Epinephrine|epinephrine|mesh-list
83223754|NCT03874091|Racepinephrine|racepinephrine|mesh-list
83223755|NCT03874091|Morphine|morphine|mesh-list
83223756|NCT03874091|Bupivacaine|bupivacaine|mesh-list
83223757|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
83223758|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
83223759|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
83223760|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223761|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223762|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
83223763|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223764|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83223765|NCT03874091|Narcotics|narcotics|mesh-ancestor
83223766|NCT03874091|Analgesics|analgesics|mesh-ancestor
83223767|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83223768|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83223769|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
83223770|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223771|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223772|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83223773|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83223774|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
83223775|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83223776|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
83223777|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
83223778|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
83223779|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83223780|NCT01362491|Ibuprofen|ibuprofen|mesh-list
83223781|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83223782|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223783|NCT01362491|Analgesics|analgesics|mesh-ancestor
83223784|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
83223785|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223786|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223787|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223788|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223789|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83223790|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223791|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223792|NCT03560297|Nitrazepam|nitrazepam|mesh-list
83223793|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
83223794|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83223795|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223796|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223797|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83223798|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83223799|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83223800|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
83223801|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
83223802|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223803|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223804|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83223805|NCT04122287|Levofloxacin|levofloxacin|mesh-list
83223806|NCT04122287|Tinidazole|tinidazole|mesh-list
83223807|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83223808|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223809|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83223810|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83223811|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83223812|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223813|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223814|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223815|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83223816|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83223817|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
83223818|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83223819|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83223820|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83223821|NCT05746351|Fentanyl|fentanyl|mesh-list
83223822|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
83223823|NCT05746351|Nalbuphine|nalbuphine|mesh-list
83223824|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83223825|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223826|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223827|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223828|NCT05746351|Analgesics|analgesics|mesh-ancestor
83223829|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
83223830|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223831|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83223832|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83223833|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83223834|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83223835|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223836|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223837|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83223838|NCT05746351|Narcotics|narcotics|mesh-ancestor
83223839|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83223840|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83223841|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
83223842|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
83223843|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83223844|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
83223845|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223846|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223847|NCT05403281|Incretins|incretins|mesh-ancestor
83223848|NCT05403281|Hormones|hormones|mesh-ancestor
83223849|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223850|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83223851|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
83223852|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223853|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223854|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83223855|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83223856|NCT03115099|Liraglutide|liraglutide|mesh-list
83223857|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83223858|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223859|NCT03115099|Incretins|incretins|mesh-ancestor
83223861|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83223862|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83223863|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
83223864|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223865|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223866|NCT03165097|ACT-709478|act-709478|mesh-list
83223867|NCT03165097|Midazolam|midazolam|mesh-list
83223868|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83223869|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83223870|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83223871|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223872|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83223873|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83223874|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83223875|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83223876|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
83223877|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
83223878|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
83223879|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
83223880|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223881|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223882|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83223883|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83223884|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83223885|NCT03165409|Nivolumab|nivolumab|mesh-list
83223886|NCT03165409|Ipilimumab|ipilimumab|mesh-list
83223887|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83223888|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223889|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83223890|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223891|NCT05403125|Listerine|listerine|mesh-list
83223892|NCT05403125|Fluorides|fluorides|mesh-list
83223893|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
83223894|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
83223895|NCT05403125|Protective Agents|protective agents|mesh-ancestor
83223896|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223897|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83223898|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223899|NCT05701423|Natalizumab|natalizumab|mesh-list
83223900|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
83223901|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223902|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
83223903|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
83223904|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83223905|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83223906|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223907|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223908|NCT02795351|Urological Agents|urological agents|mesh-ancestor
83223909|NCT05403047|Tenofovir|tenofovir|mesh-list
83223910|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
83223911|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223912|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83223913|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83223914|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223915|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223916|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83223917|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83223918|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
83223919|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83223920|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223921|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83223922|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83223923|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223924|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223925|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223926|NCT03927443|Bimatoprost|bimatoprost|mesh-list
83223927|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83223928|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
83223929|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83223930|NCT05124353|Protective Agents|protective agents|mesh-ancestor
83223931|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223932|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
83223933|NCT03913247|Metronidazole|metronidazole|mesh-list
83223934|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223935|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83223936|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83223937|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83223938|NCT03805841|Bromides|bromides|mesh-list
83223939|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
83223940|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
83223941|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83223942|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223943|NCT02684617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83223944|NCT02684617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223945|NCT01999972|Axitinib|axitinib|mesh-list
83223946|NCT01999972|Crizotinib|crizotinib|mesh-list
83223947|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83223948|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83223949|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223950|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223951|NCT04055389|Antithrombins|antithrombins|mesh-list
83223952|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
83223953|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83223954|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
83223955|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223956|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223957|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
83223958|NCT05697055|Ritonavir|ritonavir|mesh-list
83223959|NCT05697055|Nirmatrelvir|nirmatrelvir|mesh-list
83223960|NCT05697055|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83223961|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83223962|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83223963|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
83223964|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83223965|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223966|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83223967|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83223968|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
83223969|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223970|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83223971|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83223972|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
83223973|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83223974|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83223975|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83223976|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83223977|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83223978|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
83223979|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83223980|NCT01999894|Memantine|memantine|mesh-list
83223981|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83223982|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83223983|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
83223984|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83223985|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83223986|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223987|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83223988|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83223989|NCT01976806|Aspirin|aspirin|mesh-list
83223990|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83223991|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83223992|NCT01976806|Analgesics|analgesics|mesh-ancestor
83223993|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
83223994|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83223995|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83223996|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83223997|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83223998|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83223999|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83224000|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224001|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83224002|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83224003|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224004|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
83224005|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83224006|NCT01976728|Hormones|hormones|mesh-ancestor
83224007|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224008|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224009|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83224010|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224011|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224012|NCT02689219|Immunotoxins|immunotoxins|mesh-ancestor
83224013|NCT02689219|Immunoconjugates|immunoconjugates|mesh-ancestor
83224014|NCT02689219|Immunologic Factors|immunologic factors|mesh-ancestor
83224015|NCT02689219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224016|NCT03165253|Amoxicillin|amoxicillin|mesh-list
83224017|NCT03165253|Clarithromycin|clarithromycin|mesh-list
83224018|NCT03165253|Omeprazole|omeprazole|mesh-list
83224019|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224020|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224021|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83224022|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224023|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83224024|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224025|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224026|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83224027|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83224028|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83224029|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83224030|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83224031|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224032|NCT04718389|Benralizumab|benralizumab|mesh-list
83224033|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83224034|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
83224035|NCT03161977|Mannitol|mannitol|mesh-list
83224036|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83224037|NCT03161977|Diuretics|diuretics|mesh-ancestor
83224038|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
83224039|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224040|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83224041|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83224042|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224043|NCT02683525|Incretins|incretins|mesh-ancestor
83224044|NCT02683525|Hormones|hormones|mesh-ancestor
83224045|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224046|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83224047|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
83224048|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224049|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224050|NCT01976338|Ranibizumab|ranibizumab|mesh-list
83224051|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224052|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83224053|NCT01976338|Growth Substances|growth substances|mesh-ancestor
83224054|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224055|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
83224056|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224057|NCT02651987|Lanreotide|lanreotide|mesh-list
83224058|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224059|NCT05115773|Anesthetics|anesthetics|mesh-list
83224060|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224061|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224063|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224064|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224065|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224066|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224067|NCT04657939|Pioglitazone|pioglitazone|mesh-list
83224068|NCT04657939|Liraglutide|liraglutide|mesh-list
83224069|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83224070|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224071|NCT04657939|Incretins|incretins|mesh-ancestor
83224072|NCT04657939|Hormones|hormones|mesh-ancestor
83224073|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224074|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
83224075|NCT01999114|Naltrexone|naltrexone|mesh-list
83224076|NCT01999114|Buprenorphine|buprenorphine|mesh-list
83224077|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83224078|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224079|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224080|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83224081|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83224082|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224083|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224084|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224085|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83224086|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
83224087|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83224088|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224089|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83224090|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83224091|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83224092|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83224093|NCT01999114|Narcotics|narcotics|mesh-ancestor
83224094|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224095|NCT01999114|Analgesics|analgesics|mesh-ancestor
83224096|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
83224097|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224098|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83224099|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83224100|NCT04500275|Vancomycin|vancomycin|mesh-list
83224101|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224102|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224103|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83224104|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83224105|NCT04503161|Estradiol|estradiol|mesh-list
83224106|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83224107|NCT04503161|Estrogens|estrogens|mesh-ancestor
83224108|NCT04503161|Hormones|hormones|mesh-ancestor
83224109|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224110|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224111|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83224112|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
83224113|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83224114|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83224115|NCT02214407|Decitabine|decitabine|mesh-list
83224116|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
83224117|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83224118|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
83224119|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224120|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224121|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224122|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
83224123|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83224124|NCT01899989|Carboplatin|carboplatin|mesh-list
83224125|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224126|NCT02261285|Nivolumab|nivolumab|mesh-list
83224127|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224128|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224129|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83224130|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224131|NCT01288625|Amifostine|amifostine|mesh-list
83224132|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83224133|NCT01288625|Protective Agents|protective agents|mesh-ancestor
83224134|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224135|NCT01374451|Everolimus|everolimus|mesh-list
83224136|NCT01374451|Pasireotide|pasireotide|mesh-list
83224137|NCT01374451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83224138|NCT01374451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224139|NCT01374451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224140|NCT01374451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224141|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224142|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
83224143|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224144|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224145|NCT01374451|Hormones|hormones|mesh-ancestor
83224146|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224147|NCT02674399|Hylan|hylan|mesh-list
83224148|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
83224149|NCT02674399|Protective Agents|protective agents|mesh-ancestor
83224150|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224151|NCT03161509|Acetaminophen|acetaminophen|mesh-list
83224152|NCT03161509|Lamotrigine|lamotrigine|mesh-list
83224153|NCT03161509|Carbamazepine|carbamazepine|mesh-list
83224154|NCT03161509|Phenytoin|phenytoin|mesh-list
83224155|NCT03161509|Valproic Acid|valproic acid|mesh-list
83224156|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
83224157|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83224158|NCT03161509|Analgesics|analgesics|mesh-ancestor
83224159|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
83224160|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224161|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224162|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
83224163|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83224164|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83224165|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224166|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83224167|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83224168|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83224169|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224170|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83224171|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83224172|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224173|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
83224174|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224175|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
83224176|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83224177|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83224178|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83224179|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83224180|NCT02676895|Vaccines|vaccines|mesh-list
83224181|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
83224182|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224183|NCT04440085|Midodrine|midodrine|mesh-list
83224184|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
83224185|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
83224186|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224187|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224188|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83224189|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83224190|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83224191|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83224192|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
83224193|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224194|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224195|NCT05129033|Omalizumab|omalizumab|mesh-list
83224196|NCT05129033|Itraconazole|itraconazole|mesh-list
83224197|NCT05129033|Prednisone|prednisone|mesh-list
83224198|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224199|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
83224200|NCT05129033|Hormones|hormones|mesh-ancestor
83224201|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224202|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224203|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224204|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224205|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
83224206|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224207|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83224208|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83224209|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224210|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224211|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83224212|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
83224213|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83224214|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83224215|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83224216|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
83224217|NCT05128721|Vaccines|vaccines|mesh-list
83224218|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
83224219|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224220|NCT05128175|Levodopa|levodopa|mesh-list
83224221|NCT05128175|Carbidopa|carbidopa|mesh-list
83224222|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83224223|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83224224|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83224225|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
83224226|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224227|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224228|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224229|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83224230|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224231|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83224232|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
83224233|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
83224234|NCT04184453|Deferiprone|deferiprone|mesh-list
83224235|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83224236|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
83224237|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
83224238|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224239|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
83224240|NCT05127707|Narcotics|narcotics|mesh-ancestor
83224241|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224242|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224243|NCT05127707|Analgesics|analgesics|mesh-ancestor
83224244|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
83224245|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224246|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
83224247|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224248|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224249|NCT05205109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83224250|NCT05205109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224251|NCT02207465|Paclitaxel|paclitaxel|mesh-list
83224252|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83224253|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83224254|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224255|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
83224256|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
83224257|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
83224258|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224259|NCT00719225|Abatacept|abatacept|mesh-list
83224260|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83224261|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224262|NCT00719225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224263|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224264|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224265|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
83224266|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224267|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224268|NCT05134337|Itraconazole|itraconazole|mesh-list
83224269|NCT05134337|Rifampin|rifampin|mesh-list
83224270|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
83224271|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224272|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83224273|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83224274|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224275|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224276|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83224277|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
83224278|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224279|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224280|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83224281|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83224282|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
83224283|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224284|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
83224285|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83224286|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83224287|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83224288|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83224289|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83224290|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83224291|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83224292|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83224293|NCT04499495|Mesalamine|mesalamine|mesh-list
83224294|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83224295|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83224296|NCT04499495|Analgesics|analgesics|mesh-ancestor
83224297|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
83224298|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224299|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224300|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224301|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224302|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
83224303|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224304|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224305|NCT05323175|Ropivacaine|ropivacaine|mesh-list
83224306|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
83224307|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
83224308|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224309|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224310|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
83224311|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224312|NCT05279963|Amitriptyline|amitriptyline|mesh-list
83224313|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83224314|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
83224315|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83224316|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83224317|NCT05279963|Analgesics|analgesics|mesh-ancestor
83224318|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
83224319|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224320|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224321|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83224322|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83224323|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83224324|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224326|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224327|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
83224328|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83224329|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83224330|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224331|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
83224332|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224333|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224334|NCT05133791|Annexin A5|annexin a5|mesh-list
83224335|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224336|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224337|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
83224338|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83224339|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83224340|NCT05133635|Prednisolone|prednisolone|mesh-list
83224341|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
83224342|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83224343|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
83224344|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224345|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
83224346|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
83224347|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224348|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224349|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224350|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
83224351|NCT05133635|Hormones|hormones|mesh-ancestor
83224352|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224353|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83224354|NCT05133635|Protective Agents|protective agents|mesh-ancestor
83224355|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224356|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224357|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
83224358|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83224359|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83224360|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224361|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
83224362|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
83224363|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224364|NCT05132777|Osimertinib|osimertinib|mesh-list
83224365|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224366|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224367|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224368|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224369|NCT05422027|Dexamethasone|dexamethasone|mesh-list
83224370|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
83224371|NCT05422027|Lenalidomide|lenalidomide|mesh-list
83224372|NCT05422027|Bortezomib|bortezomib|mesh-list
83224373|NCT05422027|BB 1101|bb 1101|mesh-list
83224374|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224375|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
83224376|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
83224377|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224378|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224379|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224380|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
83224381|NCT05422027|Hormones|hormones|mesh-ancestor
83224382|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224383|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224384|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224385|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
83224386|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224387|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224388|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
83224389|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224390|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83224391|NCT05422027|Growth Substances|growth substances|mesh-ancestor
83224392|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
83224394|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83224395|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83224396|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83224397|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83224398|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224399|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
83224400|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224401|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224402|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83224403|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224404|NCT01674725|Ribavirin|ribavirin|mesh-list
83224405|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
83224406|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224407|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
83224408|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224409|NCT05404061|Hormones|hormones|mesh-list
83224410|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224411|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224412|NCT05051293|Testosterone|testosterone|mesh-list
83224413|NCT05051293|Estrogens|estrogens|mesh-list
83224414|NCT05051293|Androgens|androgens|mesh-ancestor
83224415|NCT05051293|Hormones|hormones|mesh-ancestor
83224416|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224417|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224418|NCT03161041|Bevacizumab|bevacizumab|mesh-list
83224419|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
83224420|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224421|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224422|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224423|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83224424|NCT03161041|Growth Substances|growth substances|mesh-ancestor
83224425|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224426|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
83224427|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
83224428|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224429|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224430|NCT04139317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83224431|NCT04139317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224432|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
83224433|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83224434|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224435|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224436|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83224437|NCT03163693|Analgesics|analgesics|mesh-ancestor
83224438|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
83224439|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224440|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83224441|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83224442|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83224443|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
83224444|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224445|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224446|NCT05030545|Eplerenone|eplerenone|mesh-list
83224447|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83224448|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
83224449|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83224450|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224451|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224452|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83224453|NCT05030545|Diuretics|diuretics|mesh-ancestor
83224454|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
83224455|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83224456|NCT05030545|Hormones|hormones|mesh-ancestor
83224457|NCT03164161|Endorphins|endorphins|mesh-list
83224458|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224459|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224460|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224461|NCT00754949|Azithromycin|azithromycin|mesh-list
83224462|NCT00754949|Dexamethasone|dexamethasone|mesh-list
83224463|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
83224464|NCT00754949|BB 1101|bb 1101|mesh-list
83224465|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224466|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
83224467|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
83224468|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224469|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224470|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224471|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
83224472|NCT00754949|Hormones|hormones|mesh-ancestor
83224473|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224474|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224475|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224476|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
83224477|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224478|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224479|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224480|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224481|NCT03160807|Levofloxacin|levofloxacin|mesh-list
83224482|NCT03160807|Ofloxacin|ofloxacin|mesh-list
83224483|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83224484|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224485|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224486|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83224487|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83224488|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224489|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224490|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224491|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83224492|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83224493|NCT01674569|Ranibizumab|ranibizumab|mesh-list
83224494|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224495|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83224496|NCT01674569|Growth Substances|growth substances|mesh-ancestor
83224497|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224498|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
83224499|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224500|NCT03160729|Dexamethasone|dexamethasone|mesh-list
83224501|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224502|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
83224503|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
83224504|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224505|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224506|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224507|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
83224508|NCT03160729|Hormones|hormones|mesh-ancestor
83224509|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224510|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224511|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224512|NCT04439929|Adalimumab|adalimumab|mesh-list
83224513|NCT04439929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83224514|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224515|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224516|NCT05131841|Vinorelbine|vinorelbine|mesh-list
83224517|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83224518|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224519|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
83224520|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
83224521|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
83224522|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224523|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
83224524|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
83224525|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224526|NCT03163381|Apatinib|apatinib|mesh-list
83224527|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224528|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224529|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224530|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224531|NCT05131295|Dapsone|dapsone|mesh-list
83224532|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83224533|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224534|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
83224535|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83224536|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83224537|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83224538|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224539|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224540|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
83224541|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224542|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83224543|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
83224544|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224545|NCT05131295|Antacids|antacids|mesh-ancestor
83224546|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224548|NCT01374217|Dexamethasone|dexamethasone|mesh-list
83224549|NCT01374217|Lenalidomide|lenalidomide|mesh-list
83224550|NCT01374217|Tadalafil|tadalafil|mesh-list
83224551|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224552|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
83224553|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
83224554|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224555|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224556|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224557|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
83224558|NCT01374217|Hormones|hormones|mesh-ancestor
83224559|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224560|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224561|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224562|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
83224563|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224564|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83224565|NCT01374217|Growth Substances|growth substances|mesh-ancestor
83224566|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
83224567|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224568|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224569|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83224570|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224571|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224572|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83224573|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83224574|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
83224575|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83224576|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83224577|NCT01374217|Urological Agents|urological agents|mesh-ancestor
83224578|NCT04494503|Rituximab|rituximab|mesh-list
83224579|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224580|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224581|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
83224582|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224583|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224584|NCT04941937|Thalidomide|thalidomide|mesh-list
83224585|NCT04941937|Dexamethasone|dexamethasone|mesh-list
83224586|NCT04941937|Lenalidomide|lenalidomide|mesh-list
83224587|NCT04941937|Pomalidomide|pomalidomide|mesh-list
83224588|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224589|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
83224590|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
83224591|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224592|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224593|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224594|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
83224595|NCT04941937|Hormones|hormones|mesh-ancestor
83224596|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224597|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224598|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224599|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
83224600|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224601|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83224602|NCT04941937|Growth Substances|growth substances|mesh-ancestor
83224603|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
83224604|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224605|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
83224606|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83224607|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224608|NCT02959619|Ensartinib|ensartinib|mesh-list
83224609|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224610|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224611|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224612|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224613|NCT04935931|Naltrexone|naltrexone|mesh-list
83224614|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83224615|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83224616|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224617|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
83224618|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224619|NCT05124431|Everolimus|everolimus|mesh-list
83224620|NCT05124431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83224621|NCT05124431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224622|NCT05124431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224623|NCT05124431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224624|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224625|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
83224626|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224627|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224628|NCT04877275|Dexamethasone|dexamethasone|mesh-list
83224629|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
83224630|NCT04877275|Doxorubicin|doxorubicin|mesh-list
83224631|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83224632|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224633|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
83224634|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224635|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224636|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83224637|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
83224638|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224639|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224640|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83224641|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224642|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
83224643|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
83224644|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224645|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83224646|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
83224647|NCT04877275|Hormones|hormones|mesh-ancestor
83224648|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224649|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224650|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83224651|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83224652|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83224653|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224654|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
83224655|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83224656|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224657|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224658|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83224659|NCT04955249|Analgesics|analgesics|mesh-ancestor
83224660|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
83224661|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224662|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83224663|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83224664|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83224665|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
83224666|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224667|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224668|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
83224669|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
83224670|NCT05676463|Hormones|hormones|mesh-list
83224671|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83224672|NCT05676463|Androgens|androgens|mesh-list
83224673|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
83224674|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224675|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224676|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
83224677|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224678|NCT05676463|Protective Agents|protective agents|mesh-ancestor
83224679|NCT05676463|Vitamins|vitamins|mesh-ancestor
83224680|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
83224681|NCT05676463|Estrogens|estrogens|mesh-ancestor
83224682|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83224683|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224684|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
83224685|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
83224686|NCT03114085|Capecitabine|capecitabine|mesh-list
83224687|NCT03114085|Apatinib|apatinib|mesh-list
83224688|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83224689|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
83224690|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224691|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224692|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224693|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224694|NCT04886453|Morphine|morphine|mesh-list
83224695|NCT04886453|Anesthetics|anesthetics|mesh-list
83224696|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224697|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224698|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83224699|NCT04886453|Narcotics|narcotics|mesh-ancestor
83224700|NCT04886453|Analgesics|analgesics|mesh-ancestor
83224701|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
83224702|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224703|NCT05136521|Trazodone|trazodone|mesh-list
83224704|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83224705|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83224706|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224707|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224708|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83224709|NCT05136521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83224710|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83224711|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83224712|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224713|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224714|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
83224715|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83224716|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
83224717|NCT05343013|Trifluridine|trifluridine|mesh-list
83224718|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
83224719|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224720|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
83224721|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224722|NCT02388373|Fluticasone|fluticasone|mesh-list
83224723|NCT02388373|Xhance|xhance|mesh-list
83224724|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
83224725|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83224726|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224727|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83224728|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
83224729|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224730|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224731|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83224732|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
83224733|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
83224734|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83224735|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83224736|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83224737|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83224738|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
83224739|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224740|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224741|NCT01674647|Vitamin K|vitamin k|mesh-list
83224742|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
83224743|NCT01674647|Vitamins|vitamins|mesh-ancestor
83224744|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
83224745|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224746|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83224747|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
83224748|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83224749|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
83224750|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224751|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224752|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
83224753|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83224754|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83224755|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
83224756|NCT01674647|Coagulants|coagulants|mesh-ancestor
83224757|NCT02669407|Lidocaine|lidocaine|mesh-list
83224758|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
83224759|NCT02669407|Anesthetics|anesthetics|mesh-list
83224760|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224761|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224762|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
83224763|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224764|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83224765|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83224766|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83224767|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83224768|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224769|NCT04909853|Ritonavir|ritonavir|mesh-list
83224770|NCT04909853|Nirmatrelvir|nirmatrelvir|mesh-list
83224771|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83224772|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83224773|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
83224774|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224775|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224776|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83224777|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83224778|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
83224779|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224780|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83224781|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83224783|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83224784|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83224785|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83224786|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83224787|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224788|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83224789|NCT02388061|Plasminogen|plasminogen|mesh-list
83224790|NCT02388061|Tenecteplase|tenecteplase|mesh-list
83224791|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83224792|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83224793|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362187|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362188|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362189|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83362190|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83362191|NCT01683071|Bupivacaine|bupivacaine|mesh-list
83362192|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
83362193|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
83362194|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362195|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362196|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
83362197|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362198|NCT04707508|Metformin|metformin|mesh-list
83362199|NCT04707508|Valsartan|valsartan|mesh-list
83362200|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362201|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362202|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83362203|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83362204|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83362205|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362206|NCT05145400|Dexamethasone|dexamethasone|mesh-list
83362207|NCT05145400|Lenalidomide|lenalidomide|mesh-list
83362208|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362209|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
83362210|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
83362211|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362212|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362213|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362214|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
83362215|NCT05145400|Hormones|hormones|mesh-ancestor
83362216|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362217|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362218|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362219|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
83362220|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83362221|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83362222|NCT05145400|Growth Substances|growth substances|mesh-ancestor
83362223|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
83362224|NCT01567865|Vaccines|vaccines|mesh-list
83362225|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
83362226|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362227|NCT05049226|Vaccines|vaccines|mesh-list
83362228|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
83362229|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362230|NCT01567163|Docetaxel|docetaxel|mesh-list
83362231|NCT01567163|Ramucirumab|ramucirumab|mesh-list
83362232|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362233|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83362234|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83362235|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83362236|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362237|NCT05002114|Cannabidiol|cannabidiol|mesh-list
83362238|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
83362239|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
83362240|NCT04973566|Etanercept|etanercept|mesh-list
83224794|NCT04556357|Phenylephrine|phenylephrine|mesh-list
83224795|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
83224796|NCT04556357|Norepinephrine|norepinephrine|mesh-list
83224797|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83224798|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83224799|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
83224800|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
83224801|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224802|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224803|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
83224804|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
83224805|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
83224806|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83224807|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83224808|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83224809|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
83224810|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224811|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224812|NCT04556357|Protective Agents|protective agents|mesh-ancestor
83224813|NCT04553939|Gemcitabine|gemcitabine|mesh-list
83224814|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83224815|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
83224816|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224817|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224818|NCT02790853|Proflavine|proflavine|mesh-list
83224819|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83224820|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224821|NCT03113773|Aldesleukin|aldesleukin|mesh-list
83224822|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224823|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83224824|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83224825|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
83224826|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224827|NCT05306041|Inavolisib|inavolisib|mesh-list
83224828|NCT05306041|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83224829|NCT05306041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224830|NCT05306041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224831|NCT04874831|Avelumab|avelumab|mesh-list
83224832|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224833|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224834|NCT05122169|Iodine|iodine|mesh-list
83224835|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
83224836|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83224837|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
83224838|NCT05122169|Povidone|povidone|mesh-list
83224839|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83224840|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224841|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
83224842|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
83224843|NCT05122169|Trace Elements|trace elements|mesh-ancestor
83224844|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
83224845|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224846|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
83224847|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
83224848|NCT04359329|Estradiol|estradiol|mesh-list
83224849|NCT04359329|Estrogens|estrogens|mesh-ancestor
83224850|NCT04359329|Hormones|hormones|mesh-ancestor
83224851|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224852|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224853|NCT05403749|Aflibercept|aflibercept|mesh-list
83224854|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83224855|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83224856|NCT05403749|Growth Substances|growth substances|mesh-ancestor
83224857|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224858|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
83224859|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224860|NCT04203875|Abatacept|abatacept|mesh-list
83224861|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83224862|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224863|NCT04203875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224864|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224865|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224866|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
83224867|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224868|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224869|NCT04491383|Tocovid|tocovid|mesh-list
83224870|NCT04491383|Vitamins|vitamins|mesh-ancestor
83224871|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
83224872|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224873|NCT05900674|Reteplase|reteplase|mesh-list
83224874|NCT05900674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83224875|NCT05900674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83224876|NCT05900674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224877|NCT05900661|Inositol|inositol|mesh-list
83224878|NCT05900661|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83224879|NCT05900661|Vitamin B Complex|vitamin b complex|mesh-ancestor
83224880|NCT05900661|Vitamins|vitamins|mesh-ancestor
83224881|NCT05900661|Micronutrients|micronutrients|mesh-ancestor
83224882|NCT05900661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224883|NCT05900661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83224884|NCT05900661|Immunologic Factors|immunologic factors|mesh-ancestor
83224885|NCT05900635|Lactoferrin|lactoferrin|mesh-list
83224886|NCT05900635|Glycine|glycine|mesh-list
83224887|NCT05900635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83224888|NCT05900635|Glycine Agents|glycine agents|mesh-ancestor
83224889|NCT05900635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224890|NCT05900635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224891|NCT05900635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224892|NCT05900531|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83224893|NCT05900531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83224894|NCT05900531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224896|NCT05900531|Hormones|hormones|mesh-ancestor
83224897|NCT05900531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83224898|NCT05900531|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83224899|NCT05900531|Protease Inhibitors|protease inhibitors|mesh-ancestor
83224900|NCT05900531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224901|NCT05900531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224902|NCT05900401|Cyclophosphamide|cyclophosphamide|mesh-list
83224903|NCT05900401|Rituximab|rituximab|mesh-list
83224904|NCT05900401|Fludarabine|fludarabine|mesh-list
83224905|NCT05900401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224906|NCT05900401|Immunologic Factors|immunologic factors|mesh-ancestor
83224907|NCT05900401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224908|NCT05900401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224909|NCT05900401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83224910|NCT05900401|Alkylating Agents|alkylating agents|mesh-ancestor
83224911|NCT05900401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224912|NCT05900401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224913|NCT05900401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83224914|NCT05900401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224915|NCT05900388|Rivaroxaban|rivaroxaban|mesh-list
83224916|NCT05900388|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83224917|NCT05900388|Antithrombins|antithrombins|mesh-ancestor
83224918|NCT05900388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83224919|NCT05900388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83224920|NCT05900388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224921|NCT05900388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224922|NCT05900388|Anticoagulants|anticoagulants|mesh-ancestor
83224923|NCT05900349|Caffeine|caffeine|mesh-list
83224924|NCT05900349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83224925|NCT05900349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224926|NCT05900349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83224927|NCT05900349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224928|NCT05900349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224929|NCT05900349|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83224930|NCT05900349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83224931|NCT05900349|Purinergic Agents|purinergic agents|mesh-ancestor
83224932|NCT05900349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83224933|NCT05900336|Naproxen|naproxen|mesh-list
83224934|NCT05900336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83224935|NCT05900336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83224936|NCT05900336|Analgesics|analgesics|mesh-ancestor
83224937|NCT05900336|Sensory System Agents|sensory system agents|mesh-ancestor
83224938|NCT05900336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224939|NCT05900336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224940|NCT05900336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83224941|NCT05900336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224942|NCT05900336|Gout Suppressants|gout suppressants|mesh-ancestor
83224943|NCT05900336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83224944|NCT05900336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224945|NCT05900336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224946|NCT05900284|Metformin|metformin|mesh-list
83224947|NCT05900284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83224948|NCT05900284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224949|NCT05900258|Tirbanibulin|tirbanibulin|mesh-list
83224950|NCT05900258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224951|NCT05900258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224952|NCT05900245|Propofol|propofol|mesh-list
83224953|NCT05900245|Anesthetics|anesthetics|mesh-list
83224954|NCT05900245|Succinylcholine|succinylcholine|mesh-list
83224955|NCT05900245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83224956|NCT05900245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83224957|NCT05900245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224958|NCT05900245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83224959|NCT05900245|Anesthetics, General|anesthetics, general|mesh-ancestor
83224960|NCT05900245|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83224961|NCT05900245|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83224962|NCT05900245|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83224963|NCT05900245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83224964|NCT05900232|Antibodies|antibodies|mesh-list
83224965|NCT05900232|Immunologic Factors|immunologic factors|mesh-ancestor
83224966|NCT05900232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224967|NCT05900219|Vemurafenib|vemurafenib|mesh-list
83224968|NCT05900219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224969|NCT05900219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83224970|NCT05900219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224971|NCT05900219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224972|NCT05900206|Paclitaxel|paclitaxel|mesh-list
83224973|NCT05900206|Docetaxel|docetaxel|mesh-list
83224974|NCT05900206|Cyclophosphamide|cyclophosphamide|mesh-list
83224975|NCT05900206|Carboplatin|carboplatin|mesh-list
83224976|NCT05900206|Trastuzumab|trastuzumab|mesh-list
83224977|NCT05900206|Letrozole|letrozole|mesh-list
83224978|NCT05900206|Epirubicin|epirubicin|mesh-list
83224979|NCT05900206|Pertuzumab|pertuzumab|mesh-list
83224980|NCT05900206|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83224981|NCT05900206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83224982|NCT05900206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83224983|NCT05900206|Tubulin Modulators|tubulin modulators|mesh-ancestor
83224984|NCT05900206|Antimitotic Agents|antimitotic agents|mesh-ancestor
83224985|NCT05900206|Mitosis Modulators|mitosis modulators|mesh-ancestor
83224986|NCT05900206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83224987|NCT05900206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83224988|NCT05900206|Immunologic Factors|immunologic factors|mesh-ancestor
83224989|NCT05900206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83224990|NCT05900206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83224991|NCT05900206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83224992|NCT05900206|Alkylating Agents|alkylating agents|mesh-ancestor
83224993|NCT05900206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83224994|NCT05900206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83224995|NCT05900206|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83224996|NCT05900206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83224997|NCT05900206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83224998|NCT05900206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83224999|NCT05900206|Hormone Antagonists|hormone antagonists|mesh-ancestor
83225000|NCT05900206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225001|NCT05900206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83225002|NCT05900206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225003|NCT05900206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225004|NCT05900206|Immunoconjugates|immunoconjugates|mesh-ancestor
83225005|NCT05899933|Erythritol|erythritol|mesh-list
83225006|NCT05899933|Vasodilator Agents|vasodilator agents|mesh-ancestor
83225007|NCT05899829|Rifampin|rifampin|mesh-list
83225008|NCT05899829|Rabeprazole|rabeprazole|mesh-list
83225009|NCT05899829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83225010|NCT05899829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83225011|NCT05899829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83225012|NCT05899829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225013|NCT05899829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225014|NCT05899829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83225015|NCT05899829|Antitubercular Agents|antitubercular agents|mesh-ancestor
83225016|NCT05899829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83225017|NCT05899829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225018|NCT05899829|Leprostatic Agents|leprostatic agents|mesh-ancestor
83225019|NCT05899829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83225020|NCT05899829|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83225021|NCT05899829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83225022|NCT05899829|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83225023|NCT05899829|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83225024|NCT05899829|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83225025|NCT05899829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83225026|NCT05899764|Brivaracetam|brivaracetam|mesh-list
83225027|NCT05899764|Anticonvulsants|anticonvulsants|mesh-ancestor
83225028|NCT05899751|Methotrexate|methotrexate|mesh-list
83225029|NCT05899751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83225030|NCT05899751|Abortifacient Agents|abortifacient agents|mesh-ancestor
83225031|NCT05899751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83225032|NCT05899751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225033|NCT05899751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83225034|NCT05899751|Antimetabolites|antimetabolites|mesh-ancestor
83225035|NCT05899751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225036|NCT05899751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225037|NCT05899751|Dermatologic Agents|dermatologic agents|mesh-ancestor
83225038|NCT05899751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225039|NCT05899751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83225040|NCT05899751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225041|NCT05899751|Immunologic Factors|immunologic factors|mesh-ancestor
83225042|NCT05899751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83225043|NCT05899751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83225044|NCT05899621|Prednisone|prednisone|mesh-list
83225045|NCT05899621|Cyclophosphamide|cyclophosphamide|mesh-list
83225046|NCT05899621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83225047|NCT05899621|Doxorubicin|doxorubicin|mesh-list
83225048|NCT05899621|Vincristine|vincristine|mesh-list
83225049|NCT05899621|Lenalidomide|lenalidomide|mesh-list
83225050|NCT05899621|Obinutuzumab|obinutuzumab|mesh-list
83225051|NCT05899621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225052|NCT05899621|Immunologic Factors|immunologic factors|mesh-ancestor
83225053|NCT05899621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225054|NCT05899621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83225055|NCT05899621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83225056|NCT05899621|Alkylating Agents|alkylating agents|mesh-ancestor
83225057|NCT05899621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225058|NCT05899621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225059|NCT05899621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83225060|NCT05899621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83225061|NCT05899621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225062|NCT05899621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225063|NCT05899621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225064|NCT05899621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225065|NCT05899621|Glucocorticoids|glucocorticoids|mesh-ancestor
83225066|NCT05899621|Hormones|hormones|mesh-ancestor
83225067|NCT05899621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225068|NCT05899621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225069|NCT05899621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83225070|NCT05899621|Tubulin Modulators|tubulin modulators|mesh-ancestor
83225071|NCT05899621|Antimitotic Agents|antimitotic agents|mesh-ancestor
83225072|NCT05899621|Mitosis Modulators|mitosis modulators|mesh-ancestor
83225073|NCT05899621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83225074|NCT05899621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83225075|NCT05899621|Growth Substances|growth substances|mesh-ancestor
83225076|NCT05899621|Growth Inhibitors|growth inhibitors|mesh-ancestor
83225077|NCT05899621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225078|NCT05899517|Oxytocin|oxytocin|mesh-list
83225079|NCT05899517|Oxytocics|oxytocics|mesh-ancestor
83225080|NCT05899517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83225081|NCT05899517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225082|NCT05899465|Tranexamic Acid|tranexamic acid|mesh-list
83225083|NCT05899465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83225084|NCT05899465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83225085|NCT05899465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225086|NCT05899465|Hemostatics|hemostatics|mesh-ancestor
83225087|NCT05899465|Coagulants|coagulants|mesh-ancestor
83225088|NCT05899127|Lidocaine|lidocaine|mesh-list
83225089|NCT05899127|Sufentanil|sufentanil|mesh-list
83225090|NCT05899127|Remifentanil|remifentanil|mesh-list
83225091|NCT05899127|Dsuvia|dsuvia|mesh-list
83225092|NCT05899127|Propofol|propofol|mesh-list
83225093|NCT05899127|Etomidate|etomidate|mesh-list
83225094|NCT05899127|Rocuronium|rocuronium|mesh-list
83225095|NCT05899127|Anesthetics, Local|anesthetics, local|mesh-ancestor
83225096|NCT05899127|Anesthetics|anesthetics|mesh-ancestor
83225097|NCT05899127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225098|NCT05899127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225099|NCT05899127|Sensory System Agents|sensory system agents|mesh-ancestor
83225100|NCT05899127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225101|NCT05899127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83225102|NCT05899127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83225103|NCT05899127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83225104|NCT05899127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83225105|NCT05899127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225106|NCT05899127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83225107|NCT05899127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83225108|NCT05899127|Anesthetics, General|anesthetics, general|mesh-ancestor
83225109|NCT05899127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83225110|NCT05899127|Narcotics|narcotics|mesh-ancestor
83225111|NCT05899127|Analgesics|analgesics|mesh-ancestor
83225112|NCT05899127|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83225113|NCT05899127|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83225114|NCT05899127|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83225115|NCT05899127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83225116|NCT05899049|Pembrolizumab|pembrolizumab|mesh-list
83225117|NCT05899049|Lenvatinib|lenvatinib|mesh-list
83225118|NCT05899049|Belzutifan|belzutifan|mesh-list
83225119|NCT05899049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225120|NCT05899049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225121|NCT05899049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83225122|NCT05899049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225123|NCT05899049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225124|NCT05899049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225125|NCT05899010|Progesterone|progesterone|mesh-list
83225126|NCT05899010|Progestins|progestins|mesh-ancestor
83225127|NCT05899010|Hormones|hormones|mesh-ancestor
83225128|NCT05899010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225129|NCT05899010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225130|NCT05898984|Beclomethasone|beclomethasone|mesh-list
83225131|NCT05898984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225132|NCT05898984|Glucocorticoids|glucocorticoids|mesh-ancestor
83225133|NCT05898984|Hormones|hormones|mesh-ancestor
83225134|NCT05898984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225135|NCT05898984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225136|NCT05898984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83225137|NCT05898984|Respiratory System Agents|respiratory system agents|mesh-ancestor
83225138|NCT05898763|Pembrolizumab|pembrolizumab|mesh-list
83225139|NCT05898763|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83225140|NCT05898763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225141|NCT05898763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225142|NCT05898763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83225143|NCT05898763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225144|NCT05898763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83225145|NCT05898763|Immunologic Factors|immunologic factors|mesh-ancestor
83225146|NCT05898763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225147|NCT05898724|Zinc Oxide|zinc oxide|mesh-list
83225148|NCT05898724|Dermatologic Agents|dermatologic agents|mesh-ancestor
83225149|NCT05898724|Sunscreening Agents|sunscreening agents|mesh-ancestor
83225150|NCT05898724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83225151|NCT05898724|Protective Agents|protective agents|mesh-ancestor
83225152|NCT05898724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225153|NCT05898672|Ritonavir|ritonavir|mesh-list
83225154|NCT05898672|Nirmatrelvir|nirmatrelvir|mesh-list
83225155|NCT05898672|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83225156|NCT05898672|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83225157|NCT05898672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83225158|NCT05898672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83225159|NCT05898672|Protease Inhibitors|protease inhibitors|mesh-ancestor
83225160|NCT05898672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225161|NCT05898672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225162|NCT05898672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83225163|NCT05898672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83225164|NCT05898672|Antiviral Agents|antiviral agents|mesh-ancestor
83225165|NCT05898672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225166|NCT05898672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83225167|NCT05898672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83225168|NCT05898672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83225169|NCT05898672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83225170|NCT05898672|Antimetabolites|antimetabolites|mesh-ancestor
83225171|NCT05898672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83225172|NCT05898672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83225176|NCT05898633|Pulmonary Surfactant-Associated Protein D|pulmonary surfactant-associated protein d|mesh-list
83225177|NCT05898633|Respiratory System Agents|respiratory system agents|mesh-ancestor
83225179|NCT05898451|Dacarbazine|dacarbazine|mesh-list
83225180|NCT05898451|Lomustine|lomustine|mesh-list
83225181|NCT05898451|Thymalfasin|thymalfasin|mesh-list
83225182|NCT05898451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225183|NCT05898451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83225184|NCT05898451|Alkylating Agents|alkylating agents|mesh-ancestor
83225185|NCT05898451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225186|NCT05898451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83225187|NCT05898451|Immunologic Factors|immunologic factors|mesh-ancestor
83225188|NCT05898451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225189|NCT05898399|Olaparib|olaparib|mesh-list
83225190|NCT05898399|Talazoparib|talazoparib|mesh-list
83225191|NCT05898399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83225192|NCT05898399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225193|NCT05898399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225194|NCT05898399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225195|NCT05898373|Antineoplastic Agents|antineoplastic agents|mesh-list
83225196|NCT05898321|Goserelin|goserelin|mesh-list
83225197|NCT05898321|Mifepristone|mifepristone|mesh-list
83225198|NCT05898321|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83225199|NCT05898321|Abortifacient Agents|abortifacient agents|mesh-ancestor
83225200|NCT05898321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83225201|NCT05898321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225202|NCT05898321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83225203|NCT05898321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83225204|NCT05898321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83225205|NCT05898321|Contraceptive Agents|contraceptive agents|mesh-ancestor
83225206|NCT05898321|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83225207|NCT05898321|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83225208|NCT05898321|Hormone Antagonists|hormone antagonists|mesh-ancestor
83225209|NCT05898321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225210|NCT05898321|Luteolytic Agents|luteolytic agents|mesh-ancestor
83225211|NCT05898321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83225212|NCT05898321|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83225213|NCT05898321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225214|NCT05898321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225215|NCT05898308|Rituximab|rituximab|mesh-list
83225216|NCT05898308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225217|NCT05898308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225218|NCT05898308|Immunologic Factors|immunologic factors|mesh-ancestor
83225219|NCT05898308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225220|NCT05898308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83225221|NCT05898256|Gemcitabine|gemcitabine|mesh-list
83225222|NCT05898256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225223|NCT05898256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83225224|NCT05898256|Antimetabolites|antimetabolites|mesh-ancestor
83225225|NCT05898256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225226|NCT05898087|Bupivacaine|bupivacaine|mesh-list
83225227|NCT05898087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83225228|NCT05898087|Anesthetics, Local|anesthetics, local|mesh-ancestor
83225229|NCT05898087|Anesthetics|anesthetics|mesh-ancestor
83225230|NCT05898087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225231|NCT05898087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225232|NCT05898087|Sensory System Agents|sensory system agents|mesh-ancestor
83225233|NCT05898087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225234|NCT05898022|Furosemide|furosemide|mesh-list
83225235|NCT05898022|Diuretics|diuretics|mesh-ancestor
83225236|NCT05898022|Natriuretic Agents|natriuretic agents|mesh-ancestor
83225237|NCT05898022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225238|NCT05898022|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83225239|NCT05898022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83225240|NCT05898022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225241|NCT05897918|Tranexamic Acid|tranexamic acid|mesh-list
83225242|NCT05897918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83225243|NCT05897918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83225244|NCT05897918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225245|NCT05897918|Hemostatics|hemostatics|mesh-ancestor
83225246|NCT05897918|Coagulants|coagulants|mesh-ancestor
83225247|NCT05897034|Doxycycline|doxycycline|mesh-list
83225248|NCT05897034|Nitazoxanide|nitazoxanide|mesh-list
83225249|NCT05897034|Pentoxifylline|pentoxifylline|mesh-list
83225250|NCT05897034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83225251|NCT05897034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225252|NCT05897034|Antimalarials|antimalarials|mesh-ancestor
83225253|NCT05897034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83225254|NCT05897034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83225255|NCT05897034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83225256|NCT05897034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225257|NCT05897034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225258|NCT05897034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83225259|NCT05897034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83225260|NCT05897034|Protective Agents|protective agents|mesh-ancestor
83225261|NCT05897034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225262|NCT05897034|Vasodilator Agents|vasodilator agents|mesh-ancestor
83225263|NCT05897034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83225264|NCT05897034|Antioxidants|antioxidants|mesh-ancestor
83225265|NCT05897008|Omalizumab|omalizumab|mesh-list
83225266|NCT05897008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83225267|NCT05897008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83225268|NCT05897008|Respiratory System Agents|respiratory system agents|mesh-ancestor
83225269|NCT05895747|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
83225270|NCT05895747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83225271|NCT05895747|Antidepressive Agents|antidepressive agents|mesh-ancestor
83225272|NCT05895747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83225273|NCT05892939|Oxytocin|oxytocin|mesh-list
83225274|NCT05892939|Oxytocics|oxytocics|mesh-ancestor
83225275|NCT05892939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83225276|NCT05892939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225277|NCT05890534|Pycnogenols|pycnogenols|mesh-list
83225278|NCT05890534|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83225279|NCT05890534|Immunologic Factors|immunologic factors|mesh-ancestor
83225280|NCT05890534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225281|NCT05890534|Antioxidants|antioxidants|mesh-ancestor
83225282|NCT05890534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225283|NCT05890534|Protective Agents|protective agents|mesh-ancestor
83225284|NCT05890534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83225285|NCT05888896|Antihypertensive Agents|antihypertensive agents|mesh-list
83225286|NCT05888896|Methyldopa|methyldopa|mesh-list
83225287|NCT05888896|Sympatholytics|sympatholytics|mesh-ancestor
83225288|NCT05888896|Autonomic Agents|autonomic agents|mesh-ancestor
83225289|NCT05888896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225290|NCT05888896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225291|NCT05888896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83225292|NCT05888896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83225293|NCT05888896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83225294|NCT05888896|Adrenergic Agents|adrenergic agents|mesh-ancestor
83225295|NCT05888896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225296|NCT05888896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225297|NCT05886049|Cytarabine|cytarabine|mesh-list
83225298|NCT05886049|Daunorubicin|daunorubicin|mesh-list
83225299|NCT05886049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83225300|NCT05886049|Antimetabolites|antimetabolites|mesh-ancestor
83225301|NCT05886049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225302|NCT05886049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225303|NCT05886049|Antiviral Agents|antiviral agents|mesh-ancestor
83225304|NCT05886049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225305|NCT05886049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225306|NCT05886049|Immunologic Factors|immunologic factors|mesh-ancestor
83225307|NCT05886049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225308|NCT05886049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83225309|NCT05886049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225310|NCT05886049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225311|NCT05886049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225313|NCT05886036|Rituximab|rituximab|mesh-list
83225314|NCT05886036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83225315|NCT05886036|Antibodies|antibodies|mesh-list
83225316|NCT05886036|Immunoglobulins|immunoglobulins|mesh-list
83225317|NCT05886036|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83225318|NCT05886036|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83225319|NCT05886036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83225320|NCT05886036|Immunologic Factors|immunologic factors|mesh-ancestor
83225321|NCT05886036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225322|NCT05886036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225323|NCT05886036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83225324|NCT05886036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83225325|NCT05886036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225326|NCT05886036|Antimetabolites|antimetabolites|mesh-ancestor
83225327|NCT05886036|Antiviral Agents|antiviral agents|mesh-ancestor
83225328|NCT05886036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225329|NCT05881083|Nicotine|nicotine|mesh-list
83225330|NCT05881083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83225331|NCT05881083|Autonomic Agents|autonomic agents|mesh-ancestor
83225332|NCT05881083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225333|NCT05881083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225334|NCT05881083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83225335|NCT05881083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83225336|NCT05881083|Cholinergic Agents|cholinergic agents|mesh-ancestor
83225337|NCT05881083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225338|NCT05881083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225339|NCT05876754|Ivosidenib|ivosidenib|mesh-list
83225340|NCT05876754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225341|NCT05876754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225342|NCT05876754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225343|NCT05867147|Moxifloxacin|moxifloxacin|mesh-list
83225344|NCT05867147|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83225345|NCT05867147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83225346|NCT05867147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225347|NCT05867147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225348|NCT05867147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225349|NCT05867147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225350|NCT05867147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225351|NCT05867147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225352|NCT05867147|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83225353|NCT05867147|Contraceptive Agents|contraceptive agents|mesh-ancestor
83225354|NCT05867147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83225355|NCT05867147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225356|NCT05867147|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83225357|NCT05867147|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83225358|NCT05867147|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83225359|NCT05861765|Papaverine|papaverine|mesh-list
83225360|NCT05861765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83225361|NCT05861765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225362|NCT05861765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225363|NCT05861765|Vasodilator Agents|vasodilator agents|mesh-ancestor
83225364|NCT05861765|Urological Agents|urological agents|mesh-ancestor
83225365|NCT05849207|Cyclophosphamide|cyclophosphamide|mesh-list
83225366|NCT05849207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225367|NCT05849207|Immunologic Factors|immunologic factors|mesh-ancestor
83225368|NCT05849207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225369|NCT05849207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83225370|NCT05849207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83225371|NCT05849207|Alkylating Agents|alkylating agents|mesh-ancestor
83225372|NCT05849207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225373|NCT05849207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225374|NCT05849207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83225376|NCT05818618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225377|NCT05818618|Glucocorticoids|glucocorticoids|mesh-ancestor
83225378|NCT05818618|Hormones|hormones|mesh-ancestor
83225379|NCT05818618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225380|NCT05818618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225381|NCT05809921|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83225382|NCT05809921|Tenecteplase|tenecteplase|mesh-list
83225383|NCT05809921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83225384|NCT05809921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83225385|NCT05809921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225386|NCT05804513|Lixisenatide|lixisenatide|mesh-list
83225387|NCT05804513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83225388|NCT05804513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225389|NCT05783219|Lidocaine|lidocaine|mesh-list
83225390|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
83225391|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
83225392|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225393|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225394|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
83362241|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
83225398|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83225399|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83225400|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225401|NCT05765851|Trastuzumab|trastuzumab|mesh-list
83225402|NCT05765851|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83225403|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225404|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225405|NCT05765851|Immunoconjugates|immunoconjugates|mesh-ancestor
83225406|NCT05765851|Immunologic Factors|immunologic factors|mesh-ancestor
83225407|NCT05765851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225411|NCT05747352|Insulin|insulin|mesh-list
83225412|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83225413|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225414|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83225415|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83225416|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225417|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
83225418|NCT05741060|Equol|equol|mesh-list
83225419|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
83225420|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83225421|NCT05741060|Estrogens|estrogens|mesh-ancestor
83225422|NCT05741060|Hormones|hormones|mesh-ancestor
83225423|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225424|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225425|NCT05738161|Cisplatin|cisplatin|mesh-list
83225426|NCT05738161|Gemcitabine|gemcitabine|mesh-list
83225427|NCT05738161|Magrolimab|magrolimab|mesh-list
83225428|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225429|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83225430|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
83225431|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225432|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225433|NCT05733598|Bevacizumab|bevacizumab|mesh-list
83225434|NCT05733598|Atezolizumab|atezolizumab|mesh-list
83225435|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225436|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225437|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83225438|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83225439|NCT05733598|Growth Substances|growth substances|mesh-ancestor
83225440|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225441|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
83225442|NCT05733598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83225443|NCT05733598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225444|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83225445|NCT05733507|Tenecteplase|tenecteplase|mesh-list
83225446|NCT05733507|Tirofiban|tirofiban|mesh-list
83225447|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83225448|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83225449|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225450|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83225451|NCT05724134|Insulin|insulin|mesh-list
83225452|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83225453|NCT05724134|Octreotide|octreotide|mesh-list
83225454|NCT05724134|Glucagon|glucagon|mesh-list
83225455|NCT05724134|Hormones|hormones|mesh-list
83225456|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83225457|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225458|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225459|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83225460|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225461|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225462|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
83225463|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83225464|NCT05709444|alpha-MSH|alpha-msh|mesh-list
83225465|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83225466|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83225467|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
83225468|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225469|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225470|NCT05709444|Hormones|hormones|mesh-ancestor
83225471|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225472|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225473|NCT05704036|Estradiol|estradiol|mesh-list
83225474|NCT05704036|Estrogens|estrogens|mesh-list
83225475|NCT05704036|Progesterone|progesterone|mesh-list
83225476|NCT05704036|Hormones|hormones|mesh-ancestor
83225477|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225478|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225479|NCT05704036|Progestins|progestins|mesh-ancestor
83225480|NCT05683223|Sertraline|sertraline|mesh-list
83225481|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
83225482|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83225483|NCT05683223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83225484|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83225485|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83225486|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225487|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225489|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225490|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
83225491|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225492|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
83225493|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225494|NCT05668585|Trametinib|trametinib|mesh-list
83225495|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225496|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225497|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225498|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225499|NCT05662332|Insulin|insulin|mesh-list
83225500|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83225501|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
83225502|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83225503|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225504|NCT05658575|Dapansutrile|dapansutrile|mesh-list
83225505|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225506|NCT05613088|Paclitaxel|paclitaxel|mesh-list
83225507|NCT05613088|Doxorubicin|doxorubicin|mesh-list
83225508|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83225509|NCT05613088|Topotecan|topotecan|mesh-list
83225510|NCT05613088|Farletuzumab|farletuzumab|mesh-list
83225511|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83225512|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225513|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83225514|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83225515|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83225516|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225517|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83225518|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225519|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225520|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225521|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83225522|NCT05583721|Regadenoson|regadenoson|mesh-list
83225523|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83225524|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83225525|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
83225526|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
83225527|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225528|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225529|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225530|NCT05583110|Trastuzumab|trastuzumab|mesh-list
83225531|NCT05583110|Vinorelbine|vinorelbine|mesh-list
83225532|NCT05583110|Tucatinib|tucatinib|mesh-list
83225533|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225534|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225535|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83225536|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83225537|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83225538|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83225539|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225540|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225541|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225542|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83225543|NCT05564039|Dulaglutide|dulaglutide|mesh-list
83225544|NCT05564039|Tirzepatide|tirzepatide|mesh-list
83225545|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83225546|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225547|NCT05564039|Incretins|incretins|mesh-ancestor
83225548|NCT05564039|Hormones|hormones|mesh-ancestor
83225549|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225550|NCT05556265|Deucravacitinib|deucravacitinib|mesh-list
83225551|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
83225552|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225553|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225554|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225555|NCT05537935|Naltrexone|naltrexone|mesh-list
83225556|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83225557|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83225558|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225559|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
83225560|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225561|NCT05522673|Rolipram|rolipram|mesh-list
83225562|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
83225563|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83225564|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83225565|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83225566|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225567|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225568|NCT05483933|Doxorubicin|doxorubicin|mesh-list
83225569|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83225570|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83225571|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225572|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225573|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225574|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225575|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225576|NCT05478499|Deucravacitinib|deucravacitinib|mesh-list
83225577|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
83225578|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225579|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225580|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225581|NCT05456256|Carboplatin|carboplatin|mesh-list
83225582|NCT05456256|Pemetrexed|pemetrexed|mesh-list
83225583|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225584|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225585|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225586|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83225587|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83225588|NCT05455697|Prednisone|prednisone|mesh-list
83225589|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
83225590|NCT05455697|Rituximab|rituximab|mesh-list
83225591|NCT05455697|Doxorubicin|doxorubicin|mesh-list
83225592|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83225593|NCT05455697|Vincristine|vincristine|mesh-list
83225594|NCT05455697|Daunorubicin|daunorubicin|mesh-list
83225595|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
83225596|NCT05455697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83225597|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225598|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
83225599|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225600|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83225601|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83225602|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
83225603|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225604|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225605|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83225606|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225607|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83225608|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225609|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225610|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225611|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225612|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
83225613|NCT05455697|Hormones|hormones|mesh-ancestor
83225614|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225615|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225616|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83225617|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
83225618|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
83225619|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
83225620|NCT05455697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83225621|NCT05440786|Irinotecan|irinotecan|mesh-list
83225622|NCT05440786|Temozolomide|temozolomide|mesh-list
83225623|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83225624|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225625|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225626|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225627|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225628|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83225629|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
83225630|NCT05411679|Olaparib|olaparib|mesh-list
83225631|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83225632|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225633|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225634|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225635|NCT05407636|Aflibercept|aflibercept|mesh-list
83225636|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83225637|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83225638|NCT05407636|Growth Substances|growth substances|mesh-ancestor
83225639|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225640|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
83225641|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225642|NCT05406479|Bedaquiline|bedaquiline|mesh-list
83225643|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
83225644|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83225645|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225646|NCT05384665|Sufentanil|sufentanil|mesh-list
83225647|NCT05384665|Remifentanil|remifentanil|mesh-list
83225648|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83225649|NCT05384665|Narcotics|narcotics|mesh-ancestor
83225650|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225651|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225652|NCT05384665|Analgesics|analgesics|mesh-ancestor
83225653|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
83225654|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225655|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83225656|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83225657|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
83225658|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
83225659|NCT05363319|Cemiplimab|cemiplimab|mesh-list
83225660|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225661|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225662|NCT05357989|Phenserine|phenserine|mesh-list
83225663|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83225664|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225665|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225666|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
83225667|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225668|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225669|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
83225670|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225671|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225672|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83225673|NCT05354453|Protective Agents|protective agents|mesh-ancestor
83225674|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225675|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225676|NCT05333458|Atezolizumab|atezolizumab|mesh-list
83225677|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83225678|NCT05333458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83225679|NCT05333458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225680|NCT05333458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225681|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225682|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
83225683|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225684|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
83225685|NCT05325281|Gemcitabine|gemcitabine|mesh-list
83225686|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83225687|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
83225688|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225689|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225690|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
83225691|NCT05325281|Protective Agents|protective agents|mesh-ancestor
83225692|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225693|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
83225694|NCT05325281|Vitamins|vitamins|mesh-ancestor
83225695|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
83225696|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83225697|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225698|NCT05260008|Epinephrine|epinephrine|mesh-list
83225699|NCT05260008|Bupivacaine|bupivacaine|mesh-list
83225700|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
83225701|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
83225702|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225703|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225704|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
83225705|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225706|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83225707|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83225708|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
83225709|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225710|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225711|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83225712|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83225713|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
83225714|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83225715|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
83225716|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
83225717|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
83225718|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83225719|NCT05255601|Nivolumab|nivolumab|mesh-list
83225720|NCT05255601|Relatlimab|relatlimab|mesh-list
83225721|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225722|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225723|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83225724|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225725|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
83225726|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83225727|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225728|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
83225729|NCT05220046|Psilocybin|psilocybin|mesh-list
83225730|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
83225731|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225732|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83225733|NCT05204927|Prednisone|prednisone|mesh-list
83225734|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225735|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
83225736|NCT05204927|Hormones|hormones|mesh-ancestor
83225737|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225738|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225739|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225740|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225741|NCT05193994|Lamivudine|lamivudine|mesh-list
83225742|NCT05193994|Abacavir|abacavir|mesh-list
83225743|NCT05193994|Dolutegravir|dolutegravir|mesh-list
83225744|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83225745|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83225746|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225747|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225748|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
83225749|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225750|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83225751|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83225752|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83225753|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83225754|NCT05191784|Bevacizumab|bevacizumab|mesh-list
83225755|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225756|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225757|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83225758|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83225759|NCT05191784|Growth Substances|growth substances|mesh-ancestor
83225760|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225761|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
83225762|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83225763|NCT05159934|Nicotine|nicotine|mesh-list
83225764|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83225765|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
83225766|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225767|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225768|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83225769|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83225815|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83225816|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225817|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225818|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83225819|NCT05020821|Analgesics|analgesics|mesh-ancestor
83225820|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
83225821|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225822|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83225823|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83225824|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83225825|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
83225826|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225827|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225828|NCT05020665|Cytarabine|cytarabine|mesh-list
83225829|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83225830|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
83225831|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225832|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225833|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
83225834|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83225835|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225836|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
83225837|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225838|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
83225839|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83225840|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225841|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225842|NCT04992065|Evolocumab|evolocumab|mesh-list
83225843|NCT04992065|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83225844|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83225845|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83225846|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
83225847|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225848|NCT04992065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83225849|NCT04992065|Protease Inhibitors|protease inhibitors|mesh-ancestor
83225850|NCT04992065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225851|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83225853|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
83225854|NCT04941716|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83225855|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225856|NCT04941716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225857|NCT04941716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225858|NCT04941716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225859|NCT04911062|Epinephrine|epinephrine|mesh-list
83225860|NCT04911062|Bupivacaine|bupivacaine|mesh-list
83225861|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
83225862|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
83225863|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225864|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225865|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
83225866|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225867|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83225868|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83225869|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83225870|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225871|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225872|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83225873|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83225874|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
83225875|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83225876|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
83225877|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
83225878|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
83225879|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83225880|NCT04906395|Tamoxifen|tamoxifen|mesh-list
83225881|NCT04906395|Letrozole|letrozole|mesh-list
83225882|NCT04906395|Anastrozole|anastrozole|mesh-list
83225883|NCT04906395|Exemestane|exemestane|mesh-list
83225884|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225885|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83225886|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83225887|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225888|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225889|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83225890|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
83225891|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225892|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225893|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225894|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83225895|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83225896|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83225897|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
83225898|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225899|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225900|NCT04892472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83225901|NCT04892472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225902|NCT04877990|Deucravacitinib|deucravacitinib|mesh-list
83225903|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
83225904|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225905|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225906|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225907|NCT04818749|Dexamethasone|dexamethasone|mesh-list
83225908|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
83225909|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
83225910|NCT04818749|BB 1101|bb 1101|mesh-list
83225911|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225912|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
83225913|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
83225914|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225915|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225916|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83225917|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
83225918|NCT04818749|Hormones|hormones|mesh-ancestor
83225919|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225920|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225921|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225922|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
83225923|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225924|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225925|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83225926|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83225927|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83225928|NCT04818749|Analgesics|analgesics|mesh-ancestor
83225929|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
83225930|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83225931|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83225932|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83225933|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
83225934|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225935|NCT04790903|Prednisone|prednisone|mesh-list
83225936|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
83225937|NCT04790903|Rituximab|rituximab|mesh-list
83225938|NCT04790903|Doxorubicin|doxorubicin|mesh-list
83225939|NCT04790903|Venetoclax|venetoclax|mesh-list
83225940|NCT04790903|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83225941|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83225942|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
83225943|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225944|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83225945|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83225946|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
83225947|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225948|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225949|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83225950|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225951|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83225952|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83225953|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83225954|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225955|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225956|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
83225957|NCT04790903|Hormones|hormones|mesh-ancestor
83225958|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225959|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225960|NCT04790903|Immunoconjugates|immunoconjugates|mesh-ancestor
83225961|NCT04776395|Dexamethasone|dexamethasone|mesh-list
83225962|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
83225963|NCT04776395|Ichthammol|ichthammol|mesh-list
83225964|NCT04776395|BB 1101|bb 1101|mesh-list
83225965|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83225966|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
83225967|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
83225968|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83225969|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225970|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83225971|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
83225972|NCT04776395|Hormones|hormones|mesh-ancestor
83225973|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83225974|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83225975|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225976|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83225977|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225978|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225979|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
83225980|NCT04772079|Deucravacitinib|deucravacitinib|mesh-list
83225981|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
83225982|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83225983|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83225984|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225985|NCT04751383|Dinutuximab|dinutuximab|mesh-list
83225986|NCT04751383|Magrolimab|magrolimab|mesh-list
83225987|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83225988|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83225989|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
83225990|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225991|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83225992|NCT04738643|Varenicline|varenicline|mesh-list
83225993|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83225994|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83225995|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
83225996|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83225997|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83225998|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83225999|NCT04733534|Dasatinib|dasatinib|mesh-list
83226000|NCT04733534|Quercetin|quercetin|mesh-list
83226001|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226002|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226003|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226004|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226005|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
83226006|NCT04733534|Protective Agents|protective agents|mesh-ancestor
83226007|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226008|NCT04704661|Trastuzumab|trastuzumab|mesh-list
83226009|NCT04704661|Camptothecin|camptothecin|mesh-list
83226010|NCT04704661|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83226011|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
83226012|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226013|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226014|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
83226015|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226016|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83226017|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83226018|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83226019|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226020|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226021|NCT04663308|Volixibat|volixibat|mesh-list
83226022|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83226023|NCT04588688|Mifepristone|mifepristone|mesh-list
83226024|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83226025|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
83226026|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83226027|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226028|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83226029|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83226030|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83226031|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
83226032|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83226033|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83226034|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
83226035|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226036|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
83226037|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83226038|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83226039|NCT04587830|Temozolomide|temozolomide|mesh-list
83226040|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83226041|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
83226042|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226043|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226044|NCT04558281|Ropivacaine|ropivacaine|mesh-list
83226045|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
83226046|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
83226047|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83226048|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226049|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
83226050|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226051|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
83226052|NCT04520607|Lorecivivint|lorecivivint|mesh-list
83226053|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226054|NCT04498468|Dexamethasone|dexamethasone|mesh-list
83226055|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226056|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
83226057|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
83226058|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226059|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226060|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226061|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
83226062|NCT04498468|Hormones|hormones|mesh-ancestor
83226063|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226064|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226065|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226066|NCT04486391|Tislelizumab|tislelizumab|mesh-list
83226067|NCT04486391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226068|NCT04486391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226069|NCT04434092|Eculizumab|eculizumab|mesh-list
83226070|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83226071|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226072|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
83226073|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226075|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83226076|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226077|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
83226078|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226079|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
83226080|NCT04396574|Lasmiditan|lasmiditan|mesh-list
83226081|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83226082|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
83226083|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226084|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226085|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226086|NCT04396236|Lasmiditan|lasmiditan|mesh-list
83226087|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83226088|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
83226089|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226090|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226091|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226092|NCT04345913|Halichondrin B|halichondrin b|mesh-list
83226093|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
83226094|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
83226095|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
83226096|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226097|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226098|NCT04343222|Bromfenac|bromfenac|mesh-list
83226099|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
83226100|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83226101|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83226102|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83226103|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83226104|NCT04343222|Analgesics|analgesics|mesh-ancestor
83226105|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
83226106|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226107|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226108|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226109|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226110|NCT04342039|Budesonide|budesonide|mesh-list
83226111|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226112|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83226113|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
83226114|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226115|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226116|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83226117|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83226118|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
83226119|NCT04342039|Hormones|hormones|mesh-ancestor
83226120|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226121|NCT04311671|Ivermectin|ivermectin|mesh-list
83226122|NCT04311671|Albendazole|albendazole|mesh-list
83226123|NCT04311671|Moxidectin|moxidectin|mesh-list
83226124|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83226125|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226126|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
83226127|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
83226128|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83226129|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83226130|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83226131|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83226132|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83226133|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226134|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226135|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
83226136|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
83226137|NCT04303169|Tretinoin|tretinoin|mesh-list
83226138|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226139|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226140|NCT04303169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226141|NCT04303169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226142|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
83226143|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
83226144|NCT04281108|Fluticasone|fluticasone|mesh-list
83226146|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226147|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83226148|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
83226149|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226150|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226151|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83226152|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
83226153|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
83226154|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83226155|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83226156|NCT04268849|Hematinics|hematinics|mesh-ancestor
83226157|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83226158|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83226159|NCT04258046|Trametinib|trametinib|mesh-list
83226160|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226161|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226162|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226163|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226164|NCT04248829|Gefitinib|gefitinib|mesh-list
83226165|NCT04248829|Lazertinib|lazertinib|mesh-list
83226166|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226167|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226168|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226169|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226170|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83226171|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226172|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
83226173|NCT04230265|Fludarabine|fludarabine|mesh-list
83226174|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226175|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
83226176|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226177|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226178|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83226179|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
83226180|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226181|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226182|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83226183|NCT04215978|Tislelizumab|tislelizumab|mesh-list
83226184|NCT04215978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226185|NCT04215978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226186|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
83226187|NCT04210115|Leucovorin|leucovorin|mesh-list
83226188|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
83226189|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
83226190|NCT04210115|Calcium|calcium|mesh-list
83226191|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
83226192|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226193|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226194|NCT04210115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226195|NCT04210115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226196|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83226197|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226198|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83226199|NCT04210115|Antidotes|antidotes|mesh-ancestor
83226200|NCT04210115|Protective Agents|protective agents|mesh-ancestor
83226201|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
83226202|NCT04210115|Vitamins|vitamins|mesh-ancestor
83226203|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
83226204|NCT04189055|Irinotecan|irinotecan|mesh-list
83226205|NCT04189055|Cetuximab|cetuximab|mesh-list
83226206|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83226207|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83226208|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226209|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226210|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226211|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226212|NCT04184622|Tirzepatide|tirzepatide|mesh-list
83226213|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83226214|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226215|NCT04184622|Incretins|incretins|mesh-ancestor
83226216|NCT04184622|Hormones|hormones|mesh-ancestor
83226217|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226218|NCT04147806|Dexamethasone|dexamethasone|mesh-list
83226219|NCT04147806|Tamsulosin|tamsulosin|mesh-list
83226220|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226221|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
83226222|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
83226223|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226224|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226225|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226226|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
83226227|NCT04147806|Hormones|hormones|mesh-ancestor
83226228|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226229|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226230|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226231|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83226232|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83226233|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83226234|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
83226235|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226236|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226237|NCT04147806|Urological Agents|urological agents|mesh-ancestor
83226238|NCT04122625|Nivolumab|nivolumab|mesh-list
83226239|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226240|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226241|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226242|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226243|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83226244|NCT04117945|Cetuximab|cetuximab|mesh-list
83226245|NCT04117945|Panitumumab|panitumumab|mesh-list
83226246|NCT04117945|Irinotecan|irinotecan|mesh-list
83226247|NCT04117945|Antibodies|antibodies|mesh-list
83226248|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
83226249|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83226250|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
83226251|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226252|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226253|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83226254|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83226255|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226256|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226257|NCT04097561|Belimumab|belimumab|mesh-list
83226258|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226259|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
83226260|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226262|NCT04088188|Gemcitabine|gemcitabine|mesh-list
83226263|NCT04088188|Ivosidenib|ivosidenib|mesh-list
83226264|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226265|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226266|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
83226267|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226268|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226269|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
83226270|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83226271|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
83226272|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226273|NCT04076462|Octreotide|octreotide|mesh-list
83226274|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226275|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226276|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226277|NCT04066348|Etanercept|etanercept|mesh-list
83226278|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83226279|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83226280|NCT04066348|Analgesics|analgesics|mesh-ancestor
83226281|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
83226282|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226283|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226284|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226285|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226286|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226287|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226288|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
83226289|NCT04064060|Luspatercept|luspatercept|mesh-list
83226290|NCT04064060|Hematinics|hematinics|mesh-ancestor
83226291|NCT04057898|Ibudilast|ibudilast|mesh-list
83226292|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83226293|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
83226294|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226295|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226296|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83226297|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83226298|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83226299|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226300|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226301|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83226302|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
83226303|NCT04044313|Lenvatinib|lenvatinib|mesh-list
83226304|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226305|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226306|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226307|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226308|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
83226309|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83226310|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
83226311|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226312|NCT03847428|Bevacizumab|bevacizumab|mesh-list
83226313|NCT03847428|Durvalumab|durvalumab|mesh-list
83226314|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226315|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226316|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83226317|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83226318|NCT03847428|Growth Substances|growth substances|mesh-ancestor
83226319|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226320|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
83226321|NCT03828201|Levofloxacin|levofloxacin|mesh-list
83226322|NCT03828201|Linezolid|linezolid|mesh-list
83226323|NCT03828201|Bedaquiline|bedaquiline|mesh-list
83226324|NCT03828201|Clofazimine|clofazimine|mesh-list
83226325|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83226326|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226327|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83226328|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83226329|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83226330|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226331|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226332|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226333|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83226334|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83226335|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83226336|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
83226337|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226338|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
83226339|NCT03824704|Nivolumab|nivolumab|mesh-list
83226340|NCT03824704|Rucaparib|rucaparib|mesh-list
83226341|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226342|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226343|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226344|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226345|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83226346|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226347|NCT03798106|Durvalumab|durvalumab|mesh-list
83226348|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226349|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226350|NCT03767075|Atezolizumab|atezolizumab|mesh-list
83226351|NCT03767075|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
83226352|NCT03767075|Futibatinib|futibatinib|mesh-list
83226353|NCT03767075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226354|NCT03767075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226355|NCT03767075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226356|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226357|NCT03766581|Aspirin|aspirin|mesh-list
83226358|NCT03766581|Clopidogrel|clopidogrel|mesh-list
83226359|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83226360|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83226361|NCT03766581|Analgesics|analgesics|mesh-ancestor
83226362|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
83226363|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226364|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226365|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226366|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226367|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83226368|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83226369|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226370|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83226371|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83226372|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226373|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
83226374|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83226375|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83226376|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83226377|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
83226378|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226379|NCT03702725|Dexamethasone|dexamethasone|mesh-list
83226380|NCT03702725|Lenalidomide|lenalidomide|mesh-list
83226381|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226382|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
83226383|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
83226384|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226385|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226386|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226387|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
83226388|NCT03702725|Hormones|hormones|mesh-ancestor
83226389|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226390|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226391|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226392|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
83226393|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83226394|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83226395|NCT03702725|Growth Substances|growth substances|mesh-ancestor
83226396|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
83226397|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
83226398|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
83226399|NCT03670966|Fludarabine|fludarabine|mesh-list
83226400|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
83226401|NCT03670966|Tacrolimus|tacrolimus|mesh-list
83226402|NCT03670966|Antibodies|antibodies|mesh-list
83226403|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83226404|NCT03670966|Lenograstim|lenograstim|mesh-list
83226405|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226406|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
83226407|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226408|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226409|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83226410|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
83226411|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226412|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226413|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83226414|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226415|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
83226416|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226417|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83226418|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226419|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83226420|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83226421|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
83226422|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83226423|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83226424|NCT03653247|Plerixafor|plerixafor|mesh-list
83226425|NCT03653247|Busulfan|busulfan|mesh-list
83226426|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
83226427|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226428|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226429|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
83226430|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226431|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83226432|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226433|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83226434|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83226435|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83226436|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
83226437|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226438|NCT03635983|Nivolumab|nivolumab|mesh-list
83226439|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226440|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226441|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226442|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226443|NCT03527745|Albendazole|albendazole|mesh-list
83226444|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
83226445|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83226446|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226447|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
83226448|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83226450|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
83226451|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
83226452|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
83226453|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226454|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226455|NCT03522584|Durvalumab|durvalumab|mesh-list
83226456|NCT03522584|Ipilimumab|ipilimumab|mesh-list
83226457|NCT03522584|Tremelimumab|tremelimumab|mesh-list
83226458|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
83226459|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83226460|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
83226461|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226462|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226463|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
83226464|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226465|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226466|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226467|NCT03377361|Nivolumab|nivolumab|mesh-list
83226468|NCT03377361|Ipilimumab|ipilimumab|mesh-list
83226469|NCT03377361|Trametinib|trametinib|mesh-list
83226470|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226471|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226472|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226473|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226474|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226475|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226476|NCT03330405|Avelumab|avelumab|mesh-list
83226477|NCT03330405|Talazoparib|talazoparib|mesh-list
83226478|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83226479|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226480|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226481|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
83226482|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226483|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83226484|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226485|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226486|NCT03284463|Glyburide|glyburide|mesh-list
83226487|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83226488|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226489|NCT03223103|Poly ICLC|poly iclc|mesh-list
83226490|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
83226491|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
83226492|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226493|NCT03215030|Dexamethasone|dexamethasone|mesh-list
83226494|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226495|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
83226496|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
83226497|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226498|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226499|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226500|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
83226501|NCT03215030|Hormones|hormones|mesh-ancestor
83226502|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226503|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226504|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226505|NCT03174782|Bupivacaine|bupivacaine|mesh-list
83226506|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
83226507|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
83226508|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83226509|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226510|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
83226511|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226512|NCT03128034|Cyclosporine|cyclosporine|mesh-list
83226513|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
83226514|NCT03128034|Fludarabine|fludarabine|mesh-list
83226515|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
83226516|NCT03128034|Cyclosporins|cyclosporins|mesh-list
83362242|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83226523|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226524|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226525|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
83226526|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226527|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
83226528|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226529|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83226530|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83226531|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83226532|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
83226533|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83226534|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
83226535|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226536|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226537|NCT03064490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226538|NCT03064490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226539|NCT02953509|Rituximab|rituximab|mesh-list
83226540|NCT02953509|Magrolimab|magrolimab|mesh-list
83226541|NCT02953509|Gemcitabine|gemcitabine|mesh-list
83226542|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
83226543|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226544|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226545|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
83226546|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226547|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226548|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226549|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
83226550|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226551|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
83226552|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226553|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226554|NCT02919969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226555|NCT02919969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226556|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
83226557|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226558|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226559|NCT02837263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226560|NCT02837263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226567|NCT02670707|Cytarabine|cytarabine|mesh-list
83226568|NCT02670707|Prednisone|prednisone|mesh-list
83226569|NCT02670707|Vinblastine|vinblastine|mesh-list
83226570|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226571|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
83226572|NCT02670707|Hormones|hormones|mesh-ancestor
83226573|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226574|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226575|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226576|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226577|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226578|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
83226579|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226580|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
83226581|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226582|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226583|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
83226584|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83226585|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83226586|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83226587|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83226588|NCT02616640|Dexamethasone|dexamethasone|mesh-list
83226589|NCT02616640|Durvalumab|durvalumab|mesh-list
83226590|NCT02616640|Pomalidomide|pomalidomide|mesh-list
83226591|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226592|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
83226593|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
83226594|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226595|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226596|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226597|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
83226598|NCT02616640|Hormones|hormones|mesh-ancestor
83226599|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226600|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226601|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226602|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226603|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
83226604|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83226605|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83226606|NCT02616640|Growth Substances|growth substances|mesh-ancestor
83226607|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
83226608|NCT02352883|Hormones|hormones|mesh-list
83226609|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226610|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226611|NCT02307812|Paclitaxel|paclitaxel|mesh-list
83226612|NCT02307812|Ramucirumab|ramucirumab|mesh-list
83226613|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83226614|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226615|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83226616|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83226617|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83226618|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226619|NCT02270632|Methotrexate|methotrexate|mesh-list
83226620|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83226621|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
83226622|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83226623|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226624|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226625|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
83226626|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226627|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226628|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
83226629|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226630|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83226631|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226632|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
83226633|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226634|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83226635|NCT02231749|Nivolumab|nivolumab|mesh-list
83226636|NCT02231749|Ipilimumab|ipilimumab|mesh-list
83226637|NCT02231749|Sunitinib|sunitinib|mesh-list
83226638|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226639|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226640|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226641|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226642|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83226643|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83226644|NCT02231749|Growth Substances|growth substances|mesh-ancestor
83226645|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226646|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
83226647|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226648|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226649|NCT02065765|Ramucirumab|ramucirumab|mesh-list
83226650|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226651|NCT02003209|Carboplatin|carboplatin|mesh-list
83226652|NCT02003209|Docetaxel|docetaxel|mesh-list
83226653|NCT02003209|Trastuzumab|trastuzumab|mesh-list
83226654|NCT02003209|Pertuzumab|pertuzumab|mesh-list
83226655|NCT02003209|Goserelin|goserelin|mesh-list
83226656|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83226657|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83226658|NCT02003209|Antibodies|antibodies|mesh-list
83226659|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
83226660|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83226661|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83226662|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
83226663|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226664|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226665|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83226666|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83226667|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83226668|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226669|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226670|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83226671|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226672|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83226673|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
83226674|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226675|NCT01968109|Nivolumab|nivolumab|mesh-list
83226676|NCT01968109|Relatlimab|relatlimab|mesh-list
83226677|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226678|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226679|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83226680|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226681|NCT01891344|Rucaparib|rucaparib|mesh-list
83226682|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83226683|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226684|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226685|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226686|NCT01828099|Carboplatin|carboplatin|mesh-list
83226687|NCT01828099|Pemetrexed|pemetrexed|mesh-list
83226688|NCT01828099|Ceritinib|ceritinib|mesh-list
83226689|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226690|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226691|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226692|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83226693|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83226694|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226695|NCT01188096|Poly ICLC|poly iclc|mesh-list
83226696|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
83226697|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
83226698|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226699|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
83226700|NCT01176006|Busulfan|busulfan|mesh-list
83226701|NCT01176006|Fludarabine|fludarabine|mesh-list
83226702|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
83226703|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226704|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
83226705|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226706|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226707|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83226708|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
83226709|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226710|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226711|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83226712|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226713|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
83226714|NCT01121588|Crizotinib|crizotinib|mesh-list
83226715|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226716|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226717|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226718|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226719|NCT00632853|Carboplatin|carboplatin|mesh-list
83226720|NCT00632853|Etoposide|etoposide|mesh-list
83226721|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226722|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83226723|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83226724|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83226725|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226726|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226727|NCT00579826|Letrozole|letrozole|mesh-list
83226728|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226729|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83226730|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83226731|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226732|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226733|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83226734|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
83226735|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226736|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226737|NCT00106691|Toremifene|toremifene|mesh-list
83226738|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226739|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362243|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83226740|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83226741|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83226742|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
83226743|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226744|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226745|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83226746|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83226747|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83226748|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83226749|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83226750|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226751|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226752|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226753|NCT00071708|Analgesics|analgesics|mesh-ancestor
83226754|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
83226755|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226756|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
83226757|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83226758|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
83226759|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
83226760|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226761|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226762|NCT04576325|Voriconazole|voriconazole|mesh-list
83226763|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
83226764|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226765|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83226766|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83226767|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226768|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226769|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83226770|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
83226771|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226772|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226773|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83226775|NCT04564625|Vitamins|vitamins|mesh-ancestor
83226776|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
83226777|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226778|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83226779|NCT03126617|Elotuzumab|elotuzumab|mesh-list
83226780|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226781|NCT04422743|Tramiprosate|tramiprosate|mesh-list
83226782|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83226783|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
83226784|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
83226785|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
83226786|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
83226787|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226788|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226789|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226790|NCT02535221|Epirubicin|epirubicin|mesh-list
83226791|NCT02535221|Goserelin|goserelin|mesh-list
83226792|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83226793|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226794|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83226795|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83226796|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226797|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226798|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226799|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
83226800|NCT00000587|Hematinics|hematinics|mesh-ancestor
83226801|NCT04592159|Nabiximols|nabiximols|mesh-list
83226802|NCT04592159|Analgesics|analgesics|mesh-ancestor
83226803|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
83226804|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226805|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226806|NCT05137145|Linaclotide|linaclotide|mesh-list
83226807|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83226808|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
83226809|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226810|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226811|NCT04419389|Rituximab|rituximab|mesh-list
83226812|NCT04419389|Venetoclax|venetoclax|mesh-list
83226814|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83226815|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226816|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
83226817|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226818|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226819|NCT05304845|Aspirin|aspirin|mesh-list
83226820|NCT05304845|Fexuprazan|fexuprazan|mesh-list
83226821|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83226822|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83226823|NCT05304845|Analgesics|analgesics|mesh-ancestor
83226824|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
83226825|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226826|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226827|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226828|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226829|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83226830|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83226831|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226832|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83226833|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83226834|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226835|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
83226836|NCT05304845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226837|NCT05303597|Lidocaine|lidocaine|mesh-list
83226838|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
83226839|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
83226840|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83226841|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226842|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
83226843|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226844|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83226845|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83226846|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83226847|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83226848|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226849|NCT04892459|Vaccines|vaccines|mesh-list
83226850|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
83226851|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226852|NCT04881539|Cannabidiol|cannabidiol|mesh-list
83226853|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
83226854|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83226855|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
83226856|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226857|NCT04280939|Anesthetics|anesthetics|mesh-list
83226858|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83226859|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226860|NCT05302817|Xenon|xenon|mesh-list
83226861|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83226862|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
83226863|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
83226864|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83226865|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226866|NCT04489589|Midodrine|midodrine|mesh-list
83226867|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
83226868|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
83226869|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226870|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226871|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83226872|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83226873|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83226874|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83226875|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
83226876|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226877|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226878|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
83226879|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83226880|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
83226881|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226882|NCT04314713|Scopolamine|scopolamine|mesh-list
83226883|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83226884|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83226885|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
83226886|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
83226887|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226888|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226889|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226890|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
83226891|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83226892|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
83226893|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226894|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226895|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83226896|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
83226897|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
83226898|NCT04121507|Thiotepa|thiotepa|mesh-list
83226899|NCT04121507|Fludarabine|fludarabine|mesh-list
83226900|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226901|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
83226902|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226903|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226904|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83226905|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
83226906|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226907|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226908|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83226909|NCT04719221|Evolocumab|evolocumab|mesh-list
83226910|NCT04719221|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83226911|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83226912|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83226913|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
83226914|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226915|NCT04719221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83226916|NCT04719221|Protease Inhibitors|protease inhibitors|mesh-ancestor
83226917|NCT04719221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226918|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83226919|NCT03790397|Osimertinib|osimertinib|mesh-list
83226920|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226921|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226922|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83226923|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226924|NCT03718559|Edoxaban|edoxaban|mesh-list
83226925|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83226926|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83226927|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
83226928|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83226929|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
83226930|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226931|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226932|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
83226933|NCT01228331|Cytarabine|cytarabine|mesh-list
83226934|NCT01228331|Dexamethasone|dexamethasone|mesh-list
83226935|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
83226936|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
83226937|NCT01228331|Doxorubicin|doxorubicin|mesh-list
83226938|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83226939|NCT01228331|Methotrexate|methotrexate|mesh-list
83226940|NCT01228331|Etoposide|etoposide|mesh-list
83226941|NCT01228331|Vincristine|vincristine|mesh-list
83226942|NCT01228331|Daunorubicin|daunorubicin|mesh-list
83226943|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
83226944|NCT01228331|Clofarabine|clofarabine|mesh-list
83226945|NCT01228331|Pegaspargase|pegaspargase|mesh-list
83226946|NCT01228331|Thioguanine|thioguanine|mesh-list
83226947|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
83226948|NCT01228331|Amsacrine|amsacrine|mesh-list
83226949|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83226950|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
83226951|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226952|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83226953|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83226954|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
83226955|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226956|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83226957|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83226958|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83226959|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
83226960|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
83226961|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83226962|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83226965|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83226966|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83226967|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83226968|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83226969|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83226970|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83226971|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83226972|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
83226973|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83226974|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83226975|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
83226976|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
83226977|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83226978|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83226979|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83226980|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
83226981|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83226982|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
83226983|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
83226984|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
83226985|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83226986|NCT01228331|Protective Agents|protective agents|mesh-ancestor
83226987|NCT01171937|Risperidone|risperidone|mesh-list
83226988|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83226989|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
83226990|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83226991|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83226992|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83226993|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83226994|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83226995|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83226996|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83226997|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83226998|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
83226999|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
83227000|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83227001|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83227002|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227003|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
83227004|NCT03136445|Coagulants|coagulants|mesh-ancestor
83227005|NCT00887783|Vinorelbine|vinorelbine|mesh-list
83227006|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83227007|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227008|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
83227009|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
83227010|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
83227011|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227012|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83227013|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227014|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227015|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
83227016|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227017|NCT01125371|Ethanol|ethanol|mesh-list
83227018|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83227019|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227020|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227021|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227022|NCT03199547|Azithromycin|azithromycin|mesh-list
83227023|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83227024|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227025|NCT03189641|Cilostazol|cilostazol|mesh-list
83227026|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83227027|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
83227028|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227029|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227030|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83227031|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
83227032|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83227033|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83227034|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227035|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83227036|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
83227037|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83227038|NCT03189641|Protective Agents|protective agents|mesh-ancestor
83227039|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83227040|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83227041|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227042|NCT00416351|Clofarabine|clofarabine|mesh-list
83227043|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83227044|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
83227045|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227046|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227048|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
83227049|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83227050|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227051|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227052|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227053|NCT03938831|Analgesics|analgesics|mesh-ancestor
83227054|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
83227055|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227056|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83227057|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83227058|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83227059|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
83227060|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227061|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227062|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83227063|NCT03938831|Narcotics|narcotics|mesh-ancestor
83227064|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83227065|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83227066|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
83227067|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
83227068|NCT02592707|Dexamethasone|dexamethasone|mesh-list
83227069|NCT02592707|Ondansetron|ondansetron|mesh-list
83227070|NCT02592707|Antiemetics|antiemetics|mesh-list
83227071|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83227072|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227073|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
83227074|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227075|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227076|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83227077|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
83227078|NCT02592707|Hormones|hormones|mesh-ancestor
83227079|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227080|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83227081|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227082|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227083|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
83227084|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227085|NCT02592707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83227086|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83227087|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
83227088|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227089|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
83227090|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
83227091|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
83227092|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
83227093|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227094|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83227095|NCT03104855|Calcifediol|calcifediol|mesh-list
83227096|NCT03104855|Vitamins|vitamins|mesh-ancestor
83227097|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
83227098|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227099|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83227100|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
83227101|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83227102|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227103|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
83227104|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83227105|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227106|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227107|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227108|NCT03102359|Analgesics|analgesics|mesh-ancestor
83227109|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
83227110|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227111|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83227112|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83227113|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83227114|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
83227115|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227116|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227117|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
83227118|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83227119|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
83227120|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83227121|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227122|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83227123|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83227124|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83227125|NCT03832049|Vaccines|vaccines|mesh-list
83227126|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
83227127|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227128|NCT02102477|Androgens|androgens|mesh-list
83227129|NCT02102477|Hormones|hormones|mesh-ancestor
83227130|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227131|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227132|NCT03103685|Clopidogrel|clopidogrel|mesh-list
83227133|NCT03103685|Ticagrelor|ticagrelor|mesh-list
83227134|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83227135|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83227136|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83227137|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83227138|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83227139|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
83227140|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227141|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227142|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227143|NCT03748433|Insulin|insulin|mesh-list
83227144|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227145|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227146|NCT00540995|Etoposide|etoposide|mesh-list
83227147|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
83227148|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
83227149|NCT00540995|Busulfan|busulfan|mesh-list
83227150|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83227151|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227152|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83227153|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83227154|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227155|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227156|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
83227157|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227158|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
83227159|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227160|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83227161|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83227162|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
83227163|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227164|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
83227165|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
83227166|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
83227167|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83227168|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
83227169|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227170|NCT05103215|Lidocaine|lidocaine|mesh-list
83227171|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
83227172|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
83227173|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227174|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227175|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
83227176|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227177|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83227178|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83227179|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83227180|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83227181|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227182|NCT05001815|Insulin|insulin|mesh-list
83227183|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83227184|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227185|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227187|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227188|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227189|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83227190|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227191|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
83227192|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83227193|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227194|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227195|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227196|NCT04771637|Analgesics|analgesics|mesh-ancestor
83227197|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
83227198|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227199|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83227200|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83227201|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83227202|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
83227203|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227204|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227205|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83227206|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227207|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227208|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
83227209|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227210|NCT04701593|Triamcinolone|triamcinolone|mesh-list
83227211|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83227212|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83227213|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83227214|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227215|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
83227216|NCT04701593|Hormones|hormones|mesh-ancestor
83227217|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227218|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227219|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227220|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
83227221|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227222|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227223|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83227224|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227225|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227226|NCT05243693|Immunotoxins|immunotoxins|mesh-ancestor
83227227|NCT05243693|Immunoconjugates|immunoconjugates|mesh-ancestor
83227228|NCT05243693|Immunologic Factors|immunologic factors|mesh-ancestor
83227229|NCT05243693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227230|NCT04552847|Octreotide|octreotide|mesh-list
83227231|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
83227232|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83227233|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83227234|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227235|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83227236|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227237|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
83227238|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83227239|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
83227240|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
83227241|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227242|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227243|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227244|NCT05167331|Analgesics|analgesics|mesh-ancestor
83227245|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
83227246|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227247|NCT04509401|Vitamins|vitamins|mesh-list
83227248|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
83227249|NCT04509401|Pyridoxal|pyridoxal|mesh-list
83227250|NCT04509401|Pyridoxine|pyridoxine|mesh-list
83227251|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
83227252|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
83227253|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227254|NCT05155007|Cyclosporine|cyclosporine|mesh-list
83227255|NCT05155007|Cyclosporins|cyclosporins|mesh-list
83227256|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227257|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227258|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227259|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
83227260|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227261|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
83227262|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227263|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227264|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83227265|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83227266|NCT01641107|Ponatinib|ponatinib|mesh-list
83227267|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227268|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227269|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227270|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227271|NCT03101423|Interleukin-2|interleukin-2|mesh-list
83227272|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227273|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227274|NCT03101423|Analgesics|analgesics|mesh-ancestor
83227275|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
83227276|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227277|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227278|NCT05073029|Vitamin D|vitamin d|mesh-list
83227279|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
83227280|NCT05073029|Vitamins|vitamins|mesh-ancestor
83227281|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
83227282|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227283|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83227284|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83227285|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
83227287|NCT02642159|Niacinamide|niacinamide|mesh-list
83227288|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83227289|NCT02642159|Ezetimibe|ezetimibe|mesh-list
83227290|NCT02642159|Alirocumab|alirocumab|mesh-list
83227291|NCT02642159|Fenofibrate|fenofibrate|mesh-list
83227292|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227293|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227294|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
83227295|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227296|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227297|NCT02642159|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83227298|NCT02642159|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83227299|NCT02642159|Protease Inhibitors|protease inhibitors|mesh-ancestor
83227300|NCT02642159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227301|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
83227302|NCT02642159|Vitamins|vitamins|mesh-ancestor
83227303|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
83227304|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227305|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
83227307|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83227308|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83227309|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227310|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
83227311|NCT05072873|Coagulants|coagulants|mesh-ancestor
83227312|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83227313|NCT05072405|Simvastatin|simvastatin|mesh-list
83227314|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227315|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227316|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
83227317|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227318|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227319|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83227320|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227321|NCT03101579|Folic Acid|folic acid|mesh-list
83227322|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
83227323|NCT03101579|Dexamethasone|dexamethasone|mesh-list
83227324|NCT03101579|Pemetrexed|pemetrexed|mesh-list
83227325|NCT03101579|Vitamins|vitamins|mesh-ancestor
83227326|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
83227327|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227328|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227329|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
83227330|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
83227331|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227332|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83227333|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
83227334|NCT03101579|Hormones|hormones|mesh-ancestor
83227335|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227336|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83227337|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227338|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227348|NCT03882905|Ezetimibe|ezetimibe|mesh-list
83227349|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227350|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227351|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
83227352|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227353|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227354|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83227355|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227356|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227357|NCT04479865|Donepezil|donepezil|mesh-list
83227358|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83227359|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227360|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227361|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
83227362|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227363|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227364|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
83227375|NCT02668393|Docetaxel|docetaxel|mesh-list
83227376|NCT02668393|Nintedanib|nintedanib|mesh-list
83227377|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227378|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
83227379|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
83227380|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
83227381|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227382|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227383|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227384|NCT05251129|Atorvastatin|atorvastatin|mesh-list
83227385|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227386|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227387|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
83227388|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227389|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227390|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83227391|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227392|NCT01797523|Metformin|metformin|mesh-list
83227393|NCT01797523|Everolimus|everolimus|mesh-list
83227394|NCT01797523|Letrozole|letrozole|mesh-list
83227395|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227396|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227397|NCT01797523|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83227398|NCT01797523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227399|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227400|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227401|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227402|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
83227403|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227404|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83227405|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83227406|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83227407|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
83227408|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227410|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83227411|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83227412|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227413|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227414|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83227415|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227416|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227417|NCT03377023|Nivolumab|nivolumab|mesh-list
83227418|NCT03377023|Ipilimumab|ipilimumab|mesh-list
83227419|NCT03377023|Nintedanib|nintedanib|mesh-list
83227420|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227421|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227422|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83227423|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227424|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227425|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227426|NCT01226563|Calcium|calcium|mesh-list
83227427|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83227428|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227429|NCT02382757|Insulin|insulin|mesh-list
83227430|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83227431|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227432|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227433|NCT02382679|Vitamins|vitamins|mesh-list
83227434|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
83227435|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227436|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
83227437|NCT00916747|Pravastatin|pravastatin|mesh-list
83227438|NCT00916747|Lonafarnib|lonafarnib|mesh-list
83227439|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83227440|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227441|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227442|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227443|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
83227444|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227445|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227446|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83227447|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227448|NCT02391883|Clopidogrel|clopidogrel|mesh-list
83227449|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83227450|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83227451|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83227452|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83227453|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
83227454|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227455|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227456|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227457|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83227458|NCT02382523|Hormones|hormones|mesh-ancestor
83227459|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227460|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227461|NCT02391805|Tenofovir|tenofovir|mesh-list
83227462|NCT02391805|Entecavir|entecavir|mesh-list
83227463|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
83227464|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227465|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83227466|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83227467|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227468|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227469|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83227470|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83227471|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83227472|NCT02391181|Hematinics|hematinics|mesh-ancestor
83227473|NCT02381899|Rituximab|rituximab|mesh-list
83227474|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83227475|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227476|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227477|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
83227478|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227479|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83227480|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83227481|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
83227482|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227483|NCT01998958|Esketamine|esketamine|mesh-list
83227484|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
83227485|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83227486|NCT02386111|Sunitinib|sunitinib|mesh-list
83227487|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227488|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83227489|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83227490|NCT02386111|Growth Substances|growth substances|mesh-ancestor
83227491|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227492|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
83227493|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227494|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227495|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227496|NCT02386033|Atorvastatin|atorvastatin|mesh-list
83227497|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227498|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227499|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
83227500|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227501|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227502|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83227503|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227504|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83227505|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83227506|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413649|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83227507|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227508|NCT02381275|Tenofovir|tenofovir|mesh-list
83227509|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
83227510|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227511|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83227512|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83227513|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227514|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227515|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83227516|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83227517|NCT04693507|Antarelix|antarelix|mesh-list
83227518|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
83227519|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227520|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227521|NCT03105661|Atenolol|atenolol|mesh-list
83227522|NCT03105661|Labetalol|labetalol|mesh-list
83227523|NCT03105661|Nifedipine|nifedipine|mesh-list
83227524|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83227525|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83227526|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227527|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83227528|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227529|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
83227530|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
83227531|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83227532|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83227533|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83227534|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
83227535|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
83227536|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227537|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83227538|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83227539|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83227540|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
83227541|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227542|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
83227543|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83227544|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83227545|NCT01998880|Rituximab|rituximab|mesh-list
83227546|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
83227547|NCT01998880|Chlorambucil|chlorambucil|mesh-list
83227548|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227549|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227550|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
83227551|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227552|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83227553|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83227554|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
83227555|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227556|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83227557|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83227558|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227559|NCT02385019|Immunomodulating Agents|immunomodulating agents|mesh-list
83227561|NCT02385019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227562|NCT02380417|Ropivacaine|ropivacaine|mesh-list
83227563|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
83227564|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
83227565|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227566|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227567|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
83227568|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227569|NCT02390089|Capsaicin|capsaicin|mesh-list
83227570|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
83227571|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227572|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
83227573|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227574|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227575|NCT02379793|Mineral Oil|mineral oil|mesh-list
83227576|NCT02379793|Emollients|emollients|mesh-ancestor
83227577|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227578|NCT01975246|Amlodipine|amlodipine|mesh-list
83227579|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83227580|NCT01975246|Telmisartan|telmisartan|mesh-list
83227581|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83413650|NCT01702831|Lenalidomide|lenalidomide|mesh-list
83227582|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83227583|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83227584|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83227585|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227586|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83227587|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227588|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
83227589|NCT01975246|Diuretics|diuretics|mesh-ancestor
83227590|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
83227591|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83227592|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83227593|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83227594|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83227595|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83227596|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227597|NCT02379715|Remifentanil|remifentanil|mesh-list
83227598|NCT02379715|Desflurane|desflurane|mesh-list
83227599|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83227600|NCT02379715|Narcotics|narcotics|mesh-ancestor
83227601|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227602|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227603|NCT02379715|Analgesics|analgesics|mesh-ancestor
83227604|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
83227605|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227606|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83227607|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
83227608|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
83227609|NCT04439773|Lidocaine|lidocaine|mesh-list
83227610|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
83227611|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
83227612|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227613|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227614|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
83227615|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227616|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83227617|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83227618|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83227619|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83227620|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227621|NCT02389231|Interleukin-2|interleukin-2|mesh-list
83227622|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227623|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227624|NCT02389231|Analgesics|analgesics|mesh-ancestor
83227625|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
83227626|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227627|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227628|NCT02383927|Tipifarnib|tipifarnib|mesh-list
83227629|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227630|NCT02383771|Aspirin|aspirin|mesh-list
83227631|NCT02383771|Ticagrelor|ticagrelor|mesh-list
83227632|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83227633|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227635|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
83227636|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227637|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227638|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227639|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83227640|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83227641|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83227642|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227643|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83227644|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83227645|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227646|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
83227647|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83227648|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83227649|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83227650|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
83227651|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227652|NCT02378623|Apixaban|apixaban|mesh-list
83227653|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83227654|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
83227655|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83227656|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
83227657|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227658|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227659|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
83227660|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
83227661|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83227662|NCT02372149|Antibodies|antibodies|mesh-list
83227663|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
83227664|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83227665|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
83227666|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227667|NCT02661061|Midazolam|midazolam|mesh-list
83227668|NCT02661061|Ketamine|ketamine|mesh-list
83227669|NCT02661061|Analgesics|analgesics|mesh-ancestor
83227670|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
83227671|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227672|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227673|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83227674|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83227675|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
83227676|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
83227677|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227678|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83227679|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83227680|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227681|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227682|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83227683|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83227684|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83227685|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83227686|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83227687|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
83227688|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
83227689|NCT02376985|Everolimus|everolimus|mesh-list
83227690|NCT02376985|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83227691|NCT02376985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227692|NCT02376985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227693|NCT02376985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227694|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227695|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
83227696|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227697|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227698|NCT02371993|Choline|choline|mesh-list
83227699|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
83227700|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227701|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
83227702|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227703|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83227704|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227705|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
83227706|NCT02371603|Pioglitazone|pioglitazone|mesh-list
83227707|NCT02371603|Trimethoprim|trimethoprim|mesh-list
83227708|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83227709|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227710|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227711|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
83227712|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227713|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227714|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83227715|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227716|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227717|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227718|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83227719|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227720|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
83227721|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83227722|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83227723|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83227724|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83227725|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83227726|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83227727|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
83227728|NCT04230109|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83227729|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227730|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227731|NCT04230109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83227732|NCT04230109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227733|NCT04230109|Immunoconjugates|immunoconjugates|mesh-ancestor
83227734|NCT04230109|Immunologic Factors|immunologic factors|mesh-ancestor
83227735|NCT04230109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227736|NCT04149145|Niraparib|niraparib|mesh-list
83227737|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83227738|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227739|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227740|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227741|NCT02378389|Docetaxel|docetaxel|mesh-list
83227742|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227743|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
83227744|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
83227745|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
83227746|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227747|NCT02376595|Bromides|bromides|mesh-list
83227748|NCT02376595|Rocuronium|rocuronium|mesh-list
83227749|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
83227750|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83227751|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83227752|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83227753|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227754|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227755|NCT02370745|Insulin|insulin|mesh-list
83227756|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83227757|NCT02370745|Incretins|incretins|mesh-list
83227758|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227759|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227760|NCT02370745|Hormones|hormones|mesh-ancestor
83227761|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227762|NCT02376049|Betamethasone|betamethasone|mesh-list
83227763|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
83227764|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83227765|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
83227766|NCT02376049|Clobetasol|clobetasol|mesh-list
83227767|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
83227768|NCT02376049|Emollients|emollients|mesh-list
83227769|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83227770|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227771|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
83227772|NCT02376049|Hormones|hormones|mesh-ancestor
83227773|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227774|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227775|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83227776|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
83227777|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83227778|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227779|NCT02376049|Analgesics|analgesics|mesh-ancestor
83227780|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
83227781|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227782|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83227783|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227784|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227785|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
83227786|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83227787|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227788|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227789|NCT02376205|Bupivacaine|bupivacaine|mesh-list
83227790|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83227791|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
83227792|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
83227793|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83227794|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227795|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
83227796|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227797|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
83227798|NCT02370433|Neostigmine|neostigmine|mesh-list
83227799|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83227800|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227801|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227802|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
83227803|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227804|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227805|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83227806|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
83227807|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227808|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83227809|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83227810|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83227811|NCT01957150|Fluticasone|fluticasone|mesh-list
83227813|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227814|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83227815|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
83227816|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227817|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227818|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83227819|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
83227820|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227821|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83227822|NCT01995526|Insulin|insulin|mesh-list
83227823|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227824|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227825|NCT01973218|Vaccines|vaccines|mesh-list
83227826|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
83227827|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227828|NCT01946152|Dexamethasone|dexamethasone|mesh-list
83227829|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
83227830|NCT01946152|Pomalidomide|pomalidomide|mesh-list
83227831|NCT01946152|Ichthammol|ichthammol|mesh-list
83227832|NCT01946152|Lenograstim|lenograstim|mesh-list
83227833|NCT01946152|BB 1101|bb 1101|mesh-list
83227834|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227835|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
83227836|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
83227837|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227838|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227839|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83227840|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
83227841|NCT01946152|Hormones|hormones|mesh-ancestor
83227842|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227843|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83227845|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83227846|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
83227847|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
83227848|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227849|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227850|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83227851|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83227852|NCT01946152|Growth Substances|growth substances|mesh-ancestor
83227853|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
83227854|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83227855|NCT01971346|Etanercept|etanercept|mesh-list
83227856|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83227857|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83227858|NCT01971346|Analgesics|analgesics|mesh-ancestor
83227859|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
83227860|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83227861|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227862|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83227864|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83227865|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227866|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
83227867|NCT01945216|Alogliptin|alogliptin|mesh-list
83227868|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227869|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227870|NCT01945216|Incretins|incretins|mesh-ancestor
83227871|NCT01945216|Hormones|hormones|mesh-ancestor
83227872|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227873|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83227874|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
83227875|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227876|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227877|NCT02641379|Ribavirin|ribavirin|mesh-list
83227878|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83227879|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
83227880|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227881|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
83227882|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227883|NCT02660983|Donepezil|donepezil|mesh-list
83227884|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83227885|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413651|NCT01702831|Melphalan|melphalan|mesh-list
83227886|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227887|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
83227888|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227889|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227890|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
83227891|NCT05070221|Axitinib|axitinib|mesh-list
83227892|NCT05070221|Antibodies|antibodies|mesh-list
83227893|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83227894|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
83227895|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227896|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227897|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227898|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227899|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227900|NCT04404439|Topiramate|topiramate|mesh-list
83227901|NCT04404439|Verapamil|verapamil|mesh-list
83227902|NCT04404439|Paroxetine|paroxetine|mesh-list
83227903|NCT04404439|Nortriptyline|nortriptyline|mesh-list
83227904|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
83227905|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83227906|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227907|NCT04404439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83227908|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83227909|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83227910|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227911|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83227912|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
83227913|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83227914|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
83227915|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83227916|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83227917|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83227919|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83227920|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83227921|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83227922|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
83227923|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83227924|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83227925|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
83227926|NCT01953328|Atorvastatin|atorvastatin|mesh-list
83227927|NCT01953328|Evolocumab|evolocumab|mesh-list
83227928|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83227929|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83227930|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83227931|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
83227932|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227933|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83227934|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83227935|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227936|NCT01953328|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83227937|NCT01953328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83227938|NCT01953328|Protease Inhibitors|protease inhibitors|mesh-ancestor
83227939|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
83227940|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227941|NCT03100955|Cisplatin|cisplatin|mesh-list
83227942|NCT03100955|Etoposide|etoposide|mesh-list
83227943|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
83227944|NCT03100955|Apatinib|apatinib|mesh-list
83227945|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227946|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83227947|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83227948|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83227949|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227950|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227951|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83227952|NCT02377609|Tacrolimus|tacrolimus|mesh-list
83227953|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83227954|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
83227955|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227956|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83227957|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227958|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227959|NCT02369965|Ritonavir|ritonavir|mesh-list
83227960|NCT02369965|Lopinavir|lopinavir|mesh-list
83227961|NCT02369965|Tenofovir|tenofovir|mesh-list
83227962|NCT02369965|Lamivudine|lamivudine|mesh-list
83227963|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83227964|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83227965|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
83227966|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83227967|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227968|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83227969|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83227970|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
83227971|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227972|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83227973|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83227974|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83227975|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83227976|NCT02640755|Paclitaxel|paclitaxel|mesh-list
83227977|NCT02640755|Fulvestrant|fulvestrant|mesh-list
83227978|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83227979|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227980|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
83227981|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
83227982|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
83227983|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227984|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83227985|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83227986|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83227987|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83227988|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83227989|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83227990|NCT04400539|Nivolumab|nivolumab|mesh-list
83227991|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83227992|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83227993|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83227994|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83227996|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
83227997|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83227998|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83227999|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228000|NCT02375503|Vitamin D|vitamin d|mesh-list
83228001|NCT02375503|Calcium|calcium|mesh-list
83228002|NCT02375503|Vitamins|vitamins|mesh-ancestor
83228003|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
83228004|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228005|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83228006|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83228007|NCT00867191|Desloratadine|desloratadine|mesh-list
83228008|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83228009|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
83228010|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228011|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228012|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228013|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83228014|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83228015|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
83228016|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
83228017|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
83228018|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228019|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
83228020|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83228021|NCT02299141|Nintedanib|nintedanib|mesh-list
83228022|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228023|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228024|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228025|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228026|NCT02643251|Clonidine|clonidine|mesh-list
83228027|NCT02643251|Analgesics|analgesics|mesh-ancestor
83228028|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
83228029|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228030|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228031|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83228032|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
83228033|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
83228034|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83228035|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83228036|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83228037|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
83228038|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228039|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228040|NCT02375191|Fentanyl|fentanyl|mesh-list
83228041|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
83228042|NCT02375191|Ropivacaine|ropivacaine|mesh-list
83228043|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83228044|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228045|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228046|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228047|NCT02375191|Analgesics|analgesics|mesh-ancestor
83228048|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
83228049|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228050|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83228051|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83228052|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83228053|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83228054|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228055|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228056|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
83228057|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
83228058|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83228059|NCT02375191|Narcotics|narcotics|mesh-ancestor
83228060|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83228061|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83228062|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
83228063|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
83228064|NCT03100877|Melphalan|melphalan|mesh-list
83228065|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
83228066|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83228068|NCT03100877|Lenograstim|lenograstim|mesh-list
83228069|NCT03100877|Mitogens|mitogens|mesh-list
83228070|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83228071|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
83228072|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228073|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228074|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83228075|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
83228076|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228077|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228078|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83228079|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83228080|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83228081|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83228082|NCT03100877|Growth Substances|growth substances|mesh-ancestor
83228083|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
83228084|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
83228085|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
83228086|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228087|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228088|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228089|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228090|NCT00794495|Cetirizine|cetirizine|mesh-list
83228091|NCT00794495|Desloratadine|desloratadine|mesh-list
83228092|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83228093|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83228094|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83228095|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
83228096|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
83228097|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228098|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228099|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228100|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83228101|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
83228102|NCT04157075|Bupivacaine|bupivacaine|mesh-list
83228103|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
83228104|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
83228105|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228106|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228107|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
83228108|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228109|NCT00763529|Fluticasone|fluticasone|mesh-list
83228110|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
83228111|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228112|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83228113|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
83228114|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228115|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228116|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83228117|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
83228118|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
83228119|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83228120|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
83228121|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83228122|NCT03105505|Permethrin|permethrin|mesh-list
83228123|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83228124|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228125|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228126|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83228127|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228128|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83228129|NCT03105193|Lidocaine|lidocaine|mesh-list
83228130|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
83228131|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
83228132|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228133|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228134|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
83228135|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228136|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83228137|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83228138|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83228139|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83228140|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228141|NCT05066633|Metoprolol|metoprolol|mesh-list
83228142|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83228143|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83228144|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
83228145|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
83228146|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228147|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228148|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83228149|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83228150|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83228151|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
83228152|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228153|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228154|NCT04439305|Dasatinib|dasatinib|mesh-list
83228155|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228156|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228157|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228158|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228159|NCT02368951|Aprutumab ixadotin|aprutumab ixadotin|mesh-list
83228160|NCT02368951|Immunoconjugates|immunoconjugates|mesh-ancestor
83228161|NCT02368951|Immunologic Factors|immunologic factors|mesh-ancestor
83228162|NCT02368951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228163|NCT02368795|Indomethacin|indomethacin|mesh-list
83228164|NCT02368795|Isosorbide|isosorbide|mesh-list
83228165|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83228166|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83228167|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83228168|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228169|NCT02368795|Analgesics|analgesics|mesh-ancestor
83228170|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
83228171|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228172|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228173|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228174|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228175|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
83228176|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
83228177|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83228178|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83228179|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228180|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228181|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83228182|NCT02368795|Diuretics|diuretics|mesh-ancestor
83228183|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
83228184|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
83228185|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83228186|NCT00650663|Simvastatin|simvastatin|mesh-list
83228187|NCT00650663|Ezetimibe|ezetimibe|mesh-list
83228188|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83228189|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83228190|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
83228191|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228192|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83228193|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83228194|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228195|NCT02368717|Mesalamine|mesalamine|mesh-list
83228196|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83228197|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228198|NCT02368717|Analgesics|analgesics|mesh-ancestor
83228199|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
83228200|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228201|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228202|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228203|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228204|NCT04231565|Tenofovir|tenofovir|mesh-list
83228205|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
83228206|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228207|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83228208|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83228209|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228210|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228211|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83228212|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83228213|NCT03100565|Lidocaine|lidocaine|mesh-list
83228214|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
83228215|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
83228216|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228217|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228218|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
83228219|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228220|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83228221|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83228222|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83228223|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83228224|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228226|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
83228227|NCT05035277|Apixaban|apixaban|mesh-list
83228228|NCT05035277|Edoxaban|edoxaban|mesh-list
83228229|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83228230|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
83228231|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83228232|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
83228233|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228234|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228235|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
83228236|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83228237|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228238|NCT05035277|Analgesics|analgesics|mesh-ancestor
83228239|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
83228240|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228241|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228242|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228243|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228244|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83228245|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83228246|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83228247|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83228248|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
83228249|NCT02374645|Gefitinib|gefitinib|mesh-list
83228250|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228251|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228252|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228253|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228254|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
83228256|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83228257|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
83228258|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228259|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
83228260|NCT02368561|Protective Agents|protective agents|mesh-ancestor
83228261|NCT04095845|Tacrine|tacrine|mesh-list
83228262|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83228263|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228264|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228265|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
83228266|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228267|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228268|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83228269|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
83228270|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228271|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
83228272|NCT02374489|Ceritinib|ceritinib|mesh-list
83228273|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228274|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228275|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228276|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228277|NCT02374567|Topiramate|topiramate|mesh-list
83228278|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
83228279|NCT02374567|Promethazine|promethazine|mesh-list
83228280|NCT02374567|Pregabalin|pregabalin|mesh-list
83228281|NCT02374567|Lamotrigine|lamotrigine|mesh-list
83228282|NCT02374567|Lacosamide|lacosamide|mesh-list
83228283|NCT02374567|Carbamazepine|carbamazepine|mesh-list
83228284|NCT02374567|Phenytoin|phenytoin|mesh-list
83228285|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
83228286|NCT02374567|Nicergoline|nicergoline|mesh-list
83228287|NCT02374567|Midazolam|midazolam|mesh-list
83228288|NCT02374567|Diazepam|diazepam|mesh-list
83228289|NCT02374567|Triazolam|triazolam|mesh-list
83228290|NCT02374567|Acamprosate|acamprosate|mesh-list
83228291|NCT02374567|Gabapentin|gabapentin|mesh-list
83228292|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83228293|NCT02374567|Amitriptyline|amitriptyline|mesh-list
83228294|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
83228295|NCT02374567|Levetiracetam|levetiracetam|mesh-list
83228296|NCT02374567|Valproic Acid|valproic acid|mesh-list
83228297|NCT02374567|Lorazepam|lorazepam|mesh-list
83228298|NCT02374567|Clonazepam|clonazepam|mesh-list
83228299|NCT02374567|Phenobarbital|phenobarbital|mesh-list
83228300|NCT02374567|Clobazam|clobazam|mesh-list
83228301|NCT02374567|Zaleplon|zaleplon|mesh-list
83228302|NCT02374567|Nitrazepam|nitrazepam|mesh-list
83228303|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
83228304|NCT02374567|Memantine|memantine|mesh-list
83228305|NCT02374567|Biperiden|biperiden|mesh-list
83228306|NCT02374567|Haloperidol|haloperidol|mesh-list
83228307|NCT02374567|Pimozide|pimozide|mesh-list
83228308|NCT02374567|Olanzapine|olanzapine|mesh-list
83228309|NCT02374567|Zolpidem|zolpidem|mesh-list
83228310|NCT02374567|Alprazolam|alprazolam|mesh-list
83228311|NCT02374567|Zopiclone|zopiclone|mesh-list
83228312|NCT02374567|Agomelatine|agomelatine|mesh-list
83228313|NCT02374567|Doxepin|doxepin|mesh-list
83228314|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
83228315|NCT02374567|Oxazepam|oxazepam|mesh-list
83228316|NCT02374567|Temazepam|temazepam|mesh-list
83228317|NCT02374567|Brotizolam|brotizolam|mesh-list
83228318|NCT02374567|Lormetazepam|lormetazepam|mesh-list
83228319|NCT02374567|Flurazepam|flurazepam|mesh-list
83228320|NCT02374567|Mirtazapine|mirtazapine|mesh-list
83228321|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
83228322|NCT02374567|Buspirone|buspirone|mesh-list
83228323|NCT02374567|Trazodone|trazodone|mesh-list
83228324|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
83228325|NCT02374567|Bromazepam|bromazepam|mesh-list
83228326|NCT02374567|Risperidone|risperidone|mesh-list
83228327|NCT02374567|Melatonin|melatonin|mesh-list
83228328|NCT02374567|Aripiprazole|aripiprazole|mesh-list
83228329|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83228330|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83228331|NCT02374567|Ziprasidone|ziprasidone|mesh-list
83228332|NCT02374567|Clozapine|clozapine|mesh-list
83228333|NCT02374567|Amisulpride|amisulpride|mesh-list
83228334|NCT02374567|Flupenthixol|flupenthixol|mesh-list
83228335|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83228336|NCT02374567|Perphenazine|perphenazine|mesh-list
83228337|NCT02374567|Sertindole|sertindole|mesh-list
83228338|NCT02374567|Sulpiride|sulpiride|mesh-list
83228339|NCT02374567|Fluphenazine|fluphenazine|mesh-list
83228340|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
83228341|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
83228342|NCT02374567|Thioridazine|thioridazine|mesh-list
83228343|NCT02374567|Pipamperone|pipamperone|mesh-list
83228344|NCT02374567|Clopenthixol|clopenthixol|mesh-list
83228345|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
83228346|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
83228347|NCT02374567|Fluspirilene|fluspirilene|mesh-list
83228348|NCT02374567|Benperidol|benperidol|mesh-list
83228349|NCT02374567|Bromperidol|bromperidol|mesh-list
83228350|NCT02374567|Perazine|perazine|mesh-list
83228351|NCT02374567|Rivastigmine|rivastigmine|mesh-list
83228352|NCT02374567|Piracetam|piracetam|mesh-list
83228353|NCT02374567|Donepezil|donepezil|mesh-list
83228354|NCT02374567|Galantamine|galantamine|mesh-list
83228355|NCT02374567|Citalopram|citalopram|mesh-list
83228356|NCT02374567|Bupropion|bupropion|mesh-list
83228357|NCT02374567|Sertraline|sertraline|mesh-list
83228358|NCT02374567|Fluoxetine|fluoxetine|mesh-list
83228359|NCT02374567|Paroxetine|paroxetine|mesh-list
83228360|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83228361|NCT02374567|Nortriptyline|nortriptyline|mesh-list
83228362|NCT02374567|Reboxetine|reboxetine|mesh-list
83228363|NCT02374567|Imipramine|imipramine|mesh-list
83228364|NCT02374567|Clomipramine|clomipramine|mesh-list
83228365|NCT02374567|Mianserin|mianserin|mesh-list
83228366|NCT02374567|Moclobemide|moclobemide|mesh-list
83228367|NCT02374567|Opipramol|opipramol|mesh-list
83228368|NCT02374567|Trimipramine|trimipramine|mesh-list
83228369|NCT02374567|Maprotiline|maprotiline|mesh-list
83228370|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
83228371|NCT02374567|Escitalopram|escitalopram|mesh-list
83228372|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83228373|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83228374|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228375|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228376|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83228377|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83228378|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83228379|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83228380|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
83228381|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
83228382|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
83228383|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
83228384|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228385|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228386|NCT02374567|Analgesics|analgesics|mesh-ancestor
83228387|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
83228388|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228389|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
83228390|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83228391|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83228392|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83228393|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83228394|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83228395|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
83228396|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83228397|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
83228398|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83228399|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83228400|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
83228401|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
83228402|NCT02374567|Protective Agents|protective agents|mesh-ancestor
83228403|NCT02374567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83228404|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83228405|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83228406|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83228407|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
83228408|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
83228409|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83228410|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83228411|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
83228412|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83228413|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
83228414|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
83228415|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228416|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83228417|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83228418|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83228419|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228420|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
83228421|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83228422|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83228423|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83228424|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83228425|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83228426|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83228427|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
83228428|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83228429|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83228430|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83228431|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
83228432|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83228433|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
83228434|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
83228435|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83228436|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
83228437|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
83228438|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83228439|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
83228440|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83228441|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83228442|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83228443|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83228444|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83228445|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83228447|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83228448|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83228449|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83228450|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83228451|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83228452|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83228453|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83228454|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83228455|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
83228456|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83228457|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83228458|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83228459|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83228460|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83228461|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83228462|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
83228464|NCT03965741|Apixaban|apixaban|mesh-list
83228465|NCT03965741|Dabigatran|dabigatran|mesh-list
83228466|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83228467|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
83228468|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83228469|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
83228470|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228471|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228472|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
83228473|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
83228474|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
83228475|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83228476|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
83228477|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228478|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228479|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83228480|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
83228481|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83228482|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
83228483|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228484|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228485|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83228486|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
83228487|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
83228488|NCT02368171|Protective Agents|protective agents|mesh-ancestor
83228489|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
83228490|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
83228491|NCT05063513|Rituximab|rituximab|mesh-list
83228492|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83228493|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228494|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
83228495|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228496|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228497|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83228498|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83228499|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
83228500|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83228501|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228502|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228503|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228504|NCT02364583|Primaquine|primaquine|mesh-list
83228505|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
83228506|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83228507|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83228508|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228509|NCT02368015|Cefazolin|cefazolin|mesh-list
83228510|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83228511|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228513|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
83228514|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228515|NCT02373943|Protective Agents|protective agents|mesh-ancestor
83228516|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228517|NCT04632433|Cemiplimab|cemiplimab|mesh-list
83228518|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83228519|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228520|NCT02368249|Terlipressin|terlipressin|mesh-list
83228521|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83228522|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83228523|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
83228524|NCT02367937|Midazolam|midazolam|mesh-list
83228525|NCT02367937|Omeprazole|omeprazole|mesh-list
83228526|NCT02367937|Simvastatin|simvastatin|mesh-list
83228527|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83228528|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83228529|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228530|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228531|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83228532|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83228533|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83228534|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83228535|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
83228536|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
83228537|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
83228538|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
83228539|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228540|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228541|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83228542|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83228543|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
83228544|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83228545|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83228546|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228547|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83228548|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228549|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83228550|NCT02367937|Analgesics|analgesics|mesh-ancestor
83228551|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
83228552|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228553|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83228554|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228555|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228556|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228557|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83228558|NCT05011487|Pemetrexed|pemetrexed|mesh-list
83228559|NCT05011487|Osimertinib|osimertinib|mesh-list
83228560|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228561|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228562|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228563|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83228564|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83228565|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228566|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83228567|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83228568|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83228569|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
83228570|NCT05061641|Progesterone|progesterone|mesh-list
83228571|NCT05061641|Progestins|progestins|mesh-ancestor
83228572|NCT05061641|Hormones|hormones|mesh-ancestor
83228573|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83228574|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228575|NCT03100019|Resveratrol|resveratrol|mesh-list
83228576|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
83228577|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228578|NCT03100019|Protective Agents|protective agents|mesh-ancestor
83228579|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228580|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228581|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83228582|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
83228583|NCT05047055|Rifampin|rifampin|mesh-list
83228584|NCT05047055|Isoniazid|isoniazid|mesh-list
83228585|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
83228586|NCT05047055|Ethambutol|ethambutol|mesh-list
83228587|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83228588|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228589|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83228590|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83228591|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228592|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228593|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228594|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83228595|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
83228596|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
83228597|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83228598|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83228599|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83228600|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83228601|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83228602|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83228603|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83228604|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83228605|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83228606|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
83228607|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83228608|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83228609|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228610|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228611|NCT05046041|Misoprostol|misoprostol|mesh-list
83228612|NCT05046041|Mifepristone|mifepristone|mesh-list
83228613|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83228614|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
83228615|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83228616|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228617|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83228618|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228619|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
83228620|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83228621|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83228622|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83228623|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83228624|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
83228625|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83228626|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83228627|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
83228628|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83228629|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
83228630|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83228631|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83228632|NCT01970878|Bromides|bromides|mesh-list
83228633|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
83228634|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83228635|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
83228636|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228637|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228638|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83228639|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
83228640|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
83228641|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83228642|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
83228643|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228644|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228645|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
83228646|NCT05045651|Cimetidine|cimetidine|mesh-list
83228647|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83228648|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228649|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83228650|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
83228651|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
83228652|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228653|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228654|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228655|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83228656|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83228657|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228658|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
83228659|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83228660|NCT05059145|Fluconazole|fluconazole|mesh-list
83228661|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83228662|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228663|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
83228664|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83228665|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
83228666|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83228667|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83228668|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228669|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228670|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83228671|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
83228672|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83228673|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228674|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83228675|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83228676|NCT05058677|Lidocaine|lidocaine|mesh-list
83228677|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
83228678|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
83228679|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228680|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228681|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
83228682|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228683|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83228684|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83228685|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83228686|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83228687|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228689|NCT01970488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83228690|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228691|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83228692|NCT03097835|Anesthetics|anesthetics|mesh-list
83228693|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228694|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228695|NCT03097601|Sunitinib|sunitinib|mesh-list
83228696|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228697|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83228698|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83228699|NCT03097601|Growth Substances|growth substances|mesh-ancestor
83228700|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228701|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
83228702|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228703|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228704|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228705|NCT05058755|Etoposide|etoposide|mesh-list
83228706|NCT05058755|Lenalidomide|lenalidomide|mesh-list
83228707|NCT05058755|Azacitidine|azacitidine|mesh-list
83228708|NCT05058755|Tislelizumab|tislelizumab|mesh-list
83228709|NCT05058755|Pegaspargase|pegaspargase|mesh-list
83228710|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83228711|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228712|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83228713|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83228714|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228715|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228716|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
83228717|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228718|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83228719|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83228720|NCT05058755|Growth Substances|growth substances|mesh-ancestor
83228721|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
83228722|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83228723|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
83228724|NCT05058755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83228725|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
83228726|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83228727|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
83228728|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228729|NCT05058209|Triamcinolone|triamcinolone|mesh-list
83228730|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83228731|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83228732|NCT05058209|Betamethasone|betamethasone|mesh-list
83228733|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
83228734|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83228735|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
83228736|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
83228737|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83228738|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83228739|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83228740|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
83228741|NCT05058209|Hormones|hormones|mesh-ancestor
83228742|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83228743|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228744|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83228745|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
83228746|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228747|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228748|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83228749|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
83228750|NCT05057663|Fluorouracil|fluorouracil|mesh-list
83228751|NCT05057663|Bleomycin|bleomycin|mesh-list
83228752|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
83228753|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228754|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83228755|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228756|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83228757|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
83228758|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228767|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83228768|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228769|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228770|NCT05057351|Glycerol|glycerol|mesh-list
83228771|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83228772|NCT05057351|Protective Agents|protective agents|mesh-ancestor
83228773|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228774|NCT03097211|Levodopa|levodopa|mesh-list
83228775|NCT03097211|Benserazide|benserazide|mesh-list
83228776|NCT03097211|Resveratrol|resveratrol|mesh-list
83228777|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83228778|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83228779|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83228780|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
83228781|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228782|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228783|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228784|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
83228785|NCT03097211|Protective Agents|protective agents|mesh-ancestor
83228786|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228787|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83228788|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
83228789|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83228790|NCT05056337|Lenvatinib|lenvatinib|mesh-list
83228791|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228792|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228793|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228794|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228795|NCT05056025|Vitamins|vitamins|mesh-list
83228796|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
83228797|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228798|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83228799|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83228800|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228801|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83228802|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228803|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228804|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228805|NCT01952080|Teduglutide|teduglutide|mesh-list
83228806|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228807|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83228808|NCT01952080|Protective Agents|protective agents|mesh-ancestor
83228809|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228810|NCT01951378|Albuterol|albuterol|mesh-list
83228811|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83228812|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
83228813|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228814|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228815|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83228816|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
83228817|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
83228818|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83228819|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83228820|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83228821|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83228822|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
83228823|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228824|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228837|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
83228838|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83228839|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228840|NCT03258853|Pancrelipase|pancrelipase|mesh-list
83228841|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228842|NCT05054465|Venetoclax|venetoclax|mesh-list
83228843|NCT05054465|Navitoclax|navitoclax|mesh-list
83228844|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228845|NCT03860233|Oxytocin|oxytocin|mesh-list
83228846|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
83228847|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83228848|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228849|NCT04154189|Etoposide|etoposide|mesh-list
83228850|NCT04154189|Ifosfamide|ifosfamide|mesh-list
83228851|NCT04154189|Lenvatinib|lenvatinib|mesh-list
83228852|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83228853|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228854|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83228855|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83228856|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83228857|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228858|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83228859|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
83228860|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83228861|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83228862|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
83228863|NCT01361009|Pramipexole|pramipexole|mesh-list
83228864|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
83228865|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228866|NCT01361009|Protective Agents|protective agents|mesh-ancestor
83228867|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228868|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83228869|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83228870|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
83228871|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
83228872|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228873|NCT02373163|Amlodipine|amlodipine|mesh-list
83228874|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83228875|NCT02373163|Telmisartan|telmisartan|mesh-list
83228876|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83228877|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83228878|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83228879|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228880|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83228881|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228882|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
83228883|NCT02373163|Diuretics|diuretics|mesh-ancestor
83228884|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
83228885|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83228886|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83228887|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83228888|NCT02366377|Metformin|metformin|mesh-list
83228889|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83228890|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228891|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
83228892|NCT02366299|Propofol|propofol|mesh-list
83228893|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83228894|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228895|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228896|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228897|NCT02366299|Analgesics|analgesics|mesh-ancestor
83228898|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
83228899|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228900|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83228901|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83228902|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83228903|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83228904|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228905|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228906|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83228907|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
83228908|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
83228909|NCT05041985|Diazepam|diazepam|mesh-list
83228910|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83228911|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
83228912|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
83228913|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
83228914|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228915|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228916|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228917|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83228918|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228919|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83228920|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83228921|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83228922|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83228923|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83228924|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83228925|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
83228926|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
83228927|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
83228928|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
83228929|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83228930|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228931|NCT05053841|Metformin|metformin|mesh-list
83228932|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83228933|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228934|NCT02372461|Amoxicillin|amoxicillin|mesh-list
83228935|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83228936|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83228937|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
83228938|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83228939|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
83228940|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83228941|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228942|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83228944|NCT04499131|Progestins|progestins|mesh-ancestor
83228945|NCT04499131|Hormones|hormones|mesh-ancestor
83228946|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83228947|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228948|NCT02366065|Acetaminophen|acetaminophen|mesh-list
83228949|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83228950|NCT02366065|Analgesics|analgesics|mesh-ancestor
83228951|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
83228952|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228953|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228954|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
83228955|NCT02362945|Oxytocin|oxytocin|mesh-list
83228956|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
83228957|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83228958|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228959|NCT02365909|Bupivacaine|bupivacaine|mesh-list
83228960|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
83228961|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
83228962|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83228963|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228964|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
83228965|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83228966|NCT05052515|Choline|choline|mesh-list
83228967|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228968|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
83228969|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83228970|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
83228971|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228972|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83228973|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
83228974|NCT02365675|Petrolatum|petrolatum|mesh-list
83228975|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83228976|NCT02365675|Laxatives|laxatives|mesh-ancestor
83228977|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83228978|NCT02365675|Emollients|emollients|mesh-ancestor
83228979|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
83228980|NCT05052437|Capecitabine|capecitabine|mesh-list
83228981|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83228982|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
83228983|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83228984|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83228985|NCT05052359|Lectins|lectins|mesh-list
83228986|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
83228987|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
83228988|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228989|NCT05052359|Coagulants|coagulants|mesh-ancestor
83228990|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
83228991|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83228992|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83228993|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
83228994|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83228995|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83228996|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83228997|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83228998|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83228999|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83229000|NCT02362711|Estrogens|estrogens|mesh-ancestor
83229001|NCT02362711|Hormones|hormones|mesh-ancestor
83229002|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229003|NCT01944046|Oxytocin|oxytocin|mesh-list
83229004|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
83229005|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83229006|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229007|NCT00773695|Paclitaxel|paclitaxel|mesh-list
83229008|NCT00773695|Docetaxel|docetaxel|mesh-list
83229009|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
83229010|NCT00773695|Bevacizumab|bevacizumab|mesh-list
83229011|NCT00773695|Fluorouracil|fluorouracil|mesh-list
83229012|NCT00773695|Epirubicin|epirubicin|mesh-list
83229013|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83229014|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83229015|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229016|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83229017|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83229018|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83229019|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229020|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229021|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
83229022|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229023|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229024|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83229025|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
83229026|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83229027|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83229028|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83229029|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83229030|NCT00773695|Growth Substances|growth substances|mesh-ancestor
83229031|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
83229032|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
83229033|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83229034|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83229035|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229036|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83229037|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
83229038|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229039|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83229040|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83229041|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83229042|NCT01969084|Linagliptin|linagliptin|mesh-list
83229043|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83229044|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229045|NCT01969084|Incretins|incretins|mesh-ancestor
83229046|NCT01969084|Hormones|hormones|mesh-ancestor
83229047|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229048|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83229049|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
83229050|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229051|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229052|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
83229053|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229054|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
83229055|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83229056|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83229057|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229058|NCT02362399|Urological Agents|urological agents|mesh-ancestor
83229059|NCT04410887|Olaparib|olaparib|mesh-list
83229060|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83229061|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229062|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229063|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229064|NCT02358499|Posaconazole|posaconazole|mesh-list
83229065|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
83229066|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229067|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83229068|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83229069|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83229070|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83229071|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83229072|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229073|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229074|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83229075|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83229076|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229077|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229078|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
83229079|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
83229080|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
83229081|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229082|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83229083|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
83229084|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
83229085|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229086|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229087|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229088|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83229089|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
83229090|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83229091|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
83229092|NCT01968694|Promethazine|promethazine|mesh-list
83229093|NCT01968694|Lidocaine|lidocaine|mesh-list
83229094|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
83229095|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
83229096|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229097|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229098|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
83229099|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229100|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83229101|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83229102|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83229103|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229104|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229105|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83229106|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83229107|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
83229108|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
83229109|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229110|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83229111|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
83229112|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
83229113|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229114|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83229115|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
83229116|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
83229117|NCT05038007|Bupivacaine|bupivacaine|mesh-list
83229118|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83229119|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
83229120|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229121|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229122|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
83229123|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229124|NCT02362165|Dexamethasone|dexamethasone|mesh-list
83229125|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
83229126|NCT02362165|Doxorubicin|doxorubicin|mesh-list
83229127|NCT02362165|Bortezomib|bortezomib|mesh-list
83229128|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229129|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
83229130|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229131|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229132|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83229133|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
83229134|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229135|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229136|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83229137|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229138|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
83229139|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
83229140|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229141|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229142|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
83229143|NCT02362165|Hormones|hormones|mesh-ancestor
83229144|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229145|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83229146|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83229147|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83229148|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83229149|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229150|NCT05049473|Cytarabine|cytarabine|mesh-list
83229151|NCT05049473|Dexamethasone|dexamethasone|mesh-list
83229152|NCT05049473|Prednisone|prednisone|mesh-list
83229153|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
83229154|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
83229155|NCT05049473|Rituximab|rituximab|mesh-list
83229156|NCT05049473|Doxorubicin|doxorubicin|mesh-list
83229157|NCT05049473|Methotrexate|methotrexate|mesh-list
83229158|NCT05049473|Etoposide|etoposide|mesh-list
83229159|NCT05049473|Vincristine|vincristine|mesh-list
83229160|NCT05049473|Vindesine|vindesine|mesh-list
83229161|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229162|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
83229163|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229164|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229165|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83229166|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
83229167|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229168|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229169|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83229170|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83229171|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229172|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
83229173|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
83229174|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229175|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229176|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
83229177|NCT05049473|Hormones|hormones|mesh-ancestor
83229178|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229179|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83229180|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83229181|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83229182|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83229183|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229184|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83229185|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
83229186|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83229187|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83229188|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
83229189|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
83229190|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83229191|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83229192|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83229193|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
83229194|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229195|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
83229196|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
83229197|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
83229198|NCT02357797|Vortioxetine|vortioxetine|mesh-list
83229199|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
83229200|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229201|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83229202|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83229203|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229204|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229205|NCT02357797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83229206|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83229207|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229208|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229209|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229210|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
83413652|NCT01702831|Busulfan|busulfan|mesh-list
83229211|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83229212|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83229213|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83229214|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83229215|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
83229216|NCT02361931|Hematinics|hematinics|mesh-ancestor
83229217|NCT05037695|Empagliflozin|empagliflozin|mesh-list
83229218|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83229219|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229220|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83229221|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229222|NCT02357563|Leuprolide|leuprolide|mesh-list
83229223|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
83229224|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83229225|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
83229226|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83229227|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229228|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83229229|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229230|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83229231|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
83229232|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83229233|NCT02640053|Paclitaxel|paclitaxel|mesh-list
83229234|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83229235|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83229236|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229237|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83229238|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83229239|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83229240|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229241|NCT03160261|Exenatide|exenatide|mesh-list
83229242|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83229243|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229244|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83229245|NCT03160261|Incretins|incretins|mesh-ancestor
83229246|NCT03160261|Hormones|hormones|mesh-ancestor
83229247|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229248|NCT02361775|Ropivacaine|ropivacaine|mesh-list
83229249|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
83229250|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
83229251|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229252|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229253|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
83229254|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229255|NCT02361619|Clarithromycin|clarithromycin|mesh-list
83229256|NCT02361619|Diclofenac|diclofenac|mesh-list
83229257|NCT02361619|Metoprolol|metoprolol|mesh-list
83229258|NCT02361619|Midazolam|midazolam|mesh-list
83229259|NCT02361619|Caffeine|caffeine|mesh-list
83229260|NCT02361619|Esomeprazole|esomeprazole|mesh-list
83229261|NCT02361619|Dabigatran|dabigatran|mesh-list
83229262|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83229263|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83229264|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229265|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229266|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83229267|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83229268|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229269|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83229270|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
83229271|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
83229272|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
83229273|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
83229274|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229275|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229276|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83229277|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229278|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83229279|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229280|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83229281|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83229282|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83229284|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
83229285|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83229286|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83229287|NCT02361619|Analgesics|analgesics|mesh-ancestor
83229288|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
83229289|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229290|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229291|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229292|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83229293|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83229294|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229295|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83229296|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83229297|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83229298|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
83229299|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83229300|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
83229301|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
83229302|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83229303|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83229304|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
83229305|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
83229306|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83229307|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83229308|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83229309|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
83229310|NCT02352025|Equol|equol|mesh-list
83229311|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
83229312|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83229313|NCT02352025|Estrogens|estrogens|mesh-ancestor
83229314|NCT02352025|Hormones|hormones|mesh-ancestor
83229315|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229316|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229317|NCT01950364|Rifampin|rifampin|mesh-list
83229318|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83229319|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83229320|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83229321|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229322|NCT01950364|Immunotoxins|immunotoxins|mesh-ancestor
83229323|NCT01950364|Immunoconjugates|immunoconjugates|mesh-ancestor
83229324|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
83229325|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229326|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83229327|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
83229328|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83229329|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229330|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
83229331|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83229332|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229333|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229334|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83229335|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83229336|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83229337|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83229338|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83229339|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83229340|NCT05047991|Leucovorin|leucovorin|mesh-list
83229341|NCT05047991|Paclitaxel|paclitaxel|mesh-list
83229342|NCT05047991|Gemcitabine|gemcitabine|mesh-list
83229343|NCT05047991|Fluorouracil|fluorouracil|mesh-list
83229344|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
83229345|NCT05047991|Irinotecan|irinotecan|mesh-list
83229346|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83229347|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229348|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83229349|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83229350|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83229351|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229352|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83229353|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
83229354|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229355|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
83229356|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229357|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83229358|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83229359|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229360|NCT05047991|Antidotes|antidotes|mesh-ancestor
83229361|NCT05047991|Protective Agents|protective agents|mesh-ancestor
83229362|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
83229363|NCT05047991|Vitamins|vitamins|mesh-ancestor
83229364|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
83229365|NCT00014443|Thalidomide|thalidomide|mesh-list
83229366|NCT00014443|Topotecan|topotecan|mesh-list
83229367|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83229368|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83229369|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229370|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229371|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229372|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229373|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
83229374|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229375|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
83229376|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83229377|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229378|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83229379|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83229380|NCT00014443|Growth Substances|growth substances|mesh-ancestor
83229381|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
83229382|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
83229383|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83229384|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83229385|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229386|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
83229387|NCT05047133|Coagulants|coagulants|mesh-ancestor
83229388|NCT04334863|Tyrphostins|tyrphostins|mesh-list
83229389|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229390|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229391|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229392|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
83229393|NCT02357407|Ofloxacin|ofloxacin|mesh-list
83229394|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83229395|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229396|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83229397|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83229398|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229399|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229400|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229401|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83229402|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83229403|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83229404|NCT02038699|TIC10 compound|tic10 compound|mesh-list
83229405|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229406|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
83229407|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83229408|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83229409|NCT03160651|Prednisolone|prednisolone|mesh-list
83229410|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
83229411|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83229412|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
83229413|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229414|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
83229415|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
83229416|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229417|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229418|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229419|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
83229420|NCT03160651|Hormones|hormones|mesh-ancestor
83229421|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229422|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83229423|NCT03160651|Protective Agents|protective agents|mesh-ancestor
83229424|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83229425|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229427|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83229428|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
83229429|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229430|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
83229431|NCT05034965|Protective Agents|protective agents|mesh-ancestor
83229432|NCT03160339|Vaccines|vaccines|mesh-list
83229433|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
83229434|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229435|NCT05034887|Trastuzumab|trastuzumab|mesh-list
83229436|NCT05034887|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83229437|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83229438|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229439|NCT05034887|Immunoconjugates|immunoconjugates|mesh-ancestor
83229440|NCT05034887|Immunologic Factors|immunologic factors|mesh-ancestor
83229441|NCT05034887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229442|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
83229443|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83229444|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
83229445|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229446|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229447|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83229448|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229449|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
83229450|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83229451|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
83229452|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229453|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229454|NCT05024825|Acetaminophen|acetaminophen|mesh-list
83229455|NCT05024825|Ibuprofen|ibuprofen|mesh-list
83229456|NCT05024825|Gabapentin|gabapentin|mesh-list
83229457|NCT05024825|Hydrocodone|hydrocodone|mesh-list
83229458|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83229459|NCT05024825|Analgesics|analgesics|mesh-ancestor
83229460|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
83229461|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229462|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229463|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
83229464|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83229465|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229466|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229467|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83229468|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229469|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229470|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
83229471|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83229472|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83229473|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229474|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229475|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83229476|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83229477|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229478|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
83229479|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83229480|NCT05024825|Narcotics|narcotics|mesh-ancestor
83229481|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
83229482|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229483|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83229484|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229485|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
83229486|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
83229487|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
83229488|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229489|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83229490|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229491|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229492|NCT03149653|SMOFlipid|smoflipid|mesh-list
83229493|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83229494|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83229495|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83229496|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
83229497|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83229498|NCT03093545|Antibodies|antibodies|mesh-list
83229499|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
83229500|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229501|NCT05024357|Dasatinib|dasatinib|mesh-list
83229502|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229503|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83229504|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229505|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229506|NCT03095105|Resveratrol|resveratrol|mesh-list
83229507|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
83229508|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229509|NCT03095105|Protective Agents|protective agents|mesh-ancestor
83229510|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229511|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229512|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83229513|NCT01968070|Celecoxib|celecoxib|mesh-list
83229514|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83229515|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83229516|NCT01968070|Analgesics|analgesics|mesh-ancestor
83229517|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
83229518|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229519|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229520|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229521|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229522|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83229523|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83229524|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229525|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229526|NCT01949662|Lorazepam|lorazepam|mesh-list
83229527|NCT01949662|Haloperidol|haloperidol|mesh-list
83229528|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
83229529|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
83229530|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
83229531|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229532|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229533|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229534|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83229535|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83229536|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229537|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229538|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83229539|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
83229540|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229541|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229542|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83229543|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
83229544|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83229545|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83229546|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
83229547|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
83229548|NCT03093389|Resveratrol|resveratrol|mesh-list
83229549|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
83229550|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229551|NCT03093389|Protective Agents|protective agents|mesh-ancestor
83229552|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229553|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229554|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83229555|NCT01949116|Folic Acid|folic acid|mesh-list
83229556|NCT01949116|Methotrexate|methotrexate|mesh-list
83229557|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83229558|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
83229559|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83229560|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229561|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83229562|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
83229563|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229564|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229565|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
83229566|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229567|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83229568|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229569|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
83229570|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229571|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83229572|NCT01949116|Hematinics|hematinics|mesh-ancestor
83229573|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
83229574|NCT01949116|Vitamins|vitamins|mesh-ancestor
83229575|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
83229576|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
83229577|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229578|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83229579|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229580|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229581|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
83229582|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83229583|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83229584|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
83229585|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229586|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229587|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229588|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
83229589|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
83229590|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229592|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83229593|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229595|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83229596|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83229597|NCT02350543|Analgesics|analgesics|mesh-ancestor
83229598|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
83229599|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229600|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229601|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229602|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229603|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83229604|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83229605|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229606|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83229607|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83229608|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229609|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
83229610|NCT05023577|Metronidazole|metronidazole|mesh-list
83229611|NCT05023577|Clarithromycin|clarithromycin|mesh-list
83229612|NCT05023577|Levofloxacin|levofloxacin|mesh-list
83229613|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
83229614|NCT05023577|Rabeprazole|rabeprazole|mesh-list
83229615|NCT05023577|Bismuth|bismuth|mesh-list
83229616|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229617|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229618|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83229619|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83229620|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83229621|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83229622|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229623|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83229624|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83229625|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83229626|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83229627|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83229628|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229629|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83229630|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83229631|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229632|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83229633|NCT05023577|Antacids|antacids|mesh-ancestor
83229634|NCT05023577|Diuretics|diuretics|mesh-ancestor
83229635|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
83229636|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229637|NCT05023577|Expectorants|expectorants|mesh-ancestor
83229638|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229639|NCT03149419|Paroxetine|paroxetine|mesh-list
83229640|NCT03149419|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83229641|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83229642|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229643|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229644|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229645|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
83229646|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229647|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83229648|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
83229649|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229650|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83229651|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83229652|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229653|NCT03092765|Quetmolimab|quetmolimab|mesh-list
83229654|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229655|NCT01939366|Pregabalin|pregabalin|mesh-list
83229656|NCT01939366|Analgesics|analgesics|mesh-ancestor
83229657|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
83229658|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229659|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229660|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
83229661|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83229662|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229663|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229664|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83229665|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83229666|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83229667|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229668|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229669|NCT04434365|Aspirin|aspirin|mesh-list
83229670|NCT04434365|Clopidogrel|clopidogrel|mesh-list
83229671|NCT04434365|Atorvastatin|atorvastatin|mesh-list
83229672|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83229673|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83229674|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83229675|NCT04434365|Analgesics|analgesics|mesh-ancestor
83229676|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
83229677|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229678|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229679|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229680|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229681|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83229682|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83229683|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229684|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83229685|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83229686|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229687|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
83229688|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83229689|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83229690|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
83229691|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83229692|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83229693|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83229694|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83229695|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83229696|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
83229697|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229698|NCT05032235|Fluzoparib|fluzoparib|mesh-list
83229699|NCT05032235|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83229700|NCT05032235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229701|NCT05032235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229702|NCT05032235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229703|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
83229704|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83229705|NCT03149575|Carboplatin|carboplatin|mesh-list
83229706|NCT03149575|Temozolomide|temozolomide|mesh-list
83229707|NCT03149575|Lomustine|lomustine|mesh-list
83229708|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
83229709|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229710|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83229711|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
83229712|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229713|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83229714|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83229715|NCT05032001|Biguanides|biguanides|mesh-list
83229716|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229717|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83229718|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229719|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
83229720|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229721|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
83229722|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83229723|NCT05031689|Protective Agents|protective agents|mesh-ancestor
83229724|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229725|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
83229726|NCT02350231|Progesterone|progesterone|mesh-list
83229727|NCT02350231|Progestins|progestins|mesh-ancestor
83229728|NCT02350231|Hormones|hormones|mesh-ancestor
83229729|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229730|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229731|NCT01918306|Cisplatin|cisplatin|mesh-list
83229732|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229733|NCT05031143|Triamcinolone|triamcinolone|mesh-list
83229734|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83229735|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83229736|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83229737|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229738|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
83229739|NCT05031143|Hormones|hormones|mesh-ancestor
83229740|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229741|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229742|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229743|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
83229744|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229745|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229746|NCT01916980|Desloratadine|desloratadine|mesh-list
83229747|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83229748|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
83229749|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229750|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229751|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229752|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83229753|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83229754|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
83229755|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
83229756|NCT02348281|Bicalutamide|bicalutamide|mesh-list
83229757|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
83229758|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
83229759|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229760|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229761|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229762|NCT04638400|Simvastatin|simvastatin|mesh-list
83229763|NCT04638400|Ezetimibe|ezetimibe|mesh-list
83229764|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83229765|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83229766|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
83229767|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229768|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83229769|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83229770|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229771|NCT02349919|Procaterol|procaterol|mesh-list
83229772|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83229773|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
83229774|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229775|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229776|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83229777|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229778|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
83229779|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83229780|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83229781|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83229782|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83229783|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229784|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229785|NCT02349763|Dexamethasone|dexamethasone|mesh-list
83229786|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
83229787|NCT02349763|BB 1101|bb 1101|mesh-list
83229788|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229789|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
83229790|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
83229791|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229792|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229793|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229794|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
83229795|NCT02349763|Hormones|hormones|mesh-ancestor
83229796|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229797|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83229798|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229799|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
83229800|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229801|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229802|NCT02349841|Amoxicillin|amoxicillin|mesh-list
83229803|NCT02349841|Meropenem|meropenem|mesh-list
83229804|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
83229805|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
83229806|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83229807|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229808|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229809|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229810|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83229811|NCT02354053|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
83229812|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83229813|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83229814|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
83229815|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229816|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83229817|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229818|NCT03094481|Epinephrine|epinephrine|mesh-list
83229819|NCT03094481|Bupivacaine|bupivacaine|mesh-list
83229820|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
83229821|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
83229822|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229823|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229824|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
83229825|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229826|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83229827|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83229828|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
83229829|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229830|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229831|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83229832|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83229833|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
83229834|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83229835|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229836|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
83229837|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
83229838|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83229839|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
83229840|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
83229841|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83229842|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83229843|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229844|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229845|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229846|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229847|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
83229848|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
83229849|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229850|NCT02348125|Protective Agents|protective agents|mesh-ancestor
83229851|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229852|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
83229853|NCT02348125|Vitamins|vitamins|mesh-ancestor
83229854|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
83229855|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
83229856|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83229857|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83229858|NCT03094403|Azelaic acid|azelaic acid|mesh-list
83229859|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229860|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83229861|NCT02347891|Belimumab|belimumab|mesh-list
83229862|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229863|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
83229864|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229865|NCT03147157|Tacrolimus|tacrolimus|mesh-list
83229866|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229867|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
83229868|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229869|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83229870|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229871|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229872|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83229873|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83229874|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229875|NCT02347501|Incretins|incretins|mesh-ancestor
83229876|NCT02347501|Hormones|hormones|mesh-ancestor
83229877|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229878|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83229879|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
83229880|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229881|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229882|NCT03148717|Misoprostol|misoprostol|mesh-list
83229883|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83229884|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
83229885|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83229886|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229887|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83229889|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
83229890|NCT02349607|Ibuprofen|ibuprofen|mesh-list
83229891|NCT02349607|Pregabalin|pregabalin|mesh-list
83229892|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83229893|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83229894|NCT02349607|Analgesics|analgesics|mesh-ancestor
83229895|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
83229896|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229897|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229898|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83229899|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229900|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83229901|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229902|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229903|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
83229904|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83229905|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229906|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83229908|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83229909|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83229910|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83229911|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
83229912|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
83229913|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229914|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229915|NCT04478461|Antibodies|antibodies|mesh-list
83229916|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83229917|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
83229918|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229919|NCT04108481|Durvalumab|durvalumab|mesh-list
83229920|NCT04108481|Methamphetamine|methamphetamine|mesh-list
83229921|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83229922|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83229923|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229924|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
83229925|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229926|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83229927|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
83229928|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
83229929|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229930|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
83229931|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229932|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229933|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
83229934|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83229935|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83229936|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229937|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83229938|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83229939|NCT02353507|Laxatives|laxatives|mesh-ancestor
83229940|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229941|NCT03148561|Misoprostol|misoprostol|mesh-list
83229942|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83229943|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
83229944|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83229945|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229946|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83229947|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83229948|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
83229949|NCT02353429|Toremifene|toremifene|mesh-list
83229950|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83229951|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83229952|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83229953|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83229954|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
83229955|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83229956|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229957|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83229958|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83229959|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83229960|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229961|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229962|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83229963|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83229964|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229965|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
83229966|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229967|NCT03112135|Epinephrine|epinephrine|mesh-list
83229968|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
83229969|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83229970|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83229971|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229972|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
83229973|NCT03112135|Coagulants|coagulants|mesh-ancestor
83229974|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83229975|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83229976|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
83229977|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83229978|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229979|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83229980|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83229981|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
83229982|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83229983|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83229984|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
83229985|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
83229986|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
83229987|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83229988|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83229989|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83229990|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83229991|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83229992|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
83229993|NCT03146533|Fludarabine|fludarabine|mesh-list
83229994|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83229995|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
83229996|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83229997|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83229998|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83229999|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
83230000|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230001|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230002|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83230003|NCT03090971|Diclofenac|diclofenac|mesh-list
83230004|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83230005|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83230006|NCT03090971|Analgesics|analgesics|mesh-ancestor
83230007|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
83230008|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230009|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230010|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230011|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230012|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83230013|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230014|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230015|NCT03146689|Ibuprofen|ibuprofen|mesh-list
83230016|NCT03146689|Capsaicin|capsaicin|mesh-list
83230017|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83230018|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83230019|NCT03146689|Analgesics|analgesics|mesh-ancestor
83230020|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
83230021|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230022|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230023|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230024|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230025|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83230026|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230027|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230028|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
83230029|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
83230030|NCT05255575|Ertapenem|ertapenem|mesh-list
83230031|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230032|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230033|NCT05026229|Cytarabine|cytarabine|mesh-list
83230034|NCT05026229|Prednisone|prednisone|mesh-list
83230035|NCT05026229|Methotrexate|methotrexate|mesh-list
83230036|NCT05026229|Vincristine|vincristine|mesh-list
83230037|NCT05026229|Dasatinib|dasatinib|mesh-list
83230038|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230039|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
83230040|NCT05026229|Hormones|hormones|mesh-ancestor
83230041|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230042|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230043|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83230045|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83230046|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
83230047|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83230048|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83230049|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
83230050|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230051|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
83230052|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230053|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83230054|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83230055|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
83230056|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230057|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83230058|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
83230059|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230060|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83230061|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
83230062|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
83230063|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
83230064|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83230065|NCT02343679|Ceritinib|ceritinib|mesh-list
83230066|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230067|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83230068|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230069|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230070|NCT04954781|Tislelizumab|tislelizumab|mesh-list
83230071|NCT04954781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230072|NCT04954781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230073|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83230074|NCT02348905|Hormones|hormones|mesh-ancestor
83230075|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230076|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230077|NCT02347033|Sertraline|sertraline|mesh-list
83230078|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
83230079|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83230080|NCT02347033|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83230081|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83230082|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230083|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230084|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230085|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
83230086|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230087|NCT04949633|Oxytocin|oxytocin|mesh-list
83230088|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
83230089|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83230090|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230091|NCT03146377|Capecitabine|capecitabine|mesh-list
83230092|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
83230093|NCT03146377|Irinotecan|irinotecan|mesh-list
83230094|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83230095|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
83230096|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230097|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230098|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83230099|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83230100|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230101|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
83230102|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230103|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230104|NCT02346955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83230105|NCT02346955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230106|NCT03079505|Dasatinib|dasatinib|mesh-list
83230107|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230108|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83230110|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230111|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
83230112|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83230113|NCT02343211|Antibodies|antibodies|mesh-list
83230114|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
83230115|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230116|NCT03090503|Risperidone|risperidone|mesh-list
83230117|NCT03090503|Aripiprazole|aripiprazole|mesh-list
83230118|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83230119|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
83230120|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230121|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230122|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230123|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83230124|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83230125|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230126|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83230127|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83230128|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
83230129|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
83230130|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
83230131|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83230132|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83230133|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83230134|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83230135|NCT02343289|Clarithromycin|clarithromycin|mesh-list
83230136|NCT02343289|Esketamine|esketamine|mesh-list
83230137|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230138|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230139|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83230140|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230141|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230142|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83230143|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83230144|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
83230145|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83230146|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
83230147|NCT05008523|Narcotics|narcotics|mesh-ancestor
83230148|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230149|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230150|NCT05008523|Analgesics|analgesics|mesh-ancestor
83230151|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
83230152|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230153|NCT03090269|Methylphenidate|methylphenidate|mesh-list
83230154|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83230155|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230156|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83230157|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83230158|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230159|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230160|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
83230161|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230162|NCT05008679|Oseltamivir|oseltamivir|mesh-list
83230163|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
83230164|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230165|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230166|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230167|NCT03090035|Interferons|interferons|mesh-list
83230168|NCT03090035|Ribavirin|ribavirin|mesh-list
83230169|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230170|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
83230171|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230172|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
83230173|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230174|NCT05008367|Dexamethasone|dexamethasone|mesh-list
83230175|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230176|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
83230177|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
83230178|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230179|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230180|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83230181|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
83230182|NCT05008367|Hormones|hormones|mesh-ancestor
83230183|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230184|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83230185|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230186|NCT02342587|Lapatinib|lapatinib|mesh-list
83230187|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230188|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83230189|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230190|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230191|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83230192|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230193|NCT02342509|Sevoflurane|sevoflurane|mesh-list
83230194|NCT02342509|Desflurane|desflurane|mesh-list
83230195|NCT02342509|Isoflurane|isoflurane|mesh-list
83230196|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83230197|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83230198|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
83230199|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
83230200|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230201|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230202|NCT03079271|Benzocaine|benzocaine|mesh-list
83230203|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
83230204|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
83230205|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230206|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230207|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
83230208|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230209|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83230210|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230211|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83230212|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230213|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230214|NCT02337127|Lamivudine|lamivudine|mesh-list
83230215|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83230216|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83230217|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230218|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230219|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
83230220|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230221|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83230222|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83230223|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
83230224|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230225|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230226|NCT05007587|Leucovorin|leucovorin|mesh-list
83230227|NCT05007587|Fluorouracil|fluorouracil|mesh-list
83230228|NCT05007587|Raltitrexed|raltitrexed|mesh-list
83230229|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
83230230|NCT05007587|Lenvatinib|lenvatinib|mesh-list
83230231|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
83230232|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230233|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83230234|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230235|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83230236|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
83230237|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230238|NCT05007587|Antidotes|antidotes|mesh-ancestor
83230239|NCT05007587|Protective Agents|protective agents|mesh-ancestor
83230240|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
83230242|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
83230243|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83230244|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230245|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83230246|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
83230247|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
83230248|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83230249|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83230250|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230251|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230252|NCT03945643|Urological Agents|urological agents|mesh-ancestor
83230253|NCT02039323|Tenofovir|tenofovir|mesh-list
83230254|NCT02039323|Maraviroc|maraviroc|mesh-list
83230255|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
83230256|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230257|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83230258|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83230260|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230261|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83230262|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83230263|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83230264|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83230265|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83230266|NCT03079115|Atorvastatin|atorvastatin|mesh-list
83230267|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83230268|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83230269|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
83230270|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230271|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83230272|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83230273|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230274|NCT05917431|Tislelizumab|tislelizumab|mesh-list
83230275|NCT05917431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230276|NCT05917431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230277|NCT05917405|Fludarabine|fludarabine|mesh-list
83230278|NCT05917405|Busulfan|busulfan|mesh-list
83230279|NCT05917405|Clofarabine|clofarabine|mesh-list
83230280|NCT05917405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230281|NCT05917405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83230282|NCT05917405|Antimetabolites|antimetabolites|mesh-ancestor
83230283|NCT05917405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230284|NCT05917405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83230285|NCT05917405|Immunologic Factors|immunologic factors|mesh-ancestor
83230286|NCT05917405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230287|NCT05917405|Alkylating Agents|alkylating agents|mesh-ancestor
83230288|NCT05917405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83230289|NCT05917405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83230290|NCT05917340|Aspirin|aspirin|mesh-list
83230291|NCT05917340|Moxifloxacin|moxifloxacin|mesh-list
83230292|NCT05917340|Rifampin|rifampin|mesh-list
83230293|NCT05917340|Isoniazid|isoniazid|mesh-list
83230294|NCT05917340|Pyrazinamide|pyrazinamide|mesh-list
83230295|NCT05917340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83230296|NCT05917340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83230297|NCT05917340|Analgesics|analgesics|mesh-ancestor
83230298|NCT05917340|Sensory System Agents|sensory system agents|mesh-ancestor
83230299|NCT05917340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230300|NCT05917340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230301|NCT05917340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230302|NCT05917340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230303|NCT05917340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83230304|NCT05917340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83430113|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83230305|NCT05917340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230306|NCT05917340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83230307|NCT05917340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83230308|NCT05917340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230310|NCT05917340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230311|NCT05917340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230312|NCT05917340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83230313|NCT05917340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83230314|NCT05917340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230315|NCT05917340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83230316|NCT05917340|Antitubercular Agents|antitubercular agents|mesh-ancestor
83230317|NCT05917340|Leprostatic Agents|leprostatic agents|mesh-ancestor
83230318|NCT05917340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83230319|NCT05917340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83230320|NCT05917340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83230321|NCT05917340|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83230322|NCT05917340|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83230323|NCT05917340|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83230324|NCT05917340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83230325|NCT05917340|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83230326|NCT05917340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83230327|NCT05917340|Antimetabolites|antimetabolites|mesh-ancestor
83230328|NCT05917340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83230329|NCT05917288|Belimumab|belimumab|mesh-list
83230330|NCT05917288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83230331|NCT05917288|Immunologic Factors|immunologic factors|mesh-ancestor
83230336|NCT05917275|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83230337|NCT05917275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83230338|NCT05917275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83230339|NCT05917275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230340|NCT05917275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230341|NCT05917275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83230342|NCT05917275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230343|NCT05917275|Vasodilator Agents|vasodilator agents|mesh-ancestor
83230344|NCT05917275|Diuretics|diuretics|mesh-ancestor
83230345|NCT05917275|Natriuretic Agents|natriuretic agents|mesh-ancestor
83230346|NCT05917275|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83230347|NCT05917275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83230348|NCT05917275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83230349|NCT05917223|Caseins|caseins|mesh-list
83230350|NCT05917223|Chelating Agents|chelating agents|mesh-ancestor
83230351|NCT05917223|Sequestering Agents|sequestering agents|mesh-ancestor
83230352|NCT05917223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230353|NCT05917067|Parathyroid Hormone|parathyroid hormone|mesh-list
83230354|NCT05917067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83230355|NCT05917067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230356|NCT05916963|Furosemide|furosemide|mesh-list
83230357|NCT05916963|Diuretics|diuretics|mesh-ancestor
83230358|NCT05916963|Natriuretic Agents|natriuretic agents|mesh-ancestor
83230359|NCT05916963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230360|NCT05916963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83230361|NCT05916963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230362|NCT05916963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230366|NCT05916937|Omalizumab|omalizumab|mesh-list
83230367|NCT05916937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83230368|NCT05916937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83230369|NCT05916937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83230370|NCT05916937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83230371|NCT05916937|Immunologic Factors|immunologic factors|mesh-ancestor
83230372|NCT05916937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230373|NCT02342977|Lacosamide|lacosamide|mesh-list
83230374|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
83230375|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83230376|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83230377|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230378|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230379|NCT05916781|Mycophenolic Acid|mycophenolic acid|mesh-list
83230380|NCT05916781|Tacrolimus|tacrolimus|mesh-list
83230381|NCT05916781|Glucocorticoids|glucocorticoids|mesh-list
83230382|NCT05916781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83230383|NCT05916781|Immunologic Factors|immunologic factors|mesh-ancestor
83230384|NCT05916781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230385|NCT05916781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83230386|NCT05916781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230387|NCT05916781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230388|NCT05916781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83230389|NCT05916781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230390|NCT05916781|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83230391|NCT05916781|Antitubercular Agents|antitubercular agents|mesh-ancestor
83230392|NCT05916781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230393|NCT05916781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230395|NCT05916781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230396|NCT05916755|Cyclophosphamide|cyclophosphamide|mesh-list
83230397|NCT05916755|Carboplatin|carboplatin|mesh-list
83230398|NCT05916755|Pembrolizumab|pembrolizumab|mesh-list
83230399|NCT05916755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83230400|NCT05916755|Immunologic Factors|immunologic factors|mesh-ancestor
83230401|NCT05916755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230402|NCT05916755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230403|NCT05916755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83230404|NCT05916755|Alkylating Agents|alkylating agents|mesh-ancestor
83230405|NCT05916755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230406|NCT05916755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230407|NCT05916755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83230408|NCT05916755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230409|NCT05916755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83230410|NCT05916742|Dipyrone|dipyrone|mesh-list
83230411|NCT05916742|Amoxicillin|amoxicillin|mesh-list
83230412|NCT05916742|Chlorhexidine|chlorhexidine|mesh-list
83230413|NCT05916742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230414|NCT05916742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230415|NCT05916742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83230416|NCT05916742|Disinfectants|disinfectants|mesh-ancestor
83230417|NCT05916742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83230418|NCT05916742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83230419|NCT05916742|Analgesics|analgesics|mesh-ancestor
83230420|NCT05916742|Sensory System Agents|sensory system agents|mesh-ancestor
83230421|NCT05916742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230422|NCT05916742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230423|NCT05916742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230424|NCT05916742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230425|NCT05916742|Antipyretics|antipyretics|mesh-ancestor
83230426|NCT05916729|Miconazole|miconazole|mesh-list
83230427|NCT05916729|Antifungal Agents|antifungal agents|mesh-ancestor
83230428|NCT05916729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230429|NCT05916729|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83230430|NCT05916729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83230431|NCT05916729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230432|NCT05916729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230433|NCT05916729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83230434|NCT05916729|Hormone Antagonists|hormone antagonists|mesh-ancestor
83230435|NCT05916729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230436|NCT05916729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230437|NCT05916729|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83230438|NCT05916729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83230439|NCT05916716|Dipyrone|dipyrone|mesh-list
83230440|NCT05916716|Amoxicillin|amoxicillin|mesh-list
83230441|NCT05916716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230442|NCT05916716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230443|NCT05916716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83230444|NCT05916716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83230445|NCT05916716|Analgesics|analgesics|mesh-ancestor
83230446|NCT05916716|Sensory System Agents|sensory system agents|mesh-ancestor
83230447|NCT05916716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230448|NCT05916716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230449|NCT05916716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230450|NCT05916716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230451|NCT05916716|Antipyretics|antipyretics|mesh-ancestor
83230452|NCT05916690|Bleomycin|bleomycin|mesh-list
83230453|NCT05916690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230454|NCT05916690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83230455|NCT05916586|Prednisone|prednisone|mesh-list
83230456|NCT05916586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230457|NCT05916586|Glucocorticoids|glucocorticoids|mesh-ancestor
83230458|NCT05916586|Hormones|hormones|mesh-ancestor
83230459|NCT05916586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230460|NCT05916586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230461|NCT05916586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83230462|NCT05916586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230463|NCT05916521|Fluorides|fluorides|mesh-list
83230464|NCT05916521|Tin Fluorides|tin fluorides|mesh-list
83230465|NCT05916521|Fluorophosphate|fluorophosphate|mesh-list
83230466|NCT05916521|Cariostatic Agents|cariostatic agents|mesh-ancestor
83230467|NCT05916521|Protective Agents|protective agents|mesh-ancestor
83230468|NCT05916521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230469|NCT05916508|Fluorides|fluorides|mesh-list
83230470|NCT05916508|Tin Fluorides|tin fluorides|mesh-list
83230471|NCT05916508|Fluorophosphate|fluorophosphate|mesh-list
83230472|NCT05916508|Cariostatic Agents|cariostatic agents|mesh-ancestor
83230473|NCT05916508|Protective Agents|protective agents|mesh-ancestor
83230474|NCT05916508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230475|NCT05916469|Levonorgestrel|levonorgestrel|mesh-list
83230476|NCT05916469|Norethindrone|norethindrone|mesh-list
83230477|NCT05916469|Norethindrone Acetate|norethindrone acetate|mesh-list
83230478|NCT05916469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83230479|NCT05916469|Contraceptive Agents|contraceptive agents|mesh-ancestor
83230480|NCT05916469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83230481|NCT05916469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230482|NCT05916469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83230483|NCT05916469|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83230485|NCT05916469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83230486|NCT05916352|Caffeine|caffeine|mesh-list
83230487|NCT05916352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83230488|NCT05916352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230489|NCT05916352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83230490|NCT05916352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230491|NCT05916352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230492|NCT05916352|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83230493|NCT05916352|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83230494|NCT05916352|Purinergic Agents|purinergic agents|mesh-ancestor
83230495|NCT05916352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230496|NCT05916339|Methylphenidate|methylphenidate|mesh-list
83230497|NCT05916339|Amphetamine|amphetamine|mesh-list
83230498|NCT05916339|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83230499|NCT05916339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230500|NCT05916339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83230501|NCT05916339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83230502|NCT05916339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230503|NCT05916339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230504|NCT05916339|Dopamine Agents|dopamine agents|mesh-ancestor
83230505|NCT05916339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230506|NCT05916339|Sympathomimetics|sympathomimetics|mesh-ancestor
83230507|NCT05916339|Autonomic Agents|autonomic agents|mesh-ancestor
83230508|NCT05916339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230509|NCT05916339|Adrenergic Agents|adrenergic agents|mesh-ancestor
83230510|NCT05916339|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83230511|NCT05916287|Antihypertensive Agents|antihypertensive agents|mesh-list
83230512|NCT05916105|Ciprofloxacin|ciprofloxacin|mesh-list
83230513|NCT05916105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230514|NCT05916105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230515|NCT05916105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83230516|NCT05916105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83230517|NCT05916105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230518|NCT05916105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230519|NCT05916105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230520|NCT05916105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83230521|NCT05916105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83230522|NCT05916066|Niacinamide|niacinamide|mesh-list
83230523|NCT05916066|Niacin|niacin|mesh-list
83230524|NCT05916066|Nicotinic Acids|nicotinic acids|mesh-list
83230525|NCT05916066|Vitamin B Complex|vitamin b complex|mesh-ancestor
83230526|NCT05916066|Vitamins|vitamins|mesh-ancestor
83230527|NCT05916066|Micronutrients|micronutrients|mesh-ancestor
83230528|NCT05916066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230529|NCT05916066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83230530|NCT05916066|Antimetabolites|antimetabolites|mesh-ancestor
83230531|NCT05916066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230532|NCT05916066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83230533|NCT05916066|Vasodilator Agents|vasodilator agents|mesh-ancestor
83230534|NCT05916053|Vitamin D|vitamin d|mesh-list
83230535|NCT05916053|Vitamins|vitamins|mesh-ancestor
83230536|NCT05916053|Micronutrients|micronutrients|mesh-ancestor
83230537|NCT05916053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230538|NCT05916053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83230539|NCT05915949|Dapagliflozin|dapagliflozin|mesh-list
83230540|NCT05915949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83230541|NCT05915949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230542|NCT05915949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83230543|NCT05915949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230544|NCT05915884|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83230545|NCT05915884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230546|NCT05915884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83230547|NCT05915884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230548|NCT05915871|Clarithromycin|clarithromycin|mesh-list
83230549|NCT05915871|Bismuth|bismuth|mesh-list
83230550|NCT05915871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230551|NCT05915871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230552|NCT05915871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83230553|NCT05915871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230554|NCT05915871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230555|NCT05915871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83230556|NCT05915871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83230557|NCT05915871|Antacids|antacids|mesh-ancestor
83230558|NCT05915871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83230559|NCT05915728|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83230560|NCT05915728|Chelating Agents|chelating agents|mesh-ancestor
83230561|NCT05915728|Sequestering Agents|sequestering agents|mesh-ancestor
83230562|NCT05915728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230563|NCT05915702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83230564|NCT05915702|Chelating Agents|chelating agents|mesh-ancestor
83230565|NCT05915702|Sequestering Agents|sequestering agents|mesh-ancestor
83230566|NCT05915702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230567|NCT05915676|Immunoglobulins|immunoglobulins|mesh-list
83230568|NCT05915676|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83230569|NCT05915676|Antibodies|antibodies|mesh-list
83230570|NCT05915676|Immunologic Factors|immunologic factors|mesh-ancestor
83230571|NCT05915676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230572|NCT05915520|Pantoprazole|pantoprazole|mesh-list
83230573|NCT05915520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83230574|NCT05915520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83230575|NCT05915520|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83230576|NCT05915520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230577|NCT05915520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230578|NCT05915481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83230579|NCT05915481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230580|NCT05915481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230581|NCT05915481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230582|NCT05915442|Quemliclustat|quemliclustat|mesh-list
83230583|NCT05915442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83230584|NCT05915442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230585|NCT05915442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230586|NCT05915442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230587|NCT05915286|Chlorthalidone|chlorthalidone|mesh-list
83230588|NCT05915286|Furosemide|furosemide|mesh-list
83230589|NCT05915286|Diuretics|diuretics|mesh-ancestor
83230590|NCT05915286|Natriuretic Agents|natriuretic agents|mesh-ancestor
83230591|NCT05915286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430114|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
83230592|NCT05915286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83230593|NCT05915286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230594|NCT05915286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230595|NCT05915286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83230596|NCT05915286|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83230597|NCT05915260|Adenosine|adenosine|mesh-list
83230598|NCT05915260|Analgesics|analgesics|mesh-ancestor
83230599|NCT05915260|Sensory System Agents|sensory system agents|mesh-ancestor
83230600|NCT05915260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230601|NCT05915260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230602|NCT05915260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83230603|NCT05915260|Vasodilator Agents|vasodilator agents|mesh-ancestor
83230604|NCT05915260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83230605|NCT05915260|Purinergic Agonists|purinergic agonists|mesh-ancestor
83230606|NCT05915260|Purinergic Agents|purinergic agents|mesh-ancestor
83230607|NCT05915260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230608|NCT05915260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230609|NCT05915182|Budesonide|budesonide|mesh-list
83230610|NCT05915182|Glycopyrrolate|glycopyrrolate|mesh-list
83230611|NCT05915182|Bromides|bromides|mesh-list
83230612|NCT05915182|Formoterol Fumarate|formoterol fumarate|mesh-list
83230613|NCT05915182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230614|NCT05915182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83230615|NCT05915182|Autonomic Agents|autonomic agents|mesh-ancestor
83230616|NCT05915182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230617|NCT05915182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230618|NCT05915182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83230619|NCT05915182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83230620|NCT05915182|Glucocorticoids|glucocorticoids|mesh-ancestor
83230621|NCT05915182|Hormones|hormones|mesh-ancestor
83362244|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230622|NCT05915182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230623|NCT05915182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83230624|NCT05915182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83230625|NCT05915182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83230626|NCT05915182|Adrenergic Agents|adrenergic agents|mesh-ancestor
83230627|NCT05915182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230628|NCT05915182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230629|NCT05915182|Anticonvulsants|anticonvulsants|mesh-ancestor
83230630|NCT05915182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83230631|NCT05915182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83230632|NCT05915182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83230633|NCT05915182|Cholinergic Agents|cholinergic agents|mesh-ancestor
83230634|NCT05915169|Chrysarobin|chrysarobin|mesh-list
83230635|NCT05915169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83230636|NCT05915169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83230637|NCT05915169|Analgesics|analgesics|mesh-ancestor
83230638|NCT05915169|Sensory System Agents|sensory system agents|mesh-ancestor
83230639|NCT05915169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230640|NCT05915169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230641|NCT05915169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230642|NCT05915169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230644|NCT05915104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230645|NCT05915104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83230646|NCT05915104|Autonomic Agents|autonomic agents|mesh-ancestor
83230647|NCT05915104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230648|NCT05915104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230649|NCT05915104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83230650|NCT05915104|Respiratory System Agents|respiratory system agents|mesh-ancestor
83230651|NCT05915104|Glucocorticoids|glucocorticoids|mesh-ancestor
83230652|NCT05915104|Hormones|hormones|mesh-ancestor
83230653|NCT05915104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230654|NCT05915013|Ketamine|ketamine|mesh-list
83230655|NCT05915013|Analgesics|analgesics|mesh-ancestor
83230657|NCT05915013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230658|NCT05915013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230659|NCT05915013|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83230660|NCT05915013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83230661|NCT05915013|Anesthetics, General|anesthetics, general|mesh-ancestor
83230662|NCT05915013|Anesthetics|anesthetics|mesh-ancestor
83230663|NCT05915013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230664|NCT05915013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83230665|NCT05915013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83230666|NCT05915013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230667|NCT05915013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230668|NCT05914857|Dapagliflozin|dapagliflozin|mesh-list
83230669|NCT05914857|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83230670|NCT05914857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230671|NCT05914857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83230672|NCT05914857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230673|NCT05914805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83230674|NCT05914779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83230675|NCT05914779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83230676|NCT05914779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230677|NCT05914779|Antitubercular Agents|antitubercular agents|mesh-ancestor
83230678|NCT05914753|Cyclophosphamide|cyclophosphamide|mesh-list
83230679|NCT05914753|Docetaxel|docetaxel|mesh-list
83230680|NCT05914753|Epirubicin|epirubicin|mesh-list
83230681|NCT05914753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83230682|NCT05914753|Immunologic Factors|immunologic factors|mesh-ancestor
83230683|NCT05914753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230684|NCT05914753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230685|NCT05914753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83230686|NCT05914753|Alkylating Agents|alkylating agents|mesh-ancestor
83230687|NCT05914753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230688|NCT05914753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230689|NCT05914753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83230690|NCT05914753|Tubulin Modulators|tubulin modulators|mesh-ancestor
83230691|NCT05914753|Antimitotic Agents|antimitotic agents|mesh-ancestor
83230692|NCT05914753|Mitosis Modulators|mitosis modulators|mesh-ancestor
83230693|NCT05914753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83230694|NCT05914753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83230695|NCT05914753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83230696|NCT05914753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230697|NCT05914701|Letermovir|letermovir|mesh-list
83230698|NCT05914701|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83230699|NCT05914701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230700|NCT05914701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230701|NCT05914701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230702|NCT05914701|Antiviral Agents|antiviral agents|mesh-ancestor
83230703|NCT05914701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230704|NCT05914675|Letermovir|letermovir|mesh-list
83230705|NCT05914675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83230706|NCT05914675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230707|NCT05914675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230708|NCT05914675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230709|NCT05914675|Antiviral Agents|antiviral agents|mesh-ancestor
83230710|NCT05914675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230711|NCT05914662|Rituximab|rituximab|mesh-list
83230712|NCT05914662|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83230713|NCT05914662|Zanubrutinib|zanubrutinib|mesh-list
83230714|NCT05914662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230715|NCT05914662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230716|NCT05914662|Immunologic Factors|immunologic factors|mesh-ancestor
83230717|NCT05914662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230718|NCT05914662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230719|NCT05914662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83230720|NCT05914662|Alkylating Agents|alkylating agents|mesh-ancestor
83430115|NCT01013779|Carboplatin|carboplatin|mesh-list
83230721|NCT05914662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230723|NCT05914662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230724|NCT05914610|Oxaliplatin|oxaliplatin|mesh-list
83230725|NCT05914610|Tegafur|tegafur|mesh-list
83230726|NCT05914610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230727|NCT05914610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83230728|NCT05914610|Antimetabolites|antimetabolites|mesh-ancestor
83230729|NCT05914610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230730|NCT05914545|Immunoconjugates|immunoconjugates|mesh-list
83230731|NCT05914545|Immunologic Factors|immunologic factors|mesh-ancestor
83230732|NCT05914545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230733|NCT05914467|Teicoplanin|teicoplanin|mesh-list
83230734|NCT05914467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230735|NCT05914467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230736|NCT05914454|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83230737|NCT05914454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230738|NCT05914389|Capecitabine|capecitabine|mesh-list
83230739|NCT05914389|Oxaliplatin|oxaliplatin|mesh-list
83230740|NCT05914389|Antibodies|antibodies|mesh-list
83230741|NCT05914389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83230742|NCT05914389|Immunologic Factors|immunologic factors|mesh-ancestor
83230743|NCT05914389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230744|NCT05914389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83230745|NCT05914389|Antimetabolites|antimetabolites|mesh-ancestor
83230746|NCT05914389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230747|NCT05914389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230748|NCT05914350|Methylprednisolone|methylprednisolone|mesh-list
83230749|NCT05914350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83230750|NCT05914350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83230751|NCT05914350|Prednisolone|prednisolone|mesh-list
83230752|NCT05914350|Prednisolone acetate|prednisolone acetate|mesh-list
83230753|NCT05914350|Lidocaine|lidocaine|mesh-list
83230754|NCT05914350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83230755|NCT05914350|Prednisolone phosphate|prednisolone phosphate|mesh-list
83230756|NCT05914350|Anesthetics, Local|anesthetics, local|mesh-ancestor
83230757|NCT05914350|Anesthetics|anesthetics|mesh-ancestor
83230758|NCT05914350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230759|NCT05914350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230760|NCT05914350|Sensory System Agents|sensory system agents|mesh-ancestor
83230761|NCT05914350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230762|NCT05914350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83230763|NCT05914350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83230764|NCT05914350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83230765|NCT05914350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230766|NCT05914350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230767|NCT05914350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230768|NCT05914350|Antiemetics|antiemetics|mesh-ancestor
83230769|NCT05914350|Autonomic Agents|autonomic agents|mesh-ancestor
83230770|NCT05914350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83230771|NCT05914350|Glucocorticoids|glucocorticoids|mesh-ancestor
83230772|NCT05914350|Hormones|hormones|mesh-ancestor
83230773|NCT05914350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230774|NCT05914350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83230775|NCT05914350|Protective Agents|protective agents|mesh-ancestor
83230776|NCT05914350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83230777|NCT05914350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230778|NCT05914285|Albuterol|albuterol|mesh-list
83230779|NCT05914285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83230780|NCT05914285|Autonomic Agents|autonomic agents|mesh-ancestor
83230781|NCT05914285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230782|NCT05914285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230783|NCT05914285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83230784|NCT05914285|Respiratory System Agents|respiratory system agents|mesh-ancestor
83230785|NCT05914285|Tocolytic Agents|tocolytic agents|mesh-ancestor
83230786|NCT05914285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83230787|NCT05914285|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83230788|NCT05914285|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83230789|NCT05914285|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83230790|NCT05914285|Adrenergic Agents|adrenergic agents|mesh-ancestor
83230791|NCT05914285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230792|NCT05914285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230793|NCT05914194|Mazindol|mazindol|mesh-list
83230794|NCT05914194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83230795|NCT05914194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413653|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
83230796|NCT05914194|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83230797|NCT05914194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83230798|NCT05914194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83230799|NCT05914194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230800|NCT05914194|Adrenergic Agents|adrenergic agents|mesh-ancestor
83230801|NCT05914194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230802|NCT05914194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83230803|NCT05914194|Dopamine Agents|dopamine agents|mesh-ancestor
83230804|NCT05914155|Rituximab|rituximab|mesh-list
83230805|NCT05914155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230806|NCT05914155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230807|NCT05914155|Immunologic Factors|immunologic factors|mesh-ancestor
83230808|NCT05914155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230809|NCT05914155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230810|NCT05914129|Liver Extracts|liver extracts|mesh-list
83230811|NCT05914129|Hematinics|hematinics|mesh-ancestor
83230812|NCT05914077|Secretin|secretin|mesh-list
83230813|NCT05914077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83230814|NCT05914077|Hormones|hormones|mesh-ancestor
83230815|NCT05914077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230816|NCT05914077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230817|NCT05913947|Cariprazine|cariprazine|mesh-list
83230818|NCT05913947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83230819|NCT05913947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83230820|NCT05913947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230821|NCT05913947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230822|NCT05913947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83230823|NCT05913921|Amphotericin B|amphotericin b|mesh-list
83230824|NCT05913921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83230825|NCT05913921|Amebicides|amebicides|mesh-ancestor
83230826|NCT05913921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83230827|NCT05913921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83230828|NCT05913921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230829|NCT05913921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83230830|NCT05913921|Antifungal Agents|antifungal agents|mesh-ancestor
83230831|NCT05913856|Chlorhexidine|chlorhexidine|mesh-list
83230832|NCT05913856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83230833|NCT05913856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230834|NCT05913856|Disinfectants|disinfectants|mesh-ancestor
83230835|NCT05913661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83230836|NCT05913661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230837|NCT05913661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230838|NCT05913661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230839|NCT05913596|Daratumumab|daratumumab|mesh-list
83230840|NCT05913596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230841|NCT05913583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83230842|NCT05913583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230843|NCT05913583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230844|NCT05913583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230845|NCT05913570|Antibodies|antibodies|mesh-list
83230846|NCT05913570|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83230847|NCT05913570|Immunologic Factors|immunologic factors|mesh-ancestor
83230848|NCT05913570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230849|NCT05913466|Tranexamic Acid|tranexamic acid|mesh-list
83230850|NCT05913466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83230851|NCT05913466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83230852|NCT05913466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230853|NCT05913466|Hemostatics|hemostatics|mesh-ancestor
83230854|NCT05913466|Coagulants|coagulants|mesh-ancestor
83230855|NCT05913427|Cisplatin|cisplatin|mesh-list
83230856|NCT05913427|Doxorubicin|doxorubicin|mesh-list
83230857|NCT05913427|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83230858|NCT05913427|Etoposide|etoposide|mesh-list
83230859|NCT05913427|Etoposide phosphate|etoposide phosphate|mesh-list
83230860|NCT05913427|Megestrol|megestrol|mesh-list
83230861|NCT05913427|Megestrol Acetate|megestrol acetate|mesh-list
83230862|NCT05913427|Mitotane|mitotane|mesh-list
83230863|NCT05913427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230864|NCT05913427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83230865|NCT05913427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83230866|NCT05913427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83230867|NCT05913427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230868|NCT05913427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230869|NCT05913427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83230870|NCT05913427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83230871|NCT05913427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83230872|NCT05913427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83230873|NCT05913427|Contraceptive Agents|contraceptive agents|mesh-ancestor
83230874|NCT05913427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83230875|NCT05913427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230876|NCT05913427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83230877|NCT05913427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83230878|NCT05913427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83230879|NCT05913427|Appetite Stimulants|appetite stimulants|mesh-ancestor
83230880|NCT05913427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83230881|NCT05913414|Iron|iron|mesh-list
83230882|NCT05913414|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83230883|NCT05913414|Ferric Compounds|ferric compounds|mesh-list
83230884|NCT05913414|Trace Elements|trace elements|mesh-ancestor
83230885|NCT05913414|Micronutrients|micronutrients|mesh-ancestor
83230886|NCT05913414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230887|NCT05913414|Hematinics|hematinics|mesh-ancestor
83230888|NCT05913388|Pembrolizumab|pembrolizumab|mesh-list
83230889|NCT05913388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230890|NCT05913388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230891|NCT05913388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83230892|NCT05913388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230893|NCT05913284|Morphine|morphine|mesh-list
83230894|NCT05913284|Methadone|methadone|mesh-list
83230895|NCT05913284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83230896|NCT05913284|Narcotics|narcotics|mesh-ancestor
83230897|NCT05913284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230898|NCT05913284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230899|NCT05913284|Analgesics|analgesics|mesh-ancestor
83230900|NCT05913284|Sensory System Agents|sensory system agents|mesh-ancestor
83230901|NCT05913284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230902|NCT05913284|Antitussive Agents|antitussive agents|mesh-ancestor
83230903|NCT05913284|Respiratory System Agents|respiratory system agents|mesh-ancestor
83230904|NCT05913232|Timolol|timolol|mesh-list
83230905|NCT05913232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83230906|NCT05913232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83230907|NCT05913232|Adrenergic Agents|adrenergic agents|mesh-ancestor
83230908|NCT05913232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83230909|NCT05913232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230910|NCT05913232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230911|NCT05913232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83230912|NCT05913232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83230913|NCT05913180|Ascorbic Acid|ascorbic acid|mesh-list
83230914|NCT05913180|Vitamins|vitamins|mesh-ancestor
83230915|NCT05913180|Micronutrients|micronutrients|mesh-ancestor
83230916|NCT05913180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230917|NCT05913180|Antioxidants|antioxidants|mesh-ancestor
83230918|NCT05913180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230919|NCT05913180|Protective Agents|protective agents|mesh-ancestor
83230920|NCT05913115|Bemarituzumab|bemarituzumab|mesh-list
83230921|NCT05913115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230922|NCT05913115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230924|NCT05912946|Hyaluronic Acid|hyaluronic acid|mesh-list
83230925|NCT05912946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230926|NCT05912946|Antiviral Agents|antiviral agents|mesh-ancestor
83230927|NCT05912946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83230928|NCT05912946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83230929|NCT05912946|Immunologic Factors|immunologic factors|mesh-ancestor
83230930|NCT05912946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230931|NCT05912946|Viscosupplements|viscosupplements|mesh-ancestor
83230932|NCT05912946|Protective Agents|protective agents|mesh-ancestor
83230933|NCT05912816|Tislelizumab|tislelizumab|mesh-list
83230934|NCT05912816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83230935|NCT05912816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83230936|NCT05912712|Infliximab|infliximab|mesh-list
83230937|NCT05912712|Mesalamine|mesalamine|mesh-list
83230938|NCT05912712|Thrombin|thrombin|mesh-list
83230939|NCT05912712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83230940|NCT05912712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230941|NCT05912712|Dermatologic Agents|dermatologic agents|mesh-ancestor
83230942|NCT05912712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83230943|NCT05912712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83230944|NCT05912712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83230945|NCT05912712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83230946|NCT05912712|Analgesics|analgesics|mesh-ancestor
83230947|NCT05912712|Sensory System Agents|sensory system agents|mesh-ancestor
83230948|NCT05912712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230949|NCT05912712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230950|NCT05912712|Hemostatics|hemostatics|mesh-ancestor
83230951|NCT05912712|Coagulants|coagulants|mesh-ancestor
83230952|NCT05912686|Atorvastatin|atorvastatin|mesh-list
83230953|NCT05912686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83230954|NCT05912686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83230955|NCT05912686|Antimetabolites|antimetabolites|mesh-ancestor
83230956|NCT05912686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230957|NCT05912686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83230958|NCT05912686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83230959|NCT05912686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230960|NCT05912621|Tirzepatide|tirzepatide|mesh-list
83230961|NCT05912621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83230962|NCT05912621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230963|NCT05912621|Incretins|incretins|mesh-ancestor
83230964|NCT05912621|Hormones|hormones|mesh-ancestor
83230965|NCT05912621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83230966|NCT05912387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83230967|NCT05912387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83230968|NCT05912387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83230969|NCT05912387|Antimetabolites|antimetabolites|mesh-ancestor
83230970|NCT05912387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230971|NCT05912387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83230972|NCT05912387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83230973|NCT05912387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83230974|NCT05912335|Anesthetics|anesthetics|mesh-list
83230975|NCT05912335|Anesthetics, Local|anesthetics, local|mesh-list
83230976|NCT05912335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83230977|NCT05912335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230978|NCT05912335|Sensory System Agents|sensory system agents|mesh-ancestor
83230979|NCT05912335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83230980|NCT05912205|Disitamab vedotin|disitamab vedotin|mesh-list
83230981|NCT05912205|Immunoconjugates|immunoconjugates|mesh-ancestor
83230982|NCT05912205|Immunologic Factors|immunologic factors|mesh-ancestor
83230983|NCT05912205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230984|NCT05912192|Mometasone Furoate|mometasone furoate|mesh-list
83230985|NCT05912192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83230986|NCT05912192|Dermatologic Agents|dermatologic agents|mesh-ancestor
83230987|NCT05912192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83230988|NCT05912179|Liver Extracts|liver extracts|mesh-list
83230989|NCT05912179|Hematinics|hematinics|mesh-ancestor
83230990|NCT05912114|Mannitol|mannitol|mesh-list
83230991|NCT05912114|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83230992|NCT05912114|Diuretics|diuretics|mesh-ancestor
83230993|NCT05912114|Natriuretic Agents|natriuretic agents|mesh-ancestor
83230994|NCT05912114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83230995|NCT05912075|Capecitabine|capecitabine|mesh-list
83230996|NCT05912075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83230997|NCT05912075|Antimetabolites|antimetabolites|mesh-ancestor
83230998|NCT05912075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83230999|NCT05912075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231000|NCT05912062|Paclitaxel|paclitaxel|mesh-list
83231001|NCT05912062|Trastuzumab|trastuzumab|mesh-list
83231002|NCT05912062|Pertuzumab|pertuzumab|mesh-list
83231003|NCT05912062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231004|NCT05912062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231005|NCT05912062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231006|NCT05912062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231007|NCT05912062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231008|NCT05912062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231009|NCT05912062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231010|NCT05911906|Remdesivir|remdesivir|mesh-list
83231011|NCT05911906|Antimetabolites|antimetabolites|mesh-ancestor
83231012|NCT05911906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231013|NCT05911906|Antiviral Agents|antiviral agents|mesh-ancestor
83231014|NCT05911906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231015|NCT05911828|Ferroquine|ferroquine|mesh-list
83231016|NCT05911828|Antimalarials|antimalarials|mesh-ancestor
83231017|NCT05911828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83231018|NCT05911828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83231019|NCT05911828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231020|NCT05911776|Dexmedetomidine|dexmedetomidine|mesh-list
83231021|NCT05911776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83231022|NCT05911776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231023|NCT05911776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231024|NCT05911776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83231025|NCT05911776|Analgesics|analgesics|mesh-ancestor
83231026|NCT05911776|Sensory System Agents|sensory system agents|mesh-ancestor
83231027|NCT05911776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231028|NCT05911776|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83231029|NCT05911776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83231030|NCT05911776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83231031|NCT05911776|Adrenergic Agents|adrenergic agents|mesh-ancestor
83231032|NCT05911776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231033|NCT05911776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231034|NCT05911659|Ticagrelor|ticagrelor|mesh-list
83231035|NCT05911659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83231036|NCT05911659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83231037|NCT05911659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83231038|NCT05911659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83231039|NCT05911659|Purinergic Agents|purinergic agents|mesh-ancestor
83231040|NCT05911659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231041|NCT05911659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231042|NCT05911659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231043|NCT05911594|Solifenacin Succinate|solifenacin succinate|mesh-list
83231044|NCT05911594|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83231045|NCT05911594|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83231046|NCT05911594|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83231047|NCT05911594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231048|NCT05911594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231049|NCT05911594|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83231050|NCT05911594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83231051|NCT05911594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231052|NCT05911594|Cholinergic Agents|cholinergic agents|mesh-ancestor
83231053|NCT05911594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231054|NCT05911594|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83231055|NCT05911594|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83231056|NCT05911594|Urological Agents|urological agents|mesh-ancestor
83231057|NCT05911503|Ganciclovir|ganciclovir|mesh-list
83231058|NCT05911503|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83231059|NCT05911503|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83231060|NCT05911503|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83231061|NCT05911503|Antiviral Agents|antiviral agents|mesh-ancestor
83231062|NCT05911503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231063|NCT05911503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83231064|NCT05911503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231065|NCT05911503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231066|NCT05911438|Epoetin Alfa|epoetin alfa|mesh-list
83231067|NCT05911438|Hematinics|hematinics|mesh-ancestor
83231068|NCT05911347|Psyllium|psyllium|mesh-list
83231069|NCT05911347|Cathartics|cathartics|mesh-ancestor
83231070|NCT05911347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83231071|NCT05911321|Dexamethasone|dexamethasone|mesh-list
83231072|NCT05911321|Pomalidomide|pomalidomide|mesh-list
83231073|NCT05911321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231074|NCT05911321|Antiemetics|antiemetics|mesh-ancestor
83231075|NCT05911321|Autonomic Agents|autonomic agents|mesh-ancestor
83231076|NCT05911321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231077|NCT05911321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231078|NCT05911321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83231079|NCT05911321|Glucocorticoids|glucocorticoids|mesh-ancestor
83231080|NCT05911321|Hormones|hormones|mesh-ancestor
83231081|NCT05911321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83231082|NCT05911321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83231083|NCT05911321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231084|NCT05911321|Immunologic Factors|immunologic factors|mesh-ancestor
83231085|NCT05911321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83231086|NCT05911321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83231087|NCT05911321|Growth Substances|growth substances|mesh-ancestor
83231088|NCT05911321|Growth Inhibitors|growth inhibitors|mesh-ancestor
83231090|NCT05911308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83231091|NCT05911308|Carboplatin|carboplatin|mesh-list
83231092|NCT05911308|Pemetrexed|pemetrexed|mesh-list
83231093|NCT05911308|Durvalumab|durvalumab|mesh-list
83231094|NCT05911308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231095|NCT05911308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231096|NCT05911308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231097|NCT05911308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231098|NCT05911308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231099|NCT05911308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231100|NCT05911308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231101|NCT05911308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83231102|NCT05911308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83231103|NCT05911308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231104|NCT05911295|Carboplatin|carboplatin|mesh-list
83231105|NCT05911295|Gemcitabine|gemcitabine|mesh-list
83231106|NCT05911295|Pembrolizumab|pembrolizumab|mesh-list
83231107|NCT05911295|Disitamab vedotin|disitamab vedotin|mesh-list
83231108|NCT05911295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231109|NCT05911295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83231110|NCT05911295|Antimetabolites|antimetabolites|mesh-ancestor
83231111|NCT05911295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231112|NCT05911295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231113|NCT05911295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83231114|NCT05911295|Immunoconjugates|immunoconjugates|mesh-ancestor
83231115|NCT05911295|Immunologic Factors|immunologic factors|mesh-ancestor
83231116|NCT05911295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231117|NCT05911282|Acetylcysteine|acetylcysteine|mesh-list
83231118|NCT05911282|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83231119|NCT05911282|Antiviral Agents|antiviral agents|mesh-ancestor
83231120|NCT05911282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231121|NCT05911282|Expectorants|expectorants|mesh-ancestor
83231122|NCT05911282|Respiratory System Agents|respiratory system agents|mesh-ancestor
83231123|NCT05911282|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83231124|NCT05911282|Antioxidants|antioxidants|mesh-ancestor
83231125|NCT05911282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231126|NCT05911282|Protective Agents|protective agents|mesh-ancestor
83231127|NCT05911282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231128|NCT05911282|Antidotes|antidotes|mesh-ancestor
83231129|NCT05911022|Colchicine|colchicine|mesh-list
83231130|NCT05911022|Gout Suppressants|gout suppressants|mesh-ancestor
83231131|NCT05911022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231132|NCT05911022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231133|NCT05911022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231134|NCT05911022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231135|NCT05911022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231136|NCT05911022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231137|NCT05910970|Lenvatinib|lenvatinib|mesh-list
83231138|NCT05910970|Tislelizumab|tislelizumab|mesh-list
83231139|NCT05910970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231140|NCT05910970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83231141|NCT05910970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231142|NCT05910970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231143|NCT05910970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231144|NCT05910827|Docetaxel|docetaxel|mesh-list
83231145|NCT05910827|Cetuximab|cetuximab|mesh-list
83231146|NCT05910827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231147|NCT05910827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231148|NCT05910827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231149|NCT05910827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231150|NCT05910827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231151|NCT05910827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231153|NCT05910801|Venetoclax|venetoclax|mesh-list
83231154|NCT05910801|Immunoglobulins|immunoglobulins|mesh-list
83231155|NCT05910801|Immunologic Factors|immunologic factors|mesh-ancestor
83231156|NCT05910801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231157|NCT05910801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83231158|NCT05910801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83231159|NCT05910801|Growth Substances|growth substances|mesh-ancestor
83231160|NCT05910801|Growth Inhibitors|growth inhibitors|mesh-ancestor
83231161|NCT05910801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231162|NCT05909644|Efavirenz|efavirenz|mesh-list
83231163|NCT05909644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83231164|NCT05909644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83231165|NCT05909644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231166|NCT05909644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231167|NCT05909644|Antiviral Agents|antiviral agents|mesh-ancestor
83231168|NCT05909644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231169|NCT05909644|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83231170|NCT05909644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83231171|NCT05909644|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83231172|NCT05909644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83231173|NCT05909644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83231174|NCT05909644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83231175|NCT05909553|Venetoclax|venetoclax|mesh-list
83231176|NCT05909553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231177|NCT05909150|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83231178|NCT05907655|Nitroglycerin|nitroglycerin|mesh-list
83231179|NCT05907655|Vasodilator Agents|vasodilator agents|mesh-ancestor
83231180|NCT05907525|Propofol|propofol|mesh-list
83231181|NCT05907525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83231182|NCT05907525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231183|NCT05907525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231184|NCT05907525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83231185|NCT05907525|Anesthetics, General|anesthetics, general|mesh-ancestor
83231186|NCT05907525|Anesthetics|anesthetics|mesh-ancestor
83231187|NCT05907512|Endostar protein|endostar protein|mesh-list
83231188|NCT05907512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83231189|NCT05907512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83231190|NCT05907512|Growth Substances|growth substances|mesh-ancestor
83231191|NCT05907512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231192|NCT05907512|Growth Inhibitors|growth inhibitors|mesh-ancestor
83231193|NCT05907512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231194|NCT05907304|Trametinib|trametinib|mesh-list
83231195|NCT05907304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231196|NCT05907304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83231197|NCT05907304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231198|NCT05907304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231199|NCT05906303|Sodium Benzoate|sodium benzoate|mesh-list
83231200|NCT05906303|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
83231201|NCT05906303|Caffeine|caffeine|mesh-list
83231202|NCT05906303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83231203|NCT05906303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231204|NCT05906303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83231205|NCT05906303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231206|NCT05906303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231207|NCT05906303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83231208|NCT05906303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83231209|NCT05906303|Purinergic Agents|purinergic agents|mesh-ancestor
83231210|NCT05906303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231211|NCT05906303|Antifungal Agents|antifungal agents|mesh-ancestor
83231212|NCT05906303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231213|NCT05906303|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83231214|NCT05906303|Protective Agents|protective agents|mesh-ancestor
83231215|NCT05906303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83231216|NCT05906303|Analgesics|analgesics|mesh-ancestor
83231217|NCT05906303|Sensory System Agents|sensory system agents|mesh-ancestor
83231218|NCT05906303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231219|NCT05906056|Zoledronic Acid|zoledronic acid|mesh-list
83231220|NCT05906056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83231221|NCT05906056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231222|NCT05905770|Alemtuzumab|alemtuzumab|mesh-list
83231223|NCT05905770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231224|NCT05905770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231225|NCT05905510|Anesthetics|anesthetics|mesh-list
83231226|NCT05905510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231227|NCT05905510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231228|NCT05904964|Disitamab vedotin|disitamab vedotin|mesh-list
83231229|NCT05904964|Immunoconjugates|immunoconjugates|mesh-ancestor
83231230|NCT05904964|Immunologic Factors|immunologic factors|mesh-ancestor
83231231|NCT05904964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231232|NCT05904730|Axitinib|axitinib|mesh-list
83231233|NCT05904730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231234|NCT05904730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83231235|NCT05904730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231236|NCT05904730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231237|NCT05904353|Zoledronic Acid|zoledronic acid|mesh-list
83231238|NCT05904353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83231239|NCT05904353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231240|NCT05903417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83231241|NCT05903417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83231242|NCT05903417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83231243|NCT05903417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231244|NCT05903014|Acetylcysteine|acetylcysteine|mesh-list
83231245|NCT05903014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83231246|NCT05903014|Antiviral Agents|antiviral agents|mesh-ancestor
83231247|NCT05903014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231248|NCT05903014|Expectorants|expectorants|mesh-ancestor
83231249|NCT05903014|Respiratory System Agents|respiratory system agents|mesh-ancestor
83231250|NCT05903014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83231251|NCT05903014|Antioxidants|antioxidants|mesh-ancestor
83231252|NCT05903014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231253|NCT05903014|Protective Agents|protective agents|mesh-ancestor
83231254|NCT05903014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231255|NCT05903014|Antidotes|antidotes|mesh-ancestor
83231256|NCT05899816|KHK4083|khk4083|mesh-list
83231257|NCT05899816|Dermatologic Agents|dermatologic agents|mesh-ancestor
83231258|NCT05897554|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83231259|NCT05897554|Plasminogen|plasminogen|mesh-list
83231260|NCT05897554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83231261|NCT05897554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83231262|NCT05897554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231263|NCT05896566|Anastrozole|anastrozole|mesh-list
83231264|NCT05896566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83231265|NCT05896566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83231266|NCT05896566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231267|NCT05896566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83231268|NCT05896566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83231269|NCT05896566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231270|NCT05896566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231271|NCT05896566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83231272|NCT05896566|Hormone Antagonists|hormone antagonists|mesh-ancestor
83231273|NCT05896566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83231274|NCT05896566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231275|NCT05896566|Luteolytic Agents|luteolytic agents|mesh-ancestor
83231276|NCT05896566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83231277|NCT05896566|Contraceptive Agents|contraceptive agents|mesh-ancestor
83231278|NCT05896566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83231279|NCT05896566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83231282|NCT05894239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231283|NCT05894239|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83231284|NCT05894239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231285|NCT05894239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231286|NCT05888870|Daratumumab|daratumumab|mesh-list
83231287|NCT05888870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231288|NCT05888532|Copper|copper|mesh-list
83231289|NCT05888532|Trace Elements|trace elements|mesh-ancestor
83231290|NCT05888532|Micronutrients|micronutrients|mesh-ancestor
83231291|NCT05888532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231292|NCT05888389|Anesthetics|anesthetics|mesh-list
83231293|NCT05888389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83231294|NCT05888389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231295|NCT05888389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231296|NCT05884528|Botulinum Toxins|botulinum toxins|mesh-list
83231297|NCT05884528|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83231298|NCT05884528|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83231299|NCT05884528|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83231300|NCT05884528|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83231301|NCT05884528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83231302|NCT05884528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231303|NCT05884528|Cholinergic Agents|cholinergic agents|mesh-ancestor
83231304|NCT05884528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231305|NCT05884528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231306|NCT05884528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83231307|NCT05884528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231308|NCT05875857|Analgesics, Opioid|analgesics, opioid|mesh-list
83231310|NCT05875857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231311|NCT05875857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231312|NCT05875857|Analgesics|analgesics|mesh-ancestor
83231313|NCT05875857|Sensory System Agents|sensory system agents|mesh-ancestor
83231314|NCT05875857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231315|NCT05875727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83231316|NCT05875727|Immunologic Factors|immunologic factors|mesh-ancestor
83231317|NCT05875727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231318|NCT05874492|Dermatologic Agents|dermatologic agents|mesh-list
83231319|NCT05872854|Hypericin|hypericin|mesh-list
83231320|NCT05872854|Antidepressive Agents|antidepressive agents|mesh-ancestor
83231321|NCT05872854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83231322|NCT05872854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231323|NCT05872854|Antiviral Agents|antiviral agents|mesh-ancestor
83231324|NCT05872854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231325|NCT05872854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231326|NCT05872854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231327|NCT05872854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83231328|NCT05872854|Immunologic Factors|immunologic factors|mesh-ancestor
83231329|NCT05872854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231330|NCT05867329|Cyclosporine|cyclosporine|mesh-list
83231331|NCT05867329|Prednisone|prednisone|mesh-list
83231332|NCT05867329|Methylprednisolone|methylprednisolone|mesh-list
83231333|NCT05867329|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83231334|NCT05867329|Upadacitinib|upadacitinib|mesh-list
83231335|NCT05867329|Cyclosporins|cyclosporins|mesh-list
83231336|NCT05867329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231337|NCT05867329|Glucocorticoids|glucocorticoids|mesh-ancestor
83231338|NCT05867329|Hormones|hormones|mesh-ancestor
83231339|NCT05867329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83231340|NCT05867329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231341|NCT05867329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83231342|NCT05867329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231343|NCT05867329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231344|NCT05867329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231345|NCT05867329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83231346|NCT05867329|Immunologic Factors|immunologic factors|mesh-ancestor
83231347|NCT05867329|Antifungal Agents|antifungal agents|mesh-ancestor
83231348|NCT05867329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231349|NCT05867329|Dermatologic Agents|dermatologic agents|mesh-ancestor
83231350|NCT05867329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231351|NCT05867329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83231352|NCT05867329|Antiemetics|antiemetics|mesh-ancestor
83231353|NCT05867329|Autonomic Agents|autonomic agents|mesh-ancestor
83231354|NCT05867329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231355|NCT05867329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83231356|NCT05867329|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83231357|NCT05867329|Protective Agents|protective agents|mesh-ancestor
83231358|NCT05867329|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83231359|NCT05867329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83231360|NCT05861999|Risdiplam|risdiplam|mesh-list
83231361|NCT05861999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83231362|NCT05861999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231363|NCT05861999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231364|NCT05861986|Risdiplam|risdiplam|mesh-list
83231365|NCT05861986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83231366|NCT05861986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231367|NCT05861986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231368|NCT05860881|Sirolimus|sirolimus|mesh-list
83231369|NCT05860881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83231370|NCT05860881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231371|NCT05860881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83231372|NCT05860881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231373|NCT05860881|Antifungal Agents|antifungal agents|mesh-ancestor
83231374|NCT05860881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83231375|NCT05860881|Immunologic Factors|immunologic factors|mesh-ancestor
83231376|NCT05860881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231377|NCT05860400|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83231378|NCT05860400|Immunologic Factors|immunologic factors|mesh-ancestor
83231379|NCT05860400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231381|NCT05860270|Cholecalciferol|cholecalciferol|mesh-list
83231382|NCT05860270|Vitamins|vitamins|mesh-ancestor
83231383|NCT05860270|Micronutrients|micronutrients|mesh-ancestor
83231384|NCT05860270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231385|NCT05860270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83231386|NCT05860270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83231387|NCT05859464|Pembrolizumab|pembrolizumab|mesh-list
83231388|NCT05859464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231389|NCT05859464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231390|NCT05859464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83231391|NCT05859464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231392|NCT05856331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83231393|NCT05856331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83231394|NCT05856331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83231395|NCT05856331|Protease Inhibitors|protease inhibitors|mesh-ancestor
83231396|NCT05856331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231397|NCT05856331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231398|NCT05856305|Copper|copper|mesh-list
83231399|NCT05856305|Chlorophyllin|chlorophyllin|mesh-list
83231400|NCT05856305|Trace Elements|trace elements|mesh-ancestor
83231401|NCT05856305|Micronutrients|micronutrients|mesh-ancestor
83231402|NCT05856305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231403|NCT05856305|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83231404|NCT05856305|Protective Agents|protective agents|mesh-ancestor
83231405|NCT05856227|Ceftobiprole|ceftobiprole|mesh-list
83231406|NCT05856227|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83231407|NCT05856227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83231408|NCT05856227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231409|NCT05848375|Levobupivacaine|levobupivacaine|mesh-list
83231410|NCT05848375|Ropivacaine|ropivacaine|mesh-list
83231411|NCT05848375|Anesthetics, Local|anesthetics, local|mesh-ancestor
83231412|NCT05848375|Anesthetics|anesthetics|mesh-ancestor
83231413|NCT05848375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231414|NCT05848375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231415|NCT05848375|Sensory System Agents|sensory system agents|mesh-ancestor
83231416|NCT05848375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231417|NCT05845450|Trastuzumab|trastuzumab|mesh-list
83231418|NCT05845450|Durvalumab|durvalumab|mesh-list
83231419|NCT05845450|Panitumumab|panitumumab|mesh-list
83231420|NCT05845450|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83231421|NCT05845450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231422|NCT05845450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231423|NCT05845450|Immunoconjugates|immunoconjugates|mesh-ancestor
83231424|NCT05845450|Immunologic Factors|immunologic factors|mesh-ancestor
83231425|NCT05845450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231426|NCT05845138|Capecitabine|capecitabine|mesh-list
83231427|NCT05845138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83231428|NCT05845138|Antimetabolites|antimetabolites|mesh-ancestor
83231429|NCT05845138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231430|NCT05845138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231431|NCT05838664|Rivaroxaban|rivaroxaban|mesh-list
83231432|NCT05838664|Apixaban|apixaban|mesh-list
83231433|NCT05838664|Dabigatran|dabigatran|mesh-list
83231434|NCT05838664|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83231435|NCT05838664|Antithrombins|antithrombins|mesh-ancestor
83231436|NCT05838664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83231437|NCT05838664|Protease Inhibitors|protease inhibitors|mesh-ancestor
83231438|NCT05838664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231439|NCT05838664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231440|NCT05838664|Anticoagulants|anticoagulants|mesh-ancestor
83231441|NCT05831124|Vaccines|vaccines|mesh-list
83231442|NCT05831124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83231443|NCT05831124|Immunologic Factors|immunologic factors|mesh-ancestor
83231444|NCT05831124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231445|NCT05823896|Ritonavir|ritonavir|mesh-list
83231446|NCT05823896|Nirmatrelvir|nirmatrelvir|mesh-list
83231447|NCT05823896|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83231448|NCT05823896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83231449|NCT05823896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83231450|NCT05823896|Protease Inhibitors|protease inhibitors|mesh-ancestor
83231451|NCT05823896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231452|NCT05823896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231453|NCT05823896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83231454|NCT05823896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83231455|NCT05823896|Antiviral Agents|antiviral agents|mesh-ancestor
83231456|NCT05823896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231457|NCT05823896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83231458|NCT05823896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83231459|NCT05821088|Carboplatin|carboplatin|mesh-list
83231460|NCT05821088|Etoposide|etoposide|mesh-list
83231461|NCT05821088|Lenalidomide|lenalidomide|mesh-list
83231462|NCT05821088|Etoposide phosphate|etoposide phosphate|mesh-list
83231463|NCT05821088|Ifosfamide|ifosfamide|mesh-list
83231464|NCT05821088|Isophosphamide mustard|isophosphamide mustard|mesh-list
83231465|NCT05821088|Podophyllotoxin|podophyllotoxin|mesh-list
83231466|NCT05821088|Immunoglobulins|immunoglobulins|mesh-list
83231467|NCT05821088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231468|NCT05821088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231469|NCT05821088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83231470|NCT05821088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83231471|NCT05821088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231472|NCT05821088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231473|NCT05821088|Immunologic Factors|immunologic factors|mesh-ancestor
83231474|NCT05821088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231475|NCT05821088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83231476|NCT05821088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83231477|NCT05821088|Growth Substances|growth substances|mesh-ancestor
83231478|NCT05821088|Growth Inhibitors|growth inhibitors|mesh-ancestor
83231479|NCT05821088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83231480|NCT05821088|Alkylating Agents|alkylating agents|mesh-ancestor
83231481|NCT05821088|Keratolytic Agents|keratolytic agents|mesh-ancestor
83231482|NCT05821088|Dermatologic Agents|dermatologic agents|mesh-ancestor
83231483|NCT05821088|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231484|NCT05821088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231485|NCT05821088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231487|NCT05819619|Ondansetron|ondansetron|mesh-list
83231488|NCT05819619|Misoprostol|misoprostol|mesh-list
83231489|NCT05819619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83231490|NCT05819619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83231491|NCT05819619|Analgesics|analgesics|mesh-ancestor
83231492|NCT05819619|Sensory System Agents|sensory system agents|mesh-ancestor
83231493|NCT05819619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231494|NCT05819619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231495|NCT05819619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231496|NCT05819619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231497|NCT05819619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83231498|NCT05819619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231499|NCT05819619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231500|NCT05819619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83231501|NCT05819619|Abortifacient Agents|abortifacient agents|mesh-ancestor
83231502|NCT05819619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83231503|NCT05819619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83231504|NCT05819619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83231505|NCT05819619|Oxytocics|oxytocics|mesh-ancestor
83231506|NCT05819619|Antiemetics|antiemetics|mesh-ancestor
83231507|NCT05819619|Autonomic Agents|autonomic agents|mesh-ancestor
83231508|NCT05819619|Antipruritics|antipruritics|mesh-ancestor
83231509|NCT05819619|Dermatologic Agents|dermatologic agents|mesh-ancestor
83231510|NCT05819619|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83231511|NCT05819619|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83231512|NCT05819619|Serotonin Agents|serotonin agents|mesh-ancestor
83231513|NCT05819619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231514|NCT05813288|Pramipexole|pramipexole|mesh-list
83231515|NCT05813288|Antioxidants|antioxidants|mesh-ancestor
83231516|NCT05813288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231517|NCT05813288|Protective Agents|protective agents|mesh-ancestor
83231518|NCT05813288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231519|NCT05813288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83231520|NCT05813288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83231521|NCT05813288|Dopamine Agonists|dopamine agonists|mesh-ancestor
83231522|NCT05813288|Dopamine Agents|dopamine agents|mesh-ancestor
83231523|NCT05813288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231524|NCT05808764|Risdiplam|risdiplam|mesh-list
83231525|NCT05808764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83231526|NCT05808764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362245|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231527|NCT05808764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231528|NCT05794581|Liraglutide|liraglutide|mesh-list
83231529|NCT05794581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83231530|NCT05794581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231531|NCT05794581|Incretins|incretins|mesh-ancestor
83231532|NCT05794581|Hormones|hormones|mesh-ancestor
83231533|NCT05794581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83231534|NCT05794555|Lactulose|lactulose|mesh-list
83231535|NCT05794555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83231536|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
83231537|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231538|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231539|NCT05789082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83430116|NCT01013779|Etoposide|etoposide|mesh-list
83231540|NCT05789082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231541|NCT05784012|Niraparib|niraparib|mesh-list
83231542|NCT05784012|Dostarlimab|dostarlimab|mesh-list
83231543|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231544|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83231545|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231546|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231547|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
83231548|NCT05777993|Mitapivat|mitapivat|mesh-list
83231549|NCT05777993|Enzyme Activators|enzyme activators|mesh-ancestor
83231550|NCT05777993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231551|NCT05776524|Paclitaxel|paclitaxel|mesh-list
83231552|NCT05776524|Gemcitabine|gemcitabine|mesh-list
83231553|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231554|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231555|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231556|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231557|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231558|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231559|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83231560|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
83231561|NCT05769153|Aflibercept|aflibercept|mesh-list
83231562|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83231563|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83231564|NCT05769153|Growth Substances|growth substances|mesh-ancestor
83231565|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231566|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
83231567|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231568|NCT05768854|Diphosphonates|diphosphonates|mesh-list
83231569|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83231570|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231571|NCT05768360|Metformin|metformin|mesh-list
83231572|NCT05768360|Digoxin|digoxin|mesh-list
83231573|NCT05768360|Furosemide|furosemide|mesh-list
83231574|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83231575|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83231576|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231577|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83231578|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83231579|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
83231580|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231581|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83231582|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83231583|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231584|NCT05768360|Diuretics|diuretics|mesh-ancestor
83231585|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
83231586|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83231587|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83231588|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83231589|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83231590|NCT05768360|Protective Agents|protective agents|mesh-ancestor
83231591|NCT05767944|Anesthetics|anesthetics|mesh-list
83231592|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231593|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231594|NCT05763121|Pramipexole|pramipexole|mesh-list
83231595|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
83231596|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231597|NCT05763121|Protective Agents|protective agents|mesh-ancestor
83231598|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231599|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83231600|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83231601|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
83231618|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231619|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231620|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231621|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231622|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231623|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231624|NCT05751265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231626|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
83231627|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231628|NCT05748600|Protective Agents|protective agents|mesh-ancestor
83231629|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231630|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83231631|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83231632|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
83231633|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
83231634|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231635|NCT05733611|Bevacizumab|bevacizumab|mesh-list
83231636|NCT05733611|Atezolizumab|atezolizumab|mesh-list
83231637|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231638|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231639|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83231640|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83231641|NCT05733611|Growth Substances|growth substances|mesh-ancestor
83231642|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231643|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
83231644|NCT05733611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83231645|NCT05733611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231661|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
83231662|NCT05722418|Fludarabine|fludarabine|mesh-list
83231663|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83231664|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
83231665|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231666|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231667|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83231668|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
83231669|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231670|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231671|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83231672|NCT05722015|Paclitaxel|paclitaxel|mesh-list
83231673|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83231674|NCT05722015|Carboplatin|carboplatin|mesh-list
83231675|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
83231676|NCT05722015|Pemetrexed|pemetrexed|mesh-list
83231677|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231678|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231679|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231680|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231681|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231682|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231683|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231684|NCT05722015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83231685|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231686|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83231687|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83231688|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
83231689|NCT05716854|Clarithromycin|clarithromycin|mesh-list
83231690|NCT05716854|Cobicistat|cobicistat|mesh-list
83231691|NCT05716854|Pimozide|pimozide|mesh-list
83231692|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83231693|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83231694|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231695|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83231696|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83231697|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231698|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231699|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231700|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83231701|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
83231702|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83231703|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231704|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83231705|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83231706|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83231707|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83231708|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83231709|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83231710|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83231711|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83231712|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
83231713|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83231714|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83231715|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83231716|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83231717|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83231718|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
83231719|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231720|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83231721|NCT05714553|Leucovorin|leucovorin|mesh-list
83231722|NCT05714553|Docetaxel|docetaxel|mesh-list
83231723|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
83231724|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
83231725|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231726|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231727|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231728|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231729|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231730|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231731|NCT05714553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83231732|NCT05714553|Antidotes|antidotes|mesh-ancestor
83231733|NCT05714553|Protective Agents|protective agents|mesh-ancestor
83231734|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231735|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
83231736|NCT05714553|Vitamins|vitamins|mesh-ancestor
83231737|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
83231738|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
83231739|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231740|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231741|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
83231742|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83231743|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83231744|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231745|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
83231746|NCT05713630|Coagulants|coagulants|mesh-ancestor
83231747|NCT05712356|Paclitaxel|paclitaxel|mesh-list
83231748|NCT05712356|Docetaxel|docetaxel|mesh-list
83231749|NCT05712356|Gemcitabine|gemcitabine|mesh-list
83231750|NCT05712356|Durvalumab|durvalumab|mesh-list
83231751|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231752|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231753|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83231754|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83231755|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83231756|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231757|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83231758|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
83231759|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231760|NCT05710783|Vaccines|vaccines|mesh-list
83231761|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
83231762|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231763|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
83231764|NCT05702853|Fludarabine|fludarabine|mesh-list
83231765|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83231766|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
83231767|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231768|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83231769|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83231770|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
83231771|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231772|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231773|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83231774|NCT05701488|Durvalumab|durvalumab|mesh-list
83231775|NCT05701488|Tremelimumab|tremelimumab|mesh-list
83231776|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231777|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231778|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83231779|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83231780|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231781|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
83231782|NCT05694013|Atezolizumab|atezolizumab|mesh-list
83231783|NCT05694013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83231784|NCT05694013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231785|NCT05694013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231786|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231787|NCT05689021|Prednisone|prednisone|mesh-list
83231788|NCT05689021|Cortisone|cortisone|mesh-list
83231789|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
83231790|NCT05689021|Niraparib|niraparib|mesh-list
83231791|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231792|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
83231793|NCT05689021|Hormones|hormones|mesh-ancestor
83231794|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83231795|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231796|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83231797|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231798|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83231799|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231800|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231801|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
83231802|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83231803|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83231804|NCT05686044|Phenserine|phenserine|mesh-list
83231805|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83231806|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231807|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231808|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
83231809|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231810|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231811|NCT05685407|Caffeine|caffeine|mesh-list
83231812|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83231813|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231814|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83231815|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231816|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231817|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83231818|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83231819|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
83231820|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231821|NCT05684276|Paclitaxel|paclitaxel|mesh-list
83231822|NCT05684276|Carboplatin|carboplatin|mesh-list
83231823|NCT05684276|Nivolumab|nivolumab|mesh-list
83231824|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83231825|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231945|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231947|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83231948|NCT05672342|Analgesics|analgesics|mesh-ancestor
83231949|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
83231950|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231951|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83231952|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83231953|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83231954|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231955|NCT05672342|Hormones|hormones|mesh-ancestor
83231956|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83231957|NCT05672095|Selenium|selenium|mesh-list
83231958|NCT05672095|Niraparib|niraparib|mesh-list
83231959|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83231960|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83231961|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83231962|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231963|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
83231964|NCT05672095|Protective Agents|protective agents|mesh-ancestor
83231965|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231966|NCT05672095|Trace Elements|trace elements|mesh-ancestor
83231967|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
83231968|NCT05669989|Dexamethasone|dexamethasone|mesh-list
83231969|NCT05669989|Lenalidomide|lenalidomide|mesh-list
83231970|NCT05669989|Pomalidomide|pomalidomide|mesh-list
83231971|NCT05669989|Cemiplimab|cemiplimab|mesh-list
83231972|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83231973|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
83231974|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
83231975|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83231976|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83231977|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83231978|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
83231979|NCT05669989|Hormones|hormones|mesh-ancestor
83231980|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83231981|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83231982|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83231983|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
83231984|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83231985|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83231986|NCT05669989|Growth Substances|growth substances|mesh-ancestor
83231987|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
83231988|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83231989|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
83231990|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
83231991|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83231992|NCT05667116|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83231993|NCT05667116|Antiviral Agents|antiviral agents|mesh-ancestor
83231994|NCT05667116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83231995|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83231996|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83231997|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83231998|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
83231999|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232000|NCT05655182|Vaccines|vaccines|mesh-list
83232001|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
83232002|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232003|NCT05654623|Fulvestrant|fulvestrant|mesh-list
83232004|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232005|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232006|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83232007|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83232008|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
83232009|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232010|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232011|NCT05644600|Nintedanib|nintedanib|mesh-list
83232012|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232013|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83232014|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232015|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232016|NCT05641051|Metoclopramide|metoclopramide|mesh-list
83232017|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
83232018|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
83232019|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232020|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232021|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83232022|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83232023|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83232024|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
83232025|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232026|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232027|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
83232028|NCT05633615|Fludarabine|fludarabine|mesh-list
83232029|NCT05633615|Tisagenlecleucel|tisagenlecleucel|mesh-list
83232030|NCT05633615|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83232031|NCT05633615|Antibodies|antibodies|mesh-list
83232032|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
83232033|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232034|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83232035|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
83232036|NCT05633615|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83232037|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232038|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
83232039|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232040|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232041|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232042|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
83232043|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232044|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232045|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83232046|NCT05633615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232047|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83232048|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83232049|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232050|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83232051|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83232052|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232053|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232054|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
83232069|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232071|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232072|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232073|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83232074|NCT05625412|Docetaxel|docetaxel|mesh-list
83232075|NCT05625412|Capecitabine|capecitabine|mesh-list
83232076|NCT05625412|Nivolumab|nivolumab|mesh-list
83232077|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232078|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
83232079|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
83232080|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
83232081|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232082|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232083|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
83232084|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232085|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232086|NCT05624996|Paclitaxel|paclitaxel|mesh-list
83232087|NCT05624996|Etoposide|etoposide|mesh-list
83232088|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
83232089|NCT05624996|Cisplatin|cisplatin|mesh-list
83232090|NCT05624996|Carboplatin|carboplatin|mesh-list
83232091|NCT05624996|Pemetrexed|pemetrexed|mesh-list
83232092|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83232093|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
83232094|NCT05624996|Durvalumab|durvalumab|mesh-list
83232095|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
83232096|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232097|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
83232098|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83232099|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232100|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
83232101|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
83232102|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
83232103|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232104|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83232105|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83232106|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232107|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83232108|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83232109|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232110|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
83232111|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232112|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
83232113|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
83232128|NCT05618808|Enoxaparin|enoxaparin|mesh-list
83232129|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
83232130|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83232131|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83232155|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232156|NCT05587998|Analgesics|analgesics|mesh-ancestor
83232157|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
83232158|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232159|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
83232160|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83232161|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83232162|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83232163|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83232164|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232165|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232166|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
83232167|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232168|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232169|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83232170|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232171|NCT05581589|Camptothecin|camptothecin|mesh-list
83232172|NCT05581589|Irinotecan|irinotecan|mesh-list
83232173|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
83232174|NCT05581589|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83232175|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
83232176|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232177|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83232178|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232179|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83232180|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83232181|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232182|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232215|NCT05576077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232216|NCT05571735|Vaccines|vaccines|mesh-list
83232217|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
83232218|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232219|NCT05570812|Neurosteroids|neurosteroids|mesh-list
83232220|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430117|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232221|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232222|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232223|NCT05569512|Fludarabine|fludarabine|mesh-list
83232224|NCT05569512|Busulfan|busulfan|mesh-list
83232225|NCT05569512|Clofarabine|clofarabine|mesh-list
83232226|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232227|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232228|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
83232229|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232230|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232231|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
83232232|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232233|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
83232234|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232235|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83232236|NCT05568095|Leucovorin|leucovorin|mesh-list
83232237|NCT05568095|Fluorouracil|fluorouracil|mesh-list
83232238|NCT05568095|Capecitabine|capecitabine|mesh-list
83232239|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
83232240|NCT05568095|Nivolumab|nivolumab|mesh-list
83232241|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
83232242|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232243|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232244|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232245|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232246|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
83232247|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232248|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232249|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232250|NCT05568095|Antidotes|antidotes|mesh-ancestor
83232251|NCT05568095|Protective Agents|protective agents|mesh-ancestor
83232252|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
83232253|NCT05568095|Vitamins|vitamins|mesh-ancestor
83232254|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
83232255|NCT05561387|Dexamethasone|dexamethasone|mesh-list
83232256|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
83232257|NCT05561387|Lenalidomide|lenalidomide|mesh-list
83232258|NCT05561387|Bortezomib|bortezomib|mesh-list
83232259|NCT05561387|Daratumumab|daratumumab|mesh-list
83232260|NCT05561387|Ichthammol|ichthammol|mesh-list
83232261|NCT05561387|BB 1101|bb 1101|mesh-list
83232262|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232263|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83232264|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
83232265|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
83232266|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232267|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232268|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83232269|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
83232270|NCT05561387|Hormones|hormones|mesh-ancestor
83232271|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232272|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232274|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
83232275|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232276|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232277|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
83232278|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83232279|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83232280|NCT05561387|Growth Substances|growth substances|mesh-ancestor
83232281|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
83232282|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
83232283|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
83232285|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232286|NCT05558982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232287|NCT05558982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232288|NCT05556616|Lenalidomide|lenalidomide|mesh-list
83232289|NCT05556616|Pomalidomide|pomalidomide|mesh-list
83232290|NCT05556616|Bortezomib|bortezomib|mesh-list
83232291|NCT05556616|Daratumumab|daratumumab|mesh-list
83232292|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
83232293|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232294|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83232295|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83232296|NCT05556616|Growth Substances|growth substances|mesh-ancestor
83232297|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
83232298|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232299|NCT05554354|Fulvestrant|fulvestrant|mesh-list
83232300|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232301|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232302|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83232303|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83232304|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
83232305|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232306|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232307|NCT05554237|Ceftibuten|ceftibuten|mesh-list
83232308|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83232309|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232310|NCT05552976|Dexamethasone|dexamethasone|mesh-list
83232311|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83232312|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
83232313|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
83232314|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232315|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232316|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83232317|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
83232318|NCT05552976|Hormones|hormones|mesh-ancestor
83232319|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232320|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232321|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232322|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
83232323|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83232324|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232325|NCT05548296|Gemcitabine|gemcitabine|mesh-list
83232326|NCT05548296|Prexasertib|prexasertib|mesh-list
83232327|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232328|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
83232329|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232330|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232331|NCT05548296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83232332|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232333|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
83232334|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83232335|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
83232336|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232337|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
83232338|NCT05544695|Protective Agents|protective agents|mesh-ancestor
83232340|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83232341|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
83232342|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83232343|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232344|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232345|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83232346|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83232347|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83232348|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232349|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83232350|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83232351|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83232352|NCT05538663|Gemcitabine|gemcitabine|mesh-list
83232353|NCT05538663|Docetaxel|docetaxel|mesh-list
83232354|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
83232355|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232356|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
83232357|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232358|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232359|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
83232360|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
83232361|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
83232362|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83232363|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
83232364|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232365|NCT05538312|Itraconazole|itraconazole|mesh-list
83232366|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
83232367|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232368|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83232369|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83232370|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232371|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232372|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83232373|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
83232374|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232375|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232376|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83232377|NCT05534984|Tecovirimat|tecovirimat|mesh-list
83232378|NCT05534984|Antiviral Agents|antiviral agents|mesh-ancestor
83232379|NCT05534984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232380|NCT05533775|Rituximab|rituximab|mesh-list
83232381|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
83232382|NCT05533775|Carboplatin|carboplatin|mesh-list
83232383|NCT05533775|Etoposide|etoposide|mesh-list
83232384|NCT05533775|Ifosfamide|ifosfamide|mesh-list
83232385|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232386|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232387|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
83232388|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232389|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232390|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83232391|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83232392|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83232393|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232394|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232395|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232396|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
83232397|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
83232398|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83232399|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232400|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83232401|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232402|NCT05512819|Vaccines|vaccines|mesh-list
83232403|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83232404|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
83232405|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232406|NCT05511038|Aflibercept|aflibercept|mesh-list
83232407|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83232408|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83232409|NCT05511038|Growth Substances|growth substances|mesh-ancestor
83232410|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232411|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
83232412|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232413|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83232414|NCT05507476|Epinephrine|epinephrine|mesh-list
83232415|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83232416|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83232417|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
83232418|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232419|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232420|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232421|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83232422|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83232423|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
83232424|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232425|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83232426|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
83232427|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
83232428|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
83232429|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83232430|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
83232431|NCT05507476|Coagulants|coagulants|mesh-ancestor
83232432|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83232433|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
83232434|NCT05503797|Cobicistat|cobicistat|mesh-list
83232435|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83232436|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83232437|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
83232438|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232439|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83232440|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83232441|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232442|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232443|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
83232444|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232445|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232446|NCT05500326|Ivermectin|ivermectin|mesh-list
83232447|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83232448|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232449|NCT05494125|Ropivacaine|ropivacaine|mesh-list
83232450|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
83232451|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
83232452|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83232453|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232454|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
83232455|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232456|NCT05484401|Ibuprofen|ibuprofen|mesh-list
83232457|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83232458|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83232459|NCT05484401|Analgesics|analgesics|mesh-ancestor
83232460|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
83232461|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232462|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232463|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83232464|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232465|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83232466|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232467|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232468|NCT05477576|Everolimus|everolimus|mesh-list
83232469|NCT05477576|Sunitinib|sunitinib|mesh-list
83232470|NCT05477576|Octreotide|octreotide|mesh-list
83232471|NCT05477576|Lanreotide|lanreotide|mesh-list
83232472|NCT05477576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83232473|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83232474|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232475|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232476|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232477|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
83232478|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232479|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232480|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83232481|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83232482|NCT05477576|Growth Substances|growth substances|mesh-ancestor
83232483|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
83232484|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83232485|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232486|NCT05470491|Maraviroc|maraviroc|mesh-list
83232487|NCT05470491|Plerixafor|plerixafor|mesh-list
83232488|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83232489|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83232490|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232491|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83232492|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83232493|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
83232494|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232495|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83232496|NCT05469737|Azacitidine|azacitidine|mesh-list
83232497|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232498|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
83232499|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232500|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232501|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232502|NCT05468697|Palbociclib|palbociclib|mesh-list
83232503|NCT05468697|Belzutifan|belzutifan|mesh-list
83232504|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232505|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83232506|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232543|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83232544|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83232545|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83232546|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232547|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232548|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
83232549|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
83232550|NCT05442580|Fludarabine|fludarabine|mesh-list
83232551|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232552|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
83232553|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232554|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232555|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232556|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
83232557|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232558|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232559|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83232560|NCT05439616|Cariprazine|cariprazine|mesh-list
83232561|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83232562|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83232563|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83232564|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232565|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83232566|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83232567|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83232568|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
83232569|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
83232570|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
83232571|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83232572|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232573|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83232574|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232575|NCT05432388|Remibrutinib|remibrutinib|mesh-list
83232576|NCT05432388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83232577|NCT05432388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232578|NCT05432388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232579|NCT05428969|Azacitidine|azacitidine|mesh-list
83232580|NCT05428969|Venetoclax|venetoclax|mesh-list
83232581|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232582|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
83232583|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232584|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232585|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232586|NCT05423340|Nicotine|nicotine|mesh-list
83232587|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83232588|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
83232589|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232590|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232591|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83232592|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83232593|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
83232594|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232595|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232596|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
83232597|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83232598|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232599|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
83232600|NCT05419505|Coagulants|coagulants|mesh-ancestor
83232601|NCT05418582|Carbamazepine|carbamazepine|mesh-list
83232602|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
83232603|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
83232604|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83232605|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83232606|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232607|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83232608|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83232609|NCT05418582|Analgesics|analgesics|mesh-ancestor
83232610|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
83232611|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232612|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83232613|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232614|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232615|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83232616|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83232618|NCT05417425|Protective Agents|protective agents|mesh-list
83232619|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
83232620|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
83232621|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83232622|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232623|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
83232624|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232625|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83232626|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83232627|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83232628|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232629|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232630|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
83232631|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232632|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83232633|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232634|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232635|NCT05409066|Rituximab|rituximab|mesh-list
83232636|NCT05409066|Lenalidomide|lenalidomide|mesh-list
83232637|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232638|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232639|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
83232640|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232641|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232642|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83232643|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83232644|NCT05409066|Growth Substances|growth substances|mesh-ancestor
83232645|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
83232646|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83232647|NCT05408845|Trastuzumab|trastuzumab|mesh-list
83232648|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83232649|NCT05408845|Docetaxel|docetaxel|mesh-list
83232650|NCT05408845|Maytansine|maytansine|mesh-list
83232651|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83232652|NCT05408845|Antibodies|antibodies|mesh-list
83232653|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
83232654|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232655|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
83232658|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232659|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83232660|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83232661|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83232662|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232663|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83232664|NCT05408845|Immunotoxins|immunotoxins|mesh-ancestor
83232665|NCT05407675|Nivolumab|nivolumab|mesh-list
83232666|NCT05407675|Ipilimumab|ipilimumab|mesh-list
83232667|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232668|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232669|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232670|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232671|NCT05407441|Nivolumab|nivolumab|mesh-list
83232672|NCT05407441|Ipilimumab|ipilimumab|mesh-list
83232673|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232674|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232675|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232676|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232677|NCT05406401|Prednisone|prednisone|mesh-list
83232678|NCT05406401|Prednisolone|prednisolone|mesh-list
83232679|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
83232680|NCT05406401|Rituximab|rituximab|mesh-list
83232681|NCT05406401|Doxorubicin|doxorubicin|mesh-list
83232682|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232683|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
83232684|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232685|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232686|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232687|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
83232688|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232689|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232690|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83232691|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232692|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83232693|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83232694|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83232695|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232696|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83232697|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
83232698|NCT05406401|Hormones|hormones|mesh-ancestor
83232699|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232700|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232701|NCT05394103|Pembrolizumab|pembrolizumab|mesh-list
83232702|NCT05394103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232703|NCT05394103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232704|NCT05394103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232705|NCT05394103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232706|NCT05388474|Ibalizumab|ibalizumab|mesh-list
83232707|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232708|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83232709|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83232710|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
83232711|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232712|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
83232713|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232714|NCT05382559|Cetuximab|cetuximab|mesh-list
83232715|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232716|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232717|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
83232718|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83232719|NCT05371093|Prednisone|prednisone|mesh-list
83232720|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
83232721|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83232722|NCT05371093|Rituximab|rituximab|mesh-list
83232723|NCT05371093|Doxorubicin|doxorubicin|mesh-list
83232724|NCT05371093|Fludarabine|fludarabine|mesh-list
83232725|NCT05371093|Vincristine|vincristine|mesh-list
83232726|NCT05371093|Lenalidomide|lenalidomide|mesh-list
83232727|NCT05371093|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83232728|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232729|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
83232730|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232731|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232732|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232733|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
83232734|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232735|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232736|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83232737|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232738|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83232739|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83232740|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83232741|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232742|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83232743|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
83232745|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232746|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232747|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83232748|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
83232749|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
83232750|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
83232751|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83232752|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83232753|NCT05371093|Growth Substances|growth substances|mesh-ancestor
83232754|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
83232755|NCT05362318|Nicotine|nicotine|mesh-list
83232756|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83232757|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
83232758|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232759|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232760|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83232761|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83232762|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
83232763|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232764|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232765|NCT05359068|Valsartan|valsartan|mesh-list
83232766|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83232767|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83232768|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83232769|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232770|NCT05358886|BPN14770|bpn14770|mesh-list
83232771|NCT05358886|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83232772|NCT05358886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83232773|NCT05358886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232774|NCT05358886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232775|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83232776|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232777|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232778|NCT05357794|Immunotoxins|immunotoxins|mesh-ancestor
83232779|NCT05357794|Immunoconjugates|immunoconjugates|mesh-ancestor
83232780|NCT05357794|Immunologic Factors|immunologic factors|mesh-ancestor
83232781|NCT05357794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232782|NCT05352815|Insulin|insulin|mesh-list
83232783|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83232784|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232786|NCT05352672|Cemiplimab|cemiplimab|mesh-list
83232787|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232788|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232789|NCT05352672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232790|NCT05352672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232791|NCT05348356|Nirogacestat|nirogacestat|mesh-list
83232792|NCT05348356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83232793|NCT05348356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232794|NCT05348356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232795|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232796|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
83232797|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232798|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
83232799|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232800|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232801|NCT05346484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232802|NCT05346484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232806|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232807|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83232808|NCT05342844|Analgesics|analgesics|mesh-ancestor
83232809|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
83232810|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232811|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83232812|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83232813|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83232814|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
83232815|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232816|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232817|NCT05339087|Riociguat|riociguat|mesh-list
83232818|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
83232819|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232820|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
83232821|NCT05334329|Fludarabine|fludarabine|mesh-list
83232822|NCT05334329|Atezolizumab|atezolizumab|mesh-list
83232823|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
83232824|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232825|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232826|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
83232827|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232828|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232829|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83232830|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
83232831|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232832|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83232833|NCT05334329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232834|NCT05334329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232835|NCT05328908|Trifluridine|trifluridine|mesh-list
83232836|NCT05328908|Nivolumab|nivolumab|mesh-list
83232837|NCT05328908|Relatlimab|relatlimab|mesh-list
83232838|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232839|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232840|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232841|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232842|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
83232843|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
83232844|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232845|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
83232846|NCT05327686|Nivolumab|nivolumab|mesh-list
83232847|NCT05327686|Ipilimumab|ipilimumab|mesh-list
83232848|NCT05327686|Avelumab|avelumab|mesh-list
83232849|NCT05327686|Lenvatinib|lenvatinib|mesh-list
83232850|NCT05327686|Axitinib|axitinib|mesh-list
83232851|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232852|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232853|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232854|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232855|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232856|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83232857|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232858|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
83232859|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232863|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
83232864|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232865|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232866|NCT05323656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232867|NCT05323656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232868|NCT05323617|Cyclosporine|cyclosporine|mesh-list
83232869|NCT05323617|Cyclosporins|cyclosporins|mesh-list
83232870|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83232871|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232872|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232873|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232874|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
83232875|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232876|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
83232877|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232899|NCT05306873|Cyclosporine|cyclosporine|mesh-list
83232900|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83232901|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232902|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83232903|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
83232904|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83232905|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232906|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232907|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232908|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
83232909|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
83232910|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83232911|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
83232912|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232913|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83232914|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83232915|NCT05289687|Daratumumab|daratumumab|mesh-list
83232916|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232917|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232918|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
83232919|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232920|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83232921|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83232922|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232923|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83232924|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83232925|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83232926|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232927|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
83232928|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83232929|NCT05281510|Vesatolimod|vesatolimod|mesh-list
83232930|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
83232931|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83232932|NCT05272384|Nivolumab|nivolumab|mesh-list
83232933|NCT05272384|Decitabine|decitabine|mesh-list
83232934|NCT05272384|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83232935|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232936|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232937|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232938|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232939|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83232940|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
83232941|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232942|NCT05267613|Esomeprazole|esomeprazole|mesh-list
83232943|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83232944|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83232945|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83232946|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232947|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232948|NCT05262400|Letrozole|letrozole|mesh-list
83232949|NCT05262400|Fulvestrant|fulvestrant|mesh-list
83232950|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232951|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83232952|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83232953|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232954|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232955|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83232956|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
83232957|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232958|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232959|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232960|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83232961|NCT05251233|Pantoprazole|pantoprazole|mesh-list
83232962|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83232963|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83232964|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83232965|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83232966|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232967|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
83232968|NCT05239728|Belzutifan|belzutifan|mesh-list
83232969|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83232970|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232971|NCT05239728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83232972|NCT05239728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232973|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
83232974|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83232975|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83232976|NCT05232929|Risdiplam|risdiplam|mesh-list
83232977|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83232978|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232979|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232980|NCT05231629|Dexamethasone|dexamethasone|mesh-list
83232981|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
83232982|NCT05231629|Melphalan|melphalan|mesh-list
83232983|NCT05231629|Lenalidomide|lenalidomide|mesh-list
83232984|NCT05231629|Bortezomib|bortezomib|mesh-list
83232985|NCT05231629|Daratumumab|daratumumab|mesh-list
83232986|NCT05231629|BB 1101|bb 1101|mesh-list
83232987|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83232988|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83232989|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
83232990|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
83232991|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83232992|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83232993|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83232995|NCT05231629|Hormones|hormones|mesh-ancestor
83232996|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83232997|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83232998|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83232999|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
83233000|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233001|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233002|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83233003|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
83233004|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83233005|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233006|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
83233007|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83233008|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83233009|NCT05231629|Growth Substances|growth substances|mesh-ancestor
83233010|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
83233011|NCT05229965|Acetaminophen|acetaminophen|mesh-list
83233012|NCT05229965|Codeine|codeine|mesh-list
83233013|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83233014|NCT05229965|Analgesics|analgesics|mesh-ancestor
83233015|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
83233016|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83233017|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233018|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
83233019|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83233020|NCT05229965|Narcotics|narcotics|mesh-ancestor
83233021|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83233022|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
83233023|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
83233024|NCT05227391|Letrozole|letrozole|mesh-list
83233025|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83233026|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83233027|NCT05227391|Estradiol|estradiol|mesh-list
83233028|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83233029|NCT05227391|Estrogens|estrogens|mesh-ancestor
83233030|NCT05227391|Hormones|hormones|mesh-ancestor
83233031|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233032|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233033|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83233034|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
83233035|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83233036|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83233037|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233038|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83233039|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83233040|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233041|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233042|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83233043|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
83233044|NCT05224141|Carboplatin|carboplatin|mesh-list
83233045|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
83233046|NCT05224141|Etoposide|etoposide|mesh-list
83233047|NCT05224141|Atezolizumab|atezolizumab|mesh-list
83233048|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233049|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233050|NCT05224141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233051|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233052|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233053|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83233054|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83233055|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233057|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83233058|NCT05214287|Protective Agents|protective agents|mesh-ancestor
83233059|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233060|NCT05208047|Sunitinib|sunitinib|mesh-list
83233061|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233062|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83233063|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83233064|NCT05208047|Growth Substances|growth substances|mesh-ancestor
83233065|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233066|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
83233067|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83233068|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233069|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233070|NCT05207709|Paclitaxel|paclitaxel|mesh-list
83233071|NCT05207709|Letrozole|letrozole|mesh-list
83233072|NCT05207709|Fulvestrant|fulvestrant|mesh-list
83233073|NCT05207709|Palbociclib|palbociclib|mesh-list
83233074|NCT05207709|Tislelizumab|tislelizumab|mesh-list
83233075|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233076|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233077|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233078|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233079|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233080|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233081|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83233082|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83233083|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233084|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83233085|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
83233086|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233087|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233088|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233089|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83233090|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83233091|NCT05207709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233092|NCT05203276|Endostar protein|endostar protein|mesh-list
83233093|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83233094|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83233095|NCT05203276|Growth Substances|growth substances|mesh-ancestor
83233096|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233097|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
83233098|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233099|NCT05201547|Paclitaxel|paclitaxel|mesh-list
83233100|NCT05201547|Carboplatin|carboplatin|mesh-list
83233101|NCT05201547|Dostarlimab|dostarlimab|mesh-list
83233103|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233104|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233105|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233106|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233107|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233108|NCT05201066|Azacitidine|azacitidine|mesh-list
83233109|NCT05201066|Decitabine|decitabine|mesh-list
83233110|NCT05201066|Venetoclax|venetoclax|mesh-list
83233111|NCT05201066|Spartalizumab|spartalizumab|mesh-list
83233112|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233113|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
83233114|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233115|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233116|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233117|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233118|NCT05201066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233120|NCT05192200|Interferon-beta|interferon-beta|mesh-list
83233121|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233122|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
83233123|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83233124|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
83233125|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233126|NCT05180240|Cannabidiol|cannabidiol|mesh-list
83233127|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
83233128|NCT05175105|Mitapivat|mitapivat|mesh-list
83233129|NCT05175105|Enzyme Activators|enzyme activators|mesh-ancestor
83233130|NCT05175105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233131|NCT05173987|Paclitaxel|paclitaxel|mesh-list
83233132|NCT05173987|Docetaxel|docetaxel|mesh-list
83233133|NCT05173987|Carboplatin|carboplatin|mesh-list
83233134|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
83233135|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233136|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233137|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233138|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233139|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233140|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233141|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233142|NCT05173987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233143|NCT05169437|Niraparib|niraparib|mesh-list
83233144|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83233145|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233146|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233147|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233148|NCT05167487|Cisplatin|cisplatin|mesh-list
83233149|NCT05167487|Carboplatin|carboplatin|mesh-list
83233150|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233151|NCT05163808|BPN14770|bpn14770|mesh-list
83233152|NCT05163808|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83233153|NCT05163808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83233154|NCT05163808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233155|NCT05163808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233156|NCT05162976|Nivolumab|nivolumab|mesh-list
83233157|NCT05162976|Azacitidine|azacitidine|mesh-list
83233158|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233159|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233160|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233161|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233162|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233163|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
83233164|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233165|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
83233166|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233167|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233168|NCT05159778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233169|NCT05159778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233170|NCT05159050|Paclitaxel|paclitaxel|mesh-list
83233171|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233172|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233173|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233174|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233175|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233176|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233177|NCT05153915|Tacrolimus|tacrolimus|mesh-list
83233178|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233179|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
83233180|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233181|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83233182|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233183|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233184|NCT05152888|Evolocumab|evolocumab|mesh-list
83233185|NCT05152888|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83233186|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83233187|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83233188|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
83233189|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233190|NCT05152888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83233191|NCT05152888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83233192|NCT05152888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233193|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83233194|NCT05152628|Tacrolimus|tacrolimus|mesh-list
83233195|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233196|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
83233197|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233198|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83233199|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233200|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233201|NCT05151731|Ranibizumab|ranibizumab|mesh-list
83233202|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83233203|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83233204|NCT05151731|Growth Substances|growth substances|mesh-ancestor
83233205|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233206|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
83233207|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233208|NCT05151484|Alendronate|alendronate|mesh-list
83233209|NCT05151484|Teriparatide|teriparatide|mesh-list
83233210|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83233211|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233212|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83233213|NCT05145010|Infigratinib|infigratinib|mesh-list
83233214|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233215|NCT05144256|Mitapivat|mitapivat|mesh-list
83233216|NCT05144256|Enzyme Activators|enzyme activators|mesh-ancestor
83233217|NCT05144256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233218|NCT05144009|Rituximab|rituximab|mesh-list
83233219|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83233220|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233221|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233222|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
83233223|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233224|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83233225|NCT05143840|Niacinamide|niacinamide|mesh-list
83233226|NCT05143840|Vitamin B Complex|vitamin b complex|mesh-ancestor
83233227|NCT05143840|Vitamins|vitamins|mesh-ancestor
83233228|NCT05143840|Micronutrients|micronutrients|mesh-ancestor
83233229|NCT05143840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233230|NCT05142189|Docetaxel|docetaxel|mesh-list
83233231|NCT05142189|Cemiplimab|cemiplimab|mesh-list
83233232|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233233|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233234|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233235|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233236|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233237|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233238|NCT05139017|Rituximab|rituximab|mesh-list
83233239|NCT05139017|Gemcitabine|gemcitabine|mesh-list
83233240|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
83233241|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83233242|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233243|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233244|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
83233245|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233246|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83233247|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233248|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
83233249|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233250|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83233251|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
83233253|NCT05131828|Clemastine|clemastine|mesh-list
83233254|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83233255|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233256|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
83233257|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83233258|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83233259|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
83233260|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
83233261|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83233262|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233263|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83233264|NCT05130268|Dronedarone|dronedarone|mesh-list
83233265|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83233266|NCT05122546|Nivolumab|nivolumab|mesh-list
83233267|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233268|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233269|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233270|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233271|NCT05120895|Pravastatin|pravastatin|mesh-list
83233272|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83233273|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83233274|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
83233275|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233276|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83233277|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83233278|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233279|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
83233280|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233281|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233282|NCT05117476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233283|NCT05117476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233284|NCT05116202|Nivolumab|nivolumab|mesh-list
83233285|NCT05116202|Ipilimumab|ipilimumab|mesh-list
83233286|NCT05116202|Atezolizumab|atezolizumab|mesh-list
83233287|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233288|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233289|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233290|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233291|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83233292|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
83233293|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83233294|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233295|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
83233296|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233297|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83233298|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83233299|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
83233300|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83233301|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
83233302|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83233303|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233304|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83233305|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233306|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233307|NCT05109442|Atezolizumab|atezolizumab|mesh-list
83233308|NCT05109442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233309|NCT05109442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233310|NCT05109442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233311|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233312|NCT05104554|Folic Acid|folic acid|mesh-list
83233313|NCT05104554|Micronutrients|micronutrients|mesh-list
83233314|NCT05104554|Trace Elements|trace elements|mesh-list
83233315|NCT05104554|Hematinics|hematinics|mesh-ancestor
83233316|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
83233317|NCT05104554|Vitamins|vitamins|mesh-ancestor
83233318|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233319|NCT05103696|Propofol|propofol|mesh-list
83233320|NCT05103696|Etomidate|etomidate|mesh-list
83233321|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83233322|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83233323|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233324|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83233325|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
83233326|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
83233327|NCT05101551|Gemcitabine|gemcitabine|mesh-list
83233328|NCT05101551|Topotecan|topotecan|mesh-list
83233329|NCT05101551|Talazoparib|talazoparib|mesh-list
83233330|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233331|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
83233332|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233333|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233334|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83233335|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83233336|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233337|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83233338|NCT05095376|Temozolomide|temozolomide|mesh-list
83233339|NCT05095376|Lomustine|lomustine|mesh-list
83233340|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83233341|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
83233342|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233343|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233344|NCT05092958|Avelumab|avelumab|mesh-list
83233345|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83233346|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233347|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233348|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
83233349|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233350|NCT05091567|Carboplatin|carboplatin|mesh-list
83233351|NCT05091567|Etoposide|etoposide|mesh-list
83233352|NCT05091567|Atezolizumab|atezolizumab|mesh-list
83233353|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233354|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233355|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83233356|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83233357|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233358|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233359|NCT05091567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233360|NCT05091567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233361|NCT05088252|Propofol|propofol|mesh-list
83233362|NCT05088252|Desflurane|desflurane|mesh-list
83233363|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83233364|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83233365|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233366|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83233367|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
83233368|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
83233369|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83233370|NCT05077904|Alprazolam|alprazolam|mesh-list
83233371|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83233372|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83233373|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233374|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83233375|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83233376|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83233377|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
83233378|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
83233379|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83233380|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233381|NCT05076617|Alprazolam|alprazolam|mesh-list
83233382|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83233383|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83233384|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233385|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83233386|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83233387|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83233388|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
83233389|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
83233390|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83233391|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233392|NCT05076175|Ozanimod|ozanimod|mesh-list
83233393|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83233394|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233395|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233396|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
83233397|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233398|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
83233399|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83233400|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
83233401|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233402|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
83233403|NCT05073575|Protective Agents|protective agents|mesh-ancestor
83233405|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
83233406|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233407|NCT05069298|Silybin|silybin|mesh-list
83233408|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233409|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233410|NCT05069298|Protective Agents|protective agents|mesh-ancestor
83233411|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233412|NCT05062044|Folic Acid|folic acid|mesh-list
83233413|NCT05062044|Hematinics|hematinics|mesh-ancestor
83233414|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
83233415|NCT05062044|Vitamins|vitamins|mesh-ancestor
83233416|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
83233417|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233418|NCT05059522|Pemetrexed|pemetrexed|mesh-list
83233419|NCT05059522|Avelumab|avelumab|mesh-list
83233420|NCT05059522|Axitinib|axitinib|mesh-list
83233421|NCT05059522|Talazoparib|talazoparib|mesh-list
83233422|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233423|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233424|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233425|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83233426|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83233427|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233428|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83233429|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83233430|NCT05058651|Cisplatin|cisplatin|mesh-list
83233431|NCT05058651|Carboplatin|carboplatin|mesh-list
83233432|NCT05058651|Etoposide|etoposide|mesh-list
83233433|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
83233434|NCT05058651|Atezolizumab|atezolizumab|mesh-list
83233435|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
83233436|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83233437|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233438|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233439|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83233440|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83233441|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233442|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233443|NCT05058651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233444|NCT05058651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233445|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
83233446|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233447|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
83233448|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
83233449|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233450|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233451|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233452|NCT05057494|Venetoclax|venetoclax|mesh-list
83233453|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
83233454|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
83233455|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233456|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233457|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
83233458|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83233459|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83233460|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233461|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
83233462|NCT05053867|Coagulants|coagulants|mesh-ancestor
83233463|NCT05053152|Relugolix|relugolix|mesh-list
83233464|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
83233465|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
83233466|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233467|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233468|NCT05050162|Cisplatin|cisplatin|mesh-list
83233469|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
83233470|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233471|NCT05050084|Leuprolide|leuprolide|mesh-list
83233472|NCT05050084|Goserelin|goserelin|mesh-list
83233473|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83233474|NCT05050084|Flutamide|flutamide|mesh-list
83233475|NCT05050084|Bicalutamide|bicalutamide|mesh-list
83233476|NCT05050084|Tryptophan|tryptophan|mesh-list
83233477|NCT05050084|Buserelin|buserelin|mesh-list
83233478|NCT05050084|Hormones|hormones|mesh-list
83233479|NCT05050084|Relugolix|relugolix|mesh-list
83233480|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233481|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233482|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83233483|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
83233484|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83233485|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233486|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233487|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
83233488|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
83233489|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
83233490|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83233491|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
83233492|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83233493|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83233494|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
83233495|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83233497|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
83233498|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233499|NCT05047250|Atezolizumab|atezolizumab|mesh-list
83233500|NCT05047250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233501|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233502|NCT05047250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233503|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233504|NCT05046314|Vincristine|vincristine|mesh-list
83233505|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233506|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233507|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233508|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233509|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233510|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233511|NCT05043714|Nivolumab|nivolumab|mesh-list
83233512|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233513|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233514|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233515|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233516|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83233517|NCT05039073|Nivolumab|nivolumab|mesh-list
83233518|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83233519|NCT05039073|Antibodies|antibodies|mesh-list
83233520|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
83233521|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83233522|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
83233523|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
83233524|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233525|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233526|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233527|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233528|NCT05039073|Immunotoxins|immunotoxins|mesh-ancestor
83233529|NCT05038228|Vitamin K|vitamin k|mesh-list
83233530|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
83233531|NCT05038228|Apixaban|apixaban|mesh-list
83233532|NCT05038228|Dabigatran|dabigatran|mesh-list
83233533|NCT05038228|Vitamins|vitamins|mesh-ancestor
83233534|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
83233535|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233536|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83233537|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
83233538|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83233539|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
83233540|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233541|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233542|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
83233543|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83233544|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83233545|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
83233546|NCT05038228|Coagulants|coagulants|mesh-ancestor
83233547|NCT05031780|Mitapivat|mitapivat|mesh-list
83233548|NCT05031780|Enzyme Activators|enzyme activators|mesh-ancestor
83233549|NCT05031780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233550|NCT05029999|Doxorubicin|doxorubicin|mesh-list
83233551|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83233552|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83233553|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233554|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83233555|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83233556|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233557|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233558|NCT05023967|Metformin|metformin|mesh-list
83233559|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83233560|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233561|NCT05022004|Brinzolamide|brinzolamide|mesh-list
83233562|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83233563|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233564|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233565|NCT05013229|Insulin|insulin|mesh-list
83233566|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83233567|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
83233568|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
83233569|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83233570|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233571|NCT05012254|Paclitaxel|paclitaxel|mesh-list
83233572|NCT05012254|Cisplatin|cisplatin|mesh-list
83233573|NCT05012254|Carboplatin|carboplatin|mesh-list
83233574|NCT05012254|Nivolumab|nivolumab|mesh-list
83233575|NCT05012254|Pemetrexed|pemetrexed|mesh-list
83233576|NCT05012254|Ipilimumab|ipilimumab|mesh-list
83233577|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233578|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233579|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233580|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233581|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233582|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233583|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233584|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233585|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233586|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83233587|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83233588|NCT05009069|Fluorouracil|fluorouracil|mesh-list
83233589|NCT05009069|Capecitabine|capecitabine|mesh-list
83233590|NCT05009069|Atezolizumab|atezolizumab|mesh-list
83233591|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
83233592|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233593|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233594|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233595|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233596|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
83233597|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233598|NCT05009069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233599|NCT05009069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233600|NCT05002569|Nivolumab|nivolumab|mesh-list
83233601|NCT05002569|Relatlimab|relatlimab|mesh-list
83233602|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233603|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233604|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233605|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233606|NCT04995978|Pioglitazone|pioglitazone|mesh-list
83233607|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83233608|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233609|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83233610|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83233611|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83233612|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83233613|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233614|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233615|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
83233616|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83233617|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83233618|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83233620|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
83233621|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83233622|NCT04987242|Rasburicase|rasburicase|mesh-list
83233623|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
83233624|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83233625|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
83233626|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83233627|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83233628|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83233629|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83233630|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233631|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
83233632|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83233633|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233634|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83233635|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83233636|NCT04976192|Omalizumab|omalizumab|mesh-list
83233637|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83233638|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83233639|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
83233640|NCT04975997|Dexamethasone|dexamethasone|mesh-list
83233641|NCT04975997|Bortezomib|bortezomib|mesh-list
83233642|NCT04975997|Daratumumab|daratumumab|mesh-list
83233643|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83233644|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
83233645|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
83233646|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83233647|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233648|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83233649|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
83233650|NCT04975997|Hormones|hormones|mesh-ancestor
83233651|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233652|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233653|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233654|NCT04974528|Insulin|insulin|mesh-list
83233655|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83233656|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
83233657|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
83233658|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
83233659|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
83233660|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
83233661|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
83233662|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83233663|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233664|NCT04971785|Firsocostat|firsocostat|mesh-list
83233665|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233666|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233667|NCT04958486|Trastuzumab|trastuzumab|mesh-list
83233668|NCT04958486|Azacitidine|azacitidine|mesh-list
83233669|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233670|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233671|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233672|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
83233673|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233674|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233675|NCT04942210|Vaccines|vaccines|mesh-list
83233676|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
83233677|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233678|NCT04940767|Minocycline|minocycline|mesh-list
83233679|NCT04940767|Isotretinoin|isotretinoin|mesh-list
83233680|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83233681|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83233682|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
83233683|NCT04929223|Bevacizumab|bevacizumab|mesh-list
83233684|NCT04929223|Cetuximab|cetuximab|mesh-list
83233685|NCT04929223|Atezolizumab|atezolizumab|mesh-list
83233686|NCT04929223|Inavolisib|inavolisib|mesh-list
83233687|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233688|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233689|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83233690|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83233691|NCT04929223|Growth Substances|growth substances|mesh-ancestor
83233692|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233693|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
83233694|NCT04929223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233695|NCT04929223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233696|NCT04929223|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83233697|NCT04929223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233698|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
83233699|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233700|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233701|NCT04925986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233702|NCT04925986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233703|NCT04913805|Niacinamide|niacinamide|mesh-list
83233705|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
83233706|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
83233707|NCT04913805|Vitamins|vitamins|mesh-ancestor
83233708|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
83233709|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233713|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83233714|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
83233716|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233717|NCT04901377|Dienogest|dienogest|mesh-list
83233718|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83233719|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83233720|NCT04901377|Estradiol|estradiol|mesh-list
83233721|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83233722|NCT04901377|Estrogens|estrogens|mesh-ancestor
83233723|NCT04901377|Hormones|hormones|mesh-ancestor
83233724|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233725|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233726|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83233727|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
83233728|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83233729|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83233730|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83233731|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83233732|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83233733|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
83233734|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233735|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233736|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
83233737|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83233738|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83233739|NCT04900220|Prednisolone|prednisolone|mesh-list
83233740|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
83233741|NCT04900220|Betamethasone|betamethasone|mesh-list
83233742|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83233743|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
83233744|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83233745|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
83233746|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
83233747|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83233748|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233749|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83233750|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
83233751|NCT04900220|Hormones|hormones|mesh-ancestor
83233752|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233753|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83233754|NCT04900220|Protective Agents|protective agents|mesh-ancestor
83233755|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233756|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233757|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83233758|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
83233759|NCT04897217|Megestrol|megestrol|mesh-list
83233760|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
83233761|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
83233762|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83233763|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
83233764|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83233765|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233766|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83233767|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83233768|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83233769|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83233770|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233771|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233772|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
83233773|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83233774|NCT04896320|Tucatinib|tucatinib|mesh-list
83233775|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233776|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83233777|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233778|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233783|NCT04895358|Paclitaxel|paclitaxel|mesh-list
83233784|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83233785|NCT04895358|Doxorubicin|doxorubicin|mesh-list
83233786|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83233787|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
83233788|NCT04895358|Capecitabine|capecitabine|mesh-list
83233789|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233790|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233791|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233792|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233793|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233794|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233795|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83233796|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83233797|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83233798|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233799|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233800|NCT04895358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233801|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233802|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
83233803|NCT04887259|Interleukin-2|interleukin-2|mesh-list
83233804|NCT04887259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233805|NCT04887259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83233806|NCT04887259|Analgesics|analgesics|mesh-ancestor
83233807|NCT04887259|Sensory System Agents|sensory system agents|mesh-ancestor
83233808|NCT04887259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83233809|NCT04887259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233810|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
83233811|NCT04877613|Fludarabine|fludarabine|mesh-list
83233812|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233813|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
83233814|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233815|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83233816|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83233817|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
83233818|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233819|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233820|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83233821|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
83233822|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233823|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233824|NCT04875195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233825|NCT04875195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233827|NCT04871607|Etoposide|etoposide|mesh-list
83233828|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
83233829|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
83233830|NCT04871607|Carmustine|carmustine|mesh-list
83233831|NCT04871607|Basiliximab|basiliximab|mesh-list
83233832|NCT04871607|Lenograstim|lenograstim|mesh-list
83233833|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233834|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233835|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83233836|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83233837|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233838|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233839|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233840|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
83233841|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
83233842|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83233843|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233844|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
83233845|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233846|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83233847|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83233848|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
83233849|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
83233850|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
83233851|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233852|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233853|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233854|NCT04865042|Gabapentin|gabapentin|mesh-list
83233855|NCT04865042|Analgesics|analgesics|mesh-ancestor
83233856|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
83233857|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83233858|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233859|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
83233860|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83233861|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83233862|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83233863|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83233864|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83233865|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83233866|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83233867|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233868|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
83233869|NCT04858334|Olaparib|olaparib|mesh-list
83233870|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83233871|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233872|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233873|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233874|NCT04857138|Atezolizumab|atezolizumab|mesh-list
83233875|NCT04857138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233876|NCT04857138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233877|NCT04857138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233878|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233879|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83233880|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
83233881|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233882|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83233883|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83233884|NCT04832854|Paclitaxel|paclitaxel|mesh-list
83233885|NCT04832854|Carboplatin|carboplatin|mesh-list
83233886|NCT04832854|Gemcitabine|gemcitabine|mesh-list
83233887|NCT04832854|Pemetrexed|pemetrexed|mesh-list
83233888|NCT04832854|Atezolizumab|atezolizumab|mesh-list
83233889|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83233890|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233891|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233892|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233893|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233894|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233895|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83233896|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
83233897|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233898|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83233899|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83233900|NCT04832854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233901|NCT04832854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233902|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
83233903|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233904|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233905|NCT04830592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233906|NCT04830592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233907|NCT04827576|Docetaxel|docetaxel|mesh-list
83233908|NCT04827576|Magrolimab|magrolimab|mesh-list
83233909|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233910|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83233911|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83233912|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83233913|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233914|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233915|NCT04824794|Daratumumab|daratumumab|mesh-list
83233916|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233917|NCT04824131|Tenofovir|tenofovir|mesh-list
83233918|NCT04824131|Emtricitabine|emtricitabine|mesh-list
83233919|NCT04824131|Cabotegravir|cabotegravir|mesh-list
83233920|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
83233921|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83233922|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83233923|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83233924|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233925|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233926|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83233927|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83233928|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83233929|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83233930|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
83233931|NCT04812028|Analgesics|analgesics|mesh-ancestor
83233932|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
83233933|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83233934|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233935|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
83233936|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83233938|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
83233939|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83233940|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83233941|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233942|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83233943|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
83233944|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83233945|NCT04808843|Dienogest|dienogest|mesh-list
83233946|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83233947|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
83233948|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83233949|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233950|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83233951|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83233952|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83233953|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83233954|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
83233955|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83233956|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83233957|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233958|NCT04804644|Memantine|memantine|mesh-list
83233959|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83233960|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83233961|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
83233962|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83233963|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233964|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233965|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83233966|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83233967|NCT04802759|Trastuzumab|trastuzumab|mesh-list
83233968|NCT04802759|Atezolizumab|atezolizumab|mesh-list
83233969|NCT04802759|Pertuzumab|pertuzumab|mesh-list
83233970|NCT04802759|Everolimus|everolimus|mesh-list
83233971|NCT04802759|Palbociclib|palbociclib|mesh-list
83233972|NCT04802759|Ipatasertib|ipatasertib|mesh-list
83233973|NCT04802759|Inavolisib|inavolisib|mesh-list
83233974|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233975|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233976|NCT04802759|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83233977|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83233978|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83233979|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233980|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83233981|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
83233982|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83233983|NCT04802759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233984|NCT04802759|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83233985|NCT04800822|Cetuximab|cetuximab|mesh-list
83233986|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233987|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233988|NCT04776447|Carboplatin|carboplatin|mesh-list
83233989|NCT04776447|Atezolizumab|atezolizumab|mesh-list
83233990|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83233991|NCT04776447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83233992|NCT04776447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83233993|NCT04776447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83233994|NCT04775953|Vancomycin|vancomycin|mesh-list
83233995|NCT04775953|Cefazolin|cefazolin|mesh-list
83233996|NCT04775953|Daptomycin|daptomycin|mesh-list
83233997|NCT04775953|Dalbavancin|dalbavancin|mesh-list
83233998|NCT04775953|Oxacillin|oxacillin|mesh-list
83233999|NCT04775953|Nafcillin|nafcillin|mesh-list
83234000|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83234001|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234002|NCT04770896|Sorafenib|sorafenib|mesh-list
83234003|NCT04770896|Atezolizumab|atezolizumab|mesh-list
83234004|NCT04770896|Lenvatinib|lenvatinib|mesh-list
83234005|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234006|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234007|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234008|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234009|NCT04770896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234010|NCT04770896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234011|NCT04770779|Mitapivat|mitapivat|mesh-list
83234012|NCT04770779|Enzyme Activators|enzyme activators|mesh-ancestor
83234013|NCT04770779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234014|NCT04770753|Mitapivat|mitapivat|mesh-list
83234015|NCT04770753|Enzyme Activators|enzyme activators|mesh-ancestor
83234016|NCT04770753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234017|NCT04768504|Tofacitinib|tofacitinib|mesh-list
83234018|NCT04768504|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83234019|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234020|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234021|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234022|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
83234023|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83234024|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83234025|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83234026|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83234027|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83234028|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234029|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
83234030|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234031|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234032|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83234033|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234034|NCT04765202|Carisoprodol|carisoprodol|mesh-list
83234035|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83234036|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234037|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83234038|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234039|NCT04756037|Relugolix|relugolix|mesh-list
83234040|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
83234041|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
83234042|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234043|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234044|NCT04748172|Antibodies|antibodies|mesh-list
83234045|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
83234046|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234047|NCT04736823|Paclitaxel|paclitaxel|mesh-list
83234048|NCT04736823|Docetaxel|docetaxel|mesh-list
83234049|NCT04736823|Carboplatin|carboplatin|mesh-list
83234050|NCT04736823|Pemetrexed|pemetrexed|mesh-list
83234051|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234052|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234053|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234054|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234055|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234056|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234057|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234058|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83234059|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83234060|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
83234061|NCT04736706|Lenvatinib|lenvatinib|mesh-list
83234062|NCT04736706|Belzutifan|belzutifan|mesh-list
83234063|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234064|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234065|NCT04736706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234066|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234067|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234068|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234069|NCT04729621|Denosumab|denosumab|mesh-list
83234070|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83234071|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234072|NCT04725383|Amitriptyline|amitriptyline|mesh-list
83234073|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83234074|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
83234075|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83234076|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83234077|NCT04725383|Analgesics|analgesics|mesh-ancestor
83234078|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
83234079|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234080|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234081|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83234082|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83234083|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83234084|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234093|NCT04700124|Cisplatin|cisplatin|mesh-list
83234094|NCT04700124|Gemcitabine|gemcitabine|mesh-list
83234095|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
83234096|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234097|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234098|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
83234099|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234100|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234101|NCT04700124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234102|NCT04665739|Everolimus|everolimus|mesh-list
83234103|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83234104|NCT04665739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83234105|NCT04665739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234106|NCT04665739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234107|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234108|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234109|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
83234110|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234111|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234112|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83234113|NCT04664023|Vaccines|vaccines|mesh-list
83234114|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
83234115|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234116|NCT04655755|Decitabine|decitabine|mesh-list
83234117|NCT04655755|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83234118|NCT04655755|Venetoclax|venetoclax|mesh-list
83234119|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234120|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
83234121|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234122|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234123|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234124|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
83234125|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234126|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
83234127|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234128|NCT04633889|Deferoxamine|deferoxamine|mesh-list
83234129|NCT04633889|Siderophores|siderophores|mesh-ancestor
83234130|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83234131|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
83234132|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
83234133|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234134|NCT04630886|Lidocaine|lidocaine|mesh-list
83234135|NCT04630886|Epinephrine|epinephrine|mesh-list
83234136|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
83234137|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
83234138|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
83234139|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83234140|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234141|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
83234142|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234143|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83234144|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83234145|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83234146|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83234147|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234148|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83234149|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83234150|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
83234151|NCT04630886|Coagulants|coagulants|mesh-ancestor
83234152|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83234153|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83234154|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83234155|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234156|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83234157|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83234158|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
83234159|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83234160|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
83234161|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
83234162|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
83234163|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83234164|NCT04628767|Cisplatin|cisplatin|mesh-list
83234165|NCT04628767|Gemcitabine|gemcitabine|mesh-list
83234166|NCT04628767|Doxorubicin|doxorubicin|mesh-list
83234167|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83234168|NCT04628767|Methotrexate|methotrexate|mesh-list
83234169|NCT04628767|Durvalumab|durvalumab|mesh-list
83234170|NCT04628767|Vinblastine|vinblastine|mesh-list
83234171|NCT04628767|Lenograstim|lenograstim|mesh-list
83234172|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
83234173|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234174|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
83234175|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234176|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234177|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
83234178|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234179|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83234180|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83234181|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83234182|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234183|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83234184|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
83234185|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83234186|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234187|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
83234188|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83234189|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234190|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
83234191|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234192|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83234193|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83234194|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234195|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234196|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234197|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234198|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234199|NCT04622228|Carboplatin|carboplatin|mesh-list
83234200|NCT04622228|Etoposide|etoposide|mesh-list
83234201|NCT04622228|Atezolizumab|atezolizumab|mesh-list
83234202|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234203|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234204|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83234205|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83234206|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234207|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234208|NCT04622228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234209|NCT04622228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234210|NCT04619316|Trametinib|trametinib|mesh-list
83234211|NCT04619316|Dabrafenib|dabrafenib|mesh-list
83234212|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234213|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234214|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234215|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234216|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
83234217|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234218|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
83234219|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234220|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234221|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234222|NCT04609111|Aspirin|aspirin|mesh-list
83234223|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83234224|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83234225|NCT04609111|Analgesics|analgesics|mesh-ancestor
83234226|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
83234227|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234228|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234229|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83234230|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234231|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83234232|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83234233|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234234|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83234235|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83234236|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234238|NCT04607421|Leucovorin|leucovorin|mesh-list
83234239|NCT04607421|Bevacizumab|bevacizumab|mesh-list
83234240|NCT04607421|Cetuximab|cetuximab|mesh-list
83234241|NCT04607421|Fluorouracil|fluorouracil|mesh-list
83234242|NCT04607421|Capecitabine|capecitabine|mesh-list
83234243|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
83234244|NCT04607421|Irinotecan|irinotecan|mesh-list
83234245|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234246|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234247|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83234248|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83234249|NCT04607421|Growth Substances|growth substances|mesh-ancestor
83234250|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234251|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
83234252|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
83234253|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234254|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234255|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234256|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
83234257|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83234258|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83234259|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234260|NCT04607421|Antidotes|antidotes|mesh-ancestor
83234261|NCT04607421|Protective Agents|protective agents|mesh-ancestor
83234262|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
83234263|NCT04607421|Vitamins|vitamins|mesh-ancestor
83234264|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
83234265|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83234266|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234267|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234268|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83234269|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234270|NCT04590196|Curcumin|curcumin|mesh-list
83234271|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83234272|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83234273|NCT04590196|Analgesics|analgesics|mesh-ancestor
83234274|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
83234275|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234276|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234277|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83234278|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234279|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234280|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234281|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234282|NCT04589208|Ketamine|ketamine|mesh-list
83234283|NCT04589208|Analgesics|analgesics|mesh-ancestor
83234284|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
83234285|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234286|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234287|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83234288|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83234289|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
83234290|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
83234291|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83234292|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83234293|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83234294|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234295|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234296|NCT04588246|Memantine|memantine|mesh-list
83234297|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83234298|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83234299|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
83234300|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234301|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234302|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234303|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83234304|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83234305|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83234306|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234307|NCT04585815|Axitinib|axitinib|mesh-list
83234308|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234309|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234310|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234311|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234325|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
83234327|NCT04566328|Bortezomib|bortezomib|mesh-list
83234328|NCT04566328|Daratumumab|daratumumab|mesh-list
83234329|NCT04566328|Ichthammol|ichthammol|mesh-list
83234330|NCT04566328|BB 1101|bb 1101|mesh-list
83234331|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234332|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83234333|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
83234334|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
83234335|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234336|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234337|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83234338|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
83234339|NCT04566328|Hormones|hormones|mesh-ancestor
83234340|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234341|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234342|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234343|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
83234344|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234345|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234346|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
83234347|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83234348|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83234349|NCT04566328|Growth Substances|growth substances|mesh-ancestor
83234350|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
83234351|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83234352|NCT04565236|Factor VIII|factor viii|mesh-list
83234353|NCT04565236|Coagulants|coagulants|mesh-ancestor
83234354|NCT04563520|Coagulants|coagulants|mesh-list
83234355|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
83234356|NCT04559139|Cisplatin|cisplatin|mesh-list
83234357|NCT04559139|Gemcitabine|gemcitabine|mesh-list
83234358|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234359|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234360|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
83234361|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234362|NCT04557449|Letrozole|letrozole|mesh-list
83234363|NCT04557449|Fulvestrant|fulvestrant|mesh-list
83234364|NCT04557449|Midazolam|midazolam|mesh-list
83234365|NCT04557449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83234366|NCT04557449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83234367|NCT04557449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83234368|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234369|NCT04557449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83234370|NCT04557449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83234371|NCT04557449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83234372|NCT04557449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83234373|NCT04557449|Anesthetics, General|anesthetics, general|mesh-ancestor
83234374|NCT04557449|Anesthetics|anesthetics|mesh-ancestor
83234375|NCT04557449|GABA Modulators|gaba modulators|mesh-ancestor
83234376|NCT04557449|GABA Agents|gaba agents|mesh-ancestor
83234377|NCT04557449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234378|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234379|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234380|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83234381|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83234382|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234383|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83234384|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83234385|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234386|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234387|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83234388|NCT04556773|Paclitaxel|paclitaxel|mesh-list
83234389|NCT04556773|Capecitabine|capecitabine|mesh-list
83234391|NCT04556773|Durvalumab|durvalumab|mesh-list
83234392|NCT04556773|Fulvestrant|fulvestrant|mesh-list
83234393|NCT04556773|Anastrozole|anastrozole|mesh-list
83234394|NCT04556773|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83234395|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234396|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234397|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234398|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234399|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234400|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234401|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234402|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
83234403|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234404|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234405|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83234406|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83234407|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
83234408|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234409|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234410|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83234411|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83234412|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234413|NCT04556773|Immunoconjugates|immunoconjugates|mesh-ancestor
83234414|NCT04556773|Immunologic Factors|immunologic factors|mesh-ancestor
83234415|NCT04551222|Probenecid|probenecid|mesh-list
83234416|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
83234417|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
83234418|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234419|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
83234420|NCT04548752|Olaparib|olaparib|mesh-list
83234421|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83234422|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234423|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234424|NCT04548752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234425|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234426|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234427|NCT04543617|Atezolizumab|atezolizumab|mesh-list
83234428|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234429|NCT04543617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234430|NCT04543617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234431|NCT04543617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234432|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234433|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
83234434|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234435|NCT04542148|Insulin|insulin|mesh-list
83234436|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83234437|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
83234438|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
83234439|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83234440|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234441|NCT04533750|Peposertib|peposertib|mesh-list
83234442|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234443|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234444|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234445|NCT04528082|Apremilast|apremilast|mesh-list
83234446|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83234447|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83234449|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
83234450|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234451|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234452|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83234453|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234454|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83234455|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83234456|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234457|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234458|NCT04527991|Paclitaxel|paclitaxel|mesh-list
83234459|NCT04527991|Docetaxel|docetaxel|mesh-list
83234460|NCT04527991|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83234461|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234462|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234463|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234464|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234465|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234466|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234467|NCT04527991|Immunoconjugates|immunoconjugates|mesh-ancestor
83234468|NCT04527991|Immunologic Factors|immunologic factors|mesh-ancestor
83234469|NCT04527991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234470|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
83234471|NCT04527549|Trametinib|trametinib|mesh-list
83234472|NCT04527549|Dabrafenib|dabrafenib|mesh-list
83234473|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83234474|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
83234475|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83234476|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83234477|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234478|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234479|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234480|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234481|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234482|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234483|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83234484|NCT04527549|Protective Agents|protective agents|mesh-ancestor
83234485|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234486|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83234487|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
83234488|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83234489|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234490|NCT04513717|Leuprolide|leuprolide|mesh-list
83234491|NCT04513717|Goserelin|goserelin|mesh-list
83234492|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83234493|NCT04513717|Flutamide|flutamide|mesh-list
83234494|NCT04513717|Bicalutamide|bicalutamide|mesh-list
83234495|NCT04513717|Tryptophan|tryptophan|mesh-list
83234496|NCT04513717|Buserelin|buserelin|mesh-list
83234497|NCT04513717|Hormones|hormones|mesh-list
83234498|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234499|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234500|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83234501|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
83234502|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83234503|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234504|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234505|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
83234506|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
83234507|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
83234508|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83234509|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
83234510|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83234511|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83234512|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
83234513|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83234514|NCT04512430|Bevacizumab|bevacizumab|mesh-list
83234515|NCT04512430|Atezolizumab|atezolizumab|mesh-list
83234516|NCT04512430|Carboplatin|carboplatin|mesh-list
83234517|NCT04512430|Pemetrexed|pemetrexed|mesh-list
83234518|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234522|NCT04512430|Growth Substances|growth substances|mesh-ancestor
83234523|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234524|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
83234525|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234526|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234527|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83234528|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83234529|NCT04512430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234530|NCT04504734|Bucillamine|bucillamine|mesh-list
83234531|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83234532|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83234533|NCT04504734|Analgesics|analgesics|mesh-ancestor
83234534|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
83234535|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234536|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234537|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83234538|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234539|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
83234540|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234541|NCT04504734|Protective Agents|protective agents|mesh-ancestor
83234542|NCT04504669|Durvalumab|durvalumab|mesh-list
83234543|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234544|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234545|NCT04502433|Poractant alfa|poractant alfa|mesh-list
83234546|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83234547|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
83234550|NCT04484818|Leuprolide|leuprolide|mesh-list
83234551|NCT04484818|Goserelin|goserelin|mesh-list
83234552|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83234553|NCT04484818|Tryptophan|tryptophan|mesh-list
83234554|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
83234555|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234556|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234557|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83234558|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
83234559|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83234560|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234561|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234562|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
83234563|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83234564|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
83234565|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83234566|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83234567|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
83234568|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83234569|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
83234570|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
83234571|NCT04484012|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83234572|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234573|NCT04484012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234574|NCT04484012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234575|NCT04484012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234576|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
83234577|NCT04477200|Temozolomide|temozolomide|mesh-list
83234578|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83234579|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234580|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83234581|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
83234582|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83234583|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234584|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234585|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234586|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83234587|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
83234590|NCT04455802|Morphine|morphine|mesh-list
83234591|NCT04455802|Buprenorphine|buprenorphine|mesh-list
83234592|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83234593|NCT04455802|Narcotics|narcotics|mesh-ancestor
83234594|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83234595|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234596|NCT04455802|Analgesics|analgesics|mesh-ancestor
83234597|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
83234598|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234599|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83234600|NCT04454437|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83234601|NCT04454437|Immunoconjugates|immunoconjugates|mesh-ancestor
83234602|NCT04454437|Immunologic Factors|immunologic factors|mesh-ancestor
83234603|NCT04454437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234604|NCT04444921|Paclitaxel|paclitaxel|mesh-list
83234605|NCT04444921|Carboplatin|carboplatin|mesh-list
83234606|NCT04444921|Nivolumab|nivolumab|mesh-list
83234607|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83234608|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234609|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234610|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234611|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234612|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234613|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234614|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234615|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234616|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
83234617|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234618|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234619|NCT04443088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234620|NCT04443088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234621|NCT04438382|Prednisone|prednisone|mesh-list
83234622|NCT04438382|Infliximab|infliximab|mesh-list
83234623|NCT04438382|Cortisone|cortisone|mesh-list
83234624|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
83234625|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83234626|NCT04438382|Antibodies|antibodies|mesh-list
83234627|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
83234628|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83234629|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
83234630|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83234631|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
83234632|NCT04438382|Hormones|hormones|mesh-ancestor
83234633|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234634|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234635|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234636|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234637|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
83234638|NCT04438382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83234639|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
83234640|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83234641|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234642|NCT04434040|Atezolizumab|atezolizumab|mesh-list
83234643|NCT04434040|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83234644|NCT04434040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234645|NCT04434040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234646|NCT04434040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234647|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234648|NCT04434040|Immunoconjugates|immunoconjugates|mesh-ancestor
83234649|NCT04434040|Immunologic Factors|immunologic factors|mesh-ancestor
83234650|NCT04434040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234651|NCT04426890|Omalizumab|omalizumab|mesh-list
83234652|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234653|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83234654|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83234655|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
83234656|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
83234657|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234658|NCT04423211|Leuprolide|leuprolide|mesh-list
83234659|NCT04423211|Goserelin|goserelin|mesh-list
83234660|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83234661|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
83234662|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83234663|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234664|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83234665|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234666|NCT04417062|Olaparib|olaparib|mesh-list
83234667|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83234668|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234669|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234670|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234672|NCT04416984|Fludarabine|fludarabine|mesh-list
83234673|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234674|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
83234675|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234676|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234677|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83234678|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
83234679|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234680|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234681|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83234682|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
83234683|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
83234684|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83234685|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234686|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234687|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234688|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83234689|NCT04411836|Primaquine|primaquine|mesh-list
83234690|NCT04411836|Tafenoquine|tafenoquine|mesh-list
83234691|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
83234692|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83234693|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83234694|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234695|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83234696|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83234697|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234698|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83234699|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
83234700|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83234701|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83234702|NCT04394858|Temozolomide|temozolomide|mesh-list
83234704|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83234705|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83234706|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
83234707|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234708|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234709|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234710|NCT04394546|Anticoagulants|anticoagulants|mesh-list
83234711|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83234712|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
83234713|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
83234714|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
83234715|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83234716|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83234717|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234718|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234719|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234720|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234721|NCT04380545|Interferons|interferons|mesh-list
83234722|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
83234723|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
83234724|NCT04380545|Fluorouracil|fluorouracil|mesh-list
83234725|NCT04380545|Nivolumab|nivolumab|mesh-list
83234726|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
83234727|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234728|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234729|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234730|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234731|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
83234732|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234733|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234734|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234735|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
83234736|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234737|NCT04368559|Fluconazole|fluconazole|mesh-list
83234738|NCT04368559|Posaconazole|posaconazole|mesh-list
83234739|NCT04368559|Rezafungin|rezafungin|mesh-list
83234740|NCT04368559|Trimethoprim|trimethoprim|mesh-list
83234741|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
83234742|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83234743|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
83234744|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234745|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83234746|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83234747|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234748|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234749|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83234750|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
83234751|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83234752|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234753|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83234754|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83234755|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83234756|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
83234757|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83234758|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83234759|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83234760|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83234761|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83234762|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83234763|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83234764|NCT04364048|Cisplatin|cisplatin|mesh-list
83234765|NCT04364048|Carboplatin|carboplatin|mesh-list
83234766|NCT04364048|Etoposide|etoposide|mesh-list
83234767|NCT04364048|Pemetrexed|pemetrexed|mesh-list
83234768|NCT04364048|Durvalumab|durvalumab|mesh-list
83234769|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234770|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234771|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234772|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83234773|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83234774|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234775|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234776|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83234777|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83234778|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234779|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
83234780|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234781|NCT04338269|Atezolizumab|atezolizumab|mesh-list
83234782|NCT04338269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234783|NCT04338269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234784|NCT04338269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234785|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234786|NCT04336098|Paclitaxel|paclitaxel|mesh-list
83234787|NCT04336098|Gemcitabine|gemcitabine|mesh-list
83234788|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
83234789|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83234790|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234791|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234792|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234793|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234794|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234795|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234796|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234797|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
83234798|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234799|NCT04336098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234800|NCT04328727|Cyclosporine|cyclosporine|mesh-list
83234801|NCT04328727|Cyclosporins|cyclosporins|mesh-list
83234802|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83234803|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
83234804|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234805|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234806|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234807|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
83234808|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234809|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
83234810|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234811|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
83234812|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83234813|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83234814|NCT04319198|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83234815|NCT04319198|Immunoconjugates|immunoconjugates|mesh-ancestor
83234816|NCT04319198|Immunologic Factors|immunologic factors|mesh-ancestor
83234817|NCT04319198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234818|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
83234819|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83234820|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83234821|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234822|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
83234823|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
83234824|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83234825|NCT04313634|Dasatinib|dasatinib|mesh-list
83234826|NCT04313634|Quercetin|quercetin|mesh-list
83234827|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234828|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83234829|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234830|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234831|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
83234832|NCT04313634|Protective Agents|protective agents|mesh-ancestor
83234833|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234834|NCT04311580|Mitomycins|mitomycins|mesh-list
83234835|NCT04311580|Mitomycin|mitomycin|mesh-list
83234836|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83234837|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234838|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
83234839|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234840|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83234841|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83234842|NCT04310007|Paclitaxel|paclitaxel|mesh-list
83234843|NCT04310007|Docetaxel|docetaxel|mesh-list
83234844|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83234845|NCT04310007|Gemcitabine|gemcitabine|mesh-list
83234846|NCT04310007|Nivolumab|nivolumab|mesh-list
83234847|NCT04310007|Ramucirumab|ramucirumab|mesh-list
83234848|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83234849|NCT04310007|Antibodies|antibodies|mesh-list
83234850|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
83234851|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234852|NCT04310007|Lexatumumab|lexatumumab|mesh-list
83234853|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234854|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234855|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234856|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234857|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234858|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234859|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
83234860|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234861|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83234862|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
83234863|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234864|NCT04303858|Atezolizumab|atezolizumab|mesh-list
83234865|NCT04303858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234866|NCT04303858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234867|NCT04303858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234868|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234869|NCT04301492|Vortioxetine|vortioxetine|mesh-list
83234870|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
83234871|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83234872|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83234873|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83234874|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83234875|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234876|NCT04301492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83234877|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83234878|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83234879|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234880|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234881|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
83234882|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83234883|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83234884|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83234885|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83234886|NCT04301076|Prednisone|prednisone|mesh-list
83234887|NCT04301076|Cortisone|cortisone|mesh-list
83234888|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
83234889|NCT04301076|Doxorubicin|doxorubicin|mesh-list
83234890|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83234891|NCT04301076|Etoposide|etoposide|mesh-list
83234892|NCT04301076|Vincristine|vincristine|mesh-list
83234893|NCT04301076|Lenalidomide|lenalidomide|mesh-list
83234894|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
83234895|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
83234896|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83234918|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83234919|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83234920|NCT04301076|Growth Substances|growth substances|mesh-ancestor
83234921|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
83234922|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
83234923|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
83234924|NCT04290039|Atropine|atropine|mesh-list
83234925|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83234926|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83234927|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83234928|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83234929|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83234930|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
83234931|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83234932|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234933|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83234934|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83234935|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
83234936|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
83234937|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83234938|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83234939|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
83234940|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83234941|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234966|NCT04266249|Paclitaxel|paclitaxel|mesh-list
83234967|NCT04266249|Maytansine|maytansine|mesh-list
83234968|NCT04266249|Docetaxel|docetaxel|mesh-list
83234969|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83234970|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83234971|NCT04266249|Trastuzumab|trastuzumab|mesh-list
83234972|NCT04266249|Pertuzumab|pertuzumab|mesh-list
83234973|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83234974|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83234975|NCT04266249|Antibodies|antibodies|mesh-list
83234976|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
83234977|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83234978|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
83234979|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83234980|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234981|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
83234982|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
83234983|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
83234984|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234985|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
83234986|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83234987|NCT04266249|Immunotoxins|immunotoxins|mesh-ancestor
83234988|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
83234989|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83234990|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83234991|NCT04260126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83234992|NCT04260126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83234993|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
83234994|NCT04248452|Leucovorin|leucovorin|mesh-list
83234995|NCT04248452|Folic Acid|folic acid|mesh-list
83234996|NCT04248452|Fluorouracil|fluorouracil|mesh-list
83234997|NCT04248452|Capecitabine|capecitabine|mesh-list
83234998|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
83234999|NCT04248452|Calcium|calcium|mesh-list
83235000|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
83235001|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83235002|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235003|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83235004|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
83235005|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235006|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235007|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235008|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235009|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
83235010|NCT04248452|Antidotes|antidotes|mesh-ancestor
83235011|NCT04248452|Protective Agents|protective agents|mesh-ancestor
83235012|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
83235013|NCT04248452|Vitamins|vitamins|mesh-ancestor
83235014|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
83235015|NCT04248452|Hematinics|hematinics|mesh-ancestor
83235016|NCT04240054|Dexamethasone|dexamethasone|mesh-list
83235017|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
83235018|NCT04240054|Bortezomib|bortezomib|mesh-list
83235019|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235020|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
83235021|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235022|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235023|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235024|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
83235025|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235026|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235027|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83235028|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83235029|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
83235030|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
83235031|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235032|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235033|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
83235034|NCT04240054|Hormones|hormones|mesh-ancestor
83235035|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235036|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83235037|NCT04240002|Cytarabine|cytarabine|mesh-list
83235038|NCT04240002|Fludarabine|fludarabine|mesh-list
83235039|NCT04240002|Lenograstim|lenograstim|mesh-list
83235040|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235041|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235042|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
83235043|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235044|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235045|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
83235046|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235047|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
83235048|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235049|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83235050|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
83235051|NCT04233866|Leucovorin|leucovorin|mesh-list
83235055|NCT04233866|Gemcitabine|gemcitabine|mesh-list
83235056|NCT04233866|Fluorouracil|fluorouracil|mesh-list
83235057|NCT04233866|Irinotecan|irinotecan|mesh-list
83235058|NCT04233866|Calcium|calcium|mesh-list
83235059|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
83235060|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235061|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235062|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235063|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235064|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235065|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235066|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235067|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
83235068|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83235069|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235070|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83235071|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235072|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
83235073|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83235074|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83235075|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235076|NCT04233866|Antidotes|antidotes|mesh-ancestor
83235077|NCT04233866|Protective Agents|protective agents|mesh-ancestor
83235078|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
83235079|NCT04233866|Vitamins|vitamins|mesh-ancestor
83235080|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
83235081|NCT04233866|Hematinics|hematinics|mesh-ancestor
83235082|NCT04233112|Melatonin|melatonin|mesh-list
83235083|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
83235084|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235085|NCT04233112|Protective Agents|protective agents|mesh-ancestor
83235086|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235087|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83235091|NCT04223856|Carboplatin|carboplatin|mesh-list
83235092|NCT04223856|Gemcitabine|gemcitabine|mesh-list
83235093|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
83235094|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235095|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235096|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
83235097|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235098|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235099|NCT04223856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235100|NCT04221438|Alovudine|alovudine|mesh-list
83235101|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
83235102|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235103|NCT04217954|Bevacizumab|bevacizumab|mesh-list
83235104|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235105|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235106|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83235107|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83235108|NCT04217954|Growth Substances|growth substances|mesh-ancestor
83235109|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235110|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
83235111|NCT04216316|Carboplatin|carboplatin|mesh-list
83235112|NCT04216316|Gemcitabine|gemcitabine|mesh-list
83235113|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
83235114|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235115|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235116|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
83235117|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235118|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235119|NCT04216316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235120|NCT04214249|Cytarabine|cytarabine|mesh-list
83235121|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
83235122|NCT04214249|Daunorubicin|daunorubicin|mesh-list
83235123|NCT04214249|Idarubicin|idarubicin|mesh-list
83235124|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235125|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235126|NCT04214249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235127|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235128|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235129|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
83235130|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
83235131|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235132|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235133|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
83235134|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235135|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83235136|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83235137|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83235138|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235139|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83235140|NCT04210427|Laxatives|laxatives|mesh-ancestor
83235141|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235142|NCT04209114|Nivolumab|nivolumab|mesh-list
83235143|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235144|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235145|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235146|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235147|NCT04200443|Temozolomide|temozolomide|mesh-list
83235148|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235149|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
83235150|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235151|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235152|NCT04194034|Flucytosine|flucytosine|mesh-list
83235153|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
83235154|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235155|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
83235156|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235157|NCT04191187|Fludarabine|fludarabine|mesh-list
83235158|NCT04191187|Melphalan|melphalan|mesh-list
83235159|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235160|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235161|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235162|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
83235163|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235164|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235165|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
83235166|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83235167|NCT04191135|Carboplatin|carboplatin|mesh-list
83235168|NCT04191135|Gemcitabine|gemcitabine|mesh-list
83235169|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
83235170|NCT04191135|Olaparib|olaparib|mesh-list
83235171|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235172|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235173|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
83235174|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235175|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235176|NCT04191135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235177|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83235178|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235179|NCT04356170|Docetaxel|docetaxel|mesh-list
83235180|NCT04356170|Fluorouracil|fluorouracil|mesh-list
83235181|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235182|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235183|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235184|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235185|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235187|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235188|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235189|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
83235190|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235191|NCT04188418|Fentanyl|fentanyl|mesh-list
83235192|NCT04188418|Morphine|morphine|mesh-list
83235193|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83235194|NCT04188418|Narcotics|narcotics|mesh-ancestor
83235195|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83235196|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235197|NCT04188418|Analgesics|analgesics|mesh-ancestor
83235198|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
83235199|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235200|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83235201|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83235202|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
83235203|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
83235204|NCT04181060|Bevacizumab|bevacizumab|mesh-list
83235205|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83235206|NCT04181060|Osimertinib|osimertinib|mesh-list
83235207|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
83235208|NCT04181060|Antibodies|antibodies|mesh-list
83235209|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
83235210|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83235211|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
83235212|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235213|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83235214|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83235215|NCT04181060|Growth Substances|growth substances|mesh-ancestor
83235216|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235217|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
83235218|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
83235219|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235220|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83235221|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235222|NCT04166409|Carboplatin|carboplatin|mesh-list
83235223|NCT04166409|Vincristine|vincristine|mesh-list
83235224|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235225|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235226|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235227|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235228|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235229|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235230|NCT04166318|Fluorouracil|fluorouracil|mesh-list
83235231|NCT04166318|Capecitabine|capecitabine|mesh-list
83235232|NCT04166318|Mitomycins|mitomycins|mesh-list
83235233|NCT04166318|Mitomycin|mitomycin|mesh-list
83235234|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
83235235|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235236|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235237|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235238|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235239|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
83235240|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235241|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83235242|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
83235243|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83235244|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235245|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
83235246|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83235247|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
83235248|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235249|NCT04164082|Gemcitabine|gemcitabine|mesh-list
83235250|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
83235251|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235252|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
83235253|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235254|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235255|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235256|NCT04164082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235257|NCT04150614|Dexamethasone|dexamethasone|mesh-list
83235258|NCT04150614|Ondansetron|ondansetron|mesh-list
83235259|NCT04150614|Granisetron|granisetron|mesh-list
83235260|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83235261|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
83235262|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
83235263|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235264|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235265|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235266|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
83235267|NCT04150614|Hormones|hormones|mesh-ancestor
83235268|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235269|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83235270|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235271|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
83235272|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
83235273|NCT04150614|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83235274|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83235275|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
83235276|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83235277|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235278|NCT04148911|Paclitaxel|paclitaxel|mesh-list
83235279|NCT04148911|Atezolizumab|atezolizumab|mesh-list
83235280|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235281|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235282|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235283|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235284|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235285|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235286|NCT04148911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235287|NCT04148911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235288|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
83235289|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
83235290|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83235291|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83235292|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235293|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235294|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235295|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235296|NCT04134260|Hormones|hormones|mesh-list
83235297|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235298|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235299|NCT04126096|Lactams|lactams|mesh-list
83235300|NCT04126096|beta-Lactams|beta-lactams|mesh-list
83235301|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83235302|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235303|NCT04125836|Octreotide|octreotide|mesh-list
83235304|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235305|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83235306|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235307|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
83235308|NCT04123795|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83235309|NCT04123795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83235310|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235311|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
83235312|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235313|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235314|NCT04121455|Bevacizumab|bevacizumab|mesh-list
83235315|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
83235316|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235317|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235318|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83235319|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83235320|NCT04121455|Growth Substances|growth substances|mesh-ancestor
83235321|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235322|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
83235323|NCT04121455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235324|NCT04121455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235325|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
83235326|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
83235327|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235328|NCT04115631|Cytarabine|cytarabine|mesh-list
83235329|NCT04115631|Rituximab|rituximab|mesh-list
83235330|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83235331|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83235332|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
83235333|NCT04115631|Antibodies|antibodies|mesh-list
83235334|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
83235335|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83235336|NCT04115631|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83235337|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
83235338|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235339|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235340|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235341|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235342|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
83235343|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235344|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
83235345|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235346|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235347|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235348|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
83235349|NCT04115631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83235350|NCT04115631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235351|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
83235352|NCT04109482|Fludarabine|fludarabine|mesh-list
83235353|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235354|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
83235355|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235356|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235391|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83235392|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83235393|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235394|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
83235395|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235424|NCT04086264|Azacitidine|azacitidine|mesh-list
83235425|NCT04086264|Decitabine|decitabine|mesh-list
83235426|NCT04086264|Venetoclax|venetoclax|mesh-list
83235427|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235428|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
83235429|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235430|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235431|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235432|NCT04083599|Paclitaxel|paclitaxel|mesh-list
83235442|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235443|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235444|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235446|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235447|NCT04083599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235448|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235449|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83235450|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83235451|NCT04082754|Antibodies|antibodies|mesh-list
83235452|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83235453|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
83235454|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235455|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
83235456|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235457|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235458|NCT04076059|Androgens|androgens|mesh-list
83235459|NCT04076059|Hormones|hormones|mesh-ancestor
83235460|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235461|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235462|NCT04075292|Rituximab|rituximab|mesh-list
83235463|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
83235464|NCT04075292|Chlorambucil|chlorambucil|mesh-list
83235465|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235466|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235467|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
83235468|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235469|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235470|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235471|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
83235472|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235473|NCT04071236|Avelumab|avelumab|mesh-list
83235474|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83235475|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83235476|NCT04071236|Peposertib|peposertib|mesh-list
83235477|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235478|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235479|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
83235480|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235481|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83235482|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235483|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235484|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83235485|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235495|NCT04064359|Antibodies|antibodies|mesh-list
83235496|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
83235497|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
83235498|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235499|NCT04053634|Benralizumab|benralizumab|mesh-list
83235500|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83235501|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
83235502|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
83235503|NCT04047628|Ofatumumab|ofatumumab|mesh-list
83235504|NCT04047628|Cladribine|cladribine|mesh-list
83235505|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
83235506|NCT04047628|Natalizumab|natalizumab|mesh-list
83235507|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235508|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235509|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
83235515|NCT04047472|Growth Substances|growth substances|mesh-ancestor
83235516|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235517|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
83235518|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235519|NCT04047355|Propranolol|propranolol|mesh-list
83235520|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83235521|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83235522|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83235523|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83235524|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235525|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235526|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83235527|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83235528|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
83235529|NCT04045431|Hylan|hylan|mesh-list
83235530|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
83235531|NCT04045431|Protective Agents|protective agents|mesh-ancestor
83235532|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235533|NCT04037254|Niraparib|niraparib|mesh-list
83235534|NCT04037254|Hormones|hormones|mesh-list
83235535|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83235536|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83235537|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235538|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235539|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83235540|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235541|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235542|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235548|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
83235549|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
83235550|NCT04022239|Melphalan|melphalan|mesh-list
83235551|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83235552|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
83235553|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83235554|NCT04022239|Rituximab|rituximab|mesh-list
83235555|NCT04022239|Fludarabine|fludarabine|mesh-list
83235556|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83235557|NCT04022239|Tacrolimus|tacrolimus|mesh-list
83235558|NCT04022239|Antibodies|antibodies|mesh-list
83235559|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
83235560|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83235561|NCT04022239|Lenograstim|lenograstim|mesh-list
83235562|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235563|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
83235564|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235565|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235566|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235567|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
83235568|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235569|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235570|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83235571|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83235572|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83235573|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235574|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83235575|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83235576|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
83235577|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83235578|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235579|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
83235580|NCT04020341|Gepotidacin|gepotidacin|mesh-list
83235581|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83235582|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235583|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83235584|NCT04020341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83235585|NCT04020341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235612|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235613|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235644|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83235645|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83235646|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
83235647|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235648|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235649|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83235650|NCT04001829|Paclitaxel|paclitaxel|mesh-list
83235651|NCT04001829|Docetaxel|docetaxel|mesh-list
83235652|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83235653|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235654|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235655|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235656|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235657|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235658|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235659|NCT03989271|Quercetin|quercetin|mesh-list
83235660|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
83235661|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235663|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235664|NCT03987711|Warfarin|warfarin|mesh-list
83235665|NCT03987711|Apixaban|apixaban|mesh-list
83235666|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
83235667|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83235668|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
83235669|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83235670|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
83235671|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235672|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235673|NCT03970447|Temozolomide|temozolomide|mesh-list
83235674|NCT03970447|Lomustine|lomustine|mesh-list
83235675|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
83235676|NCT03970447|GDC-0084|gdc-0084|mesh-list
83235677|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83235678|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
83235679|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235680|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235681|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235682|NCT03969212|Baloxavir|baloxavir|mesh-list
83235683|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
83235684|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235685|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235686|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235687|NCT03953898|Olaparib|olaparib|mesh-list
83235688|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83235689|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235690|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235691|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235692|NCT03950739|Treprostinil|treprostinil|mesh-list
83235693|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83235694|NCT03939767|Aflibercept|aflibercept|mesh-list
83235695|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83235696|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83235697|NCT03939767|Growth Substances|growth substances|mesh-ancestor
83235698|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235699|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
83235700|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235701|NCT03937635|Dexamethasone|dexamethasone|mesh-list
83235702|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
83235703|NCT03937635|Lenalidomide|lenalidomide|mesh-list
83235704|NCT03937635|Daratumumab|daratumumab|mesh-list
83235705|NCT03937635|Ichthammol|ichthammol|mesh-list
83235706|NCT03937635|BB 1101|bb 1101|mesh-list
83235707|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83235708|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
83235709|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
83235710|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235711|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235712|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235713|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
83235714|NCT03937635|Hormones|hormones|mesh-ancestor
83235715|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83235716|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83235717|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235718|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
83235719|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83235720|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83235721|NCT03937635|Growth Substances|growth substances|mesh-ancestor
83235722|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
83235723|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
83235724|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235725|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235726|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
83235727|NCT03930953|Rituximab|rituximab|mesh-list
83235728|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
83235729|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235730|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235731|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
83235732|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235733|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235734|NCT03892044|Nivolumab|nivolumab|mesh-list
83235735|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235736|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235737|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235738|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235739|NCT03891953|Spartalizumab|spartalizumab|mesh-list
83235740|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235741|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235742|NCT03891953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235743|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235744|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
83235745|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83235746|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
83235747|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83235748|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
83235750|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235751|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
83235752|NCT03885037|Infliximab|infliximab|mesh-list
83235753|NCT03885037|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83235754|NCT03885037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83235755|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
83235756|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235757|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235758|NCT03884439|Infliximab|infliximab|mesh-list
83235759|NCT03884439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83235760|NCT03884439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83235761|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
83235762|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235763|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83235764|NCT03879629|Carvedilol|carvedilol|mesh-list
83235765|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83235766|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83235767|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
83235768|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83235769|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235770|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235771|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83235772|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
83235773|NCT03879629|Protective Agents|protective agents|mesh-ancestor
83235774|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83235775|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83235776|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83235777|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
83235778|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83235779|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83235780|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
83235781|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
83235782|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235783|NCT03871257|Carboplatin|carboplatin|mesh-list
83235784|NCT03871257|Vincristine|vincristine|mesh-list
83235785|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235786|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235787|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235788|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235789|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235790|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235791|NCT03869190|Gemcitabine|gemcitabine|mesh-list
83235792|NCT03869190|Atezolizumab|atezolizumab|mesh-list
83235793|NCT03869190|Niraparib|niraparib|mesh-list
83235794|NCT03869190|Magrolimab|magrolimab|mesh-list
83235795|NCT03869190|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83235796|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235797|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235798|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
83235799|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235800|NCT03869190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235801|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235802|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83235803|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235804|NCT03869190|Immunoconjugates|immunoconjugates|mesh-ancestor
83235805|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
83235806|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235807|NCT03867851|Heparin|heparin|mesh-list
83235808|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
83235809|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83235810|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83235811|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235813|NCT03866382|Ipilimumab|ipilimumab|mesh-list
83235814|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235815|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235816|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235817|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235819|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
83235820|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83235821|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
83235822|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235823|NCT03850691|Aldesleukin|aldesleukin|mesh-list
83235824|NCT03850691|Nivolumab|nivolumab|mesh-list
83235825|NCT03850691|Ipilimumab|ipilimumab|mesh-list
83235826|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235827|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235828|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235829|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235830|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83235831|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83235832|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
83235833|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83235834|NCT03842228|Durvalumab|durvalumab|mesh-list
83235835|NCT03842228|Olaparib|olaparib|mesh-list
83235836|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83235837|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
83235838|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83235839|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
83235840|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235841|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235842|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
83235843|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235844|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235845|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235846|NCT03836040|Erenumab|erenumab|mesh-list
83235847|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83235848|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83235849|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235850|NCT03836040|Analgesics|analgesics|mesh-ancestor
83235851|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
83235852|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235853|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235854|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
83235855|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
83235856|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83235857|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83235858|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235859|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
83235860|NCT03822793|Coagulants|coagulants|mesh-ancestor
83235861|NCT03816163|Paclitaxel|paclitaxel|mesh-list
83235862|NCT03816163|Gemcitabine|gemcitabine|mesh-list
83235863|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235864|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235865|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235866|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235867|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235868|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235869|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235870|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
83235871|NCT03811015|Cisplatin|cisplatin|mesh-list
83235872|NCT03811015|Nivolumab|nivolumab|mesh-list
83235873|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235874|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235875|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235876|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235877|NCT03809780|Dexamethasone|dexamethasone|mesh-list
83235878|NCT03809780|Lenalidomide|lenalidomide|mesh-list
83235879|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83235880|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
83235881|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
83235882|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235883|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235884|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83235885|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
83235886|NCT03809780|Hormones|hormones|mesh-ancestor
83235892|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83235893|NCT03809780|Growth Substances|growth substances|mesh-ancestor
83235894|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
83235895|NCT03808818|Nicotine|nicotine|mesh-list
83235896|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83235897|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
83235898|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83235899|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235900|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83235901|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83235902|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
83235903|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83235904|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235905|NCT03802604|Atezolizumab|atezolizumab|mesh-list
83235906|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83235907|NCT03802604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235908|NCT03802604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235909|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235910|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235911|NCT03801876|Paclitaxel|paclitaxel|mesh-list
83235912|NCT03801876|Docetaxel|docetaxel|mesh-list
83235913|NCT03801876|Carboplatin|carboplatin|mesh-list
83235914|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83235915|NCT03801876|Fluorouracil|fluorouracil|mesh-list
83235916|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83235917|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235918|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
83235919|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
83235920|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
83235921|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235922|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
83235923|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235924|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235925|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
83235926|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235933|NCT03785873|Leucovorin|leucovorin|mesh-list
83235934|NCT03785873|Fluorouracil|fluorouracil|mesh-list
83235935|NCT03785873|Nivolumab|nivolumab|mesh-list
83235936|NCT03785873|Irinotecan|irinotecan|mesh-list
83235937|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
83235938|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83235939|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83235940|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235941|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83235942|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
83235943|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235944|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83235945|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83235946|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83235947|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83235948|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83235949|NCT03785873|Antidotes|antidotes|mesh-ancestor
83235950|NCT03785873|Protective Agents|protective agents|mesh-ancestor
83235951|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
83235952|NCT03785873|Vitamins|vitamins|mesh-ancestor
83235953|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
83235954|NCT03784677|SOR-C13|sor-c13|mesh-list
83235955|NCT03784677|Calcium|calcium|mesh-list
83235956|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83235957|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83235958|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83235959|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83235960|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83235961|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236000|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236001|NCT03764293|Sorafenib|sorafenib|mesh-list
83236002|NCT03764293|Apatinib|apatinib|mesh-list
83236003|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236004|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236005|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236006|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236007|NCT03763643|Rituximab|rituximab|mesh-list
83236008|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236009|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236010|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
83236011|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236012|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236013|NCT03761095|Dacarbazine|dacarbazine|mesh-list
83236014|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236015|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
83236016|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236017|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236018|NCT03747042|Letrozole|letrozole|mesh-list
83236019|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236020|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83236021|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83236022|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236023|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236024|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83236025|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
83236026|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236027|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236028|NCT03745326|Aldesleukin|aldesleukin|mesh-list
83236029|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
83236030|NCT03745326|Fludarabine|fludarabine|mesh-list
83236031|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236032|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
83236033|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236034|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236035|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236036|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
83236037|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236038|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236039|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236040|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83236041|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83236042|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
83236043|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236044|NCT03739112|Vaccines|vaccines|mesh-list
83236045|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
83236046|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236047|NCT03734237|Vaccines|vaccines|mesh-list
83236048|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
83236049|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236050|NCT03724071|Flucytosine|flucytosine|mesh-list
83236051|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
83236052|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236053|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
83236054|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236055|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
83236056|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236057|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236058|NCT03712605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236059|NCT03712605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236060|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
83236061|NCT03709680|Temozolomide|temozolomide|mesh-list
83236062|NCT03709680|Irinotecan|irinotecan|mesh-list
83236063|NCT03709680|Topotecan|topotecan|mesh-list
83236064|NCT03709680|Palbociclib|palbociclib|mesh-list
83236065|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236066|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
83236067|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236068|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236069|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236070|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
83236071|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236072|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236073|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236074|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83236075|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83236076|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236077|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236078|NCT03709446|Leflunomide|leflunomide|mesh-list
83236079|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236080|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236081|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236082|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
83236083|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236084|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83236085|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
83236086|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236087|NCT03678883|Paclitaxel|paclitaxel|mesh-list
83236088|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83236089|NCT03678883|Carboplatin|carboplatin|mesh-list
83236090|NCT03678883|Gemcitabine|gemcitabine|mesh-list
83236091|NCT03678883|Doxorubicin|doxorubicin|mesh-list
83236092|NCT03678883|Irinotecan|irinotecan|mesh-list
83236093|NCT03678883|Lomustine|lomustine|mesh-list
83236094|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236095|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236096|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236097|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236098|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236099|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236100|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236101|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
83236102|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83236103|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83236104|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83236105|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236106|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83236107|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236108|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
83236109|NCT03678753|Cenobamate|cenobamate|mesh-list
83236110|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
83236111|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83236112|NCT03678350|Trioxsalen|trioxsalen|mesh-list
83236141|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
83236142|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236143|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236144|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
83236145|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236146|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236147|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
83236148|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236150|NCT03648437|Ibuprofen|ibuprofen|mesh-list
83236151|NCT03648437|Indomethacin|indomethacin|mesh-list
83236152|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83236153|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83236154|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83236155|NCT03648437|Analgesics|analgesics|mesh-ancestor
83236156|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
83236157|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83236158|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236159|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83236160|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236161|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83236162|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236163|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236164|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
83236165|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
83236166|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
83236167|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83236168|NCT03646058|Buprenorphine|buprenorphine|mesh-list
83236169|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83236170|NCT03646058|Narcotics|narcotics|mesh-ancestor
83236171|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83236172|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236173|NCT03646058|Analgesics|analgesics|mesh-ancestor
83236174|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
83236175|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83236176|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83236177|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
83236178|NCT03644485|Tacrolimus|tacrolimus|mesh-list
83236179|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236180|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
83236181|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236182|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83236183|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236184|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236185|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83236186|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236187|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83236194|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236195|NCT03641209|Acetaminophen|acetaminophen|mesh-list
83236196|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83236197|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83236198|NCT03641209|Analgesics|analgesics|mesh-ancestor
83236199|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
83236200|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83236201|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236202|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
83236203|NCT03622593|Aflibercept|aflibercept|mesh-list
83236204|NCT03622593|Faricimab|faricimab|mesh-list
83236205|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236206|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236207|NCT03622593|Growth Substances|growth substances|mesh-ancestor
83236208|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236209|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236210|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236217|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
83236218|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
83236219|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
83236220|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236221|NCT03597581|Bevacizumab|bevacizumab|mesh-list
83236222|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236223|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236224|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236225|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236226|NCT03597581|Growth Substances|growth substances|mesh-ancestor
83236227|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236228|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236229|NCT03593655|Tenofovir|tenofovir|mesh-list
83236230|NCT03593655|Emtricitabine|emtricitabine|mesh-list
83236231|NCT03593655|Dapivirine|dapivirine|mesh-list
83236232|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
83236233|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236234|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83236235|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83236236|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236237|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236238|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83236239|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83236240|NCT03586661|Niraparib|niraparib|mesh-list
83236241|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83236242|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236243|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236244|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236245|NCT03572530|Azacitidine|azacitidine|mesh-list
83236246|NCT03572530|Decitabine|decitabine|mesh-list
83236247|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236248|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
83236249|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236250|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236251|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236252|NCT03570619|Nivolumab|nivolumab|mesh-list
83236253|NCT03570619|Ipilimumab|ipilimumab|mesh-list
83236254|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236255|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236256|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236257|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236258|NCT03568383|Pyridoxine|pyridoxine|mesh-list
83236259|NCT03568383|Pyridoxal|pyridoxal|mesh-list
83236260|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
83236261|NCT03568383|Isoniazid|isoniazid|mesh-list
83236262|NCT03568383|Vitamins|vitamins|mesh-ancestor
83236263|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
83236264|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236265|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
83236266|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
83236267|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83236268|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236269|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83236270|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83236271|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
83236272|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236273|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83236274|NCT03558087|Gemcitabine|gemcitabine|mesh-list
83236275|NCT03558087|Nivolumab|nivolumab|mesh-list
83236276|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236277|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236278|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
83236279|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236280|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236281|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236282|NCT03542695|Alendronate|alendronate|mesh-list
83236283|NCT03542695|Copper|copper|mesh-list
83236284|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83236285|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236286|NCT03542695|Trace Elements|trace elements|mesh-ancestor
83236287|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
83236288|NCT03541902|Sunitinib|sunitinib|mesh-list
83236289|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236290|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236291|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236292|NCT03541902|Growth Substances|growth substances|mesh-ancestor
83236293|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236294|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236295|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236296|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236297|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236298|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83236299|NCT03534180|Venetoclax|venetoclax|mesh-list
83236300|NCT03534180|Romidepsin|romidepsin|mesh-list
83236301|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236302|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236303|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83236304|NCT03534180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83236305|NCT03534180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236306|NCT03534180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236307|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
83236308|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
83236309|NCT03516279|Dasatinib|dasatinib|mesh-list
83236310|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236311|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236312|NCT03516279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236313|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236314|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236315|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236316|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83236317|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
83236318|NCT03512405|Blinatumomab|blinatumomab|mesh-list
83236319|NCT03512405|Antibodies|antibodies|mesh-list
83236320|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
83236321|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236322|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
83236323|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83236324|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
83236325|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236326|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236327|NCT03512405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236328|NCT03512405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236329|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236330|NCT03505320|Leucovorin|leucovorin|mesh-list
83236331|NCT03505320|Folic Acid|folic acid|mesh-list
83236332|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
83236333|NCT03505320|Nivolumab|nivolumab|mesh-list
83236334|NCT03505320|Fluorouracil|fluorouracil|mesh-list
83236335|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
83236336|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
83236337|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236338|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236339|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236340|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236341|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
83236343|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236344|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
83236345|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236346|NCT03505320|Antidotes|antidotes|mesh-ancestor
83236347|NCT03505320|Protective Agents|protective agents|mesh-ancestor
83236348|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
83236349|NCT03505320|Vitamins|vitamins|mesh-ancestor
83236350|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
83236351|NCT03505320|Hematinics|hematinics|mesh-ancestor
83236352|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83236353|NCT03497676|Rilpivirine|rilpivirine|mesh-list
83236354|NCT03497676|Cabotegravir|cabotegravir|mesh-list
83236355|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
83236356|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236357|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83236358|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83236359|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236360|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236361|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83236362|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83236363|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83236364|NCT03493425|Cisplatin|cisplatin|mesh-list
83236365|NCT03493425|Carboplatin|carboplatin|mesh-list
83236366|NCT03493425|Docetaxel|docetaxel|mesh-list
83236367|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236368|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236369|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236370|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236371|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236372|NCT03478865|Vitamin A|vitamin a|mesh-list
83236373|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
83236374|NCT03478865|Vitamins|vitamins|mesh-ancestor
83236375|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
83236376|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236377|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
83236378|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236379|NCT03478865|Protective Agents|protective agents|mesh-ancestor
83236380|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83236381|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236383|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83236384|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236385|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236386|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
83236387|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236388|NCT03464045|Empagliflozin|empagliflozin|mesh-list
83236389|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83236390|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83236391|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236392|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83236393|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236394|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
83236395|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236396|NCT03462719|Venetoclax|venetoclax|mesh-list
83236397|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
83236398|NCT03462719|Chlorambucil|chlorambucil|mesh-list
83236399|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236400|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236401|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236402|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
83236403|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236404|NCT03458416|Cannabidiol|cannabidiol|mesh-list
83236405|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
83236406|NCT03452332|Durvalumab|durvalumab|mesh-list
83236407|NCT03452332|Ipilimumab|ipilimumab|mesh-list
83236408|NCT03452332|Tremelimumab|tremelimumab|mesh-list
83236409|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
83236410|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236411|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
83236412|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236413|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236414|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
83236415|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236416|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236417|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236418|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83236419|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236420|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236421|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236422|NCT03440372|Ozanimod|ozanimod|mesh-list
83236423|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83236424|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236425|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236426|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
83236427|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236428|NCT03430219|Calcium|calcium|mesh-list
83236429|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83236430|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236431|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
83236432|NCT03419234|Prednisone|prednisone|mesh-list
83236433|NCT03419234|Cortisone|cortisone|mesh-list
83236434|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
83236435|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
83236436|NCT03419234|Hormones|hormones|mesh-list
83236437|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83236438|NCT03419234|Androgens|androgens|mesh-list
83236439|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
83236440|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83236441|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
83236442|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236443|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236444|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236445|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236446|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83236447|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236448|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236449|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
83236450|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83236451|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
83236452|NCT03419234|Protective Agents|protective agents|mesh-ancestor
83236453|NCT03419234|Vitamins|vitamins|mesh-ancestor
83236454|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
83236455|NCT03419234|Estrogens|estrogens|mesh-ancestor
83236456|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
83236457|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
83236458|NCT03391466|Fludarabine|fludarabine|mesh-list
83236459|NCT03391466|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83236460|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236461|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
83236462|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236463|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236464|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236465|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
83236466|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236467|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236468|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236469|NCT03391466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236470|NCT03384914|Vaccines|vaccines|mesh-list
83236471|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
83236472|NCT03384914|Immunomodulating Agents|immunomodulating agents|mesh-list
83236473|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236474|NCT03382561|Cisplatin|cisplatin|mesh-list
83236475|NCT03382561|Carboplatin|carboplatin|mesh-list
83236476|NCT03382561|Nivolumab|nivolumab|mesh-list
83236477|NCT03382561|Etoposide|etoposide|mesh-list
83236478|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
83236479|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
83236480|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236481|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236482|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236483|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236484|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236485|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83236486|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83236487|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236488|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
83236489|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
83236490|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236491|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236492|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236493|NCT03346135|Melphalan|melphalan|mesh-list
83236494|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
83236495|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83236496|NCT03346135|Daratumumab|daratumumab|mesh-list
83236497|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236498|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
83236499|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236500|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236501|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236502|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236503|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
83236504|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236505|NCT03339128|Eluxadoline|eluxadoline|mesh-list
83236506|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83236507|NCT03337698|Linagliptin|linagliptin|mesh-list
83236508|NCT03337698|Bevacizumab|bevacizumab|mesh-list
83236509|NCT03337698|Atezolizumab|atezolizumab|mesh-list
83236510|NCT03337698|Carboplatin|carboplatin|mesh-list
83236511|NCT03337698|Gemcitabine|gemcitabine|mesh-list
83236512|NCT03337698|Docetaxel|docetaxel|mesh-list
83236513|NCT03337698|Pemetrexed|pemetrexed|mesh-list
83236514|NCT03337698|Ipatasertib|ipatasertib|mesh-list
83236515|NCT03337698|Evolocumab|evolocumab|mesh-list
83236516|NCT03337698|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83236517|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236518|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236519|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236520|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236521|NCT03337698|Growth Substances|growth substances|mesh-ancestor
83236522|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236523|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236524|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236525|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
83236526|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236527|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236528|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236529|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236530|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236531|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83236532|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83236533|NCT03337698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236534|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83236535|NCT03337698|Incretins|incretins|mesh-ancestor
83236536|NCT03337698|Hormones|hormones|mesh-ancestor
83236537|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236538|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83236539|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
83236540|NCT03337698|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83236541|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83236542|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83236543|NCT03337698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83236544|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83236545|NCT03337698|Immunoconjugates|immunoconjugates|mesh-ancestor
83236546|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
83236547|NCT03337698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236548|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
83236549|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236550|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236551|NCT03319940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236552|NCT03319940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236553|NCT03280563|Tamoxifen|tamoxifen|mesh-list
83236554|NCT03280563|Bevacizumab|bevacizumab|mesh-list
83236555|NCT03280563|Atezolizumab|atezolizumab|mesh-list
83236556|NCT03280563|Fulvestrant|fulvestrant|mesh-list
83236557|NCT03280563|Exemestane|exemestane|mesh-list
83236558|NCT03280563|Entinostat|entinostat|mesh-list
83236559|NCT03280563|Ipatasertib|ipatasertib|mesh-list
83236560|NCT03280563|Antibodies|antibodies|mesh-list
83236561|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236562|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236563|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236564|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236565|NCT03280563|Growth Substances|growth substances|mesh-ancestor
83236566|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236567|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236568|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
83236569|NCT03280563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236570|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236571|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83236572|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
83236573|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236574|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236575|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83236576|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83236577|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83236578|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83236579|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83236580|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83236581|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236582|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83236583|NCT03280563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236585|NCT03274258|Ipilimumab|ipilimumab|mesh-list
83236586|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236587|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236588|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236589|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236590|NCT03269669|Prednisone|prednisone|mesh-list
83236591|NCT03269669|Cortisone|cortisone|mesh-list
83236592|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
83236593|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83236594|NCT03269669|Doxorubicin|doxorubicin|mesh-list
83236595|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83236596|NCT03269669|Vincristine|vincristine|mesh-list
83236597|NCT03269669|Lenalidomide|lenalidomide|mesh-list
83236598|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
83236599|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236600|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
83236601|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236602|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236603|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236604|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
83236605|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236606|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236607|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236608|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83236609|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83236610|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83236611|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236612|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83236613|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
83236614|NCT03269669|Hormones|hormones|mesh-ancestor
83236615|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236616|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236617|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236618|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236619|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236620|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236621|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236622|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236623|NCT03269669|Growth Substances|growth substances|mesh-ancestor
83236624|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236625|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236626|NCT03267433|Rituximab|rituximab|mesh-list
83236627|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236628|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236629|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
83236630|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236631|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236632|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
83236633|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83236634|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
83236635|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83236636|NCT03238300|Expectorants|expectorants|mesh-ancestor
83236637|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
83236638|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83236639|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
83236640|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236641|NCT03238300|Protective Agents|protective agents|mesh-ancestor
83236642|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236643|NCT03238300|Antidotes|antidotes|mesh-ancestor
83236644|NCT03215511|Selitrectinib|selitrectinib|mesh-list
83236645|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236646|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236648|NCT03214003|Etoposide|etoposide|mesh-list
83236649|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
83236650|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236651|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236652|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83236653|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83236654|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236655|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236656|NCT03191149|Osimertinib|osimertinib|mesh-list
83236657|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236658|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236659|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236660|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236661|NCT03181100|Paclitaxel|paclitaxel|mesh-list
83236662|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83236663|NCT03181100|Bevacizumab|bevacizumab|mesh-list
83236664|NCT03181100|Atezolizumab|atezolizumab|mesh-list
83236665|NCT03181100|Vemurafenib|vemurafenib|mesh-list
83236666|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83236667|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
83236668|NCT03181100|Antibodies|antibodies|mesh-list
83236669|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
83236670|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236671|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
83236672|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236673|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236674|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236675|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236676|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236677|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236678|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236679|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236680|NCT03181100|Growth Substances|growth substances|mesh-ancestor
83236681|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236682|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236683|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
83236684|NCT03181100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236685|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236686|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236687|NCT03180502|Temozolomide|temozolomide|mesh-list
83236688|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236689|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
83236690|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236691|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236692|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
83236693|NCT03160079|Blinatumomab|blinatumomab|mesh-list
83236694|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236695|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236696|NCT03160079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236697|NCT03160079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236698|NCT03155620|Olaparib|olaparib|mesh-list
83236699|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83236700|NCT03155620|Palbociclib|palbociclib|mesh-list
83236701|NCT03155620|Vemurafenib|vemurafenib|mesh-list
83236702|NCT03155620|Tipifarnib|tipifarnib|mesh-list
83236703|NCT03155620|Ensartinib|ensartinib|mesh-list
83236704|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236705|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236706|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236707|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236708|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
83236709|NCT03139370|Fludarabine|fludarabine|mesh-list
83236710|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236711|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
83236712|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236713|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236714|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236715|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
83236716|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236717|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236718|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236719|NCT03133221|Idelalisib|idelalisib|mesh-list
83236720|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236721|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236722|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236724|NCT03113500|Cortisone|cortisone|mesh-list
83236725|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
83236726|NCT03113500|Doxorubicin|doxorubicin|mesh-list
83236727|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83236728|NCT03113500|Etoposide|etoposide|mesh-list
83236729|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
83236730|NCT03113500|Daunorubicin|daunorubicin|mesh-list
83236731|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83236732|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
83236733|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83236734|NCT03113500|Antibodies|antibodies|mesh-list
83236735|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
83236736|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236737|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
83236738|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236739|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
83236740|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236741|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236742|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236743|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
83236744|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236745|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236746|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236747|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83236748|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83236749|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83236750|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236751|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83236752|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
83236753|NCT03113500|Hormones|hormones|mesh-ancestor
83236754|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236755|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236756|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236757|NCT03113500|Immunotoxins|immunotoxins|mesh-ancestor
83236758|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
83236759|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
83236760|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236761|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236762|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236763|NCT03108131|Atezolizumab|atezolizumab|mesh-list
83236764|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236765|NCT03108131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236766|NCT03108131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236767|NCT03108131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236768|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236769|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
83236770|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236771|NCT03099174|Letrozole|letrozole|mesh-list
83236772|NCT03099174|Fulvestrant|fulvestrant|mesh-list
83236773|NCT03099174|Anastrozole|anastrozole|mesh-list
83236774|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236775|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83236776|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83236777|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236778|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236779|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83236780|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
83236781|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236782|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236783|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236784|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83236785|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
83236786|NCT03089203|Fludarabine|fludarabine|mesh-list
83236787|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236788|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
83236789|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236790|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236791|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83236792|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
83236793|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236794|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236795|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83236803|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236804|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236805|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83236806|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236807|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236808|NCT03076554|Avelumab|avelumab|mesh-list
83236809|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236810|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236811|NCT03049540|Tadalafil|tadalafil|mesh-list
83236812|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
83236813|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83236814|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83236815|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236816|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236817|NCT03049540|Urological Agents|urological agents|mesh-ancestor
83236818|NCT03040596|Fluticasone|fluticasone|mesh-list
83236819|NCT03040596|Xhance|xhance|mesh-list
83236820|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83236821|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83236822|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
83236823|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83236824|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236825|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83236826|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
83236827|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
83236828|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83236829|NCT03012880|Dexamethasone|dexamethasone|mesh-list
83236830|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
83236831|NCT03012880|Lenalidomide|lenalidomide|mesh-list
83236832|NCT03012880|Daratumumab|daratumumab|mesh-list
83236833|NCT03012880|Ixazomib|ixazomib|mesh-list
83236834|NCT03012880|Ichthammol|ichthammol|mesh-list
83236835|NCT03012880|BB 1101|bb 1101|mesh-list
83236836|NCT03012880|Glycine|glycine|mesh-list
83236837|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83236838|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
83236839|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
83236840|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83236841|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236842|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83236843|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
83236844|NCT03012880|Hormones|hormones|mesh-ancestor
83236845|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236846|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236847|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236848|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
83236849|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236850|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236851|NCT03012880|Growth Substances|growth substances|mesh-ancestor
83236852|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236853|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236854|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
83236855|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236856|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
83236857|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
83236858|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83236865|NCT02999087|Cetuximab|cetuximab|mesh-list
83236866|NCT02999087|Avelumab|avelumab|mesh-list
83236867|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236868|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236869|NCT02997228|Leucovorin|leucovorin|mesh-list
83236870|NCT02997228|Bevacizumab|bevacizumab|mesh-list
83236871|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83236872|NCT02997228|Atezolizumab|atezolizumab|mesh-list
83236873|NCT02997228|Fluorouracil|fluorouracil|mesh-list
83236874|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
83236875|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
83236876|NCT02997228|Antibodies|antibodies|mesh-list
83236877|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
83236878|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236879|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
83236880|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236881|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83236882|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83236883|NCT02997228|Growth Substances|growth substances|mesh-ancestor
83236884|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236885|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
83236886|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
83236887|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
83236888|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236889|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236890|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236891|NCT02997228|Antidotes|antidotes|mesh-ancestor
83236892|NCT02997228|Protective Agents|protective agents|mesh-ancestor
83236893|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
83236894|NCT02997228|Vitamins|vitamins|mesh-ancestor
83236895|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
83236896|NCT02997228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236897|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
83236898|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
83236899|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83236900|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83236901|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236902|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236903|NCT02983461|Urological Agents|urological agents|mesh-ancestor
83236904|NCT02973789|Docetaxel|docetaxel|mesh-list
83236905|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83236906|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236907|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236908|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236909|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236910|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236911|NCT02973789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236912|NCT02936102|Spartalizumab|spartalizumab|mesh-list
83236913|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236914|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236915|NCT02936102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236916|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236917|NCT02927301|Atezolizumab|atezolizumab|mesh-list
83236918|NCT02927301|Antibodies|antibodies|mesh-list
83236919|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83236920|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
83236921|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236922|NCT02927301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83236923|NCT02927301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236924|NCT02927301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236925|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236926|NCT02924727|Valsartan|valsartan|mesh-list
83236927|NCT02924727|Ramipril|ramipril|mesh-list
83236928|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83236929|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83236930|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83236931|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83236932|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236933|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83236934|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
83236935|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236936|NCT02905110|Methotrexate|methotrexate|mesh-list
83236937|NCT02905110|Etoposide|etoposide|mesh-list
83236938|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83236939|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
83236940|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83236941|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236942|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236943|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
83236944|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236945|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236946|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
83236947|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83236948|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83236949|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83236950|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
83236951|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83236952|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83236953|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236954|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83236955|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83236956|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
83236957|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83236958|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83236959|NCT02798523|Prednisolone|prednisolone|mesh-list
83236960|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
83236961|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
83236962|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83236963|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
83236964|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83236965|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
83236966|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
83236967|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83236968|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236969|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83236970|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
83236971|NCT02798523|Hormones|hormones|mesh-ancestor
83236972|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83236973|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83236974|NCT02798523|Protective Agents|protective agents|mesh-ancestor
83236975|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236976|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236977|NCT02797977|Gemcitabine|gemcitabine|mesh-list
83236978|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236979|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83236980|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
83236981|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236982|NCT02772588|Leuprolide|leuprolide|mesh-list
83236983|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83236984|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
83236985|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83236986|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83236987|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83236988|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236989|NCT02766582|Paclitaxel|paclitaxel|mesh-list
83236990|NCT02766582|Carboplatin|carboplatin|mesh-list
83236991|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
83236992|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83236993|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83236994|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83236995|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83236996|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83236997|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83236998|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83236999|NCT02766582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237000|NCT02759419|Riociguat|riociguat|mesh-list
83237001|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
83237002|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237003|NCT02720692|Meloxicam|meloxicam|mesh-list
83237004|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83237005|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83237006|NCT02720692|Analgesics|analgesics|mesh-ancestor
83237007|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
83237008|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237009|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237010|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83237011|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237012|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83237013|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83237014|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237015|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237016|NCT02712151|Ropivacaine|ropivacaine|mesh-list
83237017|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
83237018|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
83237019|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83237020|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237021|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
83237022|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237023|NCT02707484|Thalidomide|thalidomide|mesh-list
83237024|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237025|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
83237026|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237027|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
83237028|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83237029|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237030|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83237031|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83237032|NCT02707484|Growth Substances|growth substances|mesh-ancestor
83237033|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
83237034|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237035|NCT02703623|Prednisone|prednisone|mesh-list
83237036|NCT02703623|Cortisone|cortisone|mesh-list
83237037|NCT02703623|Carboplatin|carboplatin|mesh-list
83237038|NCT02703623|Ipilimumab|ipilimumab|mesh-list
83237039|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
83237040|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237041|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83237042|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
83237043|NCT02703623|Hormones|hormones|mesh-ancestor
83237044|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83237045|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237046|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83237047|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237048|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237049|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237050|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83237051|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237052|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
83237053|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83237054|NCT02651662|Cemiplimab|cemiplimab|mesh-list
83237055|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237056|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237057|NCT02646683|Vedolizumab|vedolizumab|mesh-list
83237058|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83237059|NCT02628626|Clonidine|clonidine|mesh-list
83237060|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83237061|NCT02628626|Analgesics|analgesics|mesh-ancestor
83237062|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
83237063|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237064|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237065|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83237066|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
83237067|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
83237068|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83237069|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83237070|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83237071|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
83237072|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83237073|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237074|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83237075|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83237076|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
83237077|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83237078|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
83237079|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237080|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237081|NCT02625961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237082|NCT02625961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237083|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83237084|NCT02616965|Romidepsin|romidepsin|mesh-list
83237085|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237086|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237087|NCT02616965|Immunotoxins|immunotoxins|mesh-ancestor
83237088|NCT02616965|Immunoconjugates|immunoconjugates|mesh-ancestor
83237089|NCT02616965|Immunologic Factors|immunologic factors|mesh-ancestor
83237090|NCT02616965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237091|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83237092|NCT02616965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83237093|NCT02616965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237094|NCT02616965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237095|NCT02595424|Carboplatin|carboplatin|mesh-list
83237096|NCT02595424|Capecitabine|capecitabine|mesh-list
83237097|NCT02595424|Etoposide|etoposide|mesh-list
83237099|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237100|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237101|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
83237102|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237103|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237104|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237105|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237106|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237107|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237108|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
83237109|NCT02554812|Avelumab|avelumab|mesh-list
83237110|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237111|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237112|NCT02544815|Digoxin|digoxin|mesh-list
83237113|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83237114|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83237115|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237116|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237117|NCT02544815|Protective Agents|protective agents|mesh-ancestor
83237118|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237119|NCT02527707|Ritonavir|ritonavir|mesh-list
83237120|NCT02527707|Lonafarnib|lonafarnib|mesh-list
83237121|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83237122|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83237123|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
83237124|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237125|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237126|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83237127|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83237128|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
83237129|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237130|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83237131|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83237132|NCT02521363|Taxane|taxane|mesh-list
83237133|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237134|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83237135|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237136|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237137|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
83237139|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237140|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237141|NCT02437136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237142|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237143|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83237144|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237145|NCT02421939|Cytarabine|cytarabine|mesh-list
83237146|NCT02421939|Fludarabine|fludarabine|mesh-list
83237147|NCT02421939|Etoposide|etoposide|mesh-list
83237148|NCT02421939|Azacitidine|azacitidine|mesh-list
83237149|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
83237150|NCT02421939|Idarubicin|idarubicin|mesh-list
83237151|NCT02421939|Lenograstim|lenograstim|mesh-list
83237152|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237153|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237154|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
83237155|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237156|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237157|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
83237158|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237159|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237160|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237161|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237162|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237163|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
83237164|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237165|NCT02421939|Analgesics|analgesics|mesh-ancestor
83237166|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
83237167|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237168|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83237169|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83237170|NCT02367924|Trabectedin|trabectedin|mesh-list
83237171|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237172|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
83237173|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237174|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237175|NCT02352090|Dienogest|dienogest|mesh-list
83237176|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83237177|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83237178|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83237179|NCT02352090|Estradiol|estradiol|mesh-list
83237180|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83237181|NCT02352090|Nandrolone|nandrolone|mesh-list
83237182|NCT02352090|Estrogens|estrogens|mesh-ancestor
83237183|NCT02352090|Hormones|hormones|mesh-ancestor
83237184|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83237185|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237186|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83237187|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
83237188|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83237189|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83237190|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83237191|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83237192|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83237193|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
83237194|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83237195|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237196|NCT02352090|Androgens|androgens|mesh-ancestor
83237197|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
83237198|NCT02261883|Treprostinil|treprostinil|mesh-list
83237199|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83237200|NCT02135107|Rabeprazole|rabeprazole|mesh-list
83237201|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83237202|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83237203|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83237204|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237205|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237206|NCT02135042|Paclitaxel|paclitaxel|mesh-list
83237207|NCT02135042|Cisplatin|cisplatin|mesh-list
83237208|NCT02135042|Gemcitabine|gemcitabine|mesh-list
83237209|NCT02135042|Fluorouracil|fluorouracil|mesh-list
83237210|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83237211|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237212|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237213|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237214|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237215|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237216|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237217|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237218|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
83237219|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237220|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
83237221|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237222|NCT02099058|Nivolumab|nivolumab|mesh-list
83237223|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83237224|NCT02099058|Osimertinib|osimertinib|mesh-list
83237225|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83237226|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237227|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237228|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237229|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237230|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237231|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237232|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
83237233|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237234|NCT02085148|Irinotecan|irinotecan|mesh-list
83237235|NCT02085148|Vincristine|vincristine|mesh-list
83237236|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83237237|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237238|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237239|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237240|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237241|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237242|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237243|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237244|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237245|NCT02081378|Niacinamide|niacinamide|mesh-list
83237246|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
83237247|NCT02081378|Dasatinib|dasatinib|mesh-list
83237248|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237249|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237251|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237252|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
83237253|NCT02081378|Vitamins|vitamins|mesh-ancestor
83237254|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
83237255|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237256|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
83237257|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237258|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83237259|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237260|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237261|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
83237262|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83237263|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237264|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83237265|NCT02016924|Cobicistat|cobicistat|mesh-list
83237266|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83237267|NCT02016924|Emtricitabine|emtricitabine|mesh-list
83237268|NCT02016924|Tenofovir|tenofovir|mesh-list
83237269|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237270|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237271|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83237272|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83237273|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
83237274|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237275|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83237276|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83237277|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83237278|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83237279|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83237280|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83237281|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83237282|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
83237283|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237284|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237285|NCT01982448|Paclitaxel|paclitaxel|mesh-list
83237286|NCT01982448|Cisplatin|cisplatin|mesh-list
83237287|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237288|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237289|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237290|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237291|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237292|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237293|NCT01938261|Acetaminophen|acetaminophen|mesh-list
83237294|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83237295|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83237296|NCT01938261|Analgesics|analgesics|mesh-ancestor
83237297|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
83237298|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237299|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237300|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
83237301|NCT01932125|Bevacizumab|bevacizumab|mesh-list
83237302|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237303|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237304|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83237305|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83237306|NCT01932125|Growth Substances|growth substances|mesh-ancestor
83237307|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237308|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
83237309|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83237310|NCT01896999|Nivolumab|nivolumab|mesh-list
83237311|NCT01896999|Ipilimumab|ipilimumab|mesh-list
83237312|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83237313|NCT01896999|Antibodies|antibodies|mesh-list
83237314|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
83237315|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83237316|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
83237317|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
83237318|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237319|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237320|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237321|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237322|NCT01896999|Immunotoxins|immunotoxins|mesh-ancestor
83237323|NCT01844986|Olaparib|olaparib|mesh-list
83237324|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83237325|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237326|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237327|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237328|NCT01844518|Abatacept|abatacept|mesh-list
83237329|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237330|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237331|NCT01844518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237332|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237333|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237334|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
83237335|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237336|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237337|NCT01809041|Remifentanil|remifentanil|mesh-list
83237338|NCT01809041|Propofol|propofol|mesh-list
83237339|NCT01809041|Sevoflurane|sevoflurane|mesh-list
83237340|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83237341|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83237342|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237343|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83237344|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
83237345|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
83237346|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83237347|NCT01809041|Narcotics|narcotics|mesh-ancestor
83237348|NCT01809041|Analgesics|analgesics|mesh-ancestor
83237349|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
83237350|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237351|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83237352|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83237353|NCT01757535|Azacitidine|azacitidine|mesh-list
83237354|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237355|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
83237356|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237357|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237358|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237359|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
83237360|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83237361|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237362|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
83237363|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83237364|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237365|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
83237366|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83237367|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237368|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
83237369|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83237370|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237371|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
83237372|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83237373|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237374|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
83237375|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83237376|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237377|NCT01659151|Aldesleukin|aldesleukin|mesh-list
83237378|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
83237379|NCT01659151|Fludarabine|fludarabine|mesh-list
83237380|NCT01659151|Interleukin-2|interleukin-2|mesh-list
83237381|NCT01659151|Vemurafenib|vemurafenib|mesh-list
83237382|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83237383|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237384|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
83237385|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237386|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237387|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237388|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
83237389|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237390|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237391|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237392|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83237393|NCT01659151|Analgesics|analgesics|mesh-ancestor
83237394|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
83237395|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237396|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83237397|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83237398|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
83237399|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237400|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237401|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
83237402|NCT01593254|Dasatinib|dasatinib|mesh-list
83237403|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237404|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237405|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237406|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237407|NCT01553214|Dexamethasone|dexamethasone|mesh-list
83237408|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83237409|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
83237410|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
83237411|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237412|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237413|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83237414|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
83237415|NCT01553214|Hormones|hormones|mesh-ancestor
83237416|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83237417|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83237418|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237419|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83237420|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237421|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
83237422|NCT01525394|Lenvatinib|lenvatinib|mesh-list
83237423|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83237424|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237425|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237426|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237427|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237428|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237429|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237430|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237431|NCT01454934|Gemcitabine|gemcitabine|mesh-list
83237432|NCT01454934|Docetaxel|docetaxel|mesh-list
83237433|NCT01454934|Pemetrexed|pemetrexed|mesh-list
83237434|NCT01454934|Vinorelbine|vinorelbine|mesh-list
83237435|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237436|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
83237437|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237438|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237439|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237440|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237441|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237442|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237443|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83237444|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83237445|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237446|NCT01442246|Leuprolide|leuprolide|mesh-list
83237447|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83237448|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
83237449|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83237450|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237451|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83237452|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237453|NCT01439282|Capecitabine|capecitabine|mesh-list
83237454|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237455|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
83237456|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237457|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237458|NCT01391962|Sunitinib|sunitinib|mesh-list
83237459|NCT01391962|Cediranib|cediranib|mesh-list
83237460|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237462|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83237463|NCT01391962|Growth Substances|growth substances|mesh-ancestor
83237464|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237465|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83237466|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237467|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237468|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237469|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83237470|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237471|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237472|NCT01352520|Immunotoxins|immunotoxins|mesh-ancestor
83237473|NCT01352520|Immunoconjugates|immunoconjugates|mesh-ancestor
83237474|NCT01352520|Immunologic Factors|immunologic factors|mesh-ancestor
83237475|NCT01352520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237476|NCT01351103|Spartalizumab|spartalizumab|mesh-list
83237477|NCT01351103|LGK974|lgk974|mesh-list
83237478|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83237479|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237480|NCT01351103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237481|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237482|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237483|NCT01326312|Leuprolide|leuprolide|mesh-list
83237484|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83237485|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
83237486|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83237487|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237488|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83237489|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237490|NCT01321554|Lenvatinib|lenvatinib|mesh-list
83237491|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237492|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237493|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237494|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237495|NCT01308437|Insulin|insulin|mesh-list
83237496|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83237497|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
83237498|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83237499|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237500|NCT01268293|Lenvatinib|lenvatinib|mesh-list
83237501|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237502|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237503|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237504|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237505|NCT01267175|Insulin|insulin|mesh-list
83237506|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83237507|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237508|NCT01231841|Cyclosporine|cyclosporine|mesh-list
83237509|NCT01231841|Cyclosporins|cyclosporins|mesh-list
83237510|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
83237511|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83237512|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
83237513|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237514|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237515|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237516|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
83237517|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237518|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
83237519|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237520|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
83237521|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237522|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83237523|NCT01133756|Carboplatin|carboplatin|mesh-list
83237524|NCT01133756|Gemcitabine|gemcitabine|mesh-list
83237525|NCT01133756|Lenvatinib|lenvatinib|mesh-list
83237526|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237527|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237528|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
83237529|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237530|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237531|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237532|NCT01126736|Pemetrexed|pemetrexed|mesh-list
83237533|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237534|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237535|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237536|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83237537|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83237538|NCT01111461|Lenvatinib|lenvatinib|mesh-list
83237539|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237540|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237541|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237542|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237543|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83237544|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237545|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237546|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237547|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237548|NCT01067287|Pidilizumab|pidilizumab|mesh-list
83237549|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237550|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237551|NCT01005745|Aldesleukin|aldesleukin|mesh-list
83237552|NCT01005745|Interleukin-2|interleukin-2|mesh-list
83237553|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237554|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83237555|NCT01005745|Analgesics|analgesics|mesh-ancestor
83237556|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
83237557|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237558|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237559|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83237560|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83237561|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
83237562|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237563|NCT00978458|Temozolomide|temozolomide|mesh-list
83237564|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237565|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
83237566|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237567|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237568|NCT00956007|Cetuximab|cetuximab|mesh-list
83237569|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237570|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237571|NCT00887146|Vincristine|vincristine|mesh-list
83237572|NCT00887146|Temozolomide|temozolomide|mesh-list
83237573|NCT00887146|Procarbazine|procarbazine|mesh-list
83237574|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237575|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237576|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237577|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237578|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237579|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237580|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237581|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
83237582|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83237583|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83237584|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237585|NCT00796263|Dolutegravir|dolutegravir|mesh-list
83237586|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83237587|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83237588|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237589|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237590|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83237591|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83237592|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
83237593|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237594|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83237595|NCT00769379|Trastuzumab|trastuzumab|mesh-list
83237596|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83237597|NCT00769379|Antibodies|antibodies|mesh-list
83237598|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
83237599|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83237600|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
83237601|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237602|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237603|NCT00715442|Sunitinib|sunitinib|mesh-list
83237604|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237605|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83237606|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83237607|NCT00715442|Growth Substances|growth substances|mesh-ancestor
83237608|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237609|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
83237610|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237611|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237612|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237613|NCT00697684|Clofarabine|clofarabine|mesh-list
83237614|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83237615|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237616|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
83237617|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237618|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237619|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
83237620|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237621|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237622|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
83237623|NCT00675922|Mafenide|mafenide|mesh-list
83237624|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83237625|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237626|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83237627|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83237628|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237629|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237630|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
83237631|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237632|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
83237633|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237634|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237635|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237636|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
83237637|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237638|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237639|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237640|NCT00244933|Gemcitabine|gemcitabine|mesh-list
83237642|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237643|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
83237644|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237645|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237646|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83237647|NCT00244933|Protective Agents|protective agents|mesh-ancestor
83237648|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237649|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237650|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237651|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
83237652|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83237653|NCT00244933|Estrogens|estrogens|mesh-ancestor
83237654|NCT00244933|Hormones|hormones|mesh-ancestor
83237655|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83237656|NCT00121719|Lenvatinib|lenvatinib|mesh-list
83237657|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237658|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83237659|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237660|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237661|NCT00065676|Quercetin|quercetin|mesh-list
83237662|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
83237663|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237664|NCT00065676|Protective Agents|protective agents|mesh-ancestor
83237665|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237666|NCT00053209|Gemcitabine|gemcitabine|mesh-list
83237667|NCT00053209|Pemetrexed|pemetrexed|mesh-list
83237668|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237669|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
83237670|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237671|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237672|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237673|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83237674|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83237675|NCT00039429|Atrasentan|atrasentan|mesh-list
83237676|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237677|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83237678|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83237679|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237680|NCT00014508|Cyclosporine|cyclosporine|mesh-list
83237681|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
83237682|NCT00014508|Melphalan|melphalan|mesh-list
83237683|NCT00014508|Fludarabine|fludarabine|mesh-list
83237684|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
83237685|NCT00014508|Cyclosporins|cyclosporins|mesh-list
83237686|NCT00014508|Sargramostim|sargramostim|mesh-list
83237687|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237688|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
83237689|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237690|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237691|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237692|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
83237693|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237694|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237695|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237696|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237697|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
83237698|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237699|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
83237700|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237701|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
83237702|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83237703|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
83237704|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
83237705|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237706|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
83237707|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237708|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237709|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237710|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
83237711|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237712|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237713|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237714|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237715|NCT00005962|Cytarabine|cytarabine|mesh-list
83237716|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
83237717|NCT00005962|Daunorubicin|daunorubicin|mesh-list
83237718|NCT00005962|Topotecan|topotecan|mesh-list
83237719|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
83237720|NCT00005962|Sargramostim|sargramostim|mesh-list
83237721|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237722|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
83237723|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237724|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237725|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237726|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
83237727|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237728|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237729|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237730|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237731|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
83237732|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
83237733|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237734|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83237735|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237736|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237737|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237738|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83237739|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237740|NCT00005962|Immunotoxins|immunotoxins|mesh-ancestor
83237741|NCT00005962|Immunoconjugates|immunoconjugates|mesh-ancestor
83237742|NCT00005847|Interferons|interferons|mesh-list
83237743|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
83237744|NCT00005847|Paclitaxel|paclitaxel|mesh-list
83237745|NCT00005847|Vinorelbine|vinorelbine|mesh-list
83237746|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
83237747|NCT00005847|Estramustine|estramustine|mesh-list
83237748|NCT00005847|Isotretinoin|isotretinoin|mesh-list
83237749|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237750|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237751|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237752|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237753|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237754|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237755|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
83237756|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237757|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
83237758|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237759|NCT00005847|Analgesics|analgesics|mesh-ancestor
83237760|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
83237761|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237762|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237763|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237764|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237765|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83237766|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237767|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
83237768|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83237769|NCT00005644|Paclitaxel|paclitaxel|mesh-list
83237770|NCT00005644|Gemcitabine|gemcitabine|mesh-list
83237771|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237772|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237773|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237774|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237775|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237776|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237777|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237778|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
83237779|NCT00003871|Vaccines|vaccines|mesh-list
83237780|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
83237781|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237782|NCT00003809|Cetuximab|cetuximab|mesh-list
83237783|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237784|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83237785|NCT00003808|Theophylline|theophylline|mesh-list
83237786|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83237787|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
83237788|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83237789|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237790|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83237791|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
83237792|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83237793|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237794|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237795|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
83237796|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83237797|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83237798|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
83237799|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83237800|NCT00003592|Paclitaxel|paclitaxel|mesh-list
83237801|NCT00003592|Methotrexate|methotrexate|mesh-list
83237802|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237803|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237804|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237805|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237806|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237807|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237808|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83237809|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
83237811|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237812|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237813|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
83237814|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
83237815|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237816|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83237817|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237818|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
83237819|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237820|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83237821|NCT00003518|Paclitaxel|paclitaxel|mesh-list
83237822|NCT00003518|Gemcitabine|gemcitabine|mesh-list
83237823|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237824|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237825|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237826|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237827|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237828|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237829|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237830|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
83237831|NCT00003444|Interferons|interferons|mesh-list
83237832|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
83237833|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237834|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
83237835|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237836|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
83237837|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237838|NCT00003388|Cytarabine|cytarabine|mesh-list
83237839|NCT00003388|Prednisone|prednisone|mesh-list
83237840|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
83237841|NCT00003388|Doxorubicin|doxorubicin|mesh-list
83237842|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83237843|NCT00003388|Methotrexate|methotrexate|mesh-list
83237844|NCT00003388|Vincristine|vincristine|mesh-list
83237845|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237846|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
83237847|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237848|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237849|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237850|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
83237851|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237853|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237854|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83237855|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237856|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237857|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237858|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83237859|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
83237860|NCT00003388|Hormones|hormones|mesh-ancestor
83237861|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83237862|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83237863|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83237864|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
83237865|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83237866|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237867|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
83237868|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
83237869|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83237870|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83237871|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
83237872|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237873|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237874|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237875|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237876|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237877|NCT00003376|Paclitaxel|paclitaxel|mesh-list
83237878|NCT00003376|Vinblastine|vinblastine|mesh-list
83237879|NCT00003376|Carboplatin|carboplatin|mesh-list
83237880|NCT00003376|Doxorubicin|doxorubicin|mesh-list
83237881|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83237882|NCT00003376|Methotrexate|methotrexate|mesh-list
83237883|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237884|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237885|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237886|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237887|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237888|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237889|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83237890|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237891|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237892|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237893|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83237894|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
83237895|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83237896|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237897|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237898|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
83237899|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
83237900|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83237901|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237902|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
83237903|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237904|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83237905|NCT00003353|Melphalan|melphalan|mesh-list
83237906|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
83237907|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237908|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237909|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
83237910|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237911|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237912|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237913|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237914|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
83237915|NCT00003309|Etoposide|etoposide|mesh-list
83237916|NCT00003309|Vincristine|vincristine|mesh-list
83237917|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237918|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
83237919|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237920|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83237921|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237922|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
83237923|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237924|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237925|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83237926|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237927|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237929|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237930|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237931|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237932|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237933|NCT00003237|Paclitaxel|paclitaxel|mesh-list
83237934|NCT00003237|Cisplatin|cisplatin|mesh-list
83237935|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237936|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237937|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237938|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237939|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237940|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237942|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237943|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237944|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237945|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237946|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237947|NCT00003027|Interferons|interferons|mesh-list
83237948|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
83237949|NCT00003027|Aldesleukin|aldesleukin|mesh-list
83237950|NCT00003027|Dacarbazine|dacarbazine|mesh-list
83237951|NCT00003027|Vinblastine|vinblastine|mesh-list
83237952|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237953|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
83237954|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237955|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
83237956|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83237957|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83237958|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83237959|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83237960|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
83237961|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237962|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237963|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
83237964|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
83237965|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
83237966|NCT00002914|Piritrexim|piritrexim|mesh-list
83237967|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237968|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83237969|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237970|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237971|NCT00002872|Doxycycline|doxycycline|mesh-list
83237972|NCT00002872|Bleomycin|bleomycin|mesh-list
83237973|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83237974|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237975|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
83237976|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83237977|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83237978|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83237979|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237980|NCT00002868|Interferons|interferons|mesh-list
83237981|NCT00002868|Cytarabine|cytarabine|mesh-list
83237982|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
83237983|NCT00002868|Etoposide|etoposide|mesh-list
83237984|NCT00002868|Idarubicin|idarubicin|mesh-list
83237985|NCT00002868|Busulfan|busulfan|mesh-list
83237986|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
83237987|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83237988|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83237989|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83237990|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83237991|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83237992|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83237993|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
83237994|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83237995|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83237996|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
83237997|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83237998|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
83237999|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238000|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
83238001|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83238002|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83238003|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83238004|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
83238005|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83238007|NCT00002650|Hematinics|hematinics|mesh-ancestor
83238008|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
83238009|NCT00002650|Vitamins|vitamins|mesh-ancestor
83238010|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
83238011|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238012|NCT00001337|Rituximab|rituximab|mesh-list
83238013|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83238014|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238015|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
83238016|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238017|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83238018|NCT03078725|Metformin|metformin|mesh-list
83238019|NCT03078725|Glyburide|glyburide|mesh-list
83238020|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83238021|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238022|NCT02341963|Ketamine|ketamine|mesh-list
83238023|NCT02341963|Analgesics|analgesics|mesh-ancestor
83238024|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
83238025|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238026|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238027|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83238028|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83238029|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
83238030|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
83238031|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238032|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83238033|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83238034|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238035|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238036|NCT05014685|Amoxicillin|amoxicillin|mesh-list
83238037|NCT05014685|Metronidazole|metronidazole|mesh-list
83238038|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
83238039|NCT05014685|Rabeprazole|rabeprazole|mesh-list
83238040|NCT05014685|Bismuth|bismuth|mesh-list
83238041|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238042|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238043|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238044|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83238045|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83238046|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83238047|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238048|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83238049|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238050|NCT05014685|Antacids|antacids|mesh-ancestor
83238051|NCT05014685|Diuretics|diuretics|mesh-ancestor
83238052|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
83238053|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238054|NCT05014685|Expectorants|expectorants|mesh-ancestor
83238055|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
83238056|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
83238057|NCT03111901|Interleukin-2|interleukin-2|mesh-list
83238058|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83238059|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238060|NCT03111901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83238061|NCT03111901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238062|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83238063|NCT03111901|Analgesics|analgesics|mesh-ancestor
83238064|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
83238065|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238066|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238067|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83238068|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83238069|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
83238070|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238071|NCT02341729|Ticagrelor|ticagrelor|mesh-list
83238072|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83238073|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83238074|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83238075|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83238076|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
83238077|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238078|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238079|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238080|NCT05014373|Favipiravir|favipiravir|mesh-list
83238081|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
83238082|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238083|NCT04762459|Pemetrexed|pemetrexed|mesh-list
83238084|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238085|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238086|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238087|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83238088|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83238089|NCT03078569|Testosterone|testosterone|mesh-list
83238090|NCT03078569|Androgens|androgens|mesh-ancestor
83238091|NCT03078569|Hormones|hormones|mesh-ancestor
83238092|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238093|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238094|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83238095|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
83238096|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83238097|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
83238098|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238099|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238100|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83238101|NCT03078257|Aspirin|aspirin|mesh-list
83238102|NCT03078257|Tirofiban|tirofiban|mesh-list
83238103|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
83238104|NCT03078257|Clopidogrel|clopidogrel|mesh-list
83238105|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83238106|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83238107|NCT03078257|Analgesics|analgesics|mesh-ancestor
83238108|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
83238109|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238110|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238111|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238112|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83238113|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83238114|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83238115|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238116|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83238117|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83238118|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238119|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
83238120|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83238121|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83238122|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83238123|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
83238124|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238125|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
83238126|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83238127|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
83238128|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
83238129|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238130|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238131|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
83238132|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83238133|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238134|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238135|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83238136|NCT05005715|Analgesics|analgesics|mesh-ancestor
83238137|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
83238138|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238139|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83238140|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83238141|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83238142|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
83238143|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238144|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238145|NCT02345707|Cabotegravir|cabotegravir|mesh-list
83238146|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83238147|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83238148|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238149|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238150|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83238151|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83238152|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
83238153|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238154|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
83238155|NCT05005637|Prednisone|prednisone|mesh-list
83238156|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238157|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
83238158|NCT05005637|Hormones|hormones|mesh-ancestor
83238159|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238160|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238161|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238162|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238163|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238164|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238165|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83238166|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83238167|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238168|NCT02336659|Incretins|incretins|mesh-ancestor
83238169|NCT02336659|Hormones|hormones|mesh-ancestor
83238170|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238171|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83238172|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
83238173|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238174|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238175|NCT03081923|Durvalumab|durvalumab|mesh-list
83238176|NCT03081923|Tremelimumab|tremelimumab|mesh-list
83238177|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83238178|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238179|NCT02341105|Amiodarone|amiodarone|mesh-list
83238180|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83238181|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
83238182|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83238183|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238184|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238185|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83238186|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83238187|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83238188|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238189|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83238190|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83238191|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83238192|NCT03078101|Empagliflozin|empagliflozin|mesh-list
83238193|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83238194|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238195|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83238196|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238198|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83238199|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238200|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83238201|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238202|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238203|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
83238204|NCT04688203|Labetalol|labetalol|mesh-list
83238205|NCT04688203|Analgesics|analgesics|mesh-ancestor
83238206|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
83238207|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238208|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238209|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
83238210|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238211|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83238212|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
83238213|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83238214|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238215|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238216|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83238217|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
83238218|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83238219|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83238220|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83238221|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
83238222|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238223|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83238224|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
83238225|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
83238226|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83238227|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83238228|NCT05254561|Immunomodulating Agents|immunomodulating agents|mesh-list
83238229|NCT05254561|Immunologic Factors|immunologic factors|mesh-ancestor
83238230|NCT05254561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238231|NCT04509973|Dexamethasone|dexamethasone|mesh-list
83238232|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238233|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
83238234|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
83238235|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238236|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238237|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238238|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
83238239|NCT04509973|Hormones|hormones|mesh-ancestor
83238240|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238241|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238242|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238243|NCT02336347|Quinidine|quinidine|mesh-list
83238244|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
83238245|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
83238246|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
83238247|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83238248|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83238249|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238250|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238251|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238252|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83238253|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83238254|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
83238255|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83238256|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
83238257|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83238258|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83238259|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238260|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238261|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83238262|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83238263|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
83238264|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83238265|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83238266|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238267|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83238268|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83238269|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
83238270|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
83238271|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83238272|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83238273|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238274|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83238275|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83238276|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83238277|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
83238278|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
83238279|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83238280|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238281|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238282|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
83238283|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83238284|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238285|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238286|NCT02340481|Simethicone|simethicone|mesh-list
83238287|NCT02340481|Loperamide|loperamide|mesh-list
83238288|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
83238289|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238290|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
83238291|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238292|NCT02340481|Emollients|emollients|mesh-ancestor
83238293|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
83238294|NCT03077633|Progesterone|progesterone|mesh-list
83238295|NCT03077633|Progestins|progestins|mesh-ancestor
83238296|NCT03077633|Hormones|hormones|mesh-ancestor
83238297|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238298|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238300|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83238301|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83238302|NCT05253781|Analgesics|analgesics|mesh-ancestor
83238303|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
83238304|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238305|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238306|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238307|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83238308|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83238309|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83238310|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238311|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83238312|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83238313|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238314|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
83238315|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
83238316|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83238317|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83238318|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238319|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238320|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238321|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83238322|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83238323|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83238324|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238325|NCT02340247|Cathartics|cathartics|mesh-ancestor
83238326|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83238327|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
83238328|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83238329|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83238330|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83238331|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
83238332|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83238333|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238334|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83238335|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83238336|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83238337|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238338|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238339|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
83238340|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
83238341|NCT05178823|Fluorides|fluorides|mesh-list
83238342|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
83238343|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
83238344|NCT05178823|Protective Agents|protective agents|mesh-ancestor
83238345|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238346|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83238347|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238348|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
83238349|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
83238350|NCT03105583|Vitamins|vitamins|mesh-list
83238351|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
83238352|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238353|NCT03105115|Fentanyl|fentanyl|mesh-list
83238354|NCT03105115|Bupivacaine|bupivacaine|mesh-list
83238355|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
83238356|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
83238357|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238358|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238359|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
83238360|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238361|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83238362|NCT03105115|Narcotics|narcotics|mesh-ancestor
83238363|NCT03105115|Analgesics|analgesics|mesh-ancestor
83238364|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83238365|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83238366|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
83238367|NCT03105349|Ribavirin|ribavirin|mesh-list
83238368|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
83238369|NCT03105349|Grazoprevir|grazoprevir|mesh-list
83238370|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83238371|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
83238372|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238373|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
83238374|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238375|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83238376|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83238377|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83238378|NCT03077555|Estradiol|estradiol|mesh-list
83238379|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83238380|NCT03077555|Estrogens|estrogens|mesh-ancestor
83238381|NCT03077555|Hormones|hormones|mesh-ancestor
83238382|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238383|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238384|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83238385|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
83238386|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83238387|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83238388|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83238389|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83238390|NCT02335255|Naftifine|naftifine|mesh-list
83238391|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
83238392|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238393|NCT05012033|Prednisolone|prednisolone|mesh-list
83238394|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238395|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
83238396|NCT05012033|Hormones|hormones|mesh-ancestor
83238397|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238398|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238399|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238400|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238401|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
83238402|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238403|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238404|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83238405|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83238406|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238407|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238408|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238409|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
83238410|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83238411|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83238412|NCT02334475|Prednisolone|prednisolone|mesh-list
83238413|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
83238414|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83238415|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
83238416|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238417|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
83238418|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
83238419|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238420|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238421|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238422|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
83238423|NCT02334475|Hormones|hormones|mesh-ancestor
83238424|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238425|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83238426|NCT02334475|Protective Agents|protective agents|mesh-ancestor
83238427|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238428|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238429|NCT02334631|Simethicone|simethicone|mesh-list
83238430|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
83238431|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238432|NCT02334631|Emollients|emollients|mesh-ancestor
83238433|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83238434|NCT02338687|Calcium|calcium|mesh-list
83238435|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83238436|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238437|NCT02338531|Nirogacestat|nirogacestat|mesh-list
83238438|NCT02338531|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83238439|NCT02338531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238440|NCT02338531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238441|NCT02332135|Vitamin D|vitamin d|mesh-list
83238442|NCT02332135|Vitamins|vitamins|mesh-ancestor
83238443|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
83238444|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238445|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83238446|NCT02334163|Metronidazole|metronidazole|mesh-list
83238447|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
83238448|NCT02334163|Lactulose|lactulose|mesh-list
83238449|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238450|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238451|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83238452|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83238453|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238454|NCT02332057|Diclofenac|diclofenac|mesh-list
83238455|NCT02332057|Lidocaine|lidocaine|mesh-list
83238456|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
83238457|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
83238458|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238459|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238460|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
83238461|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238462|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83238463|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83238464|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83238465|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238466|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238467|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83238468|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83238469|NCT02332057|Analgesics|analgesics|mesh-ancestor
83238470|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238471|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83238472|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83238473|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238474|NCT02331745|Lenograstim|lenograstim|mesh-list
83238475|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83238476|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
83238477|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238479|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
83238480|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
83238481|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83238482|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
83238483|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83238484|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
83238485|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238486|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238487|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
83238488|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
83238489|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83238490|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238491|NCT02334007|Dalteparin|dalteparin|mesh-list
83238493|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83238494|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
83238495|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83238496|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83238497|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238498|NCT02637323|Triamcinolone|triamcinolone|mesh-list
83238499|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83238500|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83238501|NCT02637323|FX006|fx006|mesh-list
83238502|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83238503|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238504|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
83238505|NCT02637323|Hormones|hormones|mesh-ancestor
83238506|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238507|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238508|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83238509|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
83238510|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238511|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238512|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
83238513|NCT02331823|Isoniazid|isoniazid|mesh-list
83238514|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
83238515|NCT02331823|Ethambutol|ethambutol|mesh-list
83238516|NCT02331823|Rifabutin|rifabutin|mesh-list
83238517|NCT02331823|Streptomycin|streptomycin|mesh-list
83238518|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238519|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238520|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83238521|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83238522|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238523|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238524|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238525|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83238526|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
83238527|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83238528|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83238529|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
83238530|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83238531|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83238532|NCT02890459|Denatonium|denatonium|mesh-list
83238533|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
83238534|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238535|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
83238536|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238537|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
83238538|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238539|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
83238540|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83238541|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
83238542|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238543|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
83238544|NCT03077009|Protective Agents|protective agents|mesh-ancestor
83238545|NCT04477525|Bupivacaine|bupivacaine|mesh-list
83238546|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
83238547|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
83238548|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238549|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238550|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
83238551|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238552|NCT03079973|Calcipotriene|calcipotriene|mesh-list
83238553|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
83238554|NCT03861871|Fenfluramine|fenfluramine|mesh-list
83238555|NCT03861871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83238556|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83238557|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238558|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238559|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238560|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
83238561|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238562|NCT05004545|Propofol|propofol|mesh-list
83238563|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83238564|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238565|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238566|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83238567|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
83238568|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
83238569|NCT03079895|Nicotine|nicotine|mesh-list
83238570|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83238571|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
83238572|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238573|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238574|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83238575|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83238576|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
83238577|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238578|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238579|NCT04463615|Leflunomide|leflunomide|mesh-list
83238580|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238581|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238582|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83238583|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
83238584|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238585|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
83238586|NCT05003765|Buprenorphine|buprenorphine|mesh-list
83238587|NCT05003765|Bupivacaine|bupivacaine|mesh-list
83238588|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83238589|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
83238590|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
83238591|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238592|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238593|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
83238594|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238595|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83238596|NCT05003765|Narcotics|narcotics|mesh-ancestor
83238597|NCT05003765|Analgesics|analgesics|mesh-ancestor
83238598|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83238599|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83238600|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
83238601|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83238602|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238603|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238604|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83238605|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
83238606|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83238607|NCT02337283|BI 425809|bi 425809|mesh-list
83238608|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
83238609|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
83238610|NCT02333305|Vitamins|vitamins|mesh-ancestor
83238611|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
83238612|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238613|NCT02326987|Pregabalin|pregabalin|mesh-list
83238614|NCT02326987|Analgesics|analgesics|mesh-ancestor
83238615|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
83238616|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238617|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238618|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
83238619|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83238620|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238621|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238622|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83238623|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83238624|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83238625|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238626|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83238628|NCT02331511|Clopidogrel|clopidogrel|mesh-list
83238629|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83238630|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83238631|NCT02331511|Analgesics|analgesics|mesh-ancestor
83238632|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
83238633|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238634|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238635|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238636|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83238637|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83238638|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83238639|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238640|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83238641|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83238642|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238643|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
83238644|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83238645|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83238646|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83238647|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
83238648|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238649|NCT02326441|KX2-361|kx2-361|mesh-list
83238650|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83238651|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238652|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238653|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83238654|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83238655|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83238656|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238657|NCT02039791|Paclitaxel|paclitaxel|mesh-list
83238658|NCT02039791|Carboplatin|carboplatin|mesh-list
83238659|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
83238660|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83238661|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238662|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
83238663|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
83238664|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
83238665|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238666|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83238667|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
83238668|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83238669|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
83238670|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238671|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238672|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83238673|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
83238674|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83238675|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83238676|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83238677|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
83238678|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238679|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238680|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
83238681|NCT03111511|Drospirenone|drospirenone|mesh-list
83238682|NCT03111511|Midazolam|midazolam|mesh-list
83238683|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83238684|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83238685|NCT03111511|Betadex|betadex|mesh-list
83238686|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83238687|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83238688|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238689|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238690|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83238691|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83238692|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83238693|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83238694|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
83238695|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
83238696|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
83238697|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
83238698|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238699|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238700|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83238701|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83238702|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83238703|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
83238704|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83238705|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83238706|NCT03111511|Estrogens|estrogens|mesh-ancestor
83238707|NCT03111511|Hormones|hormones|mesh-ancestor
83238708|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238709|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83238710|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
83238711|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83238712|NCT03111511|Diuretics|diuretics|mesh-ancestor
83238713|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
83238714|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
83238715|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238716|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
83238717|NCT03144115|Oxytocin|oxytocin|mesh-list
83238718|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
83238719|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83238720|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238721|NCT02326285|Docetaxel|docetaxel|mesh-list
83238722|NCT02326285|Gefitinib|gefitinib|mesh-list
83238723|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238724|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
83238725|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
83238726|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
83238727|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238728|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83238729|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238730|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
83238731|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83238732|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83238733|NCT02332603|Prednisolone|prednisolone|mesh-list
83238734|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
83238735|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83238736|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
83238737|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238738|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
83238739|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
83238740|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238741|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238742|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238743|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
83238744|NCT02332603|Hormones|hormones|mesh-ancestor
83238745|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238746|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83238747|NCT02332603|Protective Agents|protective agents|mesh-ancestor
83238748|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238749|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238750|NCT02332447|Naloxone|naloxone|mesh-list
83238751|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83238752|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238753|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
83238754|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238755|NCT05077813|Vitamin D|vitamin d|mesh-list
83238756|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
83238757|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
83238758|NCT05077813|Vitamins|vitamins|mesh-list
83238759|NCT05077813|Minocycline|minocycline|mesh-list
83238760|NCT05077813|Tretinoin|tretinoin|mesh-list
83238761|NCT05077813|Alitretinoin|alitretinoin|mesh-list
83238762|NCT05077813|Isotretinoin|isotretinoin|mesh-list
83238763|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
83238764|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238765|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83238766|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83238767|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238768|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238769|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238770|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
83238771|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83238772|NCT02326051|Enoxaparin|enoxaparin|mesh-list
83238773|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
83238774|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
83238775|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83238776|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83238777|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238778|NCT05076955|Vancomycin|vancomycin|mesh-list
83238779|NCT05076955|Tobramycin|tobramycin|mesh-list
83238780|NCT05076955|Itraconazole|itraconazole|mesh-list
83238781|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238782|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238783|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
83238784|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83238785|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83238786|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238787|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238788|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83238789|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
83238790|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238791|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238792|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83238793|NCT05077111|Anesthetics|anesthetics|mesh-list
83238794|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238795|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238796|NCT05075863|Letrozole|letrozole|mesh-list
83238797|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238798|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83238799|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83238800|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238801|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238802|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83238803|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
83238804|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238805|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238806|NCT02330419|Naltrexone|naltrexone|mesh-list
83238807|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83238808|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83238809|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238810|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
83238811|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238812|NCT05068141|Paclitaxel|paclitaxel|mesh-list
83238813|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83238814|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238815|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
83238816|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
83238817|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
83238818|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238819|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
83238820|NCT03142165|Promethazine|promethazine|mesh-list
83238821|NCT03142165|Famotidine|famotidine|mesh-list
83238822|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83238823|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83238824|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238825|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238826|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
83238827|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
83238828|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
83238829|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238830|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
83238831|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
83238832|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238833|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83238834|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
83238835|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
83238836|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238837|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238838|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83238839|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
83238840|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
83238841|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83238842|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83238844|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83238845|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83238846|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238847|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83238848|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238849|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
83238850|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
83238851|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238852|NCT04988971|Corticosterone|corticosterone|mesh-list
83238853|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
83238854|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238855|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83238856|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
83238857|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
83238858|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238859|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238860|NCT02329795|Temozolomide|temozolomide|mesh-list
83238861|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83238862|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
83238863|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238864|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238865|NCT02329561|Tramadol|tramadol|mesh-list
83238866|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83238867|NCT02329561|Narcotics|narcotics|mesh-ancestor
83238868|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238869|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238870|NCT02329561|Analgesics|analgesics|mesh-ancestor
83238871|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
83238872|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238873|NCT03143491|Paclitaxel|paclitaxel|mesh-list
83238874|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83238875|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238876|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
83238877|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
83238878|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83238879|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238880|NCT05002673|Anesthetics|anesthetics|mesh-list
83238881|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238882|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238883|NCT03076151|Tacrolimus|tacrolimus|mesh-list
83238884|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83238885|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
83238886|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238887|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83238888|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238889|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238890|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
83238891|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83238892|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83238893|NCT05002517|Prednisolone|prednisolone|mesh-list
83238894|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
83238895|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83238896|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
83238897|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238898|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
83238899|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
83238900|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238901|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238902|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238903|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
83238904|NCT05002517|Hormones|hormones|mesh-ancestor
83238905|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238906|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83238907|NCT05002517|Protective Agents|protective agents|mesh-ancestor
83238908|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238909|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238910|NCT05002361|Dexamethasone|dexamethasone|mesh-list
83238911|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83238912|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
83238913|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
83238914|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238915|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238916|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238917|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
83238918|NCT05002361|Hormones|hormones|mesh-ancestor
83238919|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83238920|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83238921|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238922|NCT02329405|Rifampin|rifampin|mesh-list
83238923|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83238924|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
83238925|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83238926|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83238927|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
83238928|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83238929|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238930|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238931|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83238932|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83238933|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83238934|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83238935|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83238936|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83238937|NCT02329171|Imiquimod|imiquimod|mesh-list
83238938|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83238939|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
83238940|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238941|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83238942|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
83238943|NCT04498741|Midazolam|midazolam|mesh-list
83238944|NCT04498741|Dabigatran|dabigatran|mesh-list
83238945|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83238946|NCT04498741|Tacrolimus|tacrolimus|mesh-list
83238947|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83238949|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238950|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83238951|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238952|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238953|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83238954|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83238955|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83238956|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83238957|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83238958|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83238959|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83238960|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
83238961|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
83238962|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
83238963|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
83238964|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238965|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83238966|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83238967|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
83238968|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83238969|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83238970|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
83238971|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83238972|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
83238973|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
83238974|NCT03551743|Edoxaban|edoxaban|mesh-list
83238975|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83238976|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
83238977|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83238978|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
83238979|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238980|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238981|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
83238982|NCT04654429|Ondansetron|ondansetron|mesh-list
83238983|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
83238984|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
83238985|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83238986|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83238987|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83238988|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
83238989|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
83238990|NCT04654429|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83238991|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83238992|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
83238993|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83238994|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83238995|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
83238996|NCT03111121|Neostigmine|neostigmine|mesh-list
83238997|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83238998|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83238999|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239000|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
83239001|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239002|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239003|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83239004|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
83239005|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239006|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83239007|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83239008|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83239009|NCT02328469|Doxycycline|doxycycline|mesh-list
83239010|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
83239011|NCT02328469|Acyclovir|acyclovir|mesh-list
83239012|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83239013|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239014|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
83239015|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83239016|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83239017|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
83239018|NCT04998071|Bupivacaine|bupivacaine|mesh-list
83239019|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239020|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
83239021|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239022|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239023|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
83239024|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239025|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83239026|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239027|NCT03073343|Betaine|betaine|mesh-list
83239028|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239029|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
83239030|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83239031|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
83239032|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239033|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83239034|NCT03073265|Apixaban|apixaban|mesh-list
83239035|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83239036|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
83239037|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83239038|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
83239039|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239040|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239041|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
83239042|NCT04997837|Capecitabine|capecitabine|mesh-list
83239043|NCT04997837|Tegafur|tegafur|mesh-list
83239044|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
83239045|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83239046|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83239047|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
83239048|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239049|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239050|NCT04997837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239051|NCT04202263|Minocycline|minocycline|mesh-list
83239053|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239054|NCT04996979|Ropivacaine|ropivacaine|mesh-list
83239055|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239056|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
83239057|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239058|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239059|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
83239060|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239061|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
83239062|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239063|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83239064|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239065|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239066|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
83239067|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239068|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239069|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83239070|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
83239071|NCT04997291|Razoxane|razoxane|mesh-list
83239072|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239073|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83239074|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83239075|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83239076|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239077|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239078|NCT04997291|Protective Agents|protective agents|mesh-ancestor
83239079|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239080|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83239081|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83239082|NCT02328079|Acyclovir|acyclovir|mesh-list
83239083|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
83239084|NCT02328079|Prednisolone|prednisolone|mesh-list
83239085|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83239086|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
83239087|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83239088|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
83239089|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83239090|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
83239091|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239092|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
83239093|NCT02328079|Hormones|hormones|mesh-ancestor
83239094|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239095|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239096|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83239097|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239098|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
83239099|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
83239100|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239101|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239102|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83239104|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239105|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
83239106|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83239107|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83239108|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
83239109|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239110|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239111|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239112|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
83239113|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
83239114|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239115|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
83239116|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83239117|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
83239118|NCT02578069|Sirolimus|sirolimus|mesh-list
83239119|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83239120|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239121|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83239122|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239123|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
83239124|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239125|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
83239126|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239127|NCT03074825|Chiauranib|chiauranib|mesh-list
83239128|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239129|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83239130|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239131|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239132|NCT03072485|Metformin|metformin|mesh-list
83239133|NCT03072485|Sirolimus|sirolimus|mesh-list
83239134|NCT03072485|Diclofenac|diclofenac|mesh-list
83239135|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83239136|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239137|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83239138|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239139|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83239140|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239141|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
83239142|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239143|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
83239144|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239145|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239146|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83239147|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239148|NCT03072485|Analgesics|analgesics|mesh-ancestor
83239149|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
83239150|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239151|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239152|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239153|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83239154|NCT05080543|Terlipressin|terlipressin|mesh-list
83239155|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83239156|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83239157|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
83239158|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83239159|NCT03074591|Hematinics|hematinics|mesh-ancestor
83239160|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
83239161|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83239162|NCT03111433|Ubiquinone|ubiquinone|mesh-list
83239163|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
83239164|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239165|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
83239166|NCT03111433|Vitamins|vitamins|mesh-ancestor
83239167|NCT03143023|Fluorides|fluorides|mesh-list
83239168|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
83239169|NCT03143023|Protective Agents|protective agents|mesh-ancestor
83239170|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239171|NCT03074435|Ivermectin|ivermectin|mesh-list
83239172|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83239173|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239174|NCT03142789|Cerivastatin|cerivastatin|mesh-list
83239175|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83239176|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83239177|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83239178|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
83239179|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239180|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239181|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83239182|NCT03072329|Bupivacaine|bupivacaine|mesh-list
83239183|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239184|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
83239185|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239186|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239187|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
83239188|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239189|NCT02327689|Emtricitabine|emtricitabine|mesh-list
83239190|NCT02327689|Adefovir|adefovir|mesh-list
83239191|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83239192|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
83239193|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239194|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83239195|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83239196|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239197|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239198|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83239199|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83239200|NCT02327923|Ketorolac|ketorolac|mesh-list
83239201|NCT02327923|Lidocaine|lidocaine|mesh-list
83239202|NCT02327923|Atropine|atropine|mesh-list
83239203|NCT02327923|Ephedrine|ephedrine|mesh-list
83239204|NCT02327923|Fentanyl|fentanyl|mesh-list
83239205|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
83239206|NCT02327923|Morphine|morphine|mesh-list
83239207|NCT02327923|Tramadol|tramadol|mesh-list
83239208|NCT02327923|Ondansetron|ondansetron|mesh-list
83239209|NCT02327923|Bupivacaine|bupivacaine|mesh-list
83239210|NCT02327923|Propofol|propofol|mesh-list
83239211|NCT02327923|Neostigmine|neostigmine|mesh-list
83239212|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
83239213|NCT02327923|Esmolol|esmolol|mesh-list
83239214|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239215|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
83239216|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239217|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239218|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
83239219|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239220|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239221|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83239222|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83239223|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239224|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239225|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83239226|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83239227|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
83239228|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83239229|NCT02327923|Narcotics|narcotics|mesh-ancestor
83239230|NCT02327923|Analgesics|analgesics|mesh-ancestor
83239231|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83239232|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239233|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
83239234|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
83239235|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239236|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
83239237|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
83239238|NCT02327923|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83239239|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83239240|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
83239241|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239242|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83239243|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239244|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239245|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83239246|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239247|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83239248|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83239249|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
83239250|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
83239251|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
83239252|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83239253|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83239254|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
83239255|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83239256|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83239257|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83239258|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83239259|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83239260|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
83239261|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83239262|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
83239263|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83239264|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83239265|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83239266|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83239267|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83239268|NCT04991207|Bosentan|bosentan|mesh-list
83239269|NCT04991207|Zamicastat|zamicastat|mesh-list
83239270|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83239271|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83239272|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239273|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239274|NCT03072173|Xylometazoline|xylometazoline|mesh-list
83239275|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
83239276|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83239277|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
83239278|NCT03074123|Cosyntropin|cosyntropin|mesh-list
83239279|NCT03074123|Hormones|hormones|mesh-ancestor
83239280|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239281|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239282|NCT02327299|Fesoterodine|fesoterodine|mesh-list
83239283|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83239284|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83239285|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
83239286|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239287|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239288|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239289|NCT02327299|Urological Agents|urological agents|mesh-ancestor
83239290|NCT03494569|Fludarabine|fludarabine|mesh-list
83239291|NCT03494569|Melphalan|melphalan|mesh-list
83239292|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
83239293|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83239295|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239296|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239297|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
83239298|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239299|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83239300|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
83239301|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83239302|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
83239303|NCT03071549|Salicylates|salicylates|mesh-list
83239304|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239305|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
83239306|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
83239307|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
83239308|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83239309|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239310|NCT03071549|Analgesics|analgesics|mesh-ancestor
83239311|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
83239312|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239313|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239314|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239315|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239316|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83239317|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239318|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239319|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
83239320|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83239321|NCT04994951|Triamcinolone|triamcinolone|mesh-list
83239322|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83239323|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83239324|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83239325|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239326|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
83239327|NCT04994951|Hormones|hormones|mesh-ancestor
83239328|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239329|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239330|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239331|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
83239332|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239333|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239334|NCT03073889|Ropivacaine|ropivacaine|mesh-list
83239335|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239336|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
83239337|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239338|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239339|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
83239340|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239341|NCT03071705|Metformin|metformin|mesh-list
83239342|NCT03071705|Gefitinib|gefitinib|mesh-list
83239343|NCT03071705|Afatinib|afatinib|mesh-list
83239344|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83239345|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239346|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239347|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83239348|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239349|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239350|NCT03351439|Celecoxib|celecoxib|mesh-list
83239351|NCT03351439|Naproxen|naproxen|mesh-list
83239352|NCT03351439|Gabapentin|gabapentin|mesh-list
83239353|NCT03351439|Zopiclone|zopiclone|mesh-list
83239354|NCT03351439|Analgesics|analgesics|mesh-ancestor
83239355|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
83239356|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239357|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239358|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
83239359|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83239360|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83239361|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239362|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83239363|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83239364|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83239365|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239366|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239367|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
83239368|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83239369|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239370|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239371|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239372|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83239373|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83239374|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239375|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
83239376|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83239377|NCT03139747|Everolimus|everolimus|mesh-list
83239378|NCT03139747|Lenvatinib|lenvatinib|mesh-list
83239379|NCT03139747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83239380|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83239381|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239382|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239383|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239384|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
83239385|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239386|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239387|NCT02037919|Etonogestrel|etonogestrel|mesh-list
83239388|NCT02037919|Desogestrel|desogestrel|mesh-list
83239389|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83239390|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
83239391|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83239392|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239393|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83239394|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83239395|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83239396|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83239397|NCT02037919|Progestins|progestins|mesh-ancestor
83239398|NCT02037919|Hormones|hormones|mesh-ancestor
83239399|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239400|NCT03139591|Dexamethasone|dexamethasone|mesh-list
83239401|NCT03139591|Lidocaine|lidocaine|mesh-list
83239402|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239403|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
83239404|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
83239405|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239406|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239407|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239408|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
83239409|NCT03139591|Hormones|hormones|mesh-ancestor
83239410|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239411|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83239412|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239413|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239414|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
83239415|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239416|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
83239417|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239418|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83239419|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83239420|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239421|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239422|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83239423|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83239424|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239425|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239426|NCT03139513|Vemurafenib|vemurafenib|mesh-list
83239427|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239428|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83239429|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239430|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239431|NCT04986995|Opicapone|opicapone|mesh-list
83239432|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83239433|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239434|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239435|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83239436|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83239437|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83239438|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83239439|NCT03971929|Diuretics|diuretics|mesh-ancestor
83239440|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
83239441|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239442|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83239443|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239444|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239445|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
83239446|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83239447|NCT04986371|Niraparib|niraparib|mesh-list
83239448|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83239449|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239450|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239451|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239452|NCT04988945|Durvalumab|durvalumab|mesh-list
83239453|NCT04988945|Tremelimumab|tremelimumab|mesh-list
83239454|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239455|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239456|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
83239457|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83239458|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83239459|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239460|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
83239461|NCT03070847|Coagulants|coagulants|mesh-ancestor
83239462|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
83239463|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83239464|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83239465|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83239466|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239467|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239468|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
83239469|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239470|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239471|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83239472|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239473|NCT04989257|Clopidogrel|clopidogrel|mesh-list
83239474|NCT04989257|Ticagrelor|ticagrelor|mesh-list
83239475|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83239476|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83239477|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83239478|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83239479|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
83239480|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430118|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83239481|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239482|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239484|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
83239485|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83239486|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239487|NCT03140449|Calcitriol|calcitriol|mesh-list
83239488|NCT03140449|Sirolimus|sirolimus|mesh-list
83239489|NCT03140449|Temsirolimus|temsirolimus|mesh-list
83239490|NCT03140449|MTOR Inhibitors|mtor inhibitors|mesh-list
83239491|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83239492|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239493|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83239494|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239495|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
83239496|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239497|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
83239498|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239499|NCT03140449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83239500|NCT03140449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239501|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239502|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83239503|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83239504|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239505|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83239506|NCT03140449|Vitamins|vitamins|mesh-ancestor
83239507|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
83239508|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83239509|NCT02659813|Copper|copper|mesh-list
83239510|NCT02659813|Nickel|nickel|mesh-list
83239511|NCT02659813|Trace Elements|trace elements|mesh-ancestor
83239512|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
83239513|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239514|NCT04985435|Adalimumab|adalimumab|mesh-list
83239515|NCT04985435|Etanercept|etanercept|mesh-list
83239516|NCT04985435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83239517|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239518|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239519|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83239520|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239521|NCT04985435|Analgesics|analgesics|mesh-ancestor
83239522|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
83239523|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239524|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239525|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239526|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239527|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
83239528|NCT05084365|Sulforaphane|sulforaphane|mesh-list
83239529|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83239530|NCT05084365|Protective Agents|protective agents|mesh-ancestor
83239531|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239532|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239533|NCT03070613|Lectins|lectins|mesh-list
83239534|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
83239535|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
83239536|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239537|NCT03070613|Coagulants|coagulants|mesh-ancestor
83239538|NCT03441139|Analgesics|analgesics|mesh-list
83239539|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
83239540|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239541|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239542|NCT04988789|Paclitaxel|paclitaxel|mesh-list
83239543|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83239544|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239545|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
83239546|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
83239547|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
83239548|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239550|NCT04985669|Laxatives|laxatives|mesh-ancestor
83239551|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239552|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83239553|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83239554|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
83239555|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239556|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239557|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239558|NCT04753957|Progesterone|progesterone|mesh-list
83239559|NCT04753957|Progestins|progestins|mesh-ancestor
83239560|NCT04753957|Hormones|hormones|mesh-ancestor
83239561|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239562|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239563|NCT03070379|Lidocaine|lidocaine|mesh-list
83239564|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239565|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
83239566|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239567|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239568|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
83239569|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239570|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239571|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83239572|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83239573|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239574|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239575|NCT03227263|Bevacizumab|bevacizumab|mesh-list
83239576|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239577|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239578|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83239579|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83239580|NCT03227263|Growth Substances|growth substances|mesh-ancestor
83239581|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239582|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
83239583|NCT04985201|Irinotecan|irinotecan|mesh-list
83239584|NCT04985201|Simvastatin|simvastatin|mesh-list
83239585|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83239586|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83239587|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239588|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239589|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239590|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83239591|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83239592|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
83239593|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83239594|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83239595|NCT02031601|Carboplatin|carboplatin|mesh-list
83239597|NCT02031601|Pemetrexed|pemetrexed|mesh-list
83239598|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83239599|NCT02031601|Gefitinib|gefitinib|mesh-list
83239600|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239601|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
83239602|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
83239603|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
83239604|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239605|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239606|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83239607|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83239608|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83239609|NCT04984577|Edaravone|edaravone|mesh-list
83239610|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83239611|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
83239612|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239613|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83239614|NCT04984577|Protective Agents|protective agents|mesh-ancestor
83239615|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239616|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
83239617|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83239618|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83239619|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
83239620|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239621|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239622|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83239623|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
83239624|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
83239625|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83239626|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
83239627|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239628|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239629|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83239630|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83239631|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83239632|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
83239633|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83239634|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83239635|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83239636|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
83239637|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239638|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83239639|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83239640|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239641|NCT03068429|Sertraline|sertraline|mesh-list
83239642|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
83239643|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83239644|NCT03068429|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83239645|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83239646|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239647|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239648|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239649|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
83239650|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239651|NCT03068351|Daratumumab|daratumumab|mesh-list
83239652|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239653|NCT03140293|Lidocaine|lidocaine|mesh-list
83239654|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
83239655|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239656|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
83239657|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239658|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239659|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
83239660|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239661|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239662|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83239663|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83239664|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239665|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239666|NCT04982861|Cefixime|cefixime|mesh-list
83239667|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83239668|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239669|NCT04572217|Topiramate|topiramate|mesh-list
83239670|NCT04572217|Phentermine|phentermine|mesh-list
83239671|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
83239672|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83239673|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239674|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83239675|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
83239676|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83239677|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
83239678|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
83239679|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239680|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
83239681|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239682|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239683|NCT05635955|Propofol|propofol|mesh-list
83239684|NCT05635955|Esketamine|esketamine|mesh-list
83239685|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83239686|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239687|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239688|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83239689|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
83239690|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
83239691|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
83239692|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83239693|NCT04452461|Leucovorin|leucovorin|mesh-list
83239694|NCT04452461|Paclitaxel|paclitaxel|mesh-list
83239695|NCT04452461|Gemcitabine|gemcitabine|mesh-list
83239696|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
83239697|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83239698|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239699|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
83239700|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
83239701|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
83239702|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239703|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83239704|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
83239705|NCT04452461|Antidotes|antidotes|mesh-ancestor
83239706|NCT04452461|Protective Agents|protective agents|mesh-ancestor
83239707|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239708|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
83239709|NCT04452461|Vitamins|vitamins|mesh-ancestor
83239710|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
83239711|NCT03137017|Acetaminophen|acetaminophen|mesh-list
83239712|NCT03137017|Hydrocodone|hydrocodone|mesh-list
83239713|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239714|NCT03137017|Analgesics|analgesics|mesh-ancestor
83239715|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
83239716|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239717|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239718|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
83239719|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83239720|NCT03137017|Narcotics|narcotics|mesh-ancestor
83239721|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239722|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
83239723|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
83239724|NCT03019003|Durvalumab|durvalumab|mesh-list
83239725|NCT03019003|Decitabine|decitabine|mesh-list
83239726|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239727|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239728|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83239729|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
83239730|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239731|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239732|NCT03013933|Cyclosporine|cyclosporine|mesh-list
83239733|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83239734|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83239735|NCT03013933|Verapamil|verapamil|mesh-list
83239736|NCT03013933|Antibodies|antibodies|mesh-list
83239737|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
83239738|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83239740|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
83239741|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
83239742|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239743|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239744|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239745|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239746|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239747|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
83239748|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239749|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
83239750|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239751|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83239752|NCT03013933|Immunotoxins|immunotoxins|mesh-ancestor
83239753|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239754|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83239755|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239756|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83239757|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
83239758|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83239759|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83239760|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239761|NCT04262479|Vitamin D|vitamin d|mesh-list
83239762|NCT04262479|Vitamins|vitamins|mesh-ancestor
83239763|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
83239764|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239765|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83239766|NCT04133311|Latanoprost|latanoprost|mesh-list
83239767|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83239768|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83239769|NCT03217825|Losartan|losartan|mesh-list
83239770|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239771|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83239772|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83239773|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83239774|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239775|NCT04035187|Itraconazole|itraconazole|mesh-list
83239776|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83239777|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83239778|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
83239779|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239780|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83239781|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83239782|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239783|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239784|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83239785|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
83239786|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239787|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239788|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83239789|NCT00157963|Losartan|losartan|mesh-list
83239790|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83239791|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239792|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83239793|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83239794|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83239795|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239796|NCT00157963|Diuretics|diuretics|mesh-ancestor
83239797|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
83239798|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239799|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83239800|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239801|NCT05087797|Nicorandil|nicorandil|mesh-list
83239802|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239803|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83239804|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
83239805|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
83239806|NCT05087797|Vitamins|vitamins|mesh-ancestor
83239807|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
83239808|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239809|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
83239810|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83239811|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
83239812|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239813|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
83239814|NCT03906877|Protective Agents|protective agents|mesh-ancestor
83239815|NCT03867799|Nivolumab|nivolumab|mesh-list
83239816|NCT03867799|Relatlimab|relatlimab|mesh-list
83239817|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239818|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239819|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83239820|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239821|NCT05086081|Ticagrelor|ticagrelor|mesh-list
83239822|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83239823|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83239824|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83239825|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83239826|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83239827|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
83239828|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239829|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239830|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239831|NCT04873297|Metoclopramide|metoclopramide|mesh-list
83239832|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
83239833|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
83239834|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239835|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239836|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239837|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83239838|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83239839|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
83239840|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239841|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239842|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
83239843|NCT05634473|Miotics|miotics|mesh-ancestor
83239844|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
83239845|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239846|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239847|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83239848|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83239849|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
83239850|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83239851|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83239852|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
83239853|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239854|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239855|NCT03138499|Nivolumab|nivolumab|mesh-list
83239856|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83239857|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239858|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239859|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83239860|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239861|NCT03138499|Immunotoxins|immunotoxins|mesh-ancestor
83239862|NCT03138499|Immunoconjugates|immunoconjugates|mesh-ancestor
83239863|NCT03138499|Immunologic Factors|immunologic factors|mesh-ancestor
83239864|NCT03138499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239865|NCT04858711|Lidocaine|lidocaine|mesh-list
83239866|NCT04858711|Fentanyl|fentanyl|mesh-list
83239867|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
83239868|NCT04858711|Ketamine|ketamine|mesh-list
83239869|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
83239870|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
83239871|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239872|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239873|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
83239874|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239875|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83239876|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83239877|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83239878|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83239879|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239880|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83239881|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239882|NCT04858711|Analgesics|analgesics|mesh-ancestor
83239883|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83239884|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83239885|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83239886|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
83239887|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239888|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83239889|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83239890|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
83239891|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83239892|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83239893|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83239894|NCT04858711|Narcotics|narcotics|mesh-ancestor
83239895|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83239896|NCT03068975|Alvimopan|alvimopan|mesh-list
83239897|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83239898|NCT02034331|Acetylcholine|acetylcholine|mesh-list
83239899|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239900|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
83239901|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83239902|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
83239903|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239904|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239905|NCT03067883|Ritonavir|ritonavir|mesh-list
83239906|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83239907|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83239908|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
83239909|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239910|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239911|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83239912|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83239913|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
83239914|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83239915|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83239916|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83239917|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83239918|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83239919|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83239920|NCT02936843|Analgesics|analgesics|mesh-ancestor
83239921|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
83239922|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239923|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239924|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239925|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83239926|NCT03285763|Atezolizumab|atezolizumab|mesh-list
83239927|NCT03285763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83239928|NCT03285763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239929|NCT03285763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239930|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239931|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83239932|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83239933|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239934|NCT04705727|Budesonide|budesonide|mesh-list
83239935|NCT04705727|Terbutaline|terbutaline|mesh-list
83239936|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
83239937|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83239938|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239939|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83239940|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
83239941|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83239942|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239943|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83239944|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
83239945|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
83239946|NCT04705727|Hormones|hormones|mesh-ancestor
83239947|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239948|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83239949|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83239950|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83239951|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
83239952|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83239953|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239954|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
83239955|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
83239956|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83239957|NCT03085771|Deferoxamine|deferoxamine|mesh-list
83239958|NCT03085771|Siderophores|siderophores|mesh-ancestor
83239959|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83239960|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
83239961|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
83239962|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239963|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83239964|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83239965|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239966|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
83239967|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239968|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239969|NCT04659629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83239970|NCT04659629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239971|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
83239972|NCT02998567|Guadecitabine|guadecitabine|mesh-list
83239973|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239974|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239975|NCT02998567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83239976|NCT02998567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239977|NCT02985619|Triamcinolone|triamcinolone|mesh-list
83239978|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83239979|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83239980|NCT02985619|Bevacizumab|bevacizumab|mesh-list
83239981|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83239982|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83239983|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83239984|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83239985|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83239986|NCT02985619|Growth Substances|growth substances|mesh-ancestor
83239987|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83239988|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
83239989|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83239990|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
83239991|NCT02985619|Hormones|hormones|mesh-ancestor
83239992|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83239993|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83239994|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
83239995|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83239996|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83239997|NCT03110653|Remifentanil|remifentanil|mesh-list
83239998|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83239999|NCT03110653|Narcotics|narcotics|mesh-ancestor
83240000|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240001|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240002|NCT03110653|Analgesics|analgesics|mesh-ancestor
83240003|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
83240004|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240005|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
83240006|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240007|NCT02037529|Paclitaxel|paclitaxel|mesh-list
83240008|NCT02037529|Halichondrin B|halichondrin b|mesh-list
83240009|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83240010|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240011|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240012|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240013|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240014|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240015|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240016|NCT04450199|Vitamin D|vitamin d|mesh-list
83240017|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
83240018|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
83240019|NCT04450199|Vitamins|vitamins|mesh-list
83240020|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
83240021|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240022|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83240023|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83240024|NCT01884259|Docetaxel|docetaxel|mesh-list
83240025|NCT01884259|Fluorouracil|fluorouracil|mesh-list
83240026|NCT01884259|Cetuximab|cetuximab|mesh-list
83240027|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240028|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240029|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240030|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240031|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240032|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
83240033|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83240034|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83240035|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
83240036|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240037|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240038|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
83240039|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83240040|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240041|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83240042|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240043|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
83240044|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83240045|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
83240046|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83240047|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83240048|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240049|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83240050|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240051|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83240052|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240053|NCT03067727|Dinoprostone|dinoprostone|mesh-list
83240054|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
83240055|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83240056|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240057|NCT01794793|Cabergoline|cabergoline|mesh-list
83240058|NCT01794793|Pasireotide|pasireotide|mesh-list
83240059|NCT01794793|Somatostatin|somatostatin|mesh-list
83240060|NCT01794793|Hormones|hormones|mesh-ancestor
83240061|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240062|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240063|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83240064|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83240065|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
83240066|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
83240067|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240068|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240069|NCT03067103|Ketamine|ketamine|mesh-list
83240070|NCT03067103|Tramadol|tramadol|mesh-list
83240071|NCT03067103|Analgesics|analgesics|mesh-ancestor
83240072|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
83240073|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240074|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240075|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83240076|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83240077|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
83240078|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
83240079|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240080|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83240081|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83240082|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240083|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240084|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83240085|NCT03067103|Narcotics|narcotics|mesh-ancestor
83240086|NCT05492123|Cisplatin|cisplatin|mesh-list
83240087|NCT05492123|Nivolumab|nivolumab|mesh-list
83240088|NCT05492123|Ipilimumab|ipilimumab|mesh-list
83240089|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240090|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240091|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83240092|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240093|NCT01398319|Ethanol|ethanol|mesh-list
83240094|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83240095|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240096|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240097|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240098|NCT01305889|Sertraline|sertraline|mesh-list
83240099|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
83240100|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83240101|NCT01305889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83240102|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83240103|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240104|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240105|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240106|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
83240107|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240108|NCT05392075|Vaccines|vaccines|mesh-list
83240109|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
83240110|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240111|NCT00223171|Androgens|androgens|mesh-list
83240112|NCT00223171|Hormones|hormones|mesh-ancestor
83240113|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240114|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240115|NCT03138031|Ethanol|ethanol|mesh-list
83240116|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83240117|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240118|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240119|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240120|NCT02735057|Paclitaxel|paclitaxel|mesh-list
83240121|NCT02735057|Carboplatin|carboplatin|mesh-list
83240122|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240123|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240124|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240125|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240126|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240127|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240128|NCT05431283|Tofacitinib|tofacitinib|mesh-list
83240129|NCT05431283|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83240130|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83240131|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240132|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240133|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
83240134|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83240135|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
83240136|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83240137|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240138|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83240139|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
83240140|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240141|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
83240142|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240143|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240144|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83240145|NCT03630835|Annexin A5|annexin a5|mesh-list
83240146|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240147|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240149|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83240150|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240151|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83240152|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240153|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
83240154|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83240155|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83240156|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240157|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
83240158|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
83240159|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240160|NCT05391451|Anesthetics|anesthetics|mesh-list
83240161|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240162|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240163|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
83240164|NCT03110341|Hematinics|hematinics|mesh-ancestor
83240165|NCT04648189|Cetuximab|cetuximab|mesh-list
83240166|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240167|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240168|NCT04537897|Midazolam|midazolam|mesh-list
83240169|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83240170|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83240171|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240172|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240173|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83240174|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83240175|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83240176|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83240177|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
83240178|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
83240179|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
83240180|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
83240181|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240182|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240183|NCT04405063|Paclitaxel|paclitaxel|mesh-list
83240184|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240185|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240186|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240187|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240188|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240189|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240190|NCT05090449|Losartan|losartan|mesh-list
83240191|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
83240192|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83240193|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83240194|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83240195|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83240196|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240197|NCT05090449|Diuretics|diuretics|mesh-ancestor
83240198|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
83240199|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240200|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83240201|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240203|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
83240204|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240205|NCT03067415|Latanoprost|latanoprost|mesh-list
83240206|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83240207|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83240208|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
83240209|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83240210|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
83240211|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240212|NCT05089981|Expectorants|expectorants|mesh-ancestor
83240213|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
83240214|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83240215|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
83240216|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240217|NCT05089981|Protective Agents|protective agents|mesh-ancestor
83240218|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240219|NCT05089981|Antidotes|antidotes|mesh-ancestor
83240220|NCT04271189|Metformin|metformin|mesh-list
83240221|NCT04271189|Pioglitazone|pioglitazone|mesh-list
83240222|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83240223|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83240224|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240225|NCT04271189|Incretins|incretins|mesh-ancestor
83240226|NCT04271189|Hormones|hormones|mesh-ancestor
83240227|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240228|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83240229|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
83240230|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240231|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240232|NCT05730413|Bisoprolol|bisoprolol|mesh-list
83240233|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83240234|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
83240235|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
83240236|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240237|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240238|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83240239|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83240240|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83240241|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
83240242|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240243|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240244|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
83240245|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83240246|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240247|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240248|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83240249|NCT04206059|Analgesics|analgesics|mesh-ancestor
83240250|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
83240251|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240252|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83240253|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83240254|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83240255|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
83240256|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240257|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240258|NCT05431049|Anesthetics|anesthetics|mesh-list
83240259|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240260|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240261|NCT04132817|Paclitaxel|paclitaxel|mesh-list
83240262|NCT04132817|Nivolumab|nivolumab|mesh-list
83240263|NCT04132817|Ipilimumab|ipilimumab|mesh-list
83240264|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240265|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240266|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240267|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240268|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240269|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240270|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240271|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83240272|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
83240273|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83240274|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83240275|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83240276|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240277|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240278|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
83240279|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240280|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240281|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83240282|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240283|NCT03136237|Cyclosporine|cyclosporine|mesh-list
83240284|NCT03136237|Digoxin|digoxin|mesh-list
83240285|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83240286|NCT03136237|Cyclosporins|cyclosporins|mesh-list
83240287|NCT03136237|Berotralstat|berotralstat|mesh-list
83240288|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240289|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240290|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83240291|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
83240292|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240293|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
83240294|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240295|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
83240296|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240297|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83240298|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83240299|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83240300|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
83240301|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83240302|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83240303|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83240304|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83240305|NCT03136237|Protective Agents|protective agents|mesh-ancestor
83240306|NCT03136237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83240307|NCT03136237|Protease Inhibitors|protease inhibitors|mesh-ancestor
83240308|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
83240309|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83240310|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
83240311|NCT04021381|Cathartics|cathartics|mesh-ancestor
83240312|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83240313|NCT03066791|Curcumin|curcumin|mesh-list
83240314|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83240315|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83240316|NCT03066791|Analgesics|analgesics|mesh-ancestor
83240317|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
83240318|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240319|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240320|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240321|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240322|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240323|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240324|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240325|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
83240326|NCT05729555|Promethazine|promethazine|mesh-list
83240327|NCT05729555|Ibuprofen|ibuprofen|mesh-list
83240328|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83240329|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83240330|NCT05729555|Analgesics|analgesics|mesh-ancestor
83240331|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
83240332|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240333|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240334|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240335|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240336|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83240337|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240338|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240339|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83240340|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83240341|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240342|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
83240343|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
83240344|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
83240345|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
83240346|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83240347|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83240348|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
83240349|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
83240350|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240351|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83240352|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
83240353|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
83240354|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83240355|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83240356|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240357|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240358|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83240359|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240360|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240361|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
83240362|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240363|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83240364|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83240365|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83240366|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83240367|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
83240368|NCT03136003|Coagulants|coagulants|mesh-ancestor
83240369|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83240370|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
83240371|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240372|NCT04945213|Biperiden|biperiden|mesh-list
83240373|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83240374|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83240375|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
83240376|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
83240377|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240378|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240379|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83240380|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83240381|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
83240382|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240383|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240384|NCT05410847|Paclitaxel|paclitaxel|mesh-list
83240385|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240386|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240387|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240388|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240389|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240390|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240391|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
83240392|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83240393|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83240394|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83240395|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240396|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240397|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
83240398|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240399|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240400|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83240401|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240402|NCT03726749|Prednisone|prednisone|mesh-list
83240403|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
83240404|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240405|NCT03726749|Hormones|hormones|mesh-ancestor
83240406|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240407|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240408|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83240409|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240410|NCT03821077|Immunomodulating Agents|immunomodulating agents|mesh-list
83240411|NCT03821077|Immunologic Factors|immunologic factors|mesh-ancestor
83240412|NCT03821077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240413|NCT03136705|Niacinamide|niacinamide|mesh-list
83240415|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
83240416|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
83240417|NCT03136705|Vitamins|vitamins|mesh-ancestor
83240418|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
83240419|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240420|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83240421|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
83240422|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240423|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83240424|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
83240425|NCT04540861|Siponimod|siponimod|mesh-list
83240426|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83240427|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240428|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83240429|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
83240430|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240431|NCT03066557|Apatinib|apatinib|mesh-list
83240432|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
83240433|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240434|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83240436|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240437|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83240438|NCT03066557|Estrogens|estrogens|mesh-ancestor
83240439|NCT03066557|Hormones|hormones|mesh-ancestor
83240440|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240441|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240442|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83240443|NCT05728619|Temozolomide|temozolomide|mesh-list
83240444|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83240445|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
83240446|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240447|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240448|NCT05737303|Paclitaxel|paclitaxel|mesh-list
83240449|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83240450|NCT05737303|Carboplatin|carboplatin|mesh-list
83240451|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240452|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240453|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240454|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240455|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240456|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240457|NCT03066089|Fenugreek seed meal|fenugreek seed meal|mesh-list
83240458|NCT03066089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83240459|NCT03066089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240460|NCT05188313|Paclitaxel|paclitaxel|mesh-list
83240461|NCT05188313|Carboplatin|carboplatin|mesh-list
83240462|NCT05188313|Trastuzumab|trastuzumab|mesh-list
83240463|NCT05188313|Pertuzumab|pertuzumab|mesh-list
83240464|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240465|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240466|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240467|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240468|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240469|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240470|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240471|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83240472|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240473|NCT03066011|Voriconazole|voriconazole|mesh-list
83240474|NCT03066011|Posaconazole|posaconazole|mesh-list
83240475|NCT03066011|Isavuconazole|isavuconazole|mesh-list
83240476|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
83240477|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240478|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83240479|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83240480|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240481|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240482|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83240483|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
83240484|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240485|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240486|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83240487|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83240488|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83240489|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83240490|NCT03135769|Avelumab|avelumab|mesh-list
83240491|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240492|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240493|NCT03123211|Veliparib|veliparib|mesh-list
83240494|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83240495|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240496|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240497|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240498|NCT05520749|Luspatercept|luspatercept|mesh-list
83240499|NCT05520749|Hematinics|hematinics|mesh-ancestor
83240500|NCT03073525|Atezolizumab|atezolizumab|mesh-list
83240501|NCT03073525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83240502|NCT03073525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240503|NCT03073525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240504|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240505|NCT02563015|Vitamin D|vitamin d|mesh-list
83240506|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
83240507|NCT02563015|Vitamins|vitamins|mesh-ancestor
83240508|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
83240509|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240510|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83240511|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83240512|NCT02382445|Anesthetics|anesthetics|mesh-list
83240513|NCT02382445|Propofol|propofol|mesh-list
83240514|NCT02382445|Sevoflurane|sevoflurane|mesh-list
83240515|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240516|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240517|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83240518|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83240519|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
83240520|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83240521|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83240522|NCT05736757|Plasminogen|plasminogen|mesh-list
83240523|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83240524|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83240525|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83240526|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240527|NCT04483739|Dexamethasone|dexamethasone|mesh-list
83240528|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
83240529|NCT04483739|Lenalidomide|lenalidomide|mesh-list
83240530|NCT04483739|BB 1101|bb 1101|mesh-list
83240531|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240532|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
83240533|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
83240534|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240535|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240536|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83240537|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
83240538|NCT04483739|Hormones|hormones|mesh-ancestor
83240539|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240540|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83240541|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240542|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
83240543|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240544|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240545|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
83240546|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83240547|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83240548|NCT04483739|Growth Substances|growth substances|mesh-ancestor
83240549|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
83240550|NCT05727475|Fluorides|fluorides|mesh-list
83240551|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
83240552|NCT05727475|Protective Agents|protective agents|mesh-ancestor
83240553|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240554|NCT05091775|Mesalamine|mesalamine|mesh-list
83240555|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83240556|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83240558|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
83240559|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240560|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240561|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240562|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240563|NCT04821869|Albuterol|albuterol|mesh-list
83240564|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83240566|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240567|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240568|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83240569|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
83240570|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83240571|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83240572|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83240573|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
83240574|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240575|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240576|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
83240577|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83240578|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
83240579|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83240580|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
83240581|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240582|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
83240583|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83240584|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240585|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
83240586|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83240587|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83240588|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83240589|NCT02631551|Analgesics|analgesics|mesh-ancestor
83240590|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
83240591|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240592|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240593|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240594|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83240595|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83240596|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
83240597|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
83240598|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240599|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240600|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
83240601|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83240602|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240603|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240604|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83240605|NCT05091151|Analgesics|analgesics|mesh-ancestor
83240606|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
83240607|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240608|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83240609|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83240610|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83240611|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
83240612|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240613|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240614|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83240615|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83240616|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83240617|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240618|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240619|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
83240620|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240621|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240622|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83240623|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240624|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
83240625|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240626|NCT04447235|Ivermectin|ivermectin|mesh-list
83240627|NCT04447235|Losartan|losartan|mesh-list
83240628|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83240629|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83240630|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83240631|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83240632|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240633|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83240634|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240635|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
83240636|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240637|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240638|NCT01700569|Leucovorin|leucovorin|mesh-list
83240639|NCT01700569|Folic Acid|folic acid|mesh-list
83240640|NCT01700569|Temozolomide|temozolomide|mesh-list
83240641|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
83240642|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240643|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83240644|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
83240645|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240646|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240647|NCT01700569|Antidotes|antidotes|mesh-ancestor
83240648|NCT01700569|Protective Agents|protective agents|mesh-ancestor
83240649|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
83240650|NCT01700569|Vitamins|vitamins|mesh-ancestor
83240651|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
83240652|NCT01700569|Hematinics|hematinics|mesh-ancestor
83240653|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
83240654|NCT05090761|Buprenorphine|buprenorphine|mesh-list
83240655|NCT05090761|Bupivacaine|bupivacaine|mesh-list
83240656|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83240657|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
83240658|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
83240659|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240660|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240661|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
83240662|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240663|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83240664|NCT05090761|Narcotics|narcotics|mesh-ancestor
83240665|NCT05090761|Analgesics|analgesics|mesh-ancestor
83240666|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83240667|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83240668|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
83240669|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83240670|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240671|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240672|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83240673|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
83240674|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83240675|NCT03065309|Remifentanil|remifentanil|mesh-list
83240676|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83240677|NCT03065309|Narcotics|narcotics|mesh-ancestor
83240678|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240679|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240680|NCT03065309|Analgesics|analgesics|mesh-ancestor
83240681|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
83240682|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240683|NCT02819479|Bevacizumab|bevacizumab|mesh-list
83240685|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240686|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240687|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83240688|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83240689|NCT02819479|Growth Substances|growth substances|mesh-ancestor
83240690|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240691|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
83240692|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83240693|NCT02819479|Diuretics|diuretics|mesh-ancestor
83240694|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
83240695|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
83240696|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240697|NCT04074785|Bevacizumab|bevacizumab|mesh-list
83240698|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240699|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240700|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83240701|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83240702|NCT04074785|Growth Substances|growth substances|mesh-ancestor
83240703|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240704|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
83240705|NCT04533841|Propranolol|propranolol|mesh-list
83240706|NCT04533841|Misoprostol|misoprostol|mesh-list
83240707|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83240708|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
83240709|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83240710|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240711|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83240712|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83240713|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
83240714|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83240715|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83240716|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
83240717|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240718|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240719|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83240720|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83240721|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
83240722|NCT04536805|Metformin|metformin|mesh-list
83240723|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83240724|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240725|NCT05376865|Vitamin D|vitamin d|mesh-list
83240726|NCT05376865|Vitamins|vitamins|mesh-ancestor
83240727|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
83240728|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240729|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83240730|NCT04064411|Abaloparatide|abaloparatide|mesh-list
83240731|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
83240732|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83240733|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240734|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83240735|NCT04012931|Rilpivirine|rilpivirine|mesh-list
83240736|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83240737|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83240738|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240739|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240740|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
83240741|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240742|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83240743|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83240744|NCT03063359|Fentanyl|fentanyl|mesh-list
83240745|NCT03063359|Morphine|morphine|mesh-list
83240746|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83240747|NCT03063359|Narcotics|narcotics|mesh-ancestor
83240748|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240749|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240750|NCT03063359|Analgesics|analgesics|mesh-ancestor
83240751|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
83240752|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240753|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83240754|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83240755|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
83240756|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
83240757|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
83240758|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
83240759|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83240760|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83240761|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83240762|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83240763|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240764|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
83240765|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240766|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240767|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83240768|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240769|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
83240770|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
83240771|NCT02660359|Coagulants|coagulants|mesh-ancestor
83240772|NCT04901299|Fulvestrant|fulvestrant|mesh-list
83240773|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83240774|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240775|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83240776|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83240777|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413586|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240778|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240779|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240780|NCT05067985|Anesthetics|anesthetics|mesh-list
83240781|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240782|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240784|NCT04262869|Carboplatin|carboplatin|mesh-list
83240785|NCT04262869|Pemetrexed|pemetrexed|mesh-list
83240786|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83240787|NCT04262869|Durvalumab|durvalumab|mesh-list
83240788|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
83240789|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83240790|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
83240791|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240792|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240793|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240794|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240795|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240796|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240797|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240798|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83240799|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83240800|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240801|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
83240802|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240803|NCT05092165|Methylene Blue|methylene blue|mesh-list
83240804|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240805|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240806|NCT03062813|Entecavir|entecavir|mesh-list
83240807|NCT03062813|Tacrolimus|tacrolimus|mesh-list
83240808|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83240809|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
83240810|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240811|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83240812|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240813|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240814|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
83240815|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240816|NCT04893161|Belimumab|belimumab|mesh-list
83240817|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83240818|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
83240819|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240820|NCT04884035|Prednisone|prednisone|mesh-list
83240821|NCT04884035|Prednisolone|prednisolone|mesh-list
83240822|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
83240823|NCT04884035|Rituximab|rituximab|mesh-list
83240824|NCT04884035|Doxorubicin|doxorubicin|mesh-list
83240825|NCT04884035|Vincristine|vincristine|mesh-list
83240826|NCT04884035|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83240827|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83240828|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
83240829|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240830|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240831|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83240832|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
83240833|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240834|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240835|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83240836|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240837|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83240838|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83240839|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83240840|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240841|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240842|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
83240843|NCT04884035|Hormones|hormones|mesh-ancestor
83240844|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240845|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83240846|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240847|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240848|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240849|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240850|NCT04884035|Immunoconjugates|immunoconjugates|mesh-ancestor
83240851|NCT04582981|Raltitrexed|raltitrexed|mesh-list
83240852|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83240853|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
83240854|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240855|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240856|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83240857|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240858|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
83240859|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83240860|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
83240861|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240862|NCT04531579|Valproic Acid|valproic acid|mesh-list
83240863|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83240864|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
83240865|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240866|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240867|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
83240868|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240869|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240870|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
83240871|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83240872|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83240873|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83240874|NCT03839459|Denosumab|denosumab|mesh-list
83240875|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83240876|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240877|NCT05097781|Antibodies|antibodies|mesh-list
83240878|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
83240879|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
83240880|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240881|NCT01117441|Cytarabine|cytarabine|mesh-list
83240882|NCT01117441|Dexamethasone|dexamethasone|mesh-list
83240883|NCT01117441|Prednisone|prednisone|mesh-list
83240884|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
83240885|NCT01117441|Ifosfamide|ifosfamide|mesh-list
83240886|NCT01117441|Doxorubicin|doxorubicin|mesh-list
83240887|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83240888|NCT01117441|Methotrexate|methotrexate|mesh-list
83240889|NCT01117441|Fludarabine|fludarabine|mesh-list
83240890|NCT01117441|Etoposide|etoposide|mesh-list
83240891|NCT01117441|Vincristine|vincristine|mesh-list
83240892|NCT01117441|Daunorubicin|daunorubicin|mesh-list
83240893|NCT01117441|Asparaginase|asparaginase|mesh-list
83240894|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
83240895|NCT01117441|Thioguanine|thioguanine|mesh-list
83240896|NCT01117441|Pegaspargase|pegaspargase|mesh-list
83240897|NCT01117441|Vindesine|vindesine|mesh-list
83240898|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83240899|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
83240900|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240901|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240902|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83240903|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
83240904|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240905|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240906|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83240907|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240908|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
83240909|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
83240910|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240911|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83240912|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
83240913|NCT01117441|Hormones|hormones|mesh-ancestor
83240914|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240915|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83240916|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83240917|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83240918|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83240919|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240920|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83240921|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
83240922|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83240923|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83240924|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
83240925|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
83240926|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83240927|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83240928|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83240929|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
83240930|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240931|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83240932|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83240933|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83240934|NCT01101451|Cisplatin|cisplatin|mesh-list
83240935|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240936|NCT03656627|Nivolumab|nivolumab|mesh-list
83240937|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83240938|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240939|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83240940|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240941|NCT04759703|Pramipexole|pramipexole|mesh-list
83240942|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
83240943|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240944|NCT04759703|Protective Agents|protective agents|mesh-ancestor
83240945|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240946|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83240947|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83240948|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
83240949|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
83240950|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83240951|NCT05026801|Azithromycin|azithromycin|mesh-list
83240952|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
83240953|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83240954|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240955|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
83240956|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83240957|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83240958|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240959|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240960|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83240961|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
83240962|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83240963|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83240964|NCT03511625|Prednisolone|prednisolone|mesh-list
83240965|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
83240966|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83240967|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
83240968|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83240969|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83240970|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
83240971|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
83240972|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83240973|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83240974|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83240975|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
83240976|NCT03511625|Hormones|hormones|mesh-ancestor
83240977|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83240978|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83240979|NCT03511625|Protective Agents|protective agents|mesh-ancestor
83240980|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83240981|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240982|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
83240983|NCT03493061|Irinotecan|irinotecan|mesh-list
83240984|NCT03493061|Floxuridine|floxuridine|mesh-list
83240985|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83240986|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83240987|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83240988|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83240989|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83240990|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83240991|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
83240992|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
83240993|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83240994|NCT03809533|Velpatasvir|velpatasvir|mesh-list
83240995|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
83240996|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83240997|NCT04523935|Topiramate|topiramate|mesh-list
83240998|NCT04523935|Lamotrigine|lamotrigine|mesh-list
83240999|NCT04523935|Diazepam|diazepam|mesh-list
83241000|NCT04523935|Gabapentin|gabapentin|mesh-list
83241001|NCT04523935|Amitriptyline|amitriptyline|mesh-list
83241002|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
83241003|NCT04523935|Clonazepam|clonazepam|mesh-list
83241004|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
83241005|NCT04523935|Baclofen|baclofen|mesh-list
83241006|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
83241007|NCT04523935|Analgesics|analgesics|mesh-ancestor
83241008|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
83241009|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241010|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241011|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83241012|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83241013|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241014|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83241015|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83241016|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83241017|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241018|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241019|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
83241020|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83241021|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83241022|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83241023|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83241024|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83241025|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83241026|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83241027|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83241028|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83241029|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
83241030|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
83241031|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83241032|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
83241033|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83241034|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83241035|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83241036|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
83241037|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83241038|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
83241039|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
83241040|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241041|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83241042|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83241043|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
83241044|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
83241045|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
83241046|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83241047|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83241048|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83241049|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83241050|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
83241051|NCT02630693|Tamoxifen|tamoxifen|mesh-list
83241052|NCT02630693|Fulvestrant|fulvestrant|mesh-list
83241053|NCT02630693|Palbociclib|palbociclib|mesh-list
83241054|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83241055|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83241056|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
83241057|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241058|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241059|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241060|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241061|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83241062|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83241063|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83241064|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83241065|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83241066|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241067|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241068|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83241070|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83241071|NCT01938430|Ledipasvir|ledipasvir|mesh-list
83241072|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
83241073|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241074|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
83241075|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
83241076|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83241077|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83241078|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241079|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
83241080|NCT04625530|Coagulants|coagulants|mesh-ancestor
83241081|NCT04625530|Hematinics|hematinics|mesh-ancestor
83241082|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83241083|NCT01916824|Mirtazapine|mirtazapine|mesh-list
83241084|NCT01916824|Citalopram|citalopram|mesh-list
83241085|NCT01916824|Bupropion|bupropion|mesh-list
83241086|NCT01916824|Fluoxetine|fluoxetine|mesh-list
83241087|NCT01916824|Paroxetine|paroxetine|mesh-list
83241088|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83241089|NCT01916824|Sertraline|sertraline|mesh-list
83241090|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
83241091|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83241092|NCT01916824|Escitalopram|escitalopram|mesh-list
83241093|NCT01916824|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83241094|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83241095|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83241096|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241097|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241098|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
83241099|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241100|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241101|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83241102|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83241103|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83241104|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
83241105|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83241106|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83241107|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241108|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83241109|NCT01916824|Analgesics|analgesics|mesh-ancestor
83241110|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
83241111|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83241112|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
83241113|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
83241114|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83241115|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83241116|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241117|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83241118|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83241119|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83241120|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
83241121|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83241122|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83241123|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83241124|NCT01915732|Clindamycin|clindamycin|mesh-list
83241125|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
83241126|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
83241127|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83241128|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241129|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83241130|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241131|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241132|NCT01936870|Fesoterodine|fesoterodine|mesh-list
83241133|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83241134|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83241135|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
83241136|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241137|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241138|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241139|NCT01936870|Urological Agents|urological agents|mesh-ancestor
83241140|NCT01618708|Hylan|hylan|mesh-list
83241141|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
83241142|NCT01618708|Protective Agents|protective agents|mesh-ancestor
83241143|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241144|NCT02229149|Paclitaxel|paclitaxel|mesh-list
83241145|NCT02229149|Vinorelbine|vinorelbine|mesh-list
83241146|NCT02229149|Docetaxel|docetaxel|mesh-list
83241147|NCT02229149|Capecitabine|capecitabine|mesh-list
83241148|NCT02229149|Trastuzumab|trastuzumab|mesh-list
83241149|NCT02229149|Pertuzumab|pertuzumab|mesh-list
83241150|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83241151|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241152|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83241153|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83241154|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83241155|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241156|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83241157|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
83241158|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241159|NCT04642469|Durvalumab|durvalumab|mesh-list
83241160|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241161|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241162|NCT04440371|Betamethasone|betamethasone|mesh-list
83241163|NCT04440371|Calcipotriene|calcipotriene|mesh-list
83241164|NCT04440371|Tacrolimus|tacrolimus|mesh-list
83241165|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241166|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
83241167|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241168|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83241169|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241170|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241171|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241173|NCT04440371|Hormones|hormones|mesh-ancestor
83241174|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241175|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83241176|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
83241177|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
83241178|NCT01750073|Paclitaxel|paclitaxel|mesh-list
83241179|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
83241180|NCT01750073|Doxorubicin|doxorubicin|mesh-list
83241181|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83241182|NCT01750073|Trastuzumab|trastuzumab|mesh-list
83241183|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83241184|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83241185|NCT01750073|Antibodies|antibodies|mesh-list
83241186|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
83241187|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83241188|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83241189|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241190|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
83241191|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
83241192|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
83241193|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241194|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241195|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
83241196|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241197|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241198|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83241199|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
83241200|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83241201|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83241202|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83241203|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83241204|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241206|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
83241207|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83241208|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241209|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241210|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
83241211|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
83241212|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241213|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241214|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
83241215|NCT01550003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83241216|NCT01550003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241217|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241218|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
83241219|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241220|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241221|NCT00694655|Vaccines|vaccines|mesh-list
83241222|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
83241223|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241224|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
83241225|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241226|NCT04982549|Paclitaxel|paclitaxel|mesh-list
83241227|NCT04982549|Carboplatin|carboplatin|mesh-list
83241228|NCT04982549|Pemetrexed|pemetrexed|mesh-list
83241229|NCT04982549|Durvalumab|durvalumab|mesh-list
83241230|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83241231|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241232|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
83241233|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
83241234|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83241235|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241236|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241237|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83241238|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83241239|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241240|NCT02875223|Itraconazole|itraconazole|mesh-list
83241241|NCT02875223|Rifampin|rifampin|mesh-list
83241242|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
83241243|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
83241244|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241245|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83241246|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83241247|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241248|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241249|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83241250|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
83241251|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241252|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241253|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83241254|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83241255|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
83241256|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83241257|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
83241258|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83241259|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83241260|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83241261|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83241262|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83241263|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83241264|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83241265|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241266|NCT02621021|Aldesleukin|aldesleukin|mesh-list
83241267|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
83241268|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
83241269|NCT02621021|Fludarabine|fludarabine|mesh-list
83241270|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241271|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
83241272|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241273|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241274|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83241275|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
83241276|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241277|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241278|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83241279|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241280|NCT02621021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83241281|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83241282|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83241283|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
83241284|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241285|NCT02592317|Pioglitazone|pioglitazone|mesh-list
83241286|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83241287|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83241288|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83241289|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
83241290|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241291|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83241292|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83241293|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241294|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83241295|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241296|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
83241297|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
83241298|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241299|NCT00790933|Vedolizumab|vedolizumab|mesh-list
83241300|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241301|NCT04981457|Misoprostol|misoprostol|mesh-list
83241302|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83241303|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
83241304|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83241305|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241306|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83241307|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241308|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
83241309|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83241310|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
83241311|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241312|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
83241313|NCT04981379|Favipiravir|favipiravir|mesh-list
83241314|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
83241315|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83241316|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83241317|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241318|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241319|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241320|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241321|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
83241323|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83241324|NCT04389775|Incretins|incretins|mesh-ancestor
83241326|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241327|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241328|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241329|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
83241330|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241331|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
83241332|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241333|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241334|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83241335|NCT02102789|Leucovorin|leucovorin|mesh-list
83241336|NCT02102789|Dexamethasone|dexamethasone|mesh-list
83241337|NCT02102789|Fluorouracil|fluorouracil|mesh-list
83241338|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
83241339|NCT02102789|Floxuridine|floxuridine|mesh-list
83241340|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241341|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
83241342|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
83241343|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241344|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241345|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241346|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
83241347|NCT02102789|Hormones|hormones|mesh-ancestor
83241348|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241349|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241350|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241351|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241352|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
83241353|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83241354|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241355|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
83241356|NCT02102789|Antidotes|antidotes|mesh-ancestor
83241357|NCT02102789|Protective Agents|protective agents|mesh-ancestor
83241358|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
83241359|NCT02102789|Vitamins|vitamins|mesh-ancestor
83241360|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
83241361|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
83241362|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83241363|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83241364|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241365|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
83241366|NCT02926651|Coagulants|coagulants|mesh-ancestor
83241367|NCT04305145|Prednisone|prednisone|mesh-list
83241368|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
83241369|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83241370|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83241371|NCT04305145|Prednisolone|prednisolone|mesh-list
83241372|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
83241373|NCT04305145|Infliximab|infliximab|mesh-list
83241374|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83241375|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
83241376|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241377|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
83241378|NCT04305145|Hormones|hormones|mesh-ancestor
83241379|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241380|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241381|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241382|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241383|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
83241384|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
83241385|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241386|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241387|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83241388|NCT04305145|Protective Agents|protective agents|mesh-ancestor
83241389|NCT04305145|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83241390|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83241391|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241392|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
83241393|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
83241394|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241395|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241396|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241397|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
83241398|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
83241399|NCT04188145|Bevacizumab|bevacizumab|mesh-list
83241400|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241401|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241402|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83241403|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83241404|NCT04188145|Growth Substances|growth substances|mesh-ancestor
83241405|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241406|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
83241407|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
83241408|NCT03063983|Methotrexate|methotrexate|mesh-list
83241409|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241410|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
83241411|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241412|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241413|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83241414|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
83241415|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241416|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241417|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83241418|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83241419|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
83241420|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83241421|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83241422|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
83241423|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
83241424|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241425|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83241426|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83241428|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83241429|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241430|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241431|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241432|NCT01876355|Clonidine|clonidine|mesh-list
83241433|NCT01876355|Analgesics|analgesics|mesh-ancestor
83241434|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
83241435|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241436|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241437|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83241438|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
83241439|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
83241440|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83241441|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83241442|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83241443|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83241444|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241445|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241446|NCT02747407|Vaccines|vaccines|mesh-list
83241447|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
83241448|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241449|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
83241450|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83241451|NCT01870193|Glycine|glycine|mesh-list
83241452|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
83241453|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241454|NCT01870193|Expectorants|expectorants|mesh-ancestor
83241455|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
83241456|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83241457|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
83241458|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241459|NCT01870193|Protective Agents|protective agents|mesh-ancestor
83241460|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241461|NCT01870193|Antidotes|antidotes|mesh-ancestor
83241462|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
83241463|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241464|NCT03063905|Buprenorphine|buprenorphine|mesh-list
83241465|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83241466|NCT03063905|Narcotics|narcotics|mesh-ancestor
83241467|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241468|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241469|NCT03063905|Analgesics|analgesics|mesh-ancestor
83241470|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
83241471|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241472|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83241473|NCT04432415|Fluorides|fluorides|mesh-list
83241474|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
83241475|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
83241476|NCT04432415|Protective Agents|protective agents|mesh-ancestor
83241477|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241478|NCT01402271|Paclitaxel|paclitaxel|mesh-list
83241479|NCT01402271|Carboplatin|carboplatin|mesh-list
83241480|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83241481|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241482|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
83241483|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
83241484|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
83241485|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241486|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
83241487|NCT03063671|Ketamine|ketamine|mesh-list
83241488|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83241489|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241490|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241491|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83241492|NCT03063671|Analgesics|analgesics|mesh-ancestor
83241493|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
83241494|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241495|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83241496|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83241497|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83241498|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
83241499|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241500|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241501|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83241502|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83241503|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
83241504|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
83241505|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83241506|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83241507|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83241508|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83241509|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83241510|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241511|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241512|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83241513|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83241514|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241515|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
83241516|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241517|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
83241518|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83241519|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
83241520|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241521|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241522|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83241523|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83241524|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83241525|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
83241526|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83241527|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
83241528|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83241529|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241530|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83241531|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241532|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241533|NCT02958709|Rifampin|rifampin|mesh-list
83241534|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83241535|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
83241536|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83241537|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241538|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
83241539|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83241540|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241541|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241542|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83241543|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83241544|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83241545|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83241546|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83241547|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83241548|NCT04979663|Gemcitabine|gemcitabine|mesh-list
83241549|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
83241550|NCT04979663|Tislelizumab|tislelizumab|mesh-list
83241551|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83241552|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
83241553|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241554|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241555|NCT04979663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241556|NCT04979585|Paclitaxel|paclitaxel|mesh-list
83241557|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83241558|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241559|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
83241560|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
83241561|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
83241562|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241563|NCT05103397|Prednisolone|prednisolone|mesh-list
83241564|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83241565|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
83241566|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83241567|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
83241568|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83241569|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
83241570|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241571|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
83241573|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241574|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241575|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241576|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241577|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
83241578|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
83241579|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241580|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241581|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83241582|NCT05103397|Protective Agents|protective agents|mesh-ancestor
83241583|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
83241584|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83241585|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241586|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83241587|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
83241588|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83241589|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241590|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241591|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241592|NCT05101291|Bupivacaine|bupivacaine|mesh-list
83241593|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
83241594|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
83241595|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241596|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241597|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
83241598|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241599|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
83241600|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
83241601|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83241602|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83241603|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241604|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241605|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241606|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241607|NCT04979273|Epinephrine|epinephrine|mesh-list
83241608|NCT04979273|Racepinephrine|racepinephrine|mesh-list
83241609|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
83241610|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83241611|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83241612|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
83241613|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241614|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241615|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241616|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83241617|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83241618|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
83241619|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241620|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83241621|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83241622|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
83241623|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
83241624|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83241625|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
83241626|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83241627|NCT05103007|Estrogens|estrogens|mesh-ancestor
83241628|NCT05103007|Hormones|hormones|mesh-ancestor
83241629|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241630|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241631|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241632|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241633|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
83241634|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83241635|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83241636|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241637|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
83241638|NCT05092555|Coagulants|coagulants|mesh-ancestor
83241639|NCT05036473|Levodopa|levodopa|mesh-list
83241640|NCT05036473|Carbidopa|carbidopa|mesh-list
83241641|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83241642|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83241643|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83241644|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
83241645|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241646|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241647|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241648|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83241649|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241650|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83241651|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
83241652|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
83241653|NCT04985851|Durvalumab|durvalumab|mesh-list
83241654|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83241655|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241656|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241657|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
83241658|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241659|NCT05099575|Oxytocin|oxytocin|mesh-list
83241660|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
83241661|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83241662|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241663|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83241664|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83241665|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241666|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241667|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
83241668|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241669|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241670|NCT04973579|Anesthetics|anesthetics|mesh-list
83241671|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241672|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241673|NCT04834063|Selenium|selenium|mesh-list
83241674|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
83241675|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241676|NCT04834063|Protective Agents|protective agents|mesh-ancestor
83241677|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241678|NCT04834063|Trace Elements|trace elements|mesh-ancestor
83241679|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
83241680|NCT04794205|Caryophyllene|caryophyllene|mesh-list
83241681|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83241682|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83241683|NCT04794205|Analgesics|analgesics|mesh-ancestor
83241684|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
83241685|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241686|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241687|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241688|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241690|NCT04973033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83241691|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83241692|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241693|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241694|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
83241695|NCT03061565|Hematinics|hematinics|mesh-ancestor
83241696|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
83241697|NCT02660281|Melphalan|melphalan|mesh-list
83241698|NCT02660281|Busulfan|busulfan|mesh-list
83241699|NCT02660281|Thiotepa|thiotepa|mesh-list
83241700|NCT02660281|Fludarabine|fludarabine|mesh-list
83241701|NCT02660281|Mesna|mesna|mesh-list
83241702|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241703|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
83241704|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241705|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241706|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83241707|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
83241708|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241709|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241710|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83241711|NCT02660281|Protective Agents|protective agents|mesh-ancestor
83241712|NCT02438995|Cetuximab|cetuximab|mesh-list
83241713|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241714|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241715|NCT05107921|Bromfenac|bromfenac|mesh-list
83241716|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83241717|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83241718|NCT05107921|Analgesics|analgesics|mesh-ancestor
83241719|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
83241720|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241721|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241722|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241723|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241724|NCT01669811|Esomeprazole|esomeprazole|mesh-list
83241725|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83241726|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241727|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83241728|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241729|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241730|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83241731|NCT05164081|Clindamycin|clindamycin|mesh-list
83241732|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
83241733|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
83241734|NCT05164081|Gentamicins|gentamicins|mesh-list
83241735|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83241736|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241737|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
83241738|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83241739|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241740|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241741|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83241742|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83241743|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83241744|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241745|NCT04437017|Dexamethasone|dexamethasone|mesh-list
83241746|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
83241747|NCT04437017|Olanzapine|olanzapine|mesh-list
83241748|NCT04437017|Serotonin|serotonin|mesh-list
83241749|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241750|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
83241751|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
83241752|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241753|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241754|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241755|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
83241756|NCT04437017|Hormones|hormones|mesh-ancestor
83241757|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241758|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241759|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241760|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83241761|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83241762|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241763|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83241764|NCT04437017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83241765|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83241766|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83241767|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241768|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241769|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
83241770|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83241771|NCT03061253|Nicotine|nicotine|mesh-list
83241772|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83241773|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
83241774|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241775|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241776|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83241777|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83241778|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
83241779|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241780|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241781|NCT05107063|Pravastatin|pravastatin|mesh-list
83241782|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83241783|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83241784|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
83241785|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241786|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83241787|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83241788|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241789|NCT04977401|Glycerol|glycerol|mesh-list
83241790|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83241791|NCT04977401|Protective Agents|protective agents|mesh-ancestor
83241792|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241793|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
83241794|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83241795|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
83241796|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241797|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
83241798|NCT05106751|Protective Agents|protective agents|mesh-ancestor
83241799|NCT04977557|Thiamine|thiamine|mesh-list
83241800|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
83241801|NCT04977557|Vitamins|vitamins|mesh-ancestor
83241802|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
83241803|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241804|NCT04316143|Zamicastat|zamicastat|mesh-list
83241805|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241806|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241807|NCT05104801|Tislelizumab|tislelizumab|mesh-list
83241808|NCT05104801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241809|NCT05104801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241810|NCT04530877|Infliximab|infliximab|mesh-list
83241811|NCT04530877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83241812|NCT04530877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241813|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
83241814|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241815|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241816|NCT04274023|Dostarlimab|dostarlimab|mesh-list
83241817|NCT04274023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241818|NCT04971239|Methotrexate|methotrexate|mesh-list
83241819|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83241820|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
83241821|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83241822|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241823|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83241824|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
83241825|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241826|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241827|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
83241828|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241829|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83241830|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83241831|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
83241832|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241833|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83241834|NCT04903093|Famotidine|famotidine|mesh-list
83241835|NCT04903093|Abrocitinib|abrocitinib|mesh-list
83241836|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83241837|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241838|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83241839|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
83241840|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
83241841|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241842|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241843|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241844|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83241845|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241846|NCT04529785|Ethanol|ethanol|mesh-list
83241847|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83241848|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241849|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241850|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241851|NCT04271293|Edoxaban|edoxaban|mesh-list
83241852|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83241853|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
83241854|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83241855|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
83241856|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241857|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241858|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
83241859|NCT03059849|Adalimumab|adalimumab|mesh-list
83241860|NCT03059849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83241861|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241862|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83241863|NCT04970693|Aflutinib|aflutinib|mesh-list
83241864|NCT04970693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83241865|NCT04970693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241866|NCT04970693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241867|NCT04970069|Analgesics|analgesics|mesh-list
83241868|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
83241869|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241870|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241871|NCT04970303|Methylphenidate|methylphenidate|mesh-list
83241872|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83241873|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241874|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83241875|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83241876|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83241877|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241878|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
83241879|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241880|NCT04432259|Dexamethasone|dexamethasone|mesh-list
83241881|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83241882|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
83241883|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
83241884|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241885|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241886|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241887|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
83241888|NCT04432259|Hormones|hormones|mesh-ancestor
83241889|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83241890|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83241891|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241892|NCT04964219|Ketamine|ketamine|mesh-list
83241893|NCT04964219|Esketamine|esketamine|mesh-list
83241894|NCT04964219|Analgesics|analgesics|mesh-ancestor
83241895|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
83241896|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241897|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241898|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83241900|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
83241901|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
83241902|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241903|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83241904|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83241905|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241906|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241907|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
83241908|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83241909|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
83241910|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83241911|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
83241912|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241913|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
83241914|NCT04975373|Protective Agents|protective agents|mesh-ancestor
83241915|NCT04974827|Carboplatin|carboplatin|mesh-list
83241916|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241917|NCT04963595|Vinorelbine|vinorelbine|mesh-list
83241918|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83241919|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241920|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
83241921|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
83241922|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
83241923|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241924|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83241925|NCT04968509|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83241926|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83241927|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83241928|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
83241929|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241930|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241931|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83241932|NCT04968509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83241933|NCT04968509|Protease Inhibitors|protease inhibitors|mesh-ancestor
83241934|NCT04962425|Trastuzumab|trastuzumab|mesh-list
83241935|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241936|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241937|NCT03060707|Bromides|bromides|mesh-list
83241938|NCT03060707|Rocuronium|rocuronium|mesh-list
83241939|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
83241940|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83241941|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83241942|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83241943|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241944|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241945|NCT04967417|Paclitaxel|paclitaxel|mesh-list
83241946|NCT04967417|Carboplatin|carboplatin|mesh-list
83241947|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
83241948|NCT04967417|Pemetrexed|pemetrexed|mesh-list
83241949|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83241950|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83241951|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83241952|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83241953|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83241954|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241955|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83241956|NCT04967417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83241957|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83241958|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83241959|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83241960|NCT03060005|Dextrans|dextrans|mesh-list
83241961|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
83241962|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
83241963|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
83241965|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
83241966|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241967|NCT04418531|Antibodies|antibodies|mesh-list
83241968|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
83241969|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83241970|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
83241971|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241972|NCT02615119|Isoproterenol|isoproterenol|mesh-list
83241973|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83241974|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83241975|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
83241976|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83241977|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83241978|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241979|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83241980|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
83241981|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83241982|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83241983|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
83241984|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83241985|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
83241986|NCT02615119|Protective Agents|protective agents|mesh-ancestor
83241987|NCT02555293|Rifaximin|rifaximin|mesh-list
83241988|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83241989|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83241990|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83241991|NCT05104255|Anesthetics|anesthetics|mesh-list
83241992|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83241993|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241994|NCT03293017|Diazepam|diazepam|mesh-list
83241995|NCT03293017|Baclofen|baclofen|mesh-list
83241996|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83241997|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83241998|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83241999|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242000|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83242001|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
83242002|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
83242003|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242004|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242005|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83242006|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
83242007|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
83242008|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
83242009|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242010|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83242011|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242012|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83242013|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83242014|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83242015|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83242016|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
83242017|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
83242018|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
83242019|NCT03198559|Vorinostat|vorinostat|mesh-list
83242020|NCT03198559|Disulfiram|disulfiram|mesh-list
83242021|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242022|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83242023|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242024|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242025|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83242026|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
83242027|NCT02625623|Paclitaxel|paclitaxel|mesh-list
83242028|NCT02625623|Irinotecan|irinotecan|mesh-list
83242029|NCT02625623|Avelumab|avelumab|mesh-list
83242030|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83242031|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242032|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
83242033|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
83242034|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
83242035|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242036|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83242037|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83242038|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242039|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242040|NCT02749513|Itraconazole|itraconazole|mesh-list
83242041|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
83242042|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242043|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83242044|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83242045|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242046|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242047|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83242048|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
83242049|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242050|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242051|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83242052|NCT02684227|Paclitaxel|paclitaxel|mesh-list
83242053|NCT02684227|Carboplatin|carboplatin|mesh-list
83242054|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83242055|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83242056|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242057|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83242058|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83242059|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83242060|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242061|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
83242062|NCT05110339|Ropivacaine|ropivacaine|mesh-list
83242063|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83242064|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242065|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242066|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83242067|NCT05110339|Analgesics|analgesics|mesh-ancestor
83242068|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
83242069|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242070|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83242071|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83242072|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83242073|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242074|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242075|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242076|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
83242077|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
83242079|NCT04965545|Trace Elements|trace elements|mesh-ancestor
83242080|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
83242081|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242082|NCT04425629|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83242083|NCT04425629|Antiviral Agents|antiviral agents|mesh-ancestor
83242084|NCT04425629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242085|NCT05105347|Prednisone|prednisone|mesh-list
83242086|NCT05105347|Adalimumab|adalimumab|mesh-list
83242087|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242088|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
83242089|NCT05105347|Hormones|hormones|mesh-ancestor
83242090|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242091|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242092|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242093|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242094|NCT05105347|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83242095|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242096|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
83242097|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
83242098|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83242099|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83242100|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242101|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242102|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242103|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242104|NCT03060785|Tenofovir|tenofovir|mesh-list
83242105|NCT03060785|Emtricitabine|emtricitabine|mesh-list
83242106|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
83242107|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242108|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83242109|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83242110|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242111|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242112|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83242113|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83242114|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
83242115|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
83242116|NCT04952207|Grazoprevir|grazoprevir|mesh-list
83242117|NCT04952207|Ledipasvir|ledipasvir|mesh-list
83242118|NCT04952207|Velpatasvir|velpatasvir|mesh-list
83242119|NCT04952207|Asunaprevir|asunaprevir|mesh-list
83242120|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242121|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
83242122|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242123|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242124|NCT04632589|Losartan|losartan|mesh-list
83242125|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83242126|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83242127|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83242128|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83242129|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242130|NCT05108545|Amphotericin B|amphotericin b|mesh-list
83242131|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83242132|NCT05108545|Amebicides|amebicides|mesh-ancestor
83242133|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83242134|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83242135|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242136|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83242137|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
83242138|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
83242139|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83242140|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83242141|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242142|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
83242143|NCT05102695|Coagulants|coagulants|mesh-ancestor
83242144|NCT04952129|Selenium|selenium|mesh-list
83242145|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
83242146|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
83242147|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242148|NCT04952129|Protective Agents|protective agents|mesh-ancestor
83242149|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242150|NCT04952129|Trace Elements|trace elements|mesh-ancestor
83242151|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
83242152|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83242153|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242154|NCT05007769|Atezolizumab|atezolizumab|mesh-list
83242155|NCT05007769|Ramucirumab|ramucirumab|mesh-list
83242156|NCT05007769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83242157|NCT05007769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242158|NCT05007769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242159|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242160|NCT04952051|Folic Acid|folic acid|mesh-list
83242161|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
83242162|NCT04952051|Amlodipine|amlodipine|mesh-list
83242163|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83242164|NCT04952051|Enalapril|enalapril|mesh-list
83242165|NCT04952051|Enalaprilat|enalaprilat|mesh-list
83242166|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83242167|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83242168|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83242169|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242170|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83242171|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242172|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
83242173|NCT04952051|Diuretics|diuretics|mesh-ancestor
83242174|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
83242175|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83242176|NCT04952051|Hematinics|hematinics|mesh-ancestor
83242177|NCT04952051|Vitamins|vitamins|mesh-ancestor
83242178|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
83242179|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83242180|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
83242181|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242182|NCT04960943|Trastuzumab|trastuzumab|mesh-list
83242183|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242184|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242185|NCT04431713|Exenatide|exenatide|mesh-list
83242186|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83242187|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242188|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83242189|NCT04431713|Incretins|incretins|mesh-ancestor
83242190|NCT04431713|Hormones|hormones|mesh-ancestor
83242191|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242192|NCT05104333|Vaccines|vaccines|mesh-list
83242193|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
83242194|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242195|NCT03059615|Doxorubicin|doxorubicin|mesh-list
83242196|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83242197|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242198|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83242199|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83242200|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242201|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242202|NCT04951505|Cefepime|cefepime|mesh-list
83242203|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83242204|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242205|NCT04951349|Petrolatum|petrolatum|mesh-list
83242206|NCT04951349|Emollients|emollients|mesh-ancestor
83242207|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
83242208|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
83242209|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242210|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242211|NCT02658019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83242212|NCT02658019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242213|NCT03059303|Simeprevir|simeprevir|mesh-list
83242214|NCT03059303|Odalasvir|odalasvir|mesh-list
83242215|NCT03059303|Omeprazole|omeprazole|mesh-list
83242216|NCT03059303|Lansoprazole|lansoprazole|mesh-list
83242217|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
83242218|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83242219|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242220|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83242221|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242222|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242223|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
83242224|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242225|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
83242226|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83242227|NCT03059537|Cathartics|cathartics|mesh-ancestor
83242228|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242229|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
83242230|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
83242231|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
83242232|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242233|NCT04428775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83242234|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242235|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83242236|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
83242237|NCT04950569|Simendan|simendan|mesh-list
83242238|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83242239|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
83242240|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83242241|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83242242|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242243|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242244|NCT04950569|Protective Agents|protective agents|mesh-ancestor
83242245|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242246|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
83242247|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
83242248|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
83242249|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242250|NCT04436419|Protective Agents|protective agents|mesh-ancestor
83242251|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242252|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
83242253|NCT04436419|Vitamins|vitamins|mesh-ancestor
83242254|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
83242255|NCT04944173|Durvalumab|durvalumab|mesh-list
83242256|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242257|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242258|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
83242259|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242260|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
83242261|NCT01675765|Cisplatin|cisplatin|mesh-list
83242262|NCT01675765|Pemetrexed|pemetrexed|mesh-list
83242263|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
83242264|NCT01675765|Immunomodulating Agents|immunomodulating agents|mesh-list
83242265|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83242266|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242267|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242268|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83242269|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
83242270|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242271|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242272|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83242273|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242274|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83242275|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83242277|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83242278|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242279|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83242280|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83242281|NCT04943237|Analgesics|analgesics|mesh-ancestor
83242282|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
83242283|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242284|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242285|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242286|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242287|NCT04285255|Lidocaine|lidocaine|mesh-list
83242288|NCT04285255|Fentanyl|fentanyl|mesh-list
83242289|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
83242290|NCT04285255|Ketamine|ketamine|mesh-list
83242291|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
83242292|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
83242293|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242294|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242295|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
83242296|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242297|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83242298|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83242299|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83242300|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83242301|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242302|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83242303|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83242304|NCT04285255|Analgesics|analgesics|mesh-ancestor
83242305|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83242306|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83242307|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83242308|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242309|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242310|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83242311|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83242312|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
83242313|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83242314|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83242315|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83242316|NCT04285255|Narcotics|narcotics|mesh-ancestor
83242317|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83242318|NCT04121299|Amlodipine|amlodipine|mesh-list
83242319|NCT04121299|Carvedilol|carvedilol|mesh-list
83242320|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83242321|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83242322|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83242323|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242324|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83242325|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242326|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
83242327|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83242328|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83242329|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242330|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242331|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
83242333|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83242334|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83242335|NCT04942769|Selenium|selenium|mesh-list
83242336|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
83242337|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242338|NCT04942769|Protective Agents|protective agents|mesh-ancestor
83242339|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242340|NCT04942769|Trace Elements|trace elements|mesh-ancestor
83242341|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
83242342|NCT04942301|Endostar protein|endostar protein|mesh-list
83242343|NCT04942301|Endostatins|endostatins|mesh-list
83242344|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83242345|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83242346|NCT04942301|Growth Substances|growth substances|mesh-ancestor
83242347|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242348|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
83242349|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242350|NCT03057899|Fenugreek seed meal|fenugreek seed meal|mesh-list
83242351|NCT03057899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83242352|NCT03057899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242353|NCT04434001|Thrombin|thrombin|mesh-list
83242354|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
83242355|NCT04434001|Coagulants|coagulants|mesh-ancestor
83242356|NCT03540901|Acetazolamide|acetazolamide|mesh-list
83242357|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
83242358|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83242359|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242360|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242361|NCT03540901|Diuretics|diuretics|mesh-ancestor
83242362|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
83242363|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242364|NCT03517735|Remifentanil|remifentanil|mesh-list
83242365|NCT03517735|Propofol|propofol|mesh-list
83242366|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83242367|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242368|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242369|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83242370|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
83242371|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
83242372|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83242373|NCT03517735|Narcotics|narcotics|mesh-ancestor
83242374|NCT03517735|Analgesics|analgesics|mesh-ancestor
83242375|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
83242376|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242377|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
83242378|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83242379|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
83242380|NCT04941131|Povidone|povidone|mesh-list
83242381|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83242382|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242383|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
83242384|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
83242385|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
83242386|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
83242387|NCT03400501|Insulin|insulin|mesh-list
83242388|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83242389|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
83242390|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83242391|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242392|NCT04426591|Biotin|biotin|mesh-list
83242393|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
83242394|NCT04426591|Vitamins|vitamins|mesh-ancestor
83242395|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
83242396|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242397|NCT04940273|Remifentanil|remifentanil|mesh-list
83242398|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83242399|NCT04940273|Narcotics|narcotics|mesh-ancestor
83242400|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242401|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242402|NCT04940273|Analgesics|analgesics|mesh-ancestor
83242403|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
83242404|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242405|NCT04948385|Propofol|propofol|mesh-list
83242406|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83242407|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242408|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242409|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83242410|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
83242411|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
83242412|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83242413|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83242414|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242415|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
83242416|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
83242417|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83242418|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83242419|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242420|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242421|NCT04948151|Urological Agents|urological agents|mesh-ancestor
83242422|NCT02633293|Treprostinil|treprostinil|mesh-list
83242423|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83242424|NCT04938713|Ketamine|ketamine|mesh-list
83242425|NCT04938713|Esketamine|esketamine|mesh-list
83242426|NCT04938713|Analgesics|analgesics|mesh-ancestor
83242427|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
83242428|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242429|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242430|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83242431|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83242432|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
83242433|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
83242434|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242435|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83242436|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83242437|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242438|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242439|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
83242440|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83242441|NCT04938011|Progesterone|progesterone|mesh-list
83242442|NCT04938011|Progestins|progestins|mesh-ancestor
83242443|NCT04938011|Hormones|hormones|mesh-ancestor
83242444|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242445|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242446|NCT03057509|Octreotide|octreotide|mesh-list
83242447|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242448|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242449|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242450|NCT04946825|Nicotine|nicotine|mesh-list
83242451|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83242452|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
83242453|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242454|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242455|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83242456|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83242457|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
83242458|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242459|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242460|NCT03572413|Bromides|bromides|mesh-list
83242461|NCT03572413|Rocuronium|rocuronium|mesh-list
83242462|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
83242463|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83242464|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83242465|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83242466|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242467|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242468|NCT04956419|Fluconazole|fluconazole|mesh-list
83242469|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
83242470|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242471|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83242472|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83242473|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242474|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242475|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83242477|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242478|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242479|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83242480|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83242481|NCT04946669|Abatacept|abatacept|mesh-list
83242482|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83242483|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242484|NCT04946669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242485|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242486|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83242487|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
83242488|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242489|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242490|NCT03219775|Nivolumab|nivolumab|mesh-list
83242491|NCT03219775|Ipilimumab|ipilimumab|mesh-list
83242492|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242493|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242494|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83242495|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242496|NCT03100045|Artesunate|artesunate|mesh-list
83242497|NCT03100045|Artemisinins|artemisinins|mesh-list
83242498|NCT03100045|Artemisinin|artemisinin|mesh-list
83242499|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
83242500|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83242501|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83242502|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242503|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242504|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
83242505|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
83242506|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83242507|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
83242508|NCT04946123|Selenium|selenium|mesh-list
83242509|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
83242510|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242511|NCT04946123|Protective Agents|protective agents|mesh-ancestor
83242512|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242513|NCT04946123|Trace Elements|trace elements|mesh-ancestor
83242514|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
83242515|NCT04945577|Vitamin D|vitamin d|mesh-list
83242516|NCT04945577|Vitamins|vitamins|mesh-ancestor
83242517|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
83242518|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242519|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83242520|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
83242521|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83242522|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83242523|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83242524|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242525|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83242526|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242527|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242528|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83242529|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242531|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83242532|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
83242533|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
83242534|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242535|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242536|NCT04936295|Fulvestrant|fulvestrant|mesh-list
83242537|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242538|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242539|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83242540|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83242541|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
83242542|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242543|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242544|NCT05114239|Timolol|timolol|mesh-list
83242545|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83242546|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83242547|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83242548|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83242549|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242550|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242551|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242552|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242553|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83242554|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83242555|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83242556|NCT04418999|Dexamethasone|dexamethasone|mesh-list
83242557|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242558|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
83242559|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
83242560|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242561|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242562|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242563|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
83242564|NCT04418999|Hormones|hormones|mesh-ancestor
83242565|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242566|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242567|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242568|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83242569|NCT05113459|Disitamab vedotin|disitamab vedotin|mesh-list
83242570|NCT05113459|Immunoconjugates|immunoconjugates|mesh-ancestor
83242571|NCT05113459|Immunologic Factors|immunologic factors|mesh-ancestor
83242572|NCT05113459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242573|NCT04526197|Celecoxib|celecoxib|mesh-list
83242574|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83242575|NCT04526197|Choline|choline|mesh-list
83242576|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83242577|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83242578|NCT04526197|Analgesics|analgesics|mesh-ancestor
83242579|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
83242580|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242581|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242582|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242583|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242584|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83242585|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83242586|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242587|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242588|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
83242589|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83242590|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
83242591|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242592|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83242593|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
83242594|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
83242595|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
83242596|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83242597|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83242598|NCT04526197|Growth Substances|growth substances|mesh-ancestor
83242599|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
83242600|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242601|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83242602|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242603|NCT05060965|Nicotine|nicotine|mesh-list
83242604|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83242605|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
83242606|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242607|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242608|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83242609|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83242610|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
83242611|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242612|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242613|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83242614|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83242615|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83242616|NCT04935515|Anticoagulants|anticoagulants|mesh-list
83242617|NCT04935515|Coagulants|coagulants|mesh-list
83242618|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
83242619|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83242620|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242621|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
83242622|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
83242623|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242624|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242625|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242626|NCT04376281|Norepinephrine|norepinephrine|mesh-list
83242627|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83242628|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83242629|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242630|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242631|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242632|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242633|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
83242634|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
83242635|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242636|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83242637|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
83242638|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83242639|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
83242640|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242641|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
83242642|NCT04332445|Protective Agents|protective agents|mesh-ancestor
83242643|NCT03890887|Itraconazole|itraconazole|mesh-list
83242644|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
83242645|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242646|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83242647|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83242648|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242649|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242650|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83242651|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
83242652|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242653|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242654|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83242655|NCT04516993|Aspirin|aspirin|mesh-list
83242656|NCT04516993|Plasminogen|plasminogen|mesh-list
83242657|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83242658|NCT04516993|Tenecteplase|tenecteplase|mesh-list
83242659|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83242660|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83242661|NCT04516993|Analgesics|analgesics|mesh-ancestor
83242662|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
83242663|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242664|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242665|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242666|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242667|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83242668|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83242669|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242670|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83242671|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83242672|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242673|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
83242674|NCT05015335|Adalimumab|adalimumab|mesh-list
83242675|NCT05015335|Methotrexate|methotrexate|mesh-list
83242676|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83242677|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
83242678|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83242679|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242680|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83242681|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
83242682|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242683|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242684|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
83242685|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242686|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83242687|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83242688|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
83242689|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242690|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83242691|NCT05015335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83242692|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242693|NCT03056261|Anesthetics|anesthetics|mesh-list
83242694|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242695|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242696|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83242697|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83242698|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242699|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
83242700|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242701|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83242702|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242703|NCT04574479|Morphine|morphine|mesh-list
83242704|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83242705|NCT04574479|Narcotics|narcotics|mesh-ancestor
83242706|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242707|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242708|NCT04574479|Analgesics|analgesics|mesh-ancestor
83242709|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
83242710|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242711|NCT04931225|Landiolol|landiolol|mesh-list
83242712|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83242713|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83242714|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242715|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242716|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242717|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242718|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83242719|NCT04516057|Nabilone|nabilone|mesh-list
83242720|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
83242721|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
83242722|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242723|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242724|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242725|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83242726|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83242727|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242728|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83242729|NCT02195947|Hormones|hormones|mesh-list
83242730|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242731|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242732|NCT01698307|Adalimumab|adalimumab|mesh-list
83242733|NCT01698307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83242734|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242735|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242736|NCT04954339|Bevacizumab|bevacizumab|mesh-list
83242737|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242738|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242739|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83242740|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83242741|NCT04954339|Growth Substances|growth substances|mesh-ancestor
83242742|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242743|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83242744|NCT01966263|Epinephrine|epinephrine|mesh-list
83242745|NCT01966263|Racepinephrine|racepinephrine|mesh-list
83242746|NCT01966263|Ropivacaine|ropivacaine|mesh-list
83242747|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
83242748|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
83242749|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
83242750|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242751|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242752|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
83242753|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242754|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83242755|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83242756|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242757|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242758|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242759|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83242760|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83242761|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
83242762|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83242763|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
83242764|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
83242765|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
83242766|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83242768|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83242769|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242770|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242771|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83242772|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
83242773|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
83242774|NCT04423107|Acetaminophen|acetaminophen|mesh-list
83242775|NCT04423107|Ibuprofen|ibuprofen|mesh-list
83242776|NCT04423107|Oxycodone|oxycodone|mesh-list
83242777|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83242778|NCT04423107|Analgesics|analgesics|mesh-ancestor
83242779|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
83242780|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242781|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242782|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
83242783|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83242784|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242785|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242786|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83242787|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242788|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242789|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83242790|NCT04423107|Narcotics|narcotics|mesh-ancestor
83242791|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242792|NCT01675531|Oxycodone|oxycodone|mesh-list
83242793|NCT01675531|Naloxone|naloxone|mesh-list
83242794|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83242795|NCT01675531|Narcotics|narcotics|mesh-ancestor
83242796|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242797|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242798|NCT01675531|Analgesics|analgesics|mesh-ancestor
83242799|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
83242800|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242801|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83242802|NCT05406999|Prednisolone|prednisolone|mesh-list
83242803|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
83242804|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83242805|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242806|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
83242807|NCT05406999|Hormones|hormones|mesh-ancestor
83242808|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242809|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242810|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242811|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242812|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83242813|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242814|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242815|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
83242816|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83242817|NCT04930211|Dexamethasone|dexamethasone|mesh-list
83242818|NCT04930211|Lidocaine|lidocaine|mesh-list
83242819|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242820|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
83242821|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
83242822|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242823|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242824|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242825|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
83242826|NCT04930211|Hormones|hormones|mesh-ancestor
83242827|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242828|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242829|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242830|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
83242831|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
83242832|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242833|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
83242834|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83242835|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83242836|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83242837|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83242838|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242839|NCT04912271|Dexamethasone|dexamethasone|mesh-list
83242840|NCT04912271|Aprepitant|aprepitant|mesh-list
83242841|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
83242842|NCT04912271|Palonosetron|palonosetron|mesh-list
83242843|NCT04912271|Granisetron|granisetron|mesh-list
83242844|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242845|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
83242846|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
83242847|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242848|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242849|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242850|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
83242851|NCT04912271|Hormones|hormones|mesh-ancestor
83242852|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242853|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242854|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242855|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83242856|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242857|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242858|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83242859|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83242860|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
83242861|NCT02807779|Dexamethasone|dexamethasone|mesh-list
83242862|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242863|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
83242864|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
83242865|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242866|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242867|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242868|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
83242869|NCT02807779|Hormones|hormones|mesh-ancestor
83242870|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242871|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242872|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242873|NCT04912193|Antithrombins|antithrombins|mesh-list
83242874|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
83242875|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83242876|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
83242877|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242878|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242879|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
83242880|NCT02680561|Fluticasone|fluticasone|mesh-list
83242882|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83242883|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83242884|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242885|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83242886|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
83242887|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242888|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242889|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83242890|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
83242891|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
83242892|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83242893|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83242894|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83242895|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83242896|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
83242897|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83242898|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242899|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
83242900|NCT02680561|Hormones|hormones|mesh-ancestor
83242901|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242902|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
83242903|NCT05025163|Fluorides|fluorides|mesh-list
83242904|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
83242905|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
83242906|NCT05025163|Protective Agents|protective agents|mesh-ancestor
83242907|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242908|NCT02592031|Goserelin|goserelin|mesh-list
83242909|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242910|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242911|NCT04784299|Lidocaine|lidocaine|mesh-list
83242912|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
83242913|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
83242914|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242915|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242916|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
83242917|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242918|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83242919|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83242920|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83242921|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83242922|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242923|NCT02333149|Melatonin|melatonin|mesh-list
83242924|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
83242925|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242926|NCT02333149|Protective Agents|protective agents|mesh-ancestor
83242927|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242928|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242929|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
83242930|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83242931|NCT03807817|Ethanol|ethanol|mesh-list
83242932|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83242933|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83242934|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83242935|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242936|NCT05122117|Methylene Blue|methylene blue|mesh-list
83242937|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242938|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242939|NCT05117125|Heparin|heparin|mesh-list
83242940|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
83242941|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83242942|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83242943|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242944|NCT05116345|Dexamethasone|dexamethasone|mesh-list
83242945|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
83242946|NCT05116345|BB 1101|bb 1101|mesh-list
83242947|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242948|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
83242949|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
83242950|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242951|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242952|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242953|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
83242954|NCT05116345|Hormones|hormones|mesh-ancestor
83242955|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242956|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242957|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242958|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
83242959|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242960|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242961|NCT05076097|Rituximab|rituximab|mesh-list
83242962|NCT05076097|Lenalidomide|lenalidomide|mesh-list
83242963|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242964|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242965|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
83242966|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242967|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83242968|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83242969|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83242970|NCT05076097|Growth Substances|growth substances|mesh-ancestor
83242971|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
83242972|NCT04513639|Dexamethasone|dexamethasone|mesh-list
83242973|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
83242974|NCT04513639|Daratumumab|daratumumab|mesh-list
83242976|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83242977|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83242978|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
83242979|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
83242980|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83242981|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83242982|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83242983|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
83242984|NCT04513639|Hormones|hormones|mesh-ancestor
83242985|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83242986|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83242987|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242988|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
83242989|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83242990|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242991|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
83242992|NCT04675333|Carboplatin|carboplatin|mesh-list
83242993|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
83242994|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83242995|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83242996|NCT04675333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83242997|NCT04675333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83242998|NCT05229913|Esketamine|esketamine|mesh-list
83242999|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
83243000|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83243001|NCT05108155|Tacrine|tacrine|mesh-list
83243002|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83243003|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243004|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243005|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243006|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243007|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243008|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83243009|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
83243010|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243011|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
83243012|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83243013|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
83243014|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83243015|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83243016|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83243017|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243018|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243019|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83243020|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83243021|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83243022|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
83243023|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243024|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243025|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83243026|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83243027|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
83243028|NCT05228743|Paclitaxel|paclitaxel|mesh-list
83243029|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83243030|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243031|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
83243032|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
83243033|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
83243034|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243035|NCT03321019|Capsaicin|capsaicin|mesh-list
83243036|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
83243037|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
83243038|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
83243039|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243040|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243041|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
83243042|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243043|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243044|NCT04990921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83243045|NCT04990921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243046|NCT04507477|Rituximab|rituximab|mesh-list
83243047|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243048|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243049|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
83243050|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243051|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83243053|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
83243054|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243055|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83243056|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83243057|NCT01675141|Growth Substances|growth substances|mesh-ancestor
83243058|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
83243059|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243060|NCT05102149|Vildagliptin|vildagliptin|mesh-list
83243061|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243062|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243063|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83243064|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
83243065|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243066|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243067|NCT04412395|Lactoferrin|lactoferrin|mesh-list
83243068|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243069|NCT04987099|Choline|choline|mesh-list
83243070|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
83243071|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83243072|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
83243073|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243074|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243075|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83243076|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
83243077|NCT03906721|Oxycodone|oxycodone|mesh-list
83243078|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83243079|NCT03906721|Narcotics|narcotics|mesh-ancestor
83243080|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243081|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243082|NCT03906721|Analgesics|analgesics|mesh-ancestor
83243083|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
83243084|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243085|NCT04663711|Anesthetics|anesthetics|mesh-list
83243086|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243087|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243088|NCT04529863|Abatacept|abatacept|mesh-list
83243089|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83243090|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243091|NCT04529863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243092|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243093|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83243094|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
83243095|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243096|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83243097|NCT04582591|Cannabidiol|cannabidiol|mesh-list
83243098|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
83243099|NCT04497883|Maribavir|maribavir|mesh-list
83243100|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
83243101|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243102|NCT03688633|Candesartan|candesartan|mesh-list
83243103|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83243104|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83243105|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83243106|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243107|NCT03963895|Thrombin|thrombin|mesh-list
83243108|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
83243109|NCT03963895|Coagulants|coagulants|mesh-ancestor
83243110|NCT03662815|Molgramostim|molgramostim|mesh-list
83243111|NCT03662815|Sargramostim|sargramostim|mesh-list
83243112|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
83243113|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243114|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243115|NCT03490903|Fentanyl|fentanyl|mesh-list
83243116|NCT03490903|Midazolam|midazolam|mesh-list
83243117|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83243118|NCT03490903|Narcotics|narcotics|mesh-ancestor
83243119|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243120|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243121|NCT03490903|Analgesics|analgesics|mesh-ancestor
83243122|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
83243123|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243124|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83243125|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83243126|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
83243127|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
83243128|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83243129|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83243130|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83243131|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83243132|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
83243133|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
83243134|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243135|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243136|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
83243137|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243138|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83243139|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83243140|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83243141|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243142|NCT04169191|Urological Agents|urological agents|mesh-ancestor
83243143|NCT03954613|Memantine|memantine|mesh-list
83243144|NCT03954613|Donepezil|donepezil|mesh-list
83243145|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83243146|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243147|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243148|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243149|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243150|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243151|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
83243152|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83243153|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83243154|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
83243155|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83243156|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83243157|NCT03367819|Cemiplimab|cemiplimab|mesh-list
83243158|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243159|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243160|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
83243161|NCT04023253|Mirabegron|mirabegron|mesh-list
83243162|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83243163|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83243164|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243165|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243166|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243167|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243168|NCT04023253|Urological Agents|urological agents|mesh-ancestor
83243169|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83243170|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83243171|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83243172|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243173|NCT03066739|Remifentanil|remifentanil|mesh-list
83243174|NCT03066739|Naloxone|naloxone|mesh-list
83243175|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83243176|NCT03066739|Narcotics|narcotics|mesh-ancestor
83243177|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243178|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243179|NCT03066739|Analgesics|analgesics|mesh-ancestor
83243180|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
83243181|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243182|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83243183|NCT04875871|Copper|copper|mesh-list
83243184|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83243185|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83243186|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243187|NCT04875871|Trace Elements|trace elements|mesh-ancestor
83243188|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
83243189|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243190|NCT04781725|Cisplatin|cisplatin|mesh-list
83243191|NCT04781725|Vinblastine|vinblastine|mesh-list
83243192|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243193|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83243194|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
83243195|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
83243196|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
83243197|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243198|NCT03580525|Nicotine|nicotine|mesh-list
83243199|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83243200|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
83243201|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243202|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243203|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83243204|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83243205|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243206|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243207|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243208|NCT03554707|Bevacizumab|bevacizumab|mesh-list
83243209|NCT03554707|Irinotecan|irinotecan|mesh-list
83243210|NCT03554707|Temozolomide|temozolomide|mesh-list
83243211|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243212|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243213|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83243214|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83243215|NCT03554707|Growth Substances|growth substances|mesh-ancestor
83243216|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243217|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83243218|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83243219|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83243220|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243221|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243222|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83243223|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
83243224|NCT04264663|Furazolidone|furazolidone|mesh-list
83243225|NCT04264663|Tinidazole|tinidazole|mesh-list
83243226|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83243227|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243228|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83243229|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83243230|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83243231|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83243232|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83243233|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243234|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243235|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
83243236|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83243237|NCT05403307|Vaccines|vaccines|mesh-list
83243238|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
83243239|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243240|NCT04563559|Prednisolone|prednisolone|mesh-list
83243241|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83243242|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
83243243|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83243244|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
83243245|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83243246|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
83243247|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83243248|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
83243249|NCT04563559|Hormones|hormones|mesh-ancestor
83243250|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243251|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243252|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83243253|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243254|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
83243255|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
83243256|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243257|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243258|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83243259|NCT04563559|Protective Agents|protective agents|mesh-ancestor
83243260|NCT02124187|Nicotine|nicotine|mesh-list
83243261|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83243262|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
83243263|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243264|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243265|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83243266|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83243267|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243268|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243269|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243270|NCT02002819|Levetiracetam|levetiracetam|mesh-list
83243271|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
83243272|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
83243273|NCT01597193|Fulvestrant|fulvestrant|mesh-list
83243274|NCT01597193|Anastrozole|anastrozole|mesh-list
83243275|NCT01597193|Exemestane|exemestane|mesh-list
83243276|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83243277|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243278|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83243279|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83243280|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83243281|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243282|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243283|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83243284|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83243285|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243286|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243288|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243289|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83243290|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243291|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243292|NCT03057041|Fentanyl|fentanyl|mesh-list
83243293|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83243294|NCT03057041|Narcotics|narcotics|mesh-ancestor
83243295|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243296|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243297|NCT03057041|Analgesics|analgesics|mesh-ancestor
83243298|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
83243299|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243300|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83243301|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83243302|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
83243303|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
83243304|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83243305|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243306|NCT05123287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243307|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243308|NCT04165993|Docetaxel|docetaxel|mesh-list
83243309|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243310|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83243311|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83243312|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83243313|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243314|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
83243315|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83243316|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83243317|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243318|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
83243319|NCT04911413|Coagulants|coagulants|mesh-ancestor
83243320|NCT03889795|Metformin|metformin|mesh-list
83243321|NCT03889795|Digoxin|digoxin|mesh-list
83243322|NCT03889795|Simvastatin|simvastatin|mesh-list
83243323|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243324|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243325|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83243326|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83243327|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
83243328|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243329|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83243330|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83243331|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243332|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83243333|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83243334|NCT03889795|Protective Agents|protective agents|mesh-ancestor
83243335|NCT02622113|Canagliflozin|canagliflozin|mesh-list
83243336|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243337|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243338|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83243339|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243340|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
83243341|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83243342|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83243343|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243344|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
83243345|NCT04430777|Coagulants|coagulants|mesh-ancestor
83243346|NCT04910477|Atropine|atropine|mesh-list
83243347|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
83243348|NCT04910477|Neostigmine|neostigmine|mesh-list
83243349|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83243350|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243351|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243352|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83243354|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
83243355|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243356|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83243357|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83243358|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83243359|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243360|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243361|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243362|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83243363|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83243364|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83243365|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
83243366|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83243367|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
83243368|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
83243369|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
83243370|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83243371|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83243372|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243373|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83243374|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243375|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83243376|NCT03843151|Itraconazole|itraconazole|mesh-list
83243377|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
83243378|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243379|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83243380|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83243381|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243382|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243383|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83243384|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
83243385|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243386|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243387|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83243388|NCT04929509|Listerine|listerine|mesh-list
83243389|NCT04929509|Fluorides|fluorides|mesh-list
83243390|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
83243391|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
83243392|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
83243393|NCT04929509|Protective Agents|protective agents|mesh-ancestor
83243394|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243395|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83243396|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243397|NCT03054467|Amlodipine|amlodipine|mesh-list
83243398|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83243399|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83243400|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83243401|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243402|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83243403|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243404|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
83243405|NCT04910165|Ropivacaine|ropivacaine|mesh-list
83243406|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
83243407|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
83243408|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243409|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243410|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
83243411|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243412|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
83243413|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83243414|NCT02730325|Antibodies|antibodies|mesh-list
83243415|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
83243416|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243417|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
83243418|NCT04928495|Bromhexine|bromhexine|mesh-list
83243419|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83243420|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243421|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
83243422|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243423|NCT04928495|Protective Agents|protective agents|mesh-ancestor
83243424|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
83243425|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243427|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
83243428|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83243429|NCT04928495|Antidotes|antidotes|mesh-ancestor
83243430|NCT01573429|Bisphenol A|bisphenol a|mesh-list
83243431|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83243432|NCT01573429|Estrogens|estrogens|mesh-ancestor
83243433|NCT01573429|Hormones|hormones|mesh-ancestor
83243434|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243435|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243436|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83243438|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243439|NCT01573429|Protective Agents|protective agents|mesh-ancestor
83243440|NCT04909931|Vitamin D|vitamin d|mesh-list
83243441|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
83243442|NCT04909931|Vitamins|vitamins|mesh-ancestor
83243443|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
83243444|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243445|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83243446|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83243447|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
83243448|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83243449|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83243450|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243451|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
83243452|NCT04918589|Coagulants|coagulants|mesh-ancestor
83243453|NCT04928651|Clonidine|clonidine|mesh-list
83243454|NCT04928651|Analgesics|analgesics|mesh-ancestor
83243455|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
83243456|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243457|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243458|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83243459|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
83243460|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
83243461|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83243462|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83243463|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83243464|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243465|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243466|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243467|NCT04101643|Evolocumab|evolocumab|mesh-list
83243468|NCT04101643|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83243469|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83243470|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83243471|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
83243472|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243473|NCT04101643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83243474|NCT04101643|Protease Inhibitors|protease inhibitors|mesh-ancestor
83243475|NCT04101643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243476|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83243477|NCT02620787|Tedizolid|tedizolid|mesh-list
83243478|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83243479|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243480|NCT04909619|Anesthetics|anesthetics|mesh-list
83243481|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
83243482|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243483|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243484|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
83243485|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243486|NCT03520231|Vitamin D|vitamin d|mesh-list
83243487|NCT03520231|Denosumab|denosumab|mesh-list
83243488|NCT03520231|Carboplatin|carboplatin|mesh-list
83243489|NCT03520231|Gemcitabine|gemcitabine|mesh-list
83243491|NCT03520231|Vitamins|vitamins|mesh-ancestor
83243492|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
83243493|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243494|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243495|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83243496|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
83243497|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243498|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83243499|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83243500|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
83243501|NCT04927481|Analgesics|analgesics|mesh-ancestor
83243502|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
83243503|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243504|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243505|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243506|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83243507|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83243508|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243509|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243510|NCT03056495|Vorinostat|vorinostat|mesh-list
83243511|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243512|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83243513|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243514|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243515|NCT03171805|Propranolol|propranolol|mesh-list
83243516|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83243517|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83243518|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243519|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243520|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243521|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243522|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83243523|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83243524|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
83243525|NCT04918433|Anesthetics|anesthetics|mesh-list
83243526|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243527|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243528|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83243529|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83243530|NCT03053219|Abivertinib|abivertinib|mesh-list
83243531|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83243532|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243533|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243534|NCT03055793|Budesonide|budesonide|mesh-list
83243535|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
83243536|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83243537|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83243538|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
83243539|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243540|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243541|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83243542|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
83243543|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
83243544|NCT03055793|Hormones|hormones|mesh-ancestor
83243545|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243546|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83243547|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83243548|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83243549|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243550|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243551|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243552|NCT04926155|Metformin|metformin|mesh-list
83243553|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243554|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243555|NCT04909775|Gemcitabine|gemcitabine|mesh-list
83243556|NCT04909775|Tislelizumab|tislelizumab|mesh-list
83243557|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243558|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83243559|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
83243560|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243561|NCT04909775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243562|NCT04925141|Dasatinib|dasatinib|mesh-list
83243563|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243564|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83243565|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243566|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243567|NCT02651155|Lubiprostone|lubiprostone|mesh-list
83243568|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83243569|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83243570|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243571|NCT04925063|Metformin|metformin|mesh-list
83243572|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243573|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243574|NCT04909151|Methamphetamine|methamphetamine|mesh-list
83243575|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83243576|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243577|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
83243578|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
83243579|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243580|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
83243581|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243582|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243583|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243584|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83243585|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83243586|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83243587|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83243588|NCT05132413|Bevacizumab|bevacizumab|mesh-list
83243589|NCT05132413|Cisplatin|cisplatin|mesh-list
83243590|NCT05132413|Carboplatin|carboplatin|mesh-list
83243591|NCT05132413|Pemetrexed|pemetrexed|mesh-list
83243592|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243593|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243594|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83243595|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83243596|NCT05132413|Growth Substances|growth substances|mesh-ancestor
83243597|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243598|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
83243599|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243600|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243601|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83243602|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83243603|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83243604|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
83243605|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83243606|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83243607|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83243608|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83243609|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83243610|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243611|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243612|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243613|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243614|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83243615|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243616|NCT04917497|Simendan|simendan|mesh-list
83243617|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83243618|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
83243619|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83243620|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83243621|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243622|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243623|NCT04917497|Protective Agents|protective agents|mesh-ancestor
83243624|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243625|NCT03933007|Fexofenadine|fexofenadine|mesh-list
83243626|NCT03933007|Colchicine|colchicine|mesh-list
83243627|NCT03933007|Midazolam|midazolam|mesh-list
83243628|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83243629|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83243630|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243631|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243632|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83243633|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83243634|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83243635|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83243636|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
83243637|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
83243638|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
83243639|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
83243640|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243641|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243642|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
83243643|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83243644|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
83243645|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
83243646|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
83243647|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243648|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83243649|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83243651|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
83243652|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
83243653|NCT04907747|Amoxicillin|amoxicillin|mesh-list
83243654|NCT04907747|Furazolidone|furazolidone|mesh-list
83243655|NCT04907747|Esomeprazole|esomeprazole|mesh-list
83243656|NCT04907747|Bismuth|bismuth|mesh-list
83243657|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83243658|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243659|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83243660|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243661|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83243662|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243663|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243664|NCT04907747|Antacids|antacids|mesh-ancestor
83243665|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83243666|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83243667|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83243668|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83243669|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83243670|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83243671|NCT03052673|Fentanyl|fentanyl|mesh-list
83243672|NCT03052673|Ketamine|ketamine|mesh-list
83243673|NCT03052673|Analgesics|analgesics|mesh-ancestor
83243674|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
83243675|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243676|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243677|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83243678|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83243679|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
83243680|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
83243681|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243682|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83243683|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83243684|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243685|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243686|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83243687|NCT03052673|Narcotics|narcotics|mesh-ancestor
83243688|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83243689|NCT04907123|Diuretics|diuretics|mesh-list
83243690|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
83243691|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243692|NCT05030857|Midazolam|midazolam|mesh-list
83243693|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83243694|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83243695|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243696|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243697|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83243698|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83243699|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83243700|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83243701|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
83243702|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
83243703|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
83243704|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
83243705|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243706|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243707|NCT03319459|Trastuzumab|trastuzumab|mesh-list
83243708|NCT03319459|Cetuximab|cetuximab|mesh-list
83243709|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243710|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243711|NCT04916951|Amoxicillin|amoxicillin|mesh-list
83243712|NCT04916951|Cephalexin|cephalexin|mesh-list
83243713|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83243714|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243715|NCT04430933|Paclitaxel|paclitaxel|mesh-list
83243716|NCT04430933|Docetaxel|docetaxel|mesh-list
83243717|NCT04430933|Carboplatin|carboplatin|mesh-list
83243718|NCT04430933|Pemetrexed|pemetrexed|mesh-list
83243719|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83243720|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243721|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
83243722|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
83243723|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
83243724|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243725|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243726|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83243727|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83243728|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
83243729|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83243730|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83243731|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83243732|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243733|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243734|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243735|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243736|NCT03055091|Sorbitol|sorbitol|mesh-list
83243737|NCT03055091|Cathartics|cathartics|mesh-ancestor
83243738|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243739|NCT02648581|Ustekinumab|ustekinumab|mesh-list
83243740|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
83243741|NCT02609815|Metformin|metformin|mesh-list
83243742|NCT02609815|Glimepiride|glimepiride|mesh-list
83243743|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243744|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243745|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83243746|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83243747|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
83243748|NCT05132023|Metformin|metformin|mesh-list
83243749|NCT05132023|Empagliflozin|empagliflozin|mesh-list
83243750|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243751|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243752|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83243753|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243754|NCT05131711|Immunomodulating Agents|immunomodulating agents|mesh-list
83243755|NCT05131711|Immunologic Factors|immunologic factors|mesh-ancestor
83243756|NCT05131711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243757|NCT02619617|Pasireotide|pasireotide|mesh-list
83243758|NCT02619617|Hormones|hormones|mesh-ancestor
83243759|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243760|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243761|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
83243762|NCT04012957|Hematinics|hematinics|mesh-ancestor
83243763|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
83243764|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83243765|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83243766|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243767|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
83243768|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83243769|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
83243770|NCT05125627|Progesterone|progesterone|mesh-list
83243771|NCT05125627|Progestins|progestins|mesh-ancestor
83243772|NCT05125627|Hormones|hormones|mesh-ancestor
83243773|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243774|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243775|NCT05125549|Clopidogrel|clopidogrel|mesh-list
83243776|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83243777|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83243778|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83243779|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83243780|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
83243781|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243782|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243783|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243784|NCT04398719|Capsaicin|capsaicin|mesh-list
83243785|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
83243786|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
83243787|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
83243788|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243789|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243790|NCT04903847|Tenofovir|tenofovir|mesh-list
83243791|NCT04903847|Lamivudine|lamivudine|mesh-list
83243792|NCT04903847|Dolutegravir|dolutegravir|mesh-list
83243793|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
83243794|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243795|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83243796|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83243797|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243798|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243799|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83243800|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83243801|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83243802|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83243803|NCT04905953|Neostigmine|neostigmine|mesh-list
83243804|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83243805|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243806|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243807|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
83243808|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243809|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243810|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83243811|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
83243812|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243813|NCT04916093|Metformin|metformin|mesh-list
83243814|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83243815|NCT04916093|Vildagliptin|vildagliptin|mesh-list
83243816|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243817|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243818|NCT04916093|Incretins|incretins|mesh-ancestor
83243819|NCT04916093|Hormones|hormones|mesh-ancestor
83243820|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83243821|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83243822|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
83243823|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243824|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243825|NCT05130619|Ethanol|ethanol|mesh-list
83243826|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83243827|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243828|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83243829|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243830|NCT03512119|Ivacaftor|ivacaftor|mesh-list
83243831|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83243832|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83243833|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243834|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
83243835|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243836|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243837|NCT02642809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83243838|NCT02642809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243839|NCT03052361|Ondansetron|ondansetron|mesh-list
83243840|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
83243841|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
83243842|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243843|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243844|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243845|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
83243846|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83243847|NCT03052361|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83243848|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83243849|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
83243850|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243851|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243852|NCT02370589|Vaccines|vaccines|mesh-list
83243853|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
83243854|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243855|NCT01752049|Timolol|timolol|mesh-list
83243856|NCT01752049|Maleic acid|maleic acid|mesh-list
83243857|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243858|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243859|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83243860|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83243861|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243862|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243863|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243864|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83243865|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83243866|NCT04966507|Listerine|listerine|mesh-list
83243867|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83243868|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243869|NCT04949113|Nivolumab|nivolumab|mesh-list
83243870|NCT04949113|Ipilimumab|ipilimumab|mesh-list
83243871|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243872|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243873|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83243874|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243875|NCT05057845|Lenvatinib|lenvatinib|mesh-list
83243876|NCT05057845|Tislelizumab|tislelizumab|mesh-list
83243877|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243878|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83243879|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243880|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243881|NCT05057845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243882|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
83243883|NCT05109949|Empagliflozin|empagliflozin|mesh-list
83243884|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83243885|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243886|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83243887|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243888|NCT04901663|Amoxicillin|amoxicillin|mesh-list
83243889|NCT04901663|Clarithromycin|clarithromycin|mesh-list
83243890|NCT04901663|Omeprazole|omeprazole|mesh-list
83243891|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83243892|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243893|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83243894|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243895|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83243896|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243897|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243898|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83243899|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83243900|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83243901|NCT05134519|Trastuzumab|trastuzumab|mesh-list
83243902|NCT05134519|Antibodies|antibodies|mesh-list
83243903|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83243904|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
83243905|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243906|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243907|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243908|NCT04394663|Omeprazole|omeprazole|mesh-list
83243909|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83243910|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243911|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83243912|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243913|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243914|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83243915|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83243916|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243917|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
83243918|NCT04901117|Amoxicillin|amoxicillin|mesh-list
83243919|NCT04901117|Metronidazole|metronidazole|mesh-list
83243920|NCT04901117|Clarithromycin|clarithromycin|mesh-list
83243921|NCT04901117|Tetracycline|tetracycline|mesh-list
83243922|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
83243923|NCT04901117|Bismuth|bismuth|mesh-list
83243924|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243925|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83243926|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243927|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83243928|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83243929|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83243930|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243931|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83243932|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83243933|NCT04901117|Antacids|antacids|mesh-ancestor
83243934|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83243935|NCT04901117|Diuretics|diuretics|mesh-ancestor
83243936|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
83243937|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243938|NCT04901117|Expectorants|expectorants|mesh-ancestor
83243939|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
83243940|NCT05121571|Sorafenib|sorafenib|mesh-list
83243941|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243942|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83243943|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83243944|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243945|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
83243946|NCT03051269|Calcium|calcium|mesh-list
83243947|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83243948|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243949|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83243950|NCT04576663|Phenylephrine|phenylephrine|mesh-list
83243951|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
83243952|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83243954|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
83243955|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83243956|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243957|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
83243958|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83243959|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
83243960|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
83243961|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83243962|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83243963|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83243964|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
83243965|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83243966|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243967|NCT04576663|Protective Agents|protective agents|mesh-ancestor
83243968|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83243969|NCT05281549|Tenecteplase|tenecteplase|mesh-list
83243970|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83243971|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83243972|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243973|NCT04400695|Paclitaxel|paclitaxel|mesh-list
83243974|NCT04400695|Vinorelbine|vinorelbine|mesh-list
83243975|NCT04400695|Docetaxel|docetaxel|mesh-list
83243976|NCT04400695|Capecitabine|capecitabine|mesh-list
83243977|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83243978|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243979|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
83243980|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
83243981|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
83243982|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83243983|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83243984|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
83243985|NCT05205499|Sirolimus|sirolimus|mesh-list
83243986|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83243987|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83243988|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83243989|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243990|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
83243991|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83243992|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
83243993|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243994|NCT05191225|Rituximab|rituximab|mesh-list
83243995|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83243996|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83243997|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
83243998|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83243999|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244000|NCT03909217|Dexetimide|dexetimide|mesh-list
83244001|NCT03909217|Citalopram|citalopram|mesh-list
83244002|NCT03909217|Escitalopram|escitalopram|mesh-list
83244003|NCT03909217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83244004|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83244005|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83244006|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244007|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244008|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
83244009|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244010|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83244011|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83244012|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
83244013|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
83244014|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244015|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83244016|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83244017|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
83244018|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83244019|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
83244020|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83244021|NCT02650921|Lidocaine|lidocaine|mesh-list
83244022|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
83244023|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
83244024|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244025|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244026|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
83244027|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244028|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83244029|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83244030|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83244031|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83244032|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244034|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83244035|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244036|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83244037|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
83244038|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
83244039|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244040|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244041|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244042|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83244043|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83244044|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244045|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
83244046|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83244047|NCT01596335|Antibodies|antibodies|mesh-list
83244048|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
83244049|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244050|NCT04891679|Misoprostol|misoprostol|mesh-list
83244051|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83244052|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
83244053|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83244054|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244055|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83244056|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244057|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
83244058|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
83244059|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83244060|NCT04913831|Protective Agents|protective agents|mesh-ancestor
83244061|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244062|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
83244063|NCT04900415|Vitamin A|vitamin a|mesh-list
83244064|NCT04900415|Vitamins|vitamins|mesh-ancestor
83244065|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
83244066|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244067|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
83244068|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83244069|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244070|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244071|NCT04891211|Vitamin D|vitamin d|mesh-list
83244072|NCT04891211|Vitamins|vitamins|mesh-ancestor
83244073|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
83244074|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244075|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83244076|NCT04817189|Dexamethasone|dexamethasone|mesh-list
83244077|NCT04817189|Ondansetron|ondansetron|mesh-list
83244078|NCT04817189|Palonosetron|palonosetron|mesh-list
83244079|NCT04817189|Granisetron|granisetron|mesh-list
83244080|NCT04817189|Tropisetron|tropisetron|mesh-list
83244081|NCT04817189|Dolasetron|dolasetron|mesh-list
83244082|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244083|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
83244084|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
83244085|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244086|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244087|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244088|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
83244089|NCT04817189|Hormones|hormones|mesh-ancestor
83244090|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244091|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244092|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244093|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
83244094|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244095|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83244096|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83244097|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
83244098|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244099|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244100|NCT03050957|Menthol|menthol|mesh-list
83244101|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
83244102|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244103|NCT04885049|Racecadotril|racecadotril|mesh-list
83244104|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
83244105|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244106|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83244107|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244108|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244109|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83244110|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244111|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83244112|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
83244113|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244114|NCT04430621|Hormones|hormones|mesh-list
83244115|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83244116|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244117|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244118|NCT04884503|Clonazepam|clonazepam|mesh-list
83244119|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
83244120|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
83244121|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
83244122|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244123|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244124|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244125|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
83244126|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244127|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83244128|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244129|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244130|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413587|NCT04873284|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83244131|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244132|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244133|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83244134|NCT04898699|Tenofovir|tenofovir|mesh-list
83244135|NCT04898699|Emtricitabine|emtricitabine|mesh-list
83244136|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83244137|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
83244138|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244139|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83244140|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83244141|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244142|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244143|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83244144|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83244145|NCT04888715|Pirfenidone|pirfenidone|mesh-list
83244146|NCT04888715|Nintedanib|nintedanib|mesh-list
83244147|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244148|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244149|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244150|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244151|NCT04888715|Analgesics|analgesics|mesh-ancestor
83244152|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
83244153|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244154|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244155|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83244156|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83244157|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244158|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244159|NCT04888403|Paclitaxel|paclitaxel|mesh-list
83244160|NCT04888403|Nedaplatin|nedaplatin|mesh-list
83244161|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83244162|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244163|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244164|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244165|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244166|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244167|NCT03050177|Gefitinib|gefitinib|mesh-list
83244168|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244169|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244170|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244171|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244172|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83244173|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83244174|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244175|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83244176|NCT03050411|Apatinib|apatinib|mesh-list
83244177|NCT03050411|Gefitinib|gefitinib|mesh-list
83244178|NCT03050411|Osimertinib|osimertinib|mesh-list
83244179|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244180|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244181|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244182|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244183|NCT04887311|Tempol|tempol|mesh-list
83244184|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
83244185|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244186|NCT04887311|Protective Agents|protective agents|mesh-ancestor
83244187|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244188|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83244189|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244190|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83244191|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83244192|NCT04898387|Timolol|timolol|mesh-list
83244193|NCT04898387|Bimatoprost|bimatoprost|mesh-list
83244194|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83244195|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83244196|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
83244197|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244198|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244199|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244200|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83244201|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83244202|NCT03051503|Fentanyl|fentanyl|mesh-list
83244203|NCT03051503|Morphine|morphine|mesh-list
83244204|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83244205|NCT03051503|Narcotics|narcotics|mesh-ancestor
83244206|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244207|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244208|NCT03051503|Analgesics|analgesics|mesh-ancestor
83244209|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
83244210|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244211|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83244212|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83244213|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
83244214|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
83244215|NCT04896125|Bimatoprost|bimatoprost|mesh-list
83244216|NCT04896125|Latanoprost|latanoprost|mesh-list
83244217|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83244218|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83244219|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83244220|NCT04895657|Tazobactam|tazobactam|mesh-list
83244221|NCT04895657|Piperacillin|piperacillin|mesh-list
83244222|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83244223|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244224|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244225|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83244226|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244227|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244228|NCT04895423|Cyclosporine|cyclosporine|mesh-list
83244229|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
83244230|NCT04895423|Methotrexate|methotrexate|mesh-list
83244231|NCT04895423|Cyclosporins|cyclosporins|mesh-list
83244232|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83244233|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
83244234|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83244235|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244236|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83244237|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
83244238|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244239|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244240|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244241|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244242|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83244243|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83244244|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
83244245|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244246|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83244247|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
83244248|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244249|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83244250|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83244251|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83244252|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
83244253|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244255|NCT04882163|Rituximab|rituximab|mesh-list
83244256|NCT04882163|Gemcitabine|gemcitabine|mesh-list
83244257|NCT04882163|Lenalidomide|lenalidomide|mesh-list
83244258|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83244259|NCT04882163|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83244260|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244261|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244262|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
83244263|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244264|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244265|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244266|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
83244267|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
83244268|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244269|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244270|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
83244271|NCT04882163|Hormones|hormones|mesh-ancestor
83244272|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244273|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244274|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83244275|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
83244276|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244277|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83244278|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83244279|NCT04882163|Growth Substances|growth substances|mesh-ancestor
83244280|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
83244281|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83244282|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
83244283|NCT04882163|Immunoconjugates|immunoconjugates|mesh-ancestor
83244284|NCT04885751|Rebamipide|rebamipide|mesh-list
83244285|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83244286|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244287|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
83244288|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244289|NCT04885751|Protective Agents|protective agents|mesh-ancestor
83244290|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244291|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244292|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
83244293|NCT03049163|Propoxycaine|propoxycaine|mesh-list
83244294|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
83244295|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244296|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244297|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
83244298|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
83244299|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244301|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
83244302|NCT04881851|Inositol|inositol|mesh-list
83244303|NCT04881851|Hematinics|hematinics|mesh-ancestor
83244304|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
83244305|NCT04881851|Vitamins|vitamins|mesh-ancestor
83244306|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
83244307|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244308|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
83244309|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244310|NCT04881851|Protective Agents|protective agents|mesh-ancestor
83244311|NCT04871633|Azithromycin|azithromycin|mesh-list
83244312|NCT04871633|Remdesivir|remdesivir|mesh-list
83244313|NCT04871633|Dexamethasone|dexamethasone|mesh-list
83244314|NCT04871633|Prednisolone|prednisolone|mesh-list
83244315|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83244316|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244317|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
83244318|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
83244319|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244320|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244321|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244322|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
83244323|NCT04871633|Hormones|hormones|mesh-ancestor
83244324|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244325|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244326|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244327|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244328|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83244329|NCT04871633|Protective Agents|protective agents|mesh-ancestor
83244330|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244331|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244332|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
83244333|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
83244334|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
83244335|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83244336|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244337|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83244338|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244339|NCT03046979|Apatinib|apatinib|mesh-list
83244340|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244341|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244342|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244343|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244344|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83244345|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83244346|NCT04676399|Diuretics|diuretics|mesh-ancestor
83244347|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
83244348|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244349|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83244350|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83244351|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244352|NCT03047057|Lidocaine|lidocaine|mesh-list
83244353|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
83244354|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
83244355|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244356|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244357|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
83244358|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244359|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83244360|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83244361|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83244362|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83244363|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244364|NCT04550195|Famotidine|famotidine|mesh-list
83244365|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83244366|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244367|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83244368|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
83244369|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
83244370|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244371|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244372|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244373|NCT04525391|Durvalumab|durvalumab|mesh-list
83244374|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244375|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244376|NCT04879511|Metformin|metformin|mesh-list
83244377|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83244378|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244379|NCT04361825|Durvalumab|durvalumab|mesh-list
83244380|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244381|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244382|NCT03046901|Vancomycin|vancomycin|mesh-list
83244383|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244384|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244385|NCT03871049|Dexamethasone|dexamethasone|mesh-list
83244386|NCT03871049|Bupivacaine|bupivacaine|mesh-list
83244387|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244388|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
83244389|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
83244390|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244391|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244392|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244393|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
83244394|NCT03871049|Hormones|hormones|mesh-ancestor
83244395|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244396|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244397|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244398|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
83244399|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
83244400|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244401|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
83244402|NCT04870541|Nefopam|nefopam|mesh-list
83244403|NCT04870541|Ondansetron|ondansetron|mesh-list
83244404|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
83244405|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
83244406|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244407|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244408|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244409|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
83244410|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244411|NCT04870541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83244412|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83244413|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
83244414|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244415|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244416|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83244417|NCT04870541|Analgesics|analgesics|mesh-ancestor
83244418|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
83244419|NCT04870073|Mannitol|mannitol|mesh-list
83244420|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83244421|NCT04870073|Diuretics|diuretics|mesh-ancestor
83244422|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
83244423|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244424|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83244425|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83244426|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83244427|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
83244428|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244430|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
83244431|NCT04878497|Dabigatran|dabigatran|mesh-list
83244432|NCT04878497|Apixaban|apixaban|mesh-list
83244433|NCT04878497|Edoxaban|edoxaban|mesh-list
83244434|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
83244435|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83244436|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
83244437|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83244438|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
83244439|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244440|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244441|NCT03257033|Paclitaxel|paclitaxel|mesh-list
83244442|NCT03257033|Gemcitabine|gemcitabine|mesh-list
83244443|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83244444|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244445|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244446|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244447|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244448|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244449|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83244450|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
83244451|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
83244452|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244453|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244454|NCT02614859|Metformin|metformin|mesh-list
83244455|NCT02614859|Bicalutamide|bicalutamide|mesh-list
83244456|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83244457|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244458|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
83244459|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
83244460|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244461|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244462|NCT01495637|Sargramostim|sargramostim|mesh-list
83244463|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
83244464|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244465|NCT04876859|Anesthetics|anesthetics|mesh-list
83244466|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244467|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244468|NCT04876313|Paclitaxel|paclitaxel|mesh-list
83244469|NCT04876313|Nivolumab|nivolumab|mesh-list
83244470|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83244471|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244472|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244473|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244474|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244475|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244476|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244477|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244478|NCT03049085|Aspirin|aspirin|mesh-list
83244479|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244480|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83244481|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83244482|NCT03049085|Analgesics|analgesics|mesh-ancestor
83244483|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
83244484|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244485|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244486|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244487|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83244488|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83244489|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244490|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83244491|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83244492|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244494|NCT04875611|Nivolumab|nivolumab|mesh-list
83244495|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244496|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244497|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244498|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244499|NCT04386317|Terazosin|terazosin|mesh-list
83244500|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83244501|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83244502|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83244503|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
83244504|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244505|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244506|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244507|NCT04386317|Urological Agents|urological agents|mesh-ancestor
83244508|NCT05256953|Anesthetics|anesthetics|mesh-list
83244509|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244510|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244511|NCT05256719|Abatacept|abatacept|mesh-list
83244512|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244513|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244514|NCT05256719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244515|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244516|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83244517|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
83244518|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244519|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244520|NCT04874675|Acetaminophen|acetaminophen|mesh-list
83244521|NCT04874675|Ibuprofen|ibuprofen|mesh-list
83244522|NCT04874675|Diclofenac|diclofenac|mesh-list
83244523|NCT04874675|Codeine|codeine|mesh-list
83244524|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83244525|NCT04874675|Analgesics|analgesics|mesh-ancestor
83244526|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
83244527|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244528|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244529|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
83244530|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83244531|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244532|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244533|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83244534|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244535|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244536|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83244537|NCT04874675|Narcotics|narcotics|mesh-ancestor
83244538|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244539|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
83244540|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
83244541|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
83244542|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83244543|NCT04868513|Fluorides|fluorides|mesh-list
83244544|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
83244545|NCT04868513|Protective Agents|protective agents|mesh-ancestor
83244546|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244547|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83244548|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244549|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
83244550|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244551|NCT03047837|Aspirin|aspirin|mesh-list
83244552|NCT03047837|Metformin|metformin|mesh-list
83244553|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83244554|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244555|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83244556|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83244558|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
83244559|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244560|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244561|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244562|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83244563|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83244564|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244565|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83244566|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83244567|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244568|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
83244569|NCT05256173|Melatonin|melatonin|mesh-list
83244570|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
83244571|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244572|NCT05256173|Protective Agents|protective agents|mesh-ancestor
83244573|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244574|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244575|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
83244576|NCT02648347|Hematinics|hematinics|mesh-ancestor
83244577|NCT02614703|Acetic Acid|acetic acid|mesh-list
83244578|NCT02614703|Retinol acetate|retinol acetate|mesh-list
83244579|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244580|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244581|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83244582|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
83244583|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244584|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83244585|NCT02614703|Protective Agents|protective agents|mesh-ancestor
83244586|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244587|NCT01669343|Letrozole|letrozole|mesh-list
83244588|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244589|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83244590|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83244591|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244592|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244593|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83244594|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
83244595|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244596|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244597|NCT04383743|Cisplatin|cisplatin|mesh-list
83244598|NCT04383743|Doxorubicin|doxorubicin|mesh-list
83244599|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83244600|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
83244601|NCT04383743|Methotrexate|methotrexate|mesh-list
83244602|NCT04383743|Daunorubicin|daunorubicin|mesh-list
83244603|NCT04383743|Vinblastine|vinblastine|mesh-list
83244604|NCT04383743|Lenograstim|lenograstim|mesh-list
83244605|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244606|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83244607|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83244608|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83244609|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244610|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244611|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244612|NCT04383743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244613|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83244614|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
83244615|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83244616|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244617|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83244618|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
83244619|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244620|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83244621|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83244622|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
83244623|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244624|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83244625|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83244626|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83244627|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244628|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244629|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244630|NCT03126643|Nivolumab|nivolumab|mesh-list
83244631|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244632|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244633|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244634|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244635|NCT04617067|Paclitaxel|paclitaxel|mesh-list
83244636|NCT04617067|Gemcitabine|gemcitabine|mesh-list
83244637|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83244638|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244639|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244640|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244641|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244642|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244643|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83244644|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
83244645|NCT01594931|Artesunate|artesunate|mesh-list
83244646|NCT01594931|Pyronaridine|pyronaridine|mesh-list
83244647|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
83244648|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83244649|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83244650|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244651|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244652|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
83244653|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
83244654|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83244655|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
83244656|NCT03045185|Metronidazole|metronidazole|mesh-list
83244657|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
83244658|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244659|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244660|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83244661|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83244662|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83244663|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83244664|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244665|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244666|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244667|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83244668|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83244670|NCT04969237|Vitamins|vitamins|mesh-ancestor
83244671|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
83244672|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244673|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83244674|NCT04341467|Olanzapine|olanzapine|mesh-list
83244675|NCT04341467|Amisulpride|amisulpride|mesh-list
83244676|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
83244677|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
83244678|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244679|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244680|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244681|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83244682|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83244683|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244684|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83244685|NCT04341467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83244686|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83244687|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83244688|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244689|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244690|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
83244691|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83244692|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
83244693|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83244694|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
83244695|NCT04872881|Fentanyl|fentanyl|mesh-list
83244696|NCT04872881|Propofol|propofol|mesh-list
83244697|NCT04872881|Rocuronium|rocuronium|mesh-list
83244698|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83244699|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244700|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244701|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83244702|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
83244703|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
83244704|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83244705|NCT04872881|Narcotics|narcotics|mesh-ancestor
83244706|NCT04872881|Analgesics|analgesics|mesh-ancestor
83244707|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
83244708|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244709|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83244710|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83244711|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83244712|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83244713|NCT03044873|Deucravacitinib|deucravacitinib|mesh-list
83244714|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83244715|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83244716|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83244717|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
83244718|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244719|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83244720|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83244721|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244722|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244723|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244724|NCT03044795|Veliparib|veliparib|mesh-list
83244725|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83244726|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244727|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244728|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244729|NCT04341155|Dexamethasone|dexamethasone|mesh-list
83244730|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
83244731|NCT04341155|BB 1101|bb 1101|mesh-list
83244732|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244733|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
83244734|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
83244735|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244736|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244737|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244738|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
83244739|NCT04341155|Hormones|hormones|mesh-ancestor
83244740|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244741|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244742|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244743|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
83244744|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244745|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244746|NCT04865705|Paclitaxel|paclitaxel|mesh-list
83244747|NCT04865705|Cisplatin|cisplatin|mesh-list
83244748|NCT04865705|Carboplatin|carboplatin|mesh-list
83244749|NCT04865705|Tislelizumab|tislelizumab|mesh-list
83244750|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83244751|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244752|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244753|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244754|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244755|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244756|NCT04865705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244757|NCT04858997|Palbociclib|palbociclib|mesh-list
83244758|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244759|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244760|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244761|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244762|NCT05135143|Antioxidants|antioxidants|mesh-list
83244763|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244764|NCT05135143|Protective Agents|protective agents|mesh-ancestor
83244765|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244766|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83244767|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83244768|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
83244769|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244770|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83244771|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83244772|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
83244773|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244774|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244775|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83244776|NCT05305183|Alendronate|alendronate|mesh-list
83244777|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83244778|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244779|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
83244780|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
83244781|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244782|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244783|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244784|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
83244785|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
83244786|NCT05304559|Ketamine|ketamine|mesh-list
83244787|NCT05304559|Esketamine|esketamine|mesh-list
83244788|NCT05304559|Analgesics|analgesics|mesh-ancestor
83244789|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
83244790|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244791|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244792|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83244793|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83244794|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
83244795|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
83244796|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83244797|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83244798|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83244799|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244800|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244801|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
83244802|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83244803|NCT02613221|Panitumumab|panitumumab|mesh-list
83244804|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244805|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244806|NCT05304169|Leuprolide|leuprolide|mesh-list
83244807|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83244808|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
83244809|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83244810|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244811|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244812|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244813|NCT04858841|Levetiracetam|levetiracetam|mesh-list
83244814|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
83244815|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
83244816|NCT04858529|Carboplatin|carboplatin|mesh-list
83244817|NCT04858529|Docetaxel|docetaxel|mesh-list
83244818|NCT04858529|Trastuzumab|trastuzumab|mesh-list
83244819|NCT04858529|Pertuzumab|pertuzumab|mesh-list
83244820|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244821|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244822|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244823|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244824|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244825|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244826|NCT03919435|Trimethoprim|trimethoprim|mesh-list
83244827|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83244828|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
83244829|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83244830|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244831|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
83244832|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83244833|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83244834|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83244835|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244836|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244837|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83244838|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83244839|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83244840|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83244841|NCT05302921|Nivolumab|nivolumab|mesh-list
83244842|NCT05302921|Ipilimumab|ipilimumab|mesh-list
83244843|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244844|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244845|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244846|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244847|NCT04682743|Acetaminophen|acetaminophen|mesh-list
83244848|NCT04682743|Ondansetron|ondansetron|mesh-list
83244849|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83244850|NCT04682743|Analgesics|analgesics|mesh-ancestor
83244851|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
83244852|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244853|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244854|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
83244855|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
83244856|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
83244857|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244858|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
83244859|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244860|NCT04682743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83244862|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
83244863|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244864|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244865|NCT03472573|Dexamethasone|dexamethasone|mesh-list
83244866|NCT03472573|Palbociclib|palbociclib|mesh-list
83244867|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244868|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
83244869|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
83244870|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244871|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244872|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244873|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
83244874|NCT03472573|Hormones|hormones|mesh-ancestor
83244875|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244876|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244877|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244878|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83244879|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244880|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244881|NCT04636333|Vaccines|vaccines|mesh-list
83244882|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
83244883|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244884|NCT03103009|Pasireotide|pasireotide|mesh-list
83244885|NCT03103009|Hormones|hormones|mesh-ancestor
83244886|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244887|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244888|NCT03694249|Ifetroban|ifetroban|mesh-list
83244889|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83244890|NCT03020875|Acetaminophen|acetaminophen|mesh-list
83244891|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83244892|NCT03020875|Analgesics|analgesics|mesh-ancestor
83244893|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
83244894|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244895|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244896|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
83244897|NCT02996305|Gaboxadol|gaboxadol|mesh-list
83244898|NCT02996305|Analgesics|analgesics|mesh-ancestor
83244899|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
83244900|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244901|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244902|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
83244903|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
83244904|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
83244905|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83244906|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244907|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
83244908|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244909|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244910|NCT04866485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244911|NCT04866485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244912|NCT02888041|Dinoprostone|dinoprostone|mesh-list
83244913|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
83244914|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83244915|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244916|NCT02838745|Pemetrexed|pemetrexed|mesh-list
83244917|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244918|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244919|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244920|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83244921|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83244922|NCT00136435|Leucovorin|leucovorin|mesh-list
83244923|NCT00136435|Cytarabine|cytarabine|mesh-list
83244924|NCT00136435|Dexamethasone|dexamethasone|mesh-list
83244925|NCT00136435|Prednisone|prednisone|mesh-list
83244926|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
83244927|NCT00136435|Doxorubicin|doxorubicin|mesh-list
83244928|NCT00136435|Methotrexate|methotrexate|mesh-list
83244929|NCT00136435|Vincristine|vincristine|mesh-list
83244930|NCT00136435|Asparaginase|asparaginase|mesh-list
83244931|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
83244932|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83244933|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
83244934|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
83244935|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83244936|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244937|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83244938|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
83244939|NCT00136435|Hormones|hormones|mesh-ancestor
83244940|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83244941|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83244942|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244943|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83244944|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83244945|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83244946|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244947|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244948|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83244949|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
83244950|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83244951|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83244952|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
83244953|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83244954|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83244955|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83244956|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
83244957|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244958|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83244959|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
83244960|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83244961|NCT00136435|Antidotes|antidotes|mesh-ancestor
83244962|NCT00136435|Protective Agents|protective agents|mesh-ancestor
83244963|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
83244964|NCT00136435|Vitamins|vitamins|mesh-ancestor
83244965|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
83244966|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83244967|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83244968|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83244969|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83244970|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83244971|NCT04864379|Molgramostim|molgramostim|mesh-list
83244972|NCT04864379|Sargramostim|sargramostim|mesh-list
83244973|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244974|NCT04864379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244975|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244976|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
83244977|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244978|NCT04336241|Nivolumab|nivolumab|mesh-list
83244979|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83244980|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83244981|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83244982|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244983|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
83244984|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83244985|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
83244986|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83244987|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83244988|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83244989|NCT03044561|Urological Agents|urological agents|mesh-ancestor
83244990|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
83244991|NCT02455141|Carboplatin|carboplatin|mesh-list
83244992|NCT02455141|Epirubicin|epirubicin|mesh-list
83244993|NCT02455141|Taxane|taxane|mesh-list
83244994|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83244995|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
83244996|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83244997|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83244998|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83244999|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
83245000|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245001|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245002|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83245003|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83245004|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83245005|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83245006|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245007|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
83245008|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83245009|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83245010|NCT02439385|Curcumin|curcumin|mesh-list
83245011|NCT02439385|Bevacizumab|bevacizumab|mesh-list
83245012|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83245013|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245014|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83245015|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83245016|NCT02439385|Growth Substances|growth substances|mesh-ancestor
83245017|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245018|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
83245019|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83245020|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83245021|NCT02439385|Analgesics|analgesics|mesh-ancestor
83245022|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
83245023|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245024|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245025|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245026|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245027|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245028|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
83245029|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83245030|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
83245031|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245032|NCT03104959|Expectorants|expectorants|mesh-ancestor
83245033|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
83245034|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83245035|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
83245036|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245037|NCT03104959|Protective Agents|protective agents|mesh-ancestor
83245038|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245039|NCT03104959|Antidotes|antidotes|mesh-ancestor
83245040|NCT03044171|Listerine|listerine|mesh-list
83245041|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83245042|NCT03044171|Fluorides|fluorides|mesh-list
83245043|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
83245044|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
83245045|NCT03044171|Protective Agents|protective agents|mesh-ancestor
83245046|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245047|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83245048|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245049|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
83245050|NCT04856969|Olmesartan|olmesartan|mesh-list
83245051|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83245052|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245053|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83245054|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245055|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83245056|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83245057|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83245058|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
83245059|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
83245060|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245061|NCT04856111|Pirfenidone|pirfenidone|mesh-list
83245062|NCT04856111|Nintedanib|nintedanib|mesh-list
83245063|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245064|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83245065|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245066|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245067|NCT04856111|Analgesics|analgesics|mesh-ancestor
83245068|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
83245069|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245070|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245071|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83245072|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83245073|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245074|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245075|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
83245076|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83245077|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245078|NCT01371981|Cytarabine|cytarabine|mesh-list
83245079|NCT01371981|Etoposide|etoposide|mesh-list
83245080|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
83245081|NCT01371981|Daunorubicin|daunorubicin|mesh-list
83245082|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
83245083|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
83245084|NCT01371981|Bortezomib|bortezomib|mesh-list
83245085|NCT01371981|Sorafenib|sorafenib|mesh-list
83245086|NCT01371981|Asparaginase|asparaginase|mesh-list
83245087|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83245088|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245089|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83245090|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83245091|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245092|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245093|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245094|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
83245095|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
83245096|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245097|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245098|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
83245099|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245100|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83245101|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83245102|NCT01371981|Analgesics|analgesics|mesh-ancestor
83245103|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
83245104|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245105|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
83245106|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
83245107|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83245108|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83245109|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83245110|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83245111|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
83245112|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83245113|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83245114|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83245115|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245116|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245117|NCT01799629|Glycerol|glycerol|mesh-list
83245118|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83245119|NCT01799629|Protective Agents|protective agents|mesh-ancestor
83245120|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245121|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83245122|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83245123|NCT03044093|Misoprostol|misoprostol|mesh-list
83245124|NCT03044093|Mifepristone|mifepristone|mesh-list
83245125|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83245126|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
83245127|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83245128|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245129|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83245130|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245131|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
83245132|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83245133|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83245134|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83245135|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83245136|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
83245137|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83245138|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83245139|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83245140|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245141|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
83245142|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83245143|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83245144|NCT01553071|Fenretinide|fenretinide|mesh-list
83245145|NCT01553071|Safingol|safingol|mesh-list
83245146|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245147|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83245148|NCT01553071|Protective Agents|protective agents|mesh-ancestor
83245149|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245150|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245151|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245152|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
83245153|NCT01506973|Gemcitabine|gemcitabine|mesh-list
83245154|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83245155|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245156|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
83245157|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245158|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245159|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
83245160|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83245161|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83245162|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245163|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245164|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245165|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83245166|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245167|NCT03101995|Gemcitabine|gemcitabine|mesh-list
83245168|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245169|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
83245170|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245171|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245172|NCT04848467|Vaccines|vaccines|mesh-list
83245173|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
83245174|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245175|NCT03104335|Apatinib|apatinib|mesh-list
83245176|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245177|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83245178|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245179|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245180|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83245181|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83245182|NCT00484471|Valproic Acid|valproic acid|mesh-list
83245183|NCT00484471|Aripiprazole|aripiprazole|mesh-list
83245184|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
83245185|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83245186|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83245187|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83245188|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245189|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245190|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
83245191|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
83245192|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245193|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245194|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83245195|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83245196|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
83245197|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83245198|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83245199|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83245200|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83245201|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
83245202|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245203|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
83245204|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
83245205|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83245206|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83245207|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245208|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
83245209|NCT01746849|Thiotepa|thiotepa|mesh-list
83245210|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245211|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
83245212|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245213|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245214|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83245215|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
83245216|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245218|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83245219|NCT04847921|Dalbavancin|dalbavancin|mesh-list
83245220|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83245221|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245222|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
83245223|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83245224|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83245225|NCT04847687|Prednisolone|prednisolone|mesh-list
83245226|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
83245227|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83245228|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
83245229|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245230|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
83245231|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
83245232|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245233|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245234|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245235|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
83245236|NCT04847687|Hormones|hormones|mesh-ancestor
83245237|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245238|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83245239|NCT04847687|Protective Agents|protective agents|mesh-ancestor
83245240|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83245241|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245242|NCT01729455|Belimumab|belimumab|mesh-list
83245243|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245244|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
83245245|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245246|NCT03103867|Insulin|insulin|mesh-list
83245247|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83245248|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245249|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83245250|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
83245251|NCT04737343|Azathioprine|azathioprine|mesh-list
83245252|NCT04737343|Leflunomide|leflunomide|mesh-list
83245253|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
83245254|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245255|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245256|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245257|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245258|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
83245259|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245260|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245261|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245262|NCT05579769|Cyclosporine|cyclosporine|mesh-list
83245263|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
83245264|NCT05579769|Busulfan|busulfan|mesh-list
83245265|NCT05579769|Thiotepa|thiotepa|mesh-list
83245266|NCT05579769|Methotrexate|methotrexate|mesh-list
83245267|NCT05579769|Fludarabine|fludarabine|mesh-list
83245268|NCT05579769|Cyclosporins|cyclosporins|mesh-list
83245269|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
83245270|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83245271|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245272|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
83245273|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245274|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245275|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83245276|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
83245277|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245278|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245279|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83245280|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83245281|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
83245282|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83245283|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245284|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
83245285|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
83245286|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245287|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83245288|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83245289|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
83245290|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245291|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83245292|NCT02609399|Oseltamivir|oseltamivir|mesh-list
83245293|NCT02609399|Peramivir|peramivir|mesh-list
83245294|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
83245295|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245296|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245297|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245298|NCT05430217|Buspirone|buspirone|mesh-list
83245299|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83245300|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83245301|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245302|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245303|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83245304|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83245305|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
83245306|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245307|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245308|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
83245309|NCT03103555|Bortezomib|bortezomib|mesh-list
83245310|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245311|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
83245312|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245313|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245314|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83245315|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
83245316|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245317|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245318|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83245319|NCT02720185|Dasatinib|dasatinib|mesh-list
83245320|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245321|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83245322|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245323|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245324|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
83245325|NCT04846673|Pregabalin|pregabalin|mesh-list
83245326|NCT04846673|Analgesics|analgesics|mesh-ancestor
83245327|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
83245328|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245329|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245330|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
83245331|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83245332|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83245333|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245334|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83245335|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83245336|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83245337|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245338|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83245339|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
83245340|NCT04846673|Protective Agents|protective agents|mesh-ancestor
83245341|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
83245342|NCT04846673|Vitamins|vitamins|mesh-ancestor
83245343|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
83245344|NCT04498273|Aspirin|aspirin|mesh-list
83245345|NCT04498273|Apixaban|apixaban|mesh-list
83245346|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83245347|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83245348|NCT04498273|Analgesics|analgesics|mesh-ancestor
83245349|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
83245350|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245351|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245352|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245353|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245354|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83245355|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83245356|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245357|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83245358|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83245359|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245360|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
83245361|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83245362|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
83245363|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83245364|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
83245365|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
83245366|NCT01660971|Gemcitabine|gemcitabine|mesh-list
83245367|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83245368|NCT01660971|Dasatinib|dasatinib|mesh-list
83245369|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245370|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
83245371|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245372|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245373|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83245374|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245375|NCT04853615|Empagliflozin|empagliflozin|mesh-list
83245376|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83245377|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245378|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83245379|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245380|NCT05573607|Chromium|chromium|mesh-list
83245381|NCT05573607|Trace Elements|trace elements|mesh-ancestor
83245382|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
83245383|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245384|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
83245385|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245386|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83245387|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
83245388|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245389|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245390|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245391|NCT03040817|Esomeprazole|esomeprazole|mesh-list
83245392|NCT03040817|Mosapride|mosapride|mesh-list
83245393|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245394|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83245395|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245396|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83245397|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245398|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83245399|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
83245400|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245401|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245402|NCT04853069|Estradiol|estradiol|mesh-list
83245403|NCT04853069|Estrogens|estrogens|mesh-ancestor
83245404|NCT04853069|Hormones|hormones|mesh-ancestor
83245405|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245406|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245407|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83245408|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83245409|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245410|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83245411|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83245412|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83245413|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245414|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
83245415|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245416|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
83245417|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
83245418|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83245420|NCT05244811|Estradiol|estradiol|mesh-list
83245421|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83245422|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245423|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83245424|NCT05244811|Hormones|hormones|mesh-ancestor
83245425|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245426|NCT05244811|Estrogens|estrogens|mesh-ancestor
83245427|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
83245428|NCT05564403|Leucovorin|leucovorin|mesh-list
83245429|NCT05564403|Folic Acid|folic acid|mesh-list
83245430|NCT05564403|Fluorouracil|fluorouracil|mesh-list
83245431|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
83245432|NCT05564403|Calcium|calcium|mesh-list
83245433|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
83245434|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83245435|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245436|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83245437|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
83245438|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245439|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245440|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245441|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245442|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
83245443|NCT05564403|Antidotes|antidotes|mesh-ancestor
83245444|NCT05564403|Protective Agents|protective agents|mesh-ancestor
83245445|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
83245446|NCT05564403|Vitamins|vitamins|mesh-ancestor
83245447|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
83245448|NCT05564403|Hematinics|hematinics|mesh-ancestor
83245449|NCT05395065|Listerine|listerine|mesh-list
83245450|NCT05395065|Fluorides|fluorides|mesh-list
83245451|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
83245452|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
83245453|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
83245454|NCT05395065|Protective Agents|protective agents|mesh-ancestor
83245455|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245456|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83245457|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245458|NCT02710669|Propafenone|propafenone|mesh-list
83245459|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83245460|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83245461|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83245462|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83245463|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245464|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
83245465|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83245466|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245467|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83245468|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245469|NCT04851977|Vaccines|vaccines|mesh-list
83245470|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
83245471|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245472|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83245473|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83245474|NCT05370417|Fluorides|fluorides|mesh-list
83245475|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
83245476|NCT05370417|Protective Agents|protective agents|mesh-ancestor
83245477|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245478|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
83245479|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
83245480|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245481|NCT05369793|Protective Agents|protective agents|mesh-ancestor
83245482|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245483|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
83245484|NCT05369793|Vitamins|vitamins|mesh-ancestor
83245485|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
83245486|NCT04844333|Anesthetics|anesthetics|mesh-list
83245487|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245488|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245489|NCT04423185|Atezolizumab|atezolizumab|mesh-list
83245490|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
83245491|NCT04423185|Palbociclib|palbociclib|mesh-list
83245492|NCT04423185|Niraparib|niraparib|mesh-list
83245493|NCT04423185|Vemurafenib|vemurafenib|mesh-list
83245494|NCT04423185|Crizotinib|crizotinib|mesh-list
83245495|NCT04423185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83245496|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245497|NCT04423185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83245498|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245499|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83245500|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245501|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83245502|NCT05414877|Phenylephrine|phenylephrine|mesh-list
83245503|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
83245504|NCT05414877|Norepinephrine|norepinephrine|mesh-list
83245505|NCT05414877|Ephedrine|ephedrine|mesh-list
83245506|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83245507|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
83245508|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
83245509|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245510|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245511|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
83245512|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83245513|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
83245514|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
83245515|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83245516|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83245517|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83245518|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
83245519|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245520|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245521|NCT05414877|Protective Agents|protective agents|mesh-ancestor
83245522|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83245523|NCT04850885|Dexamethasone|dexamethasone|mesh-list
83245524|NCT04850885|Lidocaine|lidocaine|mesh-list
83245525|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245526|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
83245527|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
83245528|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245529|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245530|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245531|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
83245532|NCT04850885|Hormones|hormones|mesh-ancestor
83245533|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245534|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83245535|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245536|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
83245537|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
83245538|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245539|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
83245540|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83245541|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83245542|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83245543|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83245544|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245546|NCT04850417|Clopidogrel|clopidogrel|mesh-list
83245547|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83245548|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83245549|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83245550|NCT04850417|Analgesics|analgesics|mesh-ancestor
83245551|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
83245552|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245553|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245554|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245555|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83245556|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83245557|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83245558|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245559|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83245560|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83245561|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245562|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
83245563|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83245564|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83245565|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83245566|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
83245567|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245568|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83245569|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
83245570|NCT04843943|Bevacizumab|bevacizumab|mesh-list
83245571|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83245572|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245573|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83245574|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83245575|NCT04843943|Growth Substances|growth substances|mesh-ancestor
83245576|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245577|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
83245578|NCT04850261|Nafarelin|nafarelin|mesh-list
83245579|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83245580|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
83245581|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83245582|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245583|NCT04843553|Niacinamide|niacinamide|mesh-list
83245585|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
83245586|NCT04843553|Vitamins|vitamins|mesh-ancestor
83245587|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
83245588|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245589|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
83245591|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
83245592|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245593|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83245594|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
83245595|NCT02684461|Paclitaxel|paclitaxel|mesh-list
83245596|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
83245597|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83245598|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245599|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
83245600|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
83245601|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
83245602|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245603|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83245604|NCT02684461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83245605|NCT03040193|Lidocaine|lidocaine|mesh-list
83245606|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
83245607|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
83245608|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245609|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245610|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
83245611|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245612|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83245613|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83245614|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83245616|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245617|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
83245618|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83245619|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245620|NCT03039101|Montelukast|montelukast|mesh-list
83245621|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83245622|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
83245623|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83245624|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
83245625|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245626|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245627|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83245628|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83245629|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245630|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83245631|NCT03594175|Reteplase|reteplase|mesh-list
83245632|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83245633|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83245634|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245635|NCT03103399|Levodopa|levodopa|mesh-list
83245636|NCT03103399|Carbidopa|carbidopa|mesh-list
83245637|NCT03103399|Entacapone|entacapone|mesh-list
83245638|NCT03103399|Benserazide|benserazide|mesh-list
83245639|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
83245640|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
83245641|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83245642|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83245643|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
83245644|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245645|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245646|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245647|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245648|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83245649|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83245650|NCT05357833|Hematinics|hematinics|mesh-ancestor
83245651|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83245652|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83245653|NCT03043157|Rocuronium|rocuronium|mesh-list
83245654|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83245655|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83245656|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83245657|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245658|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245659|NCT05339113|FAPI-46|fapi-46|mesh-list
83245660|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83245661|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245662|NCT05332795|Metformin|metformin|mesh-list
83245663|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83245664|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245665|NCT04370483|Leflunomide|leflunomide|mesh-list
83245666|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245667|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245668|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83245669|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
83245670|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245671|NCT03042923|Mannitol|mannitol|mesh-list
83245672|NCT03042923|Lactulose|lactulose|mesh-list
83245673|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83245674|NCT03042923|Diuretics|diuretics|mesh-ancestor
83245675|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
83245676|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245677|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245678|NCT04429295|Vaccines|vaccines|mesh-list
83245679|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
83245680|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245681|NCT05258851|Colistin|colistin|mesh-list
83245682|NCT05258851|Ceftazidime|ceftazidime|mesh-list
83245683|NCT05258851|Avibactam|avibactam|mesh-list
83245684|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83245685|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83245686|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245687|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83245688|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245689|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245690|NCT03043001|Memantine|memantine|mesh-list
83245691|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83245692|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83245693|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
83245694|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245695|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245696|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245697|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83245698|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83245699|NCT04843007|Pemetrexed|pemetrexed|mesh-list
83245700|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245701|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245702|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245703|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83245704|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83245705|NCT04840745|Leuprolide|leuprolide|mesh-list
83245706|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83245707|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
83245708|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83245709|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245710|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83245711|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245712|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
83245713|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83245714|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
83245715|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245716|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
83245717|NCT05072899|Protective Agents|protective agents|mesh-ancestor
83245718|NCT04839653|Vancomycin|vancomycin|mesh-list
83245719|NCT04839653|Gentamicins|gentamicins|mesh-list
83245720|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
83245721|NCT04839653|Polymyxins|polymyxins|mesh-list
83245722|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83245723|NCT04839653|Cefotaxime|cefotaxime|mesh-list
83245724|NCT04839653|Cefoxitin|cefoxitin|mesh-list
83245725|NCT04839653|Polymyxin B|polymyxin b|mesh-list
83245726|NCT04839653|Amphotericin B|amphotericin b|mesh-list
83245727|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83245728|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245729|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83245730|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245731|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245732|NCT04839653|Amebicides|amebicides|mesh-ancestor
83245733|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83245734|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83245735|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
83245736|NCT04842383|Peppermint oil|peppermint oil|mesh-list
83245737|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
83245738|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
83245739|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245740|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245741|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245742|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
83245743|NCT04884139|Tenofovir|tenofovir|mesh-list
83245744|NCT04884139|Lamivudine|lamivudine|mesh-list
83245745|NCT04884139|Emtricitabine|emtricitabine|mesh-list
83245746|NCT04884139|Dolutegravir|dolutegravir|mesh-list
83245747|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
83245748|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245749|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83245750|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83245751|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245752|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245753|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83245754|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83245755|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83245756|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83245757|NCT04860167|Diclofenac|diclofenac|mesh-list
83245758|NCT04860167|Lidocaine|lidocaine|mesh-list
83245759|NCT04860167|Propofol|propofol|mesh-list
83245760|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83245761|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245762|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245763|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83245764|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
83245765|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
83245766|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83245773|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83245774|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245775|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245776|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
83245777|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83245779|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83245780|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83245781|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
83245782|NCT02514031|Paclitaxel|paclitaxel|mesh-list
83245783|NCT02514031|Gemcitabine|gemcitabine|mesh-list
83245784|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83245785|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245786|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
83245787|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
83245788|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
83245789|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245790|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83245791|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
83245792|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245793|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83245794|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83245795|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245796|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
83245802|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
83245803|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83245804|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83245805|NCT04622917|Prednisolone|prednisolone|mesh-list
83245806|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
83245807|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83245808|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
83245809|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245810|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
83245811|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
83245812|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245813|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245814|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245815|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
83245816|NCT04622917|Hormones|hormones|mesh-ancestor
83245817|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245818|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83245819|NCT04622917|Protective Agents|protective agents|mesh-ancestor
83245820|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83245821|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245822|NCT03038477|Durvalumab|durvalumab|mesh-list
83245823|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83245824|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245825|NCT03038243|Vaccines|vaccines|mesh-list
83245826|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
83245827|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245828|NCT03038321|Levofloxacin|levofloxacin|mesh-list
83245829|NCT03038321|Lornoxicam|lornoxicam|mesh-list
83245830|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83245831|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245832|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83245833|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83245834|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83245835|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245836|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245837|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245838|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83245839|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83245840|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83245841|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83245842|NCT03038321|Analgesics|analgesics|mesh-ancestor
83245843|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
83245844|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245845|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245846|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245848|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83245849|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
83245850|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245851|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
83245852|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83245853|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83245854|NCT03042377|Calcium|calcium|mesh-list
83245855|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83245856|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245857|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83245858|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245859|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
83245860|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
83245861|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83245862|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245863|NCT04859777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83245864|NCT04859777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245865|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
83245866|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83245867|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83245868|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245869|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
83245870|NCT05562609|Coagulants|coagulants|mesh-ancestor
83245871|NCT05071339|Ganirelix|ganirelix|mesh-list
83245872|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
83245873|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245874|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245875|NCT02606279|Valsartan|valsartan|mesh-list
83245876|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83245877|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83245878|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83245879|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245880|NCT04859621|Vitamin D|vitamin d|mesh-list
83245881|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
83245882|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
83245883|NCT04859621|Vitamins|vitamins|mesh-list
83245884|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83245885|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
83245886|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245887|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83245888|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83245889|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83245890|NCT03039491|Vaccines|vaccines|mesh-list
83245891|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83245892|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
83245893|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245894|NCT03037775|Nicotine|nicotine|mesh-list
83245895|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83245896|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
83245897|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245898|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245899|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83245900|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83245901|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
83245902|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245903|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245904|NCT03039257|Vitamin A|vitamin a|mesh-list
83245905|NCT03039257|Vitamins|vitamins|mesh-ancestor
83245906|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
83245907|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245908|NCT03038009|Pantoprazole|pantoprazole|mesh-list
83245909|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83245910|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245911|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83245912|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245913|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245914|NCT03466801|Prednisone|prednisone|mesh-list
83245915|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
83245916|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83245917|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245918|NCT03466801|Hormones|hormones|mesh-ancestor
83245919|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245920|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245921|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83245922|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245923|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
83245924|NCT05069779|Diazepam|diazepam|mesh-list
83245925|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83245926|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
83245927|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
83245928|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
83245929|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245930|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245931|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245932|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83245933|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245934|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83245935|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83245936|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83245937|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83245938|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83245939|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83245940|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
83245941|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
83245942|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
83245943|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
83245944|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245945|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245946|NCT03251911|Ivacaftor|ivacaftor|mesh-list
83245947|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83245948|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83245949|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245950|NCT02643355|Clonidine|clonidine|mesh-list
83245951|NCT02643355|Olanzapine|olanzapine|mesh-list
83245952|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
83245953|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
83245954|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245955|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245956|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245957|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83245958|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83245959|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245960|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83245961|NCT02643355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83245962|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83245963|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83245964|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245965|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83245966|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
83245967|NCT02643355|Analgesics|analgesics|mesh-ancestor
83245968|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
83245969|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83245970|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
83245971|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83245972|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83245973|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83245974|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
83245975|NCT03036605|Dexamethasone|dexamethasone|mesh-list
83245976|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
83245977|NCT03036605|Bupivacaine|bupivacaine|mesh-list
83245978|NCT03036605|BB 1101|bb 1101|mesh-list
83245979|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83245980|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
83245981|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
83245982|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83245983|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83245984|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83245985|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
83245986|NCT03036605|Hormones|hormones|mesh-ancestor
83245987|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83245988|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83245989|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83245990|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
83245991|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83245992|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83245993|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
83245994|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
83245995|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83245996|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
83245997|NCT03098875|Remifentanil|remifentanil|mesh-list
83245998|NCT03098875|Propofol|propofol|mesh-list
83245999|NCT03098875|Sevoflurane|sevoflurane|mesh-list
83246000|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83246001|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246002|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246003|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83246004|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
83246005|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
83246006|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83246007|NCT03098875|Narcotics|narcotics|mesh-ancestor
83246008|NCT03098875|Analgesics|analgesics|mesh-ancestor
83246009|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
83246010|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246011|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83246012|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83246013|NCT03099031|Tinzaparin|tinzaparin|mesh-list
83246014|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83246015|NCT03099031|Dalteparin|dalteparin|mesh-list
83246016|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
83246017|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83246018|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83246019|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246020|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83246021|NCT04785287|Nivolumab|nivolumab|mesh-list
83246022|NCT04785287|Antibodies|antibodies|mesh-list
83246023|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
83246024|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83246025|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
83246026|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246027|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246028|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83246029|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246030|NCT03101137|Dexamethasone|dexamethasone|mesh-list
83246031|NCT03101137|Bupivacaine|bupivacaine|mesh-list
83246032|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246033|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
83246034|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
83246035|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246036|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246037|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246038|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
83246039|NCT03101137|Hormones|hormones|mesh-ancestor
83246040|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246041|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83246042|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246043|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
83246044|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
83246045|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246046|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
83246047|NCT04833257|Tislelizumab|tislelizumab|mesh-list
83246048|NCT04833257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246049|NCT04833257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246050|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83246051|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83246052|NCT04833101|Vaccines|vaccines|mesh-list
83246053|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
83246054|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246055|NCT00794599|Cetirizine|cetirizine|mesh-list
83246056|NCT00794599|Desloratadine|desloratadine|mesh-list
83246057|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83246058|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83246059|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83246060|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
83246061|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
83246062|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246063|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246064|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246065|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83246066|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
83246067|NCT00783133|Fexofenadine|fexofenadine|mesh-list
83246068|NCT00783133|Desloratadine|desloratadine|mesh-list
83246069|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83246070|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
83246071|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246072|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246073|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246074|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83246075|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83246076|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
83246077|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
83246078|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83246079|NCT03098407|Buprenorphine|buprenorphine|mesh-list
83246080|NCT03098407|Methadone|methadone|mesh-list
83246081|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83246082|NCT03098407|Narcotics|narcotics|mesh-ancestor
83246083|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246084|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246085|NCT03098407|Analgesics|analgesics|mesh-ancestor
83246086|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
83246087|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246088|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83246089|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
83246090|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
83246091|NCT04836143|Mitogens|mitogens|mesh-list
83246092|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
83246093|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83246094|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246095|NCT04836143|Growth Substances|growth substances|mesh-ancestor
83246096|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246097|NCT05068453|Antibodies|antibodies|mesh-list
83246098|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83246099|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
83246100|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246101|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
83246102|NCT00751075|Amoxicillin|amoxicillin|mesh-list
83246103|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246104|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246105|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246106|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246107|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83246108|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
83246109|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246110|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246111|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83246112|NCT04836299|Ivermectin|ivermectin|mesh-list
83246113|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83246114|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246115|NCT00651391|Simvastatin|simvastatin|mesh-list
83246116|NCT00651391|Ezetimibe|ezetimibe|mesh-list
83246117|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83246118|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83246119|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
83246120|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246121|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83246122|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83246123|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246124|NCT00650689|Atorvastatin|atorvastatin|mesh-list
83246125|NCT00650689|Ezetimibe|ezetimibe|mesh-list
83246126|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83246127|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83246128|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
83246129|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246130|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83246131|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83246132|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246133|NCT05067517|Nintedanib|nintedanib|mesh-list
83246134|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246135|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83246136|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246137|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246138|NCT03100513|Lactulose|lactulose|mesh-list
83246139|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246140|NCT00552097|Simvastatin|simvastatin|mesh-list
83246141|NCT00552097|Ezetimibe|ezetimibe|mesh-list
83246142|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83246143|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83246145|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246146|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83246147|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83246148|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246149|NCT00396175|Finasteride|finasteride|mesh-list
83246150|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246151|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246152|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83246153|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83246154|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246155|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
83246156|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246157|NCT00396175|Urological Agents|urological agents|mesh-ancestor
83246158|NCT02603393|Fluticasone|fluticasone|mesh-list
83246159|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
83246160|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83246161|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246162|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83246163|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
83246164|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246165|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246166|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83246167|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
83246168|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246169|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83246170|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
83246171|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83246172|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
83246173|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246174|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246175|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83246176|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83246177|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83246178|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
83246179|NCT04832945|Ivermectin|ivermectin|mesh-list
83246180|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83246181|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246182|NCT02642653|Lovastatin|lovastatin|mesh-list
83246183|NCT02642653|L 647318|l 647318|mesh-list
83246184|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
83246185|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83246186|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83246187|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
83246188|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246189|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83246190|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83246191|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246192|NCT01659567|Interferons|interferons|mesh-list
83246193|NCT01659567|Ribavirin|ribavirin|mesh-list
83246194|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
83246195|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
83246196|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83246197|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246198|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
83246199|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246200|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
83246201|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246202|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
83246203|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246204|NCT05363631|Selenium|selenium|mesh-list
83246205|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
83246206|NCT05363631|Axitinib|axitinib|mesh-list
83246207|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246208|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246209|NCT05363631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83246210|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246211|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83246212|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246213|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
83246214|NCT05363631|Protective Agents|protective agents|mesh-ancestor
83246215|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246216|NCT05363631|Trace Elements|trace elements|mesh-ancestor
83246217|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
83246218|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
83246219|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83246220|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246221|NCT03036995|Apremilast|apremilast|mesh-list
83246222|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83246223|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83246224|NCT03036995|Analgesics|analgesics|mesh-ancestor
83246225|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
83246226|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246227|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246228|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246229|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246230|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83246231|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83246232|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246233|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246234|NCT05066035|Neostigmine|neostigmine|mesh-list
83246235|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83246236|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246237|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246238|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
83246239|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246240|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246241|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83246242|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
83246243|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246245|NCT04822649|Analgesics|analgesics|mesh-ancestor
83246246|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
83246247|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246248|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246249|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83246250|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
83246251|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83246252|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
83246253|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
83246254|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246255|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246256|NCT04822415|Mepivacaine|mepivacaine|mesh-list
83246257|NCT04822415|Carticaine|carticaine|mesh-list
83246258|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
83246259|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
83246260|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246261|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246262|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
83246263|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246264|NCT05065177|Vaccines|vaccines|mesh-list
83246265|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
83246266|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246267|NCT04821947|Bupivacaine|bupivacaine|mesh-list
83246268|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
83246269|NCT04821947|Anesthetics|anesthetics|mesh-list
83246270|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246271|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246272|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
83246273|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246274|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83246275|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83246276|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83246277|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83246278|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246279|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246280|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246281|NCT03037073|Analgesics|analgesics|mesh-ancestor
83246282|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
83246283|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246284|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
83246285|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83246286|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
83246287|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83246288|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83246289|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246290|NCT04470973|Amikacin|amikacin|mesh-list
83246291|NCT04470973|Cefuroxime|cefuroxime|mesh-list
83246292|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
83246293|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246294|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246295|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
83246296|NCT05046457|Provitamins|provitamins|mesh-ancestor
83246297|NCT05046457|Vitamins|vitamins|mesh-ancestor
83246298|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
83246299|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246300|NCT05063071|Tenofovir|tenofovir|mesh-list
83246301|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
83246302|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246303|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83246304|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83246305|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246306|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246307|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83246308|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83246309|NCT05062681|Dexamethasone|dexamethasone|mesh-list
83246310|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
83246311|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83246312|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83246313|NCT05062681|Prednisolone|prednisolone|mesh-list
83246314|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
83246315|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83246316|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
83246317|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246318|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
83246319|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
83246320|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246321|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246322|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246323|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
83246325|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246326|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83246327|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246328|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83246329|NCT05062681|Protective Agents|protective agents|mesh-ancestor
83246330|NCT05056519|Vaccines|vaccines|mesh-list
83246331|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
83246332|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246333|NCT05045443|Curcumin|curcumin|mesh-list
83246334|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83246335|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83246336|NCT05045443|Analgesics|analgesics|mesh-ancestor
83246337|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
83246338|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246339|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246340|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246341|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246342|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246343|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246344|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246345|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83246346|NCT05045053|Lifitegrast|lifitegrast|mesh-list
83246347|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83246348|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83246349|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
83246350|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246351|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246352|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246353|NCT05060809|Vitamin K|vitamin k|mesh-list
83246354|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
83246355|NCT05060809|Vitamins|vitamins|mesh-ancestor
83246356|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
83246357|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246358|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83246359|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83246360|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246361|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
83246362|NCT05060809|Coagulants|coagulants|mesh-ancestor
83246363|NCT05060419|Meropenem|meropenem|mesh-list
83246364|NCT05060419|Tazobactam|tazobactam|mesh-list
83246365|NCT05060419|Piperacillin|piperacillin|mesh-list
83246366|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83246367|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246368|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246369|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83246371|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246372|NCT03097003|Apremilast|apremilast|mesh-list
83246373|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83246374|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83246375|NCT03097003|Analgesics|analgesics|mesh-ancestor
83246376|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
83246377|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246378|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246379|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246380|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246381|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83246382|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83246383|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246384|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246385|NCT02605967|Spartalizumab|spartalizumab|mesh-list
83246386|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83246387|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246388|NCT02605967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246389|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246390|NCT03036059|Ivermectin|ivermectin|mesh-list
83246391|NCT03036059|Albendazole|albendazole|mesh-list
83246392|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83246393|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246394|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
83246395|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
83246396|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83246397|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83246398|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83246399|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83246400|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83246401|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246402|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246403|NCT04834427|Ketamine|ketamine|mesh-list
83246404|NCT04834427|Esketamine|esketamine|mesh-list
83246405|NCT04834427|Analgesics|analgesics|mesh-ancestor
83246406|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
83246407|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246408|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246409|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83246410|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83246411|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
83246412|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
83246413|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246414|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83246415|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83246416|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246417|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246418|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
83246419|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83246420|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83246421|NCT05035849|Acarbose|acarbose|mesh-list
83246422|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83246423|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246424|NCT05035849|Incretins|incretins|mesh-ancestor
83246425|NCT05035849|Hormones|hormones|mesh-ancestor
83246426|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246427|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83246428|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
83246429|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246430|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246431|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83246432|NCT04428437|Lenvatinib|lenvatinib|mesh-list
83246433|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246434|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83246435|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246436|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246437|NCT05035381|Leucovorin|leucovorin|mesh-list
83246438|NCT05035381|Bevacizumab|bevacizumab|mesh-list
83246439|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
83246441|NCT05035381|Irinotecan|irinotecan|mesh-list
83246442|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83246443|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246444|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246445|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83246446|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83246447|NCT05035381|Growth Substances|growth substances|mesh-ancestor
83246448|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246449|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
83246450|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246451|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
83246452|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83246453|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83246454|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
83246455|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83246456|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83246457|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246458|NCT05035381|Antidotes|antidotes|mesh-ancestor
83246459|NCT05035381|Protective Agents|protective agents|mesh-ancestor
83246460|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
83246461|NCT05035381|Vitamins|vitamins|mesh-ancestor
83246462|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
83246463|NCT04821323|Indomethacin|indomethacin|mesh-list
83246464|NCT04821323|Mannitol|mannitol|mesh-list
83246465|NCT04821323|Lactulose|lactulose|mesh-list
83246466|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83246467|NCT04821323|Diuretics|diuretics|mesh-ancestor
83246468|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
83246469|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246470|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83246471|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83246472|NCT04821323|Analgesics|analgesics|mesh-ancestor
83246473|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
83246474|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246475|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246476|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246477|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
83246478|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
83246479|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83246480|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83246481|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246482|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246483|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246484|NCT05035069|Propofol|propofol|mesh-list
83246485|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83246486|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246487|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246488|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83246489|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
83246490|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
83246491|NCT05035147|Paclitaxel|paclitaxel|mesh-list
83246492|NCT05035147|Gemcitabine|gemcitabine|mesh-list
83246493|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83246494|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83246495|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246496|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
83246497|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
83246498|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
83246499|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246500|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83246501|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
83246502|NCT04834115|Ivermectin|ivermectin|mesh-list
83246503|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83246504|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246505|NCT01505465|Melatonin|melatonin|mesh-list
83246506|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
83246507|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246508|NCT01505465|Protective Agents|protective agents|mesh-ancestor
83246509|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246510|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246511|NCT04831229|Menthol|menthol|mesh-list
83246512|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
83246513|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246514|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
83246515|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83246516|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83246517|NCT04816253|Prednisolone|prednisolone|mesh-list
83246518|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
83246519|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83246520|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
83246522|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246523|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
83246524|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
83246525|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246526|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246527|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246528|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
83246529|NCT04816253|Hormones|hormones|mesh-ancestor
83246530|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246531|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83246532|NCT04816253|Protective Agents|protective agents|mesh-ancestor
83246533|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83246534|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246535|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83246536|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
83246537|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
83246538|NCT04816097|Dexamethasone|dexamethasone|mesh-list
83246539|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83246540|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246541|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
83246542|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
83246543|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246544|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246545|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246546|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
83246547|NCT04816097|Hormones|hormones|mesh-ancestor
83246548|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246549|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83246550|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246551|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
83246552|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83246553|NCT02600351|Ledipasvir|ledipasvir|mesh-list
83246554|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
83246555|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246556|NCT04829435|Rasburicase|rasburicase|mesh-list
83246557|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
83246558|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246559|NCT05042635|Ixekizumab|ixekizumab|mesh-list
83246560|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246561|NCT04815395|Oxytocin|oxytocin|mesh-list
83246562|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
83246563|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83246564|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246565|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
83246566|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246567|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
83246568|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
83246569|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246570|NCT05034055|Atezolizumab|atezolizumab|mesh-list
83246571|NCT05034055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83246572|NCT05034055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246573|NCT05034055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246574|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246575|NCT05042245|Silymarin|silymarin|mesh-list
83246576|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
83246577|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
83246578|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246579|NCT05042245|Protective Agents|protective agents|mesh-ancestor
83246580|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246581|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83246582|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83246583|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246584|NCT03095209|Paclitaxel|paclitaxel|mesh-list
83246585|NCT03095209|Carboplatin|carboplatin|mesh-list
83246586|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83246587|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246588|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83246589|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83246590|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83246591|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246592|NCT05034133|Cisplatin|cisplatin|mesh-list
83246593|NCT05034133|Etoposide|etoposide|mesh-list
83246594|NCT05034133|Durvalumab|durvalumab|mesh-list
83246595|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246596|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83246597|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83246598|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83246599|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246600|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246601|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246602|NCT03096457|Paromomycin|paromomycin|mesh-list
83246603|NCT03096457|Pentamidine|pentamidine|mesh-list
83246604|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246605|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246606|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83246607|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83246608|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
83246609|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83246610|NCT03096223|KHK4083|khk4083|mesh-list
83246611|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246612|NCT04814303|Morphine|morphine|mesh-list
83246613|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83246614|NCT04814303|Narcotics|narcotics|mesh-ancestor
83246615|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246616|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246617|NCT04814303|Analgesics|analgesics|mesh-ancestor
83246618|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
83246619|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246620|NCT05053009|Ibuprofen|ibuprofen|mesh-list
83246621|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83246622|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83246623|NCT05053009|Analgesics|analgesics|mesh-ancestor
83246624|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
83246625|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246626|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246627|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246628|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246629|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83246630|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246631|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246632|NCT04813913|Bevacizumab|bevacizumab|mesh-list
83246633|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246634|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246635|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83246636|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83246637|NCT04813913|Growth Substances|growth substances|mesh-ancestor
83246638|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246639|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
83246640|NCT03094663|Cefazolin|cefazolin|mesh-list
83246641|NCT03094663|Dexamethasone|dexamethasone|mesh-list
83246642|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
83246643|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
83246644|NCT03094663|Epinephrine|epinephrine|mesh-list
83246645|NCT03094663|Bupivacaine|bupivacaine|mesh-list
83246646|NCT03094663|BB 1101|bb 1101|mesh-list
83246647|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246648|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
83246649|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
83246650|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246651|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246652|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246653|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
83246654|NCT03094663|Hormones|hormones|mesh-ancestor
83246655|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246656|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83246657|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246658|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
83246659|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246660|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246661|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
83246662|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
83246663|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246664|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
83246665|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83246666|NCT03094663|Protective Agents|protective agents|mesh-ancestor
83246667|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83246668|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83246669|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
83246670|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246671|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83246672|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83246673|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83246674|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
83246675|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
83246676|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
83246677|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83246678|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246679|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246680|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
83246681|NCT04814381|Ketamine|ketamine|mesh-list
83246682|NCT04814381|Analgesics|analgesics|mesh-ancestor
83246683|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
83246684|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246685|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246686|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83246687|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83246688|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
83246689|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
83246690|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246691|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83246692|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83246693|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246694|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246695|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83246696|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
83246697|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83246698|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83246699|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83246700|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
83246701|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83246702|NCT04819217|Charcoal|charcoal|mesh-list
83246703|NCT04819217|Antidotes|antidotes|mesh-ancestor
83246704|NCT04819217|Protective Agents|protective agents|mesh-ancestor
83246705|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246706|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83246707|NCT05052619|Cefmetazole|cefmetazole|mesh-list
83246708|NCT05052619|Sulperazone|sulperazone|mesh-list
83246709|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246710|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83246711|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
83246712|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83246713|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246714|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
83246715|NCT04813523|Cisplatin|cisplatin|mesh-list
83246716|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
83246717|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246718|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246719|NCT04813523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83246720|NCT04813523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246721|NCT05032261|Norepinephrine|norepinephrine|mesh-list
83246722|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83246723|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83246724|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83246725|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246726|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246727|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246728|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
83246729|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
83246730|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246731|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83246732|NCT05619341|Psyllium|psyllium|mesh-list
83246733|NCT05619341|Cathartics|cathartics|mesh-ancestor
83246734|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246735|NCT04814069|Tislelizumab|tislelizumab|mesh-list
83246736|NCT04814069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246737|NCT04814069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246738|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
83246739|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
83246740|NCT05051137|Infliximab|infliximab|mesh-list
83246741|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
83246742|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83246743|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83246744|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246745|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246746|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246747|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83246748|NCT05051137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83246749|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246750|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246751|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246752|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83246753|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83246754|NCT05051137|Analgesics|analgesics|mesh-ancestor
83246755|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
83246756|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246757|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246758|NCT05038969|Esomeprazole|esomeprazole|mesh-list
83246759|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83246760|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246761|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83246762|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246763|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246764|NCT05038657|Atezolizumab|atezolizumab|mesh-list
83246765|NCT05038657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83246766|NCT05038657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246767|NCT05038657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83246768|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246769|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
83246770|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83246771|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246772|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246773|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83246774|NCT05038111|Analgesics|analgesics|mesh-ancestor
83246775|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
83246776|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246777|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83246778|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83246779|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83246780|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
83246781|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83246782|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246783|NCT05030077|Carboplatin|carboplatin|mesh-list
83246784|NCT05030077|Gemcitabine|gemcitabine|mesh-list
83246785|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246786|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83246787|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
83246788|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246789|NCT05029531|Immunomodulating Agents|immunomodulating agents|mesh-list
83246790|NCT05029531|Immunologic Factors|immunologic factors|mesh-ancestor
83246791|NCT05029531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246792|NCT05029453|Apatinib|apatinib|mesh-list
83246793|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246794|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83246795|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246796|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246797|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
83246798|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
83246799|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246800|NCT05037253|Vitamin D|vitamin d|mesh-list
83246801|NCT05037253|Vitamins|vitamins|mesh-ancestor
83246802|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
83246803|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246804|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83246805|NCT05029297|Capsaicin|capsaicin|mesh-list
83246806|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
83246807|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246808|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
83246809|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246810|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246811|NCT05028907|Tocopherols|tocopherols|mesh-list
83246812|NCT05028907|Vitamin E|vitamin e|mesh-list
83246813|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
83246814|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
83246815|NCT05028907|Dexamethasone|dexamethasone|mesh-list
83246816|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
83246817|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
83246818|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83246819|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
83246820|NCT05028907|BB 1101|bb 1101|mesh-list
83246821|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246822|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
83246823|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
83246824|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246825|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246826|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246828|NCT05028907|Hormones|hormones|mesh-ancestor
83246829|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246830|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83246831|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246832|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83246833|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
83246834|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
83246835|NCT05028907|Protective Agents|protective agents|mesh-ancestor
83246836|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
83246837|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246838|NCT05028907|Vitamins|vitamins|mesh-ancestor
83246839|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
83246840|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
83246841|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246842|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246843|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246844|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83246845|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83246846|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83246847|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
83246848|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
83246849|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83246850|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
83246851|NCT05050357|Norethindrone|norethindrone|mesh-list
83246852|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
83246853|NCT05050357|Progestins|progestins|mesh-list
83246854|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83246855|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83246856|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83246857|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
83246858|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83246859|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246860|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83246861|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83246862|NCT05050357|Hormones|hormones|mesh-ancestor
83246863|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246864|NCT05028049|Sufentanil|sufentanil|mesh-list
83246865|NCT05028049|Remifentanil|remifentanil|mesh-list
83246866|NCT05028049|Dsuvia|dsuvia|mesh-list
83246867|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83246868|NCT05028049|Narcotics|narcotics|mesh-ancestor
83246869|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246870|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246871|NCT05028049|Analgesics|analgesics|mesh-ancestor
83246872|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
83246873|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246874|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83246875|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83246876|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
83246877|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
83246878|NCT05023915|Dexamethasone|dexamethasone|mesh-list
83246879|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
83246880|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246881|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
83246882|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
83246883|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246884|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246885|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83246886|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
83246887|NCT05023915|Hormones|hormones|mesh-ancestor
83246888|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83246889|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83246890|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246891|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
83246892|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83246893|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
83246894|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246895|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
83246896|NCT05027581|Protective Agents|protective agents|mesh-ancestor
83246897|NCT05027191|Sevoflurane|sevoflurane|mesh-list
83246899|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83246900|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83246901|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
83246902|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
83246903|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246904|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246905|NCT03094507|Dolutegravir|dolutegravir|mesh-list
83246906|NCT03094507|Darunavir|darunavir|mesh-list
83246907|NCT03094507|Cobicistat|cobicistat|mesh-list
83246908|NCT03094507|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83246909|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83246910|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83246911|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246912|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246913|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83246914|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83246915|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
83246916|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246917|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83246918|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83246919|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
83246920|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83246921|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83246922|NCT02528253|Tramadol|tramadol|mesh-list
83246923|NCT02528253|Tanezumab|tanezumab|mesh-list
83246924|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83246925|NCT02528253|Narcotics|narcotics|mesh-ancestor
83246926|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83246927|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246928|NCT02528253|Analgesics|analgesics|mesh-ancestor
83246929|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
83246930|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246931|NCT03093103|Empagliflozin|empagliflozin|mesh-list
83246932|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83246933|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246935|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246936|NCT03093805|Calcipotriene|calcipotriene|mesh-list
83246937|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246938|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83246939|NCT03093883|Hematinics|hematinics|mesh-ancestor
83246940|NCT05023759|Cannabidiol|cannabidiol|mesh-list
83246941|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
83246942|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
83246943|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83246944|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83246945|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83246946|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83246947|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
83246948|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246949|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246950|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246951|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246952|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
83246953|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246954|NCT05047393|Vitamin D|vitamin d|mesh-list
83246955|NCT05047393|Vitamins|vitamins|mesh-ancestor
83246956|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
83246957|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246958|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83246959|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83246960|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246961|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83246962|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83246963|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83246964|NCT05021887|Fluticasone|fluticasone|mesh-list
83246965|NCT05021887|Xhance|xhance|mesh-list
83246966|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83246967|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83246968|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
83246969|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83246970|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83246971|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83246972|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
83246973|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
83246974|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83246975|NCT05021731|Rifampin|rifampin|mesh-list
83246976|NCT05021731|Rifapentine|rifapentine|mesh-list
83246977|NCT05021731|Isoniazid|isoniazid|mesh-list
83246978|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83246979|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
83246980|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83246981|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83246982|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
83246983|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83246984|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83246985|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83246986|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83246987|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83246988|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83246989|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83246990|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83246991|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83246992|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83246993|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83246994|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
83246995|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83246996|NCT05009953|Leucovorin|leucovorin|mesh-list
83246997|NCT05009953|Fluorouracil|fluorouracil|mesh-list
83246998|NCT05009953|Irinotecan|irinotecan|mesh-list
83246999|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
83247000|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247001|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83247002|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247003|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83247004|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
83247005|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247006|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83247007|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83247008|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247009|NCT05009953|Antidotes|antidotes|mesh-ancestor
83247010|NCT05009953|Protective Agents|protective agents|mesh-ancestor
83247011|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
83247012|NCT05009953|Vitamins|vitamins|mesh-ancestor
83247013|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
83247014|NCT03079453|Dexamethasone|dexamethasone|mesh-list
83247015|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247016|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
83247017|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
83247018|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247019|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247020|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247021|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
83247022|NCT03079453|Hormones|hormones|mesh-ancestor
83247023|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83247024|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83247025|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247026|NCT05009017|Bevacizumab|bevacizumab|mesh-list
83247027|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83247028|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247029|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83247030|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83247031|NCT05009017|Growth Substances|growth substances|mesh-ancestor
83247032|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247033|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
83247034|NCT05008939|Sevoflurane|sevoflurane|mesh-list
83247035|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83247036|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83247037|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
83247038|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
83247039|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247040|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247041|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
83247042|NCT05008861|Nivolumab|nivolumab|mesh-list
83247043|NCT05008861|Durvalumab|durvalumab|mesh-list
83247044|NCT05008861|Tislelizumab|tislelizumab|mesh-list
83247045|NCT05008861|Antibodies|antibodies|mesh-list
83247046|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83247047|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
83247048|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247049|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83247050|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247051|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83247052|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247053|NCT05360277|Capecitabine|capecitabine|mesh-list
83247054|NCT05360277|Tislelizumab|tislelizumab|mesh-list
83247055|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83247056|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
83247057|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247058|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247059|NCT05360277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83247060|NCT05016973|Disitamab vedotin|disitamab vedotin|mesh-list
83247061|NCT05016973|Immunoconjugates|immunoconjugates|mesh-ancestor
83247062|NCT05016973|Immunologic Factors|immunologic factors|mesh-ancestor
83247063|NCT05016973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247064|NCT03091699|Nicotine|nicotine|mesh-list
83247065|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83247066|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
83247067|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247068|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247070|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83247071|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
83247072|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247073|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247074|NCT05344209|Sargramostim|sargramostim|mesh-list
83247075|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
83247076|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247077|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83247078|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247079|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247080|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
83247081|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247082|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247083|NCT04253457|Triamcinolone|triamcinolone|mesh-list
83247084|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247085|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
83247086|NCT04253457|Hormones|hormones|mesh-ancestor
83247087|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83247088|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247089|NCT05380947|Rabeprazole|rabeprazole|mesh-list
83247090|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83247091|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247092|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83247093|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247094|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247095|NCT02525133|Bupivacaine|bupivacaine|mesh-list
83247096|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
83247097|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
83247098|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247099|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247100|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
83247101|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247102|NCT05602311|Anesthetics|anesthetics|mesh-list
83247103|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
83247104|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247105|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247106|NCT05016349|Tamoxifen|tamoxifen|mesh-list
83247107|NCT05016349|Tocopherols|tocopherols|mesh-list
83247108|NCT05016349|Tretinoin|tretinoin|mesh-list
83247109|NCT05016349|Alitretinoin|alitretinoin|mesh-list
83247110|NCT05016349|Cannabidiol|cannabidiol|mesh-list
83247111|NCT05016349|Isotretinoin|isotretinoin|mesh-list
83247112|NCT05016349|Mifepristone|mifepristone|mesh-list
83247113|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83247114|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
83247115|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83247116|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247117|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83247118|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247119|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83247120|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83247121|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83247122|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
83247123|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
83247124|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
83247125|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83247126|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
83247127|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83247128|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83247129|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83247130|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83247131|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
83247132|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83247133|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83247134|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
83247135|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83247136|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83247137|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
83247138|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247139|NCT05016349|Protective Agents|protective agents|mesh-ancestor
83247140|NCT05016349|Vitamins|vitamins|mesh-ancestor
83247141|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
83247142|NCT05380635|Hypericin|hypericin|mesh-list
83247143|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
83247144|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83247145|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247146|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
83247147|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247148|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247149|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247150|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83247151|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
83247152|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247153|NCT05538819|Glimepiride|glimepiride|mesh-list
83247154|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83247155|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83247156|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247157|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83247158|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
83247159|NCT03079219|Dexamethasone|dexamethasone|mesh-list
83247160|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
83247161|NCT03079219|Ondansetron|ondansetron|mesh-list
83247162|NCT03079219|Olanzapine|olanzapine|mesh-list
83247163|NCT03079219|Aprepitant|aprepitant|mesh-list
83247164|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
83247165|NCT03079219|BB 1101|bb 1101|mesh-list
83247166|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247167|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
83247168|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
83247169|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247170|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247171|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247172|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
83247173|NCT03079219|Hormones|hormones|mesh-ancestor
83247174|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83247175|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83247176|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247177|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
83247178|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247179|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247180|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
83247181|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83247182|NCT03079219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83247183|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83247184|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
83247185|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247186|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83247187|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83247188|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247189|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83247190|NCT03079219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83247191|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83247192|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83247193|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83247194|NCT03078829|Leuprolide|leuprolide|mesh-list
83247195|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83247196|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
83247197|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83247198|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247199|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83247200|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247201|NCT05008237|Docetaxel|docetaxel|mesh-list
83247202|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247203|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83247204|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83247205|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83247206|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247208|NCT05014711|Remifentanil|remifentanil|mesh-list
83247209|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83247210|NCT05014711|Narcotics|narcotics|mesh-ancestor
83247211|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247212|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247213|NCT05014711|Analgesics|analgesics|mesh-ancestor
83247214|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
83247215|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247216|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83247217|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83247218|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
83247219|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
83247220|NCT05018923|Metronidazole|metronidazole|mesh-list
83247221|NCT05018923|Doxycycline|doxycycline|mesh-list
83247222|NCT05018923|Tetracycline|tetracycline|mesh-list
83247223|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
83247224|NCT05018923|Rabeprazole|rabeprazole|mesh-list
83247225|NCT05018923|Bismuth|bismuth|mesh-list
83247226|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247227|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247228|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83247229|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83247230|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83247231|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
83247232|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83247233|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247234|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83247235|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247236|NCT05018923|Antacids|antacids|mesh-ancestor
83247237|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83247238|NCT05018923|Diuretics|diuretics|mesh-ancestor
83247239|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
83247240|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247241|NCT05018923|Expectorants|expectorants|mesh-ancestor
83247242|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
83247243|NCT03086473|Caffeine|caffeine|mesh-list
83247244|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
83247245|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247246|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83247247|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247248|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83247249|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247250|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83247251|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83247252|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
83247253|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247254|NCT03086005|Metformin|metformin|mesh-list
83247255|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83247256|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247257|NCT03079141|Eplerenone|eplerenone|mesh-list
83247258|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83247259|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
83247260|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83247261|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247262|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83247263|NCT03079141|Diuretics|diuretics|mesh-ancestor
83247264|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
83247265|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83247266|NCT03085849|Durvalumab|durvalumab|mesh-list
83247267|NCT03085849|Tremelimumab|tremelimumab|mesh-list
83247268|NCT03085849|Guadecitabine|guadecitabine|mesh-list
83247269|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83247270|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247271|NCT05001529|Antibodies|antibodies|mesh-list
83247272|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
83247273|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247274|NCT05001061|Misoprostol|misoprostol|mesh-list
83247275|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83247276|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
83247277|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83247278|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247279|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83247280|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247281|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
83247282|NCT05531955|Pirfenidone|pirfenidone|mesh-list
83247283|NCT05531955|Analgesics|analgesics|mesh-ancestor
83247284|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
83247285|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247286|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247287|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83247288|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247289|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247290|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247291|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247292|NCT05339529|Glycine|glycine|mesh-list
83247293|NCT05339529|Thymalfasin|thymalfasin|mesh-list
83247294|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
83247295|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247296|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247297|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247298|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83247299|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
83247300|NCT05006911|Bromfenac|bromfenac|mesh-list
83247301|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83247302|NCT05006911|Phenylephrine|phenylephrine|mesh-list
83247303|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
83247304|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
83247305|NCT05006911|Pilocarpine|pilocarpine|mesh-list
83247306|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83247307|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
83247308|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247309|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
83247310|NCT05006911|Protective Agents|protective agents|mesh-ancestor
83247311|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83247312|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83247313|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83247314|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83247315|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
83247316|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247317|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247318|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
83247319|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
83247320|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247321|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
83247322|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83247323|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
83247324|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83247325|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
83247326|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83247327|NCT05006911|Miotics|miotics|mesh-ancestor
83247328|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83247329|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83247330|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
83247331|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83247332|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247333|NCT05006911|Analgesics|analgesics|mesh-ancestor
83247334|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
83247335|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247336|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247337|NCT05339295|Levofloxacin|levofloxacin|mesh-list
83247338|NCT05339295|Ofloxacin|ofloxacin|mesh-list
83247339|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83247340|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247341|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83247342|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83247343|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83247344|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247345|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247346|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247347|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83247348|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83247350|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
83247351|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83247352|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247353|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83247354|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247355|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
83247356|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83247357|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83247358|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
83247359|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247360|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
83247361|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
83247362|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
83247363|NCT02637895|Vortioxetine|vortioxetine|mesh-list
83247364|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
83247365|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83247366|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83247367|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83247368|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247369|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247370|NCT02637895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83247371|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83247372|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83247373|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247374|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247375|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
83247376|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83247377|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83247378|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83247379|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83247380|NCT05013697|Paclitaxel|paclitaxel|mesh-list
83247381|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83247382|NCT05013697|Cisplatin|cisplatin|mesh-list
83247383|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83247384|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247385|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
83247386|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
83247387|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
83247388|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247389|NCT05509647|Heparin|heparin|mesh-list
83247390|NCT05509647|Calcium heparin|calcium heparin|mesh-list
83247391|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
83247392|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83247393|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83247394|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247395|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
83247396|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83247397|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247398|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83247399|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247400|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83247401|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247402|NCT05007223|Doxycycline|doxycycline|mesh-list
83247403|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83247404|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247405|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
83247406|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83247407|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83247408|NCT05000281|Ibuprofen|ibuprofen|mesh-list
83247409|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83247410|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247411|NCT05000281|Analgesics|analgesics|mesh-ancestor
83247412|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
83247413|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247414|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247415|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247416|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247417|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83247418|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247419|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247421|NCT03081949|Selenious Acid|selenious acid|mesh-list
83247422|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
83247423|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
83247424|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247425|NCT03081949|Protective Agents|protective agents|mesh-ancestor
83247426|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247427|NCT03081949|Trace Elements|trace elements|mesh-ancestor
83247428|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
83247429|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
83247430|NCT05347173|Nalbuphine|nalbuphine|mesh-list
83247431|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83247432|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247433|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247434|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247435|NCT05347173|Analgesics|analgesics|mesh-ancestor
83247436|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
83247437|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247438|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83247439|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83247440|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83247441|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
83247442|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247443|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247444|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83247445|NCT05347173|Narcotics|narcotics|mesh-ancestor
83247446|NCT05006287|Warfarin|warfarin|mesh-list
83247447|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
83247448|NCT05006287|Dabigatran|dabigatran|mesh-list
83247449|NCT05006287|Apixaban|apixaban|mesh-list
83247450|NCT05006287|Anticoagulants|anticoagulants|mesh-list
83247451|NCT05006287|Edoxaban|edoxaban|mesh-list
83247452|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83247453|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
83247454|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83247455|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
83247456|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247457|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247458|NCT05013151|Castor Oil|castor oil|mesh-list
83247459|NCT05013151|Cathartics|cathartics|mesh-ancestor
83247460|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247461|NCT05006209|Calcium|calcium|mesh-list
83247462|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83247463|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247464|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
83247465|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83247466|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247467|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83247468|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247469|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
83247470|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83247471|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247472|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247473|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247474|NCT03076099|Analgesics|analgesics|mesh-ancestor
83247475|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
83247476|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247477|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83247478|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83247479|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83247480|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
83247481|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247482|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247483|NCT05554965|Propofol|propofol|mesh-list
83247484|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83247485|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247486|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247487|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83247488|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
83247489|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
83247490|NCT05554419|Cytarabine|cytarabine|mesh-list
83247491|NCT05554419|Azacitidine|azacitidine|mesh-list
83247492|NCT05554419|Daunorubicin|daunorubicin|mesh-list
83247493|NCT05554419|Venetoclax|venetoclax|mesh-list
83247494|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83247495|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
83247496|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247497|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247498|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
83247499|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247500|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83247501|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
83247502|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247503|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247504|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83247505|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83247506|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83247507|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
83247508|NCT05505825|Chiauranib|chiauranib|mesh-list
83247509|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247510|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83247511|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247512|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247513|NCT05331573|Apomorphine|apomorphine|mesh-list
83247514|NCT05331573|Emetics|emetics|mesh-ancestor
83247515|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247516|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
83247517|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247518|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247519|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
83247520|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
83247521|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247522|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247523|NCT05260359|Ethanol|ethanol|mesh-list
83247524|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
83247525|NCT05260359|Petrolatum|petrolatum|mesh-list
83247526|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83247527|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247528|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247529|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247530|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83247531|NCT05260359|Protective Agents|protective agents|mesh-ancestor
83247532|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83247533|NCT05260359|Emollients|emollients|mesh-ancestor
83247534|NCT05329155|Heparin|heparin|mesh-list
83247535|NCT05329155|Calcium heparin|calcium heparin|mesh-list
83247536|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
83247537|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83247538|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83247539|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247540|NCT05294835|Ketamine|ketamine|mesh-list
83247541|NCT05294835|Analgesics|analgesics|mesh-ancestor
83247542|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
83247543|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247544|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247545|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83247546|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83247547|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
83247548|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
83247549|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247550|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83247551|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83247552|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247553|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247555|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
83247556|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
83247557|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
83247558|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247559|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247560|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
83247561|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247562|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83247563|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83247564|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83247565|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83247566|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247567|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
83247568|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247569|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83247570|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
83247571|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
83247572|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247573|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247574|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247575|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
83247576|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
83247577|NCT01659021|Ofatumumab|ofatumumab|mesh-list
83247578|NCT01659021|Idelalisib|idelalisib|mesh-list
83247579|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247580|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247581|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247582|NCT05012137|Ropivacaine|ropivacaine|mesh-list
83247583|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
83247584|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
83247585|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247586|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247588|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247589|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
83247590|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
83247591|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247592|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247593|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247594|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
83247595|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
83247596|NCT04925167|Heparin|heparin|mesh-list
83247597|NCT04925167|Calcium heparin|calcium heparin|mesh-list
83247598|NCT04925167|Argatroban|argatroban|mesh-list
83247599|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
83247600|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83247601|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83247602|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247603|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
83247604|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83247605|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83247606|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247607|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83247608|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83247609|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83247610|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83247611|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247612|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247613|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83247614|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83247615|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83247616|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83247617|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
83247618|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247619|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247620|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83247621|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83247622|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
83247623|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83247624|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83247625|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
83247626|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
83247627|NCT02524665|Salicylates|salicylates|mesh-list
83247628|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83247629|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247630|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
83247631|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
83247632|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
83247633|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83247634|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247635|NCT02524665|Analgesics|analgesics|mesh-ancestor
83247636|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
83247637|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247638|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247639|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247640|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247641|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83247642|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247643|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247644|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83247645|NCT04998253|Propofol|propofol|mesh-list
83247646|NCT04998253|Sevoflurane|sevoflurane|mesh-list
83247647|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83247648|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247649|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247650|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83247651|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
83247652|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
83247653|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83247654|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83247655|NCT02638129|Naltrexone|naltrexone|mesh-list
83247656|NCT02638129|Bupropion|bupropion|mesh-list
83247657|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83247658|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83247659|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247660|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
83247661|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247662|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83247663|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
83247664|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83247665|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83247666|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83247667|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83247668|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247670|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247671|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83247672|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83247673|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247674|NCT02524275|Docetaxel|docetaxel|mesh-list
83247675|NCT02524275|Capecitabine|capecitabine|mesh-list
83247676|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247677|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
83247678|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
83247679|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
83247680|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247681|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83247682|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
83247683|NCT03079687|Olaparib|olaparib|mesh-list
83247684|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83247685|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247686|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247687|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247688|NCT04997707|Propofol|propofol|mesh-list
83247689|NCT04997707|Sevoflurane|sevoflurane|mesh-list
83247690|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83247691|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247692|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247693|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83247694|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
83247695|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
83247696|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83247697|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83247698|NCT05010499|Bupivacaine|bupivacaine|mesh-list
83247699|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
83247700|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
83247701|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
83247702|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247703|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247704|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
83247705|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247706|NCT03075241|Zolpidem|zolpidem|mesh-list
83247707|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83247708|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83247709|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247710|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247711|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83247712|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
83247713|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
83247714|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247715|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247716|NCT04994119|Warfarin|warfarin|mesh-list
83247717|NCT04994119|Zamicastat|zamicastat|mesh-list
83247718|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
83247719|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247720|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247721|NCT01658943|Fluorouracil|fluorouracil|mesh-list
83247722|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
83247723|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
83247724|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247725|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83247726|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247727|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83247728|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
83247729|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247730|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83247731|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83247732|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83247733|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
83247734|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247735|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83247736|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83247737|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83247738|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
83247739|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247740|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83247741|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83247742|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247743|NCT04996459|Tislelizumab|tislelizumab|mesh-list
83247744|NCT04996459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83247745|NCT04996459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247746|NCT03074773|Dexamethasone|dexamethasone|mesh-list
83247747|NCT03074773|Bupivacaine|bupivacaine|mesh-list
83247748|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247749|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
83247750|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
83247751|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247752|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247753|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247754|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
83247755|NCT03074773|Hormones|hormones|mesh-ancestor
83247756|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83247757|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83247758|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247759|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
83247760|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
83247761|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247762|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
83247763|NCT03077581|Anesthetics|anesthetics|mesh-list
83247764|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247765|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247766|NCT03077503|Fentanyl|fentanyl|mesh-list
83247767|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
83247768|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83247769|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247770|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247771|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247772|NCT03077503|Analgesics|analgesics|mesh-ancestor
83247773|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
83247774|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247775|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83247776|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83247777|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83247778|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
83247779|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247780|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247781|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83247782|NCT03077503|Narcotics|narcotics|mesh-ancestor
83247783|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83247784|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83247785|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
83247786|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
83247787|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
83247788|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
83247789|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247790|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
83247791|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83247792|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247793|NCT03073057|Budesonide|budesonide|mesh-list
83247794|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
83247795|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83247797|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247798|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83247799|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
83247800|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247801|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247802|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83247803|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
83247804|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
83247805|NCT03073057|Hormones|hormones|mesh-ancestor
83247806|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83247807|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83247808|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83247809|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83247810|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83247811|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247812|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247813|NCT03073057|Antidotes|antidotes|mesh-ancestor
83247814|NCT03073057|Protective Agents|protective agents|mesh-ancestor
83247815|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
83247816|NCT03073369|Vitamin D|vitamin d|mesh-list
83247817|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83247818|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247819|NCT03073369|Vitamins|vitamins|mesh-ancestor
83247820|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
83247821|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83247822|NCT04433611|Lidocaine|lidocaine|mesh-list
83247823|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
83247824|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
83247825|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247826|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247827|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
83247828|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247829|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83247830|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83247831|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83247832|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83247833|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247834|NCT04992481|Fluorides|fluorides|mesh-list
83247835|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
83247836|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
83247837|NCT04992481|Protective Agents|protective agents|mesh-ancestor
83247838|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247839|NCT02597933|Nintedanib|nintedanib|mesh-list
83247840|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247841|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83247842|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247843|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247844|NCT04911127|Cannabidiol|cannabidiol|mesh-list
83247845|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
83247846|NCT04995133|Colistin|colistin|mesh-list
83247847|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83247848|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247849|NCT04362839|Nivolumab|nivolumab|mesh-list
83247850|NCT04362839|Ipilimumab|ipilimumab|mesh-list
83247851|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83247852|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247853|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83247854|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247855|NCT04360889|Tocopherols|tocopherols|mesh-list
83247856|NCT04360889|Vitamin E|vitamin e|mesh-list
83247857|NCT04360889|Tocotrienols|tocotrienols|mesh-list
83247858|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
83247859|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
83247860|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247861|NCT04360889|Protective Agents|protective agents|mesh-ancestor
83247862|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247863|NCT04360889|Vitamins|vitamins|mesh-ancestor
83247864|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
83247865|NCT03072589|Regadenoson|regadenoson|mesh-list
83247866|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83247867|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83247868|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
83247869|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
83247870|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247871|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247872|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247873|NCT04994743|Cortisone|cortisone|mesh-list
83247874|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247875|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83247876|NCT04807829|Nabilone|nabilone|mesh-list
83247877|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
83247878|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
83247879|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247880|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247881|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83247882|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83247883|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83247884|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83247885|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83247886|NCT04811573|Thalidomide|thalidomide|mesh-list
83247887|NCT04811573|Apremilast|apremilast|mesh-list
83247888|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83247889|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247890|NCT04811573|Analgesics|analgesics|mesh-ancestor
83247891|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
83247892|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247893|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247894|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247895|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247896|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83247897|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83247898|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247899|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247900|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83247901|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
83247902|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
83247903|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83247904|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83247905|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83247906|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83247907|NCT04811573|Growth Substances|growth substances|mesh-ancestor
83247908|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
83247909|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247910|NCT03072511|Nicotine|nicotine|mesh-list
83247911|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83247912|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
83247913|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247914|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247915|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83247916|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83247917|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
83247918|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247919|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247920|NCT03072121|Aspirin|aspirin|mesh-list
83247921|NCT03072121|Metoprolol|metoprolol|mesh-list
83247922|NCT03072121|Isosorbide|isosorbide|mesh-list
83247923|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83247924|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83247926|NCT03072121|Clopidogrel|clopidogrel|mesh-list
83247927|NCT03072121|Atorvastatin|atorvastatin|mesh-list
83247928|NCT03072121|Calcium|calcium|mesh-list
83247929|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83247930|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247931|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83247932|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247933|NCT03072121|Analgesics|analgesics|mesh-ancestor
83247934|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
83247935|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247936|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247937|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247938|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83247939|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83247940|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247941|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83247942|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83247943|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247944|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
83247945|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83247946|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83247947|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
83247948|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83247949|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83247950|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83247951|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83247952|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83247953|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
83247954|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83247955|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83247956|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83247957|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
83247958|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
83247959|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83247960|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83247961|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83247962|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83247963|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83247964|NCT03072121|Diuretics|diuretics|mesh-ancestor
83247965|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
83247966|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
83247967|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83247968|NCT02597855|Aflibercept|aflibercept|mesh-list
83247969|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83247970|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83247971|NCT02597855|Growth Substances|growth substances|mesh-ancestor
83247972|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247973|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
83247974|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247975|NCT04987567|Antioxidants|antioxidants|mesh-list
83247976|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247977|NCT04987567|Protective Agents|protective agents|mesh-ancestor
83247978|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247979|NCT03072199|Rituximab|rituximab|mesh-list
83247980|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83247981|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83247982|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
83247983|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247984|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247985|NCT04806737|Teriflunomide|teriflunomide|mesh-list
83247986|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83247987|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83247988|NCT04806737|Analgesics|analgesics|mesh-ancestor
83247989|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
83247990|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83247991|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83247992|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83247993|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83247994|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83247995|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
83247996|NCT04991155|Zamicastat|zamicastat|mesh-list
83247997|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83247998|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83247999|NCT04462315|Cobalt|cobalt|mesh-list
83248000|NCT04462315|Chromium|chromium|mesh-list
83248001|NCT04462315|Everolimus|everolimus|mesh-list
83248002|NCT04462315|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83248003|NCT04462315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83248004|NCT04462315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248005|NCT04462315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248006|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83248007|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
83248008|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248009|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248010|NCT04462315|Trace Elements|trace elements|mesh-ancestor
83248011|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
83248012|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83248013|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83248014|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83248015|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83248016|NCT03071731|Bromides|bromides|mesh-list
83248017|NCT03071731|Ipratropium|ipratropium|mesh-list
83248018|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
83248019|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
83248020|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
83248021|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248022|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248023|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83248024|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248025|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248026|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248027|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83248028|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
83248029|NCT04809935|Ethanol|ethanol|mesh-list
83248030|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83248031|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248032|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248033|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248034|NCT04255927|Triclosan|triclosan|mesh-list
83248035|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83248036|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248037|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83248043|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83248044|NCT03069781|Estradiol|estradiol|mesh-list
83248045|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83248046|NCT03069781|Estrogens|estrogens|mesh-ancestor
83248047|NCT03069781|Hormones|hormones|mesh-ancestor
83248048|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248049|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248050|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83248051|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
83248052|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83248053|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83248054|NCT03071575|Vaccines|vaccines|mesh-list
83248055|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
83248056|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248057|NCT04798391|Dexamethasone|dexamethasone|mesh-list
83248058|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83248059|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
83248060|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
83248061|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248062|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248063|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248064|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
83248065|NCT04798391|Hormones|hormones|mesh-ancestor
83248066|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248067|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83248068|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248069|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
83248070|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
83248071|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83248072|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
83248073|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248074|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248075|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
83248076|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
83248077|NCT04986319|Vitamin D|vitamin d|mesh-list
83248078|NCT04986319|Vitamins|vitamins|mesh-ancestor
83248079|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
83248080|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248081|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83248082|NCT02593097|Metformin|metformin|mesh-list
83248083|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83248084|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248085|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83248086|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
83248087|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248093|NCT01657461|Plasminogen|plasminogen|mesh-list
83248094|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83248095|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83248096|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83248097|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248098|NCT05001919|Mitogens|mitogens|mesh-list
83248099|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
83248100|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248101|NCT05001763|Prucalopride|prucalopride|mesh-list
83248102|NCT05001763|Laxatives|laxatives|mesh-ancestor
83248103|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248104|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83248105|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83248106|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
83248107|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248108|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248109|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248110|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
83248111|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248112|NCT02592551|Durvalumab|durvalumab|mesh-list
83248113|NCT02592551|Tremelimumab|tremelimumab|mesh-list
83248114|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248115|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248116|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83248118|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83248119|NCT04989127|Analgesics|analgesics|mesh-list
83248120|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248121|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
83248122|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
83248123|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248124|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248125|NCT04982809|Dexamethasone|dexamethasone|mesh-list
83248126|NCT04982809|Prednisolone|prednisolone|mesh-list
83248127|NCT04982809|Betamethasone|betamethasone|mesh-list
83248128|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83248129|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
83248130|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
83248131|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248132|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248133|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248134|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
83248135|NCT04982809|Hormones|hormones|mesh-ancestor
83248136|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248137|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83248138|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248139|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83248140|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248141|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
83248142|NCT03068533|Calcium|calcium|mesh-list
83248143|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83248144|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248145|NCT03068533|Antacids|antacids|mesh-ancestor
83248146|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248147|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248148|NCT05281341|Hormones|hormones|mesh-list
83248149|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248150|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248151|NCT04808687|Paclitaxel|paclitaxel|mesh-list
83248152|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83248153|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248155|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
83248156|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
83248157|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248158|NCT05279703|Epinephrine|epinephrine|mesh-list
83248159|NCT05279703|Racepinephrine|racepinephrine|mesh-list
83248160|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
83248161|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83248162|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83248163|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
83248164|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248165|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248166|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248167|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83248168|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83248169|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
83248170|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248171|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83248172|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248173|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
83248174|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
83248175|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83248176|NCT05392933|Lidocaine|lidocaine|mesh-list
83248177|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
83248178|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
83248179|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248180|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248181|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
83248182|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248183|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83248184|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83248185|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83248186|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248187|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248188|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
83248189|NCT04796675|Fludarabine|fludarabine|mesh-list
83248190|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83248191|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
83248192|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248193|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83248194|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83248195|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
83248196|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248197|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248198|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83248199|NCT05635357|Letrozole|letrozole|mesh-list
83248200|NCT05635357|Anastrozole|anastrozole|mesh-list
83248201|NCT05635357|Exemestane|exemestane|mesh-list
83248202|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248203|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83248204|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83248205|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248206|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248207|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83248208|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
83248209|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248210|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248211|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83248212|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
83248213|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
83248214|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83248215|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83248216|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248217|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248218|NCT05275725|Urological Agents|urological agents|mesh-ancestor
83248219|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
83248220|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83248221|NCT04785755|Etilefrine|etilefrine|mesh-list
83248222|NCT04785755|Furosemide|furosemide|mesh-list
83248223|NCT04785755|Spironolactone|spironolactone|mesh-list
83248224|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83248225|NCT04785755|Diuretics|diuretics|mesh-list
83248226|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
83248227|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248228|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83248229|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248230|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248231|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83248232|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83248233|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248234|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83248235|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83248236|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83248237|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
83248238|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248239|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83248240|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
83248241|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
83248242|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248243|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83248244|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83248245|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83248246|NCT04785755|Protective Agents|protective agents|mesh-ancestor
83248247|NCT04785911|Antiemetics|antiemetics|mesh-list
83248248|NCT04785911|Histamine|histamine|mesh-list
83248249|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
83248250|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
83248251|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248252|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248253|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248254|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
83248255|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248256|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248257|NCT04240821|Theophylline|theophylline|mesh-list
83248258|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83248259|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
83248260|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248261|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248262|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83248263|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248264|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83248265|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248266|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248267|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
83248268|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83248269|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83248270|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
83248271|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248273|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83248274|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248275|NCT05314101|Bevacizumab|bevacizumab|mesh-list
83248276|NCT05314101|Tislelizumab|tislelizumab|mesh-list
83248277|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248278|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248279|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83248280|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83248281|NCT05314101|Growth Substances|growth substances|mesh-ancestor
83248282|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248283|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
83248285|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
83248286|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83248287|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248288|NCT05221749|Fluorides|fluorides|mesh-list
83248289|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
83248290|NCT05221749|Protective Agents|protective agents|mesh-ancestor
83248291|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248292|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
83248293|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83248294|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
83248295|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248296|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
83248297|NCT04426721|Protective Agents|protective agents|mesh-ancestor
83248298|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
83248299|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83248300|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248301|NCT04794413|Pimavanserin|pimavanserin|mesh-list
83248302|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83248303|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83248304|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83248305|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83248306|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248307|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248308|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83248309|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83248310|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83248311|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
83248312|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248313|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248314|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83248315|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83248316|NCT05214573|Glucagon|glucagon|mesh-list
83248317|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83248318|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248319|NCT05214573|Hormones|hormones|mesh-ancestor
83248320|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248321|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248322|NCT05214573|Incretins|incretins|mesh-ancestor
83248323|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
83248324|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248325|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248326|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83248327|NCT04988191|Bevacizumab|bevacizumab|mesh-list
83248328|NCT04988191|Irinotecan|irinotecan|mesh-list
83248329|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248330|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248331|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83248332|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83248333|NCT04988191|Growth Substances|growth substances|mesh-ancestor
83248334|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248335|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
83248336|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83248337|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83248338|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248339|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248340|NCT03069001|Ribavirin|ribavirin|mesh-list
83248341|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
83248342|NCT03069001|Simeprevir|simeprevir|mesh-list
83248343|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
83248344|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248345|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
83248346|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248347|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
83248348|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248349|NCT03070405|Tenofovir|tenofovir|mesh-list
83248350|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83248351|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
83248352|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248353|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83248354|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83248355|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248356|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248357|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83248358|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83248359|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
83248360|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83248361|NCT03068065|Metformin|metformin|mesh-list
83248362|NCT03068065|Liraglutide|liraglutide|mesh-list
83248363|NCT03068065|Gliclazide|gliclazide|mesh-list
83248364|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83248365|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248366|NCT03068065|Incretins|incretins|mesh-ancestor
83248367|NCT03068065|Hormones|hormones|mesh-ancestor
83248368|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248369|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
83248370|NCT05161611|Astringents|astringents|mesh-ancestor
83248371|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248372|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
83248373|NCT03660475|Naltrexone|naltrexone|mesh-list
83248374|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83248375|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83248376|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248377|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
83248378|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248379|NCT05211609|Methyldopa|methyldopa|mesh-list
83248380|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83248381|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
83248382|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
83248383|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248384|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248385|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83248386|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83248387|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83248388|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83248389|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248390|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248391|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83248392|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83248393|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83248394|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248395|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248396|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83248397|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248398|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248399|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
83248400|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248401|NCT02594735|Abatacept|abatacept|mesh-list
83248402|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83248403|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248404|NCT02594735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248405|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248406|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83248407|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
83248408|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248409|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83248410|NCT05209425|Vitamin D|vitamin d|mesh-list
83248411|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
83248412|NCT05209425|Vitamins|vitamins|mesh-ancestor
83248413|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
83248414|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248415|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83248416|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83248417|NCT04793243|Vitamin D|vitamin d|mesh-list
83248419|NCT04793243|Vitamins|vitamins|mesh-ancestor
83248420|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
83248421|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248422|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83248423|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83248424|NCT04793399|Atezolizumab|atezolizumab|mesh-list
83248425|NCT04793399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83248426|NCT04793399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248427|NCT04793399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248428|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248429|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
83248430|NCT05157711|Phenylephrine|phenylephrine|mesh-list
83248431|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
83248432|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
83248433|NCT05157711|Bismuth|bismuth|mesh-list
83248434|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83248435|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
83248436|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
83248437|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248438|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248439|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
83248440|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83248441|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
83248442|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248443|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83248444|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83248445|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83248446|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
83248447|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248448|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248449|NCT05157711|Protective Agents|protective agents|mesh-ancestor
83248450|NCT05157711|Antacids|antacids|mesh-ancestor
83248451|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248452|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
83248453|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
83248454|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83248455|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248456|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
83248457|NCT05157711|Coagulants|coagulants|mesh-ancestor
83248458|NCT05105997|Dexamethasone|dexamethasone|mesh-list
83248459|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83248460|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
83248461|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
83248462|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248463|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248464|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248465|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
83248466|NCT05105997|Hormones|hormones|mesh-ancestor
83248467|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248468|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83248469|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248470|NCT03424525|Trimethoprim|trimethoprim|mesh-list
83248471|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83248472|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248473|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
83248474|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83248475|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83248476|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83248477|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248478|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248479|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83248480|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83248481|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83248482|NCT05104983|Sirolimus|sirolimus|mesh-list
83248483|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83248484|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248485|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83248487|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
83248488|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83248489|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
83248490|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248491|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
83248492|NCT04801511|Vitamins|vitamins|mesh-ancestor
83248493|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
83248494|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248495|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
83248496|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248497|NCT04801511|Protective Agents|protective agents|mesh-ancestor
83248498|NCT04230759|Fluorouracil|fluorouracil|mesh-list
83248499|NCT04230759|Durvalumab|durvalumab|mesh-list
83248500|NCT04230759|Mitomycins|mitomycins|mesh-list
83248501|NCT04230759|Mitomycin|mitomycin|mesh-list
83248502|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83248503|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
83248504|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248505|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83248506|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248507|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83248508|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
83248509|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248510|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248511|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83248512|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
83248513|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83248514|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248515|NCT05471687|Adenosine|adenosine|mesh-list
83248516|NCT05471687|Analgesics|analgesics|mesh-ancestor
83248517|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
83248518|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248519|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248520|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83248521|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
83248522|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83248523|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
83248524|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
83248525|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248526|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248527|NCT05471609|Levodopa|levodopa|mesh-list
83248528|NCT05471609|Carbidopa|carbidopa|mesh-list
83248529|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83248530|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83248531|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
83248532|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248533|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248534|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248535|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83248536|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248537|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
83248538|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83248539|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
83248540|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248541|NCT05370729|Expectorants|expectorants|mesh-ancestor
83248542|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248543|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83248544|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
83248545|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248546|NCT05370729|Protective Agents|protective agents|mesh-ancestor
83248547|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248548|NCT05370729|Antidotes|antidotes|mesh-ancestor
83248549|NCT05471531|Vaccines|vaccines|mesh-list
83248550|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83248551|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
83248552|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248553|NCT05204667|Acetaminophen|acetaminophen|mesh-list
83248554|NCT05204667|Aspirin|aspirin|mesh-list
83248555|NCT05204667|Methocarbamol|methocarbamol|mesh-list
83248556|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83248557|NCT05204667|Analgesics|analgesics|mesh-ancestor
83248558|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
83248559|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248560|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248561|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
83248562|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83248563|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83248564|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83248565|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83248566|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83248567|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248568|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83248569|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83248570|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248571|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83248572|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83248573|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83248574|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83248575|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248576|NCT04801199|Incretins|incretins|mesh-ancestor
83248577|NCT04801199|Hormones|hormones|mesh-ancestor
83248578|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248579|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83248580|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
83248581|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248582|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248583|NCT04340141|Leucovorin|leucovorin|mesh-list
83248584|NCT04340141|Fluorouracil|fluorouracil|mesh-list
83248585|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
83248586|NCT04340141|Irinotecan|irinotecan|mesh-list
83248587|NCT04340141|Calcium|calcium|mesh-list
83248588|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
83248589|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83248590|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248591|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
83248592|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248593|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83248594|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248595|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83248596|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
83248597|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83248598|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83248599|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248600|NCT04340141|Antidotes|antidotes|mesh-ancestor
83248601|NCT04340141|Protective Agents|protective agents|mesh-ancestor
83248602|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
83248603|NCT04340141|Vitamins|vitamins|mesh-ancestor
83248604|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
83248605|NCT05445791|Metformin|metformin|mesh-list
83248606|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83248607|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248608|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83248609|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
83248610|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83248611|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83248612|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
83248613|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248614|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248615|NCT05201313|Lidocaine|lidocaine|mesh-list
83248616|NCT05201313|Mepivacaine|mepivacaine|mesh-list
83248617|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
83248618|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
83248619|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248620|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248621|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
83248622|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248623|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83248624|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83248625|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83248626|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248627|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248628|NCT05201001|Carboplatin|carboplatin|mesh-list
83248629|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248630|NCT04799639|Paclitaxel|paclitaxel|mesh-list
83248631|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83248632|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248633|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
83248634|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
83248635|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
83248636|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248638|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
83248639|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83248640|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248641|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
83248642|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
83248643|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
83248644|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248645|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83248646|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
83248647|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248648|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
83248649|NCT04798703|Protective Agents|protective agents|mesh-ancestor
83248651|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83248652|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248653|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
83248654|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
83248655|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
83248656|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248657|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248658|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
83248659|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248660|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83248661|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248662|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248663|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83248664|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83248665|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248666|NCT05092581|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83248667|NCT05092581|Antiviral Agents|antiviral agents|mesh-ancestor
83248668|NCT05092581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248669|NCT04848857|Colchicine|colchicine|mesh-list
83248670|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
83248671|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83248672|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
83248673|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
83248674|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
83248675|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248676|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248677|NCT04338659|Antibodies|antibodies|mesh-list
83248678|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83248679|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
83248680|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248681|NCT05189535|Paclitaxel|paclitaxel|mesh-list
83248682|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
83248683|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83248684|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248685|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
83248686|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
83248687|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
83248688|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248689|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83248690|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248691|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83248692|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83248693|NCT05189535|Protective Agents|protective agents|mesh-ancestor
83248694|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248695|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
83248696|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83248697|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
83248698|NCT02633059|Dexamethasone|dexamethasone|mesh-list
83248699|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
83248700|NCT02633059|Ixazomib|ixazomib|mesh-list
83248701|NCT02633059|Ichthammol|ichthammol|mesh-list
83248702|NCT02633059|BB 1101|bb 1101|mesh-list
83248703|NCT02633059|Glycine|glycine|mesh-list
83248704|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83248705|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
83248706|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
83248707|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248708|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248709|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248710|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
83248711|NCT02633059|Hormones|hormones|mesh-ancestor
83248712|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248713|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83248714|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248715|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248716|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
83248717|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248718|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
83248719|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
83248720|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248721|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
83248722|NCT05089461|Analgesics|analgesics|mesh-ancestor
83248723|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
83248724|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248725|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248726|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248727|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83248728|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83248729|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248730|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248731|NCT05730439|Lobeline|lobeline|mesh-list
83248732|NCT05730439|Nicotine|nicotine|mesh-list
83248733|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83248734|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
83248735|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248736|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248737|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83248738|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83248739|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
83248740|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248741|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248742|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248743|NCT04224987|Azithromycin|azithromycin|mesh-list
83248744|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83248745|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248746|NCT04805515|Nicotine|nicotine|mesh-list
83248747|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83248748|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
83248749|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248750|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248751|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83248752|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83248753|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
83248754|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248755|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248756|NCT05195177|Anesthetics|anesthetics|mesh-list
83248757|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
83248758|NCT05195177|Histamine|histamine|mesh-list
83248759|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
83248760|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83248761|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248762|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248763|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
83248764|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248765|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
83248766|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
83248767|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248768|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248769|NCT05170919|Olanzapine|olanzapine|mesh-list
83248770|NCT05170919|Mirtazapine|mirtazapine|mesh-list
83248771|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
83248772|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
83248773|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248774|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248775|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248776|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83248777|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83248778|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248779|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83248780|NCT05170919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83248781|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83248782|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248783|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248784|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248785|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
83248786|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83248787|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83248788|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
83248790|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83248791|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83248792|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83248793|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83248794|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
83248795|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83248796|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83248797|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83248798|NCT05613491|Insulin|insulin|mesh-list
83248799|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83248800|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83248801|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248802|NCT05597839|Nivolumab|nivolumab|mesh-list
83248803|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248804|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248805|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83248806|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248807|NCT05151263|Salicylates|salicylates|mesh-list
83248808|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83248809|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83248810|NCT05151263|Analgesics|analgesics|mesh-ancestor
83248811|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
83248812|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248813|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248814|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83248815|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83248816|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248817|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83248818|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248819|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
83248820|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83248821|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248822|NCT03066427|Sunitinib|sunitinib|mesh-list
83248823|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248824|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83248825|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83248826|NCT03066427|Growth Substances|growth substances|mesh-ancestor
83248827|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248828|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
83248829|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83248830|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248831|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248832|NCT05177133|Capecitabine|capecitabine|mesh-list
83248833|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
83248834|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83248835|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
83248836|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248837|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248838|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
83248839|NCT02866643|Etonogestrel|etonogestrel|mesh-list
83248840|NCT02866643|Desogestrel|desogestrel|mesh-list
83248841|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83248842|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248843|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83248844|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83248845|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83248846|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83248847|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83248848|NCT02866643|Progestins|progestins|mesh-ancestor
83248849|NCT02866643|Hormones|hormones|mesh-ancestor
83248850|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248851|NCT05176821|Amoxicillin|amoxicillin|mesh-list
83248852|NCT05176821|Furazolidone|furazolidone|mesh-list
83248853|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
83248854|NCT05176821|Esomeprazole|esomeprazole|mesh-list
83248855|NCT05176821|Bismuth|bismuth|mesh-list
83248856|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248857|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83248858|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248859|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83248860|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83248861|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83248862|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248863|NCT05176821|Antacids|antacids|mesh-ancestor
83248864|NCT05176821|Diuretics|diuretics|mesh-ancestor
83248865|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
83248866|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248867|NCT05176821|Expectorants|expectorants|mesh-ancestor
83248868|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83248869|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83248870|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83248871|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83248872|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83248873|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83248874|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83248875|NCT05555641|Nafamostat|nafamostat|mesh-list
83248876|NCT05555641|Heparin|heparin|mesh-list
83248877|NCT05555641|Calcium heparin|calcium heparin|mesh-list
83248878|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
83248879|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83248880|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83248881|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248882|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83248883|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83248884|NCT05555641|Analgesics|analgesics|mesh-ancestor
83248885|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
83248886|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248887|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248888|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83248889|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83248890|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
83248891|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248892|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83248893|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83248894|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83248895|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83248896|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
83248897|NCT05115513|Dronabinol|dronabinol|mesh-list
83248898|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
83248899|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248900|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83248901|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83248902|NCT05115513|Analgesics|analgesics|mesh-ancestor
83248903|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
83248904|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248905|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83248906|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83248907|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248908|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248909|NCT05115513|Hormones|hormones|mesh-ancestor
83248910|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248911|NCT01672801|Nimodipine|nimodipine|mesh-list
83248912|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83248913|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83248914|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248915|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248916|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83248917|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248918|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
83248919|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83248920|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
83248921|NCT05613335|Coagulants|coagulants|mesh-ancestor
83248922|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83248923|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
83248924|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
83248925|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
83248926|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83248927|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248928|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
83248929|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248930|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83248931|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83248932|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
83248933|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248934|NCT05078463|Protective Agents|protective agents|mesh-ancestor
83248936|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83248937|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248938|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83248939|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83248940|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248941|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83248942|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83248943|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
83248944|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248945|NCT05169957|Nivolumab|nivolumab|mesh-list
83248946|NCT05169957|Ipilimumab|ipilimumab|mesh-list
83248947|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248948|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248949|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83248950|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248951|NCT05611463|Docetaxel|docetaxel|mesh-list
83248952|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248953|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
83248954|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
83248955|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
83248956|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248957|NCT05611385|Amphetamine|amphetamine|mesh-list
83248958|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83248959|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248960|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
83248961|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
83248962|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83248963|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
83248964|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83248965|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248966|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
83248967|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83248968|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83248969|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83248970|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83248971|NCT05475041|Liver Extracts|liver extracts|mesh-list
83248972|NCT05475041|Hematinics|hematinics|mesh-ancestor
83248973|NCT05611307|Hormones|hormones|mesh-list
83248974|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83248975|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248976|NCT02631577|Lenalidomide|lenalidomide|mesh-list
83248977|NCT02631577|Atezolizumab|atezolizumab|mesh-list
83248978|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
83248979|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
83248980|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83248981|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83248982|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83248983|NCT02631577|Growth Substances|growth substances|mesh-ancestor
83248984|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
83248985|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83248986|NCT02631577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83248987|NCT02631577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83248988|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83248990|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
83248991|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83248992|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
83248993|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83248994|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83248995|NCT03067753|Prednisolone|prednisolone|mesh-list
83248996|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
83248997|NCT03067753|Hormones|hormones|mesh-list
83248998|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83248999|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
83249000|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249001|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249002|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249003|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
83249004|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
83249005|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249006|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249007|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
83249008|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83249009|NCT03067753|Protective Agents|protective agents|mesh-ancestor
83249010|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83249011|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249012|NCT04331639|Vitamin D|vitamin d|mesh-list
83249013|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
83249014|NCT04331639|Vitamins|vitamins|mesh-ancestor
83249015|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
83249016|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249017|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83249018|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83249019|NCT03067597|Dinoprostone|dinoprostone|mesh-list
83249020|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
83249021|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83249022|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249023|NCT02518971|Tamsulosin|tamsulosin|mesh-list
83249024|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83249025|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83249026|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83249027|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
83249028|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249029|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249030|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249031|NCT02518971|Urological Agents|urological agents|mesh-ancestor
83249032|NCT04733963|Bevacizumab|bevacizumab|mesh-list
83249033|NCT04733963|Capecitabine|capecitabine|mesh-list
83249034|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83249035|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249036|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83249037|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83249038|NCT04733963|Growth Substances|growth substances|mesh-ancestor
83249039|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249040|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
83249041|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83249042|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
83249043|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249044|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
83249045|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83249046|NCT04222023|Antibodies|antibodies|mesh-list
83249047|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
83249048|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83249049|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
83249050|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249051|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
83249052|NCT03066115|Ketorolac|ketorolac|mesh-list
83249053|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83249054|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83249055|NCT03066115|Analgesics|analgesics|mesh-ancestor
83249056|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
83249057|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249058|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249059|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249060|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249061|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83249062|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249063|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249064|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
83249065|NCT03066115|Protective Agents|protective agents|mesh-ancestor
83249066|NCT03066115|Vitamins|vitamins|mesh-ancestor
83249067|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
83249068|NCT04212039|Bupivacaine|bupivacaine|mesh-list
83249069|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
83249070|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
83249071|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249072|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249073|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
83249074|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249075|NCT04716413|Dsuvia|dsuvia|mesh-list
83249076|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83249077|NCT04716413|Narcotics|narcotics|mesh-ancestor
83249078|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249079|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249080|NCT04716413|Analgesics|analgesics|mesh-ancestor
83249081|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
83249082|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249083|NCT05048589|Vaccines|vaccines|mesh-list
83249084|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
83249085|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249086|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83249087|NCT05728333|Tirofiban|tirofiban|mesh-list
83249088|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83249089|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83249090|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249091|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83249092|NCT04447651|Immunomodulating Agents|immunomodulating agents|mesh-list
83249093|NCT04447651|Immunologic Factors|immunologic factors|mesh-ancestor
83249094|NCT04447651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249095|NCT01364727|Amrubicin|amrubicin|mesh-list
83249096|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249097|NCT04990869|Niacinamide|niacinamide|mesh-list
83249098|NCT04990869|Niacin|niacin|mesh-list
83249099|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
83249100|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
83249101|NCT04990869|Vitamins|vitamins|mesh-ancestor
83249102|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
83249103|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249104|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83249105|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
83249106|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249107|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83249108|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
83249109|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83249110|NCT04401553|Vancomycin|vancomycin|mesh-list
83249111|NCT04401553|Cephalosporins|cephalosporins|mesh-list
83249112|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249113|NCT01364649|Vortioxetine|vortioxetine|mesh-list
83249114|NCT01364649|Escitalopram|escitalopram|mesh-list
83249115|NCT01364649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83249116|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83249117|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83249118|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249119|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249120|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
83249121|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249122|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
83249123|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83249124|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83249125|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83249126|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249127|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83249128|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83249129|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83249130|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83249131|NCT03065569|Bupivacaine|bupivacaine|mesh-list
83249132|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
83249133|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
83249134|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249135|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249136|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
83249137|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249138|NCT05723419|Anesthetics|anesthetics|mesh-list
83249139|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
83249140|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249141|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249142|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
83249143|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249144|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83249145|NCT02588261|Gefitinib|gefitinib|mesh-list
83249146|NCT02588261|Naquotinib|naquotinib|mesh-list
83249147|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249148|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83249149|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249150|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249151|NCT04989699|Aflibercept|aflibercept|mesh-list
83249152|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83249153|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83249154|NCT04989699|Growth Substances|growth substances|mesh-ancestor
83249155|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249156|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
83249157|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249158|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
83249159|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249160|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249162|NCT04426487|Progestins|progestins|mesh-ancestor
83249163|NCT04426487|Hormones|hormones|mesh-ancestor
83249164|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249165|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249166|NCT04988217|Interferons|interferons|mesh-list
83249167|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
83249169|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249170|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
83249171|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249172|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
83249173|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249174|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83249175|NCT05038839|Pamiparib|pamiparib|mesh-list
83249176|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249177|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249178|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249179|NCT01672723|Naltrexone|naltrexone|mesh-list
83249180|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83249181|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83249182|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249183|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
83249184|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249185|NCT04443673|Glycine|glycine|mesh-list
83249186|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
83249187|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249188|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249189|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249190|NCT05036577|Dexamethasone|dexamethasone|mesh-list
83249191|NCT05036577|Rituximab|rituximab|mesh-list
83249192|NCT05036577|Methotrexate|methotrexate|mesh-list
83249193|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83249194|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249195|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
83249196|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249197|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249198|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249199|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
83249200|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
83249201|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249202|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249203|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
83249204|NCT05036577|Hormones|hormones|mesh-ancestor
83249205|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249206|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83249207|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83249208|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
83249209|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83249210|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83249211|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
83249212|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249213|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
83249214|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249215|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83249216|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249217|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83249218|NCT04982367|Sirolimus|sirolimus|mesh-list
83249219|NCT04982367|Paclitaxel|paclitaxel|mesh-list
83249220|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83249221|NCT04982367|Temsirolimus|temsirolimus|mesh-list
83249222|NCT04982367|MTOR Inhibitors|mtor inhibitors|mesh-list
83249223|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83249224|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249225|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
83249226|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
83249227|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
83249228|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249229|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83249230|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249231|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83249232|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
83249233|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249234|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
83249235|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249236|NCT04982367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83249237|NCT04982367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249238|NCT05034627|Asparaginase|asparaginase|mesh-list
83249239|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249240|NCT05031975|Irinotecan|irinotecan|mesh-list
83249241|NCT05031975|Temozolomide|temozolomide|mesh-list
83249242|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83249243|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83249244|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249245|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249246|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249247|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83249248|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
83249249|NCT02632747|Empagliflozin|empagliflozin|mesh-list
83249250|NCT02632747|Ramipril|ramipril|mesh-list
83249251|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83249252|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249253|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83249254|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249255|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83249256|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
83249257|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249258|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83249259|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
83249260|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
83249261|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249262|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83249263|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249264|NCT04216797|Diazepam|diazepam|mesh-list
83249265|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83249266|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
83249267|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
83249268|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
83249269|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249270|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249271|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249272|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83249273|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249274|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83249275|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83249276|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83249277|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83249278|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83249279|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83249280|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
83249281|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
83249282|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
83249283|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
83249284|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249285|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249286|NCT05029401|Ibogaine|ibogaine|mesh-list
83249287|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
83249288|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249289|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83249290|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83249291|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83249292|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249293|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249294|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
83249295|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83249296|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249297|NCT05025813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83249298|NCT05025813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249299|NCT04033237|Nicotine|nicotine|mesh-list
83249300|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83249301|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
83249302|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249303|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249304|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83249305|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83249306|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
83249307|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249308|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249309|NCT04421547|Letrozole|letrozole|mesh-list
83249310|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249311|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83249312|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83249313|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249314|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249315|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83249316|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
83249317|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249318|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249319|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
83249320|NCT03066817|Vitamin D|vitamin d|mesh-list
83249321|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83249322|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249323|NCT03066817|Vitamins|vitamins|mesh-ancestor
83249324|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
83249325|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83249326|NCT05060913|Lidocaine|lidocaine|mesh-list
83249327|NCT05060913|Prilocaine|prilocaine|mesh-list
83249328|NCT05060913|Benzocaine|benzocaine|mesh-list
83249329|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83249330|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
83249331|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
83249332|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249333|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249334|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
83249335|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249336|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83249337|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83249338|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83249339|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83249340|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249341|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83249342|NCT05165251|Amlodipine|amlodipine|mesh-list
83249343|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
83249344|NCT05165251|Atorvastatin|atorvastatin|mesh-list
83249345|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83249346|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83249347|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
83249348|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249349|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83249350|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83249351|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249352|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83249353|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83249354|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83249355|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83249356|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249357|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
83249358|NCT04209075|Metformin|metformin|mesh-list
83249359|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83249360|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249361|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83249362|NCT05023473|Morphine|morphine|mesh-list
83249363|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83249364|NCT05023473|Narcotics|narcotics|mesh-ancestor
83249365|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249366|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249367|NCT05023473|Analgesics|analgesics|mesh-ancestor
83249368|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
83249369|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249370|NCT03066661|Entrectinib|entrectinib|mesh-list
83249371|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83249372|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249373|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249374|NCT05022147|Dopamine|dopamine|mesh-list
83249375|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
83249376|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83249377|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
83249378|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
83249379|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249380|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249381|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
83249382|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249383|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249384|NCT05022147|Protective Agents|protective agents|mesh-ancestor
83249386|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83249387|NCT03775629|Narcotics|narcotics|mesh-ancestor
83249388|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249389|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249390|NCT03775629|Analgesics|analgesics|mesh-ancestor
83249391|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
83249392|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249393|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
83249394|NCT01671319|Docetaxel|docetaxel|mesh-list
83249395|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249396|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
83249397|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249398|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249399|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83249400|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
83249401|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249402|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249403|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83249404|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
83249405|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
83249406|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
83249407|NCT05019885|Ketamine|ketamine|mesh-list
83249408|NCT05019885|Analgesics|analgesics|mesh-ancestor
83249409|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
83249410|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249411|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249412|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83249413|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83249414|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
83249415|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
83249416|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249417|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83249418|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83249419|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249420|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249421|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
83249422|NCT05016609|Velpatasvir|velpatasvir|mesh-list
83249423|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83249424|NCT05016609|Antibodies|antibodies|mesh-list
83249425|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
83249426|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
83249427|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249428|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
83249429|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249430|NCT03763305|Fentanyl|fentanyl|mesh-list
83249431|NCT03763305|Remifentanil|remifentanil|mesh-list
83249432|NCT03763305|Propofol|propofol|mesh-list
83249433|NCT03763305|Sevoflurane|sevoflurane|mesh-list
83249434|NCT03763305|Desflurane|desflurane|mesh-list
83249435|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83249436|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83249437|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249438|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249439|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83249441|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
83249442|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83249443|NCT03763305|Narcotics|narcotics|mesh-ancestor
83249444|NCT03763305|Analgesics|analgesics|mesh-ancestor
83249445|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
83249446|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249447|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83249448|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83249449|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83249450|NCT05054361|Mannitol|mannitol|mesh-list
83249451|NCT05054361|Lactulose|lactulose|mesh-list
83249452|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83249453|NCT05054361|Diuretics|diuretics|mesh-ancestor
83249454|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
83249455|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249456|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249457|NCT04970355|Erenumab|erenumab|mesh-list
83249458|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83249459|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249460|NCT04970355|Analgesics|analgesics|mesh-ancestor
83249461|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
83249462|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249463|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249464|NCT04906213|Empagliflozin|empagliflozin|mesh-list
83249465|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83249466|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249467|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83249468|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249469|NCT01670539|Triamcinolone|triamcinolone|mesh-list
83249470|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249471|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
83249473|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249474|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249475|NCT02252887|Gemcitabine|gemcitabine|mesh-list
83249476|NCT02252887|Trastuzumab|trastuzumab|mesh-list
83249477|NCT02252887|Pertuzumab|pertuzumab|mesh-list
83249478|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83249479|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
83249480|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249481|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249482|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83249483|NCT04431895|Tofacitinib|tofacitinib|mesh-list
83249484|NCT04431895|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83249485|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83249486|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249487|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249488|NCT03064633|Dexamethasone|dexamethasone|mesh-list
83249489|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
83249490|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
83249491|NCT03064633|Bupivacaine|bupivacaine|mesh-list
83249492|NCT03064633|BB 1101|bb 1101|mesh-list
83249493|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249494|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
83249495|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
83249496|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249497|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249498|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249499|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
83249500|NCT03064633|Hormones|hormones|mesh-ancestor
83249501|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249502|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83249503|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249504|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
83249505|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249506|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249507|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83249509|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249510|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
83249511|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83249512|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83249513|NCT03064633|Analgesics|analgesics|mesh-ancestor
83249514|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83249515|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83249516|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83249517|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
83249518|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249519|NCT04950465|Fluorides|fluorides|mesh-list
83249520|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
83249521|NCT04950465|Protective Agents|protective agents|mesh-ancestor
83249522|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249523|NCT04877821|Paclitaxel|paclitaxel|mesh-list
83249524|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
83249525|NCT04877821|Carboplatin|carboplatin|mesh-list
83249526|NCT04877821|Epirubicin|epirubicin|mesh-list
83249527|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83249528|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249529|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
83249530|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
83249531|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
83249532|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249533|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249535|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249536|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249537|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83249538|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
83249539|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83249540|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83249541|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83249542|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83249543|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249544|NCT02589665|Mirikizumab|mirikizumab|mesh-list
83249545|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83249546|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83249547|NCT02589665|Analgesics|analgesics|mesh-ancestor
83249548|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
83249549|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249550|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249551|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249552|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249553|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83249554|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249555|NCT05011383|Testosterone|testosterone|mesh-list
83249556|NCT05011383|Androgens|androgens|mesh-list
83249557|NCT05011383|Hormones|hormones|mesh-ancestor
83249558|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249559|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249560|NCT01697527|Aldesleukin|aldesleukin|mesh-list
83249561|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
83249562|NCT01697527|Fludarabine|fludarabine|mesh-list
83249563|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
83249564|NCT01697527|Interleukin-2|interleukin-2|mesh-list
83249565|NCT01697527|Vaccines|vaccines|mesh-list
83249566|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83249567|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249568|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
83249569|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249570|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249571|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83249572|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
83249573|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249574|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249575|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83249576|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83249577|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
83249578|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83249579|NCT01697527|Analgesics|analgesics|mesh-ancestor
83249580|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
83249581|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249582|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83249583|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83249584|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
83249585|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249586|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83249587|NCT04426409|Ofloxacin|ofloxacin|mesh-list
83249588|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83249589|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249590|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83249591|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83249592|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83249593|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249594|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249595|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249596|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83249597|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83249598|NCT04426097|Iodine|iodine|mesh-list
83249599|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83249600|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249601|NCT04426097|Trace Elements|trace elements|mesh-ancestor
83249602|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
83249603|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249604|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
83249605|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
83249606|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83249607|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83249608|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249609|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249610|NCT05556083|Urological Agents|urological agents|mesh-ancestor
83249611|NCT05556005|Trimetazidine|trimetazidine|mesh-list
83249612|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
83249613|NCT05008809|Leucovorin|leucovorin|mesh-list
83249614|NCT05008809|Fluorouracil|fluorouracil|mesh-list
83249615|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
83249616|NCT05008809|Irinotecan|irinotecan|mesh-list
83249617|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
83249618|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
83249619|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249620|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83249621|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249622|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249623|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
83249624|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249625|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83249626|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83249627|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249628|NCT05008809|Antidotes|antidotes|mesh-ancestor
83249630|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
83249631|NCT05008809|Vitamins|vitamins|mesh-ancestor
83249632|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
83249633|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
83249634|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
83249635|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83249636|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83249637|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249638|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
83249639|NCT04373603|Coagulants|coagulants|mesh-ancestor
83249640|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83249641|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
83249642|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249643|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
83249644|NCT04373603|Protective Agents|protective agents|mesh-ancestor
83249645|NCT02519595|Ketamine|ketamine|mesh-list
83249646|NCT02519595|Analgesics|analgesics|mesh-ancestor
83249647|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
83249648|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249649|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249650|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83249651|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83249652|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
83249653|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
83249654|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249655|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83249656|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83249657|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249658|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249659|NCT04278755|Drospirenone|drospirenone|mesh-list
83249660|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83249661|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
83249662|NCT04278755|Estradiol|estradiol|mesh-list
83249663|NCT04278755|Estrogens|estrogens|mesh-ancestor
83249664|NCT04278755|Hormones|hormones|mesh-ancestor
83249665|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249666|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249667|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83249668|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
83249669|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83249670|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83249671|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83249672|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83249673|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83249674|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
83249675|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83249676|NCT04278755|Diuretics|diuretics|mesh-ancestor
83249677|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
83249678|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
83249679|NCT04277975|Narcotics|narcotics|mesh-ancestor
83249680|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249681|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249682|NCT04277975|Analgesics|analgesics|mesh-ancestor
83249683|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
83249684|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249685|NCT04062695|Tofacitinib|tofacitinib|mesh-list
83249686|NCT04062695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83249687|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83249688|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249689|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249690|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
83249691|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83249692|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249693|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83249694|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249696|NCT00660673|Carbidopa|carbidopa|mesh-list
83249697|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83249698|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83249699|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83249700|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
83249701|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249702|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249703|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249704|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83249705|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249706|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83249707|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
83249708|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
83249709|NCT03644381|Immunomodulating Agents|immunomodulating agents|mesh-list
83249710|NCT03644381|Immunologic Factors|immunologic factors|mesh-ancestor
83249711|NCT03644381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249712|NCT05612711|Dronabinol|dronabinol|mesh-list
83249713|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
83249714|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249715|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83249716|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83249717|NCT05612711|Analgesics|analgesics|mesh-ancestor
83249718|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
83249719|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249720|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83249721|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83249722|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249723|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249724|NCT05612711|Hormones|hormones|mesh-ancestor
83249725|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249726|NCT04807309|Danazol|danazol|mesh-list
83249727|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83249728|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
83249729|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249730|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249731|NCT04744649|Fluorouracil|fluorouracil|mesh-list
83249732|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
83249733|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249734|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83249735|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249736|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249737|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
83249738|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249739|NCT04426955|Paclitaxel|paclitaxel|mesh-list
83249740|NCT04426955|Cisplatin|cisplatin|mesh-list
83249741|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83249742|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249743|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
83249744|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
83249745|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
83249746|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249747|NCT02630563|Cyclosporine|cyclosporine|mesh-list
83249748|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
83249749|NCT02630563|Cyclosporins|cyclosporins|mesh-list
83249750|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249751|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249752|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249753|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
83249754|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249755|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
83249756|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249757|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
83249758|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249760|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83249761|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249762|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83249763|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
83249764|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83249765|NCT05700695|Lactulose|lactulose|mesh-list
83249766|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249767|NCT05555147|Ropivacaine|ropivacaine|mesh-list
83249768|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
83249769|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
83249770|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249771|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249772|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
83249773|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249774|NCT02587247|Antibodies|antibodies|mesh-list
83249775|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
83249776|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249777|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
83249778|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83249779|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
83249780|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83249781|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
83249782|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249783|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249784|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
83249785|NCT02521415|Acetaminophen|acetaminophen|mesh-list
83249786|NCT02521415|Ibuprofen|ibuprofen|mesh-list
83249787|NCT02521415|Fentanyl|fentanyl|mesh-list
83249788|NCT02521415|Ketamine|ketamine|mesh-list
83249789|NCT02521415|Analgesics|analgesics|mesh-list
83249790|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
83249791|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249792|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249793|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83249794|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83249795|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
83249796|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
83249797|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249798|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83249799|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83249800|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249801|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249802|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83249803|NCT02521415|Narcotics|narcotics|mesh-ancestor
83249804|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83249805|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83249806|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
83249807|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83249808|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249809|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249810|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83249811|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249812|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
83249813|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
83249814|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249815|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
83249816|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249817|NCT02588339|Sirolimus|sirolimus|mesh-list
83249818|NCT02588339|Panobinostat|panobinostat|mesh-list
83249819|NCT02588339|Tacrolimus|tacrolimus|mesh-list
83249820|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83249821|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
83249822|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249823|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83249824|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249825|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249826|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83249827|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249828|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83249829|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249830|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
83249831|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83249832|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
83249833|NCT01752491|Temozolomide|temozolomide|mesh-list
83249834|NCT01752491|Vitamins|vitamins|mesh-ancestor
83249835|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
83249836|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249837|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83249838|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
83249839|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249840|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249841|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
83249842|NCT01752491|Protective Agents|protective agents|mesh-ancestor
83249843|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
83249844|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83249845|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83249846|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249847|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
83249848|NCT05554211|Coagulants|coagulants|mesh-ancestor
83249849|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83249850|NCT05554055|Dalteparin|dalteparin|mesh-list
83249851|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
83249852|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83249853|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83249854|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249855|NCT05700617|Dobutamine|dobutamine|mesh-list
83249856|NCT05700617|Milrinone|milrinone|mesh-list
83249857|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83249858|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
83249859|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
83249860|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249861|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249862|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83249863|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83249864|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83249865|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
83249866|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249867|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249868|NCT05700617|Protective Agents|protective agents|mesh-ancestor
83249869|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83249870|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
83249871|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83249872|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83249873|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249874|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83249875|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249876|NCT05553665|Lidocaine|lidocaine|mesh-list
83249877|NCT05553665|Fentanyl|fentanyl|mesh-list
83249878|NCT05553665|Midazolam|midazolam|mesh-list
83249879|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
83249880|NCT05553665|Complement C4|complement c4|mesh-list
83249881|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
83249882|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
83249883|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249884|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249885|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
83249886|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249887|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83249888|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83249889|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83249890|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83249891|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249892|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83249893|NCT05553665|Narcotics|narcotics|mesh-ancestor
83249894|NCT05553665|Analgesics|analgesics|mesh-ancestor
83249895|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83249896|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83249897|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
83249898|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83249899|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83249900|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83249901|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83249902|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
83249903|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
83249904|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249905|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
83249906|NCT02629159|Adalimumab|adalimumab|mesh-list
83249907|NCT02629159|Upadacitinib|upadacitinib|mesh-list
83249908|NCT02629159|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83249909|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83249910|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83249911|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83249912|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83249914|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249915|NCT05548985|Midodrine|midodrine|mesh-list
83249916|NCT05548985|Metoclopramide|metoclopramide|mesh-list
83249917|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
83249918|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
83249919|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249920|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249921|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83249922|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83249923|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83249924|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
83249925|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249926|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249927|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
83249928|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83249929|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83249930|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83249931|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83249932|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
83249933|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
83249934|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83249935|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83249936|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249937|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
83249938|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249939|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249940|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
83249941|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83249942|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83249943|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249944|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83249945|NCT04981951|Analgesics|analgesics|mesh-ancestor
83249946|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
83249947|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83249948|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83249949|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83249950|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83249951|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
83249952|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249953|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249954|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
83249955|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83249956|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83249957|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249958|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
83249959|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
83249960|NCT02628769|Solithromycin|solithromycin|mesh-list
83249961|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83249962|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249963|NCT05552807|Paclitaxel|paclitaxel|mesh-list
83249964|NCT05552807|Docetaxel|docetaxel|mesh-list
83249965|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83249966|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83249967|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83249968|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83249969|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83249970|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249971|NCT05552729|Vitamin D|vitamin d|mesh-list
83249972|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
83249973|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
83249974|NCT05552729|Vitamins|vitamins|mesh-list
83249975|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
83249976|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249977|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83249978|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83249979|NCT05699993|Itraconazole|itraconazole|mesh-list
83249980|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
83249981|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
83249982|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83249983|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83249984|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83249985|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83249986|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83249987|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83249988|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
83249989|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83249990|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83249991|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83249992|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
83249993|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
83249994|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83249995|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83249996|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83249997|NCT05552651|Paclitaxel|paclitaxel|mesh-list
83249998|NCT05552651|Carboplatin|carboplatin|mesh-list
83249999|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83250000|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83250001|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250002|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
83250003|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
83250004|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
83250005|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250006|NCT04981327|Apixaban|apixaban|mesh-list
83250007|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83250008|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
83250009|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83250010|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
83250011|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250012|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250013|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
83250014|NCT05547659|Acetaminophen|acetaminophen|mesh-list
83250015|NCT05547659|Celecoxib|celecoxib|mesh-list
83250016|NCT05547659|Pregabalin|pregabalin|mesh-list
83250017|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250018|NCT05547659|Analgesics|analgesics|mesh-ancestor
83250019|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
83250020|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250021|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250022|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
83250023|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
83250024|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83250025|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83250026|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250027|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83250028|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83250029|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83250030|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250031|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83250032|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83250033|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250034|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250035|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83250036|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83250037|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250038|NCT05541419|Budesonide|budesonide|mesh-list
83250039|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250040|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83250041|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
83250042|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250043|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250044|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83250045|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
83250046|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
83250047|NCT05541419|Hormones|hormones|mesh-ancestor
83250048|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250049|NCT05546879|Bevacizumab|bevacizumab|mesh-list
83250050|NCT05546879|Atezolizumab|atezolizumab|mesh-list
83250051|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250052|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250053|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83250054|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83250055|NCT05546879|Growth Substances|growth substances|mesh-ancestor
83250056|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250057|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
83250058|NCT05546879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83250059|NCT05546879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250060|NCT05541185|Naproxen|naproxen|mesh-list
83250061|NCT05541185|Lidocaine|lidocaine|mesh-list
83250062|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
83250063|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
83250064|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250065|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250066|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
83250067|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250068|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83250069|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83250070|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83250071|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83250072|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250073|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83250074|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250075|NCT05541185|Analgesics|analgesics|mesh-ancestor
83250076|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250077|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250078|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
83250079|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83250080|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250081|NCT02518113|Dexamethasone|dexamethasone|mesh-list
83250082|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250084|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
83250085|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250086|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250087|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250088|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
83250089|NCT02518113|Hormones|hormones|mesh-ancestor
83250090|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250091|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250092|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250093|NCT05541107|Amphotericin B|amphotericin b|mesh-list
83250094|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83250095|NCT05541107|Amebicides|amebicides|mesh-ancestor
83250096|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83250097|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83250098|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250099|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83250100|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
83250101|NCT03062839|Melatonin|melatonin|mesh-list
83250102|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
83250103|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250104|NCT03062839|Protective Agents|protective agents|mesh-ancestor
83250105|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250106|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250107|NCT05540951|Bevacizumab|bevacizumab|mesh-list
83250108|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250109|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250110|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83250111|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83250112|NCT05540951|Growth Substances|growth substances|mesh-ancestor
83250113|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250114|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
83250115|NCT04964505|Azacitidine|azacitidine|mesh-list
83250116|NCT04964505|Venetoclax|venetoclax|mesh-list
83250117|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250118|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
83250119|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250120|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250121|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250122|NCT04981093|Dexamethasone|dexamethasone|mesh-list
83250123|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
83250124|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250125|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
83250126|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
83250127|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250128|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250129|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250130|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
83250131|NCT04981093|Hormones|hormones|mesh-ancestor
83250132|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250133|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250134|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250135|NCT05551247|Endostatins|endostatins|mesh-list
83250136|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250137|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83250138|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83250139|NCT05551247|Growth Substances|growth substances|mesh-ancestor
83250140|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250141|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
83250142|NCT05540483|Disitamab vedotin|disitamab vedotin|mesh-list
83250143|NCT05540483|Immunoconjugates|immunoconjugates|mesh-ancestor
83250144|NCT05540483|Immunologic Factors|immunologic factors|mesh-ancestor
83250145|NCT05540483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250146|NCT05698511|Psilocybin|psilocybin|mesh-list
83250147|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
83250148|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250149|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83250150|NCT02629861|Calcitonin|calcitonin|mesh-list
83250151|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83250152|NCT02629861|Katacalcin|katacalcin|mesh-list
83250153|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83250154|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250155|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83250156|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
83250157|NCT02513823|Vitamin D|vitamin d|mesh-list
83250158|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
83250160|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
83250161|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250162|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83250163|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83250164|NCT05545475|Heparin|heparin|mesh-list
83250165|NCT05545475|Enoxaparin|enoxaparin|mesh-list
83250166|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83250167|NCT05545475|Tinzaparin|tinzaparin|mesh-list
83250168|NCT05545475|Dalteparin|dalteparin|mesh-list
83250169|NCT05545475|Nadroparin|nadroparin|mesh-list
83250170|NCT05545475|Warfarin|warfarin|mesh-list
83250171|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
83250172|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83250173|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83250174|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250175|NCT05545397|Propofol|propofol|mesh-list
83250176|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83250177|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250178|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250179|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83250180|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
83250181|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
83250182|NCT04952727|Vaccines|vaccines|mesh-list
83250183|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
83250184|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250185|NCT04433143|Minocycline|minocycline|mesh-list
83250186|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83250187|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250188|NCT01665911|Listerine|listerine|mesh-list
83250189|NCT01665911|Fluorides|fluorides|mesh-list
83250190|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
83250191|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
83250192|NCT01665911|Protective Agents|protective agents|mesh-ancestor
83250193|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250194|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83250195|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250196|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
83250197|NCT03063073|Bupivacaine|bupivacaine|mesh-list
83250198|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
83250199|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
83250200|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250201|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250202|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
83250203|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250204|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83250205|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250206|NCT03063073|Analgesics|analgesics|mesh-ancestor
83250207|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83250208|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83250209|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83250210|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
83250211|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250212|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250213|NCT04620733|Seladelpar|seladelpar|mesh-list
83250214|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83250215|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
83250216|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250217|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83250219|NCT02476617|Ribavirin|ribavirin|mesh-list
83250220|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83250221|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83250222|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
83250223|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250224|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250225|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83250226|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83250227|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
83250228|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250229|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83250230|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83250231|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
83250232|NCT04428307|Artemisinins|artemisinins|mesh-list
83250233|NCT04428307|Artemisinin|artemisinin|mesh-list
83250234|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
83250235|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83250236|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83250237|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250238|NCT05535725|Vancomycin|vancomycin|mesh-list
83250239|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83250240|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250241|NCT05535569|Paclitaxel|paclitaxel|mesh-list
83250242|NCT05535569|Nivolumab|nivolumab|mesh-list
83250243|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83250244|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250245|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
83250246|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
83250247|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
83250248|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250249|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250250|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83250251|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83250252|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83250253|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250254|NCT03064165|Epinephrine|epinephrine|mesh-list
83250255|NCT03064165|Bupivacaine|bupivacaine|mesh-list
83250256|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
83250257|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
83250258|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250259|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250260|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
83250261|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250262|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83250263|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83250264|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
83250265|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250266|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250267|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83250268|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83250269|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
83250270|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83250271|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
83250272|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
83250273|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
83250274|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83250275|NCT05535413|Capecitabine|capecitabine|mesh-list
83250276|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250278|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250279|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250280|NCT03813199|Methotrexate|methotrexate|mesh-list
83250281|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83250282|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
83250283|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83250284|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250285|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250286|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
83250287|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250288|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250289|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
83250290|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250291|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83250292|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83250293|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
83250294|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250295|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83250296|NCT05699135|Avelumab|avelumab|mesh-list
83250297|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250298|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250299|NCT03791593|Evolocumab|evolocumab|mesh-list
83250300|NCT03791593|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83250301|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83250302|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83250303|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
83250304|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250305|NCT03791593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83250306|NCT03791593|Protease Inhibitors|protease inhibitors|mesh-ancestor
83250307|NCT03791593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250308|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83250310|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250311|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83250312|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250313|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250314|NCT03765619|Aspirin|aspirin|mesh-list
83250315|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83250316|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250317|NCT03765619|Analgesics|analgesics|mesh-ancestor
83250318|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
83250319|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250320|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250321|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250322|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250323|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83250324|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83250325|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250326|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83250327|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83250328|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250329|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
83250330|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
83250331|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83250332|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83250333|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250334|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
83250335|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83250336|NCT04979923|Lidocaine|lidocaine|mesh-list
83250337|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
83250338|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
83250339|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250340|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250341|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
83250342|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250343|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83250344|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83250345|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83250346|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83250347|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250348|NCT03706885|Efavirenz|efavirenz|mesh-list
83250349|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83250350|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83250351|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250352|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250353|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
83250354|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250355|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83250356|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83250357|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83250358|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83250359|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83250360|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83250361|NCT01665599|Testosterone|testosterone|mesh-list
83250362|NCT01665599|Androgens|androgens|mesh-ancestor
83250363|NCT01665599|Hormones|hormones|mesh-ancestor
83250364|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250365|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250367|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
83250368|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
83250369|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250370|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83250371|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
83250372|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
83250373|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250374|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250375|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250376|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83250377|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
83250378|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83250379|NCT05697809|Dexamethasone|dexamethasone|mesh-list
83250380|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250381|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
83250382|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
83250383|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250384|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250385|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250386|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
83250387|NCT05697809|Hormones|hormones|mesh-ancestor
83250388|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250389|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250390|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250391|NCT03980483|Methotrexate|methotrexate|mesh-list
83250392|NCT03980483|Tofacitinib|tofacitinib|mesh-list
83250393|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83250394|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
83250395|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83250396|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250397|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250398|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
83250399|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250400|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250401|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
83250402|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250403|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83250404|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83250405|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
83250406|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250407|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83250408|NCT03980483|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83250409|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83250410|NCT03611881|Nicotine|nicotine|mesh-list
83250411|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83250412|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
83250413|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250414|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250415|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83250416|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83250417|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
83250418|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250419|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250420|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
83250421|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
83250422|NCT03063775|Coagulants|coagulants|mesh-ancestor
83250423|NCT03063541|Aspirin|aspirin|mesh-list
83250424|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83250425|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250426|NCT03063541|Analgesics|analgesics|mesh-ancestor
83250427|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
83250428|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250429|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250430|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250431|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250432|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83250433|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83250434|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250435|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83250436|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83250437|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250438|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
83250439|NCT04978597|Opicapone|opicapone|mesh-list
83250440|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83250441|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250442|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250443|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83250444|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83250445|NCT03490513|Anastrozole|anastrozole|mesh-list
83250446|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250447|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250448|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83250449|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83250450|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250451|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250452|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83250453|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
83250454|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250455|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250456|NCT03439345|Fenofibrate|fenofibrate|mesh-list
83250457|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83250458|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
83250459|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250460|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83250461|NCT04977661|Vitamin E|vitamin e|mesh-list
83250462|NCT04977661|Tocopherols|tocopherols|mesh-list
83250463|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
83250464|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
83250465|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83250466|NCT04977661|Vitamins|vitamins|mesh-ancestor
83250467|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
83250468|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250469|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
83250470|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250471|NCT04977661|Protective Agents|protective agents|mesh-ancestor
83250472|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83250473|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250474|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83250475|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83250476|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
83250477|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83250478|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83250479|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250480|NCT04977427|Prednisolone|prednisolone|mesh-list
83250481|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83250482|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
83250483|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83250484|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
83250485|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83250486|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
83250487|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250488|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
83250489|NCT04977427|Hormones|hormones|mesh-ancestor
83250490|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250491|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250492|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250493|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250494|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
83250495|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
83250496|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250497|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250498|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83250499|NCT04977427|Protective Agents|protective agents|mesh-ancestor
83250500|NCT03327805|Choline|choline|mesh-list
83250501|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
83250502|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83250503|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
83250504|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250505|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250506|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83250507|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
83250508|NCT04261855|Avelumab|avelumab|mesh-list
83250509|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83250510|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250511|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250512|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83250513|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250515|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83250516|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83250517|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250518|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250519|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250520|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
83250521|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250522|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250523|NCT03239899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83250524|NCT03239899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250525|NCT03061981|Metformin|metformin|mesh-list
83250526|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83250527|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250528|NCT02510001|Crizotinib|crizotinib|mesh-list
83250529|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250530|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83250531|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250532|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250533|NCT02452047|Imipenem|imipenem|mesh-list
83250534|NCT02452047|Relebactam|relebactam|mesh-list
83250535|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83250536|NCT02452047|Cilastatin|cilastatin|mesh-list
83250537|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83250538|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250539|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83250540|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250541|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250542|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83250543|NCT04925505|Anesthetics|anesthetics|mesh-list
83250544|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250545|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250546|NCT02475369|Pancrelipase|pancrelipase|mesh-list
83250547|NCT02475369|Pancreatin|pancreatin|mesh-list
83250548|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250549|NCT02474589|Tecovirimat|tecovirimat|mesh-list
83250550|NCT02474589|Antiviral Agents|antiviral agents|mesh-ancestor
83250551|NCT02474589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250552|NCT03862157|Azacitidine|azacitidine|mesh-list
83250553|NCT03862157|Venetoclax|venetoclax|mesh-list
83250554|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83250555|NCT03862157|Pevonedistat|pevonedistat|mesh-list
83250556|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250557|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
83250558|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250559|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250560|NCT02474355|Osimertinib|osimertinib|mesh-list
83250561|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250562|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83250563|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250564|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250565|NCT02474199|Acetaminophen|acetaminophen|mesh-list
83250566|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
83250567|NCT02474199|Promethazine|promethazine|mesh-list
83250568|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250569|NCT02474199|Analgesics|analgesics|mesh-ancestor
83250570|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
83250571|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250572|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250573|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
83250574|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83250575|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83250576|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250577|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
83250578|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
83250579|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
83250580|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
83250581|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250582|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83250583|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
83250584|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
83250585|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250586|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250587|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83250588|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
83250589|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
83250590|NCT02450487|Piroxicam|piroxicam|mesh-list
83250591|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83250592|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250593|NCT02450487|Analgesics|analgesics|mesh-ancestor
83250594|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
83250595|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250596|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250597|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250598|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250599|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83250600|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250601|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250602|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
83250603|NCT02506881|Hematinics|hematinics|mesh-ancestor
83250604|NCT02506257|Biguanides|biguanides|mesh-list
83250605|NCT02506257|Polihexanide|polihexanide|mesh-list
83250606|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83250607|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250608|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
83250609|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250610|NCT02505945|Omeprazole|omeprazole|mesh-list
83250611|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83250612|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250613|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83250614|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250615|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250616|NCT04213885|Riboflavin|riboflavin|mesh-list
83250617|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
83250618|NCT04213885|Vitamins|vitamins|mesh-ancestor
83250619|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
83250620|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250621|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83250622|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
83250623|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
83250624|NCT02448771|Palbociclib|palbociclib|mesh-list
83250625|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250626|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83250627|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430119|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83250628|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250629|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83250630|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83250631|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
83250632|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250633|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250634|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83250635|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
83250636|NCT02504541|Testosterone|testosterone|mesh-list
83250637|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
83250638|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
83250639|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83250640|NCT02504541|Androgens|androgens|mesh-ancestor
83250641|NCT02504541|Hormones|hormones|mesh-ancestor
83250642|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250643|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250644|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250645|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250646|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
83250647|NCT04924257|Esketamine|esketamine|mesh-list
83250648|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
83250649|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83250650|NCT04924179|Tislelizumab|tislelizumab|mesh-list
83250651|NCT04924179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250652|NCT04924179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250653|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
83250654|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83250655|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250656|NCT03063307|Fluorides|fluorides|mesh-list
83250657|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
83250658|NCT03063307|Protective Agents|protective agents|mesh-ancestor
83250659|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250660|NCT04874935|Lansoprazole|lansoprazole|mesh-list
83250661|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
83250662|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83250663|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250664|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83250665|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250666|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250667|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
83250668|NCT02961361|Ropivacaine|ropivacaine|mesh-list
83250669|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83250670|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250671|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250672|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250673|NCT02961361|Analgesics|analgesics|mesh-ancestor
83250674|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
83250675|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250676|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83250677|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83250678|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83250679|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83250680|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250681|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250682|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
83250684|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
83250685|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
83250686|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250687|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83250688|NCT02725177|Hormones|hormones|mesh-ancestor
83250689|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250690|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250691|NCT02426281|Paclitaxel|paclitaxel|mesh-list
83250692|NCT02426281|Gemcitabine|gemcitabine|mesh-list
83250693|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83250694|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250695|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83250696|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83250697|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83250698|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250699|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250700|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
83250701|NCT02448537|Gemcitabine|gemcitabine|mesh-list
83250702|NCT02448537|Doxorubicin|doxorubicin|mesh-list
83250703|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83250704|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250705|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
83250706|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250707|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250708|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83250709|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83250710|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83250711|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250712|NCT04838743|Xultophy|xultophy|mesh-list
83250713|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83250714|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250715|NCT04838743|Incretins|incretins|mesh-ancestor
83250716|NCT04838743|Hormones|hormones|mesh-ancestor
83250717|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250718|NCT03060265|Acetaminophen|acetaminophen|mesh-list
83250719|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250720|NCT03060265|Analgesics|analgesics|mesh-ancestor
83250721|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
83250722|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250723|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250724|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
83250725|NCT02504151|Cannabidiol|cannabidiol|mesh-list
83250726|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
83250727|NCT02448381|Hypericin|hypericin|mesh-list
83250728|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
83250729|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83250730|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250731|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
83250732|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250733|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250734|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250735|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83250736|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
83250737|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250738|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
83250739|NCT02448225|Fluorides|fluorides|mesh-list
83250740|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83250741|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
83250742|NCT02448225|Protective Agents|protective agents|mesh-ancestor
83250743|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250744|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83250745|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250746|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
83250747|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
83250748|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250749|NCT02447991|Rizatriptan|rizatriptan|mesh-list
83250750|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83250751|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
83250752|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250753|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250754|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250755|NCT02586155|Atorvastatin|atorvastatin|mesh-list
83250756|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83250757|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83250758|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83250759|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
83250760|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250761|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83250762|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83250763|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250764|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83250765|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83250766|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250767|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83250768|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
83250769|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83250770|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83250771|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
83250772|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
83250773|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83250774|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
83250775|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250776|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
83250777|NCT05536661|Protective Agents|protective agents|mesh-ancestor
83250778|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83250779|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83250780|NCT05536271|Bisoprolol|bisoprolol|mesh-list
83250781|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83250782|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
83250783|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
83250784|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250785|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250786|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83250787|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83250788|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83250789|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
83250790|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250791|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250792|NCT05536193|Metformin|metformin|mesh-list
83250793|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
83250794|NCT05536193|Salicylates|salicylates|mesh-list
83250796|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83250797|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250798|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
83250799|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250800|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250801|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
83250802|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
83250803|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83250804|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83250805|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250806|NCT05536193|Analgesics|analgesics|mesh-ancestor
83250807|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
83250808|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250809|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250810|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250811|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83250812|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250813|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
83250814|NCT04425707|Ivermectin|ivermectin|mesh-list
83250815|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
83250816|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83250817|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83250818|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250819|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250820|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250821|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250823|NCT05697185|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83250824|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83250825|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83250826|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
83250827|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250828|NCT05697185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83250829|NCT05697185|Protease Inhibitors|protease inhibitors|mesh-ancestor
83250830|NCT05697185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250831|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83250832|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83250833|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83250834|NCT02581163|Ritonavir|ritonavir|mesh-list
83250835|NCT02581163|Ribavirin|ribavirin|mesh-list
83250836|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83250837|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83250838|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
83250839|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250840|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250841|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83250842|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83250843|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
83250844|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250845|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83250846|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83250847|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
83250848|NCT05591417|Dexamethasone|dexamethasone|mesh-list
83250849|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
83250850|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
83250851|NCT05591417|Morphine|morphine|mesh-list
83250852|NCT05591417|BB 1101|bb 1101|mesh-list
83250853|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250854|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
83250855|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
83250856|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83250857|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250858|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83250860|NCT05591417|Hormones|hormones|mesh-ancestor
83413588|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83250861|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250862|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250863|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250864|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
83250865|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250866|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250867|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83250868|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250869|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83250870|NCT05591417|Analgesics|analgesics|mesh-ancestor
83250871|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
83250872|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83250873|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83250874|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83250875|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
83250876|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83250877|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83250878|NCT05591417|Narcotics|narcotics|mesh-ancestor
83250879|NCT01938547|Clevidipine|clevidipine|mesh-list
83250880|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83250881|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83250882|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250883|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83250884|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250885|NCT05695625|Anesthetics|anesthetics|mesh-list
83250886|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250887|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250888|NCT05586737|Rituximab|rituximab|mesh-list
83250889|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250890|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250891|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
83250892|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250893|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250894|NCT05678933|Prednisone|prednisone|mesh-list
83250895|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
83250896|NCT05678933|Vincristine|vincristine|mesh-list
83250897|NCT05678933|Azacitidine|azacitidine|mesh-list
83250898|NCT05678933|Epirubicin|epirubicin|mesh-list
83250899|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83250900|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
83250901|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250902|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83250903|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83250904|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
83250905|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250906|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250907|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83250908|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250909|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
83250910|NCT05678933|Hormones|hormones|mesh-ancestor
83250911|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83250912|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83250913|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83250914|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
83250915|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
83250916|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
83250917|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83250918|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
83250919|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250920|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83250921|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83250922|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83250923|NCT05678621|Amoxicillin|amoxicillin|mesh-list
83250924|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
83250925|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
83250926|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
83250927|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83250928|NCT05678621|Trimethoprim|trimethoprim|mesh-list
83250929|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
83250930|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
83250931|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83250932|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250933|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
83250934|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250935|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83250936|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83250937|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250938|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250939|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250940|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83250941|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83250942|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83250943|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
83250944|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83250945|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83250946|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83250947|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83250948|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83250949|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83250950|NCT05697029|Tetrandrine|tetrandrine|mesh-list
83250951|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
83250952|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83250953|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83250954|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83250955|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83250956|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250957|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
83250958|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83250959|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83250960|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250961|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83250962|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250963|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83250964|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
83250965|NCT04708613|Corticosterone|corticosterone|mesh-list
83250966|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83250967|NCT02627677|Ponatinib|ponatinib|mesh-list
83250968|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250969|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83250970|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250971|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250972|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
83250973|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83250974|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250975|NCT04964479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83250976|NCT04964479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250977|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
83250978|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83250979|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83250980|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
83250981|NCT02585999|Ortho Evra|ortho evra|mesh-list
83250982|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83250983|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250984|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83250985|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
83250986|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
83250987|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83250988|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83250989|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250990|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83250991|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83250992|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83250993|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83250994|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83250995|NCT05677373|Trametinib|trametinib|mesh-list
83250996|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83250997|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83250998|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83250999|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251000|NCT05041907|Ritonavir|ritonavir|mesh-list
83251001|NCT05041907|Ivermectin|ivermectin|mesh-list
83251002|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
83251003|NCT05041907|Remdesivir|remdesivir|mesh-list
83251004|NCT05041907|Favipiravir|favipiravir|mesh-list
83251005|NCT05041907|Nirmatrelvir|nirmatrelvir|mesh-list
83251006|NCT05041907|Sotrovimab|sotrovimab|mesh-list
83251007|NCT05041907|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83251008|NCT05041907|Molnupiravir|molnupiravir|mesh-list
83413589|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
83251009|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83251010|NCT05041907|Fluoxetine|fluoxetine|mesh-list
83251011|NCT05041907|Antibodies|antibodies|mesh-list
83251012|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
83251013|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83251014|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
83251015|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251016|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251017|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83251018|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83251019|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
83251020|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251021|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251022|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83251023|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83251024|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
83251025|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251026|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83251027|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83251028|NCT05041907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83251029|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83251030|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83251031|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251032|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
83251033|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83251034|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
83251035|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83251036|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83251037|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83251038|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
83251039|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
83251040|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83251041|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
83251042|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83251043|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251044|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251045|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251047|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
83251048|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251049|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83251050|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83251051|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83251052|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
83251053|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251054|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251055|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251056|NCT02500641|Naproxen|naproxen|mesh-list
83251057|NCT02500641|Colchicine|colchicine|mesh-list
83251058|NCT02500641|Allopurinol|allopurinol|mesh-list
83251059|NCT02500641|Febuxostat|febuxostat|mesh-list
83251060|NCT02500641|Omeprazole|omeprazole|mesh-list
83251061|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83251062|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251063|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83251064|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251065|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251066|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83251067|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251068|NCT02500641|Analgesics|analgesics|mesh-ancestor
83251069|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
83251070|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251071|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251072|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251073|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251074|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
83251075|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83251076|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
83251077|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
83251078|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
83251079|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251080|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
83251081|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83251082|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
83251083|NCT02500641|Protective Agents|protective agents|mesh-ancestor
83251084|NCT04973293|Bevacizumab|bevacizumab|mesh-list
83251085|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251086|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251087|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83251088|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83251089|NCT04973293|Growth Substances|growth substances|mesh-ancestor
83251090|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251091|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
83251092|NCT04962451|Ticagrelor|ticagrelor|mesh-list
83251093|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83251094|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83251095|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83251096|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83251097|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
83251098|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251099|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251100|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251101|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83251102|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251103|NCT03059719|Exenatide|exenatide|mesh-list
83251104|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83251105|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251106|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83251107|NCT03059719|Incretins|incretins|mesh-ancestor
83251108|NCT03059719|Hormones|hormones|mesh-ancestor
83251109|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251110|NCT03060031|Oxytocin|oxytocin|mesh-list
83251111|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
83251112|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83251113|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251114|NCT02499783|Adalimumab|adalimumab|mesh-list
83251115|NCT02499783|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83251116|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251117|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251118|NCT04972045|Curcumin|curcumin|mesh-list
83251119|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83251120|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251121|NCT04972045|Analgesics|analgesics|mesh-ancestor
83251122|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
83251123|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251124|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251125|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251126|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251127|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251128|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251129|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251130|NCT03059017|Albuterol|albuterol|mesh-list
83251131|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83251132|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
83251133|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251134|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251135|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83251136|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
83251137|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
83251138|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83251139|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83251140|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83251141|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83251142|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
83251143|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251144|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251145|NCT04971577|Simvastatin|simvastatin|mesh-list
83251146|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83251147|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83251148|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
83251149|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251150|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83251151|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83251152|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251153|NCT04425655|Fludarabine|fludarabine|mesh-list
83251154|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251155|NCT04970719|Remdesivir|remdesivir|mesh-list
83251156|NCT04970719|Dexamethasone|dexamethasone|mesh-list
83251157|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83251158|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251159|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
83251160|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
83251161|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251162|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251163|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251164|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
83251165|NCT04970719|Hormones|hormones|mesh-ancestor
83251166|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251167|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83251168|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251169|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
83251170|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251171|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
83251172|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251173|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83251174|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251175|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83251176|NCT02466399|Latanoprost|latanoprost|mesh-list
83251177|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83251178|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
83251179|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251180|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251181|NCT04970251|Aflibercept|aflibercept|mesh-list
83251182|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83251183|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83251184|NCT04970251|Growth Substances|growth substances|mesh-ancestor
83251185|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251186|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
83251187|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251188|NCT04201197|Dronabinol|dronabinol|mesh-list
83251189|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
83251190|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251191|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83251192|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251193|NCT04201197|Analgesics|analgesics|mesh-ancestor
83251194|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
83251195|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251196|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83251197|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83251198|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251199|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251200|NCT04201197|Hormones|hormones|mesh-ancestor
83251201|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251202|NCT04970329|Dextrans|dextrans|mesh-list
83251203|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
83251204|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
83251205|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
83251206|NCT04960657|Glyburide|glyburide|mesh-list
83251207|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
83251208|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83251209|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251210|NCT04960657|Growth Substances|growth substances|mesh-ancestor
83251211|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83251212|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251213|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251214|NCT02464059|Vitamin D|vitamin d|mesh-list
83251215|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
83251216|NCT02464059|Vitamins|vitamins|mesh-ancestor
83251217|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
83251218|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251219|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83251220|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83251221|NCT02463357|Metformin|metformin|mesh-list
83251222|NCT02463357|Nifedipine|nifedipine|mesh-list
83251223|NCT02463357|Methazolamide|methazolamide|mesh-list
83251224|NCT02463357|Quercetin|quercetin|mesh-list
83251225|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83251226|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251227|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83251228|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83251229|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251230|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83251232|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
83251233|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83251234|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
83251235|NCT02463357|Protective Agents|protective agents|mesh-ancestor
83251236|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83251237|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251238|NCT02463357|Diuretics|diuretics|mesh-ancestor
83251239|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
83251240|NCT04150939|Immunomodulating Agents|immunomodulating agents|mesh-list
83251241|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
83251242|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251243|NCT04959721|Triamcinolone|triamcinolone|mesh-list
83251244|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83251245|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83251246|NCT04959721|Bupivacaine|bupivacaine|mesh-list
83251247|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83251248|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251249|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
83251250|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251251|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251252|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
83251253|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251254|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251255|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
83251256|NCT04959721|Hormones|hormones|mesh-ancestor
83251257|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251258|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83251259|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
83251260|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251261|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251262|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83251263|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251264|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251265|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
83251266|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251267|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251268|NCT04676555|Ofatumumab|ofatumumab|mesh-list
83251269|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
83251270|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251271|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
83251272|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251273|NCT04314167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83251274|NCT04314167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83251275|NCT04314167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83251276|NCT04314167|Antimetabolites|antimetabolites|mesh-ancestor
83251277|NCT04314167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251278|NCT04314167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83251279|NCT04314167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83251280|NCT04314167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251281|NCT04314167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83251282|NCT05575427|Levofloxacin|levofloxacin|mesh-list
83251283|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83251284|NCT05575427|Minocycline|minocycline|mesh-list
83251285|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83251286|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251287|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83251288|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83251289|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83251290|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251291|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251292|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251293|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83251294|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83251295|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
83251296|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83251297|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83251299|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
83251300|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251301|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83251302|NCT02499159|Bupivacaine|bupivacaine|mesh-list
83251303|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251304|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
83251305|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251306|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251307|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
83251308|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251309|NCT01664039|Bimatoprost|bimatoprost|mesh-list
83251310|NCT01664039|Travoprost|travoprost|mesh-list
83251311|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83251312|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83251313|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83251314|NCT05645705|Listerine|listerine|mesh-list
83251315|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83251316|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
83251317|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
83251318|NCT05645705|Protective Agents|protective agents|mesh-ancestor
83251319|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251320|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251321|NCT02445339|Naltrexone|naltrexone|mesh-list
83251322|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83251323|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83251324|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251325|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
83251326|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251327|NCT04959409|Tetracaine|tetracaine|mesh-list
83251328|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251329|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
83251330|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251331|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251332|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
83251333|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251334|NCT03058939|Tamoxifen|tamoxifen|mesh-list
83251335|NCT03058939|Paclitaxel|paclitaxel|mesh-list
83251336|NCT03058939|Carboplatin|carboplatin|mesh-list
83251337|NCT03058939|Trastuzumab|trastuzumab|mesh-list
83251338|NCT03058939|Letrozole|letrozole|mesh-list
83251339|NCT03058939|Pertuzumab|pertuzumab|mesh-list
83251340|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83251341|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251342|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
83251343|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
83251344|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
83251345|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251346|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251347|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83251348|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83251349|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251350|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83251351|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
83251352|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251353|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251354|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83251355|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83251356|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83251357|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83251358|NCT03058471|Methotrexate|methotrexate|mesh-list
83251359|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83251360|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
83251361|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83251362|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251363|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83251364|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
83251365|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251366|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251367|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
83251368|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251369|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83251370|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83251371|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
83251372|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251373|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83251374|NCT02579603|Pirfenidone|pirfenidone|mesh-list
83251375|NCT02579603|Nintedanib|nintedanib|mesh-list
83251376|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251377|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83251378|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251379|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251380|NCT02579603|Analgesics|analgesics|mesh-ancestor
83251381|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
83251382|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251383|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251384|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83251385|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251386|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251387|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251388|NCT04291079|Antibodies|antibodies|mesh-list
83251389|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
83251390|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251391|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
83251392|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83251393|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83251394|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251395|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
83251396|NCT03060889|Coagulants|coagulants|mesh-ancestor
83251397|NCT05546957|Aspirin|aspirin|mesh-list
83251398|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
83251399|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83251400|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251401|NCT05546957|Analgesics|analgesics|mesh-ancestor
83251402|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
83251403|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251404|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251405|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251406|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251407|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83251408|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83251409|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251410|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83251411|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83251412|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251413|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
83251414|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83251415|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
83251416|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83251417|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
83251418|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
83251419|NCT04950205|Sevoflurane|sevoflurane|mesh-list
83251420|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83251421|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83251422|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
83251423|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
83251424|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251425|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251426|NCT02625259|Lansoprazole|lansoprazole|mesh-list
83251427|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
83251428|NCT02625259|Serabelisib|serabelisib|mesh-list
83251429|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83251430|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251431|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83251432|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430120|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83251433|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251434|NCT02577107|Ranibizumab|ranibizumab|mesh-list
83251435|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83251436|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83251437|NCT02577107|Growth Substances|growth substances|mesh-ancestor
83251438|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251439|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
83251440|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251441|NCT04958473|Axitinib|axitinib|mesh-list
83251442|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251443|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83251444|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251445|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251446|NCT04957927|Fluticasone|fluticasone|mesh-list
83251447|NCT04957927|Xhance|xhance|mesh-list
83251448|NCT04957927|Montelukast|montelukast|mesh-list
83251449|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251450|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83251451|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
83251452|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251453|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251454|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83251455|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
83251456|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
83251457|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83251458|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83251459|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
83251460|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251461|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83251462|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83251463|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251464|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
83251465|NCT04950049|Dexamethasone|dexamethasone|mesh-list
83251466|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
83251467|NCT04950049|BB 1101|bb 1101|mesh-list
83251468|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251469|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
83251470|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
83251471|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251472|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251473|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251474|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
83251475|NCT04950049|Hormones|hormones|mesh-ancestor
83251476|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251477|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83251478|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251479|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83251480|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251481|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251482|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
83251483|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83251484|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83251485|NCT05587673|Prednisolone|prednisolone|mesh-list
83251486|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
83251487|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83251488|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
83251489|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251490|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
83251491|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
83251492|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251493|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251494|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251495|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
83251496|NCT05587673|Hormones|hormones|mesh-ancestor
83251497|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251498|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83251499|NCT05587673|Protective Agents|protective agents|mesh-ancestor
83251500|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83251501|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251502|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
83251503|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251504|NCT04966429|Maraviroc|maraviroc|mesh-list
83251505|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83251506|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83251507|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251508|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83251509|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83251510|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
83251511|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251512|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83251513|NCT04949347|Glycerol|glycerol|mesh-list
83251514|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83251515|NCT04949347|Protective Agents|protective agents|mesh-ancestor
83251516|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251517|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
83251518|NCT04948957|Esmolol|esmolol|mesh-list
83251519|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
83251520|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83251521|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83251522|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83251523|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
83251524|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251525|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251526|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251527|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
83251528|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83251529|NCT04948801|Velpatasvir|velpatasvir|mesh-list
83251530|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
83251531|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251532|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
83251533|NCT04948567|Analgesics|analgesics|mesh-ancestor
83251534|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
83251535|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413590|NCT01450865|Flupirtine|flupirtine|mesh-list
83251536|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251537|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
83251538|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251539|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83251540|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
83251541|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83251542|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83251543|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251544|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83251545|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
83251546|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83251547|NCT04419181|Carboplatin|carboplatin|mesh-list
83251548|NCT04419181|Docetaxel|docetaxel|mesh-list
83251549|NCT04419181|Trastuzumab|trastuzumab|mesh-list
83251550|NCT04419181|Pertuzumab|pertuzumab|mesh-list
83251551|NCT04419181|Maytansine|maytansine|mesh-list
83251552|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83251553|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251554|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83251555|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83251556|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83251557|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83430121|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251558|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251559|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83251560|NCT04419181|Immunotoxins|immunotoxins|mesh-ancestor
83251561|NCT04419181|Immunoconjugates|immunoconjugates|mesh-ancestor
83251562|NCT04419181|Immunologic Factors|immunologic factors|mesh-ancestor
83251563|NCT04419181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251564|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83251565|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
83251566|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251567|NCT04946929|Heparin|heparin|mesh-list
83251568|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83251569|NCT04946929|Tinzaparin|tinzaparin|mesh-list
83251570|NCT04946929|Dalteparin|dalteparin|mesh-list
83251571|NCT04946929|Ticagrelor|ticagrelor|mesh-list
83251572|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
83251573|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83251574|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83251575|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251576|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83251577|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83251578|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83251579|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83251580|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
83251581|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251582|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251583|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
83251584|NCT03058237|Baclofen|baclofen|mesh-list
83251585|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83251586|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251587|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83251588|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251589|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83251590|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
83251591|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
83251592|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251593|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251594|NCT04947241|Gemcitabine|gemcitabine|mesh-list
83251595|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83251596|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251597|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83251598|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
83251599|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251600|NCT04947241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251601|NCT04410991|Teriflunomide|teriflunomide|mesh-list
83251602|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83251603|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251604|NCT04410991|Analgesics|analgesics|mesh-ancestor
83251605|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
83251606|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251607|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251608|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251609|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251610|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83251611|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
83251612|NCT04933279|Iodine|iodine|mesh-list
83251613|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
83251614|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83251615|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251616|NCT04933279|Trace Elements|trace elements|mesh-ancestor
83251617|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
83251618|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251619|NCT02577029|Interferons|interferons|mesh-list
83251620|NCT02577029|Tenofovir|tenofovir|mesh-list
83251621|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
83251622|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
83251623|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83251624|NCT02577029|Entecavir|entecavir|mesh-list
83251625|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
83251626|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83251627|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251628|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
83251629|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251630|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83251631|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83251632|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251633|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251634|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83251635|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83251636|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
83251637|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251638|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
83251639|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251640|NCT04946383|Dasatinib|dasatinib|mesh-list
83251641|NCT04946383|Quercetin|quercetin|mesh-list
83251642|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251643|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83251644|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251645|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251646|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
83251647|NCT04946383|Protective Agents|protective agents|mesh-ancestor
83251648|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251649|NCT04943653|Paclitaxel|paclitaxel|mesh-list
83251650|NCT04943653|Capecitabine|capecitabine|mesh-list
83251651|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
83251652|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83251653|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251654|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
83251655|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
83251656|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
83251657|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251658|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83251659|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
83251660|NCT04943029|Paclitaxel|paclitaxel|mesh-list
83251661|NCT04943029|Carboplatin|carboplatin|mesh-list
83251662|NCT04943029|Pemetrexed|pemetrexed|mesh-list
83251663|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83251664|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251665|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
83251666|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
83251667|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
83251668|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251669|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251670|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83251671|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83251672|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
83251673|NCT03660059|Peficitinib|peficitinib|mesh-list
83251674|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251675|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251676|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83251677|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
83251678|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251679|NCT04946227|Paclitaxel|paclitaxel|mesh-list
83251680|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
83251681|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83251682|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251683|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83251684|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83251685|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83251686|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413591|NCT01450865|Analgesics|analgesics|mesh-ancestor
83251687|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251688|NCT04946227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83251689|NCT04932187|Capecitabine|capecitabine|mesh-list
83251690|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83251691|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
83251692|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251693|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251694|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83251695|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
83251696|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251697|NCT03597347|Molgramostim|molgramostim|mesh-list
83251698|NCT03597347|Sargramostim|sargramostim|mesh-list
83251699|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251700|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
83251701|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251702|NCT04930627|Empagliflozin|empagliflozin|mesh-list
83251703|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83251704|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251705|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83251706|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251707|NCT03057769|Indomethacin|indomethacin|mesh-list
83251708|NCT03057769|Epinephrine|epinephrine|mesh-list
83251709|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83251710|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83251711|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
83251712|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251713|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251714|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251715|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83251716|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83251717|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
83251718|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251719|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83251720|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
83251721|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
83251722|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
83251723|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83251724|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83251725|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251726|NCT03057769|Analgesics|analgesics|mesh-ancestor
83251727|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
83251728|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251729|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83251730|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
83251731|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
83251732|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83251733|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83251734|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251735|NCT04633577|Lidocaine|lidocaine|mesh-list
83251736|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251737|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
83251738|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251739|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251740|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
83251741|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251742|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83251743|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83251744|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83251745|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83251746|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251747|NCT04941625|Cystatins|cystatins|mesh-list
83251748|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83251749|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
83251750|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251751|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251752|NCT03534323|Venetoclax|venetoclax|mesh-list
83251753|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251755|NCT04922047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251756|NCT04922047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251757|NCT04406389|Heparin|heparin|mesh-list
83251758|NCT04406389|Calcium heparin|calcium heparin|mesh-list
83251759|NCT04406389|Enoxaparin|enoxaparin|mesh-list
83251760|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
83251762|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
83251763|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83251764|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83251765|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251766|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
83251767|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83251768|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
83251769|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251770|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83251771|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83251772|NCT04921657|Simvastatin|simvastatin|mesh-list
83251773|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83251774|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83251775|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
83251776|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251777|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83251778|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83251779|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251781|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83251782|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251783|NCT04940689|Lidocaine|lidocaine|mesh-list
83251784|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
83251785|NCT04940689|Remifentanil|remifentanil|mesh-list
83251786|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251787|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
83251788|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251789|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251790|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
83251792|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83251793|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83251794|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83251795|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83251796|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251797|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83251798|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83251800|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83251801|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83251802|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83251803|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
83251804|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251805|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83251806|NCT04940689|Narcotics|narcotics|mesh-ancestor
83251807|NCT05530811|Dexamethasone|dexamethasone|mesh-list
83251808|NCT05530811|Bupivacaine|bupivacaine|mesh-list
83251809|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251810|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
83251811|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
83251812|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251813|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251814|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251815|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
83251816|NCT05530811|Hormones|hormones|mesh-ancestor
83251817|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251818|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83251819|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251820|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251821|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
83251822|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251823|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
83251824|NCT04940845|Denosumab|denosumab|mesh-list
83251825|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83251826|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251827|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
83251828|NCT04921111|Vaccines|vaccines|mesh-list
83251829|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
83251830|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251831|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83251832|NCT04921111|Antacids|antacids|mesh-ancestor
83251833|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251834|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251835|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83251836|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83251837|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251839|NCT03057145|Prexasertib|prexasertib|mesh-list
83251840|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83251841|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413592|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
83251842|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251843|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251844|NCT03057145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83251845|NCT05421065|Ketamine|ketamine|mesh-list
83251846|NCT05421065|Psilocybin|psilocybin|mesh-list
83251847|NCT05421065|Analgesics|analgesics|mesh-ancestor
83251848|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
83251849|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251850|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251851|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83251852|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83251854|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
83251855|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251856|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83251857|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83251858|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430157|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83251859|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251860|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
83251861|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83251862|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
83430158|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
83251863|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83251864|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83251865|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83430159|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
83251866|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83251867|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251869|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251870|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251871|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83251872|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251874|NCT04939675|Zonisamide|zonisamide|mesh-list
83251875|NCT04939675|Levetiracetam|levetiracetam|mesh-list
83251876|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
83251877|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
83251878|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83251879|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83251880|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251881|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83251882|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251883|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83251884|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83251885|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251886|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83251887|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83251888|NCT04938583|Paclitaxel|paclitaxel|mesh-list
83251889|NCT04938583|Bevacizumab|bevacizumab|mesh-list
83251890|NCT04938583|Carboplatin|carboplatin|mesh-list
83251891|NCT04938583|Oregovomab|oregovomab|mesh-list
83251892|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83251893|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251894|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
83251895|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
83251896|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
83251897|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251898|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83251899|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83251900|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83251902|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251903|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
83251904|NCT03055663|Midazolam|midazolam|mesh-list
83251905|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83251906|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83251907|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251908|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251909|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83251910|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83251911|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83251912|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83251913|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
83251914|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
83251915|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
83251916|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
83251917|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251918|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251919|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
83251920|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83251922|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83251923|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
83251924|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251925|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
83251926|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83251927|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83251928|NCT04938037|Prednisolone|prednisolone|mesh-list
83251929|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
83251930|NCT04938037|Bupivacaine|bupivacaine|mesh-list
83251931|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83251932|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
83251933|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251934|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
83251935|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251936|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251937|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
83251938|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251939|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83251941|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
83251942|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251943|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
83251944|NCT04938037|Hormones|hormones|mesh-ancestor
83251945|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83251946|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83251947|NCT04938037|Protective Agents|protective agents|mesh-ancestor
83251948|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83251949|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83251950|NCT04937569|Ivermectin|ivermectin|mesh-list
83251951|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83251952|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83251953|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
83251954|NCT04937101|Codeine|codeine|mesh-list
83251955|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83251956|NCT04937101|Narcotics|narcotics|mesh-ancestor
83251957|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251958|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251959|NCT04937101|Analgesics|analgesics|mesh-ancestor
83251960|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
83251961|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251962|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
83251963|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
83251964|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
83251965|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83251966|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83251967|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
83251968|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
83251969|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251970|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251971|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83251972|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83251973|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83251974|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83251975|NCT04936711|Bupivacaine|bupivacaine|mesh-list
83251976|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
83251977|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
83251978|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83251979|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251980|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
83251981|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83251982|NCT04431349|Clopidogrel|clopidogrel|mesh-list
83251983|NCT04431349|Ticagrelor|ticagrelor|mesh-list
83251984|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83251985|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83251986|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83251987|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83251988|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
83251989|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251990|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251991|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251992|NCT03055741|Donepezil|donepezil|mesh-list
83251993|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83251994|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83251995|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83251996|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
83251997|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83251998|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83251999|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
83252000|NCT04927039|Iloprost|iloprost|mesh-list
83252001|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83252002|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
83252003|NCT04917679|Diacerein|diacerein|mesh-list
83252004|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252005|NCT02443155|Liraglutide|liraglutide|mesh-list
83252006|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83252007|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252008|NCT02443155|Incretins|incretins|mesh-ancestor
83252009|NCT02443155|Hormones|hormones|mesh-ancestor
83252010|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252011|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
83252012|NCT04935541|Remifentanil|remifentanil|mesh-list
83252013|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83252014|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252015|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252016|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83252017|NCT04935541|Analgesics|analgesics|mesh-ancestor
83252018|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
83252019|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252020|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83252021|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83252022|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83252023|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
83252024|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252025|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252026|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83252027|NCT04935541|Narcotics|narcotics|mesh-ancestor
83252028|NCT04935073|Cetrorelix|cetrorelix|mesh-list
83252029|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83252030|NCT04935073|Hormones|hormones|mesh-ancestor
83252031|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252032|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252033|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83252034|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
83252035|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83252036|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
83252037|NCT04917757|Dexamethasone|dexamethasone|mesh-list
83252038|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252039|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
83252040|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
83252041|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252042|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252043|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252044|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
83252045|NCT04917757|Hormones|hormones|mesh-ancestor
83252046|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252047|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83252048|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252049|NCT04916899|Rifampin|rifampin|mesh-list
83252050|NCT04916899|Isoniazid|isoniazid|mesh-list
83252051|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
83252052|NCT04916899|Ethambutol|ethambutol|mesh-list
83252053|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83252054|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
83252055|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83252056|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252057|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
83252058|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83252059|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252060|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252061|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83252062|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83252063|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83252064|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83252065|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83252066|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83252067|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83252068|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83252069|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
83252070|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83252071|NCT04916821|Propolis|propolis|mesh-list
83252072|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252073|NCT04916665|Teduglutide|teduglutide|mesh-list
83252074|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252075|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83252076|NCT04916665|Protective Agents|protective agents|mesh-ancestor
83252077|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252078|NCT04916353|Triamcinolone|triamcinolone|mesh-list
83252079|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83252080|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83252081|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83252082|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252083|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
83252084|NCT04916353|Hormones|hormones|mesh-ancestor
83252085|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252086|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252087|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252088|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
83252089|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252090|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252091|NCT03056599|Interferons|interferons|mesh-list
83252092|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
83252093|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
83252094|NCT03056599|Aldesleukin|aldesleukin|mesh-list
83252095|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
83252096|NCT03056599|Gemcitabine|gemcitabine|mesh-list
83252098|NCT03056599|Doxorubicin|doxorubicin|mesh-list
83252099|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
83252100|NCT03056599|Nivolumab|nivolumab|mesh-list
83252101|NCT03056599|Bortezomib|bortezomib|mesh-list
83252102|NCT03056599|Ipilimumab|ipilimumab|mesh-list
83252103|NCT03056599|Atezolizumab|atezolizumab|mesh-list
83252104|NCT03056599|Durvalumab|durvalumab|mesh-list
83252105|NCT03056599|Avelumab|avelumab|mesh-list
83252106|NCT03056599|Trabectedin|trabectedin|mesh-list
83252107|NCT03056599|Olaratumab|olaratumab|mesh-list
83252108|NCT03056599|Entrectinib|entrectinib|mesh-list
83252109|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83252110|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
83252111|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252112|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252113|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83252114|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83252115|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83252116|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83252117|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83252118|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83252119|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252120|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252121|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83252122|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
83252123|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252124|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
83252125|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252126|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83252127|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83252128|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83252129|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
83252130|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83252131|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
83252132|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83252133|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252134|NCT04915963|Vitamin D|vitamin d|mesh-list
83252135|NCT04915963|Vitamins|vitamins|mesh-ancestor
83252136|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
83252137|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252138|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83252139|NCT04915807|Paclitaxel|paclitaxel|mesh-list
83252140|NCT04915807|Irinotecan|irinotecan|mesh-list
83252141|NCT04915807|Ramucirumab|ramucirumab|mesh-list
83252142|NCT04915807|Taxane|taxane|mesh-list
83252143|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83252144|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252145|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83252146|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83252147|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83252148|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252149|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83252150|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83252151|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252152|NCT01360021|Budesonide|budesonide|mesh-list
83252153|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83252154|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252155|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83252156|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
83252157|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252158|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252159|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83252160|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
83252161|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
83252162|NCT01360021|Hormones|hormones|mesh-ancestor
83252163|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252164|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83252165|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
83252166|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252167|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83252168|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83252169|NCT02497287|Sertraline|sertraline|mesh-list
83252170|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
83252171|NCT02497287|Esketamine|esketamine|mesh-list
83252172|NCT02497287|Escitalopram|escitalopram|mesh-list
83252173|NCT02497287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83252174|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83252175|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83252176|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252177|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252178|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
83252179|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252180|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252181|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83252182|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83252183|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83252184|NCT02497287|Analgesics|analgesics|mesh-ancestor
83252185|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
83252186|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
83252187|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83252188|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83252189|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252190|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
83252191|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252192|NCT02458287|Bococizumab|bococizumab|mesh-list
83252193|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83252194|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83252195|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
83252196|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252197|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83252198|NCT03056053|Zolpidem|zolpidem|mesh-list
83252199|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83252200|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83252201|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252202|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252203|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83252204|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
83252205|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
83252206|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252207|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252208|NCT02496039|Quinidine|quinidine|mesh-list
83252209|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
83252210|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
83252211|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
83252212|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83252213|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83252214|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252215|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252216|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252217|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83252218|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83252219|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
83252220|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83252221|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
83252222|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83252223|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83252224|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252225|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252226|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83252227|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83252228|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
83252229|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83252230|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83252231|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83252232|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83252233|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83252234|NCT04922359|Lidocaine|lidocaine|mesh-list
83252235|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
83252236|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
83252237|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252238|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252239|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
83252240|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252241|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83252242|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83252244|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83252245|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252246|NCT02495883|Ethanol|ethanol|mesh-list
83252247|NCT02495883|Propranolol|propranolol|mesh-list
83252248|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83252249|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83252250|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
83252251|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252252|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252253|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252254|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83252255|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83252256|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
83252257|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83252258|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252259|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252260|NCT04910347|Nivolumab|nivolumab|mesh-list
83252261|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252262|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252263|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83252264|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252265|NCT02439957|Valganciclovir|valganciclovir|mesh-list
83252266|NCT02439957|Brincidofovir|brincidofovir|mesh-list
83252267|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
83252268|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252269|NCT02457195|Granisetron|granisetron|mesh-list
83252270|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
83252271|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
83252272|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252273|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252274|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252275|NCT02457195|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83252276|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83252277|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
83252278|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252279|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252280|NCT04913779|Immunomodulating Agents|immunomodulating agents|mesh-list
83252281|NCT04913779|Immunologic Factors|immunologic factors|mesh-ancestor
83252282|NCT04913779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252283|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
83252284|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83252285|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83252286|NCT03054259|Prednisolone|prednisolone|mesh-list
83252287|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
83252288|NCT03054259|Rituximab|rituximab|mesh-list
83252289|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83252290|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
83252291|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252292|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252293|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
83252294|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252295|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83252296|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252297|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
83252298|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
83252299|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252300|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252301|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
83252302|NCT03054259|Hormones|hormones|mesh-ancestor
83252303|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252304|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83252305|NCT03054259|Protective Agents|protective agents|mesh-ancestor
83252306|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83252307|NCT01653327|Ketamine|ketamine|mesh-list
83252308|NCT01653327|Analgesics|analgesics|mesh-ancestor
83252309|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
83252310|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252311|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252312|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83252313|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83252314|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
83252315|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
83252316|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252317|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83252318|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83252319|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252320|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252321|NCT03053869|Diazepam|diazepam|mesh-list
83252322|NCT03053869|Lorazepam|lorazepam|mesh-list
83252323|NCT03053869|Alprazolam|alprazolam|mesh-list
83252324|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
83252325|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
83252326|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
83252327|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252328|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252329|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252330|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83252331|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252332|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83252333|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83252334|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83252335|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
83252336|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
83252337|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252338|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252339|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83252340|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83252341|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83252342|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83252343|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
83252344|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
83252345|NCT03053947|Ketamine|ketamine|mesh-list
83252346|NCT03053947|Analgesics|analgesics|mesh-ancestor
83252347|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
83252348|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252349|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252350|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83252351|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83252352|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
83252353|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
83252354|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252355|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83252356|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83252357|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252358|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252359|NCT04893733|Folic Acid|folic acid|mesh-list
83252360|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
83252361|NCT04893733|Vitamins|vitamins|mesh-ancestor
83252362|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
83252363|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252364|NCT04893733|Hematinics|hematinics|mesh-ancestor
83252365|NCT02493855|Ritonavir|ritonavir|mesh-list
83252366|NCT02493855|Ribavirin|ribavirin|mesh-list
83252367|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83252368|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83252369|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
83252370|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252371|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252372|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83252373|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83252374|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
83252375|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252376|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83252377|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83252378|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
83252379|NCT04892563|Morphine|morphine|mesh-list
83252380|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83252381|NCT04892563|Narcotics|narcotics|mesh-ancestor
83252382|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252383|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252384|NCT04892563|Analgesics|analgesics|mesh-ancestor
83252385|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
83252386|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252387|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
83252388|NCT04909255|Mirabegron|mirabegron|mesh-list
83252389|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83252390|NCT04909255|Oxybutynin|oxybutynin|mesh-list
83252391|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83252392|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83252393|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
83252394|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252395|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252396|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252397|NCT04909255|Urological Agents|urological agents|mesh-ancestor
83252398|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83252399|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83252400|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83252401|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
83252402|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
83252403|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
83252404|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252405|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
83252406|NCT04891861|Apixaban|apixaban|mesh-list
83252407|NCT04891861|Edoxaban|edoxaban|mesh-list
83252408|NCT04891861|Dabigatran|dabigatran|mesh-list
83252409|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83252410|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
83252411|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83252412|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
83252413|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252414|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252415|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
83252416|NCT03053167|Irinotecan|irinotecan|mesh-list
83252417|NCT03053167|Raltitrexed|raltitrexed|mesh-list
83252418|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83252419|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83252420|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252421|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252422|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252423|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83252424|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
83252425|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83252426|NCT04901923|Itraconazole|itraconazole|mesh-list
83252427|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
83252428|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
83252429|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252430|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83252431|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83252432|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252433|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252434|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83252435|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
83252436|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252437|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252438|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83252439|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252440|NCT03050905|Ritonavir|ritonavir|mesh-list
83252441|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83252442|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83252443|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
83252444|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252445|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252446|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83252447|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83252448|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
83252449|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252450|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83252451|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83252452|NCT03050827|Oxybutynin|oxybutynin|mesh-list
83252453|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
83252454|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
83252455|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252456|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252457|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83252458|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83252459|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
83252460|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252461|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252462|NCT03050827|Urological Agents|urological agents|mesh-ancestor
83252463|NCT02438787|Golimumab|golimumab|mesh-list
83252464|NCT02438787|Ustekinumab|ustekinumab|mesh-list
83252465|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
83252466|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83252467|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252468|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252469|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
83252470|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252471|NCT04901065|Lidocaine|lidocaine|mesh-list
83252472|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
83252473|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
83252474|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252475|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252476|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
83252477|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252478|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83252479|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83252480|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83252481|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83252482|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252483|NCT02493777|Methylphenidate|methylphenidate|mesh-list
83252484|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83252485|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252486|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83252487|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83252488|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83252489|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252490|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
83252491|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252492|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83252494|NCT04906915|Analgesics|analgesics|mesh-ancestor
83252495|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
83252496|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252497|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252498|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83252499|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83252500|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
83252501|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
83252502|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252503|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83252504|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83252505|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252506|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252507|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83252508|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
83252509|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252510|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
83252511|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252512|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
83252513|NCT04900129|Diclofenac|diclofenac|mesh-list
83252514|NCT04900129|Salicylates|salicylates|mesh-list
83252515|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
83252516|NCT04900129|Menthol|menthol|mesh-list
83252517|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83252518|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83252519|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83252520|NCT04900129|Analgesics|analgesics|mesh-ancestor
83252521|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
83252522|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252523|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252524|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252525|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83252526|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83252527|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252528|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252529|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
83252530|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
83252531|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
83252532|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252533|NCT04900129|Expectorants|expectorants|mesh-ancestor
83252534|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
83252535|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83252536|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
83252537|NCT04900129|Protective Agents|protective agents|mesh-ancestor
83252538|NCT04900129|Antidotes|antidotes|mesh-ancestor
83252539|NCT02616601|Fluorouracil|fluorouracil|mesh-list
83252540|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
83252541|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252542|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83252543|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252544|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252545|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
83252546|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252547|NCT02492997|Glycerol|glycerol|mesh-list
83252548|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83252549|NCT02492997|Protective Agents|protective agents|mesh-ancestor
83252550|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252551|NCT04393207|Dexamethasone|dexamethasone|mesh-list
83252552|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
83252553|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
83252554|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83252555|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83252556|NCT04393207|Prednisolone|prednisolone|mesh-list
83252557|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
83252558|NCT04393207|Bupivacaine|bupivacaine|mesh-list
83252559|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83252560|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
83252561|NCT04393207|BB 1101|bb 1101|mesh-list
83252562|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252563|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
83252564|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
83252565|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252566|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252567|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252568|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
83252569|NCT04393207|Hormones|hormones|mesh-ancestor
83252570|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252571|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83252572|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252573|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
83252574|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252575|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252576|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
83252577|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
83252578|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252579|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
83252580|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83252581|NCT04393207|Protective Agents|protective agents|mesh-ancestor
83252582|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
83252583|NCT02492841|Calcium|calcium|mesh-list
83252584|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83252585|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252586|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83252587|NCT04814875|Carboplatin|carboplatin|mesh-list
83252588|NCT04814875|Doxorubicin|doxorubicin|mesh-list
83252589|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83252590|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252591|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83252592|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83252593|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83252594|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252595|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252596|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
83252597|NCT04812535|Vilobelimab|vilobelimab|mesh-list
83252598|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252599|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252600|NCT04812535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83252601|NCT04812535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252602|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83252603|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252604|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
83252605|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252606|NCT02492763|Metformin|metformin|mesh-list
83252607|NCT02492763|Liraglutide|liraglutide|mesh-list
83252608|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83252609|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252610|NCT02492763|Incretins|incretins|mesh-ancestor
83252611|NCT02492763|Hormones|hormones|mesh-ancestor
83252612|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252613|NCT04899817|Granisetron|granisetron|mesh-list
83252614|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
83252615|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
83252616|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252617|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252618|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252619|NCT04899817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83252620|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83252621|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
83252622|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252623|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252625|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252626|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252627|NCT04397107|Aldesleukin|aldesleukin|mesh-list
83252628|NCT04397107|Interleukin-2|interleukin-2|mesh-list
83252629|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252630|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83252631|NCT04397107|Analgesics|analgesics|mesh-ancestor
83252632|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
83252633|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252634|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252635|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83252636|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83252637|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
83252638|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252639|NCT02453841|Phenylephrine|phenylephrine|mesh-list
83252640|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
83252641|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83252642|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83252643|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
83252644|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252645|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252646|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252647|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
83252648|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
83252649|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252650|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
83252651|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83252652|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
83252653|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83252654|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
83252655|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83252656|NCT02453841|Protective Agents|protective agents|mesh-ancestor
83252657|NCT03081689|Paclitaxel|paclitaxel|mesh-list
83252658|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83252659|NCT03081689|Carboplatin|carboplatin|mesh-list
83252660|NCT03081689|Nivolumab|nivolumab|mesh-list
83252661|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83252662|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252663|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
83252664|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
83252665|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
83252666|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252667|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252668|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83252669|NCT04888663|Paclitaxel|paclitaxel|mesh-list
83252670|NCT04888663|Trastuzumab|trastuzumab|mesh-list
83252671|NCT04888663|Ramucirumab|ramucirumab|mesh-list
83252672|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83252673|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252674|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
83252675|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
83252676|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
83252677|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252678|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252679|NCT04899427|Tislelizumab|tislelizumab|mesh-list
83252680|NCT04899427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252681|NCT04899427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252682|NCT02453685|Insulin|insulin|mesh-list
83252683|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83252684|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
83252685|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
83252686|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
83252687|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83252688|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
83252689|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83252690|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83252691|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252692|NCT03051841|Dexamethasone|dexamethasone|mesh-list
83252693|NCT03051841|Bortezomib|bortezomib|mesh-list
83252694|NCT03051841|CKD-581|ckd-581|mesh-list
83252695|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252696|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
83252697|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
83252698|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252699|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252700|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252701|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
83252702|NCT03051841|Hormones|hormones|mesh-ancestor
83252703|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252704|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83252705|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252706|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252707|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252708|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83252709|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
83252710|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252711|NCT02436759|Phenylephrine|phenylephrine|mesh-list
83252712|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
83252713|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83252714|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83252715|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83252716|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83252717|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
83252718|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252719|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252720|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252721|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
83252722|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
83252723|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252724|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
83252725|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83252726|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
83252727|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83252728|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
83252729|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83252730|NCT02436759|Protective Agents|protective agents|mesh-ancestor
83252731|NCT04888741|Cyclosporine|cyclosporine|mesh-list
83252732|NCT04888741|Sirolimus|sirolimus|mesh-list
83252733|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
83252734|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
83252735|NCT04888741|Cyclosporins|cyclosporins|mesh-list
83252736|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
83252737|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252738|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
83252739|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252740|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83252741|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83252742|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
83252743|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252744|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252745|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83252746|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252747|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
83252748|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252749|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
83252750|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83252751|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83252752|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83252753|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
83252754|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83252755|NCT04888819|Fexuprazan|fexuprazan|mesh-list
83252756|NCT04888819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252757|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
83252758|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
83252759|NCT04904185|Fludarabine|fludarabine|mesh-list
83252760|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
83252761|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252762|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
83252763|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252764|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83252765|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83252766|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
83252767|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252768|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252770|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252771|NCT04904185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83252772|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83252773|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
83252774|NCT04898725|Vitamin D|vitamin d|mesh-list
83252775|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
83252776|NCT04898725|Vitamins|vitamins|mesh-ancestor
83252777|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
83252778|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252779|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83252780|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83252781|NCT04887961|Trabectedin|trabectedin|mesh-list
83252782|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83252783|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
83252784|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252785|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252786|NCT04887649|Morphine|morphine|mesh-list
83252787|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83252788|NCT04887649|Narcotics|narcotics|mesh-ancestor
83252789|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252790|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252791|NCT04887649|Analgesics|analgesics|mesh-ancestor
83252792|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
83252793|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252794|NCT03050437|Pemetrexed|pemetrexed|mesh-list
83252795|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252796|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252797|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252798|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83252799|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83252800|NCT02436135|Idelalisib|idelalisib|mesh-list
83252801|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252802|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252803|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252804|NCT04917861|Vaccines|vaccines|mesh-list
83252805|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
83252806|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252807|NCT02435277|Metformin|metformin|mesh-list
83252808|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83252809|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252810|NCT02420223|Propranolol|propranolol|mesh-list
83252811|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83252812|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83252813|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
83252814|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252815|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252816|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252817|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83252818|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83252819|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
83252820|NCT02433483|Cytarabine|cytarabine|mesh-list
83252821|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
83252822|NCT02433483|Methotrexate|methotrexate|mesh-list
83252823|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83252824|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
83252825|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83252826|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252827|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83252828|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
83252829|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252830|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252831|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
83252832|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252833|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83252834|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252835|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
83252836|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83252837|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83252838|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
83252839|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252840|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252841|NCT02419755|Cytarabine|cytarabine|mesh-list
83252842|NCT02419755|Dexamethasone|dexamethasone|mesh-list
83252843|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
83252844|NCT02419755|Doxorubicin|doxorubicin|mesh-list
83252845|NCT02419755|Methotrexate|methotrexate|mesh-list
83252846|NCT02419755|Bortezomib|bortezomib|mesh-list
83252847|NCT02419755|Asparaginase|asparaginase|mesh-list
83252848|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
83252849|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
83252850|NCT02419755|Vorinostat|vorinostat|mesh-list
83252851|NCT02419755|Pegaspargase|pegaspargase|mesh-list
83252852|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83252854|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
83252855|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252856|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252857|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252858|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
83252859|NCT02419755|Hormones|hormones|mesh-ancestor
83252860|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252861|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83252862|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252863|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83252864|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83252865|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83252866|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252867|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252868|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83252869|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
83252870|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83252871|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83252872|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
83252873|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
83252874|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83252875|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83252876|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
83252877|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83252878|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83252879|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
83252880|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83252881|NCT02419755|Analgesics|analgesics|mesh-ancestor
83252882|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
83252883|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83252884|NCT04914195|Leuprolide|leuprolide|mesh-list
83252885|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83252886|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
83252887|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83252888|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252889|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83252890|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252891|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
83252892|NCT04913025|Nivolumab|nivolumab|mesh-list
83252893|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83252894|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252895|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83252896|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252897|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
83252898|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252899|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
83252900|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252901|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252902|NCT04887493|Alprostadil|alprostadil|mesh-list
83252903|NCT04887493|Misoprostol|misoprostol|mesh-list
83252904|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83252905|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
83252906|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83252907|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252908|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83252909|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83252910|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
83252911|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83252912|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
83252913|NCT04887493|Urological Agents|urological agents|mesh-ancestor
83252914|NCT02486757|Estradiol|estradiol|mesh-list
83252915|NCT02486757|Progesterone|progesterone|mesh-list
83252916|NCT02486757|Estrogens|estrogens|mesh-ancestor
83252917|NCT02486757|Hormones|hormones|mesh-ancestor
83252918|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252919|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252920|NCT02486757|Progestins|progestins|mesh-ancestor
83252921|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83252922|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
83252923|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83252924|NCT03051529|Anesthetics|anesthetics|mesh-list
83252925|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252926|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252927|NCT04886869|Caffeine|caffeine|mesh-list
83252928|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83252929|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252930|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83252931|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252932|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252933|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83252934|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83252935|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
83252936|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252937|NCT04897477|Azacitidine|azacitidine|mesh-list
83252938|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83252939|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83252940|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
83252941|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252942|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83252943|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252944|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83252945|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
83252946|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83252947|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
83252948|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83252949|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252950|NCT04882813|Incretins|incretins|mesh-ancestor
83252951|NCT04882813|Hormones|hormones|mesh-ancestor
83252952|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83252953|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83252954|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
83252955|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252956|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252957|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83252958|NCT02576639|Umibecestat|umibecestat|mesh-list
83252959|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83252960|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252961|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83252962|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83252963|NCT02418585|Sertraline|sertraline|mesh-list
83252964|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
83252965|NCT02418585|Esketamine|esketamine|mesh-list
83252966|NCT02418585|Escitalopram|escitalopram|mesh-list
83252967|NCT02418585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83252968|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83252969|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83252970|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252971|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83252972|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
83252973|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252974|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83252975|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83252976|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83252977|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83252978|NCT02418585|Analgesics|analgesics|mesh-ancestor
83252979|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
83252980|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
83252981|NCT05529875|Propofol|propofol|mesh-list
83252982|NCT05529875|Sevoflurane|sevoflurane|mesh-list
83252983|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83252984|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83252985|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252986|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83252987|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
83252988|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
83252989|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83252990|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83252991|NCT03051451|Metformin|metformin|mesh-list
83252992|NCT03051451|Fluoxetine|fluoxetine|mesh-list
83252993|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83252994|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83252995|NCT03051451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83252996|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83252997|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83252998|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83252999|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253000|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
83253001|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83253002|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
83253003|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83253004|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83253005|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83253006|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253007|NCT02417961|Benralizumab|benralizumab|mesh-list
83253008|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83253009|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
83253010|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
83253011|NCT02869217|Fludarabine|fludarabine|mesh-list
83253012|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253013|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
83253014|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253015|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253016|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83253017|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
83253018|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253019|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253020|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83253021|NCT04883125|Pioglitazone|pioglitazone|mesh-list
83253022|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83253023|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253024|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
83253026|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83253027|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253028|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253029|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253030|NCT05474183|Analgesics|analgesics|mesh-ancestor
83253031|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
83253032|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253033|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83253034|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83253035|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83253036|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
83253037|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253038|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253039|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83253040|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83253041|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
83253042|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
83253043|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83253044|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83253045|NCT04885777|Lidocaine|lidocaine|mesh-list
83253046|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
83253047|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
83253048|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253049|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253050|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
83253051|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253052|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83253053|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83253054|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83253055|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83413593|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253056|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253057|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
83253058|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
83253059|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253060|NCT02632721|Decitabine|decitabine|mesh-list
83253061|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253062|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
83253063|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253064|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253065|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253066|NCT05529095|Apomorphine|apomorphine|mesh-list
83253067|NCT05529095|Emetics|emetics|mesh-ancestor
83253068|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253069|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
83253070|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253071|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253072|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
83253073|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
83253074|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253075|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253076|NCT01596127|Rituximab|rituximab|mesh-list
83253077|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253078|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253079|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
83253080|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253081|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253082|NCT03051373|Paclitaxel|paclitaxel|mesh-list
83253083|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83253084|NCT03051373|Gemcitabine|gemcitabine|mesh-list
83253085|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83253086|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253087|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
83253088|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
83253089|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
83253090|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253091|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253092|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
83253093|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83253094|NCT04895059|Ezetimibe|ezetimibe|mesh-list
83253095|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83253096|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83253097|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
83253098|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253099|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83253100|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83253101|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253102|NCT05467475|Esomeprazole|esomeprazole|mesh-list
83253103|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83253104|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253105|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83253106|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253107|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253108|NCT05534165|Tecovirimat|tecovirimat|mesh-list
83253109|NCT05534165|Antiviral Agents|antiviral agents|mesh-ancestor
83253110|NCT05534165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253111|NCT04895137|Bevacizumab|bevacizumab|mesh-list
83253112|NCT04895137|Antibodies|antibodies|mesh-list
83253113|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83253114|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253115|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253116|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83253117|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83253118|NCT04895137|Growth Substances|growth substances|mesh-ancestor
83253119|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253120|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
83253121|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
83253122|NCT02326805|Metronidazole|metronidazole|mesh-list
83253123|NCT02326805|Vaccines|vaccines|mesh-list
83253124|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
83253125|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253126|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253127|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83253128|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83253129|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83253130|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
83253131|NCT01595581|Testosterone|testosterone|mesh-list
83253132|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
83253133|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
83253134|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83253135|NCT01595581|Androgens|androgens|mesh-ancestor
83253136|NCT01595581|Hormones|hormones|mesh-ancestor
83253137|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253138|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253139|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83253140|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253141|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
83253142|NCT04885153|Fenofibrate|fenofibrate|mesh-list
83253143|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83253144|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
83253145|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253146|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83253147|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83253148|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253149|NCT04884997|Temozolomide|temozolomide|mesh-list
83253150|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83253151|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
83253152|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253153|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253154|NCT04885075|Midazolam|midazolam|mesh-list
83253155|NCT04885075|Diazepam|diazepam|mesh-list
83253156|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83253157|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83253158|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253159|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253160|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83253161|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83253162|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83253163|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83253164|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
83253166|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
83253167|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
83253168|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253169|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253170|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
83253171|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
83253172|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
83253173|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253174|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253175|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83253176|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83253177|NCT01610687|Nabiximols|nabiximols|mesh-list
83253178|NCT01610687|Analgesics|analgesics|mesh-ancestor
83253179|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
83253180|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253181|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253182|NCT04884919|Chitosan|chitosan|mesh-list
83253183|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83253184|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83253185|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
83253186|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253187|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83253188|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
83253189|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
83253190|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
83253191|NCT04884919|Coagulants|coagulants|mesh-ancestor
83253192|NCT04878835|Ranibizumab|ranibizumab|mesh-list
83253193|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83253194|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83253195|NCT04878835|Growth Substances|growth substances|mesh-ancestor
83253196|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253197|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
83253198|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253199|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
83253200|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253201|NCT04872283|Aspirin|aspirin|mesh-list
83253202|NCT04872283|Acetaminophen|acetaminophen|mesh-list
83253203|NCT04872283|Ketorolac|ketorolac|mesh-list
83253204|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83253205|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83253206|NCT04872283|Oxycodone|oxycodone|mesh-list
83253207|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83253208|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253209|NCT04872283|Analgesics|analgesics|mesh-ancestor
83253210|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
83253211|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253212|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253213|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253214|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253215|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83253216|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83253217|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253218|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83253219|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83253220|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253221|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
83253222|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83253223|NCT04872283|Narcotics|narcotics|mesh-ancestor
83253224|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253225|NCT05182385|Venetoclax|venetoclax|mesh-list
83253226|NCT05182385|Blinatumomab|blinatumomab|mesh-list
83253227|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253228|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83253229|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253230|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253231|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
83253232|NCT04389073|Bevacizumab|bevacizumab|mesh-list
83253233|NCT04389073|Capecitabine|capecitabine|mesh-list
83253234|NCT04389073|Vinorelbine|vinorelbine|mesh-list
83253235|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253236|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
83253237|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253238|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253239|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83253240|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
83253241|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253242|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253243|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83253244|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253245|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83253246|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83253247|NCT04389073|Growth Substances|growth substances|mesh-ancestor
83253248|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
83253249|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253250|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
83253251|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83253252|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
83253253|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
83253254|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
83253255|NCT04371445|Dexamethasone|dexamethasone|mesh-list
83253256|NCT04371445|Prednisolone|prednisolone|mesh-list
83253257|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83253258|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
83253259|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83253260|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
83253261|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83253262|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
83253263|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253264|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
83253265|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
83253266|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253267|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253268|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253269|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
83253270|NCT04371445|Hormones|hormones|mesh-ancestor
83253271|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253272|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83253273|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253274|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83253275|NCT04371445|Protective Agents|protective agents|mesh-ancestor
83253276|NCT03049267|Apremilast|apremilast|mesh-list
83253277|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83253278|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253279|NCT03049267|Analgesics|analgesics|mesh-ancestor
83253280|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
83253281|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253282|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253284|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253285|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83253286|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83253287|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253288|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253289|NCT05524259|Folic Acid|folic acid|mesh-list
83253290|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
83253291|NCT05524259|Inositol|inositol|mesh-list
83253292|NCT05524259|Hematinics|hematinics|mesh-ancestor
83253293|NCT05524259|Vitamins|vitamins|mesh-ancestor
83253294|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
83253295|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253296|NCT04112095|Norgestrel|norgestrel|mesh-list
83253297|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83253298|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83253299|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83253300|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
83253301|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83253302|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253303|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83253304|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83253305|NCT05257993|Paclitaxel|paclitaxel|mesh-list
83253306|NCT05257993|Gemcitabine|gemcitabine|mesh-list
83253307|NCT05257993|Folfirinox|folfirinox|mesh-list
83253308|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83253309|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253310|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83253311|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83253312|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83253313|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253314|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253315|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
83253316|NCT05533073|Etoricoxib|etoricoxib|mesh-list
83253317|NCT05533073|Tramadol|tramadol|mesh-list
83253318|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83253319|NCT05533073|Narcotics|narcotics|mesh-ancestor
83253320|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253321|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253322|NCT05533073|Analgesics|analgesics|mesh-ancestor
83253323|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
83253324|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253325|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83253326|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253327|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253328|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253329|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83253330|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83253331|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253332|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253333|NCT04050553|Tirzepatide|tirzepatide|mesh-list
83253334|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83253335|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253336|NCT04050553|Incretins|incretins|mesh-ancestor
83253337|NCT04050553|Hormones|hormones|mesh-ancestor
83253338|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253339|NCT03946891|Furosemide|furosemide|mesh-list
83253340|NCT03946891|Diuretics|diuretics|mesh-ancestor
83253341|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
83253342|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83430160|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83253343|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83253344|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83253345|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253346|NCT04300049|Glucagon|glucagon|mesh-list
83253347|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83253348|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253349|NCT04300049|Hormones|hormones|mesh-ancestor
83253350|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253351|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253352|NCT04300049|Incretins|incretins|mesh-ancestor
83253353|NCT03849625|Aspirin|aspirin|mesh-list
83253354|NCT03849625|Acetaminophen|acetaminophen|mesh-list
83253355|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83253356|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253357|NCT03849625|Analgesics|analgesics|mesh-ancestor
83253358|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
83253359|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253360|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253361|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253362|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253363|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83253364|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83253365|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253366|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83253367|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83253368|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253369|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
83253370|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83253371|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
83253372|NCT03049345|Methylene Blue|methylene blue|mesh-list
83253373|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253374|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253375|NCT05526911|Tenofovir|tenofovir|mesh-list
83253376|NCT05526911|Lamivudine|lamivudine|mesh-list
83253382|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253383|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253385|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83253386|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83253387|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83253388|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
83253389|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
83253390|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
83253391|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
83253392|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253393|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253394|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
83253395|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253396|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83253397|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83253398|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253399|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83253400|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83253401|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83253402|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83253403|NCT05526911|Protective Agents|protective agents|mesh-ancestor
83253404|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83253405|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83253406|NCT04870489|Isotretinoin|isotretinoin|mesh-list
83253407|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
83253408|NCT02574845|Metformin|metformin|mesh-list
83253409|NCT02574845|Furosemide|furosemide|mesh-list
83253410|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83253411|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83253412|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253413|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83253414|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83253415|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
83253416|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253417|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83253418|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83253419|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253420|NCT02574845|Diuretics|diuretics|mesh-ancestor
83253421|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
83253422|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83253423|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83253424|NCT05334485|Bromides|bromides|mesh-list
83253425|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83253426|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
83253427|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83253428|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253429|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253430|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
83253431|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253432|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253433|NCT05231941|Lidocaine|lidocaine|mesh-list
83253434|NCT05231941|Ropivacaine|ropivacaine|mesh-list
83253435|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
83253436|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
83253437|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253438|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253439|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
83253440|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253441|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83253442|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83253443|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83253444|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83253445|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253446|NCT05216575|Almitrine|almitrine|mesh-list
83253447|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
83253476|NCT04877509|Vitamin A|vitamin a|mesh-list
83253477|NCT04877509|Selenium|selenium|mesh-list
83253478|NCT04877509|Copper|copper|mesh-list
83253479|NCT04877509|Vitamins|vitamins|mesh-ancestor
83253480|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
83253481|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253482|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
83253483|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253484|NCT04877509|Protective Agents|protective agents|mesh-ancestor
83253485|NCT04877509|Trace Elements|trace elements|mesh-ancestor
83253486|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83253487|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
83253488|NCT03044743|Fludarabine|fludarabine|mesh-list
83253489|NCT03044743|Interleukin-2|interleukin-2|mesh-list
83253490|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253491|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
83253492|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253493|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253494|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83253495|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
83253496|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253497|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253498|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83253499|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253500|NCT03044743|Analgesics|analgesics|mesh-ancestor
83253501|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
83253502|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253503|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83253504|NCT03044665|Ezetimibe|ezetimibe|mesh-list
83253505|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83253506|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83253507|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
83253508|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253509|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83253510|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83253511|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253512|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
83253513|NCT05525351|Alfentanil|alfentanil|mesh-list
83253514|NCT05525351|Propofol|propofol|mesh-list
83253515|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83253516|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253517|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253518|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253519|NCT05525351|Analgesics|analgesics|mesh-ancestor
83253520|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
83253521|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253522|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83253523|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83253524|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83253525|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83253526|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253527|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253528|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83253529|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
83253530|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
83253532|NCT05525351|Narcotics|narcotics|mesh-ancestor
83253533|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
83253534|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253535|NCT05521763|Vaccines|vaccines|mesh-list
83253536|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
83253537|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253538|NCT05100017|Methocarbamol|methocarbamol|mesh-list
83253539|NCT05100017|Oxybutynin|oxybutynin|mesh-list
83253540|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
83253541|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
83253542|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253543|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253544|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83253545|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83253546|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
83253547|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253548|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253549|NCT05100017|Urological Agents|urological agents|mesh-ancestor
83253550|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83253551|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83253552|NCT04865185|Ethanol|ethanol|mesh-list
83253553|NCT04865185|Lidocaine|lidocaine|mesh-list
83253554|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83253555|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253556|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253557|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253558|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
83253559|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
83253560|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
83253561|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253562|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83253563|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83253564|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83253565|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83253566|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253567|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
83253568|NCT04876807|Omeprazole|omeprazole|mesh-list
83253569|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83253570|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253571|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83253572|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253573|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253574|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253575|NCT05518409|Donepezil|donepezil|mesh-list
83253576|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83253577|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253578|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253579|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
83253580|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253581|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253582|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
83253583|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
83253584|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
83253585|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
83253586|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253587|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83253588|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
83253589|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
83253590|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253591|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253592|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253593|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83253594|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
83253595|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83253596|NCT04864717|Doxycycline|doxycycline|mesh-list
83253597|NCT04864717|Isotretinoin|isotretinoin|mesh-list
83253598|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83253599|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253600|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
83253601|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83253602|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83253603|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83253604|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
83253605|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253606|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
83253607|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253609|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253610|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83253611|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
83253612|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83253613|NCT02613871|Ledipasvir|ledipasvir|mesh-list
83253614|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
83253615|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253616|NCT04869709|Betamethasone|betamethasone|mesh-list
83253617|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
83253618|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83253619|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
83253620|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83253621|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253622|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
83253623|NCT04869709|Hormones|hormones|mesh-ancestor
83253624|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253625|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253626|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83253627|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
83253628|NCT02612077|Bevacizumab|bevacizumab|mesh-list
83253629|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253630|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253631|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83253632|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83253633|NCT02612077|Growth Substances|growth substances|mesh-ancestor
83253634|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253635|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
83253636|NCT04622735|Acetaminophen|acetaminophen|mesh-list
83253637|NCT04622735|Nefopam|nefopam|mesh-list
83253638|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253639|NCT04622735|Analgesics|analgesics|mesh-ancestor
83253640|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
83253641|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253642|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253643|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
83253644|NCT05531591|Aripiprazole|aripiprazole|mesh-list
83253645|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
83253646|NCT05531591|Bupropion|bupropion|mesh-list
83253647|NCT05531591|Nortriptyline|nortriptyline|mesh-list
83253648|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83253649|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
83253650|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83253651|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83253652|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83253653|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83253654|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253655|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
83253656|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253657|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253658|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83253659|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83253660|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253661|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83253662|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83253663|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253664|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
83253665|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83253666|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83253667|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
83253668|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83253669|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83253670|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83253671|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83253672|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
83253673|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83253674|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83253675|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
83253677|NCT05048615|Azacitidine|azacitidine|mesh-list
83253678|NCT05048615|Venetoclax|venetoclax|mesh-list
83253679|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253680|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
83253681|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253682|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253683|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253684|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
83253685|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253686|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83253687|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83253688|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83253689|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
83253690|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253691|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253692|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83253693|NCT05531435|Anesthetics|anesthetics|mesh-list
83253694|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
83253695|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253696|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253697|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
83253698|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253699|NCT05517239|Gemcitabine|gemcitabine|mesh-list
83253700|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
83253701|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253702|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
83253703|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253704|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253705|NCT05519813|Metformin|metformin|mesh-list
83253706|NCT05519813|Pioglitazone|pioglitazone|mesh-list
83253707|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83253708|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253709|NCT02613403|Ribavirin|ribavirin|mesh-list
83253710|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
83253711|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
83253712|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253713|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
83253714|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253715|NCT05002127|Paclitaxel|paclitaxel|mesh-list
83253716|NCT05002127|Trastuzumab|trastuzumab|mesh-list
83253717|NCT05002127|Ramucirumab|ramucirumab|mesh-list
83253718|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83253719|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253720|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
83253721|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
83253722|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
83253723|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253724|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253725|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
83253726|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
83253727|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83253728|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83253729|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253730|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253731|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253732|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253733|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
83253734|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83253735|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83253736|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253737|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
83253738|NCT03044041|Coagulants|coagulants|mesh-ancestor
83253739|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83253740|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83253741|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253742|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83253743|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83253744|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253745|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253746|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
83253747|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253748|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
83253749|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253750|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253751|NCT04863079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83253752|NCT04863079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253753|NCT05512325|Bevacizumab|bevacizumab|mesh-list
83253754|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253755|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253756|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83253757|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83253758|NCT05512325|Growth Substances|growth substances|mesh-ancestor
83253759|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253760|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
83253761|NCT04868227|Vitamin D|vitamin d|mesh-list
83253762|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
83253763|NCT04868227|Vitamins|vitamins|mesh-ancestor
83253764|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
83253765|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253766|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83253767|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83253768|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83253769|NCT04873531|Neostigmine|neostigmine|mesh-list
83253770|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83253771|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253772|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253773|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
83253774|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253775|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253776|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83253777|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
83253778|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253779|NCT04862845|Pregabalin|pregabalin|mesh-list
83253780|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83253781|NCT04862845|Analgesics|analgesics|mesh-ancestor
83253782|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
83253783|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253784|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253785|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
83253786|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83253787|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83253788|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253789|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83253790|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83253791|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83253792|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83253793|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83253794|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83253795|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83253796|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253797|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
83253798|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
83253799|NCT04862377|Budesonide|budesonide|mesh-list
83253800|NCT04862377|Poractant alfa|poractant alfa|mesh-list
83253801|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253802|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83253803|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
83253804|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253805|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253806|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83253807|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
83253808|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
83253809|NCT04862377|Hormones|hormones|mesh-ancestor
83253810|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253811|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83253812|NCT04867993|Amikacin|amikacin|mesh-list
83253813|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83253814|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83253815|NCT04872985|Paclitaxel|paclitaxel|mesh-list
83253816|NCT04872985|Docetaxel|docetaxel|mesh-list
83253817|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
83253818|NCT04872985|Doxorubicin|doxorubicin|mesh-list
83253819|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83253820|NCT04872985|Epirubicin|epirubicin|mesh-list
83253821|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83253822|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253823|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83253824|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83253825|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83253826|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253827|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253828|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
83253829|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253830|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253831|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83253832|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
83253833|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83253834|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83253835|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83253836|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83253837|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253838|NCT04872907|Fluorides|fluorides|mesh-list
83253839|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
83253840|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
83253841|NCT04872907|Protective Agents|protective agents|mesh-ancestor
83253842|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253843|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
83253844|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
83253846|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
83253847|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253848|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253849|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83253850|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
83253851|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
83253852|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83253853|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
83253854|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253855|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253856|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83253857|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83253858|NCT05507411|Immunomodulating Agents|immunomodulating agents|mesh-list
83253859|NCT05507411|Immunologic Factors|immunologic factors|mesh-ancestor
83253860|NCT05507411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253861|NCT05512013|Ibuprofen|ibuprofen|mesh-list
83253862|NCT05512013|Celecoxib|celecoxib|mesh-list
83253863|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
83253864|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83253865|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83253866|NCT05512013|Analgesics|analgesics|mesh-ancestor
83253867|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
83253868|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253869|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253870|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253871|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253872|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83253873|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83253874|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253875|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83253876|NCT04894643|Paclitaxel|paclitaxel|mesh-list
83253877|NCT04894643|Gemcitabine|gemcitabine|mesh-list
83253878|NCT04894643|Capecitabine|capecitabine|mesh-list
83253879|NCT04894643|Pancrelipase|pancrelipase|mesh-list
83253880|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83253881|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253882|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
83253883|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
83253884|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
83253885|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253886|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253887|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
83253888|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253889|NCT05511623|Tislelizumab|tislelizumab|mesh-list
83253890|NCT05511623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83253891|NCT05511623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253892|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
83253893|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83253894|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
83253895|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253896|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253897|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83253898|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
83253899|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
83253901|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
83253902|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253903|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253904|NCT03048019|Tirofiban|tirofiban|mesh-list
83253905|NCT03048019|Cangrelor|cangrelor|mesh-list
83253906|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83253907|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83253908|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253909|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83253910|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83253911|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83253912|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83253913|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
83253914|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253915|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253916|NCT05506319|Vasopressins|vasopressins|mesh-list
83253917|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
83253918|NCT05506319|Norepinephrine|norepinephrine|mesh-list
83253919|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83253920|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83253921|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
83253922|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253923|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253924|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253925|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
83253926|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
83253927|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253928|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83253929|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
83253930|NCT05506319|Coagulants|coagulants|mesh-ancestor
83253931|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83253932|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
83253933|NCT05505539|Fluorouracil|fluorouracil|mesh-list
83253934|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
83253935|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253936|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253937|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253938|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253939|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
83253940|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253941|NCT05505461|Antibodies|antibodies|mesh-list
83253942|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
83253943|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253944|NCT05514275|Capecitabine|capecitabine|mesh-list
83253945|NCT05514275|Endostatins|endostatins|mesh-list
83253946|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83253947|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
83253948|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253949|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253950|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83253951|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83253952|NCT05514275|Growth Substances|growth substances|mesh-ancestor
83253953|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253954|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
83253955|NCT05514119|Fenofibrate|fenofibrate|mesh-list
83253956|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83253957|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
83253958|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253959|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83253960|NCT05514041|Varenicline|varenicline|mesh-list
83253961|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83253962|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83253963|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
83253964|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83253965|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253966|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253967|NCT04667663|Dexamethasone|dexamethasone|mesh-list
83253968|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
83253969|NCT04667663|Daratumumab|daratumumab|mesh-list
83253970|NCT04667663|Pomalidomide|pomalidomide|mesh-list
83253971|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83253972|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
83253973|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83253974|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83253975|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83253976|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
83253977|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83253978|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253979|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83253980|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83253981|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
83253982|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
83253983|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83253984|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83253985|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
83253986|NCT04667663|Hormones|hormones|mesh-ancestor
83253987|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83253988|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83253989|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83253990|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83253991|NCT04667663|Growth Substances|growth substances|mesh-ancestor
83253992|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
83253993|NCT02570711|Paclitaxel|paclitaxel|mesh-list
83253994|NCT02570711|Gemcitabine|gemcitabine|mesh-list
83253995|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
83253996|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83253997|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83253998|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
83253999|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
83254000|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
83254001|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254002|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83254003|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
83254004|NCT05513729|Pioglitazone|pioglitazone|mesh-list
83254005|NCT05513729|Canagliflozin|canagliflozin|mesh-list
83254006|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83254007|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254008|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83254009|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254010|NCT05504603|Rituximab|rituximab|mesh-list
83254011|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
83254012|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254013|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254014|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
83254015|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254016|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254017|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254018|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254019|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254020|NCT05504213|Fulvestrant|fulvestrant|mesh-list
83254021|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254022|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254023|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83254024|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83254025|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
83254026|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254027|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254028|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
83254029|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254030|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254031|NCT02564471|Doxycycline|doxycycline|mesh-list
83254032|NCT02564471|Chloroquine|chloroquine|mesh-list
83254033|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83254034|NCT02564471|Atovaquone|atovaquone|mesh-list
83254035|NCT02564471|Proguanil|proguanil|mesh-list
83254036|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83254037|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254038|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
83254039|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83254040|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83254041|NCT02564471|Amebicides|amebicides|mesh-ancestor
83254042|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254043|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83254044|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83254045|NCT02564471|Analgesics|analgesics|mesh-ancestor
83254046|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
83254047|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254048|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254049|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254050|NCT02564471|Filaricides|filaricides|mesh-ancestor
83254051|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
83254052|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
83254053|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254054|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254055|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
83254056|NCT05503667|Bevacizumab|bevacizumab|mesh-list
83254057|NCT05503667|Aflutinib|aflutinib|mesh-list
83254058|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254059|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254060|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83254061|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83254062|NCT05503667|Growth Substances|growth substances|mesh-ancestor
83254063|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254064|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
83254065|NCT05503667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254066|NCT05503667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254067|NCT05503667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254068|NCT05512481|Temozolomide|temozolomide|mesh-list
83254069|NCT05512481|Apatinib|apatinib|mesh-list
83254070|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83254071|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
83254072|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254073|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254074|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254075|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254076|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
83254077|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83254078|NCT02563067|Growth Substances|growth substances|mesh-ancestor
83254079|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254080|NCT02568683|Vincristine|vincristine|mesh-list
83254081|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83254082|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254083|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
83254084|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
83254085|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
83254086|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254087|NCT05502731|Adalimumab|adalimumab|mesh-list
83254088|NCT05502731|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83254089|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254090|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254091|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
83254092|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83254093|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
83254094|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
83254095|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254096|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254097|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83254098|NCT05510141|Analgesics|analgesics|mesh-ancestor
83254099|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
83254100|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254101|NCT05503043|Lidocaine|lidocaine|mesh-list
83254102|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
83254103|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
83254104|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254105|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254106|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
83254107|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254108|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83254109|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83254110|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83254111|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83254112|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254113|NCT02563925|Durvalumab|durvalumab|mesh-list
83254114|NCT02563925|Tremelimumab|tremelimumab|mesh-list
83254115|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254116|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254117|NCT01663727|Paclitaxel|paclitaxel|mesh-list
83254118|NCT01663727|Bevacizumab|bevacizumab|mesh-list
83254119|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83254120|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254121|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
83254122|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
83254123|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
83254124|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254125|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254126|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83254127|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83254128|NCT01663727|Growth Substances|growth substances|mesh-ancestor
83254129|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254130|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
83254131|NCT03042325|Alogliptin|alogliptin|mesh-list
83254132|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83254133|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254134|NCT03042325|Incretins|incretins|mesh-ancestor
83254135|NCT03042325|Hormones|hormones|mesh-ancestor
83254136|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254137|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83254138|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
83254139|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254140|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254141|NCT01594333|Methotrexate|methotrexate|mesh-list
83254142|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83254143|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
83254144|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83254145|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254146|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83254147|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
83254148|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254149|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254150|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
83254152|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83254153|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254154|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
83254155|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254156|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83254157|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
83254158|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
83254159|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83254160|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254161|NCT04338529|Vitamins|vitamins|mesh-ancestor
83254162|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
83254163|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83254164|NCT04338529|Antacids|antacids|mesh-ancestor
83254165|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254166|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83254167|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
83254168|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
83254169|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83254170|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83254171|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254172|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254173|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254174|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254175|NCT03043495|Dexamethasone|dexamethasone|mesh-list
83254176|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254177|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
83254178|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
83254179|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254180|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254181|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83254182|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
83254183|NCT03043495|Hormones|hormones|mesh-ancestor
83254184|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254185|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254186|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254187|NCT03043027|Bupivacaine|bupivacaine|mesh-list
83254188|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
83254189|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
83254190|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254191|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254192|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
83254193|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254194|NCT04861207|Cladribine|cladribine|mesh-list
83254195|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254196|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254197|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
83254198|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254199|NCT04858087|Lumefantrine|lumefantrine|mesh-list
83254200|NCT04858087|Artemether|artemether|mesh-list
83254201|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83254202|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
83254203|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83254204|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83254205|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254206|NCT03041935|Acetaminophen|acetaminophen|mesh-list
83254207|NCT03041935|Dexamethasone|dexamethasone|mesh-list
83254208|NCT03041935|Ketorolac|ketorolac|mesh-list
83254209|NCT03041935|Morphine|morphine|mesh-list
83254210|NCT03041935|Remifentanil|remifentanil|mesh-list
83254211|NCT03041935|Ondansetron|ondansetron|mesh-list
83254212|NCT03041935|Propofol|propofol|mesh-list
83254213|NCT03041935|Ropivacaine|ropivacaine|mesh-list
83254214|NCT03041935|Sevoflurane|sevoflurane|mesh-list
83254215|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254216|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
83254217|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
83254218|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254219|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254220|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83254221|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
83254222|NCT03041935|Hormones|hormones|mesh-ancestor
83254223|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254224|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254225|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254226|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83254227|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254228|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83254229|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
83254230|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
83254231|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83254232|NCT03041935|Narcotics|narcotics|mesh-ancestor
83254233|NCT03041935|Analgesics|analgesics|mesh-ancestor
83254234|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
83254235|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
83254236|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83254237|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
83254238|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83254239|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83254240|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
83254241|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
83254242|NCT03041935|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83254243|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83254244|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
83254245|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254246|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254247|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83254248|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254249|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83254250|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254251|NCT03042013|Naquotinib|naquotinib|mesh-list
83254252|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254253|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254254|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254255|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254256|NCT03042871|Ranibizumab|ranibizumab|mesh-list
83254257|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83254258|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83254259|NCT03042871|Growth Substances|growth substances|mesh-ancestor
83254260|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254261|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
83254262|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254263|NCT03042637|Tacrolimus|tacrolimus|mesh-list
83254264|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254265|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
83254266|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254267|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83254268|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254269|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254270|NCT03045133|Morphine|morphine|mesh-list
83254271|NCT03045133|Methadone|methadone|mesh-list
83254272|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83254273|NCT03045133|Narcotics|narcotics|mesh-ancestor
83254274|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254275|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254276|NCT03045133|Analgesics|analgesics|mesh-ancestor
83254277|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
83254278|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254279|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
83254280|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
83254281|NCT02609659|Ritonavir|ritonavir|mesh-list
83254282|NCT02609659|Ribavirin|ribavirin|mesh-list
83254283|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83254284|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83254285|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
83254286|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254287|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254288|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83254289|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83254290|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
83254291|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254292|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83254293|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83254294|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
83254295|NCT04429711|Ivermectin|ivermectin|mesh-list
83254296|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83254297|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254298|NCT04429633|Candesartan|candesartan|mesh-list
83254299|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83254300|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83254301|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83254302|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254303|NCT03042091|Metronidazole|metronidazole|mesh-list
83254304|NCT03042091|Ethanol|ethanol|mesh-list
83254305|NCT03042091|Neomycin|neomycin|mesh-list
83254306|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254307|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83254308|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83254309|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83254310|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83254311|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254312|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254313|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83254314|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254315|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254316|NCT04859569|Denosumab|denosumab|mesh-list
83254317|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83254318|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254319|NCT04856371|Letrozole|letrozole|mesh-list
83254320|NCT04856371|Fulvestrant|fulvestrant|mesh-list
83254321|NCT04856371|Palbociclib|palbociclib|mesh-list
83254322|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254323|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83254324|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83254325|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254326|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254327|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83254328|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
83254329|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254330|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254331|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254332|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83254333|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254334|NCT03041779|Acetaminophen|acetaminophen|mesh-list
83254335|NCT03041779|Diclofenac|diclofenac|mesh-list
83254336|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83254337|NCT03041779|Analgesics|analgesics|mesh-ancestor
83254338|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
83254339|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254340|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254341|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
83254342|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83254343|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254344|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254345|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83254346|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254347|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254348|NCT02612779|Dexamethasone|dexamethasone|mesh-list
83254349|NCT02612779|Nivolumab|nivolumab|mesh-list
83254350|NCT02612779|Pomalidomide|pomalidomide|mesh-list
83254351|NCT02612779|Elotuzumab|elotuzumab|mesh-list
83254352|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254353|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
83254354|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
83254355|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254356|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254357|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83254358|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
83254359|NCT02612779|Hormones|hormones|mesh-ancestor
83254360|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254361|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254362|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254363|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254364|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83254365|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254366|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
83254367|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83254368|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83254369|NCT02612779|Growth Substances|growth substances|mesh-ancestor
83254370|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
83254371|NCT04866355|Ibuprofen|ibuprofen|mesh-list
83254372|NCT04866355|Scopolamine|scopolamine|mesh-list
83254373|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83254374|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83254375|NCT04866355|Analgesics|analgesics|mesh-ancestor
83254376|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
83254377|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254378|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254379|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254380|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254381|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83254382|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254383|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254384|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83254385|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
83254386|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
83254387|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83254388|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
83254389|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83254390|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
83254391|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254392|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83254394|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83254395|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254396|NCT02607865|Incretins|incretins|mesh-ancestor
83254397|NCT02607865|Hormones|hormones|mesh-ancestor
83254398|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254399|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83254400|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
83254401|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254402|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254403|NCT04856137|Paclitaxel|paclitaxel|mesh-list
83254404|NCT04856137|Rituximab|rituximab|mesh-list
83254405|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83254406|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254407|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83254408|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83254409|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83254410|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254411|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254412|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
83254413|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254414|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254415|NCT04855279|Listerine|listerine|mesh-list
83254416|NCT04855279|Fluorides|fluorides|mesh-list
83254417|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
83254418|NCT04855279|Glycerol|glycerol|mesh-list
83254419|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
83254420|NCT04855279|Protective Agents|protective agents|mesh-ancestor
83254421|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254422|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83254423|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254424|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83254425|NCT04848259|Dexamethasone|dexamethasone|mesh-list
83254426|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
83254427|NCT04848259|BB 1101|bb 1101|mesh-list
83254428|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254429|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
83254430|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
83254431|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254432|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254434|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
83254435|NCT04848259|Hormones|hormones|mesh-ancestor
83254436|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254437|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254438|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254439|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
83254440|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254441|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254442|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83254443|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
83254444|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83254445|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
83254446|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83254447|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254448|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83254449|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254450|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254451|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
83254452|NCT04848181|Finasteride|finasteride|mesh-list
83254453|NCT04848181|Cyproterone|cyproterone|mesh-list
83254454|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83254455|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83254456|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254457|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254458|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
83254459|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254460|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254461|NCT04848181|Urological Agents|urological agents|mesh-ancestor
83254462|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
83254463|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254464|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83254465|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
83254466|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83254467|NCT04847791|Lactoferrin|lactoferrin|mesh-list
83254468|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254469|NCT04375813|Sirolimus|sirolimus|mesh-list
83254470|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83254471|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254472|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83254473|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254474|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
83254475|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254476|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
83254477|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254478|NCT04847245|Pregabalin|pregabalin|mesh-list
83254479|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83254480|NCT04847245|Esketamine|esketamine|mesh-list
83254481|NCT04847245|Analgesics|analgesics|mesh-ancestor
83254482|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
83254483|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254484|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254485|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
83254486|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83254487|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83254488|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254489|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83254490|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83254491|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83254492|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254493|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83254494|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83254495|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83254496|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254497|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
83254498|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
83254499|NCT04839913|Antibodies|antibodies|mesh-list
83254500|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
83254501|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254502|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
83254503|NCT04846621|Calcium|calcium|mesh-list
83254504|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83254505|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254506|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83254507|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254508|NCT04854577|Anesthetics|anesthetics|mesh-list
83254509|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254510|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254511|NCT04839445|Anesthetics|anesthetics|mesh-list
83254512|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254513|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254514|NCT04845607|Amiodarone|amiodarone|mesh-list
83254515|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83254516|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
83254517|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83254518|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83254519|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254520|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83254521|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83254522|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83254523|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254524|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83254525|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83254526|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83254528|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83254529|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254530|NCT03040531|Vitamin D|vitamin d|mesh-list
83254531|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
83254532|NCT03040531|Alendronate|alendronate|mesh-list
83254533|NCT03040531|Genistein|genistein|mesh-list
83254534|NCT03040531|Calcium|calcium|mesh-list
83254535|NCT03040531|Vitamins|vitamins|mesh-ancestor
83254536|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
83254537|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254538|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83254539|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83254540|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83254541|NCT03040531|Protective Agents|protective agents|mesh-ancestor
83254542|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254543|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254544|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254545|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254546|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
83254547|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83254548|NCT03040531|Estrogens|estrogens|mesh-ancestor
83254549|NCT03040531|Hormones|hormones|mesh-ancestor
83254550|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254551|NCT04838665|Phenylephrine|phenylephrine|mesh-list
83254552|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
83254553|NCT04838665|Tropicamide|tropicamide|mesh-list
83254554|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
83254555|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83254556|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
83254557|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
83254558|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254559|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254560|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
83254561|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83254562|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
83254563|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
83254564|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83254565|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83254566|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83254567|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
83254568|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254569|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254570|NCT04838665|Protective Agents|protective agents|mesh-ancestor
83254571|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83254572|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83254573|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
83254574|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
83254575|NCT04845061|Nebivolol|nebivolol|mesh-list
83254576|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83254577|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
83254581|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
83254582|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254583|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254584|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254585|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
83254586|NCT03040765|Denosumab|denosumab|mesh-list
83254587|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83254588|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254589|NCT01668667|Gabapentin|gabapentin|mesh-list
83254590|NCT01668667|Analgesics|analgesics|mesh-ancestor
83254591|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
83254592|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254593|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254594|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
83254595|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83254596|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83254597|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254598|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83254599|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83254600|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83254601|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254602|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254603|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
83254604|NCT03040219|Folic Acid|folic acid|mesh-list
83254605|NCT03040219|Hematinics|hematinics|mesh-ancestor
83254606|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
83254607|NCT03040219|Vitamins|vitamins|mesh-ancestor
83254608|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
83254609|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254610|NCT03038503|Terlipressin|terlipressin|mesh-list
83254611|NCT03038503|Methylene Blue|methylene blue|mesh-list
83254612|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254613|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254614|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83254615|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83254616|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
83254617|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83254618|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254619|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
83254620|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
83254621|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254622|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254623|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83254624|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
83254625|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83254626|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
83254627|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
83254628|NCT04852315|Caffeine|caffeine|mesh-list
83254629|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83254630|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254631|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83254632|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254633|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254634|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83254635|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83254636|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
83254637|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254638|NCT03038425|Ropivacaine|ropivacaine|mesh-list
83254639|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
83254640|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
83254641|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254642|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254643|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
83254644|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254645|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83254646|NCT04851769|Alirocumab|alirocumab|mesh-list
83254647|NCT04851769|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83254648|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83254649|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83254650|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
83254651|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254652|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254653|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83254654|NCT04851769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83254655|NCT04851769|Protease Inhibitors|protease inhibitors|mesh-ancestor
83254656|NCT04843267|Tislelizumab|tislelizumab|mesh-list
83254657|NCT04843267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254658|NCT04843267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254659|NCT04852081|Tamoxifen|tamoxifen|mesh-list
83254660|NCT04852081|Letrozole|letrozole|mesh-list
83254661|NCT04852081|Fulvestrant|fulvestrant|mesh-list
83254662|NCT04852081|Palbociclib|palbociclib|mesh-list
83254663|NCT04852081|Anastrozole|anastrozole|mesh-list
83254664|NCT04852081|Exemestane|exemestane|mesh-list
83254665|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254666|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83254667|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83254668|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254669|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254670|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83254671|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
83254672|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254673|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254674|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254675|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83254676|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83254677|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83254678|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83254679|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254680|NCT04851457|Tirofiban|tirofiban|mesh-list
83254681|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83254682|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83254683|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254684|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83254685|NCT02608099|Apixaban|apixaban|mesh-list
83254686|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83254687|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
83254688|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83254689|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
83254690|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254691|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254692|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
83254693|NCT04850755|Nivolumab|nivolumab|mesh-list
83254694|NCT04850755|Ipilimumab|ipilimumab|mesh-list
83254695|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254696|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254697|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83254698|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254699|NCT04842487|Prednisone|prednisone|mesh-list
83254700|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
83254701|NCT04842487|Rituximab|rituximab|mesh-list
83254702|NCT04842487|Vincristine|vincristine|mesh-list
83254703|NCT04842487|Lenalidomide|lenalidomide|mesh-list
83254704|NCT04842487|Doxorubicin|doxorubicin|mesh-list
83254705|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83254706|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254707|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
83254708|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254709|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254710|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83254711|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
83254712|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254713|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254714|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83254715|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254716|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254717|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
83254718|NCT04842487|Hormones|hormones|mesh-ancestor
83254719|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254720|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254721|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83254722|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
83254723|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
83254724|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
83254725|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83254726|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83254727|NCT04842487|Growth Substances|growth substances|mesh-ancestor
83254728|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
83254729|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83254730|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83254731|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83254732|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254733|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
83254734|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83254735|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
83254736|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254737|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254738|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83254739|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
83254740|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83254741|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
83254742|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254743|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254744|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83254745|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
83254746|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
83254747|NCT04842331|Protective Agents|protective agents|mesh-ancestor
83254748|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83254749|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83254750|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254751|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
83254752|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254753|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254754|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
83254755|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83254756|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
83254757|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254758|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254759|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83254760|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
83254761|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83254762|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
83413594|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254763|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254764|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254765|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83254766|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
83254767|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
83254768|NCT04312243|Protective Agents|protective agents|mesh-ancestor
83254769|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
83254770|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83254771|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83254772|NCT04837651|Antibodies|antibodies|mesh-list
83254773|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
83254774|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254775|NCT03039205|Clopidogrel|clopidogrel|mesh-list
83254776|NCT03039205|Ticagrelor|ticagrelor|mesh-list
83254777|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83254778|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83254779|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83254780|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83254781|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
83254782|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254783|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254784|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254785|NCT04837261|Propranolol|propranolol|mesh-list
83254786|NCT04837261|Amiodarone|amiodarone|mesh-list
83254787|NCT04837261|Flecainide|flecainide|mesh-list
83254788|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83254789|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83254790|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
83254791|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254792|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254793|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254794|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83254795|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83254797|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83254798|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83254799|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83254800|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83254801|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83254802|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254803|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83254804|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83254805|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83254806|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83254807|NCT04792645|Memantine|memantine|mesh-list
83254808|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83254809|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83254810|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
83254811|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254812|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254813|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254814|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83254815|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83254816|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
83254817|NCT04824937|Talazoparib|talazoparib|mesh-list
83254818|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83254819|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254820|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254821|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254822|NCT03036085|Epinephrine|epinephrine|mesh-list
83254823|NCT03036085|Bupivacaine|bupivacaine|mesh-list
83254824|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
83254825|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
83254826|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254827|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254828|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
83254829|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254830|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83254831|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83254832|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
83254833|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254834|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254835|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83254836|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83254838|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83254839|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
83254840|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
83254841|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
83254842|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83254843|NCT04831255|Triamcinolone|triamcinolone|mesh-list
83254844|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83254845|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83254846|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83254847|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254848|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
83254849|NCT04831255|Hormones|hormones|mesh-ancestor
83254850|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254851|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254852|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254853|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
83254854|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254855|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254856|NCT02431533|Calcium|calcium|mesh-list
83254857|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83254858|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254859|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
83254860|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83254861|NCT02413593|Ledipasvir|ledipasvir|mesh-list
83254862|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
83254863|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254864|NCT01652703|Evolocumab|evolocumab|mesh-list
83254865|NCT01652703|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83254866|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83254867|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83254868|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
83254869|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254870|NCT01652703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83254872|NCT01652703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254873|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83254874|NCT01652469|Docetaxel|docetaxel|mesh-list
83254875|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83254876|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254877|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
83254878|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
83254879|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
83254880|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254881|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83254882|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254883|NCT02429427|Celecoxib|celecoxib|mesh-list
83254884|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83254885|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83254886|NCT02429427|Analgesics|analgesics|mesh-ancestor
83254887|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
83254888|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254889|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254890|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254891|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254892|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83254893|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83254894|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254895|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254896|NCT02412657|Dexamethasone|dexamethasone|mesh-list
83254897|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254898|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
83254899|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
83254900|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254901|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254903|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
83254904|NCT02412657|Hormones|hormones|mesh-ancestor
83254905|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254906|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83254907|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254908|NCT02412111|Ivacaftor|ivacaftor|mesh-list
83254909|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83254910|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83254911|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254912|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
83254913|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83254914|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254915|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83254916|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254917|NCT02484651|Rocuronium|rocuronium|mesh-list
83254918|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83254919|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83254920|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83254921|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254922|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254923|NCT02410551|Fludarabine|fludarabine|mesh-list
83254924|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
83254925|NCT02410551|Busulfan|busulfan|mesh-list
83254926|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254927|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83254928|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
83254929|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254930|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254931|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
83254932|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254933|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
83254934|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83254935|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83254936|NCT02424591|Ketamine|ketamine|mesh-list
83254937|NCT02424591|Analgesics|analgesics|mesh-ancestor
83254938|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
83254939|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254940|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254941|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83254942|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83254943|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
83254944|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
83254945|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83254946|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83254947|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83254948|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83254949|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254950|NCT02408523|Lacosamide|lacosamide|mesh-list
83254951|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83254952|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
83254953|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83254954|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83254955|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83254956|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254958|NCT04822909|Apremilast|apremilast|mesh-list
83254959|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83254960|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83254961|NCT04822909|Analgesics|analgesics|mesh-ancestor
83254962|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
83254963|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83254964|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254965|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83254966|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83254967|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83254968|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83254969|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254970|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254971|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83254972|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
83254973|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
83254974|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83254975|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83254976|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83254977|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83254978|NCT04822909|Growth Substances|growth substances|mesh-ancestor
83254979|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
83254980|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254981|NCT04831099|Testosterone|testosterone|mesh-list
83254982|NCT04831099|Androgens|androgens|mesh-ancestor
83254983|NCT04831099|Hormones|hormones|mesh-ancestor
83254984|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83254985|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254986|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
83254987|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83254988|NCT02603419|Avelumab|avelumab|mesh-list
83254989|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83254990|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83254991|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83254992|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
83254993|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83254994|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
83254995|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83254996|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83254997|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83254998|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83254999|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83255000|NCT04367935|Protective Agents|protective agents|mesh-ancestor
83255001|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255002|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
83255003|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83255004|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
83255005|NCT04829773|Midazolam|midazolam|mesh-list
83255006|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83255007|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83255008|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255009|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255010|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83255011|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83255012|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83255013|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83255014|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
83255015|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
83255016|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
83255017|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
83255018|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255019|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255020|NCT04829695|Artesunate|artesunate|mesh-list
83255021|NCT04829695|Lumefantrine|lumefantrine|mesh-list
83255022|NCT04829695|Artemether|artemether|mesh-list
83255023|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83255024|NCT04829695|Amodiaquine|amodiaquine|mesh-list
83255025|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
83255026|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83255027|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83255028|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255029|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255030|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
83255031|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
83255032|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83255033|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
83255034|NCT04835233|Methyldopa|methyldopa|mesh-list
83255035|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83255036|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
83255037|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
83255038|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255039|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255040|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83255041|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83255042|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83255043|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
83255044|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255045|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255046|NCT03035695|Hemostatics|hemostatics|mesh-list
83255047|NCT03035695|Coagulants|coagulants|mesh-ancestor
83255048|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
83255049|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255050|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
83255051|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
83255052|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255053|NCT04828525|Dexamethasone|dexamethasone|mesh-list
83255054|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255055|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
83255056|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
83255057|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255058|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255059|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255060|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
83255061|NCT04828525|Hormones|hormones|mesh-ancestor
83255062|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255063|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83255064|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255065|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
83255066|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83255067|NCT04821193|Disinfectants|disinfectants|mesh-list
83255068|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83255069|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83255070|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255071|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
83255072|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
83255073|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83255074|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255075|NCT04827667|Dimercaprol|dimercaprol|mesh-list
83255076|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
83255077|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
83255078|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255079|NCT04360135|Acetaminophen|acetaminophen|mesh-list
83255080|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255081|NCT04360135|Analgesics|analgesics|mesh-ancestor
83255082|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
83255083|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255084|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255085|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
83255086|NCT05617885|Leuprolide|leuprolide|mesh-list
83255087|NCT05617885|Goserelin|goserelin|mesh-list
83255088|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83255089|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83255090|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
83255091|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83255092|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255093|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83255094|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255095|NCT05617885|Hormones|hormones|mesh-ancestor
83255096|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255097|NCT02605837|Budesonide|budesonide|mesh-list
83255098|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255099|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83255100|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
83255101|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255102|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255103|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83255104|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
83255105|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
83255106|NCT02605837|Hormones|hormones|mesh-ancestor
83255107|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255108|NCT04834375|Dexamethasone|dexamethasone|mesh-list
83255109|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
83255110|NCT04834375|BB 1101|bb 1101|mesh-list
83255111|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255112|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
83255113|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
83255114|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255115|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255116|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255117|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
83255118|NCT04834375|Hormones|hormones|mesh-ancestor
83255119|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255120|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83255121|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255122|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
83255123|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255124|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255125|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
83255126|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83255127|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255128|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255129|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255130|NCT04820101|Analgesics|analgesics|mesh-ancestor
83255131|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
83255132|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255133|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83255134|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83255135|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83255136|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
83255137|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255138|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255139|NCT04819867|Propolis|propolis|mesh-list
83255140|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255141|NCT02423343|Nivolumab|nivolumab|mesh-list
83255142|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255143|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255144|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83255145|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255146|NCT04909515|Isotretinoin|isotretinoin|mesh-list
83255147|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
83255148|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
83255150|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
83255151|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
83255152|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83255153|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255154|NCT04818931|Cefazolin|cefazolin|mesh-list
83255155|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83255156|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255157|NCT02406261|Midazolam|midazolam|mesh-list
83255158|NCT02406261|Donepezil|donepezil|mesh-list
83255159|NCT02406261|Simvastatin|simvastatin|mesh-list
83255160|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83255161|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83255162|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255163|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255164|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83255165|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83255166|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83255167|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83255168|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
83255170|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
83255171|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
83255172|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255173|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255174|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83255175|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83255176|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
83255177|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83255178|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83255179|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255180|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83255181|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
83255182|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
83255183|NCT02485353|Cytarabine|cytarabine|mesh-list
83255184|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83255185|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
83255186|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255187|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255188|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
83255189|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255190|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83255191|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
83255192|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255193|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83255194|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255195|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255196|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
83255197|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255198|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83255199|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83255200|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83255201|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83255202|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
83255203|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83255204|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
83255205|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255206|NCT04826497|Nicorandil|nicorandil|mesh-list
83255207|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83255208|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83255209|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
83255210|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
83255211|NCT04826497|Vitamins|vitamins|mesh-ancestor
83255212|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
83255213|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255214|NCT04819243|Atezolizumab|atezolizumab|mesh-list
83255215|NCT04819243|Talazoparib|talazoparib|mesh-list
83255216|NCT04819243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83255217|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255218|NCT04819243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255219|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255220|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83255221|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255222|NCT02604589|Hydromorphone|hydromorphone|mesh-list
83255223|NCT02604589|Bupivacaine|bupivacaine|mesh-list
83255224|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
83255225|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
83255226|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255227|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255228|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
83255229|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255230|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83255231|NCT02604589|Narcotics|narcotics|mesh-ancestor
83255232|NCT02604589|Analgesics|analgesics|mesh-ancestor
83255233|NCT04818151|Warfarin|warfarin|mesh-list
83255234|NCT04818151|Apixaban|apixaban|mesh-list
83255235|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
83255236|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83255237|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
83255238|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83255239|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
83255240|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255241|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255242|NCT04817527|Edaravone|edaravone|mesh-list
83255243|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83255244|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
83255245|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255246|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83255247|NCT04817527|Protective Agents|protective agents|mesh-ancestor
83255248|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255249|NCT04357795|Cyclosporine|cyclosporine|mesh-list
83255250|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83255251|NCT04357795|Cyclosporins|cyclosporins|mesh-list
83255252|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255253|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255254|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83255255|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
83255256|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255257|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
83255258|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255259|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
83255260|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255261|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83255262|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83255263|NCT02604199|Tenofovir|tenofovir|mesh-list
83255264|NCT02604199|Entecavir|entecavir|mesh-list
83255265|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
83255266|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83255267|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
83255268|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255269|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83255270|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83255271|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255272|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255273|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83255274|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83255275|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
83255276|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255277|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255278|NCT04807543|Castor Oil|castor oil|mesh-list
83255279|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
83255280|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
83255281|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83255282|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
83255283|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255284|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255285|NCT04807543|Progestins|progestins|mesh-ancestor
83255286|NCT04807543|Hormones|hormones|mesh-ancestor
83255287|NCT04807543|Cathartics|cathartics|mesh-ancestor
83255288|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255289|NCT04797949|Aspirin|aspirin|mesh-list
83255290|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255291|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255292|NCT04797949|Analgesics|analgesics|mesh-ancestor
83255293|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
83255294|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255295|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255296|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255297|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255298|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83255299|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83255300|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255301|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83255302|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83255303|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255304|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
83255305|NCT04797793|Adapalene|adapalene|mesh-list
83255306|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255307|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255308|NCT04797793|Analgesics|analgesics|mesh-ancestor
83255309|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
83255310|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255311|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255312|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255313|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255314|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
83255315|NCT04796857|Lenalidomide|lenalidomide|mesh-list
83255316|NCT04796857|Tislelizumab|tislelizumab|mesh-list
83255317|NCT04796857|Antibodies|antibodies|mesh-list
83255318|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
83255319|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255320|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83255321|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83255322|NCT04796857|Growth Substances|growth substances|mesh-ancestor
83255323|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
83255324|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255325|NCT04796857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255327|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83255328|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255329|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83255330|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83255331|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
83255332|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255333|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255334|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
83255335|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83255336|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255337|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255338|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255339|NCT04815265|Analgesics|analgesics|mesh-ancestor
83255340|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
83255341|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255342|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83255343|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83255344|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83255345|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
83255346|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255347|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255348|NCT04815187|Montelukast|montelukast|mesh-list
83255349|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83255350|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
83255351|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83255352|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
83255353|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255354|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255355|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83255356|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83255357|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255358|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
83255359|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
83255360|NCT04805827|Gabapentin|gabapentin|mesh-list
83255361|NCT04805827|Analgesics|analgesics|mesh-ancestor
83255362|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
83255363|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255364|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255365|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
83255366|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83255367|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83255368|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255369|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83255370|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83255371|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83255372|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255373|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255374|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
83255375|NCT02596711|Nicotine|nicotine|mesh-list
83255376|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
83255377|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83255378|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
83255379|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255380|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255381|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83255382|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83255383|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
83255384|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255385|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255386|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
83255387|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
83255388|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
83255389|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
83255390|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83255391|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255392|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255394|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83255395|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255396|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255398|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83255399|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83255400|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255401|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
83255402|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
83255403|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
83255404|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255405|NCT04804423|Listerine|listerine|mesh-list
83255406|NCT04804423|Fluorides|fluorides|mesh-list
83255407|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
83255408|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
83255409|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
83255410|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
83255411|NCT04804423|Protective Agents|protective agents|mesh-ancestor
83255412|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255413|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83255414|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255415|NCT04794049|Lactulose|lactulose|mesh-list
83255416|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255417|NCT04794127|Pioglitazone|pioglitazone|mesh-list
83255418|NCT04794127|Trabectedin|trabectedin|mesh-list
83255419|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83255420|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255421|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83255422|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
83255423|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255424|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255425|NCT04804267|Linaclotide|linaclotide|mesh-list
83255426|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83255427|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
83255428|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255429|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255430|NCT04813471|Folic Acid|folic acid|mesh-list
83255431|NCT04813471|Nicorandil|nicorandil|mesh-list
83255432|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
83255433|NCT04813471|Atorvastatin|atorvastatin|mesh-list
83255434|NCT04813471|Vitamins|vitamins|mesh-ancestor
83255435|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
83255436|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255437|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83255438|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83255439|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
83255440|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255441|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83255442|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83255443|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255444|NCT04813471|Hematinics|hematinics|mesh-ancestor
83255445|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83255446|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83255447|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
83255448|NCT04803175|Valsartan|valsartan|mesh-list
83255449|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83255450|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83255451|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83255452|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83255453|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255454|NCT04792723|Aspirin|aspirin|mesh-list
83255455|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255456|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255457|NCT04792723|Analgesics|analgesics|mesh-ancestor
83255458|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
83255459|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255460|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255461|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255462|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255463|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83255464|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83255465|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255466|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83255467|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83255468|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255469|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
83255470|NCT04792333|Firibastat|firibastat|mesh-list
83255471|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83255472|NCT04802785|Aspirin|aspirin|mesh-list
83255473|NCT04802785|Domperidone|domperidone|mesh-list
83255474|NCT04802785|Melatonin|melatonin|mesh-list
83255475|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83255476|NCT04802785|Simethicone|simethicone|mesh-list
83255477|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83255478|NCT04802785|Citric Acid|citric acid|mesh-list
83255479|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
83255480|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
83255481|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83255482|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
83255483|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
83255484|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255485|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
83255486|NCT04802785|Protective Agents|protective agents|mesh-ancestor
83255487|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255488|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255489|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255490|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255491|NCT04802785|Analgesics|analgesics|mesh-ancestor
83255492|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
83255493|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255494|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255495|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255496|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83255497|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83255498|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83255499|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83255500|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255501|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
83255502|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
83255503|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
83255504|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255505|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83255506|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
83255507|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255508|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
83255509|NCT04802785|Emollients|emollients|mesh-ancestor
83255510|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83255511|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
83255512|NCT04802785|Antacids|antacids|mesh-ancestor
83255513|NCT02598193|Pirfenidone|pirfenidone|mesh-list
83255514|NCT02598193|Nintedanib|nintedanib|mesh-list
83255515|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255516|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83255517|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255518|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255519|NCT02598193|Analgesics|analgesics|mesh-ancestor
83255520|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
83255521|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255522|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255523|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255524|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255525|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255526|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255527|NCT04802083|Eculizumab|eculizumab|mesh-list
83255528|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83255529|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83255530|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
83255531|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255532|NCT04801303|Calcitriol|calcitriol|mesh-list
83255533|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83255534|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255535|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83255536|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83255537|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255538|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83255539|NCT04801303|Vitamins|vitamins|mesh-ancestor
83255540|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
83255541|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83255542|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83255543|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
83255544|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83255545|NCT04790383|Protective Agents|protective agents|mesh-ancestor
83255546|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255547|NCT02388165|Vaccines|vaccines|mesh-list
83255548|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
83255549|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255550|NCT04811911|Methotrexate|methotrexate|mesh-list
83255551|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83255552|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
83255553|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83255554|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255555|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83255556|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
83255557|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255558|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255559|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
83255560|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255561|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83255562|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83255563|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
83255564|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255565|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83255566|NCT04788979|Melatonin|melatonin|mesh-list
83255567|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
83255568|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255569|NCT04788979|Protective Agents|protective agents|mesh-ancestor
83255570|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255571|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255572|NCT04811209|Analgesics|analgesics|mesh-list
83255573|NCT04811209|Anesthetics|anesthetics|mesh-list
83255574|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255575|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255576|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
83255577|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255578|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
83255579|NCT04788355|Apixaban|apixaban|mesh-list
83255580|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
83255581|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83255582|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83255583|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255584|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255585|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255586|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255587|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83255588|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
83255589|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83255590|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
83255591|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
83255592|NCT04799743|Resveratrol|resveratrol|mesh-list
83255593|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
83255594|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255595|NCT04799743|Protective Agents|protective agents|mesh-ancestor
83255596|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255597|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255598|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83255599|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
83255600|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83255601|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83255602|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255603|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
83255604|NCT04788121|Coagulants|coagulants|mesh-ancestor
83255605|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
83255606|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83255607|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83255608|NCT04810819|Prednisolone|prednisolone|mesh-list
83255609|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
83255610|NCT04810819|Dyphylline|dyphylline|mesh-list
83255611|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83255612|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
83255613|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255614|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
83255615|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
83255616|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255617|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255618|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255619|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
83255620|NCT04810819|Hormones|hormones|mesh-ancestor
83255621|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255623|NCT04810819|Protective Agents|protective agents|mesh-ancestor
83255624|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83255625|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255626|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83255627|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83255628|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
83255629|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83255630|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255631|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255632|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
83255633|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83255634|NCT04810507|Anagliptin|anagliptin|mesh-list
83255635|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83255636|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255637|NCT04810507|Incretins|incretins|mesh-ancestor
83255638|NCT04810507|Hormones|hormones|mesh-ancestor
83255639|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255640|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83255641|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
83255642|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255643|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255644|NCT04810585|Aflibercept|aflibercept|mesh-list
83255645|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83255646|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83255647|NCT04810585|Growth Substances|growth substances|mesh-ancestor
83255648|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255649|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
83255650|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255651|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
83255652|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255653|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
83255654|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
83255655|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
83255656|NCT04809649|Itraconazole|itraconazole|mesh-list
83255657|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
83255658|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255659|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83255660|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83255661|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255662|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255663|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83255664|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
83255665|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255666|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255667|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83255668|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83255669|NCT04786795|Pancreatin|pancreatin|mesh-list
83255670|NCT04786795|Pancrelipase|pancrelipase|mesh-list
83255671|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83255672|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83255673|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
83255674|NCT02596945|Hematinics|hematinics|mesh-ancestor
83255675|NCT04786327|Edetic Acid|edetic acid|mesh-list
83255676|NCT04786327|Mitogens|mitogens|mesh-list
83255677|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
83255678|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
83255679|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255680|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
83255681|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83255682|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
83255683|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
83255684|NCT04786327|Antidotes|antidotes|mesh-ancestor
83255685|NCT04786327|Protective Agents|protective agents|mesh-ancestor
83255686|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255687|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83255688|NCT04153435|Calcium|calcium|mesh-list
83255689|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83255690|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255691|NCT01667419|Vemurafenib|vemurafenib|mesh-list
83255692|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255693|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83255694|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255695|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255696|NCT04808791|Trifluridine|trifluridine|mesh-list
83255697|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
83255698|NCT04808791|Irinotecan|irinotecan|mesh-list
83255699|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255700|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83255701|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83255702|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255703|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255704|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
83255705|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
83255706|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255707|NCT04023019|Thrombin|thrombin|mesh-list
83255708|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
83255709|NCT04023019|Coagulants|coagulants|mesh-ancestor
83255710|NCT04785547|Blinatumomab|blinatumomab|mesh-list
83255711|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255713|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83255714|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83255715|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83255716|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83255717|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255718|NCT03843853|Bevacizumab|bevacizumab|mesh-list
83255719|NCT03843853|Pemetrexed|pemetrexed|mesh-list
83255720|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255721|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255722|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83255723|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83255724|NCT03843853|Growth Substances|growth substances|mesh-ancestor
83255725|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255726|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
83255727|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255728|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255729|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83255730|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83255731|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
83255732|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83255733|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
83255734|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255735|NCT05054179|Ropivacaine|ropivacaine|mesh-list
83255736|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83255737|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
83255738|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
83255739|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255740|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255741|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
83255742|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255743|NCT03497689|Treprostinil|treprostinil|mesh-list
83255744|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83255745|NCT05611879|Paclitaxel|paclitaxel|mesh-list
83255746|NCT05611879|Carboplatin|carboplatin|mesh-list
83255747|NCT05611879|Pemetrexed|pemetrexed|mesh-list
83255748|NCT05611879|Tislelizumab|tislelizumab|mesh-list
83255749|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83255750|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255751|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
83255752|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
83255753|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
83255754|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255755|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255756|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83255757|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83255758|NCT05611879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255759|NCT04789057|Atorvastatin|atorvastatin|mesh-list
83255760|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83255761|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83255762|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
83255763|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255764|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83255765|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83255766|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255767|NCT05613361|Colistin|colistin|mesh-list
83255768|NCT05613361|Curcumin|curcumin|mesh-list
83255769|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255770|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255772|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
83255773|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255774|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255775|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255776|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255777|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255778|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255779|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255780|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83255781|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255782|NCT05611645|Bevacizumab|bevacizumab|mesh-list
83255783|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255784|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255785|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83255786|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83255787|NCT05611645|Growth Substances|growth substances|mesh-ancestor
83255788|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255789|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
83255790|NCT03267121|Apatinib|apatinib|mesh-list
83255791|NCT03267121|Tegafur|tegafur|mesh-list
83255792|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255793|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83255794|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255795|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255796|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83255797|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
83255798|NCT02835079|Tamoxifen|tamoxifen|mesh-list
83255799|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83255800|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
83255801|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255802|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255803|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83255804|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255805|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83255806|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83255807|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83255808|NCT01667107|Posaconazole|posaconazole|mesh-list
83255809|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
83255810|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255811|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83255812|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83255813|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83255814|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83255815|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83255816|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255817|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255818|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83255819|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
83255820|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83255821|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255823|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
83255824|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83255825|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
83255826|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255827|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
83255828|NCT04589611|Protective Agents|protective agents|mesh-ancestor
83255829|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83255830|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255831|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
83255832|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
83255833|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255834|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255835|NCT05269849|Sirolimus|sirolimus|mesh-list
83255836|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83255837|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255838|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83255839|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255840|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
83255841|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83255842|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
83255843|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255844|NCT05240131|Atezolizumab|atezolizumab|mesh-list
83255845|NCT05240131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83255846|NCT05240131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255847|NCT05240131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255848|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255849|NCT05188339|Heparin|heparin|mesh-list
83255850|NCT05188339|Citric Acid|citric acid|mesh-list
83255851|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
83255852|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
83255853|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83255854|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
83255855|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
83255856|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255857|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83255858|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83255859|NCT05614765|Ezetimibe|ezetimibe|mesh-list
83255860|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83255861|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83255862|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
83255863|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255864|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83255865|NCT02590003|Paclitaxel|paclitaxel|mesh-list
83255866|NCT02590003|Carboplatin|carboplatin|mesh-list
83255867|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83255868|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255869|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
83255870|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
83255871|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
83255872|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255873|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
83255874|NCT04134325|Nivolumab|nivolumab|mesh-list
83255875|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255876|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255877|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83255878|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255879|NCT05474053|Ticagrelor|ticagrelor|mesh-list
83255880|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83255881|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83255882|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83255883|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83255884|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
83255885|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255886|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255887|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255888|NCT05473819|Anesthetics|anesthetics|mesh-list
83255889|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255890|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255891|NCT04330729|Aspirin|aspirin|mesh-list
83255892|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255893|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255894|NCT04330729|Analgesics|analgesics|mesh-ancestor
83255895|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
83255896|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255897|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255898|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83255899|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255900|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83255901|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83255902|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255903|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83255904|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83255905|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83255906|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
83255907|NCT05473741|Risperidone|risperidone|mesh-list
83255908|NCT05473741|Aripiprazole|aripiprazole|mesh-list
83255909|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83255910|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
83255911|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83255912|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
83255913|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255914|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255915|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255916|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83255917|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83255918|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83255919|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83255920|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
83255921|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
83255922|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
83255923|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83255924|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83255925|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83255926|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83255927|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
83255928|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
83255929|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255930|NCT04762771|Colchicine|colchicine|mesh-list
83255931|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
83255932|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83255933|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83255934|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83255935|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83255936|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255937|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255938|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83255939|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83255940|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83255941|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83255942|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255943|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
83255944|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83255945|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255946|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255947|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83255948|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83255949|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255950|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
83255951|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83255952|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
83255953|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83255954|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
83255955|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83255956|NCT04481035|Expectorants|expectorants|mesh-ancestor
83255957|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
83255958|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83255959|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
83255960|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255961|NCT04481035|Protective Agents|protective agents|mesh-ancestor
83255962|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255963|NCT04481035|Antidotes|antidotes|mesh-ancestor
83255964|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83255965|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83255966|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
83255967|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255968|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
83255969|NCT03032107|Trastuzumab|trastuzumab|mesh-list
83255970|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83255971|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255972|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255973|NCT03032107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83255974|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255975|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
83255976|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
83255977|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
83255978|NCT03032107|Immunotoxins|immunotoxins|mesh-ancestor
83255979|NCT03032107|Immunoconjugates|immunoconjugates|mesh-ancestor
83255980|NCT03032107|Immunologic Factors|immunologic factors|mesh-ancestor
83255981|NCT03032107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83255982|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83255983|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
83255984|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
83255985|NCT05700955|Temozolomide|temozolomide|mesh-list
83255986|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83255987|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83255988|NCT05700955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83255989|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83255990|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83255991|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
83255993|NCT01650519|Ketorolac|ketorolac|mesh-list
83255994|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83255995|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83255996|NCT01650519|Analgesics|analgesics|mesh-ancestor
83255997|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
83255998|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83255999|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256000|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256001|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256002|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83256003|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256004|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256005|NCT02197039|Esomeprazole|esomeprazole|mesh-list
83256006|NCT02197039|Pantoprazole|pantoprazole|mesh-list
83256007|NCT02197039|Hemostatics|hemostatics|mesh-list
83256008|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83256009|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256010|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83256011|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256012|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256013|NCT02197039|Coagulants|coagulants|mesh-ancestor
83256014|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83256015|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
83256016|NCT05557903|Antibodies|antibodies|mesh-list
83256017|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
83256018|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83256019|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
83256020|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256021|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256022|NCT02386839|Mecasermin|mecasermin|mesh-list
83256023|NCT02386839|Growth Substances|growth substances|mesh-ancestor
83256024|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256025|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83256026|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
83256027|NCT05347459|Empagliflozin|empagliflozin|mesh-list
83256028|NCT05347459|Linagliptin|linagliptin|mesh-list
83256030|NCT05347459|Vildagliptin|vildagliptin|mesh-list
83256031|NCT05347459|Saxagliptin|saxagliptin|mesh-list
83256032|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83256033|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256034|NCT05347459|Incretins|incretins|mesh-ancestor
83256035|NCT05347459|Hormones|hormones|mesh-ancestor
83256036|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256037|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83256038|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
83256039|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256040|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256041|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83256042|NCT05346445|Fluoxetine|fluoxetine|mesh-list
83256043|NCT05346445|Citalopram|citalopram|mesh-list
83256044|NCT05346445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83256045|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83256046|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83256047|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256048|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256049|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
83256050|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256051|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83256052|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
83256053|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83256054|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83256055|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83256056|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256057|NCT01649271|Trastuzumab|trastuzumab|mesh-list
83256058|NCT01649271|Afatinib|afatinib|mesh-list
83256059|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256060|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256061|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83256062|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256063|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256064|NCT02385669|Ipilimumab|ipilimumab|mesh-list
83256065|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256066|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256067|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83256068|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256069|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
83256070|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83256071|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83256072|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256073|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
83256074|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
83256075|NCT02400333|Ticagrelor|ticagrelor|mesh-list
83256076|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83256077|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83256078|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83256079|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83256080|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
83256081|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256082|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256083|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256084|NCT02399475|Hormones|hormones|mesh-list
83256085|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
83256086|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256087|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256088|NCT02399163|Fluorides|fluorides|mesh-list
83256089|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
83256090|NCT02399163|Protective Agents|protective agents|mesh-ancestor
83256091|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256092|NCT02397837|Pramipexole|pramipexole|mesh-list
83256093|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
83256094|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256095|NCT02397837|Protective Agents|protective agents|mesh-ancestor
83256096|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256097|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83256098|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83256099|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
83256100|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
83256101|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256102|NCT05549167|Sirolimus|sirolimus|mesh-list
83256103|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83256104|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256105|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83256106|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256107|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
83256108|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256109|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
83256110|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256111|NCT05542615|Pirfenidone|pirfenidone|mesh-list
83256112|NCT05542615|Analgesics|analgesics|mesh-ancestor
83256113|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
83256114|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256115|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256116|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83256117|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83256118|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256119|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256120|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256121|NCT05700721|Niraparib|niraparib|mesh-list
83256122|NCT05700721|Dostarlimab|dostarlimab|mesh-list
83256123|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83256124|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256125|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256126|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256127|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
83256128|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256129|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256130|NCT04134559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83256131|NCT04134559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256132|NCT05542147|Fenofibrate|fenofibrate|mesh-list
83256133|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83256134|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
83256135|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256136|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83256137|NCT05548465|Sufentanil|sufentanil|mesh-list
83256138|NCT05548465|Remifentanil|remifentanil|mesh-list
83256139|NCT05548465|Dsuvia|dsuvia|mesh-list
83256140|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83256141|NCT05548465|Narcotics|narcotics|mesh-ancestor
83256142|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256143|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256144|NCT05548465|Analgesics|analgesics|mesh-ancestor
83256145|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
83256146|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256147|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83256148|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83256149|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
83256150|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
83256151|NCT05548075|Psilocybin|psilocybin|mesh-list
83256152|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83256153|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
83256154|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256155|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83256156|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83256157|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
83256158|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256159|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256160|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83256161|NCT05554003|Temozolomide|temozolomide|mesh-list
83256162|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83256163|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
83256164|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256165|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256166|NCT05541757|Heparin|heparin|mesh-list
83256167|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
83256168|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83256169|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83256170|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256171|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83256172|NCT05700565|Immunomodulating Agents|immunomodulating agents|mesh-list
83256173|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
83256174|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256175|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
83256176|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256177|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256178|NCT05541445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83256179|NCT05541445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256180|NCT04325503|Levodopa|levodopa|mesh-list
83256181|NCT04325503|Carbidopa|carbidopa|mesh-list
83256182|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83256183|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83256184|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
83256185|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256186|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256187|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256188|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83256189|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256190|NCT05540977|Donepezil|donepezil|mesh-list
83256191|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83256192|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256193|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256194|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
83256195|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256196|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256197|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
83256198|NCT05547685|Methylene Blue|methylene blue|mesh-list
83256199|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256200|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256201|NCT05540587|Warfarin|warfarin|mesh-list
83256202|NCT05540587|Edoxaban|edoxaban|mesh-list
83256203|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
83256204|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83256205|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
83256206|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83256207|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
83256208|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256209|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256210|NCT05540431|Charcoal|charcoal|mesh-list
83256211|NCT05540431|Antidotes|antidotes|mesh-ancestor
83256212|NCT05540431|Protective Agents|protective agents|mesh-ancestor
83256213|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256214|NCT05553067|Antibodies|antibodies|mesh-list
83256215|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
83256216|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256217|NCT05540275|Bevacizumab|bevacizumab|mesh-list
83256218|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256219|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256220|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83256221|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83256222|NCT05540275|Growth Substances|growth substances|mesh-ancestor
83256223|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256224|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
83256225|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
83256226|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83256227|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83256228|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83256229|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83256230|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256231|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
83256232|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256233|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256234|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83256235|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256237|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256238|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
83256239|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256240|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83256241|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256242|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256243|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83256244|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
83256245|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256246|NCT05550415|Simvastatin|simvastatin|mesh-list
83256247|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83256248|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83256249|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
83256250|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256251|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83256252|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83256253|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256254|NCT02586727|Aflibercept|aflibercept|mesh-list
83256255|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83256256|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83256257|NCT02586727|Growth Substances|growth substances|mesh-ancestor
83256258|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256259|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
83256260|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256261|NCT05550025|Apatinib|apatinib|mesh-list
83256262|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256263|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83256264|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256265|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256266|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
83256267|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83256268|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
83256269|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256270|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
83256271|NCT05700253|Protective Agents|protective agents|mesh-ancestor
83256272|NCT05544253|Mitomycins|mitomycins|mesh-list
83256273|NCT05544253|Mitomycin|mitomycin|mesh-list
83256274|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83256275|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256276|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
83256277|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413595|NCT01308619|Doxycycline|doxycycline|mesh-list
83256278|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83256279|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256280|NCT05535517|Emollients|emollients|mesh-list
83256281|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
83256282|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
83256283|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83256284|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256285|NCT02580877|Insulin|insulin|mesh-list
83256286|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83256287|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
83256288|NCT02580877|Methamphetamine|methamphetamine|mesh-list
83256289|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83256293|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
83256294|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256295|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
83256296|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256297|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256298|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
83256299|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83256300|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83256301|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83256302|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83256303|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
83256304|NCT01905631|Promethazine|promethazine|mesh-list
83256305|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83256306|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83256307|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256308|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256309|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
83256310|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
83256311|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
83256312|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256313|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
83256314|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
83256315|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256316|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83256317|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
83256318|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
83256319|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256320|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256321|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83256322|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
83256323|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83256324|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
83256325|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
83256326|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256327|NCT05679037|Protective Agents|protective agents|mesh-ancestor
83256328|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256329|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
83256330|NCT05679037|Vitamins|vitamins|mesh-ancestor
83256331|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
83256336|NCT05197621|Vaccines|vaccines|mesh-list
83256337|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
83256338|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256339|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
83256340|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83256341|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83256342|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256343|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
83256344|NCT05672407|Coagulants|coagulants|mesh-ancestor
83256345|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
83256346|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83256347|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83256348|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256349|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83256350|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83256351|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
83256352|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256353|NCT02582749|Bicalutamide|bicalutamide|mesh-list
83256354|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83256355|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
83256356|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
83256357|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256358|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256359|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256360|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83256361|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
83256362|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256363|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83256364|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83256365|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
83256366|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256367|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256368|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83256370|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83256371|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
83256372|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83256373|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
83256375|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83256376|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
83256377|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256378|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
83256379|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
83256380|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
83256381|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256382|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256383|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
83256384|NCT05461261|Hormones|hormones|mesh-ancestor
83256385|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256386|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256387|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83256388|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
83256389|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
83256390|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256391|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256392|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83256393|NCT05461261|Protective Agents|protective agents|mesh-ancestor
83256394|NCT05678413|Paclitaxel|paclitaxel|mesh-list
83256395|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83256396|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256397|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
83256398|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
83256399|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
83256400|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256401|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
83256402|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83256403|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
83256404|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256405|NCT05123365|Expectorants|expectorants|mesh-ancestor
83256406|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
83256407|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83256408|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
83256409|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256410|NCT05123365|Protective Agents|protective agents|mesh-ancestor
83256411|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256412|NCT05123365|Antidotes|antidotes|mesh-ancestor
83256413|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
83256414|NCT05678335|Tacrolimus|tacrolimus|mesh-list
83256415|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256416|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
83256417|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256418|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83256419|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256420|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256421|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
83256422|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83256423|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83256424|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256425|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256426|NCT02582671|Ritonavir|ritonavir|mesh-list
83256427|NCT02582671|Ribavirin|ribavirin|mesh-list
83256428|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83256429|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83256430|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
83256431|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256432|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256433|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83256434|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83256435|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
83256436|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256437|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83256438|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83256439|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
83256440|NCT05696977|Cyclosporine|cyclosporine|mesh-list
83256441|NCT05696977|Cyclosporins|cyclosporins|mesh-list
83256442|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256443|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256444|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256445|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
83256446|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256447|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
83256448|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256449|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
83256450|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256451|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83256452|NCT05051449|Ketamine|ketamine|mesh-list
83256453|NCT05051449|Analgesics|analgesics|mesh-ancestor
83256454|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
83256455|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256456|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256457|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83256458|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83256459|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
83256460|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
83256461|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256462|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83256463|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83256464|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256465|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256466|NCT02585713|Dalteparin|dalteparin|mesh-list
83256467|NCT02585713|Tinzaparin|tinzaparin|mesh-list
83256468|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83256469|NCT02585713|Apixaban|apixaban|mesh-list
83256470|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83256471|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
83256472|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83256473|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
83256474|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256475|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256476|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
83256477|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83256478|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83256479|NCT05078671|Cobicistat|cobicistat|mesh-list
83256480|NCT05078671|Olaparib|olaparib|mesh-list
83256481|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83256482|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256483|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256484|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256485|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83256486|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83256487|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
83256488|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256489|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83256490|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83256491|NCT02579863|Dexamethasone|dexamethasone|mesh-list
83256492|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
83256493|NCT02579863|Lenalidomide|lenalidomide|mesh-list
83256494|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256495|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
83256496|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
83256497|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256498|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256499|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256500|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
83256501|NCT02579863|Hormones|hormones|mesh-ancestor
83256502|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256503|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83256504|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256505|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256506|NCT02579863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83256507|NCT02579863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256508|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
83256509|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83256510|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83256511|NCT02579863|Growth Substances|growth substances|mesh-ancestor
83256512|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
83256513|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83256514|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83256515|NCT05677945|Simvastatin|simvastatin|mesh-list
83256516|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256517|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
83256518|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83256520|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
83256521|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256522|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83256523|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83256524|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256525|NCT04964947|Tobramycin|tobramycin|mesh-list
83256526|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83256527|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256528|NCT02582515|Cycloserine|cycloserine|mesh-list
83256529|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83256530|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256531|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83256532|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
83256533|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83256534|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
83256535|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256536|NCT02579629|Ropivacaine|ropivacaine|mesh-list
83256537|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
83256538|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
83256539|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256540|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256541|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
83256542|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256543|NCT05677555|Colchicine|colchicine|mesh-list
83256544|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
83256545|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256546|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
83256547|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
83256548|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
83256549|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256550|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256551|NCT02343939|Cytarabine|cytarabine|mesh-list
83256552|NCT02343939|Azacitidine|azacitidine|mesh-list
83256553|NCT02343939|Decitabine|decitabine|mesh-list
83256554|NCT02343939|Daunorubicin|daunorubicin|mesh-list
83256555|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83256556|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
83256557|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256558|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256559|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
83256560|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256561|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256562|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
83256563|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256564|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256565|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83256566|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83256567|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83256568|NCT02343549|Bevacizumab|bevacizumab|mesh-list
83256569|NCT02343549|Temozolomide|temozolomide|mesh-list
83256570|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256571|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256572|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83256573|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83256574|NCT02343549|Growth Substances|growth substances|mesh-ancestor
83256575|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256576|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
83256577|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83256578|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
83256579|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256580|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83256581|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83256582|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256583|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
83256584|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256585|NCT02395653|Fentanyl|fentanyl|mesh-list
83256586|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83256587|NCT02395653|Narcotics|narcotics|mesh-ancestor
83256588|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256589|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256590|NCT02395653|Analgesics|analgesics|mesh-ancestor
83256591|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
83256592|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256593|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83256594|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83256595|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
83256596|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
83256597|NCT01664923|Bicalutamide|bicalutamide|mesh-list
83256598|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
83256599|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
83256600|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256601|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256602|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256603|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83256604|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83256605|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83256606|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256607|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256608|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
83256609|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256610|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83256611|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83256612|NCT04403347|Losartan|losartan|mesh-list
83256613|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
83256614|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83256615|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83256616|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83256617|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256618|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83256619|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256620|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83256621|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256622|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256623|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83256624|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83256625|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83256626|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256627|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256628|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83256629|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83256630|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256631|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
83256632|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256633|NCT05692297|Denosumab|denosumab|mesh-list
83256634|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83256635|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256636|NCT05696509|Anesthetics|anesthetics|mesh-list
83256637|NCT05696509|Propofol|propofol|mesh-list
83256638|NCT05696509|Sevoflurane|sevoflurane|mesh-list
83256639|NCT05696509|Isoflurane|isoflurane|mesh-list
83256640|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256641|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256642|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83256643|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83256644|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
83256645|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83256646|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83256647|NCT02584855|Ixekizumab|ixekizumab|mesh-list
83256648|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
83256649|NCT02581891|Aflibercept|aflibercept|mesh-list
83256650|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83256651|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83256652|NCT02581891|Growth Substances|growth substances|mesh-ancestor
83256653|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256654|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
83256655|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256656|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
83256657|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
83256658|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83256659|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83256660|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256661|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256662|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256663|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256665|NCT02581345|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83256666|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256667|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256669|NCT05579509|Midazolam|midazolam|mesh-list
83256670|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83256671|NCT05579509|Narcotics|narcotics|mesh-ancestor
83256672|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256673|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256674|NCT05579509|Analgesics|analgesics|mesh-ancestor
83256675|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
83256676|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256677|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83256678|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83256679|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
83256680|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
83256681|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83256682|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83256683|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83256684|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83256685|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
83256686|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
83256687|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256688|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256689|NCT05696431|Fluorides|fluorides|mesh-list
83256690|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
83256691|NCT05696431|Protective Agents|protective agents|mesh-ancestor
83256692|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256693|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
83256694|NCT05628883|Fludarabine|fludarabine|mesh-list
83256695|NCT05628883|Interleukin-2|interleukin-2|mesh-list
83256696|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256697|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
83256698|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256699|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256700|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83256701|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
83256702|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256703|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256704|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83256705|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83256706|NCT05628883|Analgesics|analgesics|mesh-ancestor
83256707|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
83256708|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256709|NCT05575219|Clonidine|clonidine|mesh-list
83256710|NCT05575219|Analgesics|analgesics|mesh-ancestor
83256711|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
83256712|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256713|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256714|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83256715|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
83256716|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
83256717|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83256718|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83256719|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83256720|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
83256721|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256722|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256723|NCT04341571|Metformin|metformin|mesh-list
83256724|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83256725|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256726|NCT05568745|Misoprostol|misoprostol|mesh-list
83256727|NCT05568745|Oxytocin|oxytocin|mesh-list
83256728|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
83256729|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83256730|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256731|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83256732|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
83256733|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83256734|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256735|NCT04314895|Paclitaxel|paclitaxel|mesh-list
83256736|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83256737|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83256738|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256739|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
83256740|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
83256741|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
83256742|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256743|NCT02581189|Ritonavir|ritonavir|mesh-list
83256744|NCT02581189|Ribavirin|ribavirin|mesh-list
83256745|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83256746|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83256747|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
83256748|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256749|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256750|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83256751|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83256752|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
83256753|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256754|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83256755|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83256756|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
83256757|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83256758|NCT05569681|Bemiparin|bemiparin|mesh-list
83256759|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
83256760|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83256761|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83256762|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256763|NCT00352027|Prednisone|prednisone|mesh-list
83256764|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
83256765|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
83256766|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
83256767|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83256768|NCT00352027|Doxorubicin|doxorubicin|mesh-list
83256769|NCT00352027|Etoposide|etoposide|mesh-list
83256770|NCT00352027|Vincristine|vincristine|mesh-list
83256771|NCT00352027|Bleomycin|bleomycin|mesh-list
83256772|NCT00352027|Vinblastine|vinblastine|mesh-list
83256773|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83256774|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
83256775|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256776|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256777|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83256778|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
83256779|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256780|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256781|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83256782|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83256783|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83256784|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83256785|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256786|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256787|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
83256788|NCT00352027|Hormones|hormones|mesh-ancestor
83256789|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256790|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83256791|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83256792|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
83256793|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
83256794|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
83256795|NCT02576977|Dexamethasone|dexamethasone|mesh-list
83256796|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
83256798|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256799|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
83256800|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
83256801|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256802|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256803|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256804|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
83256805|NCT02576977|Hormones|hormones|mesh-ancestor
83256806|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256807|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83256808|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256809|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256810|NCT02576977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83256811|NCT02576977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256812|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
83256813|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83256814|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83256815|NCT02576977|Growth Substances|growth substances|mesh-ancestor
83256816|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
83256818|NCT05867251|Letrozole|letrozole|mesh-list
83256819|NCT05867251|Fulvestrant|fulvestrant|mesh-list
83256820|NCT05867251|Palbociclib|palbociclib|mesh-list
83256821|NCT05867251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256822|NCT05867251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83256823|NCT05867251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83256824|NCT05867251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256825|NCT05867251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256826|NCT05867251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83256827|NCT05867251|Hormone Antagonists|hormone antagonists|mesh-ancestor
83256828|NCT05867251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256829|NCT05867251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256830|NCT05867251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83256831|NCT05867251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83256832|NCT05867251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83256833|NCT05867212|Cabotegravir|cabotegravir|mesh-list
83256834|NCT05867212|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83256835|NCT05867212|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83256836|NCT05867212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256837|NCT05867212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256838|NCT05867212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83256839|NCT05867212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83256840|NCT05867212|Antiviral Agents|antiviral agents|mesh-ancestor
83256841|NCT05867212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256842|NCT05867056|Cysteamine|cysteamine|mesh-list
83256843|NCT05867056|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83256844|NCT05867056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256845|NCT05867030|Rituximab|rituximab|mesh-list
83256846|NCT05867030|Lenalidomide|lenalidomide|mesh-list
83256847|NCT05867030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256848|NCT05867030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256849|NCT05867030|Immunologic Factors|immunologic factors|mesh-ancestor
83256850|NCT05867030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256851|NCT05867030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256852|NCT05867030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83256853|NCT05867030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83256854|NCT05867030|Growth Substances|growth substances|mesh-ancestor
83256855|NCT05867030|Growth Inhibitors|growth inhibitors|mesh-ancestor
83256856|NCT05866848|Caffeine|caffeine|mesh-list
83256857|NCT05866848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83256858|NCT05866848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256859|NCT05866848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83256860|NCT05866848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256861|NCT05866848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256862|NCT05866848|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83256863|NCT05866848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83256864|NCT05866848|Purinergic Agents|purinergic agents|mesh-ancestor
83256865|NCT05866848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256866|NCT05866627|Famotidine|famotidine|mesh-list
83256867|NCT05866627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83256868|NCT05866627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83256869|NCT05866627|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83256870|NCT05866627|Histamine Antagonists|histamine antagonists|mesh-ancestor
83256871|NCT05866627|Histamine Agents|histamine agents|mesh-ancestor
83256872|NCT05866627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256873|NCT05866627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256874|NCT05866627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256875|NCT05866614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83256876|NCT05866614|Immunologic Factors|immunologic factors|mesh-ancestor
83256877|NCT05866614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256878|NCT05866588|Coal Tar|coal tar|mesh-list
83256879|NCT05866588|Keratolytic Agents|keratolytic agents|mesh-ancestor
83256880|NCT05866588|Dermatologic Agents|dermatologic agents|mesh-ancestor
83256881|NCT05866575|Vortioxetine|vortioxetine|mesh-list
83256882|NCT05866575|Escitalopram|escitalopram|mesh-list
83256883|NCT05866575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83256884|NCT05866575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83256885|NCT05866575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83256886|NCT05866575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256887|NCT05866575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256888|NCT05866575|Serotonin Agents|serotonin agents|mesh-ancestor
83256889|NCT05866575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256890|NCT05866575|Antidepressive Agents|antidepressive agents|mesh-ancestor
83256891|NCT05866575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83256892|NCT05866575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83256893|NCT05866575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83256894|NCT05866575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256895|NCT05866575|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83256896|NCT05866575|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83256897|NCT05866575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83256898|NCT05866575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83256899|NCT05866354|Tisotumab vedotin|tisotumab vedotin|mesh-list
83256900|NCT05866354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256901|NCT05866354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256902|NCT05866172|Zoledronic Acid|zoledronic acid|mesh-list
83256903|NCT05866172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83256904|NCT05866172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256905|NCT05866068|Clomiphene|clomiphene|mesh-list
83256906|NCT05866068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83256907|NCT05866068|Hormone Antagonists|hormone antagonists|mesh-ancestor
83256908|NCT05866068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256909|NCT05866068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256910|NCT05866068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83256911|NCT05866068|Fertility Agents|fertility agents|mesh-ancestor
83256912|NCT05866068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83256913|NCT05866068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83256914|NCT05866068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83256915|NCT05866055|Midazolam|midazolam|mesh-list
83256916|NCT05866055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83256917|NCT05866055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83256918|NCT05866055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256919|NCT05866055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256920|NCT05866055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83256921|NCT05866055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83256922|NCT05866055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83256923|NCT05866055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83256924|NCT05866055|Anesthetics, General|anesthetics, general|mesh-ancestor
83256925|NCT05866055|Anesthetics|anesthetics|mesh-ancestor
83256926|NCT05866055|GABA Modulators|gaba modulators|mesh-ancestor
83256927|NCT05866055|GABA Agents|gaba agents|mesh-ancestor
83256928|NCT05866055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83256929|NCT05866055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256930|NCT05866029|Denosumab|denosumab|mesh-list
83256931|NCT05866029|Teriparatide|teriparatide|mesh-list
83256932|NCT05866029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83256933|NCT05866029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256934|NCT05866029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83256935|NCT05865990|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
83256936|NCT05865990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256937|NCT05865990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256938|NCT05865925|Irinotecan|irinotecan|mesh-list
83256939|NCT05865925|Floxuridine|floxuridine|mesh-list
83256940|NCT05865925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83256941|NCT05865925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83256942|NCT05865925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256943|NCT05865925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256944|NCT05865925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256945|NCT05865925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83256946|NCT05865925|Antimetabolites|antimetabolites|mesh-ancestor
83256947|NCT05865548|Aspirin|aspirin|mesh-list
83256948|NCT05865548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83256949|NCT05865548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83256950|NCT05865548|Analgesics|analgesics|mesh-ancestor
83256951|NCT05865548|Sensory System Agents|sensory system agents|mesh-ancestor
83256952|NCT05865548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83256953|NCT05865548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256954|NCT05865548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256955|NCT05865548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83256956|NCT05865548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83256957|NCT05865548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83256958|NCT05865548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256959|NCT05865548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83256960|NCT05865548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83256961|NCT05865548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256962|NCT05865548|Antipyretics|antipyretics|mesh-ancestor
83256963|NCT05861440|Antitubercular Agents|antitubercular agents|mesh-list
83256964|NCT05861440|Prednisolone|prednisolone|mesh-list
83256965|NCT05861440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83256966|NCT05861440|Glucocorticoids|glucocorticoids|mesh-ancestor
83256967|NCT05861440|Hormones|hormones|mesh-ancestor
83256968|NCT05861440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83256969|NCT05861440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256970|NCT05861440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83256971|NCT05861440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256972|NCT05861440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83256973|NCT05861440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83256974|NCT05859074|Pembrolizumab|pembrolizumab|mesh-list
83256975|NCT05859074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83256976|NCT05859074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256977|NCT05859074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83256978|NCT05859074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256979|NCT05849298|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83256980|NCT05849298|177Lu-PSMA-617|177lu-psma-617|mesh-list
83256981|NCT05849298|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83256982|NCT05849298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256983|NCT05827068|Vaccines|vaccines|mesh-list
83256984|NCT05827068|Immunologic Factors|immunologic factors|mesh-ancestor
83256985|NCT05827068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256986|NCT05819710|Zopiclone|zopiclone|mesh-list
83256987|NCT05819710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83256988|NCT05819710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83256989|NCT05819710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83256990|NCT05816356|Decitabine|decitabine|mesh-list
83256991|NCT05816356|Tetrahydrouridine|tetrahydrouridine|mesh-list
83256992|NCT05816356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83256993|NCT05816356|Antimetabolites|antimetabolites|mesh-ancestor
83256994|NCT05816356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83256995|NCT05816356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83256996|NCT05816356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83256997|NCT05815680|Metformin|metformin|mesh-list
83256998|NCT05815680|Digoxin|digoxin|mesh-list
83256999|NCT05815680|Warfarin|warfarin|mesh-list
83257000|NCT05815680|Atorvastatin|atorvastatin|mesh-list
83257001|NCT05815680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83257002|NCT05815680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257003|NCT05815680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83257004|NCT05815680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83257005|NCT05815680|Antimetabolites|antimetabolites|mesh-ancestor
83257006|NCT05815680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257007|NCT05815680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83257008|NCT05815680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83257009|NCT05815680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257010|NCT05815680|Anticoagulants|anticoagulants|mesh-ancestor
83257011|NCT05815680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83257012|NCT05815680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83257013|NCT05815680|Protective Agents|protective agents|mesh-ancestor
83257014|NCT05801419|Nicotine|nicotine|mesh-list
83257015|NCT05801419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83257016|NCT05801419|Autonomic Agents|autonomic agents|mesh-ancestor
83257017|NCT05801419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257018|NCT05801419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257019|NCT05801419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83257020|NCT05801419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83257021|NCT05801419|Cholinergic Agents|cholinergic agents|mesh-ancestor
83257022|NCT05801419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257023|NCT05801419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257024|NCT05789069|Tislelizumab|tislelizumab|mesh-list
83257025|NCT05789069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257026|NCT05789069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257027|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
83257028|NCT05786417|Calcium|calcium|mesh-list
83257029|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83257030|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83257031|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257032|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83257033|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
83257034|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257035|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257036|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83257037|NCT05781217|Goserelin|goserelin|mesh-list
83257038|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83257040|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83257041|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257042|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
83257043|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83257044|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
83257045|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83257046|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257047|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83257048|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83257049|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
83257050|NCT05776823|Naloxone|naloxone|mesh-list
83257051|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83257052|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257053|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
83257054|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257055|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
83257056|NCT05769530|Nalbuphine|nalbuphine|mesh-list
83257057|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83257058|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257059|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257060|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257061|NCT05769530|Analgesics|analgesics|mesh-ancestor
83257062|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
83257063|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257064|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83257065|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83257066|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83257067|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
83257068|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257069|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257070|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83257071|NCT05769530|Narcotics|narcotics|mesh-ancestor
83257072|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83257073|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83257074|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83257076|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83257077|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83257078|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83257079|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83257080|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
83257081|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257082|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257083|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257084|NCT05753189|Miotics|miotics|mesh-ancestor
83257085|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
83257086|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257087|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83257088|NCT05740618|Mannitol|mannitol|mesh-list
83257089|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83257090|NCT05740618|Diuretics|diuretics|mesh-ancestor
83257091|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
83257092|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257093|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83257094|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83257095|NCT05728944|Aceclidine|aceclidine|mesh-list
83257096|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83257097|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83257098|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83257099|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83257100|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83257101|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83257102|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257103|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257104|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257105|NCT05728944|Miotics|miotics|mesh-ancestor
83257106|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
83257107|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257108|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83257109|NCT05705505|Letrozole|letrozole|mesh-list
83257110|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257111|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83257112|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83257113|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257114|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257115|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83257116|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
83257117|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257118|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257119|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83257121|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83257122|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83257123|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83257124|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257125|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257126|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257127|NCT05677295|Analgesics|analgesics|mesh-ancestor
83257128|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
83257129|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257130|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
83257131|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257133|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83257134|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83257135|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
83257136|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83257137|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83257138|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
83257139|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83257140|NCT05664750|Antibodies|antibodies|mesh-list
83257141|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
83257142|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257143|NCT05626322|Lenalidomide|lenalidomide|mesh-list
83257144|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
83257145|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257146|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83257147|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83257148|NCT05626322|Growth Substances|growth substances|mesh-ancestor
83257149|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
83257150|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257151|NCT05623020|Dexamethasone|dexamethasone|mesh-list
83257152|NCT05623020|Lenalidomide|lenalidomide|mesh-list
83257153|NCT05623020|Daratumumab|daratumumab|mesh-list
83257154|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257155|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
83257156|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
83257157|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257158|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257159|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83257160|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
83257161|NCT05623020|Hormones|hormones|mesh-ancestor
83257162|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257163|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83257164|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257165|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
83257166|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83257167|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83257168|NCT05623020|Growth Substances|growth substances|mesh-ancestor
83257169|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
83257170|NCT05621616|Mirabegron|mirabegron|mesh-list
83257171|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83257172|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83257173|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83257174|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
83257175|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257176|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257177|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257178|NCT05621616|Urological Agents|urological agents|mesh-ancestor
83257179|NCT05580523|Aspirin|aspirin|mesh-list
83257180|NCT05580523|Metformin|metformin|mesh-list
83257181|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83257182|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257183|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83257184|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257185|NCT05580523|Analgesics|analgesics|mesh-ancestor
83257186|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
83257188|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257190|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83257191|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83257192|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257193|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83257194|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83257195|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257196|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
83257199|NCT05557877|Aspirin|aspirin|mesh-list
83257200|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83257201|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257202|NCT05557877|Analgesics|analgesics|mesh-ancestor
83257203|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
83257204|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257205|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257206|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257207|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257208|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83257209|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83257210|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257211|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83257212|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83257213|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257214|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
83257215|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83257216|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83257217|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83257218|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257219|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257220|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83257221|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83257222|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257223|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
83257224|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257225|NCT05502315|Nivolumab|nivolumab|mesh-list
83257226|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257227|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257228|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257229|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257230|NCT05476991|Aspirin|aspirin|mesh-list
83257231|NCT05476991|Colchicine|colchicine|mesh-list
83257232|NCT05476991|Ticagrelor|ticagrelor|mesh-list
83257233|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83257234|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257235|NCT05476991|Analgesics|analgesics|mesh-ancestor
83257236|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
83257237|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257238|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257239|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257240|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257241|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83257242|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83257243|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257244|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83257245|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83257246|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257247|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
83257248|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83257249|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83257250|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83257252|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257253|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
83257254|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257255|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
83257256|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257257|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257258|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
83257259|NCT05465226|Narcotics|narcotics|mesh-ancestor
83257260|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257261|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257263|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
83257264|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257265|NCT05463393|Xanthohumol|xanthohumol|mesh-list
83257266|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257267|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83257268|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83257269|NCT05463393|Growth Substances|growth substances|mesh-ancestor
83257270|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257271|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
83257272|NCT05419050|Denosumab|denosumab|mesh-list
83257273|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83257274|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257275|NCT05393271|Midazolam|midazolam|mesh-list
83257276|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83257277|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83257278|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257279|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257280|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83257281|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83257282|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257283|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83257284|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
83257285|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
83257286|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
83257287|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
83257288|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257289|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257290|NCT05382806|Flumazenil|flumazenil|mesh-list
83257291|NCT05382806|Antidotes|antidotes|mesh-ancestor
83257292|NCT05382806|Protective Agents|protective agents|mesh-ancestor
83257293|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257294|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
83257295|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
83257296|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257297|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257298|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
83257299|NCT05379972|Olaparib|olaparib|mesh-list
83257300|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257301|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257302|NCT05379972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257303|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257304|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83257305|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257306|NCT05367245|Butyric Acid|butyric acid|mesh-list
83257307|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257308|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
83257309|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
83257310|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257311|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257312|NCT05312008|Oxytocin|oxytocin|mesh-list
83257313|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
83257314|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83257315|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257316|NCT05265546|Psilocybin|psilocybin|mesh-list
83257317|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
83257318|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257319|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257320|NCT05246670|Palmidrol|palmidrol|mesh-list
83257321|NCT05246670|Analgesics|analgesics|mesh-ancestor
83257322|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
83257323|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257324|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257325|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83257326|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257327|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257328|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257329|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
83257330|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257331|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83257332|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83257333|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257334|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257335|NCT05246670|Hormones|hormones|mesh-ancestor
83257336|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257337|NCT05238883|Tislelizumab|tislelizumab|mesh-list
83257338|NCT05238883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257339|NCT05238883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257341|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
83257342|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257343|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257344|NCT05163496|Psilocybin|psilocybin|mesh-list
83257345|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
83257346|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257347|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257348|NCT05162443|Adagrasib|adagrasib|mesh-list
83257349|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257350|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
83257351|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257352|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257353|NCT05128487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257354|NCT05128487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257355|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83257356|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83257357|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83257358|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257359|NCT05097599|Pembrolizumab|pembrolizumab|mesh-list
83257360|NCT05097599|Trastuzumab|trastuzumab|mesh-list
83257361|NCT05097599|Axitinib|axitinib|mesh-list
83257362|NCT05097599|Talazoparib|talazoparib|mesh-list
83257363|NCT05097599|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83257364|NCT05097599|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83257365|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257366|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257367|NCT05097599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257368|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257369|NCT05097599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83257370|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257371|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83257372|NCT05097599|Immunoconjugates|immunoconjugates|mesh-ancestor
83257373|NCT05097599|Immunologic Factors|immunologic factors|mesh-ancestor
83257374|NCT05097599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257375|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
83257376|NCT05068791|Psilocybin|psilocybin|mesh-list
83257378|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257379|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257380|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
83257381|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
83257382|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83257383|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83257384|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257385|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257386|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83257387|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83257388|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257389|NCT04996004|Doxorubicin|doxorubicin|mesh-list
83257390|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83257391|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257392|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83257393|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83257394|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257395|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257396|NCT04952402|Vaccines|vaccines|mesh-list
83257397|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
83257398|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257399|NCT04941144|Vaccines|vaccines|mesh-list
83257400|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
83257401|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257402|NCT04907227|Dexamethasone|dexamethasone|mesh-list
83257403|NCT04907227|Prednisone|prednisone|mesh-list
83257404|NCT04907227|Docetaxel|docetaxel|mesh-list
83257405|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
83257406|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257407|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
83257408|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
83257409|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257410|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257411|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83257412|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
83257413|NCT04907227|Hormones|hormones|mesh-ancestor
83257414|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257415|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83257416|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257417|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257418|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83257419|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257420|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257421|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257422|NCT04907227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257423|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
83257424|NCT04892277|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83257425|NCT04892277|Fludarabine|fludarabine|mesh-list
83257426|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257427|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
83257428|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257429|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257430|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83257431|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
83257432|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257433|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257434|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83257435|NCT04842045|Midazolam|midazolam|mesh-list
83257436|NCT04842045|Psilocybin|psilocybin|mesh-list
83257437|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83257438|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83257439|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257440|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257441|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83257442|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83257444|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83257445|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
83257446|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
83257447|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
83257448|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
83257449|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257450|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257451|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
83257452|NCT04754945|Dexamethasone|dexamethasone|mesh-list
83257453|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
83257454|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
83257455|NCT04754945|Bortezomib|bortezomib|mesh-list
83257456|NCT04754945|Ichthammol|ichthammol|mesh-list
83257457|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83257458|NCT04754945|BB 1101|bb 1101|mesh-list
83257459|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257460|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
83257461|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257462|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257463|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83257464|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
83257465|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257466|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257467|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83257468|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257469|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
83257470|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
83257471|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257472|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83257473|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
83257474|NCT04754945|Hormones|hormones|mesh-ancestor
83257475|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257476|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83257477|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
83257478|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257479|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
83257480|NCT04730037|Warfarin|warfarin|mesh-list
83257481|NCT04730037|Edoxaban|edoxaban|mesh-list
83257482|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
83257483|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83257484|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
83257485|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83257486|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
83257494|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257495|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257496|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
83257497|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257498|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257499|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83257500|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83257501|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83257502|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257503|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83257504|NCT04715646|Brivaracetam|brivaracetam|mesh-list
83257505|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
83257506|NCT04704999|Chloroquine|chloroquine|mesh-list
83257507|NCT04704999|Lumefantrine|lumefantrine|mesh-list
83257508|NCT04704999|Artemether|artemether|mesh-list
83257509|NCT04704999|Tafenoquine|tafenoquine|mesh-list
83257510|NCT04704999|Amebicides|amebicides|mesh-ancestor
83257511|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83257512|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83257513|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257514|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
83257515|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257516|NCT04699188|Tislelizumab|tislelizumab|mesh-list
83257517|NCT04699188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257518|NCT04699188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257526|NCT04640779|Salicylates|salicylates|mesh-list
83257527|NCT04640779|Choline|choline|mesh-list
83257528|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
83257529|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83257530|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
83257531|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257532|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83257533|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83257534|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
83257535|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83257536|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257537|NCT04640779|Analgesics|analgesics|mesh-ancestor
83257538|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
83257539|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257540|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257541|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257542|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257543|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83257544|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257545|NCT04612751|Carboplatin|carboplatin|mesh-list
83257546|NCT04612751|Durvalumab|durvalumab|mesh-list
83257547|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257548|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257549|NCT04582669|Triamcinolone|triamcinolone|mesh-list
83257550|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83257551|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83257552|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83257553|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257554|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
83257555|NCT04582669|Hormones|hormones|mesh-ancestor
83257556|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257557|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257558|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257559|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
83257560|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257561|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257562|NCT04580498|Paclitaxel|paclitaxel|mesh-list
83257563|NCT04580498|Carboplatin|carboplatin|mesh-list
83257568|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257569|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257570|NCT04571619|Buprenorphine|buprenorphine|mesh-list
83257571|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83257572|NCT04571619|Narcotics|narcotics|mesh-ancestor
83257573|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257574|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257575|NCT04571619|Analgesics|analgesics|mesh-ancestor
83257576|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
83257577|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257578|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83257583|NCT04493060|Niraparib|niraparib|mesh-list
83257584|NCT04493060|Dostarlimab|dostarlimab|mesh-list
83257585|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
83257586|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
83257587|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
83257588|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257589|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83257590|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257591|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257592|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257593|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83257594|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257595|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83257596|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83257597|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257598|NCT04428385|Artemisinins|artemisinins|mesh-list
83257599|NCT04428385|Artemisinin|artemisinin|mesh-list
83257600|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
83257601|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83257602|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83257603|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257604|NCT04080427|Dronabinol|dronabinol|mesh-list
83257605|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
83257606|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257607|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257608|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257609|NCT04080427|Analgesics|analgesics|mesh-ancestor
83257610|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
83257611|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257612|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83257613|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83257614|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257615|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257616|NCT04080427|Hormones|hormones|mesh-ancestor
83257617|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257618|NCT04074161|Liraglutide|liraglutide|mesh-list
83257619|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83257620|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257621|NCT04074161|Incretins|incretins|mesh-ancestor
83257622|NCT04074161|Hormones|hormones|mesh-ancestor
83257623|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257624|NCT04046575|Paclitaxel|paclitaxel|mesh-list
83257625|NCT04046575|Carboplatin|carboplatin|mesh-list
83257626|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83257627|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257628|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257629|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
83257630|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257631|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257632|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
83257633|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257634|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83257635|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257636|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257637|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
83257638|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
83257639|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83257640|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
83257641|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257642|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257643|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257644|NCT03970096|Cyclosporine|cyclosporine|mesh-list
83257645|NCT03970096|Sirolimus|sirolimus|mesh-list
83257646|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
83257647|NCT03970096|Busulfan|busulfan|mesh-list
83257648|NCT03970096|Thiotepa|thiotepa|mesh-list
83257649|NCT03970096|Methotrexate|methotrexate|mesh-list
83257650|NCT03970096|Fludarabine|fludarabine|mesh-list
83257651|NCT03970096|Tacrolimus|tacrolimus|mesh-list
83257652|NCT03970096|Cyclosporins|cyclosporins|mesh-list
83257653|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257654|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
83257655|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257656|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257657|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83257658|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
83257659|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257660|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257661|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83257662|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83257663|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
83257664|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83257665|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83257666|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
83257667|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
83257668|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257669|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83257670|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83257671|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83257672|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
83257673|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257674|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83257675|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83257676|NCT03913559|Acetaminophen|acetaminophen|mesh-list
83257677|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
83257678|NCT03913559|Promethazine|promethazine|mesh-list
83257679|NCT03913559|Cytarabine|cytarabine|mesh-list
83257680|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
83257681|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83257682|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
83257683|NCT03913559|Methotrexate|methotrexate|mesh-list
83257684|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83257685|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83257686|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
83257687|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83257688|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257689|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83257690|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
83257691|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257692|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257693|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
83257694|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257695|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83257696|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257697|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
83257698|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257699|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83257700|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
83257701|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257702|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257703|NCT03913559|Analgesics|analgesics|mesh-ancestor
83257704|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
83257705|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257706|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
83257707|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257708|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
83257709|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
83257710|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83257712|NCT03913559|Hormones|hormones|mesh-ancestor
83257713|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83257714|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83257715|NCT03913559|Protective Agents|protective agents|mesh-ancestor
83257716|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83257717|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83257718|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83257719|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257720|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
83257722|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83257723|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
83257724|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
83257725|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257726|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83257727|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
83257728|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257729|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83257730|NCT03913559|Immunotoxins|immunotoxins|mesh-ancestor
83257731|NCT03913559|Immunoconjugates|immunoconjugates|mesh-ancestor
83257732|NCT03843528|Azacitidine|azacitidine|mesh-list
83257733|NCT03843528|Vorinostat|vorinostat|mesh-list
83257734|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83257735|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
83257736|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257737|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257738|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257739|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83257740|NCT03779789|Vortioxetine|vortioxetine|mesh-list
83257741|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
83257742|NCT03779789|Citalopram|citalopram|mesh-list
83257743|NCT03779789|Fluoxetine|fluoxetine|mesh-list
83257744|NCT03779789|Paroxetine|paroxetine|mesh-list
83257745|NCT03779789|Sertraline|sertraline|mesh-list
83257746|NCT03779789|Escitalopram|escitalopram|mesh-list
83257747|NCT03779789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83257748|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83257749|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83257750|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257751|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83257752|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
83257753|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257754|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83257755|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
83257756|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83257757|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83257758|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83257759|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257760|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83257761|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83257762|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257763|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83257764|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83257765|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83257766|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83257767|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83257768|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83257769|NCT03747939|Thalidomide|thalidomide|mesh-list
83257770|NCT03747939|Apremilast|apremilast|mesh-list
83257771|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83257772|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83257773|NCT03747939|Analgesics|analgesics|mesh-ancestor
83257774|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
83257775|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257777|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83257778|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257779|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83257780|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83257781|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257782|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257783|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257784|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
83257785|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
83257786|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83257787|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257788|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83257789|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83257790|NCT03747939|Growth Substances|growth substances|mesh-ancestor
83257791|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
83257792|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257793|NCT03733210|Panitumumab|panitumumab|mesh-list
83257794|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257795|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257796|NCT03733132|Metformin|metformin|mesh-list
83257797|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83257798|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257799|NCT03667820|Osimertinib|osimertinib|mesh-list
83257800|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257801|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83257802|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257803|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257804|NCT03654053|Simvastatin|simvastatin|mesh-list
83257805|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83257806|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83257807|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
83257808|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257809|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83257810|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83257811|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257812|NCT03627468|Bromides|bromides|mesh-list
83257813|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
83257814|NCT03620019|Denosumab|denosumab|mesh-list
83257815|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
83257816|NCT03620019|Nivolumab|nivolumab|mesh-list
83257817|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257818|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257819|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257820|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257821|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83257822|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257823|NCT03614949|Atezolizumab|atezolizumab|mesh-list
83257824|NCT03614949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257825|NCT03614949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257826|NCT03614949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257827|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257828|NCT03613116|Vitamin D|vitamin d|mesh-list
83257829|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
83257830|NCT03613116|Vitamins|vitamins|mesh-ancestor
83257831|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
83257832|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257833|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83257834|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83257835|NCT03588039|Paclitaxel|paclitaxel|mesh-list
83257836|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
83257837|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83257838|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257839|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257840|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
83257841|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257842|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257843|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257844|NCT03588039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257846|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83257847|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257848|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257849|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257850|NCT03539822|Durvalumab|durvalumab|mesh-list
83257851|NCT03539822|Tremelimumab|tremelimumab|mesh-list
83257852|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83257853|NCT03539822|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83257854|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257855|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257856|NCT03539822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83257857|NCT03539822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257858|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257859|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
83257860|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
83257861|NCT03516617|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83257862|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257863|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257864|NCT03516617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83257867|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
83257868|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257869|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257870|NCT03488667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257871|NCT03488667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257872|NCT03406247|Nivolumab|nivolumab|mesh-list
83257873|NCT03406247|Ipilimumab|ipilimumab|mesh-list
83257874|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257875|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257876|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257877|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257878|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83257879|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
83257880|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257881|NCT03371017|Carboplatin|carboplatin|mesh-list
83257882|NCT03371017|Gemcitabine|gemcitabine|mesh-list
83257883|NCT03371017|Capecitabine|capecitabine|mesh-list
83257884|NCT03371017|Atezolizumab|atezolizumab|mesh-list
83257885|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257886|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83257887|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
83257888|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257889|NCT03371017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257890|NCT03371017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257891|NCT03317535|Anesthetics|anesthetics|mesh-list
83257892|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257893|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257894|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
83257895|NCT03313206|Lenvatinib|lenvatinib|mesh-list
83257896|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257897|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257898|NCT03313206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257899|NCT03313206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257900|NCT03313206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83257901|NCT03313206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257903|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
83257906|NCT03077542|Sirolimus|sirolimus|mesh-list
83257907|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
83257908|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
83257909|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
83257910|NCT03077542|Pentostatin|pentostatin|mesh-list
83257911|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83257912|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
83257913|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257914|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83257915|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83257916|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
83257917|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257918|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257919|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83257920|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83257921|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257922|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83257923|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
83257924|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257925|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257926|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
83257927|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83257928|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83257929|NCT03071406|Nivolumab|nivolumab|mesh-list
83257930|NCT03071406|Ipilimumab|ipilimumab|mesh-list
83257931|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257932|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257933|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257934|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257935|NCT03066648|Azacitidine|azacitidine|mesh-list
83257936|NCT03066648|Decitabine|decitabine|mesh-list
83257937|NCT03066648|Spartalizumab|spartalizumab|mesh-list
83257938|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83257939|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
83257940|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257941|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257942|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257943|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257944|NCT03066648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257945|NCT03052816|Hydromorphone|hydromorphone|mesh-list
83257946|NCT03052816|Analgesics|analgesics|mesh-ancestor
83257947|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
83257948|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83257949|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257950|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83257951|NCT03052816|Narcotics|narcotics|mesh-ancestor
83257952|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83257953|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83257954|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83257955|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83257956|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
83257957|NCT02955940|Capecitabine|capecitabine|mesh-list
83257958|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83257959|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
83257960|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257961|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257962|NCT02883062|Paclitaxel|paclitaxel|mesh-list
83257963|NCT02883062|Carboplatin|carboplatin|mesh-list
83257964|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83257965|NCT02883062|Atezolizumab|atezolizumab|mesh-list
83257966|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83257967|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83257968|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257969|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257970|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83257971|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257972|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257973|NCT02883062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257974|NCT02883062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257975|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
83257976|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83257977|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
83257978|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257979|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257980|NCT02721732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257981|NCT02721732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257982|NCT02684058|Carboplatin|carboplatin|mesh-list
83257983|NCT02684058|Vincristine|vincristine|mesh-list
83257984|NCT02684058|Trametinib|trametinib|mesh-list
83257985|NCT02684058|Dabrafenib|dabrafenib|mesh-list
83257986|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257987|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83257988|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
83257989|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
83257990|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
83257991|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83257992|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83257993|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83257994|NCT02393625|Nivolumab|nivolumab|mesh-list
83257995|NCT02393625|Ceritinib|ceritinib|mesh-list
83257996|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83257997|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83257998|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83257999|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258000|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83258001|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258002|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83258003|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
83258004|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258005|NCT02168829|Aspirin|aspirin|mesh-list
83258006|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
83258007|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83258008|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83258009|NCT02168829|Analgesics|analgesics|mesh-ancestor
83258010|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
83258011|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258012|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258013|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258014|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258015|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83258016|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83258017|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258018|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83258019|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83258020|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258022|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83258023|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
83258024|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83258025|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
83258026|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
83258027|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83258028|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
83258029|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258030|NCT01433289|Protective Agents|protective agents|mesh-ancestor
83258031|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258032|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83258033|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83258034|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258035|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83258036|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
83258037|NCT01413100|Plerixafor|plerixafor|mesh-list
83258038|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
83258039|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
83258040|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83258041|NCT01413100|Lenograstim|lenograstim|mesh-list
83258042|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258043|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
83258044|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258045|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258046|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83258047|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
83258048|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258049|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258050|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83258051|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83258052|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83258053|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83258054|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
83258055|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83258056|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258057|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258058|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83258059|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83258060|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
83258061|NCT00995475|Fluticasone|fluticasone|mesh-list
83258062|NCT00995475|Xhance|xhance|mesh-list
83258063|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258064|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83258065|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
83258066|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258067|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258068|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83258069|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258070|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83258071|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83258072|NCT00980460|Sirolimus|sirolimus|mesh-list
83258073|NCT00980460|Cisplatin|cisplatin|mesh-list
83258074|NCT00980460|Doxorubicin|doxorubicin|mesh-list
83258075|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83258076|NCT00980460|Fluorouracil|fluorouracil|mesh-list
83258077|NCT00980460|Irinotecan|irinotecan|mesh-list
83258078|NCT00980460|Vincristine|vincristine|mesh-list
83258079|NCT00980460|Temsirolimus|temsirolimus|mesh-list
83258080|NCT00980460|Camptothecin|camptothecin|mesh-list
83258081|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
83258082|NCT00980460|Razoxane|razoxane|mesh-list
83258083|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
83258084|NCT00980460|MTOR Inhibitors|mtor inhibitors|mesh-list
83258085|NCT00980460|Liver Extracts|liver extracts|mesh-list
83258086|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258087|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83258088|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83258089|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83258090|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258091|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258092|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
83258093|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83258094|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258095|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
83258096|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258097|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83258098|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83258099|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
83258100|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
83258101|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83258102|NCT00980460|Hematinics|hematinics|mesh-ancestor
83258103|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83258104|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258105|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
83258106|NCT00980460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83258107|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83258108|NCT00980460|Protective Agents|protective agents|mesh-ancestor
83258109|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
83258110|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83258111|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
83258112|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258113|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258114|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83258115|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258116|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83258117|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
83258118|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258119|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258120|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83258121|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
83258122|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
83258123|NCT00945529|Protective Agents|protective agents|mesh-ancestor
83258124|NCT00921115|Fulvestrant|fulvestrant|mesh-list
83258125|NCT00921115|Anastrozole|anastrozole|mesh-list
83258126|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83258127|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258128|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83258129|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83258130|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
83258131|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258132|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258133|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83258134|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83258135|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258136|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258137|NCT00720785|Bortezomib|bortezomib|mesh-list
83258138|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258139|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
83258140|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83258142|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258143|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258144|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83258145|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258146|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83258147|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83258148|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83258149|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83258150|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258151|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258152|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83258153|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
83258154|NCT04425187|Bevacizumab|bevacizumab|mesh-list
83258155|NCT04425187|Gefitinib|gefitinib|mesh-list
83258156|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258157|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258158|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83258159|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83258160|NCT04425187|Growth Substances|growth substances|mesh-ancestor
83258161|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258162|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
83258163|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83258164|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258165|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258166|NCT05519839|Vaccines|vaccines|mesh-list
83258167|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
83258168|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258169|NCT05529667|Paclitaxel|paclitaxel|mesh-list
83258170|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83258171|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258172|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
83258173|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
83258174|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
83258175|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258176|NCT03571633|Paclitaxel|paclitaxel|mesh-list
83258177|NCT03571633|Trastuzumab|trastuzumab|mesh-list
83258178|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83258179|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258180|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
83258181|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
83258182|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
83258183|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258184|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258185|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
83258186|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83258187|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258188|NCT05533255|Z 350|z 350|mesh-list
83258189|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83258190|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83258191|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258192|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258193|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
83258194|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258195|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258196|NCT05529355|Tegafur|tegafur|mesh-list
83258197|NCT05529355|Endostar protein|endostar protein|mesh-list
83258198|NCT05529355|Endostatins|endostatins|mesh-list
83258199|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83258200|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
83258201|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258202|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258203|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83258204|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83258205|NCT05529355|Growth Substances|growth substances|mesh-ancestor
83258206|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258207|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
83258208|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
83258209|NCT05528887|Fludarabine|fludarabine|mesh-list
83258210|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258211|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
83258212|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258213|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258214|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83258215|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
83258216|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258217|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258218|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83258219|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
83258220|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258221|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258222|NCT05501821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83258223|NCT05501821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258224|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83258225|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
83258226|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258227|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83258228|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83258229|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258230|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258231|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83258232|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83258233|NCT03009019|Celecoxib|celecoxib|mesh-list
83258234|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83258235|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83258236|NCT03009019|Analgesics|analgesics|mesh-ancestor
83258237|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
83258238|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258239|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258240|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258241|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258242|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83258243|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83258244|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258245|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258246|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
83258247|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258248|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258249|NCT02575807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83258250|NCT02575807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258251|NCT02813785|Docetaxel|docetaxel|mesh-list
83258252|NCT02813785|Atezolizumab|atezolizumab|mesh-list
83258253|NCT02813785|Antibodies|antibodies|mesh-list
83258254|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
83258255|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258256|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258257|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
83258258|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
83258259|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
83258260|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258261|NCT02813785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83258262|NCT02813785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258263|NCT04302181|Ropivacaine|ropivacaine|mesh-list
83258264|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
83258265|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
83258266|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258267|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258268|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
83258269|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258270|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
83258271|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258272|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258273|NCT02644369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83258274|NCT02644369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258275|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
83258276|NCT05527795|Immunomodulating Agents|immunomodulating agents|mesh-list
83258277|NCT05527795|Immunologic Factors|immunologic factors|mesh-ancestor
83258278|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258279|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83258280|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83258281|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
83258282|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258283|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258284|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
83258285|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
83258286|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258287|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
83258288|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83258289|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258290|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
83258291|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83258292|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258293|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
83258294|NCT02431897|Estrogens|estrogens|mesh-list
83258295|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83258296|NCT02431897|Hormones|hormones|mesh-ancestor
83258297|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258298|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258299|NCT05532163|Natalizumab|natalizumab|mesh-list
83258300|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
83258301|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258302|NCT05532085|Analgesics|analgesics|mesh-list
83258303|NCT05532085|Anesthetics|anesthetics|mesh-list
83258304|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258305|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258306|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
83258307|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258308|NCT02303119|Rituximab|rituximab|mesh-list
83258309|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258310|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258311|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
83258312|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258313|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258314|NCT02575339|Sorafenib|sorafenib|mesh-list
83258315|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258316|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83258317|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258318|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258319|NCT01640587|Artesunate|artesunate|mesh-list
83258320|NCT01640587|Piperaquine|piperaquine|mesh-list
83258321|NCT01640587|Artenimol|artenimol|mesh-list
83258322|NCT01640587|Mefloquine|mefloquine|mesh-list
83258323|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
83258324|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83258325|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83258326|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258327|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258328|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
83258329|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
83258330|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83258331|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
83258333|NCT01610713|Analgesics|analgesics|mesh-ancestor
83258334|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
83258335|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258336|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258337|NCT01606189|Nabiximols|nabiximols|mesh-list
83258338|NCT01606189|Analgesics|analgesics|mesh-ancestor
83258339|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
83258340|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258341|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258342|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
83258343|NCT05525065|Hormones|hormones|mesh-ancestor
83258344|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258345|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258346|NCT01663987|Bromides|bromides|mesh-list
83258347|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
83258348|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83258349|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
83258350|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258351|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258352|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83258353|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258354|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
83258355|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83258356|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
83258357|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258358|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258359|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
83258360|NCT05111353|Poly ICLC|poly iclc|mesh-list
83258361|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
83258362|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
83258363|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258364|NCT05305651|Sotrovimab|sotrovimab|mesh-list
83258365|NCT05305651|Antiviral Agents|antiviral agents|mesh-ancestor
83258366|NCT05305651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258367|NCT05526469|Bupivacaine|bupivacaine|mesh-list
83258368|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
83258369|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
83258370|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258371|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258372|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
83258373|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258374|NCT05155033|Aldesleukin|aldesleukin|mesh-list
83258375|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
83258376|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258377|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258378|NCT05155033|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83258379|NCT05155033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258380|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83258381|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83258382|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
83258383|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258384|NCT02380287|Antibodies|antibodies|mesh-list
83258385|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83258386|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
83258387|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258388|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
83258389|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83258390|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
83258391|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258393|NCT02342223|Protective Agents|protective agents|mesh-ancestor
83258394|NCT02393547|Varenicline|varenicline|mesh-list
83258395|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83258396|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83258397|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
83258398|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258399|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258400|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258401|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83258402|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
83258403|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258404|NCT05531383|Memantine|memantine|mesh-list
83258405|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83258406|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83258407|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
83258408|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258409|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258410|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258411|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83258412|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83258413|NCT02392611|Fulvestrant|fulvestrant|mesh-list
83258414|NCT02392611|Exemestane|exemestane|mesh-list
83258415|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83258416|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258417|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83258418|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83258419|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
83258420|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258421|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258422|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83258423|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83258424|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258425|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258426|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
83258427|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83258428|NCT02378961|Velpatasvir|velpatasvir|mesh-list
83258429|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
83258430|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258431|NCT05140525|Macitentan|macitentan|mesh-list
83258432|NCT05140525|Riociguat|riociguat|mesh-list
83258433|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83258434|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83258435|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258436|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83258437|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
83258438|NCT05518513|Bupivacaine|bupivacaine|mesh-list
83258439|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
83258440|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
83258441|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258442|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258443|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
83258444|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258445|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
83258446|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83258447|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83258448|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258449|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
83258450|NCT05518279|Coagulants|coagulants|mesh-ancestor
83258451|NCT05523661|Dasatinib|dasatinib|mesh-list
83258452|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258453|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83258454|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258455|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258456|NCT05523037|Sevoflurane|sevoflurane|mesh-list
83258457|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83258458|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83258459|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
83258460|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
83258461|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258462|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258463|NCT04625647|Sotorasib|sotorasib|mesh-list
83258464|NCT04625647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83258465|NCT04625647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258466|NCT04625647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258467|NCT04625647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258468|NCT05122741|Aspirin|aspirin|mesh-list
83258469|NCT05122741|Clopidogrel|clopidogrel|mesh-list
83258470|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83258471|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83258472|NCT05122741|Analgesics|analgesics|mesh-ancestor
83258473|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
83258474|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258475|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258476|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258477|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258478|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83258479|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83258480|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258481|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83258482|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83258483|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258484|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
83258485|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83258486|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83258487|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83258488|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
83258489|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258490|NCT05525767|Bevacizumab|bevacizumab|mesh-list
83258491|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258492|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258493|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83258494|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83258495|NCT05525767|Growth Substances|growth substances|mesh-ancestor
83258496|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258497|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
83258498|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83258499|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258500|NCT05025085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258501|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258502|NCT05522491|Olaparib|olaparib|mesh-list
83258503|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83258504|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258505|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258506|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258507|NCT02340975|Durvalumab|durvalumab|mesh-list
83258508|NCT02340975|Tremelimumab|tremelimumab|mesh-list
83258509|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83258510|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258511|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258512|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
83258513|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258514|NCT02392377|Leucovorin|leucovorin|mesh-list
83258515|NCT02392377|Paclitaxel|paclitaxel|mesh-list
83258516|NCT02392377|Carboplatin|carboplatin|mesh-list
83258517|NCT02392377|Fluorouracil|fluorouracil|mesh-list
83258518|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
83258519|NCT02392377|Calcium|calcium|mesh-list
83258520|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
83258521|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83258522|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258523|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
83258524|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
83258525|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
83258526|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258527|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83258528|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258529|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
83258530|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83258531|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258532|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
83258533|NCT02392377|Antidotes|antidotes|mesh-ancestor
83258534|NCT02392377|Protective Agents|protective agents|mesh-ancestor
83258535|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
83258536|NCT02392377|Vitamins|vitamins|mesh-ancestor
83258537|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
83258538|NCT02340819|Teduglutide|teduglutide|mesh-list
83258539|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83258540|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83258542|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258543|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83258544|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83258545|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258546|NCT04903509|Acetaminophen|acetaminophen|mesh-list
83258547|NCT04903509|Liraglutide|liraglutide|mesh-list
83258548|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83258549|NCT04903509|Analgesics|analgesics|mesh-ancestor
83258550|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
83258551|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258552|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258553|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
83258554|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83258555|NCT04903509|Incretins|incretins|mesh-ancestor
83258556|NCT04903509|Hormones|hormones|mesh-ancestor
83258557|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258558|NCT05517499|Dexamethasone|dexamethasone|mesh-list
83258559|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
83258560|NCT05517499|BB 1101|bb 1101|mesh-list
83258561|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258562|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
83258563|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
83258564|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258565|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258566|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83258567|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
83258568|NCT05517499|Hormones|hormones|mesh-ancestor
83258569|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258570|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83258571|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258572|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
83258573|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258574|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258575|NCT05512351|Bevacizumab|bevacizumab|mesh-list
83258576|NCT05512351|Tislelizumab|tislelizumab|mesh-list
83258577|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258578|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258579|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83258580|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83258581|NCT05512351|Growth Substances|growth substances|mesh-ancestor
83258582|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258583|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
83258584|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
83258585|NCT02569957|Topotecan|topotecan|mesh-list
83258586|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83258587|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83258588|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83258589|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258590|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258591|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258592|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
83258593|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258594|NCT02569957|Expectorants|expectorants|mesh-ancestor
83258595|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258596|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83258597|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
83258598|NCT02569957|Protective Agents|protective agents|mesh-ancestor
83258599|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258600|NCT02569957|Antidotes|antidotes|mesh-ancestor
83258601|NCT01649427|Tacrolimus|tacrolimus|mesh-list
83258602|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258603|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
83258604|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258605|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83258607|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258608|NCT05521633|Metformin|metformin|mesh-list
83258609|NCT05521633|Pioglitazone|pioglitazone|mesh-list
83258610|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83258611|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258612|NCT02336607|Metoprolol|metoprolol|mesh-list
83258613|NCT02336607|Felodipine|felodipine|mesh-list
83258614|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83258615|NCT02336607|Lisinopril|lisinopril|mesh-list
83258616|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83258617|NCT02336607|Diuretics|diuretics|mesh-ancestor
83258618|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
83258619|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258620|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83258621|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83258622|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258623|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83258624|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
83258625|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
83258626|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258627|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83258628|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83258629|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83258630|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
83258631|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258632|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83258633|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
83258634|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258635|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83258636|NCT02336607|Protective Agents|protective agents|mesh-ancestor
83258637|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83258638|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83258639|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
83258640|NCT02569801|Fulvestrant|fulvestrant|mesh-list
83258641|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83258642|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258643|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83258644|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83258645|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
83258646|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258647|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258648|NCT02573311|Tamsulosin|tamsulosin|mesh-list
83258649|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83258650|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83258651|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83258652|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
83258653|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258654|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258655|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258656|NCT02573311|Urological Agents|urological agents|mesh-ancestor
83258657|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83258658|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258659|NCT05520853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258660|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258661|NCT05516251|Topiramate|topiramate|mesh-list
83258662|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
83258663|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83258664|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258665|NCT04292743|Leucovorin|leucovorin|mesh-list
83258666|NCT04292743|Fluorouracil|fluorouracil|mesh-list
83258667|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
83258668|NCT04292743|Irinotecan|irinotecan|mesh-list
83258669|NCT04292743|Folfirinox|folfirinox|mesh-list
83258670|NCT04292743|Eryaspase|eryaspase|mesh-list
83258671|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
83258672|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258673|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83258674|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258675|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258676|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
83258677|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258678|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83258679|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83258680|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258681|NCT04292743|Antidotes|antidotes|mesh-ancestor
83258682|NCT04292743|Protective Agents|protective agents|mesh-ancestor
83258683|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
83258684|NCT04292743|Vitamins|vitamins|mesh-ancestor
83258685|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
83258686|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83258687|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83258688|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83258689|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83258690|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258691|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258692|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258693|NCT05086393|Analgesics|analgesics|mesh-ancestor
83258694|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
83258695|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258696|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
83258697|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83258698|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
83258699|NCT02571049|Sumatriptan|sumatriptan|mesh-list
83258700|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83258701|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83258702|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83258703|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
83258704|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258705|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258706|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258707|NCT05515939|Insulin|insulin|mesh-list
83258708|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83258709|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258710|NCT04295941|Trazodone|trazodone|mesh-list
83258711|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83258712|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83258713|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258714|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258715|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83258716|NCT04295941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83258717|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83258718|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83258719|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258720|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258721|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
83258722|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83258723|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
83258724|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83258725|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258726|NCT04294771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258727|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258728|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
83258729|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83258730|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
83258731|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258732|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258733|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83258734|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258735|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
83258736|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83258737|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
83258738|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258739|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258740|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83258741|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83258742|NCT05515315|Paclitaxel|paclitaxel|mesh-list
83258743|NCT05515315|Tislelizumab|tislelizumab|mesh-list
83258744|NCT05515315|Nedaplatin|nedaplatin|mesh-list
83258745|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83258746|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258747|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
83258748|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
83258749|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
83258750|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258751|NCT05515315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258752|NCT05519371|Propofol|propofol|mesh-list
83258753|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83258754|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258755|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258756|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83258757|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
83258758|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
83258759|NCT04847947|Vitamin D|vitamin d|mesh-list
83258760|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
83258761|NCT04847947|Vitamins|vitamins|mesh-ancestor
83258762|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
83258763|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258764|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83258765|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83258767|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258768|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258769|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83258770|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83258771|NCT05514925|Growth Substances|growth substances|mesh-ancestor
83258772|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258773|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
83258774|NCT05514847|Aspirin|aspirin|mesh-list
83258775|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83258776|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83258777|NCT05514847|Analgesics|analgesics|mesh-ancestor
83258778|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
83258779|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258780|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258781|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258782|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258783|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83258784|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83258785|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258786|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83258787|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83258788|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258789|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
83258790|NCT05510323|Prednisolone|prednisolone|mesh-list
83258791|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83258792|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
83258793|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83258794|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
83258795|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
83258796|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83258797|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
83258798|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258799|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
83258800|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258801|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258802|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83258803|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
83258804|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258805|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258806|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83258807|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258808|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
83258809|NCT05510323|Hormones|hormones|mesh-ancestor
83258810|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258811|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83258812|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
83258813|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
83258814|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258815|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83258816|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83258817|NCT05510323|Protective Agents|protective agents|mesh-ancestor
83258818|NCT04843579|Clarithromycin|clarithromycin|mesh-list
83258819|NCT04843579|Dexamethasone|dexamethasone|mesh-list
83258820|NCT04843579|Pomalidomide|pomalidomide|mesh-list
83258821|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83258822|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
83258823|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
83258824|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83258825|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258826|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83258827|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
83258828|NCT04843579|Hormones|hormones|mesh-ancestor
83258829|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258830|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83258831|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258832|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83258833|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258834|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83258835|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258836|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258837|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83258838|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83258839|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
83258840|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83258841|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83258842|NCT04843579|Growth Substances|growth substances|mesh-ancestor
83258843|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
83258844|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
83258845|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83258846|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
83258847|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258848|NCT02568397|Dabigatran|dabigatran|mesh-list
83258849|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
83258850|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83258851|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
83258852|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258853|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258854|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
83258855|NCT04812379|Aripiprazole|aripiprazole|mesh-list
83258856|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
83258857|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83258858|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83258859|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83258860|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258861|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258862|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
83258863|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
83258864|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258865|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258866|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83258867|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83258868|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
83258869|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83258870|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83258871|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83258872|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83258873|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
83258874|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83258875|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
83258876|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83258877|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
83258878|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258879|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258880|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
83258881|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
83258882|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83258883|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
83258884|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83258885|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
83258886|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258887|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258888|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
83258889|NCT05506969|Vaccines|vaccines|mesh-list
83258890|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
83258891|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
83258892|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258893|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83258894|NCT04291885|Avelumab|avelumab|mesh-list
83258895|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258896|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258897|NCT05513209|Anesthetics|anesthetics|mesh-list
83258898|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258899|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258900|NCT05513131|Azacitidine|azacitidine|mesh-list
83258901|NCT05513131|Venetoclax|venetoclax|mesh-list
83258902|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
83258903|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83258904|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
83258905|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258906|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258907|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258908|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83258909|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83258911|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83258912|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258913|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83258914|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83258915|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258916|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
83258917|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
83258918|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
83258919|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83258920|NCT05509153|Expectorants|expectorants|mesh-ancestor
83258921|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
83258922|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83258923|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
83258924|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258925|NCT05509153|Protective Agents|protective agents|mesh-ancestor
83258926|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258927|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83258928|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83258929|NCT04584853|Tamoxifen|tamoxifen|mesh-list
83258930|NCT04584853|Letrozole|letrozole|mesh-list
83258931|NCT04584853|Anastrozole|anastrozole|mesh-list
83258932|NCT04584853|Exemestane|exemestane|mesh-list
83258933|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258934|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83258935|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83258936|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258937|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258938|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83258939|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
83258940|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83258941|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258942|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83258943|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83258944|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83258945|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83258946|NCT05505877|Tislelizumab|tislelizumab|mesh-list
83258947|NCT05505877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258948|NCT05505877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258949|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
83258950|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83258951|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258952|NCT04712851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83258953|NCT04712851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258954|NCT02336451|Ceritinib|ceritinib|mesh-list
83258955|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258956|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83258957|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258958|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258959|NCT01648101|Ezogabine|ezogabine|mesh-list
83258960|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
83258961|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83258962|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258963|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
83258964|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258965|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
83258966|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258967|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258968|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83258969|NCT02372799|Fluoxetine|fluoxetine|mesh-list
83258970|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83258971|NCT02372799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83258972|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83258973|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83258974|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258975|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83258976|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
83258977|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258978|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83258979|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
83258980|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83258981|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83258982|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83258983|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83258984|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83258985|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83258986|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
83258987|NCT02566993|Doxorubicin|doxorubicin|mesh-list
83258988|NCT02566993|Vincristine|vincristine|mesh-list
83258989|NCT02566993|Topotecan|topotecan|mesh-list
83258990|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83258991|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
83258992|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83258993|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83258994|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83258995|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
83258996|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83258997|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83258998|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83258999|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83259000|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83259001|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83259002|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259003|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83259004|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83259005|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83259006|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83259007|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83259008|NCT02311881|Acetaminophen|acetaminophen|mesh-list
83259009|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83259010|NCT02311881|Analgesics|analgesics|mesh-ancestor
83259011|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
83259012|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259013|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259014|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
83259015|NCT02565511|Umibecestat|umibecestat|mesh-list
83259016|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259017|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259018|NCT04549051|Anesthetics|anesthetics|mesh-list
83259019|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
83259020|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259021|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259022|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
83259023|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259024|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
83259025|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83259026|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83259027|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259028|NCT05505253|Vitamins|vitamins|mesh-ancestor
83259029|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
83259030|NCT04697719|Aspirin|aspirin|mesh-list
83259031|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83259032|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83259033|NCT04697719|Analgesics|analgesics|mesh-ancestor
83259034|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
83259035|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259036|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259037|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259038|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259039|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83259040|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413596|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83259041|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259042|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83259043|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83259044|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259045|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
83259046|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83259047|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
83259048|NCT05504863|Hematinics|hematinics|mesh-ancestor
83259049|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
83259050|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83259051|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83259052|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259053|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
83259054|NCT05507983|Coagulants|coagulants|mesh-ancestor
83259055|NCT02335983|Dexamethasone|dexamethasone|mesh-list
83259056|NCT02335983|Lenalidomide|lenalidomide|mesh-list
83259057|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259058|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
83259059|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
83259060|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259061|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259062|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259063|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
83259064|NCT02335983|Hormones|hormones|mesh-ancestor
83259065|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259066|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83259067|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259068|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
83259069|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83259070|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83259071|NCT02335983|Growth Substances|growth substances|mesh-ancestor
83259073|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
83259074|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
83259075|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83259076|NCT04578691|Protective Agents|protective agents|mesh-ancestor
83259077|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259078|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83259079|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83259080|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
83259081|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83259082|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83259083|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83259084|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259085|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259086|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
83259087|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259088|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259089|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83259090|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259091|NCT02310789|Ivacaftor|ivacaftor|mesh-list
83259092|NCT02310789|Pilocarpine|pilocarpine|mesh-list
83259093|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
83259094|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83259095|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259096|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259097|NCT02310789|Miotics|miotics|mesh-ancestor
83259098|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
83259099|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259100|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259101|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83259102|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83259103|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
83259104|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259105|NCT02372253|Verapamil|verapamil|mesh-list
83259106|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83259107|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83259108|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259109|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259110|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83259111|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259112|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
83259113|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
83259114|NCT02371629|Bromides|bromides|mesh-list
83259115|NCT02371629|Albuterol|albuterol|mesh-list
83259116|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
83259117|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83259118|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
83259119|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259120|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259121|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83259122|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
83259123|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
83259124|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83259125|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83259126|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83259127|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83259128|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
83259129|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259130|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259131|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83259132|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83259133|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83259134|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
83259136|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83259137|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
83259138|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259139|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259140|NCT04577443|Adenosine|adenosine|mesh-list
83259141|NCT04577443|Analgesics|analgesics|mesh-ancestor
83259142|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
83259143|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259144|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259145|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83259146|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
83259147|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83259148|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
83259149|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
83259150|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259151|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259152|NCT04411537|Capecitabine|capecitabine|mesh-list
83259153|NCT04411537|Irinotecan|irinotecan|mesh-list
83259154|NCT04411537|Antibodies|antibodies|mesh-list
83259155|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
83259156|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259157|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83259158|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
83259159|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259160|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259161|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83259162|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83259163|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259164|NCT04630171|Anesthetics|anesthetics|mesh-list
83259165|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259166|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259167|NCT05503147|Nabiximols|nabiximols|mesh-list
83259168|NCT05503147|Analgesics|analgesics|mesh-ancestor
83259169|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
83259170|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259171|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259172|NCT04619095|Psyllium|psyllium|mesh-list
83259173|NCT04619095|Cathartics|cathartics|mesh-ancestor
83259174|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259175|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83259176|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83259177|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259178|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
83259179|NCT05502991|Bevacizumab|bevacizumab|mesh-list
83259180|NCT05502991|Tislelizumab|tislelizumab|mesh-list
83259181|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259182|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259183|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83259184|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83259185|NCT05502991|Growth Substances|growth substances|mesh-ancestor
83259186|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259187|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
83259188|NCT02563561|Apaziquone|apaziquone|mesh-list
83259189|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259190|NCT05498233|Pyridoxine|pyridoxine|mesh-list
83259191|NCT05498233|Doxylamine|doxylamine|mesh-list
83259192|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
83259193|NCT05498233|Vitamins|vitamins|mesh-ancestor
83259194|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
83259195|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259196|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
83259197|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
83259198|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259199|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259200|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83259201|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
83259202|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
83259203|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259204|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259205|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83259206|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259207|NCT05497843|Chiauranib|chiauranib|mesh-list
83259208|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259209|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83259210|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259211|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259212|NCT05497765|Silybin|silybin|mesh-list
83259213|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83259214|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259215|NCT05497765|Protective Agents|protective agents|mesh-ancestor
83259216|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259217|NCT04424875|Melatonin|melatonin|mesh-list
83259218|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
83259219|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259220|NCT04424875|Protective Agents|protective agents|mesh-ancestor
83259221|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259222|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259223|NCT04277845|Dexamethasone|dexamethasone|mesh-list
83259224|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
83259225|NCT04277845|Lenalidomide|lenalidomide|mesh-list
83259226|NCT04277845|Bortezomib|bortezomib|mesh-list
83259227|NCT04277845|BB 1101|bb 1101|mesh-list
83259228|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259229|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
83259230|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
83259231|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259232|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259233|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259234|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
83259235|NCT04277845|Hormones|hormones|mesh-ancestor
83259236|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259237|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83259238|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259239|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
83259240|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259241|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259242|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
83259243|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83259244|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83259245|NCT04277845|Growth Substances|growth substances|mesh-ancestor
83259246|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
83259247|NCT02559505|Vaccines|vaccines|mesh-list
83259248|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
83259249|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259250|NCT04471597|Bupivacaine|bupivacaine|mesh-list
83259251|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
83259252|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
83259253|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259254|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259255|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
83259256|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259257|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
83259258|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
83259259|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
83259260|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83259261|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83259262|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259263|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83259264|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259265|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259266|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83259267|NCT05560945|Listerine|listerine|mesh-list
83259268|NCT05560945|Fluorides|fluorides|mesh-list
83259269|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
83259270|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
83259271|NCT05560945|Protective Agents|protective agents|mesh-ancestor
83259272|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259273|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83259274|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259275|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
83259276|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83259277|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83259278|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259279|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
83259280|NCT04424563|Coagulants|coagulants|mesh-ancestor
83259281|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
83259282|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
83259283|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259284|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
83259285|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259286|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259287|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83259288|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
83259289|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259290|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259291|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83259292|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83259293|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83259294|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
83259295|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83259296|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259297|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259298|NCT03542461|Nivolumab|nivolumab|mesh-list
83259299|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259300|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259301|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83259302|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259303|NCT02556307|Ribavirin|ribavirin|mesh-list
83259304|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83259305|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
83259306|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259307|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
83259308|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259309|NCT04352101|Bupropion|bupropion|mesh-list
83259310|NCT04352101|Escitalopram|escitalopram|mesh-list
83259311|NCT04352101|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83259312|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83259313|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259314|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259315|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259316|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
83259317|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259318|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83259319|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
83259320|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83259321|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83259322|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
83259323|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83259324|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83259325|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259326|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
83259327|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83259328|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259329|NCT05494645|Bupivacaine|bupivacaine|mesh-list
83259330|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
83259331|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
83259332|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259333|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259334|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
83259335|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259337|NCT05494567|Tamsulosin|tamsulosin|mesh-list
83259338|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
83259339|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
83259340|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83259341|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83259342|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259343|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259344|NCT05494567|Urological Agents|urological agents|mesh-ancestor
83259345|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83259346|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83259347|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83259348|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83259349|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259350|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259351|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83259352|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83259353|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
83259354|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
83259355|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
83259356|NCT04339777|Busulfan|busulfan|mesh-list
83259357|NCT04339777|Fludarabine|fludarabine|mesh-list
83259358|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
83259359|NCT04339777|Tacrolimus|tacrolimus|mesh-list
83259360|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259361|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
83259362|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259363|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259364|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83259365|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
83259366|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259367|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259368|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83259369|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83259370|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259371|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83259372|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83259373|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
83259374|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83259375|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259376|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259377|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
83259378|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
83259379|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259380|NCT05494411|Mitomycins|mitomycins|mesh-list
83259381|NCT05494411|Mitomycin|mitomycin|mesh-list
83259382|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83259383|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259384|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
83259385|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259386|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83259387|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259388|NCT04085887|Panitumumab|panitumumab|mesh-list
83259389|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259390|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259391|NCT04080895|Lumefantrine|lumefantrine|mesh-list
83259392|NCT04080895|Artemether|artemether|mesh-list
83259393|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83259394|NCT04080895|Amodiaquine|amodiaquine|mesh-list
83259395|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
83259396|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83259397|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83259398|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259399|NCT04251169|Paclitaxel|paclitaxel|mesh-list
83259400|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
83259401|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83259402|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259403|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
83259404|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
83259405|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
83259406|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259407|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259408|NCT04251169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83259409|NCT04279561|Edetic Acid|edetic acid|mesh-list
83259410|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83259411|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
83259412|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
83259413|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259414|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
83259415|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83259416|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83259417|NCT01662895|Deferoxamine|deferoxamine|mesh-list
83259418|NCT01662895|Siderophores|siderophores|mesh-ancestor
83259419|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83259420|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
83259421|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
83259422|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259423|NCT05493709|Leuprolide|leuprolide|mesh-list
83259424|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83259425|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
83259426|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83259427|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259428|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83259429|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259430|NCT05498857|Ephedrine|ephedrine|mesh-list
83259431|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83259432|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259433|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
83259434|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
83259435|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259436|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83259437|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
83259438|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259439|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259440|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83259441|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259442|NCT04139395|Citric Acid|citric acid|mesh-list
83259443|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
83259444|NCT04139395|Gallium citrate|gallium citrate|mesh-list
83259445|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
83259446|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83259447|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
83259448|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
83259449|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259450|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83259451|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83259452|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
83259453|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259454|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
83259455|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259456|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
83259457|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83259458|NCT02555683|Growth Substances|growth substances|mesh-ancestor
83259459|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259460|NCT02554981|Cyclosporine|cyclosporine|mesh-list
83259461|NCT02554981|Cyclosporins|cyclosporins|mesh-list
83259462|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259463|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259464|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259465|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
83259466|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259467|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
83259468|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259469|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
83259470|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259471|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83259472|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
83259473|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83259474|NCT02556775|Antibodies|antibodies|mesh-list
83259475|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
83259476|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83259477|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
83259478|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259479|NCT04080739|Ropivacaine|ropivacaine|mesh-list
83259480|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
83259481|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
83259482|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259483|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259484|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
83259485|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259486|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
83259487|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83259488|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83259489|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83259490|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259491|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259492|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
83259493|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259494|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259495|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83259496|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259497|NCT03879109|Folfirinox|folfirinox|mesh-list
83259498|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259499|NCT05488327|Lenalidomide|lenalidomide|mesh-list
83259500|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
83259501|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259502|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83259503|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83259504|NCT05488327|Growth Substances|growth substances|mesh-ancestor
83259505|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
83259506|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259507|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83259508|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
83259509|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259510|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83259511|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
83259512|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259513|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259514|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83259515|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83259516|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259517|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
83259518|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
83259519|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83259520|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83259521|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259522|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
83259523|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
83259524|NCT05484817|Hormones|hormones|mesh-list
83259525|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259526|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259527|NCT05484583|Carboplatin|carboplatin|mesh-list
83259528|NCT05484583|Etoposide|etoposide|mesh-list
83259529|NCT05484583|Durvalumab|durvalumab|mesh-list
83259530|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83259531|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259532|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83259533|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83259534|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83259535|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259536|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259537|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259538|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
83259539|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259540|NCT05479747|Analgesics|analgesics|mesh-list
83259541|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
83259542|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259543|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259544|NCT05487469|Thymalfasin|thymalfasin|mesh-list
83259545|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83259546|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
83259547|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259548|NCT05479357|Oxytocin|oxytocin|mesh-list
83259549|NCT05479357|Carbetocin|carbetocin|mesh-list
83259550|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
83259551|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83259552|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259553|NCT05487391|Paclitaxel|paclitaxel|mesh-list
83259554|NCT05487391|Vinorelbine|vinorelbine|mesh-list
83259555|NCT05487391|Carboplatin|carboplatin|mesh-list
83259556|NCT05487391|Pemetrexed|pemetrexed|mesh-list
83259557|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83259558|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259559|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
83259560|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
83259561|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
83259562|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259563|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259564|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83259565|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83259566|NCT05484193|Progesterone|progesterone|mesh-list
83259567|NCT05484193|Progestins|progestins|mesh-ancestor
83259568|NCT05484193|Hormones|hormones|mesh-ancestor
83259569|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259570|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259571|NCT03796195|Bupivacaine|bupivacaine|mesh-list
83259572|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
83259573|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
83259574|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259575|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259576|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
83259577|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259578|NCT04274179|Lamotrigine|lamotrigine|mesh-list
83259579|NCT04274179|Valproic Acid|valproic acid|mesh-list
83259580|NCT04274179|Ethosuximide|ethosuximide|mesh-list
83259581|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
83259582|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83259583|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259584|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259585|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83259586|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259587|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83259588|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83259589|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259590|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83259591|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83259592|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259593|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
83259594|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259595|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
83259596|NCT05479123|Timolol|timolol|mesh-list
83259597|NCT05479123|Propranolol|propranolol|mesh-list
83259598|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83259599|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83259600|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
83259601|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259602|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259603|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259604|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83259605|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83259606|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
83259607|NCT04268407|Amoxicillin|amoxicillin|mesh-list
83259608|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
83259609|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
83259610|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83259611|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83259612|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259613|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83259614|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259615|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259616|NCT05487001|Dexamethasone|dexamethasone|mesh-list
83259617|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259618|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
83259619|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
83259620|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259621|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259622|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259623|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
83259624|NCT05487001|Hormones|hormones|mesh-ancestor
83259625|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259626|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83259627|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259628|NCT05483647|Anesthetics|anesthetics|mesh-list
83259629|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259630|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259631|NCT05475379|Vaccines|vaccines|mesh-list
83259632|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
83259633|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259634|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
83259635|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
83259636|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259637|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
83259638|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259639|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259640|NCT03684811|Gemcitabine|gemcitabine|mesh-list
83259641|NCT03684811|Nivolumab|nivolumab|mesh-list
83259642|NCT03684811|Azacitidine|azacitidine|mesh-list
83259643|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259644|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83259645|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
83259646|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259647|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259648|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83259649|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259650|NCT04542733|Everolimus|everolimus|mesh-list
83259651|NCT04542733|Tacrolimus|tacrolimus|mesh-list
83259652|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259653|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
83259654|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259655|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83259656|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259657|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259658|NCT04542733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83259659|NCT04542733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83259660|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259661|NCT04424017|Antibodies|antibodies|mesh-list
83259662|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
83259663|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259664|NCT05477797|Lenalidomide|lenalidomide|mesh-list
83259665|NCT05477797|Ixazomib|ixazomib|mesh-list
83259666|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
83259667|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259668|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83259669|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83259670|NCT05477797|Growth Substances|growth substances|mesh-ancestor
83259671|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
83259672|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259673|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
83259674|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259675|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259676|NCT03386929|Palbociclib|palbociclib|mesh-list
83259677|NCT03386929|Avelumab|avelumab|mesh-list
83259678|NCT03386929|Axitinib|axitinib|mesh-list
83259679|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259680|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83259681|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259682|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259683|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259684|NCT05472337|Colchicine|colchicine|mesh-list
83259685|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
83259686|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259687|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
83259688|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
83259689|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
83259690|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259691|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259692|NCT05472259|Leucovorin|leucovorin|mesh-list
83259693|NCT05472259|Fluorouracil|fluorouracil|mesh-list
83259694|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
83259695|NCT05472259|Irinotecan|irinotecan|mesh-list
83259696|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
83259697|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259698|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83259699|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259700|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259701|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
83259702|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259703|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83259704|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83259705|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259706|NCT05472259|Antidotes|antidotes|mesh-ancestor
83259707|NCT05472259|Protective Agents|protective agents|mesh-ancestor
83259708|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
83259709|NCT05472259|Vitamins|vitamins|mesh-ancestor
83259710|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
83259711|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
83259712|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83259713|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259714|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259715|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83259716|NCT04266145|Analgesics|analgesics|mesh-ancestor
83259717|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
83259718|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259719|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83259720|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83259721|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83259722|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83259723|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259724|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259725|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83259726|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
83259727|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259728|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83259729|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259730|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83259731|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259732|NCT02554279|Menotropins|menotropins|mesh-list
83259733|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83259734|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
83259735|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83259736|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259737|NCT02554903|Macitentan|macitentan|mesh-list
83259738|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83259739|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83259740|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259741|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83259742|NCT02332707|Ribavirin|ribavirin|mesh-list
83259743|NCT02332707|Grazoprevir|grazoprevir|mesh-list
83259744|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
83259745|NCT02332707|Ruzasvir|ruzasvir|mesh-list
83259746|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
83259747|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259748|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
83259749|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259750|NCT02370615|Itraconazole|itraconazole|mesh-list
83259752|NCT02370615|Midazolam|midazolam|mesh-list
83259753|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
83259754|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83259755|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83259756|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259757|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259758|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83259759|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83259760|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83259761|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83259762|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
83259763|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
83259764|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
83259765|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
83259766|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259767|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259768|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
83259769|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259770|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83259771|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83259772|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259773|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83259774|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
83259775|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259776|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83259777|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83259778|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83259779|NCT02370615|Protective Agents|protective agents|mesh-ancestor
83259780|NCT02307513|Apremilast|apremilast|mesh-list
83259781|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83259782|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83259783|NCT02307513|Analgesics|analgesics|mesh-ancestor
83259784|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
83259785|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259786|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259787|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259788|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259789|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83259790|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83259791|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259792|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259793|NCT02328105|Paclitaxel|paclitaxel|mesh-list
83259794|NCT02328105|Carboplatin|carboplatin|mesh-list
83259795|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83259796|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83259797|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259798|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
83259799|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
83259800|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
83259801|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259802|NCT02305797|Lorazepam|lorazepam|mesh-list
83259803|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
83259804|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
83259805|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
83259806|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259807|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259808|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259809|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83259810|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259811|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83259812|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83259814|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
83259815|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
83259816|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259817|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259819|NCT01646073|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83259820|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259821|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83259822|NCT02551159|Carboplatin|carboplatin|mesh-list
83259823|NCT02551159|Fluorouracil|fluorouracil|mesh-list
83259824|NCT02551159|Cetuximab|cetuximab|mesh-list
83259825|NCT02551159|Durvalumab|durvalumab|mesh-list
83259826|NCT02551159|Tremelimumab|tremelimumab|mesh-list
83259827|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83259828|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259829|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
83259830|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259831|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83259832|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259833|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
83259834|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259835|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259836|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
83259837|NCT04539379|Analgesics|analgesics|mesh-ancestor
83259838|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
83259839|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259840|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259841|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
83259842|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259843|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83259844|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
83259845|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83259846|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83259847|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259848|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83259849|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
83259850|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83259851|NCT05470075|Tramadol|tramadol|mesh-list
83259852|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83259853|NCT05470075|Narcotics|narcotics|mesh-ancestor
83259854|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83259855|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259856|NCT05470075|Analgesics|analgesics|mesh-ancestor
83259857|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
83259858|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259859|NCT05481619|Vedolizumab|vedolizumab|mesh-list
83259860|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259861|NCT02305563|Cytarabine|cytarabine|mesh-list
83259862|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83259863|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
83259864|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259865|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259866|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
83259867|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259868|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259869|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
83259870|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259871|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
83259872|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
83259873|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83259874|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83259875|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259876|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259878|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
83259879|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259880|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259881|NCT02553499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83259882|NCT02553499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259883|NCT02553265|Carbidopa|carbidopa|mesh-list
83259884|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83259885|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83259886|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
83259887|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259888|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259889|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259890|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83259891|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259892|NCT03215095|Durvalumab|durvalumab|mesh-list
83259893|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259894|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259895|NCT01663103|Rilonacept|rilonacept|mesh-list
83259896|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259897|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
83259898|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83259899|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
83259900|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259901|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259902|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83259903|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
83259904|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
83259905|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83259906|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
83259907|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83259908|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259909|NCT05284643|Bevacizumab|bevacizumab|mesh-list
83259910|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259911|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259912|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83259913|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83259914|NCT05284643|Growth Substances|growth substances|mesh-ancestor
83259915|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259916|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
83259917|NCT04577963|Tislelizumab|tislelizumab|mesh-list
83259918|NCT04577963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259919|NCT04577963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259920|NCT05092373|Paclitaxel|paclitaxel|mesh-list
83259921|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83259922|NCT05092373|Atezolizumab|atezolizumab|mesh-list
83259923|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83259924|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83259925|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259926|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
83259927|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
83259928|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
83259929|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259930|NCT05092373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83259931|NCT05092373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259932|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
83259933|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259934|NCT04532645|Olaparib|olaparib|mesh-list
83259935|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83259936|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259937|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259938|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259939|NCT02560025|Cytarabine|cytarabine|mesh-list
83259940|NCT02560025|Daunorubicin|daunorubicin|mesh-list
83259941|NCT02560025|Idarubicin|idarubicin|mesh-list
83259942|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83259943|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
83259944|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259945|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259946|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
83259947|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259948|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83259949|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
83259950|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259951|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83259952|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83259953|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83259954|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259955|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83259956|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83259957|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259958|NCT04524455|Dexamethasone|dexamethasone|mesh-list
83259959|NCT04524455|Blinatumomab|blinatumomab|mesh-list
83259960|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83259961|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
83259962|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
83259963|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83259964|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259965|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83259966|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
83259967|NCT04524455|Hormones|hormones|mesh-ancestor
83259968|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83259969|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83259970|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259971|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
83259972|NCT04411901|Vitamin D|vitamin d|mesh-list
83259973|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83259974|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83259975|NCT04411901|Vitamins|vitamins|mesh-ancestor
83259976|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
83259977|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83259978|NCT05508737|Trifluridine|trifluridine|mesh-list
83259979|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
83259980|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83259981|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83259982|NCT05508737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83259983|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259984|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
83259985|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
83259986|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83259987|NCT05508035|Valsartan|valsartan|mesh-list
83259988|NCT05508035|Ramipril|ramipril|mesh-list
83259989|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83259990|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83259991|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83259992|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83259993|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83259994|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83259995|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
83259996|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83259997|NCT02566889|Infliximab|infliximab|mesh-list
83259998|NCT02566889|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83259999|NCT02566889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260000|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
83260001|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260002|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260003|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
83260004|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83260005|NCT05507957|Ethanol|ethanol|mesh-list
83260006|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
83260007|NCT05507957|Disinfectants|disinfectants|mesh-list
83260008|NCT05507957|Povidone|povidone|mesh-list
83260009|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83260010|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260011|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
83260012|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260013|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260015|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
83260016|NCT04282109|Paclitaxel|paclitaxel|mesh-list
83260017|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83260018|NCT04282109|Nivolumab|nivolumab|mesh-list
83260019|NCT04282109|Cetuximab|cetuximab|mesh-list
83260020|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83260021|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260022|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
83260023|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
83260024|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
83260025|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260026|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260027|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83260028|NCT03150173|Buprenorphine|buprenorphine|mesh-list
83260029|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83260030|NCT03150173|Narcotics|narcotics|mesh-ancestor
83260031|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260032|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260033|NCT03150173|Analgesics|analgesics|mesh-ancestor
83260034|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
83260035|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260036|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83260037|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83260038|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
83260039|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83260041|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
83260042|NCT05563571|Lidocaine|lidocaine|mesh-list
83260043|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83260044|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
83260045|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
83260046|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
83260047|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260048|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260049|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
83260050|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260051|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83260052|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83260053|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83260054|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83260055|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260056|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260057|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
83260058|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
83260059|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260060|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
83260061|NCT05563571|Hormones|hormones|mesh-ancestor
83260062|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260063|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83260064|NCT05563571|Protective Agents|protective agents|mesh-ancestor
83260065|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260066|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260067|NCT02717507|Carvedilol|carvedilol|mesh-list
83260068|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83260069|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83260070|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
83260071|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260072|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260073|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260074|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83260075|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
83260076|NCT02717507|Protective Agents|protective agents|mesh-ancestor
83260077|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83260078|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83260079|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83260080|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
83260081|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83260082|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83260083|NCT02489903|Paclitaxel|paclitaxel|mesh-list
83260084|NCT02489903|Etoposide|etoposide|mesh-list
83260085|NCT02489903|Vinorelbine|vinorelbine|mesh-list
83260086|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83260087|NCT02489903|Carboplatin|carboplatin|mesh-list
83260088|NCT02489903|Gemcitabine|gemcitabine|mesh-list
83260089|NCT02489903|Irinotecan|irinotecan|mesh-list
83260090|NCT02489903|Pemetrexed|pemetrexed|mesh-list
83260091|NCT02489903|Taxane|taxane|mesh-list
83260092|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83260093|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260094|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
83260095|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
83260096|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
83260097|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260098|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83260099|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
83260100|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83260101|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83260102|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260103|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83260104|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83260105|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83260106|NCT01174199|Sirolimus|sirolimus|mesh-list
83260107|NCT01174199|Vorinostat|vorinostat|mesh-list
83260108|NCT01174199|Temsirolimus|temsirolimus|mesh-list
83260109|NCT01174199|MTOR Inhibitors|mtor inhibitors|mesh-list
83260110|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83260111|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260112|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83260113|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260114|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
83260115|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260116|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
83260117|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260118|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83260119|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260120|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260121|NCT01174199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83260122|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83260123|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83260124|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260126|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83260127|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260128|NCT05562869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260129|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260130|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260131|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
83260132|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260133|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260134|NCT04085237|Ropivacaine|ropivacaine|mesh-list
83260135|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
83260136|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
83260137|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260138|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260139|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
83260140|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260141|NCT04080869|Vitamin A|vitamin a|mesh-list
83260142|NCT04080869|Tretinoin|tretinoin|mesh-list
83260143|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
83260144|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260145|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
83260146|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
83260147|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
83260148|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260149|NCT04080869|Protective Agents|protective agents|mesh-ancestor
83260150|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260151|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83260152|NCT04080869|Vitamins|vitamins|mesh-ancestor
83260153|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
83260154|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83260155|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83260156|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
83260157|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
83260158|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260159|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260160|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83260161|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83260162|NCT00560495|Growth Substances|growth substances|mesh-ancestor
83260163|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260164|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
83260165|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260166|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83260167|NCT02559713|Vedolizumab|vedolizumab|mesh-list
83260168|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260169|NCT05499065|Cetuximab|cetuximab|mesh-list
83260170|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260171|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260172|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
83260173|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
83260174|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83260175|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260176|NCT04038437|Venetoclax|venetoclax|mesh-list
83260177|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260178|NCT05498675|Valsartan|valsartan|mesh-list
83260179|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83260180|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83260181|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83260182|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83260183|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260184|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83260185|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
83260186|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83260187|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83260188|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83260189|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
83260190|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83260191|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260192|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83260193|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83260194|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83260195|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260196|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260197|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83260198|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
83260199|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83260200|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83260201|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83260202|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260203|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260204|NCT05485883|Lenvatinib|lenvatinib|mesh-list
83260205|NCT05485883|Tislelizumab|tislelizumab|mesh-list
83260206|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260207|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83260208|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260209|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260210|NCT05485883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260211|NCT04273607|Heparin|heparin|mesh-list
83260212|NCT04273607|Calcium heparin|calcium heparin|mesh-list
83260213|NCT04273607|Enoxaparin|enoxaparin|mesh-list
83260214|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
83260215|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83260216|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83260217|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260218|NCT05476081|Aspirin|aspirin|mesh-list
83260219|NCT05476081|Clopidogrel|clopidogrel|mesh-list
83260220|NCT05476081|Ticagrelor|ticagrelor|mesh-list
83260221|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260222|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260223|NCT05476081|Analgesics|analgesics|mesh-ancestor
83260224|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
83260225|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260226|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260227|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260228|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260229|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83260230|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83260231|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260232|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83260233|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260234|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260235|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
83260236|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83260237|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83260238|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83260239|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
83260240|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260241|NCT05476003|Midazolam|midazolam|mesh-list
83260242|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83260243|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83260244|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260245|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260246|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83260247|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83260248|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83260249|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83260250|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
83260251|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
83260252|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
83260253|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
83260254|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260255|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260256|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83260257|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
83260258|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260259|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
83260260|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
83260261|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83260262|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
83260263|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260264|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260265|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260266|NCT02535715|Insulin|insulin|mesh-list
83260267|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83260268|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83260269|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260270|NCT02336815|Dexamethasone|dexamethasone|mesh-list
83260271|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260272|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
83260273|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
83260274|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260275|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260276|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260277|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
83260278|NCT02336815|Hormones|hormones|mesh-ancestor
83260279|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260280|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260281|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260282|NCT05434039|Diclofenac|diclofenac|mesh-list
83260283|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260284|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260285|NCT05434039|Analgesics|analgesics|mesh-ancestor
83260286|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
83260287|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260288|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260289|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260290|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260291|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260292|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260293|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260294|NCT05466175|Prednisone|prednisone|mesh-list
83260295|NCT05466175|Vincristine|vincristine|mesh-list
83260296|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260297|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
83260298|NCT05466175|Hormones|hormones|mesh-ancestor
83260299|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260300|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260301|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260302|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260303|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83260304|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
83260305|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
83260306|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
83260307|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260308|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83260309|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83260310|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83260311|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
83260312|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260313|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83260314|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83260315|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260316|NCT02545933|Aspirin|aspirin|mesh-list
83260317|NCT02545933|Ticagrelor|ticagrelor|mesh-list
83260318|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83260319|NCT02545933|Vorapaxar|vorapaxar|mesh-list
83260320|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260321|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260322|NCT02545933|Analgesics|analgesics|mesh-ancestor
83260323|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
83260324|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260325|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260326|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260327|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260328|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83260329|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83260330|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260331|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83260332|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260333|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260334|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
83260335|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83260336|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83260337|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83260338|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
83260339|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260341|NCT02545075|Dacarbazine|dacarbazine|mesh-list
83260342|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260343|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260344|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83260345|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260346|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83260347|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
83260348|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
83260349|NCT03007537|Hematinics|hematinics|mesh-ancestor
83260350|NCT03004183|Valacyclovir|valacyclovir|mesh-list
83260351|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
83260352|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260353|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260354|NCT03004183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83260355|NCT03004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260356|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
83260357|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260358|NCT02544763|Cannabidiol|cannabidiol|mesh-list
83260359|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
83260360|NCT02556203|Aspirin|aspirin|mesh-list
83260361|NCT02556203|Vitamin K|vitamin k|mesh-list
83260362|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
83260363|NCT02556203|Clopidogrel|clopidogrel|mesh-list
83260364|NCT02556203|Vitamins|vitamins|mesh-ancestor
83260365|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
83260366|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260367|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83260368|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83260369|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83260370|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83260371|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
83260372|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260373|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260374|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83260375|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
83260376|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83260377|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
83260378|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260379|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
83260380|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260381|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260382|NCT02556203|Analgesics|analgesics|mesh-ancestor
83260383|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
83260384|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260385|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260386|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260387|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83260388|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83260389|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260390|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
83260391|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83260392|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
83260393|NCT02556203|Coagulants|coagulants|mesh-ancestor
83260394|NCT05485571|Methotrexate|methotrexate|mesh-list
83260395|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83260396|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
83260397|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83260398|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260399|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83260401|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260402|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260403|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
83260404|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260405|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83260406|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260407|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
83260408|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260409|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83260410|NCT05496725|Micafungin|micafungin|mesh-list
83260411|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
83260412|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260413|NCT05490719|Cisplatin|cisplatin|mesh-list
83260414|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260415|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
83260416|NCT04424459|Narcotics|narcotics|mesh-ancestor
83260417|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260418|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260419|NCT04424459|Analgesics|analgesics|mesh-ancestor
83260420|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
83260421|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260422|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
83260423|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
83260424|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260425|NCT05485259|Protective Agents|protective agents|mesh-ancestor
83260426|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260427|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
83260428|NCT05485259|Vitamins|vitamins|mesh-ancestor
83260429|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
83260430|NCT05490485|Cisplatin|cisplatin|mesh-list
83260431|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260432|NCT05485103|Glycerol|glycerol|mesh-list
83260433|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83260434|NCT05485103|Protective Agents|protective agents|mesh-ancestor
83260435|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260436|NCT05490407|Carboplatin|carboplatin|mesh-list
83260437|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260438|NCT05490095|Everolimus|everolimus|mesh-list
83260439|NCT05490095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83260440|NCT05490095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83260441|NCT05490095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260442|NCT05490095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260443|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260444|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
83260445|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260446|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260447|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
83260448|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83260449|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
83260450|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83260451|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
83260452|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260453|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260454|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
83260455|NCT05496179|Metoclopramide|metoclopramide|mesh-list
83260456|NCT05496179|Prucalopride|prucalopride|mesh-list
83260457|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
83260458|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
83260459|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260460|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260461|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260462|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83260463|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83260464|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
83260465|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260466|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260467|NCT05496179|Laxatives|laxatives|mesh-ancestor
83260468|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83260469|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83260470|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
83260471|NCT05489939|Salicylates|salicylates|mesh-list
83260472|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
83260473|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260474|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260475|NCT05489939|Analgesics|analgesics|mesh-ancestor
83260476|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
83260477|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260478|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260479|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260480|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260481|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260482|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260483|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260484|NCT05495945|Propofol|propofol|mesh-list
83260485|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83260486|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260487|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260488|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83260489|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
83260490|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
83260491|NCT03999749|Nivolumab|nivolumab|mesh-list
83260492|NCT03999749|Ipilimumab|ipilimumab|mesh-list
83260493|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260494|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260495|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83260496|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260497|NCT05483543|Pamiparib|pamiparib|mesh-list
83260498|NCT05483543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83260499|NCT05483543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260500|NCT05483543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260501|NCT05483543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260502|NCT04139213|Naltrexone|naltrexone|mesh-list
83260503|NCT04139213|Buprenorphine|buprenorphine|mesh-list
83260504|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83260505|NCT04139213|Naloxone|naloxone|mesh-list
83260506|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83260507|NCT04139213|Narcotics|narcotics|mesh-ancestor
83260508|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260509|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260510|NCT04139213|Analgesics|analgesics|mesh-ancestor
83260511|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
83260512|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260513|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83260514|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83260515|NCT05494775|Mitogens|mitogens|mesh-list
83260516|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
83260517|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
83260518|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260519|NCT05494775|Growth Substances|growth substances|mesh-ancestor
83260520|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260521|NCT05488925|Vitamin E|vitamin e|mesh-list
83260522|NCT05488925|Diclofenac|diclofenac|mesh-list
83260523|NCT05488925|Piroxicam|piroxicam|mesh-list
83260524|NCT05488925|Tramadol|tramadol|mesh-list
83260525|NCT05488925|Vitamins|vitamins|mesh-ancestor
83260526|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
83260527|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260528|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260529|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260531|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
83260532|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260533|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260534|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260535|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260536|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260537|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260538|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83260539|NCT05488925|Narcotics|narcotics|mesh-ancestor
83260540|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260541|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
83260542|NCT05488925|Protective Agents|protective agents|mesh-ancestor
83260543|NCT05494385|Gabapentin|gabapentin|mesh-list
83260544|NCT05494385|Analgesics|analgesics|mesh-ancestor
83260545|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
83260546|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260547|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260548|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
83260549|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83260550|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83260551|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260552|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83260553|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83260554|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83260555|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260556|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260557|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
83260558|NCT05482763|Itraconazole|itraconazole|mesh-list
83260559|NCT05482763|Terbinafine|terbinafine|mesh-list
83260560|NCT05482763|Ciclopirox|ciclopirox|mesh-list
83260561|NCT05482763|Amorolfine|amorolfine|mesh-list
83260562|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
83260563|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260564|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83260565|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83260566|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260567|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260568|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83260569|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
83260570|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260571|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260572|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83260573|NCT05482373|Oleuropein|oleuropein|mesh-list
83260574|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260575|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83260576|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
83260577|NCT05482295|Vaccines|vaccines|mesh-list
83260578|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
83260579|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260580|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
83260581|NCT04245839|Fludarabine|fludarabine|mesh-list
83260582|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260583|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
83260584|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260585|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260586|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83260587|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
83260588|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260589|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260590|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83260591|NCT05494307|Terbutaline|terbutaline|mesh-list
83260592|NCT05494307|Danazol|danazol|mesh-list
83260593|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83260594|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
83260595|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260596|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260597|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83260598|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
83260599|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
83260600|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
83260601|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83260602|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83260603|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83260604|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83260605|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
83260606|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260607|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260608|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83260609|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
83260610|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260612|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
83260613|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83260614|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260615|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83260616|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260617|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260618|NCT05481437|Immunotoxins|immunotoxins|mesh-ancestor
83260619|NCT05481437|Immunoconjugates|immunoconjugates|mesh-ancestor
83260620|NCT05481437|Immunologic Factors|immunologic factors|mesh-ancestor
83260621|NCT05481437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260622|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
83260623|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83260624|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83260625|NCT05487521|Prednisolone|prednisolone|mesh-list
83260626|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
83260627|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83260628|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
83260629|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260630|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
83260631|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
83260632|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260633|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260634|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260635|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
83260636|NCT05487521|Hormones|hormones|mesh-ancestor
83260637|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260638|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83260639|NCT05487521|Protective Agents|protective agents|mesh-ancestor
83260640|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260641|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260642|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
83260643|NCT05481281|Ketamine|ketamine|mesh-list
83260644|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83260645|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260646|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260647|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260648|NCT05481281|Analgesics|analgesics|mesh-ancestor
83260649|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
83260650|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260651|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83260652|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83260653|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83260654|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
83260655|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260656|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260657|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83260658|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83260659|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
83260660|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
83260661|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83260662|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83260663|NCT05487443|Gemcitabine|gemcitabine|mesh-list
83260664|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83260665|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
83260666|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260667|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260669|NCT02558231|Tadalafil|tadalafil|mesh-list
83260670|NCT02558231|Macitentan|macitentan|mesh-list
83260671|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
83260672|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83260673|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83260674|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260675|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260676|NCT02558231|Urological Agents|urological agents|mesh-ancestor
83260677|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83260678|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83260679|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83260680|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83260681|NCT05493371|Empagliflozin|empagliflozin|mesh-list
83260682|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83260683|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260684|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83260685|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260686|NCT05486819|Propofol|propofol|mesh-list
83260687|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83260688|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260689|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260690|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83260691|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
83260692|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
83260693|NCT03860987|Prednisone|prednisone|mesh-list
83260694|NCT03860987|Goserelin|goserelin|mesh-list
83260695|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260696|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
83260697|NCT03860987|Hormones|hormones|mesh-ancestor
83260698|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260699|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260700|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260701|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260702|NCT05480111|Anesthetics|anesthetics|mesh-list
83260703|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260704|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260705|NCT05475431|Bismuth|bismuth|mesh-list
83260706|NCT05475431|Antacids|antacids|mesh-ancestor
83260707|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260708|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260709|NCT05492669|Lidocaine|lidocaine|mesh-list
83260710|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
83260711|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
83260712|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260713|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260714|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
83260715|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260716|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83260717|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83260718|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83260719|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83260720|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260721|NCT05492591|Valacyclovir|valacyclovir|mesh-list
83260722|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
83260723|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260724|NCT02554721|Aspirin|aspirin|mesh-list
83260725|NCT02554721|Cilostazol|cilostazol|mesh-list
83260726|NCT02554721|Clopidogrel|clopidogrel|mesh-list
83260727|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83260728|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83260729|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83260730|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83260731|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
83260732|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260733|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260734|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260735|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260736|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260737|NCT02554721|Analgesics|analgesics|mesh-ancestor
83260738|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
83260739|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260740|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260741|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260742|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83260743|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83260744|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260745|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260746|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
83260747|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83260748|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
83260749|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83260750|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
83260751|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
83260752|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83260753|NCT02554721|Protective Agents|protective agents|mesh-ancestor
83260754|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83260755|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83260756|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
83260757|NCT03810911|Hematinics|hematinics|mesh-ancestor
83260758|NCT02552225|Amitriptyline|amitriptyline|mesh-list
83260759|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83260760|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
83260761|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83260762|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260763|NCT02552225|Analgesics|analgesics|mesh-ancestor
83260764|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
83260765|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260766|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260767|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83260768|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83260769|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83260770|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260771|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
83260772|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260773|NCT02552147|Nicotine|nicotine|mesh-list
83260774|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83260775|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
83260776|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260777|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260778|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83260779|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83260780|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
83260781|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260782|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260783|NCT05479487|Apatinib|apatinib|mesh-list
83260784|NCT05479487|Fluzoparib|fluzoparib|mesh-list
83260785|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260786|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83260787|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260788|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260789|NCT05479487|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83260790|NCT05479175|Ibuprofen|ibuprofen|mesh-list
83260791|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83260792|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83260793|NCT05479175|Analgesics|analgesics|mesh-ancestor
83260794|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
83260795|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260796|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260797|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260798|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260799|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83260800|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260801|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260802|NCT02534935|Vaccines|vaccines|mesh-list
83260803|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
83260804|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260805|NCT02544451|Ivacaftor|ivacaftor|mesh-list
83260806|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83260807|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83260808|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260809|NCT02551991|Leucovorin|leucovorin|mesh-list
83260810|NCT02551991|Fluorouracil|fluorouracil|mesh-list
83260811|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
83260812|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
83260813|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260814|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83260815|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260816|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260817|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
83260818|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260819|NCT02551991|Antidotes|antidotes|mesh-ancestor
83260820|NCT02551991|Protective Agents|protective agents|mesh-ancestor
83260821|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
83260822|NCT02551991|Vitamins|vitamins|mesh-ancestor
83260823|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
83260824|NCT05491811|Bevacizumab|bevacizumab|mesh-list
83260825|NCT05491811|Ensartinib|ensartinib|mesh-list
83260826|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83260827|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260828|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83260829|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83260830|NCT05491811|Growth Substances|growth substances|mesh-ancestor
83260831|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260832|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
83260833|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83260834|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260835|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260836|NCT05478785|Cisplatin|cisplatin|mesh-list
83260837|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260838|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
83260839|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
83260840|NCT02880293|Melphalan|melphalan|mesh-list
83260841|NCT02880293|Thiotepa|thiotepa|mesh-list
83260842|NCT02880293|Fludarabine|fludarabine|mesh-list
83260843|NCT02880293|Tacrolimus|tacrolimus|mesh-list
83260844|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260845|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
83260846|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260847|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260848|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83260849|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
83260850|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260851|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260852|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83260853|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83260854|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260855|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83260856|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83260857|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
83260858|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83260859|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260860|NCT02865551|Anesthetics|anesthetics|mesh-list
83260861|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83260862|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260863|NCT05478083|Leuprolide|leuprolide|mesh-list
83260864|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83260865|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
83260866|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83260867|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260868|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260869|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260870|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
83260871|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
83260872|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260873|NCT02544217|Protective Agents|protective agents|mesh-ancestor
83260874|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260875|NCT05427565|Caffeine|caffeine|mesh-list
83260876|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83260877|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260878|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83260879|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260880|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260881|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83260882|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83260883|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
83260884|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260885|NCT02533453|Exenatide|exenatide|mesh-list
83260886|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83260887|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260888|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83260889|NCT02533453|Incretins|incretins|mesh-ancestor
83260890|NCT02533453|Hormones|hormones|mesh-ancestor
83260891|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260892|NCT05424835|Capecitabine|capecitabine|mesh-list
83260893|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83260894|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
83260895|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260896|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260897|NCT02533375|Adalimumab|adalimumab|mesh-list
83260898|NCT02533375|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83260899|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260900|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83260901|NCT01553149|Lenalidomide|lenalidomide|mesh-list
83260902|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
83260903|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260904|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83260905|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83260906|NCT01553149|Growth Substances|growth substances|mesh-ancestor
83260907|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
83260908|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260910|NCT02551055|Docetaxel|docetaxel|mesh-list
83260911|NCT02551055|Serabelisib|serabelisib|mesh-list
83260912|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83260913|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260914|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
83260915|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
83260916|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83260917|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260918|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260919|NCT05470673|Metronidazole|metronidazole|mesh-list
83260920|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260921|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83260922|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83260923|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83260924|NCT05459285|Dulaglutide|dulaglutide|mesh-list
83260925|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83260926|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260927|NCT02542943|Fluorides|fluorides|mesh-list
83260928|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
83260929|NCT02542943|Protective Agents|protective agents|mesh-ancestor
83260930|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260931|NCT03284957|Everolimus|everolimus|mesh-list
83260932|NCT03284957|Palbociclib|palbociclib|mesh-list
83260933|NCT03284957|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83260934|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83260935|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260936|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260937|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83260938|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
83260939|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260940|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260941|NCT05469893|Dexamethasone|dexamethasone|mesh-list
83260942|NCT05469893|Lenalidomide|lenalidomide|mesh-list
83260943|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83260944|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
83260945|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
83260946|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260947|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260948|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260949|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
83260950|NCT05469893|Hormones|hormones|mesh-ancestor
83260951|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83260952|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83260953|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260954|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
83260955|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83260956|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83260957|NCT05469893|Growth Substances|growth substances|mesh-ancestor
83260958|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
83260959|NCT03629171|Cytarabine|cytarabine|mesh-list
83260960|NCT03629171|Daunorubicin|daunorubicin|mesh-list
83260961|NCT03629171|Venetoclax|venetoclax|mesh-list
83260962|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83260963|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
83260964|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260965|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260966|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
83260967|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83260969|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
83260970|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260971|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83260972|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83260973|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83260974|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260975|NCT02542631|Insulin|insulin|mesh-list
83260976|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83260977|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83260978|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260979|NCT02549573|Apomorphine|apomorphine|mesh-list
83260980|NCT02549573|Emetics|emetics|mesh-ancestor
83260981|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83260982|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
83260983|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83260984|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83260985|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
83260986|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
83260987|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83260988|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260989|NCT05477615|Carboplatin|carboplatin|mesh-list
83260990|NCT05477615|Pemetrexed|pemetrexed|mesh-list
83260991|NCT05477615|Lazertinib|lazertinib|mesh-list
83260992|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83260993|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83260994|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83260995|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83260996|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83260997|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83260998|NCT02710097|Ethanol|ethanol|mesh-list
83260999|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83261000|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261001|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261002|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261003|NCT05468957|Hemostatics|hemostatics|mesh-list
83261004|NCT05468957|Coagulants|coagulants|mesh-ancestor
83261005|NCT02529553|LY3076226|ly3076226|mesh-list
83261006|NCT02529553|Immunoconjugates|immunoconjugates|mesh-ancestor
83261007|NCT02529553|Immunologic Factors|immunologic factors|mesh-ancestor
83261008|NCT02529553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261009|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
83261010|NCT02547935|Saxagliptin|saxagliptin|mesh-list
83261011|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83261012|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261013|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83261014|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261015|NCT02547935|Incretins|incretins|mesh-ancestor
83261016|NCT02547935|Hormones|hormones|mesh-ancestor
83261017|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261018|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83261019|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83261020|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261021|NCT04258111|Antibodies|antibodies|mesh-list
83261022|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
83261023|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
83261024|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261025|NCT02327169|Paclitaxel|paclitaxel|mesh-list
83261026|NCT02327169|Irinotecan|irinotecan|mesh-list
83261027|NCT02327169|Cetuximab|cetuximab|mesh-list
83261028|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83261029|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261030|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
83261031|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
83261032|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
83261033|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261034|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83261035|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83261036|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261037|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261038|NCT02327013|Vortioxetine|vortioxetine|mesh-list
83261039|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
83261040|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83261041|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83261042|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83261043|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261044|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261045|NCT02327013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83261046|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83261047|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83261048|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261049|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261050|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
83261051|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83261052|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83261053|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83261054|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83261055|NCT02301975|Fluticasone|fluticasone|mesh-list
83261057|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83261058|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261059|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83261060|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
83261061|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261062|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261063|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83261064|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83261065|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
83261066|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83261067|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83261068|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83261069|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83261070|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83261071|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261072|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261073|NCT04882839|Psilocybin|psilocybin|mesh-list
83261074|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
83261075|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261076|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83261077|NCT02300259|Itraconazole|itraconazole|mesh-list
83261078|NCT02300259|Diltiazem|diltiazem|mesh-list
83261079|NCT02300259|Tadalafil|tadalafil|mesh-list
83261080|NCT02300259|Simvastatin|simvastatin|mesh-list
83261081|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83261082|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83261083|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
83261084|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261085|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83261086|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83261087|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261088|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
83261089|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261090|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83261091|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83261093|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
83261094|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261095|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261096|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83261097|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
83261098|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83261099|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83261100|NCT02300259|Urological Agents|urological agents|mesh-ancestor
83261101|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83261102|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83261103|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83261104|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83261105|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
83261106|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83261107|NCT02300103|Velpatasvir|velpatasvir|mesh-list
83261108|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
83261109|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261110|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
83261111|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83261112|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83261113|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261114|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
83261115|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
83261116|NCT02299635|Nirogacestat|nirogacestat|mesh-list
83261117|NCT02299635|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83261118|NCT02299635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261119|NCT02299635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261120|NCT02366091|Methotrexate|methotrexate|mesh-list
83261121|NCT02366091|Colchicine|colchicine|mesh-list
83261122|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83261123|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
83261124|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83261125|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261126|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261127|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
83261128|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261129|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261130|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
83261131|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261132|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83261133|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261134|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
83261135|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261136|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83261137|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
83261138|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
83261139|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
83261140|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
83261141|NCT05476679|Celecoxib|celecoxib|mesh-list
83261142|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261143|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261144|NCT05476679|Analgesics|analgesics|mesh-ancestor
83261145|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
83261146|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261147|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261148|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261149|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261150|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83261151|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83261152|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261153|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261154|NCT02546765|Acetaminophen|acetaminophen|mesh-list
83261155|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
83261156|NCT02546765|Propofol|propofol|mesh-list
83261157|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83261158|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261159|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261160|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261161|NCT02546765|Analgesics|analgesics|mesh-ancestor
83261162|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
83261163|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261164|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83261165|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83261166|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83261167|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83261168|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261169|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261170|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83261171|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
83261172|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
83261173|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
83261174|NCT02553629|Rocuronium|rocuronium|mesh-list
83261175|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83261176|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83261177|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83261178|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261179|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261180|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
83261181|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261182|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
83261183|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261184|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261185|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83261186|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
83261187|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261188|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261189|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83261190|NCT03029351|Exenatide|exenatide|mesh-list
83261191|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83261192|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261193|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83261194|NCT03029351|Incretins|incretins|mesh-ancestor
83261195|NCT03029351|Hormones|hormones|mesh-ancestor
83261196|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261197|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83261198|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
83261199|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261200|NCT02365233|Insulin|insulin|mesh-list
83261201|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83261202|NCT02365233|Pioglitazone|pioglitazone|mesh-list
83261203|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83261204|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
83261205|NCT02365233|Saxagliptin|saxagliptin|mesh-list
83261206|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83261207|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83261208|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261209|NCT02365233|Incretins|incretins|mesh-ancestor
83261210|NCT02365233|Hormones|hormones|mesh-ancestor
83261211|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261212|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
83261213|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261214|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261215|NCT02364999|Paclitaxel|paclitaxel|mesh-list
83261216|NCT02364999|Bevacizumab|bevacizumab|mesh-list
83261217|NCT02364999|Carboplatin|carboplatin|mesh-list
83261218|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83261219|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261220|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
83261221|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
83261222|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
83261223|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261224|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261225|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83261226|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83261227|NCT02364999|Growth Substances|growth substances|mesh-ancestor
83261228|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261229|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
83261230|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
83261231|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
83261232|NCT02363283|Immunotoxins|immunotoxins|mesh-list
83261233|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83261234|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
83261235|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261236|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261237|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261238|NCT02321319|Hydromorphone|hydromorphone|mesh-list
83261239|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83261240|NCT02321319|Narcotics|narcotics|mesh-ancestor
83261241|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261242|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261243|NCT02321319|Analgesics|analgesics|mesh-ancestor
83261244|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
83261245|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261247|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
83261248|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261249|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
83261250|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261251|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261252|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
83261253|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261254|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261255|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
83261256|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261257|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
83261258|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261259|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83261260|NCT02294019|Ibuprofen|ibuprofen|mesh-list
83261261|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261262|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261263|NCT02294019|Analgesics|analgesics|mesh-ancestor
83261264|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
83261265|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261266|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261267|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261268|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261269|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83261270|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261271|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261272|NCT02320149|Sarecycline|sarecycline|mesh-list
83261273|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83261274|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261275|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
83261276|NCT05450965|Onvansertib|onvansertib|mesh-list
83261277|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83261278|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261279|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261280|NCT05405725|Denosumab|denosumab|mesh-list
83261281|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83261282|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261283|NCT02293863|Oseltamivir|oseltamivir|mesh-list
83261284|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
83261285|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261286|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261287|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261288|NCT02293395|Aspirin|aspirin|mesh-list
83261289|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
83261290|NCT02293395|Clopidogrel|clopidogrel|mesh-list
83261291|NCT02293395|Ticagrelor|ticagrelor|mesh-list
83261292|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261293|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261294|NCT02293395|Analgesics|analgesics|mesh-ancestor
83261295|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
83261296|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261297|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261298|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261299|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261300|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83261301|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83261302|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261303|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83261304|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83261305|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261306|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
83261307|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83261308|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83261309|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83261310|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
83261311|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261313|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
83261314|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83261315|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
83261316|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
83261318|NCT05447065|Vitamins|vitamins|mesh-ancestor
83261319|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
83261320|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261321|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83261322|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
83261323|NCT01351909|Veliparib|veliparib|mesh-list
83261324|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261325|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
83261326|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261327|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261328|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83261329|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
83261330|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261331|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261332|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83261333|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83261334|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261335|NCT05401357|Bimatoprost|bimatoprost|mesh-list
83261336|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83261337|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83261338|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83261339|NCT05401279|Gemcitabine|gemcitabine|mesh-list
83261340|NCT05401279|Tislelizumab|tislelizumab|mesh-list
83261341|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261342|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261343|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
83261344|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261345|NCT05401279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261346|NCT05400577|Sotorasib|sotorasib|mesh-list
83261347|NCT05400577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83261348|NCT05400577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261349|NCT05400577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261350|NCT05400577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261351|NCT05451095|Ketamine|ketamine|mesh-list
83261352|NCT05451095|Analgesics|analgesics|mesh-ancestor
83261353|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
83261354|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261355|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261356|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83261357|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83261358|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
83261359|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
83261360|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261361|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83261362|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83261363|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261364|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261365|NCT02954081|Apremilast|apremilast|mesh-list
83261366|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261367|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261368|NCT02954081|Analgesics|analgesics|mesh-ancestor
83261369|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
83261370|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261371|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261372|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261373|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261374|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83261375|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83261376|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261377|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261378|NCT02532283|Oseltamivir|oseltamivir|mesh-list
83261379|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
83261380|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261381|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261382|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261383|NCT01349959|Azacitidine|azacitidine|mesh-list
83261384|NCT01349959|Entinostat|entinostat|mesh-list
83261385|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83261386|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261387|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
83261388|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261389|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261390|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261391|NCT01349881|Eflornithine|eflornithine|mesh-list
83261392|NCT01349881|Sulindac|sulindac|mesh-list
83261393|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261394|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83261395|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83261396|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83261397|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261398|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83261399|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261400|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261401|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261402|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261403|NCT01349881|Analgesics|analgesics|mesh-ancestor
83261404|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
83261405|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261406|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261407|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261408|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261409|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83261410|NCT05417971|Fludarabine|fludarabine|mesh-list
83261411|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261412|NCT05398705|Cepharanthine|cepharanthine|mesh-list
83261413|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261414|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261415|NCT05398705|Analgesics|analgesics|mesh-ancestor
83261416|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
83261417|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261418|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261419|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261420|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261421|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83261422|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261423|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83261424|NCT05398705|Protective Agents|protective agents|mesh-ancestor
83261425|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
83261426|NCT04468061|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83261427|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261428|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261429|NCT04468061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83261430|NCT04468061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261431|NCT04468061|Immunoconjugates|immunoconjugates|mesh-ancestor
83261432|NCT04468061|Immunologic Factors|immunologic factors|mesh-ancestor
83261433|NCT04468061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261434|NCT05416021|Dapivirine|dapivirine|mesh-list
83261435|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83261436|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83261437|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
83261438|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261439|NCT05415865|Lidocaine|lidocaine|mesh-list
83261440|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
83261441|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
83261442|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261443|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261444|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
83261445|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261446|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83261447|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83261448|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83261449|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83261450|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261451|NCT05415709|Paclitaxel|paclitaxel|mesh-list
83261452|NCT05415709|Cisplatin|cisplatin|mesh-list
83261453|NCT05415709|Carboplatin|carboplatin|mesh-list
83261454|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83261455|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83261456|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261457|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
83261458|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
83261459|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
83261460|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261461|NCT04262843|Vidarabine|vidarabine|mesh-list
83261462|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
83261463|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
83261464|NCT04262843|Fludarabine|fludarabine|mesh-list
83261465|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
83261466|NCT04262843|Tacrolimus|tacrolimus|mesh-list
83261467|NCT04262843|Lenograstim|lenograstim|mesh-list
83261468|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261469|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
83261470|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261471|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261472|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83261473|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
83261474|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261475|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261476|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83261477|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261478|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
83261479|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
83261480|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261481|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83261482|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261483|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83261484|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83261485|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
83261486|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83261487|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83261488|NCT02552303|Modafinil|modafinil|mesh-list
83261489|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83261490|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261491|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83261492|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83261493|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83261494|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261495|NCT01660711|Leucovorin|leucovorin|mesh-list
83261496|NCT01660711|Fluorouracil|fluorouracil|mesh-list
83261497|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
83261498|NCT01660711|Irinotecan|irinotecan|mesh-list
83261499|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
83261500|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261501|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261502|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261503|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261504|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
83261505|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261507|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83261508|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261509|NCT01660711|Antidotes|antidotes|mesh-ancestor
83261510|NCT01660711|Protective Agents|protective agents|mesh-ancestor
83261511|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
83261512|NCT01660711|Vitamins|vitamins|mesh-ancestor
83261513|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
83261514|NCT05475665|Amlodipine|amlodipine|mesh-list
83261515|NCT05475665|Irbesartan|irbesartan|mesh-list
83261516|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83261517|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83261518|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83261519|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261520|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83261521|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261522|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
83261523|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83261524|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83261525|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
83261526|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83261527|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
83261528|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261529|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261530|NCT02538965|Lenalidomide|lenalidomide|mesh-list
83261531|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
83261532|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261533|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83261534|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83261535|NCT02538965|Growth Substances|growth substances|mesh-ancestor
83261536|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
83261537|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261538|NCT02543801|Ketorolac|ketorolac|mesh-list
83261539|NCT02543801|Clonidine|clonidine|mesh-list
83261540|NCT02543801|Epinephrine|epinephrine|mesh-list
83261541|NCT02543801|Bupivacaine|bupivacaine|mesh-list
83261542|NCT02543801|Ropivacaine|ropivacaine|mesh-list
83261543|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
83261544|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
83261545|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261546|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261547|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
83261548|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261549|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83261550|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83261551|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
83261552|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261553|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261554|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83261555|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83261556|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
83261557|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83261558|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
83261559|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
83261560|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
83261561|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83261562|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261563|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261564|NCT02543801|Analgesics|analgesics|mesh-ancestor
83261565|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261566|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261567|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83261568|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261569|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83261570|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
83261571|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83261573|NCT02481635|Gemcitabine|gemcitabine|mesh-list
83261574|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83261575|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261576|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83261577|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83261578|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83261579|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261580|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261581|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
83261582|NCT02470091|Denosumab|denosumab|mesh-list
83261583|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83261584|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261585|NCT02362503|Fostemsavir|fostemsavir|mesh-list
83261586|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83261587|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83261588|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
83261589|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261590|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83261591|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83261592|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261593|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
83261594|NCT05411159|Anesthetics|anesthetics|mesh-list
83261595|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261596|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261597|NCT05411159|Narcotics|narcotics|mesh-ancestor
83261598|NCT05411159|Analgesics|analgesics|mesh-ancestor
83261599|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
83261600|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261601|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
83261602|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83261603|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
83261604|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261605|NCT02362425|Expectorants|expectorants|mesh-ancestor
83261606|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
83261607|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83261608|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
83261609|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261610|NCT02362425|Protective Agents|protective agents|mesh-ancestor
83261611|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261612|NCT02362425|Antidotes|antidotes|mesh-ancestor
83261613|NCT02362269|Vitamin D|vitamin d|mesh-list
83261614|NCT02362269|Vitamins|vitamins|mesh-ancestor
83261615|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
83261616|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261617|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83261618|NCT02529995|Osimertinib|osimertinib|mesh-list
83261619|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261620|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83261621|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261622|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261623|NCT02319759|Ustekinumab|ustekinumab|mesh-list
83261624|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
83261625|NCT02318667|Golimumab|golimumab|mesh-list
83261626|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83261627|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261628|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261629|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
83261630|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261631|NCT02292771|Vasotocin|vasotocin|mesh-list
83261632|NCT02292771|Atosiban|atosiban|mesh-list
83261633|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
83261634|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261635|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261636|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
83261637|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83261638|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
83261639|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83261640|NCT02291913|Tamoxifen|tamoxifen|mesh-list
83261641|NCT02291913|Everolimus|everolimus|mesh-list
83261642|NCT02291913|Letrozole|letrozole|mesh-list
83261643|NCT02291913|Fulvestrant|fulvestrant|mesh-list
83261644|NCT02291913|Anastrozole|anastrozole|mesh-list
83261645|NCT02291913|Exemestane|exemestane|mesh-list
83261646|NCT02291913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83261647|NCT02291913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83261648|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261649|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261650|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261651|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
83261652|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261653|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261654|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83261655|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83261656|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83261657|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
83261658|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261659|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83261660|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83261661|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83261662|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83261663|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83261664|NCT02291679|Linaclotide|linaclotide|mesh-list
83261665|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83261666|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
83261667|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261668|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83261669|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
83261670|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83261671|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83261672|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261673|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
83261674|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
83261675|NCT02360475|Vaccines|vaccines|mesh-list
83261676|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
83261677|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261678|NCT02360397|Ranolazine|ranolazine|mesh-list
83261679|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83261680|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83261681|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261682|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83261683|NCT02317809|Hormones|hormones|mesh-ancestor
83261684|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261685|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261686|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
83261687|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261688|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261689|NCT02359851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83261690|NCT02359851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261691|NCT01607905|Acetaminophen|acetaminophen|mesh-list
83261692|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261693|NCT01607905|Analgesics|analgesics|mesh-ancestor
83261694|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
83261695|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261696|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261697|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
83261698|NCT02389543|Dexamethasone|dexamethasone|mesh-list
83261699|NCT02389543|Lenalidomide|lenalidomide|mesh-list
83261700|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261701|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
83261702|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
83261703|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261704|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261705|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83261706|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
83261707|NCT02389543|Hormones|hormones|mesh-ancestor
83261708|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261709|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83261710|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261711|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
83261712|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83261713|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83261714|NCT02389543|Growth Substances|growth substances|mesh-ancestor
83261715|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
83261716|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
83261717|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83261718|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261719|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
83261720|NCT00843037|Sunitinib|sunitinib|mesh-list
83261721|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261722|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83261723|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83261724|NCT00843037|Growth Substances|growth substances|mesh-ancestor
83261725|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261726|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
83261727|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83261728|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261729|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261730|NCT00602641|Thalidomide|thalidomide|mesh-list
83261731|NCT00602641|Prednisone|prednisone|mesh-list
83261732|NCT00602641|Cortisone|cortisone|mesh-list
83261733|NCT00602641|Lenalidomide|lenalidomide|mesh-list
83261734|NCT00602641|Melphalan|melphalan|mesh-list
83261735|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
83261736|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83261737|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261738|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
83261739|NCT00602641|Hormones|hormones|mesh-ancestor
83261740|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261741|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261742|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83261743|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261744|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
83261745|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83261746|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83261747|NCT00602641|Growth Substances|growth substances|mesh-ancestor
83261748|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
83261749|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83261750|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
83261751|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261752|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83261753|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261754|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
83261755|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83261756|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261757|NCT05441527|Muramidase|muramidase|mesh-list
83261758|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261759|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83261760|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83261761|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261762|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83261763|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261765|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261766|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261767|NCT04261387|LUT014|lut014|mesh-list
83261768|NCT04261387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83261769|NCT04261387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261770|NCT04261387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261771|NCT05411965|Pioglitazone|pioglitazone|mesh-list
83261772|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
83261773|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83261774|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261775|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83261776|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261777|NCT04261075|Durvalumab|durvalumab|mesh-list
83261778|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261779|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261780|NCT05436769|Clarithromycin|clarithromycin|mesh-list
83261781|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83261782|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261783|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83261784|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261785|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261786|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83261787|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83261788|NCT05378737|Exatecan|exatecan|mesh-list
83261789|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83261790|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83261791|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261792|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261793|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261794|NCT03929029|Nivolumab|nivolumab|mesh-list
83261795|NCT03929029|Ipilimumab|ipilimumab|mesh-list
83261796|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83261797|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261798|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261799|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83261800|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261801|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83261802|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
83261803|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261804|NCT01659853|Azelaic acid|azelaic acid|mesh-list
83261805|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83261806|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83261807|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83261808|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83261809|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83261810|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
83261811|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261812|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261813|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261814|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261815|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
83261816|NCT05376553|Docetaxel|docetaxel|mesh-list
83261817|NCT05376553|Cemiplimab|cemiplimab|mesh-list
83261818|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261819|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
83261820|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
83261821|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
83261822|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261823|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261824|NCT05385367|Anesthetics|anesthetics|mesh-list
83261825|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
83261826|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261827|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261828|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83261829|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83261830|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
83261831|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261832|NCT05576389|Fluzoparib|fluzoparib|mesh-list
83261833|NCT05576389|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83261834|NCT05576389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261835|NCT05576389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261836|NCT05576389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261837|NCT05341609|Ritonavir|ritonavir|mesh-list
83261838|NCT05341609|Nirmatrelvir|nirmatrelvir|mesh-list
83261839|NCT05341609|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83261840|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83261841|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83261842|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
83261843|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261844|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261845|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83261846|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83261847|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
83261848|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83261849|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83261850|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83261851|NCT05371015|Ropivacaine|ropivacaine|mesh-list
83261852|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
83261853|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
83261854|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261855|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261856|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
83261857|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261858|NCT02531113|Ozanimod|ozanimod|mesh-list
83261859|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83261860|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261861|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83261862|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
83261863|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261864|NCT05509933|Budesonide|budesonide|mesh-list
83261865|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261866|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83261867|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
83261868|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261869|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261870|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83261871|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
83261872|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
83261873|NCT05509933|Hormones|hormones|mesh-ancestor
83261874|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83261875|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83261876|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83261877|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
83261878|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261879|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83261880|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83261881|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
83261882|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
83261883|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261884|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261885|NCT04248595|Azacitidine|azacitidine|mesh-list
83261886|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
83261887|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261888|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
83261889|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261890|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261891|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261892|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83261893|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83261894|NCT05335993|Niraparib|niraparib|mesh-list
83261895|NCT05335993|Oregovomab|oregovomab|mesh-list
83261896|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83261897|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261898|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261899|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261900|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261901|NCT05305105|Psilocybin|psilocybin|mesh-list
83261902|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
83261903|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261904|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83261905|NCT05334277|Bevacizumab|bevacizumab|mesh-list
83261906|NCT05334277|Carboplatin|carboplatin|mesh-list
83261907|NCT05334277|Pemetrexed|pemetrexed|mesh-list
83261908|NCT05334277|Aflutinib|aflutinib|mesh-list
83261909|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83261910|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261911|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83261912|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83261913|NCT05334277|Growth Substances|growth substances|mesh-ancestor
83261914|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261915|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
83261916|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261917|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261918|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83261919|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83261920|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83261921|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83261922|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
83261923|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83261924|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83261925|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83261926|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261927|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261928|NCT05332717|Melatonin|melatonin|mesh-list
83261929|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261930|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
83261931|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261932|NCT05332717|Protective Agents|protective agents|mesh-ancestor
83261933|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261934|NCT05300269|Capecitabine|capecitabine|mesh-list
83261935|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
83261936|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83261937|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
83261938|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261939|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261940|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
83261941|NCT05325853|Propoxycaine|propoxycaine|mesh-list
83261942|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
83261943|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
83261944|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261945|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261946|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
83261947|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261948|NCT05353933|Pantoprazole|pantoprazole|mesh-list
83261949|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83261950|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83261951|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83261952|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261953|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261954|NCT05352685|Propofol|propofol|mesh-list
83261955|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83261956|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83261957|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261958|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83261959|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
83261960|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
83261961|NCT05351593|Lenalidomide|lenalidomide|mesh-list
83261962|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
83261963|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261964|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83261965|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83261966|NCT05351593|Growth Substances|growth substances|mesh-ancestor
83261967|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
83261968|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83261970|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83261971|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83261972|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83261973|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261974|NCT05347069|Aspirin|aspirin|mesh-list
83261975|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83261976|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83261977|NCT05347069|Analgesics|analgesics|mesh-ancestor
83261978|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
83261979|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261980|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261981|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83261982|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83261983|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83261984|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83261985|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83261986|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83261987|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83261988|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83261989|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
83261990|NCT05516953|Baclofen|baclofen|mesh-list
83261991|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83261992|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83261993|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83261994|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83261995|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83261996|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
83261997|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
83261998|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83261999|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262000|NCT02522767|Mesalamine|mesalamine|mesh-list
83262001|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262002|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262003|NCT02522767|Analgesics|analgesics|mesh-ancestor
83262004|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
83262005|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262006|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262007|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262008|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262009|NCT02522377|Midazolam|midazolam|mesh-list
83262010|NCT02522377|Ketamine|ketamine|mesh-list
83262011|NCT02522377|Analgesics|analgesics|mesh-ancestor
83262012|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
83262013|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262014|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262015|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83262016|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83262017|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
83262018|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
83262019|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262020|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83262021|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83262022|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262023|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262024|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83262025|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83262026|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83262027|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83262028|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83262029|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
83262030|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
83262031|NCT05345509|Donepezil|donepezil|mesh-list
83262032|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83262033|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262034|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262035|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
83262036|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262037|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262038|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
83262039|NCT05318755|Testosterone|testosterone|mesh-list
83262040|NCT05318755|Androgens|androgens|mesh-ancestor
83262041|NCT05318755|Hormones|hormones|mesh-ancestor
83262042|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262043|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262044|NCT05267743|Lansoprazole|lansoprazole|mesh-list
83262045|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
83262046|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83262047|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83262048|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83262049|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262050|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262051|NCT05291845|Vaccines|vaccines|mesh-list
83262052|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
83262053|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262054|NCT05314621|Fluticasone|fluticasone|mesh-list
83262055|NCT05314621|Xhance|xhance|mesh-list
83262056|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83262057|NCT05314621|Dextrans|dextrans|mesh-list
83262058|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83262059|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83262060|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262061|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83262062|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
83262063|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262064|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262065|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83262066|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
83262067|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83262068|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83262069|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262070|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262071|NCT05314621|Analgesics|analgesics|mesh-ancestor
83262072|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
83262073|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262074|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83262075|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83262076|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
83262077|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
83262078|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262079|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262080|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
83262081|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
83262082|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
83262083|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
83262084|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83262085|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
83262086|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262087|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83262088|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
83262089|NCT05263609|Axitinib|axitinib|mesh-list
83262090|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262091|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262092|NCT05263609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83262093|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262094|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262095|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262096|NCT05313997|Diclofenac|diclofenac|mesh-list
83262097|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262098|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262100|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
83262101|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262102|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262103|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262104|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262105|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83262106|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262107|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262108|NCT05259241|Thrombin|thrombin|mesh-list
83262109|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
83262110|NCT05259241|Coagulants|coagulants|mesh-ancestor
83262111|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
83262112|NCT05511415|Oxytocin|oxytocin|mesh-list
83262113|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83262114|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262115|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262116|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262117|NCT05511415|Analgesics|analgesics|mesh-ancestor
83262118|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
83262119|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262120|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83262121|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83262122|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83262123|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262124|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262125|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262126|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
83262127|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83262128|NCT01657903|Listerine|listerine|mesh-list
83262129|NCT01657903|Fluorides|fluorides|mesh-list
83262130|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
83262131|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
83262132|NCT01657903|Protective Agents|protective agents|mesh-ancestor
83262133|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262134|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83262135|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262136|NCT05256823|Celecoxib|celecoxib|mesh-list
83262137|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262138|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262139|NCT05256823|Analgesics|analgesics|mesh-ancestor
83262140|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
83262141|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262142|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262143|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262144|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262145|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83262146|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83262147|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262148|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262149|NCT05255653|Cisplatin|cisplatin|mesh-list
83262150|NCT05255653|Carboplatin|carboplatin|mesh-list
83262151|NCT05255653|Durvalumab|durvalumab|mesh-list
83262152|NCT05255653|Olaparib|olaparib|mesh-list
83262153|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83262154|NCT05255653|Megestrol|megestrol|mesh-list
83262155|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
83262156|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
83262157|NCT05255653|Progestins|progestins|mesh-list
83262158|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262159|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262160|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262161|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83262162|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262163|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83262164|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83262165|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83262166|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
83262167|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83262168|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262169|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83262170|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83262171|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83262172|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83262173|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
83262174|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83262175|NCT05255653|Hormones|hormones|mesh-ancestor
83262176|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262177|NCT05284591|Daratumumab|daratumumab|mesh-list
83262178|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262179|NCT04243837|Pirfenidone|pirfenidone|mesh-list
83262180|NCT04243837|Analgesics|analgesics|mesh-ancestor
83262181|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
83262182|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262183|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262184|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262185|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262186|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262187|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262188|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262189|NCT05253937|Epinephrine|epinephrine|mesh-list
83262190|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83262191|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83262192|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262193|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262194|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262195|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262196|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83262197|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83262198|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
83262199|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262200|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83262201|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83262202|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
83262203|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
83262204|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83262205|NCT05218603|Bortezomib|bortezomib|mesh-list
83262206|NCT05218603|Daratumumab|daratumumab|mesh-list
83262207|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262208|NCT05280769|Lobeline|lobeline|mesh-list
83262209|NCT05280769|Nicotine|nicotine|mesh-list
83262210|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83262211|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
83262212|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262213|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262214|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83262215|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83262216|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
83262217|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262218|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262219|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
83262220|NCT05214001|Almotriptan|almotriptan|mesh-list
83262221|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83262222|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
83262223|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262224|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262225|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262226|NCT05249959|Rituximab|rituximab|mesh-list
83262227|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83262228|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83262229|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262230|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262231|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
83262232|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262233|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262234|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83262235|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
83262236|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262237|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
83262238|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83262239|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262240|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262241|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262242|NCT05280223|Analgesics|analgesics|mesh-ancestor
83262243|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
83262244|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262245|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83262246|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83262247|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83262248|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262249|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262250|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262251|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83262252|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83262253|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262254|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262255|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83262256|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83262257|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262258|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
83262259|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262260|NCT05248945|Carbamazepine|carbamazepine|mesh-list
83262261|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
83262262|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
83262263|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83262264|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262265|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262266|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83262267|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262268|NCT05248945|Analgesics|analgesics|mesh-ancestor
83262269|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
83262270|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262271|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83262272|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83262273|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262274|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83262275|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83262276|NCT04239313|Vaccines|vaccines|mesh-list
83262277|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
83262278|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262279|NCT05209867|Cannabidiol|cannabidiol|mesh-list
83262280|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
83262281|NCT05273827|Paclitaxel|paclitaxel|mesh-list
83262282|NCT05273827|Pemetrexed|pemetrexed|mesh-list
83262283|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83262284|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262285|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83262286|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83262287|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83262288|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262289|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262290|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83262291|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83262292|NCT05209711|Lidocaine|lidocaine|mesh-list
83262293|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
83262294|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
83262295|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262296|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262297|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
83262298|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262299|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83262300|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83262301|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83262302|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83262303|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262304|NCT05243563|Clobetasol|clobetasol|mesh-list
83262305|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262306|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
83262307|NCT05243563|Hormones|hormones|mesh-ancestor
83262308|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262309|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262310|NCT05272969|Vitamin D|vitamin d|mesh-list
83262311|NCT05272969|Calcium|calcium|mesh-list
83262312|NCT05272969|Vitamins|vitamins|mesh-ancestor
83262313|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
83262314|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262315|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83262316|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83262317|NCT05208619|Anesthetics|anesthetics|mesh-list
83262318|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262319|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262320|NCT05206747|Methamphetamine|methamphetamine|mesh-list
83262321|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83262322|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262323|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
83262324|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
83262325|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262326|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
83262327|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262328|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262329|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262330|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83262331|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83262332|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83262333|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83262334|NCT05206435|Nicotine|nicotine|mesh-list
83262335|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83262336|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
83262337|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262338|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262339|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83262340|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83262341|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
83262342|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262343|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262344|NCT05205811|Zonisamide|zonisamide|mesh-list
83262345|NCT05205811|Bupropion|bupropion|mesh-list
83262346|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83262347|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
83262348|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83262349|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83262350|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83262351|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83262352|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262353|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
83262354|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262355|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262356|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83262357|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83262358|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262359|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
83262360|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83262361|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83262362|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83262363|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
83262364|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262365|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83262366|NCT05166343|Epinephrine|epinephrine|mesh-list
83262367|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83262368|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83262369|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262370|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262371|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262372|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262373|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83262374|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83262375|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
83262376|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262377|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83262378|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
83262379|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
83262380|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
83262381|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83262382|NCT05237947|Vaccines|vaccines|mesh-list
83262383|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
83262384|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262385|NCT01656733|Nicotine|nicotine|mesh-list
83262386|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83262387|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
83262388|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262389|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262390|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83262391|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83262392|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
83262393|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262394|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262395|NCT05236543|Itraconazole|itraconazole|mesh-list
83262396|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
83262397|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262398|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83262399|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83262400|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262401|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262402|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83262403|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
83262404|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262405|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262406|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83262407|NCT05159245|Trastuzumab|trastuzumab|mesh-list
83262408|NCT05159245|Atezolizumab|atezolizumab|mesh-list
83262409|NCT05159245|Pertuzumab|pertuzumab|mesh-list
83262410|NCT05159245|Trametinib|trametinib|mesh-list
83262411|NCT05159245|Vemurafenib|vemurafenib|mesh-list
83262412|NCT05159245|Dabrafenib|dabrafenib|mesh-list
83262413|NCT05159245|Pralsetinib|pralsetinib|mesh-list
83262414|NCT05159245|Entrectinib|entrectinib|mesh-list
83262415|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262416|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262417|NCT05159245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83262418|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262419|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262420|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262421|NCT05157841|Bupivacaine|bupivacaine|mesh-list
83262422|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
83262423|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
83262424|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262425|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262426|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
83262427|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262428|NCT05154487|Fulvestrant|fulvestrant|mesh-list
83262430|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262431|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83262432|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83262433|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
83262434|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262435|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262436|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
83262437|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83262438|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262440|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
83262441|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83262442|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83262443|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262444|NCT05190445|Paclitaxel|paclitaxel|mesh-list
83262445|NCT05190445|Ramucirumab|ramucirumab|mesh-list
83262446|NCT05190445|Tucatinib|tucatinib|mesh-list
83262447|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83262448|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262449|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
83262450|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
83262451|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
83262452|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262453|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262454|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262455|NCT05189977|Propranolol|propranolol|mesh-list
83262456|NCT05189977|Prazosin|prazosin|mesh-list
83262457|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83262458|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83262459|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262460|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262461|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262462|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262463|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83262464|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83262465|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
83262466|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83262467|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83262468|NCT05148949|Vaccines|vaccines|mesh-list
83262469|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
83262470|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262471|NCT05107999|Doxepin|doxepin|mesh-list
83262472|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
83262473|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83262474|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83262475|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83262476|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83262477|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262478|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262479|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83262480|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
83262481|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
83262482|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262483|NCT05186545|Fulvestrant|fulvestrant|mesh-list
83262484|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83262485|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262486|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83262487|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83262488|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83262489|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262490|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262491|NCT05107765|Pioglitazone|pioglitazone|mesh-list
83262492|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83262493|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262494|NCT05185999|Icodextrin|icodextrin|mesh-list
83262495|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
83262496|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83262497|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
83262498|NCT05106127|Lenvatinib|lenvatinib|mesh-list
83262499|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262500|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262501|NCT05106127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83262502|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262503|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262504|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262505|NCT05183737|Propolis|propolis|mesh-list
83262506|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262507|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83262508|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
83262509|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262510|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83262511|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83262512|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
83262513|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262514|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262515|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83262516|NCT05094427|Anesthetics|anesthetics|mesh-list
83262517|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
83262518|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262519|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262520|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
83262521|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262522|NCT05139043|Dexamethasone|dexamethasone|mesh-list
83262523|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
83262524|NCT05139043|Ichthammol|ichthammol|mesh-list
83262525|NCT05139043|BB 1101|bb 1101|mesh-list
83262526|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262527|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
83262528|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
83262529|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262530|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262531|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83262532|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
83262533|NCT05139043|Hormones|hormones|mesh-ancestor
83262534|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262535|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83262536|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262537|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
83262538|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262539|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262540|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
83262541|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
83262542|NCT05175781|Ketamine|ketamine|mesh-list
83262543|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83262544|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262545|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262546|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262547|NCT05175781|Analgesics|analgesics|mesh-ancestor
83262548|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
83262549|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262550|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83262551|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83262552|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83262553|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262554|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262555|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262556|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83262557|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83262558|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
83262559|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
83262560|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83262561|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83262562|NCT04421911|Diclofenac|diclofenac|mesh-list
83262563|NCT04421911|Ketoprofen|ketoprofen|mesh-list
83262564|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262565|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262566|NCT04421911|Analgesics|analgesics|mesh-ancestor
83262567|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
83262568|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262569|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262570|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262571|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262572|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83262573|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262574|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262575|NCT05174611|Vitamin D|vitamin d|mesh-list
83262576|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
83262578|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
83262579|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262580|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83262581|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83262582|NCT05133817|Norepinephrine|norepinephrine|mesh-list
83262583|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83262584|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83262585|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83262586|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262587|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262588|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262589|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262590|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
83262591|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
83262592|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262593|NCT05171335|Lenvatinib|lenvatinib|mesh-list
83262594|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262595|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262596|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262597|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262598|NCT02522299|Nemiralisib|nemiralisib|mesh-list
83262599|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262600|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262601|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262602|NCT05086627|Capecitabine|capecitabine|mesh-list
83262603|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
83262604|NCT05086627|Tislelizumab|tislelizumab|mesh-list
83262605|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83262606|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
83262607|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262608|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262609|NCT05086627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262610|NCT01365091|Metformin|metformin|mesh-list
83262611|NCT01365091|Saxagliptin|saxagliptin|mesh-list
83262612|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83262613|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262614|NCT01365091|Incretins|incretins|mesh-ancestor
83262615|NCT01365091|Hormones|hormones|mesh-ancestor
83262616|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262617|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83262618|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
83262619|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262620|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262621|NCT05082025|Fulvestrant|fulvestrant|mesh-list
83262622|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83262623|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262624|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83262625|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83262626|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
83262627|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262628|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262629|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
83262630|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83262631|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
83262632|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262633|NCT05081479|Expectorants|expectorants|mesh-ancestor
83262634|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
83262635|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83262636|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
83262637|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262638|NCT05081479|Protective Agents|protective agents|mesh-ancestor
83262639|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262640|NCT05081479|Antidotes|antidotes|mesh-ancestor
83262641|NCT05079763|Monolaurin|monolaurin|mesh-list
83262642|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
83262643|NCT05079763|Protective Agents|protective agents|mesh-ancestor
83262644|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262645|NCT05050981|Hormones|hormones|mesh-list
83262646|NCT05050981|Serotonin|serotonin|mesh-list
83262647|NCT05050981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83262648|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262649|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262650|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83262651|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
83262652|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262653|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262654|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83262655|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83262657|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83262658|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83262659|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262660|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
83262661|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262662|NCT05039281|Atezolizumab|atezolizumab|mesh-list
83262663|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83262664|NCT05039281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83262665|NCT05039281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262666|NCT05039281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262667|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262668|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
83262669|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262670|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83262671|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
83262672|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83262673|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
83262674|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262675|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
83262676|NCT01364467|Guaifenesin|guaifenesin|mesh-list
83262677|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83262678|NCT01364467|Expectorants|expectorants|mesh-ancestor
83262679|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
83262680|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83262681|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83262682|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262683|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262684|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262685|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262686|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
83262687|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83262688|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
83262689|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
83262690|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262691|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
83262692|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83262693|NCT04226365|Nortriptyline|nortriptyline|mesh-list
83262694|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83262695|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
83262696|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83262697|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83262698|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83262699|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83262700|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262701|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262702|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262703|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262704|NCT05062837|Apatinib|apatinib|mesh-list
83262706|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262707|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262708|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262709|NCT05110417|Bromides|bromides|mesh-list
83262710|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83262711|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
83262712|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83262713|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262714|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262715|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
83262716|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262717|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262718|NCT05033665|Benzocaine|benzocaine|mesh-list
83262719|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
83262720|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
83262721|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262722|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262723|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
83262724|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262725|NCT05031481|Butoconazole|butoconazole|mesh-list
83262726|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
83262727|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262728|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
83262729|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83262730|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262731|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83262732|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262734|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83262735|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83262736|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262737|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262738|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83262739|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83262740|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83262741|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83262742|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
83262743|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
83262744|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
83262745|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
83262746|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262747|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262748|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83262749|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
83262750|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
83262751|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
83262752|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262753|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83262754|NCT04997239|Vaccines|vaccines|mesh-list
83262755|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
83262756|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262757|NCT04216693|Digoxin|digoxin|mesh-list
83262758|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83262759|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83262760|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262761|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262762|NCT04216693|Protective Agents|protective agents|mesh-ancestor
83262763|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262764|NCT01364389|Prednisone|prednisone|mesh-list
83262765|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262766|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
83262767|NCT01364389|Hormones|hormones|mesh-ancestor
83262768|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262769|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262770|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83262771|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262772|NCT05054881|Iodine|iodine|mesh-list
83262773|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83262774|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262775|NCT05054881|Trace Elements|trace elements|mesh-ancestor
83262776|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
83262777|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262778|NCT04949425|Adavosertib|adavosertib|mesh-list
83262779|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262780|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262781|NCT04203901|Nivolumab|nivolumab|mesh-list
83262782|NCT04203901|Ipilimumab|ipilimumab|mesh-list
83262783|NCT04203901|Everolimus|everolimus|mesh-list
83262784|NCT04203901|Lenvatinib|lenvatinib|mesh-list
83262785|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262786|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262787|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83262788|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262789|NCT04203901|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83262790|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262791|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262792|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83262793|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
83262794|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262795|NCT04421209|Propranolol|propranolol|mesh-list
83262796|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83262797|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83262798|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262799|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262800|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262801|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262802|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83262803|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83262804|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
83262805|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83262806|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83262807|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262808|NCT04984993|Tadalafil|tadalafil|mesh-list
83262809|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83262810|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83262811|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83262812|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262813|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262814|NCT04984993|Urological Agents|urological agents|mesh-ancestor
83262815|NCT04984837|Gemcitabine|gemcitabine|mesh-list
83262816|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
83262817|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83262818|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
83262819|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262820|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262821|NCT04983121|Antibodies|antibodies|mesh-list
83262822|NCT04983121|Mitogens|mitogens|mesh-list
83262823|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
83262824|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
83262825|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262826|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
83262827|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262828|NCT02291289|Bevacizumab|bevacizumab|mesh-list
83262829|NCT02291289|Trastuzumab|trastuzumab|mesh-list
83262830|NCT02291289|Cetuximab|cetuximab|mesh-list
83262831|NCT02291289|Atezolizumab|atezolizumab|mesh-list
83262832|NCT02291289|Pertuzumab|pertuzumab|mesh-list
83262833|NCT02291289|Capecitabine|capecitabine|mesh-list
83262834|NCT02291289|Fluorouracil|fluorouracil|mesh-list
83262835|NCT02291289|Vemurafenib|vemurafenib|mesh-list
83262836|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83262837|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262838|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83262839|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83262840|NCT02291289|Growth Substances|growth substances|mesh-ancestor
83262841|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262842|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
83262843|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83262844|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
83430161|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83262845|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262846|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83262847|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
83262848|NCT02291289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83262849|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262850|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262851|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
83262852|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83262853|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262854|NCT02289963|Alirocumab|alirocumab|mesh-list
83262855|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83262856|NCT02289963|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83262857|NCT02289963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83262858|NCT02289963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83262859|NCT02289963|Antimetabolites|antimetabolites|mesh-ancestor
83262860|NCT02289963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262861|NCT02289963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83262862|NCT02289963|Protease Inhibitors|protease inhibitors|mesh-ancestor
83262863|NCT02289963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262864|NCT02289963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83262865|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
83262866|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262867|NCT02358369|Timolol|timolol|mesh-list
83262868|NCT02358369|Bimatoprost|bimatoprost|mesh-list
83262869|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83262870|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83262871|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83262872|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83262873|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
83262874|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262875|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262876|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262877|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83262878|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83262880|NCT02316171|Mitomycin|mitomycin|mesh-list
83262881|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83262882|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262883|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
83262884|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262885|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83262886|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262888|NCT02315625|Sunitinib|sunitinib|mesh-list
83262889|NCT02315625|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83262890|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83262891|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262892|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262893|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83262894|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
83262895|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262896|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262897|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83262898|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83262899|NCT02315625|Growth Substances|growth substances|mesh-ancestor
83262900|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
83262901|NCT02357979|Fluorides|fluorides|mesh-list
83262902|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
83262903|NCT02357979|Protective Agents|protective agents|mesh-ancestor
83262904|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262905|NCT02357901|Buprenorphine|buprenorphine|mesh-list
83262906|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83262907|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83262908|NCT02357901|Narcotics|narcotics|mesh-ancestor
83262909|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262910|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262911|NCT02357901|Analgesics|analgesics|mesh-ancestor
83262912|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
83262913|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262914|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83262915|NCT01601847|Vitamin D|vitamin d|mesh-list
83262916|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
83262917|NCT01601847|Vitamins|vitamins|mesh-ancestor
83262918|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
83262919|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262920|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83262921|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83262922|NCT02515279|Ribavirin|ribavirin|mesh-list
83262923|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83262924|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
83262925|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262926|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
83262927|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262928|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
83262929|NCT02515045|Prednisolone|prednisolone|mesh-list
83262930|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83262931|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
83262932|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83262933|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
83262934|NCT02515045|Nepafenac|nepafenac|mesh-list
83262935|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83262936|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
83262937|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262938|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
83262939|NCT02515045|Hormones|hormones|mesh-ancestor
83262940|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262941|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262942|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83262943|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83262944|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
83262945|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
83262946|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262947|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83262948|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83262949|NCT02515045|Protective Agents|protective agents|mesh-ancestor
83262950|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83262951|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83262952|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83262953|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83262954|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262955|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262956|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262957|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262958|NCT02515045|Analgesics|analgesics|mesh-ancestor
83262959|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
83262960|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262961|NCT02513485|Levodopa|levodopa|mesh-list
83262962|NCT02513485|Carbidopa|carbidopa|mesh-list
83262963|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83262964|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83262965|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
83262966|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83262967|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262968|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262969|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83262970|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262971|NCT02289417|Apremilast|apremilast|mesh-list
83262972|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83262973|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83262974|NCT02289417|Analgesics|analgesics|mesh-ancestor
83262975|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
83262976|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262977|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262978|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83262979|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83262980|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83262981|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83262982|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83262983|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83262984|NCT02512861|Bupivacaine|bupivacaine|mesh-list
83262985|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
83262986|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
83262987|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83262988|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262989|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
83262990|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83262991|NCT04979611|Exenatide|exenatide|mesh-list
83262992|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83262993|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83262994|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83262995|NCT04979611|Incretins|incretins|mesh-ancestor
83262996|NCT04979611|Hormones|hormones|mesh-ancestor
83262997|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83262998|NCT04979065|Vitamin D|vitamin d|mesh-list
83262999|NCT04979065|Vitamins|vitamins|mesh-ancestor
83263000|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
83263001|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263002|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83263003|NCT02288325|Milnacipran|milnacipran|mesh-list
83263004|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
83263005|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83263006|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83263007|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263008|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263009|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263010|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263011|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
83263012|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83263013|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263014|NCT02288325|Analgesics|analgesics|mesh-ancestor
83263015|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
83263016|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263017|NCT04978051|Icatibant|icatibant|mesh-list
83263018|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83430162|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
83263019|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263020|NCT04978051|Analgesics|analgesics|mesh-ancestor
83263021|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
83263022|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263023|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263024|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263025|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263026|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83263027|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83263028|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263029|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83263030|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83263031|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
83263032|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83263033|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83263034|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263035|NCT05010421|Clobetasol|clobetasol|mesh-list
83263036|NCT05010421|Emollients|emollients|mesh-list
83263037|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263038|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
83263039|NCT05010421|Hormones|hormones|mesh-ancestor
83263040|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263041|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263042|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
83263043|NCT02504827|Ceftazidime|ceftazidime|mesh-list
83263044|NCT02504827|Avibactam|avibactam|mesh-list
83263045|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83263046|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83263047|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263048|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83263049|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263050|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263051|NCT02504671|Folic Acid|folic acid|mesh-list
83263052|NCT02504671|Hematinics|hematinics|mesh-ancestor
83263053|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
83263054|NCT02504671|Vitamins|vitamins|mesh-ancestor
83263055|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
83263056|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263057|NCT02314143|Trametinib|trametinib|mesh-list
83263058|NCT02314143|Dabrafenib|dabrafenib|mesh-list
83263059|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263060|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263061|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263062|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263063|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
83263064|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83263065|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263066|NCT05007613|Atezolizumab|atezolizumab|mesh-list
83263067|NCT05007613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83430163|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263068|NCT05007613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263069|NCT05007613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263070|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263071|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
83263072|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83263073|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83263074|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83263075|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83263076|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263077|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263078|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
83263079|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263080|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263081|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83263082|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263083|NCT02501629|Reslizumab|reslizumab|mesh-list
83263084|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83263085|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
83263086|NCT02501473|Rituximab|rituximab|mesh-list
83263087|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
83263088|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263089|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263090|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
83263091|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263092|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263093|NCT02501473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83263094|NCT02501473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263095|NCT02501161|Insulin|insulin|mesh-list
83263096|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83263097|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
83263098|NCT02501161|Liraglutide|liraglutide|mesh-list
83263099|NCT02501161|Xultophy|xultophy|mesh-list
83263100|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83263101|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263102|NCT02501161|Incretins|incretins|mesh-ancestor
83263103|NCT02501161|Hormones|hormones|mesh-ancestor
83263104|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263105|NCT04966585|Posaconazole|posaconazole|mesh-list
83263106|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
83263107|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263108|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83263109|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83263110|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83263111|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83263112|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83263113|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263114|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263115|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83263116|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
83263117|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263118|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263119|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
83263120|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83263121|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263122|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263123|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263124|NCT04205539|Analgesics|analgesics|mesh-ancestor
83263125|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
83263126|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263127|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83263128|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83263129|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83263130|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
83263131|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263132|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263133|NCT02313909|Aspirin|aspirin|mesh-list
83263134|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
83263135|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83263136|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263137|NCT02313909|Analgesics|analgesics|mesh-ancestor
83263138|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
83263139|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263140|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263141|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263142|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263143|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83263144|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83263145|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263146|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83263147|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83263148|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263149|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
83263150|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83263151|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
83263152|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83263153|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
83263154|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
83263155|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
83263156|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83263157|NCT02287467|Antibodies|antibodies|mesh-list
83263158|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
83263159|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83263160|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
83263161|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263162|NCT02287233|Cytarabine|cytarabine|mesh-list
83263163|NCT02287233|Venetoclax|venetoclax|mesh-list
83263164|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83263165|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
83263166|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263167|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263168|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
83263169|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263170|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83263171|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
83263172|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263173|NCT01646385|Etanercept|etanercept|mesh-list
83263174|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
83263175|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83263176|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263177|NCT01646385|Analgesics|analgesics|mesh-ancestor
83263178|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
83263179|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263180|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263181|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263182|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263183|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83263184|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
83263185|NCT02286843|Trastuzumab|trastuzumab|mesh-list
83263186|NCT02286843|Pertuzumab|pertuzumab|mesh-list
83263187|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263188|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263189|NCT02281773|BI 409306|bi 409306|mesh-list
83263190|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83263191|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263192|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263193|NCT02354235|Canagliflozin|canagliflozin|mesh-list
83263194|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83263195|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263196|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83263197|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263198|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83263199|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
83263200|NCT02284893|Saxagliptin|saxagliptin|mesh-list
83263201|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83263202|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263203|NCT02284893|Incretins|incretins|mesh-ancestor
83263204|NCT02284893|Hormones|hormones|mesh-ancestor
83263205|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263206|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83263207|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
83263208|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263209|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263210|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83263211|NCT04965181|Nicotine|nicotine|mesh-list
83263212|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83263213|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
83263214|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263215|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263216|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83263217|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83263218|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
83263219|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263220|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263221|NCT02483611|Lidocaine|lidocaine|mesh-list
83263222|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
83263223|NCT02483611|Cisatracurium|cisatracurium|mesh-list
83263224|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
83263225|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
83263226|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263227|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263228|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
83263229|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263230|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83263231|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83263232|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83263233|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263234|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263235|NCT02483611|Analgesics|analgesics|mesh-ancestor
83263236|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
83263237|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83263238|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83263239|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
83263240|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83263241|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83263242|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83263243|NCT02482129|Dexamethasone|dexamethasone|mesh-list
83263244|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83263245|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83263247|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
83263248|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
83263249|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263250|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263251|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263252|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
83263253|NCT02482129|Hormones|hormones|mesh-ancestor
83263254|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263255|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263256|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263257|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
83263258|NCT02495857|Viscosupplements|viscosupplements|mesh-list
83263259|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83263260|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
83263261|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263262|NCT02495857|Protective Agents|protective agents|mesh-ancestor
83263263|NCT02495389|Mirabegron|mirabegron|mesh-list
83263264|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83263265|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83263266|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83263267|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
83263268|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263269|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263270|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263271|NCT02495389|Urological Agents|urological agents|mesh-ancestor
83263272|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83263273|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263274|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263275|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263276|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263277|NCT02495077|Acetaminophen|acetaminophen|mesh-list
83263278|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
83263279|NCT02495077|Promethazine|promethazine|mesh-list
83263280|NCT02495077|Loratadine|loratadine|mesh-list
83263281|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
83263282|NCT02495077|Prednisone|prednisone|mesh-list
83263283|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
83263284|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83263285|NCT02495077|Infliximab|infliximab|mesh-list
83263286|NCT02495077|Tacrolimus|tacrolimus|mesh-list
83263287|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
83263288|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83263289|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263290|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
83263291|NCT02495077|Hormones|hormones|mesh-ancestor
83263292|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263293|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263294|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263295|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263296|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83263297|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
83263298|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83263299|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263300|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263301|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263302|NCT02495077|Analgesics|analgesics|mesh-ancestor
83263303|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
83263304|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263305|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
83263306|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83263307|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83263308|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
83263309|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83263310|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263311|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
83263312|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
83263313|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263314|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83263315|NCT02495077|Protective Agents|protective agents|mesh-ancestor
83263316|NCT02495077|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83263317|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
83263318|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263319|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83263320|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83263321|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263322|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
83263323|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
83263324|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83263325|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
83263326|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
83263327|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263328|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83263329|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
83263330|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83263331|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
83263332|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
83263333|NCT02278341|Hematinics|hematinics|mesh-ancestor
83263334|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
83263335|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83263336|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83263337|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263338|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
83263339|NCT02278263|Coagulants|coagulants|mesh-ancestor
83263340|NCT02494921|Prednisone|prednisone|mesh-list
83263341|NCT02494921|Docetaxel|docetaxel|mesh-list
83263342|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263343|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
83263344|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
83263345|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
83263346|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263347|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263348|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
83263349|NCT02494921|Hormones|hormones|mesh-ancestor
83263350|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263351|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263352|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263353|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
83263354|NCT01653847|Everolimus|everolimus|mesh-list
83263355|NCT01653847|Tacrolimus|tacrolimus|mesh-list
83263356|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83263357|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
83263358|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263359|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83263360|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263361|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263362|NCT01653847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83263363|NCT01653847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263364|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263365|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83263366|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83263367|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
83263368|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83263369|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263370|NCT02493751|Avelumab|avelumab|mesh-list
83263371|NCT02493751|Axitinib|axitinib|mesh-list
83263372|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263373|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263374|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263375|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263376|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263377|NCT02493517|Lanreotide|lanreotide|mesh-list
83263378|NCT02493517|Somatostatin|somatostatin|mesh-list
83263379|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263380|NCT02493517|Hormones|hormones|mesh-ancestor
83263381|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263382|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263383|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
83263384|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263385|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263386|NCT02493361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83263387|NCT02493361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263388|NCT04959799|Dalbavancin|dalbavancin|mesh-list
83263389|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83263390|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263391|NCT04959331|Fosfomycin|fosfomycin|mesh-list
83263392|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
83263393|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
83263394|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83263395|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263396|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83263397|NCT02478463|Cabotegravir|cabotegravir|mesh-list
83263398|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83263399|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83263400|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263401|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263402|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83263403|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83263404|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
83263405|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263406|NCT02491411|Dexamethasone|dexamethasone|mesh-list
83263407|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
83263408|NCT02491411|Ichthammol|ichthammol|mesh-list
83263409|NCT02491411|BB 1101|bb 1101|mesh-list
83263410|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263411|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
83263412|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
83263413|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263414|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263415|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263416|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
83263417|NCT02491411|Hormones|hormones|mesh-ancestor
83263418|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263419|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263420|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263421|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
83263422|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263423|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263424|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
83263425|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
83263426|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83263427|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
83263428|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83263429|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263431|NCT02490475|Docetaxel|docetaxel|mesh-list
83263432|NCT02490475|Pertuzumab|pertuzumab|mesh-list
83263433|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263434|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
83263435|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
83263436|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
83263437|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263438|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263439|NCT02477839|Lacosamide|lacosamide|mesh-list
83263440|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
83263441|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83263442|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83263443|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263444|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263445|NCT04939987|Acetaminophen|acetaminophen|mesh-list
83263446|NCT04939987|Ketorolac|ketorolac|mesh-list
83263447|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83263448|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83263449|NCT04939987|Ketamine|ketamine|mesh-list
83263450|NCT04939987|Oxycodone|oxycodone|mesh-list
83263451|NCT04939987|Gabapentin|gabapentin|mesh-list
83263452|NCT04939987|Tramadol|tramadol|mesh-list
83263453|NCT04939987|Hydrocodone|hydrocodone|mesh-list
83263454|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
83263455|NCT04939987|Analgesics|analgesics|mesh-ancestor
83263456|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
83263457|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263458|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263459|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83263460|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83263461|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
83263462|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
83263463|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263464|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83263465|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83263466|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263467|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263468|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263469|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
83263470|NCT04939987|Narcotics|narcotics|mesh-ancestor
83263471|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
83263472|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83263473|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83263474|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83263475|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
83263476|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83263477|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263478|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263479|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83263480|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263481|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
83263482|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
83263483|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83263484|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83263485|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83263486|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
83263487|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263488|NCT02477215|Dexamethasone|dexamethasone|mesh-list
83263489|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83263490|NCT02477215|Ixazomib|ixazomib|mesh-list
83263491|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263492|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
83263493|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
83263494|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263495|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263496|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263497|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
83263498|NCT02477215|Hormones|hormones|mesh-ancestor
83263499|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263500|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263501|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263502|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83263503|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
83263504|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263505|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
83263506|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263507|NCT02487199|Ritonavir|ritonavir|mesh-list
83263508|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83263509|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83263510|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
83263511|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263512|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263513|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83263514|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83263515|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
83263516|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263517|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83263518|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83263519|NCT02475733|Metronidazole|metronidazole|mesh-list
83263520|NCT02475733|Meropenem|meropenem|mesh-list
83263521|NCT02475733|Ceftazidime|ceftazidime|mesh-list
83263522|NCT02475733|Avibactam|avibactam|mesh-list
83263523|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83263524|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263525|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83263526|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83263527|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83263528|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83263529|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263530|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263531|NCT02486653|Tamsulosin|tamsulosin|mesh-list
83263532|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83263533|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83263534|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83263535|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
83263536|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263537|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263538|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263539|NCT02486653|Urological Agents|urological agents|mesh-ancestor
83263540|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
83263541|NCT02475265|Estradiol|estradiol|mesh-list
83263542|NCT02475265|Estrogens|estrogens|mesh-ancestor
83263543|NCT02475265|Hormones|hormones|mesh-ancestor
83263544|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263545|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263546|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83263547|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
83263548|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83263549|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83263550|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83263551|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83263553|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263554|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
83263555|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
83263556|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
83263557|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263558|NCT02449915|Bupivacaine|bupivacaine|mesh-list
83263559|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
83263560|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
83263561|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263562|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263563|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
83263564|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263565|NCT02472847|Dronabinol|dronabinol|mesh-list
83263566|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
83263567|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263568|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83263569|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263570|NCT02472847|Analgesics|analgesics|mesh-ancestor
83263571|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
83263572|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263573|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83263574|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83263575|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263576|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263577|NCT02472847|Hormones|hormones|mesh-ancestor
83263578|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263579|NCT02472145|Decitabine|decitabine|mesh-list
83263580|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83263581|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
83263582|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263583|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263584|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263585|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
83263586|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
83263587|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
83263588|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263589|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83263590|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
83263591|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
83263592|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263593|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263594|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263595|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83263596|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
83263597|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83263598|NCT04912765|Nivolumab|nivolumab|mesh-list
83263599|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263600|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263601|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83263602|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263603|NCT02448043|Bimatoprost|bimatoprost|mesh-list
83263604|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83263605|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
83263606|NCT02447887|Ixazomib|ixazomib|mesh-list
83263607|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263608|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
83263609|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263610|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263611|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
83263612|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263613|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83263614|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
83263615|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83263616|NCT02417935|Pregabalin|pregabalin|mesh-list
83263617|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83263618|NCT02417935|Analgesics|analgesics|mesh-ancestor
83263619|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
83263620|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263621|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263622|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
83263623|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83263624|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263625|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263626|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83263627|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83263628|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83263629|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263630|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83263631|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83263632|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83263633|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263634|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
83263635|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
83263636|NCT02447029|Lidocaine|lidocaine|mesh-list
83263637|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
83263638|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
83263639|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263640|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263641|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
83263642|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263643|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83263644|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83263645|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83263646|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263647|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263648|NCT02416453|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83263649|NCT02416453|Antiviral Agents|antiviral agents|mesh-ancestor
83263650|NCT02416453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263651|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
83263652|NCT02469961|Propofol|propofol|mesh-list
83263653|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83263654|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263655|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263656|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263657|NCT02469961|Analgesics|analgesics|mesh-ancestor
83263658|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
83263659|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263660|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83263661|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83263662|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83263663|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
83263664|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263665|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263666|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83263667|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
83263668|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
83263669|NCT02415595|BMS-955176|bms-955176|mesh-list
83263670|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83263671|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83263672|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
83263673|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263674|NCT02446717|Ribavirin|ribavirin|mesh-list
83263675|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
83263676|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263677|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
83263678|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263679|NCT02469415|Azacitidine|azacitidine|mesh-list
83263680|NCT02469415|Decitabine|decitabine|mesh-list
83263681|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83263682|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
83263683|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263684|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263685|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263686|NCT02446171|Naloxegol|naloxegol|mesh-list
83263687|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83263688|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263689|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
83263690|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263691|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83263692|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
83263693|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83263694|NCT02415127|Interferons|interferons|mesh-list
83263695|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
83263696|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263697|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
83263698|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263699|NCT02468557|Paclitaxel|paclitaxel|mesh-list
83263700|NCT02468557|Idelalisib|idelalisib|mesh-list
83263701|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83263702|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263703|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
83263704|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
83263705|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
83263706|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263707|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263708|NCT02413489|Daratumumab|daratumumab|mesh-list
83263709|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263710|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
83263711|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83263712|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
83263713|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263714|NCT02444533|Bupivacaine|bupivacaine|mesh-list
83263715|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
83263716|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
83263717|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263718|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263719|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
83263720|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263721|NCT01651039|Dexamethasone|dexamethasone|mesh-list
83263722|NCT01651039|Lenalidomide|lenalidomide|mesh-list
83263723|NCT01651039|Panobinostat|panobinostat|mesh-list
83263724|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263725|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
83263726|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
83263727|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263728|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263729|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263730|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
83263732|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263733|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263734|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263735|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
83263736|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83263737|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83263738|NCT01651039|Growth Substances|growth substances|mesh-ancestor
83263739|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83263740|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83263741|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263742|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263743|NCT02349633|Palbociclib|palbociclib|mesh-list
83263744|NCT02349633|Avelumab|avelumab|mesh-list
83263745|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263746|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263747|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263748|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263749|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263750|NCT02275611|Oxytocin|oxytocin|mesh-list
83263751|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
83263752|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83263753|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263754|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
83263755|NCT04875585|Lenvatinib|lenvatinib|mesh-list
83263756|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263757|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263758|NCT04875585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83263759|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263760|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263761|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263762|NCT02273973|Letrozole|letrozole|mesh-list
83263763|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263764|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83263765|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83263766|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263767|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263768|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83263769|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
83263770|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263771|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263772|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83263773|NCT05649111|Difluprednate|difluprednate|mesh-list
83263774|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83263775|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
83263776|NCT05649111|Hormones|hormones|mesh-ancestor
83263777|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263778|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263779|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
83263780|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83263781|NCT02465515|Incretins|incretins|mesh-ancestor
83263782|NCT02465515|Hormones|hormones|mesh-ancestor
83263783|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263784|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263785|NCT05561361|Spironolactone|spironolactone|mesh-list
83263786|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83263787|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
83263788|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263789|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263790|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83263791|NCT05561361|Diuretics|diuretics|mesh-ancestor
83263792|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
83263793|NCT02412631|Varenicline|varenicline|mesh-list
83263794|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83263795|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83263796|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
83263797|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263798|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263799|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263800|NCT02272803|Dexamethasone|dexamethasone|mesh-list
83263801|NCT02272803|Lenalidomide|lenalidomide|mesh-list
83263802|NCT02272803|Elotuzumab|elotuzumab|mesh-list
83263803|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263804|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
83263805|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
83263806|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263807|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263808|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263809|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
83263810|NCT02272803|Hormones|hormones|mesh-ancestor
83263811|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263812|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263813|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263814|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
83263815|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83263816|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83263817|NCT02272803|Growth Substances|growth substances|mesh-ancestor
83263818|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
83263819|NCT02272725|Ibuprofen|ibuprofen|mesh-list
83263820|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83263821|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263822|NCT02272725|Analgesics|analgesics|mesh-ancestor
83263823|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
83263824|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263825|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263826|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263827|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263828|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83263829|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263830|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263831|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
83263832|NCT01650805|Ponatinib|ponatinib|mesh-list
83263833|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263834|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263835|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263836|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263837|NCT04922827|Infliximab|infliximab|mesh-list
83263838|NCT04922827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83263839|NCT04922827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263840|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83263841|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263842|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263843|NCT02442349|Osimertinib|osimertinib|mesh-list
83263844|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263845|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83263846|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263847|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263848|NCT02442271|Ritonavir|ritonavir|mesh-list
83263849|NCT02442271|Ribavirin|ribavirin|mesh-list
83263850|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83263851|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83263852|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
83263853|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263854|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263855|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83263856|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83263857|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
83263858|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263859|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83263860|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83263861|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
83263862|NCT02463409|Theophylline|theophylline|mesh-list
83263863|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83263864|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
83263865|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263866|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263867|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83263868|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
83263869|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83263870|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83263871|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263872|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
83263873|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83263874|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83263875|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
83263876|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263877|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
83263878|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263879|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263880|NCT02528357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83263881|NCT02528357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263882|NCT04910503|Dexamethasone|dexamethasone|mesh-list
83263883|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83263884|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263885|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
83263886|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
83263887|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263888|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263889|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263890|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
83263891|NCT04910503|Hormones|hormones|mesh-ancestor
83263892|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263893|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263894|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263895|NCT04910425|Fluorides|fluorides|mesh-list
83263896|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
83263897|NCT04910425|Protective Agents|protective agents|mesh-ancestor
83263898|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263899|NCT02463331|Chloroquine|chloroquine|mesh-list
83263900|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83263901|NCT02463331|Prednisone|prednisone|mesh-list
83263902|NCT02463331|Azathioprine|azathioprine|mesh-list
83263903|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83263904|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
83263905|NCT02463331|Hormones|hormones|mesh-ancestor
83263906|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83263907|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263908|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83263909|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263910|NCT02463331|Amebicides|amebicides|mesh-ancestor
83263911|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83263912|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83263913|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263914|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
83263915|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83263916|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83263917|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83263918|NCT02463331|Analgesics|analgesics|mesh-ancestor
83263919|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
83263920|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263921|NCT02463331|Filaricides|filaricides|mesh-ancestor
83263922|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
83263923|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
83263924|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
83263925|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263926|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83263927|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83263928|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
83263930|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83263931|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263932|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
83263933|NCT05427149|Analgesics|analgesics|mesh-ancestor
83263934|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
83263935|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263936|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263937|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
83263938|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263940|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
83263941|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83263942|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263943|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263944|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83263945|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
83263946|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83263947|NCT02462473|Olanzapine|olanzapine|mesh-list
83263948|NCT02462473|Risperidone|risperidone|mesh-list
83263949|NCT02462473|Aripiprazole|aripiprazole|mesh-list
83263950|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83263951|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83263952|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83263953|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
83263954|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83263955|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83263956|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263957|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83263958|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83263959|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83263960|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83263961|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83263962|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
83263963|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
83263964|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
83263965|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83263966|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83263967|NCT02462473|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83263968|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83263969|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83263970|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
83263971|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
83263972|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83263973|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83263974|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83263975|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83263976|NCT02440789|Sirolimus|sirolimus|mesh-list
83263977|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83263978|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263979|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83263980|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263981|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
83263982|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83263983|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
83263984|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263985|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
83263986|NCT02538107|Hematinics|hematinics|mesh-ancestor
83263987|NCT02272413|Bevacizumab|bevacizumab|mesh-list
83263988|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83263989|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83263990|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83263991|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83263992|NCT02272413|Growth Substances|growth substances|mesh-ancestor
83263993|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83263994|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
83263995|NCT05648799|Molnupiravir|molnupiravir|mesh-list
83263996|NCT05648799|Antiviral Agents|antiviral agents|mesh-ancestor
83263997|NCT05648799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83263998|NCT05400863|Metformin|metformin|mesh-list
83263999|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83264000|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264001|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
83264003|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264004|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264005|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264006|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83264007|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83264008|NCT02120807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83264009|NCT02120807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264010|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83264011|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
83264012|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264013|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264014|NCT02532647|Midazolam|midazolam|mesh-list
83264015|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83264016|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83264017|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264018|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264019|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83264020|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83264021|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264022|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83264023|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
83264024|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
83264025|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
83264026|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
83264027|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264028|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264029|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
83264030|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
83264031|NCT02537015|Bimatoprost|bimatoprost|mesh-list
83264032|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83264033|NCT01660763|Sufentanil|sufentanil|mesh-list
83264034|NCT01660763|Dsuvia|dsuvia|mesh-list
83264035|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83264036|NCT01660763|Narcotics|narcotics|mesh-ancestor
83264037|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264038|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264039|NCT01660763|Analgesics|analgesics|mesh-ancestor
83264040|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
83264041|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264042|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83264043|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83264044|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
83264045|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
83264046|NCT01937117|Trastuzumab|trastuzumab|mesh-list
83264047|NCT01937117|Pertuzumab|pertuzumab|mesh-list
83264048|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264049|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264050|NCT04256213|Nivolumab|nivolumab|mesh-list
83264051|NCT04256213|Ipilimumab|ipilimumab|mesh-list
83264052|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264053|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264054|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264055|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264056|NCT02268045|Rituximab|rituximab|mesh-list
83264057|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264058|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264059|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
83264060|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264061|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264062|NCT02267187|Anesthetics|anesthetics|mesh-list
83264063|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264064|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264065|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
83264066|NCT05388929|Methocarbamol|methocarbamol|mesh-list
83264067|NCT05388929|Narcotics|narcotics|mesh-ancestor
83264068|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264069|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264070|NCT05388929|Analgesics|analgesics|mesh-ancestor
83264071|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
83264072|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264073|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83264074|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83264075|NCT05416229|Psilocybin|psilocybin|mesh-list
83264077|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264078|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264079|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83264080|NCT01638533|Romidepsin|romidepsin|mesh-list
83264081|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264082|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83264083|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264084|NCT01638533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83264085|NCT01638533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264086|NCT01638533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264088|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83264089|NCT01641939|Maytansine|maytansine|mesh-list
83264090|NCT01641939|Taxane|taxane|mesh-list
83264091|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264092|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264093|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83264094|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
83264095|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
83264096|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
83264097|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264098|NCT01641939|Immunotoxins|immunotoxins|mesh-ancestor
83264099|NCT01641939|Immunoconjugates|immunoconjugates|mesh-ancestor
83264100|NCT01641939|Immunologic Factors|immunologic factors|mesh-ancestor
83264101|NCT01641939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264102|NCT02409355|Carboplatin|carboplatin|mesh-list
83264103|NCT02409355|Gemcitabine|gemcitabine|mesh-list
83264104|NCT02409355|Atezolizumab|atezolizumab|mesh-list
83264105|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264106|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83264107|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
83264108|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264109|NCT02409355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264110|NCT02409355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264111|NCT02438371|Indomethacin|indomethacin|mesh-list
83264112|NCT02438371|Nifedipine|nifedipine|mesh-list
83264113|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83264114|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264115|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264116|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83264117|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264118|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
83264119|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
83264120|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83264121|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83264122|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83264123|NCT02438371|Analgesics|analgesics|mesh-ancestor
83264124|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
83264125|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264126|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264127|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264128|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
83264129|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83264130|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264131|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83264132|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
83264133|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83264134|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
83264135|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264136|NCT04920565|Polymyxins|polymyxins|mesh-list
83264137|NCT04920565|Polymyxin B|polymyxin b|mesh-list
83264138|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83264139|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264140|NCT04934683|Propofol|propofol|mesh-list
83264141|NCT04934683|Etomidate|etomidate|mesh-list
83264142|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83264143|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264144|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264145|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83264146|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
83264147|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
83264148|NCT04909333|Exenatide|exenatide|mesh-list
83264149|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83264150|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83264151|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264152|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83264153|NCT04909333|Incretins|incretins|mesh-ancestor
83264154|NCT04909333|Hormones|hormones|mesh-ancestor
83264155|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264156|NCT04909021|Vaccines|vaccines|mesh-list
83264157|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
83264158|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264159|NCT02460991|Sorafenib|sorafenib|mesh-list
83264160|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264161|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83264162|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264163|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264164|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83264165|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83264166|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264167|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83264168|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264169|NCT02436889|Mirabegron|mirabegron|mesh-list
83264170|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83264171|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83264172|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83264173|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83264174|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
83264175|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264176|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264177|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264178|NCT02436889|Urological Agents|urological agents|mesh-ancestor
83264179|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83264180|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83264181|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
83264182|NCT02436577|Ticagrelor|ticagrelor|mesh-list
83264183|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83264184|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83264185|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83264186|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83264187|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
83264188|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264189|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264190|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264191|NCT02459665|Metronidazole|metronidazole|mesh-list
83264192|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264193|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83264194|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83264195|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83264196|NCT02265237|Ritonavir|ritonavir|mesh-list
83264197|NCT02265237|Ribavirin|ribavirin|mesh-list
83264198|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83264199|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83264200|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
83264201|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264202|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264203|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83264204|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83264205|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
83264206|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264207|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83264208|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83264209|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
83264210|NCT04874025|Palbociclib|palbociclib|mesh-list
83264211|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264212|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83264213|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264214|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264215|NCT02263365|Loperamide|loperamide|mesh-list
83264216|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
83264217|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264218|NCT04858269|Paclitaxel|paclitaxel|mesh-list
83264219|NCT04858269|Carboplatin|carboplatin|mesh-list
83264220|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
83264221|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83264222|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264223|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
83264224|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
83264225|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
83264226|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264227|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264228|NCT04858269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264229|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
83264230|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83264231|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83264232|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83264233|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264234|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264235|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
83264236|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264237|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264238|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83264239|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264240|NCT02260791|Adalimumab|adalimumab|mesh-list
83264241|NCT02260791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83264242|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264243|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264244|NCT02260635|Evacetrapib|evacetrapib|mesh-list
83264245|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83264246|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83264247|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
83264248|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264249|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83264250|NCT05646459|Cannabidiol|cannabidiol|mesh-list
83264251|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
83264252|NCT02259231|Nivolumab|nivolumab|mesh-list
83264253|NCT02259231|Ipilimumab|ipilimumab|mesh-list
83264254|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264255|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264256|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264257|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264258|NCT02258529|Rituximab|rituximab|mesh-list
83264259|NCT02258529|Idelalisib|idelalisib|mesh-list
83264260|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264261|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264262|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
83264263|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264264|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264265|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264266|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264267|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
83264268|NCT02256969|Prednisolone|prednisolone|mesh-list
83264269|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83264270|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
83264271|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83264272|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
83264273|NCT02256969|Mineral Oil|mineral oil|mesh-list
83264274|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83264275|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
83264276|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264277|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
83264278|NCT02256969|Hormones|hormones|mesh-ancestor
83264279|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264280|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264281|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83264282|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264283|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
83264284|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
83264285|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264286|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264287|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83264288|NCT02256969|Protective Agents|protective agents|mesh-ancestor
83264289|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83264290|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264291|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83264292|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83264293|NCT02256969|Emollients|emollients|mesh-ancestor
83264294|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
83264295|NCT05645913|Anticoagulants|anticoagulants|mesh-list
83264296|NCT02256267|Rifampin|rifampin|mesh-list
83264297|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83264298|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
83264299|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83264300|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264301|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
83264302|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83264303|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264304|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264305|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83264306|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83264307|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83264308|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83264309|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83264310|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83264312|NCT05429463|Carboplatin|carboplatin|mesh-list
83264313|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83264314|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83264315|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264316|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
83264317|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
83264318|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
83264319|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264320|NCT02255565|Methylphenidate|methylphenidate|mesh-list
83264321|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83264322|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264323|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83264324|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83264325|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264326|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264327|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
83264328|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264329|NCT01640301|Aldesleukin|aldesleukin|mesh-list
83264330|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
83264331|NCT01640301|Fludarabine|fludarabine|mesh-list
83264332|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
83264333|NCT01640301|Interleukin-2|interleukin-2|mesh-list
83264334|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83264335|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
83264336|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264337|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264338|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83264339|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
83264340|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264341|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264342|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83264343|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83264344|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
83264345|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83264346|NCT01640301|Analgesics|analgesics|mesh-ancestor
83264347|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
83264348|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264349|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83264350|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83264351|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
83264352|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264353|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
83264354|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
83264355|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83264356|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83264357|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264358|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264359|NCT01642407|Urological Agents|urological agents|mesh-ancestor
83264360|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
83264361|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264362|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264363|NCT02255097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264364|NCT02255097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264365|NCT02254551|Bortezomib|bortezomib|mesh-list
83264366|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264367|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
83264368|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83264369|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83264370|NCT05640375|Prednisolone|prednisolone|mesh-list
83264371|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
83264372|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83264373|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
83264374|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264375|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
83264376|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
83264377|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264378|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264379|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264380|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
83264381|NCT05640375|Hormones|hormones|mesh-ancestor
83264382|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264383|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83264384|NCT05640375|Protective Agents|protective agents|mesh-ancestor
83264385|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83264386|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264387|NCT01641237|Listerine|listerine|mesh-list
83264388|NCT01641237|Fluorides|fluorides|mesh-list
83264389|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
83264390|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
83264391|NCT01641237|Protective Agents|protective agents|mesh-ancestor
83264392|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264393|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83264394|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264395|NCT05650437|Vitamin D|vitamin d|mesh-list
83264396|NCT05650437|Vitamins|vitamins|mesh-ancestor
83264397|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
83264398|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264399|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83264400|NCT05617209|Thrombin|thrombin|mesh-list
83264401|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
83264402|NCT05617209|Coagulants|coagulants|mesh-ancestor
83264403|NCT01639833|Hemostatics|hemostatics|mesh-list
83264404|NCT01639833|Coagulants|coagulants|mesh-ancestor
83264405|NCT01639131|Gemcitabine|gemcitabine|mesh-list
83264406|NCT01639131|Docetaxel|docetaxel|mesh-list
83264407|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83264408|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
83264409|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264410|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264411|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
83264412|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
83264413|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
83264414|NCT01641159|Buspirone|buspirone|mesh-list
83264415|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83264416|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83264417|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264418|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264419|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264420|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83264421|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
83264422|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264423|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264424|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
83264425|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83264426|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
83264427|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264428|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264429|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83264430|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
83264431|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83264432|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83264433|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83264434|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83264435|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264436|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264437|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
83264438|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83264439|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83264440|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264441|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
83264442|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
83264443|NCT05369481|Minoxidil|minoxidil|mesh-list
83264444|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
83264445|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
83264446|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83264447|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83264448|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264449|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264450|NCT05369481|Urological Agents|urological agents|mesh-ancestor
83264451|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83264452|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
83264453|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83264454|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
83264455|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264456|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
83264457|NCT04853589|Protective Agents|protective agents|mesh-ancestor
83264458|NCT01638429|Rifaximin|rifaximin|mesh-list
83264459|NCT01638429|Neomycin|neomycin|mesh-list
83264460|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83264461|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264462|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264463|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83264464|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264465|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264466|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83264467|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83264468|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264469|NCT04853355|Spironolactone|spironolactone|mesh-list
83264470|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83264471|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
83264472|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264473|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264474|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83264475|NCT04853355|Diuretics|diuretics|mesh-ancestor
83264476|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
83264477|NCT05369091|Simvastatin|simvastatin|mesh-list
83264478|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83264479|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83264480|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
83264481|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264482|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83264483|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83264484|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264485|NCT01601535|Irinotecan|irinotecan|mesh-list
83264486|NCT01601535|Temozolomide|temozolomide|mesh-list
83264487|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83264488|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83264489|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264490|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264491|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264492|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83264493|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
83264494|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83264495|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
83264496|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83264497|NCT05422365|Antibodies|antibodies|mesh-list
83264498|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
83264499|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83264500|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
83264501|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264502|NCT04641273|Pregabalin|pregabalin|mesh-list
83264503|NCT04641273|Analgesics|analgesics|mesh-ancestor
83264504|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
83264505|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264506|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264507|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
83264508|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83264509|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264510|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264511|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83264512|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83264513|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83264514|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264515|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264516|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
83264517|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83264518|NCT04843917|Antibodies|antibodies|mesh-list
83264519|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
83264520|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
83264521|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264522|NCT04586985|Midazolam|midazolam|mesh-list
83264523|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83264524|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83264525|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264526|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264527|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83264528|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83264529|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264530|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83264531|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
83264533|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
83264534|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
83264535|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264536|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264537|NCT04841343|Triamcinolone|triamcinolone|mesh-list
83264538|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264539|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
83264540|NCT04841343|Hormones|hormones|mesh-ancestor
83264541|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264542|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264543|NCT05244057|Interferons|interferons|mesh-list
83264544|NCT05244057|Tenofovir|tenofovir|mesh-list
83264545|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
83264546|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
83264547|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83264548|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264549|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
83264550|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264551|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83264552|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83264553|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264554|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264555|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83264556|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83264557|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
83264558|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264559|NCT05408403|Anesthetics|anesthetics|mesh-list
83264560|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264561|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264562|NCT04830735|Dasatinib|dasatinib|mesh-list
83264563|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264564|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83264565|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264566|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264567|NCT05335317|Hormones|hormones|mesh-list
83264568|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264569|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264570|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83264571|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264572|NCT04419441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264573|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264574|NCT05329779|Pregnanolone|pregnanolone|mesh-list
83264575|NCT05329779|Brexanolone|brexanolone|mesh-list
83264576|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
83264577|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264578|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264579|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
83264580|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264581|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264582|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
83264583|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
83264584|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
83264585|NCT04464759|Nivolumab|nivolumab|mesh-list
83264586|NCT04464759|Ipilimumab|ipilimumab|mesh-list
83264587|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264588|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264589|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264590|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264591|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
83264592|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83264593|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83264594|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264595|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264596|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264597|NCT04850937|Esketamine|esketamine|mesh-list
83264598|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
83264599|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264600|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83264601|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83264602|NCT04411329|Dexamethasone|dexamethasone|mesh-list
83264603|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
83264604|NCT04411329|Bupivacaine|bupivacaine|mesh-list
83264605|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264606|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
83264607|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
83264608|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264609|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264610|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264611|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
83264612|NCT04411329|Hormones|hormones|mesh-ancestor
83264613|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264614|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83264615|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264616|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
83264617|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
83264618|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264619|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
83264620|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83264621|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83264622|NCT04411329|Analgesics|analgesics|mesh-ancestor
83264623|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83264624|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83264625|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83264626|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
83264627|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264628|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264629|NCT05171673|Diclofenac|diclofenac|mesh-list
83264630|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83264631|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83264632|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83264633|NCT05171673|Analgesics|analgesics|mesh-ancestor
83264634|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
83264635|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264636|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264637|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264638|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264639|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83264640|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264641|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264642|NCT05147415|Metoprolol|metoprolol|mesh-list
83264643|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83264644|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83264645|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
83264646|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
83264647|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264648|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264649|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83264650|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83264651|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83264652|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
83264653|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264654|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264655|NCT04390581|Lidocaine|lidocaine|mesh-list
83264656|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
83264657|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
83264658|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264659|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264660|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
83264661|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264662|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83264663|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83264664|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83264665|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264666|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264667|NCT05396859|Decitabine|decitabine|mesh-list
83264668|NCT05396859|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83264669|NCT05396859|Entrectinib|entrectinib|mesh-list
83264670|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83264671|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
83264672|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264673|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264674|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264675|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83264676|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83264677|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264678|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264679|NCT04254549|Rifaximin|rifaximin|mesh-list
83264680|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83264681|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264682|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264683|NCT04225767|Calcium|calcium|mesh-list
83264684|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83264685|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264686|NCT04820673|Sarecycline|sarecycline|mesh-list
83264687|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83264688|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264689|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
83264690|NCT04114539|Ecopipam|ecopipam|mesh-list
83264691|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83264692|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83264693|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264694|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264695|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264696|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83264697|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
83264698|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264699|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264700|NCT03301857|Denosumab|denosumab|mesh-list
83264701|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
83264702|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
83264703|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
83264704|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264705|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83264706|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83264707|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83264708|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
83264709|NCT03263559|Thiotepa|thiotepa|mesh-list
83264710|NCT03263559|Fludarabine|fludarabine|mesh-list
83264711|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
83264712|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
83264713|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83264714|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
83264715|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264716|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264717|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83264718|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
83264719|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264720|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264721|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83264722|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
83264723|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264724|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83264725|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
83264726|NCT03257163|Capecitabine|capecitabine|mesh-list
83264727|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264728|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264729|NCT03257163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264730|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264731|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83264732|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
83264733|NCT03256149|Dexamethasone|dexamethasone|mesh-list
83264734|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264735|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
83264736|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
83264737|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264738|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264739|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264740|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
83264741|NCT03256149|Hormones|hormones|mesh-ancestor
83264742|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264743|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83264744|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264745|NCT03253263|Mecasermin|mecasermin|mesh-list
83264746|NCT03253263|Growth Substances|growth substances|mesh-ancestor
83264747|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264748|NCT01636947|Dexamethasone|dexamethasone|mesh-list
83264749|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
83264750|NCT01636947|Ondansetron|ondansetron|mesh-list
83264751|NCT01636947|Aprepitant|aprepitant|mesh-list
83264752|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
83264753|NCT01636947|Metoclopramide|metoclopramide|mesh-list
83264754|NCT01636947|Granisetron|granisetron|mesh-list
83264755|NCT01636947|Tropisetron|tropisetron|mesh-list
83264756|NCT01636947|Dolasetron|dolasetron|mesh-list
83264757|NCT01636947|Alizapride|alizapride|mesh-list
83264758|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83264759|NCT01636947|BB 1101|bb 1101|mesh-list
83264760|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264761|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
83264762|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
83264763|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264764|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264765|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264766|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
83264767|NCT01636947|Hormones|hormones|mesh-ancestor
83264768|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264769|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83264770|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264771|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
83264772|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264773|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264774|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
83264775|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
83264776|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83264777|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83264778|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
83264779|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264780|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83264781|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83264782|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83264783|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
83264784|NCT03052725|Reslizumab|reslizumab|mesh-list
83264785|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83264786|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
83264787|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
83264788|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264789|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264790|NCT04793919|Tretinoin|tretinoin|mesh-list
83264791|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
83264792|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
83264793|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264794|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
83264795|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
83264796|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264797|NCT04793919|Immunotoxins|immunotoxins|mesh-ancestor
83264798|NCT04793919|Immunoconjugates|immunoconjugates|mesh-ancestor
83264799|NCT04793919|Immunologic Factors|immunologic factors|mesh-ancestor
83264800|NCT04793919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264801|NCT02817633|Carboplatin|carboplatin|mesh-list
83264802|NCT02817633|Docetaxel|docetaxel|mesh-list
83264803|NCT02817633|Nivolumab|nivolumab|mesh-list
83264804|NCT02817633|Pemetrexed|pemetrexed|mesh-list
83264805|NCT02817633|Dostarlimab|dostarlimab|mesh-list
83264806|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264807|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
83264808|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
83264809|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
83264810|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264811|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264812|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264813|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264814|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83264815|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83264816|NCT05651607|Cannabidiol|cannabidiol|mesh-list
83264817|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
83264818|NCT02775435|Paclitaxel|paclitaxel|mesh-list
83264819|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83264820|NCT02775435|Carboplatin|carboplatin|mesh-list
83264821|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
83264823|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264824|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83264825|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83264826|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83264827|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264828|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264829|NCT02775435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264830|NCT02774421|Trastuzumab|trastuzumab|mesh-list
83264831|NCT02774421|Molgramostim|molgramostim|mesh-list
83264832|NCT02774421|Sargramostim|sargramostim|mesh-list
83264833|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264834|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264835|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
83264836|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264837|NCT04791969|Naltrexone|naltrexone|mesh-list
83264838|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83264839|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83264840|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264841|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
83264842|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264843|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
83264844|NCT05651373|Prednisone|prednisone|mesh-list
83264845|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
83264846|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83264847|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
83264848|NCT05651373|Hormones|hormones|mesh-ancestor
83264849|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83264850|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264851|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83264852|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264853|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
83264854|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83264855|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83264856|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83264857|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264858|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264859|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264860|NCT05651373|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83264861|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83264862|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
83264863|NCT03905889|Sunitinib|sunitinib|mesh-list
83264864|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264865|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83264866|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83264867|NCT03905889|Growth Substances|growth substances|mesh-ancestor
83264868|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264869|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
83264870|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83264871|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264872|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264873|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83264874|NCT03846765|Phenylephrine|phenylephrine|mesh-list
83264875|NCT03846765|Dobutamine|dobutamine|mesh-list
83264876|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
83264877|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83264878|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
83264879|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
83264880|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264881|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264882|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
83264883|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83264884|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
83264885|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
83264886|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83264887|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83264888|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83264889|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
83264890|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264891|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264892|NCT03846765|Protective Agents|protective agents|mesh-ancestor
83264893|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83264894|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83264895|NCT05163405|Bortezomib|bortezomib|mesh-list
83264896|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264897|NCT03822897|Cisplatin|cisplatin|mesh-list
83264898|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264899|NCT02311179|Cimetidine|cimetidine|mesh-list
83264900|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83264901|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83264902|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83264903|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
83264904|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
83264905|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264906|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264907|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264908|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83264909|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83264910|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264911|NCT04801953|Nimodipine|nimodipine|mesh-list
83264912|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83264913|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83264914|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264915|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264916|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83264917|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264918|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
83264919|NCT01635153|Micronutrients|micronutrients|mesh-list
83264920|NCT01635153|Trace Elements|trace elements|mesh-list
83264921|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264922|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83264923|NCT04446039|Vortioxetine|vortioxetine|mesh-list
83264924|NCT04446039|Mirtazapine|mirtazapine|mesh-list
83264925|NCT04446039|Bupropion|bupropion|mesh-list
83264926|NCT04446039|Fluoxetine|fluoxetine|mesh-list
83264927|NCT04446039|Paroxetine|paroxetine|mesh-list
83264928|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83264929|NCT04446039|Sertraline|sertraline|mesh-list
83264930|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83264931|NCT04446039|Tianeptine|tianeptine|mesh-list
83264932|NCT04446039|Escitalopram|escitalopram|mesh-list
83264933|NCT04446039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83264934|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83264935|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264936|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264937|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83264938|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
83264939|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264940|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264941|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83264942|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
83264943|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83264944|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83264945|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
83264946|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83264947|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83264948|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264949|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83264950|NCT04446039|Analgesics|analgesics|mesh-ancestor
83264951|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
83264952|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83264953|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83264954|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264955|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83264956|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83264957|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83264958|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83264959|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83264960|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
83264961|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
83264962|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83264963|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83264964|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83264966|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83264967|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83264968|NCT04192773|Lidocaine|lidocaine|mesh-list
83264969|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
83264970|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
83264971|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83264972|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264973|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
83264974|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83264975|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83264976|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83264977|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83264978|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83264979|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264980|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
83264981|NCT04784247|Lenvatinib|lenvatinib|mesh-list
83264982|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83264983|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83264984|NCT04784247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83264985|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83264986|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83264987|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83264988|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
83264989|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
83264990|NCT05031897|Melphalan|melphalan|mesh-list
83264991|NCT05031897|Fludarabine|fludarabine|mesh-list
83264992|NCT05031897|Tacrolimus|tacrolimus|mesh-list
83264993|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83264994|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
83264995|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83264996|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83264997|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83264998|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
83264999|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265000|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265001|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83265002|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83265003|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265004|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83265005|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83265006|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
83265007|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83265008|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265009|NCT04800471|Insulin|insulin|mesh-list
83265010|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83265011|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265012|NCT01582191|Everolimus|everolimus|mesh-list
83265013|NCT01582191|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83265014|NCT01582191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265015|NCT01582191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265016|NCT01582191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265017|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265018|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
83265019|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265020|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265021|NCT03591861|Carmustine|carmustine|mesh-list
83265022|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83265023|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
83265024|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265025|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265026|NCT01600053|Lenalidomide|lenalidomide|mesh-list
83265027|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
83265028|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265029|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83265030|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83265031|NCT01600053|Growth Substances|growth substances|mesh-ancestor
83265032|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
83265033|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265034|NCT03573297|Cariprazine|cariprazine|mesh-list
83265035|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83265036|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83265037|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265038|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265040|NCT03569241|Androgens|androgens|mesh-list
83265041|NCT03569241|Hormones|hormones|mesh-ancestor
83265042|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265043|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265044|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
83265045|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
83265046|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83265047|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265048|NCT01068249|Everolimus|everolimus|mesh-list
83265049|NCT01068249|Letrozole|letrozole|mesh-list
83265050|NCT01068249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83265051|NCT01068249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265052|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265053|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265054|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265055|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
83265056|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265057|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265058|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83265059|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83265060|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83265061|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
83265062|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265063|NCT01035099|Letrozole|letrozole|mesh-list
83265064|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265065|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83265066|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83265067|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265068|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265069|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83265070|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
83265071|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265072|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265073|NCT03560349|Lidocaine|lidocaine|mesh-list
83265074|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
83265075|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
83265076|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265077|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265078|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
83265079|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265080|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83265081|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83265082|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83265083|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83265084|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265085|NCT04435431|Mesdopetam|mesdopetam|mesh-list
83265086|NCT04435431|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83265087|NCT04435431|Dopamine Agents|dopamine agents|mesh-ancestor
83265088|NCT04435431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265089|NCT04435431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265090|NCT04435431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265091|NCT00098475|Thalidomide|thalidomide|mesh-list
83265092|NCT00098475|Dexamethasone|dexamethasone|mesh-list
83265093|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
83265094|NCT00098475|Lenalidomide|lenalidomide|mesh-list
83265095|NCT00098475|Ichthammol|ichthammol|mesh-list
83265096|NCT00098475|BB 1101|bb 1101|mesh-list
83265097|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265098|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
83265099|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
83265100|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265101|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265102|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265103|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
83265104|NCT00098475|Hormones|hormones|mesh-ancestor
83265105|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265106|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83265107|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265108|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
83265109|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265110|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265111|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
83265112|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83265113|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83265114|NCT00098475|Growth Substances|growth substances|mesh-ancestor
83265115|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
83265116|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265117|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
83265118|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83265119|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265120|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83265121|NCT02246673|Febuxostat|febuxostat|mesh-list
83265122|NCT02246673|Verinurad|verinurad|mesh-list
83265123|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
83265124|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265125|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83265126|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83265127|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83265128|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265129|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265130|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
83265131|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265132|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83265133|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83265134|NCT04191447|Budesonide|budesonide|mesh-list
83265135|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
83265136|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83265137|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265138|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83265139|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
83265140|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265141|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265142|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83265143|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265144|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
83265145|NCT04191447|Hormones|hormones|mesh-ancestor
83265146|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265147|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83265148|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83265149|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83265150|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
83265151|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265152|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265153|NCT04274361|Ketamine|ketamine|mesh-list
83265154|NCT04274361|Analgesics|analgesics|mesh-ancestor
83265155|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
83265156|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265157|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265158|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83265159|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83265160|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
83265161|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
83265162|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265163|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83265164|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83265165|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265166|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265167|NCT04251819|Baclofen|baclofen|mesh-list
83265168|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83265169|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265170|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83265171|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265172|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83265173|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
83265174|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
83265175|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265176|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265178|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
83265179|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
83265180|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265181|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
83265182|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83265183|NCT03401073|Antibodies|antibodies|mesh-list
83265184|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
83265185|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83265186|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
83265187|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265188|NCT02242305|Scopolamine|scopolamine|mesh-list
83265189|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83265190|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83265191|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
83265192|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
83265193|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265194|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265195|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265196|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
83265197|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83265198|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
83265199|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265200|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265201|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83265202|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
83265203|NCT02240121|Rifaximin|rifaximin|mesh-list
83265204|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83265205|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265206|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265207|NCT04780269|Dinoprostone|dinoprostone|mesh-list
83265208|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
83265209|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83265210|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265211|NCT02238483|AZD7624|azd7624|mesh-list
83265212|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265213|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265214|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265215|NCT01632891|Ritonavir|ritonavir|mesh-list
83265216|NCT01632891|Lopinavir|lopinavir|mesh-list
83265217|NCT01632891|Tenofovir|tenofovir|mesh-list
83265218|NCT01632891|Emtricitabine|emtricitabine|mesh-list
83265219|NCT01632891|Nevirapine|nevirapine|mesh-list
83265220|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83265221|NCT01632891|Efavirenz|efavirenz|mesh-list
83265222|NCT01632891|Trimethoprim|trimethoprim|mesh-list
83265223|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
83265224|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83265225|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83265226|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
83265227|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265228|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265229|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83265230|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83265231|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
83265232|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265233|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83265234|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83265235|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83265236|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83265237|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83265238|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83265239|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83265240|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83265241|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83265242|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83265243|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
83265244|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83265245|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83265246|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83265247|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83265248|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83265249|NCT02208843|Afatinib|afatinib|mesh-list
83265250|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265251|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265252|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265253|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265254|NCT02208063|Vancomycin|vancomycin|mesh-list
83265255|NCT02208063|Cefazolin|cefazolin|mesh-list
83265256|NCT02208063|Daptomycin|daptomycin|mesh-list
83265257|NCT02208063|Penicillins|penicillins|mesh-list
83265258|NCT02208063|Cloxacillin|cloxacillin|mesh-list
83265259|NCT02208063|Oxacillin|oxacillin|mesh-list
83265260|NCT02208063|Telavancin|telavancin|mesh-list
83265261|NCT02208063|Nafcillin|nafcillin|mesh-list
83265262|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83265263|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265264|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83265265|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265266|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265267|NCT03729609|Immunotoxins|immunotoxins|mesh-ancestor
83265268|NCT03729609|Immunoconjugates|immunoconjugates|mesh-ancestor
83265269|NCT03729609|Immunologic Factors|immunologic factors|mesh-ancestor
83265270|NCT03729609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265271|NCT02207907|Listerine|listerine|mesh-list
83265272|NCT02207907|Fluorides|fluorides|mesh-list
83265273|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
83265274|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
83265275|NCT02207907|Protective Agents|protective agents|mesh-ancestor
83265276|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265277|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83265278|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265279|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
83265280|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83265281|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
83265282|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265283|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265284|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83265285|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265286|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
83265287|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83265288|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83265289|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265290|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265291|NCT02237157|Gemcitabine|gemcitabine|mesh-list
83265292|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83265293|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
83265294|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265295|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265296|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
83265297|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83265298|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83265299|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83265300|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
83265301|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265302|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265303|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265304|NCT02233803|Budesonide|budesonide|mesh-list
83265305|NCT02233803|Albuterol|albuterol|mesh-list
83265306|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83265307|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265308|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83265309|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
83265310|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265311|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265312|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83265313|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265314|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
83265315|NCT02233803|Hormones|hormones|mesh-ancestor
83265316|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265317|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
83265318|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83265319|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83265320|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83265321|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83265322|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
83265323|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265324|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265325|NCT02233647|Cocaine|cocaine|mesh-list
83265326|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
83265327|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
83265328|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265329|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265330|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
83265331|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265332|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83265333|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83265334|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83265335|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83265336|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265337|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
83265338|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265339|NCT01632579|Celecoxib|celecoxib|mesh-list
83265340|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83265341|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83265342|NCT01632579|Analgesics|analgesics|mesh-ancestor
83265343|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
83265344|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265345|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265346|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265347|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265348|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83265349|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83265350|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265351|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265353|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83265354|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83265355|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83265356|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265357|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265358|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
83265359|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265360|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83265361|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83265362|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83265363|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83265364|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83265365|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83265366|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83265367|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83265368|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
83265369|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
83265370|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83265371|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83265372|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265373|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265374|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265375|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265376|NCT02205333|Rituximab|rituximab|mesh-list
83265377|NCT02205333|Durvalumab|durvalumab|mesh-list
83265378|NCT02205333|Tremelimumab|tremelimumab|mesh-list
83265379|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265380|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265381|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
83265382|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265383|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265384|NCT04776369|Lidocaine|lidocaine|mesh-list
83265385|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
83265386|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
83265387|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
83265388|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265389|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265390|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
83265391|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265392|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83265393|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83265394|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83265395|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83265396|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265397|NCT04776369|Analgesics|analgesics|mesh-ancestor
83265398|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
83265399|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83265400|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83265401|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
83265402|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83265403|NCT02230527|Clopidogrel|clopidogrel|mesh-list
83265404|NCT02230527|Ticagrelor|ticagrelor|mesh-list
83265405|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83265406|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83265407|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83265408|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83265409|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
83265410|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265411|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265412|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265413|NCT03155061|Nivolumab|nivolumab|mesh-list
83265414|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265415|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265416|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83265417|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265418|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
83265419|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83265420|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265421|NCT02203149|Grazoprevir|grazoprevir|mesh-list
83265423|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265424|NCT02520063|Everolimus|everolimus|mesh-list
83265425|NCT02520063|Letrozole|letrozole|mesh-list
83265426|NCT02520063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83265427|NCT02520063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265428|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265429|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265430|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265431|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
83265432|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265433|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265434|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83265435|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83265436|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83265437|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
83265438|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265439|NCT02202837|Etanercept|etanercept|mesh-list
83265440|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83265441|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83265442|NCT02202837|Analgesics|analgesics|mesh-ancestor
83265443|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
83265444|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265445|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265446|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265447|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265448|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265449|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265450|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
83265451|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
83265452|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83265453|NCT02226549|Ledipasvir|ledipasvir|mesh-list
83265454|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
83265455|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265456|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83265457|NCT02226003|Glimepiride|glimepiride|mesh-list
83265458|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
83265459|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83265460|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265461|NCT02226003|Incretins|incretins|mesh-ancestor
83265462|NCT02226003|Hormones|hormones|mesh-ancestor
83265463|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265464|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83265465|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
83265466|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265467|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265468|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83265469|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265470|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
83265471|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83265473|NCT02469519|Betamethasone|betamethasone|mesh-list
83265474|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265475|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
83265476|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
83265477|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265478|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265479|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265480|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
83265481|NCT02469519|Hormones|hormones|mesh-ancestor
83265482|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265483|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83265484|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265485|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83265486|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265487|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
83265488|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83265489|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
83265490|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265491|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265492|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83265493|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265494|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
83265495|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83265496|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
83265497|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265498|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265499|NCT02404441|Spartalizumab|spartalizumab|mesh-list
83265500|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83265501|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265502|NCT02404441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265503|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265504|NCT02101281|Mitogens|mitogens|mesh-list
83265505|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83265506|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265507|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
83265508|NCT02224599|Imiquimod|imiquimod|mesh-list
83265509|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265510|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
83265511|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265512|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265513|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83265514|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
83265515|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265516|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265517|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83265518|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83265519|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
83265520|NCT04763577|Bradykinin|bradykinin|mesh-list
83265521|NCT04763577|Kininogens|kininogens|mesh-list
83265522|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
83265523|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83265524|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
83265525|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265526|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265527|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
83265528|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83265529|NCT02201901|Velpatasvir|velpatasvir|mesh-list
83265530|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
83265531|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265532|NCT02224053|Osimertinib|osimertinib|mesh-list
83265533|NCT02224053|Omeprazole|omeprazole|mesh-list
83265534|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83265535|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265536|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83265537|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265538|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265539|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265540|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265541|NCT04762875|Plerixafor|plerixafor|mesh-list
83265542|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83265543|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83265544|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
83265545|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265546|NCT04774107|Ribavirin|ribavirin|mesh-list
83265547|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
83265548|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265549|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
83265550|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265551|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
83265552|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265553|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265554|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265555|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265556|NCT02434939|Ketamine|ketamine|mesh-list
83265557|NCT02434939|Morphine|morphine|mesh-list
83265558|NCT02434939|Analgesics|analgesics|mesh-ancestor
83265559|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
83265560|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265561|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265562|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83265563|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83265564|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
83265565|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
83265566|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265567|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83265568|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83265569|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265570|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265571|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83265572|NCT02434939|Narcotics|narcotics|mesh-ancestor
83265573|NCT02457325|Carticaine|carticaine|mesh-list
83265574|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
83265575|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
83265576|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265577|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265578|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
83265579|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265580|NCT02434081|Nivolumab|nivolumab|mesh-list
83265581|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265582|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265583|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83265584|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265585|NCT02222493|Infliximab|infliximab|mesh-list
83265586|NCT02222493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83265587|NCT02222493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265588|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
83265589|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265590|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265591|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83265592|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
83265593|NCT01439997|Coagulants|coagulants|mesh-ancestor
83265594|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83265595|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
83265596|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265597|NCT02403271|Durvalumab|durvalumab|mesh-list
83265598|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265599|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265600|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
83265601|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83265602|NCT02219685|Ledipasvir|ledipasvir|mesh-list
83265603|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
83265604|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265605|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
83265606|NCT02457247|Antacids|antacids|mesh-ancestor
83265607|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265608|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265609|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83265610|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83265611|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265612|NCT02198235|Dexamethasone|dexamethasone|mesh-list
83265613|NCT02198235|Buprenorphine|buprenorphine|mesh-list
83265614|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265615|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
83265616|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
83265617|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265618|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265619|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265621|NCT02198235|Hormones|hormones|mesh-ancestor
83265622|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265623|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83265624|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265625|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83265626|NCT02198235|Narcotics|narcotics|mesh-ancestor
83265627|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265628|NCT02198235|Analgesics|analgesics|mesh-ancestor
83265629|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
83265630|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83265631|NCT00346125|Doxorubicin|doxorubicin|mesh-list
83265632|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83265633|NCT00346125|Ifosfamide|ifosfamide|mesh-list
83265634|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83265635|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83265636|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265637|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83265638|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83265639|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265640|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265641|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83265642|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
83265643|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83265644|NCT04929379|Fenofibrate|fenofibrate|mesh-list
83265645|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83265646|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
83265647|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265648|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83265649|NCT02217501|Aspirin|aspirin|mesh-list
83265650|NCT02217501|Clopidogrel|clopidogrel|mesh-list
83265651|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83265652|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83265653|NCT02217501|Analgesics|analgesics|mesh-ancestor
83265654|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
83265655|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265656|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265657|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265658|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265659|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83265660|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83265661|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265662|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83265663|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83265664|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265665|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
83265666|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83265667|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83265668|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83265669|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
83265670|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265671|NCT01649869|Valganciclovir|valganciclovir|mesh-list
83265672|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
83265673|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265674|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
83265675|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83265676|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265677|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
83265678|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
83265679|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
83265680|NCT02399449|Hematinics|hematinics|mesh-ancestor
83265681|NCT02217345|Hormones|hormones|mesh-list
83265682|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265683|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265684|NCT02428855|Dasatinib|dasatinib|mesh-list
83265685|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265686|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265687|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265688|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265689|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
83265690|NCT02428699|Liver Extracts|liver extracts|mesh-list
83265691|NCT02428699|Hematinics|hematinics|mesh-ancestor
83265692|NCT02428699|Vitamins|vitamins|mesh-ancestor
83265693|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
83265694|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265696|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
83265697|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265698|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
83265699|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265700|NCT02427841|Paclitaxel|paclitaxel|mesh-list
83265701|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83265702|NCT02427841|Gemcitabine|gemcitabine|mesh-list
83265703|NCT02427841|Fluorouracil|fluorouracil|mesh-list
83265704|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83265705|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265706|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
83265707|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
83265708|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
83265709|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265710|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83265711|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
83265712|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265713|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
83265714|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265715|NCT02397889|Midazolam|midazolam|mesh-list
83265716|NCT02397889|Ketamine|ketamine|mesh-list
83265717|NCT02397889|Analgesics|analgesics|mesh-ancestor
83265718|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
83265719|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265720|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265721|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83265722|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83265723|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
83265724|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
83265725|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265726|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83265727|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83265728|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265729|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265730|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83265731|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83265732|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83265733|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83265734|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83265735|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
83265736|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
83265737|NCT02396953|Lanreotide|lanreotide|mesh-list
83265738|NCT02396953|Somatostatin|somatostatin|mesh-list
83265739|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265740|NCT02396953|Hormones|hormones|mesh-ancestor
83265741|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265742|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265743|NCT02387983|Posaconazole|posaconazole|mesh-list
83265744|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
83265745|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265746|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83265747|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83265748|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83265749|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83265750|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83265751|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265752|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265753|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83265754|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
83265755|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265756|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265757|NCT02395627|Tamoxifen|tamoxifen|mesh-list
83265758|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
83265759|NCT02395627|Vorinostat|vorinostat|mesh-list
83265760|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265761|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265762|NCT02395627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83265763|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265764|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83265765|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
83265766|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265767|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265768|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83265769|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83265770|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83265771|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83265772|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83265773|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265774|NCT02395081|Vitamin D|vitamin d|mesh-list
83265775|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
83265776|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
83265777|NCT02395081|Vitamins|vitamins|mesh-list
83265778|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
83265779|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265780|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83265781|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83265782|NCT04905277|Atenolol|atenolol|mesh-list
83265783|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83265784|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83265785|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
83265786|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
83265787|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265788|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265789|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83265790|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83265791|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83265792|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
83265793|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265794|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265795|NCT02426125|Docetaxel|docetaxel|mesh-list
83265796|NCT02426125|Ramucirumab|ramucirumab|mesh-list
83265797|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265798|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
83265799|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
83265800|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
83265801|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265802|NCT02425111|Vedolizumab|vedolizumab|mesh-list
83265803|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83265804|NCT02393755|Capecitabine|capecitabine|mesh-list
83265806|NCT02393755|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83265807|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83265808|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
83265809|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265810|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265811|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83265812|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265813|NCT02393209|Docetaxel|docetaxel|mesh-list
83265814|NCT02393209|Serabelisib|serabelisib|mesh-list
83265815|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265816|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83265817|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83265818|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83265819|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265820|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265821|NCT02424097|Listerine|listerine|mesh-list
83265822|NCT02424097|Fluorides|fluorides|mesh-list
83265823|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
83265824|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
83265825|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
83265826|NCT02424097|Protective Agents|protective agents|mesh-ancestor
83265827|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265828|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83265829|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265830|NCT02392507|Paclitaxel|paclitaxel|mesh-list
83265831|NCT02392507|Carboplatin|carboplatin|mesh-list
83265832|NCT02392507|Necitumumab|necitumumab|mesh-list
83265833|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83265834|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265835|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
83265836|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
83265837|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
83265838|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265839|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83265840|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
83265841|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83265842|NCT04904341|Protective Agents|protective agents|mesh-ancestor
83265843|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265844|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
83265845|NCT02385799|Sertraline|sertraline|mesh-list
83265846|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
83265847|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83265848|NCT02385799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83265849|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83265850|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83265851|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265852|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265853|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
83265854|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265855|NCT02422303|Ketamine|ketamine|mesh-list
83265856|NCT02422303|Analgesics|analgesics|mesh-ancestor
83265857|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
83265858|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265859|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265860|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83265861|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83265862|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
83265863|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
83265864|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83265865|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83265866|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83265867|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265868|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265869|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
83265870|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83265871|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83265872|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362246|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265873|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83265874|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83265875|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265876|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83265877|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265878|NCT02384395|Lamivudine|lamivudine|mesh-list
83265879|NCT02384395|Abacavir|abacavir|mesh-list
83265880|NCT02384395|Dolutegravir|dolutegravir|mesh-list
83265881|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83265882|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83265883|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265884|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265885|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
83265886|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265887|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83265888|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83265889|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83265890|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83265891|NCT02391337|Digoxin|digoxin|mesh-list
83265892|NCT02391337|Bisoprolol|bisoprolol|mesh-list
83265893|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83265894|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83265895|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265896|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265897|NCT02391337|Protective Agents|protective agents|mesh-ancestor
83265898|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265899|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83265900|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
83265901|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
83265902|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265903|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83265904|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83265905|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83265906|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
83265907|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265908|NCT01649791|Lenalidomide|lenalidomide|mesh-list
83265909|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
83265910|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265911|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83265912|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83265913|NCT01649791|Growth Substances|growth substances|mesh-ancestor
83265914|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
83265915|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265916|NCT02347657|Ivacaftor|ivacaftor|mesh-list
83265917|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83265918|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83265919|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265920|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
83265921|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83265922|NCT02346721|Velpatasvir|velpatasvir|mesh-list
83265923|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
83265924|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265925|NCT02388997|Omalizumab|omalizumab|mesh-list
83265926|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83265927|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83265928|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265929|NCT02345161|Budesonide|budesonide|mesh-list
83265930|NCT02345161|Albuterol|albuterol|mesh-list
83265931|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
83265932|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83265933|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83265934|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83265935|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
83265936|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83265937|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265938|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83265939|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265940|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
83265941|NCT02345161|Hormones|hormones|mesh-ancestor
83265942|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83265943|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83265944|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83265945|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83265946|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83265947|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83265948|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265949|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
83265950|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83265951|NCT02251275|Tolvaptan|tolvaptan|mesh-list
83265952|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83265953|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265954|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
83265955|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265956|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
83265957|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83265958|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
83265959|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265960|NCT02379637|Expectorants|expectorants|mesh-ancestor
83265961|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
83265962|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83265963|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
83265964|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265965|NCT02379637|Protective Agents|protective agents|mesh-ancestor
83265966|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265967|NCT02379637|Antidotes|antidotes|mesh-ancestor
83265968|NCT02195583|Zinc|zinc|mesh-list
83265969|NCT02195583|Listerine|listerine|mesh-list
83265970|NCT02195583|Fluorides|fluorides|mesh-list
83265971|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
83265972|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
83265973|NCT02195583|Protective Agents|protective agents|mesh-ancestor
83265974|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265975|NCT02195583|Trace Elements|trace elements|mesh-ancestor
83265976|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
83265977|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83265978|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83265979|NCT02379091|Leucovorin|leucovorin|mesh-list
83265980|NCT02379091|Folic Acid|folic acid|mesh-list
83265981|NCT02379091|Methotrexate|methotrexate|mesh-list
83265982|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
83265983|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83265984|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
83265985|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83265986|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83265987|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83265988|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
83265989|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83265990|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83265991|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
83265992|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83265993|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83265994|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83265995|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
83265996|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83265997|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83265998|NCT02379091|Antidotes|antidotes|mesh-ancestor
83265999|NCT02379091|Protective Agents|protective agents|mesh-ancestor
83266000|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
83266001|NCT02379091|Vitamins|vitamins|mesh-ancestor
83266002|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
83266003|NCT02379091|Hematinics|hematinics|mesh-ancestor
83266004|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
83266005|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83266006|NCT02378935|Velpatasvir|velpatasvir|mesh-list
83266007|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
83266008|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266009|NCT02250651|Timolol|timolol|mesh-list
83266010|NCT02250651|Bimatoprost|bimatoprost|mesh-list
83266011|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83266012|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83266013|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83266014|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266015|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266016|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266017|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83266018|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83266019|NCT02214225|Vaccines|vaccines|mesh-list
83266020|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
83266021|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266022|NCT02249949|Efatutazone|efatutazone|mesh-list
83266023|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266024|NCT02249091|Cytarabine|cytarabine|mesh-list
83266025|NCT02249091|Idarubicin|idarubicin|mesh-list
83266026|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266027|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
83266028|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266029|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266030|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
83266031|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266032|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266033|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
83266034|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266035|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83266036|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83266037|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83266038|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266039|NCT02213055|Permethrin|permethrin|mesh-list
83266040|NCT02213055|Malathion|malathion|mesh-list
83266041|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266042|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266043|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83266044|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
83266045|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266046|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266047|NCT02309515|Lenalidomide|lenalidomide|mesh-list
83266048|NCT02309515|Vaccines|vaccines|mesh-list
83266049|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
83266050|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266051|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83266052|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83266053|NCT02309515|Growth Substances|growth substances|mesh-ancestor
83266054|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
83266055|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266056|NCT02309359|Methotrexate|methotrexate|mesh-list
83266057|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83266058|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
83266059|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266060|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266061|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266062|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
83266063|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266064|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266065|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83266066|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266067|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83266068|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266069|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
83266070|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266071|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83266073|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83266074|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83266075|NCT02375971|Growth Substances|growth substances|mesh-ancestor
83266076|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266077|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
83266078|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266079|NCT04886323|Itraconazole|itraconazole|mesh-list
83266080|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
83266081|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266082|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83266083|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83266084|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266085|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266086|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83266087|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
83266088|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266089|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266090|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83266091|NCT02212197|Leuprolide|leuprolide|mesh-list
83266092|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83266093|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
83266094|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266095|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266096|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266097|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266098|NCT02193165|Triclosan|triclosan|mesh-list
83266099|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
83266100|NCT02193165|Fluorides|fluorides|mesh-list
83266101|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
83266102|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
83266103|NCT02193165|Protective Agents|protective agents|mesh-ancestor
83266104|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266105|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83266106|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266107|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83266108|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83266109|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
83266110|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266111|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83266112|NCT01617460|Aripiprazole|aripiprazole|mesh-list
83266113|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
83266114|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83266115|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83266116|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83266117|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266118|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266119|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
83266120|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
83266121|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266122|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266123|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83266124|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83266125|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
83266126|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83266127|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83266128|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83266129|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83266130|NCT01889602|Topiramate|topiramate|mesh-list
83266131|NCT01889602|Lorazepam|lorazepam|mesh-list
83266132|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
83266133|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83266134|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266135|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
83266136|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
83266137|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266138|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266139|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83266140|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266141|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83266142|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83266143|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83266144|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
83266145|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
83266146|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266147|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266148|NCT01935700|Colchicine|colchicine|mesh-list
83266149|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
83266150|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266151|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
83266152|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
83266153|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
83266154|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266155|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266156|NCT01618162|Liraglutide|liraglutide|mesh-list
83266157|NCT01618162|Xultophy|xultophy|mesh-list
83266158|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83266159|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266160|NCT01618162|Incretins|incretins|mesh-ancestor
83266161|NCT01618162|Hormones|hormones|mesh-ancestor
83266162|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266163|NCT04771767|Ketamine|ketamine|mesh-list
83266164|NCT04771767|Analgesics|analgesics|mesh-ancestor
83266165|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
83266166|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266167|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266168|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83266169|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83266170|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
83266171|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
83266172|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362247|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266173|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83266175|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266176|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266177|NCT02341417|Cinacalcet|cinacalcet|mesh-list
83266178|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83266179|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266180|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83266181|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
83266182|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266183|NCT02340949|Leucovorin|leucovorin|mesh-list
83266184|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
83266185|NCT02340949|Aflibercept|aflibercept|mesh-list
83266186|NCT02340949|Fluorouracil|fluorouracil|mesh-list
83266187|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266188|NCT02340949|Antidotes|antidotes|mesh-ancestor
83266189|NCT02340949|Protective Agents|protective agents|mesh-ancestor
83266190|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266191|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
83266192|NCT02340949|Vitamins|vitamins|mesh-ancestor
83266193|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
83266194|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83266195|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83266196|NCT02340949|Growth Substances|growth substances|mesh-ancestor
83266197|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
83266198|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
83266199|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266200|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266201|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266202|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
83266203|NCT02374957|Cilostazol|cilostazol|mesh-list
83266204|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83266205|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
83266206|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266207|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266208|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83266209|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
83266210|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83266211|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83266212|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266213|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83266214|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
83266215|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83266216|NCT02374957|Protective Agents|protective agents|mesh-ancestor
83266217|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83266218|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83266219|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266220|NCT02308033|Metronidazole|metronidazole|mesh-list
83266221|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266222|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83266223|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83266224|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83266225|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
83266226|NCT02339155|Promethazine|promethazine|mesh-list
83266227|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83266228|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83266229|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266230|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266231|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
83266232|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
83266233|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
83266234|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266235|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
83266236|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
83266237|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266238|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83266239|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
83266240|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
83266241|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266242|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266243|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83266244|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
83266245|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
83266246|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83266247|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
83266248|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83266249|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83266250|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83266251|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266253|NCT02210091|BAX 855|bax 855|mesh-list
83266254|NCT02210091|Coagulants|coagulants|mesh-ancestor
83266255|NCT02338999|Pioglitazone|pioglitazone|mesh-list
83266256|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83266257|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266258|NCT02169219|Prednisone|prednisone|mesh-list
83266259|NCT02169219|Rituximab|rituximab|mesh-list
83266260|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
83266261|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83266262|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266263|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
83266264|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266265|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266266|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266267|NCT02169219|Hormones|hormones|mesh-ancestor
83266268|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266269|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266270|NCT02191137|Riociguat|riociguat|mesh-list
83266271|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
83266272|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266273|NCT02168439|Midazolam|midazolam|mesh-list
83266274|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
83266275|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83266276|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266277|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266278|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83266279|NCT02168439|Analgesics|analgesics|mesh-ancestor
83266280|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
83266281|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266282|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83266283|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83266284|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83266285|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
83266286|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266287|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266288|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83266289|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83266290|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83266291|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83266292|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83266293|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
83266295|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
83266296|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
83266297|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
83266298|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83266299|NCT02135445|Relugolix|relugolix|mesh-list
83266300|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
83266301|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
83266302|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266303|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266304|NCT02374099|Azacitidine|azacitidine|mesh-list
83266305|NCT02374099|Fulvestrant|fulvestrant|mesh-list
83266306|NCT02374099|Cc-486|cc-486|mesh-list
83266307|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266308|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
83266309|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266310|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266311|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266312|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266313|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83266314|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83266315|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
83266316|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266317|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266318|NCT02134977|Leuprolide|leuprolide|mesh-list
83266319|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83266320|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
83266321|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266322|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266323|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266324|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266325|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
83266327|NCT02374021|Adalimumab|adalimumab|mesh-list
83266328|NCT02374021|Etanercept|etanercept|mesh-list
83266329|NCT02374021|Methotrexate|methotrexate|mesh-list
83266330|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83266331|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
83266332|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266333|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266334|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266335|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
83266336|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266337|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266338|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
83266339|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266340|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83266341|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266342|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
83266343|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266344|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83266345|NCT02374021|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83266346|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266347|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
83266348|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83266349|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83266350|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266351|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83266352|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83266353|NCT02374021|Analgesics|analgesics|mesh-ancestor
83266354|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
83266355|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266356|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266358|NCT02372383|Rifampin|rifampin|mesh-list
83266359|NCT02372383|Ethambutol|ethambutol|mesh-list
83266360|NCT02372383|Pancrelipase|pancrelipase|mesh-list
83266361|NCT02372383|Pancreatin|pancreatin|mesh-list
83266362|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83266363|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266364|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83266365|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
83266366|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
83266367|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83266368|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266369|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266370|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83266371|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83266372|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83266373|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83266374|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83266375|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83266376|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266377|NCT01648699|Hydromorphone|hydromorphone|mesh-list
83266378|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83266379|NCT01648699|Narcotics|narcotics|mesh-ancestor
83266380|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266381|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266382|NCT01648699|Analgesics|analgesics|mesh-ancestor
83266383|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
83266384|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266385|NCT02134353|Mannitol|mannitol|mesh-list
83266386|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83266387|NCT02134353|Diuretics|diuretics|mesh-ancestor
83266388|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
83266389|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266390|NCT01646125|Docetaxel|docetaxel|mesh-list
83266391|NCT01646125|Pemetrexed|pemetrexed|mesh-list
83266392|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266393|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
83266394|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
83266395|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
83266396|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266397|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266398|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83266399|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83266400|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
83266401|NCT01362790|Pentostatin|pentostatin|mesh-list
83266402|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83266403|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266404|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
83266405|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266406|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266407|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83266408|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
83266409|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266410|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266411|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83266412|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83266413|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266414|NCT02167893|Leuprolide|leuprolide|mesh-list
83266415|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83266416|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
83266417|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266418|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266419|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266420|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266421|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
83266422|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83266423|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83266424|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
83266425|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266426|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266427|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266428|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83266429|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83266430|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83266432|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83266433|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83266434|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83266435|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83266436|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266437|NCT02337907|Donepezil|donepezil|mesh-list
83266438|NCT02337907|BI 409306|bi 409306|mesh-list
83266439|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83266440|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266441|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266442|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
83266443|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266444|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266445|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
83266446|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83266447|NCT01913470|Losartan|losartan|mesh-list
83266448|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83266449|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83266450|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83266451|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83266452|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266453|NCT02166333|Vitamin D|vitamin d|mesh-list
83266454|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
83266455|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
83266456|NCT02166333|Vitamins|vitamins|mesh-list
83266457|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
83266458|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266459|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83266460|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83266461|NCT02132949|Paclitaxel|paclitaxel|mesh-list
83266462|NCT02132949|Docetaxel|docetaxel|mesh-list
83266463|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
83266464|NCT02132949|Doxorubicin|doxorubicin|mesh-list
83266465|NCT02132949|Fluorouracil|fluorouracil|mesh-list
83266466|NCT02132949|Trastuzumab|trastuzumab|mesh-list
83266467|NCT02132949|Epirubicin|epirubicin|mesh-list
83266468|NCT02132949|Pertuzumab|pertuzumab|mesh-list
83266469|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83266470|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266471|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
83266472|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
83266473|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
83266474|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266475|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266476|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
83266477|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266478|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266479|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83266480|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
83266481|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83266482|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83266483|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83266484|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83266485|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266486|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
83266487|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266488|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83266489|NCT02165397|Rituximab|rituximab|mesh-list
83266490|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83266491|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266492|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
83266493|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266494|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266496|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83266497|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
83266498|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83266499|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266500|NCT02164929|Acetaminophen|acetaminophen|mesh-list
83266501|NCT02164929|Dexamethasone|dexamethasone|mesh-list
83266502|NCT02164929|Lidocaine|lidocaine|mesh-list
83266503|NCT02164929|Epinephrine|epinephrine|mesh-list
83266504|NCT02164929|Midazolam|midazolam|mesh-list
83266505|NCT02164929|Hydromorphone|hydromorphone|mesh-list
83266506|NCT02164929|Ropivacaine|ropivacaine|mesh-list
83266507|NCT02164929|Propofol|propofol|mesh-list
83266508|NCT02164929|Sevoflurane|sevoflurane|mesh-list
83266509|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266510|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
83266511|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
83266512|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266513|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266514|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266515|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
83266516|NCT02164929|Hormones|hormones|mesh-ancestor
83266517|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266518|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266519|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266520|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
83266521|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
83266522|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266523|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
83266524|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83266525|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83266526|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83266527|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83266528|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266529|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83266530|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83266531|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
83266532|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83266533|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83266534|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83266535|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83266536|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
83266537|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
83266538|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266539|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83266540|NCT02164929|Analgesics|analgesics|mesh-ancestor
83266541|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
83266542|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83266543|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83266544|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83266545|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83266546|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
83266547|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83266548|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83266549|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83266550|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
83266551|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
83266552|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
83266553|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83266554|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83266555|NCT02164929|Narcotics|narcotics|mesh-ancestor
83266556|NCT01888432|Everolimus|everolimus|mesh-list
83266557|NCT01888432|Tacrolimus|tacrolimus|mesh-list
83266558|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266559|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
83266560|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266561|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83266562|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266563|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266564|NCT01888432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83266565|NCT01888432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83266566|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266567|NCT02188719|Acetaminophen|acetaminophen|mesh-list
83266568|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
83266569|NCT02188719|Promethazine|promethazine|mesh-list
83266570|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
83266571|NCT02188719|Valganciclovir|valganciclovir|mesh-list
83266572|NCT02188719|Ganciclovir|ganciclovir|mesh-list
83266573|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
83266575|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83266576|NCT02188719|Everolimus|everolimus|mesh-list
83266577|NCT02188719|Liver Extracts|liver extracts|mesh-list
83266578|NCT02188719|Tacrolimus|tacrolimus|mesh-list
83266579|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
83266580|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83266581|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266582|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
83266583|NCT02188719|Hormones|hormones|mesh-ancestor
83266584|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266585|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266586|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266587|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266588|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266589|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
83266590|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83266591|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266592|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266593|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83266594|NCT02188719|Analgesics|analgesics|mesh-ancestor
83266595|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
83266596|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266597|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
83266598|NCT02188719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83266599|NCT02188719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83266600|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83266601|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83266602|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
83266603|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83266604|NCT02188719|Hematinics|hematinics|mesh-ancestor
83266605|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83266606|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83266607|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266608|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
83266609|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
83266610|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
83266611|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
83266612|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266613|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83266614|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
83266615|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
83266616|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266617|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83266618|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
83266619|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
83266620|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
83266621|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83266622|NCT02188719|Protective Agents|protective agents|mesh-ancestor
83266623|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83266624|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83266625|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266626|NCT01933672|Incretins|incretins|mesh-ancestor
83266627|NCT01933672|Hormones|hormones|mesh-ancestor
83266628|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266629|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83266630|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
83266631|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266632|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266634|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83266635|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83266636|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83266637|NCT02132247|Analgesics|analgesics|mesh-ancestor
83266638|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
83266639|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266640|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266641|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266642|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266643|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83266644|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266645|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266646|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
83266647|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83266648|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
83266649|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83266650|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
83266651|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266652|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266653|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
83266654|NCT05269017|Vitamin D|vitamin d|mesh-list
83266655|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
83266656|NCT05269017|Budesonide|budesonide|mesh-list
83266657|NCT05269017|Vitamins|vitamins|mesh-ancestor
83266658|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
83266659|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266660|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83266661|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83266662|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266663|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83266664|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
83266665|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266666|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83266667|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
83266668|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
83266669|NCT05269017|Hormones|hormones|mesh-ancestor
83266670|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266671|NCT01628913|Everolimus|everolimus|mesh-list
83266672|NCT01628913|Dactolisib|dactolisib|mesh-list
83266673|NCT01628913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83266674|NCT01628913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83266675|NCT01628913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266676|NCT01628913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266677|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266678|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
83266679|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266680|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266681|NCT02164383|Nicotine|nicotine|mesh-list
83266682|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83266683|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
83266684|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266685|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266686|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83266687|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83266688|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
83266689|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266690|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266691|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
83266692|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83266693|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83266694|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83266695|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
83266696|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266697|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83266698|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83266699|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266700|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266701|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83266702|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83266703|NCT02131155|Afatinib|afatinib|mesh-list
83266704|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266705|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83266706|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266707|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266708|NCT01933594|Romidepsin|romidepsin|mesh-list
83266709|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83266710|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266711|NCT01933594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83266712|NCT01933594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266713|NCT01933594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266714|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83266715|NCT02305849|Methotrexate|methotrexate|mesh-list
83266716|NCT02305849|Peficitinib|peficitinib|mesh-list
83266717|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83266718|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
83266719|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266720|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266721|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266722|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
83266723|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266724|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266725|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83266726|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266727|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83266728|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266729|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
83266730|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266731|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83266732|NCT02371759|Anesthetics|anesthetics|mesh-list
83266733|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266734|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266735|NCT02531633|Prednisone|prednisone|mesh-list
83266736|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83266737|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266738|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
83266739|NCT02531633|Hormones|hormones|mesh-ancestor
83266740|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266741|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266742|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266743|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266744|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
83266745|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
83266746|NCT02536313|Velpatasvir|velpatasvir|mesh-list
83266747|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
83266748|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266749|NCT05412875|Nicotine|nicotine|mesh-list
83266750|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83266751|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
83266752|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266753|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266754|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83266755|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83266756|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
83266757|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266758|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266759|NCT02187861|Rituximab|rituximab|mesh-list
83266760|NCT02187861|Venetoclax|venetoclax|mesh-list
83266761|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83266762|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83266763|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266764|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
83266765|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266766|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266767|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83266768|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
83266769|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266770|NCT05379179|Fentanyl|fentanyl|mesh-list
83266771|NCT05379179|Ketamine|ketamine|mesh-list
83266772|NCT05379179|Analgesics|analgesics|mesh-ancestor
83266773|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
83266774|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266775|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266776|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83266777|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83266778|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
83266779|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
83266780|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266781|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83266782|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83266783|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266784|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266785|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83266786|NCT05379179|Narcotics|narcotics|mesh-ancestor
83266787|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83266788|NCT05383001|Durvalumab|durvalumab|mesh-list
83266789|NCT05383001|Tremelimumab|tremelimumab|mesh-list
83266790|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83266791|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266792|NCT05381753|Sunitinib|sunitinib|mesh-list
83266793|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
83266794|NCT05381753|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83266795|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266796|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83266797|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83266798|NCT05381753|Growth Substances|growth substances|mesh-ancestor
83266799|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266800|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
83266801|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83266802|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266803|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266804|NCT02527421|Betamethasone|betamethasone|mesh-list
83266805|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266806|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
83266807|NCT02527421|Hormones|hormones|mesh-ancestor
83266808|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266809|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266810|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83266811|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
83266812|NCT05610371|Lidocaine|lidocaine|mesh-list
83266813|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
83266814|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
83266815|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266816|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266817|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
83266818|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266819|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83266820|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83266821|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83266822|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83266823|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266824|NCT02163759|Adalimumab|adalimumab|mesh-list
83266825|NCT02163759|Etrolizumab|etrolizumab|mesh-list
83266826|NCT02163759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83266827|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266828|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266829|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266830|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
83266831|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266832|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83266833|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83266834|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266835|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
83266836|NCT02163447|Piperaquine|piperaquine|mesh-list
83266837|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
83266838|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83266839|NCT02163447|Artenimol|artenimol|mesh-list
83266840|NCT02163447|Artemisinins|artemisinins|mesh-list
83266841|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
83266842|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83266843|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83266844|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266845|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83266846|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266847|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266848|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83266849|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
83266850|NCT01887418|Testosterone|testosterone|mesh-list
83266851|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
83266852|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
83266853|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83266854|NCT01887418|Androgens|androgens|mesh-ancestor
83266855|NCT01887418|Hormones|hormones|mesh-ancestor
83266856|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83266857|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266858|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83266859|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266860|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
83266861|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83266862|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83266863|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83266864|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83266865|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266866|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266867|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266868|NCT01912612|Analgesics|analgesics|mesh-ancestor
83266869|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
83266870|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266871|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
83266872|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83266873|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
83266874|NCT02302807|Paclitaxel|paclitaxel|mesh-list
83266875|NCT02302807|Docetaxel|docetaxel|mesh-list
83266876|NCT02302807|Atezolizumab|atezolizumab|mesh-list
83266877|NCT02302807|Antibodies|antibodies|mesh-list
83266878|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83266879|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266880|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
83266881|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
83266882|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
83266883|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266884|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
83266885|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266886|NCT02302807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83266887|NCT02302807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83266888|NCT05342519|Sirolimus|sirolimus|mesh-list
83266889|NCT05342519|Temsirolimus|temsirolimus|mesh-list
83266890|NCT05342519|MTOR Inhibitors|mtor inhibitors|mesh-list
83266891|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83266892|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266893|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83266894|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266895|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
83266896|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266897|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
83266898|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266899|NCT05342519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83266900|NCT05342519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266901|NCT05342519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266902|NCT05379491|Linaclotide|linaclotide|mesh-list
83266903|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83266904|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
83266905|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266906|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83266907|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
83266908|NCT05308901|Lenvatinib|lenvatinib|mesh-list
83266909|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83266910|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266911|NCT05308901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83266912|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266913|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83266914|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266915|NCT01931566|Pioglitazone|pioglitazone|mesh-list
83266916|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83266917|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266918|NCT05372939|Adalimumab|adalimumab|mesh-list
83266919|NCT05372939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83266920|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83266921|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83266922|NCT01912456|Complement C1s|complement c1s|mesh-list
83266923|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83266924|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83266925|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
83266926|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266927|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83266928|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83266929|NCT04251065|Daratumumab|daratumumab|mesh-list
83266930|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266931|NCT01885936|Albuterol|albuterol|mesh-list
83266932|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83266933|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
83266934|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266935|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266936|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83266937|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
83266938|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
83266939|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266940|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83266941|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83266942|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83266943|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
83266944|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266945|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266946|NCT05305859|Azacitidine|azacitidine|mesh-list
83266947|NCT05305859|Venetoclax|venetoclax|mesh-list
83266948|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83266949|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
83266950|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266951|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83266952|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83266953|NCT05368415|Norepinephrine|norepinephrine|mesh-list
83266954|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83266955|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83266956|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
83266957|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266958|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266959|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266960|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
83266961|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
83266962|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266963|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83266964|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
83266965|NCT05529173|Povidone|povidone|mesh-list
83266966|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
83266967|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
83266968|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83266969|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83266970|NCT05335109|Xenon|xenon|mesh-list
83266971|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83266972|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
83266973|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
83266974|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83266975|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266976|NCT05300087|Albuterol|albuterol|mesh-list
83266977|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83266978|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
83266979|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83266980|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266981|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83266982|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
83266983|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
83266984|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83266985|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83266986|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83266987|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83266988|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
83266989|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266990|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266991|NCT05333549|Istradefylline|istradefylline|mesh-list
83266992|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83266993|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83266994|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83266995|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
83266996|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83266997|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83266998|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83266999|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83267000|NCT01912222|Ixazomib|ixazomib|mesh-list
83267001|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267002|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
83267003|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267004|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267005|NCT05366933|Folic Acid|folic acid|mesh-list
83267006|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
83267007|NCT05366933|Vitamins|vitamins|mesh-ancestor
83267008|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
83267009|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267010|NCT05366933|Hematinics|hematinics|mesh-ancestor
83267011|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83267012|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
83267013|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83267014|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267015|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267016|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83267017|NCT05500703|Analgesics|analgesics|mesh-ancestor
83267018|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
83267019|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267020|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83267021|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83267022|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83267023|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
83267024|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267025|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267026|NCT04246151|Vancomycin|vancomycin|mesh-list
83267027|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83267028|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267029|NCT05331521|Vincristine|vincristine|mesh-list
83267030|NCT05331521|Temozolomide|temozolomide|mesh-list
83267031|NCT05331521|Lomustine|lomustine|mesh-list
83267032|NCT05331521|Procarbazine|procarbazine|mesh-list
83267033|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83267034|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267035|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267036|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267037|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267038|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267039|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83267040|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
83267041|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
83267042|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83267043|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267044|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267045|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83267046|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83267047|NCT02524847|Methoxsalen|methoxsalen|mesh-list
83267048|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83267049|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83267050|NCT05363267|Curcumin|curcumin|mesh-list
83267051|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83267052|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83267053|NCT05363267|Analgesics|analgesics|mesh-ancestor
83267054|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
83267055|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267056|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267057|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267058|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83267059|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267060|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267061|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267062|NCT04422275|Budesonide|budesonide|mesh-list
83267063|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267064|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83267065|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
83267066|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267067|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267068|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83267069|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
83267070|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
83267071|NCT04422275|Hormones|hormones|mesh-ancestor
83267072|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267073|NCT05361941|Tobramycin|tobramycin|mesh-list
83267074|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83267075|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267076|NCT05290025|Nicotine|nicotine|mesh-list
83267077|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83267078|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
83267079|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267080|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267081|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83267082|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83267083|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
83267084|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267085|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267087|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83267088|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267089|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267090|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83267091|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83267092|NCT05324735|Protective Agents|protective agents|mesh-ancestor
83267093|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267094|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
83267095|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83267096|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
83267097|NCT05359055|Itraconazole|itraconazole|mesh-list
83267098|NCT05359055|Rifampin|rifampin|mesh-list
83267099|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
83267100|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267101|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83267102|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83267103|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267104|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267105|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83267106|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
83267107|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267108|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267109|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83267110|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83267111|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
83267112|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83267113|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
83267114|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83267115|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83267116|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83267117|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83267118|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83267119|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83267120|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83267121|NCT02524379|Glyburide|glyburide|mesh-list
83267122|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83267123|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267124|NCT02524145|Isoproterenol|isoproterenol|mesh-list
83267126|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
83267127|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83267128|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267129|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267130|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83267131|NCT02524145|Analgesics|analgesics|mesh-ancestor
83267132|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
83267133|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267134|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83267135|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83267136|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83267137|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
83267138|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267139|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267140|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83267141|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83267142|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83267143|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
83267144|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83267145|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83267146|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
83267147|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83267148|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
83267149|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83267150|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
83267151|NCT02524145|Protective Agents|protective agents|mesh-ancestor
83267152|NCT05357417|Bevacizumab|bevacizumab|mesh-list
83267153|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267154|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267155|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83267156|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83267157|NCT05357417|Growth Substances|growth substances|mesh-ancestor
83267158|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267159|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
83267160|NCT01658813|Interferons|interferons|mesh-list
83267161|NCT01658813|Fluorouracil|fluorouracil|mesh-list
83267162|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
83267163|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267164|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83267165|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267166|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83267167|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
83267168|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267169|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
83267170|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267171|NCT02187471|Pregabalin|pregabalin|mesh-list
83267172|NCT02187471|Analgesics|analgesics|mesh-ancestor
83267173|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
83267174|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267175|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267176|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
83267177|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83267178|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267179|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267180|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83267181|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83267182|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83267183|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267184|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267185|NCT02525471|RNS60|rns60|mesh-list
83267186|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83267187|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83267188|NCT02525471|Analgesics|analgesics|mesh-ancestor
83267189|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
83267190|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267191|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267192|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267193|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83267194|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83267195|NCT05284409|Acetaminophen|acetaminophen|mesh-list
83267196|NCT05284409|Dexamethasone|dexamethasone|mesh-list
83267197|NCT05284409|Meperidine|meperidine|mesh-list
83267198|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267199|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
83267200|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
83267201|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267202|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267203|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83267204|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
83267205|NCT05284409|Hormones|hormones|mesh-ancestor
83267206|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267207|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83267208|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267209|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83267210|NCT05284409|Analgesics|analgesics|mesh-ancestor
83267211|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
83267212|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
83267213|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83267214|NCT05284409|Narcotics|narcotics|mesh-ancestor
83267215|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267216|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83267217|NCT02523599|Bupivacaine|bupivacaine|mesh-list
83267218|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
83267219|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
83267220|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267221|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267222|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
83267223|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267224|NCT05296577|Vinorelbine|vinorelbine|mesh-list
83267225|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83267226|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267227|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267228|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267229|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267230|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267231|NCT05354999|Caffeine|caffeine|mesh-list
83267232|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83267233|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267234|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83267235|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267236|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267237|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83267238|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83267239|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
83267240|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267241|NCT02187159|Pregabalin|pregabalin|mesh-list
83267242|NCT02187159|Analgesics|analgesics|mesh-ancestor
83267243|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
83267244|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267245|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267246|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
83267247|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83267248|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267249|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267250|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83267251|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83267252|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83267253|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267254|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267255|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
83267256|NCT02335411|Capecitabine|capecitabine|mesh-list
83267257|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267258|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267259|NCT02335411|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83267260|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267261|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83267262|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
83267263|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83267264|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267265|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83267266|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267267|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267268|NCT02161731|Warfarin|warfarin|mesh-list
83267269|NCT02161731|Evacetrapib|evacetrapib|mesh-list
83267271|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83267272|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83267273|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
83267274|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267275|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83267276|NCT02124759|Sevelamer|sevelamer|mesh-list
83267277|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
83267278|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
83267279|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267280|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
83267281|NCT02302339|Nivolumab|nivolumab|mesh-list
83267282|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
83267283|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83267284|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267285|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267286|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83267287|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267288|NCT02302339|Immunoconjugates|immunoconjugates|mesh-ancestor
83267289|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
83267290|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267291|NCT04895917|Daratumumab|daratumumab|mesh-list
83267292|NCT04895917|Pomalidomide|pomalidomide|mesh-list
83267293|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267294|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
83267295|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267296|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83267297|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83267298|NCT04895917|Growth Substances|growth substances|mesh-ancestor
83267299|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
83267300|NCT02161575|Ranibizumab|ranibizumab|mesh-list
83267301|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83267302|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83267303|NCT02161575|Growth Substances|growth substances|mesh-ancestor
83267304|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267305|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
83267306|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267307|NCT02161185|Midazolam|midazolam|mesh-list
83267308|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83267309|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83267310|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267311|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267312|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83267313|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83267314|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267315|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83267316|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
83267317|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
83267318|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
83267319|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
83267320|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267321|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267322|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
83267323|NCT02159469|Testosterone|testosterone|mesh-list
83267324|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
83267325|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
83267326|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83267327|NCT02159469|Androgens|androgens|mesh-ancestor
83267328|NCT02159469|Hormones|hormones|mesh-ancestor
83267329|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267330|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267331|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83267332|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267333|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
83267334|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
83267335|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83267336|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
83267337|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267338|NCT02123511|Expectorants|expectorants|mesh-ancestor
83267339|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
83267340|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83267341|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
83267342|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267343|NCT02123511|Protective Agents|protective agents|mesh-ancestor
83267344|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267345|NCT02123511|Antidotes|antidotes|mesh-ancestor
83267346|NCT04746339|Apixaban|apixaban|mesh-list
83267347|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83267348|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
83267349|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83267350|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
83267351|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267352|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267353|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
83267354|NCT02301403|Nicotine|nicotine|mesh-list
83267355|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83267356|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
83267357|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267358|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267359|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83267360|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83267361|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
83267362|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267363|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267364|NCT02333383|Adalimumab|adalimumab|mesh-list
83267365|NCT02333383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83267366|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267367|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83267368|NCT02369341|Vaccines|vaccines|mesh-list
83267369|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
83267370|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267371|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83267372|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
83267373|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267374|NCT02158533|Naltrexone|naltrexone|mesh-list
83267375|NCT02158533|Buprenorphine|buprenorphine|mesh-list
83267376|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83267377|NCT02158533|Narcotics|narcotics|mesh-ancestor
83267378|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267379|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267380|NCT02158533|Analgesics|analgesics|mesh-ancestor
83267381|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
83267382|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267383|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83267384|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83267385|NCT02120469|Everolimus|everolimus|mesh-list
83267386|NCT02120469|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83267387|NCT02120469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83267388|NCT02120469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267389|NCT02120469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267390|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83267391|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
83267392|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267393|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267394|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
83267395|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267396|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267397|NCT02180061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83267398|NCT02180061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267399|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
83267400|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
83267401|NCT02120157|Busulfan|busulfan|mesh-list
83267402|NCT02120157|Tacrolimus|tacrolimus|mesh-list
83267403|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83267404|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
83267405|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267406|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83267407|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83267408|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
83267409|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267410|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267411|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83267412|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83267413|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267414|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83267415|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83267416|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
83267417|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83267418|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267419|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83267420|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
83267421|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267422|NCT02155881|Ciclesonide|ciclesonide|mesh-list
83267423|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
83267424|NCT02155881|Hormones|hormones|mesh-ancestor
83267425|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267426|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267427|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83267428|NCT05279807|Amlodipine|amlodipine|mesh-list
83267429|NCT05279807|Zofenopril|zofenopril|mesh-list
83267430|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83267431|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83267432|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267433|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267434|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83267435|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267436|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
83267437|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83267438|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
83267439|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267441|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267442|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83267443|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267444|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267445|NCT05276531|Progesterone|progesterone|mesh-list
83267446|NCT05276531|Progestins|progestins|mesh-ancestor
83267447|NCT05276531|Hormones|hormones|mesh-ancestor
83267448|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267449|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267450|NCT01658579|Insulin|insulin|mesh-list
83267451|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83267452|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
83267453|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83267454|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267455|NCT05561309|Ropivacaine|ropivacaine|mesh-list
83267456|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
83267457|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
83267458|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267459|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267460|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
83267461|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267462|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
83267463|NCT05268497|Esketamine|esketamine|mesh-list
83267464|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267465|NCT05266859|Calcium|calcium|mesh-list
83267466|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83267467|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267468|NCT05346731|Dexamethasone|dexamethasone|mesh-list
83267469|NCT05346731|Ondansetron|ondansetron|mesh-list
83267470|NCT05346731|Olanzapine|olanzapine|mesh-list
83267471|NCT05346731|Aprepitant|aprepitant|mesh-list
83267472|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267473|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
83267474|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
83267475|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267476|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267477|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83267478|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
83267479|NCT05346731|Hormones|hormones|mesh-ancestor
83267480|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267481|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83267482|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267483|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
83267484|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
83267485|NCT05346731|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83267486|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83267487|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
83267488|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267489|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267490|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83267491|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83267492|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267493|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267494|NCT05346731|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83267495|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83267496|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267497|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83267499|NCT02118597|Ribavirin|ribavirin|mesh-list
83267500|NCT02118597|Simeprevir|simeprevir|mesh-list
83267501|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267502|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
83267503|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267504|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
83267505|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267506|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
83267507|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267508|NCT05218889|Paclitaxel|paclitaxel|mesh-list
83267509|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83267510|NCT05218889|Gemcitabine|gemcitabine|mesh-list
83267511|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83267512|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267513|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267514|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267515|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267516|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267517|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83267518|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
83267519|NCT05554367|Palbociclib|palbociclib|mesh-list
83267520|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267521|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83267522|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267523|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267524|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83267525|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83267526|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
83267527|NCT02117349|Coagulants|coagulants|mesh-ancestor
83267528|NCT02177175|Carvedilol|carvedilol|mesh-list
83267529|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83267530|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83267531|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
83267532|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267533|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267534|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267535|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83267536|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
83267537|NCT02177175|Protective Agents|protective agents|mesh-ancestor
83267538|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83267539|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267540|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83267541|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
83267542|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83267543|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83267544|NCT01657877|Calcium|calcium|mesh-list
83267545|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83267546|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267547|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
83267548|NCT05254925|Petrolatum|petrolatum|mesh-list
83267549|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83267550|NCT05254925|Protective Agents|protective agents|mesh-ancestor
83267551|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267552|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
83267553|NCT05254925|Emollients|emollients|mesh-ancestor
83267554|NCT05205473|Lidocaine|lidocaine|mesh-list
83267555|NCT05205473|Anesthetics|anesthetics|mesh-list
83267556|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
83267557|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267558|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267559|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
83267560|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267561|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83267562|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83267563|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83267564|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267565|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267566|NCT05253053|Paclitaxel|paclitaxel|mesh-list
83267567|NCT05253053|Atezolizumab|atezolizumab|mesh-list
83267568|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83267569|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267570|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267571|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267572|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267573|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267574|NCT05253053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83267575|NCT05253053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267576|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83267577|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83267578|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83267579|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267580|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267581|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83267582|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267583|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267584|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
83267585|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267586|NCT05252429|Docetaxel|docetaxel|mesh-list
83267587|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
83267588|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267589|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267590|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267591|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267592|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267593|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267594|NCT05252429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83267595|NCT05157971|Cytarabine|cytarabine|mesh-list
83267596|NCT05157971|Prednisone|prednisone|mesh-list
83267597|NCT05157971|Cortisone|cortisone|mesh-list
83267598|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
83267599|NCT05157971|Methotrexate|methotrexate|mesh-list
83267600|NCT05157971|Vincristine|vincristine|mesh-list
83267601|NCT05157971|Daunorubicin|daunorubicin|mesh-list
83267602|NCT05157971|Venetoclax|venetoclax|mesh-list
83267603|NCT05157971|Asparaginase|asparaginase|mesh-list
83267604|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
83267605|NCT05157971|Pegaspargase|pegaspargase|mesh-list
83267606|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83267607|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
83267608|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267609|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83267610|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83267611|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
83267612|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267613|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267614|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83267615|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267616|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
83267617|NCT05157971|Hormones|hormones|mesh-ancestor
83267618|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267619|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83267620|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83267621|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
83267622|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83267623|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83267624|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
83267625|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
83267626|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267627|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83267628|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83267629|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
83267630|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267631|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83267632|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267633|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267634|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267635|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83267636|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83267637|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83267640|NCT02175771|Albuterol|albuterol|mesh-list
83267641|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83267642|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83267643|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
83267644|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267645|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83267646|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
83267647|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267648|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267649|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83267650|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
83267651|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
83267652|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83267653|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83267654|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83267655|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
83267656|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267657|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267658|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
83267659|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83267660|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
83267661|NCT02175771|Hormones|hormones|mesh-ancestor
83267662|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267663|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
83267664|NCT01657799|Veliparib|veliparib|mesh-list
83267665|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83267666|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267667|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267668|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267669|NCT02116803|Fulvestrant|fulvestrant|mesh-list
83267670|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83267671|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267672|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83267673|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83267674|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
83267675|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267676|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267677|NCT02115321|Grazoprevir|grazoprevir|mesh-list
83267678|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
83267679|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267680|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
83267681|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83267682|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267683|NCT05248139|Prednisolone|prednisolone|mesh-list
83267684|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83267685|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
83267686|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83267687|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
83267688|NCT05248139|Triamcinolone|triamcinolone|mesh-list
83267689|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83267690|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83267691|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83267692|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
83267693|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267694|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
83267695|NCT05248139|Hormones|hormones|mesh-ancestor
83267696|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267697|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267698|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83267699|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267700|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
83267701|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
83267702|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267703|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83267704|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83267705|NCT05248139|Protective Agents|protective agents|mesh-ancestor
83267706|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83267707|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
83267708|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83267709|NCT05247125|Melatonin|melatonin|mesh-list
83267710|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267711|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
83267712|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267713|NCT05247125|Protective Agents|protective agents|mesh-ancestor
83267714|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267715|NCT05154383|Vaccines|vaccines|mesh-list
83267716|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
83267717|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267718|NCT05196815|Dobutamine|dobutamine|mesh-list
83267719|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83267720|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
83267721|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
83267722|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267723|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267724|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83267725|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83267726|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83267727|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
83267728|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267729|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267730|NCT05196815|Protective Agents|protective agents|mesh-ancestor
83267731|NCT05245877|Enoxaparin|enoxaparin|mesh-list
83267732|NCT05245877|Dalteparin|dalteparin|mesh-list
83267733|NCT05245877|Tinzaparin|tinzaparin|mesh-list
83267734|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83267735|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
83267736|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83267737|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83267738|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267739|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
83267740|NCT02367781|Paclitaxel|paclitaxel|mesh-list
83267741|NCT02367781|Carboplatin|carboplatin|mesh-list
83267742|NCT02367781|Pemetrexed|pemetrexed|mesh-list
83267743|NCT02367781|Atezolizumab|atezolizumab|mesh-list
83267744|NCT02367781|Antibodies|antibodies|mesh-list
83267745|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83267746|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83267747|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267748|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267749|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267750|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267751|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267752|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
83267753|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267754|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267755|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83267756|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83267757|NCT02367781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83267758|NCT02367781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267759|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
83267760|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267761|NCT04242173|Cemiplimab|cemiplimab|mesh-list
83267762|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267763|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267764|NCT05189015|Olmesartan|olmesartan|mesh-list
83267765|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83267766|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83267767|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83267768|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83267769|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267770|NCT05239091|Lidocaine|lidocaine|mesh-list
83267771|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
83267772|NCT05239091|Anesthetics|anesthetics|mesh-list
83267773|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267774|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267775|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
83267776|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267777|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83267778|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83267779|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83267780|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267781|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267782|NCT02152371|Metformin|metformin|mesh-list
83267783|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
83267784|NCT02152371|Dulaglutide|dulaglutide|mesh-list
83267785|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83267786|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267787|NCT02332291|Bupropion|bupropion|mesh-list
83267788|NCT02332291|Escitalopram|escitalopram|mesh-list
83267789|NCT02332291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83267790|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83267791|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267792|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267793|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267794|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
83267795|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267796|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83267797|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
83267798|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267799|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83267800|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
83267801|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83267802|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83267803|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267804|NCT01656395|Montelukast|montelukast|mesh-list
83267805|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83267806|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
83267807|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83267808|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
83267809|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267810|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267811|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83267812|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83267813|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267815|NCT02114931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83267816|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267817|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83267818|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
83267819|NCT05185739|Lenvatinib|lenvatinib|mesh-list
83267820|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267821|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267822|NCT05185739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83267823|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267824|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83267825|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267826|NCT05237687|Sirolimus|sirolimus|mesh-list
83267827|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83267828|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267829|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83267830|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267831|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
83267832|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83267833|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
83267834|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267835|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83267836|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83267837|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267838|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83267839|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83267840|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83267841|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267842|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
83267843|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267844|NCT05182151|Istradefylline|istradefylline|mesh-list
83267845|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83267846|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83267847|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83267848|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
83267849|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267850|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267851|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267852|NCT05181605|Folfirinox|folfirinox|mesh-list
83267853|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267854|NCT04883281|Paclitaxel|paclitaxel|mesh-list
83267855|NCT04883281|Carboplatin|carboplatin|mesh-list
83267856|NCT04883281|Cetuximab|cetuximab|mesh-list
83267857|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83267858|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267859|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83267860|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83267861|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83267862|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267863|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267864|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
83267865|NCT02300311|Capsaicin|capsaicin|mesh-list
83267866|NCT02300311|Nonivamide|nonivamide|mesh-list
83267867|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
83267868|NCT02300311|Vitamins|vitamins|mesh-ancestor
83267869|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
83267870|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267871|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
83267872|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267873|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
83267874|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
83267875|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83267876|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267877|NCT05140499|Bupivacaine|bupivacaine|mesh-list
83267878|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
83267879|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
83267880|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267881|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267882|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
83267883|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267884|NCT04229381|Coal Tar|coal tar|mesh-list
83267885|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
83267886|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
83267887|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83267888|NCT05178485|Bupivacaine|bupivacaine|mesh-list
83267889|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
83267890|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
83267891|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267892|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267893|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
83267894|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267895|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267896|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
83267897|NCT05178485|Hormones|hormones|mesh-ancestor
83267898|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267899|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83267900|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
83267901|NCT04228289|Oxytocin|oxytocin|mesh-list
83267902|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
83267903|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83267904|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267905|NCT05228951|Trastuzumab|trastuzumab|mesh-list
83267906|NCT05228951|Letrozole|letrozole|mesh-list
83267907|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83267908|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267909|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83267910|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83267911|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267912|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267913|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83267914|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
83267915|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83267916|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267917|NCT05227937|Amikacin|amikacin|mesh-list
83267918|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83267919|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267920|NCT05174039|Miglustat|miglustat|mesh-list
83267921|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267922|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267923|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83267924|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83267925|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
83267926|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83267927|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83267928|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83267929|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267930|NCT05138549|Beta Carotene|beta carotene|mesh-list
83267931|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267932|NCT05138549|Provitamins|provitamins|mesh-ancestor
83267933|NCT05138549|Vitamins|vitamins|mesh-ancestor
83267934|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
83267935|NCT04241549|Azacitidine|azacitidine|mesh-list
83267936|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83267937|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
83267938|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267939|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83267940|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83267941|NCT02175225|Deferoxamine|deferoxamine|mesh-list
83267942|NCT02175225|Siderophores|siderophores|mesh-ancestor
83267943|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83267944|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
83267945|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
83267946|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267947|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83267948|NCT05170841|Tramadol|tramadol|mesh-list
83267949|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83267950|NCT05170841|Narcotics|narcotics|mesh-ancestor
83267951|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267952|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267953|NCT05170841|Analgesics|analgesics|mesh-ancestor
83267954|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
83267955|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267956|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83267957|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83267958|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83267959|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83267960|NCT05135273|Vaccines|vaccines|mesh-list
83267961|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
83267962|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267963|NCT02299375|Albuterol|albuterol|mesh-list
83267964|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83267965|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
83267966|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83267967|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267968|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83267969|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
83267970|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
83267971|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83267972|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83267973|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83267974|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83267975|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83267976|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267977|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267978|NCT02151591|Varenicline|varenicline|mesh-list
83267979|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83267980|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83267981|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
83267982|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267983|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267984|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267985|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83267986|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83267987|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83267988|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83267989|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83267990|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83267991|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83267992|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83267993|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83267994|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
83267995|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83267996|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83267997|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83267998|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83267999|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
83268000|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83268001|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83268002|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
83268003|NCT04881799|Topiramate|topiramate|mesh-list
83268004|NCT04881799|Phentermine|phentermine|mesh-list
83268005|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
83268006|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268007|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268008|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83268009|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
83268010|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83268011|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
83268012|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
83268013|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268014|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268015|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268016|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268017|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83268018|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83268019|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268020|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
83268021|NCT02114385|Vaccines|vaccines|mesh-list
83268022|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
83268023|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268024|NCT05098457|Lidocaine|lidocaine|mesh-list
83268025|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
83268026|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
83268027|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268028|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268029|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
83268030|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268031|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83268032|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83268033|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83268034|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268035|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268037|NCT02114151|Simeprevir|simeprevir|mesh-list
83268038|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
83268039|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268040|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268041|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268042|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268043|NCT05220293|Betamethasone|betamethasone|mesh-list
83268044|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
83268045|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83268046|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
83268047|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83268048|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268049|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
83268050|NCT05220293|Hormones|hormones|mesh-ancestor
83268051|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268052|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268053|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83268054|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
83268055|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
83268056|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83268057|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
83268058|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83268059|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268060|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268061|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268062|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268063|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268064|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83268065|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
83268066|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
83268067|NCT02297503|Protective Agents|protective agents|mesh-ancestor
83268068|NCT02366767|Insulin|insulin|mesh-list
83268069|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268070|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268071|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
83268072|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83268073|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83268074|NCT02149875|Protective Agents|protective agents|mesh-ancestor
83268075|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268076|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
83268077|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83268078|NCT05095961|Prednisone|prednisone|mesh-list
83268079|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268080|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
83268081|NCT05095961|Hormones|hormones|mesh-ancestor
83268082|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268083|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268084|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83268085|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268086|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
83268087|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83268088|NCT05124899|Protective Agents|protective agents|mesh-ancestor
83268089|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268090|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
83268091|NCT05093621|Torsemide|torsemide|mesh-list
83268092|NCT05093621|Furosemide|furosemide|mesh-list
83268093|NCT05093621|Diuretics|diuretics|mesh-ancestor
83268094|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
83268095|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268096|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83268097|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268098|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268099|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83268100|NCT02112045|Melphalan|melphalan|mesh-list
83268101|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83268102|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
83268103|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268104|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268105|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83268106|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83268107|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
83268108|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268109|NCT02147691|Azelaic acid|azelaic acid|mesh-list
83268110|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83268111|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83268112|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83268113|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83268114|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83268115|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268116|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268117|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268118|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268119|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268120|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
83268121|NCT01655693|Doxorubicin|doxorubicin|mesh-list
83268122|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83268123|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83268124|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268125|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83268126|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83268127|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268128|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268129|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
83268130|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83268131|NCT05090657|Methylene Blue|methylene blue|mesh-list
83268132|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83268133|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268134|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
83268135|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
83268136|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268137|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268138|NCT05048849|Somatomedin B|somatomedin b|mesh-list
83268139|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83268140|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83268141|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268142|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268143|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268144|NCT05116085|Tislelizumab|tislelizumab|mesh-list
83268145|NCT05116085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83268146|NCT05116085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268147|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83268148|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
83268149|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83268150|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
83268151|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83268152|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268153|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83268154|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83268155|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268156|NCT05046431|Golimumab|golimumab|mesh-list
83268157|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83268158|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268159|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83268160|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
83268161|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268162|NCT05078879|Empagliflozin|empagliflozin|mesh-list
83268163|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83268164|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268165|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268166|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268167|NCT05074433|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83268168|NCT05074433|Antiviral Agents|antiviral agents|mesh-ancestor
83268169|NCT05074433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268170|NCT04757883|Antibodies|antibodies|mesh-list
83268171|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
83268172|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268173|NCT04751877|Dexamethasone|dexamethasone|mesh-list
83268174|NCT04751877|Lenalidomide|lenalidomide|mesh-list
83268175|NCT04751877|Bortezomib|bortezomib|mesh-list
83268176|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268177|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
83268178|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
83268179|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268180|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268181|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83268183|NCT04751877|Hormones|hormones|mesh-ancestor
83268184|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268185|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83268186|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268187|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
83268188|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83268189|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83268190|NCT04751877|Growth Substances|growth substances|mesh-ancestor
83268191|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
83268192|NCT02147067|Ranolazine|ranolazine|mesh-list
83268193|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83268194|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268195|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268196|NCT02107131|Ranibizumab|ranibizumab|mesh-list
83268197|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83268198|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83268199|NCT02107131|Growth Substances|growth substances|mesh-ancestor
83268200|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268201|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
83268202|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268203|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
83268204|NCT02106975|Vitamins|vitamins|mesh-ancestor
83268205|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
83268206|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268207|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
83268208|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268209|NCT02106975|Protective Agents|protective agents|mesh-ancestor
83268210|NCT05133765|Insulin|insulin|mesh-list
83268211|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268212|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268213|NCT02520011|Cytarabine|cytarabine|mesh-list
83268214|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
83268215|NCT02520011|Alvocidib|alvocidib|mesh-list
83268216|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83268217|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
83268218|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268219|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268220|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
83268221|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268222|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83268223|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
83268224|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268225|NCT02520011|Analgesics|analgesics|mesh-ancestor
83268226|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
83268227|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268228|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83268229|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83268230|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268231|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
83268232|NCT02520011|Growth Substances|growth substances|mesh-ancestor
83268233|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83268234|NCT05037539|Fentanyl|fentanyl|mesh-list
83268235|NCT05037539|Morphine|morphine|mesh-list
83268236|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83268237|NCT05037539|Narcotics|narcotics|mesh-ancestor
83268238|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268239|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268240|NCT05037539|Analgesics|analgesics|mesh-ancestor
83268241|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
83268242|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268243|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83268244|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83268245|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
83268246|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
83268247|NCT02519231|Naproxen|naproxen|mesh-list
83268248|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83268249|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83268250|NCT02519231|Analgesics|analgesics|mesh-ancestor
83268251|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
83268252|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268253|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268254|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268255|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268256|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
83268257|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83268258|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268259|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268260|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
83268261|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83268262|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83268263|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83268264|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268265|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268266|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268267|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268268|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268269|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83268270|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268271|NCT02075073|Trastuzumab|trastuzumab|mesh-list
83268272|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83268273|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268274|NCT01364597|Brivaracetam|brivaracetam|mesh-list
83268275|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
83268276|NCT04738149|Bimatoprost|bimatoprost|mesh-list
83268277|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83268278|NCT04995497|Lidocaine|lidocaine|mesh-list
83268279|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
83268280|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
83268281|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268282|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268283|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
83268284|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268285|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83268286|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83268287|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83268288|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268289|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268290|NCT05063201|Cariprazine|cariprazine|mesh-list
83268291|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83268292|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83268293|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268294|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268295|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83268296|NCT05060627|Dexamethasone|dexamethasone|mesh-list
83268297|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268298|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
83268299|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
83268300|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268301|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268302|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83268303|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
83268304|NCT05060627|Hormones|hormones|mesh-ancestor
83268305|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268306|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83268307|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268308|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
83268309|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83268310|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268311|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268312|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83268313|NCT05025605|Analgesics|analgesics|mesh-ancestor
83268314|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
83268315|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268316|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83268317|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83268318|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83268319|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268320|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268321|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268322|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83268323|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
83268324|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268325|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83268326|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83268327|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
83268328|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268329|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268330|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83268331|NCT05024747|Nicotine|nicotine|mesh-list
83268332|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83268333|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
83268334|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268335|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268336|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83268337|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83268338|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268339|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268340|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268341|NCT05056883|Ivermectin|ivermectin|mesh-list
83268342|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83268343|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268344|NCT05055323|Pyrvinium|pyrvinium|mesh-list
83268345|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
83268346|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83268347|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268348|NCT04991597|Lidocaine|lidocaine|mesh-list
83268349|NCT04991597|Epinephrine|epinephrine|mesh-list
83268350|NCT04991597|Racepinephrine|racepinephrine|mesh-list
83268351|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
83268352|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
83268353|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
83268354|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268355|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268356|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
83268357|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268358|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83268359|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83268360|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83268361|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268362|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268363|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83268364|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83268365|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268366|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268367|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83268368|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83268369|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
83268370|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83268371|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
83268372|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
83268373|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
83268374|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83268375|NCT04949867|Glucagon|glucagon|mesh-list
83268376|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83268377|NCT04949867|Hormones|hormones|mesh-ancestor
83268378|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268379|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268380|NCT04989491|Rituximab|rituximab|mesh-list
83268381|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83268382|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268383|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
83268384|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268385|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268386|NCT05018117|Nicotine|nicotine|mesh-list
83268387|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83268388|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
83268389|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268390|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268391|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83268392|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83268393|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268394|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268395|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268396|NCT05016869|Capecitabine|capecitabine|mesh-list
83268397|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83268398|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
83268399|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268400|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268401|NCT02141997|Adalimumab|adalimumab|mesh-list
83268402|NCT02141997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83268403|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268404|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268405|NCT04411433|Azithromycin|azithromycin|mesh-list
83268406|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
83268407|NCT04411433|Favipiravir|favipiravir|mesh-list
83268408|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83268409|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268410|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
83268411|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83268412|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83268413|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268414|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268415|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268416|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
83268417|NCT04987463|Sirolimus|sirolimus|mesh-list
83268418|NCT04987463|Vigabatrin|vigabatrin|mesh-list
83268419|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83268420|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268421|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83268422|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268423|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
83268424|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83268425|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
83268426|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268427|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268428|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268429|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
83268430|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
83268431|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268432|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
83268433|NCT05012735|Provitamins|provitamins|mesh-list
83268434|NCT05012735|Vitamins|vitamins|mesh-ancestor
83268435|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
83268436|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268437|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
83268438|NCT02519777|Dolutegravir|dolutegravir|mesh-list
83268439|NCT02519777|Maraviroc|maraviroc|mesh-list
83268440|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83268441|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83268442|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268443|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268444|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83268445|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83268446|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
83268447|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268448|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83268449|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83268450|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83268451|NCT05008913|Adavosertib|adavosertib|mesh-list
83268452|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268453|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268454|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83268455|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268456|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268457|NCT04982705|Incretins|incretins|mesh-ancestor
83268458|NCT04982705|Hormones|hormones|mesh-ancestor
83268459|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268460|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83268461|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268462|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268463|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268464|NCT04944095|Antibodies|antibodies|mesh-list
83268465|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
83268466|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268467|NCT02141295|Leucovorin|leucovorin|mesh-list
83268468|NCT02141295|Folic Acid|folic acid|mesh-list
83268469|NCT02141295|Bevacizumab|bevacizumab|mesh-list
83268470|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
83268471|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
83268472|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83268473|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268474|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83268475|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83268476|NCT02141295|Growth Substances|growth substances|mesh-ancestor
83268477|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268478|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
83268479|NCT02141295|Antidotes|antidotes|mesh-ancestor
83268480|NCT02141295|Protective Agents|protective agents|mesh-ancestor
83268481|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
83268482|NCT02141295|Vitamins|vitamins|mesh-ancestor
83268483|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
83268484|NCT02141295|Hematinics|hematinics|mesh-ancestor
83268485|NCT02514551|Paclitaxel|paclitaxel|mesh-list
83268486|NCT02514551|Ramucirumab|ramucirumab|mesh-list
83268487|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83268488|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268489|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
83268490|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
83268491|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
83268492|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268493|NCT02141217|Amoxicillin|amoxicillin|mesh-list
83268494|NCT02141217|Clindamycin|clindamycin|mesh-list
83268495|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
83268496|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
83268497|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
83268498|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
83268499|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83268500|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83268501|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268502|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83268503|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268504|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268505|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83268506|NCT02514473|Ivacaftor|ivacaftor|mesh-list
83268507|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83268508|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268509|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268510|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83268511|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268512|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268513|NCT02513771|Incretins|incretins|mesh-ancestor
83268514|NCT02513771|Hormones|hormones|mesh-ancestor
83268515|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268516|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83268517|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268518|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268519|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268520|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83268521|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
83268522|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268523|NCT04725201|Heparin|heparin|mesh-list
83268524|NCT04725201|Calcium heparin|calcium heparin|mesh-list
83268525|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
83268526|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83268527|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83268528|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268529|NCT02069379|Metformin|metformin|mesh-list
83268530|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268531|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268532|NCT02511431|Ritonavir|ritonavir|mesh-list
83268533|NCT02511431|Lonafarnib|lonafarnib|mesh-list
83268534|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83268535|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83268536|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268537|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268538|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268539|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83268540|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83268541|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
83268542|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268543|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83268544|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83268545|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83268546|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83268547|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83268548|NCT05003453|Palmidrol|palmidrol|mesh-list
83268549|NCT05003453|Analgesics|analgesics|mesh-ancestor
83268550|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
83268551|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268552|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268553|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83268554|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83268555|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268556|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268558|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268559|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83268560|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83268561|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268562|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268563|NCT05003453|Hormones|hormones|mesh-ancestor
83268564|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268565|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
83268566|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83268567|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83268568|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268569|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268570|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268571|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268572|NCT01655069|Urological Agents|urological agents|mesh-ancestor
83268573|NCT01654601|Clozapine|clozapine|mesh-list
83268574|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83268575|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
83268576|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268577|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268578|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268579|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83268580|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83268581|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268582|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83268583|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
83268584|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
83268585|NCT02068443|Metformin|metformin|mesh-list
83268586|NCT02068443|Alogliptin|alogliptin|mesh-list
83268587|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268588|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268589|NCT02068443|Incretins|incretins|mesh-ancestor
83268590|NCT02068443|Hormones|hormones|mesh-ancestor
83268591|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268592|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83268593|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268594|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268595|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268596|NCT04978649|Amlodipine|amlodipine|mesh-list
83268597|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83268598|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83268599|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268600|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268601|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83268602|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268603|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
83268604|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83268605|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83268606|NCT02508935|Narcotics|narcotics|mesh-ancestor
83268607|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268608|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268609|NCT02508935|Analgesics|analgesics|mesh-ancestor
83268610|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
83268611|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268612|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83268614|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268615|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268616|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83268617|NCT02507375|Pertuzumab|pertuzumab|mesh-list
83268618|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268619|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83268620|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268621|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268622|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83268623|NCT02507219|Ibuprofen|ibuprofen|mesh-list
83268624|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83268625|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83268626|NCT02507219|Analgesics|analgesics|mesh-ancestor
83268627|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
83268628|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268629|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268630|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268631|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268632|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83268633|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268634|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268635|NCT02483975|Albuterol|albuterol|mesh-list
83268636|NCT02483975|Montelukast|montelukast|mesh-list
83268637|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83268638|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83268639|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83268640|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
83268641|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268642|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268643|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83268644|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83268645|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268646|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83268647|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
83268648|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268649|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
83268650|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83268651|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83268652|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83268653|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83268654|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268655|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268656|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83268657|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83268658|NCT02047227|Hormones|hormones|mesh-ancestor
83268659|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268660|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268661|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83268662|NCT02483585|Erenumab|erenumab|mesh-list
83268663|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83268664|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268665|NCT02483585|Analgesics|analgesics|mesh-ancestor
83268666|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
83268667|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268668|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268669|NCT02101983|Cytarabine|cytarabine|mesh-list
83268670|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83268671|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
83268672|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268673|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268674|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
83268675|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268676|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83268677|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
83268678|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268679|NCT04974281|Lenvatinib|lenvatinib|mesh-list
83268680|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268681|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83268682|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268683|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268684|NCT02503865|Orlistat|orlistat|mesh-list
83268685|NCT02503865|Diltiazem|diltiazem|mesh-list
83268686|NCT02503865|Atorvastatin|atorvastatin|mesh-list
83268687|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83268688|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83268689|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
83268690|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268691|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83268692|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83268693|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268694|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83268695|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83268696|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268697|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83268698|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268699|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
83268700|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83268702|NCT02481947|Lubiprostone|lubiprostone|mesh-list
83268703|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83268704|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268705|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268706|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83268707|NCT02503085|Ibuprofen|ibuprofen|mesh-list
83268708|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83268709|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83268710|NCT02503085|Analgesics|analgesics|mesh-ancestor
83268711|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
83268712|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268713|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268714|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268715|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268716|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83268717|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268718|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268719|NCT02502149|Factor VIII|factor viii|mesh-list
83268720|NCT02502149|Coagulants|coagulants|mesh-ancestor
83268721|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83268722|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268723|NCT02480621|Bupivacaine|bupivacaine|mesh-list
83268724|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
83268725|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
83268726|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268727|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268728|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
83268729|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268730|NCT02046603|Methotrexate|methotrexate|mesh-list
83268731|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83268732|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
83268733|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83268734|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268735|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83268736|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
83268737|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268738|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268739|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
83268740|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268741|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83268742|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83268743|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
83268744|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268745|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83268746|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83268747|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83268748|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83268749|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268750|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268751|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83268752|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83268753|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83268754|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83268755|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268756|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268757|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268758|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83268759|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83268760|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
83268761|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83268762|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83268763|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
83268764|NCT02101359|Tetracaine|tetracaine|mesh-list
83268765|NCT02101359|Tropicamide|tropicamide|mesh-list
83268766|NCT02101359|Mydriatics|mydriatics|mesh-list
83268767|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
83268768|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
83268769|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268770|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268771|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
83268772|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268773|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
83268774|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83268775|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83268776|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268777|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268778|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268779|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
83268780|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
83268781|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83268782|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83268783|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
83268784|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268785|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83268786|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83268787|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83268788|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83268789|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83268790|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268791|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268792|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268793|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268794|NCT01883362|Midostaurin|midostaurin|mesh-list
83268795|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268796|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83268797|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268798|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268799|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
83268800|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
83268801|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
83268802|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268803|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268804|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83268805|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83268806|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
83268807|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
83268808|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268809|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268810|NCT02045979|Adalimumab|adalimumab|mesh-list
83268811|NCT02045979|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83268812|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268813|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268814|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
83268815|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
83268816|NCT04734405|Fluconazole|fluconazole|mesh-list
83268817|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
83268818|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268819|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83268820|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83268821|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268822|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268823|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83268824|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
83268825|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268826|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268827|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83268828|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83268829|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83268830|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83268831|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83268832|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83268833|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268834|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83268835|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83268836|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83268837|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83268838|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
83268839|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268840|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268841|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83268842|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83268843|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
83268844|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83268845|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83268846|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
83268847|NCT01928758|Nicotine|nicotine|mesh-list
83268848|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83268849|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
83268850|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268851|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268852|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83268853|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83268854|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268855|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268856|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268857|NCT01614886|Rivastigmine|rivastigmine|mesh-list
83268858|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83268859|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268860|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268861|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268862|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268863|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268864|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83268865|NCT01614886|Protective Agents|protective agents|mesh-ancestor
83268866|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
83268867|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83268868|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83268869|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83268870|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83268871|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268872|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268873|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
83268874|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268875|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268876|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83268877|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268878|NCT04171726|Edoxaban|edoxaban|mesh-list
83268879|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83268880|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
83268881|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83268882|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268883|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268884|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268885|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
83268886|NCT02100657|Dexamethasone|dexamethasone|mesh-list
83268887|NCT02100657|Bortezomib|bortezomib|mesh-list
83268888|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268889|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
83268890|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
83268891|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83268892|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268893|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83268894|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
83268895|NCT02100657|Hormones|hormones|mesh-ancestor
83268896|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268897|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83268898|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268899|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
83268900|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83268901|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
83268902|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83268903|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268904|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83268905|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83268906|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83268907|NCT01909804|Ribavirin|ribavirin|mesh-list
83268908|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
83268909|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83268910|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
83268911|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268912|NCT01880086|Clomiphene|clomiphene|mesh-list
83268913|NCT01880086|Enclomiphene|enclomiphene|mesh-list
83268914|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
83268915|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83268916|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
83268917|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268918|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268919|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83268920|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
83268921|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83268922|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83268923|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83268924|NCT01879618|Dalteparin|dalteparin|mesh-list
83268925|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
83268926|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83268927|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83268928|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268929|NCT01926886|Trastuzumab|trastuzumab|mesh-list
83268930|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83268931|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268932|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83268933|NCT01925950|Beclomethasone|beclomethasone|mesh-list
83268934|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268935|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
83268936|NCT01925950|Hormones|hormones|mesh-ancestor
83268937|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268938|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268939|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83268940|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
83268941|NCT04415320|Ensartinib|ensartinib|mesh-list
83268942|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268943|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83268944|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268945|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268946|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83268947|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
83268948|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83268949|NCT01878292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83268950|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83268951|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83268952|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268953|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83268954|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
83268955|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268956|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83268957|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83268958|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83268959|NCT01907854|Liraglutide|liraglutide|mesh-list
83268960|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268961|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268962|NCT01907854|Incretins|incretins|mesh-ancestor
83268963|NCT01907854|Hormones|hormones|mesh-ancestor
83268964|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83268965|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83268966|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
83268967|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268968|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268969|NCT02480153|Adalimumab|adalimumab|mesh-list
83268970|NCT02480153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83268971|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268972|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268973|NCT04972253|Infigratinib|infigratinib|mesh-list
83268974|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268975|NCT02500979|Insulin|insulin|mesh-list
83268976|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83268977|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
83268978|NCT02500979|Pramlintide|pramlintide|mesh-list
83268979|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83268980|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83268981|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83268982|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
83268983|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83268984|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83268985|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268986|NCT02500901|Niraparib|niraparib|mesh-list
83268987|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83268988|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268989|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83268990|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83268991|NCT01877668|Adalimumab|adalimumab|mesh-list
83268992|NCT01877668|Tofacitinib|tofacitinib|mesh-list
83268993|NCT01877668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83268994|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83268995|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83268996|NCT01877668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83268997|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83268998|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83268999|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269001|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83269002|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83269003|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
83269004|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269005|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269006|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269007|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269008|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83269009|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83269010|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269011|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
83269012|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83269013|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
83269014|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269015|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83269016|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83269017|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83269018|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269019|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
83269020|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
83269021|NCT01876732|Vitamins|vitamins|mesh-ancestor
83269022|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
83269023|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269024|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
83269025|NCT01876732|Hematinics|hematinics|mesh-ancestor
83269026|NCT01905592|Niraparib|niraparib|mesh-list
83269027|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83269028|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269029|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269030|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269031|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
83269032|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269033|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269034|NCT02500121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83269035|NCT02500121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269036|NCT01875250|Metronidazole|metronidazole|mesh-list
83269037|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269038|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83269039|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83269040|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83269041|NCT01904032|Vitamin D|vitamin d|mesh-list
83269042|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
83269043|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
83269044|NCT01904032|Vitamins|vitamins|mesh-list
83269045|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
83269046|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269047|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83269048|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83269049|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83269050|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83269051|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83269052|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269053|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269054|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
83269055|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269056|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269057|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83269058|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269059|NCT02325739|Spartalizumab|spartalizumab|mesh-list
83269060|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83269061|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269062|NCT02325739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269063|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269064|NCT01903720|Dexamethasone|dexamethasone|mesh-list
83269065|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269066|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
83269067|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
83269068|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269069|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269070|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269071|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
83269072|NCT01903720|Hormones|hormones|mesh-ancestor
83269073|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269074|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83269075|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269076|NCT02366689|Triclosan|triclosan|mesh-list
83269077|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
83269078|NCT02366689|Fluorides|fluorides|mesh-list
83269079|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
83269080|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
83269081|NCT02366689|Protective Agents|protective agents|mesh-ancestor
83269082|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269083|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83269084|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269085|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83269086|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83269087|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
83269088|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269089|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83269090|NCT01903252|Mesalamine|mesalamine|mesh-list
83269091|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83269092|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83269093|NCT01903252|Analgesics|analgesics|mesh-ancestor
83269094|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
83269095|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269096|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269097|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269098|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269099|NCT01613716|Dexamethasone|dexamethasone|mesh-list
83269100|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269101|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
83269102|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
83269103|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269104|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269105|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269106|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
83269107|NCT01613716|Hormones|hormones|mesh-ancestor
83269108|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269109|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83269110|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269111|NCT05112952|Lazertinib|lazertinib|mesh-list
83269112|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83269113|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269114|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269115|NCT01872910|Celecoxib|celecoxib|mesh-list
83269116|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83269117|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83269118|NCT01872910|Analgesics|analgesics|mesh-ancestor
83269119|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
83269120|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269121|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269122|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269123|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269124|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83269125|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83269126|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269127|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269128|NCT01920568|Vitamin D|vitamin d|mesh-list
83269129|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
83269130|NCT01920568|Denosumab|denosumab|mesh-list
83269131|NCT01920568|Calcium|calcium|mesh-list
83269132|NCT01920568|Vitamins|vitamins|mesh-ancestor
83269133|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
83269134|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269135|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83269136|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83269137|NCT01901848|Bupropion|bupropion|mesh-list
83269138|NCT01901848|Nicotine|nicotine|mesh-list
83269139|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83269140|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
83269141|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269142|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269143|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83269144|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83269145|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
83269146|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269147|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269148|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83269149|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
83269150|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83269151|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83269152|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83269153|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269154|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
83269155|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83269156|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83269157|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269158|NCT01901614|Anesthetics|anesthetics|mesh-list
83269159|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269160|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269161|NCT02499575|Bupivacaine|bupivacaine|mesh-list
83269162|NCT02499575|Ropivacaine|ropivacaine|mesh-list
83269163|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
83269164|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
83269165|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269166|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269167|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
83269168|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269169|NCT02065791|Canagliflozin|canagliflozin|mesh-list
83269170|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83269171|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269172|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83269173|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269174|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
83269175|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83269176|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
83269177|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269178|NCT02499029|Expectorants|expectorants|mesh-ancestor
83269179|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
83269180|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83269181|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
83269182|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269183|NCT02499029|Protective Agents|protective agents|mesh-ancestor
83269184|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269185|NCT02499029|Antidotes|antidotes|mesh-ancestor
83269187|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83269188|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83269189|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
83269190|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269191|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269192|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269193|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83269194|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
83269195|NCT04939883|Protective Agents|protective agents|mesh-ancestor
83269196|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83269197|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269198|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83269199|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
83269200|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83269201|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83269202|NCT02065713|Golimumab|golimumab|mesh-list
83269203|NCT02065713|Methotrexate|methotrexate|mesh-list
83269204|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83269205|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
83269206|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83269207|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269208|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83269209|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
83430164|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83269210|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269211|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269212|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
83269213|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269214|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83269215|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83269216|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
83269217|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269218|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83269219|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83269220|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269221|NCT02497781|Ceftazidime|ceftazidime|mesh-list
83269222|NCT02497781|Cefepime|cefepime|mesh-list
83269223|NCT02497781|Avibactam|avibactam|mesh-list
83269224|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83269225|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83269226|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269227|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83269228|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269229|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269230|NCT02497469|Adalimumab|adalimumab|mesh-list
83269231|NCT02497469|Vedolizumab|vedolizumab|mesh-list
83269232|NCT02497469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83269233|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269234|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269235|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269236|NCT02497391|Evacetrapib|evacetrapib|mesh-list
83269237|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83269238|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83269239|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
83269240|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269241|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83269242|NCT02476175|Mirabegron|mirabegron|mesh-list
83269243|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83269244|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83269245|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83269246|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
83269247|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269248|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269249|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269250|NCT02476175|Urological Agents|urological agents|mesh-ancestor
83269251|NCT02065557|Adalimumab|adalimumab|mesh-list
83269252|NCT02065557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83269253|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269254|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269255|NCT02065245|Penicillins|penicillins|mesh-list
83269256|NCT02065245|Streptomycin|streptomycin|mesh-list
83269257|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83269258|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269259|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83269260|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269261|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269262|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
83269263|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83269264|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83269265|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
83269266|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
83269267|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269268|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269269|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83269270|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83269271|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
83269272|NCT04182555|Bilirubin|bilirubin|mesh-list
83269273|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
83269274|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269275|NCT04182555|Protective Agents|protective agents|mesh-ancestor
83269276|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269277|NCT02366143|Paclitaxel|paclitaxel|mesh-list
83269278|NCT02366143|Bevacizumab|bevacizumab|mesh-list
83269279|NCT02366143|Carboplatin|carboplatin|mesh-list
83269280|NCT02366143|Atezolizumab|atezolizumab|mesh-list
83269281|NCT02366143|Antibodies|antibodies|mesh-list
83269282|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83269283|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83269284|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269285|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
83269286|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
83269287|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83269288|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269289|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269290|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83269291|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83269292|NCT02366143|Growth Substances|growth substances|mesh-ancestor
83269293|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269294|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
83269295|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
83269296|NCT02366143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83269298|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83269299|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269300|NCT02098395|Incretins|incretins|mesh-ancestor
83269301|NCT02098395|Hormones|hormones|mesh-ancestor
83269302|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269303|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83269304|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83269305|NCT02096835|Dexamethasone|dexamethasone|mesh-list
83269306|NCT02096835|Tropisetron|tropisetron|mesh-list
83269307|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269308|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
83269309|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
83269310|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269311|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269312|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269313|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
83269314|NCT02096835|Hormones|hormones|mesh-ancestor
83269315|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269316|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83269317|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269318|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83269319|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83269320|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
83269321|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269322|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269323|NCT02294773|Letrozole|letrozole|mesh-list
83269324|NCT02294773|Clomiphene|clomiphene|mesh-list
83269325|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269326|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83269327|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83269328|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269329|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269330|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83269332|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269333|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269334|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83269335|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
83269336|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83269337|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83269338|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83269339|NCT02365285|Heparin|heparin|mesh-list
83269340|NCT02365285|Galantamine|galantamine|mesh-list
83269341|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83269342|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
83269343|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83269344|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83269345|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269346|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83269347|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83269348|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83269349|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83269350|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269351|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
83269352|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269353|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269354|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83269355|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
83269356|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269357|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
83269358|NCT02041299|Deferiprone|deferiprone|mesh-list
83269359|NCT02041299|Deferoxamine|deferoxamine|mesh-list
83269360|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83269361|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
83269362|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
83269363|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269364|NCT02041299|Siderophores|siderophores|mesh-ancestor
83269365|NCT01645735|Vancomycin|vancomycin|mesh-list
83269366|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
83269367|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83269368|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83269369|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269370|NCT01645111|Clevidipine|clevidipine|mesh-list
83269371|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83269372|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269373|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269374|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83269375|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269376|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
83269377|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83269378|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269379|NCT01919164|Mitogens|mitogens|mesh-list
83269380|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
83269381|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269382|NCT01901224|Metformin|metformin|mesh-list
83269383|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83269384|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269385|NCT01901146|Paclitaxel|paclitaxel|mesh-list
83269386|NCT01901146|Trastuzumab|trastuzumab|mesh-list
83269387|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83269388|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269389|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
83269390|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
83269391|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
83269392|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269393|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269394|NCT01644643|Metronidazole|metronidazole|mesh-list
83269396|NCT01644643|Avibactam|avibactam|mesh-list
83269397|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269398|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83269399|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83269400|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83269401|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83269402|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269403|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269404|NCT01864174|Metformin|metformin|mesh-list
83269405|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83269406|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269407|NCT04420351|Aspirin|aspirin|mesh-list
83269408|NCT04420351|Clopidogrel|clopidogrel|mesh-list
83269409|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83269410|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83269411|NCT04420351|Analgesics|analgesics|mesh-ancestor
83269412|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
83269413|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269414|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269415|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269416|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269417|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83269418|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83269419|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269420|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83269421|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83269422|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269423|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
83269424|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83269425|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83269426|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83269427|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
83269428|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269429|NCT01864018|Dexamethasone|dexamethasone|mesh-list
83269430|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
83269431|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
83269432|NCT01864018|Ixazomib|ixazomib|mesh-list
83269433|NCT01864018|Ichthammol|ichthammol|mesh-list
83269434|NCT01864018|BB 1101|bb 1101|mesh-list
83269435|NCT01864018|Glycine|glycine|mesh-list
83269436|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83269437|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
83269438|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269439|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269440|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83269441|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
83269442|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269443|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269444|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83269445|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269446|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
83269447|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
83269448|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269449|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269450|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
83269451|NCT01864018|Hormones|hormones|mesh-ancestor
83269452|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269453|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83269454|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
83269455|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269456|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
83269457|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
83269458|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269459|NCT01900444|Vaccines|vaccines|mesh-list
83269460|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
83269461|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269462|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
83269463|NCT02496221|Incretins|incretins|mesh-ancestor
83269464|NCT02496221|Hormones|hormones|mesh-ancestor
83269465|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269466|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269467|NCT02475629|Ibalizumab|ibalizumab|mesh-list
83269468|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83269469|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83269470|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
83269471|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269472|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83269473|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83269474|NCT01653743|Hormones|hormones|mesh-ancestor
83269475|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269476|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269477|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83269478|NCT02293993|Guadecitabine|guadecitabine|mesh-list
83269479|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269480|NCT02322775|Benralizumab|benralizumab|mesh-list
83269481|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83269482|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
83269483|NCT01646827|Aripiprazole|aripiprazole|mesh-list
83269484|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
83269485|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83269486|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83269487|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83269488|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269489|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269490|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
83269491|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
83269492|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269493|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269494|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83269495|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83269496|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
83269497|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83269498|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83269499|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83269500|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83269501|NCT02360995|Triclosan|triclosan|mesh-list
83269502|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
83269503|NCT02360995|Fluorides|fluorides|mesh-list
83269504|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
83269505|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
83269506|NCT02360995|Protective Agents|protective agents|mesh-ancestor
83269507|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269508|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83269509|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269510|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83269511|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83269512|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
83269513|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269514|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83269515|NCT02359903|Infliximab|infliximab|mesh-list
83269516|NCT02359903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83269517|NCT02359903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269518|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83269519|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269520|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269521|NCT02291419|Aspirin|aspirin|mesh-list
83269522|NCT02291419|Ticagrelor|ticagrelor|mesh-list
83269523|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83269524|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83269525|NCT02291419|Analgesics|analgesics|mesh-ancestor
83269526|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
83269527|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269528|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269529|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269530|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269531|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83269532|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83269533|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269534|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83269535|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83269536|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269537|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
83269538|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83269539|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83269540|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83269541|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
83269542|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269543|NCT02319031|Ribavirin|ribavirin|mesh-list
83269544|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
83269545|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
83269546|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269547|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
83269548|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269549|NCT02359435|Amoxicillin|amoxicillin|mesh-list
83269550|NCT02359435|Metronidazole|metronidazole|mesh-list
83269551|NCT02359435|Clarithromycin|clarithromycin|mesh-list
83269552|NCT02359435|Pantoprazole|pantoprazole|mesh-list
83269553|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83269554|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269555|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83269556|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83269557|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83269558|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269559|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269560|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83269561|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83269562|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83269563|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269564|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83269565|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
83269566|NCT04599868|Analgesics|analgesics|mesh-ancestor
83269567|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
83269568|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269569|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269570|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
83269571|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269572|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83269573|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
83269574|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83269575|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269576|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269577|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83269578|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
83269579|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83269580|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
83269581|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83269582|NCT01612156|Lidocaine|lidocaine|mesh-list
83269583|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
83269584|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
83269585|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269586|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269587|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
83269588|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269589|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83269590|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83269591|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83269592|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269593|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269594|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
83269595|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83269596|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
83269597|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269598|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269599|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83269600|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
83269601|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
83269602|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83269603|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
83269604|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269605|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269606|NCT01615822|Artefenomel|artefenomel|mesh-list
83269607|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
83269608|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83269609|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83269610|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269611|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
83269613|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
83269614|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83269615|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
83269616|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269617|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269618|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83269619|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
83269620|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
83269621|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83269622|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
83269623|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269624|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269625|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
83269626|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83269627|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83269628|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83269629|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83269630|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
83269631|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83269632|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83269633|NCT01898806|Triamcinolone|triamcinolone|mesh-list
83269634|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83269635|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83269636|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83269637|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269638|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
83269639|NCT01898806|Hormones|hormones|mesh-ancestor
83269640|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269641|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269642|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83269643|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
83269644|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269645|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269646|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83269647|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
83269648|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269649|NCT02290873|Midazolam|midazolam|mesh-list
83269650|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83269651|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83269652|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269653|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269654|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83269655|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83269656|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83269657|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83269658|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
83269659|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
83269660|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
83269661|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
83269662|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269663|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269664|NCT02358343|Sertraline|sertraline|mesh-list
83269665|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
83269666|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83269667|NCT02358343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83269668|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83269669|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269670|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269671|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269673|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269674|NCT02318095|Paclitaxel|paclitaxel|mesh-list
83269675|NCT02318095|Gemcitabine|gemcitabine|mesh-list
83269676|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83269677|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269678|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
83269679|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
83269680|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
83269681|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269682|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83269683|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
83269684|NCT02317627|Belumosudil|belumosudil|mesh-list
83269685|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83269686|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269687|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269688|NCT02517905|Bupivacaine|bupivacaine|mesh-list
83269689|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
83269690|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
83269691|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269692|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269693|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
83269694|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269695|NCT02473913|Silymarin|silymarin|mesh-list
83269696|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
83269697|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269698|NCT02473913|Protective Agents|protective agents|mesh-ancestor
83269699|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269700|NCT02316847|Diazepam|diazepam|mesh-list
83269701|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83269702|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
83269703|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
83269704|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
83269705|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269706|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269707|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269708|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83269709|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269710|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83269711|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83269712|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83269713|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83269714|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83269715|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83269716|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
83269717|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
83269718|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
83269719|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
83269720|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269721|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269722|NCT02473445|Cysteamine|cysteamine|mesh-list
83269723|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
83269724|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269725|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
83269726|NCT02473367|Antacids|antacids|mesh-list
83269727|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83269728|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83269729|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
83269730|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269731|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83269732|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83269733|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269734|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269735|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269736|NCT04965701|Osimertinib|osimertinib|mesh-list
83269737|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269738|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83269739|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269740|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269741|NCT02316613|Rituximab|rituximab|mesh-list
83269742|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269743|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269744|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
83269745|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269746|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269747|NCT02492165|Vaccines|vaccines|mesh-list
83269748|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
83269749|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269750|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83269751|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
83269752|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269753|NCT02286895|Vaccines|vaccines|mesh-list
83269754|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
83269755|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269756|NCT02472977|Nivolumab|nivolumab|mesh-list
83269757|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269758|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269759|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83269760|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269761|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
83269762|NCT02060487|Citric Acid|citric acid|mesh-list
83269763|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
83269764|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
83269765|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83269766|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
83269767|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
83269768|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269769|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
83269770|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83269771|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83269772|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269773|NCT02060487|Urological Agents|urological agents|mesh-ancestor
83269774|NCT02059239|Cytarabine|cytarabine|mesh-list
83269775|NCT02059239|Rituximab|rituximab|mesh-list
83269776|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
83269777|NCT02059239|Etoposide|etoposide|mesh-list
83269778|NCT02059239|Melphalan|melphalan|mesh-list
83269779|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83269780|NCT02059239|Carmustine|carmustine|mesh-list
83269781|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269782|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269783|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
83269784|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269785|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269786|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83269787|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83269788|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83269789|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269790|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269791|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83269792|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
83269793|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
83269794|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269795|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83269796|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83269797|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
83269798|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83269799|NCT02059161|Insulin|insulin|mesh-list
83269800|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83269801|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
83269802|NCT02059161|MK-1293|mk-1293|mesh-list
83269803|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83269804|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269805|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83269806|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
83269807|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269808|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83269809|NCT01897714|Dexamethasone|dexamethasone|mesh-list
83269810|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269811|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
83269812|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
83269813|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269814|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269815|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269816|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
83269817|NCT01897714|Hormones|hormones|mesh-ancestor
83269818|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269819|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83269820|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269821|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
83269822|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83269823|NCT01860976|Abatacept|abatacept|mesh-list
83269824|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83269825|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269826|NCT01860976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269827|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269828|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83269829|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
83269830|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269831|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269832|NCT01860040|Gemcitabine|gemcitabine|mesh-list
83269833|NCT01860040|Pemetrexed|pemetrexed|mesh-list
83269834|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269835|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83269836|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
83269837|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269838|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269839|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83269840|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83269841|NCT04618744|Insulin|insulin|mesh-list
83269842|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83269843|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83269844|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269845|NCT01896934|Sertraline|sertraline|mesh-list
83269846|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
83269847|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83269848|NCT01896934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83269849|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83269850|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269851|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269852|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269853|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
83269854|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269855|NCT02039505|Vedolizumab|vedolizumab|mesh-list
83269856|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269857|NCT02095197|Triamcinolone|triamcinolone|mesh-list
83269858|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269859|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
83269860|NCT02095197|Hormones|hormones|mesh-ancestor
83269861|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269862|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269863|NCT02039427|Dexamethasone|dexamethasone|mesh-list
83269864|NCT02039427|Ketorolac|ketorolac|mesh-list
83269865|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269866|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
83269867|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
83269868|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269869|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269870|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83269871|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
83269872|NCT02039427|Hormones|hormones|mesh-ancestor
83269873|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269874|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83269875|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269876|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83269877|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83269878|NCT02039427|Analgesics|analgesics|mesh-ancestor
83269879|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
83269880|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269881|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83269882|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269883|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269884|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83269885|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
83269886|NCT02094885|Coagulants|coagulants|mesh-ancestor
83269887|NCT01896856|Trifluridine|trifluridine|mesh-list
83269888|NCT01896856|Irinotecan|irinotecan|mesh-list
83269889|NCT01896856|Guadecitabine|guadecitabine|mesh-list
83269890|NCT01896856|Azacitidine|azacitidine|mesh-list
83269891|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83269892|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83269893|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269894|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269895|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269896|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
83269897|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
83269898|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269899|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83269900|NCT01896700|Methylphenidate|methylphenidate|mesh-list
83269901|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83269902|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269903|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83269904|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83269905|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83269906|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269907|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
83269908|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269909|NCT01896232|Cinacalcet|cinacalcet|mesh-list
83269910|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83269911|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269912|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83269913|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
83269914|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83269915|NCT02460224|Spartalizumab|spartalizumab|mesh-list
83269916|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83269917|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269918|NCT02460224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269919|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269920|NCT02058537|Bethanechol|bethanechol|mesh-list
83269921|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83269922|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
83269923|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269924|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269925|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83269926|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83269927|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
83269928|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269929|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269930|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
83269931|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
83269932|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
83269933|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269934|NCT01612000|Coagulants|coagulants|mesh-ancestor
83269935|NCT02409680|Aspirin|aspirin|mesh-list
83269936|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83269937|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83269938|NCT02409680|Analgesics|analgesics|mesh-ancestor
83269939|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
83269940|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83269941|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269942|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83269943|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83269944|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83269945|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83269946|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269947|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83269948|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83269949|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269950|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
83269951|NCT01894984|Risperidone|risperidone|mesh-list
83269952|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
83269953|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83269954|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
83269955|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83269956|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269957|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269958|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83269959|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83269960|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83269961|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83269962|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
83269963|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
83269964|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83269965|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269966|NCT02375672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83430165|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83269967|NCT02375672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269968|NCT02491463|Vaccines|vaccines|mesh-list
83269969|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
83269970|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269971|NCT02038881|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83269972|NCT02038881|Antiviral Agents|antiviral agents|mesh-ancestor
83269973|NCT02038881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83269974|NCT01857622|Edoxaban|edoxaban|mesh-list
83269975|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83269976|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
83269977|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83269978|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
83269979|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269980|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269981|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
83269982|NCT01857310|Folic Acid|folic acid|mesh-list
83269983|NCT01857310|Hematinics|hematinics|mesh-ancestor
83269984|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
83269985|NCT01857310|Vitamins|vitamins|mesh-ancestor
83269986|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
83269987|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269988|NCT02472353|Metformin|metformin|mesh-list
83269989|NCT02472353|Doxorubicin|doxorubicin|mesh-list
83269990|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83269991|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83269992|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83269993|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83269994|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83269995|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83269996|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83269997|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83269998|NCT02314117|Fluorouracil|fluorouracil|mesh-list
83269999|NCT02314117|Capecitabine|capecitabine|mesh-list
83270000|NCT02314117|Ramucirumab|ramucirumab|mesh-list
83270001|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270002|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
83270003|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270004|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83270005|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270006|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
83270007|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270008|NCT02058147|Insulin|insulin|mesh-list
83270009|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83270010|NCT02058147|Metformin|metformin|mesh-list
83270011|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
83270012|NCT02058147|Lixisenatide|lixisenatide|mesh-list
83270013|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270014|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270015|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
83270016|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83270017|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
83270018|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270019|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270020|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83270021|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
83270022|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
83270023|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83270024|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
83270025|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270026|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270027|NCT02471183|Selexipag|selexipag|mesh-list
83270028|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83270029|NCT04964063|Listerine|listerine|mesh-list
83270030|NCT04964063|Fluorides|fluorides|mesh-list
83270031|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
83270032|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
83270033|NCT04964063|Protective Agents|protective agents|mesh-ancestor
83270034|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270035|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83270036|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270037|NCT04204967|Fentanyl|fentanyl|mesh-list
83270038|NCT04204967|Remifentanil|remifentanil|mesh-list
83270039|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83270040|NCT04204967|Narcotics|narcotics|mesh-ancestor
83270041|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270042|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270043|NCT04204967|Analgesics|analgesics|mesh-ancestor
83270044|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
83270045|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270046|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83270047|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83270048|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
83270050|NCT01855828|Paclitaxel|paclitaxel|mesh-list
83270051|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
83270052|NCT01855828|Fluorouracil|fluorouracil|mesh-list
83270053|NCT01855828|Trastuzumab|trastuzumab|mesh-list
83270054|NCT01855828|Epirubicin|epirubicin|mesh-list
83270055|NCT01855828|Pertuzumab|pertuzumab|mesh-list
83270056|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83270057|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270058|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
83270059|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
83270060|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
83270061|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270062|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270063|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
83270064|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270065|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270066|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83270067|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
83270068|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83270069|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
83270070|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83270071|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270072|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83270073|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83270074|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83270075|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270076|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
83270077|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83270078|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
83270079|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270080|NCT02351167|Nicotine|nicotine|mesh-list
83270081|NCT02351167|Varenicline|varenicline|mesh-list
83270082|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83270083|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
83270084|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270085|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270086|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83270087|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83270088|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
83270089|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270090|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270091|NCT02350309|Lemborexant|lemborexant|mesh-list
83270092|NCT02350309|Flurazepam|flurazepam|mesh-list
83270093|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83270094|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270095|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270096|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83270097|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83270098|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270099|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270100|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83270101|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83270102|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83270103|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
83270104|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
83270105|NCT02038647|Paclitaxel|paclitaxel|mesh-list
83270106|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83270107|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270108|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
83270109|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
83270110|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
83270111|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270112|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
83270113|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83270114|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270115|NCT02037477|Esomeprazole|esomeprazole|mesh-list
83270116|NCT02037477|Rabeprazole|rabeprazole|mesh-list
83270117|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83270118|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270119|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83270121|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270122|NCT02057523|Hormones|hormones|mesh-list
83270123|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83270124|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83270125|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
83270126|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270127|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270128|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270129|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270130|NCT02037165|Celecoxib|celecoxib|mesh-list
83270131|NCT02037165|Pregabalin|pregabalin|mesh-list
83270132|NCT02037165|Analgesics|analgesics|mesh-ancestor
83270133|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
83270134|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270135|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270136|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
83270137|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83270138|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83270139|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270140|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83270141|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83270142|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83270143|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270144|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83270145|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83270146|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83270147|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270148|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270149|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83270150|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83270151|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270152|NCT02470403|Licogliflozin|licogliflozin|mesh-list
83270153|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83270154|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270155|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270156|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270157|NCT01855750|Prednisone|prednisone|mesh-list
83270158|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
83270159|NCT01855750|Rituximab|rituximab|mesh-list
83270160|NCT01855750|Doxorubicin|doxorubicin|mesh-list
83270161|NCT01855750|Vincristine|vincristine|mesh-list
83270162|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270163|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
83270164|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270165|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270166|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83270167|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
83270168|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270169|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270170|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83270171|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270172|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83270173|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83270174|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83270175|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270176|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270177|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
83270178|NCT01855750|Hormones|hormones|mesh-ancestor
83270179|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270180|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83270181|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83270182|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83270183|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83270184|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83270185|NCT04963439|Macitentan|macitentan|mesh-list
83270186|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83270188|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270189|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83270190|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
83270191|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
83270192|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83270193|NCT01622673|Antacids|antacids|mesh-list
83270194|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
83270195|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
83270196|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
83270197|NCT01622673|TEMPO|tempo|mesh-list
83270198|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270199|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83270200|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83270201|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
83270202|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270203|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83270204|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83270205|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270206|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270207|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270208|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83270209|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
83270210|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
83270211|NCT01622673|Protective Agents|protective agents|mesh-ancestor
83270212|NCT02469077|Morphine|morphine|mesh-list
83270213|NCT02469077|Naloxone|naloxone|mesh-list
83270214|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83270215|NCT02469077|Narcotics|narcotics|mesh-ancestor
83270216|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270217|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270218|NCT02469077|Analgesics|analgesics|mesh-ancestor
83270219|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
83270220|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270221|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83270222|NCT02486627|Levofloxacin|levofloxacin|mesh-list
83270223|NCT02486627|Meropenem|meropenem|mesh-list
83270224|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83270225|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270226|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83270227|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83270228|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83270229|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270230|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270231|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270232|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83270233|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83270234|NCT02282293|Piperaquine|piperaquine|mesh-list
83270235|NCT02282293|Trimethoprim|trimethoprim|mesh-list
83270236|NCT02282293|Artenimol|artenimol|mesh-list
83270237|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
83270238|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
83270239|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83270240|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83270241|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270242|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83270243|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83270244|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270245|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270246|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83270247|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83270248|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83270249|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
83270250|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
83270251|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83270252|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
83270253|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270254|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270255|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83270256|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
83270257|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83270258|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83270259|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83270260|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
83270261|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270262|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270263|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83270264|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83270265|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83270266|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
83270267|NCT01892020|Insulin|insulin|mesh-list
83270268|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83270269|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
83270270|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
83270271|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270272|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270273|NCT02485691|Prednisone|prednisone|mesh-list
83270274|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
83270275|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270276|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
83270277|NCT02485691|Hormones|hormones|mesh-ancestor
83270278|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270279|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270280|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83270281|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270282|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83270283|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270284|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270285|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
83270286|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83270287|NCT02517515|Ritonavir|ritonavir|mesh-list
83270288|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83270289|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83270290|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
83270291|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270292|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270293|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83270294|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83270295|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
83270296|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270297|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83270298|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83270299|NCT01891864|Etanercept|etanercept|mesh-list
83270301|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83270302|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83270303|NCT01891864|Analgesics|analgesics|mesh-ancestor
83270304|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
83270305|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270306|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270307|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270308|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270309|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270310|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270311|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
83270312|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
83270313|NCT02484911|Dexamethasone|dexamethasone|mesh-list
83270314|NCT02484911|Olanzapine|olanzapine|mesh-list
83270315|NCT02484911|Aprepitant|aprepitant|mesh-list
83270316|NCT02484911|Palonosetron|palonosetron|mesh-list
83270317|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270318|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
83270319|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
83270320|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270321|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270322|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270323|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
83270324|NCT02484911|Hormones|hormones|mesh-ancestor
83270325|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270326|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83270327|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270328|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83270329|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83270330|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270331|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83270332|NCT02484911|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83270333|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83270334|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83270335|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270336|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270337|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
83270338|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83270339|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83270340|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83270342|NCT04306367|Olaparib|olaparib|mesh-list
83270343|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270344|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270345|NCT04306367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83270346|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270347|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83270348|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270349|NCT04616014|Insulin|insulin|mesh-list
83270350|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83270351|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270352|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270353|NCT02451917|Insulin|insulin|mesh-list
83270354|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83270355|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
83270356|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
83270357|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
83270358|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
83270359|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270360|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270361|NCT02349451|Adalimumab|adalimumab|mesh-list
83270362|NCT02349451|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83270363|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270364|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270365|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
83270366|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83270367|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270368|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270369|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270370|NCT02409368|Nivolumab|nivolumab|mesh-list
83270371|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270372|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270373|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83270374|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270375|NCT04891484|Ondansetron|ondansetron|mesh-list
83270376|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
83270377|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
83270378|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270379|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270380|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270381|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
83270382|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
83270383|NCT04891484|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83270384|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83270385|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
83270386|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270387|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270388|NCT02408120|Insulin|insulin|mesh-list
83270389|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83270390|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
83270391|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
83270392|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
83270393|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83270394|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270395|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270396|NCT01853644|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83270397|NCT01853644|Tivozanib|tivozanib|mesh-list
83270398|NCT01853644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83270399|NCT01853644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270400|NCT01853644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270401|NCT01853254|Ribavirin|ribavirin|mesh-list
83270402|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83270403|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
83430166|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
83270404|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270405|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
83270406|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270407|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83270408|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83270409|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270410|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270411|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
83270412|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270413|NCT01853176|Bupivacaine|bupivacaine|mesh-list
83270414|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
83270415|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
83270416|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270417|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270418|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
83270419|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270420|NCT02340962|Interferons|interferons|mesh-list
83270422|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
83270423|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
83270424|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270425|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
83270426|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270427|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
83270428|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270429|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
83270430|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270431|NCT01852942|Losartan|losartan|mesh-list
83270432|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83270433|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83270434|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83270435|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83270436|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270437|NCT01852162|Dabigatran|dabigatran|mesh-list
83270438|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
83270439|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83270440|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
83270441|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270442|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270443|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
83270444|NCT01835470|Abatacept|abatacept|mesh-list
83270445|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83270446|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270447|NCT01835470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270448|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270449|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270450|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
83270451|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270452|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270453|NCT02451137|Insulin|insulin|mesh-list
83270454|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83270455|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
83270456|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
83270457|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270458|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270459|NCT02372006|Afatinib|afatinib|mesh-list
83270460|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270461|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83270462|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270463|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270464|NCT02406248|Ticagrelor|ticagrelor|mesh-list
83270465|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83270466|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83270467|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83270468|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83270469|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
83270470|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270471|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270472|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270473|NCT02450903|Ceritinib|ceritinib|mesh-list
83270474|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270475|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83270476|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270477|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270478|NCT02371616|Listerine|listerine|mesh-list
83270479|NCT02371616|Calcium|calcium|mesh-list
83270480|NCT02371616|Fluorides|fluorides|mesh-list
83270481|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
83270482|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
83270483|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83270484|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270485|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
83270486|NCT02371616|Protective Agents|protective agents|mesh-ancestor
83270487|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83270488|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270489|NCT01835158|Sunitinib|sunitinib|mesh-list
83270490|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270491|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83270492|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83270493|NCT01835158|Growth Substances|growth substances|mesh-ancestor
83270494|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270495|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
83270496|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83270497|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270498|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270499|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
83270500|NCT01833832|Antidotes|antidotes|mesh-ancestor
83270501|NCT01833832|Protective Agents|protective agents|mesh-ancestor
83270502|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270503|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
83270504|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270505|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
83270506|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83270507|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270508|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
83270509|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
83270510|NCT01850602|Sevelamer|sevelamer|mesh-list
83270511|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
83270512|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
83270513|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270514|NCT02405780|Adalimumab|adalimumab|mesh-list
83270515|NCT02405780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83270516|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270517|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270518|NCT02369510|Epinephrine|epinephrine|mesh-list
83270519|NCT02369510|Racepinephrine|racepinephrine|mesh-list
83270520|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
83270521|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83270522|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83270523|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83270524|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270525|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270526|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270527|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83270528|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83270529|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
83270530|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270531|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83270532|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
83270533|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
83270534|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
83270535|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83270536|NCT01650194|Prednisone|prednisone|mesh-list
83270537|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
83270538|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270539|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
83270540|NCT01650194|Hormones|hormones|mesh-ancestor
83270541|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270542|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270543|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83270544|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270545|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83270546|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270547|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270548|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
83270549|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83270550|NCT02404220|Dexamethasone|dexamethasone|mesh-list
83270551|NCT02404220|Vincristine|vincristine|mesh-list
83270552|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270553|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
83270554|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
83270555|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270556|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270557|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270558|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
83270559|NCT02404220|Hormones|hormones|mesh-ancestor
83270560|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270561|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83270562|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270563|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83270564|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
83270565|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
83270566|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
83270567|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270568|NCT02366468|Ranibizumab|ranibizumab|mesh-list
83270569|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83270570|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83270571|NCT02366468|Growth Substances|growth substances|mesh-ancestor
83270572|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270573|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
83270574|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270575|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83270576|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83270577|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83270578|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83270579|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270580|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270581|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270582|NCT02335346|Analgesics|analgesics|mesh-ancestor
83270583|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
83270584|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270585|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
83270586|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83270587|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
83270588|NCT02403674|Tenofovir|tenofovir|mesh-list
83270589|NCT02403674|Lamivudine|lamivudine|mesh-list
83270590|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83270591|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
83270592|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270593|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83270594|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83270595|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270596|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270597|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83270598|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83270599|NCT02401256|Efavirenz|efavirenz|mesh-list
83270600|NCT02401256|Bupropion|bupropion|mesh-list
83270601|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83270602|NCT02401256|Montelukast|montelukast|mesh-list
83270603|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83270604|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83270605|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
83270606|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270607|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83270608|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83270609|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270610|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83270611|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
83270612|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83270613|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83270614|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83270615|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83270616|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
83270617|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270618|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270619|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83270620|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83270621|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83270622|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83270623|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83270624|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
83270625|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270626|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83270627|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83270628|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83270629|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83270630|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
83270631|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270632|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83270633|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83270634|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83270635|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83270636|NCT02349295|Ixekizumab|ixekizumab|mesh-list
83270637|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
83270638|NCT04877587|Gemcitabine|gemcitabine|mesh-list
83270639|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83270640|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
83270641|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270642|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270643|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
83270644|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83270645|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270646|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270647|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83270648|NCT02284243|Analgesics|analgesics|mesh-ancestor
83270649|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
83270650|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270651|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83270652|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83270653|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83270654|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83270655|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270656|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270657|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
83270658|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270659|NCT02284009|Incretins|incretins|mesh-ancestor
83270660|NCT02284009|Hormones|hormones|mesh-ancestor
83270661|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270662|NCT02400476|Budesonide|budesonide|mesh-list
83270663|NCT02400476|Loperamide|loperamide|mesh-list
83270664|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
83270665|NCT02400476|Colestipol|colestipol|mesh-list
83270666|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270667|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83270668|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
83270669|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270670|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270671|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83270672|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
83270673|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
83270674|NCT02400476|Hormones|hormones|mesh-ancestor
83270675|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270676|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270677|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83270678|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
83270679|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270680|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83270681|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
83270682|NCT02363738|Infliximab|infliximab|mesh-list
83270683|NCT02363738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83270684|NCT02363738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270685|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
83270686|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270687|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270688|NCT02331680|Tolvaptan|tolvaptan|mesh-list
83270689|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83270690|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270691|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
83270692|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270693|NCT02349061|Ustekinumab|ustekinumab|mesh-list
83270694|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
83270695|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
83270696|NCT02331368|Lenalidomide|lenalidomide|mesh-list
83270698|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270699|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270700|NCT02331368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83270701|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270702|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
83270703|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270704|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83270705|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83270706|NCT02331368|Growth Substances|growth substances|mesh-ancestor
83270707|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
83270708|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83270709|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
83270710|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83270711|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270712|NCT02280421|Cyclosporine|cyclosporine|mesh-list
83270713|NCT02280421|Cyclosporins|cyclosporins|mesh-list
83270714|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270715|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270716|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270717|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
83270718|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270719|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
83270720|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270721|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
83270722|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270723|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83270724|NCT04906382|Paclitaxel|paclitaxel|mesh-list
83270725|NCT04906382|Carboplatin|carboplatin|mesh-list
83270726|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83270727|NCT04906382|Tislelizumab|tislelizumab|mesh-list
83270728|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83270729|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270730|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
83270731|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
83270732|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
83270733|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270734|NCT04906382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270735|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83270736|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
83270737|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83270738|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83270739|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83270740|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270741|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270742|NCT02347813|Pioglitazone|pioglitazone|mesh-list
83270743|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270744|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270745|NCT02359994|Hemostatics|hemostatics|mesh-list
83270746|NCT02359994|Coagulants|coagulants|mesh-ancestor
83270747|NCT04905446|Niacinamide|niacinamide|mesh-list
83270748|NCT04905446|Niacin|niacin|mesh-list
83270749|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
83270750|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
83270751|NCT04905446|Vitamins|vitamins|mesh-ancestor
83270752|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
83270753|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270754|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83270755|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
83270756|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270757|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83270758|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
83270759|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
83270760|NCT02326298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83270761|NCT02326298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270762|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270763|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
83270764|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270765|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83270766|NCT02279719|Sorafenib|sorafenib|mesh-list
83270767|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270768|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83270769|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270770|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270771|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
83270772|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83270773|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270774|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270775|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270776|NCT02326220|Alirocumab|alirocumab|mesh-list
83270777|NCT02326220|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83270778|NCT02326220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83270779|NCT02326220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83270780|NCT02326220|Antimetabolites|antimetabolites|mesh-ancestor
83270781|NCT02326220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270782|NCT02326220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83270783|NCT02326220|Protease Inhibitors|protease inhibitors|mesh-ancestor
83270784|NCT02326220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270785|NCT02326220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83270787|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270788|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270789|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
83270790|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83270791|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83270792|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270793|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
83270794|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83270795|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83270796|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83270797|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83270798|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
83270799|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270800|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270801|NCT05650099|Cimetidine|cimetidine|mesh-list
83270802|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83270803|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270804|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83270805|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
83270806|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
83270807|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270808|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270809|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270810|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83270811|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83270812|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270813|NCT02278471|Losartan|losartan|mesh-list
83270814|NCT02278471|Amlodipine|amlodipine|mesh-list
83270815|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83270816|NCT02278471|Atorvastatin|atorvastatin|mesh-list
83270817|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83270818|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83270819|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
83270820|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270821|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83270822|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83270823|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270824|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83270825|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83270826|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83270827|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83270828|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270829|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
83270830|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83270831|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83270832|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83270833|NCT02278471|Diuretics|diuretics|mesh-ancestor
83270834|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
83270835|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83270836|NCT05565235|Nalbuphine|nalbuphine|mesh-list
83270837|NCT05565235|Bupivacaine|bupivacaine|mesh-list
83270838|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
83270839|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
83270840|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270841|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270842|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
83270843|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270844|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83270845|NCT05565235|Narcotics|narcotics|mesh-ancestor
83270846|NCT05565235|Analgesics|analgesics|mesh-ancestor
83270847|NCT02278003|Propofol|propofol|mesh-list
83270848|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83270849|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83270850|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270851|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83270852|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
83270853|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
83270854|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83270855|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
83270856|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270857|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83270858|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83270859|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83270860|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270862|NCT02395172|Avelumab|avelumab|mesh-list
83270863|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270864|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
83270865|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
83270866|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
83270867|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270868|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83270869|NCT04876027|Dulaglutide|dulaglutide|mesh-list
83270870|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83270871|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270872|NCT02358044|Ribavirin|ribavirin|mesh-list
83270873|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
83270874|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83270875|NCT02358044|Grazoprevir|grazoprevir|mesh-list
83270876|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83270877|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
83270878|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270879|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
83270880|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270881|NCT05536219|Antibodies|antibodies|mesh-list
83270882|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
83270883|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270884|NCT05649241|Nicotine|nicotine|mesh-list
83270885|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83270886|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
83270887|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270888|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270889|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83270890|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83270891|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
83270892|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270893|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270894|NCT01850524|Dexamethasone|dexamethasone|mesh-list
83270895|NCT01850524|Lenalidomide|lenalidomide|mesh-list
83270896|NCT01850524|Ixazomib|ixazomib|mesh-list
83270897|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83270898|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
83270899|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
83270900|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83270901|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270902|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83270903|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
83270904|NCT01850524|Hormones|hormones|mesh-ancestor
83270905|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83270906|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83270907|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270908|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
83270909|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83270910|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83270911|NCT01850524|Growth Substances|growth substances|mesh-ancestor
83270912|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
83270913|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
83270914|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270915|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270916|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
83270917|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270918|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83270919|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270920|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270921|NCT02357810|Topotecan|topotecan|mesh-list
83270922|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83270923|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83270924|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270925|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270926|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270927|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83270928|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83270929|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83270930|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83270931|NCT01850446|Oseltamivir|oseltamivir|mesh-list
83270932|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
83270933|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270934|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270935|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270936|NCT01644175|Alirocumab|alirocumab|mesh-list
83270937|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83270938|NCT01644175|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83270939|NCT01644175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83270940|NCT01644175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83270941|NCT01644175|Antimetabolites|antimetabolites|mesh-ancestor
83270942|NCT01644175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270943|NCT01644175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83270944|NCT01644175|Protease Inhibitors|protease inhibitors|mesh-ancestor
83270945|NCT01644175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270946|NCT01644175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83270947|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
83270948|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270949|NCT04856761|Capecitabine|capecitabine|mesh-list
83270950|NCT04856761|Tegafur|tegafur|mesh-list
83270951|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83270952|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
83270953|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270954|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270955|NCT01832038|Lacosamide|lacosamide|mesh-list
83270956|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
83270957|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83270958|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83270959|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83270960|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270961|NCT01849588|Sorafenib|sorafenib|mesh-list
83270962|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270963|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83270964|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270965|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270966|NCT02357342|Sirolimus|sirolimus|mesh-list
83270967|NCT02357342|Aflibercept|aflibercept|mesh-list
83270968|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83270969|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83270970|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83270971|NCT02357342|Growth Substances|growth substances|mesh-ancestor
83270972|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270973|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
83270974|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83270975|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83270976|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83270977|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
83270978|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83270979|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
83270980|NCT02325518|Timolol|timolol|mesh-list
83270981|NCT02325518|Dorzolamide|dorzolamide|mesh-list
83270982|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83270983|NCT02325518|Maleic acid|maleic acid|mesh-list
83270984|NCT02325518|Brinzolamide|brinzolamide|mesh-list
83270985|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83270986|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83270987|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83270988|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83270989|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83270990|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
83270991|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83270992|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83270993|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83270994|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83270995|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83270996|NCT02270983|Linaclotide|linaclotide|mesh-list
83270997|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83270998|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
83270999|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271000|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271001|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83271002|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83271003|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271004|NCT02324270|Diclofenac|diclofenac|mesh-list
83271005|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
83271006|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83271007|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271008|NCT02324270|Analgesics|analgesics|mesh-ancestor
83271009|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
83271010|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271011|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271012|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271013|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271014|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83271015|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271016|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271018|NCT05648071|Nedaplatin|nedaplatin|mesh-list
83271019|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271020|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271021|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271022|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83271023|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83271024|NCT03689699|Nivolumab|nivolumab|mesh-list
83271025|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271026|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271027|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83271028|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271029|NCT01849276|Metformin|metformin|mesh-list
83271030|NCT01849276|Cytarabine|cytarabine|mesh-list
83271031|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271032|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271033|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271034|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
83271035|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271036|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271037|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
83271038|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271039|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271040|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
83271041|NCT02465489|Deferiprone|deferiprone|mesh-list
83271042|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83271043|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
83271044|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
83271045|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271046|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
83271047|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83271048|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271049|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83271050|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83271051|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271052|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271053|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271054|NCT01601821|Sirolimus|sirolimus|mesh-list
83271055|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83271056|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271057|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83271058|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271059|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
83271060|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271061|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
83271062|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271064|NCT01846624|Azacitidine|azacitidine|mesh-list
83271065|NCT01846624|Midostaurin|midostaurin|mesh-list
83271066|NCT01846624|Staurosporine|staurosporine|mesh-list
83271067|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271068|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
83271069|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271070|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271071|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271072|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83271073|NCT01827670|Fluorides|fluorides|mesh-list
83271074|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
83271075|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
83271076|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
83271077|NCT01827670|Protective Agents|protective agents|mesh-ancestor
83271078|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271079|NCT01844830|Phenylephrine|phenylephrine|mesh-list
83271080|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
83271081|NCT01844830|Tetracaine|tetracaine|mesh-list
83271082|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
83271083|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
83271084|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271085|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271086|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
83271087|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271088|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83271089|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83271090|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
83271091|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271092|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271093|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
83271094|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
83271095|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
83271096|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83271097|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
83271098|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83271099|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
83271100|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83271101|NCT01844830|Protective Agents|protective agents|mesh-ancestor
83271102|NCT02323334|Itraconazole|itraconazole|mesh-list
83271103|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
83271104|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271105|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83271106|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83271107|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271108|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271109|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83271110|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
83271111|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271112|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271113|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83271114|NCT02322866|Sarecycline|sarecycline|mesh-list
83271115|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83271116|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271117|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
83271118|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83271119|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83271120|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83271121|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271122|NCT02356562|Ritonavir|ritonavir|mesh-list
83271123|NCT02356562|Ribavirin|ribavirin|mesh-list
83271124|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
83271125|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83271126|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83271127|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
83271128|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271129|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271130|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83271131|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83271132|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
83271133|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271134|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83271135|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83271136|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
83271137|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
83271138|NCT02354690|Fludarabine|fludarabine|mesh-list
83271139|NCT02354690|Interleukin-2|interleukin-2|mesh-list
83271140|NCT02354690|Vemurafenib|vemurafenib|mesh-list
83271141|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271142|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
83271143|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271144|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271145|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83271146|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
83271147|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271148|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271149|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83271150|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271151|NCT02354690|Analgesics|analgesics|mesh-ancestor
83271152|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
83271153|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271154|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83271155|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271156|NCT02354222|Canagliflozin|canagliflozin|mesh-list
83271157|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83271158|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271160|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271161|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
83271162|NCT02351960|Lansoprazole|lansoprazole|mesh-list
83271163|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83271164|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271165|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83271166|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271167|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271168|NCT02351180|Beclomethasone|beclomethasone|mesh-list
83271169|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271170|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
83271171|NCT02351180|Hormones|hormones|mesh-ancestor
83271172|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271173|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271174|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83271175|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
83271176|NCT02350478|Linagliptin|linagliptin|mesh-list
83271177|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271178|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271179|NCT02350478|Incretins|incretins|mesh-ancestor
83271180|NCT02350478|Hormones|hormones|mesh-ancestor
83271181|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271182|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83271183|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
83271184|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271185|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271186|NCT02349542|Bupivacaine|bupivacaine|mesh-list
83271187|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
83271188|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
83271189|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271190|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271191|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
83271192|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271193|NCT02321930|Tofacitinib|tofacitinib|mesh-list
83271194|NCT02321930|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83271195|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83271196|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271197|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271198|NCT02264821|Morphine|morphine|mesh-list
83271199|NCT02264821|Ropivacaine|ropivacaine|mesh-list
83271200|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
83271201|NCT02264821|Anesthetics|anesthetics|mesh-list
83271202|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83271203|NCT02264821|Narcotics|narcotics|mesh-ancestor
83271204|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271205|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271206|NCT02264821|Analgesics|analgesics|mesh-ancestor
83271207|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
83271208|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271209|NCT04854889|Decitabine|decitabine|mesh-list
83271210|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271211|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
83271212|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271213|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271214|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271215|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
83271216|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83271217|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83271218|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83271219|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271220|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271221|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
83271222|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271223|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271224|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83271225|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271226|NCT05341843|Sertraline|sertraline|mesh-list
83271227|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
83271228|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83271229|NCT05341843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83271230|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83271231|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271232|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271233|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271235|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271236|NCT05646199|Metformin|metformin|mesh-list
83271237|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271238|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271239|NCT02258659|Paclitaxel|paclitaxel|mesh-list
83271240|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83271241|NCT02258659|Carboplatin|carboplatin|mesh-list
83271242|NCT02258659|Fluorouracil|fluorouracil|mesh-list
83271243|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
83271244|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83271245|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271246|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
83271247|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
83271248|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
83271249|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271250|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
83271251|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271252|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271253|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
83271254|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271255|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
83271256|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271257|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83271258|NCT02320058|Nivolumab|nivolumab|mesh-list
83271259|NCT02320058|Ipilimumab|ipilimumab|mesh-list
83271260|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271261|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271262|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83271263|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271264|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
83271265|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83271266|NCT02319668|Listerine|listerine|mesh-list
83271267|NCT02319668|Fluorides|fluorides|mesh-list
83271268|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
83271269|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
83271270|NCT02319668|Protective Agents|protective agents|mesh-ancestor
83271271|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271272|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83271273|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271274|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
83271275|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
83271276|NCT02092467|Adalimumab|adalimumab|mesh-list
83271277|NCT02092467|Etanercept|etanercept|mesh-list
83271278|NCT02092467|Tofacitinib|tofacitinib|mesh-list
83271279|NCT02092467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83271280|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271281|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271282|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83271283|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271284|NCT02092467|Analgesics|analgesics|mesh-ancestor
83271285|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
83271286|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271287|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271288|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271289|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271290|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
83271291|NCT02092467|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83271292|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83271293|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271294|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271295|NCT04951115|Carboplatin|carboplatin|mesh-list
83271296|NCT04951115|Etoposide|etoposide|mesh-list
83271297|NCT04951115|Durvalumab|durvalumab|mesh-list
83271298|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271299|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83271300|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83271301|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83271302|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271303|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271304|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271305|NCT04420871|Capecitabine|capecitabine|mesh-list
83271306|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271307|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
83271308|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271309|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271310|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83271312|NCT02349386|Estradiol|estradiol|mesh-list
83271313|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83271314|NCT02349386|Estrogens|estrogens|mesh-ancestor
83271315|NCT02349386|Hormones|hormones|mesh-ancestor
83271316|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271317|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271318|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83271319|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
83271320|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83271321|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83271322|NCT04892888|Vaccines|vaccines|mesh-list
83271323|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
83271324|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271325|NCT02036775|Ambroxol|ambroxol|mesh-list
83271326|NCT02036775|Expectorants|expectorants|mesh-ancestor
83271327|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
83271328|NCT02034591|Apixaban|apixaban|mesh-list
83271329|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83271330|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
83271331|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83271332|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
83271333|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271334|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271335|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
83271336|NCT02091921|Ticagrelor|ticagrelor|mesh-list
83271337|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83271338|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83271339|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83271340|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83271341|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
83271342|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271343|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271344|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271345|NCT04716933|Carboplatin|carboplatin|mesh-list
83271346|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
83271347|NCT04716933|Pemetrexed|pemetrexed|mesh-list
83271348|NCT04716933|Lenvatinib|lenvatinib|mesh-list
83271349|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271350|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271351|NCT04716933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83271352|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271353|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271354|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83271355|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83271356|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83271358|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83271359|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
83271360|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
83271361|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271362|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271363|NCT02461745|Ribavirin|ribavirin|mesh-list
83271364|NCT02461745|Ritonavir|ritonavir|mesh-list
83271365|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
83271366|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271367|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
83271368|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271369|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83271370|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83271371|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
83271372|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271373|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83271374|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83271375|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83271376|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83271377|NCT02034435|Amlodipine|amlodipine|mesh-list
83271378|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83271379|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83271380|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271381|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271382|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83271383|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271384|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
83271385|NCT02033889|Insulin|insulin|mesh-list
83271386|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83271387|NCT02033889|Metformin|metformin|mesh-list
83271388|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
83271389|NCT02033889|Glimepiride|glimepiride|mesh-list
83271390|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
83271391|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
83271392|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271393|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271394|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83271395|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271396|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
83271397|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83271398|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271399|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
83271400|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271401|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271402|NCT02447003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83271403|NCT02447003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271404|NCT04594018|Minoxidil|minoxidil|mesh-list
83271405|NCT04594018|Finasteride|finasteride|mesh-list
83271406|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83271407|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
83271408|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83271409|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83271410|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271411|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271412|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
83271413|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271414|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271415|NCT04594018|Urological Agents|urological agents|mesh-ancestor
83271416|NCT02054481|Ustekinumab|ustekinumab|mesh-list
83271417|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83271418|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
83271419|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
83271420|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271421|NCT02054325|Polidocanol|polidocanol|mesh-list
83271422|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83271423|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83271424|NCT02091375|Cannabidiol|cannabidiol|mesh-list
83271425|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
83271426|NCT02032875|Ribavirin|ribavirin|mesh-list
83271427|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
83271428|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
83430167|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
83271429|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271430|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
83271431|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271432|NCT02032407|Dapsone|dapsone|mesh-list
83271433|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271434|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
83271435|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83271436|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83271437|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83271438|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271439|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271440|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
83271441|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83271442|NCT01843660|Acetaminophen|acetaminophen|mesh-list
83271443|NCT01843660|Tramadol|tramadol|mesh-list
83271444|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271445|NCT01843660|Analgesics|analgesics|mesh-ancestor
83271446|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
83271447|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271448|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271449|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
83271450|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83271451|NCT01843660|Narcotics|narcotics|mesh-ancestor
83271452|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271453|NCT02032173|Ranibizumab|ranibizumab|mesh-list
83271454|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83271455|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83271456|NCT02032173|Growth Substances|growth substances|mesh-ancestor
83271457|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271458|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
83271459|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271460|NCT02461589|Liraglutide|liraglutide|mesh-list
83271461|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271462|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271463|NCT02461589|Incretins|incretins|mesh-ancestor
83271464|NCT02461589|Hormones|hormones|mesh-ancestor
83271465|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271466|NCT02089737|Panitumumab|panitumumab|mesh-list
83271467|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271468|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271469|NCT02089347|Vaccines|vaccines|mesh-list
83271470|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
83271471|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271472|NCT02419469|Cytarabine|cytarabine|mesh-list
83271473|NCT02419469|Dexamethasone|dexamethasone|mesh-list
83271474|NCT02419469|Prednisone|prednisone|mesh-list
83271475|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
83271476|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
83271477|NCT02419469|Rituximab|rituximab|mesh-list
83271478|NCT02419469|Doxorubicin|doxorubicin|mesh-list
83271479|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83271480|NCT02419469|Methotrexate|methotrexate|mesh-list
83271481|NCT02419469|Vincristine|vincristine|mesh-list
83271482|NCT02419469|Daunorubicin|daunorubicin|mesh-list
83271483|NCT02419469|Asparaginase|asparaginase|mesh-list
83271484|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
83271485|NCT02419469|Ofatumumab|ofatumumab|mesh-list
83271486|NCT02419469|Pegaspargase|pegaspargase|mesh-list
83271487|NCT02419469|Thioguanine|thioguanine|mesh-list
83271488|NCT02419469|BB 1101|bb 1101|mesh-list
83271489|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271490|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
83271491|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271492|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271493|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83271494|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
83271495|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271496|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271497|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83271498|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271499|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271500|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
83271501|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
83271502|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271503|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271504|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
83271505|NCT02419469|Hormones|hormones|mesh-ancestor
83430122|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271506|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271507|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83271508|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83271509|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83271510|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83271511|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271512|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83271513|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
83271514|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83271515|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271516|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
83271517|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
83271518|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83271519|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83271520|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
83271521|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271522|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83271523|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
83271524|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
83271525|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
83271526|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
83271527|NCT04687761|Cytarabine|cytarabine|mesh-list
83271528|NCT04687761|Azacitidine|azacitidine|mesh-list
83271529|NCT04687761|Venetoclax|venetoclax|mesh-list
83271530|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271531|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
83271532|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271533|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271534|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
83271535|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271536|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271537|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
83271538|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271539|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271540|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83271541|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83271542|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271543|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271544|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83271545|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271546|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271547|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
83271548|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271549|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
83271550|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83271551|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271552|NCT04730193|Caffeine|caffeine|mesh-list
83271553|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83271554|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271555|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83271556|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271557|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271558|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83271559|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83271560|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
83271561|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271562|NCT02088957|Phenytoin|phenytoin|mesh-list
83271563|NCT02088957|Brivaracetam|brivaracetam|mesh-list
83271564|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83271565|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
83271566|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83271567|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83271568|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271569|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271570|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83271571|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83271572|NCT02088177|Naltrexone|naltrexone|mesh-list
83271573|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83271574|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83271575|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271576|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
83271577|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271578|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
83271579|NCT02030535|Olodaterol|olodaterol|mesh-list
83271580|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83271581|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
83271582|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271583|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271584|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83271585|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
83271586|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
83271587|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83271588|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
83271589|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271590|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271591|NCT02029989|Chrysarobin|chrysarobin|mesh-list
83271592|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83271593|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271594|NCT02029989|Analgesics|analgesics|mesh-ancestor
83271595|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
83271596|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271597|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271598|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271599|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271600|NCT02048241|Guanfacine|guanfacine|mesh-list
83271601|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83271602|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83271603|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83271604|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83271605|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
83271606|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271607|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271608|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271609|NCT02087943|Thalidomide|thalidomide|mesh-list
83271610|NCT02087943|Apremilast|apremilast|mesh-list
83271611|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83271612|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271613|NCT02087943|Analgesics|analgesics|mesh-ancestor
83271614|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
83271615|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271616|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271617|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271618|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271619|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83271620|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83271621|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271622|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271623|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271624|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
83271625|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
83271626|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83271627|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271628|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83271629|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83271630|NCT02087943|Growth Substances|growth substances|mesh-ancestor
83271631|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
83271632|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271633|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83271634|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83271635|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271636|NCT04709211|Bupivacaine|bupivacaine|mesh-list
83271637|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
83271638|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
83271639|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271640|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271641|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
83271642|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271643|NCT02443883|Ramucirumab|ramucirumab|mesh-list
83271644|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271645|NCT02087241|Carboplatin|carboplatin|mesh-list
83271646|NCT02087241|Pemetrexed|pemetrexed|mesh-list
83271647|NCT02087241|Adavosertib|adavosertib|mesh-list
83271648|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271649|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271650|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271651|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83271652|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83271653|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83271654|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83271655|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83271656|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83271657|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83271658|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
83271659|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271660|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271661|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271662|NCT04685577|Nefopam|nefopam|mesh-list
83271663|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271664|NCT04685577|Analgesics|analgesics|mesh-ancestor
83271665|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
83271666|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271667|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271668|NCT02443337|Necitumumab|necitumumab|mesh-list
83271669|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271670|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271671|NCT02443103|Guanabenz|guanabenz|mesh-list
83271672|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83271673|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83271674|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83271675|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83271676|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
83271677|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271678|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271679|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271680|NCT02022657|Tenofovir|tenofovir|mesh-list
83271681|NCT02022657|Emtricitabine|emtricitabine|mesh-list
83271682|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83271683|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
83271684|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271685|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83271686|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83271687|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271688|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271689|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83271690|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83271691|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
83271692|NCT02021643|Ribavirin|ribavirin|mesh-list
83271693|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
83271694|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271695|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
83271696|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271697|NCT02415959|Pancrelipase|pancrelipase|mesh-list
83271698|NCT02415959|Pancreatin|pancreatin|mesh-list
83271699|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271700|NCT02021331|Cimetidine|cimetidine|mesh-list
83271701|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83271702|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271703|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83271704|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
83271705|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
83271706|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271707|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271708|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271709|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83271710|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83271711|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271712|NCT04681833|Vaccines|vaccines|mesh-list
83271713|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
83271714|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271715|NCT02441309|Ifosfamide|ifosfamide|mesh-list
83271716|NCT02441309|Mifamurtide|mifamurtide|mesh-list
83271717|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83271718|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
83271719|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271720|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271721|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83271722|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
83271723|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271724|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83271725|NCT01652729|Exenatide|exenatide|mesh-list
83271726|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271727|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271728|NCT01652729|Incretins|incretins|mesh-ancestor
83271729|NCT01652729|Hormones|hormones|mesh-ancestor
83271730|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271731|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83271732|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
83271733|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271734|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271735|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83271736|NCT02083965|Factor VIII|factor viii|mesh-list
83271737|NCT02083965|Coagulants|coagulants|mesh-ancestor
83271738|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83271739|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271740|NCT04681287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83271741|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271742|NCT04683627|Diclofenac|diclofenac|mesh-list
83271743|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83271744|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271745|NCT04683627|Analgesics|analgesics|mesh-ancestor
83271746|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
83271747|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271748|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271749|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271750|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271751|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83271752|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271753|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271754|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
83271755|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83271756|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271757|NCT02458469|Buspirone|buspirone|mesh-list
83271758|NCT02458469|Trazodone|trazodone|mesh-list
83271759|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83271760|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83271761|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271762|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271763|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83271764|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83271765|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
83271766|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271767|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271768|NCT02458469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83271769|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83271770|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271771|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83271772|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
83271773|NCT01843348|Cyclosporine|cyclosporine|mesh-list
83271774|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
83271775|NCT01843348|Everolimus|everolimus|mesh-list
83271776|NCT01843348|Tacrolimus|tacrolimus|mesh-list
83271777|NCT01843348|Cyclosporins|cyclosporins|mesh-list
83271778|NCT01843348|Basiliximab|basiliximab|mesh-list
83271779|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271780|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
83271781|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271782|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83271783|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271784|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271785|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
83271786|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271787|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
83271788|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83271789|NCT01843348|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83271790|NCT01843348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83271791|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271792|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83271793|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83271794|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
83271795|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83271797|NCT01825876|Evacetrapib|evacetrapib|mesh-list
83271798|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
83271799|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83271800|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83271801|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
83271802|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271803|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83271804|NCT01825798|Metformin|metformin|mesh-list
83271805|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83271806|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271807|NCT05370599|Losartan|losartan|mesh-list
83271808|NCT05370599|Amlodipine|amlodipine|mesh-list
83271809|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
83271810|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
83271811|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83271812|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271813|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271814|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83271815|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271816|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
83271817|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83271818|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83271819|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83271820|NCT05370599|Diuretics|diuretics|mesh-ancestor
83271821|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
83271822|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83271823|NCT02412761|Amlodipine|amlodipine|mesh-list
83271824|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83271825|NCT02412761|Lisinopril|lisinopril|mesh-list
83271826|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
83271827|NCT02412761|Diuretics|diuretics|mesh-list
83271828|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
83271829|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83271830|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83271831|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83271832|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271833|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83271834|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271835|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271836|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
83271837|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
83271838|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
83271839|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83271840|NCT02412761|Protective Agents|protective agents|mesh-ancestor
83271841|NCT01842334|Nicotine|nicotine|mesh-list
83271842|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83271843|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
83271844|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271845|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271846|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83271847|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83271848|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
83271849|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271850|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271851|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
83271852|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83271853|NCT02457611|Ledipasvir|ledipasvir|mesh-list
83271854|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
83271855|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271856|NCT02083653|Fluorouracil|fluorouracil|mesh-list
83271857|NCT02083653|Capecitabine|capecitabine|mesh-list
83271858|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83271859|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
83271860|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271861|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271862|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271863|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83271864|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
83271865|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271866|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83271867|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
83271868|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83271869|NCT02436239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83271870|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83271871|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271872|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271873|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271874|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
83271875|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271876|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83271877|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83271878|NCT02026011|Naltrexone|naltrexone|mesh-list
83271879|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83271880|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83271881|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271882|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
83271883|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271884|NCT02456909|Morphine|morphine|mesh-list
83271885|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83271886|NCT02456909|Narcotics|narcotics|mesh-ancestor
83271887|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271888|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271889|NCT02456909|Analgesics|analgesics|mesh-ancestor
83271890|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
83271891|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271892|NCT02025621|Simendan|simendan|mesh-list
83271893|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83271894|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
83271895|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83271896|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83271897|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271898|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271899|NCT02025621|Protective Agents|protective agents|mesh-ancestor
83271900|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271901|NCT04729023|Temazepam|temazepam|mesh-list
83271902|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83271903|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83271904|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271905|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83271906|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83271907|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83271908|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
83271909|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
83271910|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83271911|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271912|NCT02020941|Dexamethasone|dexamethasone|mesh-list
83271913|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271914|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
83271915|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
83271916|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271917|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271918|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83271919|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
83271920|NCT02020941|Hormones|hormones|mesh-ancestor
83271921|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271922|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83271923|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271924|NCT01823224|Acetaminophen|acetaminophen|mesh-list
83271925|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83271926|NCT01823224|Analgesics|analgesics|mesh-ancestor
83271927|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
83271928|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271929|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271930|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
83271931|NCT01840228|Progesterone|progesterone|mesh-list
83271932|NCT01840228|Progestins|progestins|mesh-ancestor
83271933|NCT01840228|Hormones|hormones|mesh-ancestor
83271934|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271935|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271936|NCT01823146|Oxytocin|oxytocin|mesh-list
83271937|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
83271938|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83271939|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271940|NCT02083185|Leuprolide|leuprolide|mesh-list
83271941|NCT02083185|Relugolix|relugolix|mesh-list
83271942|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83271943|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
83271944|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83271945|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271946|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83271947|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271948|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
83271949|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
83271950|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83271951|NCT02412371|Paclitaxel|paclitaxel|mesh-list
83271952|NCT02412371|Carboplatin|carboplatin|mesh-list
83271953|NCT02412371|Veliparib|veliparib|mesh-list
83271954|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83271955|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271956|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
83271957|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
83271958|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
83271959|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271960|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83271961|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83271962|NCT01822756|Paclitaxel|paclitaxel|mesh-list
83271963|NCT01822756|Gemcitabine|gemcitabine|mesh-list
83271964|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83271965|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83271966|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
83271967|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
83271968|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
83271969|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271970|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83271971|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
83271972|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83271973|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
83271974|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83271975|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83271976|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83271977|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83271978|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
83271979|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
83271980|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83271981|NCT01611298|Vaccines|vaccines|mesh-list
83271983|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271984|NCT01822132|Naltrexone|naltrexone|mesh-list
83271985|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83271986|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83271987|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271988|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
83271989|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271990|NCT01821898|Budesonide|budesonide|mesh-list
83271991|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83271992|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83271993|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
83271994|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83271995|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83271996|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83271997|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
83271998|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
83271999|NCT01821898|Hormones|hormones|mesh-ancestor
83272000|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272001|NCT02411591|Necitumumab|necitumumab|mesh-list
83272002|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272003|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272004|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83272005|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
83272006|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
83272007|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272008|NCT01838044|Celecoxib|celecoxib|mesh-list
83272009|NCT01838044|Pregabalin|pregabalin|mesh-list
83272010|NCT01838044|Analgesics|analgesics|mesh-ancestor
83272011|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
83272012|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83430123|NCT05630846|Vaccines|vaccines|mesh-list
83272013|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272015|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83272016|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272017|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272018|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83272019|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83272020|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83272021|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272022|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83272023|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83272024|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83272025|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272026|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272027|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83272028|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83272029|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272030|NCT02435147|Denosumab|denosumab|mesh-list
83272031|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83272032|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272033|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83272034|NCT02435069|Glycerol|glycerol|mesh-list
83272035|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83272036|NCT02435069|Protective Agents|protective agents|mesh-ancestor
83272037|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272038|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
83272039|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83272040|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83272041|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83272042|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272043|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272044|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
83272045|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272046|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272047|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83272048|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272049|NCT01820572|Cyclosporine|cyclosporine|mesh-list
83272050|NCT01820572|Abatacept|abatacept|mesh-list
83272051|NCT01820572|Tacrolimus|tacrolimus|mesh-list
83272052|NCT01820572|Cyclosporins|cyclosporins|mesh-list
83272053|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83272054|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
83272055|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272056|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83272057|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272058|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272059|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
83272060|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272061|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272062|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272063|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83272064|NCT01820572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272065|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272066|NCT01610596|Halobetasol|halobetasol|mesh-list
83272067|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83272068|NCT01818700|Buprenorphine|buprenorphine|mesh-list
83272069|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83272070|NCT01818700|Narcotics|narcotics|mesh-ancestor
83272071|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272072|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272073|NCT01818700|Analgesics|analgesics|mesh-ancestor
83272074|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
83272075|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272076|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83272077|NCT01817764|Fluticasone|fluticasone|mesh-list
83272079|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83272080|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272081|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83272082|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
83272083|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272084|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272086|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
83272087|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272088|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83272089|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83272090|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83272091|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83272092|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
83272093|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272094|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272095|NCT04726618|Xenon|xenon|mesh-list
83272096|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83272097|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
83272098|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
83272099|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272100|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272101|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83272102|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83272103|NCT01817530|Norethindrone|norethindrone|mesh-list
83272104|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
83272105|NCT01817530|Estradiol|estradiol|mesh-list
83272106|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83272107|NCT01817530|Estrogens|estrogens|mesh-ancestor
83272108|NCT01817530|Hormones|hormones|mesh-ancestor
83272109|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272110|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272111|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83272112|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
83272113|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83272114|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83272115|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83272116|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83272117|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83272118|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83272119|NCT01816984|Cetuximab|cetuximab|mesh-list
83272120|NCT01816984|Antibodies|antibodies|mesh-list
83272121|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
83272122|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83272123|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
83272124|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272125|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272126|NCT01816594|Paclitaxel|paclitaxel|mesh-list
83272127|NCT01816594|Trastuzumab|trastuzumab|mesh-list
83272128|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83272129|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272130|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
83272132|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
83272133|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272134|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272135|NCT02453711|Liraglutide|liraglutide|mesh-list
83272136|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83272137|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272138|NCT02453711|Incretins|incretins|mesh-ancestor
83272139|NCT02453711|Hormones|hormones|mesh-ancestor
83272140|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272141|NCT02453555|Empagliflozin|empagliflozin|mesh-list
83272142|NCT02453555|Linagliptin|linagliptin|mesh-list
83272143|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83272144|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272145|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83272146|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272147|NCT02453555|Incretins|incretins|mesh-ancestor
83272148|NCT02453555|Hormones|hormones|mesh-ancestor
83272149|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272150|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83272151|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
83272152|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272153|NCT02453321|Bupivacaine|bupivacaine|mesh-list
83272154|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
83272155|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
83272156|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272157|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272158|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
83272159|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272160|NCT01610284|Fulvestrant|fulvestrant|mesh-list
83272161|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83272162|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272163|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83272164|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83272165|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
83272166|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272167|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272168|NCT02452463|Durvalumab|durvalumab|mesh-list
83272169|NCT02452463|Nintedanib|nintedanib|mesh-list
83272170|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
83272171|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83272172|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
83272173|NCT02452463|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83272174|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272175|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272176|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
83272177|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272178|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83272179|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272180|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272181|NCT04916327|Antioxidants|antioxidants|mesh-list
83272182|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272183|NCT04916327|Protective Agents|protective agents|mesh-ancestor
83272184|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272185|NCT03628391|Haloperidol|haloperidol|mesh-list
83272186|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
83272187|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
83272188|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
83272189|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272190|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272191|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272192|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83272193|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83272194|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272195|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83272196|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83272197|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
83272198|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272199|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272200|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83272201|NCT01610206|Gemcitabine|gemcitabine|mesh-list
83272202|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83272203|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
83272204|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272205|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272206|NCT01816048|Listerine|listerine|mesh-list
83272207|NCT01816048|Fluorides|fluorides|mesh-list
83272208|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
83272209|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
83272210|NCT01816048|Protective Agents|protective agents|mesh-ancestor
83272211|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272212|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83272213|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272214|NCT01612858|Metformin|metformin|mesh-list
83272215|NCT01612858|Pioglitazone|pioglitazone|mesh-list
83272216|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83272217|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272218|NCT01612702|Dexamethasone|dexamethasone|mesh-list
83272219|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272220|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
83272221|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
83272222|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272223|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272224|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272225|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
83272226|NCT01612702|Hormones|hormones|mesh-ancestor
83272227|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272228|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83272229|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272230|NCT02431559|Doxorubicin|doxorubicin|mesh-list
83272231|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83272232|NCT02431559|Durvalumab|durvalumab|mesh-list
83272233|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83272234|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272235|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83272236|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83272237|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272238|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272239|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272240|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83272241|NCT04926545|Fluorouracil|fluorouracil|mesh-list
83272242|NCT04926545|Irinotecan|irinotecan|mesh-list
83272243|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
83272244|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272245|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83272246|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272247|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83272248|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
83272249|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272250|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83272251|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83272252|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272253|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83272254|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
83272255|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272256|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83272257|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83272258|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83272259|NCT01652573|Calcitonin|calcitonin|mesh-list
83272260|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
83272261|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83272262|NCT01652573|Katacalcin|katacalcin|mesh-list
83272263|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83272264|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272265|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83272266|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
83272267|NCT02388191|Naproxen|naproxen|mesh-list
83272268|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83272269|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83272270|NCT02388191|Analgesics|analgesics|mesh-ancestor
83272271|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
83272272|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272273|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272274|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272275|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272276|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
83272277|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83272278|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272279|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272280|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83272281|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
83272282|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272283|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83272284|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83272285|NCT02387957|Bevacizumab|bevacizumab|mesh-list
83272286|NCT02387957|Ranibizumab|ranibizumab|mesh-list
83272287|NCT02387957|Aflibercept|aflibercept|mesh-list
83272288|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272289|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272290|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83272291|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83272292|NCT02387957|Growth Substances|growth substances|mesh-ancestor
83272293|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272294|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
83272295|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83272296|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83272297|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83272298|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83272299|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272300|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272301|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
83272302|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272303|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83272304|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83272306|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
83272307|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272308|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83272309|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83272310|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272311|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272312|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83272313|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83272314|NCT01799590|Topiramate|topiramate|mesh-list
83272315|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
83272316|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83272317|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272318|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83272319|NCT04902131|Menotropins|menotropins|mesh-list
83272320|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83272321|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
83272322|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83272323|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272324|NCT01815424|Tofacitinib|tofacitinib|mesh-list
83272325|NCT01815424|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83272326|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83272327|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272328|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272329|NCT02431247|Tenofovir|tenofovir|mesh-list
83272330|NCT02431247|Emtricitabine|emtricitabine|mesh-list
83272331|NCT02431247|Darunavir|darunavir|mesh-list
83272332|NCT02431247|Cobicistat|cobicistat|mesh-list
83272333|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83272334|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83272335|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
83272336|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272337|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83272338|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83272339|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272340|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272341|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83272342|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83272343|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83272344|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83272345|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
83272346|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83272347|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83272348|NCT01814878|Acetaminophen|acetaminophen|mesh-list
83272349|NCT01814878|Tramadol|tramadol|mesh-list
83272350|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83272351|NCT01814878|Analgesics|analgesics|mesh-ancestor
83272352|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
83272353|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272354|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272355|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
83272356|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83272357|NCT01814878|Narcotics|narcotics|mesh-ancestor
83272358|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272359|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
83272360|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
83272361|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272362|NCT02407223|Ustekinumab|ustekinumab|mesh-list
83272363|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272364|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
83272365|NCT04602754|Empagliflozin|empagliflozin|mesh-list
83272366|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83272367|NCT04602754|Calcium|calcium|mesh-list
83272368|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83272369|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272370|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83272371|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83272372|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83272373|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
83272374|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272375|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83272376|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83272377|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272378|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83272379|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83272380|NCT01813474|Olaparib|olaparib|mesh-list
83272381|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83272382|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272383|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272384|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272385|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
83272386|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83272387|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272388|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
83272389|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83272390|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83272391|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83272392|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272393|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272394|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
83272395|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272396|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272397|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83272398|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272399|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
83272400|NCT02383589|Rituximab|rituximab|mesh-list
83272401|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272402|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272403|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
83272404|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272405|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272406|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83272407|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83272408|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
83272409|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83272410|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272411|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272412|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272413|NCT01810432|Evacetrapib|evacetrapib|mesh-list
83272414|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83272415|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83272416|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
83272417|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272418|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83272419|NCT02404805|Dolutegravir|dolutegravir|mesh-list
83272420|NCT02404805|Simeprevir|simeprevir|mesh-list
83272421|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83272422|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83272423|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272424|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272425|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83272426|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83272427|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
83272428|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272429|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
83272430|NCT02430311|Paclitaxel|paclitaxel|mesh-list
83272431|NCT02430311|Olaparib|olaparib|mesh-list
83272432|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83272433|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272434|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
83272435|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
83272436|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
83272437|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272438|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83272439|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272440|NCT02383433|Gemcitabine|gemcitabine|mesh-list
83272441|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83272442|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
83272443|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272444|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272445|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
83272446|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83272447|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83272448|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
83272449|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272450|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83272451|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83272452|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272453|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272454|NCT02404493|Decanoic acid|decanoic acid|mesh-list
83272455|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
83272456|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272457|NCT02379221|Lidocaine|lidocaine|mesh-list
83272458|NCT02379221|Epinephrine|epinephrine|mesh-list
83272459|NCT02379221|Benzocaine|benzocaine|mesh-list
83272460|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
83272461|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
83272462|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272463|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272464|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
83272465|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272466|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83272467|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83272468|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83272469|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272470|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272471|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83272472|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83272473|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
83272474|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272475|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83272476|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83272477|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
83272478|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83272479|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
83272480|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
83272481|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
83272482|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83272483|NCT02404103|Flunisolide|flunisolide|mesh-list
83272484|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272485|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83272486|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
83272487|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
83272488|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
83272489|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272490|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83272491|NCT02403635|Midazolam|midazolam|mesh-list
83272492|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83272493|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83272494|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272495|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272496|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83272497|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83272498|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83272499|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83272500|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
83272501|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
83272503|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
83272504|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272505|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272506|NCT02402933|Glucagon|glucagon|mesh-list
83272507|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83272508|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272509|NCT02402933|Hormones|hormones|mesh-ancestor
83272510|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272511|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272512|NCT02402933|Incretins|incretins|mesh-ancestor
83272513|NCT01796470|Idelalisib|idelalisib|mesh-list
83272514|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272515|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272516|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272517|NCT04414852|Apatinib|apatinib|mesh-list
83272518|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272519|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83272520|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272521|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272522|NCT04415008|Cytarabine|cytarabine|mesh-list
83272523|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83272524|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
83272525|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272526|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272527|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
83272528|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272529|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83272530|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
83272531|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272532|NCT01810042|Ranibizumab|ranibizumab|mesh-list
83272533|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83272534|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83272535|NCT01810042|Growth Substances|growth substances|mesh-ancestor
83272536|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272537|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
83272538|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272539|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
83272540|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
83272541|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272542|NCT01867294|Doxycycline|doxycycline|mesh-list
83272543|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
83272544|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83272545|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83272546|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83272547|NCT01867294|Spironolactone|spironolactone|mesh-list
83272548|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
83272549|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272550|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83272551|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272552|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
83272553|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83272554|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83272555|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83272556|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
83272557|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272558|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272559|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83272560|NCT01867294|Diuretics|diuretics|mesh-ancestor
83272561|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
83272562|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83272563|NCT01867294|Protective Agents|protective agents|mesh-ancestor
83272564|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272565|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83272566|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272567|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272568|NCT02423291|Immunotoxins|immunotoxins|mesh-ancestor
83272569|NCT02423291|Immunoconjugates|immunoconjugates|mesh-ancestor
83272570|NCT02423291|Immunologic Factors|immunologic factors|mesh-ancestor
83272571|NCT02423291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272572|NCT02401529|Acetaminophen|acetaminophen|mesh-list
83272573|NCT02401529|Dexamethasone|dexamethasone|mesh-list
83272574|NCT02401529|Prednisolone|prednisolone|mesh-list
83272575|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272576|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
83272577|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
83272578|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272579|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272580|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272581|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
83272582|NCT02401529|Hormones|hormones|mesh-ancestor
83272583|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272584|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83272585|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272586|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83272587|NCT02401529|Analgesics|analgesics|mesh-ancestor
83272588|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
83272589|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
83272590|NCT01866826|Rifaximin|rifaximin|mesh-list
83272591|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83272592|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272593|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272594|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83272595|NCT01865812|Cathartics|cathartics|mesh-ancestor
83272596|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272597|NCT01808092|Meropenem|meropenem|mesh-list
83272598|NCT01808092|Ceftazidime|ceftazidime|mesh-list
83272599|NCT01808092|Avibactam|avibactam|mesh-list
83272600|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83272601|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83272602|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272603|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83272604|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272605|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272606|NCT01807234|Ketorolac|ketorolac|mesh-list
83272607|NCT01807234|Sumatriptan|sumatriptan|mesh-list
83272608|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83272609|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83272610|NCT01807234|Analgesics|analgesics|mesh-ancestor
83272611|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
83272612|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272613|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272614|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272615|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272616|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83272617|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272618|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272619|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83272620|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83272621|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83272622|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
83272623|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272624|NCT02421887|Antioxidants|antioxidants|mesh-list
83272625|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272626|NCT02421887|Protective Agents|protective agents|mesh-ancestor
83272627|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272628|NCT01789606|Ibuprofen|ibuprofen|mesh-list
83272629|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83272630|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83272631|NCT01789606|Analgesics|analgesics|mesh-ancestor
83272632|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
83272633|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272634|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272635|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272636|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272637|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83272638|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272639|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272640|NCT01788358|Candesartan|candesartan|mesh-list
83272641|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
83272642|NCT01788358|Nifedipine|nifedipine|mesh-list
83272643|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83272644|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83272645|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83272646|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272647|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83272648|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272649|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83272650|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272651|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
83272652|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
83272653|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83272654|NCT01773070|Ritonavir|ritonavir|mesh-list
83272655|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83272656|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83272657|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
83272658|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272659|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272660|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83272661|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83272662|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
83272663|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272664|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83272665|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83272666|NCT01772368|Fluticasone|fluticasone|mesh-list
83272668|NCT01772368|Albuterol|albuterol|mesh-list
83272669|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83272670|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83272671|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
83272672|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272673|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83272674|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
83272675|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272676|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272677|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83272678|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
83272679|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272680|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83272681|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83272682|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83272683|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
83272684|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272685|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272686|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
83272687|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83272688|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
83272689|NCT01772368|Hormones|hormones|mesh-ancestor
83272690|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272691|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
83272692|NCT01806298|Hormones|hormones|mesh-list
83272693|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272694|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272695|NCT01772134|Fluticasone|fluticasone|mesh-list
83272696|NCT01772134|Xhance|xhance|mesh-list
83272697|NCT01772134|Bromides|bromides|mesh-list
83272698|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83272699|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272700|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83272701|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
83272702|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272703|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272704|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83272705|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
83272706|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272707|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83272708|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83272709|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83272710|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83272711|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
83272712|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272713|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272714|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
83272715|NCT02017899|Vaccines|vaccines|mesh-list
83272716|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
83272717|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272718|NCT01993329|Mitomycin|mitomycin|mesh-list
83272719|NCT01993329|Cisplatin|cisplatin|mesh-list
83272720|NCT01993329|Ifosfamide|ifosfamide|mesh-list
83272721|NCT01993329|Mesna|mesna|mesh-list
83272722|NCT01993329|Protective Agents|protective agents|mesh-ancestor
83272723|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272724|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
83272725|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272726|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83272727|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272728|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83272729|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272730|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83272731|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83272732|NCT02016183|Candesartan|candesartan|mesh-list
83272733|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
83272734|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83272735|NCT02016183|Diuretics|diuretics|mesh-ancestor
83272736|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
83272737|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272738|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83272739|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272740|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272741|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83272742|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83272743|NCT02421419|Dexamethasone|dexamethasone|mesh-list
83272744|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
83272745|NCT02421419|Lidocaine|lidocaine|mesh-list
83272746|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83272747|NCT02421419|BB 1101|bb 1101|mesh-list
83272748|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272749|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
83272750|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
83272751|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272752|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272753|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272754|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
83272755|NCT02421419|Hormones|hormones|mesh-ancestor
83272756|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272757|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83272758|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272759|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
83272760|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
83272761|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272762|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
83272763|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83272764|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83272765|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83272766|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272767|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272768|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
83272769|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272770|NCT02420717|Leucovorin|leucovorin|mesh-list
83272771|NCT02420717|Cytarabine|cytarabine|mesh-list
83272772|NCT02420717|Dexamethasone|dexamethasone|mesh-list
83272773|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
83272774|NCT02420717|Prednisone|prednisone|mesh-list
83272775|NCT02420717|Cortisone|cortisone|mesh-list
83272776|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
83272777|NCT02420717|Rituximab|rituximab|mesh-list
83272778|NCT02420717|Doxorubicin|doxorubicin|mesh-list
83272779|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83272780|NCT02420717|Methotrexate|methotrexate|mesh-list
83272781|NCT02420717|Vincristine|vincristine|mesh-list
83272782|NCT02420717|Daunorubicin|daunorubicin|mesh-list
83272783|NCT02420717|Dasatinib|dasatinib|mesh-list
83272784|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
83272785|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83272786|NCT02420717|Antibodies|antibodies|mesh-list
83272787|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
83272788|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83272789|NCT02420717|BB 1101|bb 1101|mesh-list
83272790|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83272791|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
83272792|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272793|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272794|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83272795|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
83272796|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272797|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272798|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83272799|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272800|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
83272801|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
83272802|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272803|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272804|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
83272805|NCT02420717|Hormones|hormones|mesh-ancestor
83272806|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83272807|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83272808|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
83272809|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430124|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
83272810|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83272811|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83272812|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83272813|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83272814|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
83272815|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83272816|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83272817|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
83272818|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272819|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83272820|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83272821|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
83272822|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272823|NCT02420717|Antidotes|antidotes|mesh-ancestor
83272824|NCT02420717|Protective Agents|protective agents|mesh-ancestor
83272825|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
83272826|NCT02420717|Vitamins|vitamins|mesh-ancestor
83272827|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
83272828|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83272829|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
83272830|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
83272831|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
83272832|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83272833|NCT02016105|Adalimumab|adalimumab|mesh-list
83272834|NCT02016105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83272835|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272836|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272837|NCT02400749|Apremilast|apremilast|mesh-list
83272838|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83272839|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83272840|NCT02400749|Analgesics|analgesics|mesh-ancestor
83272841|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
83272842|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272843|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272844|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272845|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272846|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83272847|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83272848|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272849|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272850|NCT02420327|Galantamine|galantamine|mesh-list
83272851|NCT02420327|Nicotine|nicotine|mesh-list
83272852|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83272853|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
83272854|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272855|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272856|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83272857|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83272858|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
83272859|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272860|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272861|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83272862|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272863|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83272864|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
83272865|NCT02374853|Vancomycin|vancomycin|mesh-list
83272866|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83272867|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272868|NCT02015793|Adalimumab|adalimumab|mesh-list
83272869|NCT02015793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83272870|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83272871|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83272872|NCT02347631|Dipivefrin|dipivefrin|mesh-list
83272873|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83272874|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
83272875|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272876|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272877|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272878|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
83272879|NCT02015637|Delafloxacin|delafloxacin|mesh-list
83272880|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83272881|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272883|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
83272884|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83272885|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
83272887|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272888|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83272889|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
83272890|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83272891|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83272892|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83272893|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
83272894|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272895|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272896|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83272897|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83272898|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83272899|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
83272900|NCT04898075|Nicotine|nicotine|mesh-list
83272901|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83272902|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
83272903|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272904|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272905|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83272906|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83272907|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
83272908|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272909|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272910|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83272911|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83272912|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83272913|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272914|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272915|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272916|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272917|NCT01621191|Analgesics|analgesics|mesh-ancestor
83272918|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
83272919|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272920|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
83272921|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83272922|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
83272923|NCT02343263|Bupivacaine|bupivacaine|mesh-list
83272924|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83272925|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
83272926|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
83272927|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272928|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272929|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
83272930|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272931|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
83272932|NCT02343263|Coagulants|coagulants|mesh-ancestor
83272933|NCT02342639|Rifaximin|rifaximin|mesh-list
83272934|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83272935|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272936|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83272937|NCT01625091|Naltrexone|naltrexone|mesh-list
83272938|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83272939|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83272940|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272941|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
83272942|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272943|NCT02396537|Lidocaine|lidocaine|mesh-list
83272944|NCT02396537|Midazolam|midazolam|mesh-list
83272945|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
83272946|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
83272947|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83272948|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272949|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
83272950|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83272951|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83272952|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83272953|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83272954|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430168|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
83272955|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272956|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83272957|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83272958|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83272959|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83272960|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83272961|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83272962|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
83272963|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
83272965|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272966|NCT01624467|Necitumumab|necitumumab|mesh-list
83272967|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83272968|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272969|NCT01624233|Ixekizumab|ixekizumab|mesh-list
83272970|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
83272971|NCT01993017|Bupropion|bupropion|mesh-list
83272972|NCT01993017|Sertraline|sertraline|mesh-list
83272973|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
83272974|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83272975|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83272976|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83272977|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83272978|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83272979|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272980|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
83272981|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83272982|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83272983|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83272984|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83272985|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272986|NCT01993017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83272987|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
83272988|NCT01988493|Sorafenib|sorafenib|mesh-list
83272989|NCT01988493|Tepotinib|tepotinib|mesh-list
83272990|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83272991|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83272992|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83272993|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83272994|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
83272995|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83272996|NCT02081079|Ledipasvir|ledipasvir|mesh-list
83272997|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
83272998|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83272999|NCT02081001|Glucagon|glucagon|mesh-list
83273000|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273001|NCT02081001|Hormones|hormones|mesh-ancestor
83273002|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273003|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273004|NCT02080221|Leucovorin|leucovorin|mesh-list
83273005|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
83273006|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273007|NCT02080221|Antidotes|antidotes|mesh-ancestor
83273008|NCT02080221|Protective Agents|protective agents|mesh-ancestor
83273009|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273010|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
83273011|NCT02080221|Vitamins|vitamins|mesh-ancestor
83273012|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
83273013|NCT02014467|Vitamin D|vitamin d|mesh-list
83273014|NCT02014467|Denosumab|denosumab|mesh-list
83273015|NCT02014467|Calcium|calcium|mesh-list
83273016|NCT02014467|Vitamins|vitamins|mesh-ancestor
83273017|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
83273018|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273019|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83273020|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83273021|NCT02013765|Trastuzumab|trastuzumab|mesh-list
83273022|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273023|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273024|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
83273025|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
83273026|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273027|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273028|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273030|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
83273031|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
83273032|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
83273033|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273034|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273035|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273036|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
83273038|NCT01988103|Thalidomide|thalidomide|mesh-list
83273039|NCT01988103|Apremilast|apremilast|mesh-list
83273040|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83273041|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83273042|NCT01988103|Analgesics|analgesics|mesh-ancestor
83273043|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
83273044|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273045|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273046|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273047|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273048|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83273049|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83273050|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273051|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273052|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273053|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
83273054|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
83273055|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83273056|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273057|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83273058|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83273059|NCT01988103|Growth Substances|growth substances|mesh-ancestor
83273060|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
83273061|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273062|NCT02013375|Sirolimus|sirolimus|mesh-list
83273063|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
83273064|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
83273065|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273066|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
83273067|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273068|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273069|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83273070|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
83273071|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273072|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273073|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83273074|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83273075|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273076|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83273077|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
83273078|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273079|NCT02079519|Bevacizumab|bevacizumab|mesh-list
83273080|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273081|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273082|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83273083|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83273084|NCT02079519|Growth Substances|growth substances|mesh-ancestor
83273085|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273086|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
83273087|NCT02078817|Ketamine|ketamine|mesh-list
83273088|NCT02078817|Analgesics|analgesics|mesh-ancestor
83273089|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
83273090|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273091|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273092|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83273093|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83273094|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
83273095|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
83273096|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273097|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83273098|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83273099|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273100|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273101|NCT02011113|Dexamethasone|dexamethasone|mesh-list
83273102|NCT02011113|Pomalidomide|pomalidomide|mesh-list
83273103|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273104|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
83273105|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
83273106|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273107|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273108|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273111|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273112|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83273113|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273114|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
83273115|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83273116|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83273117|NCT02011113|Growth Substances|growth substances|mesh-ancestor
83273118|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
83273119|NCT01807156|Tivozanib|tivozanib|mesh-list
83273120|NCT01807156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83273121|NCT01807156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273122|NCT01807156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273123|NCT01987479|Methotrexate|methotrexate|mesh-list
83273124|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83273125|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
83273126|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83273127|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273128|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273129|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
83273130|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273131|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273132|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
83273133|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273134|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83273135|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273136|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
83273137|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273138|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83273139|NCT01620489|Liraglutide|liraglutide|mesh-list
83273140|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273141|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273142|NCT01620489|Incretins|incretins|mesh-ancestor
83273143|NCT01620489|Hormones|hormones|mesh-ancestor
83273144|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273145|NCT02010567|Capecitabine|capecitabine|mesh-list
83273146|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273147|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
83273148|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273149|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273150|NCT01806064|Axitinib|axitinib|mesh-list
83273151|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273152|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83273153|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273154|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273155|NCT01787188|Meloxicam|meloxicam|mesh-list
83273156|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83273157|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83273158|NCT01787188|Analgesics|analgesics|mesh-ancestor
83273159|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
83273160|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273161|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273162|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273163|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273164|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83273165|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83273166|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273167|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273168|NCT01787032|Ketoconazole|ketoconazole|mesh-list
83273169|NCT01787032|Voriconazole|voriconazole|mesh-list
83273170|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
83273171|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273172|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83273173|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83273174|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273175|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273176|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83273177|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
83273178|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273179|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273180|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83273181|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83273182|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
83273183|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83273184|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83273185|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83273186|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273187|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273188|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
83273189|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273190|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273191|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83273192|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83273193|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273194|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273195|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
83273196|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273198|NCT01768858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83273199|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273200|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273201|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
83273202|NCT01736254|Evacetrapib|evacetrapib|mesh-list
83273203|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83273204|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
83273205|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273206|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83273207|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83273208|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83273209|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273210|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83273211|NCT01785472|Olmesartan|olmesartan|mesh-list
83273212|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83273213|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83273214|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83273215|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83273216|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83273217|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273218|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
83273219|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83273220|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83273221|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
83273222|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273223|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83273224|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83273225|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273226|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273227|NCT01736176|Levodopa|levodopa|mesh-list
83273228|NCT01736176|Carbidopa|carbidopa|mesh-list
83273229|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83273230|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83273231|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83273232|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
83273233|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273234|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273235|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273236|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83273237|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273238|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83273239|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
83273240|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
83273241|NCT01735630|Inositol|inositol|mesh-list
83273242|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
83273243|NCT01735630|Vitamins|vitamins|mesh-ancestor
83273244|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
83273245|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273246|NCT04575922|Nivolumab|nivolumab|mesh-list
83273247|NCT04575922|Ipilimumab|ipilimumab|mesh-list
83273248|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273249|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273250|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83273251|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273252|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
83273253|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273254|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83273255|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273256|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273257|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
83273258|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273259|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273260|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83273261|NCT01734850|Busulfan|busulfan|mesh-list
83273262|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
83273263|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273264|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273265|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
83273266|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273267|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83273268|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273269|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83273270|NCT01766050|Abatacept|abatacept|mesh-list
83273271|NCT01766050|Losartan|losartan|mesh-list
83273272|NCT01766050|Midazolam|midazolam|mesh-list
83273273|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
83273274|NCT01766050|Caffeine|caffeine|mesh-list
83273275|NCT01766050|Omeprazole|omeprazole|mesh-list
83273276|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83273277|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83273278|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273279|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273280|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83273281|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83273282|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83273283|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83273284|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
83273285|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
83273286|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
83273287|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
83273288|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273289|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273290|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83273291|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83273292|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83273293|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83273294|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83273295|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83273296|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273297|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83273298|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83273299|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
83273300|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83273301|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273302|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83273303|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
83273304|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
83273305|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83273306|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83273307|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83273308|NCT01766050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273309|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273310|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273311|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
83273312|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273313|NCT02341625|Nivolumab|nivolumab|mesh-list
83273314|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273315|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273316|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83273317|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273318|NCT02370095|Treprostinil|treprostinil|mesh-list
83273319|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83273320|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83273322|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
83273323|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273324|NCT01734772|Dabigatran|dabigatran|mesh-list
83273325|NCT01734772|Ticagrelor|ticagrelor|mesh-list
83273326|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83273327|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83273328|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83273329|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83273330|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
83273331|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273332|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273333|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273334|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
83273335|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83273336|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
83273337|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273338|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
83273339|NCT02340221|Fulvestrant|fulvestrant|mesh-list
83273340|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83273341|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273342|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83273343|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83273344|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
83273345|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273346|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273347|NCT02395055|Adalimumab|adalimumab|mesh-list
83273348|NCT02395055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83273349|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273350|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273351|NCT02369159|Oseltamivir|oseltamivir|mesh-list
83273352|NCT02369159|Peramivir|peramivir|mesh-list
83273353|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
83273354|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273355|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273356|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273357|NCT02394665|Temozolomide|temozolomide|mesh-list
83273358|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83273359|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
83273360|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273361|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273362|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
83273363|NCT02367833|NuvaRing|nuvaring|mesh-list
83273364|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
83273365|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83273366|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83273367|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273368|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83273369|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83273370|NCT02338193|Metformin|metformin|mesh-list
83273371|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
83273372|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273373|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273374|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83273375|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273376|NCT01783444|Capecitabine|capecitabine|mesh-list
83273377|NCT01783444|Everolimus|everolimus|mesh-list
83273378|NCT01783444|Exemestane|exemestane|mesh-list
83273379|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273380|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
83273381|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273382|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273383|NCT01783444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83273384|NCT01783444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83273385|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273386|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273387|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
83273388|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273389|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83273391|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83273392|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
83273393|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273394|NCT02367131|Empagliflozin|empagliflozin|mesh-list
83273395|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83273396|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273397|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273398|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273399|NCT01608724|Saxagliptin|saxagliptin|mesh-list
83273400|NCT01608724|Incretins|incretins|mesh-ancestor
83273401|NCT01608724|Hormones|hormones|mesh-ancestor
83273402|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273403|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273404|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83273405|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
83273406|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273407|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273408|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273409|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83273410|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273411|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273412|NCT04905251|Misoprostol|misoprostol|mesh-list
83273413|NCT04905251|Mifepristone|mifepristone|mesh-list
83273414|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83273415|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
83273416|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83273417|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273418|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83273419|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273420|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
83273421|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83273422|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83273423|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83273424|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83273425|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
83273426|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83273427|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83273428|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
83273429|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273430|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
83273431|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83273432|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83273433|NCT02364947|Nalmefene|nalmefene|mesh-list
83273434|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83273435|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273436|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
83273437|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273438|NCT02337491|Bevacizumab|bevacizumab|mesh-list
83273439|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
83273440|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273441|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273442|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83273443|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83273444|NCT02337491|Growth Substances|growth substances|mesh-ancestor
83273445|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273446|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
83273447|NCT02337491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83273448|NCT02337491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273449|NCT01765582|Leucovorin|leucovorin|mesh-list
83273450|NCT01765582|Folic Acid|folic acid|mesh-list
83273451|NCT01765582|Bevacizumab|bevacizumab|mesh-list
83273452|NCT01765582|Fluorouracil|fluorouracil|mesh-list
83273453|NCT01765582|Capecitabine|capecitabine|mesh-list
83273454|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
83273455|NCT01765582|Irinotecan|irinotecan|mesh-list
83273456|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
83273457|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273458|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273459|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83273460|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83273461|NCT01765582|Growth Substances|growth substances|mesh-ancestor
83273462|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273464|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
83273465|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273466|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273467|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273468|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
83273469|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83273470|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83273471|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273472|NCT01765582|Antidotes|antidotes|mesh-ancestor
83273473|NCT01765582|Protective Agents|protective agents|mesh-ancestor
83273474|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
83273475|NCT01765582|Vitamins|vitamins|mesh-ancestor
83273477|NCT01765582|Hematinics|hematinics|mesh-ancestor
83273478|NCT04413838|Nivolumab|nivolumab|mesh-list
83273479|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273480|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273481|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83273482|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273483|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83273484|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
83273485|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273486|NCT01648283|Methadone|methadone|mesh-list
83273487|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83273488|NCT01648283|Narcotics|narcotics|mesh-ancestor
83273489|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273490|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273491|NCT01648283|Analgesics|analgesics|mesh-ancestor
83273492|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
83273493|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273494|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
83273495|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
83273496|NCT01649297|Empagliflozin|empagliflozin|mesh-list
83273497|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83273498|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273499|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273500|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273501|NCT01648205|Ranolazine|ranolazine|mesh-list
83273502|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83273503|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83273504|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273505|NCT02391545|Rituximab|rituximab|mesh-list
83273506|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
83273507|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273508|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273509|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
83273510|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273511|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273512|NCT02362451|Vaccines|vaccines|mesh-list
83273513|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
83273514|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273515|NCT01765270|Saxagliptin|saxagliptin|mesh-list
83273516|NCT01765270|Incretins|incretins|mesh-ancestor
83273517|NCT01765270|Hormones|hormones|mesh-ancestor
83273518|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273519|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273520|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83273521|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
83273522|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273523|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273524|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273525|NCT01733758|Liraglutide|liraglutide|mesh-list
83273526|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
83273527|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83273528|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273529|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273530|NCT01733758|Incretins|incretins|mesh-ancestor
83273531|NCT01733758|Hormones|hormones|mesh-ancestor
83273532|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273533|NCT01607554|Irinotecan|irinotecan|mesh-list
83273534|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83273535|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83273536|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273537|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273538|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273540|NCT01607476|Flutemetamol|flutemetamol|mesh-list
83273541|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273542|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83273543|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273544|NCT01765192|Montelukast|montelukast|mesh-list
83273545|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83273546|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
83273547|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83273548|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413597|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273549|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273550|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273551|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83273552|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83273553|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273554|NCT01733680|Amiloride|amiloride|mesh-list
83273555|NCT01733680|Diuretics|diuretics|mesh-ancestor
83273556|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
83273557|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273558|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83273559|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83273560|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83273561|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273562|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83273563|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83273564|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
83273565|NCT02348216|Fludarabine|fludarabine|mesh-list
83273566|NCT02348216|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83273567|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273568|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
83273569|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273570|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273571|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83273572|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
83273573|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273574|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273575|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83273576|NCT02348216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273577|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83273578|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273579|NCT04892498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273580|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273581|NCT04887506|Prednisone|prednisone|mesh-list
83273582|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
83273583|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273584|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
83273585|NCT04887506|Hormones|hormones|mesh-ancestor
83273586|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273587|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273588|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83273589|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273590|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83273591|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273592|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273593|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
83273594|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83273595|NCT02336165|Bevacizumab|bevacizumab|mesh-list
83273596|NCT02336165|Durvalumab|durvalumab|mesh-list
83273597|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273598|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273599|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83273600|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83273601|NCT02336165|Growth Substances|growth substances|mesh-ancestor
83273602|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273603|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
83273604|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
83273605|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273606|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
83273607|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273608|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273609|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83273610|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
83273611|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273612|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273613|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83273614|NCT02319044|Durvalumab|durvalumab|mesh-list
83273615|NCT02319044|Tremelimumab|tremelimumab|mesh-list
83273616|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83273617|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273618|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273619|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
83273620|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273621|NCT01649765|Belimumab|belimumab|mesh-list
83273622|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273623|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
83273624|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273625|NCT02317016|Osimertinib|osimertinib|mesh-list
83273626|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83273627|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83273628|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83273629|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
83273630|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273631|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83273632|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83273633|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273634|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273635|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83273636|NCT02311478|Copper|copper|mesh-list
83273637|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
83273638|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83273639|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273640|NCT02311478|Trace Elements|trace elements|mesh-ancestor
83273641|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
83273642|NCT02281760|Trametinib|trametinib|mesh-list
83273643|NCT02281760|Dabrafenib|dabrafenib|mesh-list
83273644|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83273645|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273646|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83273647|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273648|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273649|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83273650|NCT02281760|Protective Agents|protective agents|mesh-ancestor
83273651|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273652|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83273653|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
83273654|NCT02390531|Bevacizumab|bevacizumab|mesh-list
83273655|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273656|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273657|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83273658|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83273659|NCT02390531|Growth Substances|growth substances|mesh-ancestor
83273660|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273661|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
83273662|NCT02390219|Ivacaftor|ivacaftor|mesh-list
83273663|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83273664|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83273665|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273666|NCT02334215|Methadone|methadone|mesh-list
83273667|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83273668|NCT02334215|Narcotics|narcotics|mesh-ancestor
83273669|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273670|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273671|NCT02334215|Analgesics|analgesics|mesh-ancestor
83273672|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
83273673|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273674|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
83273675|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
83273676|NCT02359877|Interferons|interferons|mesh-list
83273677|NCT02359877|Interferon-beta|interferon-beta|mesh-list
83273678|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
83273679|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273680|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
83273681|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273682|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
83273683|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273684|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83273685|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
83273686|NCT02389829|Promethazine|promethazine|mesh-list
83273687|NCT02389829|Hydromorphone|hydromorphone|mesh-list
83273688|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
83273689|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83273690|NCT02389829|Narcotics|narcotics|mesh-ancestor
83273691|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273692|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273693|NCT02389829|Analgesics|analgesics|mesh-ancestor
83273694|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
83273695|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273696|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83273697|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83273698|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
83273699|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
83273700|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
83273701|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
83273702|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273703|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83273704|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
83273705|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
83273706|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273707|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273708|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83273709|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
83273710|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
83273711|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83273712|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83273713|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83273714|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83273715|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
83273716|NCT02358863|Leucovorin|leucovorin|mesh-list
83273717|NCT02358863|Cisplatin|cisplatin|mesh-list
83273718|NCT02358863|Docetaxel|docetaxel|mesh-list
83273719|NCT02358863|Capecitabine|capecitabine|mesh-list
83273720|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
83273721|NCT02358863|Irinotecan|irinotecan|mesh-list
83273722|NCT02358863|Epirubicin|epirubicin|mesh-list
83273723|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273724|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
83273725|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
83273726|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
83273727|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273728|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273729|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
83273730|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83273731|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83273732|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273733|NCT02358863|Antidotes|antidotes|mesh-ancestor
83273734|NCT02358863|Protective Agents|protective agents|mesh-ancestor
83273735|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273736|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
83273737|NCT02358863|Vitamins|vitamins|mesh-ancestor
83273738|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
83273739|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83273740|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83273741|NCT02358473|Docetaxel|docetaxel|mesh-list
83273742|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
83273743|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273744|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
83273745|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
83273746|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
83273747|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273748|NCT02357459|Triamcinolone|triamcinolone|mesh-list
83273749|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83273750|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83273751|NCT02357459|FX006|fx006|mesh-list
83273752|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83273753|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273754|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
83273755|NCT02357459|Hormones|hormones|mesh-ancestor
83273756|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273757|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273758|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273759|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
83273760|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273761|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273762|NCT02332889|Decitabine|decitabine|mesh-list
83273763|NCT02332889|Poly ICLC|poly iclc|mesh-list
83273764|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273765|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
83273766|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273767|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273768|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273769|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
83273770|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
83273771|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273772|NCT02357147|Pemetrexed|pemetrexed|mesh-list
83273773|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273774|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273775|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273776|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83273777|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83273778|NCT02332655|Cannabidiol|cannabidiol|mesh-list
83273779|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
83273780|NCT02388737|Lansoprazole|lansoprazole|mesh-list
83273781|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
83273782|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83273783|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273784|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83273785|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273786|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273787|NCT02355665|Nicotine|nicotine|mesh-list
83273788|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83273789|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
83273790|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273791|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273792|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83273793|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83273794|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
83273795|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273796|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273797|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
83273798|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83273799|NCT02010255|Ledipasvir|ledipasvir|mesh-list
83273800|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
83273801|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273802|NCT04666701|Ketorolac|ketorolac|mesh-list
83273803|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83273804|NCT04666701|Scopolamine|scopolamine|mesh-list
83273805|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83273806|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83273807|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83273808|NCT04666701|Analgesics|analgesics|mesh-ancestor
83273809|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
83273810|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273811|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273812|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273813|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273814|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83273815|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273816|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273817|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83273818|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
83273819|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
83273820|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273821|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
83273822|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83273823|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
83273824|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273825|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83273826|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
83273827|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
83273828|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83273829|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273830|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83273831|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83273832|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
83273833|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273834|NCT01620177|Ethanol|ethanol|mesh-list
83273835|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83273836|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273837|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273838|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273839|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
83273840|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83273841|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273842|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273843|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273844|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
83273845|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83273846|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83273847|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83273848|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83273849|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273850|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
83273851|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273852|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273853|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83273854|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273856|NCT04673175|Ceftolozane|ceftolozane|mesh-list
83273857|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83273858|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83273859|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273860|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83273861|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273862|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273863|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83273864|NCT02009397|Ipilimumab|ipilimumab|mesh-list
83273865|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273866|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273867|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83273868|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273869|NCT02312219|Folic Acid|folic acid|mesh-list
83273870|NCT02312219|Methotrexate|methotrexate|mesh-list
83273871|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83273872|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
83273873|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83273874|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273875|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273876|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
83273877|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273878|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273879|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83273880|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273881|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83273882|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273883|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
83273884|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273885|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83273886|NCT02312219|Hematinics|hematinics|mesh-ancestor
83273887|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
83273888|NCT02312219|Vitamins|vitamins|mesh-ancestor
83273889|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
83273890|NCT01986231|Glucagon|glucagon|mesh-list
83273891|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273892|NCT01986231|Hormones|hormones|mesh-ancestor
83273893|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273894|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273895|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83273896|NCT02312063|Glimepiride|glimepiride|mesh-list
83273897|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83273898|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273899|NCT02312063|Incretins|incretins|mesh-ancestor
83273900|NCT02312063|Hormones|hormones|mesh-ancestor
83273901|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273902|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83273903|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
83273904|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273905|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273906|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83273907|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273908|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
83273909|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
83273910|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83273911|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273912|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273913|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83273914|NCT02353169|Analgesics|analgesics|mesh-ancestor
83273915|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
83273916|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273917|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83273918|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83273919|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83273920|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
83273921|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273922|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273923|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83273924|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83273925|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273926|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83273927|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83273928|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83273929|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273930|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
83273931|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83273932|NCT01983969|Pyridoxine|pyridoxine|mesh-list
83273933|NCT01983969|Dexamethasone|dexamethasone|mesh-list
83273934|NCT01983969|Rituximab|rituximab|mesh-list
83273935|NCT01983969|Gemcitabine|gemcitabine|mesh-list
83273936|NCT01983969|Azacitidine|azacitidine|mesh-list
83273937|NCT01983969|Melphalan|melphalan|mesh-list
83273938|NCT01983969|Busulfan|busulfan|mesh-list
83273939|NCT01983969|Vorinostat|vorinostat|mesh-list
83273940|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273941|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273942|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
83273943|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273944|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273945|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83273946|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
83273947|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
83273948|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83273949|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273950|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
83273951|NCT01983969|Hormones|hormones|mesh-ancestor
83273952|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83273953|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83273954|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83273955|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
83273956|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273957|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273958|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83273959|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
83273960|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83273961|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83273962|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83273963|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
83273964|NCT01983969|Vitamins|vitamins|mesh-ancestor
83273965|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
83273966|NCT02008773|Valacyclovir|valacyclovir|mesh-list
83273967|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
83273968|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83273969|NCT02257567|Rituximab|rituximab|mesh-list
83273970|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
83273971|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83273972|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83273973|NCT02257567|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83273974|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
83273975|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273976|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273977|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
83273978|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273979|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83273980|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83273981|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
83273982|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273983|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
83273984|NCT01642615|Lansoprazole|lansoprazole|mesh-list
83273985|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83273986|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83273987|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83273988|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83273989|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83273990|NCT03571945|Anesthetics|anesthetics|mesh-list
83273991|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83273992|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83273993|NCT02311361|Durvalumab|durvalumab|mesh-list
83273994|NCT02311361|Tremelimumab|tremelimumab|mesh-list
83273995|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83273996|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83273997|NCT02329223|Omalizumab|omalizumab|mesh-list
83273998|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83273999|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83274000|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
83274001|NCT05302297|Cemiplimab|cemiplimab|mesh-list
83274002|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274003|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274004|NCT02310581|Buprenorphine|buprenorphine|mesh-list
83274005|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83274006|NCT02310581|Narcotics|narcotics|mesh-ancestor
83274007|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274008|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274009|NCT02310581|Analgesics|analgesics|mesh-ancestor
83274010|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
83274011|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274012|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83274013|NCT04892693|Talazoparib|talazoparib|mesh-list
83274014|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83274015|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274016|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274017|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274018|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
83274019|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83274020|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
83274021|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83274022|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
83274023|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274024|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274025|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
83274026|NCT02008227|Docetaxel|docetaxel|mesh-list
83274027|NCT02008227|Atezolizumab|atezolizumab|mesh-list
83274028|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274029|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
83274030|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
83274031|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
83274032|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274033|NCT02008227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83274034|NCT02008227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274035|NCT04198649|Azithromycin|azithromycin|mesh-list
83274036|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83274037|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274038|NCT02348723|Warfarin|warfarin|mesh-list
83274039|NCT02348723|Dabigatran|dabigatran|mesh-list
83274040|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
83274041|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
83274042|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83274043|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
83274044|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274045|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274046|NCT02006667|Gemcitabine|gemcitabine|mesh-list
83274048|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274049|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274050|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
83274051|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274052|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274053|NCT01983111|Acetaminophen|acetaminophen|mesh-list
83274054|NCT01983111|Buprenorphine|buprenorphine|mesh-list
83274055|NCT01983111|Tramadol|tramadol|mesh-list
83274056|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83274057|NCT01983111|Analgesics|analgesics|mesh-ancestor
83274058|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
83274059|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274060|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274061|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
83274062|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83274063|NCT01983111|Narcotics|narcotics|mesh-ancestor
83274064|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274065|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83274066|NCT04672941|Bromides|bromides|mesh-list
83274067|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
83274068|NCT04672941|Olodaterol|olodaterol|mesh-list
83274069|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83274070|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
83274071|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274072|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274073|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83274074|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
83274075|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
83274076|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83274077|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
83274078|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274079|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274080|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
83274081|NCT02348489|Guadecitabine|guadecitabine|mesh-list
83274082|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274083|NCT01966107|Bromides|bromides|mesh-list
83274084|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
83274085|NCT01982331|Vaccines|vaccines|mesh-list
83274086|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
83274087|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274088|NCT02326025|Doxorubicin|doxorubicin|mesh-list
83274089|NCT02326025|Olaratumab|olaratumab|mesh-list
83274090|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83274091|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274092|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83274093|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83274094|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274095|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274096|NCT01619865|Edotreotide|edotreotide|mesh-list
83274097|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83274098|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274099|NCT02006121|Apomorphine|apomorphine|mesh-list
83274100|NCT02006121|Emetics|emetics|mesh-ancestor
83274101|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274102|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
83274103|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274104|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274105|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
83274106|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
83274107|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274108|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274109|NCT02005887|Letrozole|letrozole|mesh-list
83274110|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83274111|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274112|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83274113|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83274114|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274115|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274116|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83274117|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
83274118|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274119|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274120|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
83274121|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83274122|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
83274123|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83274124|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83274125|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83274127|NCT01981473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83274128|NCT01981473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274129|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
83274130|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274131|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274132|NCT02005029|Erythromycin|erythromycin|mesh-list
83274133|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
83274134|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83274135|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
83274136|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83274137|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274138|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274139|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83274140|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274141|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274142|NCT04672005|Leucovorin|leucovorin|mesh-list
83274143|NCT04672005|Paclitaxel|paclitaxel|mesh-list
83274144|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83274145|NCT04672005|Gemcitabine|gemcitabine|mesh-list
83274146|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
83274147|NCT04672005|Irinotecan|irinotecan|mesh-list
83274148|NCT04672005|Folfirinox|folfirinox|mesh-list
83274149|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83274150|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274151|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
83274152|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
83274153|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
83274154|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274155|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274156|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
83274157|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83274158|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83274159|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274160|NCT04672005|Antidotes|antidotes|mesh-ancestor
83274161|NCT04672005|Protective Agents|protective agents|mesh-ancestor
83274162|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274163|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
83274165|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
83274166|NCT04416399|Budesonide|budesonide|mesh-list
83274167|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274168|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83274169|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
83274170|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274171|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274172|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83274173|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
83274174|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
83274175|NCT04416399|Hormones|hormones|mesh-ancestor
83274176|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274177|NCT02282345|Talazoparib|talazoparib|mesh-list
83274178|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83274179|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274180|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274181|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274182|NCT01732822|Clopidogrel|clopidogrel|mesh-list
83274183|NCT01732822|Ticagrelor|ticagrelor|mesh-list
83274184|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83274185|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83274186|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83274187|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83274188|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
83274189|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274190|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274191|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274192|NCT02004093|Paclitaxel|paclitaxel|mesh-list
83274193|NCT02004093|Carboplatin|carboplatin|mesh-list
83274194|NCT02004093|Gemcitabine|gemcitabine|mesh-list
83274195|NCT02004093|Pertuzumab|pertuzumab|mesh-list
83274196|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83274197|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274198|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
83274199|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
83274201|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274202|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274203|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
83274204|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274205|NCT01641367|Tenofovir|tenofovir|mesh-list
83274206|NCT01641367|Emtricitabine|emtricitabine|mesh-list
83274207|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
83274208|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83274209|NCT01641367|Darunavir|darunavir|mesh-list
83274210|NCT01641367|Etravirine|etravirine|mesh-list
83274211|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
83274212|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
83274213|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
83274214|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274215|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83274216|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83274217|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274218|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274219|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83274220|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83274221|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83274222|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83274223|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83274224|NCT02325713|Praziquantel|praziquantel|mesh-list
83274225|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
83274226|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83274227|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274228|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
83274229|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83274230|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274231|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274232|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83274233|NCT04877639|Analgesics|analgesics|mesh-ancestor
83274234|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
83274235|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274236|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83274237|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83274238|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83274239|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
83274240|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274241|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274242|NCT02325401|Metformin|metformin|mesh-list
83274243|NCT02325401|Cisplatin|cisplatin|mesh-list
83274244|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274245|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83274246|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274247|NCT02324699|Prednisone|prednisone|mesh-list
83274248|NCT02324699|Vedolizumab|vedolizumab|mesh-list
83274249|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274250|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
83274251|NCT02324699|Hormones|hormones|mesh-ancestor
83274252|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274253|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274254|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83274255|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274256|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274257|NCT01979523|Trametinib|trametinib|mesh-list
83274258|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274259|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83274260|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274261|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274262|NCT02255461|Palbociclib|palbociclib|mesh-list
83274263|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274264|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83274265|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274266|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274267|NCT01764022|Paclitaxel|paclitaxel|mesh-list
83274268|NCT01764022|Trastuzumab|trastuzumab|mesh-list
83274269|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83274270|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274271|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83274272|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83274273|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83274274|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274275|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274276|NCT02003391|Timolol|timolol|mesh-list
83274277|NCT02003391|Travoprost|travoprost|mesh-list
83274278|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83274279|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83274280|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83274281|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83274282|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
83274283|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274284|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274285|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274286|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83274287|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83274288|NCT02254681|Gemcitabine|gemcitabine|mesh-list
83274289|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274290|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274291|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
83274292|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274293|NCT01965327|Interferons|interferons|mesh-list
83274294|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
83274295|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274296|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
83274297|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274298|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
83274299|NCT04872595|Melphalan|melphalan|mesh-list
83274300|NCT04872595|Busulfan|busulfan|mesh-list
83274301|NCT04872595|Thiotepa|thiotepa|mesh-list
83274302|NCT04872595|Fludarabine|fludarabine|mesh-list
83274303|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274304|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
83274305|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274306|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274307|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83274308|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
83274309|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274310|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274311|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83274313|NCT01639729|Dsuvia|dsuvia|mesh-list
83274314|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83274315|NCT01639729|Narcotics|narcotics|mesh-ancestor
83274316|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274317|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274318|NCT01639729|Analgesics|analgesics|mesh-ancestor
83274319|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
83274320|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274321|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83274322|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83274323|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
83274324|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
83274325|NCT02002221|Metformin|metformin|mesh-list
83274326|NCT02002221|Vildagliptin|vildagliptin|mesh-list
83274327|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83274328|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274329|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83274330|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
83274331|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274332|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274333|NCT05650723|Venetoclax|venetoclax|mesh-list
83274334|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
83274335|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
83274336|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274337|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274338|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83274339|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274340|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274341|NCT05247697|Mirtazapine|mirtazapine|mesh-list
83274342|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
83274343|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83274344|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83274345|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
83274346|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
83274347|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430169|NCT03590444|Ranibizumab|ranibizumab|mesh-list
83274348|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274349|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274351|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83274352|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274353|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83274354|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83274355|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83274356|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
83274357|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83274358|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83274359|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
83274360|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83274361|NCT05243797|Lenalidomide|lenalidomide|mesh-list
83274362|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
83274363|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274364|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83274365|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83274366|NCT05243797|Growth Substances|growth substances|mesh-ancestor
83274367|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
83274368|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274369|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83274370|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83274371|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83274372|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274373|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274374|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83274375|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83274376|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274377|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
83274378|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274379|NCT02001987|Methotrexate|methotrexate|mesh-list
83274380|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83274381|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
83274382|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83274383|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274384|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274385|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
83274386|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274387|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274388|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83274389|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274390|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83274391|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274392|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
83274393|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274394|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83274395|NCT01763164|Dacarbazine|dacarbazine|mesh-list
83274396|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83274397|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
83274398|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274399|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274400|NCT01782742|Bexarotene|bexarotene|mesh-list
83274401|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274402|NCT04561180|Dexamethasone|dexamethasone|mesh-list
83274403|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274404|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
83274405|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
83274406|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274407|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274408|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274409|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
83274410|NCT04561180|Hormones|hormones|mesh-ancestor
83274411|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274412|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83274413|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274414|NCT01732588|Artefenomel|artefenomel|mesh-list
83274415|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
83274416|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83274417|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83274418|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274419|NCT01639339|Belimumab|belimumab|mesh-list
83274420|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274421|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
83274422|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274423|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83274424|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
83274425|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274426|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
83274427|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
83274428|NCT04836637|Calcium|calcium|mesh-list
83274429|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83274430|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274431|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83274432|NCT04836637|Antacids|antacids|mesh-ancestor
83274433|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274434|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274435|NCT04419259|Erenumab|erenumab|mesh-list
83274436|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83274437|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274438|NCT04419259|Analgesics|analgesics|mesh-ancestor
83274439|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
83274440|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274441|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274442|NCT02000427|Blinatumomab|blinatumomab|mesh-list
83274443|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274444|NCT04845217|Peppermint oil|peppermint oil|mesh-list
83274445|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
83274446|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
83274447|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274448|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274449|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274450|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
83274451|NCT05359393|Tislelizumab|tislelizumab|mesh-list
83274452|NCT05359393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274453|NCT05359393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274454|NCT01600885|Guanfacine|guanfacine|mesh-list
83274455|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83274456|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83274457|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83274458|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83274459|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
83274460|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274461|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274462|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274463|NCT04625257|Antibodies|antibodies|mesh-list
83274464|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
83274465|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274466|NCT05011513|Ritonavir|ritonavir|mesh-list
83274467|NCT05011513|Nirmatrelvir|nirmatrelvir|mesh-list
83274468|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83274469|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83274470|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
83274471|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274472|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274473|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83274474|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83274475|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
83274476|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274477|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83274478|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83274479|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
83274480|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274481|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83274482|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274483|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274484|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
83274485|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83274486|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83274487|NCT04832269|Prednisolone|prednisolone|mesh-list
83274488|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
83274489|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83274490|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
83274491|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274492|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
83274493|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
83274494|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274495|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274496|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274497|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
83274499|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274500|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83274501|NCT04832269|Protective Agents|protective agents|mesh-ancestor
83274502|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83274503|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274504|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
83274505|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83274506|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274507|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274508|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83274509|NCT04608331|Analgesics|analgesics|mesh-ancestor
83274510|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
83274511|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274512|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83274513|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83274514|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83274515|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
83274516|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274517|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274518|NCT01637077|Pregabalin|pregabalin|mesh-list
83274519|NCT01637077|Analgesics|analgesics|mesh-ancestor
83274520|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
83274521|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274522|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274523|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
83274524|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83274525|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83274526|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274527|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83274528|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83274529|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83274530|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274531|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83274532|NCT02308163|Etanercept|etanercept|mesh-list
83274533|NCT02308163|Peficitinib|peficitinib|mesh-list
83413598|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
83274534|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83274535|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83274536|NCT02308163|Analgesics|analgesics|mesh-ancestor
83274537|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
83274538|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274539|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274540|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274541|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274542|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274543|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274544|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
83274545|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274546|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274547|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
83274548|NCT04001647|Nitroprusside|nitroprusside|mesh-list
83274549|NCT04001647|Acetylcholine|acetylcholine|mesh-list
83274550|NCT04001647|Vitamins|vitamins|mesh-ancestor
83274551|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
83274552|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274553|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
83274554|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274555|NCT04001647|Protective Agents|protective agents|mesh-ancestor
83274556|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83274557|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
83274558|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83274559|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83274560|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
83274561|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274562|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
83274563|NCT03939637|Antibodies|antibodies|mesh-list
83274564|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
83274565|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83274566|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83274567|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
83274568|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274569|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
83274570|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274571|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274572|NCT04479241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83274573|NCT04479241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274574|NCT04880707|Anesthetics|anesthetics|mesh-list
83274575|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
83274576|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274577|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274578|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
83274579|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274580|NCT01999335|Dexamethasone|dexamethasone|mesh-list
83274581|NCT01999335|Pomalidomide|pomalidomide|mesh-list
83274582|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274583|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
83274584|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
83274585|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274586|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274587|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274588|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
83274589|NCT01999335|Hormones|hormones|mesh-ancestor
83274590|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274591|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83274592|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274593|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
83274594|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83274595|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83274596|NCT01999335|Growth Substances|growth substances|mesh-ancestor
83274597|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
83274598|NCT01999179|Heparin|heparin|mesh-list
83274599|NCT01999179|Enoxaparin|enoxaparin|mesh-list
83274600|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83274601|NCT01999179|Tinzaparin|tinzaparin|mesh-list
83274602|NCT01999179|Dalteparin|dalteparin|mesh-list
83274603|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
83274605|NCT01999179|Apixaban|apixaban|mesh-list
83274606|NCT01999179|Anticoagulants|anticoagulants|mesh-list
83274607|NCT01999179|Edoxaban|edoxaban|mesh-list
83274608|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83274609|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83274610|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274611|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83274612|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
83274613|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83274614|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
83274615|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274616|NCT01977729|Sertraline|sertraline|mesh-list
83274617|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
83274618|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83274619|NCT01977729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83274620|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83274621|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83274622|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274623|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274624|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
83274625|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274626|NCT01998399|Ticagrelor|ticagrelor|mesh-list
83274627|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83274628|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83274629|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83274630|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83274631|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
83274632|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274633|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274634|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274635|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
83274636|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83274637|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274638|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274639|NCT01731886|Dexamethasone|dexamethasone|mesh-list
83274640|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
83274642|NCT01731886|Lenalidomide|lenalidomide|mesh-list
83274643|NCT01731886|Lenograstim|lenograstim|mesh-list
83274644|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274645|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
83274646|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274647|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274648|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83274649|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
83274650|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274651|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274652|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83274653|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274654|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
83274655|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
83274656|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274657|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274658|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
83274659|NCT01731886|Hormones|hormones|mesh-ancestor
83274660|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274661|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83274662|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83274663|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83274664|NCT01731886|Growth Substances|growth substances|mesh-ancestor
83274665|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
83274666|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83274667|NCT01759420|Ondansetron|ondansetron|mesh-list
83274668|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
83274669|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
83274670|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274671|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274672|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274673|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
83274674|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
83274675|NCT01759420|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83274676|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83274677|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
83274678|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274679|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274680|NCT01781026|Vemurafenib|vemurafenib|mesh-list
83274681|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274682|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83274683|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274684|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274686|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83274687|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274688|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83274689|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83274690|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274691|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274692|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
83274693|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274694|NCT04572256|Montelukast|montelukast|mesh-list
83274695|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83274696|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
83274697|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83274698|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
83274699|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274700|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274701|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83274702|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83274703|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274704|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
83274705|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83274706|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
83274707|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274708|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274709|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274710|NCT01975701|Infigratinib|infigratinib|mesh-list
83274711|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274712|NCT01962987|Diclofenac|diclofenac|mesh-list
83274713|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83274715|NCT01962987|Analgesics|analgesics|mesh-ancestor
83274716|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
83274717|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274718|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274719|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274720|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274721|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83274722|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274723|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274724|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
83274725|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
83274726|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274727|NCT01638013|Peficitinib|peficitinib|mesh-list
83274728|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274729|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274730|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274731|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
83274732|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274733|NCT01637623|Allopurinol|allopurinol|mesh-list
83274734|NCT01637623|Losartan|losartan|mesh-list
83274735|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83274736|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83274737|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83274738|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83274739|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274740|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
83274741|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274742|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
83274743|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274744|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83274745|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
83274746|NCT01637623|Protective Agents|protective agents|mesh-ancestor
83274747|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274748|NCT01995825|Lamotrigine|lamotrigine|mesh-list
83274749|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
83274750|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83274751|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83274752|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274753|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83274754|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274755|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83274756|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83274757|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274758|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83274759|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83274760|NCT04267081|Venetoclax|venetoclax|mesh-list
83274761|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274762|NCT04792567|Siponimod|siponimod|mesh-list
83274763|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83274764|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274765|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274766|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
83274767|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274768|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
83274769|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83274770|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
83274771|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274772|NCT04419025|Expectorants|expectorants|mesh-ancestor
83274773|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83274774|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83274775|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
83274776|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274777|NCT04419025|Protective Agents|protective agents|mesh-ancestor
83274778|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274779|NCT04419025|Antidotes|antidotes|mesh-ancestor
83274780|NCT04781647|Interferons|interferons|mesh-list
83274781|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
83274782|NCT04781647|Entecavir|entecavir|mesh-list
83274783|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274784|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
83274785|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274786|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
83274787|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274788|NCT03593473|Oxytocin|oxytocin|mesh-list
83274789|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
83274790|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83274791|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274792|NCT05259787|Propofol|propofol|mesh-list
83274793|NCT05259787|Etomidate|etomidate|mesh-list
83274794|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83274795|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274796|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274797|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83274798|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
83274799|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
83274800|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
83274801|NCT04196413|Fludarabine|fludarabine|mesh-list
83274802|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274803|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
83274804|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274805|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274806|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83274807|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
83274808|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274809|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274810|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83274811|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83274812|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
83274813|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274814|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83274815|NCT01756456|Mitogens|mitogens|mesh-list
83274816|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
83274817|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274818|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
83274819|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83274820|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274821|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274822|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83274823|NCT05226325|Analgesics|analgesics|mesh-ancestor
83274824|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
83274825|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274826|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83274827|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83274828|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83274829|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
83274830|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274831|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274832|NCT04745299|Riluzole|riluzole|mesh-list
83274833|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
83274834|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83274835|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83274836|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274837|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274838|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274839|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83274840|NCT04745299|Protective Agents|protective agents|mesh-ancestor
83274841|NCT05221021|Mirabegron|mirabegron|mesh-list
83274842|NCT05221021|Estradiol|estradiol|mesh-list
83274843|NCT05221021|Estrogens|estrogens|mesh-list
83274844|NCT05221021|Hormones|hormones|mesh-ancestor
83274845|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83274846|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274847|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83274848|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83274849|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83274850|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
83274851|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83274852|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274853|NCT05221021|Urological Agents|urological agents|mesh-ancestor
83274854|NCT03167437|Vorinostat|vorinostat|mesh-list
83274855|NCT03167437|Ustekinumab|ustekinumab|mesh-list
83274856|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274857|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83274858|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274859|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274860|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
83274861|NCT03164473|Rituximab|rituximab|mesh-list
83274862|NCT03164473|Azathioprine|azathioprine|mesh-list
83274863|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83274864|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274865|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
83274866|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274867|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274868|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
83274869|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274870|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274871|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274872|NCT05218915|Dulaglutide|dulaglutide|mesh-list
83274873|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83274874|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274875|NCT01995201|Methotrexate|methotrexate|mesh-list
83274876|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83274877|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
83274878|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83274879|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274880|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274881|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
83274882|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274883|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274884|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
83274885|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274886|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83274887|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83274888|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
83274889|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274890|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83274891|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83274892|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
83274893|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274894|NCT05165641|Anesthetics|anesthetics|mesh-list
83274895|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83274896|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274897|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83274898|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83274899|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274900|NCT05814432|Amphotericin B|amphotericin b|mesh-list
83274901|NCT05814432|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83274902|NCT05814432|Amebicides|amebicides|mesh-ancestor
83274903|NCT05814432|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83274904|NCT05814432|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83274905|NCT05814432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274906|NCT05814432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83274907|NCT05814432|Antifungal Agents|antifungal agents|mesh-ancestor
83274908|NCT05814354|Paclitaxel|paclitaxel|mesh-list
83274909|NCT05814354|Gemcitabine|gemcitabine|mesh-list
83274910|NCT05814354|Capecitabine|capecitabine|mesh-list
83274911|NCT05814354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83274912|NCT05814354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83274913|NCT05814354|Tubulin Modulators|tubulin modulators|mesh-ancestor
83274914|NCT05814354|Antimitotic Agents|antimitotic agents|mesh-ancestor
83274915|NCT05814354|Mitosis Modulators|mitosis modulators|mesh-ancestor
83274916|NCT05814354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274917|NCT05814354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83274918|NCT05814354|Antimetabolites|antimetabolites|mesh-ancestor
83274919|NCT05814302|Acetaminophen|acetaminophen|mesh-list
83274920|NCT05814302|Ibuprofen|ibuprofen|mesh-list
83274921|NCT05814302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83274923|NCT05814302|Analgesics|analgesics|mesh-ancestor
83274924|NCT05814302|Sensory System Agents|sensory system agents|mesh-ancestor
83274925|NCT05814302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83274926|NCT05814302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274927|NCT05814302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83274928|NCT05814302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274929|NCT05814302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83274930|NCT05814302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274931|NCT05814302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274932|NCT05814302|Antipyretics|antipyretics|mesh-ancestor
83274933|NCT05814159|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83274934|NCT05814159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83274935|NCT05814146|Dialysis Solutions|dialysis solutions|mesh-list
83274936|NCT05814146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83274937|NCT05814068|Antihypertensive Agents|antihypertensive agents|mesh-list
83274938|NCT05813964|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83274939|NCT05813964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83274940|NCT05813964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83274941|NCT05813964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83274942|NCT05813964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274943|NCT05813964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274944|NCT05813964|Antiviral Agents|antiviral agents|mesh-ancestor
83274945|NCT05813964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274946|NCT05813964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83274947|NCT05813964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83274948|NCT05813951|Linezolid|linezolid|mesh-list
83274949|NCT05813951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83274950|NCT05813951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274951|NCT05813951|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83274952|NCT05813951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274953|NCT05813951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274954|NCT05813821|Anti-Infective Agents|anti-infective agents|mesh-list
83274955|NCT05813821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83274956|NCT05813691|Antibodies|antibodies|mesh-list
83274957|NCT05813691|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
83274958|NCT05813691|Immunologic Factors|immunologic factors|mesh-ancestor
83274959|NCT05813691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274960|NCT05813665|Denosumab|denosumab|mesh-list
83274961|NCT05813665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83274962|NCT05813665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274963|NCT05813600|Ritonavir|ritonavir|mesh-list
83274964|NCT05813600|Nirmatrelvir|nirmatrelvir|mesh-list
83274965|NCT05813600|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83274966|NCT05813600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83274967|NCT05813600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83274968|NCT05813600|Protease Inhibitors|protease inhibitors|mesh-ancestor
83274969|NCT05813600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274970|NCT05813600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274971|NCT05813600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83274972|NCT05813600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83274973|NCT05813600|Antiviral Agents|antiviral agents|mesh-ancestor
83274974|NCT05813600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83274975|NCT05813600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83274976|NCT05813600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83274978|NCT05813561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83274979|NCT05813522|Aflutinib|aflutinib|mesh-list
83274980|NCT05813522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83274981|NCT05813522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83274982|NCT05813522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274983|NCT05813496|Thioctic Acid|thioctic acid|mesh-list
83274984|NCT05813496|Antioxidants|antioxidants|mesh-ancestor
83274985|NCT05813496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83274986|NCT05813496|Protective Agents|protective agents|mesh-ancestor
83274987|NCT05813496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274988|NCT05813496|Vitamin B Complex|vitamin b complex|mesh-ancestor
83274989|NCT05813496|Vitamins|vitamins|mesh-ancestor
83274990|NCT05813496|Micronutrients|micronutrients|mesh-ancestor
83274991|NCT05813470|Omalizumab|omalizumab|mesh-list
83274992|NCT05813470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83274993|NCT05813470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83274994|NCT05813470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83274995|NCT05813470|Respiratory System Agents|respiratory system agents|mesh-ancestor
83274996|NCT05813470|Immunologic Factors|immunologic factors|mesh-ancestor
83274997|NCT05813470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83274998|NCT05813405|Antihypertensive Agents|antihypertensive agents|mesh-list
83275000|NCT05813366|Pyridoxal|pyridoxal|mesh-list
83275001|NCT05813366|Pyridoxine|pyridoxine|mesh-list
83275002|NCT05813366|Tryptophan|tryptophan|mesh-list
83275003|NCT05813366|Vitamins|vitamins|mesh-ancestor
83275004|NCT05813366|Micronutrients|micronutrients|mesh-ancestor
83275005|NCT05813366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275006|NCT05813366|Vitamin B Complex|vitamin b complex|mesh-ancestor
83275007|NCT05813366|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83275008|NCT05813366|Antidepressive Agents|antidepressive agents|mesh-ancestor
83275009|NCT05813366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83275010|NCT05813327|Ifosfamide|ifosfamide|mesh-list
83275011|NCT05813327|Mesna|mesna|mesh-list
83275012|NCT05813327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275013|NCT05813327|Alkylating Agents|alkylating agents|mesh-ancestor
83275014|NCT05813327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275015|NCT05813327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275016|NCT05813327|Protective Agents|protective agents|mesh-ancestor
83275017|NCT05813327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275018|NCT05813314|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
83275019|NCT05813314|Natriuretic Agents|natriuretic agents|mesh-ancestor
83275020|NCT05813314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275021|NCT05813249|Tocopherols|tocopherols|mesh-list
83275022|NCT05813249|Vitamin E|vitamin e|mesh-list
83275023|NCT05813249|Tocotrienols|tocotrienols|mesh-list
83275024|NCT05813249|alpha-Tocopherol|alpha-tocopherol|mesh-list
83275025|NCT05813249|Antioxidants|antioxidants|mesh-ancestor
83275026|NCT05813249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275027|NCT05813249|Protective Agents|protective agents|mesh-ancestor
83275028|NCT05813249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275029|NCT05813249|Vitamins|vitamins|mesh-ancestor
83275030|NCT05813249|Micronutrients|micronutrients|mesh-ancestor
83275031|NCT05813184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83275032|NCT05813184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275033|NCT05813145|Fenofibrate|fenofibrate|mesh-list
83275034|NCT05813145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83275035|NCT05813145|Antimetabolites|antimetabolites|mesh-ancestor
83275036|NCT05813145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275037|NCT05813145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83275038|NCT05813132|Cytarabine|cytarabine|mesh-list
83275039|NCT05813132|Carboplatin|carboplatin|mesh-list
83275040|NCT05813132|Etoposide|etoposide|mesh-list
83275041|NCT05813132|Etoposide phosphate|etoposide phosphate|mesh-list
83275042|NCT05813132|Melphalan|melphalan|mesh-list
83275043|NCT05813132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83275044|NCT05813132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275045|NCT05813132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83275046|NCT05813132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83275047|NCT05813132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83275048|NCT05813132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275049|NCT05813132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275050|NCT05813132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83275051|NCT05813132|Antimetabolites|antimetabolites|mesh-ancestor
83275052|NCT05813132|Antiviral Agents|antiviral agents|mesh-ancestor
83275053|NCT05813132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275054|NCT05813132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275055|NCT05813132|Immunologic Factors|immunologic factors|mesh-ancestor
83275056|NCT05813132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275057|NCT05813132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275058|NCT05813132|Alkylating Agents|alkylating agents|mesh-ancestor
83275059|NCT05813132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83275060|NCT05813106|Dexmedetomidine|dexmedetomidine|mesh-list
83275061|NCT05813106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83275062|NCT05813106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275063|NCT05813106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275064|NCT05813106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83275065|NCT05813106|Analgesics|analgesics|mesh-ancestor
83275066|NCT05813106|Sensory System Agents|sensory system agents|mesh-ancestor
83275067|NCT05813106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275068|NCT05813106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83275069|NCT05813106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83275070|NCT05813106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83275071|NCT05813106|Adrenergic Agents|adrenergic agents|mesh-ancestor
83275072|NCT05813106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275073|NCT05813106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275075|NCT05813015|Tegafur|tegafur|mesh-list
83275076|NCT05813015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275077|NCT05813015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275078|NCT05813015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275079|NCT05813015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275080|NCT05813015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275081|NCT05813015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83275082|NCT05813015|Antimetabolites|antimetabolites|mesh-ancestor
83275083|NCT05812807|Pembrolizumab|pembrolizumab|mesh-list
83275084|NCT05812807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275085|NCT05812807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275086|NCT05812807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275087|NCT05812807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275088|NCT05811403|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83275089|NCT05811403|Eusol|eusol|mesh-list
83275090|NCT05811403|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83275091|NCT05811403|Disinfectants|disinfectants|mesh-ancestor
83275092|NCT05811403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275093|NCT05811403|Antioxidants|antioxidants|mesh-ancestor
83275094|NCT05811403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275095|NCT05811403|Protective Agents|protective agents|mesh-ancestor
83275096|NCT05811403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275097|NCT05811403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83275098|NCT05811403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83275099|NCT05811403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275100|NCT05811403|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83275101|NCT05808582|Fulvestrant|fulvestrant|mesh-list
83275102|NCT05808582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275103|NCT05808582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275104|NCT05808582|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83275105|NCT05808582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83275106|NCT05808582|Hormone Antagonists|hormone antagonists|mesh-ancestor
83275107|NCT05808582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275108|NCT05808582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275109|NCT05802849|Acetazolamide|acetazolamide|mesh-list
83275110|NCT05802849|Anticonvulsants|anticonvulsants|mesh-ancestor
83275111|NCT05802849|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83275112|NCT05802849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275113|NCT05802849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275114|NCT05802849|Diuretics|diuretics|mesh-ancestor
83275115|NCT05802849|Natriuretic Agents|natriuretic agents|mesh-ancestor
83275116|NCT05802849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275117|NCT05796804|Anesthetics|anesthetics|mesh-list
83275118|NCT05796804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275119|NCT05796804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275120|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83275121|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83275122|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275123|NCT05788289|Lenalidomide|lenalidomide|mesh-list
83275124|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
83275125|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275126|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83275127|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83275128|NCT05788289|Growth Substances|growth substances|mesh-ancestor
83275129|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
83275130|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275132|NCT05787613|Carboplatin|carboplatin|mesh-list
83275133|NCT05787613|Pemetrexed|pemetrexed|mesh-list
83275134|NCT05787613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83275135|NCT05787613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275136|NCT05787613|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275137|NCT05787613|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275138|NCT05787613|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275139|NCT05787613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275140|NCT05787613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275141|NCT05787613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83275142|NCT05787613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83275143|NCT05775887|Vaccines|vaccines|mesh-list
83275144|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
83275145|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275146|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83275147|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
83275148|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275150|NCT05757388|Parecoxib|parecoxib|mesh-list
83275151|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83275152|NCT05757388|Analgesics|analgesics|mesh-ancestor
83275153|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
83275154|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275155|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275156|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
83275157|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83275158|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83275159|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275160|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275161|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83275162|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275163|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275164|NCT05755334|Ropivacaine|ropivacaine|mesh-list
83275165|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
83275166|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
83275167|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275168|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275169|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
83275170|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275171|NCT05750459|Artesunate|artesunate|mesh-list
83275172|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
83275173|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83275174|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83275175|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275176|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275177|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
83275178|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
83275179|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83275180|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
83275181|NCT05749393|Heparin|heparin|mesh-list
83275182|NCT05749393|Calcium heparin|calcium heparin|mesh-list
83275183|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
83275184|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83275185|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83275186|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275187|NCT05732883|Dexamethasone|dexamethasone|mesh-list
83275188|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275189|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
83275190|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
83275191|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275192|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275193|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83275194|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
83275195|NCT05732883|Hormones|hormones|mesh-ancestor
83275196|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275197|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275198|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275199|NCT05720455|Fexofenadine|fexofenadine|mesh-list
83275200|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
83275201|NCT05720455|Ephedrine|ephedrine|mesh-list
83275202|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83275203|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
83275204|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275205|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275206|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83275207|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
83275208|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
83275209|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83275210|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83275211|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
83275212|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
83275213|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275214|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275215|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83275216|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83275217|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83275218|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
83275219|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
83275220|NCT05715814|Empagliflozin|empagliflozin|mesh-list
83275221|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83275222|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275223|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83275224|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275226|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
83275227|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275228|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275229|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275230|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275231|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275232|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275233|NCT05688735|Isosorbide|isosorbide|mesh-list
83275234|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83275235|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83275236|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83275237|NCT05688735|Diuretics|diuretics|mesh-ancestor
83275238|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
83275239|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275240|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
83275241|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83275242|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275243|NCT05674994|Prednisone|prednisone|mesh-list
83275244|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275245|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
83275246|NCT05674994|Hormones|hormones|mesh-ancestor
83275247|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275248|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275249|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275250|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275251|NCT05662397|Cemiplimab|cemiplimab|mesh-list
83275252|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275253|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275254|NCT05627596|Nicotine|nicotine|mesh-list
83275255|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83275256|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
83275257|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275258|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275259|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83275260|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83275261|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
83275262|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275263|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275264|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
83275265|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83275266|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275267|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275268|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83275269|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83275270|NCT05552196|Carbamazepine|carbamazepine|mesh-list
83275271|NCT05552196|Ponesimod|ponesimod|mesh-list
83275272|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
83275273|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
83275274|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83275275|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275276|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275277|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83275278|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83275279|NCT05552196|Analgesics|analgesics|mesh-ancestor
83275280|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
83275281|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275282|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83275283|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83275284|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275285|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83275286|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83275287|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83275288|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275289|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
83275290|NCT05538247|Indomethacin|indomethacin|mesh-list
83275291|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83275292|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83275293|NCT05538247|Analgesics|analgesics|mesh-ancestor
83275294|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
83275295|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275296|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275297|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275298|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275299|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
83275300|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
83275301|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83275302|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83275303|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275304|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275305|NCT05536414|Escitalopram|escitalopram|mesh-list
83275306|NCT05536414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83275307|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83275308|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83275309|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275310|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275311|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
83275312|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275313|NCT05496192|Nivolumab|nivolumab|mesh-list
83275314|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275315|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275316|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275317|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275318|NCT05472623|Nivolumab|nivolumab|mesh-list
83275319|NCT05472623|Adagrasib|adagrasib|mesh-list
83275320|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275321|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275322|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275323|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275324|NCT05438394|Melphalan|melphalan|mesh-list
83275325|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275326|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
83275327|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275328|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275329|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83275330|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275331|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
83275332|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275333|NCT05386030|Lidocaine|lidocaine|mesh-list
83275334|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
83275335|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
83275336|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275337|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275338|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
83275339|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275340|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83275341|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83275342|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83275343|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83275344|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275345|NCT05324852|Midazolam|midazolam|mesh-list
83275346|NCT05324852|Loxapine|loxapine|mesh-list
83275347|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83275348|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83275349|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275350|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275351|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83275352|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83275353|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83275354|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83275355|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
83275356|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
83275357|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
83275358|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
83275359|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275360|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275361|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83275362|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83275363|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
83275364|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
83275365|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
83275366|NCT05293041|Coagulants|coagulants|mesh-ancestor
83413599|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83275367|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83275368|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83275369|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
83275370|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275371|NCT05287568|Venetoclax|venetoclax|mesh-list
83275372|NCT05287568|Cc-486|cc-486|mesh-list
83275373|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275374|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
83275375|NCT05287191|Digoxin|digoxin|mesh-list
83275376|NCT05287191|Amiodarone|amiodarone|mesh-list
83275377|NCT05287191|Analgesics|analgesics|mesh-ancestor
83275378|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
83275379|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275380|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275381|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
83275382|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275383|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83275384|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
83275385|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83275386|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83275387|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275388|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83275389|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
83275390|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83275391|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83275392|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275393|NCT05287191|Protective Agents|protective agents|mesh-ancestor
83275394|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
83275395|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83275396|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83275397|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83275398|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83275399|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83275400|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83275401|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83275402|NCT05279417|Methotrexate|methotrexate|mesh-list
83275403|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83275404|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
83275405|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83275406|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275407|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83275408|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
83275409|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275410|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275411|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
83275412|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275413|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83275414|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275415|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
83275416|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275417|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83275418|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
83275419|NCT05259046|Vitamin K|vitamin k|mesh-list
83275420|NCT05259046|Menaquinone 7|menaquinone 7|mesh-list
83275421|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83275422|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83275423|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275424|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
83275425|NCT05259046|Coagulants|coagulants|mesh-ancestor
83275426|NCT05259046|Vitamins|vitamins|mesh-ancestor
83275427|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
83275428|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275429|NCT05206682|Leuprolide|leuprolide|mesh-list
83275430|NCT05206682|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83275431|NCT05206682|Fertility Agents|fertility agents|mesh-ancestor
83275432|NCT05206682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83275433|NCT05206682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275434|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275435|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275436|NCT05197842|Prednisone|prednisone|mesh-list
83275437|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
83275438|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
83275439|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275440|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
83275441|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275442|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275443|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275444|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
83275445|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275446|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275447|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83275448|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275449|NCT05197842|Hormones|hormones|mesh-ancestor
83275450|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275451|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275452|NCT05189457|Docetaxel|docetaxel|mesh-list
83275453|NCT05189457|Tislelizumab|tislelizumab|mesh-list
83275454|NCT05189457|Leuprolide|leuprolide|mesh-list
83275455|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83275456|NCT05189457|Hormones|hormones|mesh-list
83275457|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83275458|NCT05189457|Relugolix|relugolix|mesh-list
83275459|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275460|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275461|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275462|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275463|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275464|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275465|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275466|NCT05189457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275467|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83275468|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
83275469|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83275470|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275471|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
83275472|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83275473|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
83275474|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83275475|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
83275476|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
83275477|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
83275478|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275479|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
83275480|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275481|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275482|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275483|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
83275484|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275485|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275486|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83275487|NCT05135910|Terbinafine|terbinafine|mesh-list
83275488|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
83275489|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275490|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275491|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275492|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
83275493|NCT05129748|Mannitol|mannitol|mesh-list
83275494|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83275495|NCT05129748|Diuretics|diuretics|mesh-ancestor
83275496|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
83275497|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275498|NCT05129748|Antidotes|antidotes|mesh-ancestor
83275499|NCT05129748|Protective Agents|protective agents|mesh-ancestor
83275501|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275502|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
83275503|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83275504|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275505|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
83275506|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
83275507|NCT05127746|Donepezil|donepezil|mesh-list
83275508|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83275509|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275510|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275511|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
83275512|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275513|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275514|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
83275515|NCT05109234|Brivaracetam|brivaracetam|mesh-list
83275516|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
83275517|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
83275518|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83275519|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83275520|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275521|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
83275522|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
83275523|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275524|NCT05024552|Cytarabine|cytarabine|mesh-list
83275525|NCT05024552|Daunorubicin|daunorubicin|mesh-list
83275526|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83275527|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
83275528|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275529|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275530|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
83275531|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275532|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275533|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
83275534|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275535|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83275536|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83275537|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83275538|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275539|NCT05004662|Nicotine|nicotine|mesh-list
83275540|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83275541|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
83275542|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275543|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275544|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83275545|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83275546|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
83275547|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275548|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275549|NCT04969887|Nivolumab|nivolumab|mesh-list
83275550|NCT04969887|Ipilimumab|ipilimumab|mesh-list
83275551|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275552|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275553|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275554|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275555|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
83275556|NCT04933084|Narcotics|narcotics|mesh-ancestor
83275557|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275558|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275559|NCT04933084|Analgesics|analgesics|mesh-ancestor
83275560|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
83275561|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275562|NCT04930887|Bupivacaine|bupivacaine|mesh-list
83275563|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
83275564|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
83275565|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275566|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275567|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
83275568|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275569|NCT04915612|Cytarabine|cytarabine|mesh-list
83275570|NCT04915612|Daunorubicin|daunorubicin|mesh-list
83275571|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
83275572|NCT04915612|Calicheamicins|calicheamicins|mesh-list
83275573|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83275574|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
83275575|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275576|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275577|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
83275578|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275579|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275580|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
83275581|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275582|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83275583|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83275584|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83275585|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275586|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275587|NCT04915612|Immunotoxins|immunotoxins|mesh-ancestor
83275588|NCT04915612|Immunoconjugates|immunoconjugates|mesh-ancestor
83275589|NCT04863248|Docetaxel|docetaxel|mesh-list
83275590|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275591|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275592|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275593|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275594|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275595|NCT04815902|Losartan|losartan|mesh-list
83275596|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83275597|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83275598|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83275599|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83275600|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275601|NCT04807140|Paclitaxel|paclitaxel|mesh-list
83275602|NCT04807140|Carboplatin|carboplatin|mesh-list
83275603|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83275604|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275605|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275606|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275607|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275608|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275609|NCT04759248|Trastuzumab|trastuzumab|mesh-list
83275610|NCT04759248|Atezolizumab|atezolizumab|mesh-list
83275611|NCT04759248|Vinorelbine|vinorelbine|mesh-list
83275612|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275613|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275614|NCT04759248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275615|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275616|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83275617|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275618|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275619|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275620|NCT04756726|Dexamethasone|dexamethasone|mesh-list
83275621|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275622|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
83275623|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
83275624|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275625|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275626|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83275627|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
83275628|NCT04756726|Hormones|hormones|mesh-ancestor
83275629|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275630|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275631|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275632|NCT04725188|Docetaxel|docetaxel|mesh-list
83275633|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
83275634|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275635|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275636|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275637|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275638|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275639|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275640|NCT04725188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275641|NCT04704505|Androgens|androgens|mesh-list
83275642|NCT04704505|Hormones|hormones|mesh-ancestor
83275643|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275644|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275645|NCT04558918|Eculizumab|eculizumab|mesh-list
83275646|NCT04558918|Ravulizumab|ravulizumab|mesh-list
83275647|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83275648|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275649|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
83275650|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275651|NCT04529278|Liraglutide|liraglutide|mesh-list
83275652|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83275653|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275655|NCT04529278|Hormones|hormones|mesh-ancestor
83275656|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275657|NCT04526730|Nivolumab|nivolumab|mesh-list
83275658|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275659|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275660|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275661|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275662|NCT04503148|Propofol|propofol|mesh-list
83275663|NCT04503148|Anesthetics|anesthetics|mesh-list
83275664|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
83275665|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
83275666|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83275667|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275668|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275669|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83275670|NCT04498832|Vaccines|vaccines|mesh-list
83275671|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
83275672|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275673|NCT04493203|Nivolumab|nivolumab|mesh-list
83275674|NCT04493203|Axitinib|axitinib|mesh-list
83275675|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275676|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275677|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275678|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275679|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83275680|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275681|NCT04458545|Heroin|heroin|mesh-list
83275682|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83275683|NCT04458545|Narcotics|narcotics|mesh-ancestor
83275684|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275685|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275686|NCT04458545|Analgesics|analgesics|mesh-ancestor
83275687|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
83275688|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275689|NCT04429516|Morphine|morphine|mesh-list
83275690|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83275691|NCT04429516|Narcotics|narcotics|mesh-ancestor
83275692|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275693|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275694|NCT04429516|Analgesics|analgesics|mesh-ancestor
83275695|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
83275696|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275697|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
83275698|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275699|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275700|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275701|NCT04412096|Timolol|timolol|mesh-list
83275702|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83275703|NCT04412096|Latanoprost|latanoprost|mesh-list
83275704|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83275705|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83275706|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83275707|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
83275708|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275709|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275710|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275711|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83275712|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83275713|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
83275714|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83275715|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83275716|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275717|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
83275718|NCT04410042|Coagulants|coagulants|mesh-ancestor
83275719|NCT04405167|Dexamethasone|dexamethasone|mesh-list
83275720|NCT04405167|Lenalidomide|lenalidomide|mesh-list
83275721|NCT04405167|Ixazomib|ixazomib|mesh-list
83275722|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275723|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
83275724|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
83275725|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275726|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275727|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83275728|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
83275730|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275731|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275732|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275733|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
83275734|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275735|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275736|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
83275737|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83275738|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83275739|NCT04405167|Growth Substances|growth substances|mesh-ancestor
83275740|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83275741|NCT04388852|Ipilimumab|ipilimumab|mesh-list
83275742|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275743|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275744|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275745|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275746|NCT04388839|Dactinomycin|dactinomycin|mesh-list
83275747|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
83275748|NCT04388839|Vincristine|vincristine|mesh-list
83275749|NCT04388839|Vinorelbine|vinorelbine|mesh-list
83275750|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275751|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
83275752|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275753|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275754|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275755|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
83275756|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275757|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275758|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83275759|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83275760|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275761|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275762|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275763|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83275764|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275765|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83275766|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83275767|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275768|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83275769|NCT04357951|Cycloserine|cycloserine|mesh-list
83275770|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83275771|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275772|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83275773|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
83275774|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83275775|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
83275776|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275777|NCT04285229|Ixekizumab|ixekizumab|mesh-list
83275778|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
83275779|NCT04282668|Tretinoin|tretinoin|mesh-list
83275780|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275781|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
83275782|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
83275783|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
83275784|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
83275785|NCT04259060|Hematinics|hematinics|mesh-ancestor
83275786|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
83275787|NCT04259060|Vitamins|vitamins|mesh-ancestor
83275788|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
83275789|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275790|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
83275791|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83275792|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83275793|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275794|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
83275795|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
83275796|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275797|NCT04218240|Lofexidine|lofexidine|mesh-list
83275798|NCT04218240|Pregabalin|pregabalin|mesh-list
83275799|NCT04218240|Analgesics|analgesics|mesh-ancestor
83275800|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
83275801|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275802|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275804|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83275805|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83275806|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275807|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83275808|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83275809|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83275810|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275811|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83275812|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83275813|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83275814|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83275815|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83275816|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83275817|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83275818|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83275819|NCT04212793|Bevacizumab|bevacizumab|mesh-list
83275820|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275821|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275822|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83275823|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83275824|NCT04212793|Growth Substances|growth substances|mesh-ancestor
83275825|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275826|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
83275828|NCT04084951|Ipilimumab|ipilimumab|mesh-list
83275829|NCT04084951|Atezolizumab|atezolizumab|mesh-list
83275830|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275831|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275832|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275833|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275834|NCT04083898|Prednisone|prednisone|mesh-list
83275835|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83275836|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275837|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
83275838|NCT04083898|Hormones|hormones|mesh-ancestor
83275839|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275840|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275841|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83275842|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275843|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275844|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
83275845|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275846|NCT04035837|Interferons|interferons|mesh-list
83275847|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
83275848|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275849|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
83275850|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275851|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
83275852|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275853|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
83275854|NCT04024462|Docetaxel|docetaxel|mesh-list
83275855|NCT04024462|Doxorubicin|doxorubicin|mesh-list
83275856|NCT04024462|Trastuzumab|trastuzumab|mesh-list
83275857|NCT04024462|Pertuzumab|pertuzumab|mesh-list
83275858|NCT04024462|Hormones|hormones|mesh-list
83275859|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275860|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
83275861|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275862|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275863|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275864|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
83275865|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275866|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275867|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83275868|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83275869|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83275870|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83275871|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83275872|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83275873|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83275874|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275875|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275876|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83275878|NCT04023227|Enalapril|enalapril|mesh-list
83275879|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83275880|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83275881|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83275882|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83275883|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275884|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83275885|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
83275886|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275887|NCT04022135|Folic Acid|folic acid|mesh-list
83275888|NCT04022135|Hematinics|hematinics|mesh-ancestor
83275889|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
83275890|NCT04022135|Vitamins|vitamins|mesh-ancestor
83275891|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
83275892|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275893|NCT04001777|Osimertinib|osimertinib|mesh-list
83275894|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275895|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83275896|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275897|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275898|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
83275899|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83413600|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83275900|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275901|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
83275902|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275903|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275904|NCT03983668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275905|NCT03983668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275906|NCT03977012|Buprenorphine|buprenorphine|mesh-list
83275907|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83275908|NCT03977012|Narcotics|narcotics|mesh-ancestor
83275909|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83275910|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275911|NCT03977012|Analgesics|analgesics|mesh-ancestor
83275912|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
83275913|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275914|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83275915|NCT03915964|Adalimumab|adalimumab|mesh-list
83275916|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83275917|NCT03915964|Etanercept|etanercept|mesh-list
83275918|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83275919|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83275920|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83275921|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83275922|NCT03915964|Analgesics|analgesics|mesh-ancestor
83275923|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
83275924|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83275925|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275926|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83275927|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275928|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
83275929|NCT03907423|Metformin|metformin|mesh-list
83275930|NCT03907423|Glimepiride|glimepiride|mesh-list
83275931|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83275932|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83275933|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275934|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83275935|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83275936|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
83275937|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275938|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83275939|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83275940|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275941|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83275942|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275943|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
83275944|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
83275945|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83275946|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83275947|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275948|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
83275949|NCT03897621|Coagulants|coagulants|mesh-ancestor
83275950|NCT03896269|Cytarabine|cytarabine|mesh-list
83275952|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83275953|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
83275954|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275955|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275956|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
83275957|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83275958|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83275959|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
83275960|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275961|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83275962|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83275963|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83275964|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275965|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
83275966|NCT03809884|Diuretics|diuretics|mesh-ancestor
83275967|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
83275968|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83275969|NCT03809884|Expectorants|expectorants|mesh-ancestor
83275970|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
83275971|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
83275972|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
83275973|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275974|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275975|NCT03805594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83413601|NCT02611752|Buprenorphine|buprenorphine|mesh-list
83275976|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275977|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83275978|NCT03768427|Atorvastatin|atorvastatin|mesh-list
83275979|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83275980|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83275981|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
83275982|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275983|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83275984|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83275985|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83275986|NCT03758781|Nivolumab|nivolumab|mesh-list
83275987|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83275988|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275989|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83275990|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275991|NCT03746080|Plerixafor|plerixafor|mesh-list
83275992|NCT03746080|Temozolomide|temozolomide|mesh-list
83275993|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83275994|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
83275995|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83275996|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83275997|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83275998|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83275999|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
83276000|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276001|NCT03737994|Cisplatin|cisplatin|mesh-list
83276002|NCT03737994|Carboplatin|carboplatin|mesh-list
83276003|NCT03737994|Pemetrexed|pemetrexed|mesh-list
83276004|NCT03737994|Crizotinib|crizotinib|mesh-list
83276005|NCT03737994|Ceritinib|ceritinib|mesh-list
83276006|NCT03737994|Ensartinib|ensartinib|mesh-list
83276007|NCT03737994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83276008|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276009|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276010|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276011|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83276012|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83276013|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83276014|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83276015|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83276016|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
83276017|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276018|NCT03702270|Penicillins|penicillins|mesh-list
83276019|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276020|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276021|NCT03598309|Curcumin|curcumin|mesh-list
83276022|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83276023|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83276024|NCT03598309|Analgesics|analgesics|mesh-ancestor
83276025|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
83276026|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276027|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276028|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276029|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276030|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276031|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276032|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276033|NCT03572933|Pregnanolone|pregnanolone|mesh-list
83276034|NCT03572933|Ganaxolone|ganaxolone|mesh-list
83276035|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
83276036|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276037|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276038|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276039|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
83276040|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
83276041|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
83276042|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276043|NCT03558152|Vedolizumab|vedolizumab|mesh-list
83276044|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276045|NCT03511196|Prednisone|prednisone|mesh-list
83276046|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
83276047|NCT03511196|Androgens|androgens|mesh-list
83276048|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276049|NCT03511196|Hormones|hormones|mesh-ancestor
83276050|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276051|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276052|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276053|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276054|NCT03502668|Decitabine|decitabine|mesh-list
83276055|NCT03502668|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83276056|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276057|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
83276058|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276059|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276060|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276061|NCT03501368|Trametinib|trametinib|mesh-list
83276062|NCT03501368|Ceritinib|ceritinib|mesh-list
83276063|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276064|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83276065|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276066|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276067|NCT03477175|Sorafenib|sorafenib|mesh-list
83276068|NCT03477175|Lenvatinib|lenvatinib|mesh-list
83276069|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276070|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83276071|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276072|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276073|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83276074|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
83276075|NCT03461406|Coagulants|coagulants|mesh-ancestor
83276076|NCT03431974|Aminopterin|aminopterin|mesh-list
83276077|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83276078|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276079|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276080|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
83276081|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276082|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276083|NCT03416335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276084|NCT03416335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276085|NCT03317496|Cisplatin|cisplatin|mesh-list
83276086|NCT03317496|Carboplatin|carboplatin|mesh-list
83276087|NCT03317496|Gemcitabine|gemcitabine|mesh-list
83276088|NCT03317496|Pemetrexed|pemetrexed|mesh-list
83276089|NCT03317496|Avelumab|avelumab|mesh-list
83276091|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276092|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276093|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
83276094|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276095|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276096|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83276097|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83276098|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276099|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
83276100|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276101|NCT03311308|Metformin|metformin|mesh-list
83276102|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
83276103|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83276104|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276105|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276106|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276107|NCT03311308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276108|NCT03311308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276109|NCT03288545|Carboplatin|carboplatin|mesh-list
83276110|NCT03288545|Gemcitabine|gemcitabine|mesh-list
83276111|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
83276112|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276113|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276114|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
83276115|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276116|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276117|NCT03288545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276118|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83276119|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83276120|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276121|NCT03229499|Anastrozole|anastrozole|mesh-list
83276122|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276123|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276124|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83276125|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83276126|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413602|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83276127|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276128|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83276129|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
83276130|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276131|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276132|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
83276133|NCT03215810|Nivolumab|nivolumab|mesh-list
83276134|NCT03215810|Fludarabine|fludarabine|mesh-list
83276135|NCT03215810|Interleukin-2|interleukin-2|mesh-list
83276136|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276137|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
83276138|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276139|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276140|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83276141|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
83276142|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276143|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276144|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83276145|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276146|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276147|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83276148|NCT03215810|Analgesics|analgesics|mesh-ancestor
83276149|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
83276150|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276151|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83276152|NCT03179449|Hematinics|hematinics|mesh-ancestor
83276153|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83276154|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83276155|NCT03132454|Dexamethasone|dexamethasone|mesh-list
83276156|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
83276157|NCT03132454|Sorafenib|sorafenib|mesh-list
83276158|NCT03132454|Decitabine|decitabine|mesh-list
83276159|NCT03132454|Palbociclib|palbociclib|mesh-list
83276160|NCT03132454|Ichthammol|ichthammol|mesh-list
83276161|NCT03132454|BB 1101|bb 1101|mesh-list
83276162|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276163|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
83276164|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
83276165|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276166|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276167|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276168|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
83276169|NCT03132454|Hormones|hormones|mesh-ancestor
83276170|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276171|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276172|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276173|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276174|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276175|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276176|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83276177|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276178|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
83276179|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
83276180|NCT02964078|Aldesleukin|aldesleukin|mesh-list
83276181|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
83276182|NCT02964078|Interleukin-2|interleukin-2|mesh-list
83276183|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276184|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276185|NCT02964078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276186|NCT02964078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276187|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83276188|NCT02964078|Analgesics|analgesics|mesh-ancestor
83276189|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
83276190|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276191|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276192|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83276193|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83276194|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
83276195|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276196|NCT02960659|Metformin|metformin|mesh-list
83276197|NCT02960659|Liraglutide|liraglutide|mesh-list
83276198|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83276199|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276200|NCT02960659|Incretins|incretins|mesh-ancestor
83276201|NCT02960659|Hormones|hormones|mesh-ancestor
83276202|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276203|NCT02915744|Paclitaxel|paclitaxel|mesh-list
83276204|NCT02915744|Vinorelbine|vinorelbine|mesh-list
83276205|NCT02915744|Docetaxel|docetaxel|mesh-list
83276206|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83276207|NCT02915744|Gemcitabine|gemcitabine|mesh-list
83276208|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
83276209|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83276210|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276211|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
83276212|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
83276213|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83276214|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276215|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276216|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
83276217|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83276218|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83276219|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276220|NCT02782949|Curcumin|curcumin|mesh-list
83276221|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83276222|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83276223|NCT02782949|Analgesics|analgesics|mesh-ancestor
83276224|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
83276225|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276226|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276227|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276228|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276229|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276230|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276231|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276232|NCT02736656|Viloxazine|viloxazine|mesh-list
83276233|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83276234|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
83276235|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83276236|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83276237|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83276238|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83276239|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276240|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
83276241|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276242|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276243|NCT02506933|Vaccines|vaccines|mesh-list
83276244|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
83276245|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276246|NCT02491632|Dexamethasone|dexamethasone|mesh-list
83276247|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
83276248|NCT02491632|Ichthammol|ichthammol|mesh-list
83276249|NCT02491632|BB 1101|bb 1101|mesh-list
83276250|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276251|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
83276252|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
83276253|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276254|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276255|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276256|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
83276257|NCT02491632|Hormones|hormones|mesh-ancestor
83276258|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276259|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276260|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276261|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276262|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276263|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276264|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
83276265|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
83276266|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83276267|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276268|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276269|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83276270|NCT02409810|Analgesics|analgesics|mesh-ancestor
83276271|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
83276272|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276273|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83276274|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83276275|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83276276|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
83276277|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276278|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276279|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83276280|NCT02324608|Cetuximab|cetuximab|mesh-list
83276281|NCT02324608|Antibodies|antibodies|mesh-list
83276282|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
83276283|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83276284|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
83276285|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276286|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276287|NCT02286726|Cytarabine|cytarabine|mesh-list
83276288|NCT02286726|Daunorubicin|daunorubicin|mesh-list
83276289|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276290|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
83276291|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276292|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276293|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
83276294|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276295|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276296|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
83276297|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276298|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83276299|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83276300|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83276301|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276302|NCT02206815|Aspirin|aspirin|mesh-list
83276303|NCT02206815|Warfarin|warfarin|mesh-list
83276304|NCT02206815|Clopidogrel|clopidogrel|mesh-list
83276305|NCT02206815|Ticagrelor|ticagrelor|mesh-list
83276306|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83276307|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83276308|NCT02206815|Analgesics|analgesics|mesh-ancestor
83276309|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
83276310|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276311|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276312|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276313|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276314|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83276315|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83276316|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276317|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83276318|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83276319|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276320|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
83276321|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83276322|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83276323|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83276324|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
83276325|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276326|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
83276327|NCT02175680|Leronlimab|leronlimab|mesh-list
83276328|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83276329|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83276330|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276331|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83276332|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83276333|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
83276334|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276335|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83276336|NCT01983462|Clonidine|clonidine|mesh-list
83276337|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83276338|NCT01983462|Diuretics|diuretics|mesh-ancestor
83276339|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
83276340|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276341|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83276342|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83276343|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276344|NCT01983462|Analgesics|analgesics|mesh-ancestor
83276345|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
83276346|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276347|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
83276348|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
83276349|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83276350|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83276351|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83276352|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
83276353|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276354|NCT01919086|Dexamethasone|dexamethasone|mesh-list
83276355|NCT01919086|Lenalidomide|lenalidomide|mesh-list
83276356|NCT01919086|Bortezomib|bortezomib|mesh-list
83276357|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276358|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
83276359|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
83276360|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276361|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276362|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276363|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
83276364|NCT01919086|Hormones|hormones|mesh-ancestor
83276365|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276366|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276367|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276368|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
83276369|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83276370|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83276371|NCT01919086|Growth Substances|growth substances|mesh-ancestor
83276372|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
83276373|NCT01779375|Metformin|metformin|mesh-list
83276374|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
83276375|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83276376|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276377|NCT01559935|Clarithromycin|clarithromycin|mesh-list
83276378|NCT01559935|Dexamethasone|dexamethasone|mesh-list
83276379|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
83276380|NCT01559935|Lenalidomide|lenalidomide|mesh-list
83276381|NCT01559935|BB 1101|bb 1101|mesh-list
83276382|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276383|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
83276385|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276386|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276387|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276388|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
83276389|NCT01559935|Hormones|hormones|mesh-ancestor
83276390|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276391|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276392|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276393|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276394|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276395|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276396|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
83276397|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83276398|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83276399|NCT01559935|Growth Substances|growth substances|mesh-ancestor
83276400|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
83276401|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276402|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276403|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83276404|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83276405|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83276406|NCT01358877|Paclitaxel|paclitaxel|mesh-list
83276407|NCT01358877|Docetaxel|docetaxel|mesh-list
83276408|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
83276409|NCT01358877|Carboplatin|carboplatin|mesh-list
83276410|NCT01358877|Doxorubicin|doxorubicin|mesh-list
83276411|NCT01358877|Fluorouracil|fluorouracil|mesh-list
83276412|NCT01358877|Trastuzumab|trastuzumab|mesh-list
83276413|NCT01358877|Epirubicin|epirubicin|mesh-list
83276414|NCT01358877|Pertuzumab|pertuzumab|mesh-list
83276415|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83276416|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276417|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
83276418|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
83276419|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
83276420|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276421|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276422|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
83276423|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276424|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276425|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83276426|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
83276427|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83276428|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83276429|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83276430|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83276431|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276432|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
83276433|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276434|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276435|NCT00981058|Gemcitabine|gemcitabine|mesh-list
83276436|NCT00981058|Necitumumab|necitumumab|mesh-list
83276437|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276438|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276439|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
83276440|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276441|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276442|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83276443|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
83276444|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83276445|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
83276446|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83276447|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276448|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83276449|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276450|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276451|NCT00565851|Paclitaxel|paclitaxel|mesh-list
83276452|NCT00565851|Docetaxel|docetaxel|mesh-list
83276453|NCT00565851|Bevacizumab|bevacizumab|mesh-list
83276454|NCT00565851|Carboplatin|carboplatin|mesh-list
83276455|NCT00565851|Gemcitabine|gemcitabine|mesh-list
83276456|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83276457|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83276458|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
83276459|NCT00565851|Antibodies|antibodies|mesh-list
83276460|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
83276461|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83276462|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
83276463|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83276464|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276465|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
83276466|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
83276467|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
83276468|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276469|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83276470|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83276471|NCT00565851|Growth Substances|growth substances|mesh-ancestor
83276472|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276473|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
83276474|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
83276475|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276476|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
83276477|NCT00238563|Triamcinolone|triamcinolone|mesh-list
83276478|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276479|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
83276480|NCT00238563|Hormones|hormones|mesh-ancestor
83276481|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276482|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276483|NCT04499677|Ritonavir|ritonavir|mesh-list
83276484|NCT04499677|Lopinavir|lopinavir|mesh-list
83276485|NCT04499677|Favipiravir|favipiravir|mesh-list
83276486|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83276487|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83276488|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276489|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276490|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276491|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83276492|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83276493|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
83276494|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276495|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83276496|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83276497|NCT05652751|Mitogens|mitogens|mesh-list
83276498|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
83276499|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276500|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
83276501|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
83276502|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276503|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
83276504|NCT02909335|Prednisone|prednisone|mesh-list
83276505|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
83276506|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83276507|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83276508|NCT02909335|Prednisolone|prednisolone|mesh-list
83276509|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
83276510|NCT02909335|Everolimus|everolimus|mesh-list
83276511|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83276512|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
83276513|NCT02909335|Tacrolimus|tacrolimus|mesh-list
83276514|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276515|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
83276516|NCT02909335|Hormones|hormones|mesh-ancestor
83276517|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276518|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276519|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276520|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276521|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276522|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
83276523|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83276524|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276525|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276526|NCT02909335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83276527|NCT02909335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83276528|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83276529|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83276530|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
83276531|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276532|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276534|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
83276535|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276536|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276537|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83276538|NCT02909335|Protective Agents|protective agents|mesh-ancestor
83276539|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
83276540|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276541|NCT05652517|Ethanol|ethanol|mesh-list
83276542|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83276543|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276544|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276545|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276546|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83276547|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83276548|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83276549|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276550|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
83276551|NCT02619253|Vorinostat|vorinostat|mesh-list
83276552|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276553|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276554|NCT02619253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276555|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276556|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83276557|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276558|NCT03998293|Somatostatin|somatostatin|mesh-list
83276559|NCT03998293|Hormones|hormones|mesh-ancestor
83276560|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276561|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276562|NCT01606306|Fluticasone|fluticasone|mesh-list
83276563|NCT01606306|Xhance|xhance|mesh-list
83276564|NCT01606306|Montelukast|montelukast|mesh-list
83276565|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276566|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83276567|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
83276568|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276569|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276570|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83276571|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
83276572|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
83276573|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83276574|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83276575|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
83276576|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276577|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83276578|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83276579|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276580|NCT04567108|Benzocaine|benzocaine|mesh-list
83276581|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
83276582|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
83276583|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276584|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276585|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
83276586|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276587|NCT01753570|Interferon-beta|interferon-beta|mesh-list
83276588|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276589|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
83276590|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276591|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
83276592|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276593|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
83276594|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83276595|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83276596|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83276597|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83276598|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276599|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
83276600|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276601|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276602|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83276603|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276604|NCT01777282|Biguanides|biguanides|mesh-list
83276605|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83276606|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83276607|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
83276608|NCT01777282|Incretins|incretins|mesh-ancestor
83276609|NCT01777282|Hormones|hormones|mesh-ancestor
83276610|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276611|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276612|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83276613|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276614|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276615|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
83276616|NCT04571632|Ipilimumab|ipilimumab|mesh-list
83276617|NCT04571632|Avelumab|avelumab|mesh-list
83276618|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276619|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276620|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276621|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276622|NCT01975389|Bococizumab|bococizumab|mesh-list
83276623|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83276624|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83276625|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
83276626|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276627|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83276628|NCT01974141|Dapsone|dapsone|mesh-list
83276629|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276630|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
83276631|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83276632|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83276633|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83276634|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276635|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276636|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
83276637|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276638|NCT01945593|Factor VIII|factor viii|mesh-list
83276639|NCT01945593|BAX 855|bax 855|mesh-list
83276640|NCT01945593|Coagulants|coagulants|mesh-ancestor
83276641|NCT01945281|Amphotericin B|amphotericin b|mesh-list
83276642|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83276643|NCT01945281|Caspofungin|caspofungin|mesh-list
83276644|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
83276645|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
83276646|NCT01945281|Amebicides|amebicides|mesh-ancestor
83276647|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83276648|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83276649|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276650|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276651|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
83276652|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276653|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276654|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83276655|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276656|NCT01961349|Propofol|propofol|mesh-list
83276657|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83276658|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83276659|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276660|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276661|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83276662|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
83276663|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
83276664|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83276665|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83276666|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83276667|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
83276668|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
83276669|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276670|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276671|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276672|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
83276673|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
83276674|NCT04661397|Tenofovir|tenofovir|mesh-list
83276675|NCT04661397|Emtricitabine|emtricitabine|mesh-list
83276676|NCT04661397|Darunavir|darunavir|mesh-list
83276677|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83276678|NCT04661397|Cobicistat|cobicistat|mesh-list
83276679|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83276680|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83276681|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
83276682|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276683|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83276684|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83276685|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276686|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276687|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83276688|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83276689|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83276690|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83276691|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276692|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83276693|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83276694|NCT01973439|Abacavir|abacavir|mesh-list
83276695|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
83276696|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83276697|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83276698|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276699|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276700|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
83276701|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276702|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83276703|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83276704|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
83276705|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83276706|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
83276707|NCT01973283|Escitalopram|escitalopram|mesh-list
83276708|NCT01973283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83276709|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83276710|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83276711|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276712|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276713|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
83276714|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276715|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276716|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83276717|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83276718|NCT01973283|Analgesics|analgesics|mesh-ancestor
83276719|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
83276720|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
83276721|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
83276722|NCT01972659|Analgesics|analgesics|mesh-ancestor
83276723|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
83276724|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276725|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276726|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
83276727|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276728|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83276729|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
83276730|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83276731|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83276732|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276733|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83276734|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
83276735|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83276736|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
83276737|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
83276738|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276739|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276740|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276741|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
83276742|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
83276743|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83276744|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83276745|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276746|NCT01774786|Fluorouracil|fluorouracil|mesh-list
83276747|NCT01774786|Capecitabine|capecitabine|mesh-list
83276748|NCT01774786|Trastuzumab|trastuzumab|mesh-list
83276750|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276751|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
83276752|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276753|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276754|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276755|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
83276756|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276757|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276758|NCT01942161|Aripiprazole|aripiprazole|mesh-list
83276759|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
83276760|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83276761|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83276762|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83276763|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276764|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276765|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
83276766|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
83276767|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276768|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276769|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83276770|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83276771|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
83276772|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83276773|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83276774|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83276775|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83276776|NCT01971645|Dexamethasone|dexamethasone|mesh-list
83276777|NCT01971645|Ropivacaine|ropivacaine|mesh-list
83276778|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276779|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
83276780|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
83276781|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276782|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276783|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83276784|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
83276785|NCT01971645|Hormones|hormones|mesh-ancestor
83276786|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276787|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83276788|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276789|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
83276790|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
83276791|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276792|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
83276793|NCT01941537|Fezakinumab|fezakinumab|mesh-list
83276794|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
83276795|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
83276796|NCT01960413|Montelukast|montelukast|mesh-list
83276797|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83276798|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
83276799|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83276800|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
83276801|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83276802|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276803|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83276804|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83276805|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276806|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276807|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
83276808|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276809|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83276810|NCT01970475|Adalimumab|adalimumab|mesh-list
83276811|NCT01970475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83276812|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83276813|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276814|NCT01939977|Calcifediol|calcifediol|mesh-list
83276815|NCT01939977|Vitamins|vitamins|mesh-ancestor
83276816|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
83276817|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276818|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83276819|NCT01939899|Ixazomib|ixazomib|mesh-list
83276820|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276821|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276822|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276823|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276824|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
83276825|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83276826|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
83276827|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276828|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
83276829|NCT01970397|Protective Agents|protective agents|mesh-ancestor
83276830|NCT01970241|Insulin|insulin|mesh-list
83276831|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83276832|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83276833|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276834|NCT01728376|Daptomycin|daptomycin|mesh-list
83276835|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276836|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276837|NCT02488759|Nivolumab|nivolumab|mesh-list
83276838|NCT02488759|Ipilimumab|ipilimumab|mesh-list
83276839|NCT02488759|Relatlimab|relatlimab|mesh-list
83276840|NCT02488759|Daratumumab|daratumumab|mesh-list
83276841|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276842|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276843|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276844|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276845|NCT02217709|Phenelzine|phenelzine|mesh-list
83276846|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
83276847|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83276848|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83276849|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276850|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276851|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
83276852|NCT02161783|Fludarabine|fludarabine|mesh-list
83276853|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276854|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
83276855|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276856|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276857|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83276858|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
83276859|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276860|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276861|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83276862|NCT02158507|Lapatinib|lapatinib|mesh-list
83276863|NCT02158507|Veliparib|veliparib|mesh-list
83276864|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276865|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83276866|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276867|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276868|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83276869|NCT04791553|Cenobamate|cenobamate|mesh-list
83276870|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
83276871|NCT05651347|Melatonin|melatonin|mesh-list
83276872|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
83276873|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276874|NCT05651347|Protective Agents|protective agents|mesh-ancestor
83276875|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276876|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276877|NCT05651269|Gemcitabine|gemcitabine|mesh-list
83276878|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276879|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
83276880|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276881|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276882|NCT01707004|Vidarabine|vidarabine|mesh-list
83276883|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
83276884|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
83276885|NCT01707004|Busulfan|busulfan|mesh-list
83276886|NCT01707004|Fludarabine|fludarabine|mesh-list
83276887|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
83276888|NCT01707004|Azacitidine|azacitidine|mesh-list
83276889|NCT01707004|Decitabine|decitabine|mesh-list
83276890|NCT01707004|Tacrolimus|tacrolimus|mesh-list
83276891|NCT01707004|Lenograstim|lenograstim|mesh-list
83276892|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276893|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
83276894|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276895|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83276896|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83276897|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
83276898|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276899|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276900|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83276901|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276902|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
83276903|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
83276904|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276905|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83276906|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83276907|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276908|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83276909|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83276910|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
83276911|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276912|NCT01939197|Ritonavir|ritonavir|mesh-list
83276913|NCT01939197|Ribavirin|ribavirin|mesh-list
83276914|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83276915|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83276916|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276917|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276918|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276919|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83276920|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83276921|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
83276922|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276923|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83276924|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83276925|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
83276926|NCT01969851|Lacosamide|lacosamide|mesh-list
83276927|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
83276928|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83276929|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83276930|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83276931|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276932|NCT01938573|Sirolimus|sirolimus|mesh-list
83276933|NCT01938573|Cisplatin|cisplatin|mesh-list
83276934|NCT01938573|Gemcitabine|gemcitabine|mesh-list
83276935|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276936|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83276937|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
83276938|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276939|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83276940|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83276941|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83276942|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
83276943|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83276944|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
83276945|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276946|NCT05546515|Suvorexant|suvorexant|mesh-list
83276947|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
83276948|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83276949|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83276950|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83276951|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276952|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276953|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276954|NCT04789837|Cilostazol|cilostazol|mesh-list
83276955|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83276956|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
83276957|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83276958|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276959|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83276960|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
83276961|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83276962|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83276963|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276964|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83276965|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
83276966|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83276967|NCT04789837|Protective Agents|protective agents|mesh-ancestor
83276968|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83276969|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83276970|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276971|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
83276972|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83276973|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
83276974|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83276975|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
83276976|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276977|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276978|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
83276979|NCT01937871|Tadalafil|tadalafil|mesh-list
83276980|NCT01937871|Tamsulosin|tamsulosin|mesh-list
83276981|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83276982|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83276983|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83276984|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83276985|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83276986|NCT01937871|Urological Agents|urological agents|mesh-ancestor
83276987|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83276988|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83276989|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83276990|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
83276991|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83276992|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83276993|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
83276994|NCT03220477|Guadecitabine|guadecitabine|mesh-list
83276995|NCT03220477|Mocetinostat|mocetinostat|mesh-list
83276996|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83276997|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83276998|NCT03220477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83276999|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277000|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83277001|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277002|NCT01747447|Vitamin D|vitamin d|mesh-list
83277003|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
83277004|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
83277005|NCT01747447|Vitamins|vitamins|mesh-list
83277006|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
83277007|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277008|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83277009|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83277010|NCT02740699|Atorvastatin|atorvastatin|mesh-list
83277011|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83277012|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83277013|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83277014|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
83277015|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277016|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83277017|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83277018|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277019|NCT01287091|Rabeprazole|rabeprazole|mesh-list
83277020|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83277021|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277022|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83277023|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277024|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277025|NCT01269463|Methylphenidate|methylphenidate|mesh-list
83277026|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83277027|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277028|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83277029|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83277030|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83277031|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277032|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
83277033|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277034|NCT02539459|Everolimus|everolimus|mesh-list
83277035|NCT02539459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83277036|NCT02539459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83277037|NCT02539459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277038|NCT02539459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277039|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277040|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
83277041|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277042|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277043|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
83277044|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83277045|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277046|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
83277047|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277048|NCT01634113|Bromides|bromides|mesh-list
83277049|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
83277050|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83277051|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
83277052|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277053|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277054|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83277055|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
83277056|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
83277057|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83277058|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277059|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277060|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277061|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
83277062|NCT01937715|Bevacizumab|bevacizumab|mesh-list
83277063|NCT01937715|Gedatolisib|gedatolisib|mesh-list
83277064|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277065|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277066|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83277067|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83277068|NCT01937715|Growth Substances|growth substances|mesh-ancestor
83277069|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277070|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
83277071|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83277072|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277073|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277074|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
83277075|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83277076|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83277077|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277078|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
83277079|NCT01937559|Coagulants|coagulants|mesh-ancestor
83277080|NCT01918371|Ranibizumab|ranibizumab|mesh-list
83277081|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83277082|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83277083|NCT01918371|Growth Substances|growth substances|mesh-ancestor
83277084|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277085|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
83277086|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277087|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83277088|NCT01916967|Desloratadine|desloratadine|mesh-list
83277089|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83277090|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277091|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277092|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277093|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277094|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83277095|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83277096|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
83277097|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
83277098|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83277099|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83277100|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83277101|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83277102|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83277103|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83277104|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83277105|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277106|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277107|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277108|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277109|NCT01916109|Carboplatin|carboplatin|mesh-list
83277110|NCT01916109|Gemcitabine|gemcitabine|mesh-list
83277111|NCT01916109|Panitumumab|panitumumab|mesh-list
83277112|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277113|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83277114|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
83277115|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277116|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277117|NCT01958619|Artefenomel|artefenomel|mesh-list
83277118|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
83277119|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83277120|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83277121|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277122|NCT01726270|Tamsulosin|tamsulosin|mesh-list
83277123|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83277124|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83277125|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83277126|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277127|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277128|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277129|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277130|NCT01726270|Urological Agents|urological agents|mesh-ancestor
83277131|NCT00942331|Bevacizumab|bevacizumab|mesh-list
83277132|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83277133|NCT00942331|Cisplatin|cisplatin|mesh-list
83277134|NCT00942331|Gemcitabine|gemcitabine|mesh-list
83277135|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
83277136|NCT00942331|Antibodies|antibodies|mesh-list
83277137|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
83277138|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83277139|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
83277140|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277141|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83277142|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83277143|NCT00942331|Growth Substances|growth substances|mesh-ancestor
83277144|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277145|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
83277146|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
83277147|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83277148|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
83277149|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277150|NCT00630565|Dexamethasone|dexamethasone|mesh-list
83277151|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
83277152|NCT00630565|Busulfan|busulfan|mesh-list
83277153|NCT00630565|Etoposide|etoposide|mesh-list
83277154|NCT00630565|Sargramostim|sargramostim|mesh-list
83277155|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277156|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
83277157|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277158|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277159|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83277160|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
83277161|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277162|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277163|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83277164|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83277165|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
83277166|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
83277167|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277168|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277169|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
83277170|NCT00630565|Hormones|hormones|mesh-ancestor
83277171|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277172|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83277173|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83277174|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83277175|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83277176|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277177|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83277178|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83277179|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83277180|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277181|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277182|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83277183|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83277184|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83277185|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83277186|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277187|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277188|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277189|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83277190|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83277191|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
83277192|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83277193|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83277194|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
83277195|NCT01545271|Xenon|xenon|mesh-list
83277196|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83277197|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
83277198|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
83277199|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277200|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277201|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83277202|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83277203|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277204|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277205|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83277206|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83277207|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277208|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277209|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277210|NCT01617447|Aripiprazole|aripiprazole|mesh-list
83277211|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
83277212|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83277213|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83277214|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83277215|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277216|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277217|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
83277218|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
83277219|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277220|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277221|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83277222|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83277223|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
83277224|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83277225|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83277226|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83277227|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83277228|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
83277229|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83277230|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277231|NCT04798027|Vaccines|vaccines|mesh-list
83277232|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
83277233|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277234|NCT05238025|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83277235|NCT05238025|Antiviral Agents|antiviral agents|mesh-ancestor
83277236|NCT05238025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277237|NCT04797325|Prednisolone|prednisolone|mesh-list
83277238|NCT04797325|Infliximab|infliximab|mesh-list
83277239|NCT04797325|Vedolizumab|vedolizumab|mesh-list
83277240|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83277241|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
83277242|NCT04797325|Hormones|hormones|mesh-ancestor
83277243|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277244|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277245|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83277246|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277247|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277248|NCT04797325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83277249|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
83277250|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277251|NCT02246647|Mannitol|mannitol|mesh-list
83277252|NCT02246647|Lactulose|lactulose|mesh-list
83277253|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83277254|NCT02246647|Diuretics|diuretics|mesh-ancestor
83277255|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
83277256|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277257|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277258|NCT02244619|Acetaminophen|acetaminophen|mesh-list
83277259|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83277260|NCT02244619|Analgesics|analgesics|mesh-ancestor
83277261|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
83277262|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277263|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277264|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
83277265|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
83277266|NCT02243371|Nivolumab|nivolumab|mesh-list
83277267|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
83277268|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277269|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277270|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277271|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83277272|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
83277273|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277274|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277275|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83277276|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277277|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83277278|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83277279|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83277280|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83277281|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83277282|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277283|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277284|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277285|NCT01931475|Analgesics|analgesics|mesh-ancestor
83277286|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
83277287|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277288|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
83277289|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83277290|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
83277291|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
83277292|NCT04630821|Eusol|eusol|mesh-list
83277293|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
83277294|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277295|NCT01646177|Etanercept|etanercept|mesh-list
83277296|NCT01646177|Ixekizumab|ixekizumab|mesh-list
83277297|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83277298|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83277299|NCT01646177|Analgesics|analgesics|mesh-ancestor
83277300|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
83277301|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277302|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277303|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83277304|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277305|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277306|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277307|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
83277308|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
83277309|NCT01929135|Atorvastatin|atorvastatin|mesh-list
83277310|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83277311|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83277312|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
83277313|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277314|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83277315|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83277316|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277317|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83277318|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83277319|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83277320|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277321|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277322|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83277323|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83277324|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83277325|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83277326|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277327|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277328|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277329|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83277330|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83277331|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
83277332|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83277333|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83277334|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
83277335|NCT02324153|Riboflavin|riboflavin|mesh-list
83277336|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
83277337|NCT02324153|Vitamins|vitamins|mesh-ancestor
83277338|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
83277339|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277340|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83277341|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
83277342|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83277343|NCT02280473|Laxatives|laxatives|mesh-ancestor
83277344|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277345|NCT02308007|Metronidazole|metronidazole|mesh-list
83277346|NCT02308007|Terconazole|terconazole|mesh-list
83277347|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277348|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83277349|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83277350|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83277351|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
83277352|NCT01910181|Vemurafenib|vemurafenib|mesh-list
83277353|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277354|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83277355|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277356|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277357|NCT04885907|Vaccines|vaccines|mesh-list
83277358|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
83277359|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277360|NCT01957215|Indomethacin|indomethacin|mesh-list
83277361|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83277362|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83277363|NCT01957215|Analgesics|analgesics|mesh-ancestor
83277364|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
83277365|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277366|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277367|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83277368|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277369|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
83277370|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
83277371|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83277372|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83277373|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277374|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277375|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
83277376|NCT01928433|Finafloxacin|finafloxacin|mesh-list
83277377|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
83277378|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83277379|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277380|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83277381|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83277382|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277383|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277384|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277385|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83277386|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83277387|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83277388|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83277389|NCT02322281|Paclitaxel|paclitaxel|mesh-list
83277390|NCT02322281|Docetaxel|docetaxel|mesh-list
83277391|NCT02322281|Gemcitabine|gemcitabine|mesh-list
83277392|NCT02322281|Pemetrexed|pemetrexed|mesh-list
83277393|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83277394|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277395|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
83277396|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
83277397|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
83277398|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277399|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83277400|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
83277401|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277402|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83277403|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83277404|NCT02243293|Ribavirin|ribavirin|mesh-list
83277405|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
83277406|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277407|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
83277408|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277409|NCT02322047|Prazosin|prazosin|mesh-list
83277410|NCT02322047|Naltrexone|naltrexone|mesh-list
83277411|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83277412|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83277413|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277414|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
83277415|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277416|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83277417|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83277418|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83277419|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83277420|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277421|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277422|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277423|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83277424|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83277425|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277426|NCT02254291|Incretins|incretins|mesh-ancestor
83277427|NCT02254291|Hormones|hormones|mesh-ancestor
83277428|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277429|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83277430|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
83277431|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277432|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277433|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83277434|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
83277435|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277436|NCT02320721|Insulin|insulin|mesh-list
83277437|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83277438|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
83277439|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83277440|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277441|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83277442|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
83277443|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83277444|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
83277445|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277446|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277447|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277448|NCT04197089|Vitamin D|vitamin d|mesh-list
83277449|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
83277450|NCT04197089|Vitamins|vitamins|mesh-ancestor
83277451|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
83277452|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277453|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83277454|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83277455|NCT02252965|Metformin|metformin|mesh-list
83277456|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83277457|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277458|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
83277459|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83277460|NCT02251717|Ledipasvir|ledipasvir|mesh-list
83277461|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
83277462|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277463|NCT02242201|Ketorolac|ketorolac|mesh-list
83277464|NCT02242201|Epinephrine|epinephrine|mesh-list
83277465|NCT02242201|Bupivacaine|bupivacaine|mesh-list
83277466|NCT02242201|Ropivacaine|ropivacaine|mesh-list
83277467|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
83277468|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
83277469|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277470|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277471|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
83277472|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277473|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83277474|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83277475|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277476|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277477|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277478|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83277479|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83277480|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
83277481|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83277482|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
83277483|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
83277484|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
83277485|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83277486|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83277487|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83277488|NCT02242201|Analgesics|analgesics|mesh-ancestor
83277489|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83277490|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277491|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83277492|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277493|NCT02242045|Idelalisib|idelalisib|mesh-list
83277494|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277495|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277496|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277497|NCT02241889|Pancrelipase|pancrelipase|mesh-list
83277498|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277499|NCT02241187|Cetuximab|cetuximab|mesh-list
83277500|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277501|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277502|NCT02249767|Tretinoin|tretinoin|mesh-list
83277503|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277504|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
83277505|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
83277506|NCT04783675|Rituximab|rituximab|mesh-list
83277507|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277508|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277509|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
83277510|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277511|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83277512|NCT04892953|Paclitaxel|paclitaxel|mesh-list
83277513|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83277514|NCT04892953|Carboplatin|carboplatin|mesh-list
83277515|NCT04892953|Gemcitabine|gemcitabine|mesh-list
83277516|NCT04892953|Pemetrexed|pemetrexed|mesh-list
83277517|NCT04892953|Durvalumab|durvalumab|mesh-list
83277518|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
83277519|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83277520|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
83277521|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83277522|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277523|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83277524|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83277525|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83277526|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277527|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83277528|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
83277529|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277530|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83277531|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83277532|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277533|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
83277534|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277535|NCT02238379|Oxytocin|oxytocin|mesh-list
83277536|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
83277537|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83277538|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277539|NCT02207491|Timolol|timolol|mesh-list
83277540|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83277541|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83277542|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277543|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83277544|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83277545|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277546|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277547|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277548|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83277549|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83277550|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83277551|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
83277552|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
83277553|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277554|NCT02207413|Vaccines|vaccines|mesh-list
83277555|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
83277556|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277557|NCT02276027|Ceritinib|ceritinib|mesh-list
83277558|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277559|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83277560|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277561|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277562|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
83277563|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83277564|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83277565|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83277566|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277567|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277568|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277569|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277570|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
83277571|NCT04761133|Povidone|povidone|mesh-list
83277572|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
83277573|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
83277574|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83277575|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277576|NCT02233309|Anesthetics|anesthetics|mesh-list
83277577|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277578|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277579|NCT02280044|Rifaximin|rifaximin|mesh-list
83277580|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83277581|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277582|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277583|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
83277584|NCT02308748|Lidocaine|lidocaine|mesh-list
83277585|NCT02308748|Mexiletine|mexiletine|mesh-list
83277586|NCT02308748|Dofetilide|dofetilide|mesh-list
83277587|NCT02308748|Diltiazem|diltiazem|mesh-list
83277588|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
83277589|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
83277590|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277591|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277592|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
83277593|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277594|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83277595|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83277596|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83277597|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83277598|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277599|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83277600|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277601|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83277602|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83277603|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277604|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277605|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83277606|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83277607|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83277608|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
83277609|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83277610|NCT04745689|Carboplatin|carboplatin|mesh-list
83277611|NCT04745689|Etoposide|etoposide|mesh-list
83277612|NCT04745689|Durvalumab|durvalumab|mesh-list
83277613|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277614|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83277615|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83277616|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83277617|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277618|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277619|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277620|NCT02308124|Midodrine|midodrine|mesh-list
83277621|NCT02308124|Bromides|bromides|mesh-list
83277622|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83277623|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
83277624|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
83277625|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
83277626|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277627|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277628|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83277629|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83277630|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83277631|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83277632|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277633|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277634|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277635|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83277636|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277637|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277638|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83277639|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83277640|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277641|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277642|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
83277643|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277644|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
83277645|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
83277646|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83277647|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
83277648|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277649|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277650|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83277651|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
83277652|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
83277653|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83277654|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277655|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277656|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277657|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83277658|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83277659|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83277660|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277661|NCT02308046|Terconazole|terconazole|mesh-list
83277662|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
83277663|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277664|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83277665|NCT02318693|Glyburide|glyburide|mesh-list
83277666|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83277667|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277668|NCT02318693|Incretins|incretins|mesh-ancestor
83277670|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277671|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83277672|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
83277673|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277674|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277676|NCT02230891|Spironolactone|spironolactone|mesh-list
83277677|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83277678|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
83277679|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277680|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277681|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83277682|NCT02230891|Diuretics|diuretics|mesh-ancestor
83277683|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
83277684|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83277685|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83277686|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277687|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277688|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277689|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83277690|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
83277691|NCT02230891|Protective Agents|protective agents|mesh-ancestor
83277692|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83277693|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83277694|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83277695|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
83277696|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83277697|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83277698|NCT02302859|Nicotine|nicotine|mesh-list
83277699|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83277700|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
83277701|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277702|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277703|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83277704|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83277705|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277706|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277707|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277708|NCT02274311|Clomiphene|clomiphene|mesh-list
83277709|NCT02274311|Enclomiphene|enclomiphene|mesh-list
83277710|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
83277711|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83277712|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413603|NCT02611752|Narcotics|narcotics|mesh-ancestor
83277713|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277714|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277715|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83277716|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
83277717|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83277718|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83277719|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83277720|NCT02316353|Complement C1s|complement c1s|mesh-list
83277721|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83277722|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83277723|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
83277724|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277725|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83277726|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277727|NCT02279732|Paclitaxel|paclitaxel|mesh-list
83277728|NCT02279732|Carboplatin|carboplatin|mesh-list
83277729|NCT02279732|Ipilimumab|ipilimumab|mesh-list
83277730|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83277731|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277732|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
83277733|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
83277734|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
83277735|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277736|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277737|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83277738|NCT05649956|Letrozole|letrozole|mesh-list
83277739|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277740|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83277741|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83277742|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277743|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277744|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83277745|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
83277746|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277747|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277748|NCT04876430|Meropenem|meropenem|mesh-list
83277749|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83277750|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277751|NCT02305238|Aflibercept|aflibercept|mesh-list
83277752|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83277753|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83277754|NCT02305238|Growth Substances|growth substances|mesh-ancestor
83277755|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277756|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
83277757|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277758|NCT02304926|Simvastatin|simvastatin|mesh-list
83277759|NCT02304926|Ezetimibe|ezetimibe|mesh-list
83277760|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83277761|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83277762|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83277763|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
83277764|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277765|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83277766|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83277767|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277768|NCT01646255|Levodopa|levodopa|mesh-list
83277769|NCT01646255|Rotigotine|rotigotine|mesh-list
83277770|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83277771|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83277772|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
83277773|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277774|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277775|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277776|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
83277777|NCT02203591|Ethanol|ethanol|mesh-list
83277778|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
83277779|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83277780|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83277781|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277782|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277783|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277784|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
83277785|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
83277786|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
83277787|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83277788|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83277789|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277790|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277791|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277792|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277793|NCT01642277|Urological Agents|urological agents|mesh-ancestor
83277794|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
83277795|NCT02230189|Miotics|miotics|mesh-ancestor
83277796|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
83277797|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277798|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277799|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83277800|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83277801|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
83277802|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83277803|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83277804|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277805|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277806|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277807|NCT02304302|Memantine|memantine|mesh-list
83277808|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83277809|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83277810|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
83277811|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277812|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277813|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277814|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83277815|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83277816|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83277818|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83277819|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
83277820|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277821|NCT02301143|Paclitaxel|paclitaxel|mesh-list
83277822|NCT02301143|Gemcitabine|gemcitabine|mesh-list
83277823|NCT02301143|Capecitabine|capecitabine|mesh-list
83277824|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83277825|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277826|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
83277827|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
83277828|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
83277829|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277830|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83277831|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
83277832|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
83277833|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
83277834|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83277835|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
83277836|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277837|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277838|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83277839|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
83277840|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
83277841|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83277842|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
83277843|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277844|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277845|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83277846|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83277847|NCT02275052|Albuterol|albuterol|mesh-list
83277848|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83277849|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
83277850|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277851|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277852|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83277853|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
83277854|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
83277855|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83277856|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83277857|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83277858|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83277859|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277860|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277861|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277862|NCT05649020|Prilocaine|prilocaine|mesh-list
83277863|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
83277864|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
83277865|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277866|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277867|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
83277868|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277869|NCT04869488|Prednisone|prednisone|mesh-list
83277870|NCT04869488|Apatinib|apatinib|mesh-list
83277871|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
83277872|NCT04869488|Fluzoparib|fluzoparib|mesh-list
83277873|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83277874|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
83277875|NCT04869488|Hormones|hormones|mesh-ancestor
83277876|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277877|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277878|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83277879|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277880|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83277881|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277882|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277883|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83277884|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
83277885|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83277886|NCT04869488|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83277887|NCT02274038|Pemetrexed|pemetrexed|mesh-list
83277888|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277889|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277890|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277891|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83277892|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83277893|NCT01646021|Sirolimus|sirolimus|mesh-list
83277894|NCT01646021|Temsirolimus|temsirolimus|mesh-list
83277895|NCT01646021|MTOR Inhibitors|mtor inhibitors|mesh-list
83277896|NCT01646021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83277897|NCT01646021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277898|NCT01646021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277899|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277900|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
83277901|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277902|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277903|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83277904|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83277905|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83277906|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
83277907|NCT01750918|Fluorouracil|fluorouracil|mesh-list
83277908|NCT01750918|Panitumumab|panitumumab|mesh-list
83277909|NCT01750918|Trametinib|trametinib|mesh-list
83277910|NCT01750918|Dabrafenib|dabrafenib|mesh-list
83277911|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
83277912|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277913|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83277914|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277915|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83277916|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
83277917|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277918|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83277919|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83277920|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277921|NCT01750840|Cimetidine|cimetidine|mesh-list
83277922|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83277923|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83277924|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83277925|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
83277926|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
83277927|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277928|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277929|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277930|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83277931|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83277932|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277933|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83277934|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83277935|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83277936|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83277937|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277938|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83277939|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83277940|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83277941|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
83277942|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277943|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277944|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83277945|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83277946|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
83277947|NCT02269943|Azacitidine|azacitidine|mesh-list
83277948|NCT02269943|Cc-486|cc-486|mesh-list
83277949|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83277950|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
83277951|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277952|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83277953|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277954|NCT01605370|Metoprolol|metoprolol|mesh-list
83277955|NCT01605370|Nebivolol|nebivolol|mesh-list
83277956|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83277957|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83277958|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
83277959|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
83277960|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83277961|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277962|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83277964|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83277965|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
83277966|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83277967|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277968|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
83277969|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83277970|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83277971|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83277972|NCT01605136|Afamelanotide|afamelanotide|mesh-list
83277973|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
83277974|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
83277975|NCT01706146|Apixaban|apixaban|mesh-list
83277976|NCT01706146|Dabigatran|dabigatran|mesh-list
83277977|NCT01706146|Anticoagulants|anticoagulants|mesh-list
83277978|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83277979|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
83277980|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83277981|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
83277982|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83277983|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83277984|NCT02269241|Drospirenone|drospirenone|mesh-list
83277985|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83277986|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
83277987|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83277988|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277989|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83277990|NCT02269241|Diuretics|diuretics|mesh-ancestor
83277991|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
83277992|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
83277993|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83277994|NCT01750294|Diuretics|diuretics|mesh-ancestor
83277995|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
83277996|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83277997|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83277998|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83277999|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278000|NCT01749982|Choline|choline|mesh-list
83278001|NCT01749982|Betaine|betaine|mesh-list
83278002|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
83278003|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83278004|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
83278005|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278006|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278007|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83278008|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
83278009|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
83278010|NCT02269163|Antibodies|antibodies|mesh-list
83278011|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
83278012|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83278013|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83278014|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
83278015|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
83278016|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278017|NCT01749826|Morphine|morphine|mesh-list
83278018|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83278019|NCT01749826|Narcotics|narcotics|mesh-ancestor
83278020|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278021|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278022|NCT01749826|Analgesics|analgesics|mesh-ancestor
83278023|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
83278024|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278025|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
83278026|NCT01724866|Docetaxel|docetaxel|mesh-list
83278027|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278028|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
83278029|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278030|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278031|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83278032|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
83278033|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278034|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278035|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83278036|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
83278037|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
83278038|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
83278039|NCT02266433|Dexamethasone|dexamethasone|mesh-list
83278040|NCT02266433|Ketorolac|ketorolac|mesh-list
83278041|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278042|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
83278043|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
83278044|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278045|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278046|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278047|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
83278048|NCT02266433|Hormones|hormones|mesh-ancestor
83278049|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278050|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83278051|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278052|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83278053|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83278054|NCT02266433|Analgesics|analgesics|mesh-ancestor
83278055|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
83278056|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278057|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83278058|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278059|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278060|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
83278061|NCT02273726|Hematinics|hematinics|mesh-ancestor
83278062|NCT01723228|Rasagiline|rasagiline|mesh-list
83278063|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83278064|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278065|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278066|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83278067|NCT01723228|Protective Agents|protective agents|mesh-ancestor
83278068|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278069|NCT02273180|Insulin|insulin|mesh-list
83278070|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83278071|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
83278072|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
83278073|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278074|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278075|NCT01745380|Phenylephrine|phenylephrine|mesh-list
83278076|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
83278077|NCT01745380|Tetracaine|tetracaine|mesh-list
83278078|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
83278079|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
83278080|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278081|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278082|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
83278083|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278084|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83278085|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83278086|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
83278087|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413604|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278088|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278089|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
83278090|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
83278091|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
83278092|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83278093|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
83278094|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83278095|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
83278096|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83278097|NCT01745380|Protective Agents|protective agents|mesh-ancestor
83278098|NCT04550104|Olaparib|olaparib|mesh-list
83278099|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83278100|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278101|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278102|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278103|NCT05648318|Lactulose|lactulose|mesh-list
83278104|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278105|NCT02203513|Prexasertib|prexasertib|mesh-list
83278106|NCT02203513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83278108|NCT02203513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278109|NCT01703260|Pioglitazone|pioglitazone|mesh-list
83278110|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278111|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278112|NCT02299388|Liraglutide|liraglutide|mesh-list
83278113|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278114|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278115|NCT02299388|Incretins|incretins|mesh-ancestor
83278116|NCT02299388|Hormones|hormones|mesh-ancestor
83278117|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278118|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
83278119|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
83278120|NCT02202577|Povidone|povidone|mesh-list
83278121|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83278122|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278123|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
83278124|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
83278125|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
83278126|NCT01723072|Omalizumab|omalizumab|mesh-list
83278127|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83278128|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83278129|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83278130|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
83278131|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
83278132|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278133|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83278134|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278135|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278136|NCT02169505|Immunotoxins|immunotoxins|mesh-ancestor
83278137|NCT02169505|Immunoconjugates|immunoconjugates|mesh-ancestor
83278138|NCT02169505|Immunologic Factors|immunologic factors|mesh-ancestor
83278139|NCT02169505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278140|NCT01909791|Aflibercept|aflibercept|mesh-list
83278141|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83278142|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83278143|NCT01909791|Growth Substances|growth substances|mesh-ancestor
83278144|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278145|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
83278146|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278147|NCT02202499|Varenicline|varenicline|mesh-list
83278148|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83278149|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83278150|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83278151|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278152|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278153|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278154|NCT02227849|Canagliflozin|canagliflozin|mesh-list
83278155|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83278156|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278157|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278158|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278159|NCT02169271|Aspirin|aspirin|mesh-list
83278160|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83278161|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83278162|NCT02169271|Analgesics|analgesics|mesh-ancestor
83278163|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
83278164|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278165|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278166|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278167|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278168|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83278169|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83278170|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278171|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83278172|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83278173|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278174|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
83278175|NCT01644188|Ezetimibe|ezetimibe|mesh-list
83278176|NCT01644188|Alirocumab|alirocumab|mesh-list
83278177|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83278178|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83278179|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83278180|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
83278181|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278182|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83278184|NCT01644188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83278185|NCT01644188|Protease Inhibitors|protease inhibitors|mesh-ancestor
83278186|NCT01644188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278187|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
83278188|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278189|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
83278190|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
83278191|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278192|NCT02271854|Diclofenac|diclofenac|mesh-list
83278193|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83278194|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83278195|NCT02271854|Analgesics|analgesics|mesh-ancestor
83278196|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
83278197|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278198|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278199|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278200|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278201|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83278202|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278203|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278204|NCT02296892|Midazolam|midazolam|mesh-list
83278205|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83278206|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83278207|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278208|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278209|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83278210|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83278211|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83278212|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83278213|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
83278214|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
83278215|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
83278216|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
83278217|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278218|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278219|NCT02168803|Evacetrapib|evacetrapib|mesh-list
83278220|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83278221|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83278222|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
83278223|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278224|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83278225|NCT02201329|Azacitidine|azacitidine|mesh-list
83278226|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83278227|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
83278228|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278229|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278230|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278231|NCT01927419|Nivolumab|nivolumab|mesh-list
83278232|NCT01927419|Ipilimumab|ipilimumab|mesh-list
83278233|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278234|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278235|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83278236|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278237|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
83278238|NCT02168491|Lixisenatide|lixisenatide|mesh-list
83278239|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278240|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278241|NCT01721746|Paclitaxel|paclitaxel|mesh-list
83278242|NCT01721746|Carboplatin|carboplatin|mesh-list
83278243|NCT01721746|Nivolumab|nivolumab|mesh-list
83278244|NCT01721746|Dacarbazine|dacarbazine|mesh-list
83278245|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83278246|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278247|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
83278248|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
83278249|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
83278250|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278251|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278252|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83278253|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83278254|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
83278255|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
83278256|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278257|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
83278258|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278259|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278260|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83278261|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
83278262|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278263|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278264|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83278265|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83278266|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
83278267|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278268|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83278269|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
83278270|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278271|NCT02296190|Etripamil|etripamil|mesh-list
83278272|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83278273|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83278274|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278275|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83278276|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278277|NCT04875026|Fluorouracil|fluorouracil|mesh-list
83278278|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
83278279|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278280|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83278281|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278282|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278283|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
83278284|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278285|NCT02296112|Trametinib|trametinib|mesh-list
83278286|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278287|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83278288|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278289|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278290|NCT02269670|Tamoxifen|tamoxifen|mesh-list
83278291|NCT02269670|Everolimus|everolimus|mesh-list
83278292|NCT02269670|Letrozole|letrozole|mesh-list
83278293|NCT02269670|Fulvestrant|fulvestrant|mesh-list
83278294|NCT02269670|Anastrozole|anastrozole|mesh-list
83278295|NCT02269670|Megestrol|megestrol|mesh-list
83278296|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
83278297|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278298|NCT02269670|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83278299|NCT02269670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83278300|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278301|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278302|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
83278303|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278304|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278305|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83278306|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83278307|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83278308|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
83278309|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278310|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83278311|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83278312|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83278313|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83278314|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83278315|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83278316|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83278317|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83278318|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
83278319|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83278320|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83278321|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83278322|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
83278323|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83278324|NCT02225353|Progesterone|progesterone|mesh-list
83278325|NCT02225353|Progestins|progestins|mesh-ancestor
83278326|NCT02225353|Hormones|hormones|mesh-ancestor
83278327|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278328|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278329|NCT01641926|Interferons|interferons|mesh-list
83278330|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
83278331|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
83278332|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83278333|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83278334|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278335|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
83278336|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278337|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
83278338|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278339|NCT02294786|Capecitabine|capecitabine|mesh-list
83278340|NCT02294786|Lapatinib|lapatinib|mesh-list
83278341|NCT02294786|Octreotide|octreotide|mesh-list
83278342|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83278343|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
83278344|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278345|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278346|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83278347|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278348|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278349|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83278350|NCT04880876|Eluxadoline|eluxadoline|mesh-list
83278351|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278352|NCT01927341|Panitumumab|panitumumab|mesh-list
83278353|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278354|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278355|NCT02294474|Insulin|insulin|mesh-list
83278356|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83278357|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
83278358|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
83278359|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278360|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278361|NCT02168101|Ixazomib|ixazomib|mesh-list
83278362|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278363|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
83278364|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278365|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278366|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83278367|NCT01956123|Hormones|hormones|mesh-ancestor
83278368|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278369|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278370|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83278371|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83278372|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83278373|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
83278374|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278375|NCT02298179|Antacids|antacids|mesh-ancestor
83278376|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278377|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278378|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83278379|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
83278380|NCT02298023|Coagulants|coagulants|mesh-ancestor
83278381|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
83278382|NCT02296931|Analgesics|analgesics|mesh-ancestor
83278383|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
83278384|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278385|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278386|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
83278387|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278388|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83278389|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
83278390|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83278391|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83278392|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278394|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
83278395|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83278396|NCT02166697|Candesartan|candesartan|mesh-list
83278397|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
83278398|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83278399|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83278400|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83278401|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278402|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83278403|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83278404|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278405|NCT02197897|Tamoxifen|tamoxifen|mesh-list
83278406|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83278407|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
83278408|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278409|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278410|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83278411|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278412|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83278419|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
83278420|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278421|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278422|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83278423|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
83278424|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278425|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83278426|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83278427|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278428|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278429|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
83278431|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83278432|NCT02294396|Propiverine|propiverine|mesh-list
83278433|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83278434|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83278435|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
83278436|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278437|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278438|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278439|NCT02294396|Urological Agents|urological agents|mesh-ancestor
83278440|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83278441|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83278442|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83278443|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
83278444|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
83278445|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
83278446|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278447|NCT02164981|Nitroprusside|nitroprusside|mesh-list
83278448|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83278449|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
83278450|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83278451|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278452|NCT01908699|Beraprost|beraprost|mesh-list
83278453|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83278454|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
83278455|NCT01363011|Darunavir|darunavir|mesh-list
83278456|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83278457|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83278458|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83278459|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
83278460|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278461|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278462|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83278463|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83278464|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
83278465|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278473|NCT02263547|Colestipol|colestipol|mesh-list
83278474|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83278475|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83278476|NCT02263547|Analgesics|analgesics|mesh-ancestor
83278477|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
83278478|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278479|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278480|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278481|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278482|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278483|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
83278484|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83278485|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
83278486|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278487|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83278488|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
83278489|NCT04620759|Psilocybin|psilocybin|mesh-list
83278490|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83278491|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
83278492|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278493|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83278494|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83278495|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
83278496|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278497|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278498|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83278499|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
83278500|NCT01925703|Hematinics|hematinics|mesh-ancestor
83278501|NCT01617681|Valsartan|valsartan|mesh-list
83278502|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83278503|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83278504|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83278505|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278506|NCT02263079|Interferons|interferons|mesh-list
83278507|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
83278508|NCT02263079|Lamivudine|lamivudine|mesh-list
83278509|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
83278510|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83278511|NCT02263079|Entecavir|entecavir|mesh-list
83278512|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278513|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
83278514|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278515|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
83278516|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278517|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83278518|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83278519|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278520|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278521|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83278522|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83278523|NCT02260817|Choline|choline|mesh-list
83278524|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
83278525|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83278526|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
83278527|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278528|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278529|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83278530|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
83278531|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83278532|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278533|NCT01642589|Vaccines|vaccines|mesh-list
83278534|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
83278535|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278536|NCT01954251|Vaccines|vaccines|mesh-list
83278537|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
83278538|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278539|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83278540|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83278541|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278542|NCT04620603|Immunomodulating Agents|immunomodulating agents|mesh-list
83278543|NCT04620603|Immunologic Factors|immunologic factors|mesh-ancestor
83278544|NCT04620603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278545|NCT02257385|Albuterol|albuterol|mesh-list
83278546|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
83278547|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83278548|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
83278549|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278550|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278551|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83278552|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
83278553|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
83278554|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83278555|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
83278556|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278557|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278558|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
83278559|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83278560|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83278561|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83278562|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83278563|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
83278564|NCT05647265|Nivolumab|nivolumab|mesh-list
83278565|NCT05647265|Ipilimumab|ipilimumab|mesh-list
83278566|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278567|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278568|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83278569|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278570|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83278571|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
83278572|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278573|NCT01645280|Methotrexate|methotrexate|mesh-list
83278574|NCT01645280|Ustekinumab|ustekinumab|mesh-list
83278575|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83278576|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
83278577|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83278578|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278579|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83278580|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
83278581|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278582|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278583|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
83278584|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278585|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83278586|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278587|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
83278588|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278589|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83278590|NCT01629589|Vaccines|vaccines|mesh-list
83278591|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
83278592|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278593|NCT04188223|Vaccines|vaccines|mesh-list
83278594|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
83278595|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278596|NCT02220907|Canagliflozin|canagliflozin|mesh-list
83278597|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83278598|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278599|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278600|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278601|NCT01601873|Heparin|heparin|mesh-list
83278602|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
83278603|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83278604|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83278605|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278606|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
83278607|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
83278608|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278609|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278610|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278611|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
83278612|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
83278613|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
83278614|NCT04420247|Chloroquine|chloroquine|mesh-list
83278615|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
83278616|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83278617|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83278618|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278619|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278620|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278621|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278622|NCT04420247|Amebicides|amebicides|mesh-ancestor
83278623|NCT01644890|Paclitaxel|paclitaxel|mesh-list
83278624|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83278625|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278626|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
83278627|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
83278628|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
83278629|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278630|NCT04865237|Remdesivir|remdesivir|mesh-list
83278631|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
83278632|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278633|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
83278634|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278635|NCT01628965|Rotigotine|rotigotine|mesh-list
83278636|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
83278637|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
83278638|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278639|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278640|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278641|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
83278642|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83278643|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
83278644|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278645|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278646|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83278647|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83278648|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
83278649|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83278650|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
83278651|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278652|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278653|NCT02255279|Vaccines|vaccines|mesh-list
83278654|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
83278655|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278656|NCT04865159|Tipifarnib|tipifarnib|mesh-list
83278657|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278658|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83278659|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83278660|NCT02266706|Tazobactam|tazobactam|mesh-list
83278661|NCT02266706|Ceftolozane|ceftolozane|mesh-list
83278662|NCT02266706|Cephalosporins|cephalosporins|mesh-list
83278663|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83278664|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
83278665|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83278666|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278667|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83278668|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278669|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278670|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83278671|NCT02292719|Ritonavir|ritonavir|mesh-list
83278672|NCT02292719|Ribavirin|ribavirin|mesh-list
83278673|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
83278674|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83278675|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83278676|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
83278677|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278678|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278679|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83278680|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83278681|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
83278682|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278683|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83278684|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83278685|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
83278686|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
83278687|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278688|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
83278689|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83278690|NCT02264990|Paclitaxel|paclitaxel|mesh-list
83278691|NCT02264990|Carboplatin|carboplatin|mesh-list
83278692|NCT02264990|Pemetrexed|pemetrexed|mesh-list
83278693|NCT02264990|Veliparib|veliparib|mesh-list
83278694|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83278695|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278696|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
83278697|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
83278698|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
83278699|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278700|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278701|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83278702|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83278703|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83278704|NCT02289833|Trastuzumab|trastuzumab|mesh-list
83278705|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83278706|NCT02289833|Maytansine|maytansine|mesh-list
83278707|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278708|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278709|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83278710|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
83278711|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83278712|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83278713|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278714|NCT02289833|Immunotoxins|immunotoxins|mesh-ancestor
83278715|NCT02289833|Immunoconjugates|immunoconjugates|mesh-ancestor
83278716|NCT02289833|Immunologic Factors|immunologic factors|mesh-ancestor
83278717|NCT02289833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278718|NCT01702558|Capecitabine|capecitabine|mesh-list
83278719|NCT01702558|Trastuzumab|trastuzumab|mesh-list
83278720|NCT01702558|Maytansine|maytansine|mesh-list
83278721|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83278722|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83278723|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
83278724|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278725|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278726|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278727|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83278728|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
83278729|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
83278730|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
83278731|NCT01702558|Immunotoxins|immunotoxins|mesh-ancestor
83278732|NCT01702558|Immunoconjugates|immunoconjugates|mesh-ancestor
83278733|NCT01702558|Immunologic Factors|immunologic factors|mesh-ancestor
83278734|NCT01702558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278735|NCT05650775|Methylphenidate|methylphenidate|mesh-list
83278736|NCT05650775|Adderall|adderall|mesh-list
83278737|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83278738|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278739|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83278740|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83278741|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83278742|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278743|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
83278744|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278745|NCT02194465|Spironolactone|spironolactone|mesh-list
83278746|NCT02194465|Tadalafil|tadalafil|mesh-list
83278747|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83278748|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
83278749|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
83278750|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83278751|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83278752|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278753|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278754|NCT02194465|Urological Agents|urological agents|mesh-ancestor
83278755|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
83278756|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278757|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278758|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83278759|NCT02194465|Diuretics|diuretics|mesh-ancestor
83278760|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
83278761|NCT02194465|Hormones|hormones|mesh-ancestor
83278762|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83278763|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278764|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278765|NCT01720264|Incretins|incretins|mesh-ancestor
83278766|NCT01720264|Hormones|hormones|mesh-ancestor
83278767|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278768|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83278769|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
83278770|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278771|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278772|NCT04564846|Insulin|insulin|mesh-list
83278773|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278774|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278775|NCT01702246|Simvastatin|simvastatin|mesh-list
83278776|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83278777|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83278778|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
83278779|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278780|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83278781|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83278782|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278783|NCT01631227|Eprosartan|eprosartan|mesh-list
83278784|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83278785|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
83278786|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83278787|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278788|NCT05645861|Benzocaine|benzocaine|mesh-list
83278789|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
83278790|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
83278791|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278792|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278793|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
83278794|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278795|NCT01719172|Hemostatics|hemostatics|mesh-list
83278796|NCT01719172|Coagulants|coagulants|mesh-ancestor
83278797|NCT02285855|Metformin|metformin|mesh-list
83278798|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83278799|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278800|NCT02285153|Aspirin|aspirin|mesh-list
83278801|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
83278802|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83278803|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83278804|NCT02285153|Analgesics|analgesics|mesh-ancestor
83278805|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
83278806|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278807|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278808|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278809|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278810|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83278811|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83278812|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278813|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83278814|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83278815|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278816|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
83278817|NCT01632241|Belimumab|belimumab|mesh-list
83278818|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278819|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
83278820|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278821|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
83278822|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83278823|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278824|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278825|NCT02263508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83278826|NCT02263508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278827|NCT01741792|Blinatumomab|blinatumomab|mesh-list
83278828|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278829|NCT02289950|Farletuzumab|farletuzumab|mesh-list
83278830|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278831|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83278832|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
83278833|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83278834|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83278835|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83278836|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278837|NCT01740388|Besifloxacin|besifloxacin|mesh-list
83278838|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83278839|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278840|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83278841|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83278842|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278843|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278844|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278845|NCT01740154|Sunitinib|sunitinib|mesh-list
83278846|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278847|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83278848|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83278849|NCT01740154|Growth Substances|growth substances|mesh-ancestor
83278850|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278851|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
83278852|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83278853|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278854|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278855|NCT02287610|Prednisone|prednisone|mesh-list
83278856|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278857|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
83278858|NCT02287610|Hormones|hormones|mesh-ancestor
83278859|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278860|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278861|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83278862|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278863|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
83278864|NCT02262728|Simeprevir|simeprevir|mesh-list
83278865|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
83278866|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278867|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
83278868|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278869|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278870|NCT01717768|Testosterone|testosterone|mesh-list
83278871|NCT01717768|Androgens|androgens|mesh-ancestor
83278872|NCT01717768|Hormones|hormones|mesh-ancestor
83278873|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278874|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278875|NCT02260934|Acetaminophen|acetaminophen|mesh-list
83278876|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
83278877|NCT02260934|Promethazine|promethazine|mesh-list
83278878|NCT02260934|Prednisone|prednisone|mesh-list
83278879|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
83278880|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83278881|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83278882|NCT02260934|Prednisolone|prednisolone|mesh-list
83278883|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
83278884|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
83278885|NCT02260934|Rituximab|rituximab|mesh-list
83278886|NCT02260934|Belimumab|belimumab|mesh-list
83278887|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83278888|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
83278889|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83278890|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
83278891|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278892|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83278893|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83278894|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
83278895|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278896|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278897|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83278898|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83278899|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83278900|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
83278901|NCT02260934|Hormones|hormones|mesh-ancestor
83278902|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83278903|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83278904|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83278905|NCT02260934|Analgesics|analgesics|mesh-ancestor
83278906|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
83278907|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278908|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
83278909|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
83278910|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
83278911|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278912|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83278913|NCT02260934|Protective Agents|protective agents|mesh-ancestor
83278914|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83278915|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83278916|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278917|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
83278918|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
83278919|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83278920|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
83278921|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
83278922|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278923|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83278924|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
83278925|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
83278926|NCT02260388|Mexiletine|mexiletine|mesh-list
83278927|NCT02260388|Pregabalin|pregabalin|mesh-list
83278928|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83278929|NCT02260388|Nortriptyline|nortriptyline|mesh-list
83278930|NCT02260388|Analgesics|analgesics|mesh-ancestor
83278931|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
83278932|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278933|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278934|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
83278935|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83278936|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83278937|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278938|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83278939|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83278940|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83278941|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83278942|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83278943|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83278944|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83278945|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83278946|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
83278947|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
83278948|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83278949|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83278950|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
83278951|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83278952|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83278953|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83278954|NCT02260154|Mebeverine|mebeverine|mesh-list
83278955|NCT02260154|Alverine|alverine|mesh-list
83278956|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
83278957|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
83278958|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
83278959|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83278960|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83278961|NCT01643408|Asparaginase|asparaginase|mesh-list
83278962|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278963|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
83278964|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83278965|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83278966|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83278967|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83278968|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83278969|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278970|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278971|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278972|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
83278973|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83278974|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83278975|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83278976|NCT01739764|Vemurafenib|vemurafenib|mesh-list
83278977|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83278978|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83278979|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278980|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278981|NCT01700530|Simvastatin|simvastatin|mesh-list
83278982|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83278983|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83278984|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83278985|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
83278986|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83278987|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83278988|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83278989|NCT01717456|Loperamide|loperamide|mesh-list
83278990|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
83278991|NCT01717456|Laxatives|laxatives|mesh-list
83278992|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83278993|NCT01716754|Omalizumab|omalizumab|mesh-list
83278994|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83278995|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83278996|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
83278997|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83278998|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83278999|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83279000|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83279001|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279002|NCT01698814|Analgesics|analgesics|mesh-ancestor
83279003|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
83279004|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279005|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279006|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279007|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279008|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83279009|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83279010|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83279011|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
83279012|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
83279013|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279014|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279016|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83279017|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279018|NCT01738594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83279019|NCT01738594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279020|NCT01738594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279021|NCT01697956|Beclomethasone|beclomethasone|mesh-list
83279022|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279023|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
83279024|NCT01697956|Hormones|hormones|mesh-ancestor
83279025|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279026|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279027|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279028|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279029|NCT01697800|Tadalafil|tadalafil|mesh-list
83279030|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
83279031|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83279032|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83279033|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279034|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279035|NCT01697800|Urological Agents|urological agents|mesh-ancestor
83279036|NCT04553770|Trastuzumab|trastuzumab|mesh-list
83279037|NCT04553770|Anastrozole|anastrozole|mesh-list
83279038|NCT04553770|Camptothecin|camptothecin|mesh-list
83279039|NCT04553770|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83279040|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
83279041|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279042|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279043|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279044|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83279045|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83279046|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279047|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279048|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83279049|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
83279050|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279051|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279052|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
83279053|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83279054|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83279055|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83279056|NCT01644500|Glimepiride|glimepiride|mesh-list
83279057|NCT01644500|Dulaglutide|dulaglutide|mesh-list
83279058|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83279059|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83279060|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279061|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83279062|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
83279063|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
83279064|NCT04877834|Lansoprazole|lansoprazole|mesh-list
83279065|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83279066|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279067|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83279068|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279069|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279070|NCT01604824|Alirocumab|alirocumab|mesh-list
83279071|NCT01604824|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83279072|NCT01604824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83279073|NCT01604824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83279074|NCT01604824|Antimetabolites|antimetabolites|mesh-ancestor
83279075|NCT01604824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279076|NCT01604824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83279077|NCT01604824|Protease Inhibitors|protease inhibitors|mesh-ancestor
83279078|NCT01604824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279079|NCT01604824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83279080|NCT01716052|Ibuprofen|ibuprofen|mesh-list
83279081|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83279082|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279083|NCT01716052|Analgesics|analgesics|mesh-ancestor
83279084|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
83279085|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279086|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279087|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279088|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279089|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83279090|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279091|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279092|NCT01641692|Albuterol|albuterol|mesh-list
83279093|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83279094|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
83279095|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279096|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279097|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279098|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279099|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
83279100|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83279101|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83279102|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83279103|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83279104|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
83279105|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279106|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279107|NCT01682512|Rituximab|rituximab|mesh-list
83279108|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279109|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279110|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
83279111|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279112|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279114|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83279115|NCT04863716|Narcotics|narcotics|mesh-ancestor
83279116|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279117|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279118|NCT04863716|Analgesics|analgesics|mesh-ancestor
83279119|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
83279120|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279121|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83279122|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83279123|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
83279124|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
83279125|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
83279126|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279127|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279128|NCT04135352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279129|NCT04135352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279130|NCT01715896|Golimumab|golimumab|mesh-list
83279131|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
83279132|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83279133|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279134|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83279135|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
83279136|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279137|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279138|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
83279139|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279140|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279141|NCT05642780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279142|NCT05642780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279143|NCT05642702|Vitamins|vitamins|mesh-list
83279144|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
83279145|NCT05642702|Niacinamide|niacinamide|mesh-list
83279146|NCT05642702|Niacin|niacin|mesh-list
83279147|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
83279148|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83279149|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
83279150|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279151|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
83279152|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279153|NCT05642702|Protective Agents|protective agents|mesh-ancestor
83279154|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
83279155|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83279156|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
83279157|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83279158|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
83279159|NCT05544734|Acetaminophen|acetaminophen|mesh-list
83279160|NCT05544734|Ibuprofen|ibuprofen|mesh-list
83279161|NCT05544734|Hydrocodone|hydrocodone|mesh-list
83279162|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279163|NCT05544734|Analgesics|analgesics|mesh-ancestor
83279164|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
83279165|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279166|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279168|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83279169|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279170|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279171|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83279172|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279173|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279174|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83279175|NCT05544734|Narcotics|narcotics|mesh-ancestor
83279176|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279177|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
83279178|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279179|NCT02254772|Ipilimumab|ipilimumab|mesh-list
83279180|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279181|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279182|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279183|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279184|NCT01682044|Rituximab|rituximab|mesh-list
83279185|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279186|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279187|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
83279188|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279189|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279190|NCT05640596|Betamethasone|betamethasone|mesh-list
83279191|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279192|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
83279193|NCT05640596|Hormones|hormones|mesh-ancestor
83279194|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279195|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279196|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279197|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279198|NCT05651126|Psilocybin|psilocybin|mesh-list
83279199|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
83279200|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279201|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83279202|NCT01696942|Mesalamine|mesalamine|mesh-list
83279203|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279204|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279205|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279206|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83279207|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279208|NCT01696942|Analgesics|analgesics|mesh-ancestor
83279209|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
83279210|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279211|NCT05493566|Aldesleukin|aldesleukin|mesh-list
83279212|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
83279213|NCT05493566|Interleukin-2|interleukin-2|mesh-list
83279214|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279215|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279216|NCT05493566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279217|NCT05493566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279218|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279219|NCT05493566|Analgesics|analgesics|mesh-ancestor
83279220|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
83279221|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279222|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279223|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83279224|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83279225|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
83279226|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279227|NCT04871204|Octreotide|octreotide|mesh-list
83279228|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279229|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279230|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279231|NCT05615948|Ketamine|ketamine|mesh-list
83279232|NCT05615948|Analgesics|analgesics|mesh-ancestor
83279233|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
83279234|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279235|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279236|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279237|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83279238|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83279239|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
83279240|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
83279241|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279242|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83279243|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83279244|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279245|NCT05650268|Vitamin D|vitamin d|mesh-list
83279246|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
83279247|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
83279248|NCT05650268|Vitamins|vitamins|mesh-list
83279249|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
83279250|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279251|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83279252|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83279253|NCT04835870|Prednisone|prednisone|mesh-list
83279254|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
83279255|NCT04835870|Rituximab|rituximab|mesh-list
83279256|NCT04835870|Doxorubicin|doxorubicin|mesh-list
83279257|NCT04835870|Vincristine|vincristine|mesh-list
83279258|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
83279259|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83279260|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
83279261|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279262|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279263|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83279264|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
83279265|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279266|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279267|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83279268|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279269|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83279270|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83279271|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83279272|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279273|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279274|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
83279275|NCT04835870|Hormones|hormones|mesh-ancestor
83279276|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279277|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279278|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83279279|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
83279280|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
83279281|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
83279282|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83279283|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83279284|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
83279285|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279286|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83279287|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279288|NCT04834310|Clindamycin|clindamycin|mesh-list
83279289|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
83279290|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
83279291|NCT04834310|Cefazolin|cefazolin|mesh-list
83279292|NCT04834310|Cephalexin|cephalexin|mesh-list
83279293|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83279294|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279295|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83279296|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279297|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279298|NCT04848116|Nivolumab|nivolumab|mesh-list
83279299|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279300|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279301|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279302|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279303|NCT05372198|Immunomodulating Agents|immunomodulating agents|mesh-list
83279304|NCT05372198|Immunologic Factors|immunologic factors|mesh-ancestor
83279305|NCT05372198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279306|NCT05359406|Tislelizumab|tislelizumab|mesh-list
83279307|NCT05359406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279308|NCT05359406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279309|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
83279310|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279311|NCT04654208|Palbociclib|palbociclib|mesh-list
83279312|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279313|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83279314|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279315|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279316|NCT04652960|Nivolumab|nivolumab|mesh-list
83279317|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279318|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279319|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279320|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279321|NCT05357846|Paclitaxel|paclitaxel|mesh-list
83279322|NCT05357846|Cisplatin|cisplatin|mesh-list
83279323|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83279324|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279325|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
83279326|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
83279327|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
83279328|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279329|NCT05031494|Paclitaxel|paclitaxel|mesh-list
83279330|NCT05031494|Gemcitabine|gemcitabine|mesh-list
83279331|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83279332|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279333|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
83279334|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
83279335|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
83279336|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279337|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83279338|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
83279339|NCT04844216|Lidocaine|lidocaine|mesh-list
83279340|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
83279341|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
83279342|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
83279343|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279344|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279345|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
83279346|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279347|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83279348|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83279349|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83279350|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83279351|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279352|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83279353|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
83279354|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
83279355|NCT04844216|Protective Agents|protective agents|mesh-ancestor
83279356|NCT05345678|Durvalumab|durvalumab|mesh-list
83279357|NCT05345678|Tremelimumab|tremelimumab|mesh-list
83279358|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279359|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279360|NCT05327738|Atezolizumab|atezolizumab|mesh-list
83279361|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83279362|NCT05327738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279363|NCT05327738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279364|NCT05327738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279365|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279366|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
83279367|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279368|NCT04419662|Phenylephrine|phenylephrine|mesh-list
83279369|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
83279370|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83279371|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
83279372|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
83279373|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279374|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279375|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
83279376|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83279377|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
83279378|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279379|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83279380|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83279381|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83279382|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83279383|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279384|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279385|NCT04419662|Protective Agents|protective agents|mesh-ancestor
83279386|NCT04589546|Niacinamide|niacinamide|mesh-list
83279387|NCT04589546|Niacin|niacin|mesh-list
83279388|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
83279389|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
83279391|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
83279392|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279393|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83279394|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
83279395|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279396|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83279397|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
83279398|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
83279399|NCT05369468|Bupivacaine|bupivacaine|mesh-list
83279400|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
83279401|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
83279402|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279403|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279404|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
83279405|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279406|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83279407|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279408|NCT05369468|Analgesics|analgesics|mesh-ancestor
83279409|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83279410|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83279411|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83279412|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
83279413|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279414|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279415|NCT02164513|Fluticasone|fluticasone|mesh-list
83279416|NCT02164513|Xhance|xhance|mesh-list
83279417|NCT02164513|Bromides|bromides|mesh-list
83279418|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279419|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83279420|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
83279421|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279422|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279423|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279424|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279425|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
83279426|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83279427|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
83279428|NCT04562246|Antibodies|antibodies|mesh-list
83279429|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
83279430|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279431|NCT04532372|Leflunomide|leflunomide|mesh-list
83279432|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279433|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279434|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83279435|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
83279436|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279437|NCT05410418|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83279438|NCT05410418|Immunoconjugates|immunoconjugates|mesh-ancestor
83279439|NCT05410418|Immunologic Factors|immunologic factors|mesh-ancestor
83279440|NCT05410418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279441|NCT04513184|Dexamethasone|dexamethasone|mesh-list
83279442|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
83279443|NCT04513184|BB 1101|bb 1101|mesh-list
83279444|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279445|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
83279446|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
83279447|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279448|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279449|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279450|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
83279451|NCT04513184|Hormones|hormones|mesh-ancestor
83279452|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279453|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279454|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279455|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
83279456|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279457|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279458|NCT04756531|Nirmatrelvir|nirmatrelvir|mesh-list
83279459|NCT04756531|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83279460|NCT04756531|Protease Inhibitors|protease inhibitors|mesh-ancestor
83279461|NCT04756531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279462|NCT04756531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279463|NCT04756531|Antiviral Agents|antiviral agents|mesh-ancestor
83279464|NCT04756531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279466|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83279467|NCT01713946|Everolimus|everolimus|mesh-list
83279468|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
83279469|NCT01713946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83279470|NCT01713946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83279471|NCT01713946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279472|NCT01713946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279473|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83279474|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
83279475|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279476|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279477|NCT04464512|Sufentanil|sufentanil|mesh-list
83279478|NCT04464512|Buprenorphine|buprenorphine|mesh-list
83279479|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83279480|NCT04464512|Narcotics|narcotics|mesh-ancestor
83279481|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279482|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279483|NCT04464512|Analgesics|analgesics|mesh-ancestor
83279484|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
83279485|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279486|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83279487|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83279488|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83279489|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
83279490|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
83279491|NCT05369234|Sucralfate|sucralfate|mesh-list
83279492|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83279493|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279494|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
83279495|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83279496|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
83279497|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279498|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
83279499|NCT04839692|Protective Agents|protective agents|mesh-ancestor
83279500|NCT04827446|Methamphetamine|methamphetamine|mesh-list
83279501|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83279502|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279503|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
83279504|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
83279505|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279506|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
83279507|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279508|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279509|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
83279510|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83279511|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83279512|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83279513|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83279514|NCT02191579|Topiramate|topiramate|mesh-list
83279515|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
83279516|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83279517|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83279518|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83279519|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83279520|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279521|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
83279522|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279523|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279524|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83279525|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279526|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
83279527|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83279528|NCT05324462|Xultophy|xultophy|mesh-list
83279529|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83279530|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279531|NCT05324462|Incretins|incretins|mesh-ancestor
83279532|NCT05324462|Hormones|hormones|mesh-ancestor
83279533|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279534|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83279535|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83279536|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83279537|NCT01363700|Epinastine|epinastine|mesh-list
83279538|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83279539|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279540|NCT01363700|Analgesics|analgesics|mesh-ancestor
83279541|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
83279542|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279543|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279544|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279545|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279546|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83279547|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83279548|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83279549|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
83279550|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
83279551|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279552|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279553|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
83279554|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279555|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279556|NCT04372706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83279557|NCT04372706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279558|NCT04178642|Idarubicin|idarubicin|mesh-list
83279559|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
83279560|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83279561|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279562|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83279563|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83279564|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279565|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279566|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
83279567|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
83279568|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83279569|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279570|NCT04838288|Tacrolimus|tacrolimus|mesh-list
83279571|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83279572|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
83279573|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279574|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83279575|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279576|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279577|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
83279578|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83279579|NCT04327934|Testosterone|testosterone|mesh-list
83279580|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
83279581|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
83279582|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83279583|NCT04327934|Hormones|hormones|mesh-ancestor
83279584|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279585|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279586|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279587|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279588|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
83279589|NCT04327934|Androgens|androgens|mesh-ancestor
83279590|NCT04791566|Dexamethasone|dexamethasone|mesh-list
83279591|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279592|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
83279593|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
83279594|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279595|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279596|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279597|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
83279598|NCT04791566|Hormones|hormones|mesh-ancestor
83279599|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279600|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279601|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279602|NCT04129736|Teriflunomide|teriflunomide|mesh-list
83279603|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83279604|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279605|NCT04129736|Analgesics|analgesics|mesh-ancestor
83279606|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
83279607|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279608|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279610|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279611|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83279612|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
83279613|NCT01637402|Prednisone|prednisone|mesh-list
83279614|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
83279615|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279616|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
83279617|NCT01637402|Hormones|hormones|mesh-ancestor
83279618|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279619|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279620|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279621|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279622|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83279623|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279624|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279625|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
83279626|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83279627|NCT04419038|Mitomycins|mitomycins|mesh-list
83279628|NCT04419038|Mitomycin|mitomycin|mesh-list
83279629|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83279630|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279631|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
83279632|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279633|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83279634|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279635|NCT04824638|Vaccines|vaccines|mesh-list
83279636|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
83279637|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279638|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
83279639|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83279640|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279641|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83279642|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83279643|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
83279644|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279645|NCT04818944|Tirofiban|tirofiban|mesh-list
83279646|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83279647|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83279648|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279649|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83279650|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
83279651|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83279652|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83279653|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279654|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
83279655|NCT04818866|Coagulants|coagulants|mesh-ancestor
83279656|NCT02189941|Deferiprone|deferiprone|mesh-list
83279657|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83279658|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
83279659|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
83279660|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279661|NCT01601132|Colchicine|colchicine|mesh-list
83279662|NCT01601132|Theophylline|theophylline|mesh-list
83279663|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
83279664|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279665|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
83279666|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
83279667|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
83279668|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279669|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279670|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83279671|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
83279672|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279673|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279674|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279675|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279676|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83279677|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279678|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
83279679|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83279680|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83279681|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
83279682|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279683|NCT04836962|Dexamethasone|dexamethasone|mesh-list
83279684|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279685|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
83279686|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
83279687|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279688|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279689|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279690|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
83279691|NCT04836962|Hormones|hormones|mesh-ancestor
83279692|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279693|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279694|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279695|NCT05289440|Esketamine|esketamine|mesh-list
83279696|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
83279697|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83279698|NCT04016090|Folic Acid|folic acid|mesh-list
83279699|NCT04016090|Hematinics|hematinics|mesh-ancestor
83279700|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
83279701|NCT04016090|Vitamins|vitamins|mesh-ancestor
83279702|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
83279703|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279704|NCT04809974|Niacinamide|niacinamide|mesh-list
83279705|NCT04809974|Vitamins|vitamins|mesh-ancestor
83279706|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
83279707|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279708|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
83279709|NCT04691960|Metformin|metformin|mesh-list
83279710|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83279711|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279712|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
83279713|NCT04809038|Analgesics|analgesics|mesh-ancestor
83279714|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
83279715|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279716|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279717|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
83279718|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279719|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83279720|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
83279721|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83279722|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83279723|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279724|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83279725|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
83279726|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83279727|NCT05221190|Lidocaine|lidocaine|mesh-list
83279728|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
83279729|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
83279730|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279731|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279732|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
83279733|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279734|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83279735|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83279736|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83279737|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83279738|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279739|NCT04816682|Silymarin|silymarin|mesh-list
83279740|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
83279741|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279742|NCT04816682|Protective Agents|protective agents|mesh-ancestor
83279743|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279744|NCT02162719|Paclitaxel|paclitaxel|mesh-list
83279745|NCT02162719|Ipatasertib|ipatasertib|mesh-list
83279746|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83279747|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279748|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
83279749|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
83279751|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279752|NCT02162719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83279753|NCT02162719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279754|NCT04808882|Tinzaparin|tinzaparin|mesh-list
83279755|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83279756|NCT04808882|Dalteparin|dalteparin|mesh-list
83279757|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
83279758|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83279759|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83279760|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279761|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
83279762|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83279763|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279764|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83279765|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83279766|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83279768|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279769|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279770|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279771|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279772|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83279773|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83279774|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83279775|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
83279776|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279777|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279778|NCT04794842|Phenol|phenol|mesh-list
83279779|NCT04794842|Tetracaine|tetracaine|mesh-list
83279780|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
83279781|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
83279782|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83279783|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279784|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
83279785|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279786|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83279787|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279788|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
83279789|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83279790|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83279791|NCT03029000|Lenograstim|lenograstim|mesh-list
83279792|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83279793|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
83279794|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279795|NCT03783182|Betamethasone|betamethasone|mesh-list
83279796|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
83279797|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83279798|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
83279799|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83279800|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
83279801|NCT03783182|Hormones|hormones|mesh-ancestor
83279802|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279803|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279804|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279805|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279806|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279807|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
83279808|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83279809|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279810|NCT05651750|Fluticasone|fluticasone|mesh-list
83279811|NCT05651750|Xhance|xhance|mesh-list
83279812|NCT05651750|Montelukast|montelukast|mesh-list
83279813|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279814|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83279815|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
83279816|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279817|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279818|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279819|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279820|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
83279821|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83279822|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83279823|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
83279824|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279825|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83279826|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83279827|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279828|NCT02160145|Tolvaptan|tolvaptan|mesh-list
83279829|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83279830|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279831|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
83279832|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279833|NCT04793906|Iron|iron|mesh-list
83279834|NCT04793906|Trace Elements|trace elements|mesh-ancestor
83279835|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
83279836|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279837|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
83279838|NCT02216071|Dexamethasone|dexamethasone|mesh-list
83279839|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
83279840|NCT02216071|BB 1101|bb 1101|mesh-list
83279841|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279842|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
83279843|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
83279844|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279845|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279846|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279847|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
83279848|NCT02216071|Hormones|hormones|mesh-ancestor
83279849|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279850|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279851|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279852|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
83279853|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279854|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279855|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83279856|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279857|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83279858|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83279859|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83279860|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83279861|NCT01681576|Valsartan|valsartan|mesh-list
83279862|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83279863|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83279864|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83279865|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83279866|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279867|NCT02188459|Bupropion|bupropion|mesh-list
83279868|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83279869|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
83279870|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83279871|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83279872|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83279873|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83279874|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279875|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
83279876|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279877|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279878|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83279879|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83279880|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279881|NCT02743364|Simvastatin|simvastatin|mesh-list
83279882|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83279883|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83279884|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
83279885|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279886|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83279887|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83279888|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279889|NCT04192136|Niacinamide|niacinamide|mesh-list
83279890|NCT04192136|Niacin|niacin|mesh-list
83279891|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
83279892|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
83279893|NCT04192136|Vitamins|vitamins|mesh-ancestor
83279894|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
83279895|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279896|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83279897|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
83279898|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279899|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83279900|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
83279901|NCT02214121|Ticagrelor|ticagrelor|mesh-list
83279902|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83279903|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83279904|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83279905|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83279906|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
83279907|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83279908|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279909|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279910|NCT01681186|Lansoprazole|lansoprazole|mesh-list
83279911|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
83279912|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83279913|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279914|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83279915|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279916|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279917|NCT01695772|Bevacizumab|bevacizumab|mesh-list
83279918|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83279919|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279920|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83279921|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83279922|NCT01695772|Growth Substances|growth substances|mesh-ancestor
83279923|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279924|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
83279925|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83279926|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83279927|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83279928|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279929|NCT01636934|Minocycline|minocycline|mesh-list
83279930|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83279931|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83279932|NCT01712854|Budesonide|budesonide|mesh-list
83279933|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83279934|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279935|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83279936|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
83279937|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279938|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279939|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83279940|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
83279941|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
83279942|NCT01712854|Hormones|hormones|mesh-ancestor
83279943|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279944|NCT02986594|Aspirin|aspirin|mesh-list
83279945|NCT02986594|Heparin|heparin|mesh-list
83279946|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83279947|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83279948|NCT02986594|Analgesics|analgesics|mesh-ancestor
83279949|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
83279950|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279951|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279952|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279953|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83279954|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83279955|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83279956|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279957|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83279958|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83279959|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279960|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
83279961|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
83279963|NCT02159365|Lenalidomide|lenalidomide|mesh-list
83279964|NCT02159365|Elotuzumab|elotuzumab|mesh-list
83279965|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279966|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
83279967|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
83279968|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83279969|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279970|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83279971|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
83279972|NCT02159365|Hormones|hormones|mesh-ancestor
83279973|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279974|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279975|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279976|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
83279977|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83279978|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83279979|NCT02159365|Growth Substances|growth substances|mesh-ancestor
83279980|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
83279981|NCT02072200|Prednisone|prednisone|mesh-list
83279982|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83279983|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
83279984|NCT02072200|Hormones|hormones|mesh-ancestor
83279985|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83279986|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83279987|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83279988|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83279989|NCT01691794|Ritonavir|ritonavir|mesh-list
83279990|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83279991|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83279992|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83279993|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
83279994|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83279995|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83279996|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83279997|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83279998|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
83279999|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280000|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83280001|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83280002|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83280003|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
83280004|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280005|NCT02158975|Ixazomib|ixazomib|mesh-list
83280006|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280007|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
83280008|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280009|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280010|NCT02661464|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83280011|NCT02661464|Antiviral Agents|antiviral agents|mesh-ancestor
83280012|NCT02661464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280013|NCT02158039|Ethanol|ethanol|mesh-list
83280014|NCT02158039|Lidocaine|lidocaine|mesh-list
83280015|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
83280016|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
83280017|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280018|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280019|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
83280020|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280021|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83280022|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83280023|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83280024|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280025|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280026|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83280027|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280028|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83280029|NCT03563222|SMOFlipid|smoflipid|mesh-list
83280030|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83280031|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83280032|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83280033|NCT04803734|Albuterol|albuterol|mesh-list
83280034|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83280035|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
83280036|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280037|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280038|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83280039|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83280040|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
83280041|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83280042|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83280043|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83280044|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83280045|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
83280046|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280047|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280048|NCT04802408|Listerine|listerine|mesh-list
83280049|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
83280050|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83280051|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280052|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
83280053|NCT04802408|Protective Agents|protective agents|mesh-ancestor
83280054|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280055|NCT02490800|Lisavanbulin|lisavanbulin|mesh-list
83280056|NCT02490800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83280057|NCT02490800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280058|NCT02490800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280059|NCT02490800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280061|NCT01635764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83280062|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280063|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280064|NCT03341078|Ibudilast|ibudilast|mesh-list
83280065|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83280066|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
83280067|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280068|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280069|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83280070|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
83280071|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83280072|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280073|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280074|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83280075|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
83280076|NCT04810598|Venetoclax|venetoclax|mesh-list
83280077|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280078|NCT04627064|Belzutifan|belzutifan|mesh-list
83280079|NCT04627064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280080|NCT04511078|Panitumumab|panitumumab|mesh-list
83280081|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280082|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280083|NCT02158052|Tacrolimus|tacrolimus|mesh-list
83280084|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83280085|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280086|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
83280087|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280088|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83280089|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280090|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280091|NCT01635218|Fluoxetine|fluoxetine|mesh-list
83280092|NCT01635218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83280093|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83280094|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280095|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280096|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280097|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
83280098|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280099|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83280100|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
83280101|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83280102|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83280103|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83280104|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280105|NCT05351684|Dolutegravir|dolutegravir|mesh-list
83280106|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83280107|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83280108|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280109|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280110|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83280111|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83280112|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
83280113|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280114|NCT02049866|Denosumab|denosumab|mesh-list
83280115|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83280116|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280117|NCT04787744|Prednisone|prednisone|mesh-list
83280118|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
83280119|NCT04787744|Docetaxel|docetaxel|mesh-list
83280120|NCT04787744|Leuprolide|leuprolide|mesh-list
83280121|NCT04787744|Goserelin|goserelin|mesh-list
83280122|NCT04787744|Bicalutamide|bicalutamide|mesh-list
83280123|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83280124|NCT04787744|Flutamide|flutamide|mesh-list
83280125|NCT04787744|Nilutamide|nilutamide|mesh-list
83280126|NCT04787744|Relugolix|relugolix|mesh-list
83280127|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280128|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
83280129|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
83280130|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
83280131|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280132|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280133|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
83280134|NCT04787744|Hormones|hormones|mesh-ancestor
83280135|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280136|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280137|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83280138|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
83280139|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
83280140|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280141|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83280142|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83280143|NCT04787744|Protective Agents|protective agents|mesh-ancestor
83280144|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83280145|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
83280146|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83280147|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
83280148|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
83280149|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
83280150|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83280151|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
83280152|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83280153|NCT04274894|Testosterone|testosterone|mesh-list
83280154|NCT04274894|Androgens|androgens|mesh-ancestor
83280155|NCT04274894|Hormones|hormones|mesh-ancestor
83280156|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280157|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280158|NCT04786964|Folic Acid|folic acid|mesh-list
83280159|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
83280160|NCT04786964|Dexamethasone|dexamethasone|mesh-list
83280161|NCT04786964|Carboplatin|carboplatin|mesh-list
83280162|NCT04786964|Pemetrexed|pemetrexed|mesh-list
83280163|NCT04786964|Vitamins|vitamins|mesh-ancestor
83280164|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
83280165|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280166|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280167|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
83280168|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
83280169|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280170|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83280171|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
83280172|NCT04786964|Hormones|hormones|mesh-ancestor
83280173|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280174|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83280175|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280176|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280177|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280178|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83280179|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83280180|NCT04786964|Hematinics|hematinics|mesh-ancestor
83280181|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
83280182|NCT04269200|Paclitaxel|paclitaxel|mesh-list
83280183|NCT04269200|Carboplatin|carboplatin|mesh-list
83280184|NCT04269200|Durvalumab|durvalumab|mesh-list
83280185|NCT04269200|Olaparib|olaparib|mesh-list
83280186|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83280187|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83280188|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280189|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83280190|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83280191|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83280192|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280193|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280194|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
83280195|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280196|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83280197|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280198|NCT02213263|Rituximab|rituximab|mesh-list
83280199|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280200|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280201|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
83280202|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280203|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280204|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
83280205|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83280206|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280207|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
83280208|NCT04216784|Furosemide|furosemide|mesh-list
83280209|NCT04216784|Diuretics|diuretics|mesh-ancestor
83280210|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
83280211|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280212|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83280213|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280214|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280215|NCT05173298|Bevacizumab|bevacizumab|mesh-list
83280216|NCT05173298|Atezolizumab|atezolizumab|mesh-list
83280217|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280218|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280219|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83280220|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83280221|NCT05173298|Growth Substances|growth substances|mesh-ancestor
83280222|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280223|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
83280224|NCT05173298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83280225|NCT05173298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280226|NCT05168930|Venetoclax|venetoclax|mesh-list
83280227|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
83280228|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280229|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280230|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280231|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280232|NCT05170724|Remibrutinib|remibrutinib|mesh-list
83280233|NCT05170724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280234|NCT05170724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280235|NCT05170724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280236|NCT01975064|Propofol|propofol|mesh-list
83280237|NCT01975064|Sevoflurane|sevoflurane|mesh-list
83280238|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83280239|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280240|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280241|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83280242|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
83280243|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
83280244|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83280245|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83280246|NCT04062266|Azacitidine|azacitidine|mesh-list
83280247|NCT04062266|Venetoclax|venetoclax|mesh-list
83280248|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280249|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
83280250|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280251|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280252|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280253|NCT02210689|Clindamycin|clindamycin|mesh-list
83280254|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
83280255|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
83280256|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280257|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280258|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83280259|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280260|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280261|NCT02209597|Bupropion|bupropion|mesh-list
83280262|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83280263|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
83280264|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83280265|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83280266|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83280267|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280268|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280269|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
83280270|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280271|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280272|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83280273|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83280274|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280275|NCT03965468|Paclitaxel|paclitaxel|mesh-list
83280276|NCT03965468|Carboplatin|carboplatin|mesh-list
83280277|NCT03965468|Durvalumab|durvalumab|mesh-list
83280278|NCT03965468|Tremelimumab|tremelimumab|mesh-list
83280279|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83280280|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280281|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
83280282|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
83280283|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
83280284|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280285|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280286|NCT01469156|Ranibizumab|ranibizumab|mesh-list
83280287|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83280288|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83280289|NCT01469156|Growth Substances|growth substances|mesh-ancestor
83280290|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280291|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
83280292|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280293|NCT04191434|Budesonide|budesonide|mesh-list
83280294|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
83280295|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83280296|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280297|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83280298|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
83280299|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280300|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280301|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83280302|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83280303|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
83280304|NCT04191434|Hormones|hormones|mesh-ancestor
83280305|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280306|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83280307|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83280308|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83280309|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83280310|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280311|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280312|NCT03835676|Treprostinil|treprostinil|mesh-list
83280313|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83280314|NCT03651128|Dexamethasone|dexamethasone|mesh-list
83280315|NCT03651128|Lenalidomide|lenalidomide|mesh-list
83280316|NCT03651128|Bortezomib|bortezomib|mesh-list
83280317|NCT03651128|Daratumumab|daratumumab|mesh-list
83280318|NCT03651128|Pomalidomide|pomalidomide|mesh-list
83280319|NCT03651128|Ixazomib|ixazomib|mesh-list
83280320|NCT03651128|Elotuzumab|elotuzumab|mesh-list
83280321|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280322|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
83280323|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
83280324|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280325|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280326|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83280327|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
83280328|NCT03651128|Hormones|hormones|mesh-ancestor
83280329|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280330|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83280331|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280332|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
83280333|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83280334|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83280335|NCT03651128|Growth Substances|growth substances|mesh-ancestor
83280336|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
83280337|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
83280338|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280339|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280340|NCT00664898|Bortezomib|bortezomib|mesh-list
83280341|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280342|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
83280343|NCT04827992|Narcotics|narcotics|mesh-ancestor
83280344|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280345|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280346|NCT04827992|Analgesics|analgesics|mesh-ancestor
83280347|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
83280348|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280349|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83280350|NCT04776980|Hematinics|hematinics|mesh-ancestor
83280351|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83280352|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83280353|NCT02187055|Adalimumab|adalimumab|mesh-list
83280354|NCT02187055|Methotrexate|methotrexate|mesh-list
83280355|NCT02187055|Tofacitinib|tofacitinib|mesh-list
83280356|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83280357|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
83280358|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83280359|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280360|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280361|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
83280362|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280364|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
83280365|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280366|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83280367|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280368|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
83280369|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280370|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83280371|NCT02187055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83280372|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280373|NCT02187055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83280374|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280375|NCT00119366|Iodine|iodine|mesh-list
83280376|NCT00119366|Cyclosporine|cyclosporine|mesh-list
83280377|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
83280378|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83280379|NCT00119366|Fludarabine|fludarabine|mesh-list
83280380|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
83280381|NCT00119366|Antibodies|antibodies|mesh-list
83280382|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
83280383|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83280384|NCT00119366|Cyclosporins|cyclosporins|mesh-list
83280385|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
83280386|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280387|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280388|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280389|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
83280390|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280392|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280393|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
83280394|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280395|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
83280396|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280397|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83280398|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83280399|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83280400|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
83280401|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280402|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83280403|NCT00119366|Trace Elements|trace elements|mesh-ancestor
83280404|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
83280405|NCT02246660|Resveratrol|resveratrol|mesh-list
83280406|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
83280407|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280408|NCT02246660|Protective Agents|protective agents|mesh-ancestor
83280409|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280410|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280411|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83280412|NCT03471260|Azacitidine|azacitidine|mesh-list
83280413|NCT03471260|Venetoclax|venetoclax|mesh-list
83280414|NCT03471260|Ivosidenib|ivosidenib|mesh-list
83280415|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280416|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
83280417|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280418|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280419|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280420|NCT02246582|Insulin|insulin|mesh-list
83280421|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83280422|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280423|NCT02137369|Dexetimide|dexetimide|mesh-list
83280424|NCT02137369|Citalopram|citalopram|mesh-list
83280425|NCT02137369|Sertraline|sertraline|mesh-list
83280426|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
83280427|NCT02137369|Escitalopram|escitalopram|mesh-list
83280428|NCT02137369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83280429|NCT02137369|Serotonin|serotonin|mesh-list
83280430|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83280431|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280432|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280433|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280434|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
83280435|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280436|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83280437|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83280438|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
83280439|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
83280440|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280441|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83280442|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83280443|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
83280444|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83280445|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83280446|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83280447|NCT02155309|Scopolamine|scopolamine|mesh-list
83280448|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83280449|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83280450|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
83280451|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
83280452|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280453|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280454|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83280455|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
83280456|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83280457|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
83280458|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280459|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280460|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83280461|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
83280462|NCT02186821|Ceritinib|ceritinib|mesh-list
83280463|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280464|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280465|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280466|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280467|NCT01710358|Adalimumab|adalimumab|mesh-list
83280468|NCT01710358|Methotrexate|methotrexate|mesh-list
83280469|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83280470|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
83280471|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83280472|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280473|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280474|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
83280475|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280476|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280477|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
83280478|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280479|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83280480|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280481|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
83280482|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280483|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83280484|NCT01710358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83280485|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280486|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
83280487|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83280488|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
83280489|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83280490|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280491|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280492|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
83280493|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280494|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83280495|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280496|NCT03455270|Palbociclib|palbociclib|mesh-list
83280497|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280498|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280499|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280500|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280501|NCT01691482|Albuterol|albuterol|mesh-list
83280502|NCT01691482|Ipratropium|ipratropium|mesh-list
83280503|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83280504|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
83280505|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280506|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280507|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83280508|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
83280509|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
83280510|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83280511|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83280512|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83280514|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
83280515|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280516|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280517|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83280518|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
83280519|NCT01710046|Tofacitinib|tofacitinib|mesh-list
83280520|NCT01710046|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83280521|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280522|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280523|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280524|NCT02154529|Trastuzumab|trastuzumab|mesh-list
83280525|NCT02154529|XL647|xl647|mesh-list
83280526|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280527|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280528|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280529|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280530|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280531|NCT02154139|Leuprolide|leuprolide|mesh-list
83280532|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83280533|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
83280534|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83280535|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280536|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83280537|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280538|NCT02154061|Metronidazole|metronidazole|mesh-list
83280540|NCT02154061|Neomycin|neomycin|mesh-list
83280541|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280542|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280543|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83280544|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83280545|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83280546|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280547|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280548|NCT01907217|Methohexital|methohexital|mesh-list
83280549|NCT01907217|Succinylcholine|succinylcholine|mesh-list
83280550|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83280551|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83280552|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83280553|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280554|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280555|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83280556|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
83280557|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
83280558|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280559|NCT01953783|Ixazomib|ixazomib|mesh-list
83280560|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280561|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
83280562|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280563|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280564|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83280565|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280566|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280567|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280568|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280569|NCT04619979|Anesthetics|anesthetics|mesh-list
83280570|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280571|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280572|NCT01630135|Fluticasone|fluticasone|mesh-list
83280573|NCT01630135|Xhance|xhance|mesh-list
83280574|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280575|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83280576|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
83280577|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280578|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280579|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83280580|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
83280581|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
83280582|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83280583|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
83280584|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280585|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280586|NCT01924767|Empagliflozin|empagliflozin|mesh-list
83280587|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83280588|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280589|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83280590|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280592|NCT01691092|Analgesics|analgesics|mesh-ancestor
83280593|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
83280594|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280595|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280596|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83280597|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83280598|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
83280599|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
83280600|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280601|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83280602|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83280603|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280604|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280605|NCT02133001|Esketamine|esketamine|mesh-list
83280606|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
83280607|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83280608|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
83280609|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
83280610|NCT01709578|Methotrexate|methotrexate|mesh-list
83280611|NCT01709578|Leflunomide|leflunomide|mesh-list
83280612|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83280613|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
83280614|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83280615|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280616|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280617|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
83280618|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280619|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280620|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
83280621|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280622|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83280623|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280624|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
83280625|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280626|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83280627|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
83280628|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83280629|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83280630|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280631|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83280632|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83280633|NCT01709578|Analgesics|analgesics|mesh-ancestor
83280634|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
83280635|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280636|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280637|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83280638|NCT02132767|Digoxin|digoxin|mesh-list
83280639|NCT02132767|Amiodarone|amiodarone|mesh-list
83280640|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
83280641|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83280642|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280643|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83280644|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83280645|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280646|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280647|NCT02132767|Protective Agents|protective agents|mesh-ancestor
83280648|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
83280649|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83280650|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280651|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83280652|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83280653|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83280654|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83280655|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83280656|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83280657|NCT02153905|Aldesleukin|aldesleukin|mesh-list
83280658|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
83280659|NCT02153905|Fludarabine|fludarabine|mesh-list
83280660|NCT02153905|Interleukin-2|interleukin-2|mesh-list
83280661|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280662|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
83280663|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280664|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280665|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83280666|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
83280667|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280668|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280669|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83280670|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83280671|NCT02153905|Analgesics|analgesics|mesh-ancestor
83280672|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
83280673|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280674|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83280675|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83280676|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
83280677|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280678|NCT04752631|Tenecteplase|tenecteplase|mesh-list
83280679|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83280680|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83280681|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280682|NCT04546672|Neostigmine|neostigmine|mesh-list
83280683|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83280684|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280685|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280686|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
83280687|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280688|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280689|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83280690|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
83280691|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280692|NCT02244944|Ezetimibe|ezetimibe|mesh-list
83280693|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83280694|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83280695|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
83280696|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280697|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83280698|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83280699|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
83280700|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280701|NCT01591096|Plasminogen|plasminogen|mesh-list
83280702|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83280703|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83280704|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83280705|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280706|NCT01953003|Capecitabine|capecitabine|mesh-list
83280707|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280708|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
83280709|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280710|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280711|NCT01709500|Atorvastatin|atorvastatin|mesh-list
83280712|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83280713|NCT01709500|Simvastatin|simvastatin|mesh-list
83280714|NCT01709500|Alirocumab|alirocumab|mesh-list
83280715|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83280716|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83280717|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
83280718|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280719|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83280720|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83280721|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280722|NCT01709500|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83280723|NCT01709500|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83280724|NCT01709500|Protease Inhibitors|protease inhibitors|mesh-ancestor
83280725|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
83280726|NCT01599806|Ceftazidime|ceftazidime|mesh-list
83280727|NCT01599806|Avibactam|avibactam|mesh-list
83280728|NCT01599806|Doripenem|doripenem|mesh-list
83280729|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83280730|NCT01599806|Trimethoprim|trimethoprim|mesh-list
83280731|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
83280732|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280733|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280734|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83280735|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83280736|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280737|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280738|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280739|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83280740|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83280741|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83280742|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
83280743|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83280744|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83280745|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83280746|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83280747|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83280748|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83280749|NCT01599325|Azacitidine|azacitidine|mesh-list
83280750|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83280751|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
83280752|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280753|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280754|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280755|NCT01924299|Fluconazole|fluconazole|mesh-list
83280756|NCT01924299|Ketoconazole|ketoconazole|mesh-list
83280757|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
83280758|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280759|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83280760|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83280761|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280762|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280763|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83280764|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
83280765|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280766|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280767|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83280768|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83280769|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83280770|NCT02182999|Ropivacaine|ropivacaine|mesh-list
83280771|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
83280772|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
83280773|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280774|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280775|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
83280776|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280777|NCT01598311|Vancomycin|vancomycin|mesh-list
83280778|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280779|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280780|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
83280781|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83280782|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280783|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280784|NCT02978222|Molgramostim|molgramostim|mesh-list
83280785|NCT02978222|Sargramostim|sargramostim|mesh-list
83280786|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
83280787|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280788|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280789|NCT02181673|Golimumab|golimumab|mesh-list
83280790|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83280791|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280792|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280793|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
83280794|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280795|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
83280796|NCT02152345|Abatacept|abatacept|mesh-list
83280797|NCT02152345|Tacrolimus|tacrolimus|mesh-list
83280798|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83280799|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
83280800|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83280801|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
83280802|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280803|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83280804|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280805|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280806|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280808|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
83280809|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
83280810|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280811|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83280812|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
83280813|NCT02152345|Hormones|hormones|mesh-ancestor
83280814|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280815|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83280816|NCT02152345|Protective Agents|protective agents|mesh-ancestor
83280817|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83280818|NCT02152345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280819|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280820|NCT02180659|Buprenorphine|buprenorphine|mesh-list
83280821|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83280822|NCT02180659|Narcotics|narcotics|mesh-ancestor
83280823|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280824|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280826|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
83280827|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280828|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83280829|NCT02207816|Vaccines|vaccines|mesh-list
83280830|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
83280831|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280832|NCT05156606|Testosterone|testosterone|mesh-list
83280833|NCT05156606|Androgens|androgens|mesh-ancestor
83280834|NCT05156606|Hormones|hormones|mesh-ancestor
83280835|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83280836|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280837|NCT02241512|Ibuprofen|ibuprofen|mesh-list
83280838|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83280839|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83280840|NCT02241512|Analgesics|analgesics|mesh-ancestor
83280841|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
83280842|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280843|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280844|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280845|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83280846|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83280847|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280848|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280849|NCT01709110|Vitamin D|vitamin d|mesh-list
83280850|NCT01709110|Teriparatide|teriparatide|mesh-list
83280851|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
83280852|NCT01709110|Calcium|calcium|mesh-list
83280853|NCT01709110|Vitamins|vitamins|mesh-ancestor
83280854|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
83280855|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280856|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83280857|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83280858|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83280859|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83280860|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280861|NCT02240108|Rifaximin|rifaximin|mesh-list
83280862|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280863|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280864|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83280865|NCT01590082|Doxycycline|doxycycline|mesh-list
83280866|NCT01590082|Temozolomide|temozolomide|mesh-list
83280867|NCT01590082|Ipilimumab|ipilimumab|mesh-list
83280868|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83280869|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
83280870|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280871|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280872|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280873|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83280874|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83280875|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83280876|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
83280877|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83280878|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83280879|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83280880|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83280881|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83280882|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280883|NCT02179177|Apixaban|apixaban|mesh-list
83280884|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83280885|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
83280886|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83280887|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
83280888|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280889|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280890|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
83280891|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83280892|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83280893|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83280894|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280895|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280896|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83280897|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83280898|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83280899|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83280900|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
83280901|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280902|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280903|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83280904|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83280905|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
83280906|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83280907|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83280908|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
83280909|NCT02129647|Axitinib|axitinib|mesh-list
83280910|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280911|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83280912|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280913|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280914|NCT02238626|Ibudilast|ibudilast|mesh-list
83280915|NCT02238626|Riluzole|riluzole|mesh-list
83280916|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
83280917|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83280918|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83280919|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280920|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280921|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280922|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83280923|NCT02238626|Protective Agents|protective agents|mesh-ancestor
83280924|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83280925|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
83280926|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280927|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83280928|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
83280929|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83280930|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280931|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83280932|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
83280934|NCT02151643|Trace Elements|trace elements|mesh-ancestor
83280935|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
83280936|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280937|NCT02203838|Risperidone|risperidone|mesh-list
83280938|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83280939|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
83280940|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280941|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280942|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280943|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83280944|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83280945|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280946|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83280947|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83280948|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
83280949|NCT02178709|Leucovorin|leucovorin|mesh-list
83280950|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
83280951|NCT02178709|Irinotecan|irinotecan|mesh-list
83280952|NCT02178709|Folfirinox|folfirinox|mesh-list
83280953|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280954|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83280955|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83280956|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83280957|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280958|NCT02178709|Antidotes|antidotes|mesh-ancestor
83280959|NCT02178709|Protective Agents|protective agents|mesh-ancestor
83280960|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280961|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
83280962|NCT02178709|Vitamins|vitamins|mesh-ancestor
83280963|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
83280964|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
83280965|NCT02238080|Hematinics|hematinics|mesh-ancestor
83280966|NCT02178553|Bupivacaine|bupivacaine|mesh-list
83280967|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
83280968|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
83280969|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83280970|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280971|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
83280972|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280973|NCT01627327|Fluticasone|fluticasone|mesh-list
83280974|NCT01627327|Xhance|xhance|mesh-list
83280975|NCT01627327|Bromides|bromides|mesh-list
83280976|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
83280977|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83280978|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83280979|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
83280980|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83280981|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83280982|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83280983|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
83280984|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
83280985|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83280986|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
83280987|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83280988|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
83280989|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83280990|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83280991|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
83280992|NCT01627249|Bevacizumab|bevacizumab|mesh-list
83280993|NCT01627249|Ranibizumab|ranibizumab|mesh-list
83280994|NCT01627249|Aflibercept|aflibercept|mesh-list
83280995|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83280996|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83280997|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83280998|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83280999|NCT01627249|Growth Substances|growth substances|mesh-ancestor
83281000|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281001|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
83281002|NCT01688830|Dabigatran|dabigatran|mesh-list
83281003|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
83281004|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83281005|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
83281006|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281007|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281008|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
83281009|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
83281010|NCT01604278|Bromides|bromides|mesh-list
83281011|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
83281012|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83281013|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83281014|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83281015|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
83281016|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281017|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281018|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281019|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
83281020|NCT01687270|Ribavirin|ribavirin|mesh-list
83281021|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
83281022|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281023|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
83281024|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281025|NCT01588990|Leucovorin|leucovorin|mesh-list
83281026|NCT01588990|Bevacizumab|bevacizumab|mesh-list
83281027|NCT01588990|Capecitabine|capecitabine|mesh-list
83281028|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
83281029|NCT01588990|Irinotecan|irinotecan|mesh-list
83281030|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83281031|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281032|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83281033|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83281035|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281036|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
83281037|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83281038|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
83281039|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281040|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83281041|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83281042|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281043|NCT01588990|Antidotes|antidotes|mesh-ancestor
83281044|NCT01588990|Protective Agents|protective agents|mesh-ancestor
83281045|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
83281046|NCT01588990|Vitamins|vitamins|mesh-ancestor
83281047|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
83281048|NCT02126839|Albuterol|albuterol|mesh-list
83281049|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83281050|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
83281051|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281052|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281053|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83281054|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
83281055|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
83281056|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83281057|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83281058|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83281059|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83281060|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
83281061|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281062|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281063|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
83281064|NCT04747795|Vitamins|vitamins|mesh-ancestor
83281065|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
83281066|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281067|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
83281068|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281069|NCT04747795|Protective Agents|protective agents|mesh-ancestor
83281070|NCT02125279|Calcitriol|calcitriol|mesh-list
83281071|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83281072|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281073|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83281074|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281075|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281076|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83281077|NCT02125279|Vitamins|vitamins|mesh-ancestor
83281078|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
83281079|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83281080|NCT02124811|Minocycline|minocycline|mesh-list
83281081|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83281082|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281083|NCT02148445|Nicotine|nicotine|mesh-list
83281084|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83281085|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
83281086|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281087|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281088|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83281089|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83281090|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83281091|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281092|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281093|NCT02147587|Tofacitinib|tofacitinib|mesh-list
83281094|NCT02147587|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83281095|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83281096|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281097|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281098|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
83281099|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83281100|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
83281101|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83281102|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281103|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83281104|NCT04751929|Atezolizumab|atezolizumab|mesh-list
83281105|NCT04751929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83281106|NCT04751929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281107|NCT04751929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83281108|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281109|NCT02176291|Buprenorphine|buprenorphine|mesh-list
83281110|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83281111|NCT02176291|Narcotics|narcotics|mesh-ancestor
83281112|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281113|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281114|NCT02176291|Analgesics|analgesics|mesh-ancestor
83281115|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
83281116|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281117|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83281118|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83281119|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
83281120|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281121|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281122|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281123|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
83281125|NCT01568866|Dexamethasone|dexamethasone|mesh-list
83281126|NCT01568866|Bortezomib|bortezomib|mesh-list
83281127|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83281128|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
83281129|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
83281130|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281131|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281132|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83281133|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
83281134|NCT01568866|Hormones|hormones|mesh-ancestor
83281135|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281136|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83281137|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281138|NCT01567852|Ketamine|ketamine|mesh-list
83281139|NCT01567852|Methohexital|methohexital|mesh-list
83281140|NCT01567852|Analgesics|analgesics|mesh-ancestor
83281141|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
83281142|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281143|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281144|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83281145|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83281146|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
83281147|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
83281148|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281149|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83281150|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83281151|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281152|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281153|NCT01587274|Acetaminophen|acetaminophen|mesh-list
83281154|NCT01587274|Naproxen|naproxen|mesh-list
83281155|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83281156|NCT01587274|Oxycodone|oxycodone|mesh-list
83281157|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
83281158|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83281159|NCT01587274|Analgesics|analgesics|mesh-ancestor
83281160|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
83281161|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281162|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281163|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
83281164|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83281165|NCT01587274|Narcotics|narcotics|mesh-ancestor
83281166|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281167|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83281168|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83281169|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83281170|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
83281171|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83281172|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281173|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281174|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83281175|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
83281176|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83281177|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83281178|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83281179|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83281180|NCT01587118|Asenapine|asenapine|mesh-list
83281181|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83281182|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83281183|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281184|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281185|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83281186|NCT01905657|Docetaxel|docetaxel|mesh-list
83281187|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
83281188|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281189|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
83281190|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
83281191|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
83281192|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281193|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83281194|NCT01905657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83281195|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
83281196|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
83281197|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281198|NCT01952145|Insulin|insulin|mesh-list
83281199|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83281200|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
83281201|NCT01952145|Liraglutide|liraglutide|mesh-list
83281202|NCT01952145|Xultophy|xultophy|mesh-list
83281203|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83281204|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281205|NCT01952145|Incretins|incretins|mesh-ancestor
83281206|NCT01952145|Hormones|hormones|mesh-ancestor
83281207|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281208|NCT01923363|Tazobactam|tazobactam|mesh-list
83281209|NCT01923363|Piperacillin|piperacillin|mesh-list
83281210|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83281211|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83281212|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281213|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83281214|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281215|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281216|NCT01904721|Bimatoprost|bimatoprost|mesh-list
83281217|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83281218|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83281219|NCT01922739|Hydrocodone|hydrocodone|mesh-list
83281220|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83281221|NCT01922739|Narcotics|narcotics|mesh-ancestor
83281222|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281223|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281224|NCT01922739|Analgesics|analgesics|mesh-ancestor
83281225|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
83281226|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281227|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
83281228|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
83281229|NCT02236988|Thalidomide|thalidomide|mesh-list
83281230|NCT02236988|Apremilast|apremilast|mesh-list
83281231|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83281232|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83281233|NCT02236988|Analgesics|analgesics|mesh-ancestor
83281234|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
83281235|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281236|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281237|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83281238|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83281239|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83281240|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83281241|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281242|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281243|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83281244|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
83281245|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
83281246|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83281247|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281248|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83281249|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83281251|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
83281252|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281253|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
83281254|NCT02236520|Spironolactone|spironolactone|mesh-list
83281255|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83281256|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
83281257|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281258|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281259|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83281260|NCT02236520|Diuretics|diuretics|mesh-ancestor
83281261|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
83281262|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83281263|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83281264|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281265|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281266|NCT04769414|Gemcitabine|gemcitabine|mesh-list
83281267|NCT04769414|Fluorouracil|fluorouracil|mesh-list
83281268|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83281269|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
83281270|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281271|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281272|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83281273|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
83281274|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281275|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
83281276|NCT01922271|Albuterol|albuterol|mesh-list
83281277|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
83281278|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83281279|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
83281280|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281281|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281282|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83281283|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
83281284|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
83281285|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83281286|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
83281287|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281288|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281289|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
83281290|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83281291|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83281292|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83281293|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83281294|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
83281295|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83281296|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83281297|NCT02236130|Acetaminophen|acetaminophen|mesh-list
83281298|NCT02236130|Morphine|morphine|mesh-list
83281299|NCT02236130|Hydrocodone|hydrocodone|mesh-list
83281300|NCT02236130|Analgesics|analgesics|mesh-list
83281301|NCT02236130|Anesthetics|anesthetics|mesh-list
83281302|NCT02236130|Ropivacaine|ropivacaine|mesh-list
83281303|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
83281304|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281305|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281306|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83281307|NCT02236130|Narcotics|narcotics|mesh-ancestor
83281308|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
83281309|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281310|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83281311|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
83281312|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
83281313|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
83281314|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83281315|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83281316|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83281317|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
83281318|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83281319|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281320|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83281321|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83281322|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83281323|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83281324|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83281325|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83281326|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83281327|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83281328|NCT01641809|Tenofovir|tenofovir|mesh-list
83281329|NCT01641809|Lamivudine|lamivudine|mesh-list
83281330|NCT01641809|Emtricitabine|emtricitabine|mesh-list
83281331|NCT01641809|Efavirenz|efavirenz|mesh-list
83281332|NCT01641809|Abacavir|abacavir|mesh-list
83281333|NCT01641809|Rilpivirine|rilpivirine|mesh-list
83281334|NCT01641809|Cabotegravir|cabotegravir|mesh-list
83281335|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
83281336|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281337|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83281338|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83281339|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281340|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281341|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83281342|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83281343|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83281344|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83281345|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83281346|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83281347|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83281348|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83281349|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83281350|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83281351|NCT01632566|Celecoxib|celecoxib|mesh-list
83281352|NCT01632566|Simvastatin|simvastatin|mesh-list
83281353|NCT01632566|LY3031207|ly3031207|mesh-list
83281354|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83281355|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83281356|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
83281357|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281358|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83281359|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83281360|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281361|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83281362|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83281363|NCT01632566|Analgesics|analgesics|mesh-ancestor
83281364|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
83281365|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281366|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281367|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83281368|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83281369|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83281370|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83281371|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
83281372|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
83281373|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281374|NCT02254304|Interferons|interferons|mesh-list
83281375|NCT02254304|Interferon-beta|interferon-beta|mesh-list
83281376|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
83281377|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281378|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
83281379|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281380|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
83281381|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281382|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83281383|NCT05650151|Vitamin D|vitamin d|mesh-list
83281384|NCT05650151|Vitamins|vitamins|mesh-ancestor
83281385|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
83281386|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281387|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83281388|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
83281389|NCT02174731|Hematinics|hematinics|mesh-ancestor
83281390|NCT01922037|Omalizumab|omalizumab|mesh-list
83281391|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83281392|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83281393|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
83281394|NCT02282813|Calcitriol|calcitriol|mesh-list
83281395|NCT02282813|Calcifediol|calcifediol|mesh-list
83281396|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
83281397|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83281398|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281399|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83281400|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281401|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281402|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83281403|NCT02282813|Vitamins|vitamins|mesh-ancestor
83281404|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
83281405|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83281406|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
83281407|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
83281408|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281409|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83281410|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83281411|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281412|NCT04859465|Doxorubicin|doxorubicin|mesh-list
83281413|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83281414|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83281415|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83281416|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281417|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83281418|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83281419|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281420|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281421|NCT02121847|Cyclosporine|cyclosporine|mesh-list
83281422|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83281423|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83281424|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
83281425|NCT02121847|Cyclosporins|cyclosporins|mesh-list
83281426|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281427|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281428|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83281429|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
83281430|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281431|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
83281432|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281433|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
83281434|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83281435|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83281436|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83281437|NCT02121847|Laxatives|laxatives|mesh-ancestor
83281438|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83281439|NCT01586806|Dexamethasone|dexamethasone|mesh-list
83281440|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
83281441|NCT01586806|Bupivacaine|bupivacaine|mesh-list
83281442|NCT01586806|BB 1101|bb 1101|mesh-list
83281443|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83281444|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
83281445|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
83281446|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281447|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281448|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83281449|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
83281450|NCT01586806|Hormones|hormones|mesh-ancestor
83281451|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281452|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83281453|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281454|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
83281455|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281456|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281457|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
83281458|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
83281459|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281460|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
83281461|NCT05631041|Silymarin|silymarin|mesh-list
83281462|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
83430125|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281463|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281464|NCT05631041|Protective Agents|protective agents|mesh-ancestor
83281465|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281466|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83281467|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83281468|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83281469|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
83281470|NCT05544071|Sertraline|sertraline|mesh-list
83281471|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
83281472|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83281473|NCT05544071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83281474|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83281475|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281476|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281477|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281478|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
83281479|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281480|NCT02143843|Bimatoprost|bimatoprost|mesh-list
83281481|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83281482|NCT05598905|Pregabalin|pregabalin|mesh-list
83281483|NCT05598905|Lacosamide|lacosamide|mesh-list
83281484|NCT05598905|Oxycodone|oxycodone|mesh-list
83281485|NCT05598905|Analgesics|analgesics|mesh-ancestor
83281486|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
83281487|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281488|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281489|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
83281490|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83281491|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281492|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281493|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83281494|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83281495|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83281496|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281497|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83281498|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83281499|NCT05598905|Narcotics|narcotics|mesh-ancestor
83281500|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83281501|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83281502|NCT01586338|Hylan|hylan|mesh-list
83281503|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
83281504|NCT01586338|Protective Agents|protective agents|mesh-ancestor
83281505|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281506|NCT02143141|Morphine|morphine|mesh-list
83281507|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83281508|NCT02143141|Narcotics|narcotics|mesh-ancestor
83281509|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281510|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281511|NCT02143141|Analgesics|analgesics|mesh-ancestor
83281512|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
83281513|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281514|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
83281515|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83281516|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83281517|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83281518|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
83281519|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281520|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281521|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281522|NCT05497583|Factor VIII|factor viii|mesh-list
83281523|NCT05497583|Coagulants|coagulants|mesh-ancestor
83281524|NCT02253992|Nivolumab|nivolumab|mesh-list
83281525|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83281526|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281527|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83281528|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281529|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
83281530|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83281531|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281532|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
83281533|NCT01585558|Tamoxifen|tamoxifen|mesh-list
83281534|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83281535|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
83281536|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281537|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281538|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83281539|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281540|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83281541|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83281542|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83281543|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
83281544|NCT01585246|Urological Agents|urological agents|mesh-ancestor
83281545|NCT01585168|Memantine|memantine|mesh-list
83281546|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83281547|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83281548|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
83281549|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281550|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281551|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281552|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83281553|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83281554|NCT02252042|Docetaxel|docetaxel|mesh-list
83281555|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
83281556|NCT02252042|Methotrexate|methotrexate|mesh-list
83281557|NCT02252042|Cetuximab|cetuximab|mesh-list
83281558|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281559|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
83281560|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
83281561|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
83281562|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281563|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83281564|NCT02252042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83281565|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83281566|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
83281567|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83281568|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281569|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83281570|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
83281571|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
83281572|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281573|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83281574|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83281575|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
83281576|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83281577|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83281578|NCT02231918|Pramipexole|pramipexole|mesh-list
83281579|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
83281580|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281581|NCT02231918|Protective Agents|protective agents|mesh-ancestor
83281582|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281583|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83281584|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83281585|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
83281586|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
83281587|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281588|NCT02199314|Desflurane|desflurane|mesh-list
83281589|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83281590|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
83281591|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
83281592|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281593|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281594|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
83281595|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83281596|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83281597|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281598|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
83281599|NCT02199080|Coagulants|coagulants|mesh-ancestor
83281600|NCT02197520|Insulin|insulin|mesh-list
83281601|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83281602|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
83281603|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
83281604|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83281605|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281606|NCT02230904|Rotigotine|rotigotine|mesh-list
83281607|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
83281608|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
83281609|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281610|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281611|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281612|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
83281613|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
83281614|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281615|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281616|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281617|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
83281618|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
83281619|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
83281620|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83281621|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
83281622|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83281623|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83281624|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
83281625|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281626|NCT02228096|Tisagenlecleucel|tisagenlecleucel|mesh-list
83281627|NCT02228096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83281628|NCT02228096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281629|NCT01683994|Prednisone|prednisone|mesh-list
83281630|NCT01683994|Docetaxel|docetaxel|mesh-list
83281631|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281632|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
83281633|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
83281634|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
83281635|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281636|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83281637|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
83281638|NCT01683994|Hormones|hormones|mesh-ancestor
83281639|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281640|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281641|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83281642|NCT02247440|Interferons|interferons|mesh-list
83281643|NCT02247440|Ribavirin|ribavirin|mesh-list
83281644|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281645|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
83281646|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281647|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
83281648|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281649|NCT04844099|Piperaquine|piperaquine|mesh-list
83281650|NCT04844099|Artenimol|artenimol|mesh-list
83281651|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
83281652|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83281653|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83281654|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281655|NCT04857203|Vitamin D|vitamin d|mesh-list
83281656|NCT04857203|Vitamins|vitamins|mesh-ancestor
83281657|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
83281658|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281659|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83281660|NCT05381597|Fluorouracil|fluorouracil|mesh-list
83281661|NCT05381597|Calcipotriene|calcipotriene|mesh-list
83281662|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
83281663|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281664|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83281665|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281666|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83281667|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
83281668|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281669|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
83281670|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
83281671|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83281672|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281673|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281674|NCT05417165|Vaccines|vaccines|mesh-list
83281675|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83281676|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
83281677|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281678|NCT04660643|Tirzepatide|tirzepatide|mesh-list
83281679|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83281680|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281681|NCT04660643|Incretins|incretins|mesh-ancestor
83281682|NCT04660643|Hormones|hormones|mesh-ancestor
83430126|NCT05630768|Vitamin D|vitamin d|mesh-list
83281683|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281684|NCT04659317|Oxycodone|oxycodone|mesh-list
83281685|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83281686|NCT04659317|Narcotics|narcotics|mesh-ancestor
83281687|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281688|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281689|NCT04659317|Analgesics|analgesics|mesh-ancestor
83281690|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
83281691|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281692|NCT03602261|Calcifediol|calcifediol|mesh-list
83281693|NCT03602261|Vitamins|vitamins|mesh-ancestor
83281694|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
83281695|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281696|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83281697|NCT02141659|Relugolix|relugolix|mesh-list
83281698|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
83281699|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
83281700|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281701|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281702|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83281703|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83281704|NCT05422703|Analgesics|analgesics|mesh-list
83281705|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
83281706|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281707|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281708|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
83281709|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83281710|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281711|NCT02120833|Decanoic acid|decanoic acid|mesh-list
83281712|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
83281713|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281715|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
83281716|NCT02170207|Lansoprazole|lansoprazole|mesh-list
83281717|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
83281718|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83281719|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83281720|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83281721|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281722|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281723|NCT02227784|Atorvastatin|atorvastatin|mesh-list
83281724|NCT02227784|Ezetimibe|ezetimibe|mesh-list
83281725|NCT02227784|Evacetrapib|evacetrapib|mesh-list
83281726|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83281727|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83281728|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
83281729|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281730|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83281731|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83281732|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281733|NCT04577417|Methylphenidate|methylphenidate|mesh-list
83281734|NCT04577417|Amphetamine|amphetamine|mesh-list
83281735|NCT04577417|Adderall|adderall|mesh-list
83281736|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
83281737|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83281738|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83281739|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281740|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83281741|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83281742|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281743|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281744|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
83281745|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281746|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
83281747|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
83281748|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281749|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
83281750|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83281751|NCT01683058|Aripiprazole|aripiprazole|mesh-list
83281752|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
83281753|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83281754|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83281755|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83281756|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430127|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
83281757|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281758|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
83281759|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
83281760|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281761|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281762|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83281763|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83281764|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
83281765|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83281766|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83281767|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83281768|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83281769|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
83281770|NCT02193776|Rifampin|rifampin|mesh-list
83281771|NCT02193776|Isoniazid|isoniazid|mesh-list
83281772|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
83281773|NCT02193776|Ethambutol|ethambutol|mesh-list
83281774|NCT02193776|Bedaquiline|bedaquiline|mesh-list
83281775|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83281776|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281777|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83281778|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83281779|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281780|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281781|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281782|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83281783|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
83281784|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
83281785|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83281786|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83281787|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83281788|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83281789|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83281790|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83281791|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83281792|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83281793|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83281794|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
83281795|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83281796|NCT04740697|Tamoxifen|tamoxifen|mesh-list
83281797|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83281798|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
83281799|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281800|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281801|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83281802|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281803|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83281804|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83281805|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83281806|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83281807|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
83281808|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83281809|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83281810|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281811|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281812|NCT04562285|Antibodies|antibodies|mesh-list
83281813|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
83281814|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281815|NCT05344625|Ketamine|ketamine|mesh-list
83281816|NCT05344625|Analgesics|analgesics|mesh-ancestor
83281817|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
83281818|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281819|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281820|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83281821|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83281822|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
83281823|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
83281824|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281825|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83281826|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83281827|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281828|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281829|NCT02169830|Topiramate|topiramate|mesh-list
83281830|NCT02169830|Nortriptyline|nortriptyline|mesh-list
83281831|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
83281832|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83281833|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281834|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83281835|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
83281836|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83281837|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83281838|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83281839|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83281840|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281841|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
83281842|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83281843|NCT04854551|Naltrexone|naltrexone|mesh-list
83281844|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83281845|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83281846|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281847|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
83281848|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281849|NCT04536467|Goserelin|goserelin|mesh-list
83281850|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83281851|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281852|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
83281853|NCT05341349|Nivolumab|nivolumab|mesh-list
83281854|NCT05341349|Ipilimumab|ipilimumab|mesh-list
83281855|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83281856|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281857|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83281858|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281859|NCT04530149|Acetaminophen|acetaminophen|mesh-list
83281860|NCT04530149|Bupivacaine|bupivacaine|mesh-list
83281861|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
83281862|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
83281863|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83281864|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281865|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
83281866|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83281867|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83281868|NCT04530149|Analgesics|analgesics|mesh-ancestor
83281869|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
83281870|NCT04525547|Nintedanib|nintedanib|mesh-list
83281871|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281872|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83281873|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281874|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281875|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83281876|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281877|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83281878|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281879|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281880|NCT02119819|Metformin|metformin|mesh-list
83281881|NCT02119819|Exenatide|exenatide|mesh-list
83281882|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83281883|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281884|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83281885|NCT02119819|Incretins|incretins|mesh-ancestor
83281886|NCT02119819|Hormones|hormones|mesh-ancestor
83281887|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83281888|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
83281889|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83281890|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
83281891|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281892|NCT04766450|Expectorants|expectorants|mesh-ancestor
83281893|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
83281894|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83281895|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
83281896|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281897|NCT04766450|Protective Agents|protective agents|mesh-ancestor
83281898|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281899|NCT04766450|Antidotes|antidotes|mesh-ancestor
83281900|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
83281901|NCT02168816|Metronidazole|metronidazole|mesh-list
83281902|NCT02168816|Vancomycin|vancomycin|mesh-list
83281903|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
83281904|NCT02168816|Clindamycin|clindamycin|mesh-list
83281905|NCT02168816|Meropenem|meropenem|mesh-list
83281906|NCT02168816|Linezolid|linezolid|mesh-list
83281907|NCT02168816|Tazobactam|tazobactam|mesh-list
83281908|NCT02168816|Piperacillin|piperacillin|mesh-list
83281909|NCT02168816|Daptomycin|daptomycin|mesh-list
83281910|NCT02168816|Cefepime|cefepime|mesh-list
83281911|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83281912|NCT02168816|Aztreonam|aztreonam|mesh-list
83281913|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83281914|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83281915|NCT02168816|Trimethoprim|trimethoprim|mesh-list
83281916|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
83281917|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83281918|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83281919|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83281920|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281921|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281922|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281923|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83281924|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83281925|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83281926|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83281927|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83281928|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83281929|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83281930|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
83281931|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83281932|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83281933|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83281934|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
83281935|NCT01584232|Dulaglutide|dulaglutide|mesh-list
83281936|NCT01584232|Biguanides|biguanides|mesh-list
83281937|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83281938|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281939|NCT02119663|Capecitabine|capecitabine|mesh-list
83281940|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83281941|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
83281942|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281943|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281944|NCT04481009|Paclitaxel|paclitaxel|mesh-list
83281945|NCT04481009|Gemcitabine|gemcitabine|mesh-list
83281946|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83281947|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281948|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83281949|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83281950|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83281951|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281952|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83281953|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
83281954|NCT05327231|Docetaxel|docetaxel|mesh-list
83281955|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281956|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
83281957|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
83281958|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
83281959|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281960|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
83281961|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281962|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281963|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
83281964|NCT01628107|Hematinics|hematinics|mesh-ancestor
83281965|NCT04745377|Antibodies|antibodies|mesh-list
83281966|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
83281967|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281968|NCT01583530|Belimumab|belimumab|mesh-list
83281969|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83281970|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
83281971|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281972|NCT01639001|Carboplatin|carboplatin|mesh-list
83281973|NCT01639001|Pemetrexed|pemetrexed|mesh-list
83281974|NCT01639001|Crizotinib|crizotinib|mesh-list
83281975|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281976|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281977|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281978|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83281979|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83281980|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83281981|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
83281982|NCT02168270|Temozolomide|temozolomide|mesh-list
83281983|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83281984|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
83281985|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281986|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281987|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
83281988|NCT02168270|Protective Agents|protective agents|mesh-ancestor
83281989|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83281990|NCT02168270|Vitamins|vitamins|mesh-ancestor
83281991|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
83281992|NCT02167256|Saracatinib|saracatinib|mesh-list
83281993|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83281994|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83281995|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83281996|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83281997|NCT02166476|Levofloxacin|levofloxacin|mesh-list
83281998|NCT02166476|Meropenem|meropenem|mesh-list
83281999|NCT02166476|Tazobactam|tazobactam|mesh-list
83282000|NCT02166476|Piperacillin|piperacillin|mesh-list
83282001|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83282002|NCT02166476|Vaborbactam|vaborbactam|mesh-list
83282003|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83282004|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282005|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83282006|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83282007|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83282008|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282009|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282010|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282011|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83282012|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83282013|NCT02224274|Clopidogrel|clopidogrel|mesh-list
83282014|NCT02224274|Ticagrelor|ticagrelor|mesh-list
83282015|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83282016|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83282017|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83282018|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83282019|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
83282020|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282021|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282022|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282023|NCT05219669|Nalmefene|nalmefene|mesh-list
83282024|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83282025|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282026|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
83282027|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282028|NCT04837859|Tislelizumab|tislelizumab|mesh-list
83282029|NCT04837859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282030|NCT04837859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282031|NCT04763252|Coal Tar|coal tar|mesh-list
83282032|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
83282033|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
83282034|NCT05369039|Prednisolone|prednisolone|mesh-list
83282035|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282036|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
83282037|NCT05369039|Hormones|hormones|mesh-ancestor
83282038|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282039|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282040|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83282041|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282043|NCT04373369|Vorolanib|vorolanib|mesh-list
83282044|NCT04373369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83282045|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282046|NCT04373369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282047|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282048|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83282049|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282050|NCT04285853|Oxycodone|oxycodone|mesh-list
83282051|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83282052|NCT04285853|Narcotics|narcotics|mesh-ancestor
83282053|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282054|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282055|NCT04285853|Analgesics|analgesics|mesh-ancestor
83282056|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
83282057|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282058|NCT04791059|Sufentanil|sufentanil|mesh-list
83282059|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
83282060|NCT04791059|Ketamine|ketamine|mesh-list
83282061|NCT04791059|Esketamine|esketamine|mesh-list
83282062|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83282063|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282064|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282065|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83282066|NCT04791059|Analgesics|analgesics|mesh-ancestor
83282067|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
83282068|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282069|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83282070|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83282071|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83282072|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
83282073|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282074|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282075|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83282076|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83282077|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
83282078|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
83282079|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83282080|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83282081|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83282082|NCT04791059|Narcotics|narcotics|mesh-ancestor
83282083|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83282084|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
83282085|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83282086|NCT05398913|Rimonabant|rimonabant|mesh-list
83282087|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83282088|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83282089|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83282090|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282091|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282092|NCT05398913|Hormones|hormones|mesh-ancestor
83282093|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282094|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282095|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83282096|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83282097|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83282098|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282099|NCT01583374|Thalidomide|thalidomide|mesh-list
83282100|NCT01583374|Apremilast|apremilast|mesh-list
83282101|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83282102|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83282103|NCT01583374|Analgesics|analgesics|mesh-ancestor
83282104|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
83282105|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282106|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282107|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282108|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83282109|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83282110|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83282111|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282112|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282113|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282114|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
83282115|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
83282116|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83282117|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282118|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83282119|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83282120|NCT01583374|Growth Substances|growth substances|mesh-ancestor
83282121|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
83282122|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282123|NCT04245215|Ustekinumab|ustekinumab|mesh-list
83282124|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
83282125|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
83282126|NCT05387759|Aticaprant|aticaprant|mesh-list
83282127|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83282128|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282129|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83282130|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83282131|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282132|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282133|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282134|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282135|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83282136|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
83282137|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282138|NCT02222714|Protein C|protein c|mesh-list
83282139|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
83282140|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83282141|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83282142|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282143|NCT04809311|Insulin|insulin|mesh-list
83282144|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83282145|NCT04809311|Glucagon|glucagon|mesh-list
83282146|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83282147|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83282148|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282149|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83282150|NCT04809311|Hormones|hormones|mesh-ancestor
83282151|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282152|NCT04809311|Incretins|incretins|mesh-ancestor
83282153|NCT04145219|Immunomodulating Agents|immunomodulating agents|mesh-list
83282154|NCT04145219|Immunologic Factors|immunologic factors|mesh-ancestor
83282155|NCT04145219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282156|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
83282157|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282158|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282159|NCT03184571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83282160|NCT03184571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282161|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83282162|NCT02164916|Cetuximab|cetuximab|mesh-list
83282163|NCT02164916|Irinotecan|irinotecan|mesh-list
83282164|NCT02164916|Camptothecin|camptothecin|mesh-list
83282165|NCT02164916|Vemurafenib|vemurafenib|mesh-list
83282172|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282173|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282174|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83282175|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83282176|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282177|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282178|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
83282179|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83282180|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83282181|NCT04091867|Cetuximab|cetuximab|mesh-list
83282182|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282183|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282184|NCT04060277|Acetic Acid|acetic acid|mesh-list
83282185|NCT04060277|Letermovir|letermovir|mesh-list
83282186|NCT04060277|Vaccines|vaccines|mesh-list
83282187|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
83282188|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282189|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83282190|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282191|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282192|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282193|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282194|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83282195|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
83282196|NCT05651789|Propranolol|propranolol|mesh-list
83282197|NCT05651789|Carvedilol|carvedilol|mesh-list
83282198|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83282199|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83282200|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
83282201|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282202|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282203|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282204|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83282205|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83282206|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
83282207|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
83282208|NCT05651789|Protective Agents|protective agents|mesh-ancestor
83282209|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83282210|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282211|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83282212|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83282213|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83282214|NCT02999477|Paclitaxel|paclitaxel|mesh-list
83282215|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
83282216|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83282217|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282218|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83282219|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83282220|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83282221|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282222|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282223|NCT02999477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83282224|NCT02222558|Testosterone|testosterone|mesh-list
83282225|NCT02222558|Androgens|androgens|mesh-ancestor
83282226|NCT02222558|Hormones|hormones|mesh-ancestor
83282227|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282228|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282229|NCT02975999|Vasopressins|vasopressins|mesh-list
83282230|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
83282231|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
83282232|NCT02975999|Coagulants|coagulants|mesh-ancestor
83282233|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83282234|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83282235|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
83282236|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282253|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83282254|NCT02222246|Narcotics|narcotics|mesh-ancestor
83282255|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282256|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282257|NCT02222246|Analgesics|analgesics|mesh-ancestor
83282258|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
83282259|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282260|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83282261|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83282262|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
83282263|NCT04013555|Tryptophan|tryptophan|mesh-list
83282264|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83282265|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
83282266|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282267|NCT04013555|Expectorants|expectorants|mesh-ancestor
83282268|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
83282269|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83282270|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
83282271|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282272|NCT04013555|Protective Agents|protective agents|mesh-ancestor
83282273|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282274|NCT04013555|Antidotes|antidotes|mesh-ancestor
83282275|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83282276|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
83282277|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83282278|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
83282279|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
83282280|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282281|NCT02220920|Canagliflozin|canagliflozin|mesh-list
83282282|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83282283|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282284|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83282285|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282286|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
83282287|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
83282288|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
83282289|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282290|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282291|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83282292|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83282293|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83282294|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282295|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83282296|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83282297|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
83282298|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282299|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282300|NCT03943901|Prednisone|prednisone|mesh-list
83282301|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
83282302|NCT03943901|Rituximab|rituximab|mesh-list
83282303|NCT03943901|Doxorubicin|doxorubicin|mesh-list
83282304|NCT03943901|Vincristine|vincristine|mesh-list
83282305|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282306|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
83282307|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282308|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83282309|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83282310|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
83282311|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282312|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282313|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83282314|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282315|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83282316|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83282317|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83282318|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282319|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282320|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
83282321|NCT03943901|Hormones|hormones|mesh-ancestor
83282322|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282323|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83282324|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83282325|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
83282326|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
83282327|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83282328|NCT04790279|Amlodipine|amlodipine|mesh-list
83282329|NCT04790279|Nifedipine|nifedipine|mesh-list
83282330|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83282331|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83282332|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282333|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282334|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83282335|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282336|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
83282337|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
83282338|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83282339|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83282340|NCT03877289|Oxybutynin|oxybutynin|mesh-list
83282341|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282342|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
83282343|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
83282344|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282345|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282346|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83282347|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83282348|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
83282349|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282350|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282351|NCT03877289|Urological Agents|urological agents|mesh-ancestor
83282352|NCT05554679|Metformin|metformin|mesh-list
83282353|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83282354|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282355|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
83282356|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83282357|NCT05494619|Antibodies|antibodies|mesh-list
83282358|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
83282359|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83282360|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
83282361|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282362|NCT01583218|Enoxaparin|enoxaparin|mesh-list
83282363|NCT01583218|Betrixaban|betrixaban|mesh-list
83282364|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
83282365|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83282366|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83282367|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282368|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83282369|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
83282370|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83282371|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
83282372|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282373|NCT01634555|Leucovorin|leucovorin|mesh-list
83282374|NCT01634555|Folic Acid|folic acid|mesh-list
83282375|NCT01634555|Fluorouracil|fluorouracil|mesh-list
83282376|NCT01634555|Irinotecan|irinotecan|mesh-list
83282377|NCT01634555|Ramucirumab|ramucirumab|mesh-list
83282378|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
83282379|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
83282380|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282381|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83282382|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282383|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282384|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
83282385|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282386|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83282387|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83282388|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282389|NCT01634555|Antidotes|antidotes|mesh-ancestor
83282390|NCT01634555|Protective Agents|protective agents|mesh-ancestor
83282391|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
83282392|NCT01634555|Vitamins|vitamins|mesh-ancestor
83282393|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
83282394|NCT01634555|Hematinics|hematinics|mesh-ancestor
83282395|NCT05355155|Bevacizumab|bevacizumab|mesh-list
83282396|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282397|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282398|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83282399|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83282400|NCT05355155|Growth Substances|growth substances|mesh-ancestor
83282401|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282402|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
83282403|NCT01634243|Rotigotine|rotigotine|mesh-list
83282404|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
83282405|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
83282406|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282407|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282408|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282409|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
83282410|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83282411|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83282412|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83282413|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83282414|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
83282415|NCT04104646|Morphine|morphine|mesh-list
83282416|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83282417|NCT04104646|Narcotics|narcotics|mesh-ancestor
83282418|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282419|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282420|NCT04104646|Analgesics|analgesics|mesh-ancestor
83282421|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
83282422|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282423|NCT04814615|Daratumumab|daratumumab|mesh-list
83282424|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282425|NCT03800693|Leucovorin|leucovorin|mesh-list
83282426|NCT03800693|Fluorouracil|fluorouracil|mesh-list
83282427|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
83282428|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
83282429|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282430|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83282431|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282432|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282433|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
83282434|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282435|NCT03800693|Antidotes|antidotes|mesh-ancestor
83282436|NCT03800693|Protective Agents|protective agents|mesh-ancestor
83282437|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
83282438|NCT03800693|Vitamins|vitamins|mesh-ancestor
83282439|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
83282440|NCT04814537|Bupivacaine|bupivacaine|mesh-list
83282441|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
83282442|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
83282443|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282444|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282445|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
83282446|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282447|NCT01582282|Psyllium|psyllium|mesh-list
83282448|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
83282449|NCT01582282|Cathartics|cathartics|mesh-ancestor
83282450|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83282451|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
83282452|NCT01599650|Ranibizumab|ranibizumab|mesh-list
83282453|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83282454|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83282455|NCT01599650|Growth Substances|growth substances|mesh-ancestor
83282456|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282457|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
83282458|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282459|NCT03774875|Apremilast|apremilast|mesh-list
83282460|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83282461|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83282462|NCT03774875|Analgesics|analgesics|mesh-ancestor
83282463|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
83282464|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282465|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282466|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282467|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83282468|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83282469|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83282470|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282471|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282473|NCT01563172|Fluorides|fluorides|mesh-list
83282474|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
83282475|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
83282476|NCT01563172|Protective Agents|protective agents|mesh-ancestor
83282477|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282478|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83282479|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282480|NCT04755764|Atenolol|atenolol|mesh-list
83282481|NCT04755764|Labetalol|labetalol|mesh-list
83282482|NCT04755764|Nifedipine|nifedipine|mesh-list
83282483|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83282484|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282485|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282486|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83282487|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282488|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
83282489|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
83282490|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83282491|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83282492|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83282493|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
83282494|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
83282495|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282496|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83282497|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83282498|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83282499|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
83282500|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282501|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
83282502|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83282503|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83282504|NCT04113616|Cytarabine|cytarabine|mesh-list
83282505|NCT04113616|Decitabine|decitabine|mesh-list
83282506|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83282507|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
83282508|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282509|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282510|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
83282511|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282512|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282513|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
83282514|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282515|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282516|NCT03774641|Lamotrigine|lamotrigine|mesh-list
83282517|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
83282518|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83282519|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282520|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282521|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83282522|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282523|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83282524|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83282525|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282526|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83282527|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83282528|NCT02161718|Olanzapine|olanzapine|mesh-list
83282529|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
83282530|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
83282531|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282532|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282533|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83282534|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83282535|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83282536|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282537|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83282538|NCT02161718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83282539|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83282540|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282541|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282542|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282543|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
83282544|NCT02074631|Vitamin D|vitamin d|mesh-list
83282545|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
83282546|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
83282547|NCT02074631|Pamidronate|pamidronate|mesh-list
83282548|NCT02074631|Calcium|calcium|mesh-list
83282549|NCT02074631|Vitamins|vitamins|mesh-ancestor
83282550|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
83282551|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282552|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83282553|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83282554|NCT04813991|Ibuprofen|ibuprofen|mesh-list
83282555|NCT04813991|Oxycodone|oxycodone|mesh-list
83282556|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83282557|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83282558|NCT04813991|Analgesics|analgesics|mesh-ancestor
83282559|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
83282560|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282561|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282562|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282563|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83282564|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83282565|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282566|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282567|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83282568|NCT04813991|Narcotics|narcotics|mesh-ancestor
83282569|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282570|NCT03624101|Ivacaftor|ivacaftor|mesh-list
83282571|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83282572|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282573|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282574|NCT02218736|Aticaprant|aticaprant|mesh-list
83282575|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
83282576|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282577|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
83282578|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282579|NCT03623243|Siponimod|siponimod|mesh-list
83282580|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83282581|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282582|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282583|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
83282584|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282585|NCT04801589|Midazolam|midazolam|mesh-list
83282586|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
83282587|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83282588|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282589|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282590|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83282591|NCT04801589|Analgesics|analgesics|mesh-ancestor
83282592|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
83282593|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282594|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83282595|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83282596|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83282597|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
83282598|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282599|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282600|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83282601|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83282602|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83282603|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83282604|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83282605|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
83282606|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
83282607|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
83282608|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
83282609|NCT01580488|Calcitriol|calcitriol|mesh-list
83282610|NCT01580488|Calcipotriene|calcipotriene|mesh-list
83282611|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83282612|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
83282613|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83282614|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282615|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83282616|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282617|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282618|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83282619|NCT01580488|Vitamins|vitamins|mesh-ancestor
83282620|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
83282621|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83282622|NCT01580020|Dexamethasone|dexamethasone|mesh-list
83282623|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282624|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
83282625|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
83282626|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282627|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282628|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83282629|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
83282630|NCT01580020|Hormones|hormones|mesh-ancestor
83282631|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282632|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83282633|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282634|NCT01579318|Interleukin-12|interleukin-12|mesh-list
83282635|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83282636|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
83282637|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282638|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83282639|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83282640|NCT01579318|Growth Substances|growth substances|mesh-ancestor
83282641|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
83282642|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282643|NCT01578850|Etanercept|etanercept|mesh-list
83282644|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83282645|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83282646|NCT01578850|Analgesics|analgesics|mesh-ancestor
83282647|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
83282648|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282649|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282650|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282651|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83282652|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83282653|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282654|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
83282655|NCT01539538|Sufentanil|sufentanil|mesh-list
83282656|NCT01539538|Morphine|morphine|mesh-list
83282657|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83282658|NCT01539538|Narcotics|narcotics|mesh-ancestor
83282659|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282660|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282661|NCT01539538|Analgesics|analgesics|mesh-ancestor
83282662|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
83282663|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282664|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83282665|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83282666|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
83282667|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
83282668|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
83282669|NCT01562548|Guaifenesin|guaifenesin|mesh-list
83282670|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83282671|NCT01562548|Expectorants|expectorants|mesh-ancestor
83282672|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
83282673|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83282674|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83282675|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
83282676|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282677|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282678|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282679|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
83282680|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83282681|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
83282682|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
83282683|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282684|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
83282685|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83282686|NCT03027934|Ticagrelor|ticagrelor|mesh-list
83282687|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83282688|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83282689|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83282690|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83282691|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83282692|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
83282693|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282694|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282695|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282696|NCT01562314|Cannabidiol|cannabidiol|mesh-list
83282697|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
83282698|NCT04112368|Estradiol|estradiol|mesh-list
83282699|NCT04112368|Progesterone|progesterone|mesh-list
83282700|NCT04112368|Estrogens|estrogens|mesh-ancestor
83282701|NCT04112368|Hormones|hormones|mesh-ancestor
83282702|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282703|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282704|NCT04112368|Progestins|progestins|mesh-ancestor
83282705|NCT01539226|Dapivirine|dapivirine|mesh-list
83282706|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83282707|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83282708|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
83282709|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282710|NCT01537120|Vildagliptin|vildagliptin|mesh-list
83282711|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83282712|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282713|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83282714|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83282715|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282716|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282717|NCT01537042|Rotigotine|rotigotine|mesh-list
83282718|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
83282719|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
83282720|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282721|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282722|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282723|NCT01536574|Ropinirole|ropinirole|mesh-list
83282724|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83282725|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83282726|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
83282727|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
83282728|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282729|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282730|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282731|NCT04410094|Itraconazole|itraconazole|mesh-list
83282732|NCT04410094|Rifampin|rifampin|mesh-list
83282733|NCT04410094|Lazertinib|lazertinib|mesh-list
83282734|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
83282735|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282736|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83282737|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83282738|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282739|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282740|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83282741|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
83430128|NCT05630768|Calcium|calcium|mesh-list
83282742|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282743|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282744|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83282745|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83282746|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
83282747|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83282748|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
83282749|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83282750|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83282751|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83282752|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83282753|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83282754|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83282755|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83282756|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83282757|NCT01576042|Amiodarone|amiodarone|mesh-list
83282758|NCT01576042|Sotalol|sotalol|mesh-list
83282759|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83282760|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
83282761|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83282762|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282763|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282764|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83282765|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83282766|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83282767|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282768|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83282769|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83282770|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83282771|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83282772|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83282774|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282775|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282776|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
83282777|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
83282778|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282779|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
83282780|NCT01536262|Olodaterol|olodaterol|mesh-list
83282781|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83282782|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
83282783|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282784|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282785|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83282786|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
83282787|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
83282788|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83282789|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
83282790|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282791|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282792|NCT04102618|Trastuzumab|trastuzumab|mesh-list
83282793|NCT04102618|Atezolizumab|atezolizumab|mesh-list
83282794|NCT04102618|Letrozole|letrozole|mesh-list
83282795|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282796|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282797|NCT04102618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83282798|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282799|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83282800|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83282801|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282802|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83282803|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
83282804|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83282805|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282806|NCT01575028|Bupivacaine|bupivacaine|mesh-list
83282807|NCT01575028|Ropivacaine|ropivacaine|mesh-list
83282808|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
83282809|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
83282810|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282811|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282812|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
83282813|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282814|NCT04963283|Nivolumab|nivolumab|mesh-list
83282815|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282816|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282817|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83282818|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282819|NCT04443569|Lidocaine|lidocaine|mesh-list
83282820|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
83282821|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
83282822|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83282823|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282824|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
83282825|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282826|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83282827|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83282828|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83282829|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282830|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282831|NCT01792583|Modafinil|modafinil|mesh-list
83282832|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83282833|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282834|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83282835|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83282836|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83282837|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282838|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
83282839|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282840|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282841|NCT04691375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83282842|NCT04691375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282843|NCT03508895|Caseins|caseins|mesh-list
83282844|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
83282845|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
83282846|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282847|NCT03507491|Paclitaxel|paclitaxel|mesh-list
83282848|NCT03507491|Gemcitabine|gemcitabine|mesh-list
83282849|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83282850|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282851|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
83282852|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
83282853|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
83282854|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282855|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83282856|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
83282857|NCT04566653|Calcium|calcium|mesh-list
83282858|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
83282859|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83282860|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282861|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
83282862|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
83282863|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282864|NCT04521569|Regadenoson|regadenoson|mesh-list
83282865|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83282866|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83282867|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
83282868|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
83282869|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282870|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282871|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282872|NCT01574716|Gemcitabine|gemcitabine|mesh-list
83282873|NCT01574716|Docetaxel|docetaxel|mesh-list
83282874|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83282875|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
83282876|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282877|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282878|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
83282879|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
83282880|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
83282882|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83282883|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83282884|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83282885|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
83282886|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
83282887|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282888|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
83282889|NCT01559116|Olodaterol|olodaterol|mesh-list
83282890|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83282891|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
83282892|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282893|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282894|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83282895|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
83282896|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
83282897|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83282898|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
83282899|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282900|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282901|NCT01574326|Sevelamer|sevelamer|mesh-list
83282902|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
83282903|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
83282904|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282905|NCT01574248|Icatibant|icatibant|mesh-list
83282906|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83282907|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83282908|NCT01574248|Analgesics|analgesics|mesh-ancestor
83282909|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
83282910|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282911|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282912|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83282913|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83282914|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83282915|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83282916|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282917|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83282918|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282919|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
83282920|NCT04761094|Insulin|insulin|mesh-list
83282921|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83282922|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282923|NCT01557946|Citalopram|citalopram|mesh-list
83282924|NCT01557946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83282925|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83282926|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83282927|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282928|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282929|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
83282930|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282931|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83282932|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
83282933|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83282934|NCT01534078|Doxorubicin|doxorubicin|mesh-list
83282935|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83282936|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83282937|NCT01534078|Dacarbazine|dacarbazine|mesh-list
83282938|NCT01534078|Vinblastine|vinblastine|mesh-list
83282939|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83282940|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282941|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83282942|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83282943|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83282944|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282945|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282946|NCT01534078|Immunotoxins|immunotoxins|mesh-ancestor
83282947|NCT01534078|Immunoconjugates|immunoconjugates|mesh-ancestor
83282948|NCT01534078|Immunologic Factors|immunologic factors|mesh-ancestor
83282949|NCT01534078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282950|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83282951|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
83282952|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83282953|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
83282954|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
83282955|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
83282956|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
83282957|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83282958|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282959|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
83282960|NCT02161406|Abatacept|abatacept|mesh-list
83282961|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83282962|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282963|NCT02161406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83282964|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282965|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83282966|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
83282967|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282968|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83282969|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
83282970|NCT01573000|Antibodies|antibodies|mesh-list
83282971|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
83282972|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
83282973|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282974|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83282975|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
83282976|NCT01572844|Antidotes|antidotes|mesh-ancestor
83282977|NCT01572844|Protective Agents|protective agents|mesh-ancestor
83282978|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282979|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
83282980|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282981|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
83282982|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83282983|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83282984|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
83282985|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
83282986|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
83282987|NCT01533922|Olodaterol|olodaterol|mesh-list
83282988|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83282989|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
83282990|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83282991|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83282992|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83282993|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
83282994|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
83282995|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83282996|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
83282997|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83282998|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83282999|NCT01533688|Bisacodyl|bisacodyl|mesh-list
83283000|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83283001|NCT01533688|Cathartics|cathartics|mesh-ancestor
83283002|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83283003|NCT01533688|Laxatives|laxatives|mesh-ancestor
83283004|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
83283005|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
83283006|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283007|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83283008|NCT02217878|Morphine|morphine|mesh-list
83283009|NCT02217878|Ticagrelor|ticagrelor|mesh-list
83283010|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83283011|NCT02217878|Narcotics|narcotics|mesh-ancestor
83283012|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283013|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283014|NCT02217878|Analgesics|analgesics|mesh-ancestor
83283015|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
83283016|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283017|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83283018|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83283019|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83283020|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83283021|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
83283022|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430129|NCT05630768|Vitamins|vitamins|mesh-ancestor
83283023|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283024|NCT02217566|Prednisone|prednisone|mesh-list
83283025|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
83283026|NCT02217566|Androgens|androgens|mesh-list
83283027|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283028|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
83283029|NCT02217566|Hormones|hormones|mesh-ancestor
83283030|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283031|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283032|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83283033|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283034|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83283035|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283036|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283037|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
83283038|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83283039|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
83283040|NCT02217410|Tacrolimus|tacrolimus|mesh-list
83283041|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283042|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
83283043|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283044|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83283045|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283046|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283047|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83283048|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283049|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83283050|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
83283051|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83283052|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283053|NCT02217332|Pramipexole|pramipexole|mesh-list
83283054|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
83283055|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283056|NCT02217332|Protective Agents|protective agents|mesh-ancestor
83283057|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283058|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83283059|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83283060|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
83283061|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
83283062|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283063|NCT02184572|Vaccines|vaccines|mesh-list
83283064|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
83283065|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283066|NCT04755218|Misoprostol|misoprostol|mesh-list
83283067|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83283069|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83283070|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283071|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83283072|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83283073|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
83283074|NCT02181842|Pioglitazone|pioglitazone|mesh-list
83283075|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83283076|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283077|NCT01632020|Metformin|metformin|mesh-list
83283078|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83283079|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283080|NCT02181296|Ropivacaine|ropivacaine|mesh-list
83283081|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83283082|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
83283083|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283084|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283085|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
83283086|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283087|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
83283088|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
83283089|NCT02158442|Ticarcillin|ticarcillin|mesh-list
83283090|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83283091|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283092|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283093|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83283094|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283095|NCT02158364|Vaccines|vaccines|mesh-list
83283096|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
83283097|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283098|NCT02180672|Fluticasone|fluticasone|mesh-list
83283099|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283100|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83283101|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
83283102|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283103|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283104|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83283105|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
83283106|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283107|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83283108|NCT01920711|Valsartan|valsartan|mesh-list
83413605|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283109|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83283110|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83283111|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83283112|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83283113|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283114|NCT02180438|Tenofovir|tenofovir|mesh-list
83283115|NCT02180438|Emtricitabine|emtricitabine|mesh-list
83283116|NCT02180438|Cobicistat|cobicistat|mesh-list
83283117|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83283118|NCT02180438|Elvitegravir|elvitegravir|mesh-list
83283119|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
83283120|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283121|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83283122|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83283123|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283124|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283125|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83283126|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83283127|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83283128|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83283129|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83283130|NCT02157116|Docetaxel|docetaxel|mesh-list
83283131|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283132|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
83283133|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
83283134|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
83283135|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283136|NCT01920555|Midazolam|midazolam|mesh-list
83283137|NCT01920555|Ketamine|ketamine|mesh-list
83283138|NCT01920555|Analgesics|analgesics|mesh-ancestor
83283139|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
83283140|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283141|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283142|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83283143|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83283144|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
83283145|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
83283146|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283147|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83283148|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83283149|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283150|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283151|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83283152|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83283153|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83283154|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83283155|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83283156|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
83283157|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
83283158|NCT02156804|Nivolumab|nivolumab|mesh-list
83283159|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83283160|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283161|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83283162|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283163|NCT02156492|Atorvastatin|atorvastatin|mesh-list
83283164|NCT02156492|Simvastatin|simvastatin|mesh-list
83283165|NCT02156492|Evacetrapib|evacetrapib|mesh-list
83283166|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83283167|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83283168|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
83430130|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
83283169|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283170|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83283171|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83283172|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283173|NCT04753970|Cilostazol|cilostazol|mesh-list
83283174|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83283175|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
83283176|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283177|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283178|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83283179|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83283180|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83283181|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83283182|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283183|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83283184|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
83283185|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83283186|NCT04753970|Protective Agents|protective agents|mesh-ancestor
83283187|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83283188|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83283189|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283190|NCT01920477|Ofatumumab|ofatumumab|mesh-list
83283191|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283192|NCT04641195|Vitamin D|vitamin d|mesh-list
83283193|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
83283194|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
83283195|NCT04641195|Vitamins|vitamins|mesh-list
83283196|NCT04641195|Zinc|zinc|mesh-list
83283197|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
83283198|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283199|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83283200|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83283201|NCT04641195|Trace Elements|trace elements|mesh-ancestor
83283202|NCT02213042|Trastuzumab|trastuzumab|mesh-list
83283203|NCT02213042|Lapatinib|lapatinib|mesh-list
83283204|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83283205|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83283206|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283207|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83283208|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283209|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283210|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83283211|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83283212|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
83283213|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283214|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283215|NCT04418180|Fenofibrate|fenofibrate|mesh-list
83283216|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83283217|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
83283218|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283219|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83283220|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
83283221|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83283222|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283223|NCT02212730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83283224|NCT02212730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283225|NCT02178956|Paclitaxel|paclitaxel|mesh-list
83283226|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83283227|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283228|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
83283229|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
83283230|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
83283231|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283232|NCT02211638|Candesartan|candesartan|mesh-list
83283233|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
83283234|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83283235|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83283236|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83283237|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283238|NCT02178566|Treprostinil|treprostinil|mesh-list
83283239|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83283240|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
83283241|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283242|NCT01631864|Amlodipine|amlodipine|mesh-list
83283243|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83283244|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83283245|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83283246|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83283247|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283248|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83283249|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283250|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
83283251|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83283252|NCT01557244|Fesoterodine|fesoterodine|mesh-list
83283253|NCT01557244|Oxybutynin|oxybutynin|mesh-list
83283254|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83283255|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83283256|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
83283257|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283258|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283259|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283260|NCT01557244|Urological Agents|urological agents|mesh-ancestor
83283261|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
83283262|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
83283263|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283264|NCT02177942|Micronutrients|micronutrients|mesh-list
83283265|NCT02177942|Trace Elements|trace elements|mesh-list
83283266|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283267|NCT02155322|Interferons|interferons|mesh-list
83283268|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
83283269|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
83283270|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83283271|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283272|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
83283273|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283274|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
83283275|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283276|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83283277|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83283278|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83283279|NCT02209454|Analgesics|analgesics|mesh-ancestor
83283280|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
83283281|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283282|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283283|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283284|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283285|NCT01557166|Liraglutide|liraglutide|mesh-list
83283286|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83283287|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283288|NCT01557166|Incretins|incretins|mesh-ancestor
83283289|NCT01557166|Hormones|hormones|mesh-ancestor
83283290|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283291|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
83283292|NCT01556932|Promethazine|promethazine|mesh-list
83283293|NCT01556932|Lorazepam|lorazepam|mesh-list
83283294|NCT01556932|Haloperidol|haloperidol|mesh-list
83283295|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83283296|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83283297|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283298|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283299|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
83283300|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
83283301|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
83283302|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283303|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
83283304|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
83283305|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83283306|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83283307|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
83283308|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
83283309|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283310|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283311|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83283312|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
83283313|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283314|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83283315|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83283316|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83283317|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83283318|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
83283319|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83283320|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
83283321|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83283322|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
83283323|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
83283324|NCT02985736|Desoximetasone|desoximetasone|mesh-list
83283325|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283326|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
83283327|NCT02985736|Hormones|hormones|mesh-ancestor
83283328|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283329|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283330|NCT02985658|Cisplatin|cisplatin|mesh-list
83283331|NCT02985658|Vinorelbine|vinorelbine|mesh-list
83283332|NCT02985658|Veliparib|veliparib|mesh-list
83283333|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283334|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83283335|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
83283336|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
83283337|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
83283338|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283339|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83283340|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283341|NCT02177786|Selonsertib|selonsertib|mesh-list
83283342|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83283343|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283344|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283345|NCT02153918|Metronidazole|metronidazole|mesh-list
83283346|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283347|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83283348|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83283349|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83283350|NCT04752566|Eculizumab|eculizumab|mesh-list
83283351|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83283352|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283353|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
83283354|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283355|NCT01571362|Naltrexone|naltrexone|mesh-list
83283356|NCT01571362|Oxycodone|oxycodone|mesh-list
83283357|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83283358|NCT01571362|Narcotics|narcotics|mesh-ancestor
83283359|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283360|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283361|NCT01571362|Analgesics|analgesics|mesh-ancestor
83283362|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
83283363|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283364|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83283365|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83283366|NCT01571284|Aflibercept|aflibercept|mesh-list
83283367|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83283368|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83283369|NCT01571284|Growth Substances|growth substances|mesh-ancestor
83283370|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283371|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
83283372|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283373|NCT02137772|Letermovir|letermovir|mesh-list
83283374|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83283375|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283376|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283377|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283378|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
83283379|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283380|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83283381|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83283383|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283384|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283385|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83283386|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
83283387|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83283388|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83283389|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83283390|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
83283391|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283392|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283393|NCT02137226|Adalimumab|adalimumab|mesh-list
83283394|NCT02137226|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83283395|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283396|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283397|NCT01530334|Gefitinib|gefitinib|mesh-list
83283398|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283399|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83283400|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283401|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283402|NCT01570192|Vancomycin|vancomycin|mesh-list
83283403|NCT01570192|Gentamicins|gentamicins|mesh-list
83283404|NCT01570192|Meropenem|meropenem|mesh-list
83283405|NCT01570192|Linezolid|linezolid|mesh-list
83283406|NCT01570192|Tobramycin|tobramycin|mesh-list
83283407|NCT01570192|Amikacin|amikacin|mesh-list
83283408|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83283409|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283410|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83283411|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283412|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283413|NCT02136914|Amantadine|amantadine|mesh-list
83283414|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83283415|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83283416|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
83283417|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283418|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
83283419|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283420|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283421|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283422|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83283423|NCT02136914|Analgesics|analgesics|mesh-ancestor
83283424|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
83283425|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283426|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
83283427|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83283428|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83283429|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83283430|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
83283431|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283432|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283433|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283434|NCT01554514|Rituximab|rituximab|mesh-list
83283435|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83283436|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283437|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
83283438|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283439|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283440|NCT01553188|Prednisone|prednisone|mesh-list
83283441|NCT01553188|Trebananib|trebananib|mesh-list
83283442|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283443|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
83283444|NCT01553188|Hormones|hormones|mesh-ancestor
83283445|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283446|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283447|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83283448|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283449|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83283450|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83283451|NCT01553188|Growth Substances|growth substances|mesh-ancestor
83283452|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
83283453|NCT02175758|Ribavirin|ribavirin|mesh-list
83283454|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
83283455|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
83283456|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283457|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
83283458|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283459|NCT01599104|Olmesartan|olmesartan|mesh-list
83283460|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83283461|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83283462|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83283463|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83283464|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283465|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
83283466|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83283467|NCT01518244|Timolol|timolol|mesh-list
83283468|NCT01518244|Brinzolamide|brinzolamide|mesh-list
83283469|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283470|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283471|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83283472|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83283473|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
83283474|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283475|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283476|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83283477|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83283478|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83283479|NCT01552408|Ranibizumab|ranibizumab|mesh-list
83283480|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83283481|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83283482|NCT01552408|Growth Substances|growth substances|mesh-ancestor
83283483|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283484|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
83283485|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283486|NCT04099888|Gemcitabine|gemcitabine|mesh-list
83283487|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283488|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83283489|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
83283490|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283491|NCT02174276|Tenofovir|tenofovir|mesh-list
83283492|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
83283493|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283494|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83283495|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83283496|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283497|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283498|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83283499|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83283500|NCT01527682|Dorzolamide|dorzolamide|mesh-list
83283501|NCT01527682|Latanoprost|latanoprost|mesh-list
83283502|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83283503|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83283504|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83283505|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83283506|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283507|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283508|NCT01516216|Vitamin D|vitamin d|mesh-list
83283509|NCT01516216|Leucovorin|leucovorin|mesh-list
83283510|NCT01516216|Bevacizumab|bevacizumab|mesh-list
83283511|NCT01516216|Fluorouracil|fluorouracil|mesh-list
83283512|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
83283513|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83283514|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283515|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83283516|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83283517|NCT01516216|Growth Substances|growth substances|mesh-ancestor
83283518|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283519|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
83283520|NCT01516216|Vitamins|vitamins|mesh-ancestor
83283521|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
83283522|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83283523|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
83283524|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283525|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83283526|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283527|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
83283528|NCT01516216|Antidotes|antidotes|mesh-ancestor
83283529|NCT01516216|Protective Agents|protective agents|mesh-ancestor
83283531|NCT01950819|Cyclosporine|cyclosporine|mesh-list
83283532|NCT01950819|Prednisone|prednisone|mesh-list
83283533|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
83283534|NCT01950819|Tacrolimus|tacrolimus|mesh-list
83283535|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
83283536|NCT01950819|Cyclosporins|cyclosporins|mesh-list
83283537|NCT01950819|Basiliximab|basiliximab|mesh-list
83283538|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283539|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
83283540|NCT01950819|Hormones|hormones|mesh-ancestor
83283541|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283542|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283543|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83283544|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283545|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
83283546|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
83283547|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283548|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83283549|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83283550|NCT01950819|Protective Agents|protective agents|mesh-ancestor
83283551|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283552|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
83283553|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83283554|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283555|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283556|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283557|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
83283558|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283559|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283560|NCT01514422|Minocycline|minocycline|mesh-list
83283561|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83283562|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283563|NCT01524796|Pregabalin|pregabalin|mesh-list
83283564|NCT01524796|Analgesics|analgesics|mesh-ancestor
83283565|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
83283566|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283567|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283568|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
83283569|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83283570|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83283571|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283572|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83283573|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83283574|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83283575|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283576|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83283577|NCT01547728|Antithrombins|antithrombins|mesh-list
83283578|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
83283579|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83283580|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
83283581|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283582|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283583|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
83283584|NCT01523392|Clopidogrel|clopidogrel|mesh-list
83283585|NCT01523392|Ticagrelor|ticagrelor|mesh-list
83283586|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83283587|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83283588|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83283589|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83283590|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
83283591|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283592|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283593|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283594|NCT01512160|Ibuprofen|ibuprofen|mesh-list
83283595|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83283596|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83283597|NCT01512160|Analgesics|analgesics|mesh-ancestor
83283598|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
83283599|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283600|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283601|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283602|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283603|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83283604|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283605|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283607|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83283608|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83283609|NCT01950741|Growth Substances|growth substances|mesh-ancestor
83283610|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283611|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
83283612|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283613|NCT01950273|Rituximab|rituximab|mesh-list
83283614|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83283615|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283616|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
83283617|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283618|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283619|NCT01919229|Letrozole|letrozole|mesh-list
83283620|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283621|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83283622|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83283623|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283624|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283625|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83283626|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
83283627|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283628|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283629|NCT01511536|Prednisone|prednisone|mesh-list
83283630|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
83283631|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283632|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
83283633|NCT01511536|Hormones|hormones|mesh-ancestor
83283634|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283635|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283636|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83283637|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283638|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83283639|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283640|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283641|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
83283642|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83283643|NCT01510912|Diclofenac|diclofenac|mesh-list
83283644|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83283645|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83283646|NCT01510912|Analgesics|analgesics|mesh-ancestor
83283647|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
83283648|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283649|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283650|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283651|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283652|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83283653|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283654|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283655|NCT01510756|Sorafenib|sorafenib|mesh-list
83283656|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283657|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83283658|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283659|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283660|NCT01522456|Tretinoin|tretinoin|mesh-list
83283661|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283662|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283663|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
83283664|NCT01521364|Clarithromycin|clarithromycin|mesh-list
83283665|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83283666|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283667|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83283668|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283669|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283670|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83283671|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83283672|NCT01545388|Metformin|metformin|mesh-list
83283673|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83283674|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83283675|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283676|NCT01545388|Incretins|incretins|mesh-ancestor
83283677|NCT01545388|Hormones|hormones|mesh-ancestor
83283678|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283679|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83283680|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83283681|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283682|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283683|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
83283684|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
83283685|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283686|NCT01544920|Interferons|interferons|mesh-list
83283687|NCT01544920|Ribavirin|ribavirin|mesh-list
83283688|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
83283689|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
83283690|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83283691|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283692|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
83283693|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283694|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
83283695|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283696|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
83283697|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283698|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83283699|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
83283700|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
83283701|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83283702|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
83283703|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283704|NCT01543204|Etanercept|etanercept|mesh-list
83283705|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83283706|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83283707|NCT01543204|Analgesics|analgesics|mesh-ancestor
83283708|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
83283709|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283710|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283711|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283712|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283713|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83283714|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283715|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
83283716|NCT01518946|Midodrine|midodrine|mesh-list
83283717|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
83283718|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
83283719|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283720|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283721|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83283722|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83283723|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83283724|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83283725|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
83283726|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283727|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283728|NCT01507246|Morphine|morphine|mesh-list
83283729|NCT01507246|Bupivacaine|bupivacaine|mesh-list
83283730|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
83283731|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
83283732|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283733|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283734|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
83283735|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283736|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83283737|NCT01507246|Narcotics|narcotics|mesh-ancestor
83283738|NCT01507246|Analgesics|analgesics|mesh-ancestor
83283739|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
83283740|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
83283741|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283742|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
83283743|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283744|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283746|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83283747|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283748|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83283749|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83283750|NCT02073448|Analgesics|analgesics|mesh-ancestor
83283751|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
83283752|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283753|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283754|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283755|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283756|NCT01487200|Triamcinolone|triamcinolone|mesh-list
83283757|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83283758|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83283760|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83283761|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283762|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
83283763|NCT01487200|Hormones|hormones|mesh-ancestor
83283764|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283765|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283766|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283767|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
83283768|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283769|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283770|NCT01505608|Irinotecan|irinotecan|mesh-list
83283771|NCT01505608|Temozolomide|temozolomide|mesh-list
83283772|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83283773|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83283774|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283775|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283776|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283777|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83283778|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
83283779|NCT01486966|Insulin|insulin|mesh-list
83283780|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83283781|NCT01486966|Metformin|metformin|mesh-list
83283782|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
83283783|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
83283784|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
83283785|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
83283786|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
83283787|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83283788|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283789|NCT04080076|Tacrolimus|tacrolimus|mesh-list
83283790|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283791|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
83283792|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283793|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83283794|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283795|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283796|NCT01900431|Leucovorin|leucovorin|mesh-list
83283797|NCT01900431|Folic Acid|folic acid|mesh-list
83283798|NCT01900431|Prednisone|prednisone|mesh-list
83283799|NCT01900431|Methotrexate|methotrexate|mesh-list
83283800|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
83283801|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283802|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
83283803|NCT01900431|Hormones|hormones|mesh-ancestor
83283804|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83283805|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283806|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83283807|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283808|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83283809|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
83283810|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83283811|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83283812|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
83283813|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283814|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283815|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283816|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83283818|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
83283819|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283820|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83283821|NCT01900431|Antidotes|antidotes|mesh-ancestor
83283822|NCT01900431|Protective Agents|protective agents|mesh-ancestor
83283823|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
83283824|NCT01900431|Vitamins|vitamins|mesh-ancestor
83283825|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
83283826|NCT01900431|Hematinics|hematinics|mesh-ancestor
83283828|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83283829|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283830|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283831|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
83283832|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283833|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283834|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83283835|NCT01948791|Protective Agents|protective agents|mesh-ancestor
83283836|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
83283837|NCT01898091|Glycerol|glycerol|mesh-list
83283838|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
83283839|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283840|NCT01898091|Protective Agents|protective agents|mesh-ancestor
83283841|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283842|NCT01898091|Vitamins|vitamins|mesh-ancestor
83283843|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
83283844|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83283845|NCT01947855|Empagliflozin|empagliflozin|mesh-list
83283846|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83283847|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283848|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83283849|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283850|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
83283851|NCT01888497|Promethazine|promethazine|mesh-list
83283852|NCT01888497|Triazolam|triazolam|mesh-list
83283853|NCT01888497|Gabapentin|gabapentin|mesh-list
83283854|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283855|NCT01888497|Analgesics|analgesics|mesh-ancestor
83283856|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
83283857|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283858|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283859|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
83283860|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83283861|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83283862|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283863|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83283864|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83283865|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83283866|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283867|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
83283868|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83283869|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83283870|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
83283871|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
83283872|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
83283873|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
83283874|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83283875|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83283876|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
83283877|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
83283878|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83283879|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
83283880|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283881|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83283882|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
83283883|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
83283884|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
83283885|NCT01485796|Antibodies|antibodies|mesh-list
83283886|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
83283887|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83283888|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83283889|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
83283890|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283891|NCT01897233|Ivacaftor|ivacaftor|mesh-list
83283892|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83283893|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83283894|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283895|NCT01887717|Sorafenib|sorafenib|mesh-list
83283896|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283897|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83283898|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283899|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283900|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
83283901|NCT01946529|Temozolomide|temozolomide|mesh-list
83283902|NCT01946529|Ifosfamide|ifosfamide|mesh-list
83283903|NCT01946529|Bevacizumab|bevacizumab|mesh-list
83283904|NCT01946529|Doxorubicin|doxorubicin|mesh-list
83283905|NCT01946529|Etoposide|etoposide|mesh-list
83283906|NCT01946529|Vincristine|vincristine|mesh-list
83283907|NCT01946529|Sorafenib|sorafenib|mesh-list
83283908|NCT01946529|Temsirolimus|temsirolimus|mesh-list
83283909|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83283910|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
83283911|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283912|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283913|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83283914|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
83283915|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283916|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83283917|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83283918|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83283919|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83283920|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83283921|NCT01946529|Growth Substances|growth substances|mesh-ancestor
83283922|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
83283923|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83283924|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83283925|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83283926|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83283927|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83283928|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
83283929|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
83283930|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
83283931|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83283932|NCT01946529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83283933|NCT01463098|Zolpidem|zolpidem|mesh-list
83283934|NCT01463098|Lemborexant|lemborexant|mesh-list
83283935|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83283936|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83283937|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283938|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283939|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83283940|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
83283941|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
83283942|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283943|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283944|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83283945|NCT01462942|Bromides|bromides|mesh-list
83283946|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
83283947|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83283948|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
83283949|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283950|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283951|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83283952|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
83283953|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83283954|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83283955|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83283956|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
83283957|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283958|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283959|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
83283960|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83283961|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83283962|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283963|NCT01504204|Adapalene|adapalene|mesh-list
83283964|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83283965|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83283966|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
83283967|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83283968|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83283970|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
83283971|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83283972|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283973|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83283974|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83283975|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83283976|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83283977|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83283978|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83283979|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283980|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83283981|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83283982|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83283983|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83283984|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
83283985|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83283986|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83283987|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83283988|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83283989|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
83283990|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83283991|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83283992|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
83283993|NCT02118961|Vaccines|vaccines|mesh-list
83283994|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
83283995|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283996|NCT02140645|Linagliptin|linagliptin|mesh-list
83283997|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83283998|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83283999|NCT02140645|Incretins|incretins|mesh-ancestor
83284000|NCT02140645|Hormones|hormones|mesh-ancestor
83284001|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284002|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83284003|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
83284004|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284005|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284006|NCT02140411|Ranibizumab|ranibizumab|mesh-list
83284007|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83284008|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83284009|NCT02140411|Growth Substances|growth substances|mesh-ancestor
83284010|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284011|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
83284012|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284013|NCT02139943|Canagliflozin|canagliflozin|mesh-list
83284014|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83284015|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284016|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83284017|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284018|NCT01485172|Ropinirole|ropinirole|mesh-list
83284019|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83284020|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83284021|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
83284022|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
83284023|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284024|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284025|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284026|NCT02105701|Ribavirin|ribavirin|mesh-list
83284027|NCT02105701|Grazoprevir|grazoprevir|mesh-list
83284028|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
83284029|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284030|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
83284031|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284032|NCT04411225|Cannabidiol|cannabidiol|mesh-list
83284033|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
83284034|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83284035|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83284036|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284037|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284038|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83284039|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284040|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284041|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
83284042|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284043|NCT01502644|Morphine|morphine|mesh-list
83284044|NCT01502644|Oxycodone|oxycodone|mesh-list
83284045|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83284046|NCT01502644|Narcotics|narcotics|mesh-ancestor
83284047|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284048|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284049|NCT01502644|Analgesics|analgesics|mesh-ancestor
83284050|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
83284051|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284052|NCT01462318|Vitamin K|vitamin k|mesh-list
83284053|NCT01462318|Midazolam|midazolam|mesh-list
83284054|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
83284055|NCT01462318|Caffeine|caffeine|mesh-list
83284056|NCT01462318|Omeprazole|omeprazole|mesh-list
83284057|NCT01462318|Warfarin|warfarin|mesh-list
83284058|NCT01462318|Daclizumab|daclizumab|mesh-list
83284059|NCT01462318|Vitamins|vitamins|mesh-ancestor
83284060|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
83284061|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284062|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83284063|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83284064|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284065|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83284066|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83284067|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284068|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83284069|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
83284070|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
83284071|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
83284072|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
83284073|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284074|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284075|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
83284076|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83284077|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83284078|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284079|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83284080|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83284081|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
83284082|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83284083|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83284084|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83284085|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83284086|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83284087|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
83284088|NCT01462318|Coagulants|coagulants|mesh-ancestor
83284089|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
83284090|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
83284091|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83284092|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83284093|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284094|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
83284095|NCT01485094|Pregabalin|pregabalin|mesh-list
83284096|NCT01485094|Analgesics|analgesics|mesh-ancestor
83284097|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
83284098|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284099|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284100|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
83284101|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83284102|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284103|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284104|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83284105|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83284106|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83284107|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284108|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284109|NCT04079686|Cefazolin|cefazolin|mesh-list
83284110|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83284111|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284112|NCT01502410|Sorafenib|sorafenib|mesh-list
83284113|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284114|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83284115|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284116|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284117|NCT04757636|Aflibercept|aflibercept|mesh-list
83284118|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83284119|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83284120|NCT04757636|Growth Substances|growth substances|mesh-ancestor
83284121|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284122|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
83284123|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284125|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
83284126|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83284127|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
83284128|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
83284129|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284130|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284131|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
83284132|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83284133|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
83284134|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83284135|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83284136|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83284137|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83284138|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83284139|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284140|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284141|NCT02132312|Protective Agents|protective agents|mesh-ancestor
83284142|NCT02150954|Oxytocin|oxytocin|mesh-list
83284143|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
83284144|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83284145|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284146|NCT04188392|Pimavanserin|pimavanserin|mesh-list
83284147|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83284148|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83284149|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83284150|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83284151|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284152|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284153|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284154|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83284155|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83284156|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
83284157|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284158|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284159|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83284160|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83284161|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284162|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83284163|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83284164|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284165|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284166|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
83284167|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284168|NCT02131064|Carboplatin|carboplatin|mesh-list
83284169|NCT02131064|Docetaxel|docetaxel|mesh-list
83284170|NCT02131064|Trastuzumab|trastuzumab|mesh-list
83284171|NCT02131064|Pertuzumab|pertuzumab|mesh-list
83284172|NCT02131064|Maytansine|maytansine|mesh-list
83284173|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83284174|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284175|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
83284176|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
83284177|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
83284178|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284179|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284180|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83284181|NCT02131064|Immunotoxins|immunotoxins|mesh-ancestor
83284182|NCT02131064|Immunoconjugates|immunoconjugates|mesh-ancestor
83284183|NCT02131064|Immunologic Factors|immunologic factors|mesh-ancestor
83284184|NCT02131064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284185|NCT02130284|Insulin|insulin|mesh-list
83284186|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83284187|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83284188|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284189|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83284190|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
83284191|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284192|NCT04748822|Ethanol|ethanol|mesh-list
83284193|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83284195|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284196|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284197|NCT04739150|Nintedanib|nintedanib|mesh-list
83284198|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284199|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83284200|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284201|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284202|NCT02147132|Nicotine|nicotine|mesh-list
83284203|NCT02147132|Varenicline|varenicline|mesh-list
83284204|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83284205|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
83284206|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284207|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284208|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83284209|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83284210|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
83284211|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284212|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284213|NCT02146430|Pregabalin|pregabalin|mesh-list
83284214|NCT02146430|Analgesics|analgesics|mesh-ancestor
83284215|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
83284216|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284217|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284218|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
83284219|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83284220|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284221|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284222|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83284223|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83284224|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83284225|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284226|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284227|NCT02129192|Amlodipine|amlodipine|mesh-list
83284228|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83284229|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83284230|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284231|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284232|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83284233|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284234|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
83284235|NCT02128490|Naproxen|naproxen|mesh-list
83284236|NCT02128490|Colchicine|colchicine|mesh-list
83284237|NCT02128490|Febuxostat|febuxostat|mesh-list
83284238|NCT02128490|Lansoprazole|lansoprazole|mesh-list
83284239|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
83284240|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83284241|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83284242|NCT02128490|Analgesics|analgesics|mesh-ancestor
83284243|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
83284244|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284245|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284246|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83284247|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284248|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
83284249|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83284250|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284251|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284252|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
83284253|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
83284254|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
83284255|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284256|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83284257|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83284258|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83284259|NCT02105636|Docetaxel|docetaxel|mesh-list
83284260|NCT02105636|Nivolumab|nivolumab|mesh-list
83284261|NCT02105636|Methotrexate|methotrexate|mesh-list
83284262|NCT02105636|Cetuximab|cetuximab|mesh-list
83284263|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284264|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
83284265|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
83284266|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
83284267|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284268|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284269|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83284270|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83284271|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
83284272|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83284273|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284274|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83284275|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
83284276|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
83284277|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284278|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83284279|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284280|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
83284281|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284282|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83284283|NCT04748042|Prednisone|prednisone|mesh-list
83284284|NCT04748042|Olaparib|olaparib|mesh-list
83284285|NCT04748042|Androgens|androgens|mesh-list
83284286|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83284287|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
83284288|NCT04748042|Hormones|hormones|mesh-ancestor
83284289|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284290|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284291|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83284292|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284293|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83284294|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284295|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284296|NCT01626872|Risperidone|risperidone|mesh-list
83284297|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83284298|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
83284299|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284300|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284301|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284302|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83284303|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83284304|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284305|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284306|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83284307|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
83284308|NCT01598090|Ribavirin|ribavirin|mesh-list
83284309|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83284310|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
83284311|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284312|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
83284313|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284314|NCT02145182|Eculizumab|eculizumab|mesh-list
83284315|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83284316|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284317|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
83284318|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284319|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
83284320|NCT02145026|Hematinics|hematinics|mesh-ancestor
83284321|NCT02144012|Docetaxel|docetaxel|mesh-list
83284322|NCT02144012|Trastuzumab|trastuzumab|mesh-list
83284323|NCT02144012|Maytansine|maytansine|mesh-list
83284324|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83284325|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284326|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
83284327|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
83284328|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
83284329|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284330|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284331|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83284332|NCT02144012|Immunotoxins|immunotoxins|mesh-ancestor
83284333|NCT02144012|Immunoconjugates|immunoconjugates|mesh-ancestor
83284334|NCT02144012|Immunologic Factors|immunologic factors|mesh-ancestor
83284335|NCT02144012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284336|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83284337|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284338|NCT02141672|Cyclosporine|cyclosporine|mesh-list
83284339|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
83284340|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284341|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
83284342|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284343|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284344|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284345|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
83284346|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284347|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284348|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83284349|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
83284350|NCT01628120|Hematinics|hematinics|mesh-ancestor
83284351|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83284352|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83284353|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284354|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
83284355|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284356|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
83284357|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83284358|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284359|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284360|NCT02123966|Sirolimus|sirolimus|mesh-list
83284361|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83284362|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284363|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83284364|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284365|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
83284366|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284367|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
83284368|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284369|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
83284370|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83284371|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284372|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284373|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83284374|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83284375|NCT02123576|Protective Agents|protective agents|mesh-ancestor
83284376|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284377|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
83284378|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83284379|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
83284380|NCT05235347|Sotrovimab|sotrovimab|mesh-list
83284381|NCT05235347|Antiviral Agents|antiviral agents|mesh-ancestor
83284382|NCT05235347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284383|NCT03368729|Trastuzumab|trastuzumab|mesh-list
83284384|NCT03368729|Niraparib|niraparib|mesh-list
83284385|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284386|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284387|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83284388|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284389|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284390|NCT02140970|Ibuprofen|ibuprofen|mesh-list
83284391|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83284392|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83284393|NCT02140970|Analgesics|analgesics|mesh-ancestor
83284394|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
83284395|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284396|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284397|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83284398|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284399|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83284400|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284401|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284402|NCT02101112|Apixaban|apixaban|mesh-list
83284403|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83284404|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
83284405|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83284406|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
83284407|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284408|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284409|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
83284410|NCT02139644|Fluticasone|fluticasone|mesh-list
83284411|NCT02139644|Xhance|xhance|mesh-list
83284412|NCT02139644|Beclomethasone|beclomethasone|mesh-list
83284413|NCT02139644|Albuterol|albuterol|mesh-list
83284414|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83284415|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
83284416|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83284417|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83284418|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
83284419|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284420|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284421|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83284422|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
83284423|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
83284424|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83284425|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83284426|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83284427|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
83284428|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284429|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284430|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
83284431|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83284432|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
83284434|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284435|NCT02100644|Lamotrigine|lamotrigine|mesh-list
83284436|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
83284437|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83284438|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284439|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284440|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83284441|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284442|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83284443|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83284444|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284445|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284446|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83284447|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
83284448|NCT04798469|Testosterone|testosterone|mesh-list
83284449|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
83284450|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
83284451|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83284452|NCT04798469|Androgens|androgens|mesh-ancestor
83284453|NCT04798469|Hormones|hormones|mesh-ancestor
83284454|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284455|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284456|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83284457|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284458|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
83284459|NCT02074982|Ustekinumab|ustekinumab|mesh-list
83284460|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83284461|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
83284462|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284463|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
83284464|NCT04150913|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
83284465|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83284466|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284467|NCT04150913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284468|NCT04150913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284469|NCT04798001|Vaccines|vaccines|mesh-list
83284470|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
83284471|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284472|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
83284473|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
83284474|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284475|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
83413606|NCT02611752|Analgesics|analgesics|mesh-ancestor
83284476|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83284477|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83284478|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83284479|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284480|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284481|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
83284482|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284483|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284484|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83284485|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284486|NCT04070573|Aspirin|aspirin|mesh-list
83284487|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83284488|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83284489|NCT04070573|Analgesics|analgesics|mesh-ancestor
83284490|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
83284491|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284492|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284494|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284495|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83284496|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83284497|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284498|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83284499|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83284500|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284501|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
83284502|NCT02099708|Lansoprazole|lansoprazole|mesh-list
83284503|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
83284504|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83284505|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83284506|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83284507|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284508|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284509|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
83284510|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83284511|NCT02073656|Ledipasvir|ledipasvir|mesh-list
83284512|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
83284513|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284514|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
83284515|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83284516|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284517|NCT02209181|Acetaminophen|acetaminophen|mesh-list
83284518|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83284519|NCT02209181|Analgesics|analgesics|mesh-ancestor
83284520|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
83284521|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284522|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284523|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
83284524|NCT02242487|Levodopa|levodopa|mesh-list
83284525|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83284526|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83284527|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
83284528|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284529|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284530|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284531|NCT02241785|Natalizumab|natalizumab|mesh-list
83284532|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
83284533|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284534|NCT02241551|Paclitaxel|paclitaxel|mesh-list
83284535|NCT02241551|Gemcitabine|gemcitabine|mesh-list
83284536|NCT02241551|Fluorouracil|fluorouracil|mesh-list
83284537|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
83284538|NCT02241551|Irinotecan|irinotecan|mesh-list
83284539|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83284540|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284541|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
83284542|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
83284543|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
83284544|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284545|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83284546|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
83284547|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284548|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
83284549|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284550|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83284551|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83284552|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284553|NCT02207621|Timolol|timolol|mesh-list
83284554|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83284555|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83284556|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284557|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83284558|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83284559|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
83284560|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284561|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284562|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83284563|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83284564|NCT02240693|BI 409306|bi 409306|mesh-list
83284565|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83284566|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284567|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284568|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83284569|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83284570|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
83284571|NCT02072096|Metformin|metformin|mesh-list
83284572|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
83284573|NCT02072096|Pioglitazone|pioglitazone|mesh-list
83284574|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83284575|NCT02072096|Liraglutide|liraglutide|mesh-list
83284576|NCT02072096|Exenatide|exenatide|mesh-list
83284577|NCT02072096|Glimepiride|glimepiride|mesh-list
83284578|NCT02072096|Linagliptin|linagliptin|mesh-list
83284579|NCT02072096|Acarbose|acarbose|mesh-list
83284580|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83284581|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284582|NCT02072096|Incretins|incretins|mesh-ancestor
83284583|NCT02072096|Hormones|hormones|mesh-ancestor
83284584|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284585|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83284586|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
83284587|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284588|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284589|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83284590|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83284591|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284592|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
83284593|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83284594|NCT01631825|Rotigotine|rotigotine|mesh-list
83284595|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
83284596|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
83284597|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284598|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284599|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284600|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83284601|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83284602|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83284603|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
83284604|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284605|NCT03836105|Cemiplimab|cemiplimab|mesh-list
83284606|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284607|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284608|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
83284609|NCT02123108|Tacrolimus|tacrolimus|mesh-list
83284610|NCT02123108|Basiliximab|basiliximab|mesh-list
83284611|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284612|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
83284613|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284614|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83284615|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284616|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284617|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83284618|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284619|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83284620|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
83284621|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83284622|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284623|NCT02121392|Bupivacaine|bupivacaine|mesh-list
83284624|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83284625|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
83284626|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284627|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284628|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
83284629|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284630|NCT02097056|Donepezil|donepezil|mesh-list
83284631|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83284632|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284633|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284634|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
83284635|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284636|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284637|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
83284638|NCT02121002|Diclofenac|diclofenac|mesh-list
83284639|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83284640|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83284641|NCT02121002|Analgesics|analgesics|mesh-ancestor
83284642|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
83284643|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284644|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284646|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284647|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83284648|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284649|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284650|NCT02096900|Midazolam|midazolam|mesh-list
83284651|NCT02096900|Zolpidem|zolpidem|mesh-list
83284652|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83284653|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83284654|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284655|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284656|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83284657|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83284658|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284659|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83284660|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
83284661|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
83284662|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
83284663|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
83284664|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284665|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284666|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83284667|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83284668|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
83284669|NCT02120924|Azelaic acid|azelaic acid|mesh-list
83284670|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284671|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
83284672|NCT02096744|Clonidine|clonidine|mesh-list
83284673|NCT02096744|Analgesics|analgesics|mesh-ancestor
83284674|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
83284675|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284676|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284677|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83284678|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
83284679|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
83284680|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83284681|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83284682|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83284683|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
83284684|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284685|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284686|NCT02096042|Azacitidine|azacitidine|mesh-list
83284687|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83284688|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83284689|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
83284690|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284691|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284692|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284693|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284694|NCT02096042|Immunotoxins|immunotoxins|mesh-ancestor
83284695|NCT02096042|Immunoconjugates|immunoconjugates|mesh-ancestor
83284696|NCT02096042|Immunologic Factors|immunologic factors|mesh-ancestor
83284697|NCT02096042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284698|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
83284699|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
83284700|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284701|NCT02069366|Dronabinol|dronabinol|mesh-list
83284702|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
83284703|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284704|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83284705|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83284706|NCT02069366|Analgesics|analgesics|mesh-ancestor
83284707|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
83284708|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284709|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83284710|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83284711|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284712|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284713|NCT02069366|Hormones|hormones|mesh-ancestor
83430131|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284714|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284716|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
83284717|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284718|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284720|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83284721|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284722|NCT02207231|Adalimumab|adalimumab|mesh-list
83284723|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83284724|NCT02207231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83284725|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83284726|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284727|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
83284728|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284729|NCT02206685|Methadone|methadone|mesh-list
83284730|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83284731|NCT02206685|Narcotics|narcotics|mesh-ancestor
83284732|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83284733|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284734|NCT02206685|Analgesics|analgesics|mesh-ancestor
83284735|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
83284736|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284737|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
83284738|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
83284739|NCT02095106|Calpastatin|calpastatin|mesh-list
83284740|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83284741|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
83284742|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284743|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284744|NCT03736889|Tislelizumab|tislelizumab|mesh-list
83284745|NCT03736889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284746|NCT03736889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284747|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
83284748|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83284749|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284750|NCT02235311|Pantoprazole|pantoprazole|mesh-list
83284751|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83284752|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83284753|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83284754|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284755|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284756|NCT02235077|Spironolactone|spironolactone|mesh-list
83284757|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83284758|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
83284759|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284760|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284761|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83284762|NCT02235077|Diuretics|diuretics|mesh-ancestor
83284763|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
83284764|NCT02234141|Selonsertib|selonsertib|mesh-list
83284765|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83284766|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284767|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284768|NCT01896531|Leucovorin|leucovorin|mesh-list
83284769|NCT01896531|Fluorouracil|fluorouracil|mesh-list
83284770|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
83284771|NCT01896531|Ipatasertib|ipatasertib|mesh-list
83284772|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
83284773|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284774|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83284775|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284776|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284777|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
83284778|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284779|NCT01896531|Antidotes|antidotes|mesh-ancestor
83284780|NCT01896531|Protective Agents|protective agents|mesh-ancestor
83284781|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
83284782|NCT01896531|Vitamins|vitamins|mesh-ancestor
83284783|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
83284784|NCT01896531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83284785|NCT01896531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284786|NCT01618305|Lamivudine|lamivudine|mesh-list
83284787|NCT01618305|Zidovudine|zidovudine|mesh-list
83284788|NCT01618305|Efavirenz|efavirenz|mesh-list
83284789|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83284790|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
83284791|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83284792|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83284793|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284794|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284795|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
83284796|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284797|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83284798|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83284799|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
83284800|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83284801|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83284802|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83284803|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83284804|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83284805|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83284806|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83284807|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83284808|NCT01896297|Dabigatran|dabigatran|mesh-list
83284809|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
83284810|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83284811|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
83284812|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284813|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284814|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
83284815|NCT01884675|Ambrisentan|ambrisentan|mesh-list
83284816|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83284817|NCT01884597|Ranibizumab|ranibizumab|mesh-list
83284818|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83284819|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83284820|NCT01884597|Growth Substances|growth substances|mesh-ancestor
83284821|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284822|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
83284823|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284824|NCT01864005|Clopidogrel|clopidogrel|mesh-list
83284825|NCT01864005|Ticagrelor|ticagrelor|mesh-list
83284826|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83284827|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83284828|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83284829|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83284830|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
83284831|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284832|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284833|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284834|NCT01863771|Golimumab|golimumab|mesh-list
83284835|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83284836|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83284837|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284838|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
83284839|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284840|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83284841|NCT01894581|Hormones|hormones|mesh-ancestor
83284842|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284843|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284844|NCT02203331|Anastrozole|anastrozole|mesh-list
83284845|NCT02203331|Leuprolide|leuprolide|mesh-list
83284846|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
83284847|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83284848|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284849|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83284850|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83284851|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284852|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284853|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83284854|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
83284855|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284856|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284857|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83284858|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
83284859|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83284860|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83284861|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
83284862|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83284863|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83284864|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83284865|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
83284866|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83284867|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83284868|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83284869|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83284870|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284871|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284872|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
83284873|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284874|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284875|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83284876|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284877|NCT01862991|Digoxin|digoxin|mesh-list
83284878|NCT01862991|Misoprostol|misoprostol|mesh-list
83284879|NCT01862991|Mifepristone|mifepristone|mesh-list
83284880|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83284881|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
83284882|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83284883|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284884|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83284885|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83284886|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
83284887|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83284888|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83284889|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284890|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284891|NCT01862991|Protective Agents|protective agents|mesh-ancestor
83284892|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83284893|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83284894|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83284895|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83284896|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
83284897|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83284898|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83284899|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
83284900|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284901|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
83284902|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83284903|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83284904|NCT02202551|Amantadine|amantadine|mesh-list
83284905|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83284906|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83284907|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
83284908|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284909|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
83284910|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284911|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284912|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284913|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83284914|NCT02202551|Analgesics|analgesics|mesh-ancestor
83284915|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
83284916|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83284917|NCT02118337|Nivolumab|nivolumab|mesh-list
83284918|NCT02118337|Durvalumab|durvalumab|mesh-list
83284919|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284920|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284921|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83284922|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284923|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83284924|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
83284925|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284926|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
83284927|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
83284928|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284929|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284930|NCT02105467|Grazoprevir|grazoprevir|mesh-list
83284931|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83284932|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
83284933|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284934|NCT02202161|Metformin|metformin|mesh-list
83284935|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83284936|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83284937|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284938|NCT02202161|Incretins|incretins|mesh-ancestor
83284939|NCT02202161|Hormones|hormones|mesh-ancestor
83284940|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284941|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83284942|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
83284943|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83284944|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284945|NCT03109847|Metformin|metformin|mesh-list
83284946|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83284947|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284948|NCT01461928|Rituximab|rituximab|mesh-list
83284949|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83284950|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284951|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
83284952|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284953|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83284954|NCT02623205|Escitalopram|escitalopram|mesh-list
83284955|NCT02623205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83284956|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83284957|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83284958|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284959|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284960|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
83284961|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284962|NCT01500694|Guanfacine|guanfacine|mesh-list
83284963|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83284964|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83284965|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83284966|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83284967|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
83284968|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284969|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284970|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284971|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83284972|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83284973|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83284974|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83284975|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83284976|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
83284977|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83284978|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284979|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284980|NCT01500382|Urological Agents|urological agents|mesh-ancestor
83284981|NCT02137837|Everolimus|everolimus|mesh-list
83284982|NCT02137837|Fulvestrant|fulvestrant|mesh-list
83284983|NCT02137837|Anastrozole|anastrozole|mesh-list
83284984|NCT02137837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83284985|NCT02137837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83284987|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83284988|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83284989|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
83284990|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83284991|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83284992|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83284993|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83284994|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83284995|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
83284996|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83284997|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83284998|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83284999|NCT01483690|Dexamethasone|dexamethasone|mesh-list
83285000|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
83285001|NCT01483690|Methotrexate|methotrexate|mesh-list
83285002|NCT01483690|Vincristine|vincristine|mesh-list
83285003|NCT01483690|Decitabine|decitabine|mesh-list
83285004|NCT01483690|Asparaginase|asparaginase|mesh-list
83285005|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
83285006|NCT01483690|Vorinostat|vorinostat|mesh-list
83285007|NCT01483690|Pegaspargase|pegaspargase|mesh-list
83285008|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83285009|NCT01483690|BB 1101|bb 1101|mesh-list
83285010|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285011|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
83285012|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
83285013|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285014|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285015|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285016|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
83285017|NCT01483690|Hormones|hormones|mesh-ancestor
83285018|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285019|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83285020|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285021|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
83285022|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285023|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285024|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83285025|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
83285026|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83285027|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83285028|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
83285029|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
83285030|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83285031|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285032|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
83285033|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285034|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83285035|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83285036|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
83285037|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
83285038|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
83285039|NCT01483690|Analgesics|analgesics|mesh-ancestor
83285040|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
83285041|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83285042|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83285043|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83285044|NCT01483144|Eflornithine|eflornithine|mesh-list
83285045|NCT01483144|Sulindac|sulindac|mesh-list
83285046|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285047|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83285048|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83285049|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83285050|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285051|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
83285052|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285053|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285054|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83285055|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83285056|NCT01483144|Analgesics|analgesics|mesh-ancestor
83285057|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
83285058|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285059|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285060|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285061|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285062|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83285063|NCT01881789|Dexamethasone|dexamethasone|mesh-list
83285064|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
83285065|NCT01881789|Lenalidomide|lenalidomide|mesh-list
83285066|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285067|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
83285068|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285069|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285070|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83285071|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
83285072|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285073|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285074|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83285075|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285076|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
83285077|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
83285078|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285079|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285080|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
83285081|NCT01881789|Hormones|hormones|mesh-ancestor
83285082|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285083|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83285084|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83285085|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83285086|NCT01881789|Growth Substances|growth substances|mesh-ancestor
83285087|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
83285088|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
83285089|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83285090|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
83285091|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285092|NCT01892163|Dexamethasone|dexamethasone|mesh-list
83285093|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285094|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
83285095|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
83285096|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285097|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285098|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285099|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
83285100|NCT01892163|Hormones|hormones|mesh-ancestor
83285101|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285102|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83285103|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285104|NCT01500226|Dexamethasone|dexamethasone|mesh-list
83285105|NCT01500226|Granisetron|granisetron|mesh-list
83285106|NCT01500226|Rolapitant|rolapitant|mesh-list
83285107|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285108|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
83285109|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
83285110|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285111|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285112|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285113|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
83285114|NCT01500226|Hormones|hormones|mesh-ancestor
83285115|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285116|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83285117|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285118|NCT01500226|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83285119|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83285120|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
83285121|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285122|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285123|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83285124|NCT02075047|Ziprasidone|ziprasidone|mesh-list
83285125|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83285126|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
83285127|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285128|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285129|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285130|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83285131|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83285132|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83285133|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83285134|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83285135|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
83285136|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83285137|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83285138|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285139|NCT01859793|Incretins|incretins|mesh-ancestor
83285140|NCT01859793|Hormones|hormones|mesh-ancestor
83285141|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285142|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83285143|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
83285144|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285145|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285146|NCT01859715|Oxycodone|oxycodone|mesh-list
83285147|NCT01859715|Hydrocodone|hydrocodone|mesh-list
83285148|NCT01859715|Ondansetron|ondansetron|mesh-list
83285149|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83285150|NCT01859715|Narcotics|narcotics|mesh-ancestor
83285151|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83285152|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285153|NCT01859715|Analgesics|analgesics|mesh-ancestor
83285154|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
83285155|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285156|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
83285157|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
83285158|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285159|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
83285160|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
83285161|NCT01859715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83285162|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83285163|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
83285164|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285165|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285166|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
83285167|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
83285168|NCT04599465|Ivacaftor|ivacaftor|mesh-list
83285169|NCT04599465|Elexacaftor|elexacaftor|mesh-list
83285170|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83285171|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285172|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285173|NCT04590495|Cannabidiol|cannabidiol|mesh-list
83285174|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
83285175|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83285176|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83285177|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83285178|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285179|NCT01461538|Immunotoxins|immunotoxins|mesh-ancestor
83285180|NCT01461538|Immunoconjugates|immunoconjugates|mesh-ancestor
83285181|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
83285182|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285183|NCT02117479|Capecitabine|capecitabine|mesh-list
83285184|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83285185|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
83285186|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285187|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285188|NCT01482910|Aflibercept|aflibercept|mesh-list
83285189|NCT01482910|Verteporfin|verteporfin|mesh-list
83285190|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83285191|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83285192|NCT01482910|Growth Substances|growth substances|mesh-ancestor
83285193|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285194|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
83285195|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285196|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83285197|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83285198|NCT04077190|Cortisone|cortisone|mesh-list
83285199|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285200|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83285201|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
83285202|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285203|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
83285204|NCT02229539|Promethazine|promethazine|mesh-list
83285205|NCT02229539|Lidocaine|lidocaine|mesh-list
83285206|NCT02229539|Doxepin|doxepin|mesh-list
83285207|NCT02229539|Antacids|antacids|mesh-list
83285208|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
83285209|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
83285210|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83285211|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285212|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
83285213|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285214|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83285215|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83285216|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83285217|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285218|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285219|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83285220|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83285221|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
83285222|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
83285223|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285224|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83285225|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
83285226|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
83285227|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285228|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83285229|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
83285230|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
83285231|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83285232|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
83285233|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83285234|NCT01835223|Tivozanib|tivozanib|mesh-list
83285235|NCT01835223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83285236|NCT01835223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285237|NCT01835223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285238|NCT02229383|Exenatide|exenatide|mesh-list
83285239|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83285240|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285241|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83285242|NCT02229383|Incretins|incretins|mesh-ancestor
83285243|NCT02229383|Hormones|hormones|mesh-ancestor
83285244|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285245|NCT01499368|Omeprazole|omeprazole|mesh-list
83285246|NCT01499368|Famotidine|famotidine|mesh-list
83285247|NCT01499368|Lafutidine|lafutidine|mesh-list
83285248|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83285249|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285250|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83285251|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285252|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285253|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83285254|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
83285255|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
83285256|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285257|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285258|NCT01835145|Temozolomide|temozolomide|mesh-list
83285259|NCT01835145|Dacarbazine|dacarbazine|mesh-list
83285260|NCT01835145|Imidazole|imidazole|mesh-list
83285261|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83285262|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
83285263|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285264|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285265|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285266|NCT02229227|Insulin|insulin|mesh-list
83285267|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
83285268|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
83285269|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
83285270|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83285271|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285272|NCT02229227|Incretins|incretins|mesh-ancestor
83285273|NCT02229227|Hormones|hormones|mesh-ancestor
83285274|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285275|NCT01499290|Metronidazole|metronidazole|mesh-list
83285276|NCT01499290|Meropenem|meropenem|mesh-list
83285277|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285278|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83285279|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83285280|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83285281|NCT01833897|Cycloserine|cycloserine|mesh-list
83285282|NCT01833897|Ketamine|ketamine|mesh-list
83285283|NCT01833897|Olanzapine|olanzapine|mesh-list
83285284|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83285285|NCT01833897|Fluoxetine|fluoxetine|mesh-list
83285286|NCT01833897|Analgesics|analgesics|mesh-ancestor
83285287|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
83285288|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285289|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285290|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83285291|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83285292|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
83285293|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
83285294|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83285295|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83285296|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83285297|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285298|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285299|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
83285300|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
83285301|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285302|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83285303|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83285304|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83285305|NCT01833897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83285306|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83285307|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285308|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
83285309|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
83285310|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83285311|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83285312|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83285313|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285314|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83285315|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285316|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83285317|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
83285318|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83285319|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
83285320|NCT02226653|Evacetrapib|evacetrapib|mesh-list
83285321|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83285322|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83285324|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285325|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83285326|NCT02201771|Aspirin|aspirin|mesh-list
83285327|NCT02201771|Ticagrelor|ticagrelor|mesh-list
83285328|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83285329|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83285330|NCT02201771|Analgesics|analgesics|mesh-ancestor
83285331|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
83285332|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285333|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285334|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285335|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285336|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83285337|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83285338|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285339|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83285340|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83285341|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285342|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
83285343|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83285344|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83285345|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83285346|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
83285347|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285348|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
83285349|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83285350|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285351|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83285352|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83285353|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285354|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285355|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285356|NCT01460290|Asenapine|asenapine|mesh-list
83285357|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83285358|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83285359|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83285360|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285361|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83285362|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
83285363|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83285364|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83285365|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83285366|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285367|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285368|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
83285369|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285370|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285371|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83285372|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285373|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
83285374|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
83285375|NCT01459666|Coagulants|coagulants|mesh-ancestor
83285376|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83285377|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
83285378|NCT01645475|Coagulants|coagulants|mesh-ancestor
83285379|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83285381|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285382|NCT04767113|Heparin|heparin|mesh-list
83285383|NCT04767113|Calcium heparin|calcium heparin|mesh-list
83285384|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
83285385|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83285386|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83285387|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285388|NCT04774991|Azithromycin|azithromycin|mesh-list
83285389|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83285390|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285391|NCT02199509|Levetiracetam|levetiracetam|mesh-list
83285392|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
83285393|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
83285394|NCT01458574|Tofacitinib|tofacitinib|mesh-list
83285395|NCT01458574|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83285396|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83285397|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285398|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285399|NCT02224703|Cannabidiol|cannabidiol|mesh-list
83285400|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
83285401|NCT01458106|Factor VIII|factor viii|mesh-list
83285402|NCT01458106|Coagulants|coagulants|mesh-ancestor
83285403|NCT01457950|Denosumab|denosumab|mesh-list
83285404|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83285405|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285406|NCT01499134|Metoprolol|metoprolol|mesh-list
83285407|NCT01499134|Nebivolol|nebivolol|mesh-list
83285408|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83285409|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83285410|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
83285411|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
83285412|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285413|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285414|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83285415|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83285416|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83285417|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
83285418|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285419|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285420|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
83285421|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83285422|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83285423|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83285424|NCT02198651|Adalimumab|adalimumab|mesh-list
83285425|NCT02198651|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83285426|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285427|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285428|NCT03026842|Cytarabine|cytarabine|mesh-list
83285429|NCT03026842|Decitabine|decitabine|mesh-list
83285430|NCT03026842|Daunorubicin|daunorubicin|mesh-list
83285431|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
83285432|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
83285433|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83285434|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
83285435|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285436|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285437|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
83285438|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285439|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285440|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
83285441|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285442|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83285443|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83285444|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83285445|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285446|NCT03026842|Analgesics|analgesics|mesh-ancestor
83285447|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
83285448|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285449|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83285451|NCT01498822|Levetiracetam|levetiracetam|mesh-list
83285452|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
83285453|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
83285454|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83285455|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83285456|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285457|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285458|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83285459|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83285460|NCT01498120|Rotigotine|rotigotine|mesh-list
83285461|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
83285462|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
83285463|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285464|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285465|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285466|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83285467|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83285468|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285469|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285470|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
83285471|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285472|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
83285473|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83285474|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83285475|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285476|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
83285477|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
83285478|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83285479|NCT02197247|Rifampin|rifampin|mesh-list
83285480|NCT02197247|Osimertinib|osimertinib|mesh-list
83285481|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83285482|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
83285483|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83285484|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285485|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
83285486|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83285487|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285488|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285489|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83285490|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83285491|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83285492|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83285493|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83285494|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83285495|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285496|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83285497|NCT02224157|Budesonide|budesonide|mesh-list
83285498|NCT02224157|Terbutaline|terbutaline|mesh-list
83285499|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
83285500|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285501|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83285502|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
83285503|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285504|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285505|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83285506|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
83285507|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
83285508|NCT02224157|Hormones|hormones|mesh-ancestor
83285509|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285510|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83285511|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83285512|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83285513|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
83285514|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285515|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285516|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
83285517|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
83285518|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83285519|NCT02196701|Adalimumab|adalimumab|mesh-list
83285520|NCT02196701|Methotrexate|methotrexate|mesh-list
83285521|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83285522|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
83285523|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83285524|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285525|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83285526|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
83285527|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285528|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285529|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83285530|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285531|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83285532|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285533|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
83285534|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285535|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83285536|NCT02196701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83285537|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285538|NCT01481116|Glimepiride|glimepiride|mesh-list
83285539|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83285540|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83285541|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285542|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285543|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
83285544|NCT02222207|Ranibizumab|ranibizumab|mesh-list
83285545|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83285546|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83285547|NCT02222207|Growth Substances|growth substances|mesh-ancestor
83285548|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285549|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
83285550|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285551|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
83285552|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83285553|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83285554|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83285555|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285556|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285557|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
83285558|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285559|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285560|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83285561|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285562|NCT02252081|Metformin|metformin|mesh-list
83285563|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83285564|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285565|NCT01623752|Etanercept|etanercept|mesh-list
83285566|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83285567|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83285568|NCT01623752|Analgesics|analgesics|mesh-ancestor
83285569|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
83285570|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285571|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285572|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285573|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285574|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83285575|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285576|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
83285577|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83285578|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83285579|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285580|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285581|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
83285582|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285583|NCT02219477|Ritonavir|ritonavir|mesh-list
83285584|NCT02219477|Ribavirin|ribavirin|mesh-list
83285585|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83285586|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83285587|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
83285588|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285589|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285590|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83285591|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83285592|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
83285593|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285594|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83285595|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83285596|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
83285598|NCT02093390|Atorvastatin|atorvastatin|mesh-list
83285599|NCT02093390|Relugolix|relugolix|mesh-list
83285600|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83285601|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83285602|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
83285603|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285604|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83285605|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83285606|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285607|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
83285608|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285609|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83285610|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83285611|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83285612|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
83285613|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285614|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285615|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83285616|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83285617|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
83285618|NCT02219087|Bupivacaine|bupivacaine|mesh-list
83285619|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
83285620|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
83285621|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83285622|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285623|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
83285624|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285625|NCT02248961|Losartan|losartan|mesh-list
83285626|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83285627|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83285628|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83285629|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83285630|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285631|NCT02219009|Aripiprazole|aripiprazole|mesh-list
83285632|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
83285633|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83285634|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83285635|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83285636|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83285637|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285638|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
83285639|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
83285640|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285641|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285642|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83285643|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83285644|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
83285645|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83285646|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83285647|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83285648|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83285649|NCT01456936|Bupropion|bupropion|mesh-list
83285650|NCT01456936|Nicotine|nicotine|mesh-list
83285651|NCT01456936|Varenicline|varenicline|mesh-list
83285652|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83285653|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
83285654|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285655|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285656|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83285657|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83285658|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
83285659|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285660|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285661|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83285662|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
83285663|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83285664|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83285665|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83285666|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285667|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
83285668|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83285669|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83285670|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285671|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83285672|NCT01456780|Tobramycin|tobramycin|mesh-list
83285673|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
83285674|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83285675|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285676|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83285677|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83285678|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83285679|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83285680|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
83285681|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285682|NCT01479868|Interferons|interferons|mesh-list
83285683|NCT01479868|Ribavirin|ribavirin|mesh-list
83285684|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
83285685|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
83285686|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83285687|NCT01479868|Simeprevir|simeprevir|mesh-list
83285688|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285689|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
83285690|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285691|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
83285692|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285693|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
83285694|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285695|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
83285696|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285697|NCT01455220|Natalizumab|natalizumab|mesh-list
83285698|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
83285699|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285700|NCT01454596|Aldesleukin|aldesleukin|mesh-list
83285701|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
83285702|NCT01454596|Fludarabine|fludarabine|mesh-list
83285704|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285705|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
83285706|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285707|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285708|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83285709|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
83285710|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285711|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285712|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83285713|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
83285714|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83285715|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83285716|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
83285717|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285718|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
83285719|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83285720|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285721|NCT04541290|Tacrolimus|tacrolimus|mesh-list
83285722|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285723|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
83285724|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285725|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83285726|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285727|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285728|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83285729|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
83285730|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285731|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83285732|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83285733|NCT01495000|Denosumab|denosumab|mesh-list
83285734|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83285735|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285736|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83285737|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83285738|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
83285739|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285740|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285741|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83285742|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
83285743|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
83285744|NCT01494610|Hormones|hormones|mesh-ancestor
83285745|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285746|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
83285747|NCT02116777|Temozolomide|temozolomide|mesh-list
83285748|NCT02116777|Talazoparib|talazoparib|mesh-list
83285749|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83285750|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
83285751|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285752|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285753|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83285754|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285755|NCT01494532|Ropinirole|ropinirole|mesh-list
83285756|NCT01494532|Levodopa|levodopa|mesh-list
83285757|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83285758|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
83285759|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285760|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285761|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285762|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83285763|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83285764|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
83285765|NCT02191397|Dexetimide|dexetimide|mesh-list
83285766|NCT02191397|Citalopram|citalopram|mesh-list
83285767|NCT02191397|Bupropion|bupropion|mesh-list
83285768|NCT02191397|Escitalopram|escitalopram|mesh-list
83285769|NCT02191397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83285770|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83285771|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285772|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285773|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285774|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
83285775|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285776|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83285777|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83285778|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
83285779|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
83285780|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285781|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83285782|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83285783|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
83285784|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83285785|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
83285786|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83285787|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83285788|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
83285789|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83285790|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83285791|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285792|NCT01630811|Quinidine|quinidine|mesh-list
83285793|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
83285794|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
83285795|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
83285796|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83285797|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83285798|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285799|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285800|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285801|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83285802|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83285803|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
83285804|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83285805|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
83285806|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83285807|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83285808|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285809|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285810|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83285811|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83285812|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
83285813|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83285814|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83285815|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83285816|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83285817|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83285818|NCT02170025|Riociguat|riociguat|mesh-list
83285819|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
83285820|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285821|NCT02169791|Ixazomib|ixazomib|mesh-list
83285822|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285823|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
83285824|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285825|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285826|NCT02216357|Ifetroban|ifetroban|mesh-list
83285827|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83285828|NCT01492426|Ribavirin|ribavirin|mesh-list
83285829|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83285830|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
83285831|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285832|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
83285833|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285834|NCT01453348|Vaccines|vaccines|mesh-list
83285835|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
83285836|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285837|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
83285838|NCT01475734|Incretins|incretins|mesh-ancestor
83285839|NCT01475734|Hormones|hormones|mesh-ancestor
83285840|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83285841|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285842|NCT02189837|Atorvastatin|atorvastatin|mesh-list
83285843|NCT02189837|Evolocumab|evolocumab|mesh-list
83285844|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83285845|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83285846|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83285847|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
83285848|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285849|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83285850|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83285851|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285852|NCT02189837|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83285853|NCT02189837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83285854|NCT02189837|Protease Inhibitors|protease inhibitors|mesh-ancestor
83285855|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
83285856|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285857|NCT02216123|Chloroquine|chloroquine|mesh-list
83285858|NCT02216123|Primaquine|primaquine|mesh-list
83285859|NCT02216123|Tafenoquine|tafenoquine|mesh-list
83285860|NCT02216123|Amebicides|amebicides|mesh-ancestor
83285861|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83285862|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83285863|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285864|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
83285865|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285866|NCT01490866|Leucovorin|leucovorin|mesh-list
83285867|NCT01490866|Bevacizumab|bevacizumab|mesh-list
83285868|NCT01490866|Fluorouracil|fluorouracil|mesh-list
83285869|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
83285870|NCT01490866|Axitinib|axitinib|mesh-list
83285871|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83285872|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285873|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83285874|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83285875|NCT01490866|Growth Substances|growth substances|mesh-ancestor
83285876|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285877|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
83285878|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
83285879|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285880|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83285881|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285882|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
83285883|NCT01490866|Antidotes|antidotes|mesh-ancestor
83285884|NCT01490866|Protective Agents|protective agents|mesh-ancestor
83285885|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
83285886|NCT01490866|Vitamins|vitamins|mesh-ancestor
83285887|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
83285888|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83285889|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285890|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
83285891|NCT02215967|Fludarabine|fludarabine|mesh-list
83285892|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83285893|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
83285894|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285895|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285896|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83285897|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
83285898|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285899|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83285900|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83285901|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
83285902|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83285903|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
83285904|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285905|NCT02168387|Expectorants|expectorants|mesh-ancestor
83285906|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
83285907|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83285908|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
83285909|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285910|NCT02168387|Protective Agents|protective agents|mesh-ancestor
83285911|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285912|NCT02168387|Antidotes|antidotes|mesh-ancestor
83285913|NCT04418219|Interferons|interferons|mesh-list
83285914|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
83285915|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
83285916|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
83285917|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
83285931|NCT02167451|Maraviroc|maraviroc|mesh-list
83285932|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83285933|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83285934|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285935|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83285936|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83285937|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
83285938|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83285939|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83285940|NCT02167139|Adalimumab|adalimumab|mesh-list
83285941|NCT02167139|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83285942|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285943|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285957|NCT02116309|Indomethacin|indomethacin|mesh-list
83285958|NCT02116309|Epinephrine|epinephrine|mesh-list
83285959|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83285960|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83285961|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
83285962|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83285963|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83285964|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285965|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83285966|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83285967|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
83285968|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83285969|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83285970|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
83285971|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
83285972|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
83285973|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83285974|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83285975|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83285976|NCT02116309|Analgesics|analgesics|mesh-ancestor
83285977|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
83285978|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83285979|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83285980|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
83285981|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
83285982|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83285983|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83285984|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83285985|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
83285986|NCT01474486|Thiamine|thiamine|mesh-list
83285987|NCT01474486|Micronutrients|micronutrients|mesh-list
83285988|NCT01474486|Trace Elements|trace elements|mesh-list
83285989|NCT01474486|Vitamins|vitamins|mesh-ancestor
83285990|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285991|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
83285992|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83285993|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83285994|NCT01451398|Insulin|insulin|mesh-list
83285995|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83285996|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83285997|NCT02073565|Everolimus|everolimus|mesh-list
83285998|NCT02073565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83285999|NCT02073565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83286000|NCT02073565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286001|NCT02073565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286002|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286003|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
83286004|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286005|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286006|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83286007|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
83286008|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83286009|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
83286010|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286011|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286012|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83286013|NCT01450696|Capecitabine|capecitabine|mesh-list
83286014|NCT01450696|Trastuzumab|trastuzumab|mesh-list
83286015|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286016|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83286017|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
83286018|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286019|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83286020|NCT02070991|Macitentan|macitentan|mesh-list
83286021|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83286022|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83286023|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286024|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83286025|NCT01490086|Aripiprazole|aripiprazole|mesh-list
83286026|NCT01490086|RP5063|rp5063|mesh-list
83286027|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
83286028|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83286029|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83286030|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83286031|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286032|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286033|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
83286034|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
83286035|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286036|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286037|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83286038|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83286039|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
83286040|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83286041|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83286042|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83286043|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83286044|NCT02113579|Fluorides|fluorides|mesh-list
83286045|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
83286046|NCT02113579|Protective Agents|protective agents|mesh-ancestor
83286047|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286048|NCT01474018|Bromocriptine|bromocriptine|mesh-list
83286049|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83286050|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83286051|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
83286052|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286053|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286054|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
83286055|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
83286056|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286057|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286058|NCT02100475|Insulin|insulin|mesh-list
83286059|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83286060|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
83286061|NCT02100475|Liraglutide|liraglutide|mesh-list
83286062|NCT02100475|Xultophy|xultophy|mesh-list
83286063|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83286064|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286065|NCT02100475|Incretins|incretins|mesh-ancestor
83286066|NCT02100475|Hormones|hormones|mesh-ancestor
83286067|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286068|NCT04075240|Aspirin|aspirin|mesh-list
83286069|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
83286070|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83286071|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83286072|NCT04075240|Analgesics|analgesics|mesh-ancestor
83286073|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
83286074|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286075|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286076|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286077|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286078|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83286079|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83286080|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286081|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83286082|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83286083|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286084|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
83286085|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83286086|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
83286087|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83286088|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286089|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
83286090|NCT02070757|Meropenem|meropenem|mesh-list
83286091|NCT02070757|Tazobactam|tazobactam|mesh-list
83286092|NCT02070757|Ceftolozane|ceftolozane|mesh-list
83286093|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83286094|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83286095|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286096|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83286097|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286098|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286099|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83286100|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83286101|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83286102|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83286103|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286104|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
83286105|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83286106|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286107|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286108|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83286109|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83286110|NCT01625845|Protective Agents|protective agents|mesh-ancestor
83286111|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286112|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
83286113|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83286114|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
83286115|NCT01473940|Gemcitabine|gemcitabine|mesh-list
83286116|NCT01473940|Ipilimumab|ipilimumab|mesh-list
83286117|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83286118|NCT01473940|Antibodies|antibodies|mesh-list
83286119|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
83286120|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83286121|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
83286122|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286123|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83286124|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
83286125|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286126|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286127|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83286128|NCT01832727|Dexamethasone|dexamethasone|mesh-list
83286129|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286130|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
83286131|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
83286132|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286133|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286134|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286135|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
83286136|NCT01832727|Hormones|hormones|mesh-ancestor
83286137|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286138|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83286139|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286140|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83286141|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
83286142|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83286143|NCT01473394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83286144|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83286145|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83286146|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286147|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286148|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
83286149|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286150|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83286151|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83286153|NCT04408144|Progestins|progestins|mesh-ancestor
83286154|NCT04408144|Hormones|hormones|mesh-ancestor
83286155|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286156|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286157|NCT01449682|Dexamethasone|dexamethasone|mesh-list
83286158|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
83286159|NCT01449682|BB 1101|bb 1101|mesh-list
83286160|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286161|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
83286162|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
83286163|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286164|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286165|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286166|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
83286167|NCT01449682|Hormones|hormones|mesh-ancestor
83286168|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286169|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83286170|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286171|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286172|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286173|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286174|NCT01831791|Dutasteride|dutasteride|mesh-list
83286175|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83286176|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83286177|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286178|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286179|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
83286180|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286181|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286182|NCT01857531|Nicotine|nicotine|mesh-list
83286183|NCT01857531|Ganaxolone|ganaxolone|mesh-list
83286184|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83286185|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
83286186|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286187|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286188|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83286189|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83286190|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
83286191|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286192|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286193|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
83286194|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
83286195|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
83286196|NCT02166047|Vesatolimod|vesatolimod|mesh-list
83286197|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
83286198|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286199|NCT01831089|Paclitaxel|paclitaxel|mesh-list
83286200|NCT01831089|Bevacizumab|bevacizumab|mesh-list
83286201|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83286202|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286204|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
83286205|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
83286206|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286207|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83286208|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83286209|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83286210|NCT01831089|Growth Substances|growth substances|mesh-ancestor
83286211|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286212|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
83286214|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286215|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
83286216|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
83286217|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286218|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286219|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286220|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
83286221|NCT02111785|Hormones|hormones|mesh-ancestor
83286222|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286223|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83286224|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286225|NCT02068495|Amlodipine|amlodipine|mesh-list
83286226|NCT02068495|Candesartan|candesartan|mesh-list
83286227|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
83286228|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83286229|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83286230|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83286231|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286232|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83286233|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286234|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
83286235|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83286236|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83286237|NCT02097823|Olanzapine|olanzapine|mesh-list
83286238|NCT02097823|Aprepitant|aprepitant|mesh-list
83286239|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
83286240|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
83286241|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286242|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286243|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286244|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83286245|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83286246|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286247|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83286248|NCT02097823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83286249|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83286250|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83286251|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286252|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286253|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
83286254|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83286255|NCT01857063|Montelukast|montelukast|mesh-list
83286256|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83286257|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
83286258|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83286259|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
83286260|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286261|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286262|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83286263|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83286264|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286265|NCT01856907|Metformin|metformin|mesh-list
83286266|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83286267|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83286268|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286269|NCT01856907|Incretins|incretins|mesh-ancestor
83286270|NCT01856907|Hormones|hormones|mesh-ancestor
83430170|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83286271|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286272|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83286273|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286274|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286275|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286276|NCT02097745|Rituximab|rituximab|mesh-list
83286277|NCT02097745|Methotrexate|methotrexate|mesh-list
83286278|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83286279|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286280|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
83286281|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286282|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286283|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83286284|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
83286285|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83286286|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83286287|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
83286288|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286289|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286290|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286291|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83286292|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286293|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83286294|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
83286295|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83286296|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286297|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
83286298|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83286299|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
83286300|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83286301|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286302|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83286303|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
83286304|NCT02212379|Etravirine|etravirine|mesh-list
83286305|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83286306|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83286307|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
83286308|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286309|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83286310|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83286311|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286312|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286313|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83286314|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83286315|NCT02187809|Clobazam|clobazam|mesh-list
83286316|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
83286317|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83286318|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83286319|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286320|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286321|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83286322|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83286323|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
83286324|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
83286325|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286326|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286327|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83286328|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83286329|NCT02110225|Mitogens|mitogens|mesh-list
83286330|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
83286331|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286332|NCT04756505|Interleukin-12|interleukin-12|mesh-list
83286333|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
83286334|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83286335|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
83286336|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286337|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83286338|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83286339|NCT04756505|Growth Substances|growth substances|mesh-ancestor
83286340|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
83286341|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286342|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
83286343|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83286344|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286345|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83286346|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83286347|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286348|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286349|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286350|NCT02162771|Prednisone|prednisone|mesh-list
83286351|NCT02162771|Prednisolone|prednisolone|mesh-list
83286352|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
83286353|NCT02162771|Rituximab|rituximab|mesh-list
83286354|NCT02162771|Vincristine|vincristine|mesh-list
83286355|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286356|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
83286357|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286358|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286359|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83286360|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
83286361|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286362|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286363|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83286364|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83286365|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286366|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
83286367|NCT02162771|Hormones|hormones|mesh-ancestor
83286368|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286369|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83286370|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83286371|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
83286372|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
83286373|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
83286374|NCT02160041|Infigratinib|infigratinib|mesh-list
83286375|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286376|NCT02186873|Golimumab|golimumab|mesh-list
83286377|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83286378|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286379|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286380|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
83286381|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286382|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83286383|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
83286384|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286385|NCT01830543|Aspirin|aspirin|mesh-list
83286386|NCT01830543|Vitamin K|vitamin k|mesh-list
83286387|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
83286388|NCT01830543|Clopidogrel|clopidogrel|mesh-list
83286389|NCT01830543|Ticagrelor|ticagrelor|mesh-list
83286390|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83286391|NCT01830543|Vitamins|vitamins|mesh-ancestor
83286392|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
83286393|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286394|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83286395|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83286396|NCT01830543|Analgesics|analgesics|mesh-ancestor
83286397|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
83286398|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286399|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286400|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286401|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83286402|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83286403|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286404|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83286405|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83286406|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286407|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
83286408|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83286409|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83286410|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83286411|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
83286412|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286413|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83286414|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
83286415|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83286416|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286417|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
83286418|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83286419|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
83286420|NCT01830543|Coagulants|coagulants|mesh-ancestor
83286421|NCT02109445|Paclitaxel|paclitaxel|mesh-list
83286422|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83286423|NCT02109445|Gemcitabine|gemcitabine|mesh-list
83286424|NCT02109445|Nirogacestat|nirogacestat|mesh-list
83286425|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83286426|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286427|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
83286428|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
83286429|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
83286430|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286431|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83286432|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
83286433|NCT02109445|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83286434|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286435|NCT02109133|Rocuronium|rocuronium|mesh-list
83286436|NCT02109133|Atracurium|atracurium|mesh-list
83286437|NCT02109133|Neostigmine|neostigmine|mesh-list
83286438|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83286439|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83286440|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83286441|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286442|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286443|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83286444|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286445|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286446|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
83286447|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286448|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83286449|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
83286450|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83286451|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83286452|NCT01623271|Gabapentin|gabapentin|mesh-list
83286453|NCT01623271|Analgesics|analgesics|mesh-ancestor
83286454|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
83286455|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286456|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286457|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
83286458|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83286459|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83286460|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286461|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83286462|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83286463|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83286464|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286465|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286466|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
83286467|NCT02095951|Ethanol|ethanol|mesh-list
83286468|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83286469|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286470|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286471|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286472|NCT02095873|Resveratrol|resveratrol|mesh-list
83286473|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
83286474|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286475|NCT02095873|Protective Agents|protective agents|mesh-ancestor
83286476|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286477|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286478|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83286479|NCT02094937|Fluticasone|fluticasone|mesh-list
83286480|NCT02094937|Xhance|xhance|mesh-list
83286481|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286482|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83286483|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
83286484|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286485|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286486|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83286487|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
83286488|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286489|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83286490|NCT04724629|Aldesleukin|aldesleukin|mesh-list
83286492|NCT04724629|Ixekizumab|ixekizumab|mesh-list
83286493|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286494|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83286495|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83286496|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
83286497|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286498|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
83286499|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286500|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
83286501|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
83286502|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
83286503|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286504|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286505|NCT02186015|Vitamin D|vitamin d|mesh-list
83286506|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
83286507|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
83286508|NCT02186015|Vitamins|vitamins|mesh-list
83286509|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
83286510|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286511|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83286512|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83286513|NCT02066389|Upadacitinib|upadacitinib|mesh-list
83286514|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83286515|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83286516|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286517|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286518|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286519|NCT02106403|Disinfectants|disinfectants|mesh-list
83286520|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286521|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
83286522|NCT02133131|Grazoprevir|grazoprevir|mesh-list
83286523|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83286524|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
83286525|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286526|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
83286527|NCT02106325|Promethazine|promethazine|mesh-list
83286528|NCT02106325|Ketamine|ketamine|mesh-list
83286529|NCT02106325|Analgesics|analgesics|mesh-ancestor
83286530|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
83286531|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286532|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286533|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83286534|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83286535|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
83286536|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
83286537|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286538|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83286539|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83286540|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286541|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286542|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83286543|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83286544|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
83286545|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
83286546|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
83286547|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286548|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83286549|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
83286550|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
83286551|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83286552|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
83286553|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286554|NCT02184611|Bromides|bromides|mesh-list
83286555|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
83286556|NCT02066311|Nelfinavir|nelfinavir|mesh-list
83286557|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83286558|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83286559|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286560|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286561|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286562|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83286563|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83286564|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
83286565|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286566|NCT01625611|Naltrexone|naltrexone|mesh-list
83286567|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83286568|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83286569|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286570|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
83286571|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286572|NCT02159807|Fentanyl|fentanyl|mesh-list
83286573|NCT02159807|Bupivacaine|bupivacaine|mesh-list
83286574|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
83286575|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
83286576|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286577|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286578|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
83286579|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286580|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83286581|NCT02159807|Narcotics|narcotics|mesh-ancestor
83286582|NCT02159807|Analgesics|analgesics|mesh-ancestor
83286583|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83286584|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83286585|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
83286586|NCT02183675|Amlodipine|amlodipine|mesh-list
83286587|NCT02183675|Telmisartan|telmisartan|mesh-list
83286588|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83286589|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83286590|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83286591|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83286592|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83286593|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286594|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83286595|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286596|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
83286597|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83286598|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83286599|NCT02183675|Diuretics|diuretics|mesh-ancestor
83286600|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
83286601|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83286602|NCT02183519|Capsaicin|capsaicin|mesh-list
83286603|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
83286604|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286605|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
83286606|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286607|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286608|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83286609|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83286610|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
83286611|NCT02132195|Hormones|hormones|mesh-ancestor
83286612|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286613|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286614|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286615|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286616|NCT02182895|Saxagliptin|saxagliptin|mesh-list
83286617|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83286618|NCT02182895|Incretins|incretins|mesh-ancestor
83286619|NCT02182895|Hormones|hormones|mesh-ancestor
83286620|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286621|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286622|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286623|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286624|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286625|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83286626|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
83286627|NCT01625377|Everolimus|everolimus|mesh-list
83286628|NCT01625377|Tacrolimus|tacrolimus|mesh-list
83286629|NCT01625377|Basiliximab|basiliximab|mesh-list
83286630|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286631|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
83286632|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286633|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83286634|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286635|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286637|NCT01625377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83286638|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286639|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83286640|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83286641|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
83286642|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83286643|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286644|NCT02132117|Phenylephrine|phenylephrine|mesh-list
83286645|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
83286646|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83286647|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83286648|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
83286649|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286650|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286651|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286652|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
83286653|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
83286654|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286655|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
83286656|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83286657|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
83286658|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83286659|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
83286660|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83286661|NCT02132117|Protective Agents|protective agents|mesh-ancestor
83286662|NCT02047045|Prucalopride|prucalopride|mesh-list
83286664|NCT02047045|Laxatives|laxatives|mesh-ancestor
83286665|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286666|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83286667|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83286668|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
83286669|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286670|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286671|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286672|NCT02131259|Afatinib|afatinib|mesh-list
83286673|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286674|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83286675|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286676|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286677|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
83286678|NCT01829295|Prednisone|prednisone|mesh-list
83286679|NCT01829295|Methotrexate|methotrexate|mesh-list
83286680|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286681|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
83286682|NCT01829295|Hormones|hormones|mesh-ancestor
83286683|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286684|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286685|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83286686|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286687|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83286688|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
83286689|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83286690|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83286691|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
83286692|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286693|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286694|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286695|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83286696|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286697|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
83286698|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286699|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83286700|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83286701|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83286702|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
83286703|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83286704|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286705|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
83286706|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83286707|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83286708|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
83286709|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286710|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286711|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83286712|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
83286713|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83286714|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83286715|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83286716|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
83286717|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286718|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286719|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
83286720|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83286721|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
83286722|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286723|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286724|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83286725|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83286726|NCT01623115|Alirocumab|alirocumab|mesh-list
83286727|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83286728|NCT01623115|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83286729|NCT01623115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83286730|NCT01623115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83286731|NCT01623115|Antimetabolites|antimetabolites|mesh-ancestor
83286732|NCT01623115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286733|NCT01623115|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83286734|NCT01623115|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286735|NCT01623115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286736|NCT01623115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83286737|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
83286738|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286739|NCT02092285|Golimumab|golimumab|mesh-list
83286740|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83286741|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286742|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286743|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
83286744|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286745|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
83286746|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83286747|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83286748|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83286749|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83286750|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83286751|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286752|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
83286753|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286754|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286755|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83286756|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286757|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
83286758|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
83286759|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83286760|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
83286761|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286762|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286763|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83286764|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
83286765|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83286766|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83286767|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83286768|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
83286769|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286770|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286771|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286772|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286773|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83286774|NCT01827267|Sirolimus|sirolimus|mesh-list
83286775|NCT01827267|Temsirolimus|temsirolimus|mesh-list
83286776|NCT01827267|MTOR Inhibitors|mtor inhibitors|mesh-list
83286777|NCT01827267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83286778|NCT01827267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286779|NCT01827267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286780|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286781|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
83286782|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286783|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286784|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83286785|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286786|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83286787|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
83286788|NCT01827111|Paclitaxel|paclitaxel|mesh-list
83286789|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83286790|NCT01827111|Ipilimumab|ipilimumab|mesh-list
83286791|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83286792|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286793|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
83286794|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
83286795|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
83286796|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286797|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83286798|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83286799|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
83286800|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83286801|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
83286802|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83286803|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
83286804|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286805|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286806|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
83286807|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
83286808|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286809|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83286810|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286811|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286812|NCT01854645|Bromides|bromides|mesh-list
83286813|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
83286814|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83286815|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
83286816|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286817|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286818|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83286819|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
83286820|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
83286821|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83286822|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
83286823|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286824|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286825|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
83286826|NCT04418089|Simvastatin|simvastatin|mesh-list
83286827|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83286828|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83286829|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
83286830|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286831|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83286832|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83286833|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286834|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
83286835|NCT01825941|Promethazine|promethazine|mesh-list
83286836|NCT01825941|Metoclopramide|metoclopramide|mesh-list
83286837|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83286838|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83286839|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83286840|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286841|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
83286842|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
83286843|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
83286844|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286845|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
83286846|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
83286847|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83286848|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83286849|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
83286850|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
83286851|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286852|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286853|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83286854|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
83286855|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286856|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83286857|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83286858|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
83286859|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
83286860|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83286861|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286862|NCT02180165|Voriconazole|voriconazole|mesh-list
83286863|NCT02180165|Posaconazole|posaconazole|mesh-list
83286864|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
83286865|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286866|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83286867|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83286868|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286869|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286870|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83286871|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
83286872|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286873|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286874|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83286875|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83286876|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83286877|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83286878|NCT02155985|Aspirin|aspirin|mesh-list
83286879|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83286880|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83286881|NCT02155985|Analgesics|analgesics|mesh-ancestor
83286882|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
83286883|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286884|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286886|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286887|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83286888|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83286889|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286890|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83286891|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83286892|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286893|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
83286894|NCT02155829|Riluzole|riluzole|mesh-list
83286895|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
83286896|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83286897|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83286898|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286899|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286900|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286901|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83286902|NCT02155829|Protective Agents|protective agents|mesh-ancestor
83286903|NCT02178995|Methylphenidate|methylphenidate|mesh-list
83286904|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83286905|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286906|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83286907|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83286908|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83286909|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286910|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
83286911|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286912|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
83286913|NCT02154425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83286914|NCT02154425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286915|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286916|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
83286917|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286918|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286919|NCT02154347|Mitiglinide|mitiglinide|mesh-list
83286920|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83286921|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286922|NCT01627067|Metformin|metformin|mesh-list
83286923|NCT01627067|Everolimus|everolimus|mesh-list
83286924|NCT01627067|Exemestane|exemestane|mesh-list
83286925|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83286926|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286927|NCT01627067|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83286928|NCT01627067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83286929|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286930|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286931|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286932|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
83286933|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83286934|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83286935|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83286936|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83286937|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
83286938|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83286939|NCT02178059|Terbutaline|terbutaline|mesh-list
83286940|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83286941|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
83286942|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286943|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286944|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83286945|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
83286946|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
83286947|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
83286948|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83286949|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83286950|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83286951|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83286952|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
83286953|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83286954|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286955|NCT02128217|Ribavirin|ribavirin|mesh-list
83286956|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
83286957|NCT02128217|Ledipasvir|ledipasvir|mesh-list
83286958|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83286959|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
83286960|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286961|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
83286962|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286964|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83286965|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83286966|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286967|NCT02127125|Sevelamer|sevelamer|mesh-list
83286968|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
83286969|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
83286970|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286971|NCT02090413|Aspirin|aspirin|mesh-list
83286972|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83286973|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83286974|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83286975|NCT02090413|Analgesics|analgesics|mesh-ancestor
83286976|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
83286977|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83286978|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83286979|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83286980|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83286981|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83286982|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83286983|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286984|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83286985|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83286986|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83286987|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
83286988|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
83286989|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83286990|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
83286991|NCT02125877|Deferasirox|deferasirox|mesh-list
83286992|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83286993|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
83286994|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
83286995|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83286996|NCT01598987|Cyclosporine|cyclosporine|mesh-list
83286997|NCT01598987|Everolimus|everolimus|mesh-list
83286998|NCT01598987|Tacrolimus|tacrolimus|mesh-list
83286999|NCT01598987|Cyclosporins|cyclosporins|mesh-list
83287000|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287001|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
83287002|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287003|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83287004|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287005|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287006|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
83287007|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287008|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
83287009|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287010|NCT01598987|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83287011|NCT01598987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83287012|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287013|NCT02062879|Ketamine|ketamine|mesh-list
83287014|NCT02062879|Hydromorphone|hydromorphone|mesh-list
83287015|NCT02062879|Analgesics|analgesics|mesh-ancestor
83287016|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
83287017|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287018|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287019|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83287020|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83287021|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
83287022|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
83287023|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287024|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83287025|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83287026|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287027|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287028|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83287029|NCT02062879|Narcotics|narcotics|mesh-ancestor
83287030|NCT02062645|Amlodipine|amlodipine|mesh-list
83287031|NCT02062645|Valsartan|valsartan|mesh-list
83287032|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83287033|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83287034|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83287035|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287036|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287037|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83287038|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287039|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
83287040|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83287041|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83287043|NCT04700839|Canagliflozin|canagliflozin|mesh-list
83287044|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83287045|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287046|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287047|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287048|NCT02043301|Bococizumab|bococizumab|mesh-list
83287049|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83287050|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83287051|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
83287052|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287053|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83287054|NCT01598753|Tramadol|tramadol|mesh-list
83287055|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83287056|NCT01598753|Narcotics|narcotics|mesh-ancestor
83287057|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287058|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287059|NCT01598753|Analgesics|analgesics|mesh-ancestor
83287060|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
83287061|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287062|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
83287063|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
83287065|NCT01824693|Busulfan|busulfan|mesh-list
83287066|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
83287067|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83287068|NCT01824693|Fludarabine|fludarabine|mesh-list
83287069|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
83287070|NCT01824693|Tacrolimus|tacrolimus|mesh-list
83287071|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287072|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
83287073|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287074|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287075|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83287076|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
83287077|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287078|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287079|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83287080|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83287081|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
83287082|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83287083|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287084|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83287085|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83287086|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
83287087|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287088|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287089|NCT02176655|Aspirin|aspirin|mesh-list
83287090|NCT02176655|Sumatriptan|sumatriptan|mesh-list
83287091|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83287092|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83287093|NCT02176655|Analgesics|analgesics|mesh-ancestor
83287094|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
83287095|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287096|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287097|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287098|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287099|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83287100|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83287101|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287102|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83287103|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83287104|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287105|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
83287106|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83287107|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83287108|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83287109|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
83287110|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287111|NCT01622569|Fluticasone|fluticasone|mesh-list
83287112|NCT01622569|Xhance|xhance|mesh-list
83287113|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287114|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83287115|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
83287116|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287117|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287118|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83287119|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
83287120|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
83287121|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83287122|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83287123|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287124|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83287125|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287126|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287127|NCT04747301|Dinoprostone|dinoprostone|mesh-list
83287128|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
83287129|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83287130|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287131|NCT02152163|Ibuprofen|ibuprofen|mesh-list
83287132|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83287133|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83287134|NCT02152163|Analgesics|analgesics|mesh-ancestor
83287135|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
83287136|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287137|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287138|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287139|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287140|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83287141|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287142|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287143|NCT02152007|Sirolimus|sirolimus|mesh-list
83287144|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287145|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287146|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83287147|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287148|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
83287149|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287150|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
83287151|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287152|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
83287153|NCT02151851|Methotrexate|methotrexate|mesh-list
83287154|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83287155|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
83287156|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83287157|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287158|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83287159|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
83287160|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287161|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287162|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
83287163|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287164|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83287165|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287166|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
83287167|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287168|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83287169|NCT02151851|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83287170|NCT02151851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287171|NCT02176421|Lidocaine|lidocaine|mesh-list
83287172|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
83287173|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
83287174|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287175|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287176|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
83287177|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287178|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83287179|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83287180|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83287181|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287182|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287183|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
83287184|NCT02042443|Leucovorin|leucovorin|mesh-list
83287185|NCT02042443|Folic Acid|folic acid|mesh-list
83287186|NCT02042443|Fluorouracil|fluorouracil|mesh-list
83287187|NCT02042443|Capecitabine|capecitabine|mesh-list
83287188|NCT02042443|Trametinib|trametinib|mesh-list
83287189|NCT02042443|Calcium|calcium|mesh-list
83287190|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
83287191|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83287192|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287193|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83287194|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
83287195|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287196|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83287197|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287198|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287199|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
83287200|NCT02042443|Antidotes|antidotes|mesh-ancestor
83287201|NCT02042443|Protective Agents|protective agents|mesh-ancestor
83287202|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
83287203|NCT02042443|Vitamins|vitamins|mesh-ancestor
83287204|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
83287205|NCT02042443|Hematinics|hematinics|mesh-ancestor
83287206|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83287207|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287208|NCT04747145|Temozolomide|temozolomide|mesh-list
83287209|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83287210|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
83287211|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287212|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287213|NCT02118896|Tacrolimus|tacrolimus|mesh-list
83287214|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287215|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
83287216|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287217|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83287218|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287219|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287220|NCT02124707|Paclitaxel|paclitaxel|mesh-list
83287221|NCT02124707|Carboplatin|carboplatin|mesh-list
83287222|NCT02124707|Cetuximab|cetuximab|mesh-list
83287223|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83287224|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287225|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
83287226|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
83287227|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
83287228|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287229|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83287230|NCT04723862|Spironolactone|spironolactone|mesh-list
83287231|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83287232|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
83287233|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287234|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287235|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83287236|NCT04723862|Diuretics|diuretics|mesh-ancestor
83287237|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
83287238|NCT02092220|Pancrelipase|pancrelipase|mesh-list
83287239|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83287240|NCT02066402|Linezolid|linezolid|mesh-list
83287241|NCT02066402|Tedizolid|tedizolid|mesh-list
83287242|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
83287243|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287244|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287245|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83287246|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287247|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287248|NCT02060383|Metformin|metformin|mesh-list
83287249|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83287250|NCT02060383|Liraglutide|liraglutide|mesh-list
83287251|NCT02060383|Pasireotide|pasireotide|mesh-list
83287252|NCT02060383|Somatostatin|somatostatin|mesh-list
83287253|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287254|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287255|NCT02060383|Incretins|incretins|mesh-ancestor
83287256|NCT02060383|Hormones|hormones|mesh-ancestor
83287257|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287258|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83287259|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
83287260|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287261|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287262|NCT02086591|Doxycycline|doxycycline|mesh-list
83287263|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287264|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287265|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
83287266|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83287267|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83287268|NCT02065622|Adalimumab|adalimumab|mesh-list
83287269|NCT02065622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83287270|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287271|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287272|NCT02117648|Clarithromycin|clarithromycin|mesh-list
83287273|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287274|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287275|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83287276|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287277|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287278|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83287279|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83287280|NCT02124161|Vaccines|vaccines|mesh-list
83287281|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83287282|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
83287283|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287284|NCT02117570|Vaccines|vaccines|mesh-list
83287285|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
83287286|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287287|NCT02123459|Cephalexin|cephalexin|mesh-list
83287288|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287289|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287290|NCT01853475|Artefenomel|artefenomel|mesh-list
83287291|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
83287292|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83287293|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83287294|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287295|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
83287296|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287297|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
83287298|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287299|NCT04411160|Protective Agents|protective agents|mesh-ancestor
83287300|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83287301|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
83287302|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287303|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83287304|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
83287305|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83287306|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287307|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83287308|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
83287309|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
83287310|NCT02151773|Vaccines|vaccines|mesh-list
83287311|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
83287312|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287313|NCT02151461|Metformin|metformin|mesh-list
83287314|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287315|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287316|NCT02091986|Budesonide|budesonide|mesh-list
83287317|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83287318|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287319|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83287320|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
83287321|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287322|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287323|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83287324|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
83287325|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
83287326|NCT02091986|Hormones|hormones|mesh-ancestor
83287327|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287328|NCT02117024|Paclitaxel|paclitaxel|mesh-list
83287329|NCT02117024|Vinorelbine|vinorelbine|mesh-list
83287330|NCT02117024|Docetaxel|docetaxel|mesh-list
83287331|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
83287332|NCT02117024|Gemcitabine|gemcitabine|mesh-list
83287333|NCT02117024|Pemetrexed|pemetrexed|mesh-list
83287334|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83287335|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83287336|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287337|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
83287338|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
83287339|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
83287340|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287341|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287342|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
83287343|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287344|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287345|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83287346|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
83287347|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83287348|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83287349|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
83287350|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287351|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83287352|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83287353|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83287355|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83287357|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287358|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
83287359|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287360|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287361|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
83287362|NCT02151149|Paclitaxel|paclitaxel|mesh-list
83287363|NCT02151149|Carboplatin|carboplatin|mesh-list
83287364|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83287365|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287366|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
83287367|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
83287368|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
83287369|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287370|NCT02150213|Dexamethasone|dexamethasone|mesh-list
83287371|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287372|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
83287373|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
83287374|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287375|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287376|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83287377|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
83287378|NCT02150213|Hormones|hormones|mesh-ancestor
83287379|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287380|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83287381|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287382|NCT02091362|Metformin|metformin|mesh-list
83287383|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287384|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287385|NCT02091206|Cannabidiol|cannabidiol|mesh-list
83287386|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
83287387|NCT02062658|Ketamine|ketamine|mesh-list
83287388|NCT02062658|Analgesics|analgesics|mesh-ancestor
83287389|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
83287390|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287391|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287392|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83287393|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83287394|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
83287395|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
83287396|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287397|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83287398|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83287399|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287400|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287401|NCT02115308|Regadenoson|regadenoson|mesh-list
83287402|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83287403|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83287404|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
83287405|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
83287406|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287407|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287408|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287409|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
83287410|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287411|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287412|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83287413|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83287414|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287415|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287416|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287417|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
83287418|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
83287419|NCT02090114|Testosterone|testosterone|mesh-list
83287420|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
83287421|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
83287422|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83287423|NCT02090114|Androgens|androgens|mesh-ancestor
83287424|NCT02090114|Hormones|hormones|mesh-ancestor
83287425|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287426|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287427|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83287428|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287429|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
83287430|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83287431|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287432|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287433|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
83287434|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83287435|NCT04742036|Paclitaxel|paclitaxel|mesh-list
83287436|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83287437|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287438|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
83287439|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
83287440|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
83287441|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287442|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
83287443|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83287444|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
83287445|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83287446|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
83287447|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287448|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287449|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
83287450|NCT02111096|Metformin|metformin|mesh-list
83287451|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83287452|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287453|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287454|NCT02111096|Incretins|incretins|mesh-ancestor
83287455|NCT02111096|Hormones|hormones|mesh-ancestor
83287456|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287457|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83287458|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
83287459|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287460|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287461|NCT02110706|Rituximab|rituximab|mesh-list
83287462|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83287463|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287464|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
83287465|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287466|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287467|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
83287468|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83287469|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
83287470|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287471|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
83287472|NCT02110238|Protective Agents|protective agents|mesh-ancestor
83287473|NCT02107898|Alirocumab|alirocumab|mesh-list
83287474|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83287475|NCT02107898|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83287476|NCT02107898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83287477|NCT02107898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83287478|NCT02107898|Antimetabolites|antimetabolites|mesh-ancestor
83287479|NCT02107898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287480|NCT02107898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83287481|NCT02107898|Protease Inhibitors|protease inhibitors|mesh-ancestor
83287482|NCT02107898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287483|NCT02107898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83287484|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
83287485|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287486|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
83287487|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83287488|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83287489|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287490|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287491|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
83287492|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287493|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287494|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83287495|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287496|NCT02107274|Azithromycin|azithromycin|mesh-list
83287497|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287498|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287499|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
83287500|NCT02173769|Olodaterol|olodaterol|mesh-list
83287501|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83287502|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
83287503|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287504|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287505|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83287506|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
83287507|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
83287508|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83287509|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
83287510|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287511|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287512|NCT02121509|Metformin|metformin|mesh-list
83287513|NCT02121509|Linagliptin|linagliptin|mesh-list
83287514|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287515|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287516|NCT02121509|Incretins|incretins|mesh-ancestor
83287517|NCT02121509|Hormones|hormones|mesh-ancestor
83287518|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287519|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83287520|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
83287521|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287522|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287523|NCT02149199|Budesonide|budesonide|mesh-list
83287524|NCT02149199|Terbutaline|terbutaline|mesh-list
83287525|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
83287526|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287527|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83287528|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
83287529|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287530|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287531|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83287532|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
83287533|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
83287534|NCT02149199|Hormones|hormones|mesh-ancestor
83287535|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287536|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83287537|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83287538|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83287539|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
83287540|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287541|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287542|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
83287543|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
83287544|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83287545|NCT02120417|Capecitabine|capecitabine|mesh-list
83287546|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83287547|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
83287548|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287549|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287550|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
83287551|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83287552|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83287553|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83287554|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287555|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287556|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
83287557|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287558|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287559|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83287560|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287561|NCT02058368|Tamsulosin|tamsulosin|mesh-list
83287562|NCT02058368|Dutasteride|dutasteride|mesh-list
83287563|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83287564|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83287565|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83287566|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
83287567|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287568|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287569|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287570|NCT02058368|Urological Agents|urological agents|mesh-ancestor
83287571|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83287572|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83287573|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287574|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
83287575|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287576|NCT02058290|Morphine|morphine|mesh-list
83287577|NCT02058290|Bupivacaine|bupivacaine|mesh-list
83287578|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
83287579|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
83287580|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287581|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287582|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
83287583|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287584|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83287585|NCT02058290|Narcotics|narcotics|mesh-ancestor
83287586|NCT02058290|Analgesics|analgesics|mesh-ancestor
83287587|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
83287588|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83287589|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83287590|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287591|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287592|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83287593|NCT04718480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83287594|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83287595|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287596|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287597|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287598|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
83287599|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83287600|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
83287601|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83287602|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83287603|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287604|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83287605|NCT02106884|Paclitaxel|paclitaxel|mesh-list
83287606|NCT02106884|Gemcitabine|gemcitabine|mesh-list
83287607|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83287608|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287609|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
83287610|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
83287611|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
83287612|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287613|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83287614|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
83287615|NCT02081690|Macitentan|macitentan|mesh-list
83287616|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83287617|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83287618|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287619|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83287620|NCT01625000|Risperidone|risperidone|mesh-list
83287621|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83287622|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
83287623|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287624|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287625|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287626|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83287627|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83287628|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287629|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83287630|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83287631|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
83287632|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83287633|NCT02057198|Metronidazole|metronidazole|mesh-list
83287634|NCT02057198|Vancomycin|vancomycin|mesh-list
83287635|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
83287636|NCT02057198|Amebicides|amebicides|mesh-list
83287637|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287638|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83287639|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83287640|NCT02056340|Atorvastatin|atorvastatin|mesh-list
83287641|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83287642|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83287643|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
83287644|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287645|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83287646|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83287647|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287648|NCT04726592|Ketoprofen|ketoprofen|mesh-list
83287649|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
83287650|NCT04726592|Metoclopramide|metoclopramide|mesh-list
83287651|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
83287652|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
83287653|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287654|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287655|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83287656|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83287657|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83287658|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
83287659|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287660|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287661|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83287662|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83287663|NCT04726592|Analgesics|analgesics|mesh-ancestor
83287664|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
83287665|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287666|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287667|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83287668|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287669|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
83287670|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83287671|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83287672|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287673|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83287674|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
83287675|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
83287676|NCT02046122|Cytarabine|cytarabine|mesh-list
83287677|NCT02046122|Idarubicin|idarubicin|mesh-list
83287678|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83287679|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
83287680|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287681|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287682|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
83287683|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287684|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287685|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
83287686|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287687|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83287688|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83287689|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83287690|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287691|NCT02080832|Dexetimide|dexetimide|mesh-list
83287692|NCT02080832|Citalopram|citalopram|mesh-list
83287693|NCT02080832|Escitalopram|escitalopram|mesh-list
83287694|NCT02080832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83287695|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83287696|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287697|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287698|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287699|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
83287700|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287701|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83287702|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
83287703|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83287704|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83287705|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83287706|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
83287707|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
83287708|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287709|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83287710|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83287711|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
83287712|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
83287713|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83287714|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287715|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83287716|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287717|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287718|NCT02078102|Meloxicam|meloxicam|mesh-list
83287719|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287720|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83287721|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83287722|NCT02078102|Analgesics|analgesics|mesh-ancestor
83287723|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
83287724|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287725|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287726|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287727|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83287728|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83287729|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287730|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287731|NCT02054702|Aripiprazole|aripiprazole|mesh-list
83287732|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
83287733|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
83287734|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83287735|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83287736|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83287737|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287738|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287739|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
83287740|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
83287741|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287742|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287743|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83287744|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83287745|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
83287746|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83287747|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83287748|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83287749|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83287750|NCT02044094|Buprenorphine|buprenorphine|mesh-list
83287751|NCT02044094|Hydromorphone|hydromorphone|mesh-list
83287752|NCT02044094|Naloxone|naloxone|mesh-list
83287753|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83287754|NCT02044094|Narcotics|narcotics|mesh-ancestor
83287755|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287756|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287757|NCT02044094|Analgesics|analgesics|mesh-ancestor
83287758|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
83287759|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287760|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83287761|NCT02053610|Rituximab|rituximab|mesh-list
83287762|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
83287763|NCT02053610|Chlorambucil|chlorambucil|mesh-list
83287764|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83287765|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287766|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
83287767|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287768|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83287769|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83287770|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
83287771|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287772|NCT02075606|Lanreotide|lanreotide|mesh-list
83287773|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287774|NCT04701008|Ketamine|ketamine|mesh-list
83287776|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
83287777|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287778|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287779|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83287780|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83287781|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
83287782|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
83287783|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287784|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83287785|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83287786|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287787|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287788|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
83287789|NCT04700696|Narcotics|narcotics|mesh-ancestor
83287790|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287791|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287792|NCT04700696|Analgesics|analgesics|mesh-ancestor
83287793|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
83287794|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287795|NCT02052440|Baclofen|baclofen|mesh-list
83287796|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83287797|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287798|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83287799|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287800|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83287801|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
83287802|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
83287803|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287804|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287805|NCT02049944|Cefazolin|cefazolin|mesh-list
83287806|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287807|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287808|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
83287809|NCT01621880|Bevacizumab|bevacizumab|mesh-list
83287810|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83287811|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287812|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83287813|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83287814|NCT01621880|Growth Substances|growth substances|mesh-ancestor
83287815|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287816|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
83287817|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287818|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
83287819|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
83287820|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287821|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83287822|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
83287823|NCT01621880|Hormones|hormones|mesh-ancestor
83287824|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287825|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83287826|NCT01621880|Protective Agents|protective agents|mesh-ancestor
83287827|NCT02041429|Paclitaxel|paclitaxel|mesh-list
83287828|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83287829|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287830|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83287831|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83287832|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83287833|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287834|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83287835|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83287836|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287837|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
83287838|NCT02083783|Amphetamine|amphetamine|mesh-list
83287839|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83287840|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287841|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
83287842|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
83287843|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287844|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
83287845|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287846|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287847|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
83287848|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83287849|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83287850|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287851|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83287852|NCT02059135|Antithrombins|antithrombins|mesh-list
83287853|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
83287854|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83287855|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
83287856|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287857|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287858|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
83287859|NCT04720105|Halobetasol|halobetasol|mesh-list
83287860|NCT04720105|Tazarotene|tazarotene|mesh-list
83287861|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
83287862|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
83287863|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83287864|NCT04695769|Ribavirin|ribavirin|mesh-list
83287865|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
83287866|NCT04695769|Velpatasvir|velpatasvir|mesh-list
83287867|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83287868|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
83287869|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287870|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
83287871|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287872|NCT02038933|Nivolumab|nivolumab|mesh-list
83287873|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83287874|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287875|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83287876|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287877|NCT02081599|Insulin|insulin|mesh-list
83287878|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287879|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287880|NCT02038153|Lenalidomide|lenalidomide|mesh-list
83287881|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
83287882|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287883|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83287884|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83287885|NCT02038153|Growth Substances|growth substances|mesh-ancestor
83287886|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
83287887|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287888|NCT02079805|Telmisartan|telmisartan|mesh-list
83287889|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83287890|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83287891|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83287892|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83287893|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287894|NCT02037295|Vancomycin|vancomycin|mesh-list
83287895|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83287896|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83287897|NCT02079649|Dexamethasone|dexamethasone|mesh-list
83287898|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83287899|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83287900|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83287901|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
83287902|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
83287903|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287904|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287905|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83287906|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
83287907|NCT02079649|Hormones|hormones|mesh-ancestor
83287908|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287909|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83287910|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287911|NCT02036515|Metformin|metformin|mesh-list
83287912|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83287913|NCT02036515|Glimepiride|glimepiride|mesh-list
83287914|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
83287915|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83287916|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287917|NCT02036515|Incretins|incretins|mesh-ancestor
83287918|NCT02036515|Hormones|hormones|mesh-ancestor
83287919|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83287920|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83287921|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
83287922|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287923|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287924|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83287925|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83287926|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
83287927|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83287928|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
83287929|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83287930|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287931|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
83287932|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83287933|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83287934|NCT05887479|Botulinum Toxins|botulinum toxins|mesh-list
83287935|NCT05887479|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83287936|NCT05887479|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83287937|NCT05887479|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83287938|NCT05887479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83287939|NCT05887479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287940|NCT05887479|Cholinergic Agents|cholinergic agents|mesh-ancestor
83287941|NCT05887479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287942|NCT05887479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287943|NCT05887479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83287944|NCT05887479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287945|NCT05887375|Glycopyrrolate|glycopyrrolate|mesh-list
83287946|NCT05887375|Bromides|bromides|mesh-list
83287947|NCT05887375|Rocuronium|rocuronium|mesh-list
83287948|NCT05887375|Neostigmine|neostigmine|mesh-list
83287949|NCT05887375|Anticonvulsants|anticonvulsants|mesh-ancestor
83287950|NCT05887375|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83287951|NCT05887375|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83287952|NCT05887375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83287953|NCT05887375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287954|NCT05887375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287955|NCT05887375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83287956|NCT05887375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83287957|NCT05887375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287958|NCT05887375|Cholinergic Agents|cholinergic agents|mesh-ancestor
83287959|NCT05887375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83287960|NCT05887375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83287961|NCT05887375|Autonomic Agents|autonomic agents|mesh-ancestor
83287962|NCT05887375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83287963|NCT05887375|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83287964|NCT05887375|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83287965|NCT05887258|Analgesics, Opioid|analgesics, opioid|mesh-list
83287966|NCT05887258|Anesthetics|anesthetics|mesh-list
83287967|NCT05887258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83287968|NCT05887258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287969|NCT05887258|Narcotics|narcotics|mesh-ancestor
83287970|NCT05887258|Analgesics|analgesics|mesh-ancestor
83287971|NCT05887258|Sensory System Agents|sensory system agents|mesh-ancestor
83287972|NCT05887258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83287973|NCT05887219|Azelaic acid|azelaic acid|mesh-list
83287974|NCT05887219|Tranexamic Acid|tranexamic acid|mesh-list
83287975|NCT05887219|Hydroquinone|hydroquinone|mesh-list
83287976|NCT05887219|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83287977|NCT05887219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83287978|NCT05887219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287979|NCT05887219|Hemostatics|hemostatics|mesh-ancestor
83287980|NCT05887219|Coagulants|coagulants|mesh-ancestor
83287981|NCT05887219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83287982|NCT05887219|Dermatologic Agents|dermatologic agents|mesh-ancestor
83287983|NCT05887219|Antioxidants|antioxidants|mesh-ancestor
83287984|NCT05887219|Protective Agents|protective agents|mesh-ancestor
83287985|NCT05887219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83287986|NCT05887219|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83287987|NCT05886998|Heparin|heparin|mesh-list
83287988|NCT05886998|Anticoagulants|anticoagulants|mesh-ancestor
83287989|NCT05886998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83287990|NCT05886998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83287991|NCT05886998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287992|NCT05886933|Fexuprazan|fexuprazan|mesh-list
83287993|NCT05886933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83287994|NCT05886829|Chlorpheniramine|chlorpheniramine|mesh-list
83287995|NCT05886829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83287996|NCT05886829|Antipruritics|antipruritics|mesh-ancestor
83287997|NCT05886829|Dermatologic Agents|dermatologic agents|mesh-ancestor
83287998|NCT05886829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83287999|NCT05886829|Histamine Antagonists|histamine antagonists|mesh-ancestor
83288000|NCT05886829|Histamine Agents|histamine agents|mesh-ancestor
83288001|NCT05886829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288002|NCT05886829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288003|NCT05886829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83288004|NCT05886790|Vaccines|vaccines|mesh-list
83288005|NCT05886790|Immunologic Factors|immunologic factors|mesh-ancestor
83288006|NCT05886790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288007|NCT05886660|Scopolamine|scopolamine|mesh-list
83288008|NCT05886660|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83288009|NCT05886660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83288010|NCT05886660|Antiemetics|antiemetics|mesh-ancestor
83288011|NCT05886660|Autonomic Agents|autonomic agents|mesh-ancestor
83288012|NCT05886660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288013|NCT05886660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288014|NCT05886660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83288015|NCT05886660|Mydriatics|mydriatics|mesh-ancestor
83288016|NCT05886660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83288017|NCT05886660|Cholinergic Agents|cholinergic agents|mesh-ancestor
83288018|NCT05886660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288019|NCT05886660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288020|NCT05886660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83288021|NCT05886660|Parasympatholytics|parasympatholytics|mesh-ancestor
83288022|NCT05886582|Rotigotine|rotigotine|mesh-list
83288023|NCT05886582|Dopamine Agonists|dopamine agonists|mesh-ancestor
83288024|NCT05886582|Dopamine Agents|dopamine agents|mesh-ancestor
83288025|NCT05886582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288026|NCT05886582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288027|NCT05886582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288028|NCT05886465|Bevacizumab|bevacizumab|mesh-list
83288029|NCT05886465|Atezolizumab|atezolizumab|mesh-list
83288030|NCT05886465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288031|NCT05886465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288032|NCT05886465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288033|NCT05886465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288034|NCT05886465|Growth Substances|growth substances|mesh-ancestor
83288035|NCT05886465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288036|NCT05886465|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288037|NCT05886465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288038|NCT05886465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288039|NCT05886439|Pembrolizumab|pembrolizumab|mesh-list
83288040|NCT05886439|Durvalumab|durvalumab|mesh-list
83288041|NCT05886439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288042|NCT05886439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288043|NCT05886439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288044|NCT05886439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288045|NCT05886257|Bevacizumab|bevacizumab|mesh-list
83288046|NCT05886257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288047|NCT05886257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288048|NCT05886257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288049|NCT05886257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288050|NCT05886257|Growth Substances|growth substances|mesh-ancestor
83288051|NCT05886257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288052|NCT05886257|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288053|NCT05886244|Eculizumab|eculizumab|mesh-list
83288054|NCT05886244|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83288055|NCT05886244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288056|NCT05886244|Immunologic Factors|immunologic factors|mesh-ancestor
83288057|NCT05886244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288058|NCT05886192|Vasopressins|vasopressins|mesh-list
83288059|NCT05886192|Arginine Vasopressin|arginine vasopressin|mesh-list
83288060|NCT05886192|Norepinephrine|norepinephrine|mesh-list
83288061|NCT05886192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83288062|NCT05886192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83288063|NCT05886192|Adrenergic Agents|adrenergic agents|mesh-ancestor
83288064|NCT05886192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430171|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288065|NCT05886192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288066|NCT05886192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288067|NCT05886192|Sympathomimetics|sympathomimetics|mesh-ancestor
83288068|NCT05886192|Autonomic Agents|autonomic agents|mesh-ancestor
83288069|NCT05886192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288070|NCT05886192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83288071|NCT05886192|Hemostatics|hemostatics|mesh-ancestor
83288072|NCT05886192|Coagulants|coagulants|mesh-ancestor
83288073|NCT05886192|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83288074|NCT05886192|Natriuretic Agents|natriuretic agents|mesh-ancestor
83288075|NCT05886140|Paclitaxel|paclitaxel|mesh-list
83288076|NCT05886140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288077|NCT05886140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288078|NCT05886140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288079|NCT05886140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288080|NCT05886140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288081|NCT05886140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288082|NCT05886127|Hemostatics|hemostatics|mesh-list
83288083|NCT05886127|Coagulants|coagulants|mesh-ancestor
83288084|NCT05886088|Dapagliflozin|dapagliflozin|mesh-list
83288085|NCT05886088|Linagliptin|linagliptin|mesh-list
83288086|NCT05886088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83288087|NCT05886088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288088|NCT05886088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83288089|NCT05886088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288090|NCT05886088|Incretins|incretins|mesh-ancestor
83288091|NCT05886088|Hormones|hormones|mesh-ancestor
83288092|NCT05886088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288093|NCT05886088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83288094|NCT05886088|Protease Inhibitors|protease inhibitors|mesh-ancestor
83288095|NCT05886088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288096|NCT05885932|Aspirin|aspirin|mesh-list
83288097|NCT05885932|Sirolimus|sirolimus|mesh-list
83288098|NCT05885932|Clopidogrel|clopidogrel|mesh-list
83288099|NCT05885932|Ticagrelor|ticagrelor|mesh-list
83288100|NCT05885932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83288101|NCT05885932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83288102|NCT05885932|Analgesics|analgesics|mesh-ancestor
83288103|NCT05885932|Sensory System Agents|sensory system agents|mesh-ancestor
83288104|NCT05885932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288105|NCT05885932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288106|NCT05885932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83288107|NCT05885932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288108|NCT05885932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83288109|NCT05885932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83288110|NCT05885932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288111|NCT05885932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83288112|NCT05885932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83288113|NCT05885932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288114|NCT05885932|Antipyretics|antipyretics|mesh-ancestor
83288115|NCT05885932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83288116|NCT05885932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83288117|NCT05885932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83288118|NCT05885932|Purinergic Agents|purinergic agents|mesh-ancestor
83288119|NCT05885932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288120|NCT05885932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83288121|NCT05885932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288122|NCT05885932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83288123|NCT05885932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288124|NCT05885932|Antifungal Agents|antifungal agents|mesh-ancestor
83288125|NCT05885932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288126|NCT05885932|Immunologic Factors|immunologic factors|mesh-ancestor
83288127|NCT05885919|Edaravone|edaravone|mesh-list
83288128|NCT05885919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83288129|NCT05885919|Antioxidants|antioxidants|mesh-ancestor
83288130|NCT05885919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288131|NCT05885919|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83288132|NCT05885919|Protective Agents|protective agents|mesh-ancestor
83288133|NCT05885919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288134|NCT05885802|Anesthetics|anesthetics|mesh-list
83288135|NCT05885802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288136|NCT05885802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288137|NCT05885776|Trastuzumab|trastuzumab|mesh-list
83288138|NCT05885776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288139|NCT05885776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288141|NCT05885646|Anticonvulsants|anticonvulsants|mesh-ancestor
83288142|NCT05885542|Cannabidiol|cannabidiol|mesh-list
83288143|NCT05885542|Anticonvulsants|anticonvulsants|mesh-ancestor
83288144|NCT05885503|Aflibercept|aflibercept|mesh-list
83288145|NCT05885503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288146|NCT05885503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288147|NCT05885503|Growth Substances|growth substances|mesh-ancestor
83288148|NCT05885503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288149|NCT05885503|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288150|NCT05885503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288151|NCT05884372|Vitamin D|vitamin d|mesh-list
83288152|NCT05884372|Denosumab|denosumab|mesh-list
83288153|NCT05884372|Eldecalcitol|eldecalcitol|mesh-list
83288154|NCT05884372|Calcium|calcium|mesh-list
83288155|NCT05884372|Vitamins|vitamins|mesh-ancestor
83288156|NCT05884372|Micronutrients|micronutrients|mesh-ancestor
83288157|NCT05884372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288158|NCT05884372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83288159|NCT05884372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83288161|NCT05882643|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83288162|NCT05882643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288163|NCT05882643|Trace Elements|trace elements|mesh-ancestor
83288164|NCT05882643|Micronutrients|micronutrients|mesh-ancestor
83288165|NCT05882643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288166|NCT05880862|Mirabegron|mirabegron|mesh-list
83288167|NCT05880862|Trospium chloride|trospium chloride|mesh-list
83288168|NCT05880862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83288169|NCT05880862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83288170|NCT05880862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83288171|NCT05880862|Adrenergic Agents|adrenergic agents|mesh-ancestor
83288172|NCT05880862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288173|NCT05880862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288174|NCT05880862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288175|NCT05880862|Urological Agents|urological agents|mesh-ancestor
83288176|NCT05880862|Parasympatholytics|parasympatholytics|mesh-ancestor
83288177|NCT05880862|Autonomic Agents|autonomic agents|mesh-ancestor
83288178|NCT05880862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288179|NCT05880862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83288180|NCT05880862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83288181|NCT05880862|Cholinergic Agents|cholinergic agents|mesh-ancestor
83288182|NCT05878405|Anti-Infective Agents|anti-infective agents|mesh-list
83288183|NCT05878405|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83288184|NCT05878405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83288185|NCT05878405|Analgesics|analgesics|mesh-list
83288186|NCT05878405|Methylene Blue|methylene blue|mesh-list
83288187|NCT05878405|Sensory System Agents|sensory system agents|mesh-ancestor
83288188|NCT05878405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288189|NCT05878405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288190|NCT05878405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288191|NCT05878405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288192|NCT05877430|Pembrolizumab|pembrolizumab|mesh-list
83288193|NCT05877430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288194|NCT05877430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288195|NCT05877430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288196|NCT05877430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288197|NCT05852691|Paclitaxel|paclitaxel|mesh-list
83288198|NCT05852691|Pembrolizumab|pembrolizumab|mesh-list
83288199|NCT05852691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288200|NCT05852691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288201|NCT05852691|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288202|NCT05852691|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288203|NCT05852691|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288204|NCT05852691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288205|NCT05852691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288206|NCT05852691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288207|NCT05827016|Lenalidomide|lenalidomide|mesh-list
83288208|NCT05827016|Immunologic Factors|immunologic factors|mesh-ancestor
83288209|NCT05827016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288210|NCT05827016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288211|NCT05827016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288212|NCT05827016|Growth Substances|growth substances|mesh-ancestor
83288213|NCT05827016|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288214|NCT05827016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288215|NCT05802056|Calcium, Dietary|calcium, dietary|mesh-list
83288216|NCT05802056|Leucovorin|leucovorin|mesh-list
83288217|NCT05802056|Folic Acid|folic acid|mesh-list
83288218|NCT05802056|Aldesleukin|aldesleukin|mesh-list
83288219|NCT05802056|Fluorouracil|fluorouracil|mesh-list
83288220|NCT05802056|Oxaliplatin|oxaliplatin|mesh-list
83288221|NCT05802056|Nivolumab|nivolumab|mesh-list
83288222|NCT05802056|Interleukin-2|interleukin-2|mesh-list
83288223|NCT05802056|Calcium|calcium|mesh-list
83288224|NCT05802056|Levoleucovorin|levoleucovorin|mesh-list
83288225|NCT05802056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83288226|NCT05802056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288227|NCT05802056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83288228|NCT05802056|Antimetabolites|antimetabolites|mesh-ancestor
83288229|NCT05802056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288230|NCT05802056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83288231|NCT05802056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288232|NCT05802056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288233|NCT05802056|Immunologic Factors|immunologic factors|mesh-ancestor
83288234|NCT05802056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288235|NCT05802056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288236|NCT05802056|Antidotes|antidotes|mesh-ancestor
83288237|NCT05802056|Protective Agents|protective agents|mesh-ancestor
83288238|NCT05802056|Vitamin B Complex|vitamin b complex|mesh-ancestor
83288239|NCT05802056|Vitamins|vitamins|mesh-ancestor
83288240|NCT05802056|Micronutrients|micronutrients|mesh-ancestor
83288241|NCT05802056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83288242|NCT05802056|Analgesics|analgesics|mesh-ancestor
83288243|NCT05802056|Sensory System Agents|sensory system agents|mesh-ancestor
83288244|NCT05802056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288245|NCT05802056|Hematinics|hematinics|mesh-ancestor
83288246|NCT05802056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83288247|NCT05802056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83288248|NCT05802056|Antiviral Agents|antiviral agents|mesh-ancestor
83288249|NCT05802056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288250|NCT05794477|Paclitaxel|paclitaxel|mesh-list
83288251|NCT05794477|Carboplatin|carboplatin|mesh-list
83288252|NCT05794477|Pemetrexed|pemetrexed|mesh-list
83288253|NCT05794477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288254|NCT05794477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288255|NCT05794477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288256|NCT05794477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288257|NCT05794477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288258|NCT05794477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288259|NCT05794477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288260|NCT05794477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83288261|NCT05794477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83288262|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
83288263|NCT05789381|Analgesics|analgesics|mesh-ancestor
83288264|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
83288265|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288266|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288267|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
83288268|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288269|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83288270|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
83288271|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83288272|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83288273|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288274|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83288275|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
83288276|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83288277|NCT05773989|Clopidogrel|clopidogrel|mesh-list
83288278|NCT05773989|Ticagrelor|ticagrelor|mesh-list
83288279|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83288280|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288281|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288282|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83288283|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83288284|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83288285|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83288286|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
83288287|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288288|NCT05772169|Mifepristone|mifepristone|mesh-list
83288289|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83288290|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
83288291|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83288292|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288293|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83288294|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83288295|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83288296|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
83288297|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83288298|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83288299|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
83288300|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288301|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
83288302|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83288303|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83288304|NCT05769478|Amifampridine|amifampridine|mesh-list
83288305|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83288306|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288307|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288308|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83288309|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83288310|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288311|NCT05745701|Cyclosporine|cyclosporine|mesh-list
83288312|NCT05745701|Itraconazole|itraconazole|mesh-list
83288313|NCT05745701|Cyclosporins|cyclosporins|mesh-list
83288314|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288315|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288316|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288317|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
83288318|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288319|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
83288320|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288321|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
83288322|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288323|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83288324|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83288325|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83288326|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83288327|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
83288328|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288329|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83288330|NCT05742594|Lazertinib|lazertinib|mesh-list
83288331|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83288332|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288333|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288334|NCT05741086|Atorvastatin|atorvastatin|mesh-list
83288335|NCT05741086|Evolocumab|evolocumab|mesh-list
83288336|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83288337|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83288338|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
83288339|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288340|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83288341|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83288342|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288343|NCT05741086|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83288344|NCT05741086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83288345|NCT05741086|Protease Inhibitors|protease inhibitors|mesh-ancestor
83288346|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
83288347|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83288348|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288349|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83288350|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288351|NCT05714059|Insulin|insulin|mesh-list
83288352|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83288353|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288354|NCT05713994|Bevacizumab|bevacizumab|mesh-list
83288355|NCT05713994|Atezolizumab|atezolizumab|mesh-list
83288356|NCT05713994|Sorafenib|sorafenib|mesh-list
83288357|NCT05713994|Apatinib|apatinib|mesh-list
83288358|NCT05713994|Lenvatinib|lenvatinib|mesh-list
83288359|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83288360|NCT05713994|Antibodies|antibodies|mesh-list
83288361|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83288362|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288363|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288364|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288365|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288366|NCT05713994|Growth Substances|growth substances|mesh-ancestor
83288367|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288368|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288369|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
83288370|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83288371|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288372|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288373|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
83288374|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83288375|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
83288376|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
83288377|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288378|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288379|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83288380|NCT05710887|Analgesics|analgesics|mesh-ancestor
83288381|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
83288382|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288383|NCT05707351|Factor VIII|factor viii|mesh-list
83288384|NCT05707351|BAX 855|bax 855|mesh-list
83288385|NCT05707351|Coagulants|coagulants|mesh-ancestor
83288386|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83288387|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288388|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83288389|NCT05662306|Aripiprazole|aripiprazole|mesh-list
83288390|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
83288391|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
83288392|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83288393|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83288394|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83288395|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288396|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288397|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
83288398|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
83288399|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288400|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288401|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83288402|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83288403|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
83288404|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83288405|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83288406|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83288407|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83288408|NCT05657041|Clopidogrel|clopidogrel|mesh-list
83288409|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83288410|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83288411|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83288412|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83288413|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83288414|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
83288415|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288416|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288417|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288418|NCT05656599|Letermovir|letermovir|mesh-list
83288419|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83288420|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288421|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288422|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288423|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
83288424|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288425|NCT05644665|Ozanimod|ozanimod|mesh-list
83288426|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83288427|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288428|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288429|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
83288430|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288431|NCT05643573|Apixaban|apixaban|mesh-list
83288432|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83288433|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
83288434|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83288435|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
83288436|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288437|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288438|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
83288439|NCT05634707|Temozolomide|temozolomide|mesh-list
83288440|NCT05634707|Fluoxetine|fluoxetine|mesh-list
83288441|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83288442|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
83288443|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288444|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288445|NCT05634707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83288446|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83288447|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83288448|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288449|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
83288450|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288451|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83288452|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
83288453|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83288454|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83288455|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83288456|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288457|NCT05747794|Paclitaxel|paclitaxel|mesh-list
83288458|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288459|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288460|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288461|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288462|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288463|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288464|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
83288465|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288466|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288467|NCT05607316|Metformin|metformin|mesh-list
83288468|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83288469|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288470|NCT05605587|Leflunomide|leflunomide|mesh-list
83288471|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288472|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288473|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288474|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
83288475|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288476|NCT05597878|Acetaminophen|acetaminophen|mesh-list
83288477|NCT05597878|Ketorolac|ketorolac|mesh-list
83288478|NCT05597878|Ketamine|ketamine|mesh-list
83288479|NCT05597878|Oxycodone|oxycodone|mesh-list
83288480|NCT05597878|Analgesics|analgesics|mesh-ancestor
83288481|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
83288482|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288483|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288484|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83288485|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83288486|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
83288487|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
83288488|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288489|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83288490|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83288491|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288492|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288493|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83288494|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
83288495|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83288496|NCT05597878|Narcotics|narcotics|mesh-ancestor
83288497|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83288498|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83288499|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288500|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83288501|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288502|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
83288503|NCT05586477|Promethazine|promethazine|mesh-list
83288504|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83288505|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83288506|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288507|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288508|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
83288510|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
83288511|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288512|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
83288513|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
83288514|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83288515|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83288516|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
83288517|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
83288518|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288519|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288520|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83288521|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
83288522|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
83288523|NCT05582993|Factor VIII|factor viii|mesh-list
83288524|NCT05582993|Coagulants|coagulants|mesh-ancestor
83288525|NCT05581758|Sotorasib|sotorasib|mesh-list
83288526|NCT05581758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288527|NCT05581758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288528|NCT05581758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288529|NCT05581758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288530|NCT05557591|Cemiplimab|cemiplimab|mesh-list
83288531|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288532|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288533|NCT05554146|Dronabinol|dronabinol|mesh-list
83288534|NCT05554146|Hallucinogens|hallucinogens|mesh-ancestor
83288535|NCT05554146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288536|NCT05554146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83288537|NCT05554146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83288538|NCT05554146|Analgesics|analgesics|mesh-ancestor
83288539|NCT05554146|Sensory System Agents|sensory system agents|mesh-ancestor
83288540|NCT05554146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288541|NCT05554146|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83288542|NCT05554146|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83288543|NCT05554146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288544|NCT05554146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288545|NCT05554146|Hormones|hormones|mesh-ancestor
83288546|NCT05554146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288547|NCT05553301|Vaccines|vaccines|mesh-list
83288548|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
83288549|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288550|NCT05535738|Fluticasone|fluticasone|mesh-list
83288551|NCT05535738|Xhance|xhance|mesh-list
83288552|NCT05535738|Adalimumab|adalimumab|mesh-list
83288553|NCT05535738|Triamcinolone|triamcinolone|mesh-list
83288554|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83288555|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83288556|NCT05535738|Betamethasone|betamethasone|mesh-list
83288557|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
83288558|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83288559|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
83288560|NCT05535738|Ustekinumab|ustekinumab|mesh-list
83288561|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83288562|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
83288563|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83288564|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83288565|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83288566|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
83288567|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288568|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288569|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83288570|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
83288571|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
83288572|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83288573|NCT05535738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83288574|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288575|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
83288576|NCT05535738|Hormones|hormones|mesh-ancestor
83430132|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83288577|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288578|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288579|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
83288580|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288581|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288582|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83288584|NCT05518110|Trametinib|trametinib|mesh-list
83288585|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
83288586|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83288587|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83288588|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288589|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288590|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288591|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288592|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288593|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83288594|NCT05508867|Gemcitabine|gemcitabine|mesh-list
83288595|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
83288596|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83288597|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83288598|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
83288599|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288600|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288601|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288602|NCT05508867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288603|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83288604|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
83288605|NCT05486481|Dexamethasone|dexamethasone|mesh-list
83288606|NCT05486481|Venetoclax|venetoclax|mesh-list
83288607|NCT05486481|Daratumumab|daratumumab|mesh-list
83288608|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83288609|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83288610|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
83288611|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
83288612|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288613|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288614|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83288615|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
83288616|NCT05486481|Hormones|hormones|mesh-ancestor
83288617|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288618|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83288619|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288620|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
83288621|NCT05459129|Paclitaxel|paclitaxel|mesh-list
83288622|NCT05459129|Carboplatin|carboplatin|mesh-list
83288623|NCT05459129|Atezolizumab|atezolizumab|mesh-list
83288624|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288625|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288626|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288627|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288628|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288629|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288630|NCT05459129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288631|NCT05459129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288632|NCT05446870|Paclitaxel|paclitaxel|mesh-list
83288633|NCT05446870|Docetaxel|docetaxel|mesh-list
83288634|NCT05446870|Bevacizumab|bevacizumab|mesh-list
83288635|NCT05446870|Carboplatin|carboplatin|mesh-list
83288636|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
83288637|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288638|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288639|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288640|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288641|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288642|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288643|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288644|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288645|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288646|NCT05446870|Growth Substances|growth substances|mesh-ancestor
83288647|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288648|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288649|NCT05446870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288651|NCT05441410|Pyronaridine|pyronaridine|mesh-list
83288652|NCT05441410|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83288653|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
83288654|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83288655|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83288656|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288657|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288658|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
83288659|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
83288660|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83288661|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
83288662|NCT05431595|Valproic Acid|valproic acid|mesh-list
83288663|NCT05431595|Haloperidol|haloperidol|mesh-list
83288664|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
83288665|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
83288666|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
83288667|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
83288668|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288669|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288670|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83288671|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83288672|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83288673|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288674|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83288675|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83288676|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
83288677|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288678|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288679|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83288680|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
83288681|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288682|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
83288683|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
83288684|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
83288685|NCT05351489|Bupivacaine|bupivacaine|mesh-list
83288686|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
83288687|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
83288688|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83288689|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288690|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
83288691|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288692|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83288693|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83288694|NCT05351489|Analgesics|analgesics|mesh-ancestor
83288695|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83288696|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83288697|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83288698|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
83288699|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288700|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288701|NCT05345717|Abatacept|abatacept|mesh-list
83288702|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83288703|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288704|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288705|NCT05345717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288706|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288707|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288708|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
83288709|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288710|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288711|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
83288712|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288713|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
83288714|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83288715|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288716|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83288717|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288718|NCT05298423|Paclitaxel|paclitaxel|mesh-list
83288719|NCT05298423|Etoposide|etoposide|mesh-list
83288720|NCT05298423|Carboplatin|carboplatin|mesh-list
83288721|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
83288722|NCT05298423|Pemetrexed|pemetrexed|mesh-list
83288723|NCT05298423|Durvalumab|durvalumab|mesh-list
83288724|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288725|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288726|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288727|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288728|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288729|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288730|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288731|NCT05298423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288732|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83288733|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83288734|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288735|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83288736|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83288737|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
83288738|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83288739|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288740|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83288741|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
83288742|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83288743|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288744|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288745|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288746|NCT05245968|Sunitinib|sunitinib|mesh-list
83288747|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
83288748|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288749|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288750|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288751|NCT05245968|Growth Substances|growth substances|mesh-ancestor
83288752|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288753|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288754|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83288755|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288756|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288758|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288759|NCT05220514|PK 11195|pk 11195|mesh-list
83288760|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288761|NCT05194969|Petrolatum|petrolatum|mesh-list
83288762|NCT05194969|Emollients|emollients|mesh-ancestor
83288763|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
83288764|NCT05181735|Luspatercept|luspatercept|mesh-list
83288765|NCT05181735|Hematinics|hematinics|mesh-ancestor
83288766|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
83288767|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288768|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288769|NCT05166239|Lenvatinib|lenvatinib|mesh-list
83288770|NCT05166239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83288771|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288772|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83288773|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288774|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288775|NCT05166239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288776|NCT05145296|Daratumumab|daratumumab|mesh-list
83288777|NCT05145296|Abatacept|abatacept|mesh-list
83288778|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288779|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288780|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288781|NCT05145296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288782|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288783|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
83288784|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288785|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288786|NCT05122767|Dolutegravir|dolutegravir|mesh-list
83288787|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83288788|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83288789|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288790|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288791|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83288792|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83288793|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
83288794|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288795|NCT05115110|Risdiplam|risdiplam|mesh-list
83288796|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83288797|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288798|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288799|NCT05112965|Atezolizumab|atezolizumab|mesh-list
83288800|NCT05112965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288801|NCT05112965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288802|NCT05112965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288803|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288804|NCT05100654|Doxycycline|doxycycline|mesh-list
83288805|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
83288806|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83288807|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83288808|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83288809|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83288810|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
83288811|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83288812|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83288813|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83288814|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83288815|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288816|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288817|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288818|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83288819|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83288820|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83288821|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83288822|NCT05095922|Valsartan|valsartan|mesh-list
83288823|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
83288824|NCT05095922|Calcium|calcium|mesh-list
83288825|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83288826|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288827|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83288828|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83288841|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83288842|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
83288843|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
83288844|NCT05084222|Hormones|hormones|mesh-ancestor
83288845|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288846|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83288847|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83288848|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83288849|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83288850|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83288851|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288852|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
83288853|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83288854|NCT05062980|Docetaxel|docetaxel|mesh-list
83288855|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
83288856|NCT05062980|Ramucirumab|ramucirumab|mesh-list
83288857|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288858|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288859|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288860|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288861|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288862|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288863|NCT05062980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288875|NCT05014412|Dexamethasone|dexamethasone|mesh-list
83288876|NCT05014412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83288877|NCT05014412|Antiemetics|antiemetics|mesh-ancestor
83288878|NCT05014412|Autonomic Agents|autonomic agents|mesh-ancestor
83288879|NCT05014412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83288880|NCT05014412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288881|NCT05014412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83288882|NCT05014412|Glucocorticoids|glucocorticoids|mesh-ancestor
83288883|NCT05014412|Hormones|hormones|mesh-ancestor
83288884|NCT05014412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288885|NCT05014412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83288886|NCT05014412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288887|NCT05007106|Docetaxel|docetaxel|mesh-list
83288888|NCT05007106|Bevacizumab|bevacizumab|mesh-list
83288889|NCT05007106|Carboplatin|carboplatin|mesh-list
83288890|NCT05007106|Gemcitabine|gemcitabine|mesh-list
83288891|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
83288892|NCT05007106|Fluorouracil|fluorouracil|mesh-list
83288893|NCT05007106|Capecitabine|capecitabine|mesh-list
83288894|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
83288895|NCT05007106|Lenvatinib|lenvatinib|mesh-list
83288896|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288897|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288898|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288899|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288900|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288901|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288902|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288903|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288904|NCT05007106|Growth Substances|growth substances|mesh-ancestor
83288905|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288906|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288907|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83288908|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
83288909|NCT05007106|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288910|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288911|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
83288912|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83288913|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288914|NCT05006794|Gemcitabine|gemcitabine|mesh-list
83288915|NCT05006794|Docetaxel|docetaxel|mesh-list
83288916|NCT05006794|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83288917|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83288918|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
83288919|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288920|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288921|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288922|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288923|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288924|NCT05006794|Immunoconjugates|immunoconjugates|mesh-ancestor
83288925|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
83288926|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288927|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
83288928|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288929|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288930|NCT05005442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288931|NCT05005442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288932|NCT04931342|Maytansine|maytansine|mesh-list
83288933|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83288934|NCT04931342|Cyclophosphamide|cyclophosphamide|mesh-list
83288935|NCT04931342|Bevacizumab|bevacizumab|mesh-list
83288936|NCT04931342|Trastuzumab|trastuzumab|mesh-list
83288937|NCT04931342|Atezolizumab|atezolizumab|mesh-list
83288938|NCT04931342|Letrozole|letrozole|mesh-list
83288939|NCT04931342|Olaparib|olaparib|mesh-list
83288940|NCT04931342|Palbociclib|palbociclib|mesh-list
83288941|NCT04931342|Ipatasertib|ipatasertib|mesh-list
83288942|NCT04931342|Hormones|hormones|mesh-list
83288943|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83288944|NCT04931342|Inavolisib|inavolisib|mesh-list
83288945|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83288946|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83288947|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
83288948|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
83288949|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
83288950|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288951|NCT04931342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83288952|NCT04931342|Immunologic Factors|immunologic factors|mesh-ancestor
83288953|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288954|NCT04931342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83288955|NCT04931342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83288956|NCT04931342|Alkylating Agents|alkylating agents|mesh-ancestor
83288957|NCT04931342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83288958|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83288959|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288960|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288961|NCT04931342|Growth Substances|growth substances|mesh-ancestor
83288962|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288963|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83288964|NCT04931342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83288965|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83288966|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83288967|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83288968|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83288969|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
83288970|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83288971|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83288972|NCT04931342|Immunotoxins|immunotoxins|mesh-ancestor
83288973|NCT04931342|Immunoconjugates|immunoconjugates|mesh-ancestor
83288974|NCT04931342|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83288975|NCT04924322|Enoxaparin|enoxaparin|mesh-list
83288976|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
83288977|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83288978|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83288979|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288980|NCT04907253|Quercetin|quercetin|mesh-list
83288981|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
83288990|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83288992|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83288993|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83288994|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83288995|NCT04902443|Growth Substances|growth substances|mesh-ancestor
83288996|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
83288997|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
83288998|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
83288999|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289000|NCT04898023|Protective Agents|protective agents|mesh-ancestor
83289001|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289002|NCT04898023|Vitamins|vitamins|mesh-ancestor
83289003|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
83289013|NCT04882085|Ceftazidime|ceftazidime|mesh-list
83289014|NCT04882085|Avibactam|avibactam|mesh-list
83289015|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83289016|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83289017|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289018|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83289019|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289020|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289021|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
83289022|NCT04881240|Fludarabine|fludarabine|mesh-list
83289023|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289024|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
83289025|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289026|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289027|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83289028|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
83289029|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289030|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289031|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83289032|NCT04875715|Hydroquinone|hydroquinone|mesh-list
83289033|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
83289034|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289035|NCT04875715|Protective Agents|protective agents|mesh-ancestor
83289036|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289037|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83289038|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83289039|NCT04875702|Allopurinol|allopurinol|mesh-list
83289040|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
83289041|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289042|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289043|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
83289044|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289045|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83289046|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
83289047|NCT04875702|Protective Agents|protective agents|mesh-ancestor
83289048|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289049|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
83289050|NCT04862221|Promethazine|promethazine|mesh-list
83289051|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
83289052|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83289053|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83289054|NCT04862221|Prednisolone|prednisolone|mesh-list
83289055|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
83289056|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83289058|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83289059|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83289060|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
83289061|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
83289062|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289063|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289064|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83289065|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
83289066|NCT04862221|Hormones|hormones|mesh-ancestor
83289067|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289068|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83289069|NCT04862221|Protective Agents|protective agents|mesh-ancestor
83289070|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289071|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289072|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
83289073|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289074|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83289075|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83289076|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83289077|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
83289078|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
83289079|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
83289080|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83289081|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
83289082|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
83289083|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289084|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289085|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83289086|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
83289087|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
83289088|NCT04852887|Tamoxifen|tamoxifen|mesh-list
83289089|NCT04852887|Letrozole|letrozole|mesh-list
83289090|NCT04852887|Exemestane|exemestane|mesh-list
83289091|NCT04852887|Anastrozole|anastrozole|mesh-list
83289092|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289093|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83289094|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83289095|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289096|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289097|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83289098|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
83289099|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289100|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289101|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289102|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83289103|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83289104|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83289105|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83289106|NCT04836429|Trioxsalen|trioxsalen|mesh-list
83289107|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289108|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
83289109|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83289110|NCT04822467|Ethanol|ethanol|mesh-list
83289111|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83289112|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289113|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83289114|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289115|NCT04813926|Riociguat|riociguat|mesh-list
83289116|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
83289117|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289118|NCT04801368|Anesthetics|anesthetics|mesh-list
83289119|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
83289120|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83289121|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289122|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
83289123|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289124|NCT04783935|Cladribine|cladribine|mesh-list
83289125|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289126|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289127|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
83289128|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289129|NCT04769713|Ropivacaine|ropivacaine|mesh-list
83289130|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
83289131|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
83289132|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83289133|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289134|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
83289135|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289136|NCT04751370|Nivolumab|nivolumab|mesh-list
83289137|NCT04751370|Ipilimumab|ipilimumab|mesh-list
83289138|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289139|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289140|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289141|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289142|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83289143|NCT04750954|Peposertib|peposertib|mesh-list
83289144|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289145|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83289146|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289147|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289148|NCT04746235|Decitabine|decitabine|mesh-list
83289149|NCT04746235|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83289150|NCT04746235|Venetoclax|venetoclax|mesh-list
83289151|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289152|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
83289153|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289154|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289155|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289156|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
83289157|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289158|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289159|NCT04738487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289160|NCT04738487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289161|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83289162|NCT04728581|Mirtazapine|mirtazapine|mesh-list
83289163|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
83289164|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83289165|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83289166|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83289167|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83289168|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289169|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83289170|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
83289171|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
83289172|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289173|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289174|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83289175|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83289176|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83289177|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83289178|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
83289179|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83289180|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83289181|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
83289182|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83289183|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83289184|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289185|NCT04677543|Azithromycin|azithromycin|mesh-list
83289186|NCT04677543|Amikacin|amikacin|mesh-list
83289187|NCT04677543|Ethambutol|ethambutol|mesh-list
83289188|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83289189|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289190|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
83289191|NCT04662840|Anesthetics|anesthetics|mesh-list
83289192|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
83289193|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83289194|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289195|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
83289196|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289197|NCT04579224|Paclitaxel|paclitaxel|mesh-list
83289198|NCT04579224|Docetaxel|docetaxel|mesh-list
83289199|NCT04579224|Halichondrin B|halichondrin b|mesh-list
83289200|NCT04579224|Gemcitabine|gemcitabine|mesh-list
83289201|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83289202|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289203|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289204|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289205|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289206|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289218|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83289219|NCT04567303|Growth Substances|growth substances|mesh-ancestor
83289220|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289221|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
83289222|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289224|NCT04544293|Sargramostim|sargramostim|mesh-list
83289225|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
83289226|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289227|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289228|NCT04478266|Letrozole|letrozole|mesh-list
83289229|NCT04478266|Palbociclib|palbociclib|mesh-list
83289230|NCT04478266|Goserelin|goserelin|mesh-list
83289231|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289232|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83289233|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83289234|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289235|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289236|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83289237|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
83289238|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289239|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289240|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289241|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289242|NCT04413201|Osimertinib|osimertinib|mesh-list
83289243|NCT04413201|Afatinib|afatinib|mesh-list
83289244|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289245|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289246|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289247|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289248|NCT04267939|Niraparib|niraparib|mesh-list
83289249|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83289250|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289251|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289252|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289253|NCT04254627|Etanercept|etanercept|mesh-list
83289254|NCT04254627|Mifepristone|mifepristone|mesh-list
83289255|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83289256|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83289257|NCT04254627|Analgesics|analgesics|mesh-ancestor
83289258|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
83289259|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289260|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289261|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83289262|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289263|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83289264|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289265|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
83289266|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83289267|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
83289268|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83289269|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83289270|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83289271|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83289272|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
83289273|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83289274|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83289275|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
83289276|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289277|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
83289278|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83289279|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83289280|NCT04250155|Atezolizumab|atezolizumab|mesh-list
83289281|NCT04250155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289282|NCT04250155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289283|NCT04250155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289284|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289286|NCT04224493|Lenalidomide|lenalidomide|mesh-list
83289287|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289288|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289289|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
83289290|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289291|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289292|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83289293|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83289295|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
83289296|NCT04212013|Rituximab|rituximab|mesh-list
83289297|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289298|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289299|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
83289300|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289301|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289302|NCT04161885|Azacitidine|azacitidine|mesh-list
83289303|NCT04161885|Venetoclax|venetoclax|mesh-list
83289304|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289305|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
83289306|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289307|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289308|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289309|NCT04160052|Azacitidine|azacitidine|mesh-list
83289310|NCT04160052|Venetoclax|venetoclax|mesh-list
83289311|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289312|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
83289313|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289314|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289315|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289316|NCT04139902|Dostarlimab|dostarlimab|mesh-list
83289317|NCT04139902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289318|NCT04136366|Methotrexate|methotrexate|mesh-list
83289319|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83289320|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
83289321|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83289322|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289323|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289324|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
83289325|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289326|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289327|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
83289328|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289329|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83289330|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289331|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
83289332|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289333|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83289334|NCT04124432|Nicotine|nicotine|mesh-list
83289335|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83289336|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
83289337|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289338|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289339|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83289340|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83289341|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
83289342|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289343|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289344|NCT04091217|Bevacizumab|bevacizumab|mesh-list
83289345|NCT04091217|Atezolizumab|atezolizumab|mesh-list
83289346|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289347|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289348|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83289349|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83289350|NCT04091217|Growth Substances|growth substances|mesh-ancestor
83289351|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289352|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
83289353|NCT04091217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289354|NCT04091217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289355|NCT04081688|Atezolizumab|atezolizumab|mesh-list
83289356|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83289357|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
83289358|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
83289359|NCT04081688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289360|NCT04081688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289361|NCT04081688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289362|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289363|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
83430172|NCT03590444|Growth Substances|growth substances|mesh-ancestor
83289364|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289365|NCT04081389|Interferons|interferons|mesh-list
83289366|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
83289367|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
83289368|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83289369|NCT04081389|Celecoxib|celecoxib|mesh-list
83289370|NCT04081389|Paclitaxel|paclitaxel|mesh-list
83289371|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
83289372|NCT04081389|Doxorubicin|doxorubicin|mesh-list
83289373|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83289374|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83289375|NCT04081389|Daunorubicin|daunorubicin|mesh-list
83289376|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
83289377|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289378|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289379|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289380|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289381|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289382|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289383|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289384|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
83289385|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289386|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289387|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83289388|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
83289389|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83289390|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83289391|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83289392|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83289393|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289394|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
83289395|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289396|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83289397|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83289398|NCT04081389|Analgesics|analgesics|mesh-ancestor
83289399|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
83289400|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289401|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83289402|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83289403|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83289404|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83289405|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
83289406|NCT04068103|Leucovorin|leucovorin|mesh-list
83289407|NCT04068103|Folic Acid|folic acid|mesh-list
83289408|NCT04068103|Fluorouracil|fluorouracil|mesh-list
83289409|NCT04068103|Capecitabine|capecitabine|mesh-list
83289410|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
83289411|NCT04068103|Calcium|calcium|mesh-list
83289412|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
83289413|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83289414|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289415|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83289416|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
83289417|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289418|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289419|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289420|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289421|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
83289422|NCT04068103|Antidotes|antidotes|mesh-ancestor
83289423|NCT04068103|Protective Agents|protective agents|mesh-ancestor
83289424|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
83289425|NCT04068103|Vitamins|vitamins|mesh-ancestor
83289426|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
83289427|NCT04068103|Hematinics|hematinics|mesh-ancestor
83289428|NCT04060862|Fulvestrant|fulvestrant|mesh-list
83289429|NCT04060862|Palbociclib|palbociclib|mesh-list
83289430|NCT04060862|Ipatasertib|ipatasertib|mesh-list
83289431|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289432|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289434|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83289435|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
83289436|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289437|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289438|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289439|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289440|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289441|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
83289442|NCT04032704|SGN-LIV1A|sgn-liv1a|mesh-list
83289443|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289444|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289445|NCT04032704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289446|NCT04032704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289447|NCT04032704|Immunoconjugates|immunoconjugates|mesh-ancestor
83289448|NCT04032704|Immunologic Factors|immunologic factors|mesh-ancestor
83289449|NCT04032704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289450|NCT03941860|Lenalidomide|lenalidomide|mesh-list
83289451|NCT03941860|Ixazomib|ixazomib|mesh-list
83289452|NCT03941860|Glycine|glycine|mesh-list
83289453|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
83289454|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289455|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83289456|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83289457|NCT03941860|Growth Substances|growth substances|mesh-ancestor
83289458|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
83289459|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289460|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289461|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
83289462|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289463|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
83289464|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289465|NCT03856658|Floxuridine|floxuridine|mesh-list
83289466|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289467|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
83289468|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289469|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289470|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
83289471|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289472|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289473|NCT03848845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289474|NCT03848845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289475|NCT03811847|Methylphenidate|methylphenidate|mesh-list
83289476|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83289477|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289478|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83289479|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83289480|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83289481|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289482|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
83289483|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289484|NCT03809000|Leuprolide|leuprolide|mesh-list
83289485|NCT03809000|Goserelin|goserelin|mesh-list
83289486|NCT03809000|Bicalutamide|bicalutamide|mesh-list
83289487|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289488|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289489|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83289490|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
83289491|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83289492|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289493|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289494|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
83289495|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
83289496|NCT03742102|Paclitaxel|paclitaxel|mesh-list
83289497|NCT03742102|Trastuzumab|trastuzumab|mesh-list
83289498|NCT03742102|Durvalumab|durvalumab|mesh-list
83289499|NCT03742102|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83289500|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289501|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289502|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289503|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289504|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289505|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289506|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289507|NCT03742102|Immunoconjugates|immunoconjugates|mesh-ancestor
83289508|NCT03742102|Immunologic Factors|immunologic factors|mesh-ancestor
83289509|NCT03742102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289510|NCT03698552|Epratuzumab|epratuzumab|mesh-list
83289511|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289512|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289513|NCT03653364|Baloxavir|baloxavir|mesh-list
83289514|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
83289515|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289516|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289517|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289518|NCT03600350|Nivolumab|nivolumab|mesh-list
83289519|NCT03600350|Sargramostim|sargramostim|mesh-list
83289520|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289521|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289522|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289523|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289524|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
83289525|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289526|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
83289527|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289528|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289529|NCT03598608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289530|NCT03598608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289531|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
83289532|NCT03598595|Gemcitabine|gemcitabine|mesh-list
83289533|NCT03598595|Docetaxel|docetaxel|mesh-list
83289534|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289535|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
83289536|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289537|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289538|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289539|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289540|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289541|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
83289542|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83289543|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83289544|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289545|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289546|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289547|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
83289548|NCT03590054|Abexinostat|abexinostat|mesh-list
83289549|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289550|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289551|NCT03590054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289552|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289553|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83289554|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289555|NCT03568097|Avelumab|avelumab|mesh-list
83289556|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289557|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289558|NCT03768063|Atezolizumab|atezolizumab|mesh-list
83289559|NCT03768063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289560|NCT03768063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289561|NCT03768063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289562|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289563|NCT03564691|Paclitaxel|paclitaxel|mesh-list
83289564|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83289565|NCT03564691|Cisplatin|cisplatin|mesh-list
83289566|NCT03564691|Carboplatin|carboplatin|mesh-list
83289567|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
83289568|NCT03564691|Pemetrexed|pemetrexed|mesh-list
83289569|NCT03564691|Lenvatinib|lenvatinib|mesh-list
83289570|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289571|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289572|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289573|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289574|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289575|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289576|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289577|NCT03564691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289578|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289579|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83289580|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83289581|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289583|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289584|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289585|NCT03546582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289586|NCT03546582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289587|NCT03473756|Atezolizumab|atezolizumab|mesh-list
83289588|NCT03473756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289589|NCT03473756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289590|NCT03473756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289591|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289592|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83289593|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
83289594|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289595|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83289596|NCT03384238|Panitumumab|panitumumab|mesh-list
83289597|NCT03384238|Antibodies|antibodies|mesh-list
83289598|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
83289599|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83289600|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
83289601|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289602|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289603|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
83289604|NCT03226249|Doxorubicin|doxorubicin|mesh-list
83289605|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83289606|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
83289607|NCT03226249|Dacarbazine|dacarbazine|mesh-list
83289608|NCT03226249|Vinblastine|vinblastine|mesh-list
83289609|NCT03226249|Imidazole|imidazole|mesh-list
83289610|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83289611|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83289612|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289613|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83289614|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83289615|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289616|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289617|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289618|NCT03226249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289619|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83289620|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83289621|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
83289622|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289623|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289624|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289625|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289626|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
83289627|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
83289628|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289629|NCT03184155|Nicardipine|nicardipine|mesh-list
83289630|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83289631|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83289632|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83289633|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289634|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83289635|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289636|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
83289637|NCT03175432|Bevacizumab|bevacizumab|mesh-list
83289638|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83289639|NCT03175432|Atezolizumab|atezolizumab|mesh-list
83289640|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
83289641|NCT03175432|Antibodies|antibodies|mesh-list
83289642|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
83289643|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83289644|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
83289645|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289646|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83289647|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83289648|NCT03175432|Growth Substances|growth substances|mesh-ancestor
83289649|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289650|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
83289651|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
83289652|NCT03175432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289653|NCT03175432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289654|NCT03172624|Nivolumab|nivolumab|mesh-list
83289655|NCT03172624|Ipilimumab|ipilimumab|mesh-list
83289656|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289657|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289658|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289659|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289660|NCT03101748|Paclitaxel|paclitaxel|mesh-list
83289661|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
83289662|NCT03101748|Doxorubicin|doxorubicin|mesh-list
83289663|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83289664|NCT03101748|Trastuzumab|trastuzumab|mesh-list
83289665|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83289666|NCT03101748|Daunorubicin|daunorubicin|mesh-list
83289667|NCT03101748|Pertuzumab|pertuzumab|mesh-list
83289668|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
83289669|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83289670|NCT03101748|Antibodies|antibodies|mesh-list
83289671|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
83289672|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83289673|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289674|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289675|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289676|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289677|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289678|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289679|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289680|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
83289681|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289682|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289683|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83289684|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
83289685|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83289686|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83289687|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83289688|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83289689|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289690|NCT03085147|Olaparib|olaparib|mesh-list
83289691|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83289692|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289693|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289694|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289695|NCT03063944|Azacitidine|azacitidine|mesh-list
83289696|NCT03063944|Decitabine|decitabine|mesh-list
83289697|NCT03063944|Venetoclax|venetoclax|mesh-list
83289698|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289699|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
83289700|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289701|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289702|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289703|NCT03062631|Amifampridine|amifampridine|mesh-list
83289704|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83289705|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289706|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289707|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83289708|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83289709|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289710|NCT02979873|Sirolimus|sirolimus|mesh-list
83289711|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83289712|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289713|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83289714|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289715|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
83289716|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289717|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
83289718|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289719|NCT02941926|Letrozole|letrozole|mesh-list
83289720|NCT02941926|Leuprolide|leuprolide|mesh-list
83289721|NCT02941926|Goserelin|goserelin|mesh-list
83289722|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289723|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83289724|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83289725|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289726|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289727|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83289728|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
83289729|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289730|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289731|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83289732|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
83289733|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83289734|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289735|NCT02933255|Nivolumab|nivolumab|mesh-list
83289736|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289737|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289738|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289739|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289740|NCT02910700|Nivolumab|nivolumab|mesh-list
83289741|NCT02910700|Trametinib|trametinib|mesh-list
83289742|NCT02910700|Dabrafenib|dabrafenib|mesh-list
83289743|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289744|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289745|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289746|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289747|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289748|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289749|NCT02849548|Suvorexant|suvorexant|mesh-list
83289750|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83289751|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83289752|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83289753|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289754|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83289755|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289756|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289757|NCT02815995|Durvalumab|durvalumab|mesh-list
83289758|NCT02815995|Tremelimumab|tremelimumab|mesh-list
83289759|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289760|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289761|NCT02780310|Lenvatinib|lenvatinib|mesh-list
83289762|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289763|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289764|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289765|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289766|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
83289767|NCT02758431|Anastrozole|anastrozole|mesh-list
83289768|NCT02758431|Testosterone|testosterone|mesh-list
83289769|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
83289770|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
83289771|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83289772|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83289773|NCT02758431|Acyline|acyline|mesh-list
83289774|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
83289775|NCT02758431|Hormones|hormones|mesh-ancestor
83289776|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289777|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289778|NCT02758431|Androgens|androgens|mesh-ancestor
83289779|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289780|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289781|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
83289782|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83289783|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289784|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289785|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83289786|NCT02756000|Dobutamine|dobutamine|mesh-list
83289787|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83289788|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
83289789|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
83289790|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289791|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289792|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83289793|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83289794|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83289795|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
83289796|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289797|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289798|NCT02756000|Protective Agents|protective agents|mesh-ancestor
83289799|NCT02698254|Bevacizumab|bevacizumab|mesh-list
83289800|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83289801|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
83289802|NCT02698254|Antibodies|antibodies|mesh-list
83289803|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
83289804|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83289805|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
83289806|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289807|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83289808|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83289809|NCT02698254|Growth Substances|growth substances|mesh-ancestor
83289810|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289811|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
83289812|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
83289814|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
83289815|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83289816|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
83289817|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289818|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
83289819|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83289820|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289821|NCT02639273|Nalmefene|nalmefene|mesh-list
83289822|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83289823|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289824|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
83289825|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289826|NCT02601365|Molgramostim|molgramostim|mesh-list
83289827|NCT02601365|Sargramostim|sargramostim|mesh-list
83289828|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
83289829|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289830|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289831|NCT02583893|Cytarabine|cytarabine|mesh-list
83289832|NCT02583893|Sirolimus|sirolimus|mesh-list
83289833|NCT02583893|Etoposide|etoposide|mesh-list
83289834|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
83289835|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
83289836|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289837|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289838|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83289839|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83289840|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289841|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289842|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289843|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
83289844|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
83289845|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289846|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289847|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
83289848|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289849|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83289850|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83289851|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
83289852|NCT02583893|Analgesics|analgesics|mesh-ancestor
83289853|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
83289854|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289855|NCT02520154|Paclitaxel|paclitaxel|mesh-list
83289856|NCT02520154|Carboplatin|carboplatin|mesh-list
83289857|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
83289858|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83289859|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289860|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289861|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289862|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289863|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289864|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289865|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83289866|NCT02520154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83289867|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83289868|NCT02411448|Gefitinib|gefitinib|mesh-list
83289869|NCT02411448|Osimertinib|osimertinib|mesh-list
83289870|NCT02411448|Ramucirumab|ramucirumab|mesh-list
83289871|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289872|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83289873|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289874|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289875|NCT02107144|Trimetazidine|trimetazidine|mesh-list
83289876|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
83289877|NCT02003222|Cytarabine|cytarabine|mesh-list
83289878|NCT02003222|Dexamethasone|dexamethasone|mesh-list
83289879|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
83289880|NCT02003222|Prednisone|prednisone|mesh-list
83289881|NCT02003222|Cortisone|cortisone|mesh-list
83289882|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
83289883|NCT02003222|Rituximab|rituximab|mesh-list
83289884|NCT02003222|Methotrexate|methotrexate|mesh-list
83289885|NCT02003222|Etoposide|etoposide|mesh-list
83289886|NCT02003222|Vincristine|vincristine|mesh-list
83289887|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
83289888|NCT02003222|Daunorubicin|daunorubicin|mesh-list
83289889|NCT02003222|Asparaginase|asparaginase|mesh-list
83289890|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
83289891|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
83289892|NCT02003222|Pegaspargase|pegaspargase|mesh-list
83289893|NCT02003222|Blinatumomab|blinatumomab|mesh-list
83289894|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83289895|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
83289896|NCT02003222|Antibodies|antibodies|mesh-list
83289897|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
83289898|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83289899|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83289900|NCT02003222|BB 1101|bb 1101|mesh-list
83289901|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289902|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
83289903|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289904|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289905|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83289906|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
83289907|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289908|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289909|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83289910|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83289911|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
83289912|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
83289913|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289914|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83289915|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
83289916|NCT02003222|Hormones|hormones|mesh-ancestor
83289917|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289918|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289919|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
83289920|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289921|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83289922|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
83289923|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83289924|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289925|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
83289926|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83289927|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83289928|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83289929|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289930|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83289931|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83289932|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
83289933|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83289934|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289935|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289936|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289937|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83289938|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
83289939|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
83289940|NCT01864109|Temozolomide|temozolomide|mesh-list
83289941|NCT01864109|Ifosfamide|ifosfamide|mesh-list
83289942|NCT01864109|Doxorubicin|doxorubicin|mesh-list
83289943|NCT01864109|Irinotecan|irinotecan|mesh-list
83289944|NCT01864109|Etoposide|etoposide|mesh-list
83289945|NCT01864109|Vincristine|vincristine|mesh-list
83289946|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
83289947|NCT01864109|Razoxane|razoxane|mesh-list
83289948|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289949|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
83289950|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289951|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289952|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83289953|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
83289954|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289955|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289956|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83289957|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83289958|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83289959|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83289960|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83289961|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83289962|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83289963|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
83289964|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
83289965|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
83289966|NCT01864109|Protective Agents|protective agents|mesh-ancestor
83289967|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83289968|NCT01862315|Dexamethasone|dexamethasone|mesh-list
83289969|NCT01862315|Gemcitabine|gemcitabine|mesh-list
83289970|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
83289971|NCT01862315|Floxuridine|floxuridine|mesh-list
83289972|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83289973|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
83289974|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
83289975|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83289976|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289977|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83289978|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
83289979|NCT01862315|Hormones|hormones|mesh-ancestor
83289980|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83289981|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83289982|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289983|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83289984|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
83289985|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289986|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
83289987|NCT01860170|Bortezomib|bortezomib|mesh-list
83289988|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83289989|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
83289990|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83289991|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83289992|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83289993|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
83289994|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83289995|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83289996|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83289997|NCT01847274|Niraparib|niraparib|mesh-list
83289998|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83289999|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290000|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290001|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290002|NCT01712620|Spironolactone|spironolactone|mesh-list
83290003|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83290004|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
83290005|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290006|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290007|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83290008|NCT01712620|Diuretics|diuretics|mesh-ancestor
83290009|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
83290010|NCT01697566|Metformin|metformin|mesh-list
83290011|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290012|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290013|NCT03193190|Leucovorin|leucovorin|mesh-list
83290014|NCT03193190|Paclitaxel|paclitaxel|mesh-list
83290015|NCT03193190|Bevacizumab|bevacizumab|mesh-list
83290016|NCT03193190|Gemcitabine|gemcitabine|mesh-list
83290017|NCT03193190|Fluorouracil|fluorouracil|mesh-list
83290018|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
83290019|NCT03193190|Atezolizumab|atezolizumab|mesh-list
83290020|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83290021|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290022|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
83290023|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
83290024|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
83290025|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290026|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290027|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83290028|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83290029|NCT03193190|Growth Substances|growth substances|mesh-ancestor
83290030|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290031|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
83290032|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290033|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
83290034|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290035|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
83290037|NCT03193190|Protective Agents|protective agents|mesh-ancestor
83290038|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
83290039|NCT03193190|Vitamins|vitamins|mesh-ancestor
83290040|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
83290041|NCT03193190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83290042|NCT01566695|Azacitidine|azacitidine|mesh-list
83290043|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290044|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
83290045|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290046|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290047|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290048|NCT01471106|Dasatinib|dasatinib|mesh-list
83290049|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290050|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290051|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290052|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290053|NCT01445509|Bevacizumab|bevacizumab|mesh-list
83290054|NCT01445509|Dasatinib|dasatinib|mesh-list
83290055|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290056|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290057|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83290058|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83290059|NCT01445509|Growth Substances|growth substances|mesh-ancestor
83290060|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290061|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
83290062|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290063|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290064|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290065|NCT01330446|Modafinil|modafinil|mesh-list
83290066|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83290067|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290068|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83290069|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83290070|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83290071|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290072|NCT01258933|Ofatumumab|ofatumumab|mesh-list
83290073|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290074|NCT00866554|Tamoxifen|tamoxifen|mesh-list
83290075|NCT00866554|Bicalutamide|bicalutamide|mesh-list
83290076|NCT00866554|Dutasteride|dutasteride|mesh-list
83290077|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83290078|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
83290079|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290080|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290081|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83290082|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290083|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83290084|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83290085|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83290086|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
83290087|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83290088|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83290089|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290090|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290091|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
83290092|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290093|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290094|NCT00452023|Interferons|interferons|mesh-list
83290095|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
83290096|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
83290097|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83290098|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290099|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
83290100|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290101|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
83290102|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290103|NCT00442104|Ganaxolone|ganaxolone|mesh-list
83290104|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
83290105|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290106|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290107|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290108|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
83290110|NCT00441896|Ganaxolone|ganaxolone|mesh-list
83290111|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
83290112|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290113|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290114|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290115|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
83290116|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
83290117|NCT00254423|Dasatinib|dasatinib|mesh-list
83290118|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290119|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290120|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290121|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290122|NCT00202800|Gemcitabine|gemcitabine|mesh-list
83290123|NCT00202800|Etoposide|etoposide|mesh-list
83290124|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290125|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
83290126|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290127|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290128|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83290129|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83290130|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83290131|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290132|NCT00194714|Vaccines|vaccines|mesh-list
83290133|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
83290134|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290135|NCT00018057|Fluoxetine|fluoxetine|mesh-list
83290136|NCT00018057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83290137|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83290138|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290139|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290140|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290141|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
83290142|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290143|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83290144|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
83290145|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83290146|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83290147|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83290148|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290149|NCT00018044|Clofazimine|clofazimine|mesh-list
83290150|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290151|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
83290152|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83290153|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290154|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83290155|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
83290156|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290157|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83290158|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
83290159|NCT02034799|Coagulants|coagulants|mesh-ancestor
83290160|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83290161|NCT02057575|Latanoprost|latanoprost|mesh-list
83290162|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83290163|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83290164|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
83290165|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290166|NCT02034565|Apixaban|apixaban|mesh-list
83290167|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83290168|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
83290169|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83290170|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
83290171|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290172|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290173|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
83290174|NCT02075515|Vaccines|vaccines|mesh-list
83290175|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
83290176|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290178|NCT04682587|Avelumab|avelumab|mesh-list
83290179|NCT04682587|Axitinib|axitinib|mesh-list
83290180|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290181|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290182|NCT04682587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83290183|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290184|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290186|NCT04417543|Memantine|memantine|mesh-list
83290187|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83290188|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83290189|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
83290190|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290191|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290192|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290193|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83290194|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83290195|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
83290196|NCT02021318|Hematinics|hematinics|mesh-ancestor
83290197|NCT02020616|Metformin|metformin|mesh-list
83290198|NCT02020616|Exenatide|exenatide|mesh-list
83290199|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290200|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290201|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83290202|NCT02020616|Incretins|incretins|mesh-ancestor
83290203|NCT02020616|Hormones|hormones|mesh-ancestor
83290204|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290205|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83290206|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83290207|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290208|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290209|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
83290210|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290211|NCT01622660|Gemcitabine|gemcitabine|mesh-list
83290212|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290213|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
83290214|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290215|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290216|NCT04697498|Anesthetics|anesthetics|mesh-list
83290217|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290218|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290219|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
83290220|NCT02019602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83290221|NCT02019602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290222|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290223|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
83290224|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290225|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290226|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83290227|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
83290228|NCT02040428|Coagulants|coagulants|mesh-ancestor
83290229|NCT02018822|Urethane|urethane|mesh-list
83290230|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290231|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83290232|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
83290233|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
83290234|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290235|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290236|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
83290237|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
83290238|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290239|NCT02022007|Metformin|metformin|mesh-list
83290240|NCT02022007|Saxagliptin|saxagliptin|mesh-list
83290241|NCT02022007|Biguanides|biguanides|mesh-list
83290242|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83290243|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290244|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290245|NCT02022007|Incretins|incretins|mesh-ancestor
83290246|NCT02022007|Hormones|hormones|mesh-ancestor
83290247|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290248|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83290249|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290250|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290251|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
83290252|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83290253|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
83290254|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83290255|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
83290256|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290257|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290258|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
83290259|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83290260|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290261|NCT02053753|Denosumab|denosumab|mesh-list
83290262|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83290263|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290264|NCT02019979|Metformin|metformin|mesh-list
83290265|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290266|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290267|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
83290268|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83290269|NCT02019667|Protective Agents|protective agents|mesh-ancestor
83290270|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290271|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
83290272|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
83290273|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290274|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290275|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
83290276|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
83290277|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83290278|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83290279|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290280|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
83290281|NCT02030821|Coagulants|coagulants|mesh-ancestor
83290282|NCT02052739|Brexanolone|brexanolone|mesh-list
83290283|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
83290284|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290285|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290286|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290287|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
83290288|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
83290289|NCT02019277|Paclitaxel|paclitaxel|mesh-list
83290290|NCT02019277|Docetaxel|docetaxel|mesh-list
83290291|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83290292|NCT02019277|Trastuzumab|trastuzumab|mesh-list
83290293|NCT02019277|Pertuzumab|pertuzumab|mesh-list
83290294|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83290295|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290296|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
83290297|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
83290298|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
83290299|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290300|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290301|NCT01823835|Palbociclib|palbociclib|mesh-list
83290302|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290303|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290304|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290305|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290306|NCT01823679|Capecitabine|capecitabine|mesh-list
83290307|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290308|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
83290309|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290310|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290311|NCT01823289|Itraconazole|itraconazole|mesh-list
83290312|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
83290313|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290314|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83290315|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83290316|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290317|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290318|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83290319|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
83290320|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290321|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290322|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83290323|NCT01822899|Fluticasone|fluticasone|mesh-list
83290325|NCT01822899|Bromides|bromides|mesh-list
83290326|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83290327|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290328|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83290329|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
83290330|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290331|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290332|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83290333|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
83290334|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
83290335|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83290336|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83290337|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83290338|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83290339|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290340|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290341|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290342|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
83290343|NCT01822821|Acetaminophen|acetaminophen|mesh-list
83290344|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83290345|NCT01822821|Analgesics|analgesics|mesh-ancestor
83290346|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
83290347|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290348|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290349|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
83290350|NCT01822665|Acetaminophen|acetaminophen|mesh-list
83290351|NCT01822665|Ibuprofen|ibuprofen|mesh-list
83290352|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83290353|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83290354|NCT01822665|Analgesics|analgesics|mesh-ancestor
83290355|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
83290356|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290357|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290358|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290359|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290360|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83290361|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290362|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290363|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
83290364|NCT01822587|Propranolol|propranolol|mesh-list
83290365|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83290366|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83290367|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290368|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290369|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290370|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290371|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83290372|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83290373|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
83290374|NCT01821963|Interferons|interferons|mesh-list
83290375|NCT01821963|Ribavirin|ribavirin|mesh-list
83290376|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
83290377|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
83290378|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83290379|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290380|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
83290381|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290382|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
83290383|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290384|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
83290385|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290386|NCT01821729|Leucovorin|leucovorin|mesh-list
83290387|NCT01821729|Fluorouracil|fluorouracil|mesh-list
83290388|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
83290389|NCT01821729|Folfirinox|folfirinox|mesh-list
83290390|NCT01821729|Losartan|losartan|mesh-list
83290391|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
83290392|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290393|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290394|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290395|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290397|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290398|NCT01821729|Antidotes|antidotes|mesh-ancestor
83290399|NCT01821729|Protective Agents|protective agents|mesh-ancestor
83290400|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
83290401|NCT01821729|Vitamins|vitamins|mesh-ancestor
83290402|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
83290403|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83290404|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83290405|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83290406|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83290407|NCT01820637|Paclitaxel|paclitaxel|mesh-list
83290408|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83290409|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290410|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
83290411|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
83290412|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
83290413|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290414|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
83290415|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290416|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
83290417|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83290418|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83290419|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
83290420|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83290421|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83290422|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290423|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290424|NCT02171429|Adalimumab|adalimumab|mesh-list
83290425|NCT02171429|Etrolizumab|etrolizumab|mesh-list
83290426|NCT02171429|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83290427|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290428|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290429|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83290430|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
83290431|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290432|NCT01818141|Vancomycin|vancomycin|mesh-list
83290433|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
83290434|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83290435|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290436|NCT01849497|Evolocumab|evolocumab|mesh-list
83290437|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83290438|NCT01849497|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83290439|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83290440|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83290441|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
83290442|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290443|NCT01849497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83290444|NCT01849497|Protease Inhibitors|protease inhibitors|mesh-ancestor
83290445|NCT01849497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290446|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83290447|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
83290448|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290449|NCT04170465|Metformin|metformin|mesh-list
83290450|NCT04170465|Paclitaxel|paclitaxel|mesh-list
83290451|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
83290452|NCT04170465|Doxorubicin|doxorubicin|mesh-list
83290453|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83290454|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290455|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
83290456|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
83290457|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
83290458|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290459|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290460|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
83290461|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290462|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290463|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83290464|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
83290465|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83290466|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290467|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83290468|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83290469|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83290470|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290471|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83290472|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290473|NCT01847313|Liraglutide|liraglutide|mesh-list
83290474|NCT01847313|Glucagon|glucagon|mesh-list
83290475|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83290476|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290477|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290478|NCT01847313|Incretins|incretins|mesh-ancestor
83290479|NCT01847313|Hormones|hormones|mesh-ancestor
83290480|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290481|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83290482|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83290483|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
83290484|NCT02117687|Glycerol|glycerol|mesh-list
83290485|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83290486|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
83290487|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290489|NCT02117687|Protective Agents|protective agents|mesh-ancestor
83290490|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83290491|NCT02117687|Laxatives|laxatives|mesh-ancestor
83290492|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83290493|NCT04740593|Methamphetamine|methamphetamine|mesh-list
83290494|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83290495|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290496|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
83290497|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
83290498|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290499|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
83290500|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290501|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290502|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290503|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83290504|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83290505|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290506|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83290507|NCT02141633|Fluticasone|fluticasone|mesh-list
83290508|NCT02141633|Xhance|xhance|mesh-list
83290509|NCT02141633|Albuterol|albuterol|mesh-list
83290510|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290511|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83290512|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
83290513|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290514|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290515|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83290516|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
83290517|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
83290518|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83290519|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
83290520|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83290521|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83290522|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83290523|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83290524|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290525|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290526|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290527|NCT01846611|Dexamethasone|dexamethasone|mesh-list
83290528|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83290529|NCT01846611|Doxorubicin|doxorubicin|mesh-list
83290530|NCT01846611|Trabectedin|trabectedin|mesh-list
83290531|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290532|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
83290533|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
83290534|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290535|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290536|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83290537|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
83290538|NCT01846611|Hormones|hormones|mesh-ancestor
83290539|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290540|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83290541|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290542|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83290543|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83290544|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83290545|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290546|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290547|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83290548|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
83290549|NCT01846299|Ranibizumab|ranibizumab|mesh-list
83290550|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83290551|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83290552|NCT01846299|Growth Substances|growth substances|mesh-ancestor
83290553|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290554|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
83290555|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290556|NCT01628393|Ozanimod|ozanimod|mesh-list
83290557|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83290558|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290559|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290560|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
83290561|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290562|NCT01846221|Clonidine|clonidine|mesh-list
83290563|NCT01846221|Fentanyl|fentanyl|mesh-list
83290564|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83290565|NCT01846221|Narcotics|narcotics|mesh-ancestor
83290566|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290567|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290568|NCT01846221|Analgesics|analgesics|mesh-ancestor
83290569|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
83290570|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290571|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83290572|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83290573|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
83290574|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
83290575|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83290576|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
83290577|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
83290578|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83290579|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83290580|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83290581|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290582|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290583|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290584|NCT01845831|Metformin|metformin|mesh-list
83290585|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
83290586|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83290587|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290588|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290589|NCT01845831|Incretins|incretins|mesh-ancestor
83290590|NCT01845831|Hormones|hormones|mesh-ancestor
83290591|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290592|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83290593|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
83290594|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290595|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290596|NCT01844895|Abatacept|abatacept|mesh-list
83290597|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83290598|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290599|NCT01844895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290600|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290601|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290602|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
83290603|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290604|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290605|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
83290606|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83290607|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83290608|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83290609|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290610|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290611|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
83290612|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290613|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290614|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83290615|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290616|NCT04594239|Lidocaine|lidocaine|mesh-list
83290617|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
83290618|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
83290619|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
83290620|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290621|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290622|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
83290623|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290624|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83290625|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83290626|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83290627|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290628|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290629|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83290630|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
83290631|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
83290632|NCT04594239|Protective Agents|protective agents|mesh-ancestor
83290633|NCT04585737|Tenofovir|tenofovir|mesh-list
83290634|NCT04585737|Lamivudine|lamivudine|mesh-list
83290635|NCT04585737|Emtricitabine|emtricitabine|mesh-list
83290636|NCT04585737|Dolutegravir|dolutegravir|mesh-list
83290637|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83290638|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
83290639|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290640|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83290641|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83290642|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290643|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290644|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83290645|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83290646|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83290647|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83290649|NCT01814553|Loperamide|loperamide|mesh-list
83290650|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
83290651|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290652|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290653|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290654|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290655|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83290656|NCT02116205|Vaccines|vaccines|mesh-list
83290657|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
83290658|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290659|NCT01844583|Rifampin|rifampin|mesh-list
83290660|NCT01844583|Esomeprazole|esomeprazole|mesh-list
83290661|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83290662|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83290663|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83290664|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290665|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290666|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83290667|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
83290668|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83290669|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290670|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
83290671|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83290672|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83290673|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83290674|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83290675|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83290676|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83290677|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83290678|NCT04742075|Durvalumab|durvalumab|mesh-list
83290679|NCT04742075|Olaparib|olaparib|mesh-list
83290680|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83290681|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290682|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290683|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
83290684|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290685|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83290686|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290687|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290688|NCT02115113|Everolimus|everolimus|mesh-list
83290689|NCT02115113|Tacrolimus|tacrolimus|mesh-list
83290690|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290691|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
83290692|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290693|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83290694|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290695|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290696|NCT02115113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83290697|NCT02115113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290698|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290699|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
83290700|NCT02114177|Simeprevir|simeprevir|mesh-list
83290701|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
83290702|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290703|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
83290704|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290705|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290706|NCT02138825|Riociguat|riociguat|mesh-list
83290707|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
83290708|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290709|NCT02138747|Mirabegron|mirabegron|mesh-list
83290710|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83290711|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83290712|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83290713|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83290714|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290715|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290716|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290717|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290718|NCT02138747|Urological Agents|urological agents|mesh-ancestor
83290719|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83290720|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83290721|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
83290722|NCT02105285|Carteolol|carteolol|mesh-list
83290723|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83290724|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83290725|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83290726|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83290727|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290728|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290729|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290730|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290731|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83290732|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83290733|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
83290734|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
83290735|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290736|NCT01621490|Nivolumab|nivolumab|mesh-list
83290737|NCT01621490|Ipilimumab|ipilimumab|mesh-list
83290738|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290739|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290740|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83290741|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290742|NCT02030041|Vitamin D|vitamin d|mesh-list
83290743|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
83290744|NCT02030041|Simvastatin|simvastatin|mesh-list
83290745|NCT02030041|Vitamins|vitamins|mesh-ancestor
83290746|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
83290747|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290748|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83290749|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83290750|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83290751|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83290752|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
83290753|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290754|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83290755|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83290756|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290757|NCT01844505|Nivolumab|nivolumab|mesh-list
83290758|NCT01844505|Ipilimumab|ipilimumab|mesh-list
83290759|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290760|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290761|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83290762|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290763|NCT01994720|Aspirin|aspirin|mesh-list
83290764|NCT01994720|Ticagrelor|ticagrelor|mesh-list
83290765|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83290766|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83290767|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83290768|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83290769|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
83290770|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290771|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290772|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290773|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83290774|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83290776|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
83290777|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290778|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290779|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290780|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83290781|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83290782|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83290783|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290784|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
83290785|NCT01814397|Letrozole|letrozole|mesh-list
83290786|NCT01814397|Anastrozole|anastrozole|mesh-list
83290787|NCT01814397|Exemestane|exemestane|mesh-list
83290788|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290789|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83290790|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83290791|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290792|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290793|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83290794|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
83290795|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83290796|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290797|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83290798|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83290799|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
83290800|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83290801|NCT01844115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83290802|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83290803|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290804|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290805|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290806|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
83290807|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290808|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83290809|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83290810|NCT02018042|Abatacept|abatacept|mesh-list
83290811|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83290812|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290813|NCT02018042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83290814|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290815|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290816|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
83290817|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290818|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290819|NCT02017171|Allopurinol|allopurinol|mesh-list
83290820|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
83290821|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290822|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290823|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
83290824|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290825|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83290826|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
83290827|NCT02017171|Protective Agents|protective agents|mesh-ancestor
83290828|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290829|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
83290830|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83290831|NCT02029417|Cytarabine|cytarabine|mesh-list
83290832|NCT02029417|Decitabine|decitabine|mesh-list
83290833|NCT02029417|Azacitidine|azacitidine|mesh-list
83290834|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
83290835|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290836|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
83290837|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290838|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290839|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
83290840|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290841|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290842|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
83290843|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290844|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290845|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83290846|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83290847|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83290848|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
83290849|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290850|NCT04694846|Bupropion|bupropion|mesh-list
83290851|NCT04694846|Nicotine|nicotine|mesh-list
83290852|NCT04694846|Varenicline|varenicline|mesh-list
83290853|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83290854|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
83290855|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290856|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290857|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83290858|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83290859|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
83290860|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290861|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290862|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83290863|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
83290864|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83290865|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83290866|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83290867|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290868|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
83290869|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83290870|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83290871|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290872|NCT02050321|Vemurafenib|vemurafenib|mesh-list
83290873|NCT02050321|Acitretin|acitretin|mesh-list
83290874|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290875|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290876|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290877|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290878|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
83290879|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
83290880|NCT02017015|Paclitaxel|paclitaxel|mesh-list
83290881|NCT02017015|Gemcitabine|gemcitabine|mesh-list
83290882|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83290883|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290884|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83290885|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83290886|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83290887|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290888|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83290889|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
83290890|NCT02016625|Cyclosporine|cyclosporine|mesh-list
83290891|NCT02016625|Tacrolimus|tacrolimus|mesh-list
83290892|NCT02016625|Cyclosporins|cyclosporins|mesh-list
83290893|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83290894|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
83290895|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290896|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83290897|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290898|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290899|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
83290900|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83290901|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
83290902|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290903|NCT02016482|Adalimumab|adalimumab|mesh-list
83290904|NCT02016482|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83290905|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83290906|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83290907|NCT02028871|Insulin|insulin|mesh-list
83290909|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290910|NCT02028715|Acetaminophen|acetaminophen|mesh-list
83290911|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83290912|NCT02028715|Analgesics|analgesics|mesh-ancestor
83290913|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
83290914|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290915|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290916|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
83290917|NCT02016170|Ticagrelor|ticagrelor|mesh-list
83290918|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83290919|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83290920|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83290921|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83290922|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83290923|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
83290924|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290925|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290926|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290927|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83290928|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
83290929|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83290930|NCT02015546|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83290931|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83290932|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83290933|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290934|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290935|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
83290936|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290937|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83290938|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83290939|NCT02038790|Buprenorphine|buprenorphine|mesh-list
83290940|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83290941|NCT02038790|Naloxone|naloxone|mesh-list
83290942|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83290943|NCT02038790|Narcotics|narcotics|mesh-ancestor
83290944|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290945|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290946|NCT02038790|Analgesics|analgesics|mesh-ancestor
83290947|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
83290948|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290949|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83290950|NCT02027311|Midazolam|midazolam|mesh-list
83290951|NCT02027311|Meperidine|meperidine|mesh-list
83290952|NCT02027311|Etomidate|etomidate|mesh-list
83290953|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83290954|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83290955|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290956|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290957|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83290958|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83290959|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83290960|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83290961|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
83290962|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
83290963|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
83290964|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
83290965|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290966|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290967|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83290968|NCT02027311|Narcotics|narcotics|mesh-ancestor
83290969|NCT02027311|Analgesics|analgesics|mesh-ancestor
83290970|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
83290971|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290972|NCT02047903|Afatinib|afatinib|mesh-list
83290973|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83290974|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83290975|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83290976|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290977|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
83290978|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83290979|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83290980|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290981|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83290982|NCT02026141|Analgesics|analgesics|mesh-ancestor
83290983|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
83290984|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83290985|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83290986|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83290987|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83290988|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
83290989|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83290990|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290991|NCT02025907|Canagliflozin|canagliflozin|mesh-list
83290992|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83290993|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83290994|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83290995|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83290996|NCT02025751|Metoclopramide|metoclopramide|mesh-list
83290997|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
83290998|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
83290999|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291000|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291001|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83291002|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83291003|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83291004|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
83291005|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291006|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291007|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83291008|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83291009|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291010|NCT02024971|Metformin|metformin|mesh-list
83291011|NCT02024971|Pioglitazone|pioglitazone|mesh-list
83291012|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291013|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291014|NCT01843023|Naltrexone|naltrexone|mesh-list
83291015|NCT01843023|Buprenorphine|buprenorphine|mesh-list
83291016|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83291017|NCT01843023|Narcotics|narcotics|mesh-ancestor
83291018|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291019|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291020|NCT01843023|Analgesics|analgesics|mesh-ancestor
83291021|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
83291022|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291023|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83291024|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83291025|NCT01812759|Fentanyl|fentanyl|mesh-list
83291026|NCT01812759|Hydromorphone|hydromorphone|mesh-list
83291027|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83291028|NCT01812759|Narcotics|narcotics|mesh-ancestor
83291029|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291030|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291031|NCT01812759|Analgesics|analgesics|mesh-ancestor
83291032|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
83291033|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291034|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83291035|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83291036|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
83291037|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
83291038|NCT01812057|Dexamethasone|dexamethasone|mesh-list
83291039|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291040|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
83291041|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
83291042|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291043|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291044|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83291045|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
83291046|NCT01812057|Hormones|hormones|mesh-ancestor
83291047|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291048|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83291049|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291050|NCT01842633|Acetaminophen|acetaminophen|mesh-list
83291051|NCT01842633|Ibuprofen|ibuprofen|mesh-list
83291052|NCT01842633|Caffeine|caffeine|mesh-list
83291053|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83291054|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83291056|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
83291057|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291058|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291059|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291060|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291061|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83291062|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291063|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291064|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
83291065|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83291066|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83291067|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83291068|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83291069|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
83291070|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291071|NCT01841697|Metformin|metformin|mesh-list
83291072|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83291073|NCT01841697|Glimepiride|glimepiride|mesh-list
83291074|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291075|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291076|NCT01841697|Incretins|incretins|mesh-ancestor
83291077|NCT01841697|Hormones|hormones|mesh-ancestor
83291078|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291079|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83291080|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291081|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291082|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291083|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83291084|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291085|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
83291086|NCT01809327|Metformin|metformin|mesh-list
83291087|NCT01809327|Canagliflozin|canagliflozin|mesh-list
83291088|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291089|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291090|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83291091|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291092|NCT03272139|Bupivacaine|bupivacaine|mesh-list
83291093|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
83291094|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
83291095|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291096|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291097|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
83291098|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291099|NCT01808313|Ambrisentan|ambrisentan|mesh-list
83291100|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83291101|NCT01840605|Ketotifen|ketotifen|mesh-list
83291102|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
83291103|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
83291104|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291105|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83291106|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
83291107|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
83291108|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291109|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291110|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291111|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83291112|NCT02023879|Alirocumab|alirocumab|mesh-list
83291113|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83291114|NCT02023879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83291115|NCT02023879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83291116|NCT02023879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83291117|NCT02023879|Antimetabolites|antimetabolites|mesh-ancestor
83291118|NCT02023879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291119|NCT02023879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83291120|NCT02023879|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291121|NCT02023879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291122|NCT02023879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83291123|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
83291124|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291125|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83291126|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291127|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291128|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
83291129|NCT02013817|Rituximab|rituximab|mesh-list
83291130|NCT02013817|Fludarabine|fludarabine|mesh-list
83291131|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291132|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
83291133|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291134|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291135|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83291136|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
83291137|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291138|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291139|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83291140|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291141|NCT02023099|Ritonavir|ritonavir|mesh-list
83291142|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83291143|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83291144|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291145|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291146|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291147|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83291148|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83291149|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
83291150|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291151|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83291152|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83291153|NCT02013037|Eculizumab|eculizumab|mesh-list
83291154|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83291155|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291156|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
83291157|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291158|NCT04416607|Menotropins|menotropins|mesh-list
83291159|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83291160|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
83291161|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83291162|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291163|NCT01967173|Fluticasone|fluticasone|mesh-list
83291165|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83291166|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83291167|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
83291168|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291169|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291170|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83291171|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
83291172|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
83291173|NCT01967173|Hormones|hormones|mesh-ancestor
83291174|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291175|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
83291176|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291177|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291178|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83291179|NCT01993927|Voglibose|voglibose|mesh-list
83291180|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291181|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291182|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83291183|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291184|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291185|NCT02012959|Tolvaptan|tolvaptan|mesh-list
83291186|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83291187|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291188|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
83291189|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291190|NCT02012491|Misoprostol|misoprostol|mesh-list
83291191|NCT02012491|Mifepristone|mifepristone|mesh-list
83291192|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83291193|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
83291194|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83291195|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291196|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83291197|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83291198|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
83291199|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83291200|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83291201|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83291202|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83291203|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
83291204|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83291205|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83291206|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
83291207|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291208|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
83291209|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83291210|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83291211|NCT02038010|Trastuzumab|trastuzumab|mesh-list
83291212|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83291213|NCT02038010|Maytansine|maytansine|mesh-list
83291214|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
83291215|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
83291216|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291217|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291218|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83291219|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
83291220|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
83291221|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
83291222|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291223|NCT02038010|Immunotoxins|immunotoxins|mesh-ancestor
83291224|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
83291225|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291226|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291227|NCT04678154|Vancomycin|vancomycin|mesh-list
83291228|NCT04678154|Tobramycin|tobramycin|mesh-list
83291229|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83291230|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291231|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
83291232|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291233|NCT01989572|Sargramostim|sargramostim|mesh-list
83291234|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
83291235|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291236|NCT01988402|Allopurinol|allopurinol|mesh-list
83291237|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
83291238|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291239|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291240|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
83291241|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291242|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83291243|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
83291244|NCT01988402|Protective Agents|protective agents|mesh-ancestor
83291245|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291246|NCT01988090|Vitamin D|vitamin d|mesh-list
83291247|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
83291248|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
83291249|NCT01988090|Vitamins|vitamins|mesh-list
83291250|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
83291251|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291252|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83291253|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83291254|NCT02011945|Nivolumab|nivolumab|mesh-list
83291255|NCT02011945|Dasatinib|dasatinib|mesh-list
83291256|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291257|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291258|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83291259|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291260|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83291261|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291262|NCT02013830|Bevacizumab|bevacizumab|mesh-list
83291263|NCT02013830|Capecitabine|capecitabine|mesh-list
83291264|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291265|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291266|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83291267|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83291268|NCT02013830|Growth Substances|growth substances|mesh-ancestor
83291269|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291270|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
83291271|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83291272|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
83291273|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291274|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
83291275|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83291276|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83291277|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83291278|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291279|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291280|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
83291281|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291282|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291283|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83291284|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291285|NCT01619059|Metformin|metformin|mesh-list
83291286|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
83291287|NCT01619059|Saxagliptin|saxagliptin|mesh-list
83291288|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291289|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291290|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83291291|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291292|NCT01619059|Incretins|incretins|mesh-ancestor
83291293|NCT01619059|Hormones|hormones|mesh-ancestor
83291294|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291295|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83291296|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291297|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291298|NCT04691804|Prednisone|prednisone|mesh-list
83291299|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
83291300|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291301|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
83291302|NCT04691804|Hormones|hormones|mesh-ancestor
83291303|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291304|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291305|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83291306|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291307|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83291308|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291309|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291310|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
83291311|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83291312|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83291313|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291314|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83291315|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291316|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291317|NCT01807923|Ivacaftor|ivacaftor|mesh-list
83291318|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83291319|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291320|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291321|NCT01966003|Paclitaxel|paclitaxel|mesh-list
83291322|NCT01966003|Bevacizumab|bevacizumab|mesh-list
83291323|NCT01966003|Carboplatin|carboplatin|mesh-list
83291324|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83291325|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291326|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
83291327|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
83291328|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
83291329|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291330|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291331|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83291332|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83291333|NCT01966003|Growth Substances|growth substances|mesh-ancestor
83291334|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291335|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
83291336|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
83291337|NCT01839279|Tizanidine|tizanidine|mesh-list
83291338|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83291339|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291340|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83291341|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83291342|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291343|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291344|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291345|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291346|NCT01839279|Analgesics|analgesics|mesh-ancestor
83291347|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
83291348|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291349|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
83291350|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83291351|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83291352|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
83291353|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
83291354|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83291355|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83291356|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83291357|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
83291358|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291359|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
83291360|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83291361|NCT01965535|Ledipasvir|ledipasvir|mesh-list
83291362|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
83291363|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291364|NCT01964755|Leucovorin|leucovorin|mesh-list
83291365|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
83291366|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83291367|NCT01964755|Zidovudine|zidovudine|mesh-list
83291368|NCT01964755|Rituximab|rituximab|mesh-list
83291369|NCT01964755|Doxorubicin|doxorubicin|mesh-list
83291370|NCT01964755|Methotrexate|methotrexate|mesh-list
83291371|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
83291372|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
83291373|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291374|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291375|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
83291376|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291377|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291378|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83291379|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83291380|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83291381|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291382|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291383|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83291384|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
83291385|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83291386|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83291387|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
83291388|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291389|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83291390|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291391|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83291392|NCT01964755|Antidotes|antidotes|mesh-ancestor
83291393|NCT01964755|Protective Agents|protective agents|mesh-ancestor
83291394|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
83291395|NCT01964755|Vitamins|vitamins|mesh-ancestor
83291396|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
83291397|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83291398|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
83291399|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291400|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83291401|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83291402|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
83291403|NCT01991743|Bupivacaine|bupivacaine|mesh-list
83291404|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
83291405|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
83291406|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291407|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291408|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
83291409|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291410|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83291411|NCT01991197|Gliclazide|gliclazide|mesh-list
83291412|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291413|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291414|NCT01991197|Incretins|incretins|mesh-ancestor
83291415|NCT01991197|Hormones|hormones|mesh-ancestor
83291416|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291417|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83291418|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291419|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291420|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291421|NCT01990573|Methadone|methadone|mesh-list
83291422|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83291423|NCT01990573|Narcotics|narcotics|mesh-ancestor
83291424|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291425|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291426|NCT01990573|Analgesics|analgesics|mesh-ancestor
83291427|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
83291428|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291429|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
83291430|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
83291431|NCT01990339|Lansoprazole|lansoprazole|mesh-list
83291432|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
83291433|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83291434|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83291435|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83291436|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291437|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291438|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
83291439|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83291440|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83291441|NCT02007577|Analgesics|analgesics|mesh-ancestor
83291442|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
83291443|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291444|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291445|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291446|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291447|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83291448|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291449|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83291450|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291451|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291452|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
83291453|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83291454|NCT01962493|Listerine|listerine|mesh-list
83291455|NCT01962493|Fluorides|fluorides|mesh-list
83291456|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
83291457|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
83291458|NCT01962493|Protective Agents|protective agents|mesh-ancestor
83291459|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291460|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83291461|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291462|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
83291463|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291464|NCT01989169|Midazolam|midazolam|mesh-list
83291465|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83291466|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83291467|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291468|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291469|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83291470|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83291471|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83291472|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83291473|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
83291474|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
83291475|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
83291476|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
83291477|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291478|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291479|NCT01988779|Levofloxacin|levofloxacin|mesh-list
83291480|NCT01988779|Ofloxacin|ofloxacin|mesh-list
83291481|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83291482|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291483|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83291484|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83291485|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83291486|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291487|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291488|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291489|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83291490|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83291491|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83291492|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83291493|NCT01987232|Carboplatin|carboplatin|mesh-list
83291494|NCT01987232|Etoposide|etoposide|mesh-list
83291495|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291496|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83291497|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83291498|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83291499|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291500|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291501|NCT04676204|Teriflunomide|teriflunomide|mesh-list
83291502|NCT04676204|Cladribine|cladribine|mesh-list
83291503|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83291504|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83291505|NCT04676204|Ozanimod|ozanimod|mesh-list
83291506|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291507|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291508|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
83291509|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291510|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83291511|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291512|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291513|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83291514|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83291515|NCT04676204|Analgesics|analgesics|mesh-ancestor
83291516|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
83291517|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291518|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291519|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291520|NCT02010632|Clopidogrel|clopidogrel|mesh-list
83291521|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83291522|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83291523|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83291524|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83291525|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
83291526|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291527|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291528|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291529|NCT01986062|Amphetamine|amphetamine|mesh-list
83291530|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83291540|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83291541|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291542|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83291552|NCT01985126|Acetaminophen|acetaminophen|mesh-list
83291553|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
83291554|NCT01985126|Promethazine|promethazine|mesh-list
83291555|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
83291556|NCT01985126|Daratumumab|daratumumab|mesh-list
83291557|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83291558|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83291559|NCT01985126|Analgesics|analgesics|mesh-ancestor
83291560|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
83291561|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291562|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291563|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
83291564|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291565|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
83291566|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
83291567|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83291568|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
83291569|NCT01985126|Hormones|hormones|mesh-ancestor
83291570|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291571|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83291572|NCT01985126|Protective Agents|protective agents|mesh-ancestor
83291573|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291574|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
83291575|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83291576|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83291577|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291578|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
83291579|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
83291580|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83291581|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
83291582|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
83291583|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291584|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291585|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83291586|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
83291587|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291588|NCT01984892|Poly ICLC|poly iclc|mesh-list
83291589|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
83291590|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
83291591|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291592|NCT01807221|Eplerenone|eplerenone|mesh-list
83291593|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83291594|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
83291595|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291596|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291597|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83291598|NCT01807221|Diuretics|diuretics|mesh-ancestor
83291599|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
83291600|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83291601|NCT02031458|Atezolizumab|atezolizumab|mesh-list
83291602|NCT02031458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83291603|NCT02031458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291604|NCT02031458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291605|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291606|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83291607|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
83291608|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291609|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
83291610|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83291611|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
83291612|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291613|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291614|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83291615|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
83291616|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
83291617|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83291618|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
83291619|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291620|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291622|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291623|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291624|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
83291625|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
83291626|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291627|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291628|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291629|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
83291630|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
83291631|NCT01984424|Atorvastatin|atorvastatin|mesh-list
83291632|NCT01984424|Ezetimibe|ezetimibe|mesh-list
83291633|NCT01984424|Evolocumab|evolocumab|mesh-list
83291634|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83291635|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83291636|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83291637|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
83291638|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291639|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83291640|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83291641|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291642|NCT01984424|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83291643|NCT01984424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83291644|NCT01984424|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291645|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
83291646|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291647|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83291648|NCT01837719|Cobicistat|cobicistat|mesh-list
83291649|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83291650|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83291651|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291652|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291653|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291654|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83291655|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83291656|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
83291657|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291658|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83291659|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83291660|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83291661|NCT01984268|Hormones|hormones|mesh-ancestor
83291662|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83291663|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291664|NCT02009384|Ipilimumab|ipilimumab|mesh-list
83291665|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291666|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291667|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83291668|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291669|NCT01805037|Rituximab|rituximab|mesh-list
83291670|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83291671|NCT01805037|Antibodies|antibodies|mesh-list
83291672|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
83291673|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83291674|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
83291675|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
83291676|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291677|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291678|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291679|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291680|NCT01805037|Immunotoxins|immunotoxins|mesh-ancestor
83291681|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83291682|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83291683|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83291684|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291685|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291686|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291687|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291688|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
83291689|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83291690|NCT01836549|Imetelstat|imetelstat|mesh-list
83291691|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
83291692|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291693|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291694|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83291695|NCT01836471|Fluticasone|fluticasone|mesh-list
83291696|NCT01836471|Xhance|xhance|mesh-list
83291697|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
83291698|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291699|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83291700|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
83291701|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291702|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291703|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83291704|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
83291705|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291706|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83291707|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83291708|NCT01836471|Growth Substances|growth substances|mesh-ancestor
83291709|NCT02030600|Insulin|insulin|mesh-list
83291710|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83291711|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
83291712|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291713|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291714|NCT01802775|Aspirin|aspirin|mesh-list
83291715|NCT01802775|Edoxaban|edoxaban|mesh-list
83291716|NCT01802775|Clopidogrel|clopidogrel|mesh-list
83291717|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83291718|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83291719|NCT01802775|Analgesics|analgesics|mesh-ancestor
83291720|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
83291721|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291722|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291723|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291724|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291725|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83291726|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83291727|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291728|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83291729|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83291730|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291732|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83291733|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83291734|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83291735|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
83291736|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291737|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83291738|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
83291739|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83291740|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
83291741|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
83291742|NCT01802385|Sertraline|sertraline|mesh-list
83291743|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
83291744|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83291745|NCT01802385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83291746|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83291747|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291748|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291749|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291750|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
83291751|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291752|NCT01773993|Pregabalin|pregabalin|mesh-list
83291753|NCT01773993|Analgesics|analgesics|mesh-ancestor
83291754|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
83291755|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291756|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291757|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
83291758|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83291759|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291760|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291761|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83291762|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83291763|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83291764|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291765|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83291767|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83291768|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291769|NCT01607073|Verapamil|verapamil|mesh-list
83291770|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83291771|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83291772|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291773|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291774|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83291775|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291776|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
83291777|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83291778|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
83291779|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291780|NCT01801917|Siponimod|siponimod|mesh-list
83291781|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83291782|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291783|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291784|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
83291785|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291786|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83291787|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
83291788|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291789|NCT01772823|Tenofovir|tenofovir|mesh-list
83291790|NCT01772823|Emtricitabine|emtricitabine|mesh-list
83291791|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83291792|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
83291793|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291794|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83291795|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83291796|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291797|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291798|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83291799|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83291800|NCT04177082|Riboflavin|riboflavin|mesh-list
83291801|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
83291802|NCT04177082|Vitamins|vitamins|mesh-ancestor
83291803|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
83291804|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291805|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83291806|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291807|NCT04177004|Sirolimus|sirolimus|mesh-list
83291808|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
83291809|NCT04177004|Etoposide|etoposide|mesh-list
83291810|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
83291811|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
83291812|NCT04177004|Tacrolimus|tacrolimus|mesh-list
83291813|NCT04177004|Mitogens|mitogens|mesh-list
83291814|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291815|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
83291816|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291817|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291818|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83291819|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
83291820|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291821|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291822|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83291823|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83291824|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83291825|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83291826|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291827|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83291828|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83291829|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291830|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83291831|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
83291832|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83291833|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
83291834|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291835|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83291836|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83291837|NCT01982942|Ibudilast|ibudilast|mesh-list
83291838|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83291839|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
83291840|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291841|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291842|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83291843|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
83291844|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83291845|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291846|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291847|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83291848|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
83291849|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83291850|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83291851|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83291852|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291853|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291854|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
83291855|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291856|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83291857|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83291858|NCT01769391|Paclitaxel|paclitaxel|mesh-list
83291859|NCT01769391|Carboplatin|carboplatin|mesh-list
83291860|NCT01769391|Necitumumab|necitumumab|mesh-list
83291861|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83291862|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291863|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
83291864|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
83291865|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
83291866|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291867|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83291868|NCT01767987|Ranolazine|ranolazine|mesh-list
83291869|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83291870|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291871|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291872|NCT01767909|Insulin|insulin|mesh-list
83291873|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83291874|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83291875|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291876|NCT02029274|Siponimod|siponimod|mesh-list
83291877|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83291878|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291879|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83291880|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
83291881|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291882|NCT02008370|Bupivacaine|bupivacaine|mesh-list
83291883|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
83291884|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
83291885|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291886|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291887|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
83291888|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291889|NCT01981616|Vedolizumab|vedolizumab|mesh-list
83291890|NCT01981616|Vaccines|vaccines|mesh-list
83291891|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
83291892|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291893|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83291894|NCT01962103|Paclitaxel|paclitaxel|mesh-list
83291895|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83291896|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83291897|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291898|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
83291899|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
83291900|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
83291901|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291902|NCT01961323|Nebivolol|nebivolol|mesh-list
83291903|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83291904|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
83291905|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83291906|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83291907|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83291908|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
83291909|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291910|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291911|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291912|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
83291913|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83291914|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83291915|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291916|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
83291917|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291918|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
83291919|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
83291920|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291921|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291922|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291923|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
83291924|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
83291925|NCT01960855|Upadacitinib|upadacitinib|mesh-list
83291926|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83291927|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83291928|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291929|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291930|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291931|NCT02007434|Loratadine|loratadine|mesh-list
83291932|NCT02007434|Ibuprofen|ibuprofen|mesh-list
83291933|NCT02007434|Lidocaine|lidocaine|mesh-list
83291934|NCT02007434|Epinephrine|epinephrine|mesh-list
83291935|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
83291936|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
83291937|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
83291938|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83291939|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291940|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
83291941|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83291942|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83291943|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83291944|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83291945|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83291946|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291947|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83291948|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83291949|NCT02007434|Analgesics|analgesics|mesh-ancestor
83291950|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83291951|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83291952|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83291953|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83291954|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83291955|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83291956|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83291957|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291958|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83291959|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83291960|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
83291961|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83291962|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83291963|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
83291964|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
83291965|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83291966|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
83291967|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
83291968|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83291969|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83291970|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83291971|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
83291972|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
83291973|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83291974|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83291975|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
83291976|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83291977|NCT01987453|Ledipasvir|ledipasvir|mesh-list
83291978|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
83291979|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291980|NCT02006641|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83291981|NCT02006641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83291982|NCT02006641|Serotonin Agents|serotonin agents|mesh-ancestor
83291983|NCT02006641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83291984|NCT02006641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83291985|NCT02006641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291986|NCT01959919|Factor VIII|factor viii|mesh-list
83291987|NCT01959919|Coagulants|coagulants|mesh-ancestor
83291988|NCT01986907|Ranibizumab|ranibizumab|mesh-list
83291989|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83291990|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83291991|NCT01986907|Growth Substances|growth substances|mesh-ancestor
83291992|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83291993|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
83291994|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83291995|NCT01959841|Valacyclovir|valacyclovir|mesh-list
83291996|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
83291997|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83291998|NCT02005627|Immunomodulating Agents|immunomodulating agents|mesh-list
83291999|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
83292000|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292001|NCT02073929|Liraglutide|liraglutide|mesh-list
83292002|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292003|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292004|NCT02073929|Incretins|incretins|mesh-ancestor
83292005|NCT02073929|Hormones|hormones|mesh-ancestor
83292006|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292007|NCT02113007|Rituximab|rituximab|mesh-list
83292008|NCT02113007|Temozolomide|temozolomide|mesh-list
83292009|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292010|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292011|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
83292012|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292013|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292014|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83292015|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
83292016|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292017|NCT02005471|Rituximab|rituximab|mesh-list
83292018|NCT02005471|Venetoclax|venetoclax|mesh-list
83292019|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83292020|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292021|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292022|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
83292023|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292024|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292025|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83292026|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
83292027|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292028|NCT02104505|Tocopherols|tocopherols|mesh-list
83292029|NCT02104505|Vitamin E|vitamin e|mesh-list
83292030|NCT02104505|Tocotrienols|tocotrienols|mesh-list
83292031|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
83292032|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
83292033|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
83292034|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292035|NCT02104505|Protective Agents|protective agents|mesh-ancestor
83292036|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292037|NCT02104505|Vitamins|vitamins|mesh-ancestor
83292038|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
83292039|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83292040|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83292041|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83292042|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
83292043|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292044|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83292045|NCT02111369|Propranolol|propranolol|mesh-list
83292046|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
83292047|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83292048|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292049|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292050|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
83292051|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292052|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292053|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83292054|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83292055|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
83292056|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83292057|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83292058|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
83292059|NCT02069093|Dexamethasone|dexamethasone|mesh-list
83292060|NCT02069093|Everolimus|everolimus|mesh-list
83292061|NCT02069093|Exemestane|exemestane|mesh-list
83292062|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292063|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
83292064|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
83292065|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292066|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292067|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292068|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
83292069|NCT02069093|Hormones|hormones|mesh-ancestor
83292070|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292071|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83292072|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292073|NCT02069093|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83292074|NCT02069093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292075|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292076|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292077|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292078|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
83292079|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83292080|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83292081|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83292082|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
83292083|NCT02109029|Insulin|insulin|mesh-list
83292084|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83292085|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292086|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292087|NCT02007278|Metformin|metformin|mesh-list
83292088|NCT02007278|Glimepiride|glimepiride|mesh-list
83292089|NCT02007278|Vildagliptin|vildagliptin|mesh-list
83292090|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292091|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292092|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83292093|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292094|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
83292095|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83292096|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
83292097|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292098|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292099|NCT02028338|Dapivirine|dapivirine|mesh-list
83292100|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83292101|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83292102|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
83292103|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292104|NCT01625897|Risperidone|risperidone|mesh-list
83292105|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83292106|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
83292107|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292108|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292109|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292110|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83292111|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83292112|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292113|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83292114|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83292115|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
83292116|NCT02106923|Metformin|metformin|mesh-list
83292117|NCT02106923|Empagliflozin|empagliflozin|mesh-list
83292118|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292119|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292120|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83292121|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292122|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
83292123|NCT02006732|Olodaterol|olodaterol|mesh-list
83292124|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83292125|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
83292126|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292127|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292128|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83292129|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
83292130|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
83292131|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83292132|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
83292133|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292134|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292135|NCT02098733|Pioglitazone|pioglitazone|mesh-list
83292136|NCT02098733|Glimepiride|glimepiride|mesh-list
83292137|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292138|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292139|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83292140|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292141|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
83292142|NCT02098109|Plerixafor|plerixafor|mesh-list
83292143|NCT02098109|Lenograstim|lenograstim|mesh-list
83292144|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83292145|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
83292146|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292147|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83292148|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83292149|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
83292150|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292151|NCT02097719|Timolol|timolol|mesh-list
83292152|NCT02097719|Bimatoprost|bimatoprost|mesh-list
83292153|NCT02097719|Travoprost|travoprost|mesh-list
83292154|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292155|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83292156|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83292157|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
83292158|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292159|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292160|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83292161|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83292162|NCT01449370|Serabelisib|serabelisib|mesh-list
83292163|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292164|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292165|NCT02066129|Fluticasone|fluticasone|mesh-list
83292167|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292168|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83292169|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
83292170|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292171|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292172|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83292173|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
83292174|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292175|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83292176|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83292177|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83292178|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292179|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
83292180|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83292181|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292182|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292183|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83292184|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292185|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83292186|NCT02006654|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83292187|NCT02006654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83292188|NCT02006654|Serotonin Agents|serotonin agents|mesh-ancestor
83292189|NCT02006654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292190|NCT02006654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292191|NCT02006654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292192|NCT02006576|Ibuprofen|ibuprofen|mesh-list
83292193|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83292194|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83292195|NCT02006576|Analgesics|analgesics|mesh-ancestor
83292196|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
83292197|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292198|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292199|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292200|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292201|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83292202|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292203|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292204|NCT01448824|Ketoconazole|ketoconazole|mesh-list
83292205|NCT01448824|Evacetrapib|evacetrapib|mesh-list
83292206|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
83292207|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292208|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83292209|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83292210|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292211|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292212|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83292213|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
83292214|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292215|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292216|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83292217|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83292218|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83292219|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
83292220|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83292221|NCT02005562|Cyclosporine|cyclosporine|mesh-list
83292222|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
83292223|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
83292224|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83292225|NCT02005562|Cyclosporins|cyclosporins|mesh-list
83292226|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292227|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292228|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292229|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
83292230|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292231|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
83292232|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292233|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292234|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292235|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83292236|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83292237|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292238|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83292239|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
83292240|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83292241|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292242|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
83292243|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
83292244|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292245|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292246|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
83292247|NCT02005562|Hormones|hormones|mesh-ancestor
83292248|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292249|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83292250|NCT02005562|Protective Agents|protective agents|mesh-ancestor
83292251|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83292252|NCT01448044|Interferons|interferons|mesh-list
83292253|NCT01448044|Ribavirin|ribavirin|mesh-list
83292254|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
83292255|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
83292256|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83292257|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292258|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
83292259|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292260|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
83292261|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292262|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
83292263|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292264|NCT01472380|Efavirenz|efavirenz|mesh-list
83292265|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
83292266|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83292267|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83292268|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292269|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292270|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
83292271|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292272|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83292273|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83292274|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83292275|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83292276|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83292277|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83292278|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83292279|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83292281|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83292282|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
83292283|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83292284|NCT01447420|Ribavirin|ribavirin|mesh-list
83292285|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83292286|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
83292287|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292288|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
83292289|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292290|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
83292291|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83292292|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292293|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
83292294|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
83292295|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
83292296|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83292297|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292298|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83292299|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83292300|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
83292301|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83292302|NCT01438840|Maleic acid|maleic acid|mesh-list
83292303|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292304|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292305|NCT01471054|Dexamethasone|dexamethasone|mesh-list
83292306|NCT01471054|Bevacizumab|bevacizumab|mesh-list
83292307|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292308|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292309|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83292310|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83292311|NCT01471054|Growth Substances|growth substances|mesh-ancestor
83292312|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292313|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
83292314|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292315|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
83292316|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
83292317|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292318|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292319|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
83292320|NCT01471054|Hormones|hormones|mesh-ancestor
83292321|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292322|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83292323|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
83292324|NCT01978184|Gemcitabine|gemcitabine|mesh-list
83292325|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83292326|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83292327|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
83292328|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292329|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292330|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
83292331|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83292332|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83292333|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292334|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292335|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292336|NCT01445548|Sirolimus|sirolimus|mesh-list
83292337|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83292338|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292339|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83292340|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292341|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
83292342|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292343|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
83292344|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292345|NCT01977794|Amlodipine|amlodipine|mesh-list
83292346|NCT01977794|Bisoprolol|bisoprolol|mesh-list
83292347|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83292348|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83292349|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292350|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292351|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83292352|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292353|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
83292354|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
83292355|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
83292356|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292357|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83292358|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83292359|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83292360|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
83292361|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292363|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292364|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292365|NCT01597973|Meropenem|meropenem|mesh-list
83292366|NCT01597973|Colistin|colistin|mesh-list
83292367|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83292368|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292369|NCT02047253|Acyclovir|acyclovir|mesh-list
83292370|NCT02047253|Dexamethasone|dexamethasone|mesh-list
83292371|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292372|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
83292373|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
83292374|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292375|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292376|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292377|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
83292378|NCT02047253|Hormones|hormones|mesh-ancestor
83292379|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292380|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83292381|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292382|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
83292383|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292384|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
83292385|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83292386|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292387|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292388|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292389|NCT02096003|Morphine|morphine|mesh-list
83292390|NCT02096003|Hydromorphone|hydromorphone|mesh-list
83292391|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83292392|NCT02096003|Narcotics|narcotics|mesh-ancestor
83292393|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292394|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292395|NCT02096003|Analgesics|analgesics|mesh-ancestor
83292396|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
83292397|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292398|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
83292399|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83292400|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83292401|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292402|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
83292403|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292404|NCT02059187|Insulin|insulin|mesh-list
83292405|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83292406|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
83292407|NCT02059187|MK-1293|mk-1293|mesh-list
83292408|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292409|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292410|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83292411|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
83292412|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292413|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83292414|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83292415|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292416|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292417|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292418|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83292419|NCT01622231|Fluticasone|fluticasone|mesh-list
83292420|NCT01622231|Xhance|xhance|mesh-list
83292421|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292422|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83292423|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
83292424|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292425|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292426|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83292427|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
83292428|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292429|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83292430|NCT02042183|Lubiprostone|lubiprostone|mesh-list
83292431|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83292432|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292433|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292434|NCT02058095|Tadalafil|tadalafil|mesh-list
83292435|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
83292436|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83292437|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83292438|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292439|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292440|NCT02058095|Urological Agents|urological agents|mesh-ancestor
83292441|NCT02023112|Ritonavir|ritonavir|mesh-list
83292442|NCT02023112|Ribavirin|ribavirin|mesh-list
83292443|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83292444|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83292445|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
83292446|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292447|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292448|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83292449|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83292450|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
83292451|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292452|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83292453|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83292454|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
83292455|NCT04670666|Metformin|metformin|mesh-list
83292456|NCT04670666|Empagliflozin|empagliflozin|mesh-list
83292457|NCT04670666|Linagliptin|linagliptin|mesh-list
83292458|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292459|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292460|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83292461|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292462|NCT04670666|Incretins|incretins|mesh-ancestor
83292463|NCT04670666|Hormones|hormones|mesh-ancestor
83292464|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292465|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83292466|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
83292467|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292468|NCT01976624|Timolol|timolol|mesh-list
83292469|NCT01976624|Bimatoprost|bimatoprost|mesh-list
83292470|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83292471|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83292472|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
83292473|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292474|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292475|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292476|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83292477|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83292478|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83292479|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
83292480|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292481|NCT04717973|Vitamin D|vitamin d|mesh-list
83292482|NCT04717973|Vitamins|vitamins|mesh-list
83292483|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
83292484|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
83292485|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
83292486|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292487|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83292488|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
83292489|NCT04717973|Hematinics|hematinics|mesh-ancestor
83292490|NCT02057549|Haloperidol|haloperidol|mesh-list
83292491|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
83292492|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
83292493|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
83292494|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292495|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292496|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292497|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83292498|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83292499|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292500|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83292501|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83292502|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
83292503|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292504|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292505|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83292507|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292508|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292509|NCT02040779|Beclomethasone|beclomethasone|mesh-list
83292510|NCT02040779|Albuterol|albuterol|mesh-list
83292511|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
83292512|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
83292513|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292514|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292515|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83292516|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
83292517|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
83292518|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83292519|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83292520|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83292521|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83292522|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
83292523|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292524|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292525|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292526|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
83292527|NCT02040779|Hormones|hormones|mesh-ancestor
83292528|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292529|NCT02056301|Morphine|morphine|mesh-list
83292530|NCT02056301|Hydromorphone|hydromorphone|mesh-list
83292531|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83292532|NCT02056301|Narcotics|narcotics|mesh-ancestor
83292533|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292534|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292535|NCT02056301|Analgesics|analgesics|mesh-ancestor
83292536|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
83292537|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292538|NCT01967576|Axitinib|axitinib|mesh-list
83292539|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292540|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292541|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292542|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292543|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83292544|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83292545|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83292546|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83292547|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83292548|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
83292549|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292550|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292551|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292552|NCT01976312|Ranibizumab|ranibizumab|mesh-list
83292553|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83292554|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83292555|NCT01976312|Growth Substances|growth substances|mesh-ancestor
83292556|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292557|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
83292558|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292559|NCT02053493|Isosorbide|isosorbide|mesh-list
83292560|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83292561|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83292562|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83292563|NCT02053493|Diuretics|diuretics|mesh-ancestor
83292564|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
83292565|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292566|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
83292567|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83292568|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292569|NCT02003144|Eculizumab|eculizumab|mesh-list
83292570|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83292571|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292572|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
83292573|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292574|NCT02038907|Vaccines|vaccines|mesh-list
83292575|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
83292576|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292577|NCT02052011|Ranolazine|ranolazine|mesh-list
83292578|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83292579|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292580|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292581|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
83292582|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83292583|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83292584|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83292585|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292586|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292587|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
83292588|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292589|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292590|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83292591|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292592|NCT02035553|Pimavanserin|pimavanserin|mesh-list
83292593|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83292594|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83292595|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83292596|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83292597|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292598|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292599|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83292600|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83292601|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83292602|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
83292603|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292604|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292605|NCT01445080|Sorafenib|sorafenib|mesh-list
83292606|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292607|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292608|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292609|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292610|NCT04709471|Nicotine|nicotine|mesh-list
83292611|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83292612|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
83292613|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292614|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292615|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83292616|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83292617|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
83292618|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292619|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292620|NCT01959529|Insulin|insulin|mesh-list
83292621|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83292622|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
83292623|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292624|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292625|NCT02033369|Pramipexole|pramipexole|mesh-list
83292626|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
83292627|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292628|NCT02033369|Protective Agents|protective agents|mesh-ancestor
83292629|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292630|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83292631|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83292632|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
83292633|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
83292634|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292635|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
83292636|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
83292637|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292638|NCT04681469|Niraparib|niraparib|mesh-list
83292639|NCT04681469|Dostarlimab|dostarlimab|mesh-list
83292640|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83292641|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292642|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292643|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292644|NCT01986751|Clonidine|clonidine|mesh-list
83292645|NCT01986751|Ropivacaine|ropivacaine|mesh-list
83292646|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
83292647|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
83292648|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292649|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292650|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
83292651|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292652|NCT01986751|Analgesics|analgesics|mesh-ancestor
83292653|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83292654|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
83292655|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
83292656|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83292657|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83292658|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83292659|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
83292660|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292661|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292662|NCT01438060|Aripiprazole|aripiprazole|mesh-list
83292663|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
83292664|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83292665|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83292666|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83292667|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292668|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292669|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
83292670|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
83292671|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292672|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292673|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83292674|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83292675|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
83292676|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83292677|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83292678|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83292679|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83292680|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
83292681|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83292682|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292683|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292684|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
83292685|NCT01443364|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83292686|NCT01443364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292687|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292688|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
83292689|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292690|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292692|NCT02020577|Afatinib|afatinib|mesh-list
83292693|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292694|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292695|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292696|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292697|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292698|NCT02020031|Vancomycin|vancomycin|mesh-list
83292699|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83292700|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292701|NCT02030405|Ixazomib|ixazomib|mesh-list
83292702|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
83292703|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292704|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
83292705|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292706|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292707|NCT01975376|Bococizumab|bococizumab|mesh-list
83292708|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83292709|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83292710|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
83292711|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292712|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83292713|NCT01443130|Chloroquine|chloroquine|mesh-list
83292714|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
83292715|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
83292716|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83292717|NCT01443130|Amebicides|amebicides|mesh-ancestor
83292718|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83292719|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83292720|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292721|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
83292722|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292723|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83292724|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292725|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292726|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83292727|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
83292728|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
83292729|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292730|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292731|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292732|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
83292734|NCT01436500|Ifetroban|ifetroban|mesh-list
83292735|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83292736|NCT01958827|Adalimumab|adalimumab|mesh-list
83292737|NCT01958827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83292738|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292739|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292740|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
83292741|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292742|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292743|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83292744|NCT01436110|Fluticasone|fluticasone|mesh-list
83292745|NCT01436110|Xhance|xhance|mesh-list
83292746|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292747|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83292748|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
83292749|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292750|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292751|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83292752|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
83292753|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292754|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83292755|NCT01619852|Lidocaine|lidocaine|mesh-list
83292756|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
83292757|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
83292758|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292759|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292760|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
83292761|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292762|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83292763|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83292764|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83292765|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292766|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292767|NCT04069936|Nivolumab|nivolumab|mesh-list
83292768|NCT04069936|Tadalafil|tadalafil|mesh-list
83292769|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292770|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292771|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83292772|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292773|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
83292774|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83292775|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83292776|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292777|NCT04069936|Urological Agents|urological agents|mesh-ancestor
83292778|NCT02000882|Capecitabine|capecitabine|mesh-list
83292779|NCT02000882|Trastuzumab|trastuzumab|mesh-list
83292780|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83292781|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
83292782|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292783|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292784|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292785|NCT04666129|Prednisone|prednisone|mesh-list
83292786|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
83292787|NCT04666129|Docetaxel|docetaxel|mesh-list
83292788|NCT04666129|Relugolix|relugolix|mesh-list
83292789|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292790|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
83292791|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
83292792|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
83292793|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292794|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292795|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
83292796|NCT04666129|Hormones|hormones|mesh-ancestor
83292797|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292798|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292799|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83292800|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
83292801|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
83292802|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292803|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292804|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83292805|NCT04666129|Protective Agents|protective agents|mesh-ancestor
83292806|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
83292807|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
83292808|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83292809|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
83292810|NCT04666051|Coagulants|coagulants|mesh-ancestor
83292811|NCT01965704|Ondansetron|ondansetron|mesh-list
83292812|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
83292813|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
83292814|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292815|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292816|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292817|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
83292818|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292819|NCT01965704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83292820|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83292821|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
83292822|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292823|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292824|NCT02003365|Triamcinolone|triamcinolone|mesh-list
83292825|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83292826|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83292827|NCT02003365|FX006|fx006|mesh-list
83292828|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83292829|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83292830|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
83292831|NCT02003365|Hormones|hormones|mesh-ancestor
83292832|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83292833|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292834|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292835|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
83292836|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292837|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292838|NCT01975220|Metformin|metformin|mesh-list
83292839|NCT01975220|Empagliflozin|empagliflozin|mesh-list
83292840|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292841|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292842|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83292843|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292844|NCT01974752|Dacarbazine|dacarbazine|mesh-list
83292845|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83292846|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
83292847|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292848|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292849|NCT01999946|Naltrexone|naltrexone|mesh-list
83292850|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83292851|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83292852|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292853|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
83292854|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292855|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
83292856|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83292857|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
83292858|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292859|NCT02002975|Pioglitazone|pioglitazone|mesh-list
83292860|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292861|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292862|NCT02001181|Tofacitinib|tofacitinib|mesh-list
83292863|NCT02001181|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83292864|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292865|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292866|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292867|NCT04176055|Haloperidol|haloperidol|mesh-list
83292868|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
83292869|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
83292870|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
83292871|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292872|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292873|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292874|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83292875|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83292876|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292877|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83292878|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83292879|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
83292880|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292881|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292882|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83292883|NCT04659278|Peppermint oil|peppermint oil|mesh-list
83292884|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
83292885|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
83292886|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292887|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292888|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83292889|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
83292891|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83292893|NCT04659044|Antibodies|antibodies|mesh-list
83292894|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
83292895|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83292896|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
83292897|NCT04659044|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83292898|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
83292899|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292900|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292901|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292902|NCT01999868|Abatacept|abatacept|mesh-list
83292903|NCT01999868|Ustekinumab|ustekinumab|mesh-list
83292904|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
83292905|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
83292906|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292907|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83292908|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292909|NCT01999868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292910|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292911|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83292912|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83292913|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
83292914|NCT03511963|Bevacizumab|bevacizumab|mesh-list
83292915|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83292916|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292917|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83292918|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83292919|NCT03511963|Growth Substances|growth substances|mesh-ancestor
83292920|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292921|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
83292922|NCT01999322|Insulin|insulin|mesh-list
83292923|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83292924|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
83292925|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
83292926|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83292927|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292928|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292929|NCT01964924|Trametinib|trametinib|mesh-list
83292930|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292931|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292932|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292933|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292934|NCT01964378|Morphine|morphine|mesh-list
83292935|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83292936|NCT01964378|Narcotics|narcotics|mesh-ancestor
83292937|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83292938|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292939|NCT01964378|Analgesics|analgesics|mesh-ancestor
83292940|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
83292941|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292942|NCT01442038|Ranolazine|ranolazine|mesh-list
83292943|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83292944|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83292945|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292946|NCT01998919|Carboplatin|carboplatin|mesh-list
83292947|NCT01998919|Gemcitabine|gemcitabine|mesh-list
83292948|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83292949|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292950|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83292951|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
83292952|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292953|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292954|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292955|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83292956|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
83292957|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83292959|NCT01972724|Pioglitazone|pioglitazone|mesh-list
83292960|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83292961|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292962|NCT01441960|Rocuronium|rocuronium|mesh-list
83292963|NCT01441960|Succinylcholine|succinylcholine|mesh-list
83292964|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83292965|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83292966|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83292967|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292968|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292969|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83292970|NCT01955707|Natalizumab|natalizumab|mesh-list
83292971|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
83292972|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292973|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
83292974|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
83292975|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
83292976|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83292977|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83292978|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292979|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292980|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292981|NCT01955161|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83292982|NCT01955161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83292983|NCT01955161|Serotonin Agents|serotonin agents|mesh-ancestor
83292984|NCT01955161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83292985|NCT01955161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292986|NCT01955161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292987|NCT01441414|Axitinib|axitinib|mesh-list
83292988|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83292989|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83292990|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83292991|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83292992|NCT01954927|Gabapentin|gabapentin|mesh-list
83292993|NCT01954927|Analgesics|analgesics|mesh-ancestor
83292994|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
83292995|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83292996|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83292997|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
83292998|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83292999|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83293000|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293001|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83293002|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83293003|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83293004|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293005|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293006|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
83293007|NCT01953913|Afatinib|afatinib|mesh-list
83293008|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293009|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83293010|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293011|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293012|NCT01970540|Doxorubicin|doxorubicin|mesh-list
83293013|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83293014|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293015|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83293016|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83293017|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293018|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293019|NCT01996826|Bevacizumab|bevacizumab|mesh-list
83293020|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83293021|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83293022|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293023|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83293024|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83293025|NCT01996826|Growth Substances|growth substances|mesh-ancestor
83293026|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293027|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
83293028|NCT01996826|Laxatives|laxatives|mesh-ancestor
83293029|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83293030|NCT01621178|Insulin|insulin|mesh-list
83293031|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83293032|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
83293033|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
83293034|NCT01621178|Dulaglutide|dulaglutide|mesh-list
83293035|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293036|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293038|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83293039|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293040|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83293041|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
83293042|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293043|NCT01962896|Sirolimus|sirolimus|mesh-list
83293044|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83293045|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293046|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83293047|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293048|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293049|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293050|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293051|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83293052|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
83293053|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83293054|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
83293055|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293056|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83293057|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293058|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293059|NCT01970462|Incretins|incretins|mesh-ancestor
83293060|NCT01970462|Hormones|hormones|mesh-ancestor
83293061|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83293062|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83293063|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
83293064|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293065|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293066|NCT01958671|Metformin|metformin|mesh-list
83293067|NCT01958671|Glimepiride|glimepiride|mesh-list
83293068|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
83293069|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293070|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293071|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83293072|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83293073|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
83293074|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83293075|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293076|NCT01995266|Asunaprevir|asunaprevir|mesh-list
83293077|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
83293078|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293079|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293080|NCT01969058|Isotretinoin|isotretinoin|mesh-list
83293081|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
83293082|NCT01968980|Bococizumab|bococizumab|mesh-list
83293083|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83293084|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83293085|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
83293086|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293087|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83293088|NCT01968434|Carbocysteine|carbocysteine|mesh-list
83293089|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83293090|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293091|NCT01968434|Expectorants|expectorants|mesh-ancestor
83293092|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293093|NCT01946438|Vaccines|vaccines|mesh-list
83293094|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
83293095|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293096|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
83293097|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
83293098|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83293099|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293100|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293101|NCT01917656|Metformin|metformin|mesh-list
83293102|NCT01917656|Liraglutide|liraglutide|mesh-list
83293103|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293104|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293105|NCT01917656|Incretins|incretins|mesh-ancestor
83293106|NCT01917656|Hormones|hormones|mesh-ancestor
83293107|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83293108|NCT02018861|Rituximab|rituximab|mesh-list
83293109|NCT02018861|Carboplatin|carboplatin|mesh-list
83293110|NCT02018861|Etoposide|etoposide|mesh-list
83293111|NCT02018861|Ifosfamide|ifosfamide|mesh-list
83293112|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83293113|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293114|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
83293115|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293116|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293117|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83293118|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83293119|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83293120|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293121|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293122|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83293123|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
83293124|NCT02017535|Fluoxetine|fluoxetine|mesh-list
83293125|NCT02017535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83293126|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83293127|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293128|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293129|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293130|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
83293131|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293132|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83293133|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
83293134|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83293135|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83293136|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83293137|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293138|NCT01944098|Lidocaine|lidocaine|mesh-list
83293139|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
83293140|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
83293141|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293142|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293143|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
83293144|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293145|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83293146|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83293147|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83293148|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293149|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293150|NCT01943552|Bromides|bromides|mesh-list
83293151|NCT01943552|Ipratropium|ipratropium|mesh-list
83293152|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
83293153|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83293154|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
83293155|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293156|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293157|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83293158|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293159|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83293160|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
83293161|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293162|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293163|NCT01915940|Timolol|timolol|mesh-list
83293164|NCT01915940|Bimatoprost|bimatoprost|mesh-list
83293165|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83293166|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83293167|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83293168|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83293169|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
83293170|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293171|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293172|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293173|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83293174|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83293175|NCT01914926|Metoprolol|metoprolol|mesh-list
83293176|NCT01914926|Diltiazem|diltiazem|mesh-list
83293177|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83293178|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83293179|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
83293180|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
83293181|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293182|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293183|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83293184|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83293185|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83293186|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
83293187|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293188|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293189|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83293190|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293191|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83293192|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
83293193|NCT05119166|Niacinamide|niacinamide|mesh-list
83293194|NCT05119166|Niacin|niacin|mesh-list
83293195|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
83293196|NCT05119166|Azithromycin|azithromycin|mesh-list
83293197|NCT05119166|Vitamins|vitamins|mesh-ancestor
83293198|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
83293199|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293200|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293201|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293202|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
83293203|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83293204|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
83293205|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293206|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83293207|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
83293208|NCT01942148|Aripiprazole|aripiprazole|mesh-list
83293209|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
83293210|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83293211|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83293212|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83293213|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293214|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293215|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
83293216|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
83293217|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293218|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293219|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83293220|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83293221|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
83293222|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83293223|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83293224|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83293225|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83293226|NCT02030015|Miglustat|miglustat|mesh-list
83293227|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293228|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293229|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83293230|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83293231|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
83293232|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293233|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83293234|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293235|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293236|NCT02029235|Acetaminophen|acetaminophen|mesh-list
83293237|NCT02029235|Ibuprofen|ibuprofen|mesh-list
83293238|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83293239|NCT02029235|Hydrocodone|hydrocodone|mesh-list
83293240|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293241|NCT02029235|Analgesics|analgesics|mesh-ancestor
83293242|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
83293243|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293244|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293245|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
83293246|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293247|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293248|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293249|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83293250|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293251|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293252|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83293253|NCT02029235|Narcotics|narcotics|mesh-ancestor
83293254|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293255|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
83293256|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293257|NCT01617434|Liraglutide|liraglutide|mesh-list
83293258|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293259|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293260|NCT01617434|Incretins|incretins|mesh-ancestor
83293261|NCT01617434|Hormones|hormones|mesh-ancestor
83293262|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83293263|NCT01940900|Ranibizumab|ranibizumab|mesh-list
83293264|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83293265|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83293266|NCT01940900|Growth Substances|growth substances|mesh-ancestor
83293267|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293268|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
83293269|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293270|NCT01911260|Chelating Agents|chelating agents|mesh-list
83293271|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
83293272|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293273|NCT02015819|Leucovorin|leucovorin|mesh-list
83293274|NCT02015819|Flucytosine|flucytosine|mesh-list
83293275|NCT02015819|Calcium|calcium|mesh-list
83293276|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
83293277|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83293278|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293279|NCT02015819|Antidotes|antidotes|mesh-ancestor
83293280|NCT02015819|Protective Agents|protective agents|mesh-ancestor
83293281|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
83293282|NCT02015819|Vitamins|vitamins|mesh-ancestor
83293283|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
83293284|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
83293285|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293286|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
83293287|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293288|NCT01939496|Canagliflozin|canagliflozin|mesh-list
83293289|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83293290|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293291|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293292|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293293|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83293294|NCT01938716|Gemcitabine|gemcitabine|mesh-list
83293295|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83293296|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
83293297|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293298|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293299|NCT01937390|Bromides|bromides|mesh-list
83293300|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
83293301|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83293302|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
83293303|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293304|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293305|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83293306|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293307|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
83293308|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83293309|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
83293310|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293311|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293312|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
83293313|NCT02028767|Metformin|metformin|mesh-list
83293314|NCT02028767|Empagliflozin|empagliflozin|mesh-list
83293315|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83293316|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293317|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83293318|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293319|NCT04678895|Naltrexone|naltrexone|mesh-list
83293320|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83293321|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83293322|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293323|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
83293324|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293325|NCT04683965|Bevacizumab|bevacizumab|mesh-list
83293326|NCT04683965|Pemetrexed|pemetrexed|mesh-list
83293327|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83293328|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293329|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83293330|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83293331|NCT04683965|Growth Substances|growth substances|mesh-ancestor
83293332|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293333|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
83293334|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293335|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293336|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83293337|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83293339|NCT02015195|Acetic Acid|acetic acid|mesh-list
83293340|NCT02015195|Retinol acetate|retinol acetate|mesh-list
83293341|NCT02015195|Lidocaine|lidocaine|mesh-list
83293342|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
83293343|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
83293344|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293345|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293346|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
83293347|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293348|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83293349|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83293350|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83293351|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293352|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293353|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83293354|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293355|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293356|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83293357|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
83293358|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83293359|NCT02015195|Protective Agents|protective agents|mesh-ancestor
83293360|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293361|NCT02025725|Metoclopramide|metoclopramide|mesh-list
83293362|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
83293363|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
83293364|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293365|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293366|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83293367|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83293368|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83293369|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
83293370|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293371|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293372|NCT02025179|Teriparatide|teriparatide|mesh-list
83293373|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83293374|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293375|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83293376|NCT02013791|Cyclosporine|cyclosporine|mesh-list
83293377|NCT02013791|Cyclosporins|cyclosporins|mesh-list
83293378|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293379|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293380|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83293381|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
83293382|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293383|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
83293384|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293385|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
83293386|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293387|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83293388|NCT02024867|Trimethoprim|trimethoprim|mesh-list
83293389|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83293390|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
83293391|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83293392|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293393|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
83293394|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83293395|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83293396|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83293397|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293398|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293399|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83293400|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83293401|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83293402|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293403|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83293404|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293405|NCT01951417|Adapalene|adapalene|mesh-list
83293406|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83293407|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
83293408|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293409|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293410|NCT01951417|Analgesics|analgesics|mesh-ancestor
83293411|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
83293412|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293413|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293414|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293415|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293416|NCT02023151|Omalizumab|omalizumab|mesh-list
83293417|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83293418|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83293419|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293420|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83293421|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83293422|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293423|NCT01979185|Simvastatin|simvastatin|mesh-list
83293424|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83293425|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83293426|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
83293427|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293428|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83293429|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83293430|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293431|NCT01946425|Vaccines|vaccines|mesh-list
83293432|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
83293433|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293434|NCT01959698|Rituximab|rituximab|mesh-list
83293435|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83293436|NCT01959698|Carboplatin|carboplatin|mesh-list
83293437|NCT01959698|Etoposide|etoposide|mesh-list
83293438|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
83293439|NCT01959698|Ifosfamide|ifosfamide|mesh-list
83293440|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
83293441|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
83293442|NCT01959698|Antibodies|antibodies|mesh-list
83293443|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
83293444|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83293445|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
83293446|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293447|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293448|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293449|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83293450|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83293451|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83293452|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293453|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293454|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83293455|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
83293456|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
83293457|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
83293458|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
83293459|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
83293460|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
83293461|NCT01910402|Ritonavir|ritonavir|mesh-list
83293462|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83293463|NCT01910402|Tenofovir|tenofovir|mesh-list
83293464|NCT01910402|Lamivudine|lamivudine|mesh-list
83293465|NCT01910402|Emtricitabine|emtricitabine|mesh-list
83293466|NCT01910402|Dolutegravir|dolutegravir|mesh-list
83293467|NCT01910402|Abacavir|abacavir|mesh-list
83293468|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83293469|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83293470|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
83293471|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293472|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293473|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83293474|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83293475|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
83293476|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293477|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83293478|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83293479|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83293480|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83293481|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83293482|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83293483|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83293484|NCT01937312|Travoprost|travoprost|mesh-list
83293485|NCT01937312|Brinzolamide|brinzolamide|mesh-list
83293486|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83293487|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83293488|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83293489|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83293490|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83293491|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293492|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293493|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293494|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83293495|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293496|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83293497|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83293498|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293499|NCT01909934|Immunotoxins|immunotoxins|mesh-ancestor
83293500|NCT01909934|Immunoconjugates|immunoconjugates|mesh-ancestor
83293501|NCT01909934|Immunologic Factors|immunologic factors|mesh-ancestor
83293502|NCT01909934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293503|NCT01935128|Everolimus|everolimus|mesh-list
83293504|NCT01935128|Tacrolimus|tacrolimus|mesh-list
83293505|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83293506|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
83293507|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293508|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83293509|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293510|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293511|NCT01935128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83293512|NCT01935128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83293513|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293514|NCT01934972|Cycloserine|cycloserine|mesh-list
83293515|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83293516|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293517|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83293518|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
83293519|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293520|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
83293521|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293522|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83293523|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83293524|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83293525|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83293526|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83293527|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83293528|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83293529|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
83293530|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293531|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293532|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293533|NCT01977937|Gabapentin|gabapentin|mesh-list
83293534|NCT01977937|Analgesics|analgesics|mesh-ancestor
83293535|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
83293536|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293537|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293538|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
83293539|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83293540|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83293541|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293542|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83293543|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83293544|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83293545|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293546|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293547|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
83293548|NCT02015663|Tobramycin|tobramycin|mesh-list
83293549|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293550|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293551|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83293552|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
83293553|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293554|NCT01951105|Naproxen|naproxen|mesh-list
83293555|NCT01951105|Levodopa|levodopa|mesh-list
83293556|NCT01951105|Carbidopa|carbidopa|mesh-list
83293557|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83293558|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293559|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293560|NCT01951105|Analgesics|analgesics|mesh-ancestor
83293561|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
83293562|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293563|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293564|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293565|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293566|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
83293567|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83293568|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293569|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293570|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83293571|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83293572|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
83293573|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293574|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83293575|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83293576|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
83293577|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
83293578|NCT01958918|Ranibizumab|ranibizumab|mesh-list
83293579|NCT01958918|Aflibercept|aflibercept|mesh-list
83293580|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83293581|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83293582|NCT01958918|Growth Substances|growth substances|mesh-ancestor
83293583|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293584|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
83293585|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293586|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
83293587|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83293588|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83293589|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83293590|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293591|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293592|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
83293593|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293594|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293595|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83293596|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293597|NCT01934894|Lapatinib|lapatinib|mesh-list
83293598|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293599|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83293600|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293601|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293602|NCT01950169|Vitamin D|vitamin d|mesh-list
83293603|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
83293604|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
83293605|NCT01950169|Diphosphonates|diphosphonates|mesh-list
83293606|NCT01950169|Calcium|calcium|mesh-list
83293607|NCT01950169|Vitamins|vitamins|mesh-ancestor
83293608|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
83293609|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293610|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83293611|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83293612|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83293613|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293614|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293615|NCT01909466|Aripiprazole|aripiprazole|mesh-list
83293616|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
83293617|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83293618|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83293619|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83293620|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293621|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293622|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
83293623|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
83293624|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293625|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293626|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83293627|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83293628|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
83293629|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83293630|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83293631|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83293632|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83293633|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83293634|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83293635|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293636|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83293637|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83293638|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293639|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293640|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
83293641|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293642|NCT01995071|Ribavirin|ribavirin|mesh-list
83293643|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
83293644|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293645|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
83293646|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293647|NCT01994837|Venetoclax|venetoclax|mesh-list
83293648|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293649|NCT02010593|Dapivirine|dapivirine|mesh-list
83293650|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83293651|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83293652|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
83293653|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293654|NCT01994291|Ranibizumab|ranibizumab|mesh-list
83293655|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83293656|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83293657|NCT01994291|Growth Substances|growth substances|mesh-ancestor
83293658|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293659|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
83293660|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293661|NCT04667039|Ranibizumab|ranibizumab|mesh-list
83293662|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83293663|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83293664|NCT04667039|Growth Substances|growth substances|mesh-ancestor
83293665|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293666|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83293667|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293668|NCT01993823|Clotrimazole|clotrimazole|mesh-list
83293669|NCT01993823|Miconazole|miconazole|mesh-list
83293670|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83293671|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293672|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
83293673|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83293674|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83293675|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293676|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293677|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83293678|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
83293679|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83293680|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293681|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83293682|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83293683|NCT01993667|Acetazolamide|acetazolamide|mesh-list
83293684|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
83293685|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83293686|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293687|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293689|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
83293690|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293691|NCT01934192|Metoclopramide|metoclopramide|mesh-list
83293692|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
83293693|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
83293694|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293695|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293696|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83293697|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83293698|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83293699|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
83293700|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293701|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293702|NCT01933880|Methylphenidate|methylphenidate|mesh-list
83293703|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83293704|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293705|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83293706|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83293707|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293708|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293709|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
83293710|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293711|NCT02008877|Sirolimus|sirolimus|mesh-list
83293712|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293713|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293714|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83293715|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293716|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
83293717|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83293718|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
83293719|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293720|NCT01933334|Pirfenidone|pirfenidone|mesh-list
83293721|NCT01933334|Analgesics|analgesics|mesh-ancestor
83293722|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
83293723|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293724|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293725|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293726|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293727|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293728|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293729|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293730|NCT01908140|Fluticasone|fluticasone|mesh-list
83293731|NCT01908140|Bromides|bromides|mesh-list
83293732|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
83293733|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83293734|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293735|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83293736|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
83293737|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293738|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293739|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83293740|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293741|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
83293742|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83293743|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83293744|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83293745|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83293746|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
83293747|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293748|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293749|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
83293750|NCT02008565|Loperamide|loperamide|mesh-list
83293751|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
83293752|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83293753|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83293754|NCT01931150|Dapsone|dapsone|mesh-list
83293755|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293756|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
83293757|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83293758|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83293759|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83293760|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293761|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293762|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
83293764|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
83293765|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
83293766|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293767|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293768|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
83293769|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293770|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83293771|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83293772|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83293773|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83293774|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293775|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
83293776|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293777|NCT04645004|Aspirin|aspirin|mesh-list
83293778|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293779|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293780|NCT04645004|Analgesics|analgesics|mesh-ancestor
83293781|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
83293782|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293783|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293784|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293785|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293786|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83293787|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83293788|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293789|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83293790|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83293791|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293792|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
83293793|NCT01929980|Bortezomib|bortezomib|mesh-list
83293794|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293795|NCT01363076|Ketorolac|ketorolac|mesh-list
83293796|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83293797|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293798|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293799|NCT01363076|Analgesics|analgesics|mesh-ancestor
83293800|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
83293801|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293802|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293803|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293804|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293805|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83293806|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293807|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293808|NCT01929044|Anisodamine|anisodamine|mesh-list
83293809|NCT01929044|Scopolamine|scopolamine|mesh-list
83293810|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83293811|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83293812|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
83293813|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
83293814|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293815|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293816|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83293817|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
83293818|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83293819|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
83293820|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293821|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293822|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83293823|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
83293824|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83293825|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83293826|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
83293827|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83293828|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293829|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293830|NCT01929044|Analgesics|analgesics|mesh-ancestor
83293831|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
83293832|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293833|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293834|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83293835|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
83293836|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83293837|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
83293838|NCT01929044|Protective Agents|protective agents|mesh-ancestor
83293839|NCT01957202|Levocabastine|levocabastine|mesh-list
83293840|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83293841|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83293842|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
83293843|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
83293844|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293845|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293846|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293847|NCT01616654|Tazarotene|tazarotene|mesh-list
83293848|NCT01616654|Trifarotene|trifarotene|mesh-list
83293849|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
83293850|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
83293851|NCT01902290|Brodalumab|brodalumab|mesh-list
83293852|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
83293853|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
83293854|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83293855|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
83293856|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293857|NCT01467466|Expectorants|expectorants|mesh-ancestor
83293858|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293859|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83293860|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
83293861|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293862|NCT01467466|Protective Agents|protective agents|mesh-ancestor
83293863|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293864|NCT01467466|Antidotes|antidotes|mesh-ancestor
83293865|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
83293866|NCT01441180|Ribavirin|ribavirin|mesh-list
83293867|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
83293868|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293869|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
83293870|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293871|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
83293872|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
83293873|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
83293874|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83293875|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83293876|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293877|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293878|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293879|NCT04061980|Nivolumab|nivolumab|mesh-list
83293880|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83293881|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293882|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83293883|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293884|NCT01467076|Alprostadil|alprostadil|mesh-list
83293885|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83293886|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
83293887|NCT01467076|Urological Agents|urological agents|mesh-ancestor
83293888|NCT01466062|Palivizumab|palivizumab|mesh-list
83293889|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
83293890|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293891|NCT04504864|Aspirin|aspirin|mesh-list
83293892|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83293893|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83293894|NCT04504864|Analgesics|analgesics|mesh-ancestor
83293895|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
83293896|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293897|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293898|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83293899|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83293900|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83293901|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83293902|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293903|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83293904|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83293905|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293906|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
83293907|NCT04060342|Paclitaxel|paclitaxel|mesh-list
83293908|NCT04060342|Gemcitabine|gemcitabine|mesh-list
83293909|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
83293910|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83293911|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293912|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
83293913|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
83293914|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
83293915|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293916|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83293917|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
83293918|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83293919|NCT04060342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83293920|NCT01435018|Tenofovir|tenofovir|mesh-list
83293921|NCT01435018|Emtricitabine|emtricitabine|mesh-list
83293922|NCT01435018|Efavirenz|efavirenz|mesh-list
83293923|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83293924|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83293925|NCT01435018|Paclitaxel|paclitaxel|mesh-list
83293926|NCT01435018|Etoposide|etoposide|mesh-list
83293927|NCT01435018|Vincristine|vincristine|mesh-list
83293928|NCT01435018|Bleomycin|bleomycin|mesh-list
83293929|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83293930|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293931|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
83293932|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
83293933|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
83293934|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293935|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83293936|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83293937|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293938|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
83293939|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293940|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83293941|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83293942|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83293943|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83293944|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83293945|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83293946|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83293947|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83293948|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83293949|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83293950|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83293952|NCT01419184|Daptomycin|daptomycin|mesh-list
83293953|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83293954|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83293955|NCT01417156|Nintedanib|nintedanib|mesh-list
83293956|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83293957|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83293958|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293959|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293960|NCT01417078|Diazepam|diazepam|mesh-list
83293961|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83293962|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
83293963|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
83293964|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
83293965|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83293966|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83293967|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83293968|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83293969|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83293970|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83293971|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83293972|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83293973|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83293974|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83293975|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83293976|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
83293977|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
83293978|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
83293979|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
83293980|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83293981|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293982|NCT01954394|Alirocumab|alirocumab|mesh-list
83293983|NCT01954394|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83293984|NCT01954394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83293985|NCT01954394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83293986|NCT01954394|Antimetabolites|antimetabolites|mesh-ancestor
83293987|NCT01954394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83293988|NCT01954394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83293989|NCT01954394|Protease Inhibitors|protease inhibitors|mesh-ancestor
83293990|NCT01954394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83293991|NCT01954394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83293992|NCT01464424|Bimatoprost|bimatoprost|mesh-list
83293993|NCT01464424|Travoprost|travoprost|mesh-list
83293994|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83293995|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83293996|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83293997|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83293998|NCT01902134|Tramadol|tramadol|mesh-list
83293999|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83294000|NCT01902134|Narcotics|narcotics|mesh-ancestor
83294001|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294002|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294003|NCT01902134|Analgesics|analgesics|mesh-ancestor
83294005|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294006|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83294007|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83294008|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294009|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294010|NCT01954082|Inositol|inositol|mesh-list
83294011|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
83294012|NCT01954082|Vitamins|vitamins|mesh-ancestor
83294013|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
83294014|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294015|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
83294016|NCT01417000|Pancrelipase|pancrelipase|mesh-list
83294017|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294018|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
83294019|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294020|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294021|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83294022|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
83294023|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294024|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294025|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83294026|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83294027|NCT01415986|Temoporfin|temoporfin|mesh-list
83294028|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294029|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83294030|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
83294031|NCT01415518|Budesonide|budesonide|mesh-list
83294032|NCT01415518|Theophylline|theophylline|mesh-list
83294033|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
83294034|NCT01415518|Ipratropium|ipratropium|mesh-list
83294035|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83294036|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294037|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83294038|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
83294039|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294040|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294041|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83294042|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294043|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
83294044|NCT01415518|Hormones|hormones|mesh-ancestor
83294045|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294046|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83294047|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83294048|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83294049|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294050|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294051|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294052|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83294053|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
83294054|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83294055|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294056|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
83294057|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83294058|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83294059|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
83294061|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83294062|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83294063|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83294064|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294065|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294066|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294067|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294068|NCT04767178|Acetaminophen|acetaminophen|mesh-list
83294069|NCT04767178|Ibuprofen|ibuprofen|mesh-list
83294070|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83294071|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83294072|NCT04767178|Analgesics|analgesics|mesh-ancestor
83294073|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
83294074|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294075|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294076|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294077|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294078|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83294079|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294080|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294081|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
83294082|NCT01432600|Dexamethasone|dexamethasone|mesh-list
83294083|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
83294084|NCT01432600|Pomalidomide|pomalidomide|mesh-list
83294085|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294086|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
83294087|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294088|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294089|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83294090|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
83413607|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
83294091|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294092|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294093|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83294094|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294095|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
83294096|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
83294097|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294098|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83294099|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
83294100|NCT01432600|Hormones|hormones|mesh-ancestor
83294101|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294102|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83294103|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83294104|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83294105|NCT01432600|Growth Substances|growth substances|mesh-ancestor
83294106|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
83294107|NCT01432444|Aripiprazole|aripiprazole|mesh-list
83294108|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
83294109|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83294110|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83294111|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83294112|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294113|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294114|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
83294115|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
83294116|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294117|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294118|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83294119|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83294120|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
83294121|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83294122|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83294123|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83294124|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83294125|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83294126|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83294127|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294128|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83294129|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83294130|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83294131|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294132|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
83294133|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294134|NCT01932788|Vitamin D|vitamin d|mesh-list
83294135|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
83294136|NCT01932788|Vitamins|vitamins|mesh-list
83294137|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
83294138|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294139|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83294140|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83294141|NCT01431976|Lamotrigine|lamotrigine|mesh-list
83294142|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
83294143|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83294144|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83294145|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294146|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83294147|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294148|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83294149|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83294150|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294151|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83294152|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83294153|NCT01413958|Loratadine|loratadine|mesh-list
83294154|NCT01413958|Phenylephrine|phenylephrine|mesh-list
83294155|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
83294156|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83294157|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
83294158|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
83294159|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294160|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294161|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
83294162|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83294163|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
83294164|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294165|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83294166|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83294167|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83294168|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294169|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294170|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294171|NCT01413958|Protective Agents|protective agents|mesh-ancestor
83294172|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
83294173|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
83294174|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83294175|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83294176|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83294177|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
83294178|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
83294179|NCT01413178|Melphalan|melphalan|mesh-list
83294180|NCT01413178|Busulfan|busulfan|mesh-list
83294181|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83294182|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
83294183|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294184|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294185|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83294186|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294187|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
83294188|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294189|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83294190|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
83294191|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294192|NCT03025906|Valproic Acid|valproic acid|mesh-list
83294193|NCT03025906|Phenobarbital|phenobarbital|mesh-list
83294194|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
83294195|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294196|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294197|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
83294198|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294199|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294200|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
83294201|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83294202|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294203|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83294204|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83294205|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83294206|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83294207|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
83294208|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83294209|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83294210|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83294212|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83294213|NCT04053712|Hormones|hormones|mesh-ancestor
83294214|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294215|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294216|NCT01798485|Docetaxel|docetaxel|mesh-list
83294217|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294218|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
83294219|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
83294220|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
83294221|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294222|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
83294223|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
83294224|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83294225|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83294226|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83294227|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83294228|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294229|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
83294230|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294231|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294232|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83294233|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294234|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83294235|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83294236|NCT01767519|Urological Agents|urological agents|mesh-ancestor
83294237|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
83294238|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83294239|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83294240|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83294241|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83294242|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294243|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
83294244|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294245|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294246|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83294247|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294248|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83294249|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294250|NCT01765569|Vemurafenib|vemurafenib|mesh-list
83294251|NCT01765569|Digoxin|digoxin|mesh-list
83294252|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83294253|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83294254|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294255|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294256|NCT01765569|Protective Agents|protective agents|mesh-ancestor
83294257|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294258|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294259|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83294260|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83294261|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
83294262|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294263|NCT01609023|Rituximab|rituximab|mesh-list
83294264|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294265|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294266|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
83294267|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294268|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294269|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
83294270|NCT01765179|Testosterone|testosterone|mesh-list
83294271|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
83294272|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
83294273|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83294274|NCT01765179|Androgens|androgens|mesh-ancestor
83294275|NCT01765179|Hormones|hormones|mesh-ancestor
83294276|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294277|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294278|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83294279|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294280|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
83294281|NCT01793883|Laninamivir|laninamivir|mesh-list
83294282|NCT01793883|Zanamivir|zanamivir|mesh-list
83294283|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
83294284|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294285|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294286|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294287|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
83294288|NCT01953692|Lenalidomide|lenalidomide|mesh-list
83294289|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294290|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294291|NCT01953692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83294292|NCT01953692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294293|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
83294294|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294295|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83294296|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83294297|NCT01953692|Growth Substances|growth substances|mesh-ancestor
83294298|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
83294299|NCT01791153|Prednisone|prednisone|mesh-list
83294300|NCT01791153|Methotrexate|methotrexate|mesh-list
83294301|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294302|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
83294303|NCT01791153|Hormones|hormones|mesh-ancestor
83294304|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294305|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294306|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83294307|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294308|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83294309|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
83294310|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83294311|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83294312|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
83294313|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294314|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
83294315|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294316|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83294317|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294318|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
83294319|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294320|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83294321|NCT01926782|Alirocumab|alirocumab|mesh-list
83294322|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83294323|NCT01926782|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83294324|NCT01926782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83294325|NCT01926782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83294326|NCT01926782|Antimetabolites|antimetabolites|mesh-ancestor
83294327|NCT01926782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294328|NCT01926782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83294329|NCT01926782|Protease Inhibitors|protease inhibitors|mesh-ancestor
83294330|NCT01926782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294331|NCT01926782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83294332|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
83294333|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294334|NCT01926626|Moclobemide|moclobemide|mesh-list
83294335|NCT01926626|Nicotine|nicotine|mesh-list
83294336|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83294337|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
83294338|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294339|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294340|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83294341|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83294342|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
83294343|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294344|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294345|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
83294346|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83294347|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83294348|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294350|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
83294351|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294352|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294353|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
83294354|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294355|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294356|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
83294357|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83294358|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294359|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83294360|NCT01952834|Vancomycin|vancomycin|mesh-list
83294361|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83294362|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294363|NCT01952054|Denosumab|denosumab|mesh-list
83294364|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83294365|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294366|NCT01925768|Apremilast|apremilast|mesh-list
83294367|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83294368|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83294369|NCT01925768|Analgesics|analgesics|mesh-ancestor
83294370|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
83294371|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294372|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294373|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294374|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294375|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83294376|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83294377|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294378|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294379|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
83294380|NCT01431274|Olodaterol|olodaterol|mesh-list
83294381|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83294382|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
83294383|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294384|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294385|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83294386|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294387|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
83294388|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83294389|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
83294390|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294391|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294392|NCT01991795|Ticagrelor|ticagrelor|mesh-list
83294393|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83294394|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83294395|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83294396|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83294397|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
83294398|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294399|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294400|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294401|NCT02076100|Ruzasvir|ruzasvir|mesh-list
83294402|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
83294403|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294404|NCT01411774|Cycloserine|cycloserine|mesh-list
83294405|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83294406|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294407|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83294408|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
83294409|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83294410|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
83294411|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294412|NCT01410604|Metformin|metformin|mesh-list
83294413|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83294414|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294415|NCT01410448|Cyclosporine|cyclosporine|mesh-list
83294416|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
83294417|NCT01410448|Everolimus|everolimus|mesh-list
83294418|NCT01410448|Cyclosporins|cyclosporins|mesh-list
83294419|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294420|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294421|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294422|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
83294423|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294424|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
83294425|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294426|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83294427|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294428|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83294429|NCT01410448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83294430|NCT01410448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83294431|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294432|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83294433|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83294434|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
83294435|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83294436|NCT04037176|Omalizumab|omalizumab|mesh-list
83294437|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83294438|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83294439|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294440|NCT01430104|Teriparatide|teriparatide|mesh-list
83294441|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83294442|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294443|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83294444|NCT01990859|Ipilimumab|ipilimumab|mesh-list
83294445|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294446|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294447|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83294448|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294449|NCT02093897|Factor VIII|factor viii|mesh-list
83294450|NCT02093897|Coagulants|coagulants|mesh-ancestor
83294451|NCT01976845|Midazolam|midazolam|mesh-list
83294452|NCT01976845|Propofol|propofol|mesh-list
83294453|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83294454|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294455|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294456|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83294457|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
83294458|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
83294459|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83294460|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83294461|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83294462|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83294463|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
83294464|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
83294465|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413608|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294466|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294467|NCT01989689|Etanercept|etanercept|mesh-list
83294468|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83294469|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83294470|NCT01989689|Analgesics|analgesics|mesh-ancestor
83294471|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
83294472|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294473|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294474|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294475|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294476|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83294477|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294478|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
83294479|NCT01942993|Vemurafenib|vemurafenib|mesh-list
83294480|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294481|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83294482|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294483|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294484|NCT01989455|Deferiprone|deferiprone|mesh-list
83294485|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83294486|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
83294487|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
83294488|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294489|NCT01987895|Vancomycin|vancomycin|mesh-list
83294490|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
83294491|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83294492|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294493|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83294494|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294495|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294496|NCT01618669|Regadenoson|regadenoson|mesh-list
83294497|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83294498|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83294499|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
83294500|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
83294501|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294502|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294503|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294504|NCT01390948|Bevacizumab|bevacizumab|mesh-list
83294505|NCT01390948|Temozolomide|temozolomide|mesh-list
83294506|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294507|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294508|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83294509|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83294510|NCT01390948|Growth Substances|growth substances|mesh-ancestor
83294511|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294512|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
83294513|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83294514|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
83294515|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294516|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
83294517|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83294518|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
83294519|NCT01429792|Ribavirin|ribavirin|mesh-list
83294520|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83294521|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
83294522|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294523|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
83294524|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294525|NCT01940887|Bevacizumab|bevacizumab|mesh-list
83294526|NCT01940887|Aflibercept|aflibercept|mesh-list
83294527|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294528|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294529|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83294530|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83294531|NCT01940887|Growth Substances|growth substances|mesh-ancestor
83294532|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294533|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
83294535|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
83294536|NCT01925612|Rituximab|rituximab|mesh-list
83294537|NCT01925612|Doxorubicin|doxorubicin|mesh-list
83294538|NCT01925612|Vincristine|vincristine|mesh-list
83294539|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83294540|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83294541|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294542|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
83294543|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294544|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294545|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83294546|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
83294547|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294548|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294549|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83294550|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294551|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83294552|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83294553|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83294554|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294555|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294556|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
83294557|NCT01925612|Hormones|hormones|mesh-ancestor
83294558|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294559|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83294560|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83294561|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83294562|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83294563|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83294564|NCT01925612|Immunotoxins|immunotoxins|mesh-ancestor
83294565|NCT01925612|Immunoconjugates|immunoconjugates|mesh-ancestor
83294566|NCT02093663|Mesalamine|mesalamine|mesh-list
83294567|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83294568|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83294569|NCT02093663|Analgesics|analgesics|mesh-ancestor
83294570|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
83294571|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294572|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294573|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294574|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294575|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83294576|NCT01408888|Dulaglutide|dulaglutide|mesh-list
83294577|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83294578|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294579|NCT01408888|Incretins|incretins|mesh-ancestor
83294580|NCT01408888|Hormones|hormones|mesh-ancestor
83294581|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294582|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83294583|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83294584|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294585|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294586|NCT01918033|Desloratadine|desloratadine|mesh-list
83294587|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83294588|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
83294589|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294590|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294591|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294592|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83294593|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83294594|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
83294595|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
83294596|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
83294597|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83294598|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83294599|NCT01390402|Aldesleukin|aldesleukin|mesh-list
83294600|NCT01390402|Methotrexate|methotrexate|mesh-list
83294601|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
83294602|NCT01390402|Fludarabine|fludarabine|mesh-list
83294603|NCT01390402|Busulfan|busulfan|mesh-list
83294604|NCT01390402|Interleukin-2|interleukin-2|mesh-list
83294605|NCT01390402|Tacrolimus|tacrolimus|mesh-list
83294606|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
83294607|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83294608|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83294609|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
83294610|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83294611|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294612|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83294613|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
83294614|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294615|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294616|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
83294617|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294618|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83294619|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294620|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
83294621|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294622|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83294623|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
83294624|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294625|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83294626|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
83294627|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83294628|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83294629|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83294630|NCT01390402|Analgesics|analgesics|mesh-ancestor
83294631|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
83294632|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294633|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83294634|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83294636|NCT04661683|Antidotes|antidotes|mesh-ancestor
83294637|NCT04661683|Protective Agents|protective agents|mesh-ancestor
83294638|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294639|NCT01428076|Polidocanol|polidocanol|mesh-list
83294640|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83294641|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83294642|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83294643|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294644|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83294645|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294646|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294647|NCT02093351|Tamoxifen|tamoxifen|mesh-list
83294648|NCT02093351|Letrozole|letrozole|mesh-list
83294649|NCT02093351|Olaparib|olaparib|mesh-list
83294650|NCT02093351|Anastrozole|anastrozole|mesh-list
83294651|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294652|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83294653|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83294654|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294655|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294656|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83294657|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
83294658|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294659|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294660|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83294661|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83294662|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83294663|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83294664|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83294665|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83294666|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83294667|NCT02078284|Protective Agents|protective agents|mesh-ancestor
83294668|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294669|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83294670|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
83294671|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294672|NCT02092961|Adalimumab|adalimumab|mesh-list
83294673|NCT02092961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83294674|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294675|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294676|NCT01940497|Paclitaxel|paclitaxel|mesh-list
83294677|NCT01940497|Docetaxel|docetaxel|mesh-list
83294678|NCT01940497|Doxorubicin|doxorubicin|mesh-list
83294679|NCT01940497|Trastuzumab|trastuzumab|mesh-list
83294680|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83294681|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294682|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
83294683|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
83294684|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
83294685|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294686|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83294687|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83294688|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83294689|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294690|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294691|NCT01987505|Rituximab|rituximab|mesh-list
83294692|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294693|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294694|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
83294695|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294696|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294697|NCT01923896|Cycloserine|cycloserine|mesh-list
83294698|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83294699|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294700|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83294701|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
83294702|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83294703|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
83294704|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294705|NCT01938625|Cyclosporine|cyclosporine|mesh-list
83294706|NCT01938625|Ribavirin|ribavirin|mesh-list
83294707|NCT01938625|Simeprevir|simeprevir|mesh-list
83294708|NCT01938625|Tacrolimus|tacrolimus|mesh-list
83294709|NCT01938625|Cyclosporins|cyclosporins|mesh-list
83294710|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294711|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
83294712|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294713|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83294714|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294715|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294716|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
83294717|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294718|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
83294719|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294720|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
83294721|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
83294722|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
83294723|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
83294724|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
83294725|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294726|NCT01975285|Dexamethasone|dexamethasone|mesh-list
83294727|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294728|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
83294729|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
83294730|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294731|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294732|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83294733|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
83294734|NCT01975285|Hormones|hormones|mesh-ancestor
83294735|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294736|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83294737|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294738|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83294739|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
83294740|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294741|NCT04624399|Atezolizumab|atezolizumab|mesh-list
83294742|NCT04624399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83294743|NCT04624399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294744|NCT04624399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294745|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294746|NCT01915849|Licogliflozin|licogliflozin|mesh-list
83294747|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83294748|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294749|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83294750|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294752|NCT01915303|Pasireotide|pasireotide|mesh-list
83294753|NCT01915303|Hormones|hormones|mesh-ancestor
83294754|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294755|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294756|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83294757|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83294758|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
83294759|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
83294760|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294761|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294762|NCT01987427|Phentermine|phentermine|mesh-list
83294763|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83294764|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294765|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
83294766|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83294767|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
83294768|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
83294769|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294770|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294771|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294772|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294774|NCT01937299|Travoprost|travoprost|mesh-list
83294775|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83294776|NCT01937299|Brinzolamide|brinzolamide|mesh-list
83294777|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83294778|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83294779|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83294780|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83294781|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83294782|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294783|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294784|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294785|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294786|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83294787|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294788|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83294789|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
83294790|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294791|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
83294792|NCT01597557|Analgesics|analgesics|mesh-ancestor
83294793|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
83294794|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294795|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294796|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
83294797|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294798|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83294799|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
83294800|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83294801|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83294802|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294803|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83294804|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
83294805|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83294806|NCT01914757|Benralizumab|benralizumab|mesh-list
83294807|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83294808|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294809|NCT02003573|Decitabine|decitabine|mesh-list
83294810|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83294811|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
83294812|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294813|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294814|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294815|NCT01789281|Everolimus|everolimus|mesh-list
83294816|NCT01789281|Octreotide|octreotide|mesh-list
83294817|NCT01789281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83294818|NCT01789281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83294819|NCT01789281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294820|NCT01789281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294821|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294822|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
83294823|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294824|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294825|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83294826|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83294828|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83294829|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294830|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83294831|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83294832|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294833|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294834|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294835|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83294836|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83294837|NCT01789047|Topiramate|topiramate|mesh-list
83294838|NCT01789047|Amantadine|amantadine|mesh-list
83294839|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
83294840|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83294841|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294842|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83294843|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83294844|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
83294845|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294846|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
83294847|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294848|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294849|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83294850|NCT01789047|Analgesics|analgesics|mesh-ancestor
83294851|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
83294852|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294853|NCT01617187|Olanzapine|olanzapine|mesh-list
83294854|NCT01617187|Asenapine|asenapine|mesh-list
83294855|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
83294856|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
83294857|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294858|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294859|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83294860|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83294861|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83294862|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83294863|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83294864|NCT01617187|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83294865|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83294866|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83294867|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294868|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294869|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
83294870|NCT01759407|Epinephrine|epinephrine|mesh-list
83294871|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83294872|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83294873|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294874|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294875|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294876|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294877|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83294878|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83294879|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
83294880|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294881|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83294882|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294883|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
83294884|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
83294885|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83294886|NCT01787331|Itraconazole|itraconazole|mesh-list
83294887|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
83294888|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294889|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83294890|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83294891|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294892|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294893|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83294894|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
83294895|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294896|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294897|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83294898|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
83294899|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83294900|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83294901|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
83294902|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294903|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294904|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83294905|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294906|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83294907|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83294908|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83294909|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294910|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294911|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294912|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83294913|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83294914|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294915|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83294916|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
83294917|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294919|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83294920|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294921|NCT01786551|Eplerenone|eplerenone|mesh-list
83294922|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83294923|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
83294924|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294925|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294926|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83294927|NCT01786551|Diuretics|diuretics|mesh-ancestor
83294928|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
83294929|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83294930|NCT01973569|Denosumab|denosumab|mesh-list
83294931|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83294932|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294933|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
83294934|NCT01951586|Denosumab|denosumab|mesh-list
83294935|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83294936|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294937|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83294938|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294939|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
83294940|NCT04641728|Olaparib|olaparib|mesh-list
83294941|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294942|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294943|NCT04641728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83294944|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294945|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83294946|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294947|NCT01756833|Doxycycline|doxycycline|mesh-list
83294948|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83294949|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294950|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
83294951|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83294952|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83294953|NCT01785615|Atorvastatin|atorvastatin|mesh-list
83294954|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83294955|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83294956|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
83294957|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294958|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83294959|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83294960|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294961|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83294962|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294963|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83294964|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294965|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294966|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
83294967|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
83294968|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83294969|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83294970|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83294971|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83294972|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294973|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83294974|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
83294975|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83294976|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294977|NCT01783821|Budesonide|budesonide|mesh-list
83294978|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
83294979|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83294980|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83294981|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
83294982|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83294983|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83294984|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83294985|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
83294986|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
83294987|NCT01783821|Hormones|hormones|mesh-ancestor
83294988|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83294989|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83294990|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83294991|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83294992|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
83294993|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83294994|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83294995|NCT01608087|Bevacizumab|bevacizumab|mesh-list
83294996|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83294997|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83294998|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83294999|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295000|NCT01608087|Growth Substances|growth substances|mesh-ancestor
83295001|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295002|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295003|NCT01912963|Trastuzumab|trastuzumab|mesh-list
83295005|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83295006|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295007|NCT01912807|Ondansetron|ondansetron|mesh-list
83295008|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
83295009|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
83295010|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295011|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295012|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83295013|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
83295014|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
83295015|NCT01912807|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83295016|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83295017|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
83295018|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295019|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295020|NCT01782885|Acetaminophen|acetaminophen|mesh-list
83295021|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83295022|NCT01782885|Analgesics|analgesics|mesh-ancestor
83295023|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
83295024|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295025|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295026|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
83295027|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83295028|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83295029|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83295030|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295031|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295032|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295033|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295034|NCT01754493|Analgesics|analgesics|mesh-ancestor
83295035|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
83295036|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295037|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
83295038|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83295039|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
83295040|NCT01972789|Ranibizumab|ranibizumab|mesh-list
83295041|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83295042|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295043|NCT01972789|Growth Substances|growth substances|mesh-ancestor
83295044|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295045|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295046|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295047|NCT01910389|Tadalafil|tadalafil|mesh-list
83295048|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
83295049|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83295050|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83295051|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295052|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295053|NCT01910389|Urological Agents|urological agents|mesh-ancestor
83295054|NCT01970995|Menthol|menthol|mesh-list
83295055|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
83295056|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
83295057|NCT01932697|Docetaxel|docetaxel|mesh-list
83295058|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295059|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
83295060|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
83295061|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
83295062|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295063|NCT01970527|Ipilimumab|ipilimumab|mesh-list
83295064|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83295065|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83413609|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83295066|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83295067|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295068|NCT01408576|Epratuzumab|epratuzumab|mesh-list
83295069|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83295070|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295071|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
83295072|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
83295073|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83295074|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83295075|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295076|NCT01427608|Olanzapine|olanzapine|mesh-list
83295077|NCT01427608|Sertraline|sertraline|mesh-list
83295078|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
83295079|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
83295080|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295081|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295082|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83295083|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83295084|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83295085|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295086|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83295087|NCT01427608|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83295088|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83295089|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295090|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295091|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295092|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
83295093|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
83295094|NCT01408030|Bevacizumab|bevacizumab|mesh-list
83295095|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
83295096|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
83295097|NCT01408030|Estrogens|estrogens|mesh-list
83295098|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83295099|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295100|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83295101|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295102|NCT01408030|Growth Substances|growth substances|mesh-ancestor
83295103|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295104|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295105|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83295106|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83295107|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295108|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
83295109|NCT01408030|Coagulants|coagulants|mesh-ancestor
83295110|NCT01408030|Hormones|hormones|mesh-ancestor
83295111|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295112|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83295113|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83295114|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295115|NCT01897532|Linagliptin|linagliptin|mesh-list
83295116|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83295117|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295118|NCT01897532|Incretins|incretins|mesh-ancestor
83295119|NCT01897532|Hormones|hormones|mesh-ancestor
83295120|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295121|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83295122|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
83295123|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295124|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295125|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
83295126|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295127|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83295128|NCT04641026|Protective Agents|protective agents|mesh-ancestor
83295129|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295130|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
83295131|NCT04173416|Narcotics|narcotics|mesh-ancestor
83295132|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295133|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295135|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
83295136|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295137|NCT01896128|Modafinil|modafinil|mesh-list
83295138|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83295139|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295140|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83295141|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83295142|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83295143|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295144|NCT01949870|Gemcitabine|gemcitabine|mesh-list
83295145|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295146|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83295147|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
83295148|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295149|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
83295150|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
83295151|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295152|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295153|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295154|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
83295155|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
83295156|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83295157|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
83295158|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295159|NCT01405924|Dexamethasone|dexamethasone|mesh-list
83295160|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
83295161|NCT01405924|Aprepitant|aprepitant|mesh-list
83295162|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295163|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
83295164|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
83295165|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295166|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295167|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83295168|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
83295169|NCT01405924|Hormones|hormones|mesh-ancestor
83295170|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295171|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295172|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295173|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83295174|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295175|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295176|NCT01426438|Aspirin|aspirin|mesh-list
83295177|NCT01426438|Niacin|niacin|mesh-list
83295178|NCT01426438|Fenofibrate|fenofibrate|mesh-list
83295179|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83295180|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83295181|NCT01426438|Analgesics|analgesics|mesh-ancestor
83295182|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
83295183|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295184|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295185|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295186|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83295187|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83295188|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83295189|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295190|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83295191|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83295192|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295194|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83295195|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
83295196|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83295197|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
83295198|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
83295199|NCT01426438|Vitamins|vitamins|mesh-ancestor
83295200|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
83295201|NCT01782495|Ritonavir|ritonavir|mesh-list
83295202|NCT01782495|Ribavirin|ribavirin|mesh-list
83295203|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83295204|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83295205|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
83295207|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295208|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83295209|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83295210|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
83295211|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295212|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83295213|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83295214|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
83295215|NCT01922102|Ranibizumab|ranibizumab|mesh-list
83295216|NCT01922102|Verteporfin|verteporfin|mesh-list
83413610|NCT01307605|Rituximab|rituximab|mesh-list
83295217|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83295218|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295219|NCT01922102|Growth Substances|growth substances|mesh-ancestor
83295220|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295221|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295222|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295223|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83295224|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83295225|NCT01405768|Lidocaine|lidocaine|mesh-list
83295226|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
83295227|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
83295228|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295229|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295230|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
83295231|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295232|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83295233|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83295234|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83295235|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295236|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295237|NCT01913353|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83295238|NCT01913353|Antiviral Agents|antiviral agents|mesh-ancestor
83295239|NCT01913353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295240|NCT01754259|Ranolazine|ranolazine|mesh-list
83295241|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83295242|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295243|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295244|NCT01405456|Eplerenone|eplerenone|mesh-list
83295245|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83295246|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
83295247|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295248|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295249|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83295250|NCT01405456|Diuretics|diuretics|mesh-ancestor
83295251|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
83295252|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83295253|NCT01404208|Cycloserine|cycloserine|mesh-list
83295254|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83295255|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295256|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83295257|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
83295258|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83295259|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
83295260|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295261|NCT01617668|Paclitaxel|paclitaxel|mesh-list
83295262|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83295263|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295264|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
83295265|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
83295266|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
83295267|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295269|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83295270|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83295271|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295272|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295273|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83295274|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295276|NCT01424644|Vaccines|vaccines|mesh-list
83295277|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
83295278|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295279|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
83295280|NCT01403116|Testosterone|testosterone|mesh-list
83295281|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
83295282|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
83295283|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83295284|NCT01403116|Androgens|androgens|mesh-ancestor
83295285|NCT01403116|Hormones|hormones|mesh-ancestor
83295286|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295287|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295288|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295289|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295290|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
83295291|NCT01753401|Prednisone|prednisone|mesh-list
83295292|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83295293|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295294|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
83295295|NCT01753401|Hormones|hormones|mesh-ancestor
83295296|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295297|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295298|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295299|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295300|NCT01894568|Insulin|insulin|mesh-list
83295301|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83295302|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
83295303|NCT01894568|Pioglitazone|pioglitazone|mesh-list
83295304|NCT01894568|Biguanides|biguanides|mesh-list
83295305|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83295306|NCT01894568|Meglitinide|meglitinide|mesh-list
83295307|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295308|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
83295309|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83295310|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
83295311|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295312|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
83295313|NCT01920152|Protective Agents|protective agents|mesh-ancestor
83295314|NCT01752933|Guadecitabine|guadecitabine|mesh-list
83295315|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295316|NCT01752855|Adalimumab|adalimumab|mesh-list
83295317|NCT01752855|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83295318|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295319|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83295320|NCT01402492|Naltrexone|naltrexone|mesh-list
83295321|NCT01402492|Buprenorphine|buprenorphine|mesh-list
83295322|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83295323|NCT01402492|Naloxone|naloxone|mesh-list
83295324|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83295325|NCT01402492|Narcotics|narcotics|mesh-ancestor
83295326|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295327|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295328|NCT01402492|Analgesics|analgesics|mesh-ancestor
83295329|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
83295330|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295331|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83295332|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83295333|NCT01894256|Olaparib|olaparib|mesh-list
83295334|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83295335|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295336|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295337|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295338|NCT01780935|Ranibizumab|ranibizumab|mesh-list
83295339|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83295340|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295341|NCT01780935|Growth Substances|growth substances|mesh-ancestor
83295342|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295343|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295344|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295345|NCT01422538|Mannitol|mannitol|mesh-list
83295346|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83295347|NCT01422538|Diuretics|diuretics|mesh-ancestor
83295348|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
83295349|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295350|NCT04026256|Denosumab|denosumab|mesh-list
83295351|NCT04026256|Teriparatide|teriparatide|mesh-list
83295352|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83295353|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295354|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83295355|NCT01422382|Diltiazem|diltiazem|mesh-list
83295356|NCT01422382|Pitavastatin|pitavastatin|mesh-list
83295357|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83295358|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83295359|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295360|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295361|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83295362|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295363|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
83295364|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83295365|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83295366|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83295367|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
83295368|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295369|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83295370|NCT01401322|Lenalidomide|lenalidomide|mesh-list
83295371|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
83295372|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295373|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83295374|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295375|NCT01401322|Growth Substances|growth substances|mesh-ancestor
83295376|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295377|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295378|NCT01401010|Doripenem|doripenem|mesh-list
83295379|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83295380|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295381|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83295382|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
83295383|NCT01890746|Cytarabine|cytarabine|mesh-list
83295384|NCT01890746|Daunorubicin|daunorubicin|mesh-list
83295385|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83295386|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
83295387|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295388|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295389|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
83295390|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295391|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83295392|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
83295393|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295394|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83295395|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83295396|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83295397|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295398|NCT01422304|Atropine|atropine|mesh-list
83295399|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
83295400|NCT01422304|Neostigmine|neostigmine|mesh-list
83295401|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83295402|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83295403|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83295404|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
83295405|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295406|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295407|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83295408|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
83295409|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
83295410|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
83295411|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83295412|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83295413|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
83295414|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295415|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295416|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83295417|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295418|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83295419|NCT01387516|Nicotine|nicotine|mesh-list
83295420|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83295421|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
83295422|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295423|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295424|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83295425|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83295426|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83295427|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295428|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295429|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83295430|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83295431|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83295432|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295433|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295434|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83295435|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83295436|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83295437|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83295438|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
83295439|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295440|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295441|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83295442|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83295443|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
83295444|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83295445|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83295446|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
83295447|NCT01894022|Ambrisentan|ambrisentan|mesh-list
83295448|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83295449|NCT01386970|Lamivudine|lamivudine|mesh-list
83295450|NCT01386970|Zidovudine|zidovudine|mesh-list
83295451|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83295452|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83295453|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83295454|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295455|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295456|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
83295457|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295458|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83295459|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83295460|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
83295461|NCT01385566|Vaccines|vaccines|mesh-list
83295462|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
83295463|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295464|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
83295465|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
83295466|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295467|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
83295468|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295469|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295470|NCT01780545|Docetaxel|docetaxel|mesh-list
83295471|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295472|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
83295473|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
83295474|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
83295475|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295476|NCT01780389|Milnacipran|milnacipran|mesh-list
83295477|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
83295478|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83295479|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83295480|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295481|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295482|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295483|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295484|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83295485|NCT01780389|Analgesics|analgesics|mesh-ancestor
83295486|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
83295487|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295488|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
83295489|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83295490|NCT01778985|Estrogens|estrogens|mesh-list
83295491|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83295492|NCT01778985|Hormones|hormones|mesh-ancestor
83295493|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295494|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295496|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
83295497|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83295498|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83295500|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295501|NCT01865084|Urological Agents|urological agents|mesh-ancestor
83295502|NCT01399372|Cytarabine|cytarabine|mesh-list
83295503|NCT01399372|Rituximab|rituximab|mesh-list
83295504|NCT01399372|Methotrexate|methotrexate|mesh-list
83295505|NCT01399372|Vincristine|vincristine|mesh-list
83295506|NCT01399372|Procarbazine|procarbazine|mesh-list
83295507|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83295508|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295509|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
83295510|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295511|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83295512|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83295513|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
83295514|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83295515|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83295516|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
83295517|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295518|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
83295519|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295520|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83295521|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83295522|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83295523|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
83295524|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295525|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83295526|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83295527|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83295528|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83295529|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
83295530|NCT01385098|Vitamin D|vitamin d|mesh-list
83295531|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
83295532|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
83295533|NCT01385098|Vitamins|vitamins|mesh-list
83295534|NCT01385098|Calcium|calcium|mesh-list
83295535|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
83295536|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295537|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83295538|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83295539|NCT01398514|Escitalopram|escitalopram|mesh-list
83295540|NCT01398514|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83295541|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83295542|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295543|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295544|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295545|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
83295546|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295547|NCT03025282|Betamethasone|betamethasone|mesh-list
83295548|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
83295549|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83295550|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295551|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
83295552|NCT03025282|Hormones|hormones|mesh-ancestor
83295553|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295554|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295555|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83295556|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
83295557|NCT01778049|Empagliflozin|empagliflozin|mesh-list
83295558|NCT01778049|Linagliptin|linagliptin|mesh-list
83295559|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83295560|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295561|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83295562|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295563|NCT01778049|Incretins|incretins|mesh-ancestor
83295564|NCT01778049|Hormones|hormones|mesh-ancestor
83295565|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295566|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83295567|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83295568|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295569|NCT01777581|Milnacipran|milnacipran|mesh-list
83295570|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
83295571|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83295572|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83295573|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295574|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295575|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295576|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295577|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83295578|NCT01777581|Analgesics|analgesics|mesh-ancestor
83295579|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
83295580|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295581|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
83295582|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83295583|NCT01864148|Interferons|interferons|mesh-list
83295584|NCT01864148|Interferon-beta|interferon-beta|mesh-list
83295585|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
83295586|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295587|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
83295588|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295589|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
83295590|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295591|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83295592|NCT01890122|Metformin|metformin|mesh-list
83295593|NCT01890122|Alogliptin|alogliptin|mesh-list
83295594|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83295595|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295596|NCT01890122|Incretins|incretins|mesh-ancestor
83295597|NCT01890122|Hormones|hormones|mesh-ancestor
83295598|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295599|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83295600|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
83295601|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295602|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295603|NCT01397890|Budesonide|budesonide|mesh-list
83295604|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
83295605|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
83295606|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83295607|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295608|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83295609|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
83295610|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295611|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295612|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83295613|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
83295614|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
83295615|NCT01397890|Hormones|hormones|mesh-ancestor
83295616|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295617|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83295618|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83295619|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83295620|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
83295621|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295622|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295623|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
83295624|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83295625|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
83295626|NCT01777269|Tamsulosin|tamsulosin|mesh-list
83295627|NCT01777269|Dutasteride|dutasteride|mesh-list
83295628|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83295629|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83295630|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83295631|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
83295632|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295633|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295634|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295635|NCT01777269|Urological Agents|urological agents|mesh-ancestor
83295636|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83295637|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83295638|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295639|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
83295640|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295641|NCT04024696|Abexinostat|abexinostat|mesh-list
83295642|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83295643|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295644|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295645|NCT01777191|Ixekizumab|ixekizumab|mesh-list
83295646|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
83295647|NCT01896050|Tamoxifen|tamoxifen|mesh-list
83295648|NCT01896050|Letrozole|letrozole|mesh-list
83295649|NCT01896050|Anastrozole|anastrozole|mesh-list
83295650|NCT01896050|Exemestane|exemestane|mesh-list
83295651|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295652|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83295653|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83295654|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295655|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295656|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83295657|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
83295658|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295659|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295660|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295661|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83295662|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83295663|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83295664|NCT01775787|Menthol|menthol|mesh-list
83295665|NCT01775787|Nicotine|nicotine|mesh-list
83295666|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83295667|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
83295668|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295669|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295670|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83295671|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83295672|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
83295673|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295674|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295675|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
83295676|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
83295677|NCT01775475|Prednisone|prednisone|mesh-list
83295678|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
83295679|NCT01775475|Lomustine|lomustine|mesh-list
83295680|NCT01775475|Doxorubicin|doxorubicin|mesh-list
83295681|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83295682|NCT01775475|Etoposide|etoposide|mesh-list
83295683|NCT01775475|Vincristine|vincristine|mesh-list
83295684|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
83295685|NCT01775475|Procarbazine|procarbazine|mesh-list
83295686|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83295687|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
83295688|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295689|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83295690|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83295691|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
83295692|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295693|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295694|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83295695|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83295696|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83295697|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83295698|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295699|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295700|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
83295701|NCT01775475|Hormones|hormones|mesh-ancestor
83295702|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295703|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295704|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83295705|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
83295706|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
83295707|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
83295708|NCT01774929|Fentanyl|fentanyl|mesh-list
83295709|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83295710|NCT01774929|Narcotics|narcotics|mesh-ancestor
83295711|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295712|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295713|NCT01774929|Analgesics|analgesics|mesh-ancestor
83295714|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
83295715|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295716|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83295717|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83295719|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
83295720|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
83295721|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83295722|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295723|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295724|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83295725|NCT01774305|Analgesics|analgesics|mesh-ancestor
83295726|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
83295727|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295728|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83295729|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83295730|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83295731|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
83295732|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295733|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295734|NCT01397422|Amantadine|amantadine|mesh-list
83295735|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83295736|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83295737|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
83295738|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295739|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
83295740|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295741|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295742|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295743|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83295744|NCT01397422|Analgesics|analgesics|mesh-ancestor
83295745|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
83295746|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295747|NCT01736475|Factor VIII|factor viii|mesh-list
83295748|NCT01736475|BAX 855|bax 855|mesh-list
83295749|NCT01736475|Coagulants|coagulants|mesh-ancestor
83295750|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83295751|NCT01863680|Hormones|hormones|mesh-list
83295752|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83295753|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295754|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295755|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83295756|NCT01747629|Albuterol|albuterol|mesh-list
83295757|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83295758|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
83295759|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295760|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295761|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83295762|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
83295763|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
83295764|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83295765|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83295766|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83295767|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83295768|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
83295769|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295770|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295771|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83295772|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
83295773|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83295774|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83295775|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83295776|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83295777|NCT01886690|Laxatives|laxatives|mesh-ancestor
83295778|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83295779|NCT04590404|Nicotine|nicotine|mesh-list
83295780|NCT04590404|Varenicline|varenicline|mesh-list
83295781|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83295782|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
83295783|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295784|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295785|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83295786|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83295787|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
83295788|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295789|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295790|NCT01885208|Exenatide|exenatide|mesh-list
83295791|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83295792|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295793|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83295794|NCT01885208|Incretins|incretins|mesh-ancestor
83295796|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295797|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
83295798|NCT01859702|Dexamethasone|dexamethasone|mesh-list
83295799|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83295800|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295801|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
83295802|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
83295803|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295804|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295805|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83295806|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
83295807|NCT01859702|Hormones|hormones|mesh-ancestor
83295808|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295809|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295810|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295811|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83295812|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83295813|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295814|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83295815|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83295816|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295817|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295818|NCT01747551|Leucovorin|leucovorin|mesh-list
83295819|NCT01747551|Fluorouracil|fluorouracil|mesh-list
83295820|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
83295821|NCT01747551|Aflibercept|aflibercept|mesh-list
83295822|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
83295823|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295824|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83295825|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295826|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83295827|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
83295828|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295829|NCT01747551|Antidotes|antidotes|mesh-ancestor
83295830|NCT01747551|Protective Agents|protective agents|mesh-ancestor
83295831|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
83295832|NCT01747551|Vitamins|vitamins|mesh-ancestor
83295833|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
83295834|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83295835|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295836|NCT01747551|Growth Substances|growth substances|mesh-ancestor
83295837|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295838|NCT01859390|Antioxidants|antioxidants|mesh-list
83295839|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295840|NCT01859390|Protective Agents|protective agents|mesh-ancestor
83295841|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295842|NCT01858766|Ribavirin|ribavirin|mesh-list
83295843|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
83295844|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295845|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
83295846|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295847|NCT01745367|Paclitaxel|paclitaxel|mesh-list
83295848|NCT01745367|Tivozanib|tivozanib|mesh-list
83295849|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83295850|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295851|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
83295852|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
83295853|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
83295854|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295855|NCT01745367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83295856|NCT01745367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295857|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
83295858|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83295859|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83295860|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295861|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295862|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83295863|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295864|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295865|NCT01383928|Dexamethasone|dexamethasone|mesh-list
83295867|NCT01383928|Ixazomib|ixazomib|mesh-list
83295868|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295869|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
83295870|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
83295871|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295872|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295873|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83295874|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
83295875|NCT01383928|Hormones|hormones|mesh-ancestor
83295876|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295877|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295878|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295879|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
83295880|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83295881|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83295882|NCT01383928|Growth Substances|growth substances|mesh-ancestor
83295883|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
83295884|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
83295885|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295886|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295887|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83295888|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295889|NCT05368012|Dexamethasone|dexamethasone|mesh-list
83295890|NCT05368012|Bupivacaine|bupivacaine|mesh-list
83295891|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295892|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
83295893|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
83295894|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295895|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295896|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83295897|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
83295898|NCT05368012|Hormones|hormones|mesh-ancestor
83295899|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295900|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83295901|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295902|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
83295903|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
83295904|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295905|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
83295906|NCT05893329|Cytarabine|cytarabine|mesh-list
83295907|NCT05893329|Venetoclax|venetoclax|mesh-list
83295908|NCT05893329|Mitoxantrone|mitoxantrone|mesh-list
83295909|NCT05893329|Homoharringtonine|homoharringtonine|mesh-list
83295910|NCT05893329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83295911|NCT05893329|Antimetabolites|antimetabolites|mesh-ancestor
83295912|NCT05893329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295913|NCT05893329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83295914|NCT05893329|Antiviral Agents|antiviral agents|mesh-ancestor
83295915|NCT05893329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295916|NCT05893329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83295917|NCT05893329|Immunologic Factors|immunologic factors|mesh-ancestor
83295918|NCT05893329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295919|NCT05893329|Analgesics|analgesics|mesh-ancestor
83295920|NCT05893329|Sensory System Agents|sensory system agents|mesh-ancestor
83295921|NCT05893329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295922|NCT05893329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83295923|NCT05893329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83295924|NCT05893329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295925|NCT05893329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83295926|NCT05893329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83295927|NCT05893225|Metformin|metformin|mesh-list
83295928|NCT05893225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83295929|NCT05893225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295930|NCT05893147|Lactams|lactams|mesh-list
83295931|NCT05893147|Cephalosporins|cephalosporins|mesh-list
83295932|NCT05893147|beta-Lactams|beta-lactams|mesh-list
83295933|NCT05893147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83295934|NCT05893147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83295935|NCT05893108|Triamcinolone|triamcinolone|mesh-list
83295936|NCT05893108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83295937|NCT05893108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83295938|NCT05893108|Losartan|losartan|mesh-list
83295939|NCT05893108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83295940|NCT05893108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83295941|NCT05893108|Glucocorticoids|glucocorticoids|mesh-ancestor
83295942|NCT05893108|Hormones|hormones|mesh-ancestor
83295943|NCT05893108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83295944|NCT05893108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295945|NCT05893108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83295946|NCT05893108|Immunologic Factors|immunologic factors|mesh-ancestor
83295947|NCT05893108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83295948|NCT05893108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295949|NCT05893108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83295950|NCT05893108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83295951|NCT05893108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83295952|NCT05893108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83295953|NCT05892887|Bupivacaine|bupivacaine|mesh-list
83295954|NCT05892887|Anesthetics, Local|anesthetics, local|mesh-ancestor
83295955|NCT05892887|Anesthetics|anesthetics|mesh-ancestor
83295956|NCT05892887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295957|NCT05892887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295958|NCT05892887|Sensory System Agents|sensory system agents|mesh-ancestor
83295959|NCT05892887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295960|NCT05892770|Zinc|zinc|mesh-list
83295961|NCT05892770|Botulinum Toxins|botulinum toxins|mesh-list
83295962|NCT05892770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83295963|NCT05892770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83295964|NCT05892770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83295965|NCT05892770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295966|NCT05892770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295967|NCT05892770|Cholinergic Agents|cholinergic agents|mesh-ancestor
83295968|NCT05892770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295969|NCT05892770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295970|NCT05892770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83295971|NCT05892770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295972|NCT05892770|Trace Elements|trace elements|mesh-ancestor
83295973|NCT05892770|Micronutrients|micronutrients|mesh-ancestor
83295974|NCT05892744|Sertraline|sertraline|mesh-list
83295975|NCT05892744|Antidepressive Agents|antidepressive agents|mesh-ancestor
83295976|NCT05892744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83295977|NCT05892744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83295978|NCT05892744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83295979|NCT05892744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83295980|NCT05892744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295981|NCT05892744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295982|NCT05892744|Serotonin Agents|serotonin agents|mesh-ancestor
83295983|NCT05892744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295984|NCT05892705|Dexmedetomidine|dexmedetomidine|mesh-list
83295985|NCT05892705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83295986|NCT05892705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83295987|NCT05892705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83295988|NCT05892705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83295989|NCT05892705|Analgesics|analgesics|mesh-ancestor
83295990|NCT05892705|Sensory System Agents|sensory system agents|mesh-ancestor
83295991|NCT05892705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83295992|NCT05892705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83295993|NCT05892705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83295994|NCT05892705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83295995|NCT05892705|Adrenergic Agents|adrenergic agents|mesh-ancestor
83295996|NCT05892705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83295997|NCT05892705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83295998|NCT05892471|Propofol|propofol|mesh-list
83295999|NCT05892471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83296000|NCT05892471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296001|NCT05892471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296002|NCT05892471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83296003|NCT05892471|Anesthetics, General|anesthetics, general|mesh-ancestor
83296004|NCT05892471|Anesthetics|anesthetics|mesh-ancestor
83296005|NCT05892393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83296006|NCT05892393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83296007|NCT05892393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296008|NCT05892341|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83296009|NCT05892341|Laxatives|laxatives|mesh-ancestor
83296010|NCT05892341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83296011|NCT05892276|Cannabidiol|cannabidiol|mesh-list
83296012|NCT05892276|Anticonvulsants|anticonvulsants|mesh-ancestor
83296013|NCT05892237|Immunomodulating Agents|immunomodulating agents|mesh-list
83296014|NCT05892237|Immunologic Factors|immunologic factors|mesh-ancestor
83296015|NCT05892237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296016|NCT05892068|Tucatinib|tucatinib|mesh-list
83296017|NCT05892068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296018|NCT05892068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296019|NCT05892068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296020|NCT05892068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296021|NCT05892042|Rivaroxaban|rivaroxaban|mesh-list
83296022|NCT05892042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83296023|NCT05892042|Antithrombins|antithrombins|mesh-ancestor
83296024|NCT05892042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83296025|NCT05892042|Protease Inhibitors|protease inhibitors|mesh-ancestor
83296026|NCT05892042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296027|NCT05892042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296028|NCT05892042|Anticoagulants|anticoagulants|mesh-ancestor
83296029|NCT05891613|Bupivacaine|bupivacaine|mesh-list
83296030|NCT05891613|Anesthetics, Local|anesthetics, local|mesh-ancestor
83296031|NCT05891613|Anesthetics|anesthetics|mesh-ancestor
83296032|NCT05891613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296033|NCT05891613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296034|NCT05891613|Sensory System Agents|sensory system agents|mesh-ancestor
83296035|NCT05891613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296036|NCT05891561|Pertuzumab|pertuzumab|mesh-list
83296037|NCT05891561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296038|NCT05891561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296039|NCT05890963|Ibalizumab|ibalizumab|mesh-list
83296040|NCT05890963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83296041|NCT05890963|Antiviral Agents|antiviral agents|mesh-ancestor
83296042|NCT05890963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296043|NCT05890963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83296044|NCT05890118|Ustekinumab|ustekinumab|mesh-list
83296045|NCT05890118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83296046|NCT05889949|Sorafenib|sorafenib|mesh-list
83296047|NCT05889949|Lenvatinib|lenvatinib|mesh-list
83296048|NCT05889949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296049|NCT05889949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296050|NCT05889949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296051|NCT05889949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296052|NCT05887804|Triamcinolone|triamcinolone|mesh-list
83296053|NCT05887804|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83296054|NCT05887804|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83296055|NCT05887804|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83296056|NCT05887804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296057|NCT05887804|Glucocorticoids|glucocorticoids|mesh-ancestor
83296058|NCT05887804|Hormones|hormones|mesh-ancestor
83296059|NCT05887804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296060|NCT05887804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296061|NCT05887804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296062|NCT05887804|Immunologic Factors|immunologic factors|mesh-ancestor
83296063|NCT05887804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296064|NCT05887804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296065|NCT05875272|Hemostatics|hemostatics|mesh-list
83296066|NCT05875272|Coagulants|coagulants|mesh-ancestor
83296067|NCT05854966|Metformin|metformin|mesh-list
83296068|NCT05854966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83296069|NCT05854966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296070|NCT05845814|Pembrolizumab|pembrolizumab|mesh-list
83296071|NCT05845814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296072|NCT05845814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296073|NCT05845814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296074|NCT05845814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296075|NCT05809700|Hyaluronic Acid|hyaluronic acid|mesh-list
83296076|NCT05809700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83296077|NCT05809700|Immunologic Factors|immunologic factors|mesh-ancestor
83296078|NCT05809700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296079|NCT05809700|Viscosupplements|viscosupplements|mesh-ancestor
83296080|NCT05809700|Protective Agents|protective agents|mesh-ancestor
83296081|NCT05808725|Amlodipine|amlodipine|mesh-list
83296082|NCT05808725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83296083|NCT05808725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83296084|NCT05808725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83296085|NCT05808725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83296086|NCT05808725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296087|NCT05808725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83296088|NCT05808725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296089|NCT05808725|Vasodilator Agents|vasodilator agents|mesh-ancestor
83296090|NCT05797506|Sulforaphane|sulforaphane|mesh-list
83296091|NCT05797506|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83296092|NCT05797506|Protective Agents|protective agents|mesh-ancestor
83296093|NCT05797506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296094|NCT05797506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296095|NCT05792540|Dapagliflozin|dapagliflozin|mesh-list
83296097|NCT05792540|Atorvastatin|atorvastatin|mesh-list
83296098|NCT05792540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83296099|NCT05792540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83296100|NCT05792540|Antimetabolites|antimetabolites|mesh-ancestor
83296101|NCT05792540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296102|NCT05792540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83296103|NCT05792540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83296104|NCT05792540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296105|NCT05792540|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83296106|NCT05792540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83296107|NCT05792540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296108|NCT05792540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83296109|NCT05792540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83296110|NCT05792540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83296111|NCT05792540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296112|NCT05792540|Serotonin Agents|serotonin agents|mesh-ancestor
83296113|NCT05792540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83296114|NCT05792540|Antidepressive Agents|antidepressive agents|mesh-ancestor
83296115|NCT05792540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83296116|NCT05792540|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83296117|NCT05792540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83296118|NCT05781711|Metformin|metformin|mesh-list
83296119|NCT05781711|Levodopa|levodopa|mesh-list
83296120|NCT05781711|Carbidopa|carbidopa|mesh-list
83296121|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83296122|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83296123|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296124|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83296125|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83296126|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
83296127|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296128|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296129|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83296130|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296131|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83296132|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
83296133|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
83296134|NCT05780879|Venetoclax|venetoclax|mesh-list
83296135|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296136|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83296137|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
83296138|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296139|NCT05776953|Ketorolac|ketorolac|mesh-list
83296140|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83296141|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83296142|NCT05776953|Analgesics|analgesics|mesh-ancestor
83296143|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
83296144|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296145|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296146|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296147|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296148|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83296149|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296150|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296151|NCT05776134|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
83296152|NCT05776134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296153|NCT05776134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296154|NCT05748665|Etomidate|etomidate|mesh-list
83296155|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83296156|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296157|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296158|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83296159|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
83296160|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
83296161|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
83296162|NCT05746208|Lenvatinib|lenvatinib|mesh-list
83296163|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296172|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296173|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296174|NCT05742958|Analgesics|analgesics|mesh-ancestor
83296175|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
83296176|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296185|NCT05718323|Niraparib|niraparib|mesh-list
83296186|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83296187|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296188|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296189|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296190|NCT05710666|Trastuzumab|trastuzumab|mesh-list
83296191|NCT05710666|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83296192|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296193|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296194|NCT05710666|Immunoconjugates|immunoconjugates|mesh-ancestor
83296195|NCT05710666|Immunologic Factors|immunologic factors|mesh-ancestor
83296196|NCT05710666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296197|NCT05701215|Venetoclax|venetoclax|mesh-list
83296198|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296199|NCT05700214|Lidocaine|lidocaine|mesh-list
83296200|NCT05700214|Ropivacaine|ropivacaine|mesh-list
83296201|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
83296202|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
83296203|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296204|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296205|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
83296206|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296207|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83296208|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83296209|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83296210|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83296211|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296212|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
83296213|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83296214|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296215|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296216|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83296217|NCT05700045|Analgesics|analgesics|mesh-ancestor
83296218|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
83296219|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296220|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83296221|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83296222|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83296223|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
83296224|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296225|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296226|NCT05681039|Carboplatin|carboplatin|mesh-list
83296227|NCT05681039|Atezolizumab|atezolizumab|mesh-list
83296228|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296229|NCT05681039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296230|NCT05681039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296231|NCT05681039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296232|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
83296233|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
83296234|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83296235|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83296236|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296237|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83296238|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296239|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296240|NCT05676294|Olanzapine|olanzapine|mesh-list
83296241|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
83296242|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
83296243|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296244|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296245|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83296246|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83296247|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83296248|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296249|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83296250|NCT05676294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83296251|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83296252|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83296253|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296254|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296255|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
83296256|NCT05659576|Sucralfate|sucralfate|mesh-list
83296257|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83296258|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83296259|NCT05646303|Psilocybin|psilocybin|mesh-list
83296260|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
83296261|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296262|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83296263|NCT05638867|Aspirin|aspirin|mesh-list
83296264|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
83296265|NCT05638867|Clopidogrel|clopidogrel|mesh-list
83296266|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83296267|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83296268|NCT05638867|Analgesics|analgesics|mesh-ancestor
83296269|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
83296270|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296271|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296272|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296273|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296274|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83296275|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83296276|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296277|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83296278|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83296279|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296280|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
83296281|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83296282|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83296283|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83296284|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
83296285|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296286|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83296287|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
83296288|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83296289|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
83296290|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
83296291|NCT05630976|Isavuconazole|isavuconazole|mesh-list
83296292|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
83296293|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296294|NCT05607407|Methimazole|methimazole|mesh-list
83296295|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
83296296|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
83296297|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296298|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296299|NCT05600686|Prednisone|prednisone|mesh-list
83296300|NCT05600686|Cortisone|cortisone|mesh-list
83296301|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
83296302|NCT05600686|Rituximab|rituximab|mesh-list
83296303|NCT05600686|Doxorubicin|doxorubicin|mesh-list
83296304|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83296305|NCT05600686|Etoposide|etoposide|mesh-list
83296306|NCT05600686|Vincristine|vincristine|mesh-list
83296307|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
83296308|NCT05600686|Daunorubicin|daunorubicin|mesh-list
83296309|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
83296310|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83296311|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83296312|NCT05600686|Antibodies|antibodies|mesh-list
83296313|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
83296314|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83296315|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296316|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
83296317|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296318|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296319|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83296320|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
83296321|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296322|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296323|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83296324|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83296325|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83296326|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83296327|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296328|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296329|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
83296330|NCT05600686|Hormones|hormones|mesh-ancestor
83296331|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296332|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296333|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83296334|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
83296335|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
83296336|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
83296337|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
83296338|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
83296339|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
83296340|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296341|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296342|NCT05600309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296343|NCT05600309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296344|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
83296345|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296346|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296347|NCT05585034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296348|NCT05585034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296349|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
83296350|NCT05565378|Dostarlimab|dostarlimab|mesh-list
83296351|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296352|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296353|NCT05565378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296354|NCT05565378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296355|NCT05564338|Tislelizumab|tislelizumab|mesh-list
83296356|NCT05564338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296357|NCT05564338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296358|NCT05545384|Rituximab|rituximab|mesh-list
83296359|NCT05545384|Azathioprine|azathioprine|mesh-list
83296360|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296361|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296362|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
83296363|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296364|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296365|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
83296366|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296367|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83296368|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296369|NCT05536284|Bisoprolol|bisoprolol|mesh-list
83296370|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83296371|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
83296372|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
83296373|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296374|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296375|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83296376|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83296377|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83296378|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
83296379|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296380|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296381|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
83296382|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83296383|NCT05517668|Fomepizole|fomepizole|mesh-list
83296384|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
83296385|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296386|NCT05517668|Expectorants|expectorants|mesh-ancestor
83296387|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
83296388|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83296389|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
83296390|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296391|NCT05517668|Protective Agents|protective agents|mesh-ancestor
83296392|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296393|NCT05517668|Antidotes|antidotes|mesh-ancestor
83296394|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296395|NCT05503030|Nintedanib|nintedanib|mesh-list
83296396|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296397|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296398|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296399|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296400|NCT05476926|Ranibizumab|ranibizumab|mesh-list
83296401|NCT05476926|Faricimab|faricimab|mesh-list
83296402|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83296403|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83296404|NCT05476926|Growth Substances|growth substances|mesh-ancestor
83296405|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296406|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
83296407|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296408|NCT05468320|Prednisone|prednisone|mesh-list
83296409|NCT05468320|Prednisolone|prednisolone|mesh-list
83296410|NCT05468320|Antibodies|antibodies|mesh-list
83296411|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
83296412|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296413|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296414|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296415|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
83296416|NCT05468320|Hormones|hormones|mesh-ancestor
83296417|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296418|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296419|NCT05456490|Bupivacaine|bupivacaine|mesh-list
83296420|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
83296421|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
83296422|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296423|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296424|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
83296425|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296426|NCT05416333|Azelaic acid|azelaic acid|mesh-list
83296427|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296428|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
83296429|NCT05409391|Insulin|insulin|mesh-list
83296430|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83296431|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296432|NCT05401110|Osimertinib|osimertinib|mesh-list
83296433|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296434|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296435|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296436|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296437|NCT05394493|Avelumab|avelumab|mesh-list
83296438|NCT05394493|Axitinib|axitinib|mesh-list
83296439|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296440|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296441|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296442|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296443|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296444|NCT05382208|Doxycycline|doxycycline|mesh-list
83296445|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83296446|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296447|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
83296448|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83296449|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83296450|NCT05372367|Itraconazole|itraconazole|mesh-list
83296451|NCT05372367|Rifampin|rifampin|mesh-list
83296452|NCT05372367|Antifungal Agents|antifungal agents|mesh-ancestor
83296453|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296454|NCT05372367|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83296455|NCT05372367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83296456|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296457|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296458|NCT05372367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83296459|NCT05372367|Hormone Antagonists|hormone antagonists|mesh-ancestor
83296460|NCT05372367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296461|NCT05372367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296462|NCT05372367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83296463|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83296464|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
83296465|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83296466|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
83296467|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83296468|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83296469|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83296470|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83296471|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83296472|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83296473|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83296474|NCT05372354|Dexamethasone|dexamethasone|mesh-list
83296475|NCT05372354|Trametinib|trametinib|mesh-list
83296476|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296477|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
83296478|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
83296479|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296480|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296481|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83296482|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
83296483|NCT05372354|Hormones|hormones|mesh-ancestor
83296484|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296485|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296486|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296487|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296488|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296489|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296490|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83296491|NCT05367063|Canagliflozin|canagliflozin|mesh-list
83296492|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83296493|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296494|NCT05367063|Incretins|incretins|mesh-ancestor
83296495|NCT05367063|Hormones|hormones|mesh-ancestor
83296496|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296497|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83296498|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
83296499|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296500|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296501|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83296502|NCT05358548|Paclitaxel|paclitaxel|mesh-list
83296503|NCT05358548|Carboplatin|carboplatin|mesh-list
83296504|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
83296505|NCT05358548|Fluorouracil|fluorouracil|mesh-list
83296506|NCT05358548|Pemetrexed|pemetrexed|mesh-list
83296507|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83296508|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296509|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
83296510|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
83296511|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
83296512|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296513|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296514|NCT05358548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296515|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
83296516|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83296517|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296518|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
83296519|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296520|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296521|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83296522|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83296523|NCT05358249|Cetuximab|cetuximab|mesh-list
83296524|NCT05358249|Trametinib|trametinib|mesh-list
83296525|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296526|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296527|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296528|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296529|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296530|NCT05334004|Ritonavir|ritonavir|mesh-list
83296531|NCT05334004|Lopinavir|lopinavir|mesh-list
83296532|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83296533|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83296534|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
83296535|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296536|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296537|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83296538|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83296539|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
83296540|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296541|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83296542|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83296543|NCT05306340|Tamoxifen|tamoxifen|mesh-list
83296544|NCT05306340|Dexamethasone|dexamethasone|mesh-list
83296545|NCT05306340|Fulvestrant|fulvestrant|mesh-list
83296546|NCT05306340|Everolimus|everolimus|mesh-list
83296547|NCT05306340|Exemestane|exemestane|mesh-list
83296548|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296549|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
83296550|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
83296551|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296552|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296553|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83296554|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
83296555|NCT05306340|Hormones|hormones|mesh-ancestor
83296556|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296557|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296558|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296559|NCT05306340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83296560|NCT05306340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296561|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296562|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296563|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296564|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
83296565|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83296566|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
83296567|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83296568|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83296569|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83296570|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83296571|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83296572|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83296573|NCT05280548|Venglustat|venglustat|mesh-list
83296574|NCT05280548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296575|NCT05280548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296576|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
83296577|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83296578|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83296579|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296580|NCT05262556|Nivolumab|nivolumab|mesh-list
83296581|NCT05262556|Ipilimumab|ipilimumab|mesh-list
83296582|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296583|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296584|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296585|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296586|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
83296587|NCT05244070|Fludarabine|fludarabine|mesh-list
83296588|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296589|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
83296590|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296591|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296592|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83296593|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
83296594|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296595|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296596|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83296597|NCT05236777|Natalizumab|natalizumab|mesh-list
83296598|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
83296599|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296600|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83296601|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83296602|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296603|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296604|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83296605|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83296606|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296607|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
83296608|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296610|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296611|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296612|NCT05205486|Cefazolin|cefazolin|mesh-list
83296613|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83296614|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296615|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83296616|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83296617|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
83296618|NCT05168813|Vaccines|vaccines|mesh-list
83296619|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
83296620|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296621|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
83296622|NCT05167409|Cetuximab|cetuximab|mesh-list
83296623|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296624|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296625|NCT05167409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296626|NCT05167409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296627|NCT05161195|Tamoxifen|tamoxifen|mesh-list
83296628|NCT05161195|Letrozole|letrozole|mesh-list
83296629|NCT05161195|Fulvestrant|fulvestrant|mesh-list
83296630|NCT05161195|Anastrozole|anastrozole|mesh-list
83296631|NCT05161195|Goserelin|goserelin|mesh-list
83296632|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296633|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83296634|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83296635|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296636|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296637|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83296638|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
83296639|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296640|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296641|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296642|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83296643|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83296644|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83296645|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83296646|NCT05130060|Trifluridine|trifluridine|mesh-list
83296647|NCT05130060|Vaccines|vaccines|mesh-list
83296648|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
83296649|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296650|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
83296651|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296652|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
83296653|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296654|NCT05113940|Midazolam|midazolam|mesh-list
83296655|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83296656|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83296657|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296658|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296659|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83296660|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83296661|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83296662|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83296663|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
83296664|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
83296665|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
83296666|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
83296667|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296668|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296669|NCT05096117|ASP8062|asp8062|mesh-list
83296670|NCT05096117|Analgesics|analgesics|mesh-ancestor
83296671|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
83296672|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296673|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296674|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
83296675|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
83296676|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296677|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296678|NCT05081180|Lenvatinib|lenvatinib|mesh-list
83296679|NCT05081180|Avelumab|avelumab|mesh-list
83296680|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296681|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296682|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296683|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296684|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296685|NCT05072093|Tenofovir|tenofovir|mesh-list
83296686|NCT05072093|Emtricitabine|emtricitabine|mesh-list
83296688|NCT05072093|Doxycycline|doxycycline|mesh-list
83296689|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
83296690|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296691|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83296692|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83296693|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296694|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296695|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83296696|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83296697|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83296698|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
83296699|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83296700|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83296701|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83296702|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83296703|NCT05062083|11C-PS13|11c-ps13|mesh-list
83296704|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83296705|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296706|NCT05047718|Vaccines|vaccines|mesh-list
83296707|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
83296708|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296709|NCT05027633|Carboplatin|carboplatin|mesh-list
83296710|NCT05027633|Docetaxel|docetaxel|mesh-list
83296711|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
83296712|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296713|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
83296714|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
83296715|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
83296716|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296717|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296718|NCT05027633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296719|NCT05011188|Antibodies|antibodies|mesh-list
83296720|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
83296721|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
83296722|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
83296723|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296724|NCT04979052|Interferons|interferons|mesh-list
83296725|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
83296726|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296727|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
83296728|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296729|NCT04978584|Prednisone|prednisone|mesh-list
83296730|NCT04978584|Cortisone|cortisone|mesh-list
83296731|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
83296732|NCT04978584|Rituximab|rituximab|mesh-list
83296733|NCT04978584|Doxorubicin|doxorubicin|mesh-list
83296734|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83296735|NCT04978584|Vincristine|vincristine|mesh-list
83296736|NCT04978584|Lenalidomide|lenalidomide|mesh-list
83296737|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
83296738|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83296739|NCT04978584|Antibodies|antibodies|mesh-list
83296740|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
83296741|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83296742|NCT04978584|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83296743|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296744|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
83296745|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296746|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296747|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83296748|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
83296749|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296750|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296751|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83296752|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83296753|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83296754|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83296755|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296756|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296757|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
83296759|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296760|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296761|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83296762|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
83296763|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
83296764|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
83296765|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83296766|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83296767|NCT04978584|Growth Substances|growth substances|mesh-ancestor
83296768|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
83296769|NCT04978584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296770|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
83296771|NCT04976634|Lenvatinib|lenvatinib|mesh-list
83296772|NCT04976634|Belzutifan|belzutifan|mesh-list
83296773|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296774|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296775|NCT04976634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296776|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296777|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296778|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296779|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83296780|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83296781|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296782|NCT04950608|Psilocybin|psilocybin|mesh-list
83296783|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
83296784|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296785|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83296786|NCT04940052|Trametinib|trametinib|mesh-list
83296787|NCT04940052|Dabrafenib|dabrafenib|mesh-list
83296788|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296789|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83296790|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296791|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296792|NCT04929028|Fluorouracil|fluorouracil|mesh-list
83296793|NCT04929028|Capecitabine|capecitabine|mesh-list
83296794|NCT04929028|Nivolumab|nivolumab|mesh-list
83296795|NCT04929028|Mitomycins|mitomycins|mesh-list
83296796|NCT04929028|Mitomycin|mitomycin|mesh-list
83296797|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
83296798|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296799|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83296800|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296801|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296802|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
83296803|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296804|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296805|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296806|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83296807|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
83296808|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83296809|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296810|NCT04924075|Belzutifan|belzutifan|mesh-list
83296811|NCT04924075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296812|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83296813|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83296814|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83296815|NCT04892446|Dexamethasone|dexamethasone|mesh-list
83296816|NCT04892446|Bortezomib|bortezomib|mesh-list
83296817|NCT04892446|Daratumumab|daratumumab|mesh-list
83296818|NCT04892446|Pomalidomide|pomalidomide|mesh-list
83296819|NCT04892446|Magrolimab|magrolimab|mesh-list
83296820|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296821|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
83296822|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
83296823|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296824|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296825|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83296826|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
83296827|NCT04892446|Hormones|hormones|mesh-ancestor
83296828|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296829|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296830|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296831|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
83296832|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83296833|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83296834|NCT04892446|Growth Substances|growth substances|mesh-ancestor
83296835|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
83296836|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296837|NCT04862260|Atorvastatin|atorvastatin|mesh-list
83296838|NCT04862260|Ezetimibe|ezetimibe|mesh-list
83296839|NCT04862260|Evolocumab|evolocumab|mesh-list
83296840|NCT04862260|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83296841|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83296842|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83296843|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
83296844|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296845|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83296846|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83296847|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296848|NCT04862260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83296849|NCT04862260|Protease Inhibitors|protease inhibitors|mesh-ancestor
83296850|NCT04851613|Fulvestrant|fulvestrant|mesh-list
83296851|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83296852|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296853|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83296854|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83296855|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
83296856|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296857|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296858|NCT04844866|Rituximab|rituximab|mesh-list
83296859|NCT04844866|Gemcitabine|gemcitabine|mesh-list
83296860|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
83296861|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83296862|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83296863|NCT04844866|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83296864|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
83296865|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296866|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296867|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
83296868|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296869|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296870|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83296871|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
83296872|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296873|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83296874|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
83296875|NCT04843904|Rituximab|rituximab|mesh-list
83296876|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
83296877|NCT04843904|Venetoclax|venetoclax|mesh-list
83296878|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296879|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296880|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
83296881|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296882|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83296883|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83296884|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83296885|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296886|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
83296887|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296888|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296889|NCT04837196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296890|NCT04837196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296891|NCT04820933|Tenofovir|tenofovir|mesh-list
83296892|NCT04820933|Emtricitabine|emtricitabine|mesh-list
83296893|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
83296894|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83296895|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83296896|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83296897|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296898|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296899|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83296900|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83296901|NCT04784715|Trastuzumab|trastuzumab|mesh-list
83296902|NCT04784715|Pertuzumab|pertuzumab|mesh-list
83296904|NCT04784715|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83296905|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296906|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296907|NCT04784715|Immunoconjugates|immunoconjugates|mesh-ancestor
83296908|NCT04784715|Immunologic Factors|immunologic factors|mesh-ancestor
83296909|NCT04784715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296910|NCT04740931|Aflibercept|aflibercept|mesh-list
83296911|NCT04740931|Faricimab|faricimab|mesh-list
83296912|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83296913|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83296914|NCT04740931|Growth Substances|growth substances|mesh-ancestor
83296915|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296917|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296918|NCT04702880|Carboplatin|carboplatin|mesh-list
83296919|NCT04702880|Nivolumab|nivolumab|mesh-list
83296920|NCT04702880|Etoposide|etoposide|mesh-list
83296921|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296922|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296923|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83296924|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296925|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83296926|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83296927|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83296928|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296929|NCT04677816|Vitamin D|vitamin d|mesh-list
83296930|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
83296931|NCT04677816|Vitamins|vitamins|mesh-ancestor
83296932|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
83296933|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296934|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83296935|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83296936|NCT04629248|Acetaminophen|acetaminophen|mesh-list
83296937|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
83296938|NCT04629248|Promethazine|promethazine|mesh-list
83296939|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
83296940|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
83296941|NCT04629248|Tacrolimus|tacrolimus|mesh-list
83296942|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83296943|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
83296944|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296945|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83296946|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296947|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83296948|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83296949|NCT04629248|Analgesics|analgesics|mesh-ancestor
83296950|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
83296951|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296952|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
83296953|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83296954|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
83296955|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
83296956|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83296957|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
83296958|NCT04629248|Hormones|hormones|mesh-ancestor
83296959|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296960|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83296961|NCT04629248|Protective Agents|protective agents|mesh-ancestor
83296962|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296963|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83296964|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83296965|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83296966|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296967|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
83296968|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
83296969|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83296970|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
83296971|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
83296972|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83296973|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83296974|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
83296975|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
83296976|NCT04628026|Venetoclax|venetoclax|mesh-list
83296977|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83296978|NCT04605861|Liraglutide|liraglutide|mesh-list
83296979|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83296980|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296982|NCT04605861|Hormones|hormones|mesh-ancestor
83296983|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83296984|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
83296985|NCT04600414|Narcotics|narcotics|mesh-ancestor
83296986|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83296987|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296988|NCT04600414|Analgesics|analgesics|mesh-ancestor
83296989|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
83296990|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83296991|NCT04564443|Calcium|calcium|mesh-list
83296992|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83296993|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296994|NCT04560595|Caffeine|caffeine|mesh-list
83296995|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83296996|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83296997|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83296998|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83296999|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297000|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83297001|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83297002|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
83297003|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297004|NCT04550260|Cisplatin|cisplatin|mesh-list
83297005|NCT04550260|Fluorouracil|fluorouracil|mesh-list
83297006|NCT04550260|Capecitabine|capecitabine|mesh-list
83297007|NCT04550260|Durvalumab|durvalumab|mesh-list
83297008|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297009|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
83297010|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297011|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297012|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297013|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
83297014|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297015|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297016|NCT04538742|Paclitaxel|paclitaxel|mesh-list
83297017|NCT04538742|Trastuzumab|trastuzumab|mesh-list
83297018|NCT04538742|Durvalumab|durvalumab|mesh-list
83297019|NCT04538742|Pertuzumab|pertuzumab|mesh-list
83297020|NCT04538742|Tucatinib|tucatinib|mesh-list
83297021|NCT04538742|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83297022|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83297023|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297024|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297025|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297026|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297027|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297028|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297029|NCT04538742|Immunoconjugates|immunoconjugates|mesh-ancestor
83297030|NCT04538742|Immunologic Factors|immunologic factors|mesh-ancestor
83297031|NCT04538742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297032|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297033|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297034|NCT04530630|Emtricitabine|emtricitabine|mesh-list
83297035|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
83297036|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297037|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83297038|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83297039|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297040|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297041|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83297042|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83297043|NCT04469764|Letrozole|letrozole|mesh-list
83297044|NCT04469764|Anastrozole|anastrozole|mesh-list
83297045|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297046|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83297047|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83297048|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297049|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297050|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83297051|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
83297052|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297053|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297054|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297056|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
83297057|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297058|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297059|NCT04449874|Bevacizumab|bevacizumab|mesh-list
83297060|NCT04449874|Cetuximab|cetuximab|mesh-list
83297061|NCT04449874|Atezolizumab|atezolizumab|mesh-list
83297062|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83297063|NCT04449874|Inavolisib|inavolisib|mesh-list
83297064|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297065|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297066|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83297067|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83297068|NCT04449874|Growth Substances|growth substances|mesh-ancestor
83297069|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297070|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
83297071|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297072|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297073|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297074|NCT04449874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83297075|NCT04449874|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
83297076|NCT04439292|Trametinib|trametinib|mesh-list
83297077|NCT04439292|Dabrafenib|dabrafenib|mesh-list
83297078|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83297079|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297080|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297081|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297082|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297083|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83297084|NCT04439292|Protective Agents|protective agents|mesh-ancestor
83297085|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297086|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83297087|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
83297088|NCT04439227|Adavosertib|adavosertib|mesh-list
83297089|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297090|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297091|NCT04439188|GSK2636771|gsk2636771|mesh-list
83297092|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297093|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297094|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297095|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297096|NCT04439149|GSK2636771|gsk2636771|mesh-list
83297097|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297098|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297099|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297100|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297101|NCT04421963|Olaparib|olaparib|mesh-list
83297102|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83297103|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297104|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297105|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297106|NCT04416737|Insulin|insulin|mesh-list
83297107|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83297108|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297109|NCT04364607|Neostigmine|neostigmine|mesh-list
83297110|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83297111|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297112|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297113|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
83297114|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297115|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297116|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83297117|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
83297118|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297119|NCT04354012|Gentian Violet|gentian violet|mesh-list
83297120|NCT04354012|Methylene Blue|methylene blue|mesh-list
83297121|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297122|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297123|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83297124|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297125|NCT04348383|Defibrotide|defibrotide|mesh-list
83297126|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83297128|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297129|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83297130|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
83297131|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297132|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297133|NCT04323202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83297134|NCT04323202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297135|NCT04305691|Ixazomib|ixazomib|mesh-list
83297136|NCT04305691|Glycine|glycine|mesh-list
83297137|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297138|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297139|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297140|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297141|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
83297142|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297143|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297144|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
83297145|NCT04284787|Azacitidine|azacitidine|mesh-list
83297147|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297148|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297149|NCT04284787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83297150|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297151|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297152|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
83297153|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297154|NCT04278781|Ivosidenib|ivosidenib|mesh-list
83297155|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297156|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297157|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297158|NCT04263792|Trimethoprim|trimethoprim|mesh-list
83297159|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83297160|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297161|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
83297162|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83297163|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83297164|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83297165|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297166|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297167|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83297168|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83297169|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83297170|NCT04230564|Azacitidine|azacitidine|mesh-list
83297171|NCT04230564|Venetoclax|venetoclax|mesh-list
83297172|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297173|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
83297174|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297175|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297176|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297177|NCT04218409|Oxycodone|oxycodone|mesh-list
83297178|NCT04218409|Oxytocin|oxytocin|mesh-list
83297179|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
83297180|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83297181|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297182|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83297183|NCT04218409|Narcotics|narcotics|mesh-ancestor
83297184|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83297185|NCT04218409|Analgesics|analgesics|mesh-ancestor
83297186|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
83297187|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297188|NCT04085172|Guanfacine|guanfacine|mesh-list
83297189|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83297190|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83297191|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83297192|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83297193|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297194|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
83297195|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297196|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297197|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83297198|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83297199|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83297200|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83297201|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
83297203|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83297204|NCT04081545|Anesthetics|anesthetics|mesh-list
83297205|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83297206|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297207|NCT04081545|Narcotics|narcotics|mesh-ancestor
83297208|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
83297209|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297210|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83297211|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83297212|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297213|NCT04064697|Valganciclovir|valganciclovir|mesh-list
83297214|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
83297215|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297217|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83297218|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83297219|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
83297220|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297221|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297222|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297223|NCT03971409|Doxorubicin|doxorubicin|mesh-list
83297224|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83297225|NCT03971409|Avelumab|avelumab|mesh-list
83297226|NCT03971409|Camptothecin|camptothecin|mesh-list
83297227|NCT03971409|Antibodies|antibodies|mesh-list
83297228|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83297229|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
83297230|NCT03971409|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83297231|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
83297232|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
83297233|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297234|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83297235|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297236|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83297237|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83297238|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297239|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297240|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297241|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83297242|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83297243|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83297244|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
83297245|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297246|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83297247|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
83297248|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297249|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
83297250|NCT03914625|Leucovorin|leucovorin|mesh-list
83297251|NCT03914625|Folic Acid|folic acid|mesh-list
83297252|NCT03914625|Cytarabine|cytarabine|mesh-list
83297253|NCT03914625|Dexamethasone|dexamethasone|mesh-list
83297254|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
83297255|NCT03914625|Prednisone|prednisone|mesh-list
83297256|NCT03914625|Prednisolone|prednisolone|mesh-list
83297257|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83297258|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
83297259|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83297260|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
83297261|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
83297262|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83297263|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83297264|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83297265|NCT03914625|Cortisone|cortisone|mesh-list
83297266|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
83297267|NCT03914625|Doxorubicin|doxorubicin|mesh-list
83297268|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83297269|NCT03914625|Methotrexate|methotrexate|mesh-list
83297270|NCT03914625|Vincristine|vincristine|mesh-list
83297271|NCT03914625|Asparaginase|asparaginase|mesh-list
83297272|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
83297273|NCT03914625|Pegaspargase|pegaspargase|mesh-list
83297274|NCT03914625|Thioguanine|thioguanine|mesh-list
83297275|NCT03914625|Blinatumomab|blinatumomab|mesh-list
83297276|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83297277|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
83297278|NCT03914625|Antibodies|antibodies|mesh-list
83297279|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
83297280|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83297281|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83297282|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83297283|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
83297284|NCT03914625|BB 1101|bb 1101|mesh-list
83297285|NCT03914625|Calcium|calcium|mesh-list
83297286|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
83297287|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
83297288|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297289|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
83297290|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297291|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297292|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83297293|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
83297294|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297295|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297296|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83297297|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297298|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
83297299|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
83297300|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297301|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297302|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
83297304|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297305|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297306|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297307|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297308|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83297309|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83297310|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83297311|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83297312|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83297313|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83297314|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
83297315|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83297316|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297317|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
83297318|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297319|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83297320|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83297321|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
83297322|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297323|NCT03914625|Antidotes|antidotes|mesh-ancestor
83297324|NCT03914625|Protective Agents|protective agents|mesh-ancestor
83297325|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
83297326|NCT03914625|Vitamins|vitamins|mesh-ancestor
83297327|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
83297328|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83297329|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297330|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297331|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297332|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83297333|NCT03914625|Hematinics|hematinics|mesh-ancestor
83297334|NCT03896230|Ketamine|ketamine|mesh-list
83297335|NCT03896230|Analgesics|analgesics|mesh-ancestor
83297336|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
83297337|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297338|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297339|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83297340|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83297341|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
83297342|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
83297343|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83297344|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83297345|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83297346|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297347|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297348|NCT03878316|Oxytocin|oxytocin|mesh-list
83297349|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
83297350|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83297351|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297352|NCT03854929|Azithromycin|azithromycin|mesh-list
83297353|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
83297354|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83297355|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297356|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83297357|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83297358|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297359|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297360|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297361|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83297362|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83297363|NCT03852628|Naltrexone|naltrexone|mesh-list
83297364|NCT03852628|Buprenorphine|buprenorphine|mesh-list
83297365|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83297366|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83297367|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297368|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
83297369|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297370|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83297371|NCT03852628|Narcotics|narcotics|mesh-ancestor
83297372|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83297373|NCT03852628|Analgesics|analgesics|mesh-ancestor
83297374|NCT03836261|Venetoclax|venetoclax|mesh-list
83297375|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
83297376|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
83297377|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297378|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297379|NCT03826524|Epinephrine|epinephrine|mesh-list
83297380|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83297381|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83297382|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
83297383|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297384|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297385|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297386|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83297387|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83297388|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
83297389|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297390|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83297391|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
83297392|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
83297393|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
83297394|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83297395|NCT03798678|Dexamethasone|dexamethasone|mesh-list
83297396|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
83297397|NCT03798678|Ichthammol|ichthammol|mesh-list
83297398|NCT03798678|BB 1101|bb 1101|mesh-list
83297399|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297400|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
83297401|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
83297402|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297403|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297404|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297405|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
83297406|NCT03798678|Hormones|hormones|mesh-ancestor
83297407|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297408|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297409|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297410|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297411|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297412|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297413|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297414|NCT03770260|Ixazomib|ixazomib|mesh-list
83297415|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83297416|NCT03770260|Pevonedistat|pevonedistat|mesh-list
83297417|NCT03770260|Glycine|glycine|mesh-list
83297418|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297419|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297420|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297421|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
83297422|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297423|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297424|NCT03741426|Durvalumab|durvalumab|mesh-list
83297425|NCT03741426|Olaparib|olaparib|mesh-list
83297426|NCT03741426|Cediranib|cediranib|mesh-list
83297427|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297428|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297429|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83297430|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297431|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297432|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297433|NCT03727776|Hormones|hormones|mesh-list
83297434|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83297435|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83297436|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
83297437|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297438|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297439|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297440|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297441|NCT03698162|Bevacizumab|bevacizumab|mesh-list
83297442|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297443|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297444|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83297445|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83297446|NCT03698162|Growth Substances|growth substances|mesh-ancestor
83297447|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297448|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
83297449|NCT03623633|Denosumab|denosumab|mesh-list
83297450|NCT03623633|Alendronate|alendronate|mesh-list
83297451|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83297452|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83297453|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297454|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83297455|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
83297456|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297457|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83297458|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83297459|NCT03603808|Vaccines|vaccines|mesh-list
83297460|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
83297461|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297462|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83297463|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83297464|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297465|NCT03554174|Psilocybin|psilocybin|mesh-list
83297466|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
83297467|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297468|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83297469|NCT03508440|Prednisone|prednisone|mesh-list
83297470|NCT03508440|Prednisolone|prednisolone|mesh-list
83297471|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297472|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
83297473|NCT03508440|Hormones|hormones|mesh-ancestor
83297474|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297475|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297476|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297477|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297478|NCT03474107|Paclitaxel|paclitaxel|mesh-list
83297479|NCT03474107|Docetaxel|docetaxel|mesh-list
83297480|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83297481|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297482|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297483|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297484|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297485|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297486|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83297487|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297488|NCT03422861|Nabilone|nabilone|mesh-list
83297489|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
83297490|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
83297491|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297492|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297493|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297494|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83297495|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83297496|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83297497|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83362248|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362249|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362250|NCT04973566|Analgesics|analgesics|mesh-ancestor
83362251|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
83362252|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362253|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362254|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362255|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362256|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297498|NCT03421496|Cannabidiol|cannabidiol|mesh-list
83297499|NCT03421496|Vigabatrin|vigabatrin|mesh-list
83297500|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
83297501|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297502|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297503|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
83297504|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297505|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297506|NCT03421353|Paclitaxel|paclitaxel|mesh-list
83297507|NCT03421353|Carboplatin|carboplatin|mesh-list
83297508|NCT03421353|Gemcitabine|gemcitabine|mesh-list
83297509|NCT03421353|Durvalumab|durvalumab|mesh-list
83297510|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83297511|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297512|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297513|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297514|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297515|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297516|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297517|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
83297518|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297519|NCT03401320|Letrozole|letrozole|mesh-list
83297520|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297521|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83297522|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83297523|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297524|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297525|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83297526|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
83297527|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297528|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297529|NCT03374085|Dexamethasone|dexamethasone|mesh-list
83297530|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297531|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
83297532|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
83297533|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297534|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297535|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297536|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
83297537|NCT03374085|Hormones|hormones|mesh-ancestor
83297538|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297539|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297540|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297541|NCT03328026|Interferons|interferons|mesh-list
83297542|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
83297543|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297544|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
83297545|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297546|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297547|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83297548|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
83297549|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297550|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297551|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83297552|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
83297553|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297554|NCT03278106|Trifluridine|trifluridine|mesh-list
83297555|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
83297556|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297557|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
83297558|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297559|NCT03255252|Cisplatin|cisplatin|mesh-list
83297560|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297561|NCT03203525|Leucovorin|leucovorin|mesh-list
83297562|NCT03203525|Sirolimus|sirolimus|mesh-list
83297563|NCT03203525|Bevacizumab|bevacizumab|mesh-list
83297564|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83297565|NCT03203525|Doxorubicin|doxorubicin|mesh-list
83297566|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83297567|NCT03203525|Fluorouracil|fluorouracil|mesh-list
83297568|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
83297569|NCT03203525|Temsirolimus|temsirolimus|mesh-list
83297570|NCT03203525|MTOR Inhibitors|mtor inhibitors|mesh-list
83297571|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
83297572|NCT03203525|Antibodies|antibodies|mesh-list
83297573|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
83297574|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83297575|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
83297576|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297577|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83297578|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83297579|NCT03203525|Growth Substances|growth substances|mesh-ancestor
83297580|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297581|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
83297582|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
83297583|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83297584|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83297585|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83297586|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297587|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297588|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
83297589|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297590|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297591|NCT03203525|Antidotes|antidotes|mesh-ancestor
83297592|NCT03203525|Protective Agents|protective agents|mesh-ancestor
83297593|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
83297594|NCT03203525|Vitamins|vitamins|mesh-ancestor
83297595|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
83297596|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83297597|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297598|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
83297599|NCT03203525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297600|NCT03192215|Aspirin|aspirin|mesh-list
83297601|NCT03192215|Apixaban|apixaban|mesh-list
83297602|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83297603|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83297604|NCT03192215|Analgesics|analgesics|mesh-ancestor
83297605|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
83297606|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297607|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297608|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297609|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297610|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83297611|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83297612|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297613|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83297614|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83297615|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297616|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
83297617|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83297618|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
83297619|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83297620|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297621|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
83297622|NCT03182907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83297623|NCT03182907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297625|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
83297626|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
83297627|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297628|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297629|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297630|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83297631|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83297632|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83297633|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83297634|NCT03118986|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83297635|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83297636|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83297637|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297638|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297639|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
83297640|NCT03052608|Crizotinib|crizotinib|mesh-list
83297641|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297642|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297643|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297644|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297645|NCT03031730|Dexamethasone|dexamethasone|mesh-list
83297646|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
83297647|NCT03031730|Lenalidomide|lenalidomide|mesh-list
83297648|NCT03031730|Ichthammol|ichthammol|mesh-list
83297649|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83297650|NCT03031730|BB 1101|bb 1101|mesh-list
83362257|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
83297651|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297652|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
83297653|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
83297654|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297655|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297656|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297657|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
83297658|NCT03031730|Hormones|hormones|mesh-ancestor
83297659|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297660|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297661|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297662|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297663|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297664|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297665|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
83297666|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83297667|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83297668|NCT03031730|Growth Substances|growth substances|mesh-ancestor
83297669|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
83297670|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297671|NCT03004443|Infliximab|infliximab|mesh-list
83297672|NCT03004443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83297673|NCT03004443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297674|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297675|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297676|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297677|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83297678|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83297679|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
83297680|NCT02883049|Leucovorin|leucovorin|mesh-list
83297681|NCT02883049|Folic Acid|folic acid|mesh-list
83297682|NCT02883049|Cytarabine|cytarabine|mesh-list
83297683|NCT02883049|Dexamethasone|dexamethasone|mesh-list
83297684|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
83297685|NCT02883049|Prednisone|prednisone|mesh-list
83297686|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
83297687|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83297688|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83297689|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83297690|NCT02883049|Cortisone|cortisone|mesh-list
83297691|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
83297692|NCT02883049|Doxorubicin|doxorubicin|mesh-list
83297693|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83297694|NCT02883049|Methotrexate|methotrexate|mesh-list
83297695|NCT02883049|Etoposide|etoposide|mesh-list
83297696|NCT02883049|Vincristine|vincristine|mesh-list
83297697|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
83297698|NCT02883049|Daunorubicin|daunorubicin|mesh-list
83297699|NCT02883049|Asparaginase|asparaginase|mesh-list
83297700|NCT02883049|Dasatinib|dasatinib|mesh-list
83297701|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
83297702|NCT02883049|Clofarabine|clofarabine|mesh-list
83297703|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
83297704|NCT02883049|Pegaspargase|pegaspargase|mesh-list
83297705|NCT02883049|Thioguanine|thioguanine|mesh-list
83297706|NCT02883049|BB 1101|bb 1101|mesh-list
83297707|NCT02883049|Calcium|calcium|mesh-list
83297708|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
83297709|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
83297710|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297711|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
83297712|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297713|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297714|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83297715|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
83297716|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297717|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297718|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83297719|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297720|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
83297721|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
83297722|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297723|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297724|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
83297725|NCT02883049|Hormones|hormones|mesh-ancestor
83297726|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297727|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297728|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297729|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297730|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83362258|NCT04635826|Adderall|adderall|mesh-list
83297731|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83297732|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83297733|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83297734|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83297735|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83297736|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
83297737|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83297738|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297739|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
83297740|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297741|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83297742|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83297743|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83297744|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
83297745|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297746|NCT02883049|Antidotes|antidotes|mesh-ancestor
83297747|NCT02883049|Protective Agents|protective agents|mesh-ancestor
83297748|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
83297749|NCT02883049|Vitamins|vitamins|mesh-ancestor
83297750|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
83297751|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297752|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297753|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297754|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297755|NCT02883049|Hematinics|hematinics|mesh-ancestor
83297756|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
83297757|NCT02865018|Cetirizine|cetirizine|mesh-list
83297758|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83297759|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83297760|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83297761|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
83297762|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
83297763|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297764|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297765|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297766|NCT02795143|Isotretinoin|isotretinoin|mesh-list
83297767|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297768|NCT02790736|Propranolol|propranolol|mesh-list
83297769|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83297770|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83297771|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
83297772|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297773|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297774|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297775|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83297776|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83297777|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
83297779|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83297780|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83297781|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
83297782|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83297783|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297784|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
83297785|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
83297786|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297787|NCT02704208|Nicotine|nicotine|mesh-list
83297788|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83297789|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
83297790|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297791|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297792|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83297793|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83297794|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
83297795|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83297796|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297797|NCT02553460|Leucovorin|leucovorin|mesh-list
83297798|NCT02553460|Cytarabine|cytarabine|mesh-list
83297799|NCT02553460|Dexamethasone|dexamethasone|mesh-list
83297800|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
83297801|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
83297802|NCT02553460|Methotrexate|methotrexate|mesh-list
83297803|NCT02553460|Etoposide|etoposide|mesh-list
83297804|NCT02553460|Vincristine|vincristine|mesh-list
83297805|NCT02553460|Bortezomib|bortezomib|mesh-list
83297806|NCT02553460|Asparaginase|asparaginase|mesh-list
83297807|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
83297808|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
83297809|NCT02553460|Vorinostat|vorinostat|mesh-list
83297810|NCT02553460|Pegaspargase|pegaspargase|mesh-list
83297811|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
83297812|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297813|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
83297814|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297815|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297816|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83297817|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
83297818|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297819|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297820|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83297821|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297822|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
83297823|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
83297824|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297825|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297826|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
83297827|NCT02553460|Hormones|hormones|mesh-ancestor
83297828|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297829|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297830|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83297831|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
83297832|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83297833|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297834|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
83297835|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297836|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297837|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83297838|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83297839|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83297840|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83297841|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83297842|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
83297843|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297844|NCT02553460|Antidotes|antidotes|mesh-ancestor
83297845|NCT02553460|Protective Agents|protective agents|mesh-ancestor
83297846|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
83297848|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
83297849|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297850|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297851|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297852|NCT02553460|Analgesics|analgesics|mesh-ancestor
83297853|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
83297854|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83297855|NCT02530034|Antibodies|antibodies|mesh-list
83297856|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83297857|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
83297858|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297859|NCT02516670|Vitamins|vitamins|mesh-list
83297860|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
83297861|NCT02516670|Docetaxel|docetaxel|mesh-list
83297862|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
83297863|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297864|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297865|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297866|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297867|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297868|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297869|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
83297870|NCT02516670|Protective Agents|protective agents|mesh-ancestor
83297871|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83297872|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83297873|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83297874|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297875|NCT02315326|Rituximab|rituximab|mesh-list
83297876|NCT02315326|Methotrexate|methotrexate|mesh-list
83297877|NCT02315326|Procarbazine|procarbazine|mesh-list
83297878|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297879|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297880|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
83297881|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297882|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297883|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83297884|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
83297885|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83297886|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297888|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297889|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297890|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297891|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83297892|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297893|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83297894|NCT02288247|Prednisolone|prednisolone|mesh-list
83297895|NCT02288247|Docetaxel|docetaxel|mesh-list
83297896|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297897|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
83297898|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
83297899|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
83297900|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297901|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297902|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
83297903|NCT02288247|Hormones|hormones|mesh-ancestor
83297904|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297905|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297906|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297907|NCT02280525|Cytarabine|cytarabine|mesh-list
83297908|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
83297909|NCT02280525|Rituximab|rituximab|mesh-list
83297910|NCT02280525|Fludarabine|fludarabine|mesh-list
83297911|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
83297912|NCT02280525|Lenalidomide|lenalidomide|mesh-list
83297913|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83297914|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
83297915|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297916|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83297917|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83297918|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
83430133|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83297919|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297920|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297921|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83297922|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297923|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83297925|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
83297926|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297927|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83297928|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83297929|NCT02280525|Growth Substances|growth substances|mesh-ancestor
83297930|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
83297931|NCT02157883|Itraconazole|itraconazole|mesh-list
83297932|NCT02157883|Osimertinib|osimertinib|mesh-list
83297933|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
83297934|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83297935|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83297936|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83297937|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297938|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297939|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83297940|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
83297941|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297942|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297943|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83297944|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297945|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297946|NCT02101944|Dexamethasone|dexamethasone|mesh-list
83297947|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
83297948|NCT02101944|Ichthammol|ichthammol|mesh-list
83297949|NCT02101944|BB 1101|bb 1101|mesh-list
83297950|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297951|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
83297952|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
83297953|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83297954|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297955|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83297956|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
83297957|NCT02101944|Hormones|hormones|mesh-ancestor
83297958|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297959|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297960|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297961|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
83297962|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297963|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297964|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
83297965|NCT02091141|Trastuzumab|trastuzumab|mesh-list
83297966|NCT02091141|Atezolizumab|atezolizumab|mesh-list
83297967|NCT02091141|Pertuzumab|pertuzumab|mesh-list
83297968|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83297969|NCT02091141|Vemurafenib|vemurafenib|mesh-list
83297970|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83297971|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297972|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297973|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297974|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297975|NCT02091141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83297976|NCT02066181|Sorafenib|sorafenib|mesh-list
83297977|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297978|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297979|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297980|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297981|NCT01972217|Prednisone|prednisone|mesh-list
83297982|NCT01972217|Prednisolone|prednisolone|mesh-list
83297983|NCT01972217|Olaparib|olaparib|mesh-list
83297984|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83297985|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
83297986|NCT01972217|Hormones|hormones|mesh-ancestor
83297987|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83297988|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83297989|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83297990|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297991|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83297992|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297993|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297994|NCT01970865|Crizotinib|crizotinib|mesh-list
83297995|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83297996|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83297997|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83297998|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83297999|NCT01928576|Nivolumab|nivolumab|mesh-list
83298000|NCT01928576|Azacitidine|azacitidine|mesh-list
83298001|NCT01928576|Entinostat|entinostat|mesh-list
83298002|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83298003|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298004|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83298005|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298006|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298007|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
83298008|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298009|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83298010|NCT01869114|Sirolimus|sirolimus|mesh-list
83298011|NCT01869114|Azacitidine|azacitidine|mesh-list
83298012|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298013|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
83298014|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298015|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298016|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298017|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83298018|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298019|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83298020|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
83298021|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298022|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
83298023|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298024|NCT01843751|Buprenorphine|buprenorphine|mesh-list
83298025|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83298026|NCT01843751|Naloxone|naloxone|mesh-list
83298027|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83298028|NCT01843751|Narcotics|narcotics|mesh-ancestor
83298029|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298030|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298031|NCT01843751|Analgesics|analgesics|mesh-ancestor
83298032|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
83298033|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298034|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83298035|NCT01756248|Aflibercept|aflibercept|mesh-list
83298036|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83298037|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83298038|NCT01756248|Growth Substances|growth substances|mesh-ancestor
83298039|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298040|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
83298041|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298042|NCT01744652|Dasatinib|dasatinib|mesh-list
83298043|NCT01744652|Crizotinib|crizotinib|mesh-list
83298044|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298045|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298046|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298047|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298048|NCT01711541|Paclitaxel|paclitaxel|mesh-list
83298049|NCT01711541|Cisplatin|cisplatin|mesh-list
83298050|NCT01711541|Carboplatin|carboplatin|mesh-list
83298051|NCT01711541|Fluorouracil|fluorouracil|mesh-list
83298052|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83298053|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
83298054|NCT01711541|Veliparib|veliparib|mesh-list
83298055|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83298056|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298057|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
83298058|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
83298059|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298060|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298061|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
83298062|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298063|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298064|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
83298065|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298066|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
83298067|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298068|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83298069|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83298070|NCT01500551|Tofacitinib|tofacitinib|mesh-list
83298071|NCT01500551|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83298072|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298073|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298074|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298075|NCT01370512|Droxidopa|droxidopa|mesh-list
83298076|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83298077|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83298078|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83298079|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83298080|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298081|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298082|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
83298083|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298084|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298085|NCT01294020|Tacrolimus|tacrolimus|mesh-list
83298086|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298087|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
83298088|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298089|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83298090|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298091|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298092|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83298093|NCT00215813|Poly I-C|poly i-c|mesh-list
83298094|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
83298095|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298096|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
83298097|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
83298098|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298099|NCT00179465|Tiagabine|tiagabine|mesh-list
83298100|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
83298101|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83298102|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298103|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298104|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83298105|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
83298106|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83298107|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83298108|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298109|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298110|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
83298111|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298112|NCT00134030|Interferons|interferons|mesh-list
83298113|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
83298114|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
83298115|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83298116|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83298117|NCT00134030|Cisplatin|cisplatin|mesh-list
83298118|NCT00134030|Doxorubicin|doxorubicin|mesh-list
83298119|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83298120|NCT00134030|Methotrexate|methotrexate|mesh-list
83298121|NCT00134030|Etoposide|etoposide|mesh-list
83298122|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
83298123|NCT00134030|Ifosfamide|ifosfamide|mesh-list
83298124|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
83298125|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
83298126|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298127|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83298128|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83298129|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83298130|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298131|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298132|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83298133|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
83298134|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83298135|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298136|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298137|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
83298138|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
83298139|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83298140|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298141|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
83298142|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83298143|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83298144|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83298145|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
83298146|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298147|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83298148|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
83298149|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
83298150|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
83298151|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
83298152|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298153|NCT00114101|Lenalidomide|lenalidomide|mesh-list
83298154|NCT00114101|Melphalan|melphalan|mesh-list
83298155|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
83298156|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83298157|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
83298158|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298159|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83298160|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83298161|NCT00114101|Growth Substances|growth substances|mesh-ancestor
83298162|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
83298163|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298164|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83298165|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
83298166|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298167|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83298168|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298169|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
83298170|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83298171|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83298172|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298173|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
83298174|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
83298175|NCT01381900|Metformin|metformin|mesh-list
83298176|NCT01381900|Canagliflozin|canagliflozin|mesh-list
83298177|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83298178|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298179|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83298180|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298181|NCT01744197|Lidocaine|lidocaine|mesh-list
83298182|NCT01744197|Tetracaine|tetracaine|mesh-list
83298183|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
83298184|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
83298185|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298186|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298187|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
83298188|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298189|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83298190|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83298191|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83298192|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298193|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298195|NCT04565301|Neostigmine|neostigmine|mesh-list
83298196|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83298197|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
83298198|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
83298199|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298200|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298201|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298202|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
83298203|NCT04565301|Hormones|hormones|mesh-ancestor
83298204|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298205|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83298206|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298207|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83298208|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298209|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298210|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
83298211|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298212|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83298213|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83298214|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83298215|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83298216|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83298217|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83298218|NCT01743027|Analgesics|analgesics|mesh-ancestor
83298219|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
83298220|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298221|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298222|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83298223|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83298224|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83298225|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83298226|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83298227|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
83298228|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
83298229|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298230|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298231|NCT01380730|Evolocumab|evolocumab|mesh-list
83298232|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83298233|NCT01380730|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83298234|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83298235|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83298236|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
83298237|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298238|NCT01380730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83298239|NCT01380730|Protease Inhibitors|protease inhibitors|mesh-ancestor
83298240|NCT01380730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298241|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83298242|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
83298243|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298244|NCT04010968|Venetoclax|venetoclax|mesh-list
83298245|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298246|NCT01395784|Pioglitazone|pioglitazone|mesh-list
83298247|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83298248|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298249|NCT01380184|Sirolimus|sirolimus|mesh-list
83298250|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83298251|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298252|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83298253|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298254|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
83298255|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298256|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
83298257|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298258|NCT00002826|Paclitaxel|paclitaxel|mesh-list
83298259|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83298260|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298261|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
83298263|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298264|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298265|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
83298266|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83298267|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298268|NCT04331938|Anesthetics|anesthetics|mesh-list
83298269|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298270|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298271|NCT01731951|Imetelstat|imetelstat|mesh-list
83298272|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
83298273|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413611|NCT01307605|Lenalidomide|lenalidomide|mesh-list
83298274|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298275|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298276|NCT01741545|Interferons|interferons|mesh-list
83298277|NCT01741545|Ribavirin|ribavirin|mesh-list
83298278|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298279|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
83298280|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298281|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
83298282|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298283|NCT01884350|Apixaban|apixaban|mesh-list
83298284|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83298285|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
83298286|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83298287|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
83298288|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298289|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298290|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
83298291|NCT01614795|Sirolimus|sirolimus|mesh-list
83298292|NCT01614795|Temsirolimus|temsirolimus|mesh-list
83298293|NCT01614795|MTOR Inhibitors|mtor inhibitors|mesh-list
83298294|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83298295|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83298296|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298297|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83298298|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298299|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
83298300|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298301|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
83298302|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298303|NCT01614795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298304|NCT01614795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298305|NCT01614795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298306|NCT01834586|Anesthetics|anesthetics|mesh-list
83298307|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298308|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298309|NCT01614093|Oxytocin|oxytocin|mesh-list
83298310|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
83298311|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83298312|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298313|NCT04559607|Apatinib|apatinib|mesh-list
83298314|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298315|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298316|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298317|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298318|NCT01834274|Metformin|metformin|mesh-list
83298319|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83298320|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83298321|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298322|NCT01834274|Incretins|incretins|mesh-ancestor
83298323|NCT01834274|Hormones|hormones|mesh-ancestor
83298324|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298325|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83298326|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
83298327|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298328|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298329|NCT01739595|Enclomiphene|enclomiphene|mesh-list
83298330|NCT01739595|Clomiphene|clomiphene|mesh-list
83298331|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
83298332|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83298333|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
83430134|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83298334|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298335|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298336|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83298337|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
83298338|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83298339|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83298340|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83298341|NCT01738971|Progestins|progestins|mesh-list
83298342|NCT01738971|Hormones|hormones|mesh-ancestor
83298343|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298344|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298345|NCT01738503|Buprenorphine|buprenorphine|mesh-list
83298346|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83298347|NCT01738503|Narcotics|narcotics|mesh-ancestor
83298348|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298349|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298350|NCT01738503|Analgesics|analgesics|mesh-ancestor
83298351|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
83298352|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298353|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83298354|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83298355|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83298356|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83298357|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298358|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298359|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
83298360|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298361|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298362|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
83298363|NCT01737879|Hematinics|hematinics|mesh-ancestor
83298364|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
83298365|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83298366|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298367|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298368|NCT01726335|Risperidone|risperidone|mesh-list
83298369|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83298370|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
83298371|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298372|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298373|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298374|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83298375|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83298376|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298377|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83298378|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83298379|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
83298380|NCT01726023|Metronidazole|metronidazole|mesh-list
83298381|NCT01726023|Meropenem|meropenem|mesh-list
83298382|NCT01726023|Ceftazidime|ceftazidime|mesh-list
83298383|NCT01726023|Avibactam|avibactam|mesh-list
83298384|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83298385|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298386|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83298387|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83298388|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83298389|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83298390|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298391|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298392|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
83298393|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298394|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
83298395|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83298396|NCT04609761|Antibodies|antibodies|mesh-list
83298397|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
83298398|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83298399|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
83298400|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298401|NCT01858532|Atrasentan|atrasentan|mesh-list
83298402|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298403|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83298404|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83298405|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298407|NCT04613960|Analgesics|analgesics|mesh-ancestor
83298408|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
83298409|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298410|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298411|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
83298412|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298413|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83298414|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
83298415|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83298416|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298417|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298418|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83298419|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
83298420|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83298421|NCT04599140|Nivolumab|nivolumab|mesh-list
83298422|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83298423|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298424|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83298425|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298426|NCT01857206|Vaccines|vaccines|mesh-list
83298427|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
83298428|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298429|NCT01882088|Psyllium|psyllium|mesh-list
83298430|NCT01882088|Cathartics|cathartics|mesh-ancestor
83298431|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298432|NCT01722669|Quercetin|quercetin|mesh-list
83298433|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
83298434|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298435|NCT01722669|Protective Agents|protective agents|mesh-ancestor
83298436|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298437|NCT01707147|Linagliptin|linagliptin|mesh-list
83298438|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83298439|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298440|NCT01707147|Incretins|incretins|mesh-ancestor
83298441|NCT01707147|Hormones|hormones|mesh-ancestor
83298442|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298443|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83298444|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83298445|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298446|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298447|NCT01876251|Docetaxel|docetaxel|mesh-list
83298448|NCT01876251|Nirogacestat|nirogacestat|mesh-list
83298449|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298450|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
83298451|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
83298452|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298453|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298454|NCT01876251|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83298455|NCT01876251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298456|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
83298457|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83298458|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83298459|NCT01875237|Prednisolone|prednisolone|mesh-list
83298460|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
83298461|NCT01875237|Methotrexate|methotrexate|mesh-list
83298462|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
83298463|NCT01875237|Fludarabine|fludarabine|mesh-list
83298464|NCT01875237|Melphalan|melphalan|mesh-list
83298465|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
83298466|NCT01875237|Tacrolimus|tacrolimus|mesh-list
83298467|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83298468|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
83298469|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83298470|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
83298471|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83298472|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298473|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298474|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
83298475|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298476|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298477|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
83298478|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298479|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83298480|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298481|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
83298482|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83298483|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83298484|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83298485|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83298486|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
83298487|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
83298488|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298489|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298490|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
83298491|NCT01875237|Hormones|hormones|mesh-ancestor
83298492|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298493|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83298494|NCT01875237|Protective Agents|protective agents|mesh-ancestor
83298495|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83298496|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83298497|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
83298498|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83298499|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83298500|NCT01874535|Esomeprazole|esomeprazole|mesh-list
83298501|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83298502|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298503|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83298504|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298505|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298506|NCT01722045|Aflibercept|aflibercept|mesh-list
83298507|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83298508|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83298509|NCT01722045|Growth Substances|growth substances|mesh-ancestor
83298510|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298511|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
83298512|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298513|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83298514|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83298515|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83298516|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
83298517|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298518|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
83298519|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
83298520|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83298521|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
83298522|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298523|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298524|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83298525|NCT04415385|Apatinib|apatinib|mesh-list
83298526|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298527|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298528|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298529|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298530|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
83298531|NCT01720797|Anesthetics|anesthetics|mesh-list
83298532|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
83298533|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298534|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298535|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83298536|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298537|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
83298538|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
83298539|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298540|NCT01831466|Tofacitinib|tofacitinib|mesh-list
83298541|NCT01831466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83298542|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298543|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298544|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298545|NCT01881230|Paclitaxel|paclitaxel|mesh-list
83298546|NCT01881230|Carboplatin|carboplatin|mesh-list
83298547|NCT01881230|Gemcitabine|gemcitabine|mesh-list
83298548|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83298549|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298550|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83298551|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83298552|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298553|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298554|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298555|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
83298556|NCT01856114|Fentanyl|fentanyl|mesh-list
83298557|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83298558|NCT01856114|Narcotics|narcotics|mesh-ancestor
83298559|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298560|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298561|NCT01856114|Analgesics|analgesics|mesh-ancestor
83298562|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
83298563|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298564|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83298565|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83298566|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
83298567|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
83298568|NCT01614470|Ivacaftor|ivacaftor|mesh-list
83298569|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83298570|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298571|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298572|NCT01880528|Lisinopril|lisinopril|mesh-list
83298573|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83298574|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
83298575|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298576|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298577|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83298578|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83298579|NCT01880528|Protective Agents|protective agents|mesh-ancestor
83298580|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298581|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
83298582|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
83298583|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298584|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298585|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298586|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
83298587|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
83298588|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
83298589|NCT01854710|Loxapine|loxapine|mesh-list
83298590|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83298591|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298592|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83298593|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83298594|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298595|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298596|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298597|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298598|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83298599|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83298600|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298601|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83298602|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83298603|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
83298604|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298605|NCT01828034|Gemcitabine|gemcitabine|mesh-list
83298606|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298607|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298608|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
83298609|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298610|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83298611|NCT01853696|Prednisolone|prednisolone|mesh-list
83298612|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83298613|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
83298614|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83298615|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
83298616|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83298617|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
83298618|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83298619|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
83298620|NCT01853696|Hormones|hormones|mesh-ancestor
83298621|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298622|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298623|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83298624|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298625|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
83298626|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
83298627|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298628|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298629|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83298630|NCT01853696|Protective Agents|protective agents|mesh-ancestor
83298631|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83298632|NCT01719861|Desipramine|desipramine|mesh-list
83298633|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83298634|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
83298635|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83298636|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298637|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298638|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83298639|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83298640|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298641|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
83298642|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298643|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298644|NCT01853618|Tremelimumab|tremelimumab|mesh-list
83298645|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298646|NCT01719783|Vaccines|vaccines|mesh-list
83298647|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
83298648|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298649|NCT01878890|Efavirenz|efavirenz|mesh-list
83298650|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83298651|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83298652|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298653|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298654|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
83298655|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298656|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83298657|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83298658|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83298659|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83298660|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83298661|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83298662|NCT01827332|Oxytocin|oxytocin|mesh-list
83298663|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
83298664|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83298665|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298666|NCT01719003|Metformin|metformin|mesh-list
83298667|NCT01719003|Empagliflozin|empagliflozin|mesh-list
83298668|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83298669|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298670|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83298671|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298672|NCT01853228|Cytarabine|cytarabine|mesh-list
83298673|NCT01853228|Decitabine|decitabine|mesh-list
83298674|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298675|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
83298676|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298677|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298678|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
83298679|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298680|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298681|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
83298682|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298683|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298684|NCT01705587|Teriparatide|teriparatide|mesh-list
83298685|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83298686|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298687|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83298688|NCT01705509|Ranolazine|ranolazine|mesh-list
83298689|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83298690|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298691|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298692|NCT01853072|Prednisolone|prednisolone|mesh-list
83298693|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83298694|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
83298695|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83298696|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
83298697|NCT01853072|Nepafenac|nepafenac|mesh-list
83298698|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83298699|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
83298700|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83298701|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
83298702|NCT01853072|Hormones|hormones|mesh-ancestor
83298703|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298704|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298705|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83298706|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298707|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
83298708|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
83298709|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298710|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298711|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83298712|NCT01853072|Protective Agents|protective agents|mesh-ancestor
83298713|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83298714|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83298716|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
83298717|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83298718|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
83298719|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83298720|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83298721|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
83298722|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298723|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83298724|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83298725|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298726|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298727|NCT04605393|Dronabinol|dronabinol|mesh-list
83298728|NCT04605393|Cannabidiol|cannabidiol|mesh-list
83298729|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
83298730|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
83298731|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298732|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83298733|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83298734|NCT04605393|Analgesics|analgesics|mesh-ancestor
83298735|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
83298736|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298737|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83298738|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83298739|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298740|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298741|NCT04605393|Hormones|hormones|mesh-ancestor
83298742|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298743|NCT01827254|Sunitinib|sunitinib|mesh-list
83298744|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298745|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83298746|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83298747|NCT01827254|Growth Substances|growth substances|mesh-ancestor
83298748|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298749|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
83298750|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298751|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298752|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298753|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83298754|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
83298755|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83298756|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83298757|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298758|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298759|NCT01704651|Alvimopan|alvimopan|mesh-list
83298760|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298761|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83298762|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298763|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83298764|NCT01876082|Methotrexate|methotrexate|mesh-list
83298765|NCT01876082|Vinblastine|vinblastine|mesh-list
83298766|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83298767|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
83298768|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83298769|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298770|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298771|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
83298772|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298773|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298774|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
83298775|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298776|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83298777|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298778|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
83298779|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83298780|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83298781|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83298783|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
83298784|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298785|NCT01716585|Ribavirin|ribavirin|mesh-list
83298786|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
83298787|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298788|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
83298789|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298790|NCT01852292|Paclitaxel|paclitaxel|mesh-list
83298791|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83298792|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298793|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
83298794|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
83298795|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298796|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298797|NCT01715805|Cariprazine|cariprazine|mesh-list
83298798|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
83298799|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83298800|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83298801|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83298802|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298803|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298804|NCT01852214|Ticagrelor|ticagrelor|mesh-list
83298805|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83298806|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83298807|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83298808|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83298809|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83298810|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
83298811|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298812|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298813|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298814|NCT04594772|Paclitaxel|paclitaxel|mesh-list
83298815|NCT04594772|Gemcitabine|gemcitabine|mesh-list
83298816|NCT04594772|Fluorouracil|fluorouracil|mesh-list
83298817|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
83298818|NCT04594772|Irinotecan|irinotecan|mesh-list
83298819|NCT04594772|Folfirinox|folfirinox|mesh-list
83298820|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83298821|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298822|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83298823|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83298824|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83298825|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298826|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298827|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
83298828|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298829|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
83298830|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298831|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83298832|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83298833|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298834|NCT01393990|Tamoxifen|tamoxifen|mesh-list
83298835|NCT01393990|Midazolam|midazolam|mesh-list
83298836|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83298837|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83298838|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298839|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298840|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83298841|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83298842|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83298843|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83298844|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
83298845|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
83298846|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
83298847|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
83298848|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298849|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298850|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83298851|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
83298852|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298853|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83298854|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298855|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83298856|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83298857|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83298858|NCT00210184|Leucovorin|leucovorin|mesh-list
83298859|NCT00210184|Fluorouracil|fluorouracil|mesh-list
83298860|NCT00210184|Irinotecan|irinotecan|mesh-list
83298861|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
83298862|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298863|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83298864|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298865|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298866|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
83298867|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298868|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83298869|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83298870|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298871|NCT00210184|Antidotes|antidotes|mesh-ancestor
83298872|NCT00210184|Protective Agents|protective agents|mesh-ancestor
83298873|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
83298874|NCT00210184|Vitamins|vitamins|mesh-ancestor
83298875|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
83298876|NCT05364190|Empagliflozin|empagliflozin|mesh-list
83298877|NCT05364190|Canagliflozin|canagliflozin|mesh-list
83298878|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83298879|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298880|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83298881|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298882|NCT00210964|Linezolid|linezolid|mesh-list
83298883|NCT00210964|Ceftazidime|ceftazidime|mesh-list
83298884|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
83298885|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83298886|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83298887|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298888|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83298889|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298890|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298891|NCT03997786|Etanercept|etanercept|mesh-list
83298892|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83298893|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83298894|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83298895|NCT03997786|Analgesics|analgesics|mesh-ancestor
83298896|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
83298897|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298898|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298899|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83298900|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83298901|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83298902|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83298903|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
83298904|NCT05630638|Dolutegravir|dolutegravir|mesh-list
83298905|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83298906|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83298907|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298908|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298910|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83298911|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
83298912|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298913|NCT03593434|Xenon|xenon|mesh-list
83298914|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83298915|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
83298916|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
83298917|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83298918|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298919|NCT03792958|Vorolanib|vorolanib|mesh-list
83298920|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83298921|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298922|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298923|NCT03789604|Antibodies|antibodies|mesh-list
83298924|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83298925|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
83298926|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298927|NCT03989362|Ipilimumab|ipilimumab|mesh-list
83298928|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83298929|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83298930|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83298931|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298932|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
83298933|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
83298934|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83298935|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
83298936|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83298937|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83298938|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298939|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83298940|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298941|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298942|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83298943|NCT04407130|Doxycycline|doxycycline|mesh-list
83298944|NCT04407130|Ivermectin|ivermectin|mesh-list
83298945|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83298946|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298947|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
83298948|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83298949|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83298950|NCT03599284|Clopidogrel|clopidogrel|mesh-list
83298951|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83298952|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83298953|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83298954|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83298955|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
83298956|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298957|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298958|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298959|NCT03024814|Acetaminophen|acetaminophen|mesh-list
83298960|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83298961|NCT03024814|Analgesics|analgesics|mesh-ancestor
83298962|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
83298963|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298964|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298965|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
83298966|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
83298967|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83298968|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83298969|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83298970|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83298971|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298972|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
83298973|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83298974|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298975|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83298976|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83298977|NCT03024502|Clotrimazole|clotrimazole|mesh-list
83298978|NCT03024502|Miconazole|miconazole|mesh-list
83298979|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83298980|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83298981|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
83298982|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83298983|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83298984|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83298985|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83298986|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83298987|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
83298988|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83298989|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83298990|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83298991|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83298992|NCT03024580|Tamoxifen|tamoxifen|mesh-list
83298993|NCT03024580|Letrozole|letrozole|mesh-list
83298994|NCT03024580|Fulvestrant|fulvestrant|mesh-list
83298995|NCT03024580|Anastrozole|anastrozole|mesh-list
83298996|NCT03024580|Exemestane|exemestane|mesh-list
83298997|NCT03024580|Megestrol|megestrol|mesh-list
83298998|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
83298999|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299000|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83299001|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83299002|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299003|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299004|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83299005|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
83299006|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299007|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299008|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299009|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83299010|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83299011|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83299012|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83299013|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83299014|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83299015|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83299016|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
83299017|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83299018|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83299019|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83299020|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
83299021|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83299022|NCT01851590|Terbinafine|terbinafine|mesh-list
83299023|NCT01851590|Amorolfine|amorolfine|mesh-list
83299024|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
83299025|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299026|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299027|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299028|NCT03598816|Durvalumab|durvalumab|mesh-list
83299029|NCT03598816|Tremelimumab|tremelimumab|mesh-list
83299030|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299031|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299032|NCT05633758|Metolazone|metolazone|mesh-list
83299033|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83299034|NCT05633758|Diuretics|diuretics|mesh-ancestor
83299035|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
83299036|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299037|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83299038|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83299039|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299040|NCT03978442|Bupropion|bupropion|mesh-list
83299041|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83299042|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
83299043|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83299044|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83299045|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83299046|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83299047|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299048|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
83299049|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299050|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299051|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83299052|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83299053|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299054|NCT03598738|Esomeprazole|esomeprazole|mesh-list
83299055|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83299056|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299057|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83299058|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299059|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299060|NCT03594214|Vitamin D|vitamin d|mesh-list
83299061|NCT03594214|Vitamins|vitamins|mesh-ancestor
83299062|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
83299063|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299064|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83299065|NCT04003948|Ibogaine|ibogaine|mesh-list
83299066|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
83299067|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299068|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83299069|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83299070|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83299071|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299072|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299073|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
83299074|NCT03598582|Hematinics|hematinics|mesh-ancestor
83299075|NCT03593668|Metformin|metformin|mesh-list
83299076|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83299077|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299078|NCT03598348|Capecitabine|capecitabine|mesh-list
83299079|NCT03598348|Apatinib|apatinib|mesh-list
83299080|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83299081|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
83299082|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299084|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83299085|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299086|NCT03976258|Naltrexone|naltrexone|mesh-list
83299087|NCT03976258|Buprenorphine|buprenorphine|mesh-list
83299088|NCT03976258|Methadone|methadone|mesh-list
83299089|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83299090|NCT03976258|Heroin|heroin|mesh-list
83299091|NCT03976258|Naloxone|naloxone|mesh-list
83299092|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83299093|NCT03976258|Narcotics|narcotics|mesh-ancestor
83299094|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299095|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299096|NCT03976258|Analgesics|analgesics|mesh-ancestor
83299097|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
83299098|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299099|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83299100|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83299101|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
83299102|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
83299103|NCT03598192|Sufentanil|sufentanil|mesh-list
83299104|NCT03598192|Dsuvia|dsuvia|mesh-list
83299105|NCT03598192|Ropivacaine|ropivacaine|mesh-list
83299106|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
83299107|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
83299108|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299109|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299110|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
83299111|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299112|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83299113|NCT03598192|Narcotics|narcotics|mesh-ancestor
83299114|NCT03598192|Analgesics|analgesics|mesh-ancestor
83299115|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83299116|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83299117|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
83299118|NCT04003246|Durvalumab|durvalumab|mesh-list
83299119|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83299120|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299121|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299122|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
83299123|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299124|NCT00218296|Lobeline|lobeline|mesh-list
83299125|NCT00218296|Nicotine|nicotine|mesh-list
83299126|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83299127|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
83299128|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299129|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299130|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83299131|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83299132|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
83299133|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299134|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299135|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
83299137|NCT00217672|Docetaxel|docetaxel|mesh-list
83299138|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299139|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299140|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83299141|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83299142|NCT00217672|Growth Substances|growth substances|mesh-ancestor
83299143|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299144|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
83299145|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
83299146|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
83299147|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
83299148|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299149|NCT00216736|Dexamethasone|dexamethasone|mesh-list
83299150|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299151|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
83299152|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
83299153|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299154|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299155|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299156|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
83299157|NCT00216736|Hormones|hormones|mesh-ancestor
83299158|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299159|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299160|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299161|NCT01850030|Progesterone|progesterone|mesh-list
83299162|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
83299163|NCT01850030|Progestins|progestins|mesh-ancestor
83299164|NCT01850030|Hormones|hormones|mesh-ancestor
83299165|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299166|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299167|NCT00215644|Capecitabine|capecitabine|mesh-list
83299168|NCT00215644|Epirubicin|epirubicin|mesh-list
83299169|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299170|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83299171|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
83299172|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299173|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83299174|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83299175|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83299176|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299177|NCT00213148|Anastrozole|anastrozole|mesh-list
83299178|NCT00213148|Citric Acid|citric acid|mesh-list
83299179|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
83299180|NCT00213148|Clomiphene|clomiphene|mesh-list
83299181|NCT00213148|Enclomiphene|enclomiphene|mesh-list
83299182|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
83299183|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
83299184|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83299185|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
83299186|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
83299187|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299188|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299189|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299190|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83299191|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83299192|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299193|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83299194|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
83299195|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299196|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299197|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83299198|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
83299199|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83299200|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83299201|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83299202|NCT01704261|Metformin|metformin|mesh-list
83299203|NCT01704261|Glimepiride|glimepiride|mesh-list
83299204|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83299205|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299206|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83299207|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83299208|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
83299209|NCT00212758|Hormones|hormones|mesh-list
83299210|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299211|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299212|NCT01824290|Tadalafil|tadalafil|mesh-list
83299213|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
83299214|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83299215|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83299216|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299217|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299218|NCT01824290|Urological Agents|urological agents|mesh-ancestor
83299219|NCT03592342|Clobetasol|clobetasol|mesh-list
83299220|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299221|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
83299222|NCT03592342|Hormones|hormones|mesh-ancestor
83299223|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299224|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299225|NCT01715415|Ribavirin|ribavirin|mesh-list
83299226|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
83299227|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299228|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
83299229|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299230|NCT00211510|Insulin|insulin|mesh-list
83299231|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83299232|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299233|NCT04198636|Denosumab|denosumab|mesh-list
83299234|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83299235|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299236|NCT04414995|Acetaminophen|acetaminophen|mesh-list
83299237|NCT04414995|Ibuprofen|ibuprofen|mesh-list
83299238|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83299239|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83299240|NCT04414995|Analgesics|analgesics|mesh-ancestor
83299241|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
83299242|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299243|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299244|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299245|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83299246|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83299247|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299248|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299249|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
83299250|NCT01869699|Acetaminophen|acetaminophen|mesh-list
83299251|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83299252|NCT01869699|Analgesics|analgesics|mesh-ancestor
83299253|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
83299254|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299255|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299256|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
83299257|NCT03981796|Paclitaxel|paclitaxel|mesh-list
83299258|NCT03981796|Carboplatin|carboplatin|mesh-list
83299259|NCT03981796|Niraparib|niraparib|mesh-list
83299260|NCT03981796|Dostarlimab|dostarlimab|mesh-list
83299261|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83299262|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299263|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83299264|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83299265|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83299266|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299267|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83299268|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299269|NCT01875848|Buprenorphine|buprenorphine|mesh-list
83299270|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83299271|NCT01875848|Naloxone|naloxone|mesh-list
83299272|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83299273|NCT01875848|Narcotics|narcotics|mesh-ancestor
83299274|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299275|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299276|NCT01875848|Analgesics|analgesics|mesh-ancestor
83299277|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
83299278|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299279|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83299280|NCT03591172|Propolis|propolis|mesh-list
83299281|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299282|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83299283|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83299284|NCT04197622|Diuretics|diuretics|mesh-ancestor
83299285|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
83299286|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299287|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83299288|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83299289|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299290|NCT03595930|Fluticasone|fluticasone|mesh-list
83299291|NCT03595930|Xhance|xhance|mesh-list
83299292|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299293|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83299294|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
83299295|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299296|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299297|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83299298|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
83299299|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
83299300|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83299301|NCT03595852|Cefazolin|cefazolin|mesh-list
83299302|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83299303|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299304|NCT04191382|Letrozole|letrozole|mesh-list
83299305|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299306|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83299307|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83299308|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299309|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299310|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83299311|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
83299312|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299313|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299314|NCT01703091|Docetaxel|docetaxel|mesh-list
83299315|NCT01703091|Ramucirumab|ramucirumab|mesh-list
83299316|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299317|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
83299318|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
83299319|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
83299320|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299321|NCT04196998|Tenofovir|tenofovir|mesh-list
83299322|NCT04196998|Entecavir|entecavir|mesh-list
83299323|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
83299324|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299325|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83299326|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83299327|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299328|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299329|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83299330|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83299331|NCT04196452|Ipilimumab|ipilimumab|mesh-list
83299332|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299333|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299334|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83299335|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299336|NCT01867671|Immunomodulating Agents|immunomodulating agents|mesh-list
83299337|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
83299338|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299339|NCT03967054|Ivermectin|ivermectin|mesh-list
83299340|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83299341|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299342|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
83299343|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83299344|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299345|NCT04196608|Tazobactam|tazobactam|mesh-list
83299346|NCT04196608|Imipenem|imipenem|mesh-list
83299347|NCT04196608|Ceftolozane|ceftolozane|mesh-list
83299348|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83299349|NCT04196608|Relebactam|relebactam|mesh-list
83299350|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83299351|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299352|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83299353|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299354|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299355|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83299356|NCT04022200|Paclitaxel|paclitaxel|mesh-list
83299357|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83299358|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299359|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
83299360|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
83299361|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
83299362|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299363|NCT04552743|Plerixafor|plerixafor|mesh-list
83299364|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83299365|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83299366|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
83299367|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299368|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
83299369|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83299370|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83299371|NCT03590080|Prednisolone|prednisolone|mesh-list
83299372|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
83299373|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83299374|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
83299375|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299376|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
83299377|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
83299378|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299379|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299380|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299381|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
83299382|NCT03590080|Hormones|hormones|mesh-ancestor
83299383|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299384|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83299385|NCT03590080|Protective Agents|protective agents|mesh-ancestor
83299386|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299387|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299388|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83299389|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83299390|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299391|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299392|NCT03594058|Solabegron|solabegron|mesh-list
83299393|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83299394|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83299395|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83299396|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
83299397|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299398|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299399|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299400|NCT03970954|Interleukin-2|interleukin-2|mesh-list
83299401|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299402|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83299403|NCT03970954|Analgesics|analgesics|mesh-ancestor
83299404|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
83299405|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299406|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299407|NCT03970720|Metoclopramide|metoclopramide|mesh-list
83299408|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
83299409|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
83299410|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299411|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299412|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299413|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83299414|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83299415|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
83299416|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299417|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299418|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83299419|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83299420|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299421|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
83299422|NCT04194658|Letrozole|letrozole|mesh-list
83299423|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299425|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83299426|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299427|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299428|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83299429|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
83299430|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299431|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299432|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83299433|NCT04028518|Plasminogen|plasminogen|mesh-list
83299434|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83299435|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83299436|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299437|NCT04747678|Ivermectin|ivermectin|mesh-list
83299438|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83299439|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299440|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
83299441|NCT04027972|Neostigmine|neostigmine|mesh-list
83299442|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83299443|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299444|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299445|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
83299446|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299447|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299448|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83299449|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
83299450|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299451|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83299452|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83299453|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83299454|NCT04191928|Apixaban|apixaban|mesh-list
83299455|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83299456|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
83299457|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83299458|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
83299459|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299460|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299461|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
83299462|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83299463|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299464|NCT04027192|Midazolam|midazolam|mesh-list
83299465|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83299466|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83299467|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299468|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299469|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83299470|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83299471|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83299472|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83299473|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
83299474|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
83299475|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
83299476|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
83299477|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299478|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299479|NCT04406506|Erythromycin|erythromycin|mesh-list
83299480|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
83299481|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83299482|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
83299483|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83299484|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299485|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299486|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83299487|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299488|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299489|NCT03828292|Dexamethasone|dexamethasone|mesh-list
83299490|NCT03828292|Bortezomib|bortezomib|mesh-list
83299491|NCT03828292|Pomalidomide|pomalidomide|mesh-list
83299492|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299493|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
83299494|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
83299495|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299496|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299497|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299498|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
83299499|NCT03828292|Hormones|hormones|mesh-ancestor
83299500|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299501|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299502|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299503|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
83299504|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83299505|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83299506|NCT03828292|Growth Substances|growth substances|mesh-ancestor
83299507|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
83299508|NCT04191694|Ondansetron|ondansetron|mesh-list
83299509|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
83299510|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
83299511|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299512|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299513|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299514|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
83299515|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
83299516|NCT04191694|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83299517|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83299518|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
83299519|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299520|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299521|NCT04026022|Fentanyl|fentanyl|mesh-list
83299522|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83299523|NCT04026022|Narcotics|narcotics|mesh-ancestor
83299524|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299525|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299526|NCT04026022|Analgesics|analgesics|mesh-ancestor
83299527|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
83299528|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299529|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83299530|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83299531|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
83299532|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
83299533|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83299534|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299535|NCT04020328|Prednisone|prednisone|mesh-list
83299536|NCT04020328|Leflunomide|leflunomide|mesh-list
83299537|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299538|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
83299539|NCT04020328|Hormones|hormones|mesh-ancestor
83299540|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299541|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299542|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299543|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299544|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299545|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299546|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83299547|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
83299548|NCT04020094|Atezolizumab|atezolizumab|mesh-list
83299549|NCT04020094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83299550|NCT04020094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299551|NCT04020094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299552|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299553|NCT02080468|Norgestimate|norgestimate|mesh-list
83299554|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83299555|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
83299556|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83299557|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299558|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83299559|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83299560|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83299561|NCT04020016|Nalbuphine|nalbuphine|mesh-list
83299562|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83299563|NCT04020016|Narcotics|narcotics|mesh-ancestor
83299564|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299565|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299566|NCT04020016|Analgesics|analgesics|mesh-ancestor
83299567|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
83299568|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299569|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83299570|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83299571|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83299573|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299574|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299575|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299576|NCT01874054|Immunotoxins|immunotoxins|mesh-ancestor
83299577|NCT01874054|Immunoconjugates|immunoconjugates|mesh-ancestor
83299578|NCT01874054|Immunologic Factors|immunologic factors|mesh-ancestor
83299579|NCT01874054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299580|NCT04029610|Lidocaine|lidocaine|mesh-list
83299581|NCT04029610|Epinephrine|epinephrine|mesh-list
83299582|NCT04029610|Racepinephrine|racepinephrine|mesh-list
83299583|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
83299584|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
83299585|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
83299586|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299587|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299588|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
83299589|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299590|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83299591|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83299592|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83299593|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83299594|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299595|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83299596|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83299597|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
83299598|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299599|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83299600|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83299601|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
83299602|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83299603|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
83299604|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
83299605|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
83299606|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83299607|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
83299608|NCT04026880|Testosterone|testosterone|mesh-list
83299609|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
83299610|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
83299611|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83299612|NCT04026880|Androgens|androgens|mesh-ancestor
83299613|NCT04026880|Hormones|hormones|mesh-ancestor
83299614|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299615|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299616|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299617|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299618|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
83299619|NCT04024384|Daratumumab|daratumumab|mesh-list
83299620|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299621|NCT01849562|Ribavirin|ribavirin|mesh-list
83299622|NCT01849562|Odalasvir|odalasvir|mesh-list
83299623|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
83299624|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299625|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
83299626|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299627|NCT04023760|Apixaban|apixaban|mesh-list
83299628|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83299629|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
83299630|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83299631|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
83299632|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299633|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299634|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
83299635|NCT04020718|Nicotine|nicotine|mesh-list
83299636|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83299637|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
83299638|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299639|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299640|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83299641|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83299642|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
83299643|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299644|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299645|NCT04027348|Dexamethasone|dexamethasone|mesh-list
83299646|NCT04027348|Octreotide|octreotide|mesh-list
83299647|NCT04027348|Metoclopramide|metoclopramide|mesh-list
83299648|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299649|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
83299650|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
83299651|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299652|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299653|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299654|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
83299655|NCT04027348|Hormones|hormones|mesh-ancestor
83299656|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299657|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299658|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299659|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83299660|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83299661|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
83299662|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299663|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299664|NCT04195204|Tropisetron|tropisetron|mesh-list
83299665|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
83299666|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
83299667|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299668|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299669|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299670|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83299671|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83299672|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
83299673|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299674|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299675|NCT04023292|Tamoxifen|tamoxifen|mesh-list
83299676|NCT04023292|Letrozole|letrozole|mesh-list
83299677|NCT04023292|Exemestane|exemestane|mesh-list
83299678|NCT04023292|Anastrozole|anastrozole|mesh-list
83299679|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299680|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83299681|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83299682|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299683|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299684|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83299685|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
83299686|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299687|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299688|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299689|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83299690|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83299691|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83299692|NCT03022240|Ondansetron|ondansetron|mesh-list
83299693|NCT03022240|Propofol|propofol|mesh-list
83299694|NCT03022240|Sevoflurane|sevoflurane|mesh-list
83299695|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83299696|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299697|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299698|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83299699|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
83299700|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
83299701|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83299702|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83299703|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
83299704|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
83299705|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299706|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299707|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
83299708|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
83299709|NCT03022240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83299710|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83299711|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
83299712|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299713|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299714|NCT02704390|Methylphenidate|methylphenidate|mesh-list
83299715|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83299716|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299717|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83299718|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83299719|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83299720|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299721|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
83299722|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299723|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
83299724|NCT04147390|Tacrolimus|tacrolimus|mesh-list
83299725|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83299726|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
83299727|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299728|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83299729|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299730|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299731|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83299732|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299733|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83299734|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
83299735|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83299736|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299737|NCT02708680|Atezolizumab|atezolizumab|mesh-list
83299738|NCT02708680|Entinostat|entinostat|mesh-list
83299739|NCT02708680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83299740|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299741|NCT02708680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299742|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299743|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83299744|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299745|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
83299746|NCT03931642|Blinatumomab|blinatumomab|mesh-list
83299747|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299748|NCT04021420|Nivolumab|nivolumab|mesh-list
83299749|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299750|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299751|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83299752|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299753|NCT04144582|Docetaxel|docetaxel|mesh-list
83299754|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299755|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83299756|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83299757|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83299758|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299759|NCT01611974|Maribavir|maribavir|mesh-list
83299760|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
83299761|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299762|NCT01871870|Pancrelipase|pancrelipase|mesh-list
83299763|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299764|NCT02080780|Clarithromycin|clarithromycin|mesh-list
83299765|NCT02080780|Diltiazem|diltiazem|mesh-list
83299766|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83299767|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299768|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83299769|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299770|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299771|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83299772|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83299773|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83299774|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83299775|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83299776|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83299777|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299778|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
83299779|NCT01871558|Metformin|metformin|mesh-list
83299780|NCT01871558|Vildagliptin|vildagliptin|mesh-list
83299781|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83299782|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299783|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83299784|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
83299785|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299786|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299787|NCT01711359|Folic Acid|folic acid|mesh-list
83299788|NCT01711359|Methotrexate|methotrexate|mesh-list
83299789|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83299790|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
83299791|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83299792|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299793|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83299794|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
83299795|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299796|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299797|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
83299798|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299799|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83299800|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83299801|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
83299802|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83299803|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83299804|NCT01711359|Hematinics|hematinics|mesh-ancestor
83299805|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
83299806|NCT01711359|Vitamins|vitamins|mesh-ancestor
83299807|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
83299808|NCT04149964|Acetaminophen|acetaminophen|mesh-list
83299809|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83299810|NCT04149964|Oxycodone|oxycodone|mesh-list
83299811|NCT04149964|Hydrocodone|hydrocodone|mesh-list
83299812|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83299813|NCT04149964|Analgesics|analgesics|mesh-ancestor
83299814|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
83299815|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299816|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299817|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
83299818|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83299819|NCT04149964|Narcotics|narcotics|mesh-ancestor
83299820|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299821|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
83299822|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
83299823|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83299824|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299825|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83299826|NCT04140136|Tocotrienols|tocotrienols|mesh-list
83299827|NCT04140136|Vitamin E|vitamin e|mesh-list
83299828|NCT04140136|Tocopherols|tocopherols|mesh-list
83299829|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
83299830|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299831|NCT04140136|Protective Agents|protective agents|mesh-ancestor
83299832|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299833|NCT04140136|Vitamins|vitamins|mesh-ancestor
83299834|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
83299835|NCT04146532|Aspirin|aspirin|mesh-list
83362259|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83299836|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83299837|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83299838|NCT04146532|Analgesics|analgesics|mesh-ancestor
83299839|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
83299840|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299841|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299842|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299843|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83299844|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83299845|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83299846|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299847|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83299848|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83299849|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299850|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
83299852|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83299853|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299854|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83299855|NCT03928288|Cabergoline|cabergoline|mesh-list
83299856|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83299857|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83299858|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
83299859|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
83299860|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299861|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299862|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299864|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
83299865|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
83299866|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299867|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
83299868|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83299869|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83299870|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299871|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
83299872|NCT04146376|Coagulants|coagulants|mesh-ancestor
83299873|NCT01710657|Lacosamide|lacosamide|mesh-list
83299874|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
83299875|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83299876|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83299877|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83299878|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299879|NCT04145518|Naproxen|naproxen|mesh-list
83299880|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83299881|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83299882|NCT04145518|Analgesics|analgesics|mesh-ancestor
83299883|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
83299884|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299885|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299886|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299887|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83299888|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
83299889|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83299890|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299891|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299892|NCT03021772|Dexamethasone|dexamethasone|mesh-list
83299893|NCT03021772|Neostigmine|neostigmine|mesh-list
83299894|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83299895|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
83299896|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
83299897|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299898|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299899|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299900|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
83299901|NCT03021772|Hormones|hormones|mesh-ancestor
83299902|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299903|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299904|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299905|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83299906|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299907|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299908|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
83299909|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83299910|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83299911|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
83299912|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83299913|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299914|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
83299915|NCT05581420|Trace Elements|trace elements|mesh-ancestor
83299916|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
83299917|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299918|NCT03904498|Tolcapone|tolcapone|mesh-list
83299919|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83299920|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83299921|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83299922|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299923|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299924|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
83299925|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83299926|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83299927|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299928|NCT04405960|Vitamins|vitamins|mesh-ancestor
83299929|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
83299930|NCT03945604|Apatinib|apatinib|mesh-list
83299931|NCT03945604|Fluzoparib|fluzoparib|mesh-list
83299932|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299933|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83299934|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299935|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299936|NCT03945604|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83299937|NCT03944434|Leuprolide|leuprolide|mesh-list
83299938|NCT03944434|Goserelin|goserelin|mesh-list
83299939|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83299940|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83299941|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83299942|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
83299943|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83299944|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299945|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83299946|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299947|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
83299948|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83299949|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
83299950|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83299951|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83299952|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299953|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299954|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83299955|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
83299956|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83299957|NCT03944356|Trametinib|trametinib|mesh-list
83299958|NCT03944356|Dabrafenib|dabrafenib|mesh-list
83299959|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299960|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83299961|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83299962|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299963|NCT01701063|Ribavirin|ribavirin|mesh-list
83299964|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83299965|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
83299966|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299967|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
83299968|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83299969|NCT03920722|Rituximab|rituximab|mesh-list
83299970|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299971|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299972|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
83299973|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299974|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83299975|NCT05580094|Anesthetics|anesthetics|mesh-list
83299976|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83299977|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299978|NCT05589766|Niacinamide|niacinamide|mesh-list
83299979|NCT05589766|Niacin|niacin|mesh-list
83299980|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
83299981|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
83299982|NCT05589766|Vitamins|vitamins|mesh-ancestor
83299983|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
83299984|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299985|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83299986|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
83299987|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83299988|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83299989|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
83299990|NCT05586100|Cetuximab|cetuximab|mesh-list
83299991|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83299992|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83299993|NCT05585086|Peppermint oil|peppermint oil|mesh-list
83299994|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
83299995|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
83299996|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83299997|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83299998|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83299999|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
83300000|NCT01710501|Interferons|interferons|mesh-list
83300001|NCT01710501|Ribavirin|ribavirin|mesh-list
83300002|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
83300003|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
83300004|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83300005|NCT01710501|Grazoprevir|grazoprevir|mesh-list
83300006|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300007|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
83300008|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300009|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
83300010|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300011|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
83300012|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300014|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300015|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300016|NCT01700829|Midazolam|midazolam|mesh-list
83300017|NCT01700829|Ketamine|ketamine|mesh-list
83300018|NCT01700829|Analgesics|analgesics|mesh-ancestor
83300019|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
83300020|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300021|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300022|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83300023|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83300024|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
83300025|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
83300026|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300027|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83300028|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83300029|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300030|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300031|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83300032|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83300033|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83300034|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83300035|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83300036|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
83300037|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
83300038|NCT04143880|Progesterone|progesterone|mesh-list
83300039|NCT04143880|Progestins|progestins|mesh-ancestor
83300040|NCT04143880|Hormones|hormones|mesh-ancestor
83300041|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300042|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300043|NCT04144192|Lidocaine|lidocaine|mesh-list
83300044|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
83300045|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
83300046|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300047|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300048|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
83300049|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300050|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83300051|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83300052|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83300053|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83300054|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300055|NCT01710345|Sufentanil|sufentanil|mesh-list
83300056|NCT01710345|Dsuvia|dsuvia|mesh-list
83300057|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83300058|NCT01710345|Narcotics|narcotics|mesh-ancestor
83300059|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300060|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300061|NCT01710345|Analgesics|analgesics|mesh-ancestor
83300062|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
83300063|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300064|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83300065|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83300066|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
83300068|NCT03022006|Grazoprevir|grazoprevir|mesh-list
83300069|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
83300070|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300071|NCT04143256|Menthol|menthol|mesh-list
83300072|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
83300073|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
83300074|NCT04143412|Ramipril|ramipril|mesh-list
83300075|NCT04143412|Eplerenone|eplerenone|mesh-list
83300076|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83300077|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
83300078|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300079|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300080|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83300081|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83300082|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
83300083|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300084|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300085|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83300086|NCT04143412|Diuretics|diuretics|mesh-ancestor
83300087|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
83300088|NCT05582278|Lenvatinib|lenvatinib|mesh-list
83300089|NCT05582278|Tislelizumab|tislelizumab|mesh-list
83300090|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83300091|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300092|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83300093|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300094|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300095|NCT05582278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300096|NCT01710033|Tofacitinib|tofacitinib|mesh-list
83300097|NCT01710033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83300098|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83300099|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300100|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300101|NCT01822496|Paclitaxel|paclitaxel|mesh-list
83300102|NCT01822496|Etoposide|etoposide|mesh-list
83300103|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
83300104|NCT01822496|Cisplatin|cisplatin|mesh-list
83300105|NCT01822496|Carboplatin|carboplatin|mesh-list
83300106|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83300107|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
83300108|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83300109|NCT01822496|Crizotinib|crizotinib|mesh-list
83300110|NCT01822496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83300111|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83300112|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300113|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
83300114|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
83300115|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
83300116|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300117|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83300118|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83300119|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300120|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83300121|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
83300122|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
83300123|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83300124|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
83300125|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300126|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300127|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
83300128|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83300129|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300130|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300131|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300132|NCT03588988|Analgesics|analgesics|mesh-ancestor
83300133|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
83300134|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300135|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83300136|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83300137|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83300138|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
83300139|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300140|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300141|NCT04414137|Daptomycin|daptomycin|mesh-list
83300142|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83300143|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300144|NCT01821560|Baclofen|baclofen|mesh-list
83300145|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83300146|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300147|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83300148|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300149|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83300150|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
83300151|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
83300152|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300153|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300154|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
83300155|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83300156|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
83300157|NCT03588676|Melatonin|melatonin|mesh-list
83300158|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
83300159|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300160|NCT03588676|Protective Agents|protective agents|mesh-ancestor
83300161|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300162|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300163|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83300164|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83300165|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
83300166|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300167|NCT01709721|Hydromorphone|hydromorphone|mesh-list
83300168|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83300169|NCT01709721|Narcotics|narcotics|mesh-ancestor
83300170|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300171|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300172|NCT01709721|Analgesics|analgesics|mesh-ancestor
83300173|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
83300174|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300175|NCT01866657|Phenylephrine|phenylephrine|mesh-list
83300176|NCT01866657|Dopamine|dopamine|mesh-list
83300177|NCT01866657|Ephedrine|ephedrine|mesh-list
83300178|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83300179|NCT01866657|Propofol|propofol|mesh-list
83300180|NCT01866657|Sevoflurane|sevoflurane|mesh-list
83300181|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
83300182|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300183|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300184|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83300185|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83300186|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
83300187|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83300188|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83300189|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83300190|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
83300191|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
83300192|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300193|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
83300194|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
83300195|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
83300196|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83300197|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83300198|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83300199|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
83300200|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300201|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300202|NCT01866657|Protective Agents|protective agents|mesh-ancestor
83300203|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83300204|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
83300205|NCT03584152|Acetaminophen|acetaminophen|mesh-list
83300206|NCT03584152|Ibuprofen|ibuprofen|mesh-list
83300207|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300208|NCT03584152|Analgesics|analgesics|mesh-ancestor
83300209|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
83300210|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300211|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300212|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
83300213|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300214|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300215|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300216|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83300217|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300218|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300219|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
83300220|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
83300221|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300222|NCT03589690|Protective Agents|protective agents|mesh-ancestor
83300223|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300224|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
83300225|NCT03589690|Vitamins|vitamins|mesh-ancestor
83300226|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
83300227|NCT03587194|Apremilast|apremilast|mesh-list
83300228|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300229|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300230|NCT03587194|Analgesics|analgesics|mesh-ancestor
83300231|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
83300232|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300233|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300234|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300235|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300236|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83300237|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83300238|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300239|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300240|NCT01699815|Acetaminophen|acetaminophen|mesh-list
83300241|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300242|NCT01699815|Analgesics|analgesics|mesh-ancestor
83300243|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
83300244|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300245|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300246|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
83300247|NCT03589222|Dexamethasone|dexamethasone|mesh-list
83300248|NCT03589222|Bortezomib|bortezomib|mesh-list
83300249|NCT03589222|Daratumumab|daratumumab|mesh-list
83300250|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300251|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
83300252|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
83300253|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300254|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300255|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300256|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
83300257|NCT03589222|Hormones|hormones|mesh-ancestor
83300258|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300259|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83300260|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300261|NCT01846208|Immunomodulating Agents|immunomodulating agents|mesh-list
83300262|NCT01846208|Immunologic Factors|immunologic factors|mesh-ancestor
83300263|NCT01846208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300264|NCT03589066|Rotigotine|rotigotine|mesh-list
83300265|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
83300266|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
83300267|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300268|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300269|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300270|NCT03020368|Diclofenac|diclofenac|mesh-list
83300271|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300272|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300273|NCT03020368|Analgesics|analgesics|mesh-ancestor
83300274|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
83300275|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300276|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300277|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300278|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300279|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83300280|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300281|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300282|NCT03891706|Interleukin-2|interleukin-2|mesh-list
83300283|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300284|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300285|NCT03891706|Analgesics|analgesics|mesh-ancestor
83300286|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
83300287|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300288|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300289|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83300290|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83300291|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300292|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
83300293|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83300294|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83300295|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83300296|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300297|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300298|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300299|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83300300|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
83300301|NCT03580876|Azathioprine|azathioprine|mesh-list
83300302|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
83300303|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300304|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83300305|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300306|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83300307|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
83300308|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300309|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300310|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
83300311|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300312|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300313|NCT03586024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83413612|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300314|NCT03586024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300315|NCT03585556|Prednisolone|prednisolone|mesh-list
83300316|NCT03585556|Ranibizumab|ranibizumab|mesh-list
83300317|NCT03585556|Aflibercept|aflibercept|mesh-list
83300318|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300319|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83300320|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83300321|NCT03585556|Growth Substances|growth substances|mesh-ancestor
83300322|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300323|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
83300324|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300325|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
83300326|NCT03585556|Hormones|hormones|mesh-ancestor
83300327|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300328|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83300329|NCT05702398|Vitamins|vitamins|mesh-list
83300330|NCT05702398|Vitamin A|vitamin a|mesh-list
83300331|NCT05702398|Niacin|niacin|mesh-list
83300332|NCT05702398|Niacinamide|niacinamide|mesh-list
83300333|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
83300334|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
83300335|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300336|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
83300337|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300338|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83300339|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
83300340|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83300341|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
83300342|NCT01709409|Poractant alfa|poractant alfa|mesh-list
83300343|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83300344|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
83300345|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
83300346|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300347|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300348|NCT01698879|Immunotoxins|immunotoxins|mesh-ancestor
83300349|NCT01698879|Immunoconjugates|immunoconjugates|mesh-ancestor
83300350|NCT01698879|Immunologic Factors|immunologic factors|mesh-ancestor
83300351|NCT01698879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300352|NCT02335294|Morphine|morphine|mesh-list
83300353|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83300354|NCT02335294|Narcotics|narcotics|mesh-ancestor
83300355|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300356|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300357|NCT02335294|Analgesics|analgesics|mesh-ancestor
83300358|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
83300359|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300360|NCT01698801|Dexamethasone|dexamethasone|mesh-list
83300361|NCT01698801|Lenalidomide|lenalidomide|mesh-list
83300362|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300363|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
83300364|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
83300365|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300366|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300367|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300368|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
83300369|NCT01698801|Hormones|hormones|mesh-ancestor
83300370|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300371|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83300372|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300373|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
83300374|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83300375|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83300376|NCT01698801|Growth Substances|growth substances|mesh-ancestor
83300377|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
83300378|NCT03735628|Nivolumab|nivolumab|mesh-list
83300379|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300380|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300381|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83300382|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300383|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83300384|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83300385|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83300386|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
83300387|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83300388|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83300389|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300390|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
83300391|NCT03580018|Coagulants|coagulants|mesh-ancestor
83300392|NCT03584854|Carboprost|carboprost|mesh-list
83300393|NCT03584854|Dinoprost|dinoprost|mesh-list
83300394|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
83300395|NCT03584854|Methylergonovine|methylergonovine|mesh-list
83300396|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83300397|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
83300398|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83300399|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300400|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
83300401|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
83300402|NCT03584698|Misoprostol|misoprostol|mesh-list
83300403|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83300404|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
83300405|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83300406|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300407|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83300408|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300409|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
83300410|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300411|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300412|NCT03584698|Analgesics|analgesics|mesh-ancestor
83300413|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
83300414|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300415|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300416|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300417|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83300418|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
83300419|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300420|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83300421|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
83300422|NCT03587038|Temozolomide|temozolomide|mesh-list
83300423|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83300424|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
83300425|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300426|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300427|NCT03582124|Panitumumab|panitumumab|mesh-list
83300428|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300429|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300430|NCT01682031|Selenium|selenium|mesh-list
83300431|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
83300432|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300433|NCT01682031|Protective Agents|protective agents|mesh-ancestor
83300434|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300435|NCT01682031|Trace Elements|trace elements|mesh-ancestor
83300436|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
83300437|NCT03020134|Ritonavir|ritonavir|mesh-list
83300438|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83300439|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83300440|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
83300441|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300442|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300443|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83300444|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83300445|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
83300446|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300447|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83300448|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83300449|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83300451|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83300452|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300453|NCT03020056|Protective Agents|protective agents|mesh-ancestor
83300454|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300455|NCT03026062|Durvalumab|durvalumab|mesh-list
83300456|NCT03026062|Ipilimumab|ipilimumab|mesh-list
83300457|NCT03026062|Tremelimumab|tremelimumab|mesh-list
83300458|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
83300459|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83300460|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
83300461|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300462|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300463|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
83300464|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300465|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83300466|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300467|NCT03584074|Celecoxib|celecoxib|mesh-list
83300468|NCT03584074|Pregabalin|pregabalin|mesh-list
83300469|NCT03584074|Analgesics|analgesics|mesh-ancestor
83300470|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
83300471|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300472|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300473|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
83300474|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83300475|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83300476|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300477|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83300478|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83300479|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83300480|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300481|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83300482|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300483|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300484|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300485|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300486|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83300487|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83300488|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300489|NCT03583138|Buprenorphine|buprenorphine|mesh-list
83300490|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83300491|NCT03583138|Narcotics|narcotics|mesh-ancestor
83300492|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300493|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300494|NCT03583138|Analgesics|analgesics|mesh-ancestor
83300495|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
83300496|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300497|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83300498|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
83300499|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300500|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300501|NCT03020602|Ubiquinone|ubiquinone|mesh-list
83300502|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
83300503|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
83300504|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300505|NCT03020602|Vitamins|vitamins|mesh-ancestor
83300506|NCT01567527|Aripiprazole|aripiprazole|mesh-list
83300507|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
83300508|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83300509|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83300510|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83300511|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300512|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300513|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
83300515|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300516|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300517|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83300518|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83300519|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
83300520|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83300521|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83300522|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83300523|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83300524|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83300525|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83300526|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
83300527|NCT05701540|Esomeprazole|esomeprazole|mesh-list
83300528|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83300529|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300530|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83300531|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300532|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300533|NCT03159598|Urethane|urethane|mesh-list
83300534|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300535|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83300536|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
83300537|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
83300538|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300539|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300540|NCT01818752|Prednisone|prednisone|mesh-list
83300541|NCT01818752|Bortezomib|bortezomib|mesh-list
83300542|NCT01818752|Melphalan|melphalan|mesh-list
83300543|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300544|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
83300545|NCT01818752|Hormones|hormones|mesh-ancestor
83300546|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300547|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300548|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83300549|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300550|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83300551|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
83300552|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300553|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83300554|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83300555|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
83300556|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
83300557|NCT03582280|Calcium|calcium|mesh-list
83300558|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83300559|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300560|NCT03582280|Antacids|antacids|mesh-ancestor
83300561|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300562|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300563|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83300564|NCT03159754|Metronidazole|metronidazole|mesh-list
83300565|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
83300566|NCT03159754|Tazobactam|tazobactam|mesh-list
83300567|NCT03159754|Piperacillin|piperacillin|mesh-list
83300568|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83300569|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300570|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83300571|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83300572|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83300573|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83300574|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300575|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300576|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300577|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83300578|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83300579|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83300580|NCT05701384|Lazertinib|lazertinib|mesh-list
83300581|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83300582|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300583|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300584|NCT01362608|Triamcinolone|triamcinolone|mesh-list
83300585|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83300586|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83300587|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83300588|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300589|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
83300590|NCT01362608|Hormones|hormones|mesh-ancestor
83300591|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300592|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300593|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83300594|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
83300595|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300596|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300597|NCT03581968|Pancrelipase|pancrelipase|mesh-list
83300598|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300599|NCT03158584|Morphine|morphine|mesh-list
83300600|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83300601|NCT03158584|Narcotics|narcotics|mesh-ancestor
83300602|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300603|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300604|NCT03158584|Analgesics|analgesics|mesh-ancestor
83300605|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
83300606|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300607|NCT04765228|Doxorubicin|doxorubicin|mesh-list
83300608|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83300609|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83300610|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300611|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83300612|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83300613|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300614|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300615|NCT05696626|Fulvestrant|fulvestrant|mesh-list
83300616|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83300617|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300618|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83300619|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83300620|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
83300621|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300622|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300623|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83300624|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83300625|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83300626|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
83300627|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300628|NCT04140448|Ranibizumab|ranibizumab|mesh-list
83300629|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83300630|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83300631|NCT04140448|Growth Substances|growth substances|mesh-ancestor
83300632|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300633|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
83300634|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300635|NCT03156322|Fentanyl|fentanyl|mesh-list
83300636|NCT03156322|Bupivacaine|bupivacaine|mesh-list
83300637|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
83300638|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
83300639|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300640|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300641|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
83300642|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300643|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83300644|NCT03156322|Narcotics|narcotics|mesh-ancestor
83300645|NCT03156322|Analgesics|analgesics|mesh-ancestor
83300646|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83300647|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83300648|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
83300649|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83300650|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300651|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300652|NCT04140058|Ondansetron|ondansetron|mesh-list
83300653|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
83300654|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
83300655|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300656|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300657|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300658|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
83300659|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
83300660|NCT04140058|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83300661|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83300662|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
83300663|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300664|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300665|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
83300666|NCT04146298|Fludarabine|fludarabine|mesh-list
83300668|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83300669|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83300670|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
83300671|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300672|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300673|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83300674|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
83300675|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300676|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300677|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83300678|NCT02899078|Nivolumab|nivolumab|mesh-list
83300679|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300680|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300681|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83300682|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300683|NCT01670734|Alirocumab|alirocumab|mesh-list
83300684|NCT01670734|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83300685|NCT01670734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83300686|NCT01670734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83300687|NCT01670734|Antimetabolites|antimetabolites|mesh-ancestor
83300688|NCT01670734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300689|NCT01670734|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83300690|NCT01670734|Protease Inhibitors|protease inhibitors|mesh-ancestor
83300691|NCT01670734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300692|NCT01670734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83300693|NCT01670890|Cisplatin|cisplatin|mesh-list
83300694|NCT01670890|Temozolomide|temozolomide|mesh-list
83300695|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300696|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83300697|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
83300698|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300699|NCT04551196|Acetaminophen|acetaminophen|mesh-list
83300700|NCT04551196|Ibuprofen|ibuprofen|mesh-list
83300701|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300702|NCT04551196|Analgesics|analgesics|mesh-ancestor
83300703|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
83300704|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300705|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300706|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
83300707|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300708|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300709|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300710|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83300711|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300712|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300713|NCT01923298|Estradiol|estradiol|mesh-list
83300714|NCT01923298|Estrogens|estrogens|mesh-ancestor
83300715|NCT01923298|Hormones|hormones|mesh-ancestor
83300716|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300717|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300718|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
83300719|NCT04417192|Olaparib|olaparib|mesh-list
83300720|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300721|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300722|NCT04417192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83300723|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300724|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83300725|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300726|NCT05212246|Imiquimod|imiquimod|mesh-list
83300727|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83300728|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
83300729|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300730|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300731|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
83300732|NCT04297618|Lifitegrast|lifitegrast|mesh-list
83300733|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83300734|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83300735|NCT03154918|Dexamethasone|dexamethasone|mesh-list
83300736|NCT03154918|Gemcitabine|gemcitabine|mesh-list
83300738|NCT03154918|Ifosfamide|ifosfamide|mesh-list
83300739|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300741|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
83300742|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300743|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300744|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300745|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
83300746|NCT03154918|Hormones|hormones|mesh-ancestor
83300747|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300748|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83300749|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300750|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300751|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300752|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83300753|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
83300754|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83300755|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83300756|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83300757|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83300758|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
83300759|NCT01671904|Rituximab|rituximab|mesh-list
83300760|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
83300761|NCT01671904|Venetoclax|venetoclax|mesh-list
83300762|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83300763|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300764|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300765|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
83300766|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300767|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300768|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83300769|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
83413613|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300770|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300771|NCT01671982|Tenofovir|tenofovir|mesh-list
83300772|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
83300773|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300774|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83300775|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83300776|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300777|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300778|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83300779|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83300780|NCT04040452|Ketorolac|ketorolac|mesh-list
83300781|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300782|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300783|NCT04040452|Analgesics|analgesics|mesh-ancestor
83300784|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
83300785|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300786|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300787|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300788|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300789|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83300790|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300791|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300792|NCT04027894|Rifamycins|rifamycins|mesh-list
83300793|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
83300794|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83300795|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300796|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300797|NCT02564068|Oxytocin|oxytocin|mesh-list
83300798|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
83300799|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83300800|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300801|NCT03154528|Vitamin D|vitamin d|mesh-list
83300802|NCT03154528|Vitamins|vitamins|mesh-ancestor
83300803|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
83300804|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300805|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83300806|NCT03154372|Metronidazole|metronidazole|mesh-list
83300807|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300808|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83300809|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83300810|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83300811|NCT01676506|Ranibizumab|ranibizumab|mesh-list
83300812|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83300813|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83300815|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300816|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
83300817|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300819|NCT03154294|Serabelisib|serabelisib|mesh-list
83300820|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83300821|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300822|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
83300823|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
83300824|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
83300825|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300826|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300827|NCT03154606|Calcium|calcium|mesh-list
83300828|NCT03154606|Caseins|caseins|mesh-list
83300829|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83300830|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300831|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
83300832|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
83300833|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300834|NCT01672450|Ipilimumab|ipilimumab|mesh-list
83300835|NCT01672450|Interleukin-2|interleukin-2|mesh-list
83300836|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300837|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300838|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83300839|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300840|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300841|NCT01672450|Analgesics|analgesics|mesh-ancestor
83300842|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
83300843|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300844|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300845|NCT01854268|Capsaicin|capsaicin|mesh-list
83300846|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
83300847|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
83300848|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
83300849|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300850|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300851|NCT01672606|Rocuronium|rocuronium|mesh-list
83300852|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83300853|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83300854|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83300855|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300856|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300857|NCT01594281|Ranibizumab|ranibizumab|mesh-list
83300858|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83300859|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83300860|NCT01594281|Growth Substances|growth substances|mesh-ancestor
83300861|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300862|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
83300863|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300864|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
83300865|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83300866|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
83300867|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300868|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300869|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83300870|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83300871|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83300872|NCT04964050|Diuretics|diuretics|mesh-ancestor
83300873|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
83300874|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300875|NCT03526900|Atezolizumab|atezolizumab|mesh-list
83300876|NCT03526900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83300877|NCT03526900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300878|NCT03526900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83300879|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300880|NCT03420742|Midazolam|midazolam|mesh-list
83300881|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83300882|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83300883|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300884|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300885|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83300886|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83300887|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83300888|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83300889|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
83300890|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
83300891|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
83300892|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
83300893|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300894|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300895|NCT01818284|Plerixafor|plerixafor|mesh-list
83300896|NCT01818284|Lenograstim|lenograstim|mesh-list
83300897|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83300898|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
83300899|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300900|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83300901|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83300902|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
83300903|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83300904|NCT02081014|Glucagon|glucagon|mesh-list
83300905|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83300906|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300907|NCT02081014|Hormones|hormones|mesh-ancestor
83300908|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300909|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300910|NCT02081014|Incretins|incretins|mesh-ancestor
83300911|NCT03025594|Ketorolac|ketorolac|mesh-list
83300912|NCT03025594|Epinephrine|epinephrine|mesh-list
83300913|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
83300914|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83300915|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83300916|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
83300917|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300918|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300919|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300920|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83300921|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83300922|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
83300923|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300924|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83300925|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
83300926|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
83300927|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
83300928|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83300929|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83300930|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83300931|NCT03025594|Analgesics|analgesics|mesh-ancestor
83300932|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
83300933|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83300934|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83300935|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83300936|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300937|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
83300938|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
83300939|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300940|NCT04404946|Phenylephrine|phenylephrine|mesh-list
83300941|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
83300942|NCT04404946|Norepinephrine|norepinephrine|mesh-list
83300943|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83300944|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
83300945|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
83300946|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300947|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300948|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
83300949|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83300950|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
83300951|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83300952|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83300953|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83300954|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83300955|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
83300956|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83300957|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300958|NCT04404946|Protective Agents|protective agents|mesh-ancestor
83300959|NCT01673542|Lidocaine|lidocaine|mesh-list
83300960|NCT01673542|Prilocaine|prilocaine|mesh-list
83300961|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83300963|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
83300964|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83300965|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300966|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
83300967|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83300968|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83300969|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83300970|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83300971|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83300972|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300973|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83300974|NCT04804540|Vedolizumab|vedolizumab|mesh-list
83300975|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83300976|NCT01610492|Belimumab|belimumab|mesh-list
83300977|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83300978|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
83300979|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300980|NCT02738866|Fulvestrant|fulvestrant|mesh-list
83300981|NCT02738866|Palbociclib|palbociclib|mesh-list
83300982|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83300983|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83300984|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83300985|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83300986|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
83300987|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83300988|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83300989|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83300990|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83300991|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300992|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83300993|NCT01817582|Cyclosporine|cyclosporine|mesh-list
83300994|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83300995|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
83300996|NCT01817582|Cyclosporins|cyclosporins|mesh-list
83300997|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413614|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
83300998|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83300999|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301000|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
83301001|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301002|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
83301003|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301004|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83301005|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301006|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83301007|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83301008|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83301009|NCT01594125|Nintedanib|nintedanib|mesh-list
83301010|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301011|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83301012|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301013|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301014|NCT01592409|Dronabinol|dronabinol|mesh-list
83301015|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
83301016|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301017|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301018|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83301019|NCT01592409|Analgesics|analgesics|mesh-ancestor
83301020|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
83301021|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301022|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83301023|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83301024|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301025|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301026|NCT01592409|Hormones|hormones|mesh-ancestor
83301027|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301028|NCT02081638|Aspirin|aspirin|mesh-list
83301029|NCT02081638|Atorvastatin|atorvastatin|mesh-list
83301030|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83301031|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83301032|NCT02081638|Analgesics|analgesics|mesh-ancestor
83301033|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
83301034|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301035|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301036|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83301037|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301038|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83301039|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83301040|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301041|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83301042|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83301043|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301044|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
83301045|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83301046|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83301047|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
83301048|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83301049|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83301050|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
83301051|NCT04603508|Empagliflozin|empagliflozin|mesh-list
83301052|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83301053|NCT04603508|Calcium|calcium|mesh-list
83301054|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83301055|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301056|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83301057|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83301058|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83301059|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
83301060|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301061|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83301062|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83301063|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301064|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83301065|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83301066|NCT01674166|Prucalopride|prucalopride|mesh-list
83301067|NCT01674166|Laxatives|laxatives|mesh-ancestor
83301068|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301069|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83301070|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83301071|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
83301072|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301073|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301074|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301075|NCT02235688|Gemcitabine|gemcitabine|mesh-list
83301076|NCT02235688|Doxorubicin|doxorubicin|mesh-list
83301077|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301078|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
83301079|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301080|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301081|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83301082|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83301083|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83301084|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301085|NCT03152578|Capsaicin|capsaicin|mesh-list
83301086|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
83301087|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
83301088|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
83301089|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301090|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301091|NCT01065532|Paclitaxel|paclitaxel|mesh-list
83301092|NCT01065532|Everolimus|everolimus|mesh-list
83301093|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83301094|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301095|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
83301096|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
83301097|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
83430135|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301098|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301100|NCT01065532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83301101|NCT01065532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301102|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301103|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
83301104|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301105|NCT04764916|Bupivacaine|bupivacaine|mesh-list
83301106|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
83301108|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301109|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301110|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
83301111|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301112|NCT01674868|Fluoxetine|fluoxetine|mesh-list
83301113|NCT01674868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83301114|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83301115|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301116|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301117|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301118|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
83301119|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301120|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83301121|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
83301122|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301123|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83301124|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83301125|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301126|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
83301127|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
83301128|NCT01674946|Cathartics|cathartics|mesh-ancestor
83301129|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301130|NCT01675024|Rotigotine|rotigotine|mesh-list
83301131|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
83301132|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
83301133|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301134|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301135|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301136|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
83301137|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83301138|NCT03883828|Mupirocin|mupirocin|mesh-list
83301139|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83301140|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301141|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
83301142|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83301143|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83301144|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83301145|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301146|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301147|NCT02081950|Enoxaparin|enoxaparin|mesh-list
83301148|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
83301149|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
83301150|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83301151|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83301152|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301153|NCT01675648|Lofexidine|lofexidine|mesh-list
83301154|NCT01675648|Clonidine|clonidine|mesh-list
83301155|NCT01675648|Diazepam|diazepam|mesh-list
83301156|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83301157|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
83301158|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
83301159|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
83301160|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301161|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301162|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301163|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83301164|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301165|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83301166|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83301167|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83301168|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83301169|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301171|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
83301172|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
83301173|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
83301174|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
83301175|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301176|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301177|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83301178|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83301179|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
83301180|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83301181|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83301182|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83301183|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
83301184|NCT01675648|Analgesics|analgesics|mesh-ancestor
83301185|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
83301186|NCT01566435|Paclitaxel|paclitaxel|mesh-list
83301187|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83301188|NCT01566435|Fluorouracil|fluorouracil|mesh-list
83301189|NCT01566435|Cetuximab|cetuximab|mesh-list
83301190|NCT01566435|Antibodies|antibodies|mesh-list
83301191|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83301192|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83301193|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301194|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
83301195|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
83301196|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
83301197|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301198|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
83301199|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301200|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
83301201|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301202|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301203|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301204|NCT01675804|Methylphenidate|methylphenidate|mesh-list
83301205|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83301206|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301207|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83301208|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83301209|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301210|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301211|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
83301212|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301213|NCT01696695|Capecitabine|capecitabine|mesh-list
83301214|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301215|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
83301216|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301217|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301218|NCT05261386|Betadex|betadex|mesh-list
83301219|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
83301220|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301221|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
83301222|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301223|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301224|NCT03899805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83301225|NCT03899805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301226|NCT04768023|Vitamin D|vitamin d|mesh-list
83301227|NCT04768023|Vitamins|vitamins|mesh-ancestor
83301228|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
83301229|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301230|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83301231|NCT03861988|Ketamine|ketamine|mesh-list
83301232|NCT03861988|Analgesics|analgesics|mesh-ancestor
83301233|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
83301234|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301235|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301236|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83301237|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83301238|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
83301239|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
83301240|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301241|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83301242|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83301243|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301244|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301245|NCT03755440|Antibodies|antibodies|mesh-list
83301246|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
83301247|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301248|NCT03749902|Misoprostol|misoprostol|mesh-list
83301249|NCT03749902|Oxytocin|oxytocin|mesh-list
83301250|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
83301251|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83301252|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301253|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83301254|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
83301255|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83301256|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301258|NCT01565889|Ribavirin|ribavirin|mesh-list
83301259|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83301260|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83301261|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
83301262|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301263|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301264|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83301265|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83301266|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
83301267|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301268|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83301269|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83301270|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
83301271|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
83301272|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83301273|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
83301274|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301275|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301276|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83301277|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
83301278|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
83301279|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83301280|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
83301281|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301282|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301283|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
83301284|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83301285|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301286|NCT01591785|Retapamulin|retapamulin|mesh-list
83301287|NCT01591785|Petrolatum|petrolatum|mesh-list
83301288|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83301289|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301290|NCT01591785|Emollients|emollients|mesh-ancestor
83301291|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83301292|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83301293|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
83301294|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
83301295|NCT03660046|Etonogestrel|etonogestrel|mesh-list
83301296|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83301297|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
83301298|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83301299|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301300|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83301301|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83301302|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83301303|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83301304|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83301305|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83301306|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301307|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
83301308|NCT03654040|Everolimus|everolimus|mesh-list
83301309|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301310|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
83301311|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301312|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301313|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83301314|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
83301315|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301316|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301317|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83301318|NCT03654040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83301319|NCT03654040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83301320|NCT03654040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301321|NCT03844048|Venetoclax|venetoclax|mesh-list
83301322|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301323|NCT03833440|Docetaxel|docetaxel|mesh-list
83301324|NCT03833440|Durvalumab|durvalumab|mesh-list
83301325|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301326|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
83301327|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
83301328|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
83301329|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301330|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301331|NCT01677442|Anesthetics|anesthetics|mesh-list
83301332|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301333|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301334|NCT01695135|Prednisone|prednisone|mesh-list
83301335|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
83301336|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83301337|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
83301338|NCT01695135|Hormones|hormones|mesh-ancestor
83301339|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301340|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301341|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83301342|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301343|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83301344|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301345|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301346|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
83301347|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83301348|NCT01590771|Metformin|metformin|mesh-list
83301349|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83301350|NCT01590771|Glimepiride|glimepiride|mesh-list
83301351|NCT01590771|Gliclazide|gliclazide|mesh-list
83301352|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83301353|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301354|NCT01590771|Incretins|incretins|mesh-ancestor
83301355|NCT01590771|Hormones|hormones|mesh-ancestor
83301356|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301357|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83301358|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
83301359|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301360|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301361|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83301362|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301363|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
83301364|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83301365|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83301366|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301367|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
83301368|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301369|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301370|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
83301371|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
83301372|NCT03735316|Vitamins|vitamins|mesh-ancestor
83301373|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
83301374|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301375|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
83301376|NCT03735316|Hematinics|hematinics|mesh-ancestor
83301377|NCT01694433|Vitamin D|vitamin d|mesh-list
83301378|NCT01694433|Calcitriol|calcitriol|mesh-list
83301379|NCT01694433|Calcipotriene|calcipotriene|mesh-list
83301380|NCT01694433|Vitamins|vitamins|mesh-ancestor
83301381|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
83301382|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301383|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83301384|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
83301385|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83301386|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83301387|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301388|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301389|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83301390|NCT01693185|Midazolam|midazolam|mesh-list
83301391|NCT01693185|Meperidine|meperidine|mesh-list
83301392|NCT01693185|Remifentanil|remifentanil|mesh-list
83301393|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83301394|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83301395|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301396|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301397|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83301398|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83301399|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301400|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83301401|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
83301402|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
83301403|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
83301404|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
83301405|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301406|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301407|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83301408|NCT01693185|Narcotics|narcotics|mesh-ancestor
83301409|NCT01693185|Analgesics|analgesics|mesh-ancestor
83301410|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
83301411|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301412|NCT03824938|Aspirin|aspirin|mesh-list
83301413|NCT03824938|Acetaminophen|acetaminophen|mesh-list
83301414|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83301415|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83301416|NCT03824938|Analgesics|analgesics|mesh-ancestor
83301417|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
83301418|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301419|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301420|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83301421|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301422|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83301423|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83301424|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301425|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83301426|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83301427|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301428|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
83301429|NCT03630640|Nivolumab|nivolumab|mesh-list
83301430|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301431|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301432|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83301433|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301434|NCT03820726|Nintedanib|nintedanib|mesh-list
83301435|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301436|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83301437|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301438|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301439|NCT03625726|Thrombin|thrombin|mesh-list
83301440|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
83301441|NCT03625726|Coagulants|coagulants|mesh-ancestor
83301442|NCT03814954|Epinephrine|epinephrine|mesh-list
83301443|NCT03814954|Albuterol|albuterol|mesh-list
83301444|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83301445|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83301446|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
83301447|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301448|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301449|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301450|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83301451|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83301452|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
83301453|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301454|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83301455|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
83301456|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
83301457|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
83301458|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83301459|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
83301460|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83301461|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83301462|NCT03813160|Dronabinol|dronabinol|mesh-list
83301463|NCT03813160|Lenabasum|lenabasum|mesh-list
83301464|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83301465|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83301466|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301467|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301468|NCT03813160|Hormones|hormones|mesh-ancestor
83301469|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301470|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301471|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
83301472|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301473|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83301474|NCT03813160|Analgesics|analgesics|mesh-ancestor
83301475|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
83301476|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301477|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83301478|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83301479|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
83301480|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301481|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301482|NCT03807856|Dabigatran|dabigatran|mesh-list
83301483|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
83301484|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83301485|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
83301486|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301487|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301488|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
83301489|NCT03806530|Gabapentin|gabapentin|mesh-list
83301490|NCT03806530|Ropinirole|ropinirole|mesh-list
83301491|NCT03806530|Analgesics|analgesics|mesh-ancestor
83301492|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
83301493|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301494|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301495|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
83301496|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83301497|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83301498|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301499|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301500|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83301501|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83301502|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301503|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301504|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
83301505|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83301506|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83301507|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
83301508|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
83301509|NCT00003820|Rituximab|rituximab|mesh-list
83301510|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301511|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301512|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
83301513|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301514|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301515|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
83301516|NCT01693029|Hematinics|hematinics|mesh-ancestor
83301517|NCT01589445|Metformin|metformin|mesh-list
83301518|NCT01589445|Pioglitazone|pioglitazone|mesh-list
83301519|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83301520|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301521|NCT00003910|Prednisone|prednisone|mesh-list
83301522|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
83301523|NCT00003910|Methotrexate|methotrexate|mesh-list
83301524|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301525|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
83301526|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301527|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301528|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83301529|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
83301530|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301531|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301532|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83301533|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83301534|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
83301535|NCT00003910|Hormones|hormones|mesh-ancestor
83301536|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301537|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83301538|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83301539|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
83301540|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83301541|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301542|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
83301543|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83301544|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301545|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83301546|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83301547|NCT01561989|Vitamin D|vitamin d|mesh-list
83301548|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
83301549|NCT01561989|Vaccines|vaccines|mesh-list
83301550|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
83301551|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301552|NCT01561989|Vitamins|vitamins|mesh-ancestor
83301553|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
83301554|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83301555|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83301556|NCT00004054|Paclitaxel|paclitaxel|mesh-list
83301557|NCT00004054|Etoposide|etoposide|mesh-list
83301558|NCT00004054|Bicalutamide|bicalutamide|mesh-list
83301559|NCT00004054|Flutamide|flutamide|mesh-list
83301560|NCT00004054|Estramustine|estramustine|mesh-list
83301561|NCT00004054|Warfarin|warfarin|mesh-list
83301562|NCT00004054|Hormones|hormones|mesh-list
83301563|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83301564|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83301565|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301566|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
83301567|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
83301568|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
83301569|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301570|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83301571|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83301572|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301573|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301574|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301575|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
83301576|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
83301577|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
83301578|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83301579|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83301580|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
83301581|NCT01587885|Omeprazole|omeprazole|mesh-list
83301582|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83301583|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301584|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83301585|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301586|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301587|NCT03802240|Pemetrexed|pemetrexed|mesh-list
83301588|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301589|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301590|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301591|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83301592|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83301593|NCT03710122|Vancomycin|vancomycin|mesh-list
83301594|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83301595|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301596|NCT01587651|Ticagrelor|ticagrelor|mesh-list
83301597|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83301598|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83301599|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83301600|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83301601|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83301602|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
83301603|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301604|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301605|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301606|NCT04763434|Dexamethasone|dexamethasone|mesh-list
83301607|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
83301608|NCT04763434|Ropivacaine|ropivacaine|mesh-list
83301609|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83301610|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
83301611|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
83301612|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301613|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301614|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301615|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
83301616|NCT04763434|Hormones|hormones|mesh-ancestor
83301617|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301618|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83301619|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301620|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83301621|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301622|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83301623|NCT04763434|Analgesics|analgesics|mesh-ancestor
83301624|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
83301625|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83301626|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83301627|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83301628|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
83301629|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301630|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301631|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
83301632|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
83301633|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83301634|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
83301635|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301636|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301637|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
83301638|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301639|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301640|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83301641|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83301642|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301643|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
83301645|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83301646|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301647|NCT03602560|Seladelpar|seladelpar|mesh-list
83301648|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83301649|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
83301650|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301651|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83301652|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
83301653|NCT03797326|Lenvatinib|lenvatinib|mesh-list
83301654|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301655|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301656|NCT03797326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83301657|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301658|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83301659|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301660|NCT00779116|Cetirizine|cetirizine|mesh-list
83301661|NCT00779116|Desloratadine|desloratadine|mesh-list
83301662|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83301663|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83301664|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83301665|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
83301666|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
83301667|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301668|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301669|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301670|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83301671|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
83301672|NCT01691781|Lisinopril|lisinopril|mesh-list
83301673|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83301674|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
83301675|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301676|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301677|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83301678|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83301679|NCT01691781|Protective Agents|protective agents|mesh-ancestor
83301680|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301681|NCT04112043|Niacinamide|niacinamide|mesh-list
83301682|NCT04112043|Niacin|niacin|mesh-list
83301683|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
83301684|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
83301685|NCT04112043|Vitamins|vitamins|mesh-ancestor
83301686|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
83301687|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301688|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83301689|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
83301690|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301691|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83301692|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
83301693|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
83301694|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83301696|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
83301697|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83301698|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
83301699|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301700|NCT03789214|Suvorexant|suvorexant|mesh-list
83301701|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83301702|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83301703|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83301704|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301705|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83301706|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301707|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301708|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
83301709|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83301710|NCT04124367|Protective Agents|protective agents|mesh-ancestor
83301711|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301712|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
83301714|NCT01560507|Nicotine|nicotine|mesh-list
83301715|NCT01560507|Varenicline|varenicline|mesh-list
83301716|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83301717|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
83301718|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301719|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301720|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83301721|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83301722|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
83301723|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301724|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301725|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83301726|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
83301727|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83301728|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83301729|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83301730|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301731|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
83301732|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83301733|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83301734|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301735|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
83301736|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301737|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301738|NCT03694834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83301739|NCT03694834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301740|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83301741|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301742|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301743|NCT03587740|Immunotoxins|immunotoxins|mesh-ancestor
83301744|NCT03587740|Immunoconjugates|immunoconjugates|mesh-ancestor
83301745|NCT03587740|Immunologic Factors|immunologic factors|mesh-ancestor
83301746|NCT03587740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301747|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
83301748|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
83301749|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
83301750|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301751|NCT03586414|Ubiquinone|ubiquinone|mesh-list
83301752|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
83301753|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301754|NCT03684538|Zinc|zinc|mesh-list
83301755|NCT03684538|Trace Elements|trace elements|mesh-ancestor
83301756|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
83301757|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301758|NCT03682978|Baclofen|baclofen|mesh-list
83301759|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83301760|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301761|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83301762|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301763|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83301764|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
83301765|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
83301766|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301767|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301768|NCT03676192|Bevacizumab|bevacizumab|mesh-list
83301769|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301770|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301771|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83301772|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83301773|NCT03676192|Growth Substances|growth substances|mesh-ancestor
83301774|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301775|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
83301776|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
83301777|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83301778|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83301779|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83301780|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301781|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301782|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
83301784|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301785|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83301786|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301787|NCT03580408|Nivolumab|nivolumab|mesh-list
83301788|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301789|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301790|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83301791|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301792|NCT03775096|Carvedilol|carvedilol|mesh-list
83301793|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83301794|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83301795|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
83301796|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301797|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301798|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301799|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83301800|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
83301801|NCT03775096|Protective Agents|protective agents|mesh-ancestor
83301802|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83301803|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301804|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83301805|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
83301806|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83301807|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83301808|NCT03774394|Clopidogrel|clopidogrel|mesh-list
83301809|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83301810|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83301811|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83301812|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83301813|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
83301814|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301815|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301816|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301817|NCT03772834|Methylphenidate|methylphenidate|mesh-list
83301818|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83301819|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301820|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83301821|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83301822|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83301823|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301824|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
83301825|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301826|NCT03675256|Vaccines|vaccines|mesh-list
83301827|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
83301828|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301829|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
83301830|NCT03766750|Linagliptin|linagliptin|mesh-list
83301831|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83301832|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301833|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83301834|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301835|NCT03766750|Incretins|incretins|mesh-ancestor
83301836|NCT03766750|Hormones|hormones|mesh-ancestor
83301837|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301838|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83301839|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
83301840|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301841|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
83301842|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
83301843|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301844|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
83301845|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301846|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301847|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83301848|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
83301849|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301850|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301851|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83301852|NCT04762810|Hormones|hormones|mesh-ancestor
83301853|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83301855|NCT03674242|Gemcitabine|gemcitabine|mesh-list
83301856|NCT03674242|Asparaginase|asparaginase|mesh-list
83301857|NCT03674242|Eryaspase|eryaspase|mesh-list
83301858|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301859|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301860|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
83301861|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301862|NCT04761952|Infliximab|infliximab|mesh-list
83301863|NCT04761952|Azathioprine|azathioprine|mesh-list
83301864|NCT04761952|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83301865|NCT04761952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83301866|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
83301867|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301868|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301869|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
83301870|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301871|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301872|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301873|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301874|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
83301875|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301876|NCT03673072|Gemcitabine|gemcitabine|mesh-list
83301877|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301878|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301879|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
83301880|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301881|NCT01690299|Etanercept|etanercept|mesh-list
83301882|NCT01690299|Apremilast|apremilast|mesh-list
83301883|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83301884|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83301885|NCT01690299|Analgesics|analgesics|mesh-ancestor
83301886|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
83301887|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83301888|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301889|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83301890|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301891|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83301892|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301893|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
83301894|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83301895|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83301896|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301897|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301898|NCT03570814|Azithromycin|azithromycin|mesh-list
83301900|NCT03570814|Albendazole|albendazole|mesh-list
83301901|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83301902|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83301903|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83301904|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
83301905|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
83301906|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83301907|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83301908|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
83301909|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
83301910|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
83301911|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301912|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301913|NCT00723736|Desloratadine|desloratadine|mesh-list
83301914|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83301915|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
83301916|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83301917|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301918|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301919|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83301920|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83301921|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
83301922|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
83301923|NCT00305344|Vaccines|vaccines|mesh-list
83301924|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
83301925|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301926|NCT01690143|Melphalan|melphalan|mesh-list
83301927|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83301928|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
83301929|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301930|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301931|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83301932|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83301933|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
83301934|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301935|NCT05347498|Febuxostat|febuxostat|mesh-list
83301936|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
83301937|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83301938|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
83301939|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83301940|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83301941|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301942|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
83301943|NCT03553186|Coagulants|coagulants|mesh-ancestor
83301944|NCT01677364|Oxytocin|oxytocin|mesh-list
83301945|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
83301946|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83301947|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301948|NCT03563248|Nivolumab|nivolumab|mesh-list
83301949|NCT03563248|Folfirinox|folfirinox|mesh-list
83301950|NCT03563248|Losartan|losartan|mesh-list
83301951|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301952|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301953|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83301954|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301955|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83301956|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83301957|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83301958|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83301959|NCT04403776|Tofacitinib|tofacitinib|mesh-list
83301960|NCT04403776|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83301961|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83301962|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83301963|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301964|NCT03662074|Gemcitabine|gemcitabine|mesh-list
83301965|NCT03662074|Nivolumab|nivolumab|mesh-list
83301966|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301967|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
83301968|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301969|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301970|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301971|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83301973|NCT03559348|Gemcitabine|gemcitabine|mesh-list
83301974|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83301975|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
83301976|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301977|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301978|NCT03559348|Antidotes|antidotes|mesh-ancestor
83301979|NCT03559348|Protective Agents|protective agents|mesh-ancestor
83301980|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83301981|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
83301982|NCT03559348|Vitamins|vitamins|mesh-ancestor
83301983|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
83301984|NCT04762030|Paclitaxel|paclitaxel|mesh-list
83301985|NCT04762030|Carboplatin|carboplatin|mesh-list
83301986|NCT04762030|Durvalumab|durvalumab|mesh-list
83301987|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83301988|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83301989|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
83301990|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
83301991|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
83301992|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83301993|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83301994|NCT01559259|Acetaminophen|acetaminophen|mesh-list
83301995|NCT01559259|Ibuprofen|ibuprofen|mesh-list
83301996|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83301997|NCT01559259|Analgesics|analgesics|mesh-ancestor
83301998|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
83301999|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302000|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302001|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
83302002|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83302003|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302004|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302005|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83302006|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302007|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302008|NCT03088306|Acetaminophen|acetaminophen|mesh-list
83302009|NCT03088306|Fentanyl|fentanyl|mesh-list
83302010|NCT03088306|Ketamine|ketamine|mesh-list
83302011|NCT03088306|Gabapentin|gabapentin|mesh-list
83302012|NCT03088306|Hydromorphone|hydromorphone|mesh-list
83302013|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
83302014|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302015|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302016|NCT03088306|Analgesics|analgesics|mesh-ancestor
83302017|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
83302018|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302019|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83302020|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83302021|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
83302022|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83302023|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83302024|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302025|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302026|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83302027|NCT03088306|Narcotics|narcotics|mesh-ancestor
83302028|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83302029|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83302030|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
83302031|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
83302032|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83302033|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83302034|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83302035|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
83302036|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
83302037|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83302038|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302039|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83302040|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302041|NCT03088384|Ketamine|ketamine|mesh-list
83302042|NCT03088384|Analgesics|analgesics|mesh-ancestor
83302043|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
83302044|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302045|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302046|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83302047|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83302048|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
83302049|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
83302050|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302051|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83302052|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83302053|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302054|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302055|NCT01677598|Ustekinumab|ustekinumab|mesh-list
83302056|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302057|NCT01677754|Memantine|memantine|mesh-list
83302058|NCT01677754|Rivastigmine|rivastigmine|mesh-list
83302059|NCT01677754|Donepezil|donepezil|mesh-list
83302060|NCT01677754|Galantamine|galantamine|mesh-list
83302061|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83302062|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302063|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302064|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
83302065|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302066|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302067|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
83302068|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83302069|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83302070|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
83302071|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83302072|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83302073|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83302074|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
83302075|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302076|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83302077|NCT01677754|Protective Agents|protective agents|mesh-ancestor
83302078|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
83302079|NCT01670500|Cisplatin|cisplatin|mesh-list
83302080|NCT01670500|Doxorubicin|doxorubicin|mesh-list
83302081|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302082|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
83302083|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302084|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302085|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83302086|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
83302087|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302088|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302089|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83302090|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83302091|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83302092|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83302093|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302094|NCT01678612|Copper|copper|mesh-list
83302095|NCT01678612|Trace Elements|trace elements|mesh-ancestor
83302096|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
83302097|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302098|NCT03525574|Ivacaftor|ivacaftor|mesh-list
83302099|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83302100|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83302101|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302102|NCT02402920|Cisplatin|cisplatin|mesh-list
83302103|NCT02402920|Carboplatin|carboplatin|mesh-list
83302104|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
83302105|NCT02402920|Etoposide|etoposide|mesh-list
83302106|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
83302107|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
83302108|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302109|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302110|NCT02402920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83302111|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302112|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83302113|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83302114|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83302115|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302116|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
83302117|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302118|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
83302119|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
83302120|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
83302121|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83302122|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83302123|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302124|NCT02405260|Incretins|incretins|mesh-ancestor
83302125|NCT02405260|Hormones|hormones|mesh-ancestor
83302126|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83302127|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83302128|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
83302129|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302130|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302131|NCT03519646|Eliglustat|eliglustat|mesh-list
83302132|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302133|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302134|NCT02984722|Metformin|metformin|mesh-list
83302135|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83302136|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302137|NCT02401750|Naltrexone|naltrexone|mesh-list
83302138|NCT02401750|Oxycodone|oxycodone|mesh-list
83302139|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83302140|NCT02401750|Narcotics|narcotics|mesh-ancestor
83302141|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302142|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302143|NCT02401750|Analgesics|analgesics|mesh-ancestor
83302144|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
83302145|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302146|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83302147|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83302148|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
83302149|NCT03087136|Antibodies|antibodies|mesh-list
83302150|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
83302151|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302152|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83302153|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83302154|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302155|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
83302156|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302157|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
83302158|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83302159|NCT03087136|Protective Agents|protective agents|mesh-ancestor
83302161|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302162|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83302163|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302164|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302165|NCT01689363|Histamine|histamine|mesh-list
83302166|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
83302167|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
83302168|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302169|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302170|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302171|NCT03455140|BCT-100|bct-100|mesh-list
83302172|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302173|NCT03502018|Bupivacaine|bupivacaine|mesh-list
83302174|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
83302175|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
83302176|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302177|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302178|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
83302179|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302180|NCT01689207|Aztreonam|aztreonam|mesh-list
83302181|NCT01689207|Avibactam|avibactam|mesh-list
83302182|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83302183|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302184|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83302185|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302186|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302187|NCT00089284|Rituximab|rituximab|mesh-list
83302188|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
83302189|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302190|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302191|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
83302192|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302193|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302194|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83302195|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302196|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83302197|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302198|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83302199|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302200|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302201|NCT00087646|Ribavirin|ribavirin|mesh-list
83302202|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83302203|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
83302204|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
83302205|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302206|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
83302207|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302208|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
83302209|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302210|NCT03492658|Methotrexate|methotrexate|mesh-list
83302211|NCT03492658|Abatacept|abatacept|mesh-list
83302212|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83302213|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
83302214|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83302215|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302216|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83302217|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
83302218|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302219|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302220|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302221|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302222|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83302223|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302224|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
83302225|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302226|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83302227|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83302228|NCT03492658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302229|NCT03085654|Oxytocin|oxytocin|mesh-list
83302230|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
83302231|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83302232|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302233|NCT00087568|Ribavirin|ribavirin|mesh-list
83302234|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83302235|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
83302236|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302237|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
83302238|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302239|NCT04402762|Enoxaparin|enoxaparin|mesh-list
83302240|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
83302241|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
83302242|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83302243|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83302244|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302245|NCT00085540|Romidepsin|romidepsin|mesh-list
83302246|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83302247|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302248|NCT00085540|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83302249|NCT00085540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302250|NCT00085540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302251|NCT01688739|Erenumab|erenumab|mesh-list
83302252|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83302253|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302254|NCT01688739|Analgesics|analgesics|mesh-ancestor
83302255|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
83302256|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302257|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302258|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
83302259|NCT00084838|Leucovorin|leucovorin|mesh-list
83302260|NCT00084838|Cytarabine|cytarabine|mesh-list
83302261|NCT00084838|Dactinomycin|dactinomycin|mesh-list
83302262|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
83302263|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83302264|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83302265|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83302266|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
83302267|NCT00084838|Temozolomide|temozolomide|mesh-list
83302268|NCT00084838|Cisplatin|cisplatin|mesh-list
83302269|NCT00084838|Doxorubicin|doxorubicin|mesh-list
83302270|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83302271|NCT00084838|Methotrexate|methotrexate|mesh-list
83302272|NCT00084838|Etoposide|etoposide|mesh-list
83302273|NCT00084838|Vincristine|vincristine|mesh-list
83302274|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
83302275|NCT00084838|Razoxane|razoxane|mesh-list
83302276|NCT00084838|Lenograstim|lenograstim|mesh-list
83302277|NCT00084838|Calcium|calcium|mesh-list
83302278|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
83302279|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302280|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
83302281|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302282|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302283|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83302284|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
83302285|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302286|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302287|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83302288|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83302289|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83302290|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83302291|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302292|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83302293|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83302294|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83302295|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
83302296|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83302297|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83302298|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
83302299|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302300|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83302301|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83302302|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83302303|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
83302304|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302305|NCT00084838|Antidotes|antidotes|mesh-ancestor
83302306|NCT00084838|Protective Agents|protective agents|mesh-ancestor
83302307|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
83302308|NCT00084838|Vitamins|vitamins|mesh-ancestor
83302309|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
83302310|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83302311|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
83302312|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
83302313|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
83302314|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302315|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83302316|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83302317|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83302319|NCT01558089|Methotrexate|methotrexate|mesh-list
83302320|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83302321|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
83302322|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83302323|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302324|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83302325|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
83302326|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302327|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302328|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302329|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302330|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83302331|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302332|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
83302333|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302334|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83302335|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83302336|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83302337|NCT01558089|Analgesics|analgesics|mesh-ancestor
83302338|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
83302339|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302340|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302341|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83302342|NCT00084682|Romidepsin|romidepsin|mesh-list
83302343|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83302344|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302345|NCT00084682|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83302346|NCT00084682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302347|NCT00084682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302348|NCT01556997|Amlodipine|amlodipine|mesh-list
83302349|NCT01556997|Perindopril|perindopril|mesh-list
83302350|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83302351|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83302352|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83302353|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302354|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83302355|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302356|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
83302357|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83302358|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
83302359|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302360|NCT00082888|Tipifarnib|tipifarnib|mesh-list
83302361|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302362|NCT03409588|Riociguat|riociguat|mesh-list
83302363|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
83302364|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302365|NCT03085186|Crizotinib|crizotinib|mesh-list
83302366|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302367|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83302368|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302369|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302370|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83302371|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83302372|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83302373|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302374|NCT00082810|Fulvestrant|fulvestrant|mesh-list
83302375|NCT00082810|Tipifarnib|tipifarnib|mesh-list
83302376|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83302377|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302378|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83302379|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83302380|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
83302381|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83302382|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302383|NCT03480334|Nivolumab|nivolumab|mesh-list
83302389|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302390|NCT03085030|Protective Agents|protective agents|mesh-ancestor
83302391|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302392|NCT03443128|Vinorelbine|vinorelbine|mesh-list
83302393|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83302394|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302395|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
83302396|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
83302397|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
83302398|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302399|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
83302400|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83302401|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83302402|NCT03437746|Prednisolone|prednisolone|mesh-list
83302403|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
83302404|NCT03437746|Anesthetics|anesthetics|mesh-list
83302405|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83302406|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
83302407|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302408|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
83302409|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
83302410|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302411|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302412|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83302413|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
83302414|NCT03437746|Hormones|hormones|mesh-ancestor
83302415|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83302416|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83302417|NCT03437746|Protective Agents|protective agents|mesh-ancestor
83302418|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83302419|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302420|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302421|NCT03479476|Metformin|metformin|mesh-list
83302422|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83302423|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302429|NCT03084250|Tenofovir|tenofovir|mesh-list
83302430|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83302431|NCT03084250|Entecavir|entecavir|mesh-list
83302432|NCT03084250|Adefovir|adefovir|mesh-list
83302433|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
83302434|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302435|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83302436|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83302437|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302438|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302439|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83302440|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83302441|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
83302442|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83302443|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83302444|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83302445|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302446|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
83302447|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302448|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302449|NCT03084328|Vitamin D|vitamin d|mesh-list
83302450|NCT03084328|Vitamins|vitamins|mesh-ancestor
83302451|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
83302452|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302453|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83302454|NCT03435718|Albendazole|albendazole|mesh-list
83302455|NCT03435718|Oxfendazole|oxfendazole|mesh-list
83302456|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
83302457|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83302458|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302459|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
83302460|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83302461|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83302462|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
83302463|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
83302464|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
83302465|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302466|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302467|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
83302468|NCT01678690|Gemcitabine|gemcitabine|mesh-list
83302469|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83302470|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
83302471|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302472|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302473|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
83302474|NCT01679080|Teriparatide|teriparatide|mesh-list
83302475|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83302476|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302477|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83302478|NCT03083782|Cyclosporine|cyclosporine|mesh-list
83302479|NCT03083782|Apixaban|apixaban|mesh-list
83302480|NCT03083782|Tacrolimus|tacrolimus|mesh-list
83302481|NCT03083782|Cyclosporins|cyclosporins|mesh-list
83302482|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302483|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
83302484|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302485|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83302486|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302487|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302488|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
83302489|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302490|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302491|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302492|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83302493|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
83302494|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83302495|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
83302496|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
83302497|NCT03083704|Enoxaparin|enoxaparin|mesh-list
83302498|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
83302499|NCT03083704|Apixaban|apixaban|mesh-list
83302500|NCT03083704|Edoxaban|edoxaban|mesh-list
83302501|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
83302502|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83302503|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
83302504|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83302505|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
83302506|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302507|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302508|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
83302509|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83302510|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83302511|NCT03471442|Bupivacaine|bupivacaine|mesh-list
83302512|NCT03471442|Ropivacaine|ropivacaine|mesh-list
83302513|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
83302514|NCT03471442|Anesthetics|anesthetics|mesh-list
83302515|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
83302516|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302517|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302518|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
83302519|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302520|NCT01679392|Ropivacaine|ropivacaine|mesh-list
83302521|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83302522|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
83302523|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302524|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302525|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
83302526|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302527|NCT03083080|Epinephrine|epinephrine|mesh-list
83302528|NCT03083080|Ropivacaine|ropivacaine|mesh-list
83302529|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
83302530|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
83302531|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302532|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302533|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
83302534|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302535|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83302536|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83302537|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
83302538|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302539|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302540|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83302541|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83302542|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
83302543|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83302544|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
83302546|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
83302547|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83302548|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
83302549|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302550|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302551|NCT03087760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83302552|NCT03087760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302553|NCT03466294|Azacitidine|azacitidine|mesh-list
83302554|NCT03466294|Venetoclax|venetoclax|mesh-list
83302555|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83302556|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
83302557|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302558|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302559|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302560|NCT03082300|Naquotinib|naquotinib|mesh-list
83302561|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302562|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83302563|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302564|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302565|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
83302566|NCT01679860|Immunomodulating Agents|immunomodulating agents|mesh-list
83302567|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
83302568|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302569|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302570|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302571|NCT05346952|Carboplatin|carboplatin|mesh-list
83302572|NCT05346952|Pemetrexed|pemetrexed|mesh-list
83302573|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302574|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302575|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302576|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83302577|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83302578|NCT03081442|Misoprostol|misoprostol|mesh-list
83302579|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
83302580|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83302581|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
83302582|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83302583|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302584|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83302585|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83302586|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
83302587|NCT03431194|Midodrine|midodrine|mesh-list
83302588|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
83302589|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
83302590|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302591|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302592|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83302593|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83302594|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83302595|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83302596|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
83302597|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302598|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302599|NCT03080740|Metronidazole|metronidazole|mesh-list
83302600|NCT03080740|Clindamycin|clindamycin|mesh-list
83302601|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
83302602|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
83302603|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302604|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83302605|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83302606|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83302607|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83302608|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302609|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302610|NCT03081832|Oxytocin|oxytocin|mesh-list
83302611|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
83302612|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83302613|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302615|NCT05345938|Analgesics|analgesics|mesh-ancestor
83302616|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
83302617|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302618|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302619|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302620|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83302621|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83302622|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302623|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302624|NCT03080350|Fentanyl|fentanyl|mesh-list
83302625|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83302626|NCT03080350|Narcotics|narcotics|mesh-ancestor
83302627|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302628|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302629|NCT03080350|Analgesics|analgesics|mesh-ancestor
83302630|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
83302631|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302632|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83302633|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83302634|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
83302635|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
83302636|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83302637|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83302638|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83302639|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302640|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302641|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83302642|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83302643|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83302644|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
83302645|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302646|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302647|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83302648|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83302649|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
83302651|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302652|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83302653|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302654|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302655|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
83302656|NCT03323866|Budesonide|budesonide|mesh-list
83302657|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302658|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83302659|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
83302660|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302661|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302662|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83302663|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
83302664|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
83302665|NCT03323866|Hormones|hormones|mesh-ancestor
83302666|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83302667|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
83302668|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83302669|NCT05688670|Ropivacaine|ropivacaine|mesh-list
83302670|NCT05688670|Anesthetics|anesthetics|mesh-ancestor
83302671|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302672|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302673|NCT05688670|Anesthetics, Local|anesthetics, local|mesh-ancestor
83302674|NCT05688670|Sensory System Agents|sensory system agents|mesh-ancestor
83302675|NCT05688670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302676|NCT05684848|Resveratrol|resveratrol|mesh-list
83302677|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
83302678|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302679|NCT05684848|Protective Agents|protective agents|mesh-ancestor
83302680|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302681|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302682|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83302683|NCT03366298|Epinephrine|epinephrine|mesh-list
83302684|NCT03366298|Racepinephrine|racepinephrine|mesh-list
83302685|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
83302686|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83302687|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83302688|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
83302689|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302690|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302691|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302692|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83302693|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83302694|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
83302695|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302696|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83302697|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
83302698|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
83302699|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
83302700|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83302701|NCT05688436|Interferons|interferons|mesh-list
83302702|NCT05688436|Interferon-beta|interferon-beta|mesh-list
83302703|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
83302704|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
83302705|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
83302706|NCT05688436|Natalizumab|natalizumab|mesh-list
83302707|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83302708|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
83302709|NCT05688436|Siponimod|siponimod|mesh-list
83302710|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302711|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
83302712|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302713|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302714|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
83302715|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302716|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83302717|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302718|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302719|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83302720|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302721|NCT03386578|Tenofovir|tenofovir|mesh-list
83302722|NCT03386578|Emtricitabine|emtricitabine|mesh-list
83302723|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83302724|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
83302725|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302726|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83302727|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83302728|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302729|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302730|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83302731|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83302732|NCT05688202|Acetaminophen|acetaminophen|mesh-list
83302733|NCT05688202|Lidocaine|lidocaine|mesh-list
83302734|NCT05688202|Prilocaine|prilocaine|mesh-list
83302735|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83302736|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
83302737|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
83302738|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302739|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302740|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
83302741|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302742|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83302743|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83302744|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83302745|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83302746|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302747|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83302748|NCT05688202|Analgesics|analgesics|mesh-ancestor
83302749|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
83302750|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83302751|NCT05688124|Esomeprazole|esomeprazole|mesh-list
83302752|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83302753|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83302754|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83302755|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302756|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302757|NCT01842620|Metformin|metformin|mesh-list
83302758|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83302759|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302760|NCT05687344|Nifedipine|nifedipine|mesh-list
83302761|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83302762|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83302763|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302764|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83302765|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302766|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
83302767|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
83302768|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83302769|NCT04760704|Antibodies|antibodies|mesh-list
83302770|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
83302771|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302772|NCT03356860|Paclitaxel|paclitaxel|mesh-list
83302773|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
83302774|NCT03356860|Durvalumab|durvalumab|mesh-list
83302775|NCT03356860|Epirubicin|epirubicin|mesh-list
83302776|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83302777|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302778|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
83302779|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
83302780|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
83302781|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302782|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302783|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
83302784|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302785|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302786|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83302787|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
83302788|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83302789|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302790|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83302791|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83302792|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83302793|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302794|NCT01931839|Ivacaftor|ivacaftor|mesh-list
83302795|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83302796|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83302797|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302799|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
83302800|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83302801|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83302802|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
83302803|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302804|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302805|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83302806|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302807|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
83302808|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302809|NCT01931059|Risperidone|risperidone|mesh-list
83302810|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83302811|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
83302812|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302813|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302814|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302815|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83302816|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83302817|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302818|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83302819|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83302820|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
83302821|NCT01841762|Macitentan|macitentan|mesh-list
83302822|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83302823|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83302824|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302825|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83302826|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
83302827|NCT03301636|Nivolumab|nivolumab|mesh-list
83302828|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302829|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302830|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83302831|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302832|NCT04602494|Varenicline|varenicline|mesh-list
83302833|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83302834|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83302835|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
83302836|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302837|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302838|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302839|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83302840|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
83302841|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
83302842|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302843|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302844|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83302845|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83302846|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
83302847|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83302848|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302849|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83302850|NCT01970371|Meropenem|meropenem|mesh-list
83302851|NCT01970371|Colistin|colistin|mesh-list
83302852|NCT01970371|Tigecycline|tigecycline|mesh-list
83302853|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302854|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83302855|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302856|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302857|NCT04621435|Copper|copper|mesh-list
83302858|NCT04621435|Trace Elements|trace elements|mesh-ancestor
83302859|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
83302860|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302861|NCT04171700|Rucaparib|rucaparib|mesh-list
83302862|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83302863|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302864|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302865|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302866|NCT05604742|Belimumab|belimumab|mesh-list
83302867|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83302868|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
83302869|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302870|NCT03350386|Oxaprozin|oxaprozin|mesh-list
83302871|NCT03350386|Dotinurad|dotinurad|mesh-list
83302872|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
83302873|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
83302874|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302875|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83302876|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83302877|NCT03350386|Analgesics|analgesics|mesh-ancestor
83302878|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
83302879|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302880|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302881|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302882|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83302883|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302884|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302885|NCT05567458|Luspatercept|luspatercept|mesh-list
83302886|NCT05567458|Hematinics|hematinics|mesh-ancestor
83302887|NCT03344692|Alirocumab|alirocumab|mesh-list
83302888|NCT03344692|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83302889|NCT03344692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83302890|NCT03344692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83302891|NCT03344692|Antimetabolites|antimetabolites|mesh-ancestor
83302892|NCT03344692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302893|NCT03344692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83302894|NCT03344692|Protease Inhibitors|protease inhibitors|mesh-ancestor
83302895|NCT03344692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302896|NCT03344692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83302897|NCT05305924|Fulvestrant|fulvestrant|mesh-list
83302898|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83302899|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302900|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83302901|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83302902|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
83302903|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83302904|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302905|NCT05548582|Acetaminophen|acetaminophen|mesh-list
83302906|NCT05548582|Ibuprofen|ibuprofen|mesh-list
83302907|NCT05548582|Oxycodone|oxycodone|mesh-list
83302908|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83302909|NCT05548582|Analgesics|analgesics|mesh-ancestor
83302910|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
83302911|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83302912|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302914|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83302915|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302916|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83302917|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83302918|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302919|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302920|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83302921|NCT05548582|Narcotics|narcotics|mesh-ancestor
83302922|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302923|NCT05084638|Ofatumumab|ofatumumab|mesh-list
83302924|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302925|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83302926|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
83302927|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302928|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
83302929|NCT05223088|Apatinib|apatinib|mesh-list
83302930|NCT05223088|Tislelizumab|tislelizumab|mesh-list
83302931|NCT05223088|Tegafur|tegafur|mesh-list
83302932|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302933|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83302934|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302935|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302936|NCT05223088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302937|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83302938|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
83302939|NCT01838876|Cariprazine|cariprazine|mesh-list
83302940|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
83302941|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83302942|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83302943|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83302944|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83302945|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302946|NCT03279250|Prednisone|prednisone|mesh-list
83302947|NCT03279250|Cortisone|cortisone|mesh-list
83302948|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
83302949|NCT03279250|Hormones|hormones|mesh-list
83302950|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83302951|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83302952|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
83302953|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83302954|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83302955|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83302956|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302957|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83302958|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302959|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302960|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
83302961|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83302962|NCT01838642|Ponatinib|ponatinib|mesh-list
83302963|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302964|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83302965|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302966|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302967|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83302968|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83302969|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
83302970|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83302971|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83302972|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302973|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
83302974|NCT01813058|Coagulants|coagulants|mesh-ancestor
83302975|NCT05491330|Ritonavir|ritonavir|mesh-list
83302976|NCT05491330|Nirmatrelvir|nirmatrelvir|mesh-list
83302977|NCT05491330|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83302978|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83302979|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83302980|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
83302981|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83302982|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83302983|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83302984|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83302985|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
83302986|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302987|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83302988|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83302989|NCT04601402|Avelumab|avelumab|mesh-list
83302990|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83302991|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83302992|NCT01811732|Vancomycin|vancomycin|mesh-list
83302993|NCT01811732|Aztreonam|aztreonam|mesh-list
83302994|NCT01811732|Delafloxacin|delafloxacin|mesh-list
83302995|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83302996|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83302997|NCT05139004|Fludarabine|fludarabine|mesh-list
83302998|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
83302999|NCT05139004|Melphalan|melphalan|mesh-list
83303000|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
83303001|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83303002|NCT05139004|Basiliximab|basiliximab|mesh-list
83303003|NCT05139004|Mitogens|mitogens|mesh-list
83303004|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
83303005|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303006|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83303007|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
83303008|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303009|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303010|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
83303011|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303012|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83303013|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
83303014|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83303015|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83303016|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
83303017|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
83303018|NCT01811186|Oxycodone|oxycodone|mesh-list
83303019|NCT01811186|Naloxone|naloxone|mesh-list
83303021|NCT01811186|Narcotics|narcotics|mesh-ancestor
83303022|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303023|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303024|NCT01811186|Analgesics|analgesics|mesh-ancestor
83303025|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
83303026|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303027|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83303028|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
83303029|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303030|NCT01866098|Naltrexone|naltrexone|mesh-list
83303031|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83303032|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83303033|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303034|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
83303035|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303036|NCT04885972|Triamcinolone|triamcinolone|mesh-list
83303037|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83303038|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83303039|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83303040|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303041|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
83303042|NCT04885972|Hormones|hormones|mesh-ancestor
83303043|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303044|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303045|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303046|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
83303047|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303048|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303049|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83303050|NCT04039750|Clindamycin|clindamycin|mesh-list
83303051|NCT04039750|Gentamicins|gentamicins|mesh-list
83303052|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303053|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83303054|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303055|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303056|NCT03236428|Daratumumab|daratumumab|mesh-list
83303057|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303058|NCT03985540|Methamphetamine|methamphetamine|mesh-list
83303059|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83303060|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303061|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
83303062|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
83303063|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303064|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
83303065|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303066|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303067|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
83303068|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83303069|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83303070|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83303071|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83303072|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83303073|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
83303074|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
83303075|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303076|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303077|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
83303078|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303079|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83303080|NCT01865552|Etanercept|etanercept|mesh-list
83303081|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83303082|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83303083|NCT01865552|Analgesics|analgesics|mesh-ancestor
83303084|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
83303085|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303086|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303087|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303088|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83303089|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303090|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303091|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
83303092|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
83303093|NCT01809314|Hematinics|hematinics|mesh-ancestor
83303094|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83303095|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83303096|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303097|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303098|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
83303099|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303100|NCT05185024|Iron|iron|mesh-list
83303101|NCT05185024|Trace Elements|trace elements|mesh-ancestor
83303102|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
83303103|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303104|NCT01808690|Metformin|metformin|mesh-list
83303105|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83303106|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303107|NCT04583618|Vaccines|vaccines|mesh-list
83303108|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83303109|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
83303110|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303111|NCT04413734|Cisplatin|cisplatin|mesh-list
83303112|NCT04413734|Gemcitabine|gemcitabine|mesh-list
83303113|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303114|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83303115|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
83303116|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303117|NCT03229798|Sumatriptan|sumatriptan|mesh-list
83303118|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83303119|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83303120|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83303121|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
83303122|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303123|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303124|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303125|NCT04805944|Dolutegravir|dolutegravir|mesh-list
83303126|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83303127|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83303128|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303129|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303130|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83303131|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83303132|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
83303133|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303134|NCT03906292|Niacinamide|niacinamide|mesh-list
83303135|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
83303136|NCT03906292|Dasatinib|dasatinib|mesh-list
83303137|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303138|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303139|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303140|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303141|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
83303142|NCT03906292|Vitamins|vitamins|mesh-ancestor
83303143|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
83303144|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303145|NCT03229174|Droxidopa|droxidopa|mesh-list
83303146|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83303147|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83303148|NCT03227926|Panitumumab|panitumumab|mesh-list
83303149|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303150|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303151|NCT03615742|Budesonide|budesonide|mesh-list
83303152|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303153|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83303154|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
83303155|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303156|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303157|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83303158|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
83303159|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
83303160|NCT03615742|Hormones|hormones|mesh-ancestor
83303161|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303162|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83303163|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303164|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303165|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83303167|NCT01363297|Immunoconjugates|immunoconjugates|mesh-ancestor
83303168|NCT01363297|Immunologic Factors|immunologic factors|mesh-ancestor
83303169|NCT01363297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303170|NCT04756804|Ethanol|ethanol|mesh-list
83303171|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
83303172|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83303173|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83303174|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303175|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303176|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303177|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
83303178|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
83303179|NCT03829462|Irinotecan|irinotecan|mesh-list
83303180|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83303181|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83303182|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303183|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303184|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303185|NCT03199924|Diclofenac|diclofenac|mesh-list
83303186|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83303187|NCT03199924|Lidocaine|lidocaine|mesh-list
83303188|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
83303189|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
83303190|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
83303191|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303192|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303193|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
83303194|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303195|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83303196|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83303197|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83303198|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83303199|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303200|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83303201|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83303202|NCT03199924|Analgesics|analgesics|mesh-ancestor
83303203|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83303204|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83303205|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303206|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
83303207|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83303208|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83303209|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
83303210|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83303211|NCT03199300|Trastuzumab|trastuzumab|mesh-list
83303212|NCT03199300|Bleomycin|bleomycin|mesh-list
83303213|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303214|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303215|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83303216|NCT04746430|Dexamethasone|dexamethasone|mesh-list
83303217|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303218|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
83303219|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
83303220|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303221|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303222|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303223|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
83303224|NCT04746430|Hormones|hormones|mesh-ancestor
83303225|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303226|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83303227|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303228|NCT03781414|Tacrolimus|tacrolimus|mesh-list
83303229|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303230|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
83303231|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303232|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83303233|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303234|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303235|NCT03642028|Suvorexant|suvorexant|mesh-list
83303236|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83303237|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83303238|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303239|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303240|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83303241|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303242|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303243|NCT04407442|Dexamethasone|dexamethasone|mesh-list
83303244|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
83303245|NCT04407442|Azacitidine|azacitidine|mesh-list
83303246|NCT04407442|Daratumumab|daratumumab|mesh-list
83303247|NCT04407442|Ichthammol|ichthammol|mesh-list
83303248|NCT04407442|BB 1101|bb 1101|mesh-list
83303249|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303250|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
83303251|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
83303252|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303253|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303254|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303255|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
83303256|NCT04407442|Hormones|hormones|mesh-ancestor
83303257|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303258|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83303259|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303260|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
83303261|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303262|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303263|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83303264|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
83303265|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
83303266|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
83303267|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303268|NCT03197662|Oxytocin|oxytocin|mesh-list
83303269|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
83303270|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83303271|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303272|NCT03194542|Luspatercept|luspatercept|mesh-list
83303273|NCT03194542|Hematinics|hematinics|mesh-ancestor
83303274|NCT03247582|Edoxaban|edoxaban|mesh-list
83303275|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83303276|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
83303277|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83303278|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
83303279|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303280|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303281|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
83303282|NCT01808612|Fluoxetine|fluoxetine|mesh-list
83303283|NCT01808612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83303284|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83303285|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83303286|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303287|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303288|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
83303289|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303290|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83303291|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
83303292|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83303293|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83303294|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83303295|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303296|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
83303298|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83303299|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83303300|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83303301|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303302|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303303|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303304|NCT01908829|Urological Agents|urological agents|mesh-ancestor
83303305|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83303306|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83303307|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83303308|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
83303310|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303311|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
83303312|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83303313|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83303314|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83303315|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303316|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303317|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
83303318|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303319|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
83303320|NCT01808534|Ifosfamide|ifosfamide|mesh-list
83303321|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83303322|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
83303323|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303324|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303325|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
83303326|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83303327|NCT03218800|Ertapenem|ertapenem|mesh-list
83303328|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303329|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303330|NCT01802216|Minocycline|minocycline|mesh-list
83303331|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303332|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303333|NCT03621904|Tamoxifen|tamoxifen|mesh-list
83303334|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
83303335|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
83303336|NCT03621904|Progesterone|progesterone|mesh-list
83303337|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83303338|NCT03621904|Progestins|progestins|mesh-ancestor
83303339|NCT03621904|Hormones|hormones|mesh-ancestor
83303340|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303341|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303342|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83303343|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
83303344|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83303345|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83303346|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83303347|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83303348|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303349|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303350|NCT01808144|Febuxostat|febuxostat|mesh-list
83303351|NCT01808144|Lesinurad|lesinurad|mesh-list
83303352|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
83303353|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83303354|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
83303355|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
83303356|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303357|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303358|NCT02085070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83303359|NCT02085070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303360|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83303361|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
83303362|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303363|NCT01801436|Bortezomib|bortezomib|mesh-list
83303364|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303365|NCT01771250|Insulin|insulin|mesh-list
83303366|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83303367|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
83303368|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83303369|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303370|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83303371|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83303372|NCT03568708|Estradiol|estradiol|mesh-list
83303373|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83303374|NCT03568708|Estrogens|estrogens|mesh-list
83303375|NCT03568708|Hormones|hormones|mesh-ancestor
83303376|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303377|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303378|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83303379|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
83303380|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83303381|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83303382|NCT04305106|Bevacizumab|bevacizumab|mesh-list
83303383|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303384|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303385|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83303386|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83303387|NCT04305106|Growth Substances|growth substances|mesh-ancestor
83303388|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303389|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83303390|NCT01770392|Rifampin|rifampin|mesh-list
83303391|NCT01770392|Nintedanib|nintedanib|mesh-list
83303392|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83303393|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
83303394|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303395|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303396|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
83303397|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83303398|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303399|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303400|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83303401|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83303402|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83303403|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83303404|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83303405|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83303406|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303407|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303408|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
83303409|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83303410|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83303411|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83303412|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83303413|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303414|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
83303415|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303416|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303417|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83303418|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303419|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
83303420|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83303421|NCT03492112|Velpatasvir|velpatasvir|mesh-list
83303422|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
83303423|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303424|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
83303425|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83303426|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303427|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303428|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83303429|NCT04397458|Dexamethasone|dexamethasone|mesh-list
83303430|NCT04397458|Bupivacaine|bupivacaine|mesh-list
83303431|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303432|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
83303433|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
83303434|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303435|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303436|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303437|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
83303438|NCT04397458|Hormones|hormones|mesh-ancestor
83303439|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303440|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83303441|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303442|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
83303443|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
83303444|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303445|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
83303446|NCT04398316|Lidocaine|lidocaine|mesh-list
83303447|NCT04398316|Hydromorphone|hydromorphone|mesh-list
83303448|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
83303449|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
83303450|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303451|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303452|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
83303453|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303454|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83303455|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83303456|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83303457|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83303458|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303459|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83303460|NCT04398316|Narcotics|narcotics|mesh-ancestor
83303461|NCT04398316|Analgesics|analgesics|mesh-ancestor
83303462|NCT01576575|Rifampin|rifampin|mesh-list
83303463|NCT01576575|Ketoconazole|ketoconazole|mesh-list
83303464|NCT01576575|Buprenorphine|buprenorphine|mesh-list
83303465|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83303466|NCT01576575|Narcotics|narcotics|mesh-ancestor
83303467|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303468|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303469|NCT01576575|Analgesics|analgesics|mesh-ancestor
83303470|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
83303471|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303472|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83303473|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83303474|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
83303475|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303476|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303477|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
83303478|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83303479|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303480|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303481|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83303482|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83303483|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83303484|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83303485|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83303486|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83303487|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
83303488|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83303489|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83303490|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83303491|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
83303492|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303493|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83303494|NCT05051566|Esomeprazole|esomeprazole|mesh-list
83303495|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83303496|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303497|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83303498|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303499|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303500|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
83303501|NCT01576341|Hematinics|hematinics|mesh-ancestor
83303502|NCT04276090|Dexamethasone|dexamethasone|mesh-list
83303503|NCT04276090|Floxuridine|floxuridine|mesh-list
83303504|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303505|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
83303506|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
83303507|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303508|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303509|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303510|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
83303511|NCT04276090|Hormones|hormones|mesh-ancestor
83303512|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303513|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83303514|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303515|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83303516|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
83303517|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303518|NCT04226248|Rivastigmine|rivastigmine|mesh-list
83303519|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83303520|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303521|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303522|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
83303523|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303524|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303525|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83303526|NCT04226248|Protective Agents|protective agents|mesh-ancestor
83303527|NCT01892722|Interferons|interferons|mesh-list
83303528|NCT01892722|Interferon-beta|interferon-beta|mesh-list
83303529|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
83303530|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83303531|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303532|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
83303533|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303534|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
83303535|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303536|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83303537|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83303538|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303539|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303540|NCT04398004|Clarithromycin|clarithromycin|mesh-list
83303541|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303542|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303543|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83303544|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303545|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303546|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83303547|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83303548|NCT01687413|Cisplatin|cisplatin|mesh-list
83303549|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303550|NCT01555671|Meperidine|meperidine|mesh-list
83303551|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83303552|NCT01555671|Narcotics|narcotics|mesh-ancestor
83303553|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303554|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303555|NCT01555671|Analgesics|analgesics|mesh-ancestor
83303556|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
83303557|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303558|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83303559|NCT03226756|Nivolumab|nivolumab|mesh-list
83303560|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303561|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303562|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83303563|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303564|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83303565|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
83303566|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303567|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303568|NCT01807598|Immunotoxins|immunotoxins|mesh-ancestor
83303569|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
83303570|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303571|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
83303572|NCT01801280|Pantoprazole|pantoprazole|mesh-list
83303573|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83303574|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303575|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83303576|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
83303577|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303578|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303579|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303580|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303581|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83303582|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303583|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83303584|NCT01769456|Tenofovir|tenofovir|mesh-list
83303585|NCT01769456|Emtricitabine|emtricitabine|mesh-list
83303586|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83303587|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
83303588|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303589|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83303590|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83303591|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303592|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303593|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83303594|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83303596|NCT01769378|Dulaglutide|dulaglutide|mesh-list
83303597|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83303598|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83303599|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303600|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303601|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
83303602|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83303603|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
83303604|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303605|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83303606|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
83303607|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303608|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83303609|NCT01768286|Ledipasvir|ledipasvir|mesh-list
83303610|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
83303611|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303612|NCT01800968|Liraglutide|liraglutide|mesh-list
83303613|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83303614|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303615|NCT01800968|Incretins|incretins|mesh-ancestor
83303616|NCT01800968|Hormones|hormones|mesh-ancestor
83303617|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303618|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
83303619|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
83303620|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303621|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83303622|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
83303623|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
83303624|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303625|NCT01687101|Menthol|menthol|mesh-list
83303626|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
83303627|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83303628|NCT01968967|Bococizumab|bococizumab|mesh-list
83303629|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83303630|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83303631|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
83303632|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303633|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83303634|NCT01806662|Ustekinumab|ustekinumab|mesh-list
83303635|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
83303636|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
83303637|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
83303638|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83303639|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83303640|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
83303641|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303642|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83303643|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83303644|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303645|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303646|NCT01930045|Antacids|antacids|mesh-ancestor
83303647|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303648|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
83303649|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83303650|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
83303651|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303652|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
83303653|NCT04631263|Protective Agents|protective agents|mesh-ancestor
83303654|NCT01929343|Lidocaine|lidocaine|mesh-list
83303655|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
83303656|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
83303657|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303658|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303659|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
83303660|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303661|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83303662|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83303663|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83303664|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83303665|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303666|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83303667|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
83303668|NCT01806584|Coagulants|coagulants|mesh-ancestor
83303669|NCT01798706|Lixisenatide|lixisenatide|mesh-list
83303670|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83303671|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303672|NCT01767194|Sirolimus|sirolimus|mesh-list
83303673|NCT01767194|Irinotecan|irinotecan|mesh-list
83303674|NCT01767194|Camptothecin|camptothecin|mesh-list
83303675|NCT01767194|Temozolomide|temozolomide|mesh-list
83303676|NCT01767194|Temsirolimus|temsirolimus|mesh-list
83303677|NCT01767194|Dinutuximab|dinutuximab|mesh-list
83303678|NCT01767194|MTOR Inhibitors|mtor inhibitors|mesh-list
83303679|NCT01767194|Sargramostim|sargramostim|mesh-list
83303680|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83303681|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83303682|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303683|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303684|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303685|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83303686|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
83303687|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303688|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303689|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83303690|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
83303691|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83303692|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
83303693|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303694|NCT01767194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303695|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83303696|NCT01575873|Denosumab|denosumab|mesh-list
83303697|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83303698|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303699|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
83303700|NCT04276636|Antacids|antacids|mesh-ancestor
83303701|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303702|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83303703|NCT00002644|Tamoxifen|tamoxifen|mesh-list
83303704|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83303705|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
83303706|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303707|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303708|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83303709|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303710|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83303711|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83303712|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83303713|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83303714|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83303715|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83303716|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303717|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303718|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83303719|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83303720|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83303721|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83303722|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
83303723|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303724|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303725|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83303726|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83303727|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
83303728|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83303729|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83303730|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
83303731|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
83303732|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303733|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303734|NCT03021460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83303735|NCT03021460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303736|NCT04397770|Temozolomide|temozolomide|mesh-list
83303738|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83303739|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
83303740|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303741|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303742|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303743|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303744|NCT03082846|Temozolomide|temozolomide|mesh-list
83303745|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83303746|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
83303747|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303748|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303749|NCT05249920|Edaravone|edaravone|mesh-list
83303750|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83303751|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
83303752|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303753|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83303754|NCT05249920|Protective Agents|protective agents|mesh-ancestor
83303755|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303756|NCT01609790|Bevacizumab|bevacizumab|mesh-list
83303757|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83303758|NCT01609790|Trebananib|trebananib|mesh-list
83303759|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
83303760|NCT01609790|Antibodies|antibodies|mesh-list
83303761|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
83303762|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83303763|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
83303764|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303765|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83303766|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83303767|NCT01609790|Growth Substances|growth substances|mesh-ancestor
83303768|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303769|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
83303770|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
83303771|NCT01767116|Ribavirin|ribavirin|mesh-list
83303772|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
83303773|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303774|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
83303775|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303776|NCT01574703|Bupropion|bupropion|mesh-list
83303777|NCT01574703|Nicotine|nicotine|mesh-list
83303778|NCT01574703|Varenicline|varenicline|mesh-list
83303779|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83303780|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
83303781|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303782|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303783|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83303784|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83303785|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
83303786|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303787|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303788|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83303789|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
83303790|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83303791|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83303792|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83303793|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83303794|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
83303795|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83303796|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83303797|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303798|NCT01686633|Fluticasone|fluticasone|mesh-list
83303799|NCT01686633|Xhance|xhance|mesh-list
83303800|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303801|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83303802|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
83303803|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303804|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303805|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83303806|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
83303807|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
83303808|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83303810|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303811|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303812|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303813|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303815|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
83303816|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303817|NCT03141424|Fluticasone|fluticasone|mesh-list
83303818|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
83303819|NCT03141424|Ciclesonide|ciclesonide|mesh-list
83303820|NCT03141424|Budesonide|budesonide|mesh-list
83303821|NCT03141424|Beclomethasone|beclomethasone|mesh-list
83303822|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303823|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83303824|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
83303825|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303826|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303827|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83303828|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
83303829|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
83303830|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83303831|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
83303832|NCT03141424|Hormones|hormones|mesh-ancestor
83303833|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303834|NCT03614494|Piroxicam|piroxicam|mesh-list
83303835|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
83303836|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83303837|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
83303838|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83303839|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303840|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83303841|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83303842|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83303843|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83303844|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83303845|NCT03614494|Analgesics|analgesics|mesh-ancestor
83303846|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
83303847|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303848|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303849|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83303850|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83303851|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303852|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303853|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
83303854|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303855|NCT04276480|Tazobactam|tazobactam|mesh-list
83303856|NCT04276480|Piperacillin|piperacillin|mesh-list
83303857|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83303858|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83303859|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83303860|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83303861|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303862|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303863|NCT05245708|Oxytocin|oxytocin|mesh-list
83303864|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
83303865|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83303866|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303867|NCT01922596|Ropivacaine|ropivacaine|mesh-list
83303868|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
83303869|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
83303870|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303871|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303872|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
83303873|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303874|NCT01573767|Fluticasone|fluticasone|mesh-list
83303875|NCT01573767|Xhance|xhance|mesh-list
83303876|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303877|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83303878|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
83303879|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303880|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303881|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83303882|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
83303883|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
83303884|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83303885|NCT04396990|Prednisolone|prednisolone|mesh-list
83303886|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303887|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
83303888|NCT04396990|Hormones|hormones|mesh-ancestor
83303889|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303890|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303891|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83303892|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303893|NCT03133546|Bevacizumab|bevacizumab|mesh-list
83303894|NCT03133546|Osimertinib|osimertinib|mesh-list
83303895|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303896|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303897|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83303898|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83303899|NCT03133546|Growth Substances|growth substances|mesh-ancestor
83303900|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303901|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
83303902|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303903|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303904|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303905|NCT01551303|Oxytocin|oxytocin|mesh-list
83303906|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
83303907|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83303908|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303909|NCT01685073|Zolpidem|zolpidem|mesh-list
83303910|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83303911|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83303912|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303913|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303914|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83303915|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
83303916|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
83303917|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303918|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303919|NCT05241028|Ensartinib|ensartinib|mesh-list
83303920|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303921|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303922|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303923|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303924|NCT01572675|Celecoxib|celecoxib|mesh-list
83303925|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83303926|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83303927|NCT01572675|Analgesics|analgesics|mesh-ancestor
83303928|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
83303929|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303930|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303931|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83303932|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83303933|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83303934|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83303935|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303936|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303937|NCT01550289|Vaccines|vaccines|mesh-list
83303938|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
83303939|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303940|NCT01968031|Istradefylline|istradefylline|mesh-list
83303941|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
83303942|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83303943|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83303944|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
83303945|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83303946|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303947|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303948|NCT01684215|Letrozole|letrozole|mesh-list
83303949|NCT01684215|Palbociclib|palbociclib|mesh-list
83303950|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303951|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83303952|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83303953|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303954|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303955|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83303956|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
83362260|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303957|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83303958|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303959|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303960|NCT01908205|Oxytocin|oxytocin|mesh-list
83303961|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
83303962|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83303963|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303964|NCT03911739|Buprenorphine|buprenorphine|mesh-list
83303965|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83303966|NCT03911739|Narcotics|narcotics|mesh-ancestor
83303967|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303968|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303969|NCT03911739|Analgesics|analgesics|mesh-ancestor
83303970|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
83303971|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83303972|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83303973|NCT01549041|Asenapine|asenapine|mesh-list
83303974|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83303975|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83303976|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83303977|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303978|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83303979|NCT04106115|Durvalumab|durvalumab|mesh-list
83303980|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83303981|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83303982|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303983|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83303984|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
83303985|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83303986|NCT01907815|Trametinib|trametinib|mesh-list
83303987|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83303988|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83303989|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83303990|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83303991|NCT01548573|Thalidomide|thalidomide|mesh-list
83303992|NCT01548573|Dexamethasone|dexamethasone|mesh-list
83303993|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
83303994|NCT01548573|Melphalan|melphalan|mesh-list
83303995|NCT01548573|Doxorubicin|doxorubicin|mesh-list
83303996|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83303997|NCT01548573|Etoposide|etoposide|mesh-list
83303998|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
83303999|NCT01548573|Bortezomib|bortezomib|mesh-list
83304000|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304001|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
83304002|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304003|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304004|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304005|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
83304006|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304007|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304008|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83304009|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304010|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
83304011|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
83304012|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304013|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304014|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
83304015|NCT01548573|Hormones|hormones|mesh-ancestor
83304016|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304017|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83304018|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83304019|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83304020|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83304021|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304022|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83304023|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
83304024|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304025|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304026|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83304027|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83304028|NCT01548573|Growth Substances|growth substances|mesh-ancestor
83304029|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
83304030|NCT01570491|Anesthetics|anesthetics|mesh-list
83304031|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304032|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304033|NCT01518153|Methotrexate|methotrexate|mesh-list
83304034|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
83304035|NCT01518153|Fludarabine|fludarabine|mesh-list
83304036|NCT01518153|Melphalan|melphalan|mesh-list
83304037|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
83304038|NCT01518153|Tacrolimus|tacrolimus|mesh-list
83304039|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83304040|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
83304041|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83304042|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304043|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83304044|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
83304045|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304046|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304047|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
83304048|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304049|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83304050|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304051|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
83304052|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304053|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83304054|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83304055|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304056|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
83304057|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83304058|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304059|NCT04620343|Anesthetics|anesthetics|mesh-list
83304060|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304061|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304062|NCT01517373|Glimepiride|glimepiride|mesh-list
83304063|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83304064|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83304065|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304066|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304067|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
83304068|NCT01517295|Hydrocodone|hydrocodone|mesh-list
83304069|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83304070|NCT01517295|Narcotics|narcotics|mesh-ancestor
83304071|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304072|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304073|NCT01517295|Analgesics|analgesics|mesh-ancestor
83304074|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
83304075|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304076|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
83304077|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
83304078|NCT01548417|Mifepristone|mifepristone|mesh-list
83304079|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83304080|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
83304081|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83304082|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304083|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83304084|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83304085|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83304086|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
83304087|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83304088|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83304089|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
83304090|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304091|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
83304092|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83304093|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83304094|NCT01546857|Gabapentin|gabapentin|mesh-list
83304095|NCT01546857|Analgesics|analgesics|mesh-ancestor
83304096|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
83304097|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304098|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304099|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
83304100|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83304101|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83304102|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304103|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83304104|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83304105|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83304106|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362261|NCT04338802|Nintedanib|nintedanib|mesh-list
83304107|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304108|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
83304109|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83304110|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304111|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83304112|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83304113|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83304114|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83304115|NCT00637000|Buprenorphine|buprenorphine|mesh-list
83304116|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83304117|NCT00637000|Naloxone|naloxone|mesh-list
83304118|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83304119|NCT00637000|Narcotics|narcotics|mesh-ancestor
83304120|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304121|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304122|NCT00637000|Analgesics|analgesics|mesh-ancestor
83304123|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
83304124|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304125|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83304126|NCT01515189|Ipilimumab|ipilimumab|mesh-list
83304127|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304128|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304129|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83304130|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304131|NCT01546623|Leuprolide|leuprolide|mesh-list
83304132|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83304133|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
83304134|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83304135|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304136|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83304137|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304138|NCT00636610|Bevacizumab|bevacizumab|mesh-list
83304139|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304140|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304141|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83304142|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83304143|NCT00636610|Growth Substances|growth substances|mesh-ancestor
83304144|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304145|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83304146|NCT00635050|Paclitaxel|paclitaxel|mesh-list
83304147|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
83304148|NCT00635050|Bevacizumab|bevacizumab|mesh-list
83304149|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83304150|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304151|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
83304152|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
83304153|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
83304154|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304155|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304156|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
83304157|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304159|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304160|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
83304161|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83304162|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304163|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83304164|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83304165|NCT00635050|Growth Substances|growth substances|mesh-ancestor
83304166|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
83304167|NCT05240404|Immunomodulating Agents|immunomodulating agents|mesh-list
83304168|NCT05240404|Immunologic Factors|immunologic factors|mesh-ancestor
83304169|NCT05240404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304170|NCT01923376|Lactulose|lactulose|mesh-list
83304171|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83304172|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304173|NCT01923376|Laxatives|laxatives|mesh-ancestor
83304174|NCT05245786|Copper|copper|mesh-list
83304175|NCT05245786|Antibodies|antibodies|mesh-list
83304176|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83304177|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
83304178|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304179|NCT05245786|Trace Elements|trace elements|mesh-ancestor
83304180|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
83304181|NCT00634504|Leucovorin|leucovorin|mesh-list
83304182|NCT00634504|Methotrexate|methotrexate|mesh-list
83304183|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
83304184|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83304185|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
83304186|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83304187|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304188|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83304189|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
83304190|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304191|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304192|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
83304193|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304194|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83304195|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304196|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
83304197|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304198|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83304199|NCT00634504|Antidotes|antidotes|mesh-ancestor
83304200|NCT00634504|Protective Agents|protective agents|mesh-ancestor
83304201|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
83304202|NCT00634504|Vitamins|vitamins|mesh-ancestor
83304203|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
83304204|NCT03101254|Vemurafenib|vemurafenib|mesh-list
83304205|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304206|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83304207|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304208|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304209|NCT00634114|Esomeprazole|esomeprazole|mesh-list
83304210|NCT00634114|Omeprazole|omeprazole|mesh-list
83304211|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83304212|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304213|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83304214|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304215|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304216|NCT00634036|Pioglitazone|pioglitazone|mesh-list
83304217|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83304218|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304219|NCT05241496|Lidocaine|lidocaine|mesh-list
83304220|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
83304221|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
83304222|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304223|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304224|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
83304225|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304226|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83304227|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83304228|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83304229|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304230|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304231|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83304232|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
83304233|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304235|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83304236|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
83304237|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
83304238|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304239|NCT03156790|Asparaginase|asparaginase|mesh-list
83304240|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304241|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
83304242|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304243|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304244|NCT03153202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83304245|NCT03153202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304246|NCT04410081|Lazertinib|lazertinib|mesh-list
83304247|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83304248|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304249|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304250|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83304251|NCT01923844|Beractant|beractant|mesh-list
83304252|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
83304253|NCT01924000|Minoxidil|minoxidil|mesh-list
83304254|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83304255|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
83304256|NCT01924078|Capecitabine|capecitabine|mesh-list
83304257|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83304258|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83304259|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
83304260|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304261|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304262|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83304263|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304264|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83304265|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
83304266|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304267|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304268|NCT00630994|Decitabine|decitabine|mesh-list
83304269|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83304270|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
83304271|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304272|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304273|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304274|NCT03126214|Warfarin|warfarin|mesh-list
83304275|NCT03126214|Anticoagulants|anticoagulants|mesh-list
83304276|NCT01924234|Morphine|morphine|mesh-list
83304277|NCT01924234|Remifentanil|remifentanil|mesh-list
83304278|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83304279|NCT01924234|Narcotics|narcotics|mesh-ancestor
83304280|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304281|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304282|NCT01924234|Analgesics|analgesics|mesh-ancestor
83304283|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
83304284|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304285|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
83304286|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
83304287|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83304288|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83304289|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
83304290|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304291|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
83304292|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304293|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304294|NCT01927198|Verinurad|verinurad|mesh-list
83304295|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
83304296|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304297|NCT01924468|Haloperidol|haloperidol|mesh-list
83304298|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
83304299|NCT01924468|Methylphenidate|methylphenidate|mesh-list
83304300|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83304301|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304302|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83304303|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83304304|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304305|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304307|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304308|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
83304309|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
83304310|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304311|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304312|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83304313|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83304314|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304315|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83304316|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83304317|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83304318|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
83304319|NCT01923064|Polidocanol|polidocanol|mesh-list
83304320|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304321|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83304322|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83304323|NCT01924624|Thalidomide|thalidomide|mesh-list
83304324|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304325|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
83304326|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304327|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
83304328|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304329|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304330|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83304331|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83304332|NCT01924624|Growth Substances|growth substances|mesh-ancestor
83304333|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
83304334|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304336|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
83304337|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304338|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
83304339|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304340|NCT00989950|Methylphenidate|methylphenidate|mesh-list
83304341|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83304342|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304343|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83304344|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83304345|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304346|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304347|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
83304348|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304349|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83304350|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83304351|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304352|NCT01925092|Mifepristone|mifepristone|mesh-list
83304353|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83304354|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
83304355|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83304356|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304357|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83304358|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83304359|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83304360|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
83304361|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83304362|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83304363|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
83304364|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304365|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
83304366|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83304367|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83304368|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
83304369|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83304370|NCT01905943|Chlorambucil|chlorambucil|mesh-list
83304371|NCT01905943|Fludarabine|fludarabine|mesh-list
83304372|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
83304373|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304374|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
83304375|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304376|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304377|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304378|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
83304379|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304380|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304381|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83304382|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304384|NCT01929031|Caffeine|caffeine|mesh-list
83304385|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83304386|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83304387|NCT01929031|Analgesics|analgesics|mesh-ancestor
83304388|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
83304389|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304390|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304391|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304392|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304393|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83304394|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304395|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304396|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83304397|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83304398|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83304399|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83304400|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
83304401|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304402|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
83304403|NCT00989092|Hematinics|hematinics|mesh-ancestor
83304404|NCT00988858|Pemetrexed|pemetrexed|mesh-list
83304405|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304406|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304407|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304408|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83304409|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83304410|NCT01920334|Zolpidem|zolpidem|mesh-list
83304411|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83304412|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83304413|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304414|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304415|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83304416|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
83304417|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
83304418|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304419|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304420|NCT03096418|Paclitaxel|paclitaxel|mesh-list
83304421|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83304422|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304423|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
83304424|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
83304425|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
83304426|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304427|NCT00986986|Niacin|niacin|mesh-list
83304428|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83304429|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
83304430|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304431|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83304432|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
83304433|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
83304434|NCT00986986|Vitamins|vitamins|mesh-ancestor
83304435|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
83304436|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304437|NCT01928719|Nicotine|nicotine|mesh-list
83304438|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83304439|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
83304440|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304441|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304442|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83304443|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83304444|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
83304445|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304446|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304447|NCT00986674|Paclitaxel|paclitaxel|mesh-list
83304448|NCT00986674|Carboplatin|carboplatin|mesh-list
83304450|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83304451|NCT00986674|Antibodies|antibodies|mesh-list
83304452|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
83304453|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83304454|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83304455|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304456|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
83304457|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
83304458|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
83304459|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304460|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
83304461|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304462|NCT00986440|Efatutazone|efatutazone|mesh-list
83304463|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304464|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
83304465|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
83304466|NCT03118492|Melphalan|melphalan|mesh-list
83304467|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
83304468|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83304469|NCT03118492|Fludarabine|fludarabine|mesh-list
83304470|NCT03118492|Tacrolimus|tacrolimus|mesh-list
83304471|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304472|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
83304473|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304474|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304475|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304476|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
83304477|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304478|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304479|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83304480|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83304481|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304491|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304492|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304493|NCT01904149|Analgesics|analgesics|mesh-ancestor
83304494|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
83304495|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304496|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83304497|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83304498|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304499|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304508|NCT01925638|Ketoconazole|ketoconazole|mesh-list
83304509|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
83304510|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304511|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83304512|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83304513|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304514|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304515|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83304516|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
83304517|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304518|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304519|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83304520|NCT00985738|Dutasteride|dutasteride|mesh-list
83304521|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83304522|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83304523|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304524|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304525|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
83304526|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304527|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304528|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83304529|NCT00985504|Escitalopram|escitalopram|mesh-list
83304530|NCT00985504|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83304531|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83304532|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304533|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304534|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304535|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
83304536|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304537|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304538|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
83304539|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83304540|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83304541|NCT00985504|Analgesics|analgesics|mesh-ancestor
83304542|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
83304543|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
83304544|NCT01921192|Folic Acid|folic acid|mesh-list
83304545|NCT01921192|Hematinics|hematinics|mesh-ancestor
83304546|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
83304547|NCT01921192|Vitamins|vitamins|mesh-ancestor
83304548|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
83304549|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304550|NCT04275388|Interferons|interferons|mesh-list
83304551|NCT04275388|Ritonavir|ritonavir|mesh-list
83304552|NCT04275388|Lopinavir|lopinavir|mesh-list
83304553|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
83304554|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
83304555|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304556|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
83304557|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304558|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83304559|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83304560|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83304561|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304562|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304563|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83304564|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83304565|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83304566|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83304567|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
83304568|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304569|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
83304570|NCT01921426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83304571|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
83304572|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304573|NCT01921426|Protective Agents|protective agents|mesh-ancestor
83304574|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304575|NCT01921582|Methylphenidate|methylphenidate|mesh-list
83304576|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83304577|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304578|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83304579|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83304580|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304581|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304582|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
83304583|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304584|NCT00985426|Vaccines|vaccines|mesh-list
83304585|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
83304586|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304587|NCT00985192|Everolimus|everolimus|mesh-list
83304588|NCT00985192|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83304589|NCT00985192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83304590|NCT00985192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304591|NCT00985192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304592|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304593|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
83304594|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304595|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304596|NCT03390010|Misoprostol|misoprostol|mesh-list
83304597|NCT03390010|Carboprost|carboprost|mesh-list
83304598|NCT03390010|Oxytocin|oxytocin|mesh-list
83304599|NCT03390010|Methylergonovine|methylergonovine|mesh-list
83304600|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
83304601|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83304602|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
83304603|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83304604|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304605|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83304606|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304607|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
83304608|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
83304609|NCT00984568|Prednisolone|prednisolone|mesh-list
83304610|NCT00984568|Infliximab|infliximab|mesh-list
83304611|NCT00984568|Mesalamine|mesalamine|mesh-list
83304612|NCT00984568|Azathioprine|azathioprine|mesh-list
83304613|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304614|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
83304615|NCT00984568|Hormones|hormones|mesh-ancestor
83304616|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304617|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304618|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83304619|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304620|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304621|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304622|NCT00984568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83304623|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
83304624|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304625|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
83304626|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304627|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83304628|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304629|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
83304630|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83304631|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83304632|NCT00984568|Analgesics|analgesics|mesh-ancestor
83304633|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
83304634|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
83304635|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304636|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304637|NCT02984176|Simethicone|simethicone|mesh-list
83304638|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
83304639|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304640|NCT02984176|Emollients|emollients|mesh-ancestor
83304641|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
83304642|NCT01921738|Azithromycin|azithromycin|mesh-list
83304643|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304644|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304645|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
83304646|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83304647|NCT00984256|Atovaquone|atovaquone|mesh-list
83304648|NCT00984256|Proguanil|proguanil|mesh-list
83304649|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83304650|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304651|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
83304652|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83304653|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83304654|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413615|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304655|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304656|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
83304657|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83304658|NCT00984022|Laxatives|laxatives|mesh-ancestor
83304659|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304660|NCT01890265|Pirfenidone|pirfenidone|mesh-list
83304661|NCT01890265|Nintedanib|nintedanib|mesh-list
83304662|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
83304663|NCT01890265|Antibodies|antibodies|mesh-list
83304664|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
83304665|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83304666|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
83304667|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304668|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304669|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83304670|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304671|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304672|NCT01890265|Analgesics|analgesics|mesh-ancestor
83304673|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
83304674|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304675|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83304676|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83304677|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304678|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304679|NCT01926652|Amlodipine|amlodipine|mesh-list
83304680|NCT01926652|Candesartan|candesartan|mesh-list
83304681|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
83304682|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83304683|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83304684|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304685|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304686|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83304687|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304688|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
83304689|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83304690|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83304691|NCT03110926|Leucovorin|leucovorin|mesh-list
83304692|NCT03110926|Paclitaxel|paclitaxel|mesh-list
83304693|NCT03110926|Carboplatin|carboplatin|mesh-list
83304694|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
83304695|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83304696|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304697|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
83304698|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
83304699|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
83304700|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304701|NCT03110926|Antidotes|antidotes|mesh-ancestor
83304702|NCT03110926|Protective Agents|protective agents|mesh-ancestor
83304703|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304704|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
83304714|NCT01890109|Erenumab|erenumab|mesh-list
83304715|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83304716|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304717|NCT01890109|Analgesics|analgesics|mesh-ancestor
83304718|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
83304719|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304720|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304721|NCT03069976|Metronidazole|metronidazole|mesh-list
83304722|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304723|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304724|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83304725|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83304726|NCT00982930|Tobramycin|tobramycin|mesh-list
83304727|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304728|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304729|NCT03088540|Paclitaxel|paclitaxel|mesh-list
83304730|NCT03088540|Carboplatin|carboplatin|mesh-list
83304731|NCT03088540|Gemcitabine|gemcitabine|mesh-list
83304732|NCT03088540|Pemetrexed|pemetrexed|mesh-list
83304733|NCT03088540|Cemiplimab|cemiplimab|mesh-list
83304734|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83304735|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304736|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
83304737|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
83304738|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
83304739|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304740|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83304741|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
83304742|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304743|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83304744|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83304745|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304746|NCT01903993|Docetaxel|docetaxel|mesh-list
83304747|NCT01903993|Atezolizumab|atezolizumab|mesh-list
83304748|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304749|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
83304750|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
83304751|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
83304752|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304753|NCT01903993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83304754|NCT01903993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304755|NCT00980044|Tramadol|tramadol|mesh-list
83304756|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83304757|NCT00980044|Narcotics|narcotics|mesh-ancestor
83304758|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304759|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304760|NCT00980044|Analgesics|analgesics|mesh-ancestor
83304761|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
83304762|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304763|NCT03049306|Propranolol|propranolol|mesh-list
83304764|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83304765|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83304766|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
83304767|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304768|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304769|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304770|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83304771|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83304772|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
83304797|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83304798|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304799|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304800|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
83304801|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83304802|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304803|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304804|NCT01927588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83304805|NCT01927588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83304806|NCT05601466|Cytarabine|cytarabine|mesh-list
83304807|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
83304808|NCT05601466|Fludarabine|fludarabine|mesh-list
83304809|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304810|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
83304811|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304812|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304813|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304814|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
83304815|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304816|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304817|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83304818|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83304819|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
83304820|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
83304821|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304822|NCT01903837|Naltrexone|naltrexone|mesh-list
83304823|NCT01903837|Olanzapine|olanzapine|mesh-list
83304824|NCT01903837|ALKS-33|alks-33|mesh-list
83304825|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
83304826|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
83304827|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304828|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304829|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304830|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83304831|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83304832|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304833|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83304834|NCT01903837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83304835|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83304836|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304837|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83413616|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304838|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304839|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
83304840|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83304841|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83304842|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
83304843|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
83304844|NCT00982696|Mitogens|mitogens|mesh-list
83304845|NCT00982696|Enkephalins|enkephalins|mesh-list
83304846|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
83304847|NCT00982696|Narcotics|narcotics|mesh-ancestor
83304848|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304849|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304850|NCT00982696|Analgesics|analgesics|mesh-ancestor
83304851|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
83304852|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304853|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
83304854|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304855|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304856|NCT00981526|Telmisartan|telmisartan|mesh-list
83304858|NCT00981526|Clozapine|clozapine|mesh-list
83304859|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
83304860|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
83304861|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304862|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304863|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304864|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83304865|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83304866|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304867|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83304868|NCT00981526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83304869|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83304870|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304871|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304872|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304873|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
83304874|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83304875|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83304876|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83304877|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83304878|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
83304879|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
83304880|NCT04274920|Calcium|calcium|mesh-list
83304881|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83304882|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304883|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
83304884|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83304885|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83304886|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83304887|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304888|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304889|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
83304890|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304891|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304892|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83304893|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304894|NCT05607940|Chrysarobin|chrysarobin|mesh-list
83304895|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83304896|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83304897|NCT05607940|Analgesics|analgesics|mesh-ancestor
83304898|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
83304899|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304900|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304901|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304902|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304903|NCT04394728|Trabectedin|trabectedin|mesh-list
83304904|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304905|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
83304906|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304907|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304908|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83304909|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304910|NCT01616173|Dexamethasone|dexamethasone|mesh-list
83304911|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
83304912|NCT01616173|BB 1101|bb 1101|mesh-list
83304913|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304914|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
83304915|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
83304916|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304917|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304918|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83304919|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
83304920|NCT01616173|Hormones|hormones|mesh-ancestor
83304921|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304922|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83304923|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304924|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
83304925|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304926|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304927|NCT05609500|Warfarin|warfarin|mesh-list
83304928|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
83304929|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
83304930|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83304931|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
83304932|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304933|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304934|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83304935|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
83304936|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83304938|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304939|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83304940|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83304941|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
83304942|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
83304943|NCT03044314|Protective Agents|protective agents|mesh-ancestor
83304944|NCT05608642|Prednisolone|prednisolone|mesh-list
83304945|NCT05608642|Lidocaine|lidocaine|mesh-list
83304946|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
83304947|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
83304948|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83304949|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304950|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
83304951|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83304952|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83304953|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83304954|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83304955|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83304956|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304957|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304958|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
83304959|NCT05608642|Hormones|hormones|mesh-ancestor
83304960|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83304961|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83304962|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304963|NCT05608564|Amoxicillin|amoxicillin|mesh-list
83304964|NCT05608564|Metronidazole|metronidazole|mesh-list
83304965|NCT05608564|Tazobactam|tazobactam|mesh-list
83304966|NCT05608564|Piperacillin|piperacillin|mesh-list
83304967|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83304968|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83304969|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83304970|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83304971|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83304972|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304973|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304974|NCT03036904|Prednisone|prednisone|mesh-list
83304975|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
83304976|NCT03036904|Rituximab|rituximab|mesh-list
83304977|NCT03036904|Doxorubicin|doxorubicin|mesh-list
83304978|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83304979|NCT03036904|Etoposide|etoposide|mesh-list
83304980|NCT03036904|Vincristine|vincristine|mesh-list
83304981|NCT03036904|Venetoclax|venetoclax|mesh-list
83304982|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83304983|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
83304984|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83304985|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83304986|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83304987|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
83304988|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83304989|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83304990|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83304991|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83304992|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83304993|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83304994|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83304995|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83304996|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83304997|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
83304998|NCT03036904|Hormones|hormones|mesh-ancestor
83304999|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305000|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305001|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83305002|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
83305003|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
83305004|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
83305005|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83305006|NCT05604898|Antibodies|antibodies|mesh-list
83305007|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
83305008|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83305009|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
83305010|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305011|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305012|NCT04392700|Tenofovir|tenofovir|mesh-list
83305013|NCT04392700|Entecavir|entecavir|mesh-list
83305014|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
83305015|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305016|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83305017|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83305018|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305019|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305020|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83305021|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83305022|NCT03828058|Tacrolimus|tacrolimus|mesh-list
83305023|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83305024|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
83305025|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305026|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83305027|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305028|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305029|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83305030|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
83305031|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305032|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83305033|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83305034|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83305035|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305036|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305037|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83305038|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305039|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305040|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
83305041|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305042|NCT03827200|Ambrisentan|ambrisentan|mesh-list
83305043|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83305044|NCT02983630|Penicillins|penicillins|mesh-list
83305045|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83305046|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305047|NCT03827278|Itraconazole|itraconazole|mesh-list
83305048|NCT03827278|Voriconazole|voriconazole|mesh-list
83305049|NCT03827278|Amphotericin B|amphotericin b|mesh-list
83305050|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
83305051|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305052|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83305053|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83305054|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305055|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305056|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83305057|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
83305058|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305059|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305060|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83305061|NCT03827278|Amebicides|amebicides|mesh-ancestor
83305062|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83305063|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83305064|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83305065|NCT01513473|Insulin|insulin|mesh-list
83305066|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83305067|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
83305068|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
83305069|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305070|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305071|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
83305072|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83305073|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305074|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305075|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305076|NCT03109990|Analgesics|analgesics|mesh-ancestor
83305077|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
83305078|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305079|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83305080|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83305081|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83305082|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
83305083|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305084|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305085|NCT03071536|Furosemide|furosemide|mesh-list
83305086|NCT03071536|Diuretics|diuretics|mesh-ancestor
83305087|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
83305088|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305089|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83305090|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305091|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305092|NCT01513317|Siltuximab|siltuximab|mesh-list
83305093|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305094|NCT03825250|Valproic Acid|valproic acid|mesh-list
83305095|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
83305096|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305097|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305098|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
83305099|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305100|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305101|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
83305102|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83305103|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305104|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83305105|NCT03825328|Paclitaxel|paclitaxel|mesh-list
83305106|NCT03825328|Gemcitabine|gemcitabine|mesh-list
83305107|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
83305108|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83305109|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83305110|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305111|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
83305112|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
83305113|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
83305114|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305115|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83305116|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
83305117|NCT03825016|Diclofenac|diclofenac|mesh-list
83305118|NCT03825016|Lidocaine|lidocaine|mesh-list
83305119|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
83305120|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
83305121|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305122|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305123|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
83305124|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305125|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83305126|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83305127|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83305128|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305129|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305130|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305131|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305132|NCT03825016|Analgesics|analgesics|mesh-ancestor
83305133|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305134|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305135|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305136|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305137|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
83305138|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83305139|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83305140|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
83305141|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83305142|NCT03043924|Estradiol|estradiol|mesh-list
83305143|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83305144|NCT03043924|Cyproterone|cyproterone|mesh-list
83305145|NCT03043924|Estrogens|estrogens|mesh-ancestor
83305146|NCT03043924|Hormones|hormones|mesh-ancestor
83305147|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305148|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305149|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83305150|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
83305151|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83305152|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83305153|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83305154|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83305155|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83305156|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
83305157|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
83305158|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305159|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83305161|NCT03824314|Midazolam|midazolam|mesh-list
83305162|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83305163|NCT03824314|Narcotics|narcotics|mesh-ancestor
83305164|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305165|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305166|NCT03824314|Analgesics|analgesics|mesh-ancestor
83305167|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
83305168|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305169|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83305170|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83305171|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
83305172|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
83305173|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83305174|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83305175|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83305176|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83305177|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
83305178|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
83305179|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305180|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305181|NCT03824002|Insulin|insulin|mesh-list
83305182|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83305183|NCT03824002|Metformin|metformin|mesh-list
83305184|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
83305185|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
83305186|NCT03824002|Dulaglutide|dulaglutide|mesh-list
83305187|NCT03824002|Repaglinide|repaglinide|mesh-list
83305188|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
83305189|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83305190|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305191|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305192|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
83305193|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83305194|NCT03823846|Parecoxib|parecoxib|mesh-list
83305195|NCT03823846|Dezocine|dezocine|mesh-list
83305196|NCT03823846|Analgesics|analgesics|mesh-ancestor
83305197|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
83305198|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305199|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305200|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305201|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305202|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305203|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305204|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305205|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305206|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305207|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83305208|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83305209|NCT03823846|Narcotics|narcotics|mesh-ancestor
83305210|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305211|NCT02908750|Fexofenadine|fexofenadine|mesh-list
83305212|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305213|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83305214|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83305215|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83305216|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
83305217|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
83305218|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305219|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305220|NCT03823612|Calcium|calcium|mesh-list
83305221|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83305222|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305223|NCT02810704|Aspirin|aspirin|mesh-list
83305224|NCT02810704|Warfarin|warfarin|mesh-list
83305225|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
83305226|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305227|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305228|NCT02810704|Analgesics|analgesics|mesh-ancestor
83305229|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
83305230|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305231|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305232|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305233|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305234|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83305235|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83305236|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305237|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83305238|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305239|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305241|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
83305242|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83305243|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
83305244|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83305245|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
83305246|NCT02735902|Aspirin|aspirin|mesh-list
83305247|NCT02735902|Vitamin K|vitamin k|mesh-list
83305248|NCT02735902|Anticoagulants|anticoagulants|mesh-list
83305249|NCT02735902|Vitamins|vitamins|mesh-ancestor
83305250|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
83305251|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305252|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305253|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305254|NCT02735902|Analgesics|analgesics|mesh-ancestor
83305255|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
83305256|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305257|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305258|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305259|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83305260|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83305261|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305262|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83305263|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305264|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305265|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
83305266|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83305267|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
83305268|NCT02735902|Coagulants|coagulants|mesh-ancestor
83305269|NCT02926222|Lomustine|lomustine|mesh-list
83305270|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83305271|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
83305272|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305273|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305274|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
83305275|NCT04273282|Dexamethasone|dexamethasone|mesh-list
83305276|NCT04273282|Prednisolone|prednisolone|mesh-list
83305277|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83305278|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
83305279|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83305280|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
83305281|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83305282|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
83305283|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305284|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
83305285|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
83305286|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305287|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305288|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83305289|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
83305290|NCT04273282|Hormones|hormones|mesh-ancestor
83305291|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305292|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305293|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305294|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83305295|NCT04273282|Protective Agents|protective agents|mesh-ancestor
83305296|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83305297|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305298|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83305299|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83305300|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305301|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305302|NCT01454440|Eptifibatide|eptifibatide|mesh-list
83305303|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83305304|NCT01454518|Anesthetics|anesthetics|mesh-list
83305305|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
83305306|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305307|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305308|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
83305309|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305310|NCT02983084|Copper|copper|mesh-list
83305311|NCT02983084|Nickel|nickel|mesh-list
83305312|NCT02983084|Trace Elements|trace elements|mesh-ancestor
83305313|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
83305314|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305315|NCT01455142|Insulin|insulin|mesh-list
83305316|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
83305317|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305318|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305319|NCT01455532|Carboplatin|carboplatin|mesh-list
83305320|NCT01455532|Gemcitabine|gemcitabine|mesh-list
83305321|NCT01455532|Doxorubicin|doxorubicin|mesh-list
83305322|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83305323|NCT01455532|Iniparib|iniparib|mesh-list
83305324|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305325|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83305326|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
83305327|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305328|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83305329|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83305330|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83305331|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305332|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83305333|NCT01455922|Glimepiride|glimepiride|mesh-list
83305334|NCT01455922|Exenatide|exenatide|mesh-list
83305335|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83305336|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305337|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305338|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83305339|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
83305340|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83305341|NCT01455922|Incretins|incretins|mesh-ancestor
83305342|NCT01455922|Hormones|hormones|mesh-ancestor
83305343|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305344|NCT01456234|Oseltamivir|oseltamivir|mesh-list
83305345|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
83305346|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305347|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305348|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305349|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83305350|NCT01456312|Entecavir|entecavir|mesh-list
83305351|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
83305352|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305353|NCT02542696|Apomorphine|apomorphine|mesh-list
83305354|NCT02542696|Emetics|emetics|mesh-ancestor
83305355|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305356|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
83305357|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305358|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83305359|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
83305360|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
83305361|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305362|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305363|NCT01456468|Tretinoin|tretinoin|mesh-list
83305364|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305365|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
83305366|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
83305367|NCT01456546|Proguanil|proguanil|mesh-list
83305368|NCT01456546|Clopidogrel|clopidogrel|mesh-list
83305369|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83305370|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83305371|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83305372|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83305373|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
83305374|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305375|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305376|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305377|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
83305378|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83305379|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83305380|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305381|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
83305382|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
83305383|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305384|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305385|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
83305386|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83305387|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305388|NCT01457716|Budesonide|budesonide|mesh-list
83305389|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
83305390|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305391|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83305392|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
83305393|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305394|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305395|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83305396|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
83305397|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
83305398|NCT01457716|Hormones|hormones|mesh-ancestor
83305399|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305400|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83305401|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83305402|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83305403|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
83305404|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305405|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305406|NCT02880982|Vitamin D|vitamin d|mesh-list
83305407|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
83305408|NCT02880982|Vitamins|vitamins|mesh-ancestor
83305409|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
83305410|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305411|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83305412|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83305413|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83305414|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
83305415|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83305416|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83305417|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83305418|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305419|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305420|NCT01459198|Vaccines|vaccines|mesh-list
83305421|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
83305422|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305423|NCT02490904|Eplerenone|eplerenone|mesh-list
83305424|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83305425|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
83305426|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305427|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305428|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83305429|NCT02490904|Diuretics|diuretics|mesh-ancestor
83305430|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
83305431|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83305432|NCT04390984|Apatinib|apatinib|mesh-list
83305433|NCT04390984|Gefitinib|gefitinib|mesh-list
83305434|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305435|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83305436|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305437|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305438|NCT02873806|Tobramycin|tobramycin|mesh-list
83305439|NCT02873806|Dexamethasone|dexamethasone|mesh-list
83305440|NCT02873806|Travoprost|travoprost|mesh-list
83305441|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305442|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
83305443|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
83305444|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305445|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305446|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83305447|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
83305448|NCT02873806|Hormones|hormones|mesh-ancestor
83305449|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305450|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305451|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305453|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83305454|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305455|NCT01890772|Vitamin D|vitamin d|mesh-list
83305456|NCT01890772|Ribavirin|ribavirin|mesh-list
83305457|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83305458|NCT01890772|Vitamins|vitamins|mesh-ancestor
83305459|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
83305460|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305461|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83305462|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
83305463|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305464|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
83305465|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305466|NCT01891084|Acetaminophen|acetaminophen|mesh-list
83305467|NCT01891084|Ibuprofen|ibuprofen|mesh-list
83305468|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305469|NCT01891084|Analgesics|analgesics|mesh-ancestor
83305470|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
83305471|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305472|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305473|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
83305474|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305475|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305476|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305477|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305478|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305479|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305480|NCT01891708|Bevacizumab|bevacizumab|mesh-list
83305481|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83305482|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305483|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83305484|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83305485|NCT01891708|Growth Substances|growth substances|mesh-ancestor
83305486|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305487|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
83305488|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
83305489|NCT01892098|Astringents|astringents|mesh-ancestor
83305490|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305491|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
83305492|NCT01892176|Ubiquinone|ubiquinone|mesh-list
83305493|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
83305494|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
83305495|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305496|NCT01892176|Vitamins|vitamins|mesh-ancestor
83305497|NCT01892254|Metformin|metformin|mesh-list
83305498|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305499|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305500|NCT01892332|Lidocaine|lidocaine|mesh-list
83305501|NCT01892332|Fentanyl|fentanyl|mesh-list
83305502|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
83305503|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
83305504|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305505|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305506|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
83305507|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305508|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83305509|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83305510|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83305511|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305512|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305513|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83305514|NCT01892332|Narcotics|narcotics|mesh-ancestor
83305515|NCT01892332|Analgesics|analgesics|mesh-ancestor
83305516|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83305517|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83305518|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
83305519|NCT01892488|Sultamicillin|sultamicillin|mesh-list
83305520|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83305521|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83305522|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305523|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305524|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305525|NCT02809690|Clevudine|clevudine|mesh-list
83305526|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
83305527|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305528|NCT01892644|Deferasirox|deferasirox|mesh-list
83305529|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83305530|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
83305531|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
83305532|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305533|NCT01901653|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
83305534|NCT01901653|Immunoconjugates|immunoconjugates|mesh-ancestor
83305535|NCT01901653|Immunologic Factors|immunologic factors|mesh-ancestor
83305536|NCT01901653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305537|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
83305538|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305539|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305540|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
83305541|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
83305542|NCT02798536|Paclitaxel|paclitaxel|mesh-list
83305543|NCT02798536|LMB-100|lmb-100|mesh-list
83305544|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83305545|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305546|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
83305547|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
83305548|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
83305549|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305550|NCT02798536|Immunoconjugates|immunoconjugates|mesh-ancestor
83305551|NCT02798536|Immunologic Factors|immunologic factors|mesh-ancestor
83305552|NCT02798536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305553|NCT04758286|Anesthetics|anesthetics|mesh-list
83305554|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305555|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305556|NCT01453660|Cisplatin|cisplatin|mesh-list
83305557|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305558|NCT01615939|Bupivacaine|bupivacaine|mesh-list
83305559|NCT01615939|Ropivacaine|ropivacaine|mesh-list
83305560|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
83305561|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
83305562|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305563|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305564|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
83305565|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305566|NCT02789878|Prednisone|prednisone|mesh-list
83305567|NCT02789878|Goserelin|goserelin|mesh-list
83305568|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305569|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
83305570|NCT02789878|Hormones|hormones|mesh-ancestor
83305571|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305572|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305573|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305574|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305575|NCT01901185|Etanercept|etanercept|mesh-list
83305576|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305577|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305578|NCT01901185|Analgesics|analgesics|mesh-ancestor
83305579|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
83305580|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305581|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305582|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305583|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305584|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83305585|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83305586|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
83305587|NCT01893424|Dronabinol|dronabinol|mesh-list
83305588|NCT01893424|Nabiximols|nabiximols|mesh-list
83305589|NCT01893424|Cannabidiol|cannabidiol|mesh-list
83305590|NCT01893424|Piperine|piperine|mesh-list
83305591|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
83305592|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
83305593|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305594|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83305595|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305596|NCT01893424|Analgesics|analgesics|mesh-ancestor
83305597|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
83305598|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305599|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83305600|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83305601|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305602|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305603|NCT01893424|Hormones|hormones|mesh-ancestor
83305604|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305605|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83305606|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305607|NCT02788708|Paclitaxel|paclitaxel|mesh-list
83305608|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83305609|NCT02788708|Lenvatinib|lenvatinib|mesh-list
83305610|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83305611|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305612|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
83305613|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
83305614|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
83305615|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305616|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83305617|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305618|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
83305619|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83305620|NCT01888003|Hematinics|hematinics|mesh-ancestor
83305621|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
83305622|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83305623|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305624|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305625|NCT02780128|Ceritinib|ceritinib|mesh-list
83305626|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305627|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83305628|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305629|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305630|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
83305631|NCT02773732|Etoposide|etoposide|mesh-list
83305632|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83305633|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305634|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83305635|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83305636|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305637|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305638|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83305639|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305640|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83305641|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83305642|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
83305643|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83305644|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305645|NCT02769520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83305646|NCT02769520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305647|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
83305648|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305649|NCT02735122|Acetaminophen|acetaminophen|mesh-list
83305650|NCT02735122|Ibuprofen|ibuprofen|mesh-list
83305651|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305652|NCT02735122|Analgesics|analgesics|mesh-ancestor
83305653|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
83305654|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305655|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305656|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
83305657|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305658|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305659|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305660|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305661|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305662|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305663|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83305664|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83305665|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83305666|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305667|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305668|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
83305669|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305670|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305671|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83305672|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305673|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
83305674|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83305675|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
83305676|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305677|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305678|NCT01893658|Omalizumab|omalizumab|mesh-list
83305679|NCT01893658|Prednisone|prednisone|mesh-list
83305680|NCT01893658|Prednisolone|prednisolone|mesh-list
83305681|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305682|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
83305683|NCT01893658|Hormones|hormones|mesh-ancestor
83362262|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305684|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305685|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305686|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305687|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305688|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83305689|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83305690|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
83305691|NCT02703610|Acetaminophen|acetaminophen|mesh-list
83305692|NCT02703610|Ibuprofen|ibuprofen|mesh-list
83305693|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83305694|NCT02703610|Oxycodone|oxycodone|mesh-list
83305695|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305696|NCT02703610|Analgesics|analgesics|mesh-ancestor
83305697|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
83305698|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305699|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305700|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
83305701|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305702|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305703|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305704|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305705|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305706|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305707|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83305708|NCT02703610|Narcotics|narcotics|mesh-ancestor
83305709|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305710|NCT02688556|Cyclosporine|cyclosporine|mesh-list
83305711|NCT02688556|Cyclosporins|cyclosporins|mesh-list
83305712|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305713|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305714|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83305715|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
83305716|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305717|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
83305718|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305719|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
83305720|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305721|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83305722|NCT02684032|Letrozole|letrozole|mesh-list
83305723|NCT02684032|Fulvestrant|fulvestrant|mesh-list
83305724|NCT02684032|Palbociclib|palbociclib|mesh-list
83305725|NCT02684032|Gedatolisib|gedatolisib|mesh-list
83305726|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305727|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83305728|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83305729|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305730|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305731|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83305732|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
83305733|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305734|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305735|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305737|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83305738|NCT02388178|Fluorides|fluorides|mesh-list
83305739|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
83305740|NCT02388178|Protective Agents|protective agents|mesh-ancestor
83305741|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305742|NCT02384668|Vitamin D|vitamin d|mesh-list
83305743|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
83305744|NCT02384668|Vitamins|vitamins|mesh-ancestor
83305745|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
83305746|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305747|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83305748|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83305749|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83305750|NCT01898923|Laxatives|laxatives|mesh-ancestor
83305751|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83305752|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83305753|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83305754|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305755|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83305756|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83305757|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305758|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305760|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305761|NCT01886287|Octreotide|octreotide|mesh-list
83305762|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83305763|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305764|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305765|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
83305766|NCT02707588|Cetuximab|cetuximab|mesh-list
83305767|NCT02707588|Antibodies|antibodies|mesh-list
83305768|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
83305769|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
83305770|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305771|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83305772|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305773|NCT02707588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83305774|NCT02707588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305775|NCT05602480|Vaccines|vaccines|mesh-list
83305776|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
83305777|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305778|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
83305779|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83305780|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
83305781|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305782|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305783|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
83305784|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305785|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
83305786|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83305787|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
83305788|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305789|NCT05604586|Expectorants|expectorants|mesh-ancestor
83305790|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
83305791|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83305792|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
83305793|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305794|NCT05604586|Protective Agents|protective agents|mesh-ancestor
83305795|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305796|NCT05604586|Antidotes|antidotes|mesh-ancestor
83305797|NCT05604118|Aspirin|aspirin|mesh-list
83305798|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83305799|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305800|NCT05604118|Analgesics|analgesics|mesh-ancestor
83305801|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
83305802|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305803|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305804|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305805|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83305806|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83305807|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83305808|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305809|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83305810|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83305811|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305813|NCT05603884|Cytarabine|cytarabine|mesh-list
83305814|NCT05603884|Azacitidine|azacitidine|mesh-list
83305815|NCT05603884|Venetoclax|venetoclax|mesh-list
83305816|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
83305817|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83305818|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
83305819|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305820|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305821|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
83305822|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305823|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83305824|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
83305825|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305826|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305827|NCT05603884|Analgesics|analgesics|mesh-ancestor
83305828|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
83305829|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305830|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83305831|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83305832|NCT05603650|Listerine|listerine|mesh-list
83305833|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83305834|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305835|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83305836|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
83305837|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
83305838|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305839|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83305840|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305841|NCT03313804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83305842|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305843|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
83305844|NCT04393792|Povidone|povidone|mesh-list
83305845|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
83305846|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
83305847|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83305848|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305849|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
83305850|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83305851|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83305852|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83305853|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83305854|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305855|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305856|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
83305857|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305858|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305859|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83305860|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305861|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83305862|NCT02315872|Hormones|hormones|mesh-ancestor
83305863|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305864|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305865|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
83305866|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83305867|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305868|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305869|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83305870|NCT04127500|Analgesics|analgesics|mesh-ancestor
83305871|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
83305872|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305873|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83305874|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83305875|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83305876|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
83305877|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83305878|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305879|NCT03017326|Carboplatin|carboplatin|mesh-list
83305880|NCT03017326|Gemcitabine|gemcitabine|mesh-list
83305881|NCT03017326|Doxorubicin|doxorubicin|mesh-list
83305882|NCT03017326|Fluorouracil|fluorouracil|mesh-list
83305883|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
83305884|NCT03017326|Irinotecan|irinotecan|mesh-list
83305885|NCT03017326|Etoposide|etoposide|mesh-list
83305886|NCT03017326|Vincristine|vincristine|mesh-list
83305887|NCT03017326|Sorafenib|sorafenib|mesh-list
83305888|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305889|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83305890|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
83305891|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305892|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83305893|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83305894|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83305895|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305896|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83305897|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
83305898|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305899|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83305900|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83305901|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83305902|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83305903|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83305904|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83305905|NCT04126330|Vitamin D|vitamin d|mesh-list
83305906|NCT04126330|Vitamins|vitamins|mesh-ancestor
83305907|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
83305908|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305909|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83305910|NCT04126720|Vitamin E|vitamin e|mesh-list
83305911|NCT04126720|Vitamins|vitamins|mesh-ancestor
83305912|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
83305913|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305914|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
83305915|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305916|NCT04126720|Protective Agents|protective agents|mesh-ancestor
83305917|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
83305918|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305919|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
83305920|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83305921|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83305922|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305923|NCT04126252|Urological Agents|urological agents|mesh-ancestor
83305924|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83305925|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83305926|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305927|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
83305928|NCT03007732|Prednisone|prednisone|mesh-list
83305929|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
83305930|NCT03007732|Leuprolide|leuprolide|mesh-list
83305931|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
83305932|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
83305933|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83305934|NCT03007732|Androgens|androgens|mesh-list
83305935|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83305936|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305937|NCT03007732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83305938|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305939|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83305940|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
83305941|NCT03007732|Hormones|hormones|mesh-ancestor
83305942|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83305943|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305944|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83305945|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83305946|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
83305947|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83305948|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83305949|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83305950|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
83305951|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83305952|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
83305953|NCT03007732|Protective Agents|protective agents|mesh-ancestor
83305954|NCT03007732|Vitamins|vitamins|mesh-ancestor
83305955|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
83305956|NCT03007732|Estrogens|estrogens|mesh-ancestor
83305957|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
83305958|NCT03007420|Lidocaine|lidocaine|mesh-list
83305959|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
83305960|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
83305961|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83305962|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305963|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
83305964|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83305965|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83305966|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83305967|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83305968|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83305969|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305970|NCT04125706|Metronidazole|metronidazole|mesh-list
83305971|NCT04125706|Minocycline|minocycline|mesh-list
83305972|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83305973|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83305974|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83305975|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83305976|NCT03005782|Cemiplimab|cemiplimab|mesh-list
83305977|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83305978|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83305979|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83305980|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83305981|NCT04125082|Insulin|insulin|mesh-list
83305982|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83305983|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305984|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305985|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
83305986|NCT04393246|Ambrisentan|ambrisentan|mesh-list
83305987|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83305988|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83305989|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305990|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305991|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83305992|NCT04124302|Insulin|insulin|mesh-list
83305993|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83305994|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
83305995|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
83305996|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
83305997|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83305998|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83305999|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83306000|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83306001|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306002|NCT04411069|Droperidol|droperidol|mesh-list
83306003|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83306004|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
83306005|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
83306006|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306007|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306008|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306009|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83306010|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83306011|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83306012|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83306013|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83306014|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83306015|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
83306016|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83306017|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306018|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
83306019|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83306020|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
83306021|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306022|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
83306023|NCT03003130|Protective Agents|protective agents|mesh-ancestor
83306024|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
83306025|NCT01884571|Prednisone|prednisone|mesh-list
83306026|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
83306027|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83306028|NCT01884571|Tacrolimus|tacrolimus|mesh-list
83306029|NCT01884571|Basiliximab|basiliximab|mesh-list
83306030|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306031|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
83306033|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306034|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306035|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306036|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306037|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306038|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
83306039|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83306040|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306041|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306042|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83306043|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83306044|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
83306045|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83306046|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306047|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
83306048|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
83306049|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306050|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306051|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83306052|NCT01884571|Protective Agents|protective agents|mesh-ancestor
83306053|NCT01884337|Apixaban|apixaban|mesh-list
83306054|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83306055|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
83306056|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83306057|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
83306058|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306059|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306060|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
83306062|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83306063|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83306064|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306065|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83306066|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306067|NCT04123210|Vitamin A|vitamin a|mesh-list
83306068|NCT04123210|Vitamins|vitamins|mesh-ancestor
83306069|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
83306070|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306071|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83306072|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83306073|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306074|NCT04121416|Sufentanil|sufentanil|mesh-list
83306075|NCT04121416|Oxycodone|oxycodone|mesh-list
83306076|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83306077|NCT04121416|Narcotics|narcotics|mesh-ancestor
83306078|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83306079|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306080|NCT04121416|Analgesics|analgesics|mesh-ancestor
83306081|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
83306082|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306083|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83306084|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83306085|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
83306086|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
83306087|NCT04121338|Bupivacaine|bupivacaine|mesh-list
83306088|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
83306089|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
83306090|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83306091|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306092|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
83306093|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306094|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
83306095|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
83306096|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306097|NCT01922011|Vancomycin|vancomycin|mesh-list
83306098|NCT01922011|Daptomycin|daptomycin|mesh-list
83306099|NCT01922011|Nafcillin|nafcillin|mesh-list
83306100|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83306101|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306102|NCT04127968|Vitamin A|vitamin a|mesh-list
83306103|NCT04127968|Vitamins|vitamins|mesh-ancestor
83306104|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
83306105|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306106|NCT01921387|Cytarabine|cytarabine|mesh-list
83306107|NCT01921387|Etoposide|etoposide|mesh-list
83306108|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
83306109|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
83306110|NCT01921387|Melphalan|melphalan|mesh-list
83306111|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
83306112|NCT01921387|Carmustine|carmustine|mesh-list
83306113|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83306114|NCT01921387|Antibodies|antibodies|mesh-list
83306115|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83306116|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
83306117|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306118|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83306119|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306120|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83306121|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83306122|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306123|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306124|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306125|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
83306126|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
83306127|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306128|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306129|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83306130|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
83306131|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83306132|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
83306133|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
83306134|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306135|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306136|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306137|NCT04129996|Paclitaxel|paclitaxel|mesh-list
83306138|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83306139|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306140|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306141|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306142|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306143|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306144|NCT04129216|Tamoxifen|tamoxifen|mesh-list
83306145|NCT04129216|Letrozole|letrozole|mesh-list
83306146|NCT04129216|Exemestane|exemestane|mesh-list
83306147|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306148|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306149|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83306150|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83306151|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306152|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83306153|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
83306154|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306155|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306156|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306157|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83306158|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83306159|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83306160|NCT01895335|Teriflunomide|teriflunomide|mesh-list
83306161|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83306162|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83306163|NCT01895335|Analgesics|analgesics|mesh-ancestor
83306164|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
83306165|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306166|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306167|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306168|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306169|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306170|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
83306171|NCT02980510|Leucovorin|leucovorin|mesh-list
83306172|NCT02980510|Folic Acid|folic acid|mesh-list
83306173|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
83306174|NCT02980510|Irinotecan|irinotecan|mesh-list
83306175|NCT02980510|Panitumumab|panitumumab|mesh-list
83306176|NCT02980510|Fluorouracil|fluorouracil|mesh-list
83306177|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
83306178|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306179|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83306180|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83306181|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306182|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306183|NCT02980510|Antidotes|antidotes|mesh-ancestor
83306184|NCT02980510|Protective Agents|protective agents|mesh-ancestor
83306185|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306186|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
83306187|NCT02980510|Vitamins|vitamins|mesh-ancestor
83306188|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
83306189|NCT02980510|Hematinics|hematinics|mesh-ancestor
83306190|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83306191|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
83306192|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306193|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306194|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
83306195|NCT03829696|Misoprostol|misoprostol|mesh-list
83306196|NCT03829696|Mifepristone|mifepristone|mesh-list
83306197|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
83306198|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83306199|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
83306200|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83306201|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306202|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83306203|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306204|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
83306205|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83306206|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83306207|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83306208|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83306209|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
83306210|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83306211|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83306212|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
83306213|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306214|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
83306215|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83306216|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83306217|NCT03829774|Acetaminophen|acetaminophen|mesh-list
83306218|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83306219|NCT03829774|Analgesics|analgesics|mesh-ancestor
83306220|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
83306221|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306222|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306223|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
83306224|NCT02977780|Temozolomide|temozolomide|mesh-list
83306225|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83306226|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
83306227|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306228|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306229|NCT02974738|Belzutifan|belzutifan|mesh-list
83306230|NCT02974738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306231|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
83306232|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83306233|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
83306234|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306235|NCT02972398|Expectorants|expectorants|mesh-ancestor
83306236|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
83306237|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83306238|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
83306239|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306240|NCT02972398|Protective Agents|protective agents|mesh-ancestor
83306241|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306242|NCT02972398|Antidotes|antidotes|mesh-ancestor
83306243|NCT01617655|Alirocumab|alirocumab|mesh-list
83306244|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83306245|NCT01617655|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83306246|NCT01617655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83306247|NCT01617655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83306248|NCT01617655|Antimetabolites|antimetabolites|mesh-ancestor
83306249|NCT01617655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306250|NCT01617655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83306251|NCT01617655|Protease Inhibitors|protease inhibitors|mesh-ancestor
83306252|NCT01617655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306253|NCT01617655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83306254|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
83306255|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306256|NCT02965768|Naltrexone|naltrexone|mesh-list
83306257|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83306258|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83306259|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306260|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
83306261|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306262|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
83306263|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83306264|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83306265|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306266|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
83306267|NCT01895101|Coagulants|coagulants|mesh-ancestor
83306268|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
83306269|NCT03828682|Prednisone|prednisone|mesh-list
83306270|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
83306271|NCT03828682|Tacrolimus|tacrolimus|mesh-list
83306272|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
83306273|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83306274|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306275|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
83306276|NCT03828682|Hormones|hormones|mesh-ancestor
83306277|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306278|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306279|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306280|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306281|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306282|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
83306283|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83306284|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306285|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306286|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83306287|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83306288|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
83306289|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83306290|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306291|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
83306292|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
83306293|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306294|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306295|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83306296|NCT03828682|Protective Agents|protective agents|mesh-ancestor
83306297|NCT03483649|Bevacizumab|bevacizumab|mesh-list
83306298|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83306299|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306300|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83306301|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83306302|NCT03483649|Growth Substances|growth substances|mesh-ancestor
83306303|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306304|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
83306305|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
83306306|NCT03822520|Celecoxib|celecoxib|mesh-list
83306307|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83306308|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306309|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83306310|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83306311|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306312|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306313|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306314|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306315|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83306316|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83306317|NCT03822520|Analgesics|analgesics|mesh-ancestor
83306318|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
83306319|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306320|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306321|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306322|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83306323|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83306324|NCT01894477|Fludarabine|fludarabine|mesh-list
83306325|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
83306326|NCT01894477|Treosulfan|treosulfan|mesh-list
83306327|NCT01894477|Busulfan|busulfan|mesh-list
83306328|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306329|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306330|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
83306331|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306332|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306333|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
83306334|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306335|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83306336|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
83306337|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83306338|NCT04391998|Metronidazole|metronidazole|mesh-list
83306339|NCT04391998|Albendazole|albendazole|mesh-list
83306340|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306341|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83306342|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83306343|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83306344|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
83306345|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
83306346|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83306347|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306348|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306349|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306350|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306351|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306352|NCT03820180|Fluticasone|fluticasone|mesh-list
83306353|NCT03820180|Xhance|xhance|mesh-list
83306354|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83306355|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83306356|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306357|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83306358|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
83306359|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306360|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306361|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83306362|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
83306363|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
83306364|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83306365|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83306366|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83306367|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83306368|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
83306369|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83306370|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306371|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
83306372|NCT03820180|Hormones|hormones|mesh-ancestor
83306373|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306374|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
83306375|NCT01894243|Olaparib|olaparib|mesh-list
83306376|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83306377|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306378|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306379|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306380|NCT01450384|Pemetrexed|pemetrexed|mesh-list
83306381|NCT01450384|Sorafenib|sorafenib|mesh-list
83306382|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306383|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306384|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306385|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83306386|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83306387|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83306388|NCT01450462|Vitamin D|vitamin d|mesh-list
83306389|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
83306390|NCT01450462|Vitamins|vitamins|mesh-ancestor
83306391|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
83306392|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306393|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83306394|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83306395|NCT01450774|Beclomethasone|beclomethasone|mesh-list
83306396|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
83306397|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83306398|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
83306399|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306400|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306401|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83306402|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
83306403|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83306404|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83306405|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83306406|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
83306407|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83306408|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306409|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306410|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
83306411|NCT01450774|Hormones|hormones|mesh-ancestor
83306412|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306413|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
83306414|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83306415|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83306416|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83306417|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306418|NCT02913196|Prednisone|prednisone|mesh-list
83306419|NCT02913196|Docetaxel|docetaxel|mesh-list
83306420|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
83306421|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306422|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306423|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306424|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306425|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306426|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306427|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
83306428|NCT02913196|Hormones|hormones|mesh-ancestor
83306429|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306430|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306431|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306432|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83306433|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306434|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
83306435|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83306436|NCT01451086|Vaccines|vaccines|mesh-list
83306437|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
83306438|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306439|NCT01451710|Prednisone|prednisone|mesh-list
83306440|NCT01451710|Prednisolone|prednisolone|mesh-list
83306441|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83306442|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
83306443|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83306444|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
83306445|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83306446|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
83306447|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306448|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
83306449|NCT01451710|Hormones|hormones|mesh-ancestor
83306450|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306451|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306452|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306453|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306454|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
83306455|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
83306456|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306457|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306458|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83306459|NCT01451710|Protective Agents|protective agents|mesh-ancestor
83306460|NCT01451788|Thrombin|thrombin|mesh-list
83306461|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
83306462|NCT01451788|Coagulants|coagulants|mesh-ancestor
83306463|NCT01452100|Prednisone|prednisone|mesh-list
83306464|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306465|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
83306466|NCT01452100|Hormones|hormones|mesh-ancestor
83306467|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306468|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306469|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306470|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306471|NCT01452334|BMS-936559|bms-936559|mesh-list
83306472|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83306473|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306474|NCT01452568|Aspirin|aspirin|mesh-list
83306475|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
83306476|NCT01452568|Salicylates|salicylates|mesh-list
83306477|NCT01452568|Warfarin|warfarin|mesh-list
83306478|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83306479|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83306480|NCT01452568|Analgesics|analgesics|mesh-ancestor
83306481|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
83306482|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306483|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306484|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306485|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306486|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83306487|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83306488|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306489|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83306490|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83306491|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306492|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
83306493|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
83306494|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306495|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
83306496|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
83306497|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
83306498|NCT01452724|Lansoprazole|lansoprazole|mesh-list
83306499|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
83306500|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83306501|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306502|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83306503|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306504|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306505|NCT02620072|Insulin|insulin|mesh-list
83306506|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83306507|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306508|NCT01452880|Remifentanil|remifentanil|mesh-list
83306509|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83306510|NCT01452880|Narcotics|narcotics|mesh-ancestor
83306511|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83306512|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306513|NCT01452880|Analgesics|analgesics|mesh-ancestor
83306514|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
83306515|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306516|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
83306517|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83306518|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83306519|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
83306520|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306521|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83306522|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83306523|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306524|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306525|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83306526|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83306527|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306528|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
83306529|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306530|NCT01453504|Everolimus|everolimus|mesh-list
83306531|NCT01453504|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83306532|NCT01453504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83306533|NCT01453504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306534|NCT01453504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306535|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306536|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
83306537|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306538|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306539|NCT01453582|Propolis|propolis|mesh-list
83306540|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306541|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
83306542|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83306543|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83306544|NCT04847752|Aspirin|aspirin|mesh-list
83306545|NCT04847752|Warfarin|warfarin|mesh-list
83306546|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
83306548|NCT04847752|Anticoagulants|anticoagulants|mesh-list
83306549|NCT04847752|Clopidogrel|clopidogrel|mesh-list
83306550|NCT04847752|Atorvastatin|atorvastatin|mesh-list
83306551|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83306552|NCT04847752|Evolocumab|evolocumab|mesh-list
83306553|NCT04847752|Alirocumab|alirocumab|mesh-list
83306554|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83306555|NCT04847752|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83306556|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83306557|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83306558|NCT04847752|Analgesics|analgesics|mesh-ancestor
83306559|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
83306560|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306561|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306562|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306563|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306564|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83306565|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83306566|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306567|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83306568|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83306569|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306570|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
83306571|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83306572|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83306573|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
83306574|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83306575|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83306576|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83306577|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83306578|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
83306579|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83306580|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83306581|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
83306582|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83306583|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
83306584|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83306585|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
83306586|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
83306587|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306588|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83306589|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
83306590|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83306591|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306592|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83306593|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83306594|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83306595|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
83306596|NCT02864914|Empagliflozin|empagliflozin|mesh-list
83306597|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83306598|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83306599|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306600|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83306601|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306602|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
83306603|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306604|NCT04840264|Docetaxel|docetaxel|mesh-list
83306605|NCT04840264|Fluorouracil|fluorouracil|mesh-list
83306606|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
83306607|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306608|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306609|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306610|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306611|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306612|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
83306613|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306614|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306615|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
83306616|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306617|NCT04841434|Methotrexate|methotrexate|mesh-list
83306618|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83306619|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
83306620|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83306621|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306622|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306623|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
83306624|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306625|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306626|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
83306627|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306628|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83306629|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306630|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
83306631|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306632|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83306633|NCT04840342|Amlodipine|amlodipine|mesh-list
83306634|NCT04840342|Eplerenone|eplerenone|mesh-list
83306635|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83306636|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83306637|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83306638|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306639|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83306640|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306641|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
83306642|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83306643|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
83306644|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306645|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83306646|NCT04840342|Diuretics|diuretics|mesh-ancestor
83306647|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
83306648|NCT02849470|Complement Factor H|complement factor h|mesh-list
83306649|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83306650|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306651|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
83306652|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306653|NCT05021926|Lidocaine|lidocaine|mesh-list
83306654|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
83306655|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
83306656|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
83306657|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83306658|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306659|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
83306660|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306661|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83306662|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83306663|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83306664|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83306665|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306666|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83306667|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
83306668|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
83306669|NCT05021926|Protective Agents|protective agents|mesh-ancestor
83306670|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83306671|NCT05024188|Metronidazole|metronidazole|mesh-list
83306672|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
83306673|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306674|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83306675|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83306676|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83306677|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83306678|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306679|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306680|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306681|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83306682|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83306683|NCT04390594|Nafamostat|nafamostat|mesh-list
83306684|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83306685|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83306686|NCT04390594|Analgesics|analgesics|mesh-ancestor
83306687|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
83306688|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306689|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306690|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306691|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306692|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
83306693|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
83306694|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306695|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306696|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83306697|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83306698|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83306699|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306700|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
83306701|NCT05024422|Pyridoxine|pyridoxine|mesh-list
83306702|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
83306703|NCT05024422|Cabergoline|cabergoline|mesh-list
83306704|NCT05024422|Vitamins|vitamins|mesh-ancestor
83306705|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
83306706|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306707|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
83306708|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83306709|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83306710|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
83306711|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
83306712|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83306713|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306714|NCT02819596|Durvalumab|durvalumab|mesh-list
83306715|NCT02819596|Tremelimumab|tremelimumab|mesh-list
83306716|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83306717|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306718|NCT02818894|Lidocaine|lidocaine|mesh-list
83306719|NCT02818894|Bupivacaine|bupivacaine|mesh-list
83306720|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
83306721|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
83306722|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83306723|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306724|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
83306725|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306726|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83306727|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83306728|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83306729|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83306730|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306731|NCT02668666|Tamoxifen|tamoxifen|mesh-list
83306732|NCT02668666|Palbociclib|palbociclib|mesh-list
83306733|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83306734|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
83306735|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306736|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306737|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306738|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306739|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83306740|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83306741|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83306742|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83306743|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306744|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306745|NCT05586568|Itraconazole|itraconazole|mesh-list
83306746|NCT05586568|Rifampin|rifampin|mesh-list
83306747|NCT05586568|Esomeprazole|esomeprazole|mesh-list
83306748|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83306749|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306750|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83306751|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306752|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306753|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
83306754|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306755|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83306756|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83306757|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83306758|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
83306759|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306760|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306761|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83306762|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83306763|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
83306764|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83306765|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
83306766|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83306767|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83306768|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83306769|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83306770|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83306771|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83306772|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83306773|NCT02632708|Cytarabine|cytarabine|mesh-list
83306774|NCT02632708|Etoposide|etoposide|mesh-list
83306775|NCT02632708|Daunorubicin|daunorubicin|mesh-list
83306776|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
83306777|NCT02632708|Idarubicin|idarubicin|mesh-list
83306778|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83306779|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306780|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83306781|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83306782|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306783|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306784|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306785|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
83306786|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
83306787|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306788|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306789|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
83306790|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306791|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83306792|NCT02632708|Analgesics|analgesics|mesh-ancestor
83306793|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
83306794|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306795|NCT02624908|Canagliflozin|canagliflozin|mesh-list
83306796|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83306797|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306798|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83306799|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306800|NCT02614534|Mitomycins|mitomycins|mesh-list
83306801|NCT02614534|Mitomycin|mitomycin|mesh-list
83306802|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83306803|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306804|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
83306805|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306806|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83306807|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306808|NCT02608216|Paclitaxel|paclitaxel|mesh-list
83306809|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83306810|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306811|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306812|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306813|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306814|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306815|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
83306816|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83306817|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
83306818|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83306819|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306820|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83306821|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
83306822|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83306823|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306825|NCT02556424|Triamcinolone|triamcinolone|mesh-list
83306826|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306827|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
83306828|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
83306829|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306830|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306831|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306832|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
83306833|NCT02556424|Hormones|hormones|mesh-ancestor
83430173|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306834|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306835|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306836|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306837|NCT02543944|Clonidine|clonidine|mesh-list
83306838|NCT02543944|Naltrexone|naltrexone|mesh-list
83306839|NCT02543944|Buprenorphine|buprenorphine|mesh-list
83306840|NCT02543944|Gabapentin|gabapentin|mesh-list
83306841|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83306842|NCT02543944|Narcotics|narcotics|mesh-ancestor
83306843|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83306844|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306845|NCT02543944|Analgesics|analgesics|mesh-ancestor
83306846|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
83306847|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306848|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83306849|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
83306850|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83306851|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83306852|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83306853|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83306854|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83306855|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83306856|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306857|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
83306858|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83306859|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83306860|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
83306861|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
83306862|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83306863|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83306864|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83306865|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
83306866|NCT02538484|Letrozole|letrozole|mesh-list
83306867|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306868|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83306869|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83306870|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306871|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306872|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83306873|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
83306874|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306875|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306876|NCT02531308|Metformin|metformin|mesh-list
83306877|NCT02531308|Prednisone|prednisone|mesh-list
83306878|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
83306879|NCT02531308|Rituximab|rituximab|mesh-list
83306880|NCT02531308|Doxorubicin|doxorubicin|mesh-list
83306881|NCT02531308|Vincristine|vincristine|mesh-list
83306882|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306883|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
83306884|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306885|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306886|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83306887|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
83306888|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306889|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306890|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83306891|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83306892|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83306893|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83306894|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83306895|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83306896|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306897|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306898|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
83306899|NCT02531308|Hormones|hormones|mesh-ancestor
83306900|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306901|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306902|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83306903|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306904|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306905|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306906|NCT02523976|Cytarabine|cytarabine|mesh-list
83306907|NCT02523976|Dexamethasone|dexamethasone|mesh-list
83306908|NCT02523976|Prednisone|prednisone|mesh-list
83306909|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
83306910|NCT02523976|Methotrexate|methotrexate|mesh-list
83306911|NCT02523976|Etoposide|etoposide|mesh-list
83306912|NCT02523976|Vincristine|vincristine|mesh-list
83306913|NCT02523976|Daunorubicin|daunorubicin|mesh-list
83306914|NCT02523976|Dasatinib|dasatinib|mesh-list
83306915|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
83306916|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
83306917|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83306918|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
83306919|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306920|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83306921|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83306922|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
83306923|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306924|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306925|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83306926|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306927|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
83306928|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
83306929|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306930|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306931|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
83306932|NCT02523976|Hormones|hormones|mesh-ancestor
83306933|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306934|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306935|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83306936|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
83306937|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83306938|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306939|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
83306940|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
83306941|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306942|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83306943|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83306944|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83306945|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83306946|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83306947|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
83306948|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83306949|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306950|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306951|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306952|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83306953|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83306954|NCT02523976|Analgesics|analgesics|mesh-ancestor
83306955|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
83306956|NCT02514382|Dexamethasone|dexamethasone|mesh-list
83306957|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
83306958|NCT02514382|Bortezomib|bortezomib|mesh-list
83306959|NCT02514382|Ichthammol|ichthammol|mesh-list
83306960|NCT02514382|BB 1101|bb 1101|mesh-list
83306961|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83306962|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
83306963|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
83306964|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83306965|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306966|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83306967|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
83306968|NCT02514382|Hormones|hormones|mesh-ancestor
83306969|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83306970|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83306971|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306972|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
83306973|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83306974|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306975|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
83306976|NCT02495896|Paclitaxel|paclitaxel|mesh-list
83306977|NCT02495896|Docetaxel|docetaxel|mesh-list
83306978|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83306979|NCT02495896|Cisplatin|cisplatin|mesh-list
83306980|NCT02495896|Gemcitabine|gemcitabine|mesh-list
83306981|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83306982|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83306983|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
83306984|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
83306985|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
83306986|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83306987|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83306988|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
83306989|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83306991|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83306992|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
83306993|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83306994|NCT02493322|Diuretics|diuretics|mesh-ancestor
83306995|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
83306996|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83306997|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83306998|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83306999|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307000|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83307001|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83307002|NCT04757974|Fostemsavir|fostemsavir|mesh-list
83307003|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83307004|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83307005|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
83307006|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307007|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83307008|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83307009|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307010|NCT04757506|Naltrexone|naltrexone|mesh-list
83307011|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83307012|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83307013|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307014|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
83307015|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307016|NCT02477644|Olaparib|olaparib|mesh-list
83307017|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83307018|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307019|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307020|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307021|NCT02466334|Calcitonin|calcitonin|mesh-list
83307022|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
83307023|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83307024|NCT02466334|Katacalcin|katacalcin|mesh-list
83307025|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83307026|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307027|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83307028|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
83307029|NCT02460874|Glyburide|glyburide|mesh-list
83307030|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83307031|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307032|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
83307033|NCT02443324|Ramucirumab|ramucirumab|mesh-list
83307034|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307035|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307036|NCT02443324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83307037|NCT02443324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307038|NCT01894048|Beclomethasone|beclomethasone|mesh-list
83307039|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307040|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
83307041|NCT01894048|Hormones|hormones|mesh-ancestor
83307042|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307043|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307044|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83307045|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
83307046|NCT02420860|Lenalidomide|lenalidomide|mesh-list
83307047|NCT02420860|Elotuzumab|elotuzumab|mesh-list
83307048|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
83307049|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307050|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83307051|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83307052|NCT02420860|Growth Substances|growth substances|mesh-ancestor
83307053|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
83307054|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307055|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
83307056|NCT02420314|Paclitaxel|paclitaxel|mesh-list
83307057|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83307058|NCT02420314|Carboplatin|carboplatin|mesh-list
83307059|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83307060|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307061|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
83307062|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
83307063|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
83307064|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307065|NCT02420314|Vitamins|vitamins|mesh-ancestor
83307066|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
83307067|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307068|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
83307069|NCT02420314|Protective Agents|protective agents|mesh-ancestor
83307070|NCT02403778|Ipilimumab|ipilimumab|mesh-list
83307071|NCT02403778|Tretinoin|tretinoin|mesh-list
83307072|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307073|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307074|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83307075|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307076|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
83307077|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
83307078|NCT01539291|Idelalisib|idelalisib|mesh-list
83307079|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307080|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307081|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307082|NCT04746040|Fluticasone|fluticasone|mesh-list
83307083|NCT04746040|Xhance|xhance|mesh-list
83307084|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83307085|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83307086|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307087|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83307088|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
83307089|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307090|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307091|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83307092|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
83307093|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
83307094|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83307095|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83307096|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83307097|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83307098|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
83307099|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307100|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307101|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
83307102|NCT04746040|Hormones|hormones|mesh-ancestor
83307103|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307104|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
83307105|NCT02400814|Atezolizumab|atezolizumab|mesh-list
83307106|NCT02400814|Antibodies|antibodies|mesh-list
83307107|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83307108|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
83307109|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307110|NCT02400814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83307111|NCT02400814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307112|NCT02400814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307113|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307114|NCT02398240|Rituximab|rituximab|mesh-list
83307115|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83307117|NCT02398240|Vincristine|vincristine|mesh-list
83307118|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307119|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307120|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
83307121|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307122|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307123|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307124|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307125|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307126|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307127|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307128|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83307129|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
83307130|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
83307131|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
83307132|NCT02398240|Immunotoxins|immunotoxins|mesh-ancestor
83307133|NCT02398240|Immunoconjugates|immunoconjugates|mesh-ancestor
83307134|NCT02022280|Lansoprazole|lansoprazole|mesh-list
83307135|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
83307136|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83307137|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83307138|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83307139|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307140|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307141|NCT02363374|Leucovorin|leucovorin|mesh-list
83307142|NCT02363374|Folic Acid|folic acid|mesh-list
83307143|NCT02363374|Fluorouracil|fluorouracil|mesh-list
83307144|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
83307145|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
83307146|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
83307147|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307148|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83307149|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307150|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307151|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
83307152|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307153|NCT02363374|Antidotes|antidotes|mesh-ancestor
83307154|NCT02363374|Protective Agents|protective agents|mesh-ancestor
83307155|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
83307156|NCT02363374|Vitamins|vitamins|mesh-ancestor
83307157|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
83307158|NCT02363374|Hematinics|hematinics|mesh-ancestor
83307159|NCT01511445|Silicon|silicon|mesh-list
83307160|NCT01511445|Trace Elements|trace elements|mesh-ancestor
83307161|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
83307162|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307163|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
83307164|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307165|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307166|NCT02362594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83307167|NCT02362594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307168|NCT02344186|Liraglutide|liraglutide|mesh-list
83307169|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83307170|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307171|NCT02344186|Incretins|incretins|mesh-ancestor
83307172|NCT02344186|Hormones|hormones|mesh-ancestor
83307173|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307174|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
83307175|NCT01537887|Evacetrapib|evacetrapib|mesh-list
83307176|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307177|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307178|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307179|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307180|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307181|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307182|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307183|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83307184|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83307185|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
83307186|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83307187|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83307188|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83307189|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307190|NCT02297698|Trastuzumab|trastuzumab|mesh-list
83307191|NCT02297698|Sargramostim|sargramostim|mesh-list
83307192|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307193|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307194|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
83307195|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307196|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
83307197|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307198|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307199|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83307200|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
83307201|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307202|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307203|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307204|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307205|NCT01928056|Montelukast|montelukast|mesh-list
83307206|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83307207|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
83307208|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83307209|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
83307210|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307211|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307212|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83307213|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83307214|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307215|NCT05585866|Anesthetics|anesthetics|mesh-list
83307216|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83307217|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307218|NCT01992952|Fulvestrant|fulvestrant|mesh-list
83307219|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83307220|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307221|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83307222|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83307223|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
83307224|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307225|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307226|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
83307227|NCT01928134|Calcium|calcium|mesh-list
83307228|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83307229|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307230|NCT01928134|Antacids|antacids|mesh-ancestor
83307231|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307232|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83307233|NCT02285140|Vancomycin|vancomycin|mesh-list
83307234|NCT02285140|Cefazolin|cefazolin|mesh-list
83307235|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307236|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307237|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83307238|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83307239|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83307240|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307241|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307242|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
83307243|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307244|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307245|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83307246|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307247|NCT04756492|Cyclosporine|cyclosporine|mesh-list
83307248|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
83307249|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307250|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
83307251|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307252|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307253|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307254|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
83307255|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307256|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307257|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83307258|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
83307259|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307260|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307261|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307262|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307263|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307264|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307265|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307266|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
83307267|NCT04767633|Analgesics|analgesics|mesh-ancestor
83307268|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
83307269|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307270|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307271|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
83307272|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83307273|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83307274|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
83307275|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83307276|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430174|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
83307277|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307278|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83307279|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
83307280|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83307281|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
83307282|NCT01928914|Tafenoquine|tafenoquine|mesh-list
83307283|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307284|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307285|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307286|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307287|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307288|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307289|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307290|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
83307291|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83307292|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83307293|NCT02249104|Adapalene|adapalene|mesh-list
83307294|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83307295|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83307296|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
83307297|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83307298|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83307299|NCT02249104|Analgesics|analgesics|mesh-ancestor
83307300|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
83307301|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307302|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307303|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307304|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307305|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83307306|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83307307|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83307308|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
83307309|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307310|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83307311|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83307312|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307313|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
83307314|NCT01536561|Antibodies|antibodies|mesh-list
83307315|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83307316|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
83307317|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
83307318|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307319|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307320|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
83307321|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83307322|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83307323|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83307324|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307325|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307326|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
83307327|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307328|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307329|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83307330|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307331|NCT01916278|Lidocaine|lidocaine|mesh-list
83307332|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
83307333|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
83307334|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83307335|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307336|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
83307337|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307338|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83307339|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83307340|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83307341|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307342|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307343|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
83307344|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307345|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307346|NCT03084640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83307347|NCT03084640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307348|NCT04409691|Sirolimus|sirolimus|mesh-list
83307349|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307350|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307351|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307352|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307353|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
83307354|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307355|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
83307356|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307357|NCT02223208|Prednisone|prednisone|mesh-list
83307358|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
83307359|NCT02223208|Doxorubicin|doxorubicin|mesh-list
83307360|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83307361|NCT02223208|Etoposide|etoposide|mesh-list
83307362|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
83307363|NCT02223208|Romidepsin|romidepsin|mesh-list
83307364|NCT02223208|Vincristine|vincristine|mesh-list
83307365|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307366|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
83307367|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307368|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307369|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83307370|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
83307371|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307372|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307373|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83307374|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307375|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307376|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307377|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307378|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307379|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
83307380|NCT02223208|Hormones|hormones|mesh-ancestor
83307381|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307382|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83307383|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83307384|NCT02223208|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83307385|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
83307386|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
83307387|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
83307388|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
83307389|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83307390|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83307391|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83307392|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307393|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
83307394|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83307395|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83307396|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307397|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83307398|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307399|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307400|NCT01516606|Clarithromycin|clarithromycin|mesh-list
83307401|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307402|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307403|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83307404|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307405|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307406|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83307407|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83307408|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
83307409|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
83307410|NCT02209636|Vitamins|vitamins|mesh-ancestor
83307411|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
83307412|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307413|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
83307414|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307415|NCT02209636|Protective Agents|protective agents|mesh-ancestor
83307416|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
83307417|NCT01508325|Metoprolol|metoprolol|mesh-list
83307418|NCT01508325|Bisoprolol|bisoprolol|mesh-list
83307419|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83307420|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83307421|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
83307422|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
83307423|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307424|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307425|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83307426|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83307427|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83307428|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
83307429|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307430|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307431|NCT01514344|Rituximab|rituximab|mesh-list
83307432|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307433|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307434|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
83307435|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307436|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307437|NCT01506856|Paclitaxel|paclitaxel|mesh-list
83307438|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83307439|NCT01506856|Carboplatin|carboplatin|mesh-list
83307440|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83307441|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307442|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
83307443|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
83307444|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
83307445|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307446|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
83307447|NCT02191930|Doxorubicin|doxorubicin|mesh-list
83307448|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83307449|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83307450|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307451|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
83307452|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307453|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307454|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83307455|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
83307456|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307457|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307458|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83307459|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307460|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307461|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307462|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307463|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307464|NCT02191930|Immunotoxins|immunotoxins|mesh-ancestor
83307465|NCT02191930|Immunoconjugates|immunoconjugates|mesh-ancestor
83307466|NCT01536015|Rotigotine|rotigotine|mesh-list
83307467|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
83307468|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
83307469|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307470|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307471|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307472|NCT01865110|Prednisone|prednisone|mesh-list
83307473|NCT01865110|Rituximab|rituximab|mesh-list
83307474|NCT01865110|Lenalidomide|lenalidomide|mesh-list
83307475|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
83307476|NCT01865110|Vincristine|vincristine|mesh-list
83307477|NCT01865110|Doxorubicin|doxorubicin|mesh-list
83307478|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307479|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307480|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
83307481|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307482|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307483|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83307484|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83307485|NCT01865110|Growth Substances|growth substances|mesh-ancestor
83307486|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
83307487|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307488|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83307489|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
83307490|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307491|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83307492|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307493|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
83307494|NCT01865110|Hormones|hormones|mesh-ancestor
83307495|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307496|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83307497|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83307498|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83307499|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83307500|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83307501|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307502|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307503|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307504|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307505|NCT01484691|Budesonide|budesonide|mesh-list
83307506|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307507|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83307508|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
83307509|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307510|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307511|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83307512|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
83307513|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
83307514|NCT01484691|Hormones|hormones|mesh-ancestor
83307515|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307516|NCT01464034|Dexamethasone|dexamethasone|mesh-list
83307517|NCT01464034|Pomalidomide|pomalidomide|mesh-list
83307518|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307519|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
83307520|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
83307521|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307522|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307523|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83307524|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
83307525|NCT01464034|Hormones|hormones|mesh-ancestor
83307526|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307527|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83307528|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307529|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
83307530|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83307531|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83307532|NCT01464034|Growth Substances|growth substances|mesh-ancestor
83307533|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
83307534|NCT01535235|Lisinopril|lisinopril|mesh-list
83307535|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83307536|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
83307537|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307538|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307539|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83307540|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83307541|NCT01535235|Protective Agents|protective agents|mesh-ancestor
83307542|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307543|NCT02317744|Naltrexone|naltrexone|mesh-list
83307544|NCT02317744|Bupropion|bupropion|mesh-list
83307545|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83307546|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83307547|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307548|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
83307549|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307550|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83307551|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
83307552|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83307553|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83307554|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83307555|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307556|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307557|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
83307558|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307559|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83307560|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83307561|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307562|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
83307563|NCT01810588|Rituximab|rituximab|mesh-list
83307564|NCT01810588|Fludarabine|fludarabine|mesh-list
83307565|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
83307566|NCT01810588|Melphalan|melphalan|mesh-list
83307567|NCT01810588|Tacrolimus|tacrolimus|mesh-list
83307568|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83307569|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
83307570|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307571|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307572|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
83307573|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307574|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307575|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83307576|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
83307577|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307578|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307579|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307580|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83307581|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307582|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307583|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83307584|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
83307585|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307586|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83307587|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
83307588|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83307589|NCT02144584|Memantine|memantine|mesh-list
83307590|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83307591|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83307592|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
83307593|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307594|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307595|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307596|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83307597|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83307598|NCT05577442|Trastuzumab|trastuzumab|mesh-list
83307599|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307600|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307601|NCT01895764|Adalimumab|adalimumab|mesh-list
83307602|NCT01895764|Methotrexate|methotrexate|mesh-list
83307603|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83307604|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
83307605|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83307606|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307607|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83307608|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
83307609|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307610|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307611|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
83307612|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307613|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83307614|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307615|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
83307616|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307617|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83307618|NCT01895764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83307619|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307620|NCT01894360|Belimumab|belimumab|mesh-list
83307621|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307622|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
83307623|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307624|NCT01483599|Adalimumab|adalimumab|mesh-list
83307625|NCT01483599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83307626|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307627|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307628|NCT01407562|Paclitaxel|paclitaxel|mesh-list
83307629|NCT01407562|Carboplatin|carboplatin|mesh-list
83307630|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83307631|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307632|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83307633|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83307634|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83307635|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307636|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83307637|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
83307638|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307639|NCT01393522|Milnacipran|milnacipran|mesh-list
83307640|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
83307641|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83307642|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83307643|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307644|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307645|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307646|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307647|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83307648|NCT01393522|Analgesics|analgesics|mesh-ancestor
83307649|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
83307650|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307651|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
83307652|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83307653|NCT02086786|Risperidone|risperidone|mesh-list
83307654|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83307655|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
83307656|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307657|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307658|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307659|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83307660|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83307661|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83307662|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83307663|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83307664|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
83307665|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83307666|NCT01787500|Cetuximab|cetuximab|mesh-list
83307667|NCT01787500|Irinotecan|irinotecan|mesh-list
83307668|NCT01787500|Camptothecin|camptothecin|mesh-list
83307669|NCT01787500|Vemurafenib|vemurafenib|mesh-list
83307670|NCT01787500|Antibodies|antibodies|mesh-list
83307671|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
83307672|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83307673|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
83307674|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307675|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307676|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83307677|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307678|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307679|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307680|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83307681|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83307682|NCT01782352|Vitamin D|vitamin d|mesh-list
83307683|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
83307684|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
83307685|NCT01782352|Vitamins|vitamins|mesh-list
83307686|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
83307687|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307688|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83307689|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83307690|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
83307691|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83307692|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83307693|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83307694|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307695|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307696|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
83307697|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307698|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307699|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83307700|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307701|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83307702|NCT01895218|Hematinics|hematinics|mesh-ancestor
83307703|NCT01895998|Albuterol|albuterol|mesh-list
83307704|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83307705|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
83307706|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307707|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307708|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83307709|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
83307710|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
83307711|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83307712|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83307714|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83307715|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
83307716|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307717|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307718|NCT01895296|Pasireotide|pasireotide|mesh-list
83307719|NCT01895296|Hormones|hormones|mesh-ancestor
83307720|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307721|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307722|NCT01276600|Tenofovir|tenofovir|mesh-list
83307723|NCT01276600|Emtricitabine|emtricitabine|mesh-list
83307724|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
83307725|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307726|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83307727|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83307728|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307729|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307730|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83307731|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83307732|NCT02040376|Metformin|metformin|mesh-list
83307733|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83307734|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307735|NCT04755868|Talazoparib|talazoparib|mesh-list
83307736|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83307737|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307738|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307739|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307740|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83307741|NCT05228314|Vaccines|vaccines|mesh-list
83307742|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
83307743|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
83307744|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307745|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83307746|NCT05228314|Antacids|antacids|mesh-ancestor
83307747|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307748|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83307749|NCT01659658|Thalidomide|thalidomide|mesh-list
83307750|NCT01659658|Dexamethasone|dexamethasone|mesh-list
83307751|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
83307752|NCT01659658|Melphalan|melphalan|mesh-list
83307753|NCT01659658|Lenalidomide|lenalidomide|mesh-list
83307754|NCT01659658|Ixazomib|ixazomib|mesh-list
83307755|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307756|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
83307757|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307758|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307759|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83307760|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
83307761|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307762|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307763|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83307764|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307765|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
83307766|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
83307767|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307768|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83307769|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
83307770|NCT01659658|Hormones|hormones|mesh-ancestor
83307771|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307772|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83307773|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83307774|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83307775|NCT01659658|Growth Substances|growth substances|mesh-ancestor
83307776|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
83307777|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
83307778|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83307779|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307780|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
83307781|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307782|NCT01639690|Busulfan|busulfan|mesh-list
83307783|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
83307784|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307785|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83307786|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
83307787|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307788|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83307789|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307790|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83307791|NCT01621906|Alovudine|alovudine|mesh-list
83307792|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
83307793|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307794|NCT01615510|Tapentadol|tapentadol|mesh-list
83307795|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83307796|NCT01615510|Narcotics|narcotics|mesh-ancestor
83307797|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83307798|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307799|NCT01615510|Analgesics|analgesics|mesh-ancestor
83307800|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
83307801|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307802|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83307803|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83307804|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307805|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307806|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
83307807|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307808|NCT00530062|Albuterol|albuterol|mesh-list
83307809|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83307810|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
83307811|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307812|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307813|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83307814|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
83307815|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
83307816|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83307817|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83307818|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83307819|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83307820|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83307821|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307822|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307823|NCT04283656|Tenofovir|tenofovir|mesh-list
83307824|NCT04283656|Lamivudine|lamivudine|mesh-list
83307825|NCT04283656|Spironolactone|spironolactone|mesh-list
83307826|NCT04283656|Estradiol|estradiol|mesh-list
83307827|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
83307828|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307829|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83307830|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83307831|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307832|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307833|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83307834|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83307835|NCT04283656|Estrogens|estrogens|mesh-ancestor
83307836|NCT04283656|Hormones|hormones|mesh-ancestor
83307837|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307838|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307839|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83307840|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
83307841|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83307843|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
83307844|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
83307845|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83307846|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83307847|NCT01209364|Prednisolone|prednisolone|mesh-list
83307848|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
83307849|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83307850|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
83307851|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307852|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
83307853|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
83307854|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307855|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307856|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83307857|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
83307858|NCT01209364|Hormones|hormones|mesh-ancestor
83307859|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307860|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83307861|NCT01209364|Protective Agents|protective agents|mesh-ancestor
83307862|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83307863|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307864|NCT05080192|Fenofibrate|fenofibrate|mesh-list
83307865|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83307866|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
83307867|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307868|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83307869|NCT00479128|Gemcitabine|gemcitabine|mesh-list
83307870|NCT00479128|Doxorubicin|doxorubicin|mesh-list
83307871|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83307872|NCT00479128|Bortezomib|bortezomib|mesh-list
83307873|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83307874|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
83307875|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307876|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307877|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83307878|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83307879|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83307880|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307881|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83307882|NCT00472966|Tretinoin|tretinoin|mesh-list
83307883|NCT00472966|Glycolic acid|glycolic acid|mesh-list
83307884|NCT00472966|Hydroquinone|hydroquinone|mesh-list
83307885|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307886|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
83307887|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
83307888|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307889|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
83307890|NCT00472966|Hormones|hormones|mesh-ancestor
83307891|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307892|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307893|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
83307894|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307895|NCT00472966|Protective Agents|protective agents|mesh-ancestor
83307896|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83307897|NCT01573780|Gemcitabine|gemcitabine|mesh-list
83307898|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83307899|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
83307900|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307901|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307902|NCT01547260|Gemcitabine|gemcitabine|mesh-list
83307904|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83307905|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
83307906|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307907|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307908|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
83307909|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307910|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83307911|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83307912|NCT01547260|Growth Substances|growth substances|mesh-ancestor
83307913|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
83307914|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83307915|NCT04205266|Hematinics|hematinics|mesh-ancestor
83307916|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83307917|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83307918|NCT01896388|Ifenprodil|ifenprodil|mesh-list
83307919|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83307920|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83307921|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
83307922|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307923|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307924|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307925|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
83307926|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83307927|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83307928|NCT01125436|Vitamin D|vitamin d|mesh-list
83307929|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
83307930|NCT01125436|Vitamins|vitamins|mesh-ancestor
83307931|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
83307932|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307933|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83307934|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83307935|NCT04755322|Aspirin|aspirin|mesh-list
83307936|NCT04755322|Folic Acid|folic acid|mesh-list
83307937|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
83307938|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83307939|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83307941|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
83307942|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307943|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307944|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307945|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83307946|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83307947|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83307948|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307949|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83307950|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83307951|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83307952|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
83307953|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
83307954|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83307955|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83307956|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83307957|NCT04755322|Hematinics|hematinics|mesh-ancestor
83307958|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
83307959|NCT04755322|Vitamins|vitamins|mesh-ancestor
83307960|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
83307961|NCT00436540|Clobetasol|clobetasol|mesh-list
83307962|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307963|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
83307964|NCT00436540|Hormones|hormones|mesh-ancestor
83307965|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307966|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307967|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83307968|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83307969|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83307970|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83307971|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83307972|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83307973|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307974|NCT00425230|Analgesics|analgesics|mesh-ancestor
83307975|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
83307976|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307977|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
83307978|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83307979|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
83307981|NCT00410956|Bevacizumab|bevacizumab|mesh-list
83307982|NCT00410956|Floxuridine|floxuridine|mesh-list
83307983|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83307984|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83307985|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83307986|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83307987|NCT00410956|Growth Substances|growth substances|mesh-ancestor
83307988|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83307989|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
83307990|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83307991|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
83307992|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
83307993|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83307994|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83307995|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
83307996|NCT00410956|Hormones|hormones|mesh-ancestor
83307997|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83307998|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83307999|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308000|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
83308001|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308002|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83308003|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
83308004|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308005|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83308006|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308007|NCT04634578|Bevacizumab|bevacizumab|mesh-list
83308008|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308009|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308010|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83308011|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83308012|NCT04634578|Growth Substances|growth substances|mesh-ancestor
83308013|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308014|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
83308015|NCT01066858|Tenofovir|tenofovir|mesh-list
83308016|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
83308017|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308018|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83308019|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83308020|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308021|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308022|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83308023|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83308024|NCT04777552|Diazepam|diazepam|mesh-list
83308025|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83308026|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
83308027|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
83308028|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
83308029|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308030|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308031|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308032|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83308033|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308034|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83308035|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83308036|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83308037|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83308038|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308039|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83308040|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
83308041|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
83308042|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
83308043|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
83308044|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308045|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308046|NCT01506609|Paclitaxel|paclitaxel|mesh-list
83308047|NCT01506609|Carboplatin|carboplatin|mesh-list
83308048|NCT01506609|Temozolomide|temozolomide|mesh-list
83308049|NCT01506609|Veliparib|veliparib|mesh-list
83308050|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83308051|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308052|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308053|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308054|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308055|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308056|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83308057|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
83308058|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83308059|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308060|NCT04777162|Tislelizumab|tislelizumab|mesh-list
83308061|NCT04777162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308062|NCT04777162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308063|NCT03027219|Alprostadil|alprostadil|mesh-list
83308064|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83308065|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
83308066|NCT03027219|Urological Agents|urological agents|mesh-ancestor
83308067|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
83308068|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
83308069|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308070|NCT01506453|Gabapentin|gabapentin|mesh-list
83308071|NCT01506453|Analgesics|analgesics|mesh-ancestor
83308072|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
83308073|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308074|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308075|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
83308076|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83308077|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83308078|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308079|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308080|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83308081|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83308082|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308083|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308084|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
83308085|NCT04389580|Tamoxifen|tamoxifen|mesh-list
83308086|NCT04389580|Isotretinoin|isotretinoin|mesh-list
83308087|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83308088|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
83308089|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308090|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308091|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308092|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308093|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83308094|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83308095|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83308096|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308097|NCT00199108|Dexamethasone|dexamethasone|mesh-list
83308098|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308099|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
83308100|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
83308101|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308102|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308103|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308104|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
83308105|NCT00199108|Hormones|hormones|mesh-ancestor
83308106|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308107|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308108|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308109|NCT01504971|Rabeprazole|rabeprazole|mesh-list
83308110|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83308111|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308112|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83308113|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308114|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308115|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83308116|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308117|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308118|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308119|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308121|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83308122|NCT04753918|Trioxsalen|trioxsalen|mesh-list
83308123|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308124|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308125|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83308126|NCT04161664|Paclitaxel|paclitaxel|mesh-list
83308127|NCT04161664|Carboplatin|carboplatin|mesh-list
83308128|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83308129|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308130|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308131|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308132|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308133|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308134|NCT00936832|Leucovorin|leucovorin|mesh-list
83308135|NCT00936832|Fluorouracil|fluorouracil|mesh-list
83308136|NCT00936832|Irinotecan|irinotecan|mesh-list
83308137|NCT00936832|Sunitinib|sunitinib|mesh-list
83308138|NCT00936832|Calcium|calcium|mesh-list
83308139|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
83308140|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83308141|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308142|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
83308143|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308144|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308145|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308146|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308147|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
83308148|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83308149|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83308150|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308151|NCT00936832|Antidotes|antidotes|mesh-ancestor
83308152|NCT00936832|Protective Agents|protective agents|mesh-ancestor
83308153|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
83308154|NCT00936832|Vitamins|vitamins|mesh-ancestor
83308155|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
83308156|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83308157|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83308158|NCT00936832|Growth Substances|growth substances|mesh-ancestor
83308159|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
83308160|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308161|NCT01479621|Fluticasone|fluticasone|mesh-list
83308162|NCT01479621|Xhance|xhance|mesh-list
83308163|NCT01479621|Albuterol|albuterol|mesh-list
83308164|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
83308165|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308166|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83308167|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
83308168|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308169|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308170|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83308171|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
83308172|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308173|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83308174|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
83308175|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83308176|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83308177|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83308178|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
83308179|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308180|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308182|NCT04776226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83308183|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83308184|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308185|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308186|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308187|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
83308188|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308189|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83308190|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
83308191|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308192|NCT02319304|Leucovorin|leucovorin|mesh-list
83308193|NCT02319304|Fluorouracil|fluorouracil|mesh-list
83308194|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
83308195|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
83308196|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308197|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308198|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308199|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308200|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
83308201|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308202|NCT02319304|Antidotes|antidotes|mesh-ancestor
83308203|NCT02319304|Protective Agents|protective agents|mesh-ancestor
83308204|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
83308205|NCT02319304|Vitamins|vitamins|mesh-ancestor
83308206|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
83308207|NCT00885664|Ritonavir|ritonavir|mesh-list
83308208|NCT00885664|Lopinavir|lopinavir|mesh-list
83308209|NCT00885664|Tenofovir|tenofovir|mesh-list
83308210|NCT00885664|Emtricitabine|emtricitabine|mesh-list
83308211|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83308212|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83308213|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83308214|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
83308215|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308216|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308217|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83308218|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83308219|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
83308220|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308221|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83308222|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83308223|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83308224|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83308225|NCT04784104|Epinephrine|epinephrine|mesh-list
83308226|NCT04784104|Racepinephrine|racepinephrine|mesh-list
83308227|NCT04784104|Bupivacaine|bupivacaine|mesh-list
83308228|NCT04784104|Prilocaine|prilocaine|mesh-list
83308229|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83308230|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
83308231|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
83308232|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
83308233|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308234|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308235|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
83308236|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308237|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83308238|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83308239|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
83308240|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308241|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308242|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83308243|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83308244|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
83308245|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83308246|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
83308247|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
83308248|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
83308249|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83308250|NCT00880594|Desipramine|desipramine|mesh-list
83308251|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83308252|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
83308253|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308254|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308255|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308256|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83308257|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83308258|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308259|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
83308260|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308261|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308262|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
83308263|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83308264|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308265|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308266|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308268|NCT00878254|Cytarabine|cytarabine|mesh-list
83308269|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
83308270|NCT00878254|Ifosfamide|ifosfamide|mesh-list
83308271|NCT00878254|Rituximab|rituximab|mesh-list
83308272|NCT00878254|Doxorubicin|doxorubicin|mesh-list
83308273|NCT00878254|Methotrexate|methotrexate|mesh-list
83308274|NCT00878254|Etoposide|etoposide|mesh-list
83308275|NCT00878254|Vincristine|vincristine|mesh-list
83308276|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308277|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
83308278|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308279|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83308280|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83308281|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
83308282|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308283|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308284|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83308285|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308286|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83308287|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83308288|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83308289|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308290|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83308291|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
83308292|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83308293|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308294|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
83308295|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308296|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83308297|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83308298|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83308299|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
83308300|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308301|NCT00878254|Antidotes|antidotes|mesh-ancestor
83308302|NCT00878254|Protective Agents|protective agents|mesh-ancestor
83308303|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
83308304|NCT00878254|Vitamins|vitamins|mesh-ancestor
83308305|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
83308306|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308307|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308308|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308309|NCT04783636|Leuprolide|leuprolide|mesh-list
83308310|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83308311|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
83308312|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83308313|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308314|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308315|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308317|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
83308318|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308319|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83308320|NCT03364348|Trastuzumab|trastuzumab|mesh-list
83308321|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83308322|NCT03364348|Maytansine|maytansine|mesh-list
83308323|NCT03364348|Antibodies|antibodies|mesh-list
83308324|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
83308325|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83308326|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
83308327|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
83308328|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
83308329|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308330|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308331|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83308332|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308333|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308334|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308335|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308336|NCT03364348|Immunotoxins|immunotoxins|mesh-ancestor
83308337|NCT04782622|Apatinib|apatinib|mesh-list
83308338|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308339|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308340|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308341|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308342|NCT04775212|Sevoflurane|sevoflurane|mesh-list
83308343|NCT04775212|Desflurane|desflurane|mesh-list
83308344|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83308345|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83308346|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
83308347|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
83308348|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308349|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308350|NCT04774822|Mydriatics|mydriatics|mesh-list
83308351|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
83308352|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308353|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308354|NCT04782388|Alprazolam|alprazolam|mesh-list
83308355|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83308356|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308357|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308358|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83308359|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83308360|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308361|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
83308362|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
83308363|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308364|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308365|NCT04782076|Dabigatran|dabigatran|mesh-list
83308366|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
83308367|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83308368|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
83308369|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308370|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308371|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
83308372|NCT04782310|Pregabalin|pregabalin|mesh-list
83308373|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83308374|NCT04782310|Analgesics|analgesics|mesh-ancestor
83308375|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
83308376|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308377|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308378|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
83308379|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83308380|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308381|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308382|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83308383|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83308384|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83308385|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308386|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308387|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83308388|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83308389|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308390|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
83308391|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
83308392|NCT04781998|Liraglutide|liraglutide|mesh-list
83308393|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308394|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308396|NCT04781998|Hormones|hormones|mesh-ancestor
83308397|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308398|NCT03300544|Leucovorin|leucovorin|mesh-list
83308399|NCT03300544|Fluorouracil|fluorouracil|mesh-list
83308400|NCT03300544|Capecitabine|capecitabine|mesh-list
83308401|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
83308402|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83308403|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
83308404|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308405|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308406|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308407|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308408|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
83308409|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308410|NCT03300544|Antidotes|antidotes|mesh-ancestor
83308411|NCT03300544|Protective Agents|protective agents|mesh-ancestor
83308412|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
83308413|NCT03300544|Vitamins|vitamins|mesh-ancestor
83308414|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
83308415|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308416|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
83308417|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83308418|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83308419|NCT03249844|Prednisolone|prednisolone|mesh-list
83308420|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
83308421|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83308422|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
83308423|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308424|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
83308425|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
83308426|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308427|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308428|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308429|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
83308430|NCT03249844|Hormones|hormones|mesh-ancestor
83308431|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308432|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83308433|NCT03249844|Protective Agents|protective agents|mesh-ancestor
83308434|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308435|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308436|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
83308437|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83308438|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
83308439|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308440|NCT00637624|Expectorants|expectorants|mesh-ancestor
83308441|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
83308442|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83308443|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
83308444|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308445|NCT00637624|Protective Agents|protective agents|mesh-ancestor
83308446|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308447|NCT00637624|Antidotes|antidotes|mesh-ancestor
83308448|NCT01479465|Leucovorin|leucovorin|mesh-list
83308449|NCT01479465|Fluorouracil|fluorouracil|mesh-list
83308450|NCT01479465|Irinotecan|irinotecan|mesh-list
83308451|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
83308452|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308453|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308454|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308455|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308456|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
83308457|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308458|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83308459|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83308460|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308461|NCT01479465|Antidotes|antidotes|mesh-ancestor
83308462|NCT01479465|Protective Agents|protective agents|mesh-ancestor
83308463|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
83308464|NCT01479465|Vitamins|vitamins|mesh-ancestor
83308465|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
83308466|NCT02428192|Nivolumab|nivolumab|mesh-list
83308467|NCT02428192|Ipilimumab|ipilimumab|mesh-list
83308468|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308469|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308470|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83308471|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308473|NCT04781686|Apatinib|apatinib|mesh-list
83308474|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308475|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308476|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308477|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308478|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308479|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308480|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308481|NCT02390284|Timolol|timolol|mesh-list
83308482|NCT02390284|Bimatoprost|bimatoprost|mesh-list
83308483|NCT02390284|Travoprost|travoprost|mesh-list
83308484|NCT02390284|Dorzolamide|dorzolamide|mesh-list
83308485|NCT02390284|Acetazolamide|acetazolamide|mesh-list
83308486|NCT02390284|Methazolamide|methazolamide|mesh-list
83308487|NCT02390284|Latanoprost|latanoprost|mesh-list
83308488|NCT02390284|Brinzolamide|brinzolamide|mesh-list
83308489|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83308490|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83308491|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
83308492|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308493|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308494|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308495|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83308496|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83308497|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83308498|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83308499|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
83308500|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83308501|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308502|NCT02390284|Diuretics|diuretics|mesh-ancestor
83308503|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
83308504|NCT04780750|Docetaxel|docetaxel|mesh-list
83308505|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308506|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308507|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308508|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308509|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308510|NCT04780984|Bromides|bromides|mesh-list
83308511|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
83308512|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83308513|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
83308514|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308515|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308516|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83308517|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
83308518|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
83308519|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83308520|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
83308521|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308522|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308523|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
83308524|NCT02090374|Vitamin D|vitamin d|mesh-list
83308525|NCT02090374|Poly ICLC|poly iclc|mesh-list
83308526|NCT02090374|Vitamins|vitamins|mesh-ancestor
83308527|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
83308528|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308529|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83308530|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
83308531|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
83308532|NCT02222740|Hydrocodone|hydrocodone|mesh-list
83308533|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83308534|NCT02222740|Narcotics|narcotics|mesh-ancestor
83308535|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308536|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308537|NCT02222740|Analgesics|analgesics|mesh-ancestor
83308538|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
83308539|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308540|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
83308541|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
83308542|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
83308543|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83308544|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308545|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308546|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308548|NCT04779892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83308549|NCT04779892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308550|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308551|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308552|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83308553|NCT04389424|Tamoxifen|tamoxifen|mesh-list
83308554|NCT04389424|Anastrozole|anastrozole|mesh-list
83308555|NCT04389424|Exemestane|exemestane|mesh-list
83308556|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83308557|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
83308558|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308559|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308560|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308561|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308562|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83308563|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83308564|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83308565|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83308566|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83308567|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308568|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308569|NCT04771390|Selitrectinib|selitrectinib|mesh-list
83308570|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308571|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308572|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
83308573|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83308574|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83308575|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308576|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
83308577|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308578|NCT05411380|Capecitabine|capecitabine|mesh-list
83308579|NCT05411380|Letrozole|letrozole|mesh-list
83308580|NCT05411380|Fulvestrant|fulvestrant|mesh-list
83308581|NCT05411380|Anastrozole|anastrozole|mesh-list
83308582|NCT05411380|Exemestane|exemestane|mesh-list
83308583|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308584|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
83308585|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308586|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308587|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83308588|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83308589|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308590|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83308591|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
83308592|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308593|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308594|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308595|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83308596|NCT04779580|Anesthetics|anesthetics|mesh-list
83308597|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
83308598|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308599|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308600|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
83308601|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308602|NCT04770688|Osimertinib|osimertinib|mesh-list
83308603|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308604|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308605|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308606|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308607|NCT05390476|Capecitabine|capecitabine|mesh-list
83308608|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308609|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
83308610|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308611|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308612|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83308613|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83308614|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308615|NCT04769908|Lenvatinib|lenvatinib|mesh-list
83308616|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308617|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308618|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308676|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308677|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308678|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308679|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
83308680|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308681|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83308682|NCT00060424|Cyclosporine|cyclosporine|mesh-list
83308683|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
83308684|NCT00060424|Fludarabine|fludarabine|mesh-list
83308685|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
83308686|NCT00060424|Cyclosporins|cyclosporins|mesh-list
83308687|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308688|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308689|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
83308690|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308691|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308692|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
83308693|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308694|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308695|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
83308696|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308697|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308698|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83308699|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83308700|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83308701|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83308702|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
83308703|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83308705|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308706|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308707|NCT00063232|Metformin|metformin|mesh-list
83308708|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308709|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308710|NCT00063622|Vitamin E|vitamin e|mesh-list
83308711|NCT00063622|Pioglitazone|pioglitazone|mesh-list
83308712|NCT00063622|Vitamins|vitamins|mesh-ancestor
83308713|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
83308714|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308715|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308716|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
83308717|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308718|NCT00063622|Protective Agents|protective agents|mesh-ancestor
83308719|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83308720|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83308721|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83308722|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308723|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308724|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83308725|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308726|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308727|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
83308728|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308729|NCT00153166|Pioglitazone|pioglitazone|mesh-list
83308730|NCT00153166|Atorvastatin|atorvastatin|mesh-list
83308731|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83308732|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83308733|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
83308734|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308735|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83308736|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83308737|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308738|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308739|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308740|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
83308741|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83308742|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83308743|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83308744|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308745|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308746|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
83308747|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308748|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308749|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83308750|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308751|NCT01475721|Fluticasone|fluticasone|mesh-list
83308752|NCT01475721|Xhance|xhance|mesh-list
83308753|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83308754|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83308755|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
83308756|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308757|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308758|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83308759|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
83308760|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
83308761|NCT01475721|Hormones|hormones|mesh-ancestor
83308762|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308763|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
83308764|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308765|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
83308766|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83308767|NCT00065806|Atorvastatin|atorvastatin|mesh-list
83308768|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83308769|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83308770|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
83308771|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308772|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83308773|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83308774|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308775|NCT00068770|Celecoxib|celecoxib|mesh-list
83308776|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83308777|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83308778|NCT00068770|Analgesics|analgesics|mesh-ancestor
83308779|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
83308780|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308781|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308782|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308783|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83308784|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83308785|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83308786|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308787|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308788|NCT01475331|Ethanol|ethanol|mesh-list
83308789|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83308790|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308791|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308792|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308793|NCT01500213|Dexamethasone|dexamethasone|mesh-list
83308794|NCT01500213|Granisetron|granisetron|mesh-list
83308795|NCT01500213|Rolapitant|rolapitant|mesh-list
83308796|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308797|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
83308798|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
83308799|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308800|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308801|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308802|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
83308803|NCT01500213|Hormones|hormones|mesh-ancestor
83308804|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308805|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308806|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308807|NCT01500213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83308808|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83308809|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
83308810|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308811|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308812|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83308813|NCT00069160|Docetaxel|docetaxel|mesh-list
83308814|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
83308815|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308816|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
83308817|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
83308818|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
83308819|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308820|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83308821|NCT00071890|Aldesleukin|aldesleukin|mesh-list
83308822|NCT00071890|Interleukin-2|interleukin-2|mesh-list
83308823|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308824|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83308825|NCT00071890|Analgesics|analgesics|mesh-ancestor
83308826|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
83308827|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308828|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308829|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83308830|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83308831|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
83308832|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308833|NCT01475253|Lidocaine|lidocaine|mesh-list
83308834|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
83308835|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
83308836|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308837|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308838|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
83308839|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308840|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83308841|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83308842|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83308843|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308844|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308845|NCT00072514|Dexamethasone|dexamethasone|mesh-list
83308846|NCT00072514|Rituximab|rituximab|mesh-list
83308847|NCT00072514|Carboplatin|carboplatin|mesh-list
83308848|NCT00072514|Gemcitabine|gemcitabine|mesh-list
83308849|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308850|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308851|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
83308852|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308853|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83308854|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308855|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
83308856|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
83308857|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308858|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308859|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
83308860|NCT00072514|Hormones|hormones|mesh-ancestor
83308861|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308862|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308863|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83308864|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
83308865|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308866|NCT00074308|Bevacizumab|bevacizumab|mesh-list
83308867|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83308868|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
83308869|NCT00074308|Antibodies|antibodies|mesh-list
83308870|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
83308871|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83308872|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308873|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83308874|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83308875|NCT00074308|Growth Substances|growth substances|mesh-ancestor
83308876|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308877|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
83308878|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
83308879|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308880|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308881|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308882|NCT00166036|Atorvastatin|atorvastatin|mesh-list
83308883|NCT00166036|Pravastatin|pravastatin|mesh-list
83308884|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83308885|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83308886|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
83308887|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308888|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83308889|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83308890|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308891|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
83308892|NCT00167206|Fludarabine|fludarabine|mesh-list
83308893|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308894|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
83308895|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308897|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83308898|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
83308899|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308900|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308901|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83308902|NCT01474551|Vemurafenib|vemurafenib|mesh-list
83308903|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308904|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308905|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308906|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308907|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83308908|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83308909|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308910|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83308911|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
83308912|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308913|NCT00168298|Dexamethasone|dexamethasone|mesh-list
83308914|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
83308915|NCT00168298|BB 1101|bb 1101|mesh-list
83308916|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83308917|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
83308918|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
83308919|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83308920|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308921|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83308922|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
83308924|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83308925|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83308926|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308927|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
83308928|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308929|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308930|NCT00076258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83308931|NCT00076258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83308932|NCT00076258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308933|NCT00076258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308934|NCT00076258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308935|NCT00076258|Serotonin Agents|serotonin agents|mesh-ancestor
83308936|NCT00076258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308937|NCT00078286|Sertraline|sertraline|mesh-list
83308938|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
83308939|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308940|NCT00078286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83308941|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83308942|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308943|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308944|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308945|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
83308946|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308947|NCT00078754|Valproic Acid|valproic acid|mesh-list
83308948|NCT00078754|Fluoxetine|fluoxetine|mesh-list
83308949|NCT00078754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83308950|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83308951|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83308952|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308953|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83308954|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
83308955|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308956|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83308957|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
83308958|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83308959|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83308960|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83308961|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308962|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
83308963|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
83308964|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
83308965|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83308966|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83308967|NCT00081328|Metformin|metformin|mesh-list
83308968|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
83308969|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83308970|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308971|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
83308972|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83308973|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308974|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83308975|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
83308976|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83308977|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83308978|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308979|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308980|NCT00083122|Cisplatin|cisplatin|mesh-list
83308981|NCT00083122|Alvocidib|alvocidib|mesh-list
83308982|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308983|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
83308984|NCT00083122|Growth Substances|growth substances|mesh-ancestor
83308985|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308986|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83308987|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83308988|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83308989|NCT01474239|Bevacizumab|bevacizumab|mesh-list
83308990|NCT01474239|Fotemustine|fotemustine|mesh-list
83308991|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83308992|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83308993|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83308994|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83308995|NCT01474239|Growth Substances|growth substances|mesh-ancestor
83308996|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83308997|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
83308998|NCT01473381|Dexetimide|dexetimide|mesh-list
83308999|NCT01473381|Citalopram|citalopram|mesh-list
83309000|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
83309001|NCT01473381|Escitalopram|escitalopram|mesh-list
83309002|NCT01473381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83309003|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83309004|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83309005|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309006|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309007|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
83309008|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309009|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83309010|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
83309011|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309012|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83309013|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83309014|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
83309015|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
83309016|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309017|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83309018|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83309019|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
83309020|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83309021|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83309022|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
83309023|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83309024|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83309025|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83309026|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83309027|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309028|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
83309029|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309030|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309031|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83309032|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309034|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83309035|NCT01499277|Aztreonam|aztreonam|mesh-list
83309036|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309037|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309038|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
83309039|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
83309040|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
83309041|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309042|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309043|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309044|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309045|NCT00176800|Growth Substances|growth substances|mesh-ancestor
83309046|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309047|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309048|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309049|NCT00176878|Fludarabine|fludarabine|mesh-list
83309050|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
83309051|NCT00176878|Busulfan|busulfan|mesh-list
83309052|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83309053|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309054|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309055|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
83309056|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309057|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309058|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
83309059|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309060|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
83309061|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83309062|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83309063|NCT01898182|Kinetin|kinetin|mesh-list
83309064|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
83309065|NCT01898182|Growth Substances|growth substances|mesh-ancestor
83309066|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309067|NCT01499199|Dolutegravir|dolutegravir|mesh-list
83309068|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83309069|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83309070|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309071|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309072|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83309073|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83309074|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
83309075|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309076|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83309077|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
83309078|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83309079|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
83309080|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83309081|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309082|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83309083|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83309084|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309085|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83309087|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309088|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83309089|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309090|NCT01897012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83309091|NCT01897012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309092|NCT01897012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309093|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83309094|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83309095|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309096|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309097|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
83309098|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309099|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
83309100|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83309101|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309102|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83309103|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309104|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83309105|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
83309106|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
83309107|NCT01527357|Coagulants|coagulants|mesh-ancestor
83309108|NCT00181714|Methylphenidate|methylphenidate|mesh-list
83309109|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83309110|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309111|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83309112|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83309113|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83309114|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309115|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
83309116|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309117|NCT01472835|Fentanyl|fentanyl|mesh-list
83309118|NCT01472835|Midazolam|midazolam|mesh-list
83309119|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83309120|NCT01472835|Narcotics|narcotics|mesh-ancestor
83309121|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83309122|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309123|NCT01472835|Analgesics|analgesics|mesh-ancestor
83309124|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
83309125|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309126|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83309127|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83309128|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
83309129|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
83309130|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83309131|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83309132|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83309133|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309134|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
83309135|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
83309136|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309137|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309138|NCT00185692|Acetaminophen|acetaminophen|mesh-list
83309139|NCT00185692|Cyclosporine|cyclosporine|mesh-list
83309140|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
83309141|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
83309142|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83309143|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83309144|NCT00185692|Prednisolone|prednisolone|mesh-list
83309145|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
83309146|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
83309147|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83309148|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83309149|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83309150|NCT00185692|Cyclosporins|cyclosporins|mesh-list
83309151|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83309152|NCT00185692|Lenograstim|lenograstim|mesh-list
83309153|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83309154|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
83309155|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309156|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309157|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309158|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
83309159|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309160|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
83309161|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309162|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
83309163|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309164|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83309165|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309166|NCT00185692|Analgesics|analgesics|mesh-ancestor
83309167|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
83309168|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309169|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
83309170|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83309171|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309172|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83309173|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
83309174|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309175|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309176|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
83309177|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
83309178|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83309179|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
83309181|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83309182|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83309183|NCT00185692|Protective Agents|protective agents|mesh-ancestor
83309184|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83309185|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83309186|NCT01526733|Insulin|insulin|mesh-list
83309187|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83309188|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
83309189|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
83309190|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83309191|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309192|NCT00094900|Rilonacept|rilonacept|mesh-list
83309193|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309194|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
83309195|NCT00096460|Carmustine|carmustine|mesh-list
83309196|NCT00096460|Rituximab|rituximab|mesh-list
83309197|NCT00096460|Methotrexate|methotrexate|mesh-list
83309198|NCT00096460|Fludarabine|fludarabine|mesh-list
83309199|NCT00096460|Etoposide|etoposide|mesh-list
83309200|NCT00096460|Tacrolimus|tacrolimus|mesh-list
83309201|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309202|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
83309203|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309204|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309205|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83309206|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
83309207|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309208|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309209|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83309210|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309211|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83309212|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
83309213|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83309214|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309215|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
83309216|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
83309217|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309218|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83309219|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83309220|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83309221|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83309222|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83309223|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83309224|NCT00006178|Sirolimus|sirolimus|mesh-list
83309225|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
83309226|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309227|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309228|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83309229|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309230|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
83309231|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309232|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
83309233|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309234|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
83309235|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83309236|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83309237|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309238|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309239|NCT00098956|Topotecan|topotecan|mesh-list
83309240|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83309241|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83309242|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83309243|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309244|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309245|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309246|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83309247|NCT02197156|Acetaminophen|acetaminophen|mesh-list
83309248|NCT02197156|Hydrocodone|hydrocodone|mesh-list
83309249|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309250|NCT02197156|Analgesics|analgesics|mesh-ancestor
83309251|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
83309252|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309253|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309254|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
83309255|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83309256|NCT02197156|Narcotics|narcotics|mesh-ancestor
83309257|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83309258|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
83309259|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
83309260|NCT00187720|Metformin|metformin|mesh-list
83309261|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83309262|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309263|NCT00006244|Interferons|interferons|mesh-list
83309264|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
83309265|NCT00006244|Aldesleukin|aldesleukin|mesh-list
83309266|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
83309267|NCT00006244|Melphalan|melphalan|mesh-list
83309268|NCT00006244|Interleukin-2|interleukin-2|mesh-list
83309269|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309270|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
83309271|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309272|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83309273|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
83309274|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309275|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83309276|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309277|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
83309278|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309279|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309280|NCT00006244|Analgesics|analgesics|mesh-ancestor
83309281|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
83309282|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309283|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83309284|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83309285|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
83309286|NCT01525875|Antacids|antacids|mesh-ancestor
83309287|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309288|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83309289|NCT01525641|Pramipexole|pramipexole|mesh-list
83309290|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
83309291|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309292|NCT01525641|Protective Agents|protective agents|mesh-ancestor
83309293|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309294|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83309295|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83309296|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
83309298|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309299|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
83309300|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309301|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
83309302|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309303|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309304|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83309305|NCT01496469|Febuxostat|febuxostat|mesh-list
83309306|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
83309307|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309308|NCT00189436|Budesonide|budesonide|mesh-list
83309309|NCT00189436|Albuterol|albuterol|mesh-list
83309310|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309311|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83309312|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
83309313|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309314|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309315|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83309316|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
83309317|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
83309318|NCT00189436|Hormones|hormones|mesh-ancestor
83309319|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83309320|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
83309321|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83309322|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83309323|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83309324|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83309325|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
83309326|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309327|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309328|NCT01471353|Capecitabine|capecitabine|mesh-list
83309329|NCT01471353|Sorafenib|sorafenib|mesh-list
83309330|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309331|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
83309332|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309333|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309334|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83309335|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309336|NCT01525407|Atorvastatin|atorvastatin|mesh-list
83309337|NCT01525407|Calcium|calcium|mesh-list
83309338|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83309339|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309340|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83309341|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83309342|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
83309343|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309344|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83309345|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83309346|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309347|NCT01471197|Pemetrexed|pemetrexed|mesh-list
83309348|NCT01471197|Ipilimumab|ipilimumab|mesh-list
83309349|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309350|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309351|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309352|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83309353|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83309354|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309355|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83309356|NCT04408989|Bevacizumab|bevacizumab|mesh-list
83309357|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309358|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309359|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309360|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309361|NCT04408989|Growth Substances|growth substances|mesh-ancestor
83309362|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309363|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309364|NCT00011986|Paclitaxel|paclitaxel|mesh-list
83309365|NCT00011986|Carboplatin|carboplatin|mesh-list
83309366|NCT00011986|Gemcitabine|gemcitabine|mesh-list
83309367|NCT00011986|Doxorubicin|doxorubicin|mesh-list
83309368|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83309369|NCT00011986|Topotecan|topotecan|mesh-list
83309370|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83309371|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309372|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
83309373|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
83309374|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
83309375|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309376|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309377|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
83309378|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83309379|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83309380|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83309381|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309382|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83309383|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83309384|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83309385|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
83309386|NCT01524783|Everolimus|everolimus|mesh-list
83309387|NCT01524783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83309388|NCT01524783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83309389|NCT01524783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309390|NCT01524783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309391|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309392|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
83309393|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309394|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309395|NCT01494987|Glimepiride|glimepiride|mesh-list
83309396|NCT01494987|Ranolazine|ranolazine|mesh-list
83309397|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83309398|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83309399|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309400|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309401|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
83309402|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83309403|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83309404|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309406|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
83309407|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
83309408|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309409|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309410|NCT01470417|Gemcitabine|gemcitabine|mesh-list
83309411|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83309412|NCT01470417|Paclitaxel|paclitaxel|mesh-list
83309413|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309414|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
83309415|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309416|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309417|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83309418|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
83309419|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
83309420|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
83309421|NCT01524627|Varenicline|varenicline|mesh-list
83309422|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83309423|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83309424|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
83309425|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309426|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309427|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309428|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
83309429|NCT01469637|Mesalamine|mesalamine|mesh-list
83309430|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309431|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83309432|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309433|NCT01469637|Analgesics|analgesics|mesh-ancestor
83309434|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
83309435|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309436|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309437|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309438|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309439|NCT04409223|Sunitinib|sunitinib|mesh-list
83309440|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309441|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309442|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309443|NCT04409223|Growth Substances|growth substances|mesh-ancestor
83309444|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309445|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309446|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83309447|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309448|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309450|NCT00012298|Oprelvekin|oprelvekin|mesh-list
83309451|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83309452|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309453|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309454|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
83309455|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309456|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309457|NCT00193258|Bevacizumab|bevacizumab|mesh-list
83309458|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83309459|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
83309460|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309461|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309462|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309463|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309464|NCT00193258|Growth Substances|growth substances|mesh-ancestor
83309465|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309466|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309467|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83309468|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309469|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309470|NCT00029536|Progesterone|progesterone|mesh-list
83309471|NCT00029536|Progestins|progestins|mesh-ancestor
83309472|NCT00029536|Hormones|hormones|mesh-ancestor
83309473|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83309474|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309475|NCT00193492|Bevacizumab|bevacizumab|mesh-list
83309476|NCT00193492|Rituximab|rituximab|mesh-list
83309477|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309478|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309479|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309480|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309481|NCT00193492|Growth Substances|growth substances|mesh-ancestor
83309482|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309483|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309484|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
83309485|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309487|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
83309488|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309489|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309490|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
83309491|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309492|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309493|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
83309494|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83309495|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83309496|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309497|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
83309498|NCT02096458|Lansoprazole|lansoprazole|mesh-list
83309499|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83309500|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83309501|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83309502|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309503|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309504|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
83309505|NCT00194896|Glyburide|glyburide|mesh-list
83309506|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83309507|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309508|NCT04348474|Azithromycin|azithromycin|mesh-list
83309509|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
83309510|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309511|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309512|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
83309513|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83309514|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83309515|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309516|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309517|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309518|NCT00107536|Lapatinib|lapatinib|mesh-list
83309519|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309520|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83309521|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309522|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309523|NCT00108550|Gabapentin|gabapentin|mesh-list
83309524|NCT00108550|Analgesics|analgesics|mesh-ancestor
83309525|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
83309526|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309527|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309528|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
83309529|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83309530|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83309531|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83309532|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309533|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83309534|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83309535|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309536|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309537|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
83309538|NCT02093962|Pemetrexed|pemetrexed|mesh-list
83309539|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309540|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309541|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309542|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83309543|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83309544|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83309545|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83309546|NCT00200902|Escitalopram|escitalopram|mesh-list
83309547|NCT00200902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83309548|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83309549|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83309550|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309551|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309552|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
83309553|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309554|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309555|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83309556|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
83309557|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309558|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83309559|NCT00200902|Analgesics|analgesics|mesh-ancestor
83309560|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
83309561|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
83309562|NCT00201448|Vaccines|vaccines|mesh-list
83309563|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
83309564|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309565|NCT00201760|Gemcitabine|gemcitabine|mesh-list
83309566|NCT00201760|Trastuzumab|trastuzumab|mesh-list
83309567|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309568|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309569|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
83309570|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309571|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309572|NCT00201838|Etanercept|etanercept|mesh-list
83309573|NCT00201838|Gemcitabine|gemcitabine|mesh-list
83309574|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309575|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
83309576|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309577|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309578|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83309579|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309580|NCT00201838|Analgesics|analgesics|mesh-ancestor
83309581|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
83309582|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309583|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309584|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309585|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309586|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83309587|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309588|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
83309589|NCT00040846|Cyclosporine|cyclosporine|mesh-list
83309590|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
83309591|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83309592|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
83309593|NCT00040846|Fludarabine|fludarabine|mesh-list
83309594|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
83309595|NCT00040846|Antibodies|antibodies|mesh-list
83309596|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
83309597|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83309598|NCT00040846|Cyclosporins|cyclosporins|mesh-list
83309599|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
83309600|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309601|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309602|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309603|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
83309604|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309605|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309606|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309607|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
83309608|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309609|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
83309610|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309611|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83309612|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83309613|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83309614|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
83309615|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309616|NCT00041938|Aspirin|aspirin|mesh-list
83309617|NCT00041938|Warfarin|warfarin|mesh-list
83309618|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83309619|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309620|NCT00041938|Analgesics|analgesics|mesh-ancestor
83309621|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
83309622|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309623|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309624|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309625|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309626|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83309627|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83309628|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309629|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83309630|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83309631|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309632|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
83309633|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
83309634|NCT00202930|Rituximab|rituximab|mesh-list
83309635|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309636|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309637|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
83309638|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309639|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309640|NCT00044044|Haloperidol|haloperidol|mesh-list
83309641|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
83309642|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83309643|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
83309644|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
83309645|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309646|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309647|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83309648|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83309649|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83309650|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83309651|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309652|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83309653|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
83309654|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309655|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309656|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83309657|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83309658|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83309659|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83309660|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
83309661|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83309662|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83309663|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
83309664|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83309665|NCT00112918|Leucovorin|leucovorin|mesh-list
83309666|NCT00112918|Bevacizumab|bevacizumab|mesh-list
83309667|NCT00112918|Fluorouracil|fluorouracil|mesh-list
83309668|NCT00112918|Capecitabine|capecitabine|mesh-list
83309669|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
83309670|NCT00112918|Calcium|calcium|mesh-list
83309671|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
83309672|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309673|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309674|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309675|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309676|NCT00112918|Growth Substances|growth substances|mesh-ancestor
83309677|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309678|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309679|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83309680|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
83309681|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309682|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309683|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309684|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
83309685|NCT00112918|Antidotes|antidotes|mesh-ancestor
83309686|NCT00112918|Protective Agents|protective agents|mesh-ancestor
83309687|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
83309688|NCT00112918|Vitamins|vitamins|mesh-ancestor
83309689|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
83309690|NCT00046228|Reteplase|reteplase|mesh-list
83309691|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83309692|NCT00046228|Abciximab|abciximab|mesh-list
83309693|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
83309694|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83309695|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83309696|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83309697|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309698|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
83309699|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83309700|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83309701|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
83309702|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83309703|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309704|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83309705|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83309706|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83309707|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309708|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309709|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83309710|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83309711|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309712|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309713|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309714|NCT00113230|Bevacizumab|bevacizumab|mesh-list
83309715|NCT00113230|Capecitabine|capecitabine|mesh-list
83309716|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309717|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309718|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309719|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309720|NCT00113230|Growth Substances|growth substances|mesh-ancestor
83309721|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309722|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309723|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309724|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
83309725|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309726|NCT00049036|Prednisone|prednisone|mesh-list
83309727|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
83309728|NCT00049036|Rituximab|rituximab|mesh-list
83309729|NCT00049036|Doxorubicin|doxorubicin|mesh-list
83309730|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83309731|NCT00049036|Etoposide|etoposide|mesh-list
83309732|NCT00049036|Vincristine|vincristine|mesh-list
83309733|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
83309734|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309735|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
83309736|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309737|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309738|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83309739|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
83309740|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309741|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309742|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83309743|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309744|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83309745|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83309746|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83309747|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309748|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309749|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
83309750|NCT00049036|Hormones|hormones|mesh-ancestor
83309751|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83309752|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83309753|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83309754|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
83309755|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
83309756|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
83309757|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
83309758|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
83309759|NCT00049504|Fludarabine|fludarabine|mesh-list
83309760|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
83309761|NCT00049504|Tacrolimus|tacrolimus|mesh-list
83309762|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309763|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
83309764|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309765|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309766|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83309767|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
83309768|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309769|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309770|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83309771|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83309772|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
83309773|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83309774|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309775|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83309776|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83309777|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
83309778|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309779|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309780|NCT00050986|Temozolomide|temozolomide|mesh-list
83309781|NCT00050986|Tipifarnib|tipifarnib|mesh-list
83309782|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83309783|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
83309784|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309785|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309786|NCT00118144|Bortezomib|bortezomib|mesh-list
83309787|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309788|NCT00118378|Modafinil|modafinil|mesh-list
83309789|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83309790|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309791|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83309792|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83309793|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83309794|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309795|NCT00217438|Melphalan|melphalan|mesh-list
83309796|NCT00217438|Amifostine|amifostine|mesh-list
83309797|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83309798|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
83309799|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309800|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309801|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83309802|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83309803|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
83309804|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309805|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83309806|NCT00217438|Protective Agents|protective agents|mesh-ancestor
83309807|NCT04480450|Rituximab|rituximab|mesh-list
83309808|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309809|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309810|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
83309811|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309812|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309813|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
83309814|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309815|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309816|NCT00052078|Sertraline|sertraline|mesh-list
83309817|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
83309818|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83309819|NCT00052078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83309820|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83309821|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83309822|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309823|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309824|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
83309825|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309826|NCT05820594|BCG Vaccine|bcg vaccine|mesh-list
83309827|NCT05820594|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83309828|NCT05820594|Immunologic Factors|immunologic factors|mesh-ancestor
83309829|NCT05820594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309830|NCT05820503|Anesthetics|anesthetics|mesh-list
83309831|NCT05820503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83309832|NCT05820503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309833|NCT05820347|Rocuronium|rocuronium|mesh-list
83309834|NCT05820347|Succinylcholine|succinylcholine|mesh-list
83309835|NCT05820347|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83309836|NCT05820347|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83309837|NCT05820347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83309838|NCT05820347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309839|NCT05820347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309840|NCT05820347|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83309841|NCT05820256|Caseins|caseins|mesh-list
83309842|NCT05820256|Chelating Agents|chelating agents|mesh-ancestor
83309844|NCT05820256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309845|NCT05820048|Lansoprazole|lansoprazole|mesh-list
83309846|NCT05820048|Dexlansoprazole|dexlansoprazole|mesh-list
83309847|NCT05820048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83309848|NCT05820048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83309849|NCT05820048|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83309850|NCT05820048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309851|NCT05820048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309852|NCT05819983|Ivermectin|ivermectin|mesh-list
83309853|NCT05819983|Permethrin|permethrin|mesh-list
83309854|NCT05819983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83309855|NCT05819983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309856|NCT05819983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309857|NCT05819983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309858|NCT05819970|Allyl sulfide|allyl sulfide|mesh-list
83309859|NCT05819970|Antioxidants|antioxidants|mesh-ancestor
83309860|NCT05819970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309861|NCT05819970|Protective Agents|protective agents|mesh-ancestor
83309862|NCT05819970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309863|NCT05819970|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83309864|NCT05819970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309865|NCT05819970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83309866|NCT05819970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309867|NCT05819632|Curcumin|curcumin|mesh-list
83309868|NCT05819632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83309869|NCT05819632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309870|NCT05819632|Analgesics|analgesics|mesh-ancestor
83309871|NCT05819632|Sensory System Agents|sensory system agents|mesh-ancestor
83309872|NCT05819632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309873|NCT05819632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309874|NCT05819632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309875|NCT05819632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309876|NCT05819632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309877|NCT05819632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309878|NCT05819632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309879|NCT05819541|Albuterol|albuterol|mesh-list
83309880|NCT05819541|Montelukast|montelukast|mesh-list
83309881|NCT05819541|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83309882|NCT05819541|Respiratory System Agents|respiratory system agents|mesh-ancestor
83309883|NCT05819541|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83309884|NCT05819541|Hormone Antagonists|hormone antagonists|mesh-ancestor
83309885|NCT05819541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83309886|NCT05819541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309887|NCT05819541|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83309888|NCT05819541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83309889|NCT05819541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309890|NCT05819541|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83309891|NCT05819541|Autonomic Agents|autonomic agents|mesh-ancestor
83309892|NCT05819541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309893|NCT05819541|Tocolytic Agents|tocolytic agents|mesh-ancestor
83309894|NCT05819541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83309895|NCT05819541|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83309896|NCT05819541|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83309897|NCT05819541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83309898|NCT05819541|Adrenergic Agents|adrenergic agents|mesh-ancestor
83309899|NCT05819541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309900|NCT05819229|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83309901|NCT05819229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309902|NCT05819060|Bevacizumab|bevacizumab|mesh-list
83309903|NCT05819060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309904|NCT05819060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309905|NCT05819060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83309906|NCT05819060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83309907|NCT05819060|Growth Substances|growth substances|mesh-ancestor
83309908|NCT05819060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309909|NCT05819060|Growth Inhibitors|growth inhibitors|mesh-ancestor
83309910|NCT05818995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83309911|NCT05818995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83309912|NCT05818995|Calcium Channel Blockers|calcium channel blockers|mesh-list
83309913|NCT05818995|Angiotensin II|angiotensin ii|mesh-list
83309914|NCT05818995|Giapreza|giapreza|mesh-list
83309915|NCT05818995|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83309916|NCT05818995|Angiotensinogen|angiotensinogen|mesh-list
83309917|NCT05818995|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83309918|NCT05818995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
83309919|NCT05818995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83309920|NCT05818995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309921|NCT05818995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309922|NCT05818995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83309923|NCT05818995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83309924|NCT05818995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83309925|NCT05818995|Protease Inhibitors|protease inhibitors|mesh-ancestor
83309926|NCT05818995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83309927|NCT05818982|Irinotecan|irinotecan|mesh-list
83309928|NCT05818982|Afatinib|afatinib|mesh-list
83309929|NCT05818982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83309930|NCT05818982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83309931|NCT05818982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309932|NCT05818982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309933|NCT05818982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309934|NCT05818982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83309935|NCT05818826|Hydrocortisone|hydrocortisone|mesh-list
83309936|NCT05818826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83309937|NCT05818826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309938|NCT05818670|Tadalafil|tadalafil|mesh-list
83309939|NCT05818670|Tamsulosin|tamsulosin|mesh-list
83309940|NCT05818670|Vasodilator Agents|vasodilator agents|mesh-ancestor
83309941|NCT05818670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83309942|NCT05818670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83309943|NCT05818670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309944|NCT05818670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309945|NCT05818670|Urological Agents|urological agents|mesh-ancestor
83309946|NCT05818670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83309947|NCT05818670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83309948|NCT05818670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83309949|NCT05818670|Adrenergic Agents|adrenergic agents|mesh-ancestor
83309950|NCT05818670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83309951|NCT05818670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309952|NCT05816512|Chlorhexidine|chlorhexidine|mesh-list
83309953|NCT05816512|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83309954|NCT05816512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83309955|NCT05816512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309956|NCT05816512|Disinfectants|disinfectants|mesh-ancestor
83309957|NCT05816512|Dermatologic Agents|dermatologic agents|mesh-ancestor
83309958|NCT05816499|Docetaxel|docetaxel|mesh-list
83309959|NCT05816499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309960|NCT05816499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83309961|NCT05816499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83309962|NCT05816499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83309963|NCT05816499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309964|NCT05816343|Orlistat|orlistat|mesh-list
83309965|NCT05816343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309966|NCT05816343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309967|NCT05816343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83309968|NCT05816343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83309969|NCT05816226|Hydrocortisone|hydrocortisone|mesh-list
83309970|NCT05816226|Diclofenac|diclofenac|mesh-list
83309971|NCT05816226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83309972|NCT05816226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83309973|NCT05816226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83309974|NCT05816226|Analgesics|analgesics|mesh-ancestor
83309975|NCT05816226|Sensory System Agents|sensory system agents|mesh-ancestor
83309976|NCT05816226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83309977|NCT05816226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83309978|NCT05816226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83309979|NCT05816226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83309980|NCT05816226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309981|NCT05816226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309982|NCT05816070|Ofloxacin|ofloxacin|mesh-list
83309983|NCT05816070|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83309984|NCT05816070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83309985|NCT05816070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83309986|NCT05816070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83309987|NCT05816070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83309988|NCT05816070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83309989|NCT05816070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83309990|NCT05816070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83309991|NCT05816070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83309992|NCT05816070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309993|NCT05816070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83309994|NCT05816070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83309995|NCT05815927|Pembrolizumab|pembrolizumab|mesh-list
83309996|NCT05815927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83309997|NCT05815927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83309998|NCT05815927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83309999|NCT05815927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310000|NCT05815901|Febuxostat|febuxostat|mesh-list
83310001|NCT05815901|Gout Suppressants|gout suppressants|mesh-ancestor
83310002|NCT05815901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83310003|NCT05815784|Atropine|atropine|mesh-list
83310004|NCT05815784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83310005|NCT05815784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83310006|NCT05815784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83310007|NCT05815784|Autonomic Agents|autonomic agents|mesh-ancestor
83310008|NCT05815784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310009|NCT05815784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310010|NCT05815784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83310011|NCT05815784|Respiratory System Agents|respiratory system agents|mesh-ancestor
83310012|NCT05815784|Mydriatics|mydriatics|mesh-ancestor
83310013|NCT05815784|Parasympatholytics|parasympatholytics|mesh-ancestor
83310014|NCT05815784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83310015|NCT05815784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83310016|NCT05815784|Cholinergic Agents|cholinergic agents|mesh-ancestor
83310017|NCT05815784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310018|NCT05815784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310019|NCT05815719|Hormones|hormones|mesh-list
83310020|NCT05815719|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83310021|NCT05815719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310022|NCT05815719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310023|NCT05815654|Analgesics|analgesics|mesh-list
83310024|NCT05815654|Sensory System Agents|sensory system agents|mesh-ancestor
83310025|NCT05815654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310026|NCT05815654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310027|NCT05815303|Capecitabine|capecitabine|mesh-list
83310028|NCT05815303|Oxaliplatin|oxaliplatin|mesh-list
83310029|NCT05815303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83310030|NCT05815303|Antimetabolites|antimetabolites|mesh-ancestor
83310031|NCT05815303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310032|NCT05815303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310033|NCT05815264|Vaccines|vaccines|mesh-list
83310034|NCT05815264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83310035|NCT05815264|Immunologic Factors|immunologic factors|mesh-ancestor
83310036|NCT05815264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310037|NCT05815199|Nicotine|nicotine|mesh-list
83310038|NCT05815199|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83310039|NCT05815199|Autonomic Agents|autonomic agents|mesh-ancestor
83310040|NCT05815199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310041|NCT05815199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310042|NCT05815199|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83310043|NCT05815199|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83310044|NCT05815199|Cholinergic Agents|cholinergic agents|mesh-ancestor
83310045|NCT05815199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310046|NCT05815199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310048|NCT05815186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310049|NCT05815186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310050|NCT05815186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310051|NCT05815186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310052|NCT05814939|Tofacitinib|tofacitinib|mesh-list
83310053|NCT05814939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310054|NCT05814939|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83310055|NCT05814939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310056|NCT05814939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310058|NCT05814874|Antioxidants|antioxidants|mesh-ancestor
83310059|NCT05814874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310060|NCT05814874|Protective Agents|protective agents|mesh-ancestor
83310061|NCT05814874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310062|NCT05814874|Trace Elements|trace elements|mesh-ancestor
83310063|NCT05814874|Micronutrients|micronutrients|mesh-ancestor
83310064|NCT05814770|Spironolactone|spironolactone|mesh-list
83310065|NCT05814770|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83310066|NCT05814770|Hormone Antagonists|hormone antagonists|mesh-ancestor
83310067|NCT05814770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310068|NCT05814770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310069|NCT05814770|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83310070|NCT05814770|Diuretics|diuretics|mesh-ancestor
83310071|NCT05814770|Natriuretic Agents|natriuretic agents|mesh-ancestor
83310072|NCT05814731|Cytarabine|cytarabine|mesh-list
83310073|NCT05814731|Cyclophosphamide|cyclophosphamide|mesh-list
83310074|NCT05814731|Busulfan|busulfan|mesh-list
83310075|NCT05814731|Semustine|semustine|mesh-list
83310076|NCT05814731|Mitoxantrone|mitoxantrone|mesh-list
83310077|NCT05814731|Thymoglobulin|thymoglobulin|mesh-list
83310078|NCT05814731|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83310079|NCT05814731|Immunoglobulins|immunoglobulins|mesh-list
83310080|NCT05814731|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83310081|NCT05814731|Antibodies|antibodies|mesh-list
83310082|NCT05814731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83310083|NCT05814731|Immunologic Factors|immunologic factors|mesh-ancestor
83310084|NCT05814731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310085|NCT05814731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83310086|NCT05814731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83310087|NCT05814731|Alkylating Agents|alkylating agents|mesh-ancestor
83310088|NCT05814731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310089|NCT05814731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310090|NCT05814731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83310091|NCT05814731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83310092|NCT05814731|Antimetabolites|antimetabolites|mesh-ancestor
83310093|NCT05814731|Antiviral Agents|antiviral agents|mesh-ancestor
83310094|NCT05814731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310095|NCT05814731|Analgesics|analgesics|mesh-ancestor
83310096|NCT05814731|Sensory System Agents|sensory system agents|mesh-ancestor
83310097|NCT05814731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310098|NCT05814731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83310099|NCT05814731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83310100|NCT05814731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310101|NCT05814718|Cytarabine|cytarabine|mesh-list
83310102|NCT05814718|Etoposide|etoposide|mesh-list
83310103|NCT05814718|Mitoxantrone|mitoxantrone|mesh-list
83310104|NCT05814718|Etoposide phosphate|etoposide phosphate|mesh-list
83310105|NCT05814718|Melphalan|melphalan|mesh-list
83310106|NCT05814718|Carmustine|carmustine|mesh-list
83310107|NCT05814718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83310108|NCT05814718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310109|NCT05814718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83310110|NCT05814718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83310111|NCT05814718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310112|NCT05814718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310113|NCT05814718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83310114|NCT05814718|Antimetabolites|antimetabolites|mesh-ancestor
83310115|NCT05814718|Antiviral Agents|antiviral agents|mesh-ancestor
83310116|NCT05814718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310117|NCT05814718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83310118|NCT05814718|Immunologic Factors|immunologic factors|mesh-ancestor
83310119|NCT05814718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310120|NCT05814718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83310121|NCT05814718|Alkylating Agents|alkylating agents|mesh-ancestor
83310122|NCT05814718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83310123|NCT05814718|Analgesics|analgesics|mesh-ancestor
83310124|NCT05814718|Sensory System Agents|sensory system agents|mesh-ancestor
83310125|NCT05814718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310126|NCT05814666|Pembrolizumab|pembrolizumab|mesh-list
83310127|NCT05814666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310128|NCT05814666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310129|NCT05814666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310130|NCT05814666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310131|NCT05814640|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83310132|NCT05814640|Olanzapine|olanzapine|mesh-list
83310133|NCT05814640|Aripiprazole|aripiprazole|mesh-list
83310135|NCT05814640|Vortioxetine|vortioxetine|mesh-list
83310136|NCT05814640|Sertraline|sertraline|mesh-list
83310137|NCT05814640|Fluoxetine|fluoxetine|mesh-list
83310138|NCT05814640|Antiemetics|antiemetics|mesh-ancestor
83310139|NCT05814640|Autonomic Agents|autonomic agents|mesh-ancestor
83310140|NCT05814640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310141|NCT05814640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310142|NCT05814640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83310143|NCT05814640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83310144|NCT05814640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83310145|NCT05814640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310146|NCT05814640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83310147|NCT05814640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83310148|NCT05814640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83310149|NCT05814640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83310150|NCT05814640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310151|NCT05814640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310152|NCT05814640|Serotonin Agents|serotonin agents|mesh-ancestor
83310153|NCT05814640|Antidepressive Agents|antidepressive agents|mesh-ancestor
83310154|NCT05814640|Dopamine Agonists|dopamine agonists|mesh-ancestor
83310155|NCT05814640|Dopamine Agents|dopamine agents|mesh-ancestor
83310156|NCT05814640|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83310157|NCT05814640|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83310158|NCT05814640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83310159|NCT05814640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83310160|NCT05814640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83310161|NCT05814640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83310162|NCT05814640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83310163|NCT05814640|Analgesics|analgesics|mesh-ancestor
83310164|NCT05814640|Sensory System Agents|sensory system agents|mesh-ancestor
83310165|NCT05814640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83310166|NCT05814640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83310167|NCT05814640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83310168|NCT05814640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310169|NCT05814640|Antimanic Agents|antimanic agents|mesh-ancestor
83310170|NCT05814640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83310171|NCT05814640|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83310172|NCT05814601|Norepinephrine|norepinephrine|mesh-list
83310173|NCT05814601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83310174|NCT05814601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83310175|NCT05814601|Adrenergic Agents|adrenergic agents|mesh-ancestor
83310176|NCT05814601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310177|NCT05814601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310178|NCT05814601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310179|NCT05814601|Sympathomimetics|sympathomimetics|mesh-ancestor
83310180|NCT05814601|Autonomic Agents|autonomic agents|mesh-ancestor
83310181|NCT05814601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310182|NCT05814601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83310183|NCT05810363|Propofol|propofol|mesh-list
83310184|NCT05810363|Etomidate|etomidate|mesh-list
83310185|NCT05810363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83310186|NCT05810363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310187|NCT05810363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310188|NCT05810363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83310189|NCT05810363|Anesthetics, General|anesthetics, general|mesh-ancestor
83310190|NCT05810363|Anesthetics|anesthetics|mesh-ancestor
83310191|NCT05797662|Propranolol|propranolol|mesh-list
83310192|NCT05797662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83310193|NCT05797662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83310194|NCT05797662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83310195|NCT05797662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310196|NCT05797662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310197|NCT05797662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310198|NCT05797662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83310199|NCT05797662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83310200|NCT05797662|Vasodilator Agents|vasodilator agents|mesh-ancestor
83310201|NCT05795257|Dimercaprol|dimercaprol|mesh-list
83310202|NCT05795257|Chelating Agents|chelating agents|mesh-ancestor
83310203|NCT05795257|Sequestering Agents|sequestering agents|mesh-ancestor
83310204|NCT05795257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310205|NCT05786378|Anesthetics|anesthetics|mesh-list
83310206|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310207|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310208|NCT05779241|Risperidone|risperidone|mesh-list
83310209|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83310210|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
83310211|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310212|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310213|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310214|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83310215|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83310216|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310217|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83310218|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83310219|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
83310220|NCT05766358|Tirzepatide|tirzepatide|mesh-list
83310221|NCT05766358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83310222|NCT05766358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310223|NCT05766358|Incretins|incretins|mesh-ancestor
83310224|NCT05766358|Hormones|hormones|mesh-ancestor
83310225|NCT05766358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310226|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
83310227|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83310228|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
83310229|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310230|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310231|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83310232|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
83310233|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83310234|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
83310235|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310236|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310237|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83310238|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
83310239|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
83310240|NCT05757557|Protective Agents|protective agents|mesh-ancestor
83310241|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83310242|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310243|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83310244|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
83310245|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310246|NCT05712096|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
83310247|NCT05712096|Antiviral Agents|antiviral agents|mesh-ancestor
83310248|NCT05712096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310249|NCT05700344|Avelumab|avelumab|mesh-list
83310250|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310251|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310252|NCT05690984|Dexamethasone|dexamethasone|mesh-list
83310253|NCT05690984|Lenalidomide|lenalidomide|mesh-list
83310254|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83310255|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
83310256|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
83310257|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310258|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310259|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83310260|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
83310261|NCT05690984|Hormones|hormones|mesh-ancestor
83310262|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310263|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83310264|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310265|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
83310266|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83310267|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83310268|NCT05690984|Growth Substances|growth substances|mesh-ancestor
83310269|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
83310270|NCT05688904|Imipramine|imipramine|mesh-list
83310271|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83310272|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
83310273|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83310274|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83310275|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83310276|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83310277|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310278|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83310279|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310280|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310281|NCT05687357|Paclitaxel|paclitaxel|mesh-list
83310282|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
83310283|NCT05687357|Tislelizumab|tislelizumab|mesh-list
83310284|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83310285|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310286|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
83310287|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
83310288|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
83310289|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310290|NCT05687357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310291|NCT05679492|Meplazumab|meplazumab|mesh-list
83310292|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
83310293|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310294|NCT05675943|Antibodies|antibodies|mesh-list
83310295|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
83310296|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310297|NCT05632133|Lacosamide|lacosamide|mesh-list
83310298|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
83310299|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83310300|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83310301|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83310302|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310303|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
83310304|NCT05629585|Durvalumab|durvalumab|mesh-list
83310305|NCT05629585|Capecitabine|capecitabine|mesh-list
83310306|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310307|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310308|NCT05629585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310309|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310310|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83310311|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
83310312|NCT05626803|Vaccines|vaccines|mesh-list
83310313|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
83310314|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310315|NCT05619289|Vitamin D|vitamin d|mesh-list
83310316|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
83310317|NCT05619289|Vitamins|vitamins|mesh-ancestor
83310318|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
83310319|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310320|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83310321|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83310322|NCT05618002|Clonidine|clonidine|mesh-list
83310323|NCT05618002|Lemborexant|lemborexant|mesh-list
83310324|NCT05618002|Zopiclone|zopiclone|mesh-list
83310325|NCT05618002|Analgesics|analgesics|mesh-ancestor
83310326|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
83310327|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310328|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310329|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83310330|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
83310331|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
83310332|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83310333|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83310334|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83310335|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
83310336|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310337|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310338|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83310339|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83310340|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83310341|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310342|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83310343|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310344|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83310345|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83310346|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
83310347|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310348|NCT05605470|Vaccines|vaccines|mesh-list
83310349|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
83310350|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310351|NCT05604222|Mirabegron|mirabegron|mesh-list
83310352|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83310353|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83310354|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83310355|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
83310356|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310357|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310358|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310359|NCT05604222|Urological Agents|urological agents|mesh-ancestor
83310360|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
83310361|NCT05603910|Lenvatinib|lenvatinib|mesh-list
83310362|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310363|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310364|NCT05603910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310365|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310366|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310367|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310368|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
83310369|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83310370|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83310371|NCT05586776|Mupirocin|mupirocin|mesh-list
83310372|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310373|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
83310374|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
83310375|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83310376|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83310377|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310378|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310379|NCT05586360|Simvastatin|simvastatin|mesh-list
83310380|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83310381|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83310382|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
83310383|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310384|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83310385|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83310386|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310387|NCT05567094|Dexamethasone|dexamethasone|mesh-list
83310388|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83310389|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
83310390|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
83310391|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310392|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310393|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83310394|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
83310395|NCT05567094|Hormones|hormones|mesh-ancestor
83310396|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310397|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83310398|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310399|NCT05565222|Meropenem|meropenem|mesh-list
83310400|NCT05565222|Tazobactam|tazobactam|mesh-list
83310401|NCT05565222|Piperacillin|piperacillin|mesh-list
83310402|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83310403|NCT05565222|Temocillin|temocillin|mesh-list
83310404|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83310405|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310406|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83310407|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310408|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310409|NCT05563766|Itraconazole|itraconazole|mesh-list
83310410|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
83310411|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310412|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83310413|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83310414|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310415|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310416|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83310417|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
83310418|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310419|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310420|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83310421|NCT05562492|Insulin|insulin|mesh-list
83310422|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83310423|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310424|NCT05549661|Onvansertib|onvansertib|mesh-list
83310425|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310426|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310427|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310428|NCT05526989|Niraparib|niraparib|mesh-list
83310429|NCT05526989|Dostarlimab|dostarlimab|mesh-list
83310430|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83310431|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310432|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310433|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310434|NCT05497778|Paclitaxel|paclitaxel|mesh-list
83310435|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83310436|NCT05497778|Gemcitabine|gemcitabine|mesh-list
83310437|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83310438|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310439|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
83310440|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
83310441|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
83310442|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310443|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83310444|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
83310445|NCT05493501|Paclitaxel|paclitaxel|mesh-list
83310446|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83310447|NCT05493501|Carboplatin|carboplatin|mesh-list
83310448|NCT05493501|Gemcitabine|gemcitabine|mesh-list
83310449|NCT05493501|Pemetrexed|pemetrexed|mesh-list
83310450|NCT05493501|Osimertinib|osimertinib|mesh-list
83310451|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83310452|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310453|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
83310454|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
83310455|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
83310456|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310457|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83310458|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
83310459|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310460|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83310461|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83310462|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310463|NCT05483491|Aldesleukin|aldesleukin|mesh-list
83310464|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310465|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83310466|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83310467|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
83310468|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310469|NCT05482789|Exenatide|exenatide|mesh-list
83310470|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83310471|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310472|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83310473|NCT05482789|Incretins|incretins|mesh-ancestor
83310474|NCT05482789|Hormones|hormones|mesh-ancestor
83310475|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310476|NCT05474950|Minocycline|minocycline|mesh-list
83310477|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83310478|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310479|NCT05664386|Propofol|propofol|mesh-list
83310480|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83310481|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310482|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310483|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83310484|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
83310485|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
83310486|NCT05461404|Emollients|emollients|mesh-list
83310487|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
83362263|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310488|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
83310489|NCT05449392|Petrolatum|petrolatum|mesh-list
83310490|NCT05449392|Emollients|emollients|mesh-ancestor
83310491|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
83310492|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83310494|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83310495|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83310496|NCT05445076|Antibodies|antibodies|mesh-list
83310497|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
83310498|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83310499|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
83310500|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310501|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310502|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83310503|NCT05421741|Vancomycin|vancomycin|mesh-list
83310504|NCT05421741|Gentamicins|gentamicins|mesh-list
83310505|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310506|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83310507|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310508|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310509|NCT05405439|Prednisone|prednisone|mesh-list
83310510|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
83310511|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83310512|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
83310513|NCT05405439|Hormones|hormones|mesh-ancestor
83310514|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310515|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310516|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83310517|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310518|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83310519|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310520|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310521|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
83310522|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83310523|NCT05389722|Itraconazole|itraconazole|mesh-list
83310524|NCT05389722|Rifampin|rifampin|mesh-list
83310525|NCT05389722|Digoxin|digoxin|mesh-list
83310526|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83310527|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83310528|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83310529|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
83310530|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310531|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83310532|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83310533|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310534|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
83310535|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310536|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83310537|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83310538|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83310539|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
83310540|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310541|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310542|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83310543|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83310544|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
83310545|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83310546|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
83310547|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83310548|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83310549|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83310550|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83310551|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83310552|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83310553|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83310554|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83310555|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83310556|NCT05389722|Protective Agents|protective agents|mesh-ancestor
83310557|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
83310558|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310559|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310560|NCT05383170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310561|NCT05383170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310562|NCT05378464|Trastuzumab|trastuzumab|mesh-list
83310563|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310564|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310566|NCT05373680|Empagliflozin|empagliflozin|mesh-list
83310567|NCT05373680|Biguanides|biguanides|mesh-list
83310568|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83310569|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310570|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83310571|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310572|NCT05353348|Iron|iron|mesh-list
83310573|NCT05353348|Ascorbic Acid|ascorbic acid|mesh-list
83310574|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
83310575|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83310576|NCT05353348|Trace Elements|trace elements|mesh-ancestor
83310577|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
83310578|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310579|NCT05353348|Antioxidants|antioxidants|mesh-ancestor
83310580|NCT05353348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310581|NCT05353348|Protective Agents|protective agents|mesh-ancestor
83310582|NCT05353348|Vitamins|vitamins|mesh-ancestor
83310583|NCT05353348|Hematinics|hematinics|mesh-ancestor
83310584|NCT05304520|Natalizumab|natalizumab|mesh-list
83310585|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
83310586|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310587|NCT05300152|Antibodies|antibodies|mesh-list
83310588|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
83310589|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
83310590|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310591|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83310592|NCT05295173|Plasminogen|plasminogen|mesh-list
83310593|NCT05295173|Reteplase|reteplase|mesh-list
83310594|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83310595|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83310596|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310597|NCT05294263|Varenicline|varenicline|mesh-list
83310598|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83310599|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83310600|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
83310601|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310602|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310603|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310604|NCT05265728|Natalizumab|natalizumab|mesh-list
83310605|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
83310606|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310607|NCT05261594|Caffeine|caffeine|mesh-list
83310608|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83310609|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310610|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83310611|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310612|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310613|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83310614|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83310615|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
83310616|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310617|NCT05256290|Temozolomide|temozolomide|mesh-list
83310618|NCT05256290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83310619|NCT05256290|Alkylating Agents|alkylating agents|mesh-ancestor
83310620|NCT05256290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310621|NCT05256290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310622|NCT05254743|Pirtobrutinib|pirtobrutinib|mesh-list
83310623|NCT05254743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310624|NCT05254743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310625|NCT05254743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310626|NCT05246111|Topotecan|topotecan|mesh-list
83310627|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83310628|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83310629|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310630|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310631|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310632|NCT05242965|Vaccines|vaccines|mesh-list
83310633|NCT05242965|Sargramostim|sargramostim|mesh-list
83310634|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
83310635|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310636|NCT05241288|Albuterol|albuterol|mesh-list
83310637|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83310638|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
83310639|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310640|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310641|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83310642|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
83310643|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
83310644|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83310645|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83310646|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83310647|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83310648|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
83310649|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310650|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310651|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
83310652|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310653|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310654|NCT05220748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310655|NCT05220748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310656|NCT05180357|Benralizumab|benralizumab|mesh-list
83310657|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83310658|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
83310659|NCT05169684|Docetaxel|docetaxel|mesh-list
83310660|NCT05169684|Nivolumab|nivolumab|mesh-list
83310661|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310662|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
83310663|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
83310664|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
83310665|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310666|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310667|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310668|NCT05144542|Nicotine|nicotine|mesh-list
83310669|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83310670|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
83310671|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310672|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310673|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83310674|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83310675|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
83310676|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310677|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310678|NCT05141708|Talazoparib|talazoparib|mesh-list
83310679|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83310680|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310681|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310682|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310683|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83310684|NCT05137119|Vancomycin|vancomycin|mesh-list
83310685|NCT05137119|Clindamycin|clindamycin|mesh-list
83310686|NCT05137119|Cefazolin|cefazolin|mesh-list
83310687|NCT05137119|Daptomycin|daptomycin|mesh-list
83310688|NCT05137119|Penicillins|penicillins|mesh-list
83310689|NCT05137119|Penicillin G|penicillin g|mesh-list
83310690|NCT05137119|Lincomycin|lincomycin|mesh-list
83310691|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310692|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83310693|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310694|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310695|NCT05117489|Cortisone|cortisone|mesh-list
83310696|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83310697|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83310698|NCT05085808|Trazodone|trazodone|mesh-list
83310699|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
83310700|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83310701|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83310702|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83310703|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310704|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310705|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83310706|NCT05085808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83310707|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83310708|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83310709|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310710|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310711|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
83310712|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83310713|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
83310714|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310715|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310716|NCT05081609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310717|NCT05081609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310718|NCT05078944|Donepezil|donepezil|mesh-list
83310719|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83310720|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310721|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310722|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
83310723|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310724|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310725|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
83310726|NCT05076019|Atorvastatin|atorvastatin|mesh-list
83310727|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83310728|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83310729|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
83310730|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310731|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83310732|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83310733|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310734|NCT05071937|Talazoparib|talazoparib|mesh-list
83310735|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83310736|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310737|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310738|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310739|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
83310740|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
83310741|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310742|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
83310743|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310744|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310745|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
83310746|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310747|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310748|NCT05059470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310749|NCT05059470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310750|NCT05036005|Pertuzumab|pertuzumab|mesh-list
83310751|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310752|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310753|NCT05033769|Paclitaxel|paclitaxel|mesh-list
83310754|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83310755|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83310756|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310757|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
83310758|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
83310759|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
83310760|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310761|NCT05019846|Bicalutamide|bicalutamide|mesh-list
83310762|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83310763|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
83310764|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
83310765|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310766|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310767|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310768|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
83310769|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83310770|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
83310771|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83310772|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83310773|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83310774|NCT05004025|Nivolumab|nivolumab|mesh-list
83310775|NCT05004025|Ipilimumab|ipilimumab|mesh-list
83310776|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310777|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310778|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310779|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310780|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
83310781|NCT04998240|Paraproteins|paraproteins|mesh-list
83310782|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
83310783|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310784|NCT04996823|Ipilimumab|ipilimumab|mesh-list
83310785|NCT04996823|Axitinib|axitinib|mesh-list
83310786|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310787|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310788|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310789|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310790|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310791|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310792|NCT04984759|Primaquine|primaquine|mesh-list
83310793|NCT04984759|Tafenoquine|tafenoquine|mesh-list
83310794|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
83310795|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83310796|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83310797|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310798|NCT04975152|Cemiplimab|cemiplimab|mesh-list
83310799|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310800|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310801|NCT04960618|Gemcitabine|gemcitabine|mesh-list
83310802|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
83310803|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83310804|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
83310805|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310806|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310807|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310808|NCT04960618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310809|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
83310810|NCT04955743|Lenvatinib|lenvatinib|mesh-list
83310811|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310812|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310813|NCT04955743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310814|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310815|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310816|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310817|NCT04952324|Folic Acid|folic acid|mesh-list
83310818|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
83310819|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
83310820|NCT04952324|Vitamins|vitamins|mesh-ancestor
83310821|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
83310822|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310823|NCT04952324|Hematinics|hematinics|mesh-ancestor
83310824|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
83310825|NCT04951726|Neostigmine|neostigmine|mesh-list
83310826|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83310827|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310828|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310829|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
83310830|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83310831|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310832|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83310833|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
83310834|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310835|NCT04950764|Seladelpar|seladelpar|mesh-list
83310836|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83310837|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
83310838|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310839|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83310840|NCT04948892|Anesthetics|anesthetics|mesh-list
83310841|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310842|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310843|NCT04943341|Triamcinolone|triamcinolone|mesh-list
83310844|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83310845|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83310846|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83310847|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83310848|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
83310849|NCT04943341|Hormones|hormones|mesh-ancestor
83310850|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310851|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310852|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83310853|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
83310854|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310855|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310856|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
83310857|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
83310858|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
83310859|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310860|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310861|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
83310862|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310863|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
83310864|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
83310865|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
83310866|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310867|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310868|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
83310869|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310870|NCT04930562|Belumosudil|belumosudil|mesh-list
83310871|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310872|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310873|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310874|NCT04926571|Dexamethasone|dexamethasone|mesh-list
83310875|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83310876|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
83310877|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
83310878|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83310879|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310880|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83310881|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
83310882|NCT04926571|Hormones|hormones|mesh-ancestor
83310883|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310884|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83310885|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310886|NCT04919382|Temozolomide|temozolomide|mesh-list
83310887|NCT04919382|Atezolizumab|atezolizumab|mesh-list
83310888|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83310889|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83310890|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
83310891|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310892|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310893|NCT04919382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310894|NCT04919382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310895|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
83310896|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310897|NCT04918823|Cyclosporine|cyclosporine|mesh-list
83310898|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83310899|NCT04918823|Cyclosporins|cyclosporins|mesh-list
83310900|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310901|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310902|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83310903|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
83310904|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310905|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
83310906|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310907|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
83310908|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83310909|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83310910|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83310911|NCT04912492|Ethanol|ethanol|mesh-list
83310912|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83310913|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310914|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310915|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310916|NCT04909073|Afatinib|afatinib|mesh-list
83310917|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310918|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83310919|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310920|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310921|NCT04833855|Omalizumab|omalizumab|mesh-list
83310922|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83310923|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83310924|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83310925|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
83310926|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
83310927|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310928|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
83310929|NCT04798339|Hematinics|hematinics|mesh-ancestor
83310930|NCT04792385|Drospirenone|drospirenone|mesh-list
83310931|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
83310932|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
83310933|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83310934|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83310935|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310936|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83310937|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83310938|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
83310939|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310940|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83310942|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
83310943|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
83310944|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83310945|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83310946|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310947|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
83310948|NCT04785651|Coagulants|coagulants|mesh-ancestor
83310949|NCT04780204|Tenofovir|tenofovir|mesh-list
83310950|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
83310951|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310952|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83310953|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83310954|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310955|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310956|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83310957|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83310958|NCT04763564|Liraglutide|liraglutide|mesh-list
83310959|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83310960|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310961|NCT04763564|Incretins|incretins|mesh-ancestor
83310962|NCT04763564|Hormones|hormones|mesh-ancestor
83310963|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83310964|NCT04748588|Sotrovimab|sotrovimab|mesh-list
83310965|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
83310966|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
83310967|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310968|NCT04741997|Nivolumab|nivolumab|mesh-list
83310969|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83310970|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83310971|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83310972|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310973|NCT04735510|Cyclosporine|cyclosporine|mesh-list
83310974|NCT04735510|Cyclosporins|cyclosporins|mesh-list
83310975|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83310976|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310977|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83310978|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
83310979|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310980|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
83310981|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83310982|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
83310983|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83310984|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83310985|NCT04696523|Xenon|xenon|mesh-list
83310986|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83310987|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
83310988|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
83310989|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83310990|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83310991|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83310992|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83310993|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83310994|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83310995|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
83310996|NCT04669197|Paclitaxel|paclitaxel|mesh-list
83310997|NCT04669197|Gemcitabine|gemcitabine|mesh-list
83310998|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83310999|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311000|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311001|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311002|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311003|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311004|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311005|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311006|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
83311007|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
83311008|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83311010|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311011|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311012|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311013|NCT04662944|Ranibizumab|ranibizumab|mesh-list
83311014|NCT04662944|Aflibercept|aflibercept|mesh-list
83311015|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83311016|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83311017|NCT04662944|Growth Substances|growth substances|mesh-ancestor
83311018|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311019|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
83311020|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311021|NCT04655222|Interferons|interferons|mesh-list
83311022|NCT04655222|Interferon-beta|interferon-beta|mesh-list
83311023|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311024|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
83311025|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311026|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
83311027|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311028|NCT04652440|Tislelizumab|tislelizumab|mesh-list
83311029|NCT04652440|Antibodies|antibodies|mesh-list
83311030|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83311031|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
83311032|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311033|NCT04652440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311034|NCT04652440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311035|NCT04615013|Leucovorin|leucovorin|mesh-list
83311036|NCT04615013|Paclitaxel|paclitaxel|mesh-list
83311037|NCT04615013|Docetaxel|docetaxel|mesh-list
83311038|NCT04615013|Carboplatin|carboplatin|mesh-list
83311039|NCT04615013|Fluorouracil|fluorouracil|mesh-list
83311040|NCT04615013|Capecitabine|capecitabine|mesh-list
83311041|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
83311042|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83311043|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311044|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311045|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311046|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311047|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311048|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311049|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
83311050|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311051|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311052|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
83311053|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311054|NCT04615013|Antidotes|antidotes|mesh-ancestor
83311055|NCT04615013|Protective Agents|protective agents|mesh-ancestor
83311056|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
83311057|NCT04615013|Vitamins|vitamins|mesh-ancestor
83311058|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
83311059|NCT04612725|Benralizumab|benralizumab|mesh-list
83311060|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83311061|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
83311062|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
83311063|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311064|NCT04592744|Vasopressins|vasopressins|mesh-list
83311065|NCT04592744|Epinephrine|epinephrine|mesh-list
83311066|NCT04592744|Norepinephrine|norepinephrine|mesh-list
83311067|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
83311068|NCT04592744|Giapreza|giapreza|mesh-list
83311069|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
83311070|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83311071|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83311072|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
83311073|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311074|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311075|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311076|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83311077|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83311078|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
83311079|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311080|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83311081|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
83311082|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
83311083|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
83311084|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83311085|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
83311086|NCT04592744|Coagulants|coagulants|mesh-ancestor
83311087|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83311088|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
83311089|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83311091|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311092|NCT04585711|Etanercept|etanercept|mesh-list
83311093|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83311094|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83311095|NCT04585711|Analgesics|analgesics|mesh-ancestor
83311096|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
83311097|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311098|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311099|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83311100|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311101|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83311102|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311103|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
83311104|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
83311105|NCT04581824|Dostarlimab|dostarlimab|mesh-list
83311106|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311107|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311108|NCT04581824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311109|NCT04581824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311110|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83311111|NCT04551495|Letrozole|letrozole|mesh-list
83311112|NCT04551495|Goserelin|goserelin|mesh-list
83311113|NCT04551495|Entrectinib|entrectinib|mesh-list
83311114|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311115|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83311116|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83311117|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311118|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311119|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83311120|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
83311121|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311122|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311123|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83311124|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311125|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83311126|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83311127|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311128|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311129|NCT04501718|Etoposide|etoposide|mesh-list
83311130|NCT04501718|Temozolomide|temozolomide|mesh-list
83311131|NCT04501718|Apatinib|apatinib|mesh-list
83311132|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311133|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311134|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83311135|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83311136|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311137|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311138|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83311139|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
83311140|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311141|NCT04501705|Apatinib|apatinib|mesh-list
83311142|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311143|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311144|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311145|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311146|NCT04463394|Vasopressins|vasopressins|mesh-list
83311147|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
83311148|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
83311149|NCT04463394|Coagulants|coagulants|mesh-ancestor
83311150|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83311151|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83311152|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
83311153|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311154|NCT04454905|Apatinib|apatinib|mesh-list
83311155|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311156|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311157|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311158|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311159|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83311160|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
83311161|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311162|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83311163|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
83311164|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362264|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311165|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311166|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83311167|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83311168|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311169|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
83311170|NCT04436601|Lactulose|lactulose|mesh-list
83311171|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83311172|NCT04397484|Lidocaine|lidocaine|mesh-list
83311173|NCT04397484|Epinephrine|epinephrine|mesh-list
83311174|NCT04397484|Racepinephrine|racepinephrine|mesh-list
83311175|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
83311176|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
83311177|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
83311178|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
83311179|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83311180|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311181|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
83311182|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311183|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83311184|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83311185|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83311186|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311187|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311188|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83311189|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83311190|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
83311191|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311192|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83311193|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83311194|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
83311195|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83311196|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
83311197|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
83311198|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
83311199|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83311200|NCT04373785|Temozolomide|temozolomide|mesh-list
83311201|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83311202|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
83311203|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311204|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311205|NCT04313712|Ibogaine|ibogaine|mesh-list
83311206|NCT04313712|Hallucinogens|hallucinogens|mesh-ancestor
83311207|NCT04313712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311208|NCT04313712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83311209|NCT04313712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83311210|NCT04313712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83311211|NCT04313712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311212|NCT04313712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311213|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
83311214|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
83311215|NCT04310995|Nicorandil|nicorandil|mesh-list
83311216|NCT04310995|Diltiazem|diltiazem|mesh-list
83311217|NCT04310995|Isosorbide|isosorbide|mesh-list
83311218|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83311219|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83311220|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83311221|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83311222|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311223|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311224|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83311225|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311226|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
83311227|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83311228|NCT04310995|Diuretics|diuretics|mesh-ancestor
83311229|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
83311230|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83311231|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83311232|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
83311233|NCT04310995|Vitamins|vitamins|mesh-ancestor
83311234|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
83311235|NCT04309552|Alovudine|alovudine|mesh-list
83311236|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
83311237|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311238|NCT04275180|Argatroban|argatroban|mesh-list
83311239|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
83311240|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83311241|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
83311242|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311243|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311244|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
83311245|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83311246|NCT04271332|Baclofen|baclofen|mesh-list
83311247|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83311248|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311249|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83311250|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311251|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83311252|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
83311253|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
83311254|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311255|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311256|NCT04267978|Irinotecan|irinotecan|mesh-list
83311257|NCT04267978|Temozolomide|temozolomide|mesh-list
83311258|NCT04267978|Endostatins|endostatins|mesh-list
83311259|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83311260|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83311261|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311262|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311263|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311264|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83311265|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
83311266|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83311267|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83311268|NCT04267978|Growth Substances|growth substances|mesh-ancestor
83311269|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311270|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
83311271|NCT04251533|Paclitaxel|paclitaxel|mesh-list
83311272|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311273|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311274|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311275|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311276|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311277|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311278|NCT04242238|Avelumab|avelumab|mesh-list
83311279|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311280|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311281|NCT04230252|Acetaminophen|acetaminophen|mesh-list
83311282|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83311283|NCT04230252|Analgesics|analgesics|mesh-ancestor
83311284|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
83311285|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311286|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311287|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
83311288|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83311289|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83311290|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
83311291|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311292|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311293|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83311294|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83311295|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311296|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311297|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83311298|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
83311299|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311300|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311301|NCT04140396|Lidocaine|lidocaine|mesh-list
83311302|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
83311303|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
83311304|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83311305|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311306|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
83311307|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311308|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83311309|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83311310|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83311311|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311312|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311315|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83311316|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311317|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311318|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
83311319|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311320|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311321|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
83311322|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83311323|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83311324|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
83311325|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83311326|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83311327|NCT04099836|Bevacizumab|bevacizumab|mesh-list
83311328|NCT04099836|Atezolizumab|atezolizumab|mesh-list
83311329|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311330|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311331|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83311332|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83311333|NCT04099836|Growth Substances|growth substances|mesh-ancestor
83311334|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311335|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
83311336|NCT04099836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311337|NCT04099836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311338|NCT04094961|Dexamethasone|dexamethasone|mesh-list
83311339|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
83311340|NCT04094961|Pomalidomide|pomalidomide|mesh-list
83311341|NCT04094961|Ixazomib|ixazomib|mesh-list
83311342|NCT04094961|BB 1101|bb 1101|mesh-list
83311343|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83311344|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
83311345|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
83311346|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311347|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311348|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83311349|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
83311350|NCT04094961|Hormones|hormones|mesh-ancestor
83311351|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311352|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83311353|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311354|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
83311355|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311356|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311357|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
83311358|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83311359|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83311360|NCT04094961|Growth Substances|growth substances|mesh-ancestor
83311361|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
83311362|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
83311363|NCT04025216|Fludarabine|fludarabine|mesh-list
83311364|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311365|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
83311366|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311367|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311368|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83311369|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
83311370|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311371|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311372|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83311373|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83311374|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311375|NCT04020185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311376|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311377|NCT03991936|Triamcinolone|triamcinolone|mesh-list
83311378|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83311379|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83311380|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83311381|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83311382|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
83311383|NCT03991936|Hormones|hormones|mesh-ancestor
83311384|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311385|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311386|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311387|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
83311388|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311389|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311390|NCT03982082|Coal Tar|coal tar|mesh-list
83311391|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
83311392|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
83311393|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
83311394|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
83311395|NCT03979599|Analgesics|analgesics|mesh-ancestor
83311396|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
83311397|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311398|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311399|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
83311400|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83311401|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83311402|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
83311403|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83311404|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311405|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311406|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83311407|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
83311408|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83311409|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
83311410|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83311411|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83311412|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311413|NCT03946514|Losartan|losartan|mesh-list
83311414|NCT03946514|Amlodipine|amlodipine|mesh-list
83311415|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83311416|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83311417|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83311418|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311419|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311420|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83311421|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311422|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
83311423|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83311424|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83311425|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83311426|NCT03946514|Diuretics|diuretics|mesh-ancestor
83311427|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
83311428|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83311429|NCT03935958|Curcumin|curcumin|mesh-list
83311430|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83311431|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83311432|NCT03935958|Analgesics|analgesics|mesh-ancestor
83311433|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
83311434|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311435|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311436|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83311437|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311438|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311439|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311440|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311441|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83311442|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83311443|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83311444|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311445|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311447|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311448|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311449|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83311450|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311451|NCT03915444|Paclitaxel|paclitaxel|mesh-list
83311452|NCT03915444|Gemcitabine|gemcitabine|mesh-list
83311453|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311454|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311455|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311456|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311457|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311458|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311459|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311460|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
83311462|NCT03892785|Methotrexate|methotrexate|mesh-list
83311463|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83311464|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
83311465|NCT03892785|Hormones|hormones|mesh-ancestor
83311466|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311467|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311468|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83311469|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311470|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83311471|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
83311472|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83311473|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311474|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
83311475|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311476|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83311477|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311478|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83311479|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311480|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
83311481|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311482|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83311483|NCT03869034|Leucovorin|leucovorin|mesh-list
83311484|NCT03869034|Fluorouracil|fluorouracil|mesh-list
83311485|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
83311486|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
83311487|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311488|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311489|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311490|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311491|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
83311492|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311493|NCT03869034|Antidotes|antidotes|mesh-ancestor
83311494|NCT03869034|Protective Agents|protective agents|mesh-ancestor
83311495|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
83311496|NCT03869034|Vitamins|vitamins|mesh-ancestor
83311497|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
83311498|NCT03841097|Tacrolimus|tacrolimus|mesh-list
83311499|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311500|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
83311501|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311502|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83311503|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311504|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311505|NCT03831425|Ubiquinone|ubiquinone|mesh-list
83311506|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
83311507|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
83311508|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311509|NCT03831425|Vitamins|vitamins|mesh-ancestor
83311510|NCT03830866|Carboplatin|carboplatin|mesh-list
83311511|NCT03830866|Durvalumab|durvalumab|mesh-list
83311512|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311513|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311514|NCT03807765|Nivolumab|nivolumab|mesh-list
83311515|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311516|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311517|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311518|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311519|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
83311520|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311521|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311522|NCT03804944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311523|NCT03804944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311524|NCT03790111|Cisplatin|cisplatin|mesh-list
83311525|NCT03790111|Gemcitabine|gemcitabine|mesh-list
83311526|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311527|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311528|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
83311529|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311530|NCT03780543|Tenofovir|tenofovir|mesh-list
83311531|NCT03780543|Entecavir|entecavir|mesh-list
83311532|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83311533|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
83311534|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311535|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83311536|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311537|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311538|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83311539|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83311540|NCT03772314|Modafinil|modafinil|mesh-list
83311541|NCT03772314|Amphetamine|amphetamine|mesh-list
83311542|NCT03772314|Adderall|adderall|mesh-list
83311543|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
83311544|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83311545|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311546|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83311547|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83311548|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83311549|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311550|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
83311551|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
83311552|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311553|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
83311554|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311555|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
83311556|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83311557|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83311558|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311559|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83311560|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
83311561|NCT03760575|Pemetrexed|pemetrexed|mesh-list
83311562|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311563|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311564|NCT03760575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311565|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311566|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311567|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83311568|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83311569|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83311570|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311571|NCT03720522|Adenosine|adenosine|mesh-list
83311572|NCT03720522|Analgesics|analgesics|mesh-ancestor
83311573|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
83311574|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311575|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311576|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83311577|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
83311578|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83311579|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
83311580|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
83311581|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311582|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311583|NCT03712943|Nivolumab|nivolumab|mesh-list
83311584|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311585|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311586|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311587|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311588|NCT03699631|Methotrexate|methotrexate|mesh-list
83311589|NCT03699631|Tacrolimus|tacrolimus|mesh-list
83311590|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83311591|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
83311592|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83311593|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311594|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311595|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
83311596|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311597|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311598|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
83311599|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311600|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83311601|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311602|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
83311603|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311604|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83311605|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83311606|NCT03686488|Ramucirumab|ramucirumab|mesh-list
83311607|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311608|NCT03686150|Vitamin D|vitamin d|mesh-list
83311609|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
83311610|NCT03686150|Vitamins|vitamins|mesh-ancestor
83311611|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
83311612|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311613|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83311614|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83311615|NCT03678233|Testosterone|testosterone|mesh-list
83311616|NCT03678233|Androgens|androgens|mesh-ancestor
83311617|NCT03678233|Hormones|hormones|mesh-ancestor
83311618|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311619|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311620|NCT03629327|Aspirin|aspirin|mesh-list
83311621|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83311622|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83311623|NCT03629327|Analgesics|analgesics|mesh-ancestor
83311624|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
83311625|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311626|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311627|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83311628|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311629|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83311630|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83311631|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311632|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83311633|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83311634|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311635|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
83311636|NCT03628209|Nivolumab|nivolumab|mesh-list
83311637|NCT03628209|Azacitidine|azacitidine|mesh-list
83311638|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311639|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311640|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311641|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311642|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311643|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
83311644|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311645|NCT03618641|Nivolumab|nivolumab|mesh-list
83311646|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311647|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311648|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311649|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311650|NCT03617718|Glycine|glycine|mesh-list
83311651|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
83311652|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311653|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311654|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311655|NCT03610061|Durvalumab|durvalumab|mesh-list
83311656|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311657|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311658|NCT03606642|Clopidogrel|clopidogrel|mesh-list
83311659|NCT03606642|Ticagrelor|ticagrelor|mesh-list
83311660|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83311661|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311662|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311663|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83311664|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83311665|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83311666|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83311667|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
83311668|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311670|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83311671|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
83311672|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311673|NCT03527043|Escitalopram|escitalopram|mesh-list
83311674|NCT03527043|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83311675|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83311676|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311677|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311678|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311679|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
83311680|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311681|NCT03521154|Osimertinib|osimertinib|mesh-list
83311682|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311683|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311684|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311685|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311686|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
83311687|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83311688|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83311689|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311690|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
83311691|NCT03505723|Coagulants|coagulants|mesh-ancestor
83311692|NCT03458221|Itraconazole|itraconazole|mesh-list
83311693|NCT03458221|Everolimus|everolimus|mesh-list
83311694|NCT03458221|Letrozole|letrozole|mesh-list
83311695|NCT03458221|Bicalutamide|bicalutamide|mesh-list
83311696|NCT03458221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83311697|NCT03458221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311698|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311699|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311700|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311701|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
83311702|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311703|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311704|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83311705|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83311706|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83311707|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
83311708|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311709|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
83311710|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311711|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83311712|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83311713|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83311714|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
83311715|NCT03451487|Acetaminophen|acetaminophen|mesh-list
83311716|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83311717|NCT03451487|Analgesics|analgesics|mesh-ancestor
83311718|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
83311719|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311720|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311721|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
83311722|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
83311723|NCT03410030|Paclitaxel|paclitaxel|mesh-list
83311724|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83311725|NCT03410030|Cisplatin|cisplatin|mesh-list
83311726|NCT03410030|Gemcitabine|gemcitabine|mesh-list
83311727|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311728|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311729|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311730|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311731|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311732|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311733|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311734|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
83311735|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
83311736|NCT03410030|Protective Agents|protective agents|mesh-ancestor
83311737|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311739|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
83311740|NCT03382301|Cyclosporine|cyclosporine|mesh-list
83311741|NCT03382301|Cyclosporins|cyclosporins|mesh-list
83311742|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311743|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311744|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311745|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
83311746|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311747|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
83311748|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311749|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
83311750|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311751|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83311752|NCT03301506|Seladelpar|seladelpar|mesh-list
83311753|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83311754|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
83311755|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311756|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83311757|NCT03290391|Naltrexone|naltrexone|mesh-list
83311758|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83311759|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83311760|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311761|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
83311762|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311763|NCT03280030|Midostaurin|midostaurin|mesh-list
83311764|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311765|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311766|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311767|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311768|NCT03263481|Secretin|secretin|mesh-list
83311769|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83311770|NCT03263481|Hormones|hormones|mesh-ancestor
83311771|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83311772|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311773|NCT03245892|Paclitaxel|paclitaxel|mesh-list
83311774|NCT03245892|Carboplatin|carboplatin|mesh-list
83311775|NCT03245892|Nivolumab|nivolumab|mesh-list
83311776|NCT03245892|Ipilimumab|ipilimumab|mesh-list
83311777|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311778|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311779|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311780|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311781|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311782|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311783|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311784|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311785|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
83311786|NCT03204188|Fludarabine|fludarabine|mesh-list
83311787|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311788|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311789|NCT03204188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311790|NCT03204188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311791|NCT03194867|Cemiplimab|cemiplimab|mesh-list
83311792|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311793|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311794|NCT03184870|Leucovorin|leucovorin|mesh-list
83311795|NCT03184870|Paclitaxel|paclitaxel|mesh-list
83311796|NCT03184870|Gemcitabine|gemcitabine|mesh-list
83311797|NCT03184870|Fluorouracil|fluorouracil|mesh-list
83311798|NCT03184870|Nivolumab|nivolumab|mesh-list
83311799|NCT03184870|Irinotecan|irinotecan|mesh-list
83311800|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311801|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311802|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311803|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311804|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311805|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311806|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311807|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
83311808|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311809|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
83311810|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311811|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311812|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311813|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83311814|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83311815|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311816|NCT03184870|Antidotes|antidotes|mesh-ancestor
83311817|NCT03184870|Protective Agents|protective agents|mesh-ancestor
83311818|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
83311819|NCT03184870|Vitamins|vitamins|mesh-ancestor
83311820|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
83311821|NCT03138720|Paclitaxel|paclitaxel|mesh-list
83311822|NCT03138720|Cisplatin|cisplatin|mesh-list
83311823|NCT03138720|Gemcitabine|gemcitabine|mesh-list
83311824|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83311825|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311826|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311827|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311828|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311829|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311830|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311831|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83311832|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
83311833|NCT03131726|Simvastatin|simvastatin|mesh-list
83311834|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83311835|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83311836|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
83311837|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311838|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83311839|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83311840|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311841|NCT03112590|Interferons|interferons|mesh-list
83311842|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
83311843|NCT03112590|Paclitaxel|paclitaxel|mesh-list
83311844|NCT03112590|Trastuzumab|trastuzumab|mesh-list
83311845|NCT03112590|Pertuzumab|pertuzumab|mesh-list
83311846|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311847|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311848|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311849|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311850|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311851|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311852|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311853|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
83311854|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311855|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
83311856|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83311857|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83311858|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311859|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
83311860|NCT03085394|Coagulants|coagulants|mesh-ancestor
83311861|NCT03065621|Palbociclib|palbociclib|mesh-list
83311862|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311863|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83311864|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311865|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311866|NCT03060434|Acetaminophen|acetaminophen|mesh-list
83311867|NCT03060434|Ibuprofen|ibuprofen|mesh-list
83311868|NCT03060434|Pregabalin|pregabalin|mesh-list
83311869|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
83311870|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83311871|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83311872|NCT03060434|Analgesics|analgesics|mesh-ancestor
83311873|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
83311874|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311875|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311876|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83311877|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311878|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83311879|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311880|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311881|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
83311882|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83311883|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83311884|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83311885|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83311886|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83311887|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83311888|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83311889|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
83311890|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83311891|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83311892|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83311893|NCT03060434|Protective Agents|protective agents|mesh-ancestor
83311894|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
83311895|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83311896|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
83311897|NCT03021486|Haloperidol|haloperidol|mesh-list
83311898|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
83311899|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
83311900|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
83311901|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
83311902|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83311903|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311904|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83311905|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83311906|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83311907|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83311908|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83311909|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83311910|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
83311911|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311912|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311913|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83311914|NCT02949128|Ravulizumab|ravulizumab|mesh-list
83311915|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83311916|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311917|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
83311918|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311919|NCT02944617|Micronutrients|micronutrients|mesh-list
83311920|NCT02944617|Trace Elements|trace elements|mesh-list
83311921|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311922|NCT02923115|Enoxaparin|enoxaparin|mesh-list
83311923|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
83311924|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83311925|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83311926|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311927|NCT02910583|Venetoclax|venetoclax|mesh-list
83311928|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311929|NCT02820857|Bevacizumab|bevacizumab|mesh-list
83311930|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311931|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311932|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83311933|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83311934|NCT02820857|Growth Substances|growth substances|mesh-ancestor
83311935|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311936|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
83311937|NCT02790710|Propranolol|propranolol|mesh-list
83311938|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83311939|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83311940|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
83311941|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83311942|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311943|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311944|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83311945|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83311946|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
83311947|NCT02779855|Paclitaxel|paclitaxel|mesh-list
83311948|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83311949|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83311950|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311951|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
83311952|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
83311953|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
83311954|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311955|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311956|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
83311957|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
83311958|NCT02661035|Fludarabine|fludarabine|mesh-list
83311959|NCT02661035|Allopurinol|allopurinol|mesh-list
83311960|NCT02661035|Tacrolimus|tacrolimus|mesh-list
83311961|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83311962|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83311963|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
83311964|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83311965|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83311966|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83311967|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
83311968|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311969|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311970|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83311971|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
83311972|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83311973|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311974|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83311975|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83311976|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
83311977|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83311978|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83311979|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
83311980|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83311981|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
83311982|NCT02661035|Protective Agents|protective agents|mesh-ancestor
83311983|NCT02648477|Doxorubicin|doxorubicin|mesh-list
83311984|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83311985|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
83311986|NCT02648477|Letrozole|letrozole|mesh-list
83311987|NCT02648477|Anastrozole|anastrozole|mesh-list
83311988|NCT02648477|Exemestane|exemestane|mesh-list
83311989|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83311990|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83311991|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83311992|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83311993|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83311994|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83311995|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83311996|NCT02648477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83311997|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83311998|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83311999|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83312000|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
83312001|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312002|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312003|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83312004|NCT02604732|Aspirin|aspirin|mesh-list
83312005|NCT02604732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83312006|NCT02604732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83312007|NCT02604732|Analgesics|analgesics|mesh-ancestor
83312008|NCT02604732|Sensory System Agents|sensory system agents|mesh-ancestor
83312009|NCT02604732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312010|NCT02604732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312011|NCT02604732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312012|NCT02604732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312013|NCT02604732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83312014|NCT02604732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83312015|NCT02604732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312016|NCT02604732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83312017|NCT02604732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83312018|NCT02604732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312019|NCT02604732|Antipyretics|antipyretics|mesh-ancestor
83312020|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
83312021|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83312022|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83312023|NCT02444429|Prednisolone|prednisolone|mesh-list
83312024|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
83312025|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83312026|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
83312027|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312028|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
83312029|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
83312030|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312031|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312032|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83312033|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
83312035|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312036|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83312037|NCT02444429|Protective Agents|protective agents|mesh-ancestor
83312038|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83312039|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312040|NCT02318342|Warfarin|warfarin|mesh-list
83312041|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
83312042|NCT02134184|Vaccines|vaccines|mesh-list
83312043|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
83312044|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312045|NCT02029846|Metformin|metformin|mesh-list
83312046|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83312047|NCT02029846|Incretins|incretins|mesh-list
83312048|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83312049|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312050|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
83312051|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312052|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312053|NCT02029846|Hormones|hormones|mesh-ancestor
83312054|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312055|NCT02020694|Vitamin D|vitamin d|mesh-list
83312056|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
83312057|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
83312058|NCT02020694|Vitamins|vitamins|mesh-list
83312059|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
83312060|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312061|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83312062|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83312069|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312070|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83312071|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83312072|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83312073|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
83312074|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
83312075|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83312076|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83312077|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83312078|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83312079|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83312080|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83312081|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83312089|NCT01907009|Lenograstim|lenograstim|mesh-list
83312090|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83312091|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
83312092|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312093|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312094|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83312095|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312096|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
83312097|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312098|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83312099|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
83312100|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312101|NCT01726582|Leucovorin|leucovorin|mesh-list
83312102|NCT01726582|Paclitaxel|paclitaxel|mesh-list
83312103|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83312104|NCT01726582|Gemcitabine|gemcitabine|mesh-list
83312105|NCT01726582|Fluorouracil|fluorouracil|mesh-list
83312106|NCT01726582|Capecitabine|capecitabine|mesh-list
83312107|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
83312108|NCT01726582|Irinotecan|irinotecan|mesh-list
83312109|NCT01726582|Cisplatin|cisplatin|mesh-list
83312110|NCT01726582|Folfirinox|folfirinox|mesh-list
83312111|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83312112|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312113|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312114|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312115|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312116|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312117|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312118|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
83312120|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
83312121|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312122|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83312123|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83312124|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312125|NCT01726582|Antidotes|antidotes|mesh-ancestor
83312126|NCT01726582|Protective Agents|protective agents|mesh-ancestor
83312127|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
83312128|NCT01726582|Vitamins|vitamins|mesh-ancestor
83312129|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
83312130|NCT01718743|Lenalidomide|lenalidomide|mesh-list
83312131|NCT01718743|Ixazomib|ixazomib|mesh-list
83312132|NCT01718743|Glycine|glycine|mesh-list
83312133|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
83312134|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312135|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83312136|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83312137|NCT01718743|Growth Substances|growth substances|mesh-ancestor
83312138|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
83312139|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312140|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312141|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
83312142|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312143|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
83312144|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312145|NCT01701674|Aldesleukin|aldesleukin|mesh-list
83312146|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
83312147|NCT01701674|Fludarabine|fludarabine|mesh-list
83312148|NCT01701674|Ipilimumab|ipilimumab|mesh-list
83312149|NCT01701674|Interleukin-2|interleukin-2|mesh-list
83312150|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312151|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
83312152|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312153|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312154|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83312155|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
83312156|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312157|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312158|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83312159|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312160|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83312161|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83312162|NCT01701674|Analgesics|analgesics|mesh-ancestor
83312163|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
83312164|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312165|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83312166|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83312167|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
83312168|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312169|NCT01686126|Metformin|metformin|mesh-list
83312170|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
83312171|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83312172|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312173|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83312174|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
83312175|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83312176|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83312177|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83312178|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83312179|NCT01531582|Minocycline|minocycline|mesh-list
83312180|NCT01531582|Tetracycline|tetracycline|mesh-list
83312181|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312182|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312183|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83312184|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312185|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312186|NCT01512888|Busulfan|busulfan|mesh-list
83312187|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
83312188|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312189|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312190|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
83312191|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312192|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83312193|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312194|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83312195|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
83312196|NCT01493453|Fludarabine|fludarabine|mesh-list
83312197|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312198|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
83312199|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312200|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312201|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83312202|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
83312203|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312204|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312205|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83312206|NCT01208662|Dexamethasone|dexamethasone|mesh-list
83312207|NCT01208662|Lenalidomide|lenalidomide|mesh-list
83312208|NCT01208662|Bortezomib|bortezomib|mesh-list
83312209|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312210|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
83312211|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
83312212|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312213|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312214|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83312215|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
83312216|NCT01208662|Hormones|hormones|mesh-ancestor
83312217|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312218|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83312219|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312220|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
83312221|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83312222|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83312223|NCT01208662|Growth Substances|growth substances|mesh-ancestor
83312224|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
83312225|NCT00920621|Vitamin D|vitamin d|mesh-list
83312226|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
83312227|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
83312228|NCT00920621|Vitamins|vitamins|mesh-list
83312229|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
83312230|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312231|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83312232|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83312233|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83312234|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312235|NCT00460486|Formaldehyde|formaldehyde|mesh-list
83312236|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
83312237|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312238|NCT00378105|Dexamethasone|dexamethasone|mesh-list
83312239|NCT00378105|Lenalidomide|lenalidomide|mesh-list
83312240|NCT00378105|Bortezomib|bortezomib|mesh-list
83312241|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312242|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
83312243|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
83312244|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312245|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312246|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83312247|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
83312248|NCT00378105|Hormones|hormones|mesh-ancestor
83312249|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312250|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83312251|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312252|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
83312253|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83312254|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83312255|NCT00378105|Growth Substances|growth substances|mesh-ancestor
83312256|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
83312257|NCT00139477|Metformin|metformin|mesh-list
83312258|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83312259|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312260|NCT00082706|Leucovorin|leucovorin|mesh-list
83312261|NCT00082706|Cisplatin|cisplatin|mesh-list
83312262|NCT00082706|Gemcitabine|gemcitabine|mesh-list
83312263|NCT00082706|Fluorouracil|fluorouracil|mesh-list
83312264|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312265|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312267|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312268|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312269|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
83312270|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312271|NCT00082706|Antidotes|antidotes|mesh-ancestor
83312272|NCT00082706|Protective Agents|protective agents|mesh-ancestor
83312273|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
83312274|NCT00082706|Vitamins|vitamins|mesh-ancestor
83312275|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
83312276|NCT00004935|Trastuzumab|trastuzumab|mesh-list
83312277|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312278|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312279|NCT00119158|Fluticasone|fluticasone|mesh-list
83312280|NCT00119158|Xhance|xhance|mesh-list
83312281|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
83312282|NCT00119158|Tacrolimus|tacrolimus|mesh-list
83312283|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312284|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83312285|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
83312286|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312287|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312288|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83312289|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
83312290|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
83312291|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83312292|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83312293|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83312294|NCT00119158|Analgesics|analgesics|mesh-ancestor
83312295|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
83312296|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312297|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312298|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
83312299|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83312300|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312301|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312302|NCT00119392|Cyclosporine|cyclosporine|mesh-list
83312303|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
83312305|NCT00119392|Fludarabine|fludarabine|mesh-list
83312306|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
83312307|NCT00119392|Cyclosporins|cyclosporins|mesh-list
83312308|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83312309|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312310|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312311|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
83312312|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312313|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312314|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312315|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
83312316|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312317|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312318|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312319|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
83312320|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312321|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
83312322|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83312323|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83312324|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83312325|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
83312326|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312327|NCT00218062|Modafinil|modafinil|mesh-list
83312328|NCT00218062|Amphetamine|amphetamine|mesh-list
83312329|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
83312330|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83312331|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312332|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83312333|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83312334|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83312335|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312336|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
83312337|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
83312338|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312339|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
83312340|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312341|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83312342|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83312343|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83312344|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83312345|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83312346|NCT00121186|Methotrexate|methotrexate|mesh-list
83312347|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
83312348|NCT00121186|Fludarabine|fludarabine|mesh-list
83312350|NCT00121186|Tacrolimus|tacrolimus|mesh-list
83312351|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83312352|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
83312353|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83312354|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312355|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312356|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
83312357|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312358|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312359|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
83312360|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312361|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83312362|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312363|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
83312364|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312365|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83312366|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83312367|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83312368|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
83312369|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83312370|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
83312371|NCT00121810|Sirolimus|sirolimus|mesh-list
83312372|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83312373|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83312374|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312375|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83312376|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
83312377|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312378|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312379|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312380|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312381|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
83312382|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312383|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
83312384|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312385|NCT00053014|Cyclosporine|cyclosporine|mesh-list
83312386|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
83312387|NCT00053014|Fludarabine|fludarabine|mesh-list
83312388|NCT00053014|Cyclosporins|cyclosporins|mesh-list
83312389|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312390|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312391|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312392|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
83312393|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312394|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312395|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
83312396|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312397|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
83312398|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312399|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83312400|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83312401|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83312402|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
83312403|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312404|NCT00123604|Metoprolol|metoprolol|mesh-list
83312405|NCT00123604|Carvedilol|carvedilol|mesh-list
83312406|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83312407|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83312408|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
83312409|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
83312410|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312411|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312412|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83312413|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83312414|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83312415|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
83312416|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312417|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312418|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
83312419|NCT00123604|Protective Agents|protective agents|mesh-ancestor
83312420|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83312421|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83312422|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83312423|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
83312424|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83312425|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83312426|NCT00221338|Gabapentin|gabapentin|mesh-list
83312427|NCT00221338|Analgesics|analgesics|mesh-ancestor
83312428|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
83312429|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312430|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312431|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
83312432|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83312433|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83312434|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312435|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83312436|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83312437|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83312438|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312439|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312440|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
83312441|NCT00223678|Sirolimus|sirolimus|mesh-list
83312442|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312443|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312444|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83312445|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312446|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
83312447|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312448|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
83312449|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312450|NCT00053482|Vaccines|vaccines|mesh-list
83312451|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
83312452|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312453|NCT00130780|Bevacizumab|bevacizumab|mesh-list
83312454|NCT00130780|Docetaxel|docetaxel|mesh-list
83312455|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312456|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312457|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83312458|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83312459|NCT00130780|Growth Substances|growth substances|mesh-ancestor
83312460|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312461|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
83312462|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312463|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312464|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312465|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312466|NCT00225784|Gemcitabine|gemcitabine|mesh-list
83312467|NCT00225784|Cetuximab|cetuximab|mesh-list
83312468|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312469|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
83312470|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312471|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312472|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312473|NCT02092168|Opicapone|opicapone|mesh-list
83312474|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83312475|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312476|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312477|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83312478|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83312479|NCT00133978|Selenium|selenium|mesh-list
83312480|NCT00133978|Antioxidants|antioxidants|mesh-list
83312481|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312482|NCT00133978|Protective Agents|protective agents|mesh-ancestor
83312483|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312484|NCT00133978|Trace Elements|trace elements|mesh-ancestor
83312485|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
83312486|NCT01897324|Hormones|hormones|mesh-list
83312487|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312488|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312489|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
83312490|NCT00254410|Rituximab|rituximab|mesh-list
83312491|NCT00254410|Fludarabine|fludarabine|mesh-list
83312492|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
83312493|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312494|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
83312495|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312496|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312497|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83312498|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
83312499|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312500|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312501|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83312502|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312503|NCT00254410|Analgesics|analgesics|mesh-ancestor
83312504|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
83312505|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312506|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83312507|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83312508|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312509|NCT00254488|Valproic Acid|valproic acid|mesh-list
83312510|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83312511|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312512|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312513|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
83312514|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83312515|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312516|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312517|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
83312518|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
83312519|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312520|NCT01899118|Capecitabine|capecitabine|mesh-list
83312521|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
83312522|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
83312523|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312524|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
83312525|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312526|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312527|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312528|NCT00231868|Paclitaxel|paclitaxel|mesh-list
83312529|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83312530|NCT00231868|Carboplatin|carboplatin|mesh-list
83312531|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83312532|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312533|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312534|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312535|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312536|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312537|NCT00257686|Pravastatin|pravastatin|mesh-list
83312538|NCT00257686|Pitavastatin|pitavastatin|mesh-list
83312539|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83312540|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83312541|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
83312542|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312543|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83312544|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83312545|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312546|NCT01469013|Methotrexate|methotrexate|mesh-list
83312547|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83312548|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
83312549|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83312550|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312551|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312552|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
83312553|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312554|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312555|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
83312556|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312557|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83312559|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
83312560|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312561|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83312562|NCT01493427|Travoprost|travoprost|mesh-list
83312563|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83312564|NCT01523457|Folfirinox|folfirinox|mesh-list
83312565|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312566|NCT01523301|Rotigotine|rotigotine|mesh-list
83312567|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
83312568|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
83312569|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312570|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312571|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312572|NCT01766336|Inositol|inositol|mesh-list
83312573|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
83312574|NCT01766336|Vitamins|vitamins|mesh-ancestor
83312575|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
83312576|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312577|NCT01797302|Vitamin D|vitamin d|mesh-list
83312578|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
83312579|NCT01797302|Vitamins|vitamins|mesh-ancestor
83312580|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
83312581|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312582|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83312583|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83312584|NCT01804946|Oseltamivir|oseltamivir|mesh-list
83312585|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
83312586|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312587|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312588|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312589|NCT01795898|Fentanyl|fentanyl|mesh-list
83312590|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83312591|NCT01795898|Narcotics|narcotics|mesh-ancestor
83312592|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312593|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312595|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
83312596|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312597|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83312598|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83312599|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
83312600|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
83312601|NCT01736696|Tofacitinib|tofacitinib|mesh-list
83312602|NCT01736696|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83312603|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83312604|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312605|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312606|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
83312607|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312608|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83312609|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83312610|NCT01764464|Gabapentin|gabapentin|mesh-list
83312611|NCT01764464|Analgesics|analgesics|mesh-ancestor
83312612|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
83312613|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312614|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312615|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
83312616|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83312617|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83312618|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312619|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83312620|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83312621|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83312622|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312623|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312624|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
83312625|NCT01763918|Evolocumab|evolocumab|mesh-list
83312626|NCT01763918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83312627|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83312628|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83312629|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
83312630|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312631|NCT01763918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83312632|NCT01763918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83312633|NCT01763918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312634|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83312635|NCT01606748|Gemcitabine|gemcitabine|mesh-list
83312636|NCT01606748|Necitumumab|necitumumab|mesh-list
83312637|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312638|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312639|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
83312640|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312641|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312642|NCT01597622|Belimumab|belimumab|mesh-list
83312643|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312644|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
83312645|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312646|NCT01761266|Sorafenib|sorafenib|mesh-list
83312647|NCT01761266|Lenvatinib|lenvatinib|mesh-list
83312648|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312649|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83312650|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312651|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312652|NCT01759862|Aminophylline|aminophylline|mesh-list
83312653|NCT01759862|Theophylline|theophylline|mesh-list
83312654|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83312655|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
83312656|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312657|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312658|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83312659|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
83312660|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83312661|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312662|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312663|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
83312664|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83312665|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83312666|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
83312667|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312668|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83312669|NCT01759862|Protective Agents|protective agents|mesh-ancestor
83312670|NCT01790828|Factor VIII|factor viii|mesh-list
83312671|NCT01790828|Coagulants|coagulants|mesh-ancestor
83312672|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
83312673|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
83312674|NCT01790594|Abatacept|abatacept|mesh-list
83312675|NCT01790594|Tacrolimus|tacrolimus|mesh-list
83312676|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
83312677|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83312678|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312679|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
83312680|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312681|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83312682|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312683|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312684|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83312685|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312686|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83312687|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
83312688|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312689|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312690|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312691|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
83312692|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
83312693|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312694|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83312695|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
83312696|NCT01790594|Hormones|hormones|mesh-ancestor
83312697|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312698|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83312699|NCT01790594|Protective Agents|protective agents|mesh-ancestor
83312700|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83312701|NCT01790594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312702|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312703|NCT01790516|Cetuximab|cetuximab|mesh-list
83312704|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312705|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312706|NCT01790438|Insulin|insulin|mesh-list
83312707|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83312708|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
83312709|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
83312710|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
83312711|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83312712|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312713|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83312714|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83312715|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312716|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83312717|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312718|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
83312719|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83312720|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
83312721|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83312722|NCT01734902|Scopolamine|scopolamine|mesh-list
83312723|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83312724|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83312725|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
83312726|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
83312727|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312728|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312729|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83312730|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
83312731|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83312732|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
83312733|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312734|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312735|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83312736|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
83312737|NCT01789970|Hydrocodone|hydrocodone|mesh-list
83312738|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83312739|NCT01789970|Narcotics|narcotics|mesh-ancestor
83312740|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312741|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312742|NCT01789970|Analgesics|analgesics|mesh-ancestor
83312743|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
83312744|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312746|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
83312747|NCT01788566|Gemcitabine|gemcitabine|mesh-list
83312748|NCT01788566|Necitumumab|necitumumab|mesh-list
83312749|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312750|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312751|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
83312752|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312753|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312754|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83312755|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
83312756|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83312757|NCT01732796|Ribavirin|ribavirin|mesh-list
83312758|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
83312759|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312760|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
83312761|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312762|NCT01732640|Paclitaxel|paclitaxel|mesh-list
83312763|NCT01732640|Cisplatin|cisplatin|mesh-list
83312764|NCT01732640|Carboplatin|carboplatin|mesh-list
83312765|NCT01732640|Afatinib|afatinib|mesh-list
83312766|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83312767|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312768|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312769|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312770|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312771|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312772|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83312773|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312774|NCT04560686|Atezolizumab|atezolizumab|mesh-list
83312775|NCT04560686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83312776|NCT04560686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312777|NCT04560686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312778|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312779|NCT01757288|Paclitaxel|paclitaxel|mesh-list
83312780|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83312781|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83312782|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312783|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312784|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312785|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312786|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312787|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83312788|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
83312789|NCT01731938|Coagulants|coagulants|mesh-ancestor
83312790|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83312791|NCT01731002|Latanoprost|latanoprost|mesh-list
83312792|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83312793|NCT01783886|Aflibercept|aflibercept|mesh-list
83312794|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83312795|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83312796|NCT01783886|Growth Substances|growth substances|mesh-ancestor
83312797|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312798|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
83312799|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312800|NCT01609556|Maytansine|maytansine|mesh-list
83312801|NCT01609556|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83312802|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83312803|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312804|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312805|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312806|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312807|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312808|NCT01609556|Immunoconjugates|immunoconjugates|mesh-ancestor
83312809|NCT01609556|Immunologic Factors|immunologic factors|mesh-ancestor
83312810|NCT01609556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312811|NCT00234832|Sibutramine|sibutramine|mesh-list
83312812|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
83312813|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83312814|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
83312815|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83312816|NCT00259090|Fulvestrant|fulvestrant|mesh-list
83312817|NCT00259090|Anastrozole|anastrozole|mesh-list
83312818|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83312819|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312820|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83312821|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83312822|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
83312823|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312824|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312825|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83312826|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83312827|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312828|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312829|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
83312830|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83312831|NCT00236938|Hematinics|hematinics|mesh-ancestor
83312832|NCT01898728|Iodine|iodine|mesh-list
83312833|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
83312834|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
83312835|NCT01898728|Povidone|povidone|mesh-list
83312836|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83312837|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83312838|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83312839|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312840|NCT01898728|Trace Elements|trace elements|mesh-ancestor
83312841|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
83312842|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312843|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
83312844|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
83312845|NCT00260962|Olanzapine|olanzapine|mesh-list
83312846|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
83312847|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
83312848|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83312849|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312850|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83312851|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83312852|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83312853|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312854|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83312855|NCT00260962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83312856|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83312857|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83312858|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312859|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312860|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
83312861|NCT00237718|Vitamin E|vitamin e|mesh-list
83312862|NCT00237718|Tocopherols|tocopherols|mesh-list
83312863|NCT00237718|Tocotrienols|tocotrienols|mesh-list
83312864|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
83312865|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
83312866|NCT00237718|Vitamins|vitamins|mesh-ancestor
83312867|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
83312868|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312869|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
83312870|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312871|NCT00237718|Protective Agents|protective agents|mesh-ancestor
83312872|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
83312873|NCT00238108|Melatonin|melatonin|mesh-list
83312874|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
83312875|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312876|NCT00238108|Protective Agents|protective agents|mesh-ancestor
83312877|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312878|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312879|NCT00266110|Trastuzumab|trastuzumab|mesh-list
83312880|NCT00266110|Vinorelbine|vinorelbine|mesh-list
83312881|NCT00266110|Sargramostim|sargramostim|mesh-list
83312882|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83312883|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312884|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83312885|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312886|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312887|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312888|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312889|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
83312890|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312891|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
83312892|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83312893|NCT00240526|Antibodies|antibodies|mesh-list
83312894|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
83312895|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312897|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83312898|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83312899|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
83312900|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312901|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312902|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312903|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83312904|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83312905|NCT01899430|Metformin|metformin|mesh-list
83312906|NCT01899430|Liraglutide|liraglutide|mesh-list
83312907|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83312908|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312909|NCT01899430|Incretins|incretins|mesh-ancestor
83312910|NCT01899430|Hormones|hormones|mesh-ancestor
83312911|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83312912|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
83312913|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83312914|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312915|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312916|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83312917|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83312918|NCT00267670|Protective Agents|protective agents|mesh-ancestor
83312919|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312920|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
83312921|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83312922|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
83312923|NCT00247624|Eszopiclone|eszopiclone|mesh-list
83312924|NCT00247624|Fluoxetine|fluoxetine|mesh-list
83312925|NCT00247624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83312926|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83312927|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83312928|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312929|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83312930|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
83312931|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312932|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83312933|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
83312934|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83312935|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83312936|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83312937|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312938|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83312939|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83312940|NCT00248560|Gemcitabine|gemcitabine|mesh-list
83312941|NCT00248560|Docetaxel|docetaxel|mesh-list
83312942|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83312943|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
83312944|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312945|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312946|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
83312947|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
83312948|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
83312949|NCT00268762|Argatroban|argatroban|mesh-list
83312950|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
83312951|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83312952|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
83312953|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312954|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312955|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
83312956|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83312957|NCT00270634|Tacrolimus|tacrolimus|mesh-list
83312958|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83312959|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
83312960|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312961|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83312962|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312963|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312964|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
83312965|NCT04110340|Gentamicins|gentamicins|mesh-list
83312966|NCT04110340|Streptomycin|streptomycin|mesh-list
83312967|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83312968|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83312969|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83312970|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83312971|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83312972|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83312973|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312974|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83312975|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83312976|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83312977|NCT00270790|Carboplatin|carboplatin|mesh-list
83312978|NCT00270790|Amifostine|amifostine|mesh-list
83312979|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83312980|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83312981|NCT00270790|Protective Agents|protective agents|mesh-ancestor
83312982|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312983|NCT00271570|Infliximab|infliximab|mesh-list
83312984|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
83312985|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83312986|NCT00271570|Antibodies|antibodies|mesh-list
83312987|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
83312988|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83312989|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
83312990|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83312991|NCT00271570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83312992|NCT00271570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83312993|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
83312994|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83312995|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83312996|NCT05237596|Acetaminophen|acetaminophen|mesh-list
83312997|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83312998|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83312999|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83313000|NCT05237596|Analgesics|analgesics|mesh-ancestor
83313001|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
83313002|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313003|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313004|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
83313005|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313006|NCT02102932|Metformin|metformin|mesh-list
83313007|NCT02102932|Empagliflozin|empagliflozin|mesh-list
83313008|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83313009|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313010|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83313011|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313012|NCT00273754|Caffeine|caffeine|mesh-list
83313013|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83313014|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313015|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83313016|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313017|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313018|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83313019|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83313020|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
83313021|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313022|NCT04751344|Bupivacaine|bupivacaine|mesh-list
83313023|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
83313024|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
83313025|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313026|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313027|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
83313028|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313029|NCT05211232|Tislelizumab|tislelizumab|mesh-list
83313030|NCT05211232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313031|NCT05211232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313032|NCT00273910|Imiquimod|imiquimod|mesh-list
83313033|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83313034|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83313035|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
83313036|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313037|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313038|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
83313039|NCT00274768|Capecitabine|capecitabine|mesh-list
83313040|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83313041|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
83313042|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313043|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313044|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83313045|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
83313046|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83313047|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83313048|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83313049|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313050|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313051|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
83313052|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313053|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313054|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83313055|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313056|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83313057|NCT01763996|Febuxostat|febuxostat|mesh-list
83313058|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
83313059|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313060|NCT01790464|Lidocaine|lidocaine|mesh-list
83313061|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
83313062|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
83313063|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313064|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313065|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
83313066|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313067|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83313068|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83313069|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83313070|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313071|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313073|NCT01790542|Trace Elements|trace elements|mesh-ancestor
83313074|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
83313075|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313076|NCT01899820|Lumefantrine|lumefantrine|mesh-list
83313077|NCT01899820|Artemether|artemether|mesh-list
83313078|NCT01899820|Piperaquine|piperaquine|mesh-list
83313079|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83313080|NCT01899820|Artenimol|artenimol|mesh-list
83313081|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
83313082|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83313083|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83313084|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313085|NCT02100748|Morphine|morphine|mesh-list
83313086|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83313087|NCT02100748|Narcotics|narcotics|mesh-ancestor
83313088|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313089|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313090|NCT02100748|Analgesics|analgesics|mesh-ancestor
83313091|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
83313092|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313093|NCT00283504|Omalizumab|omalizumab|mesh-list
83313094|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83313095|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83313096|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
83313097|NCT00283816|Metformin|metformin|mesh-list
83313098|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
83313099|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
83313100|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83313101|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83313102|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313103|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313104|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83313105|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
83313106|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83313107|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83313108|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83313109|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313110|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313111|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
83313112|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313113|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313114|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83313115|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313116|NCT04339426|Azithromycin|azithromycin|mesh-list
83313117|NCT04339426|Atovaquone|atovaquone|mesh-list
83313118|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313119|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313120|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
83313121|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83313122|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83313123|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313124|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313125|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
83313126|NCT00287716|Pirfenidone|pirfenidone|mesh-list
83313127|NCT00287716|Analgesics|analgesics|mesh-ancestor
83313128|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
83313129|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313130|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313131|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83313132|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83313133|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313134|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313135|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313137|NCT00287872|Bortezomib|bortezomib|mesh-list
83313138|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313139|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83313140|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
83313141|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313142|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
83313143|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313144|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313145|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83313146|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83313147|NCT00287872|Growth Substances|growth substances|mesh-ancestor
83313148|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
83313149|NCT00288574|Fluoxetine|fluoxetine|mesh-list
83313150|NCT00288574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83313151|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83313152|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313153|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313154|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313155|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
83313156|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313157|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83313158|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
83313159|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83313160|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83313161|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83313162|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313163|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83313164|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83313165|NCT04079218|Estradiol|estradiol|mesh-list
83313166|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83313167|NCT04079218|Estrogens|estrogens|mesh-ancestor
83313168|NCT04079218|Hormones|hormones|mesh-ancestor
83313169|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313170|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313171|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83313172|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
83313173|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313174|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83313175|NCT04061590|Cisplatin|cisplatin|mesh-list
83313176|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
83313177|NCT04061590|Pemetrexed|pemetrexed|mesh-list
83313178|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313179|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313180|NCT04061590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83313181|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313182|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313183|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83313184|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83313185|NCT01791088|Sirolimus|sirolimus|mesh-list
83313186|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313187|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313188|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83313189|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313190|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
83313191|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83313192|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
83313193|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313194|NCT00291226|Glycine|glycine|mesh-list
83313195|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
83313196|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313197|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313198|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313199|NCT01791166|Antibodies|antibodies|mesh-list
83313200|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
83313201|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313202|NCT00291694|Celecoxib|celecoxib|mesh-list
83313203|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83313204|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83313206|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
83313207|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313208|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313209|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313210|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313211|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83313212|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83313213|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313214|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313215|NCT00292162|Metoprolol|metoprolol|mesh-list
83313216|NCT00292162|Carvedilol|carvedilol|mesh-list
83313217|NCT00292162|Ramipril|ramipril|mesh-list
83313218|NCT00292162|Enalapril|enalapril|mesh-list
83313219|NCT00292162|Lisinopril|lisinopril|mesh-list
83313220|NCT00292162|Bisoprolol|bisoprolol|mesh-list
83313221|NCT00292162|Perindopril|perindopril|mesh-list
83313222|NCT00292162|Captopril|captopril|mesh-list
83313223|NCT00292162|Spironolactone|spironolactone|mesh-list
83313224|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83313225|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83313226|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83313227|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83313228|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83313229|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
83313230|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
83313231|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313232|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313233|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83313234|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83313235|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
83313236|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313237|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313238|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
83313239|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313240|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83313241|NCT00292162|Diuretics|diuretics|mesh-ancestor
83313242|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
83313243|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
83313244|NCT00292162|Protective Agents|protective agents|mesh-ancestor
83313245|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83313246|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313247|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83313248|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
83313249|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83313250|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83313251|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
83313252|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313253|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83313254|NCT00296296|Cyclosporine|cyclosporine|mesh-list
83313255|NCT00296296|Tacrolimus|tacrolimus|mesh-list
83313256|NCT00296296|Cyclosporins|cyclosporins|mesh-list
83313257|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83313258|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
83313259|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313260|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83313261|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313262|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313263|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
83313264|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313265|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
83313266|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313267|NCT01791400|Sumatriptan|sumatriptan|mesh-list
83313268|NCT01791400|Metoclopramide|metoclopramide|mesh-list
83313269|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
83313270|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
83313271|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313272|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313273|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83313274|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83313275|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83313276|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
83313277|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313278|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313279|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83313280|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83313281|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83313282|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
83313283|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
83313284|NCT00300430|Atorvastatin|atorvastatin|mesh-list
83313285|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83313286|NCT00300430|Simvastatin|simvastatin|mesh-list
83313287|NCT00300430|Fenofibrate|fenofibrate|mesh-list
83313289|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83313290|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313291|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83313292|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83313293|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83313294|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
83313295|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313296|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83313297|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83313298|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313299|NCT02104414|Epinephrine|epinephrine|mesh-list
83313300|NCT02104414|Bupivacaine|bupivacaine|mesh-list
83313301|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
83313302|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
83313303|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313304|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313305|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
83313306|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313307|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83313308|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83313309|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
83313310|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313311|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313312|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83313313|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83313314|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
83313315|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83313316|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
83313317|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
83313318|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
83313319|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83313320|NCT02100826|Cephalexin|cephalexin|mesh-list
83313321|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313322|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313323|NCT03587272|Sirolimus|sirolimus|mesh-list
83313324|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
83313325|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313326|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313327|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83313328|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313329|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
83313330|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83313331|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
83313332|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313333|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313334|NCT02101918|Aflibercept|aflibercept|mesh-list
83313335|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
83313336|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83313337|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83313338|NCT02101918|Growth Substances|growth substances|mesh-ancestor
83313339|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313340|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
83313341|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313342|NCT00300742|Topiramate|topiramate|mesh-list
83313343|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
83313344|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83313345|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313346|NCT00301756|Belinostat|belinostat|mesh-list
83313348|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83313349|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313350|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313352|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
83313353|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83313354|NCT00302068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83313355|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83313356|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313357|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313358|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313359|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
83313360|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313361|NCT00302848|Drospirenone|drospirenone|mesh-list
83313362|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
83313363|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
83313364|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
83313365|NCT00302848|Progestins|progestins|mesh-list
83313366|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83313367|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313368|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313369|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83313370|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83313371|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83313372|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
83313373|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313374|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83313375|NCT00302848|Diuretics|diuretics|mesh-ancestor
83313376|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
83313377|NCT00302848|Hormones|hormones|mesh-ancestor
83313378|NCT00303862|Cediranib|cediranib|mesh-list
83313379|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313380|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313381|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313382|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83313383|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83313384|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83313385|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
83313386|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313387|NCT05267392|Durvalumab|durvalumab|mesh-list
83313388|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313389|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313390|NCT00142168|Rituximab|rituximab|mesh-list
83313391|NCT00142168|Lenalidomide|lenalidomide|mesh-list
83313392|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313393|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313394|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
83313395|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313396|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313397|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83313398|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83313399|NCT00142168|Growth Substances|growth substances|mesh-ancestor
83313400|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
83313401|NCT02501434|Heparin|heparin|mesh-list
83313402|NCT02501434|Calcium heparin|calcium heparin|mesh-list
83313403|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
83313404|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83313405|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83313406|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313407|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83313408|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83313409|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83313410|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313411|NCT00148798|Cisplatin|cisplatin|mesh-list
83313412|NCT00148798|Cetuximab|cetuximab|mesh-list
83313413|NCT00148798|Vinorelbine|vinorelbine|mesh-list
83313414|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313415|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313416|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83313417|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
83313418|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
83313419|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
83313420|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313421|NCT00149734|Ondansetron|ondansetron|mesh-list
83313422|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
83313423|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
83313424|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313425|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313426|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83313427|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
83313428|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
83313429|NCT00149734|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83313430|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83313431|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
83313432|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313433|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313434|NCT00198328|Bleomycin|bleomycin|mesh-list
83313435|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83313436|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313437|NCT00305578|Memantine|memantine|mesh-list
83313438|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83313439|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83313440|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
83313441|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313442|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313443|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313444|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83313445|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83313446|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
83313447|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313448|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83313449|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83313450|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313451|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313452|NCT01468311|Daclizumab|daclizumab|mesh-list
83313453|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83313454|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
83313455|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313456|NCT00306202|Dasatinib|dasatinib|mesh-list
83313457|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313458|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83313459|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313460|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313461|NCT00325078|Infliximab|infliximab|mesh-list
83313462|NCT00325078|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83313463|NCT00325078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313464|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
83313465|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83313466|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313467|NCT00325780|Pitavastatin|pitavastatin|mesh-list
83313468|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83313469|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83313470|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83313471|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
83313472|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313473|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313474|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83313475|NCT00326170|Azacitidine|azacitidine|mesh-list
83313476|NCT00326170|Tretinoin|tretinoin|mesh-list
83313477|NCT00326170|Valproic Acid|valproic acid|mesh-list
83313478|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83313479|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
83313480|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313481|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313482|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313483|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
83313484|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
83313485|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
83313486|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
83313487|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313488|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313489|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
83313490|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83313491|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313492|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83313493|NCT00326872|Cediranib|cediranib|mesh-list
83313494|NCT00326872|Maleic acid|maleic acid|mesh-list
83313495|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313496|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313497|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313498|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83313500|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
83313501|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
83313502|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
83313503|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
83313504|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83313505|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313506|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83313507|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313508|NCT05266534|Terlipressin|terlipressin|mesh-list
83313509|NCT05266534|Carbetocin|carbetocin|mesh-list
83313510|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83313511|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83313512|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
83313513|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313514|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313515|NCT01730378|Vaccines|vaccines|mesh-list
83313516|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
83313517|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313518|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
83313519|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83313520|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
83313521|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313522|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83313523|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313524|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313525|NCT01790308|Liraglutide|liraglutide|mesh-list
83313526|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83313527|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313528|NCT01790308|Incretins|incretins|mesh-ancestor
83313529|NCT01790308|Hormones|hormones|mesh-ancestor
83313530|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313531|NCT01609010|Interferons|interferons|mesh-list
83313532|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
83313533|NCT01609010|Rituximab|rituximab|mesh-list
83313534|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313535|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313536|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
83313537|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313538|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313539|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
83313540|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313541|NCT01608308|Acetaminophen|acetaminophen|mesh-list
83313542|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83313543|NCT01608308|Analgesics|analgesics|mesh-ancestor
83313544|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
83313545|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313546|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313547|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
83313548|NCT00332644|Bupropion|bupropion|mesh-list
83313549|NCT00332644|Nicotine|nicotine|mesh-list
83313550|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83313551|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
83313552|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313553|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313554|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83313555|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83313556|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
83313557|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313558|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313559|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83313560|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
83313561|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83313562|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83313563|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83313564|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313565|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
83313566|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83313567|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83313568|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313569|NCT01755416|Insulin|insulin|mesh-list
83313570|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83313571|NCT01755416|Liraglutide|liraglutide|mesh-list
83313572|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83313573|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313574|NCT01755416|Incretins|incretins|mesh-ancestor
83313576|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313577|NCT01755026|Cefazolin|cefazolin|mesh-list
83313578|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313579|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313580|NCT00333814|Dexamethasone|dexamethasone|mesh-list
83313581|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
83313582|NCT00333814|BB 1101|bb 1101|mesh-list
83313583|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313584|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
83313585|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
83313586|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313587|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313588|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83313589|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
83313590|NCT00333814|Hormones|hormones|mesh-ancestor
83313591|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313592|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83313593|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313594|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
83313595|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313596|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313597|NCT01728584|Bromides|bromides|mesh-list
83313598|NCT01728584|Rocuronium|rocuronium|mesh-list
83313599|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
83313600|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83313601|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83313602|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83313603|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313604|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313605|NCT00315328|Atropine|atropine|mesh-list
83313606|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83313607|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83313608|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83313609|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
83313610|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313611|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313612|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83313613|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
83313614|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
83313615|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
83313616|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83313617|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83313618|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
83313619|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313620|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313621|NCT01522443|Prednisone|prednisone|mesh-list
83313622|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
83313623|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313624|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
83313625|NCT01522443|Hormones|hormones|mesh-ancestor
83313626|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313627|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313628|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83313629|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313630|NCT01522443|Analgesics|analgesics|mesh-ancestor
83313631|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
83313632|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313633|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83313634|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83313635|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313636|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313637|NCT00336232|Vitamin K|vitamin k|mesh-list
83313638|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
83313639|NCT00336232|Vitamins|vitamins|mesh-ancestor
83313640|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
83313641|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313642|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83313643|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83313644|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313645|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
83313646|NCT00336232|Coagulants|coagulants|mesh-ancestor
83313647|NCT00336700|Gemcitabine|gemcitabine|mesh-list
83313648|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83313649|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83313650|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
83313651|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313652|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313653|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83313654|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313655|NCT01468233|Adalimumab|adalimumab|mesh-list
83313656|NCT01468233|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83313657|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313658|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313659|NCT01754402|Dexamethasone|dexamethasone|mesh-list
83313660|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83313661|NCT01754402|Pomalidomide|pomalidomide|mesh-list
83313662|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313663|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
83313664|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
83313665|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313666|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313667|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83313668|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
83313669|NCT01754402|Hormones|hormones|mesh-ancestor
83313670|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313671|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83313672|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313673|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83313674|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
83313675|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313676|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
83313677|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83313678|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83313679|NCT01754402|Growth Substances|growth substances|mesh-ancestor
83313680|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
83313681|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83313682|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
83313683|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313684|NCT01782872|Ropivacaine|ropivacaine|mesh-list
83313685|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
83313686|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
83313687|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313688|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313689|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
83313690|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313691|NCT01490697|Cycloserine|cycloserine|mesh-list
83313692|NCT01490697|Mifepristone|mifepristone|mesh-list
83313693|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83313694|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
83313695|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313696|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313697|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83313698|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83313699|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83313700|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
83313701|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83313702|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83313703|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
83313704|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313705|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
83313706|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83313707|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83313708|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83313709|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313710|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83313711|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
83313712|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313713|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
83313714|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313715|NCT01728194|Escitalopram|escitalopram|mesh-list
83313716|NCT01728194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83313717|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83313718|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313719|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313720|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313721|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
83313722|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313723|NCT04408911|Midazolam|midazolam|mesh-list
83313724|NCT04408911|Lormetazepam|lormetazepam|mesh-list
83313725|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83313726|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83313727|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313728|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313729|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83313730|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83313731|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83313732|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83313733|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
83313734|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
83313735|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
83313736|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
83313737|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313738|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313739|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
83313740|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83313741|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83313742|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83313743|NCT01466673|Desogestrel|desogestrel|mesh-list
83313744|NCT01466673|Norgestimate|norgestimate|mesh-list
83313745|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83313746|NCT01466673|Estradiol|estradiol|mesh-list
83313747|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83313748|NCT01466673|Estrogens|estrogens|mesh-ancestor
83313749|NCT01466673|Hormones|hormones|mesh-ancestor
83313750|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313751|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313752|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83313753|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
83313754|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313755|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83313756|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83313757|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83313758|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83313759|NCT01466673|Progestins|progestins|mesh-ancestor
83313760|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313761|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313762|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83313763|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83313764|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313765|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313766|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313767|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83313768|NCT01753856|Vitamin D|vitamin d|mesh-list
83313769|NCT01753856|Denosumab|denosumab|mesh-list
83313770|NCT01753856|Teriparatide|teriparatide|mesh-list
83313771|NCT01753856|Tetracycline|tetracycline|mesh-list
83313772|NCT01753856|Demeclocycline|demeclocycline|mesh-list
83313773|NCT01753856|Calcium|calcium|mesh-list
83313774|NCT01753856|Vitamins|vitamins|mesh-ancestor
83313775|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
83313776|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313777|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83313778|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83313779|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313780|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313781|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83313782|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313783|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313784|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
83313785|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83313786|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83313787|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83313788|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313789|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313790|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
83313791|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313792|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313793|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83313794|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313796|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83313797|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313798|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313799|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
83313800|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313801|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313802|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
83313803|NCT01466595|Rifaximin|rifaximin|mesh-list
83313804|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83313805|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313806|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83313807|NCT02073747|Albuterol|albuterol|mesh-list
83313808|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83313809|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
83313810|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313811|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313812|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83313813|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
83313814|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
83313815|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313816|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83313817|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83313818|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83313819|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
83313820|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313821|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313822|NCT01465659|Temozolomide|temozolomide|mesh-list
83313823|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83313824|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
83313825|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313826|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313827|NCT01462929|Bromides|bromides|mesh-list
83313828|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
83313829|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83313830|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
83313831|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313832|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313833|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83313834|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
83313835|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
83313836|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83313837|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
83313838|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313839|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313841|NCT01462695|Sunitinib|sunitinib|mesh-list
83313842|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313843|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83313844|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83313845|NCT01462695|Growth Substances|growth substances|mesh-ancestor
83313846|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313847|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
83313848|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83313849|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313850|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313851|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
83313852|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
83313853|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313854|NCT01465347|Protective Agents|protective agents|mesh-ancestor
83313855|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313856|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83313857|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313858|NCT01465191|Morphine|morphine|mesh-list
83313859|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83313860|NCT01465191|Narcotics|narcotics|mesh-ancestor
83313861|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313862|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313863|NCT01465191|Analgesics|analgesics|mesh-ancestor
83313864|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
83313865|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313866|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
83313867|NCT01519947|Hematinics|hematinics|mesh-ancestor
83313868|NCT01462227|Naltrexone|naltrexone|mesh-list
83313870|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83313871|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313872|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
83313873|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313874|NCT01464879|Testosterone|testosterone|mesh-list
83313875|NCT01464879|Androgens|androgens|mesh-ancestor
83313876|NCT01464879|Hormones|hormones|mesh-ancestor
83313877|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83313878|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313879|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
83313880|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83313881|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313882|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
83313883|NCT01519791|Methotrexate|methotrexate|mesh-list
83313884|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83313885|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
83313886|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83313887|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313888|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83313889|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
83313890|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313891|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313892|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
83313893|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313894|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83313895|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83313896|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
83313897|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313898|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83313899|NCT01519791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83313900|NCT01519791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313901|NCT01439373|Interferons|interferons|mesh-list
83313902|NCT01439373|Ribavirin|ribavirin|mesh-list
83313903|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
83313904|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
83313905|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83313906|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313907|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
83313908|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83313909|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
83313910|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313911|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
83313912|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313913|NCT01461369|Diclofenac|diclofenac|mesh-list
83313914|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83313915|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83313916|NCT01461369|Analgesics|analgesics|mesh-ancestor
83313917|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
83313918|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313919|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313920|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83313921|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83313922|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83313923|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313924|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313925|NCT01727258|Fluorides|fluorides|mesh-list
83313926|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
83313927|NCT01727258|Protective Agents|protective agents|mesh-ancestor
83313928|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313929|NCT01781234|Insulin|insulin|mesh-list
83313930|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83313931|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313932|NCT01752842|Fenofibrate|fenofibrate|mesh-list
83313933|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83313934|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
83313935|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313936|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83313937|NCT01461057|Capecitabine|capecitabine|mesh-list
83313938|NCT01461057|Trastuzumab|trastuzumab|mesh-list
83313939|NCT01461057|Pertuzumab|pertuzumab|mesh-list
83313940|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313941|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83313942|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
83313943|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313944|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83313946|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
83313947|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
83313948|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313949|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313950|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
83313951|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313952|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83313953|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83313954|NCT01519635|Diuretics|diuretics|mesh-ancestor
83313955|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
83313956|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313957|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83313958|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83313959|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313960|NCT01519323|Vemurafenib|vemurafenib|mesh-list
83313961|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83313962|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83313963|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83313964|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313965|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
83313966|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83313967|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83313968|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313969|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
83313970|NCT01519245|Coagulants|coagulants|mesh-ancestor
83313971|NCT01519167|Fentanyl|fentanyl|mesh-list
83313972|NCT01519167|Midazolam|midazolam|mesh-list
83313973|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
83313974|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83313975|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83313976|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83313977|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83313978|NCT01519167|Analgesics|analgesics|mesh-ancestor
83313979|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
83313980|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83313981|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83313982|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83313983|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83313984|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
83313985|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83313986|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83313987|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83313988|NCT01519167|Narcotics|narcotics|mesh-ancestor
83313989|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83313990|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83313991|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
83313992|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
83313993|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83313994|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83313995|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83313996|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
83313997|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
83313998|NCT00318136|Paclitaxel|paclitaxel|mesh-list
83313999|NCT00318136|Bevacizumab|bevacizumab|mesh-list
83314000|NCT00318136|Carboplatin|carboplatin|mesh-list
83314001|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314002|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314003|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314004|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314005|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314006|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314007|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314008|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314009|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314010|NCT00318136|Growth Substances|growth substances|mesh-ancestor
83314011|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314012|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314013|NCT00318292|Epinephrine|epinephrine|mesh-list
83314014|NCT00318292|Bupivacaine|bupivacaine|mesh-list
83314015|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
83314016|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
83314017|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314018|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314019|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
83314020|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314021|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83314022|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83314023|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
83314024|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314025|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314026|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83314027|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83314029|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83314030|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
83314031|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
83314032|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
83314033|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83314034|NCT01791868|Valproic Acid|valproic acid|mesh-list
83314035|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
83314036|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314037|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314038|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
83314039|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314040|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314041|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
83314042|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83314043|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314044|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83314045|NCT03793114|Cosyntropin|cosyntropin|mesh-list
83314046|NCT03793114|Hormones|hormones|mesh-ancestor
83314047|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314048|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314049|NCT00348946|Androgens|androgens|mesh-list
83314050|NCT00348946|Oxandrolone|oxandrolone|mesh-list
83314051|NCT00348946|Hormones|hormones|mesh-ancestor
83314052|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314053|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314054|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
83314055|NCT00349336|Bevacizumab|bevacizumab|mesh-list
83314056|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314057|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314058|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314059|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314060|NCT00349336|Growth Substances|growth substances|mesh-ancestor
83314061|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314062|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314063|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83314064|NCT04751188|Bezafibrate|bezafibrate|mesh-list
83314065|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83314066|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314067|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83314068|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
83314069|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314070|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83314071|NCT00352612|Clindamycin|clindamycin|mesh-list
83314072|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
83314073|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
83314074|NCT00352612|Cephalexin|cephalexin|mesh-list
83314075|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83314076|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314077|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83314078|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314079|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314080|NCT00323362|Gemcitabine|gemcitabine|mesh-list
83314081|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
83314082|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314083|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
83314084|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314085|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314086|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314087|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314088|NCT00390364|Everolimus|everolimus|mesh-list
83314089|NCT00390364|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83314090|NCT00390364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83314091|NCT00390364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314092|NCT00390364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314093|NCT00390364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314094|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314095|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
83314096|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314097|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314098|NCT00354640|Anastrozole|anastrozole|mesh-list
83314099|NCT00354640|Simvastatin|simvastatin|mesh-list
83314100|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83314101|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83314102|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
83314103|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314104|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83314105|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83314106|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314107|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83314108|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314109|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83314110|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83314111|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83314112|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
83314113|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314114|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314115|NCT00392392|Paclitaxel|paclitaxel|mesh-list
83314116|NCT00392392|Bevacizumab|bevacizumab|mesh-list
83314117|NCT00392392|Trastuzumab|trastuzumab|mesh-list
83314118|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314119|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314120|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314121|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314122|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314123|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314124|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314125|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314126|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314127|NCT00392392|Growth Substances|growth substances|mesh-ancestor
83314128|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314129|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314130|NCT01519089|Tofacitinib|tofacitinib|mesh-list
83314131|NCT01519089|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83314132|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314133|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314134|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314135|NCT00392704|Paclitaxel|paclitaxel|mesh-list
83314136|NCT00392704|Bevacizumab|bevacizumab|mesh-list
83314137|NCT00392704|Fluorouracil|fluorouracil|mesh-list
83314138|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83314139|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314140|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314141|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314142|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314143|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314144|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314145|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314146|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314147|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314148|NCT00392704|Growth Substances|growth substances|mesh-ancestor
83314149|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314150|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314151|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
83314152|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314153|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314154|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
83314155|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314156|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314157|NCT00392782|Fludarabine|fludarabine|mesh-list
83314158|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
83314159|NCT00392782|Thiotepa|thiotepa|mesh-list
83314160|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83314161|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314162|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314163|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
83314164|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314165|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314166|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
83314167|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314168|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83314169|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
83314170|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83314172|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83314173|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83314174|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314175|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83314176|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83314177|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314178|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314179|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314180|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83314181|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
83314182|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83314183|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314184|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83314185|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83314186|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83314187|NCT01518309|Pimavanserin|pimavanserin|mesh-list
83314188|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83314189|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83314190|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83314191|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83314192|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314193|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314194|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83314195|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83314196|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83314197|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
83314198|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314199|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314200|NCT01419717|Denosumab|denosumab|mesh-list
83314201|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83314202|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314203|NCT01458951|Tofacitinib|tofacitinib|mesh-list
83314204|NCT01458951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83314205|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314206|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314207|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314209|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83314210|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
83314211|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
83314212|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314213|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314214|NCT00393796|Sunitinib|sunitinib|mesh-list
83314215|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314216|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314217|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314218|NCT00393796|Growth Substances|growth substances|mesh-ancestor
83314219|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314220|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314221|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314222|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314223|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314224|NCT00393874|Prazosin|prazosin|mesh-list
83314225|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83314226|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83314227|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83314228|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83314229|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
83314230|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314231|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314232|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314233|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
83314234|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
83314235|NCT01458171|Antibodies|antibodies|mesh-list
83314236|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
83314237|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83314238|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83314239|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
83314240|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314241|NCT00395044|Gabapentin|gabapentin|mesh-list
83314242|NCT00395044|Analgesics|analgesics|mesh-ancestor
83314243|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
83314244|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314245|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314246|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
83314247|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83314248|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83314249|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314250|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83314251|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83314252|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83314253|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314254|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314255|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
83314256|NCT01457703|Letrozole|letrozole|mesh-list
83314257|NCT01457703|Cetrorelix|cetrorelix|mesh-list
83314258|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83314259|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314260|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83314261|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83314262|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314263|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314264|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83314265|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
83314266|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314267|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314268|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83314269|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
83314270|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83314271|NCT01457703|Hormones|hormones|mesh-ancestor
83314272|NCT02076321|Acetaminophen|acetaminophen|mesh-list
83314273|NCT02076321|Ibuprofen|ibuprofen|mesh-list
83314274|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83314275|NCT02076321|Analgesics|analgesics|mesh-ancestor
83314276|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
83314277|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314278|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314279|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
83314280|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83314281|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83314282|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314283|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83314284|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314285|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314286|NCT00358462|Azithromycin|azithromycin|mesh-list
83314287|NCT00358462|Doxycycline|doxycycline|mesh-list
83314288|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83314289|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314290|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
83314291|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83314292|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83314293|NCT01437267|Vaccines|vaccines|mesh-list
83314294|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83314295|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
83314296|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314297|NCT01437111|Vitamin D|vitamin d|mesh-list
83314298|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
83314299|NCT01437111|Alendronate|alendronate|mesh-list
83314300|NCT01437111|Vitamins|vitamins|mesh-ancestor
83314301|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
83314302|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314303|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83314304|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83314305|NCT04065555|Cetuximab|cetuximab|mesh-list
83314306|NCT04065555|Avelumab|avelumab|mesh-list
83314307|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83314308|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314309|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314310|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
83314311|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314312|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83314313|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83314314|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83314315|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83314316|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314317|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314318|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314319|NCT00360724|Analgesics|analgesics|mesh-ancestor
83314320|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
83314321|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314322|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
83314323|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83314324|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
83314325|NCT00398398|Capecitabine|capecitabine|mesh-list
83314326|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
83314327|NCT00398398|Cetuximab|cetuximab|mesh-list
83314328|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314329|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
83314330|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314331|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314332|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314333|NCT00398476|Fluticasone|fluticasone|mesh-list
83314334|NCT00398476|Xhance|xhance|mesh-list
83314335|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83314336|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83314337|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
83314338|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314339|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314340|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83314341|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
83314342|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
83314343|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83314344|NCT01436643|Fluoxetine|fluoxetine|mesh-list
83314345|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83314346|NCT01436643|Citalopram|citalopram|mesh-list
83314347|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83314348|NCT01436643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83314349|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83314350|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83314351|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314352|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314353|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
83314354|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314355|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83314356|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
83314357|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83314358|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83314359|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83314360|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314361|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83314362|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83314363|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314364|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
83314365|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
83314366|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
83314367|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83314368|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83314369|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314370|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314371|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314372|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314373|NCT00361972|Lansoprazole|lansoprazole|mesh-list
83314374|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
83314375|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83314376|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314377|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83314378|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314379|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314380|NCT00362440|Metformin|metformin|mesh-list
83314381|NCT00362440|Pioglitazone|pioglitazone|mesh-list
83314382|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83314383|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314384|NCT02109640|Oxycodone|oxycodone|mesh-list
83314385|NCT02109640|Naloxone|naloxone|mesh-list
83314386|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83314387|NCT02109640|Narcotics|narcotics|mesh-ancestor
83314388|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314389|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314390|NCT02109640|Analgesics|analgesics|mesh-ancestor
83314391|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
83314392|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314393|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83314394|NCT01454739|Factor VIII|factor viii|mesh-list
83314395|NCT01454739|Coagulants|coagulants|mesh-ancestor
83314396|NCT00366106|Dexamethasone|dexamethasone|mesh-list
83314397|NCT00366106|Doxorubicin|doxorubicin|mesh-list
83314398|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83314399|NCT00366106|Bortezomib|bortezomib|mesh-list
83314400|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83314401|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
83314402|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
83314403|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314404|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314405|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314406|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
83314407|NCT00366106|Hormones|hormones|mesh-ancestor
83314408|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314409|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83314410|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314411|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83314412|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83314413|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83314414|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314415|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314416|NCT00368290|Modafinil|modafinil|mesh-list
83314417|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83314418|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314419|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83314420|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83314421|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83314422|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314423|NCT00369226|Methotrexate|methotrexate|mesh-list
83314424|NCT00369226|Bortezomib|bortezomib|mesh-list
83314425|NCT00369226|Tacrolimus|tacrolimus|mesh-list
83314426|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83314427|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
83314428|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83314429|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314430|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314431|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
83314432|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314433|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314434|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
83314435|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314436|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83314437|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314438|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
83314439|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314440|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83314441|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83314442|NCT01416441|Aripiprazole|aripiprazole|mesh-list
83314443|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
83314444|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83314445|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83314446|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83314447|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314448|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314449|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
83314450|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
83314451|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314452|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314453|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83314454|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83314455|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
83314456|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83314457|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83314458|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83314459|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83314460|NCT00406276|Docetaxel|docetaxel|mesh-list
83314461|NCT00406276|Everolimus|everolimus|mesh-list
83314462|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314463|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314464|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314465|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314466|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314467|NCT00406276|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83314468|NCT00406276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314469|NCT00406276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314470|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314471|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
83314472|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314473|NCT00408070|Paclitaxel|paclitaxel|mesh-list
83314474|NCT00408070|Bevacizumab|bevacizumab|mesh-list
83314475|NCT00408070|Carboplatin|carboplatin|mesh-list
83314476|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314477|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314478|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314479|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314480|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314481|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314482|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314483|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314484|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314485|NCT00408070|Growth Substances|growth substances|mesh-ancestor
83314486|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314487|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314488|NCT00408460|Paclitaxel|paclitaxel|mesh-list
83314489|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
83314490|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314491|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314492|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314493|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314494|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314495|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314496|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314497|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314498|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
83314499|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83314500|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314501|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
83314502|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314503|NCT02111746|Bupivacaine|bupivacaine|mesh-list
83314504|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
83314505|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
83314506|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314507|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314508|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
83314509|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314510|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
83314511|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83314512|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314513|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314514|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83314515|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83314516|NCT01793272|Protective Agents|protective agents|mesh-ancestor
83314517|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314518|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
83314519|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83314520|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
83314521|NCT00410488|Dexamethasone|dexamethasone|mesh-list
83314522|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
83314523|NCT00410488|Doxorubicin|doxorubicin|mesh-list
83314524|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83314525|NCT00410488|Vincristine|vincristine|mesh-list
83314526|NCT00410488|Ifosfamide|ifosfamide|mesh-list
83314527|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
83314528|NCT00410488|Palonosetron|palonosetron|mesh-list
83314529|NCT00410488|BB 1101|bb 1101|mesh-list
83314530|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83314531|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
83314532|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
83314533|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314534|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314535|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314536|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
83314537|NCT00410488|Hormones|hormones|mesh-ancestor
83314538|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314539|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83314540|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314541|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
83314542|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314543|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314544|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83314545|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83314546|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83314547|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314548|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314549|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314550|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314551|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83314552|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
83314553|NCT00410488|Protective Agents|protective agents|mesh-ancestor
83314554|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83314555|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83314556|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
83314557|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314558|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83314559|NCT01793350|Benphothiamine|benphothiamine|mesh-list
83314560|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83314561|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
83314562|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314563|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
83314564|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
83314565|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314566|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
83314567|NCT03127774|Antidotes|antidotes|mesh-ancestor
83314568|NCT03127774|Protective Agents|protective agents|mesh-ancestor
83314569|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314570|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
83314571|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314572|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
83314573|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83314574|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314575|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
83314576|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
83314577|NCT00416494|Bevacizumab|bevacizumab|mesh-list
83314578|NCT00416494|Capecitabine|capecitabine|mesh-list
83314579|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
83314580|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314581|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314582|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314583|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314584|NCT00416494|Growth Substances|growth substances|mesh-ancestor
83314585|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314586|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314587|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314588|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
83314589|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314590|NCT02845882|Cytarabine|cytarabine|mesh-list
83314591|NCT02845882|Dexamethasone|dexamethasone|mesh-list
83314592|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
83314593|NCT02845882|Prednisone|prednisone|mesh-list
83314594|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
83314595|NCT02845882|Ifosfamide|ifosfamide|mesh-list
83314596|NCT02845882|Doxorubicin|doxorubicin|mesh-list
83314597|NCT02845882|Methotrexate|methotrexate|mesh-list
83314598|NCT02845882|Etoposide|etoposide|mesh-list
83314599|NCT02845882|Vincristine|vincristine|mesh-list
83314600|NCT02845882|Daunorubicin|daunorubicin|mesh-list
83314601|NCT02845882|Asparaginase|asparaginase|mesh-list
83314602|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
83314603|NCT02845882|Vindesine|vindesine|mesh-list
83314604|NCT02845882|Pegaspargase|pegaspargase|mesh-list
83314605|NCT02845882|BB 1101|bb 1101|mesh-list
83314606|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314607|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
83314608|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314609|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314610|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83314611|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
83314612|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314613|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314614|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83314615|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83314616|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
83314617|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
83314618|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314619|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314620|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
83314621|NCT02845882|Hormones|hormones|mesh-ancestor
83314622|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314623|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83314624|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
83314625|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314626|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83314627|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83314628|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83314629|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83314630|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
83314631|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83314632|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314634|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
83314635|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83314636|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83314637|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314638|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
83314639|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314640|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314641|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314642|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314643|NCT00417274|Quinacrine|quinacrine|mesh-list
83314644|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
83314645|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83314646|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
83314647|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83314648|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314649|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
83314650|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83314651|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
83314652|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314653|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314654|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314655|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83314656|NCT04749940|Laxatives|laxatives|mesh-ancestor
83314657|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314658|NCT05286346|Tenofovir|tenofovir|mesh-list
83314659|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
83314660|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314661|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83314662|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83314663|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314664|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314665|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83314666|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83314667|NCT05286268|Plasminogen|plasminogen|mesh-list
83314668|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83314669|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83314670|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314671|NCT00422032|Clofarabine|clofarabine|mesh-list
83314672|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314673|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
83314674|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314675|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314676|NCT01388920|Tesamorelin|tesamorelin|mesh-list
83314677|NCT01388920|Growth Substances|growth substances|mesh-ancestor
83314678|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314679|NCT00423358|Vitamin D|vitamin d|mesh-list
83314680|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
83314681|NCT00423358|Vitamins|vitamins|mesh-ancestor
83314682|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
83314683|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314684|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83314685|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83314686|NCT00424840|Bevacizumab|bevacizumab|mesh-list
83314687|NCT00424840|Carboplatin|carboplatin|mesh-list
83314688|NCT00424840|Bortezomib|bortezomib|mesh-list
83314689|NCT00424840|Docetaxel|docetaxel|mesh-list
83314690|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314691|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314692|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314693|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314695|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314696|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314697|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314698|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314699|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314700|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314701|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83314702|NCT00425386|Sunitinib|sunitinib|mesh-list
83314703|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314704|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314705|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314706|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314707|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314708|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314709|NCT00425386|Growth Substances|growth substances|mesh-ancestor
83314710|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314711|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314712|NCT01164202|Sunitinib|sunitinib|mesh-list
83314713|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314714|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314715|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314716|NCT01164202|Growth Substances|growth substances|mesh-ancestor
83314717|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314718|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314719|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314720|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314721|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314722|NCT02112370|Epinephrine|epinephrine|mesh-list
83314723|NCT02112370|Racepinephrine|racepinephrine|mesh-list
83314724|NCT02112370|Ropivacaine|ropivacaine|mesh-list
83314725|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
83314726|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
83314727|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
83314728|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314729|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314730|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
83314731|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314732|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83314733|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83314734|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
83314735|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314736|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314737|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83314738|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83314739|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
83314740|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83314741|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
83314742|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
83314743|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
83314744|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83314745|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
83314746|NCT00427336|Fludarabine|fludarabine|mesh-list
83314747|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
83314748|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
83314749|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83314750|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314751|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
83314752|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314753|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314754|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83314755|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
83314756|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314757|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314758|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83314759|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314760|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
83314761|NCT00371176|Cycloserine|cycloserine|mesh-list
83314762|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83314763|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314764|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83314765|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
83314766|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83314767|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
83314768|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314770|NCT00428584|Interferon-beta|interferon-beta|mesh-list
83314771|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
83314772|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314773|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
83314774|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83314775|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
83314776|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314777|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83314778|NCT05187286|Apixaban|apixaban|mesh-list
83314779|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83314780|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
83314781|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83314782|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
83314783|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314784|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314785|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
83314786|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
83314787|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83314788|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83314789|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83314790|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83314791|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314792|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
83314793|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314794|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314795|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83314796|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314797|NCT00373360|Treprostinil|treprostinil|mesh-list
83314798|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83314799|NCT00455650|Mecamylamine|mecamylamine|mesh-list
83314800|NCT00455650|Varenicline|varenicline|mesh-list
83314801|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83314802|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83314803|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
83314804|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314805|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314806|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314807|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83314808|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83314809|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
83314810|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314811|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83314812|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83314813|NCT00431626|Dutasteride|dutasteride|mesh-list
83314814|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83314815|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83314816|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314817|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314818|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
83314819|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314820|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314821|NCT00455962|Estradiol|estradiol|mesh-list
83314822|NCT00455962|Progesterone|progesterone|mesh-list
83314823|NCT00455962|Estrogens|estrogens|mesh-ancestor
83314824|NCT00455962|Hormones|hormones|mesh-ancestor
83314825|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314826|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314827|NCT00455962|Progestins|progestins|mesh-ancestor
83314828|NCT00434356|Paclitaxel|paclitaxel|mesh-list
83314829|NCT00434356|Bevacizumab|bevacizumab|mesh-list
83314830|NCT00434356|Sunitinib|sunitinib|mesh-list
83314831|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314832|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314833|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314834|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314835|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314836|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314837|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83314838|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83314839|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83314840|NCT00434356|Growth Substances|growth substances|mesh-ancestor
83314841|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314842|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
83314843|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314844|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314845|NCT00376948|Gemcitabine|gemcitabine|mesh-list
83314846|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83314847|NCT00376948|Genistein|genistein|mesh-list
83314848|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314849|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
83314850|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314851|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314852|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314853|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314854|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83314855|NCT00376948|Protective Agents|protective agents|mesh-ancestor
83314856|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314857|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
83314858|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83314859|NCT00376948|Estrogens|estrogens|mesh-ancestor
83314860|NCT00376948|Hormones|hormones|mesh-ancestor
83314861|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314862|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83314863|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83314864|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314865|NCT00438100|Capecitabine|capecitabine|mesh-list
83314866|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314867|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
83314868|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314869|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314870|NCT00456508|Ecallantide|ecallantide|mesh-list
83314871|NCT00456508|Analgesics|analgesics|mesh-ancestor
83314872|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
83314873|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314874|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314875|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83314876|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83314877|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83314878|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314879|NCT00457366|Lorazepam|lorazepam|mesh-list
83314880|NCT00457366|Haloperidol|haloperidol|mesh-list
83314881|NCT00457366|Benztropine|benztropine|mesh-list
83314882|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83314883|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
83314884|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
83314885|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83314886|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83314887|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83314888|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83314889|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314890|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
83314891|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
83314892|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314893|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314894|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83314895|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
83314896|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83314897|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314898|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83314899|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
83314900|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83314901|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83314902|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
83314903|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
83314904|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83314905|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
83314906|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83314907|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83314908|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
83314909|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83314910|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83314911|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83314913|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
83314914|NCT00458848|Methotrexate|methotrexate|mesh-list
83314915|NCT00458848|Etoposide|etoposide|mesh-list
83314916|NCT00458848|Vincristine|vincristine|mesh-list
83314917|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
83314918|NCT00458848|Daunorubicin|daunorubicin|mesh-list
83314919|NCT00458848|Asparaginase|asparaginase|mesh-list
83314920|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
83314921|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
83314922|NCT00458848|Idarubicin|idarubicin|mesh-list
83314923|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83314924|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
83314925|NCT00458848|Hormones|hormones|mesh-ancestor
83314926|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83314927|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314928|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83314929|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314930|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83314931|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
83314932|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83314933|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83314934|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
83314935|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314936|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
83314937|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314938|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83314939|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314940|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
83314941|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314942|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83314943|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83314944|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83314945|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83314946|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
83314947|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
83314948|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
83314949|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
83314950|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
83314951|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83314952|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83314953|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83314954|NCT00458848|Protective Agents|protective agents|mesh-ancestor
83314955|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83314956|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83314957|NCT00458848|Analgesics|analgesics|mesh-ancestor
83314958|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
83314959|NCT00438802|Alefacept|alefacept|mesh-list
83314960|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
83314961|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
83314962|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314963|NCT00377572|Omalizumab|omalizumab|mesh-list
83314964|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83314965|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83314966|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83314967|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
83314968|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
83314969|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314970|NCT00438880|Rituximab|rituximab|mesh-list
83314971|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83314972|NCT00438880|Antibodies|antibodies|mesh-list
83314973|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
83314974|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83314975|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
83314976|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314977|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83314978|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83314979|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
83314980|NCT00378352|Hematinics|hematinics|mesh-ancestor
83314981|NCT00462280|Lovastatin|lovastatin|mesh-list
83314982|NCT00462280|L 647318|l 647318|mesh-list
83314983|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
83314984|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83314985|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83314986|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
83314987|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83314988|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83314989|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83314990|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83314991|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
83314992|NCT00381004|Rituximab|rituximab|mesh-list
83314993|NCT00381004|Fludarabine|fludarabine|mesh-list
83314994|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
83314995|NCT00381004|Sargramostim|sargramostim|mesh-list
83314996|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83314997|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
83314998|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83314999|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315000|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83315001|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
83315002|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315003|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315004|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83315005|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315006|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315007|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
83315008|NCT00381550|Fludarabine|fludarabine|mesh-list
83315009|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
83315010|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315011|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315012|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
83315013|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315014|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315015|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
83315016|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315017|NCT00440830|Nicotine|nicotine|mesh-list
83315018|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83315019|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
83315020|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315021|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315022|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83315023|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83315024|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
83315025|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315026|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315027|NCT00427804|Calcitriol|calcitriol|mesh-list
83315028|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83315029|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315030|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83315031|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315032|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315033|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83315034|NCT00427804|Vitamins|vitamins|mesh-ancestor
83315035|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
83315036|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83315037|NCT00381862|Leucovorin|leucovorin|mesh-list
83315038|NCT00381862|Dexamethasone|dexamethasone|mesh-list
83315039|NCT00381862|Fluorouracil|fluorouracil|mesh-list
83315040|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
83315041|NCT00381862|Irinotecan|irinotecan|mesh-list
83315042|NCT00381862|Camptothecin|camptothecin|mesh-list
83315043|NCT00381862|Aprepitant|aprepitant|mesh-list
83315044|NCT00381862|Palonosetron|palonosetron|mesh-list
83315045|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
83315046|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315047|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
83315048|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
83315049|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315050|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315051|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315052|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
83315053|NCT00381862|Hormones|hormones|mesh-ancestor
83315054|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315055|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83315056|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315057|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
83315058|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315059|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315060|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315061|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
83315062|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83315063|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83315064|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315066|NCT00381862|Protective Agents|protective agents|mesh-ancestor
83315067|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
83315068|NCT00381862|Vitamins|vitamins|mesh-ancestor
83315069|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
83315070|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83315071|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315072|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83315073|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83315074|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
83315075|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315076|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83315077|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83315078|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83315079|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315080|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315081|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315082|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315083|NCT00464698|Analgesics|analgesics|mesh-ancestor
83315084|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
83315085|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315086|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
83315087|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315088|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
83315089|NCT00465088|Niacin|niacin|mesh-list
83315090|NCT00465088|Niacinamide|niacinamide|mesh-list
83315091|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
83315092|NCT00465088|Atorvastatin|atorvastatin|mesh-list
83315093|NCT00465088|Simvastatin|simvastatin|mesh-list
83315094|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83315095|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83315096|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
83315097|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315098|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83315099|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83315100|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315101|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
83315102|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
83315103|NCT00465088|Vitamins|vitamins|mesh-ancestor
83315104|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
83315105|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315106|NCT01796782|Capecitabine|capecitabine|mesh-list
83315107|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315108|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
83315109|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315110|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315111|NCT00466960|Paclitaxel|paclitaxel|mesh-list
83315112|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83315113|NCT00466960|Sargramostim|sargramostim|mesh-list
83315114|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315115|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315116|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
83315117|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
83315118|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
83315119|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315120|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
83315121|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315122|NCT00383266|Carboplatin|carboplatin|mesh-list
83315123|NCT00383266|Pemetrexed|pemetrexed|mesh-list
83315124|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315125|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315126|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315127|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83315128|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83315129|NCT00384670|Vaccines|vaccines|mesh-list
83315130|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
83315131|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315132|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83315133|NCT00467350|Laxatives|laxatives|mesh-ancestor
83315134|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315135|NCT00444028|Loxapine|loxapine|mesh-list
83315136|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83315137|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83315138|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315139|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315140|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315141|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83315142|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
83315143|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315144|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315145|NCT00444964|Hormones|hormones|mesh-list
83315146|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315147|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315148|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83315149|NCT00445588|Sorafenib|sorafenib|mesh-list
83315150|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315151|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315152|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315153|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315154|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
83315155|NCT00445744|Busulfan|busulfan|mesh-list
83315156|NCT00445744|Methotrexate|methotrexate|mesh-list
83315157|NCT00445744|Tacrolimus|tacrolimus|mesh-list
83315158|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315159|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
83315160|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315161|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315162|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83315163|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
83315164|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315165|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315166|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83315167|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83315168|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
83315169|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83315170|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315171|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
83315172|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83315173|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315174|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83315175|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83315176|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83315177|NCT00468208|Abatacept|abatacept|mesh-list
83315178|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83315179|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315180|NCT00468208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315181|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315182|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315183|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
83315184|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315185|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315186|NCT00385138|Clopidogrel|clopidogrel|mesh-list
83315187|NCT00385138|Cangrelor|cangrelor|mesh-list
83315188|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83315189|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83315190|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83315191|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83315192|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
83315193|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315194|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315195|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315196|NCT00446290|Docetaxel|docetaxel|mesh-list
83315197|NCT00446290|Capecitabine|capecitabine|mesh-list
83315198|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
83315199|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315200|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
83315201|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
83315202|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
83315203|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315204|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315205|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
83315207|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83315208|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
83315209|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315210|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315211|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83315212|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83315213|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
83315214|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315215|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315216|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83315217|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315218|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315219|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315220|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315221|NCT00470392|Clobetasol|clobetasol|mesh-list
83315222|NCT00470392|Imiquimod|imiquimod|mesh-list
83315223|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83315224|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
83315225|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315226|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315227|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
83315228|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315229|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
83315231|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315232|NCT00470548|Paclitaxel|paclitaxel|mesh-list
83315233|NCT00470548|Pemetrexed|pemetrexed|mesh-list
83315234|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83315235|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315236|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315237|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
83315238|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
83315239|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
83315240|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315241|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315242|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83315243|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83315244|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83315245|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83315246|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83315247|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315248|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315249|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315250|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315251|NCT00388414|Analgesics|analgesics|mesh-ancestor
83315252|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
83315253|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315254|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
83315255|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315256|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
83315257|NCT00475150|Cediranib|cediranib|mesh-list
83315258|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315259|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315260|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315261|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315262|NCT00451048|Sunitinib|sunitinib|mesh-list
83315263|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315264|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83315265|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83315266|NCT00451048|Growth Substances|growth substances|mesh-ancestor
83315267|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315268|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
83315269|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315270|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315271|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315272|NCT00388804|Leuprolide|leuprolide|mesh-list
83315273|NCT00388804|Goserelin|goserelin|mesh-list
83315274|NCT00388804|Flutamide|flutamide|mesh-list
83315275|NCT00388804|Bicalutamide|bicalutamide|mesh-list
83315276|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83315277|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
83315278|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83315279|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315280|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83315281|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315282|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
83315283|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
83315284|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315285|NCT00389818|Prednisone|prednisone|mesh-list
83315286|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
83315287|NCT00389818|Rituximab|rituximab|mesh-list
83315288|NCT00389818|Doxorubicin|doxorubicin|mesh-list
83315289|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83315290|NCT00389818|Vincristine|vincristine|mesh-list
83315291|NCT00389818|Sargramostim|sargramostim|mesh-list
83315292|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315293|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
83315294|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315295|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315296|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83315297|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
83315298|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315299|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315300|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83315301|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315302|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83315303|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83315304|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83315306|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315307|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
83315308|NCT00389818|Hormones|hormones|mesh-ancestor
83315309|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315310|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83315311|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315312|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
83315313|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
83315314|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
83315315|NCT00452374|Cytarabine|cytarabine|mesh-list
83315316|NCT00452374|Rituximab|rituximab|mesh-list
83315317|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
83315318|NCT00452374|Fludarabine|fludarabine|mesh-list
83315319|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
83315320|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315321|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315322|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
83315323|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315324|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315325|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315326|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
83315327|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315328|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315329|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
83315330|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315331|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
83315332|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315333|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315334|NCT03286114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83315335|NCT03286114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315336|NCT00476242|Naltrexone|naltrexone|mesh-list
83315337|NCT00476242|Memantine|memantine|mesh-list
83315338|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83315339|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83315340|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
83315341|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315342|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315343|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315344|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83315345|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83315346|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83315347|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83315348|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
83315349|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315350|NCT00476788|Insulin|insulin|mesh-list
83315351|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83315352|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83315353|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315354|NCT01795144|Glucagon|glucagon|mesh-list
83315355|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83315356|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315357|NCT01795144|Hormones|hormones|mesh-ancestor
83315358|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315359|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315360|NCT01795144|Incretins|incretins|mesh-ancestor
83315361|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83315362|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
83315363|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315364|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83315365|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315366|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83315367|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83315368|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315369|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315370|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
83315371|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315373|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
83315374|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
83315375|NCT00453388|Fludarabine|fludarabine|mesh-list
83315376|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
83315377|NCT00453388|Cyclosporins|cyclosporins|mesh-list
83315378|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315379|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
83315380|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315381|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315382|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83315383|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
83315384|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315385|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315386|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83315387|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315388|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
83315389|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315390|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
83315391|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315392|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
83315393|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83315394|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83315395|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83315396|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
83315397|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83315398|NCT04062123|Fentanyl|fentanyl|mesh-list
83315399|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
83315400|NCT04062123|Propofol|propofol|mesh-list
83315401|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83315402|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315403|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315404|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83315405|NCT04062123|Analgesics|analgesics|mesh-ancestor
83315406|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
83315407|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315408|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83315409|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83315410|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83315411|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
83315412|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315413|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315414|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83315415|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
83315416|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
83315417|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83315418|NCT04062123|Narcotics|narcotics|mesh-ancestor
83315419|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83315420|NCT00389974|Sunitinib|sunitinib|mesh-list
83315421|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315422|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83315423|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83315424|NCT00389974|Growth Substances|growth substances|mesh-ancestor
83315425|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315426|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
83315427|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315428|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315429|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315430|NCT01453725|Golimumab|golimumab|mesh-list
83315431|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83315432|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315433|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315434|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
83315435|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315436|NCT00454324|Paclitaxel|paclitaxel|mesh-list
83315437|NCT00454324|Carboplatin|carboplatin|mesh-list
83315438|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83315439|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315440|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315441|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
83315442|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
83315443|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
83315444|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315445|NCT02110264|Naltrexone|naltrexone|mesh-list
83315446|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83315447|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83315448|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315449|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
83315450|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315451|NCT01795222|Midazolam|midazolam|mesh-list
83315452|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83315453|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83315454|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315455|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315456|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83315457|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83315458|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315459|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83315460|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
83315461|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
83315462|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
83315463|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
83315464|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315465|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315466|NCT01415349|Omeprazole|omeprazole|mesh-list
83315467|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83315468|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315469|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83315470|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315471|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315472|NCT00528190|Itraconazole|itraconazole|mesh-list
83315473|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
83315474|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315475|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83315476|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83315477|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315478|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315479|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83315480|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
83315481|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315482|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315483|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83315484|NCT02334813|Dexamethasone|dexamethasone|mesh-list
83315485|NCT02334813|Prednisone|prednisone|mesh-list
83315486|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315487|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
83315488|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
83315489|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315490|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315491|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315492|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
83315493|NCT02334813|Hormones|hormones|mesh-ancestor
83315494|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315495|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83315496|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315497|NCT00478036|Prednisolone|prednisolone|mesh-list
83315498|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
83315499|NCT00478036|Ketorolac|ketorolac|mesh-list
83315500|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83315501|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83315502|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315503|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
83315504|NCT00478036|Hormones|hormones|mesh-ancestor
83315505|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315506|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315507|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83315508|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315509|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315510|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315511|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83315512|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83315513|NCT00478036|Analgesics|analgesics|mesh-ancestor
83315514|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
83315515|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315516|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83315517|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315518|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315519|NCT00478036|Laxatives|laxatives|mesh-ancestor
83315520|NCT04048863|Imidacloprid|imidacloprid|mesh-list
83315521|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
83315522|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315523|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315524|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315525|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
83315526|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315527|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
83315528|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315529|NCT01453023|Fluticasone|fluticasone|mesh-list
83315530|NCT01453023|Xhance|xhance|mesh-list
83315531|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315532|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83315533|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
83315534|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315535|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315536|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83315537|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
83315538|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
83315539|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83315540|NCT01452789|Morphine|morphine|mesh-list
83315541|NCT01452789|Buprenorphine|buprenorphine|mesh-list
83315542|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83315543|NCT01452789|Narcotics|narcotics|mesh-ancestor
83315544|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315545|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315546|NCT01452789|Analgesics|analgesics|mesh-ancestor
83315547|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
83315548|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315549|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83315550|NCT00478192|Conivaptan|conivaptan|mesh-list
83315551|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83315552|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315553|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
83315554|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315555|NCT01414257|Methotrexate|methotrexate|mesh-list
83315556|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83315557|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
83315558|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83315559|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315560|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83315561|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
83315562|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315563|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315564|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
83315565|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315566|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83315567|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315568|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
83315569|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315570|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83315571|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83315572|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315573|NCT00528580|Simvastatin|simvastatin|mesh-list
83315574|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83315575|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83315576|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
83315577|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315578|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83315579|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83315580|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315581|NCT00529126|Epinephrine|epinephrine|mesh-list
83315582|NCT00529126|Bupivacaine|bupivacaine|mesh-list
83315583|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
83315584|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
83315585|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315586|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315587|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
83315588|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315589|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83315590|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83315591|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
83315592|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315593|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315594|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83315595|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83315596|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
83315597|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83315598|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
83315599|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
83315600|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
83315601|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83315602|NCT00529204|Exenatide|exenatide|mesh-list
83315603|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83315604|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315605|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83315606|NCT00529204|Incretins|incretins|mesh-ancestor
83315607|NCT00529204|Hormones|hormones|mesh-ancestor
83315608|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315609|NCT01451541|Ciclesonide|ciclesonide|mesh-list
83315610|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
83315611|NCT01451541|Hormones|hormones|mesh-ancestor
83315612|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315613|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315614|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83315615|NCT00530764|Nabiximols|nabiximols|mesh-list
83315616|NCT00530764|Dronabinol|dronabinol|mesh-list
83315617|NCT00530764|Cannabidiol|cannabidiol|mesh-list
83315618|NCT00530764|Analgesics|analgesics|mesh-ancestor
83315619|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
83315620|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315621|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315622|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
83315623|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
83315624|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315625|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83315626|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83315627|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83315628|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315629|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315630|NCT00530764|Hormones|hormones|mesh-ancestor
83315631|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315632|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83315633|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83315634|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83315635|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315636|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315637|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315638|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315639|NCT00532480|Analgesics|analgesics|mesh-ancestor
83315640|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
83315641|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315642|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
83315643|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315644|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
83315645|NCT00483262|Bortezomib|bortezomib|mesh-list
83315646|NCT00483262|Temsirolimus|temsirolimus|mesh-list
83315647|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315648|NCT00483262|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83315649|NCT00483262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315650|NCT00483262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315651|NCT00483262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315652|NCT00483262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315653|NCT00483262|Immunologic Factors|immunologic factors|mesh-ancestor
83315654|NCT00483262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315655|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
83315656|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
83315657|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83315658|NCT00483496|Protective Agents|protective agents|mesh-ancestor
83315659|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315660|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
83315661|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83315662|NCT00485836|Ranibizumab|ranibizumab|mesh-list
83315663|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83315664|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83315665|NCT00485836|Growth Substances|growth substances|mesh-ancestor
83315666|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315667|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
83315668|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315669|NCT00488488|Tigecycline|tigecycline|mesh-list
83315671|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315672|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83315673|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315674|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315676|NCT01450761|Etoposide|etoposide|mesh-list
83315677|NCT01450761|Ipilimumab|ipilimumab|mesh-list
83315678|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315679|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315680|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83315681|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83315682|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315683|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315684|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315685|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83315686|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
83315687|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315688|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
83315689|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83315690|NCT00538642|Ziprasidone|ziprasidone|mesh-list
83315691|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83315692|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
83315693|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315694|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315695|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315696|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83315697|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83315698|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315699|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315700|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83315701|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
83315702|NCT01433991|Lenvatinib|lenvatinib|mesh-list
83315703|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315704|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83315705|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315706|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315707|NCT01450683|Itraconazole|itraconazole|mesh-list
83315708|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
83315709|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315710|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83315711|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83315712|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315713|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315714|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83315715|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
83315716|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315717|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315718|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83315720|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83315721|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315722|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
83315723|NCT01450137|Hormones|hormones|mesh-ancestor
83315724|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315725|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315726|NCT04075149|Spironolactone|spironolactone|mesh-list
83315727|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83315728|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
83315729|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315730|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315731|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83315732|NCT04075149|Diuretics|diuretics|mesh-ancestor
83315733|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
83315734|NCT01412229|Paclitaxel|paclitaxel|mesh-list
83315735|NCT01412229|Carboplatin|carboplatin|mesh-list
83315736|NCT01412229|Cetuximab|cetuximab|mesh-list
83315737|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315738|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315739|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
83315740|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
83315741|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
83315742|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315743|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315744|NCT01432275|Insulin|insulin|mesh-list
83315745|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83315746|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315747|NCT01411995|Lidocaine|lidocaine|mesh-list
83315748|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
83315749|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
83315750|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315751|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315752|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
83315753|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315754|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83315755|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83315756|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83315757|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315758|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315759|NCT01411215|Etanercept|etanercept|mesh-list
83315760|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83315761|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83315762|NCT01411215|Analgesics|analgesics|mesh-ancestor
83315763|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
83315764|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315765|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315766|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315767|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315768|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315769|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315770|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
83315771|NCT01449279|Ipilimumab|ipilimumab|mesh-list
83315772|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315773|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315774|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83315775|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315776|NCT01431963|Lamotrigine|lamotrigine|mesh-list
83315777|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
83315778|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83315779|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315780|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315781|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83315782|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315783|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83315784|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83315785|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315786|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315787|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83315788|NCT01447407|Vaccines|vaccines|mesh-list
83315789|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
83315790|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
83315791|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315792|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83315793|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83315794|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
83315795|NCT00540982|Vinorelbine|vinorelbine|mesh-list
83315796|NCT00540982|Lidocaine|lidocaine|mesh-list
83315797|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
83315798|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
83315799|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315800|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315801|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
83315802|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315803|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83315804|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83315805|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83315806|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315807|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315808|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83315809|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315810|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
83315811|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
83315812|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
83315813|NCT00542308|Zalutumumab|zalutumumab|mesh-list
83315814|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83315815|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315817|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83315818|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
83315819|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
83315820|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83315821|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
83315822|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83315823|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315824|NCT00543400|Heparin|heparin|mesh-list
83315825|NCT00543400|Calcium heparin|calcium heparin|mesh-list
83315826|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
83315827|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83315828|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83315829|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315830|NCT01796938|Lacosamide|lacosamide|mesh-list
83315831|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
83315832|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83315833|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83315834|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315835|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315836|NCT00492544|Vaccines|vaccines|mesh-list
83315837|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
83315838|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315839|NCT00492622|Omeprazole|omeprazole|mesh-list
83315840|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83315841|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315842|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83315843|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315844|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315845|NCT00494494|Nepafenac|nepafenac|mesh-list
83315846|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83315847|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83315848|NCT00494494|Analgesics|analgesics|mesh-ancestor
83315849|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
83315850|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315851|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315852|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315853|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315854|NCT03145558|Doxorubicin|doxorubicin|mesh-list
83315855|NCT03145558|Tirapazamine|tirapazamine|mesh-list
83315856|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83315857|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315858|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83315859|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83315860|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315861|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315862|NCT00497770|Pemetrexed|pemetrexed|mesh-list
83315863|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83315864|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315865|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315866|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83315867|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83315868|NCT00498550|Clozapine|clozapine|mesh-list
83315869|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83315870|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
83315871|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315872|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315873|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315874|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83315875|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83315876|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315877|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315878|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
83315879|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
83315880|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83315881|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
83315882|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83315883|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83315884|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83315885|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315886|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315887|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83315888|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83315890|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315891|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83315892|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
83315893|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83315894|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315895|NCT00499408|Vitamin D|vitamin d|mesh-list
83315896|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
83315897|NCT00499408|Vitamins|vitamins|mesh-ancestor
83315898|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
83315899|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315900|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83315901|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83315902|NCT03019666|Niacinamide|niacinamide|mesh-list
83315903|NCT03019666|Niacin|niacin|mesh-list
83315904|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
83315905|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
83315906|NCT03019666|Vitamins|vitamins|mesh-ancestor
83315907|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
83315908|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315909|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83315910|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
83315911|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315912|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83315913|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
83315914|NCT00500578|Ribavirin|ribavirin|mesh-list
83315915|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
83315916|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315917|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
83315918|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83315919|NCT01430559|Meloxicam|meloxicam|mesh-list
83315920|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83315921|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83315922|NCT01430559|Analgesics|analgesics|mesh-ancestor
83315923|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
83315924|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315925|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315926|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315927|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315928|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83315929|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83315930|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83315931|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315932|NCT00500656|Icatibant|icatibant|mesh-list
83315933|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
83315934|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83315935|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83315936|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315937|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
83315938|NCT00500656|Coagulants|coagulants|mesh-ancestor
83315939|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83315940|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83315941|NCT00500656|Analgesics|analgesics|mesh-ancestor
83315942|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
83315943|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315944|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315945|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83315946|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83315947|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83315948|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83315949|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83315950|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83315951|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
83315952|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
83315953|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83315954|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315955|NCT01445847|Lidocaine|lidocaine|mesh-list
83315956|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
83315957|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
83315958|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83315959|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315960|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
83315961|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315962|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83315963|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83315964|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83315965|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83315966|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315967|NCT00502216|Naltrexone|naltrexone|mesh-list
83315968|NCT00502216|Varenicline|varenicline|mesh-list
83315969|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83315970|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83315971|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315972|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
83315973|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83315974|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83315975|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83315976|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
83315977|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315978|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315979|NCT00545662|Choline|choline|mesh-list
83315980|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83315981|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
83315982|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83315983|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
83315984|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315985|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83315986|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83315987|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
83315988|NCT00545974|Memantine|memantine|mesh-list
83315989|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83315990|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83315991|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
83315992|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83315993|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83315994|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83315995|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83315996|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83315997|NCT00548470|Varenicline|varenicline|mesh-list
83315998|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83315999|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83316000|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
83316001|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316002|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316003|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316004|NCT02675452|Itraconazole|itraconazole|mesh-list
83316005|NCT02675452|Azacitidine|azacitidine|mesh-list
83316006|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83316007|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
83316008|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316009|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316010|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316011|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
83316012|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316013|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83316014|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83316015|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83316016|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
83316017|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316018|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316019|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83316020|NCT00509002|Gefitinib|gefitinib|mesh-list
83316021|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316022|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316023|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316024|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316025|NCT00887380|Anastrozole|anastrozole|mesh-list
83316026|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83316027|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316028|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83316029|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83316030|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316031|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316032|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83316033|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
83316034|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316035|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316036|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
83316037|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316038|NCT00557284|Montelukast|montelukast|mesh-list
83316039|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83316040|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316041|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83316042|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
83316043|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316044|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316045|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83316046|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83316047|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316048|NCT00557362|Voriconazole|voriconazole|mesh-list
83316049|NCT00557362|Natamycin|natamycin|mesh-list
83316050|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
83316051|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316052|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83316053|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83316054|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316055|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316056|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83316057|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
83316058|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316059|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316060|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83316061|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83316062|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316063|NCT00512278|Infliximab|infliximab|mesh-list
83316064|NCT00512278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83316065|NCT00512278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316066|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83316067|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83316068|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316070|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
83316071|NCT01445535|Rituximab|rituximab|mesh-list
83316072|NCT01445535|Doxorubicin|doxorubicin|mesh-list
83316073|NCT01445535|Etoposide|etoposide|mesh-list
83316074|NCT01445535|Vincristine|vincristine|mesh-list
83316075|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316076|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
83316077|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316078|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316079|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316080|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
83316081|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316082|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316083|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83316084|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83316085|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83316086|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83316087|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83316088|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316089|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316090|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
83316091|NCT01445535|Hormones|hormones|mesh-ancestor
83316092|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316093|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83316094|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83316095|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
83316096|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
83316097|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316098|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
83316099|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
83316100|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83316101|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83316102|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316103|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316104|NCT01409031|Urological Agents|urological agents|mesh-ancestor
83316105|NCT01430403|Fluticasone|fluticasone|mesh-list
83316106|NCT01430403|Xhance|xhance|mesh-list
83316107|NCT01430403|Omalizumab|omalizumab|mesh-list
83316108|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83316109|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316110|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83316111|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
83316112|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316113|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316114|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83316115|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316116|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83316117|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83316118|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
83316119|NCT01408641|Topiramate|topiramate|mesh-list
83316120|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
83316121|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316122|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316123|NCT01429077|Levodopa|levodopa|mesh-list
83316124|NCT01429077|Carbidopa|carbidopa|mesh-list
83316125|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83316126|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83316127|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
83316128|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316129|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316130|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316131|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83316132|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316133|NCT01408563|Fludarabine|fludarabine|mesh-list
83316134|NCT01408563|Melphalan|melphalan|mesh-list
83316135|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316136|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316137|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316138|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
83316139|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316140|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316141|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
83316142|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83316143|NCT01442493|Methadone|methadone|mesh-list
83316144|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83316145|NCT01442493|Narcotics|narcotics|mesh-ancestor
83316146|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316147|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316148|NCT01442493|Analgesics|analgesics|mesh-ancestor
83316149|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
83316150|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316151|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
83316152|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316153|NCT04407975|Betamethasone|betamethasone|mesh-list
83316154|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316155|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
83316156|NCT04407975|Hormones|hormones|mesh-ancestor
83316157|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316158|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316159|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83316160|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316161|NCT01428063|Interferons|interferons|mesh-list
83316162|NCT01428063|Ribavirin|ribavirin|mesh-list
83316163|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
83316164|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
83316165|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83316166|NCT01428063|Asunaprevir|asunaprevir|mesh-list
83316167|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316168|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
83316169|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316170|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
83316171|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316172|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
83316173|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316174|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
83316175|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316176|NCT00513292|Paclitaxel|paclitaxel|mesh-list
83316177|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
83316178|NCT00513292|Trastuzumab|trastuzumab|mesh-list
83316179|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83316180|NCT00513292|Epirubicin|epirubicin|mesh-list
83316181|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83316182|NCT00513292|Antibodies|antibodies|mesh-list
83316183|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
83316184|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83316185|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83316186|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316188|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
83316189|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316190|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316191|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316192|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
83316193|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316194|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316195|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316196|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
83316197|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83316198|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83316199|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83316200|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83316201|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316202|NCT00513370|Adalimumab|adalimumab|mesh-list
83316203|NCT00513370|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83316204|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316205|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316206|NCT00559468|Bromides|bromides|mesh-list
83316207|NCT00559468|Propofol|propofol|mesh-list
83316208|NCT00559468|Sevoflurane|sevoflurane|mesh-list
83316209|NCT00559468|Rocuronium|rocuronium|mesh-list
83316210|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83316211|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316212|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316213|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83316214|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
83316215|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
83316216|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83316217|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83316218|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
83316219|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83316220|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83316221|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83316222|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316224|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
83316225|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316226|NCT00561418|Vorinostat|vorinostat|mesh-list
83316227|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316228|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83316229|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316230|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316231|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83316232|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
83316233|NCT00514852|Glycerol|glycerol|mesh-list
83316234|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83316235|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83316236|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83316237|NCT00514852|Protective Agents|protective agents|mesh-ancestor
83316238|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316239|NCT00514852|Laxatives|laxatives|mesh-ancestor
83316240|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83316241|NCT00555880|Midodrine|midodrine|mesh-list
83316242|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
83316243|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
83316244|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316245|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316246|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83316247|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83316248|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83316249|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83316250|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
83316251|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316252|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316253|NCT00563290|Dasatinib|dasatinib|mesh-list
83316254|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316255|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316256|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316257|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316258|NCT00556504|Ribavirin|ribavirin|mesh-list
83316259|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83316260|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83316261|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
83316262|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316263|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
83316264|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316265|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
83316266|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83316267|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316268|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83316269|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83316270|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
83316271|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316272|NCT00520234|Caspofungin|caspofungin|mesh-list
83316273|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
83316274|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316275|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316276|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316277|NCT00520468|Cyclosporine|cyclosporine|mesh-list
83316278|NCT00520468|Prednisone|prednisone|mesh-list
83316279|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
83316280|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
83316281|NCT00520468|Cyclosporins|cyclosporins|mesh-list
83316282|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316283|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
83316284|NCT00520468|Hormones|hormones|mesh-ancestor
83316285|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316286|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316287|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83316288|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316289|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316290|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316291|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316292|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
83316293|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
83316294|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316295|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
83316296|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316297|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83316299|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83316300|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83316301|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83316302|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316303|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316304|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316305|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316306|NCT05560516|Analgesics|analgesics|mesh-ancestor
83316307|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
83316308|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316309|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
83316310|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83316311|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
83316312|NCT05559268|Denosumab|denosumab|mesh-list
83316313|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83316314|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316315|NCT02121418|Cytarabine|cytarabine|mesh-list
83316316|NCT02121418|Decitabine|decitabine|mesh-list
83316317|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83316318|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
83316319|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316320|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316321|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
83316322|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316323|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316324|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
83316325|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316326|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316327|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83316328|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83316329|NCT01441635|Norethindrone|norethindrone|mesh-list
83316330|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
83316331|NCT01441635|Estradiol|estradiol|mesh-list
83316332|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83316333|NCT01441635|Progesterone|progesterone|mesh-list
83316334|NCT01441635|Estrogens|estrogens|mesh-ancestor
83316335|NCT01441635|Hormones|hormones|mesh-ancestor
83316336|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316337|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316338|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83316339|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
83316340|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83316341|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83316342|NCT01441635|Progestins|progestins|mesh-ancestor
83316343|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83316344|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83316345|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83316346|NCT01427907|Calcium|calcium|mesh-list
83316347|NCT01427907|Sevelamer|sevelamer|mesh-list
83316348|NCT01427907|Calcium acetate|calcium acetate|mesh-list
83316349|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83316350|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316351|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
83316352|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
83316353|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316354|NCT02985333|Dexamethasone|dexamethasone|mesh-list
83316355|NCT02985333|Paclitaxel|paclitaxel|mesh-list
83316356|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
83316357|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83316358|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316359|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83316360|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83316361|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316362|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316363|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316364|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
83316365|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316366|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316367|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316368|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
83316369|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83316370|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316371|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
83316372|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
83316373|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316374|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83316375|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
83316376|NCT02985333|Hormones|hormones|mesh-ancestor
83316377|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316378|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83316379|NCT01427751|Dexamethasone|dexamethasone|mesh-list
83316380|NCT01427751|Ranibizumab|ranibizumab|mesh-list
83316381|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316382|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
83316383|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
83316384|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316385|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316386|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83316387|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
83316388|NCT01427751|Hormones|hormones|mesh-ancestor
83316389|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316390|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83316391|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316392|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83316393|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83316394|NCT01427751|Growth Substances|growth substances|mesh-ancestor
83316395|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
83316396|NCT01920061|Docetaxel|docetaxel|mesh-list
83316397|NCT01920061|Gedatolisib|gedatolisib|mesh-list
83316398|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316399|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
83316400|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
83316401|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316402|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316403|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316404|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316405|NCT01426347|Vitamin D|vitamin d|mesh-list
83316406|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
83316407|NCT01426347|Vitamins|vitamins|mesh-ancestor
83316408|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
83316409|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316410|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83316411|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83316412|NCT04612309|Immunomodulating Agents|immunomodulating agents|mesh-list
83316413|NCT04612309|Immunologic Factors|immunologic factors|mesh-ancestor
83316414|NCT04612309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316415|NCT04415983|Metronidazole|metronidazole|mesh-list
83316416|NCT04415983|Clarithromycin|clarithromycin|mesh-list
83316417|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
83316418|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83316419|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316420|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316421|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83316422|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83316423|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83316424|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316425|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316426|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83316427|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83316428|NCT01426269|Metronidazole|metronidazole|mesh-list
83316429|NCT01426269|Doxycycline|doxycycline|mesh-list
83316430|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316431|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316432|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83316433|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83316434|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
83316435|NCT01426113|Timolol|timolol|mesh-list
83316436|NCT01426113|Bimatoprost|bimatoprost|mesh-list
83316437|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83316438|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83316439|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83316440|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83316441|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83316442|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316443|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316444|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316445|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83316446|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83316447|NCT01393899|Tofacitinib|tofacitinib|mesh-list
83316448|NCT01393899|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83316449|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316450|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316451|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316452|NCT02078193|Abatacept|abatacept|mesh-list
83316453|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83316454|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316455|NCT02078193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83316456|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316457|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316458|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
83316459|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316460|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316461|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83316462|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316463|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316464|NCT01405911|Incretins|incretins|mesh-ancestor
83316465|NCT01405911|Hormones|hormones|mesh-ancestor
83316466|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316467|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83316468|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
83316469|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316470|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316471|NCT01425801|Albuterol|albuterol|mesh-list
83316472|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83316473|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
83316474|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316475|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316476|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83316477|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316478|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
83316479|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83316480|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83316481|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83316482|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83316483|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
83316484|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316485|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316486|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
83316487|NCT02076243|Paclitaxel|paclitaxel|mesh-list
83316488|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83316489|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316490|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
83316491|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
83316492|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316493|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316494|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
83316495|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83316496|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83316497|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83316498|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316499|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316500|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
83316501|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316502|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316503|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83316504|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316506|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83316507|NCT01392573|Liraglutide|liraglutide|mesh-list
83316508|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
83316509|NCT01392573|Xultophy|xultophy|mesh-list
83316510|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316511|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316512|NCT01392573|Incretins|incretins|mesh-ancestor
83316513|NCT01392573|Hormones|hormones|mesh-ancestor
83316514|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316515|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
83316516|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316517|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316518|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316519|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316520|NCT01405053|Rufinamide|rufinamide|mesh-list
83316521|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
83316522|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83316523|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83316524|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316525|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316526|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83316527|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
83316528|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316529|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
83316530|NCT01392183|Sirolimus|sirolimus|mesh-list
83316531|NCT01392183|Temsirolimus|temsirolimus|mesh-list
83316532|NCT01392183|MTOR Inhibitors|mtor inhibitors|mesh-list
83316533|NCT01392183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316534|NCT01392183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316535|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316536|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316537|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
83316538|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316539|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316540|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316541|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316542|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83316543|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
83316544|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83316545|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83316546|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316547|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
83316548|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
83316549|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
83316550|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316551|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
83316552|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
83316553|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83316554|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83316555|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
83316556|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
83316557|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316558|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83316559|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
83316560|NCT01402947|Mesalamine|mesalamine|mesh-list
83316561|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316562|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316563|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83316564|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83316565|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316566|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316567|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316568|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83316569|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83316570|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83316571|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83316573|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
83316574|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316575|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316576|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316577|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316578|NCT03025893|Sunitinib|sunitinib|mesh-list
83316579|NCT03025893|Lomustine|lomustine|mesh-list
83316580|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316581|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83316582|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83316583|NCT03025893|Growth Substances|growth substances|mesh-ancestor
83316584|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316585|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
83316586|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316587|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316588|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316589|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316590|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
83316591|NCT01402869|Lidocaine|lidocaine|mesh-list
83316592|NCT01402869|Epinephrine|epinephrine|mesh-list
83316593|NCT01402869|Prilocaine|prilocaine|mesh-list
83316594|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
83316595|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
83316596|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316597|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316598|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
83316599|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316600|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83316601|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83316602|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83316603|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316604|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316605|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83316606|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83316607|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
83316608|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316609|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83316610|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83316611|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
83316612|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83316613|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316614|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
83316615|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
83316616|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83316617|NCT01391793|Dexamethasone|dexamethasone|mesh-list
83316618|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316619|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
83316620|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
83316621|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316622|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316623|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83316624|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
83316625|NCT01391793|Hormones|hormones|mesh-ancestor
83316626|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316627|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83316628|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316629|NCT01422915|Colestipol|colestipol|mesh-list
83316630|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83316631|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
83316632|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316633|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83316634|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
83316635|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
83316636|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83316637|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
83316638|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316639|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316640|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83316641|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316642|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
83316643|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83316644|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
83316645|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316646|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316647|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
83316648|NCT04558736|Fludarabine|fludarabine|mesh-list
83316649|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
83316650|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83316651|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316652|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
83316653|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316654|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316655|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316656|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
83316657|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316658|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316659|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83316660|NCT01422213|Vortioxetine|vortioxetine|mesh-list
83316661|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
83316662|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83316663|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83316664|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83316665|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316666|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316667|NCT01422213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83316668|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83316669|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316670|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316671|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316672|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
83316673|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83316674|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83316675|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83316676|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83316677|NCT01390857|Valacyclovir|valacyclovir|mesh-list
83316678|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
83316679|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316680|NCT01725386|Capecitabine|capecitabine|mesh-list
83316681|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83316682|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
83316683|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316684|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316685|NCT01402011|Lidocaine|lidocaine|mesh-list
83316686|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
83316687|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
83316688|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316689|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316690|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
83316691|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316692|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83316693|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83316694|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83316695|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316696|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316697|NCT01421667|Rituximab|rituximab|mesh-list
83316698|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83316699|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83316700|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316701|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
83316702|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316703|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316704|NCT01421667|Immunotoxins|immunotoxins|mesh-ancestor
83316705|NCT01421667|Immunoconjugates|immunoconjugates|mesh-ancestor
83316706|NCT01891669|PF-06263507|pf-06263507|mesh-list
83316707|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83316708|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316709|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
83316710|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316711|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316712|NCT01421511|Linezolid|linezolid|mesh-list
83316713|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316714|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316715|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83316716|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316717|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316718|NCT01891357|Paclitaxel|paclitaxel|mesh-list
83316719|NCT01891357|Trastuzumab|trastuzumab|mesh-list
83316720|NCT01891357|Lapatinib|lapatinib|mesh-list
83316721|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83316722|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316723|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
83316724|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
83316725|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
83316726|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316727|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83316728|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316729|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316730|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
83316731|NCT01420965|Antibodies|antibodies|mesh-list
83316732|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
83316733|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316734|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
83316735|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316736|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316737|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316738|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
83316739|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316740|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316741|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83316742|NCT04033575|Listerine|listerine|mesh-list
83316743|NCT04033575|Fluorides|fluorides|mesh-list
83316744|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
83316745|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
83316746|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
83316747|NCT04033575|Protective Agents|protective agents|mesh-ancestor
83316748|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316749|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83316750|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316751|NCT03842085|Antibodies|antibodies|mesh-list
83316752|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83316753|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
83316754|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
83316755|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316756|NCT01390389|Ubiquinone|ubiquinone|mesh-list
83316757|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
83316758|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
83316759|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316760|NCT01390389|Vitamins|vitamins|mesh-ancestor
83316761|NCT03835533|Nivolumab|nivolumab|mesh-list
83316762|NCT03835533|Poly ICLC|poly iclc|mesh-list
83316763|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83316764|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316765|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83316766|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316767|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
83316768|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
83316769|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316770|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
83316771|NCT01401465|Ciclesonide|ciclesonide|mesh-list
83316772|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83316773|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
83316774|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83316775|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
83316776|NCT01401465|Hormones|hormones|mesh-ancestor
83316777|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316778|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316779|NCT01890967|Atorvastatin|atorvastatin|mesh-list
83316780|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83316781|NCT01890967|Simvastatin|simvastatin|mesh-list
83316782|NCT01890967|Ezetimibe|ezetimibe|mesh-list
83316783|NCT01890967|Pravastatin|pravastatin|mesh-list
83316784|NCT01890967|Pitavastatin|pitavastatin|mesh-list
83316785|NCT01890967|Lovastatin|lovastatin|mesh-list
83316786|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83316787|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83316789|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316790|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83316791|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83316792|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316793|NCT01863667|Glimepiride|glimepiride|mesh-list
83316794|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83316795|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316796|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316797|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316798|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
83316799|NCT01614769|Glimepiride|glimepiride|mesh-list
83316800|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83316801|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83316802|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316803|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316804|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
83316805|NCT01614457|Ivacaftor|ivacaftor|mesh-list
83316806|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83316807|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83316808|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316809|NCT01835431|Insulin|insulin|mesh-list
83316810|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83316811|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
83316812|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
83316813|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83316814|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
83316815|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316816|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316817|NCT01880593|Ketamine|ketamine|mesh-list
83316818|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
83316819|NCT01880593|Analgesics|analgesics|mesh-ancestor
83316820|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
83316821|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316822|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316823|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83316824|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83316825|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
83316826|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
83316827|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316828|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83316829|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83316830|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316831|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316832|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
83316833|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83316834|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316835|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
83316836|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83316837|NCT01400451|Ipilimumab|ipilimumab|mesh-list
83316838|NCT01400451|Vemurafenib|vemurafenib|mesh-list
83316839|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83316840|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316841|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83316842|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316843|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316844|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316845|NCT01400139|Hydrocodone|hydrocodone|mesh-list
83316846|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83316847|NCT01400139|Narcotics|narcotics|mesh-ancestor
83316848|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316849|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316850|NCT01400139|Analgesics|analgesics|mesh-ancestor
83316851|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
83316852|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316853|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
83316854|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316855|NCT01399905|Carbidopa|carbidopa|mesh-list
83316856|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83316857|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83316858|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
83316859|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316860|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316861|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316862|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83316863|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316864|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83316865|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
83316866|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83316867|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83316868|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83316869|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316870|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316871|NCT01724528|Allopurinol|allopurinol|mesh-list
83316872|NCT01724528|Febuxostat|febuxostat|mesh-list
83316873|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
83316874|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316875|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316876|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
83316877|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83316878|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83316879|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
83316880|NCT01724528|Protective Agents|protective agents|mesh-ancestor
83316881|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316882|NCT01750268|Topiramate|topiramate|mesh-list
83316883|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
83316884|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316885|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316886|NCT01880437|Cytarabine|cytarabine|mesh-list
83316887|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83316888|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
83316889|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316890|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316891|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
83316892|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316893|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316894|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
83316895|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316896|NCT01861717|Lanreotide|lanreotide|mesh-list
83316897|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316898|NCT01834729|Alfuzosin|alfuzosin|mesh-list
83316899|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83316900|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83316901|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83316902|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
83316903|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316904|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316905|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316906|NCT01834729|Urological Agents|urological agents|mesh-ancestor
83316907|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
83316908|NCT01860703|Deferiprone|deferiprone|mesh-list
83316909|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316910|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316911|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83316912|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83316913|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316914|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316915|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316916|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83316917|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
83316918|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
83316919|NCT01399593|Eculizumab|eculizumab|mesh-list
83316920|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83316921|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83316922|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
83316923|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316924|NCT01388985|Vaccines|vaccines|mesh-list
83316925|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
83316926|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316927|NCT01388361|Insulin|insulin|mesh-list
83316928|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83316929|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
83316930|NCT01388361|Liraglutide|liraglutide|mesh-list
83316931|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316932|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316933|NCT01388361|Incretins|incretins|mesh-ancestor
83316934|NCT01388361|Hormones|hormones|mesh-ancestor
83316935|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83316936|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
83316937|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83316938|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316939|NCT01399125|Rivastigmine|rivastigmine|mesh-list
83316940|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83316941|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316942|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316943|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
83316944|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316945|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316946|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83316947|NCT01399125|Protective Agents|protective agents|mesh-ancestor
83316948|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
83316949|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83316950|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316951|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83316952|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
83316953|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83316954|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316955|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316956|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316957|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83316958|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83316959|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
83316960|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83316961|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83316962|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316963|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83316964|NCT04040439|Analgesics|analgesics|mesh-ancestor
83316965|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
83316966|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83316967|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83316968|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83316969|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83316970|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
83316971|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83316972|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316973|NCT04012827|Doxorubicin|doxorubicin|mesh-list
83316974|NCT04012827|Apatinib|apatinib|mesh-list
83316975|NCT04012827|Ifosfamide|ifosfamide|mesh-list
83316976|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83316977|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83316978|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83316979|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83316980|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83316981|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316982|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83316983|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83316984|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
83316985|NCT01879579|Insulin|insulin|mesh-list
83316986|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83316987|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316989|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83316990|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
83316991|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83316992|NCT01386645|Expectorants|expectorants|mesh-ancestor
83316993|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
83316994|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83316995|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
83316996|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83316997|NCT01386645|Protective Agents|protective agents|mesh-ancestor
83316998|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83316999|NCT01386645|Antidotes|antidotes|mesh-ancestor
83317000|NCT01831765|Insulin|insulin|mesh-list
83317001|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83317002|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
83317003|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
83317004|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83317005|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
83317006|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83317007|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317008|NCT01830595|Lactoferrin|lactoferrin|mesh-list
83317009|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317010|NCT01748162|Fluticasone|fluticasone|mesh-list
83317011|NCT01748162|Prednisolone|prednisolone|mesh-list
83317012|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317013|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83317014|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
83317015|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317016|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317017|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83317018|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
83317019|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
83317020|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83317021|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
83317022|NCT01748162|Hormones|hormones|mesh-ancestor
83317023|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317024|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317025|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317026|NCT01723904|Rotigotine|rotigotine|mesh-list
83317027|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
83317028|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
83317029|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317030|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317031|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317032|NCT01830127|Ribavirin|ribavirin|mesh-list
83317033|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
83317034|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317035|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
83317036|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317037|NCT01614067|Ganirelix|ganirelix|mesh-list
83317038|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
83317039|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317040|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317041|NCT01397409|Ranibizumab|ranibizumab|mesh-list
83317042|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83317043|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83317044|NCT01397409|Growth Substances|growth substances|mesh-ancestor
83317045|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317046|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
83317047|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317048|NCT04766775|Fluorides|fluorides|mesh-list
83317049|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
83317050|NCT04766775|Protective Agents|protective agents|mesh-ancestor
83317051|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317052|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
83317053|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83317054|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
83317055|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317056|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317057|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83317058|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
83317059|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
83317060|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83317061|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
83317062|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317063|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317064|NCT03024879|Erythromycin|erythromycin|mesh-list
83317065|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
83317066|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83317067|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
83317068|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83317069|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317070|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317071|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83317072|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317073|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317074|NCT01383993|Voriconazole|voriconazole|mesh-list
83317075|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
83317076|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317077|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83317078|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83317079|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317080|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317081|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83317082|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
83317083|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317084|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317085|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83317086|NCT01396395|Nicorandil|nicorandil|mesh-list
83317087|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83317088|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83317089|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
83317090|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
83317092|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
83317093|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317094|NCT01396083|Dexamethasone|dexamethasone|mesh-list
83317095|NCT01396083|Ranibizumab|ranibizumab|mesh-list
83317096|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317097|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
83317098|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
83317099|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317100|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317101|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317102|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
83317103|NCT01396083|Hormones|hormones|mesh-ancestor
83317104|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317105|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317106|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317107|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83317108|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83317109|NCT01396083|Growth Substances|growth substances|mesh-ancestor
83317110|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
83317111|NCT01776008|Anastrozole|anastrozole|mesh-list
83317112|NCT01776008|Goserelin|goserelin|mesh-list
83317113|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317114|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317115|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83317116|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83317117|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317118|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317119|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83317120|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
83317121|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317122|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317123|NCT01858363|Paclitaxel|paclitaxel|mesh-list
83317124|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83317125|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317126|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317127|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317128|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317129|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317130|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83317131|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
83317132|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317133|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83317134|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317135|NCT01396005|Buprenorphine|buprenorphine|mesh-list
83317136|NCT01396005|Methadone|methadone|mesh-list
83317137|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83317138|NCT01396005|Naloxone|naloxone|mesh-list
83317139|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83317140|NCT01396005|Narcotics|narcotics|mesh-ancestor
83317141|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317142|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317143|NCT01396005|Analgesics|analgesics|mesh-ancestor
83317144|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
83317145|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317146|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83317147|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
83317148|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
83317149|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
83317150|NCT03024957|Morphine|morphine|mesh-list
83317151|NCT03024957|Bupivacaine|bupivacaine|mesh-list
83317152|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
83317153|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
83317154|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317155|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317156|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
83317157|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317158|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83317159|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317160|NCT03024957|Analgesics|analgesics|mesh-ancestor
83317161|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83317162|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83317163|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83317164|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
83317165|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317166|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317167|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83317168|NCT03024957|Narcotics|narcotics|mesh-ancestor
83317169|NCT03025113|Ketoprofen|ketoprofen|mesh-list
83317170|NCT03025113|Amitriptyline|amitriptyline|mesh-list
83317171|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
83317172|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83317173|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317174|NCT03025113|Analgesics|analgesics|mesh-ancestor
83317175|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
83317176|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317177|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317178|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317179|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317180|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83317181|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317182|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317183|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83317184|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
83317185|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83317186|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83317187|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83317188|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83317189|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317190|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83317191|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83317192|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83317193|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83317194|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317195|NCT01877083|Lenvatinib|lenvatinib|mesh-list
83317196|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317197|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317198|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317199|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317200|NCT01380327|Immunomodulating Agents|immunomodulating agents|mesh-list
83317201|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
83317202|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317203|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83317204|NCT01829425|Oxybutynin|oxybutynin|mesh-list
83317205|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83317206|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83317207|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
83317208|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317209|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317210|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317211|NCT01829425|Urological Agents|urological agents|mesh-ancestor
83317212|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
83317214|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317215|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
83317216|NCT01394991|Hematinics|hematinics|mesh-ancestor
83317217|NCT01394523|Bupivacaine|bupivacaine|mesh-list
83317218|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
83317219|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
83317220|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317221|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317222|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
83317223|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317224|NCT05363553|Caseins|caseins|mesh-list
83317225|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
83317226|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
83317227|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317228|NCT01857583|PENTA|penta|mesh-list
83317229|NCT01857583|Edoxaban|edoxaban|mesh-list
83317230|NCT01857583|Fondaparinux|fondaparinux|mesh-list
83317231|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83317232|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
83317233|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83317234|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83317235|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317236|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317237|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
83317238|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83317239|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83317240|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83317241|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
83317242|NCT00211185|Prednisone|prednisone|mesh-list
83317243|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
83317244|NCT00211185|Doxorubicin|doxorubicin|mesh-list
83317245|NCT00211185|Vincristine|vincristine|mesh-list
83317246|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
83317247|NCT00211185|Lenograstim|lenograstim|mesh-list
83317248|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317249|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
83317250|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317251|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317252|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83317253|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
83317254|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317255|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317256|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83317257|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83317258|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83317259|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83317260|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317261|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317262|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
83317263|NCT00211185|Hormones|hormones|mesh-ancestor
83317264|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317265|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317266|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83317267|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317268|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317269|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317270|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83317271|NCT00219297|Epothilone B|epothilone b|mesh-list
83317272|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317273|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317274|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317275|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317276|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317277|NCT05631795|Fulvestrant|fulvestrant|mesh-list
83317278|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317279|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317280|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83317281|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83317282|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
83317283|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317284|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317285|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83317286|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317287|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317288|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317289|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317291|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317292|NCT01721486|Analgesics|analgesics|mesh-ancestor
83317293|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
83317294|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317295|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317296|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
83317297|NCT01721408|Imipenem|imipenem|mesh-list
83317298|NCT01721408|Tigecycline|tigecycline|mesh-list
83317299|NCT01721408|Cilastatin|cilastatin|mesh-list
83317300|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83317301|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317302|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83317303|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317304|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317305|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
83317306|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83317307|NCT03998709|Somatostatin|somatostatin|mesh-list
83317308|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317309|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83317310|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83317311|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83317312|NCT03998709|Hormones|hormones|mesh-ancestor
83317313|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317314|NCT01744496|Rotigotine|rotigotine|mesh-list
83317315|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
83317316|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
83317317|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317318|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317319|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317321|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83317322|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83317323|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83317324|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83317325|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
83317326|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317327|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317328|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317329|NCT01721330|Naltrexone|naltrexone|mesh-list
83317330|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83317331|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83317332|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317333|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
83317334|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317335|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
83317336|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317337|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317338|NCT03592407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83413617|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83317339|NCT03592407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317340|NCT03595371|Dapansutrile|dapansutrile|mesh-list
83317341|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317342|NCT05634057|Anisodamine|anisodamine|mesh-list
83317343|NCT05634057|Heparin|heparin|mesh-list
83317344|NCT05634057|Calcium heparin|calcium heparin|mesh-list
83317345|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
83317346|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83317347|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83317348|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317349|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83317350|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83317351|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83317352|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317353|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317354|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83317355|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83317356|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317357|NCT05634057|Analgesics|analgesics|mesh-ancestor
83317358|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
83317359|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317360|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317361|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317362|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83317363|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317364|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
83317365|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
83317366|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
83317367|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83317368|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
83317369|NCT05634057|Protective Agents|protective agents|mesh-ancestor
83317370|NCT03596385|Metoprolol|metoprolol|mesh-list
83317371|NCT03596385|Atenolol|atenolol|mesh-list
83317372|NCT03596385|Carvedilol|carvedilol|mesh-list
83317373|NCT03596385|Bisoprolol|bisoprolol|mesh-list
83317374|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83317375|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83317376|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83317377|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
83317378|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
83317379|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317380|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317381|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83317382|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83317383|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
83317384|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317385|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317386|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
83317387|NCT03596385|Protective Agents|protective agents|mesh-ancestor
83317388|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83317389|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83317390|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83317392|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83317393|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83317394|NCT01828021|Margetuximab|margetuximab|mesh-list
83317395|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317396|NCT03784599|Trastuzumab|trastuzumab|mesh-list
83317397|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83317398|NCT03784599|Osimertinib|osimertinib|mesh-list
83317399|NCT03784599|Maytansine|maytansine|mesh-list
83317400|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317401|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317402|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317403|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317404|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317405|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83317406|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317407|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317408|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317409|NCT03784599|Immunotoxins|immunotoxins|mesh-ancestor
83317410|NCT03784599|Immunoconjugates|immunoconjugates|mesh-ancestor
83317411|NCT03784599|Immunologic Factors|immunologic factors|mesh-ancestor
83317412|NCT03784599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317413|NCT01827943|Sirolimus|sirolimus|mesh-list
83317414|NCT01827943|Temsirolimus|temsirolimus|mesh-list
83317415|NCT01827943|MTOR Inhibitors|mtor inhibitors|mesh-list
83317416|NCT01827943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317417|NCT01827943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317418|NCT01827943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317419|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317420|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
83317421|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317422|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317423|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83317424|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317425|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83317426|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
83317427|NCT02985255|Docetaxel|docetaxel|mesh-list
83317428|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317429|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317430|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317431|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317432|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317433|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83317434|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317435|NCT00217971|Dronabinol|dronabinol|mesh-list
83317436|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
83317437|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317438|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83317439|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317440|NCT00217971|Analgesics|analgesics|mesh-ancestor
83317441|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
83317442|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317443|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83317444|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83317445|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317446|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317447|NCT00217971|Hormones|hormones|mesh-ancestor
83317448|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317449|NCT03976323|Cisplatin|cisplatin|mesh-list
83317450|NCT03976323|Carboplatin|carboplatin|mesh-list
83317451|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
83317452|NCT03976323|Pemetrexed|pemetrexed|mesh-list
83317453|NCT03976323|Olaparib|olaparib|mesh-list
83317454|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317455|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317456|NCT03976323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83317457|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317458|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317459|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83317460|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83317461|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83317462|NCT00217581|Bevacizumab|bevacizumab|mesh-list
83317463|NCT00217581|Docetaxel|docetaxel|mesh-list
83317464|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
83317465|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317466|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317467|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83317468|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83317469|NCT00217581|Growth Substances|growth substances|mesh-ancestor
83317470|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317471|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
83317472|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317473|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317474|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317475|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317476|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
83317477|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
83317478|NCT01856257|Abatacept|abatacept|mesh-list
83317479|NCT01856257|Tacrolimus|tacrolimus|mesh-list
83317480|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
83317481|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83317482|NCT01856257|Basiliximab|basiliximab|mesh-list
83317483|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317484|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
83317485|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317486|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83317487|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317488|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317489|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83317490|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317491|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83317492|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
83317493|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83317494|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317495|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317496|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
83317497|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
83317498|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317499|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317500|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
83317501|NCT01856257|Hormones|hormones|mesh-ancestor
83317502|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317503|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83317504|NCT01856257|Protective Agents|protective agents|mesh-ancestor
83317505|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83317506|NCT01856257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317507|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317508|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
83317509|NCT00215943|Thalidomide|thalidomide|mesh-list
83317510|NCT00215943|Dexamethasone|dexamethasone|mesh-list
83317511|NCT00215943|Doxorubicin|doxorubicin|mesh-list
83317512|NCT00215943|Vincristine|vincristine|mesh-list
83317513|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83317514|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317515|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
83317516|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
83317517|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317518|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317519|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317520|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
83317521|NCT00215943|Hormones|hormones|mesh-ancestor
83317522|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317523|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317524|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317525|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83317526|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83317527|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83317528|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317529|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317530|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83317531|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317532|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317533|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317534|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317535|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
83317536|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
83317537|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83317538|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317539|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83317540|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83317541|NCT00215943|Growth Substances|growth substances|mesh-ancestor
83317542|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
83317543|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83317545|NCT01827163|Trastuzumab|trastuzumab|mesh-list
83317546|NCT01827163|Lapatinib|lapatinib|mesh-list
83317547|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83317548|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317549|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317550|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317551|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317552|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317553|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317554|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317555|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317556|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83317557|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
83317558|NCT00214461|Vaccines|vaccines|mesh-list
83317559|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
83317560|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317561|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
83317562|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83317563|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83317564|NCT00211887|Interferons|interferons|mesh-list
83317565|NCT00211887|Interferon-beta|interferon-beta|mesh-list
83317566|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
83317567|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
83317568|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
83317569|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317570|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
83317571|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317572|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
83317573|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317574|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83317575|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317576|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317577|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83317578|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317579|NCT04002297|Rituximab|rituximab|mesh-list
83317580|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83317581|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
83317582|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317583|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317584|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
83317585|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317586|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317587|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83317588|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
83317589|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317590|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317591|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317592|NCT03592485|Acetaminophen|acetaminophen|mesh-list
83317593|NCT03592485|Oxycodone|oxycodone|mesh-list
83317594|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317595|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317596|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317597|NCT03592485|Analgesics|analgesics|mesh-ancestor
83317598|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
83317599|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317600|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
83317601|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83317602|NCT03592485|Narcotics|narcotics|mesh-ancestor
83317603|NCT04199013|Fentanyl|fentanyl|mesh-list
83317604|NCT04199013|Ropivacaine|ropivacaine|mesh-list
83317605|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
83317606|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
83317607|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317608|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317609|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
83317610|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317611|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83317612|NCT04199013|Narcotics|narcotics|mesh-ancestor
83317613|NCT04199013|Analgesics|analgesics|mesh-ancestor
83317614|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83317615|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83317616|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
83317617|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
83317618|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83317619|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
83317620|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317621|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
83317622|NCT04198467|Protective Agents|protective agents|mesh-ancestor
83317623|NCT03599427|Lidocaine|lidocaine|mesh-list
83317624|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
83317625|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
83317626|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317627|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317628|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
83317629|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317630|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83317631|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83317632|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83317633|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83317634|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317635|NCT01855789|Methotrexate|methotrexate|mesh-list
83317636|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83317637|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
83317638|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83317639|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317640|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83317641|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
83317642|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317643|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317644|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
83317645|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317646|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83317647|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317648|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
83317649|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317650|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83317651|NCT04198233|Diazepam|diazepam|mesh-list
83317652|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83317653|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
83317654|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
83317655|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
83317656|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317657|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317658|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317659|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83317660|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317661|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83317662|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83317663|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83317664|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83317665|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83317666|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83317667|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
83317668|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
83317669|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
83317670|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
83317671|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317672|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317673|NCT03591471|Prednisone|prednisone|mesh-list
83317674|NCT03591471|Benazepril|benazepril|mesh-list
83317675|NCT03591471|Heparin|heparin|mesh-list
83317676|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83317677|NCT03591471|Tinzaparin|tinzaparin|mesh-list
83317678|NCT03591471|Dalteparin|dalteparin|mesh-list
83317679|NCT03591471|Calcium heparin|calcium heparin|mesh-list
83317680|NCT03591471|Dipyridamole|dipyridamole|mesh-list
83317681|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317682|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317683|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
83317684|NCT03591471|Hormones|hormones|mesh-ancestor
83317685|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317686|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317687|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317688|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
83317689|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83317690|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83317691|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317692|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83317693|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
83317694|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317695|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83317696|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83317697|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83317698|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
83317699|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83317700|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
83317701|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317703|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83317704|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317705|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
83317706|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317707|NCT03591003|Antibodies|antibodies|mesh-list
83317708|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
83317709|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
83317710|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317711|NCT01875991|Etanercept|etanercept|mesh-list
83317712|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83317713|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317714|NCT01875991|Analgesics|analgesics|mesh-ancestor
83317715|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
83317716|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317717|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317718|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317719|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317720|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83317721|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317722|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
83317723|NCT04203927|Empagliflozin|empagliflozin|mesh-list
83317724|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83317725|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317726|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83317727|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317729|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83317730|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83317731|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317732|NCT04196829|Fluorides|fluorides|mesh-list
83317733|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
83317734|NCT04196829|Protective Agents|protective agents|mesh-ancestor
83317735|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317736|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83317737|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
83317738|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83317739|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83317740|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83317741|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317742|NCT01854697|Interferons|interferons|mesh-list
83317743|NCT01854697|Ribavirin|ribavirin|mesh-list
83317744|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
83317745|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
83317746|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83317747|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317748|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
83317749|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317750|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
83317751|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317752|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
83317753|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317754|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
83317755|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
83317756|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317757|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317758|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317759|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
83317760|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
83317761|NCT01824823|Afatinib|afatinib|mesh-list
83317762|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317763|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317764|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317765|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317766|NCT03598725|Prednisone|prednisone|mesh-list
83317767|NCT03598725|Rituximab|rituximab|mesh-list
83317768|NCT03598725|Factor VIII|factor viii|mesh-list
83317769|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317770|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317771|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
83317772|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317773|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317774|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317775|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
83317776|NCT03598725|Hormones|hormones|mesh-ancestor
83317777|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317778|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83317779|NCT03598725|Coagulants|coagulants|mesh-ancestor
83317780|NCT04766307|Interleukin-2|interleukin-2|mesh-list
83317781|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317782|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317783|NCT04766307|Analgesics|analgesics|mesh-ancestor
83317784|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
83317785|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317786|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317787|NCT01875367|Trastuzumab|trastuzumab|mesh-list
83317788|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83317789|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317790|NCT04194957|Fluorouracil|fluorouracil|mesh-list
83317791|NCT04194957|Capecitabine|capecitabine|mesh-list
83317792|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
83317793|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317794|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83317795|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317796|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317797|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
83317798|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317799|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
83317800|NCT04194255|Trace Elements|trace elements|mesh-ancestor
83317801|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
83317802|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317803|NCT04406883|Simvastatin|simvastatin|mesh-list
83317804|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83317805|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83317806|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
83317807|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317808|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83317809|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83317810|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317812|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
83317813|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317814|NCT04199325|Protective Agents|protective agents|mesh-ancestor
83317815|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317816|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
83317817|NCT03952299|Oxybutynin|oxybutynin|mesh-list
83317818|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
83317819|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
83317820|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317821|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317822|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83317823|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83317824|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
83317825|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317826|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317827|NCT03952299|Urological Agents|urological agents|mesh-ancestor
83317828|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83317829|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317830|NCT03597867|Diclofenac|diclofenac|mesh-list
83317831|NCT03597867|Indomethacin|indomethacin|mesh-list
83317832|NCT03597867|Nepafenac|nepafenac|mesh-list
83317833|NCT03597867|Bromfenac|bromfenac|mesh-list
83317834|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83317835|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83317836|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83317837|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317838|NCT03597867|Analgesics|analgesics|mesh-ancestor
83317839|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
83317840|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317841|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317842|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317843|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317844|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83317845|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317846|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317847|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
83317848|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
83317849|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83317850|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
83317851|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83317852|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83317853|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
83317854|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
83317855|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317856|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317857|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
83317858|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83317859|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83317860|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317861|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317862|NCT03597477|Analgesics|analgesics|mesh-ancestor
83317863|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
83317864|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317865|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83317866|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83317867|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83317868|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
83317869|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83317870|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317871|NCT04193319|Fluconazole|fluconazole|mesh-list
83317872|NCT04193319|Fluzoparib|fluzoparib|mesh-list
83317873|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
83317874|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317875|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83317876|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83317877|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317878|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317879|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83317880|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
83317881|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317882|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317883|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83317884|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83317885|NCT04193319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83317886|NCT04193319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317887|NCT04192617|Methotrexate|methotrexate|mesh-list
83317888|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83317889|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
83317890|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83317891|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317892|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83317893|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
83317894|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317895|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317896|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
83317897|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317898|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83317899|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83317900|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
83317901|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317902|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83317903|NCT04026009|Vaccines|vaccines|mesh-list
83317904|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
83317905|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317906|NCT01874665|Ponatinib|ponatinib|mesh-list
83317907|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317908|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317909|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317910|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317911|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
83317912|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
83317913|NCT04028739|Curcumin|curcumin|mesh-list
83317914|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83317915|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317916|NCT04028739|Analgesics|analgesics|mesh-ancestor
83317917|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
83317918|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317919|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317920|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317921|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317922|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317923|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317924|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317925|NCT04028505|Terlipressin|terlipressin|mesh-list
83317926|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83317927|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83317928|NCT04190745|Paclitaxel|paclitaxel|mesh-list
83317929|NCT04190745|Apatinib|apatinib|mesh-list
83317930|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83317931|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317932|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
83317933|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
83317934|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
83317935|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317936|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83317937|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317938|NCT04028349|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83317939|NCT04028349|Antiviral Agents|antiviral agents|mesh-ancestor
83317940|NCT04028349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317942|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83317943|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
83317944|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83317945|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
83317946|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317947|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317948|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83317949|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83317950|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317951|NCT01873729|Naltrexone|naltrexone|mesh-list
83317952|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83317953|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83317954|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317955|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
83317956|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317957|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
83317958|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83317959|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83317960|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83317961|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83317962|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83317963|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
83317964|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
83317965|NCT04027959|Vitamins|vitamins|mesh-ancestor
83317966|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
83317967|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317968|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
83317969|NCT04027959|Hematinics|hematinics|mesh-ancestor
83317970|NCT04344951|Chloroquine|chloroquine|mesh-list
83317971|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83317972|NCT04344951|Amebicides|amebicides|mesh-ancestor
83317973|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83317974|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83317975|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83317976|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
83317977|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83317978|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83317979|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83317980|NCT04344951|Analgesics|analgesics|mesh-ancestor
83317981|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
83317982|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83317983|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317984|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83317985|NCT04344951|Filaricides|filaricides|mesh-ancestor
83317986|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
83317987|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
83317988|NCT01822561|Eplerenone|eplerenone|mesh-list
83317989|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83317990|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
83317991|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83317992|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83317993|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83317995|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
83317996|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83317997|NCT02080455|Atorvastatin|atorvastatin|mesh-list
83317998|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83317999|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83318000|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
83318001|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318002|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83318003|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83318004|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318005|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83318006|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
83318007|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318008|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
83318009|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83318010|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83318011|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318012|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
83318013|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83318014|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83318015|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83318016|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318017|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318018|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
83318019|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318020|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318021|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83318022|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318023|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83318024|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83318025|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83318026|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318027|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318028|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
83318029|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318030|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318031|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83318032|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318033|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
83318034|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83318035|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83318036|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318037|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
83318038|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
83318039|NCT04199169|Vaccines|vaccines|mesh-list
83318040|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
83318041|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318042|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
83318043|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83318044|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83318045|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83318046|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
83318047|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83318048|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83318049|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83318050|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
83318051|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83318052|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
83318053|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318054|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
83318055|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318056|NCT03950427|Bupropion|bupropion|mesh-list
83318057|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83318058|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
83318059|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83318060|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83318061|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83318062|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318063|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318064|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
83318065|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318066|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318067|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83318068|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83318069|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318070|NCT01872715|Doxycycline|doxycycline|mesh-list
83318071|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318072|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318073|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
83318074|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83318075|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83318076|NCT01613599|Rituximab|rituximab|mesh-list
83318077|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83318078|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318079|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
83318080|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318081|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318082|NCT03930771|Capecitabine|capecitabine|mesh-list
83318083|NCT03930771|Temozolomide|temozolomide|mesh-list
83318084|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318085|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
83318086|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318087|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318088|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83318089|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
83318090|NCT04024683|Ropivacaine|ropivacaine|mesh-list
83318091|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
83318092|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
83318093|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318094|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318095|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
83318096|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318097|NCT04024527|Amoxicillin|amoxicillin|mesh-list
83318098|NCT04024527|Metronidazole|metronidazole|mesh-list
83318099|NCT04024527|Esomeprazole|esomeprazole|mesh-list
83318100|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318101|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318102|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83318103|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83318104|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83318105|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318106|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83318107|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318108|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318109|NCT01819129|Insulin|insulin|mesh-list
83318110|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83318111|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
83318112|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
83318113|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
83318114|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83318115|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83318116|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318117|NCT04025775|Insulin|insulin|mesh-list
83318118|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83318119|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318120|NCT04022811|Tobramycin|tobramycin|mesh-list
83318121|NCT04022811|Dexamethasone|dexamethasone|mesh-list
83318122|NCT04022811|Bromfenac|bromfenac|mesh-list
83318123|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
83318124|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318125|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
83318126|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
83318127|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318128|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318129|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318130|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
83318131|NCT04022811|Hormones|hormones|mesh-ancestor
83318132|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318133|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83318134|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318135|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318136|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318137|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83318138|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
83318139|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
83318140|NCT04022811|Protective Agents|protective agents|mesh-ancestor
83318141|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83318143|NCT04022811|Analgesics|analgesics|mesh-ancestor
83318144|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
83318145|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318146|NCT04145583|Voriconazole|voriconazole|mesh-list
83318147|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
83318148|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318149|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83318150|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83318151|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318152|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318153|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83318154|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
83318155|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318156|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318157|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83318158|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
83318159|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
83318160|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83318161|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83318162|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318163|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318164|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318165|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318166|NCT04145193|Leucovorin|leucovorin|mesh-list
83318167|NCT04145193|Fluorouracil|fluorouracil|mesh-list
83318168|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
83318169|NCT04145193|Durvalumab|durvalumab|mesh-list
83318170|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83318171|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
83318172|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318173|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318174|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318175|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318176|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
83318177|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318178|NCT04145193|Antidotes|antidotes|mesh-ancestor
83318179|NCT04145193|Protective Agents|protective agents|mesh-ancestor
83318180|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
83318181|NCT04145193|Vitamins|vitamins|mesh-ancestor
83318182|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
83318183|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83318184|NCT04147845|Triamcinolone|triamcinolone|mesh-list
83318185|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83318186|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83318187|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83318188|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318189|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
83318190|NCT04147845|Hormones|hormones|mesh-ancestor
83318191|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318192|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318193|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318194|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
83318195|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318196|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318197|NCT01849783|Thalidomide|thalidomide|mesh-list
83318198|NCT01849783|Dexamethasone|dexamethasone|mesh-list
83318199|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
83318200|NCT01849783|Melphalan|melphalan|mesh-list
83318201|NCT01849783|Doxorubicin|doxorubicin|mesh-list
83318202|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83318203|NCT01849783|Etoposide|etoposide|mesh-list
83318204|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
83318205|NCT01849783|Bortezomib|bortezomib|mesh-list
83318206|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318207|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
83318208|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318209|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318210|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83318211|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
83318212|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318213|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318214|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83318215|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318216|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
83318217|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
83318218|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318219|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318220|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
83318221|NCT01849783|Hormones|hormones|mesh-ancestor
83318222|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318223|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83318224|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83318225|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83318226|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83318227|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318228|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83318229|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
83318230|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318231|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318232|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83318233|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83318234|NCT01849783|Growth Substances|growth substances|mesh-ancestor
83318235|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
83318236|NCT01611883|Ezetimibe|ezetimibe|mesh-list
83318237|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83318238|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83318239|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
83318240|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318241|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83318242|NCT04170517|Progesterone|progesterone|mesh-list
83318243|NCT04170517|Progestins|progestins|mesh-ancestor
83318244|NCT04170517|Hormones|hormones|mesh-ancestor
83318245|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318246|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318247|NCT01848457|Methotrexate|methotrexate|mesh-list
83318248|NCT01848457|Pantoprazole|pantoprazole|mesh-list
83318249|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83318250|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
83318251|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83318252|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318253|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318254|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
83318255|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318256|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318257|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
83318258|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318259|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83318260|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318261|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
83318262|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318263|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83318264|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83318265|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318266|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83318267|NCT01870999|Aripiprazole|aripiprazole|mesh-list
83318268|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
83318269|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83318270|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83318271|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83318272|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318273|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318274|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
83318275|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
83318276|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318277|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318278|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83318279|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83318280|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
83318281|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83318282|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83318283|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83318284|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83318285|NCT01870921|Ticagrelor|ticagrelor|mesh-list
83318286|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83318287|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83318288|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83318289|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83318290|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
83318291|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318292|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318293|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318294|NCT00526474|Vorapaxar|vorapaxar|mesh-list
83318295|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83318296|NCT01848145|Ofatumumab|ofatumumab|mesh-list
83318297|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318298|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83318299|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83318300|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
83318301|NCT00527644|Hormones|hormones|mesh-ancestor
83318302|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318303|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318304|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318305|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318307|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83318308|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
83318309|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318310|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318311|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83318312|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83318313|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
83318314|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318315|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318316|NCT00527878|Ranitidine|ranitidine|mesh-list
83318317|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83318318|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83318319|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318320|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83318321|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
83318322|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
83318323|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318324|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318325|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318326|NCT05558878|Ambroxol|ambroxol|mesh-list
83318327|NCT05558878|Expectorants|expectorants|mesh-ancestor
83318328|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
83318329|NCT05621434|Maleic acid|maleic acid|mesh-list
83318330|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318331|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318332|NCT04741204|Metformin|metformin|mesh-list
83318333|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83318334|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318335|NCT01870843|Escitalopram|escitalopram|mesh-list
83318336|NCT01870843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83318337|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83318338|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318339|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318340|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318341|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
83318342|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318343|NCT01816477|Ropivacaine|ropivacaine|mesh-list
83318344|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
83318345|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
83318346|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318347|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318348|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
83318349|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318350|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
83318351|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83318352|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83318353|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318354|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
83318355|NCT01846507|Coagulants|coagulants|mesh-ancestor
83318356|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
83318357|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83318358|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
83318359|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318360|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
83318361|NCT01846039|Protective Agents|protective agents|mesh-ancestor
83318362|NCT01610167|Listerine|listerine|mesh-list
83318363|NCT01610167|Fluorides|fluorides|mesh-list
83318364|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
83318365|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
83318366|NCT01610167|Protective Agents|protective agents|mesh-ancestor
83318367|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318368|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83318370|NCT04478500|Minocycline|minocycline|mesh-list
83318371|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318372|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318373|NCT01816243|Fentanyl|fentanyl|mesh-list
83318374|NCT01816243|Morphine|morphine|mesh-list
83318375|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83318376|NCT01816243|Narcotics|narcotics|mesh-ancestor
83318377|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318378|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318379|NCT01816243|Analgesics|analgesics|mesh-ancestor
83318380|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
83318381|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318382|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83318383|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83318384|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
83318385|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
83318386|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
83318387|NCT05576896|Cetuximab|cetuximab|mesh-list
83318388|NCT05576896|Panitumumab|panitumumab|mesh-list
83318389|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83318390|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318391|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
83318392|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83318393|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83318394|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318395|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318396|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318397|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318398|NCT01845805|Azacitidine|azacitidine|mesh-list
83318399|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318400|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
83318401|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318402|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318403|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318404|NCT05575804|Capecitabine|capecitabine|mesh-list
83318405|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318406|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
83318407|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318408|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318409|NCT01845025|Fluticasone|fluticasone|mesh-list
83318410|NCT01845025|Xhance|xhance|mesh-list
83318411|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
83318412|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318413|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83318414|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
83318415|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318416|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318417|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83318418|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83318419|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
83318420|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83318421|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83318422|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83318423|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83318424|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
83318425|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318426|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318427|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83318428|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83318429|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318430|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318431|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83318432|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318433|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318434|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
83318435|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318436|NCT05072236|Lidocaine|lidocaine|mesh-list
83318437|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
83318438|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
83318439|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318440|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318441|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
83318442|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318443|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83318444|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83318445|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83318446|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318447|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318448|NCT04847440|Tenofovir|tenofovir|mesh-list
83318449|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
83318450|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318451|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83318452|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83318453|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318454|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318455|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83318456|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83318457|NCT03667846|Topiramate|topiramate|mesh-list
83318458|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
83318459|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83318460|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318461|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
83318462|NCT03519412|Temozolomide|temozolomide|mesh-list
83318463|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83318464|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318465|NCT03519412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83318466|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318467|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83318468|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
83318469|NCT01870297|Liraglutide|liraglutide|mesh-list
83318470|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83318471|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318472|NCT01870297|Incretins|incretins|mesh-ancestor
83318473|NCT01870297|Hormones|hormones|mesh-ancestor
83318474|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318475|NCT01814761|Bimatoprost|bimatoprost|mesh-list
83318476|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83318477|NCT04616248|Poly I-C|poly i-c|mesh-list
83318478|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83318479|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83318480|NCT04616248|Antibodies|antibodies|mesh-list
83318481|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
83318482|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83318483|NCT04616248|Poly ICLC|poly iclc|mesh-list
83318484|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
83318485|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
83318486|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318487|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318488|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
83318489|NCT04616248|Laxatives|laxatives|mesh-ancestor
83318490|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318491|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
83318492|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318493|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83318494|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83318495|NCT04616248|Protective Agents|protective agents|mesh-ancestor
83318496|NCT01798030|Vitamin D|vitamin d|mesh-list
83318497|NCT01798030|Vitamins|vitamins|mesh-ancestor
83318498|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
83318499|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318500|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83318501|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
83318502|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83318503|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318504|NCT03329950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83318505|NCT03329950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318506|NCT01814371|Mupirocin|mupirocin|mesh-list
83318507|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318508|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318509|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83318510|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318511|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318512|NCT03232138|Sulforaphane|sulforaphane|mesh-list
83318513|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83318514|NCT03232138|Protective Agents|protective agents|mesh-ancestor
83318515|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318516|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318517|NCT01814137|Insulin|insulin|mesh-list
83318518|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83318519|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
83318520|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
83318521|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83318522|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83318523|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318524|NCT01813435|Aspirin|aspirin|mesh-list
83318525|NCT01813435|Clopidogrel|clopidogrel|mesh-list
83318526|NCT01813435|Ticagrelor|ticagrelor|mesh-list
83318527|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83318529|NCT01813435|Analgesics|analgesics|mesh-ancestor
83318530|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
83318531|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318532|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318533|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318534|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318535|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83318536|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83318537|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318538|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83318539|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83318540|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318541|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
83318542|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83318543|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83318544|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83318545|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
83318546|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318547|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
83318548|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83318549|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
83318550|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318551|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
83318552|NCT01798498|Protective Agents|protective agents|mesh-ancestor
83318553|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83318554|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83318555|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83318556|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
83318557|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318558|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83318559|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83318560|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318561|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83318562|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318563|NCT03944902|Niraparib|niraparib|mesh-list
83318564|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83318565|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318566|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318567|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318568|NCT01811953|Metformin|metformin|mesh-list
83318569|NCT01811953|Empagliflozin|empagliflozin|mesh-list
83318570|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83318571|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318572|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83318573|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318574|NCT03895762|Fentanyl|fentanyl|mesh-list
83318575|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83318576|NCT03895762|Narcotics|narcotics|mesh-ancestor
83318577|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318578|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318579|NCT03895762|Analgesics|analgesics|mesh-ancestor
83318580|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
83318581|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318582|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83318583|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83318584|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
83318585|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
83318586|NCT01033552|Cyclosporine|cyclosporine|mesh-list
83318587|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
83318588|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
83318589|NCT01033552|Fludarabine|fludarabine|mesh-list
83318590|NCT01033552|Cyclosporins|cyclosporins|mesh-list
83318591|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83318592|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318593|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
83318594|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318595|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318596|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83318597|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
83318598|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318599|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318600|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83318601|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318602|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
83318603|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318604|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
83318605|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83318606|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83318607|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83318608|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
83318609|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318611|NCT00997906|Carboplatin|carboplatin|mesh-list
83318612|NCT00997906|Gemcitabine|gemcitabine|mesh-list
83318613|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83318614|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318615|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
83318616|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
83318617|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
83318618|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318619|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318620|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
83318621|NCT05246644|Acetaminophen|acetaminophen|mesh-list
83318622|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83318623|NCT05246644|Analgesics|analgesics|mesh-ancestor
83318624|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
83318625|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318626|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318627|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
83318628|NCT01798576|Interferons|interferons|mesh-list
83318629|NCT01798576|Ribavirin|ribavirin|mesh-list
83318630|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
83318631|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
83318632|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83318633|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318634|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
83318635|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318636|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
83318637|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318638|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
83318639|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318640|NCT00565084|Ibuprofen|ibuprofen|mesh-list
83318641|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83318642|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83318643|NCT00565084|Analgesics|analgesics|mesh-ancestor
83318644|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
83318645|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318646|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318647|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318648|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318649|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83318650|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318651|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318652|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
83318653|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
83318654|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318655|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318656|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318657|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
83318658|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
83318659|NCT04170283|Tislelizumab|tislelizumab|mesh-list
83318660|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
83318661|NCT04170283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83318662|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318663|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83318664|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318665|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318666|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83318667|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83318668|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318669|NCT01613131|Estradiol|estradiol|mesh-list
83318670|NCT01613131|Estrogens|estrogens|mesh-ancestor
83318671|NCT01613131|Hormones|hormones|mesh-ancestor
83318672|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318673|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318674|NCT05362942|Cytarabine|cytarabine|mesh-list
83318675|NCT05362942|Azacitidine|azacitidine|mesh-list
83318677|NCT05362942|Venetoclax|venetoclax|mesh-list
83318678|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318679|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
83318680|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318681|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318682|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
83318683|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318684|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318685|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
83318686|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318687|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318688|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
83318689|NCT01868893|Chlorambucil|chlorambucil|mesh-list
83318690|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83318691|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318692|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83318693|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
83318694|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318695|NCT03481972|Doxycycline|doxycycline|mesh-list
83318696|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83318697|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318698|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318699|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
83318700|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83318701|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83318702|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
83318703|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83318704|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318705|NCT01868503|Lapatinib|lapatinib|mesh-list
83318706|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318707|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83318708|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318709|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318710|NCT05204368|Meropenem|meropenem|mesh-list
83318711|NCT05204368|Imipenem|imipenem|mesh-list
83318712|NCT05204368|Cilastatin|cilastatin|mesh-list
83318713|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318714|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318715|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
83318716|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318717|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318718|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
83318719|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318720|NCT04414969|Asparaginase|asparaginase|mesh-list
83318721|NCT04414969|Pegaspargase|pegaspargase|mesh-list
83318722|NCT04414969|Antibodies|antibodies|mesh-list
83318723|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
83318724|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
83318725|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318726|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318727|NCT01609933|Interferons|interferons|mesh-list
83318728|NCT01609933|Ritonavir|ritonavir|mesh-list
83318729|NCT01609933|Ribavirin|ribavirin|mesh-list
83318730|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
83318731|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
83318732|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83318733|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318734|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
83318735|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318736|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83318737|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83318738|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
83318739|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318740|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318741|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83318742|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83318743|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83318744|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83318745|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
83318746|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
83318747|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318748|NCT05361772|Colchicine|colchicine|mesh-list
83318749|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
83318750|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318751|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83318752|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83318753|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83318754|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318755|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318756|NCT03031210|Amoxicillin|amoxicillin|mesh-list
83318757|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318758|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318759|NCT02958514|Tobramycin|tobramycin|mesh-list
83318760|NCT02958514|Dexamethasone|dexamethasone|mesh-list
83318761|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318762|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
83318763|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
83318764|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318765|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318766|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318767|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
83318768|NCT02958514|Hormones|hormones|mesh-ancestor
83318769|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318770|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83318771|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318772|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83318773|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318774|NCT01867021|Vaccines|vaccines|mesh-list
83318775|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
83318776|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318777|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
83318778|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
83318779|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
83318780|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318781|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
83318782|NCT01841593|Amlodipine|amlodipine|mesh-list
83318783|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83318784|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83318785|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318786|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318787|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83318788|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318789|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
83318790|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83318791|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83318792|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
83318793|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318794|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83318795|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83318796|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318797|NCT05236894|Nicotine|nicotine|mesh-list
83318798|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83318799|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
83318800|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318801|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318802|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83318803|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83318804|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
83318805|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318806|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318807|NCT04507204|Methylphenidate|methylphenidate|mesh-list
83318808|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83318809|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318810|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83318811|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83318812|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318813|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318814|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
83318815|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318816|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
83318818|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
83318819|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318820|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318821|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
83318822|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318823|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83318824|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
83318825|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83318826|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318827|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318828|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83318829|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
83318830|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83318831|NCT04505566|Ketorolac|ketorolac|mesh-list
83318832|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83318833|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
83318834|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83318835|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83318836|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83318837|NCT04505566|Analgesics|analgesics|mesh-ancestor
83318838|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
83318839|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318840|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318841|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83318842|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318843|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83318844|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318845|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318846|NCT05076292|Glucagon|glucagon|mesh-list
83318847|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83318848|NCT05076292|Hormones|hormones|mesh-ancestor
83318849|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83318850|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318851|NCT04789330|Phenylephrine|phenylephrine|mesh-list
83318852|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
83318853|NCT04789330|Norepinephrine|norepinephrine|mesh-list
83318854|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83318855|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
83318856|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
83318857|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318858|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318859|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
83318860|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83318861|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
83318862|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
83318863|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83318864|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83318865|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83318866|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
83318867|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318868|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318869|NCT04789330|Protective Agents|protective agents|mesh-ancestor
83318870|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
83318871|NCT02339038|Ledipasvir|ledipasvir|mesh-list
83318872|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
83318873|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318874|NCT04497298|Vaccines|vaccines|mesh-list
83318875|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
83318876|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318877|NCT04387786|Albuterol|albuterol|mesh-list
83318878|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83318879|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
83318880|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318881|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318882|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83318883|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
83318884|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
83318885|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83318886|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83318887|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83318888|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83318889|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
83318890|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318891|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318893|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83318894|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
83318895|NCT04509622|Cytarabine|cytarabine|mesh-list
83318896|NCT04509622|Venetoclax|venetoclax|mesh-list
83318897|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83318898|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
83318899|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318900|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318901|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
83318902|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83318903|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318904|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
83318905|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318906|NCT00570700|Dasatinib|dasatinib|mesh-list
83318907|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318908|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83318909|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318910|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318911|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
83318912|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83318913|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83318914|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
83318915|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318916|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318917|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318918|NCT00573508|Urological Agents|urological agents|mesh-ancestor
83318919|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83318920|NCT00574834|Ramipril|ramipril|mesh-list
83318921|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83318922|NCT00574834|Diuretics|diuretics|mesh-ancestor
83318923|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
83318924|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318925|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83318926|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83318927|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318928|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83318929|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
83318930|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318931|NCT04259398|Propofol|propofol|mesh-list
83318932|NCT04259398|Sevoflurane|sevoflurane|mesh-list
83318933|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83318934|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318935|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318936|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83318937|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
83318938|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
83318939|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83318940|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83318941|NCT01592110|Risperidone|risperidone|mesh-list
83318942|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83318943|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
83318944|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318945|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318946|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318947|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83318948|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83318949|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318950|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83318951|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83318952|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
83318953|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83318954|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
83318955|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
83318956|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83318957|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
83318958|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318959|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318960|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83318961|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
83318962|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
83318963|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83318964|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
83318965|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318966|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318967|NCT00579280|Valproic Acid|valproic acid|mesh-list
83318968|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83318969|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
83318970|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83318971|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83318972|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83318973|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318974|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318975|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
83318976|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83318977|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318978|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
83318979|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83318980|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
83318981|NCT00580294|Oxymorphone|oxymorphone|mesh-list
83318982|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83318983|NCT00580294|Narcotics|narcotics|mesh-ancestor
83318984|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83318985|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318986|NCT00580294|Analgesics|analgesics|mesh-ancestor
83318987|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
83318988|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83318989|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83318990|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
83318991|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83318992|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
83318993|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83318994|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83318995|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83318996|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
83318997|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83318998|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83318999|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83319000|NCT02134210|Etanercept|etanercept|mesh-list
83319001|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83319002|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83319003|NCT02134210|Analgesics|analgesics|mesh-ancestor
83319004|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
83319005|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319006|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319007|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319008|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319009|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319010|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319011|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
83319012|NCT00607594|Saracatinib|saracatinib|mesh-list
83319013|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319014|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319015|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319016|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
83319017|NCT01866319|Ipilimumab|ipilimumab|mesh-list
83319018|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319019|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319020|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83319021|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319022|NCT00607672|Candesartan|candesartan|mesh-list
83319023|NCT00607672|Ramipril|ramipril|mesh-list
83319024|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83319025|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83319026|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83319027|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319028|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83319029|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
83319030|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319031|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83319032|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83319033|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83319034|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319035|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319036|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
83319037|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319038|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319039|NCT01802437|Fluoxetine|fluoxetine|mesh-list
83319040|NCT01802437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83319041|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83319044|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319045|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
83319046|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319047|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83319048|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
83319049|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83319050|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83319051|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83319052|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319054|NCT00608062|Ganirelix|ganirelix|mesh-list
83319055|NCT00608062|Estrogens|estrogens|mesh-ancestor
83319056|NCT00608062|Hormones|hormones|mesh-ancestor
83319057|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319058|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319059|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
83319060|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
83319061|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83319062|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83319063|NCT02829268|Dantrolene|dantrolene|mesh-list
83319064|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83319065|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319066|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83319067|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319068|NCT02202772|Cisplatin|cisplatin|mesh-list
83319069|NCT02202772|Gemcitabine|gemcitabine|mesh-list
83319070|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319071|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319072|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
83319073|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319074|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
83319075|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319076|NCT01801735|Meloxicam|meloxicam|mesh-list
83319077|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83319078|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83319079|NCT01801735|Analgesics|analgesics|mesh-ancestor
83319080|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
83319081|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319082|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319083|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319084|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319085|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83319086|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83319087|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319088|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319092|NCT00612430|Bevacizumab|bevacizumab|mesh-list
83319093|NCT00612430|Etoposide|etoposide|mesh-list
83319094|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
83319095|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319096|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319097|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83319098|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83319099|NCT00612430|Growth Substances|growth substances|mesh-ancestor
83319100|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319101|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
83319102|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83319103|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83319104|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83319105|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319106|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319107|NCT01571128|Tenofovir|tenofovir|mesh-list
83319108|NCT01571128|Emtricitabine|emtricitabine|mesh-list
83319109|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
83319110|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319111|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83319112|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83319113|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319114|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319115|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83319116|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83319117|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
83319118|NCT00614458|Valproic Acid|valproic acid|mesh-list
83319119|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83319120|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83319121|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
83319122|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319123|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83319124|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83319125|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319126|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319127|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
83319128|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
83319129|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319130|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319131|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
83319132|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83319133|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319134|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83319135|NCT01429168|Etoricoxib|etoricoxib|mesh-list
83319136|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83319137|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83319138|NCT01429168|Analgesics|analgesics|mesh-ancestor
83319139|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
83319140|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319141|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319142|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319143|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319144|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83319145|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83319146|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319147|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319148|NCT00771160|Montelukast|montelukast|mesh-list
83319149|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83319150|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
83319151|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83319152|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
83319153|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319154|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319155|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83319156|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83319157|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319158|NCT00756418|Theophylline|theophylline|mesh-list
83319159|NCT00756418|Montelukast|montelukast|mesh-list
83319160|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83319161|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
83319162|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83319163|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
83319164|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319165|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319166|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83319167|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83319168|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319169|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83319170|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
83319171|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319172|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83319173|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319174|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
83319175|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83319176|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83319177|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
83319178|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319179|NCT00615472|Remifentanil|remifentanil|mesh-list
83319181|NCT00615472|Isoflurane|isoflurane|mesh-list
83319182|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83319183|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319184|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319185|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83319186|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
83319187|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
83319188|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83319189|NCT00615472|Narcotics|narcotics|mesh-ancestor
83319190|NCT00615472|Analgesics|analgesics|mesh-ancestor
83319191|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
83319192|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319193|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83319194|NCT00615784|Bexarotene|bexarotene|mesh-list
83319195|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319196|NCT00755794|Montelukast|montelukast|mesh-list
83319197|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83319198|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
83319199|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83319200|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
83319201|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319202|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319203|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83319204|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83319205|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319206|NCT00652444|Simvastatin|simvastatin|mesh-list
83319207|NCT00652444|Ezetimibe|ezetimibe|mesh-list
83319208|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83319209|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83319210|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
83319211|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319212|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83319213|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83319214|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319215|NCT00585910|Methylphenidate|methylphenidate|mesh-list
83319216|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83319217|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83319218|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319219|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83319220|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83319221|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319222|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319223|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
83319224|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319225|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83319226|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
83319227|NCT00489346|Fluticasone|fluticasone|mesh-list
83319228|NCT00489346|Xhance|xhance|mesh-list
83319229|NCT00489346|Montelukast|montelukast|mesh-list
83319230|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319231|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83319232|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
83319233|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319234|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319235|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83319236|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
83319237|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
83319238|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83319239|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319240|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83319241|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
83319242|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319243|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83319244|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83319245|NCT00617188|Fulvestrant|fulvestrant|mesh-list
83319246|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83319247|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319248|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83319249|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83319250|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
83319251|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319252|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319253|NCT00618436|Phenytoin|phenytoin|mesh-list
83319254|NCT00618436|Levetiracetam|levetiracetam|mesh-list
83319255|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
83319256|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
83319257|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83319258|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83319259|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319260|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319261|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83319263|NCT00619060|Niacin|niacin|mesh-list
83319264|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
83319265|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83319266|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
83319267|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319268|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83319269|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
83319270|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
83319271|NCT00619060|Vitamins|vitamins|mesh-ancestor
83319272|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
83319273|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319274|NCT05247424|Heparin|heparin|mesh-list
83319275|NCT05247424|Calcium heparin|calcium heparin|mesh-list
83319276|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
83319277|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83319278|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83319279|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319280|NCT00092716|Atorvastatin|atorvastatin|mesh-list
83319281|NCT00092716|Ezetimibe|ezetimibe|mesh-list
83319282|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83319283|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83319284|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
83319285|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319286|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83319287|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83319288|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319289|NCT00619684|Lenalidomide|lenalidomide|mesh-list
83319290|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
83319291|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319292|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83319293|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83319294|NCT00619684|Growth Substances|growth substances|mesh-ancestor
83319295|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
83319296|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319297|NCT00588406|Prednisone|prednisone|mesh-list
83319298|NCT00588406|Budesonide|budesonide|mesh-list
83319299|NCT00588406|Bromides|bromides|mesh-list
83319300|NCT00588406|Albuterol|albuterol|mesh-list
83319301|NCT00588406|Ipratropium|ipratropium|mesh-list
83319302|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319303|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
83319304|NCT00588406|Hormones|hormones|mesh-ancestor
83319305|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319306|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319307|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83319308|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319309|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83319310|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
83319311|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319312|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83319313|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
83319314|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
83319315|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
83319316|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83319317|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83319318|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83319319|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83319320|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
83319321|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319322|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319323|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83319324|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
83319325|NCT00668434|Prednisone|prednisone|mesh-list
83319326|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319327|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
83319328|NCT00668434|Hormones|hormones|mesh-ancestor
83319329|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319330|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319331|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83319332|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319333|NCT00668902|Pantoprazole|pantoprazole|mesh-list
83319334|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83319335|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319336|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83319337|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319338|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319339|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83319340|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83319341|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83319342|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83319343|NCT00621946|Dexetimide|dexetimide|mesh-list
83319344|NCT00621946|Citalopram|citalopram|mesh-list
83319345|NCT00621946|Escitalopram|escitalopram|mesh-list
83319346|NCT00621946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83319347|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83319348|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319349|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319350|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319351|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
83319352|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319353|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83319354|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83319355|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
83319356|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
83319357|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319358|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83319359|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83319360|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
83319361|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83319362|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
83319363|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83319364|NCT02139358|Gemcitabine|gemcitabine|mesh-list
83319365|NCT02139358|Trastuzumab|trastuzumab|mesh-list
83319366|NCT02139358|Pertuzumab|pertuzumab|mesh-list
83319367|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319368|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
83319369|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319370|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319371|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319372|NCT02140372|Colchicine|colchicine|mesh-list
83319373|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
83319374|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319375|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
83319376|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
83319377|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
83319378|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319379|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319380|NCT00670774|Eculizumab|eculizumab|mesh-list
83319381|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83319382|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319383|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
83319384|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319385|NCT00672100|Ropivacaine|ropivacaine|mesh-list
83319386|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
83319387|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
83319388|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319389|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319390|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
83319391|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319392|NCT00593866|Gemcitabine|gemcitabine|mesh-list
83319393|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319394|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
83319395|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319396|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319397|NCT00624910|Bupivacaine|bupivacaine|mesh-list
83319398|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
83319399|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
83319400|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319401|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319402|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
83319403|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319404|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
83319405|NCT00626626|Clofarabine|clofarabine|mesh-list
83319406|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
83319407|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319408|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319409|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319410|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
83319411|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319412|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319413|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
83319414|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319415|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319416|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83319417|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
83319418|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83319419|NCT00626782|Ranibizumab|ranibizumab|mesh-list
83319420|NCT00626782|Mitomycins|mitomycins|mesh-list
83319421|NCT00626782|Mitomycin|mitomycin|mesh-list
83319422|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83319423|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83319424|NCT00626782|Growth Substances|growth substances|mesh-ancestor
83319425|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319426|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
83319427|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319428|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83319429|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
83319430|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319431|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83319432|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319433|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
83319434|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83319435|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83319436|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
83319437|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
83319438|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319439|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319440|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83319441|NCT00627406|Buserelin|buserelin|mesh-list
83319442|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83319443|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319444|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83319445|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
83319446|NCT00673738|Docetaxel|docetaxel|mesh-list
83319447|NCT00673738|Cetuximab|cetuximab|mesh-list
83319448|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319449|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
83319450|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
83319451|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
83319452|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319453|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319454|NCT00674206|Gemcitabine|gemcitabine|mesh-list
83319455|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
83319456|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319457|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
83319458|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319459|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319460|NCT00595270|Vaccines|vaccines|mesh-list
83319461|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
83319462|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319463|NCT00628498|Defibrotide|defibrotide|mesh-list
83319464|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83319465|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83319466|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319467|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83319468|NCT00629122|Clotrimazole|clotrimazole|mesh-list
83319469|NCT00629122|Miconazole|miconazole|mesh-list
83319470|NCT00629122|Nystatin|nystatin|mesh-list
83319471|NCT00629122|Tacrolimus|tacrolimus|mesh-list
83319472|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319473|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
83319474|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319475|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83319476|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319477|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319478|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83319479|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319480|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
83319481|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83319482|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83319483|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83319484|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
83319485|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319486|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83319487|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83319488|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83319489|NCT00629122|Ionophores|ionophores|mesh-ancestor
83319490|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319491|NCT00596440|Nicotine|nicotine|mesh-list
83319492|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83319493|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
83319494|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319495|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319496|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83319497|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83319498|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
83319499|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319500|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319501|NCT00632632|Cycloserine|cycloserine|mesh-list
83319502|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83319503|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319504|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83319505|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
83319506|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83319507|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
83319508|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319509|NCT00633256|Isoniazid|isoniazid|mesh-list
83319510|NCT00633256|Cycloserine|cycloserine|mesh-list
83319511|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
83319512|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83319513|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319514|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83319515|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83319516|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
83319517|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319518|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83319519|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83319520|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83319521|NCT00634270|Sirolimus|sirolimus|mesh-list
83319522|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83319523|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319524|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83319525|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319526|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
83319527|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319528|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
83319529|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319530|NCT00678418|Naltrexone|naltrexone|mesh-list
83319531|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83319532|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83319533|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319534|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
83319535|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319536|NCT00600340|Paclitaxel|paclitaxel|mesh-list
83319537|NCT00600340|Bevacizumab|bevacizumab|mesh-list
83319538|NCT00600340|Capecitabine|capecitabine|mesh-list
83319539|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83319540|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319541|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
83319542|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
83319543|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
83319544|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319545|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319546|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83319547|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83319548|NCT00600340|Growth Substances|growth substances|mesh-ancestor
83319549|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319550|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
83319551|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319552|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
83319553|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83319554|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
83319555|NCT01799356|Metronidazole|metronidazole|mesh-list
83319556|NCT01799356|Ofloxacin|ofloxacin|mesh-list
83319557|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83319558|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319559|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
83319560|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83319561|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83319562|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319563|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319564|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319565|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83319566|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83319567|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83319568|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83319569|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83319570|NCT00602290|Methylphenidate|methylphenidate|mesh-list
83319571|NCT00602290|Citalopram|citalopram|mesh-list
83319572|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83319573|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319574|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83319575|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83319576|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319577|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319578|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
83319579|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319580|NCT00602290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83319581|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
83319582|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83319583|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
83319584|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83319585|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
83319586|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319587|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83319588|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83319589|NCT00637780|Analgesics|analgesics|mesh-ancestor
83319590|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
83319591|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319592|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319593|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319594|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319595|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319596|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
83319597|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83319598|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83319599|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
83319600|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319601|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319602|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319603|NCT01799902|Urological Agents|urological agents|mesh-ancestor
83319604|NCT00602446|Deferasirox|deferasirox|mesh-list
83319605|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83319606|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
83319607|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
83319608|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319609|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
83319610|NCT00602836|Rituximab|rituximab|mesh-list
83319611|NCT00602836|Lenalidomide|lenalidomide|mesh-list
83319612|NCT00602836|Pentostatin|pentostatin|mesh-list
83319613|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319614|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
83319615|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319616|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319617|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83319618|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
83319619|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319620|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319621|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83319622|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319623|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83319624|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83319625|NCT00602836|Growth Substances|growth substances|mesh-ancestor
83319626|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
83319627|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
83319628|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319629|NCT00683332|Tigecycline|tigecycline|mesh-list
83319630|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83319631|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319632|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83319633|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319634|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319635|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83319636|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
83319637|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319638|NCT00640822|Calcitriol|calcitriol|mesh-list
83319639|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
83319640|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83319641|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83319642|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83319643|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
83319644|NCT00640822|Calcipotriene|calcipotriene|mesh-list
83319645|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319646|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
83319647|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83319648|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319649|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83319650|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319651|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319652|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83319653|NCT00640822|Vitamins|vitamins|mesh-ancestor
83319654|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
83319655|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83319656|NCT00640978|Everolimus|everolimus|mesh-list
83319657|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83319658|NCT00640978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83319659|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83319660|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319661|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319662|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319663|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
83319664|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319665|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319666|NCT00642694|Dexetimide|dexetimide|mesh-list
83319667|NCT00642694|Citalopram|citalopram|mesh-list
83319668|NCT00642694|Escitalopram|escitalopram|mesh-list
83319669|NCT00642694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83319670|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83319671|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319672|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319673|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319674|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
83319675|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319676|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83319677|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83319678|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
83319679|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
83319680|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319681|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83319682|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83319683|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83319684|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83319685|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
83319686|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83319687|NCT00705874|Leucovorin|leucovorin|mesh-list
83319688|NCT00705874|Bevacizumab|bevacizumab|mesh-list
83319689|NCT00705874|Sunitinib|sunitinib|mesh-list
83319690|NCT00705874|Gemcitabine|gemcitabine|mesh-list
83319691|NCT00705874|Docetaxel|docetaxel|mesh-list
83319692|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83319693|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319694|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319695|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83319696|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83319697|NCT00705874|Growth Substances|growth substances|mesh-ancestor
83319698|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319699|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
83319700|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319701|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
83319702|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319703|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
83319704|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
83319705|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
83319706|NCT00705874|Antidotes|antidotes|mesh-ancestor
83319707|NCT00705874|Protective Agents|protective agents|mesh-ancestor
83319708|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
83319709|NCT00705874|Vitamins|vitamins|mesh-ancestor
83319710|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
83319712|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319713|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
83319714|NCT00647998|Hematinics|hematinics|mesh-ancestor
83319715|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
83319716|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83319717|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83319718|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319719|NCT00687076|Aspirin|aspirin|mesh-list
83319720|NCT00687076|Niacin|niacin|mesh-list
83319721|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
83319722|NCT00687076|Clopidogrel|clopidogrel|mesh-list
83319723|NCT00687076|Ezetimibe|ezetimibe|mesh-list
83319724|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83319725|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83319726|NCT00687076|Analgesics|analgesics|mesh-ancestor
83319727|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
83319728|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319729|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319730|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319731|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319732|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83319733|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83319734|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319735|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83319736|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83319737|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319738|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
83319739|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83319740|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83319741|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83319742|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
83319743|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319744|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83319745|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83319746|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
83319747|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83319748|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
83319749|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
83319750|NCT00687076|Vitamins|vitamins|mesh-ancestor
83319751|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
83319752|NCT00687544|Ribavirin|ribavirin|mesh-list
83319753|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83319754|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
83319755|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319756|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
83319757|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319758|NCT02143648|Nalbuphine|nalbuphine|mesh-list
83319759|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83319760|NCT02143648|Narcotics|narcotics|mesh-ancestor
83319761|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319762|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319763|NCT02143648|Analgesics|analgesics|mesh-ancestor
83319764|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
83319765|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319766|NCT02997982|Valacyclovir|valacyclovir|mesh-list
83319767|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
83319768|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319769|NCT00689572|Ondansetron|ondansetron|mesh-list
83319770|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
83319771|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
83319772|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319773|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319774|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319775|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
83319776|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
83319777|NCT00689572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83319778|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83319779|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
83319780|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319781|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319782|NCT01840579|Paclitaxel|paclitaxel|mesh-list
83319783|NCT01840579|Etoposide|etoposide|mesh-list
83319784|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83319785|NCT01840579|Carboplatin|carboplatin|mesh-list
83319786|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
83319787|NCT01840579|Pemetrexed|pemetrexed|mesh-list
83319788|NCT01840579|Ipilimumab|ipilimumab|mesh-list
83319789|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83319790|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319791|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
83319792|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
83319793|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
83319794|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319795|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319796|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83319797|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83319798|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83319799|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319800|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83319801|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83319802|NCT00651040|Prednisone|prednisone|mesh-list
83319803|NCT00651040|Prednisolone|prednisolone|mesh-list
83319804|NCT00651040|Methotrexate|methotrexate|mesh-list
83319805|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319806|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
83319807|NCT00651040|Hormones|hormones|mesh-ancestor
83319808|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319809|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319810|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83319811|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319812|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83319813|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
83319814|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83319815|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319816|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
83319817|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319818|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
83319819|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319820|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83319821|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319822|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
83319823|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319824|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83319825|NCT00654784|Idebenone|idebenone|mesh-list
83319826|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
83319827|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319828|NCT00654784|Protective Agents|protective agents|mesh-ancestor
83319829|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319830|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83319831|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83319832|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319833|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83319834|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319835|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319836|NCT00691600|Trimethoprim|trimethoprim|mesh-list
83319837|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
83319838|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83319839|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319840|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
83319841|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83319842|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83319843|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83319844|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319845|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319846|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83319847|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83319848|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83319849|NCT00655642|Promethazine|promethazine|mesh-list
83319850|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
83319851|NCT00655642|Ondansetron|ondansetron|mesh-list
83319852|NCT00655642|Metoclopramide|metoclopramide|mesh-list
83319853|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
83319854|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
83319855|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319856|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319857|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319858|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
83319859|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
83319860|NCT00655642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83319861|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83319863|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319864|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319865|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83319866|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83319867|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
83319868|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83319869|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
83319870|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
83319871|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83319872|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83319873|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83319874|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319875|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
83319876|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
83319877|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
83319878|NCT00656656|Dexamethasone|dexamethasone|mesh-list
83319879|NCT00656656|Rituximab|rituximab|mesh-list
83319880|NCT00656656|Azathioprine|azathioprine|mesh-list
83319881|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83319882|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319883|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
83319884|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319885|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319886|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319887|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
83319888|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
83319889|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319890|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319891|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
83319892|NCT00656656|Hormones|hormones|mesh-ancestor
83319893|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319894|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83319895|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
83319896|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319897|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319898|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319899|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
83319900|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
83319901|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319902|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
83319903|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319904|NCT00656968|Esomeprazole|esomeprazole|mesh-list
83319905|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83319906|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319907|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83319908|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319909|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319910|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83319911|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83319912|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319913|NCT00657280|Incretins|incretins|mesh-ancestor
83319914|NCT00657280|Hormones|hormones|mesh-ancestor
83319915|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319916|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83319917|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
83319918|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319919|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319920|NCT00693160|Ketorolac|ketorolac|mesh-list
83319921|NCT00693160|Remifentanil|remifentanil|mesh-list
83319922|NCT00693160|Capsaicin|capsaicin|mesh-list
83319923|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83319924|NCT00693160|Narcotics|narcotics|mesh-ancestor
83319925|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319926|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319927|NCT00693160|Analgesics|analgesics|mesh-ancestor
83319928|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
83319929|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319930|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83319931|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83319932|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319933|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319934|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83319935|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319936|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319937|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
83319938|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
83319939|NCT00695188|Methotrexate|methotrexate|mesh-list
83319940|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83319941|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
83319942|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83319943|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319944|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83319945|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
83319946|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319947|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319948|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
83319949|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319950|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83319951|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83319952|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
83319953|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83319954|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83319955|NCT00706264|Silicon|silicon|mesh-list
83319956|NCT00706264|Trace Elements|trace elements|mesh-ancestor
83319957|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
83319958|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319959|NCT00695500|Varenicline|varenicline|mesh-list
83319960|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83319961|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83319962|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
83319963|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83319964|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319965|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319966|NCT00695578|Bacitracin|bacitracin|mesh-list
83319967|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83319968|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83319969|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83319970|NCT01792102|Dexamethasone|dexamethasone|mesh-list
83319971|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83319972|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
83319973|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
83319974|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319975|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319976|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83319977|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
83319978|NCT01792102|Hormones|hormones|mesh-ancestor
83319979|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83319980|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83319981|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319982|NCT02996734|Denosumab|denosumab|mesh-list
83319983|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83319984|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319985|NCT00699010|Oxycodone|oxycodone|mesh-list
83319986|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83319987|NCT00699010|Narcotics|narcotics|mesh-ancestor
83319988|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83319989|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83319990|NCT00699010|Analgesics|analgesics|mesh-ancestor
83319991|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
83319992|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83319993|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
83319994|NCT00706810|Verapamil|verapamil|mesh-list
83319995|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83319996|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
83319997|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83319998|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83319999|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83320000|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83320001|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83320002|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320003|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320004|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320005|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
83320006|NCT00661960|Efavirenz|efavirenz|mesh-list
83320007|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
83320008|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83320009|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83320010|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320011|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320012|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
83320013|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320014|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83320015|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83320016|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83320017|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83320018|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83320019|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83320020|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83320021|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83320022|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83320023|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83320024|NCT00662818|Acetaminophen|acetaminophen|mesh-list
83320025|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83320026|NCT00662818|Analgesics|analgesics|mesh-ancestor
83320027|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
83320028|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320029|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320030|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
83320031|NCT00699556|Nicotine|nicotine|mesh-list
83320032|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83320033|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
83320034|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320035|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320036|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83320037|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83320038|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320039|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320040|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320041|NCT00700336|Cisplatin|cisplatin|mesh-list
83320042|NCT00700336|Pemetrexed|pemetrexed|mesh-list
83320043|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320044|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320045|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320046|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83320047|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83320048|NCT01795846|Immunomodulating Agents|immunomodulating agents|mesh-list
83320049|NCT01795846|Immunologic Factors|immunologic factors|mesh-ancestor
83320050|NCT01795846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320051|NCT00701896|Nicotine|nicotine|mesh-list
83320052|NCT00701896|Varenicline|varenicline|mesh-list
83320053|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83320054|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
83320055|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320056|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320057|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83320058|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83320059|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320060|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320061|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320062|NCT01839487|Dexamethasone|dexamethasone|mesh-list
83320063|NCT01839487|Paclitaxel|paclitaxel|mesh-list
83320064|NCT01839487|Gemcitabine|gemcitabine|mesh-list
83320065|NCT01839487|Enoxaparin|enoxaparin|mesh-list
83320066|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83320067|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320068|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
83320069|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
83320070|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
83320071|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320072|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83320073|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
83320074|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
83320075|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320076|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320077|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83320078|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
83320079|NCT01839487|Hormones|hormones|mesh-ancestor
83320080|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83320081|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83320082|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83320083|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
83320084|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
83320085|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83320086|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83320087|NCT00665470|Aldesleukin|aldesleukin|mesh-list
83320088|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320089|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83320090|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83320091|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
83320092|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320093|NCT00666406|Factor VIII|factor viii|mesh-list
83320094|NCT00666406|Coagulants|coagulants|mesh-ancestor
83320095|NCT02995954|Amlodipine|amlodipine|mesh-list
83320096|NCT02995954|Perindopril|perindopril|mesh-list
83320097|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83320098|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83320099|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320100|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320101|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320102|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320103|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
83320104|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83320105|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
83320106|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320107|NCT01799941|Quinidine|quinidine|mesh-list
83320108|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
83320109|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
83320110|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
83320111|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83320112|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83320113|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320114|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320115|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320116|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83320117|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83320118|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
83320119|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83320120|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
83320121|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83320122|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83320123|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320124|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320125|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83320126|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83320127|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320128|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83320129|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83320130|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320131|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83320132|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83320133|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83320134|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83320135|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83320136|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320137|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320138|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
83320139|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320140|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320141|NCT00713284|Sirolimus|sirolimus|mesh-list
83320142|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83320143|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320144|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83320145|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320146|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
83320147|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320148|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
83320149|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320150|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83320151|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
83320152|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83320153|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83320154|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83320155|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320156|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320157|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320158|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320159|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320160|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83320161|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320162|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83320163|NCT02995720|Amlodipine|amlodipine|mesh-list
83320164|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83320165|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83320166|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83320167|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320168|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320169|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320170|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320171|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
83320172|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83320173|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83320174|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
83320175|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83320176|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83320177|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320178|NCT02990728|Metformin|metformin|mesh-list
83320179|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83320180|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320181|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
83320182|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
83320183|NCT02995330|Testosterone|testosterone|mesh-list
83320184|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
83320185|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
83320186|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83320187|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320188|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
83320189|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320190|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320191|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83320192|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
83320193|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320194|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320195|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83320196|NCT02995330|Androgens|androgens|mesh-ancestor
83320197|NCT02995330|Hormones|hormones|mesh-ancestor
83320198|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83320199|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83320200|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
83320201|NCT02990884|Ketamine|ketamine|mesh-list
83320202|NCT02990884|Analgesics|analgesics|mesh-ancestor
83320203|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
83320204|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320205|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320206|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83320207|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83320208|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
83320209|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
83320210|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83320211|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83320212|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83320213|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320214|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320215|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
83320216|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320217|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320218|NCT02990416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83320219|NCT02990416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320220|NCT02999776|Etanercept|etanercept|mesh-list
83320221|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83320222|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83320223|NCT02999776|Analgesics|analgesics|mesh-ancestor
83320224|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
83320225|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320226|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320227|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83320228|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320229|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83320230|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320231|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
83320232|NCT02996656|Cefazolin|cefazolin|mesh-list
83320234|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83320235|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320236|NCT04387630|Metformin|metformin|mesh-list
83320237|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83320238|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320239|NCT04270318|Pemetrexed|pemetrexed|mesh-list
83320240|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320241|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320242|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320243|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83320244|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83320245|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
83320246|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320247|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
83320248|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320249|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320250|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83320251|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
83320252|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320253|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320254|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83320255|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
83320256|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83320257|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83320258|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320259|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83320260|NCT04270708|Analgesics|analgesics|mesh-ancestor
83320261|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
83320262|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320263|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83320264|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83320265|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83320266|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
83320267|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320268|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320269|NCT00704938|Aldesleukin|aldesleukin|mesh-list
83320270|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
83320271|NCT00704938|Fludarabine|fludarabine|mesh-list
83320272|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
83320273|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320274|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
83320275|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320276|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320277|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83320278|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
83320279|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320280|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320281|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83320282|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83320283|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
83320284|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83320285|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83320286|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
83320287|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320288|NCT02994082|Bupropion|bupropion|mesh-list
83320289|NCT02994082|Nicotine|nicotine|mesh-list
83320290|NCT02994082|Varenicline|varenicline|mesh-list
83320291|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83320292|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
83320293|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320294|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320295|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83320296|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83320297|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320298|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320299|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320300|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83320301|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
83320302|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83320303|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83320304|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83320305|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320306|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
83320307|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83320308|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83320309|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320310|NCT02995096|Sirolimus|sirolimus|mesh-list
83320311|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83320312|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320313|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83320314|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320315|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
83320316|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320317|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
83320318|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320319|NCT01275976|Complement C1s|complement c1s|mesh-list
83320320|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83320321|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83320322|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
83320323|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320324|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83320325|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320326|NCT01270438|Leucovorin|leucovorin|mesh-list
83320327|NCT01270438|Bevacizumab|bevacizumab|mesh-list
83320328|NCT01270438|Fluorouracil|fluorouracil|mesh-list
83320329|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
83320330|NCT01270438|Calcium|calcium|mesh-list
83320331|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
83320332|NCT01270438|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83320333|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320335|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83320336|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83320337|NCT01270438|Growth Substances|growth substances|mesh-ancestor
83320338|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320339|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
83320340|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320341|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
83320342|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320343|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83320344|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320345|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
83320346|NCT01270438|Antidotes|antidotes|mesh-ancestor
83320347|NCT01270438|Protective Agents|protective agents|mesh-ancestor
83320348|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
83320349|NCT01270438|Vitamins|vitamins|mesh-ancestor
83320350|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
83320351|NCT01270438|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83320352|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320353|NCT01270672|Carvedilol|carvedilol|mesh-list
83320354|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83320355|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83320356|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83320357|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
83320358|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320359|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320360|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320361|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83320362|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
83320363|NCT01270672|Protective Agents|protective agents|mesh-ancestor
83320364|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83320365|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320366|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320367|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
83320368|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83320369|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83320370|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
83320371|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83320372|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
83320373|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83320374|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83320375|NCT01276210|Sorafenib|sorafenib|mesh-list
83320376|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320377|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83320378|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320379|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320380|NCT00727636|Vaccines|vaccines|mesh-list
83320381|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
83320382|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320383|NCT01270750|Bosentan|bosentan|mesh-list
83320384|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83320385|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83320386|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320387|NCT00709696|Varenicline|varenicline|mesh-list
83320388|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83320389|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83320390|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320391|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320392|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320393|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320394|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
83320395|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320396|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83320397|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320398|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320399|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
83320400|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83320401|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320402|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320403|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83320404|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83320405|NCT02992678|Protective Agents|protective agents|mesh-ancestor
83320406|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320407|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
83320408|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83320409|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
83320410|NCT02992912|Atezolizumab|atezolizumab|mesh-list
83320411|NCT02992912|Antibodies|antibodies|mesh-list
83320412|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
83320413|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320414|NCT02992912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83320415|NCT02992912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320416|NCT02992912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320417|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320418|NCT01271140|Insulin|insulin|mesh-list
83320419|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83320420|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320421|NCT01271374|Losartan|losartan|mesh-list
83320422|NCT01271374|Amlodipine|amlodipine|mesh-list
83320423|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83320424|NCT01271374|Olmesartan|olmesartan|mesh-list
83320425|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
83320426|NCT01271374|Spironolactone|spironolactone|mesh-list
83320427|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83320428|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83320429|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320430|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320431|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320432|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320433|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
83320434|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83320435|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83320436|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83320437|NCT01271374|Diuretics|diuretics|mesh-ancestor
83320438|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
83320439|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83320440|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83320441|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
83320442|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83320443|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83320444|NCT01276834|Everolimus|everolimus|mesh-list
83320445|NCT01276834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83320446|NCT01276834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83320447|NCT01276834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320448|NCT01276834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320449|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320450|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
83320451|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320452|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320453|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
83320454|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83320455|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320457|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83320458|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320459|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83320460|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320461|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
83320462|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320463|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
83320464|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320465|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
83320466|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83320467|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320468|NCT00717418|Cyclosporine|cyclosporine|mesh-list
83320469|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
83320470|NCT00717418|Cyclosporins|cyclosporins|mesh-list
83320471|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320472|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320473|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320474|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
83320475|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320476|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
83320477|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320478|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
83320479|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320480|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83320481|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83320482|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83320483|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
83320484|NCT00717574|Propofol|propofol|mesh-list
83320485|NCT00717574|Sevoflurane|sevoflurane|mesh-list
83320486|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83320487|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83320488|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320489|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83320490|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
83320491|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
83320492|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83320493|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83320494|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83320495|NCT00717574|Analgesics|analgesics|mesh-ancestor
83320496|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
83320497|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320498|NCT00719134|Rizatriptan|rizatriptan|mesh-list
83320499|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83320500|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
83320501|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320502|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320503|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320504|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
83320505|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83320506|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
83320507|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320508|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320509|NCT00721162|Ramucirumab|ramucirumab|mesh-list
83320510|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320511|NCT01838941|Betaine|betaine|mesh-list
83320512|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83320513|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
83320514|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83320515|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
83320516|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320517|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83320518|NCT01773109|Irinotecan|irinotecan|mesh-list
83320519|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
83320520|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
83320521|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83320522|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320523|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320524|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320525|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83320526|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
83320527|NCT01772719|Simvastatin|simvastatin|mesh-list
83320528|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83320529|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83320530|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
83320531|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320532|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83320533|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83320534|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320535|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83320536|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320537|NCT05582265|Paclitaxel|paclitaxel|mesh-list
83320538|NCT05582265|Cisplatin|cisplatin|mesh-list
83320539|NCT05582265|Tislelizumab|tislelizumab|mesh-list
83320540|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83320541|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320542|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
83320543|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
83320544|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
83320545|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320546|NCT05582265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320547|NCT04144101|Etoricoxib|etoricoxib|mesh-list
83320548|NCT04144101|Aceclofenac|aceclofenac|mesh-list
83320549|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83320550|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83320551|NCT04144101|Analgesics|analgesics|mesh-ancestor
83320552|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
83320553|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320554|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320555|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83320556|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320557|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83320558|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83320559|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320560|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320562|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
83320563|NCT01278238|Phenylephrine|phenylephrine|mesh-list
83320564|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
83320565|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83320566|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
83320567|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
83320568|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320569|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320570|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
83320571|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83320572|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
83320573|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
83320574|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83320575|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83320576|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83320577|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
83320578|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320579|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320580|NCT01278238|Protective Agents|protective agents|mesh-ancestor
83320581|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83320582|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83320583|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83320584|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320585|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320586|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83320587|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320588|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320589|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320590|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320591|NCT01272310|Interferons|interferons|mesh-list
83320592|NCT01272310|Ribavirin|ribavirin|mesh-list
83320593|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
83320594|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
83320595|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83320596|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
83320597|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320598|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
83320599|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320600|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
83320601|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320602|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
83320603|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320604|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
83320605|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83320606|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83320607|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320608|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320609|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83320610|NCT04386850|Calcifediol|calcifediol|mesh-list
83320611|NCT04386850|Vitamins|vitamins|mesh-ancestor
83320612|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
83320613|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320614|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83320615|NCT01272778|Lorazepam|lorazepam|mesh-list
83320616|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
83320617|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
83320618|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
83320619|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320620|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320621|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83320622|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83320623|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83320624|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83320625|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83320626|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83320627|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
83320628|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
83320629|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320630|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320632|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83320633|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320634|NCT01272856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320635|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320636|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320637|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
83320638|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320639|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320640|NCT01273090|Imetelstat|imetelstat|mesh-list
83320641|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
83320642|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320643|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320644|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83320645|NCT01273246|Vaccines|vaccines|mesh-list
83320646|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
83320647|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320648|NCT00730522|Vigabatrin|vigabatrin|mesh-list
83320649|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
83320650|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320651|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320652|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
83320653|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320654|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320655|NCT04345276|Ritonavir|ritonavir|mesh-list
83320656|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83320657|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83320658|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
83320659|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320660|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320661|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83320662|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83320663|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
83320664|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320665|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83320666|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83320667|NCT01273558|Canagliflozin|canagliflozin|mesh-list
83413618|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83320668|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83320669|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320670|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83320671|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320672|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
83320673|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83320674|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83320675|NCT00733096|Prednisolone|prednisolone|mesh-list
83320676|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
83320677|NCT00733096|Etanercept|etanercept|mesh-list
83320678|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83320679|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
83320680|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83320681|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
83320682|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
83320683|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320684|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320685|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83320686|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
83320687|NCT00733096|Hormones|hormones|mesh-ancestor
83320688|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83320689|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83320690|NCT00733096|Protective Agents|protective agents|mesh-ancestor
83320691|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83320692|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320693|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83320694|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83320695|NCT00733096|Analgesics|analgesics|mesh-ancestor
83320696|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
83320697|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320698|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320699|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
83320700|NCT02991196|Nivolumab|nivolumab|mesh-list
83320701|NCT02991196|DS-8273a|ds-8273a|mesh-list
83320702|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320703|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320704|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83320705|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320706|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
83320707|NCT01278784|Chitosan|chitosan|mesh-list
83320708|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83320709|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83320710|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83320711|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
83320712|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320713|NCT01278784|Expectorants|expectorants|mesh-ancestor
83320714|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
83320715|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83320716|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
83320717|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320718|NCT01278784|Protective Agents|protective agents|mesh-ancestor
83320719|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320720|NCT01278784|Antidotes|antidotes|mesh-ancestor
83320721|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83320722|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83320723|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
83320724|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83320725|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
83320726|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
83320727|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
83320728|NCT01278784|Coagulants|coagulants|mesh-ancestor
83320729|NCT01276288|Empagliflozin|empagliflozin|mesh-list
83320730|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83320731|NCT01276288|Torsemide|torsemide|mesh-list
83320732|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83320733|NCT01276288|Diuretics|diuretics|mesh-ancestor
83320734|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
83320735|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320736|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83320737|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320738|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320739|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83320740|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83320741|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83320742|NCT00722566|Bortezomib|bortezomib|mesh-list
83320743|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320744|NCT00722722|Bortezomib|bortezomib|mesh-list
83320745|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320746|NCT00723580|Risperidone|risperidone|mesh-list
83320747|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83320748|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
83320749|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320750|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320751|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320752|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83320753|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83320754|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83320755|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83320756|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83320757|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
83320758|NCT01273948|Interferons|interferons|mesh-list
83320759|NCT01273948|Bavituximab|bavituximab|mesh-list
83320760|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320761|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
83320762|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320763|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320764|NCT00734344|Tenofovir|tenofovir|mesh-list
83320765|NCT00734344|Efavirenz|efavirenz|mesh-list
83320766|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
83320767|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
83320768|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320769|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83320770|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83320771|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320772|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320773|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83320774|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83320775|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83320776|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83320777|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83320778|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83320779|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83320780|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83320781|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83320782|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83320783|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
83320784|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320785|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320786|NCT04148937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83320787|NCT04148937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320788|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
83320789|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320790|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320791|NCT03021057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83320792|NCT03021057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320793|NCT00734500|Anidulafungin|anidulafungin|mesh-list
83320794|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
83320795|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320796|NCT04143321|Empagliflozin|empagliflozin|mesh-list
83320797|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83320798|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320799|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83320800|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320801|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
83320802|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83320803|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320804|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83320805|NCT00735436|Bevacizumab|bevacizumab|mesh-list
83320806|NCT00735436|Irinotecan|irinotecan|mesh-list
83320807|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320808|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320809|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83320810|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83320811|NCT00735436|Growth Substances|growth substances|mesh-ancestor
83320812|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320813|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
83320814|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83320815|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83320816|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413619|NCT01307605|Growth Substances|growth substances|mesh-ancestor
83320817|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320818|NCT04143165|Lidocaine|lidocaine|mesh-list
83320819|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
83320820|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
83320821|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83320822|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320823|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
83320824|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320825|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83320826|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83320827|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83320828|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320829|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320830|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83320831|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83320832|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83320833|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83320834|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320835|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320836|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320837|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83320838|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
83320839|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83320840|NCT00735826|Vorinostat|vorinostat|mesh-list
83320842|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83320843|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320844|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320845|NCT03916341|Nicotine|nicotine|mesh-list
83320846|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83320847|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
83320848|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320849|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320850|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83320851|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83320852|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
83320853|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320854|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320855|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83320856|NCT01276054|Methylene Blue|methylene blue|mesh-list
83320857|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83320858|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320859|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320860|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83320861|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
83320862|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83320863|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
83320864|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320865|NCT00724594|Expectorants|expectorants|mesh-ancestor
83320866|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
83320867|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83320868|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
83320869|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320870|NCT00724594|Protective Agents|protective agents|mesh-ancestor
83320871|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320872|NCT00724594|Antidotes|antidotes|mesh-ancestor
83320873|NCT04142931|Nivolumab|nivolumab|mesh-list
83320874|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320875|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320876|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83320877|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320878|NCT04143477|Peficitinib|peficitinib|mesh-list
83320879|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320880|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320881|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320882|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
83320883|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320884|NCT05586009|Cisplatin|cisplatin|mesh-list
83320885|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320886|NCT03020979|Apatinib|apatinib|mesh-list
83320887|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320888|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83320889|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320890|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320891|NCT04142151|Aspirin|aspirin|mesh-list
83320892|NCT04142151|Clopidogrel|clopidogrel|mesh-list
83320893|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83320894|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83320895|NCT04142151|Analgesics|analgesics|mesh-ancestor
83320896|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
83320897|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83320898|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320899|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83320900|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83320901|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83320902|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83320903|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320904|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83320905|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83320906|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320907|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
83320908|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83320909|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83320910|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83320911|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
83320912|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320913|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83320914|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83320915|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83320916|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
83320917|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320918|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83320919|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83320920|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320921|NCT03904329|Anticoagulants|anticoagulants|mesh-list
83320922|NCT04141995|Leucovorin|leucovorin|mesh-list
83320923|NCT04141995|Fluorouracil|fluorouracil|mesh-list
83320924|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
83320925|NCT04141995|Irinotecan|irinotecan|mesh-list
83320926|NCT04141995|Camptothecin|camptothecin|mesh-list
83320927|NCT04141995|Digoxin|digoxin|mesh-list
83320928|NCT04141995|Calcium|calcium|mesh-list
83320929|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
83320930|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83320931|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320932|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
83320933|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320934|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83320935|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320936|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320937|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
83320938|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83320939|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83320940|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320941|NCT04141995|Antidotes|antidotes|mesh-ancestor
83320942|NCT04141995|Protective Agents|protective agents|mesh-ancestor
83320943|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
83320944|NCT04141995|Vitamins|vitamins|mesh-ancestor
83320945|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
83320946|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83320947|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83320948|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83320949|NCT04149483|Atorvastatin|atorvastatin|mesh-list
83320950|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83320951|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83320952|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
83320953|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320954|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83320955|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83320956|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83320957|NCT04149327|Amoxicillin|amoxicillin|mesh-list
83320958|NCT04149327|Metronidazole|metronidazole|mesh-list
83320959|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83320960|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83320961|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83320962|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83320963|NCT05582577|Bevacizumab|bevacizumab|mesh-list
83320964|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83320965|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320966|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83320967|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83320968|NCT05582577|Growth Substances|growth substances|mesh-ancestor
83320969|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320970|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
83320971|NCT04149015|Paclitaxel|paclitaxel|mesh-list
83320972|NCT04149015|Fluorouracil|fluorouracil|mesh-list
83320973|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
83320974|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83320975|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83320976|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83320977|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83320978|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83320979|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320980|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
83320981|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83320982|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83320983|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
83320984|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320985|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
83320986|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83320987|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83320988|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320989|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
83320990|NCT04149171|Coagulants|coagulants|mesh-ancestor
83320991|NCT04140591|Propranolol|propranolol|mesh-list
83320992|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83320993|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83320994|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83320995|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
83320996|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83320997|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83320998|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83320999|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83321000|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83321001|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
83321002|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321003|NCT05582109|Lenvatinib|lenvatinib|mesh-list
83321004|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321005|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321006|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321007|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321008|NCT03020901|Teicoplanin|teicoplanin|mesh-list
83321009|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321010|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321011|NCT04140201|Simvastatin|simvastatin|mesh-list
83321012|NCT04140201|Fenofibrate|fenofibrate|mesh-list
83321013|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83321014|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83321015|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
83321016|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321017|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83321018|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83321019|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321020|NCT05581875|Dexamethasone|dexamethasone|mesh-list
83321021|NCT05581875|Daratumumab|daratumumab|mesh-list
83321022|NCT05581875|Pomalidomide|pomalidomide|mesh-list
83321023|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321024|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
83321025|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
83321026|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321027|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321028|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321029|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
83321030|NCT05581875|Hormones|hormones|mesh-ancestor
83321031|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321032|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321033|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321034|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
83321035|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83321036|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83321037|NCT05581875|Growth Substances|growth substances|mesh-ancestor
83321038|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
83321039|NCT04406025|Anesthetics|anesthetics|mesh-list
83321040|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321041|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321042|NCT05587881|Vaccines|vaccines|mesh-list
83321043|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
83321044|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321045|NCT05582421|Diclofenac|diclofenac|mesh-list
83321046|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83321047|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83321048|NCT05582421|Analgesics|analgesics|mesh-ancestor
83321049|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
83321050|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321051|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321052|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321053|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321054|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83321055|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321056|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321057|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
83321058|NCT03580473|Dexamethasone|dexamethasone|mesh-list
83321059|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83321060|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321061|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
83321062|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
83321063|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321064|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321065|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321066|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
83321067|NCT03580473|Hormones|hormones|mesh-ancestor
83321068|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321069|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321070|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321071|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321072|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321073|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321074|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321075|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83321076|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83321077|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83321078|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
83321079|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83321080|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83321081|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83321082|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83321083|NCT03897309|Vaccines|vaccines|mesh-list
83321084|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
83321085|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321086|NCT03588429|Sevoflurane|sevoflurane|mesh-list
83321087|NCT03588429|Isoflurane|isoflurane|mesh-list
83321088|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83321089|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83321090|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
83321091|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
83321092|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321093|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321094|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
83321095|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83321096|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
83321097|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
83321098|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83321099|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321100|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
83321101|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83321102|NCT03588351|Chitosan|chitosan|mesh-list
83321103|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83321104|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321105|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
83321106|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
83321107|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83321108|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83321109|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
83321110|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321111|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83321112|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
83321113|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
83321114|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
83321115|NCT03588351|Coagulants|coagulants|mesh-ancestor
83321116|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
83321117|NCT03585465|Capecitabine|capecitabine|mesh-list
83321118|NCT03585465|Nivolumab|nivolumab|mesh-list
83321119|NCT03585465|Vinblastine|vinblastine|mesh-list
83321120|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321121|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
83321122|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321123|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321124|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83321125|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
83321126|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321127|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321128|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83321129|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83321130|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
83321131|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321132|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83321133|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83321134|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
83321135|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
83321136|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
83321137|NCT03588273|Amoxicillin|amoxicillin|mesh-list
83321138|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321139|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321140|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
83321141|NCT02984865|Sufentanil|sufentanil|mesh-list
83321142|NCT02984865|Nalbuphine|nalbuphine|mesh-list
83321144|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83321145|NCT02984865|Narcotics|narcotics|mesh-ancestor
83321146|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321147|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321148|NCT02984865|Analgesics|analgesics|mesh-ancestor
83321149|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
83321150|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321151|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83321152|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83321153|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
83321154|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
83321155|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83321156|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83321157|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321158|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321159|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83321160|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321161|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321162|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83321163|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83321164|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83321165|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
83321166|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321167|NCT03935451|Apixaban|apixaban|mesh-list
83321168|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83321169|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
83321170|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83321171|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
83321172|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321173|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321174|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
83321175|NCT01611259|Rituximab|rituximab|mesh-list
83321176|NCT01611259|Lenalidomide|lenalidomide|mesh-list
83321177|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321178|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321179|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
83321180|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321181|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321182|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83321183|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83321184|NCT01611259|Growth Substances|growth substances|mesh-ancestor
83321185|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
83321186|NCT03586869|Leucovorin|leucovorin|mesh-list
83321187|NCT03586869|Paclitaxel|paclitaxel|mesh-list
83321188|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
83321189|NCT03586869|Bevacizumab|bevacizumab|mesh-list
83321190|NCT03586869|Fluorouracil|fluorouracil|mesh-list
83321191|NCT03586869|Capecitabine|capecitabine|mesh-list
83321192|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
83321193|NCT03586869|Avelumab|avelumab|mesh-list
83321194|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83321195|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321196|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
83321197|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
83321198|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
83321199|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321200|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321201|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
83321202|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321203|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321204|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83321205|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
83321206|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83321207|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321208|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83321209|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83321210|NCT03586869|Growth Substances|growth substances|mesh-ancestor
83321211|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
83321213|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83321215|NCT03586869|Protective Agents|protective agents|mesh-ancestor
83321216|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
83321217|NCT03586869|Vitamins|vitamins|mesh-ancestor
83321218|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
83321219|NCT01796197|Paclitaxel|paclitaxel|mesh-list
83321220|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
83321221|NCT01796197|Doxorubicin|doxorubicin|mesh-list
83321222|NCT01796197|Trastuzumab|trastuzumab|mesh-list
83321223|NCT01796197|Pertuzumab|pertuzumab|mesh-list
83321224|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83321225|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321226|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83321227|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83321228|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83321229|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321230|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321231|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
83321232|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321233|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321234|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83321235|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
83321236|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83321237|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83321238|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83321239|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83321240|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321241|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321242|NCT03586791|Anesthetics|anesthetics|mesh-list
83321243|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321244|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321245|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
83321246|NCT01795495|Remifentanil|remifentanil|mesh-list
83321247|NCT01795495|Methadone|methadone|mesh-list
83321248|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83321249|NCT01795495|Narcotics|narcotics|mesh-ancestor
83321250|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321251|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321252|NCT01795495|Analgesics|analgesics|mesh-ancestor
83321253|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
83321254|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321255|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
83321256|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83321257|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
83321258|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83321259|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83321260|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321261|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83321262|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
83321263|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83321264|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
83321265|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
83321266|NCT04765527|Turmeric extract|turmeric extract|mesh-list
83321267|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
83321268|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321269|NCT04765527|Protective Agents|protective agents|mesh-ancestor
83321270|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321271|NCT02947503|Metformin|metformin|mesh-list
83321272|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83321273|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321274|NCT03586323|Lidocaine|lidocaine|mesh-list
83321275|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
83321276|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
83321277|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321278|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321279|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
83321280|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321281|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83321282|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83321283|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83321284|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83321285|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321287|NCT03586089|Phenobarbital|phenobarbital|mesh-list
83321288|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83321289|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
83321290|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
83321291|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
83321292|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321293|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321294|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321295|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83321296|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321297|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83321298|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83321299|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83321300|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83321301|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83321302|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83321303|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
83321304|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
83321305|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
83321306|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
83321307|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83321308|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321309|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83321310|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83321311|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83321312|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83321313|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83321314|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
83321315|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83321316|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321317|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83321318|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321319|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
83321320|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321321|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321322|NCT04592653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83321323|NCT04592653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321325|NCT03580395|Apatinib|apatinib|mesh-list
83321326|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83321327|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321328|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
83321329|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
83321330|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
83321331|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321332|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321333|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321334|NCT01770145|Levodopa|levodopa|mesh-list
83321335|NCT01770145|Carbidopa|carbidopa|mesh-list
83321336|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83321337|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
83321338|NCT01770145|Apomorphine|apomorphine|mesh-list
83321339|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83321340|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83321341|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
83321342|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83321343|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321344|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321345|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83321346|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321347|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83321348|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
83321349|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
83321350|NCT01770145|Emetics|emetics|mesh-ancestor
83321351|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
83321352|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321353|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321354|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
83321355|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83321356|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321357|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321358|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321359|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321360|NCT03580239|Everolimus|everolimus|mesh-list
83321361|NCT03580239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83321362|NCT03580239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321363|NCT03580239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321364|NCT03580239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321365|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321366|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
83321367|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321368|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321369|NCT03156153|Bumetanide|bumetanide|mesh-list
83321370|NCT03156153|Diuretics|diuretics|mesh-ancestor
83321371|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
83321372|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321373|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83321374|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83321375|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321376|NCT03156231|Acetazolamide|acetazolamide|mesh-list
83321377|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
83321378|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83321379|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321380|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321381|NCT03156231|Diuretics|diuretics|mesh-ancestor
83321382|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
83321383|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321384|NCT05702151|Morphine|morphine|mesh-list
83321385|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83321386|NCT05702151|Narcotics|narcotics|mesh-ancestor
83321387|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321388|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321389|NCT05702151|Analgesics|analgesics|mesh-ancestor
83321390|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
83321391|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321392|NCT05701995|Deucravacitinib|deucravacitinib|mesh-list
83321393|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
83321394|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321395|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321396|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321397|NCT01985321|Ethanol|ethanol|mesh-list
83321398|NCT01985321|Glycolic acid|glycolic acid|mesh-list
83321399|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83321400|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321401|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321402|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321403|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
83321404|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
83321405|NCT03584919|Doxycycline|doxycycline|mesh-list
83321406|NCT03584919|Cefuroxime|cefuroxime|mesh-list
83321407|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
83321408|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321409|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321410|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
83321411|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83321412|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83321413|NCT03584841|Pilocarpine|pilocarpine|mesh-list
83321414|NCT03584841|Miotics|miotics|mesh-ancestor
83321415|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
83321416|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321417|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321418|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83321419|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83321420|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
83321421|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83321422|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321423|NCT02000921|Nicotine|nicotine|mesh-list
83321424|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83321425|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
83321426|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321427|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321428|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83321429|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83321430|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
83321431|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83321432|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321433|NCT03586947|Vitamin D|vitamin d|mesh-list
83321434|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
83321435|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
83321436|NCT03586947|Vitamins|vitamins|mesh-list
83321437|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
83321438|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321439|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83321440|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83321441|NCT03584529|Vitamin D|vitamin d|mesh-list
83321442|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
83321443|NCT03584529|Vitamins|vitamins|mesh-ancestor
83321444|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
83321445|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321446|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83321447|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83321448|NCT00724984|Abexinostat|abexinostat|mesh-list
83321449|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83321450|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321451|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321452|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
83321453|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83321454|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83321455|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321456|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
83321457|NCT03113253|Coagulants|coagulants|mesh-ancestor
83321458|NCT01836523|Liraglutide|liraglutide|mesh-list
83321459|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83321460|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321461|NCT01836523|Incretins|incretins|mesh-ancestor
83321462|NCT01836523|Hormones|hormones|mesh-ancestor
83321463|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321464|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
83321465|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321466|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321467|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321468|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321469|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83321470|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83321471|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321472|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
83321473|NCT02000531|Cisplatin|cisplatin|mesh-list
83321474|NCT02000531|Gemcitabine|gemcitabine|mesh-list
83321475|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83321476|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321477|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83321478|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
83321479|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321480|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321481|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321482|NCT01609231|Irinotecan|irinotecan|mesh-list
83321483|NCT01609231|Cetuximab|cetuximab|mesh-list
83321484|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83321485|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83321486|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321487|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321488|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321489|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321490|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
83321491|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83321492|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83321493|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83321494|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83321495|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321496|NCT04405011|Entecavir|entecavir|mesh-list
83321497|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
83321498|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321499|NCT01769443|Bortezomib|bortezomib|mesh-list
83321500|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321501|NCT03154827|Atezolizumab|atezolizumab|mesh-list
83321502|NCT03154827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83321503|NCT03154827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321504|NCT03154827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321505|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321506|NCT01274182|Rituximab|rituximab|mesh-list
83321507|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321508|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321509|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
83321510|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321511|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321512|NCT01984229|Posaconazole|posaconazole|mesh-list
83321513|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
83321514|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321515|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83321516|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83321517|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83321518|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83321519|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83321520|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321521|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321522|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83321523|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
83321524|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321525|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321526|NCT01274026|Verapamil|verapamil|mesh-list
83321527|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83321528|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83321529|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83321530|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321531|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83321532|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321533|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
83321534|NCT01274104|Vitamin D|vitamin d|mesh-list
83321535|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
83321536|NCT01274104|Vitamins|vitamins|mesh-ancestor
83321537|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
83321538|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321539|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83321540|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83321541|NCT01279096|Dexamethasone|dexamethasone|mesh-list
83321542|NCT01279096|Etoposide|etoposide|mesh-list
83321543|NCT01279096|Asparaginase|asparaginase|mesh-list
83321544|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
83321545|NCT01279096|Clofarabine|clofarabine|mesh-list
83321546|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321547|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
83321548|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
83321549|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321550|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321551|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321552|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
83321553|NCT01279096|Hormones|hormones|mesh-ancestor
83321554|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321555|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321556|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321557|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321558|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321559|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83321560|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83321561|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83321562|NCT01279096|Analgesics|analgesics|mesh-ancestor
83321563|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
83321564|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83321565|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
83321566|NCT01272934|Diclofenac|diclofenac|mesh-list
83321567|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83321568|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83321569|NCT01272934|Analgesics|analgesics|mesh-ancestor
83321570|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
83321571|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321572|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321573|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321574|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321575|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83321576|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321577|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321578|NCT01279252|Metronidazole|metronidazole|mesh-list
83321579|NCT01279252|Clarithromycin|clarithromycin|mesh-list
83321580|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
83321581|NCT01279252|Lansoprazole|lansoprazole|mesh-list
83321582|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
83321583|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321584|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321585|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83321586|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83321587|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83321588|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321589|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321590|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83321591|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83321592|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83321593|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83321594|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321595|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83321596|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83321597|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321598|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83321599|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83321600|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
83321601|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83321602|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83321603|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
83321604|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321605|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321606|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
83321607|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83321608|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83321609|NCT01274260|Prednisolone|prednisolone|mesh-list
83321610|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
83321611|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83321612|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
83321613|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321614|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
83321615|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
83321616|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321617|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321618|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321619|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
83321620|NCT01274260|Hormones|hormones|mesh-ancestor
83321621|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321622|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83321623|NCT01274260|Protective Agents|protective agents|mesh-ancestor
83321624|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321625|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321626|NCT03154983|Docetaxel|docetaxel|mesh-list
83321627|NCT03154983|Apatinib|apatinib|mesh-list
83321628|NCT03154983|Tegafur|tegafur|mesh-list
83321629|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321630|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
83321631|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
83321632|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
83321633|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321634|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321635|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321636|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83321637|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
83321638|NCT01983683|Vancomycin|vancomycin|mesh-list
83321639|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
83321640|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321641|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321642|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83321643|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321644|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321645|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
83321646|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
83321647|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321648|NCT03158025|Zolpidem|zolpidem|mesh-list
83321649|NCT03158025|Suvorexant|suvorexant|mesh-list
83321650|NCT03158025|Lemborexant|lemborexant|mesh-list
83321651|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83321652|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83321653|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321654|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321655|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83321656|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
83321657|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
83321658|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83321659|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321660|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83321661|NCT01998893|Rituximab|rituximab|mesh-list
83321662|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321663|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321664|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
83321665|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321666|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321667|NCT01791985|Letrozole|letrozole|mesh-list
83321668|NCT01791985|Anastrozole|anastrozole|mesh-list
83321669|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321670|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83321671|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83321672|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321673|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321674|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83321675|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
83321676|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321677|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321678|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321679|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83321680|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83321681|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321682|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83321683|NCT03154281|Everolimus|everolimus|mesh-list
83321684|NCT03154281|Niraparib|niraparib|mesh-list
83321685|NCT03154281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83321686|NCT03154281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321687|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321688|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321689|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321690|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
83321691|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321692|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321693|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83321694|NCT03157791|Simethicone|simethicone|mesh-list
83321695|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
83321696|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321697|NCT03157791|Emollients|emollients|mesh-ancestor
83321698|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
83321699|NCT05701059|Meloxicam|meloxicam|mesh-list
83321700|NCT05701059|Cimetidine|cimetidine|mesh-list
83321701|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83321702|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321703|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83321704|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
83321705|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
83321706|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83321707|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321708|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321709|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83321710|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83321711|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321712|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83321713|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83321715|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
83321716|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321717|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321718|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321719|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83321720|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83321721|NCT03157479|Anesthetics|anesthetics|mesh-list
83321722|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
83321723|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321724|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321725|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
83321726|NCT03013491|Ipilimumab|ipilimumab|mesh-list
83321727|NCT03013491|Vemurafenib|vemurafenib|mesh-list
83321728|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321729|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321730|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83321731|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321732|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83321733|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321734|NCT01272232|Liraglutide|liraglutide|mesh-list
83321735|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83321736|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321737|NCT01272232|Incretins|incretins|mesh-ancestor
83321738|NCT01272232|Hormones|hormones|mesh-ancestor
83321739|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321740|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
83321741|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83321742|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83321743|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321744|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
83321745|NCT03157401|Coagulants|coagulants|mesh-ancestor
83321746|NCT03153813|Capsaicin|capsaicin|mesh-list
83321747|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
83321748|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
83321749|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
83321750|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321751|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321752|NCT03156855|Bismuth|bismuth|mesh-list
83321753|NCT03156855|Antacids|antacids|mesh-ancestor
83321754|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321755|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321756|NCT00739960|Abatacept|abatacept|mesh-list
83321757|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83321758|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321759|NCT00739960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321760|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321761|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321762|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
83321763|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321764|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321765|NCT03153657|Piroxicam|piroxicam|mesh-list
83321766|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
83321767|NCT03153657|Betadex|betadex|mesh-list
83321768|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83321769|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83321770|NCT03153657|Analgesics|analgesics|mesh-ancestor
83321771|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
83321772|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321773|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321774|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321775|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321776|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83321777|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321778|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321779|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
83321780|NCT01670955|Folic Acid|folic acid|mesh-list
83321781|NCT01670955|Hematinics|hematinics|mesh-ancestor
83321782|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
83321783|NCT01670955|Vitamins|vitamins|mesh-ancestor
83321784|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
83321785|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321786|NCT01275274|Tretinoin|tretinoin|mesh-list
83321787|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321788|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
83321789|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
83321790|NCT01997333|Capecitabine|capecitabine|mesh-list
83321791|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83321792|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
83321793|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321794|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321795|NCT01271920|Trastuzumab|trastuzumab|mesh-list
83321796|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321797|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321798|NCT01275352|Eplerenone|eplerenone|mesh-list
83321799|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83321800|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
83321801|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321802|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321803|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83321804|NCT01275352|Diuretics|diuretics|mesh-ancestor
83321805|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
83321806|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83321807|NCT01676259|Paclitaxel|paclitaxel|mesh-list
83321808|NCT01676259|Gemcitabine|gemcitabine|mesh-list
83321809|NCT01676259|Folfirinox|folfirinox|mesh-list
83321810|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83321811|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321812|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
83321813|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
83321814|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
83321815|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321816|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83321817|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
83321818|NCT02662257|Propofol|propofol|mesh-list
83321819|NCT02662257|Sevoflurane|sevoflurane|mesh-list
83321820|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83321821|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321822|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321823|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83321824|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
83321825|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
83321826|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83321827|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83321828|NCT03153267|Doxycycline|doxycycline|mesh-list
83321829|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321830|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321831|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
83321832|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83321833|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83321834|NCT00746512|Prednisone|prednisone|mesh-list
83321835|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321836|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
83321837|NCT00746512|Hormones|hormones|mesh-ancestor
83321838|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321839|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321840|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321841|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321842|NCT05409027|Cortisone|cortisone|mesh-list
83321843|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83321844|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
83321845|NCT05409027|Hormones|hormones|mesh-ancestor
83321846|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321847|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321848|NCT01982435|Ranibizumab|ranibizumab|mesh-list
83321849|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83321850|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83321851|NCT01982435|Growth Substances|growth substances|mesh-ancestor
83321852|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321853|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
83321854|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321855|NCT00747214|Prednisolone|prednisolone|mesh-list
83321856|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
83321857|NCT00747214|Dipyridamole|dipyridamole|mesh-list
83321858|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321859|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
83321860|NCT00747214|Hormones|hormones|mesh-ancestor
83321861|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321862|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321863|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321864|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321865|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83321866|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321867|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321868|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83321869|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
83321870|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83321871|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83321872|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83321873|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83321874|NCT01279876|Melatonin|melatonin|mesh-list
83321875|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
83321876|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321877|NCT01279876|Protective Agents|protective agents|mesh-ancestor
83321878|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321879|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83321880|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83321881|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
83321882|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83321883|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83321884|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321885|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
83321886|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
83321887|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321888|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
83321889|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321890|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321891|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83321892|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
83321893|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321894|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321895|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83321896|NCT01279954|Abatacept|abatacept|mesh-list
83321897|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83321898|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321899|NCT01279954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321900|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321901|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83321902|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
83321903|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321904|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83321905|NCT00763048|Triclosan|triclosan|mesh-list
83321906|NCT00763048|Fluorides|fluorides|mesh-list
83321907|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
83321908|NCT00763048|Protective Agents|protective agents|mesh-ancestor
83321909|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321910|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83321911|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321912|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83321913|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83321914|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
83321915|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321916|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83321917|NCT01278394|Tavaborole|tavaborole|mesh-list
83321918|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
83321919|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321920|NCT00240916|Vaccines|vaccines|mesh-list
83321921|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
83321922|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321923|NCT01278160|Insulin|insulin|mesh-list
83321924|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83321925|NCT01278160|Metformin|metformin|mesh-list
83321926|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
83321927|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
83321928|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83321929|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
83321930|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83321931|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
83321932|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83321933|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321934|NCT00748072|Vasopressins|vasopressins|mesh-list
83321935|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
83321936|NCT00748072|Coagulants|coagulants|mesh-ancestor
83321937|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83321938|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83321939|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
83321940|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321941|NCT01835587|Cc-486|cc-486|mesh-list
83321942|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321943|NCT01736917|Dexamethasone|dexamethasone|mesh-list
83321944|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
83321945|NCT01736917|Aprepitant|aprepitant|mesh-list
83321946|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83321947|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
83321948|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
83321949|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83321950|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321951|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83321952|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
83321953|NCT01736917|Hormones|hormones|mesh-ancestor
83321954|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83321955|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83321956|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321957|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83321958|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83321959|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321960|NCT01277302|Ranibizumab|ranibizumab|mesh-list
83321961|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83321962|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83321963|NCT01277302|Growth Substances|growth substances|mesh-ancestor
83321964|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321965|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
83321966|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321967|NCT04414579|Insulin|insulin|mesh-list
83321968|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83321969|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
83321970|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
83321971|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83321972|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83321973|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83321974|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
83321975|NCT01980875|Idelalisib|idelalisib|mesh-list
83321976|NCT01980875|Chlorambucil|chlorambucil|mesh-list
83321977|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83321978|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321979|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321980|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321981|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83321982|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
83321983|NCT01967225|Linezolid|linezolid|mesh-list
83321984|NCT01967225|Tedizolid|tedizolid|mesh-list
83321985|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
83321986|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83321987|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83321988|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83321989|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83321990|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321991|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83321992|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83321993|NCT01790503|Temozolomide|temozolomide|mesh-list
83321994|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83321995|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
83321996|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83321997|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83321998|NCT01765543|Rifampin|rifampin|mesh-list
83321999|NCT01765543|Vemurafenib|vemurafenib|mesh-list
83322000|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83322001|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
83322002|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322003|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322004|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
83322005|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83322006|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322007|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322008|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83322009|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83322010|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83322011|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83322012|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83322013|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83322014|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322015|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83322016|NCT00248170|Letrozole|letrozole|mesh-list
83322017|NCT00248170|Anastrozole|anastrozole|mesh-list
83322018|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322019|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83322020|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83322021|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322022|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322023|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83322024|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
83322025|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322026|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322027|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83322028|NCT01764997|Adalimumab|adalimumab|mesh-list
83322029|NCT01764997|Etanercept|etanercept|mesh-list
83322030|NCT01764997|Methotrexate|methotrexate|mesh-list
83322031|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83322032|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
83322033|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83322034|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322035|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83322036|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
83322037|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322038|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322039|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
83322040|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322041|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83322042|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83322043|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
83322044|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322045|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83322046|NCT01764997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83322047|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322048|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322049|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322050|NCT01764997|Analgesics|analgesics|mesh-ancestor
83322051|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
83322052|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322053|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322054|NCT01276756|Interferons|interferons|mesh-list
83322055|NCT01276756|Ribavirin|ribavirin|mesh-list
83322056|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
83322057|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
83322058|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83322059|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
83322060|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322061|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
83322062|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322063|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
83322064|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322065|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
83322066|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322067|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83322068|NCT00246376|Niacin|niacin|mesh-list
83322069|NCT00246376|Fenofibrate|fenofibrate|mesh-list
83322070|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83322071|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
83322072|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322073|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83322075|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
83322076|NCT00246376|Vitamins|vitamins|mesh-ancestor
83322077|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
83322078|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322079|NCT03806062|Domperidone|domperidone|mesh-list
83322080|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
83322081|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
83322082|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322083|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322084|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322085|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83322086|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
83322087|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322088|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322089|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
83322090|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83322091|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
83322092|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322093|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322094|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83322095|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
83322096|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83322097|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83322098|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83322099|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83322100|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322101|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322102|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
83322103|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322104|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322105|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83322106|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83322107|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322108|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322109|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322110|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83322111|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83322112|NCT00245050|Pyridoxine|pyridoxine|mesh-list
83322113|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
83322114|NCT00245050|Doxorubicin|doxorubicin|mesh-list
83322115|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83322116|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83322117|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322118|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83322119|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83322120|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322121|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322122|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
83322123|NCT00245050|Vitamins|vitamins|mesh-ancestor
83322124|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
83322125|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322126|NCT04345588|Dexamethasone|dexamethasone|mesh-list
83322127|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
83322128|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322129|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
83322130|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
83322131|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322132|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322133|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322134|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
83322135|NCT04345588|Hormones|hormones|mesh-ancestor
83322136|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322137|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83322138|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322139|NCT03806374|Lidocaine|lidocaine|mesh-list
83322140|NCT03806374|Fentanyl|fentanyl|mesh-list
83322141|NCT03806374|Ketamine|ketamine|mesh-list
83322142|NCT03806374|Propofol|propofol|mesh-list
83322143|NCT03806374|Cisatracurium|cisatracurium|mesh-list
83322144|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
83322145|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
83322146|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322147|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322149|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322150|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83322151|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83322152|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83322153|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322154|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322155|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83322156|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83322157|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
83322158|NCT03806374|Analgesics|analgesics|mesh-ancestor
83322159|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83322160|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83322161|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83322162|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322163|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83322164|NCT03806374|Narcotics|narcotics|mesh-ancestor
83322165|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83322166|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83322167|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83322168|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
83322169|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83322170|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
83322171|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322172|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
83322173|NCT00763360|Protective Agents|protective agents|mesh-ancestor
83322174|NCT00756106|Temozolomide|temozolomide|mesh-list
83322175|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83322176|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
83322177|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322178|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322179|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
83322180|NCT00243412|Rituximab|rituximab|mesh-list
83322181|NCT00243412|Methotrexate|methotrexate|mesh-list
83322182|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83322183|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322184|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
83322185|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322186|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322187|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83322188|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
83322189|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83322190|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83322191|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
83322192|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322193|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
83322194|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322195|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83322196|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83322197|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83322198|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322200|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
83322201|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322202|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322203|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
83322204|NCT00243412|Hormones|hormones|mesh-ancestor
83322205|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322206|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83322207|NCT00243412|Protective Agents|protective agents|mesh-ancestor
83322208|NCT00765232|Ketorolac|ketorolac|mesh-list
83322209|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322210|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322211|NCT00765232|Analgesics|analgesics|mesh-ancestor
83322212|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
83322213|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322214|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322215|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322216|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322217|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83322218|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322219|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322221|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
83322222|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
83322223|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322224|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322225|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
83322226|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322227|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83322228|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83322229|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83322230|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322231|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322232|NCT03805750|Dronabinol|dronabinol|mesh-list
83322233|NCT03805750|Cannabidiol|cannabidiol|mesh-list
83322234|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
83322235|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
83322236|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322237|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322238|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322239|NCT03805750|Analgesics|analgesics|mesh-ancestor
83322240|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
83322241|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322242|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83322243|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83322244|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322245|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322246|NCT03805750|Hormones|hormones|mesh-ancestor
83322247|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322248|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83322249|NCT03804268|Pilocarpine|pilocarpine|mesh-list
83322250|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83322251|NCT03804268|Miotics|miotics|mesh-ancestor
83322252|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
83322253|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322254|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322255|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83322256|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83322257|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
83322258|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322259|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322260|NCT00765856|Oxymorphone|oxymorphone|mesh-list
83322261|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83322262|NCT00765856|Narcotics|narcotics|mesh-ancestor
83322263|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322264|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322265|NCT00765856|Analgesics|analgesics|mesh-ancestor
83322266|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
83322267|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322268|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83322269|NCT00780208|Methylphenidate|methylphenidate|mesh-list
83322270|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83322271|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322272|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83322273|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83322274|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322275|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322276|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
83322277|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322278|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
83322279|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
83322280|NCT00243022|Vitamins|vitamins|mesh-ancestor
83322281|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
83322282|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322283|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
83322284|NCT00243022|Hematinics|hematinics|mesh-ancestor
83322285|NCT03805360|Ropivacaine|ropivacaine|mesh-list
83322286|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
83322287|NCT03805360|Anesthetics|anesthetics|mesh-list
83322288|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322289|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322291|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322292|NCT00756964|Rasburicase|rasburicase|mesh-list
83322293|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
83322294|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322295|NCT00780442|Cycloserine|cycloserine|mesh-list
83322296|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83322297|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322298|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83322299|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
83322300|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322301|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
83322302|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322303|NCT04384666|Rotigotine|rotigotine|mesh-list
83322304|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
83322305|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
83322306|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322307|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322308|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322309|NCT00767572|Atorvastatin|atorvastatin|mesh-list
83322310|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83322311|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83322312|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
83322313|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322314|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83322315|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83322316|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322317|NCT00780676|Dasatinib|dasatinib|mesh-list
83322318|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322319|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83322320|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322321|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322322|NCT00768118|Curcumin|curcumin|mesh-list
83322323|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322324|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322325|NCT00768118|Analgesics|analgesics|mesh-ancestor
83322326|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
83322327|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322328|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322329|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322330|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322331|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322332|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322333|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322334|NCT04345432|Gabapentin|gabapentin|mesh-list
83322335|NCT04345432|Analgesics|analgesics|mesh-ancestor
83322336|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
83322337|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322338|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322339|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
83322340|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83322341|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83322342|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322343|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322344|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83322345|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83322346|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322347|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322348|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
83322349|NCT00757822|Dronabinol|dronabinol|mesh-list
83322350|NCT00757822|Ondansetron|ondansetron|mesh-list
83322351|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
83322352|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
83322353|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322354|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322355|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322356|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
83322357|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
83322358|NCT00757822|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83322359|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83322360|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
83322361|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322362|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322363|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
83322364|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322365|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322366|NCT00757822|Analgesics|analgesics|mesh-ancestor
83322367|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
83322368|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83322369|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83322371|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322372|NCT00758836|Acetaminophen|acetaminophen|mesh-list
83322373|NCT00758836|Ibuprofen|ibuprofen|mesh-list
83322374|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322375|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322376|NCT00758836|Analgesics|analgesics|mesh-ancestor
83322377|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
83322378|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322379|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322380|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322381|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322382|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83322383|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322384|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322385|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
83322386|NCT00769600|Itraconazole|itraconazole|mesh-list
83322387|NCT00769600|Pemetrexed|pemetrexed|mesh-list
83322388|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322389|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322390|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322391|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83322392|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83322393|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
83322394|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322395|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83322396|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83322397|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83322398|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
83322399|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322400|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322401|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83322402|NCT03809650|Macitentan|macitentan|mesh-list
83322403|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83322404|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83322405|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322406|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83322407|NCT03809260|Metformin|metformin|mesh-list
83322408|NCT03809260|Vancomycin|vancomycin|mesh-list
83322409|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83322410|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322411|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322412|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322413|NCT01763905|Ezetimibe|ezetimibe|mesh-list
83322414|NCT01763905|Evolocumab|evolocumab|mesh-list
83322415|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83322416|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83322417|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83322418|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
83322419|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322420|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83322421|NCT01763905|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83322422|NCT01763905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83322423|NCT01763905|Protease Inhibitors|protease inhibitors|mesh-ancestor
83322424|NCT01763905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322425|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
83322426|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322427|NCT05743504|Paclitaxel|paclitaxel|mesh-list
83322428|NCT05743504|Cisplatin|cisplatin|mesh-list
83322429|NCT05743504|Atezolizumab|atezolizumab|mesh-list
83322430|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83322431|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322432|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
83322433|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
83322434|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
83322435|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322436|NCT05743504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83322437|NCT05743504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83322438|NCT03803254|Lenvatinib|lenvatinib|mesh-list
83322439|NCT03803254|Antibodies|antibodies|mesh-list
83322440|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
83322441|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322442|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322443|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83322444|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322445|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322446|NCT04730999|Bevacizumab|bevacizumab|mesh-list
83322447|NCT04730999|Atezolizumab|atezolizumab|mesh-list
83322448|NCT04730999|Carboplatin|carboplatin|mesh-list
83322449|NCT04730999|Etoposide|etoposide|mesh-list
83322450|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83322451|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322452|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83322453|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83322454|NCT04730999|Growth Substances|growth substances|mesh-ancestor
83322455|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322456|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
83322457|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83322458|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83322459|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83322460|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322461|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322462|NCT04730999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83322463|NCT00759772|Teriparatide|teriparatide|mesh-list
83322464|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83322465|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322466|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83322467|NCT01977677|Plerixafor|plerixafor|mesh-list
83322468|NCT01977677|Temozolomide|temozolomide|mesh-list
83322469|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83322470|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
83322471|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322472|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322473|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83322474|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83322475|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
83322476|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322477|NCT04384744|Hormones|hormones|mesh-list
83322478|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322479|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322481|NCT01736215|Hematinics|hematinics|mesh-ancestor
83322482|NCT01786603|Rasagiline|rasagiline|mesh-list
83322483|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83322484|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322485|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322486|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83322487|NCT01786603|Protective Agents|protective agents|mesh-ancestor
83322488|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322489|NCT00786916|Lidocaine|lidocaine|mesh-list
83322490|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
83322491|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
83322492|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322493|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322494|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
83322495|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322496|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83322497|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83322498|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83322499|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322500|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322501|NCT04414267|Vaccines|vaccines|mesh-list
83322502|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
83322503|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
83322504|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322505|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83322506|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
83322507|NCT01619423|Edetic Acid|edetic acid|mesh-list
83322508|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
83322509|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83322510|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
83322511|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
83322512|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322513|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
83322514|NCT01619423|Vitamins|vitamins|mesh-ancestor
83322515|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
83322516|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322517|NCT03802552|Cephalexin|cephalexin|mesh-list
83322518|NCT03802552|Cefadroxil|cefadroxil|mesh-list
83322519|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322520|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322521|NCT01735279|Mineral Oil|mineral oil|mesh-list
83322522|NCT01735279|Emollients|emollients|mesh-ancestor
83322523|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
83322524|NCT03802318|Amoxicillin|amoxicillin|mesh-list
83322525|NCT03802318|Rabeprazole|rabeprazole|mesh-list
83322526|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322527|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322528|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83322529|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322530|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83322531|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322532|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322533|NCT01758523|Dutasteride|dutasteride|mesh-list
83322534|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83322535|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83322536|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322537|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322538|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
83322539|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322540|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322541|NCT00773422|Naltrexone|naltrexone|mesh-list
83322542|NCT00773422|Varenicline|varenicline|mesh-list
83322543|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83322544|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83322545|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322546|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
83322547|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322548|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83322549|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83322550|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
83322551|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322552|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322553|NCT00786994|Petrolatum|petrolatum|mesh-list
83322554|NCT00786994|Emollients|emollients|mesh-ancestor
83322555|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
83322557|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
83322558|NCT00774202|Rituximab|rituximab|mesh-list
83322559|NCT00774202|Vincristine|vincristine|mesh-list
83322560|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83322561|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
83322562|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322563|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322564|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83322565|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
83322566|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322567|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322568|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83322569|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83322570|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322571|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
83322572|NCT00774202|Hormones|hormones|mesh-ancestor
83322573|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322574|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83322575|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83322576|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
83322577|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
83322578|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
83322579|NCT03808168|Nivolumab|nivolumab|mesh-list
83322580|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83322581|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322583|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322584|NCT03802162|Memantine|memantine|mesh-list
83322585|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83322586|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83322587|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
83322588|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322589|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322590|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322591|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83322592|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83322593|NCT01757275|Esomeprazole|esomeprazole|mesh-list
83322594|NCT01757275|Cimetidine|cimetidine|mesh-list
83322595|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83322596|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322597|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83322598|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322599|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322600|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83322601|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
83322602|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
83322603|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322604|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322605|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83322606|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83322607|NCT00787852|Paclitaxel|paclitaxel|mesh-list
83322608|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83322609|NCT00787852|Dasatinib|dasatinib|mesh-list
83322610|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83322611|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322612|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
83322613|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
83322614|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
83322615|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322616|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83322617|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322618|NCT00788008|Propofol|propofol|mesh-list
83322619|NCT00788008|Isoflurane|isoflurane|mesh-list
83322620|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
83322621|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322622|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322623|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83322624|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83322625|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
83322626|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83322627|NCT00760006|Ampicillin|ampicillin|mesh-list
83322628|NCT00760006|Sulbactam|sulbactam|mesh-list
83322629|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83322630|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322631|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322632|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83322633|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413620|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
83322634|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322635|NCT01784965|Liraglutide|liraglutide|mesh-list
83322636|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83322637|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322638|NCT01784965|Incretins|incretins|mesh-ancestor
83322639|NCT01784965|Hormones|hormones|mesh-ancestor
83322640|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322641|NCT05742724|Dronabinol|dronabinol|mesh-list
83322642|NCT05742724|Nabiximols|nabiximols|mesh-list
83322643|NCT05742724|Cannabidiol|cannabidiol|mesh-list
83322644|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
83322645|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
83322646|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322647|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322648|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322649|NCT05742724|Analgesics|analgesics|mesh-ancestor
83322650|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
83322651|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322652|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83322653|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83322654|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322655|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322656|NCT05742724|Hormones|hormones|mesh-ancestor
83322657|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322659|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83322660|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322661|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322662|NCT01784029|Vitamin D|vitamin d|mesh-list
83322663|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
83322664|NCT01784029|Vitamins|vitamins|mesh-ancestor
83322665|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
83322666|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322667|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83322668|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83322669|NCT00789256|Bortezomib|bortezomib|mesh-list
83322670|NCT00789256|Melphalan|melphalan|mesh-list
83322671|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322672|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83322673|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
83322674|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322675|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83322676|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83322677|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
83322678|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322679|NCT01733329|Folic Acid|folic acid|mesh-list
83322680|NCT01733329|Misoprostol|misoprostol|mesh-list
83322681|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83322682|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
83322683|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83322684|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322685|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83322686|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322687|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
83322688|NCT01733329|Hematinics|hematinics|mesh-ancestor
83322689|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
83322690|NCT01733329|Vitamins|vitamins|mesh-ancestor
83322691|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
83322692|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
83322693|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83322694|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83322695|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83322696|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322697|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322698|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
83322699|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322700|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322701|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83322702|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322703|NCT05742568|Amoxicillin|amoxicillin|mesh-list
83322704|NCT05742568|Clarithromycin|clarithromycin|mesh-list
83322705|NCT05742568|Esomeprazole|esomeprazole|mesh-list
83322707|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83322708|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322709|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83322710|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322711|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83322712|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322713|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322714|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83322715|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83322716|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83322717|NCT05742568|Antacids|antacids|mesh-ancestor
83322718|NCT01607593|Sertraline|sertraline|mesh-list
83322719|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
83322720|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322721|NCT01607593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83322722|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83322723|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322724|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322725|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322726|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
83322727|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322728|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83322729|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322730|NCT01755637|Albendazole|albendazole|mesh-list
83322731|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
83322732|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83322733|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322734|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
83322735|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83322736|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83322737|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
83322738|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
83322739|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
83322740|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322741|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322742|NCT03801226|Calcium|calcium|mesh-list
83322743|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83322744|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322745|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
83322746|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322747|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83322748|NCT02148874|Vaccines|vaccines|mesh-list
83322749|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
83322750|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322751|NCT01755091|Dronabinol|dronabinol|mesh-list
83322752|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
83322753|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322754|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322755|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322756|NCT01755091|Analgesics|analgesics|mesh-ancestor
83322757|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
83322758|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322759|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83322760|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83322761|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322762|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322763|NCT01755091|Hormones|hormones|mesh-ancestor
83322764|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322765|NCT00789802|Naproxen|naproxen|mesh-list
83322766|NCT00789802|Estradiol|estradiol|mesh-list
83322767|NCT00789802|Estrogens|estrogens|mesh-ancestor
83322768|NCT00789802|Hormones|hormones|mesh-ancestor
83322769|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322770|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322771|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322772|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322773|NCT00789802|Analgesics|analgesics|mesh-ancestor
83322774|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
83322775|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322776|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322777|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322778|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
83322779|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83322780|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322781|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322782|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
83322783|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83322784|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322785|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83322786|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83322787|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83322788|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
83322789|NCT01783015|Etanercept|etanercept|mesh-list
83322790|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322791|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322792|NCT01783015|Analgesics|analgesics|mesh-ancestor
83322793|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
83322794|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322795|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322796|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322797|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322798|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83322799|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83322800|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
83322801|NCT05567770|Androgens|androgens|mesh-list
83322802|NCT05567770|Hormones|hormones|mesh-ancestor
83322803|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322804|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322805|NCT01782859|Prednisone|prednisone|mesh-list
83322806|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
83322807|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83322808|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83322809|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83322810|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322811|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
83322812|NCT01782859|Hormones|hormones|mesh-ancestor
83322813|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322814|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322815|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83322816|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322817|NCT01782313|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83322818|NCT01782313|Tivozanib|tivozanib|mesh-list
83322819|NCT01782313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83322820|NCT01782313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322821|NCT01782313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322822|NCT04574947|Lidocaine|lidocaine|mesh-list
83322823|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
83322824|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
83322825|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322826|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322827|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
83322828|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322829|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83322830|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83322831|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83322832|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322833|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322834|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83322835|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83322836|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
83322837|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322838|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83322839|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83322840|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322841|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322842|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83322843|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83322844|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83322845|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
83322846|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322847|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322848|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83322849|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83322850|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
83322851|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83322852|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83322854|NCT01781611|Aspirin|aspirin|mesh-list
83322855|NCT01781611|Dipyridamole|dipyridamole|mesh-list
83322856|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322857|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322858|NCT01781611|Analgesics|analgesics|mesh-ancestor
83322859|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
83322860|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322861|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322862|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322863|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322864|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83322865|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83322866|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322867|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83322868|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83322869|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322870|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
83322871|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83322872|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
83322873|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
83322874|NCT03802084|Vactosertib|vactosertib|mesh-list
83322875|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322876|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83322877|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322878|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322880|NCT00790270|Amitriptyline|amitriptyline|mesh-list
83322881|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
83322882|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83322883|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83322884|NCT00790270|Analgesics|analgesics|mesh-ancestor
83322885|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
83322886|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322887|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322888|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322889|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83322890|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83322891|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322892|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322893|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83322894|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
83322895|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83322896|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83322897|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83322898|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83322899|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322900|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83322901|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83322902|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83322903|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
83322904|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322905|NCT01780987|Heparin|heparin|mesh-list
83322906|NCT01780987|Calcium heparin|calcium heparin|mesh-list
83322907|NCT01780987|Warfarin|warfarin|mesh-list
83322908|NCT01780987|Apixaban|apixaban|mesh-list
83322909|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
83322910|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83322911|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83322912|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322913|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83322914|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
83322915|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83322916|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
83322917|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322918|NCT03800290|Clenbuterol|clenbuterol|mesh-list
83322919|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83322920|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83322921|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
83322922|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322923|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322924|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322925|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83322926|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
83322927|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322928|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83322929|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
83322930|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
83322931|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83322932|NCT05709184|Vancomycin|vancomycin|mesh-list
83322933|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83322934|NCT03831334|Minoxidil|minoxidil|mesh-list
83322935|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83322936|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
83322937|NCT04795336|Melatonin|melatonin|mesh-list
83322938|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
83322939|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322940|NCT04795336|Protective Agents|protective agents|mesh-ancestor
83322941|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322942|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83322943|NCT00809848|Bimatoprost|bimatoprost|mesh-list
83322944|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83322945|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83322946|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83322947|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83322948|NCT01730053|Ezetimibe|ezetimibe|mesh-list
83322949|NCT01730053|Alirocumab|alirocumab|mesh-list
83322950|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83322951|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83322952|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
83322953|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322954|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83322955|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83322956|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322957|NCT01730053|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83322958|NCT01730053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83322959|NCT01730053|Protease Inhibitors|protease inhibitors|mesh-ancestor
83322960|NCT01751113|Fluticasone|fluticasone|mesh-list
83322961|NCT01751113|Xhance|xhance|mesh-list
83322962|NCT01751113|Bromides|bromides|mesh-list
83322963|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
83322964|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83322965|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83322966|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83322967|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83322968|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
83322969|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83322970|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83322971|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83322972|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
83322973|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
83322974|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83322975|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
83322976|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83322977|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
83322978|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83322979|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322980|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83322981|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83322982|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83322983|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83322984|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
83322985|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
83322986|NCT01751113|Hormones|hormones|mesh-ancestor
83322987|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83322988|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
83322989|NCT00795340|Paclitaxel|paclitaxel|mesh-list
83322990|NCT00795340|Carboplatin|carboplatin|mesh-list
83322991|NCT00795340|Cediranib|cediranib|mesh-list
83322992|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83322993|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83322994|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
83322995|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
83322996|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
83322997|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83322998|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83322999|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83323000|NCT04753294|Diazepam|diazepam|mesh-list
83323001|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83323002|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
83323003|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
83323004|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
83323005|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323006|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323007|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323008|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83323009|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323010|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83323011|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83323012|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83323013|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83323014|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83323015|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83323016|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
83323017|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
83323018|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
83323019|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
83323020|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323021|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323023|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83323024|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323025|NCT00792142|Thalidomide|thalidomide|mesh-list
83323026|NCT00792142|Dexamethasone|dexamethasone|mesh-list
83323027|NCT00792142|Bortezomib|bortezomib|mesh-list
83323028|NCT00792142|Melphalan|melphalan|mesh-list
83323029|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323030|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
83323031|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
83323032|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323033|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323034|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323035|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
83323036|NCT00792142|Hormones|hormones|mesh-ancestor
83323037|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323038|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83323039|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323040|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83323041|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
83323042|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323043|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83323044|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83323045|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
83323046|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
83323047|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83323048|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323049|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83323050|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83323051|NCT00792142|Growth Substances|growth substances|mesh-ancestor
83323052|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
83323053|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
83323054|NCT05640778|Taxane|taxane|mesh-list
83323055|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83323056|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83323057|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
83323058|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323059|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83323060|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83323061|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
83323062|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323063|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323064|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83323065|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83323066|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323067|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83323068|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
83323069|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323070|NCT01743560|Everolimus|everolimus|mesh-list
83323071|NCT01743560|Exemestane|exemestane|mesh-list
83323072|NCT01743560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83323073|NCT01743560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83323074|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323075|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323076|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83323077|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
83323078|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323079|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323080|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83323081|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83323082|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83323083|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
83323084|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323085|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
83323086|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83323087|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
83323088|NCT00792922|Azithromycin|azithromycin|mesh-list
83323089|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83323090|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323091|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
83323092|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83323093|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83323094|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
83323095|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323096|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83323097|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83323098|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323099|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323100|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
83323101|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83323102|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323103|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323104|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83323105|NCT04382170|Analgesics|analgesics|mesh-ancestor
83323106|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
83323107|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323108|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83323109|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83323110|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323111|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323112|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323113|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323114|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83323115|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
83323116|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83323117|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
83323118|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83323119|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323120|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83323121|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83323122|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323123|NCT04718350|Simendan|simendan|mesh-list
83323124|NCT04718350|Milrinone|milrinone|mesh-list
83323125|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83323126|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
83323127|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83323128|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83323129|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323130|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323131|NCT04718350|Protective Agents|protective agents|mesh-ancestor
83323132|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323133|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83323134|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83323135|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83323136|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83323137|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83323138|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
83323139|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323140|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323141|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323142|NCT01729819|Urological Agents|urological agents|mesh-ancestor
83323143|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
83323144|NCT01729819|Coagulants|coagulants|mesh-ancestor
83323145|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83323146|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
83323147|NCT00811564|Timolol|timolol|mesh-list
83323148|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83323149|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83323150|NCT00811564|Latanoprost|latanoprost|mesh-list
83323151|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83323152|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323153|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83323154|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83323155|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323156|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323157|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323158|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83323159|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83323160|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83323161|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83323162|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323164|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83323165|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83323166|NCT04520776|Analgesics|analgesics|mesh-ancestor
83323167|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
83323168|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323169|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323170|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323171|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83323172|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83323173|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83323174|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323175|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323176|NCT01709084|Tenofovir|tenofovir|mesh-list
83323177|NCT01709084|Emtricitabine|emtricitabine|mesh-list
83323178|NCT01709084|Efavirenz|efavirenz|mesh-list
83323179|NCT01709084|Rilpivirine|rilpivirine|mesh-list
83323180|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
83323181|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323182|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83323183|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83323184|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323185|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323186|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83323187|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83323188|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83323189|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83323190|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83323191|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83323192|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83323193|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83323194|NCT01776307|Capecitabine|capecitabine|mesh-list
83323195|NCT01776307|Cetuximab|cetuximab|mesh-list
83323196|NCT01776307|Panitumumab|panitumumab|mesh-list
83323197|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83323198|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
83323199|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323200|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323201|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83323202|NCT01741532|Deferiprone|deferiprone|mesh-list
83323203|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83323204|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
83323205|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
83323206|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323207|NCT01727713|Aripiprazole|aripiprazole|mesh-list
83323208|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
83323209|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83323210|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83323211|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83323212|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323213|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323214|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
83323215|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
83323216|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323217|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323218|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83323219|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83323220|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
83323221|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83323222|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83323223|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83323224|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83323225|NCT04658927|Dexamethasone|dexamethasone|mesh-list
83323226|NCT04658927|Prednisone|prednisone|mesh-list
83323227|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323228|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
83323229|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
83323230|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323231|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323232|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323233|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
83323234|NCT04658927|Hormones|hormones|mesh-ancestor
83323235|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323236|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83323237|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323238|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
83323239|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83323240|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323241|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83323242|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83323243|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323244|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323245|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323246|NCT01976507|Dabigatran|dabigatran|mesh-list
83323247|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
83323248|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83323249|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
83323250|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323251|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323252|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
83323253|NCT01964963|Alogliptin|alogliptin|mesh-list
83323254|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83323255|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323256|NCT01964963|Incretins|incretins|mesh-ancestor
83323257|NCT01964963|Hormones|hormones|mesh-ancestor
83323258|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323259|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83323260|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
83323261|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323262|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323263|NCT01974323|Dapsone|dapsone|mesh-list
83323264|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323265|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
83323266|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83323267|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83323268|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83323269|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323270|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323271|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
83323272|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83323273|NCT01973387|Rituximab|rituximab|mesh-list
83323274|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83323275|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323276|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
83323277|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323278|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83323279|NCT01973231|Liraglutide|liraglutide|mesh-list
83323280|NCT01973231|Lixisenatide|lixisenatide|mesh-list
83323281|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83323282|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323283|NCT01973231|Incretins|incretins|mesh-ancestor
83323284|NCT01973231|Hormones|hormones|mesh-ancestor
83323285|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323286|NCT02151994|Zamicastat|zamicastat|mesh-list
83323287|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323288|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323289|NCT04382950|Tretinoin|tretinoin|mesh-list
83323290|NCT04382950|Isotretinoin|isotretinoin|mesh-list
83323291|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323292|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
83323293|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
83323294|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
83323295|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83323296|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323297|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323298|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83323299|NCT04383418|Analgesics|analgesics|mesh-ancestor
83323300|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
83323301|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323302|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83323303|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83323304|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323305|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323306|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323307|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323308|NCT03414112|Oxytocin|oxytocin|mesh-list
83323309|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
83323310|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83323311|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323312|NCT03839134|Lidocaine|lidocaine|mesh-list
83323313|NCT03839134|Epinephrine|epinephrine|mesh-list
83323314|NCT03839134|Racepinephrine|racepinephrine|mesh-list
83323315|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
83323316|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
83323317|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
83323318|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323319|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323320|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
83323321|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323322|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83323323|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83323324|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83323325|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83323326|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323327|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83323328|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323329|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323330|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323331|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83323332|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83323333|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
83323334|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83323335|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
83323336|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
83323337|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
83323338|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83323339|NCT03906526|Nivolumab|nivolumab|mesh-list
83323340|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83323341|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323342|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83323343|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323344|NCT03088930|Crizotinib|crizotinib|mesh-list
83323345|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323346|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83323347|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323348|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323349|NCT02152696|Methotrexate|methotrexate|mesh-list
83323350|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83323351|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
83323352|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83323353|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323354|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83323355|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
83323356|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323357|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323358|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
83323359|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323360|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83323361|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83323362|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
83323363|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83323364|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83323365|NCT01905436|Ivermectin|ivermectin|mesh-list
83323366|NCT01905436|Albendazole|albendazole|mesh-list
83323367|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83323368|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323369|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
83323370|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
83323371|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83323372|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83323373|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
83323374|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
83323375|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
83323376|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323377|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323378|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
83323379|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83323380|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
83323381|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323382|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323383|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83323384|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
83323385|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83323386|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83323387|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323388|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323389|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323390|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323391|NCT01149850|Bevacizumab|bevacizumab|mesh-list
83323392|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83323393|NCT01149850|Temozolomide|temozolomide|mesh-list
83323394|NCT01149850|Antibodies|antibodies|mesh-list
83323395|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
83323396|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83323397|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323398|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83323399|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83323400|NCT01149850|Growth Substances|growth substances|mesh-ancestor
83323401|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323402|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
83323403|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
83323404|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83323405|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
83323406|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323407|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
83323408|NCT01972841|Mirabegron|mirabegron|mesh-list
83323409|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83323410|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83323411|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
83323412|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323413|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323414|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323415|NCT01972841|Urological Agents|urological agents|mesh-ancestor
83323416|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83323417|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83323418|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323419|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323420|NCT01774903|Fentanyl|fentanyl|mesh-list
83323421|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83323422|NCT01774903|Narcotics|narcotics|mesh-ancestor
83323423|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323424|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323425|NCT01774903|Analgesics|analgesics|mesh-ancestor
83323426|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
83323427|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323428|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83323429|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83323430|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
83323431|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
83323432|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83323433|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83323434|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83323435|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323436|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
83323437|NCT01708915|Capsaicin|capsaicin|mesh-list
83323438|NCT01708915|Nonivamide|nonivamide|mesh-list
83323439|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
83323440|NCT01708915|Vitamins|vitamins|mesh-ancestor
83323441|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
83323442|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323443|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
83323444|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323445|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
83323446|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
83323447|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
83323448|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83323449|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
83323450|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323451|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323452|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83323453|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
83323454|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
83323455|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83323456|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
83323457|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323458|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323459|NCT01747915|Pregabalin|pregabalin|mesh-list
83323460|NCT01747915|Analgesics|analgesics|mesh-ancestor
83323461|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
83323462|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323463|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323464|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
83323465|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83323466|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83323467|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323468|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83323469|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83323470|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83323471|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323472|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83323473|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
83323474|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83323475|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83323476|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
83323477|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
83323478|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323479|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323480|NCT04656041|Paclitaxel|paclitaxel|mesh-list
83323481|NCT04656041|Carboplatin|carboplatin|mesh-list
83323482|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83323483|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323484|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83323485|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83323486|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83323487|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323488|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83323489|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
83323490|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83323491|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83323492|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83323493|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323494|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323495|NCT01970501|Metoprolol|metoprolol|mesh-list
83323496|NCT01970501|Bucindolol|bucindolol|mesh-list
83323497|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83323498|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83323499|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
83323500|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
83323501|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323502|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323503|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83323504|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83323505|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83323506|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323507|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323508|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323509|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
83323510|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
83323511|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83323512|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83323513|NCT01969799|Amikacin|amikacin|mesh-list
83323514|NCT01969799|Fosfomycin|fosfomycin|mesh-list
83323515|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83323516|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323517|NCT01969721|Fluticasone|fluticasone|mesh-list
83323519|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
83323520|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83323521|NCT01969721|Olodaterol|olodaterol|mesh-list
83323522|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323523|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83323524|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
83323525|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323526|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323527|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83323528|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
83323529|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
83323530|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83323531|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
83323532|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83323533|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
83323534|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323535|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323536|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83323537|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83323538|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323539|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323540|NCT01969565|Dexamethasone|dexamethasone|mesh-list
83323541|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323542|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
83323543|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
83323544|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323545|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323546|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323547|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
83323548|NCT01969565|Hormones|hormones|mesh-ancestor
83323549|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323550|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83323551|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323552|NCT01968707|Ethanol|ethanol|mesh-list
83323553|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
83323554|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83323555|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83323556|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323557|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323558|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323559|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
83323560|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
83323561|NCT01746901|Naltrexone|naltrexone|mesh-list
83323562|NCT01746901|Oxycodone|oxycodone|mesh-list
83323563|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83323564|NCT01746901|Narcotics|narcotics|mesh-ancestor
83323565|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323566|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323567|NCT01746901|Analgesics|analgesics|mesh-ancestor
83323568|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
83323569|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323570|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83323571|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83323572|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83323573|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83323574|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83323575|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
83323576|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323577|NCT01946165|Prednisone|prednisone|mesh-list
83323578|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
83323579|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323580|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
83323581|NCT01946165|Hormones|hormones|mesh-ancestor
83323582|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323583|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323584|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83323585|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323586|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83323587|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323588|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323589|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
83323590|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83323591|NCT01707667|Prucalopride|prucalopride|mesh-list
83323592|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83323593|NCT01707667|Laxatives|laxatives|mesh-ancestor
83323594|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323595|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83323596|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83323597|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
83323598|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323599|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323600|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323601|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83323602|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
83323603|NCT01959503|Coagulants|coagulants|mesh-ancestor
83323604|NCT01706575|Interferons|interferons|mesh-list
83323605|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323606|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
83323607|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323608|NCT01725529|Ribavirin|ribavirin|mesh-list
83323609|NCT01725529|Simeprevir|simeprevir|mesh-list
83323610|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
83323611|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323612|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
83323613|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323614|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
83323615|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323616|NCT01744093|Doxycycline|doxycycline|mesh-list
83323617|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83323618|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323619|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
83323620|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83323621|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83323622|NCT01725451|Testosterone|testosterone|mesh-list
83323623|NCT01725451|Androgens|androgens|mesh-ancestor
83323624|NCT01725451|Hormones|hormones|mesh-ancestor
83323625|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323626|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323627|NCT01707290|Ivacaftor|ivacaftor|mesh-list
83323628|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83323629|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83323630|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323631|NCT01717040|Pioglitazone|pioglitazone|mesh-list
83323632|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83323633|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323634|NCT00803062|Paclitaxel|paclitaxel|mesh-list
83323635|NCT00803062|Bevacizumab|bevacizumab|mesh-list
83323636|NCT00803062|Cisplatin|cisplatin|mesh-list
83323637|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83323638|NCT00803062|Topotecan|topotecan|mesh-list
83323639|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83323640|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
83323641|NCT00803062|Antibodies|antibodies|mesh-list
83323642|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
83323643|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83323644|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
83323645|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83323647|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
83323648|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
83323649|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
83323650|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323651|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83323652|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83323653|NCT00803062|Growth Substances|growth substances|mesh-ancestor
83323654|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323655|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
83323656|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
83323657|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83323658|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83323659|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323660|NCT01743001|Macitentan|macitentan|mesh-list
83323661|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83323662|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83323663|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323664|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83323665|NCT01704079|Calcifediol|calcifediol|mesh-list
83323666|NCT01704079|Vitamins|vitamins|mesh-ancestor
83323667|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
83323668|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323669|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83323670|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
83323671|NCT01703845|Olodaterol|olodaterol|mesh-list
83323672|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83323673|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
83323674|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323675|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323676|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83323677|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
83323678|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
83323679|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83323680|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
83323681|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323682|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323683|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83323684|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83323685|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83323686|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323687|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323688|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83323689|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83323690|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83323691|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
83323692|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323693|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323694|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83323695|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83323696|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
83323697|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83323698|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83323699|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323700|NCT01703221|Incretins|incretins|mesh-ancestor
83323701|NCT01703221|Hormones|hormones|mesh-ancestor
83323702|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323703|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83323704|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
83323705|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323706|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323707|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
83323708|NCT00803686|Calcitonin|calcitonin|mesh-list
83323709|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83323710|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323711|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83323712|NCT00823966|Delavirdine|delavirdine|mesh-list
83323713|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83323714|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83323715|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323716|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323717|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
83323718|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323719|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83323720|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83323721|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
83323722|NCT01702987|Atorvastatin|atorvastatin|mesh-list
83323723|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83323724|NCT01702987|Simvastatin|simvastatin|mesh-list
83323725|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83323726|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83323727|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
83323728|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323729|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83323730|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83323731|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323732|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
83323733|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323734|NCT01702987|Vitamins|vitamins|mesh-ancestor
83323735|NCT00824044|Escitalopram|escitalopram|mesh-list
83323736|NCT00824044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83323737|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83323738|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83323739|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323740|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323741|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
83323742|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323743|NCT01702519|Nicotine|nicotine|mesh-list
83323744|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83323745|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
83323746|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323747|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323748|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83323749|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83323750|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
83323751|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323752|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323753|NCT01739335|Mifepristone|mifepristone|mesh-list
83323754|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83323755|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
83323756|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83323757|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323758|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83323759|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83323760|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83323761|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
83323762|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83323763|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83323764|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
83323765|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323766|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
83323767|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83323768|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83323769|NCT00824746|Gefitinib|gefitinib|mesh-list
83323770|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323771|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83323772|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323773|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323774|NCT01722097|Rocuronium|rocuronium|mesh-list
83323775|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83323776|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83323777|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83323778|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323779|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323780|NCT00824824|Timolol|timolol|mesh-list
83323781|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83323782|NCT00824824|Dorzolamide|dorzolamide|mesh-list
83323783|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83323784|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83323785|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323786|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323787|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323788|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323789|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83323790|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83323791|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83323792|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83323793|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83323794|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83323795|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323796|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83323797|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83323798|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323799|NCT01701973|Incretins|incretins|mesh-ancestor
83323800|NCT01701973|Hormones|hormones|mesh-ancestor
83323801|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323802|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83323803|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
83323804|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323805|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323806|NCT00825370|Hydromorphone|hydromorphone|mesh-list
83323807|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83323808|NCT00825370|Narcotics|narcotics|mesh-ancestor
83323809|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323810|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323811|NCT00825370|Analgesics|analgesics|mesh-ancestor
83323812|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
83323813|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323814|NCT01721317|Ezogabine|ezogabine|mesh-list
83323815|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
83323816|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83323817|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323818|NCT05014438|Branebrutinib|branebrutinib|mesh-list
83323819|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83323820|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323821|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323822|NCT00828412|Desonide|desonide|mesh-list
83323823|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323824|NCT01959035|Aripiprazole|aripiprazole|mesh-list
83323825|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
83323826|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83323827|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83323828|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83323829|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323830|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323831|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
83323832|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
83323833|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323834|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323835|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83323836|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83323837|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
83323838|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83323839|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83323840|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83323841|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83323842|NCT01700959|Melatonin|melatonin|mesh-list
83323843|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
83323844|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323845|NCT01700959|Protective Agents|protective agents|mesh-ancestor
83323846|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323847|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323848|NCT00829738|Pantoprazole|pantoprazole|mesh-list
83323849|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83323850|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323851|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83323852|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323853|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323854|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
83323855|NCT01737931|Promethazine|promethazine|mesh-list
83323856|NCT01737931|Dexamethasone|dexamethasone|mesh-list
83323857|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83323858|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
83323859|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323860|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
83323861|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
83323862|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323863|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323864|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323865|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
83323866|NCT01737931|Hormones|hormones|mesh-ancestor
83323867|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83323868|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83323869|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323870|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83323871|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83323872|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323873|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
83323874|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
83323875|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
83323876|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
83323877|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323878|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323879|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83323880|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
83323881|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
83323882|NCT01958489|Pravastatin|pravastatin|mesh-list
83323883|NCT01958489|Evacetrapib|evacetrapib|mesh-list
83323884|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83323885|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83323886|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
83323887|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323888|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83323889|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83323890|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323891|NCT01700179|Ribavirin|ribavirin|mesh-list
83323892|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
83323893|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323894|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
83323895|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83323896|NCT00830362|Propranolol|propranolol|mesh-list
83323897|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83323898|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83323899|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323900|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323901|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323902|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323903|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83323904|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83323905|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
83323906|NCT01944839|Ranibizumab|ranibizumab|mesh-list
83323907|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83323908|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83323909|NCT01944839|Growth Substances|growth substances|mesh-ancestor
83323910|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323911|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
83323912|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323913|NCT01720225|Azacitidine|azacitidine|mesh-list
83323914|NCT01720225|Decitabine|decitabine|mesh-list
83323915|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83323916|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
83323917|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323918|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83323919|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323920|NCT01943435|Acetaminophen|acetaminophen|mesh-list
83323921|NCT01943435|Ibuprofen|ibuprofen|mesh-list
83323922|NCT01943435|Celecoxib|celecoxib|mesh-list
83323923|NCT01943435|Diclofenac|diclofenac|mesh-list
83323924|NCT01943435|Gabapentin|gabapentin|mesh-list
83323925|NCT01943435|Tramadol|tramadol|mesh-list
83323926|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83323927|NCT01943435|Analgesics|analgesics|mesh-list
83323928|NCT01943435|Mirtazapine|mirtazapine|mesh-list
83323929|NCT01943435|Trazodone|trazodone|mesh-list
83323930|NCT01943435|Sertraline|sertraline|mesh-list
83323931|NCT01943435|Nortriptyline|nortriptyline|mesh-list
83323932|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
83323933|NCT01943435|Misoprostol|misoprostol|mesh-list
83323934|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83323935|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
83323936|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83323937|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323938|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
83323939|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83323940|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323941|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83323942|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83323943|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83323944|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323945|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83323946|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83323947|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
83323948|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83323949|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83323950|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83323951|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
83323952|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
83323953|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83323954|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83323955|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83323956|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83323957|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83323958|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83323959|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323960|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
83323961|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83323962|NCT01943435|Narcotics|narcotics|mesh-ancestor
83323963|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83323964|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83323965|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83323966|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
83323967|NCT01943435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83323968|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
83323969|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83323970|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
83323971|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
83323972|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83323973|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83323974|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83323975|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
83323976|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83323977|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83323978|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83323979|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83323980|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83323981|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83323982|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
83323983|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
83323984|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83323985|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83323986|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83323987|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
83323988|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
83323989|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83323990|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83323991|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
83323992|NCT00807586|Prednisolone|prednisolone|mesh-list
83323993|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
83323994|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83323995|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
83323996|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83323997|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
83323998|NCT00807586|Hormones|hormones|mesh-ancestor
83323999|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324000|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324001|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83324002|NCT00807586|Protective Agents|protective agents|mesh-ancestor
83324003|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83324004|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324005|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
83324006|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
83324007|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324008|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324009|NCT01698775|Glipizide|glipizide|mesh-list
83324010|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324011|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324012|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
83324013|NCT01941095|Chloroquine|chloroquine|mesh-list
83324014|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
83324015|NCT01941095|Methotrexate|methotrexate|mesh-list
83324016|NCT01941095|Azathioprine|azathioprine|mesh-list
83324017|NCT01941095|Leflunomide|leflunomide|mesh-list
83324018|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83324019|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
83324020|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83324021|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324022|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83324023|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
83324024|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324025|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324026|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324027|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324028|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83324029|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324030|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
83324031|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324032|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83324033|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
83324034|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83324035|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83324036|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324037|NCT01941095|Amebicides|amebicides|mesh-ancestor
83324038|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83324039|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324040|NCT01941095|Analgesics|analgesics|mesh-ancestor
83324041|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
83324042|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324043|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324044|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324045|NCT00831766|Cytarabine|cytarabine|mesh-list
83324046|NCT00831766|Lenalidomide|lenalidomide|mesh-list
83324047|NCT00831766|Idarubicin|idarubicin|mesh-list
83324048|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
83324049|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83324050|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
83324051|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324052|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
83324053|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324054|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324055|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
83324056|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324057|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83324058|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83324059|NCT00831766|Growth Substances|growth substances|mesh-ancestor
83324060|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
83324061|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83324062|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83324063|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83324064|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324065|NCT01957709|Interferons|interferons|mesh-list
83324066|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
83324067|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324068|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
83324069|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324070|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83324071|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324072|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324073|NCT00832390|Incretins|incretins|mesh-ancestor
83324074|NCT00832390|Hormones|hormones|mesh-ancestor
83324075|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324076|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83324077|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
83324078|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324079|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324080|NCT04644029|Tenofovir|tenofovir|mesh-list
83324081|NCT04644029|Emtricitabine|emtricitabine|mesh-list
83324082|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83324083|NCT04644029|Islatravir|islatravir|mesh-list
83324084|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
83324085|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324086|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83324087|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83324088|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324089|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324090|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83324091|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83324092|NCT00844090|Methylphenidate|methylphenidate|mesh-list
83324093|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83324094|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324095|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83324096|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324097|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324098|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324099|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
83324100|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324101|NCT00844714|Rituximab|rituximab|mesh-list
83324102|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83324103|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324104|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
83324105|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324106|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324107|NCT00834652|Metformin|metformin|mesh-list
83324108|NCT00834652|Sertraline|sertraline|mesh-list
83324109|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324110|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324111|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
83324112|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324113|NCT00834652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83324114|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324115|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324116|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324117|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324118|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
83324119|NCT00834808|Tramadol|tramadol|mesh-list
83324120|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83324121|NCT00834808|Narcotics|narcotics|mesh-ancestor
83324122|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324123|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324124|NCT00834808|Analgesics|analgesics|mesh-ancestor
83324125|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
83324126|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324127|NCT00850096|Insulin|insulin|mesh-list
83324128|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324129|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324130|NCT00834886|Melatonin|melatonin|mesh-list
83324131|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
83324132|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324133|NCT00834886|Protective Agents|protective agents|mesh-ancestor
83324134|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324135|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324136|NCT00835198|Dapsone|dapsone|mesh-list
83324137|NCT00835198|Tretinoin|tretinoin|mesh-list
83324138|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324139|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
83324140|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324141|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324142|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
83324143|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83324144|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83324145|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83324146|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324147|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324148|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
83324149|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83324150|NCT00835510|Butenafine|butenafine|mesh-list
83324151|NCT00835510|Clotrimazole|clotrimazole|mesh-list
83324152|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
83324153|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324154|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83324155|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83324156|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83324157|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324158|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324159|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83324160|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
83324161|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324162|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324163|NCT00835900|Varenicline|varenicline|mesh-list
83324164|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83324165|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83324166|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
83324167|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324168|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324169|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324170|NCT01954121|Carbamazepine|carbamazepine|mesh-list
83324171|NCT01954121|Levetiracetam|levetiracetam|mesh-list
83324172|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
83324173|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
83324174|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
83324175|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83324176|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324177|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324178|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324179|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324180|NCT01954121|Analgesics|analgesics|mesh-ancestor
83324181|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
83324182|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324183|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83324184|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324185|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324186|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83324187|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83324188|NCT03643744|Celecoxib|celecoxib|mesh-list
83324189|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83324190|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324191|NCT03643744|Analgesics|analgesics|mesh-ancestor
83324192|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
83324193|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324194|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324195|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324196|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324197|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83324198|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83324199|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324200|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324201|NCT00838162|Ritonavir|ritonavir|mesh-list
83324202|NCT00838162|TMC-310911|tmc-310911|mesh-list
83324203|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83324204|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83324205|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
83324206|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324207|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324208|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83324209|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83324210|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
83324211|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324212|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83324213|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83324214|NCT00841204|Sulindac|sulindac|mesh-list
83324215|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83324216|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324217|NCT00841204|Analgesics|analgesics|mesh-ancestor
83324218|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
83324219|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324220|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324221|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324222|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324223|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324224|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83324225|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324226|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324228|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
83324229|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83324230|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83324231|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324232|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83324233|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83324234|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
83324235|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324236|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83324237|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
83324238|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83324239|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83324240|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324241|NCT00853840|Urological Agents|urological agents|mesh-ancestor
83324242|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
83324243|NCT00841828|Docetaxel|docetaxel|mesh-list
83324244|NCT00841828|Trastuzumab|trastuzumab|mesh-list
83324245|NCT00841828|Epirubicin|epirubicin|mesh-list
83324246|NCT00841828|Lapatinib|lapatinib|mesh-list
83324247|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324248|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
83324249|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324250|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324251|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83324252|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
83324253|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324254|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324255|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83324256|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324257|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324258|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324259|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83324260|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83324261|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83324262|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83324263|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324264|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83324265|NCT00855010|Pioglitazone|pioglitazone|mesh-list
83324266|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324267|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324268|NCT00842608|Haloperidol|haloperidol|mesh-list
83324269|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
83324270|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83324271|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
83324272|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
83324273|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324274|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324275|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324276|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83324277|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83324278|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324279|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324280|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83324281|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
83324282|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324283|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324284|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83324285|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
83324286|NCT00856024|Ribavirin|ribavirin|mesh-list
83324287|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83324288|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
83324289|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324290|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
83324291|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324292|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
83324293|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83324294|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83324295|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83324296|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324297|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324298|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
83324299|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324300|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324301|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83324302|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324303|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
83324304|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83324305|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324306|NCT00857272|Bisacodyl|bisacodyl|mesh-list
83324307|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83324308|NCT00857272|Cathartics|cathartics|mesh-ancestor
83324309|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324310|NCT00857272|Laxatives|laxatives|mesh-ancestor
83324311|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
83324312|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83324313|NCT03696784|Fludarabine|fludarabine|mesh-list
83324314|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324315|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
83324316|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324317|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324318|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83324319|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
83324320|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324321|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324322|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83324323|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
83324324|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83324325|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83324326|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83324327|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
83324328|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324329|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324330|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324331|NCT02453620|Nivolumab|nivolumab|mesh-list
83324332|NCT02453620|Ipilimumab|ipilimumab|mesh-list
83324333|NCT02453620|Entinostat|entinostat|mesh-list
83324334|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83324335|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83324336|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324337|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83324338|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324339|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324340|NCT04400890|Vitamin D|vitamin d|mesh-list
83324341|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
83324342|NCT04400890|Resveratrol|resveratrol|mesh-list
83324343|NCT04400890|Vitamins|vitamins|mesh-ancestor
83324344|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
83324345|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324346|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83324347|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83324348|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
83324349|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324350|NCT04400890|Protective Agents|protective agents|mesh-ancestor
83324351|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324352|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83324353|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83324354|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324355|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324356|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324357|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83324358|NCT04351438|Heparin|heparin|mesh-list
83324359|NCT04351438|Citric Acid|citric acid|mesh-list
83324360|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
83324361|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
83324362|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83324363|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
83324364|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
83413621|NCT04758689|Methotrexate|methotrexate|mesh-list
83324365|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324366|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83324367|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83324368|NCT00890656|Dexamethasone|dexamethasone|mesh-list
83324369|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
83324370|NCT00890656|Doxorubicin|doxorubicin|mesh-list
83324371|NCT00890656|Methotrexate|methotrexate|mesh-list
83324372|NCT00890656|Vincristine|vincristine|mesh-list
83324373|NCT00890656|Asparaginase|asparaginase|mesh-list
83324374|NCT00890656|Pegaspargase|pegaspargase|mesh-list
83324375|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324376|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
83324377|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324378|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324379|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83324380|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
83324381|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324382|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324383|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83324384|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324385|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
83324386|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
83324387|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324388|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324389|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
83324390|NCT00890656|Hormones|hormones|mesh-ancestor
83324391|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324392|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83324393|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324394|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83324395|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83324396|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83324397|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83324398|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
83324399|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83324400|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83324401|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
83324402|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324403|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83324404|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83324405|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83324406|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324407|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324408|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324409|NCT00814138|Methotrexate|methotrexate|mesh-list
83324410|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83324411|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
83324412|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83324413|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324414|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83324415|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
83324416|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324417|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324418|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324419|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324420|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83324421|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324422|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
83324423|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324424|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83324425|NCT00860938|Budesonide|budesonide|mesh-list
83324426|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324427|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83324428|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
83324429|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324430|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324431|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83324432|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
83324433|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
83324434|NCT00860938|Hormones|hormones|mesh-ancestor
83324435|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324436|NCT01719757|Oxycodone|oxycodone|mesh-list
83324437|NCT01719757|Naloxone|naloxone|mesh-list
83324438|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83324439|NCT01719757|Narcotics|narcotics|mesh-ancestor
83324440|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324441|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324442|NCT01719757|Analgesics|analgesics|mesh-ancestor
83324443|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
83324444|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324445|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83324446|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83324447|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83324448|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324449|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83324450|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324451|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324452|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324453|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
83324454|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324455|NCT01857934|Aldesleukin|aldesleukin|mesh-list
83324456|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
83324458|NCT01857934|Busulfan|busulfan|mesh-list
83324459|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
83324460|NCT01857934|Doxorubicin|doxorubicin|mesh-list
83324461|NCT01857934|Etoposide|etoposide|mesh-list
83324462|NCT01857934|Vincristine|vincristine|mesh-list
83324463|NCT01857934|Topotecan|topotecan|mesh-list
83324464|NCT01857934|Interleukin-2|interleukin-2|mesh-list
83324465|NCT01857934|Molgramostim|molgramostim|mesh-list
83324466|NCT01857934|Dinutuximab|dinutuximab|mesh-list
83324467|NCT01857934|Levetiracetam|levetiracetam|mesh-list
83324468|NCT01857934|Isotretinoin|isotretinoin|mesh-list
83324469|NCT01857934|Antibodies|antibodies|mesh-list
83324470|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
83324471|NCT01857934|Sargramostim|sargramostim|mesh-list
83324472|NCT01857934|Lenograstim|lenograstim|mesh-list
83324473|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324474|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
83324475|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324476|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324477|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83324478|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
83324479|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324480|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324481|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83324482|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83324483|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83324484|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83324485|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324486|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83324487|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324488|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324489|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324490|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83324491|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324492|NCT01857934|Analgesics|analgesics|mesh-ancestor
83324493|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
83324494|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324495|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83324496|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83324497|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
83324498|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324499|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83324500|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
83324501|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
83324502|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324503|NCT00862810|Vaccines|vaccines|mesh-list
83324504|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
83324505|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324506|NCT00863122|Lapatinib|lapatinib|mesh-list
83324507|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324508|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83324509|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324510|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324511|NCT01604785|Dopamine|dopamine|mesh-list
83324512|NCT01604785|Propofol|propofol|mesh-list
83324513|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
83324514|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83324515|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324516|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324517|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83324518|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
83324519|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
83324520|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83324521|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
83324522|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
83324523|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324524|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
83324525|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324526|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324527|NCT01604785|Protective Agents|protective agents|mesh-ancestor
83324528|NCT01681849|Paroxetine|paroxetine|mesh-list
83324529|NCT01681849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83324530|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324531|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324532|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324533|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324534|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
83324535|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324536|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83324537|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
83324538|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324539|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83324540|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83324541|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324542|NCT00863356|Hemostatics|hemostatics|mesh-list
83324543|NCT00863356|Chitosan|chitosan|mesh-list
83324544|NCT00863356|Coagulants|coagulants|mesh-ancestor
83324545|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83324546|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83324547|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
83324548|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324549|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83324550|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
83324551|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
83324552|NCT00863434|Cytarabine|cytarabine|mesh-list
83324553|NCT00863434|Clofarabine|clofarabine|mesh-list
83324554|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83324555|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
83324556|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324557|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324558|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
83324559|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324560|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324561|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
83324562|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324563|NCT04228042|Infigratinib|infigratinib|mesh-list
83324564|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324565|NCT04209790|Temozolomide|temozolomide|mesh-list
83324566|NCT04209790|Benzolamide|benzolamide|mesh-list
83324567|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83324568|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
83324569|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324570|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324571|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83324572|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324573|NCT01718353|Prednisone|prednisone|mesh-list
83324574|NCT01718353|Docetaxel|docetaxel|mesh-list
83324575|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324576|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324577|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324578|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324579|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324580|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324581|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
83324582|NCT01718353|Hormones|hormones|mesh-ancestor
83324583|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324584|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324585|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83324586|NCT01716715|Paclitaxel|paclitaxel|mesh-list
83324587|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83324588|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83324589|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324590|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324591|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324592|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324593|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324594|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
83324595|NCT01696279|Calcium|calcium|mesh-list
83324596|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83324597|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324598|NCT01696279|Antacids|antacids|mesh-ancestor
83324599|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324600|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324601|NCT01936181|Infliximab|infliximab|mesh-list
83324602|NCT01936181|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83324603|NCT01936181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324604|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324605|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324606|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324607|NCT01696045|Ipilimumab|ipilimumab|mesh-list
83324608|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83324609|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324610|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83324611|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324612|NCT01935947|Gemcitabine|gemcitabine|mesh-list
83324613|NCT01935947|Azacitidine|azacitidine|mesh-list
83324614|NCT01935947|Docetaxel|docetaxel|mesh-list
83324615|NCT01935947|Irinotecan|irinotecan|mesh-list
83324616|NCT01935947|Pemetrexed|pemetrexed|mesh-list
83324617|NCT01935947|Camptothecin|camptothecin|mesh-list
83324618|NCT01935947|Entinostat|entinostat|mesh-list
83324619|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83324620|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83324621|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
83324622|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324623|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324624|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324625|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324626|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324627|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83324628|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83324629|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324630|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83324631|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83324632|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83324633|NCT02986321|Budesonide|budesonide|mesh-list
83324634|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324635|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83324636|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
83324637|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324638|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324639|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83324640|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
83324641|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
83324642|NCT02986321|Hormones|hormones|mesh-ancestor
83324643|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324644|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83324645|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83324646|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324647|NCT01951157|Gemcitabine|gemcitabine|mesh-list
83324648|NCT01951157|Docetaxel|docetaxel|mesh-list
83324649|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83324650|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
83324651|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324652|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324653|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324654|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324655|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324656|NCT01363349|Risperidone|risperidone|mesh-list
83324657|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83324658|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
83324659|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324660|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324661|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324662|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83324663|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83324664|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324665|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324666|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83324667|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
83324668|NCT00818272|Infliximab|infliximab|mesh-list
83324669|NCT00818272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83324670|NCT00818272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324671|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324672|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324673|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324674|NCT00868348|Ketorolac|ketorolac|mesh-list
83324675|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83324676|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324677|NCT00868348|Analgesics|analgesics|mesh-ancestor
83324678|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
83324679|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324680|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324681|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324682|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324683|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83324684|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324685|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324686|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
83324687|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324688|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324689|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83324690|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83324691|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324692|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324693|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324694|NCT01933919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83324695|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324696|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324697|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324698|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
83324699|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83324700|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83324701|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83324702|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83324703|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83324704|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
83324705|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83324706|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324707|NCT01933217|Methylphenidate|methylphenidate|mesh-list
83324708|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83324709|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324710|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83324711|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324712|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324713|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324714|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
83324715|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324716|NCT01949051|Levocabastine|levocabastine|mesh-list
83324717|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83324718|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83324719|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
83324720|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
83324721|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324722|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324723|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324724|NCT01692301|Amlodipine|amlodipine|mesh-list
83324725|NCT01692301|Valsartan|valsartan|mesh-list
83324726|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83324727|NCT01692301|Olmesartan|olmesartan|mesh-list
83324728|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83324729|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83324730|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83324731|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83324732|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324733|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324734|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83324735|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324736|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
83324737|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83324738|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83324739|NCT01692301|Diuretics|diuretics|mesh-ancestor
83324740|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
83324741|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83324742|NCT01592773|Memantine|memantine|mesh-list
83324743|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83324744|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83324745|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
83324746|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324747|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324748|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324749|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83324750|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83324751|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
83324752|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83324753|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
83324754|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324755|NCT01592695|Ethanol|ethanol|mesh-list
83324756|NCT01592695|Bupropion|bupropion|mesh-list
83324757|NCT01592695|Nicotine|nicotine|mesh-list
83324758|NCT01592695|Varenicline|varenicline|mesh-list
83324759|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83324760|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
83324761|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324762|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324763|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83324764|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83324765|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
83324766|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324767|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324768|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83324769|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324770|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324771|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83324772|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
83324773|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324774|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83324775|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324776|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324777|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
83324778|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83324779|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83324780|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324781|NCT01929863|Metformin|metformin|mesh-list
83324782|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324783|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324785|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324786|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83324787|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324788|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324789|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
83324790|NCT04553263|Naltrexone|naltrexone|mesh-list
83324791|NCT04553263|Bupropion|bupropion|mesh-list
83324792|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83324793|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83324794|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324795|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
83324796|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324797|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83324798|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
83324799|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324800|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83324801|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83324802|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83324803|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324804|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
83324805|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324806|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83324807|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83324808|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324809|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83324811|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
83324812|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324813|NCT04768075|Paclitaxel|paclitaxel|mesh-list
83324814|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83324815|NCT04768075|Carboplatin|carboplatin|mesh-list
83324816|NCT04768075|Pemetrexed|pemetrexed|mesh-list
83324817|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83324818|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324819|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
83324820|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
83324821|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
83324822|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324823|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324824|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83324825|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83324826|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83324827|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324828|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83324829|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324830|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324831|NCT01929317|Ropinirole|ropinirole|mesh-list
83324832|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83324833|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83324834|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
83324835|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
83324836|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324837|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324838|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324839|NCT01711879|Aflibercept|aflibercept|mesh-list
83324840|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83324841|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83324842|NCT01711879|Growth Substances|growth substances|mesh-ancestor
83324843|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324844|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
83324845|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324846|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
83324847|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83324848|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324849|NCT01689649|Topiramate|topiramate|mesh-list
83324850|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
83324851|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324852|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324853|NCT01929083|Ibutilide|ibutilide|mesh-list
83324854|NCT01929083|Progesterone|progesterone|mesh-list
83324855|NCT01929083|Progestins|progestins|mesh-ancestor
83324856|NCT01929083|Hormones|hormones|mesh-ancestor
83324857|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324858|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324859|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83324861|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324862|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324863|NCT00891436|Fluticasone|fluticasone|mesh-list
83324864|NCT00891436|Xhance|xhance|mesh-list
83324865|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324866|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83324867|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
83324868|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324869|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324870|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83324871|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
83324872|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
83324873|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83324874|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
83324875|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83324876|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
83324877|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324878|NCT01711645|Antacids|antacids|mesh-ancestor
83324879|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324880|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83324882|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
83324883|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324884|NCT01590433|Exenatide|exenatide|mesh-list
83324885|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83324886|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324887|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83324888|NCT01590433|Incretins|incretins|mesh-ancestor
83324889|NCT01590433|Hormones|hormones|mesh-ancestor
83324890|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324891|NCT00820612|Indomethacin|indomethacin|mesh-list
83324892|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83324893|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324894|NCT00820612|Analgesics|analgesics|mesh-ancestor
83324895|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
83324896|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324897|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324898|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324899|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324900|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
83324901|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
83324902|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83324903|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83324904|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324905|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324906|NCT01928927|Telmisartan|telmisartan|mesh-list
83324907|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83324908|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83324909|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83324910|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324911|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
83324912|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83324913|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324914|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324915|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324916|NCT00871624|Analgesics|analgesics|mesh-ancestor
83324917|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
83324918|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324919|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83324920|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83324921|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83324922|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
83324923|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324924|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324925|NCT01710709|Aripiprazole|aripiprazole|mesh-list
83324926|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
83324927|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83324928|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83324929|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83324930|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324931|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324932|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
83324933|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
83324934|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324935|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324936|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83324937|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83324938|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
83324939|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83324940|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83324941|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83324942|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83324943|NCT05317546|Cannabidiol|cannabidiol|mesh-list
83324944|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
83324945|NCT01709695|Guanfacine|guanfacine|mesh-list
83324946|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83324947|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83324948|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83324949|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83324950|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
83324951|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83324952|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324953|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324954|NCT05236504|Melatonin|melatonin|mesh-list
83324955|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
83324956|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324957|NCT05236504|Protective Agents|protective agents|mesh-ancestor
83324958|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324959|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83324960|NCT01685983|Prednisolone|prednisolone|mesh-list
83324961|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
83324962|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324963|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
83324964|NCT01685983|Hormones|hormones|mesh-ancestor
83324965|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83324966|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324967|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83324968|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324969|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83324970|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324971|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324972|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
83324973|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83324974|NCT02151448|Interferons|interferons|mesh-list
83324975|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
83324976|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
83324977|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
83324978|NCT02151448|Celecoxib|celecoxib|mesh-list
83324979|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83324980|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
83324981|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83324982|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
83324983|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83324984|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83324985|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83324986|NCT02151448|Analgesics|analgesics|mesh-ancestor
83324987|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
83324988|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83324989|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83324990|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83324991|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83324992|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83324993|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83324994|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83324995|NCT00875212|Calcium|calcium|mesh-list
83324996|NCT00875212|Fluorides|fluorides|mesh-list
83324997|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
83324998|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83324999|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325000|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
83325001|NCT00875212|Protective Agents|protective agents|mesh-ancestor
83325002|NCT00875836|Buspirone|buspirone|mesh-list
83325003|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83325004|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83325005|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325006|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325007|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83325008|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83325009|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
83325010|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325011|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325012|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
83325013|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
83325014|NCT05312398|Irinotecan|irinotecan|mesh-list
83325015|NCT05312398|Cetuximab|cetuximab|mesh-list
83325016|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83325017|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83325018|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325019|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325020|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325021|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325022|NCT01685203|Ribavirin|ribavirin|mesh-list
83325023|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
83325024|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325026|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325027|NCT01928771|Benralizumab|benralizumab|mesh-list
83325028|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83325029|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
83325030|NCT01589653|Insulin|insulin|mesh-list
83325031|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83325032|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
83325033|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
83325034|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83325035|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
83325036|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
83325037|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
83325038|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83325039|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325040|NCT01928615|Trastuzumab|trastuzumab|mesh-list
83325041|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83325042|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325043|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325044|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
83325045|NCT01589497|Rifampin|rifampin|mesh-list
83325046|NCT01589497|Isoniazid|isoniazid|mesh-list
83325047|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
83325048|NCT01589497|Ethambutol|ethambutol|mesh-list
83325049|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83325050|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325051|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83325052|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83325053|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325054|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325055|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325056|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83325057|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
83325058|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
83325059|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83325060|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83325061|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83325062|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83325063|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83325064|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83325065|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83325066|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83325067|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83325068|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
83325069|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83325070|NCT01928381|Pregabalin|pregabalin|mesh-list
83325071|NCT01928381|Analgesics|analgesics|mesh-ancestor
83325072|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
83325073|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325074|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325075|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
83325076|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83325077|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325078|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325079|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83325080|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83325081|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83325082|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325083|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83325085|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
83325086|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325087|NCT01927757|Etanercept|etanercept|mesh-list
83325088|NCT01927757|Methotrexate|methotrexate|mesh-list
83325089|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83325090|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
83325091|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83325092|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325093|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83325094|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
83325095|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325096|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325097|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
83325098|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325099|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83325100|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325101|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
83325102|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325103|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83325104|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83325105|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325106|NCT01927757|Analgesics|analgesics|mesh-ancestor
83325107|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
83325108|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325109|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325110|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83325111|NCT01913639|Leucovorin|leucovorin|mesh-list
83325112|NCT01913639|Fluorouracil|fluorouracil|mesh-list
83325113|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
83325114|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
83325115|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325116|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83325117|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325118|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325119|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
83325120|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325121|NCT01913639|Antidotes|antidotes|mesh-ancestor
83325122|NCT01913639|Protective Agents|protective agents|mesh-ancestor
83325123|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
83325124|NCT01913639|Vitamins|vitamins|mesh-ancestor
83325125|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
83325126|NCT01913483|Heparin|heparin|mesh-list
83325127|NCT01913483|Calcium heparin|calcium heparin|mesh-list
83325128|NCT01913483|Bivalirudin|bivalirudin|mesh-list
83325129|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
83325130|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83325131|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83325132|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325133|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
83325134|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83325135|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325136|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325137|NCT01913405|Factor VIII|factor viii|mesh-list
83325138|NCT01913405|BAX 855|bax 855|mesh-list
83325139|NCT01913405|Coagulants|coagulants|mesh-ancestor
83325140|NCT01927055|Mannitol|mannitol|mesh-list
83325141|NCT01927055|Droxidopa|droxidopa|mesh-list
83325142|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83325143|NCT01927055|Diuretics|diuretics|mesh-ancestor
83325144|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
83325145|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325146|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83325147|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83325148|NCT01913327|Risperidone|risperidone|mesh-list
83325149|NCT01913327|Aripiprazole|aripiprazole|mesh-list
83325150|NCT01913327|Modafinil|modafinil|mesh-list
83325151|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83325152|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
83325153|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325154|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325155|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325156|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83325157|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83325158|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325159|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83325160|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83325161|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
83325162|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
83325163|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
83325164|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83325165|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83325166|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83325167|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83325168|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83325169|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83325170|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83325171|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83325172|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83325173|NCT01911845|Ribavirin|ribavirin|mesh-list
83325174|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
83325175|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325176|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
83325177|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325178|NCT01925183|Interferons|interferons|mesh-list
83325179|NCT01925183|Ribavirin|ribavirin|mesh-list
83325180|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
83325181|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
83325182|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83325183|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325184|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
83325185|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325186|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
83325187|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325188|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
83325189|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325190|NCT01910519|Vaccines|vaccines|mesh-list
83325191|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
83325192|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325193|NCT01910441|Metformin|metformin|mesh-list
83325194|NCT01910441|Glimepiride|glimepiride|mesh-list
83325195|NCT01910441|Vildagliptin|vildagliptin|mesh-list
83325196|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83325197|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325198|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83325199|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325200|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
83325201|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83325202|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325203|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325204|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325205|NCT01923467|Nicotine|nicotine|mesh-list
83325206|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83325207|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
83325208|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325209|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325210|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83325211|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83325212|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
83325213|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325214|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325215|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
83325216|NCT01908803|Dexamethasone|dexamethasone|mesh-list
83325217|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325218|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
83325219|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
83325220|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325221|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325222|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83325223|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
83325224|NCT01908803|Hormones|hormones|mesh-ancestor
83325225|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325226|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83325227|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325228|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83325229|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325230|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83325231|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83325232|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325233|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325234|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83325235|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83325237|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
83325238|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
83325239|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
83325240|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325241|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325242|NCT01588951|Cytarabine|cytarabine|mesh-list
83325243|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83325244|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
83325245|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325246|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325247|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
83325248|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325249|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325250|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
83325251|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325252|NCT01588405|Treprostinil|treprostinil|mesh-list
83325253|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83325254|NCT01923311|Elvitegravir|elvitegravir|mesh-list
83325255|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83325256|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83325257|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
83325258|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325259|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83325260|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325261|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325262|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
83325263|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83325264|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83325265|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83325266|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325267|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325268|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
83325269|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325270|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325271|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83325272|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325273|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
83325274|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83325275|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83325276|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83325277|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83325278|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325279|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325280|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
83325281|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325282|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325283|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83325284|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325285|NCT01921829|Diuretics|diuretics|mesh-list
83325286|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
83325287|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325288|NCT01904903|Trastuzumab|trastuzumab|mesh-list
83325289|NCT01904903|Pertuzumab|pertuzumab|mesh-list
83325290|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83325291|NCT01904903|Maytansine|maytansine|mesh-list
83325292|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325293|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325294|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83325295|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
83325296|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
83325297|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
83325298|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325299|NCT01904903|Immunotoxins|immunotoxins|mesh-ancestor
83325300|NCT01904903|Immunoconjugates|immunoconjugates|mesh-ancestor
83325301|NCT01904903|Immunologic Factors|immunologic factors|mesh-ancestor
83325302|NCT01904903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325303|NCT01921205|Lacosamide|lacosamide|mesh-list
83325304|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
83325305|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83325306|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83325307|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325308|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325309|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
83325310|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83325311|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325312|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
83325313|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83325314|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
83325315|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325316|NCT01709305|Metformin|metformin|mesh-list
83325317|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83325318|NCT01709305|Glimepiride|glimepiride|mesh-list
83325319|NCT01709305|Acarbose|acarbose|mesh-list
83325320|NCT01709305|Repaglinide|repaglinide|mesh-list
83325321|NCT01709305|Gliclazide|gliclazide|mesh-list
83325322|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83325323|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325324|NCT01709305|Incretins|incretins|mesh-ancestor
83325325|NCT01709305|Hormones|hormones|mesh-ancestor
83325326|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325327|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83325328|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325329|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325330|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325331|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83325332|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325333|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
83325334|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83325335|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
83325336|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83325337|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
83325338|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83325339|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325340|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325341|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325342|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
83325343|NCT01709227|Furosemide|furosemide|mesh-list
83325344|NCT01709227|Diuretics|diuretics|mesh-ancestor
83325345|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
83325346|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325347|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83325348|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325349|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325350|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
83325351|NCT00879034|Pravastatin|pravastatin|mesh-list
83325352|NCT00879034|Lonafarnib|lonafarnib|mesh-list
83325353|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83325354|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325355|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83325356|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83325357|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
83325358|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325359|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83325360|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83325361|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325362|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
83325363|NCT04088890|Fludarabine|fludarabine|mesh-list
83325364|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325365|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
83325366|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325367|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325368|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83325369|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
83325370|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325371|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325372|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83325373|NCT00879190|Gentamicins|gentamicins|mesh-list
83325374|NCT00879190|Ampicillin|ampicillin|mesh-list
83325375|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83325376|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325377|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83325378|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325379|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325380|NCT01903811|Dexamethasone|dexamethasone|mesh-list
83325381|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
83325382|NCT01903811|Ichthammol|ichthammol|mesh-list
83325383|NCT01903811|BB 1101|bb 1101|mesh-list
83325384|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325385|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
83325386|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
83325387|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325388|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325389|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83325390|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
83325391|NCT01903811|Hormones|hormones|mesh-ancestor
83325392|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325393|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83325394|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325395|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325396|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325397|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325398|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
83325399|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
83325400|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325401|NCT01709149|Riluzole|riluzole|mesh-list
83325402|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
83325403|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83325404|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83325405|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325406|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325407|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325408|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83325409|NCT01709149|Protective Agents|protective agents|mesh-ancestor
83325410|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
83325411|NCT05214196|Povidone|povidone|mesh-list
83325412|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
83325413|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
83325414|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83325415|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325416|NCT05311228|Azithromycin|azithromycin|mesh-list
83325417|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83325418|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325419|NCT04382014|Curcumin|curcumin|mesh-list
83325420|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83325421|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325422|NCT04382014|Analgesics|analgesics|mesh-ancestor
83325423|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
83325424|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325425|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325426|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325427|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325428|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325429|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325430|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325431|NCT00892606|Morphine|morphine|mesh-list
83325432|NCT00892606|Methadone|methadone|mesh-list
83325433|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83325434|NCT00892606|Narcotics|narcotics|mesh-ancestor
83325435|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325436|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325437|NCT00892606|Analgesics|analgesics|mesh-ancestor
83325438|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
83325439|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325440|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
83325441|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
83325442|NCT04416035|Paclitaxel|paclitaxel|mesh-list
83325443|NCT04416035|Bevacizumab|bevacizumab|mesh-list
83325444|NCT04416035|Carboplatin|carboplatin|mesh-list
83325445|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83325446|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325447|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
83325448|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
83325449|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
83325450|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325451|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325452|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83325453|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83325454|NCT04416035|Growth Substances|growth substances|mesh-ancestor
83325455|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325456|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
83325457|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
83325458|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83325459|NCT04381858|Antibodies|antibodies|mesh-list
83325460|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
83325461|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325462|NCT01903031|Ritonavir|ritonavir|mesh-list
83325463|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83325464|NCT01903031|Tenofovir|tenofovir|mesh-list
83325465|NCT01903031|Efavirenz|efavirenz|mesh-list
83325466|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
83325467|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83325468|NCT01903031|Etonogestrel|etonogestrel|mesh-list
83325469|NCT01903031|NuvaRing|nuvaring|mesh-list
83325470|NCT01903031|Estradiol|estradiol|mesh-list
83325471|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83325472|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83325473|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325474|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325475|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325476|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83325477|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83325478|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
83325479|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325480|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83325481|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83325482|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83325483|NCT01903031|Estrogens|estrogens|mesh-ancestor
83325484|NCT01903031|Hormones|hormones|mesh-ancestor
83325485|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325486|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325487|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83325488|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
83325489|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83325490|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83325491|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83325492|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83325493|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83325494|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83325495|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83325496|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83325497|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83325498|NCT00883168|Fluticasone|fluticasone|mesh-list
83325499|NCT00883168|Xhance|xhance|mesh-list
83325500|NCT00883168|Azelastine|azelastine|mesh-list
83325501|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325502|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83325503|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
83325504|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325505|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325506|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83325507|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
83325508|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
83325509|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83325510|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83325511|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325512|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325513|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83325514|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83325515|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
83325516|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
83325517|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325518|NCT01616693|Zinc|zinc|mesh-list
83325519|NCT01616693|Vaccines|vaccines|mesh-list
83325520|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
83325521|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325522|NCT01616693|Trace Elements|trace elements|mesh-ancestor
83325523|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
83325524|NCT00893074|Dronabinol|dronabinol|mesh-list
83325525|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
83325526|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325527|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83325528|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325529|NCT00893074|Analgesics|analgesics|mesh-ancestor
83325530|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
83325531|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325532|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83325533|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83325534|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325535|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325536|NCT00893074|Hormones|hormones|mesh-ancestor
83325537|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325538|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
83325539|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83325540|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83325541|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325542|NCT00887458|Itraconazole|itraconazole|mesh-list
83325543|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83325544|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
83325545|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325546|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83325547|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83325548|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325549|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325550|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83325551|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
83325552|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325553|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325554|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83325555|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83325556|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
83325557|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325558|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
83325559|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83325560|NCT03216304|Calcium|calcium|mesh-list
83325561|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83325562|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325563|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83325564|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83325565|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83325566|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
83325567|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325568|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83325569|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83325570|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325571|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
83325572|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83325573|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
83325574|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325575|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325576|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83325577|NCT03216538|Protective Agents|protective agents|mesh-ancestor
83325578|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83325579|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83325580|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325581|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325582|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
83325583|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325584|NCT03218722|Thrombin|thrombin|mesh-list
83325585|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
83325586|NCT03218722|Coagulants|coagulants|mesh-ancestor
83325587|NCT00888628|Etanercept|etanercept|mesh-list
83325588|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83325589|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325590|NCT00888628|Analgesics|analgesics|mesh-ancestor
83325591|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
83325592|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325593|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325594|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325595|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325596|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83325597|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325598|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
83325599|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
83325600|NCT03837886|Calcium|calcium|mesh-list
83325601|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83325602|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325603|NCT03837886|Antacids|antacids|mesh-ancestor
83325604|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325605|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83325606|NCT03219970|Osimertinib|osimertinib|mesh-list
83325607|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325608|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83325609|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325610|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325611|NCT00889330|Alcaftadine|alcaftadine|mesh-list
83325612|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83325613|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
83325614|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
83325615|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325616|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325617|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325618|NCT03219580|Fluorouracil|fluorouracil|mesh-list
83325619|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
83325620|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325621|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83325622|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325623|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325624|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
83325625|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325626|NCT03215446|Anesthetics|anesthetics|mesh-list
83325627|NCT03215446|Propofol|propofol|mesh-list
83325628|NCT03215446|Sevoflurane|sevoflurane|mesh-list
83325629|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325630|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325631|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83325632|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83325633|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
83325634|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83325635|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83325636|NCT00896038|Aprepitant|aprepitant|mesh-list
83325637|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
83325638|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
83325639|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325640|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325641|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83325642|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83325643|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325644|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325645|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
83325646|NCT04381234|Citric Acid|citric acid|mesh-list
83325647|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
83325648|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
83325649|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
83325650|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83325651|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
83325652|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
83325653|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325654|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83325655|NCT01616459|Vaccines|vaccines|mesh-list
83325656|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83325657|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
83325658|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325659|NCT03218254|Methylphenidate|methylphenidate|mesh-list
83325660|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83325661|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325662|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83325663|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83325664|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325665|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325666|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
83325667|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325668|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
83325669|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83325670|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
83325671|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
83325672|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325673|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325674|NCT01919801|Icatibant|icatibant|mesh-list
83325675|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83325676|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325677|NCT01919801|Analgesics|analgesics|mesh-ancestor
83325678|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
83325679|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325681|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325682|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325683|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83325684|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83325685|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325686|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83325687|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325688|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
83325689|NCT01919723|Ticagrelor|ticagrelor|mesh-list
83325690|NCT01919723|Eptifibatide|eptifibatide|mesh-list
83325691|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83325692|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83325693|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83325694|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83325695|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
83325696|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325697|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325698|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325699|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
83325700|NCT01919489|Liraglutide|liraglutide|mesh-list
83325701|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83325702|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325703|NCT01919489|Incretins|incretins|mesh-ancestor
83325704|NCT01919489|Hormones|hormones|mesh-ancestor
83325705|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325706|NCT01919411|Amoxicillin|amoxicillin|mesh-list
83325707|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
83325708|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
83325709|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83325710|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83325711|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325712|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83325713|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325714|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325715|NCT01901393|Ibuprofen|ibuprofen|mesh-list
83325716|NCT01901393|Ketorolac|ketorolac|mesh-list
83325717|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83325718|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83325719|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325720|NCT01901393|Analgesics|analgesics|mesh-ancestor
83325721|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
83325722|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325723|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325724|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325725|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325726|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83325727|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325728|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325729|NCT01890707|Anesthetics|anesthetics|mesh-list
83325730|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325731|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325732|NCT01890473|Abatacept|abatacept|mesh-list
83325733|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83325734|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325735|NCT01890473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325736|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325737|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325738|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
83325739|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325740|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325741|NCT01889069|Prednisone|prednisone|mesh-list
83325742|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
83325743|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83325744|NCT01889069|Rituximab|rituximab|mesh-list
83325745|NCT01889069|Doxorubicin|doxorubicin|mesh-list
83325746|NCT01889069|Vincristine|vincristine|mesh-list
83325747|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325748|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
83325749|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325750|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325751|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83325752|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
83325753|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325754|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325755|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83325756|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325757|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83325758|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83325759|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83325760|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325761|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325762|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
83325763|NCT01889069|Hormones|hormones|mesh-ancestor
83325764|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325765|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83325766|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83325767|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
83325768|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
83325769|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
83325770|NCT00898222|Aspirin|aspirin|mesh-list
83325771|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83325772|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325773|NCT00898222|Analgesics|analgesics|mesh-ancestor
83325774|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
83325775|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325776|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325777|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325778|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325779|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83325780|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83325781|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325782|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83325783|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83325784|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325785|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
83325786|NCT01830556|Cetuximab|cetuximab|mesh-list
83325787|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325788|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325789|NCT03214354|Sirolimus|sirolimus|mesh-list
83325790|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
83325791|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83325792|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325793|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83325794|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325795|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
83325796|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83325797|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
83325798|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325799|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325800|NCT03217942|Mitogens|mitogens|mesh-list
83325801|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
83325802|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325803|NCT00903448|Omeprazole|omeprazole|mesh-list
83325804|NCT00903448|Lansoprazole|lansoprazole|mesh-list
83325805|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83325806|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83325807|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83325808|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325809|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325810|NCT00895180|Ramucirumab|ramucirumab|mesh-list
83325811|NCT00895180|Olaratumab|olaratumab|mesh-list
83325812|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325813|NCT01830868|Zonisamide|zonisamide|mesh-list
83325814|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
83325815|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83325816|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325817|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325818|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83325819|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325820|NCT03213964|Interleukin-2|interleukin-2|mesh-list
83325821|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325822|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325823|NCT03213964|Analgesics|analgesics|mesh-ancestor
83325824|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
83325825|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325826|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325827|NCT03217474|Ganciclovir|ganciclovir|mesh-list
83325828|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
83325829|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
83325830|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325831|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83325832|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325833|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325834|NCT01830946|Caseins|caseins|mesh-list
83325835|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
83325836|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
83325837|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325838|NCT03213886|Vitamin D|vitamin d|mesh-list
83325839|NCT03213886|Calcifediol|calcifediol|mesh-list
83325840|NCT03213886|Vitamins|vitamins|mesh-ancestor
83325841|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
83325842|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325843|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83325844|NCT03217084|Fluorides|fluorides|mesh-list
83325845|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
83325846|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
83325847|NCT03217084|Protective Agents|protective agents|mesh-ancestor
83325848|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325849|NCT00899470|Metformin|metformin|mesh-list
83325850|NCT00899470|Saxagliptin|saxagliptin|mesh-list
83325851|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83325852|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325853|NCT00899470|Incretins|incretins|mesh-ancestor
83325854|NCT00899470|Hormones|hormones|mesh-ancestor
83325855|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83325856|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83325857|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325858|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325859|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325860|NCT01738646|Bevacizumab|bevacizumab|mesh-list
83325861|NCT01738646|Vorinostat|vorinostat|mesh-list
83325862|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325863|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325864|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83325865|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83325866|NCT01738646|Growth Substances|growth substances|mesh-ancestor
83325867|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325868|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
83325869|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83325870|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325871|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325872|NCT00904618|Lidocaine|lidocaine|mesh-list
83325873|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
83325874|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
83325875|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83325876|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325877|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
83325878|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325879|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83325880|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83325881|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83325882|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325883|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325884|NCT01839370|Pramlintide|pramlintide|mesh-list
83325885|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83325886|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325887|NCT00907426|Bimatoprost|bimatoprost|mesh-list
83325888|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83325889|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83325890|NCT01832662|Caffeine|caffeine|mesh-list
83325891|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83325892|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325893|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83325894|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325895|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325896|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83325897|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83325898|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
83325899|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83325900|NCT00909064|PENTA|penta|mesh-list
83325901|NCT00909064|Fondaparinux|fondaparinux|mesh-list
83325902|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83325903|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
83325904|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83325905|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325906|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325907|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325908|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
83325909|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83325910|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83325911|NCT01832896|Ecallantide|ecallantide|mesh-list
83325912|NCT01832896|Analgesics|analgesics|mesh-ancestor
83325913|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
83325914|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83325915|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325916|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83325917|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83325918|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83325919|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325920|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83325921|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
83325922|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83325923|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83325924|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83325925|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325926|NCT01830478|Rituximab|rituximab|mesh-list
83325927|NCT01830478|Lenalidomide|lenalidomide|mesh-list
83325928|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325929|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325930|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
83325931|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325932|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83325933|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83325934|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83325935|NCT01830478|Growth Substances|growth substances|mesh-ancestor
83325936|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
83325937|NCT04426695|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83325938|NCT04426695|Antiviral Agents|antiviral agents|mesh-ancestor
83325939|NCT04426695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325940|NCT01838200|Isoniazid|isoniazid|mesh-list
83325941|NCT01838200|Ipilimumab|ipilimumab|mesh-list
83325942|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
83325943|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325944|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325945|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83325946|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325947|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
83325948|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83325949|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83325950|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83325951|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83325952|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
83325953|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83325954|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83325955|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
83325956|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325957|NCT01720030|Simendan|simendan|mesh-list
83325958|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83325959|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
83325960|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83325961|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83325962|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325963|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325964|NCT01720030|Protective Agents|protective agents|mesh-ancestor
83325965|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325966|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
83325967|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83325968|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
83325969|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83325970|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325971|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325972|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325973|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
83325974|NCT04380220|Protein C|protein c|mesh-list
83325975|NCT04380220|Antithrombins|antithrombins|mesh-list
83325976|NCT04380220|Protein S|protein s|mesh-list
83325977|NCT04380220|Factor VIII|factor viii|mesh-list
83325979|NCT04380220|Coagulants|coagulants|mesh-ancestor
83325980|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83325981|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83325982|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83325983|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
83325984|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83325985|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
83325986|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83325987|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
83325988|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325989|NCT01832974|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
83325990|NCT01832974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325991|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83325992|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
83325993|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83325994|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83325995|NCT01671813|Immunotoxins|immunotoxins|mesh-ancestor
83325996|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
83325997|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83325998|NCT03830398|Acetaminophen|acetaminophen|mesh-list
83325999|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326000|NCT03830398|Analgesics|analgesics|mesh-ancestor
83326001|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
83326002|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326003|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326004|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
83326005|NCT04405323|Itraconazole|itraconazole|mesh-list
83326006|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
83326007|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326008|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83326009|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83326010|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326011|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326012|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83326013|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
83326014|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326015|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326016|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83326017|NCT01720498|Remifentanil|remifentanil|mesh-list
83326018|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326019|NCT01720498|Narcotics|narcotics|mesh-ancestor
83326020|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326021|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326022|NCT01720498|Analgesics|analgesics|mesh-ancestor
83326023|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
83326024|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326025|NCT01672047|Vitamin D|vitamin d|mesh-list
83326026|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
83326027|NCT01672047|Vitamins|vitamins|mesh-ancestor
83326028|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
83326029|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326030|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83326031|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83326032|NCT00911326|Dextrans|dextrans|mesh-list
83326033|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
83326034|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
83326035|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
83326036|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
83326037|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
83326038|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
83326039|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326040|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83326041|NCT01833676|Sevoflurane|sevoflurane|mesh-list
83326042|NCT01833676|Desflurane|desflurane|mesh-list
83326043|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83326044|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83326045|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
83326046|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
83326047|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326048|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326049|NCT04380376|Melphalan|melphalan|mesh-list
83326050|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83326051|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
83326052|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326053|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326054|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83326055|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83326056|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
83326057|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326058|NCT04380298|Ketorolac|ketorolac|mesh-list
83326059|NCT04380298|Epinephrine|epinephrine|mesh-list
83326060|NCT04380298|Ropivacaine|ropivacaine|mesh-list
83326061|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
83326062|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
83326063|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326064|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326065|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
83326066|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326067|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83326068|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83326069|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
83326070|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326071|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326072|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83326073|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83326074|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
83326075|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83326076|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326077|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
83326078|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
83326079|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83326080|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83326081|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326082|NCT04380298|Analgesics|analgesics|mesh-ancestor
83326083|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326084|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326085|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83326086|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326087|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83326088|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83326089|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83326090|NCT05384691|Luspatercept|luspatercept|mesh-list
83326091|NCT05384691|Hematinics|hematinics|mesh-ancestor
83326092|NCT03210610|Colchicine|colchicine|mesh-list
83326093|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
83326094|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326095|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83326096|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83326097|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83326098|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326099|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326100|NCT03152955|Sufentanil|sufentanil|mesh-list
83326101|NCT03152955|Ketamine|ketamine|mesh-list
83326102|NCT03152955|Ondansetron|ondansetron|mesh-list
83326103|NCT03152955|Analgesics|analgesics|mesh-ancestor
83326104|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
83326105|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326106|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326107|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83326108|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83326109|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
83326110|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
83326111|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326112|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83326113|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83326114|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326115|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326116|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
83326117|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
83326118|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83326119|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
83326120|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
83326121|NCT03152955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83326122|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83326123|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
83326124|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326125|NCT03152955|Narcotics|narcotics|mesh-ancestor
83326126|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83326127|NCT01676493|Codeine|codeine|mesh-list
83326128|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326129|NCT01676493|Narcotics|narcotics|mesh-ancestor
83326130|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326131|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326132|NCT01676493|Analgesics|analgesics|mesh-ancestor
83326133|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
83326134|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326135|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
83326136|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326137|NCT01721434|Simendan|simendan|mesh-list
83326138|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83326139|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
83326140|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83326141|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83326142|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326143|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326144|NCT01721434|Protective Agents|protective agents|mesh-ancestor
83326145|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326146|NCT03210532|Amlodipine|amlodipine|mesh-list
83326147|NCT03210532|Telmisartan|telmisartan|mesh-list
83326148|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83326149|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83326150|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83326151|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83326152|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83326153|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326154|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83326155|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326156|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
83326157|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83326158|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83326159|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
83326160|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83326161|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83326162|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326163|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83326164|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83326165|NCT03152565|Avelumab|avelumab|mesh-list
83326166|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83326167|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326168|NCT03210064|Fluorouracil|fluorouracil|mesh-list
83326169|NCT03210064|Apatinib|apatinib|mesh-list
83326170|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
83326171|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326172|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83326173|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326174|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83326175|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
83326176|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326177|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83326178|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326179|NCT03215524|Thalidomide|thalidomide|mesh-list
83326180|NCT03215524|Dexamethasone|dexamethasone|mesh-list
83326181|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
83326182|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
83326183|NCT03215524|Daratumumab|daratumumab|mesh-list
83326184|NCT03215524|Pomalidomide|pomalidomide|mesh-list
83326185|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83326186|NCT03215524|BB 1101|bb 1101|mesh-list
83326187|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83326188|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
83326189|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326190|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326191|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83326192|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
83326193|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326194|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326195|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83326196|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326197|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
83326198|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
83326199|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326200|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83326201|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
83326202|NCT03215524|Hormones|hormones|mesh-ancestor
83326203|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326204|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83326205|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
83326206|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326207|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83326208|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83326209|NCT03215524|Growth Substances|growth substances|mesh-ancestor
83326210|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
83326211|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
83326212|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83326213|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326214|NCT05372991|Atropine|atropine|mesh-list
83326215|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83326216|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83326217|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83326218|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
83326219|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326220|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326221|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83326222|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326223|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
83326224|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
83326225|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83326226|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83326227|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
83326228|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326229|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326230|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83326231|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326232|NCT03594435|Ibudilast|ibudilast|mesh-list
83326233|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83326234|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
83326235|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326236|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326237|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83326238|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326239|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83326240|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326241|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326242|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83326243|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
83326244|NCT01722448|Choline|choline|mesh-list
83326245|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
83326246|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83326247|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
83326248|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326249|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83326250|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83326251|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
83326252|NCT01834768|Eplerenone|eplerenone|mesh-list
83326253|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83326254|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
83326255|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326256|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326257|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83326258|NCT01834768|Diuretics|diuretics|mesh-ancestor
83326259|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
83326260|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83326261|NCT01672671|Paclitaxel|paclitaxel|mesh-list
83326262|NCT01672671|Doxorubicin|doxorubicin|mesh-list
83326263|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83326264|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326265|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
83326266|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
83326267|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
83326268|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326269|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83326270|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83326271|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83326272|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326273|NCT02459457|Paclitaxel|paclitaxel|mesh-list
83326274|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83326275|NCT02459457|Carboplatin|carboplatin|mesh-list
83326276|NCT02459457|Fluorouracil|fluorouracil|mesh-list
83326277|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83326278|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326279|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83326280|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83326281|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83326282|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326283|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
83326284|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83326285|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83326286|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
83326287|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326288|NCT01835236|Paclitaxel|paclitaxel|mesh-list
83326289|NCT01835236|Vinorelbine|vinorelbine|mesh-list
83326290|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83326291|NCT01835236|Trastuzumab|trastuzumab|mesh-list
83326292|NCT01835236|Pertuzumab|pertuzumab|mesh-list
83326293|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83326294|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326295|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
83326296|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
83326297|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
83326298|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326299|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83326300|NCT01835236|Immunotoxins|immunotoxins|mesh-ancestor
83326301|NCT01835236|Immunoconjugates|immunoconjugates|mesh-ancestor
83326302|NCT01835236|Immunologic Factors|immunologic factors|mesh-ancestor
83326303|NCT01835236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326304|NCT01671891|Capecitabine|capecitabine|mesh-list
83326305|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
83326306|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83326307|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
83326308|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326309|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326310|NCT03152409|Aspirin|aspirin|mesh-list
83326311|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
83326312|NCT03152409|Salicylates|salicylates|mesh-list
83326313|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83326314|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326315|NCT03152409|Analgesics|analgesics|mesh-ancestor
83326316|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
83326317|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326318|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326319|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326320|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326321|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83326322|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413622|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83326323|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326324|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83326325|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83326326|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326327|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
83326328|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326329|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
83326330|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
83326331|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
83326332|NCT01830322|Gemcitabine|gemcitabine|mesh-list
83326333|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83326334|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
83326335|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326336|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326337|NCT01835314|Stiripentol|stiripentol|mesh-list
83326338|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
83326339|NCT01706198|Fluticasone|fluticasone|mesh-list
83326340|NCT01706198|Xhance|xhance|mesh-list
83326341|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326342|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83326343|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
83326344|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326345|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326346|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83326347|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326348|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
83326349|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83326350|NCT04378972|Vitamin D|vitamin d|mesh-list
83326351|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
83326352|NCT04378972|Curcumin|curcumin|mesh-list
83326353|NCT04378972|Tramiprosate|tramiprosate|mesh-list
83326354|NCT04378972|Vitamins|vitamins|mesh-ancestor
83326355|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
83326356|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326357|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83326358|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83326359|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83326360|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326361|NCT04378972|Analgesics|analgesics|mesh-ancestor
83326362|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
83326363|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326364|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326365|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326366|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326367|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326368|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326369|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
83326370|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
83326371|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
83326372|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326373|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
83326374|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
83326375|NCT01723150|Ertapenem|ertapenem|mesh-list
83326376|NCT01723150|Trimethoprim|trimethoprim|mesh-list
83326377|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
83326378|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83326379|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326380|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83326381|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83326382|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326383|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326384|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326385|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83326386|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83326387|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83326388|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
83326389|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83326390|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83326391|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83326392|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83326393|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83326394|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83326395|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326396|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83326397|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326398|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326399|NCT01836016|Fluticasone|fluticasone|mesh-list
83326400|NCT01836016|Xhance|xhance|mesh-list
83326401|NCT01836016|Albuterol|albuterol|mesh-list
83326402|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
83326403|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83326404|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83326405|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326406|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83326407|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
83326408|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326409|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326410|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83326411|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326412|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
83326413|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83326414|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83326415|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83326416|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83326417|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
83326418|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326419|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326420|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
83326421|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83326422|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
83326423|NCT01836016|Hormones|hormones|mesh-ancestor
83326424|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326425|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
83326426|NCT01836094|Methylene Blue|methylene blue|mesh-list
83326427|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326428|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326429|NCT01726192|Ropivacaine|ropivacaine|mesh-list
83326431|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
83326432|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326433|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326434|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
83326435|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326436|NCT01836328|Methadone|methadone|mesh-list
83326437|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83326438|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326439|NCT01836328|Narcotics|narcotics|mesh-ancestor
83326440|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326441|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326442|NCT01836328|Analgesics|analgesics|mesh-ancestor
83326443|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
83326444|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326445|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
83326446|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326447|NCT01836406|Ketorolac|ketorolac|mesh-list
83326448|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83326449|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83326450|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326451|NCT01836406|Analgesics|analgesics|mesh-ancestor
83326452|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
83326453|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326454|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326455|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326456|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326457|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83326458|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326459|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326460|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83326461|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83326462|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326463|NCT01726816|Probucol|probucol|mesh-list
83326464|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83326465|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83326466|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
83326467|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326468|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83326469|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
83326470|NCT01726816|Protective Agents|protective agents|mesh-ancestor
83326471|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326472|NCT00915538|Budesonide|budesonide|mesh-list
83326473|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83326474|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326475|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83326476|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
83326477|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326478|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326479|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83326480|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326481|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
83326482|NCT00915538|Hormones|hormones|mesh-ancestor
83326483|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326484|NCT01724086|Interferons|interferons|mesh-list
83326485|NCT01724086|Ritonavir|ritonavir|mesh-list
83326486|NCT01724086|Ribavirin|ribavirin|mesh-list
83326487|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
83326488|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
83326489|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83326490|NCT01724086|Simeprevir|simeprevir|mesh-list
83326491|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326492|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
83326493|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326494|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83326495|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83326496|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
83326497|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326498|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326499|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83326500|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83326501|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83326502|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83326503|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
83326504|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
83326505|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326506|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
83326507|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
83326508|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326509|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326510|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326511|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83326513|NCT01727050|Coagulants|coagulants|mesh-ancestor
83326514|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
83326515|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83326516|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83326517|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326518|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
83326519|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326520|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326521|NCT01837108|Eplerenone|eplerenone|mesh-list
83326522|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83326523|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
83326524|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326525|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326526|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83326527|NCT01837108|Diuretics|diuretics|mesh-ancestor
83326528|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
83326529|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83326530|NCT01724554|Aflibercept|aflibercept|mesh-list
83326531|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83326532|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83326533|NCT01724554|Growth Substances|growth substances|mesh-ancestor
83326534|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326535|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
83326536|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326537|NCT01724788|Furosemide|furosemide|mesh-list
83326538|NCT01724788|Diuretics|diuretics|mesh-ancestor
83326539|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
83326540|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326541|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83326542|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83326543|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326544|NCT01837498|Neostigmine|neostigmine|mesh-list
83326545|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83326546|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326547|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326548|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
83326549|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326550|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326551|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83326552|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
83326553|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326554|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83326555|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
83326556|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326557|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83326558|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83326559|NCT01837576|Calcipotriene|calcipotriene|mesh-list
83326560|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
83326561|NCT01728298|Immunomodulating Agents|immunomodulating agents|mesh-list
83326562|NCT01728298|Immunologic Factors|immunologic factors|mesh-ancestor
83326563|NCT01728298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326564|NCT01737710|Vaccines|vaccines|mesh-list
83326565|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
83326566|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326567|NCT01837810|Ibuprofen|ibuprofen|mesh-list
83326568|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83326569|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326570|NCT01837810|Analgesics|analgesics|mesh-ancestor
83326571|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
83326572|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326573|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326574|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326575|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326576|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83326577|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326578|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326579|NCT01725100|Trametinib|trametinib|mesh-list
83326580|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83326581|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326582|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83326583|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326584|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326585|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83326586|NCT01725100|Protective Agents|protective agents|mesh-ancestor
83326587|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326588|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83326589|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
83326590|NCT01725412|Thiamine|thiamine|mesh-list
83326591|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
83326592|NCT01725412|Vitamins|vitamins|mesh-ancestor
83326593|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
83326594|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326595|NCT01725490|Metformin|metformin|mesh-list
83326596|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83326597|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326598|NCT04553666|Vitamins|vitamins|mesh-list
83326599|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
83326600|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83326601|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
83326602|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326603|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
83326604|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326605|NCT04553666|Protective Agents|protective agents|mesh-ancestor
83326606|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83326607|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83326608|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326609|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83326610|NCT03834766|Amphetamine|amphetamine|mesh-list
83326611|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83326612|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326613|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
83326614|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
83326615|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326616|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
83326617|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326618|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326619|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
83326620|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83326621|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83326622|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83326623|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83326624|NCT01838434|Lenalidomide|lenalidomide|mesh-list
83326625|NCT01838434|Idelalisib|idelalisib|mesh-list
83326626|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
83326627|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326628|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83326629|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83326630|NCT01838434|Growth Substances|growth substances|mesh-ancestor
83326631|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
83326632|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326633|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326634|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326635|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83326636|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
83326637|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83326638|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
83326639|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326640|NCT04377646|Zinc|zinc|mesh-list
83326641|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
83326642|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
83326643|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83326644|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83326645|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326646|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326647|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326648|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326649|NCT04377646|Trace Elements|trace elements|mesh-ancestor
83326650|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
83326651|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326652|NCT01728922|Vitamin D|vitamin d|mesh-list
83326653|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
83326654|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
83326656|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
83326657|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326658|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83326659|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83326660|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
83326661|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
83326662|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326663|NCT01838902|Primaquine|primaquine|mesh-list
83326664|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
83326665|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83326666|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83326667|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326668|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
83326669|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
83326670|NCT01714544|Hormones|hormones|mesh-ancestor
83326671|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326672|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326673|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83326674|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83326675|NCT03409432|Lenalidomide|lenalidomide|mesh-list
83326676|NCT03409432|Antibodies|antibodies|mesh-list
83326677|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
83326678|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83326679|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
83326680|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
83326681|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326682|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326683|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83326684|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83326685|NCT03409432|Growth Substances|growth substances|mesh-ancestor
83326686|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
83326687|NCT03409432|Immunotoxins|immunotoxins|mesh-ancestor
83326688|NCT01703858|Pantoprazole|pantoprazole|mesh-list
83326689|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83326690|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83326691|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83326692|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326693|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326694|NCT01729468|Aspirin|aspirin|mesh-list
83326695|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83326696|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326697|NCT01729468|Analgesics|analgesics|mesh-ancestor
83326698|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
83326699|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326700|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326701|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83326702|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83326703|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83326704|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83326705|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326706|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83326707|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83326708|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326709|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
83326710|NCT04376788|Methylene Blue|methylene blue|mesh-list
83326711|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326712|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326713|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83326714|NCT01714310|Fluoxetine|fluoxetine|mesh-list
83326715|NCT01714310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83326716|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83326717|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83326718|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326719|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326721|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326722|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83326723|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
83326724|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83326725|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83326726|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83326727|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326728|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83326729|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83326730|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
83326731|NCT03401788|Belzutifan|belzutifan|mesh-list
83326732|NCT03401788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326733|NCT01728064|Ubiquinone|ubiquinone|mesh-list
83326734|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
83326735|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326736|NCT03405142|Panitumumab|panitumumab|mesh-list
83326737|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
83326738|NCT03405142|Dextrans|dextrans|mesh-list
83326739|NCT03405142|Edetic Acid|edetic acid|mesh-list
83326740|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
83326741|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83326742|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326743|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
83326744|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
83326745|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
83326746|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83326747|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326748|NCT03405142|Antidotes|antidotes|mesh-ancestor
83326749|NCT03405142|Protective Agents|protective agents|mesh-ancestor
83326750|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326751|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
83326752|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
83326753|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83326754|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83326755|NCT03407872|Esketamine|esketamine|mesh-list
83326756|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
83326757|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83326758|NCT03834610|Tadalafil|tadalafil|mesh-list
83326759|NCT03834610|Testosterone|testosterone|mesh-list
83326760|NCT03834610|Androgens|androgens|mesh-ancestor
83326761|NCT03834610|Hormones|hormones|mesh-ancestor
83326762|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326763|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326764|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
83326765|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83326766|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83326767|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326768|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326769|NCT03834610|Urological Agents|urological agents|mesh-ancestor
83326770|NCT01681472|Leucovorin|leucovorin|mesh-list
83326771|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
83326772|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
83326773|NCT01681472|Antidotes|antidotes|mesh-ancestor
83326774|NCT01681472|Protective Agents|protective agents|mesh-ancestor
83326775|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326776|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
83326777|NCT01681472|Vitamins|vitamins|mesh-ancestor
83326778|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
83326779|NCT00915928|Perindopril|perindopril|mesh-list
83326780|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83326781|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
83326782|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326783|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326784|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83326785|NCT03407404|Midazolam|midazolam|mesh-list
83326786|NCT03407404|Ketamine|ketamine|mesh-list
83326787|NCT03407404|Morphine|morphine|mesh-list
83326788|NCT03407404|Analgesics|analgesics|mesh-ancestor
83326789|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
83326790|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326791|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326792|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83326793|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83326794|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
83326795|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
83326796|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326797|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83326798|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83326799|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326800|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326801|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326802|NCT03407404|Narcotics|narcotics|mesh-ancestor
83326803|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83326804|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83326805|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83326806|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83326807|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83326808|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
83326809|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
83326810|NCT03830086|Midazolam|midazolam|mesh-list
83326811|NCT03830086|Sufentanil|sufentanil|mesh-list
83326812|NCT03830086|Bupivacaine|bupivacaine|mesh-list
83326813|NCT03830086|Propofol|propofol|mesh-list
83326814|NCT03830086|Sevoflurane|sevoflurane|mesh-list
83326815|NCT03830086|Rocuronium|rocuronium|mesh-list
83326816|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
83326817|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
83326818|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326819|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326820|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
83326821|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326822|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83326823|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83326824|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
83326825|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83326826|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83326827|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83326828|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83326829|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
83326830|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
83326831|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326832|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326833|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83326834|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83326835|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83326836|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83326837|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83326838|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326839|NCT03830086|Narcotics|narcotics|mesh-ancestor
83326840|NCT03830086|Analgesics|analgesics|mesh-ancestor
83326841|NCT02240212|Paclitaxel|paclitaxel|mesh-list
83326842|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83326843|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326844|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
83326845|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
83326846|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
83326847|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326848|NCT01047436|Artemether|artemether|mesh-list
83326849|NCT01047436|Quinine|quinine|mesh-list
83326850|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
83326851|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83326852|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83326853|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326854|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83326855|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326856|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83326857|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326858|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326859|NCT01047436|Analgesics|analgesics|mesh-ancestor
83326860|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
83326861|NCT03406936|Midazolam|midazolam|mesh-list
83326862|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83326863|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83326864|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326865|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326866|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83326867|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83326868|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83326869|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83326870|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
83326871|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
83326872|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
83326873|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
83326874|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326875|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326876|NCT02240602|Oxycodone|oxycodone|mesh-list
83326877|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326878|NCT02240602|Narcotics|narcotics|mesh-ancestor
83326879|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326880|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326881|NCT02240602|Analgesics|analgesics|mesh-ancestor
83326882|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
83326883|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326884|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
83326885|NCT03406546|Remifentanil|remifentanil|mesh-list
83326886|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83326887|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83326888|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326889|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326890|NCT03406546|Analgesics|analgesics|mesh-ancestor
83326891|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
83326892|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326893|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83326894|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83326895|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83326896|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
83326897|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326898|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326899|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83326900|NCT03406546|Narcotics|narcotics|mesh-ancestor
83326901|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83326902|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83326903|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326904|NCT01046110|Incretins|incretins|mesh-ancestor
83326905|NCT01046110|Hormones|hormones|mesh-ancestor
83326906|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326907|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83326908|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
83326909|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326910|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326911|NCT01713530|Insulin|insulin|mesh-list
83326912|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83326913|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
83326914|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
83326915|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83326916|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83326917|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326918|NCT01045798|Caspofungin|caspofungin|mesh-list
83326919|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
83326920|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326921|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326922|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326923|NCT02982694|Bevacizumab|bevacizumab|mesh-list
83326924|NCT02982694|Atezolizumab|atezolizumab|mesh-list
83326925|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83326926|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326927|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83326928|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83326929|NCT02982694|Growth Substances|growth substances|mesh-ancestor
83326930|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326931|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
83326932|NCT02982694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83326933|NCT02982694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326934|NCT01712984|Fluconazole|fluconazole|mesh-list
83326935|NCT01712984|Vaccines|vaccines|mesh-list
83326936|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
83326937|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326938|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
83326939|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326940|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83326941|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83326942|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326943|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326944|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83326945|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
83326946|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83326947|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83326948|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83326949|NCT00921310|Sirolimus|sirolimus|mesh-list
83326950|NCT00921310|Pemetrexed|pemetrexed|mesh-list
83326951|NCT00921310|Temsirolimus|temsirolimus|mesh-list
83326952|NCT00921310|MTOR Inhibitors|mtor inhibitors|mesh-list
83326953|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83326954|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83326955|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326956|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83326957|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83326958|NCT00921310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83326959|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83326960|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
83326961|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326962|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83326963|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83326964|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83326965|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
83326966|NCT02241148|Acetaminophen|acetaminophen|mesh-list
83326967|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83326968|NCT02241148|Analgesics|analgesics|mesh-ancestor
83326969|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
83326970|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326971|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326972|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
83326973|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
83326974|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83326975|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83326976|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83326977|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
83326978|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326979|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326980|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326981|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
83326982|NCT01040728|Olodaterol|olodaterol|mesh-list
83326983|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83326984|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
83326985|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83326986|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83326987|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83326988|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
83326989|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
83326990|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83326991|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
83326992|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83326993|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83326994|NCT01593020|Paclitaxel|paclitaxel|mesh-list
83326995|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
83326996|NCT01593020|Doxorubicin|doxorubicin|mesh-list
83326997|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83326998|NCT01593020|Fluorouracil|fluorouracil|mesh-list
83326999|NCT01593020|Epirubicin|epirubicin|mesh-list
83327000|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83327001|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327002|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
83327003|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
83327004|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327005|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327006|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83327007|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
83327008|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327009|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327010|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83327011|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
83327012|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83327013|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83327014|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83327015|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83327016|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327017|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
83327018|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83327019|NCT01040260|Nicotine|nicotine|mesh-list
83327020|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83327021|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
83327022|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327023|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327024|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83327025|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83327026|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
83327027|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327028|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327029|NCT01046422|Metformin|metformin|mesh-list
83327030|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83327031|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327032|NCT03405376|Aflibercept|aflibercept|mesh-list
83327033|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83327034|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83327035|NCT03405376|Growth Substances|growth substances|mesh-ancestor
83327036|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327037|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
83327038|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327039|NCT02241460|Lidocaine|lidocaine|mesh-list
83327040|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
83327041|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
83327042|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327043|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327044|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
83327045|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327046|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83327047|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83327048|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83327049|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327050|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327051|NCT01712204|Febuxostat|febuxostat|mesh-list
83327052|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
83327053|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327054|NCT01592864|Fluorides|fluorides|mesh-list
83327055|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
83327056|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
83327057|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
83327058|NCT01592864|Protective Agents|protective agents|mesh-ancestor
83327059|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327060|NCT01592786|Memantine|memantine|mesh-list
83327061|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83327062|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83327063|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
83327064|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327065|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327066|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327067|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83327068|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83327069|NCT01592708|Erythromycin|erythromycin|mesh-list
83327070|NCT01592708|Ibuprofen|ibuprofen|mesh-list
83327071|NCT01592708|Ketorolac|ketorolac|mesh-list
83327072|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83327073|NCT01592708|Fentanyl|fentanyl|mesh-list
83327074|NCT01592708|Scopolamine|scopolamine|mesh-list
83327075|NCT01592708|Droperidol|droperidol|mesh-list
83327076|NCT01592708|Remifentanil|remifentanil|mesh-list
83327077|NCT01592708|Hydrocodone|hydrocodone|mesh-list
83327078|NCT01592708|Ondansetron|ondansetron|mesh-list
83327079|NCT01592708|Antiemetics|antiemetics|mesh-list
83327080|NCT01592708|Propofol|propofol|mesh-list
83327081|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
83327082|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327083|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327084|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83327085|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83327086|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
83327087|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83327088|NCT01592708|Narcotics|narcotics|mesh-ancestor
83327089|NCT01592708|Analgesics|analgesics|mesh-ancestor
83327090|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
83327091|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327092|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83327093|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83327094|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83327095|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327096|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327097|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83327098|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327099|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327100|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
83327101|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83327102|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
83327103|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
83327104|NCT01592708|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83327105|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83327106|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
83327107|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327108|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
83327109|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
83327110|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83327111|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327112|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83327113|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
83327114|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83327115|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
83327116|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83327117|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
83327118|NCT01592708|Hormones|hormones|mesh-ancestor
83327119|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83327120|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83327121|NCT01592708|Protective Agents|protective agents|mesh-ancestor
83327122|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83327123|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327124|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83327125|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83327126|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83327127|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83327128|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83327129|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
83327130|NCT01042522|Paclitaxel|paclitaxel|mesh-list
83327131|NCT01042522|Etoposide|etoposide|mesh-list
83327132|NCT01042522|Cisplatin|cisplatin|mesh-list
83327133|NCT01042522|Carboplatin|carboplatin|mesh-list
83327134|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83327135|NCT01042522|Bleomycin|bleomycin|mesh-list
83327136|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
83327137|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83327138|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327139|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
83327140|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
83327141|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327142|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327143|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83327144|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83327145|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327146|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83327147|NCT01702844|Paclitaxel|paclitaxel|mesh-list
83327148|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83327149|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327150|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
83327151|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
83327152|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327153|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327154|NCT01702532|Nicotine|nicotine|mesh-list
83327155|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83327156|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
83327157|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327158|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327159|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83327160|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83327161|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
83327162|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83413623|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
83327163|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327165|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
83327166|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327167|NCT03400306|Paclitaxel|paclitaxel|mesh-list
83327168|NCT03400306|Carboplatin|carboplatin|mesh-list
83327169|NCT03400306|Veliparib|veliparib|mesh-list
83327170|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83327171|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327172|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
83327173|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
83327174|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327175|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327176|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83327177|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327178|NCT03405064|Linezolid|linezolid|mesh-list
83327179|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
83327180|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83327181|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327182|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83327183|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327184|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327185|NCT03405064|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83327186|NCT03404908|Acetaminophen|acetaminophen|mesh-list
83327187|NCT03404908|Dipyrone|dipyrone|mesh-list
83327188|NCT03404908|Ketoprofen|ketoprofen|mesh-list
83327189|NCT03404908|Morphine|morphine|mesh-list
83327190|NCT03404908|Ropivacaine|ropivacaine|mesh-list
83327191|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83327192|NCT03404908|Narcotics|narcotics|mesh-ancestor
83327193|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327194|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327195|NCT03404908|Analgesics|analgesics|mesh-ancestor
83327196|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
83327197|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327198|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
83327199|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
83327200|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83327201|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
83327202|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83327203|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327204|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327205|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83327206|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327207|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327208|NCT01702298|Metformin|metformin|mesh-list
83327209|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83327210|NCT01702298|Simvastatin|simvastatin|mesh-list
83327211|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83327212|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327213|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83327214|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83327215|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
83327216|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327217|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83327218|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83327219|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327220|NCT01702298|Incretins|incretins|mesh-ancestor
83327221|NCT01702298|Hormones|hormones|mesh-ancestor
83327222|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83327223|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83327224|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
83327225|NCT03404752|Lenograstim|lenograstim|mesh-list
83327226|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83327227|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
83327228|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327229|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
83327230|NCT03401710|Hematinics|hematinics|mesh-ancestor
83327231|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83327232|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83327233|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83327234|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327235|NCT02993523|Azacitidine|azacitidine|mesh-list
83327236|NCT02993523|Venetoclax|venetoclax|mesh-list
83327237|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83327238|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
83327239|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327240|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327241|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327242|NCT01701362|Pregabalin|pregabalin|mesh-list
83327243|NCT01701362|Analgesics|analgesics|mesh-ancestor
83327244|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
83327245|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327246|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327247|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
83327248|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83327249|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327250|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327251|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83327252|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83327253|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83327254|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327255|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83327256|NCT00919126|Xenon|xenon|mesh-list
83327257|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83327258|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
83327259|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
83327260|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327261|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327262|NCT01710800|Esomeprazole|esomeprazole|mesh-list
83327263|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83327264|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83327265|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83327266|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327267|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327269|NCT01710020|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83327270|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83327271|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327272|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327273|NCT02982850|Aspirin|aspirin|mesh-list
83327274|NCT02982850|Warfarin|warfarin|mesh-list
83327275|NCT02982850|Dabigatran|dabigatran|mesh-list
83327276|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83327277|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83327278|NCT02982850|Analgesics|analgesics|mesh-ancestor
83327279|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
83327280|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327281|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327282|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327283|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327284|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83327285|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83327286|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327287|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83327288|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83327289|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327290|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
83327291|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
83327292|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
83327293|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83327294|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83327295|NCT04413890|Dinoprostone|dinoprostone|mesh-list
83327296|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
83327297|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83327298|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327299|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
83327300|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
83327301|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83327302|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
83327303|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327304|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327305|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83327306|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
83327307|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83327308|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83327309|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83327310|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83327311|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327312|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327313|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
83327314|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83327315|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
83327316|NCT03403972|Vancomycin|vancomycin|mesh-list
83327317|NCT03403972|Simvastatin|simvastatin|mesh-list
83327318|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83327319|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83327320|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
83327321|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327322|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83327323|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83327324|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327325|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83327326|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327327|NCT02242318|Valsartan|valsartan|mesh-list
83327328|NCT02242318|Telmisartan|telmisartan|mesh-list
83327329|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327330|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83327331|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83327332|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327333|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
83327334|NCT01700192|Loratadine|loratadine|mesh-list
83327335|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83327336|NCT01700192|Epinephrine|epinephrine|mesh-list
83327337|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83327338|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83327339|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83327340|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
83327341|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327342|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327343|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327344|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83327345|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83327346|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
83327347|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327348|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83327349|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
83327350|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
83327351|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
83327352|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83327353|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327354|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
83327355|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83327356|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
83327357|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83327358|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83327359|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
83327360|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
83327361|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83327362|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83327363|NCT01700192|Analgesics|analgesics|mesh-ancestor
83327364|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
83327365|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327366|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83327367|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83327368|NCT02242396|Telmisartan|telmisartan|mesh-list
83327369|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83327370|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327371|NCT02242396|Diuretics|diuretics|mesh-ancestor
83327372|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
83327373|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327374|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83327375|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327376|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327377|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83327378|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83327379|NCT02242474|Adalimumab|adalimumab|mesh-list
83327380|NCT02242474|Infliximab|infliximab|mesh-list
83327381|NCT02242474|Golimumab|golimumab|mesh-list
83327382|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
83327383|NCT02242474|Etanercept|etanercept|mesh-list
83327384|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83327385|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83327386|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327387|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327388|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
83327389|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83327390|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83327391|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83327392|NCT02242474|Analgesics|analgesics|mesh-ancestor
83327393|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
83327394|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327395|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327396|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83327397|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
83327398|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
83327399|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83327400|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83327401|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83327402|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
83327403|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327404|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327405|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327406|NCT04878315|Captopril|captopril|mesh-list
83327407|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83327408|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
83327409|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327410|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327411|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327412|NCT04374604|Mitogens|mitogens|mesh-list
83327413|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327414|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327416|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83327417|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327418|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83327419|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83327420|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327421|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83327422|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327423|NCT02242864|Diuretics|diuretics|mesh-ancestor
83327424|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
83327425|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327426|NCT01709708|Bupivacaine|bupivacaine|mesh-list
83327427|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
83327428|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
83327429|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327430|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327431|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
83327432|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327433|NCT02243098|Digoxin|digoxin|mesh-list
83327434|NCT02243098|Atorvastatin|atorvastatin|mesh-list
83327435|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83327436|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83327437|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
83327438|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327439|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83327440|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83327441|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327442|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83327443|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83327444|NCT02243098|Protective Agents|protective agents|mesh-ancestor
83327445|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327446|NCT02845323|Nivolumab|nivolumab|mesh-list
83327447|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327448|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327449|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83327450|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327451|NCT05289063|Atorvastatin|atorvastatin|mesh-list
83327452|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83327453|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83327454|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
83327455|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327456|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83327457|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83327458|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327459|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83327460|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83327461|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83327463|NCT01709318|Estradiol|estradiol|mesh-list
83327464|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83327465|NCT01709318|Estrogens|estrogens|mesh-ancestor
83327466|NCT01709318|Hormones|hormones|mesh-ancestor
83327467|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83327468|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327469|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83327470|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
83327471|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83327472|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83327473|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83327474|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83327475|NCT02243254|Ibuprofen|ibuprofen|mesh-list
83327476|NCT02243254|Remifentanil|remifentanil|mesh-list
83327477|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83327478|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83327479|NCT02243254|Analgesics|analgesics|mesh-ancestor
83327480|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
83327481|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327482|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327483|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327484|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327485|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83327486|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327487|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327488|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83327489|NCT02243254|Narcotics|narcotics|mesh-ancestor
83327490|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327491|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
83327492|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
83327493|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
83327494|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327495|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327496|NCT03402880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83327497|NCT03402880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327498|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
83327499|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327500|NCT01673997|Metoprolol|metoprolol|mesh-list
83327501|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83327502|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327503|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
83327504|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
83327505|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327506|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327507|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83327508|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83327509|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83327510|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
83327511|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327512|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327513|NCT04373824|Ivermectin|ivermectin|mesh-list
83327514|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83327515|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327516|NCT01676571|Vortioxetine|vortioxetine|mesh-list
83327517|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83327518|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83327519|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83327520|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83327521|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327522|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327523|NCT01676571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83327524|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83327525|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83430175|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327526|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327527|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327528|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
83327529|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83327530|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83327531|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83327532|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83327533|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
83327534|NCT01699178|Testosterone|testosterone|mesh-list
83327535|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
83327536|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
83327537|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83327538|NCT01699178|Androgens|androgens|mesh-ancestor
83327539|NCT01699178|Hormones|hormones|mesh-ancestor
83327540|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83327541|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327542|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83327543|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327544|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
83327545|NCT02077959|Lenalidomide|lenalidomide|mesh-list
83327546|NCT02077959|Pidilizumab|pidilizumab|mesh-list
83327547|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
83327548|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327549|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83327550|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83327551|NCT02077959|Growth Substances|growth substances|mesh-ancestor
83327552|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
83327553|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327554|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327555|NCT04548518|Vaccines|vaccines|mesh-list
83327556|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
83327557|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327558|NCT01699022|CycloProvera|cycloprovera|mesh-list
83327559|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83327560|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83327561|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83327562|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
83327563|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83327564|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327565|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83327566|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83327567|NCT01670175|Sirolimus|sirolimus|mesh-list
83327568|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
83327569|NCT01670175|Topotecan|topotecan|mesh-list
83327570|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83327571|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
83327572|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327573|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327574|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83327575|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
83327576|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327577|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327578|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83327579|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83327580|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327581|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83327582|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
83327583|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327584|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83327585|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83327586|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83327587|NCT02243566|Telmisartan|telmisartan|mesh-list
83327588|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
83327589|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327590|NCT02243566|Diuretics|diuretics|mesh-ancestor
83327591|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
83430177|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
83327592|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327593|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83327594|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327595|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327596|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83327597|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83327598|NCT02243644|Albendazole|albendazole|mesh-list
83327599|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
83327600|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83327601|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327602|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
83327603|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83327604|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83327605|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
83327606|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
83327607|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327608|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327609|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327610|NCT01988883|Propranolol|propranolol|mesh-list
83327611|NCT01988883|Modafinil|modafinil|mesh-list
83327612|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83327613|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83327614|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
83327615|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327616|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327617|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327618|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83327619|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327620|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
83327621|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83327622|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83327623|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83327624|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83327625|NCT04373356|Listerine|listerine|mesh-list
83327626|NCT04373356|Fluorides|fluorides|mesh-list
83327627|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
83327628|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
83327629|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
83327630|NCT04373356|Protective Agents|protective agents|mesh-ancestor
83327631|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327632|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83327633|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327634|NCT01745757|Paclitaxel|paclitaxel|mesh-list
83327635|NCT01745757|Bevacizumab|bevacizumab|mesh-list
83327636|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83327637|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327638|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
83327639|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
83327640|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327641|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327642|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327643|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83327644|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83327645|NCT01745757|Growth Substances|growth substances|mesh-ancestor
83327646|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327647|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
83327648|NCT01709162|Ipilimumab|ipilimumab|mesh-list
83327649|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327650|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327651|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83327652|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327653|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
83327654|NCT02243800|Vitamin D|vitamin d|mesh-list
83327655|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83327656|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327657|NCT02243800|Vitamins|vitamins|mesh-ancestor
83327658|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
83327659|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83327660|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83327661|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83327662|NCT04764045|Ropivacaine|ropivacaine|mesh-list
83327663|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
83327664|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
83327665|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327666|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327667|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
83327668|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327669|NCT01698554|Bimatoprost|bimatoprost|mesh-list
83327670|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83327671|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83327672|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83327673|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327674|NCT00895791|Umirolimus|umirolimus|mesh-list
83327675|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327676|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83327677|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
83327678|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327679|NCT01698320|Albuterol|albuterol|mesh-list
83327680|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83327681|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
83327682|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327683|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327684|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83327685|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
83327686|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
83327687|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83327688|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83327689|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83327690|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83327691|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
83327692|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327693|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327694|NCT03401476|Morphine|morphine|mesh-list
83327695|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83327696|NCT03401476|Narcotics|narcotics|mesh-ancestor
83327697|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327698|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327699|NCT03401476|Analgesics|analgesics|mesh-ancestor
83327700|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
83327701|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327702|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
83327703|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83327704|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327705|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83327706|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327707|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83327708|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83327709|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83327710|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
83327711|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327712|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83327713|NCT01674855|Lenograstim|lenograstim|mesh-list
83327714|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83327715|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
83327716|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327717|NCT03854799|Capecitabine|capecitabine|mesh-list
83327718|NCT03854799|Avelumab|avelumab|mesh-list
83327719|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83327720|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
83327721|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327722|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327723|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327724|NCT00924352|Dasatinib|dasatinib|mesh-list
83327725|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327726|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83327727|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327728|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327729|NCT01674933|Listerine|listerine|mesh-list
83327730|NCT01674933|Fluorides|fluorides|mesh-list
83327731|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
83327732|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
83327733|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
83327734|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
83327735|NCT01674933|Protective Agents|protective agents|mesh-ancestor
83327736|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327737|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83327738|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327739|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
83327741|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83327742|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83327743|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327744|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327745|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327746|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327747|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
83327748|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83327749|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327750|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
83327751|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83327752|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83327753|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83327754|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
83327755|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327756|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327757|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327758|NCT01569152|Methotrexate|methotrexate|mesh-list
83327759|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83327760|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
83327761|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83327762|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327763|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83327764|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
83327765|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327766|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327767|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83327768|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327769|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83327770|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83327771|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
83327772|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327773|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83327774|NCT01675557|Vitamin D|vitamin d|mesh-list
83327775|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
83327776|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
83327777|NCT01675557|Vitamins|vitamins|mesh-list
83327778|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
83327779|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327780|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83327781|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83327782|NCT01675947|Sirolimus|sirolimus|mesh-list
83327783|NCT01675947|Lidocaine|lidocaine|mesh-list
83327784|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
83327786|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327787|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327788|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
83327789|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327790|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83327791|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83327792|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83327793|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327794|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327795|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83327796|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327797|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83327798|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327799|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
83327800|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83327801|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
83327802|NCT03840915|Paclitaxel|paclitaxel|mesh-list
83327803|NCT03840915|Docetaxel|docetaxel|mesh-list
83327804|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83327805|NCT03840915|Carboplatin|carboplatin|mesh-list
83327806|NCT03840915|Gemcitabine|gemcitabine|mesh-list
83327807|NCT03840915|Pemetrexed|pemetrexed|mesh-list
83327808|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83327809|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327810|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
83327811|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
83327812|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
83327813|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327814|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83327815|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
83327816|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327817|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83327818|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83327819|NCT03748953|Ixazomib|ixazomib|mesh-list
83327820|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327821|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
83327822|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327823|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327824|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83327825|NCT01567826|Atorvastatin|atorvastatin|mesh-list
83327826|NCT01567826|Simvastatin|simvastatin|mesh-list
83327827|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83327828|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83327829|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
83327830|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327831|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83327832|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83327833|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327834|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83327835|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83327836|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327837|NCT03743025|Dulaglutide|dulaglutide|mesh-list
83327838|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83327839|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327840|NCT03742245|Olaparib|olaparib|mesh-list
83327841|NCT03742245|Vorinostat|vorinostat|mesh-list
83327842|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83327843|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327844|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327845|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327846|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83327847|NCT03643107|Prednisolone|prednisolone|mesh-list
83327848|NCT03643107|Irofulven|irofulven|mesh-list
83327849|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327850|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
83327851|NCT03643107|Hormones|hormones|mesh-ancestor
83327852|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83327853|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327854|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83327855|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327856|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83327857|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
83327858|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327859|NCT02083107|Misoprostol|misoprostol|mesh-list
83327860|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83327861|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
83327862|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83327863|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327864|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83327865|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83327866|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
83327867|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83327868|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83327869|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327870|NCT00925756|Maraviroc|maraviroc|mesh-list
83327871|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83327872|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83327873|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327874|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83327875|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83327876|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
83327877|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327878|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83327879|NCT04372732|Autoantibodies|autoantibodies|mesh-list
83327880|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
83327881|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327882|NCT02245126|Lidocaine|lidocaine|mesh-list
83327883|NCT02245126|Bupivacaine|bupivacaine|mesh-list
83327884|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
83327885|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
83327886|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327887|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327888|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
83327889|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327890|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83327891|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83327892|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83327893|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327894|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327895|NCT04372342|Remifentanil|remifentanil|mesh-list
83327896|NCT04372342|Nalbuphine|nalbuphine|mesh-list
83327897|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83327898|NCT04372342|Narcotics|narcotics|mesh-ancestor
83327899|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327900|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327901|NCT04372342|Analgesics|analgesics|mesh-ancestor
83327902|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
83327903|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327904|NCT04372264|Acetaminophen|acetaminophen|mesh-list
83327905|NCT04372264|Ibuprofen|ibuprofen|mesh-list
83327906|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
83327907|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83327908|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83327909|NCT04372264|Analgesics|analgesics|mesh-ancestor
83327910|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
83327911|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327912|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327913|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83327914|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83327915|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83327916|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327917|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327918|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
83327919|NCT02083809|Oxytocin|oxytocin|mesh-list
83327920|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
83327921|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83327922|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327923|NCT02244112|Midazolam|midazolam|mesh-list
83327924|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83327925|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83327926|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327927|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327928|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83327929|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83327930|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83327931|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83327932|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
83327933|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
83327934|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
83327935|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
83327936|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327937|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327939|NCT02244190|Tipranavir|tipranavir|mesh-list
83327940|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83327941|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83327942|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
83327943|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83327944|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327945|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83327946|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83327947|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
83327948|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83327949|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83327950|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83327951|NCT00926380|Denosumab|denosumab|mesh-list
83327952|NCT00926380|Teriparatide|teriparatide|mesh-list
83327953|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83327954|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327955|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83327956|NCT02244268|Tamsulosin|tamsulosin|mesh-list
83327957|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83327958|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83327959|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83327960|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
83327961|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327962|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327963|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327964|NCT02244268|Urological Agents|urological agents|mesh-ancestor
83327965|NCT03630315|Bevacizumab|bevacizumab|mesh-list
83327966|NCT03630315|Ranibizumab|ranibizumab|mesh-list
83327967|NCT03630315|Aflibercept|aflibercept|mesh-list
83327968|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327969|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327970|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83327971|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83327972|NCT03630315|Growth Substances|growth substances|mesh-ancestor
83327973|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327974|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
83327975|NCT00929344|Pregabalin|pregabalin|mesh-list
83327976|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83327977|NCT00929344|Analgesics|analgesics|mesh-ancestor
83327978|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
83327979|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83327980|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83327981|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
83327982|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83327983|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83327984|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83327985|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83327986|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83327987|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83327988|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83327989|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83327990|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83327991|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83327992|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83327993|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
83327994|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
83327995|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
83327996|NCT03630159|Tisagenlecleucel|tisagenlecleucel|mesh-list
83327997|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83327998|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83327999|NCT03630159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83328000|NCT03630159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328001|NCT04371874|Aspirin|aspirin|mesh-list
83328002|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83328003|NCT04371874|Captopril|captopril|mesh-list
83328004|NCT04371874|Nitrendipine|nitrendipine|mesh-list
83328005|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83328006|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328007|NCT04371874|Analgesics|analgesics|mesh-ancestor
83328008|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
83328009|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328010|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328011|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328012|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328013|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83328014|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83328015|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328016|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83328017|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83328018|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328019|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
83328020|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83328021|NCT04371874|Diuretics|diuretics|mesh-ancestor
83328022|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
83328023|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83328024|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328025|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83328026|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
83328027|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83328028|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83328029|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
83328030|NCT03629613|Antioxidants|antioxidants|mesh-list
83328031|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328032|NCT03629613|Protective Agents|protective agents|mesh-ancestor
83328033|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328035|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328036|NCT03720717|Baclofen|baclofen|mesh-list
83328037|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83328038|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328039|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83328040|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328041|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83328042|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
83328043|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
83328044|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328045|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328046|NCT04376554|Amoxicillin|amoxicillin|mesh-list
83328047|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
83328048|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
83328049|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83328050|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83328051|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328052|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83328053|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328054|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328055|NCT03627741|Triamcinolone|triamcinolone|mesh-list
83328056|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83328057|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83328058|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83328059|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328060|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
83328061|NCT03627741|Hormones|hormones|mesh-ancestor
83413624|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83328062|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83328063|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328064|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83328065|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
83328066|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328067|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328068|NCT03626337|Thiamine|thiamine|mesh-list
83328069|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
83328070|NCT03626337|Vitamins|vitamins|mesh-ancestor
83328071|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
83328072|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328073|NCT00929578|Fluphenazine|fluphenazine|mesh-list
83328074|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
83328075|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
83328076|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83328077|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83328078|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328079|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328080|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83328081|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83328082|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
83328083|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328084|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328085|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
83328087|NCT03615105|Busulfan|busulfan|mesh-list
83328088|NCT03615105|Thiotepa|thiotepa|mesh-list
83328089|NCT03615105|Rituximab|rituximab|mesh-list
83328090|NCT03615105|Fludarabine|fludarabine|mesh-list
83328091|NCT03615105|Clofarabine|clofarabine|mesh-list
83328092|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83328093|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
83328094|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83328095|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
83328096|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328097|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328098|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83328099|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
83328100|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328101|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328102|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83328103|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328104|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83328105|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
83328106|NCT04371406|Azithromycin|azithromycin|mesh-list
83328107|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
83328108|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83328109|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328110|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
83328111|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83328112|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83328113|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328114|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328115|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328116|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
83328117|NCT03716739|Testosterone|testosterone|mesh-list
83328118|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
83328119|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
83328120|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83328121|NCT03716739|Androgens|androgens|mesh-ancestor
83328122|NCT03716739|Hormones|hormones|mesh-ancestor
83328123|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83328124|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328125|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83328126|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328127|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
83328128|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
83328129|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83328130|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83328131|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83328132|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328133|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328134|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
83328135|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328136|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328137|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83328138|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328139|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
83328140|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328141|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328142|NCT03705429|Paclitaxel|paclitaxel|mesh-list
83328143|NCT03705429|Docetaxel|docetaxel|mesh-list
83328144|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83328145|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
83328146|NCT03705429|Trastuzumab|trastuzumab|mesh-list
83328147|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83328148|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328149|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83328150|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83328151|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83328152|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328153|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83328154|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
83328155|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328156|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328157|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83328158|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
83328159|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83328160|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328161|NCT04370782|Azithromycin|azithromycin|mesh-list
83328162|NCT04370782|Doxycycline|doxycycline|mesh-list
83328163|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
83328164|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
83328165|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83328166|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328167|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
83328168|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83328169|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83328170|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328171|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328172|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328173|NCT04370782|Astringents|astringents|mesh-ancestor
83328174|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328175|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
83328176|NCT03604653|Cisplatin|cisplatin|mesh-list
83328177|NCT03604653|Doxorubicin|doxorubicin|mesh-list
83328178|NCT03604653|Mitomycins|mitomycins|mesh-list
83328179|NCT03604653|Mitomycin|mitomycin|mesh-list
83328180|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328181|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83328182|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83328184|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328185|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328186|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
83328187|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83328188|NCT04376086|Anesthetics|anesthetics|mesh-list
83328189|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328190|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328191|NCT03703167|Rituximab|rituximab|mesh-list
83328192|NCT03703167|Lenalidomide|lenalidomide|mesh-list
83328193|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328194|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328195|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
83328196|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328197|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328198|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83328199|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83328200|NCT03703167|Growth Substances|growth substances|mesh-ancestor
83328201|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
83328202|NCT04375852|Autoantibodies|autoantibodies|mesh-list
83328203|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
83328204|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328205|NCT04364464|Riociguat|riociguat|mesh-list
83328206|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
83328207|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328208|NCT03600441|Abexinostat|abexinostat|mesh-list
83328209|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83328210|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328211|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328212|NCT01592240|Bococizumab|bococizumab|mesh-list
83328213|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83328214|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83328215|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
83328216|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328217|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83328218|NCT03594747|Paclitaxel|paclitaxel|mesh-list
83328219|NCT03594747|Carboplatin|carboplatin|mesh-list
83328220|NCT03594747|Tislelizumab|tislelizumab|mesh-list
83328221|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83328222|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328223|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
83328224|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
83328225|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
83328226|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328227|NCT03594747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328228|NCT05620654|Paclitaxel|paclitaxel|mesh-list
83328229|NCT05620654|Cisplatin|cisplatin|mesh-list
83328230|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83328231|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328232|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
83328233|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
83328235|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328236|NCT03692325|Nivolumab|nivolumab|mesh-list
83328237|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328238|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328239|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83328240|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328241|NCT04357522|Vaccines|vaccines|mesh-list
83328242|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83328243|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
83328244|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328245|NCT00005901|Pamidronate|pamidronate|mesh-list
83328246|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83328247|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328248|NCT04369534|Clopidogrel|clopidogrel|mesh-list
83328249|NCT04369534|Ticagrelor|ticagrelor|mesh-list
83328250|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83328251|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83328252|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83328253|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83328254|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
83328255|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328256|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328257|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328259|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328260|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
83328261|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
83328262|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
83328263|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
83328264|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
83328265|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83328266|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83328267|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328268|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328269|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328270|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328271|NCT03685149|Flecainide|flecainide|mesh-list
83328272|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83328273|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83328274|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83328275|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328276|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328277|NCT04370080|Fluorides|fluorides|mesh-list
83328278|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
83328279|NCT04370080|Protective Agents|protective agents|mesh-ancestor
83328280|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328281|NCT01591616|Lidocaine|lidocaine|mesh-list
83328282|NCT01591616|Prilocaine|prilocaine|mesh-list
83328283|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
83328284|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
83328285|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328286|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328287|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
83328288|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328289|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83328290|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83328291|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83328292|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328293|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328294|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
83328295|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83328296|NCT00938314|Hematinics|hematinics|mesh-ancestor
83328297|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83328298|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328299|NCT03587961|Ivacaftor|ivacaftor|mesh-list
83328300|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83328301|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328302|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328303|NCT04370392|Anesthetics|anesthetics|mesh-list
83328304|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
83328305|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328306|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328307|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
83328308|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328309|NCT04369222|Acetaminophen|acetaminophen|mesh-list
83328310|NCT04369222|Aspirin|aspirin|mesh-list
83328311|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
83328312|NCT04369222|Salicylates|salicylates|mesh-list
83328313|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83328314|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83328315|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328316|NCT04369222|Analgesics|analgesics|mesh-ancestor
83328317|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
83328318|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328319|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328320|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
83328321|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328322|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
83328323|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
83328324|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
83328325|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328326|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83328327|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328328|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328329|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83328330|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83328331|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83328332|NCT03584373|Acetaminophen|acetaminophen|mesh-list
83328333|NCT03584373|Ketorolac|ketorolac|mesh-list
83328334|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83328335|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83328336|NCT03584373|Oxycodone|oxycodone|mesh-list
83328337|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328338|NCT03584373|Analgesics|analgesics|mesh-ancestor
83328339|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
83328340|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328341|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328342|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
83328343|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83328344|NCT03584373|Narcotics|narcotics|mesh-ancestor
83328345|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328346|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83328347|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328348|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328349|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83328350|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328351|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328352|NCT01591460|Ribavirin|ribavirin|mesh-list
83328353|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83328354|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
83328355|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
83328356|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328357|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
83328358|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328359|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
83328360|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328361|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
83328362|NCT04363216|Vitamins|vitamins|mesh-ancestor
83328363|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
83328364|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328365|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
83328366|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328367|NCT04363216|Protective Agents|protective agents|mesh-ancestor
83328368|NCT03678675|Ketorolac|ketorolac|mesh-list
83328369|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83328370|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328371|NCT03678675|Analgesics|analgesics|mesh-ancestor
83328372|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
83328373|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328374|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328375|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328376|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328377|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83328378|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328379|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328380|NCT04363060|Amoxicillin|amoxicillin|mesh-list
83328381|NCT04363060|Azithromycin|azithromycin|mesh-list
83328382|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
83328383|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
83328384|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83328385|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83328386|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328387|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83328388|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328389|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328390|NCT01591382|Ketamine|ketamine|mesh-list
83328391|NCT01591382|Hydromorphone|hydromorphone|mesh-list
83328392|NCT01591382|Analgesics|analgesics|mesh-ancestor
83328393|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
83328394|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328395|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328396|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83328397|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83328398|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
83328399|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
83328400|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328401|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83328402|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83328403|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328404|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328405|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83328406|NCT01591382|Narcotics|narcotics|mesh-ancestor
83328407|NCT03677817|Lidocaine|lidocaine|mesh-list
83328408|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
83328409|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
83328410|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328411|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328412|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
83328413|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328414|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83328415|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83328416|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83328417|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328418|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328419|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
83328420|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83328421|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328422|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328423|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83328424|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
83328425|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83328426|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328427|NCT00928174|Fluorides|fluorides|mesh-list
83328428|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
83328429|NCT00928174|Protective Agents|protective agents|mesh-ancestor
83328430|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328431|NCT01696214|Fluticasone|fluticasone|mesh-list
83328433|NCT01696214|Theophylline|theophylline|mesh-list
83328434|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83328435|NCT01696214|Ipratropium|ipratropium|mesh-list
83328436|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83328437|NCT01696214|Montelukast|montelukast|mesh-list
83328438|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328439|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83328440|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
83328441|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328442|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328443|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83328444|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
83328445|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
83328446|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83328447|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83328448|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83328449|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83328450|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
83328451|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328452|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328453|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83328454|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
83328455|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83328456|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83328457|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83328458|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83328459|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
83328460|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83328461|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328462|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
83328463|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83328464|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83328465|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
83328466|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
83328468|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
83328469|NCT03794037|Montelukast|montelukast|mesh-list
83328470|NCT03794037|Progesterone|progesterone|mesh-list
83328471|NCT03794037|Progestins|progestins|mesh-ancestor
83328472|NCT03794037|Hormones|hormones|mesh-ancestor
83328473|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83328474|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328475|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83328476|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
83328477|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83328478|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
83328479|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83328480|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83328481|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328483|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328484|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328485|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83328486|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328487|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
83328488|NCT04368598|Dexamethasone|dexamethasone|mesh-list
83328489|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
83328490|NCT04368598|BB 1101|bb 1101|mesh-list
83328491|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83328492|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328493|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
83328494|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
83328495|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328496|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328497|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83328498|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
83328499|NCT04368598|Hormones|hormones|mesh-ancestor
83328500|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83328501|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83328502|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328503|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
83328504|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328505|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328506|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
83328507|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328508|NCT04368598|Expectorants|expectorants|mesh-ancestor
83328509|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
83328510|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83328511|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
83328512|NCT04368598|Protective Agents|protective agents|mesh-ancestor
83328513|NCT04368598|Antidotes|antidotes|mesh-ancestor
83328514|NCT05347641|Cytarabine|cytarabine|mesh-list
83328515|NCT05347641|Methotrexate|methotrexate|mesh-list
83328516|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328517|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
83328518|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328519|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328520|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83328521|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
83328522|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83328523|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83328524|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
83328525|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328526|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
83328527|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328528|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83328529|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83328530|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83328531|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
83328532|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328533|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
83328535|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83328536|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
83328537|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328538|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328539|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83328540|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
83328541|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
83328542|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83328543|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
83328544|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328545|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328546|NCT04368520|Vitamin D|vitamin d|mesh-list
83328547|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
83328548|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
83328550|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
83328551|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328552|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83328553|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83328554|NCT03790137|Fenfluramine|fenfluramine|mesh-list
83328555|NCT03790137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83328556|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83328557|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328558|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328559|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328560|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
83328561|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328562|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83328563|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83328564|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83328565|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
83328566|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328567|NCT03580317|Carbamazepine|carbamazepine|mesh-list
83328568|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
83328569|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
83328570|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83328571|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328572|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328573|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83328574|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328575|NCT03580317|Analgesics|analgesics|mesh-ancestor
83328576|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
83328577|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328578|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83328579|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328580|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328581|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83328582|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83328583|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
83328584|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83328585|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
83328586|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328587|NCT04356118|Methotrexate|methotrexate|mesh-list
83328588|NCT04356118|Endostatins|endostatins|mesh-list
83328589|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83328590|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
83328591|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83328592|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328593|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83328594|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
83328595|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328596|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328597|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
83328598|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328599|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83328600|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83328602|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328603|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83328604|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83328605|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83328606|NCT04356118|Growth Substances|growth substances|mesh-ancestor
83328607|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
83328608|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
83328609|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
83328610|NCT04361812|Omalizumab|omalizumab|mesh-list
83328611|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83328612|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83328613|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83328614|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
83328615|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
83328616|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328617|NCT04355962|Sevoflurane|sevoflurane|mesh-list
83328618|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83328619|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83328620|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
83328621|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
83328622|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328623|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328624|NCT00705081|Ezetimibe|ezetimibe|mesh-list
83328625|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83328626|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83328627|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
83328628|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328629|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83328630|NCT00704769|Desloratadine|desloratadine|mesh-list
83328631|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83328632|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
83328633|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328634|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328635|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328636|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83328637|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83328638|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
83328639|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
83328640|NCT00938548|Pregabalin|pregabalin|mesh-list
83328641|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328642|NCT00938548|Analgesics|analgesics|mesh-ancestor
83328643|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
83328644|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328645|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
83328646|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83328647|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328648|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328649|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83328650|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83328651|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83328652|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328653|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83328654|NCT00932620|Simvastatin|simvastatin|mesh-list
83328655|NCT00932620|Ezetimibe|ezetimibe|mesh-list
83328656|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83328657|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83328658|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
83328659|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328660|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83328661|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83328662|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328663|NCT04361188|Anesthetics|anesthetics|mesh-list
83328664|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328665|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328666|NCT04367818|Anesthetics|anesthetics|mesh-list
83328667|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
83328668|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328669|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328670|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
83328671|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328672|NCT01677273|Caseins|caseins|mesh-list
83328673|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
83328674|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
83328675|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328676|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83328677|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83328678|NCT04355806|Vaccines|vaccines|mesh-list
83328679|NCT04355806|Antibodies|antibodies|mesh-list
83328680|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
83328681|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83328682|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
83328683|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328684|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328685|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328686|NCT01677351|Clonidine|clonidine|mesh-list
83328687|NCT01677351|Analgesics|analgesics|mesh-ancestor
83328688|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
83328689|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328690|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328691|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83328692|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
83328693|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
83328694|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83328695|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83328696|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83328697|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83328698|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328699|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328700|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83328701|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
83328702|NCT00938704|Glycerol|glycerol|mesh-list
83328703|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83328704|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
83328705|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328706|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
83328707|NCT00938704|Protective Agents|protective agents|mesh-ancestor
83328708|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83328709|NCT00938704|Laxatives|laxatives|mesh-ancestor
83328710|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83328711|NCT03666351|Losartan|losartan|mesh-list
83328712|NCT03666351|Amlodipine|amlodipine|mesh-list
83328713|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
83328714|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83328715|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83328716|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328717|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328718|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83328719|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328720|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
83328721|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83328722|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83328723|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83328724|NCT03666351|Diuretics|diuretics|mesh-ancestor
83328725|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
83328726|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83328727|NCT00928642|Gemcitabine|gemcitabine|mesh-list
83328728|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
83328729|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83328730|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
83328731|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328732|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328733|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83328734|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328735|NCT03663543|Estrogens|estrogens|mesh-list
83328736|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83328737|NCT03663543|Hormones|hormones|mesh-ancestor
83328738|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83328739|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328740|NCT04361422|Isotretinoin|isotretinoin|mesh-list
83328741|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
83328742|NCT03579615|Insulin|insulin|mesh-list
83328743|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
83328744|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83328745|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328746|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83328747|NCT03575403|Methylphenidate|methylphenidate|mesh-list
83328748|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83328749|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328750|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83328751|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83328752|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83328753|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328755|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328756|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83328757|NCT03575403|Analgesics|analgesics|mesh-ancestor
83328758|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
83328759|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328760|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
83328761|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83328762|NCT03553875|Memantine|memantine|mesh-list
83328763|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83328764|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83328765|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
83328766|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328767|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328768|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328769|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83328770|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83328771|NCT04355416|Curcumin|curcumin|mesh-list
83328772|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83328773|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328774|NCT04355416|Analgesics|analgesics|mesh-ancestor
83328775|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
83328776|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328777|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328778|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328779|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328780|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328781|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328782|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328783|NCT03777813|Leucovorin|leucovorin|mesh-list
83328784|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
83328785|NCT03777813|Durvalumab|durvalumab|mesh-list
83328786|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
83328787|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328788|NCT03777813|Antidotes|antidotes|mesh-ancestor
83328789|NCT03777813|Protective Agents|protective agents|mesh-ancestor
83328790|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328791|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
83328792|NCT03777813|Vitamins|vitamins|mesh-ancestor
83328793|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
83328794|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328795|NCT04355494|Eculizumab|eculizumab|mesh-list
83328796|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83328797|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83328798|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
83328799|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328800|NCT00934024|Varenicline|varenicline|mesh-list
83328801|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83328802|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83328803|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
83328804|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328805|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328806|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328807|NCT04361032|Deferoxamine|deferoxamine|mesh-list
83328808|NCT04361032|Siderophores|siderophores|mesh-ancestor
83328809|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83328810|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
83328811|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
83328812|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328813|NCT00928954|Gabapentin|gabapentin|mesh-list
83328814|NCT00928954|Memantine|memantine|mesh-list
83328815|NCT00928954|Analgesics|analgesics|mesh-ancestor
83328816|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
83328817|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328818|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328819|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
83328820|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83328821|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83328822|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328823|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83328824|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83328825|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83328826|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328827|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328828|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
83328829|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83328830|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83328831|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
83328832|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
83328833|NCT04355026|Bromhexine|bromhexine|mesh-list
83328834|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
83328835|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83328836|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83328837|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328838|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328839|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328840|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328841|NCT04355026|Expectorants|expectorants|mesh-ancestor
83328842|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
83328843|NCT03548571|Temozolomide|temozolomide|mesh-list
83328844|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83328845|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
83328846|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328847|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328848|NCT00939562|Doxycycline|doxycycline|mesh-list
83328849|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83328850|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328851|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
83328852|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83328853|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83328855|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83328856|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328857|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328858|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328859|NCT04359862|Propofol|propofol|mesh-list
83328860|NCT04359862|Sevoflurane|sevoflurane|mesh-list
83328861|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83328862|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328863|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328864|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83328865|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
83328866|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
83328867|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83328868|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83328869|NCT04366726|Abaloparatide|abaloparatide|mesh-list
83328870|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83328871|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328872|NCT04366960|Enoxaparin|enoxaparin|mesh-list
83328873|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
83328874|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83328875|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83328876|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328877|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83328878|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83328879|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83328880|NCT03539445|Protective Agents|protective agents|mesh-ancestor
83328881|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328882|NCT04360876|Dexamethasone|dexamethasone|mesh-list
83328883|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
83328884|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328885|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
83328886|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
83328887|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328888|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328889|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83328890|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
83328891|NCT04360876|Hormones|hormones|mesh-ancestor
83328892|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83328893|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83328894|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328895|NCT04359550|Antibodies|antibodies|mesh-list
83328896|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83328897|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
83328898|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328899|NCT02084511|Celecoxib|celecoxib|mesh-list
83328900|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83328901|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328903|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
83328904|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328905|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328906|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328907|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328908|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83328909|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83328910|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328911|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328912|NCT00942448|Diclofenac|diclofenac|mesh-list
83328913|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83328914|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83328915|NCT00942448|Analgesics|analgesics|mesh-ancestor
83328917|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328918|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328919|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83328920|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328921|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83328922|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328923|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328924|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83328925|NCT02982148|Methylene Blue|methylene blue|mesh-list
83328926|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328927|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328928|NCT04359316|Azithromycin|azithromycin|mesh-list
83328929|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
83328930|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83328931|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328932|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
83328933|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83328934|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83328935|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328936|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328937|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83328938|NCT03558867|Metformin|metformin|mesh-list
83328939|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83328940|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328941|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
83328942|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83328943|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83328944|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
83328945|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328946|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83328947|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83328948|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328949|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328950|NCT03557385|Adenosine|adenosine|mesh-list
83328951|NCT03557385|Analgesics|analgesics|mesh-ancestor
83328952|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
83328953|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83328954|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328955|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83328956|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
83328957|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83328958|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
83328959|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
83328960|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328961|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328962|NCT04601350|Midazolam|midazolam|mesh-list
83328963|NCT04601350|Anesthetics|anesthetics|mesh-list
83328964|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83328965|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83328966|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83328967|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83328968|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83328969|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83328970|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83328971|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83328972|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
83328973|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
83328974|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
83328975|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83328976|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328977|NCT05346861|Trastuzumab|trastuzumab|mesh-list
83328978|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83328979|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328980|NCT04358614|Ritonavir|ritonavir|mesh-list
83328981|NCT04358614|Lopinavir|lopinavir|mesh-list
83328982|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83328983|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83328984|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
83328985|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83328986|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328987|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83328988|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83328989|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
83328990|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83328991|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83328992|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83328994|NCT01670409|Fluorouracil|fluorouracil|mesh-list
83328995|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83328996|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
83328997|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83328998|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83328999|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329000|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
83329001|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329002|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83329003|NCT04761705|Latanoprost|latanoprost|mesh-list
83329004|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83329005|NCT04358770|Clocortolone|clocortolone|mesh-list
83329006|NCT04358770|Fluocortolone|fluocortolone|mesh-list
83329007|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
83329008|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329009|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
83329010|NCT04358770|Hormones|hormones|mesh-ancestor
83329011|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329012|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329013|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
83329014|NCT03516981|Lenvatinib|lenvatinib|mesh-list
83329015|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329016|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329017|NCT03516981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83329018|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329019|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329020|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329021|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
83329022|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83329023|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83329024|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83329025|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83329026|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329027|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
83329028|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329029|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329030|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83329031|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329032|NCT04358146|Locust bean gum|locust bean gum|mesh-list
83329033|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
83329034|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83329035|NCT05620498|Lenvatinib|lenvatinib|mesh-list
83329036|NCT05620498|Tislelizumab|tislelizumab|mesh-list
83329037|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329038|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329039|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329040|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329041|NCT05620498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329042|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
83329043|NCT01670565|Belimumab|belimumab|mesh-list
83329044|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83329045|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329046|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83329047|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
83329048|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329049|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329050|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329051|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329052|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329053|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
83329054|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329055|NCT01670799|Ketorolac|ketorolac|mesh-list
83329056|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83329057|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83329058|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83329059|NCT01670799|Analgesics|analgesics|mesh-ancestor
83329060|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
83329061|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329062|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329063|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329064|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329065|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83329066|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329067|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329069|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329070|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329071|NCT04320940|Phenobarbital|phenobarbital|mesh-list
83329072|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
83329073|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83329074|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329075|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329076|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83329077|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83329078|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329079|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329080|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
83329081|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
83329082|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83329083|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83329084|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83329085|NCT03422523|Rituximab|rituximab|mesh-list
83329086|NCT03422523|Atezolizumab|atezolizumab|mesh-list
83329087|NCT03422523|Gemcitabine|gemcitabine|mesh-list
83329088|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
83329089|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329090|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329091|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
83329092|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329093|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329094|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83329095|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
83329096|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329097|NCT03422523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83329098|NCT03032536|Tenofovir|tenofovir|mesh-list
83329099|NCT03032536|Entecavir|entecavir|mesh-list
83329100|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
83329101|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329102|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83329103|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83329104|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329105|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329106|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83329107|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83329108|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
83329109|NCT03420963|Etoposide|etoposide|mesh-list
83329110|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
83329111|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
83329112|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329113|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
83329114|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329115|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329116|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83329117|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
83329118|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329119|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329120|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83329121|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83329122|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83329123|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83329124|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329125|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
83329126|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
83329127|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83329128|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83329129|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83329130|NCT03032614|Carboplatin|carboplatin|mesh-list
83329132|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329133|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83329134|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329135|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329136|NCT03032458|Ketorolac|ketorolac|mesh-list
83329137|NCT03032458|Lidocaine|lidocaine|mesh-list
83329138|NCT03032458|Meperidine|meperidine|mesh-list
83329139|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
83329140|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
83329141|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329142|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329143|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
83329144|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329145|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83329146|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83329147|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83329148|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83329149|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329150|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83329151|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83329152|NCT03032458|Analgesics|analgesics|mesh-ancestor
83329153|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329154|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329155|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83329156|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329157|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83329158|NCT03032458|Narcotics|narcotics|mesh-ancestor
83329159|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83329160|NCT02245438|Ritonavir|ritonavir|mesh-list
83329161|NCT02245438|Tipranavir|tipranavir|mesh-list
83329162|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83329163|NCT02245438|Norethindrone|norethindrone|mesh-list
83329164|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
83329165|NCT02245438|Norinyl|norinyl|mesh-list
83329166|NCT02245438|Estradiol|estradiol|mesh-list
83329167|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83329168|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83329169|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
83329170|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329171|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329172|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83329173|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83329174|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
83329175|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329176|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83329177|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83329178|NCT02245438|Estrogens|estrogens|mesh-ancestor
83329179|NCT02245438|Hormones|hormones|mesh-ancestor
83329180|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329181|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329182|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83329183|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
83329184|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83329185|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83329186|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83329187|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83329188|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83329189|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83329190|NCT03087669|Norepinephrine|norepinephrine|mesh-list
83329191|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83329192|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83329193|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
83329194|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329195|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329196|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329197|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
83329198|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
83329199|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329200|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83329201|NCT00939952|Ertapenem|ertapenem|mesh-list
83329202|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329203|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329204|NCT02401815|Sunitinib|sunitinib|mesh-list
83329205|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329206|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83329207|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83329208|NCT02401815|Growth Substances|growth substances|mesh-ancestor
83329209|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329210|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
83329211|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329212|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329213|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329214|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
83329215|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
83329216|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83329217|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
83329218|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329219|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329220|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329221|NCT03456687|Exenatide|exenatide|mesh-list
83329222|NCT03456687|Glucagon|glucagon|mesh-list
83329223|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83329224|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83329225|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329226|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83329227|NCT03456687|Incretins|incretins|mesh-ancestor
83329228|NCT03456687|Hormones|hormones|mesh-ancestor
83329229|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329230|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83329231|NCT00948298|Vitamin D|vitamin d|mesh-list
83329232|NCT00948298|Vitamins|vitamins|mesh-ancestor
83329233|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
83329234|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329235|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83329236|NCT00948610|Infliximab|infliximab|mesh-list
83329237|NCT00948610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83329238|NCT00948610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329239|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83329240|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83329241|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329242|NCT03031834|Quinapril|quinapril|mesh-list
83329243|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83329244|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
83329245|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329246|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329247|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83329248|NCT00944554|Varenicline|varenicline|mesh-list
83329249|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83329250|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83329251|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
83329252|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329253|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329254|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329255|NCT03031756|Glycine|glycine|mesh-list
83329256|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
83329257|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329258|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329259|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329260|NCT00944710|Atropine|atropine|mesh-list
83329261|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83329262|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83329263|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83329264|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
83329265|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329266|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329267|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83329268|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
83329269|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
83329270|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
83329271|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83329272|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83329273|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
83329274|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329275|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329276|NCT00949078|Omalizumab|omalizumab|mesh-list
83329277|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83329278|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83329279|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
83329281|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83329282|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
83329283|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83329284|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329285|NCT03854032|Nivolumab|nivolumab|mesh-list
83329286|NCT03854032|Linrodostat|linrodostat|mesh-list
83329287|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329288|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329289|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83329290|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329291|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329292|NCT03031444|Leucovorin|leucovorin|mesh-list
83329293|NCT03031444|Cetuximab|cetuximab|mesh-list
83329294|NCT03031444|Fluorouracil|fluorouracil|mesh-list
83329295|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
83329296|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329297|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329298|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
83329299|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329300|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83329301|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329302|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
83329303|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329304|NCT03031444|Antidotes|antidotes|mesh-ancestor
83329305|NCT03031444|Protective Agents|protective agents|mesh-ancestor
83329306|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
83329307|NCT03031444|Vitamins|vitamins|mesh-ancestor
83329308|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
83329309|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
83329310|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83329311|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
83329312|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329313|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
83329314|NCT03031054|Protective Agents|protective agents|mesh-ancestor
83329315|NCT00945334|Rifaximin|rifaximin|mesh-list
83329316|NCT00945334|Neomycin|neomycin|mesh-list
83329317|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329318|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329319|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83329320|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83329321|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329322|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329323|NCT03559114|Dalteparin|dalteparin|mesh-list
83329324|NCT03559114|Tinzaparin|tinzaparin|mesh-list
83329325|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83329326|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
83329327|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83329328|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83329329|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329330|NCT05153590|Liraglutide|liraglutide|mesh-list
83329331|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83329332|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329333|NCT05153590|Incretins|incretins|mesh-ancestor
83329334|NCT05153590|Hormones|hormones|mesh-ancestor
83329335|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329336|NCT03490864|Melatonin|melatonin|mesh-list
83329337|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
83329338|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329339|NCT03490864|Protective Agents|protective agents|mesh-ancestor
83329340|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329341|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329342|NCT04402203|Favipiravir|favipiravir|mesh-list
83329343|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
83329344|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329345|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
83329346|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329347|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
83329348|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329349|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329350|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83329351|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
83329352|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329353|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329354|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83329355|NCT00949234|Ritonavir|ritonavir|mesh-list
83329357|NCT00949234|Tenofovir|tenofovir|mesh-list
83329358|NCT00949234|Emtricitabine|emtricitabine|mesh-list
83329359|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83329360|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83329361|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
83329362|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329363|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329364|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83329365|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83329366|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
83329367|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329368|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83329369|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83329370|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83329371|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83329372|NCT03090880|Tinzaparin|tinzaparin|mesh-list
83329373|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83329374|NCT03090880|Dalteparin|dalteparin|mesh-list
83329375|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
83329376|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83329377|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83329378|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329379|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
83329380|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83329381|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83329382|NCT05097976|Prednisolone|prednisolone|mesh-list
83329383|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
83329384|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83329385|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
83329386|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329387|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
83329388|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
83329389|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329390|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329391|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83329392|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
83329393|NCT05097976|Hormones|hormones|mesh-ancestor
83329394|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329395|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83329396|NCT05097976|Protective Agents|protective agents|mesh-ancestor
83329397|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83329398|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329399|NCT03030430|Bevacizumab|bevacizumab|mesh-list
83329400|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329401|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329402|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83329403|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83329404|NCT03030430|Growth Substances|growth substances|mesh-ancestor
83329405|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329406|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
83329407|NCT00089661|Denosumab|denosumab|mesh-list
83329408|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83329409|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329410|NCT00941668|Triclosan|triclosan|mesh-list
83329411|NCT00941668|Fluorides|fluorides|mesh-list
83329412|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
83329413|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
83329414|NCT00941668|Protective Agents|protective agents|mesh-ancestor
83329415|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329416|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83329417|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329418|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83329419|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83329420|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
83329421|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329422|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83329423|NCT01597414|Trastuzumab|trastuzumab|mesh-list
83329424|NCT01597414|Pertuzumab|pertuzumab|mesh-list
83329425|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329426|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329427|NCT04984330|Dexamethasone|dexamethasone|mesh-list
83329428|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329429|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
83329430|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
83329431|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329432|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329433|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83329434|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
83329435|NCT04984330|Hormones|hormones|mesh-ancestor
83329436|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329437|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83329438|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329439|NCT03030196|Denosumab|denosumab|mesh-list
83329440|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83329441|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329442|NCT00265798|Sorafenib|sorafenib|mesh-list
83329443|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329444|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329445|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329446|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329447|NCT03035578|Morphine|morphine|mesh-list
83329448|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83329449|NCT03035578|Narcotics|narcotics|mesh-ancestor
83329450|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329451|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329452|NCT03035578|Analgesics|analgesics|mesh-ancestor
83329453|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
83329454|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329455|NCT04933942|Lomustine|lomustine|mesh-list
83329456|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83329457|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
83329458|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329459|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329460|NCT00089583|Ritonavir|ritonavir|mesh-list
83329461|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
83329462|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83329463|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83329464|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83329465|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329466|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329467|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83329468|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83329469|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
83329470|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329471|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83329472|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83329473|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
83329474|NCT03029494|Vitamins|vitamins|mesh-ancestor
83329475|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
83329476|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329477|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
83329478|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329479|NCT03029494|Protective Agents|protective agents|mesh-ancestor
83329480|NCT04402047|Diclofenac|diclofenac|mesh-list
83329481|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83329482|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83329483|NCT04402047|Analgesics|analgesics|mesh-ancestor
83329484|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
83329485|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329486|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329487|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329488|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329489|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83329490|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329491|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329492|NCT03017248|Ketamine|ketamine|mesh-list
83329493|NCT03017248|Morphine|morphine|mesh-list
83329494|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83329495|NCT03017248|Analgesics|analgesics|mesh-ancestor
83329496|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
83329497|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329498|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329499|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83329500|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83329501|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
83329502|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
83329503|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83430178|NCT00506857|Busulfan|busulfan|mesh-list
83329504|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83329505|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83329506|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329507|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329508|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83329509|NCT03017248|Narcotics|narcotics|mesh-ancestor
83329510|NCT00088881|Prednisone|prednisone|mesh-list
83329511|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
83329512|NCT00088881|Rituximab|rituximab|mesh-list
83329513|NCT00088881|Doxorubicin|doxorubicin|mesh-list
83329514|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83329515|NCT00088881|Vincristine|vincristine|mesh-list
83329516|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329517|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
83329518|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329519|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329520|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83329521|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
83329522|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329523|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329524|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83329525|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329526|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83329527|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83329528|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83329529|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329530|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329531|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
83329532|NCT00088881|Hormones|hormones|mesh-ancestor
83329533|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329534|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83329535|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83329536|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83329537|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83329538|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83329539|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
83329540|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329541|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329542|NCT02981914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83329543|NCT02981914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329544|NCT03025750|Vaccines|vaccines|mesh-list
83329545|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
83329546|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329547|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
83329548|NCT03017404|Docetaxel|docetaxel|mesh-list
83329549|NCT03017404|Doxorubicin|doxorubicin|mesh-list
83329550|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83329551|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329552|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
83329553|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329554|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329555|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83329556|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
83329557|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329558|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329559|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83329560|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
83329561|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
83329562|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
83329563|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83329564|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83329565|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83329566|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329567|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
83329568|NCT00953212|Amiodarone|amiodarone|mesh-list
83329569|NCT00953212|Metoprolol|metoprolol|mesh-list
83329570|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83329571|NCT00953212|Vitamins|vitamins|mesh-ancestor
83329572|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
83329573|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329574|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
83329575|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329576|NCT00953212|Protective Agents|protective agents|mesh-ancestor
83329577|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83329578|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
83329579|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329580|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83329581|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
83329582|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83329583|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83329584|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83329585|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83329586|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83329587|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329588|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83329589|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83329590|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83329591|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83329592|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
83329593|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
83329594|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329595|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83329596|NCT03034408|Mannitol|mannitol|mesh-list
83329597|NCT03034408|Baclofen|baclofen|mesh-list
83329598|NCT03034408|Nalmefene|nalmefene|mesh-list
83329599|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83329600|NCT03034408|Diuretics|diuretics|mesh-ancestor
83329601|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
83329602|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329603|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83329604|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83329605|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329606|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83329607|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
83329608|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
83329609|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329610|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329611|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83329612|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
83329613|NCT03023020|Aspirin|aspirin|mesh-list
83329614|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83329615|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83329616|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83329617|NCT03023020|Analgesics|analgesics|mesh-ancestor
83329618|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
83329619|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329620|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329621|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329622|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329623|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83329624|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83329625|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329626|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83329627|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329628|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
83329629|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
83329630|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83329631|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83329632|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83329633|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
83329634|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
83329635|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329636|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329637|NCT03022318|Levodopa|levodopa|mesh-list
83329638|NCT03022318|Carbidopa|carbidopa|mesh-list
83329639|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83329640|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83329641|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83329642|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
83329643|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329644|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329645|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329646|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83329647|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329648|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83329649|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
83329650|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
83329651|NCT01677897|Metformin|metformin|mesh-list
83329652|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83329653|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329654|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83329655|NCT03483363|Bacitracin|bacitracin|mesh-list
83329656|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83329657|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329658|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
83329659|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83329660|NCT03086733|Metformin|metformin|mesh-list
83329661|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83329662|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329663|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
83329664|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329665|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83329666|NCT00085917|Interferons|interferons|mesh-list
83329667|NCT00085917|Ribavirin|ribavirin|mesh-list
83329668|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
83329669|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83329670|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329671|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
83329672|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329673|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
83329674|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329675|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
83329676|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329677|NCT00084747|Bortezomib|bortezomib|mesh-list
83329678|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329679|NCT04402671|Glutaral|glutaral|mesh-list
83329680|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
83329681|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329682|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
83329683|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83329684|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329685|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83329686|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329687|NCT01678365|Metronidazole|metronidazole|mesh-list
83329688|NCT01678365|Gentamicins|gentamicins|mesh-list
83329689|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
83329690|NCT01678365|Ampicillin|ampicillin|mesh-list
83329691|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329692|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329693|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83329694|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83329695|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83329696|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329697|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329698|NCT00946270|Thalidomide|thalidomide|mesh-list
83329699|NCT00946270|Prednisone|prednisone|mesh-list
83329700|NCT00946270|Pomalidomide|pomalidomide|mesh-list
83329701|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329702|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
83329703|NCT00946270|Hormones|hormones|mesh-ancestor
83329704|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329705|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329706|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83329707|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329708|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
83329709|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83329710|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83329711|NCT00946270|Growth Substances|growth substances|mesh-ancestor
83329712|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
83329713|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329714|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
83329715|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329716|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329717|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
83329718|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329719|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329720|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83329721|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83329723|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329724|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329725|NCT03021694|Caseins|caseins|mesh-list
83329726|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
83329727|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
83329728|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329729|NCT00956254|Fentanyl|fentanyl|mesh-list
83329730|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83329731|NCT00956254|Narcotics|narcotics|mesh-ancestor
83329732|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329733|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329734|NCT00956254|Analgesics|analgesics|mesh-ancestor
83329735|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
83329736|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329737|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83329738|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83329739|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
83329740|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
83329742|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
83329743|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
83329744|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329745|NCT03020680|Vitamins|vitamins|mesh-ancestor
83329746|NCT01678599|Benzonidazole|benzonidazole|mesh-list
83329747|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329748|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
83329749|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329750|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83329751|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83329752|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83329753|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329754|NCT03019822|Amphetamine|amphetamine|mesh-list
83329755|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
83329756|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
83329757|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83329758|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83329759|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329760|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
83329761|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
83329762|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329763|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
83329764|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329765|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329766|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
83329767|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83329768|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83329769|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83329770|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83329771|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
83329772|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83329773|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
83329774|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83329775|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83329776|NCT01678677|Vaccines|vaccines|mesh-list
83329777|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
83329778|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329779|NCT00946348|Dronabinol|dronabinol|mesh-list
83329780|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
83329781|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329782|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83329783|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83329784|NCT00946348|Analgesics|analgesics|mesh-ancestor
83329785|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
83329786|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329787|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83329788|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83329789|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329790|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329791|NCT00946348|Hormones|hormones|mesh-ancestor
83329792|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329793|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
83329794|NCT00081159|Doxorubicin|doxorubicin|mesh-list
83329795|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83329796|NCT00081159|Leuprolide|leuprolide|mesh-list
83329797|NCT00081159|Goserelin|goserelin|mesh-list
83329798|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83329799|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329800|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83329801|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83329802|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329803|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329804|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83329805|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329806|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83329807|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
83329808|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83329809|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83329810|NCT03033472|Clindamycin|clindamycin|mesh-list
83329811|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
83329812|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
83329813|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329814|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329815|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83329816|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329817|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329819|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
83329820|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329821|NCT03033160|Estradiol|estradiol|mesh-list
83329822|NCT03033160|Estrogens|estrogens|mesh-ancestor
83329823|NCT03033160|Hormones|hormones|mesh-ancestor
83329824|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329825|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329826|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83329827|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83329828|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329829|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83329830|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83329831|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83329832|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329833|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
83329834|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329835|NCT03033316|Dexamethasone|dexamethasone|mesh-list
83329836|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329837|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
83329838|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
83329839|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329840|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329841|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83329842|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
83329843|NCT03033316|Hormones|hormones|mesh-ancestor
83329844|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329845|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83329846|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329847|NCT03032848|Estrogens|estrogens|mesh-list
83329848|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83329849|NCT03032848|Hormones|hormones|mesh-ancestor
83329850|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329851|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329852|NCT00080223|Pirfenidone|pirfenidone|mesh-list
83329853|NCT00080223|Analgesics|analgesics|mesh-ancestor
83329854|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
83329855|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329856|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329857|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83329858|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83329859|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83329860|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329861|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329862|NCT04402359|Meropenem|meropenem|mesh-list
83329863|NCT04402359|Ceftazidime|ceftazidime|mesh-list
83329864|NCT04402359|Avibactam|avibactam|mesh-list
83329865|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329866|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329867|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83329868|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329869|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329870|NCT00959764|Calcitonin|calcitonin|mesh-list
83329871|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
83329872|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83329873|NCT00959764|Katacalcin|katacalcin|mesh-list
83329874|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83329875|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329876|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83329877|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
83329878|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
83329879|NCT01005706|Sirolimus|sirolimus|mesh-list
83329880|NCT01005706|Temsirolimus|temsirolimus|mesh-list
83329881|NCT01005706|MTOR Inhibitors|mtor inhibitors|mesh-list
83329882|NCT01005706|Tacrolimus|tacrolimus|mesh-list
83329883|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329884|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
83329885|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329886|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83329887|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329888|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329889|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83329890|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329891|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83329892|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
83329893|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83329894|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329895|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
83329896|NCT01005706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329897|NCT03085485|Ivacaftor|ivacaftor|mesh-list
83329898|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83329899|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83329900|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329901|NCT01679691|Anesthetics|anesthetics|mesh-list
83329902|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329903|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329904|NCT03470805|Olaparib|olaparib|mesh-list
83329905|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83329906|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329907|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329908|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329909|NCT03088059|Durvalumab|durvalumab|mesh-list
83329910|NCT03088059|Palbociclib|palbociclib|mesh-list
83329911|NCT03088059|Niraparib|niraparib|mesh-list
83329912|NCT03088059|Afatinib|afatinib|mesh-list
83329913|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329914|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329915|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329916|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329917|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329918|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83329919|NCT03084549|Ropivacaine|ropivacaine|mesh-list
83329920|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
83329921|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
83329922|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83329923|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329924|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
83329925|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329926|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83329927|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329928|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
83329929|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83329930|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329931|NCT03085719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83329932|NCT03085719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329933|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83329934|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329935|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83329936|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83329937|NCT01006252|Paclitaxel|paclitaxel|mesh-list
83329938|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83329939|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329940|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
83329941|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
83329942|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
83329943|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329944|NCT03080805|Capecitabine|capecitabine|mesh-list
83329945|NCT03080805|Lapatinib|lapatinib|mesh-list
83329946|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83329947|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
83329948|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329949|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329950|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329951|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329952|NCT03019120|Vitamin D|vitamin d|mesh-list
83329953|NCT03019120|Vitamins|vitamins|mesh-ancestor
83329954|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
83329955|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329956|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83329958|NCT00960622|Lamivudine|lamivudine|mesh-list
83329959|NCT00960622|Emtricitabine|emtricitabine|mesh-list
83329960|NCT00960622|Zidovudine|zidovudine|mesh-list
83329961|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83329962|NCT00960622|Abacavir|abacavir|mesh-list
83329963|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
83329964|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83329965|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
83329966|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83329967|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83329968|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83329969|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329970|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329971|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83329972|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83329973|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
83329974|NCT03430947|Vemurafenib|vemurafenib|mesh-list
83329975|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83329976|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83329977|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83329978|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329979|NCT00960778|Nicotine|nicotine|mesh-list
83329980|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83329981|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
83329982|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83329983|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329984|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83329985|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83329986|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
83329987|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83329988|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83329989|NCT03080181|Pasireotide|pasireotide|mesh-list
83329990|NCT03080181|Hormones|hormones|mesh-ancestor
83329991|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83329992|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329993|NCT03088293|Infliximab|infliximab|mesh-list
83329994|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
83329995|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83329996|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
83329997|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83329998|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83329999|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83330000|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
83330001|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330002|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330003|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83330004|NCT03088293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83330005|NCT03088293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330006|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
83330007|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330008|NCT01008280|Baclofen|baclofen|mesh-list
83330009|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83330010|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330011|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83330012|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330013|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83330014|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
83330015|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
83330016|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330017|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330018|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83330019|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
83330020|NCT03089073|Coagulants|coagulants|mesh-ancestor
83330021|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83330022|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
83330023|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330024|NCT05688813|Anesthetics|anesthetics|mesh-list
83330025|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330026|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330027|NCT01009918|Carvedilol|carvedilol|mesh-list
83330028|NCT01009918|Lisinopril|lisinopril|mesh-list
83330029|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83330030|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83330031|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
83330032|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330033|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330034|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330035|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83330036|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
83330037|NCT01009918|Protective Agents|protective agents|mesh-ancestor
83330038|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83330039|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330040|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83330041|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
83330042|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83330043|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83330044|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83330045|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
83330046|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330047|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83330048|NCT04401657|Adenosine|adenosine|mesh-list
83330049|NCT04401657|Analgesics|analgesics|mesh-ancestor
83330050|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
83330051|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330052|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330053|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83330054|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
83330055|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83330056|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
83330057|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
83330058|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330059|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330060|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
83330061|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83330062|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83330063|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330064|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
83330065|NCT03019198|Coagulants|coagulants|mesh-ancestor
83330066|NCT03083613|Paclitaxel|paclitaxel|mesh-list
83330067|NCT03083613|Raltitrexed|raltitrexed|mesh-list
83330068|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83330069|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330070|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
83330071|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
83330072|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330073|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330074|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83330075|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
83330076|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83330077|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330078|NCT00963508|Permethrin|permethrin|mesh-list
83330079|NCT00963508|Malathion|malathion|mesh-list
83330080|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330081|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330082|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83330083|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
83330084|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330085|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330086|NCT03088371|Lidocaine|lidocaine|mesh-list
83330087|NCT03088371|Bupivacaine|bupivacaine|mesh-list
83330088|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
83330089|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
83330090|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330091|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330092|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
83330093|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330094|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83330095|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83330096|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83330097|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330098|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330099|NCT03083691|Nivolumab|nivolumab|mesh-list
83330100|NCT03083691|Ipilimumab|ipilimumab|mesh-list
83330101|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330102|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330103|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83330104|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330105|NCT05685537|Simendan|simendan|mesh-list
83330106|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83330107|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
83330108|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83330109|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83330110|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330111|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330112|NCT05685537|Protective Agents|protective agents|mesh-ancestor
83330113|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330114|NCT04400721|Ropivacaine|ropivacaine|mesh-list
83330115|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
83330116|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
83330117|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330118|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330119|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
83330120|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330121|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
83330122|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
83330123|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
83330124|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330125|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
83330126|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83330127|NCT03018652|Antibodies|antibodies|mesh-list
83330128|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
83330129|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83330130|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
83330131|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330132|NCT01012336|Dexamethasone|dexamethasone|mesh-list
83330133|NCT01012336|Aprepitant|aprepitant|mesh-list
83330134|NCT01012336|Ramosetron|ramosetron|mesh-list
83330135|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330136|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
83330137|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
83330138|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330139|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330140|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330141|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
83330142|NCT01012336|Hormones|hormones|mesh-ancestor
83330143|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330144|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83330145|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330146|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83330147|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330148|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330149|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83330150|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
83330151|NCT03387501|Mitogens|mitogens|mesh-list
83330152|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330153|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330154|NCT01012492|Abatacept|abatacept|mesh-list
83330155|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83330156|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330157|NCT01012492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330158|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330159|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330160|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
83330161|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330162|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330163|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
83330165|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83330166|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330167|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330168|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83330169|NCT05688345|Analgesics|analgesics|mesh-ancestor
83330170|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
83330171|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330172|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83330173|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83330174|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83330175|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
83330176|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330177|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330178|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83330179|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
83330180|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
83330181|NCT03083457|Anesthetics|anesthetics|mesh-list
83330182|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
83330183|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330184|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330185|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
83330187|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
83330188|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83330189|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83330190|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83330191|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
83330192|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330193|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330194|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330195|NCT01015534|Temozolomide|temozolomide|mesh-list
83330196|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83330197|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
83330198|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330199|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330200|NCT00968890|Vaccines|vaccines|mesh-list
83330201|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
83330202|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330203|NCT00970216|Telbivudine|telbivudine|mesh-list
83330204|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
83330205|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330206|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83330207|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330208|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330209|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
83330210|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83330211|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83330212|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83330213|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330214|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330215|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
83330216|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330217|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330218|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83330219|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330220|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
83330221|NCT03384537|Listerine|listerine|mesh-list
83330222|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83330223|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330224|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
83330225|NCT01884922|Vinblastine|vinblastine|mesh-list
83330226|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83330227|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330228|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
83330229|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
83330230|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330231|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330232|NCT05687409|Entecavir|entecavir|mesh-list
83330233|NCT05687409|Lactulose|lactulose|mesh-list
83330234|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83330235|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
83330236|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330237|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330238|NCT02162680|Lidocaine|lidocaine|mesh-list
83330239|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
83330240|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
83330241|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330242|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330243|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
83330244|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330245|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83330246|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83330247|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83330248|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330249|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330250|NCT05678673|Nivolumab|nivolumab|mesh-list
83330251|NCT05678673|Sunitinib|sunitinib|mesh-list
83330252|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330253|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330254|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83330255|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330256|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83330257|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83330258|NCT05678673|Growth Substances|growth substances|mesh-ancestor
83330259|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330260|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
83330261|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330262|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330263|NCT01017250|Bevacizumab|bevacizumab|mesh-list
83330264|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330265|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330266|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83330267|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83330268|NCT01017250|Growth Substances|growth substances|mesh-ancestor
83330269|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330270|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
83330271|NCT00812032|Aspirin|aspirin|mesh-list
83330272|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83330273|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83330274|NCT00812032|Analgesics|analgesics|mesh-ancestor
83330275|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
83330276|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330277|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330278|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330279|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330280|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83330281|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83330282|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330283|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83330284|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83330285|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330286|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
83330287|NCT05687253|Bromides|bromides|mesh-list
83330288|NCT05687253|Rocuronium|rocuronium|mesh-list
83330289|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
83330290|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83330291|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83330292|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83330293|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330294|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330295|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
83330296|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83330297|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330298|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83330299|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330300|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330301|NCT00417664|Midazolam|midazolam|mesh-list
83330302|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
83330304|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83330305|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330306|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330307|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83330308|NCT00417664|Analgesics|analgesics|mesh-ancestor
83330309|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
83330310|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330311|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83330312|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83330313|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83330314|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
83330315|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330316|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330317|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83330318|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
83330319|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
83330320|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83330321|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83330322|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83330323|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83330324|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
83330325|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
83330326|NCT05657613|Fluconazole|fluconazole|mesh-list
83330327|NCT05657613|Bosentan|bosentan|mesh-list
83330328|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
83330329|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330330|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83330331|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83330332|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330333|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330334|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83330335|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
83330336|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330337|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330338|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83330339|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83330340|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83330341|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83330342|NCT01021618|Dipyridamole|dipyridamole|mesh-list
83330343|NCT01021618|Regadenoson|regadenoson|mesh-list
83330344|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83330345|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83330346|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
83330347|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
83330348|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330349|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330350|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330351|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83330352|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330353|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83330354|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
83330355|NCT03082053|Capecitabine|capecitabine|mesh-list
83330356|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83330357|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
83330358|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330359|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330360|NCT03358563|Docetaxel|docetaxel|mesh-list
83330361|NCT03358563|Bicalutamide|bicalutamide|mesh-list
83330362|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83330363|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330364|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
83330365|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
83330366|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330367|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330368|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
83330369|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
83330370|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330371|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330372|NCT03358563|Hematinics|hematinics|mesh-ancestor
83330373|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83330374|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83330375|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
83330377|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83330378|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330379|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83330380|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83330381|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330382|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330383|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330384|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
83330385|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330386|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83330387|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83330388|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330389|NCT00974350|Bupivacaine|bupivacaine|mesh-list
83330390|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
83330391|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
83330392|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330393|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330394|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
83330395|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330396|NCT05395702|Interferons|interferons|mesh-list
83330397|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
83330398|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330399|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
83330400|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330401|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83330402|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83330403|NCT01023178|Estradiol|estradiol|mesh-list
83330404|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83330405|NCT01023178|Estrogens|estrogens|mesh-list
83330406|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83330407|NCT01023178|Progesterone|progesterone|mesh-list
83330408|NCT01023178|Hormones|hormones|mesh-ancestor
83330409|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330410|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330411|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83330412|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
83330413|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83330414|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83330415|NCT01023178|Progestins|progestins|mesh-ancestor
83330416|NCT03373851|Sufentanil|sufentanil|mesh-list
83330417|NCT03373851|Dsuvia|dsuvia|mesh-list
83330418|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83330419|NCT03373851|Narcotics|narcotics|mesh-ancestor
83330420|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330421|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330422|NCT03373851|Analgesics|analgesics|mesh-ancestor
83330423|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
83330424|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330425|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83330426|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83330427|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
83330428|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
83330429|NCT05623995|Evolocumab|evolocumab|mesh-list
83330430|NCT05623995|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
83330431|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83330432|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83330433|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83330434|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
83330435|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330436|NCT05623995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83330437|NCT05623995|Protease Inhibitors|protease inhibitors|mesh-ancestor
83330438|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330439|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83330440|NCT01023724|Ketorolac|ketorolac|mesh-list
83330441|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83330442|NCT01023724|Bromfenac|bromfenac|mesh-list
83330443|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83330444|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83330445|NCT01023724|Analgesics|analgesics|mesh-ancestor
83330446|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
83330447|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330448|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330449|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330450|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330451|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83330452|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330453|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330454|NCT00974818|Mitomycins|mitomycins|mesh-list
83330455|NCT00974818|Mitomycin|mitomycin|mesh-list
83330456|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
83330457|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83330458|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330459|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
83330460|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330461|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83330462|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330463|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83330464|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
83330465|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330466|NCT03371667|Methotrexate|methotrexate|mesh-list
83330467|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83330468|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
83330469|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83330470|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330471|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83330472|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
83330473|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330474|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330475|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
83330476|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330477|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83330478|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330479|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
83330480|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330481|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83330482|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
83330483|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83330484|NCT01024738|Triclosan|triclosan|mesh-list
83330485|NCT01024738|Fluorides|fluorides|mesh-list
83330486|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
83330487|NCT01024738|Protective Agents|protective agents|mesh-ancestor
83330488|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330489|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83330490|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330491|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
83330492|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
83330493|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83330494|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83330495|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
83330496|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330497|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83330498|NCT05613153|Peppermint oil|peppermint oil|mesh-list
83330499|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
83330500|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
83330501|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330502|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330503|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330504|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
83330505|NCT01024972|Mannitol|mannitol|mesh-list
83330506|NCT01024972|Dantrolene|dantrolene|mesh-list
83330507|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83330508|NCT01024972|Diuretics|diuretics|mesh-ancestor
83330509|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
83330510|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330511|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83330512|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83330513|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330514|NCT05686395|Bupivacaine|bupivacaine|mesh-list
83330515|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
83330516|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
83330517|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330518|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330519|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
83330520|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330521|NCT01025830|Lamivudine|lamivudine|mesh-list
83330522|NCT01025830|Nevirapine|nevirapine|mesh-list
83330523|NCT01025830|Stavudine|stavudine|mesh-list
83330524|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
83330525|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83330526|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83330527|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330528|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330529|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
83330530|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330531|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83330532|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83330533|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83330534|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83330535|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
83330536|NCT03081039|Carboplatin|carboplatin|mesh-list
83330537|NCT03081039|Gemcitabine|gemcitabine|mesh-list
83330538|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330539|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83330540|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
83330541|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330542|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
83330543|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83330544|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330545|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330546|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330547|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330548|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
83330549|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83330550|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83330551|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330552|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330553|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
83330554|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83330555|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330556|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
83330557|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330558|NCT00979732|Protective Agents|protective agents|mesh-ancestor
83330559|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330560|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
83330561|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83330562|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330563|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83330564|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330565|NCT03322995|Fluorouracil|fluorouracil|mesh-list
83330566|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
83330567|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330568|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83330569|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330570|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330571|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
83330572|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330573|NCT03321981|Trastuzumab|trastuzumab|mesh-list
83330574|NCT03321981|Letrozole|letrozole|mesh-list
83330575|NCT03321981|Vinorelbine|vinorelbine|mesh-list
83330576|NCT03321981|Fulvestrant|fulvestrant|mesh-list
83330577|NCT03321981|Exemestane|exemestane|mesh-list
83330578|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330579|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330580|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83330581|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83330582|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330583|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330584|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83330585|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
83330586|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330587|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330588|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83330589|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
83330590|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
83330591|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330592|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83330593|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83330594|NCT01027468|Bevacizumab|bevacizumab|mesh-list
83330595|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330596|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330597|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83330598|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83330599|NCT01027468|Growth Substances|growth substances|mesh-ancestor
83330600|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330601|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
83330602|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
83330603|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330604|NCT04278807|Anesthetics|anesthetics|mesh-list
83330605|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330606|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330607|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83330608|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330609|NCT03274401|Anticoagulants|anticoagulants|mesh-list
83330610|NCT05086107|Rifabutin|rifabutin|mesh-list
83330611|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83330612|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330613|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83330614|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
83330615|NCT01029730|Rituximab|rituximab|mesh-list
83330616|NCT01029730|Bortezomib|bortezomib|mesh-list
83330617|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83330618|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330619|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330620|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
83330621|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330622|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330623|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83330624|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
83330625|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330626|NCT05066997|Dexamethasone|dexamethasone|mesh-list
83330627|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
83330629|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330630|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
83330631|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
83330632|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330633|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330634|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330635|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
83330636|NCT05066997|Hormones|hormones|mesh-ancestor
83330637|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330638|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83330639|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330640|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
83330641|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330642|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330643|NCT05025033|Paclitaxel|paclitaxel|mesh-list
83330644|NCT05025033|Irinotecan|irinotecan|mesh-list
83330645|NCT05025033|Apatinib|apatinib|mesh-list
83330646|NCT05025033|Antibodies|antibodies|mesh-list
83330647|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
83330648|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83330649|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330650|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
83330651|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
83330652|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330653|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330654|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
83330655|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330656|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83330657|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83330658|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330659|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330660|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83330661|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
83330662|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83330663|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83330664|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330665|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330666|NCT00981214|Pancrelipase|pancrelipase|mesh-list
83330667|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330668|NCT05415657|Denosumab|denosumab|mesh-list
83330669|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83330670|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330671|NCT03016234|Propofol|propofol|mesh-list
83330672|NCT03016234|Desflurane|desflurane|mesh-list
83330673|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83330674|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330675|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330676|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83330677|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
83330678|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
83330679|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83330680|NCT02167204|Alovudine|alovudine|mesh-list
83330681|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
83330682|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330683|NCT00982072|Prednisolone|prednisolone|mesh-list
83330684|NCT00982072|Tacrolimus|tacrolimus|mesh-list
83330685|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330686|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
83330687|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330688|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83330689|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330690|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330691|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330692|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
83330693|NCT00982072|Hormones|hormones|mesh-ancestor
83330694|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330695|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83330696|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330697|NCT01899053|Serabelisib|serabelisib|mesh-list
83330698|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330699|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330700|NCT01032694|Azithromycin|azithromycin|mesh-list
83330701|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83330702|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330703|NCT04957095|Levodopa|levodopa|mesh-list
83330704|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83330705|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83330706|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
83330707|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330708|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330709|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330710|NCT01032850|Capecitabine|capecitabine|mesh-list
83330711|NCT01032850|Sorafenib|sorafenib|mesh-list
83330712|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83330713|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
83330714|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330715|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330716|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330717|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330718|NCT00983242|Colchicine|colchicine|mesh-list
83330719|NCT00983242|Verapamil|verapamil|mesh-list
83330720|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
83330721|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330722|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
83330723|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
83330724|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
83330725|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330726|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330727|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83330728|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83330729|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330730|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83330731|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330732|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
83330733|NCT00984334|Naloxone|naloxone|mesh-list
83330734|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83330735|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330736|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
83330737|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330738|NCT02168062|Leuprolide|leuprolide|mesh-list
83330739|NCT02168062|Goserelin|goserelin|mesh-list
83330740|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83330741|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83330742|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
83330743|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83330744|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330745|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83330746|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330747|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
83330748|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83330749|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
83330750|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83330751|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83330752|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330753|NCT05343117|Palbociclib|palbociclib|mesh-list
83330754|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330755|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330756|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330757|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330758|NCT01898195|Varenicline|varenicline|mesh-list
83330759|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83330760|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83330761|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
83330762|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330763|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330764|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330765|NCT01897727|Spironolactone|spironolactone|mesh-list
83330766|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83330767|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
83330768|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330769|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330770|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83330771|NCT01897727|Diuretics|diuretics|mesh-ancestor
83330772|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
83330773|NCT01897493|Digoxin|digoxin|mesh-list
83330774|NCT01897493|Evacetrapib|evacetrapib|mesh-list
83330775|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83330776|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83330777|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330778|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330779|NCT01897493|Protective Agents|protective agents|mesh-ancestor
83330780|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330781|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83330782|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83330783|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
83330784|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83330785|NCT01887353|Ranolazine|ranolazine|mesh-list
83330786|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83330787|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330788|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330789|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83330790|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
83330791|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83330792|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83330793|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83330794|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330795|NCT02160730|Roscovitine|roscovitine|mesh-list
83330796|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330797|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
83330798|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330799|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330800|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330801|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330802|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
83330803|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83330804|NCT01896869|Ipilimumab|ipilimumab|mesh-list
83330805|NCT01896869|Folfirinox|folfirinox|mesh-list
83330806|NCT01896869|Vaccines|vaccines|mesh-list
83330807|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
83330808|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330809|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330810|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330811|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83330812|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330813|NCT03329001|Niraparib|niraparib|mesh-list
83330814|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83330815|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330816|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330817|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330818|NCT01896557|Omeprazole|omeprazole|mesh-list
83330819|NCT01896557|Ranitidine|ranitidine|mesh-list
83330820|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83330821|NCT01896557|Clopidogrel|clopidogrel|mesh-list
83330822|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
83330823|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83330824|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83330825|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83330826|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
83330827|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330828|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330829|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330830|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83330831|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330832|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83330833|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330834|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83330835|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
83330836|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
83330837|NCT02160808|Secretin|secretin|mesh-list
83330838|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83330839|NCT02160808|Hormones|hormones|mesh-ancestor
83330840|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330841|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330842|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83330843|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83330844|NCT01886105|Analgesics|analgesics|mesh-ancestor
83330845|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
83330846|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330847|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330848|NCT03262779|Nivolumab|nivolumab|mesh-list
83330849|NCT03262779|Ipilimumab|ipilimumab|mesh-list
83330850|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330851|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330852|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83330853|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330854|NCT05022394|Nivolumab|nivolumab|mesh-list
83330855|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83330856|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330857|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83330858|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330859|NCT01895777|Dabigatran|dabigatran|mesh-list
83330860|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
83330861|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83330862|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
83330863|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330864|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330865|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
83330866|NCT00992602|Cytarabine|cytarabine|mesh-list
83330867|NCT00992602|Methotrexate|methotrexate|mesh-list
83330868|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83330869|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
83330870|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83330871|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330872|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83330873|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
83330874|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330875|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330876|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
83330877|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330878|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83330879|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330880|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
83330881|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330882|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83330883|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
83330884|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330885|NCT00993226|Bupivacaine|bupivacaine|mesh-list
83330886|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
83330887|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
83330888|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330889|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330890|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
83330891|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330892|NCT01885559|Telmisartan|telmisartan|mesh-list
83330893|NCT01885559|Lisinopril|lisinopril|mesh-list
83330894|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83330895|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83330896|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83330897|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83330898|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330899|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
83330900|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330901|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83330902|NCT01885559|Protective Agents|protective agents|mesh-ancestor
83330903|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330904|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
83330905|NCT00994318|Hematinics|hematinics|mesh-ancestor
83330906|NCT00995722|Prednisone|prednisone|mesh-list
83330907|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330908|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
83330909|NCT00995722|Hormones|hormones|mesh-ancestor
83330910|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83330911|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330912|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83330913|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330914|NCT00996346|Sirolimus|sirolimus|mesh-list
83330915|NCT00996346|Irinotecan|irinotecan|mesh-list
83330916|NCT00996346|Temsirolimus|temsirolimus|mesh-list
83330917|NCT00996346|MTOR Inhibitors|mtor inhibitors|mesh-list
83330918|NCT00996346|Complement Factor H|complement factor h|mesh-list
83330919|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83330920|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83330921|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330922|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330923|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330924|NCT00996346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330925|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330926|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
83330927|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330928|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83330929|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83330930|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83330931|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
83330932|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83330933|NCT03016468|Treprostinil|treprostinil|mesh-list
83330934|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83330935|NCT00997204|Icatibant|icatibant|mesh-list
83330936|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83330937|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83330938|NCT00997204|Analgesics|analgesics|mesh-ancestor
83330939|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
83330940|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330941|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330942|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83330943|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83330944|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83330945|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83330946|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330947|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83330948|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330949|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
83330950|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83330951|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
83330952|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83330953|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
83330954|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330955|NCT04225390|Dacarbazine|dacarbazine|mesh-list
83330956|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83330957|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
83330958|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330959|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330960|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
83330961|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
83330962|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83330963|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330964|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330965|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
83330966|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83330967|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83330968|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330969|NCT04606797|Nicotine|nicotine|mesh-list
83330970|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83330971|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
83330972|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83330973|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330974|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83330975|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83330976|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
83330977|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330978|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330979|NCT02164240|Sunitinib|sunitinib|mesh-list
83330980|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83330981|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83330982|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83330983|NCT02164240|Growth Substances|growth substances|mesh-ancestor
83330984|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330985|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
83330986|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83330987|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330988|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330989|NCT02169466|Opicapone|opicapone|mesh-list
83330990|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
83330991|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83330992|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83330993|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83330994|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83330995|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83330996|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
83330997|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83330998|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83330999|NCT01001806|Ketorolac|ketorolac|mesh-list
83331000|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83331001|NCT01001806|Nepafenac|nepafenac|mesh-list
83331002|NCT01001806|Bromfenac|bromfenac|mesh-list
83331003|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83331004|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83331005|NCT01001806|Analgesics|analgesics|mesh-ancestor
83331006|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
83331007|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331008|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331009|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331010|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331011|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83331012|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331013|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331014|NCT04021264|Sufentanil|sufentanil|mesh-list
83331015|NCT04021264|Ropivacaine|ropivacaine|mesh-list
83331016|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
83331017|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
83331018|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331019|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331020|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
83331021|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331022|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83331023|NCT04021264|Narcotics|narcotics|mesh-ancestor
83331024|NCT04021264|Analgesics|analgesics|mesh-ancestor
83331025|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83331026|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83331027|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
83331028|NCT03233139|Paclitaxel|paclitaxel|mesh-list
83331029|NCT03233139|Gemcitabine|gemcitabine|mesh-list
83331030|NCT03233139|Pemetrexed|pemetrexed|mesh-list
83331031|NCT03233139|Ipilimumab|ipilimumab|mesh-list
83331032|NCT03233139|Cemiplimab|cemiplimab|mesh-list
83331033|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83331034|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331035|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
83331036|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
83331037|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
83331038|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331039|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83331040|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
83331041|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331042|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83331043|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83331044|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331045|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331046|NCT04763343|Ketamine|ketamine|mesh-list
83331047|NCT04763343|Analgesics|analgesics|mesh-ancestor
83331048|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
83331049|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331050|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331051|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83331052|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83331053|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
83331054|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
83331055|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331056|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83331057|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83331058|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331059|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331060|NCT04757571|Paroxetine|paroxetine|mesh-list
83331061|NCT04757571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83331062|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83331063|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331064|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331065|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331066|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
83331067|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331068|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83331069|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
83331070|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83331071|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83331072|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83331073|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331074|NCT03232593|Atezolizumab|atezolizumab|mesh-list
83331075|NCT03232593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331076|NCT03232593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331077|NCT03232593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331078|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331079|NCT04746183|Ritonavir|ritonavir|mesh-list
83331080|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
83331081|NCT04746183|Favipiravir|favipiravir|mesh-list
83331082|NCT04746183|Nirmatrelvir|nirmatrelvir|mesh-list
83331083|NCT04746183|Sotrovimab|sotrovimab|mesh-list
83331084|NCT04746183|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
83331085|NCT04746183|Molnupiravir|molnupiravir|mesh-list
83331086|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83331087|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83331088|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
83331089|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331090|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331091|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83331092|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83331093|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
83331094|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331095|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83331096|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83331097|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83331098|NCT01895309|Etanercept|etanercept|mesh-list
83331099|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83331100|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83331101|NCT01895309|Analgesics|analgesics|mesh-ancestor
83331102|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
83331103|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331104|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331105|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331106|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331107|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83331108|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331109|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
83331110|NCT04614311|Triamcinolone|triamcinolone|mesh-list
83331111|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83331112|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83331113|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83331114|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331115|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
83331116|NCT04614311|Hormones|hormones|mesh-ancestor
83331117|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331118|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331119|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331120|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
83331121|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331122|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331123|NCT03681639|Cobalt|cobalt|mesh-list
83331124|NCT03681639|Chromium|chromium|mesh-list
83331125|NCT03681639|Trace Elements|trace elements|mesh-ancestor
83331126|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
83331127|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331128|NCT03285321|Nivolumab|nivolumab|mesh-list
83331129|NCT03285321|Ipilimumab|ipilimumab|mesh-list
83331130|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331131|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331132|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331133|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331134|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83331135|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83331136|NCT04323748|Rituximab|rituximab|mesh-list
83331137|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331138|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331139|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
83331140|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331141|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331142|NCT04197310|Nivolumab|nivolumab|mesh-list
83331143|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331144|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331145|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331146|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331147|NCT05320731|Lidocaine|lidocaine|mesh-list
83331148|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
83331149|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
83331150|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331151|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331152|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
83331153|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331154|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83331155|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83331156|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83331157|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331158|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331159|NCT02808364|Vaccines|vaccines|mesh-list
83331160|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
83331161|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331162|NCT02709616|Vaccines|vaccines|mesh-list
83331163|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
83331164|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331165|NCT04534881|Progesterone|progesterone|mesh-list
83331166|NCT04534881|Progestins|progestins|mesh-ancestor
83331167|NCT04534881|Hormones|hormones|mesh-ancestor
83331168|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331169|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331170|NCT04817956|Trastuzumab|trastuzumab|mesh-list
83331171|NCT04817956|Atezolizumab|atezolizumab|mesh-list
83331172|NCT04817956|Pertuzumab|pertuzumab|mesh-list
83331173|NCT04817956|Vemurafenib|vemurafenib|mesh-list
83331174|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83331175|NCT04817956|Entrectinib|entrectinib|mesh-list
83331176|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331177|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331178|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331179|NCT04817956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331180|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331181|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
83331182|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83331183|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331184|NCT01894919|Vaccines|vaccines|mesh-list
83331185|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
83331186|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331187|NCT04130698|Nicotine|nicotine|mesh-list
83331188|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83331189|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
83331190|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331191|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331192|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83331193|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83331194|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
83331195|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331196|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331197|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83331198|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83331199|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331200|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331201|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
83331202|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331203|NCT05306223|Levofloxacin|levofloxacin|mesh-list
83331204|NCT05306223|Cycloserine|cycloserine|mesh-list
83331205|NCT05306223|Linezolid|linezolid|mesh-list
83331206|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
83331207|NCT05306223|Bedaquiline|bedaquiline|mesh-list
83331208|NCT05306223|Clofazimine|clofazimine|mesh-list
83331209|NCT05306223|Prothionamide|prothionamide|mesh-list
83331210|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83331211|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331212|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83331213|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83331214|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83331215|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331216|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331217|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331218|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83331219|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83331220|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83331221|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83331222|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
83331223|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
83331224|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331225|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
83331226|NCT03016000|Thalidomide|thalidomide|mesh-list
83331227|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331228|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
83331229|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331230|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
83331231|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83331232|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331233|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83331234|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83331235|NCT03016000|Growth Substances|growth substances|mesh-ancestor
83331236|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
83331237|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331238|NCT04130152|Letrozole|letrozole|mesh-list
83331239|NCT04130152|Palbociclib|palbociclib|mesh-list
83331240|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331241|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83331242|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83331243|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331244|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331245|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83331246|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
83331247|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331248|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331249|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83331250|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
83331251|NCT03254589|Methotrexate|methotrexate|mesh-list
83331252|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83331253|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
83331254|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83331255|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331256|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83331257|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
83331258|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331259|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331260|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
83331261|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331262|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83331263|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331264|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
83331265|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331266|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83331267|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331268|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83331269|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83331270|NCT03254589|Analgesics|analgesics|mesh-ancestor
83331271|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
83331272|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331273|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331274|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83331275|NCT04399395|Naltrexone|naltrexone|mesh-list
83331276|NCT04399395|Bupropion|bupropion|mesh-list
83331277|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83331278|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83331279|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331280|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
83331281|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331282|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83331283|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
83331284|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83331285|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83331286|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83331287|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331288|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331289|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
83331290|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331291|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83331292|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83331293|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331294|NCT04613453|Midazolam|midazolam|mesh-list
83331295|NCT04613453|Ketamine|ketamine|mesh-list
83331296|NCT04613453|Analgesics|analgesics|mesh-ancestor
83331297|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
83331298|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331299|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331300|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83331301|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83331302|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
83331303|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
83331304|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331305|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83331306|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83331307|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331308|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331309|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83331310|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83331311|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83331312|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83331313|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83331314|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
83331315|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
83331316|NCT02000596|Trastuzumab|trastuzumab|mesh-list
83331317|NCT02000596|Pertuzumab|pertuzumab|mesh-list
83331318|NCT02000596|Fulvestrant|fulvestrant|mesh-list
83331319|NCT02000596|Anastrozole|anastrozole|mesh-list
83331320|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331321|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331322|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83331323|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83331324|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83331325|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
83331326|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331327|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331328|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83331329|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83331330|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331331|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331332|NCT03223779|Trifluridine|trifluridine|mesh-list
83331333|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
83331334|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331335|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
83331336|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331337|NCT05168865|Letrozole|letrozole|mesh-list
83331338|NCT05168865|Estradiol|estradiol|mesh-list
83331339|NCT05168865|Progesterone|progesterone|mesh-list
83331340|NCT05168865|Estrogens|estrogens|mesh-ancestor
83331341|NCT05168865|Hormones|hormones|mesh-ancestor
83331342|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331343|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331344|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331345|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83331346|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83331347|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331348|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331349|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83331350|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
83331351|NCT05168865|Progestins|progestins|mesh-ancestor
83331352|NCT01882985|Lycopene|lycopene|mesh-list
83331353|NCT01882985|Docetaxel|docetaxel|mesh-list
83331354|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331355|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
83331356|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
83331357|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
83331358|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331359|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331360|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
83331361|NCT01882985|Protective Agents|protective agents|mesh-ancestor
83331362|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331363|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83331364|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83331365|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
83331366|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83331367|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331368|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331369|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83331370|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
83331371|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331372|NCT03015922|Lenalidomide|lenalidomide|mesh-list
83331373|NCT03015922|Pomalidomide|pomalidomide|mesh-list
83331374|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
83331376|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83331377|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83331378|NCT03015922|Growth Substances|growth substances|mesh-ancestor
83331379|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
83331380|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331381|NCT01893827|Naltrexone|naltrexone|mesh-list
83331382|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83331383|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83331384|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331385|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
83331386|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331387|NCT01882907|Pioglitazone|pioglitazone|mesh-list
83331388|NCT01882907|Vildagliptin|vildagliptin|mesh-list
83331389|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83331390|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331391|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83331392|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
83331393|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331394|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331395|NCT01051570|Prednisone|prednisone|mesh-list
83331396|NCT01051570|Carboplatin|carboplatin|mesh-list
83331397|NCT01051570|Everolimus|everolimus|mesh-list
83331398|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331399|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331400|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
83331401|NCT01051570|Hormones|hormones|mesh-ancestor
83331402|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331403|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331404|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83331406|NCT01051570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83331407|NCT01051570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331408|NCT01051570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331409|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331410|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
83331411|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
83331412|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83331413|NCT01893281|Testosterone|testosterone|mesh-list
83331414|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
83331415|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
83331416|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83331417|NCT01893281|Androgens|androgens|mesh-ancestor
83331418|NCT01893281|Hormones|hormones|mesh-ancestor
83331419|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331420|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331421|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83331422|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331423|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
83331424|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83331425|NCT02981446|Latanoprost|latanoprost|mesh-list
83331426|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83331427|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83331428|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83331429|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
83331430|NCT05263947|Bevacizumab|bevacizumab|mesh-list
83331431|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331432|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331433|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83331434|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83331435|NCT05263947|Growth Substances|growth substances|mesh-ancestor
83331436|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331437|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
83331438|NCT04415567|Lenvatinib|lenvatinib|mesh-list
83331439|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331440|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83331441|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331442|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331443|NCT03280251|Methylphenidate|methylphenidate|mesh-list
83331444|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83331445|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331446|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83331447|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83331448|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331449|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331450|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
83331451|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331452|NCT01882829|Quinidine|quinidine|mesh-list
83331453|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
83331454|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
83331455|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
83331456|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83331457|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83331458|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331459|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331460|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331461|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83331462|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83331463|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
83331464|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83331465|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
83331466|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83331467|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83331468|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331469|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331470|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83331471|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83331472|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
83331473|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83331474|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83331475|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331476|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83331477|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83331478|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
83331479|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83331480|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83331481|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331482|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
83331483|NCT04760301|Coagulants|coagulants|mesh-ancestor
83331484|NCT04392375|Nifedipine|nifedipine|mesh-list
83331485|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83331486|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331487|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331488|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83331489|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331490|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
83331491|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
83331492|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83331493|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
83331494|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
83331495|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
83331496|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331497|NCT01054768|Protective Agents|protective agents|mesh-ancestor
83331498|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331499|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
83331500|NCT01054768|Vitamins|vitamins|mesh-ancestor
83331501|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
83331502|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
83331503|NCT04387617|Cannabidiol|cannabidiol|mesh-list
83331504|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
83331505|NCT03014830|Alirocumab|alirocumab|mesh-list
83331506|NCT03014830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83331507|NCT03014830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83331508|NCT03014830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83331509|NCT03014830|Antimetabolites|antimetabolites|mesh-ancestor
83331510|NCT03014830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331511|NCT03014830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83331512|NCT03014830|Protease Inhibitors|protease inhibitors|mesh-ancestor
83331513|NCT03014830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331514|NCT03014830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83331515|NCT01055704|Naltrexone|naltrexone|mesh-list
83331516|NCT01055704|Codeine|codeine|mesh-list
83331517|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
83331518|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83331519|NCT01055704|Narcotics|narcotics|mesh-ancestor
83331520|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331521|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331522|NCT01055704|Analgesics|analgesics|mesh-ancestor
83331523|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
83331524|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331525|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
83331526|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
83331527|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83331528|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83331529|NCT03280017|Ketamine|ketamine|mesh-list
83331530|NCT03280017|Analgesics|analgesics|mesh-ancestor
83331531|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
83331532|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331533|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331534|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83331535|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83331536|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
83331537|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
83331538|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331539|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83331540|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83331541|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331542|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331543|NCT01882439|Tofacitinib|tofacitinib|mesh-list
83331544|NCT01882439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83331545|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83331546|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331547|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331548|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
83331549|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
83331550|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83331551|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83331552|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331553|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331554|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331555|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331557|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83331558|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331559|NCT03915405|Avelumab|avelumab|mesh-list
83331560|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331561|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331562|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83331563|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
83331564|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331565|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331566|NCT01109056|Cyclosporine|cyclosporine|mesh-list
83331567|NCT01109056|Cyclosporins|cyclosporins|mesh-list
83331568|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331569|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331570|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331571|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
83331572|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331573|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
83331574|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331575|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83331576|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331577|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83331578|NCT03870399|Tamoxifen|tamoxifen|mesh-list
83331579|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83331580|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
83331581|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331582|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331583|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83331584|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331585|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83331586|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83331587|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83331588|NCT03867201|Erenumab|erenumab|mesh-list
83331589|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
83331590|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331591|NCT03867201|Analgesics|analgesics|mesh-ancestor
83331592|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
83331593|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331594|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331595|NCT04333407|Aspirin|aspirin|mesh-list
83331596|NCT04333407|Omeprazole|omeprazole|mesh-list
83331597|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
83331598|NCT04333407|Clopidogrel|clopidogrel|mesh-list
83331600|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83331601|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83331602|NCT04333407|Analgesics|analgesics|mesh-ancestor
83331603|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
83331604|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331605|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331606|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331607|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331608|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83331609|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83331610|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331611|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83331612|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83331613|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331614|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
83331615|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83331616|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83331617|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
83331618|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83331619|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83331620|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83331621|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83331622|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83331623|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
83331624|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331625|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83331626|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
83331627|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83331628|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
83331629|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
83331630|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83331631|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83331632|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83331633|NCT04398927|Folfirinox|folfirinox|mesh-list
83331634|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331635|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
83331636|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83331637|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83331638|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
83331639|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331640|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83331641|NCT04399083|Caffeine|caffeine|mesh-list
83331642|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83331643|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331644|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83331645|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331646|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331647|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83331648|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83331649|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
83331650|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331651|NCT01892345|Eculizumab|eculizumab|mesh-list
83331652|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83331653|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331654|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
83331655|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331656|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
83331657|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
83331658|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83331659|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83331660|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331661|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331662|NCT01059994|Urological Agents|urological agents|mesh-ancestor
83331663|NCT01111318|Empagliflozin|empagliflozin|mesh-list
83331664|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83331665|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331666|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83331667|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331668|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
83331669|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331670|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331671|NCT05165433|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331672|NCT05165433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331673|NCT01892189|Ketamine|ketamine|mesh-list
83331674|NCT01892189|Analgesics|analgesics|mesh-ancestor
83331675|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
83331676|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331677|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331678|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83331679|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83331680|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
83331681|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
83331682|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331683|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83331684|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83331685|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331686|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331687|NCT01062568|Dexamethasone|dexamethasone|mesh-list
83331688|NCT01062568|Cosyntropin|cosyntropin|mesh-list
83331689|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83331690|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83331691|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
83331692|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331694|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
83331695|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331696|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331697|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83331698|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
83331699|NCT01062568|Hormones|hormones|mesh-ancestor
83331700|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331701|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83331702|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331703|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331704|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331705|NCT05155137|Amlodipine|amlodipine|mesh-list
83331706|NCT05155137|Valsartan|valsartan|mesh-list
83331707|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83331708|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83331709|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83331710|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331711|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331712|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83331713|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331714|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
83331715|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83331716|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83331717|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
83331718|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83331719|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83331720|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331721|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83331722|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83331723|NCT01064284|Factor VIII|factor viii|mesh-list
83331724|NCT01064284|Coagulants|coagulants|mesh-ancestor
83331725|NCT01064362|Heparin|heparin|mesh-list
83331726|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83331727|NCT01064362|Tinzaparin|tinzaparin|mesh-list
83331728|NCT01064362|Dalteparin|dalteparin|mesh-list
83331729|NCT01064362|PENTA|penta|mesh-list
83331730|NCT01064362|Fondaparinux|fondaparinux|mesh-list
83331731|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
83331732|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83331733|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83331734|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331735|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83331736|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
83331737|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83331738|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
83331739|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331740|NCT03646461|Nivolumab|nivolumab|mesh-list
83331741|NCT03646461|Cetuximab|cetuximab|mesh-list
83331742|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331743|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331744|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331745|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331746|NCT01880957|Lamotrigine|lamotrigine|mesh-list
83331747|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
83331748|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
83331749|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83331750|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331751|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331752|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
83331753|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83331754|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331755|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331756|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
83331757|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83331758|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331759|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83331760|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83331761|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83331762|NCT01064830|Cyclosporine|cyclosporine|mesh-list
83331763|NCT01064830|Cyclosporins|cyclosporins|mesh-list
83331764|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331765|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331766|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331767|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
83331768|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331769|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
83331770|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331771|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
83331772|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331773|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83331774|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83331775|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83331776|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331777|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83331778|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83331779|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331780|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331781|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
83331782|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331783|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83331784|NCT01066624|Calcium|calcium|mesh-list
83331785|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83331786|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331787|NCT04398771|Valsartan|valsartan|mesh-list
83331788|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83331789|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83331790|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83331791|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
83331792|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331793|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83331794|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83331795|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331796|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83331797|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83331798|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83331799|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83331800|NCT01863953|Bimatoprost|bimatoprost|mesh-list
83331801|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83331802|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83331803|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83331804|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83331805|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83331806|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83331807|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
83331808|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331809|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331810|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331811|NCT01068964|Timolol|timolol|mesh-list
83331812|NCT01068964|Bimatoprost|bimatoprost|mesh-list
83331813|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83331814|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83331815|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83331816|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83331817|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
83331818|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331819|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331820|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331821|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83331822|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83331823|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83331824|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
83331825|NCT05111145|Ivacaftor|ivacaftor|mesh-list
83331826|NCT05111145|Elexacaftor|elexacaftor|mesh-list
83331827|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83331828|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331829|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331830|NCT02984475|Metformin|metformin|mesh-list
83331831|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83331832|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331833|NCT01069354|Lidocaine|lidocaine|mesh-list
83331834|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
83331835|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
83331836|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331837|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331838|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
83331839|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331840|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83331841|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83331842|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83331843|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331844|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331846|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83331847|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331848|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83331849|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331850|NCT01069510|Spironolactone|spironolactone|mesh-list
83331851|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83331852|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
83331853|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83331854|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331855|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83331856|NCT01069510|Diuretics|diuretics|mesh-ancestor
83331857|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
83331858|NCT04278495|Losartan|losartan|mesh-list
83331859|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83331860|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83331861|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83331862|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83331863|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331864|NCT04276545|Midazolam|midazolam|mesh-list
83331865|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83331866|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83331867|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331868|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331869|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83331870|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83331871|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83331872|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83331873|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
83331874|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
83331875|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
83331876|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
83331877|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331878|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331879|NCT01117948|Lornoxicam|lornoxicam|mesh-list
83331880|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83331881|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83331882|NCT01117948|Analgesics|analgesics|mesh-ancestor
83331883|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
83331884|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331885|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331886|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83331887|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331888|NCT03602157|Fludarabine|fludarabine|mesh-list
83331889|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83331890|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331891|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331892|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83331893|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
83331894|NCT03014440|Cannabidiol|cannabidiol|mesh-list
83331895|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
83331896|NCT03013036|Fentanyl|fentanyl|mesh-list
83331897|NCT03013036|Midazolam|midazolam|mesh-list
83331898|NCT03013036|Propofol|propofol|mesh-list
83331899|NCT03013036|Sevoflurane|sevoflurane|mesh-list
83331900|NCT03013036|Rocuronium|rocuronium|mesh-list
83331901|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83331902|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331903|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331904|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83331905|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
83331906|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
83331907|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83331908|NCT03013036|Narcotics|narcotics|mesh-ancestor
83331909|NCT03013036|Analgesics|analgesics|mesh-ancestor
83331910|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
83331911|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331912|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83331913|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83331914|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83331915|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83331916|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
83331917|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
83331918|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331919|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331920|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83331921|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83331922|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83331923|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83331924|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83331925|NCT01071538|Buprenorphine|buprenorphine|mesh-list
83331926|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83331927|NCT01071538|Narcotics|narcotics|mesh-ancestor
83331928|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331929|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331930|NCT01071538|Analgesics|analgesics|mesh-ancestor
83331931|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
83331932|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83331933|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83331934|NCT04352686|Buspirone|buspirone|mesh-list
83331935|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83331936|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83331937|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83331938|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331939|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83331940|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83331941|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
83331942|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83331943|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331944|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83331945|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331946|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
83331947|NCT02287311|Fludarabine|fludarabine|mesh-list
83331948|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83331949|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
83331950|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331951|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83331952|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83331953|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
83331954|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331955|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331956|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83331957|NCT02172742|Digoxin|digoxin|mesh-list
83331958|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83331959|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83331960|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83331961|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331962|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331963|NCT02172742|Protective Agents|protective agents|mesh-ancestor
83331964|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83331965|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
83331966|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83331967|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83331968|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83331969|NCT01075204|Clarithromycin|clarithromycin|mesh-list
83331970|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83331971|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83331972|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83331973|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331974|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331975|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83331976|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83331978|NCT01120834|Vorinostat|vorinostat|mesh-list
83331979|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83331980|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
83331981|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331982|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83331983|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331984|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83331985|NCT01122160|Omeprazole|omeprazole|mesh-list
83331986|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83331987|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83331988|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83331989|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331990|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331991|NCT02623816|Omeprazole|omeprazole|mesh-list
83331992|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83331993|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83331994|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83331995|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83331996|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83331997|NCT01122238|Nicotine|nicotine|mesh-list
83331998|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83331999|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
83332000|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332001|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332002|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83332003|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83332004|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
83332005|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332006|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332007|NCT01122316|Metformin|metformin|mesh-list
83332008|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83332009|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332010|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
83332011|NCT03049449|Fludarabine|fludarabine|mesh-list
83332012|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332013|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
83332014|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332015|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332016|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83332017|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
83332018|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332019|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332020|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83332021|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83332022|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83332023|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332024|NCT02399943|Panitumumab|panitumumab|mesh-list
83332025|NCT02399943|Trametinib|trametinib|mesh-list
83332026|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332027|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332028|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83332029|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332030|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332031|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
83332032|NCT03186027|Ubiquinone|ubiquinone|mesh-list
83332033|NCT03186027|Vitamins|vitamins|mesh-ancestor
83332034|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
83332035|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332036|NCT02595892|Gemcitabine|gemcitabine|mesh-list
83332037|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83332038|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
83332039|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332040|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332041|NCT04397913|Acetaminophen|acetaminophen|mesh-list
83332042|NCT04397913|Ibuprofen|ibuprofen|mesh-list
83332043|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332044|NCT04397913|Analgesics|analgesics|mesh-ancestor
83332045|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
83332046|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332047|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332048|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
83332049|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83332051|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332052|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83332053|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332054|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332055|NCT02176486|Ixazomib|ixazomib|mesh-list
83332056|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332057|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
83332058|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332059|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332060|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83332061|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83332062|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83332063|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83332064|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332065|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332066|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332067|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83332068|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
83332069|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83332070|NCT03013114|Bortezomib|bortezomib|mesh-list
83332071|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332072|NCT01077310|Naltrexone|naltrexone|mesh-list
83332073|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83332074|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83332075|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332076|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
83332077|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332078|NCT02989857|Ivosidenib|ivosidenib|mesh-list
83332079|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332080|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332081|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332082|NCT02393937|Metronidazole|metronidazole|mesh-list
83332083|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332084|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83332085|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83332086|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83332087|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
83332088|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83332089|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
83332090|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83332091|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
83332092|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332093|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332094|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
83332095|NCT04397601|Bevacizumab|bevacizumab|mesh-list
83332096|NCT04397601|Aflibercept|aflibercept|mesh-list
83332097|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332098|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332099|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83332100|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83332101|NCT04397601|Growth Substances|growth substances|mesh-ancestor
83332102|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332103|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
83332104|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
83332105|NCT02870829|Vitamin K|vitamin k|mesh-list
83332106|NCT02870829|Menaquinone 7|menaquinone 7|mesh-list
83332107|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83332108|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83332109|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332110|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
83332111|NCT02870829|Coagulants|coagulants|mesh-ancestor
83332112|NCT02870829|Vitamins|vitamins|mesh-ancestor
83332113|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
83332114|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332115|NCT01876823|Memantine|memantine|mesh-list
83332116|NCT01876823|Citalopram|citalopram|mesh-list
83332117|NCT01876823|Escitalopram|escitalopram|mesh-list
83332118|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83332119|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83332120|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
83332121|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332122|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332123|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332124|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83332125|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83332126|NCT01876823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83332127|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83332128|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83332129|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
83332130|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83332131|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
83332132|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83332133|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
83332134|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332135|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332136|NCT01876511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83332137|NCT01876511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332138|NCT01993719|Vidarabine|vidarabine|mesh-list
83332139|NCT01993719|Aldesleukin|aldesleukin|mesh-list
83332140|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
83332141|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
83332142|NCT01993719|Fludarabine|fludarabine|mesh-list
83332143|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
83332144|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332145|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
83332146|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332147|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332148|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83332149|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
83332150|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332151|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332152|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83332153|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332154|NCT01993719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83332155|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83332156|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
83332157|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
83332158|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332159|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83332160|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83332161|NCT02758665|Venetoclax|venetoclax|mesh-list
83332162|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
83332163|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332164|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332165|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83332166|NCT03182673|Fluzoparib|fluzoparib|mesh-list
83332167|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332168|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332169|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332170|NCT00638157|Gentamicins|gentamicins|mesh-list
83332171|NCT00638157|Daptomycin|daptomycin|mesh-list
83332172|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83332173|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332174|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83332175|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332176|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332177|NCT02530437|Paclitaxel|paclitaxel|mesh-list
83332178|NCT02530437|Carboplatin|carboplatin|mesh-list
83332179|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83332180|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83332181|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332182|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
83332183|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
83332184|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
83332185|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332186|NCT00637377|Ranibizumab|ranibizumab|mesh-list
83332187|NCT00637377|Aflibercept|aflibercept|mesh-list
83332188|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83332189|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83332190|NCT00637377|Growth Substances|growth substances|mesh-ancestor
83332191|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332192|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
83332193|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332194|NCT01787409|Vitamin D|vitamin d|mesh-list
83332195|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
83332196|NCT01787409|Vitamins|vitamins|mesh-ancestor
83332197|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
83332198|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332199|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83332200|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83332201|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
83332202|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332203|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83332204|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332205|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332206|NCT05307718|Anticoagulants|anticoagulants|mesh-list
83332207|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
83332208|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83332209|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83332210|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
83332211|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83332212|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83332213|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
83332214|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332215|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332216|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83332217|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83332218|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83332219|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
83332220|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332221|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332222|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
83332223|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83332224|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
83332225|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
83332226|NCT01033864|Prednisone|prednisone|mesh-list
83332227|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332228|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
83332229|NCT01033864|Hormones|hormones|mesh-ancestor
83332230|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332231|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332232|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332233|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332234|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83332235|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83332236|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
83332237|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83332238|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332239|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332240|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332241|NCT01082380|Crizotinib|crizotinib|mesh-list
83332242|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332243|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83332244|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332245|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332246|NCT01083706|Azacitidine|azacitidine|mesh-list
83332247|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83332248|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
83332249|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332250|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332251|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332252|NCT01035346|Ibuprofen|ibuprofen|mesh-list
83332253|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83332254|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332255|NCT01035346|Analgesics|analgesics|mesh-ancestor
83332256|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
83332257|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332258|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332259|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332260|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332261|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83332263|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332264|NCT01085344|Factor VIII|factor viii|mesh-list
83332265|NCT01085344|Coagulants|coagulants|mesh-ancestor
83332266|NCT01035658|Doxorubicin|doxorubicin|mesh-list
83332267|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83332268|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83332269|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332270|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83332271|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83332272|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332273|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332274|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
83332275|NCT01037452|Lansoprazole|lansoprazole|mesh-list
83332276|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
83332277|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
83332278|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83332279|NCT01037452|Calcium|calcium|mesh-list
83332280|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83332281|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332282|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83332283|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83332284|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83332285|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83332286|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332287|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332288|NCT01037452|Antacids|antacids|mesh-ancestor
83332289|NCT03012646|Treprostinil|treprostinil|mesh-list
83332290|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83332291|NCT05289856|Avelumab|avelumab|mesh-list
83332292|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332293|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332294|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
83332295|NCT00636441|Docetaxel|docetaxel|mesh-list
83332296|NCT00636441|Doxorubicin|doxorubicin|mesh-list
83332297|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83332298|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332299|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
83332300|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332301|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332302|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83332303|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
83332304|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332305|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332306|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83332307|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
83332308|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
83332309|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
83332310|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83332311|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83332312|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83332313|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332314|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83332315|NCT02984397|Ketotifen|ketotifen|mesh-list
83332316|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
83332317|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
83332318|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83332319|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
83332320|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
83332321|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332322|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332323|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332324|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83332325|NCT01922427|RNS60|rns60|mesh-list
83332326|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83332327|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332328|NCT01922427|Analgesics|analgesics|mesh-ancestor
83332329|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
83332330|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332331|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332332|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332333|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332334|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83332335|NCT01088464|Necitumumab|necitumumab|mesh-list
83332336|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83332337|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332338|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332339|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
83332340|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332341|NCT01090180|Dexamethasone|dexamethasone|mesh-list
83332342|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332343|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
83332344|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
83332345|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332346|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332347|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83332348|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
83332349|NCT01090180|Hormones|hormones|mesh-ancestor
83332350|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332351|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332352|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332353|NCT00636207|Montelukast|montelukast|mesh-list
83332354|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83332355|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
83332356|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83332357|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
83332358|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332359|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332360|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83332361|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83332362|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332363|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
83332364|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83332365|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83332366|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332367|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83332368|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332369|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
83332370|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332371|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
83332372|NCT03169881|Hematinics|hematinics|mesh-ancestor
83332373|NCT01092676|Ibuprofen|ibuprofen|mesh-list
83332374|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83332375|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332376|NCT01092676|Analgesics|analgesics|mesh-ancestor
83332377|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
83332378|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332379|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332380|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332381|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332382|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83332383|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332384|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332385|NCT05273320|Dronabinol|dronabinol|mesh-list
83332386|NCT05273320|Nabilone|nabilone|mesh-list
83332387|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
83332388|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
83332389|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332390|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332391|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83332392|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83332393|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83332394|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83332395|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83332396|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
83332397|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332398|NCT05273320|Analgesics|analgesics|mesh-ancestor
83332399|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
83332400|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83332401|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83332402|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332403|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332404|NCT05273320|Hormones|hormones|mesh-ancestor
83332405|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332406|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
83332407|NCT01039792|Vitamins|vitamins|mesh-ancestor
83332408|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
83332409|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332410|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
83332412|NCT01041274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83332413|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83332414|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83332415|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332416|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332417|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
83332418|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332419|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83332420|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
83332421|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83332422|NCT00635349|Acetaminophen|acetaminophen|mesh-list
83332423|NCT00635349|Meloxicam|meloxicam|mesh-list
83332424|NCT00635349|Aceclofenac|aceclofenac|mesh-list
83332425|NCT00635349|Tramadol|tramadol|mesh-list
83332426|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332427|NCT00635349|Analgesics|analgesics|mesh-ancestor
83332428|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
83332429|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332430|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332431|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
83332432|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83332433|NCT00635349|Narcotics|narcotics|mesh-ancestor
83332434|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83332435|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83332436|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332437|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332438|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83332439|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83332440|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332441|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332442|NCT00634803|Buprenorphine|buprenorphine|mesh-list
83332443|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83332444|NCT00634803|Narcotics|narcotics|mesh-ancestor
83332445|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83332446|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332447|NCT00634803|Analgesics|analgesics|mesh-ancestor
83332448|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
83332449|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332450|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83332451|NCT01042288|Carboplatin|carboplatin|mesh-list
83332452|NCT01042288|Pemetrexed|pemetrexed|mesh-list
83332453|NCT01042288|Panitumumab|panitumumab|mesh-list
83332454|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332455|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332456|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332457|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83332458|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83332459|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332460|NCT01043926|Suvorexant|suvorexant|mesh-list
83332461|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83332462|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83332463|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83332464|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332465|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83332466|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332467|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332468|NCT01044706|Bicalutamide|bicalutamide|mesh-list
83332469|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
83332470|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
83332471|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332472|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332473|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332474|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
83332475|NCT04447534|Chloroquine|chloroquine|mesh-list
83332476|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83332477|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
83332478|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83332479|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83332480|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332481|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332482|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332483|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332484|NCT04447534|Amebicides|amebicides|mesh-ancestor
83332485|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83332486|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332487|NCT04447534|Analgesics|analgesics|mesh-ancestor
83332488|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
83332489|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332490|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332491|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332492|NCT04447534|Filaricides|filaricides|mesh-ancestor
83332493|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
83332494|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
83332495|NCT01044862|Letrozole|letrozole|mesh-list
83332496|NCT01044862|Clomiphene|clomiphene|mesh-list
83332497|NCT01044862|Enclomiphene|enclomiphene|mesh-list
83332498|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
83332499|NCT01044862|Hormones|hormones|mesh-list
83332500|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83332501|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83332502|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332503|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332504|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332505|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332506|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83332507|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332508|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83332509|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
83332510|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83332511|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
83332512|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83332513|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83332514|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83332515|NCT04361656|Lubiprostone|lubiprostone|mesh-list
83332516|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83332517|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83332518|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332519|NCT01047358|Exemestane|exemestane|mesh-list
83332520|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332521|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83332522|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83332523|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332524|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332525|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83332526|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
83332527|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332528|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332529|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
83332530|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83332531|NCT01048606|Estrogens|estrogens|mesh-ancestor
83332532|NCT01048606|Hormones|hormones|mesh-ancestor
83332533|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332534|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332535|NCT04224766|Bupivacaine|bupivacaine|mesh-list
83332536|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
83332537|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
83332538|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83332539|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332540|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
83332541|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332542|NCT01772004|Avelumab|avelumab|mesh-list
83332543|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332544|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332545|NCT02930044|Insulin|insulin|mesh-list
83332546|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83332547|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
83332548|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83332549|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332550|NCT03683524|Dolutegravir|dolutegravir|mesh-list
83332551|NCT03683524|Darunavir|darunavir|mesh-list
83332552|NCT03683524|Cobicistat|cobicistat|mesh-list
83332553|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83332554|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83332555|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83332556|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332557|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332558|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83332559|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83332560|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
83332561|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332562|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83332563|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83332564|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
83332565|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83332566|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83332567|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
83332568|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83332569|NCT02246842|Antibodies|antibodies|mesh-list
83332570|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83332571|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
83332572|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
83332573|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332574|NCT02623426|Dexamethasone|dexamethasone|mesh-list
83332575|NCT02623426|Methotrexate|methotrexate|mesh-list
83332576|NCT02623426|Ranibizumab|ranibizumab|mesh-list
83332577|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332578|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
83332579|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
83332580|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332581|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332582|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83332583|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
83332584|NCT02623426|Hormones|hormones|mesh-ancestor
83332585|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332586|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332587|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332588|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83332589|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
83332590|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83332591|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83332592|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
83332593|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332594|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83332595|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332596|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83332597|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332598|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
83332599|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332600|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83332601|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83332602|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83332603|NCT02623426|Growth Substances|growth substances|mesh-ancestor
83332604|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
83332605|NCT02182492|Clarithromycin|clarithromycin|mesh-list
83332606|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
83332607|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83332608|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332609|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83332610|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332611|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332612|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83332613|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83332614|NCT02182492|Hormones|hormones|mesh-ancestor
83332615|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332616|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332618|NCT01163656|Trace Elements|trace elements|mesh-ancestor
83332619|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
83332620|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332621|NCT01165840|Dapsone|dapsone|mesh-list
83332622|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332623|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
83332624|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83332625|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83332626|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83332627|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332628|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332629|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
83332630|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83332631|NCT00952692|Lapatinib|lapatinib|mesh-list
83332632|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332633|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83332634|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332635|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332636|NCT03535506|Palbociclib|palbociclib|mesh-list
83332637|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332638|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83332639|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332640|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332641|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
83332642|NCT01170754|Laxatives|laxatives|mesh-ancestor
83332643|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83332644|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83332645|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
83332646|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
83332647|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332648|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
83332649|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332650|NCT01131052|Insulin|insulin|mesh-list
83332651|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83332652|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
83332653|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
83332654|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83332655|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332656|NCT01379274|Lenalidomide|lenalidomide|mesh-list
83332657|NCT01379274|Azacitidine|azacitidine|mesh-list
83332658|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
83332659|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332660|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83332661|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83332662|NCT01379274|Growth Substances|growth substances|mesh-ancestor
83332663|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
83332664|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332665|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83332666|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
83332667|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332668|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332669|NCT01171690|Teriparatide|teriparatide|mesh-list
83332670|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83332671|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332672|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83332673|NCT05396742|Ravulizumab|ravulizumab|mesh-list
83332674|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83332675|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332676|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
83332677|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332678|NCT05389176|Esmolol|esmolol|mesh-list
83332679|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83332680|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83332681|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83332682|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
83332683|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332684|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332685|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332686|NCT01132846|Dopamine|dopamine|mesh-list
83332687|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83332688|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83332689|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
83332690|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
83332691|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332692|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332693|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
83332694|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332695|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332696|NCT01132846|Protective Agents|protective agents|mesh-ancestor
83332697|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
83332699|NCT01133158|Rituximab|rituximab|mesh-list
83332700|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83332701|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
83332702|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332703|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332704|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
83332705|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332706|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332707|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332708|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
83332709|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
83332710|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332722|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83332723|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332724|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83332725|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83332726|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332727|NCT04092894|Suvorexant|suvorexant|mesh-list
83332728|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83332729|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83332730|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83332731|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332732|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83332733|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332734|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332735|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
83332736|NCT01134952|Sirolimus|sirolimus|mesh-list
83332737|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83332738|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332739|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83332740|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
83332741|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83332742|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332743|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332744|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332745|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
83332746|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332747|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
83332748|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332749|NCT01175902|Timolol|timolol|mesh-list
83332750|NCT01175902|Dorzolamide|dorzolamide|mesh-list
83332751|NCT01175902|Latanoprost|latanoprost|mesh-list
83332752|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83332753|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83332754|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
83332755|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332756|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332757|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332758|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83332759|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83332760|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83332761|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83332762|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83332763|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332764|NCT01135186|Verapamil|verapamil|mesh-list
83332765|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83332766|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83332767|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83332768|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332769|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83332770|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332771|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
83332792|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332793|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83332794|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332795|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332797|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
83332798|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
83332799|NCT05164770|Vincristine|vincristine|mesh-list
83332800|NCT05164770|Rituximab|rituximab|mesh-list
83332801|NCT05164770|Doxorubicin|doxorubicin|mesh-list
83332802|NCT05164770|Etoposide|etoposide|mesh-list
83332803|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332804|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83332805|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332806|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332807|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332808|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
83332809|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332810|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332811|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83332812|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
83332813|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83332814|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332815|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
83332816|NCT05164770|Hormones|hormones|mesh-ancestor
83332817|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332818|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332819|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83332820|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
83332821|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
83332822|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
83332823|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332824|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83332825|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83332826|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83332827|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
83332828|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83332829|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83332830|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
83332831|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332832|NCT01175980|Vorinostat|vorinostat|mesh-list
83332833|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332834|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83332835|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332836|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332837|NCT04246554|Acetaminophen|acetaminophen|mesh-list
83332838|NCT04246554|Ketorolac|ketorolac|mesh-list
83332839|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83332840|NCT04246554|Oxycodone|oxycodone|mesh-list
83332841|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83332842|NCT04246554|Analgesics|analgesics|mesh-ancestor
83332843|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
83332844|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332845|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332846|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
83332847|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83332848|NCT04246554|Narcotics|narcotics|mesh-ancestor
83332849|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83332850|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83332851|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332852|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332853|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83332854|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332855|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332856|NCT01922817|Saxagliptin|saxagliptin|mesh-list
83332857|NCT01922817|Incretins|incretins|mesh-ancestor
83332858|NCT01922817|Hormones|hormones|mesh-ancestor
83332859|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332860|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332861|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83332862|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
83332863|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332864|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332865|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83332867|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
83332868|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
83332869|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83332870|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83332871|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332872|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83332873|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
83332874|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83332875|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
83332876|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332877|NCT00634179|Prednisone|prednisone|mesh-list
83332878|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
83332879|NCT00634179|Rituximab|rituximab|mesh-list
83332880|NCT00634179|Doxorubicin|doxorubicin|mesh-list
83332881|NCT00634179|Vincristine|vincristine|mesh-list
83332882|NCT00634179|Bortezomib|bortezomib|mesh-list
83332883|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332884|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
83332885|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332886|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332887|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83332888|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
83332889|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332890|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332891|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83332892|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332893|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83332894|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83332895|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83332896|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332897|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332898|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
83332899|NCT00634179|Hormones|hormones|mesh-ancestor
83332900|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332901|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332902|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83332903|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
83332904|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
83332905|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
83332906|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
83332907|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
83332908|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332909|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83332910|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332911|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332912|NCT01179490|Prednisolone|prednisolone|mesh-list
83332913|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332914|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
83332915|NCT01179490|Hormones|hormones|mesh-ancestor
83332916|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332917|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332918|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332919|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332920|NCT01179568|Citalopram|citalopram|mesh-list
83332921|NCT01179568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83332922|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83332923|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83332924|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332925|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332926|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
83332927|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332928|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83332929|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
83332930|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83332931|NCT01180036|Cyclosporine|cyclosporine|mesh-list
83332932|NCT01180036|Rituximab|rituximab|mesh-list
83332933|NCT01180036|Cyclosporins|cyclosporins|mesh-list
83332934|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83332935|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332936|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
83332937|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332938|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332939|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332940|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332941|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332942|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
83332943|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83332944|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
83332945|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83332946|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83332947|NCT01180894|Hematinics|hematinics|mesh-ancestor
83332948|NCT01181674|Insulin|insulin|mesh-list
83332949|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83332950|NCT01181674|Metformin|metformin|mesh-list
83332951|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
83332952|NCT01181674|Acarbose|acarbose|mesh-list
83332953|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83332954|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332955|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83332956|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83332957|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332958|NCT01182376|Dronedarone|dronedarone|mesh-list
83332959|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83332960|NCT01183312|Flumazenil|flumazenil|mesh-list
83332961|NCT01183312|Antidotes|antidotes|mesh-ancestor
83332962|NCT01183312|Protective Agents|protective agents|mesh-ancestor
83332963|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332964|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
83332965|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
83332966|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83332967|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332968|NCT03188172|Dexamethasone|dexamethasone|mesh-list
83332969|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
83332970|NCT03188172|Melphalan|melphalan|mesh-list
83332971|NCT03188172|Lenalidomide|lenalidomide|mesh-list
83332972|NCT03188172|Bortezomib|bortezomib|mesh-list
83332973|NCT03188172|Daratumumab|daratumumab|mesh-list
83332974|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83332975|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
83332976|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83332977|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83332978|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83332979|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
83332980|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83332981|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83332982|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83332983|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83332984|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
83332985|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
83332986|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83332987|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83332988|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
83332989|NCT03188172|Hormones|hormones|mesh-ancestor
83332990|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83332991|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83332992|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83332993|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83332994|NCT03188172|Growth Substances|growth substances|mesh-ancestor
83332995|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
83332996|NCT01184014|Insulin|insulin|mesh-list
83332997|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83332998|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
83332999|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
83333000|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
83333001|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
83333002|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
83333003|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83333004|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333005|NCT05672550|Enoxaparin|enoxaparin|mesh-list
83333006|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
83333007|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
83333008|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83333009|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83333010|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333011|NCT01185028|Interferons|interferons|mesh-list
83333012|NCT01185028|Ribavirin|ribavirin|mesh-list
83333013|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
83333014|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333015|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
83333016|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333017|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
83333018|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333019|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83333020|NCT02187016|Listerine|listerine|mesh-list
83333021|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83333022|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333023|NCT05439798|Dexamethasone|dexamethasone|mesh-list
83333024|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
83333025|NCT05439798|Ondansetron|ondansetron|mesh-list
83333026|NCT05439798|Palonosetron|palonosetron|mesh-list
83333027|NCT05439798|BB 1101|bb 1101|mesh-list
83333028|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333029|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
83333030|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
83333031|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333032|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333033|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333034|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
83333035|NCT05439798|Hormones|hormones|mesh-ancestor
83333036|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333037|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83333038|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333039|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
83333040|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333041|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333042|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
83333043|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83333044|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83333045|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83333046|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
83333047|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333048|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
83333049|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83333050|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83333051|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333052|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
83333053|NCT02188576|Coagulants|coagulants|mesh-ancestor
83333054|NCT02189122|Aspirin|aspirin|mesh-list
83333055|NCT02189122|Bradykinin|bradykinin|mesh-list
83333056|NCT02189122|Kininogens|kininogens|mesh-list
83333057|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83333058|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333059|NCT02189122|Analgesics|analgesics|mesh-ancestor
83333060|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
83333061|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333062|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333063|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333064|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333065|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83333066|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83333067|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333068|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83333069|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83333070|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333071|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
83333072|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
83333073|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
83333074|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
83333075|NCT05309460|Labetalol|labetalol|mesh-list
83333077|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83333078|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83333079|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333080|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83333081|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333082|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
83333083|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
83333084|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83333085|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83333086|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83333087|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
83333088|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333089|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83333090|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
83333091|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
83333092|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333093|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83333094|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83333096|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
83333097|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
83333098|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333099|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333100|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333101|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83333102|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83333103|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
83333104|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333105|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333106|NCT01143688|Albuterol|albuterol|mesh-list
83333107|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83333108|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
83333109|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333110|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333111|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83333112|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
83333113|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
83333114|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83333115|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83333116|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83333117|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83333118|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
83333119|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333120|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333121|NCT04455594|Carboplatin|carboplatin|mesh-list
83333122|NCT04455594|Pemetrexed|pemetrexed|mesh-list
83333123|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83333124|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333125|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333126|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333127|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83333128|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83333129|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83333130|NCT01143766|Gabapentin|gabapentin|mesh-list
83333131|NCT01143766|Analgesics|analgesics|mesh-ancestor
83333132|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
83333133|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333134|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333135|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
83333136|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83333137|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83333138|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333139|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333140|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83333141|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83333142|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333143|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333144|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
83333145|NCT05439408|Dasatinib|dasatinib|mesh-list
83333146|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333147|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83333148|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333149|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333150|NCT03011476|Donepezil|donepezil|mesh-list
83333151|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83333152|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333153|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333154|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
83333155|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333156|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333157|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
83333158|NCT02522754|Vaccines|vaccines|mesh-list
83333159|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
83333160|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333161|NCT01188694|Methylene Blue|methylene blue|mesh-list
83333162|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333163|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333164|NCT01188928|Betamethasone|betamethasone|mesh-list
83333165|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
83333166|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83333167|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
83333168|NCT01188928|Calcipotriene|calcipotriene|mesh-list
83333169|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83333170|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333171|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
83333172|NCT01188928|Hormones|hormones|mesh-ancestor
83333173|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333174|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333175|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83333176|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
83333177|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
83333178|NCT05438706|Carboplatin|carboplatin|mesh-list
83333179|NCT05438706|Capecitabine|capecitabine|mesh-list
83333180|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333181|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83333182|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
83333183|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333184|NCT01189240|Bevacizumab|bevacizumab|mesh-list
83333185|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83333186|NCT01189240|Antibodies|antibodies|mesh-list
83333187|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
83333188|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83333189|NCT01189240|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
83333190|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333191|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83333192|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83333193|NCT01189240|Growth Substances|growth substances|mesh-ancestor
83333194|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333195|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
83333196|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
83333197|NCT01189240|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83333198|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333199|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333200|NCT03467334|Simethicone|simethicone|mesh-list
83333201|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
83333202|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333203|NCT03467334|Emollients|emollients|mesh-ancestor
83333204|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
83333205|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
83333206|NCT02874144|Fluticasone|fluticasone|mesh-list
83333207|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333208|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
83333209|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83333210|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83333211|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
83333212|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333213|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333214|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83333215|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
83333216|NCT03467178|Paclitaxel|paclitaxel|mesh-list
83333217|NCT03467178|Carboplatin|carboplatin|mesh-list
83333218|NCT03467178|Gemcitabine|gemcitabine|mesh-list
83333219|NCT03467178|Doxorubicin|doxorubicin|mesh-list
83333220|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83333221|NCT03467178|Decitabine|decitabine|mesh-list
83333222|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83333223|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333224|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
83333225|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
83333226|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
83333227|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333228|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83333229|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
83333230|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83333231|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83333232|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83333233|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333234|NCT04722822|Vaccines|vaccines|mesh-list
83333235|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
83333236|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333237|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83333238|NCT02835534|Plasminogen|plasminogen|mesh-list
83333239|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83333240|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83333241|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333242|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
83333243|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333244|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
83333245|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83333246|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
83333247|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333248|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333249|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83333250|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
83333251|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333252|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333253|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83333254|NCT02611830|Vedolizumab|vedolizumab|mesh-list
83333255|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333256|NCT03461718|Fentanyl|fentanyl|mesh-list
83333257|NCT03461718|Midazolam|midazolam|mesh-list
83333258|NCT03461718|Ketamine|ketamine|mesh-list
83333259|NCT03461718|Analgesics|analgesics|mesh-ancestor
83333260|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
83333261|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333262|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333263|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83333264|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83333265|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
83333266|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
83333267|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333268|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83333269|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83333270|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333271|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333272|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83333273|NCT03461718|Narcotics|narcotics|mesh-ancestor
83333274|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83333275|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83333276|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83333277|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83333278|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333279|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
83333280|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
83333281|NCT05431920|Vitamin D|vitamin d|mesh-list
83333282|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
83333283|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
83333284|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
83333285|NCT05431920|Calcifediol|calcifediol|mesh-list
83333286|NCT05431920|Vitamins|vitamins|mesh-list
83333287|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
83333288|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333289|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83333290|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83333292|NCT03467022|Vitamins|vitamins|mesh-ancestor
83333293|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
83333294|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333295|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
83333296|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333297|NCT03467022|Protective Agents|protective agents|mesh-ancestor
83333298|NCT03129594|Glucagon|glucagon|mesh-list
83333299|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83333300|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333301|NCT03129594|Hormones|hormones|mesh-ancestor
83333302|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333303|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333304|NCT03129594|Incretins|incretins|mesh-ancestor
83333305|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
83333306|NCT03466632|Propofol|propofol|mesh-list
83333307|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83333308|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333309|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333310|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333311|NCT03466632|Analgesics|analgesics|mesh-ancestor
83333312|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
83333313|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333314|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83333315|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83333316|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83333317|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
83333318|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333319|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333320|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83333321|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
83333323|NCT05339334|Ritonavir|ritonavir|mesh-list
83333324|NCT05339334|Nirmatrelvir|nirmatrelvir|mesh-list
83333325|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83333326|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83333327|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
83333328|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333329|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333330|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83333331|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83333332|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
83333333|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333334|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83333335|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83333336|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
83333337|NCT03461328|Analgesics|analgesics|mesh-ancestor
83333338|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
83333339|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333340|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333341|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
83333342|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333343|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83333344|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
83333345|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83333346|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83333347|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333348|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83333349|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
83333350|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83333351|NCT01145638|Iron|iron|mesh-list
83333352|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83333353|NCT01145638|Trace Elements|trace elements|mesh-ancestor
83333354|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
83333355|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333356|NCT01145638|Hematinics|hematinics|mesh-ancestor
83333357|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
83333358|NCT03466320|Fludarabine|fludarabine|mesh-list
83333359|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83333360|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
83333361|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333362|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333363|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83333364|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
83333365|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333366|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333367|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83333368|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
83333369|NCT03466242|Ketamine|ketamine|mesh-list
83333370|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83333371|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333372|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333373|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333374|NCT03466242|Analgesics|analgesics|mesh-ancestor
83333375|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
83333376|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333377|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83333378|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83333379|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83333380|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
83333381|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333382|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333383|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83333384|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83333385|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
83333386|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
83333387|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83333388|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83333389|NCT01190878|Bromfenac|bromfenac|mesh-list
83333390|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83333391|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333392|NCT01190878|Analgesics|analgesics|mesh-ancestor
83333393|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
83333394|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333395|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333396|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333397|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333398|NCT01146808|Adefovir|adefovir|mesh-list
83333399|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
83333400|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
83333401|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333402|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83333403|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83333404|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333405|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333406|NCT02522130|Naproxen|naproxen|mesh-list
83333407|NCT02522130|Lidocaine|lidocaine|mesh-list
83333408|NCT02522130|Misoprostol|misoprostol|mesh-list
83333409|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
83333410|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
83333411|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333412|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333413|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
83333414|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333415|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83333416|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83333417|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83333418|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83333419|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333420|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83333421|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
83333422|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83333423|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83333424|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333425|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
83333426|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83333427|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333428|NCT02522130|Analgesics|analgesics|mesh-ancestor
83333429|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333430|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333431|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
83333432|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83333433|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333434|NCT01148524|Vaccines|vaccines|mesh-list
83333435|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
83333436|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333437|NCT03460860|Tocopherols|tocopherols|mesh-list
83333438|NCT03460860|Vitamin E|vitamin e|mesh-list
83333439|NCT03460860|Tocotrienols|tocotrienols|mesh-list
83333440|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
83333441|NCT03460860|Lycopene|lycopene|mesh-list
83333442|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
83333443|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333444|NCT03460860|Protective Agents|protective agents|mesh-ancestor
83333445|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333446|NCT03460860|Vitamins|vitamins|mesh-ancestor
83333447|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
83333448|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333449|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83333450|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83333451|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333452|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
83333453|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83333454|NCT05215236|Narcotics|narcotics|mesh-ancestor
83333455|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333456|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333457|NCT05215236|Analgesics|analgesics|mesh-ancestor
83333458|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
83333459|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333460|NCT03460782|Ipilimumab|ipilimumab|mesh-list
83333461|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83333462|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333463|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83333464|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333465|NCT01099618|Metformin|metformin|mesh-list
83333466|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83333467|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83333468|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333469|NCT01099618|Incretins|incretins|mesh-ancestor
83333470|NCT01099618|Hormones|hormones|mesh-ancestor
83333471|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333472|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83333473|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
83333474|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333475|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333476|NCT01099774|Bimatoprost|bimatoprost|mesh-list
83333477|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83333478|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83333479|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83333480|NCT01100242|Bortezomib|bortezomib|mesh-list
83333481|NCT01100242|Sorafenib|sorafenib|mesh-list
83333482|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333483|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83333484|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333485|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333486|NCT01148836|Ubiquinone|ubiquinone|mesh-list
83333487|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
83333488|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
83333489|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333490|NCT01148836|Vitamins|vitamins|mesh-ancestor
83333491|NCT01149616|Dexamethasone|dexamethasone|mesh-list
83333492|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333493|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
83333494|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
83333495|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333496|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333497|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333498|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
83333499|NCT01149616|Hormones|hormones|mesh-ancestor
83333500|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333501|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83333502|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333503|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
83333504|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
83333505|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83333506|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83333507|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333508|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333509|NCT03460470|Urological Agents|urological agents|mesh-ancestor
83333510|NCT01101100|Brodalumab|brodalumab|mesh-list
83333511|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
83333512|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83333513|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333514|NCT01101880|Cytarabine|cytarabine|mesh-list
83333515|NCT01101880|Clofarabine|clofarabine|mesh-list
83333516|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83333517|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
83333518|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333519|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333520|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
83333521|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333522|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83333523|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
83333524|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333525|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83333526|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
83333527|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333528|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
83333529|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333530|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
83333531|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83333532|NCT01102270|Eszopiclone|eszopiclone|mesh-list
83333533|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83333534|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333535|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333536|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
83333537|NCT01103440|Tirofiban|tirofiban|mesh-list
83333538|NCT01103440|Ticlopidine|ticlopidine|mesh-list
83333539|NCT01103440|Abciximab|abciximab|mesh-list
83333540|NCT01103440|Clopidogrel|clopidogrel|mesh-list
83333541|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83333542|NCT01103440|Cangrelor|cangrelor|mesh-list
83333543|NCT01103440|Eptifibatide|eptifibatide|mesh-list
83333544|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83333545|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83333546|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83333547|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83333548|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
83333549|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333550|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333551|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333552|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
83333553|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83333554|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83333555|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83333556|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
83333557|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83333558|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333559|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
83333560|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333561|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
83333562|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83333563|NCT01103440|Protective Agents|protective agents|mesh-ancestor
83333564|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83333565|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83333566|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333567|NCT01105312|Letrozole|letrozole|mesh-list
83333568|NCT01105312|Panobinostat|panobinostat|mesh-list
83333569|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333570|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83333571|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83333572|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333573|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333574|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83333575|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
83333576|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333577|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333578|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83333579|NCT04488978|Amlodipine|amlodipine|mesh-list
83333580|NCT04488978|Irbesartan|irbesartan|mesh-list
83333581|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83333582|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83333583|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83333584|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333585|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83333586|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333587|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
83333588|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83333589|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83333590|NCT03460002|Vaccines|vaccines|mesh-list
83333591|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
83333592|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333593|NCT01105702|Bevacizumab|bevacizumab|mesh-list
83333594|NCT01105702|Temozolomide|temozolomide|mesh-list
83333595|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
83333596|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83333597|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333598|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83333599|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83333600|NCT01105702|Growth Substances|growth substances|mesh-ancestor
83333601|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333602|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
83333603|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83333604|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
83333605|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333606|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
83333607|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333608|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333609|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
83333610|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83333611|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333612|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83333613|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83333614|NCT04453332|Hormones|hormones|mesh-list
83333615|NCT04453332|Estradiol|estradiol|mesh-list
83333616|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83333617|NCT04453332|Progesterone|progesterone|mesh-list
83333618|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333619|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333620|NCT04453332|Estrogens|estrogens|mesh-ancestor
83333621|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83333622|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
83333623|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83333624|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83333625|NCT04453332|Progestins|progestins|mesh-ancestor
83333626|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
83333627|NCT03456570|Progestins|progestins|mesh-ancestor
83333628|NCT03456570|Hormones|hormones|mesh-ancestor
83333629|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333630|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333631|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83333632|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83333633|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83333634|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83333635|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333636|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333637|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333638|NCT03468348|Analgesics|analgesics|mesh-ancestor
83333639|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
83333640|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333641|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
83333642|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333644|NCT03464682|Atorvastatin|atorvastatin|mesh-list
83333645|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83333646|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83333647|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
83333648|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333649|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83333650|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83333651|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333652|NCT03464058|Rabeprazole|rabeprazole|mesh-list
83333653|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83333654|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333655|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83333656|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333657|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333658|NCT03451734|Metformin|metformin|mesh-list
83333659|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
83333660|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83333661|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333662|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83333663|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333664|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333665|NCT03130218|Peppermint oil|peppermint oil|mesh-list
83333666|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
83333667|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
83333668|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333669|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333670|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333671|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
83333672|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
83333673|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333674|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83333675|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333676|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333677|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
83413625|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333678|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333679|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333680|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83333681|NCT01199926|Vitamin D|vitamin d|mesh-list
83333682|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
83333683|NCT01199926|Vitamins|vitamins|mesh-ancestor
83333684|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
83333685|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333686|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83333687|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83333688|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
83333690|NCT01106950|Interleukin-2|interleukin-2|mesh-list
83333691|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
83333692|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83333693|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
83333694|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333695|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333696|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83333697|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
83333698|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333699|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333700|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83333701|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333702|NCT01106950|Analgesics|analgesics|mesh-ancestor
83333703|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
83333704|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333705|NCT03463044|Nangibotide|nangibotide|mesh-list
83333706|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333707|NCT02522208|Hydralazine|hydralazine|mesh-list
83333708|NCT02522208|Isosorbide|isosorbide|mesh-list
83333709|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83333710|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83333711|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83333712|NCT02522208|Diuretics|diuretics|mesh-ancestor
83333713|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
83333714|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333715|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
83333716|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83333717|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333718|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83333719|NCT05684172|Tenecteplase|tenecteplase|mesh-list
83333720|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83333721|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83333722|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333724|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83333725|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
83333726|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333727|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83333728|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
83333729|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
83333730|NCT01200160|Vitamins|vitamins|mesh-ancestor
83333731|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
83333732|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333733|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
83333734|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83333735|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333736|NCT01153672|Letrozole|letrozole|mesh-list
83333737|NCT01153672|Anastrozole|anastrozole|mesh-list
83333738|NCT01153672|Vorinostat|vorinostat|mesh-list
83333739|NCT01153672|Exemestane|exemestane|mesh-list
83333740|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333741|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83333742|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83333743|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333744|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333745|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83333746|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
83333747|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333748|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333749|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83333750|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83333751|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
83333752|NCT03010072|Hematinics|hematinics|mesh-ancestor
83333753|NCT03462810|Cabotegravir|cabotegravir|mesh-list
83333754|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83333755|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83333756|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333757|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333758|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83333759|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83333760|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
83333761|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333762|NCT01219738|Budesonide|budesonide|mesh-list
83333763|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333764|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83333765|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
83333766|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333767|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333768|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83333769|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
83333770|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
83333771|NCT01219738|Hormones|hormones|mesh-ancestor
83333772|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333773|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
83333774|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83333775|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333776|NCT03848754|Immunotoxins|immunotoxins|mesh-ancestor
83333777|NCT03848754|Immunoconjugates|immunoconjugates|mesh-ancestor
83333778|NCT03848754|Immunologic Factors|immunologic factors|mesh-ancestor
83333779|NCT03848754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333780|NCT01155154|Clindamycin|clindamycin|mesh-list
83333781|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
83333782|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
83333783|NCT01155154|Cephalexin|cephalexin|mesh-list
83333784|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83333785|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333786|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83333787|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333788|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333789|NCT04614714|Niacinamide|niacinamide|mesh-list
83333790|NCT04614714|Niacin|niacin|mesh-list
83333791|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
83333792|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
83333793|NCT04614714|Vitamins|vitamins|mesh-ancestor
83333794|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
83333795|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333796|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83333797|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
83333798|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333799|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83333800|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
83333801|NCT01221298|Ritonavir|ritonavir|mesh-list
83333802|NCT01221298|Ribavirin|ribavirin|mesh-list
83333803|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83333804|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83333805|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
83333806|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333807|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333808|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83333809|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83333810|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
83333811|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333812|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83333813|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83333814|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
83333815|NCT01222234|Vitamin D|vitamin d|mesh-list
83333816|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
83333817|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
83333818|NCT01222234|Calcitriol|calcitriol|mesh-list
83333819|NCT01222234|Vitamins|vitamins|mesh-list
83333820|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
83333821|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333822|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83333823|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83333824|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83333825|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83333826|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333827|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83333828|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83333829|NCT01203046|Ertapenem|ertapenem|mesh-list
83333830|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333831|NCT02460588|Prednisolone|prednisolone|mesh-list
83333832|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
83333833|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83333834|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
83333835|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333836|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333837|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83333838|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
83333839|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333840|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333841|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83333842|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333843|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
83333844|NCT02460588|Hormones|hormones|mesh-ancestor
83333845|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333846|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83333847|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83333848|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
83333849|NCT03449082|Coagulants|coagulants|mesh-ancestor
83333850|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
83333851|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83333852|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333853|NCT03449238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83333854|NCT03449238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333855|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83333856|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83333857|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83333858|NCT03413202|Protective Agents|protective agents|mesh-ancestor
83333859|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333860|NCT04169100|Prednisone|prednisone|mesh-list
83333861|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333862|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
83333863|NCT04169100|Hormones|hormones|mesh-ancestor
83333864|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333866|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83333867|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333868|NCT04155840|Rituximab|rituximab|mesh-list
83333869|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83333870|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83333871|NCT04155840|Antibodies|antibodies|mesh-list
83333872|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
83333873|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83333874|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
83333875|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333876|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333877|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83333878|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83333879|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
83333880|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333881|NCT03448770|Lactulose|lactulose|mesh-list
83333882|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333883|NCT03443778|Dexamethasone|dexamethasone|mesh-list
83333884|NCT03443778|Bupivacaine|bupivacaine|mesh-list
83333885|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83333886|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
83333887|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
83333888|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333889|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333890|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333891|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
83333892|NCT03443778|Hormones|hormones|mesh-ancestor
83333893|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333894|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83333895|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333896|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
83333897|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
83333898|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333899|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
83333900|NCT03011008|Liraglutide|liraglutide|mesh-list
83333901|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83333902|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333903|NCT03011008|Incretins|incretins|mesh-ancestor
83333904|NCT03011008|Hormones|hormones|mesh-ancestor
83333905|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83333906|NCT01157416|Cycloserine|cycloserine|mesh-list
83333907|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83333908|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83333909|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83333910|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
83333911|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83333912|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
83333913|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333914|NCT01206478|Megestrol|megestrol|mesh-list
83333915|NCT01206478|Amitriptyline|amitriptyline|mesh-list
83333916|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83333917|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
83333918|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333919|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333920|NCT01206478|Analgesics|analgesics|mesh-ancestor
83333921|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
83333922|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333923|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333924|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83333925|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83333926|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83333927|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333928|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
83333929|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333930|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83333931|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83333932|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83333933|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
83333934|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83333935|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83333936|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83333937|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83333938|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333939|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
83333940|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
83333941|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333942|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333943|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333944|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
83333945|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83333946|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333947|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333948|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
83333949|NCT01158820|Fentanyl|fentanyl|mesh-list
83333950|NCT01158820|Midazolam|midazolam|mesh-list
83333951|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
83333952|NCT01158820|Ketamine|ketamine|mesh-list
83333953|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83333954|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83333955|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83333956|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83333957|NCT01158820|Analgesics|analgesics|mesh-ancestor
83333958|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
83333959|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83333960|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83333961|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83333962|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83333963|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
83333964|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83333965|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333966|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83333967|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83333968|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
83333969|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
83333970|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83333971|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83333972|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83333973|NCT01158820|Narcotics|narcotics|mesh-ancestor
83333974|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83333975|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83333976|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83333977|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83333978|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
83333979|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
83333980|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83333981|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
83333982|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
83333983|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
83333984|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83333985|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83333986|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
83333987|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
83333988|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83333990|NCT03707028|Apatinib|apatinib|mesh-list
83333991|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83333992|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83333993|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
83333994|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
83333995|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
83333996|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83333997|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83333998|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83333999|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
83334000|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83334001|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334002|NCT03447678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83334003|NCT03447678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334004|NCT01225354|Calcium|calcium|mesh-list
83334005|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83334006|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334007|NCT02521662|Nicotine|nicotine|mesh-list
83334008|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83334009|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
83334010|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334011|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334012|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83334013|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83334014|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
83334015|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334016|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334017|NCT03499704|Metformin|metformin|mesh-list
83334018|NCT03499704|Pioglitazone|pioglitazone|mesh-list
83334019|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
83334020|NCT03499704|Alogliptin|alogliptin|mesh-list
83334021|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83334022|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334023|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83334024|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334025|NCT03499704|Incretins|incretins|mesh-ancestor
83334026|NCT03499704|Hormones|hormones|mesh-ancestor
83334027|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334028|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83334029|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
83334030|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334031|NCT05183880|Vitamins|vitamins|mesh-list
83334032|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
83334033|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
83334034|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334035|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
83334036|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334037|NCT05183880|Protective Agents|protective agents|mesh-ancestor
83334038|NCT01159054|Niacin|niacin|mesh-list
83334039|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
83334040|NCT01159054|Niacinamide|niacinamide|mesh-list
83334041|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83334042|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
83334043|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334044|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83334045|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
83334046|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
83334047|NCT01159054|Vitamins|vitamins|mesh-ancestor
83334048|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
83334049|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334050|NCT01209442|Bevacizumab|bevacizumab|mesh-list
83334051|NCT01209442|Temozolomide|temozolomide|mesh-list
83334052|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83334053|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334054|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83334055|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83334056|NCT01209442|Growth Substances|growth substances|mesh-ancestor
83334057|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334058|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
83334059|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83334060|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
83413626|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83334061|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334062|NCT01160380|Modafinil|modafinil|mesh-list
83334063|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83334064|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334065|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83334066|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83334067|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83334068|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334069|NCT04956042|Cytarabine|cytarabine|mesh-list
83334070|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83334071|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
83334072|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334073|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334074|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
83334075|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334076|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83334077|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
83334078|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334079|NCT01228084|Sulforaphane|sulforaphane|mesh-list
83334080|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83334081|NCT01228084|Protective Agents|protective agents|mesh-ancestor
83334082|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334083|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334084|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83334085|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83334086|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83334087|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83334088|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83334089|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
83334090|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334091|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334092|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334093|NCT04901208|Nicotine|nicotine|mesh-list
83334094|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83334095|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
83334096|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334097|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334098|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83334099|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83334100|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
83334101|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334102|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334103|NCT01212484|Carbidopa|carbidopa|mesh-list
83334104|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83334105|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83334106|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
83334107|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334108|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334109|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334110|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83334111|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334112|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83334113|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
83334114|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334115|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
83334116|NCT01212874|Esmolol|esmolol|mesh-list
83334117|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
83334118|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83334119|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83334120|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83334121|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
83334122|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334123|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334124|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334125|NCT01859741|Carboplatin|carboplatin|mesh-list
83334126|NCT01859741|Etoposide|etoposide|mesh-list
83334127|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334128|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83334129|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83334130|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83334131|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334132|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334133|NCT01212952|Dexamethasone|dexamethasone|mesh-list
83334134|NCT01212952|Bortezomib|bortezomib|mesh-list
83334135|NCT01212952|Pomalidomide|pomalidomide|mesh-list
83334136|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334137|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
83334138|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
83334139|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334140|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334141|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334142|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
83334143|NCT01212952|Hormones|hormones|mesh-ancestor
83334144|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334145|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83334146|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334147|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
83334148|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83334149|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83334150|NCT01212952|Growth Substances|growth substances|mesh-ancestor
83334151|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
83334152|NCT04609865|Lidocaine|lidocaine|mesh-list
83334153|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
83334154|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
83334155|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334156|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334157|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
83334158|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334159|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83334160|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83334161|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83334162|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334163|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334164|NCT01873859|Metformin|metformin|mesh-list
83334165|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83334166|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334167|NCT00493896|Enoxaparin|enoxaparin|mesh-list
83334168|NCT00493896|PENTA|penta|mesh-list
83334169|NCT00493896|Fondaparinux|fondaparinux|mesh-list
83334170|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
83334171|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83334172|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83334173|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334174|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83334175|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
83334176|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83334177|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
83334178|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334179|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
83334180|NCT04597619|Analgesics|analgesics|mesh-ancestor
83334181|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
83334182|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334183|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334184|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83334185|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
83334186|NCT03449940|Diclofenac|diclofenac|mesh-list
83334187|NCT03449940|Lidocaine|lidocaine|mesh-list
83334188|NCT03449940|Analgesics|analgesics|mesh-list
83334189|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
83334190|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
83334191|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334192|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334193|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
83334194|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334195|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83334196|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83334197|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83334198|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334199|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334200|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334201|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83334202|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334203|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334204|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334205|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83334206|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334207|NCT01230424|Triamcinolone|triamcinolone|mesh-list
83334208|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83334209|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83334210|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83334211|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334212|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
83334213|NCT01230424|Hormones|hormones|mesh-ancestor
83334214|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334215|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334216|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83334217|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
83334218|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334219|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334220|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
83334221|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83334222|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334223|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83334224|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
83334225|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83334226|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334227|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334228|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334230|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
83334231|NCT03438240|Bupivacaine|bupivacaine|mesh-list
83334232|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
83334233|NCT03438240|Anesthetics|anesthetics|mesh-list
83334234|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
83334235|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334236|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334237|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
83334238|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334239|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83334240|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334241|NCT03438240|Analgesics|analgesics|mesh-ancestor
83334242|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83334243|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83334244|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83334245|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
83334246|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334247|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334248|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83334249|NCT03438240|Narcotics|narcotics|mesh-ancestor
83334250|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83334251|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83334252|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
83334253|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
83334254|NCT01160848|Ethanol|ethanol|mesh-list
83334255|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83334256|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334257|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334258|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334259|NCT01213576|Ivermectin|ivermectin|mesh-list
83334260|NCT01213576|Albendazole|albendazole|mesh-list
83334261|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83334262|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334263|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
83334264|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
83334265|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83334266|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83334267|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
83334268|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
83334269|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
83334270|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334271|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334272|NCT04452318|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
83334273|NCT04452318|Antiviral Agents|antiviral agents|mesh-ancestor
83334274|NCT04452318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334275|NCT01161862|Glucagon|glucagon|mesh-list
83334276|NCT01161862|Pancrelipase|pancrelipase|mesh-list
83334277|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334278|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334279|NCT01161862|Hormones|hormones|mesh-ancestor
83334280|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334281|NCT01214356|Vitamin D|vitamin d|mesh-list
83334282|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
83334283|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
83334284|NCT01214356|Vitamins|vitamins|mesh-list
83334285|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
83334286|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334287|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83334288|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83334289|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
83334290|NCT01232920|Methotrexate|methotrexate|mesh-list
83334291|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83334292|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
83334293|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83334294|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334295|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83334296|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
83334297|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334298|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334299|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
83334300|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334301|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83334302|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83334303|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
83334304|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334305|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83334306|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83334307|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83334308|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
83334309|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83334310|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334311|NCT03445182|Anesthetics|anesthetics|mesh-list
83334312|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334313|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334314|NCT03010540|Fentanyl|fentanyl|mesh-list
83334315|NCT03010540|Morphine|morphine|mesh-list
83334316|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83334317|NCT03010540|Narcotics|narcotics|mesh-ancestor
83334318|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334319|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334320|NCT03010540|Analgesics|analgesics|mesh-ancestor
83334321|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
83334322|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334323|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83334324|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83334325|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
83334326|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
83334327|NCT03445104|Huperzine A|huperzine a|mesh-list
83334328|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83334329|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334330|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334331|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
83334332|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334333|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334334|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83334335|NCT03445104|Protective Agents|protective agents|mesh-ancestor
83334336|NCT01234714|Liver Extracts|liver extracts|mesh-list
83334337|NCT01234714|Hematinics|hematinics|mesh-ancestor
83334338|NCT03440502|Anesthetics|anesthetics|mesh-list
83334339|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334340|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334341|NCT01234870|Adenosine|adenosine|mesh-list
83334342|NCT01234870|Analgesics|analgesics|mesh-ancestor
83334343|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
83334344|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334345|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334346|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83334347|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
83334348|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83334349|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
83334350|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
83334351|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334352|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334353|NCT03437460|Ibuprofen|ibuprofen|mesh-list
83334354|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334355|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83334356|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334357|NCT03437460|Analgesics|analgesics|mesh-ancestor
83334358|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
83334359|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334360|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334361|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334362|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83334363|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334364|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334366|NCT03444636|Bupivacaine|bupivacaine|mesh-list
83334367|NCT03444636|Ropivacaine|ropivacaine|mesh-list
83334368|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
83334369|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
83334370|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334371|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334372|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
83334373|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334374|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83334375|NCT03444636|Narcotics|narcotics|mesh-ancestor
83334376|NCT03444636|Analgesics|analgesics|mesh-ancestor
83334377|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83334378|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83334379|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
83334380|NCT01215292|Ketoconazole|ketoconazole|mesh-list
83334381|NCT01215292|Anastrozole|anastrozole|mesh-list
83334382|NCT01215292|Testosterone|testosterone|mesh-list
83334383|NCT01215292|Dutasteride|dutasteride|mesh-list
83334384|NCT01215292|Acyline|acyline|mesh-list
83334385|NCT01215292|Androgens|androgens|mesh-ancestor
83334386|NCT01215292|Hormones|hormones|mesh-ancestor
83334387|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334388|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334389|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83334390|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334391|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83334392|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83334393|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334394|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334395|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83334396|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
83334397|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
83334398|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334399|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83334400|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83334401|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83334402|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83334403|NCT04796454|Gemcitabine|gemcitabine|mesh-list
83334404|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
83334405|NCT04796454|Temozolomide|temozolomide|mesh-list
83334406|NCT04796454|Pamiparib|pamiparib|mesh-list
83334407|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334408|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83334409|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
83334410|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334411|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83334412|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
83334413|NCT04796454|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83334414|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334415|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83334416|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83334417|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334418|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83334419|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334420|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334421|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
83334422|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83334423|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334424|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83334425|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
83334426|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83334427|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334428|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334429|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334430|NCT03437226|Simendan|simendan|mesh-list
83334431|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83334432|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
83334433|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83334434|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83334435|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334436|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334437|NCT03437226|Protective Agents|protective agents|mesh-ancestor
83334438|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334439|NCT04788420|Sorafenib|sorafenib|mesh-list
83334440|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334441|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83334442|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334443|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334444|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83334446|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83334447|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83334448|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
83334449|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
83334450|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
83334451|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83334452|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334453|NCT01282138|Analgesics|analgesics|mesh-ancestor
83334454|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
83334455|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334456|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334457|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334458|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334459|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83334460|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83334461|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83334462|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
83334463|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
83334464|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334465|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334466|NCT03444402|Esomeprazole|esomeprazole|mesh-list
83334467|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83334468|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334469|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83334470|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334471|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334472|NCT01238536|Dexamethasone|dexamethasone|mesh-list
83334473|NCT01238536|Betamethasone|betamethasone|mesh-list
83334474|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83334475|NCT01238536|Lidocaine|lidocaine|mesh-list
83334476|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
83334477|NCT01238536|Anesthetics|anesthetics|mesh-list
83334478|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334479|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
83334480|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
83334481|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334482|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334483|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334484|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
83334485|NCT01238536|Hormones|hormones|mesh-ancestor
83334486|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334487|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83334488|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334489|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334490|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334491|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
83334492|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83334493|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83334494|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83334495|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334496|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83334497|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
83334498|NCT03437070|Doxorubicin|doxorubicin|mesh-list
83334499|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83334500|NCT03437070|Trabectedin|trabectedin|mesh-list
83334501|NCT03437070|Olaratumab|olaratumab|mesh-list
83334502|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83334503|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334504|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83334505|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83334506|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334507|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334508|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83334509|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
83334510|NCT03128736|Esomeprazole|esomeprazole|mesh-list
83334511|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
83334512|NCT03128736|Lansoprazole|lansoprazole|mesh-list
83334513|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83334514|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334515|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83334517|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334518|NCT05054868|Ketorolac|ketorolac|mesh-list
83334519|NCT05054868|Oxycodone|oxycodone|mesh-list
83334520|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83334521|NCT05054868|Narcotics|narcotics|mesh-ancestor
83334522|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334523|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334524|NCT05054868|Analgesics|analgesics|mesh-ancestor
83334525|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
83334526|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334527|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83334528|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334529|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334530|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334531|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83334532|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334533|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334534|NCT01218958|Naltrexone|naltrexone|mesh-list
83334535|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83334536|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83334537|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334538|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
83334539|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334540|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
83334541|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83334542|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
83334543|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334544|NCT03440268|Expectorants|expectorants|mesh-ancestor
83334545|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
83334546|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83334547|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
83334548|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334549|NCT03440268|Protective Agents|protective agents|mesh-ancestor
83334550|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334551|NCT03440268|Antidotes|antidotes|mesh-ancestor
83334552|NCT03444246|Iodine|iodine|mesh-list
83334553|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
83334554|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83334555|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334556|NCT03444246|Trace Elements|trace elements|mesh-ancestor
83334557|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
83334558|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334559|NCT04369014|Anesthetics|anesthetics|mesh-list
83334560|NCT04369014|Propofol|propofol|mesh-list
83334561|NCT04369014|Etomidate|etomidate|mesh-list
83334562|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334563|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334564|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83334565|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83334566|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
83334567|NCT03436836|Lidocaine|lidocaine|mesh-list
83334568|NCT03436836|Nalbuphine|nalbuphine|mesh-list
83334569|NCT03436836|Bupivacaine|bupivacaine|mesh-list
83334570|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
83334571|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
83334572|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334573|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334574|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
83334575|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334576|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83334577|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83334578|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83334579|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334580|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334581|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83334582|NCT03436836|Narcotics|narcotics|mesh-ancestor
83334583|NCT03436836|Analgesics|analgesics|mesh-ancestor
83334584|NCT03444012|Ticagrelor|ticagrelor|mesh-list
83334585|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83334586|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83334587|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83334588|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83334589|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
83413627|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
83334590|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334591|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334592|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334593|NCT03440034|Pioglitazone|pioglitazone|mesh-list
83334594|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83334595|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334596|NCT03433326|Grazoprevir|grazoprevir|mesh-list
83334597|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83334598|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
83334599|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334600|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83334601|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
83334602|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83334603|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83334604|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83334605|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334606|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334607|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83334608|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334609|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334610|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
83334611|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334612|NCT04276389|Paclitaxel|paclitaxel|mesh-list
83334613|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83334614|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83334615|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334616|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
83334617|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
83334618|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
83334619|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334620|NCT03128619|Letrozole|letrozole|mesh-list
83334621|NCT03128619|Palbociclib|palbociclib|mesh-list
83334622|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334623|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83334624|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83334625|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334626|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334627|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83334628|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
83334629|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334630|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334631|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83334632|NCT03433092|Carotenoids|carotenoids|mesh-list
83334633|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
83334634|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334635|NCT03433092|Protective Agents|protective agents|mesh-ancestor
83334636|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334637|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
83334638|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
83334639|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
83334640|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334641|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334642|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
83334643|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334644|NCT01872689|Pirfenidone|pirfenidone|mesh-list
83334645|NCT01872689|Analgesics|analgesics|mesh-ancestor
83334646|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
83334647|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334648|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334649|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83334650|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334651|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334652|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334653|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334654|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83334655|NCT03435900|Metronidazole|metronidazole|mesh-list
83334656|NCT03435900|Fosfomycin|fosfomycin|mesh-list
83334657|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83334658|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334659|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
83334660|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83334661|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83334662|NCT00632931|Vorinostat|vorinostat|mesh-list
83334663|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334664|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83334665|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334666|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334667|NCT01857323|Albuterol|albuterol|mesh-list
83334668|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83334669|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
83334670|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334671|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334672|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83334673|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
83334674|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
83334675|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83334676|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83334677|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83334678|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83334679|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
83334680|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334681|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334682|NCT03104439|Nivolumab|nivolumab|mesh-list
83334683|NCT03104439|Ipilimumab|ipilimumab|mesh-list
83334684|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83334685|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334686|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83334687|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334688|NCT03432780|Docetaxel|docetaxel|mesh-list
83334689|NCT03432780|Hormones|hormones|mesh-list
83334690|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334691|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
83334692|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
83334693|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
83334694|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334695|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334696|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334697|NCT00055731|Aspirin|aspirin|mesh-list
83334698|NCT00055731|Docetaxel|docetaxel|mesh-list
83334699|NCT00055731|Goserelin|goserelin|mesh-list
83334700|NCT00055731|Bicalutamide|bicalutamide|mesh-list
83334701|NCT00055731|Estramustine|estramustine|mesh-list
83334702|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334703|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
83334704|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
83334705|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
83334706|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334707|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83334708|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334709|NCT00055731|Analgesics|analgesics|mesh-ancestor
83334710|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
83334711|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334712|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334713|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334714|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334715|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83334716|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83334717|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83334718|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83334719|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334720|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
83334721|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83334722|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
83334723|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
83334724|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334725|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83334726|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
83334727|NCT03435744|Simvastatin|simvastatin|mesh-list
83334728|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83334729|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83334730|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
83334731|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334732|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83334733|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83334734|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334735|NCT03435666|Capecitabine|capecitabine|mesh-list
83334736|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83334738|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334739|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334740|NCT00632541|Bevacizumab|bevacizumab|mesh-list
83334741|NCT00632541|Sorafenib|sorafenib|mesh-list
83334742|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83334743|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334744|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83334745|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83334746|NCT00632541|Growth Substances|growth substances|mesh-ancestor
83334747|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334748|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
83334749|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83334750|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334751|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334752|NCT01872611|Prednisolone|prednisolone|mesh-list
83334753|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83334754|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
83334755|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83334756|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
83334757|NCT01872611|Nepafenac|nepafenac|mesh-list
83334758|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83334759|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
83334760|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334761|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
83334762|NCT01872611|Hormones|hormones|mesh-ancestor
83334763|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334764|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334765|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83334766|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334767|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
83334768|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
83334769|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334770|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334771|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83334772|NCT01872611|Protective Agents|protective agents|mesh-ancestor
83334773|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83334774|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334775|NCT01872611|Analgesics|analgesics|mesh-ancestor
83334776|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
83334777|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334778|NCT03432468|Valsartan|valsartan|mesh-list
83334779|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83334780|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83334781|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83334782|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334783|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
83334784|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334785|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
83334786|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83334787|NCT03432312|Nicotine|nicotine|mesh-list
83334788|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83334789|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
83334790|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334791|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334792|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83334793|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83334794|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
83334795|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334796|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334797|NCT03438942|Folic Acid|folic acid|mesh-list
83334798|NCT03438942|Hematinics|hematinics|mesh-ancestor
83334799|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
83334800|NCT03438942|Vitamins|vitamins|mesh-ancestor
83334801|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
83334802|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334803|NCT03432156|Immunomodulating Agents|immunomodulating agents|mesh-list
83334804|NCT03432156|Immunologic Factors|immunologic factors|mesh-ancestor
83334805|NCT03432156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334806|NCT04450680|Lactams|lactams|mesh-list
83334807|NCT04450680|beta-Lactams|beta-lactams|mesh-list
83334808|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83334809|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334810|NCT03438708|Axitinib|axitinib|mesh-list
83334811|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334812|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83334813|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334814|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334815|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83334816|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
83334817|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334818|NCT01923597|Protective Agents|protective agents|mesh-ancestor
83334819|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334820|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83334821|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83334822|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334823|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83334824|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83334825|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83334826|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83334827|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334828|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334829|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83334830|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83334831|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83334832|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
83334833|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334834|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334835|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83334836|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83334837|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
83334838|NCT00631137|Testosterone|testosterone|mesh-list
83334839|NCT00631137|Androgens|androgens|mesh-ancestor
83334840|NCT00631137|Hormones|hormones|mesh-ancestor
83334841|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334842|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334843|NCT03428880|Morphine|morphine|mesh-list
83334844|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83334845|NCT03428880|Narcotics|narcotics|mesh-ancestor
83334846|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334847|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334848|NCT03428880|Analgesics|analgesics|mesh-ancestor
83334849|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
83334850|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334851|NCT01923831|Dexamethasone|dexamethasone|mesh-list
83334852|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
83334853|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334854|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
83334855|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
83334856|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334857|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334858|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334859|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
83334860|NCT01923831|Hormones|hormones|mesh-ancestor
83334861|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334862|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83334863|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334864|NCT01923831|Analgesics|analgesics|mesh-ancestor
83334865|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
83334866|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
83334867|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334868|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83334869|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
83334870|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83334871|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334872|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334873|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83334874|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
83334875|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83334876|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83334877|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334878|NCT03086343|Abatacept|abatacept|mesh-list
83334879|NCT03086343|Upadacitinib|upadacitinib|mesh-list
83334880|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83334881|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334882|NCT03086343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83334883|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334884|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83334885|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
83334886|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334887|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83334888|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83334889|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83334890|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334892|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
83334893|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334894|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334895|NCT03085563|Midazolam|midazolam|mesh-list
83334896|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
83334897|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83334898|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83334899|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83334900|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334901|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83334902|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83334903|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83334904|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83334905|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
83334906|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
83334907|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
83334908|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
83334909|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334910|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334911|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83334912|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83334913|NCT03085563|Analgesics|analgesics|mesh-ancestor
83334914|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
83334915|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334916|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
83334917|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83334918|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334919|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
83334920|NCT04450446|Heparin|heparin|mesh-list
83334921|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83334922|NCT04450446|Tinzaparin|tinzaparin|mesh-list
83334923|NCT04450446|Dalteparin|dalteparin|mesh-list
83334924|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
83334925|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83334926|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83334927|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334928|NCT03274752|Paroxetine|paroxetine|mesh-list
83334929|NCT03274752|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83334930|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83334931|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83334932|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334933|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334934|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
83334935|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334936|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83334937|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
83334938|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83334939|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83334940|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83334941|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334942|NCT03242382|Palbociclib|palbociclib|mesh-list
83334943|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334944|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83334945|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334946|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334947|NCT03902418|Tenofovir|tenofovir|mesh-list
83334948|NCT03902418|Emtricitabine|emtricitabine|mesh-list
83334949|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
83334950|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334951|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83334952|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83334953|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83334954|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334955|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83334956|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83334957|NCT03428568|Clarithromycin|clarithromycin|mesh-list
83334958|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83334959|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83334960|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83334962|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334963|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83334964|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83334965|NCT00630825|Dulaglutide|dulaglutide|mesh-list
83334966|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83334967|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334968|NCT03434340|Dexamethasone|dexamethasone|mesh-list
83334969|NCT03434340|Granisetron|granisetron|mesh-list
83334970|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83334971|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
83334972|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
83334973|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83334974|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334975|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83334976|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
83334977|NCT03434340|Hormones|hormones|mesh-ancestor
83334978|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83334979|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83334980|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334981|NCT03434340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83334982|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83334983|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
83334984|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83334985|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83334986|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83334987|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83334988|NCT01923987|Cetuximab|cetuximab|mesh-list
83334989|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83334990|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83334991|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
83334992|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83334993|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
83334994|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83334995|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
83334996|NCT03101163|Protective Agents|protective agents|mesh-ancestor
83334997|NCT01924065|Anticoagulants|anticoagulants|mesh-list
83334998|NCT03434106|Dextrans|dextrans|mesh-list
83334999|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
83335000|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
83335001|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
83335002|NCT01241344|Brincidofovir|brincidofovir|mesh-list
83335003|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
83335004|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335005|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83335006|NCT03009682|Olaparib|olaparib|mesh-list
83335007|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83335008|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335009|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335010|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335011|NCT03431142|Aspirin|aspirin|mesh-list
83335012|NCT03431142|Clopidogrel|clopidogrel|mesh-list
83335013|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335014|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335015|NCT03431142|Analgesics|analgesics|mesh-ancestor
83335016|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
83335017|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335018|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335019|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335020|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335021|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83335022|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83335023|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335024|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83335025|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83335026|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335027|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
83335028|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83335029|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83335030|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83335031|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
83335032|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335033|NCT03831321|Diclofenac|diclofenac|mesh-list
83335034|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335035|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335036|NCT03831321|Analgesics|analgesics|mesh-ancestor
83335037|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
83335038|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335039|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335040|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335041|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335042|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83335043|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335044|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335045|NCT04450134|Fexofenadine|fexofenadine|mesh-list
83335046|NCT04450134|Famotidine|famotidine|mesh-list
83335047|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83335048|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335049|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83335050|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
83335051|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
83335052|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335053|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335054|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335055|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83335056|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83335057|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83335058|NCT01286818|Leucovorin|leucovorin|mesh-list
83335059|NCT01286818|Fluorouracil|fluorouracil|mesh-list
83335060|NCT01286818|Irinotecan|irinotecan|mesh-list
83335061|NCT01286818|Ramucirumab|ramucirumab|mesh-list
83335062|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83335063|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
83335064|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
83335065|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335066|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83335067|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335068|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83335069|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
83335070|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335071|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83335072|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83335073|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335074|NCT01286818|Antidotes|antidotes|mesh-ancestor
83335075|NCT01286818|Protective Agents|protective agents|mesh-ancestor
83335076|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
83335077|NCT01286818|Vitamins|vitamins|mesh-ancestor
83335078|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
83335079|NCT03428256|Anesthetics|anesthetics|mesh-list
83335080|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335081|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335082|NCT00635505|Albuterol|albuterol|mesh-list
83335083|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83335084|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
83335085|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335086|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335087|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83335088|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335089|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
83335090|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83335091|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83335092|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83335093|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83335094|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
83335095|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335096|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335097|NCT01243450|Tretinoin|tretinoin|mesh-list
83335098|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335099|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
83335100|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
83335101|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
83335103|NCT05249751|Coagulants|coagulants|mesh-ancestor
83335104|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83335105|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83335106|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
83335107|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335108|NCT00635193|Doxorubicin|doxorubicin|mesh-list
83335109|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83335110|NCT00635193|Volociximab|volociximab|mesh-list
83335111|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83335112|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83335113|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335114|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83335115|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83335116|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335117|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335118|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83335119|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83335120|NCT00635193|Growth Substances|growth substances|mesh-ancestor
83335121|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335122|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
83335123|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
83335124|NCT00630201|Buprenorphine|buprenorphine|mesh-list
83335125|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83335126|NCT00630201|Narcotics|narcotics|mesh-ancestor
83335127|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335128|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335129|NCT00630201|Analgesics|analgesics|mesh-ancestor
83335130|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
83335131|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335132|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83335134|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335135|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335136|NCT01925547|Analgesics|analgesics|mesh-ancestor
83335137|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
83335138|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335139|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335140|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335141|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335142|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335143|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335144|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335145|NCT03122301|Bupivacaine|bupivacaine|mesh-list
83335146|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
83335147|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
83335148|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335149|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335150|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
83335151|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335152|NCT01925859|Dexamethasone|dexamethasone|mesh-list
83335153|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
83335154|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83335155|NCT01925859|BB 1101|bb 1101|mesh-list
83335156|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335157|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
83335158|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
83335159|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335160|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335161|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335162|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
83335163|NCT01925859|Hormones|hormones|mesh-ancestor
83335164|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335165|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83335166|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335167|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
83335168|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335169|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335170|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83335171|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83335172|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83335173|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335174|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335175|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83335176|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83335177|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335178|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
83335179|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335180|NCT01926639|Rituximab|rituximab|mesh-list
83335181|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83335182|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335183|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
83335184|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335185|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335186|NCT02199496|Ustekinumab|ustekinumab|mesh-list
83335187|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
83335188|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
83335189|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83335190|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
83335191|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335192|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
83335193|NCT04395417|Protective Agents|protective agents|mesh-ancestor
83335194|NCT02199574|Bupivacaine|bupivacaine|mesh-list
83335195|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
83335196|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
83335197|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335198|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335199|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
83335200|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335201|NCT02199652|Prazosin|prazosin|mesh-list
83335202|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83335203|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83335204|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83335205|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83335206|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
83335207|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335208|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335209|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335210|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
83335211|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83335212|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83335213|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
83335214|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335215|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83335216|NCT01927029|Progesterone|progesterone|mesh-list
83335217|NCT01927029|Progestins|progestins|mesh-ancestor
83335218|NCT01927029|Hormones|hormones|mesh-ancestor
83335219|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335220|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335221|NCT01921647|Amoxicillin|amoxicillin|mesh-list
83335222|NCT01921647|Clarithromycin|clarithromycin|mesh-list
83335223|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83335224|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335225|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83335226|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335227|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335228|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83335229|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83335230|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
83335231|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83335232|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
83335233|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335234|NCT01339858|Expectorants|expectorants|mesh-ancestor
83335235|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335236|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83335237|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
83335238|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335239|NCT01339858|Protective Agents|protective agents|mesh-ancestor
83335240|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335241|NCT01339858|Antidotes|antidotes|mesh-ancestor
83335242|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83335243|NCT01339936|Glycerol|glycerol|mesh-list
83335244|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83335245|NCT01339936|Protective Agents|protective agents|mesh-ancestor
83335246|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335247|NCT01339936|Laxatives|laxatives|mesh-ancestor
83335248|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335249|NCT05246865|Androgens|androgens|mesh-list
83335250|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83335251|NCT05246865|Hormones|hormones|mesh-ancestor
83335252|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335253|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335254|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83335255|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
83335256|NCT03111537|Nicotine|nicotine|mesh-list
83335257|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83335258|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
83335259|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335260|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335261|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83335262|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83335263|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
83335264|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335265|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335266|NCT05244525|Epinephrine|epinephrine|mesh-list
83335267|NCT05244525|Bupivacaine|bupivacaine|mesh-list
83335268|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
83335269|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
83335270|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335271|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335272|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
83335273|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335274|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83335275|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83335276|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
83335277|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335278|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335279|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83335280|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83335281|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
83335282|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83335283|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335284|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
83335285|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
83335286|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83335287|NCT01927263|Infliximab|infliximab|mesh-list
83335288|NCT01927263|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83335289|NCT01927263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335290|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
83335291|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335292|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335293|NCT01341730|Pioglitazone|pioglitazone|mesh-list
83335294|NCT01341730|Atorvastatin|atorvastatin|mesh-list
83335295|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83335296|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83335297|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
83335298|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335299|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83335300|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83335301|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335302|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83335303|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335304|NCT01247272|Fluoxetine|fluoxetine|mesh-list
83335305|NCT01247272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83335306|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83335307|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83335308|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335309|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335310|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
83335311|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335312|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83335313|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
83335314|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83335315|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83335316|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83335317|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335318|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
83335319|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
83335320|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83335321|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83335322|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335323|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335324|NCT01290484|Urological Agents|urological agents|mesh-ancestor
83335325|NCT04396743|Clotrimazole|clotrimazole|mesh-list
83335326|NCT04396743|Miconazole|miconazole|mesh-list
83335327|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83335328|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335329|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
83335330|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83335331|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83335332|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335333|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335334|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83335335|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
83335336|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335337|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335338|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83335339|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83335340|NCT01928043|Curcumin|curcumin|mesh-list
83335341|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335342|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335343|NCT01928043|Analgesics|analgesics|mesh-ancestor
83335344|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
83335345|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335346|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335347|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335348|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335349|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335350|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335351|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335352|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83335353|NCT02979886|Menotropins|menotropins|mesh-list
83335354|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
83335355|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83335356|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
83335357|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83335358|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335359|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83335360|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83335361|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335362|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83335363|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
83335364|NCT01928511|Interferons|interferons|mesh-list
83335365|NCT01928511|Tenofovir|tenofovir|mesh-list
83335366|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
83335367|NCT01928511|Lamivudine|lamivudine|mesh-list
83335368|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
83335369|NCT01928511|Entecavir|entecavir|mesh-list
83335370|NCT01928511|Adefovir|adefovir|mesh-list
83335371|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83335372|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335373|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
83335374|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335375|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83335376|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83335377|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335378|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335379|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83335380|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83335381|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
83335382|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335383|NCT05241249|Paclitaxel|paclitaxel|mesh-list
83335384|NCT05241249|Gemcitabine|gemcitabine|mesh-list
83335385|NCT05241249|Bethanechol|bethanechol|mesh-list
83335386|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83335387|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335388|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
83335389|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
83335390|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
83335391|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335392|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83335393|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
83335394|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83335395|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
83335397|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335398|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83335399|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83335400|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
83335401|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335402|NCT01928823|Cycloserine|cycloserine|mesh-list
83335403|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83335404|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335405|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83335406|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
83335407|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83335408|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
83335409|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335410|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
83335411|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
83335412|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83335413|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83335414|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
83335415|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335416|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335417|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83335418|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335419|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83335420|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83335421|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83335422|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
83335423|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335424|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335425|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
83335426|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83335427|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
83335428|NCT02977494|Dexamethasone|dexamethasone|mesh-list
83335429|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
83335430|NCT02977494|Bortezomib|bortezomib|mesh-list
83335431|NCT02977494|Daratumumab|daratumumab|mesh-list
83335432|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335433|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
83335434|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
83335435|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335436|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335437|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335438|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
83335439|NCT02977494|Hormones|hormones|mesh-ancestor
83335440|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335441|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83335442|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335443|NCT01929603|Rifampin|rifampin|mesh-list
83335444|NCT01929603|Olaparib|olaparib|mesh-list
83335445|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83335446|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335447|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335448|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335449|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83335450|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
83335451|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83335452|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335453|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
83335454|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83335455|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83335456|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83335457|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83335458|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83335459|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83335460|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83335461|NCT04178460|Niraparib|niraparib|mesh-list
83335462|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83335463|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335464|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335465|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335466|NCT01928901|Thymol|thymol|mesh-list
83335467|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335468|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83335469|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
83335470|NCT04395105|Dexamethasone|dexamethasone|mesh-list
83335471|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335472|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
83335473|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
83335474|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335475|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335476|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335477|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
83335478|NCT04395105|Hormones|hormones|mesh-ancestor
83335479|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335480|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83335481|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335483|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
83335484|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
83335485|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335486|NCT01291108|Bimatoprost|bimatoprost|mesh-list
83335487|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83335488|NCT01929213|Bosentan|bosentan|mesh-list
83335489|NCT01929213|Udenafil|udenafil|mesh-list
83335490|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83335491|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83335492|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335493|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83335494|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83335495|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335496|NCT03430518|Durvalumab|durvalumab|mesh-list
83335497|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83335498|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335499|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83335500|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335501|NCT01925937|Ubiquinone|ubiquinone|mesh-list
83335502|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
83335503|NCT01925937|Atorvastatin|atorvastatin|mesh-list
83335504|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83335505|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83335506|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
83335507|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335508|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83335509|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83335510|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335511|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
83335512|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335513|NCT01925937|Vitamins|vitamins|mesh-ancestor
83335514|NCT03430362|Scopolamine|scopolamine|mesh-list
83335515|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83335516|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83335517|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
83335518|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
83335519|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335520|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335521|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335522|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
83335523|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83335524|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
83335525|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335526|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335527|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83335528|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
83335529|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
83335530|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83335531|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
83335532|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335533|NCT03055377|Expectorants|expectorants|mesh-ancestor
83335534|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335535|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83335536|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
83335537|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335538|NCT03055377|Protective Agents|protective agents|mesh-ancestor
83335539|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335540|NCT03055377|Antidotes|antidotes|mesh-ancestor
83335541|NCT03428022|Apatinib|apatinib|mesh-list
83335542|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335543|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83335544|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335545|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335546|NCT03054831|Oxycodone|oxycodone|mesh-list
83335547|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83335548|NCT03054831|Narcotics|narcotics|mesh-ancestor
83335549|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335550|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335551|NCT03054831|Analgesics|analgesics|mesh-ancestor
83335552|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
83335553|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335554|NCT00989781|Dexamethasone|dexamethasone|mesh-list
83335555|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83335556|NCT00989781|Hormones|hormones|mesh-list
83335557|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83335558|NCT00989781|Cosyntropin|cosyntropin|mesh-list
83335559|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83335560|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83335561|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
83335562|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335563|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
83335564|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
83335565|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335566|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335567|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335568|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
83335569|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335570|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83335571|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335572|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83335573|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335574|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335575|NCT03430128|Immunomodulating Agents|immunomodulating agents|mesh-list
83335576|NCT03430128|Immunologic Factors|immunologic factors|mesh-ancestor
83335577|NCT03430128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335578|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
83335579|NCT03427944|Calcium|calcium|mesh-list
83335580|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83335581|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335582|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
83335583|NCT03427944|Coagulants|coagulants|mesh-ancestor
83335584|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83335585|NCT01922193|Hormones|hormones|mesh-ancestor
83335586|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335587|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335588|NCT03429972|Paclitaxel|paclitaxel|mesh-list
83335589|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83335590|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335591|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
83335592|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
83335593|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
83335594|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335595|NCT05601999|Tenecteplase|tenecteplase|mesh-list
83335596|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83335597|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83335598|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335599|NCT01347034|Immunomodulating Agents|immunomodulating agents|mesh-list
83335600|NCT01347034|Immunologic Factors|immunologic factors|mesh-ancestor
83335601|NCT01347034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335602|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
83335603|NCT03079167|Hematinics|hematinics|mesh-ancestor
83335604|NCT03079011|Letrozole|letrozole|mesh-list
83335605|NCT03079011|Fulvestrant|fulvestrant|mesh-list
83335606|NCT03079011|Palbociclib|palbociclib|mesh-list
83335607|NCT03079011|Anastrozole|anastrozole|mesh-list
83335608|NCT03079011|Exemestane|exemestane|mesh-list
83335609|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83335610|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335611|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83335612|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335613|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335614|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83335615|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
83335616|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335617|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335618|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83335619|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83335620|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83335621|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83335622|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
83335623|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83335624|NCT03427632|Protective Agents|protective agents|mesh-ancestor
83335625|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335626|NCT03427554|Tretinoin|tretinoin|mesh-list
83335627|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335628|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
83335629|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
83335630|NCT01349920|Infliximab|infliximab|mesh-list
83335631|NCT01349920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83335632|NCT01349920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335633|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
83335634|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335635|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335636|NCT03128346|Aspirin|aspirin|mesh-list
83335637|NCT03128346|Acetaminophen|acetaminophen|mesh-list
83335638|NCT03128346|Fentanyl|fentanyl|mesh-list
83335639|NCT03128346|Hydromorphone|hydromorphone|mesh-list
83335640|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335641|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335642|NCT03128346|Analgesics|analgesics|mesh-ancestor
83335643|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
83335644|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335645|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335646|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335647|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335648|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83335649|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83335650|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335651|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83335652|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83335653|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335654|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
83335655|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83335656|NCT03128346|Narcotics|narcotics|mesh-ancestor
83335657|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335658|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83335659|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83335660|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
83335661|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
83335662|NCT03423030|Macozinone|macozinone|mesh-list
83335663|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
83335664|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83335665|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335666|NCT03427242|Apatinib|apatinib|mesh-list
83335667|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335668|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83335669|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335670|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335671|NCT01252732|Vancomycin|vancomycin|mesh-list
83335672|NCT01252732|Oritavancin|oritavancin|mesh-list
83335673|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83335674|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335675|NCT00989235|Abatacept|abatacept|mesh-list
83335676|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83335677|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335678|NCT00989235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83335679|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335680|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83335681|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
83335682|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335683|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335684|NCT03422874|Nelfinavir|nelfinavir|mesh-list
83335685|NCT03422874|Ixazomib|ixazomib|mesh-list
83335686|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335687|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
83335688|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335689|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335690|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83335691|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83335692|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83335693|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83335694|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
83335695|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335696|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83335697|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83335698|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83335699|NCT01253824|Norethindrone|norethindrone|mesh-list
83335700|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
83335701|NCT01253824|Norinyl|norinyl|mesh-list
83335702|NCT01253824|Mestranol|mestranol|mesh-list
83335703|NCT01253824|Estradiol|estradiol|mesh-list
83335704|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83335705|NCT01253824|Estrogens|estrogens|mesh-ancestor
83335706|NCT01253824|Hormones|hormones|mesh-ancestor
83335707|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335708|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335709|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83335710|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
83335711|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83335712|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83335713|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83335714|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83335715|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83335716|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83335718|NCT03422796|Sumatriptan|sumatriptan|mesh-list
83335719|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83335720|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
83335721|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335722|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335723|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83335724|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335725|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83335726|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83335727|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335728|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83335729|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
83335730|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83335731|NCT03422796|Protective Agents|protective agents|mesh-ancestor
83335732|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83335733|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83335734|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335735|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83335736|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83335737|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83335738|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
83335739|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335740|NCT04396977|Histamine|histamine|mesh-list
83335741|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
83335742|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
83335743|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335744|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335745|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335746|NCT03429738|Ibuprofen|ibuprofen|mesh-list
83335747|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
83335748|NCT03429738|Ephedrine|ephedrine|mesh-list
83335749|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335750|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335751|NCT03429738|Analgesics|analgesics|mesh-ancestor
83335752|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
83335753|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335754|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335755|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335756|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335757|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83335758|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335759|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335760|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83335761|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
83335762|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83335763|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335764|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
83335765|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83335766|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83335768|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
83335769|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335770|NCT01253902|Bimatoprost|bimatoprost|mesh-list
83335771|NCT01253902|Travoprost|travoprost|mesh-list
83335772|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83335773|NCT01253902|Latanoprost|latanoprost|mesh-list
83335774|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83335775|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83335776|NCT01253980|Amoxicillin|amoxicillin|mesh-list
83335777|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83335778|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335779|NCT00988533|Ivermectin|ivermectin|mesh-list
83335780|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83335781|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335782|NCT01350388|Febuxostat|febuxostat|mesh-list
83335783|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
83335784|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335785|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
83335786|NCT03154749|Carboplatin|carboplatin|mesh-list
83335787|NCT03154749|Docetaxel|docetaxel|mesh-list
83335788|NCT03154749|Epirubicin|epirubicin|mesh-list
83335789|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83335790|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
83335791|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335792|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335793|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83335794|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
83335795|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335796|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335797|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83335798|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
83335799|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
83335800|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
83335801|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83335802|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83335803|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83335804|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335805|NCT03422640|Apremilast|apremilast|mesh-list
83335806|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335807|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335808|NCT03422640|Analgesics|analgesics|mesh-ancestor
83335809|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
83335810|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335811|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335812|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335813|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335814|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83335815|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83335816|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335817|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335818|NCT01351090|Ketorolac|ketorolac|mesh-list
83335819|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
83335820|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83335821|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83335822|NCT01351090|Analgesics|analgesics|mesh-ancestor
83335823|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
83335824|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335825|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335826|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335827|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335828|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83335829|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335830|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335831|NCT01918644|Capecitabine|capecitabine|mesh-list
83335832|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83335833|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
83335834|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335835|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335836|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
83335837|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83335838|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83335839|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
83335840|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
83335841|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335842|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335843|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335844|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
83335845|NCT00987831|Hormones|hormones|mesh-ancestor
83335846|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335847|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83335848|NCT00987831|Protective Agents|protective agents|mesh-ancestor
83335849|NCT03608358|Metformin|metformin|mesh-list
83335850|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
83335851|NCT03608358|Saxagliptin|saxagliptin|mesh-list
83335852|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83335853|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335854|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83335855|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335856|NCT03608358|Incretins|incretins|mesh-ancestor
83335857|NCT03608358|Hormones|hormones|mesh-ancestor
83335858|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83335859|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83335860|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
83335861|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335862|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
83335863|NCT04274907|Venetoclax|venetoclax|mesh-list
83335864|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83335865|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335866|NCT04274907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83335867|NCT04274907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335868|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83335869|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83335870|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
83335871|NCT01256164|Coagulants|coagulants|mesh-ancestor
83335873|NCT03427086|Vitamins|vitamins|mesh-ancestor
83335874|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
83335875|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335876|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
83335877|NCT01887522|Vinblastine|vinblastine|mesh-list
83335878|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83335879|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335880|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
83335881|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
83335882|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
83335883|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335884|NCT03422406|Iodine|iodine|mesh-list
83335885|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83335886|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335887|NCT03422406|Trace Elements|trace elements|mesh-ancestor
83335888|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
83335889|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335890|NCT00986427|Cyclosporine|cyclosporine|mesh-list
83335891|NCT00986427|Cyclosporins|cyclosporins|mesh-list
83335892|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335893|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335894|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83335895|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
83335896|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335897|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
83335898|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335899|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
83335900|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83335901|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83335902|NCT03426462|Propofol|propofol|mesh-list
83335903|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83335904|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83335905|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335906|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83335907|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
83335908|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
83335909|NCT03421860|Phenylephrine|phenylephrine|mesh-list
83335910|NCT03421860|Epinephrine|epinephrine|mesh-list
83335911|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
83335912|NCT03421860|Ephedrine|ephedrine|mesh-list
83335913|NCT03421860|Norepinephrine|norepinephrine|mesh-list
83335914|NCT03421860|Ondansetron|ondansetron|mesh-list
83335915|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83335916|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83335917|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
83335918|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335919|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335920|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335921|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83335922|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83335923|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
83335924|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83335925|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83335926|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
83335927|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
83335928|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
83335929|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83335930|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
83335931|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83335932|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
83335933|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
83335934|NCT03421860|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83335935|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83335936|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
83335937|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83335938|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
83335939|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83335940|NCT03421860|Protective Agents|protective agents|mesh-ancestor
83335941|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83335943|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
83335944|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335945|NCT03421314|Protective Agents|protective agents|mesh-ancestor
83335946|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335947|NCT03421314|Trace Elements|trace elements|mesh-ancestor
83335948|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
83335949|NCT03425994|Emtricitabine|emtricitabine|mesh-list
83335950|NCT03425994|Cobicistat|cobicistat|mesh-list
83335951|NCT03425994|Elvitegravir|elvitegravir|mesh-list
83335952|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
83335953|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335954|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83335955|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83335956|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335957|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335958|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83335959|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83335960|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83335961|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83335962|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83335963|NCT03421002|Micafungin|micafungin|mesh-list
83335964|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
83335965|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83335966|NCT00754260|Caffeine|caffeine|mesh-list
83335967|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83335968|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335969|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83335970|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83335971|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335972|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83335973|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83335974|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
83335975|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335976|NCT02546232|Paclitaxel|paclitaxel|mesh-list
83335977|NCT02546232|Carboplatin|carboplatin|mesh-list
83335978|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83335979|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335980|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
83335981|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
83335982|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
83335983|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335984|NCT02521038|Ticagrelor|ticagrelor|mesh-list
83335985|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83335986|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83335987|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83335988|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83335989|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
83335990|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83335991|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83335992|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83335993|NCT00985959|Prednisolone|prednisolone|mesh-list
83335995|NCT00985959|Melphalan|melphalan|mesh-list
83335996|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83335997|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83335998|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
83335999|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336000|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83336001|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336002|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
83336003|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336004|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336005|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
83336006|NCT00985959|Hormones|hormones|mesh-ancestor
83336007|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336008|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83336009|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83336010|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83336011|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336012|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83336013|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83336014|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336015|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336016|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
83336017|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336018|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83336019|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336020|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83336021|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336022|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336023|NCT01351480|Abatacept|abatacept|mesh-list
83336024|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83336025|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336026|NCT01351480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83336027|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336028|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336029|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
83336030|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336031|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336032|NCT01352182|Pioglitazone|pioglitazone|mesh-list
83336033|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336034|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336035|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
83336036|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83336037|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336038|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336039|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336040|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83336041|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83336042|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83336043|NCT01294384|Laxatives|laxatives|mesh-ancestor
83336044|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336045|NCT01257802|Leuprolide|leuprolide|mesh-list
83336046|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83336047|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
83336048|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83336049|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336050|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83336051|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336052|NCT05607303|Estrogens|estrogens|mesh-list
83336053|NCT05607303|Hormones|hormones|mesh-ancestor
83336054|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336055|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336056|NCT00984009|Colchicine|colchicine|mesh-list
83336057|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
83336058|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336059|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
83336060|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
83336061|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
83336062|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336064|NCT05606913|Dulaglutide|dulaglutide|mesh-list
83336065|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336066|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336067|NCT00983931|Cyclosporine|cyclosporine|mesh-list
83336068|NCT00983931|Colchicine|colchicine|mesh-list
83336069|NCT00983931|Cyclosporins|cyclosporins|mesh-list
83336070|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336071|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336072|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336073|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
83336074|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336075|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
83336076|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336077|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
83336078|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336079|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83336080|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
83336081|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
83336082|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
83336083|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
83336084|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336085|NCT00983853|Ribavirin|ribavirin|mesh-list
83336086|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83336087|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
83336088|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336090|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336091|NCT05604261|Rabeprazole|rabeprazole|mesh-list
83336092|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83336093|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336094|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83336095|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336096|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336097|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
83336098|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83336099|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
83336100|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336101|NCT03032601|Expectorants|expectorants|mesh-ancestor
83336102|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
83336103|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83336104|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
83336105|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336106|NCT03032601|Protective Agents|protective agents|mesh-ancestor
83336107|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336108|NCT03032601|Antidotes|antidotes|mesh-ancestor
83336109|NCT05603013|Vinorelbine|vinorelbine|mesh-list
83336110|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83336111|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83336112|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336113|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
83336114|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
83336115|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
83336116|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336117|NCT05603013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83336118|NCT00983073|Tapentadol|tapentadol|mesh-list
83336119|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83336120|NCT00983073|Narcotics|narcotics|mesh-ancestor
83336121|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336122|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336123|NCT00983073|Analgesics|analgesics|mesh-ancestor
83336124|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
83336125|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336126|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83336127|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83336128|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336129|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336130|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
83336131|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336132|NCT05603715|Bromides|bromides|mesh-list
83336133|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83336134|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
83336135|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83336136|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336137|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336138|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
83336139|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336140|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336141|NCT00981747|Losartan|losartan|mesh-list
83336142|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
83336143|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
83336144|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83336145|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83336146|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336147|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336148|NCT00981747|Urological Agents|urological agents|mesh-ancestor
83336149|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83336150|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83336151|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83336152|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83336153|NCT03046251|Natalizumab|natalizumab|mesh-list
83336154|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
83336155|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336156|NCT03029169|Amiodarone|amiodarone|mesh-list
83336157|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83336158|NCT03029169|Propafenone|propafenone|mesh-list
83336159|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
83336160|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83336161|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336162|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336163|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83336164|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83336165|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83336166|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336167|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83336168|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83336169|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83336170|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83336171|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
83336172|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83336173|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
83336174|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336175|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336176|NCT01353976|Econazole|econazole|mesh-list
83336177|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
83336178|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336179|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83336180|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83336181|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336182|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336183|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83336184|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
83336185|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336186|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336187|NCT01354444|Carvedilol|carvedilol|mesh-list
83336188|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83336189|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83336190|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
83336191|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336192|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336193|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336194|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83336195|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
83336196|NCT01354444|Protective Agents|protective agents|mesh-ancestor
83336197|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83336198|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336199|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83336200|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
83336201|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83336202|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83336203|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
83336204|NCT03009526|Piperaquine|piperaquine|mesh-list
83336205|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
83336206|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83336207|NCT03009526|Artenimol|artenimol|mesh-list
83336209|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83336210|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83336211|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336212|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83336213|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336214|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336215|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83336216|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83336217|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336218|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336219|NCT01354990|Incretins|incretins|mesh-ancestor
83336220|NCT01354990|Hormones|hormones|mesh-ancestor
83336221|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336222|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83336223|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
83336224|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336225|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336226|NCT01260454|Capsaicin|capsaicin|mesh-list
83336227|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
83336228|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
83336229|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
83336230|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336231|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336232|NCT01296646|Naltrexone|naltrexone|mesh-list
83336233|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83336234|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83336235|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336236|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
83336237|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336238|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83336239|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83336240|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
83336241|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83336242|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83336243|NCT01297348|Norinyl|norinyl|mesh-list
83336244|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
83336245|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
83336246|NCT01297348|Estradiol|estradiol|mesh-list
83336247|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83336248|NCT01297348|Estrogens|estrogens|mesh-ancestor
83336249|NCT01297348|Hormones|hormones|mesh-ancestor
83336250|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336251|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336252|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83336253|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83336254|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83336255|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83336256|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83336257|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83336258|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83336259|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83336260|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
83336261|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336262|NCT01260688|Dasatinib|dasatinib|mesh-list
83336263|NCT01260688|Cediranib|cediranib|mesh-list
83336264|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336265|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83336266|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336267|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336268|NCT01298128|NuvaRing|nuvaring|mesh-list
83336269|NCT01298128|Desogestrel|desogestrel|mesh-list
83336270|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83336271|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
83336272|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83336273|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336274|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83336275|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83336276|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83336277|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83336278|NCT01298128|Progestins|progestins|mesh-ancestor
83336279|NCT01298128|Hormones|hormones|mesh-ancestor
83336280|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336281|NCT02199964|Cyclosporine|cyclosporine|mesh-list
83336282|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
83336283|NCT02199964|Cyclosporins|cyclosporins|mesh-list
83336284|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336285|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336286|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336287|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
83336288|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336289|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
83336290|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336291|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
83336292|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336293|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83336294|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83336295|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83336296|NCT02323048|Methamphetamine|methamphetamine|mesh-list
83336297|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83336298|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336299|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
83336300|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
83336301|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336302|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
83336303|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336304|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336305|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
83336306|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83336307|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83336308|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336309|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83336310|NCT01265446|Lidocaine|lidocaine|mesh-list
83336311|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
83336312|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
83336313|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336314|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336315|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
83336316|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336317|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83336318|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83336319|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83336320|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336321|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336322|NCT04352062|Amoxicillin|amoxicillin|mesh-list
83336323|NCT04352062|Levofloxacin|levofloxacin|mesh-list
83336324|NCT04352062|Ofloxacin|ofloxacin|mesh-list
83336325|NCT04352062|Melatonin|melatonin|mesh-list
83336326|NCT04352062|Pantoprazole|pantoprazole|mesh-list
83336327|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83336328|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336329|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
83336330|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336331|NCT04352062|Protective Agents|protective agents|mesh-ancestor
83336332|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336333|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336334|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83336335|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83336336|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83336337|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336338|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336339|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83336340|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83336341|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83336342|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336343|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83336344|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83336345|NCT01302808|Romidepsin|romidepsin|mesh-list
83336346|NCT01302808|Antiemetics|antiemetics|mesh-list
83336347|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336348|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83336349|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336350|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336351|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83336352|NCT01302808|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83336353|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
83336354|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336355|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336356|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336357|NCT01267240|Capecitabine|capecitabine|mesh-list
83336358|NCT01267240|Vorinostat|vorinostat|mesh-list
83336359|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83336360|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
83336361|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336362|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336363|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83336364|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336365|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83336366|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83336367|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83336368|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336369|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336370|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336371|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336372|NCT01855919|Analgesics|analgesics|mesh-ancestor
83336373|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
83336374|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336375|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
83336376|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336377|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
83336378|NCT01871285|Morphine|morphine|mesh-list
83336379|NCT01871285|Oxycodone|oxycodone|mesh-list
83336380|NCT01871285|Buprenorphine|buprenorphine|mesh-list
83336381|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83336382|NCT01871285|Narcotics|narcotics|mesh-ancestor
83336383|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336384|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336385|NCT01871285|Analgesics|analgesics|mesh-ancestor
83336386|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
83336387|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336388|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83336389|NCT01358266|Sirolimus|sirolimus|mesh-list
83336390|NCT01358266|Temsirolimus|temsirolimus|mesh-list
83336391|NCT01358266|MTOR Inhibitors|mtor inhibitors|mesh-list
83336392|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83336393|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336394|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83336395|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336396|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
83336397|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336398|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
83336399|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336400|NCT01358266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83336401|NCT01358266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336402|NCT01358266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336403|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83336404|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83336405|NCT01870973|Analgesics|analgesics|mesh-list
83336406|NCT01870973|Anesthetics|anesthetics|mesh-list
83336407|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336408|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336409|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336410|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
83336411|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
83336412|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336413|NCT01267864|Ketorolac|ketorolac|mesh-list
83336414|NCT01267864|Valproic Acid|valproic acid|mesh-list
83336415|NCT01267864|Metoclopramide|metoclopramide|mesh-list
83336416|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83336417|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83336418|NCT01267864|Analgesics|analgesics|mesh-ancestor
83336419|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
83336420|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336421|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336422|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336423|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336424|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83336425|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336426|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336428|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
83336429|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336430|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
83336431|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83336432|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336433|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336434|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
83336435|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
83336436|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336437|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83336438|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83336439|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
83336440|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
83336441|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83336442|NCT01854827|Antibodies|antibodies|mesh-list
83336443|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
83336444|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83336445|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
83336446|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336447|NCT01360450|Clonidine|clonidine|mesh-list
83336448|NCT01360450|Analgesics|analgesics|mesh-ancestor
83336449|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
83336450|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336451|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336452|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83336453|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
83336454|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
83336455|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83336456|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83336457|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83336458|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
83336459|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336460|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336461|NCT01303744|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
83336462|NCT01303744|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83336463|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336464|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336465|NCT01361620|Aspirin|aspirin|mesh-list
83336466|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83336467|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83336468|NCT01361620|Analgesics|analgesics|mesh-ancestor
83336469|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
83336470|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336471|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336472|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336473|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336474|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83336475|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83336476|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336477|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83336478|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83336479|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336480|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
83336481|NCT01305772|Panitumumab|panitumumab|mesh-list
83336482|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83336483|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336484|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
83336485|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83336486|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83336487|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83336488|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336489|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336490|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
83336491|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336492|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336493|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83336494|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336495|NCT01271686|Bimatoprost|bimatoprost|mesh-list
83336496|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83336497|NCT01854047|Albuterol|albuterol|mesh-list
83336498|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83336499|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
83336500|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336501|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336502|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83336503|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83336504|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
83336505|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83336506|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83336507|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83336508|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83336509|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83336510|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336511|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336512|NCT04605731|Durvalumab|durvalumab|mesh-list
83336513|NCT04605731|Ipilimumab|ipilimumab|mesh-list
83336514|NCT04605731|Tremelimumab|tremelimumab|mesh-list
83336515|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
83336516|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83336517|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
83336518|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83336519|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336520|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
83336521|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336522|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83336523|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336524|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
83336525|NCT01307956|Leucovorin|leucovorin|mesh-list
83336526|NCT01307956|Folic Acid|folic acid|mesh-list
83336527|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83336528|NCT01307956|Panitumumab|panitumumab|mesh-list
83336529|NCT01307956|Fluorouracil|fluorouracil|mesh-list
83336530|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
83336531|NCT01307956|Antibodies|antibodies|mesh-list
83336532|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
83336533|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83336534|NCT01307956|Calcium|calcium|mesh-list
83336535|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
83336536|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
83336537|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336538|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336539|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83336540|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83336541|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
83336542|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336543|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83336544|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336545|NCT01307956|Antidotes|antidotes|mesh-ancestor
83336546|NCT01307956|Protective Agents|protective agents|mesh-ancestor
83336547|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
83336548|NCT01307956|Vitamins|vitamins|mesh-ancestor
83336549|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
83336550|NCT01307956|Hematinics|hematinics|mesh-ancestor
83336551|NCT01870739|Amlodipine|amlodipine|mesh-list
83336552|NCT01870739|Valsartan|valsartan|mesh-list
83336553|NCT01870739|Olmesartan|olmesartan|mesh-list
83336554|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83336555|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83336556|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83336557|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83336558|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336559|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336560|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83336561|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336562|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
83336563|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83336564|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83336565|NCT01272388|Tadalafil|tadalafil|mesh-list
83336566|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
83336567|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83336568|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83336569|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336570|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336571|NCT01272388|Urological Agents|urological agents|mesh-ancestor
83336572|NCT01870583|Iodine|iodine|mesh-list
83336573|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
83336574|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83336575|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
83336576|NCT01870583|Povidone|povidone|mesh-list
83336577|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83336578|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336579|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
83336580|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
83336581|NCT01870583|Trace Elements|trace elements|mesh-ancestor
83336582|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
83336583|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336584|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
83336585|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
83336586|NCT04351594|Menthol|menthol|mesh-list
83336587|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
83336588|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
83336589|NCT01308814|Estradiol|estradiol|mesh-list
83336590|NCT01308814|Estrogens|estrogens|mesh-ancestor
83336591|NCT01308814|Hormones|hormones|mesh-ancestor
83336592|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336593|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336594|NCT03009604|Simethicone|simethicone|mesh-list
83336595|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
83336596|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336597|NCT03009604|Emollients|emollients|mesh-ancestor
83336598|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
83336599|NCT01275664|Dexamethasone|dexamethasone|mesh-list
83336600|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
83336601|NCT01275664|Cisplatin|cisplatin|mesh-list
83336602|NCT01275664|Carboplatin|carboplatin|mesh-list
83336603|NCT01275664|Aprepitant|aprepitant|mesh-list
83336604|NCT01275664|Granisetron|granisetron|mesh-list
83336605|NCT01275664|Ichthammol|ichthammol|mesh-list
83336606|NCT01275664|BB 1101|bb 1101|mesh-list
83336607|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336608|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
83336609|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
83336610|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336611|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336612|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336613|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
83336614|NCT01275664|Hormones|hormones|mesh-ancestor
83336615|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336616|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83336617|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336618|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
83336619|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336620|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336621|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83336622|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336623|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
83336624|NCT01275664|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83336625|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83336626|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
83336627|NCT01613027|Rituximab|rituximab|mesh-list
83336628|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83336629|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336630|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
83336631|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336632|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336633|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
83336634|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83336635|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83336636|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83336637|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336638|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336639|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
83336640|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336641|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336642|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83336643|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336644|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
83336645|NCT01369732|Hematinics|hematinics|mesh-ancestor
83336646|NCT01869725|Octreotide|octreotide|mesh-list
83336647|NCT01869725|Edotreotide|edotreotide|mesh-list
83336648|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
83336649|NCT01869725|Somatostatin|somatostatin|mesh-list
83336650|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336651|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83336652|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336653|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336654|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336655|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83336656|NCT01869725|Hormones|hormones|mesh-ancestor
83336657|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336658|NCT01309360|Midazolam|midazolam|mesh-list
83336659|NCT01309360|Prilocaine|prilocaine|mesh-list
83336660|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83336661|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83336662|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336663|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336664|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83336665|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83336666|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336667|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83336668|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
83336669|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
83336670|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
83336671|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
83336672|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336673|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336674|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
83336675|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
83336676|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336677|NCT01851863|Flupenthixol|flupenthixol|mesh-list
83336678|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
83336679|NCT01851863|Omeprazole|omeprazole|mesh-list
83336680|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83336681|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336682|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83336683|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336684|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336685|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83336686|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83336687|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336688|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336689|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336690|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83336691|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
83336692|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336693|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
83336694|NCT01369888|Fludarabine|fludarabine|mesh-list
83336695|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336696|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
83336697|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336698|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336699|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83336700|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
83336701|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336702|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336703|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83336704|NCT01850615|Insulin|insulin|mesh-list
83336705|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83336706|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
83336707|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336708|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336709|NCT01364584|Exenatide|exenatide|mesh-list
83336710|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336711|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336712|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83336713|NCT01364584|Incretins|incretins|mesh-ancestor
83336714|NCT01364584|Hormones|hormones|mesh-ancestor
83336715|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336716|NCT04602221|Lamotrigine|lamotrigine|mesh-list
83336717|NCT04602221|BI 425809|bi 425809|mesh-list
83336718|NCT04602221|BI 409306|bi 409306|mesh-list
83336719|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
83336720|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83336721|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336722|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336723|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83336724|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336725|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83336726|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83336727|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336728|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336729|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83336730|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83336731|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336732|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
83336733|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83336734|NCT01280110|Laxatives|laxatives|mesh-ancestor
83336735|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336736|NCT01374802|Ritonavir|ritonavir|mesh-list
83336737|NCT01374802|Darunavir|darunavir|mesh-list
83336738|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83336739|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83336740|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
83336741|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336742|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336743|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83336744|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83336745|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
83336746|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336747|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83336748|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83336749|NCT01375660|Vitamin D|vitamin d|mesh-list
83336750|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
83336751|NCT01375660|Vitamins|vitamins|mesh-ancestor
83336752|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
83336753|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336754|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83336755|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83336756|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
83336757|NCT01868477|Deferasirox|deferasirox|mesh-list
83336758|NCT01868477|Hematinics|hematinics|mesh-ancestor
83336759|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83336760|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
83336761|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
83336762|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336763|NCT01849289|Insulin|insulin|mesh-list
83336764|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83336765|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
83336766|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336767|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336768|NCT01868243|Warfarin|warfarin|mesh-list
83336769|NCT01868243|Dabigatran|dabigatran|mesh-list
83336770|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
83336771|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
83336772|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83336773|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
83336774|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336775|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336776|NCT01611935|Vasopressins|vasopressins|mesh-list
83336777|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
83336778|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
83336779|NCT01611935|Coagulants|coagulants|mesh-ancestor
83336780|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83336781|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83336782|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
83336783|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336784|NCT02201212|Everolimus|everolimus|mesh-list
83336785|NCT02201212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83336786|NCT02201212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83336787|NCT02201212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336788|NCT02201212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336789|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336790|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
83336791|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336792|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336793|NCT01376362|Interferons|interferons|mesh-list
83336794|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
83336795|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336796|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
83336797|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336798|NCT03009292|Lenvatinib|lenvatinib|mesh-list
83336799|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336800|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83336801|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336802|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336804|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336805|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
83336806|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
83336807|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336808|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336809|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336810|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
83336811|NCT01962792|Hormones|hormones|mesh-ancestor
83336812|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336813|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83336814|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336815|NCT01849055|Celecoxib|celecoxib|mesh-list
83336816|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83336817|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83336818|NCT01849055|Analgesics|analgesics|mesh-ancestor
83336819|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
83336820|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336821|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336822|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336823|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336824|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83336825|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83336826|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336827|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336828|NCT01404832|Lansoprazole|lansoprazole|mesh-list
83336829|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
83336830|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83336831|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336832|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83336833|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336834|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336835|NCT03420534|Iloperidone|iloperidone|mesh-list
83336836|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83336837|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83336838|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336839|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336840|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336841|NCT01313494|Albuterol|albuterol|mesh-list
83336842|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83336843|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
83336844|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336845|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336846|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83336847|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
83336848|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
83336849|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83336850|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83336851|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83336852|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83336853|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
83336854|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336855|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336856|NCT01407094|Sertraline|sertraline|mesh-list
83336857|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
83336858|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336859|NCT01407094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83336860|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83336861|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336862|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336863|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336864|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
83336865|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336866|NCT01867307|Empagliflozin|empagliflozin|mesh-list
83336867|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83336868|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336869|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336870|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336871|NCT01845077|Metformin|metformin|mesh-list
83336872|NCT01845077|Linagliptin|linagliptin|mesh-list
83336873|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83336874|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336875|NCT01845077|Incretins|incretins|mesh-ancestor
83336876|NCT01845077|Hormones|hormones|mesh-ancestor
83336877|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336878|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83336879|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
83336880|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336881|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336882|NCT01866917|Ropivacaine|ropivacaine|mesh-list
83336883|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
83336884|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
83336885|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336886|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336887|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
83336888|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336889|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83336890|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83336891|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83336892|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83336893|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336894|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336895|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336896|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
83336897|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83336898|NCT01410058|Efavirenz|efavirenz|mesh-list
83336899|NCT01410058|Nevirapine|nevirapine|mesh-list
83336900|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83336901|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83336902|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336903|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336904|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
83336905|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336906|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83336907|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83336908|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83336909|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83336910|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83336911|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83336912|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83336913|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83336914|NCT01380106|Lenalidomide|lenalidomide|mesh-list
83336915|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
83336916|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336917|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83336918|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83336919|NCT01380106|Growth Substances|growth substances|mesh-ancestor
83336920|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83336921|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336922|NCT01381120|Acetaminophen|acetaminophen|mesh-list
83336923|NCT01381120|Oxycodone|oxycodone|mesh-list
83336924|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
83336925|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83336926|NCT01381120|Analgesics|analgesics|mesh-ancestor
83336927|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
83336928|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336929|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336930|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
83336931|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83336932|NCT01381120|Narcotics|narcotics|mesh-ancestor
83336933|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83336934|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83336935|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83336936|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
83336937|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83336938|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336939|NCT01381120|Urological Agents|urological agents|mesh-ancestor
83336940|NCT01316770|Dexamethasone|dexamethasone|mesh-list
83336941|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336943|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
83336944|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336945|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336946|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336947|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
83336948|NCT01316770|Hormones|hormones|mesh-ancestor
83336949|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336950|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83336951|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336952|NCT01318408|Levetiracetam|levetiracetam|mesh-list
83336953|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
83336954|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
83336955|NCT01319110|Ubiquinone|ubiquinone|mesh-list
83336956|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
83336957|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
83336958|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336959|NCT01319110|Vitamins|vitamins|mesh-ancestor
83336960|NCT03008512|Paclitaxel|paclitaxel|mesh-list
83336961|NCT03008512|genexol-PM|genexol-pm|mesh-list
83336962|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83336963|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336964|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
83336965|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
83336966|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
83336967|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336968|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
83336969|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
83336970|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83336971|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83336972|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336973|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83336974|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83336975|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83336976|NCT01411696|Dexamethasone|dexamethasone|mesh-list
83336977|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83336978|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
83336979|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
83336980|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83336981|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336982|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83336983|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
83336984|NCT01411696|Hormones|hormones|mesh-ancestor
83336985|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83336986|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83336987|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336988|NCT01412164|Sirolimus|sirolimus|mesh-list
83336989|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83336990|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83336991|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83336992|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83336993|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
83336994|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83336995|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
83336996|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83336997|NCT01844687|Cannabidiol|cannabidiol|mesh-list
83336998|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
83336999|NCT01844531|Metformin|metformin|mesh-list
83337000|NCT01844531|Empagliflozin|empagliflozin|mesh-list
83337001|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83337002|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337003|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83337004|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337005|NCT02367456|Azacitidine|azacitidine|mesh-list
83337006|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337007|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
83337008|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337009|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337010|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337011|NCT03420378|Vitamin D|vitamin d|mesh-list
83337012|NCT03420378|Vitamins|vitamins|mesh-ancestor
83337013|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
83337014|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337015|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83337016|NCT03425448|Heparin|heparin|mesh-list
83337017|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
83337018|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83337019|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83337020|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337021|NCT03419910|Cyclosporine|cyclosporine|mesh-list
83337022|NCT03419910|Deucravacitinib|deucravacitinib|mesh-list
83337023|NCT03419910|Cyclosporins|cyclosporins|mesh-list
83337024|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337025|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337026|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337027|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
83337028|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337029|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
83337030|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337031|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337032|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337033|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83337034|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83337035|NCT03415386|Anticoagulants|anticoagulants|mesh-list
83337036|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83337038|NCT01865747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83337039|NCT01865747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83337040|NCT01865747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337041|NCT01865747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337042|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337043|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
83337044|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337045|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337046|NCT03424980|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83337047|NCT03424980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83337048|NCT03424980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337049|NCT03424980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337050|NCT03424746|Edetic Acid|edetic acid|mesh-list
83337051|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
83337052|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
83337053|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83337054|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
83337055|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
83337056|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337057|NCT03424746|Antidotes|antidotes|mesh-ancestor
83337058|NCT03424746|Protective Agents|protective agents|mesh-ancestor
83337059|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337060|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83337061|NCT03414918|Clarithromycin|clarithromycin|mesh-list
83337062|NCT03414918|Roxithromycin|roxithromycin|mesh-list
83337063|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83337064|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337065|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83337066|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337067|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337068|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83337069|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83337070|NCT04448496|Dexamethasone|dexamethasone|mesh-list
83337071|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337072|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
83337073|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
83337074|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337075|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337076|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337077|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
83337078|NCT04448496|Hormones|hormones|mesh-ancestor
83337079|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83337080|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83337081|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337082|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
83337083|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
83337084|NCT03419442|Docetaxel|docetaxel|mesh-list
83337085|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337086|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
83337087|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
83337088|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
83337089|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337091|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
83337092|NCT01412710|Vitamins|vitamins|mesh-ancestor
83337093|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
83337094|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337095|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83337096|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83337097|NCT01843205|Methamphetamine|methamphetamine|mesh-list
83337098|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83337099|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337100|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
83337101|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
83337102|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337103|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
83337104|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337105|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337106|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337107|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83337108|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83337109|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337110|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83337111|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
83337112|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83337113|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337114|NCT03419130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83337115|NCT03419130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337116|NCT03414840|Atorvastatin|atorvastatin|mesh-list
83337117|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83337118|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83337119|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
83337120|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337121|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83337122|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83337123|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337124|NCT03418974|Atorvastatin|atorvastatin|mesh-list
83337125|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83337126|NCT03418974|Pitavastatin|pitavastatin|mesh-list
83337127|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83337128|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83337129|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
83337130|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337131|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83337132|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83337133|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337134|NCT03424356|Fentanyl|fentanyl|mesh-list
83337135|NCT03424356|Narcotics|narcotics|mesh-list
83337136|NCT03424356|Analgesics|analgesics|mesh-list
83337137|NCT03424356|Bromides|bromides|mesh-list
83337138|NCT03424356|Propofol|propofol|mesh-list
83337139|NCT03424356|Rocuronium|rocuronium|mesh-list
83337140|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83337141|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337142|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337143|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83337144|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
83337145|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
83337146|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83337147|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
83337148|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337149|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83337150|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
83337151|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83337152|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83337153|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83337154|NCT03414450|Dasatinib|dasatinib|mesh-list
83337155|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337156|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83337157|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337158|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337159|NCT01389076|Methotrexate|methotrexate|mesh-list
83337160|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
83337161|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83337162|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
83337163|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337164|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337165|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337166|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
83337167|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337168|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337169|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337170|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337171|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83337172|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337173|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
83337174|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337175|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83337176|NCT03127800|Morphine|morphine|mesh-list
83337177|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83337178|NCT03127800|Narcotics|narcotics|mesh-ancestor
83337179|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337180|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337181|NCT03127800|Analgesics|analgesics|mesh-ancestor
83337182|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
83337183|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337184|NCT01389856|Bosentan|bosentan|mesh-list
83337185|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83337186|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83337187|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337188|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83337189|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337190|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337191|NCT01323010|Albuterol|albuterol|mesh-list
83337192|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83337193|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
83337194|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337195|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337196|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83337197|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
83337198|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
83337199|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337200|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83337201|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83337202|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83337203|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337204|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337205|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337206|NCT03423810|Hydralazine|hydralazine|mesh-list
83337207|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83337208|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
83337209|NCT01390246|Bupropion|bupropion|mesh-list
83337210|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83337212|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337213|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83337214|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83337215|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337216|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337217|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
83337218|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337219|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337220|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83337221|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83337222|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337223|NCT01390870|Alfuzosin|alfuzosin|mesh-list
83337224|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337225|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337226|NCT01390870|Urological Agents|urological agents|mesh-ancestor
83337227|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83337228|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83337229|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83337230|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337231|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337232|NCT03418506|Lobeline|lobeline|mesh-list
83337233|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83337234|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
83337235|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337236|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337237|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83337238|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83337239|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
83337240|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337241|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337242|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
83337243|NCT01842581|Rifaximin|rifaximin|mesh-list
83337244|NCT01842581|Lactulose|lactulose|mesh-list
83337245|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83337246|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337247|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337248|NCT04448028|Esomeprazole|esomeprazole|mesh-list
83337249|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83337250|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83337251|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337252|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337253|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337254|NCT01833533|Ribavirin|ribavirin|mesh-list
83337255|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
83337256|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337257|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
83337258|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337259|NCT03413436|Cisplatin|cisplatin|mesh-list
83337260|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337261|NCT01833455|Flecainide|flecainide|mesh-list
83337262|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83337263|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83337264|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83337265|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337266|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337267|NCT03413358|Carboplatin|carboplatin|mesh-list
83337268|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337269|NCT01833143|Acyclovir|acyclovir|mesh-list
83337270|NCT01833143|Bortezomib|bortezomib|mesh-list
83337271|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337272|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
83337273|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337274|NCT03411096|Ropivacaine|ropivacaine|mesh-list
83337275|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337276|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
83337277|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337278|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337279|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
83337280|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337281|NCT03417648|Vitamin E|vitamin e|mesh-list
83337282|NCT03417648|Vitamins|vitamins|mesh-ancestor
83337283|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
83337284|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337285|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
83337286|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337287|NCT03417648|Protective Agents|protective agents|mesh-ancestor
83337288|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
83337290|NCT01831817|Calcium|calcium|mesh-list
83337291|NCT01831817|Fluorides|fluorides|mesh-list
83337292|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
83337293|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
83337294|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83337295|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337296|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83337297|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
83337298|NCT01831817|Protective Agents|protective agents|mesh-ancestor
83337299|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83337300|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337301|NCT03412500|Vancomycin|vancomycin|mesh-list
83337302|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83337303|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337304|NCT01840943|Topotecan|topotecan|mesh-list
83337305|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83337306|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83337307|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337308|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337309|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337310|NCT05171400|Insulin|insulin|mesh-list
83337311|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83337312|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337313|NCT02203630|Phenylephrine|phenylephrine|mesh-list
83337314|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
83337315|NCT02203630|Norepinephrine|norepinephrine|mesh-list
83337316|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83337317|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
83337318|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
83337319|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337320|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337321|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
83337322|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83337323|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
83337324|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
83337325|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83337326|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83337327|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83337328|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337329|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337330|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337331|NCT02203630|Protective Agents|protective agents|mesh-ancestor
83337332|NCT04593329|Dipyrone|dipyrone|mesh-list
83337333|NCT04593329|Tramadol|tramadol|mesh-list
83337334|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83337335|NCT04593329|Narcotics|narcotics|mesh-ancestor
83337336|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337337|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337338|NCT04593329|Analgesics|analgesics|mesh-ancestor
83337339|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
83337340|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337341|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337342|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337343|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337344|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337345|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
83337346|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83337347|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83337348|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337349|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83337350|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83337351|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337352|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337353|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
83337354|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337355|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83337356|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83337357|NCT02520570|Urinastatin|urinastatin|mesh-list
83337358|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
83337359|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83337360|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
83337361|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337362|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337363|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
83337364|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
83337365|NCT03411798|Methotrexate|methotrexate|mesh-list
83337366|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83337367|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
83337368|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337369|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337370|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337371|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
83337372|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337373|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337374|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337375|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337376|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83337377|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337378|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
83337379|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337380|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83337381|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
83337382|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83337383|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83337384|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337385|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337386|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337387|NCT03411798|Analgesics|analgesics|mesh-ancestor
83337388|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
83337389|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337390|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337391|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337392|NCT03408756|Methotrexate|methotrexate|mesh-list
83337393|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83337394|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
83337395|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337396|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337397|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337398|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
83337399|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337400|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337401|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337402|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337403|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83337404|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337405|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
83337406|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337407|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83337408|NCT01394614|Vaccines|vaccines|mesh-list
83337409|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
83337410|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337411|NCT04588818|Adalimumab|adalimumab|mesh-list
83337412|NCT04588818|Methotrexate|methotrexate|mesh-list
83337413|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83337414|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
83337415|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337416|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337417|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337418|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
83337419|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337420|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337421|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337422|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337423|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83337424|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337425|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
83337426|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337427|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83337428|NCT04588818|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83337429|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337430|NCT01422226|Alprostadil|alprostadil|mesh-list
83337431|NCT01422226|Misoprostol|misoprostol|mesh-list
83337432|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83337433|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
83337434|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337435|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337436|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83337437|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337438|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
83337439|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83337440|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
83337441|NCT01422226|Urological Agents|urological agents|mesh-ancestor
83337442|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
83337443|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
83337444|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337445|NCT01423162|Protective Agents|protective agents|mesh-ancestor
83337446|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337447|NCT01423162|Vitamins|vitamins|mesh-ancestor
83337448|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
83337449|NCT01328782|Acetaminophen|acetaminophen|mesh-list
83337450|NCT01328782|Oxycodone|oxycodone|mesh-list
83337451|NCT01328782|Bupivacaine|bupivacaine|mesh-list
83337452|NCT01328782|Ropivacaine|ropivacaine|mesh-list
83337453|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337454|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
83337455|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337456|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337457|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
83337458|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337459|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337460|NCT01328782|Analgesics|analgesics|mesh-ancestor
83337461|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
83337462|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83337463|NCT01328782|Narcotics|narcotics|mesh-ancestor
83337464|NCT04447326|Endostar protein|endostar protein|mesh-list
83337465|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83337466|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83337467|NCT04447326|Growth Substances|growth substances|mesh-ancestor
83337468|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337469|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
83337470|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337471|NCT03411330|Lidocaine|lidocaine|mesh-list
83337472|NCT03411330|Bupivacaine|bupivacaine|mesh-list
83337473|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337474|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
83337475|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337476|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337477|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
83337478|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337479|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83337480|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83337481|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83337482|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337483|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337484|NCT03411252|Mirabegron|mirabegron|mesh-list
83337485|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83337486|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83337487|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83337488|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337489|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337490|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337491|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337492|NCT03411252|Urological Agents|urological agents|mesh-ancestor
83337493|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83337494|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
83337495|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337496|NCT01830881|Ibuprofen|ibuprofen|mesh-list
83337497|NCT01830881|Lidocaine|lidocaine|mesh-list
83337498|NCT01830881|Midazolam|midazolam|mesh-list
83337499|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337500|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
83337501|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337502|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337503|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
83337504|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337505|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83337506|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83337507|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83337508|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337509|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337510|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83337511|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83337512|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83337513|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83337514|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337515|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83337516|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
83337517|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
83337518|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
83337519|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337520|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337521|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337522|NCT01830881|Analgesics|analgesics|mesh-ancestor
83337523|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337524|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337525|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83337526|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337527|NCT01396486|Inositol|inositol|mesh-list
83337528|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
83337529|NCT01396486|Vitamins|vitamins|mesh-ancestor
83337530|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
83337531|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337532|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
83337533|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
83337534|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337535|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337536|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337537|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
83337538|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
83337539|NCT03404544|Carbetocin|carbetocin|mesh-list
83337540|NCT03404544|Oxytocin|oxytocin|mesh-list
83337541|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
83337542|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337543|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337544|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
83337545|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83337546|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83337547|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337548|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
83337549|NCT01398280|Coagulants|coagulants|mesh-ancestor
83337550|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
83337551|NCT03404310|Astringents|astringents|mesh-ancestor
83337552|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337553|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337554|NCT03403842|Sufentanil|sufentanil|mesh-list
83337555|NCT03403842|Morphine|morphine|mesh-list
83337556|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83337557|NCT03403842|Narcotics|narcotics|mesh-ancestor
83337558|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337559|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337560|NCT03403842|Analgesics|analgesics|mesh-ancestor
83337561|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
83337562|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337563|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83337564|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83337565|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
83337566|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
83337567|NCT01398982|Bupivacaine|bupivacaine|mesh-list
83337568|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337569|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
83337570|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337571|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337572|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
83337573|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337574|NCT04447560|Bupivacaine|bupivacaine|mesh-list
83337575|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337576|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
83337577|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337578|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337579|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
83337580|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337581|NCT03401736|Midazolam|midazolam|mesh-list
83337582|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
83337583|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83337584|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337585|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337586|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337587|NCT03401736|Analgesics|analgesics|mesh-ancestor
83337588|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
83337589|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337590|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83337591|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83337592|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83337593|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337594|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337595|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337596|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83337597|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83337598|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83337599|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337600|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83337601|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
83337602|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
83337603|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
83337604|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
83337605|NCT02203786|Haloperidol|haloperidol|mesh-list
83337606|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
83337607|NCT02203786|Fluphenazine|fluphenazine|mesh-list
83337608|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
83337609|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
83337610|NCT02203786|Amphetamine|amphetamine|mesh-list
83337611|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
83337612|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
83337613|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
83337614|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337615|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337616|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337617|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83337618|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83337619|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337620|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337621|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83337622|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
83337623|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337624|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337625|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83337626|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83337627|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
83337628|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337629|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83337630|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83337631|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337632|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83337633|NCT03009058|Leucovorin|leucovorin|mesh-list
83337634|NCT03009058|Folic Acid|folic acid|mesh-list
83337635|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
83337636|NCT03009058|Gemcitabine|gemcitabine|mesh-list
83337637|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
83337638|NCT03009058|Fluorouracil|fluorouracil|mesh-list
83337639|NCT03009058|Capecitabine|capecitabine|mesh-list
83337640|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
83337641|NCT03009058|Nivolumab|nivolumab|mesh-list
83337642|NCT03009058|Irinotecan|irinotecan|mesh-list
83337643|NCT03009058|Cetuximab|cetuximab|mesh-list
83337644|NCT03009058|Ipilimumab|ipilimumab|mesh-list
83337645|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83337646|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
83337647|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337648|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
83337649|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337650|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337651|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83337652|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
83337653|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337654|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337655|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83337656|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337657|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
83337658|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83337659|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83337660|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83337661|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83337662|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337663|NCT03009058|Antidotes|antidotes|mesh-ancestor
83337664|NCT03009058|Protective Agents|protective agents|mesh-ancestor
83337665|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
83337666|NCT03009058|Vitamins|vitamins|mesh-ancestor
83337667|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
83337668|NCT03009058|Hematinics|hematinics|mesh-ancestor
83337669|NCT01611857|Leucovorin|leucovorin|mesh-list
83337670|NCT01611857|Fluorouracil|fluorouracil|mesh-list
83337671|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
83337672|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
83337673|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
83337674|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337675|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337676|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337677|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337678|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
83337679|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337680|NCT01611857|Antidotes|antidotes|mesh-ancestor
83337681|NCT01611857|Protective Agents|protective agents|mesh-ancestor
83337682|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
83337684|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
83337685|NCT03393858|Antibodies|antibodies|mesh-list
83337686|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
83337687|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337688|NCT03393702|Gabapentin|gabapentin|mesh-list
83337689|NCT03393702|Analgesics|analgesics|mesh-ancestor
83337690|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
83337691|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337692|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337693|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
83337694|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83337695|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83337696|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337697|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337698|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83337699|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83337700|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337701|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337702|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
83337703|NCT01829477|Glimepiride|glimepiride|mesh-list
83337704|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83337705|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83337706|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337707|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337708|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
83337709|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
83337710|NCT03126864|Fludarabine|fludarabine|mesh-list
83337711|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
83337712|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337713|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
83337714|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337715|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337716|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83337717|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
83337718|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337719|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337720|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83337721|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337722|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
83337723|NCT03399708|Apremilast|apremilast|mesh-list
83337724|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337725|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337726|NCT03399708|Analgesics|analgesics|mesh-ancestor
83337727|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
83337728|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337729|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337730|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337731|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337732|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83337733|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83337734|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337735|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337736|NCT03395730|Oxytocin|oxytocin|mesh-list
83337737|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
83337738|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337739|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337740|NCT01334086|Aprepitant|aprepitant|mesh-list
83337741|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
83337742|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
83337743|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337744|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337745|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337746|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83337747|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337748|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337749|NCT03399474|Lidocaine|lidocaine|mesh-list
83337750|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
83337751|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337752|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
83337753|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337754|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337755|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
83337756|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337757|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83337758|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83337759|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83337760|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337761|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337762|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83337763|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337764|NCT03399474|Analgesics|analgesics|mesh-ancestor
83337765|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83337766|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83337767|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83337768|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
83337769|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337770|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83337771|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83337772|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83337773|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337774|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337775|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337776|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337777|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83337778|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
83337779|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337780|NCT01430182|Morphine|morphine|mesh-list
83337781|NCT01430182|Methadone|methadone|mesh-list
83337782|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83337783|NCT01430182|Narcotics|narcotics|mesh-ancestor
83337784|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337785|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337786|NCT01430182|Analgesics|analgesics|mesh-ancestor
83337787|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
83337788|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337789|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
83337790|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
83337791|NCT05097768|Dexamethasone|dexamethasone|mesh-list
83337792|NCT05097768|Ibuprofen|ibuprofen|mesh-list
83337793|NCT05097768|Ketorolac|ketorolac|mesh-list
83337794|NCT05097768|Meloxicam|meloxicam|mesh-list
83337795|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337796|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
83337797|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
83337798|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337799|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337800|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337801|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
83337802|NCT05097768|Hormones|hormones|mesh-ancestor
83337803|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83337804|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83337805|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337806|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337807|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337808|NCT05097768|Analgesics|analgesics|mesh-ancestor
83337809|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
83337810|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337811|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83337812|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337813|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337814|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83337815|NCT01829243|Milnacipran|milnacipran|mesh-list
83337816|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
83337817|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83337818|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83337819|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337820|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337821|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337822|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337823|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337824|NCT01829243|Analgesics|analgesics|mesh-ancestor
83337825|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
83337826|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337827|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
83337828|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337829|NCT01838447|Vitamin D|vitamin d|mesh-list
83337830|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
83337831|NCT01838447|Vitamins|vitamins|mesh-ancestor
83337832|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
83337833|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337834|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83337835|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83337836|NCT03395574|Terlipressin|terlipressin|mesh-list
83337837|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83337838|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83337839|NCT04982172|Infliximab|infliximab|mesh-list
83337840|NCT04982172|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83337841|NCT04982172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337842|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337843|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83337844|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337845|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83337846|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83337847|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83337848|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
83337849|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337850|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83337851|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83337852|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337853|NCT03395262|Caffeine|caffeine|mesh-list
83337854|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83337855|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337856|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83337857|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337858|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337859|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83337860|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83337861|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
83337862|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337863|NCT03852888|Methotrexate|methotrexate|mesh-list
83337864|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
83337865|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83337866|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
83337867|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337868|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337869|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83337870|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
83337871|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337872|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337873|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
83337874|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337875|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83337876|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83337877|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
83337878|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337879|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83337880|NCT04770012|Aspirin|aspirin|mesh-list
83337881|NCT04770012|Clopidogrel|clopidogrel|mesh-list
83337882|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337883|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337884|NCT04770012|Analgesics|analgesics|mesh-ancestor
83337885|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
83337886|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337887|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337888|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337889|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337890|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83337891|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83337892|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337893|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83337894|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83337896|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
83337897|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83337898|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83337899|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83337900|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
83337901|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337902|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
83337903|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83337904|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
83337905|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337906|NCT04755972|Expectorants|expectorants|mesh-ancestor
83337907|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
83337908|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83337909|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
83337910|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337911|NCT04755972|Protective Agents|protective agents|mesh-ancestor
83337912|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337913|NCT04755972|Antidotes|antidotes|mesh-ancestor
83337914|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
83337915|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83337916|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83337917|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
83337918|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83337919|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83337920|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83337921|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337922|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337923|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83337924|NCT04697693|Escitalopram|escitalopram|mesh-list
83337925|NCT04697693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83337926|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83337927|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83337928|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337929|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83337930|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
83337931|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337932|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337933|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
83337934|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83337935|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83337936|NCT04697693|Analgesics|analgesics|mesh-ancestor
83337937|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
83337938|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
83337939|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
83337940|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83337941|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
83337942|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83337943|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337944|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83337945|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83337946|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83337947|NCT01827839|Vaccines|vaccines|mesh-list
83337948|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
83337949|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337950|NCT04709250|Bupivacaine|bupivacaine|mesh-list
83337951|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337952|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
83337953|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337954|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337955|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
83337956|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337957|NCT01401166|Trastuzumab|trastuzumab|mesh-list
83337958|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83337959|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83337960|NCT03395028|Lenograstim|lenograstim|mesh-list
83337961|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83337962|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
83337963|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337964|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83337965|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83337966|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83337967|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337968|NCT01334944|Ibuprofen|ibuprofen|mesh-list
83337969|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337970|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337971|NCT01334944|Analgesics|analgesics|mesh-ancestor
83337972|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
83337973|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337974|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337975|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337976|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337977|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83337978|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337979|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337980|NCT04567992|Bupivacaine|bupivacaine|mesh-list
83337981|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
83337982|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
83337983|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83337984|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337985|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
83337986|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337987|NCT01335724|Diclofenac|diclofenac|mesh-list
83337988|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83337989|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83337990|NCT01335724|Analgesics|analgesics|mesh-ancestor
83337991|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
83337992|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83337993|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83337994|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83337995|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83337996|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83337997|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83337998|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83337999|NCT01476202|Nicotine|nicotine|mesh-list
83338000|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83338001|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
83338002|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338003|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338004|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83338005|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83338006|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
83338007|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338008|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338009|NCT01477762|Dexamethasone|dexamethasone|mesh-list
83338010|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338011|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
83338012|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
83338013|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338014|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338015|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338016|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
83338017|NCT01477762|Hormones|hormones|mesh-ancestor
83338018|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338019|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338020|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338021|NCT01434472|Vidarabine|vidarabine|mesh-list
83338022|NCT01434472|Cyclosporine|cyclosporine|mesh-list
83338023|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
83338024|NCT01434472|Rituximab|rituximab|mesh-list
83338025|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83338026|NCT01434472|Fludarabine|fludarabine|mesh-list
83338027|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
83338028|NCT01434472|Antibodies|antibodies|mesh-list
83338029|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
83338030|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83338031|NCT01434472|Cyclosporins|cyclosporins|mesh-list
83338032|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
83338033|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338034|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338035|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338036|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83338037|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
83338038|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338039|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338040|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
83338041|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338042|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338043|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
83338044|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
83338045|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83338046|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83338047|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83338048|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
83338049|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83338050|NCT01435174|Ranolazine|ranolazine|mesh-list
83338051|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
83338052|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83338053|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83338054|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83338055|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338056|NCT01436266|Folic Acid|folic acid|mesh-list
83338057|NCT01436266|Misoprostol|misoprostol|mesh-list
83338058|NCT01436266|Vitamins|vitamins|mesh-ancestor
83338059|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
83338060|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338061|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83338062|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
83338063|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83338064|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83338065|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338066|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
83338067|NCT01436266|Hematinics|hematinics|mesh-ancestor
83338068|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
83338069|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83338070|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338071|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
83338072|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83338073|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338074|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83338075|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338076|NCT04409262|Remdesivir|remdesivir|mesh-list
83338077|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
83338078|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338079|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
83338080|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338081|NCT01481740|Phenylephrine|phenylephrine|mesh-list
83338082|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
83338083|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83338084|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
83338085|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
83338086|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338087|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338088|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
83338089|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83338090|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
83338091|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
83338092|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83338093|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83338094|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83338095|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
83338096|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338097|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338098|NCT01481740|Protective Agents|protective agents|mesh-ancestor
83338099|NCT01544062|Acetaminophen|acetaminophen|mesh-list
83338100|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338101|NCT01544062|Analgesics|analgesics|mesh-ancestor
83338102|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
83338103|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338104|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338105|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
83338106|NCT03126084|Acetaminophen|acetaminophen|mesh-list
83338107|NCT03126084|Tramadol|tramadol|mesh-list
83338108|NCT03126084|Bupivacaine|bupivacaine|mesh-list
83338109|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
83338110|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
83338111|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338112|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338113|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
83338114|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338115|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338116|NCT03126084|Analgesics|analgesics|mesh-ancestor
83338117|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
83338118|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83338119|NCT03126084|Narcotics|narcotics|mesh-ancestor
83338120|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83338122|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
83338123|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83338124|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83338125|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338126|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338127|NCT01544998|Urological Agents|urological agents|mesh-ancestor
83338128|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
83338129|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338130|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
83338131|NCT03391830|Atorvastatin|atorvastatin|mesh-list
83338132|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83338133|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83338134|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
83338135|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338136|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83338137|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83338138|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338139|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
83338140|NCT03391830|Protective Agents|protective agents|mesh-ancestor
83338141|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338142|NCT03391830|Vitamins|vitamins|mesh-ancestor
83338143|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
83338144|NCT01441570|Metoprolol|metoprolol|mesh-list
83338145|NCT01441570|Nebivolol|nebivolol|mesh-list
83338146|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83338147|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83338148|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
83338149|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
83338150|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338151|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338152|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83338153|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83338154|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83338155|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
83338156|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338157|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338158|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
83338159|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83338160|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83338161|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83338162|NCT05238012|Atorvastatin|atorvastatin|mesh-list
83338163|NCT05238012|Calcium|calcium|mesh-list
83338164|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83338165|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338166|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83338167|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83338168|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
83338169|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338170|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83338171|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83338172|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338173|NCT01441882|Dasatinib|dasatinib|mesh-list
83338174|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338175|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83338176|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338177|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338178|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83338179|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83338180|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
83338181|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338182|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338183|NCT01545700|Dexamethasone|dexamethasone|mesh-list
83338184|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
83338185|NCT01545700|BB 1101|bb 1101|mesh-list
83338186|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338187|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
83338188|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
83338189|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338190|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338191|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338193|NCT01545700|Hormones|hormones|mesh-ancestor
83338194|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338195|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338196|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338197|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
83338198|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338199|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338200|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83338201|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83338202|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338203|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83338204|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83338205|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83338206|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338207|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
83338208|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338209|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83338210|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
83338211|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83338212|NCT01444924|Bupivacaine|bupivacaine|mesh-list
83338213|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
83338214|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
83338215|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338216|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338217|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
83338218|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338219|NCT01546402|Dexamethasone|dexamethasone|mesh-list
83338220|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
83338221|NCT01546402|BB 1101|bb 1101|mesh-list
83338222|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338223|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
83338224|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
83338225|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338226|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338227|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338228|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
83338229|NCT01546402|Hormones|hormones|mesh-ancestor
83338230|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338231|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338232|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338233|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
83338234|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338235|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338236|NCT03389490|Insulin|insulin|mesh-list
83338237|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83338238|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
83338239|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
83338240|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
83338241|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
83338242|NCT03389490|Protamines|protamines|mesh-list
83338243|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83338244|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338245|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
83338246|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338247|NCT03389490|Coagulants|coagulants|mesh-ancestor
83338248|NCT03994146|Remifentanil|remifentanil|mesh-list
83338249|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83338250|NCT03994146|Narcotics|narcotics|mesh-ancestor
83338251|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338252|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338253|NCT03994146|Analgesics|analgesics|mesh-ancestor
83338254|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
83338255|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338256|NCT01547806|Plerixafor|plerixafor|mesh-list
83338257|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83338258|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83338259|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
83338260|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338261|NCT01445626|Dexamethasone|dexamethasone|mesh-list
83338262|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338263|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
83338264|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
83338265|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338266|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338267|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338268|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
83338269|NCT01445626|Hormones|hormones|mesh-ancestor
83338270|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338271|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338272|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338273|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
83338274|NCT02744742|Busulfan|busulfan|mesh-list
83338275|NCT02744742|Decitabine|decitabine|mesh-list
83338276|NCT02744742|Lenograstim|lenograstim|mesh-list
83338277|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338278|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
83338279|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338280|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338281|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83338282|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
83338283|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338284|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338285|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83338286|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83338287|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
83338288|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338289|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83338290|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83338291|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
83338292|NCT03389412|Coagulants|coagulants|mesh-ancestor
83338293|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83338294|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
83338295|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338296|NCT03125772|Paclitaxel|paclitaxel|mesh-list
83338297|NCT03125772|Everolimus|everolimus|mesh-list
83338298|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83338299|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338300|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
83338301|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
83338302|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
83338303|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338304|NCT03125772|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83338305|NCT03125772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83338306|NCT03125772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338307|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338308|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
83338309|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338310|NCT01447888|Morphine|morphine|mesh-list
83338311|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83338312|NCT01447888|Narcotics|narcotics|mesh-ancestor
83338313|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338314|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338315|NCT01447888|Analgesics|analgesics|mesh-ancestor
83338316|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
83338317|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338318|NCT03389256|Apatinib|apatinib|mesh-list
83338319|NCT03389256|Gefitinib|gefitinib|mesh-list
83338320|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338321|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83338322|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338323|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338324|NCT01490788|Amitriptyline|amitriptyline|mesh-list
83338325|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
83338326|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83338327|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
83338328|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83338329|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83338330|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338331|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83338332|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338333|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83338334|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338335|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338336|NCT01490788|Analgesics|analgesics|mesh-ancestor
83338337|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
83338338|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83338339|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83338340|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83338341|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338342|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
83338343|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338345|NCT02520180|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83338346|NCT02520180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83338347|NCT02520180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338348|NCT02520180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338349|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338350|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
83338351|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338352|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338353|NCT03391050|Dabrafenib|dabrafenib|mesh-list
83338354|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338355|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83338356|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338357|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338358|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
83338359|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83338360|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
83338361|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83338362|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338363|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338364|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338365|NCT03390972|Analgesics|analgesics|mesh-ancestor
83338366|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
83338367|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338368|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83338369|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83338370|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83338371|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
83338372|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338373|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338374|NCT01550224|Temozolomide|temozolomide|mesh-list
83338375|NCT01550224|Vorinostat|vorinostat|mesh-list
83338376|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83338377|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
83338378|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338379|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338380|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83338381|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338382|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
83338383|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83338384|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83338385|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338386|NCT00782184|Atorvastatin|atorvastatin|mesh-list
83338387|NCT00782184|Simvastatin|simvastatin|mesh-list
83338388|NCT00782184|Ezetimibe|ezetimibe|mesh-list
83338389|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
83338390|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83338391|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83338392|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
83338393|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338394|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83338395|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83338396|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338397|NCT03397914|Colistin|colistin|mesh-list
83338398|NCT03397914|Polymyxins|polymyxins|mesh-list
83338399|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83338400|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338401|NCT01450306|Cycloserine|cycloserine|mesh-list
83338402|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83338403|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338404|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83338405|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
83338406|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83338407|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
83338408|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338409|NCT03126708|Paclitaxel|paclitaxel|mesh-list
83338410|NCT03126708|Cetuximab|cetuximab|mesh-list
83338411|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83338412|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338413|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
83338414|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
83338415|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
83338416|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338417|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83338419|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83338420|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338421|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83338422|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338423|NCT03390582|Methimazole|methimazole|mesh-list
83338424|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
83338425|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
83338426|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338427|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338428|NCT03385356|Vitamin D|vitamin d|mesh-list
83338429|NCT03385356|Vitamins|vitamins|mesh-ancestor
83338430|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
83338431|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338432|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83338433|NCT03388866|Immunomodulating Agents|immunomodulating agents|mesh-list
83338434|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
83338435|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338436|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83338437|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
83338438|NCT01873170|Etonogestrel|etonogestrel|mesh-list
83338439|NCT01873170|Desogestrel|desogestrel|mesh-list
83338440|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
83338441|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
83338442|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83338443|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83338444|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83338445|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338446|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83338447|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83338448|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83338449|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338450|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338451|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83338452|NCT01873170|Progestins|progestins|mesh-ancestor
83338453|NCT01873170|Hormones|hormones|mesh-ancestor
83338454|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338455|NCT03125694|Pioglitazone|pioglitazone|mesh-list
83338456|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83338457|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83338458|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338459|NCT03125694|Incretins|incretins|mesh-ancestor
83338460|NCT03125694|Hormones|hormones|mesh-ancestor
83338461|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338462|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83338463|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
83338464|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338465|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338466|NCT02731638|Voriconazole|voriconazole|mesh-list
83338467|NCT02731638|Natamycin|natamycin|mesh-list
83338468|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
83338469|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338470|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83338471|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83338472|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338473|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338474|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83338475|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
83338476|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338477|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338478|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83338479|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83338480|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83338482|NCT01451632|Cetuximab|cetuximab|mesh-list
83338483|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83338484|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83338485|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338486|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338487|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338488|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83338489|NCT01491958|Methotrexate|methotrexate|mesh-list
83338490|NCT01491958|Atorvastatin|atorvastatin|mesh-list
83338491|NCT01491958|Tacrolimus|tacrolimus|mesh-list
83338492|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83338493|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
83338494|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83338495|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338496|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83338497|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
83338498|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338499|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338500|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
83338501|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338502|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83338503|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338504|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
83338505|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338506|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83338507|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83338508|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83338509|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83338510|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83338511|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83338512|NCT01492582|Vaccines|vaccines|mesh-list
83338513|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
83338514|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338515|NCT02214628|Becaplermin|becaplermin|mesh-list
83338516|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
83338517|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83338518|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83338519|NCT02214628|Growth Substances|growth substances|mesh-ancestor
83338520|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338521|NCT01495858|Naproxen|naproxen|mesh-list
83338522|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83338523|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338524|NCT01495858|Analgesics|analgesics|mesh-ancestor
83338525|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
83338526|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338527|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338528|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338529|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338530|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
83338531|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83338532|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338533|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338534|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
83338535|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83338536|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83338537|NCT01497496|Prednisolone|prednisolone|mesh-list
83338538|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
83338539|NCT01497496|Lenalidomide|lenalidomide|mesh-list
83338540|NCT01497496|Ofatumumab|ofatumumab|mesh-list
83338541|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83338542|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
83338543|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
83338544|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338545|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83338546|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83338547|NCT01497496|Growth Substances|growth substances|mesh-ancestor
83338548|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
83338549|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338550|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338551|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
83338552|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
83338553|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338554|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338555|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
83338556|NCT01497496|Hormones|hormones|mesh-ancestor
83338557|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338558|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83338559|NCT01497496|Protective Agents|protective agents|mesh-ancestor
83338560|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338561|NCT02208310|Vitamin D|vitamin d|mesh-list
83338562|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
83338563|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
83338564|NCT02208310|Vitamins|vitamins|mesh-list
83338565|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
83338566|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338567|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83338568|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83338569|NCT01454362|Nicotine|nicotine|mesh-list
83338570|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83338571|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
83338572|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338573|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338574|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83338575|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83338576|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
83338577|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338578|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338579|NCT01497808|Ipilimumab|ipilimumab|mesh-list
83338580|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83338581|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338582|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83338583|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338584|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
83338585|NCT01498588|Doxorubicin|doxorubicin|mesh-list
83338586|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338587|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
83338588|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338589|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338590|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83338591|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
83338592|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338593|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338594|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83338595|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83338596|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83338597|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83338598|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338599|NCT01498744|Clindamycin|clindamycin|mesh-list
83338600|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
83338601|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
83338602|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83338603|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338604|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83338605|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338606|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338607|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83338608|NCT01498978|Ipilimumab|ipilimumab|mesh-list
83338609|NCT01498978|Antibodies|antibodies|mesh-list
83338610|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
83338611|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83338612|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
83338613|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338614|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338615|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83338616|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338617|NCT01458418|Montelukast|montelukast|mesh-list
83338618|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83338619|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
83338620|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83338621|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
83338622|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338623|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338624|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83338625|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83338626|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338627|NCT01557322|Etanercept|etanercept|mesh-list
83338628|NCT01557322|Methotrexate|methotrexate|mesh-list
83338629|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83338630|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
83338631|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83338632|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338633|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83338634|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
83338635|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338637|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
83338638|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338639|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83338640|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338641|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
83338642|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338643|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83338644|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83338645|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338646|NCT01557322|Analgesics|analgesics|mesh-ancestor
83338647|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
83338648|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338649|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338650|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338651|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83338652|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83338653|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
83338654|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83338655|NCT01459588|Laxatives|laxatives|mesh-ancestor
83338656|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338657|NCT01501162|Ethanol|ethanol|mesh-list
83338658|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83338659|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338660|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338661|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338662|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
83338663|NCT01557868|Hylan|hylan|mesh-list
83338664|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83338665|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
83338666|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338667|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
83338668|NCT01557868|Protective Agents|protective agents|mesh-ancestor
83338669|NCT02208466|Fluoxetine|fluoxetine|mesh-list
83338670|NCT02208466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83338671|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83338672|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83338673|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338674|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338675|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
83338676|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338677|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83338678|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
83338679|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83338680|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83338681|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83338682|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338683|NCT02209948|Temozolomide|temozolomide|mesh-list
83338684|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83338685|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
83338686|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338687|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338688|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
83338689|NCT02981212|Prednisolone|prednisolone|mesh-list
83338690|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83338691|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83338692|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338693|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83338694|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
83338695|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83338696|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338697|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338698|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338699|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338700|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
83338702|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338703|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338704|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338705|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
83338706|NCT01464190|Sevelamer|sevelamer|mesh-list
83338707|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
83338708|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
83338709|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338710|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83338711|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338712|NCT01563406|Ethanol|ethanol|mesh-list
83338713|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
83338714|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83338715|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338716|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338717|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338718|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
83338719|NCT01468012|Levodopa|levodopa|mesh-list
83338720|NCT01468012|Carbidopa|carbidopa|mesh-list
83338721|NCT01468012|Entacapone|entacapone|mesh-list
83338722|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83338723|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83338724|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83338725|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
83338726|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338727|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338728|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338729|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83338730|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338731|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83338732|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83338733|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
83338734|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
83338735|NCT01468558|Ketoconazole|ketoconazole|mesh-list
83338736|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
83338737|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338738|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83338739|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83338740|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338741|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338742|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83338743|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
83338744|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338745|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338746|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83338747|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
83338748|NCT03730662|Tirzepatide|tirzepatide|mesh-list
83338749|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83338750|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338751|NCT03730662|Incretins|incretins|mesh-ancestor
83338752|NCT03730662|Hormones|hormones|mesh-ancestor
83338753|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338754|NCT01509586|Lobeline|lobeline|mesh-list
83338755|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83338756|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
83338757|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338758|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338759|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83338760|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83338761|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
83338762|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338763|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338764|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
83338765|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83338766|NCT01470118|Dextrans|dextrans|mesh-list
83338767|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83338768|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83338769|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
83338770|NCT01470118|Alcaftadine|alcaftadine|mesh-list
83338771|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
83338772|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
83338773|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
83338774|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83338775|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338776|NCT01470118|Analgesics|analgesics|mesh-ancestor
83338777|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
83338778|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338779|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338780|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338781|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338782|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83338783|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83338785|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
83338786|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
83338787|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338788|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338789|NCT01470196|Dexamethasone|dexamethasone|mesh-list
83338790|NCT01470196|Rituximab|rituximab|mesh-list
83338791|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83338792|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338793|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
83338794|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338795|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338796|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338797|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
83338798|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
83338799|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338800|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338801|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
83338802|NCT01470196|Hormones|hormones|mesh-ancestor
83338803|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338804|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338806|NCT03389958|Trace Elements|trace elements|mesh-ancestor
83338807|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
83338808|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338809|NCT04446234|Risperidone|risperidone|mesh-list
83338810|NCT04446234|Aripiprazole|aripiprazole|mesh-list
83338811|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83338812|NCT04446234|Ziprasidone|ziprasidone|mesh-list
83338813|NCT04446234|Amisulpride|amisulpride|mesh-list
83338814|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83338815|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
83338816|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338817|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338818|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338819|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83338820|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83338821|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338822|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83338823|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83338824|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
83338825|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
83338826|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
83338827|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83338828|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83338829|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83338830|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83338831|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83338832|NCT01511068|Sargramostim|sargramostim|mesh-list
83338833|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
83338834|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338835|NCT03613506|Captopril|captopril|mesh-list
83338836|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83338837|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
83338838|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338839|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338840|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83338841|NCT01565902|Siponimod|siponimod|mesh-list
83338842|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83338843|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338844|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83338845|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
83338846|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338847|NCT01566448|Ketamine|ketamine|mesh-list
83338848|NCT01566448|Analgesics|analgesics|mesh-ancestor
83338849|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
83338850|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338851|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338852|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83338853|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83338854|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
83338855|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
83338856|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338857|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83338858|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83338859|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338860|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338861|NCT05565976|Aspirin|aspirin|mesh-list
83338862|NCT05565976|Insulin|insulin|mesh-list
83338863|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83338864|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
83338865|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
83338866|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
83338867|NCT05565976|Biguanides|biguanides|mesh-list
83338868|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83338869|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83338870|NCT05565976|Meglitinide|meglitinide|mesh-list
83338871|NCT05565976|Clopidogrel|clopidogrel|mesh-list
83338872|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83338873|NCT05565976|Atorvastatin|atorvastatin|mesh-list
83338874|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83338875|NCT05565976|Pravastatin|pravastatin|mesh-list
83338876|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338877|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83338878|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83338879|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
83338880|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338881|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83338882|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83338883|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338884|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83338885|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83338886|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83338887|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
83338888|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338889|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83338890|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83338891|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83338892|NCT05565976|Analgesics|analgesics|mesh-ancestor
83338893|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
83338894|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338895|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338896|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83338897|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83338898|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83338899|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83338900|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
83338901|NCT01566526|Dexamethasone|dexamethasone|mesh-list
83338902|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83338903|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
83338904|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
83338905|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338906|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338907|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338908|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
83338909|NCT01566526|Hormones|hormones|mesh-ancestor
83338910|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83338911|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83338912|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338914|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
83338915|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
83338916|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338917|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338918|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
83338919|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338920|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
83338921|NCT05565664|Ketamine|ketamine|mesh-list
83338922|NCT05565664|Analgesics|analgesics|mesh-ancestor
83338923|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
83338924|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338925|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338926|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83338927|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83338928|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
83338929|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
83338930|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83338931|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83338932|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83338933|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338934|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338935|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83338937|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83338938|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83338939|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83338940|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
83338941|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83338942|NCT03125616|Vaccines|vaccines|mesh-list
83338943|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
83338944|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338945|NCT01568008|Bimatoprost|bimatoprost|mesh-list
83338946|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83338947|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83338948|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83338949|NCT05658120|Epinephrine|epinephrine|mesh-list
83338950|NCT05658120|Racepinephrine|racepinephrine|mesh-list
83338951|NCT05658120|Norepinephrine|norepinephrine|mesh-list
83338952|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
83338953|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83338954|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83338955|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
83338956|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338957|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338958|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338959|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83338960|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83338961|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
83338962|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83338963|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83338964|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
83338965|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
83338966|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
83338967|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83338968|NCT01514734|Timolol|timolol|mesh-list
83338969|NCT01514734|Brinzolamide|brinzolamide|mesh-list
83338970|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338971|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338972|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83338973|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83338974|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
83338975|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83338976|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338977|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83338978|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83338979|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83338980|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
83338981|NCT01515046|Gemcitabine|gemcitabine|mesh-list
83338982|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83338984|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338985|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83338986|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
83338987|NCT01515046|Protective Agents|protective agents|mesh-ancestor
83338988|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83338989|NCT01515046|Vitamins|vitamins|mesh-ancestor
83338990|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
83338991|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83338992|NCT01568944|Lansoprazole|lansoprazole|mesh-list
83338993|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83338994|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83338995|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83338996|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83338997|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83338998|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83338999|NCT05565274|Pentazocine|pentazocine|mesh-list
83339000|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83339001|NCT05565274|Narcotics|narcotics|mesh-ancestor
83339002|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339003|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339004|NCT05565274|Analgesics|analgesics|mesh-ancestor
83339005|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
83339006|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339007|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83339008|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83339010|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83339011|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
83339012|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339013|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339014|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83339015|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
83339016|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
83339017|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83339018|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83339019|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83339020|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83339021|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
83339022|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339023|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339024|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
83339025|NCT04671030|Neostigmine|neostigmine|mesh-list
83339026|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83339027|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339028|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339029|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
83339030|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339031|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339032|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83339033|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
83339034|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339035|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83339036|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83339037|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83339038|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
83339039|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83339040|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339041|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339042|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83339044|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339045|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339046|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339047|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83339048|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
83339049|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83339050|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339051|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83339052|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83339053|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83339054|NCT04632264|Oxytocin|oxytocin|mesh-list
83339055|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
83339056|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83339057|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339058|NCT04607928|Pirfenidone|pirfenidone|mesh-list
83339059|NCT04607928|Analgesics|analgesics|mesh-ancestor
83339060|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
83339061|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339062|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339063|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83339064|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339065|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339066|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339067|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339068|NCT03380442|Ketamine|ketamine|mesh-list
83339069|NCT03380442|Psilocybin|psilocybin|mesh-list
83339070|NCT03380442|Analgesics|analgesics|mesh-ancestor
83339071|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
83339072|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339073|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339074|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83339075|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83339076|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
83339077|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
83339078|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339079|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83339080|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83339081|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339082|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339083|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
83339084|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83339085|NCT05172570|Gabapentin|gabapentin|mesh-list
83339086|NCT05172570|Analgesics|analgesics|mesh-ancestor
83339087|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
83339088|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339089|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339090|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
83339091|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83339092|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83339093|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339094|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83339095|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83339096|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83339097|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339098|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339099|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
83339100|NCT03380130|Nivolumab|nivolumab|mesh-list
83339101|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339102|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339103|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83339104|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339105|NCT03386838|Carboplatin|carboplatin|mesh-list
83339106|NCT03386838|Fluorouracil|fluorouracil|mesh-list
83339107|NCT03386838|Nivolumab|nivolumab|mesh-list
83339108|NCT03386838|Cetuximab|cetuximab|mesh-list
83339109|NCT03386838|Linrodostat|linrodostat|mesh-list
83339110|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339111|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
83339112|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339113|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83339114|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339115|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
83339116|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339117|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339118|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83339119|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339120|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
83339121|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
83339122|NCT03379974|Coagulants|coagulants|mesh-ancestor
83339123|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83339124|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
83339125|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339126|NCT01570036|Trastuzumab|trastuzumab|mesh-list
83339127|NCT01570036|Molgramostim|molgramostim|mesh-list
83339128|NCT01570036|Sargramostim|sargramostim|mesh-list
83339129|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339130|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339131|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
83339132|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339133|NCT01516684|Lidocaine|lidocaine|mesh-list
83339134|NCT01516684|Fentanyl|fentanyl|mesh-list
83339135|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
83339136|NCT01516684|Prilocaine|prilocaine|mesh-list
83339137|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83339138|NCT01516684|Propofol|propofol|mesh-list
83339139|NCT01516684|Anesthetics|anesthetics|mesh-list
83339140|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339141|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339142|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
83339143|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339144|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83339145|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83339146|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83339147|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83339148|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339149|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83339150|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83339151|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
83339152|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83339153|NCT01516684|Narcotics|narcotics|mesh-ancestor
83339154|NCT01516684|Analgesics|analgesics|mesh-ancestor
83339155|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83339156|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83339157|NCT01517074|Sirolimus|sirolimus|mesh-list
83339158|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339159|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339160|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83339161|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339162|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
83339163|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339164|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
83339165|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339166|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
83339167|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
83339168|NCT01570348|Fludarabine|fludarabine|mesh-list
83339169|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
83339170|NCT01570348|Tacrolimus|tacrolimus|mesh-list
83339171|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339172|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
83339173|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339174|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339175|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83339176|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
83339177|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339178|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339179|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83339180|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83339181|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
83339182|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83339183|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339184|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83339185|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83339186|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
83339187|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339188|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339189|NCT03383406|Cytarabine|cytarabine|mesh-list
83339190|NCT03383406|Methotrexate|methotrexate|mesh-list
83339191|NCT03383406|Etoposide|etoposide|mesh-list
83339192|NCT03383406|Ifosfamide|ifosfamide|mesh-list
83339193|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83339194|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
83339195|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83339196|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339197|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83339198|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
83339199|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339200|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339201|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
83339202|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339203|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83339204|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339205|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
83339206|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339207|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83339208|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83339209|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83339210|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83339211|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
83339212|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339213|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83339214|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
83339215|NCT04445922|Anastrozole|anastrozole|mesh-list
83339216|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83339217|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339218|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83339219|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83339220|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339221|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339222|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83339223|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
83339224|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339225|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339226|NCT03383328|Prednisolone|prednisolone|mesh-list
83339227|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83339228|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
83339229|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83339230|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
83339231|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83339232|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83339233|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
83339234|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339235|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
83339236|NCT03383328|Hormones|hormones|mesh-ancestor
83339237|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339238|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339239|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83339240|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339241|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
83339242|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
83339243|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339244|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339245|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83339246|NCT03383328|Protective Agents|protective agents|mesh-ancestor
83339247|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339248|NCT03383328|Analgesics|analgesics|mesh-ancestor
83339249|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
83339250|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339251|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83339252|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339253|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83339254|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339255|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339256|NCT03093246|Aspirin|aspirin|mesh-list
83339257|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83339258|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339259|NCT03093246|Analgesics|analgesics|mesh-ancestor
83339260|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
83339261|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339262|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339264|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339265|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83339266|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83339267|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339268|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83339269|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83339270|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339271|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
83339272|NCT02969928|Amoxicillin|amoxicillin|mesh-list
83339273|NCT02969928|Metronidazole|metronidazole|mesh-list
83339274|NCT02969928|Clarithromycin|clarithromycin|mesh-list
83339275|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339276|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339277|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83339278|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83339279|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83339280|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339281|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339282|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83339283|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83339284|NCT02968446|Vitamin D|vitamin d|mesh-list
83339285|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
83339286|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
83339287|NCT02968446|Vitamins|vitamins|mesh-ancestor
83339288|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
83339289|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339290|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83339291|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83339292|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
83339293|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339294|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83339295|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339296|NCT03378960|Omeprazole|omeprazole|mesh-list
83339297|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83339298|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339299|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83339300|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339301|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339302|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
83339303|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
83339304|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339305|NCT03378726|Micronutrients|micronutrients|mesh-list
83339306|NCT03378726|Trace Elements|trace elements|mesh-list
83339307|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339308|NCT05137938|Ketamine|ketamine|mesh-list
83339309|NCT05137938|Analgesics|analgesics|mesh-ancestor
83339310|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
83339311|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339312|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339313|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83339314|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83339315|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
83339316|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
83339317|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339318|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83339319|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83339320|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339321|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339322|NCT03378648|Bromides|bromides|mesh-list
83339323|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
83339324|NCT01519882|Rotigotine|rotigotine|mesh-list
83339325|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
83339326|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
83339327|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339328|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339329|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339330|NCT01576276|Ketorolac|ketorolac|mesh-list
83339331|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83339332|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339333|NCT01576276|Analgesics|analgesics|mesh-ancestor
83339334|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
83339335|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339336|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339337|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339338|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339339|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83339340|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339341|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339342|NCT01576588|Rituximab|rituximab|mesh-list
83339343|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
83339344|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339345|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339346|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
83339347|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339348|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339349|NCT01576588|Hormones|hormones|mesh-ancestor
83339350|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339351|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
83339352|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
83339353|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339354|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
83339355|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83339356|NCT02247154|Antibodies|antibodies|mesh-list
83339357|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
83339358|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339359|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
83339360|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83339361|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83339362|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
83339363|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339364|NCT03007810|Hemay005|hemay005|mesh-list
83339365|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83339366|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83339367|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83339368|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339369|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339370|NCT01578772|Telmisartan|telmisartan|mesh-list
83339371|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83339372|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83339373|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83339374|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339375|NCT01804049|Metformin|metformin|mesh-list
83339376|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83339377|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339378|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83339379|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83339380|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339381|NCT02346630|Levodopa|levodopa|mesh-list
83339382|NCT02346630|Carbidopa|carbidopa|mesh-list
83339383|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83339384|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83339385|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
83339386|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339387|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339388|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339389|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83339390|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339391|NCT03385668|Pirfenidone|pirfenidone|mesh-list
83339392|NCT03385668|Analgesics|analgesics|mesh-ancestor
83339393|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
83339394|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339395|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339396|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83339397|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339398|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339399|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339400|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339401|NCT04947072|Anesthetics|anesthetics|mesh-list
83339402|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339403|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339404|NCT04942158|Eugenol|eugenol|mesh-list
83339405|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
83339406|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
83339407|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
83339408|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83339409|NCT04942158|Protective Agents|protective agents|mesh-ancestor
83339410|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339411|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339412|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
83339413|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83339414|NCT03387774|Urinastatin|urinastatin|mesh-list
83339415|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83339416|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83339417|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
83339418|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339419|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339420|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
83339421|NCT03382314|Vitamin D|vitamin d|mesh-list
83339422|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
83339423|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83339424|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339425|NCT03382314|Vitamins|vitamins|mesh-ancestor
83339426|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
83339427|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83339428|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83339429|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83339430|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
83339431|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339432|NCT03124524|Dienogest|dienogest|mesh-list
83339433|NCT03124524|Drospirenone|drospirenone|mesh-list
83339434|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83339435|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83339436|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83339437|NCT03124524|Estradiol|estradiol|mesh-list
83339438|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83339439|NCT03124524|Estrogens|estrogens|mesh-ancestor
83339440|NCT03124524|Hormones|hormones|mesh-ancestor
83339441|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339442|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339443|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83339444|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
83339445|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83339446|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83339447|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83339448|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83339449|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83339450|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
83339451|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83339452|NCT03124524|Diuretics|diuretics|mesh-ancestor
83339453|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
83339454|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83339455|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83339456|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339457|NCT03377400|Cisplatin|cisplatin|mesh-list
83339458|NCT03377400|Durvalumab|durvalumab|mesh-list
83339459|NCT03377400|Tremelimumab|tremelimumab|mesh-list
83339460|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339461|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339462|NCT01803269|Topotecan|topotecan|mesh-list
83339463|NCT01803269|Camptothecin|camptothecin|mesh-list
83339464|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83339465|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83339466|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339467|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339468|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339469|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83339471|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339472|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83339473|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339474|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339475|NCT01825577|Methylphenidate|methylphenidate|mesh-list
83339476|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83339477|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339478|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83339479|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83339480|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83339481|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339482|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
83339483|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339484|NCT03375138|Abatacept|abatacept|mesh-list
83339485|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83339486|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339487|NCT03375138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339488|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339489|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339490|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
83339491|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339492|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339493|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
83339494|NCT03124680|Narcotics|narcotics|mesh-ancestor
83339495|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339496|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339497|NCT03124680|Analgesics|analgesics|mesh-ancestor
83339498|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
83339499|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339500|NCT03374670|Aflibercept|aflibercept|mesh-list
83339501|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83339502|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83339503|NCT03374670|Growth Substances|growth substances|mesh-ancestor
83339504|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339505|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
83339506|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339507|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
83339508|NCT02963610|Lenalidomide|lenalidomide|mesh-list
83339509|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339510|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339511|NCT02963610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83339512|NCT02963610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339513|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
83339514|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339515|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83339516|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83339517|NCT02963610|Growth Substances|growth substances|mesh-ancestor
83339518|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
83339519|NCT03376932|Albuterol|albuterol|mesh-list
83339520|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
83339521|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83339522|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
83339523|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339524|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339525|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83339526|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
83339527|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
83339528|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83339529|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
83339530|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339531|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339532|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
83339533|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83339534|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83339535|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83339536|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83339537|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
83339538|NCT03007342|Amoxicillin|amoxicillin|mesh-list
83339539|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
83339540|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
83339541|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83339542|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339543|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339544|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83339545|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339546|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339547|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
83339548|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83339549|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339550|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339551|NCT01579162|Cholic Acids|cholic acids|mesh-list
83339552|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339553|NCT03007654|Chitosan|chitosan|mesh-list
83339554|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83339555|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83339556|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
83339557|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339558|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83339559|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
83339560|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
83339561|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
83339562|NCT03007654|Coagulants|coagulants|mesh-ancestor
83339563|NCT03374514|Dexamethasone|dexamethasone|mesh-list
83339564|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339565|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
83339566|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
83339567|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339568|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339569|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339570|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
83339571|NCT03374514|Hormones|hormones|mesh-ancestor
83339572|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339573|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83339574|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339575|NCT01526356|Sirolimus|sirolimus|mesh-list
83339576|NCT01526356|Temsirolimus|temsirolimus|mesh-list
83339577|NCT01526356|MTOR Inhibitors|mtor inhibitors|mesh-list
83339578|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339579|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339580|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83339581|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339582|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
83339583|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339584|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
83339585|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339586|NCT01526356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83339587|NCT01526356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339588|NCT01526356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339589|NCT02903160|Prednisone|prednisone|mesh-list
83339590|NCT02903160|Carboplatin|carboplatin|mesh-list
83339591|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
83339592|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83339593|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339594|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339595|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
83339596|NCT02903160|Hormones|hormones|mesh-ancestor
83339597|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339598|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339599|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83339600|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83339601|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339602|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339603|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
83339604|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83339605|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83339606|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83339607|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339608|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339609|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83339610|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83339611|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339612|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
83339613|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339615|NCT03374280|Pemetrexed|pemetrexed|mesh-list
83339616|NCT03374280|Gefitinib|gefitinib|mesh-list
83339617|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339618|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339619|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339620|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83339621|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83339622|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83339623|NCT03381066|Cisplatin|cisplatin|mesh-list
83339624|NCT03381066|Pemetrexed|pemetrexed|mesh-list
83339625|NCT03381066|Vinorelbine|vinorelbine|mesh-list
83339626|NCT03381066|Gefitinib|gefitinib|mesh-list
83339627|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339628|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339629|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339630|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83339631|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83339632|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83339633|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83339634|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
83339635|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83339636|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83339637|NCT03630666|Hormones|hormones|mesh-list
83339638|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83339639|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339640|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339641|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83339642|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
83339643|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83339644|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
83339645|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
83339646|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339647|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339648|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
83339649|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83339650|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83339651|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
83339652|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339653|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339654|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
83339655|NCT01580410|Mitomycins|mitomycins|mesh-list
83339656|NCT01580410|Mitomycin|mitomycin|mesh-list
83339657|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339658|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83339659|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
83339660|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339661|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83339662|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339663|NCT02606136|Mitogens|mitogens|mesh-list
83339664|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
83339665|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339666|NCT01581658|Empagliflozin|empagliflozin|mesh-list
83339667|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83339668|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339669|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83339670|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339671|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83339672|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83339673|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339675|NCT01530178|Hormones|hormones|mesh-ancestor
83339676|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339677|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83339678|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
83339679|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339680|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339681|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
83339682|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83339683|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83339684|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83339685|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83339686|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339687|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
83339688|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339689|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339690|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83339691|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339692|NCT03006874|Esomeprazole|esomeprazole|mesh-list
83339693|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83339694|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339695|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83339696|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339697|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339698|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
83339699|NCT01581970|Cetuximab|cetuximab|mesh-list
83339700|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339701|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
83339702|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339703|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339704|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83339705|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
83339706|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339707|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339708|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83339709|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339710|NCT01583686|Aldesleukin|aldesleukin|mesh-list
83339711|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
83339712|NCT01583686|Fludarabine|fludarabine|mesh-list
83339713|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339714|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
83339715|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339716|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339717|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83339718|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
83339719|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339720|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339721|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83339722|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83339723|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83339724|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
83339725|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339726|NCT01532128|Opicapone|opicapone|mesh-list
83339727|NCT01532128|Rasagiline|rasagiline|mesh-list
83339728|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83339729|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339730|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339731|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83339732|NCT01532128|Protective Agents|protective agents|mesh-ancestor
83339733|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339734|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83339735|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83339736|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83339737|NCT01584388|Rituximab|rituximab|mesh-list
83339738|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339739|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339740|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
83339741|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339742|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339743|NCT01584544|Capecitabine|capecitabine|mesh-list
83339744|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83339745|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
83339746|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339747|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339748|NCT03006952|Losartan|losartan|mesh-list
83339756|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339757|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83339758|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83339759|NCT03006952|Protective Agents|protective agents|mesh-ancestor
83339760|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339761|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
83339762|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83339764|NCT01802333|Cytarabine|cytarabine|mesh-list
83339765|NCT01802333|Daunorubicin|daunorubicin|mesh-list
83339766|NCT01802333|Vorinostat|vorinostat|mesh-list
83339767|NCT01802333|Idarubicin|idarubicin|mesh-list
83339768|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83339769|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
83339770|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339771|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339772|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
83339773|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339774|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83339775|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
83339776|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339777|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83339778|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83339779|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83339780|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339781|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83339782|NCT01585324|Ribavirin|ribavirin|mesh-list
83339783|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83339784|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
83339785|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339786|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
83339787|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339788|NCT01586962|Acetaminophen|acetaminophen|mesh-list
83339789|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
83339790|NCT01586962|Ephedrine|ephedrine|mesh-list
83339791|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339792|NCT01586962|Analgesics|analgesics|mesh-ancestor
83339793|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
83339794|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339795|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339796|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
83339797|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83339798|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
83339799|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83339800|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
83339801|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
83339802|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83339803|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83339804|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
83339805|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
83339806|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339807|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339808|NCT03006250|Sevoflurane|sevoflurane|mesh-list
83339809|NCT03006250|Desflurane|desflurane|mesh-list
83339810|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83339811|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83339812|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
83339813|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
83339814|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339815|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339824|NCT04129437|Ibuprofen|ibuprofen|mesh-list
83339825|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83339826|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339827|NCT04129437|Analgesics|analgesics|mesh-ancestor
83339828|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
83339829|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339830|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339831|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339833|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83339834|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339835|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339836|NCT04588259|Insulin|insulin|mesh-list
83339837|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83339838|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
83339839|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
83339840|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83339841|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83339842|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339843|NCT01801475|Ondansetron|ondansetron|mesh-list
83339844|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
83339845|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
83339846|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339847|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339848|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339849|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
83339850|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83339851|NCT01801475|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83339852|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83339853|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
83339854|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339855|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339856|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
83339857|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83339858|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
83339859|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339860|NCT03063021|Expectorants|expectorants|mesh-ancestor
83339861|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
83339862|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83339863|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
83339864|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339865|NCT03063021|Protective Agents|protective agents|mesh-ancestor
83339866|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339867|NCT03063021|Antidotes|antidotes|mesh-ancestor
83339868|NCT02337933|Ursolic acid|ursolic acid|mesh-list
83339869|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339870|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339871|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83339872|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339873|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83339874|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339875|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83339876|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83339877|NCT02337933|Analgesics|analgesics|mesh-ancestor
83339878|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
83339879|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339880|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339881|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339882|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83339883|NCT03028857|Choline|choline|mesh-list
83339884|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
83339885|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83339886|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
83339887|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339888|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339889|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83339890|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
83339891|NCT03062943|Nintedanib|nintedanib|mesh-list
83339892|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339893|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83339894|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339895|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339896|NCT01536886|Betamethasone|betamethasone|mesh-list
83339897|NCT01536886|Calcipotriene|calcipotriene|mesh-list
83339898|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83339899|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
83339901|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339902|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339903|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83339904|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
83339905|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
83339906|NCT02247310|Interferons|interferons|mesh-list
83339907|NCT02247310|Interferon-beta|interferon-beta|mesh-list
83339908|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
83339909|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339910|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
83339911|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339912|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
83339913|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339914|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83339915|NCT03061539|Nivolumab|nivolumab|mesh-list
83339916|NCT03061539|Ipilimumab|ipilimumab|mesh-list
83339917|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83339918|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83339919|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83339920|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339921|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
83339922|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83339923|NCT05609253|Itraconazole|itraconazole|mesh-list
83339924|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83339925|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
83339926|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339927|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83339928|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83339929|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339930|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339931|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83339932|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
83339933|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83339934|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339935|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83339936|NCT01822535|Midodrine|midodrine|mesh-list
83339937|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
83339938|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
83339939|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339940|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339941|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83339942|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83339943|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83339944|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83339945|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
83339946|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339947|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339948|NCT01537666|Vancomycin|vancomycin|mesh-list
83339949|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339950|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339951|NCT01537900|Grazoprevir|grazoprevir|mesh-list
83339952|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
83339953|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339954|NCT01799993|Amikacin|amikacin|mesh-list
83339955|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339956|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339957|NCT03005860|Fentanyl|fentanyl|mesh-list
83339958|NCT03005860|Propofol|propofol|mesh-list
83339959|NCT03005860|Sevoflurane|sevoflurane|mesh-list
83339960|NCT03005860|Atracurium|atracurium|mesh-list
83339961|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83339962|NCT03005860|Narcotics|narcotics|mesh-ancestor
83339963|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83339964|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83339965|NCT03005860|Analgesics|analgesics|mesh-ancestor
83339966|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
83339967|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83339968|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83339969|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83339970|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
83339971|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
83339972|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339973|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83339974|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83339975|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83339976|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83339977|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83339978|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83339979|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83339980|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
83339981|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83339982|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83339984|NCT01593592|Clarithromycin|clarithromycin|mesh-list
83339985|NCT01593592|Omeprazole|omeprazole|mesh-list
83339986|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83339987|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83339988|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83339989|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83339990|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83339991|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83339992|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83339993|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83339994|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83339995|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83339996|NCT03001960|Clopidogrel|clopidogrel|mesh-list
83339997|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83339998|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83339999|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83340000|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83340001|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
83340002|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340003|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340004|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340005|NCT01593670|Decitabine|decitabine|mesh-list
83340006|NCT01593670|Interleukin-2|interleukin-2|mesh-list
83340007|NCT01593670|Vorinostat|vorinostat|mesh-list
83340008|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83340009|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
83340010|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340011|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340012|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340013|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83340014|NCT01593670|Analgesics|analgesics|mesh-ancestor
83340015|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
83340016|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340017|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340018|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83340019|NCT01593748|Gemcitabine|gemcitabine|mesh-list
83340020|NCT01593748|Docetaxel|docetaxel|mesh-list
83340021|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83340022|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
83340023|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340024|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340025|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
83340026|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
83340027|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
83340028|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
83340029|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83340030|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
83340031|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340032|NCT03005704|Aspirin|aspirin|mesh-list
83340033|NCT03005704|Ticagrelor|ticagrelor|mesh-list
83340034|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83340035|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83340036|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83340037|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83340038|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
83340039|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340040|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340041|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340042|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83340043|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83340044|NCT03005704|Analgesics|analgesics|mesh-ancestor
83340045|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
83340046|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340047|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340048|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83340049|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83340050|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83340051|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83340052|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340053|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
83340054|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
83340055|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83340056|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340058|NCT01595854|Ticagrelor|ticagrelor|mesh-list
83340059|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83340060|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83340061|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83340062|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83340063|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
83340064|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340065|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340066|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340067|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
83340068|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83340069|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
83340070|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340071|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
83340072|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
83340073|NCT01596088|Razoxane|razoxane|mesh-list
83340074|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340075|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83340076|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83340077|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83340078|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340079|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340080|NCT01596088|Protective Agents|protective agents|mesh-ancestor
83340081|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340082|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
83340083|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
83340084|NCT02216422|Ritonavir|ritonavir|mesh-list
83340085|NCT02216422|Ribavirin|ribavirin|mesh-list
83340086|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83340087|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83340088|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
83340089|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340090|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340091|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83340092|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83340093|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
83340094|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340095|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83340096|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83340097|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
83340098|NCT03001570|Cetuximab|cetuximab|mesh-list
83340099|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340100|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340101|NCT03005548|Morphine|morphine|mesh-list
83340102|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83340103|NCT03005548|Narcotics|narcotics|mesh-ancestor
83340104|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340105|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340106|NCT03005548|Analgesics|analgesics|mesh-ancestor
83340107|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
83340108|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340109|NCT03373266|Anesthetics|anesthetics|mesh-list
83340110|NCT03373266|Sevoflurane|sevoflurane|mesh-list
83340111|NCT03373266|Isoflurane|isoflurane|mesh-list
83340112|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340113|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340114|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83340115|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83340116|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
83340117|NCT02217904|Islatravir|islatravir|mesh-list
83340118|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
83340119|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340120|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340121|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340122|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83340123|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83340124|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83340125|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
83340126|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83340127|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
83340128|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340129|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340131|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340132|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340133|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340134|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340135|NCT03005002|Durvalumab|durvalumab|mesh-list
83340136|NCT03005002|Ipilimumab|ipilimumab|mesh-list
83340137|NCT03005002|Tremelimumab|tremelimumab|mesh-list
83340138|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
83340139|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83340140|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
83340141|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340142|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340143|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
83340144|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340145|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83340146|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340147|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
83340148|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83340149|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
83340150|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83340151|NCT03001102|Povidone|povidone|mesh-list
83340152|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340153|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
83340154|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
83340155|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
83340156|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
83340157|NCT03000946|Octreotide|octreotide|mesh-list
83340158|NCT03000946|Somatostatin|somatostatin|mesh-list
83340159|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83340160|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83340161|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340162|NCT03000946|Hormones|hormones|mesh-ancestor
83340163|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340164|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340165|NCT03004768|Deucravacitinib|deucravacitinib|mesh-list
83340166|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
83340167|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340168|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340169|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340170|NCT03005236|Tacrolimus|tacrolimus|mesh-list
83340171|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83340172|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
83340173|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340174|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83340175|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340176|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340177|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
83340178|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340179|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
83340180|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
83340181|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
83340182|NCT02519010|Amlodipine|amlodipine|mesh-list
83340183|NCT02519010|Valsartan|valsartan|mesh-list
83340184|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
83340185|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83340186|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83340187|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83340188|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340189|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83340190|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340191|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
83340192|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83340193|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83340194|NCT03004612|Metformin|metformin|mesh-list
83340195|NCT03004612|Linagliptin|linagliptin|mesh-list
83340196|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83340197|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340198|NCT03004612|Incretins|incretins|mesh-ancestor
83340199|NCT03004612|Hormones|hormones|mesh-ancestor
83340200|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340201|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83340202|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
83340203|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340204|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340205|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
83340206|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83340207|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
83340208|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83340209|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
83340210|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340211|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340212|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
83340213|NCT03372486|Bupivacaine|bupivacaine|mesh-list
83340214|NCT03372486|Naloxone|naloxone|mesh-list
83340215|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340216|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
83340217|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340218|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340219|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
83340220|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340221|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83340222|NCT05035888|Phenylephrine|phenylephrine|mesh-list
83340223|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
83340224|NCT05035888|Norepinephrine|norepinephrine|mesh-list
83340225|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83340226|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83340227|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
83340228|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
83340229|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340230|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340231|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
83340232|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
83340233|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
83340234|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83340235|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83340236|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83340237|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
83340238|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340239|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340240|NCT05035888|Protective Agents|protective agents|mesh-ancestor
83340241|NCT03362814|Ritonavir|ritonavir|mesh-list
83340242|NCT03362814|Ribavirin|ribavirin|mesh-list
83340243|NCT03362814|Lactams|lactams|mesh-list
83340244|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83340245|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83340246|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
83340247|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340248|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340249|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83340250|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83340251|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
83340252|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340253|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83340254|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83340255|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
83340256|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83340257|NCT03004066|Daptomycin|daptomycin|mesh-list
83340258|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83340259|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340260|NCT03362736|Ustekinumab|ustekinumab|mesh-list
83340261|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
83340262|NCT03004222|Bupivacaine|bupivacaine|mesh-list
83340263|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340264|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
83340265|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340266|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340267|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
83340268|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340269|NCT03000634|Dexamethasone|dexamethasone|mesh-list
83340270|NCT03000634|Lenalidomide|lenalidomide|mesh-list
83340271|NCT03000634|Bortezomib|bortezomib|mesh-list
83340272|NCT03000634|Elotuzumab|elotuzumab|mesh-list
83340273|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340274|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
83340275|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
83340276|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340277|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340278|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83340279|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
83340280|NCT03000634|Hormones|hormones|mesh-ancestor
83340281|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340282|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83340283|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340284|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
83340285|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83340286|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83340287|NCT03000634|Growth Substances|growth substances|mesh-ancestor
83340288|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
83340289|NCT02520102|Sargramostim|sargramostim|mesh-list
83340290|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
83340291|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340292|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83340293|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
83340294|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83340295|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83340296|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
83340297|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340298|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
83340299|NCT03000556|Protective Agents|protective agents|mesh-ancestor
83340300|NCT03371862|Liraglutide|liraglutide|mesh-list
83340301|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83340302|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340303|NCT03371862|Incretins|incretins|mesh-ancestor
83340304|NCT03371862|Hormones|hormones|mesh-ancestor
83340305|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340306|NCT03368430|Melatonin|melatonin|mesh-list
83340307|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
83340308|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340309|NCT03368430|Protective Agents|protective agents|mesh-ancestor
83340310|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340311|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340312|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
83340313|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340314|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
83340315|NCT03003832|Analgesics|analgesics|mesh-list
83340316|NCT03003832|Narcotics|narcotics|mesh-ancestor
83340317|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340318|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340319|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
83340320|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340321|NCT03368352|Melatonin|melatonin|mesh-list
83340322|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
83340323|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340324|NCT03368352|Protective Agents|protective agents|mesh-ancestor
83340325|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340326|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340327|NCT02248012|Everolimus|everolimus|mesh-list
83340328|NCT02248012|Temozolomide|temozolomide|mesh-list
83340329|NCT02248012|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83340330|NCT02248012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340331|NCT02248012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340332|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340333|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83340334|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
83340335|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340336|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340337|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83340338|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
83340339|NCT03362268|Omeprazole|omeprazole|mesh-list
83340340|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83340341|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83340342|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83340343|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340344|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340345|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83340346|NCT04523844|Brinzolamide|brinzolamide|mesh-list
83340347|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83340348|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83340349|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83340350|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83340351|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
83340352|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340353|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340354|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340355|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83340356|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340357|NCT03361878|Metformin|metformin|mesh-list
83340358|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83340359|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340360|NCT03361800|Entinostat|entinostat|mesh-list
83340361|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340362|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83340363|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340364|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340365|NCT02998918|Curcumin|curcumin|mesh-list
83340366|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83340367|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83340368|NCT02998918|Analgesics|analgesics|mesh-ancestor
83340369|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
83340370|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340371|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340372|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340373|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83340374|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340375|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340376|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340377|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
83340378|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340379|NCT02998606|Naloxegol|naloxegol|mesh-list
83340380|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83340381|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340382|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
83340383|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340384|NCT05365438|Atorvastatin|atorvastatin|mesh-list
83340385|NCT05365438|Ezetimibe|ezetimibe|mesh-list
83340386|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83340387|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83340388|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
83340389|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340390|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83340391|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83340392|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340393|NCT05264506|Estradiol|estradiol|mesh-list
83340394|NCT05264506|Estrogens|estrogens|mesh-ancestor
83340395|NCT05264506|Hormones|hormones|mesh-ancestor
83340396|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340397|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340398|NCT02248168|Pramipexole|pramipexole|mesh-list
83340399|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
83340400|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340401|NCT02248168|Protective Agents|protective agents|mesh-ancestor
83340402|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340403|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83340404|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83340405|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
83340406|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
83340407|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340408|NCT05672680|Bupivacaine|bupivacaine|mesh-list
83340409|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340410|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
83340411|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340412|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340413|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
83340414|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340415|NCT05672524|Trastuzumab|trastuzumab|mesh-list
83340416|NCT05672524|Tucatinib|tucatinib|mesh-list
83340417|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340418|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340419|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340420|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340421|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340422|NCT03002428|Teriparatide|teriparatide|mesh-list
83340423|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83340424|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340425|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83340427|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83340428|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
83340429|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340430|NCT03371550|Docetaxel|docetaxel|mesh-list
83340431|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340432|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
83340433|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
83340434|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
83340435|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340436|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
83340437|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
83340438|NCT05669872|Hematinics|hematinics|mesh-ancestor
83340439|NCT04861948|Bevacizumab|bevacizumab|mesh-list
83340440|NCT04861948|Carboplatin|carboplatin|mesh-list
83340441|NCT04861948|Pemetrexed|pemetrexed|mesh-list
83340442|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340443|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340444|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83340445|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83340446|NCT04861948|Growth Substances|growth substances|mesh-ancestor
83340447|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340448|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
83340449|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340450|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340451|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83340452|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83340453|NCT04526028|Fulvestrant|fulvestrant|mesh-list
83340454|NCT04526028|Palbociclib|palbociclib|mesh-list
83340455|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83340456|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340457|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83340458|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83340459|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
83340460|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340461|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340462|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340463|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340464|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340465|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83340466|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340467|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
83340468|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340469|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
83340470|NCT03368274|Hormones|hormones|mesh-ancestor
83340471|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340472|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340473|NCT02247544|Trabectedin|trabectedin|mesh-list
83340474|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83340475|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
83340476|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340477|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340478|NCT03370848|Aspirin|aspirin|mesh-list
83340479|NCT03370848|Psyllium|psyllium|mesh-list
83340480|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83340481|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83340482|NCT03370848|Analgesics|analgesics|mesh-ancestor
83340483|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
83340484|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340485|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340486|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340487|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83340488|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83340489|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83340490|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340491|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83340492|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83340493|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340494|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
83340495|NCT03370848|Cathartics|cathartics|mesh-ancestor
83340496|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83340497|NCT02248792|Methotrexate|methotrexate|mesh-list
83340498|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83340499|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
83340500|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83340501|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340502|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83340504|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340505|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340506|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
83340507|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340508|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83340509|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83340510|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
83340511|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83340512|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83340513|NCT03367728|Ropivacaine|ropivacaine|mesh-list
83340514|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340515|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
83340516|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340517|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340518|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
83340519|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340520|NCT02248870|Dexamethasone|dexamethasone|mesh-list
83340521|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340522|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
83340523|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
83340524|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340525|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340526|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83340527|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
83340528|NCT02248870|Hormones|hormones|mesh-ancestor
83340529|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340530|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83340531|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340532|NCT04073056|Bupivacaine|bupivacaine|mesh-list
83340533|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340534|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
83340535|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340536|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340537|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
83340538|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340539|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
83340540|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83340541|NCT03361098|Exenatide|exenatide|mesh-list
83340542|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340543|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83340544|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340545|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83340546|NCT03361098|Incretins|incretins|mesh-ancestor
83340547|NCT03361098|Hormones|hormones|mesh-ancestor
83340548|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340549|NCT03367494|Bromides|bromides|mesh-list
83340550|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
83340551|NCT05594290|Etoposide|etoposide|mesh-list
83340552|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340553|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83340554|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83340555|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83340556|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340557|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340558|NCT03370380|Aflibercept|aflibercept|mesh-list
83340559|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83340560|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83340561|NCT03370380|Growth Substances|growth substances|mesh-ancestor
83340562|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340563|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
83340564|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340565|NCT04414540|Metformin|metformin|mesh-list
83340566|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
83340567|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83340568|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340569|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340570|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340571|NCT04414540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83340572|NCT04414540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340573|NCT05568160|Vasopressins|vasopressins|mesh-list
83340574|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
83340575|NCT05568160|Norepinephrine|norepinephrine|mesh-list
83340576|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83340577|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83340578|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
83340579|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340580|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340581|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340582|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
83340583|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
83340584|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340585|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83340586|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
83340587|NCT05568160|Coagulants|coagulants|mesh-ancestor
83340588|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83340589|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
83340590|NCT03367182|Paclitaxel|paclitaxel|mesh-list
83340591|NCT03367182|Bevacizumab|bevacizumab|mesh-list
83340592|NCT03367182|Doxorubicin|doxorubicin|mesh-list
83340593|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83340594|NCT03367182|Topotecan|topotecan|mesh-list
83340595|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83340596|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340597|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
83340598|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
83340599|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
83340600|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340601|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340602|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83340603|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83340604|NCT03367182|Growth Substances|growth substances|mesh-ancestor
83340605|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340606|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
83340607|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83340608|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83340609|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83340610|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340611|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83340612|NCT05561764|Imipenem|imipenem|mesh-list
83340613|NCT05561764|Relebactam|relebactam|mesh-list
83340614|NCT05561764|Cilastatin|cilastatin|mesh-list
83340615|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83340616|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340617|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
83340618|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340619|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340620|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83340621|NCT04119180|Midazolam|midazolam|mesh-list
83340622|NCT04119180|Ketamine|ketamine|mesh-list
83340623|NCT04119180|Analgesics|analgesics|mesh-ancestor
83340624|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
83340625|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340626|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340627|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83340628|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83340629|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
83340630|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
83340631|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340632|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83340633|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83340634|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83430179|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340635|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340636|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83340637|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83340638|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83340639|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83340640|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83340641|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
83340642|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
83340643|NCT03358212|Denosumab|denosumab|mesh-list
83340644|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83340645|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340646|NCT04522050|Gemcitabine|gemcitabine|mesh-list
83340647|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340648|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83340649|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
83340650|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340651|NCT03109392|Lidocaine|lidocaine|mesh-list
83340652|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340653|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
83340654|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340655|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340656|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
83340657|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340658|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83340659|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83340660|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83340661|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83340662|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340663|NCT03357900|Remifentanil|remifentanil|mesh-list
83340664|NCT03357900|Propofol|propofol|mesh-list
83340665|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83340666|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340667|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340668|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83340669|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
83340670|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
83340671|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83340672|NCT03357900|Narcotics|narcotics|mesh-ancestor
83340673|NCT03357900|Analgesics|analgesics|mesh-ancestor
83340674|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
83340675|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340676|NCT04525326|Bevacizumab|bevacizumab|mesh-list
83340677|NCT04525326|Cetuximab|cetuximab|mesh-list
83340678|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340679|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340680|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83340681|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83340682|NCT04525326|Growth Substances|growth substances|mesh-ancestor
83340683|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340684|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
83340685|NCT03357822|Interferons|interferons|mesh-list
83340686|NCT03357822|Tenofovir|tenofovir|mesh-list
83340687|NCT03357822|Entecavir|entecavir|mesh-list
83340688|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340689|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
83340690|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340691|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83340692|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83340693|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340694|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340695|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83340696|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83340697|NCT03359694|Docetaxel|docetaxel|mesh-list
83340698|NCT03359694|Doxorubicin|doxorubicin|mesh-list
83340699|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83340700|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340701|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83340702|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
83340703|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83340704|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340705|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83340706|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83340707|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83340708|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340709|NCT03123276|Gemcitabine|gemcitabine|mesh-list
83340710|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
83340711|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83340712|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
83340713|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340714|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340715|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83340716|NCT03123276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83340717|NCT03357276|Immunomodulating Agents|immunomodulating agents|mesh-list
83340718|NCT03357276|Immunologic Factors|immunologic factors|mesh-ancestor
83340719|NCT03357276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340720|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83340721|NCT02249026|Buprenorphine|buprenorphine|mesh-list
83340722|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
83340723|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83340724|NCT02249026|Narcotics|narcotics|mesh-ancestor
83340725|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340726|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340727|NCT02249026|Analgesics|analgesics|mesh-ancestor
83340728|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
83340729|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340730|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83340731|NCT04521192|Fluzoparib|fluzoparib|mesh-list
83340732|NCT04521192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83340733|NCT04521192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340734|NCT04521192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340735|NCT04521192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340736|NCT03359070|Miconazole|miconazole|mesh-list
83340737|NCT03359070|Clotrimazole|clotrimazole|mesh-list
83340738|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
83340739|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340740|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83340741|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83340742|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340743|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340744|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83340745|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
83340746|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340747|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340748|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83340749|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83340750|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83340751|NCT03366246|Lidocaine|lidocaine|mesh-list
83340752|NCT03366246|Prilocaine|prilocaine|mesh-list
83340753|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
83340754|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340755|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
83340756|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340757|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340758|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
83340759|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340760|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83340761|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83340762|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83340763|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83340764|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340765|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83340766|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
83340767|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
83340768|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83340769|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83340770|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340771|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83340772|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83340773|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83340774|NCT03556384|Temozolomide|temozolomide|mesh-list
83340775|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83340776|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
83340777|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340778|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340779|NCT04520646|Empagliflozin|empagliflozin|mesh-list
83340780|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83340781|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340782|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83340783|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340784|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
83340785|NCT01624948|Everolimus|everolimus|mesh-list
83340786|NCT01624948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83340787|NCT01624948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340788|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340789|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340790|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83340791|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
83340792|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340793|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340794|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83340795|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83340796|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
83340797|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83340798|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340799|NCT04523064|Empagliflozin|empagliflozin|mesh-list
83340800|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83340801|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340802|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83340803|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340804|NCT04520880|Antibodies|antibodies|mesh-list
83340805|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
83340806|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
83340807|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
83340808|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340809|NCT03365466|Aspirin|aspirin|mesh-list
83340810|NCT03365466|Heparin|heparin|mesh-list
83340811|NCT03365466|Calcium heparin|calcium heparin|mesh-list
83340812|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83340813|NCT03365466|Tinzaparin|tinzaparin|mesh-list
83340814|NCT03365466|Dalteparin|dalteparin|mesh-list
83340815|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83340816|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83340817|NCT03365466|Analgesics|analgesics|mesh-ancestor
83340818|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
83340819|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340820|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340821|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340822|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83340823|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83340824|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83340825|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340826|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83340827|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83340828|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340829|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
83340830|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
83340831|NCT03356964|Hormones|hormones|mesh-list
83340832|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83340833|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83340834|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340835|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
83340836|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83340837|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83340838|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83340839|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83340840|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340841|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
83340842|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340843|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340844|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83340845|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340846|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
83340847|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83340848|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
83340849|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340850|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
83340851|NCT03365388|Protective Agents|protective agents|mesh-ancestor
83340852|NCT03123744|Palbociclib|palbociclib|mesh-list
83340853|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340854|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340855|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340856|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340857|NCT03358524|Vitamins|vitamins|mesh-list
83340858|NCT03358524|Vitamin E|vitamin e|mesh-list
83340859|NCT03358524|Tocopherols|tocopherols|mesh-list
83340860|NCT03358524|Tocotrienols|tocotrienols|mesh-list
83340861|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
83340862|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
83340863|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340864|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
83340865|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340866|NCT03358524|Protective Agents|protective agents|mesh-ancestor
83340867|NCT04444986|Favipiravir|favipiravir|mesh-list
83340868|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
83340869|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340870|NCT03356730|Vitamin D|vitamin d|mesh-list
83340871|NCT03356730|Vitamins|vitamins|mesh-ancestor
83340872|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
83340873|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340874|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83340875|NCT03364998|Factor VIII|factor viii|mesh-list
83340876|NCT03364998|Coagulants|coagulants|mesh-ancestor
83340877|NCT04509102|Adderall|adderall|mesh-list
83340878|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83340879|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340880|NCT04508946|Thiamine|thiamine|mesh-list
83340881|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
83340882|NCT04508946|Vitamins|vitamins|mesh-ancestor
83340883|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
83340884|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340885|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83340886|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
83340887|NCT03364842|Furosemide|furosemide|mesh-list
83340888|NCT03364842|Diuretics|diuretics|mesh-ancestor
83340889|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
83340890|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340891|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83340892|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83340893|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340894|NCT03364764|Sirolimus|sirolimus|mesh-list
83340895|NCT03364764|Temsirolimus|temsirolimus|mesh-list
83340896|NCT03364764|MTOR Inhibitors|mtor inhibitors|mesh-list
83340897|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83340898|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340899|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83340900|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83340901|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
83340902|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83340903|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
83340904|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340905|NCT03364764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83340906|NCT03364764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83340907|NCT03364764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340908|NCT02519400|Amitriptyline|amitriptyline|mesh-list
83340909|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83340910|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
83340911|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83340912|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83340913|NCT02519400|Analgesics|analgesics|mesh-ancestor
83340914|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
83340915|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340916|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340917|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83340918|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83340919|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83340920|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340921|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
83340922|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340923|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
83340924|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
83340925|NCT04509258|Ondansetron|ondansetron|mesh-list
83340926|NCT04509258|Mineral Oil|mineral oil|mesh-list
83340927|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83340928|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
83340929|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
83340930|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340931|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340932|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83340933|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
83340934|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
83340935|NCT04509258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83340936|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83340937|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
83340938|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340939|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340940|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
83340941|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340942|NCT04509258|Expectorants|expectorants|mesh-ancestor
83340943|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
83340944|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83340945|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
83340946|NCT04509258|Protective Agents|protective agents|mesh-ancestor
83340947|NCT04509258|Antidotes|antidotes|mesh-ancestor
83340948|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
83340949|NCT04509258|Vitamins|vitamins|mesh-ancestor
83340950|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
83340951|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
83340952|NCT04509258|Emollients|emollients|mesh-ancestor
83340953|NCT03354624|Mitogens|mitogens|mesh-list
83340954|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
83340955|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340956|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
83340957|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83340958|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
83340959|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83340960|NCT03364218|Expectorants|expectorants|mesh-ancestor
83340961|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
83340962|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83340963|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
83340964|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340965|NCT03364218|Protective Agents|protective agents|mesh-ancestor
83340966|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340967|NCT03364218|Antidotes|antidotes|mesh-ancestor
83340968|NCT04444284|Vaccines|vaccines|mesh-list
83340969|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
83340970|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340971|NCT03354312|Lidocaine|lidocaine|mesh-list
83340972|NCT03354312|Epinephrine|epinephrine|mesh-list
83340973|NCT03354312|Racepinephrine|racepinephrine|mesh-list
83340974|NCT03354312|Carticaine|carticaine|mesh-list
83340975|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
83340976|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
83340977|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
83340978|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83340979|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83340980|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
83340981|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83340982|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83340983|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83340984|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83340985|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83340986|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83340987|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83340988|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83340989|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
83340990|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83340991|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83340992|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83340993|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
83340994|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83340995|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
83340996|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
83340997|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
83340998|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83340999|NCT03363984|Midazolam|midazolam|mesh-list
83341000|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83341001|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83341002|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341003|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341004|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83341005|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83341006|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83341007|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83341008|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
83341009|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
83341010|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
83341011|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
83341012|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341013|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341014|NCT03355716|Fentanyl|fentanyl|mesh-list
83341015|NCT03355716|Ketamine|ketamine|mesh-list
83341016|NCT03355716|Morphine|morphine|mesh-list
83341017|NCT03355716|Bupivacaine|bupivacaine|mesh-list
83341018|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
83341019|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
83341020|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341021|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341022|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
83341023|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341024|NCT03355716|Analgesics|analgesics|mesh-ancestor
83341025|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83341026|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83341027|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
83341028|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83341029|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83341030|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341031|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341032|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83341033|NCT03355716|Narcotics|narcotics|mesh-ancestor
83341034|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83341035|NCT04508400|Dexamethasone|dexamethasone|mesh-list
83341036|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
83341037|NCT04508400|Ondansetron|ondansetron|mesh-list
83341038|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
83341039|NCT04508400|Aprepitant|aprepitant|mesh-list
83341040|NCT04508400|BB 1101|bb 1101|mesh-list
83341041|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341042|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
83341043|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
83341044|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341045|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341046|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83341047|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
83341048|NCT04508400|Hormones|hormones|mesh-ancestor
83341049|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341050|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341051|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341052|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
83341053|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341054|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341055|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
83341056|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341057|NCT04508400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83341058|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83341059|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
83341060|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341061|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83341062|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
83341063|NCT03355638|Aflibercept|aflibercept|mesh-list
83341064|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83341065|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83341066|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83341067|NCT03355638|Growth Substances|growth substances|mesh-ancestor
83341068|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341069|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
83341070|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341071|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83341072|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83341073|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83341074|NCT03355638|Analgesics|analgesics|mesh-ancestor
83341075|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
83341076|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341077|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341079|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
83341080|NCT01626664|Gemcitabine|gemcitabine|mesh-list
83341081|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
83341082|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
83341083|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341084|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
83341085|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341086|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341087|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
83341088|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83341089|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83341090|NCT04515966|Prednisolone|prednisolone|mesh-list
83341091|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
83341092|NCT04515966|Lidocaine|lidocaine|mesh-list
83341093|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83341094|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
83341095|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
83341096|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
83341097|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341098|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341099|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
83341100|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341101|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83341102|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83341103|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83341104|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83341105|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341106|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341108|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
83341109|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83341110|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
83341111|NCT04515966|Hormones|hormones|mesh-ancestor
83341112|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341113|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83341114|NCT04515966|Protective Agents|protective agents|mesh-ancestor
83341115|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341116|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341117|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83341118|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83341119|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341120|NCT03355248|Acetaminophen|acetaminophen|mesh-list
83341121|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83341122|NCT03355248|Oxycodone|oxycodone|mesh-list
83341123|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83341124|NCT03355248|Analgesics|analgesics|mesh-ancestor
83341125|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
83341126|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341127|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341128|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
83341129|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83341130|NCT03355248|Narcotics|narcotics|mesh-ancestor
83341131|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341132|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83341133|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341134|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83341135|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83341136|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83341137|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83341138|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83341139|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341140|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341141|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341142|NCT03350334|Analgesics|analgesics|mesh-ancestor
83341143|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
83341144|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341145|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
83341146|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83341147|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
83341148|NCT02230696|Fluticasone|fluticasone|mesh-list
83341149|NCT02230696|Xhance|xhance|mesh-list
83341150|NCT02230696|Azelastine|azelastine|mesh-list
83341151|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341152|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83341153|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
83341154|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341155|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341156|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83341157|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
83341158|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341159|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83341160|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83341161|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341162|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341163|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83341164|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83341165|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
83341166|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
83341167|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341168|NCT03355014|Metformin|metformin|mesh-list
83341169|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83341170|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341171|NCT02231086|Leucovorin|leucovorin|mesh-list
83341172|NCT02231086|Fluorouracil|fluorouracil|mesh-list
83341173|NCT02231086|Capecitabine|capecitabine|mesh-list
83341174|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
83341175|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
83341176|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341177|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341179|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341180|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
83341181|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341182|NCT02231086|Antidotes|antidotes|mesh-ancestor
83341183|NCT02231086|Protective Agents|protective agents|mesh-ancestor
83341184|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
83341185|NCT02231086|Vitamins|vitamins|mesh-ancestor
83341186|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
83341187|NCT03353298|Allopurinol|allopurinol|mesh-list
83341188|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
83341189|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341190|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341191|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
83341192|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83341193|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83341194|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
83341195|NCT03353298|Protective Agents|protective agents|mesh-ancestor
83341196|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341197|NCT02509546|Adenosine|adenosine|mesh-list
83341198|NCT02509546|Analgesics|analgesics|mesh-ancestor
83341199|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
83341200|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341201|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341202|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83341203|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
83341204|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83341205|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
83341206|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
83341207|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341208|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341209|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83341210|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83341211|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341212|NCT03187210|Immunotoxins|immunotoxins|mesh-ancestor
83341213|NCT03187210|Immunoconjugates|immunoconjugates|mesh-ancestor
83341214|NCT03187210|Immunologic Factors|immunologic factors|mesh-ancestor
83341215|NCT03187210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341216|NCT03349866|Capecitabine|capecitabine|mesh-list
83341217|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
83341218|NCT03349866|Apatinib|apatinib|mesh-list
83341219|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341220|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
83341221|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341222|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341223|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83341224|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341225|NCT01631110|Vaccines|vaccines|mesh-list
83341226|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
83341227|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341228|NCT01631656|Azelaic acid|azelaic acid|mesh-list
83341229|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341230|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341231|NCT02989636|Nivolumab|nivolumab|mesh-list
83341232|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83341233|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341234|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83341235|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341236|NCT02985190|Azacitidine|azacitidine|mesh-list
83341237|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341238|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
83341239|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341240|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341241|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341242|NCT01376310|Paclitaxel|paclitaxel|mesh-list
83341243|NCT01376310|Docetaxel|docetaxel|mesh-list
83341244|NCT01376310|Carboplatin|carboplatin|mesh-list
83341245|NCT01376310|Gemcitabine|gemcitabine|mesh-list
83341246|NCT01376310|Pemetrexed|pemetrexed|mesh-list
83341247|NCT01376310|Everolimus|everolimus|mesh-list
83341248|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83341249|NCT01376310|Trametinib|trametinib|mesh-list
83341250|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83341251|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341252|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
83341253|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
83341254|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
83341255|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341256|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341257|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
83341258|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341259|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83341260|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83341261|NCT01376310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83341262|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83341263|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341264|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
83341265|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341266|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
83341267|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83341268|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341269|NCT01638052|Clonidine|clonidine|mesh-list
83341270|NCT01638052|Bupivacaine|bupivacaine|mesh-list
83341271|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
83341272|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
83341273|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341274|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341275|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
83341276|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341277|NCT01638052|Analgesics|analgesics|mesh-ancestor
83341278|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83341279|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
83341280|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
83341281|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83341282|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83341283|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83341284|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
83341285|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341286|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341287|NCT02518152|Alendronate|alendronate|mesh-list
83341288|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83341289|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341290|NCT01229878|Vitamin D|vitamin d|mesh-list
83341291|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
83341292|NCT01229878|Vitamins|vitamins|mesh-ancestor
83341293|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
83341294|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341295|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83341296|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83341297|NCT03352674|Insulin|insulin|mesh-list
83341298|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83341299|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
83341300|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83341301|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341302|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
83341303|NCT01639222|Vitamin D|vitamin d|mesh-list
83341304|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
83341305|NCT01639222|Calcium|calcium|mesh-list
83341306|NCT01639222|Vitamins|vitamins|mesh-ancestor
83341307|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
83341308|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341309|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83341310|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83341311|NCT04443270|Chloroquine|chloroquine|mesh-list
83341312|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
83341313|NCT04443270|Amebicides|amebicides|mesh-ancestor
83341314|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83341315|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83341316|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341317|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
83341318|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83341319|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83341320|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83341321|NCT04443270|Analgesics|analgesics|mesh-ancestor
83341322|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
83341323|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341324|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341325|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341326|NCT04443270|Filaricides|filaricides|mesh-ancestor
83341327|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
83341328|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
83341329|NCT03349008|Entecavir|entecavir|mesh-list
83341330|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
83341331|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
83341332|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341333|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341334|NCT03352362|Acetaminophen|acetaminophen|mesh-list
83341335|NCT03352362|Ibuprofen|ibuprofen|mesh-list
83341336|NCT03352362|Propacetamol|propacetamol|mesh-list
83341337|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83341338|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83341339|NCT03352362|Analgesics|analgesics|mesh-ancestor
83341340|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
83341341|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341342|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341343|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341344|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83341345|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83341346|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341347|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341348|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
83341349|NCT01598740|Spironolactone|spironolactone|mesh-list
83341350|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83341351|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
83341352|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341353|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341354|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83341355|NCT01598740|Diuretics|diuretics|mesh-ancestor
83341356|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
83341357|NCT00709098|Iloprost|iloprost|mesh-list
83341358|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83341359|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
83341360|NCT03348696|Dexamethasone|dexamethasone|mesh-list
83341361|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
83341362|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83341363|NCT03348696|BB 1101|bb 1101|mesh-list
83341364|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341365|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
83341366|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
83341367|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341368|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341369|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83341370|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
83341371|NCT03348696|Hormones|hormones|mesh-ancestor
83341372|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341373|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341374|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341375|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
83341376|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341377|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341378|NCT04506450|Anesthetics|anesthetics|mesh-list
83341379|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341380|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341381|NCT03352128|Calcium|calcium|mesh-list
83341382|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83341383|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341384|NCT03122730|Epoprostenol|epoprostenol|mesh-list
83341385|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83341386|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83341387|NCT04505904|Oxytocin|oxytocin|mesh-list
83341388|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
83341389|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83341390|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341391|NCT03348462|Anthralin|anthralin|mesh-list
83341392|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341393|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83341394|NCT04505514|Hematinics|hematinics|mesh-ancestor
83341395|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
83341396|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83341397|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83341398|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341399|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
83341400|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341401|NCT05585346|Prednisolone|prednisolone|mesh-list
83341402|NCT05585346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83341403|NCT05585346|Methylprednisolone|methylprednisolone|mesh-list
83341404|NCT05585346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83341405|NCT05585346|Prednisolone acetate|prednisolone acetate|mesh-list
83341406|NCT05585346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83341407|NCT05585346|Prednisolone phosphate|prednisolone phosphate|mesh-list
83341408|NCT05585346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341409|NCT05585346|Glucocorticoids|glucocorticoids|mesh-ancestor
83341410|NCT05585346|Hormones|hormones|mesh-ancestor
83341411|NCT05585346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341412|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341413|NCT05585346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341414|NCT05585346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341415|NCT05585346|Antiemetics|antiemetics|mesh-ancestor
83341416|NCT05585346|Autonomic Agents|autonomic agents|mesh-ancestor
83341417|NCT05585346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341418|NCT05585346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83341419|NCT05585346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83341420|NCT05585346|Protective Agents|protective agents|mesh-ancestor
83341421|NCT05098704|Clopidogrel|clopidogrel|mesh-list
83341422|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83341423|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83341424|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83341425|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83341426|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
83341427|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341428|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341429|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341430|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
83341431|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
83341432|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83341433|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83341434|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341435|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341436|NCT05584956|Urological Agents|urological agents|mesh-ancestor
83341437|NCT01376700|Factor VIII|factor viii|mesh-list
83341438|NCT01376700|Coagulants|coagulants|mesh-ancestor
83341439|NCT01797965|Daclizumab|daclizumab|mesh-list
83341440|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341441|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
83341442|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341443|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83341444|NCT01601236|Hormones|hormones|mesh-ancestor
83341445|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341446|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341447|NCT05584878|Chitosan|chitosan|mesh-list
83341448|NCT05584878|Calcium|calcium|mesh-list
83341449|NCT05584878|Caseins|caseins|mesh-list
83341450|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83341451|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341452|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
83341453|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
83341454|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341455|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83341456|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83341457|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
83341458|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83341459|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
83341460|NCT05584878|Coagulants|coagulants|mesh-ancestor
83341461|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83341462|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83341463|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83341464|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341465|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
83341466|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83341467|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
83341468|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341469|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341470|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
83341471|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
83341472|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341473|NCT03347916|Gabapentin|gabapentin|mesh-list
83341474|NCT03347916|Analgesics|analgesics|mesh-ancestor
83341475|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
83341476|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341477|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341478|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
83341479|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83341480|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83341481|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341482|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83341483|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83341484|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83341485|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341486|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341487|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
83341489|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341490|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83341491|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341492|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341493|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83341494|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83341495|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83341496|NCT04892706|Analgesics|analgesics|mesh-ancestor
83341497|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
83341498|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341499|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341500|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341501|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83341502|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341503|NCT01821677|Danazol|danazol|mesh-list
83341504|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83341505|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
83341506|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341507|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341508|NCT03347760|Octreotide|octreotide|mesh-list
83341509|NCT03347760|Edotreotide|edotreotide|mesh-list
83341510|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83341511|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341512|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83341513|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341514|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341515|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
83341516|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341517|NCT00709722|Gusperimus|gusperimus|mesh-list
83341518|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83341519|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341520|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83341521|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341522|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341523|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
83341524|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83341525|NCT00709722|Protective Agents|protective agents|mesh-ancestor
83341526|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83341527|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
83341528|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83341529|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83341530|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83341531|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341532|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
83341533|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83341534|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83341535|NCT02378298|Prednisolone|prednisolone|mesh-list
83341536|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
83341537|NCT02378298|Rituximab|rituximab|mesh-list
83341538|NCT02378298|Methotrexate|methotrexate|mesh-list
83341539|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83341540|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
83341541|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83341542|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341543|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
83341544|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341545|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83341546|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83341547|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
83341548|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83341549|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341550|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
83341551|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341552|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341553|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341554|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83341555|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341556|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83341557|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341559|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
83341560|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341561|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83341562|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
83341563|NCT02378298|Hormones|hormones|mesh-ancestor
83341564|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341565|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83341566|NCT02378298|Protective Agents|protective agents|mesh-ancestor
83341567|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341568|NCT02253108|Everolimus|everolimus|mesh-list
83341569|NCT02253108|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83341570|NCT02253108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83341571|NCT02253108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341572|NCT02253108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341573|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341574|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
83341575|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341576|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341577|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
83341578|NCT01603420|Docetaxel|docetaxel|mesh-list
83341579|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
83341580|NCT01603420|Hormones|hormones|mesh-list
83341581|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83341582|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
83341583|NCT01603420|Androgens|androgens|mesh-list
83341584|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341585|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
83341586|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
83341587|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
83341588|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341589|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341590|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341591|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
83341592|NCT01603420|Protective Agents|protective agents|mesh-ancestor
83341593|NCT01603420|Vitamins|vitamins|mesh-ancestor
83341594|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
83341595|NCT01603420|Estrogens|estrogens|mesh-ancestor
83341596|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341597|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
83341598|NCT02064036|Leuprolide|leuprolide|mesh-list
83341599|NCT02064036|Goserelin|goserelin|mesh-list
83341600|NCT02064036|Bicalutamide|bicalutamide|mesh-list
83341601|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83341602|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
83341603|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83341604|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341605|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341606|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341607|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
83341608|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
83341609|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341610|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83341611|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83341612|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341613|NCT04551300|Sevelamer|sevelamer|mesh-list
83341614|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
83341615|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
83341616|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341617|NCT04974580|Nicotine|nicotine|mesh-list
83341618|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83341619|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
83341620|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341621|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341622|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83341623|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83341624|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
83341625|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341626|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341627|NCT01691326|Vaccines|vaccines|mesh-list
83341628|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
83341629|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341630|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
83341631|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83341632|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341633|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341634|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83341636|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
83341637|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341638|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83341639|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83341640|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83341641|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
83341642|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341643|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341644|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
83341645|NCT01691560|Listerine|listerine|mesh-list
83341646|NCT01691560|Calcium|calcium|mesh-list
83341647|NCT01691560|Fluorides|fluorides|mesh-list
83341648|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
83341649|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
83341650|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83341651|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341652|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83341653|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
83341654|NCT01691560|Protective Agents|protective agents|mesh-ancestor
83341655|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83341656|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341657|NCT03346200|Tamoxifen|tamoxifen|mesh-list
83341658|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83341659|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
83341660|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341661|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341662|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83341663|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341664|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83341665|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83341666|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83341667|NCT01692340|Lycopene|lycopene|mesh-list
83341668|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83341669|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
83341670|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341671|NCT01692340|Protective Agents|protective agents|mesh-ancestor
83341672|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341673|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83341674|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83341675|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341676|NCT02517372|Pemirolast|pemirolast|mesh-list
83341677|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
83341678|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
83341679|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341680|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341681|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341682|NCT02516826|Olmesartan|olmesartan|mesh-list
83341683|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83341684|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83341685|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83341686|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83341687|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
83341688|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341689|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83341690|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83341691|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341692|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83341693|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83341694|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83341695|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
83341696|NCT01650298|Thrombin|thrombin|mesh-list
83341697|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
83341698|NCT01650298|Coagulants|coagulants|mesh-ancestor
83341699|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
83341700|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83341701|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
83341702|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341703|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341704|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
83341705|NCT05583006|Tenofovir|tenofovir|mesh-list
83341706|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
83341707|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341708|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83341709|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83341710|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341711|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341712|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83341713|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83341714|NCT01795937|Itraconazole|itraconazole|mesh-list
83341715|NCT01795937|Atorvastatin|atorvastatin|mesh-list
83341716|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83341717|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83341718|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83341719|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
83341720|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341721|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83341722|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83341723|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341724|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
83341725|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341726|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83341727|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83341728|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83341729|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
83341730|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341731|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341732|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83341733|NCT04501224|Tenofovir|tenofovir|mesh-list
83341734|NCT04501224|Entecavir|entecavir|mesh-list
83341735|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
83341736|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341737|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83341738|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83341739|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341740|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341742|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83341743|NCT01817777|Metformin|metformin|mesh-list
83341744|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83341745|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341746|NCT01795547|Aripiprazole|aripiprazole|mesh-list
83341747|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83341748|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
83341749|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83341750|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83341751|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83341752|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341753|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341754|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
83341755|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
83341756|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341757|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341758|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83341759|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83341760|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
83341761|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83341762|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83341763|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83341764|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83341765|NCT03923556|Neostigmine|neostigmine|mesh-list
83341766|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83341767|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341768|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341769|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
83341770|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341771|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341772|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83341773|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
83341774|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341775|NCT03863184|Rituximab|rituximab|mesh-list
83341776|NCT03863184|Lenalidomide|lenalidomide|mesh-list
83341777|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
83341778|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83341779|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341780|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
83341781|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341782|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83341783|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83341784|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83341785|NCT03863184|Growth Substances|growth substances|mesh-ancestor
83341786|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
83341787|NCT02516904|Rezafungin|rezafungin|mesh-list
83341788|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
83341789|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341790|NCT01794845|Docetaxel|docetaxel|mesh-list
83341791|NCT01794845|Cetuximab|cetuximab|mesh-list
83341792|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341793|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
83341794|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
83341795|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
83341796|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341797|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83341798|NCT01794689|Morphine|morphine|mesh-list
83341799|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83341800|NCT01794689|Narcotics|narcotics|mesh-ancestor
83341801|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341802|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341803|NCT01794689|Analgesics|analgesics|mesh-ancestor
83341804|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
83341805|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341806|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
83341807|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83341808|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83341809|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341810|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
83341811|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
83341812|NCT00708552|Donepezil|donepezil|mesh-list
83341813|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83341814|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341815|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341816|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
83341817|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341818|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341819|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
83341820|NCT02516436|Buprenorphine|buprenorphine|mesh-list
83341821|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83341822|NCT02516436|Narcotics|narcotics|mesh-ancestor
83341823|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341824|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341825|NCT02516436|Analgesics|analgesics|mesh-ancestor
83341826|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
83341827|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341828|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83341829|NCT03347526|Vigabatrin|vigabatrin|mesh-list
83341830|NCT03347526|Cosyntropin|cosyntropin|mesh-list
83341831|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
83341832|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341833|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341834|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
83341835|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341836|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341837|NCT03347526|Hormones|hormones|mesh-ancestor
83341838|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83341839|NCT03347370|Interferons|interferons|mesh-list
83341840|NCT03347370|Interferon-beta|interferon-beta|mesh-list
83341841|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
83341842|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
83341843|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341844|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
83341845|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341846|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
83341847|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341848|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83341849|NCT02515968|Propofol|propofol|mesh-list
83341850|NCT02515968|Desflurane|desflurane|mesh-list
83341851|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83341852|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341853|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341854|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83341855|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
83341856|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
83341857|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83341858|NCT03345966|Antibodies|antibodies|mesh-list
83341859|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
83341860|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341861|NCT02507700|Bupivacaine|bupivacaine|mesh-list
83341862|NCT02507700|Sevoflurane|sevoflurane|mesh-list
83341863|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
83341864|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
83341865|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83341866|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341867|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
83341868|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341869|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83341870|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83341871|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
83341872|NCT02513004|Clopidogrel|clopidogrel|mesh-list
83341873|NCT02513004|Ticagrelor|ticagrelor|mesh-list
83341874|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83341875|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83341876|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83341877|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83341878|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
83341879|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341880|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341881|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341882|NCT04500522|Isoniazid|isoniazid|mesh-list
83341883|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
83341884|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83341885|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341886|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83341887|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83341888|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
83341889|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341890|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83341892|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83341893|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
83341894|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341895|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341896|NCT02506998|Histamine|histamine|mesh-list
83341897|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
83341898|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
83341899|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
83341900|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
83341901|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
83341902|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341903|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341904|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341905|NCT02507076|Melphalan|melphalan|mesh-list
83341906|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83341907|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
83341908|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341909|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341910|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83341911|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341912|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
83341913|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341914|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83341915|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83341916|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83341917|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83341918|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341919|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341920|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341921|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83341922|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
83341923|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83341924|NCT04500678|Metformin|metformin|mesh-list
83341925|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83341926|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341927|NCT02507154|Cetuximab|cetuximab|mesh-list
83341928|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83341929|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341930|NCT02515734|Leucovorin|leucovorin|mesh-list
83341931|NCT02515734|Bevacizumab|bevacizumab|mesh-list
83341932|NCT02515734|Cetuximab|cetuximab|mesh-list
83341933|NCT02515734|Fluorouracil|fluorouracil|mesh-list
83341934|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
83341935|NCT02515734|Irinotecan|irinotecan|mesh-list
83341936|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83341937|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341938|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83341939|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83341940|NCT02515734|Growth Substances|growth substances|mesh-ancestor
83341941|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341942|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
83341943|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
83341944|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341945|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341946|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341947|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
83341948|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83341949|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83341950|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83341951|NCT02515734|Antidotes|antidotes|mesh-ancestor
83341952|NCT02515734|Protective Agents|protective agents|mesh-ancestor
83341953|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
83341954|NCT02515734|Vitamins|vitamins|mesh-ancestor
83341955|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
83341956|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
83341957|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83341958|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83341959|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83341960|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83341961|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341963|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83341964|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341965|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83341966|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83341967|NCT02506842|Leucovorin|leucovorin|mesh-list
83341968|NCT02506842|Folic Acid|folic acid|mesh-list
83341969|NCT02506842|Gemcitabine|gemcitabine|mesh-list
83341970|NCT02506842|Fluorouracil|fluorouracil|mesh-list
83341971|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
83341972|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
83341973|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83341974|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341975|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83341976|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
83341977|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83341978|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
83341979|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83341980|NCT02506842|Antidotes|antidotes|mesh-ancestor
83341981|NCT02506842|Protective Agents|protective agents|mesh-ancestor
83341982|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
83341983|NCT02506842|Vitamins|vitamins|mesh-ancestor
83341984|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
83341985|NCT02506842|Hematinics|hematinics|mesh-ancestor
83341986|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
83341987|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83341988|NCT03345498|Entecavir|entecavir|mesh-list
83341989|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
83341990|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341991|NCT02506686|Meropenem|meropenem|mesh-list
83341992|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83341993|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83341994|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83341995|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83341996|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83341997|NCT02512380|Docetaxel|docetaxel|mesh-list
83341998|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
83341999|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342000|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
83342001|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
83342002|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
83342003|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342004|NCT04497792|Metformin|metformin|mesh-list
83342005|NCT04497792|Empagliflozin|empagliflozin|mesh-list
83342006|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83342007|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342008|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83342009|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342010|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
83342011|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83342012|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83342013|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83342014|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83342015|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342016|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
83342017|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342018|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342019|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83342020|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342021|NCT02515422|Ketamine|ketamine|mesh-list
83342022|NCT02515422|Bupivacaine|bupivacaine|mesh-list
83342023|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
83342024|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
83342025|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342026|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342027|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
83342028|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342029|NCT02515422|Analgesics|analgesics|mesh-ancestor
83342030|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83342031|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83342032|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
83342033|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83342034|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83342035|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342036|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342037|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
83342038|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342039|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342040|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342041|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83342042|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342043|NCT02506140|Aspirin|aspirin|mesh-list
83342044|NCT02506140|Clopidogrel|clopidogrel|mesh-list
83342045|NCT02506140|Ticagrelor|ticagrelor|mesh-list
83342046|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83342047|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83342048|NCT02506140|Analgesics|analgesics|mesh-ancestor
83342049|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
83342050|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342051|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342052|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83342053|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83342054|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83342055|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83342056|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342057|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83342058|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83342059|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342060|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
83342061|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83342062|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83342063|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83342064|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
83342065|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342066|NCT02515188|Acetaminophen|acetaminophen|mesh-list
83342067|NCT02515188|Propacetamol|propacetamol|mesh-list
83342068|NCT02515188|Analgesics|analgesics|mesh-ancestor
83342069|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
83342070|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342071|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342072|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83342073|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83342074|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83342075|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83342076|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
83342077|NCT01696084|Cytarabine|cytarabine|mesh-list
83342078|NCT01696084|Daunorubicin|daunorubicin|mesh-list
83342079|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83342080|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
83342081|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342082|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342083|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
83342084|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342085|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83342086|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
83342087|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342088|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83342089|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83342090|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83342091|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342092|NCT02228824|Nicotine|nicotine|mesh-list
83342093|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83342094|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
83342095|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342096|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342097|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83342098|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83342099|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
83342100|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342101|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342102|NCT02511366|Caseins|caseins|mesh-list
83342103|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
83342104|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
83342105|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342106|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
83342107|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83342108|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342109|NCT04443036|Paclitaxel|paclitaxel|mesh-list
83342110|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83342111|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83342112|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342113|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
83342114|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
83342115|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
83342116|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342117|NCT01653418|Cytarabine|cytarabine|mesh-list
83342118|NCT01653418|Etoposide|etoposide|mesh-list
83342119|NCT01653418|Bortezomib|bortezomib|mesh-list
83342120|NCT01653418|Melphalan|melphalan|mesh-list
83342121|NCT01653418|Carmustine|carmustine|mesh-list
83342122|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83342123|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342124|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83342125|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83342126|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342127|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342128|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83342129|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
83342130|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
83342131|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342132|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83342133|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
83342134|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342135|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83342136|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
83342137|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83342138|NCT02514642|Clopidogrel|clopidogrel|mesh-list
83342139|NCT02514642|Ticagrelor|ticagrelor|mesh-list
83342140|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83342141|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83342142|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83342143|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83342144|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
83342145|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342146|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342147|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342148|NCT02511210|Anesthetics|anesthetics|mesh-list
83342149|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342150|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342151|NCT02237950|Metronidazole|metronidazole|mesh-list
83342152|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342153|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83342154|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83342155|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83342156|NCT02511054|Chloroquine|chloroquine|mesh-list
83342157|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
83342158|NCT02511054|Amebicides|amebicides|mesh-ancestor
83342159|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83342160|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83342161|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342162|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
83342163|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83342164|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83342165|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342166|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342167|NCT04499118|Paclitaxel|paclitaxel|mesh-list
83342168|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83342169|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83342170|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342171|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83342172|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83342173|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83342174|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342175|NCT01612546|Camptothecin|camptothecin|mesh-list
83342176|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83342177|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342178|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83342179|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83342180|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342181|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342183|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83342184|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83342185|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
83342186|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342187|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342188|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342189|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83342190|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
83342191|NCT04499898|Protective Agents|protective agents|mesh-ancestor
83342192|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83342193|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83342194|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83342195|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
83342196|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83342197|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83342198|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
83342199|NCT02514330|Vitamins|vitamins|mesh-ancestor
83342200|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
83342201|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342202|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83342203|NCT02510976|Prucalopride|prucalopride|mesh-list
83342204|NCT02510976|Laxatives|laxatives|mesh-ancestor
83342205|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83342206|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83342207|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83342208|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
83342209|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342210|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342211|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342212|NCT02505516|Metformin|metformin|mesh-list
83342213|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83342214|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342215|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
83342216|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83342217|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
83342218|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342219|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
83342220|NCT02505360|Protective Agents|protective agents|mesh-ancestor
83342221|NCT04499586|Irinotecan|irinotecan|mesh-list
83342222|NCT04499586|Raltitrexed|raltitrexed|mesh-list
83342223|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83342224|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83342225|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342226|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342227|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342228|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83342229|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
83342230|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83342231|NCT02505282|Vitamin K|vitamin k|mesh-list
83342232|NCT02505282|Vitamins|vitamins|mesh-ancestor
83342233|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
83342234|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342235|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83342236|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83342237|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342238|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
83342239|NCT02505282|Coagulants|coagulants|mesh-ancestor
83342240|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
83342241|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83342242|NCT01816295|Testosterone|testosterone|mesh-list
83342243|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
83342244|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
83342245|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83342246|NCT01816295|Androgens|androgens|mesh-ancestor
83342247|NCT01816295|Hormones|hormones|mesh-ancestor
83342248|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342249|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342250|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83342251|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342252|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
83342253|NCT02514018|Vaccines|vaccines|mesh-list
83342254|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
83342255|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342256|NCT02513862|Heparin|heparin|mesh-list
83342257|NCT02513862|Protamines|protamines|mesh-list
83342258|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
83342259|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83342260|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83342261|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342262|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
83342263|NCT02513862|Coagulants|coagulants|mesh-ancestor
83342264|NCT02510586|Sevoflurane|sevoflurane|mesh-list
83342265|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83342266|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83342267|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
83342268|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
83342269|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342270|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342271|NCT01610297|Deferasirox|deferasirox|mesh-list
83342272|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83342273|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
83342274|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
83342275|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342276|NCT01660672|Levetiracetam|levetiracetam|mesh-list
83342277|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
83342278|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
83342279|NCT02505048|Rucaparib|rucaparib|mesh-list
83342280|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83342281|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342282|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342283|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342284|NCT01793051|Minocycline|minocycline|mesh-list
83342285|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83342286|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342287|NCT01792115|Vitamins|vitamins|mesh-list
83342288|NCT01792115|Vitamin E|vitamin e|mesh-list
83342289|NCT01792115|Tocopherols|tocopherols|mesh-list
83342290|NCT01792115|Tocotrienols|tocotrienols|mesh-list
83342291|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
83342292|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
83342293|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342294|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
83342295|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342296|NCT01792115|Protective Agents|protective agents|mesh-ancestor
83342297|NCT01791803|Nicotine|nicotine|mesh-list
83342298|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83342299|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
83342300|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342301|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342302|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83342303|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83342304|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
83342305|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342306|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342307|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83342308|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
83342309|NCT01662856|Coagulants|coagulants|mesh-ancestor
83342310|NCT04499976|Misoprostol|misoprostol|mesh-list
83342311|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83342312|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
83342313|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83342314|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342315|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83342316|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83342317|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
83342318|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83342319|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
83342320|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83342321|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83342322|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83342323|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
83342324|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83342325|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342326|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83342327|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83342328|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83342329|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83342330|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342332|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342333|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83342334|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342335|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342336|NCT02509728|Choline|choline|mesh-list
83342337|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
83342338|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83342339|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
83342340|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342341|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83342342|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83342343|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
83342344|NCT02501616|Metformin|metformin|mesh-list
83342345|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
83342346|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83342347|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342348|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83342349|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342350|NCT01788215|Doxycycline|doxycycline|mesh-list
83342351|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83342352|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342353|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
83342354|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83342355|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83342356|NCT01812707|Atorvastatin|atorvastatin|mesh-list
83342357|NCT01812707|Alirocumab|alirocumab|mesh-list
83342358|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83342359|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83342360|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83342361|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
83342362|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342363|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83342364|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83342365|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342366|NCT01812707|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83342367|NCT01812707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83342368|NCT01812707|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342369|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
83342370|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342371|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83342372|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
83342373|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342374|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
83342375|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83342376|NCT02728206|Velpatasvir|velpatasvir|mesh-list
83342377|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
83342378|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342379|NCT01811225|Progesterone|progesterone|mesh-list
83342380|NCT01811225|Progestins|progestins|mesh-ancestor
83342381|NCT01811225|Hormones|hormones|mesh-ancestor
83342382|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342383|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342384|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83342385|NCT02508870|Azacitidine|azacitidine|mesh-list
83342386|NCT02508870|Atezolizumab|atezolizumab|mesh-list
83342387|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83342388|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
83342389|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342390|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342391|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342392|NCT02508870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83342393|NCT02508870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83342394|NCT01786109|Dronabinol|dronabinol|mesh-list
83342395|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
83342396|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342397|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83342398|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83342399|NCT01786109|Analgesics|analgesics|mesh-ancestor
83342400|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
83342401|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342402|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83342403|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83342404|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342405|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342406|NCT01786109|Hormones|hormones|mesh-ancestor
83342407|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342408|NCT02509104|Tamsulosin|tamsulosin|mesh-list
83342409|NCT02509104|Dutasteride|dutasteride|mesh-list
83342410|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83342411|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83342412|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83342413|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
83342414|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342415|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342416|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342417|NCT02509104|Urological Agents|urological agents|mesh-ancestor
83342418|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83342419|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83342420|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342421|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
83342422|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342423|NCT02500680|Vaccines|vaccines|mesh-list
83342424|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
83342425|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342426|NCT02500446|Dolutegravir|dolutegravir|mesh-list
83342427|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83342428|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83342429|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342430|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342431|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83342432|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83342433|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
83342434|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342435|NCT02500524|Permethrin|permethrin|mesh-list
83342436|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342437|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342438|NCT02508402|Dexamethasone|dexamethasone|mesh-list
83342439|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83342440|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
83342441|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
83342442|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342443|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342444|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83342445|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
83342446|NCT02508402|Hormones|hormones|mesh-ancestor
83342447|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342448|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83342449|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342450|NCT02500212|Tacrolimus|tacrolimus|mesh-list
83342451|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83342452|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
83342453|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342454|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83342455|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342456|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342457|NCT02508168|Metformin|metformin|mesh-list
83342458|NCT02508168|Alogliptin|alogliptin|mesh-list
83342459|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83342460|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342461|NCT02508168|Incretins|incretins|mesh-ancestor
83342462|NCT02508168|Hormones|hormones|mesh-ancestor
83342463|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342464|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83342465|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342466|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342467|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342468|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83342469|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83342470|NCT02508246|Cisplatin|cisplatin|mesh-list
83342471|NCT02508246|Docetaxel|docetaxel|mesh-list
83342472|NCT02508246|Adavosertib|adavosertib|mesh-list
83342473|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342474|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
83342475|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
83342476|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
83342477|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342478|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342479|NCT01617148|Aflibercept|aflibercept|mesh-list
83342480|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83342481|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83342482|NCT01617148|Growth Substances|growth substances|mesh-ancestor
83342483|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342484|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
83342485|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342486|NCT02499978|Dolutegravir|dolutegravir|mesh-list
83342487|NCT02499978|Darunavir|darunavir|mesh-list
83342488|NCT02499978|Cobicistat|cobicistat|mesh-list
83342489|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83342490|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83342491|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83342492|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342493|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342494|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83342495|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83342496|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
83342497|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342498|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83342499|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83342500|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342501|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83342502|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83342503|NCT01620190|Paclitaxel|paclitaxel|mesh-list
83342504|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83342505|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83342506|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342507|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
83342508|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
83342509|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
83342510|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342511|NCT04498884|Insulin|insulin|mesh-list
83342512|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83342513|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83342514|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342515|NCT01621672|Lenalidomide|lenalidomide|mesh-list
83342516|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
83342517|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342518|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83342519|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83342520|NCT01621672|Growth Substances|growth substances|mesh-ancestor
83342521|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
83342522|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342523|NCT03344328|Bortezomib|bortezomib|mesh-list
83342524|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342525|NCT02499822|Ramipril|ramipril|mesh-list
83342526|NCT02499822|Nifedipine|nifedipine|mesh-list
83342527|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83342528|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342529|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342530|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342531|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83342532|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83342533|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83342534|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83342535|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342536|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
83342537|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
83342538|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83342539|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
83342540|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342541|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83342542|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83342543|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342544|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342545|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
83342546|NCT03343548|Analgesics|analgesics|mesh-ancestor
83342547|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
83342548|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342549|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342550|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
83342551|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342552|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83342553|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
83342554|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83342555|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83342556|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342557|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83342558|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
83342559|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83342560|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
83342561|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83342562|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
83342563|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342564|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
83342565|NCT02507934|Protective Agents|protective agents|mesh-ancestor
83342566|NCT01622296|Lidocaine|lidocaine|mesh-list
83342567|NCT01622296|Epinephrine|epinephrine|mesh-list
83342568|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
83342569|NCT01622296|Anesthetics|anesthetics|mesh-list
83342570|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342571|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342572|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
83342573|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342574|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83342575|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83342576|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83342577|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83342578|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342579|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83342580|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83342581|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
83342582|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342583|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83342584|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83342585|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
83342586|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83342587|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
83342588|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
83342589|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
83342590|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83342591|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
83342592|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83342593|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342594|NCT02728830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83342595|NCT02728830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342596|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83342597|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83342598|NCT01705288|Morphine|morphine|mesh-list
83342599|NCT01705288|Narcotics|narcotics|mesh-list
83342600|NCT01705288|Anesthetics|anesthetics|mesh-list
83342601|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342602|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342603|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83342604|NCT01705288|Analgesics|analgesics|mesh-ancestor
83342605|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
83342606|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342607|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83342608|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83342609|NCT03343002|Fentanyl|fentanyl|mesh-list
83342610|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83342612|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342613|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342614|NCT03343002|Analgesics|analgesics|mesh-ancestor
83342615|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
83342616|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342617|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83342618|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83342619|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
83342620|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
83342621|NCT03120936|Tenofovir|tenofovir|mesh-list
83342622|NCT03120936|Emtricitabine|emtricitabine|mesh-list
83342623|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
83342624|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342625|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83342626|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83342627|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342628|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342629|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83342630|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83342631|NCT02234752|Memantine|memantine|mesh-list
83342632|NCT02234752|Galantamine|galantamine|mesh-list
83342633|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83342634|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83342635|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
83342636|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342637|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342638|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342639|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83342640|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83342641|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83342642|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342643|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
83342644|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83342645|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
83342646|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342647|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
83342648|NCT01665508|Nebivolol|nebivolol|mesh-list
83342649|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83342650|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
83342651|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83342652|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83342653|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83342654|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
83342655|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342656|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342657|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342658|NCT03344094|Interferons|interferons|mesh-list
83342659|NCT03344094|Interferon-beta|interferon-beta|mesh-list
83342660|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
83342661|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342662|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
83342663|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342664|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
83342665|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342666|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
83342667|NCT02498496|Analgesics|analgesics|mesh-ancestor
83342668|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
83342669|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342670|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342671|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
83342672|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342673|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83342674|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
83342675|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83342676|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83342677|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342678|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83342679|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
83342680|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83342681|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
83342682|NCT02502708|Temozolomide|temozolomide|mesh-list
83342683|NCT02502708|Etoposide|etoposide|mesh-list
83342684|NCT02502708|Tryptophan|tryptophan|mesh-list
83342685|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83342686|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
83342687|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342688|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83342689|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83342690|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
83342691|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342692|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342693|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83342694|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83342695|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83342696|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83342697|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342698|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83342699|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
83342700|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83342701|NCT01666210|Dexamethasone|dexamethasone|mesh-list
83342702|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83342703|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
83342704|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
83342705|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342706|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342707|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83342708|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
83342709|NCT01666210|Hormones|hormones|mesh-ancestor
83342710|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342711|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83342712|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342713|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
83342714|NCT01666912|Etonogestrel|etonogestrel|mesh-list
83342715|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83342716|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342717|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83342718|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83342719|NCT03341988|Ritonavir|ritonavir|mesh-list
83342720|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83342721|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83342722|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342723|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342724|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342725|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83342726|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83342727|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
83342728|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342729|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83342730|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83342731|NCT02501850|Metformin|metformin|mesh-list
83342732|NCT02501850|Liraglutide|liraglutide|mesh-list
83342733|NCT02501850|Exenatide|exenatide|mesh-list
83342734|NCT02501850|Lixisenatide|lixisenatide|mesh-list
83342735|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83342736|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342737|NCT02501850|Incretins|incretins|mesh-ancestor
83342738|NCT02501850|Hormones|hormones|mesh-ancestor
83342739|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342740|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83342742|NCT01709032|Deferiprone|deferiprone|mesh-list
83342743|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83342744|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
83342745|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
83342746|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342747|NCT02496078|Asunaprevir|asunaprevir|mesh-list
83342748|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342749|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342750|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342751|NCT02495922|Dexamethasone|dexamethasone|mesh-list
83342752|NCT02495922|Lenalidomide|lenalidomide|mesh-list
83342753|NCT02495922|Bortezomib|bortezomib|mesh-list
83342754|NCT02495922|Elotuzumab|elotuzumab|mesh-list
83342755|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83342756|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
83342757|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
83342758|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342759|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342760|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83342761|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
83342762|NCT02495922|Hormones|hormones|mesh-ancestor
83342763|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342764|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83342765|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342766|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
83342767|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83342768|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83342769|NCT02495922|Growth Substances|growth substances|mesh-ancestor
83342770|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
83342771|NCT01709422|Midazolam|midazolam|mesh-list
83342772|NCT01709422|Meperidine|meperidine|mesh-list
83342773|NCT01709422|Propofol|propofol|mesh-list
83342774|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83342775|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342776|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342777|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83342778|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
83342779|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
83342780|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83342781|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83342782|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83342783|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83342784|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
83342785|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
83342786|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342787|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342788|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83342789|NCT01709422|Narcotics|narcotics|mesh-ancestor
83342790|NCT01709422|Analgesics|analgesics|mesh-ancestor
83342791|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
83342792|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342793|NCT01669642|Ketamine|ketamine|mesh-list
83342794|NCT01669642|Analgesics|analgesics|mesh-ancestor
83342795|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
83342796|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342797|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342798|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83342799|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83342800|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
83342801|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
83342802|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342803|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83342804|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83342805|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342806|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342807|NCT01669720|Aflibercept|aflibercept|mesh-list
83342808|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83342809|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83342810|NCT01669720|Growth Substances|growth substances|mesh-ancestor
83342811|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342812|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
83342813|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342815|NCT01670110|Hormones|hormones|mesh-ancestor
83342816|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342817|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342818|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
83342819|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83342820|NCT01677286|Doxycycline|doxycycline|mesh-list
83342821|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83342822|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342823|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
83342824|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83342825|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83342826|NCT04498260|Triamcinolone|triamcinolone|mesh-list
83342827|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83342828|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83342829|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83342830|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83342831|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
83342832|NCT04498260|Hormones|hormones|mesh-ancestor
83342833|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342834|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342835|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83342836|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
83342837|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342838|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342839|NCT01680172|Ketamine|ketamine|mesh-list
83342840|NCT01680172|Analgesics|analgesics|mesh-ancestor
83342841|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
83342842|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342843|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342844|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83342845|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83342846|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
83342847|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
83342848|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342849|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83342850|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83342851|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342852|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342853|NCT02235064|Sertraline|sertraline|mesh-list
83342854|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
83342855|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83342856|NCT02235064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83342857|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83342858|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83342859|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342860|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342861|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
83342862|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342863|NCT05118490|Isoniazid|isoniazid|mesh-list
83342864|NCT05118490|Rifapentine|rifapentine|mesh-list
83342865|NCT05118490|Rifampin|rifampin|mesh-list
83342866|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
83342867|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83342868|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342869|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83342870|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83342871|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
83342872|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342873|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83342874|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83342875|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
83342876|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83342877|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342878|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83342879|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83342880|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83342881|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83342882|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83342883|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83342884|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83342886|NCT01681030|Coagulants|coagulants|mesh-ancestor
83342887|NCT02249416|Ritonavir|ritonavir|mesh-list
83342888|NCT02249416|Zidovudine|zidovudine|mesh-list
83342889|NCT02249416|Tipranavir|tipranavir|mesh-list
83342890|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83342891|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83342892|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
83342893|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342894|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342895|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83342896|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83342897|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
83342898|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342899|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83342900|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83342901|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
83342902|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83342903|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83342904|NCT01685242|Cetirizine|cetirizine|mesh-list
83342905|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83342906|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83342907|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83342908|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
83342909|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
83342910|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342911|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342912|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342913|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
83342914|NCT00708162|Elvitegravir|elvitegravir|mesh-list
83342915|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83342916|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83342917|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
83342918|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342919|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83342920|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83342921|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342922|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342923|NCT04930042|Ustekinumab|ustekinumab|mesh-list
83342924|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
83342925|NCT04898920|Dexamethasone|dexamethasone|mesh-list
83342926|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83342927|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
83342928|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
83342929|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342930|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342931|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83342932|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
83342933|NCT04898920|Hormones|hormones|mesh-ancestor
83342934|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83342935|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83342936|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83342937|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
83342938|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83342939|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342940|NCT01686646|Acetaminophen|acetaminophen|mesh-list
83342941|NCT01686646|Caffeine|caffeine|mesh-list
83342942|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83342943|NCT01686646|Analgesics|analgesics|mesh-ancestor
83342944|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
83342945|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342946|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342947|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
83342948|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83342949|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83342950|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83342951|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342952|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83342953|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83342954|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
83342955|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342956|NCT02495688|Anesthetics|anesthetics|mesh-list
83342957|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342958|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342960|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
83342961|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
83342962|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342963|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342964|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
83342965|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342966|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83342967|NCT04869592|Vaccines|vaccines|mesh-list
83342968|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
83342969|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342970|NCT05709652|Ivermectin|ivermectin|mesh-list
83342971|NCT05709652|Selamectin|selamectin|mesh-list
83342972|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83342973|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83342974|NCT01690000|Melatonin|melatonin|mesh-list
83342975|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
83342976|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342977|NCT01690000|Protective Agents|protective agents|mesh-ancestor
83342978|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342979|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342980|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
83342981|NCT02495220|Bupivacaine|bupivacaine|mesh-list
83342982|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
83342983|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
83342984|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83342985|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83342986|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
83342987|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83342988|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83342989|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83342991|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83342992|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83342993|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83342994|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
83342995|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83342996|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83342997|NCT01690546|Naltrexone|naltrexone|mesh-list
83342998|NCT01690546|Buprenorphine|buprenorphine|mesh-list
83342999|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
83343000|NCT01690546|Naloxone|naloxone|mesh-list
83343001|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83343002|NCT01690546|Narcotics|narcotics|mesh-ancestor
83343003|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343004|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343005|NCT01690546|Analgesics|analgesics|mesh-ancestor
83343006|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
83343007|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343008|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83343009|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83343010|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
83343011|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343012|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
83343013|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343014|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343015|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
83343016|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83343017|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343018|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343019|NCT02494830|Ketamine|ketamine|mesh-list
83343020|NCT02494830|Analgesics|analgesics|mesh-ancestor
83343021|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
83343022|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343023|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343024|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83343025|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83343026|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
83343027|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
83343028|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343029|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83343030|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83343031|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343032|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343033|NCT03336840|Metformin|metformin|mesh-list
83343034|NCT03336840|Promethazine|promethazine|mesh-list
83343035|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
83343036|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83343037|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343038|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
83343039|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
83343040|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83343041|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
83343042|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
83343043|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343044|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343045|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83343046|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83343047|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83343048|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343049|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
83343050|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
83343051|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
83343052|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343053|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
83343054|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
83343055|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343056|NCT02497638|Metformin|metformin|mesh-list
83343057|NCT02497638|Biguanides|biguanides|mesh-list
83343058|NCT02497638|Atorvastatin|atorvastatin|mesh-list
83343059|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83343060|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343061|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83343062|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83343063|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
83343064|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343065|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83343066|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83343067|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343068|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
83343069|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343070|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
83343071|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83343072|NCT02493192|Meperidine|meperidine|mesh-list
83343073|NCT02493192|Haloperidol|haloperidol|mesh-list
83343074|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
83343075|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
83343076|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
83343077|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343078|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343079|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343080|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83343081|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83343082|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343083|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343084|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83343085|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
83343086|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343087|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343088|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83343089|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83343090|NCT02493192|Narcotics|narcotics|mesh-ancestor
83343091|NCT02493192|Analgesics|analgesics|mesh-ancestor
83343092|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
83343093|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83343094|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
83343095|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83343096|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
83343097|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83343098|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
83343099|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343100|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343101|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
83343102|NCT02238808|Estradiol|estradiol|mesh-list
83343103|NCT02238808|Estrogens|estrogens|mesh-list
83343104|NCT02238808|Hormones|hormones|mesh-ancestor
83343105|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343106|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343108|NCT02497326|Tramadol|tramadol|mesh-list
83343109|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
83343110|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83343111|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83343112|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343113|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83343114|NCT02497326|Narcotics|narcotics|mesh-ancestor
83343115|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343116|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343117|NCT02497326|Analgesics|analgesics|mesh-ancestor
83343118|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
83343119|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343120|NCT02245672|Fluticasone|fluticasone|mesh-list
83343121|NCT02245672|Xhance|xhance|mesh-list
83343122|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83343123|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343124|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83343125|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
83343126|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343127|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343128|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83343129|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
83343130|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
83343131|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83343132|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83343133|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83343134|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83343135|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
83343136|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343137|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343138|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
83343139|NCT04461418|Hormones|hormones|mesh-ancestor
83343140|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343141|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343142|NCT03335904|Losartan|losartan|mesh-list
83343143|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83343144|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83343145|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83343146|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83343147|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343148|NCT03335826|Anesthetics|anesthetics|mesh-list
83343149|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343150|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343151|NCT03340740|Cetirizine|cetirizine|mesh-list
83343152|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83343153|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83343154|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83343155|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
83343156|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
83343157|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343158|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343159|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343160|NCT03340662|Itraconazole|itraconazole|mesh-list
83343161|NCT03340662|Rifampin|rifampin|mesh-list
83343162|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
83343163|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
83343164|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343165|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83343166|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83343167|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343168|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343169|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83343170|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
83343171|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343172|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343173|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83343174|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83343175|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
83343176|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83343177|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
83343178|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83343179|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83343180|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83343181|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83343182|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83343183|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83343184|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83343185|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83343186|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83343187|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343188|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343189|NCT03340662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83343190|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83343191|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83343192|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343193|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
83343194|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83343195|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
83343196|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83343197|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83343199|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83343200|NCT03342300|Pirarubicin|pirarubicin|mesh-list
83343201|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83343202|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343203|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83343204|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83343205|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343206|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343207|NCT01711918|Domperidone|domperidone|mesh-list
83343208|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
83343209|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
83343210|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343211|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343212|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343213|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83343214|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
83343215|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343216|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343217|NCT03120468|Topiramate|topiramate|mesh-list
83343218|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
83343219|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83343220|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
83343221|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83343222|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343223|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
83343224|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343225|NCT03120468|Expectorants|expectorants|mesh-ancestor
83343226|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
83343227|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83343228|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
83343229|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343230|NCT03120468|Protective Agents|protective agents|mesh-ancestor
83343231|NCT03120468|Antidotes|antidotes|mesh-ancestor
83343232|NCT01712230|Leuprolide|leuprolide|mesh-list
83343233|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83343234|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
83343235|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83343236|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343237|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83343238|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343239|NCT03335436|Gabapentin|gabapentin|mesh-list
83343240|NCT03335436|Analgesics|analgesics|mesh-ancestor
83343241|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
83343242|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343243|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343244|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
83343245|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83343246|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83343247|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343248|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343249|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83343250|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83343251|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343252|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343253|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
83343254|NCT02494284|Aspirin|aspirin|mesh-list
83343255|NCT02494284|Clopidogrel|clopidogrel|mesh-list
83343256|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83343257|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83343258|NCT02494284|Analgesics|analgesics|mesh-ancestor
83343259|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
83343260|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343261|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343262|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343263|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343264|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83343265|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83343266|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343267|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83343268|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83343269|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343270|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
83343271|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83343272|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83343273|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83343274|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
83343275|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343276|NCT01713400|Sirolimus|sirolimus|mesh-list
83343277|NCT01713400|Ustekinumab|ustekinumab|mesh-list
83343278|NCT01713400|Tacrolimus|tacrolimus|mesh-list
83343279|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83343280|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
83343281|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343282|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83343283|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343284|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343285|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83343286|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343287|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83343288|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343289|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
83343290|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
83343292|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83343293|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343294|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343295|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83343296|NCT04494828|Analgesics|analgesics|mesh-ancestor
83343297|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
83343298|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343299|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83343300|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83343301|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83343302|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
83343303|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343304|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343305|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
83343306|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83343307|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83343308|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343309|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
83343310|NCT01714336|Coagulants|coagulants|mesh-ancestor
83343311|NCT01716208|Ofatumumab|ofatumumab|mesh-list
83343312|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343313|NCT00706992|Aldesleukin|aldesleukin|mesh-list
83343314|NCT00706992|Vaccines|vaccines|mesh-list
83343315|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
83343316|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
83343317|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343318|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343319|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83343320|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83343321|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
83343322|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343323|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83343324|NCT03335124|Vitamins|vitamins|mesh-list
83343325|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
83343326|NCT03335124|Thiamine|thiamine|mesh-list
83343327|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
83343328|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
83343329|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343330|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343331|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
83343332|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343333|NCT03335124|Protective Agents|protective agents|mesh-ancestor
83343334|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
83343335|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
83343336|NCT03339804|Doxorubicin|doxorubicin|mesh-list
83343337|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83343338|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
83343339|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343340|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343341|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83343342|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
83343343|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343344|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343345|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83343346|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83343347|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83343348|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83343349|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343350|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
83343351|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343352|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343353|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
83343354|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343355|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343356|NCT02491320|Letrozole|letrozole|mesh-list
83343357|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343358|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83343359|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83343360|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343361|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343363|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
83343364|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343365|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343366|NCT02491242|Dolutegravir|dolutegravir|mesh-list
83343367|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83343368|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83343369|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343370|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343371|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83343372|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83343373|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
83343374|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343375|NCT03330990|Midazolam|midazolam|mesh-list
83343376|NCT03330990|Entrectinib|entrectinib|mesh-list
83343377|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83343378|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83343379|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343380|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343381|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83343382|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83343383|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343384|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83343385|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
83343386|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
83343387|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
83343388|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
83343389|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343390|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343391|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83343392|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343393|NCT03339024|Oxytocin|oxytocin|mesh-list
83343394|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
83343395|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83343396|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343397|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
83343398|NCT03330132|Vaccines|vaccines|mesh-list
83343399|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
83343400|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343401|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
83343402|NCT03330132|Coagulants|coagulants|mesh-ancestor
83343403|NCT02492412|Cyclosporine|cyclosporine|mesh-list
83343404|NCT02492412|Cyclosporins|cyclosporins|mesh-list
83343405|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343406|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343407|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83343408|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
83343409|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343410|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
83343411|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343412|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
83343413|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343414|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83343415|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83343416|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83343417|NCT03329898|Estradiol|estradiol|mesh-list
83343418|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83343419|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
83343420|NCT03329898|Estrogens|estrogens|mesh-ancestor
83343421|NCT03329898|Hormones|hormones|mesh-ancestor
83343422|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343423|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343424|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83343425|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
83343426|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83343427|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83343428|NCT03329898|Progestins|progestins|mesh-ancestor
83343429|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
83343430|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83343431|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343432|NCT02492568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83343433|NCT02492568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343434|NCT01722292|Carboplatin|carboplatin|mesh-list
83343435|NCT01722292|Etoposide|etoposide|mesh-list
83343436|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343437|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83343438|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83343439|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83343440|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343441|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343442|NCT02493894|Cefazolin|cefazolin|mesh-list
83343443|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83343444|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343445|NCT02493738|Itraconazole|itraconazole|mesh-list
83343446|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
83343447|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343448|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83343449|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83343450|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343451|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343452|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83343453|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
83343454|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343455|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343456|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83343457|NCT03875638|Levetiracetam|levetiracetam|mesh-list
83343458|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
83343459|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
83343460|NCT03858322|Paclitaxel|paclitaxel|mesh-list
83343461|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
83343462|NCT03858322|Carboplatin|carboplatin|mesh-list
83343463|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83343464|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343465|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
83343466|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
83343467|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
83343468|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343469|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83343470|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
83343471|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343472|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343473|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83343474|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
83343475|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83343476|NCT02493582|Apatinib|apatinib|mesh-list
83343477|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343478|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83343479|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343480|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343481|NCT05560360|Efavirenz|efavirenz|mesh-list
83343482|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83343483|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83343484|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343485|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343486|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
83343487|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343488|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83343489|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83343490|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83343491|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83343492|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83343493|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83343494|NCT03329118|Simvastatin|simvastatin|mesh-list
83343495|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83343496|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83343497|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
83343498|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343499|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83343500|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83343501|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343502|NCT01723384|Naltrexone|naltrexone|mesh-list
83343503|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83343504|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83343505|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343506|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
83343507|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343508|NCT02492490|Basiliximab|basiliximab|mesh-list
83343510|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
83343511|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343512|NCT03337932|Doxycycline|doxycycline|mesh-list
83343513|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83343514|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343515|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
83343516|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83343517|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83343518|NCT02493504|Heparin|heparin|mesh-list
83343519|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
83343520|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83343521|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83343522|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343523|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
83343524|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83343525|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
83343526|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343527|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343528|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83343529|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
83343530|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83343531|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83343532|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83343533|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
83343534|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343535|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343536|NCT03328728|Hylan|hylan|mesh-list
83343537|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
83343538|NCT03328728|Protective Agents|protective agents|mesh-ancestor
83343539|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343540|NCT03328494|Paclitaxel|paclitaxel|mesh-list
83343541|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83343542|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343543|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
83343544|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
83343545|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
83343546|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343547|NCT02491398|Rituximab|rituximab|mesh-list
83343548|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83343549|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83343550|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343551|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
83343552|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343553|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343554|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83343555|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
83343556|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343557|NCT03333018|Bromides|bromides|mesh-list
83343558|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
83343559|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83343560|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
83343561|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343562|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343563|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83343564|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
83343565|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83343566|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83343567|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83343568|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
83343569|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343570|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343571|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
83343572|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83343573|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83343574|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343575|NCT01723696|Vitamins|vitamins|mesh-list
83343576|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
83343577|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
83343578|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343579|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
83343580|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343581|NCT01723696|Protective Agents|protective agents|mesh-ancestor
83343582|NCT03327558|Mesalamine|mesalamine|mesh-list
83343583|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83343584|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83343585|NCT03327558|Analgesics|analgesics|mesh-ancestor
83343586|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
83343587|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343588|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343589|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343590|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343591|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
83343592|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83343593|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83343594|NCT02242630|Prednisolone|prednisolone|mesh-list
83343595|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
83343596|NCT02242630|Triamcinolone|triamcinolone|mesh-list
83343597|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83343598|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83343599|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83343600|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
83343601|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83343602|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343603|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
83343604|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
83343605|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343606|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343607|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343608|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
83343609|NCT02242630|Hormones|hormones|mesh-ancestor
83343610|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343611|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83343612|NCT02242630|Protective Agents|protective agents|mesh-ancestor
83343613|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83343614|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343615|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83343616|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
83343617|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343618|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343619|NCT03109080|Olaparib|olaparib|mesh-list
83343620|NCT03109080|Adenosine|adenosine|mesh-list
83343621|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83343622|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343623|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343624|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343625|NCT03109080|Analgesics|analgesics|mesh-ancestor
83343626|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
83343627|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343628|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343629|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83343630|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
83343631|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83343632|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
83343633|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
83343634|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343635|NCT03109158|Cetuximab|cetuximab|mesh-list
83343636|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83343637|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343638|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
83343639|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
83343640|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
83343641|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83343642|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
83343643|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
83343644|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343645|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343646|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343647|NCT03332316|Dexamethasone|dexamethasone|mesh-list
83343648|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
83343649|NCT03332316|Ropivacaine|ropivacaine|mesh-list
83343650|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83343651|NCT03332316|BB 1101|bb 1101|mesh-list
83343652|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343653|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
83343654|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
83343655|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343656|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343657|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343659|NCT03332316|Hormones|hormones|mesh-ancestor
83343660|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343661|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83343662|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343663|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
83343664|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
83343665|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343666|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
83343667|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
83343668|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343669|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343670|NCT03327168|Adenosine|adenosine|mesh-list
83343671|NCT03327168|Analgesics|analgesics|mesh-ancestor
83343672|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
83343673|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343674|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343675|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83343676|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
83343677|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83343678|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
83343679|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
83343680|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343681|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343682|NCT01726738|Trametinib|trametinib|mesh-list
83343683|NCT01726738|Dabrafenib|dabrafenib|mesh-list
83343684|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343685|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83343686|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343687|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343688|NCT02492178|Artesunate|artesunate|mesh-list
83343689|NCT02492178|Quinine|quinine|mesh-list
83343690|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
83343691|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83343692|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83343693|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343694|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343695|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
83343696|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
83343697|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83343698|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
83343699|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83343700|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343701|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83343702|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343703|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83343704|NCT02492178|Analgesics|analgesics|mesh-ancestor
83343705|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
83343706|NCT03679624|Daratumumab|daratumumab|mesh-list
83343707|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343708|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
83343709|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83343710|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83343711|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343712|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
83343713|NCT04494126|Coagulants|coagulants|mesh-ancestor
83343714|NCT01730872|Prednisolone|prednisolone|mesh-list
83343715|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83343716|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
83343717|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83343718|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
83343719|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83343720|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83343721|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83343722|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
83343723|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343724|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
83343725|NCT01730872|Hormones|hormones|mesh-ancestor
83343726|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343727|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343728|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83343729|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343730|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
83343731|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
83343732|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343733|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343734|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83343735|NCT01730872|Protective Agents|protective agents|mesh-ancestor
83343736|NCT02491086|Nicotine|nicotine|mesh-list
83343737|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83343738|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
83343739|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343740|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343741|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83343742|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83343743|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
83343744|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343745|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343746|NCT03469492|Insulin|insulin|mesh-list
83343747|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83343748|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343749|NCT03331770|Latanoprost|latanoprost|mesh-list
83343750|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83343751|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83343752|NCT05469412|Midazolam|midazolam|mesh-list
83343753|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83343754|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83343755|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343756|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343757|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83343758|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83343759|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343760|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83343761|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
83343762|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
83343763|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
83343764|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
83343765|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343766|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343767|NCT03331692|Anesthetics|anesthetics|mesh-list
83343768|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343769|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343770|NCT04826692|Metformin|metformin|mesh-list
83343771|NCT04826692|Biguanides|biguanides|mesh-list
83343772|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83343773|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343774|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83343775|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83343776|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343777|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83343778|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
83343779|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343780|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
83343781|NCT04825990|Olaparib|olaparib|mesh-list
83343782|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83343783|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343784|NCT04825990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83343785|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343786|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83343787|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343788|NCT03331302|Xenon|xenon|mesh-list
83343789|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83343790|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
83343791|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
83343792|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343793|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343794|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
83343795|NCT01738672|Entonox|entonox|mesh-list
83343796|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83343797|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
83343798|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
83343799|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343800|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343801|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83343802|NCT01738672|Analgesics|analgesics|mesh-ancestor
83343803|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
83343804|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343805|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
83343806|NCT02488512|Edotreotide|edotreotide|mesh-list
83343807|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83343808|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343809|NCT01808651|Fluoxetine|fluoxetine|mesh-list
83343810|NCT01808651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83343811|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83343812|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83343813|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343814|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343815|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
83343816|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343817|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83343818|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
83343819|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343820|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83343821|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83343822|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343823|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
83343824|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
83343825|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343826|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343827|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83343828|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
83343829|NCT05316376|Paclitaxel|paclitaxel|mesh-list
83343830|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83343831|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83343832|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343833|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
83343834|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
83343835|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
83343836|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343837|NCT01743976|Donepezil|donepezil|mesh-list
83343838|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83343839|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343840|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343841|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
83343842|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343843|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343844|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
83343845|NCT05315830|Vaccines|vaccines|mesh-list
83343846|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
83343847|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343848|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
83343849|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83343850|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83343851|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83343852|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83343853|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343854|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
83343855|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343856|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343857|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83343858|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343859|NCT04639960|Risperidone|risperidone|mesh-list
83343860|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83343861|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
83343862|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343863|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343864|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343865|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83343866|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83343867|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343868|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83343869|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83343870|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
83343871|NCT03109314|Donepezil|donepezil|mesh-list
83343872|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83343873|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343874|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343875|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
83343876|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343877|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343878|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
83343879|NCT04566016|Anesthetics|anesthetics|mesh-list
83343880|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343881|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343883|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83343884|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343885|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83343886|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343887|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343888|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
83343889|NCT03322878|Analgesics|analgesics|mesh-ancestor
83343890|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
83343891|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343892|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343893|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
83343894|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343895|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83343896|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
83343897|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83343898|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83343899|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343900|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83343901|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
83343902|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83343903|NCT03322800|Ziresovir|ziresovir|mesh-list
83343904|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
83343905|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343906|NCT03320460|Clobetasol|clobetasol|mesh-list
83343907|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343908|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
83343909|NCT03320460|Hormones|hormones|mesh-ancestor
83343910|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343911|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343912|NCT04471714|Baclofen|baclofen|mesh-list
83343913|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83343914|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343915|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83343916|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343917|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83343918|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
83343919|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
83343920|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343921|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343922|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83343923|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
83343924|NCT03325686|Vitamin D|vitamin d|mesh-list
83343925|NCT03325686|Vitamins|vitamins|mesh-ancestor
83343926|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
83343927|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343928|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83343929|NCT05315128|Methotrexate|methotrexate|mesh-list
83343930|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83343931|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
83343932|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83343933|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343934|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83343935|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
83343936|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343937|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343938|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
83343939|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343940|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83343941|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83343942|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
83343943|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83343944|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83343945|NCT03322488|Metronidazole|metronidazole|mesh-list
83343946|NCT03322488|Doxycycline|doxycycline|mesh-list
83343947|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
83343948|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83343949|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83343950|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83343951|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83343952|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
83343953|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83343954|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83343955|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343956|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343957|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343958|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83343959|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83343960|NCT01808573|Capecitabine|capecitabine|mesh-list
83343961|NCT01808573|Lapatinib|lapatinib|mesh-list
83343962|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83343963|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
83343964|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343965|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83343966|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83343967|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83343968|NCT01746940|Cocaine|cocaine|mesh-list
83343969|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83343970|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
83343971|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
83343972|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343973|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343974|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
83343975|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343976|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83343977|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83343978|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83343979|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83343980|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343981|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
83343982|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83343983|NCT01747330|Pancreatin|pancreatin|mesh-list
83343984|NCT01747330|Pancrelipase|pancrelipase|mesh-list
83343985|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83343986|NCT02990962|Triamcinolone|triamcinolone|mesh-list
83343987|NCT02990962|Lidocaine|lidocaine|mesh-list
83343988|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83343989|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
83343990|NCT02990962|Hormones|hormones|mesh-ancestor
83343991|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83343992|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83343993|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83343994|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
83343995|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
83343996|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83343997|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
83343998|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83343999|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83344000|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83344001|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83344002|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344003|NCT03322098|Atropine|atropine|mesh-list
83344004|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
83344005|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83344006|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83344007|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83344008|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
83344009|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344010|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344011|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83344012|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344013|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
83344014|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
83344015|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83344016|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83344017|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
83344018|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344019|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344020|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
83344021|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83344022|NCT01808339|Fluticasone|fluticasone|mesh-list
83344023|NCT01808339|Xhance|xhance|mesh-list
83344024|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344025|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83344026|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
83344027|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344028|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344029|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83344030|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344031|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
83344033|NCT01749904|Timolol|timolol|mesh-list
83344034|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83344035|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83344036|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
83344037|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344038|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344039|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344040|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83344041|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83344042|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83344043|NCT02484768|Hematinics|hematinics|mesh-ancestor
83344044|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
83344045|NCT03316326|Irinotecan|irinotecan|mesh-list
83344046|NCT03316326|Tegafur|tegafur|mesh-list
83344047|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344048|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83344049|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83344050|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344051|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344052|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83344053|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
83344054|NCT02487732|Ticagrelor|ticagrelor|mesh-list
83344055|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83344056|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83344057|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83344058|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83344059|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83344060|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
83344061|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344062|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344063|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344064|NCT03833362|Interferons|interferons|mesh-list
83344065|NCT03833362|Ritonavir|ritonavir|mesh-list
83344066|NCT03833362|Ribavirin|ribavirin|mesh-list
83344067|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
83344068|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
83344069|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83344070|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83344071|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344072|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
83344073|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344074|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83344075|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83344076|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
83344077|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344078|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344079|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83344080|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83344081|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83344082|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83344083|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
83344084|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
83344085|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344086|NCT05463588|Methamphetamine|methamphetamine|mesh-list
83344087|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83344088|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344089|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
83344090|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
83344091|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344092|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
83344093|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344094|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344095|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
83344096|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83344097|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83344098|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344099|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83344100|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
83344101|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83344102|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
83344103|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83344104|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344105|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83344106|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83344108|NCT02490540|Sufentanil|sufentanil|mesh-list
83344109|NCT02490540|Dsuvia|dsuvia|mesh-list
83344110|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83344111|NCT02490540|Narcotics|narcotics|mesh-ancestor
83344112|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344113|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344114|NCT02490540|Analgesics|analgesics|mesh-ancestor
83344115|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
83344116|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344117|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83344118|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83344119|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
83344120|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
83344121|NCT02484300|Melatonin|melatonin|mesh-list
83344122|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
83344123|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344124|NCT02484300|Protective Agents|protective agents|mesh-ancestor
83344125|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344126|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344127|NCT02727660|Budesonide|budesonide|mesh-list
83344128|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
83344129|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344130|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83344131|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
83344132|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344133|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344134|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83344135|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344136|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
83344137|NCT02727660|Hormones|hormones|mesh-ancestor
83344138|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344139|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83344140|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83344141|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83344142|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
83344143|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344144|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344145|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
83344146|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83344147|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344148|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344149|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83344150|NCT02490072|Analgesics|analgesics|mesh-ancestor
83344151|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
83344152|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344153|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83344154|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83344155|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83344156|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
83344157|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344158|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344159|NCT02483598|Buspirone|buspirone|mesh-list
83344160|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83344161|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83344162|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344163|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344164|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83344165|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83344166|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
83344167|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344168|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344169|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
83344170|NCT03321318|Vitamin D|vitamin d|mesh-list
83344171|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
83344172|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83344173|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344174|NCT03321318|Vitamins|vitamins|mesh-ancestor
83344175|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
83344176|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83344177|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83344178|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83344179|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
83344180|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344181|NCT01784861|Everolimus|everolimus|mesh-list
83344182|NCT01784861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83344183|NCT01784861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83344184|NCT01784861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344185|NCT01784861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344186|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344187|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
83344188|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344189|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344190|NCT03318744|Aspirin|aspirin|mesh-list
83344191|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83344192|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83344193|NCT03318744|Analgesics|analgesics|mesh-ancestor
83344194|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
83344195|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344196|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344197|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344198|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83344199|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83344200|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83344201|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344202|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83344203|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83344204|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344205|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
83344206|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83344207|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83344208|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344209|NCT01751386|Baclofen|baclofen|mesh-list
83344210|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83344211|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344212|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83344213|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344214|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83344215|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
83344216|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
83344217|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344218|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344219|NCT02489760|Adalimumab|adalimumab|mesh-list
83344220|NCT02489760|Etanercept|etanercept|mesh-list
83344221|NCT02489760|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83344222|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344223|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83344224|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83344225|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83344226|NCT02489760|Analgesics|analgesics|mesh-ancestor
83344227|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
83344228|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344229|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344230|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344231|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344232|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
83344233|NCT01752712|Oxytocin|oxytocin|mesh-list
83344234|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
83344235|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83344236|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344237|NCT05127928|Vitamins|vitamins|mesh-list
83344238|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
83344239|NCT05127928|Vitamin E|vitamin e|mesh-list
83344240|NCT05127928|Tocopherols|tocopherols|mesh-list
83344241|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
83344242|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344243|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
83344244|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344245|NCT05127928|Protective Agents|protective agents|mesh-ancestor
83344246|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
83344247|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83344248|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
83344249|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344250|NCT02483130|Expectorants|expectorants|mesh-ancestor
83344251|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344252|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83344253|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
83344254|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344255|NCT02483130|Protective Agents|protective agents|mesh-ancestor
83344256|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344257|NCT02483130|Antidotes|antidotes|mesh-ancestor
83344258|NCT03318354|Olmesartan|olmesartan|mesh-list
83344259|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
83344260|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83344261|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83344262|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83344263|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344264|NCT05113186|Lenvatinib|lenvatinib|mesh-list
83344265|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344266|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83344267|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344268|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344269|NCT05093140|Prednisone|prednisone|mesh-list
83344270|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
83344271|NCT05093140|Vincristine|vincristine|mesh-list
83344272|NCT05093140|Doxorubicin|doxorubicin|mesh-list
83344273|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83344274|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344275|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
83344276|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344277|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83344278|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83344279|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
83344280|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344281|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344282|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83344283|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344284|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
83344285|NCT05093140|Hormones|hormones|mesh-ancestor
83344286|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344287|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344288|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83344289|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
83344290|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
83344291|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
83344292|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83344293|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83344294|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83344295|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344297|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
83344298|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
83344299|NCT03315312|Protective Agents|protective agents|mesh-ancestor
83344300|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344301|NCT00705666|Ribavirin|ribavirin|mesh-list
83344302|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83344303|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
83344304|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344305|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
83344306|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344307|NCT04955236|Fentanyl|fentanyl|mesh-list
83344308|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83344309|NCT04955236|Narcotics|narcotics|mesh-ancestor
83344310|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344311|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344312|NCT04955236|Analgesics|analgesics|mesh-ancestor
83344313|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
83344314|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344315|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83344316|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83344317|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
83344318|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
83344319|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
83344320|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83344321|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344322|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344323|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83344324|NCT03957304|Analgesics|analgesics|mesh-ancestor
83344325|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
83344326|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344327|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83344328|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83344329|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83344330|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
83344331|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344332|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344333|NCT03320928|Methotrexate|methotrexate|mesh-list
83344334|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83344335|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
83344336|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83344337|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344338|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83344339|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
83344340|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344341|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344342|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
83344343|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344344|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83344345|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344346|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
83344347|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83344348|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83344349|NCT02488902|Mefloquine|mefloquine|mesh-list
83344350|NCT02488902|Tafenoquine|tafenoquine|mesh-list
83344351|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
83344352|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83344353|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83344354|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344355|NCT02253160|Lenograstim|lenograstim|mesh-list
83344356|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83344357|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
83344358|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344359|NCT02254252|Nicorandil|nicorandil|mesh-list
83344360|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
83344361|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
83344362|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83344363|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83344364|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
83344365|NCT02254252|Vitamins|vitamins|mesh-ancestor
83344366|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
83344367|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344368|NCT03315078|Busulfan|busulfan|mesh-list
83344369|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
83344370|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344371|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344372|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
83344373|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344374|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83344375|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344376|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83344377|NCT02255110|Doxorubicin|doxorubicin|mesh-list
83344378|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83344379|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344380|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83344381|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83344382|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344383|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344384|NCT03320694|Insulin|insulin|mesh-list
83344385|NCT03320694|Metformin|metformin|mesh-list
83344386|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83344387|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
83344388|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83344389|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344390|NCT02482740|Tamoxifen|tamoxifen|mesh-list
83344391|NCT02482740|Letrozole|letrozole|mesh-list
83344392|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344393|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83344394|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83344395|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344396|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344397|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83344398|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
83344399|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344400|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344401|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344402|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83344403|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83344404|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83344405|NCT03315000|Fluticasone|fluticasone|mesh-list
83344407|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344408|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83344409|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
83344410|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344411|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344412|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83344413|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344414|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
83344415|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83344416|NCT02482818|Pregabalin|pregabalin|mesh-list
83344417|NCT02482818|Analgesics|analgesics|mesh-ancestor
83344418|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
83344419|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344420|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344421|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
83344422|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83344423|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344424|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344425|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83344426|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83344427|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83344428|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344429|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83344430|NCT02989870|Sorafenib|sorafenib|mesh-list
83344431|NCT02989870|Bavituximab|bavituximab|mesh-list
83344432|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344433|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83344434|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344435|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344436|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83344437|NCT02480088|Palonosetron|palonosetron|mesh-list
83344438|NCT02480088|Ramosetron|ramosetron|mesh-list
83344439|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
83344440|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
83344441|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344442|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344443|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344444|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83344445|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83344446|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
83344447|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344448|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344449|NCT01807624|Phenylephrine|phenylephrine|mesh-list
83344450|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
83344451|NCT01807624|Tetracaine|tetracaine|mesh-list
83344452|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
83344453|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
83344454|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344455|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344456|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
83344457|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344458|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83344459|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83344460|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
83344461|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344462|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344463|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
83344464|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
83344465|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
83344466|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83344467|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344468|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83344469|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
83344470|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83344471|NCT01807624|Protective Agents|protective agents|mesh-ancestor
83344472|NCT02486640|Interferons|interferons|mesh-list
83344473|NCT02486640|Interferon-beta|interferon-beta|mesh-list
83344474|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
83344475|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344476|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
83344477|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344478|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
83344479|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344480|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83344481|NCT01808326|Chlorambucil|chlorambucil|mesh-list
83344482|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83344484|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344485|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344486|NCT03317730|Oxycodone|oxycodone|mesh-list
83344487|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83344488|NCT03317730|Narcotics|narcotics|mesh-ancestor
83344489|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344490|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344491|NCT03317730|Analgesics|analgesics|mesh-ancestor
83344492|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
83344493|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344494|NCT02486484|Aflibercept|aflibercept|mesh-list
83344495|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83344496|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83344497|NCT02486484|Growth Substances|growth substances|mesh-ancestor
83344498|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344499|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
83344500|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344501|NCT03317652|Nitroprusside|nitroprusside|mesh-list
83344502|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83344503|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
83344504|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83344505|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344506|NCT02479854|Montelukast|montelukast|mesh-list
83344507|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83344508|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344509|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83344510|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
83344511|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344512|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344513|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83344514|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83344515|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344516|NCT01809106|Fentanyl|fentanyl|mesh-list
83344517|NCT01809106|Morphine|morphine|mesh-list
83344518|NCT01809106|Oxycodone|oxycodone|mesh-list
83344519|NCT01809106|Buprenorphine|buprenorphine|mesh-list
83344520|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83344521|NCT01809106|Narcotics|narcotics|mesh-ancestor
83344522|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344523|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344524|NCT01809106|Analgesics|analgesics|mesh-ancestor
83344525|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
83344526|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344527|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83344528|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83344529|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
83344530|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
83344531|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83344532|NCT03804580|Osimertinib|osimertinib|mesh-list
83344533|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344534|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83344535|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344536|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344537|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
83344538|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83344539|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83344540|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83344541|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344542|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344543|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
83344544|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344545|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344546|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83344547|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344548|NCT01810666|Factor VIII|factor viii|mesh-list
83344549|NCT01810666|Coagulants|coagulants|mesh-ancestor
83344550|NCT02482272|Lamivudine|lamivudine|mesh-list
83344551|NCT02482272|Adefovir|adefovir|mesh-list
83344552|NCT02482272|Entecavir|entecavir|mesh-list
83344553|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83344554|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83344555|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344556|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344557|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
83344558|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344559|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83344560|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83344561|NCT01766440|Calcitriol|calcitriol|mesh-list
83344562|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83344563|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344564|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83344565|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344566|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344567|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83344568|NCT01766440|Vitamins|vitamins|mesh-ancestor
83344569|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
83344570|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83344571|NCT02479620|Dexamethasone|dexamethasone|mesh-list
83344572|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
83344573|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83344574|NCT02479620|BB 1101|bb 1101|mesh-list
83344575|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344576|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
83344577|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
83344578|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344579|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344580|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344581|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
83344582|NCT02479620|Hormones|hormones|mesh-ancestor
83344583|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344584|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344585|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344586|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
83344587|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344588|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344589|NCT02481960|Irinotecan|irinotecan|mesh-list
83344590|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83344591|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83344592|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344593|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344594|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344595|NCT02725866|Ritonavir|ritonavir|mesh-list
83344596|NCT02725866|Ribavirin|ribavirin|mesh-list
83344597|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83344598|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83344599|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
83344600|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344601|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344602|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83344603|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83344604|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
83344605|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344606|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83344607|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83344608|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
83344609|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83344610|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83344611|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344612|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
83344613|NCT03314298|Anastrozole|anastrozole|mesh-list
83344614|NCT03314298|Testosterone|testosterone|mesh-list
83344615|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
83344616|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
83344617|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83344618|NCT03314298|Androgens|androgens|mesh-ancestor
83344619|NCT03314298|Hormones|hormones|mesh-ancestor
83344620|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344621|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344622|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344623|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344624|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
83344625|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83344626|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83344627|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344628|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344629|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83344630|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
83344631|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
83344632|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83344633|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344634|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83344635|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83344636|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344637|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344638|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344639|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83344640|NCT05713578|Docetaxel|docetaxel|mesh-list
83344641|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344642|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
83344643|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
83344644|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
83344645|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344646|NCT02485548|Fluorouracil|fluorouracil|mesh-list
83344647|NCT02485548|Raltitrexed|raltitrexed|mesh-list
83344648|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344649|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
83344650|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344651|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83344652|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344653|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
83344654|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344655|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83344656|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344657|NCT02479074|Prednisolone|prednisolone|mesh-list
83344658|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83344659|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
83344660|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83344661|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
83344662|NCT02479074|Montelukast|montelukast|mesh-list
83344663|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83344664|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
83344665|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344666|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
83344667|NCT02479074|Hormones|hormones|mesh-ancestor
83344668|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344669|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344670|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344671|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344672|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
83344673|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
83344674|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344675|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344676|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83344677|NCT02479074|Protective Agents|protective agents|mesh-ancestor
83344678|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83344679|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344680|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83344681|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
83344682|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83344683|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83344684|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344685|NCT02481180|T0001|t0001|mesh-list
83344686|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
83344687|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344688|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83344689|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
83344690|NCT02480946|Methotrexate|methotrexate|mesh-list
83344691|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83344692|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
83344693|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83344694|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344695|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83344696|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
83344697|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344698|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344699|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
83344700|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344701|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83344702|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344703|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
83344704|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83344705|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83344706|NCT01769170|Cidofovir|cidofovir|mesh-list
83344707|NCT01769170|Brincidofovir|brincidofovir|mesh-list
83344708|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
83344709|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344710|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344711|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344712|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
83344713|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83344714|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344715|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83344716|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83344717|NCT02726022|Ribavirin|ribavirin|mesh-list
83344718|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83344719|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
83344720|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344721|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
83344722|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344723|NCT02478294|Warfarin|warfarin|mesh-list
83344724|NCT02478294|Anticoagulants|anticoagulants|mesh-list
83344725|NCT01770652|Deferiprone|deferiprone|mesh-list
83344726|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83344727|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
83344728|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
83344729|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344730|NCT03316482|Leuprolide|leuprolide|mesh-list
83344731|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83344732|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
83344733|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83344734|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344735|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344736|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344737|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
83344738|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83344739|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344740|NCT01772758|Antioxidants|antioxidants|mesh-list
83344741|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344742|NCT01772758|Protective Agents|protective agents|mesh-ancestor
83344743|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344744|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
83344745|NCT02485080|Simeprevir|simeprevir|mesh-list
83344746|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
83344747|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344748|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
83344749|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344750|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344751|NCT02480400|Dexetimide|dexetimide|mesh-list
83344752|NCT02480400|Citalopram|citalopram|mesh-list
83344753|NCT02480400|Escitalopram|escitalopram|mesh-list
83344754|NCT02480400|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83344755|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83344756|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344757|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344758|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344759|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
83344760|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344761|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83344762|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83344763|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
83344764|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
83344765|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344766|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83344767|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83344768|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
83344769|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83344770|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
83344771|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83344772|NCT02725710|Gabapentin|gabapentin|mesh-list
83344773|NCT02725710|Analgesics|analgesics|mesh-ancestor
83344774|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
83344775|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344776|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344777|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
83344778|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83344779|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83344780|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344781|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83344782|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83344783|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83344784|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344785|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344786|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
83344787|NCT02256358|Midazolam|midazolam|mesh-list
83344788|NCT02256358|Ketamine|ketamine|mesh-list
83344789|NCT02256358|Analgesics|analgesics|mesh-ancestor
83344790|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
83344791|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344792|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344793|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83344794|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83344795|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
83344796|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
83344797|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344798|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83344799|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83344800|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344801|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344802|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83344803|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83344804|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83344805|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83344806|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83344807|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
83344808|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
83344809|NCT01825408|Azithromycin|azithromycin|mesh-list
83344810|NCT01825408|Doxycycline|doxycycline|mesh-list
83344811|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83344812|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83344813|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344814|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
83344815|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83344816|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83344817|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83344818|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344819|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344820|NCT04945824|Dexamethasone|dexamethasone|mesh-list
83344821|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344822|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
83344823|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
83344824|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344825|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344826|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344827|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
83344828|NCT04945824|Hormones|hormones|mesh-ancestor
83344829|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344830|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344831|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344832|NCT04937634|Melphalan|melphalan|mesh-list
83344833|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83344834|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
83344835|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344836|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344837|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83344838|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344839|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
83344840|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344841|NCT02262130|Omalizumab|omalizumab|mesh-list
83344842|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83344843|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83344844|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
83344845|NCT04913610|Ivermectin|ivermectin|mesh-list
83344846|NCT04913610|Albendazole|albendazole|mesh-list
83344847|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83344848|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344849|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
83344850|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
83344851|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83344852|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83344853|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
83344854|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
83344855|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
83344856|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344857|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344858|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
83344859|NCT04887870|Nivolumab|nivolumab|mesh-list
83344860|NCT04887870|Ipilimumab|ipilimumab|mesh-list
83344861|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83344862|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344863|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83344864|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344865|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
83344866|NCT01827358|Mupirocin|mupirocin|mesh-list
83344867|NCT01827358|Calcium|calcium|mesh-list
83344868|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83344869|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344870|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83344871|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83344872|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344873|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83344874|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344875|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344876|NCT01780324|Lidocaine|lidocaine|mesh-list
83344877|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
83344878|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
83344879|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344880|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344881|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
83344882|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344883|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83344884|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83344885|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83344886|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83344887|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344888|NCT02472600|Colistin|colistin|mesh-list
83344889|NCT02472600|Polymyxins|polymyxins|mesh-list
83344890|NCT02472600|Neomycin|neomycin|mesh-list
83344891|NCT02472600|Omeprazole|omeprazole|mesh-list
83344892|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83344893|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344894|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83344895|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344896|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344897|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83344898|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344899|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83344900|NCT04858776|Dexamethasone|dexamethasone|mesh-list
83344901|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344902|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
83344903|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
83344904|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344905|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344906|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344907|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
83344908|NCT04858776|Hormones|hormones|mesh-ancestor
83344909|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344910|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344911|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344912|NCT01781806|Tenofovir|tenofovir|mesh-list
83344913|NCT01781806|Emtricitabine|emtricitabine|mesh-list
83344914|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
83344915|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344916|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83344917|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83344918|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344919|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344920|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83344921|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83344922|NCT02477514|Tedizolid|tedizolid|mesh-list
83344923|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
83344924|NCT02477514|Midazolam|midazolam|mesh-list
83344925|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83344926|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83344927|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83344928|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83344929|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344930|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83344931|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83344932|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83344933|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83344934|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
83344936|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
83344937|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
83344938|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83344939|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344940|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83344941|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83344942|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
83344943|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83344944|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83344945|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344946|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83344947|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344948|NCT01746238|Bevacizumab|bevacizumab|mesh-list
83344949|NCT01746238|Doxorubicin|doxorubicin|mesh-list
83344950|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83344951|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344952|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83344953|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83344954|NCT01746238|Growth Substances|growth substances|mesh-ancestor
83344955|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344956|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
83344957|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83344958|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83344959|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83344960|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344961|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344962|NCT02472054|Cyclosporine|cyclosporine|mesh-list
83344963|NCT02472054|Prednisolone|prednisolone|mesh-list
83344964|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83344965|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
83344966|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83344967|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
83344968|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
83344969|NCT02472054|Cyclosporins|cyclosporins|mesh-list
83344970|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83344971|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
83344972|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83344973|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83344974|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83344975|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
83344976|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83344977|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
83344978|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83344979|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
83344980|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83344981|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83344982|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83344983|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
83344984|NCT02472054|Hormones|hormones|mesh-ancestor
83344985|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83344986|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83344987|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83344988|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
83344989|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
83344990|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83344991|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83344992|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83344993|NCT02472054|Protective Agents|protective agents|mesh-ancestor
83344994|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83344995|NCT01782898|Esmolol|esmolol|mesh-list
83344996|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83344997|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83344998|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83344999|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
83345000|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345001|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345002|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345003|NCT02475876|Clindamycin|clindamycin|mesh-list
83345004|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
83345005|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
83345006|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83345007|NCT02475876|Trimethoprim|trimethoprim|mesh-list
83345008|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
83345009|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83345010|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345011|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83345012|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345013|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345014|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83345015|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
83345016|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83345017|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83345018|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83345019|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83345020|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83345021|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345022|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
83345023|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83345024|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345025|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345026|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
83345027|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345028|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345029|NCT01783054|Gemcitabine|gemcitabine|mesh-list
83345030|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83345031|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
83345032|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345033|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345034|NCT05397600|Bimatoprost|bimatoprost|mesh-list
83345035|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83345036|NCT02725008|Dexamethasone|dexamethasone|mesh-list
83345037|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345038|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
83345039|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
83345040|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345041|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345042|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345043|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
83345044|NCT02725008|Hormones|hormones|mesh-ancestor
83345045|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345046|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83345047|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345048|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
83345049|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83345050|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345051|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345052|NCT02471820|Dexamethasone|dexamethasone|mesh-list
83345053|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
83345054|NCT02471820|Lenalidomide|lenalidomide|mesh-list
83345055|NCT02471820|Doxorubicin|doxorubicin|mesh-list
83345056|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83345057|NCT02471820|BB 1101|bb 1101|mesh-list
83345058|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345059|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
83345060|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
83345061|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345062|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345063|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345064|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
83345065|NCT02471820|Hormones|hormones|mesh-ancestor
83345066|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345067|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83345068|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345069|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
83345070|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345071|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345072|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
83345073|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83345074|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83345075|NCT02471820|Growth Substances|growth substances|mesh-ancestor
83345076|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
83345077|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83345078|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83345079|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83345080|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
83345081|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83345082|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83345083|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83345084|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345085|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345087|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345088|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345089|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83345090|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345092|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83345093|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
83345094|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345095|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345096|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83345097|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83345098|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
83345099|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345100|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345101|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
83345102|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83345103|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83345104|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345105|NCT05583708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83345106|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345107|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83345108|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
83345109|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345110|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
83345111|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345112|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345113|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83345114|NCT01833988|Pancrelipase|pancrelipase|mesh-list
83345115|NCT01833988|Pancreatin|pancreatin|mesh-list
83345116|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345117|NCT05363436|Oxycodone|oxycodone|mesh-list
83345118|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83345119|NCT05363436|Narcotics|narcotics|mesh-ancestor
83345120|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345121|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345122|NCT05363436|Analgesics|analgesics|mesh-ancestor
83345123|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
83345124|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345125|NCT03582774|Edetic Acid|edetic acid|mesh-list
83345126|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83345127|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
83345128|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
83345129|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345130|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
83345131|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83345132|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83345133|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83345134|NCT02474706|Imipenem|imipenem|mesh-list
83345135|NCT02474706|Cefoxitin|cefoxitin|mesh-list
83345136|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83345137|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345138|NCT01784770|Azithromycin|azithromycin|mesh-list
83345139|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83345140|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345141|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
83345142|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83345143|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345144|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345145|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345146|NCT04491786|Gabapentin|gabapentin|mesh-list
83345147|NCT04491786|Nefopam|nefopam|mesh-list
83345148|NCT04491786|Analgesics|analgesics|mesh-ancestor
83345149|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
83345150|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345151|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345152|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
83345153|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83345154|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83345155|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345156|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83345157|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83345158|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83345159|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345160|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345161|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
83345162|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83345163|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83345164|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83345165|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345166|NCT02470026|Yohimbine|yohimbine|mesh-list
83345167|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
83345168|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
83345169|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345170|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345171|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83345172|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83345173|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83345174|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
83345175|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345176|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345177|NCT02470026|Urological Agents|urological agents|mesh-ancestor
83345178|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
83345179|NCT01807949|Ivacaftor|ivacaftor|mesh-list
83345180|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83345181|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345182|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345183|NCT02989558|Aspirin|aspirin|mesh-list
83345184|NCT02989558|Clopidogrel|clopidogrel|mesh-list
83345185|NCT02989558|Ticagrelor|ticagrelor|mesh-list
83345186|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83345187|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83345188|NCT02989558|Analgesics|analgesics|mesh-ancestor
83345189|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
83345190|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345191|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345192|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345193|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345194|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83345195|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83413654|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345196|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345197|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83345198|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83345199|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345200|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
83345201|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83345202|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83345203|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83345204|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
83345205|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345206|NCT01806779|Bupropion|bupropion|mesh-list
83345207|NCT01806779|Nicotine|nicotine|mesh-list
83345208|NCT01806779|Varenicline|varenicline|mesh-list
83345209|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83345210|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
83345211|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345212|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345213|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83345214|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83345215|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
83345216|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345217|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345218|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83345219|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
83345220|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83345221|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83345222|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83345223|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345224|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
83345225|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83345226|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345227|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345229|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
83345230|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
83345231|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345232|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345233|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345234|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83345235|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
83345236|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345237|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345238|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
83345239|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
83345240|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345241|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83345242|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
83345243|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345244|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83345245|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83345246|NCT01806623|Fluconazole|fluconazole|mesh-list
83345247|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
83345248|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345249|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83345250|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345251|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345252|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345253|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83345254|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
83345255|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345256|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345257|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83345258|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83345259|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83345260|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
83345261|NCT01806545|Coagulants|coagulants|mesh-ancestor
83345262|NCT01847014|Macitentan|macitentan|mesh-list
83345263|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
83345264|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83345265|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345266|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
83345267|NCT01847638|Nepafenac|nepafenac|mesh-list
83345268|NCT01847638|Bromfenac|bromfenac|mesh-list
83345269|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83345270|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83345271|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83345272|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83345273|NCT01847638|Analgesics|analgesics|mesh-ancestor
83345274|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
83345275|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345276|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345277|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345278|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345279|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
83345280|NCT02474628|Calcium|calcium|mesh-list
83345281|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83345282|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345283|NCT02474628|Antacids|antacids|mesh-ancestor
83345284|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345285|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345286|NCT05211570|Azacitidine|azacitidine|mesh-list
83345287|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83345288|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
83345289|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345290|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345291|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345292|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
83345293|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83345294|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345295|NCT03099564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83345296|NCT03099564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345297|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
83345298|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83345299|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83345300|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83345301|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345302|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345303|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
83345304|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345305|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345306|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83345307|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345308|NCT05328310|Nebivolol|nebivolol|mesh-list
83345309|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83345310|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
83345311|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83345312|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83345313|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83345314|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
83345315|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345316|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345317|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345318|NCT01797484|Ranolazine|ranolazine|mesh-list
83345319|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83345320|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345321|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345322|NCT01798264|Exenatide|exenatide|mesh-list
83345323|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345324|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345325|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83345326|NCT01798264|Incretins|incretins|mesh-ancestor
83345327|NCT01798264|Hormones|hormones|mesh-ancestor
83345328|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345329|NCT05326984|Metformin|metformin|mesh-list
83345330|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345331|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345332|NCT01800838|Silicon|silicon|mesh-list
83345333|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
83345334|NCT01800838|Trace Elements|trace elements|mesh-ancestor
83345335|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
83345336|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345337|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
83345338|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83345339|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83345340|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345341|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
83345342|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83345343|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
83345344|NCT01782131|Voriconazole|voriconazole|mesh-list
83345345|NCT01782131|Posaconazole|posaconazole|mesh-list
83345346|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
83345347|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345348|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83345349|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345350|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345351|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345352|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83345353|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
83345354|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345355|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345356|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83345357|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83345358|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83345359|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83345360|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
83345361|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345362|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83345363|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345364|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345365|NCT01855360|Doxycycline|doxycycline|mesh-list
83345366|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
83345367|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83345368|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345369|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
83345370|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83345371|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83345372|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
83345373|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83345374|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345376|NCT04351126|Bromocriptine|bromocriptine|mesh-list
83345377|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83345378|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83345379|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
83345380|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345381|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345382|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
83345383|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
83345384|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345385|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345386|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345387|NCT01804673|Fentanyl|fentanyl|mesh-list
83345388|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83345389|NCT01804673|Narcotics|narcotics|mesh-ancestor
83345390|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345391|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345392|NCT01804673|Analgesics|analgesics|mesh-ancestor
83345393|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
83345394|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345395|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83345396|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83345397|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
83345398|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
83345399|NCT01856530|Oxytocin|oxytocin|mesh-list
83345400|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
83345401|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83345402|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345403|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
83345404|NCT05302336|Docetaxel|docetaxel|mesh-list
83345405|NCT05302336|Doxorubicin|doxorubicin|mesh-list
83345406|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83345407|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83345408|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
83345409|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345410|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345411|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83345412|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
83345413|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345414|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345415|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83345416|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
83345417|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
83345418|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
83345419|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83345420|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83345421|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83345422|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345423|NCT01804036|Zolpidem|zolpidem|mesh-list
83345424|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83345425|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83345426|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345427|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345428|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83345429|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
83345430|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
83345431|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345432|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345433|NCT01857232|Dexamethasone|dexamethasone|mesh-list
83345434|NCT01857232|Ondansetron|ondansetron|mesh-list
83345435|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
83345436|NCT01857232|Aprepitant|aprepitant|mesh-list
83345437|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345438|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
83345439|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
83345440|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345441|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345442|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345443|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
83345444|NCT01857232|Hormones|hormones|mesh-ancestor
83345445|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345446|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83345447|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345448|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
83345449|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
83345450|NCT01857232|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83345451|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83345452|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
83345453|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345454|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345455|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83345456|NCT01766128|Zonisamide|zonisamide|mesh-list
83345457|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
83345458|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83345459|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345460|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345461|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83345462|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345463|NCT02859558|Tenofovir|tenofovir|mesh-list
83345464|NCT02859558|Emtricitabine|emtricitabine|mesh-list
83345465|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83345466|NCT02859558|Cobicistat|cobicistat|mesh-list
83345467|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
83345468|NCT02859558|Elvitegravir|elvitegravir|mesh-list
83345469|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83345470|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
83345471|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345472|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83345473|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83345474|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345475|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345476|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83345477|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83345478|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345479|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83345480|NCT01860586|Bevacizumab|bevacizumab|mesh-list
83345481|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83345482|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345483|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83345484|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83345485|NCT01860586|Growth Substances|growth substances|mesh-ancestor
83345486|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345487|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
83345488|NCT00705432|Ribavirin|ribavirin|mesh-list
83345489|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83345490|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
83345491|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345492|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
83345493|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345494|NCT00704964|Ribavirin|ribavirin|mesh-list
83345495|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83345496|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
83345497|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
83345498|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345499|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
83345500|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345501|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
83345502|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345503|NCT00704808|Temozolomide|temozolomide|mesh-list
83345504|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83345505|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
83345506|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345507|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345508|NCT05305794|Insulin|insulin|mesh-list
83345509|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83345510|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345511|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345512|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83345513|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
83345514|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345515|NCT01862536|Tadalafil|tadalafil|mesh-list
83345516|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
83345517|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83345518|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83345519|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345520|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345521|NCT01862536|Urological Agents|urological agents|mesh-ancestor
83345522|NCT01862614|Epinephrine|epinephrine|mesh-list
83345523|NCT01862614|Racepinephrine|racepinephrine|mesh-list
83345524|NCT01862614|Carticaine|carticaine|mesh-list
83345525|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
83345526|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83345527|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83345528|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
83345529|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345530|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345531|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345532|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83345533|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83345534|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
83345535|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345536|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83345537|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
83345538|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
83345539|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
83345540|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83345541|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
83345542|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
83345543|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345544|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
83345545|NCT05166876|Brequinar|brequinar|mesh-list
83345546|NCT05166876|Dipyridamole|dipyridamole|mesh-list
83345547|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83345548|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345549|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345550|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83345551|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
83345552|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345553|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83345554|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
83345555|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345556|NCT02470650|Ritonavir|ritonavir|mesh-list
83345557|NCT02470650|Darunavir|darunavir|mesh-list
83345558|NCT02470650|Tenofovir|tenofovir|mesh-list
83345559|NCT02470650|Lamivudine|lamivudine|mesh-list
83345560|NCT02470650|Emtricitabine|emtricitabine|mesh-list
83345561|NCT02470650|Abacavir|abacavir|mesh-list
83345562|NCT02470650|Cobicistat|cobicistat|mesh-list
83345563|NCT02470650|Rilpivirine|rilpivirine|mesh-list
83345564|NCT02470650|Elvitegravir|elvitegravir|mesh-list
83345565|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83345566|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83345567|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
83345568|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345569|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345570|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83345571|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83345572|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
83345573|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345574|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83345575|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345576|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83345577|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83345578|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83345579|NCT01866592|Adalimumab|adalimumab|mesh-list
83345580|NCT01866592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83345581|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345582|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345583|NCT01375608|Decitabine|decitabine|mesh-list
83345584|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83345585|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
83345586|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345587|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345588|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345589|NCT01868776|Lidocaine|lidocaine|mesh-list
83345590|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
83345591|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
83345592|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345593|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345594|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
83345595|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345596|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83345597|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83345598|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83345599|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345600|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345601|NCT00704418|Bromfenac|bromfenac|mesh-list
83345602|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83345603|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83345604|NCT00704418|Analgesics|analgesics|mesh-ancestor
83345605|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
83345606|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345607|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345608|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345609|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345610|NCT01869634|Ritonavir|ritonavir|mesh-list
83345611|NCT01869634|Darunavir|darunavir|mesh-list
83345612|NCT01869634|Emtricitabine|emtricitabine|mesh-list
83345613|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83345614|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83345615|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
83345616|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345617|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345618|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83345619|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83345620|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
83345621|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345622|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83345623|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345624|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83345625|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83345626|NCT02047578|Busulfan|busulfan|mesh-list
83345627|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
83345628|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345629|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83345630|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
83345631|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345632|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83345633|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345634|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83345635|NCT04837066|Imidacloprid|imidacloprid|mesh-list
83345636|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
83345637|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345638|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345639|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345640|NCT04807894|Testosterone|testosterone|mesh-list
83345641|NCT04807894|Androgens|androgens|mesh-ancestor
83345642|NCT04807894|Hormones|hormones|mesh-ancestor
83345643|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345644|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345645|NCT01874392|Insulin|insulin|mesh-list
83345646|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83345647|NCT01874392|Pancrelipase|pancrelipase|mesh-list
83345648|NCT01874392|Pancreatin|pancreatin|mesh-list
83345649|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345650|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345651|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345652|NCT00576654|Irinotecan|irinotecan|mesh-list
83345653|NCT00576654|Camptothecin|camptothecin|mesh-list
83345654|NCT00576654|Veliparib|veliparib|mesh-list
83345655|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83345656|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83345657|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345658|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345659|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345660|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83345661|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83345662|NCT03314064|Dolutegravir|dolutegravir|mesh-list
83345663|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83345664|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83345665|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345666|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345667|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83345668|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83345669|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
83345670|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345671|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
83345672|NCT00552058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83345673|NCT00552058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345674|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83345675|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
83345676|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345677|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345678|NCT02473302|Tocopherols|tocopherols|mesh-list
83345679|NCT02473302|Vitamin E|vitamin e|mesh-list
83345680|NCT02473302|Tocotrienols|tocotrienols|mesh-list
83345681|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
83345682|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
83345683|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345684|NCT02473302|Protective Agents|protective agents|mesh-ancestor
83345685|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345686|NCT02473302|Vitamins|vitamins|mesh-ancestor
83345687|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
83345688|NCT05747326|Capecitabine|capecitabine|mesh-list
83345689|NCT05747326|Vinorelbine|vinorelbine|mesh-list
83345690|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83345691|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
83345692|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345693|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345694|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83345695|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83345696|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83345697|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83345698|NCT03108300|Doxorubicin|doxorubicin|mesh-list
83345699|NCT03108300|Propranolol|propranolol|mesh-list
83345700|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83345701|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345702|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83345703|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83345704|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345705|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345706|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83345707|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83345708|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
83345709|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345710|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345711|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83345712|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83345713|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
83345714|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
83345715|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83345716|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345717|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345718|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345719|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
83345720|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83345721|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345722|NCT02473146|Immunotoxins|immunotoxins|mesh-ancestor
83345723|NCT02473146|Immunoconjugates|immunoconjugates|mesh-ancestor
83345724|NCT02473146|Immunologic Factors|immunologic factors|mesh-ancestor
83345725|NCT02473146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345726|NCT02989012|Oseltamivir|oseltamivir|mesh-list
83345727|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
83345728|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345729|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345730|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345731|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83345732|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83345733|NCT03832894|Estradiol|estradiol|mesh-list
83345734|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83345735|NCT03832894|Progesterone|progesterone|mesh-list
83345736|NCT03832894|Estrogens|estrogens|mesh-ancestor
83345737|NCT03832894|Hormones|hormones|mesh-ancestor
83345738|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345739|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345740|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83345741|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
83345742|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83345743|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83345744|NCT03832894|Progestins|progestins|mesh-ancestor
83345745|NCT02989324|Misoprostol|misoprostol|mesh-list
83345746|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83345747|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
83345748|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83345749|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345750|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83345751|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345752|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
83345753|NCT03686124|Nivolumab|nivolumab|mesh-list
83345754|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83345755|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345756|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83345757|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345758|NCT00550732|Posaconazole|posaconazole|mesh-list
83345759|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
83345760|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345761|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83345762|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83345763|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83345764|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83345765|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83345766|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345767|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345768|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83345769|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
83345770|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345771|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345772|NCT03311022|Nefopam|nefopam|mesh-list
83345773|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83345774|NCT03311022|Analgesics|analgesics|mesh-ancestor
83345775|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
83345776|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345777|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345778|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
83345779|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345780|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345781|NCT00559936|Bevacizumab|bevacizumab|mesh-list
83345782|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83345783|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345784|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83345785|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83345786|NCT00559936|Growth Substances|growth substances|mesh-ancestor
83345787|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345788|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
83345789|NCT05353192|Hormones|hormones|mesh-list
83345790|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345791|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345792|NCT03310242|Vitamin D|vitamin d|mesh-list
83345793|NCT03310242|Vitamins|vitamins|mesh-ancestor
83345794|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
83345795|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345796|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83345797|NCT00557128|Lisinopril|lisinopril|mesh-list
83345798|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83345799|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
83345800|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345801|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345802|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83345803|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83345804|NCT00557128|Protective Agents|protective agents|mesh-ancestor
83345805|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345806|NCT03312582|Metformin|metformin|mesh-list
83345807|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83345808|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345809|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
83345810|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83345811|NCT04350580|Antibodies|antibodies|mesh-list
83345812|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
83345813|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345814|NCT00558064|Amlodipine|amlodipine|mesh-list
83345815|NCT00558064|Telmisartan|telmisartan|mesh-list
83345816|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83345817|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83345818|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83345819|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345820|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345821|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83345822|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345823|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
83345824|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83345825|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83345826|NCT03312426|Linrodostat|linrodostat|mesh-list
83345827|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345828|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345829|NCT03309618|Valsartan|valsartan|mesh-list
83345830|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83345831|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83345832|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83345833|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345834|NCT03303924|Sulbactam|sulbactam|mesh-list
83345835|NCT03303924|Durlobactam|durlobactam|mesh-list
83345836|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83345837|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345838|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83345839|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345840|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345841|NCT00557830|Sorafenib|sorafenib|mesh-list
83345842|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345843|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83345844|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345845|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345846|NCT00557440|Fluticasone|fluticasone|mesh-list
83345847|NCT00557440|Xhance|xhance|mesh-list
83345848|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
83345849|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83345850|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83345851|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345852|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83345853|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
83345854|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345855|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345856|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83345857|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
83345858|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
83345859|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83345860|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83345861|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83345862|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83345863|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
83345864|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345865|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345866|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
83345867|NCT00557440|Hormones|hormones|mesh-ancestor
83345868|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83345869|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
83345870|NCT03311178|Dobutamine|dobutamine|mesh-list
83345871|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83345872|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
83345873|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
83345874|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345875|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345876|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83345877|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83345878|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83345879|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
83345880|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345881|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345882|NCT03311178|Protective Agents|protective agents|mesh-ancestor
83345884|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
83345885|NCT02469012|Ledipasvir|ledipasvir|mesh-list
83345886|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
83345887|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345888|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
83345889|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345890|NCT02468856|Modafinil|modafinil|mesh-list
83345891|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83345892|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345893|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
83345894|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83345895|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83345896|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345897|NCT05224336|Niacin|niacin|mesh-list
83345898|NCT05224336|Psilocybin|psilocybin|mesh-list
83345899|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83345900|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
83345901|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345902|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83345903|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
83345904|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
83345905|NCT05224336|Vitamins|vitamins|mesh-ancestor
83345906|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
83345907|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345908|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
83345909|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83345910|NCT03303378|Melatonin|melatonin|mesh-list
83345911|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
83345912|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345913|NCT03303378|Protective Agents|protective agents|mesh-ancestor
83345914|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345915|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345916|NCT04491474|Lidocaine|lidocaine|mesh-list
83345917|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
83345918|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
83345919|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345920|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345921|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
83345922|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345923|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83345924|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83345925|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83345926|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345927|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345928|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
83345929|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83345930|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345931|NCT03308604|Cisplatin|cisplatin|mesh-list
83345932|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345933|NCT00553306|Aldesleukin|aldesleukin|mesh-list
83345934|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
83345935|NCT00553306|Interleukin-2|interleukin-2|mesh-list
83345936|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83345937|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
83345938|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345939|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345940|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83345941|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
83345942|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345943|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83345944|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83345945|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83345946|NCT00553306|Analgesics|analgesics|mesh-ancestor
83345947|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
83345948|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345949|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83345950|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83345951|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
83345952|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345953|NCT02722044|Adalimumab|adalimumab|mesh-list
83345954|NCT02722044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83345955|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83345956|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83345957|NCT05728008|Ustekinumab|ustekinumab|mesh-list
83345958|NCT05728008|Tofacitinib|tofacitinib|mesh-list
83345959|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
83345960|NCT05728008|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83345961|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83345962|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83345963|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345964|NCT02988700|Bupivacaine|bupivacaine|mesh-list
83345965|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
83345966|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
83345967|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345968|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345969|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
83345970|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345971|NCT03308214|Imipenem|imipenem|mesh-list
83345972|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83345973|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83345974|NCT03308136|Lidocaine|lidocaine|mesh-list
83345975|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
83345976|NCT03308136|Anesthetics|anesthetics|mesh-list
83345977|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83345978|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345979|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
83345980|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345981|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83345982|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83345983|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83345984|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83345985|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345986|NCT02466984|Metoclopramide|metoclopramide|mesh-list
83345987|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
83345988|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
83345989|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83345990|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83345991|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83345992|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83345993|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83345994|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
83345995|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83345996|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83345997|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
83345998|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83345999|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346000|NCT03307902|Imiquimod|imiquimod|mesh-list
83346001|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83346002|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
83346003|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346004|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346005|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
83346006|NCT03302364|Risperidone|risperidone|mesh-list
83346007|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83346008|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
83346009|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346010|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346011|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346012|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83346013|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83346014|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346015|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83346016|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83346017|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
83346018|NCT02467920|Exenatide|exenatide|mesh-list
83346019|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83346020|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346021|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83346023|NCT02467920|Hormones|hormones|mesh-ancestor
83346024|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346025|NCT04927312|Metronidazole|metronidazole|mesh-list
83346026|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346027|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83346028|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83346029|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83346030|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
83346031|NCT03307590|Bupivacaine|bupivacaine|mesh-list
83346032|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
83346033|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
83346034|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346035|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346036|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
83346037|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346038|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83346039|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83346040|NCT03307590|Analgesics|analgesics|mesh-ancestor
83346041|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83346042|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83346043|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83346044|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
83346045|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346046|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346047|NCT03302208|Pregabalin|pregabalin|mesh-list
83346048|NCT03302208|Analgesics|analgesics|mesh-ancestor
83346049|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
83346050|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346051|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346052|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
83346053|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83346054|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346055|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346056|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346057|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83346058|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83346059|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346060|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83346061|NCT03307512|Insulin|insulin|mesh-list
83346062|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83346063|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
83346064|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83346065|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346066|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83346067|NCT02466828|Hematinics|hematinics|mesh-ancestor
83346068|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83346069|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83346070|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83346071|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
83346072|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346073|NCT00553462|Paclitaxel|paclitaxel|mesh-list
83346074|NCT00553462|Carboplatin|carboplatin|mesh-list
83346075|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83346076|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83346077|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83346078|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346079|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346080|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346081|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346082|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346083|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83346084|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346085|NCT04874038|Lidocaine|lidocaine|mesh-list
83346086|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
83346087|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
83346088|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346089|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346090|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
83346091|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346092|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83346093|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83346094|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83346095|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346096|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346097|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83346098|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
83346099|NCT03301974|Coagulants|coagulants|mesh-ancestor
83346100|NCT03306732|Thiamine|thiamine|mesh-list
83346101|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
83346102|NCT03306732|Vitamins|vitamins|mesh-ancestor
83346103|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
83346104|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346105|NCT00553150|Everolimus|everolimus|mesh-list
83346106|NCT00553150|Temozolomide|temozolomide|mesh-list
83346107|NCT00553150|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83346108|NCT00553150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83346109|NCT00553150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346110|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346111|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83346112|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
83346113|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346114|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346115|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346116|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
83346117|NCT02468232|Enalapril|enalapril|mesh-list
83346118|NCT02468232|Enalaprilat|enalaprilat|mesh-list
83346119|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83346120|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83346121|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
83346122|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346123|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346124|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83346125|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83346126|NCT04630834|Acetaminophen|acetaminophen|mesh-list
83346127|NCT04630834|Ibuprofen|ibuprofen|mesh-list
83346128|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83346129|NCT04630834|Analgesics|analgesics|mesh-ancestor
83346130|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
83346131|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346132|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346133|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
83346134|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83346135|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346136|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346137|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83346138|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346139|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346140|NCT03301350|Paclitaxel|paclitaxel|mesh-list
83346141|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
83346142|NCT03301350|Carboplatin|carboplatin|mesh-list
83346143|NCT03301350|Doxorubicin|doxorubicin|mesh-list
83346144|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83346145|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346146|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346147|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346148|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346149|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346150|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83346151|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
83346152|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346153|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346154|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346155|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
83346156|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83346157|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83346158|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83346159|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83346160|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346161|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
83346162|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346163|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
83346164|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
83346165|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
83346166|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
83346167|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83346169|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
83346170|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
83346171|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83346172|NCT02722278|Androgens|androgens|mesh-ancestor
83346173|NCT02722278|Hormones|hormones|mesh-ancestor
83346174|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346175|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346176|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83346177|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346178|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
83346179|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83346180|NCT03300960|Ganirelix|ganirelix|mesh-list
83346181|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83346182|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
83346183|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83346184|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346185|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83346186|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83346187|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83346188|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346189|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
83346190|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346191|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
83346192|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346193|NCT02485444|Oxytocin|oxytocin|mesh-list
83346194|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
83346195|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83346196|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346197|NCT04443010|Temozolomide|temozolomide|mesh-list
83346198|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346199|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
83346200|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346201|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346203|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346204|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83346205|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346206|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346207|NCT04601584|Antibodies|antibodies|mesh-list
83346208|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
83346209|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
83346210|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346211|NCT02359474|Trabectedin|trabectedin|mesh-list
83346212|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346213|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
83346214|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346215|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346216|NCT02467686|Tamoxifen|tamoxifen|mesh-list
83346217|NCT02467686|Exemestane|exemestane|mesh-list
83346218|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83346219|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83346220|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
83346221|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346222|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346223|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83346224|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346225|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83346226|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83346227|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83346228|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83346229|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346230|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346231|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
83346232|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
83346233|NCT05707962|Analgesics|analgesics|mesh-ancestor
83346234|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
83346235|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346236|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346237|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
83346238|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346239|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83346240|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
83346241|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83346242|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346243|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346244|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346245|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
83346246|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83346247|NCT05707962|Protective Agents|protective agents|mesh-ancestor
83346249|NCT01993810|Etoposide|etoposide|mesh-list
83346250|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
83346251|NCT01993810|Cisplatin|cisplatin|mesh-list
83346252|NCT01993810|Carboplatin|carboplatin|mesh-list
83346253|NCT01993810|Pemetrexed|pemetrexed|mesh-list
83346254|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83346255|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
83346256|NCT01993810|Durvalumab|durvalumab|mesh-list
83346257|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
83346258|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83346259|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
83346260|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83346261|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346262|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346263|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346264|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346265|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346266|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83346267|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83346268|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346269|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83346270|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83346271|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346272|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
83346273|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346274|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
83346275|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
83346276|NCT05698680|Prednisolone|prednisolone|mesh-list
83346277|NCT05698680|Colchicine|colchicine|mesh-list
83346278|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346279|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
83346280|NCT05698680|Hormones|hormones|mesh-ancestor
83346281|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346282|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346283|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83346284|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346285|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
83346286|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346287|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346288|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346289|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346290|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346291|NCT04058470|Prednisone|prednisone|mesh-list
83346292|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
83346293|NCT04058470|Rituximab|rituximab|mesh-list
83346294|NCT04058470|Doxorubicin|doxorubicin|mesh-list
83346295|NCT04058470|Vincristine|vincristine|mesh-list
83346296|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83346297|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
83346298|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346299|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346300|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346301|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
83346302|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346303|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346304|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83346305|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346306|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83346307|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83346308|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83346309|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346310|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346311|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
83346312|NCT04058470|Hormones|hormones|mesh-ancestor
83346313|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346314|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83346315|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83346316|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346317|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346318|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346319|NCT02720484|Nivolumab|nivolumab|mesh-list
83346320|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346321|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346322|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83346323|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346324|NCT05447520|Montelukast|montelukast|mesh-list
83346325|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83346326|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
83346327|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83346328|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
83346329|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346330|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346331|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83346332|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83346333|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346334|NCT05438550|Amoxicillin|amoxicillin|mesh-list
83346335|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83346336|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346337|NCT05639946|Brivaracetam|brivaracetam|mesh-list
83346338|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
83346339|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
83346340|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
83346341|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83346342|NCT03299712|Protective Agents|protective agents|mesh-ancestor
83346343|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346344|NCT05327556|Epinephrine|epinephrine|mesh-list
83346345|NCT05327556|Racepinephrine|racepinephrine|mesh-list
83346346|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
83346347|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83346348|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83346349|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
83346350|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346351|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346352|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346353|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83346354|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83346355|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
83346356|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346357|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83346358|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
83346359|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
83346360|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
83346361|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83346362|NCT02466438|Tazobactam|tazobactam|mesh-list
83346363|NCT02466438|Piperacillin|piperacillin|mesh-list
83346364|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83346365|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83346366|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346367|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83346368|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346369|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346370|NCT05587062|Aflibercept|aflibercept|mesh-list
83346371|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83346372|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83346373|NCT05587062|Growth Substances|growth substances|mesh-ancestor
83346374|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346375|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
83346376|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346377|NCT02463006|Methamphetamine|methamphetamine|mesh-list
83346378|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83346379|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346380|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
83346381|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
83346382|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346383|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
83346384|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346385|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346386|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
83346387|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83346388|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83346389|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346390|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83346391|NCT04779216|Alendronate|alendronate|mesh-list
83346392|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83346393|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346394|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83346395|NCT05216328|Antacids|antacids|mesh-ancestor
83346396|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346397|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83346398|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83346399|NCT02466204|Hormones|hormones|mesh-ancestor
83346400|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346401|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346402|NCT02715804|Paclitaxel|paclitaxel|mesh-list
83346403|NCT02715804|Gemcitabine|gemcitabine|mesh-list
83346404|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83346405|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346406|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346407|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346408|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346409|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346410|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83346411|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
83346412|NCT04745130|Cetuximab|cetuximab|mesh-list
83346413|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346414|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346415|NCT02462304|Bevacizumab|bevacizumab|mesh-list
83346416|NCT02462304|Ranibizumab|ranibizumab|mesh-list
83346417|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346418|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346419|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83346420|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83346421|NCT02462304|Growth Substances|growth substances|mesh-ancestor
83346422|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346423|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
83346424|NCT03501576|Vaccines|vaccines|mesh-list
83346425|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
83346426|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346427|NCT05124210|Sotrovimab|sotrovimab|mesh-list
83346428|NCT05124210|Antiviral Agents|antiviral agents|mesh-ancestor
83346429|NCT05124210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346430|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
83346431|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83346432|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
83346433|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83346434|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346435|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83346436|NCT04645212|Aflibercept|aflibercept|mesh-list
83346437|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83346438|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83346439|NCT04645212|Growth Substances|growth substances|mesh-ancestor
83346440|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346441|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
83346442|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346443|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
83346444|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
83346445|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83346446|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83346447|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346448|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346449|NCT04489446|Urological Agents|urological agents|mesh-ancestor
83346450|NCT02717754|Oseltamivir|oseltamivir|mesh-list
83346451|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
83346452|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346453|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346454|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346455|NCT04497168|Citalopram|citalopram|mesh-list
83346456|NCT04497168|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83346457|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83346458|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346459|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346460|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346461|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
83346462|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346463|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83346464|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
83346465|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83346466|NCT04608474|Evolocumab|evolocumab|mesh-list
83346467|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83346468|NCT04608474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83346469|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83346470|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83346471|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
83346472|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346473|NCT04608474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83346474|NCT04608474|Protease Inhibitors|protease inhibitors|mesh-ancestor
83346475|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346476|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83346477|NCT02717130|Aripiprazole|aripiprazole|mesh-list
83346478|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
83346479|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83346480|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83346481|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83346482|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346483|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346484|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
83346485|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
83346486|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346487|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346488|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83346489|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83346490|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
83346491|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83346492|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83346493|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83346494|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83346495|NCT02256696|Rifampin|rifampin|mesh-list
83346496|NCT02256696|Rifabutin|rifabutin|mesh-list
83346497|NCT02256696|Isoniazid|isoniazid|mesh-list
83346498|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
83346499|NCT02256696|Ethambutol|ethambutol|mesh-list
83346500|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83346501|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
83346502|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83346503|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346504|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
83346505|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83346506|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346507|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346508|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83346509|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83346510|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83346511|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83346512|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83346513|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83346514|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83346515|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83346516|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
83346517|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83346518|NCT01773473|Insulin|insulin|mesh-list
83346519|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83346520|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
83346521|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83346522|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346523|NCT01779869|Regadenoson|regadenoson|mesh-list
83346524|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83346525|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83346526|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
83346527|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
83346528|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346529|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346530|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346531|NCT01772537|Propofol|propofol|mesh-list
83346532|NCT01772537|Isoflurane|isoflurane|mesh-list
83346533|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83346534|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346535|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346536|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83346537|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
83346538|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
83346539|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83346540|NCT01772147|Fluticasone|fluticasone|mesh-list
83346541|NCT01772147|Xhance|xhance|mesh-list
83346542|NCT01772147|Bromides|bromides|mesh-list
83346543|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83346544|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346545|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83346546|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
83346547|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346548|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346549|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83346550|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
83346551|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
83346552|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83346553|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83346554|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83346555|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83346556|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
83346557|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346558|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346559|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
83346560|NCT01606787|Mannitol|mannitol|mesh-list
83346561|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83346562|NCT01606787|Diuretics|diuretics|mesh-ancestor
83346563|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
83346564|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346565|NCT01777997|Tenofovir|tenofovir|mesh-list
83346566|NCT01777997|Emtricitabine|emtricitabine|mesh-list
83346567|NCT01777997|Rilpivirine|rilpivirine|mesh-list
83346568|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
83346569|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346570|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83346571|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83346572|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346573|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346574|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83346575|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83346576|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83346577|NCT01770353|Hematinics|hematinics|mesh-ancestor
83346578|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83346579|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83346580|NCT01777763|Posaconazole|posaconazole|mesh-list
83346581|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
83346582|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346583|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83346584|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83346585|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83346586|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83346587|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83346588|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346589|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346590|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83346591|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
83346592|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346593|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346594|NCT01769339|Miconazole|miconazole|mesh-list
83346595|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
83346596|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346597|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
83346598|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346599|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83346600|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83346601|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346602|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346603|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83346604|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
83346605|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346606|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346607|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83346608|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83346609|NCT01777139|Ezogabine|ezogabine|mesh-list
83346610|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
83346611|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346612|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346613|NCT01768637|Aspirin|aspirin|mesh-list
83346614|NCT01768637|Clopidogrel|clopidogrel|mesh-list
83346615|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83346616|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83346617|NCT01768637|Analgesics|analgesics|mesh-ancestor
83346618|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
83346619|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346620|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346621|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346622|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346623|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83346624|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83346625|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346626|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83346627|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83346628|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346629|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
83346630|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83346631|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83346632|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83346633|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
83346634|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346635|NCT01768559|Insulin|insulin|mesh-list
83346636|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83346637|NCT01768559|Metformin|metformin|mesh-list
83346638|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
83346639|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
83346640|NCT01768559|Lixisenatide|lixisenatide|mesh-list
83346641|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83346642|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346643|NCT00983619|Rituximab|rituximab|mesh-list
83346644|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346645|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346646|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
83346647|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346648|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346649|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
83346650|NCT00653068|Leucovorin|leucovorin|mesh-list
83346651|NCT00653068|Folic Acid|folic acid|mesh-list
83346652|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
83346653|NCT00653068|Thiotepa|thiotepa|mesh-list
83346654|NCT00653068|Cisplatin|cisplatin|mesh-list
83346655|NCT00653068|Carboplatin|carboplatin|mesh-list
83346656|NCT00653068|Methotrexate|methotrexate|mesh-list
83346657|NCT00653068|Etoposide|etoposide|mesh-list
83346658|NCT00653068|Vincristine|vincristine|mesh-list
83346659|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
83346660|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
83346661|NCT00653068|Lenograstim|lenograstim|mesh-list
83346662|NCT00653068|Calcium|calcium|mesh-list
83346663|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
83346664|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83346665|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
83346666|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346667|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346668|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346669|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
83346670|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346671|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346672|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83346673|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346674|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83346675|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83346676|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
83346677|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83346678|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83346679|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
83346680|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
83346681|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346682|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83346683|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83346684|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83346685|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83346686|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83346687|NCT00653068|Antidotes|antidotes|mesh-ancestor
83346688|NCT00653068|Protective Agents|protective agents|mesh-ancestor
83346689|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
83346690|NCT00653068|Vitamins|vitamins|mesh-ancestor
83346691|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
83346692|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83346693|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346694|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346695|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346696|NCT00653068|Hematinics|hematinics|mesh-ancestor
83346697|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
83346698|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
83346699|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83346700|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346701|NCT05608785|Capecitabine|capecitabine|mesh-list
83346702|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
83346703|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83346704|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
83346705|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346706|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346707|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
83346708|NCT03037437|Sorafenib|sorafenib|mesh-list
83346709|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346710|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83346711|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346712|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346713|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
83346714|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83346715|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83346716|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346717|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346718|NCT01775501|Leucovorin|leucovorin|mesh-list
83346719|NCT01775501|Fluorouracil|fluorouracil|mesh-list
83346720|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
83346721|NCT01775501|Sorafenib|sorafenib|mesh-list
83346722|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
83346723|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346724|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83346725|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346726|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83346727|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
83346728|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346729|NCT01775501|Antidotes|antidotes|mesh-ancestor
83346730|NCT01775501|Protective Agents|protective agents|mesh-ancestor
83346731|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
83346733|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
83346734|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83346735|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346736|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
83346737|NCT04346667|Chloroquine|chloroquine|mesh-list
83346738|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
83346739|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83346740|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83346741|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346742|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346743|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346744|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346745|NCT04346667|Amebicides|amebicides|mesh-ancestor
83346746|NCT03024489|Cetuximab|cetuximab|mesh-list
83346747|NCT03024489|Palbociclib|palbociclib|mesh-list
83346748|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346749|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346750|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83346751|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346752|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346753|NCT01775189|Naltrexone|naltrexone|mesh-list
83346754|NCT01775189|Oxycodone|oxycodone|mesh-list
83346755|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83346756|NCT01775189|Narcotics|narcotics|mesh-ancestor
83346757|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83346758|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346759|NCT01775189|Analgesics|analgesics|mesh-ancestor
83346760|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
83346761|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346762|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83346763|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83346764|NCT04551963|Clarithromycin|clarithromycin|mesh-list
83346765|NCT04551963|Fluconazole|fluconazole|mesh-list
83346766|NCT04551963|Voriconazole|voriconazole|mesh-list
83346767|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
83346768|NCT04551963|Diltiazem|diltiazem|mesh-list
83346769|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83346770|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83346771|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83346772|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346773|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346774|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83346775|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83346776|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
83346777|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83346778|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83346779|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
83346780|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346781|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346782|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83346783|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83346784|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346785|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83346786|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83346787|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83346788|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346789|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346790|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
83346791|NCT01881412|Fluticasone|fluticasone|mesh-list
83346792|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346793|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83346794|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
83346795|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346796|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346797|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83346798|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
83346799|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
83346800|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83346801|NCT03832816|Dronabinol|dronabinol|mesh-list
83346803|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346804|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83346805|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83346806|NCT03832816|Analgesics|analgesics|mesh-ancestor
83346807|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
83346808|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346809|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83346810|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83346811|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346812|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346813|NCT03832816|Hormones|hormones|mesh-ancestor
83346814|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346815|NCT04231084|Epoprostenol|epoprostenol|mesh-list
83346816|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
83346817|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
83346818|NCT04231084|Tezosentan|tezosentan|mesh-list
83346819|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83346820|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
83346821|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346822|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346823|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83346824|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
83346825|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83346826|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
83346827|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346828|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346829|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83346830|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
83346831|NCT04231084|Protective Agents|protective agents|mesh-ancestor
83346832|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83346833|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83346834|NCT01770743|Vaccines|vaccines|mesh-list
83346835|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
83346836|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346837|NCT01884844|Vitamin D|vitamin d|mesh-list
83346838|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
83346839|NCT01884844|Vitamins|vitamins|mesh-ancestor
83346840|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
83346841|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346842|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83346843|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346844|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83346845|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346846|NCT04127721|Methotrexate|methotrexate|mesh-list
83346847|NCT04127721|Fludarabine|fludarabine|mesh-list
83346848|NCT04127721|Busulfan|busulfan|mesh-list
83346849|NCT04127721|Tacrolimus|tacrolimus|mesh-list
83346850|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83346851|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
83346852|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83346853|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346854|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83346855|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
83413655|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83346856|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346857|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346858|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
83346859|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346860|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83346861|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83346862|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
83346863|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346864|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83346865|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83346866|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
83346867|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346868|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83346869|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
83346870|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83346871|NCT04123743|Protective Agents|protective agents|mesh-ancestor
83346872|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346873|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
83346874|NCT02996721|Vitamin D|vitamin d|mesh-list
83346875|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
83346877|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
83346878|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346879|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83346880|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346882|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346883|NCT03926338|Celecoxib|celecoxib|mesh-list
83346884|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
83346885|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83346886|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83346887|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83346888|NCT03926338|Analgesics|analgesics|mesh-ancestor
83346889|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
83346890|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346891|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346892|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346893|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346894|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83346895|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346896|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346897|NCT03926338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346898|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346899|NCT04126941|Calcium|calcium|mesh-list
83346900|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346901|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346902|NCT02506192|Prednisone|prednisone|mesh-list
83346903|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83346904|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
83346905|NCT02506192|Hormones|hormones|mesh-ancestor
83346906|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83346907|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346908|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83346909|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346910|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
83346911|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
83346912|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83346913|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83346914|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346915|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346916|NCT04122105|Urological Agents|urological agents|mesh-ancestor
83346917|NCT04127019|Paclitaxel|paclitaxel|mesh-list
83346918|NCT04127019|Docetaxel|docetaxel|mesh-list
83346919|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
83346920|NCT04127019|Fluorouracil|fluorouracil|mesh-list
83346921|NCT04127019|Epirubicin|epirubicin|mesh-list
83346922|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83346923|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346924|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
83346925|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
83346926|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
83346927|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346928|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83346929|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
83346930|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346931|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83346932|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83346933|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
83346934|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83346935|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
83346936|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83346937|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83346938|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83346939|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83346940|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83346941|NCT02076646|Interleukin-2|interleukin-2|mesh-list
83346942|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346943|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83346944|NCT02076646|Analgesics|analgesics|mesh-ancestor
83346945|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
83346946|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346947|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346948|NCT04121091|Pramipexole|pramipexole|mesh-list
83346949|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
83346950|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346951|NCT04121091|Protective Agents|protective agents|mesh-ancestor
83346952|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346953|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83346954|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83346955|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
83346956|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
83346957|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346958|NCT03283605|Durvalumab|durvalumab|mesh-list
83346959|NCT03283605|Tremelimumab|tremelimumab|mesh-list
83346960|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83346961|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83346962|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
83346963|NCT01896544|Vitamin D|vitamin d|mesh-list
83346964|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83346965|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346966|NCT01896544|Vitamins|vitamins|mesh-ancestor
83346967|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
83346968|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83346969|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
83346970|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
83346971|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83346972|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346973|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83346974|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346975|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83346976|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83346977|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346978|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346979|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83346980|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83346981|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346982|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
83346983|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346984|NCT01932112|Adenosine|adenosine|mesh-list
83346985|NCT01932112|Analgesics|analgesics|mesh-ancestor
83346986|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
83346987|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83346988|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83346989|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83346990|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
83346991|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83346992|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
83346993|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
83346994|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83346995|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83346996|NCT04120311|Dexamethasone|dexamethasone|mesh-list
83346997|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
83346998|NCT04120311|BB 1101|bb 1101|mesh-list
83346999|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347000|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
83347001|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
83347002|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347003|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347004|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347005|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
83347006|NCT04120311|Hormones|hormones|mesh-ancestor
83347007|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347008|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83347009|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347010|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
83347011|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347012|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347013|NCT01897402|Vaccines|vaccines|mesh-list
83347014|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
83347015|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347016|NCT01897792|Vitamins|vitamins|mesh-list
83347017|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
83347018|NCT01897792|Vitamin E|vitamin e|mesh-list
83347019|NCT01897792|Tocopherols|tocopherols|mesh-list
83347020|NCT01897792|Tocotrienols|tocotrienols|mesh-list
83347021|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
83347022|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
83347023|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347024|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
83347025|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347026|NCT01897792|Protective Agents|protective agents|mesh-ancestor
83347027|NCT01933984|Fluticasone|fluticasone|mesh-list
83347047|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83347048|NCT04126083|Lofexidine|lofexidine|mesh-list
83347049|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83347050|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83347051|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347052|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
83347053|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347054|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83347055|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83347056|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83347057|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347058|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347059|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347060|NCT01935622|Doxycycline|doxycycline|mesh-list
83347061|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83347062|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347063|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
83347064|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83347065|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83347066|NCT03010917|Ethanol|ethanol|mesh-list
83347067|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83347068|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347069|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347070|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347071|NCT02979561|Warfarin|warfarin|mesh-list
83347072|NCT02979561|Dabigatran|dabigatran|mesh-list
83347073|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
83347074|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
83347075|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83347076|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
83347077|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347078|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347079|NCT01937026|Probenecid|probenecid|mesh-list
83347080|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
83347081|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
83347082|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347083|NCT01937260|Brodalumab|brodalumab|mesh-list
83347084|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
83347118|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347119|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
83347120|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347121|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83347122|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83347123|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
83347124|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83347125|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83347126|NCT01938040|Ibuprofen|ibuprofen|mesh-list
83347127|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83347128|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347129|NCT01938040|Analgesics|analgesics|mesh-ancestor
83347130|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
83347131|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347132|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347133|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347134|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347135|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83347136|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347137|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347138|NCT03829839|Lorazepam|lorazepam|mesh-list
83347139|NCT03829839|Oxytocin|oxytocin|mesh-list
83347140|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
83347141|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83347142|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347143|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
83347144|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
83347145|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
83347146|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347147|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347148|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83347149|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347150|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83347151|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83347152|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83347153|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
83347155|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347156|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347157|NCT01938664|Candesartan|candesartan|mesh-list
83347158|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83347159|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83347160|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83347161|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347162|NCT03829917|Paromomycin|paromomycin|mesh-list
83347163|NCT03829917|Miltefosine|miltefosine|mesh-list
83347164|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83347165|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347166|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83347167|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83347168|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
83347169|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347170|NCT02284126|Vancomycin|vancomycin|mesh-list
83347171|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83347172|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347173|NCT03004833|Nivolumab|nivolumab|mesh-list
83347174|NCT03004833|Doxorubicin|doxorubicin|mesh-list
83347175|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83347176|NCT03004833|Dacarbazine|dacarbazine|mesh-list
83347177|NCT03004833|Vinblastine|vinblastine|mesh-list
83347178|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347179|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347180|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83347181|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347182|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83347183|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83347184|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83347185|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347186|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83347187|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
83347188|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83347189|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
83347190|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
83347191|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
83347192|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
83347193|NCT01736579|Antibodies|antibodies|mesh-list
83347194|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
83347195|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83347196|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83347197|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
83347198|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347199|NCT03004287|Thalidomide|thalidomide|mesh-list
83347200|NCT03004287|Dexamethasone|dexamethasone|mesh-list
83347201|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
83347202|NCT03004287|Melphalan|melphalan|mesh-list
83347203|NCT03004287|Doxorubicin|doxorubicin|mesh-list
83347204|NCT03004287|Etoposide|etoposide|mesh-list
83347205|NCT03004287|Lenalidomide|lenalidomide|mesh-list
83347206|NCT03004287|Bortezomib|bortezomib|mesh-list
83347207|NCT03004287|Daratumumab|daratumumab|mesh-list
83347208|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83347209|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
83347210|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347211|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347212|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83347213|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
83347214|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347215|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347216|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83347217|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347218|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
83347219|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
83347220|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347221|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347222|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
83347223|NCT03004287|Hormones|hormones|mesh-ancestor
83347224|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347225|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83347226|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83347227|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83347228|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83347229|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347230|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83347231|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83347232|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83347233|NCT03004287|Growth Substances|growth substances|mesh-ancestor
83347234|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
83347235|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
83347236|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83347237|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347238|NCT04124913|Progesterone|progesterone|mesh-list
83347239|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
83347240|NCT04124913|Progestins|progestins|mesh-ancestor
83347241|NCT04124913|Hormones|hormones|mesh-ancestor
83347242|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347243|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347244|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
83347245|NCT02962401|Idelalisib|idelalisib|mesh-list
83347246|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347247|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347248|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347249|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347250|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83347251|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83347252|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83347253|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
83347254|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347255|NCT02987920|Acetaminophen|acetaminophen|mesh-list
83347256|NCT02987920|Celecoxib|celecoxib|mesh-list
83347257|NCT02987920|Ketorolac|ketorolac|mesh-list
83347258|NCT02987920|Oxycodone|oxycodone|mesh-list
83347259|NCT02987920|Gabapentin|gabapentin|mesh-list
83347260|NCT02987920|Hydromorphone|hydromorphone|mesh-list
83347261|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
83347262|NCT02987920|Pantoprazole|pantoprazole|mesh-list
83347263|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347264|NCT02987920|Analgesics|analgesics|mesh-ancestor
83347265|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
83347266|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347267|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347268|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
83347269|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83347270|NCT02987920|Narcotics|narcotics|mesh-ancestor
83347271|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347272|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83347273|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347274|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347275|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83347276|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83347277|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347278|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347279|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
83347280|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83347281|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83347282|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83347283|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83347284|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83347285|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347286|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
83347287|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83347288|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347289|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83347290|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
83347291|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
83347292|NCT02974257|Thiamine|thiamine|mesh-list
83347293|NCT02974257|Vitamins|vitamins|mesh-ancestor
83347294|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
83347295|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347296|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
83347297|NCT01736189|Adalimumab|adalimumab|mesh-list
83347298|NCT01736189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83347299|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347300|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347301|NCT02970981|Nivolumab|nivolumab|mesh-list
83347302|NCT02970981|Ipilimumab|ipilimumab|mesh-list
83347303|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347304|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347305|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83347306|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347307|NCT03374800|Pantoprazole|pantoprazole|mesh-list
83347308|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83347309|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347310|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83347311|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347312|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347313|NCT02983773|Dronabinol|dronabinol|mesh-list
83347314|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
83347315|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347316|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83347317|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347318|NCT02983773|Analgesics|analgesics|mesh-ancestor
83347319|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
83347320|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347321|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83347322|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83347323|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347324|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347325|NCT02983773|Hormones|hormones|mesh-ancestor
83347326|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347327|NCT01941628|Rocuronium|rocuronium|mesh-list
83347328|NCT01941628|Succinylcholine|succinylcholine|mesh-list
83347329|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83347330|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83347331|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83347332|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347333|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347334|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83347336|NCT02987218|Desflurane|desflurane|mesh-list
83347337|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83347338|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347339|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347340|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83347341|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
83347342|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
83347343|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83347344|NCT01762943|Leuprolide|leuprolide|mesh-list
83347345|NCT01762943|Estradiol|estradiol|mesh-list
83347346|NCT01762943|Progesterone|progesterone|mesh-list
83347347|NCT01762943|Estrogens|estrogens|mesh-ancestor
83347348|NCT01762943|Hormones|hormones|mesh-ancestor
83347349|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347350|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347351|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83347352|NCT01762943|Progestins|progestins|mesh-ancestor
83347353|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83347354|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
83347355|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83347356|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347357|NCT04392063|Melatonin|melatonin|mesh-list
83347358|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
83347359|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347360|NCT04392063|Protective Agents|protective agents|mesh-ancestor
83347361|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347362|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347363|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
83347364|NCT01903798|Prednisolone|prednisolone|mesh-list
83347365|NCT01903798|Rilonacept|rilonacept|mesh-list
83347366|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83347367|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347368|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83347369|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
83347370|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83347371|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347372|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347373|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347374|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347375|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
83347376|NCT01903798|Hormones|hormones|mesh-ancestor
83347377|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347378|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347379|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83347380|NCT01945138|Insulin|insulin|mesh-list
83347381|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83347382|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83347383|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347384|NCT01734785|Empagliflozin|empagliflozin|mesh-list
83347385|NCT01734785|Linagliptin|linagliptin|mesh-list
83347386|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83347387|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347388|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83347389|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347390|NCT01734785|Incretins|incretins|mesh-ancestor
83347391|NCT01734785|Hormones|hormones|mesh-ancestor
83347392|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347393|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83347394|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
83347395|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347396|NCT03821415|Estradiol|estradiol|mesh-list
83347397|NCT03821415|Estrogens|estrogens|mesh-ancestor
83347398|NCT03821415|Hormones|hormones|mesh-ancestor
83347399|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347400|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347401|NCT01734395|Galantamine|galantamine|mesh-list
83347402|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83347403|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347404|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347405|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
83347406|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347407|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347408|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83347410|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347411|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
83347412|NCT01945294|Interferons|interferons|mesh-list
83347413|NCT01945294|Ribavirin|ribavirin|mesh-list
83347414|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
83347415|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
83347416|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83347417|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347418|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
83347419|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347420|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
83347421|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347422|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
83347423|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347424|NCT04392297|Antibodies|antibodies|mesh-list
83347425|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
83347426|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
83347427|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347428|NCT01947946|Benralizumab|benralizumab|mesh-list
83347429|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83347430|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
83347431|NCT02954055|Paclitaxel|paclitaxel|mesh-list
83347432|NCT02954055|Vinorelbine|vinorelbine|mesh-list
83347433|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83347434|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
83347435|NCT02954055|Capecitabine|capecitabine|mesh-list
83347436|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83347437|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347438|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
83347439|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
83347440|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
83347441|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347442|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83347443|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
83347444|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347445|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347446|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83347447|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
83347448|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83347449|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83347450|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
83347451|NCT03313180|Nintedanib|nintedanib|mesh-list
83347452|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347453|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83347454|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347455|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347456|NCT03275506|Bevacizumab|bevacizumab|mesh-list
83347457|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
83347458|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347459|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347460|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83347461|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83347462|NCT03275506|Growth Substances|growth substances|mesh-ancestor
83347463|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347464|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
83347465|NCT03275506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83347466|NCT03275506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347467|NCT03820245|Lycopene|lycopene|mesh-list
83347468|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347469|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
83347470|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347471|NCT03820245|Protective Agents|protective agents|mesh-ancestor
83347472|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347473|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83347474|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83347475|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347476|NCT01597505|Vancomycin|vancomycin|mesh-list
83347477|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83347478|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347479|NCT03826485|Pranlukast|pranlukast|mesh-list
83347480|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83347481|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
83347482|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83347483|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
83347484|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347485|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347487|NCT03823989|Mitomycin|mitomycin|mesh-list
83347488|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83347489|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347490|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
83347491|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347492|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83347493|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347494|NCT03826875|Fluoxetine|fluoxetine|mesh-list
83347495|NCT03826875|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83347496|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83347497|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83347498|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347499|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347500|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
83347501|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347502|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83347503|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
83347504|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83347505|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83347506|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83347507|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347508|NCT01951066|Dexamethasone|dexamethasone|mesh-list
83347509|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347510|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
83347511|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
83347512|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347513|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347514|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347515|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
83347516|NCT01951066|Hormones|hormones|mesh-ancestor
83347517|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347518|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83347519|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347521|NCT02916771|Lenalidomide|lenalidomide|mesh-list
83347522|NCT02916771|Ixazomib|ixazomib|mesh-list
83347523|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347524|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
83347525|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
83347526|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347527|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347528|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347529|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
83347530|NCT02916771|Hormones|hormones|mesh-ancestor
83347531|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347532|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83347533|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347534|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
83347535|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83347536|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83347537|NCT02916771|Growth Substances|growth substances|mesh-ancestor
83347538|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
83347539|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
83347540|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347541|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347542|NCT05735626|Capsaicin|capsaicin|mesh-list
83347543|NCT05735626|Piperine|piperine|mesh-list
83347544|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
83347545|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
83347546|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
83347547|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347548|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347549|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83347550|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347551|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347552|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83347553|NCT01951768|Gentamicins|gentamicins|mesh-list
83347554|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347555|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83347556|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347557|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347558|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83347559|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347560|NCT03825861|Folfirinox|folfirinox|mesh-list
83347561|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347562|NCT01760447|Metformin|metformin|mesh-list
83347563|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83347564|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83347565|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347566|NCT01760447|Incretins|incretins|mesh-ancestor
83347567|NCT01760447|Hormones|hormones|mesh-ancestor
83347568|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347569|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83347570|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
83347571|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347572|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347573|NCT01915108|Remifentanil|remifentanil|mesh-list
83347574|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83347575|NCT01915108|Narcotics|narcotics|mesh-ancestor
83347576|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347577|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347578|NCT01915108|Analgesics|analgesics|mesh-ancestor
83347579|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
83347580|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347581|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
83347582|NCT03825471|Anesthetics|anesthetics|mesh-list
83347583|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347584|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347585|NCT03825471|Narcotics|narcotics|mesh-ancestor
83347586|NCT03825471|Analgesics|analgesics|mesh-ancestor
83347587|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
83347588|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347589|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83347590|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83347591|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347592|NCT01450215|Lenalidomide|lenalidomide|mesh-list
83347593|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
83347594|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347595|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83347596|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83347597|NCT01450215|Growth Substances|growth substances|mesh-ancestor
83347598|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
83347599|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347600|NCT02915523|Avelumab|avelumab|mesh-list
83347601|NCT02915523|Entinostat|entinostat|mesh-list
83347602|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347603|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347604|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83347605|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347606|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347607|NCT01917214|Sunitinib|sunitinib|mesh-list
83347608|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347609|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83347610|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83347611|NCT01917214|Growth Substances|growth substances|mesh-ancestor
83347612|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347613|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
83347614|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83347615|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347616|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347617|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
83347618|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83347619|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
83347620|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347621|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347622|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83347623|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
83347624|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347625|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347626|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83347627|NCT01732913|Rituximab|rituximab|mesh-list
83347628|NCT01732913|Idelalisib|idelalisib|mesh-list
83347629|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347630|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347631|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
83347632|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347633|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347634|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347635|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347636|NCT03824925|Zinc|zinc|mesh-list
83347637|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
83347638|NCT03824925|Trace Elements|trace elements|mesh-ancestor
83347639|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
83347640|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347641|NCT03824925|Astringents|astringents|mesh-ancestor
83347642|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
83347643|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83347644|NCT03825081|Pilocarpine|pilocarpine|mesh-list
83347645|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83347646|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83347647|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83347648|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83347649|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347650|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347651|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347652|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347653|NCT03825081|Miotics|miotics|mesh-ancestor
83347654|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
83347655|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347656|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83347657|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83347658|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
83347659|NCT02912715|Paclitaxel|paclitaxel|mesh-list
83347660|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83347661|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347662|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
83347663|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
83347665|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347666|NCT01920802|Olanzapine|olanzapine|mesh-list
83347667|NCT01920802|Iloperidone|iloperidone|mesh-list
83347668|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
83347669|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
83347670|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347671|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347672|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347673|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83347674|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83347675|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347676|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83347677|NCT01920802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83347678|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83347679|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83347680|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347681|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347682|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
83347683|NCT01451229|Higenamine|higenamine|mesh-list
83347684|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83347685|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83347686|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347687|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347688|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347689|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347690|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83347691|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347692|NCT01451229|Analgesics|analgesics|mesh-ancestor
83347693|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
83347694|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347695|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347696|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347697|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83347698|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83347699|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83347700|NCT01451229|Protective Agents|protective agents|mesh-ancestor
83347701|NCT03054519|Metformin|metformin|mesh-list
83347702|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83347703|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347704|NCT01921894|Vitamin D|vitamin d|mesh-list
83347705|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
83347706|NCT01921894|Vitamins|vitamins|mesh-ancestor
83347707|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
83347708|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347709|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83347710|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83347711|NCT01452009|Travoprost|travoprost|mesh-list
83347712|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83347713|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83347714|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83347715|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83347716|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
83347717|NCT03824379|Cathartics|cathartics|mesh-ancestor
83347718|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347719|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347720|NCT01957930|Insulin|insulin|mesh-list
83347721|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83347722|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83347723|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347724|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83347725|NCT01732757|Dextrans|dextrans|mesh-list
83347726|NCT01732757|Alcaftadine|alcaftadine|mesh-list
83347727|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
83347728|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
83347729|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
83347730|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83347731|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347732|NCT01732757|Analgesics|analgesics|mesh-ancestor
83347733|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
83347734|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347735|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347736|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347737|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347738|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83347739|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83347740|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83347741|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
83347742|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
83347743|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347744|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347745|NCT01758731|Cetuximab|cetuximab|mesh-list
83347746|NCT01758731|Olaparib|olaparib|mesh-list
83347747|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347748|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347749|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83347750|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347751|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347752|NCT01452477|Tanshinone|tanshinone|mesh-list
83347753|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347754|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83347755|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347756|NCT01452477|Analgesics|analgesics|mesh-ancestor
83347757|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
83347758|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347759|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347760|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347761|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347762|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
83347763|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83347764|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347765|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83347766|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
83347767|NCT01452633|Bupivacaine|bupivacaine|mesh-list
83347768|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
83347769|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
83347770|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347771|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347772|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
83347773|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347774|NCT01606319|Acetaminophen|acetaminophen|mesh-list
83347775|NCT01606319|Ibuprofen|ibuprofen|mesh-list
83347776|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83347777|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83347778|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347779|NCT01606319|Analgesics|analgesics|mesh-ancestor
83347780|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
83347781|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347782|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347783|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
83347784|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83347785|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83347786|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347787|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347788|NCT01452711|Lansoprazole|lansoprazole|mesh-list
83347789|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
83347790|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83347791|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347792|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83347793|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347794|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347795|NCT02630121|Phenylephrine|phenylephrine|mesh-list
83347796|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
83347797|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83347798|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83347799|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347800|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347801|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347802|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347803|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
83347804|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
83347805|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347806|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
83347807|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83347808|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
83347810|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
83347811|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83347812|NCT02630121|Protective Agents|protective agents|mesh-ancestor
83347813|NCT02956785|Dinoprostone|dinoprostone|mesh-list
83347814|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
83347815|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83347816|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347817|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
83347818|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83347819|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347820|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
83347821|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
83347822|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
83347823|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347824|NCT02910531|Protective Agents|protective agents|mesh-ancestor
83347825|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347826|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
83347827|NCT02910531|Vitamins|vitamins|mesh-ancestor
83347828|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
83347829|NCT02947581|Albendazole|albendazole|mesh-list
83347830|NCT02947581|Praziquantel|praziquantel|mesh-list
83347831|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
83347832|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83347833|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347834|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
83347835|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83347836|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83347837|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
83347838|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
83347839|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
83347840|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347841|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347842|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83347843|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83347844|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83347845|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347846|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347847|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83347848|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83347849|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347850|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
83347851|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347852|NCT01453881|Beclomethasone|beclomethasone|mesh-list
83347853|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
83347854|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83347855|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
83347856|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347857|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347858|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83347859|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
83347860|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83347861|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83347862|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83347863|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347864|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347865|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347866|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83347867|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
83347869|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347870|NCT04391361|Atropine|atropine|mesh-list
83347871|NCT04391361|Scopolamine|scopolamine|mesh-list
83347872|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
83347873|NCT04391361|Edaravone|edaravone|mesh-list
83347874|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83347875|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83347876|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347877|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347878|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83347879|NCT04391361|Analgesics|analgesics|mesh-ancestor
83347880|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
83347881|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347882|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83347883|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83347884|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83347885|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347886|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347887|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347888|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83347889|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83347890|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83347891|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
83347892|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83347893|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
83347894|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
83347895|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
83347896|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83347897|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83347898|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
83347899|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
83347900|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347901|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83347902|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
83347903|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83347904|NCT04391361|Protective Agents|protective agents|mesh-ancestor
83347905|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
83347906|NCT03035331|Vaccines|vaccines|mesh-list
83347907|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
83347908|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347909|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347910|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347911|NCT03035331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83347912|NCT03035331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347913|NCT04273191|Brexanolone|brexanolone|mesh-list
83347914|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
83347915|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347916|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347917|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347918|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
83347919|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
83347920|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
83347921|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
83347922|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83347923|NCT01454115|BMS 708163|bms 708163|mesh-list
83347924|NCT01454115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
83347925|NCT01454115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83347926|NCT01454115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347927|NCT01455597|Estradiol|estradiol|mesh-list
83347928|NCT01455597|Estrogens|estrogens|mesh-ancestor
83347929|NCT01455597|Hormones|hormones|mesh-ancestor
83347930|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83347931|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347932|NCT01453101|Fludarabine|fludarabine|mesh-list
83347933|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
83347934|NCT01453101|Bortezomib|bortezomib|mesh-list
83347935|NCT01453101|Melphalan|melphalan|mesh-list
83347936|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347937|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83347938|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
83347939|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347940|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83347941|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
83347942|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347943|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83347944|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
83347945|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83347946|NCT02085447|Haloperidol|haloperidol|mesh-list
83347947|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83347948|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
83347949|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
83347950|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83347951|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347952|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347953|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83347954|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83347955|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83347957|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347958|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347959|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83347960|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83347961|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
83347962|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
83347963|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
83347964|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83347965|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83347966|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83347967|NCT04847193|Xanthohumol|xanthohumol|mesh-list
83347968|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347969|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83347970|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83347971|NCT04847193|Growth Substances|growth substances|mesh-ancestor
83347972|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347973|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
83347974|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
83347975|NCT04848519|Propranolol|propranolol|mesh-list
83347976|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83347977|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83347978|NCT04848519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83347979|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83347980|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83347981|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83347982|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
83347983|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83347984|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347985|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83347986|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83347987|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
83347988|NCT04273035|Midazolam|midazolam|mesh-list
83347989|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83347990|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83347991|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83347992|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83347993|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83347994|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83347995|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83347996|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83347997|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
83347998|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
83347999|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
83348000|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
83348001|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348002|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348003|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
83348004|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83348005|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
83348006|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348007|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348008|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83348009|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
83348010|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83348011|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
83348012|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348013|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348014|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83348015|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
83348016|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
83348017|NCT02836899|Protective Agents|protective agents|mesh-ancestor
83348018|NCT02902029|Atezolizumab|atezolizumab|mesh-list
83348019|NCT02902029|Vemurafenib|vemurafenib|mesh-list
83348020|NCT02902029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348021|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348022|NCT02902029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348023|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348024|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83348025|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348026|NCT02933697|Apixaban|apixaban|mesh-list
83348027|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
83348028|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83348029|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
83348030|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83348031|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
83348032|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348033|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348034|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
83348035|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
83348036|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83348037|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
83348038|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348039|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348040|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83348041|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
83348042|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
83348043|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83348044|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
83348045|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348046|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348047|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
83348048|NCT02784171|Pemetrexed|pemetrexed|mesh-list
83348049|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348050|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348051|NCT02784171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348052|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348053|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348054|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83348055|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83348056|NCT01455441|Liraglutide|liraglutide|mesh-list
83348057|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83348058|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348059|NCT01455441|Incretins|incretins|mesh-ancestor
83348060|NCT01455441|Hormones|hormones|mesh-ancestor
83348061|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348062|NCT01455831|Tinzaparin|tinzaparin|mesh-list
83348063|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83348064|NCT01455831|Dalteparin|dalteparin|mesh-list
83348065|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
83348066|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83348067|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83348068|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348069|NCT04840641|Efavirenz|efavirenz|mesh-list
83348070|NCT04840641|Floxacillin|floxacillin|mesh-list
83348071|NCT04840641|Losartan|losartan|mesh-list
83348072|NCT04840641|Metoprolol|metoprolol|mesh-list
83348073|NCT04840641|Midazolam|midazolam|mesh-list
83348074|NCT04840641|Caffeine|caffeine|mesh-list
83348075|NCT04840641|Omeprazole|omeprazole|mesh-list
83348076|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83348077|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83348078|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348079|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348080|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83348081|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83348082|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83348083|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83348084|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
83348085|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
83348086|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
83348087|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
83348088|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348089|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348090|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83348091|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83348092|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83348093|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83348094|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83348095|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83348096|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348097|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83348098|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83348100|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83348101|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83348102|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83348103|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83348104|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83348105|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
83348106|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348107|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83348108|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83348109|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83348110|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83348111|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83348112|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83348113|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
83348114|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
83348115|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348116|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83348117|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83348118|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83348119|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
83348120|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83348121|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83348123|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83348124|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348125|NCT01455909|Incretins|incretins|mesh-ancestor
83348126|NCT01455909|Hormones|hormones|mesh-ancestor
83348127|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348128|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83348129|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
83348130|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348131|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348132|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83348133|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83348134|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83348135|NCT02555787|Tacrolimus|tacrolimus|mesh-list
83348136|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348137|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
83348138|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348139|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83348140|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348141|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348142|NCT01730729|Cabergoline|cabergoline|mesh-list
83348143|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83348144|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83348145|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
83348146|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
83348147|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348148|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348149|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348150|NCT01756157|Complement C1s|complement c1s|mesh-list
83348151|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
83348152|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
83348153|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
83348154|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348155|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83348156|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348157|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83348158|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
83348159|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
83348160|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348161|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
83348162|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348163|NCT01756079|Ribavirin|ribavirin|mesh-list
83348164|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83348165|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
83348166|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348167|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
83348168|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348169|NCT04272645|Atezolizumab|atezolizumab|mesh-list
83348170|NCT04272645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348171|NCT04272645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348172|NCT04272645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348173|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348174|NCT04390815|Insulin|insulin|mesh-list
83348175|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83348176|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83348177|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348178|NCT01456611|Diclofenac|diclofenac|mesh-list
83348179|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83348180|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83348181|NCT01456611|Analgesics|analgesics|mesh-ancestor
83348182|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
83348183|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348184|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348185|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83348186|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83348187|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83348188|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348189|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348190|NCT01456689|Midazolam|midazolam|mesh-list
83348191|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83348192|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83348193|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348194|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348195|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83348196|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83348197|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83348198|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83348199|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
83348200|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
83348201|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
83348202|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
83348203|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348204|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348205|NCT05827211|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83348206|NCT05827211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83348207|NCT05827211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348208|NCT05827211|Antitubercular Agents|antitubercular agents|mesh-ancestor
83348209|NCT05827159|Naltrexone|naltrexone|mesh-list
83348210|NCT05827159|Gabapentin|gabapentin|mesh-list
83348211|NCT05827159|Analgesics|analgesics|mesh-ancestor
83348212|NCT05827159|Sensory System Agents|sensory system agents|mesh-ancestor
83348213|NCT05827159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348214|NCT05827159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348215|NCT05827159|Anticonvulsants|anticonvulsants|mesh-ancestor
83348216|NCT05827159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83348217|NCT05827159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83348218|NCT05827159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348219|NCT05827159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83348220|NCT05827159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83348221|NCT05827159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83348222|NCT05827159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348223|NCT05827159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348224|NCT05827159|Antimanic Agents|antimanic agents|mesh-ancestor
83348225|NCT05827159|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83348226|NCT05827159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83348227|NCT05827081|Letrozole|letrozole|mesh-list
83348228|NCT05827081|Leuprolide|leuprolide|mesh-list
83348229|NCT05827081|Goserelin|goserelin|mesh-list
83348230|NCT05827081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348231|NCT05827081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83348232|NCT05827081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83348233|NCT05827081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348234|NCT05827081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348235|NCT05827081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83348236|NCT05827081|Hormone Antagonists|hormone antagonists|mesh-ancestor
83348237|NCT05827081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348238|NCT05827081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348239|NCT05827081|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83348240|NCT05827081|Fertility Agents|fertility agents|mesh-ancestor
83348241|NCT05827081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83348242|NCT05827081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83348243|NCT05827042|Tenecteplase|tenecteplase|mesh-list
83348244|NCT05827042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83348245|NCT05827042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83348246|NCT05827042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348248|NCT05826990|Enmetazobactam|enmetazobactam|mesh-list
83348249|NCT05826990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83348250|NCT05826990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348251|NCT05826990|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83348252|NCT05826990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348253|NCT05826990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348254|NCT05826821|Pirfenidone|pirfenidone|mesh-list
83348255|NCT05826821|Analgesics|analgesics|mesh-ancestor
83348256|NCT05826821|Sensory System Agents|sensory system agents|mesh-ancestor
83348257|NCT05826821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348258|NCT05826821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348259|NCT05826821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83348260|NCT05826821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83348261|NCT05826821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83348262|NCT05826821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83348263|NCT05826821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348264|NCT05826444|Calcium|calcium|mesh-list
83348265|NCT05826444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83348266|NCT05826444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348267|NCT05826249|Ritonavir|ritonavir|mesh-list
83348268|NCT05826249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83348269|NCT05826249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83348270|NCT05826249|Protease Inhibitors|protease inhibitors|mesh-ancestor
83348271|NCT05826249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348272|NCT05826249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348273|NCT05826249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83348274|NCT05826249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83348275|NCT05826249|Antiviral Agents|antiviral agents|mesh-ancestor
83348276|NCT05826249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348277|NCT05826249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83348278|NCT05826249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83348279|NCT05826015|Paclitaxel|paclitaxel|mesh-list
83348280|NCT05826015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348281|NCT05826015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348282|NCT05826015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348283|NCT05826015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83348284|NCT05826015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83348285|NCT05826015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348286|NCT05825963|Psyllium|psyllium|mesh-list
83348287|NCT05825963|Cathartics|cathartics|mesh-ancestor
83348288|NCT05825963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83348289|NCT05825872|Lidocaine|lidocaine|mesh-list
83348290|NCT05825872|Bupivacaine|bupivacaine|mesh-list
83348291|NCT05825872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83348292|NCT05825872|Anesthetics, Local|anesthetics, local|mesh-ancestor
83348293|NCT05825872|Anesthetics|anesthetics|mesh-ancestor
83348294|NCT05825872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348295|NCT05825872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348296|NCT05825872|Sensory System Agents|sensory system agents|mesh-ancestor
83348297|NCT05825872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348298|NCT05825872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83348299|NCT05825872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83348300|NCT05825872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83348301|NCT05825872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83348302|NCT05825872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348303|NCT05825781|Pertuzumab|pertuzumab|mesh-list
83348304|NCT05825781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348305|NCT05825781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348306|NCT05825625|Atezolizumab|atezolizumab|mesh-list
83348307|NCT05825625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348308|NCT05825625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348309|NCT05825625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348310|NCT05825625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348311|NCT05825599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83348312|NCT05825599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83348313|NCT05825586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83348314|NCT05825586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83348315|NCT05825430|Bupivacaine|bupivacaine|mesh-list
83348316|NCT05825430|Anesthetics|anesthetics|mesh-list
83348317|NCT05825430|Anesthetics, General|anesthetics, general|mesh-list
83348318|NCT05825430|Anesthetics, Local|anesthetics, local|mesh-ancestor
83348319|NCT05825430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348320|NCT05825430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348321|NCT05825430|Sensory System Agents|sensory system agents|mesh-ancestor
83348322|NCT05825430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348323|NCT05825417|Selexipag|selexipag|mesh-list
83348324|NCT05825417|Riociguat|riociguat|mesh-list
83348325|NCT05825417|Enzyme Activators|enzyme activators|mesh-ancestor
83348326|NCT05825417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348327|NCT05825417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83348328|NCT05825391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83348329|NCT05825378|Dexamethasone|dexamethasone|mesh-list
83348330|NCT05825378|Ropivacaine|ropivacaine|mesh-list
83348331|NCT05825378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83348332|NCT05825378|Antiemetics|antiemetics|mesh-ancestor
83348333|NCT05825378|Autonomic Agents|autonomic agents|mesh-ancestor
83348334|NCT05825378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348335|NCT05825378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348336|NCT05825378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83348337|NCT05825378|Glucocorticoids|glucocorticoids|mesh-ancestor
83348338|NCT05825378|Hormones|hormones|mesh-ancestor
83348339|NCT05825378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348340|NCT05825378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83348341|NCT05825378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348342|NCT05825378|Anesthetics, Local|anesthetics, local|mesh-ancestor
83348343|NCT05825378|Anesthetics|anesthetics|mesh-ancestor
83348344|NCT05825378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348345|NCT05825378|Sensory System Agents|sensory system agents|mesh-ancestor
83348346|NCT05825235|Pramipexole|pramipexole|mesh-list
83348347|NCT05825235|Antioxidants|antioxidants|mesh-ancestor
83348348|NCT05825235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348349|NCT05825235|Protective Agents|protective agents|mesh-ancestor
83348350|NCT05825235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348351|NCT05825235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83348352|NCT05825235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83348353|NCT05825235|Dopamine Agonists|dopamine agonists|mesh-ancestor
83348354|NCT05825235|Dopamine Agents|dopamine agents|mesh-ancestor
83348355|NCT05825235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348356|NCT05825092|Methyltestosterone|methyltestosterone|mesh-list
83348357|NCT05825092|Testosterone|testosterone|mesh-list
83348358|NCT05825092|Testosterone undecanoate|testosterone undecanoate|mesh-list
83348359|NCT05825092|Testosterone enanthate|testosterone enanthate|mesh-list
83348360|NCT05825092|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83348361|NCT05825092|Androgens|androgens|mesh-ancestor
83348362|NCT05825092|Hormones|hormones|mesh-ancestor
83348363|NCT05825092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348364|NCT05825092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348365|NCT05825092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83348366|NCT05825092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348367|NCT05825092|Anabolic Agents|anabolic agents|mesh-ancestor
83348368|NCT05825066|Paclitaxel|paclitaxel|mesh-list
83348369|NCT05825066|Gemcitabine|gemcitabine|mesh-list
83348370|NCT05825066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348371|NCT05825066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348372|NCT05825066|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348373|NCT05825066|Antimitotic Agents|antimitotic agents|mesh-ancestor
83348374|NCT05825066|Mitosis Modulators|mitosis modulators|mesh-ancestor
83348375|NCT05825066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348376|NCT05825066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83348377|NCT05825066|Antimetabolites|antimetabolites|mesh-ancestor
83348378|NCT05824897|Vitamin D|vitamin d|mesh-list
83348379|NCT05824897|Vitamins|vitamins|mesh-ancestor
83348380|NCT05824897|Micronutrients|micronutrients|mesh-ancestor
83348381|NCT05824897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348382|NCT05824897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83348383|NCT05824871|Bedaquiline|bedaquiline|mesh-list
83348384|NCT05824871|Antitubercular Agents|antitubercular agents|mesh-ancestor
83348385|NCT05824871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83348386|NCT05824871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348387|NCT05824832|Dexamethasone|dexamethasone|mesh-list
83348388|NCT05824832|Dexamethasone acetate|dexamethasone acetate|mesh-list
83348389|NCT05824832|Clonidine|clonidine|mesh-list
83348390|NCT05824832|Buprenorphine|buprenorphine|mesh-list
83348392|NCT05824832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83348393|NCT05824832|Antiemetics|antiemetics|mesh-ancestor
83348394|NCT05824832|Autonomic Agents|autonomic agents|mesh-ancestor
83348395|NCT05824832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348396|NCT05824832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348397|NCT05824832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83348398|NCT05824832|Glucocorticoids|glucocorticoids|mesh-ancestor
83348399|NCT05824832|Hormones|hormones|mesh-ancestor
83348400|NCT05824832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348401|NCT05824832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83348402|NCT05824832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348403|NCT05824832|Protease Inhibitors|protease inhibitors|mesh-ancestor
83348404|NCT05824832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348405|NCT05824832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348406|NCT05824832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83348407|NCT05824832|Narcotics|narcotics|mesh-ancestor
83348408|NCT05824832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348409|NCT05824832|Analgesics|analgesics|mesh-ancestor
83348410|NCT05824832|Sensory System Agents|sensory system agents|mesh-ancestor
83348411|NCT05824832|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83348412|NCT05824832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83348413|NCT05824832|Sympatholytics|sympatholytics|mesh-ancestor
83348414|NCT05824832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83348415|NCT05824832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83348416|NCT05824832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83348417|NCT05824832|Adrenergic Agents|adrenergic agents|mesh-ancestor
83348418|NCT05824832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348419|NCT05824806|Hyaluronic Acid|hyaluronic acid|mesh-list
83348420|NCT05824806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83348421|NCT05824806|Immunologic Factors|immunologic factors|mesh-ancestor
83348422|NCT05824806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348423|NCT05824806|Viscosupplements|viscosupplements|mesh-ancestor
83348424|NCT05824806|Protective Agents|protective agents|mesh-ancestor
83348425|NCT05824767|Angiotensin II|angiotensin ii|mesh-list
83348426|NCT05824767|Giapreza|giapreza|mesh-list
83348427|NCT05824767|Angiotensinogen|angiotensinogen|mesh-list
83348428|NCT05824767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83348429|NCT05824767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83348430|NCT05824767|Protease Inhibitors|protease inhibitors|mesh-ancestor
83348431|NCT05824767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348432|NCT05824767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348433|NCT05824728|Levetiracetam|levetiracetam|mesh-list
83348434|NCT05824728|Anticonvulsants|anticonvulsants|mesh-ancestor
83348435|NCT05824728|Nootropic Agents|nootropic agents|mesh-ancestor
83348436|NCT05823844|Suvorexant|suvorexant|mesh-list
83348437|NCT05823844|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83348438|NCT05823844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83348439|NCT05823844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348440|NCT05823844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348441|NCT05823844|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
83348442|NCT05823844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348443|NCT05823844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348444|NCT05823662|Silodosin|silodosin|mesh-list
83348445|NCT05823662|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83348446|NCT05823662|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83348447|NCT05823662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83348448|NCT05823662|Adrenergic Agents|adrenergic agents|mesh-ancestor
83348449|NCT05823662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348450|NCT05823662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348451|NCT05823662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348452|NCT05823662|Urological Agents|urological agents|mesh-ancestor
83348453|NCT05823363|Bupivacaine|bupivacaine|mesh-list
83348454|NCT05823363|Anesthetics, Local|anesthetics, local|mesh-ancestor
83348455|NCT05823363|Anesthetics|anesthetics|mesh-ancestor
83348456|NCT05823363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348457|NCT05823363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348458|NCT05823363|Sensory System Agents|sensory system agents|mesh-ancestor
83348459|NCT05823363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348460|NCT05822076|Ropivacaine|ropivacaine|mesh-list
83348461|NCT05822076|Anesthetics, Local|anesthetics, local|mesh-ancestor
83348462|NCT05822076|Anesthetics|anesthetics|mesh-ancestor
83348463|NCT05822076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348464|NCT05822076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348465|NCT05822076|Sensory System Agents|sensory system agents|mesh-ancestor
83348466|NCT05822076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348467|NCT05821543|Metformin|metformin|mesh-list
83348468|NCT05821543|Sibutramine|sibutramine|mesh-list
83348469|NCT05821543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83348470|NCT05821543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348471|NCT05821543|Antidepressive Agents|antidepressive agents|mesh-ancestor
83348472|NCT05821543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83348473|NCT05821543|Appetite Depressants|appetite depressants|mesh-ancestor
83348474|NCT05821543|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83348475|NCT05811949|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83348476|NCT05811949|Dermatologic Agents|dermatologic agents|mesh-ancestor
83348477|NCT05811949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348478|NCT05811949|Immunologic Factors|immunologic factors|mesh-ancestor
83348479|NCT05811949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348480|NCT05810233|Ascorbic Acid|ascorbic acid|mesh-list
83348481|NCT05810233|Vitamins|vitamins|mesh-ancestor
83348482|NCT05810233|Micronutrients|micronutrients|mesh-ancestor
83348483|NCT05810233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348484|NCT05810233|Antioxidants|antioxidants|mesh-ancestor
83348485|NCT05810233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348486|NCT05810233|Protective Agents|protective agents|mesh-ancestor
83348487|NCT05801978|Vaccines|vaccines|mesh-list
83348488|NCT05801978|Immunologic Factors|immunologic factors|mesh-ancestor
83348489|NCT05801978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348490|NCT05800639|Anesthetics|anesthetics|mesh-list
83348491|NCT05800639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348492|NCT05800639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348493|NCT05791565|Norflurane|norflurane|mesh-list
83348494|NCT05791565|Albuterol|albuterol|mesh-list
83348495|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83348496|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
83348497|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348498|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348499|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83348500|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
83348501|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
83348502|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83348503|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83348504|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83348505|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83348506|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
83348507|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348508|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348509|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
83348510|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348511|NCT05781152|Adalimumab|adalimumab|mesh-list
83348512|NCT05781152|Infliximab|infliximab|mesh-list
83348513|NCT05781152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83348514|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83348515|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83348516|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
83348517|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83348518|NCT05776108|Cabotegravir|cabotegravir|mesh-list
83348519|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83348520|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83348521|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348522|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348523|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83348524|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83348525|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
83348526|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348527|NCT05753618|Lenograstim|lenograstim|mesh-list
83348528|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83348529|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
83348530|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348531|NCT05752461|Enoxaparin|enoxaparin|mesh-list
83348532|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
83348533|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
83348534|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83348535|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83348536|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348537|NCT05750992|Fentanyl|fentanyl|mesh-list
83348538|NCT05750992|Meperidine|meperidine|mesh-list
83348539|NCT05750992|Bupivacaine|bupivacaine|mesh-list
83348540|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
83348541|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
83348542|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348543|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348544|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
83348545|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348546|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83348547|NCT05750992|Narcotics|narcotics|mesh-ancestor
83348548|NCT05750992|Analgesics|analgesics|mesh-ancestor
83348549|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83348550|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83348551|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
83348552|NCT05733546|Psilocybin|psilocybin|mesh-list
83348553|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
83348554|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348555|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83348556|NCT05724550|Neostigmine|neostigmine|mesh-list
83348557|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83348558|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348559|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348560|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
83348561|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348562|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348563|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83348564|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
83348565|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348566|NCT05659329|Gentamicins|gentamicins|mesh-list
83348567|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83348568|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348569|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83348570|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348571|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348572|NCT05653258|Dasatinib|dasatinib|mesh-list
83348573|NCT05653258|Quercetin|quercetin|mesh-list
83348574|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348575|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83348576|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348577|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348578|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
83348579|NCT05653258|Protective Agents|protective agents|mesh-ancestor
83348580|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348581|NCT05632627|Cannabidiol|cannabidiol|mesh-list
83348582|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
83348583|NCT05586802|Anastrozole|anastrozole|mesh-list
83348584|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83348585|NCT05586802|Testosterone|testosterone|mesh-list
83348586|NCT05586802|Androgens|androgens|mesh-ancestor
83348587|NCT05586802|Hormones|hormones|mesh-ancestor
83348588|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348589|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348590|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83348591|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348592|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83348593|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83348594|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348595|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348596|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83348597|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
83348598|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83348599|NCT05504291|Carboplatin|carboplatin|mesh-list
83348600|NCT05504291|Etoposide|etoposide|mesh-list
83348601|NCT05504291|Vincristine|vincristine|mesh-list
83348602|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
83348603|NCT05504291|Melphalan|melphalan|mesh-list
83348604|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
83348605|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
83348606|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
83348607|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348608|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348609|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348610|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83348611|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83348612|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348613|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348614|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348615|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
83348616|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
83348617|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83348618|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
83348619|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83348620|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348621|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
83348622|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
83348623|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
83348624|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
83348625|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348626|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348627|NCT05496036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348628|NCT05496036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348630|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
83348631|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348632|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348633|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83348634|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348635|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
83348636|NCT05451849|Fludarabine|fludarabine|mesh-list
83348637|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348638|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
83348639|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348640|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83348641|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83348642|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
83348643|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348644|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348645|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83348646|NCT05413304|Temozolomide|temozolomide|mesh-list
83348647|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
83348648|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83348649|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
83348650|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348651|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348652|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83348653|NCT05375084|Nivolumab|nivolumab|mesh-list
83348654|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348655|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348656|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348657|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348658|NCT05359237|Vincristine|vincristine|mesh-list
83348659|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348660|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348661|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348662|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
83348663|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
83348664|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348665|NCT05346354|Ravulizumab|ravulizumab|mesh-list
83348666|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83348667|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348668|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
83348669|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348670|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
83348671|NCT05331664|Polymyxins|polymyxins|mesh-list
83348672|NCT05331664|Trimethoprim|trimethoprim|mesh-list
83348673|NCT05331664|Prednisolone|prednisolone|mesh-list
83348674|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
83348675|NCT05331664|Triamcinolone|triamcinolone|mesh-list
83348676|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83348677|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83348678|NCT05331664|Atropine|atropine|mesh-list
83348679|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83348680|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83348681|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83348682|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
83348683|NCT05331664|Hormones|hormones|mesh-ancestor
83348684|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83348685|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348686|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83348687|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348688|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
83348690|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83348691|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348692|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83348693|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83348694|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83430180|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83348695|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348696|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83348697|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
83348698|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83348699|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83348700|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83348701|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83348702|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348703|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
83348704|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83348705|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83348706|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83348707|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83348708|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
83348709|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
83348710|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
83348711|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83348712|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83348713|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
83348714|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348715|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83348716|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
83348717|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83348718|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83348719|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83348720|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83348721|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83348722|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83348723|NCT05325632|Paclitaxel|paclitaxel|mesh-list
83348724|NCT05325632|Trastuzumab|trastuzumab|mesh-list
83348725|NCT05325632|Pertuzumab|pertuzumab|mesh-list
83348726|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348727|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348728|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348729|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
83348730|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
83348731|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348732|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348733|NCT05320068|Vancomycin|vancomycin|mesh-list
83348734|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83348735|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83348736|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83348737|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83348738|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
83348739|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348740|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348741|NCT05277402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348742|NCT05277402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348743|NCT05223647|Carboplatin|carboplatin|mesh-list
83348744|NCT05223647|Etoposide|etoposide|mesh-list
83348745|NCT05223647|Durvalumab|durvalumab|mesh-list
83348746|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348747|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348748|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83348749|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83348750|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348751|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348752|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348753|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
83348754|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348755|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348756|NCT05204160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348757|NCT05204160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348758|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
83348759|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348760|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348761|NCT05171062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348771|NCT05151744|Ranibizumab|ranibizumab|mesh-list
83348772|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83348773|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83348774|NCT05151744|Growth Substances|growth substances|mesh-ancestor
83348775|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348776|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
83348777|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348778|NCT05136677|Carboplatin|carboplatin|mesh-list
83348779|NCT05136677|Nivolumab|nivolumab|mesh-list
83348780|NCT05136677|Pemetrexed|pemetrexed|mesh-list
83348781|NCT05136677|Ipilimumab|ipilimumab|mesh-list
83348782|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348783|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348784|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348785|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348786|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348787|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83348788|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83348789|NCT05101096|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83348790|NCT05101096|Immunoconjugates|immunoconjugates|mesh-ancestor
83348791|NCT05101096|Immunologic Factors|immunologic factors|mesh-ancestor
83348792|NCT05101096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348803|NCT05080322|Fluticasone|fluticasone|mesh-list
83348804|NCT05080322|Xhance|xhance|mesh-list
83348805|NCT05080322|Azelastine|azelastine|mesh-list
83348806|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83348807|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83348808|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
83348809|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348810|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348811|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83348812|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
83348813|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
83348814|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83348815|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83348816|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348817|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348818|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83348819|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83348820|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
83348821|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
83348822|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348823|NCT05071313|Vaccines|vaccines|mesh-list
83348824|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
83348825|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348826|NCT05069597|Pancrelipase|pancrelipase|mesh-list
83348827|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83348828|NCT05065424|Atropine|atropine|mesh-list
83348829|NCT05065424|Fentanyl|fentanyl|mesh-list
83348830|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83348831|NCT05065424|Narcotics|narcotics|mesh-ancestor
83348832|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348833|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348834|NCT05065424|Analgesics|analgesics|mesh-ancestor
83348835|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
83348836|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348837|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83348838|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83348840|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
83348841|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348842|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83348843|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83348844|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
83348845|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83348846|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
83348847|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
83348848|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
83348849|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83348850|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83348851|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
83348852|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348853|NCT05041257|Maytansine|maytansine|mesh-list
83348854|NCT05041257|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
83348855|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348856|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348857|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348858|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
83348859|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
83348860|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348861|NCT05041257|Immunoconjugates|immunoconjugates|mesh-ancestor
83348862|NCT05041257|Immunologic Factors|immunologic factors|mesh-ancestor
83348863|NCT05041257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348865|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
83348866|NCT05013502|Empagliflozin|empagliflozin|mesh-list
83348867|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83348868|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348869|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83348870|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348871|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
83348872|NCT04989803|Fludarabine|fludarabine|mesh-list
83348873|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83348874|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
83348875|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348876|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83348877|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83348878|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
83348879|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348880|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348881|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83348882|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
83348883|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83348884|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83348885|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348886|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83348887|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348888|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83348889|NCT04911166|Atezolizumab|atezolizumab|mesh-list
83348890|NCT04911166|Interleukin-12|interleukin-12|mesh-list
83348891|NCT04911166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83348892|NCT04911166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348893|NCT04911166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83348894|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348895|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83348896|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
83348897|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348898|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83348899|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83348900|NCT04911166|Growth Substances|growth substances|mesh-ancestor
83348901|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
83348902|NCT04903353|Risperidone|risperidone|mesh-list
83348903|NCT04903353|Aripiprazole|aripiprazole|mesh-list
83348904|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83348905|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
83348906|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348907|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348908|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348909|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83348910|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83348911|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348912|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83348913|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83348914|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
83348915|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
83348916|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
83348917|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83348918|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83348919|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83348920|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83348921|NCT04856904|Trifarotene|trifarotene|mesh-list
83348922|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
83348923|NCT04831047|Phenylephrine|phenylephrine|mesh-list
83348924|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
83348925|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83348926|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83348927|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83348928|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83348929|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
83348930|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348931|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348932|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348933|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
83348934|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
83348935|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348936|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
83348937|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83348938|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
83348939|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83348940|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
83348941|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83348942|NCT04831047|Protective Agents|protective agents|mesh-ancestor
83348944|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
83348945|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348946|NCT04767022|Paclitaxel|paclitaxel|mesh-list
83348947|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83348948|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83348949|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83348950|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
83348951|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
83348952|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
83348953|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348954|NCT04764162|Choline|choline|mesh-list
83348955|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
83348956|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83348957|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
83348958|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348959|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83348960|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83348961|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
83348962|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83348963|NCT04747314|Aripiprazole|aripiprazole|mesh-list
83348964|NCT04747314|Mirtazapine|mirtazapine|mesh-list
83348965|NCT04747314|Bupropion|bupropion|mesh-list
83348966|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83348967|NCT04747314|Sertraline|sertraline|mesh-list
83348968|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
83348969|NCT04747314|Escitalopram|escitalopram|mesh-list
83348970|NCT04747314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83348971|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83348972|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83348973|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83348974|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83348975|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
83348976|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83348977|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83348978|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83348979|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83348980|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83348981|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
83348982|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83348983|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83348984|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83348985|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83348986|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83348987|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83348988|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
83348989|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83348990|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83348991|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83348992|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83348993|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83348994|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83348995|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83348996|NCT04747314|Analgesics|analgesics|mesh-ancestor
83348997|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
83348998|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83348999|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
83349000|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
83349001|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83349002|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83349003|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83349004|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83349005|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349006|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83349007|NCT04731363|Erythritol|erythritol|mesh-list
83349008|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
83349009|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
83349010|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83349011|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349012|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349013|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83349014|NCT04700514|Analgesics|analgesics|mesh-ancestor
83349015|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
83349016|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349017|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83349018|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83349019|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83349020|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349021|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349022|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349023|NCT04669145|Ropivacaine|ropivacaine|mesh-list
83349024|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
83349025|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
83349026|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349027|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349028|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
83349029|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349030|NCT04650074|Lidocaine|lidocaine|mesh-list
83349031|NCT04650074|Ketamine|ketamine|mesh-list
83349032|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
83349033|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
83349034|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349035|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349036|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
83349037|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349038|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83349039|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83349040|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83349041|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349042|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349043|NCT04650074|Analgesics|analgesics|mesh-ancestor
83349044|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83349045|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83349046|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
83349047|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83349048|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83349049|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349050|NCT04620304|UB-421|ub-421|mesh-list
83349051|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83349052|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
83349053|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349054|NCT04600336|Oxybutynin|oxybutynin|mesh-list
83349055|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
83349056|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
83349057|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349058|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349059|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83349060|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83349061|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
83349062|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349063|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349064|NCT04600336|Urological Agents|urological agents|mesh-ancestor
83349065|NCT04579380|Trastuzumab|trastuzumab|mesh-list
83349066|NCT04579380|Fulvestrant|fulvestrant|mesh-list
83349067|NCT04579380|Tucatinib|tucatinib|mesh-list
83349068|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349069|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349070|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83349071|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83349072|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83349073|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
83349074|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349075|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349076|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349077|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349078|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349080|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83349081|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83349082|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83349083|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83349084|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349085|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349086|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349087|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349088|NCT04550585|Insulin|insulin|mesh-list
83349089|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83349090|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83349091|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349092|NCT04545515|Ivacaftor|ivacaftor|mesh-list
83349093|NCT04545515|Elexacaftor|elexacaftor|mesh-list
83349094|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83349095|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349096|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349097|NCT04512066|Risperidone|risperidone|mesh-list
83349098|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83349099|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
83349100|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349101|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349102|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349103|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83349104|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83349105|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349106|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83349107|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83349108|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
83349109|NCT04449549|Paclitaxel|paclitaxel|mesh-list
83349110|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83349111|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349112|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
83349113|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
83349114|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
83349115|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349116|NCT04447027|Dexamethasone|dexamethasone|mesh-list
83349117|NCT04447027|Lenalidomide|lenalidomide|mesh-list
83349118|NCT04447027|Azacitidine|azacitidine|mesh-list
83349119|NCT04447027|Romidepsin|romidepsin|mesh-list
83349120|NCT04447027|Cc-486|cc-486|mesh-list
83349121|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83349122|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
83349123|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
83349124|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349125|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349126|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83349127|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
83349128|NCT04447027|Hormones|hormones|mesh-ancestor
83349129|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349130|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83349131|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349132|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
83349133|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83349134|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83349135|NCT04447027|Growth Substances|growth substances|mesh-ancestor
83349136|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
83349137|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83349138|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
83349139|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349140|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349141|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83349142|NCT04447027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83349143|NCT04421092|Lidocaine|lidocaine|mesh-list
83349144|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
83349145|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
83349146|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349147|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349148|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
83349149|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349151|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83349152|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83349153|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349154|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349155|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83349156|NCT04406727|UB-421|ub-421|mesh-list
83349157|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
83349158|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349159|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
83349160|NCT04364945|Remifentanil|remifentanil|mesh-list
83349161|NCT04364945|Sevoflurane|sevoflurane|mesh-list
83349162|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83349163|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349164|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349165|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83349166|NCT04364945|Analgesics|analgesics|mesh-ancestor
83349167|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
83349168|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349169|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83349170|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83349171|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83349172|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349173|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349174|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349175|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83349176|NCT04364945|Narcotics|narcotics|mesh-ancestor
83349177|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83349178|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83349179|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
83349180|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
83349181|NCT04256941|Letrozole|letrozole|mesh-list
83349182|NCT04256941|Fulvestrant|fulvestrant|mesh-list
83349183|NCT04256941|Palbociclib|palbociclib|mesh-list
83349184|NCT04256941|Anastrozole|anastrozole|mesh-list
83349185|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349186|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83349187|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83349188|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349189|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349190|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83349191|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
83349192|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349193|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349194|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83349195|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83349196|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349197|NCT04235608|Propofol|propofol|mesh-list
83349198|NCT04235608|Sevoflurane|sevoflurane|mesh-list
83349199|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83349200|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349201|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349202|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83349203|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
83349204|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
83349205|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83349206|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83349207|NCT04232306|Bupivacaine|bupivacaine|mesh-list
83349208|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
83349210|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349211|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349212|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
83349213|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349214|NCT04161027|Pregabalin|pregabalin|mesh-list
83349215|NCT04161027|Analgesics|analgesics|mesh-ancestor
83349216|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
83349217|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349218|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349219|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
83349220|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83349221|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349222|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349223|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83349224|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83349225|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83349226|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349227|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83349228|NCT04126135|Nicotine|nicotine|mesh-list
83349229|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83349230|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
83349231|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349232|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349233|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83349234|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83349235|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
83349236|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349237|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349238|NCT04085315|Osimertinib|osimertinib|mesh-list
83349239|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349240|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349241|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349242|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349243|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
83349244|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83349245|NCT04019964|Nivolumab|nivolumab|mesh-list
83349246|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349247|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349248|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83349249|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349250|NCT04011345|Folic Acid|folic acid|mesh-list
83349251|NCT04011345|Hematinics|hematinics|mesh-ancestor
83349252|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
83349253|NCT04011345|Vitamins|vitamins|mesh-ancestor
83349254|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
83349255|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349256|NCT03990571|Avelumab|avelumab|mesh-list
83349257|NCT03990571|Axitinib|axitinib|mesh-list
83349258|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83349259|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349260|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349261|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349262|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349263|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349264|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
83349265|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349266|NCT03937830|Bevacizumab|bevacizumab|mesh-list
83349267|NCT03937830|Durvalumab|durvalumab|mesh-list
83349268|NCT03937830|Doxorubicin|doxorubicin|mesh-list
83349269|NCT03937830|Tremelimumab|tremelimumab|mesh-list
83349270|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349271|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349272|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83349273|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83349274|NCT03937830|Growth Substances|growth substances|mesh-ancestor
83349275|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349276|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
83349277|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83349278|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83349279|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83349280|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413656|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83349281|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349282|NCT03936777|Fenfluramine|fenfluramine|mesh-list
83349283|NCT03936777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83349284|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83349285|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349286|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349287|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349288|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
83349289|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349290|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
83349291|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83349292|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349293|NCT03889756|Midazolam|midazolam|mesh-list
83349294|NCT03889756|Ketamine|ketamine|mesh-list
83349295|NCT03889756|Analgesics|analgesics|mesh-ancestor
83349296|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
83349297|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349298|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349299|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83349300|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83349301|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
83349302|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
83349303|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349304|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83349305|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83349306|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349307|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349308|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83349309|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83349310|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83349311|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83349312|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83349313|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
83349314|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
83349315|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
83349316|NCT03881696|Omalizumab|omalizumab|mesh-list
83349317|NCT03881696|Immunomodulating Agents|immunomodulating agents|mesh-list
83349318|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
83349319|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83349320|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349321|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83349322|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83349323|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
83349324|NCT03864406|Darunavir|darunavir|mesh-list
83349325|NCT03864406|Cobicistat|cobicistat|mesh-list
83349326|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
83349327|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
83349328|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83349329|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
83349330|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83349331|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
83349332|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349333|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349334|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
83349335|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83349336|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83349337|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83349338|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83349339|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
83349340|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349341|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83349342|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83349343|NCT03845114|Insulin|insulin|mesh-list
83349344|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83349345|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83349346|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349347|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
83349348|NCT03778502|Apixaban|apixaban|mesh-list
83349349|NCT03778502|Edoxaban|edoxaban|mesh-list
83349350|NCT03778502|Dabigatran|dabigatran|mesh-list
83349351|NCT03778502|Anticoagulants|anticoagulants|mesh-list
83349352|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83349353|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
83349354|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83349355|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
83349356|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413657|NCT01702831|Growth Substances|growth substances|mesh-ancestor
83349357|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349358|NCT03775200|Psilocybin|psilocybin|mesh-list
83349359|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
83349360|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349362|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
83349363|NCT03698669|Narcotics|narcotics|mesh-ancestor
83349364|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349365|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349366|NCT03698669|Analgesics|analgesics|mesh-ancestor
83349367|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
83349368|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349369|NCT03689855|Atezolizumab|atezolizumab|mesh-list
83349370|NCT03689855|Ramucirumab|ramucirumab|mesh-list
83430181|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
83349371|NCT03689855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83349372|NCT03689855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349373|NCT03689855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349374|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349375|NCT03635996|Etripamil|etripamil|mesh-list
83349376|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83349377|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349378|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349379|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83349380|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349381|NCT03613181|Paclitaxel|paclitaxel|mesh-list
83349382|NCT03613181|Capecitabine|capecitabine|mesh-list
83349383|NCT03613181|Methotrexate|methotrexate|mesh-list
83349384|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83349385|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349386|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
83349387|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
83349388|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
83349389|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349390|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83349391|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
83349392|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83349393|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
83349394|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83349395|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349396|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
83349397|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349398|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83349399|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349400|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
83349401|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83349402|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83349403|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
83349404|NCT03468478|Sirolimus|sirolimus|mesh-list
83349405|NCT03468478|Everolimus|everolimus|mesh-list
83349406|NCT03468478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83349407|NCT03468478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349408|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349409|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349410|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349411|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
83349412|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349413|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349414|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83349415|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83349416|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
83349417|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83349418|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349419|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
83349420|NCT03409367|Emollients|emollients|mesh-list
83349421|NCT03409367|Petrolatum|petrolatum|mesh-list
83349422|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
83349423|NCT03168464|Nivolumab|nivolumab|mesh-list
83349424|NCT03168464|Ipilimumab|ipilimumab|mesh-list
83349425|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349426|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349427|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83349428|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349429|NCT03164447|UB-421|ub-421|mesh-list
83349430|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83349431|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
83349432|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349433|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
83349434|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83349435|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349436|NCT03032172|Risdiplam|risdiplam|mesh-list
83349437|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83349438|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349439|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349440|NCT02985957|Prednisone|prednisone|mesh-list
83349441|NCT02985957|Nivolumab|nivolumab|mesh-list
83349443|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83349444|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
83349445|NCT02985957|Hormones|hormones|mesh-ancestor
83349446|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349447|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349448|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83349449|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349450|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349451|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83349452|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349453|NCT02875262|Deferoxamine|deferoxamine|mesh-list
83349454|NCT02875262|Siderophores|siderophores|mesh-ancestor
83349455|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83349456|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
83349457|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
83349458|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349459|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
83349460|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349461|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349462|NCT02818920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83349463|NCT02818920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349464|NCT02811510|Dronabinol|dronabinol|mesh-list
83349465|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
83349466|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349467|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83349468|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83349469|NCT02811510|Analgesics|analgesics|mesh-ancestor
83349470|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
83349471|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349472|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83349473|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83349474|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349475|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349476|NCT02811510|Hormones|hormones|mesh-ancestor
83349477|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349478|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
83349479|NCT02786264|Propofol|propofol|mesh-list
83349480|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83349481|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349482|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349483|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83349484|NCT02786264|Analgesics|analgesics|mesh-ancestor
83349485|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
83349486|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349487|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83349488|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83349489|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83349490|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349491|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349492|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349493|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83349494|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
83349495|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
83349496|NCT02778971|Flutemetamol|flutemetamol|mesh-list
83349497|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83349498|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349499|NCT02444546|Sargramostim|sargramostim|mesh-list
83349500|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
83349501|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349502|NCT01948505|Acetaminophen|acetaminophen|mesh-list
83349503|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83349504|NCT01948505|Analgesics|analgesics|mesh-ancestor
83349505|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
83349506|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83413658|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83349507|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349508|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
83349509|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83349510|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83349511|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349512|NCT01160926|Cediranib|cediranib|mesh-list
83349513|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349514|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349515|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349516|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349517|NCT01126957|Fentanyl|fentanyl|mesh-list
83349518|NCT01126957|Ketamine|ketamine|mesh-list
83349519|NCT01126957|Propofol|propofol|mesh-list
83349520|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83349521|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349522|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349523|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83349524|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
83349525|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
83349526|NCT01126957|Analgesics|analgesics|mesh-ancestor
83349527|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
83349528|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349529|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83349530|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83349531|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83349532|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349533|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349534|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83349535|NCT01126957|Narcotics|narcotics|mesh-ancestor
83349536|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83349537|NCT00811122|Corticosterone|corticosterone|mesh-list
83349538|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83349539|NCT00651885|Treprostinil|treprostinil|mesh-list
83349540|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83349541|NCT01457001|Vitamin D|vitamin d|mesh-list
83349542|NCT01457001|Vitamins|vitamins|mesh-ancestor
83349543|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
83349544|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349545|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83349546|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
83349547|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83349548|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83349549|NCT01457469|Nicotine|nicotine|mesh-list
83349550|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83349551|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
83349552|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349553|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349554|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83349555|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83349556|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
83349557|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349558|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349559|NCT01457547|Edetic Acid|edetic acid|mesh-list
83349560|NCT01457547|Vaccines|vaccines|mesh-list
83349561|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
83349562|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
83349563|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349564|NCT01457547|Antidotes|antidotes|mesh-ancestor
83349565|NCT01457547|Protective Agents|protective agents|mesh-ancestor
83349566|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
83349567|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
83349568|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349569|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83349570|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
83349571|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83349572|NCT01457859|Triclosan|triclosan|mesh-list
83349573|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83349574|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349575|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83349576|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83349577|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
83349578|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349579|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83349580|NCT01890993|Liraglutide|liraglutide|mesh-list
83349581|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83349582|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349583|NCT01890993|Incretins|incretins|mesh-ancestor
83349584|NCT01890993|Hormones|hormones|mesh-ancestor
83349585|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349586|NCT01457937|Interferons|interferons|mesh-list
83349587|NCT01457937|Ribavirin|ribavirin|mesh-list
83349589|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349590|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
83349591|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349592|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
83349593|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349594|NCT05021913|Lidocaine|lidocaine|mesh-list
83349595|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
83349596|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
83349597|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
83349598|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349599|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349600|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
83349601|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349602|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83349603|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83349604|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83349605|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349606|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349607|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83349608|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
83349609|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
83349610|NCT05021913|Protective Agents|protective agents|mesh-ancestor
83349611|NCT05025423|Venetoclax|venetoclax|mesh-list
83349612|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83349613|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349614|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83349615|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
83349616|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349617|NCT04272255|Scopolamine|scopolamine|mesh-list
83349618|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83349619|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83349620|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
83349621|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
83349622|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349623|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349624|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83349625|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
83349626|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83349627|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
83349628|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349629|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349630|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83349631|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
83349632|NCT01458015|Oxycodone|oxycodone|mesh-list
83349633|NCT01458015|Tapentadol|tapentadol|mesh-list
83349634|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83349635|NCT01458015|Narcotics|narcotics|mesh-ancestor
83349636|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349637|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349638|NCT01458015|Analgesics|analgesics|mesh-ancestor
83349639|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
83349640|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349641|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83349642|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83349643|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83349644|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349645|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349646|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349647|NCT05022927|Bevacizumab|bevacizumab|mesh-list
83349648|NCT05022927|Atezolizumab|atezolizumab|mesh-list
83349649|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349650|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349651|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83349652|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83349653|NCT05022927|Growth Substances|growth substances|mesh-ancestor
83349654|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349655|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
83349656|NCT05022927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83349657|NCT05022927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349658|NCT05026125|Remifentanil|remifentanil|mesh-list
83349659|NCT05026125|Anesthetics|anesthetics|mesh-list
83349660|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349661|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349662|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83349663|NCT05026125|Narcotics|narcotics|mesh-ancestor
83349664|NCT05026125|Analgesics|analgesics|mesh-ancestor
83349665|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
83349666|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349667|NCT01891227|Capecitabine|capecitabine|mesh-list
83349668|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83349669|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83349670|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
83349671|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349672|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349673|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83349674|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
83349675|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
83349676|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83349677|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83349678|NCT04391439|Prednisolone|prednisolone|mesh-list
83349679|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
83349680|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83349681|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
83349682|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83349683|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
83349684|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
83349685|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349686|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349687|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83349688|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
83349689|NCT04391439|Hormones|hormones|mesh-ancestor
83349690|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349691|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83349692|NCT04391439|Protective Agents|protective agents|mesh-ancestor
83349693|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83349694|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349695|NCT02884245|Estrogens|estrogens|mesh-list
83349696|NCT02884245|Hormones|hormones|mesh-ancestor
83349697|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349698|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349699|NCT01891461|Hemostatics|hemostatics|mesh-list
83349700|NCT01891461|Coagulants|coagulants|mesh-ancestor
83349701|NCT02842749|Everolimus|everolimus|mesh-list
83349702|NCT02842749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83349703|NCT02842749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349704|NCT02842749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349705|NCT02842749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349706|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349707|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
83349708|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349709|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349710|NCT04272567|Norepinephrine|norepinephrine|mesh-list
83349711|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83349712|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83349713|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349714|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349715|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349716|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349717|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
83349718|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
83349719|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349720|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83349721|NCT01891851|Ritonavir|ritonavir|mesh-list
83349722|NCT01891851|Simeprevir|simeprevir|mesh-list
83349723|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83349724|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83349725|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
83349726|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349727|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349728|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83349729|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83349730|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
83349731|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349732|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83349733|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83349734|NCT01459419|Antibodies|antibodies|mesh-list
83349735|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83349736|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
83349737|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349738|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83349739|NCT01892241|Entecavir|entecavir|mesh-list
83349740|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
83349741|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349742|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
83349743|NCT04391127|Ivermectin|ivermectin|mesh-list
83349744|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
83349745|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83349746|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83349747|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349748|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349749|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349750|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83349751|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
83349752|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83349753|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83349754|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349755|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
83349756|NCT05024253|Coagulants|coagulants|mesh-ancestor
83349757|NCT05026593|Carboplatin|carboplatin|mesh-list
83349758|NCT05026593|Etoposide|etoposide|mesh-list
83349759|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349760|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83349761|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83349762|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83349763|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349764|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349765|NCT01459809|Metformin|metformin|mesh-list
83349766|NCT01459809|Glimepiride|glimepiride|mesh-list
83349767|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83349768|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349769|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83349770|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349771|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
83349772|NCT01459887|Prednisone|prednisone|mesh-list
83349773|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
83349774|NCT01459887|Doxorubicin|doxorubicin|mesh-list
83349775|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83349776|NCT01459887|Vincristine|vincristine|mesh-list
83349777|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349778|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
83349779|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349780|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83349781|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83349782|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
83349783|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349784|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349785|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83349786|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83349787|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83349788|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83349789|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349790|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83349791|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
83349792|NCT01459887|Hormones|hormones|mesh-ancestor
83349793|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349794|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83349795|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83349796|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
83349797|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
83349798|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
83349799|NCT02876211|Vitamin D|vitamin d|mesh-list
83349800|NCT02876211|Vitamins|vitamins|mesh-ancestor
83349801|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
83349802|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349803|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83349804|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
83349805|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
83349806|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83349807|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83349808|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349809|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349810|NCT02682147|Urological Agents|urological agents|mesh-ancestor
83349811|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
83349812|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83349813|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83349814|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
83349815|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349816|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349817|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83349818|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
83349819|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83349820|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83349821|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83349822|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
83349823|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349824|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349825|NCT01893723|Remifentanil|remifentanil|mesh-list
83349826|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83349827|NCT01893723|Narcotics|narcotics|mesh-ancestor
83349828|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83349829|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349830|NCT01893723|Analgesics|analgesics|mesh-ancestor
83349831|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
83349832|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349833|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
83349834|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83349835|NCT02669901|Naloxone|naloxone|mesh-list
83349836|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83349837|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349838|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
83349839|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83349840|NCT01893099|Sorafenib|sorafenib|mesh-list
83349841|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349842|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349843|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349844|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349845|NCT02327403|Abatacept|abatacept|mesh-list
83349846|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83349847|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349848|NCT02327403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349849|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349850|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349851|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
83349852|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349853|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83349854|NCT01893177|Vaccines|vaccines|mesh-list
83349855|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
83349856|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349857|NCT05740150|Taurolidine|taurolidine|mesh-list
83349858|NCT05740150|Heparin|heparin|mesh-list
83349859|NCT05740150|Calcium heparin|calcium heparin|mesh-list
83349860|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
83349861|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349862|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83349863|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83349864|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349865|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83349866|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349867|NCT05734612|Colchicine|colchicine|mesh-list
83349868|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
83349869|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83349870|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83349871|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83349872|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83349873|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349874|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349875|NCT02349867|Gemcitabine|gemcitabine|mesh-list
83349876|NCT02349867|Sorafenib|sorafenib|mesh-list
83349877|NCT02349867|Vorinostat|vorinostat|mesh-list
83349878|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83349879|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
83349880|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349881|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349882|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83349884|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83349885|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
83349886|NCT02630043|Tolcapone|tolcapone|mesh-list
83349887|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349888|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83349889|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83349890|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83349891|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349892|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349893|NCT02629419|Amphotericin B|amphotericin b|mesh-list
83349894|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
83349895|NCT02629419|Amebicides|amebicides|mesh-ancestor
83349896|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83349897|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83349898|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349899|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83349900|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
83349901|NCT02334735|Vaccines|vaccines|mesh-list
83349902|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83349903|NCT02334735|Poly ICLC|poly iclc|mesh-list
83349904|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
83349905|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349906|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83349907|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
83349908|NCT02329600|Triamcinolone|triamcinolone|mesh-list
83349909|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83349910|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83349911|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83349912|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83349913|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
83349914|NCT02329600|Hormones|hormones|mesh-ancestor
83349915|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349916|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349917|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349918|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
83349919|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349920|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349921|NCT02620761|Fenoldopam|fenoldopam|mesh-list
83349922|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83349923|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
83349924|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
83349925|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
83349926|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83349927|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349928|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349929|NCT02615691|Factor VIII|factor viii|mesh-list
83349930|NCT02615691|BAX 855|bax 855|mesh-list
83349931|NCT02615691|Coagulants|coagulants|mesh-ancestor
83349932|NCT04758273|Vaccines|vaccines|mesh-list
83349933|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
83349934|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349935|NCT01729871|Vitamin K|vitamin k|mesh-list
83349936|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
83349937|NCT01729871|Vitamins|vitamins|mesh-ancestor
83349938|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
83349939|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349940|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83349941|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
83349942|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83349943|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
83349944|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349945|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349946|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
83349947|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83349948|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83349949|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
83349950|NCT01729871|Coagulants|coagulants|mesh-ancestor
83349951|NCT02611323|Rituximab|rituximab|mesh-list
83349952|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
83349953|NCT02611323|Venetoclax|venetoclax|mesh-list
83349954|NCT02611323|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83349955|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83349956|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349957|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
83349958|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349959|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83349960|NCT02611323|Immunoconjugates|immunoconjugates|mesh-ancestor
83349961|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
83349962|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349963|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83349964|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349965|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349966|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
83349967|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83349968|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349969|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83349970|NCT01729559|Heparin|heparin|mesh-list
83349971|NCT01729559|Enoxaparin|enoxaparin|mesh-list
83349972|NCT01729559|Calcium heparin|calcium heparin|mesh-list
83349973|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
83349974|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
83349975|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83349976|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83349977|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349978|NCT01926496|Imiquimod|imiquimod|mesh-list
83349979|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83349980|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
83349981|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83349982|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83349983|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
83349984|NCT01728779|Nelfinavir|nelfinavir|mesh-list
83349985|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83349986|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83349987|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
83349988|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83349989|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83349990|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83349991|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83349992|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
83349993|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83349994|NCT01927120|Sirolimus|sirolimus|mesh-list
83349995|NCT01927120|Aldesleukin|aldesleukin|mesh-list
83349996|NCT01927120|Tacrolimus|tacrolimus|mesh-list
83349997|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83349998|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
83349999|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350000|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83350001|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350002|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350003|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350004|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350005|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83350006|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350007|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
83350008|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83350009|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83350010|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
83350011|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
83350012|NCT02600949|Imiquimod|imiquimod|mesh-list
83350013|NCT02600949|Vaccines|vaccines|mesh-list
83350014|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350015|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350016|NCT02600949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83350017|NCT02600949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350018|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83350019|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
83350020|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350021|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
83350022|NCT01728623|Lenvatinib|lenvatinib|mesh-list
83350023|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350024|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83350025|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350026|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350027|NCT02573337|Lidocaine|lidocaine|mesh-list
83350028|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
83350029|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
83350030|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350031|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350032|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
83350033|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350034|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83350035|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83350036|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83350037|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83350038|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350039|NCT01728077|Brivaracetam|brivaracetam|mesh-list
83350040|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
83350041|NCT01606007|Metformin|metformin|mesh-list
83350042|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
83350043|NCT01606007|Saxagliptin|saxagliptin|mesh-list
83350044|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83350045|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350046|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83350047|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350048|NCT01606007|Incretins|incretins|mesh-ancestor
83350049|NCT01606007|Hormones|hormones|mesh-ancestor
83350050|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350051|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83350052|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83350053|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350054|NCT02304783|Acetaminophen|acetaminophen|mesh-list
83350055|NCT02304783|Piroxicam|piroxicam|mesh-list
83350056|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83350057|NCT02304783|Analgesics|analgesics|mesh-ancestor
83350058|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
83350059|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350060|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350061|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
83350062|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83350063|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83350064|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350065|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83350066|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350067|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350068|NCT02553447|Vitamin D|vitamin d|mesh-list
83350069|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
83350070|NCT02553447|Vitamins|vitamins|mesh-ancestor
83350071|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
83350072|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350073|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83350074|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83350075|NCT01928290|Leucovorin|leucovorin|mesh-list
83350076|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
83350077|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
83350078|NCT01928290|Fluorouracil|fluorouracil|mesh-list
83350079|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
83350080|NCT01928290|Trastuzumab|trastuzumab|mesh-list
83350081|NCT01928290|Irinotecan|irinotecan|mesh-list
83350082|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
83350083|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
83350084|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350085|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350086|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350087|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350088|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
83350089|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350090|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350091|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83350092|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83350093|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350094|NCT01928290|Antidotes|antidotes|mesh-ancestor
83350095|NCT01928290|Protective Agents|protective agents|mesh-ancestor
83350096|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
83350097|NCT01928290|Vitamins|vitamins|mesh-ancestor
83350098|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
83350099|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
83350100|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
83350101|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83350102|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350103|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350104|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83350106|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
83350107|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350108|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83350109|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83350110|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83350111|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
83350112|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350113|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350114|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
83350115|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
83350116|NCT02772081|Poractant alfa|poractant alfa|mesh-list
83350117|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
83350118|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
83350120|NCT02278965|Biguanides|biguanides|mesh-list
83350121|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83350122|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350123|NCT02766465|Sirolimus|sirolimus|mesh-list
83350124|NCT02766465|Methotrexate|methotrexate|mesh-list
83350125|NCT02766465|Fludarabine|fludarabine|mesh-list
83350126|NCT02766465|Melphalan|melphalan|mesh-list
83350127|NCT02766465|Busulfan|busulfan|mesh-list
83350128|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
83350129|NCT02766465|Tacrolimus|tacrolimus|mesh-list
83350130|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83350131|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
83350132|NCT02766465|Lenograstim|lenograstim|mesh-list
83350133|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83350134|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
83350135|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83350136|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350137|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350138|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
83350139|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350140|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350141|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
83350142|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350143|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83350144|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350145|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
83350146|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350147|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83350148|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83350149|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350150|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350151|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83350152|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
83350153|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350154|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
83350155|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83350156|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83350157|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350158|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
83350159|NCT02757885|Thiotepa|thiotepa|mesh-list
83350160|NCT02757885|Fludarabine|fludarabine|mesh-list
83350161|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
83350162|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
83350163|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83350164|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
83350165|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350166|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
83350167|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350168|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350169|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350170|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
83350171|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350172|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350173|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83350174|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350175|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
83350176|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
83350177|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350178|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83350179|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
83350180|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
83350181|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83350182|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350183|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350184|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
83350185|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83350186|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350187|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350188|NCT02983383|Anesthetics|anesthetics|mesh-list
83350189|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350190|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350191|NCT02753283|Vitamin D|vitamin d|mesh-list
83350192|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
83350193|NCT02753283|Denosumab|denosumab|mesh-list
83350194|NCT02753283|Calcium|calcium|mesh-list
83350195|NCT02753283|Vitamins|vitamins|mesh-ancestor
83350196|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
83350197|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350198|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83350199|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83350200|NCT02748369|Glucagon|glucagon|mesh-list
83350201|NCT02748369|Hormones|hormones|mesh-list
83350202|NCT02748369|Somatostatin|somatostatin|mesh-list
83350203|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350204|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350205|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83350206|NCT01928680|Capecitabine|capecitabine|mesh-list
83350207|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350208|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350209|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
83350210|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350211|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
83350212|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350213|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350214|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83350215|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83350216|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350217|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350218|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350219|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83350220|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83350221|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
83350222|NCT02248701|Finasteride|finasteride|mesh-list
83350223|NCT02248701|Testosterone|testosterone|mesh-list
83350224|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
83350225|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
83350226|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
83350227|NCT02248701|Androgens|androgens|mesh-ancestor
83350228|NCT02248701|Hormones|hormones|mesh-ancestor
83350229|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350230|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350231|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83350232|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350233|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
83350234|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83350235|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83350236|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350237|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350238|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
83350239|NCT02248701|Urological Agents|urological agents|mesh-ancestor
83350240|NCT02283814|Topiramate|topiramate|mesh-list
83350241|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83350242|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
83350243|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83350244|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350245|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83350246|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83350247|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83350248|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350249|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
83350250|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83350251|NCT05739682|Epinephrine|epinephrine|mesh-list
83350252|NCT05739682|Anesthetics|anesthetics|mesh-list
83350253|NCT05739682|Carticaine|carticaine|mesh-list
83350254|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
83350255|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350256|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350257|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83350259|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
83350260|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350261|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350262|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83350263|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83350264|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
83350265|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350266|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83350267|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
83350268|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
83350269|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
83350270|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83350271|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
83350272|NCT02462421|Canagliflozin|canagliflozin|mesh-list
83350273|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83350274|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350275|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83350276|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350277|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
83350278|NCT02727387|Temozolomide|temozolomide|mesh-list
83350279|NCT02727387|Melphalan|melphalan|mesh-list
83350280|NCT02727387|Busulfan|busulfan|mesh-list
83350281|NCT02727387|Ifosfamide|ifosfamide|mesh-list
83350282|NCT02727387|Irinotecan|irinotecan|mesh-list
83350283|NCT02727387|Etoposide|etoposide|mesh-list
83350284|NCT02727387|Vincristine|vincristine|mesh-list
83350285|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350286|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
83350287|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350288|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350289|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350290|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
83350291|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350292|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350293|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83350294|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83350295|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83350296|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350297|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83350298|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83350299|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
83350300|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
83350301|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
83350302|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
83350303|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350304|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350305|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83350306|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83350307|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350308|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350309|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350310|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83350311|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83350312|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
83350313|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83350314|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
83350315|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350316|NCT02445651|Expectorants|expectorants|mesh-ancestor
83350317|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
83350318|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83350319|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
83350320|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350321|NCT02445651|Protective Agents|protective agents|mesh-ancestor
83350322|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350323|NCT02445651|Antidotes|antidotes|mesh-ancestor
83350324|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
83350325|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83350326|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350327|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83350328|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350329|NCT05586789|Tryptophan|tryptophan|mesh-list
83350330|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83350331|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
83350332|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83350333|NCT02284516|Lifitegrast|lifitegrast|mesh-list
83350334|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83350335|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83350336|NCT02721537|Niacinamide|niacinamide|mesh-list
83350337|NCT02721537|Niacin|niacin|mesh-list
83350338|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
83350339|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
83350340|NCT02721537|Vitamins|vitamins|mesh-ancestor
83350341|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
83350342|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350343|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83350344|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
83350345|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350346|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83350347|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
83350348|NCT02185209|Amoxicillin|amoxicillin|mesh-list
83350349|NCT02185209|Metronidazole|metronidazole|mesh-list
83350350|NCT02185209|Penicillin V|penicillin v|mesh-list
83350351|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350352|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350353|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83350354|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83350355|NCT01894035|Iloprost|iloprost|mesh-list
83350356|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83350357|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
83350358|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
83350359|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83350360|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83350361|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83350362|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
83350363|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350364|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350365|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350366|NCT02716311|Cetuximab|cetuximab|mesh-list
83350367|NCT02716311|Afatinib|afatinib|mesh-list
83350368|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350369|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350370|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83350371|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350372|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350373|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
83350374|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83350375|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83350376|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350377|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
83350378|NCT05439694|Coagulants|coagulants|mesh-ancestor
83350379|NCT02714439|Proflavine|proflavine|mesh-list
83350380|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83350381|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350382|NCT02165007|Sirolimus|sirolimus|mesh-list
83350383|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350384|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350385|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83350386|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350387|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
83350388|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350389|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
83350390|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350391|NCT02290444|Hormones|hormones|mesh-list
83350392|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83350393|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
83350394|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
83350395|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350396|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350397|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350398|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350399|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83350400|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
83350401|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350402|NCT01752023|Itraconazole|itraconazole|mesh-list
83350403|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
83350405|NCT01752023|Gemcitabine|gemcitabine|mesh-list
83350406|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350407|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350408|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
83350409|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350410|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
83350411|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350412|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83350413|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83350414|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350415|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83350416|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
83350417|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350418|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350419|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83350420|NCT02986906|Triamcinolone|triamcinolone|mesh-list
83350421|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83350422|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
83350423|NCT02986906|Hormones|hormones|mesh-ancestor
83350424|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350425|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350426|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83350427|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350428|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350429|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
83350430|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
83350431|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83350432|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83350433|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350434|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350435|NCT01726049|Urological Agents|urological agents|mesh-ancestor
83350436|NCT02162667|Trastuzumab|trastuzumab|mesh-list
83350437|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350438|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350439|NCT01605617|Fesoterodine|fesoterodine|mesh-list
83350440|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83350441|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83350442|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
83350443|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350444|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350445|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350446|NCT01605617|Urological Agents|urological agents|mesh-ancestor
83350447|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
83350448|NCT05402020|Olodaterol|olodaterol|mesh-list
83350449|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83350450|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
83350451|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350452|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350453|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83350454|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
83350455|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
83350456|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83350457|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
83350458|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350459|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350460|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
83350461|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
83350462|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83350463|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83350464|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83350465|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350466|NCT01751867|Decitabine|decitabine|mesh-list
83350467|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350468|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
83350469|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350470|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350471|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350473|NCT02418195|Analgesics|analgesics|mesh-ancestor
83350474|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
83350475|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350476|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350477|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83350478|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83350479|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
83350480|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
83350481|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350482|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83350483|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83350484|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350485|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350486|NCT05633914|Paclitaxel|paclitaxel|mesh-list
83350487|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83350488|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350489|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
83350490|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
83350491|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
83350492|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350493|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83350494|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83350495|NCT05382364|Tucatinib|tucatinib|mesh-list
83350496|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350497|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83350498|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350499|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350500|NCT02712801|Ritonavir|ritonavir|mesh-list
83350501|NCT02712801|Lopinavir|lopinavir|mesh-list
83350502|NCT02712801|Lamivudine|lamivudine|mesh-list
83350503|NCT02712801|Zidovudine|zidovudine|mesh-list
83350504|NCT02712801|Nevirapine|nevirapine|mesh-list
83350505|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83350506|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83350507|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
83350508|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350509|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350510|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83350511|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83350512|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
83350513|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350514|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83350515|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83350516|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83350517|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83350518|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
83350519|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83350520|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83350521|NCT02712723|Letrozole|letrozole|mesh-list
83350522|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350523|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83350524|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83350525|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350526|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350527|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83350528|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
83350529|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350530|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350531|NCT02156739|Edetic Acid|edetic acid|mesh-list
83350532|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
83350533|NCT02156739|Antidotes|antidotes|mesh-ancestor
83350534|NCT02156739|Protective Agents|protective agents|mesh-ancestor
83350535|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350536|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
83350537|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
83350538|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350539|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83350540|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
83350541|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83350542|NCT02402439|Pancrelipase|pancrelipase|mesh-list
83350543|NCT02402439|Pancreatin|pancreatin|mesh-list
83350544|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83350545|NCT01751087|Vitamins|vitamins|mesh-list
83350546|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
83350547|NCT01751087|Misoprostol|misoprostol|mesh-list
83350548|NCT01751087|Mifepristone|mifepristone|mesh-list
83350549|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
83350550|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350551|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83350552|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
83350553|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83350554|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83350555|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83350556|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
83350557|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
83350558|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83350559|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83350560|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83350561|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83350562|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
83350563|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83350564|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83350565|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
83350566|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350567|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
83350568|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83350569|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83350570|NCT02143401|Sorafenib|sorafenib|mesh-list
83350571|NCT02143401|Navitoclax|navitoclax|mesh-list
83350572|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350573|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83350574|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350575|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350576|NCT02401503|Venetoclax|venetoclax|mesh-list
83350577|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83350578|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
83350579|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350580|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350581|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
83350582|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350583|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350584|NCT02395497|Antibodies|antibodies|mesh-list
83350585|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83350586|NCT02395497|Tacrolimus|tacrolimus|mesh-list
83350587|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
83350588|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350589|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350590|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83350591|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350592|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350593|NCT02393157|Carboplatin|carboplatin|mesh-list
83350594|NCT02393157|Etoposide|etoposide|mesh-list
83350595|NCT02393157|Ifosfamide|ifosfamide|mesh-list
83350596|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
83350597|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350598|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83350599|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83350600|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83350601|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350602|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350603|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350604|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
83350605|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350606|NCT01750697|Rituximab|rituximab|mesh-list
83350607|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350608|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350609|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
83350610|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350611|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350612|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
83350613|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83350614|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
83350615|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350617|NCT02127723|Protective Agents|protective agents|mesh-ancestor
83350618|NCT05586711|Estradiol|estradiol|mesh-list
83350619|NCT05586711|Estrogens|estrogens|mesh-ancestor
83350620|NCT05586711|Hormones|hormones|mesh-ancestor
83350621|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350622|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350623|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
83350624|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350625|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350626|NCT05317858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83350627|NCT05317858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350628|NCT01724489|Hormones|hormones|mesh-list
83350629|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350630|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350631|NCT01996293|Lamotrigine|lamotrigine|mesh-list
83350632|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
83350633|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83350634|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83350635|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350636|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83350637|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350638|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83350639|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83350640|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350641|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83350642|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83350643|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83350644|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83350645|NCT05304364|Naltrexone|naltrexone|mesh-list
83350646|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83350647|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83350648|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350649|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
83350650|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350651|NCT01724177|Lenalidomide|lenalidomide|mesh-list
83350652|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
83350653|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350654|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83350655|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83350656|NCT01724177|Growth Substances|growth substances|mesh-ancestor
83350657|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
83350658|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350659|NCT01991457|Fludarabine|fludarabine|mesh-list
83350660|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350661|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83350662|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350663|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83350664|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
83350665|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350666|NCT05524246|Pravastatin|pravastatin|mesh-list
83350667|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83350668|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83350669|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
83350670|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350671|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83350672|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83350673|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350674|NCT02685735|Gabapentin|gabapentin|mesh-list
83350675|NCT02685735|Analgesics|analgesics|mesh-ancestor
83350676|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
83350677|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350678|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350679|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
83350680|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83350681|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83350682|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350683|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83350684|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83350685|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83350686|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350687|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350688|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
83350689|NCT02074839|Ivosidenib|ivosidenib|mesh-list
83350690|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350691|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350692|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350693|NCT01530009|Amoxicillin|amoxicillin|mesh-list
83350694|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350695|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350696|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
83350697|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83350698|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350699|NCT01724021|Prednisone|prednisone|mesh-list
83350700|NCT01724021|Prednisolone|prednisolone|mesh-list
83350701|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83350702|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
83350703|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83350704|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
83350705|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
83350706|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83350707|NCT01724021|Rituximab|rituximab|mesh-list
83350708|NCT01724021|Vincristine|vincristine|mesh-list
83350709|NCT01724021|Doxorubicin|doxorubicin|mesh-list
83350710|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83350711|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83350712|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
83350713|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350714|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
83350715|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350716|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350717|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350718|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
83350719|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350720|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350721|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83350722|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350723|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83350724|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
83350726|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350727|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83350728|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83350729|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
83350730|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
83350731|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
83350732|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
83350733|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
83350734|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350735|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83350736|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83350737|NCT01724021|Protective Agents|protective agents|mesh-ancestor
83350738|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83350739|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83350740|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83350741|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350742|NCT05197504|Bevacizumab|bevacizumab|mesh-list
83350743|NCT05197504|Atezolizumab|atezolizumab|mesh-list
83350744|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350745|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350746|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83350747|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83350748|NCT05197504|Growth Substances|growth substances|mesh-ancestor
83350749|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350750|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
83350751|NCT05197504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83350752|NCT05197504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350753|NCT02293096|Metoprolol|metoprolol|mesh-list
83350754|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
83350755|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83350756|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83350757|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
83350758|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
83350759|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350760|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350761|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83350762|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83350763|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83350764|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
83350765|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350766|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350767|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
83350768|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
83350769|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83350770|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83350772|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
83350773|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83350774|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350775|NCT04223752|Tazobactam|tazobactam|mesh-list
83350776|NCT04223752|Ceftolozane|ceftolozane|mesh-list
83350777|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
83350778|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350779|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350780|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83350781|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350782|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350783|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83350784|NCT04187404|Nivolumab|nivolumab|mesh-list
83350785|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350786|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350787|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83350788|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350789|NCT04155580|Decitabine|decitabine|mesh-list
83350790|NCT04155580|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83350791|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350792|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
83350793|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350794|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350795|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350796|NCT01721759|Nivolumab|nivolumab|mesh-list
83350797|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350798|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350799|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83350800|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350801|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
83350802|NCT04776850|Dexamethasone|dexamethasone|mesh-list
83350803|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
83350804|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
83350805|NCT04776850|Busulfan|busulfan|mesh-list
83350806|NCT04776850|Rituximab|rituximab|mesh-list
83350807|NCT04776850|Fludarabine|fludarabine|mesh-list
83350808|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
83350809|NCT04776850|Bortezomib|bortezomib|mesh-list
83350810|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83350811|NCT04776850|Tacrolimus|tacrolimus|mesh-list
83350812|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
83350813|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83350814|NCT04776850|Antibodies|antibodies|mesh-list
83350815|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
83350816|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83350817|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
83350818|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83350819|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83350820|NCT04776850|BB 1101|bb 1101|mesh-list
83350821|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350822|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
83350823|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350824|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350825|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350826|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
83350827|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350828|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350829|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83350830|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83350831|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
83350832|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
83350833|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350834|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83350835|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
83350836|NCT04776850|Hormones|hormones|mesh-ancestor
83350837|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350838|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83350839|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
83350840|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350841|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350842|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
83350843|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83350844|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83350845|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83350846|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
83350847|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350848|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350849|NCT04132648|Curcumin|curcumin|mesh-list
83350850|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83350851|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83350852|NCT04132648|Analgesics|analgesics|mesh-ancestor
83350853|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
83350854|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350855|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350856|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83350857|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350858|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350859|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350860|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350861|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
83350862|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83350863|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
83350864|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350865|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350866|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83350867|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
83350868|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
83350869|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83350871|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350872|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350873|NCT04095208|Nivolumab|nivolumab|mesh-list
83350874|NCT04095208|Relatlimab|relatlimab|mesh-list
83350875|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350876|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350877|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83350878|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350879|NCT05117554|Midazolam|midazolam|mesh-list
83350880|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83350881|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83350882|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350883|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350884|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83350885|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83350886|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83350887|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83350888|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
83350889|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
83350890|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
83350891|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
83350892|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350893|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350894|NCT04093570|Decitabine|decitabine|mesh-list
83350895|NCT04093570|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
83350896|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83350897|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
83350898|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350899|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350900|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83350901|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
83350902|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350903|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350904|NCT02292082|Cefazolin|cefazolin|mesh-list
83350905|NCT02292082|Dexamethasone|dexamethasone|mesh-list
83350906|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
83350907|NCT02292082|Midazolam|midazolam|mesh-list
83350908|NCT02292082|Morphine|morphine|mesh-list
83350909|NCT02292082|Bupivacaine|bupivacaine|mesh-list
83350910|NCT02292082|Propofol|propofol|mesh-list
83350911|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83350912|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
83350913|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
83350914|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350915|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350916|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83350917|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
83350919|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83350920|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83350921|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350922|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
83350923|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
83350924|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350925|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
83350926|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83350927|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83350928|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
83350929|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83350930|NCT02292082|Narcotics|narcotics|mesh-ancestor
83350931|NCT02292082|Analgesics|analgesics|mesh-ancestor
83350932|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83350933|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83350934|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83350935|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83350936|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
83350937|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
83350938|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350939|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350940|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83350941|NCT02292082|Protective Agents|protective agents|mesh-ancestor
83350942|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83350943|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83350944|NCT05072704|Sufentanil|sufentanil|mesh-list
83350945|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
83350947|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83350948|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350949|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83350950|NCT05072704|Analgesics|analgesics|mesh-ancestor
83350951|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
83350952|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83350953|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83350954|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83350955|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83350956|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
83350957|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350958|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350959|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83350960|NCT05072704|Narcotics|narcotics|mesh-ancestor
83350961|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83350962|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83350963|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
83350964|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
83350965|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
83350966|NCT04678336|Fludarabine|fludarabine|mesh-list
83350967|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83350968|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
83350969|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350970|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83350971|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83350972|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
83350973|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350974|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350975|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83350976|NCT03195478|Nivolumab|nivolumab|mesh-list
83350977|NCT03195478|Ipilimumab|ipilimumab|mesh-list
83350978|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83350979|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350980|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83350981|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350982|NCT04607122|Landiolol|landiolol|mesh-list
83350983|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83350984|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83350985|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
83350986|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83350987|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350988|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83350989|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83350991|NCT03099382|Irinotecan|irinotecan|mesh-list
83350992|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83350993|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
83350994|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
83350995|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
83350996|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83350997|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83350998|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83350999|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351000|NCT04590664|Verteporfin|verteporfin|mesh-list
83351001|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83351002|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
83351003|NCT03818776|Durvalumab|durvalumab|mesh-list
83351004|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83351005|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351006|NCT04494412|Zanamivir|zanamivir|mesh-list
83351007|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
83351008|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351009|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351010|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351011|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83351012|NCT03583528|Edotreotide|edotreotide|mesh-list
83351013|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83351014|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351015|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
83351016|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351017|NCT01949337|Prednisone|prednisone|mesh-list
83351018|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351019|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
83351020|NCT01949337|Hormones|hormones|mesh-ancestor
83351021|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351022|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351023|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83351024|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351025|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
83351026|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83351027|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
83351028|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83351029|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
83351030|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351031|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351032|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
83351033|NCT04355832|Glucagon|glucagon|mesh-list
83351034|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83351035|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83351036|NCT04355832|Hormones|hormones|mesh-ancestor
83351037|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351038|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351039|NCT04355832|Incretins|incretins|mesh-ancestor
83351040|NCT02518594|Progesterone|progesterone|mesh-list
83351041|NCT02518594|Progestins|progestins|mesh-ancestor
83351042|NCT02518594|Hormones|hormones|mesh-ancestor
83351043|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351044|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351045|NCT01516593|Cytarabine|cytarabine|mesh-list
83351046|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351047|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
83351048|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351049|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351050|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
83351051|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351052|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351053|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
83351054|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351055|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
83351056|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
83351057|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83351058|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351059|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351060|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
83351061|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83351062|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351063|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351064|NCT02042391|Cytarabine|cytarabine|mesh-list
83351065|NCT02042391|Prednisone|prednisone|mesh-list
83351066|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
83351067|NCT02042391|Rituximab|rituximab|mesh-list
83351068|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
83351069|NCT02042391|Doxorubicin|doxorubicin|mesh-list
83351070|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83351071|NCT02042391|Vincristine|vincristine|mesh-list
83351072|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351073|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
83351074|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351075|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351076|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83351077|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
83351078|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351079|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351080|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83351081|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83351082|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351083|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
83351084|NCT02042391|Hormones|hormones|mesh-ancestor
83351085|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351086|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83351087|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351088|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
83351089|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
83351090|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351091|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83351092|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83351093|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83351094|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351095|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83351096|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
83351097|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
83351098|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
83351099|NCT02461836|Gemcitabine|gemcitabine|mesh-list
83351100|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351101|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
83351102|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351103|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351104|NCT02034981|Crizotinib|crizotinib|mesh-list
83351105|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351106|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83351107|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351108|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351109|NCT01986946|Hydromorphone|hydromorphone|mesh-list
83351110|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83351111|NCT01986946|Narcotics|narcotics|mesh-ancestor
83351112|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351113|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351114|NCT01986946|Analgesics|analgesics|mesh-ancestor
83351115|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
83351116|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351117|NCT01504815|Cisplatin|cisplatin|mesh-list
83351118|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351119|NCT01921335|Trastuzumab|trastuzumab|mesh-list
83351120|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83351121|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351122|NCT02427724|Lidocaine|lidocaine|mesh-list
83351123|NCT02427724|Tetracaine|tetracaine|mesh-list
83351124|NCT02427724|Prilocaine|prilocaine|mesh-list
83351125|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
83351126|NCT02427724|Anesthetics|anesthetics|mesh-list
83351127|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351128|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351129|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
83351130|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351131|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83351132|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83351133|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83351134|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83351135|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351136|NCT01908777|Cytarabine|cytarabine|mesh-list
83351137|NCT01908777|Etoposide|etoposide|mesh-list
83351138|NCT01908777|Melphalan|melphalan|mesh-list
83351139|NCT01908777|Carmustine|carmustine|mesh-list
83351140|NCT01908777|Romidepsin|romidepsin|mesh-list
83351141|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83351142|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351143|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83351144|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83351145|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351146|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351147|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351148|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
83351149|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
83351150|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351151|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351152|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
83351153|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351154|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83351155|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
83351156|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83351157|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83351158|NCT01908777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83351159|NCT03437200|Nivolumab|nivolumab|mesh-list
83351160|NCT03437200|Ipilimumab|ipilimumab|mesh-list
83351161|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83351162|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351163|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83351164|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351165|NCT01903473|Sirolimus|sirolimus|mesh-list
83351166|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83351167|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351168|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83351169|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351170|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
83351171|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351172|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
83351173|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351174|NCT02715726|Atorvastatin|atorvastatin|mesh-list
83351175|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83351176|NCT02715726|Simvastatin|simvastatin|mesh-list
83351177|NCT02715726|Ezetimibe|ezetimibe|mesh-list
83351178|NCT02715726|Alirocumab|alirocumab|mesh-list
83351179|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83351180|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83351181|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83351182|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
83351183|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351184|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83351185|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83351186|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351187|NCT02715726|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83351188|NCT02715726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83351189|NCT02715726|Protease Inhibitors|protease inhibitors|mesh-ancestor
83351190|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
83351191|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351192|NCT01893567|Clobetasol|clobetasol|mesh-list
83351193|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351194|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
83351195|NCT01893567|Hormones|hormones|mesh-ancestor
83351196|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351197|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351198|NCT01485861|Prednisone|prednisone|mesh-list
83351199|NCT01485861|Prednisolone|prednisolone|mesh-list
83351200|NCT01485861|Ipatasertib|ipatasertib|mesh-list
83351201|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351202|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
83351203|NCT01485861|Hormones|hormones|mesh-ancestor
83351204|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351205|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351206|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83351208|NCT01485861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83351209|NCT01485861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351210|NCT01485861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351211|NCT04249596|Tianeptine|tianeptine|mesh-list
83351212|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83351213|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
83351214|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83351215|NCT01476501|Vitamin D|vitamin d|mesh-list
83351216|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
83351217|NCT01476501|Vitamins|vitamins|mesh-ancestor
83351218|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
83351219|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351220|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83351221|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83351222|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
83351223|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83351224|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351225|NCT02464020|Vancomycin|vancomycin|mesh-list
83351226|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83351227|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351228|NCT04756089|Oxytocin|oxytocin|mesh-list
83351229|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
83351230|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83351231|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351232|NCT03397888|Betrixaban|betrixaban|mesh-list
83351233|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83351234|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
83351235|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83351236|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
83351237|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351238|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351239|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
83351240|NCT01886859|Lenalidomide|lenalidomide|mesh-list
83351241|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
83351242|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351243|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83351244|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83351245|NCT01886859|Growth Substances|growth substances|mesh-ancestor
83351246|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
83351247|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351248|NCT01989910|Efavirenz|efavirenz|mesh-list
83351249|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
83351250|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83351251|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83351252|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351253|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351254|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
83351255|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351256|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83351257|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83351258|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83351259|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83351260|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83351261|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83351262|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83351263|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83351264|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83351265|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83351266|NCT02464722|Epinephrine|epinephrine|mesh-list
83351267|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
83351268|NCT02464722|Remifentanil|remifentanil|mesh-list
83351269|NCT02464722|Propofol|propofol|mesh-list
83351270|NCT02464722|Rocuronium|rocuronium|mesh-list
83351271|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83351272|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351273|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351274|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83351275|NCT02464722|Analgesics|analgesics|mesh-ancestor
83351276|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
83351277|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351278|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83351279|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83351280|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83351281|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
83351282|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351283|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351284|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83351285|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
83351286|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
83351287|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83351288|NCT02464722|Narcotics|narcotics|mesh-ancestor
83351289|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83351290|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83351291|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
83351292|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83351293|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
83351294|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
83351295|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
83351296|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83351297|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83351298|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83351299|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83351300|NCT01991548|Insulin|insulin|mesh-list
83351301|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83351302|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351303|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
83351304|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83351305|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351306|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
83351307|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83351308|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
83351309|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351310|NCT01878669|Expectorants|expectorants|mesh-ancestor
83351311|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
83351312|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83351313|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
83351314|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351315|NCT01878669|Protective Agents|protective agents|mesh-ancestor
83351316|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351317|NCT01878669|Antidotes|antidotes|mesh-ancestor
83351318|NCT02461914|Warfarin|warfarin|mesh-list
83351319|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
83351320|NCT01991860|Amisulpride|amisulpride|mesh-list
83351321|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83351322|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83351323|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351324|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351325|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83351326|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83351327|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
83351328|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351329|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351330|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83351331|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
83351332|NCT01873131|Timolol|timolol|mesh-list
83351333|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351334|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83351335|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83351336|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
83351337|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351338|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351339|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83351340|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83351341|NCT02463552|Naproxen|naproxen|mesh-list
83351342|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83351343|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83351344|NCT02463552|Analgesics|analgesics|mesh-ancestor
83351345|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
83351346|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351347|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351348|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351349|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351350|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
83351351|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83351352|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351353|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351354|NCT01992016|Ranolazine|ranolazine|mesh-list
83351355|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83351356|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83351357|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351358|NCT01871571|Leucovorin|leucovorin|mesh-list
83351359|NCT01871571|Bevacizumab|bevacizumab|mesh-list
83351360|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83351361|NCT01871571|Fluorouracil|fluorouracil|mesh-list
83351362|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
83351363|NCT01871571|Antibodies|antibodies|mesh-list
83351364|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
83351365|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83351366|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
83351367|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351368|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83351369|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83351370|NCT01871571|Growth Substances|growth substances|mesh-ancestor
83351371|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351372|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
83351373|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
83351374|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
83351375|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351376|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351377|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351378|NCT01871571|Antidotes|antidotes|mesh-ancestor
83351379|NCT01871571|Protective Agents|protective agents|mesh-ancestor
83351380|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
83351381|NCT01871571|Vitamins|vitamins|mesh-ancestor
83351382|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
83351383|NCT02461368|Triamcinolone|triamcinolone|mesh-list
83351384|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83351385|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83351386|NCT02461368|Lidocaine|lidocaine|mesh-list
83351387|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83351388|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
83351389|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
83351390|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351391|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351392|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
83351393|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351394|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83351395|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83351396|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83351397|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83351398|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351399|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351400|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
83351401|NCT02461368|Hormones|hormones|mesh-ancestor
83351402|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351403|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351404|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
83351405|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351406|NCT01422759|Spironolactone|spironolactone|mesh-list
83351407|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83351408|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
83351409|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351410|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351411|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83351412|NCT01422759|Diuretics|diuretics|mesh-ancestor
83351413|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
83351414|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
83351415|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83351416|NCT01992172|Protective Agents|protective agents|mesh-ancestor
83351417|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351418|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
83351419|NCT03296982|Enoxaparin|enoxaparin|mesh-list
83351420|NCT03296982|Edoxaban|edoxaban|mesh-list
83351421|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
83351422|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83351423|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83351424|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351425|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83351426|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
83351427|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83351428|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
83351429|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351430|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83351431|NCT01895829|Hematinics|hematinics|mesh-ancestor
83351432|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83351433|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83351434|NCT03298698|Prednisone|prednisone|mesh-list
83351435|NCT03298698|Prednisolone|prednisolone|mesh-list
83351436|NCT03298698|Rituximab|rituximab|mesh-list
83351437|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83351438|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351439|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
83351440|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351441|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351442|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351443|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
83351444|NCT03298698|Hormones|hormones|mesh-ancestor
83351445|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351446|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83351447|NCT03389620|Dexamethasone|dexamethasone|mesh-list
83351448|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351449|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
83351450|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
83351451|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351452|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351453|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83351454|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
83351455|NCT03389620|Hormones|hormones|mesh-ancestor
83351456|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351457|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83351458|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351459|NCT02463942|Doxycycline|doxycycline|mesh-list
83351460|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83351461|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351462|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
83351463|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83351464|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83351465|NCT03298542|Golimumab|golimumab|mesh-list
83351466|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83351467|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351468|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351469|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
83351470|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351471|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
83351472|NCT03296670|Alprostadil|alprostadil|mesh-list
83351473|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
83351474|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83351475|NCT03296670|Urological Agents|urological agents|mesh-ancestor
83351476|NCT03298464|Pioglitazone|pioglitazone|mesh-list
83351477|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83351478|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351480|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
83351481|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
83351482|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351483|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83351484|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83351485|NCT04491084|Protective Agents|protective agents|mesh-ancestor
83351486|NCT01852071|Busulfan|busulfan|mesh-list
83351487|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
83351488|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351489|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351490|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
83351491|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351492|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83351493|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351494|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83351495|NCT04084548|Lidocaine|lidocaine|mesh-list
83351496|NCT04084548|Ketamine|ketamine|mesh-list
83351497|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
83351498|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
83351499|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351500|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351501|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
83351502|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351503|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83351504|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83351505|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83351506|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83351507|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351508|NCT04084548|Analgesics|analgesics|mesh-ancestor
83351509|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83351510|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83351511|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
83351512|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83351513|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83351514|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351515|NCT02059642|Metadoxine|metadoxine|mesh-list
83351516|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83351517|NCT03296358|Dexamethasone|dexamethasone|mesh-list
83351518|NCT03296358|Prednisolone|prednisolone|mesh-list
83351519|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351520|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
83351521|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
83351522|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351523|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351524|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83351525|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
83351526|NCT03296358|Hormones|hormones|mesh-ancestor
83351527|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351528|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83351529|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351530|NCT04756323|Vaccines|vaccines|mesh-list
83351531|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
83351532|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351533|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
83351534|NCT00469755|Adapalene|adapalene|mesh-list
83351535|NCT00469755|Tazarotene|tazarotene|mesh-list
83351536|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83351537|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83351538|NCT00469755|Analgesics|analgesics|mesh-ancestor
83351539|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
83351540|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351541|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351542|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351543|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351544|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
83351545|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
83351546|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
83351547|NCT00469755|Vitamins|vitamins|mesh-ancestor
83351548|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
83351549|NCT00453531|Acetylcholine|acetylcholine|mesh-list
83351550|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
83351551|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83351552|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
83351553|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351554|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351555|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351556|NCT03295968|Ibuprofen|ibuprofen|mesh-list
83351557|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83351558|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83351559|NCT03295968|Analgesics|analgesics|mesh-ancestor
83351560|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
83351561|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351562|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351563|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351564|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351565|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83351566|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351567|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351568|NCT03298074|Etoposide|etoposide|mesh-list
83351569|NCT03298074|Apatinib|apatinib|mesh-list
83351570|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83351571|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351572|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83351573|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83351574|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351575|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351576|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83351577|NCT01992874|Niacinamide|niacinamide|mesh-list
83351578|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
83351579|NCT01992874|Vitamins|vitamins|mesh-ancestor
83351580|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
83351581|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351582|NCT04755543|Fluorouracil|fluorouracil|mesh-list
83351583|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351584|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
83351585|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351586|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351587|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351588|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
83351589|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351590|NCT01993108|Naltrexone|naltrexone|mesh-list
83351591|NCT01993108|Methylphenidate|methylphenidate|mesh-list
83351592|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83351593|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83351594|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351595|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
83351596|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351597|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83351598|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83351599|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83351600|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83351601|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351602|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
83351603|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351604|NCT02307526|Bromides|bromides|mesh-list
83351605|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83351606|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
83351607|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83351608|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351609|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351610|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
83351611|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351612|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351613|NCT01371201|Sunitinib|sunitinib|mesh-list
83351614|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351615|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83351616|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83351617|NCT01371201|Growth Substances|growth substances|mesh-ancestor
83351618|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351619|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
83351620|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83351621|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351622|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351623|NCT00436527|Metronidazole|metronidazole|mesh-list
83351624|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351625|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83351626|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83351627|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83351629|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
83351630|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351631|NCT00419367|Vorinostat|vorinostat|mesh-list
83351632|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351633|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83351634|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351635|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351636|NCT01994746|Glucagon|glucagon|mesh-list
83351637|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83351638|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83351639|NCT01994746|Hormones|hormones|mesh-ancestor
83351640|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351641|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351642|NCT01994746|Incretins|incretins|mesh-ancestor
83351643|NCT04034238|Tofacitinib|tofacitinib|mesh-list
83351644|NCT04034238|LMB-100|lmb-100|mesh-list
83351645|NCT04034238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83351646|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83351647|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351648|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351649|NCT04034238|Immunoconjugates|immunoconjugates|mesh-ancestor
83351650|NCT04034238|Immunologic Factors|immunologic factors|mesh-ancestor
83351651|NCT04034238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351652|NCT00291525|Warfarin|warfarin|mesh-list
83351653|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
83351654|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
83351655|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83351656|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351657|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351658|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83351659|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83351660|NCT01337349|Protective Agents|protective agents|mesh-ancestor
83351661|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351662|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
83351663|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83351664|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
83351665|NCT01999348|Timolol|timolol|mesh-list
83351666|NCT01999348|Bimatoprost|bimatoprost|mesh-list
83351667|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83351668|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83351669|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
83351670|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351671|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351672|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351673|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83351674|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83351675|NCT00280761|Fluorouracil|fluorouracil|mesh-list
83351676|NCT00280761|Capecitabine|capecitabine|mesh-list
83351677|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
83351678|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351679|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351680|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351681|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351682|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
83351683|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351684|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83351685|NCT02463318|Melatonin|melatonin|mesh-list
83351686|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
83351687|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351688|NCT02463318|Protective Agents|protective agents|mesh-ancestor
83351689|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351690|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351691|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83351692|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351693|NCT01436968|Valacyclovir|valacyclovir|mesh-list
83351694|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
83351695|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351696|NCT02462772|Cabotegravir|cabotegravir|mesh-list
83351697|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83351698|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83351699|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83351700|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83351701|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83351702|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83351703|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351704|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351706|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83351707|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
83351708|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351709|NCT02716194|Factor VIII|factor viii|mesh-list
83351710|NCT02716194|Coagulants|coagulants|mesh-ancestor
83351711|NCT02461056|Ibuprofen|ibuprofen|mesh-list
83351712|NCT02461056|Hydromorphone|hydromorphone|mesh-list
83351713|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83351714|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83351715|NCT02461056|Analgesics|analgesics|mesh-ancestor
83351716|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
83351717|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351718|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351719|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351720|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351721|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83351722|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351723|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351724|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83351725|NCT02461056|Narcotics|narcotics|mesh-ancestor
83351726|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351728|NCT01173172|Trace Elements|trace elements|mesh-ancestor
83351729|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
83351730|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351731|NCT00003270|Cyclosporine|cyclosporine|mesh-list
83351732|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
83351733|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
83351734|NCT00003270|Busulfan|busulfan|mesh-list
83351735|NCT00003270|Cyclosporins|cyclosporins|mesh-list
83351736|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83351737|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351738|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
83351739|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351740|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351741|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83351742|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
83351743|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351744|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351745|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83351746|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351747|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
83351748|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351749|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
83351750|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83351751|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351752|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
83351753|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
83351754|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351755|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83351756|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
83351757|NCT00003270|Hormones|hormones|mesh-ancestor
83351758|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351759|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83351760|NCT00003270|Protective Agents|protective agents|mesh-ancestor
83351761|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
83351762|NCT02005354|Anesthetics|anesthetics|mesh-list
83351763|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
83351764|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351765|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351766|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
83351767|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351768|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83351769|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
83351770|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83351771|NCT02005354|Analgesics|analgesics|mesh-ancestor
83351772|NCT03290820|Aspirin|aspirin|mesh-list
83351773|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83351774|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83351775|NCT03290820|Analgesics|analgesics|mesh-ancestor
83351776|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
83351777|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351778|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351779|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351780|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83351781|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83351782|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83351783|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351784|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83351785|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83351786|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351787|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
83351788|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83351789|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
83351790|NCT03773484|Narcotics|narcotics|mesh-ancestor
83351791|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351792|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351794|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
83351795|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351796|NCT03283410|Propofol|propofol|mesh-list
83351797|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83351798|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351799|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351800|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83351801|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
83351802|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
83351803|NCT04318704|Ifenprodil|ifenprodil|mesh-list
83351804|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83351805|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83351806|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
83351807|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351808|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351809|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351810|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
83351811|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83351812|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83351813|NCT03283176|Folic Acid|folic acid|mesh-list
83351814|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
83351815|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
83351816|NCT03283176|Vitamins|vitamins|mesh-ancestor
83351817|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
83351818|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351819|NCT03283176|Hematinics|hematinics|mesh-ancestor
83351820|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
83351821|NCT03290430|Nicotine|nicotine|mesh-list
83351822|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83351823|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
83351824|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351825|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351826|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83351827|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83351828|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
83351829|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351830|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351831|NCT03294798|Interferons|interferons|mesh-list
83351832|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
83351833|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
83351834|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83351835|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351836|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
83351837|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351838|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
83351839|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351840|NCT04488744|Nicotine|nicotine|mesh-list
83351841|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83351842|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
83351843|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351844|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351845|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83351846|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83351847|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
83351848|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351849|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351850|NCT02005666|Clindamycin|clindamycin|mesh-list
83351851|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
83351852|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
83351853|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83351855|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351856|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83351857|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351858|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351859|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
83351860|NCT03283020|Naltrexone|naltrexone|mesh-list
83351861|NCT03283020|Remifentanil|remifentanil|mesh-list
83351862|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
83351863|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83351864|NCT03283020|Narcotics|narcotics|mesh-ancestor
83351865|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351866|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351867|NCT03283020|Analgesics|analgesics|mesh-ancestor
83351868|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
83351869|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351870|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83351871|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83351872|NCT00494182|Paclitaxel|paclitaxel|mesh-list
83351873|NCT00494182|Carboplatin|carboplatin|mesh-list
83351874|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83351875|NCT00494182|Sorafenib|sorafenib|mesh-list
83351876|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83351877|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351878|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
83351879|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
83351880|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
83351881|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351882|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83351883|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351884|NCT02006056|Ondansetron|ondansetron|mesh-list
83351885|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
83351886|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
83351887|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351888|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351889|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83351890|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
83351891|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
83351892|NCT02006056|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83351893|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83351894|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
83351895|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83351896|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351897|NCT03290196|Bupivacaine|bupivacaine|mesh-list
83351898|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
83351899|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
83351900|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351901|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351902|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
83351903|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351904|NCT02006836|Insulin|insulin|mesh-list
83351905|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83351906|NCT02006836|Metformin|metformin|mesh-list
83351907|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
83351908|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83351909|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351910|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
83351911|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83351912|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351913|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83351914|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83351915|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351916|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351917|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351918|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83351919|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83351920|NCT03294486|Flucytosine|flucytosine|mesh-list
83351921|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
83351922|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83351923|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
83351924|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351925|NCT03294252|Leucovorin|leucovorin|mesh-list
83351926|NCT03294252|Folic Acid|folic acid|mesh-list
83351927|NCT03294252|Fluorouracil|fluorouracil|mesh-list
83351928|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
83351929|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
83351930|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
83351931|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351932|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351933|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351934|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351935|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
83351936|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351937|NCT03294252|Antidotes|antidotes|mesh-ancestor
83351938|NCT03294252|Protective Agents|protective agents|mesh-ancestor
83351939|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
83351941|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
83351942|NCT03294252|Hematinics|hematinics|mesh-ancestor
83351943|NCT03294174|Ropivacaine|ropivacaine|mesh-list
83351944|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
83351946|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83351947|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351948|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
83351949|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351950|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
83351951|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
83351952|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83351953|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83351954|NCT03289338|Prednisolone|prednisolone|mesh-list
83351955|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
83351956|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83351957|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
83351958|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83351959|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
83351960|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
83351961|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83351962|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351963|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83351964|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
83351965|NCT03289338|Hormones|hormones|mesh-ancestor
83351966|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83351967|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83351968|NCT03289338|Protective Agents|protective agents|mesh-ancestor
83351969|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83351970|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351971|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83351972|NCT02069704|Leucovorin|leucovorin|mesh-list
83351973|NCT02069704|Folic Acid|folic acid|mesh-list
83351974|NCT02069704|Bevacizumab|bevacizumab|mesh-list
83351975|NCT02069704|Fluorouracil|fluorouracil|mesh-list
83351976|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
83351977|NCT02069704|Irinotecan|irinotecan|mesh-list
83351978|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
83351979|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83351980|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83351981|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83351982|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83351983|NCT02069704|Growth Substances|growth substances|mesh-ancestor
83351984|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83351985|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
83351986|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
83351987|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83351988|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83351989|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83351990|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
83351991|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83351992|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83351993|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83351994|NCT02069704|Antidotes|antidotes|mesh-ancestor
83351995|NCT02069704|Protective Agents|protective agents|mesh-ancestor
83351996|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
83351997|NCT02069704|Vitamins|vitamins|mesh-ancestor
83351998|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
83351999|NCT02069704|Hematinics|hematinics|mesh-ancestor
83352000|NCT02314546|Lidocaine|lidocaine|mesh-list
83352001|NCT02314546|Midazolam|midazolam|mesh-list
83352002|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83352003|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83352004|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352005|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352006|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83352007|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83352008|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83352009|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83352010|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
83352012|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
83352013|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
83352014|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352015|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352016|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
83352017|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
83352018|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352019|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83352020|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83352022|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83352023|NCT03289260|Imiquimod|imiquimod|mesh-list
83352024|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83352025|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
83352026|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352027|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352028|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
83352029|NCT03289182|Rituximab|rituximab|mesh-list
83352030|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83352031|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352032|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
83352033|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352034|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352035|NCT03289026|Aripiprazole|aripiprazole|mesh-list
83352036|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
83352037|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83352038|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83352039|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83352040|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352041|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352042|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
83352043|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
83352044|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352045|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352046|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83352047|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83352048|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
83352049|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83352050|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83352051|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83352052|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83352053|NCT02460510|Mannitol|mannitol|mesh-list
83352054|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83352055|NCT02460510|Diuretics|diuretics|mesh-ancestor
83352056|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
83352057|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352058|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
83352059|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83352060|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83352061|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83352062|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83352063|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352064|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
83352065|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352066|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352067|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83352068|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352069|NCT03288870|Docetaxel|docetaxel|mesh-list
83352070|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352071|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
83352072|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
83352073|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
83352074|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352075|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
83352076|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
83352077|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352078|NCT02460354|Metformin|metformin|mesh-list
83352079|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83352080|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352081|NCT02008942|Aspirin|aspirin|mesh-list
83352082|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83352083|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83352085|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
83352086|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352087|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352088|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352089|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352090|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83352091|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83352092|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352093|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83352094|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83352095|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352096|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
83352097|NCT03288636|Ritonavir|ritonavir|mesh-list
83352098|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83352099|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83352100|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
83352101|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352102|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352103|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83352104|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83352105|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
83352106|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352107|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83352108|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83352109|NCT03293472|Bupivacaine|bupivacaine|mesh-list
83352110|NCT03293472|Ropivacaine|ropivacaine|mesh-list
83352111|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
83352112|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
83352113|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352114|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352115|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
83352116|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352117|NCT02071810|Opicapone|opicapone|mesh-list
83352118|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83352119|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352120|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352121|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83352122|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83352123|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
83352124|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83352125|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352126|NCT01959490|Paclitaxel|paclitaxel|mesh-list
83352127|NCT01959490|Docetaxel|docetaxel|mesh-list
83352128|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
83352129|NCT01959490|Bevacizumab|bevacizumab|mesh-list
83352130|NCT01959490|Carboplatin|carboplatin|mesh-list
83352131|NCT01959490|Doxorubicin|doxorubicin|mesh-list
83352132|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83352133|NCT01959490|Trastuzumab|trastuzumab|mesh-list
83352134|NCT01959490|Pertuzumab|pertuzumab|mesh-list
83352135|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83352136|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352137|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
83352138|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
83352139|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
83352140|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352141|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83352142|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
83352143|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352144|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352145|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83352146|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
83352147|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83352148|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83352149|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83352150|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83352151|NCT01959490|Growth Substances|growth substances|mesh-ancestor
83352152|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
83352153|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83352154|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83352155|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83352156|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352157|NCT03288402|Caffeine|caffeine|mesh-list
83352158|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83352159|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352160|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83352161|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352162|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352163|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83352164|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83352165|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
83352166|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352167|NCT02341144|Ropivacaine|ropivacaine|mesh-list
83352168|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
83352169|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
83352170|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352171|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352172|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
83352173|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352174|NCT02011516|Baclofen|baclofen|mesh-list
83352175|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83352176|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352177|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83352178|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352179|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
83352180|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
83352181|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
83352182|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352183|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352184|NCT04349410|Interferons|interferons|mesh-list
83352185|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
83352186|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
83352187|NCT04349410|Remdesivir|remdesivir|mesh-list
83352188|NCT04349410|Azithromycin|azithromycin|mesh-list
83352189|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
83352190|NCT04349410|Doxycycline|doxycycline|mesh-list
83352191|NCT04349410|Clindamycin|clindamycin|mesh-list
83352192|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
83352193|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
83352194|NCT04349410|Primaquine|primaquine|mesh-list
83352195|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
83352196|NCT04349410|Losartan|losartan|mesh-list
83352197|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352198|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
83352199|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352200|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352201|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
83352202|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
83352203|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352204|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352205|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83352206|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
83352207|NCT04349410|Hormones|hormones|mesh-ancestor
83352208|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352209|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83352210|NCT04349410|Protective Agents|protective agents|mesh-ancestor
83352211|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
83352212|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83352213|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
83352214|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83352215|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83352216|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352217|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352218|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352219|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83352220|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83352221|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83352222|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83352223|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83352224|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
83352225|NCT03287388|Rocuronium|rocuronium|mesh-list
83352226|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83352227|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83352228|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83352229|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352230|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352231|NCT03293004|Vitamins|vitamins|mesh-list
83352232|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
83352233|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
83352234|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352236|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352237|NCT03293004|Protective Agents|protective agents|mesh-ancestor
83352238|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
83352239|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
83352240|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352241|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352242|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352243|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
83352244|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
83352245|NCT03282162|Oxytocin|oxytocin|mesh-list
83352246|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
83352247|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352248|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352249|NCT03287076|Exenatide|exenatide|mesh-list
83352250|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83352251|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352252|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83352253|NCT03287076|Incretins|incretins|mesh-ancestor
83352254|NCT03287076|Hormones|hormones|mesh-ancestor
83352255|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352256|NCT02460276|Rituximab|rituximab|mesh-list
83352257|NCT02460276|Lenalidomide|lenalidomide|mesh-list
83352258|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83352259|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352260|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
83352261|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352262|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352263|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83352264|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83352265|NCT02460276|Growth Substances|growth substances|mesh-ancestor
83352266|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
83352267|NCT02460432|Paclitaxel|paclitaxel|mesh-list
83352268|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83352269|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352270|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83352271|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83352272|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83352273|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352274|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
83352275|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83352276|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352277|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83352278|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
83352279|NCT03281928|Diuretics|diuretics|mesh-ancestor
83352280|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
83352281|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352282|NCT03281928|Expectorants|expectorants|mesh-ancestor
83352283|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
83352284|NCT03286764|Peppermint oil|peppermint oil|mesh-list
83352285|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
83352286|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
83352287|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352288|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352289|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83352290|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
83352291|NCT03281694|Nicotine|nicotine|mesh-list
83352292|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83352293|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
83352294|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352295|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352296|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83352297|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83352298|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83352299|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352300|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352301|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
83352302|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83352303|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
83352304|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83352305|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352306|NCT03291054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83352307|NCT03291054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352308|NCT03286296|Antibodies|antibodies|mesh-list
83352309|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83352310|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
83352311|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352312|NCT03285906|Apatinib|apatinib|mesh-list
83352313|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352314|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83352315|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352316|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352317|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83352318|NCT01895205|Hematinics|hematinics|mesh-ancestor
83352319|NCT01748175|Triamcinolone|triamcinolone|mesh-list
83352320|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83352321|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83352322|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83352323|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352324|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
83352325|NCT01748175|Hormones|hormones|mesh-ancestor
83352326|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352327|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352328|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83352329|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
83352330|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352331|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352332|NCT04755387|Ticagrelor|ticagrelor|mesh-list
83352333|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83352334|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83352335|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83352336|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83352337|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
83352338|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352339|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352340|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352341|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
83352342|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83352343|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83352344|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
83352345|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352346|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83352347|NCT03285360|Fluorides|fluorides|mesh-list
83352348|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
83352349|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
83352350|NCT03285360|Protective Agents|protective agents|mesh-ancestor
83352351|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352352|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83352353|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83352354|NCT00160173|Estradiol|estradiol|mesh-list
83352355|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83352356|NCT00160173|Estrogens|estrogens|mesh-ancestor
83352357|NCT00160173|Hormones|hormones|mesh-ancestor
83352358|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352359|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352360|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83352361|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
83352362|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352363|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83352364|NCT00136695|Anastrozole|anastrozole|mesh-list
83352365|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83352366|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352367|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83352368|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83352369|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352370|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352371|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83352372|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
83352373|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352374|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352375|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
83352376|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352377|NCT02459574|Amiodarone|amiodarone|mesh-list
83352378|NCT02459574|Sotalol|sotalol|mesh-list
83352379|NCT02459574|Flecainide|flecainide|mesh-list
83352380|NCT02459574|Propafenone|propafenone|mesh-list
83352381|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83352382|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
83352383|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83352384|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352385|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83352386|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83352387|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
83352388|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352389|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352390|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
83352391|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83352392|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83352393|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83352394|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83352395|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83352396|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352397|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83352398|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83352399|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83352400|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
83352401|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
83352402|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352403|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83352404|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83352405|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352406|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
83352407|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83352408|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83352409|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352410|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
83352411|NCT03280212|Coagulants|coagulants|mesh-ancestor
83352412|NCT03536520|Acetazolamide|acetazolamide|mesh-list
83352413|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
83352414|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83352415|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352416|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352417|NCT03536520|Diuretics|diuretics|mesh-ancestor
83352418|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
83352419|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352420|NCT01673217|Doxorubicin|doxorubicin|mesh-list
83352421|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83352422|NCT01673217|Decitabine|decitabine|mesh-list
83352423|NCT01673217|Azacitidine|azacitidine|mesh-list
83352424|NCT01673217|Vaccines|vaccines|mesh-list
83352425|NCT01673217|Sargramostim|sargramostim|mesh-list
83352426|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
83352427|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
83352428|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352429|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83352430|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352431|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83352432|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83352433|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352434|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352435|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83352436|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
83352437|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83352438|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
83352439|NCT03475134|Nivolumab|nivolumab|mesh-list
83352440|NCT03475134|Fludarabine|fludarabine|mesh-list
83352441|NCT03475134|Interleukin-2|interleukin-2|mesh-list
83352442|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83352443|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
83352444|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352445|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352446|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83352447|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
83352448|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352449|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352450|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83352451|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83352452|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83352453|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83352454|NCT03475134|Analgesics|analgesics|mesh-ancestor
83352455|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
83352456|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352457|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
83352458|NCT01668849|Fentanyl|fentanyl|mesh-list
83352459|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83352460|NCT01668849|Narcotics|narcotics|mesh-ancestor
83352461|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352462|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352463|NCT01668849|Analgesics|analgesics|mesh-ancestor
83352464|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
83352465|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352466|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83352467|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83352468|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
83352469|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
83352470|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83352471|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83352472|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352473|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352474|NCT01252719|Vancomycin|vancomycin|mesh-list
83352475|NCT01252719|Oritavancin|oritavancin|mesh-list
83352476|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83352477|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352478|NCT01230411|Ibuprofen|ibuprofen|mesh-list
83352479|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83352480|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83352481|NCT01230411|Analgesics|analgesics|mesh-ancestor
83352482|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
83352483|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352484|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352485|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352486|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352487|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83352488|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352489|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352490|NCT03283800|Copper|copper|mesh-list
83352491|NCT03283800|Trace Elements|trace elements|mesh-ancestor
83352492|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
83352493|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352494|NCT01962688|Diuretics|diuretics|mesh-list
83352495|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
83352496|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352497|NCT03274596|Vitamin E|vitamin e|mesh-list
83352498|NCT03274596|Vitamins|vitamins|mesh-ancestor
83352499|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
83352500|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352501|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
83352502|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352503|NCT03274596|Protective Agents|protective agents|mesh-ancestor
83352504|NCT01963078|Oxytocin|oxytocin|mesh-list
83352505|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
83352506|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352507|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352508|NCT03269760|Zolpidem|zolpidem|mesh-list
83352509|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83352510|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83352511|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352512|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352513|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83352514|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
83352515|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
83352516|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352517|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352518|NCT03269916|Hormones|hormones|mesh-list
83352519|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83352520|NCT03269916|Estrogens|estrogens|mesh-list
83352521|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352522|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352523|NCT02346916|Capsaicin|capsaicin|mesh-list
83352524|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
83352525|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
83352526|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
83352527|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352528|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352529|NCT02458482|Albuterol|albuterol|mesh-list
83352530|NCT02458482|Ipratropium|ipratropium|mesh-list
83352531|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83352532|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
83352533|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352534|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352535|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83352536|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
83352537|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
83352538|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352539|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83352540|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83352541|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83352542|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
83352543|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352544|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352545|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83352546|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
83352547|NCT03273192|Adalimumab|adalimumab|mesh-list
83352548|NCT03273192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83352549|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352550|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352551|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83352552|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83352553|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352554|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
83352555|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
83352556|NCT02349178|Etoposide|etoposide|mesh-list
83352557|NCT02349178|Clofarabine|clofarabine|mesh-list
83352558|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83352559|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
83352560|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352561|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352562|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83352563|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
83352564|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352565|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352566|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83352567|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83352568|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83352569|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83352570|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352571|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83352572|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
83352573|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83352574|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352575|NCT05075460|Azacitidine|azacitidine|mesh-list
83352576|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83352577|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
83352578|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352579|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352580|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352581|NCT01966978|Insulin|insulin|mesh-list
83352582|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83352583|NCT01966978|Metformin|metformin|mesh-list
83352584|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
83352585|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
83352586|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83352587|NCT01966978|Liraglutide|liraglutide|mesh-list
83352588|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
83352589|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83352590|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352591|NCT01966978|Incretins|incretins|mesh-ancestor
83352592|NCT01966978|Hormones|hormones|mesh-ancestor
83352593|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352594|NCT03269214|Phenytoin|phenytoin|mesh-list
83352595|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
83352596|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83352597|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83352598|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83352599|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352600|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83352601|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83352602|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
83352603|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83352604|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352605|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83352606|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352607|NCT05074602|Fluconazole|fluconazole|mesh-list
83352608|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
83352609|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352610|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83352611|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83352613|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352614|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83352615|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
83352616|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352617|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352618|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83352619|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83352620|NCT02457312|Letrozole|letrozole|mesh-list
83352621|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352622|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83352623|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83352624|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352625|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352626|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83352627|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
83352628|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352629|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352630|NCT03268902|Niacinamide|niacinamide|mesh-list
83352631|NCT03268902|Niacin|niacin|mesh-list
83352632|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
83352633|NCT03268902|Azithromycin|azithromycin|mesh-list
83352634|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
83352635|NCT03268902|Vitamins|vitamins|mesh-ancestor
83352636|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
83352637|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352638|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83352639|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352640|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
83352641|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83352642|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
83352643|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352644|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83352645|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
83352646|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83352647|NCT02458716|Leuprolide|leuprolide|mesh-list
83352648|NCT02458716|Bicalutamide|bicalutamide|mesh-list
83352649|NCT02458716|Androgens|androgens|mesh-list
83352650|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
83352651|NCT02458716|Hormones|hormones|mesh-ancestor
83352652|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352653|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352654|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83352655|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
83352656|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352657|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83352658|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352659|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
83352660|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
83352661|NCT03268278|Lidocaine|lidocaine|mesh-list
83352662|NCT03268278|Epinephrine|epinephrine|mesh-list
83352663|NCT03268278|Buprenorphine|buprenorphine|mesh-list
83352664|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
83352665|NCT03268278|Anesthetics|anesthetics|mesh-list
83352666|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352667|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352668|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
83352669|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352670|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83352671|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83352672|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83352673|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83352674|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352675|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83352676|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83352677|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
83352678|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352679|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83352680|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83352681|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
83352682|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83352683|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
83352684|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
83352686|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83352687|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83352688|NCT03268278|Narcotics|narcotics|mesh-ancestor
83352689|NCT03268278|Analgesics|analgesics|mesh-ancestor
83352690|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83352691|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
83352692|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83352693|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
83352694|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352695|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
83352696|NCT05045586|Protective Agents|protective agents|mesh-ancestor
83352697|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
83352698|NCT03263520|Dexamethasone|dexamethasone|mesh-list
83352699|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
83352700|NCT03263520|Nandrolone|nandrolone|mesh-list
83352701|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
83352702|NCT03263520|BB 1101|bb 1101|mesh-list
83352703|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352704|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
83352705|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
83352706|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352707|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352708|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83352709|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
83352710|NCT03263520|Hormones|hormones|mesh-ancestor
83352711|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352712|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83352713|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352714|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
83352715|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352716|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352717|NCT03263520|Androgens|androgens|mesh-ancestor
83352718|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
83352719|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83352720|NCT02456844|Leucovorin|leucovorin|mesh-list
83352721|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
83352722|NCT02456844|Methotrexate|methotrexate|mesh-list
83352723|NCT02456844|Digoxin|digoxin|mesh-list
83352724|NCT02456844|Midazolam|midazolam|mesh-list
83352725|NCT02456844|Pravastatin|pravastatin|mesh-list
83352726|NCT02456844|Montelukast|montelukast|mesh-list
83352727|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83352728|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
83352729|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352730|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352731|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83352732|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
83352733|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352734|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352735|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
83352736|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352737|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83352738|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83352739|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
83352740|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352741|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83352742|NCT02456844|Antidotes|antidotes|mesh-ancestor
83352743|NCT02456844|Protective Agents|protective agents|mesh-ancestor
83352744|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
83352745|NCT02456844|Vitamins|vitamins|mesh-ancestor
83352746|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
83352747|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83352748|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83352749|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352750|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83352751|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83352752|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83352753|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83352754|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
83352755|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
83352756|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
83352757|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
83352758|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352759|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83352760|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
83352761|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83352762|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
83352763|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352764|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83352765|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83352766|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83352767|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83352768|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83352769|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83352770|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83352771|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83352772|NCT02456844|Analgesics|analgesics|mesh-ancestor
83352773|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
83352774|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352775|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83352776|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83352777|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352778|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83352779|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
83352780|NCT03263208|Fludarabine|fludarabine|mesh-list
83352781|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83352782|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
83352783|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352784|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352785|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83352786|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
83352787|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352788|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352789|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83352790|NCT04630002|Ritonavir|ritonavir|mesh-list
83352791|NCT04630002|Darunavir|darunavir|mesh-list
83352792|NCT04630002|Etravirine|etravirine|mesh-list
83352793|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83352794|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83352795|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
83352796|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352797|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352798|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83352799|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83352800|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
83352801|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352802|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83352803|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83352804|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83352805|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83352806|NCT03259542|Itraconazole|itraconazole|mesh-list
83352807|NCT03259542|Mifepristone|mifepristone|mesh-list
83352808|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
83352809|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352810|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83352811|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83352812|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352813|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352814|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83352815|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
83352816|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352817|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352818|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83352819|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83352820|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
83352821|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352822|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83352823|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83352824|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83352825|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
83352826|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83352827|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83352828|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
83352829|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83352830|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83352831|NCT03267654|Apatinib|apatinib|mesh-list
83352832|NCT03267654|Gefitinib|gefitinib|mesh-list
83352833|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352834|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83352835|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352836|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352837|NCT03263052|Tacrolimus|tacrolimus|mesh-list
83352838|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83352839|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
83352840|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352841|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83352842|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352843|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352844|NCT03267030|Eryaspase|eryaspase|mesh-list
83352845|NCT03267030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83352846|NCT03259152|Denosumab|denosumab|mesh-list
83352847|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83352848|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352849|NCT02456142|Morphine|morphine|mesh-list
83352850|NCT02456142|Bupivacaine|bupivacaine|mesh-list
83352851|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
83352852|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
83352853|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352854|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352855|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
83352856|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352857|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83352858|NCT02456142|Narcotics|narcotics|mesh-ancestor
83352859|NCT02456142|Analgesics|analgesics|mesh-ancestor
83352860|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83352861|NCT03262740|Norethindrone|norethindrone|mesh-list
83352862|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
83352863|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
83352864|NCT03262740|Estradiol|estradiol|mesh-list
83352865|NCT03262740|Branebrutinib|branebrutinib|mesh-list
83352866|NCT03262740|Estrogens|estrogens|mesh-ancestor
83352867|NCT03262740|Hormones|hormones|mesh-ancestor
83352868|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352869|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352870|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83352871|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
83352872|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352873|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83352874|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83352875|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83352876|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83352877|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83352878|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
83352879|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83352880|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352881|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352882|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83352883|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83352884|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352885|NCT03258684|Thiamine|thiamine|mesh-list
83352886|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
83352887|NCT03258684|Vitamins|vitamins|mesh-ancestor
83352888|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
83352889|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352890|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352891|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
83352892|NCT03266250|Anesthetics|anesthetics|mesh-list
83352893|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352894|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352895|NCT03258372|Rifampin|rifampin|mesh-list
83352896|NCT03258372|Mifepristone|mifepristone|mesh-list
83352897|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83352898|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
83352899|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83352900|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83352901|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
83352902|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83352903|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479852|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352904|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352905|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83352906|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83352907|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83352908|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83352909|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83352910|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83352911|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83352912|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
83352913|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83352914|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352915|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83352916|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83352917|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83352918|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
83352919|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83352920|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83352921|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
83352922|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83352923|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
83352924|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83352925|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83352927|NCT02456454|Risperidone|risperidone|mesh-list
83352928|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83352929|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
83352930|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352931|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352932|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352933|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83352934|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83352935|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352936|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83352937|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83352938|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
83352939|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
83352940|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352941|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
83352942|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
83352943|NCT03258294|Melatonin|melatonin|mesh-list
83352944|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
83352945|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352946|NCT03258294|Protective Agents|protective agents|mesh-ancestor
83352947|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352948|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352949|NCT03265782|Acetaminophen|acetaminophen|mesh-list
83352950|NCT03265782|Ibuprofen|ibuprofen|mesh-list
83352951|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83352952|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83352953|NCT03265782|Analgesics|analgesics|mesh-ancestor
83352954|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
83352955|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352956|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352957|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83352958|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83352959|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83352960|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83352961|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352962|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
83352963|NCT03798054|Insulin|insulin|mesh-list
83352964|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83352965|NCT03798054|Metformin|metformin|mesh-list
83352966|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
83352967|NCT03798054|Lixisenatide|lixisenatide|mesh-list
83352968|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
83352969|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83352970|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352971|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352972|NCT03265470|Fentanyl|fentanyl|mesh-list
83352973|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
83352974|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83479853|NCT04930315|Apatinib|apatinib|mesh-list
83352975|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83352976|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83352977|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83352978|NCT03265470|Analgesics|analgesics|mesh-ancestor
83352979|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
83352980|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83352981|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83352982|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83352983|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83352984|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
83352985|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352986|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352987|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83352988|NCT03265470|Narcotics|narcotics|mesh-ancestor
83352989|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83352990|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83352991|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
83352992|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
83352993|NCT02019940|Riluzole|riluzole|mesh-list
83352994|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
83352995|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83352996|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83352997|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83352998|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83352999|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353000|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83353001|NCT02019940|Protective Agents|protective agents|mesh-ancestor
83353002|NCT01229943|Bevacizumab|bevacizumab|mesh-list
83353003|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83353004|NCT01229943|Everolimus|everolimus|mesh-list
83353005|NCT01229943|Octreotide|octreotide|mesh-list
83353006|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
83353007|NCT01229943|Antibodies|antibodies|mesh-list
83353008|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
83353009|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83353010|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
83353011|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353012|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83353013|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83353014|NCT01229943|Growth Substances|growth substances|mesh-ancestor
83353015|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353016|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
83353017|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
83353018|NCT01229943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83353019|NCT01229943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353020|NCT01229943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353021|NCT01229943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353022|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353023|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353024|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83353025|NCT02020408|Raclopride|raclopride|mesh-list
83353026|NCT02020408|Amphetamine|amphetamine|mesh-list
83353027|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
83353028|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83353029|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353030|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
83353031|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
83353032|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353033|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
83353034|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353035|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353036|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
83353037|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83353038|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83353039|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353040|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83353041|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83353042|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83353043|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353044|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83353045|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83353046|NCT01219257|Adalimumab|adalimumab|mesh-list
83353047|NCT01219257|Infliximab|infliximab|mesh-list
83353048|NCT01219257|Golimumab|golimumab|mesh-list
83353049|NCT01219257|Etanercept|etanercept|mesh-list
83353050|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83353051|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353052|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353053|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
83353054|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353055|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83353056|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353057|NCT01219257|Analgesics|analgesics|mesh-ancestor
83353058|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
83353059|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353060|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353061|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353062|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
83353063|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83353064|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83353065|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353066|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83353067|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83353068|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353069|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353070|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
83353071|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353072|NCT04389801|Deferoxamine|deferoxamine|mesh-list
83353073|NCT04389801|Siderophores|siderophores|mesh-ancestor
83353074|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
83353075|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
83353076|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
83353077|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353078|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
83353079|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83353080|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
83353081|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83353082|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
83353083|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353084|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353085|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
83353086|NCT03548220|Mitapivat|mitapivat|mesh-list
83353087|NCT03548220|Enzyme Activators|enzyme activators|mesh-ancestor
83353088|NCT03548220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353089|NCT03257670|Lidocaine|lidocaine|mesh-list
83353090|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353091|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
83353092|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353093|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353094|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
83353095|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353096|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353097|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83353098|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83353099|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353100|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353101|NCT03265002|Psyllium|psyllium|mesh-list
83353102|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
83353103|NCT03265002|Cathartics|cathartics|mesh-ancestor
83353104|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353105|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
83353106|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
83353107|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
83353108|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353109|NCT03257514|Protective Agents|protective agents|mesh-ancestor
83353110|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353111|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
83353112|NCT03257514|Vitamins|vitamins|mesh-ancestor
83353113|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
83353114|NCT04781751|Insulin|insulin|mesh-list
83353115|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83353116|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353117|NCT04643379|Carboplatin|carboplatin|mesh-list
83353118|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
83353119|NCT04643379|Olaparib|olaparib|mesh-list
83353120|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353121|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83353122|NCT04643379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83353123|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353124|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83353125|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353126|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83353127|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353129|NCT03261024|Trace Elements|trace elements|mesh-ancestor
83353130|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
83353131|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353132|NCT04777383|Atropine|atropine|mesh-list
83353133|NCT04777383|Phenylephrine|phenylephrine|mesh-list
83353134|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
83353135|NCT04777383|Norepinephrine|norepinephrine|mesh-list
83353137|NCT04777383|Neostigmine|neostigmine|mesh-list
83353138|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83353139|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
83353140|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
83353141|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353142|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353143|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
83353144|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83353145|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
83353146|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
83353147|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83353148|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83353149|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83353150|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
83353151|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353152|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353153|NCT04777383|Protective Agents|protective agents|mesh-ancestor
83353154|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83353155|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353156|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83353157|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83353158|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
83353159|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83353160|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83353161|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
83353162|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83353163|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353164|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83353165|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
83353166|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83353167|NCT03257124|Osimertinib|osimertinib|mesh-list
83353168|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353169|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353170|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353171|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353172|NCT02089113|Dexamethasone|dexamethasone|mesh-list
83353173|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353174|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
83353175|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
83353176|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353177|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353178|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353179|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
83353180|NCT02089113|Hormones|hormones|mesh-ancestor
83353181|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353182|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83353183|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353184|NCT04780659|Vaccines|vaccines|mesh-list
83353185|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
83353186|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353187|NCT03260634|Voriconazole|voriconazole|mesh-list
83353188|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
83353189|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353190|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83353191|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83353192|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353193|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353194|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83353195|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
83353196|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353197|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353198|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83353199|NCT04777227|Lidocaine|lidocaine|mesh-list
83353200|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353201|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
83353202|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353203|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353204|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
83353205|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353206|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353207|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83353208|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83353210|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353211|NCT03260556|Pirfenidone|pirfenidone|mesh-list
83353212|NCT03260556|Analgesics|analgesics|mesh-ancestor
83353213|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
83353214|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353215|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353216|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83353217|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353218|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353219|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353220|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353221|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83353222|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83353223|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353224|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83353225|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83353226|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353227|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353228|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
83353229|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353230|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83353231|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
83353232|NCT03252366|Coagulants|coagulants|mesh-ancestor
83353233|NCT04346277|Antibodies|antibodies|mesh-list
83353234|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83353235|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
83353236|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353237|NCT03573960|Lenvatinib|lenvatinib|mesh-list
83353238|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353239|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353240|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353241|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353242|NCT04780347|Paclitaxel|paclitaxel|mesh-list
83353243|NCT04780347|Capecitabine|capecitabine|mesh-list
83353244|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83353245|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83353246|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353247|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83353248|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83353249|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83353250|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353251|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83353252|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
83353253|NCT02455596|Interferons|interferons|mesh-list
83353254|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353255|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
83353256|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353257|NCT02455440|Propofol|propofol|mesh-list
83353258|NCT02455440|Sevoflurane|sevoflurane|mesh-list
83353259|NCT02455440|Esmolol|esmolol|mesh-list
83353260|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83353261|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353262|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353263|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83353264|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
83353265|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
83353266|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83353267|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83353268|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83353269|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83353270|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83353271|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
83353272|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353273|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353274|NCT03260166|Niacinamide|niacinamide|mesh-list
83353276|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
83353277|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
83353278|NCT03260166|Vitamins|vitamins|mesh-ancestor
83353279|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
83353280|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353281|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83353282|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
83353283|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353284|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83353285|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
83353286|NCT03260010|Fosfomycin|fosfomycin|mesh-list
83353287|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83353288|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353289|NCT00992901|Atropine|atropine|mesh-list
83353290|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83353291|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83353292|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353293|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83353294|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
83353295|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353296|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353297|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83353298|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
83353299|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
83353300|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
83353301|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83353302|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83353303|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
83353304|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353305|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353306|NCT00992901|Incretins|incretins|mesh-ancestor
83353307|NCT00992901|Hormones|hormones|mesh-ancestor
83353308|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353309|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
83353310|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83353311|NCT03260088|Antibodies|antibodies|mesh-list
83353312|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
83353313|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
83353314|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353315|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
83353316|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83353317|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353318|NCT03480672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83353319|NCT03480672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353320|NCT04776135|Edaravone|edaravone|mesh-list
83353321|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83353322|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
83353323|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353324|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83353325|NCT04776135|Protective Agents|protective agents|mesh-ancestor
83353326|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353327|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83353328|NCT03474276|Azithromycin|azithromycin|mesh-list
83353329|NCT03474276|Albendazole|albendazole|mesh-list
83353330|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
83353331|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353332|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
83353333|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
83353334|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83353335|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83353336|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
83353337|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
83353338|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
83353339|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353340|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353341|NCT04779255|Acetaminophen|acetaminophen|mesh-list
83353342|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353343|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353344|NCT04779255|Analgesics|analgesics|mesh-ancestor
83353345|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
83353346|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353347|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
83353348|NCT04779567|Acetaminophen|acetaminophen|mesh-list
83353349|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353350|NCT04779567|Analgesics|analgesics|mesh-ancestor
83353351|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
83353352|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353353|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353354|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
83353355|NCT02352844|Everolimus|everolimus|mesh-list
83353356|NCT02352844|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83353357|NCT02352844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353358|NCT02352844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353359|NCT02352844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353360|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353362|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353363|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353364|NCT03255642|Clonazepam|clonazepam|mesh-list
83353365|NCT03255642|Melatonin|melatonin|mesh-list
83353366|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
83353367|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353368|NCT03255642|Protective Agents|protective agents|mesh-ancestor
83353369|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353370|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353371|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
83353372|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
83353373|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
83353374|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353375|NCT03562377|Vaccines|vaccines|mesh-list
83353376|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
83353377|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353378|NCT02352922|Bupivacaine|bupivacaine|mesh-list
83353379|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353380|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
83353381|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353382|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353383|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
83353384|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353385|NCT03255330|Dipyrone|dipyrone|mesh-list
83353386|NCT03255330|Gabapentin|gabapentin|mesh-list
83353387|NCT03255330|Tramadol|tramadol|mesh-list
83353388|NCT03255330|Analgesics|analgesics|mesh-ancestor
83353389|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
83353390|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353391|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353392|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
83353393|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83353394|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83353395|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353396|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83353397|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83353398|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83353399|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353400|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353401|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
83353402|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83353403|NCT03255330|Narcotics|narcotics|mesh-ancestor
83353404|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83353405|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353406|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353407|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353408|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
83353409|NCT02353780|Etanercept|etanercept|mesh-list
83353410|NCT02353780|Infliximab|infliximab|mesh-list
83353411|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
83353412|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
83353413|NCT02353780|Abatacept|abatacept|mesh-list
83353414|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83353415|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353416|NCT02353780|Analgesics|analgesics|mesh-ancestor
83353417|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
83353418|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353419|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353420|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353421|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353422|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353423|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353424|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
83353425|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83353426|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353427|NCT02353780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83353428|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353429|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
83353430|NCT03176472|Ricolinostat|ricolinostat|mesh-list
83353431|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353432|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83353433|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353434|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353435|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83353436|NCT03246360|Cloxacillin|cloxacillin|mesh-list
83353437|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353438|NCT02354092|Anesthetics|anesthetics|mesh-list
83353439|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
83353440|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353441|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353442|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
83353443|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353445|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
83353446|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83353447|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83353448|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83353449|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353450|NCT00907101|Analgesics|analgesics|mesh-ancestor
83353451|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
83353452|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353453|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353454|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353455|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353456|NCT03245970|Atenolol|atenolol|mesh-list
83353457|NCT03245970|Labetalol|labetalol|mesh-list
83353458|NCT03245970|Nifedipine|nifedipine|mesh-list
83353459|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83353460|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353461|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353462|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83353463|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353464|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
83353465|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
83353466|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83353467|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353468|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83353469|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
83353470|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
83353471|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353472|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83353473|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83353474|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83353475|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
83353476|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353477|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
83353478|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83353479|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83353480|NCT02454348|Vasopressins|vasopressins|mesh-list
83353481|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
83353482|NCT02454348|Norepinephrine|norepinephrine|mesh-list
83353483|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83353484|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83353485|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
83353486|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353487|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353488|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353489|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
83353490|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
83353491|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353492|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83353494|NCT02454348|Coagulants|coagulants|mesh-ancestor
83353495|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83353496|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
83353497|NCT02455908|Aldesleukin|aldesleukin|mesh-list
83353498|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353499|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83353500|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83353501|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
83353502|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353503|NCT03245424|Ivosidenib|ivosidenib|mesh-list
83353504|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353505|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353506|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353507|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83353508|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
83353509|NCT03251040|Coagulants|coagulants|mesh-ancestor
83353511|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353512|NCT02454894|Lidocaine|lidocaine|mesh-list
83353513|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353514|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
83353515|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353516|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353517|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
83353518|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353519|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353520|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83353521|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83353522|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353523|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353524|NCT03250962|Decitabine|decitabine|mesh-list
83353525|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83353526|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
83353527|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353528|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353529|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353530|NCT04774029|Lidocaine|lidocaine|mesh-list
83353531|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353532|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
83353533|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353534|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353535|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
83353536|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353537|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353538|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83353539|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83353540|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353541|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353542|NCT03245346|Anesthetics|anesthetics|mesh-list
83353543|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353544|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353545|NCT03244956|Trametinib|trametinib|mesh-list
83353546|NCT03244956|Dabrafenib|dabrafenib|mesh-list
83353547|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353548|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353549|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353550|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353551|NCT03244488|Mecamylamine|mecamylamine|mesh-list
83353552|NCT03244488|Scopolamine|scopolamine|mesh-list
83353553|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
83353554|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83353555|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
83353556|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
83353557|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353558|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353559|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353560|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
83353561|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83353562|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
83353563|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353564|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353565|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83353566|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
83353567|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83353568|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83353569|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83353570|NCT03254784|Deucravacitinib|deucravacitinib|mesh-list
83353571|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
83353572|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353573|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353574|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353575|NCT03245658|Nabiximols|nabiximols|mesh-list
83353576|NCT03245658|Analgesics|analgesics|mesh-ancestor
83353577|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
83353578|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353579|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353580|NCT03245190|Chiauranib|chiauranib|mesh-list
83353581|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353582|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353583|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353584|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353585|NCT01969708|Bevacizumab|bevacizumab|mesh-list
83353586|NCT01969708|Aflibercept|aflibercept|mesh-list
83353587|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83353588|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353589|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83353590|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83353591|NCT01969708|Growth Substances|growth substances|mesh-ancestor
83353592|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353593|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
83353594|NCT03243864|Ceftazidime|ceftazidime|mesh-list
83353595|NCT03243864|Avibactam|avibactam|mesh-list
83353596|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
83353597|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83353598|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353599|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83353600|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353601|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353602|NCT03250494|Dexamethasone|dexamethasone|mesh-list
83353603|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
83353604|NCT03250494|BB 1101|bb 1101|mesh-list
83353605|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353606|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
83353607|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
83353608|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353609|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353610|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353611|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
83353612|NCT03250494|Hormones|hormones|mesh-ancestor
83353613|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353614|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83353615|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353616|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
83353617|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353618|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353619|NCT03254628|Misoprostol|misoprostol|mesh-list
83353620|NCT03254628|Oxytocin|oxytocin|mesh-list
83353621|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
83353622|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83353623|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353624|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83353625|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
83353626|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83353627|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353628|NCT01970176|Tadalafil|tadalafil|mesh-list
83353629|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
83353630|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83353631|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83353632|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353633|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353634|NCT01970176|Urological Agents|urological agents|mesh-ancestor
83353635|NCT02024386|Riociguat|riociguat|mesh-list
83353636|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
83353637|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353638|NCT03250338|Cytarabine|cytarabine|mesh-list
83353639|NCT03250338|Fludarabine|fludarabine|mesh-list
83353640|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
83353641|NCT03250338|Idarubicin|idarubicin|mesh-list
83353642|NCT03250338|Crenolanib|crenolanib|mesh-list
83353643|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353644|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83353646|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353647|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353648|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
83353649|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353650|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
83353651|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353652|NCT03250338|Analgesics|analgesics|mesh-ancestor
83353653|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
83353654|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353655|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83353656|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83353657|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353658|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83353659|NCT01971580|Ambrisentan|ambrisentan|mesh-list
83353660|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83353661|NCT00354562|Docetaxel|docetaxel|mesh-list
83353662|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353663|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
83353664|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
83353665|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
83353666|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353667|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83353668|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353669|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
83353670|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83353671|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353672|NCT02355886|Gabapentin|gabapentin|mesh-list
83353673|NCT02355886|Analgesics|analgesics|mesh-ancestor
83353674|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
83353675|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353676|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353677|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
83353678|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83353679|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83353680|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353681|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83353682|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83353683|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83353684|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353685|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353686|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
83353687|NCT03247413|Dexamethasone|dexamethasone|mesh-list
83353688|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353689|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
83353690|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
83353691|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353692|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353693|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353694|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
83353695|NCT03247413|Hormones|hormones|mesh-ancestor
83353696|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353697|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83353698|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353699|NCT02356198|Hydromorphone|hydromorphone|mesh-list
83353700|NCT02356198|Bupivacaine|bupivacaine|mesh-list
83353701|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353702|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
83353703|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353704|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353705|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
83353706|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353707|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83353708|NCT02356198|Narcotics|narcotics|mesh-ancestor
83353709|NCT02356198|Analgesics|analgesics|mesh-ancestor
83353710|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
83353711|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83353712|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353713|NCT03254004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83353714|NCT03254004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353715|NCT04778865|Vitamin D|vitamin d|mesh-list
83353716|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
83353717|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
83353718|NCT04778865|Vitamins|vitamins|mesh-list
83353719|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
83353720|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353721|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83353722|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83353723|NCT02025634|Acetaminophen|acetaminophen|mesh-list
83353724|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353725|NCT02025634|Analgesics|analgesics|mesh-ancestor
83353726|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
83353727|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353728|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353729|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
83353730|NCT04773951|Antibodies|antibodies|mesh-list
83353731|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83353732|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
83353733|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353734|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
83353735|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
83353736|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353737|NCT04773717|Protective Agents|protective agents|mesh-ancestor
83353738|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353739|NCT04773717|Vitamins|vitamins|mesh-ancestor
83353740|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
83353741|NCT04444167|Lenvatinib|lenvatinib|mesh-list
83353742|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353743|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353744|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353745|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353746|NCT03243006|Acetaminophen|acetaminophen|mesh-list
83353747|NCT03243006|Tramadol|tramadol|mesh-list
83353748|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353749|NCT03243006|Analgesics|analgesics|mesh-ancestor
83353750|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
83353751|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353752|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353753|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
83353754|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83353755|NCT03243006|Narcotics|narcotics|mesh-ancestor
83353756|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353757|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
83353758|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83353759|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
83353760|NCT03249402|Estradiol|estradiol|mesh-list
83353761|NCT03249402|Estrogens|estrogens|mesh-ancestor
83353762|NCT03249402|Hormones|hormones|mesh-ancestor
83353763|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353764|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353765|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83353766|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
83353767|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83353768|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83353769|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83353770|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83353771|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83353772|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83353773|NCT03242460|Dexamethasone|dexamethasone|mesh-list
83353774|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
83353775|NCT03242460|Pomalidomide|pomalidomide|mesh-list
83353776|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353777|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
83353778|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353779|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353780|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83353781|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
83353782|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353783|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353784|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83353785|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353786|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
83353787|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
83353788|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353789|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353790|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
83353791|NCT03242460|Hormones|hormones|mesh-ancestor
83353792|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353793|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83353794|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83353795|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83353796|NCT03242460|Growth Substances|growth substances|mesh-ancestor
83353797|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
83353798|NCT01972516|Tivozanib|tivozanib|mesh-list
83353799|NCT01972516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83353800|NCT01972516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353801|NCT01972516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353802|NCT03242616|Pemetrexed|pemetrexed|mesh-list
83353803|NCT03242616|Vinorelbine|vinorelbine|mesh-list
83353804|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353805|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353806|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353807|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83353808|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83353809|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83353810|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
83353811|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
83353812|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
83353813|NCT01748825|Adavosertib|adavosertib|mesh-list
83353814|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353815|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353816|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
83353817|NCT03253224|Analgesics|analgesics|mesh-ancestor
83353818|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
83353819|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353820|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353821|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
83353822|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353823|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353824|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
83353825|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83353826|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353827|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353828|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83353829|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
83353830|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83353832|NCT00789399|Fondaparinux|fondaparinux|mesh-list
83353833|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83353834|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
83353835|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83353836|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
83353837|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353838|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353839|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
83353840|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83353841|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83353842|NCT01720667|Levetiracetam|levetiracetam|mesh-list
83353843|NCT01720667|Phenobarbital|phenobarbital|mesh-list
83353844|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
83353845|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
83353846|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83353847|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353848|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353849|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83353850|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83353851|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353852|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353853|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
83353854|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
83353855|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83353856|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83353857|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83353858|NCT04773093|Lidocaine|lidocaine|mesh-list
83353859|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353860|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
83353861|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353862|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353863|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
83353864|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353865|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353866|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83353867|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83353868|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353869|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353871|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353872|NCT02455362|Morphine|morphine|mesh-list
83353873|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83353874|NCT02455362|Narcotics|narcotics|mesh-ancestor
83353875|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353876|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353877|NCT02455362|Analgesics|analgesics|mesh-ancestor
83353878|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
83353879|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353880|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
83353881|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353882|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
83353883|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83353884|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353885|NCT03253068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83353886|NCT03253068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353887|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83353888|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83353889|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353890|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83353891|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83353892|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353893|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353894|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
83353895|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353897|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83353898|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83353899|NCT04772781|Analgesics|analgesics|mesh-ancestor
83353900|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
83353901|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353902|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353903|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353904|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353905|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83353906|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353907|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353908|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83353909|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83353910|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83353911|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353912|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353913|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83353914|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353915|NCT03249168|Analgesics|analgesics|mesh-ancestor
83353916|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
83353917|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353918|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
83353919|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83353920|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
83353921|NCT03248856|Triamcinolone|triamcinolone|mesh-list
83353922|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83353923|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83353924|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83353925|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353926|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
83353927|NCT03248856|Hormones|hormones|mesh-ancestor
83353928|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353929|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353930|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353931|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
83353932|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413659|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353933|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353934|NCT03241602|Lidocaine|lidocaine|mesh-list
83353935|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
83353936|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
83353937|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83353938|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353939|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
83353941|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83353942|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83353943|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83353944|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83353945|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353946|NCT00734877|Thalidomide|thalidomide|mesh-list
83353947|NCT00734877|Dexamethasone|dexamethasone|mesh-list
83353948|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
83353949|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
83353950|NCT00734877|Melphalan|melphalan|mesh-list
83353951|NCT00734877|Cisplatin|cisplatin|mesh-list
83353952|NCT00734877|Etoposide|etoposide|mesh-list
83353953|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
83353954|NCT00734877|Doxorubicin|doxorubicin|mesh-list
83353955|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83353956|NCT00734877|Bortezomib|bortezomib|mesh-list
83353957|NCT00734877|BB 1101|bb 1101|mesh-list
83353958|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83353959|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
83353960|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83353961|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83353962|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83353963|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
83353964|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353965|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83353966|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83353967|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83353968|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
83353969|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
83353970|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83353971|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83353972|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
83353973|NCT00734877|Hormones|hormones|mesh-ancestor
83353974|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83353975|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83353976|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
83353977|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83353978|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83353979|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83353980|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83353981|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83353982|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
83353983|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83353984|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353985|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83353986|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83353987|NCT00734877|Growth Substances|growth substances|mesh-ancestor
83353988|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
83353989|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
83353990|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83353991|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
83353992|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83353993|NCT02357290|Expectorants|expectorants|mesh-ancestor
83353994|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
83353995|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83353996|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
83353997|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83353998|NCT02357290|Protective Agents|protective agents|mesh-ancestor
83353999|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354000|NCT02357290|Antidotes|antidotes|mesh-ancestor
83354001|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
83354002|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83354003|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
83354004|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83354005|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354006|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83354007|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83354008|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83354009|NCT00687765|Temozolomide|temozolomide|mesh-list
83354010|NCT00687765|Iniparib|iniparib|mesh-list
83354011|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83354012|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
83354013|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354014|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354015|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83354016|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354017|NCT03248544|Vitamin D|vitamin d|mesh-list
83354018|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
83354019|NCT03248544|Vitamins|vitamins|mesh-ancestor
83354020|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
83354021|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354022|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83354023|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83354024|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83354025|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83354026|NCT00984399|Estradiol|estradiol|mesh-list
83354027|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83354028|NCT00984399|Estrogens|estrogens|mesh-ancestor
83354029|NCT00984399|Hormones|hormones|mesh-ancestor
83354030|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354031|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354032|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83354033|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
83354034|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83354035|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83354036|NCT03248700|Vitamins|vitamins|mesh-list
83354037|NCT03248700|Vitamin A|vitamin a|mesh-list
83354038|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
83354039|NCT03248700|Retinol acetate|retinol acetate|mesh-list
83354040|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
83354041|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354042|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
83354043|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354044|NCT03248700|Protective Agents|protective agents|mesh-ancestor
83354045|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83354046|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354047|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83354048|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
83354049|NCT03238482|Fluticasone|fluticasone|mesh-list
83354050|NCT03238482|Xhance|xhance|mesh-list
83354051|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83354052|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83354053|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83354054|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83354055|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
83354056|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354057|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354058|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83354059|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
83354060|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
83354061|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83354062|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83354063|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83354064|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83354065|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
83354066|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354067|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354068|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
83354069|NCT03238482|Hormones|hormones|mesh-ancestor
83354070|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354071|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
83354072|NCT02454504|Neostigmine|neostigmine|mesh-list
83354073|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83354074|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354075|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354076|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
83354077|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354078|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354079|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83354080|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
83354081|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354082|NCT03240822|Antibodies|antibodies|mesh-list
83354083|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83354084|NCT03240822|Tacrolimus|tacrolimus|mesh-list
83354085|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
83354086|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354087|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354088|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83354089|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354090|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354091|NCT03238560|Montelukast|montelukast|mesh-list
83354092|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83354093|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
83354094|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
83354095|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
83354096|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354097|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354098|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
83354099|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83354100|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354101|NCT04486092|Valproic Acid|valproic acid|mesh-list
83354102|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
83354103|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354104|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354105|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
83354106|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354107|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354108|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
83354109|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354110|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354111|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354112|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
83354113|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83354114|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354115|NCT03238638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83354116|NCT03238638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354117|NCT00668655|Metronidazole|metronidazole|mesh-list
83354118|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354119|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83354120|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83354121|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83354122|NCT02454426|Vortioxetine|vortioxetine|mesh-list
83354123|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
83354124|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354125|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83354126|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354127|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354128|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354129|NCT02454426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83354130|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83354131|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83354132|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354133|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354134|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
83354135|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83354136|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83354137|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83354138|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83354139|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83354140|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83354142|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83354143|NCT03238092|Testosterone|testosterone|mesh-list
83354144|NCT03238092|Estrogens|estrogens|mesh-ancestor
83354145|NCT03238092|Hormones|hormones|mesh-ancestor
83354146|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354147|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354148|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83354149|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
83354150|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83354151|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83354152|NCT03238092|Androgens|androgens|mesh-ancestor
83354153|NCT03247998|Remifentanil|remifentanil|mesh-list
83354154|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354155|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354156|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83354157|NCT03247998|Narcotics|narcotics|mesh-ancestor
83354158|NCT03247998|Analgesics|analgesics|mesh-ancestor
83354159|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
83354160|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354161|NCT03248076|Fentanyl|fentanyl|mesh-list
83354162|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83354163|NCT03248076|Narcotics|narcotics|mesh-ancestor
83354164|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354165|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354167|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
83354168|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354169|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83354170|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83354171|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
83354172|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
83354173|NCT03240120|Tinzaparin|tinzaparin|mesh-list
83354174|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83354175|NCT03240120|Dalteparin|dalteparin|mesh-list
83354176|NCT03240120|Dabigatran|dabigatran|mesh-list
83354177|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
83354178|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83354179|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
83354180|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354181|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354182|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
83354183|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83354184|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83354185|NCT03237936|Cyclosporine|cyclosporine|mesh-list
83354186|NCT03237936|Cyclosporins|cyclosporins|mesh-list
83354187|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354188|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354189|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354190|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
83354191|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354192|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
83354193|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354194|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
83354195|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83354196|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83354197|NCT02759835|Osimertinib|osimertinib|mesh-list
83354198|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354199|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83354200|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354201|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354202|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83354203|NCT03247920|Amoxicillin|amoxicillin|mesh-list
83354204|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
83354205|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
83354206|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83354207|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354208|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83354209|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354210|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354211|NCT03239964|Dexamethasone|dexamethasone|mesh-list
83354212|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83354213|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
83354214|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
83354215|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354216|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354217|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83354218|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
83354219|NCT03239964|Hormones|hormones|mesh-ancestor
83354220|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354221|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83354222|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354223|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
83354224|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354225|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83354226|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354227|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354228|NCT03102723|Cangrelor|cangrelor|mesh-list
83354229|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83354230|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83354231|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83354232|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83354233|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
83354234|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354235|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354236|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354238|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354239|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354240|NCT03241914|Megestrol|megestrol|mesh-list
83354241|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
83354242|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
83354243|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83354244|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
83354245|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83354246|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354247|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83354248|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83354249|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83354250|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83354251|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83354252|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354253|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
83354254|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83354255|NCT00057681|Valproic Acid|valproic acid|mesh-list
83354256|NCT00057681|Risperidone|risperidone|mesh-list
83354257|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
83354258|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83354259|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
83354260|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354261|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354262|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354263|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83354264|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354265|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354266|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354267|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83354268|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
83354269|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
83354270|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354271|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
83354272|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
83354273|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
83354274|NCT03234816|Norepinephrine|norepinephrine|mesh-list
83354275|NCT03234816|Bupivacaine|bupivacaine|mesh-list
83354276|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
83354277|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
83354278|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354279|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354280|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
83354281|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354282|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83354283|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83354284|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
83354285|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354286|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354287|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
83354288|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
83354289|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83354290|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
83354291|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
83354292|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354293|NCT03247452|Protective Agents|protective agents|mesh-ancestor
83354294|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354295|NCT03247452|Vitamins|vitamins|mesh-ancestor
83354296|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
83354297|NCT03247140|Amlodipine|amlodipine|mesh-list
83354298|NCT03247140|Telmisartan|telmisartan|mesh-list
83354299|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
83354300|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83354301|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83354302|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83354303|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83354304|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354305|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83354306|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354307|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
83354308|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83354309|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83354310|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
83354311|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83354312|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83354313|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354314|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83354315|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83354316|NCT03237546|Anesthetics|anesthetics|mesh-list
83354317|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354318|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354320|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
83354321|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
83354322|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354323|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
83354324|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354325|NCT03247218|Memantine|memantine|mesh-list
83354326|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83354327|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83354328|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
83354329|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354330|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354331|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354332|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83354333|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83354334|NCT03237624|Chitosan|chitosan|mesh-list
83354335|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83354336|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83354337|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
83354338|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354339|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83354340|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
83354341|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
83354342|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
83354343|NCT03237624|Coagulants|coagulants|mesh-ancestor
83354344|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
83354345|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83354346|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354347|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354348|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83354349|NCT03234660|Analgesics|analgesics|mesh-ancestor
83354350|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
83354351|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354352|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83354353|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83354354|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83354355|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
83354356|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354357|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354358|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
83354359|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83354360|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83354361|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83354362|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83354363|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354364|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
83354365|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354366|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354367|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83354368|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354369|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
83354370|NCT00059475|Interleukin-2|interleukin-2|mesh-list
83354371|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83354372|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354373|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83354374|NCT00059475|Analgesics|analgesics|mesh-ancestor
83354375|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
83354376|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354377|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354378|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83354379|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
83354380|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83354381|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
83354382|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354383|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
83354384|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83354385|NCT00059475|Protective Agents|protective agents|mesh-ancestor
83354386|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
83354387|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
83354388|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
83354389|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83354390|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83354391|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354392|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
83354393|NCT02453802|Coagulants|coagulants|mesh-ancestor
83354394|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83354395|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
83354396|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83354397|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
83354398|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354399|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
83354400|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
83354401|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354402|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83354403|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83354404|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354405|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354406|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354407|NCT02028676|Lamivudine|lamivudine|mesh-list
83354408|NCT02028676|Zidovudine|zidovudine|mesh-list
83354409|NCT02028676|Efavirenz|efavirenz|mesh-list
83354410|NCT02028676|Nevirapine|nevirapine|mesh-list
83354411|NCT02028676|Abacavir|abacavir|mesh-list
83354412|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
83354413|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
83354414|NCT02028676|Trimethoprim|trimethoprim|mesh-list
83354415|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
83354416|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83354417|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83354418|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83354419|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354420|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354421|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
83354422|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354423|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83354424|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83354425|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
83354426|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83354427|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83354428|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83354429|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83354430|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83354431|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83354432|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83354433|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
83354434|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83354435|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83354436|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83354437|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83354438|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83354439|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83354440|NCT03233880|Azithromycin|azithromycin|mesh-list
83354441|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83354442|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354443|NCT00061893|Celecoxib|celecoxib|mesh-list
83354444|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
83354445|NCT00061893|Ifosfamide|ifosfamide|mesh-list
83354446|NCT00061893|Doxorubicin|doxorubicin|mesh-list
83354447|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83354448|NCT00061893|Etoposide|etoposide|mesh-list
83354449|NCT00061893|Vincristine|vincristine|mesh-list
83354450|NCT00061893|Vinblastine|vinblastine|mesh-list
83354451|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354452|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
83354453|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354454|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83354455|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83354456|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
83354457|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354458|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354459|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83354460|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83354461|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83354462|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83354464|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83354465|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
83354466|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
83354467|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
83354468|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83354469|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83354470|NCT00061893|Analgesics|analgesics|mesh-ancestor
83354471|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
83354472|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354473|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83354474|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83354475|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83354476|NCT02957019|Rituximab|rituximab|mesh-list
83354477|NCT02957019|Interleukin-2|interleukin-2|mesh-list
83354478|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83354479|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354480|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
83354481|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354482|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83354483|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83354484|NCT02957019|Analgesics|analgesics|mesh-ancestor
83354485|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
83354486|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354487|NCT02028754|Levofloxacin|levofloxacin|mesh-list
83354488|NCT02028754|Prednisolone|prednisolone|mesh-list
83354489|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
83354490|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83354491|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83354492|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
83354493|NCT02028754|Hormones|hormones|mesh-ancestor
83354494|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354495|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354496|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83354497|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354498|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83354499|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83354500|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354501|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83354502|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83354503|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83354504|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354505|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354506|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83354507|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83354508|NCT02028754|Laxatives|laxatives|mesh-ancestor
83354509|NCT02453490|Fluorouracil|fluorouracil|mesh-list
83354510|NCT02453490|Raltitrexed|raltitrexed|mesh-list
83354511|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
83354512|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354513|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83354514|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354515|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354516|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
83354517|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354518|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83354519|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354520|NCT01974700|Levetiracetam|levetiracetam|mesh-list
83354521|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
83354522|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
83354523|NCT04753203|Capecitabine|capecitabine|mesh-list
83354524|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83354525|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
83354526|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354527|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354528|NCT03236610|Tenofovir|tenofovir|mesh-list
83354529|NCT03236610|Entecavir|entecavir|mesh-list
83354530|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
83354531|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354532|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83354533|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83354534|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354535|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354536|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83354537|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83354538|NCT05287893|Pyronaridine|pyronaridine|mesh-list
83354539|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
83354540|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83354541|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83354542|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354543|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83354544|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354545|NCT02357836|Itraconazole|itraconazole|mesh-list
83354546|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
83354547|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354548|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83354549|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83354550|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354551|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354552|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83354553|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
83354554|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354555|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354556|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83354558|NCT02359006|Tetracycline|tetracycline|mesh-list
83354559|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83354560|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354561|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83354562|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354563|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354564|NCT04485702|Midazolam|midazolam|mesh-list
83354565|NCT04485702|Ketamine|ketamine|mesh-list
83354566|NCT04485702|Analgesics|analgesics|mesh-ancestor
83354567|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
83354568|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354569|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354570|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83354571|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83354572|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
83354573|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
83354574|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354575|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83354576|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83354577|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354578|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354579|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83354580|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83354581|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83354582|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354583|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354584|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
83354585|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
83354586|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83354587|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354588|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83354589|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354590|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354591|NCT03233412|Imiquimod|imiquimod|mesh-list
83354592|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83354593|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
83354594|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354595|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354596|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
83354597|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
83354598|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354599|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
83354600|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354601|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354602|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83354603|NCT01976572|Candesartan|candesartan|mesh-list
83354604|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83354605|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83354606|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83354607|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354608|NCT01976650|Dexamethasone|dexamethasone|mesh-list
83354609|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83354610|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
83354611|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
83354612|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354613|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354614|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83354615|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
83354616|NCT01976650|Hormones|hormones|mesh-ancestor
83354617|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354618|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83354619|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354620|NCT01978600|Timolol|timolol|mesh-list
83354621|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83354622|NCT01978600|Brinzolamide|brinzolamide|mesh-list
83354623|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354624|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354625|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83354626|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83354627|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
83354628|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354629|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354630|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83354631|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83354632|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83354633|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83354634|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83354635|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83354636|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
83354637|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83354638|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
83354639|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354640|NCT03236220|Expectorants|expectorants|mesh-ancestor
83354641|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
83354642|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83354643|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
83354644|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354645|NCT03236220|Protective Agents|protective agents|mesh-ancestor
83354646|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354647|NCT03236220|Antidotes|antidotes|mesh-ancestor
83354648|NCT03232632|Flutemetamol|flutemetamol|mesh-list
83354649|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83354650|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354651|NCT01747499|Azacitidine|azacitidine|mesh-list
83354652|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83354653|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
83354654|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354655|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354656|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354657|NCT00071721|Valproic Acid|valproic acid|mesh-list
83354658|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
83354659|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354660|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354661|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
83354662|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354663|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354664|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
83354665|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354666|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354667|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354668|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
83354669|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83354670|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354671|NCT05606055|Tenofovir|tenofovir|mesh-list
83354672|NCT05606055|Emtricitabine|emtricitabine|mesh-list
83354673|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
83354674|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354675|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83354676|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83354678|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354679|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83354680|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83354681|NCT01896609|Interferons|interferons|mesh-list
83354682|NCT01896609|Ribavirin|ribavirin|mesh-list
83354683|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
83354684|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
83354685|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83354686|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
83354687|NCT01896609|Complement Factor H|complement factor h|mesh-list
83354688|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354689|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
83354690|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354691|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
83354692|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354693|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
83354694|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354695|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83354696|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354697|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83354698|NCT03232554|Iron|iron|mesh-list
83354699|NCT03232554|Trace Elements|trace elements|mesh-ancestor
83354700|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
83354701|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354702|NCT03232398|Warfarin|warfarin|mesh-list
83354703|NCT03232398|Apixaban|apixaban|mesh-list
83354704|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
83354705|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83354706|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
83354707|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83354708|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
83354709|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354710|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354711|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
83354712|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
83354713|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83354714|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354715|NCT02362048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83354716|NCT02362048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354717|NCT00158223|Pimozide|pimozide|mesh-list
83354718|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83354719|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354720|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354721|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354722|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354723|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83354724|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
83354725|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354726|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354727|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83354728|NCT03228576|Everolimus|everolimus|mesh-list
83354729|NCT03228576|Tacrolimus|tacrolimus|mesh-list
83354730|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354731|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
83354732|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354733|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83354734|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354735|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354736|NCT03228576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83354737|NCT03228576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83354738|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354739|NCT00158379|Paclitaxel|paclitaxel|mesh-list
83354740|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83354741|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354742|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
83354743|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
83354744|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
83354745|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354746|NCT03228498|Choline|choline|mesh-list
83354747|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
83354748|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83354749|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
83354750|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354751|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83354752|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83354753|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
83354754|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83354755|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83354756|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354757|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354758|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83354759|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83354760|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354761|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
83354762|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354763|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
83354764|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83354765|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354766|NCT02364076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83354767|NCT02364076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354768|NCT02453022|Omeprazole|omeprazole|mesh-list
83354769|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83354770|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83354771|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83354772|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354773|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354774|NCT00163293|Ciclesonide|ciclesonide|mesh-list
83354775|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
83354776|NCT00163293|Hormones|hormones|mesh-ancestor
83354777|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354778|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354779|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83354780|NCT02365870|Rotigotine|rotigotine|mesh-list
83354781|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
83354782|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
83354783|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354784|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354785|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354786|NCT03228108|Amoxicillin|amoxicillin|mesh-list
83354787|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
83354788|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83354789|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
83354790|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
83354792|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83354793|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
83354794|NCT03228108|Trimethoprim|trimethoprim|mesh-list
83354795|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
83354796|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83354797|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354798|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83354799|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83354800|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354801|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354802|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354803|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83354804|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83354805|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83354806|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
83354807|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83354808|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83354809|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83354810|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83354811|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83354812|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83354813|NCT00078897|Selenium|selenium|mesh-list
83354814|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
83354815|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354816|NCT00078897|Protective Agents|protective agents|mesh-ancestor
83354817|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354818|NCT00078897|Trace Elements|trace elements|mesh-ancestor
83354819|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
83354820|NCT03228030|Thiamine|thiamine|mesh-list
83354821|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
83354822|NCT03228030|Vitamins|vitamins|mesh-ancestor
83354823|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
83354824|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354825|NCT01717313|Metformin|metformin|mesh-list
83354826|NCT01717313|Glimepiride|glimepiride|mesh-list
83354827|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83354828|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354829|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83354830|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354831|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
83354832|NCT00081861|Bevacizumab|bevacizumab|mesh-list
83354833|NCT00081861|Rituximab|rituximab|mesh-list
83354834|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83354835|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354836|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83354837|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83354838|NCT00081861|Growth Substances|growth substances|mesh-ancestor
83354839|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354840|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
83354841|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
83354842|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83354843|NCT03120234|Fentanyl|fentanyl|mesh-list
83354844|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
83354845|NCT03120234|Ketamine|ketamine|mesh-list
83354846|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83354847|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354848|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354849|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83354850|NCT03120234|Analgesics|analgesics|mesh-ancestor
83354851|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
83354852|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354853|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83354854|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83354855|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83354856|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
83354857|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354858|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354859|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83354860|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83354861|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
83354863|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83354864|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83354865|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83354866|NCT03120234|Narcotics|narcotics|mesh-ancestor
83354867|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83354868|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
83354869|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354870|NCT03232710|Aripiprazole|aripiprazole|mesh-list
83354871|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
83354872|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83354873|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83354874|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83354875|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354876|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354877|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
83354878|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
83354879|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354880|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354881|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83354882|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83354883|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
83354884|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83354885|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83354886|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83354887|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83354888|NCT03227484|Empagliflozin|empagliflozin|mesh-list
83354889|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83354890|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354891|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83354892|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354893|NCT02038894|Propofol|propofol|mesh-list
83354894|NCT02038894|Sevoflurane|sevoflurane|mesh-list
83354895|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83354896|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83354897|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354899|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
83354900|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
83354901|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83354902|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83354903|NCT01375374|Lacosamide|lacosamide|mesh-list
83354904|NCT01375374|Levetiracetam|levetiracetam|mesh-list
83354905|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
83354906|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
83354907|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83354908|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83354909|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83354910|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354911|NCT04348786|Amoxicillin|amoxicillin|mesh-list
83354912|NCT04348786|Doxycycline|doxycycline|mesh-list
83354913|NCT04348786|Levofloxacin|levofloxacin|mesh-list
83354914|NCT04348786|Esomeprazole|esomeprazole|mesh-list
83354915|NCT04348786|Bismuth|bismuth|mesh-list
83354916|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
83354917|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83354918|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354919|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83354920|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83354921|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83354922|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354923|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354924|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
83354925|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83354926|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83354927|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83354928|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83354929|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83354930|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354931|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83354932|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83354933|NCT04348786|Antacids|antacids|mesh-ancestor
83354934|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
83354935|NCT02369068|Triamcinolone|triamcinolone|mesh-list
83354936|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83354937|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83354938|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83354939|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83354940|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
83354941|NCT02369068|Hormones|hormones|mesh-ancestor
83354942|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83354943|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354944|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354945|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
83354946|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354947|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83354948|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354949|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83354950|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83354951|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
83354952|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83354953|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
83354954|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83354955|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354956|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83354957|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354958|NCT02371252|Alendronate|alendronate|mesh-list
83354959|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83354960|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354961|NCT03221946|Diclofenac|diclofenac|mesh-list
83354962|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83354963|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83354964|NCT03221946|Analgesics|analgesics|mesh-ancestor
83354965|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
83354966|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83354967|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354968|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83354969|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83354970|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83354971|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354972|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354973|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
83354974|NCT03229746|Vincristine|vincristine|mesh-list
83354975|NCT03229746|Azathioprine|azathioprine|mesh-list
83354976|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83354977|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83354978|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
83354979|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
83354980|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
83354981|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83354982|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
83354983|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83354984|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83354985|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83354986|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83354987|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83354988|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
83354989|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83354990|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83354991|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
83354992|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83354993|NCT02040298|Clemastine|clemastine|mesh-list
83354994|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
83354995|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
83354996|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83354997|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
83354998|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
83354999|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355000|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355001|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355002|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83355003|NCT03229668|Pregabalin|pregabalin|mesh-list
83355004|NCT03229668|Analgesics|analgesics|mesh-ancestor
83355005|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
83355006|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355007|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355008|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
83355009|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83355010|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355011|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355012|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83355013|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83355014|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83355015|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355016|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83355017|NCT03230058|Voriconazole|voriconazole|mesh-list
83355018|NCT03230058|Natamycin|natamycin|mesh-list
83355019|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83355020|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83355021|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
83355022|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355023|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83355024|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83355025|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355026|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355027|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83355028|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
83355029|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355030|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355031|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83355032|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83355033|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83355034|NCT01985542|Immunomodulating Agents|immunomodulating agents|mesh-list
83355035|NCT01985542|Immunologic Factors|immunologic factors|mesh-ancestor
83355036|NCT01985542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355037|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
83355038|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355039|NCT00081939|Thalidomide|thalidomide|mesh-list
83355040|NCT00081939|Bortezomib|bortezomib|mesh-list
83355041|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355042|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355043|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
83355044|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355045|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
83355046|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83355047|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355048|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83355049|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83355050|NCT00081939|Growth Substances|growth substances|mesh-ancestor
83355051|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
83355052|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
83355053|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83355054|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83355055|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355056|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355057|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355058|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
83355059|NCT03221634|Daratumumab|daratumumab|mesh-list
83355060|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355061|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355062|NCT03221634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83355063|NCT03221634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355064|NCT05003037|Carboplatin|carboplatin|mesh-list
83355066|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355067|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355068|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355069|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83355070|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83355071|NCT02374060|Dexamethasone|dexamethasone|mesh-list
83355072|NCT02374060|Triamcinolone|triamcinolone|mesh-list
83355073|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83355074|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83355075|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83355076|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355077|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
83355078|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
83355079|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355080|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355081|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83355082|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
83355084|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355085|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83355086|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355087|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355088|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
83355089|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355090|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355091|NCT03221166|Thalidomide|thalidomide|mesh-list
83355092|NCT03221166|Infliximab|infliximab|mesh-list
83355093|NCT03221166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83355094|NCT03221166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355095|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
83355096|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83355097|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355098|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355099|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
83355100|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355101|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
83355102|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83355103|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355104|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83355105|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83355106|NCT03221166|Growth Substances|growth substances|mesh-ancestor
83355107|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
83355108|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355109|NCT03220932|Bevacizumab|bevacizumab|mesh-list
83355110|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355111|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355112|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83355113|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83355114|NCT03220932|Growth Substances|growth substances|mesh-ancestor
83355115|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355116|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
83355117|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
83355118|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83355119|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355120|NCT04484688|Bisoprolol|bisoprolol|mesh-list
83355121|NCT04484688|Perindopril|perindopril|mesh-list
83355122|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83355123|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
83355124|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
83355125|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355126|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355127|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83355128|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83355129|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83355130|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
83355131|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355132|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355133|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83355134|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
83355135|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355136|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
83355137|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355138|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83355139|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355140|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355141|NCT00082329|Plerixafor|plerixafor|mesh-list
83355142|NCT00082329|Lenograstim|lenograstim|mesh-list
83355143|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83355144|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
83355145|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355146|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83355147|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83355148|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
83355149|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355150|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
83355151|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83355152|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355153|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83355154|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
83355155|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83355156|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355157|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83355158|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
83355159|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83355160|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83355161|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83355162|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355163|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355164|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
83355165|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355166|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355167|NCT03220542|Amoxicillin|amoxicillin|mesh-list
83355168|NCT03220542|Clarithromycin|clarithromycin|mesh-list
83355169|NCT03220542|Sulforaphane|sulforaphane|mesh-list
83355170|NCT03220542|Esomeprazole|esomeprazole|mesh-list
83355171|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83355172|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355173|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83355174|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83355175|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83355176|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355177|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355178|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83355179|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83355180|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83355181|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83355182|NCT03220542|Protective Agents|protective agents|mesh-ancestor
83355183|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355184|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355185|NCT03220152|Tenofovir|tenofovir|mesh-list
83355186|NCT03220152|Emtricitabine|emtricitabine|mesh-list
83355187|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
83355188|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355189|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83355190|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83355191|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355192|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355194|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83355195|NCT03220464|Interferons|interferons|mesh-list
83355196|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
83355197|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355198|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
83355199|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355200|NCT03206658|Spironolactone|spironolactone|mesh-list
83355201|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83355202|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
83355203|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355204|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355205|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83355206|NCT03206658|Diuretics|diuretics|mesh-ancestor
83355207|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
83355208|NCT00170157|Ipilimumab|ipilimumab|mesh-list
83355209|NCT00170157|Leuprolide|leuprolide|mesh-list
83355210|NCT00170157|Goserelin|goserelin|mesh-list
83355211|NCT00170157|Bicalutamide|bicalutamide|mesh-list
83355212|NCT00170157|Flutamide|flutamide|mesh-list
83355213|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355214|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355215|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83355216|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355217|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83355218|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
83355219|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83355220|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355221|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83355222|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
83355223|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
83355224|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355225|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
83355226|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
83355227|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355228|NCT00170625|Topotecan|topotecan|mesh-list
83355229|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83355230|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83355231|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355232|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355233|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355235|NCT02043652|Primaquine|primaquine|mesh-list
83355236|NCT02043652|Amebicides|amebicides|mesh-ancestor
83355237|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83355238|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83355239|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355240|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
83355241|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355242|NCT01898169|Nicotine|nicotine|mesh-list
83355243|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83355244|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
83355245|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355246|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355247|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83355248|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83355249|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
83355250|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355251|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355252|NCT03227016|Topotecan|topotecan|mesh-list
83355253|NCT03227016|Veliparib|veliparib|mesh-list
83355254|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83355255|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83355256|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83355257|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355258|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355259|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355260|NCT04748991|Amiodarone|amiodarone|mesh-list
83355261|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83355262|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
83355263|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83355264|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355265|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355266|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83355267|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83355268|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83355269|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355270|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83355271|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83355272|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83355273|NCT03230136|Anesthetics|anesthetics|mesh-list
83355274|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355275|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355276|NCT00176865|Cyclosporine|cyclosporine|mesh-list
83355277|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
83355278|NCT00176865|Fludarabine|fludarabine|mesh-list
83355279|NCT00176865|Melphalan|melphalan|mesh-list
83355280|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
83355281|NCT00176865|Cyclosporins|cyclosporins|mesh-list
83355282|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83355283|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
83355284|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83355285|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
83355286|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83355287|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355288|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355289|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355290|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
83355291|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355292|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355293|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
83355294|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355295|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
83355296|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355297|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83355298|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83355299|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83355300|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
83355301|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83355302|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83355303|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
83355304|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83355305|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355306|NCT02451072|Ketanserin|ketanserin|mesh-list
83355307|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
83355308|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
83355309|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355310|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83355311|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83355312|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
83355313|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355314|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355315|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83355316|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83355317|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83355318|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83355319|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355320|NCT02450994|Dexamethasone|dexamethasone|mesh-list
83355321|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355322|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
83355323|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
83355324|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355325|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355326|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83355327|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
83355328|NCT02450994|Hormones|hormones|mesh-ancestor
83355329|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355330|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83355331|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355332|NCT00177255|Docetaxel|docetaxel|mesh-list
83355333|NCT00177255|Capecitabine|capecitabine|mesh-list
83355334|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355335|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
83355336|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
83355337|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
83355338|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355339|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83355340|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
83355341|NCT02401048|Durvalumab|durvalumab|mesh-list
83355342|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355343|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355344|NCT02046382|Acetaminophen|acetaminophen|mesh-list
83355345|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83355346|NCT02046382|Analgesics|analgesics|mesh-ancestor
83355347|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
83355348|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355349|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355350|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
83355351|NCT03205176|Olaparib|olaparib|mesh-list
83355352|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83355353|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355354|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355355|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355356|NCT02046772|Morphine|morphine|mesh-list
83355357|NCT02046772|Bupivacaine|bupivacaine|mesh-list
83355358|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
83355359|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
83355360|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355361|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355362|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
83355363|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355364|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83355365|NCT02046772|Narcotics|narcotics|mesh-ancestor
83355366|NCT02046772|Analgesics|analgesics|mesh-ancestor
83355367|NCT00178503|Methylphenidate|methylphenidate|mesh-list
83355368|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83355369|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355370|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83355371|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83355372|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355373|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355374|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
83355375|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355376|NCT02376010|Warfarin|warfarin|mesh-list
83355377|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
83355378|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
83355379|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83355380|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
83355381|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83355382|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
83355383|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355384|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355385|NCT00085293|Decitabine|decitabine|mesh-list
83355386|NCT00085293|Azacitidine|azacitidine|mesh-list
83355387|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83355388|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83355389|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
83355390|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355391|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355392|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355393|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83355394|NCT02402062|Sunitinib|sunitinib|mesh-list
83355395|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355396|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83355397|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83355398|NCT02402062|Growth Substances|growth substances|mesh-ancestor
83355399|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355400|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
83355401|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83355402|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355403|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355404|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83355405|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83355406|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
83355407|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355408|NCT02450838|Antacids|antacids|mesh-ancestor
83355409|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355410|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83355412|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
83355413|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355414|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83355415|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83355416|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355417|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355418|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83355419|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83355420|NCT00085839|Paclitaxel|paclitaxel|mesh-list
83355421|NCT00085839|Carboplatin|carboplatin|mesh-list
83355422|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83355423|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83355424|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355425|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
83355426|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
83355427|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
83355428|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355429|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83355430|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355431|NCT03204474|Lacosamide|lacosamide|mesh-list
83355432|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
83355433|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83355434|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83355435|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355436|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355437|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83355438|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83355439|NCT03204318|Norethindrone|norethindrone|mesh-list
83355440|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
83355441|NCT03204318|Estradiol|estradiol|mesh-list
83355442|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83355443|NCT03204318|Relugolix|relugolix|mesh-list
83355444|NCT03204318|Estrogens|estrogens|mesh-ancestor
83355445|NCT03204318|Hormones|hormones|mesh-ancestor
83355446|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355447|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355448|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83355449|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
83355450|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83355451|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83355452|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83355453|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83355454|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83355455|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
83355456|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
83355457|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
83355458|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83355459|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355460|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355461|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83355462|NCT03204006|Analgesics|analgesics|mesh-ancestor
83355463|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
83355464|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355465|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83355466|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83355467|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83355468|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
83355469|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355470|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355471|NCT03226080|Rocuronium|rocuronium|mesh-list
83355472|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83355473|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83355474|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83355475|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355476|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355477|NCT03225924|Prednisone|prednisone|mesh-list
83355478|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
83355479|NCT03225924|Rituximab|rituximab|mesh-list
83355480|NCT03225924|Doxorubicin|doxorubicin|mesh-list
83355481|NCT03225924|Vincristine|vincristine|mesh-list
83355482|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355483|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
83355484|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355485|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355486|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83355487|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
83355488|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355489|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355490|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83355491|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355492|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83355493|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83355494|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83355495|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355496|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355497|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
83355498|NCT03225924|Hormones|hormones|mesh-ancestor
83355499|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355500|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83355501|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83355502|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
83355503|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
83355504|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
83355505|NCT03119532|Metronidazole|metronidazole|mesh-list
83355506|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355507|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83355508|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83355509|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83355510|NCT02404168|Lamotrigine|lamotrigine|mesh-list
83355511|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
83355512|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83355513|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355514|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355515|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83355516|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355517|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83355518|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83355519|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355520|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83355521|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83355522|NCT04733937|Caseins|caseins|mesh-list
83355523|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
83355524|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
83355525|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355526|NCT02051452|Methylphenidate|methylphenidate|mesh-list
83355527|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83355528|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355529|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83355530|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83355531|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355532|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355533|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
83355534|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355535|NCT00180687|Bupivacaine|bupivacaine|mesh-list
83355536|NCT00180687|Coal Tar|coal tar|mesh-list
83355537|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
83355538|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
83355539|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355540|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355541|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
83355542|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355543|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
83355544|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
83355545|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83355546|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
83355547|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355548|NCT02384044|Listerine|listerine|mesh-list
83355549|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
83355550|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
83355551|NCT02384044|Protective Agents|protective agents|mesh-ancestor
83355552|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355553|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83355554|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355555|NCT02384200|Vancomycin|vancomycin|mesh-list
83355556|NCT02384200|Gentamicins|gentamicins|mesh-list
83355557|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
83355558|NCT02384200|Ampicillin|ampicillin|mesh-list
83355559|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
83355560|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83355561|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355562|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83355563|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355564|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355565|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83355566|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
83355567|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83355568|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83355569|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355570|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
83355571|NCT02051686|Coagulants|coagulants|mesh-ancestor
83355572|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
83355573|NCT00182793|Melphalan|melphalan|mesh-list
83355574|NCT00182793|Thiotepa|thiotepa|mesh-list
83355575|NCT00182793|Carboplatin|carboplatin|mesh-list
83355576|NCT00182793|Trastuzumab|trastuzumab|mesh-list
83355577|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355578|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
83355579|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355580|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355581|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83355582|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
83355583|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355584|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355585|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83355586|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355587|NCT00183339|Fluoxetine|fluoxetine|mesh-list
83355588|NCT00183339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83355589|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83355590|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355591|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355592|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355593|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
83355594|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83413660|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83355595|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83355596|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83355597|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83355598|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83355599|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83355600|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355601|NCT00183729|Memantine|memantine|mesh-list
83355603|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83355604|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
83355605|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355606|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355607|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355608|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83355609|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83355610|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
83355611|NCT00186069|Analgesics|analgesics|mesh-ancestor
83355612|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
83355613|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355614|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355615|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
83355616|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355617|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83355618|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
83355619|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83355620|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355621|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355622|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83355623|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
83355624|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83355625|NCT01742897|Fentanyl|fentanyl|mesh-list
83355626|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83355627|NCT01742897|Narcotics|narcotics|mesh-ancestor
83355628|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355629|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355630|NCT01742897|Analgesics|analgesics|mesh-ancestor
83355631|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
83355632|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355633|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83355634|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83355635|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
83355636|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
83355637|NCT04554485|Blinatumomab|blinatumomab|mesh-list
83355638|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355639|NCT01741259|Meperidine|meperidine|mesh-list
83355640|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83355641|NCT01741259|Narcotics|narcotics|mesh-ancestor
83355642|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355643|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355644|NCT01741259|Analgesics|analgesics|mesh-ancestor
83355645|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
83355646|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355647|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83355648|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83355649|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
83355650|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83355651|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
83355652|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83355653|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355654|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83355655|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83355656|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355657|NCT02387554|Losartan|losartan|mesh-list
83355658|NCT02387554|Amlodipine|amlodipine|mesh-list
83355659|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
83355660|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83355661|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83355662|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355663|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355664|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83355665|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355666|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
83355667|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83355668|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83355669|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83355670|NCT02387554|Diuretics|diuretics|mesh-ancestor
83355671|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
83355672|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83355673|NCT02387710|Tiagabine|tiagabine|mesh-list
83355674|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
83355675|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
83355676|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83355677|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355678|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355679|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
83355680|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355681|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355682|NCT01740791|Velpatasvir|velpatasvir|mesh-list
83355683|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
83355684|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355685|NCT01740323|Curcumin|curcumin|mesh-list
83355686|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83355687|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83355688|NCT01740323|Analgesics|analgesics|mesh-ancestor
83355689|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
83355690|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355691|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355692|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355693|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355694|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355695|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355696|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355698|NCT00090051|Rituximab|rituximab|mesh-list
83355699|NCT00090051|Fludarabine|fludarabine|mesh-list
83355700|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
83355701|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355702|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
83355703|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355704|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355705|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83355706|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
83355707|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355708|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355709|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83355710|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355711|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83355712|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
83355713|NCT01740089|Ribavirin|ribavirin|mesh-list
83355714|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83355715|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
83355716|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355717|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
83355718|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355719|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
83355720|NCT01739933|Propofol|propofol|mesh-list
83355721|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83355722|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355723|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355724|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83355725|NCT01739933|Analgesics|analgesics|mesh-ancestor
83355726|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
83355727|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355728|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83355729|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83355730|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83355731|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
83355732|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355733|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355734|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83355735|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
83355736|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
83355737|NCT00094497|Doxorubicin|doxorubicin|mesh-list
83355738|NCT00094497|Etoposide|etoposide|mesh-list
83355739|NCT00094497|Mitotane|mitotane|mesh-list
83355740|NCT00094497|Streptozocin|streptozocin|mesh-list
83355741|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355742|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83355743|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83355744|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83355745|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83413661|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
83355746|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355747|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83355748|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83355749|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
83355750|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83355751|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
83355752|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355753|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355754|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83355755|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
83355756|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83355757|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
83355758|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355759|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355760|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83355761|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
83355762|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
83355763|NCT00094887|Protective Agents|protective agents|mesh-ancestor
83355764|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
83355765|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355766|NCT00097695|Icatibant|icatibant|mesh-list
83355767|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83355768|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83355769|NCT00097695|Analgesics|analgesics|mesh-ancestor
83355770|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
83355771|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355772|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355773|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355774|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355775|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
83355776|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
83355777|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355778|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83355779|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83355780|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
83355782|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355783|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83355784|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355785|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355786|NCT00195039|Antibodies|antibodies|mesh-list
83355787|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83355788|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
83355789|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355790|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
83355791|NCT04645719|Analgesics|analgesics|mesh-ancestor
83355792|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
83355793|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355794|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355795|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
83355796|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355797|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83355798|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
83355799|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83355800|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355801|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355802|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83355803|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
83355804|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83355805|NCT02054338|Paclitaxel|paclitaxel|mesh-list
83355806|NCT02054338|Gemcitabine|gemcitabine|mesh-list
83355807|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83355808|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355809|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
83355810|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
83355811|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
83355812|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355813|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83355814|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
83355815|NCT00198081|Celecoxib|celecoxib|mesh-list
83355816|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83355817|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83355818|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83355819|NCT00198081|Analgesics|analgesics|mesh-ancestor
83355820|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
83355821|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355822|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355823|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355824|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355825|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83355826|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355827|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355828|NCT00100659|Interferons|interferons|mesh-list
83355829|NCT00100659|Ribavirin|ribavirin|mesh-list
83355830|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355831|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
83355832|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355833|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
83355834|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355835|NCT00101361|Oxandrolone|oxandrolone|mesh-list
83355836|NCT00101361|Androgens|androgens|mesh-ancestor
83355837|NCT00101361|Hormones|hormones|mesh-ancestor
83355838|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355839|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355840|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
83355841|NCT03225690|Morphine|morphine|mesh-list
83355842|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83355843|NCT03225690|Narcotics|narcotics|mesh-ancestor
83355844|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355845|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355846|NCT03225690|Analgesics|analgesics|mesh-ancestor
83355847|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
83355848|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355849|NCT02389738|Temozolomide|temozolomide|mesh-list
83355850|NCT02389738|Regadenoson|regadenoson|mesh-list
83355851|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83355852|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
83355853|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355854|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355855|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83355856|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83355857|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
83355858|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
83355859|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355860|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355861|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83355862|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83355863|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83355864|NCT00201123|Interferons|interferons|mesh-list
83355865|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
83355866|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355867|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
83355868|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83355869|NCT01712009|Loratadine|loratadine|mesh-list
83355870|NCT01712009|Naproxen|naproxen|mesh-list
83355871|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83355872|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83355873|NCT01712009|Analgesics|analgesics|mesh-ancestor
83355874|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
83355875|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83355876|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355877|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83355878|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83355879|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
83355880|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83355881|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355882|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355883|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
83355884|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
83355885|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83355886|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83355887|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83355888|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
83355889|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
83355890|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355891|NCT03212352|Misoprostol|misoprostol|mesh-list
83355892|NCT03212352|Mifepristone|mifepristone|mesh-list
83355893|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83355894|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
83355895|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83355896|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355897|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83355898|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83355899|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
83355900|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83355901|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83355902|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83355903|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83355904|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
83355905|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83355906|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83355907|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
83355908|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83355909|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
83355910|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83355911|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83355912|NCT00201825|Docetaxel|docetaxel|mesh-list
83355913|NCT00201825|Capecitabine|capecitabine|mesh-list
83355914|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355915|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
83355916|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
83355917|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
83355918|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355919|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83355920|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
83355921|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
83355922|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83355923|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355924|NCT01711853|Dabigatran|dabigatran|mesh-list
83355925|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
83355926|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83355927|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
83355928|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355929|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355930|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
83355931|NCT00202449|Prazosin|prazosin|mesh-list
83355932|NCT00202449|Paroxetine|paroxetine|mesh-list
83355933|NCT00202449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83355934|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83355935|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355936|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355937|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83355938|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
83355939|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355940|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83355941|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
83355942|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83355943|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83355944|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83355945|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355946|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83355947|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83355948|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83355949|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83355950|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
83355951|NCT03203304|Nivolumab|nivolumab|mesh-list
83355952|NCT03203304|Ipilimumab|ipilimumab|mesh-list
83355953|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355954|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355955|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83355956|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355957|NCT03225456|Oxytocin|oxytocin|mesh-list
83355958|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
83355959|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83355960|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355961|NCT00203229|Lamotrigine|lamotrigine|mesh-list
83355962|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
83355963|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83355964|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83355965|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355966|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83355967|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355968|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83355969|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83355970|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83355971|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83355972|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83355973|NCT00203931|Pemetrexed|pemetrexed|mesh-list
83355974|NCT00203931|Cetuximab|cetuximab|mesh-list
83355975|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355976|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83355977|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355978|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83355979|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83355980|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355981|NCT02412982|Enoxaparin|enoxaparin|mesh-list
83355982|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
83355983|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
83355984|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83355985|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83355986|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355987|NCT03203616|Trastuzumab|trastuzumab|mesh-list
83355988|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83355989|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83355990|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83355991|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
83355992|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
83355993|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
83355994|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83355995|NCT03203616|Immunotoxins|immunotoxins|mesh-ancestor
83355996|NCT03203616|Immunoconjugates|immunoconjugates|mesh-ancestor
83355997|NCT03203616|Immunologic Factors|immunologic factors|mesh-ancestor
83355998|NCT03203616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83355999|NCT02450214|Ketamine|ketamine|mesh-list
83356000|NCT02450214|Analgesics|analgesics|mesh-ancestor
83356001|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
83356002|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356003|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356004|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83356005|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83356006|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
83356007|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
83356008|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356009|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83356010|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83356011|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356012|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356013|NCT02450682|Warfarin|warfarin|mesh-list
83356014|NCT02450682|Apixaban|apixaban|mesh-list
83356015|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
83356016|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83356017|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
83356018|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83356019|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
83356020|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356021|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356022|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
83356023|NCT01740401|Ipilimumab|ipilimumab|mesh-list
83356024|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356025|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
83356026|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356027|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356028|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356029|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
83356030|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356031|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356032|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83356033|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356034|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83356035|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
83356036|NCT03202836|Progesterone|progesterone|mesh-list
83356037|NCT03202836|Progestins|progestins|mesh-ancestor
83356038|NCT03202836|Hormones|hormones|mesh-ancestor
83356039|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356040|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356041|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83356042|NCT03203070|Dipyrone|dipyrone|mesh-list
83356043|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83356044|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83356045|NCT03203070|Analgesics|analgesics|mesh-ancestor
83356046|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
83356047|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356048|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356049|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356050|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356051|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
83356052|NCT03209856|Vitamin D|vitamin d|mesh-list
83356053|NCT03209856|Calcitriol|calcitriol|mesh-list
83356054|NCT03209856|Vitamins|vitamins|mesh-ancestor
83356055|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
83356056|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356057|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83356058|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83356059|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83356060|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83356061|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356062|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83356063|NCT02413918|Iloperidone|iloperidone|mesh-list
83356064|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83356065|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83356066|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356067|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356068|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83356069|NCT03209622|Nicotine|nicotine|mesh-list
83356070|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83356071|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
83356072|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356073|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356074|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83356075|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83356076|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
83356077|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356078|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356079|NCT00099021|Pioglitazone|pioglitazone|mesh-list
83356080|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83356081|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356082|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83356083|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83356084|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
83356085|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356086|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356087|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83356088|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
83356089|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83356090|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83356091|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83356092|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
83356093|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356094|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356095|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
83356096|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83356097|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83356098|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356099|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
83356100|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
83356101|NCT03834688|Rituximab|rituximab|mesh-list
83356102|NCT03834688|Venetoclax|venetoclax|mesh-list
83356103|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83356104|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356105|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356106|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
83356107|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356108|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356109|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356110|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
83356111|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356112|NCT01710527|Metformin|metformin|mesh-list
83356113|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83356114|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356115|NCT00354952|Azithromycin|azithromycin|mesh-list
83356116|NCT00354952|Clarithromycin|clarithromycin|mesh-list
83356117|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83356118|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356119|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83356120|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356121|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356122|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83356123|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83356126|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
83356127|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356128|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83356129|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356130|NCT04943848|Trace Elements|trace elements|mesh-ancestor
83356131|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
83356132|NCT01706939|Carboplatin|carboplatin|mesh-list
83356133|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356134|NCT04938232|Nivolumab|nivolumab|mesh-list
83356135|NCT04938232|Ipilimumab|ipilimumab|mesh-list
83356136|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356137|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356138|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83356139|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356140|NCT03209232|Infliximab|infliximab|mesh-list
83356141|NCT03209232|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83356142|NCT03209232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356143|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
83356144|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356145|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356146|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
83356147|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83356148|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356149|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
83356150|NCT01709903|Fluticasone|fluticasone|mesh-list
83356151|NCT01709903|Xhance|xhance|mesh-list
83356152|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
83356153|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83356154|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83356155|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356156|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83356157|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
83356158|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356159|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356160|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83356161|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
83356162|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
83356163|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83356164|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83356165|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83356166|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83356167|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
83356168|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356169|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356170|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
83356171|NCT01709903|Hormones|hormones|mesh-ancestor
83356172|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356173|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
83356174|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83356175|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83356176|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83356177|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
83356178|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
83356179|NCT03202446|Chitosan|chitosan|mesh-list
83356180|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356181|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
83356182|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356183|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356184|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356185|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
83356186|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356187|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356188|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83356189|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83356190|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83356191|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
83356192|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83356193|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
83356194|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
83356195|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
83356196|NCT03202446|Coagulants|coagulants|mesh-ancestor
83356197|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
83356198|NCT05718934|Neostigmine|neostigmine|mesh-list
83356199|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83356200|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356201|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356202|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
83356203|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356204|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356205|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83356206|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
83356207|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356208|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83356209|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83356210|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83356211|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
83356212|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83356213|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
83356214|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356215|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356216|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83356217|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
83356218|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83356219|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
83356220|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356221|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356222|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83356223|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
83356224|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
83356225|NCT03208764|Protective Agents|protective agents|mesh-ancestor
83356226|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83356227|NCT05718856|Antibodies|antibodies|mesh-list
83356228|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
83356229|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83356230|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
83356231|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356232|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356233|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83356234|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
83356235|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356236|NCT05718466|Bevacizumab|bevacizumab|mesh-list
83356237|NCT05718466|Carboplatin|carboplatin|mesh-list
83356238|NCT05718466|Irinotecan|irinotecan|mesh-list
83356239|NCT05718466|Etoposide|etoposide|mesh-list
83356240|NCT05718466|Temozolomide|temozolomide|mesh-list
83356241|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356242|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356243|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83356244|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83356245|NCT05718466|Growth Substances|growth substances|mesh-ancestor
83356246|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356247|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
83356248|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83356249|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83356250|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356251|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356252|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83356253|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83356254|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356255|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
83356256|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
83356257|NCT03208452|Analgesics|analgesics|mesh-ancestor
83356258|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
83356259|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356260|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356261|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
83356262|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356263|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83356264|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
83356265|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83356266|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83356267|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356268|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83356269|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
83356270|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83356271|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
83356272|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
83356273|NCT03224208|Vemurafenib|vemurafenib|mesh-list
83356274|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356275|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83356276|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356277|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356278|NCT05718232|Lenvatinib|lenvatinib|mesh-list
83356279|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356280|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83356281|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356282|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356283|NCT00355966|Misoprostol|misoprostol|mesh-list
83356284|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83356285|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
83356286|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83356287|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356288|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83356289|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356290|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
83356291|NCT03208218|Lenalidomide|lenalidomide|mesh-list
83356292|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
83356293|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356294|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83356295|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83356296|NCT03208218|Growth Substances|growth substances|mesh-ancestor
83356297|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
83356298|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356299|NCT05372380|Atorvastatin|atorvastatin|mesh-list
83356301|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83356302|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83356303|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
83356304|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356305|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83356306|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83356307|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356308|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
83356309|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83356310|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356311|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356312|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83356313|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83356314|NCT02451774|Protective Agents|protective agents|mesh-ancestor
83356315|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356316|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
83356317|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83356318|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
83356319|NCT00355576|Minocycline|minocycline|mesh-list
83356320|NCT00355576|Celecoxib|celecoxib|mesh-list
83356321|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83356322|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83356323|NCT00355576|Analgesics|analgesics|mesh-ancestor
83356324|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
83356325|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356326|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356327|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356328|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356329|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83356330|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83356331|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356332|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356333|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83356334|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356335|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
83356336|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83356337|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83356338|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356339|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
83356340|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
83356341|NCT02448264|Berotralstat|berotralstat|mesh-list
83356342|NCT02448264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83356343|NCT02448264|Protease Inhibitors|protease inhibitors|mesh-ancestor
83356344|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356345|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356346|NCT02451852|Osimertinib|osimertinib|mesh-list
83356347|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356348|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83356349|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356350|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356352|NCT00421642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83356353|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356354|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356355|NCT03200964|Anesthetics|anesthetics|mesh-list
83356356|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356357|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356359|NCT04484844|Fluorides|fluorides|mesh-list
83356360|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
83356361|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
83356362|NCT04484844|Protective Agents|protective agents|mesh-ancestor
83356363|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356364|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83356365|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356366|NCT03119454|Betamethasone|betamethasone|mesh-list
83356367|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
83356368|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356369|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
83356370|NCT03119454|Hormones|hormones|mesh-ancestor
83356371|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356372|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356373|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83356374|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
83356375|NCT04485156|Rifampin|rifampin|mesh-list
83356376|NCT04485156|Isoniazid|isoniazid|mesh-list
83356377|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
83356378|NCT04485156|Ethambutol|ethambutol|mesh-list
83356379|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83356380|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
83356381|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83356382|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356383|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
83356384|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83356385|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356386|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356387|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83356388|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83356389|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83356390|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83356391|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83356392|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83356393|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83356394|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83356395|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
83356396|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83356397|NCT04637620|Sertraline|sertraline|mesh-list
83356398|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
83356399|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83356400|NCT04637620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83356401|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83356402|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83356403|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356404|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356405|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
83356406|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356407|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
83356408|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83356409|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83356410|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356411|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
83356412|NCT00355108|Coagulants|coagulants|mesh-ancestor
83356413|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83356414|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356415|NCT05271604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356416|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356417|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83356418|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83356419|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356420|NCT03200886|Triamcinolone|triamcinolone|mesh-list
83356421|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83356422|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83356423|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83356424|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356425|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
83356426|NCT03200886|Hormones|hormones|mesh-ancestor
83356427|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356428|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356429|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356430|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
83356431|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356432|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356433|NCT05717764|Capecitabine|capecitabine|mesh-list
83356434|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
83356435|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83356436|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
83356437|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356438|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356439|NCT05717764|Analgesics|analgesics|mesh-ancestor
83356440|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
83356441|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356442|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356443|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83356444|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83356445|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356446|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
83356447|NCT03118830|Cetrorelix|cetrorelix|mesh-list
83356448|NCT03118830|Hormones|hormones|mesh-list
83356449|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83356450|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356451|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356452|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
83356453|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83356454|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
83356455|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83356456|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83356457|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83356458|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356459|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83356460|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
83356461|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
83356462|NCT03223506|Acetaminophen|acetaminophen|mesh-list
83356463|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83356464|NCT03223506|Analgesics|analgesics|mesh-ancestor
83356465|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
83356466|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356467|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356468|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
83356469|NCT04535362|Nicotine|nicotine|mesh-list
83356470|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83356471|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
83356472|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356473|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356474|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83356475|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83356476|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
83356477|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356478|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356479|NCT03223896|Naloxone|naloxone|mesh-list
83356480|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83356481|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356482|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
83356483|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356484|NCT05716516|Estradiol|estradiol|mesh-list
83356485|NCT05716516|Estrogens|estrogens|mesh-ancestor
83356486|NCT05716516|Hormones|hormones|mesh-ancestor
83356487|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356488|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356489|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
83356490|NCT02447796|Propofol|propofol|mesh-list
83356491|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83356492|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356493|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356494|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83356495|NCT02447796|Analgesics|analgesics|mesh-ancestor
83356496|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
83356497|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356498|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83356499|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83356500|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83356501|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
83356502|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356503|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356504|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83356505|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
83356506|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
83356507|NCT05225116|Lenvatinib|lenvatinib|mesh-list
83356508|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356509|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83356510|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356511|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356512|NCT03838042|Nivolumab|nivolumab|mesh-list
83356513|NCT03838042|Entinostat|entinostat|mesh-list
83356514|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356515|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356516|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83356517|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356518|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83356519|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356520|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
83356521|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
83356522|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356523|NCT03222960|Propolis|propolis|mesh-list
83356524|NCT03222960|Fluorides|fluorides|mesh-list
83356525|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
83356526|NCT03222960|Protective Agents|protective agents|mesh-ancestor
83356527|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356528|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356529|NCT05681260|Cytarabine|cytarabine|mesh-list
83356530|NCT05681260|Dexamethasone|dexamethasone|mesh-list
83356531|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
83356532|NCT05681260|Prednisone|prednisone|mesh-list
83356533|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
83356534|NCT05681260|Ifosfamide|ifosfamide|mesh-list
83356535|NCT05681260|Doxorubicin|doxorubicin|mesh-list
83356536|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83356537|NCT05681260|Methotrexate|methotrexate|mesh-list
83356538|NCT05681260|Etoposide|etoposide|mesh-list
83356539|NCT05681260|Vincristine|vincristine|mesh-list
83356540|NCT05681260|Bortezomib|bortezomib|mesh-list
83356541|NCT05681260|Daunorubicin|daunorubicin|mesh-list
83356542|NCT05681260|Asparaginase|asparaginase|mesh-list
83356543|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
83356544|NCT05681260|Vindesine|vindesine|mesh-list
83356545|NCT05681260|Pegaspargase|pegaspargase|mesh-list
83356546|NCT05681260|BB 1101|bb 1101|mesh-list
83356547|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356548|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
83356549|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356550|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356551|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356552|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
83356553|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356554|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356555|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83356556|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356557|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
83356558|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
83356559|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356560|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356561|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
83356562|NCT05681260|Hormones|hormones|mesh-ancestor
83356563|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356564|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83356565|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
83356566|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356567|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83356568|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83356569|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83356570|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83356571|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
83356572|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83356573|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83356574|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
83356575|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
83356576|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83356577|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83356578|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83356579|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
83356580|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356581|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
83356582|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
83356583|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
83356584|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
83356585|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356586|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356587|NCT03199950|Haloperidol|haloperidol|mesh-list
83356588|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
83356589|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
83356590|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
83356591|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356592|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356593|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356594|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83356595|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83356596|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356597|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83356598|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83356599|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
83356600|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356601|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356602|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83356603|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83356605|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
83356606|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356607|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83356608|NCT05156632|Antacids|antacids|mesh-ancestor
83356609|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356610|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356611|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
83356612|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83356613|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83356614|NCT02447016|Tenofovir|tenofovir|mesh-list
83356615|NCT02447016|Emtricitabine|emtricitabine|mesh-list
83356616|NCT02447016|Efavirenz|efavirenz|mesh-list
83356617|NCT02447016|Rilpivirine|rilpivirine|mesh-list
83356618|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
83356619|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356620|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83356621|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83356622|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356623|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356624|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83356625|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83356626|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83356627|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83356628|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83356629|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83356630|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83356631|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83356632|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83356633|NCT02447094|Plasminogen|plasminogen|mesh-list
83356634|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83356635|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83356636|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356637|NCT02446860|Nivolumab|nivolumab|mesh-list
83356638|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356639|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356640|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83356641|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356642|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
83356643|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83356645|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
83356646|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83356647|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
83356648|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356649|NCT02446782|Clindamycin|clindamycin|mesh-list
83356650|NCT02446782|Cefazolin|cefazolin|mesh-list
83356651|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83356652|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356653|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83356654|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356655|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356656|NCT04745260|Fentanyl|fentanyl|mesh-list
83356657|NCT04745260|Midazolam|midazolam|mesh-list
83356658|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83356659|NCT04745260|Narcotics|narcotics|mesh-ancestor
83356660|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356661|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356662|NCT04745260|Analgesics|analgesics|mesh-ancestor
83356663|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
83356664|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356665|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83356666|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83356667|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
83356668|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
83356669|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83356670|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83356671|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83356672|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83356673|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
83356674|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
83356675|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356676|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356677|NCT03199482|Dexamethasone|dexamethasone|mesh-list
83356678|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356679|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
83356680|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
83356681|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356682|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356683|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356684|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
83356685|NCT03199482|Hormones|hormones|mesh-ancestor
83356686|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356687|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83356688|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356689|NCT02446704|Temozolomide|temozolomide|mesh-list
83356690|NCT02446704|Olaparib|olaparib|mesh-list
83356691|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356692|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
83356693|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356694|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356695|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83356696|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356697|NCT01605227|Prednisone|prednisone|mesh-list
83356698|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356699|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
83356700|NCT01605227|Hormones|hormones|mesh-ancestor
83356701|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356702|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356703|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83356704|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356705|NCT02446548|Losartan|losartan|mesh-list
83356706|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83356707|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83356708|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83356709|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83356710|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356711|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83356712|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83356713|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356714|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
83356715|NCT03199170|Morphine|morphine|mesh-list
83356716|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83356717|NCT03199170|Narcotics|narcotics|mesh-ancestor
83356718|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83356719|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356720|NCT03199170|Analgesics|analgesics|mesh-ancestor
83356721|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
83356722|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356723|NCT03118128|Metformin|metformin|mesh-list
83356724|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83356725|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356726|NCT05100472|Androgens|androgens|mesh-list
83356727|NCT05100472|Hormones|hormones|mesh-ancestor
83356728|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356729|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356730|NCT05087914|Naproxen|naproxen|mesh-list
83356731|NCT05087914|Levodopa|levodopa|mesh-list
83356732|NCT05087914|Carbidopa|carbidopa|mesh-list
83356733|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83356734|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83356735|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83356736|NCT05087914|Analgesics|analgesics|mesh-ancestor
83356737|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
83356738|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356739|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356740|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356741|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356742|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
83356743|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83356744|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356745|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356746|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83356747|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83356748|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
83356749|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356750|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83356751|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83356752|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
83356753|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
83356754|NCT03194724|Vitamin A|vitamin a|mesh-list
83356755|NCT03194724|Vitamins|vitamins|mesh-ancestor
83356756|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
83356757|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356758|NCT05637970|Hemostatics|hemostatics|mesh-list
83356759|NCT05637970|Coagulants|coagulants|mesh-ancestor
83356760|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
83356761|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83356762|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83356763|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83356764|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83356765|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356766|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
83356767|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356768|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356769|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83356770|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356771|NCT01709513|Atorvastatin|atorvastatin|mesh-list
83356772|NCT01709513|Ezetimibe|ezetimibe|mesh-list
83356773|NCT01709513|Alirocumab|alirocumab|mesh-list
83356774|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83356775|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83356776|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
83356777|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356778|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83356779|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83356780|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356781|NCT01709513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83356782|NCT01709513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83356783|NCT01709513|Protease Inhibitors|protease inhibitors|mesh-ancestor
83356784|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
83356785|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83356786|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83356787|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356788|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
83356789|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
83356790|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
83356791|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83356792|NCT05631886|Paclitaxel|paclitaxel|mesh-list
83356793|NCT05631886|Antibodies|antibodies|mesh-list
83356794|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
83356795|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
83356796|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356797|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
83356798|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356799|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356800|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356801|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
83356802|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356803|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356804|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83356805|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83356806|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
83356807|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
83356808|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
83356810|NCT02446002|Clonidine|clonidine|mesh-list
83356811|NCT02446002|Naltrexone|naltrexone|mesh-list
83356812|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83356813|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83356814|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356815|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
83356816|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356817|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83356818|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83356819|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83356820|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83356821|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
83356822|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356823|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356824|NCT02446002|Analgesics|analgesics|mesh-ancestor
83356825|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
83356826|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
83356827|NCT01605071|Estradiol|estradiol|mesh-list
83356828|NCT01605071|Estrogens|estrogens|mesh-ancestor
83356829|NCT01605071|Hormones|hormones|mesh-ancestor
83356830|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356831|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356832|NCT04345198|Epinephrine|epinephrine|mesh-list
83356833|NCT04345198|Racepinephrine|racepinephrine|mesh-list
83356834|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
83356835|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83356836|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83356837|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
83356838|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356839|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356840|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356841|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83356842|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83356843|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
83356844|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356845|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83356846|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
83356847|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
83356848|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
83356849|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83356850|NCT03192618|Leucovorin|leucovorin|mesh-list
83356851|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
83356852|NCT03192618|Calcium|calcium|mesh-list
83356853|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
83356854|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83356855|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356856|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356857|NCT03192618|Antidotes|antidotes|mesh-ancestor
83356858|NCT03192618|Protective Agents|protective agents|mesh-ancestor
83356859|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
83356860|NCT03192618|Vitamins|vitamins|mesh-ancestor
83356861|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
83356862|NCT04113226|Rituximab|rituximab|mesh-list
83356863|NCT04113226|Lenalidomide|lenalidomide|mesh-list
83356864|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83356865|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356866|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
83356867|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356868|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356869|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83356870|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83356871|NCT04113226|Growth Substances|growth substances|mesh-ancestor
83356872|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
83356873|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83356874|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83356875|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356876|NCT02444364|Incretins|incretins|mesh-ancestor
83356877|NCT02444364|Hormones|hormones|mesh-ancestor
83356878|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83356879|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83356880|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
83356881|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356882|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356884|NCT05039476|Vitamins|vitamins|mesh-ancestor
83356885|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
83356886|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356887|NCT00356356|Etanercept|etanercept|mesh-list
83356888|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83356889|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83356890|NCT00356356|Analgesics|analgesics|mesh-ancestor
83356891|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
83356892|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356893|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356894|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83356895|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356896|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356897|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356898|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
83356899|NCT02443818|Sirolimus|sirolimus|mesh-list
83356900|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83356901|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83356902|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83356903|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356904|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
83356905|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356906|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
83356907|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356908|NCT01705691|Paclitaxel|paclitaxel|mesh-list
83356909|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
83356910|NCT01705691|Doxorubicin|doxorubicin|mesh-list
83356911|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83356912|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356913|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
83356914|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
83356915|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
83356916|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356917|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356918|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
83356919|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356920|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356921|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356922|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
83356923|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83356924|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83356925|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83356926|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83356927|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356928|NCT02450058|Paclitaxel|paclitaxel|mesh-list
83356929|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
83356930|NCT02450058|Fluorouracil|fluorouracil|mesh-list
83356931|NCT02450058|Epirubicin|epirubicin|mesh-list
83356932|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83356933|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356934|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
83356935|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
83356936|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
83356937|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356938|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83356939|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
83356940|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356941|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83356942|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83356943|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
83356944|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83356945|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
83356946|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83356947|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83356948|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83356949|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83356950|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356951|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83356952|NCT02445300|Laxatives|laxatives|mesh-ancestor
83356953|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83356954|NCT02445066|Vitamin D|vitamin d|mesh-list
83356955|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
83356956|NCT02445066|Vitamins|vitamins|mesh-ancestor
83356957|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
83356958|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356959|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83356960|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83356961|NCT03197298|Clopidogrel|clopidogrel|mesh-list
83356962|NCT03197298|Ticagrelor|ticagrelor|mesh-list
83356963|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83356964|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83356965|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83356966|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83356967|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
83356968|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356969|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356970|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356971|NCT00357448|Interleukin-2|interleukin-2|mesh-list
83356972|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
83356973|NCT00357448|Immunotoxins|immunotoxins|mesh-list
83356974|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83356975|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83356976|NCT00357448|Analgesics|analgesics|mesh-ancestor
83356977|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
83356978|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356979|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356980|NCT00357448|Immunoconjugates|immunoconjugates|mesh-ancestor
83356981|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
83356982|NCT05715658|Dabigatran|dabigatran|mesh-list
83356983|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
83356984|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83356985|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
83356986|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83356987|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356988|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
83356989|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83356990|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83356991|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83356992|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83356993|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83356994|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83356995|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83356996|NCT02443194|Analgesics|analgesics|mesh-ancestor
83356997|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
83356998|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83356999|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
83357000|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83357001|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
83357002|NCT03193944|Vitamin D|vitamin d|mesh-list
83357003|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
83357004|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
83357005|NCT03193944|Vitamins|vitamins|mesh-list
83357006|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
83357007|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357008|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83357009|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83357010|NCT00357604|Ritonavir|ritonavir|mesh-list
83357011|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
83357012|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
83357013|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83357014|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83357015|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83357016|NCT00357604|Norgestimate|norgestimate|mesh-list
83357017|NCT00357604|Norgestrel|norgestrel|mesh-list
83357018|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83357019|NCT00357604|Estradiol|estradiol|mesh-list
83357020|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83357021|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83357022|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83357023|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
83357024|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357025|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357026|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83357027|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83357028|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
83357029|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357030|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83357031|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83357032|NCT00357604|Estrogens|estrogens|mesh-ancestor
83357033|NCT00357604|Hormones|hormones|mesh-ancestor
83357034|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357035|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357036|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83357037|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
83357038|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83357039|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83357040|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83357041|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83357042|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83357043|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83357044|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357045|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83357046|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83357047|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357048|NCT03193788|Folic Acid|folic acid|mesh-list
83357049|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
83357050|NCT03193788|Dexamethasone|dexamethasone|mesh-list
83357051|NCT03193788|Pemetrexed|pemetrexed|mesh-list
83357052|NCT03193788|Vitamins|vitamins|mesh-ancestor
83357053|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
83357054|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357055|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357056|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
83357057|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
83357058|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357059|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357060|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
83357061|NCT03193788|Hormones|hormones|mesh-ancestor
83357062|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357063|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357064|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357065|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357066|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357067|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83357068|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83357069|NCT03193788|Hematinics|hematinics|mesh-ancestor
83357070|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
83357071|NCT02442648|Rituximab|rituximab|mesh-list
83357072|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357073|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357074|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
83357075|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357076|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357077|NCT00356824|Artesunate|artesunate|mesh-list
83357078|NCT00356824|Amodiaquine|amodiaquine|mesh-list
83357079|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
83357080|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83357081|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83357082|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357083|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357084|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
83357085|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
83357086|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83357087|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
83357088|NCT01705145|Ivacaftor|ivacaftor|mesh-list
83357089|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83357090|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357091|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357092|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83357093|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
83357094|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
83357095|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83357096|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
83357097|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357098|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83357099|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83357100|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83357101|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83357102|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357103|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
83357104|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
83357105|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83357106|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83357107|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357108|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357109|NCT02442492|Urological Agents|urological agents|mesh-ancestor
83357111|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
83357112|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357113|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
83357114|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357115|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
83357116|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83357117|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83357118|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
83357119|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357120|NCT04166669|Itraconazole|itraconazole|mesh-list
83357121|NCT04166669|Rifampin|rifampin|mesh-list
83357122|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
83357123|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357124|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83357125|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83357126|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357127|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357128|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83357129|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
83357130|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357131|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357132|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83357133|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83357134|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
83357135|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357136|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
83357137|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83357138|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83357139|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83357140|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83357141|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83357142|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83357143|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83357144|NCT03193710|Remifentanil|remifentanil|mesh-list
83357145|NCT03193710|Propofol|propofol|mesh-list
83357146|NCT03193710|Sevoflurane|sevoflurane|mesh-list
83357147|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83357148|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357149|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357150|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83357151|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
83357152|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
83357153|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83357154|NCT03193710|Narcotics|narcotics|mesh-ancestor
83357155|NCT03193710|Analgesics|analgesics|mesh-ancestor
83357156|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
83357157|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357158|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83357159|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83357160|NCT01704599|Vitamins|vitamins|mesh-list
83357161|NCT01704599|Folic Acid|folic acid|mesh-list
83357162|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
83357163|NCT01704599|Pyridoxine|pyridoxine|mesh-list
83357164|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
83357165|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
83357166|NCT01704599|Adalimumab|adalimumab|mesh-list
83357167|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
83357168|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357169|NCT01704599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83357170|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357171|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357172|NCT01704599|Hematinics|hematinics|mesh-ancestor
83357173|NCT03196362|Metformin|metformin|mesh-list
83357175|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83357176|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357177|NCT02449278|Prednisone|prednisone|mesh-list
83357178|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
83357179|NCT02449278|Doxorubicin|doxorubicin|mesh-list
83357180|NCT02449278|Vincristine|vincristine|mesh-list
83357181|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357182|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
83357183|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357185|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83357186|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
83357187|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357188|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357189|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83357190|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83357191|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83357192|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83357193|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357194|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357195|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
83357196|NCT02449278|Hormones|hormones|mesh-ancestor
83357197|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357198|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357199|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83357200|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357201|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357202|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357203|NCT03599518|Gefitinib|gefitinib|mesh-list
83357204|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357205|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83357206|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357207|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357208|NCT03099486|Leucovorin|leucovorin|mesh-list
83357209|NCT03099486|Antidotes|antidotes|mesh-ancestor
83357210|NCT03099486|Protective Agents|protective agents|mesh-ancestor
83357211|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357212|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
83357213|NCT03099486|Vitamins|vitamins|mesh-ancestor
83357214|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
83357215|NCT00358228|Rimonabant|rimonabant|mesh-list
83357216|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83357217|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83357218|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83357219|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357220|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357221|NCT00358228|Hormones|hormones|mesh-ancestor
83357222|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357223|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357224|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83357225|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83357226|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83357227|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
83357228|NCT05709028|Fosfomycin|fosfomycin|mesh-list
83357229|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357230|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357231|NCT03420508|Ensartinib|ensartinib|mesh-list
83357232|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357233|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83357234|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357235|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357236|NCT01336530|Oxethazaine|oxethazaine|mesh-list
83357237|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83357238|NCT01336530|Antacids|antacids|mesh-list
83357239|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
83357240|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83357241|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
83357242|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357243|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357244|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357245|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
83357246|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
83357247|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357248|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
83357249|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357250|NCT00777348|Reproterol|reproterol|mesh-list
83357251|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83357252|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83357253|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
83357254|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357255|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357256|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357257|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83357258|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
83357259|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357260|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83357261|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
83357262|NCT03836560|Nicotine|nicotine|mesh-list
83357263|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83357264|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
83357265|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357266|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357267|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83357268|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83357269|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
83357270|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357271|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357272|NCT04483596|Melatonin|melatonin|mesh-list
83357273|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
83357274|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357275|NCT04483596|Protective Agents|protective agents|mesh-ancestor
83357276|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357277|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357278|NCT05721586|Listerine|listerine|mesh-list
83357279|NCT05721586|Fluorides|fluorides|mesh-list
83357280|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
83357281|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
83357282|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
83357283|NCT05721586|Protective Agents|protective agents|mesh-ancestor
83357284|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357285|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83357286|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357287|NCT02978482|Durvalumab|durvalumab|mesh-list
83357288|NCT02978482|Tremelimumab|tremelimumab|mesh-list
83357289|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83357290|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357291|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357292|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
83357293|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357294|NCT00357682|Aspirin|aspirin|mesh-list
83357295|NCT00357682|Esomeprazole|esomeprazole|mesh-list
83357296|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83357297|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83357298|NCT00357682|Analgesics|analgesics|mesh-ancestor
83357299|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
83357300|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357301|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357302|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357303|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357304|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83357305|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83357306|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357307|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83357308|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83357309|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357310|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
83357311|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83357312|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357313|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83357314|NCT00105027|Triamcinolone|triamcinolone|mesh-list
83357315|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83357316|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83357317|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83357318|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357319|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
83357320|NCT00105027|Hormones|hormones|mesh-ancestor
83357321|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357322|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357323|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357324|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
83357325|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357326|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357327|NCT03145012|Ranitidine|ranitidine|mesh-list
83357328|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
83357329|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83357330|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357331|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83357332|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
83357333|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
83357334|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357335|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357336|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357337|NCT03832660|Valsartan|valsartan|mesh-list
83357338|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83357339|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83357340|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83357341|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83357342|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357343|NCT03132532|Paclitaxel|paclitaxel|mesh-list
83357344|NCT03132532|Etoposide|etoposide|mesh-list
83357345|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
83357346|NCT03132532|Cisplatin|cisplatin|mesh-list
83357347|NCT03132532|Carboplatin|carboplatin|mesh-list
83357348|NCT03132532|Pemetrexed|pemetrexed|mesh-list
83357349|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83357350|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
83357351|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83357352|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357353|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357354|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357355|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357356|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357357|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83357358|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83357359|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357360|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83357361|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83357362|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
83357363|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357364|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
83357365|NCT00030147|Estradiol|estradiol|mesh-list
83357366|NCT00030147|Estrogens|estrogens|mesh-ancestor
83357367|NCT00030147|Hormones|hormones|mesh-ancestor
83357368|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357369|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357370|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83357371|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
83357372|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83357373|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83357374|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83357375|NCT02709486|Tanezumab|tanezumab|mesh-list
83357376|NCT02709486|Analgesics|analgesics|mesh-ancestor
83357377|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
83357378|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357379|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357380|NCT00106431|Romidepsin|romidepsin|mesh-list
83357381|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83357382|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357383|NCT00106431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83357384|NCT00106431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357385|NCT00106431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357386|NCT03107416|Bumetanide|bumetanide|mesh-list
83357387|NCT03107416|Diuretics|diuretics|mesh-ancestor
83357388|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
83357389|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357390|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83357391|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357392|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357393|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83357394|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
83357395|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83357396|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
83357397|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357398|NCT03833596|Prednisone|prednisone|mesh-list
83357399|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357400|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
83357401|NCT03833596|Hormones|hormones|mesh-ancestor
83357402|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357403|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357404|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357405|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357406|NCT02831998|Ethanol|ethanol|mesh-list
83357407|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
83357408|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83357409|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83357410|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357411|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357412|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357413|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
83357414|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357415|NCT02434614|Cisplatin|cisplatin|mesh-list
83357416|NCT02434614|Docetaxel|docetaxel|mesh-list
83357417|NCT02434614|Fluorouracil|fluorouracil|mesh-list
83357418|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357419|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357420|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357421|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357422|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357423|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
83357424|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83357425|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357426|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
83357427|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357428|NCT05720260|Durvalumab|durvalumab|mesh-list
83357429|NCT05720260|Fulvestrant|fulvestrant|mesh-list
83357430|NCT05720260|Goserelin|goserelin|mesh-list
83357431|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357432|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357433|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357434|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83357435|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83357436|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
83357437|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357438|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357439|NCT05720026|Docetaxel|docetaxel|mesh-list
83357440|NCT05720026|Trastuzumab|trastuzumab|mesh-list
83357441|NCT05720026|Pertuzumab|pertuzumab|mesh-list
83357442|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357443|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357444|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357445|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357446|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357447|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357448|NCT04483674|Tenofovir|tenofovir|mesh-list
83357449|NCT04483674|Emtricitabine|emtricitabine|mesh-list
83357450|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
83357451|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357452|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83357453|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83357454|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357455|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357456|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83357457|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83357458|NCT02438982|Rituximab|rituximab|mesh-list
83357459|NCT02438982|Tacrolimus|tacrolimus|mesh-list
83357460|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83357461|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357462|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357463|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
83357464|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357465|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357466|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357467|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357468|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357469|NCT02425774|Prucalopride|prucalopride|mesh-list
83357470|NCT02425774|Laxatives|laxatives|mesh-ancestor
83357471|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357472|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83357473|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83357474|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
83357475|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357476|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357477|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357478|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
83357479|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83357480|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
83357481|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
83357482|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357483|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357484|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83357485|NCT02420002|Analgesics|analgesics|mesh-ancestor
83357486|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
83357487|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357488|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
83357489|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83357490|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83357491|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83357492|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357493|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357494|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
83357495|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357496|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357497|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83357498|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357499|NCT03117894|Acetaminophen|acetaminophen|mesh-list
83357500|NCT03117894|Etoricoxib|etoricoxib|mesh-list
83357501|NCT03117894|Morphine|morphine|mesh-list
83357502|NCT03117894|Remifentanil|remifentanil|mesh-list
83357503|NCT03117894|Ondansetron|ondansetron|mesh-list
83357504|NCT03117894|Propofol|propofol|mesh-list
83357505|NCT03117894|Ropivacaine|ropivacaine|mesh-list
83357506|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83357507|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357508|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357509|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83357510|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
83357511|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
83357512|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83357513|NCT03117894|Narcotics|narcotics|mesh-ancestor
83357514|NCT03117894|Analgesics|analgesics|mesh-ancestor
83357515|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
83357516|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357517|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
83357518|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83357519|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
83357520|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
83357521|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
83357522|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357523|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
83357524|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357525|NCT03117894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83357526|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83357527|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
83357528|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357529|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357530|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83357531|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357532|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357533|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83357534|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83357535|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357536|NCT00357292|Azithromycin|azithromycin|mesh-list
83357537|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357538|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357539|NCT05625802|Ropivacaine|ropivacaine|mesh-list
83357540|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
83357541|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
83357542|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357543|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357544|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
83357545|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357546|NCT03187548|Calcium|calcium|mesh-list
83357547|NCT03187548|Caseins|caseins|mesh-list
83357548|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83357549|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357550|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
83357551|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
83357552|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357553|NCT02042326|Sirolimus|sirolimus|mesh-list
83357554|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357555|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357556|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83357557|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357558|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
83357559|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357560|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
83357561|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357562|NCT05718544|Sufentanil|sufentanil|mesh-list
83357563|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
83357564|NCT05718544|Esketamine|esketamine|mesh-list
83357565|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83357566|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357567|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357568|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83357569|NCT05718544|Analgesics|analgesics|mesh-ancestor
83357570|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
83357571|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357572|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83357573|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83357574|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83357575|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
83357576|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357577|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357578|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83357579|NCT05718544|Narcotics|narcotics|mesh-ancestor
83357580|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83357581|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83357582|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
83357583|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
83357584|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
83357585|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83357586|NCT05616598|Ribavirin|ribavirin|mesh-list
83357587|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
83357588|NCT05616598|Simeprevir|simeprevir|mesh-list
83357589|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
83357590|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357591|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
83357592|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357593|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
83357594|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357595|NCT03187392|Lidocaine|lidocaine|mesh-list
83357596|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
83357597|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
83357598|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357599|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357600|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
83357601|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357602|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83357603|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83357604|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83357605|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357606|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357607|NCT01464268|Riboflavin|riboflavin|mesh-list
83357608|NCT01464268|Dextrans|dextrans|mesh-list
83357609|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
83357610|NCT01464268|Vitamins|vitamins|mesh-ancestor
83357611|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
83357612|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357613|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83357614|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357615|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
83357616|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
83357617|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
83357618|NCT00215787|Lansoprazole|lansoprazole|mesh-list
83357619|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
83357620|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83357621|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357622|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83357623|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357624|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357625|NCT05716906|Melatonin|melatonin|mesh-list
83357626|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
83357627|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357628|NCT05716906|Protective Agents|protective agents|mesh-ancestor
83357629|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357630|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357631|NCT00216099|Folic Acid|folic acid|mesh-list
83357632|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
83357633|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
83357634|NCT00216099|Pemetrexed|pemetrexed|mesh-list
83357635|NCT00216099|Vitamins|vitamins|mesh-ancestor
83357636|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
83357637|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357638|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357639|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357640|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357641|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83357642|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83357643|NCT00216099|Hematinics|hematinics|mesh-ancestor
83357644|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
83357645|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
83357646|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357647|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
83357648|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83357649|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83357650|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357651|NCT04565925|Urological Agents|urological agents|mesh-ancestor
83357652|NCT00039195|Prednisone|prednisone|mesh-list
83357653|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
83357654|NCT00039195|Ifosfamide|ifosfamide|mesh-list
83357655|NCT00039195|Rituximab|rituximab|mesh-list
83357656|NCT00039195|Carboplatin|carboplatin|mesh-list
83357657|NCT00039195|Doxorubicin|doxorubicin|mesh-list
83357658|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83357659|NCT00039195|Etoposide|etoposide|mesh-list
83357660|NCT00039195|Vincristine|vincristine|mesh-list
83357661|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357662|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
83357663|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357664|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357665|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83357666|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
83357667|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357668|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357669|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83357670|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357671|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83357672|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83357673|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83357674|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357675|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357676|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
83357677|NCT00039195|Hormones|hormones|mesh-ancestor
83357678|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357679|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357680|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83357681|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357682|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357683|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357684|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
83357685|NCT05591170|Vitamin D|vitamin d|mesh-list
83357686|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83357687|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357688|NCT05591170|Vitamins|vitamins|mesh-ancestor
83357689|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
83357690|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83357691|NCT00218439|Paroxetine|paroxetine|mesh-list
83357692|NCT00218439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83357693|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83357694|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357695|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357696|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357697|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
83357698|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357699|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83357700|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
83357701|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83357702|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83357703|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83357704|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357705|NCT04344730|Dexamethasone|dexamethasone|mesh-list
83357706|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
83357707|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357708|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
83357709|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
83357710|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357711|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357712|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357713|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
83357714|NCT04344730|Hormones|hormones|mesh-ancestor
83357715|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357716|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357717|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357718|NCT05716672|Lazertinib|lazertinib|mesh-list
83357719|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83357720|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357721|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357722|NCT00358384|Betamethasone|betamethasone|mesh-list
83357723|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
83357724|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
83357725|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
83357726|NCT00358384|Calcipotriene|calcipotriene|mesh-list
83357727|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
83357728|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357729|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
83357730|NCT00358384|Hormones|hormones|mesh-ancestor
83357731|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357732|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357733|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83357734|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
83357735|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357736|NCT02959060|Rifampin|rifampin|mesh-list
83357737|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83357738|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
83357739|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357740|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357741|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
83357742|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83357743|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357744|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357745|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83357746|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83357747|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83357748|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83357749|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83357750|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83357751|NCT00109005|Lenalidomide|lenalidomide|mesh-list
83357752|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
83357753|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357754|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83357755|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83357756|NCT00109005|Growth Substances|growth substances|mesh-ancestor
83357757|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
83357758|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357759|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
83357760|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357761|NCT05547100|Olanzapine|olanzapine|mesh-list
83357762|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
83357763|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
83357764|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357765|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357766|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357767|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83357769|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357770|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83357771|NCT05547100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83357772|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83357773|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357774|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357775|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357776|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
83357777|NCT00109473|Prednisone|prednisone|mesh-list
83357778|NCT00109473|Hormones|hormones|mesh-list
83357779|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357780|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
83357781|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357782|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357783|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357784|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357785|NCT05136976|Rituximab|rituximab|mesh-list
83357786|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357787|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357788|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
83357789|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357790|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357791|NCT00044655|Olanzapine|olanzapine|mesh-list
83357792|NCT00044655|Risperidone|risperidone|mesh-list
83357793|NCT00044655|Aripiprazole|aripiprazole|mesh-list
83357794|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83357795|NCT00044655|Ziprasidone|ziprasidone|mesh-list
83357796|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83357797|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
83357798|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357799|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357800|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357801|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83357802|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83357803|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83357804|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83357805|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83357806|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
83357807|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
83357808|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
83357809|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357810|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83357811|NCT00044655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83357812|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83357813|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357814|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
83357815|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
83357816|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83357817|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83357818|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83357819|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83357820|NCT05130892|Tranilast|tranilast|mesh-list
83357821|NCT05130892|Colchicine|colchicine|mesh-list
83357822|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
83357823|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357824|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357825|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357826|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357827|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357828|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357829|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83357830|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83357831|NCT05130892|Analgesics|analgesics|mesh-ancestor
83357832|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
83357833|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357834|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357835|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357836|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83357837|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83357838|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83357839|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83357840|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
83357841|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
83357842|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357843|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83357844|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83357845|NCT00223665|Leuprolide|leuprolide|mesh-list
83357846|NCT00223665|Flutamide|flutamide|mesh-list
83357847|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83357848|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
83357849|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83357850|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357851|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357852|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357853|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
83357854|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
83357855|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357856|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
83357857|NCT05311540|Astringents|astringents|mesh-ancestor
83357858|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357860|NCT00223821|Oxybutynin|oxybutynin|mesh-list
83357861|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
83357862|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
83357863|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357864|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357865|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83357866|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83357867|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
83357868|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357869|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357870|NCT00223821|Urological Agents|urological agents|mesh-ancestor
83357871|NCT00359164|Bevacizumab|bevacizumab|mesh-list
83357872|NCT00359164|Verteporfin|verteporfin|mesh-list
83357873|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83357874|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357875|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83357876|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83357877|NCT00359164|Growth Substances|growth substances|mesh-ancestor
83357878|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357879|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
83357880|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83357881|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357882|NCT00224289|Latanoprost|latanoprost|mesh-list
83357883|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83357884|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83357885|NCT00045435|Cyclosporine|cyclosporine|mesh-list
83357886|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
83357887|NCT00045435|Fludarabine|fludarabine|mesh-list
83357888|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
83357889|NCT00045435|Cyclosporins|cyclosporins|mesh-list
83357890|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357891|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83357892|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
83357893|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357894|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357895|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
83357896|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357897|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357898|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
83357899|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357900|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357901|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357902|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83357903|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83357904|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83357905|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
83357906|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357907|NCT00111657|Rasburicase|rasburicase|mesh-list
83357908|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
83357909|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83357910|NCT05292586|Beclomethasone|beclomethasone|mesh-list
83357911|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
83357912|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83357913|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
83357914|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357915|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357916|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83357917|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
83357918|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83357919|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83357920|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83357921|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
83357922|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357923|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357924|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357925|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
83357927|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357928|NCT02097303|Prednisone|prednisone|mesh-list
83357929|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
83357930|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
83357931|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83357932|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
83357933|NCT02097303|Hormones|hormones|mesh-ancestor
83357934|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83357935|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357936|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83357937|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357938|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83357939|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357940|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357941|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
83357942|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83357943|NCT00703326|Docetaxel|docetaxel|mesh-list
83357944|NCT00703326|Ramucirumab|ramucirumab|mesh-list
83357945|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357946|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357947|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357948|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357949|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357950|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
83357951|NCT02097537|Miotics|miotics|mesh-ancestor
83357952|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
83357953|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83357954|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357955|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83357956|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
83357957|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
83357958|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83357959|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83357960|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
83357961|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357962|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357963|NCT02097849|Interferons|interferons|mesh-list
83357964|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83357965|NCT02097849|Vaccines|vaccines|mesh-list
83357966|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83357967|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
83357968|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357969|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357970|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
83357971|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357972|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
83357973|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83357974|NCT00047697|Donepezil|donepezil|mesh-list
83357975|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83357976|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83357977|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357978|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
83357979|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83357980|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357981|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
83357982|NCT05094154|Penicillins|penicillins|mesh-list
83357983|NCT05094154|Cephalosporins|cephalosporins|mesh-list
83357984|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83357985|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83357986|NCT02437812|Metformin|metformin|mesh-list
83357987|NCT02437812|Paclitaxel|paclitaxel|mesh-list
83357988|NCT02437812|Carboplatin|carboplatin|mesh-list
83357989|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83357990|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83357991|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
83357992|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
83357993|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
83357994|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83357995|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83357996|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83357997|NCT00112593|Cyclosporine|cyclosporine|mesh-list
83357998|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
83357999|NCT00112593|Fludarabine|fludarabine|mesh-list
83358000|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
83358001|NCT00112593|Cyclosporins|cyclosporins|mesh-list
83358002|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358003|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83358004|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
83358005|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358006|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358007|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
83358008|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358009|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358010|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
83358011|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358012|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83358013|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358014|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83358015|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83358016|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83358017|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
83358018|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358019|NCT05280106|Citric Acid|citric acid|mesh-list
83358020|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
83358021|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
83358022|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
83358023|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83358024|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
83358025|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
83358026|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358027|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83358028|NCT00112671|Sorafenib|sorafenib|mesh-list
83358029|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358030|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83358031|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358032|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358033|NCT05279092|Dexamethasone|dexamethasone|mesh-list
83358034|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
83358035|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83358036|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83358037|NCT05279092|Prednisolone|prednisolone|mesh-list
83358038|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
83358039|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
83358040|NCT05279092|Bupivacaine|bupivacaine|mesh-list
83358041|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83358042|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
83358043|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83358044|NCT05279092|BB 1101|bb 1101|mesh-list
83358045|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83358046|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
83358047|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
83358048|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358049|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358050|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358051|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
83358052|NCT05279092|Hormones|hormones|mesh-ancestor
83358053|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358054|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83358055|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358056|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
83358057|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
83358058|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358059|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
83358060|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83358061|NCT05279092|Protective Agents|protective agents|mesh-ancestor
83358062|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
83358063|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358064|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358066|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358067|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358068|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
83358069|NCT05273632|Oxytocin|oxytocin|mesh-list
83358070|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
83358071|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83358072|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358073|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83358074|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83358075|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358076|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
83358077|NCT05273632|Coagulants|coagulants|mesh-ancestor
83358078|NCT02429622|Paclitaxel|paclitaxel|mesh-list
83358079|NCT02429622|Nedaplatin|nedaplatin|mesh-list
83358080|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83358081|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358082|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
83358083|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
83358084|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
83358085|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358086|NCT02429466|Guadecitabine|guadecitabine|mesh-list
83358087|NCT02429466|Azacitidine|azacitidine|mesh-list
83358088|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358089|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83358090|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
83358091|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358092|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358093|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
83358094|NCT02429388|Spironolactone|spironolactone|mesh-list
83358095|NCT02429388|Diuretics|diuretics|mesh-list
83358096|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
83358097|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83358098|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
83358099|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358100|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358101|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
83358102|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358103|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358104|NCT02429232|Pioglitazone|pioglitazone|mesh-list
83358105|NCT02429232|Linagliptin|linagliptin|mesh-list
83358106|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358107|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358108|NCT02429232|Incretins|incretins|mesh-ancestor
83358109|NCT02429232|Hormones|hormones|mesh-ancestor
83358110|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358111|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83358112|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
83358113|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358114|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358115|NCT03189732|Metformin|metformin|mesh-list
83358116|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358117|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358118|NCT02437032|Menotropins|menotropins|mesh-list
83358119|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83358120|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
83358121|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83358122|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358123|NCT05232994|Metformin|metformin|mesh-list
83358124|NCT05232994|Esomeprazole|esomeprazole|mesh-list
83358125|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358126|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358127|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83358128|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358129|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83358130|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358131|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358132|NCT02436798|Ondansetron|ondansetron|mesh-list
83358133|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
83358134|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
83358135|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358136|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358137|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358139|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
83358140|NCT02436798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83358141|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83358142|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
83358143|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358144|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358145|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
83358146|NCT03185130|Promethazine|promethazine|mesh-list
83358147|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
83358148|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83358149|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83358150|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358151|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358152|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
83358153|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
83358154|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
83358155|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358156|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
83358157|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
83358158|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358159|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83358160|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
83358161|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
83358162|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358163|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358164|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83358166|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
83358167|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83358168|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83358169|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83358170|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83358171|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
83358172|NCT00358618|Propofol|propofol|mesh-list
83358173|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83358174|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358175|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358176|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83358177|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
83358178|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
83358179|NCT02428764|Carboplatin|carboplatin|mesh-list
83358180|NCT02428764|Gemcitabine|gemcitabine|mesh-list
83358181|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
83358182|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358183|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83358184|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
83358185|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358186|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358187|NCT00358696|Tenofovir|tenofovir|mesh-list
83358188|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
83358189|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358190|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83358191|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83358192|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358193|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358194|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83358195|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83358196|NCT05050942|Octreotide|octreotide|mesh-list
83358197|NCT05050942|Lanreotide|lanreotide|mesh-list
83358198|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358199|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83358200|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358201|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83358202|NCT05429476|Plasminogen|plasminogen|mesh-list
83358203|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83358204|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83358205|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358206|NCT00360178|Amlodipine|amlodipine|mesh-list
83358207|NCT00360178|Valsartan|valsartan|mesh-list
83358208|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83358209|NCT00360178|Candesartan|candesartan|mesh-list
83358210|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83358211|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83358212|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358213|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358214|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83358215|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358216|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
83358217|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83358218|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83358219|NCT00360178|Diuretics|diuretics|mesh-ancestor
83358220|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
83358221|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83358222|NCT00421720|Sufentanil|sufentanil|mesh-list
83358223|NCT00421720|Remifentanil|remifentanil|mesh-list
83358224|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83358225|NCT00421720|Narcotics|narcotics|mesh-ancestor
83358226|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358227|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358228|NCT00421720|Analgesics|analgesics|mesh-ancestor
83358229|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
83358230|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358231|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83358232|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83358233|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
83358234|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
83358235|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83358236|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
83358237|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358238|NCT05008276|Dextrans|dextrans|mesh-list
83358239|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
83358240|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
83358241|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
83358242|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
83358243|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358244|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83358245|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83358246|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358247|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358248|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
83358249|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
83358250|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83358251|NCT04492306|Protective Agents|protective agents|mesh-ancestor
83358252|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358253|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83358254|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
83358255|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358256|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
83358257|NCT04469842|Prednisone|prednisone|mesh-list
83358258|NCT04469842|Azathioprine|azathioprine|mesh-list
83358259|NCT04469842|Tacrolimus|tacrolimus|mesh-list
83358260|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83358261|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
83358262|NCT04469842|Hormones|hormones|mesh-ancestor
83358263|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358264|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358265|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83358266|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358267|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358268|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
83358269|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83358270|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358271|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358272|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83358273|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83358274|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
83358275|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358276|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358277|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
83358278|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83358279|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358280|NCT04941898|Factor VIII|factor viii|mesh-list
83358281|NCT04941898|BAX 855|bax 855|mesh-list
83358282|NCT04941898|Coagulants|coagulants|mesh-ancestor
83358283|NCT04468360|Pregnanolone|pregnanolone|mesh-list
83358284|NCT04468360|Brexanolone|brexanolone|mesh-list
83358285|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
83358286|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358287|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358289|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358290|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358291|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
83358292|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
83358293|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
83358294|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358295|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83358296|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358297|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358298|NCT04907110|Niacinamide|niacinamide|mesh-list
83358299|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
83358300|NCT04907110|Vitamins|vitamins|mesh-ancestor
83358301|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
83358302|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358303|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
83358304|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358305|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83358306|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358307|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358308|NCT04887298|Annamycin|annamycin|mesh-list
83358309|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83358310|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358311|NCT02977000|Propranolol|propranolol|mesh-list
83358312|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83358313|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83358314|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
83358315|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358316|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358317|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358318|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83358319|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83358320|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
83358321|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
83358322|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83358323|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358324|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
83358325|NCT00112827|Melphalan|melphalan|mesh-list
83358326|NCT00112827|Lenalidomide|lenalidomide|mesh-list
83358327|NCT00112827|Lenograstim|lenograstim|mesh-list
83358328|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358329|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
83358330|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358331|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358332|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83358333|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
83358334|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358335|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358336|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83358337|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83358338|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83358339|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83358340|NCT00112827|Growth Substances|growth substances|mesh-ancestor
83358341|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
83358342|NCT04752111|Esmolol|esmolol|mesh-list
83358343|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83358344|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83358345|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83358346|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
83358347|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358348|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358349|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358350|NCT04343170|Folic Acid|folic acid|mesh-list
83358351|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
83358352|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
83358353|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
83358354|NCT04343170|Vitamins|vitamins|mesh-ancestor
83358355|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
83358356|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358357|NCT04343170|Hematinics|hematinics|mesh-ancestor
83358358|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
83358359|NCT00226239|Docetaxel|docetaxel|mesh-list
83358360|NCT00226239|Cetuximab|cetuximab|mesh-list
83358361|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358362|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
83358363|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
83358364|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
83358365|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358366|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358368|NCT00227019|Folic Acid|folic acid|mesh-list
83358369|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
83358370|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
83358371|NCT00227019|Dexamethasone|dexamethasone|mesh-list
83358372|NCT00227019|Bevacizumab|bevacizumab|mesh-list
83358373|NCT00227019|Pemetrexed|pemetrexed|mesh-list
83358374|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358375|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358376|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83358377|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83358378|NCT00227019|Growth Substances|growth substances|mesh-ancestor
83358379|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358380|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
83358381|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
83358382|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83358383|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
83358384|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
83358385|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358386|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358387|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
83358388|NCT00227019|Hormones|hormones|mesh-ancestor
83358389|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358390|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83358391|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358392|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358393|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83358394|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83358395|NCT00227019|Hematinics|hematinics|mesh-ancestor
83358396|NCT00113217|Bevacizumab|bevacizumab|mesh-list
83358397|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358398|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358399|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83358400|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83358401|NCT00113217|Growth Substances|growth substances|mesh-ancestor
83358402|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358403|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
83358404|NCT04718116|Tramadol|tramadol|mesh-list
83358405|NCT04718116|Tapentadol|tapentadol|mesh-list
83358406|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83358407|NCT04718116|Narcotics|narcotics|mesh-ancestor
83358408|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358409|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358410|NCT04718116|Analgesics|analgesics|mesh-ancestor
83358411|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
83358412|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358413|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83358414|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83358415|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358416|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358417|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
83358418|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358419|NCT04429503|Aflibercept|aflibercept|mesh-list
83358420|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83358421|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83358422|NCT04429503|Growth Substances|growth substances|mesh-ancestor
83358423|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358424|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
83358425|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358426|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
83358427|NCT04276792|Narcotics|narcotics|mesh-ancestor
83358428|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358429|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358430|NCT04276792|Analgesics|analgesics|mesh-ancestor
83358431|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
83358432|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358433|NCT00053703|Olanzapine|olanzapine|mesh-list
83358434|NCT00053703|Risperidone|risperidone|mesh-list
83358435|NCT00053703|Molindone|molindone|mesh-list
83358436|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83358437|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
83358438|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358439|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358440|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358441|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83358442|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83358443|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358444|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83358445|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83358446|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
83358447|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
83358448|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
83358449|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358450|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358451|NCT00053703|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83358452|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83358453|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358454|NCT02975440|Rifampin|rifampin|mesh-list
83358455|NCT02975440|Midazolam|midazolam|mesh-list
83358456|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83358457|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83358458|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358459|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358460|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83358461|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83358462|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83358463|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83358464|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
83358465|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
83358466|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
83358468|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358469|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358470|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83358471|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
83358472|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358473|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358474|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
83358475|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83358476|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358477|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83358478|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83358479|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83358480|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83358481|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83358482|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83358483|NCT00231309|Lenograstim|lenograstim|mesh-list
83358484|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83358485|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
83358486|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358487|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
83358488|NCT04267120|Lenvatinib|lenvatinib|mesh-list
83358489|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358490|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358491|NCT04267120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83358492|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358493|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83358494|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358495|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
83358496|NCT04265872|Bortezomib|bortezomib|mesh-list
83358497|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358498|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358499|NCT04265872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83358500|NCT04265872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358501|NCT00232479|Carboplatin|carboplatin|mesh-list
83358502|NCT00232479|Docetaxel|docetaxel|mesh-list
83358503|NCT00232479|Trastuzumab|trastuzumab|mesh-list
83358504|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358505|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
83358506|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
83358507|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
83358508|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358509|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358511|NCT04710628|Lenvatinib|lenvatinib|mesh-list
83358512|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358513|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358514|NCT04710628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83358515|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358516|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83358517|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358518|NCT00233103|Sertraline|sertraline|mesh-list
83358519|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
83358520|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83358521|NCT00233103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83358522|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83358523|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358524|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358525|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358526|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
83358527|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358528|NCT00703014|Progesterone|progesterone|mesh-list
83358529|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83358530|NCT00703014|Ganirelix|ganirelix|mesh-list
83358531|NCT00703014|Progestins|progestins|mesh-ancestor
83358532|NCT00703014|Hormones|hormones|mesh-ancestor
83358533|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358534|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358535|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
83358536|NCT02433522|Rituximab|rituximab|mesh-list
83358537|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358538|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358539|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
83358540|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358541|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358542|NCT00118131|Docetaxel|docetaxel|mesh-list
83358543|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358544|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
83358545|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
83358546|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
83358547|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358548|NCT02433912|Acetaminophen|acetaminophen|mesh-list
83358549|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
83358550|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83358551|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83358552|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358553|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
83358554|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
83358555|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83358556|NCT02433912|Analgesics|analgesics|mesh-ancestor
83358557|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
83358558|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358559|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358560|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
83358561|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
83358562|NCT02436486|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
83358563|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358564|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358565|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83358566|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83358567|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358568|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358569|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358570|NCT02436486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358571|NCT02436486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83358572|NCT02436486|Serotonin Agents|serotonin agents|mesh-ancestor
83358573|NCT02436486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358574|NCT04342858|Listerine|listerine|mesh-list
83358575|NCT04342858|Fluorides|fluorides|mesh-list
83358576|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
83358577|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
83358578|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358579|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
83358580|NCT04342858|Protective Agents|protective agents|mesh-ancestor
83358581|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83358582|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358583|NCT02429076|Propofol|propofol|mesh-list
83358584|NCT02429076|Sevoflurane|sevoflurane|mesh-list
83358585|NCT02429076|Methylphenidate|methylphenidate|mesh-list
83358586|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83358587|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358588|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358589|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83358590|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
83358591|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
83358592|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83358593|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83358594|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83358595|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83358596|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83358597|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358598|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358599|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
83358600|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358601|NCT00255177|Mifepristone|mifepristone|mesh-list
83358602|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83358603|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
83358604|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83358605|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358606|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83358607|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83358608|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83358609|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
83358610|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83358611|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83358612|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
83358613|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358614|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
83358615|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83358616|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83358617|NCT04670224|Anesthetics|anesthetics|mesh-list
83358618|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358619|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358620|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
83358621|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
83358622|NCT00361114|Dapsone|dapsone|mesh-list
83358623|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
83358624|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
83358625|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
83358626|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83358627|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83358628|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358629|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83358630|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358631|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358632|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83358633|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
83358634|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358635|NCT00702624|Hormones|hormones|mesh-list
83358636|NCT00702624|Progesterone|progesterone|mesh-list
83358637|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83358638|NCT00702624|Ganirelix|ganirelix|mesh-list
83358639|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358640|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358641|NCT00702624|Progestins|progestins|mesh-ancestor
83358642|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
83358643|NCT03915496|Abrocitinib|abrocitinib|mesh-list
83358644|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83358645|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358646|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358647|NCT00702546|Hormones|hormones|mesh-list
83358648|NCT00702546|Progesterone|progesterone|mesh-list
83358649|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83358650|NCT00702546|Ganirelix|ganirelix|mesh-list
83358651|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358652|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358653|NCT00702546|Progestins|progestins|mesh-ancestor
83358654|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
83358655|NCT04648930|Omalizumab|omalizumab|mesh-list
83358656|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83358657|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83358658|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
83358659|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
83358660|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83358661|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
83358662|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358663|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358664|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83358665|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
83358666|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
83358667|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83358668|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
83358669|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358670|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358671|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
83358672|NCT02428686|Hematinics|hematinics|mesh-ancestor
83358673|NCT02432976|Insulin|insulin|mesh-list
83358674|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83358675|NCT02432976|Exenatide|exenatide|mesh-list
83358676|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
83358677|NCT02432976|Incretins|incretins|mesh-list
83358678|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358679|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358680|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83358681|NCT02432976|Hormones|hormones|mesh-ancestor
83358682|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358683|NCT02428374|Clopidogrel|clopidogrel|mesh-list
83358684|NCT02428374|Ticagrelor|ticagrelor|mesh-list
83358685|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83358686|NCT02428374|Simvastatin|simvastatin|mesh-list
83358687|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83358688|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83358689|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83358690|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83358692|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358693|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358694|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358695|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83358696|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83358697|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
83358698|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83358699|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83358700|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358701|NCT04614610|Lidocaine|lidocaine|mesh-list
83358702|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
83358703|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
83358704|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358705|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358706|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
83358707|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358708|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83358709|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83358710|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83358711|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358712|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358713|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83358714|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
83358715|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358716|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
83358717|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358718|NCT04606576|Insulin|insulin|mesh-list
83358719|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83358720|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358721|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358722|NCT02428062|Phenylephrine|phenylephrine|mesh-list
83358723|NCT02428062|Dopamine|dopamine|mesh-list
83358724|NCT02428062|Epinephrine|epinephrine|mesh-list
83358725|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
83358726|NCT02428062|Norepinephrine|norepinephrine|mesh-list
83358727|NCT02428062|Ephedrine|ephedrine|mesh-list
83358728|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
83358729|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358730|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83358731|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83358732|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
83358733|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358734|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358735|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83358736|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83358737|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
83358738|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358739|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83358740|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
83358741|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
83358742|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
83358743|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83358744|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
83358745|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83358746|NCT02428062|Protective Agents|protective agents|mesh-ancestor
83358747|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83358748|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
83358749|NCT04594798|Prednisone|prednisone|mesh-list
83358750|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
83358751|NCT04594798|Rituximab|rituximab|mesh-list
83358752|NCT04594798|Doxorubicin|doxorubicin|mesh-list
83358753|NCT04594798|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83358754|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358755|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
83358756|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358757|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358758|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83358759|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
83358760|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358761|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358762|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83358763|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358764|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83358765|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83358766|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83358767|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358768|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83358769|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
83358770|NCT04594798|Hormones|hormones|mesh-ancestor
83358771|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358772|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83358773|NCT04594798|Immunoconjugates|immunoconjugates|mesh-ancestor
83358774|NCT02432664|Midazolam|midazolam|mesh-list
83358775|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83358776|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83358777|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358778|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358779|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83358780|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83358781|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83358782|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83358783|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
83358784|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
83358785|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
83358786|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
83358787|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358788|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358789|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
83358790|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358791|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358792|NCT03189186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83358793|NCT03189186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358794|NCT00361894|Enoxaparin|enoxaparin|mesh-list
83358795|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
83358796|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83358797|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
83358798|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83358799|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
83358800|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358801|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358802|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
83358804|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83358805|NCT03185988|Trastuzumab|trastuzumab|mesh-list
83358806|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358807|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358808|NCT04550494|Talazoparib|talazoparib|mesh-list
83358809|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83358810|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358811|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358812|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358813|NCT00361348|Heparin|heparin|mesh-list
83358814|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
83358815|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83358816|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83358817|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358818|NCT02431728|Melatonin|melatonin|mesh-list
83358819|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
83358820|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358821|NCT02431728|Protective Agents|protective agents|mesh-ancestor
83358822|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358823|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83358824|NCT04343326|Menthol|menthol|mesh-list
83358825|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
83358826|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
83358827|NCT00362206|Simvastatin|simvastatin|mesh-list
83358828|NCT00362206|Pravastatin|pravastatin|mesh-list
83358829|NCT00362206|Fenofibrate|fenofibrate|mesh-list
83358830|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83358831|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83358832|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
83358833|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358834|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83358835|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83358836|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358837|NCT02314468|Glycerol|glycerol|mesh-list
83358838|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83358839|NCT02314468|Protective Agents|protective agents|mesh-ancestor
83358840|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358841|NCT01704287|Paclitaxel|paclitaxel|mesh-list
83358842|NCT01704287|Carboplatin|carboplatin|mesh-list
83358843|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
83358844|NCT01704287|Temozolomide|temozolomide|mesh-list
83358845|NCT01704287|Dacarbazine|dacarbazine|mesh-list
83358846|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83358847|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358848|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
83358849|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
83358850|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
83358851|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358852|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358853|NCT01704287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83358854|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83358855|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
83358856|NCT00362752|Norfloxacin|norfloxacin|mesh-list
83358857|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358858|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358859|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83358860|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83358861|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358862|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358863|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358864|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83358865|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83358867|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
83358868|NCT00118209|Rituximab|rituximab|mesh-list
83358869|NCT00118209|Doxorubicin|doxorubicin|mesh-list
83358870|NCT00118209|Etoposide|etoposide|mesh-list
83358871|NCT00118209|Vincristine|vincristine|mesh-list
83358872|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358873|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
83358874|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358875|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358876|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83358877|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
83358878|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358879|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358880|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83358881|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358882|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83358883|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83358884|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83358885|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358886|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83358888|NCT00118209|Hormones|hormones|mesh-ancestor
83358889|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358890|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83358891|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83358892|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
83358893|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
83358894|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
83358895|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
83358896|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358897|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358898|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358899|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358900|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
83358901|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
83358902|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83358903|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83358904|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358905|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358906|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358907|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358908|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
83358909|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
83358910|NCT01682837|Citric Acid|citric acid|mesh-list
83358911|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
83358912|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
83358913|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83358914|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
83358915|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
83358916|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358917|NCT01682837|Diuretics|diuretics|mesh-ancestor
83358918|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
83358919|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358920|NCT01682837|Expectorants|expectorants|mesh-ancestor
83358921|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
83358922|NCT01682837|Cathartics|cathartics|mesh-ancestor
83358923|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83358924|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
83358925|NCT02213068|Abatacept|abatacept|mesh-list
83358926|NCT02213068|Tacrolimus|tacrolimus|mesh-list
83358927|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358928|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
83358929|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358930|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83358931|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358932|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358933|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83358934|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358935|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83358936|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
83358937|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83358938|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83358939|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83358940|NCT02213068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83358941|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358942|NCT00702234|Progesterone|progesterone|mesh-list
83358943|NCT00702234|Progestins|progestins|mesh-ancestor
83358944|NCT00702234|Hormones|hormones|mesh-ancestor
83358945|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358946|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358947|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
83358948|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
83358949|NCT04483284|Estrogens|estrogens|mesh-ancestor
83358950|NCT04483284|Hormones|hormones|mesh-ancestor
83358951|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358952|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358953|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83358954|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358955|NCT00235833|Adalimumab|adalimumab|mesh-list
83358956|NCT00235833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83358957|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83358958|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83358959|NCT00255801|Doxorubicin|doxorubicin|mesh-list
83358960|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83358961|NCT00255801|Bexarotene|bexarotene|mesh-list
83358962|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83358963|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358964|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83358965|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83358966|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83358967|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358968|NCT02431416|Hormones|hormones|mesh-list
83358969|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83358970|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358971|NCT04751955|Capecitabine|capecitabine|mesh-list
83358972|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83358973|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
83358974|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358975|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83358976|NCT01682759|Metformin|metformin|mesh-list
83358977|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
83358978|NCT01682759|Glimepiride|glimepiride|mesh-list
83358979|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358980|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358981|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83358982|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83358983|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
83358984|NCT01682681|Topiramate|topiramate|mesh-list
83358985|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
83358986|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83358987|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358988|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
83358989|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83358990|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83358991|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83358992|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83358993|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83358994|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
83358995|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83358996|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83358997|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83358998|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83358999|NCT03183024|Benralizumab|benralizumab|mesh-list
83359000|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83359001|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
83359002|NCT00240981|Testosterone|testosterone|mesh-list
83359003|NCT00240981|Androgens|androgens|mesh-ancestor
83359004|NCT00240981|Hormones|hormones|mesh-ancestor
83359005|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359006|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359007|NCT01682213|Dabrafenib|dabrafenib|mesh-list
83359008|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359009|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83359010|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359011|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359012|NCT04134923|Corticosterone|corticosterone|mesh-list
83359013|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83359014|NCT02126553|Lenalidomide|lenalidomide|mesh-list
83359015|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
83359016|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359017|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83359018|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83359019|NCT02126553|Growth Substances|growth substances|mesh-ancestor
83359020|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
83359021|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359022|NCT01703741|Testosterone|testosterone|mesh-list
83359023|NCT01703741|Androgens|androgens|mesh-ancestor
83359024|NCT01703741|Hormones|hormones|mesh-ancestor
83359025|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359026|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359027|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
83359028|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83359029|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83359030|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83359031|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83359032|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359033|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359034|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359035|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359036|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359037|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83359038|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359039|NCT02430714|Lenvatinib|lenvatinib|mesh-list
83359040|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359041|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83359042|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359043|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359044|NCT02425254|Acetaminophen|acetaminophen|mesh-list
83359045|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83359046|NCT02425254|Analgesics|analgesics|mesh-ancestor
83359047|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
83359048|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359049|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359050|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
83359051|NCT02426736|Dexamethasone|dexamethasone|mesh-list
83359052|NCT02426736|Bupivacaine|bupivacaine|mesh-list
83359053|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83359054|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
83359055|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
83359056|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359057|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359058|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359059|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
83359060|NCT02426736|Hormones|hormones|mesh-ancestor
83359061|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359062|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83359063|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359064|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
83359065|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
83359066|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359067|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
83359068|NCT03182634|Fulvestrant|fulvestrant|mesh-list
83359069|NCT03182634|Olaparib|olaparib|mesh-list
83359070|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83359071|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359072|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83359073|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83359074|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
83359075|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359076|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359077|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83359078|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359079|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359080|NCT03182322|Insulin|insulin|mesh-list
83359081|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83359082|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359083|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
83359084|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359085|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
83359086|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83359087|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83359088|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359089|NCT03185364|Urological Agents|urological agents|mesh-ancestor
83359090|NCT02424552|Vitamin D|vitamin d|mesh-list
83359091|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
83359092|NCT02424552|Vitamins|vitamins|mesh-ancestor
83359093|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
83359094|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359095|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83359096|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83359097|NCT03182088|Norepinephrine|norepinephrine|mesh-list
83359098|NCT03182088|Bupivacaine|bupivacaine|mesh-list
83359099|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
83359100|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
83359101|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359102|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359103|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
83359104|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359105|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83359106|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83359107|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
83359108|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359109|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359110|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
83359111|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
83359112|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83359113|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
83359114|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83359115|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
83359116|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83359117|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359118|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83359119|NCT02425722|Linaclotide|linaclotide|mesh-list
83359120|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
83359121|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
83359122|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359123|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359124|NCT03609580|Tamsulosin|tamsulosin|mesh-list
83359125|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83359126|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83359127|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83359128|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
83359129|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359130|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359131|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359132|NCT03609580|Urological Agents|urological agents|mesh-ancestor
83359133|NCT02061514|Propofol|propofol|mesh-list
83359134|NCT02061514|Desflurane|desflurane|mesh-list
83359135|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83359136|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359137|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359138|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83359139|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
83359140|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
83359141|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83359142|NCT03183492|Vaccines|vaccines|mesh-list
83359143|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
83359144|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359145|NCT02424318|Topiramate|topiramate|mesh-list
83359146|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
83359147|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83359148|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359149|NCT03179280|Insulin|insulin|mesh-list
83359150|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
83359151|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83359152|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359153|NCT01681433|Prednisone|prednisone|mesh-list
83359154|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
83359155|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83359156|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
83359157|NCT01681433|Hormones|hormones|mesh-ancestor
83359158|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359159|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359160|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83359161|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359162|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83359163|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359164|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359165|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
83359166|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83359167|NCT01703117|Riluzole|riluzole|mesh-list
83359168|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
83359169|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83359170|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83359171|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359172|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359173|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359174|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83359175|NCT01703117|Protective Agents|protective agents|mesh-ancestor
83359176|NCT01702961|Cytarabine|cytarabine|mesh-list
83359177|NCT01702961|Etoposide|etoposide|mesh-list
83359178|NCT01702961|Rituximab|rituximab|mesh-list
83359179|NCT01702961|Melphalan|melphalan|mesh-list
83359180|NCT01702961|Carmustine|carmustine|mesh-list
83359181|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83359182|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359183|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83359184|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83359185|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359186|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359187|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83359188|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
83359189|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
83359190|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359191|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359192|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
83359193|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359194|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83359195|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359196|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83359197|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
83359198|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83359199|NCT01702025|Aminophylline|aminophylline|mesh-list
83359200|NCT01702025|Methazolamide|methazolamide|mesh-list
83359201|NCT01702025|Theophylline|theophylline|mesh-list
83359202|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83359203|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
83359204|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359205|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359206|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83359207|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
83359208|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83359209|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359210|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359211|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
83359212|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83359213|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83359214|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
83359215|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359216|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83359217|NCT01702025|Protective Agents|protective agents|mesh-ancestor
83359218|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83359219|NCT01702025|Diuretics|diuretics|mesh-ancestor
83359220|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
83359221|NCT01592747|Memantine|memantine|mesh-list
83359222|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83359223|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83359224|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
83359225|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359226|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359227|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359228|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83359229|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83359230|NCT02425488|Coal Tar|coal tar|mesh-list
83359231|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
83359232|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359233|NCT02426112|Azithromycin|azithromycin|mesh-list
83359234|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83359235|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359236|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
83359237|NCT03117192|Astringents|astringents|mesh-ancestor
83359238|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359239|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359240|NCT04768439|Vitamin D|vitamin d|mesh-list
83359241|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
83359242|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
83359243|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
83359244|NCT04768439|Calcitriol|calcitriol|mesh-list
83359245|NCT04768439|Vitamins|vitamins|mesh-list
83359246|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
83359247|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359248|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83359249|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83359250|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83359251|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359252|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359253|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83359254|NCT02421042|Lenvatinib|lenvatinib|mesh-list
83359255|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359256|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83359257|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359258|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359259|NCT03181464|Lidocaine|lidocaine|mesh-list
83359260|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
83359261|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
83359262|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359263|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359264|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
83359265|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359266|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83359267|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83359268|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83359269|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359270|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359271|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
83359272|NCT02423928|Ipilimumab|ipilimumab|mesh-list
83359273|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359274|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
83359275|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359276|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359277|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83359278|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
83359279|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359280|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359281|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83359282|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83359283|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83359284|NCT02416128|Prednisolone|prednisolone|mesh-list
83359285|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83359286|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
83359287|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83359288|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
83359289|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83359290|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
83359291|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83359292|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
83359293|NCT02416128|Hormones|hormones|mesh-ancestor
83359294|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359295|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359296|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83359297|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359298|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
83359299|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
83359300|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359301|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359302|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83359303|NCT02416128|Protective Agents|protective agents|mesh-ancestor
83359304|NCT03106740|Minocycline|minocycline|mesh-list
83359305|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83359306|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359307|NCT03106818|Ketorolac|ketorolac|mesh-list
83359308|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
83359309|NCT03106818|Bupivacaine|bupivacaine|mesh-list
83359310|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
83359311|NCT03106818|Anesthetics|anesthetics|mesh-list
83359312|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359313|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359314|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
83359315|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359316|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83359317|NCT03106818|Analgesics|analgesics|mesh-ancestor
83359318|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83359320|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359321|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83359322|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359323|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359324|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83359325|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
83359326|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83359327|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359328|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83359329|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
83359330|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83359331|NCT01592045|Aldesleukin|aldesleukin|mesh-list
83359332|NCT01592045|Molgramostim|molgramostim|mesh-list
83359333|NCT01592045|Dinutuximab|dinutuximab|mesh-list
83359334|NCT01592045|Isotretinoin|isotretinoin|mesh-list
83359335|NCT01592045|Sargramostim|sargramostim|mesh-list
83359336|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359337|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83359338|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83359339|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
83359340|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359341|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359342|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
83359343|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359344|NCT03178656|Sorafenib|sorafenib|mesh-list
83359345|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359346|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83359347|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359348|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359349|NCT01590797|Metformin|metformin|mesh-list
83359350|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83359351|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83359352|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359353|NCT01590797|Incretins|incretins|mesh-ancestor
83359354|NCT01590797|Hormones|hormones|mesh-ancestor
83359355|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359356|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83359357|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
83359358|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359359|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359360|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
83359361|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83359362|NCT01867606|Antibodies|antibodies|mesh-list
83359363|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
83359364|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359365|NCT02415192|Amlodipine|amlodipine|mesh-list
83359366|NCT02415192|Valsartan|valsartan|mesh-list
83359367|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83359368|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83359369|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359370|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359371|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83359372|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359373|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
83359374|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83359375|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83359376|NCT02415270|Menthol|menthol|mesh-list
83359377|NCT02415270|Nicotine|nicotine|mesh-list
83359378|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83359379|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
83359380|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359381|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359382|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83359383|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83359384|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359385|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359386|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359387|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
83359388|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359389|NCT02415114|Resveratrol|resveratrol|mesh-list
83359390|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
83359391|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359392|NCT02415114|Protective Agents|protective agents|mesh-ancestor
83359393|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359394|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359395|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83359396|NCT03178422|Nicotine|nicotine|mesh-list
83359397|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83359398|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
83359399|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359400|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359401|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83359402|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83359403|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359404|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359405|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359406|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
83359407|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83359408|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359409|NCT02414880|Rocuronium|rocuronium|mesh-list
83359410|NCT02414880|Neostigmine|neostigmine|mesh-list
83359411|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83359412|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83359413|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83359414|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359415|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359416|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83359417|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359418|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359419|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359420|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359421|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83359422|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
83359423|NCT02423694|Dexetimide|dexetimide|mesh-list
83359424|NCT02423694|Citalopram|citalopram|mesh-list
83359425|NCT02423694|Escitalopram|escitalopram|mesh-list
83359426|NCT02423694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83359427|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83359428|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359429|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359430|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359431|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
83359432|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359433|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83359434|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83359435|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
83359436|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
83359437|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359438|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83359439|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83359440|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359441|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83359442|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
83359443|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83359444|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
83359445|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
83359446|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
83359447|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359448|NCT02420418|Expectorants|expectorants|mesh-ancestor
83359449|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
83359450|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83359451|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
83359452|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359453|NCT02420418|Protective Agents|protective agents|mesh-ancestor
83359454|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359455|NCT02420418|Antidotes|antidotes|mesh-ancestor
83359456|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
83359457|NCT02414802|Heparin|heparin|mesh-list
83359458|NCT02414802|Calcium heparin|calcium heparin|mesh-list
83359459|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83359460|NCT02414802|Tinzaparin|tinzaparin|mesh-list
83359461|NCT02414802|Dalteparin|dalteparin|mesh-list
83359462|NCT02414802|Calcium|calcium|mesh-list
83359463|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83359464|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359465|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83359467|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83359468|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83359469|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359470|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
83359471|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83359472|NCT01701401|Ledipasvir|ledipasvir|mesh-list
83359473|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
83359474|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359475|NCT04482504|Vitamin D|vitamin d|mesh-list
83359476|NCT04482504|Vitamins|vitamins|mesh-ancestor
83359477|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
83359478|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359479|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83359480|NCT02414568|Prednisone|prednisone|mesh-list
83359481|NCT02414568|Doxorubicin|doxorubicin|mesh-list
83359482|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83359483|NCT02414568|Vinblastine|vinblastine|mesh-list
83359484|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83359485|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359486|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83359487|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83359488|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359489|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359490|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83359491|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
83359492|NCT02414568|Hormones|hormones|mesh-ancestor
83359493|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359494|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359495|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83359496|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83359497|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
83359498|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83359499|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
83359500|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
83359501|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
83359502|NCT04348877|Antibodies|antibodies|mesh-list
83359503|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
83359504|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359505|NCT03176628|Niacinamide|niacinamide|mesh-list
83359506|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
83359507|NCT03176628|Vitamins|vitamins|mesh-ancestor
83359508|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
83359509|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359510|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
83359511|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83359512|NCT02414490|Antibodies|antibodies|mesh-list
83359513|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
83359514|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83359515|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
83359516|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359517|NCT01590017|Cisplatin|cisplatin|mesh-list
83359518|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359519|NCT01700621|Vaccines|vaccines|mesh-list
83359520|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
83359521|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359522|NCT03178500|Clomiphene|clomiphene|mesh-list
83359523|NCT03178500|Enclomiphene|enclomiphene|mesh-list
83359524|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
83359525|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83359526|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
83359527|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359528|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359529|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83359530|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
83359531|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83359532|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83359533|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83359534|NCT01700387|Topiramate|topiramate|mesh-list
83359535|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
83359536|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83359537|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83359538|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83359539|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359540|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359541|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359542|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359543|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359544|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83359545|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359546|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
83359547|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83359548|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
83359549|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83359550|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83359551|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83359552|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359553|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359554|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359555|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359556|NCT01587989|Methotrexate|methotrexate|mesh-list
83359557|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83359558|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
83359559|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83359560|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359561|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83359562|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
83359563|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359564|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359565|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359566|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359567|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83359568|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359569|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
83359570|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359571|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83359572|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83359573|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83359574|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83359575|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83359576|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83359577|NCT01697969|Analgesics|analgesics|mesh-ancestor
83359578|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
83359579|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359580|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359581|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83359582|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359583|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83359584|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83359585|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83359586|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
83359587|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
83359588|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359589|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359590|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
83359591|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83359592|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359593|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359594|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359595|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359596|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359597|NCT01697579|Ondansetron|ondansetron|mesh-list
83359598|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
83359599|NCT01697579|Aprepitant|aprepitant|mesh-list
83359600|NCT01697579|Serotonin|serotonin|mesh-list
83359601|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
83359602|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
83359603|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359604|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359605|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359606|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
83359607|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359608|NCT01697579|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83359609|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83359610|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
83359611|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359612|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359613|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83359614|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83359615|NCT01586195|Vemurafenib|vemurafenib|mesh-list
83359616|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359617|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83359618|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359619|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359620|NCT01697345|Testosterone|testosterone|mesh-list
83359621|NCT01697345|Androgens|androgens|mesh-ancestor
83359622|NCT01697345|Hormones|hormones|mesh-ancestor
83359623|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359624|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359625|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
83359626|NCT03467386|Tacrolimus|tacrolimus|mesh-list
83359627|NCT03467386|Lenograstim|lenograstim|mesh-list
83359628|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359629|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
83359630|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359631|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359632|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83359633|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
83359634|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359635|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359636|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83359637|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83359638|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83359639|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359640|NCT01352962|Carboplatin|carboplatin|mesh-list
83359641|NCT01352962|Gemcitabine|gemcitabine|mesh-list
83359642|NCT01352962|Lenalidomide|lenalidomide|mesh-list
83359643|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359644|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83359645|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
83359646|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359647|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
83359648|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359649|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83359650|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83359651|NCT01352962|Growth Substances|growth substances|mesh-ancestor
83359652|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
83359653|NCT03465592|Nivolumab|nivolumab|mesh-list
83359654|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83359655|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359656|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83359657|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359658|NCT02441062|Edotreotide|edotreotide|mesh-list
83359659|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83359660|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359661|NCT02442700|Pitavastatin|pitavastatin|mesh-list
83359662|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83359663|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83359664|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83359665|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
83359666|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359667|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359668|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83359669|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
83359670|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83359671|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359672|NCT00568672|Olanzapine|olanzapine|mesh-list
83359673|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
83359674|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
83359675|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359676|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359677|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359678|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83359679|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83359680|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359681|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83359682|NCT00568672|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83359683|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83359684|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359685|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359686|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359687|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
83359688|NCT02448862|Fentanyl|fentanyl|mesh-list
83359689|NCT02448862|Analgesics|analgesics|mesh-list
83359690|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83359691|NCT02448862|Narcotics|narcotics|mesh-ancestor
83359692|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359693|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359694|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
83359695|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359696|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83359697|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83359698|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
83359699|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
83359701|NCT01697267|Azathioprine|azathioprine|mesh-list
83359702|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83359703|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359704|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
83359705|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359706|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359707|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
83359708|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359709|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83359710|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359711|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
83359712|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83359713|NCT00362986|Protective Agents|protective agents|mesh-ancestor
83359714|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359715|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359716|NCT00363376|Zonisamide|zonisamide|mesh-list
83359717|NCT00363376|Olanzapine|olanzapine|mesh-list
83359718|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
83359719|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
83359720|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359721|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359722|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359723|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83359724|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83359725|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359726|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83359727|NCT00363376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83359728|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83359729|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359730|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359731|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359732|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
83359733|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
83359734|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83359735|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83359736|NCT02451202|Rocuronium|rocuronium|mesh-list
83359737|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83359738|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83359739|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83359740|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359741|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359742|NCT02452060|Ketamine|ketamine|mesh-list
83359743|NCT02452060|Analgesics|analgesics|mesh-ancestor
83359744|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
83359745|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359746|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359747|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83359748|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83359749|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
83359750|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
83359751|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359752|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83359753|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83359754|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359755|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359756|NCT01696955|Cetuximab|cetuximab|mesh-list
83359757|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83359758|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359759|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
83359760|NCT02452528|Promethazine|promethazine|mesh-list
83359761|NCT02452528|Tenofovir|tenofovir|mesh-list
83359762|NCT02452528|Entecavir|entecavir|mesh-list
83359763|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
83359764|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359765|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83359766|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83359767|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359768|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359769|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83359770|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83359771|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83359772|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83359773|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359774|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359775|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
83359776|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
83359777|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
83359778|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359779|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
83359780|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
83359781|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359782|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83359783|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
83359784|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
83359785|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359786|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83359787|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
83359788|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359789|NCT02702388|Lenvatinib|lenvatinib|mesh-list
83359790|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359791|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83359792|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359793|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359794|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
83359795|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
83359796|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83359797|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83359798|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359799|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359800|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83359801|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83359802|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
83359803|NCT01696877|Molgramostim|molgramostim|mesh-list
83359804|NCT01696877|Sargramostim|sargramostim|mesh-list
83359805|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359806|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
83359807|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359808|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359809|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83359810|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
83359811|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359812|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359813|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83359814|NCT02416102|Losartan|losartan|mesh-list
83359815|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83359816|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83359817|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83359818|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83359819|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359820|NCT02414256|Anesthetics|anesthetics|mesh-list
83359821|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83359822|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359823|NCT02458690|Dopamine|dopamine|mesh-list
83359824|NCT02458690|Norepinephrine|norepinephrine|mesh-list
83359825|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
83359826|NCT02458690|Serotonin|serotonin|mesh-list
83359827|NCT02458690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83359828|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
83359829|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83359830|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83359831|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
83359832|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359833|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359835|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
83359836|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
83359837|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359838|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83359839|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83359840|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83359841|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
83359842|NCT02458690|Protective Agents|protective agents|mesh-ancestor
83359843|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83359844|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
83359845|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83359846|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359847|NCT02458768|Menotropins|menotropins|mesh-list
83359848|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83359849|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
83359850|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83359851|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359852|NCT02418676|Insulin|insulin|mesh-list
83359853|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83359854|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359855|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83359856|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359857|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359858|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
83359859|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359860|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
83359861|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83359862|NCT02422836|Protective Agents|protective agents|mesh-ancestor
83359863|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359864|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359865|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
83359866|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
83359867|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
83359868|NCT00707304|Lactoferrin|lactoferrin|mesh-list
83359869|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
83359870|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359871|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359872|NCT02423980|Glucagon|glucagon|mesh-list
83359873|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83359874|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83359875|NCT02423980|Hormones|hormones|mesh-ancestor
83359876|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83359877|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359878|NCT02423980|Incretins|incretins|mesh-ancestor
83359879|NCT03176316|Naloxone|naloxone|mesh-list
83359880|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83359881|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359882|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
83359883|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359884|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
83359885|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83359886|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
83359887|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359888|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359889|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83359890|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
83359891|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359892|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359893|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83359894|NCT02974426|Cisplatin|cisplatin|mesh-list
83359895|NCT02974426|Carboplatin|carboplatin|mesh-list
83359896|NCT02974426|Pemetrexed|pemetrexed|mesh-list
83359897|NCT02974426|Vinorelbine|vinorelbine|mesh-list
83359898|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83359899|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359900|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359901|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83359902|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83359903|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83359904|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
83359905|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
83359906|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
83359907|NCT02413554|Rivastigmine|rivastigmine|mesh-list
83359908|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83359909|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359910|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359911|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359912|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359913|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359914|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83359915|NCT02413554|Protective Agents|protective agents|mesh-ancestor
83359916|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
83359917|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83359918|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
83359919|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83359920|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
83359921|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359922|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359923|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
83359924|NCT02465632|Clindamycin|clindamycin|mesh-list
83359925|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
83359926|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
83359927|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83359928|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83359929|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83359930|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83359931|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359932|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359933|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
83359934|NCT02703636|Rivastigmine|rivastigmine|mesh-list
83359935|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83359936|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83359937|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359938|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
83359939|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359940|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359941|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83359942|NCT02703636|Protective Agents|protective agents|mesh-ancestor
83359943|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
83359944|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83359945|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83359946|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359947|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
83359948|NCT02422056|Coagulants|coagulants|mesh-ancestor
83359949|NCT02466958|Milnacipran|milnacipran|mesh-list
83359950|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
83359951|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83359952|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83359953|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83359954|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359955|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359956|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359957|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
83359958|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83359959|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83359960|NCT02466958|Analgesics|analgesics|mesh-ancestor
83359961|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
83359962|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359963|NCT02467504|Folic Acid|folic acid|mesh-list
83359964|NCT02467504|Loxoprofen|loxoprofen|mesh-list
83359965|NCT02467504|Hematinics|hematinics|mesh-ancestor
83359966|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
83359967|NCT02467504|Vitamins|vitamins|mesh-ancestor
83359968|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
83359969|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359970|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83359971|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83359972|NCT02467504|Analgesics|analgesics|mesh-ancestor
83359973|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
83359974|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83359975|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83359976|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83359977|NCT02413086|Chitosan|chitosan|mesh-list
83359978|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83359979|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83359980|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
83359981|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359982|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83359983|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
83359984|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
83359986|NCT02413086|Coagulants|coagulants|mesh-ancestor
83359987|NCT02468830|Mirabegron|mirabegron|mesh-list
83359988|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83359989|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83359990|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83359991|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
83359992|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83359993|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83359994|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359995|NCT02468830|Urological Agents|urological agents|mesh-ancestor
83359996|NCT02470234|Methylphenidate|methylphenidate|mesh-list
83359997|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83359998|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83359999|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83360000|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83360001|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83360002|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360003|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
83360004|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360005|NCT02418702|Ketamine|ketamine|mesh-list
83360006|NCT02418702|Analgesics|analgesics|mesh-ancestor
83360007|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
83360008|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360009|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360010|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83360011|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83360012|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
83360013|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
83360014|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360015|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83360016|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83360017|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360018|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360019|NCT02412930|Tramadol|tramadol|mesh-list
83360020|NCT02412930|Bupivacaine|bupivacaine|mesh-list
83360021|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
83360022|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
83360023|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360024|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360025|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
83360026|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360027|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360028|NCT02412930|Narcotics|narcotics|mesh-ancestor
83360029|NCT02412930|Analgesics|analgesics|mesh-ancestor
83360030|NCT02432716|Insulin|insulin|mesh-list
83360031|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83360032|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
83360033|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83360034|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360035|NCT02418624|Carboplatin|carboplatin|mesh-list
83360036|NCT02418624|Olaparib|olaparib|mesh-list
83360037|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360038|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83360039|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360040|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360041|NCT02440204|Remifentanil|remifentanil|mesh-list
83360042|NCT02440204|Sevoflurane|sevoflurane|mesh-list
83360043|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360044|NCT02440204|Narcotics|narcotics|mesh-ancestor
83360045|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360046|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360047|NCT02440204|Analgesics|analgesics|mesh-ancestor
83360048|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
83360049|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360050|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83360051|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83360052|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
83360053|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
83360054|NCT02410590|Atropine|atropine|mesh-list
83360055|NCT02410590|Rocuronium|rocuronium|mesh-list
83360056|NCT02410590|Cisatracurium|cisatracurium|mesh-list
83360057|NCT02410590|Succinylcholine|succinylcholine|mesh-list
83360058|NCT02410590|Neostigmine|neostigmine|mesh-list
83360059|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83360060|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83360061|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83360062|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360063|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360064|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83360065|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83360066|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83360067|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
83360068|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83360069|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
83360070|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
83360071|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
83360072|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83360073|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83360074|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
83360075|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360076|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360077|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83360078|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360079|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83360080|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83360082|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
83360083|NCT02517580|Vitamins|vitamins|mesh-ancestor
83360084|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
83360085|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360086|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83360087|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83360088|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360089|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
83360090|NCT02517580|Coagulants|coagulants|mesh-ancestor
83360091|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
83360092|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360093|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
83360094|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360095|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360096|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83360097|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
83360098|NCT02412150|Remifentanil|remifentanil|mesh-list
83360099|NCT02412150|Desflurane|desflurane|mesh-list
83360100|NCT02412150|Anesthetics|anesthetics|mesh-list
83360101|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
83360102|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83360103|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360104|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360105|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83360106|NCT02412150|Analgesics|analgesics|mesh-ancestor
83360107|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
83360108|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360109|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83360110|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83360111|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83360112|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
83360113|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360114|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360115|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360116|NCT02412150|Narcotics|narcotics|mesh-ancestor
83360117|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
83360118|NCT02523196|Cholic Acids|cholic acids|mesh-list
83360119|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360120|NCT02418078|Anesthetics|anesthetics|mesh-list
83360121|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360122|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360123|NCT03175926|Budesonide|budesonide|mesh-list
83360124|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83360125|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83360126|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
83360127|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360128|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360129|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83360130|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
83360131|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
83360132|NCT03175926|Hormones|hormones|mesh-ancestor
83360133|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360134|NCT02524054|Furosemide|furosemide|mesh-list
83360135|NCT02524054|Diuretics|diuretics|mesh-ancestor
83360136|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
83360137|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360138|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83360139|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83360140|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360141|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
83360142|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83360143|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
83360144|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360145|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83360146|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83360147|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
83360148|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360149|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360150|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83360151|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
83360152|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83360153|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
83360154|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360155|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
83360156|NCT02417610|Protective Agents|protective agents|mesh-ancestor
83360157|NCT03116490|Anesthetics|anesthetics|mesh-list
83360158|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360159|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360160|NCT02417298|Ketamine|ketamine|mesh-list
83360161|NCT02417298|Analgesics|analgesics|mesh-ancestor
83360162|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
83360163|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360164|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360165|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83360166|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83360167|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
83360168|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
83360169|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360170|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83360171|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83360172|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360173|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360174|NCT02525536|Trebananib|trebananib|mesh-list
83360175|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83360176|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83360177|NCT02525536|Growth Substances|growth substances|mesh-ancestor
83360178|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360179|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
83360180|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360181|NCT02411994|Artesunate|artesunate|mesh-list
83360182|NCT02411994|Lumefantrine|lumefantrine|mesh-list
83360183|NCT02411994|Artemether|artemether|mesh-list
83360184|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83360185|NCT02411994|Pyronaridine|pyronaridine|mesh-list
83360186|NCT02411994|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
83360187|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
83360188|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83360189|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83360190|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360191|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360192|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
83360193|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
83360194|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83360195|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
83360196|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
83360197|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83360198|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83360199|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83360200|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
83360201|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360202|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360203|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360204|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
83360205|NCT03177720|Imipenem|imipenem|mesh-list
83360206|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83360207|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360208|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83360209|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83360210|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360211|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360212|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360213|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83360214|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83360215|NCT02411604|Tacrolimus|tacrolimus|mesh-list
83360216|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83360217|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
83360218|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360219|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83360220|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360221|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360222|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
83360223|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83360224|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
83360225|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360226|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
83360227|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83360228|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83360229|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360230|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
83360231|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
83360232|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
83360233|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83360234|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360235|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
83360236|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
83360237|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83360238|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360239|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360240|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83360241|NCT03174678|Analgesics|analgesics|mesh-ancestor
83360242|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
83360243|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360244|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83360245|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83360246|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83360247|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
83360248|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360249|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360250|NCT02409498|Bupivacaine|bupivacaine|mesh-list
83360251|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
83360252|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
83360253|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360254|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360255|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
83360256|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360257|NCT02409186|Paclitaxel|paclitaxel|mesh-list
83360258|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83360259|NCT02409186|Cisplatin|cisplatin|mesh-list
83360260|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
83360261|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83360262|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360263|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
83360264|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
83360265|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
83360266|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360267|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83360268|NCT02410746|Ibuprofen|ibuprofen|mesh-list
83360269|NCT02410746|Morphine|morphine|mesh-list
83360270|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
83360271|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360273|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360274|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360275|NCT02410746|Analgesics|analgesics|mesh-ancestor
83360276|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
83360277|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360278|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83360279|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83360280|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83360281|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83360282|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83360283|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360284|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360285|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
83360286|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
83360287|NCT03177174|Docetaxel|docetaxel|mesh-list
83360288|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360289|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
83360290|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
83360291|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
83360292|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360293|NCT03177252|Lidocaine|lidocaine|mesh-list
83360294|NCT03177252|Bupivacaine|bupivacaine|mesh-list
83360295|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
83360296|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
83360297|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360298|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360299|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
83360300|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360301|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83360302|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83360303|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83360304|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83360305|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360306|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
83360307|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83360308|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360309|NCT02408562|Becaplermin|becaplermin|mesh-list
83360310|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
83360311|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
83360312|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83360313|NCT02408562|Growth Substances|growth substances|mesh-ancestor
83360314|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360315|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83360316|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
83360317|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360318|NCT02701764|Pregabalin|pregabalin|mesh-list
83360319|NCT02701764|Analgesics|analgesics|mesh-ancestor
83360320|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
83360321|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360322|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360323|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
83360324|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83360325|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83360326|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360327|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83360328|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83360329|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83360330|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360331|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83360332|NCT03174288|Spironolactone|spironolactone|mesh-list
83360333|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83360334|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
83360335|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360336|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360337|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83360338|NCT03174288|Diuretics|diuretics|mesh-ancestor
83360339|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
83360340|NCT02532010|Cytarabine|cytarabine|mesh-list
83360341|NCT02532010|Decitabine|decitabine|mesh-list
83360342|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83360343|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
83360344|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360345|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360347|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360348|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83360349|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
83360350|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360351|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360352|NCT02406300|Bupivacaine|bupivacaine|mesh-list
83360353|NCT02406300|Ropivacaine|ropivacaine|mesh-list
83360354|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
83360355|NCT02406300|Sevoflurane|sevoflurane|mesh-list
83360356|NCT02406300|Desflurane|desflurane|mesh-list
83360357|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
83360358|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
83360359|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360360|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360361|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
83360362|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360363|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83360364|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83360365|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
83360366|NCT02538016|Tolvaptan|tolvaptan|mesh-list
83360367|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83360368|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360369|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
83360370|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360371|NCT02406144|Dexamethasone|dexamethasone|mesh-list
83360372|NCT02406144|Lenalidomide|lenalidomide|mesh-list
83360373|NCT02406144|Ixazomib|ixazomib|mesh-list
83360374|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83360375|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
83360376|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
83360377|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360378|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360379|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360380|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
83360381|NCT02406144|Hormones|hormones|mesh-ancestor
83360382|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360383|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83360384|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360385|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
83360386|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83360387|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83360388|NCT02406144|Growth Substances|growth substances|mesh-ancestor
83360389|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
83360390|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
83360391|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360392|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360393|NCT02416752|Remifentanil|remifentanil|mesh-list
83360394|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360395|NCT02416752|Narcotics|narcotics|mesh-ancestor
83360396|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360397|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360398|NCT02416752|Analgesics|analgesics|mesh-ancestor
83360399|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
83360400|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360401|NCT02405910|Paclitaxel|paclitaxel|mesh-list
83360402|NCT02405910|Gemcitabine|gemcitabine|mesh-list
83360403|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83360404|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360405|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
83360406|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
83360407|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
83360408|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360409|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83360410|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
83360411|NCT02539108|Vaccines|vaccines|mesh-list
83360412|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
83360413|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360414|NCT02406066|Oxazepam|oxazepam|mesh-list
83360415|NCT02406066|Metyrapone|metyrapone|mesh-list
83360416|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
83360417|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360418|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360419|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83360420|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360421|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360422|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83360423|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83360424|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83360425|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
83360426|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
83360427|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360429|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
83360430|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360431|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83360432|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360433|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83360434|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360435|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83360436|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83360437|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
83360438|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360439|NCT02539342|Calcium|calcium|mesh-list
83360440|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83360441|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360442|NCT02405988|Remifentanil|remifentanil|mesh-list
83360443|NCT02405988|Naloxone|naloxone|mesh-list
83360444|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360445|NCT02405988|Narcotics|narcotics|mesh-ancestor
83360446|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360447|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360448|NCT02405988|Analgesics|analgesics|mesh-ancestor
83360449|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
83360450|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360451|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83360452|NCT02542150|Ethanol|ethanol|mesh-list
83360453|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83360454|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360455|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360456|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360457|NCT02542462|Vaccines|vaccines|mesh-list
83360458|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
83360459|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360460|NCT03173898|Anesthetics|anesthetics|mesh-list
83360461|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360462|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360463|NCT02408172|Metoprolol|metoprolol|mesh-list
83360464|NCT02408172|Amlodipine|amlodipine|mesh-list
83360465|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83360466|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83360467|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83360468|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360469|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83360470|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360471|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
83360472|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83360473|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
83360474|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
83360475|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360476|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83360477|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83360478|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83360479|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
83360480|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360481|NCT04481100|Itraconazole|itraconazole|mesh-list
83360482|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
83360483|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360484|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83360485|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83360486|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360487|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360488|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83360489|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
83360490|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360491|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360492|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83360493|NCT02405598|Albuterol|albuterol|mesh-list
83360494|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83360495|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
83360496|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360497|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360498|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83360499|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
83360500|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
83360501|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83360502|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83360503|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83360504|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83360505|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
83360506|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360507|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360508|NCT03173508|Acetazolamide|acetazolamide|mesh-list
83360509|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
83360510|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83360511|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360512|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360513|NCT03173508|Diuretics|diuretics|mesh-ancestor
83360514|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
83360515|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360516|NCT03173430|Blinatumomab|blinatumomab|mesh-list
83360517|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360518|NCT02407782|Ivermectin|ivermectin|mesh-list
83360519|NCT02407782|Permethrin|permethrin|mesh-list
83360520|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83360521|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360522|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360523|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360524|NCT02405364|Dexamethasone|dexamethasone|mesh-list
83360525|NCT02405364|Lenalidomide|lenalidomide|mesh-list
83360526|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83360527|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
83360528|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
83360529|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360530|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360531|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360532|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
83360533|NCT02405364|Hormones|hormones|mesh-ancestor
83360534|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360535|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83360536|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360537|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
83360538|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83360539|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83360540|NCT02405364|Growth Substances|growth substances|mesh-ancestor
83360541|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
83360542|NCT02405130|Epinephrine|epinephrine|mesh-list
83360543|NCT02405130|Racepinephrine|racepinephrine|mesh-list
83360544|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
83360545|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83360546|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83360547|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
83360548|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360549|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360550|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360551|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83360552|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83360553|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
83360554|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360555|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83360556|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
83360557|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
83360558|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
83360559|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83360560|NCT03171090|Anesthetics|anesthetics|mesh-list
83360561|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
83360562|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360563|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360564|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
83360565|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360566|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83360567|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
83360568|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360569|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83360570|NCT02407626|Propofol|propofol|mesh-list
83360571|NCT02407626|Sevoflurane|sevoflurane|mesh-list
83360572|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83360573|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360574|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360575|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83360576|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
83360577|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
83360578|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83360579|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83360580|NCT02407392|Acetic Acid|acetic acid|mesh-list
83360581|NCT02407392|Retinol acetate|retinol acetate|mesh-list
83360582|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83360583|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360584|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83360585|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
83360586|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360587|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83360588|NCT02407392|Protective Agents|protective agents|mesh-ancestor
83360589|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360590|NCT02551432|Paclitaxel|paclitaxel|mesh-list
83360591|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
83360592|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83360593|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360594|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
83360595|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
83360596|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
83360597|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360598|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83360599|NCT02551432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83360600|NCT02407548|Vitamin E|vitamin e|mesh-list
83360601|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
83360602|NCT02407548|Ubiquinone|ubiquinone|mesh-list
83360603|NCT02407548|Vitamins|vitamins|mesh-ancestor
83360604|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
83360605|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360606|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
83360607|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360608|NCT02407548|Protective Agents|protective agents|mesh-ancestor
83360609|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
83360610|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
83360611|NCT01695317|Vitamins|vitamins|mesh-ancestor
83360612|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
83360613|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360614|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
83360615|NCT02551744|Pantoprazole|pantoprazole|mesh-list
83360616|NCT02551744|Famotidine|famotidine|mesh-list
83360617|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
83360618|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
83360619|NCT02551744|Histamine|histamine|mesh-list
83360620|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83360621|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360622|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360623|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360624|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
83360625|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
83360626|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360627|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360628|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
83360629|NCT04743544|Voriconazole|voriconazole|mesh-list
83360630|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
83360631|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360632|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83360633|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83360634|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360635|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360636|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83360637|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
83360638|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360639|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360640|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83360641|NCT04481802|Acemannan|acemannan|mesh-list
83360642|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83360643|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
83360644|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360645|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360646|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
83360647|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360648|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360649|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83360650|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360651|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360653|NCT02407314|Ticagrelor|ticagrelor|mesh-list
83360654|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83360655|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83360656|NCT02407314|Analgesics|analgesics|mesh-ancestor
83360657|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
83360658|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360659|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360660|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83360661|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83360662|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83360663|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83360664|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360665|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83360666|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83360667|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360668|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
83360669|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83360670|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83360671|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83360672|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
83360673|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360674|NCT02407080|Interferons|interferons|mesh-list
83360675|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
83360676|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
83360677|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83360678|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360679|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
83360680|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360681|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
83360682|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360683|NCT04743622|Latanoprost|latanoprost|mesh-list
83360684|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83360685|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83360686|NCT02701296|Epinephrine|epinephrine|mesh-list
83360687|NCT02701296|Ropivacaine|ropivacaine|mesh-list
83360688|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
83360689|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
83360690|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360691|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360692|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
83360693|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360694|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83360695|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83360696|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
83360697|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360698|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360699|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83360700|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83360701|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
83360702|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83360703|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
83360704|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
83360705|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
83360706|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83360707|NCT02558374|Timolol|timolol|mesh-list
83360708|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83360709|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83360710|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360711|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83360712|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83360713|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
83360714|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360715|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360716|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83360717|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83360718|NCT01582451|Insulin|insulin|mesh-list
83360719|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83360720|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
83360721|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83360722|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360723|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83360724|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83360725|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360726|NCT03168828|Trospium chloride|trospium chloride|mesh-list
83360727|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
83360728|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
83360729|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360730|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360731|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83360732|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83360733|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
83360734|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360735|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360736|NCT03168828|Urological Agents|urological agents|mesh-ancestor
83360737|NCT02562898|Paclitaxel|paclitaxel|mesh-list
83360738|NCT02562898|Gemcitabine|gemcitabine|mesh-list
83360739|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83360740|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360741|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
83360742|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
83360743|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
83360744|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360745|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83360746|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
83360747|NCT03168594|Cisplatin|cisplatin|mesh-list
83360748|NCT03168594|Irinotecan|irinotecan|mesh-list
83360749|NCT03168594|Etoposide|etoposide|mesh-list
83360750|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360751|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83360752|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83360753|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360754|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360755|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83360756|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83360757|NCT02563834|Insulin|insulin|mesh-list
83360758|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83360759|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360760|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
83360761|NCT02564926|Glimepiride|glimepiride|mesh-list
83360762|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83360763|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360764|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83360765|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360766|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83360767|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83360768|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
83360769|NCT02565628|PF-06669571|pf-06669571|mesh-list
83360770|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
83360771|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
83360772|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360773|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360774|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360775|NCT02567968|Caffeine|caffeine|mesh-list
83360776|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
83360777|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360778|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83360779|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360780|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83360781|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360782|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83360783|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83360784|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
83360785|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83360786|NCT02571634|Fentanyl|fentanyl|mesh-list
83360787|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360788|NCT02571634|Narcotics|narcotics|mesh-ancestor
83360789|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360790|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360791|NCT02571634|Analgesics|analgesics|mesh-ancestor
83360792|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
83360793|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360794|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83360795|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83360796|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
83360797|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
83360798|NCT02404038|NuvaRing|nuvaring|mesh-list
83360799|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
83360800|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83360801|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
83360802|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83360803|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360804|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83360805|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83360806|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83360807|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83360808|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83360809|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
83360810|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83360811|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83360812|NCT02574598|Docetaxel|docetaxel|mesh-list
83360813|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
83360814|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360815|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
83360816|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
83360817|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
83360818|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360819|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83360820|NCT02574598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83360821|NCT02574832|Lidocaine|lidocaine|mesh-list
83360822|NCT02574832|Fentanyl|fentanyl|mesh-list
83360823|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
83360824|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
83360825|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83360826|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360827|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
83360828|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360829|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83360830|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83360831|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83360832|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83360833|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360834|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83360835|NCT02574832|Narcotics|narcotics|mesh-ancestor
83360836|NCT02574832|Analgesics|analgesics|mesh-ancestor
83360837|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83360838|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83360839|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
83360840|NCT02406690|Leuprolide|leuprolide|mesh-list
83360841|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83360842|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83360843|NCT02406690|Estradiol|estradiol|mesh-list
83360844|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83360845|NCT02406690|Progesterone|progesterone|mesh-list
83360846|NCT02406690|Estrogens|estrogens|mesh-ancestor
83360847|NCT02406690|Hormones|hormones|mesh-ancestor
83360848|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360849|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360850|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83360851|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
83360852|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83360853|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83360854|NCT02406690|Progestins|progestins|mesh-ancestor
83360855|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83360856|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
83360857|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83360858|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360859|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
83360860|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
83360861|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
83360862|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360864|NCT02974348|Amoxicillin|amoxicillin|mesh-list
83360865|NCT02974348|Artesunate|artesunate|mesh-list
83360866|NCT02974348|Lumefantrine|lumefantrine|mesh-list
83360867|NCT02974348|Piperaquine|piperaquine|mesh-list
83360868|NCT02974348|Artenimol|artenimol|mesh-list
83360869|NCT02974348|Mefloquine|mefloquine|mesh-list
83360870|NCT02974348|Quinine|quinine|mesh-list
83360871|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83360872|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83360873|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83360874|NCT02974348|Analgesics|analgesics|mesh-ancestor
83360875|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
83360876|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360877|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360878|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
83360879|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
83360880|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83360881|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83360882|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360883|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
83360884|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
83360885|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83360886|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
83360887|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83360888|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83360889|NCT03170310|Apatinib|apatinib|mesh-list
83360890|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360891|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83360892|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83360893|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360894|NCT00364000|Calcium|calcium|mesh-list
83360895|NCT00364000|Sevelamer|sevelamer|mesh-list
83360896|NCT00364000|Calcium acetate|calcium acetate|mesh-list
83360897|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83360898|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360899|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
83360900|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
83360901|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360902|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
83360903|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83360904|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360905|NCT02403804|Betaine|betaine|mesh-list
83360906|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360907|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
83360908|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83360909|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
83360910|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360911|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83360912|NCT03169764|Leucovorin|leucovorin|mesh-list
83360913|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
83360914|NCT03169764|Bevacizumab|bevacizumab|mesh-list
83360915|NCT03169764|Fluorouracil|fluorouracil|mesh-list
83360916|NCT03169764|Capecitabine|capecitabine|mesh-list
83360917|NCT03169764|Nivolumab|nivolumab|mesh-list
83360918|NCT03169764|Cetuximab|cetuximab|mesh-list
83360919|NCT03169764|Fulvestrant|fulvestrant|mesh-list
83360920|NCT03169764|Avelumab|avelumab|mesh-list
83360921|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360922|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360923|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83360924|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
83360925|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360926|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83360927|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83360928|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
83360929|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83360930|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83360931|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83360932|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83360933|NCT03169764|Growth Substances|growth substances|mesh-ancestor
83360934|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
83360935|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
83360936|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83360937|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83360938|NCT03169764|Antidotes|antidotes|mesh-ancestor
83360939|NCT03169764|Protective Agents|protective agents|mesh-ancestor
83360940|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
83360941|NCT03169764|Vitamins|vitamins|mesh-ancestor
83360942|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
83360943|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83360944|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83360945|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83360946|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
83360947|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360948|NCT03874936|Dexamethasone|dexamethasone|mesh-list
83360949|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83360950|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83360951|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
83360952|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
83360953|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360954|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360955|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360956|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
83360957|NCT03874936|Hormones|hormones|mesh-ancestor
83360958|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360959|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83360960|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360961|NCT02399592|Bevacizumab|bevacizumab|mesh-list
83360962|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83360963|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360964|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83360965|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83360966|NCT02399592|Growth Substances|growth substances|mesh-ancestor
83360967|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360968|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
83360969|NCT03801304|Atezolizumab|atezolizumab|mesh-list
83360970|NCT03801304|Vinorelbine|vinorelbine|mesh-list
83360971|NCT03801304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83360972|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83360973|NCT03801304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83360974|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83360975|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83360976|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
83360977|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
83360978|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
83360979|NCT02696850|Budesonide|budesonide|mesh-list
83360980|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83360981|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83360982|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
83360983|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83360984|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360985|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83360986|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
83360987|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
83360988|NCT02696850|Hormones|hormones|mesh-ancestor
83360989|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83360990|NCT00365170|Insulin|insulin|mesh-list
83360991|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83360992|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
83360993|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83360994|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83360995|NCT02403648|Glucagon|glucagon|mesh-list
83360996|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83360997|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83360998|NCT02403648|Hormones|hormones|mesh-ancestor
83360999|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83361000|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361001|NCT02403648|Incretins|incretins|mesh-ancestor
83361002|NCT02396862|Factor VIII|factor viii|mesh-list
83361003|NCT02396862|Coagulants|coagulants|mesh-ancestor
83361004|NCT02377492|Vasopressins|vasopressins|mesh-list
83361005|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
83361006|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
83361007|NCT02377492|Coagulants|coagulants|mesh-ancestor
83361008|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83361009|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83361010|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
83361011|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361012|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83361013|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83361014|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
83361015|NCT02601976|Ribavirin|ribavirin|mesh-list
83361016|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83361017|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
83361018|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361019|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
83361020|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361021|NCT02603926|Pregnanolone|pregnanolone|mesh-list
83361022|NCT02603926|Brexanolone|brexanolone|mesh-list
83361023|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
83361024|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361025|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361026|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
83361027|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361028|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361030|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
83361031|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
83361032|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83361033|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
83361034|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361035|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361036|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83361037|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
83361038|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
83361039|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83361040|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
83361041|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361042|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361043|NCT02395926|Choline|choline|mesh-list
83361044|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
83361045|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83361046|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
83361047|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361048|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83361049|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83361050|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
83361051|NCT02402868|Ketamine|ketamine|mesh-list
83361052|NCT02402868|Analgesics|analgesics|mesh-ancestor
83361053|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
83361054|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361055|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361056|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83361057|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83361058|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
83361059|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
83361060|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361061|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83361062|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83361063|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361064|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361065|NCT02402712|Docetaxel|docetaxel|mesh-list
83361066|NCT02402712|Trastuzumab|trastuzumab|mesh-list
83361067|NCT02402712|Pertuzumab|pertuzumab|mesh-list
83361068|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361069|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
83361070|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
83361071|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
83361072|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361073|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361074|NCT02395458|Amoxicillin|amoxicillin|mesh-list
83361075|NCT02395458|Metronidazole|metronidazole|mesh-list
83361076|NCT02395458|Clarithromycin|clarithromycin|mesh-list
83361077|NCT02395458|Omeprazole|omeprazole|mesh-list
83361078|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83361079|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361080|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83361081|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83361082|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83361083|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83361084|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83361085|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361086|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361087|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83361088|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83361089|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83361090|NCT02402400|Ticagrelor|ticagrelor|mesh-list
83361091|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83361092|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83361093|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83361094|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83361095|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
83361096|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361097|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361098|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361099|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
83361100|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
83361101|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83361102|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83361103|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361104|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
83361105|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361106|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361107|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83361109|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
83361110|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83361111|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83361112|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361113|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361114|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361115|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361116|NCT02616250|Ivermectin|ivermectin|mesh-list
83361117|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83361118|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83361119|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361120|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83361121|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83361122|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83361123|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83361124|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
83361125|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361126|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361127|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361128|NCT02698410|Temozolomide|temozolomide|mesh-list
83361129|NCT02698410|Lanreotide|lanreotide|mesh-list
83361130|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83361131|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
83361132|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361133|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361134|NCT00365638|Simvastatin|simvastatin|mesh-list
83361135|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83361136|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83361137|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
83361138|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361139|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83361140|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83361141|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361142|NCT02699892|Rituximab|rituximab|mesh-list
83361143|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361144|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361145|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
83361146|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361147|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361148|NCT05731258|Doxorubicin|doxorubicin|mesh-list
83361149|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83361150|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83361151|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361152|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83361153|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83361154|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361155|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361156|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
83361157|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83361158|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361159|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83361160|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361161|NCT05730634|Atorvastatin|atorvastatin|mesh-list
83361162|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83361163|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83361164|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
83361165|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361166|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83361167|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83361168|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361169|NCT05705830|Serotonin|serotonin|mesh-list
83361170|NCT05705830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83361171|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83361172|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
83361173|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361174|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361175|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361176|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83361177|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83361179|NCT05745714|Dexamethasone|dexamethasone|mesh-list
83361180|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
83361181|NCT05745714|Venetoclax|venetoclax|mesh-list
83361182|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83361183|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
83361184|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361185|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361186|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83361187|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
83361188|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361189|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361190|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83361191|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83361192|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
83361193|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
83361194|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361195|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83361196|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
83361197|NCT05745714|Hormones|hormones|mesh-ancestor
83361198|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83361199|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83361200|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83361201|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
83361202|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
83361203|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361204|NCT02974270|Leuprolide|leuprolide|mesh-list
83361205|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83361206|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
83361207|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83361208|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361209|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83361210|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361211|NCT04050540|Doxycycline|doxycycline|mesh-list
83361212|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83361213|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361214|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
83361215|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83361216|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83361217|NCT03167268|Lycopene|lycopene|mesh-list
83361218|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83361219|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
83361220|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361221|NCT03167268|Protective Agents|protective agents|mesh-ancestor
83361222|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361223|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83361224|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83361225|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361226|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83361227|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83361228|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361229|NCT04485052|Azacitidine|azacitidine|mesh-list
83361230|NCT04485052|Decitabine|decitabine|mesh-list
83361231|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83361232|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
83361233|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361234|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361235|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361236|NCT02393898|Paclitaxel|paclitaxel|mesh-list
83361237|NCT02393898|Bevacizumab|bevacizumab|mesh-list
83361238|NCT02393898|Carboplatin|carboplatin|mesh-list
83361239|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83361240|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361241|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
83361242|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
83361243|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
83361244|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361245|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361246|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83361247|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83361248|NCT02393898|Growth Substances|growth substances|mesh-ancestor
83361249|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361250|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
83361251|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83361252|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83361253|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83361254|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361255|NCT04258852|Nicotine|nicotine|mesh-list
83361256|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83361257|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
83361258|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361259|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361260|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83361261|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83361262|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
83361263|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361264|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361265|NCT04145674|Methadone|methadone|mesh-list
83361266|NCT04145674|D-methadone|d-methadone|mesh-list
83361267|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83361268|NCT04145674|Narcotics|narcotics|mesh-ancestor
83361269|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361270|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361271|NCT04145674|Analgesics|analgesics|mesh-ancestor
83361272|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
83361273|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361274|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
83361275|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
83361276|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83361277|NCT02394054|Vasopressins|vasopressins|mesh-list
83361278|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
83361279|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
83361280|NCT02394054|Coagulants|coagulants|mesh-ancestor
83361281|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83361282|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83361283|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
83361284|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361285|NCT02393664|Bupivacaine|bupivacaine|mesh-list
83361286|NCT02393664|Propofol|propofol|mesh-list
83361287|NCT02393664|Sevoflurane|sevoflurane|mesh-list
83361288|NCT02393664|Rocuronium|rocuronium|mesh-list
83361289|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
83361290|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
83361291|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361292|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361293|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
83361294|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361295|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83361296|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83361297|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
83361298|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83361299|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83361300|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83361301|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83361302|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83361303|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83361304|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83361305|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361306|NCT02397486|Vitamin E|vitamin e|mesh-list
83361307|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
83361308|NCT02397486|Vitamins|vitamins|mesh-ancestor
83361309|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
83361310|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361311|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
83361312|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361313|NCT02397486|Protective Agents|protective agents|mesh-ancestor
83361314|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83361315|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361316|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83361317|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83361318|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
83361319|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83361320|NCT02393586|Amoxicillin|amoxicillin|mesh-list
83361321|NCT02393586|Rifampin|rifampin|mesh-list
83361322|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83361323|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
83361324|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
83361325|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83361326|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361327|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83361328|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
83361329|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
83361330|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83361331|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361332|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361333|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83361334|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83361335|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83361336|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83361337|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83361338|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83361339|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83361340|NCT02393430|Rebamipide|rebamipide|mesh-list
83361341|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83361342|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83361343|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
83361344|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361345|NCT02393430|Protective Agents|protective agents|mesh-ancestor
83361346|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361347|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361348|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
83361349|NCT03453892|Nivolumab|nivolumab|mesh-list
83361350|NCT03453892|Ipilimumab|ipilimumab|mesh-list
83361351|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361352|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361353|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83361354|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361355|NCT00367120|Amoxicillin|amoxicillin|mesh-list
83361356|NCT00367120|Azithromycin|azithromycin|mesh-list
83361357|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
83361358|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
83361359|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83361360|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83361361|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361362|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83361363|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361364|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361365|NCT03103750|Calcitriol|calcitriol|mesh-list
83361366|NCT03103750|Amphetamine|amphetamine|mesh-list
83361367|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
83361368|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83361369|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361370|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
83361371|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83361372|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361373|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83361374|NCT03103750|Vitamins|vitamins|mesh-ancestor
83361375|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
83361376|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83361377|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83361378|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
83361379|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
83361380|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361381|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
83361382|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361383|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
83361384|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83361385|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83361386|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83361387|NCT02397330|Morphine|morphine|mesh-list
83361388|NCT02397330|Bupivacaine|bupivacaine|mesh-list
83361389|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
83361390|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
83361391|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83361392|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361393|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
83361394|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361395|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83361396|NCT02397330|Narcotics|narcotics|mesh-ancestor
83361397|NCT02397330|Analgesics|analgesics|mesh-ancestor
83361398|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
83361399|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83361400|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
83361401|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361402|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361403|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83361404|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
83361405|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83361406|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
83361407|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361408|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361409|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83361410|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
83361411|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
83361412|NCT03081052|Protective Agents|protective agents|mesh-ancestor
83361413|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
83361414|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
83361415|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
83361416|NCT03015610|Lansoprazole|lansoprazole|mesh-list
83361417|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
83361418|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83361419|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83361420|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83361421|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361422|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361423|NCT00422344|Sunitinib|sunitinib|mesh-list
83361424|NCT00422344|Everolimus|everolimus|mesh-list
83361425|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361426|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83361427|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83361428|NCT00422344|Growth Substances|growth substances|mesh-ancestor
83361429|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361430|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
83361431|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83361432|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361433|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361434|NCT00422344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83361435|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83361436|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
83361437|NCT02876302|Paclitaxel|paclitaxel|mesh-list
83361438|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
83361439|NCT02876302|Doxorubicin|doxorubicin|mesh-list
83361440|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83361441|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361442|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
83361443|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
83361444|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
83361445|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361446|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83361447|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
83361448|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361449|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361450|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83361451|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
83361452|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83361453|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83361454|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83361455|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83361456|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361457|NCT00367276|Drospirenone|drospirenone|mesh-list
83361458|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83361459|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
83361460|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83361461|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361462|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83361463|NCT00367276|Diuretics|diuretics|mesh-ancestor
83361464|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
83361465|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
83361466|NCT02546986|Azacitidine|azacitidine|mesh-list
83361467|NCT02546986|Cc-486|cc-486|mesh-list
83361468|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83361469|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361470|NCT02546986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83361471|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361472|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83361473|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
83361474|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361475|NCT02689206|Glycine|glycine|mesh-list
83361476|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
83361477|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361478|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361479|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361480|NCT01695239|Adalimumab|adalimumab|mesh-list
83361481|NCT01695239|Ixekizumab|ixekizumab|mesh-list
83361482|NCT01695239|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83361483|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83361484|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83361485|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
83361486|NCT02163694|Paclitaxel|paclitaxel|mesh-list
83361487|NCT02163694|Carboplatin|carboplatin|mesh-list
83361488|NCT02163694|Veliparib|veliparib|mesh-list
83361489|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83361490|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361491|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
83361492|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
83361493|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
83361494|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361495|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83361496|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361497|NCT01587352|Vorinostat|vorinostat|mesh-list
83361498|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361499|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83361500|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361501|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361502|NCT00703222|Interleukin-2|interleukin-2|mesh-list
83361503|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361504|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83361505|NCT00703222|Analgesics|analgesics|mesh-ancestor
83361506|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
83361507|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361508|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361509|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
83361510|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83361511|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361512|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83361513|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83361514|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83361515|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361516|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
83361517|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361518|NCT04317430|Niclosamide|niclosamide|mesh-list
83361519|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
83361520|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83361521|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
83361522|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83361523|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83361524|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
83361525|NCT04277884|Firibastat|firibastat|mesh-list
83361526|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83361527|NCT03821272|Vaccines|vaccines|mesh-list
83361528|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
83361529|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361530|NCT00367822|Ropinirole|ropinirole|mesh-list
83361531|NCT00367822|Lisuride|lisuride|mesh-list
83361532|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83361533|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83361534|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
83361535|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
83361536|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361537|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361538|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361539|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83361540|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
83361541|NCT03189706|Irinotecan|irinotecan|mesh-list
83361542|NCT03189706|Temozolomide|temozolomide|mesh-list
83361543|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83361544|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83361545|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83361546|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83361547|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83361548|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83361549|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
83361550|NCT02643862|Omalizumab|omalizumab|mesh-list
83361551|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83361552|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83361553|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
83361554|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
83361555|NCT01694771|Olodaterol|olodaterol|mesh-list
83361556|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83361557|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
83361558|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83361559|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83361560|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83361561|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
83361562|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
83361563|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83361564|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
83361565|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83361566|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362265|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362266|NCT04395508|Trastuzumab|trastuzumab|mesh-list
83362267|NCT04395508|Pertuzumab|pertuzumab|mesh-list
83362268|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362269|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362270|NCT00368914|Sirolimus|sirolimus|mesh-list
83362271|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83362272|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362273|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83362274|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362275|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
83362276|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362277|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
83362278|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362279|NCT01567085|Eculizumab|eculizumab|mesh-list
83362280|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83362281|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362282|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
83362283|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362284|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
83362285|NCT04344184|Vitamins|vitamins|mesh-ancestor
83362286|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
83362287|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362288|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
83362289|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362290|NCT04344184|Protective Agents|protective agents|mesh-ancestor
83362291|NCT01566773|Bromides|bromides|mesh-list
83362292|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
83362293|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83362294|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
83362295|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362296|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362297|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83362298|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
83362299|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
83362300|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83362301|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
83362302|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362303|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362304|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
83362305|NCT04134442|Bupivacaine|bupivacaine|mesh-list
83362306|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
83362307|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
83362308|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362309|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362310|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
83362311|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362312|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
83362313|NCT04103476|Estrogens|estrogens|mesh-list
83362314|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83362315|NCT04103476|Hormones|hormones|mesh-ancestor
83362316|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362317|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362318|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83362319|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83362320|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
83362321|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83362322|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
83362323|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
83362324|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
83362325|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83362326|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
83362327|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362328|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362329|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83362330|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
83362331|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83362332|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83362333|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83362334|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
83362335|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362336|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362337|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362338|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
83362339|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83362340|NCT03417388|Aspirin|aspirin|mesh-list
83362341|NCT03417388|Losartan|losartan|mesh-list
83362342|NCT03417388|Lisinopril|lisinopril|mesh-list
83362343|NCT03417388|Atorvastatin|atorvastatin|mesh-list
83362344|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83362345|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362346|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362347|NCT03417388|Analgesics|analgesics|mesh-ancestor
83362348|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
83362349|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362350|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362351|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362352|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362353|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83362354|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83362355|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362356|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83362357|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83362358|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362359|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
83362360|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83362361|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83362362|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
83362363|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83362364|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83362365|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83362366|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83362367|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83362368|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83362369|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83362370|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
83362371|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83362372|NCT03417388|Protective Agents|protective agents|mesh-ancestor
83362373|NCT03382834|Tamoxifen|tamoxifen|mesh-list
83362374|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83362375|NCT03382834|Vorinostat|vorinostat|mesh-list
83362376|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83362377|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
83362378|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362379|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362380|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362381|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362382|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83362383|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83362384|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83362385|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83362386|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362387|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362388|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
83362389|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362390|NCT02691702|Melatonin|melatonin|mesh-list
83362391|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
83362392|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362393|NCT02691702|Protective Agents|protective agents|mesh-ancestor
83362394|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362395|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362396|NCT01564277|Allopurinol|allopurinol|mesh-list
83362397|NCT01564277|Rasburicase|rasburicase|mesh-list
83362398|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
83362399|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362400|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362401|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
83362402|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362403|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83362404|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
83362405|NCT01564277|Protective Agents|protective agents|mesh-ancestor
83362406|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362407|NCT01563185|Ibuprofen|ibuprofen|mesh-list
83362408|NCT01563185|Famotidine|famotidine|mesh-list
83362409|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362410|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362411|NCT01563185|Analgesics|analgesics|mesh-ancestor
83362412|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
83362413|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362414|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362415|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362416|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362417|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83362418|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362419|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362420|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83362421|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362422|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83362423|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
83362424|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
83362425|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362426|NCT02974660|Protamines|protamines|mesh-list
83362427|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
83362428|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362429|NCT02974660|Coagulants|coagulants|mesh-ancestor
83362430|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
83362431|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
83362432|NCT01563029|Fluticasone|fluticasone|mesh-list
83362433|NCT01563029|Xhance|xhance|mesh-list
83362434|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362435|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83362436|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
83362437|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362438|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362439|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83362440|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
83362441|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
83362442|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83362443|NCT03295240|Rituximab|rituximab|mesh-list
83362444|NCT03295240|Venetoclax|venetoclax|mesh-list
83362445|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83362446|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362447|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362448|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
83362449|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362450|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362451|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83362452|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
83362453|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362454|NCT03293368|Triamcinolone|triamcinolone|mesh-list
83362455|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83362456|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83362457|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83362458|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362459|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
83362460|NCT03293368|Hormones|hormones|mesh-ancestor
83362461|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362462|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362463|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362464|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
83362465|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362466|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362467|NCT03273712|Octreotide|octreotide|mesh-list
83362468|NCT03273712|Edotreotide|edotreotide|mesh-list
83362469|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362470|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362471|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362472|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83362473|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362474|NCT04113317|Lenograstim|lenograstim|mesh-list
83362475|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83362476|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
83362477|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362478|NCT04341844|Methylene Blue|methylene blue|mesh-list
83362479|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362480|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362481|NCT01561313|Adalimumab|adalimumab|mesh-list
83362482|NCT01561313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83362483|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362484|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362485|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
83362486|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83362487|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
83362488|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362489|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362490|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362491|NCT01561079|Buprenorphine|buprenorphine|mesh-list
83362492|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83362493|NCT01561079|Narcotics|narcotics|mesh-ancestor
83362494|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362495|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362496|NCT01561079|Analgesics|analgesics|mesh-ancestor
83362497|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
83362498|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362499|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83362500|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
83362501|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83362502|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83362503|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83362504|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83362505|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83362506|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
83362507|NCT01559675|Prednisolone|prednisolone|mesh-list
83362508|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
83362509|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83362510|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
83362511|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362512|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
83362513|NCT01559675|Hormones|hormones|mesh-ancestor
83362514|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362515|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362516|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83362517|NCT01559675|Protective Agents|protective agents|mesh-ancestor
83362518|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362519|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362520|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
83362521|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
83362522|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362523|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362524|NCT01374906|Pasireotide|pasireotide|mesh-list
83362525|NCT01374906|Hormones|hormones|mesh-ancestor
83362526|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362527|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362528|NCT03228394|Ganaxolone|ganaxolone|mesh-list
83362529|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
83362530|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362531|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362532|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362533|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
83362534|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
83362535|NCT00362596|Acyclovir|acyclovir|mesh-list
83362536|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
83362537|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362538|NCT02974504|Linagliptin|linagliptin|mesh-list
83362539|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362540|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362541|NCT02974504|Incretins|incretins|mesh-ancestor
83362542|NCT02974504|Hormones|hormones|mesh-ancestor
83362543|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362544|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83362545|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
83362546|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362547|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362548|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
83362549|NCT03013504|Docetaxel|docetaxel|mesh-list
83362550|NCT03013504|Trastuzumab|trastuzumab|mesh-list
83362551|NCT03013504|Epirubicin|epirubicin|mesh-list
83362552|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362553|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
83362554|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362555|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362556|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83362557|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
83362558|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362559|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362560|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83362561|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
83362562|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
83362563|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
83362564|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362565|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83362566|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83362567|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83362568|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362569|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
83362570|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
83362571|NCT02683746|Incretins|incretins|mesh-ancestor
83362572|NCT02683746|Hormones|hormones|mesh-ancestor
83362573|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362574|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362575|NCT01559129|Pomalidomide|pomalidomide|mesh-list
83362576|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
83362577|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362578|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83362579|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83362580|NCT01559129|Growth Substances|growth substances|mesh-ancestor
83362581|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
83362582|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362583|NCT02691468|Silicon|silicon|mesh-list
83362584|NCT02691468|Trace Elements|trace elements|mesh-ancestor
83362585|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
83362586|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362587|NCT03162120|Metoprolol|metoprolol|mesh-list
83362588|NCT03162120|Flecainide|flecainide|mesh-list
83362589|NCT03162120|Ranolazine|ranolazine|mesh-list
83362590|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83362591|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83362592|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
83362593|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
83362594|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362595|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362596|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83362597|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83362598|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83362599|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
83362600|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362601|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362602|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83362603|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362604|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83362605|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
83362606|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83362607|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
83362608|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362609|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362610|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83362611|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
83362612|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
83362613|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83362614|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
83362615|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362616|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362617|NCT03114228|Midostaurin|midostaurin|mesh-list
83362618|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362619|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83362620|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362621|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362622|NCT02678286|Meloxicam|meloxicam|mesh-list
83362623|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362624|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362625|NCT02678286|Analgesics|analgesics|mesh-ancestor
83362627|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362628|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362629|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362630|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362631|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83362632|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83362633|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362634|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362635|NCT03164694|Carboplatin|carboplatin|mesh-list
83362636|NCT03164694|Pemetrexed|pemetrexed|mesh-list
83362637|NCT03164694|Apatinib|apatinib|mesh-list
83362638|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362639|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362640|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362641|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83362642|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83362643|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83362644|NCT04775550|Dexamethasone|dexamethasone|mesh-list
83362645|NCT04775550|Lenalidomide|lenalidomide|mesh-list
83362646|NCT04775550|Bortezomib|bortezomib|mesh-list
83362648|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362649|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
83362650|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
83362651|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362652|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362653|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362654|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
83362655|NCT04775550|Hormones|hormones|mesh-ancestor
83362656|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362657|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362658|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362659|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
83362660|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83362661|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83362662|NCT04775550|Growth Substances|growth substances|mesh-ancestor
83362663|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
83362664|NCT02930902|Paclitaxel|paclitaxel|mesh-list
83362665|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83362666|NCT02930902|Gemcitabine|gemcitabine|mesh-list
83362667|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
83362668|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83362669|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362670|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
83362671|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
83362672|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
83362673|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362674|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83362675|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
83362676|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362677|NCT02930902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83362678|NCT02905318|Palbociclib|palbociclib|mesh-list
83362679|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362680|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83362681|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362682|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362683|NCT02767804|Crizotinib|crizotinib|mesh-list
83362684|NCT02767804|Ensartinib|ensartinib|mesh-list
83362685|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362686|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83362687|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362688|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362689|NCT02741128|Vaccines|vaccines|mesh-list
83362690|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
83362691|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362692|NCT01566721|Trastuzumab|trastuzumab|mesh-list
83362693|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362694|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362695|NCT01541215|Metformin|metformin|mesh-list
83362696|NCT01541215|Liraglutide|liraglutide|mesh-list
83362697|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362698|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362699|NCT01541215|Incretins|incretins|mesh-ancestor
83362700|NCT01541215|Hormones|hormones|mesh-ancestor
83362701|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362702|NCT01585987|Ipilimumab|ipilimumab|mesh-list
83362703|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362704|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362705|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83362706|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362707|NCT01585831|Testosterone|testosterone|mesh-list
83362708|NCT01585831|Androgens|androgens|mesh-ancestor
83362709|NCT01585831|Hormones|hormones|mesh-ancestor
83362710|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362711|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362712|NCT01565941|Insulin|insulin|mesh-list
83362713|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83362714|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362715|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362716|NCT01558271|Liraglutide|liraglutide|mesh-list
83362717|NCT01558271|Dulaglutide|dulaglutide|mesh-list
83362718|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362719|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362720|NCT01558271|Incretins|incretins|mesh-ancestor
83362721|NCT01558271|Hormones|hormones|mesh-ancestor
83362722|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362723|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
83362724|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83362725|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83362726|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
83362727|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362728|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362729|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362730|NCT01565707|Urological Agents|urological agents|mesh-ancestor
83362731|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83362732|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83362733|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83362734|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362735|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362736|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
83362737|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362738|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362739|NCT04756271|Antibodies|antibodies|mesh-list
83362740|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
83362741|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
83362742|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362743|NCT01538719|Rilonacept|rilonacept|mesh-list
83362744|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362745|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
83362746|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83362747|NCT01537783|Mupirocin|mupirocin|mesh-list
83362748|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83362749|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362750|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
83362751|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
83362752|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83362753|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83362754|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362755|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362756|NCT01556165|Rasagiline|rasagiline|mesh-list
83362757|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83362758|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362759|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362760|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83362761|NCT01556165|Protective Agents|protective agents|mesh-ancestor
83362762|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362763|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
83362764|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
83362765|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
83362766|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362767|NCT01537549|Protective Agents|protective agents|mesh-ancestor
83362768|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362769|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
83362770|NCT01537549|Vitamins|vitamins|mesh-ancestor
83362771|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
83362772|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
83362773|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
83362774|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83362775|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
83362776|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83362777|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362778|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83362779|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83362780|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83362782|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83362783|NCT01583179|Narcotics|narcotics|mesh-ancestor
83362784|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362785|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362786|NCT01583179|Analgesics|analgesics|mesh-ancestor
83362787|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
83362788|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362789|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83362790|NCT01582945|Ketamine|ketamine|mesh-list
83362791|NCT01582945|Analgesics|analgesics|mesh-ancestor
83362792|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
83362793|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362794|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362795|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83362796|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83362797|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
83362798|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
83362799|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362800|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83362801|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83362802|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362803|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362804|NCT01565083|Trastuzumab|trastuzumab|mesh-list
83362805|NCT01565083|Pertuzumab|pertuzumab|mesh-list
83362806|NCT01565083|Vinorelbine|vinorelbine|mesh-list
83362807|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83362808|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362809|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83362810|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83362811|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83362812|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83362813|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362814|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
83362815|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362816|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
83362817|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83362818|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
83362819|NCT01537081|Guaifenesin|guaifenesin|mesh-list
83362820|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
83362821|NCT01537081|Expectorants|expectorants|mesh-ancestor
83362822|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
83362823|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83362824|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83362825|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
83362826|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362827|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362828|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362829|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
83362830|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83362831|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
83362832|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
83362833|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362834|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
83362835|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83362836|NCT01555073|Celecoxib|celecoxib|mesh-list
83362837|NCT01555073|Pregabalin|pregabalin|mesh-list
83362838|NCT01555073|Analgesics|analgesics|mesh-ancestor
83362839|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
83362840|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362841|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362842|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
83362843|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83362844|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83362845|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362846|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83362847|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83362848|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83362849|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362850|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83362851|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362852|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362853|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362854|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362855|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83362856|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83362857|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362858|NCT01582243|Vildagliptin|vildagliptin|mesh-list
83362859|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362860|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362861|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83362862|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
83362863|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362864|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362865|NCT01536535|Prednisone|prednisone|mesh-list
83362866|NCT01536535|Mesalamine|mesalamine|mesh-list
83362867|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362868|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
83362869|NCT01536535|Hormones|hormones|mesh-ancestor
83362870|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362871|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362872|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83362873|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362874|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362875|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362877|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
83362878|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362879|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362880|NCT01553747|Eluxadoline|eluxadoline|mesh-list
83362881|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362882|NCT01536379|Belimumab|belimumab|mesh-list
83362883|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362884|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
83362885|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362886|NCT01536067|Bortezomib|bortezomib|mesh-list
83362887|NCT01536067|Ofatumumab|ofatumumab|mesh-list
83362888|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362889|NCT04410211|Midazolam|midazolam|mesh-list
83362890|NCT04410211|Sevoflurane|sevoflurane|mesh-list
83362891|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83362892|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83362893|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362894|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362895|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83362896|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83362897|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83362898|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83362899|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
83362900|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
83362901|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
83362902|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
83362903|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362904|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362905|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83362906|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83362907|NCT01582009|Everolimus|everolimus|mesh-list
83362908|NCT01582009|Panobinostat|panobinostat|mesh-list
83362909|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83362910|NCT01582009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83362911|NCT01582009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83362912|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362913|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362914|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362915|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
83362916|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362917|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362918|NCT01553591|Eluxadoline|eluxadoline|mesh-list
83362919|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83362920|NCT01581931|Metformin|metformin|mesh-list
83362921|NCT01581931|Linagliptin|linagliptin|mesh-list
83362922|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83362923|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362924|NCT01581931|Incretins|incretins|mesh-ancestor
83362925|NCT01581931|Hormones|hormones|mesh-ancestor
83362926|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83362927|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83362928|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
83362929|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83362930|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362931|NCT01581307|Leucovorin|leucovorin|mesh-list
83362932|NCT01581307|Folic Acid|folic acid|mesh-list
83362933|NCT01581307|Fluorouracil|fluorouracil|mesh-list
83362934|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
83362935|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
83362936|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
83362937|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362938|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83362939|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83362940|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83362941|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
83362942|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362943|NCT01581307|Antidotes|antidotes|mesh-ancestor
83362944|NCT01581307|Protective Agents|protective agents|mesh-ancestor
83362945|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
83362946|NCT01581307|Vitamins|vitamins|mesh-ancestor
83362947|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
83362948|NCT01581307|Hematinics|hematinics|mesh-ancestor
83362949|NCT01580995|Valacyclovir|valacyclovir|mesh-list
83362950|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
83362951|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83362952|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83362953|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
83362954|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362955|NCT01562743|Rotigotine|rotigotine|mesh-list
83362956|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
83362957|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
83362958|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362959|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362960|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362961|NCT03028571|Trimethaphan|trimethaphan|mesh-list
83362962|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
83362963|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83362964|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83362965|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
83362966|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
83362967|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362968|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362969|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
83362970|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83362971|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
83362972|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362973|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362974|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
83362975|NCT01535443|Bromfenac|bromfenac|mesh-list
83362976|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83362977|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362978|NCT01535443|Analgesics|analgesics|mesh-ancestor
83362979|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
83362980|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362981|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362982|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83362983|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83362984|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
83362985|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83362986|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83362987|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83362988|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83362989|NCT01535287|Analgesics|analgesics|mesh-ancestor
83362990|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
83362991|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83362992|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83362993|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83362994|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83362995|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
83362996|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83362997|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83362998|NCT01549613|Vancomycin|vancomycin|mesh-list
83362999|NCT01549613|Daptomycin|daptomycin|mesh-list
83363000|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363001|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363002|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
83363003|NCT04106219|Topotecan|topotecan|mesh-list
83363004|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363005|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
83363006|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363007|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363008|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83363009|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
83363010|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363011|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363012|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83363013|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83363014|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363015|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363016|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
83363017|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363018|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363019|NCT01546883|Dabigatran|dabigatran|mesh-list
83363020|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
83363021|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83363022|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
83363023|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363024|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363025|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
83363026|NCT01580293|Factor VIII|factor viii|mesh-list
83363027|NCT01580293|Coagulants|coagulants|mesh-ancestor
83363028|NCT01546649|Leuprolide|leuprolide|mesh-list
83363029|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83363030|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
83363031|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363032|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363033|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83363034|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363035|NCT02985983|Brodalumab|brodalumab|mesh-list
83363036|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363037|NCT01544309|Atorvastatin|atorvastatin|mesh-list
83363038|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83363039|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83363040|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83363041|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
83363042|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363043|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83363044|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83363045|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363046|NCT01544153|Nicotine|nicotine|mesh-list
83363047|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83363048|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
83363049|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363050|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363051|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83363052|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83363053|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
83363054|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363055|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363056|NCT01543685|Celecoxib|celecoxib|mesh-list
83363057|NCT01543685|Indomethacin|indomethacin|mesh-list
83363058|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83363059|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83363060|NCT01543685|Analgesics|analgesics|mesh-ancestor
83363061|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
83363062|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363063|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363064|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363065|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363066|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83363067|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83363068|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363069|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363070|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
83363071|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
83363072|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363073|NCT01540565|Veliparib|veliparib|mesh-list
83363074|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83363075|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363076|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363077|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363078|NCT01540487|Metformin|metformin|mesh-list
83363079|NCT01540487|Linagliptin|linagliptin|mesh-list
83363080|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83363081|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363082|NCT01540487|Incretins|incretins|mesh-ancestor
83363083|NCT01540487|Hormones|hormones|mesh-ancestor
83363084|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363085|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83363086|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
83363087|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363088|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363089|NCT01539317|Lidocaine|lidocaine|mesh-list
83363090|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
83363091|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
83363092|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363093|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363094|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
83363095|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363096|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83363097|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83363098|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83363099|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83363100|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363101|NCT01539083|Thalidomide|thalidomide|mesh-list
83363102|NCT01539083|Dexamethasone|dexamethasone|mesh-list
83363103|NCT01539083|Prednisolone|prednisolone|mesh-list
83363104|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
83363105|NCT01539083|Bortezomib|bortezomib|mesh-list
83363106|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363107|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
83363108|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363109|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363110|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83363111|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
83363112|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363113|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363114|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83363115|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363116|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
83363117|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
83363118|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363119|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363120|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
83363121|NCT01539083|Hormones|hormones|mesh-ancestor
83363122|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363123|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83363124|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
83363125|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363126|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363127|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83363128|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83363129|NCT01539083|Growth Substances|growth substances|mesh-ancestor
83363130|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
83363131|NCT01537133|Fluticasone|fluticasone|mesh-list
83363132|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363133|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83363134|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
83363135|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363136|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363137|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83363138|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
83363139|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363140|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83363141|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83363142|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83363143|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
83363144|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363145|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363146|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83363147|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
83363148|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83363149|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83363150|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83363151|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
83363152|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363153|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363154|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
83363155|NCT02985905|Astringents|astringents|mesh-ancestor
83363156|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363157|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363158|NCT01535261|Ranibizumab|ranibizumab|mesh-list
83363159|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83363160|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83363161|NCT01535261|Growth Substances|growth substances|mesh-ancestor
83363162|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363163|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
83363164|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363166|NCT01534637|Fluorouracil|fluorouracil|mesh-list
83363167|NCT01534637|Capecitabine|capecitabine|mesh-list
83363168|NCT01534637|Aprepitant|aprepitant|mesh-list
83363169|NCT01534637|Antiemetics|antiemetics|mesh-list
83363170|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363171|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
83363172|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363173|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363174|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363175|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
83363176|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363177|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
83363178|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363179|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363180|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83363181|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363182|NCT02655016|Niraparib|niraparib|mesh-list
83363183|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83363184|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363185|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363186|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363187|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
83363188|NCT01533935|Olodaterol|olodaterol|mesh-list
83363189|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83363190|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
83363191|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363192|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363193|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83363194|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
83363195|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
83363196|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83363197|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
83363198|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363199|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363200|NCT02570542|Cytarabine|cytarabine|mesh-list
83363201|NCT02570542|Plerixafor|plerixafor|mesh-list
83363202|NCT02570542|Etoposide|etoposide|mesh-list
83363203|NCT02570542|Melphalan|melphalan|mesh-list
83363204|NCT02570542|Carmustine|carmustine|mesh-list
83363205|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83363206|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363207|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83363208|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363209|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363210|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363211|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363212|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
83363213|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
83363214|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363215|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363216|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
83363217|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363218|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83363219|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
83363220|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83363221|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83363222|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83363223|NCT01532687|Gemcitabine|gemcitabine|mesh-list
83363224|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363225|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
83363226|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363227|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363228|NCT02677116|Doxorubicin|doxorubicin|mesh-list
83363229|NCT02677116|Irinotecan|irinotecan|mesh-list
83363230|NCT02677116|Vincristine|vincristine|mesh-list
83363231|NCT02677116|Ifosfamide|ifosfamide|mesh-list
83363232|NCT02677116|Olaratumab|olaratumab|mesh-list
83363233|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83363234|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363235|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83363236|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363237|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363238|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363239|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83363240|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83363241|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
83363242|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
83363243|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
83363244|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83363245|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
83363246|NCT02689518|Aflibercept|aflibercept|mesh-list
83363247|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83363248|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83363249|NCT02689518|Growth Substances|growth substances|mesh-ancestor
83363250|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363251|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
83363252|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363253|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
83363254|NCT02681094|Saxagliptin|saxagliptin|mesh-list
83363255|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83363256|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363257|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83363258|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363259|NCT02681094|Incretins|incretins|mesh-ancestor
83363260|NCT02681094|Hormones|hormones|mesh-ancestor
83363261|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363262|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83363263|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
83363264|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363265|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
83363266|NCT03164304|Analgesics|analgesics|mesh-ancestor
83363267|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
83363268|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363269|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363270|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
83363271|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363272|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83363273|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
83363274|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83363275|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83363276|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363277|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83363278|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
83363279|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363280|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
83363281|NCT02689284|Margetuximab|margetuximab|mesh-list
83363282|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83363283|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83363284|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363285|NCT02689284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83363286|NCT02689284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363287|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
83363288|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363289|NCT03165396|Propofol|propofol|mesh-list
83363290|NCT03165396|Sevoflurane|sevoflurane|mesh-list
83363291|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83363292|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363293|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363294|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83363295|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
83363296|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
83363297|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83363298|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83363299|NCT03164382|Sorafenib|sorafenib|mesh-list
83363300|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363301|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83363302|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363303|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363304|NCT03161340|Sirolimus|sirolimus|mesh-list
83363305|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363306|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363307|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83363308|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363309|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
83363310|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363311|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
83363312|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363313|NCT03161574|Fluorouracil|fluorouracil|mesh-list
83363314|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
83363315|NCT03161574|Irinotecan|irinotecan|mesh-list
83363316|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
83363317|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363318|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363319|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363320|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363321|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
83363322|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363323|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83363324|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363325|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363326|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
83363327|NCT05676216|Promethazine|promethazine|mesh-list
83363328|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83363329|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83363330|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363331|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363332|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
83363333|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
83363334|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
83363335|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363336|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
83363337|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
83363338|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363339|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83363340|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
83363341|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
83363342|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363343|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363344|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83363345|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
83363346|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363347|NCT03163914|Phenylephrine|phenylephrine|mesh-list
83363348|NCT03163914|Epinephrine|epinephrine|mesh-list
83363349|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
83363350|NCT03163914|Norepinephrine|norepinephrine|mesh-list
83363351|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83363352|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83363353|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
83363354|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363355|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363356|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363357|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83363358|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83363359|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
83363360|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363361|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83363362|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
83363363|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
83363364|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
83363365|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83363366|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83363367|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
83363368|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83363369|NCT03163914|Protective Agents|protective agents|mesh-ancestor
83363370|NCT03160872|Hormones|hormones|mesh-list
83363371|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363372|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363373|NCT03163680|Omeprazole|omeprazole|mesh-list
83363374|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83363375|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363376|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83363377|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363378|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363379|NCT04574232|Triamcinolone|triamcinolone|mesh-list
83363380|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83363381|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83363382|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83363383|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363384|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
83363385|NCT04574232|Hormones|hormones|mesh-ancestor
83363386|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363387|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363388|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363389|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
83363390|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363391|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363392|NCT05071716|Rifaximin|rifaximin|mesh-list
83363393|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363394|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363395|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363396|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83363397|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83363398|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
83363399|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363400|NCT04557384|Ramucirumab|ramucirumab|mesh-list
83363401|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363402|NCT04548648|Isavuconazole|isavuconazole|mesh-list
83363403|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
83363404|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363405|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
83363406|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363407|NCT04443348|Paclitaxel|paclitaxel|mesh-list
83363408|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
83363409|NCT04443348|Carboplatin|carboplatin|mesh-list
83363410|NCT04443348|Doxorubicin|doxorubicin|mesh-list
83363411|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
83363412|NCT04443348|Capecitabine|capecitabine|mesh-list
83363413|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83363414|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363415|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
83363416|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
83363417|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
83363418|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363419|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363420|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
83363421|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363422|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363423|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83363424|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
83363425|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83363426|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83363427|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83363428|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363429|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363430|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83363431|NCT04443348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83363432|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363433|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
83363434|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
83363435|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363436|NCT05231850|Tislelizumab|tislelizumab|mesh-list
83363437|NCT05231850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83363438|NCT05231850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363439|NCT03163212|Lactoferrin|lactoferrin|mesh-list
83363440|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363441|NCT05007678|Leflunomide|leflunomide|mesh-list
83363442|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363443|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363444|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363445|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
83363446|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363447|NCT03161106|Lactulose|lactulose|mesh-list
83363448|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363449|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
83363450|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
83363451|NCT02671500|Velpatasvir|velpatasvir|mesh-list
83363452|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
83363453|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363454|NCT02671266|Oxytocin|oxytocin|mesh-list
83363455|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
83363456|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363457|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363458|NCT03160404|Zolpidem|zolpidem|mesh-list
83363459|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83363460|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83363461|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363462|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363463|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83363464|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
83363465|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
83363466|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363467|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363468|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
83363469|NCT03162588|Hematinics|hematinics|mesh-ancestor
83363470|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
83363471|NCT03320070|Hormones|hormones|mesh-ancestor
83363472|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363473|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363474|NCT04977336|Acetaminophen|acetaminophen|mesh-list
83363475|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83363476|NCT04977336|Analgesics|analgesics|mesh-ancestor
83363477|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
83363478|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363479|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363480|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
83363481|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
83363482|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83363483|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363484|NCT03284424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83363485|NCT03284424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363486|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83363487|NCT02674854|Latanoprost|latanoprost|mesh-list
83363488|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83363489|NCT04036188|Vitamin D|vitamin d|mesh-list
83363490|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
83363491|NCT04036188|Triamcinolone|triamcinolone|mesh-list
83363492|NCT04036188|Vitamins|vitamins|mesh-ancestor
83363493|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
83363494|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363495|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83363496|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83363497|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363498|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
83363499|NCT04036188|Hormones|hormones|mesh-ancestor
83363500|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363501|NCT02388516|Vitamin D|vitamin d|mesh-list
83363502|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
83363503|NCT02388516|Vitamins|vitamins|mesh-ancestor
83363504|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
83363505|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363506|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83363507|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83363508|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83363509|NCT02135874|Cytarabine|cytarabine|mesh-list
83363510|NCT02135874|Dexamethasone|dexamethasone|mesh-list
83363511|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
83363512|NCT02135874|Rituximab|rituximab|mesh-list
83363513|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83363514|NCT02135874|Vincristine|vincristine|mesh-list
83363515|NCT02135874|Sorafenib|sorafenib|mesh-list
83363516|NCT02135874|Idarubicin|idarubicin|mesh-list
83363517|NCT02135874|Clofarabine|clofarabine|mesh-list
83363518|NCT02135874|Antibodies|antibodies|mesh-list
83363519|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
83363520|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83363521|NCT02135874|BB 1101|bb 1101|mesh-list
83363522|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
83363523|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363524|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363525|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363526|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363527|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
83363528|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
83363529|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363530|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363531|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
83363532|NCT02135874|Hormones|hormones|mesh-ancestor
83363533|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363534|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83363535|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
83363536|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363537|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363538|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363539|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
83363540|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
83363541|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363542|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363543|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83363544|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
83363545|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
83363546|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
83363547|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83363548|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83363549|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83363550|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363551|NCT01531673|Ivacaftor|ivacaftor|mesh-list
83363552|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83363553|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83363554|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363555|NCT01531205|Leuprolide|leuprolide|mesh-list
83363556|NCT01531205|Goserelin|goserelin|mesh-list
83363557|NCT01531205|Bicalutamide|bicalutamide|mesh-list
83363558|NCT01531205|Androgens|androgens|mesh-list
83363559|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83363560|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
83363561|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363562|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363563|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83363564|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363565|NCT01531205|Hormones|hormones|mesh-ancestor
83363566|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363567|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
83363568|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
83363569|NCT02985671|Acetaminophen|acetaminophen|mesh-list
83363570|NCT02985671|Diclofenac|diclofenac|mesh-list
83363571|NCT02985671|Orphenadrine|orphenadrine|mesh-list
83363572|NCT02985671|Caffeine|caffeine|mesh-list
83363573|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83363574|NCT02985671|Analgesics|analgesics|mesh-ancestor
83363575|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
83363576|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363577|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363578|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
83363579|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83363580|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83363581|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363582|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363583|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83363584|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83363585|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
83363586|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363587|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83363588|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363589|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363590|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83363591|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83363592|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83363593|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
83363594|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83363595|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
83363596|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
83363597|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83363598|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83363599|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
83363600|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
83363601|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83363602|NCT01529645|Vaccines|vaccines|mesh-list
83363603|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
83363604|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363605|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83363606|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83363607|NCT01528709|Atorvastatin|atorvastatin|mesh-list
83363608|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83363609|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83363610|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
83363611|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363612|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83363613|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83363614|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363615|NCT01527383|Vaccines|vaccines|mesh-list
83363616|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
83363617|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363619|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83363620|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363621|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
83363622|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363623|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363624|NCT01525901|Mitogens|mitogens|mesh-list
83363625|NCT01525901|Mecasermin|mecasermin|mesh-list
83363626|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363627|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
83363628|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363629|NCT01525901|Growth Substances|growth substances|mesh-ancestor
83363630|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
83363631|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83363632|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83363633|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363634|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
83363635|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363636|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
83363637|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
83363638|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363639|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363640|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
83363641|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83363642|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
83363643|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83363644|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363645|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83363646|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83363647|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83363648|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
83363649|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363650|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83363651|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83363652|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363653|NCT00264381|Dalteparin|dalteparin|mesh-list
83363654|NCT00264381|Tinzaparin|tinzaparin|mesh-list
83363655|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83363656|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
83363657|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83363658|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83363659|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363660|NCT00246441|Paroxetine|paroxetine|mesh-list
83363661|NCT00246441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83363662|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83363663|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83363664|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363665|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363666|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
83363667|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363668|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83363669|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
83363670|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83363671|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83363672|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83363673|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363674|NCT00246519|Atenolol|atenolol|mesh-list
83363675|NCT00246519|Metoprolol|metoprolol|mesh-list
83363676|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83363677|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
83363678|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83363679|NCT00246519|Diuretics|diuretics|mesh-ancestor
83363680|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
83363681|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363682|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83363683|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83363684|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363685|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83363686|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
83363687|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
83363688|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363689|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83363690|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83363691|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83363692|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
83363693|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363696|NCT00248547|Aprepitant|aprepitant|mesh-list
83363697|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363698|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
83363699|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
83363700|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363701|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363702|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363703|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
83363704|NCT00248547|Hormones|hormones|mesh-ancestor
83363705|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363706|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83363707|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363708|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
83363709|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363710|NCT00248547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83363711|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83363712|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
83363713|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363714|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363715|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83363716|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
83363717|NCT01524887|Antibodies|antibodies|mesh-list
83363718|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
83363719|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83363720|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83363721|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
83363722|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363723|NCT00266799|Doxorubicin|doxorubicin|mesh-list
83363724|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83363725|NCT00266799|Capecitabine|capecitabine|mesh-list
83363726|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83363727|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363728|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83363729|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363730|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363731|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363732|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363733|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
83363734|NCT00249249|Atorvastatin|atorvastatin|mesh-list
83363735|NCT00249249|Pitavastatin|pitavastatin|mesh-list
83363736|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83363737|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83363738|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
83363739|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363740|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83363741|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83363742|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363743|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83363744|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
83363745|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
83363746|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
83363747|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363748|NCT00125931|Pentazocine|pentazocine|mesh-list
83363749|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83363750|NCT00125931|Narcotics|narcotics|mesh-ancestor
83363751|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363752|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363753|NCT00125931|Analgesics|analgesics|mesh-ancestor
83363754|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
83363755|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363756|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83363757|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83363758|NCT00267111|Tetracaine|tetracaine|mesh-list
83363759|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
83363760|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
83363761|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363762|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363763|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
83363764|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363765|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
83363766|NCT01521923|Methotrexate|methotrexate|mesh-list
83363767|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83363768|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
83363769|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363770|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363771|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363772|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
83363773|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363774|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363775|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363776|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363777|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83363778|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363779|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
83363780|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363781|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83363782|NCT01521923|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83363783|NCT01521923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363784|NCT05240781|Sirolimus|sirolimus|mesh-list
83363785|NCT05240781|Temsirolimus|temsirolimus|mesh-list
83363786|NCT05240781|MTOR Inhibitors|mtor inhibitors|mesh-list
83363787|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363788|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363789|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83363790|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363791|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
83363792|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363793|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
83363794|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363795|NCT05240781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83363796|NCT05240781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363797|NCT05240781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363798|NCT01520987|Opicapone|opicapone|mesh-list
83363799|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83363800|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363801|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363802|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83363803|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83363804|NCT00130923|Risperidone|risperidone|mesh-list
83363805|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83363806|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
83363807|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363808|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363809|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363810|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83363811|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83363812|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363813|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83363814|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83363815|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
83363816|NCT04117581|Vitamin D|vitamin d|mesh-list
83363817|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
83363818|NCT04117581|Vitamins|vitamins|mesh-ancestor
83363819|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
83363820|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363821|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83363822|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83363823|NCT00272337|Aspirin|aspirin|mesh-list
83363824|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83363825|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83363826|NCT00272337|Analgesics|analgesics|mesh-ancestor
83363827|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
83363828|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363829|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363830|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363831|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363832|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83363833|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83363834|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363835|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83363836|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83363837|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363838|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
83363839|NCT01562275|Ipatasertib|ipatasertib|mesh-list
83363840|NCT01562275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363841|NCT01562275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83363842|NCT01562275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363843|NCT01562275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363844|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
83363847|NCT01535053|Dactinomycin|dactinomycin|mesh-list
83363848|NCT01535053|Methotrexate|methotrexate|mesh-list
83363849|NCT01535053|Calcium|calcium|mesh-list
83363850|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
83363851|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83363852|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363853|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83363854|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83363855|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
83363856|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363857|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363858|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
83363859|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363860|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363861|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363862|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363863|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83363864|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363865|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
83363866|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363867|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83363868|NCT01535053|Antidotes|antidotes|mesh-ancestor
83363869|NCT01535053|Protective Agents|protective agents|mesh-ancestor
83363870|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
83363871|NCT01535053|Vitamins|vitamins|mesh-ancestor
83363872|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
83363873|NCT01535053|Hematinics|hematinics|mesh-ancestor
83363874|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363875|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363876|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83363877|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83363878|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
83363879|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363880|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363881|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83363882|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83363883|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363884|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363885|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363886|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83363887|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83363888|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
83363889|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
83363890|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
83363891|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83363892|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83363893|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363894|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363895|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363896|NCT01578499|Methotrexate|methotrexate|mesh-list
83363897|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83363898|NCT01578499|Bexarotene|bexarotene|mesh-list
83363899|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83363900|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
83363901|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83363902|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363903|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363904|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
83363905|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363906|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363907|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
83363908|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363909|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83363910|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363912|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363913|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83363914|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83363915|NCT01578499|Immunotoxins|immunotoxins|mesh-ancestor
83363916|NCT01578499|Immunoconjugates|immunoconjugates|mesh-ancestor
83363917|NCT01561963|Rifampin|rifampin|mesh-list
83363918|NCT01561963|Apremilast|apremilast|mesh-list
83363919|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83363920|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
83363921|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83363922|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83363923|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
83363924|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83363925|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363926|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363927|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83363928|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83363929|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83363930|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83363931|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83363932|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83363933|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83363934|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83363935|NCT01561963|Analgesics|analgesics|mesh-ancestor
83363936|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
83363937|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363938|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363939|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363940|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83363941|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83363942|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83363943|NCT04852003|Morphine|morphine|mesh-list
83363944|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83363945|NCT04852003|Narcotics|narcotics|mesh-ancestor
83363946|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83363947|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363948|NCT04852003|Analgesics|analgesics|mesh-ancestor
83363949|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
83363950|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363951|NCT01534351|Tamsulosin|tamsulosin|mesh-list
83363952|NCT01534351|Finasteride|finasteride|mesh-list
83363953|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83363954|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83363955|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83363956|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
83363957|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83363958|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363959|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363960|NCT01534351|Urological Agents|urological agents|mesh-ancestor
83363961|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83363962|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83363963|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83363964|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
83363965|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363966|NCT01534195|Prednisolone|prednisolone|mesh-list
83363967|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83363968|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
83363969|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83363970|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
83363971|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83363972|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83363973|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83363974|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
83363975|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83363976|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
83363977|NCT01534195|Hormones|hormones|mesh-ancestor
83363978|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83363979|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363980|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83363981|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363982|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
83363983|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
83363984|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83363985|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83363986|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83363987|NCT01534195|Protective Agents|protective agents|mesh-ancestor
83363988|NCT01560949|Gemcitabine|gemcitabine|mesh-list
83363989|NCT01560949|Fluorouracil|fluorouracil|mesh-list
83363990|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
83363991|NCT01560949|Irinotecan|irinotecan|mesh-list
83363992|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83363993|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
83363994|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83363995|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83363996|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83363997|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
83363998|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83363999|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83364000|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83364001|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364002|NCT03113448|Capsaicin|capsaicin|mesh-list
83364003|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
83364004|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83364005|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
83364006|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364007|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364008|NCT01533493|Memantine|memantine|mesh-list
83364009|NCT01533493|Methylphenidate|methylphenidate|mesh-list
83364010|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83364011|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364012|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83364013|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83364014|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364015|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364016|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
83364017|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364018|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83364019|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83364020|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83364021|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83364022|NCT02388048|Ofatumumab|ofatumumab|mesh-list
83364023|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364024|NCT02387892|Vitamin D|vitamin d|mesh-list
83364025|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
83364026|NCT02387892|Vitamins|vitamins|mesh-ancestor
83364027|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
83364028|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364029|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83364030|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83364031|NCT00133575|Vaccines|vaccines|mesh-list
83364032|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
83364033|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364034|NCT00134043|Vorinostat|vorinostat|mesh-list
83364035|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364036|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83364037|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364038|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364039|NCT03715998|Ramipril|ramipril|mesh-list
83364040|NCT03715998|Firibastat|firibastat|mesh-list
83364041|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83364042|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
83364043|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364044|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364045|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83364046|NCT01790529|Metronidazole|metronidazole|mesh-list
83364047|NCT01790529|Cefuroxime|cefuroxime|mesh-list
83364048|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
83364049|NCT01790529|Anesthetics|anesthetics|mesh-list
83364050|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364051|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364052|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364053|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83364054|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83364055|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83364056|NCT01533181|Topotecan|topotecan|mesh-list
83364057|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83364058|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83364059|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364060|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364061|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364062|NCT04641507|Tadalafil|tadalafil|mesh-list
83364063|NCT04641507|Tamsulosin|tamsulosin|mesh-list
83364064|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
83364065|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83364066|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83364067|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364068|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364069|NCT04641507|Urological Agents|urological agents|mesh-ancestor
83364070|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83364071|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83364072|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83364073|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
83364074|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364075|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364076|NCT04489173|Trifluridine|trifluridine|mesh-list
83364077|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
83364078|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364079|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
83364080|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364081|NCT00512070|Olanzapine|olanzapine|mesh-list
83364082|NCT00512070|Melatonin|melatonin|mesh-list
83364083|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
83364084|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364085|NCT00512070|Protective Agents|protective agents|mesh-ancestor
83364086|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364087|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364088|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
83364089|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
83364090|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364091|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364092|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83364093|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83364094|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83364095|NCT00512070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83364096|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83364097|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364098|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364099|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
83364100|NCT05668026|Venetoclax|venetoclax|mesh-list
83364101|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364102|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83364103|NCT05661552|Ezetimibe|ezetimibe|mesh-list
83364104|NCT05661552|Evolocumab|evolocumab|mesh-list
83364105|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83364106|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83364107|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
83364108|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364109|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83364110|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83364111|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364112|NCT05661552|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83364113|NCT05661552|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83364114|NCT05661552|Protease Inhibitors|protease inhibitors|mesh-ancestor
83364116|NCT03534102|Narcotics|narcotics|mesh-ancestor
83364117|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364118|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364119|NCT03534102|Analgesics|analgesics|mesh-ancestor
83364120|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
83364121|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364122|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
83364123|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83364124|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83364125|NCT04051203|Prednisolone|prednisolone|mesh-list
83364126|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
83364127|NCT04051203|Lidocaine|lidocaine|mesh-list
83364128|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83364129|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
83364130|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
83364131|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
83364132|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364133|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364134|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
83364135|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364136|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83364137|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83364138|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83364139|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364140|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364141|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364142|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
83364143|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
83364144|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364145|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
83364146|NCT04051203|Hormones|hormones|mesh-ancestor
83364147|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364148|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83364149|NCT04051203|Protective Agents|protective agents|mesh-ancestor
83364150|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83364151|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364152|NCT00144963|Dexamethasone|dexamethasone|mesh-list
83364153|NCT00144963|Vincristine|vincristine|mesh-list
83364154|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364155|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
83364156|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
83364157|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364158|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364159|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364160|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
83364161|NCT00144963|Hormones|hormones|mesh-ancestor
83364162|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364163|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83364164|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364165|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83364166|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
83364167|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
83364168|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
83364169|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364170|NCT02662764|Sufentanil|sufentanil|mesh-list
83364171|NCT02662764|Dsuvia|dsuvia|mesh-list
83364172|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83364173|NCT02662764|Narcotics|narcotics|mesh-ancestor
83364174|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364175|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364176|NCT02662764|Analgesics|analgesics|mesh-ancestor
83364177|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
83364178|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364179|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83364180|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83364181|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
83364182|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
83364183|NCT01519817|Vaccines|vaccines|mesh-list
83364184|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
83364185|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364186|NCT02985593|KHK4083|khk4083|mesh-list
83364187|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
83364188|NCT03478956|Etrolizumab|etrolizumab|mesh-list
83364189|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364190|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
83364191|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364192|NCT05549154|Vitamin D|vitamin d|mesh-list
83364193|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
83364194|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
83364195|NCT05549154|Vitamins|vitamins|mesh-list
83364196|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
83364197|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364198|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83364199|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83364200|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
83364201|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83364202|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83364203|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83364204|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364205|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364206|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
83364207|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364208|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364209|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83364210|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364212|NCT02391636|Carbetocin|carbetocin|mesh-list
83364213|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
83364214|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83364215|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364216|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83364217|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
83364218|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364219|NCT02383212|Paclitaxel|paclitaxel|mesh-list
83364220|NCT02383212|Docetaxel|docetaxel|mesh-list
83364221|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
83364222|NCT02383212|Carboplatin|carboplatin|mesh-list
83364223|NCT02383212|Pemetrexed|pemetrexed|mesh-list
83364224|NCT02383212|Cemiplimab|cemiplimab|mesh-list
83364225|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83364226|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364227|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
83364228|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
83364229|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
83364230|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364231|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83364232|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
83364233|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364234|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364235|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83364236|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
83364237|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83364238|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364239|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83364240|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83364241|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83364242|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
83364243|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364244|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
83364245|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364246|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364247|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83364248|NCT01531153|Galantamine|galantamine|mesh-list
83364249|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83364250|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364251|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364252|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
83364253|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364254|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364255|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83364256|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
83364257|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364258|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
83364259|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
83364260|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
83364261|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83364262|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83364263|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364264|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
83364265|NCT03027973|Coagulants|coagulants|mesh-ancestor
83364266|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83364267|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
83364268|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83364269|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364270|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83364271|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
83364273|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83364274|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83364275|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83364276|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83364277|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364278|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83364279|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83364280|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
83364281|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364282|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83364283|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83364284|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364285|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83364286|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83364287|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83364288|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83364289|NCT04101721|Aflibercept|aflibercept|mesh-list
83364290|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83364291|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83364292|NCT04101721|Growth Substances|growth substances|mesh-ancestor
83364293|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364294|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
83364295|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364296|NCT01528969|Sorbitol|sorbitol|mesh-list
83364297|NCT01528969|Cathartics|cathartics|mesh-ancestor
83364298|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364299|NCT01514201|Temozolomide|temozolomide|mesh-list
83364300|NCT01514201|Veliparib|veliparib|mesh-list
83364301|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83364302|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
83364303|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364304|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364305|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83364306|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364307|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
83364308|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83364309|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
83364310|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364311|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83364312|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364313|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83364314|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364315|NCT01528735|Ribavirin|ribavirin|mesh-list
83364316|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
83364317|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364318|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
83364319|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364320|NCT02386488|Vortioxetine|vortioxetine|mesh-list
83364321|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
83364322|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83364323|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83364324|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83364325|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364326|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364327|NCT02386488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83364328|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83364329|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364330|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364331|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364332|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
83364333|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83364334|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83364335|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83364336|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83364338|NCT02661594|Amisulpride|amisulpride|mesh-list
83364339|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83364340|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364341|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83364342|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83364343|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364344|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364345|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364346|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364347|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83364348|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83364349|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364350|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83364351|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83364352|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
83364353|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364354|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83364355|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
83364356|NCT02386566|Natalizumab|natalizumab|mesh-list
83364357|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
83364358|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364360|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83364361|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364362|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83364363|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83364364|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
83364365|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364366|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364367|NCT01511939|Diclofenac|diclofenac|mesh-list
83364368|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83364369|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83364370|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83364371|NCT01511939|Analgesics|analgesics|mesh-ancestor
83364372|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
83364373|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364374|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364375|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364376|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83364377|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364378|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364379|NCT02391480|Venetoclax|venetoclax|mesh-list
83364380|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364381|NCT01576705|Leucovorin|leucovorin|mesh-list
83364382|NCT01576705|Folic Acid|folic acid|mesh-list
83364383|NCT01576705|Hormones|hormones|mesh-list
83364384|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
83364385|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364386|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364387|NCT01576705|Antidotes|antidotes|mesh-ancestor
83364388|NCT01576705|Protective Agents|protective agents|mesh-ancestor
83364389|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
83364390|NCT01576705|Vitamins|vitamins|mesh-ancestor
83364391|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
83364392|NCT01576705|Hematinics|hematinics|mesh-ancestor
83364393|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
83364394|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83364395|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364396|NCT02382666|Rolapitant|rolapitant|mesh-list
83364397|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83364398|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364399|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364400|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364401|NCT00145041|Vincristine|vincristine|mesh-list
83364402|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83364403|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364404|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
83364405|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
83364406|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
83364407|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364408|NCT04123561|Dexamethasone|dexamethasone|mesh-list
83364409|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
83364410|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83364411|NCT04123561|BB 1101|bb 1101|mesh-list
83364412|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364413|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
83364414|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
83364415|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364416|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364417|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364418|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
83364419|NCT04123561|Hormones|hormones|mesh-ancestor
83364420|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364421|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83364422|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364423|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
83364424|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364425|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364426|NCT01510769|Febuxostat|febuxostat|mesh-list
83364427|NCT01510769|Lesinurad|lesinurad|mesh-list
83364428|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
83364429|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364430|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
83364431|NCT02382354|Remifentanil|remifentanil|mesh-list
83364432|NCT02382354|Propofol|propofol|mesh-list
83364433|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83364434|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364435|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364436|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83364437|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
83364438|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
83364439|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83364440|NCT02382354|Narcotics|narcotics|mesh-ancestor
83364441|NCT02382354|Analgesics|analgesics|mesh-ancestor
83364442|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
83364443|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364444|NCT01510145|Travoprost|travoprost|mesh-list
83364445|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83364446|NCT03027167|Aspirin|aspirin|mesh-list
83364447|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83364448|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83364449|NCT03027167|Analgesics|analgesics|mesh-ancestor
83364450|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
83364451|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364452|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364453|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364454|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364455|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83364456|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83364457|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364458|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83364459|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83364460|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364461|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
83364462|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
83364463|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83364464|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83364465|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83364466|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
83364467|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364468|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364469|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364470|NCT02382432|Meperidine|meperidine|mesh-list
83364471|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
83364472|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83364473|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364474|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364475|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83364476|NCT02382432|Analgesics|analgesics|mesh-ancestor
83364477|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
83364478|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364479|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83364480|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83364481|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83364482|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
83364483|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364484|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364485|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83364486|NCT02382432|Narcotics|narcotics|mesh-ancestor
83364487|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83364488|NCT00145587|Antibodies|antibodies|mesh-list
83364489|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
83364490|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364491|NCT04298463|Vancomycin|vancomycin|mesh-list
83364492|NCT04298463|Daptomycin|daptomycin|mesh-list
83364493|NCT04298463|Teicoplanin|teicoplanin|mesh-list
83364494|NCT04298463|Dalbavancin|dalbavancin|mesh-list
83364495|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83364496|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364497|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
83364498|NCT02381964|Vitamins|vitamins|mesh-ancestor
83364499|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
83364500|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364501|NCT01509053|Aripiprazole|aripiprazole|mesh-list
83364502|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
83364503|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83364504|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83364505|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83364506|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364507|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364508|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
83364509|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
83364510|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364511|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364512|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83364513|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83364514|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
83364515|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83364516|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83364517|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83364518|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83364519|NCT01560403|Teduglutide|teduglutide|mesh-list
83364520|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364521|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83364522|NCT01560403|Protective Agents|protective agents|mesh-ancestor
83364523|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364524|NCT02100579|Bupivacaine|bupivacaine|mesh-list
83364525|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
83364526|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
83364527|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364528|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364529|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
83364530|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364531|NCT04251351|Acetaminophen|acetaminophen|mesh-list
83364532|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83364533|NCT04251351|Analgesics|analgesics|mesh-ancestor
83364534|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
83364535|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364536|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364537|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
83364538|NCT02390700|Golimumab|golimumab|mesh-list
83364539|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83364540|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364541|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83364542|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
83364543|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364544|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83364545|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83364546|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83364547|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364548|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
83364549|NCT01527487|Docetaxel|docetaxel|mesh-list
83364550|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83364551|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
83364552|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364553|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364554|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83364555|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
83364556|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364557|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364558|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83364559|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
83364560|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
83364561|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
83364562|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
83364563|NCT01506947|Hematinics|hematinics|mesh-ancestor
83364564|NCT00149643|Fluoxetine|fluoxetine|mesh-list
83364565|NCT00149643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83364566|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83364567|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364568|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364569|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364570|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
83364571|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364572|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83364573|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
83364574|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83364575|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83364576|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83364577|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364578|NCT02381730|Aflibercept|aflibercept|mesh-list
83364579|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83364580|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83364581|NCT02381730|Growth Substances|growth substances|mesh-ancestor
83364582|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364583|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
83364584|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364585|NCT00149799|Escitalopram|escitalopram|mesh-list
83364586|NCT00149799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83364587|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83364588|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364589|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364590|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364591|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
83364592|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364593|NCT02390544|Melphalan|melphalan|mesh-list
83364594|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83364595|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
83364596|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364597|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364598|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83364599|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83364600|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
83364601|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364602|NCT01790997|Aspirin|aspirin|mesh-list
83364603|NCT01790997|Clopidogrel|clopidogrel|mesh-list
83364604|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83364605|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83364606|NCT01790997|Analgesics|analgesics|mesh-ancestor
83364607|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
83364608|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364609|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364610|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364611|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364612|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83364613|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83364614|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364615|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83364616|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83364617|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364618|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
83364619|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83364620|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83364621|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83364622|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
83364623|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364624|NCT02385474|Fluorides|fluorides|mesh-list
83364625|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
83364626|NCT02385474|Protective Agents|protective agents|mesh-ancestor
83364627|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364628|NCT02390310|Lidocaine|lidocaine|mesh-list
83364629|NCT02390310|Prilocaine|prilocaine|mesh-list
83364630|NCT02390310|Anesthetics|anesthetics|mesh-list
83364631|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
83364632|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364633|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364634|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
83364635|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364636|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83364637|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83364638|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83364639|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364640|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364641|NCT02381184|Clomiphene|clomiphene|mesh-list
83364642|NCT02381184|Enclomiphene|enclomiphene|mesh-list
83364643|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
83364644|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83364645|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
83364646|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364647|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364648|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83364649|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
83364650|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83364651|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83364652|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83364653|NCT02381028|Emollients|emollients|mesh-list
83364654|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
83364655|NCT00326781|Nicotine|nicotine|mesh-list
83364656|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83364657|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
83364658|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364659|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364660|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83364661|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83364662|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
83364663|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364664|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364665|NCT02385396|Folic Acid|folic acid|mesh-list
83364666|NCT02385396|Inositol|inositol|mesh-list
83364667|NCT02385396|Hematinics|hematinics|mesh-ancestor
83364668|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
83364669|NCT02385396|Vitamins|vitamins|mesh-ancestor
83364670|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
83364671|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364672|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83364673|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364674|NCT02979405|Phenylephrine|phenylephrine|mesh-list
83364675|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
83364676|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83364677|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
83364678|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
83364679|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364680|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364681|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
83364682|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83364683|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
83364684|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
83364685|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83364686|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83364687|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83364688|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
83364689|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364690|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364691|NCT02979405|Protective Agents|protective agents|mesh-ancestor
83364692|NCT01791231|Canagliflozin|canagliflozin|mesh-list
83364693|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83364694|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364695|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83364696|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364697|NCT01791309|Panitumumab|panitumumab|mesh-list
83364698|NCT01791309|Vemurafenib|vemurafenib|mesh-list
83364699|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83364700|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364701|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83364702|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364703|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364704|NCT00329433|Heparin|heparin|mesh-list
83364705|NCT00329433|Desirudin|desirudin|mesh-list
83364706|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
83364707|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83364708|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83364709|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364710|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
83364711|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83364712|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364713|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
83364714|NCT02389842|Palbociclib|palbociclib|mesh-list
83364715|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364716|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83364717|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364718|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364719|NCT04932096|Melatonin|melatonin|mesh-list
83364720|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
83364721|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364722|NCT04932096|Protective Agents|protective agents|mesh-ancestor
83364723|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364724|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364725|NCT00289653|Nicotine|nicotine|mesh-list
83364726|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83364727|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
83364728|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364729|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364730|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83364731|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83364732|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
83364733|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364734|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364736|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364737|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83364738|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83364739|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364740|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364741|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83364742|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
83364743|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364744|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364745|NCT02103855|Abatacept|abatacept|mesh-list
83364746|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83364747|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364748|NCT02103855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83364749|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364750|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83364751|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
83364752|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364753|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364754|NCT03706053|Midodrine|midodrine|mesh-list
83364755|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
83364756|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
83364757|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364758|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364759|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83364760|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83364761|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83364762|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83364763|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
83364764|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364765|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364766|NCT01504841|Etravirine|etravirine|mesh-list
83364767|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83364768|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83364769|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364770|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364771|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
83364772|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364773|NCT00330915|Pemetrexed|pemetrexed|mesh-list
83364774|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364775|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364776|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364777|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83364778|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83364779|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83364780|NCT03026933|Calcium|calcium|mesh-list
83364781|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83364782|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364783|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83364784|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83364785|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
83364786|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364787|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83364788|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83364789|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364790|NCT01502423|Adalimumab|adalimumab|mesh-list
83364791|NCT01502423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83364792|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364793|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364794|NCT04861584|Gemcitabine|gemcitabine|mesh-list
83364795|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364796|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83364797|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
83364798|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364799|NCT02388750|Palonosetron|palonosetron|mesh-list
83364800|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
83364801|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
83364802|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364803|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364804|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364805|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83364806|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83364807|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
83364808|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364809|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364810|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
83364811|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83364812|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
83364813|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364814|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364815|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83364816|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
83364817|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364818|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364819|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83364820|NCT01500317|Oxycodone|oxycodone|mesh-list
83364821|NCT01500317|Tapentadol|tapentadol|mesh-list
83364822|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83364823|NCT01500317|Narcotics|narcotics|mesh-ancestor
83364824|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364825|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364826|NCT01500317|Analgesics|analgesics|mesh-ancestor
83364827|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
83364828|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364829|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83364830|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83364831|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83364832|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364833|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
83364834|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364835|NCT02379546|Desflurane|desflurane|mesh-list
83364836|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83364837|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
83364838|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
83364839|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364840|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364841|NCT00332163|Irinotecan|irinotecan|mesh-list
83364842|NCT00332163|Panitumumab|panitumumab|mesh-list
83364843|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83364844|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83364845|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364846|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364847|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364848|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83364849|NCT02379000|Triamcinolone|triamcinolone|mesh-list
83364850|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83364851|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83364852|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83364853|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364854|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
83364855|NCT02379000|Hormones|hormones|mesh-ancestor
83364856|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364857|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364858|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83364859|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
83364860|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364861|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364862|NCT00333177|Risperidone|risperidone|mesh-list
83364863|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83364864|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
83364865|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364866|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364867|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364868|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83364869|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83364870|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83364871|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83364872|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83364873|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
83364874|NCT02379156|Midodrine|midodrine|mesh-list
83364875|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
83364876|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
83364877|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364878|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364879|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83364880|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83364881|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83364882|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83364883|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
83364884|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364885|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364886|NCT00335283|Lansoprazole|lansoprazole|mesh-list
83364887|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
83364888|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83364889|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364890|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83364891|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364892|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364893|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83364894|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83364895|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
83364896|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364897|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364898|NCT02779257|Diazoxide|diazoxide|mesh-list
83364899|NCT02779257|Pasireotide|pasireotide|mesh-list
83364900|NCT02779257|Hormones|hormones|mesh-ancestor
83364901|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364902|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364903|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83364904|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
83364905|NCT00295503|Bevacizumab|bevacizumab|mesh-list
83364906|NCT00295503|Pemetrexed|pemetrexed|mesh-list
83364907|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83364908|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364909|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83364910|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83364911|NCT00295503|Growth Substances|growth substances|mesh-ancestor
83364912|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364913|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
83364914|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364915|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364916|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83364917|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83364918|NCT02371590|Lenalidomide|lenalidomide|mesh-list
83364919|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
83364920|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
83364921|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364922|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83364923|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83364924|NCT02371590|Growth Substances|growth substances|mesh-ancestor
83364925|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
83364926|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364927|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83364928|NCT00298155|Ketoconazole|ketoconazole|mesh-list
83364929|NCT00298155|Goserelin|goserelin|mesh-list
83364930|NCT00298155|Bicalutamide|bicalutamide|mesh-list
83364931|NCT00298155|Dutasteride|dutasteride|mesh-list
83364932|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83364933|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364934|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
83364935|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364936|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83364937|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83364938|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364939|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364940|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83364941|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
83364942|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364943|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364944|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83364945|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
83364946|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83364947|NCT01499849|Dexamethasone|dexamethasone|mesh-list
83364948|NCT01499849|Granisetron|granisetron|mesh-list
83364949|NCT01499849|Rolapitant|rolapitant|mesh-list
83364950|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364951|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
83364952|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
83364953|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364954|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83364955|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364956|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
83364957|NCT01499849|Hormones|hormones|mesh-ancestor
83364958|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83364959|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83364960|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364961|NCT01499849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83364962|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83364963|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
83364964|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83364965|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364966|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83364967|NCT00298233|Oseltamivir|oseltamivir|mesh-list
83364968|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
83364969|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364970|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83364971|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364972|NCT02376972|Rifaximin|rifaximin|mesh-list
83364973|NCT02376972|Metronidazole|metronidazole|mesh-list
83364974|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83364975|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364976|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83364977|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83364978|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83364979|NCT02378532|Chloroquine|chloroquine|mesh-list
83364980|NCT02378532|Temozolomide|temozolomide|mesh-list
83364981|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83364982|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
83364983|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83364984|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83364985|NCT02378532|Amebicides|amebicides|mesh-ancestor
83364986|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83364987|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83364988|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83364989|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
83364990|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83364991|NCT01498679|Fluticasone|fluticasone|mesh-list
83364992|NCT01498679|Xhance|xhance|mesh-list
83364993|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83364994|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83364995|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
83364996|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83364998|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83364999|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
83365000|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
83365001|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83365002|NCT01000467|Probucol|probucol|mesh-list
83365003|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83365004|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83365005|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
83365006|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365007|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83365008|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
83365009|NCT01000467|Protective Agents|protective agents|mesh-ancestor
83365010|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365011|NCT00198315|Bleomycin|bleomycin|mesh-list
83365012|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83365013|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365014|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
83365015|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83365016|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83365017|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
83365018|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365019|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365020|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365021|NCT01559389|Urological Agents|urological agents|mesh-ancestor
83365022|NCT01526551|Vaccines|vaccines|mesh-list
83365023|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
83365024|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365025|NCT04540692|Paclitaxel|paclitaxel|mesh-list
83365026|NCT04540692|Docetaxel|docetaxel|mesh-list
83365027|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
83365028|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365029|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365030|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365031|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365032|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365033|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365034|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83365035|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
83365036|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365037|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365038|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83365039|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
83365040|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83365042|NCT00343083|Carboplatin|carboplatin|mesh-list
83365043|NCT00343083|Cetuximab|cetuximab|mesh-list
83365044|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365045|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365046|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365047|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365048|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365049|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365050|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365051|NCT02376426|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
83365052|NCT02376426|Antiviral Agents|antiviral agents|mesh-ancestor
83365053|NCT02376426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365054|NCT00343785|Cyclosporine|cyclosporine|mesh-list
83365055|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
83365056|NCT00343785|Methotrexate|methotrexate|mesh-list
83365057|NCT00343785|Cyclosporins|cyclosporins|mesh-list
83365058|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
83365059|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83365060|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
83365061|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83365062|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
83365063|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365064|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365065|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83365066|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
83365067|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365068|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365069|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83365070|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83365071|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
83365072|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83365073|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365074|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
83365075|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
83365076|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365077|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83365078|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83365079|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
83365080|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365081|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83365082|NCT00343863|Dexamethasone|dexamethasone|mesh-list
83365083|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
83365084|NCT00343863|Doxorubicin|doxorubicin|mesh-list
83365085|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83365086|NCT00343863|Ondansetron|ondansetron|mesh-list
83365087|NCT00343863|Palonosetron|palonosetron|mesh-list
83365088|NCT00343863|Antiemetics|antiemetics|mesh-list
83365089|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83365090|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
83365091|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365092|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365093|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83365094|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
83365095|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365096|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365097|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83365098|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83365099|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
83365100|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365101|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365102|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
83365103|NCT00343863|Hormones|hormones|mesh-ancestor
83365104|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365105|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83365106|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83365107|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83365108|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365109|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365110|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
83365111|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
83365112|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83365113|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83365114|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
83365115|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365116|NCT00344175|Simvastatin|simvastatin|mesh-list
83365117|NCT00344175|Pitavastatin|pitavastatin|mesh-list
83365118|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83365119|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83365120|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
83365121|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365122|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83365123|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83365124|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365125|NCT00345033|Aripiprazole|aripiprazole|mesh-list
83365126|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
83365127|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83365128|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83365129|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83365130|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365131|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365132|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
83365133|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
83365134|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365135|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365136|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83365137|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83365138|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
83365139|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83365140|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83365141|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83365142|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83365143|NCT00345969|Testosterone|testosterone|mesh-list
83365145|NCT00345969|Hormones|hormones|mesh-ancestor
83365146|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365147|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365148|NCT01498445|Decitabine|decitabine|mesh-list
83365149|NCT01498445|Dasatinib|dasatinib|mesh-list
83365150|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365151|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
83365152|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365153|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365154|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365155|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83365156|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
83365157|NCT01525615|Olodaterol|olodaterol|mesh-list
83365158|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83365159|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
83365160|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365161|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365162|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83365163|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
83365164|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
83365165|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83365166|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
83365167|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365168|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365169|NCT00309465|Insulin|insulin|mesh-list
83365170|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83365171|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
83365172|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83365173|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365174|NCT01791699|Moxonidine|moxonidine|mesh-list
83365175|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83365176|NCT00302133|Naltrexone|naltrexone|mesh-list
83365177|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83365178|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83365179|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365180|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
83365181|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365182|NCT01525225|Metformin|metformin|mesh-list
83365183|NCT01525225|Saxagliptin|saxagliptin|mesh-list
83365184|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83365185|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365186|NCT01525225|Incretins|incretins|mesh-ancestor
83365187|NCT01525225|Hormones|hormones|mesh-ancestor
83365188|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365189|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83365190|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
83365191|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365192|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365193|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83365194|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83365195|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83365196|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83365197|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365198|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
83365199|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365200|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365201|NCT02660580|Adalimumab|adalimumab|mesh-list
83365202|NCT02660580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83365203|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83365204|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365205|NCT01524991|Gemcitabine|gemcitabine|mesh-list
83365206|NCT01524991|Ipilimumab|ipilimumab|mesh-list
83365207|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365208|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365209|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
83365210|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365211|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365212|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83365213|NCT04039230|Talazoparib|talazoparib|mesh-list
83365214|NCT04039230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
83479854|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365215|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83365216|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365217|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365218|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365219|NCT04039230|Immunoconjugates|immunoconjugates|mesh-ancestor
83365220|NCT04039230|Immunologic Factors|immunologic factors|mesh-ancestor
83365221|NCT04039230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365222|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
83365223|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83365224|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
83365225|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365226|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
83365227|NCT01524913|Protective Agents|protective agents|mesh-ancestor
83365228|NCT02376192|Phenylephrine|phenylephrine|mesh-list
83365229|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
83365230|NCT02376192|Ephedrine|ephedrine|mesh-list
83365231|NCT02376192|Bupivacaine|bupivacaine|mesh-list
83365232|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
83365233|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
83365234|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365235|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365236|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
83365237|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365238|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83365239|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
83365240|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
83365241|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
83365242|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83365243|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
83365244|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
83365245|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83365246|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83365247|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83365248|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
83365249|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365250|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365251|NCT02376192|Protective Agents|protective agents|mesh-ancestor
83365252|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83365253|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
83365254|NCT02037126|Promethazine|promethazine|mesh-list
83365256|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83365257|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83365258|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365259|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365260|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
83365261|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
83365262|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
83365263|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365264|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
83365265|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
83365266|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365267|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83365268|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
83365269|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
83365270|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365271|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365272|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83365273|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
83365274|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
83365275|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
83365276|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83365277|NCT02375880|Gemcitabine|gemcitabine|mesh-list
83365278|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365279|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365280|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
83365281|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365282|NCT01524679|Interferons|interferons|mesh-list
83365283|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
83365284|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
83365285|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83365286|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365287|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
83365288|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365289|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
83365290|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365292|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83365293|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365294|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83365295|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83365296|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83365297|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
83365298|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365299|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83365300|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83365301|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365302|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
83365303|NCT04645602|Lenvatinib|lenvatinib|mesh-list
83365304|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365305|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365306|NCT04645602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83365307|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365308|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83365309|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365310|NCT01880541|Anesthetics|anesthetics|mesh-list
83365311|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365312|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365313|NCT02368860|Capecitabine|capecitabine|mesh-list
83365314|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
83365315|NCT02368860|Irinotecan|irinotecan|mesh-list
83365316|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365317|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
83365318|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365319|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365320|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83365321|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365322|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365323|NCT02375646|Heparin|heparin|mesh-list
83365324|NCT02375646|Enoxaparin|enoxaparin|mesh-list
83365325|NCT02375646|Warfarin|warfarin|mesh-list
83365326|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
83365327|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83365328|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83365329|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365330|NCT01524289|Anacetrapib|anacetrapib|mesh-list
83365331|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83365332|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83365333|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
83365334|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365335|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83365336|NCT01498289|Leucovorin|leucovorin|mesh-list
83365337|NCT01498289|Docetaxel|docetaxel|mesh-list
83365338|NCT01498289|Fluorouracil|fluorouracil|mesh-list
83365339|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
83365340|NCT01498289|Irinotecan|irinotecan|mesh-list
83365341|NCT01498289|Calcium|calcium|mesh-list
83365342|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
83365343|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365344|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365345|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365346|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365347|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365348|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83365349|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365350|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
83365351|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365352|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83365353|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
83365354|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83365355|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365356|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365357|NCT01498289|Antidotes|antidotes|mesh-ancestor
83365358|NCT01498289|Protective Agents|protective agents|mesh-ancestor
83365359|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
83365360|NCT01498289|Vitamins|vitamins|mesh-ancestor
83365361|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
83365362|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
83365363|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
83365364|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83365365|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83365366|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365367|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365368|NCT02364882|Urological Agents|urological agents|mesh-ancestor
83365369|NCT02364804|Aprepitant|aprepitant|mesh-list
83365370|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
83365371|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
83365372|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365373|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365374|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365375|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83365376|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365377|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365378|NCT01524133|Sertraline|sertraline|mesh-list
83365379|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
83365380|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83365381|NCT01524133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83365382|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83365383|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83365384|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365385|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365386|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
83365387|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365388|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
83365389|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83365390|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365391|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365392|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365393|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83365394|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365395|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365396|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83365397|NCT04561206|Nivolumab|nivolumab|mesh-list
83365398|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83365399|NCT04561206|Antibodies|antibodies|mesh-list
83365400|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
83365401|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83365402|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
83365403|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
83365404|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365405|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365406|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83365407|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365408|NCT04561206|Immunotoxins|immunotoxins|mesh-ancestor
83365409|NCT04110301|Lenalidomide|lenalidomide|mesh-list
83365410|NCT04110301|Antibodies|antibodies|mesh-list
83365411|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83365412|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
83365413|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365414|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83365415|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83365416|NCT04110301|Growth Substances|growth substances|mesh-ancestor
83365417|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
83365418|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365419|NCT05800600|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83365420|NCT05800600|Hematinics|hematinics|mesh-ancestor
83365421|NCT05800587|Paclitaxel|paclitaxel|mesh-list
83365422|NCT05800587|Etoposide|etoposide|mesh-list
83365423|NCT05800587|Docetaxel|docetaxel|mesh-list
83365424|NCT05800587|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83365425|NCT05800587|Carboplatin|carboplatin|mesh-list
83365426|NCT05800587|Gemcitabine|gemcitabine|mesh-list
83365427|NCT05800587|Irinotecan|irinotecan|mesh-list
83365428|NCT05800587|Pemetrexed|pemetrexed|mesh-list
83365429|NCT05800587|Topotecan|topotecan|mesh-list
83365430|NCT05800587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365431|NCT05800587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365432|NCT05800587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365433|NCT05800587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365434|NCT05800587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365435|NCT05800587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365436|NCT05800587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365437|NCT05800587|Antimetabolites|antimetabolites|mesh-ancestor
83365438|NCT05800587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83365439|NCT05800587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365440|NCT05800587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365441|NCT05800587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83365442|NCT05800587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83365443|NCT05800587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83365444|NCT05800418|Ramucirumab|ramucirumab|mesh-list
83365445|NCT05800418|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83365446|NCT05800418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365447|NCT05800418|Immunologic Factors|immunologic factors|mesh-ancestor
83365448|NCT05800418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365449|NCT05800366|Prednisone|prednisone|mesh-list
83365450|NCT05800366|Methylprednisolone|methylprednisolone|mesh-list
83365451|NCT05800366|Prednisolone|prednisolone|mesh-list
83365452|NCT05800366|Cyclophosphamide|cyclophosphamide|mesh-list
83365453|NCT05800366|Rituximab|rituximab|mesh-list
83365454|NCT05800366|Doxorubicin|doxorubicin|mesh-list
83365455|NCT05800366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83365456|NCT05800366|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
83365457|NCT05800366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83365458|NCT05800366|Immunologic Factors|immunologic factors|mesh-ancestor
83365459|NCT05800366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365460|NCT05800366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365461|NCT05800366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83365462|NCT05800366|Alkylating Agents|alkylating agents|mesh-ancestor
83365463|NCT05800366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365464|NCT05800366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365465|NCT05800366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83365466|NCT05800366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365467|NCT05800366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83365468|NCT05800366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83365469|NCT05800366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365470|NCT05800366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365471|NCT05800366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83365472|NCT05800366|Glucocorticoids|glucocorticoids|mesh-ancestor
83365473|NCT05800366|Hormones|hormones|mesh-ancestor
83365474|NCT05800366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365475|NCT05800366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83365476|NCT05800366|Antiemetics|antiemetics|mesh-ancestor
83365477|NCT05800366|Autonomic Agents|autonomic agents|mesh-ancestor
83365478|NCT05800366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365479|NCT05800366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365480|NCT05800366|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83365482|NCT05800366|Immunoconjugates|immunoconjugates|mesh-ancestor
83365483|NCT05800340|Paclitaxel|paclitaxel|mesh-list
83365484|NCT05800340|Carboplatin|carboplatin|mesh-list
83365485|NCT05800340|Pemetrexed|pemetrexed|mesh-list
83365486|NCT05800340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365487|NCT05800340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365488|NCT05800340|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365489|NCT05800340|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365490|NCT05800340|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365491|NCT05800340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365492|NCT05800340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365493|NCT05800340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83365494|NCT05800340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83365495|NCT05800301|Neurotransmitter Agents|neurotransmitter agents|mesh-list
83365496|NCT05800301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365497|NCT05800301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365498|NCT05800288|Propofol|propofol|mesh-list
83365499|NCT05800288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83365500|NCT05800288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365501|NCT05800288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365502|NCT05800288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83365503|NCT05800288|Anesthetics, General|anesthetics, general|mesh-ancestor
83365504|NCT05800288|Anesthetics|anesthetics|mesh-ancestor
83365505|NCT05800275|Capecitabine|capecitabine|mesh-list
83365506|NCT05800275|Trastuzumab|trastuzumab|mesh-list
83365507|NCT05800275|Tucatinib|tucatinib|mesh-list
83365508|NCT05800275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365509|NCT05800275|Antimetabolites|antimetabolites|mesh-ancestor
83365510|NCT05800275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365512|NCT05800275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365513|NCT05800275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83365514|NCT05800275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365515|NCT05800106|Sunitinib|sunitinib|mesh-list
83365516|NCT05800106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365517|NCT05800106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83365518|NCT05800106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83365519|NCT05800106|Growth Substances|growth substances|mesh-ancestor
83365520|NCT05800106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365521|NCT05800106|Growth Inhibitors|growth inhibitors|mesh-ancestor
83365522|NCT05800106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83365523|NCT05800106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365524|NCT05800106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365525|NCT05800080|Oxaliplatin|oxaliplatin|mesh-list
83365526|NCT05800080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365527|NCT05800054|Docetaxel|docetaxel|mesh-list
83365528|NCT05800054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365529|NCT05800054|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365530|NCT05800054|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365531|NCT05800054|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365532|NCT05800054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365533|NCT05800041|Cyclophosphamide|cyclophosphamide|mesh-list
83365534|NCT05800041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83365535|NCT05800041|Immunologic Factors|immunologic factors|mesh-ancestor
83365536|NCT05800041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365537|NCT05800041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365538|NCT05800041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83365539|NCT05800041|Alkylating Agents|alkylating agents|mesh-ancestor
83365540|NCT05800041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365541|NCT05800041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365542|NCT05800041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83365543|NCT05800015|Paclitaxel|paclitaxel|mesh-list
83365544|NCT05800015|Carboplatin|carboplatin|mesh-list
83365545|NCT05800015|Pemetrexed|pemetrexed|mesh-list
83365546|NCT05800015|Cemiplimab|cemiplimab|mesh-list
83365547|NCT05800015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365548|NCT05800015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365549|NCT05800015|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365550|NCT05800015|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365551|NCT05800015|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365552|NCT05800015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365553|NCT05800015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365554|NCT05800015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83365555|NCT05800015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83365556|NCT05800015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365558|NCT05799924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
83365559|NCT05799924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83365560|NCT05799924|Analgesics|analgesics|mesh-ancestor
83365561|NCT05799924|Sensory System Agents|sensory system agents|mesh-ancestor
83365562|NCT05799924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365563|NCT05799924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365564|NCT05799924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365565|NCT05799755|Nintedanib|nintedanib|mesh-list
83365566|NCT05799755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365567|NCT05799755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83365568|NCT05799755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365569|NCT05799755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365570|NCT05799729|Ketamine|ketamine|mesh-list
83365571|NCT05799729|Analgesics|analgesics|mesh-ancestor
83365572|NCT05799729|Sensory System Agents|sensory system agents|mesh-ancestor
83365573|NCT05799729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365574|NCT05799729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365575|NCT05799729|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83365576|NCT05799729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83365577|NCT05799729|Anesthetics, General|anesthetics, general|mesh-ancestor
83365578|NCT05799729|Anesthetics|anesthetics|mesh-ancestor
83365579|NCT05799729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365580|NCT05799729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83365581|NCT05799729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83365582|NCT05799729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365583|NCT05799729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365584|NCT05799612|Interferons|interferons|mesh-list
83365585|NCT05799612|Interferon-alpha|interferon-alpha|mesh-list
83365586|NCT05799612|Interferon alpha-2|interferon alpha-2|mesh-list
83365587|NCT05799612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83365588|NCT05799612|Paclitaxel|paclitaxel|mesh-list
83365589|NCT05799612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365590|NCT05799612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365591|NCT05799612|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365592|NCT05799612|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365593|NCT05799612|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365594|NCT05799612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365595|NCT05799612|Antiviral Agents|antiviral agents|mesh-ancestor
83365596|NCT05799612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365597|NCT05799612|Immunologic Factors|immunologic factors|mesh-ancestor
83365598|NCT05799612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365599|NCT05799521|Glycine|glycine|mesh-list
83365600|NCT05799521|Glycine Agents|glycine agents|mesh-ancestor
83365601|NCT05799521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365602|NCT05799521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365603|NCT05799521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365604|NCT05799469|Cisplatin|cisplatin|mesh-list
83365605|NCT05799469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365606|NCT05799443|Irinotecan|irinotecan|mesh-list
83365607|NCT05799443|Cetuximab|cetuximab|mesh-list
83365608|NCT05799443|Tislelizumab|tislelizumab|mesh-list
83365609|NCT05799443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83365610|NCT05799443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365611|NCT05799443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365612|NCT05799443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365613|NCT05799443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365614|NCT05799443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365615|NCT05799378|Hydroxychloroquine|hydroxychloroquine|mesh-list
83365616|NCT05799378|Antimalarials|antimalarials|mesh-ancestor
83365617|NCT05799378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83365618|NCT05799378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83365619|NCT05799378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365620|NCT05799378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365621|NCT05799378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365622|NCT05799378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83365623|NCT05799300|Anesthetics|anesthetics|mesh-list
83365624|NCT05799300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365625|NCT05799300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365626|NCT05799144|Pembrolizumab|pembrolizumab|mesh-list
83365627|NCT05799144|Vaccines|vaccines|mesh-list
83365628|NCT05799144|Immunologic Factors|immunologic factors|mesh-ancestor
83365629|NCT05799144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365630|NCT05799144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365631|NCT05799144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365632|NCT05799144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83365633|NCT05799144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365634|NCT05799105|Omeprazole|omeprazole|mesh-list
83365635|NCT05799105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83365636|NCT05799105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365637|NCT05799105|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83365638|NCT05799105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365639|NCT05799105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365640|NCT05799053|Peppermint oil|peppermint oil|mesh-list
83365641|NCT05799053|Antiemetics|antiemetics|mesh-ancestor
83365642|NCT05799053|Autonomic Agents|autonomic agents|mesh-ancestor
83365643|NCT05799053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365644|NCT05799053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365645|NCT05799053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365646|NCT05799053|Parasympatholytics|parasympatholytics|mesh-ancestor
83365647|NCT05798936|Ethanol|ethanol|mesh-list
83365648|NCT05798936|Polidocanol|polidocanol|mesh-list
83365649|NCT05798936|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83365650|NCT05798936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365651|NCT05798936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365652|NCT05798936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365653|NCT05798936|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83365654|NCT05798936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83365655|NCT05798871|Erythritol|erythritol|mesh-list
83365656|NCT05798871|Vasodilator Agents|vasodilator agents|mesh-ancestor
83365657|NCT05798819|Paclitaxel|paclitaxel|mesh-list
83365658|NCT05798819|Bevacizumab|bevacizumab|mesh-list
83365659|NCT05798819|Carboplatin|carboplatin|mesh-list
83365660|NCT05798819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83365661|NCT05798819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365662|NCT05798819|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365663|NCT05798819|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365664|NCT05798819|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365665|NCT05798819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365666|NCT05798819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365667|NCT05798819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83365668|NCT05798819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83365669|NCT05798819|Growth Substances|growth substances|mesh-ancestor
83365670|NCT05798819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365671|NCT05798819|Growth Inhibitors|growth inhibitors|mesh-ancestor
83365672|NCT05798728|Misoprostol|misoprostol|mesh-list
83365673|NCT05798728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83365674|NCT05798728|Abortifacient Agents|abortifacient agents|mesh-ancestor
83365675|NCT05798728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83365676|NCT05798728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365677|NCT05798728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83365678|NCT05798728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365679|NCT05798728|Oxytocics|oxytocics|mesh-ancestor
83365680|NCT05798715|Metformin|metformin|mesh-list
83365681|NCT05798715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83365682|NCT05798715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83365683|NCT05798715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365684|NCT05798715|Incretins|incretins|mesh-ancestor
83365685|NCT05798715|Hormones|hormones|mesh-ancestor
83365686|NCT05798715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365687|NCT05798715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83365688|NCT05798715|Protease Inhibitors|protease inhibitors|mesh-ancestor
83365689|NCT05798715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365690|NCT05798715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365691|NCT05796167|Pimavanserin|pimavanserin|mesh-list
83365692|NCT05796167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83365693|NCT05796167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83365694|NCT05796167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83365695|NCT05796167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83365696|NCT05796167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365697|NCT05796167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365698|NCT05796167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83365699|NCT05796167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83365700|NCT05796167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83365701|NCT05796167|Serotonin Agents|serotonin agents|mesh-ancestor
83365702|NCT05796167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365703|NCT05796167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365704|NCT05795491|Fluconazole|fluconazole|mesh-list
83365705|NCT05795491|Antifungal Agents|antifungal agents|mesh-list
83365706|NCT05795491|Clotrimazole|clotrimazole|mesh-list
83365707|NCT05795491|Miconazole|miconazole|mesh-list
83365708|NCT05795491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365709|NCT05795491|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83365710|NCT05795491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83365711|NCT05795491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365712|NCT05795491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365713|NCT05795491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83365714|NCT05795491|Hormone Antagonists|hormone antagonists|mesh-ancestor
83365715|NCT05795491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365716|NCT05795491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365717|NCT05795491|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83365718|NCT05795491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83365719|NCT05795491|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83365720|NCT05795491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83365721|NCT05788627|Lactulose|lactulose|mesh-list
83365722|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365723|NCT05777135|Propofol|propofol|mesh-list
83365724|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83365725|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365726|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365727|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83365728|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
83365729|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
83365730|NCT05771883|Lenalidomide|lenalidomide|mesh-list
83365731|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
83365732|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365733|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83365734|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83365735|NCT05771883|Growth Substances|growth substances|mesh-ancestor
83365736|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
83365737|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365738|NCT05767892|Carboplatin|carboplatin|mesh-list
83365739|NCT05767892|Pemetrexed|pemetrexed|mesh-list
83365740|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365741|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365742|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365743|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83365744|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83365745|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
83365746|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
83365747|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365748|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83365749|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83365750|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
83365751|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365752|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365753|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83365754|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
83365755|NCT05730816|Analgesics|analgesics|mesh-ancestor
83365756|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
83365757|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365758|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365759|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
83365760|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365761|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83365762|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
83365763|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83365764|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83365765|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365766|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83365767|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
83365768|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83365769|NCT05702333|Simendan|simendan|mesh-list
83365770|NCT05702333|Dobutamine|dobutamine|mesh-list
83365771|NCT05702333|Dopamine|dopamine|mesh-list
83365772|NCT05702333|Epinephrine|epinephrine|mesh-list
83365773|NCT05702333|Norepinephrine|norepinephrine|mesh-list
83365774|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83365775|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83365776|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
83365777|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365778|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365779|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365780|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83365781|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83365782|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
83365783|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365784|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83365785|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
83365786|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
83365787|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
83365788|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83365789|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83365790|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
83365791|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83365792|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83365793|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365794|NCT05702333|Protective Agents|protective agents|mesh-ancestor
83365795|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83365796|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
83365797|NCT05671913|Ketamine|ketamine|mesh-list
83365798|NCT05671913|Analgesics|analgesics|mesh-ancestor
83365799|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
83365800|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365801|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365802|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83365803|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83365804|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
83365806|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365807|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83365808|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83365809|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365810|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365811|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
83365812|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83365813|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83365814|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365815|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83365816|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83365817|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365818|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365819|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365820|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83365821|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
83365822|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83365823|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365824|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83365825|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83365826|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83365827|NCT05668676|Prednisone|prednisone|mesh-list
83365828|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83365829|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
83365830|NCT05668676|Hormones|hormones|mesh-ancestor
83365831|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365832|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365833|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83365834|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365835|NCT05657990|Tamsulosin|tamsulosin|mesh-list
83365836|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83365837|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83365838|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83365839|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
83365840|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365841|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365842|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365843|NCT05657990|Urological Agents|urological agents|mesh-ancestor
83365844|NCT05633381|Temozolomide|temozolomide|mesh-list
83365845|NCT05633381|Trabectedin|trabectedin|mesh-list
83365846|NCT05633381|Olaparib|olaparib|mesh-list
83365847|NCT05633381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83365848|NCT05633381|Alkylating Agents|alkylating agents|mesh-ancestor
83365849|NCT05633381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365850|NCT05633381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365851|NCT05633381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83365853|NCT05627752|Docetaxel|docetaxel|mesh-list
83365854|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365855|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
83365856|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
83365857|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
83365858|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365859|NCT05609942|Azacitidine|azacitidine|mesh-list
83365860|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83365861|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
83365862|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365863|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365864|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365865|NCT05590676|Metformin|metformin|mesh-list
83365866|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83365867|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365868|NCT05576350|Ethanol|ethanol|mesh-list
83365869|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83365870|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365871|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365872|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365873|NCT05559814|Peppermint oil|peppermint oil|mesh-list
83365874|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
83365875|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
83365876|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365877|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365878|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83365879|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
83365880|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83365881|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
83365882|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
83365883|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83365884|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365885|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365886|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365887|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83365888|NCT05505292|Lifitegrast|lifitegrast|mesh-list
83365889|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83365890|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
83365891|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365892|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365893|NCT05491317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83365894|NCT05491317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365895|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
83365896|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83365897|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365898|NCT05438420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83365899|NCT05438420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365900|NCT05419466|Melatonin|melatonin|mesh-list
83365901|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
83365902|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365903|NCT05419466|Protective Agents|protective agents|mesh-ancestor
83365904|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365905|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365906|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83365907|NCT05382481|Dalteparin|dalteparin|mesh-list
83365908|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
83365909|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83365910|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83365911|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365912|NCT05353283|Tenofovir|tenofovir|mesh-list
83365913|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
83365914|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83365915|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83365916|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83365917|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365918|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365919|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83365920|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83365921|NCT05338320|Fentanyl|fentanyl|mesh-list
83365922|NCT05338320|Morphine|morphine|mesh-list
83365923|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
83365924|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365925|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365926|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83365927|NCT05338320|Narcotics|narcotics|mesh-ancestor
83365928|NCT05338320|Analgesics|analgesics|mesh-ancestor
83365929|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
83365930|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365931|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83365932|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83365933|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
83365934|NCT05323786|Anesthetics|anesthetics|mesh-list
83365935|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83365936|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365937|NCT05304767|Xanomeline|xanomeline|mesh-list
83365938|NCT05304767|Trospium chloride|trospium chloride|mesh-list
83365939|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
83365940|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
83365941|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365942|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365943|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83365944|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83365945|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
83365946|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365947|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365948|NCT05304767|Urological Agents|urological agents|mesh-ancestor
83365949|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83365950|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83365951|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83365952|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83365953|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
83365954|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83365955|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365956|NCT05256069|Propranolol|propranolol|mesh-list
83365957|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83365958|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83365959|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
83365960|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365961|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365962|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365963|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83365964|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83365965|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
83365966|NCT05252416|Carboplatin|carboplatin|mesh-list
83365967|NCT05252416|Fulvestrant|fulvestrant|mesh-list
83365968|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83365969|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83365970|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83365971|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83365972|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
83365973|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83365974|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365975|NCT05233228|Nicotine|nicotine|mesh-list
83365976|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83365977|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
83365978|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365979|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365980|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83365981|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83365982|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
83365983|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365984|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365985|NCT05221554|Tacrine|tacrine|mesh-list
83365986|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83365987|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83365988|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83365989|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
83365990|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83365991|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83365992|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83365993|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
83365994|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83365995|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
83365996|NCT05218733|Fentanyl|fentanyl|mesh-list
83365997|NCT05218733|Morphine|morphine|mesh-list
83365998|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
83365999|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366000|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366001|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83366002|NCT05218733|Narcotics|narcotics|mesh-ancestor
83366003|NCT05218733|Analgesics|analgesics|mesh-ancestor
83366004|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
83366005|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366006|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83366007|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83366008|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
83366009|NCT05162937|Antibodies|antibodies|mesh-list
83366010|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
83366011|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366012|NCT05152147|Fluorouracil|fluorouracil|mesh-list
83366013|NCT05152147|Capecitabine|capecitabine|mesh-list
83366014|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
83366015|NCT05152147|Trastuzumab|trastuzumab|mesh-list
83366016|NCT05152147|Tislelizumab|tislelizumab|mesh-list
83366017|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366018|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
83366019|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366020|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83366021|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366022|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
83366023|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366024|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366026|NCT05108688|Mirtazapine|mirtazapine|mesh-list
83366027|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83366028|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83366029|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83366030|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
83366031|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366032|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366033|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366034|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
83366035|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83366036|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83366037|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
83366038|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
83366039|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83366040|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83366041|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366042|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83366043|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83366044|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83366045|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
83366046|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83366047|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83366048|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83366049|NCT04985500|Bupivacaine|bupivacaine|mesh-list
83366050|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
83366051|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
83366052|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366053|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366054|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
83366055|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366056|NCT04973670|Sivelestat|sivelestat|mesh-list
83366057|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83366058|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
83366059|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366060|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366061|NCT04967248|Fulvestrant|fulvestrant|mesh-list
83366062|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366063|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366064|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83366065|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83366066|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
83366067|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366068|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366069|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
83366070|NCT04929626|Albuterol|albuterol|mesh-list
83366071|NCT04929626|Analgesics|analgesics|mesh-ancestor
83366072|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
83366073|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366074|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366075|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
83366076|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366077|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83366078|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
83366079|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83366080|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83366081|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366082|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83366083|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
83366084|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366085|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83366086|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
83366087|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83366088|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
83366089|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83366090|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83366091|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83366092|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
83366093|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366094|NCT04908202|Deucravacitinib|deucravacitinib|mesh-list
83366095|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
83366096|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83366097|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366098|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366100|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366101|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366102|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
83366103|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366104|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366105|NCT04879849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366106|NCT04879849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366107|NCT04826198|Olaparib|olaparib|mesh-list
83366108|NCT04826198|Niraparib|niraparib|mesh-list
83366109|NCT04826198|Rucaparib|rucaparib|mesh-list
83366110|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83366111|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366112|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366113|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366114|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
83366115|NCT04808934|Apixaban|apixaban|mesh-list
83366116|NCT04808934|Dabigatran|dabigatran|mesh-list
83366117|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83366118|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
83366119|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83366120|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
83366121|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366122|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366123|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
83366124|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
83366125|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83366126|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83366127|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366128|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
83366129|NCT04754230|Coagulants|coagulants|mesh-ancestor
83366130|NCT04733118|Trastuzumab|trastuzumab|mesh-list
83366131|NCT04733118|Pertuzumab|pertuzumab|mesh-list
83366132|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83366133|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366134|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366135|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366136|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366137|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366138|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366139|NCT04733118|Immunotoxins|immunotoxins|mesh-ancestor
83366140|NCT04733118|Immunoconjugates|immunoconjugates|mesh-ancestor
83366141|NCT04733118|Immunologic Factors|immunologic factors|mesh-ancestor
83366142|NCT04733118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366143|NCT04699461|Idelalisib|idelalisib|mesh-list
83366144|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
83366145|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366146|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366147|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366148|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366149|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83366150|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83366151|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366152|NCT04653337|Norepinephrine|norepinephrine|mesh-list
83366154|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
83366155|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83366156|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83366157|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
83366158|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366159|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366160|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366161|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
83366162|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
83366163|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366164|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83366165|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83366166|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
83366167|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83366168|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83366169|NCT04561739|Sirolimus|sirolimus|mesh-list
83366170|NCT04561739|Paclitaxel|paclitaxel|mesh-list
83366171|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83366172|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366173|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366174|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366175|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366176|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366177|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83366178|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366179|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83366180|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
83366181|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366182|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
83366183|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366184|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83366185|NCT04539626|Estradiol|estradiol|mesh-list
83366186|NCT04539626|Estrogens|estrogens|mesh-list
83366187|NCT04539626|Hormones|hormones|mesh-ancestor
83366188|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366189|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366190|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83366191|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
83366192|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366193|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83366194|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83366195|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83366196|NCT04521348|Antibodies|antibodies|mesh-list
83366197|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
83366198|NCT04521348|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
83366199|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
83366200|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366201|NCT04521348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83366202|NCT04521348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366203|NCT04521348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366204|NCT04512534|Antibodies|antibodies|mesh-list
83366205|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
83366206|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
83366207|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366208|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366209|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366210|NCT04486118|Lisinopril|lisinopril|mesh-list
83366211|NCT04486118|Benazepril|benazepril|mesh-list
83366212|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83366213|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
83366214|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366215|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366216|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83366217|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83366218|NCT04486118|Protective Agents|protective agents|mesh-ancestor
83366219|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366220|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
83366221|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366222|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366224|NCT04442581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366225|NCT04436731|Phentolamine|phentolamine|mesh-list
83366226|NCT04436731|Phenylephrine|phenylephrine|mesh-list
83366227|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
83366228|NCT04436731|Norepinephrine|norepinephrine|mesh-list
83366229|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
83366230|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83366231|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366232|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366233|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83366234|NCT04436731|Analgesics|analgesics|mesh-ancestor
83366235|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
83366236|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366237|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83366238|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83366239|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83366240|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
83366241|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366242|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366243|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83366244|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
83366245|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
83366246|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
83366247|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83366248|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
83366249|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
83366250|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83366251|NCT04436731|Protective Agents|protective agents|mesh-ancestor
83366252|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83366253|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83366254|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83366255|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
83366256|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366257|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366258|NCT04420598|Trastuzumab|trastuzumab|mesh-list
83366259|NCT04420598|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
83366260|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366261|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366262|NCT04420598|Immunoconjugates|immunoconjugates|mesh-ancestor
83366263|NCT04420598|Immunologic Factors|immunologic factors|mesh-ancestor
83366264|NCT04420598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366265|NCT04411654|Sirolimus|sirolimus|mesh-list
83366266|NCT04411654|Prednisone|prednisone|mesh-list
83366267|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
83366268|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83366269|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83366270|NCT04411654|Prednisolone|prednisolone|mesh-list
83366271|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
83366272|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83366273|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
83366274|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366275|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
83366276|NCT04411654|Hormones|hormones|mesh-ancestor
83366277|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366278|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366279|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366280|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366281|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83366282|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366283|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83366284|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
83366285|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366286|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
83366287|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
83366288|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
83366289|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366290|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366291|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83366292|NCT04411654|Protective Agents|protective agents|mesh-ancestor
83366293|NCT04381832|Docetaxel|docetaxel|mesh-list
83366294|NCT04381832|Quemliclustat|quemliclustat|mesh-list
83366295|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366296|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366297|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366298|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366299|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366300|NCT04381832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366301|NCT04381832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366302|NCT04364230|Poly ICLC|poly iclc|mesh-list
83366303|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
83366304|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366305|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
83366306|NCT04268706|Fludarabine|fludarabine|mesh-list
83366307|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83366308|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366309|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366310|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83366311|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
83366312|NCT04223609|Oxycodone|oxycodone|mesh-list
83366313|NCT04223609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83366314|NCT04223609|Narcotics|narcotics|mesh-ancestor
83366315|NCT04223609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366316|NCT04223609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366317|NCT04223609|Analgesics|analgesics|mesh-ancestor
83366318|NCT04223609|Sensory System Agents|sensory system agents|mesh-ancestor
83366319|NCT04223609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366320|NCT04120415|Vedolizumab|vedolizumab|mesh-list
83366321|NCT04120415|Vaccines|vaccines|mesh-list
83366322|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
83366323|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366324|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366325|NCT04118920|Insulin|insulin|mesh-list
83366326|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83366327|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
83366328|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83366329|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366330|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83366331|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83366332|NCT04083144|Varenicline|varenicline|mesh-list
83366333|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83366334|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83366335|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
83366336|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366337|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366338|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366339|NCT04055818|Niacinamide|niacinamide|mesh-list
83366340|NCT04055818|Niacin|niacin|mesh-list
83366341|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
83366342|NCT04055818|Decitabine|decitabine|mesh-list
83366343|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
83366344|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83366345|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
83366346|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366347|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366348|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366349|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
83366350|NCT04055818|Vitamins|vitamins|mesh-ancestor
83366351|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
83366352|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366353|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83366354|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83366355|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
83366356|NCT04047953|Paclitaxel|paclitaxel|mesh-list
83366357|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83366358|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
83366359|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83366360|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366361|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366362|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366363|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366364|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366365|NCT03981900|Tofacitinib|tofacitinib|mesh-list
83366366|NCT03981900|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83366367|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83366368|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366369|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366370|NCT03961971|Spartalizumab|spartalizumab|mesh-list
83366371|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366372|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366373|NCT03961971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366374|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366375|NCT03958877|Interferons|interferons|mesh-list
83366376|NCT03958877|Interferon-beta|interferon-beta|mesh-list
83366377|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366378|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
83366379|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366380|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
83366381|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366382|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
83366383|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366384|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366385|NCT03954067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366386|NCT03954067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366387|NCT03941288|Cannabidiol|cannabidiol|mesh-list
83366388|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
83366389|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83366390|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83366391|NCT03864419|Prednisone|prednisone|mesh-list
83366392|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
83366393|NCT03864419|Rituximab|rituximab|mesh-list
83366394|NCT03864419|Doxorubicin|doxorubicin|mesh-list
83366395|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83366396|NCT03864419|Methotrexate|methotrexate|mesh-list
83366397|NCT03864419|Etoposide|etoposide|mesh-list
83366398|NCT03864419|Vincristine|vincristine|mesh-list
83366399|NCT03864419|Daunorubicin|daunorubicin|mesh-list
83366400|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
83366401|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83366402|NCT03864419|Antibodies|antibodies|mesh-list
83366403|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
83366404|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83366405|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366406|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
83366407|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366408|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366409|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83366410|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
83366411|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366412|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366413|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83366414|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83366415|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83366416|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83366417|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366418|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366419|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
83366420|NCT03864419|Hormones|hormones|mesh-ancestor
83366421|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366422|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366423|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83366424|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
83366425|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366426|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83366427|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
83366428|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
83366429|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83366430|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83366431|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83366432|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366433|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366434|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366435|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
83366436|NCT03859427|Dexamethasone|dexamethasone|mesh-list
83366437|NCT03859427|Lenalidomide|lenalidomide|mesh-list
83366438|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366439|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
83366440|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
83366441|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366442|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366443|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366444|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
83366445|NCT03859427|Hormones|hormones|mesh-ancestor
83366446|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366447|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366448|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366449|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
83366450|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83366451|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83366452|NCT03859427|Growth Substances|growth substances|mesh-ancestor
83366453|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
83366454|NCT03856671|Metronidazole|metronidazole|mesh-list
83366455|NCT03856671|Neomycin|neomycin|mesh-list
83366456|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366457|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83366458|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83366459|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83366460|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83366461|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366462|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366463|NCT03728361|Nivolumab|nivolumab|mesh-list
83366464|NCT03728361|Temozolomide|temozolomide|mesh-list
83366465|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366466|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366467|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366468|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366469|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83366470|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
83366471|NCT03662685|Coal Tar|coal tar|mesh-list
83366472|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
83366473|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
83366474|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
83366475|NCT03617328|Poly ICLC|poly iclc|mesh-list
83366476|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
83366477|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366478|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83366479|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
83366480|NCT03570892|Tisagenlecleucel|tisagenlecleucel|mesh-list
83366481|NCT03570892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366482|NCT03570892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366483|NCT03391934|Leucovorin|leucovorin|mesh-list
83366484|NCT03391934|Fluorouracil|fluorouracil|mesh-list
83366485|NCT03391934|Irinotecan|irinotecan|mesh-list
83366486|NCT03391934|Cetuximab|cetuximab|mesh-list
83366487|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366488|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
83366489|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366490|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83366491|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366492|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366493|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
83366494|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83366495|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83366496|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366497|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366498|NCT03391934|Antidotes|antidotes|mesh-ancestor
83366499|NCT03391934|Protective Agents|protective agents|mesh-ancestor
83366500|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
83366501|NCT03391934|Vitamins|vitamins|mesh-ancestor
83366502|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
83366503|NCT03333343|Gefitinib|gefitinib|mesh-list
83366504|NCT03333343|Trametinib|trametinib|mesh-list
83366505|NCT03333343|Nazartinib|nazartinib|mesh-list
83366506|NCT03333343|Naporafenib|naporafenib|mesh-list
83366507|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366508|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83366509|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366510|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366511|NCT03326947|Docetaxel|docetaxel|mesh-list
83366512|NCT03326947|Fluorouracil|fluorouracil|mesh-list
83366513|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366514|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366515|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366516|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366517|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366518|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
83366519|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83366520|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366521|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
83366522|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366523|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
83366524|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366525|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366526|NCT03304639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366527|NCT03304639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366528|NCT03289234|Edaravone|edaravone|mesh-list
83366529|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83366530|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
83479855|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83366531|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366532|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83366533|NCT03289234|Protective Agents|protective agents|mesh-ancestor
83366534|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366535|NCT03289208|Edaravone|edaravone|mesh-list
83366536|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83366537|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
83366538|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366539|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83366540|NCT03289208|Protective Agents|protective agents|mesh-ancestor
83366541|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366542|NCT03244059|Belimumab|belimumab|mesh-list
83366543|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366544|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
83366545|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366546|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
83366547|NCT03129555|Apixaban|apixaban|mesh-list
83366548|NCT03129555|Edoxaban|edoxaban|mesh-list
83366549|NCT03129555|Dabigatran|dabigatran|mesh-list
83366550|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83366551|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
83366552|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83366553|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
83366554|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366555|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366556|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
83366557|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
83366558|NCT03129490|Apixaban|apixaban|mesh-list
83366559|NCT03129490|Edoxaban|edoxaban|mesh-list
83366560|NCT03129490|Dabigatran|dabigatran|mesh-list
83366561|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83366562|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
83366563|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83366564|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
83366565|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366566|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366567|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
83366568|NCT03078946|Midazolam|midazolam|mesh-list
83366569|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
83366570|NCT03078946|Morphine|morphine|mesh-list
83366571|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83366572|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366573|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366574|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83366575|NCT03078946|Analgesics|analgesics|mesh-ancestor
83366576|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
83366577|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366578|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83366579|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83366580|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83366581|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
83366582|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366583|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366584|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83366585|NCT03078946|Narcotics|narcotics|mesh-ancestor
83366586|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83366587|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83366588|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83366589|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83366590|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83366591|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
83366592|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
83366593|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
83366594|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
83366595|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
83366596|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
83366597|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83366598|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366599|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366600|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
83366601|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83366602|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366603|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366604|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
83366605|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83366606|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
83366607|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366609|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
83366610|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
83366611|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366612|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366613|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366614|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83366615|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
83366616|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366617|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366618|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83366619|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366620|NCT03006302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366621|NCT02927249|Aspirin|aspirin|mesh-list
83366622|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83366623|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83366624|NCT02927249|Analgesics|analgesics|mesh-ancestor
83366625|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
83366626|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366627|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366628|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366629|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366630|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83366631|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83366632|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366633|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83366634|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83366635|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366636|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
83366637|NCT02918864|Oxytocin|oxytocin|mesh-list
83366638|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
83366639|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366640|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366641|NCT02890368|Interferons|interferons|mesh-list
83366642|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
83366643|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83366644|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
83366645|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366646|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
83366647|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366648|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366649|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
83366650|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366651|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366652|NCT02754141|Nivolumab|nivolumab|mesh-list
83366653|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366654|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366655|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366656|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366657|NCT02659059|Paclitaxel|paclitaxel|mesh-list
83366658|NCT02659059|Cisplatin|cisplatin|mesh-list
83366659|NCT02659059|Carboplatin|carboplatin|mesh-list
83366660|NCT02659059|Nivolumab|nivolumab|mesh-list
83366661|NCT02659059|Pemetrexed|pemetrexed|mesh-list
83366662|NCT02659059|Ipilimumab|ipilimumab|mesh-list
83366663|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83366664|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366665|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366666|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366667|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366668|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366669|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366670|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366671|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366672|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83366673|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83366674|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
83366675|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366676|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366677|NCT02632344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83479856|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366678|NCT02632344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366680|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
83366681|NCT01997840|Pomalidomide|pomalidomide|mesh-list
83366682|NCT01997840|Ricolinostat|ricolinostat|mesh-list
83366684|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366685|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
83366686|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
83366687|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366688|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366689|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366690|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
83366691|NCT01997840|Hormones|hormones|mesh-ancestor
83366692|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366693|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366694|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366695|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
83366696|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366697|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366698|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
83366699|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83366700|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83366701|NCT01997840|Growth Substances|growth substances|mesh-ancestor
83366702|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
83366703|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83366704|NCT01505569|Etoposide|etoposide|mesh-list
83366705|NCT01505569|Carboplatin|carboplatin|mesh-list
83366706|NCT01505569|Melphalan|melphalan|mesh-list
83366707|NCT01505569|Busulfan|busulfan|mesh-list
83366708|NCT01505569|Ifosfamide|ifosfamide|mesh-list
83366709|NCT01505569|Thiotepa|thiotepa|mesh-list
83366710|NCT01505569|Lenograstim|lenograstim|mesh-list
83366711|NCT01505569|Mesna|mesna|mesh-list
83366712|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83366713|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366714|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366715|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83366716|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83366717|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366718|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83366719|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
83366720|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83366721|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366722|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
83366723|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366724|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83366725|NCT01505569|Protective Agents|protective agents|mesh-ancestor
83366726|NCT02375178|Biguanides|biguanides|mesh-list
83366727|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
83366728|NCT02375178|Polihexanide|polihexanide|mesh-list
83366729|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83366730|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366731|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
83366732|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83366733|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366734|NCT02375100|Acetaminophen|acetaminophen|mesh-list
83366735|NCT02375100|Tramadol|tramadol|mesh-list
83366736|NCT02375100|Analgesics|analgesics|mesh-list
83366737|NCT02375100|Bupivacaine|bupivacaine|mesh-list
83366738|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
83366739|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
83366740|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366741|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366742|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
83366743|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366744|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83366745|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
83366746|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83366747|NCT02375100|Narcotics|narcotics|mesh-ancestor
83366748|NCT02364258|Atorvastatin|atorvastatin|mesh-list
83366749|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83366750|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83366751|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83366752|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
83366753|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366754|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83366755|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83366756|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366757|NCT02375022|Endostar protein|endostar protein|mesh-list
83366758|NCT02375022|Endostatins|endostatins|mesh-list
83366759|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83366760|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83366761|NCT02375022|Growth Substances|growth substances|mesh-ancestor
83366762|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366763|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
83366764|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366765|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
83366766|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83366767|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83366768|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
83366769|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366771|NCT01497275|Bortezomib|bortezomib|mesh-list
83366772|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366773|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366774|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
83366775|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366776|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366777|NCT01557517|Clobetasol|clobetasol|mesh-list
83366778|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366779|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
83366780|NCT01557517|Hormones|hormones|mesh-ancestor
83366781|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366782|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366783|NCT02363556|Misoprostol|misoprostol|mesh-list
83366784|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83366785|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
83366786|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366787|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366788|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83366789|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366790|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
83366791|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83366792|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366793|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366794|NCT01557283|Etanercept|etanercept|mesh-list
83366795|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83366796|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83366797|NCT01557283|Analgesics|analgesics|mesh-ancestor
83366798|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
83366799|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366800|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366801|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366802|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366803|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366804|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366805|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
83366806|NCT02374632|Octreotide|octreotide|mesh-list
83366807|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366808|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366809|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366810|NCT02363400|Cisplatin|cisplatin|mesh-list
83366811|NCT02363400|Epirubicin|epirubicin|mesh-list
83366812|NCT02363400|Mitomycins|mitomycins|mesh-list
83366813|NCT02363400|Mitomycin|mitomycin|mesh-list
83366814|NCT02363400|Tegafur|tegafur|mesh-list
83366815|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366816|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83366817|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83366818|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83366819|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366820|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366821|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
83366822|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83366823|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83366824|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
83366825|NCT00350025|Paclitaxel|paclitaxel|mesh-list
83366826|NCT00350025|Cetuximab|cetuximab|mesh-list
83366827|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83366828|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366829|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
83366830|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366831|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366832|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366833|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366834|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83366835|NCT01496807|Ipilimumab|ipilimumab|mesh-list
83366836|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366837|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366838|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83366839|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366840|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
83366841|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366842|NCT02374320|Bupivacaine|bupivacaine|mesh-list
83366843|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
83366844|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
83366845|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366846|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366847|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
83366848|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366849|NCT01496183|Olanzapine|olanzapine|mesh-list
83366850|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
83366851|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
83366852|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366853|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366854|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366855|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83366856|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83366857|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366858|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83366859|NCT01496183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83366860|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83366861|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83366862|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366863|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366864|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
83366865|NCT01495793|Rotigotine|rotigotine|mesh-list
83366866|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
83366867|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
83366868|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83366869|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366870|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366871|NCT02374008|Dexamethasone|dexamethasone|mesh-list
83366872|NCT02374008|Ketorolac|ketorolac|mesh-list
83366873|NCT02374008|Ropivacaine|ropivacaine|mesh-list
83366874|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366875|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
83366876|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
83366877|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366878|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366879|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366880|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
83366881|NCT02374008|Hormones|hormones|mesh-ancestor
83366882|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366883|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366884|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366885|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366886|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366887|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
83366888|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
83366889|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366890|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
83366891|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83366892|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83366893|NCT02374008|Analgesics|analgesics|mesh-ancestor
83366894|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366895|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83366896|NCT04505280|Lidocaine|lidocaine|mesh-list
83366897|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
83366898|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
83366899|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83366900|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366901|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
83366902|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366903|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83366904|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83366905|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83366906|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83366907|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366908|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
83366909|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83366910|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
83366911|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366912|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
83366913|NCT02366676|Protective Agents|protective agents|mesh-ancestor
83366914|NCT02373384|Allopurinol|allopurinol|mesh-list
83366915|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
83366916|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366917|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
83366918|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366919|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
83366920|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366921|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83366922|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
83366923|NCT02373384|Protective Agents|protective agents|mesh-ancestor
83366924|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366925|NCT02373384|Diuretics|diuretics|mesh-ancestor
83366926|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
83366927|NCT02373384|Expectorants|expectorants|mesh-ancestor
83366928|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
83366929|NCT01494467|Azelaic acid|azelaic acid|mesh-list
83366930|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366931|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
83366932|NCT02881086|Cytarabine|cytarabine|mesh-list
83366933|NCT02881086|Dexamethasone|dexamethasone|mesh-list
83366934|NCT02881086|Prednisolone|prednisolone|mesh-list
83366935|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
83366936|NCT02881086|Rituximab|rituximab|mesh-list
83366937|NCT02881086|Methotrexate|methotrexate|mesh-list
83366938|NCT02881086|Fludarabine|fludarabine|mesh-list
83366939|NCT02881086|Vincristine|vincristine|mesh-list
83366940|NCT02881086|Doxorubicin|doxorubicin|mesh-list
83366941|NCT02881086|Daunorubicin|daunorubicin|mesh-list
83366942|NCT02881086|Asparaginase|asparaginase|mesh-list
83366943|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
83366944|NCT02881086|Idarubicin|idarubicin|mesh-list
83366945|NCT02881086|Pegaspargase|pegaspargase|mesh-list
83366946|NCT02881086|Vindesine|vindesine|mesh-list
83366947|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83366948|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
83366949|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366950|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83366951|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83366952|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
83366953|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83366954|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366955|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83366956|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83366957|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83366958|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
83366959|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
83366960|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83366961|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83366962|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
83366963|NCT02881086|Hormones|hormones|mesh-ancestor
83366964|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83366965|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83366966|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83366968|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83366969|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83366970|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
83366971|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
83366972|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83366973|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83366974|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83366975|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
83366976|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83366977|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83366979|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
83366980|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
83366981|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83366982|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83366983|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83366984|NCT03922542|Riboflavin|riboflavin|mesh-list
83366985|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
83366986|NCT03922542|Vitamins|vitamins|mesh-ancestor
83366987|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
83366988|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83366989|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83366990|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
83366991|NCT01493687|Azelaic acid|azelaic acid|mesh-list
83366992|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83366993|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
83366994|NCT02362308|Eplerenone|eplerenone|mesh-list
83366995|NCT02362308|Spironolactone|spironolactone|mesh-list
83366996|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
83366997|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
83366998|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
83366999|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367000|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367001|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83367002|NCT02362308|Diuretics|diuretics|mesh-ancestor
83367003|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
83367004|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83367005|NCT02362308|Hormones|hormones|mesh-ancestor
83367006|NCT02366208|Adefovir|adefovir|mesh-list
83367007|NCT02366208|Thymalfasin|thymalfasin|mesh-list
83367008|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
83367009|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367010|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83367011|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83367012|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367013|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367014|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83367015|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
83367016|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367017|NCT02373462|Olmesartan|olmesartan|mesh-list
83367018|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
83367019|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83367020|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83367021|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367022|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83367023|NCT01523587|Afatinib|afatinib|mesh-list
83367024|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367025|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367026|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367027|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367028|NCT00310401|Albuterol|albuterol|mesh-list
83367029|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83367030|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
83367031|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367032|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367033|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83367034|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
83367035|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
83367036|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83367037|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83367038|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83367039|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83367040|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
83367041|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367042|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367043|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
83367044|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83367046|NCT00310791|Estradiol|estradiol|mesh-list
83367047|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
83367048|NCT00310791|Estrogens|estrogens|mesh-list
83367049|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83367050|NCT00310791|Progestins|progestins|mesh-list
83367051|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367052|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367053|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83367054|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
83367055|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83367056|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83367057|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83367058|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83367059|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83367060|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83367061|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
83367062|NCT02362152|Diclofenac|diclofenac|mesh-list
83367063|NCT02362152|Fluorouracil|fluorouracil|mesh-list
83367064|NCT02362152|Imiquimod|imiquimod|mesh-list
83367065|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
83367066|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367067|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83367068|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367069|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83367070|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
83367071|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367072|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83367073|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367074|NCT02362152|Analgesics|analgesics|mesh-ancestor
83367075|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
83367076|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367077|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367078|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367079|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83367080|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367081|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83367082|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
83367083|NCT01493531|Allopurinol|allopurinol|mesh-list
83367084|NCT01493531|Lesinurad|lesinurad|mesh-list
83367085|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
83367086|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367087|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367088|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
83367089|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367090|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83367091|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
83367092|NCT01493531|Protective Agents|protective agents|mesh-ancestor
83367093|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367094|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
83367095|NCT02105415|Ketamine|ketamine|mesh-list
83367096|NCT02105415|Propofol|propofol|mesh-list
83367097|NCT02105415|Etomidate|etomidate|mesh-list
83367098|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83367099|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367100|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367101|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83367102|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
83367103|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
83367104|NCT02105415|Analgesics|analgesics|mesh-ancestor
83367105|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
83367106|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367107|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83367108|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83367109|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83367110|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367111|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367112|NCT01523275|Mitomycins|mitomycins|mesh-list
83367113|NCT01523275|Mitomycin|mitomycin|mesh-list
83367114|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83367115|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367116|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
83367117|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367118|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83367119|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367120|NCT00304707|Bupropion|bupropion|mesh-list
83367121|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83367122|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
83367123|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83367124|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83367125|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83367126|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367127|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367128|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
83367129|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367130|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367131|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83367132|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83367133|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367134|NCT04409483|Ritonavir|ritonavir|mesh-list
83367135|NCT04409483|Lopinavir|lopinavir|mesh-list
83367136|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83367137|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83367138|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
83367139|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367140|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367141|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83367142|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83367143|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
83367144|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367145|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83367146|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83367147|NCT02365740|Insulin|insulin|mesh-list
83367148|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83367149|NCT02365740|Hormones|hormones|mesh-list
83367150|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83367151|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367152|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367153|NCT02437110|Ritonavir|ritonavir|mesh-list
83367154|NCT02437110|Darunavir|darunavir|mesh-list
83367155|NCT02437110|Tenofovir|tenofovir|mesh-list
83367156|NCT02437110|Dolutegravir|dolutegravir|mesh-list
83367157|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83367158|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83367159|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
83367160|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367161|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367162|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83367163|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83367164|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
83367165|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367166|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83367167|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83367168|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83367169|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83367170|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83367171|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83367172|NCT05267847|Anesthetics|anesthetics|mesh-list
83367173|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367174|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367175|NCT05267457|Vanadium|vanadium|mesh-list
83367176|NCT05267457|Trace Elements|trace elements|mesh-ancestor
83367177|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
83367178|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367179|NCT00351039|Bevacizumab|bevacizumab|mesh-list
83367180|NCT00351039|Pemetrexed|pemetrexed|mesh-list
83367181|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83367182|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83367183|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367184|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367185|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367186|NCT00351039|Growth Substances|growth substances|mesh-ancestor
83367187|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367188|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367189|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367190|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367191|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83367192|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83367193|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367194|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
83367195|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
83367196|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
83367197|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367198|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367199|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367200|NCT02372916|Ranibizumab|ranibizumab|mesh-list
83367201|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367202|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367203|NCT02372916|Growth Substances|growth substances|mesh-ancestor
83367204|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367205|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367206|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367207|NCT02361528|Sargramostim|sargramostim|mesh-list
83367208|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
83367209|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367210|NCT01572727|Paclitaxel|paclitaxel|mesh-list
83367211|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83367212|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367213|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
83367214|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
83367215|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
83367216|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367217|NCT02359266|Vitamin D|vitamin d|mesh-list
83367218|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
83367219|NCT02359266|Vitamins|vitamins|mesh-ancestor
83367220|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
83367221|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367222|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83367223|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83367224|NCT02359500|Octreotide|octreotide|mesh-list
83367225|NCT02359500|Edotreotide|edotreotide|mesh-list
83367226|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367227|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83367228|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367229|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83367230|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367231|NCT02372526|Orlistat|orlistat|mesh-list
83367232|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367233|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367234|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83367235|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83367236|NCT02985697|Midazolam|midazolam|mesh-list
83367237|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
83367238|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
83367239|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83367240|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367241|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367242|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367243|NCT02985697|Analgesics|analgesics|mesh-ancestor
83367244|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
83367245|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367246|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83367247|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83367248|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83367249|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
83367250|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367251|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367252|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83367253|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83367254|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83367255|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83367256|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83367257|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
83367258|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
83367259|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
83367260|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
83367261|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83367262|NCT02372760|Lidocaine|lidocaine|mesh-list
83367263|NCT02372760|Anesthetics|anesthetics|mesh-list
83367264|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
83367265|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367266|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367267|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
83367268|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367269|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83367270|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83367271|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83367272|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367273|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367274|NCT00352911|Mifepristone|mifepristone|mesh-list
83367275|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83367276|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
83367277|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83367278|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367279|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83367280|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83367281|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83367282|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
83367283|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83367284|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83367285|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
83367286|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367287|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
83367288|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83367289|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83367290|NCT00353301|Sirolimus|sirolimus|mesh-list
83367291|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83367292|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367293|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367294|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367295|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367296|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83367297|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367298|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83367299|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
83367300|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83367301|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
83367302|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367303|NCT02372604|Cetirizine|cetirizine|mesh-list
83367304|NCT02372604|Levocetirizine|levocetirizine|mesh-list
83367305|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83367306|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83367307|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
83367308|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
83367309|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367310|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367311|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367312|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83367313|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
83367314|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83367315|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367316|NCT02358642|Lisinopril|lisinopril|mesh-list
83367317|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
83367318|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
83367319|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
83367320|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367321|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83367322|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83367323|NCT02358642|Protective Agents|protective agents|mesh-ancestor
83367324|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367325|NCT03160248|Apremilast|apremilast|mesh-list
83367326|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83367327|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367328|NCT03160248|Analgesics|analgesics|mesh-ancestor
83367329|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
83367330|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367331|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367332|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367333|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367334|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
83367335|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83367336|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367337|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367338|NCT01522651|Dronedarone|dronedarone|mesh-list
83367340|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83367341|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367342|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367343|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83367344|NCT02372292|Furosemide|furosemide|mesh-list
83367345|NCT02372292|Diuretics|diuretics|mesh-ancestor
83367346|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
83367347|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367348|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
83367349|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367350|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367351|NCT01554241|Vitamin D|vitamin d|mesh-list
83367352|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
83367353|NCT01554241|Vitamins|vitamins|mesh-ancestor
83367354|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
83367355|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367356|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83367357|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83367358|NCT02353026|Artesunate|artesunate|mesh-list
83367359|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
83367360|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83367361|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83367362|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367363|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367364|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
83367365|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
83367366|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83367367|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
83367368|NCT01521559|Aflibercept|aflibercept|mesh-list
83367369|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367370|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367371|NCT01521559|Growth Substances|growth substances|mesh-ancestor
83367372|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367373|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367374|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367375|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
83367376|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83367377|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83367378|NCT04438980|Prednisolone|prednisolone|mesh-list
83367379|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
83367380|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83367381|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
83367382|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367383|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
83367384|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
83367385|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367386|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367387|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367389|NCT04438980|Hormones|hormones|mesh-ancestor
83367390|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367391|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83367392|NCT04438980|Protective Agents|protective agents|mesh-ancestor
83367393|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83367394|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367395|NCT03824847|Clarithromycin|clarithromycin|mesh-list
83367396|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83367397|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367398|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83367399|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367400|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367401|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83367402|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83367403|NCT01554163|Celecoxib|celecoxib|mesh-list
83367404|NCT01554163|Etoricoxib|etoricoxib|mesh-list
83367405|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83367406|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367407|NCT01554163|Analgesics|analgesics|mesh-ancestor
83367408|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
83367409|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367410|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367411|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367412|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367413|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83367414|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83367415|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367416|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367417|NCT02360826|Simvastatin|simvastatin|mesh-list
83367418|NCT02360826|Pravastatin|pravastatin|mesh-list
83367419|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83367420|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83367421|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
83367422|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367423|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83367424|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83367425|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367426|NCT02361060|Atropine|atropine|mesh-list
83367427|NCT02361060|Neostigmine|neostigmine|mesh-list
83367428|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83367429|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83367430|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83367431|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
83367432|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367433|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367434|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83367435|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
83367436|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
83367437|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
83367438|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83367439|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83367440|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
83367441|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367442|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367443|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83367444|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367445|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83367446|NCT02360982|Fentanyl|fentanyl|mesh-list
83367447|NCT02360982|Propofol|propofol|mesh-list
83367448|NCT02360982|Bupivacaine|bupivacaine|mesh-list
83367449|NCT02360982|Rocuronium|rocuronium|mesh-list
83367450|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83367451|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367452|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367453|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83367454|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
83367455|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
83367456|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83367457|NCT02360982|Narcotics|narcotics|mesh-ancestor
83367458|NCT02360982|Analgesics|analgesics|mesh-ancestor
83367459|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
83367460|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367461|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83367462|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
83367463|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83367464|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83367465|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83367466|NCT03786237|ON 01910|on 01910|mesh-list
83367467|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367468|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367469|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367470|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367471|NCT01553851|Trametinib|trametinib|mesh-list
83367472|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367473|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367474|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367475|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367476|NCT02358018|Edotreotide|edotreotide|mesh-list
83367477|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83367478|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367479|NCT01552915|Methylphenidate|methylphenidate|mesh-list
83367480|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83367481|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83367482|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367483|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83367484|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83367485|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367486|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367487|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
83367488|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367489|NCT02352714|Lidocaine|lidocaine|mesh-list
83367490|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
83367491|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
83367492|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367493|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367494|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
83367495|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367496|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83367497|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83367498|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83367499|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367500|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367501|NCT03911557|Durvalumab|durvalumab|mesh-list
83367502|NCT03911557|Tremelimumab|tremelimumab|mesh-list
83367503|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83367504|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367505|NCT00356031|Bevacizumab|bevacizumab|mesh-list
83367506|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83367507|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367508|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367509|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367510|NCT00356031|Growth Substances|growth substances|mesh-ancestor
83367511|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367512|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367513|NCT02038842|Vaccines|vaccines|mesh-list
83367514|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
83367515|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367516|NCT01790139|Simethicone|simethicone|mesh-list
83367517|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
83367518|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367519|NCT01790139|Emollients|emollients|mesh-ancestor
83367520|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
83367521|NCT02360592|Interferons|interferons|mesh-list
83367522|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
83367523|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
83367524|NCT02360592|Entecavir|entecavir|mesh-list
83367525|NCT02360592|Interleukin-2|interleukin-2|mesh-list
83367526|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367527|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
83367528|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367529|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
83367530|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367531|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367532|NCT02360592|Analgesics|analgesics|mesh-ancestor
83367533|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
83367534|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367535|NCT02360202|Clobetasol|clobetasol|mesh-list
83367536|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367537|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
83367538|NCT02360202|Hormones|hormones|mesh-ancestor
83367539|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367540|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367541|NCT00322101|Cyclosporine|cyclosporine|mesh-list
83367542|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
83367543|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
83367544|NCT00322101|Busulfan|busulfan|mesh-list
83367545|NCT00322101|Methotrexate|methotrexate|mesh-list
83367546|NCT00322101|Fludarabine|fludarabine|mesh-list
83367547|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
83367548|NCT00322101|Tacrolimus|tacrolimus|mesh-list
83367549|NCT00322101|Cyclosporins|cyclosporins|mesh-list
83367550|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83367551|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
83367552|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367553|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367554|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83367555|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
83367556|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367557|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367558|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83367559|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83367560|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
83367561|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83367562|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83367563|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
83367564|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
83367565|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367566|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83367567|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83367568|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83367569|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
83367570|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367571|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83367572|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83367573|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
83367574|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83367575|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
83367576|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367577|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
83367578|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
83367579|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367580|NCT02352402|Ticagrelor|ticagrelor|mesh-list
83367581|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83367582|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83367583|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83367584|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83367585|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
83367586|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367587|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367588|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367589|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
83367590|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83367591|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
83367592|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367593|NCT00322335|PENTA|penta|mesh-list
83367594|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
83367595|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83367596|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83367597|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367598|NCT04337970|Axitinib|axitinib|mesh-list
83367599|NCT04337970|Talazoparib|talazoparib|mesh-list
83367600|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367601|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367602|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367603|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367604|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83367605|NCT03153852|Glycolic acid|glycolic acid|mesh-list
83367606|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
83367607|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
83367608|NCT04751175|Dexamethasone|dexamethasone|mesh-list
83367609|NCT04751175|Ketamine|ketamine|mesh-list
83367610|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367611|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
83367612|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
83367613|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367614|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367615|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367616|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
83367617|NCT04751175|Hormones|hormones|mesh-ancestor
83367618|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367619|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83367620|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367621|NCT04751175|Analgesics|analgesics|mesh-ancestor
83367622|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
83367623|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83367624|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83367625|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
83367626|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
83367627|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367628|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83367629|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83367630|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367631|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367633|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83367634|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367635|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
83367636|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83367637|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83367638|NCT01792713|Sertaconazole|sertaconazole|mesh-list
83367639|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
83367640|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367641|NCT02352168|Budesonide|budesonide|mesh-list
83367642|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367643|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83367644|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
83367645|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367646|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367647|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83367648|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
83367649|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
83367651|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367652|NCT02357004|Carvedilol|carvedilol|mesh-list
83367653|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
83367654|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83367655|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83367656|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
83367657|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367658|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367659|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367660|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83367661|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
83367662|NCT02357004|Protective Agents|protective agents|mesh-ancestor
83367663|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83367664|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367665|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83367666|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
83367667|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83367668|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83367669|NCT02357004|Diuretics|diuretics|mesh-ancestor
83367670|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
83367671|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83367672|NCT01570387|Dexamethasone|dexamethasone|mesh-list
83367673|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
83367674|NCT01570387|Pomalidomide|pomalidomide|mesh-list
83367675|NCT01570387|BB 1101|bb 1101|mesh-list
83367676|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367677|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
83367678|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
83367679|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367680|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367681|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367682|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
83367683|NCT01570387|Hormones|hormones|mesh-ancestor
83367684|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367685|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83367686|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367687|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
83367688|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367689|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367690|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
83367691|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367692|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367693|NCT01570387|Growth Substances|growth substances|mesh-ancestor
83367694|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367695|NCT02348424|Solithromycin|solithromycin|mesh-list
83367696|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83367697|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367698|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
83367699|NCT01570309|Vitamin D|vitamin d|mesh-list
83367700|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83367701|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367702|NCT01570309|Vitamins|vitamins|mesh-ancestor
83367703|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
83367704|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83367705|NCT02356146|Tacrolimus|tacrolimus|mesh-list
83367706|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83367707|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
83367708|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367709|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83367710|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367711|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367712|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83367713|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
83367714|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367715|NCT01519765|Misoprostol|misoprostol|mesh-list
83367716|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83367717|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
83367718|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83367719|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367720|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83367721|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367722|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
83367723|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
83367724|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
83367725|NCT03147066|Dezocine|dezocine|mesh-list
83367726|NCT03147066|Analgesics|analgesics|mesh-ancestor
83367727|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
83367728|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367729|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367730|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83367731|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367732|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367733|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367734|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83367735|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367736|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367737|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83367738|NCT03147066|Narcotics|narcotics|mesh-ancestor
83367739|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367740|NCT02351622|Dexamethasone|dexamethasone|mesh-list
83367741|NCT02351622|Caffeic acid|caffeic acid|mesh-list
83367742|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367743|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
83367744|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
83367745|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367746|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367747|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367748|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
83367749|NCT02351622|Hormones|hormones|mesh-ancestor
83367750|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367751|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83367752|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367753|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
83367754|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367755|NCT02351622|Protective Agents|protective agents|mesh-ancestor
83367756|NCT01552603|Pancrelipase|pancrelipase|mesh-list
83367757|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367758|NCT02348190|Heparin|heparin|mesh-list
83367759|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
83367760|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83367761|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83367762|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367763|NCT01552369|Valganciclovir|valganciclovir|mesh-list
83367764|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
83367765|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367766|NCT02351232|Liraglutide|liraglutide|mesh-list
83367767|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83367768|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367769|NCT02351232|Incretins|incretins|mesh-ancestor
83367770|NCT02351232|Hormones|hormones|mesh-ancestor
83367771|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367772|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
83367773|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
83367774|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83367775|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367776|NCT02355678|Acetaminophen|acetaminophen|mesh-list
83367777|NCT02355678|Dexamethasone|dexamethasone|mesh-list
83367778|NCT02355678|Propacetamol|propacetamol|mesh-list
83367779|NCT02355678|Tramadol|tramadol|mesh-list
83367780|NCT02355678|Anesthetics|anesthetics|mesh-list
83367781|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
83367782|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367783|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
83367784|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
83367785|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367786|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367787|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367788|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
83367789|NCT02355678|Hormones|hormones|mesh-ancestor
83367790|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367791|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83367792|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367793|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367794|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367795|NCT02355678|Analgesics|analgesics|mesh-ancestor
83367796|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
83367797|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
83367798|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83367799|NCT02355678|Narcotics|narcotics|mesh-ancestor
83367800|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83367801|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367802|NCT02351310|Betamethasone|betamethasone|mesh-list
83367803|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367804|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
83367805|NCT02351310|Hormones|hormones|mesh-ancestor
83367806|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367807|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367808|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83367809|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
83367810|NCT02347878|Aprepitant|aprepitant|mesh-list
83367811|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
83367812|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
83367813|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367814|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367815|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367816|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
83367817|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367818|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367819|NCT02355522|Lidocaine|lidocaine|mesh-list
83367820|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
83367821|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
83367822|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367823|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367824|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
83367825|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367826|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83367827|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83367828|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83367829|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367830|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367831|NCT02355054|Choline|choline|mesh-list
83367832|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
83367833|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83367834|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
83367835|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367836|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83367837|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83367838|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
83367839|NCT04478448|Favipiravir|favipiravir|mesh-list
83367840|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
83367841|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367842|NCT04478526|Norepinephrine|norepinephrine|mesh-list
83367843|NCT04478526|Serotonin|serotonin|mesh-list
83367844|NCT04478526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
83367845|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
83367846|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83367847|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83367848|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
83367849|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367850|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367851|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367852|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
83367853|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
83367854|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367855|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83367856|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83367857|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
83367858|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83367859|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367860|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83367861|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83367862|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83367863|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83367864|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367865|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367866|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367867|NCT01552057|Analgesics|analgesics|mesh-ancestor
83367868|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
83367869|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367870|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
83367871|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83367872|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
83367873|NCT02350686|Capecitabine|capecitabine|mesh-list
83367874|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
83367875|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83367876|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
83367877|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367878|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367879|NCT03159078|Imipenem|imipenem|mesh-list
83367880|NCT03159078|Polymyxins|polymyxins|mesh-list
83367881|NCT03159078|Polymyxin B|polymyxin b|mesh-list
83367882|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83367883|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367884|NCT01551745|Bevacizumab|bevacizumab|mesh-list
83367885|NCT01551745|Vaccines|vaccines|mesh-list
83367886|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
83367887|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367888|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83367889|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367890|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367891|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367892|NCT01551745|Growth Substances|growth substances|mesh-ancestor
83367893|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367894|NCT02350530|Bevacizumab|bevacizumab|mesh-list
83367895|NCT02350530|Fluorouracil|fluorouracil|mesh-list
83367896|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
83367897|NCT02350530|Irinotecan|irinotecan|mesh-list
83367898|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83367899|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367900|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367901|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367902|NCT02350530|Growth Substances|growth substances|mesh-ancestor
83367903|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367904|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367905|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
83367906|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367907|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83367908|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83367909|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
83367910|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83367911|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83367912|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367913|NCT01569841|Insulin|insulin|mesh-list
83367914|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83367915|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
83367916|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83367917|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367918|NCT01550965|Adalimumab|adalimumab|mesh-list
83367919|NCT01550965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83367920|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83367921|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83367922|NCT05265819|Hormones|hormones|mesh-list
83367923|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83367924|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367925|NCT02353494|Piperaquine|piperaquine|mesh-list
83367926|NCT02353494|Artenimol|artenimol|mesh-list
83367927|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
83367928|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83367929|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83367930|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367931|NCT02353260|Docetaxel|docetaxel|mesh-list
83367932|NCT02353260|Fluorouracil|fluorouracil|mesh-list
83367933|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367934|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
83367935|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
83367936|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
83367937|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367938|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
83367939|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83367940|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83367941|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
83367942|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367943|NCT03158610|Capecitabine|capecitabine|mesh-list
83367944|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83367945|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
83367946|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367947|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367948|NCT00323739|Bevacizumab|bevacizumab|mesh-list
83367949|NCT00323739|Everolimus|everolimus|mesh-list
83367950|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83367951|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367952|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83367953|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83367954|NCT00323739|Growth Substances|growth substances|mesh-ancestor
83367955|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367956|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
83367957|NCT00323739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83367958|NCT00323739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367959|NCT00323739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367960|NCT00323739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367961|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83367962|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
83367963|NCT02350218|Alprostadil|alprostadil|mesh-list
83367964|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83367965|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
83367966|NCT02350218|Urological Agents|urological agents|mesh-ancestor
83367967|NCT00390429|Docetaxel|docetaxel|mesh-list
83367968|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83367969|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83367970|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
83367971|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
83367972|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
83367973|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367974|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83367975|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83367976|NCT02349828|Acyclovir|acyclovir|mesh-list
83367977|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
83367978|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83367979|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
83367980|NCT02353182|Remifentanil|remifentanil|mesh-list
83367981|NCT02353182|Bupivacaine|bupivacaine|mesh-list
83367982|NCT02353182|Ropivacaine|ropivacaine|mesh-list
83367983|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
83367984|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
83367985|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83367986|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83367987|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
83367988|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83367989|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83367990|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83367991|NCT02353182|Analgesics|analgesics|mesh-ancestor
83367992|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83367993|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83367994|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83367995|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
83367996|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83367997|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83367998|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83367999|NCT02353182|Narcotics|narcotics|mesh-ancestor
83368000|NCT02349516|Squalamine|squalamine|mesh-list
83368001|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83368002|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83368003|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83368004|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368005|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83368006|NCT02349516|Protective Agents|protective agents|mesh-ancestor
83368007|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368008|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368009|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83368010|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83368011|NCT02349516|Growth Substances|growth substances|mesh-ancestor
83368012|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
83368013|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83368014|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83368015|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83368016|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83368017|NCT02346084|Maraviroc|maraviroc|mesh-list
83368018|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83368019|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83368020|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368021|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83368022|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83368023|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
83368024|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368025|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83368026|NCT03149250|Hemostatics|hemostatics|mesh-list
83368027|NCT03149250|Coagulants|coagulants|mesh-ancestor
83368028|NCT00391443|Bosentan|bosentan|mesh-list
83368029|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83368030|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83368031|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368032|NCT02343432|Triamcinolone|triamcinolone|mesh-list
83368033|NCT02343432|Bupivacaine|bupivacaine|mesh-list
83368034|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368035|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
83368036|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368037|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368038|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
83368039|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368040|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368041|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
83368042|NCT02343432|Hormones|hormones|mesh-ancestor
83368043|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368044|NCT02349282|Vitamin D|vitamin d|mesh-list
83368045|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
83368046|NCT02349282|Calcifediol|calcifediol|mesh-list
83368047|NCT02349282|Vitamins|vitamins|mesh-ancestor
83368048|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
83368049|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368050|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83368051|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83368053|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
83368054|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83368055|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368056|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368057|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
83368058|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
83368059|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368060|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368061|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
83368062|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83368063|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
83368064|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368065|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368066|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83368067|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
83368068|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83368069|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
83368070|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368071|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368072|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83368073|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
83368074|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
83368075|NCT02345616|Protective Agents|protective agents|mesh-ancestor
83368076|NCT00391989|Dasatinib|dasatinib|mesh-list
83368077|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368078|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83368079|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368080|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368081|NCT03148704|Palonosetron|palonosetron|mesh-list
83368082|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
83368083|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
83368084|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368085|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368086|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368087|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83368088|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83368089|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
83368090|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368091|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368092|NCT01795287|Anesthetics|anesthetics|mesh-list
83368093|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368094|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368095|NCT04976283|Pioglitazone|pioglitazone|mesh-list
83368096|NCT04976283|Empagliflozin|empagliflozin|mesh-list
83368097|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83368098|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368099|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83368100|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368101|NCT02345304|Digoxin|digoxin|mesh-list
83368102|NCT02345304|Midazolam|midazolam|mesh-list
83368103|NCT02345304|Omeprazole|omeprazole|mesh-list
83368104|NCT02345304|Warfarin|warfarin|mesh-list
83368105|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83368106|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83368107|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368108|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368109|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83368110|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83368111|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83368112|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83368113|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
83368114|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
83368115|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
83368116|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
83368117|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368118|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368119|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
83368120|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83368121|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368122|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83368123|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368124|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83368125|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83368126|NCT02345304|Protective Agents|protective agents|mesh-ancestor
83368128|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83368129|NCT01569295|Idelalisib|idelalisib|mesh-list
83368130|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83368131|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368132|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
83368133|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368134|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368135|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83368136|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
83368137|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368138|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368139|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
83368140|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368141|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
83368142|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
83368143|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
83368144|NCT02345148|Esketamine|esketamine|mesh-list
83368145|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
83368146|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83368147|NCT00394329|Beclomethasone|beclomethasone|mesh-list
83368148|NCT00394329|Albuterol|albuterol|mesh-list
83368149|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83368150|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
83368151|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368152|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368153|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83368154|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
83368155|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
83368156|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83368157|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83368158|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83368159|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83368160|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
83368161|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368162|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368163|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368164|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
83368165|NCT00394329|Hormones|hormones|mesh-ancestor
83368166|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368167|NCT03146052|Simethicone|simethicone|mesh-list
83368168|NCT03146052|Bisacodyl|bisacodyl|mesh-list
83368169|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368170|NCT03146052|Cathartics|cathartics|mesh-ancestor
83368171|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368172|NCT03146052|Laxatives|laxatives|mesh-ancestor
83368173|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
83368174|NCT03146052|Emollients|emollients|mesh-ancestor
83368175|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
83368176|NCT01549951|Prednisone|prednisone|mesh-list
83368177|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368178|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
83368179|NCT01549951|Hormones|hormones|mesh-ancestor
83368180|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368181|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368182|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83368183|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368184|NCT03148314|Misoprostol|misoprostol|mesh-list
83368185|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83368186|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
83368187|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83368188|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368189|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83368190|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368191|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
83368192|NCT01517893|Simvastatin|simvastatin|mesh-list
83368193|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83368194|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83368195|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
83368196|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368197|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83368198|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83368199|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368200|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
83368201|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83368202|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368203|NCT01489891|Lidocaine|lidocaine|mesh-list
83368204|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368205|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
83368206|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368207|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368208|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
83368209|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368210|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83368211|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83368212|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83368213|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83368214|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368215|NCT02342574|Olorofim|olorofim|mesh-list
83368216|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
83368217|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368218|NCT03148002|Lactulose|lactulose|mesh-list
83368219|NCT03148002|Sennosides|sennosides|mesh-list
83368220|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368221|NCT03148002|Laxatives|laxatives|mesh-ancestor
83368222|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83368223|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
83368224|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368225|NCT00396201|Plerixafor|plerixafor|mesh-list
83368226|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83368227|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83368228|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
83368229|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368230|NCT03145896|Vitamin D|vitamin d|mesh-list
83368231|NCT03145896|Vitamins|vitamins|mesh-ancestor
83368232|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
83368233|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368234|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83368235|NCT02341872|Calcium|calcium|mesh-list
83368236|NCT02341872|Fluorides|fluorides|mesh-list
83368237|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83368238|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368239|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
83368240|NCT02341872|Protective Agents|protective agents|mesh-ancestor
83368241|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83368242|NCT00360399|Escitalopram|escitalopram|mesh-list
83368243|NCT00360399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83368244|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83368245|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83368246|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368247|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368248|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
83368249|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368250|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368251|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
83368252|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83368253|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83368254|NCT00360399|Analgesics|analgesics|mesh-ancestor
83368255|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
83368256|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
83368257|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83368258|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83368259|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83368260|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
83368261|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368262|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83368263|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83368264|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368265|NCT02344602|Febuxostat|febuxostat|mesh-list
83368266|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
83368267|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368268|NCT02348268|Analgesics|analgesics|mesh-list
83368269|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
83368270|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368271|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368272|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
83368273|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
83368274|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
83368275|NCT02348346|Protective Agents|protective agents|mesh-ancestor
83368276|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368277|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
83368278|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83368279|NCT00361257|Minocycline|minocycline|mesh-list
83368280|NCT00361257|Tetracycline|tetracycline|mesh-list
83368281|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83368282|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368283|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83368284|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368285|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368286|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
83368287|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
83368288|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
83368289|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368290|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368291|NCT02341638|Aspirin|aspirin|mesh-list
83368292|NCT02341638|Itraconazole|itraconazole|mesh-list
83368293|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83368294|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83368295|NCT02341638|Analgesics|analgesics|mesh-ancestor
83368296|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
83368297|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368298|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368299|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368300|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368301|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83368302|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83368303|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368304|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83368305|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83368306|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368307|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
83368308|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
83368309|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368310|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83368311|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83368312|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83368313|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
83368314|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368315|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83368316|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
83368317|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83368318|NCT02337192|Curcumin|curcumin|mesh-list
83368319|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83368320|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83368321|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368322|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
83368323|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
83368324|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83368325|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83368326|NCT02337192|Analgesics|analgesics|mesh-ancestor
83368327|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
83368328|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368329|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368330|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368331|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368332|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368333|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368334|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368335|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
83368336|NCT03111966|Grazoprevir|grazoprevir|mesh-list
83368337|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
83368338|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
83368339|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368340|NCT02343666|Plerixafor|plerixafor|mesh-list
83368341|NCT02343666|Carmustine|carmustine|mesh-list
83368342|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
83368343|NCT02343666|Lenograstim|lenograstim|mesh-list
83368344|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83368345|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
83368346|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368347|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83368348|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
83368349|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368350|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368352|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83368353|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
83368354|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368355|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368356|NCT02332356|Adalimumab|adalimumab|mesh-list
83368357|NCT02332356|Infliximab|infliximab|mesh-list
83368358|NCT02332356|Azathioprine|azathioprine|mesh-list
83368359|NCT02332356|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83368360|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368361|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368362|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
83368363|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368364|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
83368365|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368366|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83368367|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368368|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83368369|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
83368370|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368371|NCT02340936|Lenalidomide|lenalidomide|mesh-list
83368372|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
83368373|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368374|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83368375|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83368376|NCT02340936|Growth Substances|growth substances|mesh-ancestor
83368377|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
83368378|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368379|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
83368380|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83368381|NCT02337036|Tacrolimus|tacrolimus|mesh-list
83368382|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83368383|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
83368384|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368385|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83368386|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368387|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368388|NCT02336568|Oxytocin|oxytocin|mesh-list
83368389|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
83368390|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83368391|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368392|NCT05253768|Glycerol|glycerol|mesh-list
83368393|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83368394|NCT05253768|Protective Agents|protective agents|mesh-ancestor
83368395|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368396|NCT04630938|Lidocaine|lidocaine|mesh-list
83368397|NCT04630938|Morphine|morphine|mesh-list
83368398|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368399|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
83368400|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368401|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368402|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
83368403|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368404|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83368405|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83368406|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83368407|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83368408|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368409|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83368410|NCT04630938|Narcotics|narcotics|mesh-ancestor
83368411|NCT04630938|Analgesics|analgesics|mesh-ancestor
83368412|NCT04594746|Amiodarone|amiodarone|mesh-list
83368413|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83368414|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
83368415|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83368416|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83368417|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368418|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83368419|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83368420|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83368421|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368422|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83368423|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83368424|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83368426|NCT02790138|Vedolizumab|vedolizumab|mesh-list
83368427|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83368428|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368429|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83368430|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83368431|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368432|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368433|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368434|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83368435|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83368436|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368437|NCT02339844|Aripiprazole|aripiprazole|mesh-list
83368438|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
83368439|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83368440|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83368441|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83368442|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368443|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368444|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
83368445|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
83368446|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368447|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368448|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83368449|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83368450|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
83368451|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83368452|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83368453|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83368454|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83368455|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
83368456|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83368457|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368458|NCT02331576|Fentanyl|fentanyl|mesh-list
83368459|NCT02331576|Ropivacaine|ropivacaine|mesh-list
83368460|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368461|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
83368462|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368463|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368464|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
83368465|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368466|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83368467|NCT02331576|Narcotics|narcotics|mesh-ancestor
83368468|NCT02331576|Analgesics|analgesics|mesh-ancestor
83368469|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83368470|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83368471|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
83368472|NCT00400803|Bevacizumab|bevacizumab|mesh-list
83368473|NCT00400803|Carboplatin|carboplatin|mesh-list
83368474|NCT00400803|Gemcitabine|gemcitabine|mesh-list
83368475|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83368476|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368477|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83368478|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83368479|NCT00400803|Growth Substances|growth substances|mesh-ancestor
83368480|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368481|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
83368482|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83368483|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
83368484|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368485|NCT04681443|Phenol|phenol|mesh-list
83368486|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83368487|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368488|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
83368489|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
83368490|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83368491|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
83368492|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83368493|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83368494|NCT02339142|Prednisolone|prednisolone|mesh-list
83368495|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
83368496|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83368497|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
83368498|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368499|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
83368500|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
83368501|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368502|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368503|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368504|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
83368505|NCT02339142|Hormones|hormones|mesh-ancestor
83368506|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368507|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83368508|NCT02339142|Protective Agents|protective agents|mesh-ancestor
83368509|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83368510|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368511|NCT00362817|Carboplatin|carboplatin|mesh-list
83368512|NCT00362817|Temozolomide|temozolomide|mesh-list
83368513|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368514|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83368515|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
83368516|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368517|NCT02330952|Prednisone|prednisone|mesh-list
83368518|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368519|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
83368520|NCT02330952|Hormones|hormones|mesh-ancestor
83368521|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368522|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368523|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83368524|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368525|NCT02338830|Progesterone|progesterone|mesh-list
83368526|NCT02338830|Progestins|progestins|mesh-ancestor
83368527|NCT02338830|Hormones|hormones|mesh-ancestor
83368528|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368529|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368530|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83368531|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83368532|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368533|NCT00364377|Incretins|incretins|mesh-ancestor
83368534|NCT00364377|Hormones|hormones|mesh-ancestor
83368535|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368536|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83368537|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
83368538|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368539|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368540|NCT04175886|Tofacitinib|tofacitinib|mesh-list
83368541|NCT04175886|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83368542|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83368543|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368544|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368545|NCT02338674|Tenofovir|tenofovir|mesh-list
83368546|NCT02338674|Telbivudine|telbivudine|mesh-list
83368547|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
83368548|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368549|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83368550|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83368551|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368552|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368553|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83368554|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83368555|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
83368556|NCT02338518|Etoposide|etoposide|mesh-list
83368557|NCT02338518|Epirubicin|epirubicin|mesh-list
83368558|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368559|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83368560|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83368561|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83368562|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83479934|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368563|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368564|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83368565|NCT01826838|Dasatinib|dasatinib|mesh-list
83368566|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368567|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83368568|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368569|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368570|NCT00365391|Bevacizumab|bevacizumab|mesh-list
83368571|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83368572|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83368573|NCT00365391|Antibodies|antibodies|mesh-list
83368574|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
83368575|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83368576|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368577|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83368578|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83368579|NCT00365391|Growth Substances|growth substances|mesh-ancestor
83368580|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368581|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
83368582|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
83368583|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83368584|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368585|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368586|NCT03105180|Mannitol|mannitol|mesh-list
83368587|NCT03105180|Sorbitol|sorbitol|mesh-list
83368588|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83368589|NCT03105180|Diuretics|diuretics|mesh-ancestor
83368590|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
83368591|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368592|NCT03105180|Cathartics|cathartics|mesh-ancestor
83368593|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368594|NCT02331030|Ropivacaine|ropivacaine|mesh-list
83368595|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368596|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
83368597|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368598|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368599|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
83368600|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368601|NCT04270929|Folfirinox|folfirinox|mesh-list
83368602|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368603|NCT00401817|Bevacizumab|bevacizumab|mesh-list
83368604|NCT00401817|Rituximab|rituximab|mesh-list
83368605|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83368606|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368607|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83368608|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83368609|NCT00401817|Growth Substances|growth substances|mesh-ancestor
83368610|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368611|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
83368612|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
83368613|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368614|NCT04417179|Bupivacaine|bupivacaine|mesh-list
83368615|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368616|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
83368617|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368618|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368619|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
83368620|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368621|NCT02330796|Bucillamine|bucillamine|mesh-list
83368622|NCT02330796|Colchicine|colchicine|mesh-list
83368623|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
83368624|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368625|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
83368626|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
83368627|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
83368628|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368629|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368630|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83368631|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83368632|NCT02330796|Analgesics|analgesics|mesh-ancestor
83368633|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
83368634|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368635|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368636|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368637|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
83368638|NCT02330796|Protective Agents|protective agents|mesh-ancestor
83368639|NCT02330640|Clopidogrel|clopidogrel|mesh-list
83368641|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83368642|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83368643|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83368644|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83368645|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
83368646|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368647|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368648|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368649|NCT02335398|Methadone|methadone|mesh-list
83368650|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83368651|NCT02335398|Narcotics|narcotics|mesh-ancestor
83368652|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368653|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368654|NCT02335398|Analgesics|analgesics|mesh-ancestor
83368655|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
83368656|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368657|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
83368658|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
83368659|NCT02338206|Hormones|hormones|mesh-list
83368660|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368661|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368662|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
83368663|NCT02338050|Immunotoxins|immunotoxins|mesh-ancestor
83368664|NCT02338050|Immunoconjugates|immunoconjugates|mesh-ancestor
83368665|NCT02338050|Immunologic Factors|immunologic factors|mesh-ancestor
83368666|NCT02338050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368667|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368668|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83368669|NCT02330406|Anagliptin|anagliptin|mesh-list
83368670|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83368671|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368672|NCT02330406|Incretins|incretins|mesh-ancestor
83368673|NCT02330406|Hormones|hormones|mesh-ancestor
83368674|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368675|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83368676|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
83368677|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368678|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368679|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
83368680|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
83368681|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368682|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
83368683|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368684|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368685|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
83368686|NCT02337972|Povidone|povidone|mesh-list
83368687|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
83368688|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
83368689|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83368690|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368691|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
83368692|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
83368693|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
83368694|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368695|NCT02335164|Coagulants|coagulants|mesh-ancestor
83368696|NCT00365859|Aripiprazole|aripiprazole|mesh-list
83368697|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
83368698|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83368699|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83368700|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83368701|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368702|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368703|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
83368704|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
83368705|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368706|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368707|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83368708|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83368709|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
83368710|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83368711|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83368712|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83368713|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83368714|NCT02337426|Temozolomide|temozolomide|mesh-list
83368715|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83368716|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83368717|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
83368718|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368719|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368720|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
83368721|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83368722|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
83368723|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368724|NCT03664830|Plerixafor|plerixafor|mesh-list
83368725|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83368726|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83368727|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
83368728|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368729|NCT00407355|Ranibizumab|ranibizumab|mesh-list
83368730|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83368731|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83368732|NCT00407355|Growth Substances|growth substances|mesh-ancestor
83368733|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368734|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
83368735|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368736|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
83368737|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83368738|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
83368739|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368740|NCT02334462|Antacids|antacids|mesh-ancestor
83368741|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368742|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368743|NCT03144882|Curcumin|curcumin|mesh-list
83368744|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83368745|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83368746|NCT03144882|Analgesics|analgesics|mesh-ancestor
83368747|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
83368748|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368749|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368750|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368751|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368752|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368753|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368754|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368755|NCT01793259|Methotrexate|methotrexate|mesh-list
83368756|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83368757|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
83368758|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83368759|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368760|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83368761|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
83368762|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368763|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368764|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
83368765|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368766|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83368767|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83368768|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
83368769|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368770|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83368771|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83368772|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83368773|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368774|NCT03111810|Prednisolone|prednisolone|mesh-list
83368775|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83368776|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
83368777|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83368778|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
83368779|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83368780|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
83368781|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368782|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
83368783|NCT03111810|Hormones|hormones|mesh-ancestor
83368784|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83368785|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368786|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83368787|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368788|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
83368789|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
83368790|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368791|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83368792|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83368793|NCT03111810|Protective Agents|protective agents|mesh-ancestor
83368794|NCT02334150|Sufentanil|sufentanil|mesh-list
83368795|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83368796|NCT02334150|Narcotics|narcotics|mesh-ancestor
83368797|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368798|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368799|NCT02334150|Analgesics|analgesics|mesh-ancestor
83368800|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
83368801|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368802|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83368803|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83368804|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
83368805|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
83368806|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83368807|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83368808|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83368809|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368810|NCT04477590|Metformin|metformin|mesh-list
83368811|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83368812|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368813|NCT02333838|Fludarabine|fludarabine|mesh-list
83368814|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
83368815|NCT02333838|Busulfan|busulfan|mesh-list
83368816|NCT02333838|Thiotepa|thiotepa|mesh-list
83368817|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368818|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83368819|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
83368820|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368821|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83368822|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
83368823|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368824|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
83368825|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83368826|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83368827|NCT02326584|Cytarabine|cytarabine|mesh-list
83368828|NCT02326584|Daunorubicin|daunorubicin|mesh-list
83368829|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83368830|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
83368831|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368832|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368833|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
83368834|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368835|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83368836|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
83368837|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368838|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83368839|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83368840|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83368841|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368842|NCT03111342|Lidocaine|lidocaine|mesh-list
83368843|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368844|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
83368845|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368846|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368847|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
83368848|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368849|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83368850|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83368851|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83368852|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83368853|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368855|NCT03111420|Ticagrelor|ticagrelor|mesh-list
83368856|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83368857|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83368858|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83368859|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83368860|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83368861|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
83368862|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368863|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368864|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368865|NCT02333682|Vitamin D|vitamin d|mesh-list
83368866|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
83368867|NCT02333682|Calcifediol|calcifediol|mesh-list
83368868|NCT02333682|Vitamins|vitamins|mesh-ancestor
83368869|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
83368870|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368871|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83368872|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83368873|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83368874|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83368875|NCT02326350|Aspirin|aspirin|mesh-list
83368876|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83368877|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83368878|NCT02326350|Analgesics|analgesics|mesh-ancestor
83368879|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
83368880|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368881|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368882|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368883|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368884|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83368885|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83368886|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368887|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83368888|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83368889|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368890|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
83368891|NCT02326194|Vaccines|vaccines|mesh-list
83368892|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
83368893|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368894|NCT02326038|Methylphenidate|methylphenidate|mesh-list
83368895|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83368896|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368897|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83368898|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83368899|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83368900|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368901|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
83368902|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368903|NCT00970866|Folic Acid|folic acid|mesh-list
83368904|NCT00970866|Micronutrients|micronutrients|mesh-list
83368905|NCT00970866|Trace Elements|trace elements|mesh-list
83368906|NCT00970866|Hematinics|hematinics|mesh-ancestor
83368907|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
83368908|NCT00970866|Vitamins|vitamins|mesh-ancestor
83368909|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368910|NCT03145584|Bupivacaine|bupivacaine|mesh-list
83368911|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
83368912|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
83368913|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368914|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368915|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
83368916|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368917|NCT03145194|Ticagrelor|ticagrelor|mesh-list
83368918|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83368919|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83368920|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83368921|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83368922|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
83368923|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83368924|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368925|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368926|NCT05076942|Cisplatin|cisplatin|mesh-list
83368927|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368929|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
83368930|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368931|NCT02039700|Lesinurad|lesinurad|mesh-list
83368932|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
83368933|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368934|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
83368935|NCT05076474|Orlistat|orlistat|mesh-list
83368936|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368937|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368938|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83368939|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83368940|NCT02328144|Metronidazole|metronidazole|mesh-list
83368941|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368942|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83368943|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83368944|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83368945|NCT02327676|Emtricitabine|emtricitabine|mesh-list
83368946|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
83368947|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368948|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83368949|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83368950|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368951|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368952|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83368953|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83368954|NCT02333058|Treosulfan|treosulfan|mesh-list
83368955|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83368956|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
83368957|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368958|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368959|NCT03111186|Acetaminophen|acetaminophen|mesh-list
83368960|NCT03111186|Ibuprofen|ibuprofen|mesh-list
83368961|NCT03111186|Oxycodone|oxycodone|mesh-list
83368962|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83368963|NCT03111186|Analgesics|analgesics|mesh-ancestor
83368964|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
83368965|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83368966|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368967|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
83368968|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83368969|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83368970|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83368971|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83368972|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368973|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368974|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83368975|NCT03111186|Narcotics|narcotics|mesh-ancestor
83368976|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83368977|NCT02332512|Apatinib|apatinib|mesh-list
83368978|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83368979|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83368980|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368981|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368982|NCT02327754|FYX-051|fyx-051|mesh-list
83368983|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83368984|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83368985|NCT03142620|Vitamin D|vitamin d|mesh-list
83368986|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
83368987|NCT03142620|Amoxicillin|amoxicillin|mesh-list
83368988|NCT03142620|Clarithromycin|clarithromycin|mesh-list
83368989|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
83368990|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83368991|NCT03142620|Esomeprazole|esomeprazole|mesh-list
83368992|NCT03142620|Vitamins|vitamins|mesh-ancestor
83368993|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
83368994|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83368995|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83368996|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83368997|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83368998|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83368999|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83369000|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83369001|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83369002|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369003|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369004|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83369005|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83369006|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83369007|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83369008|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
83369009|NCT03110952|Vaccines|vaccines|mesh-list
83369010|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
83369011|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369012|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
83369013|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369014|NCT03110952|Protective Agents|protective agents|mesh-ancestor
83369015|NCT03110952|Vitamins|vitamins|mesh-ancestor
83369016|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
83369017|NCT03143244|Ketorolac|ketorolac|mesh-list
83369018|NCT03143244|Midazolam|midazolam|mesh-list
83369019|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
83369020|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83369021|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369022|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369023|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83369024|NCT03143244|Analgesics|analgesics|mesh-ancestor
83369025|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
83369026|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369027|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83369028|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83369029|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83369030|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
83369031|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369032|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369033|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83369034|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83369035|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83369036|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369037|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83369038|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
83369039|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
83369040|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
83369041|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
83369042|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83369043|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83369044|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83369045|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83369046|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369047|NCT03838692|Ponatinib|ponatinib|mesh-list
83369048|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369049|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369050|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369051|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369052|NCT03774186|Pancrelipase|pancrelipase|mesh-list
83369053|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83369054|NCT03505944|Venetoclax|venetoclax|mesh-list
83369055|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369056|NCT01489189|Ranibizumab|ranibizumab|mesh-list
83369057|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83369058|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83369059|NCT01489189|Growth Substances|growth substances|mesh-ancestor
83369060|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369061|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
83369062|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369063|NCT01549873|Propofol|propofol|mesh-list
83369064|NCT01549873|Desflurane|desflurane|mesh-list
83369065|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83369066|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369067|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369068|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83369069|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
83369070|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
83369071|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83369072|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
83369073|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
83369074|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369075|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
83369076|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369077|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369079|NCT01488487|Pasireotide|pasireotide|mesh-list
83369080|NCT01488487|Somatostatin|somatostatin|mesh-list
83369081|NCT01488487|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83369082|NCT01488487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369083|NCT01488487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369084|NCT01488487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369085|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83369086|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
83369087|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369088|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369089|NCT01488487|Hormones|hormones|mesh-ancestor
83369090|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369091|NCT03027115|Tamsulosin|tamsulosin|mesh-list
83369092|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83369093|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83369094|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83369095|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
83369096|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369097|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369098|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369099|NCT03027115|Urological Agents|urological agents|mesh-ancestor
83369100|NCT03026881|Paclitaxel|paclitaxel|mesh-list
83369101|NCT03026881|Apatinib|apatinib|mesh-list
83369102|NCT03026881|Fluzoparib|fluzoparib|mesh-list
83369103|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83369104|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369105|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
83369106|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
83369107|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
83369108|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369109|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369110|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369111|NCT03026881|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83369112|NCT01516879|Atorvastatin|atorvastatin|mesh-list
83369113|NCT01516879|Ezetimibe|ezetimibe|mesh-list
83369114|NCT01516879|Evolocumab|evolocumab|mesh-list
83369115|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83369116|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83369117|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
83369118|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369119|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83369120|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83369121|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369122|NCT01516879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83369123|NCT01516879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83369124|NCT01516879|Protease Inhibitors|protease inhibitors|mesh-ancestor
83369125|NCT01515865|Midodrine|midodrine|mesh-list
83369126|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
83369127|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
83369128|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369129|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369130|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83369131|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83369132|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83369133|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83369134|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
83369135|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369136|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369137|NCT01547299|Leuprolide|leuprolide|mesh-list
83369138|NCT01547299|Dutasteride|dutasteride|mesh-list
83369139|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83369140|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
83369141|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83369142|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369143|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83369144|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369145|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83369146|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83369147|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369148|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369149|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
83369150|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369151|NCT04072107|Capecitabine|capecitabine|mesh-list
83369152|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83369153|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
83369154|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369155|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369156|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83369157|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369158|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369159|NCT00411411|Incretins|incretins|mesh-ancestor
83369161|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369162|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83369163|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
83369164|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369165|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369166|NCT01794273|Phenylephrine|phenylephrine|mesh-list
83369167|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
83369169|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83369170|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
83369171|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
83369172|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369173|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369174|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
83369175|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83369176|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
83369177|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
83369178|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83369179|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83369180|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83369181|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
83369182|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369183|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369184|NCT01794273|Protective Agents|protective agents|mesh-ancestor
83369185|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83369186|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
83369187|NCT01795599|Mifepristone|mifepristone|mesh-list
83369188|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83369189|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
83369190|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83369191|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369192|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83369193|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83369194|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83369195|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
83369196|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83369197|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83369198|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
83369199|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369200|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
83369201|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83369202|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83369203|NCT01794351|Resveratrol|resveratrol|mesh-list
83369204|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
83369205|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369206|NCT01794351|Protective Agents|protective agents|mesh-ancestor
83369207|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369208|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369209|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83369210|NCT04409431|Epinephrine|epinephrine|mesh-list
83369211|NCT04409431|Racepinephrine|racepinephrine|mesh-list
83369212|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
83369213|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83369214|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83369215|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
83369216|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369217|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369218|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369219|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83369220|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83369221|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
83369222|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369223|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83369224|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
83369225|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
83369226|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
83369227|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83369228|NCT01794507|Dexamethasone|dexamethasone|mesh-list
83369230|NCT01794507|Venetoclax|venetoclax|mesh-list
83369231|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83369232|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
83369233|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
83369234|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369235|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369236|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83369237|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
83369238|NCT01794507|Hormones|hormones|mesh-ancestor
83369239|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369240|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83369241|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369242|NCT00412425|Palonosetron|palonosetron|mesh-list
83369243|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
83369244|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
83369245|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369246|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369247|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83369248|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83369249|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83369250|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
83369251|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369252|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369253|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
83369254|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83369255|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83369256|NCT05287503|Ambroxol|ambroxol|mesh-list
83369257|NCT05287503|Expectorants|expectorants|mesh-ancestor
83369258|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
83369259|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83369260|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
83369261|NCT00415857|Vaccines|vaccines|mesh-list
83369262|NCT00415857|Sargramostim|sargramostim|mesh-list
83369263|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
83369264|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369265|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369266|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369267|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369268|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369269|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
83369270|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369271|NCT03491631|Apatinib|apatinib|mesh-list
83369272|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369273|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369274|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369275|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369276|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
83369277|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83369278|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
83369279|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83369280|NCT05287035|Dexamethasone|dexamethasone|mesh-list
83369281|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
83369282|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83369283|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
83369284|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
83369285|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369286|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369287|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83369288|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
83369289|NCT05287035|Hormones|hormones|mesh-ancestor
83369290|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369291|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83369292|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369293|NCT00416793|Carboplatin|carboplatin|mesh-list
83369294|NCT00416793|Bortezomib|bortezomib|mesh-list
83369295|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369296|NCT00417417|Rilonacept|rilonacept|mesh-list
83369297|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83369298|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
83369299|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83369300|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83369301|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
83369302|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369303|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369304|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369305|NCT00420459|Aripiprazole|aripiprazole|mesh-list
83369306|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
83369307|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369308|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83369309|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83369310|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369311|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369312|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
83369313|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
83369314|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369315|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369316|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83369317|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83369318|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
83369319|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83369320|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83369321|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83369322|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83369323|NCT00420771|Gabapentin|gabapentin|mesh-list
83369324|NCT00420771|Analgesics|analgesics|mesh-ancestor
83369325|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
83369326|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369327|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369328|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
83369329|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83369330|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83369331|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369332|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369333|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83369334|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83369335|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369336|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369337|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
83369338|NCT00426153|Octreotide|octreotide|mesh-list
83369339|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83369340|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83369341|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369342|NCT04750317|Tofacitinib|tofacitinib|mesh-list
83369343|NCT04750317|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83369344|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369345|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369346|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369347|NCT01996449|Amlodipine|amlodipine|mesh-list
83369348|NCT01996449|Eplerenone|eplerenone|mesh-list
83369349|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83369350|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83369351|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369352|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369353|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83369354|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369355|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
83369356|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83369357|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
83369358|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369359|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83369360|NCT01996449|Diuretics|diuretics|mesh-ancestor
83369361|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
83369362|NCT00426855|Bortezomib|bortezomib|mesh-list
83369363|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83369364|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369365|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83369366|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
83369367|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369368|NCT01491737|Trastuzumab|trastuzumab|mesh-list
83369369|NCT01491737|Pertuzumab|pertuzumab|mesh-list
83369370|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
83369371|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83369372|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369373|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83369374|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369375|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369376|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83369377|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
83369378|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369379|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369380|NCT00427557|Rituximab|rituximab|mesh-list
83369381|NCT00427557|Fludarabine|fludarabine|mesh-list
83369382|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
83369383|NCT00427557|Melphalan|melphalan|mesh-list
83369384|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83369385|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369386|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
83369387|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369388|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83369389|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83369390|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
83369391|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369392|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83369393|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83369394|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
83369395|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83369396|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
83369397|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369398|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83369399|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369400|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369401|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
83369402|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369403|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369404|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83369405|NCT04088305|Vancomycin|vancomycin|mesh-list
83369406|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83369407|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369408|NCT00427791|Rituximab|rituximab|mesh-list
83369409|NCT00427791|Etoposide|etoposide|mesh-list
83369410|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83369411|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369412|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
83369413|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369414|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83369415|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83369416|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83369417|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83369418|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369419|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369420|NCT01487161|Triamcinolone|triamcinolone|mesh-list
83369421|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83369422|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83369423|NCT01487161|FX006|fx006|mesh-list
83369424|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83369425|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83369426|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
83369427|NCT01487161|Hormones|hormones|mesh-ancestor
83369428|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369429|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369430|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83369431|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
83369432|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369433|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369434|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
83369435|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83369436|NCT00429507|Analgesics|analgesics|mesh-ancestor
83369437|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
83369438|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369439|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369440|NCT01794897|Valacyclovir|valacyclovir|mesh-list
83369441|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
83369442|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369443|NCT01794975|Ketamine|ketamine|mesh-list
83369444|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
83369445|NCT01794975|Analgesics|analgesics|mesh-ancestor
83369446|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
83369447|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369448|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369449|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83369450|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83369451|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
83369453|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369454|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83369455|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83369456|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369457|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369458|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83369459|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83369460|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369461|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
83369462|NCT05285787|Menaquinone 7|menaquinone 7|mesh-list
83369463|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
83369464|NCT05285787|Coagulants|coagulants|mesh-ancestor
83369465|NCT01491035|Vortioxetine|vortioxetine|mesh-list
83369466|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
83369467|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369468|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83369469|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83369470|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369471|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369472|NCT01491035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83369473|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83369474|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369475|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369476|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369477|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
83369478|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83369479|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83369480|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83369481|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83369482|NCT00375999|Docetaxel|docetaxel|mesh-list
83369483|NCT00375999|Epirubicin|epirubicin|mesh-list
83369484|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369485|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
83369486|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
83369487|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
83369488|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369489|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83369490|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83369491|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83369492|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369493|NCT04409327|Dactolisib|dactolisib|mesh-list
83369494|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369495|NCT01488071|Vortioxetine|vortioxetine|mesh-list
83369496|NCT01488071|Agomelatine|agomelatine|mesh-list
83369497|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
83369498|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369499|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83369500|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83369501|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369502|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369503|NCT01488071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83369504|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83369505|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369506|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369507|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369508|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
83369509|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83369510|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83369511|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83369512|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83369513|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83369514|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83369515|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83369516|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83369517|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369518|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369520|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369521|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83369522|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
83369523|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369524|NCT01484951|Timolol|timolol|mesh-list
83369525|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83369526|NCT01484951|Brinzolamide|brinzolamide|mesh-list
83369527|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83369528|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83369529|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83369530|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
83369531|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369532|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369533|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369534|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83369535|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83369536|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83369537|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369538|NCT01484873|Exenatide|exenatide|mesh-list
83369539|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369540|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369541|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83369542|NCT01484873|Incretins|incretins|mesh-ancestor
83369543|NCT01484873|Hormones|hormones|mesh-ancestor
83369544|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369545|NCT01486927|Factor VIII|factor viii|mesh-list
83369546|NCT01486927|Coagulants|coagulants|mesh-ancestor
83369547|NCT00379197|Naltrexone|naltrexone|mesh-list
83369548|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83369549|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83369550|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369551|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
83369552|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369553|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83369554|NCT01513759|Plasminogen|plasminogen|mesh-list
83369555|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83369556|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83369557|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369558|NCT01484561|Tofacitinib|tofacitinib|mesh-list
83369559|NCT01484561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83369560|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369561|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369562|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369563|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
83369564|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83369565|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
83369566|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369567|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369568|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83369569|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
83369570|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
83369571|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83369572|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
83369573|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369574|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369575|NCT01485991|Simeprevir|simeprevir|mesh-list
83369576|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
83369577|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369578|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
83369579|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369580|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369581|NCT00379821|Azithromycin|azithromycin|mesh-list
83369582|NCT00379821|Artesunate|artesunate|mesh-list
83369583|NCT00379821|Chloroquine|chloroquine|mesh-list
83369584|NCT00379821|Atovaquone|atovaquone|mesh-list
83369585|NCT00379821|Proguanil|proguanil|mesh-list
83369586|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
83369587|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83369588|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369590|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83369591|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83369592|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369593|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
83369594|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
83369596|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
83369597|NCT00379821|Amebicides|amebicides|mesh-ancestor
83369598|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83369599|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369600|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369601|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
83369602|NCT01482767|Interferons|interferons|mesh-list
83369603|NCT01482767|Ribavirin|ribavirin|mesh-list
83369604|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
83369605|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
83369606|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83369607|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369608|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
83369609|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369610|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
83369611|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369612|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
83369613|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369614|NCT00435591|Conivaptan|conivaptan|mesh-list
83369615|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83369616|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369617|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
83369618|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369619|NCT00439335|Vaccines|vaccines|mesh-list
83369620|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
83369621|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369622|NCT01545817|Everolimus|everolimus|mesh-list
83369623|NCT01545817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83369624|NCT01545817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369625|NCT01545817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369626|NCT01545817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369627|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83369628|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
83369629|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369630|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369631|NCT01512979|Metformin|metformin|mesh-list
83369632|NCT01512979|Linagliptin|linagliptin|mesh-list
83369633|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369634|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369635|NCT01512979|Incretins|incretins|mesh-ancestor
83369636|NCT01512979|Hormones|hormones|mesh-ancestor
83369637|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369638|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83369639|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
83369640|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369641|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369642|NCT00383565|Romidepsin|romidepsin|mesh-list
83369643|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83369644|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369645|NCT00383565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83369646|NCT00383565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369647|NCT00383565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369648|NCT01512745|Apatinib|apatinib|mesh-list
83369649|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369650|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369651|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369652|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369653|NCT01478321|Bevacizumab|bevacizumab|mesh-list
83369654|NCT01478321|Temozolomide|temozolomide|mesh-list
83369655|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83369656|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369657|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83369658|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83369659|NCT01478321|Growth Substances|growth substances|mesh-ancestor
83369660|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369661|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
83369662|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83369663|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
83369664|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369666|NCT01544491|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83369667|NCT01544491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369668|NCT01544491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369669|NCT01544491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369670|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83369671|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
83369672|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369673|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369675|NCT00383643|Zolpidem|zolpidem|mesh-list
83369676|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83369677|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83369678|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369679|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369680|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
83369681|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
83369682|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
83369683|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369684|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369685|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83369686|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83369687|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
83369688|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
83369689|NCT00439413|Selegiline|selegiline|mesh-list
83369690|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
83369691|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369692|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83369693|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83369694|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83369695|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369696|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369697|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83369698|NCT00439413|Protective Agents|protective agents|mesh-ancestor
83369699|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369700|NCT01477853|Metformin|metformin|mesh-list
83369701|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83369702|NCT01477853|Glimepiride|glimepiride|mesh-list
83369703|NCT01477853|Atorvastatin|atorvastatin|mesh-list
83369704|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369705|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369706|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83369707|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83369708|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
83369709|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369710|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83369711|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83369712|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369713|NCT01477853|Incretins|incretins|mesh-ancestor
83369714|NCT01477853|Hormones|hormones|mesh-ancestor
83369715|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369716|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83369717|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
83369718|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83369719|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83369720|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
83369721|NCT00440505|Nicotine|nicotine|mesh-list
83369722|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83369723|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
83369724|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369725|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369726|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83369727|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83369728|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
83369729|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369730|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369731|NCT00441285|Albendazole|albendazole|mesh-list
83369732|NCT00441285|Praziquantel|praziquantel|mesh-list
83369733|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
83369734|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83369735|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369736|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
83369737|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83369738|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83369739|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
83369740|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
83369741|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
83369742|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369743|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369744|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83369745|NCT01796613|Desogestrel|desogestrel|mesh-list
83369746|NCT01796613|Etonogestrel|etonogestrel|mesh-list
83369747|NCT01796613|NuvaRing|nuvaring|mesh-list
83369748|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83369749|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83369750|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83369751|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
83369752|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83369753|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369754|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83369755|NCT01796613|Estrogens|estrogens|mesh-ancestor
83369756|NCT01796613|Hormones|hormones|mesh-ancestor
83369757|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369758|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83369759|NCT01796613|Progestins|progestins|mesh-ancestor
83369760|NCT00442611|Abatacept|abatacept|mesh-list
83369761|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83369762|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369763|NCT00442611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83369764|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369765|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83369766|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
83369767|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369768|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83369769|NCT01511107|Amoxicillin|amoxicillin|mesh-list
83369770|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
83369771|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
83369772|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83369773|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83369774|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369775|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83369776|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369777|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369778|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83369779|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
83369780|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369781|NCT00442689|Flutamide|flutamide|mesh-list
83369782|NCT00442689|Drospirenone|drospirenone|mesh-list
83369783|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83369784|NCT00442689|Estradiol|estradiol|mesh-list
83369785|NCT00442689|Estrogens|estrogens|mesh-ancestor
83369786|NCT00442689|Hormones|hormones|mesh-ancestor
83369787|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369788|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369789|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83369790|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
83369791|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83369792|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83369793|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83369794|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83369795|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83369796|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
83369797|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83369798|NCT00442689|Diuretics|diuretics|mesh-ancestor
83369799|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
83369800|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
83369801|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83369802|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369803|NCT01484977|Lacosamide|lacosamide|mesh-list
83369804|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
83369805|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83369806|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83369807|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369808|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369809|NCT00442767|Insulin|insulin|mesh-list
83369810|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83369811|NCT00442767|Pramlintide|pramlintide|mesh-list
83369812|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
83369813|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369814|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369815|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
83369816|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83369817|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
83369818|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369820|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83369821|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83369822|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369823|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83369824|NCT00389493|Risperidone|risperidone|mesh-list
83369825|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83369826|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
83369827|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369828|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369829|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369830|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83369831|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83369832|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369833|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369834|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83369835|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
83369836|NCT04388709|Interferons|interferons|mesh-list
83369837|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369838|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
83369839|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83369840|NCT00389805|Pemetrexed|pemetrexed|mesh-list
83369841|NCT00389805|Bortezomib|bortezomib|mesh-list
83369842|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369843|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369844|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369845|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83369846|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83369847|NCT00456807|Vaccines|vaccines|mesh-list
83369848|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
83369849|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369850|NCT00456885|Exenatide|exenatide|mesh-list
83369851|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369852|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369853|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83369854|NCT00456885|Incretins|incretins|mesh-ancestor
83369855|NCT00456885|Hormones|hormones|mesh-ancestor
83369856|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369857|NCT01475825|Mipomersen|mipomersen|mesh-list
83369858|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83369859|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83369860|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
83369861|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369862|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83369863|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
83369864|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
83369865|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83369866|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83369867|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83369868|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83369869|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369870|NCT01484431|Tadalafil|tadalafil|mesh-list
83369871|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
83369872|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83369873|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83369874|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369875|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369876|NCT01484431|Urological Agents|urological agents|mesh-ancestor
83369877|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
83369878|NCT00445887|Norgestrel|norgestrel|mesh-list
83369879|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83369880|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
83369881|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83369882|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369883|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83369884|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83369885|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83369886|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83369887|NCT01473953|Liraglutide|liraglutide|mesh-list
83369888|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369889|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369891|NCT01473953|Hormones|hormones|mesh-ancestor
83369892|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369893|NCT00457977|Vaccines|vaccines|mesh-list
83369894|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83369895|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
83369896|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369897|NCT01473563|Pemetrexed|pemetrexed|mesh-list
83369898|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369899|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369900|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369901|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83369902|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83369903|NCT01795209|Ranibizumab|ranibizumab|mesh-list
83369904|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83369905|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83369906|NCT01795209|Growth Substances|growth substances|mesh-ancestor
83369907|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369908|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
83369909|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369910|NCT01484275|Siltuximab|siltuximab|mesh-list
83369911|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369912|NCT01484197|Maleic acid|maleic acid|mesh-list
83369913|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369914|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369915|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
83369916|NCT01473407|Hematinics|hematinics|mesh-ancestor
83369917|NCT04082897|Atezolizumab|atezolizumab|mesh-list
83369918|NCT04082897|Venetoclax|venetoclax|mesh-list
83369919|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
83369920|NCT04082897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83369921|NCT04082897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369922|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83369923|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369924|NCT01544179|Pemetrexed|pemetrexed|mesh-list
83369925|NCT01544179|Gefitinib|gefitinib|mesh-list
83369926|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83369927|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369928|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369929|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83369930|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83369931|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83369932|NCT01483651|Insulin|insulin|mesh-list
83369933|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83369934|NCT01483651|Glucagon|glucagon|mesh-list
83369935|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369936|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369937|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83369938|NCT01483651|Hormones|hormones|mesh-ancestor
83369939|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83369940|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
83369941|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83369942|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369943|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369944|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83369945|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83369946|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369947|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
83369948|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369949|NCT01482169|Adenosine|adenosine|mesh-list
83369950|NCT01482169|Regadenoson|regadenoson|mesh-list
83369951|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
83369952|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
83369953|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
83369954|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
83369955|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369956|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369957|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369958|NCT01482169|Analgesics|analgesics|mesh-ancestor
83369959|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
83369960|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83369961|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83369962|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
83369963|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
83369964|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83369965|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369966|NCT01509547|Varenicline|varenicline|mesh-list
83369967|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83369968|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83369969|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
83369970|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369971|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369972|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369973|NCT01509079|Vitamin D|vitamin d|mesh-list
83369974|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
83369975|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
83369976|NCT01509079|Vitamins|vitamins|mesh-list
83369977|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
83369978|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369979|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83369980|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83369981|NCT04650217|Levodopa|levodopa|mesh-list
83369982|NCT04650217|Carbidopa|carbidopa|mesh-list
83369983|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
83369984|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83369985|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83369986|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
83369987|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83369988|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83369989|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83369990|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
83369991|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83369992|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83369993|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
83369994|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
83369995|NCT01462435|Celecoxib|celecoxib|mesh-list
83369996|NCT01462435|Diclofenac|diclofenac|mesh-list
83369997|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83369998|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83369999|NCT01462435|Analgesics|analgesics|mesh-ancestor
83370000|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
83370001|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370002|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370003|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370004|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370005|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83370006|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83370007|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370008|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370009|NCT01472081|Nivolumab|nivolumab|mesh-list
83370010|NCT01472081|Ipilimumab|ipilimumab|mesh-list
83370011|NCT01472081|Sunitinib|sunitinib|mesh-list
83370012|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370013|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370014|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370015|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370016|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370017|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370018|NCT01472081|Growth Substances|growth substances|mesh-ancestor
83370019|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370020|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370021|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83370022|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370023|NCT01471691|Ranibizumab|ranibizumab|mesh-list
83370024|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370025|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370026|NCT01471691|Growth Substances|growth substances|mesh-ancestor
83370027|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370028|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370029|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370030|NCT01471379|Milnacipran|milnacipran|mesh-list
83370031|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
83370032|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83370033|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83370034|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370035|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370036|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370037|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370038|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83370039|NCT01471379|Analgesics|analgesics|mesh-ancestor
83370040|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
83370041|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370042|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
83370043|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83370044|NCT01470989|Triamcinolone|triamcinolone|mesh-list
83370045|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
83370046|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
83370047|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
83370048|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370049|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
83370050|NCT01470989|Hormones|hormones|mesh-ancestor
83370051|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370052|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370053|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370054|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
83370055|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370056|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370057|NCT01470599|Tofacitinib|tofacitinib|mesh-list
83370058|NCT01470599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83370059|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83370060|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370061|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370062|NCT01469819|Lubiprostone|lubiprostone|mesh-list
83370063|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83370064|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370065|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370066|NCT04618523|Artesunate|artesunate|mesh-list
83370067|NCT04618523|Lumefantrine|lumefantrine|mesh-list
83370068|NCT04618523|Artemether|artemether|mesh-list
83370069|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83370070|NCT04618523|Amodiaquine|amodiaquine|mesh-list
83370071|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
83370072|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83370073|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83370074|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370075|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370076|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
83370077|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
83370078|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
83370079|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
83370080|NCT01507831|Alirocumab|alirocumab|mesh-list
83370081|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83370082|NCT01507831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83370083|NCT01507831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83370084|NCT01507831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83370085|NCT01507831|Antimetabolites|antimetabolites|mesh-ancestor
83370086|NCT01507831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370087|NCT01507831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83370088|NCT01507831|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370089|NCT01507831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370090|NCT01507831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83370091|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
83370092|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370093|NCT01479439|Losartan|losartan|mesh-list
83370094|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83370095|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83370096|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83370097|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83370098|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370099|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
83370100|NCT01478971|Hematinics|hematinics|mesh-ancestor
83370101|NCT01507051|Vitamin K|vitamin k|mesh-list
83370102|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
83370103|NCT01507051|Warfarin|warfarin|mesh-list
83370104|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
83370105|NCT01507051|Vitamins|vitamins|mesh-ancestor
83370106|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
83370107|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370108|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
83370109|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83370110|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
83370111|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83370112|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370113|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370114|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370115|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83370116|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83370117|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
83370118|NCT01507051|Coagulants|coagulants|mesh-ancestor
83370119|NCT04079257|Eculizumab|eculizumab|mesh-list
83370120|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
83370121|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370122|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
83370123|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370124|NCT01478113|Amphetamine|amphetamine|mesh-list
83370126|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
83370127|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83370128|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370129|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
83370130|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
83370131|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370132|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
83370133|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370134|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370135|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
83370136|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83370137|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83370138|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370139|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83370140|NCT01506271|Imipenem|imipenem|mesh-list
83370141|NCT01506271|Relebactam|relebactam|mesh-list
83370142|NCT01506271|Cilastatin|cilastatin|mesh-list
83370143|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370144|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370145|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370146|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370147|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370148|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83370149|NCT01506193|Vaccines|vaccines|mesh-list
83370150|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
83370151|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370152|NCT01505881|Warfarin|warfarin|mesh-list
83370153|NCT01505881|Dabigatran|dabigatran|mesh-list
83370154|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
83370155|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
83370156|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83370157|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370158|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370159|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370160|NCT01505647|Vaccines|vaccines|mesh-list
83370161|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
83370162|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370163|NCT01477333|Treprostinil|treprostinil|mesh-list
83370164|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83370165|NCT01505491|Adalimumab|adalimumab|mesh-list
83370166|NCT01505491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83370167|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370168|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370169|NCT01504867|Aspirin|aspirin|mesh-list
83370170|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83370171|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83370172|NCT01504867|Analgesics|analgesics|mesh-ancestor
83370173|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
83370174|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370175|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370176|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370177|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370178|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83370179|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83370180|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370181|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83370182|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83370183|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370184|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
83370185|NCT01476475|Insulin|insulin|mesh-list
83370186|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83370187|NCT01476475|Metformin|metformin|mesh-list
83370188|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
83370189|NCT01476475|Lixisenatide|lixisenatide|mesh-list
83370190|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83370191|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370192|NCT01460719|Vaccines|vaccines|mesh-list
83370193|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
83370194|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370195|NCT00527943|Vorapaxar|vorapaxar|mesh-list
83370196|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83370197|NCT00448227|Famciclovir|famciclovir|mesh-list
83370198|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
83370199|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370200|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83370201|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370202|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370203|NCT00529191|Atorvastatin|atorvastatin|mesh-list
83370204|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83370205|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83370206|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
83370207|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370208|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83370209|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83370210|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370211|NCT00449007|Bupropion|bupropion|mesh-list
83370212|NCT00449007|Fluoxetine|fluoxetine|mesh-list
83370213|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83370214|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
83370215|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83370216|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83370217|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83370218|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370219|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370220|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
83370221|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370222|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370223|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83370224|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370225|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370226|NCT00449007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83370227|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
83370228|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
83370229|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370230|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370231|NCT03331731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370232|NCT03331731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370233|NCT00460551|Zalutumumab|zalutumumab|mesh-list
83370234|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370235|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370236|NCT01468181|Dulaglutide|dulaglutide|mesh-list
83370237|NCT01468181|Biguanides|biguanides|mesh-list
83370238|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
83370239|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
83370240|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83370241|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370242|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370243|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370244|NCT01693562|Durvalumab|durvalumab|mesh-list
83370245|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370246|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370247|NCT00461097|Immunomodulating Agents|immunomodulating agents|mesh-list
83370248|NCT00461097|Immunologic Factors|immunologic factors|mesh-ancestor
83370249|NCT00461097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370250|NCT00531453|Thalidomide|thalidomide|mesh-list
83370251|NCT00531453|Dexamethasone|dexamethasone|mesh-list
83370252|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
83370253|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
83370254|NCT00531453|Bortezomib|bortezomib|mesh-list
83370255|NCT00531453|BB 1101|bb 1101|mesh-list
83370256|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370257|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
83370258|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370259|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370260|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83370261|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
83370262|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370263|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370264|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83370265|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370266|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
83370267|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
83370268|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370269|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83370270|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
83370271|NCT00531453|Hormones|hormones|mesh-ancestor
83370272|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370273|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83370274|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370275|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370276|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
83370277|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370278|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370279|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370280|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370281|NCT00531453|Growth Substances|growth substances|mesh-ancestor
83370282|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370283|NCT00531843|PENTA|penta|mesh-list
83370284|NCT00531843|Fondaparinux|fondaparinux|mesh-list
83370285|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83370286|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
83370287|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83370288|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370289|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370290|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370291|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
83370292|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83370293|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83370294|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
83370295|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
83370296|NCT01590758|Pexiganan|pexiganan|mesh-list
83370297|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370298|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370299|NCT00534417|Capecitabine|capecitabine|mesh-list
83370300|NCT00534417|Fulvestrant|fulvestrant|mesh-list
83370301|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83370302|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
83370303|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370304|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370305|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83370306|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83370307|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83370308|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
83370309|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370310|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370311|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
83370312|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83370313|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83370314|NCT01692626|Analgesics|analgesics|mesh-ancestor
83370315|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
83370316|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370317|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370318|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370319|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370320|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
83370321|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370322|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
83370323|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83370324|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370325|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370326|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83370327|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83370328|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370329|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370330|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
83370331|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370332|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370333|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83370334|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83370335|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370336|NCT01475461|Incretins|incretins|mesh-ancestor
83370337|NCT01475461|Hormones|hormones|mesh-ancestor
83370338|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370339|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83370340|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370341|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370342|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370343|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
83370344|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
83370345|NCT01589822|Coagulants|coagulants|mesh-ancestor
83370346|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
83370347|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83370348|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83370349|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
83370350|NCT01474993|Sulforaphane|sulforaphane|mesh-list
83370351|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83370352|NCT01474993|Protective Agents|protective agents|mesh-ancestor
83370353|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370354|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370355|NCT01691768|Tenofovir|tenofovir|mesh-list
83370356|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
83370357|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370358|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83370359|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83370360|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370361|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370362|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83370363|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83370364|NCT01503229|Prednisone|prednisone|mesh-list
83370365|NCT01503229|Cortisone|cortisone|mesh-list
83370366|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
83370367|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370368|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
83370369|NCT01503229|Hormones|hormones|mesh-ancestor
83370370|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370371|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370372|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83370373|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370374|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83370375|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370376|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370377|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
83370378|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370379|NCT01460407|Clarithromycin|clarithromycin|mesh-list
83370380|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370381|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370382|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83370383|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370384|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370385|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83370386|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370387|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
83370388|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370389|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
83370390|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83370391|NCT01588496|Evolocumab|evolocumab|mesh-list
83370392|NCT01588496|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83370393|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83370394|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83370395|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
83370396|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370397|NCT01588496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83370398|NCT01588496|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370399|NCT01588496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370400|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83370401|NCT01502293|Interleukin-12|interleukin-12|mesh-list
83370402|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83370403|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
83370404|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370405|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370406|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370407|NCT01502293|Growth Substances|growth substances|mesh-ancestor
83370408|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370409|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370411|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370412|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370413|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370414|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370415|NCT01588184|Growth Substances|growth substances|mesh-ancestor
83370416|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370417|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370418|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83370419|NCT01564862|Vortioxetine|vortioxetine|mesh-list
83370420|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83370421|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83370422|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370423|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370424|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370425|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370426|NCT01564862|Analgesics|analgesics|mesh-ancestor
83370427|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
83370428|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370429|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
83370430|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83370431|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
83370432|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83370433|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83370434|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370435|NCT01564862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83370436|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
83370437|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83370438|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83370439|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83370440|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83370441|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
83370442|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370443|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370444|NCT04857164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370445|NCT04857164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370446|NCT01467479|Interferons|interferons|mesh-list
83370447|NCT01467479|Ribavirin|ribavirin|mesh-list
83370448|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
83370449|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
83370450|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83370451|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83370452|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370453|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
83370454|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370455|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
83370456|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370457|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
83370458|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370459|NCT01466387|Vaccines|vaccines|mesh-list
83370460|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
83370461|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370462|NCT00535743|Bromides|bromides|mesh-list
83370463|NCT00535743|Rocuronium|rocuronium|mesh-list
83370464|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
83370465|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83370466|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83370467|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83370468|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370469|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370470|NCT01564784|Cytarabine|cytarabine|mesh-list
83370471|NCT01564784|Fludarabine|fludarabine|mesh-list
83370472|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
83370473|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
83370474|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370475|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83370476|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
83370477|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370478|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370479|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
83370480|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370481|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
83370482|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370483|NCT01564784|Analgesics|analgesics|mesh-ancestor
83370484|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
83370485|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370486|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83370487|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83370488|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370489|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370490|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83370491|NCT01564784|Immunotoxins|immunotoxins|mesh-ancestor
83370492|NCT01564784|Immunoconjugates|immunoconjugates|mesh-ancestor
83370493|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
83370495|NCT00536601|Busulfan|busulfan|mesh-list
83370496|NCT00536601|Thiotepa|thiotepa|mesh-list
83370497|NCT00536601|Carmustine|carmustine|mesh-list
83370498|NCT00536601|Carboplatin|carboplatin|mesh-list
83370500|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
83370501|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370502|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
83370503|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370504|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370505|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83370506|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
83370507|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370508|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370509|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83370510|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83370511|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83370512|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83370513|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370514|NCT00536913|Budesonide|budesonide|mesh-list
83370515|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
83370516|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
83370517|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370518|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83370519|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
83370520|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370521|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370522|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83370523|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
83370524|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
83370525|NCT00536913|Hormones|hormones|mesh-ancestor
83370526|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370527|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83370528|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83370529|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83370530|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
83370531|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370532|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370533|NCT00462423|Bevacizumab|bevacizumab|mesh-list
83370534|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83370535|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370536|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370537|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370538|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370539|NCT00462423|Growth Substances|growth substances|mesh-ancestor
83370540|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370541|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370542|NCT00461331|Insulin|insulin|mesh-list
83370543|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83370544|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
83370545|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
83370546|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
83370547|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
83370548|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83370549|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370550|NCT00462735|Fluorouracil|fluorouracil|mesh-list
83370551|NCT00462735|Cetuximab|cetuximab|mesh-list
83370552|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
83370553|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
83370554|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370555|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83370556|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370557|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370558|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
83370559|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370560|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370561|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
83370562|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370563|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83370564|NCT01690988|Ketamine|ketamine|mesh-list
83370565|NCT01690988|Analgesics|analgesics|mesh-ancestor
83370566|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
83370567|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370568|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370569|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83370570|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83370571|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
83370573|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370574|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83370575|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83370576|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370577|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370578|NCT00463437|Vaccines|vaccines|mesh-list
83370579|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83370580|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
83370581|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370582|NCT01466153|Rituximab|rituximab|mesh-list
83370583|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83370584|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370585|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370586|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
83370587|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370588|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370589|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83370590|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
83370591|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370592|NCT00464685|Dexamethasone|dexamethasone|mesh-list
83370593|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83370594|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
83370595|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
83370596|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370597|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370598|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83370599|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
83370600|NCT00464685|Hormones|hormones|mesh-ancestor
83370601|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370602|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83370603|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370604|NCT01465997|Lacosamide|lacosamide|mesh-list
83370605|NCT01465997|Carbamazepine|carbamazepine|mesh-list
83370606|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
83370607|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83370608|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83370609|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370610|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370611|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
83370612|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83370613|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370614|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370615|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83370616|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83370617|NCT01465997|Analgesics|analgesics|mesh-ancestor
83370618|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
83370619|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370620|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83370621|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83370622|NCT00538863|Fentanyl|fentanyl|mesh-list
83370623|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83370624|NCT00538863|Narcotics|narcotics|mesh-ancestor
83370625|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370626|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370627|NCT00538863|Analgesics|analgesics|mesh-ancestor
83370628|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
83370629|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370630|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83370631|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83370632|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
83370633|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
83370634|NCT04345341|Bupivacaine|bupivacaine|mesh-list
83370635|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
83370636|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
83370637|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370638|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370639|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
83370640|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370641|NCT01465763|Tofacitinib|tofacitinib|mesh-list
83370642|NCT01465763|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83370643|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83370644|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370645|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370646|NCT00540579|Gemcitabine|gemcitabine|mesh-list
83370647|NCT00540579|Pomalidomide|pomalidomide|mesh-list
83370648|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83370649|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
83370650|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370651|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370652|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
83370653|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370654|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370655|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370656|NCT00540579|Growth Substances|growth substances|mesh-ancestor
83370657|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370658|NCT01690520|Cyclosporine|cyclosporine|mesh-list
83370659|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
83370660|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
83370661|NCT01690520|Thiotepa|thiotepa|mesh-list
83370662|NCT01690520|Fludarabine|fludarabine|mesh-list
83370663|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
83370664|NCT01690520|Cyclosporins|cyclosporins|mesh-list
83370665|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370666|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
83370667|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370668|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370669|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83370670|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
83370671|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370672|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370673|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83370674|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83370675|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
83370676|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370677|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
83370678|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370679|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
83370680|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83370681|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83370682|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83370683|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
83370684|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370685|NCT04081337|Tirzepatide|tirzepatide|mesh-list
83370686|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83370687|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370688|NCT04081337|Incretins|incretins|mesh-ancestor
83370689|NCT04081337|Hormones|hormones|mesh-ancestor
83370690|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83370691|NCT00541671|Promethazine|promethazine|mesh-list
83370692|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
83370693|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
83370694|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83370695|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
83370696|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
83370697|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370698|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370699|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370700|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83370701|NCT01563536|Ritonavir|ritonavir|mesh-list
83370702|NCT01563536|Ribavirin|ribavirin|mesh-list
83370703|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83370704|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83370705|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370706|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370707|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370708|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83370709|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83370710|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
83370711|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370712|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83370713|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370714|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
83370715|NCT01690052|Pilocarpine|pilocarpine|mesh-list
83370716|NCT01690052|Cevimeline|cevimeline|mesh-list
83370717|NCT01690052|Miotics|miotics|mesh-ancestor
83370718|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
83370719|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370720|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370721|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
83370722|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83370724|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370725|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370726|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83370727|NCT01689974|Ipilimumab|ipilimumab|mesh-list
83370728|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370729|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370730|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370731|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370732|NCT04750083|Carboplatin|carboplatin|mesh-list
83370733|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
83370734|NCT04750083|Pemetrexed|pemetrexed|mesh-list
83370735|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370736|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370737|NCT04750083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370738|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370739|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370740|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83370741|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83370742|NCT02954991|Nivolumab|nivolumab|mesh-list
83370743|NCT02954991|Mocetinostat|mocetinostat|mesh-list
83370744|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370745|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370746|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370747|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370748|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83370749|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370750|NCT02892591|Oxycodone|oxycodone|mesh-list
83370751|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83370752|NCT02892591|Narcotics|narcotics|mesh-ancestor
83370753|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370754|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370755|NCT02892591|Analgesics|analgesics|mesh-ancestor
83370756|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
83370757|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370758|NCT00470301|Paclitaxel|paclitaxel|mesh-list
83370759|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
83370760|NCT00470301|Doxorubicin|doxorubicin|mesh-list
83370761|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83370762|NCT00470301|Tipifarnib|tipifarnib|mesh-list
83370763|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83370764|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370765|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
83370766|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
83370767|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
83370768|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370769|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370770|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
83370771|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370772|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83370773|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83370774|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
83370775|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83370776|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83370777|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83370778|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83370779|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370780|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83370781|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
83370782|NCT00544713|Glycerol|glycerol|mesh-list
83370783|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83370784|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83370785|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83370786|NCT00544713|Protective Agents|protective agents|mesh-ancestor
83370787|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370788|NCT00544713|Laxatives|laxatives|mesh-ancestor
83370789|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83370790|NCT00545181|Metronidazole|metronidazole|mesh-list
83370791|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370792|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370793|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83370795|NCT01797315|Sirolimus|sirolimus|mesh-list
83370796|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370797|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370798|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83370799|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370800|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
83370801|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370802|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
83370803|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370804|NCT00471705|Miltefosine|miltefosine|mesh-list
83370805|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83370806|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
83370807|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370808|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370809|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83370810|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83370811|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
83370812|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83370813|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
83370814|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370815|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370816|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
83370817|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370819|NCT01458535|Ribavirin|ribavirin|mesh-list
83370820|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83370821|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83370822|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370823|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370824|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370825|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83370826|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83370827|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
83370828|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370829|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83370830|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370831|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
83370832|NCT01464827|Ritonavir|ritonavir|mesh-list
83370833|NCT01464827|Ribavirin|ribavirin|mesh-list
83370834|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83370835|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83370836|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370837|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370838|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370839|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83370840|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83370841|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
83370842|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370843|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83370844|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370845|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
83370846|NCT01463111|Lamotrigine|lamotrigine|mesh-list
83370847|NCT01463111|Valproic Acid|valproic acid|mesh-list
83370848|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83370849|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370850|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370851|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
83370852|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83370853|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370854|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370855|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
83370856|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83370857|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370858|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83370859|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83370860|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83370861|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
83370862|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370863|NCT01463033|Levetiracetam|levetiracetam|mesh-list
83370864|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
83370865|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
83370866|NCT01461551|Propofol|propofol|mesh-list
83370867|NCT01461551|Sevoflurane|sevoflurane|mesh-list
83370868|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83370869|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83370870|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370871|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83370873|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
83370874|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83370875|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83370877|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
83370878|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83370879|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83370880|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
83370881|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370882|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370883|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370884|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83370885|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
83370886|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83370887|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83370888|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370889|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370890|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83370891|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83370892|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
83370893|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83370894|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83370895|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370896|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83370897|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370898|NCT00546897|Lenalidomide|lenalidomide|mesh-list
83370899|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
83370900|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370901|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83370902|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83370903|NCT00546897|Growth Substances|growth substances|mesh-ancestor
83370904|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
83370905|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370906|NCT00474123|Simvastatin|simvastatin|mesh-list
83370907|NCT00474123|Ezetimibe|ezetimibe|mesh-list
83370908|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83370909|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83370910|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
83370911|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370912|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83370913|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83370914|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370915|NCT00474201|Ritonavir|ritonavir|mesh-list
83370916|NCT00474201|Lopinavir|lopinavir|mesh-list
83370917|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
83370918|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83370919|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83370920|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
83370921|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370922|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370923|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83370924|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83370925|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
83370926|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370927|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83370928|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83370929|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83370930|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
83370931|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83370932|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83370933|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
83370934|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83370935|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83370936|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370937|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
83370938|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
83370939|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
83370940|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83370941|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83370942|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83370943|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83370944|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370945|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
83370946|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83370947|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370948|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83370949|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370950|NCT00475215|Rocuronium|rocuronium|mesh-list
83370951|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83370952|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83370953|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83370954|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370955|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370956|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
83370957|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83370958|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370959|NCT02733159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83370960|NCT02733159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370961|NCT00477087|Molgramostim|molgramostim|mesh-list
83370962|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
83370963|NCT00477087|Sargramostim|sargramostim|mesh-list
83370964|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
83370965|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370966|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370967|NCT00477087|Analgesics|analgesics|mesh-ancestor
83370968|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
83370969|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83370970|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83370971|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83370972|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83370973|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83370974|NCT04409912|Sirolimus|sirolimus|mesh-list
83370975|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83370976|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83370977|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83370978|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83370979|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
83370980|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83370981|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
83370982|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370983|NCT01473589|Vitamin D|vitamin d|mesh-list
83370984|NCT01473589|Teriparatide|teriparatide|mesh-list
83370985|NCT01473589|Calcium|calcium|mesh-list
83370986|NCT01473589|Vitamins|vitamins|mesh-ancestor
83370987|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
83370988|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83370989|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83370990|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83370991|NCT00478335|Calcitonin|calcitonin|mesh-list
83370992|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
83370993|NCT00478335|Indomethacin|indomethacin|mesh-list
83370994|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83370995|NCT00478335|Amiloride|amiloride|mesh-list
83370996|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
83370997|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83370998|NCT00478335|Katacalcin|katacalcin|mesh-list
83370999|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
83371000|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83371001|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83371002|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371003|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371004|NCT00478335|Urological Agents|urological agents|mesh-ancestor
83371005|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371006|NCT00478335|Diuretics|diuretics|mesh-ancestor
83371007|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
83371008|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371009|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83371010|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371011|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83371012|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83371013|NCT00478335|Analgesics|analgesics|mesh-ancestor
83371014|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
83371015|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371016|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371018|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
83371019|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
83371020|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83371021|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83371022|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
83371023|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83371024|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
83371025|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83371026|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371027|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83371028|NCT00478569|Hormones|hormones|mesh-list
83371029|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
83371030|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371031|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371032|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371033|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
83371034|NCT00479037|Hormones|hormones|mesh-list
83371035|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
83371036|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371037|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371038|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371039|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83371040|NCT02985229|Misoprostol|misoprostol|mesh-list
83371041|NCT02985229|Mifepristone|mifepristone|mesh-list
83371042|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83371043|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
83371044|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83371045|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371046|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83371047|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83371048|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
83371049|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83371050|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83371051|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83371052|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83371053|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
83371054|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83371055|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83371056|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
83371057|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371058|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
83371059|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83371060|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83371061|NCT00479115|Plerixafor|plerixafor|mesh-list
83371062|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83371063|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83371064|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
83371065|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371066|NCT01472965|Ethanol|ethanol|mesh-list
83371067|NCT01472965|Heparin|heparin|mesh-list
83371068|NCT01472965|Calcium heparin|calcium heparin|mesh-list
83371069|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
83371070|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83371071|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83371072|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371073|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83371074|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371075|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371076|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371077|NCT00480987|Cytarabine|cytarabine|mesh-list
83371078|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
83371079|NCT00480987|Fludarabine|fludarabine|mesh-list
83371080|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
83371081|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371082|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83371083|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
83371084|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371085|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83371086|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
83371087|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371088|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
83371089|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371091|NCT01457053|Furosemide|furosemide|mesh-list
83371092|NCT01457053|Bumetanide|bumetanide|mesh-list
83371093|NCT01457053|Diuretics|diuretics|mesh-list
83371094|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
83371095|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
83371096|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371097|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371098|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371099|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371101|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
83371102|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83371103|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371104|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371105|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83371106|NCT04082767|Analgesics|analgesics|mesh-ancestor
83371107|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
83371108|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371109|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83371110|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83371111|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83371112|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
83371113|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371114|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371115|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83371116|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83371117|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83371118|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83371119|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83371120|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
83371121|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
83371122|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
83371123|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
83371124|NCT00481845|Anastrozole|anastrozole|mesh-list
83371125|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83371126|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371127|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83371128|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83371129|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371130|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371131|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83371132|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
83371133|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371134|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371135|NCT01472185|Ranolazine|ranolazine|mesh-list
83371136|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83371137|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371138|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371139|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83371140|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371141|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83371142|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371143|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371144|NCT00553839|Ketamine|ketamine|mesh-list
83371145|NCT00553839|Analgesics|analgesics|mesh-ancestor
83371146|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
83371147|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371148|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371149|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83371150|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83371151|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
83371152|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
83371153|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371154|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83371155|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83371156|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371157|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371158|NCT00554463|Etoposide|etoposide|mesh-list
83371159|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371160|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83371161|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83371162|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83371163|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371164|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371165|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
83371166|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371167|NCT00554853|Pioglitazone|pioglitazone|mesh-list
83371168|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
83371169|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83371170|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371171|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
83371172|NCT00556491|Minocycline|minocycline|mesh-list
83371173|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83371174|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371175|NCT02685969|Flutemetamol|flutemetamol|mesh-list
83371176|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83371177|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371178|NCT00483561|Etoposide|etoposide|mesh-list
83371179|NCT00483561|Gefitinib|gefitinib|mesh-list
83371180|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83371181|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371182|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83371183|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83371184|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371185|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371186|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83371187|NCT00485433|Epinephrine|epinephrine|mesh-list
83371188|NCT00485433|Bupivacaine|bupivacaine|mesh-list
83371189|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
83371190|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
83371191|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371192|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371193|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
83371194|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371195|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83371196|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83371197|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
83371198|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371199|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371200|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83371201|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83371202|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
83371203|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83371204|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
83371205|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
83371206|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
83371207|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83371208|NCT02850081|Atorvastatin|atorvastatin|mesh-list
83371209|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
83371210|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83371211|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83371212|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
83371213|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371214|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83371215|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371216|NCT01456039|Romidepsin|romidepsin|mesh-list
83371217|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83371218|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371219|NCT01456039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83371220|NCT01456039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371221|NCT01456039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371222|NCT01455415|Pregabalin|pregabalin|mesh-list
83371223|NCT01455415|Analgesics|analgesics|mesh-ancestor
83371224|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
83371225|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371226|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371227|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
83371228|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83371229|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371230|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371231|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371232|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83371233|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83371234|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371235|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83371236|NCT01471171|Bromides|bromides|mesh-list
83371237|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
83371238|NCT01471093|Rebamipide|rebamipide|mesh-list
83371239|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83371240|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83371241|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83371242|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83371243|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
83371244|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371245|NCT01471093|Protective Agents|protective agents|mesh-ancestor
83371246|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371247|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371248|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
83371249|NCT01471015|Hematinics|hematinics|mesh-ancestor
83371250|NCT01470469|Guanfacine|guanfacine|mesh-list
83371251|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371252|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83371253|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83371254|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83371255|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
83371256|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371257|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371258|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371259|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
83371260|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83371261|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83371262|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
83371263|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371264|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371265|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371266|NCT01470001|Urological Agents|urological agents|mesh-ancestor
83371267|NCT01469377|Cariprazine|cariprazine|mesh-list
83371268|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83371269|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83371270|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371271|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371272|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83371273|NCT01469221|Apaziquone|apaziquone|mesh-list
83371274|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371275|NCT01453855|Travoprost|travoprost|mesh-list
83371276|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83371277|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83371278|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371279|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
83371280|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
83371281|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371282|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371283|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
83371284|NCT01469065|Vitamins|vitamins|mesh-ancestor
83371285|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
83371286|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371287|NCT01586156|Carvedilol|carvedilol|mesh-list
83371288|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83371289|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83371290|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
83371291|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371292|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371293|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371294|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371295|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
83371296|NCT01586156|Protective Agents|protective agents|mesh-ancestor
83371297|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83371298|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371299|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371300|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
83371301|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83371302|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83371303|NCT01459913|Interferons|interferons|mesh-list
83371304|NCT01459913|Ribavirin|ribavirin|mesh-list
83371305|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
83371306|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
83371307|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83371308|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371309|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
83371310|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371311|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
83371312|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371313|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
83371314|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371315|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
83371316|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83371317|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
83371318|NCT01458275|Ciclesonide|ciclesonide|mesh-list
83371319|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
83371321|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371322|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371323|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83371324|NCT02334527|Palbociclib|palbociclib|mesh-list
83371325|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371326|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83371327|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371328|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371329|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83371330|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83371331|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83371332|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83371333|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371334|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83371335|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83371336|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371337|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371338|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
83371339|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371340|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
83371341|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
83371342|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83371343|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83371344|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371345|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371346|NCT01456169|Diuretics|diuretics|mesh-ancestor
83371347|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
83371348|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371349|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83371350|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371351|NCT01453595|Dactolisib|dactolisib|mesh-list
83371352|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371353|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
83371354|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83371355|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371356|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83371357|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
83371358|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371359|NCT04124198|Nimorazole|nimorazole|mesh-list
83371360|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
83371361|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83371362|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83371363|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371364|NCT01453205|Rituximab|rituximab|mesh-list
83371365|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83371366|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371367|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
83371368|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371369|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83371370|NCT01453049|Glimepiride|glimepiride|mesh-list
83371371|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
83371372|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83371373|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83371374|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371375|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83371376|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
83371377|NCT01452347|Warfarin|warfarin|mesh-list
83371378|NCT01452347|Dabigatran|dabigatran|mesh-list
83371379|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
83371380|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
83371381|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83371382|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371383|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371384|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371385|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
83371386|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
83371387|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371388|NCT01451723|Protective Agents|protective agents|mesh-ancestor
83371389|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371390|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
83371391|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
83371392|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371393|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83371394|NCT01451645|Colchicine|colchicine|mesh-list
83371395|NCT01451645|Allopurinol|allopurinol|mesh-list
83371396|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
83371397|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83371398|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
83371399|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
83371400|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
83371401|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371402|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371403|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
83371404|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371405|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83371406|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
83371407|NCT01451645|Protective Agents|protective agents|mesh-ancestor
83371408|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371409|NCT01450007|Dexamethasone|dexamethasone|mesh-list
83371410|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
83371411|NCT01450007|Ropivacaine|ropivacaine|mesh-list
83371412|NCT01450007|BB 1101|bb 1101|mesh-list
83371413|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371414|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
83371415|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
83371416|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371417|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371418|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83371419|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
83371420|NCT01450007|Hormones|hormones|mesh-ancestor
83371421|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371422|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83371423|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371424|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371425|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371426|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371427|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
83371428|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
83371429|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371430|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
83371431|NCT01496365|Pregabalin|pregabalin|mesh-list
83371432|NCT01496365|Analgesics|analgesics|mesh-ancestor
83371433|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
83371434|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371435|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371436|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
83371437|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83371438|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371439|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371440|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371441|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83371442|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83371443|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371444|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83371446|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83371447|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
83371448|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
83371449|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83371450|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371451|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83371452|NCT01687712|Hormones|hormones|mesh-ancestor
83371453|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371454|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371455|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
83371456|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83371457|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83371458|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83371459|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371460|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371461|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
83371462|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371463|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371464|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83371465|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371466|NCT01453153|Gemcitabine|gemcitabine|mesh-list
83371467|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83371468|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
83371469|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371470|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371471|NCT01584440|Quinidine|quinidine|mesh-list
83371472|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
83371473|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
83371474|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
83371475|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83371476|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83371477|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371478|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371479|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371480|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83371481|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83371482|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
83371483|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83371484|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
83371485|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83371486|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83371487|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371488|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371489|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83371490|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83371491|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
83371492|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83371493|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83371494|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371495|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83371496|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83371497|NCT01687478|Olanzapine|olanzapine|mesh-list
83371498|NCT01687478|Fluoxetine|fluoxetine|mesh-list
83371499|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
83371500|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
83371501|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371502|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371503|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83371504|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83371505|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83371506|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371507|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83371508|NCT01687478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83371509|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83371510|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371511|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371512|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371513|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
83371514|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83371515|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
83371516|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83371517|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83371518|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371519|NCT01468909|Paclitaxel|paclitaxel|mesh-list
83371520|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83371521|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83371522|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371523|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
83371524|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
83371525|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
83371526|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371527|NCT01687166|Acifluorfen|acifluorfen|mesh-list
83371528|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371529|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371530|NCT01561976|Metformin|metformin|mesh-list
83371531|NCT01561976|Glimepiride|glimepiride|mesh-list
83371532|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83371533|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371534|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83371535|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83371536|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
83371537|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83371538|NCT01686932|Vildagliptin|vildagliptin|mesh-list
83371539|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83371540|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371541|NCT01686932|Incretins|incretins|mesh-ancestor
83371542|NCT01686932|Hormones|hormones|mesh-ancestor
83371543|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371544|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83371545|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371546|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371547|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371549|NCT01468207|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83371550|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371551|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83371552|NCT03026725|Calcium|calcium|mesh-list
83371553|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83371554|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371555|NCT01686152|Imiquimod|imiquimod|mesh-list
83371556|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83371557|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
83371558|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371559|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371560|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
83371561|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83371562|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83371563|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83371564|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371565|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371566|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83371567|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83371568|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83371569|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
83371570|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371571|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371572|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83371573|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83371574|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
83371575|NCT01452529|Hydrocodone|hydrocodone|mesh-list
83371576|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83371577|NCT01452529|Narcotics|narcotics|mesh-ancestor
83371578|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371579|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371580|NCT01452529|Analgesics|analgesics|mesh-ancestor
83371581|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
83371582|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371583|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
83371584|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
83371585|NCT01560416|Fulvestrant|fulvestrant|mesh-list
83371586|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83371587|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371588|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
83371589|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83371590|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
83371591|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371592|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371593|NCT01685606|Immunomodulating Agents|immunomodulating agents|mesh-list
83371594|NCT01685606|Immunologic Factors|immunologic factors|mesh-ancestor
83371595|NCT01685606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371596|NCT01685372|Vaccines|vaccines|mesh-list
83371597|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
83371598|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371599|NCT01685138|Ceritinib|ceritinib|mesh-list
83371600|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371601|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83371602|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371603|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371604|NCT01685060|Ceritinib|ceritinib|mesh-list
83371605|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371606|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83371607|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371608|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371609|NCT03887936|Testosterone|testosterone|mesh-list
83371610|NCT03887936|Androgens|androgens|mesh-ancestor
83371611|NCT03887936|Hormones|hormones|mesh-ancestor
83371612|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371613|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371614|NCT01684202|Tolvaptan|tolvaptan|mesh-list
83371615|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83371616|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371617|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
83371618|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371619|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83371620|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
83371621|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371622|NCT01683266|Insulin|insulin|mesh-list
83371623|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83371624|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
83371625|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83371626|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371627|NCT01467661|Anagrelide|anagrelide|mesh-list
83371628|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83371629|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83371630|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371631|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83371632|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
83371633|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83371634|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83371635|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371637|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83371638|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83371639|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83371640|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
83371641|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371642|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371643|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83371644|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83371645|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
83371646|NCT01559012|Clonidine|clonidine|mesh-list
83371647|NCT01559012|Analgesics|analgesics|mesh-ancestor
83371648|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
83371649|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371650|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371651|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371652|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
83371653|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
83371654|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83371655|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83371656|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83371657|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
83371658|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371659|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371660|NCT01451827|Tolvaptan|tolvaptan|mesh-list
83371661|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83371662|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371663|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
83371664|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371665|NCT01557920|Propofol|propofol|mesh-list
83371666|NCT01557920|Sevoflurane|sevoflurane|mesh-list
83371667|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83371668|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371669|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371670|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83371671|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
83371672|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
83371673|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83371674|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83371675|NCT01467583|PENTA|penta|mesh-list
83371676|NCT01467583|Fondaparinux|fondaparinux|mesh-list
83371677|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83371678|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
83371679|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83371680|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371681|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371682|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371683|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
83371684|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83371685|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83371686|NCT01576718|Fluticasone|fluticasone|mesh-list
83371687|NCT01576718|Xhance|xhance|mesh-list
83371688|NCT01576718|Albuterol|albuterol|mesh-list
83371689|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
83371690|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371691|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83371692|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
83371693|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371694|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371695|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83371696|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
83371697|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
83371698|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83371699|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
83371700|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83371701|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83371702|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83371703|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
83371704|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371705|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371706|NCT01493557|Pantoprazole|pantoprazole|mesh-list
83371707|NCT01493557|Dabigatran|dabigatran|mesh-list
83371708|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
83371709|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83371710|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371711|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371712|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371713|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
83371714|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83371715|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83371716|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83371717|NCT01451749|Donepezil|donepezil|mesh-list
83371718|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83371719|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371720|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371721|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
83371722|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83371723|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371724|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
83371725|NCT01576484|Alirocumab|alirocumab|mesh-list
83371726|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83371727|NCT01576484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
83371728|NCT01576484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83371729|NCT01576484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83371730|NCT01576484|Antimetabolites|antimetabolites|mesh-ancestor
83371731|NCT01576484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371732|NCT01576484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83371733|NCT01576484|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371734|NCT01576484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371735|NCT01576484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83371736|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
83371737|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371738|NCT01467505|Interferons|interferons|mesh-list
83371739|NCT01467505|Ribavirin|ribavirin|mesh-list
83371740|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
83371741|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
83371742|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83371743|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83371744|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371745|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
83371746|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371747|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
83371748|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371749|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
83371750|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371751|NCT01449929|Ritonavir|ritonavir|mesh-list
83371752|NCT01449929|Darunavir|darunavir|mesh-list
83371753|NCT01449929|Dolutegravir|dolutegravir|mesh-list
83371754|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83371755|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83371756|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371757|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371758|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371759|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83371760|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83371761|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
83371762|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371763|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83371764|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83371765|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83371766|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83371767|NCT01451515|Cytarabine|cytarabine|mesh-list
83371768|NCT01451515|Dexamethasone|dexamethasone|mesh-list
83371769|NCT01451515|Prednisone|prednisone|mesh-list
83371770|NCT01451515|Prednisolone|prednisolone|mesh-list
83371771|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
83371772|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
83371773|NCT01451515|Doxorubicin|doxorubicin|mesh-list
83371774|NCT01451515|Methotrexate|methotrexate|mesh-list
83371775|NCT01451515|Etoposide|etoposide|mesh-list
83371776|NCT01451515|Vincristine|vincristine|mesh-list
83371777|NCT01451515|Daunorubicin|daunorubicin|mesh-list
83371778|NCT01451515|Asparaginase|asparaginase|mesh-list
83371779|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
83371780|NCT01451515|Clofarabine|clofarabine|mesh-list
83371781|NCT01451515|Pegaspargase|pegaspargase|mesh-list
83371782|NCT01451515|Thioguanine|thioguanine|mesh-list
83371783|NCT01451515|Antimetabolites|antimetabolites|mesh-list
83371784|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83371785|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
83371786|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371787|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83371788|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83371789|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
83371790|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371791|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371792|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83371793|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371794|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
83371795|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
83371796|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371797|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83371798|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
83371799|NCT01451515|Hormones|hormones|mesh-ancestor
83371800|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371801|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83371802|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83371803|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83371804|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83371805|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371806|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83371807|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
83371808|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83371809|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83371810|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
83371811|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83371812|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83371813|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83371814|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
83371815|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371816|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
83371817|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
83371818|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
83371819|NCT01576406|Crizotinib|crizotinib|mesh-list
83371820|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371821|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83371822|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371823|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371824|NCT01576172|Prednisone|prednisone|mesh-list
83371825|NCT01576172|Cortisone|cortisone|mesh-list
83371826|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
83371827|NCT01576172|Veliparib|veliparib|mesh-list
83371828|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371829|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
83371830|NCT01576172|Hormones|hormones|mesh-ancestor
83371831|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371832|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371833|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83371834|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371835|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83371836|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371837|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371838|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
83371839|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83371840|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83371841|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
83371842|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
83371843|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371844|NCT01541930|Metronidazole|metronidazole|mesh-list
83371845|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371846|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83371847|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83371848|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83371849|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
83371850|NCT03028298|Citric Acid|citric acid|mesh-list
83371851|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
83371852|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
83371853|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
83371854|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
83371855|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
83371856|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371857|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
83371858|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83371859|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83371860|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371861|NCT03028298|Urological Agents|urological agents|mesh-ancestor
83371862|NCT01540838|Acetaminophen|acetaminophen|mesh-list
83371863|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83371864|NCT01540838|Analgesics|analgesics|mesh-ancestor
83371865|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
83371866|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371867|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371868|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
83371869|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
83371870|NCT01451203|Methotrexate|methotrexate|mesh-list
83371871|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83371872|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
83371873|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83371874|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371875|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83371876|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
83371877|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371878|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371879|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
83371880|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371881|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83371882|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83371883|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
83371884|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83371885|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83371886|NCT01451203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83371887|NCT01451203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371888|NCT01556438|Dexamethasone|dexamethasone|mesh-list
83371890|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371891|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
83371892|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
83371893|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371894|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371895|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83371896|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
83371897|NCT01556438|Hormones|hormones|mesh-ancestor
83371898|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371899|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83371900|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371901|NCT02073487|Paclitaxel|paclitaxel|mesh-list
83371902|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83371903|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83371904|NCT02073487|Trastuzumab|trastuzumab|mesh-list
83371905|NCT02073487|Lapatinib|lapatinib|mesh-list
83371906|NCT02073487|Pertuzumab|pertuzumab|mesh-list
83371907|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83371908|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371909|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
83371910|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
83371911|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
83371912|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371913|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83371914|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83371915|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371916|NCT02073487|Immunotoxins|immunotoxins|mesh-ancestor
83371917|NCT02073487|Immunoconjugates|immunoconjugates|mesh-ancestor
83371918|NCT02073487|Immunologic Factors|immunologic factors|mesh-ancestor
83371919|NCT02073487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371920|NCT01466491|Lidocaine|lidocaine|mesh-list
83371922|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
83371923|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83371924|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371925|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
83371926|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371927|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83371928|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83371929|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83371930|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83371931|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371932|NCT01466179|Blinatumomab|blinatumomab|mesh-list
83371933|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371934|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83371935|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83371936|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371937|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371938|NCT01450813|Bromides|bromides|mesh-list
83371939|NCT01450813|Rocuronium|rocuronium|mesh-list
83371940|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
83371941|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83371942|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83371943|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83371944|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83371945|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371946|NCT01539512|Rituximab|rituximab|mesh-list
83371947|NCT01539512|Idelalisib|idelalisib|mesh-list
83371948|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83371949|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371950|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
83371951|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371952|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83371953|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371954|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371955|NCT01449955|Sirolimus|sirolimus|mesh-list
83371956|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83371957|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371958|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83371959|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371960|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
83371961|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83371962|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
83371963|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371964|NCT01574612|Acyclovir|acyclovir|mesh-list
83371965|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
83371966|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83371967|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
83371968|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371969|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
83371970|NCT01573910|Ofloxacin|ofloxacin|mesh-list
83371971|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83371972|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83371973|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83371974|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83371975|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83371976|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83371977|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371978|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371979|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83371980|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83371981|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83371982|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83371983|NCT01491919|Lisinopril|lisinopril|mesh-list
83371984|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83371985|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
83371986|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83371987|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83371988|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83371989|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83371990|NCT01491919|Protective Agents|protective agents|mesh-ancestor
83371991|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371992|NCT01573442|Testosterone|testosterone|mesh-list
83371993|NCT01573442|Androgens|androgens|mesh-ancestor
83371994|NCT01573442|Hormones|hormones|mesh-ancestor
83371995|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83371996|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83371997|NCT02319369|Azacitidine|azacitidine|mesh-list
83371998|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83371999|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
83372000|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372001|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372002|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372003|NCT01491841|Rituximab|rituximab|mesh-list
83372004|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83372006|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372007|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372008|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
83372009|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372010|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372011|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372012|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
83372013|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372014|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83372015|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83372016|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372017|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
83372018|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372019|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372020|NCT01553318|Ketotifen|ketotifen|mesh-list
83372021|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
83372022|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
83372023|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83372024|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
83372025|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
83372026|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372027|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372028|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372029|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83372030|NCT01572740|Liraglutide|liraglutide|mesh-list
83372031|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372032|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372033|NCT01572740|Incretins|incretins|mesh-ancestor
83372034|NCT01572740|Hormones|hormones|mesh-ancestor
83372035|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83372036|NCT01491607|Vaccines|vaccines|mesh-list
83372037|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
83372038|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372039|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
83372040|NCT02338713|Antacids|antacids|mesh-ancestor
83372041|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372042|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372043|NCT00557349|Omeprazole|omeprazole|mesh-list
83372044|NCT00557349|Famotidine|famotidine|mesh-list
83372045|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83372046|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372047|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83372048|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372049|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372050|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
83372051|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
83372052|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
83372053|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372054|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372055|NCT01553084|Nicotine|nicotine|mesh-list
83372056|NCT01553084|Varenicline|varenicline|mesh-list
83372057|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83372058|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
83372059|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372060|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372061|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83372062|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83372063|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
83372064|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372065|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372066|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
83372067|NCT01552928|Anagrelide|anagrelide|mesh-list
83372068|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83372069|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372070|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83372071|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83372072|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372073|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372074|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372075|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83372076|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83372077|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83372079|NCT01448707|Darunavir|darunavir|mesh-list
83372080|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83372081|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83372082|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
83372083|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372084|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372085|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83372086|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83372087|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
83372088|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372089|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83372090|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83372091|NCT01536704|Nicotine|nicotine|mesh-list
83372092|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83372093|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
83372094|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372095|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372096|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83372097|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83372098|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
83372099|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372100|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372101|NCT04108676|Fluzoparib|fluzoparib|mesh-list
83372102|NCT04108676|Omeprazole|omeprazole|mesh-list
83372103|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83372104|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372105|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83372106|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372107|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372108|NCT04108676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83372109|NCT04108676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372110|NCT01552772|Aripiprazole|aripiprazole|mesh-list
83372111|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
83372112|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372113|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83372114|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83372115|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372116|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372117|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
83372118|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
83372119|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372120|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372121|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83372122|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83372123|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
83372124|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83372125|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83372126|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83372127|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83372128|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83372129|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372130|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372131|NCT01552694|Incretins|incretins|mesh-ancestor
83372132|NCT01552694|Hormones|hormones|mesh-ancestor
83372133|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83372134|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83372135|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
83372136|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372137|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372138|NCT01464931|Denosumab|denosumab|mesh-list
83372139|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83372140|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372141|NCT01536392|Ondansetron|ondansetron|mesh-list
83372142|NCT01536392|Granisetron|granisetron|mesh-list
83372143|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
83372144|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
83372145|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372146|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372147|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372149|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
83372150|NCT01536392|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83372151|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83372152|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
83372153|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372154|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372155|NCT04767295|Paclitaxel|paclitaxel|mesh-list
83372156|NCT04767295|Carboplatin|carboplatin|mesh-list
83372157|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83372158|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372159|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
83372160|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
83372161|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
83372162|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372163|NCT02118831|Bevacizumab|bevacizumab|mesh-list
83372164|NCT02118831|Ranibizumab|ranibizumab|mesh-list
83372165|NCT02118831|Aflibercept|aflibercept|mesh-list
83372166|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372167|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372168|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372169|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372170|NCT02118831|Growth Substances|growth substances|mesh-ancestor
83372171|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372172|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372173|NCT00490269|Dronabinol|dronabinol|mesh-list
83372174|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
83372175|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372176|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372177|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83372178|NCT00490269|Analgesics|analgesics|mesh-ancestor
83372179|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
83372180|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372181|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83372182|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83372183|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372184|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372185|NCT00490269|Hormones|hormones|mesh-ancestor
83372186|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83372187|NCT05621499|Lenvatinib|lenvatinib|mesh-list
83372188|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372189|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83372190|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372191|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372192|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
83372193|NCT01490125|Albuterol|albuterol|mesh-list
83372194|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
83372195|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83372196|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
83372197|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372198|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372199|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83372200|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
83372201|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
83372202|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83372203|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
83372204|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372205|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372206|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
83372207|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83372208|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83372209|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83372210|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83372211|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
83372212|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83372213|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83372214|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
83372215|NCT00491751|Atorvastatin|atorvastatin|mesh-list
83372216|NCT00491751|Vitamins|vitamins|mesh-ancestor
83372217|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
83372218|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372219|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83372220|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83372221|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
83372222|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372223|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83372224|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83372225|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372226|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
83372227|NCT00491751|Protective Agents|protective agents|mesh-ancestor
83372228|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83372229|NCT01420549|Simvastatin|simvastatin|mesh-list
83372230|NCT01420549|Ezetimibe|ezetimibe|mesh-list
83372231|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83372232|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83372233|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
83372234|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372235|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83372236|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83372237|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372238|NCT01440595|Ribavirin|ribavirin|mesh-list
83372239|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83372240|NCT01440595|Grazoprevir|grazoprevir|mesh-list
83372241|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
83372242|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372243|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
83372244|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372245|NCT05560035|Lidocaine|lidocaine|mesh-list
83372246|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
83372247|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
83372248|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372249|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372250|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
83372251|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372252|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83372253|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83372254|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83372255|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372256|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372257|NCT00497055|Aripiprazole|aripiprazole|mesh-list
83372258|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
83372259|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372260|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83372261|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83372262|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372263|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372264|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
83372265|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
83372266|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372267|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372268|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83372269|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83372270|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
83372271|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83372272|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83372273|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83372274|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83372275|NCT00498615|Fasudil|fasudil|mesh-list
83372276|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83372277|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372278|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372279|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83372280|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372281|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
83372282|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83372283|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372284|NCT00498927|Temozolomide|temozolomide|mesh-list
83372285|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372286|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
83372287|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372288|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372289|NCT05555901|Bevacizumab|bevacizumab|mesh-list
83372290|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372291|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372292|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372293|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372294|NCT05555901|Growth Substances|growth substances|mesh-ancestor
83372295|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372296|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372297|NCT00499473|Sunitinib|sunitinib|mesh-list
83372298|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372299|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372300|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372301|NCT00499473|Growth Substances|growth substances|mesh-ancestor
83372302|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372303|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372304|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83372305|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372306|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372307|NCT00501891|Bevacizumab|bevacizumab|mesh-list
83372308|NCT00501891|Temozolomide|temozolomide|mesh-list
83372309|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372310|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372311|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372312|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372313|NCT00501891|Growth Substances|growth substances|mesh-ancestor
83372314|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372315|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372316|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372317|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
83372318|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372319|NCT01798017|Misoprostol|misoprostol|mesh-list
83372320|NCT01798017|Mifepristone|mifepristone|mesh-list
83372321|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83372322|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
83372323|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83372324|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372325|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83372326|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372327|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
83372328|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83372329|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83372330|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83372331|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83372332|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
83372333|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83372334|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83372335|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
83372336|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83372337|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
83372338|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83372339|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83372340|NCT00502905|Fludarabine|fludarabine|mesh-list
83372341|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
83372342|NCT00502905|Busulfan|busulfan|mesh-list
83372343|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372344|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83372345|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
83372346|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372347|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372348|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
83372349|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372350|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
83372351|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372352|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83372353|NCT05418777|Trimethoprim|trimethoprim|mesh-list
83372354|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
83372355|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
83372356|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83372357|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372358|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
83372359|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83372360|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83372361|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83372363|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372364|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83372365|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
83372366|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83372367|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83372368|NCT00505635|Interferons|interferons|mesh-list
83372369|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
83372370|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
83372371|NCT00505635|Thalidomide|thalidomide|mesh-list
83372372|NCT00505635|Cisplatin|cisplatin|mesh-list
83372373|NCT00505635|Temozolomide|temozolomide|mesh-list
83372374|NCT00505635|Interleukin-2|interleukin-2|mesh-list
83372375|NCT00505635|Vinblastine|vinblastine|mesh-list
83372376|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372377|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
83372378|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372379|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372380|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
83372381|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372382|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
83372383|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372384|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83372385|NCT00505635|Analgesics|analgesics|mesh-ancestor
83372386|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
83372387|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372388|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372389|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
83372390|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83372391|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372392|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372393|NCT00505635|Growth Substances|growth substances|mesh-ancestor
83372394|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372395|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83372396|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
83372397|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
83372398|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
83372399|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83372400|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83372401|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372402|NCT04742751|Metformin|metformin|mesh-list
83372403|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372404|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372405|NCT04479813|Moxonidine|moxonidine|mesh-list
83372406|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83372407|NCT04474899|Amlodipine|amlodipine|mesh-list
83372408|NCT04474899|Moxonidine|moxonidine|mesh-list
83372409|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83372410|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83372411|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372412|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372413|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83372414|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372415|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
83372416|NCT00511173|Warfarin|warfarin|mesh-list
83372417|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
83372418|NCT01447927|Metformin|metformin|mesh-list
83372419|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372420|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372421|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83372422|NCT00513747|Rituximab|rituximab|mesh-list
83372423|NCT00513747|Fludarabine|fludarabine|mesh-list
83372424|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
83372425|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372426|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372427|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
83372428|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372429|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372430|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83372431|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
83372432|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372433|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372434|NCT00514137|Sunitinib|sunitinib|mesh-list
83372435|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372436|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372437|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372438|NCT00514137|Growth Substances|growth substances|mesh-ancestor
83372439|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372440|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372441|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83372442|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372443|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372444|NCT00514215|Molgramostim|molgramostim|mesh-list
83372445|NCT00514215|Sargramostim|sargramostim|mesh-list
83372446|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
83372447|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372448|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372449|NCT03912909|Empagliflozin|empagliflozin|mesh-list
83372450|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83372451|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372452|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372453|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372455|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
83372456|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
83372457|NCT02130063|Trace Elements|trace elements|mesh-ancestor
83372458|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
83372459|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372460|NCT02130063|Hematinics|hematinics|mesh-ancestor
83372461|NCT00515697|Ramucirumab|ramucirumab|mesh-list
83372462|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372463|NCT00516165|Everolimus|everolimus|mesh-list
83372464|NCT00516165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83372465|NCT00516165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83372466|NCT00516165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372467|NCT00516165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372468|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372469|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
83372470|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372471|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372472|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83372473|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372474|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
83372475|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372476|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372477|NCT03419481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83372478|NCT03419481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372479|NCT02132169|Cetirizine|cetirizine|mesh-list
83372480|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83372481|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83372482|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83372483|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
83372484|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
83372485|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372486|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372487|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372488|NCT03174405|Avelumab|avelumab|mesh-list
83372489|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372490|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372491|NCT00522795|Paclitaxel|paclitaxel|mesh-list
83372492|NCT00522795|Cisplatin|cisplatin|mesh-list
83372493|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83372494|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83372495|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372496|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
83372497|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
83372498|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
83372499|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372500|NCT03121677|Poly I-C|poly i-c|mesh-list
83372501|NCT03121677|Rituximab|rituximab|mesh-list
83372502|NCT03121677|Nivolumab|nivolumab|mesh-list
83372503|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83372504|NCT03121677|Poly ICLC|poly iclc|mesh-list
83372505|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372506|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372507|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
83372508|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372509|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372510|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83372511|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372512|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
83372513|NCT03121677|Laxatives|laxatives|mesh-ancestor
83372514|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372515|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
83372516|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372517|NCT02871687|Simvastatin|simvastatin|mesh-list
83372518|NCT02871687|Pravastatin|pravastatin|mesh-list
83372519|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83372520|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83372521|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
83372522|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372523|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83372524|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83372525|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372526|NCT00525057|Dalteparin|dalteparin|mesh-list
83372527|NCT00525057|Tinzaparin|tinzaparin|mesh-list
83372528|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
83372529|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
83372530|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83372531|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83372532|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372533|NCT00525135|Valproic Acid|valproic acid|mesh-list
83372534|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
83372535|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372536|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372537|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
83372538|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372539|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372540|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
83372541|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83372542|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372543|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372544|NCT00525525|Bevacizumab|bevacizumab|mesh-list
83372545|NCT00525525|Temozolomide|temozolomide|mesh-list
83372546|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83372547|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372548|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372549|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372550|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372551|NCT00525525|Growth Substances|growth substances|mesh-ancestor
83372552|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372553|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372554|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372555|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
83372556|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372557|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83372558|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372559|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
83372560|NCT00525603|Rituximab|rituximab|mesh-list
83372561|NCT00525603|Fludarabine|fludarabine|mesh-list
83372562|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
83372563|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
83372564|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372565|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
83372566|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372567|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372568|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372569|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
83372570|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372571|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372572|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83372573|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372574|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83372575|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
83372576|NCT00398307|Cisplatin|cisplatin|mesh-list
83372577|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372578|NCT00564447|Azithromycin|azithromycin|mesh-list
83372579|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
83372580|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83372581|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372582|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83372583|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83372584|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372585|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372586|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372587|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
83372588|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83372589|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83372590|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83372591|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372592|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372593|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
83372594|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372595|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372596|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83372597|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372598|NCT00525837|Varenicline|varenicline|mesh-list
83372599|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83372600|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83372601|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
83372602|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372603|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372604|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372605|NCT00527475|Ranibizumab|ranibizumab|mesh-list
83372606|NCT00527475|Verteporfin|verteporfin|mesh-list
83372607|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372608|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372609|NCT00527475|Growth Substances|growth substances|mesh-ancestor
83372610|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372611|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372612|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372613|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83372614|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
83372615|NCT01798251|Capecitabine|capecitabine|mesh-list
83372616|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
83372617|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83372618|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
83372619|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372620|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372621|NCT02121483|Empagliflozin|empagliflozin|mesh-list
83372622|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83372623|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372624|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372625|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372627|NCT01572038|Docetaxel|docetaxel|mesh-list
83372628|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83372629|NCT01572038|Trastuzumab|trastuzumab|mesh-list
83372630|NCT01572038|Pertuzumab|pertuzumab|mesh-list
83372631|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83372632|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372633|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
83372634|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
83372635|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
83372636|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372637|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372638|NCT01448213|Fluorometholone|fluorometholone|mesh-list
83372639|NCT01448213|Prednisolone|prednisolone|mesh-list
83372640|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
83372641|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
83372642|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83372643|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
83372644|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
83372645|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
83372646|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83372647|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
83372648|NCT01448213|Hormones|hormones|mesh-ancestor
83372649|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83372650|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372651|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83372652|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372653|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
83372654|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
83372655|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372656|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372657|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83372658|NCT01448213|Protective Agents|protective agents|mesh-ancestor
83372659|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83372660|NCT01448057|Acetaminophen|acetaminophen|mesh-list
83372661|NCT01448057|Dimethindene|dimethindene|mesh-list
83372662|NCT01448057|Phenylephrine|phenylephrine|mesh-list
83372663|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
83372664|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83372665|NCT01448057|Analgesics|analgesics|mesh-ancestor
83372666|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
83372667|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372668|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372669|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
83372670|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372671|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83372672|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
83372673|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
83372674|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
83372675|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83372676|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
83372677|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
83372678|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83372679|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83372680|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83372681|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
83372682|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372683|NCT01448057|Protective Agents|protective agents|mesh-ancestor
83372684|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
83372685|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
83372686|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83372687|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
83372688|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
83372689|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83372690|NCT05246631|Dexamethasone|dexamethasone|mesh-list
83372691|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
83372692|NCT05246631|Haloperidol|haloperidol|mesh-list
83372693|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
83372694|NCT05246631|BB 1101|bb 1101|mesh-list
83372695|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83372696|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
83372697|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
83372698|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372699|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372700|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372701|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
83372702|NCT05246631|Hormones|hormones|mesh-ancestor
83372703|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83372704|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83372705|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372706|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
83372707|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372708|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372709|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83372710|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83372711|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372712|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372713|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83372714|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
83372715|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372716|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83372717|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
83372718|NCT01447433|Calcium|calcium|mesh-list
83372719|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83372720|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372721|NCT01447433|Antacids|antacids|mesh-ancestor
83372722|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372723|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372724|NCT01798875|Metformin|metformin|mesh-list
83372725|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
83372726|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
83372727|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372728|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372729|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83372730|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83372731|NCT05362851|Celecoxib|celecoxib|mesh-list
83372732|NCT05362851|Tramadol|tramadol|mesh-list
83372733|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83372734|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83372735|NCT05362851|Analgesics|analgesics|mesh-ancestor
83372736|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
83372737|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372738|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372739|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83372740|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372741|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83372742|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83372743|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372744|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372745|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83372746|NCT05362851|Narcotics|narcotics|mesh-ancestor
83372747|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372748|NCT04408235|Enoxaparin|enoxaparin|mesh-list
83372749|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
83372750|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83372751|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83372752|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372753|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
83372754|NCT03517137|Dacarbazine|dacarbazine|mesh-list
83372755|NCT03517137|Etoposide|etoposide|mesh-list
83372756|NCT03517137|Doxorubicin|doxorubicin|mesh-list
83372757|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83372758|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
83372759|NCT03517137|Vinblastine|vinblastine|mesh-list
83372760|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372761|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
83372762|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372763|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372764|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372765|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
83372766|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372767|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372768|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83372769|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83372770|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83372771|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83372772|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372773|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83372774|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372775|NCT03517137|Immunotoxins|immunotoxins|mesh-ancestor
83372776|NCT03517137|Immunoconjugates|immunoconjugates|mesh-ancestor
83372777|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
83372778|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
83372779|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
83372780|NCT01446809|Doxorubicin|doxorubicin|mesh-list
83372781|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83372782|NCT01446809|Ifosfamide|ifosfamide|mesh-list
83372783|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
83372784|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83372785|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372786|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83372787|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83372788|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372789|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372790|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372791|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
83372792|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
83372793|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83372794|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
83372795|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83372796|NCT03357159|Antibodies|antibodies|mesh-list
83372797|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372798|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
83372799|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372800|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372801|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372802|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
83372803|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372804|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372805|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83372806|NCT04387929|Antibodies|antibodies|mesh-list
83372807|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
83372808|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372809|NCT05361291|Dexamethasone|dexamethasone|mesh-list
83372810|NCT05361291|Lidocaine|lidocaine|mesh-list
83372811|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83372812|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
83372813|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
83372814|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372815|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372816|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83372817|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
83372818|NCT05361291|Hormones|hormones|mesh-ancestor
83372819|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83372820|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83372821|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372822|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372824|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
83372825|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372826|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
83372827|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83372828|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83372829|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83372830|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372831|NCT01445951|Insulin|insulin|mesh-list
83372832|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83372833|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
83372834|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83372835|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372836|NCT03169101|Nicotine|nicotine|mesh-list
83372837|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83372838|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
83372839|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372840|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372841|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83372842|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83372843|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
83372844|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372845|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372846|NCT05219877|Levofloxacin|levofloxacin|mesh-list
83372847|NCT05219877|Ofloxacin|ofloxacin|mesh-list
83372848|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83372849|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372850|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83372851|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83372852|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83372853|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372854|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372855|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372856|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83372857|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83372858|NCT00513435|Saracatinib|saracatinib|mesh-list
83372859|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372860|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372861|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372862|NCT05214339|Bevacizumab|bevacizumab|mesh-list
83372863|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372864|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372865|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83372866|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83372867|NCT05214339|Growth Substances|growth substances|mesh-ancestor
83372868|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372869|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83372870|NCT01444781|Vaccines|vaccines|mesh-list
83372871|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
83372873|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372874|NCT02471391|Venetoclax|venetoclax|mesh-list
83372875|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372876|NCT02431845|Fluoxetine|fluoxetine|mesh-list
83372877|NCT02431845|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83372878|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83372879|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372880|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372881|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372882|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
83372883|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372884|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83372885|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
83372886|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372887|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83372888|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83372889|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372890|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83372891|NCT05065671|Tolcapone|tolcapone|mesh-list
83372892|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83372893|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83372894|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372895|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372896|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83372897|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372898|NCT05065671|Analgesics|analgesics|mesh-ancestor
83372899|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
83372900|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372901|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
83372902|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372903|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
83372904|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83372905|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83372906|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83372907|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372908|NCT01443923|Interferons|interferons|mesh-list
83372909|NCT01443923|Ribavirin|ribavirin|mesh-list
83372910|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
83372911|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
83372912|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83372913|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372914|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
83372915|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372916|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
83372917|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372918|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
83372919|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372920|NCT00569673|Docetaxel|docetaxel|mesh-list
83372921|NCT00569673|Trabectedin|trabectedin|mesh-list
83372922|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372923|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
83372924|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
83372925|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
83372926|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372927|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372928|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
83372929|NCT01551212|Everolimus|everolimus|mesh-list
83372930|NCT01551212|Tacrolimus|tacrolimus|mesh-list
83372931|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372932|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
83372933|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372934|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83372935|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372936|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372937|NCT01551212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83372938|NCT01551212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83372939|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372940|NCT00573261|Pregabalin|pregabalin|mesh-list
83372941|NCT00573261|Analgesics|analgesics|mesh-ancestor
83372942|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
83372943|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83372944|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372945|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
83372946|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83372947|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83372948|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372949|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83372950|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83372951|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83372952|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372953|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83372954|NCT04268199|Bortezomib|bortezomib|mesh-list
83372955|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372956|NCT04514211|Propofol|propofol|mesh-list
83372957|NCT04514211|Sevoflurane|sevoflurane|mesh-list
83372958|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83372959|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83372960|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372961|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83372962|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
83372963|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
83372964|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83372965|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83372966|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
83372967|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83372968|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372969|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83372970|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
83372971|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83372972|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83372973|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372974|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372975|NCT00574587|Paclitaxel|paclitaxel|mesh-list
83372976|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
83372977|NCT00574587|Doxorubicin|doxorubicin|mesh-list
83372978|NCT00574587|Trastuzumab|trastuzumab|mesh-list
83372979|NCT00574587|Vorinostat|vorinostat|mesh-list
83372980|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83372981|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83372982|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
83372983|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
83372984|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
83372985|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83372986|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83372987|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
83372988|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83372989|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83372990|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83372991|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
83372992|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83372993|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83372994|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83372995|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83372996|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83372997|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83372998|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83372999|NCT00603993|Adalimumab|adalimumab|mesh-list
83373000|NCT00603993|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83373001|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373002|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373003|NCT00575367|Azithromycin|azithromycin|mesh-list
83373004|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
83373005|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83373006|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83373007|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
83373008|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83373009|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373010|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83373011|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83373012|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373013|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373015|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83373016|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
83373017|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83373018|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373019|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
83373020|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83373021|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83373022|NCT00604461|Bevacizumab|bevacizumab|mesh-list
83373023|NCT00604461|Carboplatin|carboplatin|mesh-list
83373024|NCT00604461|Pemetrexed|pemetrexed|mesh-list
83373025|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373026|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373027|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83373028|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83373029|NCT00604461|Growth Substances|growth substances|mesh-ancestor
83373030|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373031|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
83373032|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373033|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373034|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83373035|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83373036|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
83373037|NCT04417569|Estradiol|estradiol|mesh-list
83373038|NCT04417569|Progesterone|progesterone|mesh-list
83373039|NCT04417569|Hormones|hormones|mesh-ancestor
83373040|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373041|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373043|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83373044|NCT04417569|Progestins|progestins|mesh-ancestor
83373045|NCT01550744|Ustekinumab|ustekinumab|mesh-list
83373046|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
83373047|NCT00606489|Ibuprofen|ibuprofen|mesh-list
83373048|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83373049|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373050|NCT00606489|Analgesics|analgesics|mesh-ancestor
83373051|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
83373052|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373053|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373054|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373055|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373056|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83373057|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373058|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373059|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83373060|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83373061|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373062|NCT00578331|Analgesics|analgesics|mesh-ancestor
83373063|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
83373064|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373065|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373066|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373067|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373068|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83373069|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83373070|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83373071|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
83373072|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
83373073|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373074|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373075|NCT00607113|Bevacizumab|bevacizumab|mesh-list
83373076|NCT00607113|Everolimus|everolimus|mesh-list
83373077|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373078|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373079|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83373080|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83373081|NCT00607113|Growth Substances|growth substances|mesh-ancestor
83373082|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373083|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
83373084|NCT00607113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83373085|NCT00607113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83373086|NCT00607113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373087|NCT00607113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373088|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373089|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
83373090|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83373091|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83373092|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373093|NCT01549964|Incretins|incretins|mesh-ancestor
83373094|NCT01549964|Hormones|hormones|mesh-ancestor
83373095|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373096|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83373097|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
83373098|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373099|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373100|NCT00579111|Fludarabine|fludarabine|mesh-list
83373101|NCT00579111|Busulfan|busulfan|mesh-list
83373102|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
83373103|NCT00579111|Tacrolimus|tacrolimus|mesh-list
83373104|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373105|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373106|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373107|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
83373108|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373109|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83373110|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373111|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
83373112|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83373113|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83373114|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373115|NCT04363437|Colchicine|colchicine|mesh-list
83373116|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
83373117|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373118|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
83373119|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
83373120|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
83373121|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373122|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373123|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
83373124|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
83373125|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83373126|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
83373127|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83373128|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373129|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83373130|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83373131|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83373132|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83373133|NCT01570244|Estrogens|estrogens|mesh-ancestor
83373134|NCT01570244|Hormones|hormones|mesh-ancestor
83373135|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373136|NCT00579813|Pioglitazone|pioglitazone|mesh-list
83373137|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83373138|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373139|NCT01549886|Rituximab|rituximab|mesh-list
83373140|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373141|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373142|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
83373143|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373144|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373145|NCT00610311|Aldesleukin|aldesleukin|mesh-list
83373146|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
83373147|NCT00610311|Fludarabine|fludarabine|mesh-list
83373148|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
83373149|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373150|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
83373151|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373152|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373153|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83373154|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
83373155|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373156|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373157|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83373158|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83373159|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
83373160|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83373161|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83373162|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
83373163|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373164|NCT04233567|Infigratinib|infigratinib|mesh-list
83373165|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373166|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
83373167|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83373168|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83373169|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
83373170|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83480009|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373171|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373172|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373173|NCT00581061|Urological Agents|urological agents|mesh-ancestor
83373174|NCT01549652|Morphine|morphine|mesh-list
83373175|NCT01549652|Ondansetron|ondansetron|mesh-list
83373176|NCT01549652|Naloxone|naloxone|mesh-list
83373177|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83373178|NCT01549652|Narcotics|narcotics|mesh-ancestor
83373179|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373180|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373181|NCT01549652|Analgesics|analgesics|mesh-ancestor
83373182|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
83373183|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373184|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
83373185|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
83373186|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83373187|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
83373188|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
83373189|NCT01549652|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83373190|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83373191|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
83373192|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373193|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373194|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83373196|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
83373197|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
83373198|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373199|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373200|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373202|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
83373203|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
83373204|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373205|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373206|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
83373207|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373208|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83373209|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83373210|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83373211|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373212|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373213|NCT00611325|Bevacizumab|bevacizumab|mesh-list
83373215|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373216|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373217|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83373218|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83373219|NCT00611325|Growth Substances|growth substances|mesh-ancestor
83373220|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373221|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
83373222|NCT00611403|Cyclosporine|cyclosporine|mesh-list
83373223|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
83373224|NCT00611403|Cyclosporins|cyclosporins|mesh-list
83373225|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83480171|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83480172|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373226|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373227|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373228|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
83373229|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373230|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
83480173|NCT04539938|Immunoconjugates|immunoconjugates|mesh-ancestor
83373232|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
83373233|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373234|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83373235|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83373236|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83373237|NCT01534208|Enclomiphene|enclomiphene|mesh-list
83373239|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
83373240|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83373241|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
83373242|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373243|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373244|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83373245|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
83373246|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83480174|NCT04539938|Immunologic Factors|immunologic factors|mesh-ancestor
83373247|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83373248|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83373249|NCT01548638|Galantamine|galantamine|mesh-list
83373250|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83373251|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373252|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373253|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
83373254|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373255|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373256|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
83373257|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
83373258|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373259|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
83373260|NCT00612339|Bevacizumab|bevacizumab|mesh-list
83373261|NCT00612339|Temozolomide|temozolomide|mesh-list
83373262|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373263|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373264|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83373265|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83373266|NCT00612339|Growth Substances|growth substances|mesh-ancestor
83373267|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373268|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
83373269|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83373270|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
83373271|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373272|NCT01533428|Capsaicin|capsaicin|mesh-list
83373273|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
83373274|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
83373275|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
83373276|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373277|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373278|NCT04066725|Aspirin|aspirin|mesh-list
83373279|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83373280|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373281|NCT04066725|Analgesics|analgesics|mesh-ancestor
83373282|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
83373283|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373284|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373285|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373286|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373287|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83373288|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83373289|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373290|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83373291|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83373292|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373293|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
83373294|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
83373295|NCT01517984|Prednisone|prednisone|mesh-list
83373296|NCT01517984|Tacrolimus|tacrolimus|mesh-list
83373297|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
83373298|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83373299|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
83373300|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83373301|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373302|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
83373303|NCT01517984|Hormones|hormones|mesh-ancestor
83373304|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373305|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373306|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83373307|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373308|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
83373309|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373310|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373311|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83373312|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83373313|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
83373314|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83373315|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373316|NCT00612573|Doxycycline|doxycycline|mesh-list
83373317|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83373318|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373319|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
83373320|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83373321|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83373322|NCT00614445|Pyridoxine|pyridoxine|mesh-list
83373323|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
83373324|NCT00614445|Doxylamine|doxylamine|mesh-list
83373325|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
83373326|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
83373327|NCT00614445|Vitamins|vitamins|mesh-ancestor
83373328|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
83373329|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373330|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
83373331|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
83373332|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373333|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83373334|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83373335|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
83373336|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
83373337|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373338|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373339|NCT00583011|Anesthetics|anesthetics|mesh-list
83373340|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373341|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373342|NCT01547390|Aspirin|aspirin|mesh-list
83373343|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83373344|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373346|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
83373347|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373348|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373349|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373350|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373351|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83373352|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83373353|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373354|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83373355|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83373356|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373357|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
83373358|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
83373359|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373360|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
83373361|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
83373362|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373363|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83373364|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373365|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373366|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
83373368|NCT01532648|Budesonide|budesonide|mesh-list
83373369|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373370|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83373371|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
83373372|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373373|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373374|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83373375|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
83373376|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
83373377|NCT01532648|Hormones|hormones|mesh-ancestor
83373378|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373379|NCT00617097|Ketorolac|ketorolac|mesh-list
83373380|NCT00617097|Lidocaine|lidocaine|mesh-list
83373381|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
83373382|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
83373383|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373384|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373385|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
83373386|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373387|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83373388|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83373389|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83373390|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373391|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373392|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83373393|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373394|NCT00617097|Analgesics|analgesics|mesh-ancestor
83373395|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373396|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373397|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83373398|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373399|NCT01532414|Enclomiphene|enclomiphene|mesh-list
83373400|NCT01532414|Clomiphene|clomiphene|mesh-list
83373401|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
83373402|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83373403|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
83373404|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373405|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373406|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83373407|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
83373408|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83373409|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83373410|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83373411|NCT01441973|Elotuzumab|elotuzumab|mesh-list
83373412|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373413|NCT02074709|Bupivacaine|bupivacaine|mesh-list
83373414|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
83373415|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
83373416|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373417|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373418|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
83373419|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373421|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83373422|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373423|NCT01575899|Amoxicillin|amoxicillin|mesh-list
83373424|NCT01575899|Clarithromycin|clarithromycin|mesh-list
83373425|NCT01575899|Levofloxacin|levofloxacin|mesh-list
83373426|NCT01575899|Ofloxacin|ofloxacin|mesh-list
83373427|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
83373428|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83373429|NCT01575899|Rabeprazole|rabeprazole|mesh-list
83373430|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83373431|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373432|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83373433|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373434|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373435|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83373436|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83373437|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83373438|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83373439|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83373440|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373441|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83373442|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83373443|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83373444|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83373445|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83373446|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
83373447|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
83373448|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373449|NCT00620061|Lubiprostone|lubiprostone|mesh-list
83373450|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
83373451|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373452|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373453|NCT04122443|Acetaminophen|acetaminophen|mesh-list
83373454|NCT04122443|Oxycodone|oxycodone|mesh-list
83373455|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373456|NCT04122443|Analgesics|analgesics|mesh-ancestor
83373457|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
83373458|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373459|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373460|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
83373461|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83373462|NCT04122443|Narcotics|narcotics|mesh-ancestor
83373463|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373464|NCT00587769|Bupropion|bupropion|mesh-list
83373465|NCT00587769|Varenicline|varenicline|mesh-list
83373466|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83373467|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
83373468|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83373469|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83373470|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83373471|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373472|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373473|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
83373474|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373475|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373476|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
83373477|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83373478|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373479|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83373480|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83373481|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
83373482|NCT00623181|Vaccines|vaccines|mesh-list
83373483|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
83373484|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373485|NCT03433833|Digoxin|digoxin|mesh-list
83373486|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83373487|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83373488|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373489|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373490|NCT03433833|Protective Agents|protective agents|mesh-ancestor
83373491|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373492|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
83373493|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
83373494|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
83373495|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83373496|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
83373497|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373498|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373499|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83373500|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
83373501|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83373502|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83373503|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83373504|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
83373505|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373506|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373507|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
83373508|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83373509|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
83373510|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83373511|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83373512|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
83373513|NCT03179163|Enalapril|enalapril|mesh-list
83373514|NCT03179163|Captopril|captopril|mesh-list
83373515|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83373516|NCT03179163|Diuretics|diuretics|mesh-ancestor
83373517|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
83373518|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373519|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
83373520|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373521|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373522|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83373523|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
83373524|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373525|NCT01440803|Teriparatide|teriparatide|mesh-list
83373526|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83373527|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373528|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83373529|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
83373530|NCT05247177|Ketamine|ketamine|mesh-list
83373531|NCT05247177|Anesthetics|anesthetics|mesh-list
83373532|NCT05247177|Sevoflurane|sevoflurane|mesh-list
83373533|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373534|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373535|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83373536|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373537|NCT05247177|Analgesics|analgesics|mesh-ancestor
83373538|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
83373539|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373540|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83373541|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83373542|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83373543|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
83373544|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373545|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373546|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
83373547|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83373548|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
83373549|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83373550|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83373551|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83373552|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83373553|NCT00624195|Etravirine|etravirine|mesh-list
83373554|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83373555|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83373556|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83373557|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373558|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373559|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
83373560|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373561|NCT01516970|Ritonavir|ritonavir|mesh-list
83373562|NCT01516970|Lopinavir|lopinavir|mesh-list
83373563|NCT01516970|Darunavir|darunavir|mesh-list
83373564|NCT01516970|Zidovudine|zidovudine|mesh-list
83373565|NCT01516970|Efavirenz|efavirenz|mesh-list
83373566|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83373567|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83373568|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
83373569|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373570|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373571|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83373572|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83373573|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
83373574|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373575|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83373576|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83373577|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
83373578|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83373579|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83373580|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83373581|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
83373582|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83373583|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83373584|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83373585|NCT02140593|Rocuronium|rocuronium|mesh-list
83373586|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83373587|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83373588|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83373589|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373590|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373591|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
83373592|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83373593|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83373594|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83373595|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373596|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373597|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
83373598|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373599|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373600|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83373601|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373602|NCT00668811|Sunitinib|sunitinib|mesh-list
83373603|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373604|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83373605|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83373606|NCT00668811|Growth Substances|growth substances|mesh-ancestor
83373607|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373608|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
83373609|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83373610|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373611|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373612|NCT02776605|Prednisone|prednisone|mesh-list
83373613|NCT02776605|Methotrexate|methotrexate|mesh-list
83373614|NCT02776605|Vincristine|vincristine|mesh-list
83373615|NCT02776605|Daunorubicin|daunorubicin|mesh-list
83373616|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
83373617|NCT02776605|Ponatinib|ponatinib|mesh-list
83373618|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373619|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
83373620|NCT02776605|Hormones|hormones|mesh-ancestor
83373621|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373622|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373623|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83373624|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373625|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83373626|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
83373627|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83373628|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83373629|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
83480175|NCT04539938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373630|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373631|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
83373632|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373633|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83373634|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373635|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
83373636|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373637|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83373638|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83373639|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
83373640|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
83373641|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
83373642|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83373643|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83373644|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83373645|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83373647|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83373648|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83373649|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
83373650|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
83373651|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373652|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373653|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83373654|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83373655|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83373656|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
83373657|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373658|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373659|NCT00669279|Atenolol|atenolol|mesh-list
83373660|NCT00669279|Carvedilol|carvedilol|mesh-list
83373661|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83373662|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83373663|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
83373664|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373665|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373666|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373667|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83373668|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
83373669|NCT00669279|Protective Agents|protective agents|mesh-ancestor
83373670|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83373671|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373672|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83373673|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
83373674|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83373675|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83373676|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83373677|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
83373678|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
83373679|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373680|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83373681|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
83373682|NCT02394795|Leucovorin|leucovorin|mesh-list
83373683|NCT02394795|Bevacizumab|bevacizumab|mesh-list
83373684|NCT02394795|Panitumumab|panitumumab|mesh-list
83373685|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
83373686|NCT02394795|Fluorouracil|fluorouracil|mesh-list
83373687|NCT02394795|Calcium|calcium|mesh-list
83373688|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
83373689|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373690|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373691|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83373692|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83373693|NCT02394795|Growth Substances|growth substances|mesh-ancestor
83373694|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373695|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
83373696|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83373697|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83373698|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
83373699|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373700|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83373701|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373702|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
83373704|NCT02394795|Protective Agents|protective agents|mesh-ancestor
83373705|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
83373706|NCT02394795|Vitamins|vitamins|mesh-ancestor
83373707|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
83373708|NCT01546688|Zonisamide|zonisamide|mesh-list
83373709|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
83373710|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83373711|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373712|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373713|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83373714|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373715|NCT04409522|Melatonin|melatonin|mesh-list
83373716|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
83373717|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373718|NCT04409522|Protective Agents|protective agents|mesh-ancestor
83373719|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373720|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373721|NCT00672243|Sirolimus|sirolimus|mesh-list
83373722|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83373723|NCT00672243|Temsirolimus|temsirolimus|mesh-list
83373724|NCT00672243|MTOR Inhibitors|mtor inhibitors|mesh-list
83373725|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373726|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83373727|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373728|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373729|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83373730|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373731|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83373732|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
83373733|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373734|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
83373735|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373736|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
83373737|NCT04105946|Remifentanil|remifentanil|mesh-list
83373738|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83373739|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373740|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373741|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373742|NCT04105946|Analgesics|analgesics|mesh-ancestor
83373743|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
83373744|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373745|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83373746|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83373747|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83373748|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
83373749|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373750|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373751|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83373752|NCT04105946|Narcotics|narcotics|mesh-ancestor
83373753|NCT01440569|Darunavir|darunavir|mesh-list
83373754|NCT01440569|Cobicistat|cobicistat|mesh-list
83373755|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83373756|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83373757|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
83373758|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373759|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373760|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83373761|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83373762|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
83373763|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373764|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83373765|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83373766|NCT00629499|Paclitaxel|paclitaxel|mesh-list
83373767|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
83373768|NCT00629499|Trastuzumab|trastuzumab|mesh-list
83373769|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83373770|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373771|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
83373772|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
83373773|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
83373774|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373775|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373776|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
83373777|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373778|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373779|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83373780|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
83373781|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83373782|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83373783|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
83373784|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83373785|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83373786|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
83373788|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83373789|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83373790|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373791|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373792|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
83373793|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
83373794|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83373795|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
83373796|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373797|NCT01440101|Natalizumab|natalizumab|mesh-list
83373798|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
83373799|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373800|NCT01530464|Ambrisentan|ambrisentan|mesh-list
83373801|NCT01530464|Aminophylline|aminophylline|mesh-list
83373802|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83373803|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83373804|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
83373805|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373806|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373807|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83373808|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
83373809|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83373810|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83373811|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373812|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373813|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83373814|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83373815|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
83373816|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373817|NCT01530464|Protective Agents|protective agents|mesh-ancestor
83373818|NCT00633399|Ziprasidone|ziprasidone|mesh-list
83373819|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83373820|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
83373821|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373822|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373823|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373824|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83373825|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83373826|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373827|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83373828|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83373829|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
83373830|NCT01077843|Etoricoxib|etoricoxib|mesh-list
83373831|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
83373832|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
83373833|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83373834|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373835|NCT01077843|Analgesics|analgesics|mesh-ancestor
83373836|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
83373837|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373838|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373839|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373840|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83373841|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373842|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373843|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83373845|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83373846|NCT00635817|Leuprolide|leuprolide|mesh-list
83373847|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83373848|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
83373849|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83373850|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373851|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83373852|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373853|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
83373854|NCT01439945|Antacids|antacids|mesh-ancestor
83373855|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373856|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83373857|NCT00651963|Ezetimibe|ezetimibe|mesh-list
83373858|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83373859|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83373860|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
83373861|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373862|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83373863|NCT00674115|Omeprazole|omeprazole|mesh-list
83373864|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
83373865|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83373866|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83373867|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83373868|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373869|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373870|NCT02142153|Olorofim|olorofim|mesh-list
83373871|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
83373872|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373873|NCT00674583|Vaccines|vaccines|mesh-list
83373874|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
83373875|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373876|NCT01420081|Gedatolisib|gedatolisib|mesh-list
83373877|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83373878|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373879|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373880|NCT01439867|Cinacalcet|cinacalcet|mesh-list
83373881|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83373882|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373883|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
83373884|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
83373885|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373886|NCT00637923|Ribavirin|ribavirin|mesh-list
83373887|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83373888|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
83373889|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
83373890|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373891|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
83373892|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83373893|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83373894|NCT01439711|Letrozole|letrozole|mesh-list
83373895|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373896|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83373897|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83373898|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373899|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373900|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83373901|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
83373902|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83373903|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373904|NCT01439555|Simvastatin|simvastatin|mesh-list
83373905|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83373906|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83373907|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
83373908|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373909|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83373910|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83373911|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373912|NCT00674739|Imiquimod|imiquimod|mesh-list
83373913|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83373914|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
83373915|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373916|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373917|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
83373918|NCT00675909|Midazolam|midazolam|mesh-list
83373919|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83373920|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83373921|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373922|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373923|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83373924|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83373925|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83373926|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83373927|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
83373928|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
83373929|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
83373930|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
83373931|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373932|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373933|NCT03027908|Fluorides|fluorides|mesh-list
83373934|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
83373935|NCT03027908|Protective Agents|protective agents|mesh-ancestor
83373936|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373938|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83373939|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373940|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373941|NCT01439009|Tolvaptan|tolvaptan|mesh-list
83373942|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
83373943|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373944|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
83373945|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373946|NCT00675987|Losartan|losartan|mesh-list
83373947|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83373948|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83373949|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83373950|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83373951|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373952|NCT00639717|Etanercept|etanercept|mesh-list
83373953|NCT00639717|Methoxsalen|methoxsalen|mesh-list
83373954|NCT00639717|Tacrolimus|tacrolimus|mesh-list
83373955|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83373956|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
83373957|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373958|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83373959|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373960|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373961|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83373962|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83373963|NCT00639717|Analgesics|analgesics|mesh-ancestor
83373964|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
83373965|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83373966|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83373967|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83373968|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83373969|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83373970|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
83373971|NCT01571453|Vortioxetine|vortioxetine|mesh-list
83373972|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83373973|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83373974|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83373975|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83373976|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373977|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83373978|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83373979|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83373980|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
83373981|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83373982|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83373983|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83373984|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83373985|NCT01571453|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83373986|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
83373987|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83373988|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83373989|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83373990|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83373991|NCT04120961|Hirudins|hirudins|mesh-list
83373992|NCT04120961|Bivalirudin|bivalirudin|mesh-list
83373993|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
83373994|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83373995|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
83373996|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83373997|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83373998|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
83373999|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83374000|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83374001|NCT04410263|Dimercaprol|dimercaprol|mesh-list
83374002|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
83374003|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
83374004|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374005|NCT01444651|Tadalafil|tadalafil|mesh-list
83374006|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
83374007|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83374008|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83374009|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374010|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374011|NCT01444651|Urological Agents|urological agents|mesh-ancestor
83374013|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83374014|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
83374015|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83374016|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374017|NCT01419535|Mifepristone|mifepristone|mesh-list
83374018|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
83374019|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
83374020|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83374021|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374022|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83374023|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83374024|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83374025|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
83374026|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
83374027|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
83374028|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
83374029|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374030|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
83374031|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83374032|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
83374033|NCT01438151|Infliximab|infliximab|mesh-list
83374034|NCT01438151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83374035|NCT01438151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374036|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
83374037|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374038|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83389687|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389688|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83389689|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389690|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
83389691|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83389692|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83389693|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389694|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83389695|NCT04029467|Analgesics|analgesics|mesh-ancestor
83389696|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
83389697|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83389698|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83389699|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83389700|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83389701|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
83389702|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389703|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389704|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
83389705|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
83389706|NCT03402321|Coagulants|coagulants|mesh-ancestor
83389707|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
83389708|NCT03402165|Ledipasvir|ledipasvir|mesh-list
83389709|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
83389710|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
83389711|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83389712|NCT03402087|Leucovorin|leucovorin|mesh-list
83389713|NCT03402087|Methotrexate|methotrexate|mesh-list
83389714|NCT03402087|Deucravacitinib|deucravacitinib|mesh-list
83389715|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83389716|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
83389717|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83389718|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83389719|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83389720|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
83389721|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83389722|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83389723|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
83389724|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389725|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83389726|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83389727|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
83389728|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374040|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374041|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374042|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
83374043|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374044|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374045|NCT01418365|Metronidazole|metronidazole|mesh-list
83374046|NCT01418365|Mesalamine|mesalamine|mesh-list
83374047|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374048|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83374049|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83374050|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83374051|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83374052|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374053|NCT01418365|Analgesics|analgesics|mesh-ancestor
83374054|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
83374055|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374056|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374057|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374058|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374059|NCT02075125|Ticagrelor|ticagrelor|mesh-list
83374060|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
83374061|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83374062|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83374063|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83374064|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83374065|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
83374066|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374067|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374068|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374069|NCT00678015|Masoprocol|masoprocol|mesh-list
83374070|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
83374071|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374072|NCT00678015|Protective Agents|protective agents|mesh-ancestor
83374073|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374074|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83374075|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374076|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83374077|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83374078|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374079|NCT00678015|Analgesics|analgesics|mesh-ancestor
83374080|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
83374081|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374082|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374083|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374084|NCT01437995|Fluticasone|fluticasone|mesh-list
83374085|NCT01437995|Xhance|xhance|mesh-list
83374086|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83374087|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
83374088|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374089|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83374090|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
83374091|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374092|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374093|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83374094|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
83374095|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
83374096|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83374097|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83374098|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83374099|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83374100|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374101|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374102|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374103|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
83374104|NCT01437995|Hormones|hormones|mesh-ancestor
83374105|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374106|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
83374107|NCT00641745|Risperidone|risperidone|mesh-list
83374108|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
83374109|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83374110|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
83374111|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374112|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374113|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374114|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83374115|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83374116|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374117|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83374118|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83374119|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
83374120|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
83374121|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83374122|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83374123|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374124|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83374125|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83374126|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
83374127|NCT01799109|Albuterol|albuterol|mesh-list
83374128|NCT01799109|Analgesics|analgesics|mesh-ancestor
83374129|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
83374130|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374131|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374132|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
83374133|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374134|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83374135|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
83374136|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83374137|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374138|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374139|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83374140|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
83374141|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83374142|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83374143|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
83374144|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83374145|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
83374146|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83374147|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83374148|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83374149|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374150|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374151|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
83374152|NCT00588159|Promethazine|promethazine|mesh-list
83374153|NCT00588159|Gabapentin|gabapentin|mesh-list
83374154|NCT00588159|Analgesics|analgesics|mesh-ancestor
83374155|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
83374156|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374157|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374158|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
83374159|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83374160|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83374161|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374162|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83374163|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
83374164|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
83374165|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374166|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374168|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
83374169|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83374170|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
83374171|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
83374172|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
83374173|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
83374174|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374175|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83374176|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
83374177|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
83374178|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83374179|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
83374180|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
83374181|NCT01439347|Vincristine|vincristine|mesh-list
83374182|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83374183|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374184|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
83374185|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
83374186|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
83389729|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83374187|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374189|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
83374190|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
83374191|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374192|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374193|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
83374194|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374195|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83374196|NCT00589329|Metronidazole|metronidazole|mesh-list
83374197|NCT00589329|Erythromycin|erythromycin|mesh-list
83374198|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
83374199|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
83374200|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
83374201|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374202|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83374203|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83374204|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374205|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83374206|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374207|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374208|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
83374209|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83374210|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374211|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374212|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374213|NCT01438957|Analgesics|analgesics|mesh-ancestor
83374214|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
83374215|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374216|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83374217|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83374218|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83374219|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374220|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374221|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374222|NCT00589563|Sirolimus|sirolimus|mesh-list
83374223|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
83374224|NCT00589563|Melphalan|melphalan|mesh-list
83374225|NCT00589563|Methotrexate|methotrexate|mesh-list
83374226|NCT00589563|Fludarabine|fludarabine|mesh-list
83374227|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
83374228|NCT00589563|Etoposide|etoposide|mesh-list
83374229|NCT00589563|Tacrolimus|tacrolimus|mesh-list
83374230|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83374231|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83374232|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
83374233|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374234|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374235|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83374236|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
83374237|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374238|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374239|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83374240|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83374241|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
83374242|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83374243|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83374244|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
83374245|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
83374246|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374247|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83374248|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83374249|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83374250|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83374251|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83374252|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83374253|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83374254|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374255|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83374256|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
83374257|NCT00645333|Docetaxel|docetaxel|mesh-list
83374258|NCT00645333|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
83374259|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374260|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
83374261|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
83374262|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
83374263|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374264|NCT00645333|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
83374265|NCT00645333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374266|NCT00646581|Insulin|insulin|mesh-list
83374267|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83374268|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83374269|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374270|NCT00648375|Propranolol|propranolol|mesh-list
83374271|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83374272|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83374273|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374274|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374275|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374276|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374277|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83374278|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83374279|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
83374281|NCT00654069|Niacinamide|niacinamide|mesh-list
83374282|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
83374283|NCT00654069|Oxycodone|oxycodone|mesh-list
83374284|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83374285|NCT00654069|Narcotics|narcotics|mesh-ancestor
83374286|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374287|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374288|NCT00654069|Analgesics|analgesics|mesh-ancestor
83374289|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
83374290|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374291|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83374292|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
83374293|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374294|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83374295|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
83374296|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
83374298|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
83374299|NCT00654147|Ritonavir|ritonavir|mesh-list
83374300|NCT00654147|Lopinavir|lopinavir|mesh-list
83374301|NCT00654147|Tenofovir|tenofovir|mesh-list
83374302|NCT00654147|Emtricitabine|emtricitabine|mesh-list
83374303|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
83374304|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
83374305|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
83374306|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
83374307|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374308|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374309|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83374310|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83374311|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
83374312|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374313|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83374314|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83374315|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83374316|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83374317|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83374318|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83374319|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83374320|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
83374321|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374322|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
83374323|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
83374324|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374325|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374326|NCT00655083|MEN 11420|men 11420|mesh-list
83374327|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83374328|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
83374329|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374330|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374331|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83374332|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
83374333|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
83374334|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
83374335|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
83374336|NCT01418209|Estradiol|estradiol|mesh-list
83374337|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
83374339|NCT01418209|Estrogens|estrogens|mesh-ancestor
83374340|NCT01418209|Hormones|hormones|mesh-ancestor
83374341|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374342|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374343|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83374344|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
83374345|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83374346|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83374347|NCT01418209|Progestins|progestins|mesh-ancestor
83374348|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83374349|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83374350|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374351|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374352|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374353|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
83374354|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
83374355|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83374356|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
83374357|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83374359|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
83374360|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374361|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83374362|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
83374363|NCT01417195|Menotropins|menotropins|mesh-list
83374364|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
83374365|NCT01417195|Hormones|hormones|mesh-ancestor
83374366|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374367|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374368|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83374369|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
83374370|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83374371|NCT00656487|Rimonabant|rimonabant|mesh-list
83374372|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83374373|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
83374374|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83374375|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374376|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374377|NCT00656487|Hormones|hormones|mesh-ancestor
83374378|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374379|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374380|NCT01438411|Cholic Acids|cholic acids|mesh-list
83374381|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374382|NCT01438177|Chloroquine|chloroquine|mesh-list
83374383|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
83374384|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83374385|NCT01438177|Bortezomib|bortezomib|mesh-list
83374386|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83374387|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
83374388|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374389|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374390|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83374391|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
83374392|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374393|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374394|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83374395|NCT01438177|Amebicides|amebicides|mesh-ancestor
83374396|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83374397|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83374398|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374399|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
83374400|NCT01442779|Interferons|interferons|mesh-list
83374401|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
83374402|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374403|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
83374404|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374405|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
83374406|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374407|NCT01436201|Dulaglutide|dulaglutide|mesh-list
83374408|NCT01436201|Digoxin|digoxin|mesh-list
83374409|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83374410|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83374411|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374412|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374413|NCT01436201|Protective Agents|protective agents|mesh-ancestor
83374414|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374415|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83374416|NCT01437397|Bromides|bromides|mesh-list
83374417|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
83374418|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83374419|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
83374420|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374421|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374422|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83374423|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
83374424|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83374425|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83374426|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83374427|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374428|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374429|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374430|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
83374431|NCT04070833|Vitamin D|vitamin d|mesh-list
83374433|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
83374434|NCT04070833|Vitamins|vitamins|mesh-list
83374435|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
83374436|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374437|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83374438|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83374439|NCT01442155|Capecitabine|capecitabine|mesh-list
83374440|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
83374441|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83374442|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
83374443|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374444|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374445|NCT01416181|Natalizumab|natalizumab|mesh-list
83374446|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
83374447|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374448|NCT03026023|Ribavirin|ribavirin|mesh-list
83374449|NCT03026023|Grazoprevir|grazoprevir|mesh-list
83374450|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
83374451|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374452|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
83374453|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374454|NCT01441765|Pidilizumab|pidilizumab|mesh-list
83374455|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374456|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374457|NCT01419665|Rituximab|rituximab|mesh-list
83374458|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374459|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374460|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
83374461|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374462|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374463|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
83374464|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
83374465|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
83374466|NCT01436305|Abatacept|abatacept|mesh-list
83374467|NCT01436305|Tacrolimus|tacrolimus|mesh-list
83374468|NCT01436305|Basiliximab|basiliximab|mesh-list
83374469|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83374470|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
83374471|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374472|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83374473|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374474|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374475|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83374476|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374477|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83374478|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
83374479|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83374480|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374481|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374482|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
83374483|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
83374484|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374485|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374486|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
83374488|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374489|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83374490|NCT01436305|Protective Agents|protective agents|mesh-ancestor
83374491|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374492|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83374493|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374494|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83374495|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83374496|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374497|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83374498|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83374499|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374500|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374501|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
83374502|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374503|NCT04063267|Nicotine|nicotine|mesh-list
83374504|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83374505|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
83374506|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374507|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374508|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83374509|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83374510|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
83374511|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374512|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374513|NCT01415401|Timolol|timolol|mesh-list
83374514|NCT01415401|Brinzolamide|brinzolamide|mesh-list
83374515|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374516|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374517|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83374518|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83374519|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374520|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374521|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374522|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83374523|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83374524|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
83374525|NCT04049851|Ivermectin|ivermectin|mesh-list
83374526|NCT04049851|Moxidectin|moxidectin|mesh-list
83374527|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83374528|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374529|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
83374530|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
83374531|NCT01414855|Prednisone|prednisone|mesh-list
83374532|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
83374533|NCT01414855|Doxorubicin|doxorubicin|mesh-list
83374534|NCT01414855|Vincristine|vincristine|mesh-list
83374535|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
83374536|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83374537|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
83374538|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374539|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374540|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83374541|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
83374542|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374543|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374544|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83374545|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83374546|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83374547|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83374548|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374549|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374550|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
83374551|NCT01414855|Hormones|hormones|mesh-ancestor
83374552|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374553|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83374554|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83374555|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
83374556|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
83374557|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
83374558|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374559|NCT02074735|Choline|choline|mesh-list
83374560|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
83374561|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
83374562|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83374563|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
83374564|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374565|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374566|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83374567|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
83374568|NCT01527110|Zanamivir|zanamivir|mesh-list
83374569|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
83374570|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374571|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374572|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374573|NCT01441063|Zidovudine|zidovudine|mesh-list
83374574|NCT01441063|Valganciclovir|valganciclovir|mesh-list
83374575|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
83374576|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374577|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83374578|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83374579|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374580|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
83374581|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374582|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83374583|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83374584|NCT01436071|Fluticasone|fluticasone|mesh-list
83374586|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374587|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83374588|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
83374589|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374590|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374591|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83374592|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
83374593|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
83374594|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83374595|NCT01514864|Dasatinib|dasatinib|mesh-list
83374596|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374597|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83374598|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374599|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374600|NCT01514240|Mesalamine|mesalamine|mesh-list
83374601|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83374602|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374603|NCT01514240|Analgesics|analgesics|mesh-ancestor
83374604|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
83374605|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374606|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374607|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374608|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374609|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
83374610|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
83374611|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83374612|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83374613|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374614|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83374615|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83374616|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374617|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374618|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
83374619|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374620|NCT04061239|Cytarabine|cytarabine|mesh-list
83374621|NCT04061239|Azacitidine|azacitidine|mesh-list
83374622|NCT04061239|Daunorubicin|daunorubicin|mesh-list
83374623|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83374624|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
83374625|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374626|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374627|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
83374628|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374629|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83374630|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
83374631|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374632|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374633|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83374634|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83374635|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83374636|NCT01393405|Methotrexate|methotrexate|mesh-list
83374637|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83374638|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
83374639|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83374640|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374641|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83374642|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
83374643|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374644|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374645|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
83374646|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374647|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83374648|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83374649|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
83374650|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374651|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83374653|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83374654|NCT01419197|Maytansine|maytansine|mesh-list
83374655|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374656|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374657|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83374658|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
83374659|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
83374660|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
83374661|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374662|NCT01419197|Immunotoxins|immunotoxins|mesh-ancestor
83374663|NCT01419197|Immunoconjugates|immunoconjugates|mesh-ancestor
83374664|NCT01419197|Immunologic Factors|immunologic factors|mesh-ancestor
83374665|NCT01419197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374666|NCT01414075|Iron|iron|mesh-list
83374667|NCT01414075|Trace Elements|trace elements|mesh-ancestor
83374668|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
83374669|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374670|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
83374671|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
83374672|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83374673|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
83374674|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374675|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374676|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83374677|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
83374678|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
83374679|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83374680|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
83374681|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374682|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374683|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83374684|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83374685|NCT01418339|Aripiprazole|aripiprazole|mesh-list
83374686|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
83374687|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83374688|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83374689|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83374690|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374691|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374692|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
83374693|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
83374694|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374695|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374696|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83374697|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83374698|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
83374699|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
83374700|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83374701|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
83374702|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83374703|NCT01417481|Glycine|glycine|mesh-list
83374704|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
83374705|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374706|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374707|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374708|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
83374709|NCT01392469|Bosentan|bosentan|mesh-list
83374710|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
83374711|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374712|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83374713|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374714|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374715|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
83374716|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83374717|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83374718|NCT01392469|Urological Agents|urological agents|mesh-ancestor
83374719|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83374720|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
83374721|NCT01435577|Tapentadol|tapentadol|mesh-list
83374722|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83374723|NCT01435577|Narcotics|narcotics|mesh-ancestor
83374724|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374725|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374726|NCT01435577|Analgesics|analgesics|mesh-ancestor
83374727|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
83374728|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374729|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83374730|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83374731|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374732|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374733|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374734|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374735|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
83374736|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
83374737|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83374738|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83374739|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374740|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374741|NCT04039087|Urological Agents|urological agents|mesh-ancestor
83374742|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
83374743|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83374744|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374745|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
83374746|NCT01416389|Lenograstim|lenograstim|mesh-list
83374747|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83374748|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
83374749|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374750|NCT04497155|Norepinephrine|norepinephrine|mesh-list
83374751|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83374752|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83374753|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374754|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374755|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374756|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374757|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
83374758|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
83374759|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374760|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83374761|NCT01544348|Omalizumab|omalizumab|mesh-list
83374762|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83374763|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83374764|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
83374765|NCT01416155|Natalizumab|natalizumab|mesh-list
83374766|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
83374767|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374768|NCT01415921|Bromides|bromides|mesh-list
83374769|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
83374770|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
83374771|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83374772|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374773|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374774|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
83374775|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374776|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374777|NCT01415531|Nebivolol|nebivolol|mesh-list
83374778|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83374779|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
83374780|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
83374781|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83374782|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83374783|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
83374784|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374785|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374786|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374787|NCT01544114|Naproxen|naproxen|mesh-list
83374788|NCT01544114|Esomeprazole|esomeprazole|mesh-list
83374789|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83374790|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374791|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83374792|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374793|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374794|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83374795|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374796|NCT01544114|Analgesics|analgesics|mesh-ancestor
83374797|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
83374798|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374799|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374800|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374801|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374802|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
83374803|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83374804|NCT01410799|Hormones|hormones|mesh-list
83374805|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
83374806|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374807|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374808|NCT01432171|Lacosamide|lacosamide|mesh-list
83374809|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
83374810|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83374811|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83374812|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374813|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374814|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
83374815|NCT04046263|Hematinics|hematinics|mesh-ancestor
83374816|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
83374817|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374818|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374819|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
83374820|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374821|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374822|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374823|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83374824|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83374825|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
83374826|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374827|NCT05021562|Niraparib|niraparib|mesh-list
83374828|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83374829|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374830|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374831|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374832|NCT01412957|Panitumumab|panitumumab|mesh-list
83374833|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374834|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374835|NCT04973826|Aztreonam|aztreonam|mesh-list
83374836|NCT04973826|Avibactam|avibactam|mesh-list
83374837|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83374838|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374839|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83374840|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374841|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374842|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
83374843|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374844|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374845|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
83374846|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83374847|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83374848|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
83374849|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83374850|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83374851|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374852|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374853|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374854|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374855|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
83374856|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83374857|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
83374858|NCT05062278|Vinblastine|vinblastine|mesh-list
83374859|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374860|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
83374861|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374862|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374863|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83374864|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83374865|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
83374866|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
83374867|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
83374868|NCT02823990|Nivolumab|nivolumab|mesh-list
83374869|NCT02823990|Interleukin-2|interleukin-2|mesh-list
83374870|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374871|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374872|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374873|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83374874|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374875|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374876|NCT02823990|Analgesics|analgesics|mesh-ancestor
83374877|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
83374878|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374879|NCT02427126|Aspirin|aspirin|mesh-list
83374880|NCT02427126|Apixaban|apixaban|mesh-list
83374881|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83374882|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374883|NCT02427126|Analgesics|analgesics|mesh-ancestor
83374884|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
83374885|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374886|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374887|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374888|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374889|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83374890|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83374891|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374892|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83374893|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83374894|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374895|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
83374896|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83374897|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
83374898|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83374899|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
83374900|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
83374901|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83374902|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83374903|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83374904|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374905|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374906|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83374907|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83374908|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374909|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
83374910|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374911|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
83374912|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83374913|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83374914|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
83374915|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374916|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83374917|NCT04797312|Sufentanil|sufentanil|mesh-list
83374918|NCT04797312|Remifentanil|remifentanil|mesh-list
83374919|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
83374920|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
83374921|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83374922|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374923|NCT04797312|Narcotics|narcotics|mesh-ancestor
83374924|NCT04797312|Analgesics|analgesics|mesh-ancestor
83374925|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
83374926|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374927|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83374928|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83374929|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
83374930|NCT05080140|Ezetimibe|ezetimibe|mesh-list
83374931|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83374932|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83374933|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
83374934|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374935|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83374936|NCT01390441|Acetaminophen|acetaminophen|mesh-list
83374937|NCT01390441|Loratadine|loratadine|mesh-list
83374938|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
83374939|NCT01390441|Rituximab|rituximab|mesh-list
83374940|NCT01390441|Methotrexate|methotrexate|mesh-list
83374941|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83374942|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374943|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
83374944|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83374945|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83374946|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83374947|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
83374948|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83374949|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83374950|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
83374951|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374952|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
83374953|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374954|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83374955|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83374956|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83374957|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83374958|NCT01390441|Analgesics|analgesics|mesh-ancestor
83374959|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
83374960|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83374961|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
83374962|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83374963|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
83374964|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
83374965|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83374966|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
83374967|NCT01390441|Hormones|hormones|mesh-ancestor
83374968|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83374969|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83374970|NCT01390441|Protective Agents|protective agents|mesh-ancestor
83374971|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
83374972|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83374973|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83374974|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83374975|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
83374976|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
83374977|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83374978|NCT03142542|Udenafil|udenafil|mesh-list
83374979|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83374980|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83374981|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374982|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374983|NCT03025867|Niraparib|niraparib|mesh-list
83374984|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83374985|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83374986|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83374987|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83374988|NCT01412879|Leucovorin|leucovorin|mesh-list
83374989|NCT01412879|Cytarabine|cytarabine|mesh-list
83374990|NCT01412879|Dexamethasone|dexamethasone|mesh-list
83374991|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
83374992|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
83374993|NCT01412879|Rituximab|rituximab|mesh-list
83374994|NCT01412879|Doxorubicin|doxorubicin|mesh-list
83374995|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83374996|NCT01412879|Methotrexate|methotrexate|mesh-list
83374997|NCT01412879|Vincristine|vincristine|mesh-list
83374998|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
83374999|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375000|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
83375001|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375002|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375003|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83375004|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
83375005|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375006|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375007|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83375008|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375009|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83375010|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
83375011|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
83375012|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375013|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83375014|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
83375016|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375017|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83375018|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83375019|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83375020|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83375021|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375022|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83375023|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
83375024|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83375025|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83375026|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
83375027|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
83375028|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83375029|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83375030|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
83375031|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375032|NCT01412879|Antidotes|antidotes|mesh-ancestor
83375033|NCT01412879|Protective Agents|protective agents|mesh-ancestor
83375034|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
83375035|NCT01412879|Vitamins|vitamins|mesh-ancestor
83375036|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
83375037|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83375038|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
83375039|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
83375040|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
83375041|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
83375042|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83375043|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375044|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375045|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83375046|NCT03143010|Analgesics|analgesics|mesh-ancestor
83375047|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
83375048|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375049|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83375050|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83375051|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83375052|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
83375053|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375054|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375055|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83375056|NCT03142776|Clarithromycin|clarithromycin|mesh-list
83375057|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375058|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83375059|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375060|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375061|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83375062|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83375063|NCT01430611|Vaccines|vaccines|mesh-list
83375064|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
83375065|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375066|NCT03140826|Meropenem|meropenem|mesh-list
83375067|NCT03140826|Tazobactam|tazobactam|mesh-list
83375068|NCT03140826|Piperacillin|piperacillin|mesh-list
83375069|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
83375070|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83375071|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375072|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83375073|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375074|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375075|NCT01389973|Ustekinumab|ustekinumab|mesh-list
83375076|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
83375077|NCT04529460|Antibodies|antibodies|mesh-list
83375078|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
83375079|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375080|NCT04032067|Finasteride|finasteride|mesh-list
83375081|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
83375082|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83375083|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375084|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375085|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
83375086|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375087|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375088|NCT04032067|Urological Agents|urological agents|mesh-ancestor
83375089|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
83375090|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83375091|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375092|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
83375093|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
83375094|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83375095|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
83375096|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375097|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375098|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83375099|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83375100|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375101|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375103|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
83375104|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
83375105|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
83375106|NCT04051957|Diuretics|diuretics|mesh-ancestor
83375107|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
83375108|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375109|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
83375110|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
83375111|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375112|NCT05084196|Melatonin|melatonin|mesh-list
83375113|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
83375114|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375115|NCT05084196|Protective Agents|protective agents|mesh-ancestor
83375116|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375117|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375118|NCT00591123|Leucovorin|leucovorin|mesh-list
83375119|NCT00591123|Fluorouracil|fluorouracil|mesh-list
83375120|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
83375121|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
83375122|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
83375123|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375124|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
83375125|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375126|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83375127|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375128|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375129|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
83375130|NCT00591123|Antidotes|antidotes|mesh-ancestor
83375131|NCT00591123|Protective Agents|protective agents|mesh-ancestor
83375132|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
83375133|NCT00591123|Vitamins|vitamins|mesh-ancestor
83375134|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
83375135|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83375136|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375137|NCT04149990|Valsartan|valsartan|mesh-list
83375138|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83375139|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83375140|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83375141|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83375142|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375143|NCT00591825|Cycloserine|cycloserine|mesh-list
83375144|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83375145|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375146|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83375147|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
83375148|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83375149|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
83375150|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375151|NCT01429285|Hydromorphone|hydromorphone|mesh-list
83375152|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83375153|NCT01429285|Narcotics|narcotics|mesh-ancestor
83375154|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375155|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375156|NCT01429285|Analgesics|analgesics|mesh-ancestor
83375157|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
83375158|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375159|NCT00594945|Clonazepam|clonazepam|mesh-list
83375160|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
83375161|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
83375162|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
83375163|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375164|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375165|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375166|NCT00595101|Latanoprost|latanoprost|mesh-list
83375167|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83375168|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83375169|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83375170|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83375171|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375172|NCT00660075|Incretins|incretins|mesh-ancestor
83375173|NCT00660075|Hormones|hormones|mesh-ancestor
83375174|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375175|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83375176|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
83375177|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375178|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375179|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
83375180|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83375181|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375182|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83375183|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375184|NCT01429051|Fentanyl|fentanyl|mesh-list
83375185|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83375186|NCT01429051|Narcotics|narcotics|mesh-ancestor
83375187|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375188|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375189|NCT01429051|Analgesics|analgesics|mesh-ancestor
83375190|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
83375191|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375192|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83375193|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83375194|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
83375195|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
83375196|NCT03968562|Doxycycline|doxycycline|mesh-list
83375197|NCT03968562|Petrolatum|petrolatum|mesh-list
83375198|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83375199|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375200|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
83375201|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83375202|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83375203|NCT03968562|Emollients|emollients|mesh-ancestor
83375204|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
83375205|NCT03425292|Bevacizumab|bevacizumab|mesh-list
83375206|NCT03425292|Nivolumab|nivolumab|mesh-list
83375207|NCT03425292|Ipilimumab|ipilimumab|mesh-list
83375208|NCT03425292|Temozolomide|temozolomide|mesh-list
83375209|NCT03425292|Lomustine|lomustine|mesh-list
83375210|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375211|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375212|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83375213|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83375214|NCT03425292|Growth Substances|growth substances|mesh-ancestor
83375215|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375216|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
83375217|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83375218|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375219|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83375220|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
83375221|NCT00596271|Vaccines|vaccines|mesh-list
83375222|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
83375223|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375224|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
83375225|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
83375226|NCT03139422|Calcium|calcium|mesh-list
83375227|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83375228|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375229|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83375230|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83375231|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375232|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
83375233|NCT03139422|Coagulants|coagulants|mesh-ancestor
83375234|NCT01428583|Naltrexone|naltrexone|mesh-list
83375236|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83375237|NCT01428583|Narcotics|narcotics|mesh-ancestor
83375238|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375239|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375240|NCT01428583|Analgesics|analgesics|mesh-ancestor
83375241|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
83375242|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375243|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
83375244|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83375245|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
83375246|NCT00660543|Hematinics|hematinics|mesh-ancestor
83375247|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83375248|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83375249|NCT01428193|Flutamide|flutamide|mesh-list
83375250|NCT01428193|Estradiol|estradiol|mesh-list
83375251|NCT01428193|Progesterone|progesterone|mesh-list
83375252|NCT01428193|Estrogens|estrogens|mesh-ancestor
83375253|NCT01428193|Hormones|hormones|mesh-ancestor
83375254|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375255|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375256|NCT01428193|Progestins|progestins|mesh-ancestor
83375257|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
83375258|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
83375259|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83375260|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375261|NCT03864276|Propofol|propofol|mesh-list
83375262|NCT03864276|Desflurane|desflurane|mesh-list
83375263|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
83375264|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375265|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375266|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83375267|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83375268|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
83375269|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83375270|NCT05083026|Antibodies|antibodies|mesh-list
83375271|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
83375272|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
83375273|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375274|NCT03141918|Curcumin|curcumin|mesh-list
83375275|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83375276|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83375277|NCT03141918|Analgesics|analgesics|mesh-ancestor
83375278|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
83375279|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375280|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375281|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83375282|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375283|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375284|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375285|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375286|NCT01427803|Naproxen|naproxen|mesh-list
83375287|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83375288|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83375289|NCT01427803|Analgesics|analgesics|mesh-ancestor
83375290|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
83375291|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375292|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375293|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83375294|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375295|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
83375296|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83375297|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375298|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375299|NCT03139500|Midazolam|midazolam|mesh-list
83375300|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83375301|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83375302|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375303|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375304|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83375305|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83375306|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83375307|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83375308|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
83375309|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
83375310|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
83375311|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
83375312|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375313|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375314|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83375315|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83375316|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83375317|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83375318|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83375319|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
83375320|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375321|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375322|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375323|NCT04476966|Mirabegron|mirabegron|mesh-list
83375324|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
83375325|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83375326|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83375327|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
83375328|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375329|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375330|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375331|NCT04476966|Urological Agents|urological agents|mesh-ancestor
83375332|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
83375333|NCT03821610|Melphalan|melphalan|mesh-list
83375334|NCT03821610|Fludarabine|fludarabine|mesh-list
83375335|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
83375336|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375337|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
83375338|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375339|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375340|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83375341|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
83375342|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375343|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375344|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83375345|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375346|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
83375347|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
83375348|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83375349|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375350|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83375351|NCT04044001|Isoniazid|isoniazid|mesh-list
83375352|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
83375353|NCT04044001|Ethambutol|ethambutol|mesh-list
83375354|NCT04044001|Dolutegravir|dolutegravir|mesh-list
83375355|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
83375356|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83375357|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375358|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375359|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375360|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
83375361|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83375362|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
83375363|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83375364|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83375365|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83375366|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83375367|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83375368|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
83375369|NCT00684723|Lovastatin|lovastatin|mesh-list
83375370|NCT00684723|L 647318|l 647318|mesh-list
83375371|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
83375372|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83375373|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83375374|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
83375375|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375376|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83375377|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83375378|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375379|NCT01405027|Interferons|interferons|mesh-list
83375380|NCT01405027|Ribavirin|ribavirin|mesh-list
83375381|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
83375382|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
83375383|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
83375384|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83375385|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375386|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
83375387|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375388|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
83375389|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375390|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
83375391|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375392|NCT00663039|Oxytocin|oxytocin|mesh-list
83375393|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
83375394|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83375395|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375396|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
83375397|NCT04387539|Simeprevir|simeprevir|mesh-list
83375398|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
83375399|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375400|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
83375401|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375402|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375403|NCT00664755|Nicotine|nicotine|mesh-list
83375404|NCT00664755|Varenicline|varenicline|mesh-list
83375405|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83375406|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
83375407|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375408|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375409|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83375410|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83375411|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
83375412|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375413|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375414|NCT01525628|Tolbutamide|tolbutamide|mesh-list
83375415|NCT01525628|Interferons|interferons|mesh-list
83375416|NCT01525628|Tenofovir|tenofovir|mesh-list
83375417|NCT01525628|Ribavirin|ribavirin|mesh-list
83375418|NCT01525628|Midazolam|midazolam|mesh-list
83375419|NCT01525628|Caffeine|caffeine|mesh-list
83375420|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375421|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
83375422|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375423|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83375424|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83375425|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375426|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375427|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83375428|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83375429|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83375430|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83375431|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
83375432|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
83375433|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
83375434|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
83375435|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375436|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375437|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
83375438|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83375439|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375440|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83375441|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83375442|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
83375443|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83375444|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83375445|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83375446|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83375447|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
83375448|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83375449|NCT00665457|Celecoxib|celecoxib|mesh-list
83375450|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
83375451|NCT00665457|Docetaxel|docetaxel|mesh-list
83375452|NCT00665457|Doxorubicin|doxorubicin|mesh-list
83375453|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83375454|NCT00665457|Capecitabine|capecitabine|mesh-list
83375455|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375456|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
83375457|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375458|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375459|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83375460|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
83375461|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375462|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375463|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83375464|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
83375465|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
83375466|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
83375467|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83375468|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83375469|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83375470|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375471|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83375472|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
83375473|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83375474|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83375475|NCT00665457|Analgesics|analgesics|mesh-ancestor
83375476|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
83375477|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375478|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83375479|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
83375480|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83375481|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83375482|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
83375483|NCT02320695|Bacitracin|bacitracin|mesh-list
83375484|NCT02320695|Neomycin|neomycin|mesh-list
83375485|NCT02320695|Polymyxin B|polymyxin b|mesh-list
83375486|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83375487|NCT02320695|Ethanol|ethanol|mesh-list
83375488|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375489|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
83375490|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83375491|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375492|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375493|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83375494|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375495|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375496|NCT01426009|Bromides|bromides|mesh-list
83375497|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
83375498|NCT01426009|Ipratropium|ipratropium|mesh-list
83375499|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83375500|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
83375501|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375502|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375503|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83375504|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
83375505|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
83375506|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83375507|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
83375508|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375509|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375510|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
83375511|NCT01543958|Sevelamer|sevelamer|mesh-list
83375512|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
83375513|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
83375514|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375515|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83375516|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83375517|NCT01411085|Risperidone|risperidone|mesh-list
83375518|NCT01411085|Desipramine|desipramine|mesh-list
83375519|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83375520|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
83375521|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375522|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375523|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375524|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83375525|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83375526|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375527|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83375528|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83375529|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
83375530|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
83375531|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
83375532|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375533|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83375534|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83375535|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83375536|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
83375537|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
83375538|NCT01404949|Tretinoin|tretinoin|mesh-list
83375539|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375540|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
83375541|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
83375543|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83375544|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375545|NCT00601965|Escitalopram|escitalopram|mesh-list
83375546|NCT00601965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83375547|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83375548|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83375549|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375550|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375551|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
83375552|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375553|NCT04751994|Sorbitol|sorbitol|mesh-list
83375554|NCT04751994|Cathartics|cathartics|mesh-ancestor
83375555|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83375556|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
83375557|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83375558|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375559|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
83375560|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83375561|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375562|NCT04738422|Glycine|glycine|mesh-list
83375563|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
83375564|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375565|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375566|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375567|NCT02998437|Amoxicillin|amoxicillin|mesh-list
83375568|NCT02998437|Clarithromycin|clarithromycin|mesh-list
83375569|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83375570|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375571|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83375572|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375573|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375574|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83375575|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83375577|NCT02618148|Hormones|hormones|mesh-ancestor
83375578|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375579|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375580|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83375581|NCT01404325|Everolimus|everolimus|mesh-list
83375582|NCT01404325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83375583|NCT01404325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83375584|NCT01404325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375585|NCT01404325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375586|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375587|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
83375588|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375589|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375590|NCT00602355|Sertraline|sertraline|mesh-list
83375591|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
83375592|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83375593|NCT00602355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83375594|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83375595|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83375596|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375597|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375598|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
83375599|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375600|NCT01425463|Glycine|glycine|mesh-list
83375601|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
83375602|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375603|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375604|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375605|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
83375606|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
83375607|NCT02144259|Etonogestrel|etonogestrel|mesh-list
83375608|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
83375609|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83375610|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83375611|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
83375612|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83375613|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375614|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83375615|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83375616|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
83375617|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83375618|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375619|NCT04655586|Heparin|heparin|mesh-list
83375620|NCT04655586|Protein C|protein c|mesh-list
83375621|NCT04655586|Anticoagulants|anticoagulants|mesh-list
83375622|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83375623|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83375624|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375625|NCT01388647|Carboplatin|carboplatin|mesh-list
83375626|NCT01388647|Trastuzumab|trastuzumab|mesh-list
83375627|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375628|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375629|NCT03140982|Propofol|propofol|mesh-list
83375630|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83375631|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375632|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375633|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83375634|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
83375635|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
83375636|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83375637|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
83375638|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375639|NCT05392686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375640|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375641|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375642|NCT00705003|Melatonin|melatonin|mesh-list
83375643|NCT00705003|Buspirone|buspirone|mesh-list
83375645|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375646|NCT00705003|Protective Agents|protective agents|mesh-ancestor
83375647|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375648|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375649|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
83375650|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83375651|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83375652|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83375653|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
83375654|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375655|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
83375656|NCT03110640|Fludarabine|fludarabine|mesh-list
83375657|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375658|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
83375659|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375660|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375661|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83375662|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
83375663|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375664|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375665|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83375666|NCT00690495|Propofol|propofol|mesh-list
83375667|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83375668|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375669|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375670|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83375671|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
83375672|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
83375673|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
83375674|NCT00691197|Glycerol|glycerol|mesh-list
83375675|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83375676|NCT00691197|Protective Agents|protective agents|mesh-ancestor
83375677|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375678|NCT00691197|Laxatives|laxatives|mesh-ancestor
83375679|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83375680|NCT02997969|Vaccines|vaccines|mesh-list
83375681|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
83375682|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
83375683|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375684|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83375685|NCT04351230|Trastuzumab|trastuzumab|mesh-list
83375686|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
83375687|NCT04351230|Maytansine|maytansine|mesh-list
83375688|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
83375689|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375690|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375691|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83375692|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
83375693|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
83375694|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
83375695|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375696|NCT04351230|Immunotoxins|immunotoxins|mesh-ancestor
83375697|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
83375698|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375699|NCT04200534|Nicotine|nicotine|mesh-list
83375700|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
83375701|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
83375702|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375703|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375704|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83375705|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83375706|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
83375707|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375708|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375709|NCT05392374|TIC10 compound|tic10 compound|mesh-list
83375710|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375711|NCT04028388|Docetaxel|docetaxel|mesh-list
83375712|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375713|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
83375714|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
83375715|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
83375716|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375718|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
83375719|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83375720|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
83375721|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375722|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375723|NCT01796301|Teriparatide|teriparatide|mesh-list
83375724|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83375725|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375726|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83375727|NCT00868179|Dabigatran|dabigatran|mesh-list
83375728|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
83375729|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83375730|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
83375731|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375732|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375733|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
83375734|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
83375735|NCT01204905|Maraviroc|maraviroc|mesh-list
83375736|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83375737|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83375738|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
83375739|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375740|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
83375741|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
83375742|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375743|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375744|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
83375745|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
83375746|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
83375747|NCT00691665|Fluticasone|fluticasone|mesh-list
83375748|NCT00691665|Xhance|xhance|mesh-list
83375749|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
83375750|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83375751|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83375752|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
83375753|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375754|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375755|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83375756|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
83375757|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
83375758|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83375759|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83375760|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83375761|NCT00691665|Analgesics|analgesics|mesh-ancestor
83389730|NCT03402087|Antidotes|antidotes|mesh-ancestor
83375762|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
83375763|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375764|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83375765|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83375766|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
83375767|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
83375768|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375769|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375770|NCT01388335|Warfarin|warfarin|mesh-list
83375771|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
83375772|NCT00713583|Levodopa|levodopa|mesh-list
83375773|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83375774|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83375775|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
83375776|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375777|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375778|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375779|NCT03359460|Lenalidomide|lenalidomide|mesh-list
83375780|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
83375781|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375782|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83375783|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83375784|NCT03359460|Growth Substances|growth substances|mesh-ancestor
83375785|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
83375786|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375787|NCT03025477|Paclitaxel|paclitaxel|mesh-list
83375788|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83375789|NCT03025477|Cisplatin|cisplatin|mesh-list
83375790|NCT03025477|Carboplatin|carboplatin|mesh-list
83375791|NCT03025477|Epirubicin|epirubicin|mesh-list
83375792|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83375793|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375794|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
83375795|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
83375796|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
83375797|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375798|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83375799|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83375800|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83375801|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375802|NCT03147378|Docetaxel|docetaxel|mesh-list
83375803|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375804|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
83375805|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
83375806|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
83375807|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375808|NCT00159744|Olanzapine|olanzapine|mesh-list
83375809|NCT00159744|Asenapine|asenapine|mesh-list
83375810|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
83375811|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
83375812|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375813|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375814|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83375815|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83375816|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83375817|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83375818|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83375819|NCT00159744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83375820|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83375821|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83375822|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375823|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375824|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
83375825|NCT04041973|Lumefantrine|lumefantrine|mesh-list
83375826|NCT04041973|Artemether|artemether|mesh-list
83375827|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
83375828|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
83375829|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83375830|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83375831|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375832|NCT02914470|Atezolizumab|atezolizumab|mesh-list
83375833|NCT02914470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83375834|NCT02914470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375835|NCT02914470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375836|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375837|NCT05088330|Daratumumab|daratumumab|mesh-list
83375838|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375839|NCT00695097|Rituximab|rituximab|mesh-list
83375840|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375841|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375842|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
83375843|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375844|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375845|NCT01795911|Interferons|interferons|mesh-list
83375846|NCT01795911|Ribavirin|ribavirin|mesh-list
83375847|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375848|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
83375849|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375850|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
83375851|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375852|NCT03137316|Hormones|hormones|mesh-list
83375853|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
83375854|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375855|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375856|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83375857|NCT03137082|Guanfacine|guanfacine|mesh-list
83375858|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83375859|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83375860|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83375861|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83375862|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
83375863|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83375864|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375865|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375866|NCT05088174|Cyclosporine|cyclosporine|mesh-list
83375867|NCT05088174|Cyclosporins|cyclosporins|mesh-list
83375868|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375869|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375870|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375871|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
83375872|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375873|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
83375874|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375875|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
83375876|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375877|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83375878|NCT03041688|Decitabine|decitabine|mesh-list
83375879|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83375880|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
83375881|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375882|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375883|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375884|NCT00695409|Cytarabine|cytarabine|mesh-list
83375885|NCT00695409|Rituximab|rituximab|mesh-list
83375886|NCT00695409|Etoposide|etoposide|mesh-list
83375887|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
83375888|NCT00695409|Melphalan|melphalan|mesh-list
83375889|NCT00695409|Carmustine|carmustine|mesh-list
83375890|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83375891|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83375892|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375893|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
83375894|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375895|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375896|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83375897|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83375898|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83375899|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375900|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375901|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83375902|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
83375903|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
83375904|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375905|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375906|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83375907|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
83375908|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83375909|NCT03469050|Rifaximin|rifaximin|mesh-list
83375910|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83375911|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83375912|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83375913|NCT05087706|Bicalutamide|bicalutamide|mesh-list
83375915|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
83375916|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
83375917|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375918|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375919|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375920|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83375921|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
83375922|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83375923|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83375924|NCT02990403|Aspirin|aspirin|mesh-list
83375925|NCT02990403|Prednisone|prednisone|mesh-list
83375926|NCT02990403|Heparin|heparin|mesh-list
83375927|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
83375928|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
83375929|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
83375930|NCT02990403|Antibodies|antibodies|mesh-list
83375931|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83375932|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
83375933|NCT02990403|Hormones|hormones|mesh-ancestor
83375934|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83375935|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375936|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83375937|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375938|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83375939|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83375940|NCT02990403|Analgesics|analgesics|mesh-ancestor
83375941|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
83375942|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83375943|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83375944|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83375945|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83375946|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375947|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83375948|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83375949|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375950|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
83375951|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
83375952|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
83375953|NCT02990403|Progestins|progestins|mesh-ancestor
83375954|NCT00697203|Pravastatin|pravastatin|mesh-list
83375955|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
83375956|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83375957|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83375958|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
83375959|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375960|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83375961|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83375962|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375964|NCT05086848|Fluorouracil|fluorouracil|mesh-list
83375965|NCT05086848|Irinotecan|irinotecan|mesh-list
83375966|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
83375967|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375968|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83375969|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375970|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375971|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
83375972|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375973|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83375974|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83375975|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375976|NCT05086848|Antidotes|antidotes|mesh-ancestor
83375977|NCT05086848|Protective Agents|protective agents|mesh-ancestor
83375978|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
83375979|NCT05086848|Vitamins|vitamins|mesh-ancestor
83375980|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
83375981|NCT00830895|Everolimus|everolimus|mesh-list
83375982|NCT00830895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
83375983|NCT00830895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83375984|NCT00830895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375985|NCT00830895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375986|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83375987|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
83375988|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375989|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83375990|NCT01158417|Resveratrol|resveratrol|mesh-list
83375991|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
83375992|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83375993|NCT01158417|Protective Agents|protective agents|mesh-ancestor
83375994|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83375995|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83375996|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83375997|NCT05086614|Thymalfasin|thymalfasin|mesh-list
83375998|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83375999|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
83376000|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376001|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
83376002|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
83376003|NCT01795131|Vitamins|vitamins|mesh-ancestor
83376004|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
83376005|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376006|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
83376007|NCT01795131|Hematinics|hematinics|mesh-ancestor
83376008|NCT03137004|Docetaxel|docetaxel|mesh-list
83376009|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376010|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
83376011|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
83376012|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
83376013|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376014|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
83376015|NCT03113994|Vitamin D|vitamin d|mesh-list
83376016|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
83376017|NCT03113994|Ubiquinone|ubiquinone|mesh-list
83376018|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
83376019|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
83376020|NCT03113994|Calcium|calcium|mesh-list
83376021|NCT03113994|Vitamins|vitamins|mesh-ancestor
83376022|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
83376023|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376024|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83376025|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83376026|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83376027|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83376028|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
83376029|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376030|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83376031|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83376032|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376033|NCT03113994|Antacids|antacids|mesh-ancestor
83376034|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376035|NCT02003742|Tamsulosin|tamsulosin|mesh-list
83376036|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83376037|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83376038|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83376039|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
83376040|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376041|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376042|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376043|NCT02003742|Urological Agents|urological agents|mesh-ancestor
83376044|NCT03134118|Nivolumab|nivolumab|mesh-list
83376045|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376046|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376047|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83376048|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376049|NCT05085912|Ethanol|ethanol|mesh-list
83376050|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83376051|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376052|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376053|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376054|NCT02339415|Edoxaban|edoxaban|mesh-list
83376055|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
83376056|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
83376057|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
83376058|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
83376059|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376060|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376061|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
83376062|NCT02998047|Lintuzumab|lintuzumab|mesh-list
83376063|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376064|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376065|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
83376066|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
83376067|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83376068|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376069|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376070|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376071|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376072|NCT03110172|Analgesics|analgesics|mesh-ancestor
83376073|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
83376074|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376075|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
83376076|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83376077|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
83376078|NCT01400503|Siltuximab|siltuximab|mesh-list
83376079|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376081|NCT00706719|Clomiphene|clomiphene|mesh-list
83376082|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
83376083|NCT00706719|Testosterone|testosterone|mesh-list
83376084|NCT00706719|Androgens|androgens|mesh-ancestor
83376085|NCT00706719|Hormones|hormones|mesh-ancestor
83376086|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376087|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376088|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83376089|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
83376090|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83376091|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
83376092|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83376093|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83376094|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83376095|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
83376096|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83376097|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376098|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376099|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83376100|NCT05079672|Analgesics|analgesics|mesh-ancestor
83376101|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
83376102|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376103|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83376104|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83376105|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83376106|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
83376107|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376108|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376109|NCT04766827|Paclitaxel|paclitaxel|mesh-list
83376110|NCT04766827|Docetaxel|docetaxel|mesh-list
83376111|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83376112|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83376113|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376114|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
83376115|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
83376116|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
83376117|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376118|NCT02960568|Primaquine|primaquine|mesh-list
83376119|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
83376120|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83376121|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83376122|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376123|NCT02996409|Lidocaine|lidocaine|mesh-list
83376124|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
83376125|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
83376126|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376127|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376128|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
83376129|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376130|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83376131|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83376132|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83376133|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376134|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376135|NCT02864004|Apomorphine|apomorphine|mesh-list
83376136|NCT02864004|Emetics|emetics|mesh-ancestor
83376137|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376138|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
83389731|NCT03402087|Protective Agents|protective agents|mesh-ancestor
83376139|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376140|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376141|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
83376142|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
83376143|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376144|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376145|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83376146|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83376147|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376148|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376149|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83376150|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376151|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376152|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
83376153|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376155|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83376156|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83376157|NCT01421641|Lidocaine|lidocaine|mesh-list
83376158|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
83376159|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
83376160|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376161|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376162|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
83376163|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376164|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83376165|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83376166|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83376167|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376168|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376169|NCT05068206|Bevacizumab|bevacizumab|mesh-list
83376170|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376171|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376172|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376173|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83376174|NCT05068206|Growth Substances|growth substances|mesh-ancestor
83376175|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376176|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
83376177|NCT05063370|Simendan|simendan|mesh-list
83376178|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83376179|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
83376180|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
83376181|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83376182|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376183|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376184|NCT05063370|Protective Agents|protective agents|mesh-ancestor
83376185|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376186|NCT05090124|Adalimumab|adalimumab|mesh-list
83376187|NCT05090124|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83376188|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376189|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376190|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
83376191|NCT01421017|Imiquimod|imiquimod|mesh-list
83376192|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376193|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
83376194|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376195|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376196|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83376197|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
83376198|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376199|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376200|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83376201|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83376202|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
83376203|NCT05020392|Vidarabine|vidarabine|mesh-list
83376204|NCT05020392|Cyclophosphamide|cyclophosphamide|mesh-list
83376205|NCT05020392|Fludarabine|fludarabine|mesh-list
83376206|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
83376207|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376208|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
83376209|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376210|NCT05020392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376211|NCT05020392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83376212|NCT05020392|Alkylating Agents|alkylating agents|mesh-ancestor
83376213|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376214|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376215|NCT05020392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83376216|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83376217|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
83376218|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
83376219|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376220|NCT04951050|Sirolimus|sirolimus|mesh-list
83376221|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376222|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376223|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83376224|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376226|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376227|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
83376228|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376229|NCT05089344|Clomiphene|clomiphene|mesh-list
83376230|NCT05089344|Enclomiphene|enclomiphene|mesh-list
83376231|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
83376232|NCT05089344|Hormones|hormones|mesh-list
83376233|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376234|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376235|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83376236|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
83376237|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
83376238|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
83376239|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83376240|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
83376241|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
83376242|NCT01400113|Asenapine|asenapine|mesh-list
83376243|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83376244|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83376245|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376246|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376247|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83376248|NCT01399723|Amoxicillin|amoxicillin|mesh-list
83376249|NCT01399723|Penicillins|penicillins|mesh-list
83376250|NCT01399723|Penicillin G|penicillin g|mesh-list
83376251|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
83376252|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
83376253|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376254|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376255|NCT04771962|Sevoflurane|sevoflurane|mesh-list
83376256|NCT04771962|Desflurane|desflurane|mesh-list
83376257|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83376258|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83376259|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
83376260|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
83376261|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376262|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376263|NCT04726098|Dexamethasone|dexamethasone|mesh-list
83376264|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
83376265|NCT04726098|BB 1101|bb 1101|mesh-list
83376266|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376267|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
83376268|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
83376269|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376270|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376271|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376272|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
83376273|NCT04726098|Hormones|hormones|mesh-ancestor
83376274|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376275|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83376276|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376277|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
83376278|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376279|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376280|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
83376281|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
83376282|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376283|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376284|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376285|NCT05088720|Misoprostol|misoprostol|mesh-list
83376286|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83376287|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
83376288|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83376289|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376290|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83376291|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376292|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
83376293|NCT01383499|Bromides|bromides|mesh-list
83376294|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
83376295|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83376296|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
83376297|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376298|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376299|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83376300|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
83376301|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
83376302|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83376303|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
83376304|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376305|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376307|NCT05084118|Landiolol|landiolol|mesh-list
83376308|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83376309|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83376310|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
83376311|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376312|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376313|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376314|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83376315|NCT03025009|Insulin|insulin|mesh-list
83376316|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83376317|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
83376318|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83376319|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376320|NCT03135912|Terbinafine|terbinafine|mesh-list
83376321|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
83376322|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376323|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376324|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376325|NCT01397461|Retapamulin|retapamulin|mesh-list
83376326|NCT01397461|Ozenoxacin|ozenoxacin|mesh-list
83376327|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376328|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376329|NCT01397461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83376330|NCT01397461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376331|NCT01397461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376332|NCT01397461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376333|NCT04335084|Vitamin D|vitamin d|mesh-list
83376334|NCT04335084|Vitamins|vitamins|mesh-list
83376335|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
83376336|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
83376337|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376338|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83376339|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
83376340|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83376341|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83376342|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376343|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376344|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376345|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376346|NCT02996019|Etrolizumab|etrolizumab|mesh-list
83376347|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376348|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
83376349|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376350|NCT02997501|Osimertinib|osimertinib|mesh-list
83376351|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376352|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83376353|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376354|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376355|NCT02998827|Thalidomide|thalidomide|mesh-list
83376356|NCT02998827|Infliximab|infliximab|mesh-list
83376357|NCT02998827|Azathioprine|azathioprine|mesh-list
83376358|NCT02998827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83376359|NCT02998827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376360|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
83376361|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376362|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376363|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376364|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
83376365|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376366|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
83376367|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376368|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376369|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376370|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83376371|NCT02998827|Growth Substances|growth substances|mesh-ancestor
83376372|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
83376373|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376374|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
83376375|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376376|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83376378|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376379|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
83376380|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376381|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
83376382|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376383|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376384|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376385|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83376386|NCT02995707|Growth Substances|growth substances|mesh-ancestor
83376387|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
83376388|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376389|NCT01270035|Adalimumab|adalimumab|mesh-list
83376390|NCT01270035|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83376391|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376392|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376393|NCT01396447|Cariprazine|cariprazine|mesh-list
83376394|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
83376395|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83376396|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376397|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376398|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83376399|NCT05738148|Vasopressins|vasopressins|mesh-list
83376400|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
83376401|NCT05738148|Epinephrine|epinephrine|mesh-list
83376402|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83376403|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83376404|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
83376405|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376406|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376407|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376408|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83376409|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83376410|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
83376411|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376412|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83376413|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
83376414|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
83376415|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
83376416|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83376417|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
83376418|NCT05738148|Coagulants|coagulants|mesh-ancestor
83376419|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
83376420|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
83376421|NCT00704379|Sertraline|sertraline|mesh-list
83376422|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
83376423|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83376424|NCT00704379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83376425|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83376426|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376427|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376428|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376429|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
83376430|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376431|NCT02991495|Vaccines|vaccines|mesh-list
83376432|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
83376433|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376434|NCT04449042|Anesthetics|anesthetics|mesh-list
83376435|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376436|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376437|NCT04341090|Apatinib|apatinib|mesh-list
83376438|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376439|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83376440|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376441|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376442|NCT00707655|Zalutumumab|zalutumumab|mesh-list
83376443|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376444|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376445|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83376446|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376447|NCT04089150|Leucovorin|leucovorin|mesh-list
83376448|NCT04089150|Paclitaxel|paclitaxel|mesh-list
83376449|NCT04089150|Gemcitabine|gemcitabine|mesh-list
83376450|NCT04089150|Fluorouracil|fluorouracil|mesh-list
83376451|NCT04089150|Capecitabine|capecitabine|mesh-list
83376452|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
83376453|NCT04089150|Irinotecan|irinotecan|mesh-list
83376454|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83376455|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376456|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
83376457|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
83376458|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
83376459|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376460|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83376461|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
83376462|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376463|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
83376464|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376465|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
83376466|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83376467|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376468|NCT04089150|Antidotes|antidotes|mesh-ancestor
83376469|NCT04089150|Protective Agents|protective agents|mesh-ancestor
83376470|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
83376471|NCT04089150|Vitamins|vitamins|mesh-ancestor
83376472|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
83376473|NCT02076919|Acrizanib|acrizanib|mesh-list
83376474|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
83376475|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83376476|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83376477|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376478|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376479|NCT02076997|Methotrexate|methotrexate|mesh-list
83376480|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83376481|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
83376482|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83376483|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376484|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83376485|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
83376486|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376487|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376488|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
83376489|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376490|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83376491|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376492|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
83376493|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376494|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83376495|NCT05365165|Sevoflurane|sevoflurane|mesh-list
83376496|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83376497|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83376498|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
83376499|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
83376500|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376501|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376502|NCT03925350|Niraparib|niraparib|mesh-list
83376503|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
83376504|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376505|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376506|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376507|NCT00707967|Vaccines|vaccines|mesh-list
83376508|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
83376509|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376510|NCT02994381|Ozanimod|ozanimod|mesh-list
83376511|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
83376512|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376513|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376514|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
83376515|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376518|NCT00716079|Labetalol|labetalol|mesh-list
83376519|NCT00716079|Hydralazine|hydralazine|mesh-list
83376520|NCT00716079|Nicardipine|nicardipine|mesh-list
83376521|NCT00716079|Phentolamine|phentolamine|mesh-list
83376522|NCT00716079|Urapidil|urapidil|mesh-list
83376523|NCT00716079|Enalaprilat|enalaprilat|mesh-list
83376524|NCT00716079|Esmolol|esmolol|mesh-list
83376525|NCT00716079|Glycerol|glycerol|mesh-list
83376526|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83376527|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83376528|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
83376529|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
83376530|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376531|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376532|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
83376533|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83376534|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83376535|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
83376536|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376537|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376538|NCT00716079|Analgesics|analgesics|mesh-ancestor
83376539|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
83376540|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83376541|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83376542|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83376543|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
83376544|NCT00716079|Protective Agents|protective agents|mesh-ancestor
83376545|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
83376546|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
83376547|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
83376548|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
83376549|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83376550|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376551|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83376552|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83376553|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
83376554|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83376555|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
83376556|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376557|NCT01270191|Exenatide|exenatide|mesh-list
83376558|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
83376559|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83376560|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376561|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
83376562|NCT01270191|Incretins|incretins|mesh-ancestor
83376563|NCT01270191|Hormones|hormones|mesh-ancestor
83376564|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376565|NCT02999919|Bupivacaine|bupivacaine|mesh-list
83376566|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
83376567|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
83376568|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376569|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376570|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
83376571|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376572|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
83376573|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83376574|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376575|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376576|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83376577|NCT04526652|Analgesics|analgesics|mesh-ancestor
83376578|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
83376579|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376580|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83376581|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83376582|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83376583|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
83376584|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376585|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376587|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
83376588|NCT01381549|Cilastatin|cilastatin|mesh-list
83376589|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376590|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376591|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
83376592|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376593|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376594|NCT00159432|Bevacizumab|bevacizumab|mesh-list
83376595|NCT00159432|Capecitabine|capecitabine|mesh-list
83376596|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
83376597|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376598|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376599|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376600|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83376601|NCT00159432|Growth Substances|growth substances|mesh-ancestor
83376602|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376603|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
83376604|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83376605|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
83376606|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376607|NCT02969850|Vitamin D|vitamin d|mesh-list
83376608|NCT02969850|Calcium|calcium|mesh-list
83376609|NCT02969850|Vitamins|vitamins|mesh-ancestor
83376610|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
83376611|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376612|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83376613|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83376614|NCT02339766|Morphine|morphine|mesh-list
83376615|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83376616|NCT02339766|Narcotics|narcotics|mesh-ancestor
83376617|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376618|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376619|NCT02339766|Analgesics|analgesics|mesh-ancestor
83376620|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
83376621|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376622|NCT04287660|Clarithromycin|clarithromycin|mesh-list
83376623|NCT04287660|Dexamethasone|dexamethasone|mesh-list
83376624|NCT04287660|Lenalidomide|lenalidomide|mesh-list
83376625|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376626|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
83376627|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
83376628|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376629|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376630|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376631|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
83376632|NCT04287660|Hormones|hormones|mesh-ancestor
83376633|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376634|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83376635|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376636|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
83376637|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376638|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83376639|NCT04287660|Growth Substances|growth substances|mesh-ancestor
83376640|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
83376641|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376642|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376643|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83376644|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376645|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376646|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83376647|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83376648|NCT01396057|Dexamethasone|dexamethasone|mesh-list
83376649|NCT01396057|Ranibizumab|ranibizumab|mesh-list
83376650|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376651|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
83376652|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
83376653|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376654|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376655|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376656|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
83376657|NCT01396057|Hormones|hormones|mesh-ancestor
83376658|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376659|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83376660|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376661|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376662|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83376663|NCT01396057|Growth Substances|growth substances|mesh-ancestor
83376664|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
83376665|NCT02419560|Venetoclax|venetoclax|mesh-list
83389732|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
83376666|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376667|NCT04011163|Morphine|morphine|mesh-list
83376668|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83376669|NCT04011163|Narcotics|narcotics|mesh-ancestor
83376670|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376671|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376672|NCT04011163|Analgesics|analgesics|mesh-ancestor
83376673|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
83376674|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376675|NCT00704847|Calcitonin|calcitonin|mesh-list
83376676|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
83376677|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
83376678|NCT00704847|Katacalcin|katacalcin|mesh-list
83376679|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83376680|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376681|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83376682|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
83376683|NCT03393468|Dapivirine|dapivirine|mesh-list
83376684|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83376685|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83376686|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
83376687|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376688|NCT05091606|Anesthetics|anesthetics|mesh-list
83376689|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376690|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376691|NCT01395901|Ondansetron|ondansetron|mesh-list
83376692|NCT01395901|Palonosetron|palonosetron|mesh-list
83376693|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
83376694|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
83376695|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376696|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376697|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376698|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
83376699|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
83376700|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
83376701|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
83376702|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
83376703|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376704|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376705|NCT01395823|Vitamin D|vitamin d|mesh-list
83376706|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
83376707|NCT01395823|Vitamins|vitamins|mesh-ancestor
83376708|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
83376709|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376710|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83376711|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83376712|NCT02993991|Durvalumab|durvalumab|mesh-list
83376713|NCT02993991|Mocetinostat|mocetinostat|mesh-list
83376714|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376715|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376716|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
83376717|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376718|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376719|NCT00158184|Oxycodone|oxycodone|mesh-list
83376720|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83376721|NCT00158184|Narcotics|narcotics|mesh-ancestor
83376722|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376723|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376724|NCT00158184|Analgesics|analgesics|mesh-ancestor
83376725|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
83376726|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376727|NCT02405520|Vaccines|vaccines|mesh-list
83376728|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
83376729|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376730|NCT02993835|Iron|iron|mesh-list
83376731|NCT02993835|Trace Elements|trace elements|mesh-ancestor
83376732|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
83376733|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376734|NCT05091138|Buprenorphine|buprenorphine|mesh-list
83376735|NCT05091138|Bupivacaine|bupivacaine|mesh-list
83376736|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
83376737|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
83376738|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376739|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376740|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
83376741|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376742|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83376743|NCT05091138|Narcotics|narcotics|mesh-ancestor
83376744|NCT05091138|Analgesics|analgesics|mesh-ancestor
83376745|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83376747|NCT02999295|Ramucirumab|ramucirumab|mesh-list
83376748|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376749|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376750|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83376751|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376752|NCT02998905|Aspirin|aspirin|mesh-list
83376753|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83376754|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83376755|NCT02998905|Analgesics|analgesics|mesh-ancestor
83376756|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
83376757|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376758|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376759|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376760|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376761|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83376762|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83376763|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376764|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83376765|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
83376766|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376767|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
83376768|NCT05735184|Cytarabine|cytarabine|mesh-list
83376769|NCT05735184|Azacitidine|azacitidine|mesh-list
83376770|NCT05735184|Daunorubicin|daunorubicin|mesh-list
83376771|NCT05735184|Venetoclax|venetoclax|mesh-list
83376772|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83376773|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
83376774|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376775|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376776|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
83376777|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376778|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376779|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
83376780|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376781|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376782|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83376783|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83376784|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83376785|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
83376786|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83376787|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83376788|NCT02993367|Protective Agents|protective agents|mesh-ancestor
83376789|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376791|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
83376792|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
83376793|NCT05094492|Protective Agents|protective agents|mesh-ancestor
83376794|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376795|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
83376796|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83376797|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376798|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
83376799|NCT05094414|Valacyclovir|valacyclovir|mesh-list
83376800|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
83376801|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376802|NCT04386447|Oxytocin|oxytocin|mesh-list
83376803|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
83376804|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83376805|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376806|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
83376807|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83376808|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376809|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83376810|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
83376811|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83376812|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376813|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83376814|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376815|NCT01380535|Methoxsalen|methoxsalen|mesh-list
83376816|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83376817|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
83376818|NCT00725361|Ambrisentan|ambrisentan|mesh-list
83376819|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83376820|NCT02816424|TEMPO|tempo|mesh-list
83376821|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
83376822|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376823|NCT02816424|Protective Agents|protective agents|mesh-ancestor
83376824|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376825|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
83376826|NCT01275885|Vitamin D|vitamin d|mesh-list
83376827|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83376828|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376829|NCT01275885|Vitamins|vitamins|mesh-ancestor
83376830|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
83376831|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83376832|NCT02794896|Fentanyl|fentanyl|mesh-list
83376833|NCT02794896|Propofol|propofol|mesh-list
83376834|NCT02794896|Sevoflurane|sevoflurane|mesh-list
83376835|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83376836|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376837|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376838|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83376839|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
83376840|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
83376841|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83376842|NCT02794896|Narcotics|narcotics|mesh-ancestor
83376843|NCT02794896|Analgesics|analgesics|mesh-ancestor
83376844|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
83376845|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376846|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83376847|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83376848|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83376849|NCT01271283|Lenalidomide|lenalidomide|mesh-list
83376850|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
83376851|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376852|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376853|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83376854|NCT01271283|Growth Substances|growth substances|mesh-ancestor
83376855|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
83376856|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376857|NCT01271439|Cetuximab|cetuximab|mesh-list
83376858|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376859|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376860|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
83376861|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
83376862|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
83376863|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83376864|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376866|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
83376867|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83376868|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83376869|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
83376870|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376871|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376872|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83376873|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
83376874|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
83376875|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
83376876|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83376877|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83376878|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
83376879|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376880|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376881|NCT02992665|Ionophores|ionophores|mesh-list
83376882|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376883|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376884|NCT05093478|Lidocaine|lidocaine|mesh-list
83376885|NCT05093478|Capsaicin|capsaicin|mesh-list
83376886|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
83376887|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
83376888|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376889|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376890|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
83376891|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376892|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83376893|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83376894|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83376895|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83376896|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376897|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
83376898|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
83376899|NCT00725751|Interferons|interferons|mesh-list
83376901|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
83376902|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
83376903|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
83376904|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376905|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
83376906|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83376907|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
83376908|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376909|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
83376910|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376911|NCT05364385|Budesonide|budesonide|mesh-list
83376912|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
83376913|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376914|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83376915|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
83376916|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376917|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376918|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83376919|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
83376920|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
83376921|NCT05364385|Hormones|hormones|mesh-ancestor
83376922|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376923|NCT00726375|Etanercept|etanercept|mesh-list
83376924|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
83376925|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83376926|NCT00726375|Analgesics|analgesics|mesh-ancestor
83376927|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
83376928|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376929|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376930|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83376931|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83376932|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83376933|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83376934|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
83376935|NCT02693184|Vitamin D|vitamin d|mesh-list
83376936|NCT02693184|Calcium|calcium|mesh-list
83376937|NCT02693184|Vitamins|vitamins|mesh-ancestor
83376938|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
83376939|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376940|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83376941|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83376942|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
83376943|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
83376944|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376945|NCT01394185|Dronabinol|dronabinol|mesh-list
83376946|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
83376947|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376948|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83376949|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83376950|NCT01394185|Analgesics|analgesics|mesh-ancestor
83376951|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
83376952|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376953|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83376954|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83376955|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83376956|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376957|NCT01394185|Hormones|hormones|mesh-ancestor
83376958|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83376959|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
83376960|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376961|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376962|NCT04361851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83376963|NCT04361851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376964|NCT04407715|Anesthetics|anesthetics|mesh-list
83376965|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376966|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376967|NCT00727857|Metformin|metformin|mesh-list
83376968|NCT00727857|Pioglitazone|pioglitazone|mesh-list
83376969|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83376970|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376971|NCT05092152|Propofol|propofol|mesh-list
83376972|NCT05092152|Esketamine|esketamine|mesh-list
83376973|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83376974|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83376975|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376976|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83376977|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
83376978|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
83376979|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
83376980|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83376981|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
83376982|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
83376983|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376985|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
83376986|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83376987|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376988|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83376989|NCT05022810|Acetaminophen|acetaminophen|mesh-list
83376990|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83376991|NCT05022810|Analgesics|analgesics|mesh-ancestor
83376992|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
83376993|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83376994|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83376995|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
83376996|NCT01525550|Sunitinib|sunitinib|mesh-list
83376997|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83376998|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83376999|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83377000|NCT01525550|Growth Substances|growth substances|mesh-ancestor
83377001|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377002|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
83377003|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83377004|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377005|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377006|NCT04730232|Paclitaxel|paclitaxel|mesh-list
83377007|NCT04730232|Tislelizumab|tislelizumab|mesh-list
83377008|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83377009|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377010|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
83377011|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
83377012|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
83377013|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377014|NCT04730232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83377015|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
83377016|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83377017|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377018|NCT04701918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83377019|NCT04701918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377020|NCT04540848|Bupivacaine|bupivacaine|mesh-list
83377021|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
83377022|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
83377023|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377024|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377025|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
83377026|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377027|NCT04793100|Aflibercept|aflibercept|mesh-list
83377028|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83377029|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83377030|NCT04793100|Growth Substances|growth substances|mesh-ancestor
83377031|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377032|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
83377033|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377034|NCT04760028|Anesthetics|anesthetics|mesh-list
83377035|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377036|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377037|NCT05366101|Valsartan|valsartan|mesh-list
83377038|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
83377039|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83377040|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
83377041|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
83377042|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377043|NCT04993560|Vaccines|vaccines|mesh-list
83377044|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
83377045|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377046|NCT05365555|Anesthetics|anesthetics|mesh-list
83377047|NCT05365555|Ropivacaine|ropivacaine|mesh-list
83377048|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
83377049|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377050|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377051|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
83377052|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377053|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
83377054|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83377055|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377056|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83377057|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377058|NCT05374356|Morphine|morphine|mesh-list
83377059|NCT05374356|Bupivacaine|bupivacaine|mesh-list
83377060|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
83377061|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
83377062|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377063|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377064|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
83377065|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377066|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
83377067|NCT05374356|Narcotics|narcotics|mesh-ancestor
83377068|NCT05374356|Analgesics|analgesics|mesh-ancestor
83377069|NCT00717405|Bevacizumab|bevacizumab|mesh-list
83377070|NCT00717405|Trastuzumab|trastuzumab|mesh-list
83377071|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83377072|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377073|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83377074|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83377075|NCT00717405|Growth Substances|growth substances|mesh-ancestor
83377076|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377077|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
83377078|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
83377079|NCT01276977|Eletriptan|eletriptan|mesh-list
83377080|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83377081|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83377082|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
83377083|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377084|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377085|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377086|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
83377087|NCT03832699|Progesterone|progesterone|mesh-list
83377088|NCT03832699|Progestins|progestins|mesh-ancestor
83377089|NCT03832699|Hormones|hormones|mesh-ancestor
83377090|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377091|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377092|NCT01277289|Dexamethasone|dexamethasone|mesh-list
83377093|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377094|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
83377095|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
83377096|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377097|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377098|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83377099|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
83377100|NCT01277289|Hormones|hormones|mesh-ancestor
83377101|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377102|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83377103|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377104|NCT01525082|Bevacizumab|bevacizumab|mesh-list
83377105|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83377106|NCT01525082|Capecitabine|capecitabine|mesh-list
83377107|NCT01525082|Temozolomide|temozolomide|mesh-list
83377108|NCT01525082|Antibodies|antibodies|mesh-list
83377109|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
83377110|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83377111|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377112|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83377113|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83377114|NCT01525082|Growth Substances|growth substances|mesh-ancestor
83377115|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377116|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
83377117|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
83377118|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83377119|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
83377120|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377121|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83377122|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
83377123|NCT03599791|Fluticasone|fluticasone|mesh-list
83377124|NCT03599791|Xhance|xhance|mesh-list
83377125|NCT03599791|Azelastine|azelastine|mesh-list
83377126|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377127|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83377128|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
83377129|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377130|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377131|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83377132|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
83377133|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
83377134|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83377135|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
83377136|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377137|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377138|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
83377139|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83377140|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
83377141|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
83377142|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377143|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
83377144|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
83377145|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83377146|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
83377147|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377148|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377149|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377150|NCT01488578|Urological Agents|urological agents|mesh-ancestor
83377151|NCT00720369|Ubiquinone|ubiquinone|mesh-list
83377152|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
83377153|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
83377154|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377155|NCT00720369|Vitamins|vitamins|mesh-ancestor
83377156|NCT01524770|Dulaglutide|dulaglutide|mesh-list
83377157|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83377158|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377159|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
83377160|NCT04088864|Fludarabine|fludarabine|mesh-list
83377161|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83377162|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
83377163|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377164|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83377165|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83377166|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
83377167|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377168|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377169|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83377170|NCT02991339|Dexamethasone|dexamethasone|mesh-list
83377171|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
83377172|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
83377173|NCT02991339|BB 1101|bb 1101|mesh-list
83377174|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377175|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
83377176|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
83377177|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377178|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377179|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83377180|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
83377181|NCT02991339|Hormones|hormones|mesh-ancestor
83377182|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377183|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83377184|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377185|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
83377186|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377187|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377188|NCT04018105|Metformin|metformin|mesh-list
83377189|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83377190|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377191|NCT05632549|Biotin|biotin|mesh-list
83377192|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
83377193|NCT05632549|Vitamins|vitamins|mesh-ancestor
83377194|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
83377195|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377196|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
83377197|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
83377198|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
83377199|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83377200|NCT03597997|Propofol|propofol|mesh-list
83377201|NCT03597997|Sevoflurane|sevoflurane|mesh-list
83377202|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83377203|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377204|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377205|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
83377206|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
83377207|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
83377208|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83377209|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83377210|NCT01277835|Lidocaine|lidocaine|mesh-list
83377211|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
83377212|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
83377213|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377214|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377215|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
83377216|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377217|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83377218|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83377219|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83377220|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377221|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377222|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
83377224|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83377225|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
83377226|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377227|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377228|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83377229|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
83377230|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
83377231|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83377232|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
83377233|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377234|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377235|NCT05632159|Anesthetics|anesthetics|mesh-list
83377236|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377237|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377238|NCT04017013|Lidocaine|lidocaine|mesh-list
83377239|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
83377240|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
83377241|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377242|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377243|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
83377244|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377245|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83377246|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83377247|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83377248|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377249|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377250|NCT01277913|Vitamin D|vitamin d|mesh-list
83377251|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
83377252|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
83377253|NCT01277913|Vitamins|vitamins|mesh-list
83377254|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
83377255|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377256|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83377257|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83377258|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
83377259|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83377260|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83377261|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377262|NCT00729807|Pentamidine|pentamidine|mesh-list
83377263|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
83377264|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377265|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83377266|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83377267|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
83377268|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83377269|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83377270|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377271|NCT03592693|Vitamins|vitamins|mesh-list
83377272|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
83377273|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
83377274|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377275|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377276|NCT00730353|Paclitaxel|paclitaxel|mesh-list
83377277|NCT00730353|Sunitinib|sunitinib|mesh-list
83377278|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83377279|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377280|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
83377281|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
83377282|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
83377283|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377284|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83377285|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83377286|NCT00730353|Growth Substances|growth substances|mesh-ancestor
83377287|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377288|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
83377289|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83377290|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377291|NCT01272531|Valproic Acid|valproic acid|mesh-list
83377292|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
83377293|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
83377294|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377295|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377296|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
83377297|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377298|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377299|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
83377300|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
83377301|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377302|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83377303|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
83377304|NCT01272609|Timolol|timolol|mesh-list
83377305|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83377306|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83377307|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
83377308|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377309|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377310|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377311|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83377312|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83377313|NCT03595189|Cilastatin|cilastatin|mesh-list
83377314|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
83377315|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377316|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377317|NCT01410227|Factor VIII|factor viii|mesh-list
83377318|NCT01410227|Coagulants|coagulants|mesh-ancestor
83377319|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
83377320|NCT04007029|Fludarabine|fludarabine|mesh-list
83377321|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
83377322|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
83377323|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
83377324|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83377325|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
83377326|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377327|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83377328|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83377329|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
83377330|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377331|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377332|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83377333|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83377334|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
83377335|NCT01274559|Niacin|niacin|mesh-list
83377336|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83377337|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
83377338|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377339|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83377340|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
83377341|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
83377342|NCT01274559|Vitamins|vitamins|mesh-ancestor
83377343|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
83377344|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377345|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
83377346|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
83377347|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83377348|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83377349|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377350|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377351|NCT01409993|Urological Agents|urological agents|mesh-ancestor
83377352|NCT01409915|Molgramostim|molgramostim|mesh-list
83377353|NCT01409915|Sargramostim|sargramostim|mesh-list
83377354|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
83377355|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377356|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377357|NCT01272921|Bupivacaine|bupivacaine|mesh-list
83377358|NCT01272921|Ropivacaine|ropivacaine|mesh-list
83377359|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
83377360|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
83377361|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377362|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377363|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
83377364|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377365|NCT01409837|Lisinopril|lisinopril|mesh-list
83377366|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83377367|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
83377368|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377369|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377370|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83377371|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83377372|NCT01409837|Protective Agents|protective agents|mesh-ancestor
83377373|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377374|NCT01278459|Atorvastatin|atorvastatin|mesh-list
83377375|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
83377376|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83377377|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
83377378|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377379|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83377380|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
83377381|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377382|NCT00731055|Varenicline|varenicline|mesh-list
83377383|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
83377384|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
83377385|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
83377386|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377387|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377388|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377389|NCT03594565|Fluticasone|fluticasone|mesh-list
83377390|NCT03594565|Xhance|xhance|mesh-list
83377391|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377392|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83377393|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
83377394|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377395|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377396|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83377397|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
83377398|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
83377399|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83377400|NCT01430585|Letrozole|letrozole|mesh-list
83377401|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377402|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
83377403|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83377404|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377405|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377406|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83377407|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
83377408|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377409|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377410|NCT04005859|Lidocaine|lidocaine|mesh-list
83377411|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
83377412|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
83377413|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377414|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377415|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
83377416|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377417|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83377418|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83377419|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83377420|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377421|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377422|NCT05633719|Carboplatin|carboplatin|mesh-list
83377423|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377424|NCT01408901|Molgramostim|molgramostim|mesh-list
83377425|NCT01408901|Sargramostim|sargramostim|mesh-list
83377426|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
83377427|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377428|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377429|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
83377430|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
83377431|NCT02080195|Fludarabine|fludarabine|mesh-list
83377432|NCT02080195|Tacrolimus|tacrolimus|mesh-list
83377433|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
83377434|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
83377435|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83377436|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
83377437|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377438|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83377439|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83377440|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
83377441|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377442|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377443|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83377444|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
83377445|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377446|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83377447|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83377448|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
83377449|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83377450|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377451|NCT04044131|Sorbitol|sorbitol|mesh-list
83377452|NCT04044131|Cathartics|cathartics|mesh-ancestor
83377453|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83377454|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
83377455|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
83377456|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
83377457|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
83377458|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
83377459|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83377460|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377461|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
83377462|NCT01428713|Coagulants|coagulants|mesh-ancestor
83377463|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83377464|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377465|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83377466|NCT03976375|Docetaxel|docetaxel|mesh-list
83377467|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
83377468|NCT03976375|Lenvatinib|lenvatinib|mesh-list
83377469|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377470|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
83377471|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
83377472|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
83377473|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377474|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83377475|NCT03976375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83377476|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83377477|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377478|NCT01408043|Plerixafor|plerixafor|mesh-list
83377479|NCT01408043|Etoposide|etoposide|mesh-list
83377480|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
83377481|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83377482|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377483|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83377484|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83377485|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377486|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377487|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
83377488|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
83377489|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
83377490|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377491|NCT00219349|Escitalopram|escitalopram|mesh-list
83377492|NCT00219349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83377493|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83377494|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377495|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377496|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377497|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
83377498|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377499|NCT00218257|Progesterone|progesterone|mesh-list
83377500|NCT00218257|Progestins|progestins|mesh-ancestor
83377501|NCT00218257|Hormones|hormones|mesh-ancestor
83377502|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377503|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377504|NCT01523366|Clopidogrel|clopidogrel|mesh-list
83377505|NCT01523366|Ticagrelor|ticagrelor|mesh-list
83377506|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
83377507|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
83377508|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
83377509|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83377510|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
83377511|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377512|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377513|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377514|NCT03024697|Anesthetics|anesthetics|mesh-list
83377515|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
83377516|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377517|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377518|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
83377519|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377520|NCT01427933|Ramucirumab|ramucirumab|mesh-list
83377521|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377522|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
83377523|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377524|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
83377525|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
83377526|NCT03780127|Fenfluramine|fenfluramine|mesh-list
83377527|NCT03780127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83377528|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83377529|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377530|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377531|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377532|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
83377533|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377534|NCT01406873|Mexiletine|mexiletine|mesh-list
83377535|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83377536|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83377537|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83377538|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377539|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377540|NCT01406795|Heparin|heparin|mesh-list
83377541|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
83377542|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
83377543|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
83377544|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377545|NCT01406015|Spironolactone|spironolactone|mesh-list
83377546|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
83377547|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
83377548|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377549|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377550|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
83377551|NCT01406015|Diuretics|diuretics|mesh-ancestor
83377552|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
83377553|NCT00215137|Escitalopram|escitalopram|mesh-list
83377554|NCT00215137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
83377555|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83377556|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377557|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377558|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377559|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
83377560|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377561|NCT04406779|Hormones|hormones|mesh-list
83377562|NCT04406779|Autoantibodies|autoantibodies|mesh-list
83377563|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377564|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377565|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
83377566|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
83377567|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377568|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377569|NCT03598075|Pramlintide|pramlintide|mesh-list
83377570|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83377571|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377572|NCT03984097|Dexamethasone|dexamethasone|mesh-list
83377573|NCT03984097|Lenalidomide|lenalidomide|mesh-list
83377574|NCT03984097|Bortezomib|bortezomib|mesh-list
83377575|NCT03984097|Pomalidomide|pomalidomide|mesh-list
83377576|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377577|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
83377578|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
83377579|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377580|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377581|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83377582|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
83377583|NCT03984097|Hormones|hormones|mesh-ancestor
83377584|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377585|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83377586|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377587|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
83377588|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83377589|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83377590|NCT03984097|Growth Substances|growth substances|mesh-ancestor
83377591|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
83377592|NCT03597919|Vaccines|vaccines|mesh-list
83377593|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
83377594|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377595|NCT04001413|Durvalumab|durvalumab|mesh-list
83377596|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83377597|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377598|NCT01677858|Dexamethasone|dexamethasone|mesh-list
83377599|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377600|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
83377601|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
83377602|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377603|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377604|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83377605|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
83377606|NCT01677858|Hormones|hormones|mesh-ancestor
83377607|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377608|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83377609|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377610|NCT03027284|Gemcitabine|gemcitabine|mesh-list
83377611|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377612|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83377613|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
83377614|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377615|NCT03592069|Amoxicillin|amoxicillin|mesh-list
83377616|NCT03592069|Metronidazole|metronidazole|mesh-list
83377617|NCT03592069|Clarithromycin|clarithromycin|mesh-list
83377618|NCT03592069|Esomeprazole|esomeprazole|mesh-list
83377619|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83377620|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377621|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83377622|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83377623|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83377624|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83377625|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83377626|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377627|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377628|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83377629|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83377630|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83377631|NCT03591991|Empagliflozin|empagliflozin|mesh-list
83377632|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83377633|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377634|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83377635|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377636|NCT03591913|Misoprostol|misoprostol|mesh-list
83377637|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83377638|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
83377639|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83377640|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377641|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83377642|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83377643|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
83377644|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
83377645|NCT04198129|Amoxicillin|amoxicillin|mesh-list
83377646|NCT04198129|Clindamycin|clindamycin|mesh-list
83377647|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
83377648|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
83377649|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
83377650|NCT04198129|Ampicillin|ampicillin|mesh-list
83377651|NCT04198129|Sultamicillin|sultamicillin|mesh-list
83377652|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
83377653|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377654|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
83377655|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83377656|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377657|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377658|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
83377659|NCT03591757|Tolcapone|tolcapone|mesh-list
83377660|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
83377661|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
83377662|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
83377663|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377664|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377665|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
83377666|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
83377667|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
83377668|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
83377669|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83377670|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377671|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
83377672|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
83377673|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83377674|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
83377675|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377676|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
83377677|NCT04438434|Protective Agents|protective agents|mesh-ancestor
83377678|NCT03591679|Oxytocin|oxytocin|mesh-list
83377679|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
83377680|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83377681|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377682|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
83377683|NCT04064814|Flunarizine|flunarizine|mesh-list
83377684|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
83377685|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377686|NCT04064814|Protective Agents|protective agents|mesh-ancestor
83377687|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377688|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
83377689|NCT04064814|Vitamins|vitamins|mesh-ancestor
83377690|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
83377691|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
83377692|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
83377693|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377694|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
83377695|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
83377696|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
83377697|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
83377698|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377699|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
83377700|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83377701|NCT04197817|Antibodies|antibodies|mesh-list
83377702|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
83377703|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83377704|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
83377705|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377706|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377707|NCT04585854|Caffeine|caffeine|mesh-list
83377708|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83377709|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377710|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83377711|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377712|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377713|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
83377714|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
83377715|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
83377716|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377717|NCT03481842|Axitinib|axitinib|mesh-list
83377718|NCT03481842|Afatinib|afatinib|mesh-list
83377719|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377720|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83377721|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83389733|NCT03402087|Vitamins|vitamins|mesh-ancestor
83377722|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377723|NCT04197739|Amikacin|amikacin|mesh-list
83377724|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83377725|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377726|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
83377727|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
83377728|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377729|NCT04197349|Sumatriptan|sumatriptan|mesh-list
83377730|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83377731|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
83377732|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83377733|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
83377734|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377735|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377736|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377737|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
83377738|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
83377739|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
83377740|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377741|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
83377742|NCT03422094|Nivolumab|nivolumab|mesh-list
83377743|NCT03422094|Ipilimumab|ipilimumab|mesh-list
83377744|NCT03422094|Poly ICLC|poly iclc|mesh-list
83377745|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83377746|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377747|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83377748|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377749|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
83377750|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
83377751|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377752|NCT04356534|Antibodies|antibodies|mesh-list
83377753|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
83377754|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377755|NCT03591289|Bromides|bromides|mesh-list
83377756|NCT03591289|Rocuronium|rocuronium|mesh-list
83377757|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
83377758|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83377759|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83377760|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83377761|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377762|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377763|NCT05338866|Capecitabine|capecitabine|mesh-list
83377764|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83377765|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
83377766|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377767|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377768|NCT02471118|Adalimumab|adalimumab|mesh-list
83377769|NCT02471118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
83377770|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377771|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83377772|NCT04197115|Vitamins|vitamins|mesh-list
83377773|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
83377774|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
83377775|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
83377776|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
83377777|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
83377778|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
83377779|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
83377780|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377781|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377782|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
83377783|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377784|NCT04197115|Protective Agents|protective agents|mesh-ancestor
83377785|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
83377786|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83377787|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
83377788|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377789|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377790|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83377791|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
83377792|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
83377793|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
83377794|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
83377795|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83389734|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
83377796|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377797|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
83377798|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83377800|NCT03590587|Hormones|hormones|mesh-ancestor
83377801|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377802|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377803|NCT03590431|Iodine|iodine|mesh-list
83377804|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
83377805|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83377806|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377807|NCT03590431|Trace Elements|trace elements|mesh-ancestor
83377808|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
83377809|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377810|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
83377811|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377812|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
83377813|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
83377814|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377815|NCT05102448|Methotrexate|methotrexate|mesh-list
83377816|NCT05102448|Tofacitinib|tofacitinib|mesh-list
83377817|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
83377818|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
83377819|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83377820|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377821|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83377822|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
83377823|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377824|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377825|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
83377826|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377827|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83377828|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83377829|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
83377830|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83377831|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83377832|NCT05102448|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
83377833|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83377834|NCT03599323|Clotrimazole|clotrimazole|mesh-list
83377835|NCT03599323|Miconazole|miconazole|mesh-list
83377836|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83377837|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83377838|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
83377839|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
83377840|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83377841|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377842|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377843|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83377844|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
83377845|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377846|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377847|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
83377848|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83377849|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
83377850|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83377851|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
83377852|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377853|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377854|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83377855|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
83377856|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
83377857|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83377858|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83377859|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
83377860|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377861|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377862|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
83377863|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
83377864|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377865|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377866|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83377867|NCT05102058|Analgesics|analgesics|mesh-ancestor
83377868|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
83377869|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377870|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83377871|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83377872|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83377873|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
83377874|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377875|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377876|NCT03956797|Anesthetics|anesthetics|mesh-list
83377877|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377878|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377879|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
83377880|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
83377881|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
83377882|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
83377883|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377884|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377885|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
83377886|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377887|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377888|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83377889|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377890|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
83377891|NCT04195243|Empagliflozin|empagliflozin|mesh-list
83377892|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
83377893|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377894|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83377895|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377896|NCT04195321|Phenylephrine|phenylephrine|mesh-list
83377897|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
83377898|NCT04195321|Norepinephrine|norepinephrine|mesh-list
83377899|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83377900|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
83377901|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
83377902|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377903|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377904|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
83377905|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83377906|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
83377907|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
83377908|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83377909|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83377910|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83377911|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
83377912|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377913|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377914|NCT04195321|Protective Agents|protective agents|mesh-ancestor
83377915|NCT03965845|Palbociclib|palbociclib|mesh-list
83377916|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377917|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83377918|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377919|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377920|NCT04766359|Paclitaxel|paclitaxel|mesh-list
83377921|NCT04766359|Cisplatin|cisplatin|mesh-list
83377922|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
83377923|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83377924|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377925|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
83377926|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
83377927|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
83377928|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377929|NCT04020601|Ropivacaine|ropivacaine|mesh-list
83377930|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
83377931|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
83377932|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83377933|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377934|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
83377935|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377936|NCT03964051|Omalizumab|omalizumab|mesh-list
83377937|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
83377938|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83377939|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
83377940|NCT03973489|Methamphetamine|methamphetamine|mesh-list
83377941|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
83377942|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377943|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
83377944|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
83377945|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83377946|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
83377947|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83377948|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377949|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
83377950|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
83377951|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
83377952|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83377953|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
83377954|NCT04193137|Captopril|captopril|mesh-list
83377955|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
83377956|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
83377957|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377958|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377959|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83377960|NCT05060484|Vaccines|vaccines|mesh-list
83377961|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
83377962|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377963|NCT04193059|Paclitaxel|paclitaxel|mesh-list
83377964|NCT04193059|Docetaxel|docetaxel|mesh-list
83377965|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
83377966|NCT04193059|Carboplatin|carboplatin|mesh-list
83377967|NCT04193059|Trastuzumab|trastuzumab|mesh-list
83377968|NCT04193059|Epirubicin|epirubicin|mesh-list
83377969|NCT04193059|Pertuzumab|pertuzumab|mesh-list
83377970|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83377971|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377972|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
83377973|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
83377974|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
83377975|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377976|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83377977|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
83377978|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377979|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83377980|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83377981|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
83377982|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83377983|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83377984|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83377985|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83377986|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83377987|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377988|NCT03962647|Letrozole|letrozole|mesh-list
83377989|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83377991|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
83377992|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83377993|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83377994|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
83377995|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
83377996|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83377997|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83377998|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
83377999|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378000|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
83378001|NCT05092074|Velpatasvir|velpatasvir|mesh-list
83378002|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
83378003|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378004|NCT02080273|Listerine|listerine|mesh-list
83378005|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
83378006|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
83378007|NCT02080273|Protective Agents|protective agents|mesh-ancestor
83378008|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378009|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
83378010|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378011|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
83378012|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
83378013|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
83378014|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
83378015|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378016|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378017|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83378019|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
83378020|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378021|NCT04616274|Venetoclax|venetoclax|mesh-list
83378022|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378023|NCT04613622|Venetoclax|venetoclax|mesh-list
83378024|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378025|NCT04515186|Miltefosine|miltefosine|mesh-list
83378026|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
83378027|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
83378028|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378029|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378030|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
83378031|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
83378032|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
83378033|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
83378034|NCT05096676|Oxytocin|oxytocin|mesh-list
83378035|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
83378036|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83378037|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378038|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
83378039|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83378040|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378041|NCT03948763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
83378042|NCT03948763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378043|NCT05096520|Lidocaine|lidocaine|mesh-list
83378044|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
83378045|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
83378046|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378047|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378048|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
83378049|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378050|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83378051|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
83378052|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
83378053|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
83378054|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378056|NCT03832465|Ofloxacin|ofloxacin|mesh-list
83378057|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83378058|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83378059|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378060|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83378061|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83378062|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83378063|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378064|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378065|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378066|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83378067|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83378068|NCT04190173|Prucalopride|prucalopride|mesh-list
83378069|NCT04190173|Laxatives|laxatives|mesh-ancestor
83378070|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378071|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
83378072|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
83378073|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
83378074|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378075|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378076|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378077|NCT01272219|Liraglutide|liraglutide|mesh-list
83378078|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83378079|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378080|NCT01272219|Incretins|incretins|mesh-ancestor
83378081|NCT01272219|Hormones|hormones|mesh-ancestor
83378082|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378083|NCT04198363|Amoxicillin|amoxicillin|mesh-list
83378084|NCT04198363|Clarithromycin|clarithromycin|mesh-list
83378085|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
83378086|NCT04198363|Esomeprazole|esomeprazole|mesh-list
83378087|NCT04198363|Bismuth|bismuth|mesh-list
83378088|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378089|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83378090|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378091|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83378092|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378093|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83378094|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378095|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83378096|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
83378097|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83378098|NCT04198363|Antacids|antacids|mesh-ancestor
83378099|NCT04198363|Diuretics|diuretics|mesh-ancestor
83378100|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
83378101|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378102|NCT04198363|Expectorants|expectorants|mesh-ancestor
83378103|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378104|NCT05228496|Tislelizumab|tislelizumab|mesh-list
83378105|NCT05228496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83378106|NCT05228496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378107|NCT04020133|Epinephrine|epinephrine|mesh-list
83378108|NCT04020133|Bupivacaine|bupivacaine|mesh-list
83378109|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
83378110|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
83378111|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
83378112|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378113|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
83378114|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378115|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83378116|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83378117|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378118|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378119|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378120|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
83378121|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83378122|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
83378123|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83378124|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378125|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
83378126|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
83378127|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83378128|NCT04565574|Rifampin|rifampin|mesh-list
83378129|NCT04565574|Rabeprazole|rabeprazole|mesh-list
83378130|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
83378131|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378132|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
83378133|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378134|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378135|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
83378136|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
83378137|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83378138|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378139|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
83378140|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
83378141|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
83378142|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
83378143|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
83378144|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
83378145|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
83378146|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
83378147|NCT01270971|Tavaborole|tavaborole|mesh-list
83378148|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83378149|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
83378150|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378151|NCT04026841|Antibodies|antibodies|mesh-list
83378152|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
83378153|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378154|NCT04128774|Dexamethasone|dexamethasone|mesh-list
83378155|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
83378156|NCT04128774|BB 1101|bb 1101|mesh-list
83378157|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378158|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
83378159|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
83378160|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378161|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378162|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378163|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
83378164|NCT04128774|Hormones|hormones|mesh-ancestor
83378165|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378166|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83378167|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378168|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
83378169|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378170|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378171|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
83378172|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
83378173|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
83378174|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378175|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
83378176|NCT00732225|Protective Agents|protective agents|mesh-ancestor
83378177|NCT04194775|Lenvatinib|lenvatinib|mesh-list
83378178|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378179|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
83378180|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378181|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378182|NCT04026685|Phenylephrine|phenylephrine|mesh-list
83378183|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
83378184|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83378185|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
83378186|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
83378187|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378188|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378189|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
83378190|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83378191|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
83378192|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378193|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83378194|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83378195|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83378196|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378197|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378198|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378199|NCT04026685|Protective Agents|protective agents|mesh-ancestor
83378200|NCT00751179|Bromides|bromides|mesh-list
83378201|NCT00751179|Rocuronium|rocuronium|mesh-list
83378202|NCT00751179|Succinylcholine|succinylcholine|mesh-list
83378203|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
83378204|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83378205|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83378206|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83378207|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378208|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378209|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
83378210|NCT01273233|Vaccines|vaccines|mesh-list
83378211|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
83378212|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378213|NCT01277211|NuvaRing|nuvaring|mesh-list
83378214|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83378215|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
83378216|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83378217|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378218|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
83378219|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
83378220|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
83378221|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378222|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378223|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
83378224|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378225|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83378226|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
83378227|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378228|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378229|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
83378230|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
83378231|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
83378232|NCT04022161|Protective Agents|protective agents|mesh-ancestor
83378233|NCT01676220|Insulin|insulin|mesh-list
83378234|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
83378235|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
83378236|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83378237|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378238|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
83378239|NCT01275105|Phenylephrine|phenylephrine|mesh-list
83378240|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
83378241|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83378242|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
83378243|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
83378244|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
83378245|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378246|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378247|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378248|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378249|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
83378250|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
83378251|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378252|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
83378253|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
83378254|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
83378255|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
83378256|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
83378257|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
83378258|NCT01275105|Protective Agents|protective agents|mesh-ancestor
83378259|NCT01270347|Levofloxacin|levofloxacin|mesh-list
83378260|NCT01270347|Ofloxacin|ofloxacin|mesh-list
83378261|NCT01270347|Tobramycin|tobramycin|mesh-list
83378262|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83378263|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
83378264|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378265|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
83378266|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83378267|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83378268|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378269|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378270|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378271|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
83378272|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
83378273|NCT03608436|Bromides|bromides|mesh-list
83378274|NCT03608436|Rocuronium|rocuronium|mesh-list
83378275|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
83378276|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
83378277|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
83378278|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
83378279|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378280|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378281|NCT04025671|Naloxone|naloxone|mesh-list
83378282|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
83378283|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378284|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
83378285|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378286|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
83378287|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
83378288|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378289|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
83378290|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378291|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378292|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
83378293|NCT03412188|Hormones|hormones|mesh-ancestor
83378294|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378295|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
83378296|NCT03412188|Protective Agents|protective agents|mesh-ancestor
83378297|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83378298|NCT01278849|Vadimezan|vadimezan|mesh-list
83378299|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378300|NCT04949412|Vitamin D|vitamin d|mesh-list
83378301|NCT04949412|Vitamins|vitamins|mesh-ancestor
83378302|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
83378303|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378304|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
83378305|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
83378306|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
83378307|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83378308|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
83378309|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378310|NCT01485614|Metformin|metformin|mesh-list
83378311|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
83378312|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
83378313|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378314|NCT01485614|Incretins|incretins|mesh-ancestor
83378315|NCT01485614|Hormones|hormones|mesh-ancestor
83378316|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378317|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
83378318|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
83378319|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378320|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378321|NCT00722553|Vitamins|vitamins|mesh-list
83378322|NCT00722553|Folic Acid|folic acid|mesh-list
83378323|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
83378324|NCT00722553|Hydroxocobalamin|hydroxocobalamin|mesh-list
83378325|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
83378326|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
83378327|NCT00722553|Aminopterin|aminopterin|mesh-list
83378328|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
83378329|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378330|NCT00722553|Hematinics|hematinics|mesh-ancestor
83378331|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
83378332|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378333|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378334|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378335|NCT03022747|Allopurinol|allopurinol|mesh-list
83378336|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
83378337|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378338|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378339|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
83378340|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378341|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
83378342|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
83378343|NCT03022747|Protective Agents|protective agents|mesh-ancestor
83378344|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378345|NCT03928015|Analgesics|analgesics|mesh-list
83378346|NCT03928015|Dronabinol|dronabinol|mesh-list
83378347|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
83378348|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378349|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378350|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
83378351|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
83378352|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
83378353|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
83378354|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
83378355|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378356|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378357|NCT03928015|Hormones|hormones|mesh-ancestor
83378358|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378359|NCT00735969|Ribavirin|ribavirin|mesh-list
83378360|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
83378361|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378362|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
83378363|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378364|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
83378365|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378366|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
83378367|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
83378368|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
83378369|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378370|NCT03229512|Urological Agents|urological agents|mesh-ancestor
83378371|NCT01279083|Timolol|timolol|mesh-list
83378372|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
83378373|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378374|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
83378375|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
83378376|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
83378377|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378378|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378379|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
83378380|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
83378381|NCT03022201|Domperidone|domperidone|mesh-list
83378382|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
83378383|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
83378384|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
83378385|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378386|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
83378387|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
83378388|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
83378389|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378390|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378391|NCT04716114|Cytarabine|cytarabine|mesh-list
83378392|NCT04716114|Fludarabine|fludarabine|mesh-list
83378393|NCT04716114|Azacitidine|azacitidine|mesh-list
83378394|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
83378395|NCT04716114|Aclarubicin|aclarubicin|mesh-list
83378396|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378397|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83378398|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
83378399|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378400|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83378401|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
83378402|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378403|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
83378404|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
83378405|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378406|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83378407|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
83378408|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83378409|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83378410|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83378411|NCT00752973|Malathion|malathion|mesh-list
83378412|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
83378413|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378414|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378415|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
83378416|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
83378417|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378418|NCT04025593|Prednisone|prednisone|mesh-list
83378419|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
83378420|NCT04025593|Rituximab|rituximab|mesh-list
83378421|NCT04025593|Doxorubicin|doxorubicin|mesh-list
83378422|NCT04025593|Vincristine|vincristine|mesh-list
83378423|NCT04025593|Lenalidomide|lenalidomide|mesh-list
83378424|NCT04025593|Decitabine|decitabine|mesh-list
83378425|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83378426|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
83378427|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378428|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378429|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83378430|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
83378431|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378432|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378433|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83378434|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
83378435|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83378436|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83378437|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83378438|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378439|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378440|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
83378441|NCT04025593|Hormones|hormones|mesh-ancestor
83378442|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378443|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83378444|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83378445|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
83378446|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
83378447|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
83378448|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
83378449|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
83378450|NCT04025593|Growth Substances|growth substances|mesh-ancestor
83378451|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
83378452|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
83378453|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
83378454|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
83378455|NCT01279707|Epratuzumab|epratuzumab|mesh-list
83378456|NCT01279707|Veltuzumab|veltuzumab|mesh-list
83378457|NCT01279707|Antibodies|antibodies|mesh-list
83378458|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
83378459|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
83378460|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
83378461|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378462|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378463|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
83378464|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
83378465|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
83378466|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
83378467|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378468|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
83378469|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
83378470|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
83378471|NCT02595060|Molgramostim|molgramostim|mesh-list
83378472|NCT02595060|Sargramostim|sargramostim|mesh-list
83378473|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378474|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
83378475|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378476|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
83378477|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378478|NCT03023124|Doxorubicin|doxorubicin|mesh-list
83378479|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
83378480|NCT03023124|Dacarbazine|dacarbazine|mesh-list
83378481|NCT03023124|Trabectedin|trabectedin|mesh-list
83378482|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83378483|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378484|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83378485|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83378486|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378487|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378488|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83378489|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
83378490|NCT03022123|Prednisone|prednisone|mesh-list
83378491|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
83378492|NCT03022123|Doxorubicin|doxorubicin|mesh-list
83378493|NCT03022123|Vincristine|vincristine|mesh-list
83378494|NCT03022123|Epirubicin|epirubicin|mesh-list
83378495|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
83378496|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
83378497|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
83378498|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
83378499|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
83378500|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
83378501|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
83378502|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
83378503|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
83378504|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
83378505|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
83378506|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
83378507|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
83378508|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
83378509|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
83378510|NCT03022123|Hormones|hormones|mesh-ancestor
83378511|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
83378512|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
83378513|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
83378514|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
83378515|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
83378516|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor